Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" A3GALT2 "A3GALT2P, IGB3S, IGBS3S" ENSG00000184389 "Alpha 1,3-galactosyltransferase 2" U3KPV4 1 33306766-33321098 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "neutrophil: 2.1" "Lineage enriched" "Detected in single" 15 "granulocytes: 2.1" "Group enriched" "Detected in some" 4 "HeLa: 5.2;SiHa: 3.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (1.86e-2)" "unprognostic (2.36e-2)" "unprognostic (2.39e-1)" "unprognostic (1.18e-1)" "unprognostic (2.61e-3)" "unprognostic (4.96e-2)" "unprognostic (6.83e-2)" "unprognostic (5.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.89e-1)" "unprognostic (4.90e-8)" "unprognostic (1.17e-1)" "unprognostic (1.12e-2)" "unprognostic (7.87e-2)" 0.7 0.1 0.1 1.2 0.2 1.3 0.4 1.3 0.9 0.4 0.2 0.0 0.5 0.0 0.2 0.2 1.4 0.1 0.2 0.1 0.4 0.1 0.5 0.1 0.0 0.4 0.1 0.0 0.4 0.1 0.6 0.0 0.2 0.4 0.2 0.1 0.1 0.2 0.2 0.8 0.3 2.1 0.4 0.0 0.2 0.1 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.3 5.2 0.0 0.2 0.0 0.0 0.7 0.2 0.2 0.6 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 A4GALT "A14GALT, Gb3S, P(k), P1" ENSG00000128274 "Alpha 1,4-galactosyltransferase (P blood group)" Q9NPC4 22 42692112-42721298 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "NK-cell: 1.4;plasmacytoid DC: 3.4" "Group enriched" "Detected in many" 13 "dendritic cells: 3.4;NK-cells: 1.4" "Cell line enhanced" "Detected in many" "ASC diff: 21.9;ASC TERT1: 17.9;RPTEC TERT1: 14.8;TIME: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001141 Uncertain Mitochondria NA NA Mitochondria "HPA001141: AB_1078139" "unprognostic (2.59e-2)" "prognostic favorable (2.48e-4)" "unprognostic (2.24e-2)" "unprognostic (4.54e-3)" "unprognostic (7.41e-2)" "unprognostic (1.53e-1)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-1)" "unprognostic (1.28e-1)" "unprognostic (4.82e-3)" "unprognostic (4.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (8.72e-2)" "unprognostic (3.46e-2)" "unprognostic (2.74e-1)" 22.7 5.9 3.5 8.2 3.7 3.8 15.3 1.4 3.8 21.2 12.0 2.3 32.6 4.8 13.0 16.9 15.0 11.7 11.0 26.8 2.3 1.3 30.0 4.4 14.0 6.4 2.9 3.0 11.8 3.4 1.4 7.7 12.6 2.9 15.4 2.1 9.9 15.4 39.8 12.5 8.7 7.0 18.6 5.3 11.4 11.3 6.7 2.4 1.3 10.7 13.0 10.1 16.1 25.6 0.1 3.4 0.0 0.0 1.4 0.0 0.0 0.6 7.4 0.0 0.0 21.9 17.9 11.2 2.9 3.2 0.6 1.1 2.3 1.2 7.2 5.2 5.2 3.8 0.7 7.1 3.5 0.1 0.0 1.4 0.1 11.8 0.2 6.6 0.0 0.5 10.5 1.0 3.1 0.5 1.0 2.6 0.0 0.0 0.0 2.8 10.1 0.0 0.0 0.9 0.5 1.8 0.0 1.7 0.7 14.8 12.7 0.1 0.0 9.1 0.2 0.0 1.4 5.8 0.8 15.7 0.0 1.4 13.4 3.8 1.5 6.8 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.4 0.0 0.0 3.5 3.7 1.4 3.8 2.3 1.3 2.9 3.0 2.9 2.4 0.0 0.3 1.4 28.5 8.1 0.0 14.6 2.5 2.7 9.1 17.4 0.0 36.7 11.6 18.0 0.4 40.9 0.0 23.3 1.0 26.1 24.9 31.4 1.1 0.2 4.8 0.0 0.0 22.1 1.8 1.5 42.8 5.4 6.8 52.3 0.0 0.5 3.7 0.0 28.3 45.6 0.4 38.8 39.6 0.4 0.4 7.8 7.9 1.0 0.0 69.8 A4GNT alpha4GnT ENSG00000118017 Alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3 3 138123718-138132387 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "gallbladder: 25.9;pancreas: 7.0;stomach 1: 25.0" "Cell type enriched" "Detected in single" 9 "Cholangiocytes: 2.5" "Group enriched" "Detected in some" 6 "pancreatic cancer: 2.5;stomach cancer: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.6;BJ: 3.7;hTERT-RPE1: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA008017 Enhanced "Intracellular and membrane" NA NA "HPA008017: AB_1078073" "unprognostic (1.21e-1)" "unprognostic (2.52e-1)" "unprognostic (2.14e-1)" "unprognostic (1.18e-2)" "unprognostic (1.48e-2)" "unprognostic (8.79e-2)" "unprognostic (9.35e-2)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (1.85e-1)" "unprognostic (4.03e-2)" "unprognostic (1.03e-1)" "unprognostic (7.79e-2)" "unprognostic (2.55e-2)" "unprognostic (6.48e-3)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 2.5 0.1 0.1 0.1 0.1 25.9 0.1 0.1 0.1 1.5 0.4 0.3 0.1 0.1 0.1 0.2 7.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 25.0 0.1 0.1 0.1 0.3 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 2.6 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.6 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AADAC "CES5A1, DAC" ENSG00000114771 "Arylacetamide deacetylase" P22760 3 151814037-151828488 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 66.2;intestine: 81.7;liver: 123.1" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 610.4" "Cancer enriched" "Detected in many" 22 "liver cancer: 153.4" "Region enriched" "Detected in single" 7 "basal ganglia: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 11.9;ASC diff: 4.5;EFO-21: 6.4;HBEC3-KT: 5.7" "Not detected" "Not detected" HPA002911 Approved NA NA "HPA002911: AB_1078074" "unprognostic (1.26e-1)" "unprognostic (1.82e-2)" "unprognostic (8.11e-2)" "unprognostic (4.41e-2)" "unprognostic (9.23e-2)" "unprognostic (7.82e-2)" "unprognostic (2.15e-1)" "unprognostic (9.89e-2)" "prognostic favorable (5.58e-6)" "prognostic unfavorable (5.02e-4)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.22e-1)" "unprognostic (1.27e-1)" 3.9 66.2 0.1 0.1 1.6 0.0 2.1 0.1 0.1 0.1 26.1 0.5 0.4 29.6 0.1 0.3 0.3 0.2 4.3 0.2 0.1 0.0 0.1 123.1 1.7 0.1 0.1 0.1 0.1 22.7 0.0 0.1 1.7 0.2 0.3 0.0 0.1 0.3 0.1 0.2 1.7 81.7 0.1 0.1 0.1 7.3 0.3 0.1 0.1 0.2 4.8 1.3 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 4.5 0.2 0.3 0.0 0.0 0.1 0.0 1.1 0.1 0.2 6.4 0.0 0.1 0.4 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.7 0.1 0.1 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.3 0.2 1.4 0.3 0.2 0.4 2.1 0.0 2.3 0.2 1.9 0.3 0.1 0.0 0.0 0.0 0.0 2.5 0.0 2.4 1.4 0.0 0.4 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 11.0 0.0 0.0 0.2 0.0 1.1 58.6 4.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.2 0.0 0.0 610.4 0.2 0.0 0.0 3.7 10.8 0.0 0.0 0.0 3.3 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.2 0.0 0.0 0.1 AADACL3 ENSG00000188984 "Arylacetamide deacetylase like 3" Q5VUY0 1 12716115-12728759 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "placenta: 13.4;skin 1: 4.7" "Cell type enhanced" "Detected in single" 35 "Extravillous trophoblasts: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.01e-1)" "unprognostic (2.54e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AADACL4 ENSG00000204518 "Arylacetamide deacetylase like 4" Q5VUY2 1 12644547-12667086 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "adipose tissue: 2.8;epididymis: 3.5;vagina: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 2.1;REH: 1.0" "Not detected" "Not detected" NA NA "unprognostic (3.20e-1)" "unprognostic (1.89e-2)" 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.4 3.5 0.0 0.7 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.7 1.1 0.0 0.0 1.4 0.2 0.0 0.0 0.5 0.0 0.6 0.4 1.4 0.0 0.0 0.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 AASDH "ACSF4, LYS2, NRPS998" ENSG00000157426 "Aminoadipate-semialdehyde dehydrogenase" Q4L235 4 56338287-56387508 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036472, HPA036473" Approved NA NA "HPA036472: AB_2675142, HPA036473: AB_10673656" "unprognostic (1.95e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (5.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (8.75e-2)" "unprognostic (1.29e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-3)" "unprognostic (1.59e-1)" "unprognostic (1.73e-1)" "unprognostic (4.52e-2)" "unprognostic (1.85e-3)" 9.4 13.5 12.0 7.4 15.4 6.8 14.5 28.9 15.6 10.7 8.0 10.2 12.5 7.5 11.7 14.6 10.3 12.3 7.5 7.9 12.8 7.5 11.5 10.7 8.0 9.8 12.9 13.3 15.3 8.1 16.8 28.9 8.4 14.5 11.4 10.1 11.0 11.3 9.9 9.4 12.4 8.6 9.9 12.4 9.4 8.9 8.2 16.0 12.0 12.4 6.9 11.0 11.1 11.0 5.2 3.9 2.5 4.2 4.4 7.7 2.4 5.0 3.4 9.0 6.9 13.8 16.0 5.6 6.4 7.8 6.7 5.8 3.9 10.6 11.0 6.0 7.0 5.0 3.3 6.5 6.5 7.5 4.4 6.5 5.2 6.0 5.0 12.3 9.4 3.9 9.2 10.8 7.1 10.6 9.6 10.2 7.2 11.8 5.7 7.6 5.0 11.0 7.9 5.1 9.3 5.1 8.3 4.5 5.1 9.6 4.3 6.1 5.9 7.3 11.8 7.3 9.0 9.3 6.1 6.9 4.4 6.1 4.7 4.6 4.6 3.5 7.2 7.1 8.6 4.8 0.0 3.6 2.5 5.1 4.2 6.9 4.3 5.2 4.4 3.9 5.2 7.7 5.6 0.7 4.4 2.7 3.3 4.9 2.4 12.0 15.4 28.9 15.6 12.8 7.5 12.9 13.3 14.5 16.0 6.0 11.5 17.9 12.2 9.0 36.1 9.5 12.7 8.1 14.8 17.4 25.5 33.7 21.6 8.3 9.3 11.3 8.0 23.3 6.7 16.2 13.2 11.6 19.7 17.4 13.4 33.4 11.6 18.4 19.3 3.0 15.5 14.6 10.1 10.0 13.8 29.8 5.9 16.5 17.0 17.7 52.0 6.5 8.3 26.5 22.6 13.7 20.0 13.1 14.2 6.3 ABCA1 "ABC1, HDLDT1, TGD" ENSG00000165029 "ATP binding cassette subfamily A member 1" O95477 9 104781002-104928237 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" Translocase "Atherosclerosis, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 98.3;Hepatocytes: 162.2;Kupffer cells: 103.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.6;neutrophil: 10.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.6" "Cell line enhanced" "Detected in many" "HSkMC: 17.0;U-87 MG: 39.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057283, CAB069889" Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB069889: AB_10002789, HPA057283: AB_2683396" "unprognostic (1.58e-2)" "unprognostic (2.54e-1)" "unprognostic (1.46e-1)" "unprognostic (2.80e-1)" "unprognostic (7.47e-3)" "unprognostic (1.85e-1)" "unprognostic (9.22e-2)" "unprognostic (9.80e-2)" "unprognostic (2.04e-1)" "unprognostic (7.28e-3)" "unprognostic (2.14e-1)" "unprognostic (4.78e-2)" "unprognostic (1.04e-2)" "unprognostic (2.00e-3)" "unprognostic (2.51e-2)" "unprognostic (6.71e-2)" "unprognostic (2.57e-1)" 25.7 38.1 6.3 9.8 13.1 15.8 23.0 2.3 8.5 8.2 14.8 8.0 6.5 4.4 7.8 9.6 7.0 7.9 13.6 10.7 7.5 3.7 7.1 33.3 12.7 29.4 18.9 2.3 8.7 5.4 1.8 3.3 20.1 10.2 9.4 9.4 7.7 6.3 8.7 21.3 12.1 8.1 25.2 16.1 12.8 7.3 8.8 8.0 16.9 5.8 2.2 5.0 16.4 20.0 1.8 0.2 11.6 1.5 0.1 0.6 0.1 0.0 2.7 2.2 0.0 6.5 2.5 2.0 2.8 10.9 0.9 1.0 0.4 0.4 3.8 3.1 2.8 10.7 0.0 1.2 0.1 0.8 0.0 0.0 0.4 0.9 9.5 11.8 0.0 6.7 17.0 0.7 11.1 0.2 10.6 1.0 0.3 0.0 9.8 0.2 0.3 2.3 5.2 3.1 0.5 0.8 0.0 0.0 0.2 1.8 1.8 0.3 0.1 2.9 0.5 0.6 4.5 0.0 1.9 1.0 3.0 0.2 3.9 3.1 3.8 1.8 2.3 39.0 0.0 0.0 2.2 0.8 11.6 0.2 1.0 0.2 1.2 0.3 0.0 0.2 1.8 0.6 0.0 10.6 0.1 1.5 0.1 0.1 0.1 6.3 13.1 2.3 4.0 7.5 3.7 18.9 2.3 10.2 8.0 98.3 9.4 5.1 4.8 26.4 11.9 7.8 12.7 2.7 9.1 10.4 45.2 21.2 0.0 3.8 1.5 9.3 3.2 0.0 1.4 4.6 28.8 3.1 46.1 162.2 63.2 0.0 8.7 25.2 103.3 0.7 28.7 31.4 25.3 2.8 2.4 0.1 4.9 3.5 26.5 17.0 5.5 45.3 16.4 1.2 0.7 16.9 7.4 4.4 2.3 8.9 ABCA10 EST698739 ENSG00000154263 "ATP binding cassette subfamily A member 10" Q8WWZ4 17 69147214-69244846 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 11.6" "Cell type enhanced" "Detected in many" 24 "Early spermatids: 189.3;Late spermatids: 66.1;Leydig cells: 47.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 11 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "ASC diff: 1.7;HSkMC: 3.8;HUVEC TERT2: 3.7;RT4: 3.5;U-2197: 5.5" HPA014535 Uncertain NA NA "HPA014535: AB_1844426" "unprognostic (1.45e-4)" "unprognostic (3.17e-1)" "unprognostic (7.74e-2)" "unprognostic (5.18e-2)" "unprognostic (2.52e-2)" "unprognostic (1.17e-2)" "unprognostic (3.78e-2)" "unprognostic (1.40e-1)" "unprognostic (4.51e-3)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "unprognostic (4.91e-1)" "unprognostic (2.70e-4)" "unprognostic (5.23e-3)" "unprognostic (6.98e-2)" "unprognostic (4.37e-2)" "unprognostic (9.86e-3)" 4.6 0.5 0.0 0.0 0.2 0.0 10.4 5.0 0.4 1.6 1.7 0.6 2.7 2.4 1.1 6.3 3.1 2.7 0.1 0.2 0.5 2.7 2.5 0.1 0.1 11.6 1.3 0.1 1.3 0.0 0.8 3.8 2.6 0.2 3.5 4.1 1.4 1.7 0.2 0.3 1.0 1.6 3.1 0.3 1.3 1.9 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.2 0.0 1.7 0.3 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.8 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 3.8 0.5 0.8 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.9 7.1 2.4 0.0 4.0 0.0 0.0 23.6 0.0 0.0 0.4 189.3 1.7 2.5 0.0 0.2 0.0 3.8 0.3 0.0 1.0 0.1 0.0 4.7 0.6 0.0 66.1 47.2 0.9 1.7 2.8 2.9 3.1 0.6 0.0 11.0 0.3 7.6 0.0 1.4 7.7 2.8 0.4 0.0 0.0 0.5 0.5 ABCA12 "DKFZP434G232, ICR2B, LI2" ENSG00000144452 "ATP binding cassette subfamily A member 12" Q86UK0 2 214931542-215138428 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 23.1;tongue: 29.3" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 11.4;Suprabasal keratinocytes: 33.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 28.7;SK-BR-3: 13.4;T-47d: 7.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "cerebral cortex: 1.6;hippocampal formation: 1.8" HPA078239 Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoli, Cytosol" "HPA078239: AB_2732373" "unprognostic (6.12e-2)" "unprognostic (4.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.49e-1)" "unprognostic (2.13e-1)" "unprognostic (2.09e-4)" "unprognostic (6.52e-3)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (2.50e-2)" "unprognostic (7.69e-2)" "unprognostic (5.92e-2)" "unprognostic (2.64e-2)" "unprognostic (2.36e-1)" "unprognostic (5.08e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 6.9 0.1 0.1 6.2 0.3 0.0 1.4 0.0 0.0 4.4 8.4 0.1 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 6.1 4.9 0.0 0.1 0.4 0.0 0.3 0.0 0.1 23.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.1 0.0 29.3 6.1 0.1 3.7 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.7 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 2.0 0.0 13.4 0.0 0.1 7.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 11.4 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.1 0.3 0.4 0.0 0.0 0.3 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.7 0.0 0.0 0.0 0.2 0.5 0.2 33.8 2.9 0.0 0.0 2.2 ABCA13 "FLJ33876, FLJ33951" ENSG00000179869 "ATP binding cassette subfamily A member 13" 7 48171458-48647496 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 64.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.7;LHCN-M2: 3.7;U-2 OS: 10.4;U-266/84: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063601 Approved Vesicles,Centrosome,Cytosol NA NA Vesicles "Centrosome, Cytosol" "HPA063601: AB_2685057" "unprognostic (8.97e-2)" "unprognostic (5.82e-2)" "unprognostic (3.18e-1)" "unprognostic (6.48e-2)" "unprognostic (2.65e-2)" "unprognostic (5.59e-2)" "unprognostic (5.19e-2)" "unprognostic (2.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.86e-3)" "unprognostic (6.03e-3)" "unprognostic (3.26e-1)" "unprognostic (1.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (3.62e-2)" 0.3 0.2 0.1 0.3 1.0 35.4 0.7 0.0 1.1 1.2 0.3 0.4 0.0 0.3 0.3 1.1 10.3 1.8 0.5 3.5 1.8 0.2 1.1 0.7 15.7 0.2 0.1 0.0 0.4 1.2 0.1 8.7 1.2 0.4 0.2 0.4 0.0 1.7 0.4 0.8 1.3 0.3 0.2 0.9 1.3 0.2 4.2 0.0 4.6 7.1 5.4 14.4 0.5 0.3 0.6 0.6 3.2 0.7 1.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.3 1.0 0.0 0.3 0.0 0.0 0.0 2.2 0.0 1.9 0.6 1.2 2.1 0.0 8.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 1.0 0.8 0.0 0.3 0.0 0.1 3.7 0.0 0.0 0.1 0.1 0.0 2.1 0.3 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.0 0.6 10.4 0.4 1.5 3.1 4.2 0.0 1.3 0.4 0.4 3.2 0.7 0.6 0.3 0.4 0.3 0.4 0.2 0.2 0.1 0.6 0.4 0.4 1.6 1.0 0.3 0.6 0.1 0.2 0.1 1.0 0.0 1.1 1.8 0.2 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.0 0.0 64.3 9.1 1.8 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.2 0.0 0.0 0.0 0.3 0.1 ABCA2 ABC2 ENSG00000107331 "ATP binding cassette subfamily A member 2" Q9BZC7 9 137007227-137028922 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 84.3" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 35.0;Intestinal endocrine cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "dendritic cells: 2.7;NK-cells: 1.2;T-cells: 2.2" "Cell line enhanced" "Detected in many" "T-47d: 35.2" "Low region specificity" "Detected in all" HPA042886 Approved NA NA "HPA042886: AB_2678213" "unprognostic (1.01e-2)" "unprognostic (9.21e-3)" "unprognostic (9.59e-2)" "unprognostic (6.15e-2)" "unprognostic (1.02e-1)" "unprognostic (8.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.13e-2)" "unprognostic (5.61e-3)" "unprognostic (1.76e-1)" "unprognostic (2.93e-2)" "unprognostic (2.74e-2)" "unprognostic (6.78e-3)" "unprognostic (3.14e-3)" "unprognostic (1.37e-1)" "unprognostic (2.80e-1)" "unprognostic (1.36e-1)" 7.8 6.1 20.0 3.9 42.4 5.7 2.6 16.7 54.2 4.0 4.5 84.3 0.9 3.2 2.8 4.7 3.5 6.3 5.7 7.1 32.2 17.6 4.8 3.8 4.1 4.1 57.5 21.9 2.5 8.6 8.1 7.8 3.3 31.1 5.2 2.5 3.8 8.0 5.1 5.7 6.3 4.1 2.7 70.5 8.3 6.1 3.0 47.7 0.2 9.5 0.1 2.2 3.3 1.8 0.4 2.7 0.4 0.3 1.2 2.2 1.1 4.4 4.8 2.4 9.7 6.1 6.5 4.2 4.9 2.0 2.2 0.8 1.4 5.4 0.2 14.1 5.3 2.2 7.5 1.5 3.6 0.4 3.3 3.1 0.4 13.9 1.7 3.0 7.0 7.7 2.7 3.3 1.6 0.4 8.3 1.2 1.4 1.1 0.8 2.7 13.3 0.0 15.0 1.2 5.6 4.9 6.8 2.4 6.5 1.5 1.0 9.3 10.7 5.3 10.4 3.8 0.1 35.2 9.1 6.3 6.1 3.3 8.6 2.0 0.1 0.1 0.0 10.3 1.3 3.0 0.0 0.3 0.0 2.2 0.2 1.3 0.4 0.2 0.7 0.3 0.2 0.0 0.9 0.4 1.2 0.0 2.7 1.0 1.1 20.0 42.4 16.7 30.7 32.2 17.6 57.5 21.9 31.1 47.7 0.0 0.0 0.5 1.3 3.0 9.5 4.0 17.8 0.0 0.0 1.8 13.7 1.0 1.7 2.9 0.6 3.4 10.3 0.0 1.3 1.0 4.3 2.6 0.0 6.7 1.2 35.0 33.4 7.4 2.4 1.1 20.4 1.1 5.0 0.0 5.7 10.8 2.3 6.8 22.3 1.1 7.2 0.0 3.8 0.5 4.5 2.4 0.7 14.1 8.9 0.9 ABCA3 "ABC-C, ABC3, EST111653, LBM180" ENSG00000167972 "ATP binding cassette subfamily A member 3" Q99758 16 2275881-2340746 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;lung: 75.8" "Cell type enriched" "Detected in many" 6 "Alveolar cells type 2: 382.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 15.1;HDLM-2: 15.2;SCLC-21H: 21.2;SH-SY5Y: 15.3;T-47d: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007884 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007884: AB_1078077" "unprognostic (2.64e-1)" "unprognostic (2.19e-2)" "unprognostic (6.09e-3)" "unprognostic (2.61e-3)" "unprognostic (2.20e-1)" "unprognostic (1.35e-1)" "unprognostic (2.90e-2)" "unprognostic (1.86e-1)" "unprognostic (6.58e-3)" "unprognostic (3.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-2)" "unprognostic (5.33e-2)" "unprognostic (3.32e-2)" "unprognostic (7.85e-2)" "unprognostic (2.91e-1)" "unprognostic (1.30e-1)" 6.3 6.2 12.9 3.4 15.3 1.6 7.0 21.9 30.8 3.0 3.8 13.1 1.8 2.7 3.2 4.2 3.6 4.9 3.3 5.6 14.6 13.8 3.9 1.5 75.8 3.9 11.4 13.1 3.2 9.6 14.8 6.0 4.7 18.3 5.3 2.1 4.9 8.5 5.0 5.0 4.2 2.5 5.0 11.3 3.7 3.0 7.2 6.1 5.6 16.2 0.5 6.4 3.0 1.3 0.2 0.5 0.0 0.6 2.0 1.5 0.4 0.3 9.7 1.8 15.1 0.4 0.0 0.1 2.6 0.6 1.0 1.1 1.3 1.5 0.1 3.8 1.2 0.9 0.2 8.7 0.1 0.3 15.2 5.8 1.0 1.1 0.2 1.3 0.1 1.6 0.1 0.2 0.1 0.5 6.2 14.7 0.1 10.4 0.0 0.0 12.9 0.0 1.0 2.0 2.3 4.7 2.4 0.3 1.7 8.7 0.3 21.2 15.3 1.8 10.7 0.2 0.8 34.9 0.9 4.2 0.1 0.5 4.1 4.3 2.8 1.2 0.0 2.1 5.2 0.1 0.0 0.1 0.0 1.5 0.1 0.8 0.2 0.6 1.4 0.5 0.1 0.6 1.5 0.0 2.0 0.6 0.0 0.3 0.4 12.9 15.3 21.9 30.8 14.6 13.8 11.4 13.1 18.3 6.1 65.5 382.0 0.0 0.4 0.6 16.5 5.1 2.5 4.0 17.0 17.4 11.8 0.0 0.0 4.6 7.7 4.2 0.2 0.0 3.3 0.0 1.4 1.9 27.8 0.9 0.9 17.5 5.2 2.5 2.7 2.7 1.7 1.6 1.7 2.8 0.7 6.9 2.4 0.0 3.2 1.5 9.5 6.5 3.1 1.9 14.0 1.4 0.0 2.5 0.6 0.1 ABCA4 "ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1" ENSG00000198691 "ATP binding cassette subfamily A member 4" P78363 1 93992835-94121132 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" Translocase "Age-related macular degeneration, Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 142.7" "Group enriched" "Detected in some" 14 "Cone photoreceptor cells: 424.1;Rod photoreceptor cells: 455.0" "Cancer enhanced" "Detected in many" "lung cancer: 3.1" "Region enriched" "Detected in some" 13 "pons and medulla: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2;SuSa: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA064420, HPA078826" Enhanced Approved Cytosol NA NA Cytosol "HPA064420: , HPA078826: " "unprognostic (1.25e-1)" "unprognostic (3.93e-1)" "unprognostic (3.29e-2)" "unprognostic (7.17e-4)" "unprognostic (1.28e-1)" "unprognostic (3.00e-1)" "unprognostic (1.38e-2)" "prognostic favorable (2.45e-4)" "unprognostic (3.77e-2)" "unprognostic (5.25e-1)" "unprognostic (3.70e-1)" "unprognostic (5.18e-2)" "unprognostic (1.17e-9)" "unprognostic (1.61e-2)" "unprognostic (1.55e-1)" "unprognostic (2.47e-1)" "prognostic unfavorable (2.72e-4)" 0.7 0.0 0.3 0.2 0.4 0.0 1.1 0.2 0.9 0.7 0.2 3.2 0.2 3.7 0.2 12.9 0.2 0.6 0.2 0.2 2.0 0.2 6.7 1.2 0.4 0.3 0.3 0.2 0.3 0.2 0.0 0.2 0.8 25.5 0.3 0.0 142.7 0.2 2.1 0.2 3.5 4.2 0.2 0.2 0.2 0.1 2.1 0.2 0.2 0.7 0.2 0.2 0.3 0.2 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 5.0 0.2 0.3 0.0 0.2 0.1 0.0 0.0 11.2 0.5 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.7 3.5 1.2 0.6 0.0 0.0 0.5 0.0 0.5 0.0 0.2 1.0 0.0 0.0 0.2 0.0 1.4 0.5 0.0 2.0 0.0 0.0 0.2 0.3 0.3 0.5 0.5 0.0 0.0 1.0 4.2 0.2 5.1 0.4 0.0 0.2 0.3 2.2 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.9 2.0 0.2 0.3 0.2 25.5 0.2 0.0 0.6 0.0 0.2 0.1 14.3 0.8 0.0 2.7 0.0 7.0 424.1 0.1 0.0 0.0 8.5 0.8 0.0 0.0 0.0 1.1 0.2 1.5 0.0 0.0 0.1 9.5 0.0 0.6 0.0 15.5 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.4 0.0 455.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.5 ABCA5 EST90625 ENSG00000154265 "ATP binding cassette subfamily A member 5" Q8WWZ7 17 69244311-69327244 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 52.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022032, HPA062904" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022032: AB_1844427, HPA062904: AB_2732692" "unprognostic (1.24e-2)" "unprognostic (1.49e-2)" "unprognostic (1.62e-3)" "unprognostic (7.17e-2)" "unprognostic (8.05e-4)" "unprognostic (3.05e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "prognostic favorable (9.97e-5)" "unprognostic (3.60e-2)" "unprognostic (1.09e-3)" "unprognostic (1.07e-1)" "unprognostic (1.65e-1)" "unprognostic (2.55e-1)" "unprognostic (8.52e-2)" 10.5 8.6 6.7 3.8 9.8 6.0 12.7 35.6 12.4 8.8 9.6 4.3 13.5 9.7 6.0 7.7 8.6 6.6 4.6 5.2 5.3 6.2 7.9 21.7 4.9 3.3 4.1 7.9 6.9 20.3 13.0 35.9 5.3 13.6 7.4 10.6 15.5 8.2 11.4 52.8 24.0 15.5 3.4 7.6 4.3 8.9 9.0 3.9 1.7 7.9 10.3 5.9 5.5 8.1 4.2 3.9 4.5 0.7 3.0 4.2 1.2 4.2 2.0 1.6 2.5 7.9 5.7 0.5 4.5 4.9 4.7 7.0 0.6 1.6 0.0 2.4 3.9 3.7 6.4 1.0 3.7 5.3 0.1 3.0 0.0 4.8 3.0 10.5 0.0 2.7 5.6 4.6 2.0 5.4 1.0 10.2 1.6 0.0 1.7 0.4 3.7 2.6 0.0 1.6 1.6 3.0 0.3 0.1 0.4 0.9 7.2 8.9 1.4 16.1 7.4 4.6 1.5 7.6 2.7 7.4 5.3 1.5 4.9 0.9 9.2 0.2 0.3 2.2 0.0 4.8 0.7 0.7 4.5 3.1 0.2 4.2 2.4 4.0 3.4 0.5 4.2 2.1 3.4 1.9 3.0 0.1 3.9 2.4 1.2 6.7 9.8 35.6 12.4 5.3 6.2 4.1 7.9 13.6 3.9 17.9 16.9 10.2 30.0 58.2 127.4 22.1 28.1 49.5 14.8 36.6 110.0 11.6 5.0 9.2 14.9 17.1 72.6 0.0 8.6 4.9 18.8 32.6 13.9 89.4 6.2 100.1 108.2 18.4 4.8 9.5 59.0 8.9 96.2 47.7 65.8 49.9 12.8 38.6 43.2 10.2 117.6 90.5 24.0 103.0 47.0 46.9 19.8 13.8 26.6 34.4 ABCA6 EST155051 ENSG00000154262 "ATP binding cassette subfamily A member 6" Q8N139 17 69078702-69141888 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 53.9" "Group enriched" "Detected in many" 4 "Fibroblasts: 27.1;Hepatocytes: 95.4;Leydig cells: 47.5" "Cancer enriched" "Detected in some" 7 "liver cancer: 4.8" "Group enriched" "Detected in many" 5 "basal ganglia: 6.6;midbrain: 10.9;pons and medulla: 11.2;thalamus: 9.3" "Cell type enhanced" "Detected in some" "classical monocyte: 1.0;plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 20.7;ASC TERT1: 30.0;HSkMC: 13.1;HUVEC TERT2: 27.9;RT4: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA064878, HPA067180" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064878: AB_2685380, HPA067180: AB_2685797" "unprognostic (7.76e-2)" "unprognostic (6.80e-2)" "unprognostic (2.12e-1)" "unprognostic (8.01e-2)" "unprognostic (8.47e-2)" "unprognostic (9.82e-3)" "prognostic favorable (3.29e-4)" "unprognostic (1.35e-1)" "unprognostic (6.60e-2)" "unprognostic (3.00e-2)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (7.96e-4)" "unprognostic (1.61e-4)" "unprognostic (2.10e-2)" "unprognostic (3.03e-2)" "unprognostic (1.69e-1)" 31.4 4.3 1.4 2.0 6.6 0.4 12.1 0.7 1.9 12.3 9.9 4.7 2.9 1.8 7.9 6.9 10.5 4.9 7.2 13.2 1.5 0.9 3.0 53.9 9.3 3.6 10.9 0.2 22.0 1.9 1.1 6.0 1.8 11.2 8.0 3.4 4.2 7.1 1.9 6.6 5.0 3.9 9.8 21.0 1.8 4.4 5.0 9.3 0.0 6.7 6.6 2.5 16.6 11.7 0.0 1.2 0.0 1.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 20.7 30.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 13.1 0.0 1.6 0.4 0.8 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.2 1.2 0.0 0.3 1.4 6.6 0.7 1.9 1.5 0.9 10.9 0.2 11.2 9.3 0.0 0.0 2.7 0.9 2.7 13.9 4.8 0.0 0.0 1.2 3.5 5.9 0.0 0.0 0.2 2.9 2.2 0.5 0.0 0.2 0.0 27.1 0.1 0.0 95.4 1.2 0.0 2.4 2.5 1.8 2.2 47.5 2.8 5.0 1.0 0.1 3.9 0.5 0.0 11.3 0.6 13.8 0.0 1.7 0.9 1.0 2.5 0.0 0.0 0.0 0.3 ABCA7 ABCX ENSG00000064687 "ATP binding cassette subfamily A member 7" Q8IZY2 19 1040101-1065572 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Phagocytosis, Transport" Translocase "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 35.2" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 68.5;Bipolar cells: 64.0;Cone photoreceptor cells: 164.9;Extravillous trophoblasts: 217.5;Rod photoreceptor cells: 151.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 26.7;HMC-1: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041564 Enhanced Supported "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Golgi apparatus, Plasma membrane" "Cell Junctions" "HPA041564: AB_2677550" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (7.26e-4)" "prognostic favorable (1.12e-4)" "unprognostic (8.88e-2)" "unprognostic (1.13e-2)" "unprognostic (2.25e-1)" "unprognostic (4.00e-2)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "unprognostic (1.51e-3)" "unprognostic (3.68e-2)" "unprognostic (8.99e-3)" "unprognostic (2.08e-2)" "unprognostic (3.66e-1)" "unprognostic (7.88e-2)" "unprognostic (7.85e-2)" 6.0 3.5 6.2 20.2 4.8 35.2 7.6 13.6 11.1 5.0 5.8 1.9 4.7 4.9 2.1 3.9 7.5 2.8 5.5 2.3 5.3 6.5 5.3 3.6 9.5 17.7 5.2 5.1 1.0 7.0 5.6 34.5 3.1 7.7 4.9 4.2 34.7 9.9 6.5 5.5 11.1 11.1 1.8 6.7 26.6 7.9 1.6 4.3 19.8 7.0 3.9 14.5 5.1 4.9 1.5 9.9 10.8 2.5 1.9 2.6 1.2 5.7 5.4 1.1 3.4 6.7 3.0 5.6 0.8 0.8 0.3 0.6 4.1 2.2 11.2 3.8 0.8 0.4 5.7 2.3 5.1 0.3 7.4 2.1 8.6 26.7 4.1 2.6 3.2 32.2 2.8 1.8 1.5 2.9 5.5 1.9 6.1 8.7 7.0 1.0 1.4 3.1 2.3 0.6 4.2 2.5 2.9 0.6 8.0 2.8 10.8 0.7 2.2 6.3 1.9 0.6 2.5 3.7 5.2 2.8 0.6 1.4 2.9 0.8 8.1 7.9 6.1 1.4 7.7 1.3 4.3 2.5 7.0 2.6 1.7 1.6 1.0 1.5 1.8 2.8 1.5 1.4 2.1 10.8 1.9 1.6 9.9 0.6 1.2 6.2 4.8 13.6 11.1 5.3 6.5 5.2 5.1 7.7 4.3 68.5 31.1 10.2 0.6 3.0 64.0 5.6 2.5 5.3 9.1 5.2 164.9 2.4 1.7 2.7 6.0 2.9 9.0 0.0 2.1 217.5 2.8 1.4 9.3 3.2 6.9 14.3 3.4 3.1 14.8 2.9 0.0 7.0 0.0 10.0 3.8 13.0 5.9 10.5 0.0 1.3 151.3 0.0 3.1 0.7 1.9 3.0 21.5 10.2 2.9 1.7 ABCA8 KIAA0822 ENSG00000141338 "ATP binding cassette subfamily A member 8" O94911 17 68867292-68955392 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Leydig cells: 465.4;Muller glia cells: 138.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 16.6;ASC TERT1: 37.0;HSkMC: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044914 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044914: AB_10964859" "unprognostic (2.58e-2)" "unprognostic (2.76e-2)" "unprognostic (1.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.04e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (5.22e-2)" "unprognostic (6.68e-2)" "unprognostic (8.76e-2)" "unprognostic (1.42e-3)" "unprognostic (3.52e-3)" "unprognostic (1.88e-1)" "unprognostic (3.29e-1)" "unprognostic (6.14e-3)" 29.1 25.2 10.0 3.4 27.2 0.5 15.1 3.2 15.4 7.3 12.8 29.9 3.9 5.4 10.2 13.0 12.4 17.6 14.3 30.0 12.5 5.5 8.1 26.6 15.2 1.3 37.8 9.2 44.7 5.1 4.5 14.8 7.6 22.2 10.3 14.3 16.4 9.8 7.9 8.9 4.9 9.9 7.1 28.2 9.9 11.5 15.8 42.7 0.0 13.0 14.2 2.8 13.6 20.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 16.6 37.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 6.1 0.0 0.0 27.9 0.0 0.4 0.0 0.2 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.0 27.2 3.2 15.4 12.5 5.5 37.8 9.2 22.2 42.7 47.6 0.6 0.0 1.3 5.4 1.4 12.5 0.0 0.0 7.9 0.0 2.0 0.1 0.0 0.0 4.2 4.2 0.0 0.0 0.0 0.1 35.3 0.3 1.1 35.8 0.9 4.8 0.0 7.4 1.9 4.3 465.4 1.8 1.7 0.0 0.0 138.5 0.0 0.0 66.1 0.0 2.1 38.8 6.2 1.1 1.2 4.1 0.2 0.0 0.0 0.2 ABCA9 EST640918 ENSG00000154258 "ATP binding cassette subfamily A member 9" Q8IUA7 17 68974488-69061064 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 42.5" "Cell type enhanced" "Detected in many" 22 "Ito cells: 26.4;Leydig cells: 89.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "ASC diff: 14.5;ASC TERT1: 31.1;HSkMC: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052113, HPA054823" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA052113: AB_2732573, HPA054823: AB_2682615" "unprognostic (3.88e-2)" "unprognostic (9.86e-2)" "unprognostic (2.21e-1)" "unprognostic (9.75e-2)" "unprognostic (4.46e-1)" "unprognostic (5.64e-3)" "unprognostic (4.51e-4)" "unprognostic (1.83e-2)" "unprognostic (1.94e-3)" "unprognostic (7.86e-2)" "unprognostic (3.26e-3)" "unprognostic (3.51e-1)" "unprognostic (7.77e-6)" "unprognostic (5.32e-4)" "unprognostic (7.22e-2)" "unprognostic (1.84e-2)" "unprognostic (4.96e-3)" 42.5 4.2 1.2 5.5 2.8 1.7 14.1 2.7 2.6 13.4 17.4 2.6 6.8 1.7 15.5 11.8 25.5 8.8 7.2 15.0 2.1 1.9 2.5 7.6 5.6 2.1 7.8 2.0 25.2 2.3 1.7 2.8 1.1 4.4 13.9 3.8 4.1 5.7 4.7 12.4 5.4 3.7 11.9 3.8 1.6 4.8 10.9 2.1 1.0 7.6 9.9 2.5 20.4 18.7 1.8 0.9 2.9 0.8 1.2 1.3 0.0 0.2 0.4 0.5 0.6 14.5 31.1 0.5 0.3 0.3 0.0 0.2 0.4 0.4 0.4 0.1 0.5 0.3 0.4 0.3 0.5 0.2 0.2 0.4 0.5 1.3 0.4 1.6 0.6 0.9 11.1 0.4 2.3 0.2 0.6 3.1 0.4 0.5 1.1 0.2 0.2 0.2 1.4 0.3 0.1 0.3 1.5 0.1 0.2 0.1 1.3 0.6 0.5 0.4 0.3 0.3 0.4 0.3 0.5 1.3 0.9 0.4 1.7 0.3 1.0 0.3 0.3 0.3 0.3 1.5 1.7 0.8 1.4 1.3 0.6 1.3 1.1 0.8 0.5 0.9 1.8 1.3 1.3 2.9 1.2 0.5 0.7 0.4 0.0 1.2 2.8 2.7 2.6 2.1 1.9 7.8 2.0 4.4 2.1 0.0 1.0 0.0 0.2 1.5 5.4 2.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.4 0.0 0.0 0.0 10.6 0.1 0.0 9.9 0.2 0.0 0.0 26.4 1.8 2.1 89.2 0.6 0.0 0.0 0.0 12.1 0.3 0.0 14.5 0.0 6.1 12.9 1.4 1.2 0.6 1.4 0.0 0.0 0.0 0.1 ABCB1 "ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1" ENSG00000085563 "ATP binding cassette subfamily B member 1" P08183 7 87503633-87713323 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 57.8;intestine: 49.6" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 104.4;Enterocytes: 174.5;Paneth cells: 77.2" "Cancer enhanced" "Detected in many" "renal cancer: 14.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 19.2" "Group enriched" "Detected in many" 8 "NK-cells: 11.4;T-cells: 19.2" "Cell line enhanced" "Detected in some" "CACO-2: 30.1;HEK 293: 9.3;HEL: 16.7;Hep G2: 8.2;RPTEC TERT1: 11.5;SH-SY5Y: 36.8" "CAB001716, HPA002199, HPA074614" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA "Nucleoplasm, Plasma membrane" "Focal adhesion sites" "CAB001716: , HPA002199: AB_1844428, HPA074614: " "unprognostic (5.38e-3)" "unprognostic (2.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-2)" "unprognostic (9.99e-5)" "unprognostic (2.23e-3)" "unprognostic (5.65e-3)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "prognostic favorable (3.33e-4)" "unprognostic (5.19e-1)" "prognostic favorable (2.95e-4)" "unprognostic (2.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.83e-1)" "unprognostic (6.12e-2)" 2.6 57.8 9.4 3.2 11.5 1.2 3.4 5.1 10.5 5.5 22.7 3.8 2.0 14.4 9.4 3.5 2.0 3.2 9.0 1.8 9.2 6.6 19.1 15.6 3.8 2.2 9.4 5.7 2.2 1.5 1.7 1.3 3.1 11.1 2.7 10.7 7.6 1.5 2.1 1.1 1.3 49.6 5.7 9.0 2.4 1.7 1.3 8.6 0.1 2.4 1.4 2.2 2.6 5.9 1.9 0.0 0.1 0.0 11.4 19.2 1.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 9.3 16.7 1.9 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 11.5 0.1 0.4 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.4 3.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 7.8 0.0 19.2 0.4 2.0 4.7 0.0 1.9 1.2 4.8 0.1 11.4 0.0 0.0 0.0 1.5 9.4 11.5 5.1 10.5 9.2 6.6 9.4 5.7 11.1 8.6 0.0 4.8 5.9 0.1 0.7 0.6 2.8 104.4 1.4 1.2 47.1 0.0 5.0 5.0 10.2 21.6 23.1 174.5 23.3 1.6 0.1 0.5 0.1 3.5 32.6 0.4 0.0 0.0 3.7 1.2 2.5 0.9 0.8 0.0 0.0 8.9 0.0 11.4 77.2 0.0 44.0 0.9 0.0 0.8 0.5 0.4 0.5 8.2 27.3 1.7 0.1 ABCB10 "EST20237, M-ABC2, MTABC2" ENSG00000135776 "ATP binding cassette subfamily B member 10" Q9NRK6 1 229516582-229558695 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "Erythroid cells: 140.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB044063, CAB044065, HPA055175" Uncertain NA NA "CAB044063: AB_353262, CAB044065: AB_2220666, HPA055175: AB_2682727" "unprognostic (1.00e-1)" "unprognostic (1.29e-2)" "unprognostic (5.56e-3)" "unprognostic (5.64e-2)" "unprognostic (2.04e-1)" "unprognostic (8.06e-3)" "unprognostic (9.38e-2)" "unprognostic (2.05e-1)" "unprognostic (4.15e-2)" "unprognostic (5.61e-2)" "unprognostic (2.81e-1)" "unprognostic (3.13e-1)" "unprognostic (8.32e-2)" "unprognostic (2.58e-1)" "unprognostic (3.83e-1)" "unprognostic (5.29e-2)" "unprognostic (3.37e-2)" 13.2 6.4 5.5 6.7 6.0 37.1 14.0 15.1 6.1 7.9 18.8 5.4 3.7 12.6 9.9 6.9 10.7 6.1 11.9 8.3 5.5 5.4 10.9 24.7 9.8 15.5 5.2 3.8 6.3 8.2 9.0 4.2 11.4 4.9 9.9 8.6 5.3 7.1 5.9 13.9 6.0 30.1 14.7 5.0 15.0 7.8 4.0 4.2 9.4 9.6 8.3 12.1 10.0 9.1 2.4 3.2 2.9 2.7 1.3 4.1 1.3 10.4 6.2 5.2 4.2 8.9 7.7 22.7 9.7 7.3 8.8 8.0 6.4 8.0 11.5 8.9 8.8 3.6 9.1 11.1 8.0 8.9 7.8 14.1 12.6 5.6 8.1 6.4 42.4 7.1 5.3 6.9 5.3 6.2 5.3 9.4 20.7 26.9 26.6 9.0 3.3 10.7 24.3 6.9 12.2 5.3 9.8 10.3 12.2 7.1 6.8 3.8 5.8 7.5 8.4 11.8 3.3 6.5 14.8 7.2 9.5 6.0 5.9 13.1 6.5 4.8 10.0 5.0 7.4 6.0 1.7 2.4 2.9 2.8 2.7 3.6 1.8 3.3 4.1 2.8 2.4 3.0 4.0 0.4 1.3 1.9 3.2 2.7 1.3 5.5 6.0 15.1 6.1 5.5 5.4 5.2 3.8 4.9 4.2 8.9 1.3 0.8 2.5 2.9 5.8 11.8 2.5 9.4 5.7 0.0 11.8 5.1 1.7 4.1 0.0 4.5 8.0 140.2 4.5 9.3 4.8 7.1 5.7 15.3 8.1 9.5 9.8 5.5 11.0 0.2 4.6 6.4 8.5 15.4 12.8 2.9 4.3 10.5 4.2 4.5 4.5 6.5 5.2 2.9 2.9 4.4 3.0 3.9 10.5 3.5 ABCB11 "ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP" ENSG00000073734 "ATP binding cassette subfamily B member 11" O95342 2 168922938-169031322 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 47.4" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 38.7;Alveolar cells type 2: 58.1;Club cells: 35.2;granulocytes: 22.1;Hepatocytes: 17.9" "Cancer enriched" "Detected in single" 87 "liver cancer: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.0;NB-4: 1.7;PC-3: 1.0;THP-1: 2.6;TIME: 1.8;U-2197: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA019035 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA019035: AB_1844429" "unprognostic (7.78e-2)" "unprognostic (3.92e-1)" "unprognostic (8.31e-2)" "unprognostic (2.56e-1)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.00e-2)" "unprognostic (9.71e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-1)" "unprognostic (5.26e-6)" "unprognostic (7.12e-2)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.8 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 38.7 58.1 0.0 0.0 0.0 0.0 0.3 0.0 16.0 35.2 0.0 0.0 0.0 0.0 0.1 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.1 17.9 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 ABCB4 "GBD1, MDR2, MDR3, PFIC-3, PGY3" ENSG00000005471 "ATP binding cassette subfamily B member 4" P21439 7 87401697-87480435 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 93.2" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 235.3" "Cancer enriched" "Detected in some" 11 "liver cancer: 16.3" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "memory B-cell: 4.9;naive B-cell: 11.4" "Lineage enriched" "Detected in many" 8 "B-cells: 11.4" "Group enriched" "Detected in some" 5 "SH-SY5Y: 12.0;WM-115: 22.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA049395, HPA053288" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Nucleoplasm, Plasma membrane, Actin filaments" "Focal adhesion sites" "HPA049395: AB_2680745, HPA053288: AB_2682102" "unprognostic (7.92e-2)" "unprognostic (8.87e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (8.95e-2)" "unprognostic (1.06e-2)" "unprognostic (2.35e-3)" "unprognostic (9.91e-2)" "unprognostic (3.53e-1)" "unprognostic (1.19e-1)" "unprognostic (2.44e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (8.01e-3)" "unprognostic (7.12e-2)" "unprognostic (2.11e-2)" "unprognostic (2.47e-1)" 0.5 4.1 0.2 4.3 0.2 0.2 0.3 0.1 1.1 0.2 0.6 0.4 0.0 0.0 0.1 0.2 0.6 0.1 0.3 4.0 0.3 0.2 0.4 93.2 0.1 4.1 0.3 0.2 0.3 0.1 0.0 0.5 0.0 0.3 0.3 0.4 0.8 0.4 0.1 2.9 0.6 1.2 1.6 0.5 5.2 0.2 0.5 0.4 0.1 0.4 4.2 3.2 0.6 0.5 11.4 1.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 12.0 0.0 0.6 2.2 0.5 0.2 0.5 0.0 0.2 1.6 0.1 0.0 0.0 0.0 2.8 0.2 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.1 1.4 11.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.2 0.1 1.1 0.3 0.2 0.3 0.2 0.3 0.4 0.0 0.3 23.1 0.0 0.9 0.0 9.3 0.0 0.0 0.0 1.8 0.0 0.9 0.0 0.1 0.6 0.8 0.1 0.0 0.0 0.2 1.5 0.0 0.0 235.3 0.5 36.5 0.0 5.5 5.4 0.2 0.0 0.0 10.1 0.0 0.0 0.0 0.1 0.0 0.4 0.5 0.0 0.0 0.9 0.5 0.1 0.4 0.1 0.0 0.0 0.0 ABCB5 "ABCB5alpha, ABCB5beta, EST422562" ENSG00000004846 "ATP binding cassette subfamily B member 5" Q2M3G0 7 20615207-20777038 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 33.4;retina: 43.3" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 2.6;Early spermatids: 6.1;Melanocytes: 1.7" "Cancer enriched" "Detected in some" 9 "melanoma: 5.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "SK-MEL-30: 32.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.82e-1)" "unprognostic (1.57e-1)" "unprognostic (2.55e-3)" "unprognostic (1.55e-2)" "unprognostic (1.14e-2)" "unprognostic (2.98e-1)" "unprognostic (2.60e-3)" "unprognostic (1.65e-2)" "unprognostic (2.05e-1)" "unprognostic (2.63e-1)" "unprognostic (6.23e-2)" "unprognostic (5.26e-3)" "unprognostic (3.56e-3)" "unprognostic (9.30e-4)" "unprognostic (1.29e-1)" "unprognostic (1.80e-2)" "unprognostic (2.70e-2)" 10.6 0.1 0.0 0.4 0.0 0.3 8.6 0.0 0.1 4.4 3.8 0.0 5.3 0.1 1.8 33.4 0.3 0.4 2.8 0.9 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.4 0.1 2.9 0.6 43.3 0.3 0.4 1.0 2.1 0.9 1.5 0.3 0.1 0.7 2.6 0.0 0.0 0.1 0.2 0.1 1.8 1.6 0.7 0.5 2.3 0.5 0.5 0.3 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 4.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.6 0.0 0.0 0.1 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.5 0.4 0.2 0.2 0.1 0.4 0.3 0.2 0.1 0.7 0.2 0.3 0.8 0.5 0.2 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 2.6 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.9 0.7 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.3 0.5 0.2 0.5 0.0 0.0 0.0 0.7 ABCB6 "EST45597, MTABC3, umat" ENSG00000115657 "ATP binding cassette subfamily B member 6 (Langereis blood group)" Q9NP58 2 219209766-219219017 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Dyskeratosis congenita, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 4.0;Club cells: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046723, HPA058011" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol" NA NA 22000 "Golgi apparatus" "Nucleoplasm, Plasma membrane, Mitochondria, Cytosol" "HPA046723: AB_10960288, HPA058011: AB_2683578" "unprognostic (8.04e-2)" "unprognostic (3.22e-2)" "unprognostic (4.53e-3)" "unprognostic (3.19e-2)" "unprognostic (2.55e-1)" "unprognostic (9.11e-2)" "prognostic unfavorable (9.45e-7)" "unprognostic (2.26e-1)" "unprognostic (3.62e-2)" "unprognostic (1.53e-1)" "unprognostic (1.18e-4)" "unprognostic (3.02e-3)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.51e-1)" "unprognostic (9.55e-2)" "unprognostic (7.75e-2)" "unprognostic (2.30e-1)" 10.1 8.4 8.2 3.9 13.5 10.2 9.2 7.6 9.1 6.9 7.6 5.4 8.3 8.1 7.1 10.1 9.0 8.4 8.5 9.5 5.6 8.2 6.9 16.2 7.2 4.9 9.8 7.6 13.1 7.1 8.0 6.0 3.7 9.2 9.2 4.2 6.0 5.6 11.3 24.0 5.5 8.0 9.5 9.2 3.2 6.8 19.5 7.7 0.8 9.9 11.3 4.7 14.8 6.0 2.8 5.6 1.3 1.1 1.2 3.2 2.4 0.1 9.9 2.0 12.5 14.0 5.0 12.3 3.7 3.4 4.1 4.1 15.2 2.1 0.1 19.1 3.6 2.2 21.4 0.2 1.5 1.3 6.3 2.2 15.5 10.9 27.9 16.9 0.0 5.2 7.3 1.8 2.7 0.0 6.1 7.1 2.1 13.1 1.9 2.7 5.1 1.0 0.1 3.1 23.0 4.1 5.2 6.3 0.6 2.2 0.2 7.4 7.9 7.7 18.3 8.1 8.0 5.5 0.3 3.2 5.5 0.2 7.4 4.3 5.0 4.0 0.0 6.2 0.1 7.3 1.3 1.1 0.0 1.7 0.9 0.5 2.8 1.3 0.7 0.9 2.3 3.2 2.1 0.0 1.2 0.8 5.6 1.1 2.4 8.2 13.5 7.6 9.1 5.6 8.2 9.8 7.6 9.2 7.7 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 4.0 2.3 0.0 0.0 0.2 0.0 0.6 1.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.7 0.0 0.2 0.9 0.2 0.3 0.2 0.0 0.0 0.0 ABCB7 "ABC7, ASAT, Atm1p, EST140535" ENSG00000131269 "ATP binding cassette subfamily B member 7" O75027 X 75051554-75156732 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034982 Approved Approved Mitochondria NA NA Mitochondria "HPA034982: AB_10601010" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (1.49e-2)" "unprognostic (1.83e-3)" "unprognostic (4.44e-3)" "unprognostic (1.33e-2)" "unprognostic (6.31e-2)" "unprognostic (4.39e-2)" "unprognostic (1.47e-1)" "unprognostic (2.17e-1)" "unprognostic (4.14e-2)" "unprognostic (2.55e-2)" "prognostic favorable (5.31e-6)" "unprognostic (1.95e-1)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" 15.1 18.0 12.3 14.7 14.3 13.0 14.6 26.0 16.2 11.6 15.2 12.0 13.7 19.0 14.7 13.6 14.7 11.7 10.0 21.4 11.7 7.1 15.6 22.4 12.2 15.9 13.0 8.5 16.4 12.4 14.7 22.6 11.5 14.0 10.6 15.4 9.5 12.9 15.5 34.6 15.3 15.9 14.9 12.2 13.9 14.8 5.4 16.2 19.7 12.4 19.3 16.0 13.9 13.3 19.4 19.3 7.0 18.7 12.2 21.5 12.4 11.6 11.3 11.7 14.7 7.7 19.2 5.6 8.2 9.2 7.5 12.9 14.1 17.2 18.2 15.8 6.7 15.8 12.1 22.4 10.4 12.8 19.6 18.7 12.3 22.8 10.4 6.3 19.8 10.7 13.6 9.9 10.1 13.3 14.9 16.2 16.7 13.3 23.6 8.1 7.0 14.9 14.6 19.8 18.4 15.9 15.2 22.4 21.3 9.7 11.6 13.9 9.3 19.3 17.8 11.0 19.3 8.0 14.0 8.4 7.7 15.0 16.0 7.9 7.7 19.5 16.5 7.5 23.9 8.1 5.9 18.7 7.0 11.5 17.7 12.3 18.1 12.8 12.4 19.3 19.4 21.5 16.0 2.2 12.2 13.4 11.9 17.4 12.4 12.3 14.3 26.0 16.2 11.7 7.1 13.0 8.5 14.0 16.2 8.9 7.2 15.2 12.1 14.1 9.2 43.6 10.2 10.7 7.9 10.4 5.9 19.5 10.0 14.8 0.3 11.1 8.5 0.0 11.6 9.8 12.7 9.0 21.9 11.5 17.9 23.8 13.3 9.8 19.7 0.4 13.6 14.9 10.1 16.2 9.8 12.0 10.6 5.8 12.4 15.9 7.6 32.3 12.4 3.8 9.4 14.1 18.7 13.1 17.8 9.5 ABCB8 "EST328128, M-ABC1, MABC1" ENSG00000197150 "ATP binding cassette subfamily B member 8" Q9NUT2 7 151028422-151047782 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045187 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA045187: AB_10964281" "unprognostic (5.29e-2)" "unprognostic (9.17e-3)" "unprognostic (8.28e-2)" "unprognostic (8.32e-2)" "unprognostic (8.63e-3)" "prognostic favorable (5.91e-4)" "unprognostic (4.76e-2)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "prognostic favorable (3.34e-4)" "unprognostic (2.26e-1)" "prognostic favorable (5.88e-4)" "unprognostic (7.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.64e-2)" "unprognostic (1.23e-1)" 12.6 22.8 14.4 13.8 22.0 12.2 8.5 24.9 24.8 16.3 12.3 22.2 10.4 19.3 16.5 14.9 17.6 12.9 11.5 13.0 14.5 12.8 14.5 33.5 11.7 13.3 19.1 17.9 13.3 12.6 15.4 20.1 23.6 15.9 12.3 9.5 12.5 11.1 12.8 11.2 13.7 14.7 12.7 13.3 11.5 13.1 13.6 19.5 14.0 18.4 11.7 10.6 9.6 10.4 4.4 10.4 10.3 6.7 4.0 7.5 3.6 12.5 19.8 5.1 16.1 8.1 4.7 10.2 6.6 6.9 10.6 11.2 7.9 21.1 6.6 8.9 7.0 12.8 13.3 7.4 13.8 4.7 8.2 8.1 5.2 7.9 9.4 5.3 4.0 13.1 8.1 10.5 12.6 5.2 3.9 10.6 14.7 27.4 9.1 7.9 28.1 15.3 7.6 3.4 9.5 22.6 7.3 3.2 23.5 7.1 5.4 4.9 9.9 7.1 20.2 6.4 4.1 8.0 5.3 6.5 9.9 2.6 7.1 9.9 9.2 4.6 4.7 14.0 9.7 10.1 10.3 4.5 3.4 7.5 6.7 5.2 4.4 5.3 6.1 6.3 3.5 4.9 6.9 1.1 4.0 4.7 10.4 5.6 3.6 14.4 22.0 24.9 24.8 14.5 12.8 19.1 17.9 15.9 19.5 11.9 0.6 11.7 5.2 3.3 22.7 6.7 12.7 1.4 1.2 10.4 35.3 32.5 3.3 13.7 1.8 3.4 24.1 0.0 17.6 18.5 6.5 7.1 50.6 21.2 25.1 28.6 0.0 5.5 8.1 1.9 6.1 5.9 8.5 11.8 8.7 11.2 17.7 7.8 11.7 12.8 32.9 25.8 5.9 8.8 15.4 6.5 68.4 7.5 10.6 5.1 ABCB9 EST122234 ENSG00000150967 "ATP binding cassette subfamily B member 9" Q9NP78 12 122920951-122981649 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 18.3;Muller glia cells: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 6.2" "Group enriched" "Detected in many" 5 "B-cells: 6.2;granulocytes: 4.1;T-cells: 1.9" "Cell line enhanced" "Detected in many" "GAMG: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033052, HPA035113, HPA035114" Approved Supported Vesicles NA NA Vesicles "CAB033052: AB_2273463, HPA035113: AB_2674470, HPA035114: AB_10601329" "unprognostic (1.47e-2)" "unprognostic (6.46e-4)" "unprognostic (3.96e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (5.65e-4)" "unprognostic (1.46e-1)" "unprognostic (2.67e-2)" "unprognostic (2.35e-1)" "unprognostic (4.08e-2)" "unprognostic (6.07e-2)" "unprognostic (2.28e-1)" "unprognostic (1.24e-1)" "unprognostic (1.37e-2)" "unprognostic (6.97e-2)" "unprognostic (1.70e-1)" "unprognostic (3.58e-3)" "unprognostic (2.71e-2)" 3.6 4.2 9.5 3.0 13.1 5.3 3.8 19.7 17.0 2.9 4.0 5.8 2.3 5.0 4.2 9.7 4.7 4.7 4.6 4.6 9.0 11.5 3.3 2.7 3.4 3.1 10.8 10.9 4.7 4.3 6.6 9.9 3.5 9.8 3.5 4.1 3.0 7.7 5.6 3.4 6.0 6.1 3.9 7.5 4.0 4.0 21.3 6.4 2.5 3.6 2.0 3.7 2.9 2.7 6.2 0.4 4.1 0.7 0.5 1.9 1.8 3.4 6.4 3.6 3.4 1.5 3.0 1.7 2.2 3.2 3.9 2.5 2.7 3.9 3.9 2.6 2.2 19.9 3.2 2.6 5.4 1.5 0.8 5.2 16.8 5.3 4.3 1.8 0.8 6.8 4.2 2.2 5.7 1.8 9.6 4.3 3.8 3.3 2.9 2.1 7.7 1.2 1.6 1.1 3.7 6.3 4.7 1.0 3.6 1.9 2.3 3.8 1.2 1.1 8.3 8.0 1.4 9.4 1.1 1.9 2.8 9.7 8.7 6.4 9.4 5.2 1.1 4.9 1.9 15.2 4.1 0.7 0.7 0.8 0.4 1.9 6.2 0.8 0.7 0.4 1.2 1.5 1.4 1.7 0.5 0.3 0.3 0.5 1.8 9.5 13.1 19.7 17.0 9.0 11.5 10.8 10.9 9.8 6.4 6.0 5.8 0.0 2.6 2.9 7.9 2.0 0.0 0.0 3.4 3.5 13.7 4.2 0.0 3.3 7.5 2.5 2.1 0.0 1.3 1.5 2.6 1.6 2.3 0.6 0.9 6.4 1.2 1.8 0.0 18.3 2.6 0.9 5.0 0.0 1.6 20.0 1.9 0.0 2.5 0.9 5.2 6.5 3.1 6.5 3.1 2.8 1.1 2.6 2.2 1.4 ABCC1 "GS-X, MRP, MRP1" ENSG00000103222 "ATP binding cassette subfamily C member 1" P33527 16 15949577-16143074 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport "Hydrolase, Translocase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 7.5;eosinophil: 3.1;T-reg: 2.1" "Group enriched" "Detected in many" 7 "granulocytes: 7.5;T-cells: 2.1" "Cell line enhanced" "Detected in many" "EFO-21: 39.0" "Low region specificity" "Detected in all" "HPA002380, HPA076011" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA002380: AB_1844432, HPA076011: " "unprognostic (9.97e-2)" "unprognostic (2.06e-1)" "unprognostic (2.05e-2)" "unprognostic (2.94e-1)" "unprognostic (4.89e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.42e-5)" "unprognostic (3.42e-1)" "unprognostic (3.31e-1)" "unprognostic (4.07e-2)" "unprognostic (9.78e-3)" "unprognostic (7.19e-2)" "prognostic unfavorable (1.55e-6)" "unprognostic (1.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.43e-2)" "unprognostic (1.80e-2)" 8.9 8.2 2.4 8.3 3.1 8.4 9.6 4.4 5.0 8.3 10.7 2.6 15.5 3.5 10.5 12.7 14.7 5.6 9.6 8.0 2.1 2.4 4.5 1.6 10.9 12.2 3.0 2.1 6.8 5.8 18.4 4.2 5.2 4.1 9.6 4.1 12.0 16.9 10.9 20.8 6.6 8.2 16.4 4.0 9.2 10.9 15.1 2.3 26.8 15.7 12.6 15.6 15.3 11.8 0.7 0.5 7.5 0.5 0.4 2.1 0.2 2.3 24.7 0.1 6.5 5.7 3.5 1.3 7.3 8.9 6.3 6.6 3.9 17.8 6.7 39.0 14.0 5.9 6.7 2.0 7.1 4.8 11.8 2.3 8.3 14.4 14.3 17.1 3.0 21.5 7.5 4.8 1.8 1.0 5.4 6.9 12.9 8.4 3.4 1.9 4.6 5.3 2.8 3.9 3.3 3.6 18.9 3.7 3.3 2.3 8.3 3.6 5.9 9.2 10.0 2.4 6.6 3.5 1.6 0.7 0.4 1.5 5.2 5.8 6.4 3.2 2.3 3.3 3.1 0.7 7.5 0.1 3.1 0.6 0.4 0.6 0.7 0.5 0.6 0.5 0.3 0.6 0.6 0.0 0.4 0.5 0.3 2.1 0.2 2.4 3.1 4.4 5.0 2.1 2.4 3.0 2.1 4.1 2.3 23.8 6.4 10.4 6.8 7.8 3.1 5.3 5.1 2.7 12.5 5.2 21.6 0.6 3.3 8.7 7.2 6.2 1.1 0.0 5.5 2.2 3.3 13.8 20.9 0.2 7.2 4.8 17.9 8.6 15.5 11.0 6.9 10.2 3.3 6.4 7.2 1.2 8.5 3.5 6.3 1.4 8.3 0.0 3.1 2.4 5.9 4.4 0.5 9.6 3.1 8.4 ABCC10 "EST182763, MRP7, SIMRP7" ENSG00000124574 "ATP binding cassette subfamily C member 10" Q5T3U5 6 43427366-43450430 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041607, HPA045464" Approved NA NA "HPA041607: AB_2677579, HPA045464: AB_2679336" "unprognostic (2.41e-1)" "unprognostic (2.76e-1)" "unprognostic (1.85e-2)" "unprognostic (2.64e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-2)" "unprognostic (3.01e-3)" "unprognostic (1.85e-2)" "unprognostic (8.88e-2)" "unprognostic (2.64e-1)" "unprognostic (8.35e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (2.75e-1)" "unprognostic (3.85e-1)" "unprognostic (1.58e-1)" "unprognostic (2.80e-2)" 9.2 15.0 13.5 14.4 11.0 11.5 12.6 23.1 15.5 10.3 12.7 12.3 17.1 16.0 15.8 15.1 14.0 12.1 15.6 8.6 12.0 12.8 12.0 11.0 15.9 13.7 10.7 11.7 17.8 30.2 11.0 19.2 15.0 11.2 14.8 13.4 11.6 16.1 14.2 7.8 16.9 17.6 14.9 9.9 13.8 14.3 8.5 9.7 16.2 11.7 6.5 16.7 13.0 11.9 2.1 2.2 7.3 3.5 2.2 6.1 2.8 9.2 4.8 6.3 14.3 13.9 9.0 6.6 9.8 6.9 7.3 6.3 10.5 4.0 1.9 11.6 11.8 5.8 11.7 4.2 7.6 5.3 11.9 8.4 6.7 5.3 20.7 8.6 9.1 10.0 15.5 10.1 9.8 5.4 7.4 9.9 6.4 7.7 10.7 8.6 9.1 5.3 14.1 4.1 22.5 5.8 2.7 1.6 6.7 8.5 15.3 8.8 7.1 5.8 8.3 7.0 5.8 8.1 9.0 10.2 9.1 3.1 8.4 11.6 9.7 4.2 4.8 4.3 6.6 4.2 7.3 3.5 4.2 6.1 1.4 2.6 2.1 4.6 5.4 2.2 1.9 2.7 3.8 1.3 2.2 3.0 1.6 5.2 2.8 13.5 11.0 23.1 15.5 12.0 12.8 10.7 11.7 11.2 9.7 3.0 6.4 0.5 6.4 1.0 8.7 1.9 2.5 10.7 2.3 0.0 9.8 6.1 1.7 3.9 0.7 3.9 4.2 0.0 2.8 4.9 3.9 1.8 5.8 1.5 6.0 11.1 7.5 6.7 3.4 0.4 6.9 4.6 3.3 2.8 4.6 2.8 4.6 4.5 5.6 2.4 4.6 0.0 2.8 1.7 4.4 1.6 3.7 6.9 4.0 2.4 ABCC11 MRP8 ENSG00000121270 "ATP binding cassette subfamily C member 11" Q96J66 16 48166910-48247568 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "breast: 37.3" "Group enriched" "Detected in some" 5 "Early spermatids: 2.7;Hepatocytes: 2.1;Late spermatids: 1.1;Spermatocytes: 3.3" "Group enriched" "Detected in some" 6 "breast cancer: 8.7;prostate cancer: 2.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 2.6" "Group enriched" "Detected in many" 5 "B-cells: 2.6;T-cells: 1.2" "Cell line enriched" "Detected in some" 4 "T-47d: 39.4" "Not detected" "Not detected" NA NA "unprognostic (1.35e-1)" "unprognostic (3.47e-2)" "unprognostic (3.87e-2)" "unprognostic (2.47e-1)" "unprognostic (1.57e-1)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (1.56e-2)" "unprognostic (8.11e-2)" "unprognostic (2.39e-1)" "unprognostic (2.64e-1)" "unprognostic (7.05e-2)" "unprognostic (1.14e-1)" "unprognostic (2.21e-2)" "unprognostic (1.58e-1)" "unprognostic (1.13e-2)" "unprognostic (5.54e-4)" 0.1 0.0 0.8 0.1 0.8 0.1 37.3 0.2 0.5 0.1 0.1 0.1 0.1 0.2 0.1 9.3 0.1 0.4 0.1 0.1 0.4 0.2 0.1 4.0 0.1 0.1 0.7 0.1 0.4 0.1 0.0 2.0 0.1 0.6 2.7 0.0 8.4 0.1 0.1 0.1 0.9 0.1 0.1 0.4 0.1 0.0 3.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 2.6 0.3 0.0 0.2 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 9.3 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 2.6 0.2 1.2 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.2 0.5 0.4 0.2 0.7 0.1 0.6 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.3 0.4 0.0 0.2 0.0 0.0 0.0 ABCC12 MRP9 ENSG00000140798 "ATP binding cassette subfamily C member 12" Q96J65 16 48082973-48156018 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 3.5;testis: 13.4" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 3.1;Late spermatids: 1.9;Spermatocytes: 1.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 4 "cerebral cortex: 3.5;hippocampal formation: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "RPMI-8226: 2.2;T-47d: 4.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA043100 Uncertain NA NA "HPA043100: AB_10794922" "unprognostic (1.53e-1)" "unprognostic (6.87e-2)" "unprognostic (2.37e-2)" "unprognostic (4.62e-3)" "unprognostic (1.88e-1)" "unprognostic (1.59e-2)" "unprognostic (2.65e-1)" "unprognostic (7.53e-2)" "unprognostic (4.23e-1)" 0.1 0.0 0.6 0.1 0.1 0.0 1.9 0.3 3.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 2.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 13.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.3 3.5 2.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 0.0 0.0 ABCC2 "CMOAT, cMRP, DJS, MRP2" ENSG00000023839 "ATP binding cassette subfamily C member 2" Q92887 10 99782732-99852192 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 28.4;kidney: 25.6;liver: 74.3" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 52.9" "Cancer enhanced" "Detected in many" "liver cancer: 24.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.1" "Group enriched" "Detected in some" 5 "A549: 60.2;Hep G2: 60.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA071145 Enhanced NA NA "HPA071145: " "unprognostic (1.49e-3)" "unprognostic (5.92e-2)" "unprognostic (1.59e-1)" "unprognostic (3.67e-1)" "unprognostic (1.93e-2)" "unprognostic (2.33e-1)" "unprognostic (2.51e-1)" "unprognostic (7.15e-3)" "unprognostic (5.68e-2)" "unprognostic (2.01e-1)" "unprognostic (4.30e-1)" "unprognostic (1.40e-3)" "prognostic unfavorable (1.93e-5)" "unprognostic (1.31e-1)" "unprognostic (3.22e-2)" "unprognostic (2.95e-1)" "unprognostic (1.26e-2)" 0.8 0.3 0.1 0.1 0.1 0.1 1.1 0.3 0.1 0.2 13.4 0.1 0.1 16.1 0.3 0.5 0.2 0.4 13.7 0.2 0.1 0.1 25.6 74.3 0.3 0.1 0.1 0.1 0.2 0.6 0.0 0.1 1.2 0.1 0.3 0.0 0.1 0.3 0.1 0.6 0.6 28.4 0.1 0.2 0.8 0.4 0.4 0.1 0.1 0.3 0.4 0.1 0.7 0.3 0.3 0.7 4.1 0.2 0.1 0.5 0.0 0.0 60.2 0.9 3.0 4.6 3.5 1.0 0.1 0.3 0.1 0.2 12.9 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.0 0.2 60.0 0.1 0.0 0.2 0.6 4.1 0.4 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.4 0.1 11.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.9 7.4 0.1 0.0 0.1 0.1 0.1 0.2 0.3 0.1 0.2 0.0 0.0 4.9 1.0 0.3 4.1 0.2 0.3 0.3 0.0 0.4 0.2 0.3 0.1 0.3 0.3 0.3 0.1 1.3 0.1 0.1 0.7 0.5 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.1 0.0 0.2 0.4 2.5 4.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.2 1.1 52.9 0.2 0.0 0.0 0.6 1.3 0.2 0.3 0.0 5.0 0.0 0.0 0.2 0.1 0.0 0.0 9.1 1.4 0.0 0.4 0.7 0.3 0.0 1.4 0.0 0.0 0.0 ABCC3 "cMOAT2, EST90757, MLP2, MOAT-D, MRP3" ENSG00000108846 "ATP binding cassette subfamily C member 3" O15438 17 50634777-50692252 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 53.5;liver: 66.2" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 262.4;Enterocytes: 161.4;Hepatocytes: 155.5;Paneth cells: 153.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 6.2;non-classical monocyte: 7.6" "Lineage enriched" "Detected in many" 5 "monocytes: 7.6" "Cell line enhanced" "Detected in many" "A549: 31.4;CAPAN-2: 24.0;OE19: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB037136, HPA048483" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB037136: AB_477165, HPA048483: AB_2680414" "unprognostic (1.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (1.65e-2)" "unprognostic (9.67e-3)" "unprognostic (6.19e-3)" "unprognostic (7.44e-3)" "unprognostic (8.20e-2)" "unprognostic (3.18e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (9.57e-4)" "unprognostic (1.60e-3)" "prognostic unfavorable (4.68e-6)" "unprognostic (3.42e-1)" "unprognostic (4.77e-2)" "unprognostic (4.44e-2)" "unprognostic (1.57e-3)" 3.5 36.0 0.4 17.0 0.4 0.5 7.7 0.3 0.4 1.9 23.9 0.8 14.1 10.3 1.6 4.6 5.3 1.0 53.5 0.8 0.4 0.4 13.5 66.2 9.0 10.3 0.6 0.0 1.0 22.2 1.7 0.8 3.5 1.5 5.4 7.7 0.8 4.7 23.6 0.4 4.8 37.0 2.5 4.6 4.9 12.8 1.0 0.0 0.8 4.5 7.0 7.9 7.1 3.5 0.0 1.6 1.3 7.6 0.3 0.5 7.4 2.2 31.4 0.0 0.1 1.8 2.8 0.0 4.2 5.2 0.3 0.3 1.7 24.0 0.0 3.3 8.2 5.9 5.7 0.0 0.4 0.4 0.0 0.0 0.6 13.2 9.5 7.1 0.0 0.0 3.1 2.3 1.2 2.5 3.5 0.5 0.0 0.0 0.0 3.3 7.3 0.0 0.0 0.0 34.9 4.1 0.0 0.0 0.1 13.7 13.6 0.0 0.2 7.6 1.3 0.0 0.0 1.0 0.0 6.9 0.2 1.4 0.1 3.3 0.0 0.0 0.0 3.4 0.0 0.3 0.3 2.8 0.0 0.0 6.2 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 1.3 0.3 7.6 0.2 0.5 7.4 0.4 0.4 0.3 0.4 0.4 0.4 0.6 0.0 1.5 0.0 17.9 5.6 2.4 103.4 8.4 1.2 2.5 262.4 0.0 23.9 14.0 0.0 0.3 5.0 84.3 55.0 1.4 161.4 0.0 92.3 3.0 3.5 62.4 0.0 155.5 27.5 1.6 22.7 4.9 18.2 59.8 8.3 13.8 3.3 4.6 85.5 3.7 82.4 153.0 2.8 7.9 0.1 0.0 5.2 0.7 0.6 9.3 0.8 2.5 66.2 81.6 ABCC4 "EST170205, MOAT-B, MOATB, MRP4" ENSG00000125257 "ATP binding cassette subfamily C member 4" O15439 13 95019829-95301475 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 35.0" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 38.5;granulocytes: 53.1;Proximal tubular cells: 32.7" "Cancer enriched" "Detected in all" 8 "prostate cancer: 90.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HEL: 61.8;HMC-1: 67.7;RPTEC TERT1: 18.2" "Low region specificity" "Detected in all" HPA002476 Enhanced Approved "Nucleoli,Golgi apparatus,Plasma membrane" NA NA "Nucleoli, Plasma membrane" "Golgi apparatus" "HPA002476: AB_1844434" "unprognostic (8.77e-2)" "unprognostic (1.94e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.89e-4)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (7.45e-3)" "unprognostic (2.40e-2)" "unprognostic (9.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.55e-2)" "prognostic favorable (2.25e-10)" "unprognostic (7.44e-3)" "unprognostic (1.67e-1)" "unprognostic (5.55e-2)" "unprognostic (2.35e-2)" 3.2 1.7 3.8 11.8 4.7 2.9 6.2 1.0 4.6 4.4 11.6 10.3 3.9 4.1 5.8 16.4 3.0 8.6 10.3 3.5 5.7 3.9 19.6 1.9 13.8 7.4 6.6 2.2 7.2 3.5 7.0 2.8 1.8 7.4 35.0 7.3 6.0 3.3 5.2 7.6 4.5 7.4 11.1 6.5 3.8 8.2 3.8 7.0 3.4 6.6 3.1 5.8 25.6 13.4 3.6 4.1 1.0 4.8 4.1 3.6 3.4 4.5 8.0 1.3 2.4 2.5 3.3 0.3 3.6 3.7 3.3 2.8 11.1 3.4 2.5 2.4 4.9 2.4 6.2 2.0 1.8 4.1 7.5 3.1 61.8 2.5 2.2 5.1 7.0 67.7 2.5 0.8 2.3 4.8 4.7 4.2 2.8 6.4 0.1 4.4 1.4 1.3 1.1 1.5 5.5 1.9 1.9 3.7 6.6 18.2 10.3 3.3 2.4 1.2 0.2 2.5 1.5 0.0 3.8 6.9 3.5 2.2 2.9 4.3 0.0 0.0 1.0 6.6 4.0 1.7 0.6 1.2 0.4 3.2 1.2 2.7 3.6 2.6 3.6 4.1 2.7 1.6 3.5 1.0 4.1 4.8 0.7 3.3 3.4 3.8 4.7 1.0 4.6 5.7 3.9 6.6 2.2 7.4 7.0 8.9 28.3 3.7 6.2 3.8 0.0 3.1 5.1 6.7 11.4 22.7 21.6 0.1 0.0 5.2 3.2 11.3 1.4 0.0 2.6 0.4 3.9 38.5 53.1 0.0 3.8 0.0 0.0 2.5 1.0 1.7 6.4 6.3 1.7 19.0 3.2 0.3 4.1 9.3 1.8 32.7 0.7 0.0 3.9 0.6 9.1 6.6 0.2 2.2 7.8 3.7 ABCC5 "EST277145, MOAT-C, MRP5, SMRP" ENSG00000114770 "ATP binding cassette subfamily C member 5" O15440 3 183919934-184018015 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 184.6;Rod photoreceptor cells: 122.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044067, HPA052295" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA044067: AB_2678797, HPA052295: AB_2681789" "unprognostic (9.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.83e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.78e-8)" "unprognostic (4.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.02e-1)" "unprognostic (5.91e-3)" "prognostic unfavorable (3.40e-4)" "unprognostic (1.10e-1)" "unprognostic (9.05e-3)" "unprognostic (1.64e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-2)" 7.9 11.2 24.7 9.6 26.2 12.0 6.7 42.8 28.6 7.7 11.4 12.0 13.4 6.8 14.1 7.0 17.1 6.1 11.6 16.0 19.1 13.7 12.8 3.6 9.4 7.3 20.5 18.5 11.8 4.9 22.4 20.5 10.8 21.7 10.6 14.4 31.1 7.4 9.3 41.0 14.5 8.5 10.5 12.9 16.3 48.5 9.4 20.9 9.3 5.5 7.3 7.4 18.1 12.7 4.2 3.5 15.8 4.5 5.0 7.0 4.5 7.3 4.1 9.4 11.2 9.4 10.7 14.6 6.0 4.7 5.4 5.9 6.3 5.7 8.0 14.1 5.7 8.2 29.9 11.6 6.6 7.1 8.7 11.2 16.9 10.3 5.7 3.9 5.1 13.2 17.0 6.7 5.8 3.8 11.1 6.3 23.7 15.7 11.1 9.2 19.5 14.1 5.9 9.7 13.4 7.9 9.8 3.1 4.7 19.6 48.0 17.2 10.2 6.1 33.9 10.1 12.7 20.5 1.6 7.2 6.3 6.2 8.0 8.2 4.3 8.3 7.4 4.6 10.3 6.4 10.7 4.5 7.7 7.0 2.1 4.5 3.2 4.0 3.1 3.5 4.2 4.6 6.3 15.8 5.0 3.5 1.3 5.0 4.5 24.7 26.2 42.8 28.6 19.1 13.7 20.5 18.5 21.7 20.9 8.9 4.0 1.9 12.9 7.9 34.3 31.9 2.5 56.2 46.6 41.8 184.6 2.7 6.6 5.0 4.8 6.7 9.5 0.0 4.0 3.9 8.0 10.9 4.7 2.4 39.9 31.8 56.9 5.5 27.9 2.2 7.5 11.2 11.8 6.4 6.3 9.4 6.1 9.3 7.4 2.7 122.3 0.0 8.6 3.1 14.7 10.7 3.8 5.0 7.2 50.3 ABCC6 "ARA, EST349056, MLP1, MRP6, PXE, URG7" ENSG00000091262 "ATP binding cassette subfamily C member 6" O95255 16 16148928-16223522 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 27.4" "Cell type enhanced" "Detected in many" 14 "Distal tubular cells: 38.1;Hepatocytes: 56.7;Proximal tubular cells: 117.8" "Cancer enhanced" "Detected in many" "liver cancer: 16.7" "Cell type enriched" "Detected in some" 5 "classical monocyte: 7.3" "Lineage enriched" "Detected in many" 5 "monocytes: 7.3" "Cell line enriched" "Detected in some" 8 "Hep G2: 38.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA038105 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA038105: AB_2675835" "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (5.98e-2)" "unprognostic (3.15e-2)" "unprognostic (1.59e-1)" "unprognostic (3.09e-1)" "prognostic favorable (3.82e-4)" "unprognostic (6.54e-3)" "unprognostic (3.64e-1)" "unprognostic (9.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-3)" "unprognostic (3.42e-1)" "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.41e-1)" 2.3 1.4 0.2 0.0 0.2 0.0 1.1 0.0 0.0 0.1 1.5 7.0 0.0 0.0 0.0 0.3 1.2 0.8 0.1 0.1 9.0 27.4 2.8 0.0 0.2 0.1 6.7 0.5 0.1 0.0 0.7 1.2 6.7 0.2 1.7 0.0 3.7 0.0 0.2 0.1 2.2 0.0 2.2 0.0 0.0 0.0 0.2 0.9 1.3 7.3 0.6 0.1 1.2 0.0 0.9 0.4 0.0 0.0 0.5 1.1 0.0 0.2 0.6 0.9 3.8 1.5 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.4 1.1 0.1 38.6 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.6 0.1 0.5 0.1 0.2 4.9 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 7.3 0.3 0.0 1.0 0.0 0.0 0.1 0.0 0.9 0.2 0.1 0.1 1.3 0.6 0.1 0.1 0.0 1.2 26.8 26.9 3.6 0.7 0.1 0.3 2.4 20.4 18.7 9.1 8.7 0.0 0.0 38.1 1.6 0.2 0.6 19.1 0.0 7.1 0.0 1.0 1.6 1.1 56.7 1.1 0.0 2.9 1.8 4.1 0.4 1.4 1.5 1.7 1.0 13.4 1.3 2.9 3.5 5.3 117.8 0.7 0.0 0.5 0.1 0.2 0.6 0.0 0.0 13.3 0.4 ABCC8 "ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2" ENSG00000006071 "ATP binding cassette subfamily C member 8" Q09428 11 17392498-17476879 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;pancreas: 25.5;pituitary gland: 26.6" "Group enriched" "Detected in some" 8 "Bipolar cells: 39.2;Intestinal endocrine cells: 21.0" "Cancer enriched" "Detected in some" 9 "pancreatic cancer: 16.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A549: 4.7;AN3-CA: 3.8;SCLC-21H: 6.7" "Low region specificity" "Detected in all" "CAB011451, HPA042318" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" No NA Nucleoli "Golgi apparatus, Cytosol" "CAB011451: , HPA042318: AB_2677947" "unprognostic (4.30e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (4.73e-2)" "unprognostic (9.48e-3)" "unprognostic (2.23e-1)" "unprognostic (4.46e-3)" "unprognostic (2.53e-3)" "unprognostic (6.04e-2)" "unprognostic (2.34e-2)" "unprognostic (8.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.22e-2)" "unprognostic (1.96e-2)" "unprognostic (6.88e-5)" "unprognostic (2.72e-2)" "unprognostic (1.85e-1)" 1.3 6.7 4.4 0.8 6.1 0.9 4.0 28.0 12.3 3.0 1.3 2.6 7.7 1.9 3.1 3.7 0.8 1.2 0.9 2.9 5.1 4.8 1.0 0.8 2.9 0.8 3.6 7.2 0.9 25.5 1.0 26.6 1.6 8.5 2.8 1.3 0.7 0.9 8.5 2.3 1.1 1.5 1.3 4.0 0.9 3.5 1.1 2.3 0.0 6.2 0.0 0.8 0.7 0.8 0.1 0.0 0.5 0.0 0.1 0.2 0.0 0.0 4.7 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 4.4 6.1 28.0 12.3 5.1 4.8 3.6 7.2 8.5 2.3 0.0 0.0 0.0 0.0 0.0 39.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 21.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.0 0.0 1.2 0.0 1.6 0.0 0.2 0.1 0.0 0.0 0.0 0.1 ABCC9 "CMD1O, SUR2" ENSG00000069431 "ATP binding cassette subfamily C member 9" O60706 12 21797401-21942529 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" Transport Receptor "Atrial fibrillation, Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 47.6;Hepatocytes: 84.7;Sertoli cells: 129.4;Smooth muscle cells: 47.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 17.6;BJ hTERT+: 10.1;CACO-2: 16.0;HSkMC: 21.0;U-138 MG: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007279 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007279: AB_1844435" "unprognostic (4.82e-2)" "unprognostic (3.62e-2)" "unprognostic (5.51e-4)" "unprognostic (1.09e-1)" "unprognostic (1.09e-1)" "unprognostic (8.30e-2)" "unprognostic (3.17e-2)" "unprognostic (1.50e-2)" "unprognostic (2.47e-2)" "unprognostic (8.72e-2)" "unprognostic (2.51e-2)" "unprognostic (3.57e-1)" "prognostic unfavorable (1.85e-5)" "unprognostic (2.66e-2)" "unprognostic (1.21e-2)" "unprognostic (3.10e-3)" "unprognostic (8.22e-5)" 21.6 4.7 5.5 2.6 5.4 1.2 25.8 1.5 8.6 12.4 6.8 4.8 5.1 3.0 15.3 6.3 9.1 9.5 9.6 26.2 5.7 2.6 5.6 31.1 6.2 2.7 2.9 4.2 11.8 5.8 1.7 2.7 2.8 5.5 7.0 1.6 10.8 4.8 8.4 33.2 3.3 4.1 17.1 4.9 3.5 9.1 3.4 4.2 0.1 6.3 14.5 1.2 9.5 8.4 1.6 0.9 1.8 0.8 0.5 0.9 0.0 0.6 0.1 7.5 0.2 17.6 8.0 0.2 4.1 10.1 4.5 2.3 16.0 0.7 0.3 0.8 0.4 0.5 0.2 0.0 0.0 4.7 0.2 0.1 0.3 0.5 0.2 0.0 0.3 0.4 21.0 0.0 4.5 1.7 0.3 0.0 0.3 0.2 0.9 0.2 0.9 0.2 0.2 1.0 0.8 0.4 0.3 0.2 0.2 0.0 0.8 0.3 1.2 0.2 0.4 0.1 1.2 0.8 0.2 0.2 17.5 1.3 1.5 5.3 0.8 0.8 0.3 4.3 0.2 0.3 0.9 0.5 0.4 0.9 0.4 0.6 0.7 0.7 0.7 0.2 1.6 0.6 0.8 1.8 0.5 0.8 0.9 0.4 0.0 5.5 5.4 1.5 8.6 5.7 2.6 2.9 4.2 5.5 4.2 32.8 47.6 0.0 1.0 3.1 0.4 27.8 0.0 36.1 39.8 0.0 0.0 0.2 0.0 0.0 0.2 4.9 0.0 0.0 0.2 0.1 10.6 0.4 22.1 84.7 0.1 1.6 0.0 11.1 3.3 0.0 0.3 2.1 10.1 0.0 0.0 13.1 0.1 0.0 0.4 0.0 1.1 129.4 47.2 0.5 0.7 1.9 0.2 0.0 0.0 1.4 ABCD3 "PMP70, PXMP1, ZWS2" ENSG00000117528 "ATP binding cassette subfamily D member 3" P28288 1 94418455-94518666 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032026, HPA032027, CAB032516, CAB075749" Enhanced Enhanced Peroxisomes NA NA Peroxisomes "CAB032516: AB_2257637, CAB075749: AB_2665755, HPA032026: AB_2674117, HPA032027: AB_10602103" "unprognostic (1.41e-2)" "unprognostic (3.21e-1)" "prognostic favorable (1.16e-5)" "unprognostic (1.92e-1)" "unprognostic (5.42e-2)" "unprognostic (1.56e-1)" "unprognostic (1.94e-2)" "unprognostic (2.54e-2)" "unprognostic (5.10e-2)" "unprognostic (3.20e-2)" "unprognostic (1.01e-1)" "unprognostic (9.12e-2)" "prognostic favorable (4.84e-5)" "unprognostic (5.45e-2)" "unprognostic (6.20e-2)" "unprognostic (3.41e-1)" "unprognostic (1.29e-1)" 8.9 14.2 13.1 9.5 13.3 10.3 16.8 11.2 12.8 11.8 21.2 14.9 24.9 21.4 9.8 14.6 15.4 10.0 17.3 16.0 12.7 10.3 29.3 60.6 11.2 9.9 13.2 10.4 8.1 16.7 18.3 14.6 11.2 14.3 11.0 20.1 21.4 13.2 24.0 12.9 17.1 21.7 10.8 16.5 7.6 20.8 10.2 12.7 46.5 13.7 10.8 9.9 11.8 11.1 3.1 8.4 3.9 6.2 8.0 7.4 4.2 28.2 13.3 13.7 13.1 10.6 11.7 20.4 14.8 11.5 17.0 19.0 41.4 8.9 17.5 19.2 18.7 18.3 20.8 15.8 19.1 24.0 14.0 13.6 19.9 19.6 35.9 10.3 17.6 6.2 9.8 10.8 19.8 7.6 11.1 10.4 16.7 8.8 10.5 17.6 3.9 29.6 9.3 15.8 21.7 18.9 16.7 28.6 6.8 16.9 43.3 10.4 17.1 25.6 27.2 19.2 10.9 10.0 14.7 10.3 12.7 18.4 22.2 19.6 6.0 5.6 17.1 9.9 9.0 5.9 0.3 5.3 3.9 6.5 6.2 6.1 2.8 5.9 7.4 8.4 3.1 7.1 6.9 1.3 8.0 5.2 2.2 6.5 4.2 13.1 13.3 11.2 12.8 12.7 10.3 13.2 10.4 14.3 12.7 32.8 39.0 10.4 16.3 20.7 25.9 36.4 63.7 30.8 25.0 40.1 21.6 22.7 19.9 19.9 5.4 12.0 62.4 0.0 38.4 9.6 17.3 22.1 27.6 99.9 10.1 31.8 38.2 20.3 21.6 6.2 12.7 12.6 15.1 2.8 38.1 85.8 29.7 28.1 23.0 56.2 22.8 19.4 12.3 10.4 23.7 29.6 12.8 10.5 32.8 20.0 ABCD4 "EST352188, P70R, PMP69, PXMP1L" ENSG00000119688 "ATP binding cassette subfamily D member 4" O14678 14 74285423-74303056 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003396 Approved NA NA "HPA003396: AB_1078078" "unprognostic (3.92e-2)" "unprognostic (3.02e-1)" "unprognostic (3.01e-3)" "unprognostic (5.86e-2)" "unprognostic (3.69e-1)" "unprognostic (1.67e-1)" "unprognostic (5.72e-2)" "unprognostic (4.34e-2)" "unprognostic (3.46e-2)" "unprognostic (4.63e-2)" "unprognostic (2.21e-3)" "unprognostic (5.26e-2)" "unprognostic (2.35e-2)" "unprognostic (1.25e-1)" "unprognostic (6.69e-2)" "unprognostic (7.45e-3)" "unprognostic (7.93e-3)" 17.1 13.0 17.2 13.6 21.9 11.8 15.1 23.4 21.3 13.3 16.7 22.7 15.1 23.4 18.3 17.0 13.6 23.8 21.4 16.6 15.7 15.7 18.6 22.2 16.3 16.4 20.9 11.7 22.2 17.1 12.4 19.7 19.9 17.7 13.4 11.5 15.7 12.7 15.7 11.3 11.7 22.8 14.7 21.7 17.8 13.1 15.7 17.9 13.3 20.0 8.6 13.5 16.4 14.7 3.1 6.7 9.6 2.5 4.0 7.6 2.7 2.7 3.3 8.3 6.4 6.9 4.5 10.1 4.3 5.8 6.0 6.4 6.6 14.1 4.6 7.9 6.2 3.4 9.3 6.2 5.7 3.3 3.9 3.8 2.3 4.4 5.1 2.4 2.8 4.8 11.0 2.5 4.2 2.8 3.4 10.0 6.6 4.3 2.0 4.8 4.7 7.9 5.8 3.0 5.1 6.1 9.7 11.8 6.5 9.3 8.9 3.9 7.7 5.6 5.8 6.0 4.1 12.7 1.8 10.2 3.8 7.7 3.3 2.6 4.7 4.4 3.4 5.5 4.3 4.7 9.6 2.5 2.7 5.0 1.9 3.1 2.9 4.4 5.7 3.9 3.1 2.5 3.5 1.7 4.0 1.5 6.7 7.6 2.7 17.2 21.9 23.4 21.3 15.7 15.7 20.9 11.7 17.7 17.9 26.8 15.2 13.7 13.8 13.9 45.9 7.7 22.9 14.7 17.0 19.2 60.9 44.0 8.3 20.7 9.5 46.4 28.5 0.0 10.0 16.4 24.0 11.2 19.7 19.5 41.8 30.2 11.5 34.4 15.8 5.6 37.4 19.9 20.3 26.2 18.2 43.1 15.4 22.9 23.7 17.7 57.1 32.3 14.6 31.9 22.3 9.4 23.8 29.8 21.1 14.4 ABCG1 ABC8 ENSG00000160179 "ATP binding cassette subfamily G member 1" P45844 21 42199689-42297244 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 47.1;Rod photoreceptor cells: 107.9;Syncytiotrophoblasts: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 19.2;neutrophil: 20.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 20.5" "Cell line enhanced" "Detected in many" "hTCEpi: 13.2;JURKAT: 19.6;MCF7: 16.5;MOLT-4: 15.3;OE19: 27.4;RPMI-8226: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031470, HPA031471" Approved Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA031470: AB_10599188, HPA031471: AB_10600201" "unprognostic (2.89e-2)" "unprognostic (2.53e-2)" "unprognostic (9.96e-2)" "unprognostic (4.20e-3)" "unprognostic (2.87e-1)" "unprognostic (3.09e-2)" "unprognostic (5.74e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.66e-3)" "unprognostic (3.66e-3)" "unprognostic (6.37e-2)" "prognostic favorable (7.16e-6)" "unprognostic (1.40e-2)" "unprognostic (2.00e-2)" "unprognostic (1.66e-1)" "unprognostic (2.42e-2)" 19.9 36.4 14.2 10.0 17.6 6.2 13.3 15.9 15.3 7.7 12.1 17.8 3.8 15.3 5.6 3.8 4.1 6.5 11.9 9.7 12.4 8.0 8.2 5.6 25.2 23.1 20.8 12.2 6.0 4.7 15.4 11.1 12.0 9.6 6.3 13.5 12.1 13.7 6.7 26.8 15.1 18.6 5.8 7.0 29.4 13.7 1.9 19.5 15.4 8.5 5.2 10.4 12.5 12.6 4.8 1.4 20.5 0.9 3.7 4.0 1.0 0.0 3.0 2.4 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.9 0.4 0.0 0.3 0.5 0.0 4.4 0.0 4.2 0.2 5.0 10.0 0.0 9.2 0.0 0.2 1.0 13.2 0.0 2.0 0.0 9.3 19.6 0.0 0.0 0.0 16.5 15.3 0.1 0.7 27.4 5.2 0.2 0.0 12.5 0.0 1.4 11.6 3.0 1.8 6.9 0.0 0.2 2.9 0.4 5.9 0.0 2.5 0.0 0.0 6.8 1.9 0.0 0.0 1.6 0.2 0.9 0.9 19.2 1.8 0.3 3.4 3.1 3.7 3.6 0.6 4.8 3.5 2.9 20.5 3.7 0.1 1.4 4.0 1.0 14.2 17.6 15.9 15.3 12.4 8.0 20.8 12.2 9.6 19.5 6.0 8.0 6.7 6.0 7.9 46.2 7.8 2.5 1.4 5.7 24.4 47.1 5.2 3.3 2.2 3.7 31.7 7.8 0.0 1.1 1.0 4.6 3.8 0.0 0.0 15.2 11.1 3.4 39.9 25.5 4.3 0.3 18.8 3.3 5.4 9.1 14.3 1.5 4.8 1.8 0.9 107.9 6.5 5.2 0.6 0.7 5.8 52.7 12.9 0.9 2.6 ABCG2 "ABCP, BCRP, CD338, EST157481, MXR" ENSG00000118777 "ATP binding cassette subfamily G member 2 (Junior blood group)" Q9UNQ0 4 88090264-88231322 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 135.7;Extravillous trophoblasts: 47.1;Hofbauer cells: 105.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 18.8;BEWO: 32.9;OE19: 25.5;RPMI-8226: 16.5;SuSa: 12.7" "CAB037299, HPA054719" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB037299: AB_476804, HPA054719: " "unprognostic (5.04e-1)" "unprognostic (3.05e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.14e-2)" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (4.52e-2)" "unprognostic (1.67e-3)" "unprognostic (8.82e-3)" "unprognostic (7.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.92e-1)" 2.8 2.5 11.6 0.8 14.8 1.2 2.4 4.3 9.7 13.6 12.5 8.4 49.6 24.9 14.4 4.2 1.5 6.1 3.3 2.0 16.0 12.2 2.3 19.7 3.0 0.8 17.6 5.6 5.6 0.6 3.2 7.0 12.3 17.0 5.5 8.1 6.9 2.9 61.0 0.4 0.6 56.6 11.8 15.7 0.9 1.2 1.9 5.5 0.0 3.8 0.8 1.3 2.0 3.1 1.2 0.5 0.0 0.2 2.4 5.7 0.7 0.6 18.8 5.6 0.0 0.2 0.0 32.9 0.7 0.6 1.0 1.6 4.1 0.2 0.0 0.2 0.1 2.4 5.5 0.1 0.5 1.4 5.3 0.8 0.2 0.1 5.6 0.0 0.2 0.0 0.1 2.3 2.2 0.1 0.5 1.7 0.4 0.4 0.0 0.6 10.9 2.6 0.0 1.9 25.5 0.0 1.2 0.0 16.5 0.0 4.0 0.0 0.2 3.9 0.4 0.5 12.7 0.1 0.0 0.0 0.7 0.7 0.2 0.0 5.2 1.9 0.0 1.4 0.0 0.8 0.0 0.0 0.0 1.9 0.0 5.7 0.1 0.7 0.6 0.0 1.2 0.7 0.3 0.0 2.4 0.2 0.5 1.7 0.7 11.6 14.8 4.3 9.7 16.0 12.2 17.6 5.6 17.0 5.5 3.0 1.4 0.5 0.2 3.4 0.0 1.1 0.0 1.4 0.0 0.0 0.0 14.3 1.7 0.0 2.6 9.0 135.7 0.0 0.2 47.1 2.1 0.2 5.7 25.0 105.8 0.0 2.9 13.5 1.0 0.4 1.1 1.1 5.0 0.0 2.9 0.9 0.1 35.1 0.4 4.5 0.2 0.0 1.4 0.9 3.4 0.4 31.5 0.8 0.8 0.1 ABCG4 WHITE2 ENSG00000172350 "ATP binding cassette subfamily G member 4" Q9H172 11 119149012-119162653 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 20.7;parathyroid gland: 7.4;retina: 7.5;testis: 7.2" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 47.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;HAP1: 2.9;U-2 OS: 2.8" "Low region specificity" "Detected in all" HPA057635 Enhanced NA NA "HPA057635: " "unprognostic (3.26e-2)" "unprognostic (4.75e-4)" "unprognostic (6.31e-2)" "unprognostic (1.83e-3)" "unprognostic (3.76e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "unprognostic (9.35e-2)" "unprognostic (1.67e-1)" "unprognostic (9.07e-2)" "unprognostic (3.29e-2)" "unprognostic (8.78e-2)" "unprognostic (2.25e-1)" "unprognostic (4.15e-4)" "unprognostic (2.26e-1)" "unprognostic (6.48e-3)" "unprognostic (2.65e-3)" 0.7 1.6 3.9 0.7 5.7 0.3 0.4 20.7 12.8 0.8 0.8 0.8 0.0 0.9 1.1 1.3 1.9 0.6 1.2 2.2 4.9 6.6 0.8 0.5 0.5 0.5 4.7 5.2 0.5 1.2 7.4 0.3 0.7 12.7 0.9 0.7 7.5 0.4 2.0 0.4 1.2 0.7 1.4 1.5 0.5 0.5 7.2 0.5 0.6 1.5 0.0 1.5 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 1.2 5.5 0.8 0.0 0.1 0.2 0.1 0.7 1.5 0.0 0.1 0.0 0.6 0.2 2.4 0.5 2.9 0.3 0.7 0.3 1.0 1.0 0.1 0.0 1.9 0.0 1.6 0.5 0.0 1.0 0.0 0.7 1.2 2.8 0.1 0.1 0.9 0.2 0.4 0.0 2.4 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.5 1.1 1.7 0.2 0.1 0.3 0.4 0.0 0.2 0.4 2.8 0.4 0.2 0.3 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.7 20.7 12.8 4.9 6.6 4.7 5.2 12.7 0.5 0.0 0.0 0.0 0.0 0.0 11.4 0.8 0.0 0.0 0.0 0.0 55.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 47.1 0.0 0.1 3.1 0.6 0.0 0.1 0.0 0.0 0.0 ABCG5 STSL ENSG00000138075 "ATP binding cassette subfamily G member 5" Q9H222 2 43812472-43838865 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 85 "intestine: 54.3;liver: 40.9" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 47.3" "Cancer enriched" "Detected in some" 23 "liver cancer: 11.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 47 "Hep G2: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.71e-1)" "unprognostic (5.47e-2)" "unprognostic (4.01e-1)" "unprognostic (6.92e-2)" "unprognostic (2.24e-1)" "unprognostic (9.97e-2)" "prognostic favorable (2.60e-5)" "unprognostic (4.59e-2)" "unprognostic (3.10e-1)" "unprognostic (1.38e-3)" "unprognostic (3.07e-4)" "unprognostic (1.86e-1)" "unprognostic (3.07e-1)" "unprognostic (5.52e-3)" "unprognostic (8.29e-2)" "unprognostic (5.31e-2)" "unprognostic (3.08e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 19.5 0.0 0.0 27.6 0.1 0.2 0.1 0.1 0.5 0.1 0.1 0.1 0.1 40.9 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 54.3 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 5.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 ABCG8 GBD4 ENSG00000143921 "ATP binding cassette subfamily G member 8" Q9H221 2 43831942-43882987 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "intestine: 62.4;liver: 64.4" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 24.1" "Cancer enriched" "Detected in some" 30 "liver cancer: 21.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 47 "Hep G2: 14.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA019556 Uncertain Approved Vesicles NA NA Vesicles "HPA019556: AB_1844444" "unprognostic (1.99e-1)" "unprognostic (4.49e-1)" "unprognostic (3.22e-1)" "unprognostic (1.37e-1)" "unprognostic (3.09e-2)" "unprognostic (2.43e-1)" "unprognostic (1.99e-3)" "unprognostic (1.27e-1)" "unprognostic (6.28e-1)" "unprognostic (6.14e-3)" "unprognostic (4.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.68e-1)" "unprognostic (7.86e-3)" "unprognostic (5.03e-1)" "unprognostic (1.50e-1)" 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.4 0.1 21.2 0.0 0.0 24.0 0.1 0.1 0.1 0.1 1.7 0.1 0.2 0.3 0.2 64.4 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 62.4 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.6 2.1 0.3 0.5 0.8 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 14.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 2.1 0.3 0.4 0.7 0.3 0.5 0.5 0.6 0.5 0.1 0.7 0.8 0.7 1.7 0.5 0.3 0.6 0.3 0.2 0.2 0.3 0.1 0.4 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.1 0.0 1.2 1.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ABHD1 "FLJ36128, LABH1" ENSG00000143994 "Abhydrolase domain containing 1" Q96SE0 2 27123789-27130812 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 58.4" "Group enriched" "Detected in many" 22 "Early spermatids: 249.7;Late spermatids: 777.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 3.3;T-47d: 6.8;U-266/70: 6.6;U-266/84: 5.4" "Low region specificity" "Detected in all" HPA044390 Uncertain NA NA "HPA044390: AB_10959380" "unprognostic (1.20e-3)" "unprognostic (6.07e-3)" "unprognostic (7.71e-4)" "unprognostic (1.63e-2)" "unprognostic (6.68e-2)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-3)" "unprognostic (2.75e-1)" "unprognostic (1.76e-1)" "unprognostic (9.09e-4)" "unprognostic (9.76e-2)" "unprognostic (1.70e-2)" "unprognostic (6.88e-2)" "unprognostic (4.06e-2)" "unprognostic (3.09e-2)" "unprognostic (7.97e-2)" 1.3 0.9 0.9 0.2 1.4 0.0 0.7 0.3 0.8 0.3 0.2 1.2 0.5 0.1 0.4 1.4 0.2 0.3 0.3 1.6 0.5 0.4 0.5 4.4 0.2 0.8 0.6 1.0 0.5 0.3 0.6 0.4 0.0 1.0 1.0 0.0 1.1 6.4 0.3 2.2 0.2 0.2 0.5 0.8 0.3 0.3 58.4 0.2 0.0 0.5 1.5 0.1 0.2 0.2 2.3 0.3 1.9 0.8 0.0 2.7 0.7 0.2 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.2 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 1.1 0.0 0.0 3.3 0.2 0.0 0.0 0.7 0.1 0.6 0.3 0.1 6.8 0.5 0.0 0.0 0.1 0.0 0.4 6.6 5.4 0.1 0.2 0.2 0.3 0.1 0.8 1.9 2.7 0.1 0.9 2.3 1.4 1.3 0.2 0.7 1.4 0.7 1.3 0.0 0.0 0.3 0.0 0.7 0.9 1.4 0.3 0.8 0.5 0.4 0.6 1.0 1.0 0.2 0.0 0.0 0.8 2.1 0.0 4.7 2.5 0.0 1.4 0.0 0.0 7.9 0.1 0.0 0.1 249.7 0.6 0.0 23.3 0.2 0.0 0.8 3.0 1.1 2.5 0.1 0.0 0.0 2.5 0.0 777.1 6.1 0.4 0.0 0.0 0.0 8.3 0.0 0.0 5.3 2.2 5.0 0.0 0.9 23.4 3.9 0.3 0.0 0.9 0.0 2.6 ABHD12 "ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106" ENSG00000100997 "Abhydrolase domain containing 12" Q8N2K0 20 25294743-25390983 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Cataract, Deafness, Disease mutation, Neuropathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026866 Uncertain NA NA "HPA026866: AB_1844446" "prognostic unfavorable (3.81e-5)" "prognostic favorable (1.30e-5)" "unprognostic (1.32e-1)" "unprognostic (8.74e-2)" "unprognostic (3.67e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (7.18e-4)" "unprognostic (8.51e-2)" "unprognostic (7.91e-3)" "unprognostic (2.08e-1)" "unprognostic (4.08e-2)" "unprognostic (8.46e-2)" "unprognostic (1.36e-3)" "unprognostic (2.45e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-1)" "unprognostic (8.11e-3)" 11.3 13.4 27.4 10.0 32.1 9.8 10.4 22.3 39.8 11.1 15.6 30.8 14.1 20.7 9.1 58.9 20.4 11.3 14.0 12.2 41.5 25.9 18.9 13.1 14.0 10.3 31.5 21.0 13.8 65.6 16.0 14.4 25.6 26.9 15.6 15.2 11.5 13.8 17.4 4.0 16.2 21.1 9.9 43.3 7.8 22.1 7.6 19.0 10.2 36.8 7.9 16.0 15.7 10.9 3.9 14.6 12.6 14.2 11.1 11.5 6.0 14.9 34.2 8.8 11.1 18.1 10.8 21.8 21.5 18.0 16.9 19.5 20.0 22.9 4.7 12.2 16.9 40.3 24.3 11.2 12.8 14.4 4.9 9.0 7.6 9.4 27.7 14.4 7.3 16.2 13.5 8.4 20.8 9.9 20.6 7.7 8.8 5.5 71.7 16.0 30.9 11.0 7.7 6.8 18.5 21.7 8.5 22.7 44.7 11.4 31.1 11.3 9.5 18.1 44.7 31.8 16.4 15.1 12.5 9.6 21.4 14.5 13.0 12.4 8.4 7.8 7.5 14.9 8.7 13.7 9.8 14.2 12.6 8.0 12.2 6.4 3.1 8.8 11.5 14.6 3.9 7.5 7.4 1.8 11.1 13.1 13.1 7.9 6.0 27.4 32.1 22.3 39.8 41.5 25.9 31.5 21.0 26.9 19.0 6.0 6.2 9.7 26.7 15.8 33.4 14.0 38.2 10.7 9.1 26.2 9.8 77.6 23.2 30.2 42.1 13.8 92.3 0.0 29.7 81.1 22.7 35.8 10.3 16.1 103.4 39.7 32.6 11.6 27.2 80.7 15.0 39.8 32.1 91.0 27.6 27.0 20.7 45.6 19.4 19.5 20.6 25.8 14.6 18.2 32.5 15.9 109.4 13.8 31.4 31.0 ABHD13 "bA153I24.2, BEM46L1, C13orf6, FLJ14906" ENSG00000139826 "Abhydrolase domain containing 13" Q7L211 13 108218379-108234255 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032143, HPA032144" Approved Approved Cytosol NA NA Cytosol "HPA032143: AB_2674178, HPA032144: AB_10602304" "unprognostic (2.69e-1)" "unprognostic (2.81e-1)" "unprognostic (1.36e-2)" "unprognostic (2.91e-2)" "unprognostic (8.36e-2)" "unprognostic (1.48e-2)" "unprognostic (1.99e-1)" "unprognostic (2.63e-1)" "unprognostic (8.75e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-1)" "unprognostic (6.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.73e-2)" "unprognostic (1.61e-1)" "unprognostic (1.14e-1)" "unprognostic (5.62e-2)" 13.6 12.5 13.8 14.3 14.2 26.7 14.9 17.0 15.5 13.6 17.0 6.8 14.5 13.8 16.3 21.0 15.2 13.5 13.8 12.9 11.7 10.4 12.5 20.1 15.4 14.8 10.1 10.4 13.2 12.4 9.6 14.1 16.5 11.1 13.0 15.0 10.5 14.7 18.1 12.9 12.7 16.7 13.7 10.1 20.0 13.9 8.9 8.2 26.4 15.4 11.3 14.5 13.3 18.6 8.5 8.9 19.2 10.4 11.8 11.8 10.1 9.0 3.8 10.2 5.6 8.0 9.5 4.9 9.0 9.1 7.9 9.5 5.8 8.7 7.7 9.5 7.0 7.8 8.3 7.5 10.4 12.7 10.3 6.6 9.4 5.4 5.7 8.0 19.4 11.6 9.7 10.0 6.2 8.1 7.5 9.3 10.7 5.0 4.4 8.1 3.8 9.4 8.2 4.8 13.5 4.5 8.1 7.3 4.5 11.2 8.2 7.7 9.6 4.8 8.0 9.7 9.4 7.4 18.1 9.7 5.7 5.9 6.6 6.0 8.5 6.7 8.4 13.4 12.2 10.2 8.7 10.4 19.2 8.0 9.5 11.8 8.5 10.9 9.5 8.9 8.1 10.5 8.7 11.3 11.8 8.4 6.7 10.2 10.1 13.8 14.2 17.0 15.5 11.7 10.4 10.1 10.4 11.1 8.2 20.8 11.0 23.1 17.8 39.4 12.5 6.1 22.9 8.1 9.1 10.4 0.0 18.2 8.3 16.4 13.8 17.2 11.8 0.0 18.5 12.2 20.3 17.8 13.9 24.5 17.6 17.5 29.3 19.0 17.3 14.3 14.4 18.7 25.3 17.2 11.7 11.8 16.0 11.5 16.3 10.0 11.6 19.4 18.8 12.8 10.9 44.7 17.8 24.5 10.0 19.0 ABHD14A "DKFZP564O243, DORZ1" ENSG00000248487 "Abhydrolase domain containing 14A" Q9BUJ0 3 51971426-51981199 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038153, HPA056913" Approved Enhanced Vesicles NA NA 260000 Vesicles "HPA038153: AB_2675868, HPA056913: AB_2683275" "unprognostic (4.15e-3)" "unprognostic (6.73e-2)" "unprognostic (1.98e-1)" "unprognostic (3.34e-2)" "unprognostic (2.71e-1)" "unprognostic (1.08e-2)" "unprognostic (8.92e-2)" "prognostic favorable (4.72e-4)" "unprognostic (3.96e-1)" "unprognostic (2.46e-2)" "unprognostic (5.52e-3)" "unprognostic (1.51e-2)" "unprognostic (1.97e-2)" "unprognostic (9.74e-2)" "unprognostic (2.17e-1)" "unprognostic (1.33e-1)" "unprognostic (1.30e-2)" 11.8 28.0 23.3 6.0 25.8 9.0 9.2 39.6 45.0 18.3 7.3 12.2 8.5 8.0 6.9 23.2 5.4 19.6 9.3 16.4 22.3 27.8 26.2 13.0 9.7 8.9 16.6 23.4 14.8 20.6 15.6 21.3 7.0 18.7 11.6 5.6 26.1 17.7 12.5 23.8 3.9 6.6 8.8 14.5 7.7 11.0 6.2 7.0 6.6 24.1 8.4 8.8 9.2 7.4 15.4 13.9 4.5 6.0 12.0 30.9 15.3 2.8 5.4 3.5 10.6 35.3 17.8 1.9 3.8 6.3 4.6 6.2 6.2 11.5 3.2 2.6 9.4 5.2 2.4 3.8 4.2 1.5 10.3 4.3 9.4 16.2 20.5 9.9 12.8 12.6 16.7 2.9 3.9 2.0 10.3 5.9 6.2 3.8 10.9 7.1 3.2 5.9 13.1 2.0 13.5 13.0 4.2 1.8 30.3 8.8 4.4 7.3 11.3 9.5 2.0 5.6 0.8 3.0 14.1 3.4 4.2 4.5 10.0 4.3 15.9 14.8 2.6 7.8 20.6 6.0 2.1 6.0 4.5 30.2 3.5 30.9 15.4 26.7 26.8 10.4 12.4 24.6 26.2 0.6 12.0 2.2 13.9 25.7 15.3 23.3 25.8 39.6 45.0 22.3 27.8 16.6 23.4 18.7 7.0 6.0 17.1 20.4 20.4 8.7 89.3 21.0 15.3 24.1 19.4 31.4 23.6 9.0 28.2 13.8 3.6 14.2 8.5 0.0 10.8 11.5 41.8 21.4 15.0 11.6 25.9 55.6 38.7 17.2 11.8 18.4 81.4 13.0 11.8 4.6 11.8 36.2 13.3 2.9 31.1 69.3 86.1 19.4 11.3 16.9 59.2 4.8 4.1 34.6 14.0 13.2 ABHD14A-ACY1 ENSG00000114786 "ABHD14A-ACY1 readthrough" 3 51974706-51989183 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 3.7;Club cells: 3.4;Collecting duct cells: 5.2;Distal tubular cells: 3.3;Proximal tubular cells: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 3.4;HUVEC TERT2: 4.2;SH-SY5Y: 3.4" "HPA036174, HPA036175, HPA038153" Approved Uncertain Vesicles NA NA Vesicles "HPA036174: AB_2674988, HPA036175: AB_2674989, HPA038153: AB_2675868" "unprognostic (8.40e-2)" "unprognostic (1.37e-1)" "unprognostic (4.90e-2)" "unprognostic (7.22e-3)" "unprognostic (3.83e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.35e-1)" "unprognostic (6.23e-2)" "unprognostic (2.71e-1)" "unprognostic (1.10e-1)" "unprognostic (1.29e-2)" "unprognostic (9.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (7.11e-4)" 2.7 2.9 3.5 2.6 8.2 2.0 2.3 8.3 15.1 3.7 3.5 3.2 1.9 4.8 2.5 3.2 2.0 3.3 3.5 4.8 3.2 4.1 5.8 8.4 3.0 1.9 2.7 7.2 2.7 4.6 1.4 3.7 1.7 5.6 2.8 1.6 8.2 4.1 2.2 8.0 2.0 10.5 2.0 3.9 3.3 2.6 2.2 1.3 0.9 4.7 1.8 2.8 2.3 2.7 2.4 5.2 1.2 4.0 4.7 4.1 2.7 0.0 0.0 0.3 0.5 2.0 1.1 0.2 0.0 2.0 0.4 0.4 2.0 3.4 0.8 0.1 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.1 0.0 0.0 0.0 2.6 1.0 0.0 0.0 0.5 4.2 1.1 2.1 0.0 0.0 0.0 2.0 1.5 1.3 1.0 1.8 0.5 0.0 0.2 0.0 0.0 0.4 3.4 0.0 2.4 0.0 0.0 0.9 0.0 0.0 1.0 0.0 2.1 0.0 0.0 0.0 2.0 1.6 0.0 0.0 0.2 1.7 1.2 4.1 4.0 2.4 2.4 2.3 4.1 5.2 1.7 2.1 2.7 0.0 4.7 2.0 2.4 2.5 2.7 3.5 8.2 8.3 15.1 3.2 4.1 2.7 7.2 5.6 1.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 5.2 0.0 0.0 3.3 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 1.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ABHD15 ENSG00000168792 "Abhydrolase domain containing 15" Q6UXT9 17 29560547-29567137 "Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 11.1;MAIT T-cell: 5.0;NK-cell: 7.2;plasmacytoid DC: 17.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA014470 Approved Approved Nucleoplasm,Cytosol "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" "HPA014470: AB_1852993" "unprognostic (1.79e-1)" "unprognostic (4.00e-2)" "unprognostic (1.38e-1)" "unprognostic (8.60e-3)" "unprognostic (1.91e-1)" "unprognostic (1.62e-1)" "unprognostic (4.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.85e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-3)" "unprognostic (3.00e-2)" "unprognostic (3.58e-2)" "unprognostic (1.70e-1)" "unprognostic (1.71e-1)" "unprognostic (3.46e-1)" "unprognostic (5.45e-2)" 22.6 3.5 4.9 6.0 3.2 5.4 21.6 2.9 4.1 3.8 8.8 4.2 4.4 8.5 4.2 3.1 4.1 4.3 7.8 6.6 2.1 1.9 8.4 21.2 5.6 12.7 2.7 3.9 2.8 10.9 8.8 8.5 3.2 4.3 4.0 5.0 3.6 4.5 4.6 2.1 3.4 12.7 5.5 3.3 9.1 6.3 1.4 4.6 1.6 5.2 2.7 6.0 5.6 9.1 2.0 17.0 11.1 0.4 7.2 5.0 0.7 3.8 15.0 1.9 5.3 20.6 9.0 7.9 5.3 5.9 5.3 4.9 3.4 2.0 5.7 3.9 5.7 9.4 10.6 6.6 2.3 2.9 17.7 5.0 2.3 7.4 4.3 6.3 5.9 10.7 6.7 6.2 5.1 0.9 3.9 3.8 3.4 3.0 5.5 2.8 5.2 5.6 6.9 0.4 13.0 4.5 13.1 7.3 13.2 9.5 5.9 1.3 2.2 8.0 3.6 2.0 2.1 9.1 13.7 4.7 3.1 3.9 7.7 4.6 9.3 6.2 3.0 6.1 3.7 6.5 11.1 0.4 1.8 1.9 0.2 5.0 1.0 1.0 1.7 1.0 2.0 0.3 1.0 0.5 7.2 0.2 17.0 0.9 0.7 4.9 3.2 2.9 4.1 2.1 1.9 2.7 3.9 4.3 4.6 3.0 5.5 5.6 1.1 1.1 0.0 2.0 5.1 5.3 4.5 7.0 0.0 0.9 0.0 2.8 0.2 1.4 8.3 0.0 6.6 1.0 3.8 1.2 2.3 25.3 6.6 1.6 6.9 3.7 6.7 0.2 4.4 8.2 5.0 3.6 6.3 0.9 4.8 0.0 4.2 5.4 0.7 0.0 2.0 0.5 0.4 2.0 0.2 14.4 6.3 1.1 ABHD16A "BAT5, D6S82E, NG26" ENSG00000204427 "Abhydrolase domain containing 16A" O95870 6 31686949-31703444 "Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 14.2;Paneth cells: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 1.2;neutrophil: 4.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.6;BJ hTERT+ SV40 Large T+: 2.1;Daudi: 2.2;HEL: 1.4;hTEC/SVTERT24-B: 1.2;RPMI-8226: 1.4;SH-SY5Y: 2.7;U-138 MG: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058606 Approved NA NA 1400000 "HPA058606: AB_2683774" "unprognostic (1.44e-1)" "unprognostic (1.10e-1)" "unprognostic (7.26e-2)" "prognostic unfavorable (2.63e-4)" "unprognostic (3.14e-1)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" "unprognostic (8.75e-2)" "unprognostic (1.07e-1)" "unprognostic (6.17e-3)" "unprognostic (1.97e-3)" "unprognostic (6.02e-2)" "unprognostic (1.30e-2)" "unprognostic (9.35e-2)" "unprognostic (1.81e-1)" "unprognostic (5.11e-3)" "unprognostic (1.60e-3)" 6.0 9.0 7.7 10.5 8.9 11.8 9.6 15.1 11.2 10.2 8.5 6.7 6.0 5.5 8.4 5.5 18.8 13.0 21.8 11.6 7.0 8.6 7.0 11.8 10.2 7.8 12.6 5.4 6.1 12.1 5.5 16.2 8.8 11.0 9.5 5.5 5.9 6.2 9.1 12.2 9.1 10.0 6.5 12.5 7.2 7.5 15.4 10.9 9.2 18.2 5.0 6.7 7.8 5.2 0.2 0.4 4.3 0.3 0.1 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.1 0.0 0.0 0.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.5 2.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.2 1.2 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 4.3 0.1 0.1 0.0 0.0 1.2 7.7 8.9 15.1 11.2 7.0 8.6 12.6 5.4 11.0 10.9 0.0 5.1 0.0 0.3 0.3 1.2 0.4 0.0 1.4 1.2 0.0 0.0 3.0 3.3 14.2 1.0 0.7 10.0 0.0 11.6 1.3 1.9 0.4 1.1 0.8 2.9 0.0 12.0 0.6 2.7 0.0 0.9 1.7 3.3 12.6 10.0 0.5 12.1 15.6 0.4 0.6 1.3 0.0 1.4 2.5 1.1 0.9 4.5 3.2 12.0 0.2 ABHD3 LABH3 ENSG00000158201 "Abhydrolase domain containing 3" Q8WU67 18 21650897-21704805 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 54.7;RPMI-8226: 60.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010729 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Vesicles "HPA010729: AB_1844449" "unprognostic (1.46e-1)" "unprognostic (4.61e-2)" "unprognostic (2.37e-2)" "unprognostic (3.52e-1)" "unprognostic (8.46e-2)" "unprognostic (3.14e-3)" "unprognostic (3.54e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (8.52e-4)" "unprognostic (6.21e-2)" "unprognostic (1.98e-1)" "unprognostic (6.37e-2)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (3.98e-2)" "unprognostic (4.58e-2)" 9.2 5.4 12.0 14.2 10.7 8.6 20.7 19.5 11.1 6.4 34.2 4.8 5.1 23.8 6.0 5.4 12.7 7.8 13.5 7.1 8.8 8.5 8.7 21.7 12.8 21.3 11.5 5.0 9.4 8.8 10.7 11.8 10.8 16.6 6.9 37.1 14.7 10.3 4.1 10.1 3.8 45.3 5.5 12.3 17.9 19.0 4.4 10.8 20.9 12.9 6.7 13.7 9.2 25.5 7.1 6.1 33.0 23.3 7.1 17.6 9.1 7.5 5.5 5.4 3.4 3.4 2.3 0.0 5.0 2.0 3.5 4.8 5.7 7.8 21.7 9.1 1.6 16.0 25.1 8.7 4.1 5.0 13.6 6.0 2.3 9.3 9.8 5.2 10.2 7.9 2.0 4.8 5.2 2.4 1.8 2.3 7.5 6.0 12.9 3.1 3.0 9.9 11.4 2.6 24.2 12.9 54.7 4.1 60.9 9.8 7.3 4.5 2.0 11.3 10.1 2.8 6.1 3.1 18.1 1.8 3.5 5.0 6.1 7.6 14.6 9.4 22.3 4.4 13.4 7.9 29.1 10.2 11.4 11.1 17.9 8.5 7.1 10.0 10.6 6.1 5.1 8.2 10.3 33.0 7.1 23.3 4.2 17.6 9.1 12.0 10.7 19.5 11.1 8.8 8.5 11.5 5.0 16.6 10.8 8.9 9.4 22.4 33.1 29.8 13.4 3.6 45.9 16.0 7.9 3.5 45.2 23.7 1.7 47.1 3.1 9.6 90.1 0.0 24.3 19.9 15.1 42.5 11.5 26.1 56.1 0.0 34.9 12.3 24.7 1.1 6.9 28.6 30.4 17.2 46.9 9.4 35.8 46.5 6.0 7.7 13.6 12.9 15.9 3.5 8.5 13.2 78.8 38.3 23.5 28.7 ABHD6 ENSG00000163686 "Abhydrolase domain containing 6" Q9BV23 3 58237506-58295693 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.4" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 53.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017283, HPA073225" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA017283: AB_1844452, HPA073225: AB_2686583" "unprognostic (4.20e-2)" "unprognostic (7.92e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.35e-2)" "unprognostic (1.16e-2)" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (1.15e-2)" "unprognostic (9.54e-2)" "unprognostic (1.11e-3)" "unprognostic (1.34e-2)" "unprognostic (1.94e-1)" "prognostic favorable (1.11e-11)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (2.72e-1)" "unprognostic (6.31e-2)" 8.3 10.0 11.6 4.6 14.0 1.0 5.8 17.7 22.5 3.7 8.1 30.0 10.3 26.3 4.7 10.8 4.8 6.9 4.4 4.1 19.0 9.2 24.3 43.4 6.3 5.2 18.6 12.2 4.1 2.4 4.8 15.2 4.8 19.0 4.4 8.1 10.5 3.0 12.9 3.1 17.2 33.5 6.8 24.0 22.8 9.0 3.1 14.3 2.0 6.6 2.1 5.4 4.6 4.1 3.9 7.0 2.1 9.3 0.7 2.6 1.1 2.0 7.7 1.1 5.0 14.5 2.6 13.4 5.4 4.8 5.7 7.7 4.0 2.8 3.9 0.5 2.9 17.6 6.0 5.2 2.4 5.1 6.6 2.6 3.3 5.2 5.5 4.9 1.0 17.6 2.5 11.1 5.2 2.5 6.7 3.2 6.5 3.9 9.0 4.6 1.5 6.7 0.4 3.7 16.7 17.0 2.5 2.3 8.7 8.7 2.8 6.7 2.7 5.9 3.3 11.1 2.3 2.2 2.7 3.4 4.1 4.5 10.1 6.4 2.6 7.6 0.1 10.5 9.9 5.6 0.0 2.8 2.1 2.1 9.3 2.0 3.9 1.2 2.6 4.6 3.0 1.2 1.5 0.0 0.7 6.2 7.0 1.4 1.1 11.6 14.0 17.7 22.5 19.0 9.2 18.6 12.2 19.0 14.3 0.0 2.6 8.8 2.6 7.7 13.8 4.8 0.0 17.4 5.7 3.5 3.9 2.2 1.7 2.9 0.8 7.8 13.6 0.0 1.6 0.4 2.1 1.3 10.5 53.3 8.1 14.3 0.0 26.4 14.6 0.4 6.4 9.6 3.3 14.4 2.2 10.8 1.6 0.0 7.8 15.4 3.0 0.0 3.5 0.5 2.3 21.5 0.5 3.2 4.5 2.0 ABI3BP "DKFZP586L2024, NESHBP, TARSH" ENSG00000154175 "ABI family member 3 binding protein" Q7Z7G0 3 100749156-100993515 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 53.6;Club cells: 70.5;Leydig cells: 90.0;Muller glia cells: 112.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 48.4;hTEC/SVTERT24-B: 86.0;hTERT-HME1: 87.3;HUVEC TERT2: 35.5;TIME: 187.0" "Group enriched" "Detected in many" 4 "amygdala: 4.0;basal ganglia: 15.3;cerebellum: 5.8;cerebral cortex: 13.1;olfactory region: 13.7" "Low region specificity" "Detected in all" HPA044127 Uncertain "Secreted in other tissues" NA NA 570000000 "HPA044127: AB_2678823" "unprognostic (4.32e-2)" "unprognostic (3.32e-2)" "unprognostic (6.36e-2)" "unprognostic (3.41e-1)" "unprognostic (1.70e-1)" "unprognostic (7.20e-2)" "unprognostic (7.58e-2)" "unprognostic (6.25e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-1)" "unprognostic (1.08e-1)" "unprognostic (9.46e-2)" "prognostic favorable (6.14e-4)" "unprognostic (2.27e-2)" "unprognostic (2.69e-2)" "unprognostic (6.59e-2)" "unprognostic (1.07e-3)" 35.3 5.2 2.7 24.7 9.0 0.0 16.1 1.2 3.3 45.0 15.8 9.7 6.9 1.7 29.4 23.6 23.4 16.9 44.1 28.1 4.2 2.9 6.6 2.2 34.5 8.2 4.4 3.6 33.5 3.8 0.5 4.3 45.8 4.7 23.0 19.4 80.6 10.5 4.2 8.7 9.8 10.2 39.2 8.0 3.8 22.3 12.3 5.3 0.2 23.2 23.7 25.3 38.5 19.1 0.7 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 4.5 48.4 0.0 9.9 9.7 18.2 8.6 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.1 28.9 0.0 0.0 0.2 0.1 0.0 2.5 0.0 0.0 2.8 0.1 86.0 87.3 0.3 35.5 0.0 0.0 0.1 15.8 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 187.0 3.9 0.0 32.9 1.9 0.1 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 9.0 1.2 2.4 4.2 2.9 4.4 3.6 4.7 5.3 53.6 5.6 0.0 1.5 14.2 1.0 10.3 2.5 5.3 70.5 17.4 2.0 0.5 0.0 0.0 7.2 9.0 0.0 0.0 0.3 0.6 43.8 1.1 3.5 0.0 0.8 0.0 1.2 11.1 1.2 7.8 90.0 2.9 18.6 0.0 0.5 112.5 1.1 4.5 26.2 6.5 3.5 0.0 18.6 0.1 0.2 17.3 0.6 0.0 0.6 2.5 ABO "A3GALNT, A3GALT1" ENSG00000175164 "ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase" 9 133250401-133275219 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 28.2" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 56.2;Collecting duct cells: 45.4;Enterocytes: 68.1;Mucus-secreting cells: 54.8;Paneth cells: 49.5;Undifferentiated cells: 61.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 2.1;eosinophil: 3.0;naive B-cell: 2.2" "Group enriched" "Detected in many" 8 "B-cells: 2.2;granulocytes: 3.0" "Group enriched" "Detected in some" 6 "K-562: 20.4;RT4: 8.0" "Not detected" "Not detected" "Secreted to blood" NA NA "unprognostic (2.78e-3)" "unprognostic (2.56e-3)" "unprognostic (1.38e-1)" "unprognostic (1.87e-3)" "unprognostic (1.39e-1)" "unprognostic (3.10e-2)" "unprognostic (1.84e-3)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" "unprognostic (8.51e-2)" "unprognostic (9.30e-3)" "unprognostic (7.23e-2)" "unprognostic (2.67e-2)" "unprognostic (4.57e-3)" "unprognostic (1.50e-1)" "unprognostic (2.34e-1)" "unprognostic (9.04e-2)" 1.6 1.0 0.1 5.8 0.1 0.3 0.4 0.0 0.6 1.0 15.0 0.0 2.3 1.7 1.6 0.8 3.0 0.3 7.6 0.3 0.0 10.7 0.3 3.6 0.3 0.0 0.0 3.2 2.6 0.3 0.0 0.3 0.2 1.5 2.4 1.0 2.2 0.3 1.4 0.3 28.2 0.6 0.0 0.3 0.3 2.0 0.0 0.0 10.1 4.2 5.8 1.0 1.4 2.2 0.1 3.0 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 3.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 2.2 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.2 29.8 22.2 0.5 3.6 0.0 0.0 2.8 17.8 56.2 27.3 45.4 0.0 0.7 0.0 3.7 3.3 6.8 68.1 0.0 0.3 0.2 0.8 6.5 0.0 0.0 0.2 0.0 24.6 3.1 0.6 6.7 14.1 0.3 0.0 1.0 54.8 0.0 8.2 49.5 6.3 19.5 0.1 6.5 0.6 0.5 1.5 0.0 0.6 0.0 61.3 15.2 AC004691.2 ENSG00000250424 7 30852273-30923812 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.3;ASC diff: 1.1;SH-SY5Y: 1.9;SK-BR-3: 1.3" "HPA019206, HPA030130" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA019206: AB_1844965, HPA030130: AB_10601565" "unprognostic (2.15e-1)" "unprognostic (3.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.66e-1)" "unprognostic (2.72e-4)" "unprognostic (5.13e-2)" "unprognostic (3.44e-2)" "unprognostic (2.15e-1)" "unprognostic (2.88e-2)" "unprognostic (3.76e-1)" "unprognostic (2.49e-1)" "unprognostic (3.71e-2)" 0.8 0.2 0.0 0.0 0.4 0.2 0.6 0.0 0.3 1.1 1.3 1.4 1.4 1.5 0.7 2.4 3.1 0.8 0.0 0.1 0.5 0.0 1.1 0.0 0.0 0.6 2.2 0.0 0.3 0.0 0.7 0.2 0.7 1.2 0.4 0.3 0.4 2.3 0.0 0.0 0.9 0.1 0.7 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.3 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.6 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004754.1 ENSG00000269881 16 249547-269943 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "intestine: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 2.4;ASC TERT1: 2.4;EFO-21: 5.1;HHSteC: 2.5;hTERT-RPE1: 2.9" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA011651: , HPA071871: AB_2732188" "unprognostic (1.22e-1)" "unprognostic (2.09e-2)" "unprognostic (2.26e-1)" "unprognostic (1.75e-2)" "unprognostic (5.40e-2)" "unprognostic (2.56e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (3.37e-2)" "unprognostic (5.06e-2)" "unprognostic (5.24e-3)" "unprognostic (4.66e-2)" "unprognostic (7.84e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-2)" 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.3 0.6 0.6 0.2 15.3 0.3 0.3 0.1 0.2 0.0 0.9 0.4 1.4 0.3 0.1 0.0 0.0 0.7 0.1 1.7 0.0 0.2 0.0 0.2 0.0 0.0 0.3 1.0 0.1 7.4 0.2 0.7 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.8 0.4 1.8 2.4 2.4 0.5 0.0 1.2 0.0 0.1 0.3 0.1 0.0 5.1 1.1 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 2.5 0.0 0.0 1.0 0.0 0.2 1.0 2.9 0.7 0.1 0.0 0.3 0.0 2.1 0.0 0.2 1.2 0.6 0.0 1.3 0.0 0.0 0.9 0.0 0.3 1.0 0.0 0.0 0.4 0.2 1.0 0.6 0.0 0.4 0.0 1.0 0.0 0.1 0.2 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.8 0.0 0.5 1.5 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC005551.1 ENSG00000284638 19 3482804-3483446 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "intestine: 15.0;retina: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 1.6;CAPAN-2: 1.1;HEL: 1.0;OE19: 2.8;PC-3: 1.5;U-937: 2.7" "Low region specificity" "Detected in single" NA NA 0.0 0.0 0.0 0.8 0.0 2.6 0.0 0.0 0.0 0.3 6.0 0.0 1.3 15.0 0.0 1.9 0.0 0.0 0.6 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 22.4 0.0 0.6 0.0 0.0 8.9 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC006538.2 ENSG00000267001 19 2717769-2740048 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 16.4;THP-1: 14.9" HPA058526 Uncertain NA NA "HPA058526: AB_2683743" 5.2 2.1 3.0 3.0 5.5 2.5 3.9 3.2 8.9 3.6 5.9 3.8 1.7 6.1 2.3 2.5 2.2 4.3 2.5 3.0 2.9 2.5 2.2 7.3 5.0 3.0 3.4 3.4 2.7 3.0 3.8 2.3 2.6 4.1 2.8 2.5 2.6 7.8 7.1 9.7 3.1 3.0 8.2 5.3 3.2 2.5 16.9 1.9 3.5 2.8 1.2 2.0 4.2 2.3 0.3 1.2 1.1 0.8 0.0 0.8 0.9 2.9 9.6 1.8 0.0 8.3 8.7 0.0 1.7 3.8 4.5 8.4 9.3 0.5 1.7 2.7 4.5 3.5 0.0 0.0 1.9 0.0 0.0 0.0 5.0 6.9 12.7 16.4 0.0 0.0 4.5 4.8 8.8 0.3 1.6 1.7 3.9 4.2 3.6 1.3 8.2 0.4 0.0 0.7 1.1 0.0 0.8 0.5 2.5 0.0 4.5 0.2 1.6 4.8 1.4 5.1 0.0 2.6 14.9 0.0 1.3 0.3 5.0 2.5 1.8 6.6 2.4 0.8 4.7 0.6 1.1 0.8 0.3 0.0 0.5 0.8 0.0 0.3 0.2 0.9 0.3 0.0 0.1 0.0 0.0 0.0 1.2 0.5 0.9 3.0 5.5 3.2 8.9 2.9 2.5 3.4 3.4 4.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC007040.2 ENSG00000258881 2 70939318-70995336 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 2.8;testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 6.9;JURKAT: 5.2;U-2 OS: 4.8" NA NA "unprognostic (1.86e-1)" "unprognostic (2.94e-1)" "unprognostic (7.99e-4)" "unprognostic (1.36e-1)" "unprognostic (9.49e-2)" "unprognostic (1.78e-3)" "unprognostic (2.35e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-1)" "unprognostic (2.93e-1)" "unprognostic (2.53e-9)" "unprognostic (6.54e-2)" "unprognostic (7.86e-2)" "unprognostic (2.07e-1)" "unprognostic (1.32e-1)" 0.4 0.1 0.9 0.3 0.7 1.0 0.5 1.5 0.8 0.3 0.3 0.4 0.4 0.4 0.3 0.5 0.3 0.2 0.6 0.4 0.6 0.0 0.2 0.4 0.2 0.5 0.4 0.0 0.1 0.2 0.6 0.1 1.6 0.1 0.7 2.8 0.1 0.1 0.3 0.2 0.0 2.7 0.5 0.0 0.2 0.3 0.7 0.4 1.5 0.5 1.0 1.3 0.1 2.3 0.3 0.2 1.3 0.3 0.3 0.9 0.1 0.1 0.4 0.6 0.3 0.3 3.4 0.4 0.4 6.9 0.5 1.0 0.1 0.6 2.7 2.5 2.1 0.4 0.8 0.0 0.1 0.9 0.2 0.1 0.7 0.1 0.4 1.3 5.2 0.2 0.9 0.4 0.6 0.3 0.3 0.3 0.5 0.4 2.7 0.9 0.0 0.7 0.2 0.3 0.3 0.5 0.5 1.0 0.2 0.8 0.1 1.0 2.6 4.8 0.7 2.1 0.3 0.0 0.1 2.9 1.2 2.5 0.7 0.5 1.5 0.7 0.3 0.8 0.6 0.5 0.3 0.2 0.7 1.3 0.8 1.1 1.0 0.3 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC007846.2 ENSG00000285471 17 5772926-6080792 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "placenta: 3.0;testis: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RH-30: 29.7" NA NA 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 3.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 29.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008397.1 ENSG00000284797 19 18249950-18255419 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "gallbladder: 19.9;intestine: 13.8;pancreas: 12.5" "Cell type enriched" "Detected in some" 5 "Collecting duct cells: 34.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 528 "OE19: 67.7" NA NA 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.5 13.8 0.0 0.0 0.0 0.0 0.0 3.4 0.2 19.9 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.7 0.0 0.0 0.0 9.4 0.2 0.0 0.0 1.7 1.1 0.0 0.0 0.1 0.5 3.5 0.4 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC009163.4 ENSG00000261717 16 75412684-75464706 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "U-698: 20.8" HPA041316 Uncertain NA NA "HPA041316: AB_10794371" "unprognostic (1.57e-1)" 5.6 3.0 4.4 2.1 5.7 2.8 5.0 3.3 3.4 2.9 7.1 6.0 3.1 2.1 2.7 2.1 2.4 2.3 2.6 2.3 4.6 4.9 3.3 4.2 2.5 2.5 7.7 2.3 3.5 2.5 6.1 3.2 6.0 5.4 2.5 2.1 3.8 2.1 2.1 15.7 2.1 6.6 2.1 8.3 4.5 3.2 6.3 5.9 2.8 4.3 0.4 2.9 2.8 2.6 9.3 10.2 15.9 10.4 3.5 6.6 4.7 1.1 0.0 1.1 0.0 0.0 0.0 1.0 4.0 0.8 0.0 0.0 1.0 1.0 0.4 4.5 0.0 0.0 0.0 0.0 1.2 0.0 1.3 0.4 0.3 0.3 0.0 0.0 2.7 0.6 0.3 0.4 0.0 0.3 0.0 0.0 0.7 0.5 0.0 0.0 1.5 0.7 0.0 0.1 0.0 0.0 4.8 0.7 2.0 0.0 0.6 0.8 0.3 0.4 0.0 0.0 0.5 0.7 0.4 0.6 0.0 1.1 0.3 0.0 1.4 3.8 20.8 0.6 0.0 0.2 4.2 7.0 15.9 3.8 10.4 6.6 7.7 3.6 4.5 10.2 9.3 4.9 3.5 7.2 3.5 4.0 6.4 5.1 4.7 4.4 5.7 3.3 3.4 4.6 4.9 7.7 2.3 5.4 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC009477.2 ENSG00000284479 2 131035092-131035262 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "adipose tissue: 8.5;brain: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BJ: 2.9;HaCaT: 3.5;HEK 293: 5.2" NA NA 8.5 0.9 7.3 0.9 11.6 0.9 0.9 0.0 18.5 0.9 2.0 4.0 0.0 0.9 0.9 1.2 0.9 0.9 1.2 0.9 8.1 1.1 0.9 0.9 0.9 1.3 9.7 0.9 0.9 0.9 1.0 0.9 5.5 1.2 0.9 0.5 0.9 0.9 2.2 0.9 1.7 1.9 0.8 0.9 0.9 1.1 1.8 0.0 0.9 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010319.2 ENSG00000269035 19 17436611-17460804 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 32 "retina: 41.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.3;HHSteC: 1.0;THP-1: 1.2" HPA041580 Approved Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA041580: AB_10795700" 0.9 0.2 0.4 0.1 0.5 0.1 0.3 0.1 0.5 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.3 0.5 0.4 0.1 0.1 0.3 0.1 0.2 0.0 0.7 0.1 0.1 0.3 0.1 1.2 0.1 0.1 41.6 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.1 0.5 0.5 0.4 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010325.1 ENSG00000261341 19 50776141-50793142 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 51.5" "Group enriched" "Detected in some" 5 "Club cells: 1.2;Exocrine glandular cells: 1.6;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 6.7;HEK 293: 9.0" "Low region specificity" "Detected in many" NA NA "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (2.63e-2)" "unprognostic (2.47e-1)" "unprognostic (9.62e-3)" "unprognostic (9.41e-2)" "unprognostic (1.11e-2)" "unprognostic (5.95e-3)" "unprognostic (1.14e-1)" "unprognostic (1.98e-2)" "unprognostic (1.06e-1)" "unprognostic (1.52e-1)" "unprognostic (5.32e-7)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (3.37e-3)" "unprognostic (3.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 51.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.7 0.4 1.6 1.1 2.2 0.8 0.8 0.0 6.7 2.1 0.0 0.0 1.3 2.1 0.0 4.0 3.1 0.0 0.3 0.2 0.5 0.7 0.6 1.4 0.4 0.0 0.0 1.4 9.0 0.5 0.0 0.8 0.0 0.6 0.8 0.0 0.0 1.6 4.7 0.5 1.8 1.0 1.9 4.2 0.6 1.0 0.8 0.2 5.0 0.0 0.7 0.5 4.0 1.0 0.4 1.3 0.8 0.6 0.5 0.0 0.0 0.6 0.5 0.4 0.0 0.0 2.1 3.0 0.2 0.3 3.0 0.7 1.5 1.1 2.1 0.0 1.6 0.0 2.2 0.2 1.0 0.3 1.3 2.2 2.6 1.6 0.8 0.6 0.4 1.1 0.4 2.7 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC011448.1 ENSG00000258674 19 19516227-19536076 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 41.4" "Group enriched" "Detected in some" 137 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 14.5;Ciliated cells: 22.7;Club cells: 17.0;granulocytes: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 21.2" NA NA "unprognostic (8.39e-2)" "unprognostic (1.77e-2)" "unprognostic (1.69e-3)" "unprognostic (5.40e-3)" "unprognostic (1.61e-1)" "unprognostic (2.85e-2)" "unprognostic (1.77e-2)" "unprognostic (2.46e-1)" "unprognostic (1.16e-2)" "unprognostic (1.41e-2)" "unprognostic (6.73e-5)" "unprognostic (7.15e-2)" "unprognostic (5.78e-2)" "unprognostic (1.62e-2)" "unprognostic (3.46e-1)" "unprognostic (5.89e-2)" "unprognostic (2.89e-2)" 5.9 7.9 9.7 7.4 19.9 8.7 3.8 12.4 13.5 4.1 6.0 3.6 7.8 6.7 4.5 13.8 4.8 5.6 5.9 35.1 11.0 7.0 5.8 7.2 4.6 6.0 9.6 10.9 5.0 8.3 5.3 5.3 5.6 9.7 6.0 4.9 4.3 8.7 7.3 41.4 10.4 9.7 5.5 6.2 6.9 7.1 9.8 7.6 3.1 5.2 13.9 3.8 4.8 4.5 8.8 8.1 7.2 9.4 4.7 10.0 13.3 2.6 2.6 3.0 2.2 1.9 2.2 21.2 1.5 2.1 1.8 1.9 3.5 4.9 3.2 7.1 1.3 1.3 4.0 1.4 1.4 0.5 2.4 12.0 1.4 2.3 1.1 2.1 1.4 3.3 1.6 1.4 2.1 0.5 0.7 1.1 2.9 3.7 2.8 1.0 4.6 1.5 5.8 11.9 2.1 6.7 6.6 1.5 2.0 2.0 2.5 2.2 3.9 2.0 0.9 2.1 1.1 3.5 5.4 1.2 3.6 3.9 8.0 3.3 8.4 3.7 2.6 1.8 6.0 1.9 7.2 8.9 6.7 5.9 9.4 5.1 8.8 7.7 6.3 8.1 7.8 6.7 6.8 2.8 4.7 7.6 6.7 10.0 13.3 9.7 19.9 12.4 12.4 11.0 7.0 9.6 10.9 9.7 7.6 14.9 14.5 0.0 0.0 0.0 0.0 0.0 0.0 22.7 17.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011604.2 ENSG00000257046 12 20815674-21090245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "breast: 22.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.9;A549: 2.4;CAPAN-2: 4.0;GAMG: 2.4;HeLa: 6.6;PC-3: 1.5;U-2 OS: 2.2" HPA050892 Uncertain NA NA "HPA050892: AB_2681265" "unprognostic (2.74e-1)" "unprognostic (1.39e-3)" "unprognostic (3.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.7 0.0 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC018709.1 ENSG00000272297 4 186426546-186555328 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "testis: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 6.8;OE19: 3.6;T-47d: 3.5" NA NA 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC018755.2 ENSG00000268500 19 51612091-51646889 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "blood: 50.4;bone marrow: 20.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 50.4" "Group enriched" "Detected in many" 5 "granulocytes: 50.4;monocytes: 17.5" "Group enriched" "Detected in some" 11 "HMC-1: 41.2;U-937: 16.7" HPA009085 Approved NA NA "HPA009085: AB_1079965" 1.0 0.4 0.4 5.9 0.1 20.8 0.3 0.0 0.4 0.7 0.3 0.4 0.2 0.0 0.6 1.4 0.6 0.6 0.1 0.1 0.3 0.9 1.9 2.0 0.2 0.1 0.3 0.0 0.2 0.1 0.3 0.0 0.3 0.0 0.3 0.3 0.1 0.2 0.7 3.0 0.3 0.0 0.2 0.1 1.5 0.3 0.8 6.2 50.4 17.5 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 16.7 0.0 2.6 8.9 0.2 0.0 9.1 0.0 0.6 0.0 0.0 6.2 0.8 0.0 0.0 50.4 0.2 17.5 1.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC022167.5 ENSG00000283516 16 8881634-8885351 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 17.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA 0.1 0.1 0.1 0.1 0.1 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.3 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.1 1.7 0.4 0.1 0.1 0.1 0.1 17.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 2.4 1.6 3.5 1.4 2.0 1.2 0.6 0.8 0.5 0.0 0.7 0.0 0.4 2.9 0.5 0.0 0.0 0.0 0.3 1.5 0.7 0.6 0.0 0.7 0.9 0.0 0.5 0.0 1.9 0.0 1.0 1.8 1.0 0.0 0.8 1.3 0.2 0.3 1.3 0.6 0.4 0.0 2.3 0.8 2.7 0.4 1.3 1.4 1.8 0.0 0.9 0.7 1.0 0.6 1.3 0.4 1.4 0.7 0.3 0.5 1.3 0.1 0.5 1.5 0.2 1.3 0.8 2.5 0.0 0.5 1.8 2.5 0.3 0.3 0.5 0.3 3.5 1.4 0.9 1.2 0.8 1.2 1.5 1.1 0.8 0.3 2.4 1.2 1.2 3.3 2.0 0.7 1.6 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC024592.3 ENSG00000267740 19 5866171-5903787 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.9;Ciliated cells: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA072209 Uncertain Mitochondria NA NA Mitochondria "HPA072209: AB_2686495" "unprognostic (2.12e-2)" "unprognostic (2.24e-1)" "unprognostic (3.38e-1)" 8.8 15.0 8.4 8.8 8.5 11.1 10.9 8.0 17.4 10.6 9.8 5.0 8.9 10.8 9.9 7.8 12.7 6.7 9.6 24.1 7.8 9.9 8.5 14.4 8.0 11.5 9.6 10.0 8.2 16.3 3.2 7.1 6.6 7.5 7.0 3.9 7.5 12.3 8.8 22.7 12.3 10.0 9.9 8.6 7.4 7.3 5.6 5.3 7.9 8.0 16.6 7.0 12.7 8.2 7.2 10.4 6.4 8.5 5.5 7.5 12.1 5.1 6.9 2.2 5.8 4.2 0.8 1.9 3.4 4.9 6.6 4.7 2.5 4.4 4.2 3.4 2.7 3.1 3.6 1.3 4.1 1.3 1.8 2.1 1.1 3.1 5.6 2.8 1.9 2.3 1.8 7.0 5.1 2.4 2.0 2.2 6.1 1.8 5.6 1.0 4.2 6.9 1.5 3.2 2.2 3.3 6.5 2.2 5.4 3.2 1.6 3.5 4.9 2.6 3.5 3.4 1.0 2.1 6.3 4.2 1.3 3.2 8.0 6.6 5.3 5.6 2.1 4.2 6.7 2.9 6.4 8.5 4.0 6.0 7.1 5.3 7.2 6.3 5.8 8.6 6.7 7.3 5.8 4.8 5.5 6.3 10.4 7.5 12.1 8.4 8.5 8.0 17.4 7.8 9.9 9.6 10.0 7.5 5.3 3.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC026316.5 ENSG00000285218 3 170418868-170860380 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 64.6;testis: 27.4" "Cell type enriched" "Detected in single" 18 "Collecting duct cells: 1.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA 2.4 3.9 6.2 3.5 30.3 9.0 3.1 2.1 18.4 1.2 1.4 64.6 0.0 2.7 3.4 4.2 2.8 1.9 4.9 2.4 9.0 2.4 1.8 2.1 3.0 44.6 12.4 7.2 1.7 2.6 0.0 2.2 27.8 4.4 1.2 0.0 3.8 2.2 3.1 6.2 2.7 2.1 27.1 2.1 1.9 27.4 35.8 0.0 2.5 0.2 1.6 1.8 1.6 1.0 0.6 2.4 0.9 0.4 1.3 0.3 1.5 2.4 2.9 2.4 0.7 0.6 2.4 1.6 1.0 0.5 0.1 0.5 2.2 2.4 3.6 1.2 1.0 3.0 0.1 0.0 0.5 2.4 2.0 3.2 3.6 2.1 0.0 2.0 3.3 0.7 0.6 0.7 0.3 0.9 0.6 2.1 1.5 2.7 0.7 0.7 0.8 3.4 4.0 2.5 3.1 1.5 0.8 1.0 1.4 2.0 5.6 1.7 1.9 1.6 0.8 2.5 1.8 0.5 2.0 1.5 2.2 5.8 0.6 1.6 2.0 1.0 1.0 2.4 1.2 0.6 0.6 0.5 0.8 0.9 1.3 0.8 1.1 1.1 0.6 1.0 1.3 1.2 2.4 0.4 0.9 0.5 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC068580.4 ENSG00000250644 11 1734821-1763954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 84.9" "Group enriched" "Detected in some" 17 "Alveolar cells type 2: 1.7;Ciliated cells: 4.0;granulocytes: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 63.8;hTERT-RPE1: 46.3;SH-SY5Y: 14.5;U-87 MG: 17.5" HPA003001 Uncertain NA NA "HPA003001: AB_1078404" "unprognostic (5.71e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-6)" "unprognostic (1.77e-2)" "unprognostic (5.21e-2)" "unprognostic (6.20e-2)" "unprognostic (4.05e-3)" "unprognostic (1.45e-2)" "unprognostic (3.04e-1)" "unprognostic (1.14e-1)" "unprognostic (2.45e-2)" "unprognostic (1.96e-1)" "unprognostic (3.17e-3)" "unprognostic (8.30e-4)" "unprognostic (7.35e-2)" "unprognostic (5.79e-5)" "unprognostic (7.47e-2)" 33.3 84.9 5.0 5.4 5.1 15.6 13.8 12.2 25.7 7.5 8.3 7.6 7.9 5.1 7.0 9.9 6.9 5.3 17.6 18.3 5.6 8.8 32.5 35.5 22.2 17.0 9.7 4.3 7.8 12.5 3.7 4.0 11.1 8.0 6.1 4.4 50.8 20.6 22.6 14.3 10.5 19.1 3.8 7.6 16.7 7.4 7.0 5.2 3.3 6.8 8.9 7.7 13.7 8.3 0.5 3.8 7.6 6.9 8.1 2.0 4.7 0.3 2.5 0.1 0.5 0.9 0.5 0.6 0.7 1.0 0.2 0.3 0.6 63.8 0.1 0.9 3.0 2.0 4.5 0.0 0.0 0.0 0.2 0.9 0.4 0.4 0.2 1.1 0.6 1.4 2.3 0.7 0.3 0.3 46.3 0.1 0.2 0.0 1.0 5.2 6.2 0.0 0.7 0.2 2.4 0.2 0.1 0.9 0.4 2.5 2.8 0.2 14.5 0.2 4.8 9.0 0.1 11.3 0.2 1.5 3.2 0.4 0.7 1.0 2.8 6.3 0.1 17.5 0.5 2.7 1.5 6.9 2.1 1.9 3.2 1.4 0.5 1.0 1.1 2.1 0.2 1.5 2.0 7.6 8.1 4.3 3.8 1.1 4.7 5.0 5.1 12.2 10.5 5.6 8.8 9.7 4.3 8.0 5.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC068775.1 ENSG00000255641 12 10412312-10436001 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 43.7;brain: 11.4;lymphoid tissue: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "NK-cell: 43.7" "Lineage enriched" "Detected in many" 6 "NK-cells: 43.7" "Cell line enhanced" "Detected in some" "GAMG: 4.5;HeLa: 13.3;HSkMC: 2.3;SuSa: 5.1" HPA062570 Uncertain NA NA "HPA062570: AB_2684795" "unprognostic (6.09e-2)" 0.3 0.5 7.0 0.8 4.5 3.0 0.6 1.0 11.4 0.3 1.4 2.0 0.0 0.8 1.0 0.8 0.3 0.3 0.4 0.6 6.8 4.9 0.2 1.1 1.5 1.3 5.7 2.4 0.4 0.3 0.1 0.0 0.5 3.4 0.3 1.0 0.0 1.0 0.1 0.1 0.2 1.6 0.4 3.9 9.2 1.0 0.5 1.5 2.0 0.1 0.0 1.0 1.0 0.0 0.0 0.0 0.3 0.0 43.7 7.6 2.6 0.0 0.8 0.1 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.3 0.0 0.0 0.0 0.8 13.3 0.4 0.1 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 7.6 0.3 43.7 0.0 0.0 0.0 2.6 7.0 4.5 1.0 3.3 6.8 4.9 5.7 2.4 3.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC068987.5 ENSG00000284730 12 51813940-51814926 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 2.4;intestine: 1.7" "Group enriched" "Detected in some" 18 "Collecting duct cells: 1.8;Proximal tubular cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.6;SiHa: 1.8;SuSa: 1.2" NA NA 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.3 0.0 0.7 1.6 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC078864.2 ENSG00000284791 12 52079696-52108239 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lung: 23.3;prostate: 18.7;testis: 15.3" "Group enriched" "Detected in some" 17 "Ciliated cells: 2.7;Distal tubular cells: 1.7" "Cell type enriched" "Detected in single" 87 "plasmacytoid DC: 8.7" "Lineage enriched" "Detected in single" 87 "dendritic cells: 8.7" "Cell line enhanced" "Detected in some" "HHSteC: 2.5;MOLT-4: 1.6;RPMI-8226: 1.9" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 1.2 1.1 1.9 0.0 0.0 0.8 0.2 0.1 3.0 0.0 1.4 2.2 0.0 0.0 0.1 23.3 0.6 0.9 0.0 4.1 0.3 0.0 0.0 0.8 0.0 18.7 1.4 0.0 0.0 0.6 0.1 0.0 1.4 4.3 0.6 9.1 1.1 15.3 0.0 0.0 0.0 0.2 2.5 4.8 1.5 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC079341.3 ENSG00000284849 4 121758930-121765185 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "brain: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "MOLT-4: 6.8" HPA077585 Approved NA NA "HPA077585: AB_2732353" 0.3 0.3 1.1 0.3 7.1 0.3 0.3 0.0 16.4 0.3 0.3 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 6.8 0.3 0.3 0.3 0.4 0.0 7.6 0.3 0.3 0.3 0.0 1.1 0.4 0.3 0.3 0.5 0.3 0.4 0.3 0.3 0.5 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC087498.1 ENSG00000180042 17 3385930-3386874 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "blood: 5.2;testis: 2.8" "Cell type enriched" "Detected in single" 18 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 16 "dendritic cells: 5.2" "Cell line enriched" "Detected in single" 6 "HDLM-2: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (5.24e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.0 5.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092143.1 ENSG00000198211 16 89919165-89936092 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SK-MEL-30: 19.0" "CAB011512, HPA043640, HPA046280" Uncertain Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB011512: AB_444319, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.90e-4)" "unprognostic (6.87e-2)" 0.4 0.2 0.2 0.1 0.8 0.3 0.1 0.4 0.7 1.0 0.5 0.6 0.0 0.1 1.2 0.9 1.0 0.7 1.5 1.8 0.2 0.4 0.1 1.3 0.4 0.1 0.9 0.4 4.0 0.2 0.1 0.7 1.4 2.0 2.6 0.1 0.3 0.1 0.1 0.6 5.1 0.4 0.5 2.8 0.6 0.1 10.9 0.2 0.0 0.3 0.0 0.1 1.0 5.1 0.1 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.1 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.3 0.2 0.8 0.4 0.7 0.2 0.4 0.9 0.4 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092442.1 ENSG00000284684 4 6064977-6070162 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 16 "blood: 1.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.5;naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "hypothalamus: 0.7" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092718.3 ENSG00000260643 16 81053587-81096296 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Ciliated cells: 16.0;Club cells: 4.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA041368 Approved Approved Vesicles NA NA Vesicles "HPA041368: AB_10804001" "unprognostic (3.87e-2)" "unprognostic (1.79e-1)" "unprognostic (1.95e-1)" "unprognostic (2.12e-2)" "unprognostic (8.06e-2)" "unprognostic (1.08e-1)" "unprognostic (3.95e-2)" "unprognostic (8.11e-2)" "unprognostic (2.85e-1)" "unprognostic (2.42e-1)" "unprognostic (3.94e-2)" "unprognostic (3.19e-1)" "unprognostic (2.69e-2)" "unprognostic (2.11e-1)" "unprognostic (1.95e-1)" "unprognostic (9.56e-3)" "unprognostic (3.03e-1)" 5.1 2.7 4.4 1.6 6.3 1.0 2.6 2.6 10.3 1.8 1.3 5.9 5.5 0.8 3.4 7.6 1.3 7.0 1.9 3.4 5.0 6.1 6.0 1.8 1.6 6.8 6.2 2.9 3.6 5.0 2.2 4.0 7.6 2.9 1.3 3.7 3.3 2.6 8.4 1.8 1.1 2.3 5.3 1.4 2.0 5.8 7.2 2.0 15.0 1.6 0.9 1.5 0.0 4.5 5.1 1.5 1.3 3.9 3.6 2.1 4.2 3.4 5.3 3.7 12.2 4.5 5.6 2.3 1.0 2.0 0.3 0.4 5.1 0.8 4.7 1.0 4.5 3.6 3.2 1.4 2.9 1.6 5.7 0.9 1.7 3.2 4.3 3.1 2.9 5.3 6.4 3.1 2.8 5.7 2.0 6.5 3.9 0.4 2.7 4.7 4.3 14.0 2.7 3.5 1.8 12.4 1.1 2.2 7.8 1.7 4.2 4.2 2.6 1.1 4.2 5.9 1.2 5.0 2.4 0.9 2.0 2.5 1.8 3.1 3.4 5.7 2.6 2.3 2.2 1.5 1.1 1.0 3.6 0.8 3.5 4.5 2.3 1.3 2.9 3.5 3.3 2.4 0.9 3.9 1.3 5.1 0.6 2.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 16.0 4.5 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093525.1 ENSG00000259784 16 2513965-2527955 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 3.8;REH: 4.0;THP-1: 3.6;U-266/70: 4.8" NA NA 7.6 5.9 9.4 4.3 15.9 22.5 5.7 8.3 24.6 8.0 5.6 6.7 3.7 4.3 6.1 6.7 8.0 5.8 4.3 4.8 9.7 6.3 10.9 6.3 6.8 7.0 5.0 14.1 5.9 9.0 4.3 7.7 5.6 13.4 5.6 4.4 6.9 6.5 6.2 6.8 6.5 18.2 8.5 6.3 7.9 10.0 7.1 4.6 3.7 6.8 5.6 4.6 8.2 6.4 0.6 2.2 0.6 1.1 0.0 0.6 0.1 1.4 0.0 0.0 0.0 0.0 0.7 0.6 0.8 0.0 0.6 2.0 0.0 1.2 0.0 0.9 0.0 0.5 1.6 0.0 3.8 0.0 0.0 3.0 0.0 0.8 0.0 0.8 0.0 1.3 1.1 0.0 2.8 0.0 0.0 0.7 0.9 0.6 1.3 0.0 1.4 0.0 1.1 0.6 0.0 0.8 4.0 1.1 1.0 0.0 0.0 1.1 0.3 0.0 1.7 0.2 0.4 1.1 3.6 0.0 1.0 0.3 0.8 1.2 4.8 0.7 0.2 0.6 1.3 0.0 0.3 0.3 0.1 0.3 0.2 0.1 0.6 0.2 0.3 0.6 0.0 0.6 0.2 0.6 0.0 1.1 2.2 0.3 0.1 9.4 15.9 8.3 24.6 9.7 6.3 5.0 14.1 13.4 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC116565.1 ENSG00000273238 4 573880-576300 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "brain: 12.7;skin 1: 7.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "glioma: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.1;NB-4: 2.6;NTERA-2: 4.8;SCLC-21H: 10.5;U-2 OS: 2.6;U-251 MG: 3.2" "Low region specificity" "Detected in all" NA NA "unprognostic (4.13e-3)" "unprognostic (6.97e-3)" "unprognostic (2.65e-2)" 0.0 1.8 1.3 0.0 3.1 0.0 0.1 0.0 12.7 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 0.0 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.3 2.6 4.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC117457.1 ENSG00000275163 3 178419123-178843300 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 11.1;epididymis: 11.8;fallopian tube: 12.2;kidney: 5.2;pituitary gland: 19.9" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 1.4;Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "HSkMC: 5.7" NA NA 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.1 2.9 0.0 0.0 0.0 11.8 0.0 12.2 0.3 0.2 0.3 5.2 0.2 1.5 0.0 0.0 0.0 2.6 2.9 0.0 19.9 0.0 11.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC118553.2 ENSG00000283761 1 99970011-100083321 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 2.6;Ciliated cells: 9.4;Club cells: 2.3" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA073681 Approved Vesicles NA NA Vesicles "HPA073681: AB_2686625" 2.5 1.9 1.9 6.5 2.0 3.0 6.3 2.3 4.0 3.1 8.2 1.4 6.3 3.3 3.1 3.9 5.9 3.1 4.6 2.1 1.4 3.8 6.1 7.1 3.9 2.1 1.8 4.2 5.2 3.0 2.8 4.4 3.3 3.5 4.2 1.6 5.8 8.9 2.2 1.5 17.6 5.9 2.1 1.8 2.8 4.6 1.5 10.2 2.9 2.5 3.1 3.5 3.8 4.4 8.7 9.1 7.8 9.1 8.6 6.7 0.9 1.2 1.6 0.5 0.0 1.1 1.5 2.4 1.0 2.4 5.0 0.8 3.5 0.2 6.0 3.6 5.0 3.9 4.7 1.7 3.1 1.6 2.4 3.9 6.9 0.2 0.5 0.8 0.8 0.0 1.6 4.6 4.1 1.3 2.9 0.7 3.1 2.2 1.4 2.1 3.9 0.2 0.1 3.6 2.0 0.9 3.8 1.7 1.4 1.9 1.1 1.4 1.9 1.2 1.0 1.6 1.0 0.1 0.9 1.5 2.6 1.4 2.6 1.3 5.0 0.7 1.9 1.9 0.6 9.1 7.5 5.0 6.9 7.8 7.9 4.4 7.2 8.2 8.7 2.9 6.9 5.9 1.1 9.1 4.5 6.7 8.6 6.7 6.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 9.4 2.3 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC129492.3 ENSG00000263620 17 8150816-8162975 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 49.9;brain: 39.2;skeletal muscle: 55.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 23.3;HEK 293: 9.6;PC-3: 7.7;REH: 11.5" NA NA 14.0 6.0 11.2 2.6 25.6 2.6 2.7 14.6 39.2 4.9 20.3 11.0 1.3 2.6 5.9 2.6 3.4 3.3 2.6 32.0 8.5 3.0 3.6 4.4 7.5 2.9 5.3 15.7 2.6 2.6 2.6 5.4 2.6 19.9 3.3 2.6 7.6 3.1 2.6 55.4 2.6 2.6 2.6 3.7 14.9 18.7 3.0 7.0 0.7 2.6 0.6 2.6 5.2 3.1 31.4 23.7 49.9 12.9 29.2 45.5 15.5 1.6 0.2 0.2 0.0 0.0 0.0 3.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.3 3.9 0.0 0.0 0.0 23.3 9.6 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 7.7 11.5 0.0 3.1 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.5 0.5 0.7 0.0 2.9 0.0 2.6 3.9 5.9 2.6 0.0 0.0 3.7 18.0 9.8 36.6 37.5 11.4 33.1 31.4 38.0 42.3 8.7 28.3 45.5 39.7 49.9 29.2 12.9 23.7 27.2 15.5 11.2 25.6 14.6 39.2 8.5 3.0 5.3 15.7 19.9 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC131160.1 ENSG00000283765 3 183815568-183884889 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 12.1" HPA019545 Uncertain Approved Mitochondria NA NA Mitochondria "HPA019545: AB_1855796" 3.8 3.8 2.9 2.2 3.8 3.2 2.3 2.8 12.7 2.4 2.9 3.3 2.3 1.2 2.2 3.1 4.5 1.7 2.6 4.2 3.0 2.5 3.3 2.8 3.7 2.3 2.5 2.3 7.9 3.2 2.5 2.0 2.3 2.3 3.1 3.6 5.4 5.1 9.7 3.2 3.8 6.0 1.7 2.2 2.2 7.1 2.2 2.8 2.6 3.5 3.3 3.0 0.5 1.0 1.0 3.1 1.2 0.2 1.0 0.6 1.4 0.0 1.6 0.5 0.4 0.4 0.0 1.1 0.7 0.7 0.5 3.7 0.2 1.6 0.2 0.5 1.8 0.0 4.5 0.4 1.9 1.8 1.6 2.4 1.2 1.2 0.0 1.3 0.4 1.0 0.9 1.0 0.0 0.1 0.0 2.6 0.5 1.8 2.4 2.4 2.8 0.1 2.7 0.0 0.3 2.9 1.0 3.2 0.5 2.2 1.8 1.7 0.5 1.7 1.5 0.0 12.1 0.0 0.0 0.0 2.0 0.2 1.4 2.8 3.6 2.3 0.8 3.0 0.9 0.0 1.0 3.1 1.0 0.5 0.9 1.0 0.4 0.5 0.1 0.4 0.8 0.6 1.1 0.2 1.2 1.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC134669.1 ENSG00000265118 17 31305213-31318831 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "blood: 57.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 57.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 5.5;HMC-1: 5.3;Karpas-707: 4.9;MOLT-4: 9.5;RPMI-8226: 7.7" HPA045033 Uncertain NA NA "HPA045033: AB_2679191" "unprognostic (5.33e-2)" "unprognostic (3.44e-1)" "unprognostic (2.70e-2)" "unprognostic (2.23e-2)" "unprognostic (5.88e-2)" "unprognostic (2.94e-2)" "unprognostic (2.40e-2)" "unprognostic (4.63e-2)" "unprognostic (3.23e-1)" "unprognostic (5.45e-5)" "unprognostic (1.89e-3)" "unprognostic (1.81e-1)" "unprognostic (4.53e-2)" 2.4 0.3 1.4 6.6 2.1 3.0 0.5 0.5 4.5 0.3 1.1 0.5 0.2 1.2 0.5 1.1 0.8 0.7 2.0 0.4 2.6 1.5 0.6 0.7 4.9 4.0 6.8 1.8 0.6 0.3 0.1 0.4 2.0 2.1 0.7 1.2 0.5 2.2 0.6 0.6 0.4 2.6 1.1 4.4 4.5 2.4 0.8 4.3 2.2 0.7 0.2 5.9 1.7 0.5 9.3 14.7 57.6 24.1 4.7 12.3 20.3 0.1 0.0 0.0 0.0 0.0 5.5 0.1 0.4 1.0 0.6 1.2 0.0 0.0 1.0 0.0 0.4 1.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 3.5 1.8 5.3 1.2 0.1 0.0 2.3 0.6 0.0 1.9 0.0 4.9 1.8 0.0 9.5 0.8 0.0 0.0 0.0 2.9 0.6 7.7 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.1 1.9 2.2 1.0 0.2 1.1 1.2 4.7 0.0 3.6 0.3 1.6 1.1 1.7 24.1 2.0 8.6 11.0 7.9 9.3 10.0 8.9 14.7 5.6 10.1 9.1 57.6 4.7 10.9 4.8 12.3 20.3 1.4 2.1 0.5 4.5 2.6 1.5 6.8 1.8 2.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC134980.5 ENSG00000285472 15 22015233-22095857 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 103 "testis: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.3" HPA057442 Uncertain Approved Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135050.2 ENSG00000255439 16 31083439-31094956 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042720 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA042720: AB_10961864" "unprognostic (2.74e-1)" "unprognostic (9.61e-2)" "unprognostic (6.94e-2)" "unprognostic (2.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.68e-3)" "unprognostic (2.45e-3)" "unprognostic (1.34e-1)" "unprognostic (3.57e-1)" "unprognostic (2.79e-2)" "unprognostic (4.48e-3)" "unprognostic (8.49e-2)" "unprognostic (2.84e-8)" "unprognostic (4.96e-6)" "unprognostic (1.39e-1)" "unprognostic (4.81e-1)" "unprognostic (2.29e-4)" 4.5 2.6 1.6 4.8 1.7 3.0 6.4 1.9 2.6 5.4 3.9 3.3 3.2 3.3 5.1 5.9 3.7 4.0 4.9 3.7 1.8 1.8 6.9 47.1 3.6 3.7 2.4 1.1 5.6 14.1 4.6 3.1 4.8 2.3 4.8 2.2 4.4 8.3 3.8 2.0 7.8 6.0 6.3 1.8 4.3 3.5 3.6 1.5 3.0 5.7 2.4 2.6 6.5 3.9 2.3 2.6 2.9 2.7 1.4 3.8 2.0 1.2 1.2 0.0 1.2 2.7 3.6 0.3 3.7 0.9 0.0 0.5 0.6 0.7 0.7 1.9 0.3 0.0 0.5 0.0 0.4 0.0 0.4 1.7 1.5 1.2 0.5 0.0 0.0 1.5 1.0 0.6 0.6 0.0 0.6 0.0 1.1 0.0 1.5 0.3 1.2 1.0 3.1 0.3 0.1 1.6 2.9 0.2 1.1 0.0 0.8 1.0 0.9 1.8 1.0 1.9 0.0 0.0 0.4 0.0 1.2 0.0 3.2 0.9 3.6 0.8 0.0 2.9 0.9 0.4 0.8 1.6 2.9 2.7 1.6 3.5 2.3 3.4 3.8 2.3 1.8 2.1 2.8 1.5 1.4 2.7 2.6 3.4 2.0 1.6 1.7 1.9 2.6 1.8 1.8 2.4 1.1 2.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135068.1 ENSG00000182974 15 21637909-21638992 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 27 "U-2 OS: 2.7" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135068.3 ENSG00000279408 15 21651844-21652968 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;testis: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-2 OS: 3.7" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC136616.1 ENSG00000273554 Unmapped 1139577-1147868 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "skin 1: 3.0;testis: 8.5" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 36.3;Late spermatids: 27.8;Spermatocytes: 20.6;Spermatogonia: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AN3-CA: 18.7" NA NA 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 18.7 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 36.3 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 27.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 20.6 8.4 0.0 1.1 0.0 0.0 0.0 AC138811.2 ENSG00000260342 16 18788063-18801519 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 51.6;testis: 43.2" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 2: 3.5;Ciliated cells: 9.4;Club cells: 4.5;granulocytes: 2.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 28.6;HDLM-2: 34.8" HPA045307 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA045307: AB_10961042" "unprognostic (1.03e-2)" "unprognostic (8.89e-3)" "unprognostic (1.22e-1)" "unprognostic (3.59e-3)" "unprognostic (2.28e-1)" "unprognostic (6.32e-2)" "unprognostic (1.30e-3)" "unprognostic (1.39e-1)" "unprognostic (1.47e-1)" "unprognostic (1.46e-1)" "unprognostic (1.40e-2)" "unprognostic (3.27e-1)" "unprognostic (3.18e-4)" "unprognostic (2.92e-1)" "unprognostic (3.89e-2)" "unprognostic (2.65e-2)" "unprognostic (3.95e-2)" 5.0 5.8 7.8 7.0 12.6 4.6 4.4 9.4 17.0 3.8 13.5 6.3 2.3 1.9 4.2 3.1 5.6 3.5 3.8 4.8 6.9 4.8 6.4 12.1 4.3 4.0 6.6 10.6 4.1 9.3 10.8 3.6 4.0 17.1 3.6 4.1 9.6 4.1 4.1 12.0 4.0 5.9 5.5 7.0 6.0 14.6 43.2 4.0 7.5 4.5 1.6 4.1 4.7 3.9 29.2 51.6 29.0 25.8 37.2 49.0 48.3 11.6 2.3 2.0 12.2 0.7 0.3 0.4 12.6 0.7 1.2 1.6 8.3 14.9 3.1 28.6 2.9 3.1 13.9 4.4 1.8 3.6 34.8 1.3 3.3 5.3 2.2 0.0 15.8 8.2 0.7 0.4 4.2 0.0 1.2 0.7 1.5 6.7 12.1 1.3 0.0 5.5 0.2 1.1 0.7 0.3 21.1 4.5 1.6 0.8 7.0 6.4 0.7 16.3 4.3 1.1 1.1 7.8 0.3 13.1 5.7 8.9 5.6 13.0 3.3 16.5 7.2 8.1 1.9 13.2 29.0 25.8 15.0 43.5 18.0 34.2 29.0 34.9 41.5 24.5 29.2 29.8 32.9 20.1 37.2 22.9 51.6 49.0 48.3 7.8 12.6 9.4 17.0 6.9 4.8 6.6 10.6 17.1 4.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 9.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC138894.1 ENSG00000261832 16 28456371-28492098 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 3.5;Ciliated cells: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.0;BEWO: 1.3;hTCEpi: 3.4;NB-4: 1.4;REH: 1.0" HPA053611 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.93e-3)" "unprognostic (8.88e-3)" "unprognostic (4.33e-3)" "unprognostic (2.66e-1)" "unprognostic (3.59e-1)" "unprognostic (9.85e-2)" "unprognostic (3.82e-4)" "unprognostic (3.25e-2)" "unprognostic (3.44e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.59e-1)" "unprognostic (1.03e-1)" "unprognostic (6.85e-2)" "unprognostic (1.40e-1)" "unprognostic (2.37e-1)" "unprognostic (3.74e-1)" 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.6 0.0 0.8 0.3 0.5 0.0 0.1 0.0 0.3 0.2 0.1 0.3 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 3.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 1.4 0.4 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.5 0.3 0.3 0.0 0.0 0.2 0.0 6.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 9.4 1.2 0.0 0.0 0.8 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 AC171558.1 ENSG00000274792 Unmapped 386278-387620 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "testis: 1.6" "Group enriched" "Detected in some" 5 "Early spermatids: 4.8;Late spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "NTERA-2: 1.1;U-2 OS: 1.1" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 AC171558.3 ENSG00000275249 Unmapped 372322-373405 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 20 "testis: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACACB "ACC2, ACCB, HACC275" ENSG00000076555 "Acetyl-CoA carboxylase beta" O00763 12 109116595-109268226 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Allosteric enzyme, Ligase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "adipose tissue: 104.5;breast: 67.4;liver: 42.0;skeletal muscle: 154.2" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 159.9;Peritubular cells: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 15.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.5" "Cell line enriched" "Detected in many" 18 "ASC diff: 73.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA006554 Enhanced "Intracellular and membrane" NA NA "HPA006554: AB_1844495" "unprognostic (2.24e-1)" "unprognostic (4.66e-1)" "unprognostic (3.97e-2)" "unprognostic (4.54e-6)" "unprognostic (2.82e-1)" "unprognostic (1.59e-2)" "unprognostic (8.62e-3)" "unprognostic (5.81e-2)" "unprognostic (2.86e-1)" "unprognostic (1.63e-2)" "prognostic favorable (1.93e-4)" "unprognostic (6.63e-2)" "prognostic favorable (1.15e-5)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.21e-3)" "unprognostic (2.58e-2)" 104.5 8.2 4.3 10.6 4.0 1.6 67.4 3.3 3.5 3.5 19.3 3.2 6.2 3.8 4.6 4.3 4.9 3.9 10.5 12.1 4.5 2.0 5.4 42.0 3.1 4.0 6.4 2.7 6.8 8.5 8.9 7.1 1.3 3.7 3.6 3.9 4.0 5.8 9.0 154.2 2.8 4.8 7.5 6.5 2.5 5.6 1.6 4.9 0.4 6.2 12.5 1.7 7.3 6.3 2.5 0.2 15.5 0.4 0.1 1.7 0.1 0.2 1.8 1.1 2.2 73.2 0.5 0.8 0.3 0.4 0.3 0.2 1.2 0.3 0.9 0.5 0.3 0.8 1.5 0.9 0.5 0.2 1.1 1.7 2.0 1.8 1.3 0.3 1.7 0.5 0.8 0.4 0.7 0.2 0.5 0.1 1.5 0.2 0.1 0.2 0.5 1.2 1.6 1.2 0.1 3.9 0.6 1.5 0.4 0.6 0.6 0.7 1.7 1.8 0.9 1.1 0.5 0.8 1.8 0.1 0.7 0.4 0.8 0.6 2.8 1.5 1.2 1.7 1.4 0.5 4.1 0.4 15.5 1.1 0.1 0.6 1.7 1.0 0.3 0.2 2.5 1.7 0.9 0.6 0.1 0.2 0.2 0.6 0.1 4.3 4.0 3.3 3.5 4.5 2.0 6.4 2.7 3.7 4.9 6.0 0.6 0.0 2.5 2.1 1.3 29.0 28.1 1.4 2.3 22.7 0.0 0.4 1.7 1.0 27.5 7.1 12.9 0.0 3.6 0.4 5.4 1.4 1.1 159.9 1.6 22.3 9.8 31.3 8.6 31.3 27.0 2.2 5.0 1.0 8.8 7.5 3.5 7.0 47.4 6.5 4.7 6.5 7.6 2.7 2.5 1.4 0.1 0.0 9.7 0.7 ACBD4 FLJ13322 ENSG00000181513 "Acyl-CoA binding domain containing 4" Q8NC06 17 45132600-45144181 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051772 Approved Approved Nucleoplasm,Vesicles Yes No "Nucleoplasm, Vesicles" "HPA051772: AB_2681603" "unprognostic (1.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.59e-2)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (1.60e-2)" "prognostic favorable (4.76e-4)" "unprognostic (2.27e-2)" "unprognostic (9.06e-2)" "unprognostic (4.86e-2)" "prognostic favorable (4.64e-4)" "unprognostic (8.24e-2)" "unprognostic (2.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-1)" "prognostic favorable (6.53e-4)" 7.5 9.5 8.1 8.5 15.3 3.5 6.7 10.8 10.9 8.6 19.6 4.9 14.4 25.9 9.2 6.8 8.3 10.1 10.7 6.2 8.1 6.8 12.3 43.1 6.3 8.0 6.1 11.1 10.4 14.2 13.6 8.5 5.4 6.3 11.1 5.4 9.9 12.3 13.6 5.4 7.5 29.0 10.3 4.8 8.3 7.3 2.5 6.3 3.9 11.3 4.4 7.3 8.5 7.2 8.8 3.5 5.6 4.3 6.3 7.7 5.4 5.9 11.6 1.5 3.3 2.7 5.2 4.1 2.2 4.7 3.7 7.3 4.5 8.4 6.3 5.8 3.2 2.2 5.7 2.0 3.8 1.5 9.1 4.6 3.1 7.5 8.9 6.1 1.2 8.7 5.1 3.6 1.3 1.9 12.7 3.6 5.9 2.0 10.2 1.8 4.0 4.4 1.6 0.2 6.3 3.2 3.7 0.3 14.0 9.2 3.8 2.5 1.1 1.6 2.4 6.4 0.8 15.6 2.2 1.3 0.9 2.9 1.4 1.4 16.0 4.4 1.9 5.4 1.6 1.6 5.5 3.8 5.6 5.3 4.3 5.7 6.8 6.2 5.9 3.5 8.8 6.7 7.7 1.0 6.3 2.8 2.2 7.1 5.4 8.1 15.3 10.8 10.9 8.1 6.8 6.1 11.1 6.3 6.3 3.0 4.8 2.9 5.7 1.6 14.6 8.0 17.8 1.4 0.0 3.5 21.6 5.5 6.6 5.7 1.3 5.3 10.5 0.0 6.3 1.0 4.3 3.8 8.1 20.8 4.6 11.1 5.8 4.9 1.6 2.7 6.4 1.7 3.3 5.4 5.8 12.3 5.2 10.5 7.1 15.1 15.8 6.5 7.2 0.7 3.8 1.6 5.3 4.4 7.0 1.7 ACBD5 "DKFZp434A2417, KIAA1996" ENSG00000107897 "Acyl-CoA binding domain containing 5" Q5T8D3 10 27195214-27242130 "Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011861, HPA012145" Enhanced Enhanced Peroxisomes NA NA Peroxisomes "HPA011861: AB_1844493, HPA012145: AB_1844494" "prognostic unfavorable (3.33e-4)" "unprognostic (4.93e-1)" "unprognostic (3.68e-1)" "unprognostic (1.34e-1)" "unprognostic (6.21e-2)" "unprognostic (5.98e-3)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (2.69e-1)" "unprognostic (3.66e-1)" "unprognostic (1.11e-1)" "unprognostic (4.46e-2)" "prognostic favorable (4.68e-5)" "unprognostic (7.91e-3)" "unprognostic (1.71e-1)" "unprognostic (3.63e-2)" "unprognostic (3.37e-3)" 9.2 15.7 25.7 7.1 21.5 7.7 7.4 13.7 21.3 8.4 15.5 17.7 9.1 23.0 5.6 6.1 7.2 7.4 9.0 23.0 23.0 21.1 22.8 44.7 8.5 7.6 27.4 14.0 6.3 6.5 18.9 6.0 7.8 21.3 9.2 12.6 12.9 7.2 10.2 15.8 9.3 24.6 5.3 31.0 8.4 12.2 10.8 20.9 5.7 16.6 7.6 7.6 9.7 5.8 7.0 12.9 11.5 14.0 9.0 16.6 7.4 12.5 38.2 8.2 9.2 10.0 9.2 10.4 15.7 6.3 14.4 17.4 9.5 19.7 5.6 13.8 11.1 11.9 10.2 12.2 8.3 12.3 12.7 12.0 7.7 11.4 7.2 11.6 5.0 10.5 8.9 9.2 12.0 6.9 12.6 10.5 8.8 6.4 8.5 18.6 9.5 10.3 4.2 6.5 17.6 4.9 8.9 21.7 9.7 23.1 11.2 11.7 23.2 17.8 19.4 9.2 10.0 9.5 5.7 14.7 14.0 7.7 21.9 12.6 10.0 13.6 10.0 14.2 12.3 6.0 9.4 13.1 10.5 16.6 12.9 16.4 7.0 8.3 13.0 12.9 7.0 5.7 12.0 11.5 9.0 14.0 9.3 7.3 7.4 25.7 21.5 13.7 19.2 23.0 21.1 27.4 14.0 21.3 20.9 23.8 25.1 11.0 4.6 8.7 30.3 79.5 12.7 45.5 30.7 29.6 23.6 8.2 28.2 18.4 34.5 13.7 22.7 0.0 14.1 10.2 9.7 11.6 11.6 44.5 17.0 22.3 9.8 11.1 23.9 11.7 15.3 19.9 20.3 19.0 32.4 46.4 15.5 24.9 15.6 36.0 38.2 19.4 9.2 39.6 7.5 13.6 8.7 19.5 24.7 7.1 ACE "ACE1, CD143, DCP1" ENSG00000159640 "Angiotensin I converting enzyme" P12821 17 63477061-63498380 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 205.6" "Group enriched" "Detected in many" 25 "Early spermatids: 470.5;Late spermatids: 1015.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Group enriched" "Detected in many" 23 "B-cells: 3.7;monocytes: 2.0;T-cells: 1.9" "Group enriched" "Detected in some" 4 "ASC TERT1: 36.7;HUVEC TERT2: 18.7" "CAB002426, CAB002921, HPA029298, HPA069790" Enhanced Approved Vesicles "Secreted to blood" NA NA 104000000 92000000 Vesicles "CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197" "unprognostic (4.72e-2)" "unprognostic (4.16e-1)" "unprognostic (1.93e-3)" "unprognostic (6.06e-2)" "unprognostic (2.78e-1)" "unprognostic (1.35e-2)" "unprognostic (4.37e-1)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (1.25e-2)" "unprognostic (3.13e-2)" "unprognostic (2.38e-1)" "unprognostic (7.66e-2)" "unprognostic (9.07e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (2.76e-2)" 6.8 2.0 0.5 2.4 4.2 0.0 2.9 0.5 1.1 5.3 83.2 0.7 37.7 46.4 4.5 5.1 1.7 1.5 4.4 4.7 0.6 0.7 2.6 1.4 16.3 2.2 0.4 0.7 1.4 3.0 3.6 3.6 3.6 0.8 3.4 1.4 1.7 2.5 20.1 3.6 1.3 205.6 2.4 0.6 1.4 1.9 32.6 1.3 0.5 6.9 3.1 2.2 1.7 1.6 3.7 0.1 0.0 2.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 1.5 36.7 0.4 1.3 2.7 0.0 0.0 0.5 3.2 0.7 1.1 6.2 0.0 0.0 1.7 0.0 0.0 0.0 0.7 3.5 0.0 0.0 0.8 0.0 0.0 2.4 0.0 0.0 0.0 0.6 18.7 0.0 3.1 0.0 0.0 0.6 0.0 0.8 0.3 6.3 0.4 0.1 0.2 0.5 0.0 0.0 4.6 3.2 0.0 0.0 0.0 0.7 1.6 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.6 0.9 3.7 1.9 1.4 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.5 4.2 0.5 1.1 0.6 0.7 0.4 0.7 0.8 1.3 0.0 3.5 0.0 1.5 1.3 3.1 1.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 3.4 470.5 13.5 29.6 0.0 0.4 0.1 1.0 6.0 6.9 0.0 4.4 0.0 17.3 2.5 18.5 1015.1 4.0 5.1 3.3 0.0 8.7 1.9 0.7 10.2 2.5 10.7 1.0 0.0 0.9 8.1 3.4 0.1 0.1 0.9 8.6 2.1 ACE2 ENSG00000130234 "Angiotensin I converting enzyme 2" Q9BYF1 X 15561033-15602148 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" "Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 122.0" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 61.1;Enterocytes: 38.8;Proximal tubular cells: 45.6;Sertoli cells: 19.4" "Cancer enhanced" "Detected in many" "renal cancer: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.4;HaCaT: 4.1;Hep G2: 2.5;NB-4: 2.2;RPMI-8226: 2.1;RT4: 2.5;SH-SY5Y: 2.8;SuSa: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028" Enhanced "Secreted to blood" NA NA 85000 "CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160" "unprognostic (1.40e-1)" "unprognostic (7.26e-2)" "unprognostic (2.76e-2)" "unprognostic (5.71e-2)" "unprognostic (2.51e-1)" "unprognostic (5.26e-2)" "prognostic favorable (4.21e-4)" "unprognostic (2.34e-2)" "unprognostic (6.74e-3)" "unprognostic (2.54e-3)" "unprognostic (1.00e-1)" "unprognostic (1.74e-1)" "prognostic favorable (2.12e-5)" "unprognostic (1.94e-1)" "unprognostic (9.62e-2)" "unprognostic (2.11e-1)" "unprognostic (7.10e-2)" 4.5 0.4 0.2 0.8 0.2 0.0 2.3 0.2 0.2 0.4 49.1 0.2 2.3 46.0 0.4 2.7 1.2 0.6 16.4 10.5 0.2 0.1 23.2 1.2 0.8 0.6 0.2 0.2 1.3 1.6 0.0 0.2 1.0 0.2 0.5 1.3 0.2 1.1 1.2 0.7 0.2 122.0 0.3 0.2 0.2 0.5 17.9 0.2 0.2 4.5 0.5 0.2 0.4 0.9 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.0 0.4 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 0.0 0.4 4.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.2 0.2 0.0 0.0 2.1 0.4 2.5 0.6 2.8 0.1 0.3 0.2 1.9 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 2.2 0.5 0.1 0.0 9.8 61.1 0.0 0.0 0.0 0.0 2.9 3.3 0.5 0.4 0.0 38.8 0.0 0.7 0.2 0.0 0.4 0.0 0.8 0.7 0.0 6.9 0.0 0.0 1.1 7.8 0.0 0.0 0.0 1.2 0.0 0.9 4.2 5.6 45.6 0.0 19.4 0.0 1.1 0.7 0.1 10.6 0.0 3.3 1.6 ACER1 ASAH3 ENSG00000167769 "Alkaline ceramidase 1" Q8TDN7 19 6306142-6333629 "Enzymes, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "esophagus: 14.3;skin 1: 38.2;tongue: 17.3" "Cell type enhanced" "Detected in some" 23 "Melanocytes: 1.7;Spermatocytes: 1.8;Suprabasal keratinocytes: 5.1" "Group enriched" "Detected in some" 7 "head and neck cancer: 1.0;melanoma: 2.2;prostate cancer: 0.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "MCF7: 2.2;T-47d: 8.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (1.13e-2)" "unprognostic (2.87e-4)" "unprognostic (5.04e-2)" "unprognostic (6.18e-2)" "unprognostic (8.16e-4)" "unprognostic (7.27e-4)" "unprognostic (2.17e-2)" "unprognostic (1.61e-1)" "unprognostic (1.99e-1)" "unprognostic (1.02e-4)" "unprognostic (1.02e-1)" "unprognostic (1.30e-5)" "unprognostic (2.11e-1)" "unprognostic (4.44e-2)" "unprognostic (4.22e-1)" "unprognostic (2.24e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 2.2 0.1 0.1 3.8 0.1 0.1 0.1 0.0 0.4 0.1 14.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.1 0.0 0.1 1.4 0.1 0.2 38.2 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 17.3 3.5 0.1 2.2 0.6 0.4 0.4 0.2 1.0 3.6 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 8.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.0 3.6 0.1 3.5 1.6 0.0 0.6 2.3 2.3 0.4 1.0 0.2 0.4 2.0 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.5 5.1 0.0 0.0 0.0 0.1 ACER2 "ALKCDase2, ASAH3L, FLJ41587" ENSG00000177076 "Alkaline ceramidase 2" Q5QJU3 9 19409059-19452020 "Enzymes, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 41.0;urinary bladder: 31.3;vagina: 40.6" "Cell type enhanced" "Detected in some" 11 "Cone photoreceptor cells: 2.0;Early spermatids: 2.1;Ito cells: 1.8;Late spermatids: 1.8;Syncytiotrophoblasts: 3.3" "Cancer enhanced" "Detected in many" "urothelial cancer: 15.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "BEWO: 16.7;RT4: 41.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.94e-1)" "unprognostic (2.29e-1)" "unprognostic (2.06e-1)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (2.03e-1)" "unprognostic (3.90e-1)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (2.13e-2)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (7.42e-2)" "unprognostic (8.46e-3)" 17.4 1.7 3.1 0.7 5.9 0.4 20.7 2.3 6.8 1.4 3.5 0.9 5.3 3.0 1.3 3.0 1.8 2.8 1.3 3.2 3.0 1.9 1.6 2.6 1.5 0.6 4.4 0.3 1.3 4.7 2.7 1.6 20.0 4.5 9.4 3.1 1.4 1.8 6.8 2.1 4.0 1.7 2.1 2.9 1.2 41.0 1.3 4.7 0.4 1.8 1.0 0.8 31.3 40.6 1.0 1.2 0.0 3.1 0.0 1.0 0.5 0.6 1.3 2.1 1.1 3.5 0.2 16.7 1.1 0.8 0.5 0.5 0.3 1.0 0.7 0.4 0.1 0.2 2.5 0.5 3.3 0.9 1.4 0.6 1.1 1.0 1.5 0.7 0.2 1.1 1.1 3.1 1.3 1.4 0.3 3.5 1.2 1.7 2.1 1.2 1.0 1.9 0.9 1.6 6.0 0.5 1.7 0.6 0.4 0.3 41.0 3.9 0.9 0.2 1.1 0.2 5.6 1.4 1.4 1.7 0.3 0.8 0.3 0.5 0.7 0.9 0.8 0.3 0.8 0.7 0.0 0.1 0.0 0.8 3.1 0.2 1.0 0.3 0.3 0.3 0.4 1.0 0.2 0.0 0.0 0.0 1.2 0.3 0.5 3.1 5.9 2.3 6.8 3.0 1.9 4.4 0.3 4.5 4.7 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.1 2.1 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.8 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.5 0.0 3.3 0.0 0.0 0.5 ACER3 "APHC, FLJ11238, PHCA" ENSG00000078124 "Alkaline ceramidase 3" Q9NUN7 11 76860867-77026797 "Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA070087 Approved NA NA "HPA070087: AB_2732147" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "unprognostic (9.54e-3)" "unprognostic (1.37e-1)" "unprognostic (4.06e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (7.13e-2)" "unprognostic (2.35e-3)" "unprognostic (8.45e-3)" "unprognostic (1.30e-1)" "unprognostic (3.68e-3)" "prognostic unfavorable (2.73e-4)" "unprognostic (5.24e-2)" "unprognostic (3.37e-1)" "unprognostic (9.88e-2)" "unprognostic (7.97e-2)" 18.3 5.9 11.8 8.6 19.8 7.1 7.8 7.9 15.2 10.5 10.8 29.5 1.5 12.0 7.0 7.1 9.8 5.4 6.3 5.3 14.7 11.0 9.1 4.9 11.3 8.2 27.3 7.2 4.0 4.6 8.3 3.6 31.6 21.8 8.3 10.0 6.0 6.3 5.0 2.7 6.1 8.1 7.2 22.0 8.7 7.2 9.3 24.6 1.3 6.0 6.5 6.7 5.4 6.5 1.6 4.7 3.9 5.0 0.6 2.2 1.4 4.9 5.9 4.9 5.9 22.0 10.5 3.2 7.3 7.5 6.2 6.7 4.1 5.5 4.6 5.3 5.6 7.1 8.8 6.6 7.8 7.5 5.6 2.2 7.2 4.0 2.8 6.1 6.5 12.5 5.3 3.9 7.3 8.2 3.6 10.5 4.0 4.0 2.3 6.9 4.7 0.5 5.0 2.5 14.0 5.8 2.9 16.5 3.1 5.2 5.2 1.7 4.3 8.6 10.0 2.7 3.5 7.2 3.9 13.7 6.1 4.6 18.4 5.9 2.0 4.2 6.4 3.9 3.7 7.2 0.6 5.0 3.9 1.2 4.5 1.4 1.6 0.9 1.5 4.7 1.0 0.7 1.0 1.8 0.6 2.8 2.5 2.2 1.4 11.8 19.8 7.9 14.4 14.7 11.0 27.3 7.2 21.8 24.6 38.7 44.4 9.7 19.0 28.3 17.8 6.0 10.2 16.0 36.4 8.7 9.8 10.6 6.6 13.8 46.3 25.2 28.7 0.0 15.4 6.2 15.6 13.3 79.9 8.6 38.9 41.3 2.4 30.1 55.7 26.2 18.7 52.0 16.9 19.8 22.5 12.0 14.1 31.5 24.4 11.0 9.4 6.5 21.7 73.8 17.9 14.6 22.4 10.7 16.2 19.2 ACKR1 "CCBP1, CD234, DARC, Dfy, FY, GPD" ENSG00000213088 "Atypical chemokine receptor 1 (Duffy blood group)" Q16570 1 159203307-159206500 "Blood group antigen proteins, CD markers, G-protein coupled receptors, Predicted membrane proteins" "Blood group antigen, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 109.8" "Cell type enhanced" "Detected in many" 26 "Bipolar cells: 50.1;Endothelial cells: 278.7;Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEL: 22.5;HSkMC: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016421, HPA017672" Enhanced NA NA "HPA016421: AB_1849219, HPA017672: AB_1849221" "unprognostic (8.74e-3)" "prognostic favorable (2.52e-5)" "unprognostic (9.73e-2)" "unprognostic (1.91e-1)" "unprognostic (2.34e-3)" "unprognostic (3.84e-3)" "prognostic favorable (1.48e-4)" "unprognostic (7.80e-2)" "unprognostic (2.22e-1)" "unprognostic (3.46e-2)" "unprognostic (1.65e-3)" "unprognostic (1.81e-1)" "unprognostic (3.82e-3)" "unprognostic (5.17e-3)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.30e-2)" 109.8 4.0 6.7 16.2 4.2 5.7 54.5 23.3 5.4 40.1 13.1 2.4 10.2 6.5 28.8 23.0 32.6 27.1 26.9 47.1 9.1 3.4 5.7 1.3 27.8 36.8 19.2 0.6 22.3 8.1 3.9 2.0 5.8 14.0 29.1 7.1 5.3 12.8 9.8 38.3 19.8 11.5 36.6 9.4 25.0 13.0 21.6 6.4 3.0 16.5 29.9 15.5 42.3 24.2 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 22.5 0.0 0.0 4.2 0.0 0.0 24.5 0.0 0.0 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.7 4.2 23.3 5.3 9.1 3.4 19.2 0.6 14.0 6.4 6.0 19.1 0.0 1.6 0.0 50.1 8.1 0.0 1.4 3.4 0.0 2.0 0.2 0.0 0.0 1.6 278.7 0.0 116.8 9.1 0.2 6.3 1.9 4.7 0.0 0.8 6.4 0.0 6.7 0.8 2.0 1.1 0.2 0.0 0.0 0.0 6.4 0.0 0.0 0.4 0.0 3.6 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.9 ACKR2 "CCBP2, CCR10, CCR9, CMKBR9, D6" ENSG00000144648 "Atypical chemokine receptor 2" O00590 3 42804752-42887974 "G-protein coupled receptors, Predicted membrane proteins" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "placenta: 96.2;salivary gland: 74.8" "Group enriched" "Detected in many" 10 "Cytotrophoblasts: 26.5;Extravillous trophoblasts: 87.8;Syncytiotrophoblasts: 61.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 7.3;NK-cell: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 7.3;NK-cells: 2.2" "Cell line enhanced" "Detected in some" "BEWO: 32.2;HEL: 10.3;SK-BR-3: 17.2;U-937: 6.5" "Group enriched" "Detected in many" 9 "amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6" "Not detected" "Not detected" "HPA013819, HPA073493" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "HPA013819: AB_1846126, HPA073493: AB_2686610" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.90e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (1.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.74e-1)" "unprognostic (2.99e-1)" "unprognostic (6.20e-2)" "unprognostic (8.47e-2)" "unprognostic (8.45e-2)" "unprognostic (1.13e-4)" "unprognostic (5.13e-3)" "unprognostic (3.22e-1)" "unprognostic (5.58e-3)" "unprognostic (6.09e-2)" 10.4 0.9 0.4 0.7 0.5 0.4 5.3 0.2 0.4 2.9 1.8 0.1 0.6 0.7 2.0 5.2 2.5 2.4 1.2 1.0 0.5 0.4 1.1 14.5 1.5 1.0 0.5 0.2 0.9 0.7 0.3 0.6 96.2 0.2 1.1 2.0 0.3 74.8 0.4 2.1 2.5 1.0 3.2 0.7 1.1 0.9 1.5 0.1 0.4 3.8 2.3 2.0 3.2 4.1 0.8 0.4 7.3 0.6 2.2 0.4 0.3 0.1 0.0 0.1 0.2 1.5 0.1 32.2 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.1 10.3 0.2 1.8 0.0 0.1 1.2 0.3 0.3 0.0 0.0 0.0 0.0 0.3 1.3 0.2 0.2 0.2 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.4 4.5 0.1 0.1 0.8 17.2 0.0 1.9 1.7 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 6.5 0.1 0.7 0.2 7.3 0.4 0.5 0.1 0.2 0.1 0.2 0.4 0.8 0.3 0.3 1.0 2.2 0.6 0.3 0.1 0.3 0.4 0.5 0.2 0.4 0.5 0.4 0.5 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.6 2.5 1.4 0.0 0.0 2.0 26.5 1.7 0.0 1.9 1.4 2.0 0.0 0.0 87.8 1.8 0.4 2.3 5.8 4.6 1.6 1.7 3.7 0.3 1.1 0.3 0.2 0.0 0.0 0.1 2.5 0.6 0.0 1.1 0.3 0.9 0.0 0.0 4.5 3.3 0.0 61.6 0.5 0.4 0.1 ACKR3 "CMKOR1, CXCR7, GPR159, RDC1" ENSG00000144476 "Atypical chemokine receptor 3" P25106 2 236567787-236582358 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 19.6;Club cells: 21.6;Endothelial cells: 44.5;Fibroblasts: 27.8;Ito cells: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 6.1;T-cells: 6.1" "Cell line enhanced" "Detected in some" "HeLa: 23.4;MCF7: 17.2;RT4: 68.3;SiHa: 20.9;U-2197: 71.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032003, HPA049718" Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA032003: AB_2674107, HPA049718: AB_2680859" "unprognostic (1.65e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (2.50e-1)" "unprognostic (1.92e-3)" "unprognostic (2.10e-1)" "unprognostic (1.23e-1)" "unprognostic (7.34e-3)" "unprognostic (1.55e-2)" "unprognostic (1.85e-2)" "unprognostic (1.35e-1)" "unprognostic (9.70e-3)" "unprognostic (6.69e-2)" "prognostic unfavorable (1.76e-6)" "prognostic unfavorable (2.01e-4)" "unprognostic (9.71e-2)" "unprognostic (8.57e-3)" "prognostic unfavorable (2.93e-4)" 56.1 2.9 5.4 6.9 5.6 1.7 28.5 2.2 6.4 10.7 15.2 8.9 9.1 5.7 9.9 20.4 23.6 14.6 15.3 30.2 8.4 3.0 3.8 29.6 10.9 7.2 3.8 6.5 19.3 25.7 2.2 10.7 59.6 8.4 14.2 12.8 25.2 8.9 8.9 36.4 16.0 15.7 32.6 7.2 70.9 12.6 9.4 5.5 0.2 34.3 22.3 8.6 59.2 17.8 1.0 0.2 0.1 0.5 6.1 6.1 0.6 0.0 0.0 1.4 0.0 2.4 0.0 10.0 0.5 0.3 0.5 1.0 0.1 0.0 0.0 1.1 0.0 3.8 14.7 0.0 5.2 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.6 13.4 0.0 0.0 3.3 2.4 0.0 0.2 0.0 0.0 17.2 0.0 0.0 2.3 0.0 0.1 0.0 1.6 0.1 0.0 68.3 0.0 0.0 20.9 0.1 0.0 5.5 0.0 0.0 0.0 0.1 5.4 71.8 0.0 0.3 0.0 0.0 0.2 1.4 0.1 0.0 0.1 0.0 4.1 0.3 6.1 0.6 2.1 5.0 0.2 1.0 1.8 2.3 0.1 6.1 0.5 0.0 3.1 0.6 5.4 5.6 2.2 6.4 8.4 3.0 3.8 6.5 8.4 5.5 8.9 4.5 0.5 0.1 19.6 1.3 6.9 0.0 6.7 21.6 0.0 0.0 0.0 0.0 0.2 1.0 44.5 0.7 0.0 9.3 0.2 27.8 0.2 5.8 0.9 0.8 0.0 0.0 17.8 2.5 0.2 1.4 4.0 1.7 1.0 0.0 0.0 0.9 0.8 1.1 0.6 0.0 0.0 15.0 0.3 0.4 13.9 0.2 0.0 0.0 0.9 ACKR4 "CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1" ENSG00000129048 "Atypical chemokine receptor 4" Q9NPB9 3 132597237-132618967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.6;salivary gland: 29.0" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 35.7;monocytes: 11.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "basophil: 1.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.8" "Cell line enriched" "Detected in some" 6 "BJ hTERT+: 88.7" "Group enriched" "Detected in some" 7 "cerebellum: 5.3;pons and medulla: 1.6" "Low region specificity" "Detected in all" HPA054926 Approved Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" "HPA054926: " "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.62e-2)" "unprognostic (8.27e-2)" "unprognostic (5.17e-2)" "unprognostic (4.55e-3)" "unprognostic (8.93e-2)" "unprognostic (2.26e-1)" "unprognostic (4.85e-2)" "unprognostic (4.20e-3)" "unprognostic (1.03e-3)" "unprognostic (2.69e-3)" "unprognostic (1.95e-1)" "unprognostic (2.01e-1)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-1)" 13.9 1.9 0.3 2.9 0.4 0.5 10.9 0.4 0.4 3.7 8.7 0.2 4.5 16.2 5.6 7.1 5.7 2.6 9.8 7.1 0.6 0.6 6.6 2.0 10.0 2.7 0.6 0.2 2.1 3.0 0.0 8.2 0.7 0.6 5.2 1.2 1.3 29.0 2.0 3.1 10.7 35.6 5.0 0.4 1.5 10.5 3.4 0.1 0.8 1.8 12.8 1.5 8.2 4.5 0.2 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.4 3.4 0.0 14.5 88.7 0.9 2.5 0.0 0.1 1.0 0.0 9.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.4 0.6 0.6 0.6 0.2 0.6 0.1 35.7 1.4 0.0 0.4 5.8 1.8 0.7 0.0 1.4 2.3 5.2 5.9 0.2 0.0 0.2 2.1 5.1 1.3 0.0 10.8 0.0 4.1 0.4 0.0 0.0 0.4 1.6 0.0 9.8 0.8 0.0 2.0 0.0 1.7 11.8 0.0 1.1 6.6 0.0 2.5 2.4 3.1 0.0 1.9 0.1 0.0 5.6 0.2 0.0 0.6 1.0 ACMSD ENSG00000153086 "Aminocarboxymuconate semialdehyde decarboxylase" Q8TDX5 2 134838547-134902034 "Enzymes, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "kidney: 44.8;liver: 64.1" "Cell type enhanced" "Detected in some" 29 "Cholangiocytes: 58.6;Distal tubular cells: 46.4;Hepatocytes: 104.7;Proximal tubular cells: 312.9" "Group enriched" "Detected in some" 23 "liver cancer: 21.2;renal cancer: 19.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 22 "RPTEC TERT1: 24.8" "Not detected" "Not detected" "HPA010533, HPA011179" Enhanced NA NA 11000 "HPA010533: AB_1844517, HPA011179: AB_1844516" "unprognostic (1.06e-2)" "unprognostic (5.30e-2)" "unprognostic (1.40e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-2)" "unprognostic (1.36e-2)" "unprognostic (4.40e-3)" "unprognostic (1.15e-1)" "unprognostic (5.35e-4)" "unprognostic (7.60e-2)" "unprognostic (5.17e-2)" "unprognostic (2.44e-3)" "prognostic favorable (2.39e-4)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (2.93e-2)" "unprognostic (2.65e-5)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 2.5 0.0 0.0 0.0 44.8 64.1 0.1 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 1.4 0.9 0.6 0.2 1.7 0.5 0.3 0.1 0.4 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.7 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.4 0.0 0.0 0.3 0.6 0.2 1.1 0.1 0.5 0.1 0.5 0.2 24.8 0.3 1.0 0.3 0.1 0.2 0.4 0.7 0.2 0.6 0.8 0.0 0.3 0.2 0.7 0.2 0.1 0.4 0.2 0.3 0.6 0.0 0.6 0.9 0.9 0.5 0.4 1.5 0.9 1.3 0.9 1.1 1.7 0.9 0.4 0.2 0.5 1.4 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.1 58.6 0.0 0.0 8.7 0.0 0.0 46.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.7 0.0 0.0 0.0 2.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 312.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACP1 "HAAP, LMW-PTP, LMWPTP" ENSG00000143727 "Acid phosphatase 1" P24666 2 264140-278283 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 913.9;Late spermatids: 1666.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016754 Approved Approved Nucleoplasm,Cytosol NA NA 3700000 Nucleoplasm Cytosol "HPA016754: AB_1844505" "unprognostic (1.15e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (6.25e-3)" "unprognostic (1.06e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (6.67e-6)" "unprognostic (2.45e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (9.72e-3)" "unprognostic (4.89e-2)" "unprognostic (2.71e-2)" "unprognostic (7.10e-2)" "unprognostic (2.88e-2)" "unprognostic (3.39e-2)" "unprognostic (1.92e-1)" "unprognostic (2.44e-2)" 22.3 59.7 38.0 20.8 40.3 38.0 33.0 27.9 43.7 23.1 29.7 27.4 24.4 31.1 25.2 36.2 24.8 29.5 26.9 27.4 34.6 33.7 42.1 54.8 24.7 29.4 31.5 34.6 33.7 53.0 28.4 43.9 39.7 39.7 27.0 32.8 28.5 46.0 23.8 35.4 21.6 34.5 24.2 28.6 28.1 34.2 38.3 21.2 33.0 32.5 32.8 29.8 22.7 20.3 33.9 20.3 17.3 23.0 35.3 41.0 33.1 17.8 26.6 41.5 22.8 18.8 18.8 33.7 21.7 23.1 21.7 19.2 36.5 18.0 11.2 16.9 20.3 28.5 17.5 40.3 23.6 19.6 27.3 41.0 32.8 24.1 79.8 26.1 37.2 18.9 19.2 21.5 20.3 25.2 23.0 24.6 42.0 33.1 21.9 25.6 24.2 40.0 36.0 50.1 47.2 30.0 26.6 42.1 25.6 33.9 25.5 45.3 44.8 13.5 32.0 43.4 28.3 18.9 19.9 20.3 23.9 15.9 19.7 32.7 29.8 59.1 34.9 28.3 32.2 28.1 17.3 19.8 17.1 30.1 22.7 39.7 33.9 34.3 34.4 17.7 31.1 41.0 39.7 3.5 35.3 23.0 20.3 35.6 33.1 38.0 40.3 27.9 43.7 34.6 33.7 31.5 34.6 39.7 21.2 41.7 88.5 101.3 80.3 70.3 51.3 74.2 109.5 129.8 67.1 64.6 7.9 179.7 228.8 194.3 913.9 64.7 84.9 163.5 146.5 234.8 71.9 111.0 68.2 112.0 123.7 27.0 79.2 50.3 57.7 1666.6 87.5 74.7 77.6 116.4 107.9 64.8 155.5 108.7 86.7 241.7 43.6 90.5 79.3 111.8 121.7 79.7 157.0 93.8 114.3 108.3 ACP2 LAP ENSG00000134575 "Acid phosphatase 2, lysosomal" P11117 11 47239302-47248906 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 103.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 30.3" "Lineage enriched" "Detected in all" 5 "monocytes: 30.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 8100 "unprognostic (5.27e-3)" "unprognostic (1.56e-1)" "unprognostic (3.86e-2)" "prognostic favorable (1.04e-4)" "unprognostic (7.90e-3)" "unprognostic (2.93e-1)" "unprognostic (6.16e-3)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (3.28e-3)" "unprognostic (2.64e-3)" "unprognostic (5.42e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (8.68e-3)" "unprognostic (1.57e-1)" 15.7 23.6 13.1 13.9 13.6 3.6 13.0 12.5 19.5 11.3 15.4 11.7 15.4 26.9 10.5 20.0 8.9 9.3 12.4 18.1 14.4 18.2 18.7 65.4 13.3 40.7 11.8 12.7 8.1 36.2 13.6 13.8 31.3 12.2 15.3 11.7 16.4 32.3 18.5 10.1 7.0 24.4 10.8 11.0 18.9 14.2 14.6 7.1 10.0 12.4 9.6 9.7 14.3 8.0 1.0 6.6 4.6 30.3 3.8 5.6 4.2 6.8 14.2 13.8 12.2 12.4 6.2 10.7 11.3 20.2 20.7 21.6 9.8 11.2 1.8 9.3 14.4 6.2 10.1 7.2 10.4 10.0 35.2 12.4 4.6 20.9 10.2 17.2 6.8 11.8 15.1 6.6 10.7 6.3 12.5 14.9 6.2 8.3 14.8 13.5 11.1 5.6 6.1 9.5 10.4 8.6 4.4 18.7 14.9 15.5 16.0 7.3 11.4 15.6 34.8 8.0 7.5 21.2 6.0 8.8 10.5 8.8 13.7 16.1 12.4 16.0 1.5 15.5 3.4 16.1 4.6 7.2 3.0 5.6 30.3 4.4 1.0 3.5 5.0 6.6 0.7 3.1 2.7 1.2 3.8 19.5 0.2 3.6 4.2 13.1 13.6 12.5 19.5 14.4 18.2 11.8 12.7 12.2 7.1 17.9 18.1 4.5 10.0 3.7 13.1 7.3 20.4 10.7 7.9 17.4 5.9 36.5 8.3 47.8 1.4 13.9 43.0 0.0 52.7 28.2 10.4 9.4 11.5 74.2 103.8 11.1 14.5 48.5 51.1 1.7 4.6 17.1 23.6 43.3 23.6 21.3 29.5 28.1 9.9 23.4 11.5 19.4 7.5 9.7 17.0 2.0 24.5 7.5 10.9 5.1 ACP4 ACPT ENSG00000142513 "Acid phosphatase 4" Q9BZG2 19 50790415-50795224 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Hydrolase "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 4.2;testis: 4.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.4;Karpas-707: 2.9;U-266/84: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (9.41e-2)" "unprognostic (1.86e-1)" "unprognostic (4.00e-3)" "unprognostic (3.70e-3)" "unprognostic (7.62e-2)" "unprognostic (3.18e-2)" "unprognostic (3.89e-3)" "unprognostic (5.46e-2)" "unprognostic (2.47e-1)" "unprognostic (5.59e-2)" "unprognostic (3.96e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-3)" "unprognostic (2.36e-1)" "unprognostic (4.40e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.5 0.3 0.8 0.0 0.5 0.2 0.9 1.6 0.0 0.0 1.0 0.5 0.0 0.0 0.0 2.2 0.2 0.8 0.1 0.0 0.1 0.6 0.0 0.0 0.0 1.6 4.4 0.1 1.3 0.7 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 2.9 0.0 0.9 0.7 1.4 0.5 0.8 1.5 1.0 0.4 0.6 0.0 1.6 0.4 0.6 0.3 0.3 0.7 0.1 0.1 1.0 0.0 0.7 0.6 0.8 0.4 0.7 5.4 0.6 0.7 0.9 0.3 0.0 0.1 0.0 0.2 0.5 0.8 0.8 0.6 0.5 0.0 0.9 0.8 0.5 0.0 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ACPP "ACP-3, ACP3, PAP" ENSG00000014257 "Acid phosphatase, prostate" P15309 3 132317367-132368298 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "prostate: 345.2" "Cell type enriched" "Detected in many" 135 "Glandular cells: 2098.0" "Cancer enriched" "Detected in many" 275 "prostate cancer: 1227.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 43.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.2;OE19: 12.7;RPMI-8226: 32.4;U-698: 9.4;U-87 MG: 9.0" "Low region specificity" "Detected in some" "CAB000071, HPA004335, HPA063916" Enhanced "Secreted to blood" NA NA 460000 9200 "CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152" "unprognostic (6.67e-2)" "unprognostic (4.70e-2)" "unprognostic (1.76e-1)" "unprognostic (7.77e-2)" "unprognostic (1.74e-1)" "unprognostic (2.58e-2)" "unprognostic (2.46e-1)" "unprognostic (7.41e-2)" "unprognostic (1.81e-1)" "unprognostic (3.78e-3)" "unprognostic (2.14e-1)" "unprognostic (5.95e-2)" "unprognostic (9.38e-2)" "unprognostic (1.35e-1)" "unprognostic (1.18e-1)" "unprognostic (3.91e-2)" "unprognostic (1.71e-1)" 0.4 0.6 0.4 0.7 1.6 1.4 0.8 0.3 0.7 3.9 0.4 0.2 0.0 0.4 0.3 2.5 14.7 0.6 0.2 0.9 0.3 0.3 6.2 0.3 2.0 2.7 0.6 0.8 0.4 0.8 0.5 0.3 5.3 0.7 345.2 0.7 0.8 9.1 0.2 0.3 2.5 0.4 0.4 2.2 1.0 0.5 1.0 0.6 0.2 1.3 6.6 6.8 0.5 1.5 0.2 11.2 43.1 9.7 0.9 0.0 2.9 0.2 0.0 0.0 0.0 0.1 0.6 7.0 0.1 10.2 0.0 0.0 0.2 0.2 5.7 0.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 1.2 0.2 0.1 0.1 4.1 0.1 0.6 0.8 0.0 0.0 0.1 0.0 0.0 0.1 1.6 0.1 0.1 0.0 7.8 0.4 12.7 1.2 0.0 0.0 32.4 3.1 3.8 0.0 2.5 0.0 1.2 0.3 1.1 0.2 3.7 0.0 0.0 0.1 1.5 0.0 0.4 0.2 9.4 9.0 7.3 0.1 0.0 9.7 43.1 0.0 8.6 0.0 0.2 0.0 0.0 11.2 0.0 0.0 0.0 8.5 0.9 7.7 0.8 0.0 2.9 0.4 1.6 0.3 0.7 0.3 0.3 0.6 0.8 0.7 0.6 0.0 10.7 0.0 13.0 0.8 0.0 0.5 0.0 0.0 4.5 7.0 0.0 9.6 0.0 1.1 0.0 0.0 1.0 0.0 1.6 1.0 0.8 2098.0 0.0 0.0 4.1 0.0 15.5 0.0 9.2 0.0 0.0 2.8 0.0 0.0 2.4 0.3 1.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 7.4 0.0 1.0 11.5 ACSBG2 "BGR, DKFZp434K1635, PRTD-NY3" ENSG00000130377 "Acyl-CoA synthetase bubblegum family member 2" Q5FVE4 19 6135247-6193094 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis" "Developmental protein, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 71.3" "Group enriched" "Detected in some" 68 "Early spermatids: 443.1;Late spermatids: 1482.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;HEL: 3.4;Karpas-707: 2.6;MCF7: 1.0" "Not detected" "Not detected" "HPA043421, HPA051013" Enhanced Supported Cytosol NA NA Cytosol "HPA043421: AB_10794182, HPA051013: AB_2681311" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (2.47e-1)" "unprognostic (3.27e-2)" "unprognostic (4.33e-2)" "unprognostic (1.92e-4)" "unprognostic (1.96e-2)" "unprognostic (4.17e-2)" "unprognostic (2.07e-1)" "unprognostic (2.62e-1)" "unprognostic (6.88e-3)" "unprognostic (3.13e-2)" "unprognostic (3.91e-3)" "unprognostic (2.20e-1)" "unprognostic (9.23e-2)" "unprognostic (8.78e-2)" "unprognostic (4.70e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.4 0.0 0.1 0.0 0.6 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 2.6 0.0 1.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.5 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 443.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1482.1 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.0 0.0 6.5 0.0 14.2 5.7 0.0 1.1 0.0 0.0 0.0 ACSL1 "ACS1, FACL1, FACL2, LACS, LACS1, LACS2" ENSG00000151726 "Acyl-CoA synthetase long chain family member 1" P33121 4 184755595-184826818 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 105.0;liver: 190.9" "Group enriched" "Detected in many" 4 "Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 80.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 80.2" "Cell line enhanced" "Detected in many" "ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011316, HPA011964" Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA011316: AB_1844536, HPA011964: AB_1844537" "unprognostic (1.10e-2)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (1.82e-3)" "unprognostic (2.75e-2)" "unprognostic (1.79e-1)" "unprognostic (5.89e-2)" "unprognostic (9.83e-2)" "unprognostic (3.15e-1)" "prognostic favorable (1.25e-5)" "unprognostic (2.77e-1)" "unprognostic (4.38e-2)" "unprognostic (6.25e-3)" "unprognostic (3.13e-2)" 105.0 6.7 4.2 14.1 13.5 46.0 54.4 3.2 9.6 7.2 12.2 16.4 5.5 4.9 5.7 12.7 8.8 6.4 5.7 24.3 6.4 4.1 32.8 190.9 20.7 18.9 24.0 3.8 4.2 7.3 5.9 8.7 4.4 11.6 14.2 2.6 9.1 17.9 4.8 89.1 20.4 4.5 6.4 18.2 16.9 6.5 6.4 15.9 2.1 8.3 10.1 5.8 7.6 11.0 0.5 2.2 80.2 8.9 0.7 0.7 2.9 6.1 1.9 1.2 3.1 151.2 36.7 1.0 3.4 1.7 2.0 1.4 0.4 1.7 2.5 0.3 4.0 4.9 3.8 5.4 2.2 1.7 12.4 1.9 1.8 1.7 5.0 24.3 4.9 4.6 80.3 18.6 1.7 8.7 3.6 2.6 0.4 0.8 7.8 9.8 3.2 0.3 6.8 0.2 4.1 2.7 0.9 1.0 3.2 47.8 17.5 4.6 4.3 3.1 9.4 10.5 0.5 3.4 5.0 2.8 1.8 2.1 4.3 1.0 3.0 1.5 1.1 5.8 6.9 2.8 2.3 8.9 2.8 0.5 5.2 0.5 0.5 0.4 0.2 2.2 0.5 0.4 0.3 80.2 0.7 3.6 0.4 0.7 2.9 4.2 13.5 3.2 9.6 6.4 4.1 24.0 3.8 11.6 15.9 23.8 107.2 14.5 16.5 18.7 5.8 89.7 28.1 13.4 21.6 29.6 17.7 8.6 79.6 3.9 359.4 5.6 2.6 0.0 11.0 1.9 9.1 56.1 23.1 1018.8 39.4 3.2 0.0 19.0 136.2 335.5 17.8 64.1 30.4 24.4 4.2 3.3 9.0 0.9 15.6 75.0 10.3 12.9 12.0 8.1 16.7 35.9 2.9 10.0 1.7 21.4 ACSL3 "ACS3, FACL3, PRO2194" ENSG00000123983 "Acyl-CoA synthetase long chain family member 3" O95573 2 222860934-222944639 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 206.1" "Cell type enhanced" "Detected in all" 9 "Horizontal cells: 494.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 94.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011315, HPA071021" Approved Approved "Nucleoli,Nucleoli rim,Lipid droplets" NA NA "Nucleoli, Nucleoli rim" "Lipid droplets" "HPA011315: AB_1848344, HPA071021: AB_2686335" "unprognostic (1.87e-1)" "unprognostic (5.64e-2)" "unprognostic (2.36e-1)" "unprognostic (9.35e-3)" "unprognostic (7.53e-2)" "unprognostic (2.07e-2)" "prognostic unfavorable (2.75e-4)" "prognostic unfavorable (8.78e-4)" "unprognostic (3.90e-2)" "unprognostic (2.50e-1)" "unprognostic (2.64e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-1)" "unprognostic (2.72e-1)" "unprognostic (2.65e-1)" "unprognostic (1.60e-1)" 14.7 17.0 22.8 9.9 26.0 16.3 51.5 19.4 45.9 15.3 16.5 16.1 11.6 12.7 10.9 18.4 28.3 9.0 11.8 22.7 20.9 22.8 17.9 22.3 15.6 10.5 19.6 21.2 11.7 10.3 206.1 8.8 19.1 24.4 44.4 16.7 14.4 34.2 15.5 19.1 11.4 12.7 12.2 22.2 9.7 28.3 13.7 14.2 13.5 17.3 11.2 8.7 14.6 15.4 15.0 22.5 21.8 16.8 16.6 20.1 16.5 10.1 17.9 27.4 29.8 12.0 29.8 7.6 12.9 33.6 15.5 32.7 16.1 26.1 4.8 7.5 12.3 33.5 29.9 5.9 28.7 20.1 8.7 11.2 11.4 14.5 17.9 26.5 7.5 5.6 15.3 40.8 25.6 44.7 11.9 16.8 8.5 21.5 18.6 21.8 21.5 14.6 8.8 13.9 23.0 9.3 8.0 23.2 8.2 22.3 41.6 14.5 10.7 7.6 20.6 94.2 22.1 10.3 18.4 11.6 10.4 16.6 8.9 9.4 6.6 3.2 16.8 11.1 7.1 31.4 16.6 14.6 21.8 20.1 16.8 19.3 11.6 12.8 14.6 15.7 15.0 18.7 16.7 21.8 16.6 15.9 22.5 9.5 16.5 22.8 26.0 19.4 45.9 20.9 22.8 19.6 21.2 24.4 14.2 32.8 58.5 16.4 65.8 41.3 91.7 51.2 40.8 37.5 44.3 34.9 72.6 32.9 6.6 28.6 31.0 38.3 33.1 23.3 27.3 8.4 36.3 113.5 26.5 47.9 33.5 494.2 20.1 36.2 50.2 18.9 24.2 42.9 45.5 32.5 32.3 205.8 32.5 38.6 33.6 12.5 51.8 45.3 51.8 50.2 49.9 42.7 50.7 27.7 46.5 102.1 ACSL4 "ACS4, FACL4, LACS4, MRX63, MRX68" ENSG00000068366 "Acyl-CoA synthetase long chain family member 4" O60488 X 109624244-109733403 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Alveolar cells type 2: 210.9;granulocytes: 598.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 81.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000286, HPA005552" Supported Approved "Golgi apparatus,Mitochondria" NA NA 100000 "Golgi apparatus" Mitochondria "HPA000286: AB_2665966, HPA005552: AB_1078774" "unprognostic (9.13e-2)" "unprognostic (3.38e-1)" "unprognostic (1.39e-1)" "unprognostic (2.61e-1)" "unprognostic (2.55e-1)" "unprognostic (2.94e-2)" "unprognostic (5.32e-2)" "unprognostic (4.14e-3)" "unprognostic (1.92e-1)" "unprognostic (9.45e-2)" "unprognostic (1.92e-2)" "unprognostic (1.21e-1)" "unprognostic (1.64e-2)" "unprognostic (1.81e-1)" "unprognostic (4.78e-1)" "unprognostic (3.29e-2)" "prognostic favorable (5.73e-4)" 29.5 31.1 16.3 25.5 18.0 9.2 30.0 13.9 22.8 34.7 10.5 8.8 4.6 10.0 13.7 11.7 11.2 10.7 20.1 20.3 27.6 20.3 31.2 9.6 27.8 29.6 15.2 19.0 13.1 8.8 16.7 12.9 33.9 21.1 9.7 9.7 8.0 10.7 11.0 42.5 9.1 9.0 15.8 24.6 17.0 12.9 17.7 9.7 9.5 12.8 8.5 11.9 19.5 21.0 2.2 6.5 20.3 10.9 2.2 4.0 3.8 13.9 4.5 5.6 6.0 21.1 13.2 4.4 20.5 22.7 20.0 20.9 4.4 9.7 10.0 8.0 14.8 24.6 4.0 4.8 19.7 31.6 3.5 5.0 39.4 6.4 46.6 9.7 9.3 81.7 11.4 7.7 22.8 16.7 11.6 15.0 6.4 1.1 12.3 22.9 0.9 8.1 12.3 7.0 3.1 8.2 5.9 10.3 8.2 28.7 4.5 3.7 2.8 24.5 0.0 12.6 11.5 0.3 10.0 27.7 18.3 5.2 28.9 18.8 6.1 7.0 9.4 32.3 20.9 11.6 15.5 7.0 20.3 2.8 9.8 2.0 2.2 2.5 2.2 6.5 2.2 2.0 2.4 19.8 2.2 10.9 2.6 4.0 3.8 16.3 18.0 13.9 22.6 27.6 20.3 15.2 19.0 21.1 9.7 71.5 210.9 20.6 16.2 19.8 34.7 32.3 10.2 17.4 64.8 69.8 2.0 5.7 43.1 24.1 1.2 28.6 0.7 23.3 22.2 29.6 17.9 10.6 598.2 1.7 22.2 6.4 7.5 17.8 68.3 2.0 5.2 45.1 15.1 64.9 2.9 11.7 26.4 1.4 9.6 10.0 14.5 0.0 22.3 3.9 3.8 7.0 26.4 13.8 1.7 12.4 ACSL5 "ACS2, ACS5, FACL5" ENSG00000197142 "Acyl-CoA synthetase long chain family member 5" Q9ULC5 10 112374018-112428380 "Enzymes, Plasma proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 278.7" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 266.6;Paneth cells: 93.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.3;RT4: 44.2;U-937: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007162, CAB035986, CAB062546" Enhanced Supported Nucleoplasm,Mitochondria NA NA 22000 Mitochondria Nucleoplasm "CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (3.08e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.45e-1)" "unprognostic (2.13e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-2)" "unprognostic (1.67e-1)" "unprognostic (4.06e-2)" "unprognostic (4.18e-3)" "unprognostic (7.40e-2)" "unprognostic (5.25e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (5.92e-3)" "unprognostic (1.08e-3)" 10.0 1.4 3.1 12.7 3.5 2.2 6.4 1.2 3.1 9.3 84.6 1.6 3.8 64.5 8.7 41.8 4.2 8.0 11.2 3.1 3.3 3.1 3.2 56.5 10.8 7.1 4.0 1.2 5.0 1.6 0.1 1.2 2.1 3.9 7.0 21.5 8.4 2.4 4.0 2.6 1.3 278.7 2.6 3.8 12.4 7.7 2.3 2.5 6.3 3.1 2.7 7.2 17.4 6.7 10.8 19.4 16.3 17.0 16.2 25.1 11.7 11.6 0.3 0.2 0.0 0.8 0.1 1.0 0.3 2.3 0.0 0.2 10.6 43.3 14.2 2.6 0.6 2.1 0.1 0.0 0.0 0.2 11.9 0.0 11.1 0.4 18.5 2.8 17.2 18.8 1.9 0.0 0.2 0.0 0.8 0.8 0.0 0.0 6.5 0.0 0.0 0.0 7.9 0.0 9.8 0.4 3.9 0.0 8.7 1.2 44.2 0.0 0.3 17.3 6.6 0.0 0.0 0.0 9.7 12.5 0.1 0.1 0.7 0.7 4.7 0.0 6.9 0.4 21.6 0.0 14.5 9.3 16.3 16.7 17.0 16.6 10.8 13.7 18.4 19.4 8.2 9.5 14.5 2.5 16.2 15.9 6.2 25.1 11.7 3.1 3.5 1.2 3.1 3.3 3.1 4.0 1.2 3.9 2.5 11.9 43.5 21.6 7.4 3.4 0.0 1.4 12.7 5.3 33.0 0.0 3.9 1.6 0.0 12.0 65.8 24.5 266.6 0.0 5.6 1.9 1.7 5.7 17.3 79.9 16.7 0.0 39.2 16.0 19.2 29.7 14.7 23.5 3.3 4.6 84.3 0.0 29.0 93.1 11.3 0.0 1.2 0.0 1.4 1.7 1.4 1.5 0.6 14.9 90.6 41.4 ACSL6 "ACS2, FACL6, KIAA0837, LACS2, LACS5" ENSG00000164398 "Acyl-CoA synthetase long chain family member 6" Q9UKU0 5 131949973-132012243 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.0;ductus deferens: 30.1;seminal vesicle: 35.8;testis: 23.0" "Cell type enhanced" "Detected in many" 14 "Cone photoreceptor cells: 216.0;Erythroid cells: 116.8;Rod photoreceptor cells: 126.2" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "SCLC-21H: 14.9;U-937: 8.7" HPA040470 Enhanced NA NA "HPA040470: AB_10794033" "unprognostic (1.99e-2)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (5.89e-2)" "unprognostic (6.97e-2)" "unprognostic (1.92e-2)" "unprognostic (8.38e-3)" "unprognostic (5.84e-2)" "unprognostic (8.69e-2)" "unprognostic (7.57e-2)" "unprognostic (9.28e-4)" "unprognostic (8.69e-2)" "unprognostic (3.22e-2)" "unprognostic (6.24e-3)" "unprognostic (1.79e-1)" "unprognostic (6.44e-3)" "unprognostic (1.70e-1)" 0.6 4.8 16.5 1.5 15.7 21.3 0.7 22.8 34.0 0.5 0.7 5.3 30.1 5.4 0.5 1.0 0.9 0.7 0.9 2.0 12.4 9.7 2.3 2.6 0.8 2.5 9.6 12.1 0.5 1.9 13.0 2.7 1.1 12.1 0.8 0.8 3.3 0.8 35.8 3.6 0.6 3.3 0.5 4.2 1.2 1.2 23.0 4.7 0.0 0.9 0.0 1.5 0.7 0.3 0.1 0.0 0.6 0.1 1.2 4.2 1.1 0.0 0.0 0.3 0.1 0.6 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.5 0.1 1.6 0.2 0.0 0.0 0.9 0.1 0.0 2.2 0.0 0.2 2.1 0.0 0.1 0.0 0.1 0.0 0.0 2.1 1.0 0.2 0.0 0.0 0.0 1.5 0.9 0.0 0.1 0.1 0.0 0.1 0.0 0.0 14.9 0.7 0.2 0.2 1.2 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.5 0.0 0.3 8.7 0.5 0.6 0.1 0.1 1.5 0.0 3.5 0.1 2.1 4.2 0.0 0.1 3.9 1.8 0.2 1.2 0.0 0.0 0.1 1.1 16.5 15.7 22.8 18.8 12.4 9.7 9.6 12.1 12.1 4.7 23.8 33.5 0.5 1.0 1.6 55.8 0.0 2.5 14.7 29.6 1.8 216.0 0.3 6.6 0.4 22.7 0.4 0.7 116.8 0.2 0.2 1.1 1.0 9.3 5.7 0.1 20.6 2.4 2.5 1.2 3.6 0.3 7.9 0.0 0.0 0.6 20.4 0.2 0.9 1.8 0.3 126.2 0.0 0.8 16.1 1.3 1.1 0.2 10.7 0.2 0.9 ACSM1 "BUCS1, MACS1" ENSG00000166743 "Acyl-CoA synthetase medium chain family member 1" Q08AH1 16 20623237-20698890 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "breast: 83.4" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 7.6;Early spermatids: 11.5;Late spermatids: 18.5" "Group enriched" "Detected in many" 8 "liver cancer: 14.7;prostate cancer: 36.7" "Cell type enhanced" "Detected in some" "eosinophil: 3.5;memory B-cell: 3.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NTERA-2: 18.8" "Not detected" "Not detected" HPA046291 Uncertain NA NA "HPA046291: AB_10960704" "unprognostic (1.08e-2)" "unprognostic (3.07e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (5.49e-4)" "unprognostic (1.66e-1)" "unprognostic (3.50e-2)" "unprognostic (9.46e-2)" "unprognostic (3.10e-1)" "unprognostic (8.44e-3)" "unprognostic (2.10e-1)" "unprognostic (2.64e-1)" "unprognostic (8.24e-2)" "unprognostic (3.79e-2)" "unprognostic (3.01e-1)" "unprognostic (9.58e-2)" "unprognostic (2.33e-3)" 0.0 0.1 0.0 0.0 0.0 1.1 83.4 0.1 0.1 1.7 0.4 0.2 2.3 0.2 0.1 2.4 0.2 0.1 0.0 0.0 1.2 3.8 0.2 0.1 0.0 2.8 1.4 0.5 0.0 0.0 3.4 0.2 1.2 0.2 0.1 2.2 0.4 0.3 0.0 0.2 2.1 4.5 0.2 0.1 1.1 1.5 3.4 0.0 3.5 0.9 1.3 0.6 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.1 18.8 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.6 0.0 0.5 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 3.5 0.1 0.2 0.1 3.4 0.6 0.0 0.0 2.9 0.5 0.2 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.6 0.0 0.3 7.6 4.0 1.2 0.0 0.0 0.1 1.7 3.0 11.5 0.7 0.4 0.0 2.0 0.1 0.0 3.1 0.0 0.8 0.2 0.0 1.2 0.6 0.0 18.5 4.0 1.8 0.0 2.8 3.7 0.0 1.5 3.5 6.7 1.2 0.0 0.0 0.0 0.5 0.0 1.4 0.1 0.0 2.2 1.2 ACSM2B "ACSM2, HXMA, HYST1046" ENSG00000066813 "Acyl-CoA synthetase medium chain family member 2B" Q68CK6 16 20536226-20576427 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 69 "kidney: 76.1;liver: 93.4" "Group enriched" "Detected in some" 13 "Hepatocytes: 830.9;Proximal tubular cells: 347.6" "Group enriched" "Detected in some" 450 "liver cancer: 30.9;renal cancer: 17.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 5.5;Hep G2: 10.1" HPA057699 Supported NA NA "HPA057699: AB_2683506" "unprognostic (1.34e-2)" "prognostic favorable (3.31e-4)" "unprognostic (7.13e-2)" "unprognostic (2.29e-1)" "unprognostic (6.67e-2)" "unprognostic (1.24e-1)" "unprognostic (1.15e-1)" "unprognostic (2.22e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 76.1 93.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.9 1.0 0.5 0.2 1.2 0.0 1.0 0.0 5.5 1.5 0.0 0.0 1.4 0.9 0.2 0.0 0.0 1.2 0.9 0.1 2.8 0.0 0.9 0.8 0.0 0.0 0.0 1.0 0.7 0.3 1.3 10.1 0.0 1.3 1.4 0.0 0.0 0.0 0.4 0.8 0.6 0.3 0.9 1.2 0.0 0.7 0.6 1.3 1.2 1.7 0.0 0.1 1.2 0.2 0.4 0.2 1.9 1.0 2.7 0.0 1.0 0.2 2.0 0.4 0.0 0.0 1.0 0.0 0.8 0.8 0.5 0.7 0.7 3.5 1.9 0.5 0.5 0.2 0.6 0.0 0.6 0.1 0.8 0.2 0.1 0.6 0.7 1.2 1.0 0.2 0.1 0.9 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 41.9 0.0 0.2 0.0 0.3 28.1 0.0 0.0 7.0 0.0 0.0 29.9 0.1 0.7 0.5 0.0 46.7 0.0 0.0 0.0 0.0 0.0 830.9 0.1 0.0 1.7 23.9 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 347.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ACSS1 "ACAS2L, AceCS2L, dJ568C11.3, MGC33843" ENSG00000154930 "Acyl-CoA synthetase short chain family member 1" Q9NUB1 20 25006230-25058980 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.4" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 211.3;Syncytiotrophoblasts: 350.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 19.6;JURKAT: 20.6;OE19: 25.4;RPMI-8226: 29.2;U-937: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041014, HPA043228" Enhanced NA NA "HPA041014: AB_2677251, HPA043228: AB_2678372" "unprognostic (6.87e-2)" "prognostic favorable (9.37e-4)" "unprognostic (5.32e-2)" "unprognostic (1.54e-1)" "unprognostic (2.78e-1)" "unprognostic (3.03e-2)" "unprognostic (3.20e-3)" "prognostic favorable (8.33e-5)" "unprognostic (2.44e-1)" "unprognostic (2.17e-2)" "unprognostic (2.43e-1)" "unprognostic (7.72e-2)" "unprognostic (4.58e-3)" "unprognostic (5.85e-2)" "unprognostic (2.68e-1)" "unprognostic (3.69e-1)" "unprognostic (1.60e-1)" 6.1 4.8 22.8 8.6 26.6 16.3 9.1 17.1 19.6 9.0 14.0 21.8 9.7 28.1 8.5 12.3 7.5 10.8 12.4 32.4 26.3 9.2 19.5 5.5 10.8 13.4 15.1 20.4 12.3 28.8 9.3 5.7 66.4 21.3 14.8 12.5 9.9 21.8 10.2 19.5 9.3 25.9 8.0 11.1 16.1 26.9 21.6 22.9 11.9 14.9 4.8 12.2 8.7 7.1 7.2 4.4 8.7 6.3 12.6 5.5 2.7 0.0 4.7 1.4 0.0 4.5 1.7 0.1 0.5 2.0 2.0 1.4 4.7 0.6 8.2 0.8 1.9 8.8 2.4 6.9 1.0 0.4 0.0 0.6 14.1 0.1 19.6 4.6 3.3 0.1 2.9 3.5 0.2 0.0 0.0 4.4 20.6 0.7 15.8 0.1 0.5 19.0 5.6 0.1 25.4 7.6 14.9 0.4 29.2 3.0 3.7 3.4 0.1 0.9 1.9 13.1 0.1 9.1 7.5 0.6 0.0 0.0 0.0 0.2 11.0 0.7 0.0 0.2 20.3 5.2 6.3 3.7 8.7 5.5 6.3 4.5 5.2 3.7 4.8 4.4 7.2 3.2 4.9 0.8 12.6 4.1 2.8 3.2 2.7 22.8 26.6 17.1 19.6 26.3 9.2 15.1 20.4 21.3 22.9 11.9 13.7 25.6 6.7 4.6 2.4 60.2 45.9 9.4 9.1 10.4 0.0 211.3 64.6 3.4 72.5 7.1 29.0 23.3 6.7 6.5 11.6 9.5 5.7 5.0 43.5 0.0 0.0 9.2 7.5 14.5 31.9 8.1 6.8 2.8 28.5 14.3 3.0 14.0 30.4 14.0 0.7 19.4 14.4 0.9 1.1 3.8 350.8 23.5 21.3 3.0 ACSS2 "ACAS2, AceCS, ACS, ACSA, dJ1161H23.1" ENSG00000131069 "Acyl-CoA synthetase short chain family member 2" Q9NR19 20 34872146-34927962 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.4" "Cell type enhanced" "Detected in all" 5 "Enterocytes: 98.3;Mucus-secreting cells: 80.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 5 "dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6" "Cell line enhanced" "Detected in many" "RPMI-8226: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004141 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA004141: AB_1078094" "unprognostic (1.97e-2)" "unprognostic (1.33e-1)" "unprognostic (1.70e-1)" "unprognostic (2.25e-2)" "unprognostic (1.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.42e-1)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (3.92e-2)" "unprognostic (1.66e-1)" "unprognostic (1.42e-2)" "prognostic favorable (2.04e-4)" "unprognostic (2.72e-1)" "unprognostic (2.32e-1)" "unprognostic (3.08e-1)" "unprognostic (2.54e-1)" 30.3 12.6 2.8 9.2 7.0 1.9 12.4 5.6 7.0 6.8 21.0 10.6 8.3 21.4 6.6 7.0 8.1 4.5 7.7 24.8 2.9 2.5 11.2 15.7 11.7 3.2 6.8 3.2 5.1 3.2 4.7 2.5 4.6 5.5 3.4 10.4 3.5 9.8 6.8 63.4 6.8 24.1 3.0 6.1 2.7 13.4 3.1 7.1 1.1 3.9 7.3 3.0 6.5 6.1 0.7 12.6 17.0 11.6 0.3 3.0 4.7 11.9 1.6 1.2 1.6 8.5 9.0 12.4 7.1 5.5 2.0 3.5 4.3 6.6 0.0 8.1 3.1 7.7 9.0 2.9 17.9 1.5 0.1 2.8 16.6 0.8 2.0 6.2 1.6 9.1 6.1 3.9 2.9 2.8 2.9 3.1 1.2 10.5 1.3 2.7 1.4 0.5 7.3 0.8 3.6 20.3 4.4 7.8 26.2 6.8 1.2 1.1 5.4 8.7 6.4 6.9 3.4 3.1 3.6 11.7 2.4 3.3 4.3 2.3 11.3 8.2 3.8 6.7 2.6 1.9 17.0 11.6 3.0 0.6 7.2 0.5 0.4 1.6 0.7 12.6 0.7 3.0 1.5 6.5 0.3 3.4 2.1 1.1 4.7 2.8 7.0 5.6 7.0 2.9 2.5 6.8 3.2 5.5 7.1 11.9 40.9 3.0 8.5 6.9 6.0 70.4 25.5 5.3 13.6 10.4 5.9 13.6 10.0 16.5 7.2 13.2 98.3 23.3 29.5 8.5 8.9 8.8 9.2 44.8 14.7 7.9 7.5 10.4 17.2 6.0 10.6 13.8 13.5 19.8 80.6 8.8 18.1 60.0 4.2 51.2 3.4 12.9 9.9 11.6 7.3 9.5 17.5 5.0 60.0 8.9 ACSS3 FLJ21963 ENSG00000111058 "Acyl-CoA synthetase short chain family member 3" Q9H6R3 12 80936414-81261205 "Enzymes, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 42.8;Hepatocytes: 47.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "basophil: 8.3;neutrophil: 6.0" "Lineage enriched" "Detected in single" 71 "granulocytes: 8.3" "Cell line enhanced" "Detected in many" "ASC diff: 9.4;ASC TERT1: 10.7;Hep G2: 26.5;hTERT-RPE1: 9.1;RH-30: 12.3;SK-BR-3: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039353, HPA047956, HPA061517" Approved Supported Mitochondria NA NA Mitochondria "HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549" "unprognostic (8.59e-2)" "unprognostic (9.29e-4)" "unprognostic (1.47e-1)" "unprognostic (9.37e-3)" "unprognostic (2.46e-2)" "unprognostic (2.21e-1)" "unprognostic (9.25e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (7.18e-3)" "unprognostic (1.68e-1)" "unprognostic (7.79e-2)" "prognostic favorable (0.00e+0)" "unprognostic (6.16e-4)" "unprognostic (1.63e-1)" "unprognostic (2.00e-1)" "unprognostic (2.00e-4)" 19.6 18.3 7.4 1.9 8.3 1.0 8.1 2.7 7.7 13.2 2.6 5.5 10.8 1.2 18.2 14.4 2.0 8.3 8.1 10.9 6.4 3.9 24.4 37.1 8.8 1.7 7.4 6.5 16.7 2.6 21.3 11.0 4.1 6.5 7.1 1.6 10.3 20.4 11.4 9.8 2.1 1.9 6.6 5.5 2.8 1.9 4.0 4.1 0.0 9.2 2.9 1.6 3.5 6.3 0.0 0.0 8.3 0.0 0.0 0.1 0.0 0.0 0.1 2.2 0.0 9.4 10.7 0.0 1.5 7.0 1.1 1.2 0.3 0.0 0.1 0.0 3.1 3.3 0.1 0.0 0.0 0.7 0.0 1.7 0.0 0.1 26.5 3.2 0.3 0.0 7.2 0.0 0.3 0.0 9.1 0.2 0.0 0.0 0.0 5.0 0.6 0.0 0.1 3.2 0.0 0.0 0.0 12.3 1.7 0.0 0.0 2.1 0.0 0.0 11.6 0.0 4.8 5.2 0.3 0.0 1.9 1.8 0.2 0.7 0.1 0.1 0.0 2.3 0.0 2.1 8.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 7.4 8.3 2.7 7.7 6.4 3.9 7.4 6.5 6.5 4.1 20.8 42.8 0.0 7.0 0.8 31.6 19.3 15.3 6.7 5.7 12.2 3.9 1.3 5.0 4.0 33.3 1.0 0.0 0.0 2.6 0.6 4.3 4.4 0.0 47.4 0.6 27.0 0.0 3.1 2.4 6.4 22.2 0.4 0.0 0.0 0.0 19.7 0.2 0.0 22.3 26.7 4.5 6.5 5.7 4.2 0.5 0.1 0.5 0.0 0.0 2.0 ACVR1 "ACVR1A, ACVRLK2, ALK2, SKR1" ENSG00000115170 "Activin A receptor type 1" Q04771 2 157736444-157875862 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007505, HPA046514" Approved Uncertain Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA007505: AB_1844752, HPA046514: AB_2732526" "unprognostic (6.99e-2)" "unprognostic (3.32e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.73e-1)" "unprognostic (6.09e-2)" "unprognostic (3.66e-3)" "unprognostic (1.08e-1)" "unprognostic (3.99e-1)" "unprognostic (3.20e-1)" "unprognostic (2.65e-2)" "unprognostic (4.29e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (5.17e-4)" 18.9 9.2 18.0 10.0 12.7 1.6 38.7 15.3 12.2 25.2 14.4 7.4 8.4 8.9 24.8 26.8 11.0 16.6 20.5 18.8 18.7 8.6 21.7 18.9 22.5 15.1 10.4 7.9 18.5 12.3 11.3 17.0 14.2 12.3 16.8 10.5 14.3 18.1 13.6 15.6 12.8 11.5 29.2 12.3 9.2 11.8 8.8 10.9 7.5 34.0 14.6 6.9 16.1 32.5 1.4 2.4 3.8 2.6 1.9 10.0 1.6 2.1 4.3 5.0 6.5 25.4 26.5 7.0 15.4 25.6 12.4 13.2 3.4 4.8 0.0 7.1 16.6 12.0 6.0 3.6 8.3 13.3 14.7 3.1 8.7 2.5 4.9 20.1 0.6 10.4 33.2 15.8 25.3 32.3 16.2 13.4 2.4 3.2 2.4 15.5 3.8 0.1 0.2 7.5 3.0 7.8 1.4 6.7 1.8 16.0 8.1 4.4 5.5 5.9 3.4 21.1 8.2 1.8 2.3 19.3 18.8 6.2 9.2 5.8 1.6 1.2 0.1 19.3 0.5 20.2 3.8 2.6 0.2 1.1 1.7 1.2 1.4 7.8 2.5 1.8 0.8 3.1 1.5 0.8 1.9 2.3 2.4 10.0 1.6 18.0 12.7 15.3 12.2 18.7 8.6 10.4 7.9 12.3 10.9 8.9 7.0 0.8 6.8 8.8 7.5 9.2 12.7 6.7 9.1 7.0 0.0 7.0 5.0 8.4 0.5 13.5 3.1 0.0 15.5 4.4 11.6 8.9 4.7 12.1 6.5 3.2 4.1 17.2 11.6 1.1 18.7 7.7 3.3 3.6 5.2 6.1 14.7 3.5 14.9 15.3 1.5 12.9 15.5 0.5 2.5 6.6 8.8 1.0 3.5 7.6 ACVR1B "ActRIB, ACVRLK4, ALK4, SKR2" ENSG00000135503 "Activin A receptor type 1B" P36896 12 51951667-51997078 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026126, HPA063761" Approved Approved Cytosol NA NA Cytosol "CAB026126: , HPA063761: AB_2685115" "unprognostic (8.66e-2)" "unprognostic (5.72e-2)" "unprognostic (1.16e-1)" "unprognostic (3.23e-3)" "unprognostic (2.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.21e-3)" "unprognostic (1.00e-1)" "unprognostic (7.68e-2)" "unprognostic (5.29e-2)" "unprognostic (2.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.52e-2)" "unprognostic (9.02e-2)" "unprognostic (6.60e-2)" "unprognostic (8.96e-2)" "unprognostic (4.79e-2)" 11.1 7.4 12.0 6.4 14.6 7.9 14.3 14.2 24.4 8.6 16.7 5.1 28.0 19.2 6.7 13.1 14.4 10.9 11.1 7.6 11.2 10.5 24.6 21.0 10.3 7.1 8.1 14.7 7.1 35.1 24.9 10.9 7.5 7.3 10.0 17.1 8.7 21.7 34.3 11.7 30.6 19.8 8.2 5.8 6.7 17.2 10.6 4.8 3.9 9.9 5.8 8.4 10.1 12.1 0.5 1.3 6.8 4.0 0.1 1.6 0.6 6.4 14.1 11.0 6.0 12.6 9.9 6.2 7.3 8.3 7.8 5.9 28.4 10.0 2.8 10.2 7.9 8.6 11.4 10.4 8.8 8.1 4.1 12.3 6.9 3.5 8.8 14.4 11.2 26.0 19.3 11.5 8.8 11.1 8.3 10.9 10.3 7.4 8.8 6.9 13.1 10.6 9.7 10.6 13.6 4.9 5.7 8.5 3.6 21.9 9.8 14.0 11.6 7.8 11.2 5.1 8.1 12.4 7.3 6.9 5.4 8.2 6.0 3.5 5.4 3.7 3.9 5.8 5.4 6.9 4.5 2.2 6.8 0.7 3.3 1.0 0.1 0.6 0.7 1.3 0.5 1.6 0.9 1.9 0.1 4.0 0.7 1.0 0.6 12.0 14.6 14.2 24.4 11.2 10.5 8.1 14.7 7.3 4.8 3.0 12.0 3.4 9.2 16.6 41.6 5.4 22.9 13.4 14.8 24.4 27.5 0.5 3.3 12.7 2.3 9.8 23.9 0.0 12.5 0.6 5.7 12.2 10.5 19.5 3.7 35.0 23.6 14.7 16.7 6.3 9.2 7.7 6.8 2.8 32.6 10.6 12.7 24.6 8.9 16.5 23.8 6.5 15.9 3.9 16.5 22.1 0.5 2.5 22.6 11.2 ACVR1C "ACVRLK7, ALK7" ENSG00000123612 "Activin A receptor type 1C" Q8NER5 2 157526767-157629005 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 36.2;breast: 15.3" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 11.4;Leydig cells: 29.4;Paneth cells: 10.4;Undifferentiated cells: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.8" "Lineage enriched" "Detected in single" 4 "T-cells: 2.8" "Group enriched" "Detected in some" 4 "ASC diff: 15.4;HDLM-2: 6.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 29.2;cerebral cortex: 8.1;hippocampal formation: 21.6" "HPA007982, HPA011933" Approved "Intracellular and membrane" NA NA "HPA007982: AB_1078134, HPA011933: AB_1844754" "unprognostic (1.03e-1)" "unprognostic (4.55e-2)" "unprognostic (9.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (7.64e-2)" "unprognostic (1.00e-1)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (7.12e-3)" "unprognostic (3.62e-1)" "unprognostic (9.31e-6)" "unprognostic (7.28e-2)" "unprognostic (1.95e-1)" "unprognostic (9.74e-2)" "unprognostic (1.30e-1)" 36.2 3.7 3.9 2.7 10.3 0.7 15.3 1.6 4.4 0.9 9.4 2.7 0.0 5.5 0.7 1.0 0.8 0.8 1.8 1.0 9.2 3.1 1.1 3.3 0.8 1.2 3.7 3.1 5.1 2.4 0.5 12.0 0.7 3.5 0.9 4.4 0.0 1.5 1.0 1.3 0.7 4.4 0.8 2.8 0.8 3.4 1.1 4.0 0.0 0.9 0.5 1.0 0.6 2.9 0.6 0.0 0.0 0.0 0.0 2.8 0.4 2.0 0.0 0.0 0.2 15.4 0.5 0.3 0.4 0.4 0.1 0.5 2.3 0.2 0.0 0.2 1.2 1.0 0.0 0.1 0.0 0.3 6.8 1.0 0.0 0.0 0.5 0.0 0.0 1.2 0.2 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.4 0.4 0.3 0.0 0.0 1.4 0.1 0.7 0.0 0.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.3 0.0 0.3 0.0 0.8 0.2 0.0 0.2 0.8 2.4 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.5 0.0 1.0 0.6 1.8 1.2 0.0 0.5 2.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 3.9 10.3 1.6 4.4 9.2 3.1 3.7 3.1 3.5 4.0 0.0 0.6 0.0 0.9 0.6 0.0 1.2 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.2 1.1 1.0 11.4 0.0 0.2 0.3 1.2 0.8 0.0 4.7 0.1 0.0 7.5 0.0 0.0 0.4 29.4 0.0 3.3 7.2 8.4 1.0 0.4 10.4 8.5 0.7 0.0 0.0 1.0 0.0 2.0 1.3 0.2 0.0 12.1 0.4 ACVR2A "ACTRII, ACVR2" ENSG00000121989 "Activin A receptor type 2A" P27037 2 147844517-147930826 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 21.0;RH-30: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046997 Approved Approved Cytosol NA NA Cytosol "HPA046997: AB_10970077" "unprognostic (4.55e-2)" "unprognostic (2.26e-2)" "unprognostic (2.09e-1)" "unprognostic (7.34e-3)" "unprognostic (2.75e-1)" "unprognostic (1.17e-1)" "unprognostic (4.41e-3)" "unprognostic (8.73e-3)" "unprognostic (1.30e-2)" "unprognostic (3.61e-1)" "unprognostic (1.34e-2)" "unprognostic (1.52e-1)" "prognostic favorable (1.62e-4)" "unprognostic (1.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.95e-1)" "unprognostic (3.99e-2)" 12.0 6.0 13.6 8.2 9.9 3.8 10.7 14.5 14.2 10.2 14.1 4.7 9.7 10.4 9.3 9.9 13.6 7.6 17.7 5.6 10.0 9.0 9.0 10.3 7.5 4.7 5.9 10.6 7.6 9.8 8.6 15.9 10.6 7.3 12.2 9.1 7.6 12.2 12.0 19.6 29.5 17.8 13.8 5.4 6.5 9.3 11.0 6.4 1.5 9.5 6.9 6.8 13.5 11.8 0.7 3.0 0.5 3.6 7.7 4.6 1.4 1.3 1.6 10.0 3.7 5.9 3.8 4.1 3.1 3.7 5.3 9.3 4.3 6.0 0.0 2.8 4.9 1.9 4.7 9.1 4.5 6.8 1.0 5.5 0.6 2.8 7.4 21.0 0.6 0.7 6.3 5.7 3.4 6.8 4.1 4.0 1.2 1.4 2.6 3.6 3.5 0.3 0.5 11.3 4.0 2.6 0.1 17.5 0.9 4.2 8.5 9.9 5.6 2.6 3.1 3.8 4.5 1.9 1.0 3.1 4.9 5.8 4.6 2.1 0.7 0.2 1.8 3.0 0.3 3.9 0.4 3.0 0.5 1.2 3.6 0.5 0.3 4.6 2.1 2.3 0.7 3.0 0.7 0.1 7.7 3.1 3.0 0.4 1.4 13.6 9.9 14.5 14.2 10.0 9.0 5.9 10.6 7.3 6.4 6.0 6.5 0.5 6.7 26.4 15.8 7.8 10.2 8.1 11.4 7.0 13.7 3.9 1.7 5.0 4.1 9.8 13.2 0.0 5.6 2.1 13.5 6.7 0.0 8.6 4.7 11.1 8.6 12.9 9.4 0.8 9.2 7.6 10.1 8.2 13.8 3.7 6.3 8.6 10.6 5.0 8.5 32.3 14.4 13.8 12.8 26.1 4.5 5.1 8.5 7.1 ACVR2B ActR-IIB ENSG00000114739 "Activin A receptor type 2B" Q13705 3 38453851-38493142 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 16.4;NTERA-2: 20.3;SuSa: 12.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007398, CAB025115, HPA040384" Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" No No Cytosol "Nucleoplasm, Nuclear bodies" "CAB025115: , HPA007398: AB_2667822, HPA040384: AB_2732484" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.32e-2)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (1.64e-1)" "unprognostic (1.98e-1)" "unprognostic (1.83e-1)" "unprognostic (4.75e-1)" 2.8 7.4 5.5 4.6 7.9 1.1 5.5 13.2 7.5 5.2 3.4 7.2 4.5 2.8 4.7 5.1 2.5 5.6 3.3 3.9 5.9 5.4 5.3 5.4 6.9 2.2 5.9 5.4 8.3 6.1 11.3 5.1 16.0 6.5 3.9 3.6 5.0 4.6 4.2 15.9 2.4 2.8 4.6 4.7 3.1 4.0 9.1 9.1 12.8 4.8 1.7 2.2 4.2 10.3 0.3 0.3 0.5 0.2 0.5 1.6 0.3 0.8 1.4 16.4 1.4 0.6 0.4 8.8 0.3 0.5 0.3 0.7 2.3 1.1 0.1 1.2 0.3 0.5 1.0 6.3 1.0 0.9 2.4 4.1 4.2 2.5 3.5 0.8 2.9 1.6 0.7 0.9 0.5 1.8 1.0 1.1 6.2 6.9 1.4 0.3 1.3 5.1 1.9 20.3 0.8 0.7 1.7 5.5 1.0 1.0 1.9 3.8 6.7 0.4 2.5 2.2 12.2 1.3 3.9 0.9 0.5 2.7 0.4 1.4 3.9 5.4 0.9 0.6 2.5 1.1 0.5 0.1 0.1 0.4 0.2 0.6 0.2 1.0 0.5 0.0 0.3 1.6 1.5 0.3 0.5 0.2 0.3 0.7 0.3 5.5 7.9 13.2 7.0 5.9 5.4 5.9 5.4 6.5 9.1 6.0 6.7 0.5 3.6 3.5 20.7 11.6 5.1 6.7 4.5 0.0 21.6 6.7 0.0 3.2 9.1 6.1 2.9 0.0 3.3 5.8 3.1 3.2 1.1 7.5 2.2 20.6 6.9 4.9 2.1 12.6 10.9 3.2 6.8 0.0 3.2 9.6 3.8 2.5 7.4 2.8 25.5 0.0 5.6 8.1 19.0 3.4 5.1 2.5 4.7 3.3 ACVRL1 "ACVRLK1, ALK1, HHT, HHT2, ORW2" ENSG00000139567 "Activin A receptor like type 1" P37023 12 51906908-51923361 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 55.0" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 53.3;Enterocytes: 82.1;Ito cells: 40.5;Paneth cells: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 3.6;myeloid DC: 5.0" "Group enriched" "Detected in many" 12 "dendritic cells: 5.0;monocytes: 3.6" "Cell line enhanced" "Detected in some" "ASC diff: 18.5;ASC TERT1: 12.6;EFO-21: 16.4;HUVEC TERT2: 59.9;TIME: 46.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007041 Approved "Intracellular and membrane" NA NA "HPA007041: AB_1078097" "unprognostic (2.50e-1)" "unprognostic (4.83e-1)" "unprognostic (3.79e-2)" "unprognostic (3.61e-2)" "unprognostic (4.98e-1)" "unprognostic (4.06e-3)" "unprognostic (2.79e-1)" "unprognostic (1.35e-1)" "unprognostic (5.80e-2)" "unprognostic (5.10e-2)" "unprognostic (4.60e-2)" "unprognostic (4.64e-2)" "unprognostic (1.12e-3)" "unprognostic (1.39e-1)" "unprognostic (7.98e-3)" "unprognostic (2.79e-1)" "unprognostic (1.10e-1)" 25.5 5.1 3.2 9.3 4.3 0.2 15.6 1.6 3.6 15.1 20.1 3.7 13.1 4.9 12.7 11.0 12.1 13.9 11.0 15.4 3.7 3.2 13.6 3.4 55.0 19.1 4.9 3.6 5.9 6.1 21.6 2.7 44.1 5.3 12.3 14.7 12.3 6.9 10.6 14.2 8.0 11.1 8.2 3.7 14.8 8.1 3.5 3.6 1.7 12.9 6.8 5.4 9.3 11.2 0.1 5.0 0.3 3.6 0.0 0.1 0.7 0.0 0.2 0.1 0.0 18.5 12.6 0.0 0.8 1.6 0.0 0.0 0.1 0.1 0.0 16.4 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 2.7 0.0 0.4 5.2 0.0 0.1 0.0 0.0 59.9 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 46.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 3.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.7 3.2 4.3 1.6 3.6 3.7 3.2 4.9 3.6 5.3 3.6 3.0 12.2 0.0 0.2 4.6 0.0 3.9 0.0 4.0 2.3 0.0 0.0 0.5 0.0 2.5 0.0 53.3 82.1 0.0 1.2 36.2 20.2 0.5 0.0 0.0 10.2 0.0 5.2 40.5 25.4 0.7 10.9 5.6 5.0 15.4 26.0 2.3 0.0 50.9 3.2 0.0 0.2 38.8 15.3 0.1 0.7 4.6 2.2 0.0 26.4 0.4 ADA2 "ADGF, CECR1, IDGFL" ENSG00000093072 "Adenosine deaminase 2" Q9NZK5 22 17178790-17221989 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Heparin-binding, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 63.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 22.1;Ciliated cells: 28.1;Club cells: 20.5;Hofbauer cells: 58.5;Macrophages: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.2;EFO-21: 11.6;HUVEC TERT2: 12.5;Karpas-707: 22.3;MOLT-4: 20.7;U-266/70: 12.8;U-937: 21.0" "Low region specificity" "Detected in all" HPA007888 Uncertain "Secreted to blood" NA NA 50000000 "HPA007888: AB_1078495" "unprognostic (1.03e-3)" "unprognostic (2.00e-3)" "unprognostic (6.59e-2)" "unprognostic (2.50e-1)" "unprognostic (1.48e-2)" "unprognostic (7.01e-3)" "unprognostic (4.48e-2)" "unprognostic (3.09e-3)" "unprognostic (3.80e-2)" "prognostic favorable (9.26e-4)" "prognostic favorable (8.91e-4)" "unprognostic (1.41e-1)" "unprognostic (1.49e-1)" "unprognostic (4.86e-3)" "unprognostic (1.96e-2)" "unprognostic (4.83e-2)" "unprognostic (2.51e-1)" 24.7 6.6 6.9 15.3 7.5 8.7 6.3 9.7 9.2 7.8 9.8 17.3 3.9 7.0 9.6 7.0 6.9 18.2 12.4 15.9 6.4 8.8 15.2 8.5 28.6 24.3 9.2 5.8 8.9 6.7 0.6 13.7 8.4 14.5 7.4 12.3 15.3 6.9 6.3 2.5 2.5 12.6 7.9 18.2 45.0 7.2 9.7 5.3 63.0 7.5 2.9 22.6 18.0 4.1 6.1 29.8 2.6 46.4 9.5 7.9 28.3 0.0 0.0 3.4 0.0 0.0 0.6 0.1 1.2 0.2 0.0 0.0 0.0 13.2 3.0 11.6 3.6 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.2 0.1 6.3 0.0 0.1 0.0 0.0 12.5 4.4 0.1 22.3 0.5 0.0 20.7 1.5 10.3 0.0 0.0 0.4 0.0 3.2 0.0 3.9 5.9 0.1 0.0 0.1 0.0 10.6 0.0 5.9 1.4 0.0 0.1 0.1 0.0 12.8 1.1 0.7 0.1 21.0 0.1 2.6 44.1 2.4 7.9 46.4 6.3 6.1 6.4 7.9 29.8 5.0 7.6 7.8 2.1 9.5 35.2 14.7 3.6 28.3 6.9 7.5 9.7 9.2 6.4 8.8 9.2 5.8 14.5 5.3 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 28.1 20.5 5.2 0.0 0.4 6.6 2.3 0.0 0.0 0.0 0.0 4.6 0.6 0.0 0.0 4.7 0.0 58.5 0.0 0.0 0.0 0.0 0.0 0.0 37.4 0.0 1.8 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 ADAM10 "CD156c, HsT18717, kuz, MADM" ENSG00000137845 "ADAM metallopeptidase domain 10" O14672 15 58588807-58749978 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 77.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001709, HPA050670" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 8200000 "Plasma membrane" "Nucleoplasm, Vesicles" "CAB001709: , HPA050670: " "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (5.04e-2)" "unprognostic (3.09e-1)" "unprognostic (2.70e-3)" "unprognostic (7.48e-2)" "prognostic unfavorable (8.46e-5)" "unprognostic (3.99e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (6.69e-2)" "unprognostic (2.57e-2)" "unprognostic (2.57e-3)" "unprognostic (9.14e-2)" "unprognostic (2.09e-2)" "unprognostic (1.60e-2)" 25.9 11.1 15.5 17.1 17.7 15.6 20.0 25.2 17.6 18.6 20.1 15.7 12.7 13.9 19.9 11.8 17.1 13.8 18.0 18.8 17.6 13.7 20.8 14.8 25.0 26.1 23.1 12.4 13.9 13.1 10.9 11.6 36.1 14.5 23.6 16.7 14.6 12.4 19.1 8.9 15.4 15.6 12.8 30.4 40.4 18.4 8.5 18.9 38.5 27.3 9.2 14.9 30.0 19.1 6.2 12.7 26.9 23.7 9.8 12.2 12.8 12.1 27.4 7.5 8.1 9.6 13.9 18.9 10.4 31.0 7.7 10.7 12.6 16.1 5.6 32.2 9.3 13.5 24.8 4.5 11.0 10.2 8.4 5.8 9.6 10.0 11.7 10.7 6.8 27.7 12.1 8.1 5.4 7.9 11.2 14.9 12.2 6.0 15.3 13.5 4.5 22.4 7.7 10.2 4.0 3.9 9.3 24.5 14.4 17.9 32.7 8.1 5.3 11.3 13.2 18.0 17.1 7.8 13.6 10.5 10.1 11.3 77.5 10.0 8.6 18.5 6.1 14.1 13.1 17.6 12.9 18.8 10.4 8.1 21.5 12.2 5.3 8.0 7.1 12.7 6.2 8.4 7.0 26.9 9.8 23.7 5.8 10.3 12.8 15.5 17.7 25.2 16.9 17.6 13.7 23.1 12.4 14.5 18.9 77.4 49.8 30.6 25.8 23.7 20.2 29.7 30.6 30.8 35.2 76.8 25.5 27.4 1.7 45.7 21.6 61.6 39.3 0.0 27.7 46.7 28.8 75.5 27.9 30.4 56.9 42.9 34.7 76.1 87.0 16.2 16.7 64.0 43.9 13.6 45.8 27.0 37.3 43.2 15.9 20.3 32.7 12.9 28.3 13.6 16.2 19.4 22.2 43.6 33.7 59.6 ADAM11 MDC ENSG00000073670 "ADAM metallopeptidase domain 11" O75078 17 44759031-44781846 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 42.3;heart muscle: 11.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 6.1;Cardiomyocytes: 10.8;Horizontal cells: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.7" "Cell line enriched" "Detected in some" 4 "HEK 293: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074550 Enhanced NA NA "HPA074550: AB_2732259" "unprognostic (1.79e-1)" "unprognostic (7.78e-2)" "unprognostic (1.73e-3)" "unprognostic (2.59e-3)" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (6.37e-2)" "unprognostic (5.41e-2)" "unprognostic (5.46e-3)" "unprognostic (7.16e-2)" "unprognostic (9.99e-16)" "unprognostic (1.39e-1)" "unprognostic (2.51e-1)" "unprognostic (3.11e-1)" "unprognostic (3.00e-1)" 1.2 0.5 8.5 0.6 7.5 1.0 0.6 42.3 23.1 0.9 0.8 0.7 0.0 0.8 4.0 1.1 1.1 1.2 1.5 11.2 11.4 4.2 0.7 0.6 0.7 0.7 2.7 9.8 0.9 0.6 0.7 0.6 0.7 5.5 1.6 0.6 0.2 0.5 2.2 0.8 2.5 0.7 2.6 1.5 0.7 0.7 2.3 1.1 0.0 0.6 0.0 0.6 0.7 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.6 4.9 0.2 0.0 0.3 0.1 0.0 1.4 0.4 0.7 0.2 0.1 0.3 0.0 2.2 0.0 3.6 0.0 0.4 1.4 21.0 0.2 0.4 0.3 0.1 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.4 0.4 0.1 4.2 0.1 2.4 0.9 1.6 1.3 2.9 0.1 0.4 0.0 0.1 3.8 1.9 0.0 0.1 1.1 0.4 1.4 0.7 0.0 0.6 1.7 1.8 0.4 0.7 0.2 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 8.5 7.5 42.3 21.0 11.4 4.2 2.7 9.8 5.5 1.1 0.0 0.0 0.0 0.2 0.0 6.1 10.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 22.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 1.4 0.0 2.7 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.0 ADAM12 "MCMPMltna, MLTN" ENSG00000148848 "ADAM metallopeptidase domain 12" O43184 10 126012381-126388455 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 50 "placenta: 487.4" "Cell type enhanced" "Detected in many" 24 "Cone photoreceptor cells: 96.2;Extravillous trophoblasts: 348.4;Syncytiotrophoblasts: 108.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 9.8" "Lineage enriched" "Detected in single" 98 "T-cells: 9.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 47.3;hTEC/SVTERT24-B: 29.7;U-2197: 29.3;U-251 MG: 26.2;U-87 MG: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA030866, HPA030867, HPA030868" Enhanced Supported "Plasma membrane" "Secreted in female reproductive system" NA NA "Plasma membrane" "HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638" "unprognostic (3.35e-1)" "unprognostic (1.05e-3)" "unprognostic (3.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.34e-2)" "unprognostic (2.16e-1)" "unprognostic (2.91e-6)" "unprognostic (2.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.53e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.39e-14)" "unprognostic (3.11e-3)" "unprognostic (9.06e-3)" "unprognostic (4.70e-3)" "unprognostic (3.47e-3)" 6.0 0.0 0.6 2.1 2.8 0.0 5.9 0.6 0.6 8.0 0.5 0.5 0.4 0.0 2.6 0.5 0.5 0.1 4.6 0.7 0.6 0.7 1.0 0.4 1.1 1.0 0.8 0.5 8.2 0.6 0.0 1.1 487.4 0.8 0.7 0.1 0.9 1.1 0.4 0.5 0.3 0.4 1.5 0.7 0.5 0.1 0.7 0.6 0.5 0.4 0.5 1.2 4.5 0.8 0.0 0.0 0.0 0.0 0.0 9.8 0.1 5.0 0.7 2.0 0.0 6.0 12.4 0.0 13.2 1.1 4.5 11.3 0.0 0.0 0.0 0.0 47.3 9.5 0.0 0.0 0.4 4.9 0.5 0.1 0.0 8.0 0.0 0.9 0.0 10.5 15.2 0.0 29.7 0.9 8.6 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.5 1.3 0.1 13.5 0.1 9.0 1.5 0.0 0.2 0.8 0.0 0.0 0.0 16.3 5.4 29.3 26.2 0.0 0.1 0.0 22.5 0.0 10.0 0.0 0.0 0.0 0.5 0.0 9.8 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.6 2.8 0.6 0.6 0.6 0.7 0.8 0.5 0.8 0.6 0.0 3.4 0.0 0.4 1.3 0.8 1.4 0.0 1.4 0.0 0.0 96.2 12.1 0.0 7.6 6.3 1.1 0.4 0.0 1.0 348.4 2.0 0.6 49.5 0.0 14.2 6.4 0.0 2.5 0.3 1.1 15.5 0.7 1.7 15.4 0.2 5.5 1.9 0.0 0.7 0.0 31.5 0.0 1.2 5.1 5.5 0.5 108.0 3.1 0.7 0.5 ADAM15 MDC15 ENSG00000143537 "ADAM metallopeptidase domain 15" Q13444 1 155050566-155062775 "Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion, Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 139.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 17.2;intermediate monocyte: 12.0;myeloid DC: 28.7" "Group enriched" "Detected in many" 5 "dendritic cells: 28.7;monocytes: 17.2" "Cell line enhanced" "Detected in many" "PC-3: 64.1;RPMI-8226: 67.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011633, HPA072878" Uncertain Uncertain Vesicles NA NA 13000 Vesicles "HPA011633: AB_1844574, HPA072878: " "unprognostic (6.35e-3)" "unprognostic (1.51e-1)" "unprognostic (1.60e-1)" "unprognostic (7.60e-2)" "prognostic unfavorable (5.83e-5)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (2.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (5.64e-9)" "unprognostic (3.35e-2)" "unprognostic (6.20e-2)" "unprognostic (2.04e-2)" "unprognostic (7.40e-2)" 32.7 8.3 7.3 13.3 8.9 19.3 47.9 7.8 13.9 19.9 21.2 22.2 11.9 10.7 20.4 16.2 36.0 19.3 30.3 42.3 8.0 7.7 12.4 12.8 29.2 23.3 10.8 8.3 15.7 17.5 18.9 6.9 25.5 13.9 17.8 15.9 15.4 20.4 12.1 13.6 45.8 20.3 25.6 13.6 16.0 19.6 8.3 7.4 2.7 14.6 41.5 19.7 13.4 26.5 1.1 28.7 0.7 17.2 0.7 4.5 8.1 20.8 6.7 1.3 29.8 11.0 9.2 12.9 9.2 11.8 11.8 8.0 4.8 12.0 5.8 41.7 12.1 5.2 26.2 6.7 28.4 3.1 2.6 8.7 1.4 13.2 4.7 19.2 11.8 1.5 9.8 30.1 11.9 17.2 16.3 53.4 1.8 2.2 24.4 8.7 11.3 0.1 8.7 4.2 36.4 64.1 1.8 4.0 67.6 8.6 5.5 4.1 8.8 20.2 25.5 7.9 2.2 37.7 7.3 39.3 11.6 4.9 11.5 10.2 2.7 2.1 2.5 8.4 9.0 12.6 0.0 17.2 0.3 4.5 12.0 3.1 1.0 2.3 2.6 28.7 1.1 1.0 1.2 0.7 0.7 2.8 2.3 3.8 8.1 7.3 8.9 7.8 13.9 8.0 7.7 10.8 8.3 13.9 7.4 3.0 7.0 6.0 22.9 43.5 8.9 9.2 33.1 4.0 5.7 8.7 27.5 9.0 0.0 34.2 1.5 86.7 58.2 0.0 22.4 139.2 17.1 43.0 1.1 17.4 29.2 6.4 12.2 51.0 57.4 1.0 16.1 18.9 13.5 3.6 62.3 8.0 30.5 51.8 17.0 2.2 15.6 12.9 16.1 0.9 6.1 49.9 14.9 5.0 53.8 32.0 ADAM17 "CD156B, cSVP, TACE" ENSG00000151694 "ADAM metallopeptidase domain 17" P78536 2 9488486-9555792 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010738, HPA051575" Approved Supported Cytosol "Intracellular and membrane" NA NA 27000 Cytosol "HPA010738: AB_1078100, HPA051575: AB_2681539" "unprognostic (2.28e-1)" "unprognostic (1.29e-3)" "unprognostic (1.28e-1)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "unprognostic (5.15e-2)" "unprognostic (2.12e-3)" "unprognostic (1.55e-1)" "unprognostic (4.09e-2)" "unprognostic (3.69e-1)" "unprognostic (3.53e-3)" "unprognostic (3.13e-1)" "unprognostic (3.82e-3)" "unprognostic (8.63e-2)" "unprognostic (2.61e-1)" "unprognostic (4.48e-2)" "prognostic unfavorable (4.23e-5)" 18.6 11.0 13.6 15.4 13.8 21.9 14.7 20.4 15.5 14.0 11.7 13.8 8.3 8.7 14.2 15.8 18.7 10.7 17.4 13.4 11.2 12.4 12.4 7.8 24.7 15.0 11.6 11.7 18.1 9.6 10.9 11.9 29.0 11.2 8.2 9.4 10.6 12.5 9.8 12.3 16.7 11.1 13.9 14.3 21.4 8.9 17.4 12.3 14.7 12.5 13.9 20.3 12.3 14.4 7.0 7.7 16.0 10.2 6.0 7.9 6.0 7.7 12.7 13.4 13.9 26.4 19.7 24.1 8.1 13.8 9.3 13.9 11.2 18.6 22.0 11.7 10.1 27.3 14.1 9.8 17.2 12.8 8.8 9.8 11.2 9.6 9.9 37.3 11.0 12.6 22.0 17.3 14.9 29.0 20.8 23.4 8.4 15.3 8.5 10.0 7.3 8.2 11.0 11.0 10.8 5.1 9.6 13.1 10.4 12.4 12.8 7.9 19.7 9.0 11.0 19.2 15.1 5.7 14.2 18.7 16.6 8.7 11.6 15.4 11.1 9.9 19.2 13.8 7.1 19.7 16.0 9.8 7.6 6.1 10.2 7.9 7.0 5.0 5.1 7.7 5.1 4.5 4.6 11.8 6.0 9.5 4.3 5.7 6.0 13.6 13.8 20.4 13.1 11.2 12.4 11.6 11.7 11.2 12.3 44.7 76.6 33.0 41.9 115.4 24.9 2.8 12.7 25.4 40.9 29.6 51.1 25.3 5.0 20.9 64.8 44.9 15.5 23.3 16.8 39.0 58.0 41.4 29.0 11.0 32.9 9.5 18.9 42.4 70.5 10.4 17.5 74.4 38.8 26.2 13.4 12.3 18.2 17.3 15.2 7.5 38.2 38.8 26.7 25.4 37.8 135.3 46.8 26.2 12.5 92.9 ADAM18 "ADAM27, tMDCIII" ENSG00000168619 "ADAM metallopeptidase domain 18" Q9Y3Q7 8 39584489-39730064 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 98 "testis: 42.7" "Cell type enhanced" "Detected in some" 31 "Early spermatids: 41.4;Late spermatids: 19.4;Spermatocytes: 111.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.4;SuSa: 1.1" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (2.10e-4)" "unprognostic (1.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.0 111.2 2.2 0.0 2.1 0.0 0.0 0.0 ADAM19 MLTNB ENSG00000135074 "ADAM metallopeptidase domain 19" Q9H013 5 157395534-157575775 "Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 49.4;smooth muscle: 46.1" "Cell type enhanced" "Detected in many" 13 "B-cells: 69.2;Cone photoreceptor cells: 58.9;Extravillous trophoblasts: 72.0;monocytes: 134.3;Rod photoreceptor cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 32.3;eosinophil: 37.5;memory B-cell: 14.1;naive B-cell: 15.8;neutrophil: 20.1;plasmacytoid DC: 18.5" "Group enriched" "Detected in many" 5 "B-cells: 15.8;dendritic cells: 18.5;granulocytes: 37.5" "Cell line enhanced" "Detected in many" "HDLM-2: 31.7;U-251 MG: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055537 Approved Vesicles NA NA Vesicles "HPA055537: AB_2797253" "unprognostic (4.71e-1)" "unprognostic (1.01e-1)" "unprognostic (1.77e-1)" "unprognostic (4.64e-2)" "unprognostic (1.81e-3)" "unprognostic (2.63e-1)" "unprognostic (2.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (2.80e-1)" "unprognostic (1.42e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.90e-12)" "unprognostic (1.44e-1)" "unprognostic (4.38e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-2)" 3.7 2.5 1.3 49.4 1.5 4.8 2.8 6.9 2.4 4.4 15.1 1.1 3.6 3.9 8.6 5.9 4.6 5.9 14.7 18.9 1.6 1.7 1.6 4.3 9.1 19.2 1.6 1.0 3.0 0.5 0.0 1.4 33.0 3.4 5.9 4.9 5.0 6.8 4.6 3.9 0.8 14.0 46.1 2.8 16.8 7.7 1.3 0.5 5.6 3.1 3.3 29.4 17.0 3.9 15.8 18.5 37.5 3.9 0.1 4.4 2.2 11.1 1.7 3.4 0.0 0.2 0.2 22.3 13.3 4.7 8.3 6.2 5.8 9.1 5.8 0.7 6.8 1.7 9.5 0.5 0.8 7.6 31.7 0.3 0.0 0.9 0.7 2.0 0.0 0.0 1.6 0.0 6.5 1.3 9.9 9.4 0.0 1.6 0.8 17.7 0.0 0.0 0.0 3.7 0.0 5.8 0.1 19.9 4.8 0.9 0.1 1.6 1.0 0.0 4.8 0.7 14.4 0.0 0.2 14.3 9.0 9.7 2.0 60.2 3.6 0.1 20.8 2.0 0.0 4.0 32.3 3.9 37.5 0.4 0.3 1.0 14.1 4.4 1.0 1.1 15.8 0.1 0.1 20.1 0.1 0.0 18.5 4.4 2.2 1.3 1.5 6.9 2.3 1.6 1.7 1.6 1.0 3.4 0.5 6.0 1.1 69.2 0.0 1.9 32.2 3.3 0.0 0.0 1.2 3.5 58.9 0.7 0.0 0.5 3.4 3.9 0.0 0.0 1.3 72.0 4.7 0.1 0.0 8.6 1.5 14.3 0.0 6.2 14.4 1.1 5.2 6.7 1.7 134.3 0.0 2.0 1.6 0.0 7.4 0.0 47.3 6.5 5.2 0.0 1.5 1.3 7.0 10.2 0.0 0.1 ADAM2 "CT15, FTNB, PH-30b, PH30" ENSG00000104755 "ADAM metallopeptidase domain 2" Q99965 8 39743735-39838289 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 416 "testis: 50.6" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 72.7" "Cancer enhanced" "Detected in single" "prostate cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "U-266/70: 2.1" "Not detected" "Not detected" "CAB022390, HPA024621, HPA026581" Enhanced NA NA "CAB022390: , HPA024621: AB_1844576, HPA026581: AB_1844577" "unprognostic (4.74e-2)" "unprognostic (1.67e-3)" "unprognostic (3.82e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 72.7 0.2 0.0 0.2 0.0 0.0 0.0 ADAM20 ENSG00000134007 "ADAM metallopeptidase domain 20" O43506 14 70522358-70535015 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 18 "testis: 18.7" "Cell type enriched" "Detected in some" 9 "Early spermatids: 36.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in single" "Not detected" "Not detected" HPA059377 Enhanced NA NA "HPA059377: AB_2683997" "unprognostic (4.13e-3)" "unprognostic (3.45e-2)" "unprognostic (1.14e-1)" "unprognostic (8.34e-2)" "unprognostic (2.06e-1)" "unprognostic (1.57e-2)" "unprognostic (5.61e-2)" "unprognostic (2.89e-2)" "unprognostic (1.58e-3)" "unprognostic (1.77e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.46e-3)" "unprognostic (2.64e-1)" "unprognostic (6.83e-2)" "unprognostic (5.06e-2)" "unprognostic (9.52e-3)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.7 0.4 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 18.7 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.6 0.0 1.0 0.0 0.3 0.3 0.4 0.2 0.0 0.0 0.3 0.2 0.1 0.3 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.5 0.4 0.2 0.0 0.0 0.3 0.6 0.6 0.2 0.5 0.3 0.0 0.2 0.0 0.1 1.1 0.6 0.4 0.7 0.3 0.4 0.9 0.4 0.2 0.0 0.3 0.5 0.6 0.1 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.7 0.4 0.0 0.1 0.2 0.0 0.5 0.3 0.4 0.1 0.1 0.0 0.0 0.2 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 4.2 0.4 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 36.8 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.0 4.1 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.7 0.0 3.7 0.0 0.3 2.3 0.1 0.1 0.1 0.0 0.0 0.3 ADAM21 ADAM31 ENSG00000139985 "ADAM metallopeptidase domain 21" Q9UKJ8 14 70452157-70459899 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 19.7" "Group enriched" "Detected in some" 46 "Early spermatids: 54.9;Late spermatids: 93.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-138 MG: 4.5;U-251 MG: 4.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059016 Uncertain NA NA "HPA059016: AB_2683882" "unprognostic (7.85e-2)" "unprognostic (7.67e-3)" "unprognostic (4.20e-2)" "unprognostic (1.35e-2)" "unprognostic (5.12e-1)" "unprognostic (1.48e-1)" "unprognostic (5.98e-2)" "unprognostic (2.16e-1)" "unprognostic (3.30e-1)" "unprognostic (2.41e-1)" "unprognostic (1.16e-1)" "unprognostic (2.72e-1)" "unprognostic (6.78e-2)" "unprognostic (1.82e-2)" "unprognostic (1.52e-1)" "unprognostic (2.08e-1)" "unprognostic (2.72e-1)" 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 19.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 1.6 0.3 0.9 0.2 0.4 0.8 1.6 1.6 0.5 0.9 0.6 0.2 0.4 0.2 1.0 0.0 0.6 0.7 0.9 0.1 0.5 1.6 1.0 0.6 0.8 0.6 0.1 0.4 0.3 0.0 0.3 1.0 0.1 0.4 0.9 2.5 0.3 1.0 0.2 0.8 2.1 0.0 2.0 0.2 0.1 0.3 0.2 1.3 1.2 0.0 0.3 0.0 0.7 0.7 0.0 0.7 1.7 0.5 0.5 1.7 0.5 4.5 0.2 0.3 4.3 0.3 2.3 0.0 2.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.2 0.2 0.0 0.8 0.8 1.6 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.1 0.3 0.4 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 54.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 1.6 0.9 0.0 0.1 0.0 0.0 0.0 ADAM22 MDC2 ENSG00000008277 "ADAM metallopeptidase domain 22" Q9P0K1 7 87934143-88202889 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.9" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 30.7;Cone photoreceptor cells: 21.6;Horizontal cells: 14.3;Rod photoreceptor cells: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 36.3;SH-SY5Y: 34.6;U-266/84: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050325, CAB079064" Supported Approved "Cell Junctions" "Intracellular and membrane" NA NA 78000 "Cell Junctions" "CAB079064: , HPA050325: AB_2681087" "unprognostic (1.20e-2)" "unprognostic (8.61e-2)" "unprognostic (3.38e-1)" "unprognostic (1.94e-2)" "unprognostic (2.89e-2)" "unprognostic (3.09e-1)" "unprognostic (7.84e-3)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-1)" "unprognostic (3.71e-3)" "unprognostic (1.69e-1)" "unprognostic (3.47e-2)" "unprognostic (4.13e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-4)" "unprognostic (4.70e-2)" 2.9 11.7 10.9 1.5 15.7 1.5 2.1 46.9 36.4 8.6 2.3 6.2 1.6 1.3 6.3 11.2 1.6 3.7 3.7 3.0 14.0 10.6 5.5 0.8 2.0 2.9 8.8 14.4 5.6 1.8 4.5 3.7 0.9 17.0 14.5 2.3 2.9 1.5 7.1 3.3 1.8 1.9 5.0 8.2 2.9 1.4 2.7 5.7 2.8 4.5 0.0 1.9 2.1 2.9 0.4 1.2 1.9 0.0 0.5 1.6 0.1 1.1 0.3 2.1 2.6 0.6 0.1 1.6 0.0 0.2 0.1 0.2 2.2 3.6 3.2 0.9 0.0 1.5 0.0 3.0 0.0 0.0 8.7 4.0 2.4 2.3 0.6 0.0 2.9 0.0 0.3 0.0 0.0 0.1 2.8 0.2 3.5 0.1 36.3 0.1 2.8 3.7 0.6 5.1 0.2 1.1 2.2 8.4 4.6 0.0 1.7 11.6 34.6 1.8 0.0 0.3 1.7 1.5 0.3 0.0 2.2 1.5 0.4 1.5 8.4 13.9 2.5 1.8 6.1 3.1 1.9 0.0 0.0 1.0 0.0 0.1 0.4 0.3 1.0 0.0 0.3 1.6 1.2 0.2 0.5 0.0 1.2 0.0 0.1 10.9 15.7 46.9 21.8 14.0 10.6 8.8 14.4 17.0 5.7 0.0 1.3 0.0 1.8 0.5 30.7 2.9 0.0 1.4 1.2 1.8 21.6 0.3 1.7 0.0 5.9 0.7 0.0 0.0 0.0 0.1 1.0 0.3 0.0 0.0 0.1 14.3 1.2 0.0 0.0 1.1 2.3 0.0 1.7 0.0 0.8 1.4 0.0 1.5 2.5 0.8 10.6 0.0 0.9 0.5 1.1 0.4 0.0 0.5 1.0 0.1 ADAM23 MDC3 ENSG00000114948 "ADAM metallopeptidase domain 23" O75077 2 206443539-206621130 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 30.5;heart muscle: 19.3;parathyroid gland: 67.6" "Cell type enhanced" "Detected in many" 18 "Bipolar cells: 28.0;Cardiomyocytes: 52.9;Late spermatids: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory CD4 T-cell: 5.7" "Lineage enriched" "Detected in single" 14 "T-cells: 5.7" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 18.8;RH-30: 21.9;RPMI-8226: 57.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033276 Approved "Intracellular and membrane" NA NA 24000 "CAB033276: AB_2305247" "unprognostic (7.33e-2)" "unprognostic (7.80e-2)" "unprognostic (4.60e-1)" "unprognostic (5.77e-2)" "unprognostic (1.58e-1)" "unprognostic (3.59e-2)" "unprognostic (4.27e-2)" "unprognostic (1.53e-1)" "unprognostic (1.09e-1)" "unprognostic (6.84e-2)" "unprognostic (1.09e-2)" "unprognostic (2.64e-2)" "unprognostic (9.75e-6)" "unprognostic (3.32e-3)" "unprognostic (1.25e-2)" "unprognostic (2.16e-3)" "unprognostic (1.03e-3)" 2.0 4.7 8.5 2.5 30.5 2.3 1.7 14.2 27.4 3.4 2.4 3.4 0.3 2.0 2.5 3.8 3.8 1.2 4.0 19.3 8.7 11.4 1.5 1.4 2.0 2.3 9.8 13.5 2.4 5.7 67.6 4.8 1.0 22.4 1.8 2.6 2.4 1.5 2.8 8.1 1.6 2.4 4.2 3.9 1.4 2.0 6.5 4.0 0.8 1.3 1.6 2.7 3.2 2.4 0.4 0.0 0.0 0.0 0.0 5.7 0.4 0.0 0.3 7.6 0.0 4.1 6.1 0.3 0.8 0.9 1.1 0.2 8.9 0.1 1.0 0.0 1.2 13.6 11.4 4.9 0.2 0.1 4.3 4.2 0.0 0.6 0.1 4.0 0.0 0.5 2.2 0.0 0.0 0.0 18.8 13.3 0.4 0.0 0.0 2.8 0.1 0.1 0.0 15.0 0.1 1.5 0.0 21.9 57.1 0.0 5.5 6.0 2.4 0.0 0.0 4.2 3.9 0.0 0.0 11.5 3.8 3.6 2.0 1.7 15.5 0.0 0.0 7.3 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.5 30.5 14.2 25.6 8.7 11.4 9.8 13.5 22.4 4.0 0.0 0.0 0.0 0.7 0.3 28.0 52.9 0.0 1.4 0.0 1.8 2.0 0.0 0.0 0.0 9.9 2.1 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 3.2 1.7 0.0 0.0 20.6 0.6 0.0 3.3 0.0 0.0 3.5 0.1 0.0 2.8 0.0 6.0 0.0 0.4 4.5 3.6 0.4 0.1 0.0 0.0 0.1 ADAM28 "ADAM23, eMDCII, MDC-Lm, MDC-Ls" ENSG00000042980 "ADAM metallopeptidase domain 28" Q9UKQ2 8 24294040-24359018 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.1" "Cell type enhanced" "Detected in many" 15 "B-cells: 115.5;Club cells: 62.6;Macrophages: 32.1;Pancreatic endocrine cells: 32.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 24.9;naive B-cell: 32.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "CAPAN-2: 24.8;OE19: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074034 Enhanced Approved "Plasma membrane,Mitochondria" "Secreted to blood" NA NA "Plasma membrane" Mitochondria "HPA074034: AB_2686654" "unprognostic (4.23e-2)" "unprognostic (1.01e-2)" "unprognostic (2.06e-2)" "prognostic favorable (3.17e-4)" "unprognostic (2.89e-1)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.71e-1)" "unprognostic (1.35e-2)" "unprognostic (3.77e-3)" "unprognostic (7.77e-2)" "unprognostic (3.97e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.62e-1)" 2.0 1.7 7.7 17.4 8.8 3.5 2.1 0.9 5.8 6.7 5.8 12.7 2.0 3.7 3.1 133.1 2.7 5.1 16.7 1.1 8.9 5.0 3.1 1.1 3.1 10.1 12.4 3.7 1.8 2.7 1.0 22.5 1.9 10.8 3.3 5.0 1.9 12.6 5.1 0.7 1.8 17.9 1.7 26.0 15.5 38.7 0.9 12.1 0.8 1.8 0.4 19.9 7.4 1.6 32.2 7.5 12.5 0.9 0.9 0.0 0.9 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 1.0 24.8 0.2 0.8 0.0 0.8 0.1 0.0 0.8 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 3.2 0.6 7.6 0.1 0.1 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.3 0.1 0.1 1.1 2.1 0.1 1.9 0.9 0.2 12.5 0.9 6.4 0.0 0.2 0.0 24.9 0.0 0.0 7.5 32.2 0.0 0.0 1.6 0.9 0.0 0.4 0.0 0.9 7.7 8.8 0.9 5.8 8.9 5.0 12.4 3.7 10.8 12.1 3.0 5.9 115.5 2.2 0.8 0.0 0.9 25.5 17.4 62.6 3.5 0.0 0.3 0.0 7.1 0.9 0.7 0.5 0.0 3.1 8.1 1.1 2.0 2.3 0.0 9.0 0.0 0.0 0.0 12.3 1.8 0.6 32.1 5.0 5.4 0.1 0.0 32.8 0.0 0.4 3.6 0.0 6.5 0.3 0.2 0.1 0.5 0.5 6.9 0.9 6.3 ADAM29 "CT73, svph1" ENSG00000168594 "ADAM metallopeptidase domain 29" Q9UKF5 4 174829668-174978180 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 38.2" "Group enriched" "Detected in some" 68 "Early spermatids: 330.7;Late spermatids: 253.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MAIT T-cell: 1.0;naive CD8 T-cell: 1.3;T-reg: 2.2" "Lineage enriched" "Detected in single" 7 "T-cells: 2.2" "Cell line enhanced" "Detected in some" "Karpas-707: 3.3;RH-30: 2.2;U-266/70: 1.7;U-698: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.40e-3)" "unprognostic (2.03e-2)" "unprognostic (4.72e-3)" "unprognostic (4.93e-2)" "unprognostic (1.16e-6)" "unprognostic (1.35e-1)" "unprognostic (1.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.3 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 330.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 253.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 4.3 1.6 0.0 0.0 0.0 0.0 0.0 ADAM30 svph4 ENSG00000134249 "ADAM metallopeptidase domain 30" Q9UKF2 1 119893533-119896495 "Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 301 "testis: 30.0" "Cell type enriched" "Detected in some" 8 "Early spermatids: 53.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA026080 Uncertain NA NA "HPA026080: AB_1844581" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 ADAM32 ENSG00000197140 "ADAM metallopeptidase domain 32" Q8TC27 8 39106990-39284911 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 47.0" "Cell type enhanced" "Detected in many" 27 "Early spermatids: 134.9;Late spermatids: 35.0;Spermatocytes: 21.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA044156, HPA062151" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA044156: AB_10796798, HPA062151: AB_2684699" "unprognostic (2.13e-1)" "unprognostic (6.92e-2)" "unprognostic (4.63e-3)" "unprognostic (8.99e-2)" "unprognostic (1.48e-1)" "unprognostic (1.52e-2)" "unprognostic (5.66e-3)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-1)" "unprognostic (3.38e-2)" "unprognostic (1.13e-7)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (8.34e-3)" "unprognostic (7.82e-2)" 0.6 0.6 0.3 0.2 0.4 0.4 0.6 0.3 0.5 0.6 0.3 0.2 0.2 0.0 0.3 0.8 0.2 0.3 0.5 0.4 0.3 0.7 0.2 0.2 0.2 0.2 0.3 0.6 0.5 1.2 0.1 0.2 0.2 0.4 0.3 0.4 0.4 0.2 0.7 0.2 0.8 0.3 0.2 0.2 0.5 0.1 47.0 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.9 0.2 1.5 0.4 2.6 0.9 0.0 0.7 0.3 0.1 0.4 2.0 0.2 0.2 1.3 0.4 1.2 0.4 0.1 2.6 0.0 0.5 2.4 0.1 0.2 0.5 0.0 1.5 0.1 0.3 0.0 2.2 0.3 0.3 0.2 0.8 2.7 0.2 0.1 0.0 1.9 0.1 0.3 0.2 0.5 1.3 2.8 0.4 0.6 0.0 1.4 0.0 0.2 0.1 0.0 0.1 0.3 1.0 0.4 0.2 0.4 0.0 0.3 1.1 0.0 0.0 2.6 3.8 0.1 1.4 0.0 0.4 0.1 0.9 0.1 0.7 1.5 0.4 0.2 0.7 0.4 0.3 0.9 0.6 0.9 0.1 0.8 0.7 0.8 1.0 2.6 0.4 0.2 0.2 0.0 0.3 0.4 0.3 0.5 0.3 0.7 0.3 0.6 0.4 0.2 0.0 0.0 0.0 1.0 0.8 8.0 1.4 0.0 1.4 0.0 1.8 17.7 0.2 0.0 0.2 134.9 1.0 0.0 0.0 1.2 0.1 1.9 1.3 0.0 0.4 0.4 0.0 4.1 0.6 0.0 35.0 2.6 0.0 0.0 0.0 0.7 1.1 2.0 0.0 2.8 0.0 4.2 0.0 0.7 21.9 1.8 0.0 0.1 0.0 1.1 1.0 ADAM33 "C20orf153, dJ964F7.1, DKFZp434K0521" ENSG00000149451 "ADAM metallopeptidase domain 33" Q9BZ11 20 3667965-3682246 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 55.7;smooth muscle: 58.0" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 23.2;Leydig cells: 21.0;Peritubular cells: 9.6;Smooth muscle cells: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "ASC diff: 31.3;ASC TERT1: 40.6;BJ: 13.8;BJ hTERT+: 23.7;fHDF/TERT166: 14.1;U-2197: 18.9" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in all" "HPA067152, HPA071758" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA067152: AB_2685791, HPA071758: " "unprognostic (1.10e-1)" "unprognostic (3.02e-2)" "unprognostic (2.24e-2)" "unprognostic (3.35e-3)" "unprognostic (4.39e-3)" "unprognostic (7.43e-4)" "unprognostic (7.14e-3)" "unprognostic (1.67e-1)" "unprognostic (1.78e-3)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.56e-1)" "unprognostic (2.75e-11)" "unprognostic (1.05e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-5)" "unprognostic (3.10e-3)" 10.0 1.5 4.6 9.2 2.6 0.0 20.2 2.8 2.7 55.7 29.5 2.2 20.9 4.7 44.3 12.3 17.0 16.9 17.5 5.3 5.0 0.9 0.9 0.5 3.6 2.2 4.9 3.0 11.8 1.6 0.0 1.6 5.4 7.0 22.8 5.5 3.7 4.2 27.1 3.5 4.8 9.1 58.0 3.3 1.9 9.9 5.4 3.5 0.1 4.0 10.1 2.0 24.9 36.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.3 40.6 0.1 13.8 23.7 4.1 8.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 6.9 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.1 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.6 2.6 2.8 2.7 5.0 0.9 4.9 3.0 7.0 3.5 0.0 0.0 0.0 0.1 4.8 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.2 23.2 0.2 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 21.0 0.6 3.3 0.0 0.0 3.3 0.0 0.0 9.6 0.0 0.0 6.5 15.1 0.6 0.5 2.8 0.5 0.0 0.0 0.0 ADAM7 "EAPI, GP-83" ENSG00000069206 "ADAM metallopeptidase domain 7" Q9H2U9 8 24440930-24526970 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "epididymis: 309.9" "Cell type enriched" "Detected in some" 15 "Early spermatids: 89.5" "Group enriched" "Detected in some" 16 "prostate cancer: 1.0;renal cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 31 "BEWO: 4.4;NB-4: 11.0;RPMI-8226: 2.8;SH-SY5Y: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA008879 Enhanced "Intracellular and membrane" NA NA "HPA008879: AB_10601789" "unprognostic (1.03e-3)" "unprognostic (3.96e-4)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 21.7 0.0 0.1 309.9 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 1.3 0.1 0.3 0.1 0.0 0.1 0.1 0.1 6.8 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 ADAM8 "CD156, CD156a, MS2" ENSG00000151651 "ADAM metallopeptidase domain 8" P78325 10 133262403-133276868 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 56.8;bone marrow: 37.1;lymphoid tissue: 28.3" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 82.5;Macrophages: 42.6;monocytes: 115.4;T-cells: 46.3;Urothelial cells: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 20.7;eosinophil: 56.8;neutrophil: 32.9" "Lineage enriched" "Detected in all" 7 "granulocytes: 56.8" "Cell line enhanced" "Detected in some" "A-431: 22.9;BEWO: 32.9;CAPAN-2: 27.9;HaCaT: 27.4;HDLM-2: 17.6;U-87 MG: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA064637 Approved "Intracellular and membrane" NA NA "HPA064637: AB_2685306" "unprognostic (8.24e-2)" "unprognostic (6.07e-3)" "unprognostic (1.27e-3)" "unprognostic (5.18e-2)" "unprognostic (8.26e-2)" "unprognostic (6.47e-2)" "unprognostic (5.59e-2)" "unprognostic (2.22e-1)" "unprognostic (2.57e-1)" "unprognostic (1.94e-3)" "unprognostic (3.37e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (3.99e-10)" "unprognostic (1.92e-1)" "unprognostic (3.02e-2)" "unprognostic (1.28e-1)" "unprognostic (9.32e-2)" 4.8 1.0 0.7 18.0 1.6 37.1 3.1 1.7 1.2 3.8 4.8 0.9 0.2 3.5 1.8 1.6 2.8 3.6 10.1 4.1 0.8 1.1 2.8 4.3 13.0 25.0 1.0 0.2 1.7 2.4 0.1 2.0 7.5 1.6 2.9 0.9 2.9 5.5 0.7 1.5 1.9 6.0 1.6 1.5 28.3 6.9 2.3 0.5 6.6 2.0 1.8 19.7 12.0 2.8 2.5 8.6 56.8 5.4 5.5 5.5 4.6 22.9 0.7 0.2 0.3 0.2 0.0 32.9 0.2 0.5 0.1 0.1 1.8 27.9 0.4 0.6 0.0 0.2 27.4 0.0 4.7 0.0 17.6 0.3 0.3 0.1 0.0 0.2 1.3 6.4 0.1 0.4 0.2 0.4 1.5 0.0 0.2 1.2 1.0 0.0 1.8 0.0 7.7 0.1 2.7 0.6 0.1 0.2 2.5 0.3 0.5 0.0 0.3 0.1 0.1 0.4 0.4 0.4 0.7 0.6 0.0 0.6 0.2 0.4 1.4 0.8 0.2 14.0 0.7 0.1 20.7 5.4 56.8 5.5 2.1 4.0 2.5 3.7 5.2 8.6 1.5 1.4 2.0 32.9 5.5 2.0 0.1 3.8 4.6 0.7 1.6 1.7 1.2 0.8 1.1 1.0 0.2 1.6 0.5 3.0 14.6 0.9 1.4 6.9 4.1 2.0 2.5 5.3 5.7 0.0 7.9 4.1 1.7 3.0 0.9 2.2 0.0 0.0 2.3 82.5 2.9 5.5 11.6 2.1 24.1 0.0 0.0 3.1 11.1 0.2 0.9 42.6 6.8 115.4 0.2 0.2 22.9 0.0 0.0 0.3 5.3 0.0 0.8 1.4 0.7 5.6 16.7 46.3 0.4 41.4 ADAM9 "CORD9, KIAA0021, MCMP, MDC9, Mltng" ENSG00000168615 "ADAM metallopeptidase domain 9" Q13443 8 38996869-39105144 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Cone-rod dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Pancreatic endocrine cells: 140.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 11.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004000 Approved "Endoplasmic reticulum,Vesicles" "Secreted - unknown location" NA NA 640000 Vesicles "Endoplasmic reticulum" "HPA004000: AB_1844584" "prognostic unfavorable (1.14e-4)" "prognostic unfavorable (2.25e-4)" "unprognostic (1.32e-3)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (7.21e-6)" "unprognostic (5.77e-2)" "unprognostic (1.55e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.52e-5)" "unprognostic (5.83e-2)" "prognostic unfavorable (3.99e-4)" "unprognostic (2.80e-1)" "unprognostic (5.76e-2)" "unprognostic (2.27e-1)" "unprognostic (1.23e-2)" 36.7 25.0 14.7 21.7 13.6 10.4 17.1 20.9 14.4 21.8 24.4 13.2 21.8 19.4 24.9 19.8 24.1 15.5 31.7 28.5 12.5 10.1 29.4 11.6 39.2 20.3 19.2 12.9 17.6 11.1 37.5 10.4 30.1 15.8 23.8 23.8 15.4 44.5 21.4 18.3 12.8 25.4 32.8 22.0 25.7 33.2 13.7 12.7 2.4 24.0 14.9 11.7 34.8 19.2 0.6 8.1 3.4 11.4 3.1 0.8 2.8 41.2 29.9 11.8 7.2 19.2 61.9 15.4 56.1 61.4 31.5 29.5 14.2 30.0 2.1 21.2 38.6 32.2 17.7 5.0 39.6 61.1 2.0 5.1 2.2 20.8 12.2 38.8 1.6 4.8 47.5 23.5 31.0 35.3 60.1 42.9 3.6 4.3 14.1 65.5 4.0 1.6 1.0 1.7 29.5 9.7 1.4 21.4 7.2 51.2 11.8 1.6 2.4 14.9 18.0 13.6 13.3 14.5 3.0 73.6 24.1 23.2 45.5 25.6 4.5 6.9 2.3 40.0 2.7 16.4 1.4 11.4 2.2 0.6 6.1 0.3 0.1 0.3 0.8 8.1 0.6 0.1 0.6 3.4 3.1 2.6 2.7 0.4 2.8 14.7 13.6 20.9 14.4 12.5 10.1 19.2 12.9 15.8 12.7 44.7 35.4 8.2 50.9 31.9 18.5 45.6 25.5 14.7 39.8 33.2 19.6 17.9 3.3 80.4 10.3 23.6 20.8 0.0 100.4 80.2 38.5 85.4 4.7 6.7 104.9 4.8 10.3 26.4 54.2 5.1 26.4 39.7 20.3 22.6 26.3 15.2 140.3 25.9 23.3 36.6 23.8 12.9 32.5 4.3 2.0 18.7 28.7 4.1 25.8 75.5 ADAMTS1 "C3-C5, KIAA1346, METH1" ENSG00000154734 "ADAM metallopeptidase with thrombospondin type 1 motif 1" Q9UHI8 21 26835747-26845409 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 112.8" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 211.3;Sertoli cells: 207.0;Smooth muscle cells: 366.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 8.0;NK-cell: 9.0" "Group enriched" "Detected in many" 85 "NK-cells: 9.0;T-cells: 8.0" "Cell line enhanced" "Detected in many" "ASC diff: 62.1;BJ: 72.4;hTEC/SVTERT24-B: 49.9;hTERT-HME1: 45.5;RPTEC TERT1: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB016394, HPA031498" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 1900000 "Plasma membrane" "CAB016394: AB_626637, HPA031498: AB_2673907" "unprognostic (6.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (1.18e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (1.03e-1)" "unprognostic (3.28e-1)" "unprognostic (2.37e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.55e-2)" "unprognostic (9.70e-3)" "unprognostic (8.27e-3)" "unprognostic (1.12e-1)" "unprognostic (6.76e-2)" "unprognostic (1.57e-1)" 70.6 13.4 8.2 18.7 14.0 0.7 29.0 6.3 9.2 22.0 18.2 9.5 4.8 3.3 27.7 25.8 30.0 45.8 62.3 40.9 7.6 4.8 15.4 22.8 25.0 10.9 12.7 3.7 112.8 9.3 6.3 7.6 56.8 13.2 23.3 16.5 7.8 5.8 8.1 25.7 6.1 16.2 46.4 10.2 7.2 16.8 12.8 11.4 0.0 14.3 18.1 2.7 32.7 45.3 0.0 0.0 0.0 0.0 9.0 8.0 1.4 0.0 0.0 1.1 0.0 62.1 15.4 3.8 72.4 25.3 12.5 8.3 0.0 0.0 0.0 5.0 22.9 0.3 1.3 0.8 3.7 22.1 0.0 23.0 0.0 7.5 0.0 11.9 2.9 0.0 17.2 0.0 49.9 45.5 3.0 5.1 0.7 1.2 0.0 37.1 0.0 0.3 0.0 4.1 0.0 2.9 0.0 28.6 0.2 42.4 4.0 0.0 5.6 3.4 0.0 0.4 2.7 0.1 0.7 5.2 17.8 0.9 27.8 10.7 0.1 0.0 0.0 14.7 0.0 5.4 0.0 0.0 0.0 8.0 0.0 0.8 0.0 0.3 0.6 0.0 0.0 0.0 1.5 0.0 9.0 0.0 0.0 0.0 1.4 8.2 14.0 6.3 9.2 7.6 4.8 12.7 3.7 13.2 11.4 6.0 31.4 0.0 31.2 107.6 0.5 151.1 7.6 5.3 14.8 54.1 0.0 44.4 1.7 29.9 1.3 165.7 0.0 0.0 18.6 211.3 148.2 23.5 2.3 1.3 14.7 0.0 0.0 124.0 6.0 2.2 100.9 4.8 50.6 1.0 0.0 31.7 24.2 0.0 39.3 2.2 2.2 207.0 366.0 0.5 1.0 36.4 45.9 5.0 0.0 13.3 ADAMTS13 "C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP" ENSG00000160323 "ADAM metallopeptidase with thrombospondin type 1 motif 13" Q76LX8 9 133414358-133459402 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 53.7" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 7.6;Early spermatids: 20.6;Ito cells: 8.0;Late spermatids: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.3" "Cell line enhanced" "Detected in many" "SuSa: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA042014, HPA042844, HPA052077" Approved Approved Vesicles "Secreted to blood" NA NA 1300000000 38000000 Vesicles "HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: " "unprognostic (1.09e-1)" "unprognostic (1.45e-1)" "unprognostic (8.75e-4)" "unprognostic (1.49e-2)" "unprognostic (1.83e-1)" "unprognostic (3.02e-1)" "unprognostic (4.76e-2)" "unprognostic (2.54e-1)" "unprognostic (2.33e-2)" "unprognostic (1.88e-1)" "unprognostic (4.52e-5)" "unprognostic (1.11e-1)" "unprognostic (9.91e-2)" "unprognostic (4.78e-2)" "unprognostic (3.57e-1)" "unprognostic (1.82e-2)" "unprognostic (2.30e-3)" 1.4 1.0 3.1 1.4 3.7 0.5 1.4 6.6 4.2 1.4 1.4 1.4 1.4 4.1 1.6 4.0 1.4 2.1 1.5 1.7 3.4 2.2 1.8 53.7 4.8 1.4 2.1 1.4 2.3 1.8 2.2 4.2 1.7 1.6 1.6 1.1 1.6 2.5 2.0 2.6 2.9 4.4 1.4 2.0 1.4 5.5 3.8 1.4 1.4 1.7 1.4 1.4 1.7 1.4 0.3 0.0 2.3 0.0 0.0 0.5 0.1 0.0 1.3 3.3 4.6 2.7 2.4 1.2 1.1 0.9 0.4 0.6 0.5 3.6 0.4 1.5 0.8 1.1 0.6 0.3 0.6 0.1 1.9 3.0 0.4 1.3 0.7 1.9 0.1 1.1 6.4 1.6 0.5 1.2 2.2 0.3 2.3 0.1 1.4 0.5 5.5 0.1 1.5 3.5 1.9 2.0 0.4 0.4 1.6 1.5 1.4 2.1 6.8 2.3 1.3 1.8 7.1 5.8 0.6 0.8 2.4 1.4 1.6 0.0 2.5 0.6 0.5 2.0 0.4 2.8 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 3.7 6.6 4.2 3.4 2.2 2.1 1.4 1.6 1.4 0.0 1.3 0.0 0.1 0.2 1.4 3.6 7.6 0.0 3.4 0.0 0.0 0.1 1.7 0.6 20.6 0.3 1.0 0.0 0.3 0.2 0.8 0.4 0.0 1.5 0.2 3.2 1.2 8.0 0.0 10.2 0.9 0.0 0.0 0.0 1.3 1.9 0.3 1.4 1.4 0.7 1.7 0.0 0.4 4.7 3.8 0.4 0.1 0.0 0.6 0.3 ADAMTS4 "ADAMTS-2, ADMP-1, KIAA0688" ENSG00000158859 "ADAM metallopeptidase with thrombospondin type 1 motif 4" O75173 1 161184308-161199056 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 58.0" "Cell type enriched" "Detected in many" 7 "Smooth muscle cells: 356.4" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 8.0" "Lineage enriched" "Detected in many" 8 "dendritic cells: 8.0" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 10.9;HUVEC TERT2: 13.2;SH-SY5Y: 7.4;TIME: 11.1;U-138 MG: 6.9;U-251 MG: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025876, HPA051296, HPA068374" Uncertain Supported "Nuclear speckles" "Secreted to extracellular matrix" NA NA "Nuclear speckles" "CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978" "unprognostic (2.70e-2)" "unprognostic (8.10e-3)" "unprognostic (3.00e-3)" "unprognostic (2.75e-1)" "unprognostic (9.95e-3)" "unprognostic (1.19e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.20e-2)" "unprognostic (9.59e-3)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.27e-7)" "unprognostic (1.10e-2)" "unprognostic (1.04e-1)" "unprognostic (1.44e-3)" "unprognostic (3.13e-2)" 58.0 9.7 2.6 18.1 20.7 1.8 14.6 1.5 10.7 7.8 6.3 33.4 0.0 1.9 5.8 2.0 7.7 14.2 16.4 19.5 3.4 2.3 3.1 11.0 15.7 2.7 28.6 3.5 35.7 10.6 4.7 4.9 4.4 20.5 5.8 3.4 0.0 1.7 1.7 7.7 1.7 3.0 12.0 15.5 1.9 8.1 1.7 15.7 0.0 7.5 1.2 1.4 8.7 4.0 0.5 8.0 1.0 0.2 0.4 0.6 0.2 0.0 0.0 0.2 0.1 6.1 3.9 0.6 4.9 0.2 0.4 2.8 0.2 0.1 0.2 4.1 1.5 0.0 0.1 0.0 0.0 1.7 0.1 0.3 0.1 0.4 1.2 0.6 0.0 0.1 4.3 0.0 10.9 0.1 0.0 13.2 0.1 0.1 0.3 0.3 0.1 0.0 0.2 4.9 0.0 0.0 0.1 4.8 0.1 0.0 0.1 0.1 7.4 0.0 0.1 0.1 0.3 0.2 0.5 11.1 6.9 0.1 0.3 9.8 0.2 0.1 0.1 2.1 0.1 0.1 0.7 0.2 0.2 0.6 0.1 0.3 0.3 0.3 0.3 0.1 0.5 0.4 0.4 1.0 0.4 0.1 8.0 0.3 0.2 2.6 20.7 1.5 10.0 3.4 2.3 28.6 3.5 20.5 15.7 0.0 5.5 0.0 2.3 27.7 2.2 2.8 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.3 0.0 43.0 0.0 0.0 0.0 0.2 33.3 8.7 0.0 0.8 0.8 3.2 0.0 48.5 1.5 0.0 0.3 6.0 33.7 1.8 0.0 0.3 0.0 0.0 1.1 0.0 1.0 51.8 356.4 2.3 0.6 16.7 0.3 1.5 0.0 4.4 ADCY1 "AC1, DFNB44" ENSG00000164742 "Adenylate cyclase 1" Q08828 7 45574140-45723116 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, cAMP biosynthesis" "Calmodulin-binding, Lyase" "Cancer-related genes, Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0" "Group enriched" "Detected in many" 8 "Cone photoreceptor cells: 490.9;Rod photoreceptor cells: 145.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 15.3;SH-SY5Y: 17.6;SK-MEL-30: 20.3;WM-115: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018364, HPA068274" Uncertain Approved Mitochondria NA NA Mitochondria "CAB018364: AB_2223098, HPA068274: " "unprognostic (9.41e-3)" "unprognostic (7.30e-4)" "unprognostic (9.31e-2)" "unprognostic (2.98e-1)" "unprognostic (4.18e-2)" "unprognostic (3.07e-3)" "unprognostic (1.32e-1)" "unprognostic (7.31e-2)" "unprognostic (1.64e-3)" "unprognostic (2.89e-1)" "unprognostic (7.73e-3)" "unprognostic (1.54e-1)" "unprognostic (4.74e-6)" "unprognostic (2.49e-1)" "unprognostic (7.65e-3)" "unprognostic (2.87e-1)" "unprognostic (2.23e-1)" 2.8 2.8 11.5 0.7 11.7 0.4 6.8 22.7 29.0 7.8 0.9 2.0 0.0 0.7 2.7 1.1 1.2 2.4 1.2 4.0 11.6 4.0 1.8 9.6 1.0 0.8 5.8 13.4 1.2 3.6 1.0 1.5 0.9 6.2 4.1 1.0 5.0 0.8 2.1 9.2 0.6 0.7 1.6 2.2 1.0 1.8 3.9 1.2 0.0 3.0 0.2 0.8 1.0 1.5 0.5 0.4 0.6 0.1 0.0 0.2 0.0 0.5 3.9 1.5 2.2 2.9 0.0 2.7 0.1 0.0 0.5 0.2 0.4 0.0 0.0 0.2 0.1 4.0 1.2 2.5 0.2 0.0 7.0 1.8 0.0 0.0 0.3 0.0 0.1 0.0 3.4 1.9 0.3 15.3 0.0 0.1 5.8 0.2 4.7 0.2 4.6 0.0 0.0 5.7 3.3 0.0 0.0 0.0 7.6 0.0 3.8 9.2 17.6 1.4 0.0 20.3 2.2 1.3 2.3 0.0 0.4 2.9 0.3 2.3 0.0 0.0 0.0 0.0 0.0 11.6 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 11.5 11.7 22.7 29.0 11.6 4.0 5.8 13.4 6.2 1.2 0.0 0.0 0.0 0.4 0.2 35.8 9.0 0.0 0.0 0.0 0.0 490.9 0.1 1.7 0.0 2.3 1.0 0.0 0.0 0.8 0.1 1.9 2.6 0.0 34.7 0.3 39.7 30.0 18.4 3.2 0.4 1.7 0.0 3.3 0.0 0.2 11.9 0.9 0.0 7.1 0.2 145.7 0.0 5.0 0.7 6.8 0.1 0.0 0.0 0.5 0.3 ADCY10 "HCA2, RP1-313L4.2, SAC, SACI, Sacy" ENSG00000143199 "Adenylate cyclase 10" Q96PN6 1 167809388-167914215 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "liver: 14.9;testis: 38.6" "Group enriched" "Detected in some" 11 "Early spermatids: 64.6;Late spermatids: 64.3" "Cancer enhanced" "Detected in single" "liver cancer: 0.7" "Region enriched" "Detected in single" 5 "cerebellum: 1.6" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.7;T-47d: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA015243, HPA017749" Approved NA NA "HPA015243: AB_1856540, HPA017749: AB_1856541" "unprognostic (1.20e-1)" "unprognostic (2.53e-1)" "unprognostic (1.95e-2)" "unprognostic (1.17e-2)" "unprognostic (2.05e-1)" "unprognostic (1.65e-1)" "unprognostic (5.35e-2)" "unprognostic (1.56e-1)" "unprognostic (1.63e-1)" "unprognostic (3.65e-1)" "unprognostic (4.43e-2)" "unprognostic (7.83e-5)" "unprognostic (5.86e-7)" "unprognostic (4.73e-2)" "unprognostic (1.33e-1)" "unprognostic (7.83e-2)" "unprognostic (2.59e-1)" 0.1 0.1 0.2 0.1 0.3 0.0 1.3 1.6 0.3 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.3 14.9 0.1 0.1 0.2 0.3 0.1 0.4 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 38.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.4 0.6 0.0 0.3 0.4 0.3 0.1 0.2 0.2 0.6 0.5 2.7 0.1 1.0 0.3 1.1 1.6 0.1 0.2 0.3 0.0 0.0 0.0 1.1 0.1 0.2 0.4 1.6 0.5 0.3 0.7 0.1 0.0 0.0 0.1 1.9 0.8 0.6 0.3 0.0 0.7 1.2 0.1 0.1 0.0 0.5 0.8 1.0 0.8 0.0 0.1 0.0 0.3 1.2 0.0 0.4 0.0 0.0 0.0 0.5 1.6 5.0 0.8 0.1 0.2 0.0 0.3 0.1 1.2 0.6 0.8 0.7 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.4 0.2 0.3 1.6 0.3 0.3 0.2 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 64.6 0.0 0.5 0.0 0.0 0.4 0.0 0.2 0.0 5.9 0.1 0.0 0.0 1.3 0.0 64.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 4.1 0.7 0.4 1.5 0.0 0.0 0.1 ADCY2 "AC2, HBAC2, KIAA1060" ENSG00000078295 "Adenylate cyclase 2" Q08462 5 7396208-7830081 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 35.9;skeletal muscle: 58.6" "Cell type enhanced" "Detected in many" 24 "Cone photoreceptor cells: 64.8;Horizontal cells: 190.7;Melanocytes: 38.8" "Cancer enhanced" "Detected in some" "glioma: 4.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "AF22: 9.0;NTERA-2: 6.9;SK-MEL-30: 7.5;SuSa: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031482, HPA038015, HPA038483" Approved NA NA "CAB031482: AB_630838, HPA038015: AB_10673653, HPA038483: AB_10675799" "unprognostic (6.48e-2)" "unprognostic (2.60e-2)" "unprognostic (1.49e-1)" "unprognostic (5.65e-2)" "unprognostic (3.77e-1)" "unprognostic (4.03e-4)" "unprognostic (1.94e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-1)" "unprognostic (1.48e-1)" "unprognostic (2.67e-2)" "unprognostic (7.68e-2)" "unprognostic (1.09e-5)" "unprognostic (1.05e-1)" "unprognostic (7.33e-3)" "unprognostic (4.90e-2)" "unprognostic (3.92e-3)" 1.8 3.3 16.8 1.3 14.5 1.2 2.8 6.6 35.9 4.9 1.9 6.7 0.7 1.9 3.9 1.7 4.0 4.1 2.1 1.2 14.5 9.4 1.2 1.1 1.3 1.1 12.8 10.0 5.1 1.9 1.0 5.1 1.8 11.3 6.2 1.6 2.0 1.5 5.1 58.6 6.3 1.8 4.3 12.5 1.2 2.6 3.6 5.4 0.0 1.1 5.1 1.2 1.9 2.1 0.9 0.4 1.5 0.4 0.3 0.6 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.5 6.4 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.4 0.1 0.4 0.2 0.4 0.5 0.3 0.3 0.1 0.9 0.4 0.6 1.5 0.3 0.3 0.4 0.2 0.0 16.8 14.5 6.6 22.5 14.5 9.4 12.8 10.0 11.3 5.4 3.0 2.4 0.0 0.6 5.3 28.6 1.6 0.0 9.4 4.5 0.0 64.8 0.6 0.0 0.5 2.5 1.4 0.0 0.0 0.4 0.2 2.8 7.3 1.1 0.0 0.2 190.7 12.1 0.6 0.0 2.1 4.0 2.6 38.8 0.0 0.1 1.9 2.0 0.3 1.8 0.2 4.0 0.0 1.0 1.2 0.7 4.1 0.7 0.0 0.2 0.8 ADCY3 AC3 ENSG00000138031 "Adenylate cyclase 3" O60266 2 24819169-24919839 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis, Olfaction, Sensory transduction" "Calmodulin-binding, Lyase" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Leydig cells: 54.1;Sertoli cells: 109.9;Smooth muscle cells: 59.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010223 Approved NA NA "CAB010223: AB_630839" "unprognostic (3.05e-1)" "unprognostic (1.10e-1)" "unprognostic (4.91e-2)" "unprognostic (1.39e-3)" "unprognostic (5.01e-2)" "unprognostic (7.66e-2)" "unprognostic (1.28e-1)" "unprognostic (6.06e-2)" "unprognostic (8.43e-2)" "unprognostic (6.89e-2)" "unprognostic (8.22e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (1.32e-9)" "unprognostic (3.74e-2)" "unprognostic (5.56e-2)" "unprognostic (1.11e-1)" "unprognostic (8.55e-3)" 35.8 8.2 14.4 11.7 26.0 13.2 41.2 15.0 21.7 22.5 15.1 16.5 6.5 7.6 23.3 15.6 17.4 21.4 18.2 18.2 13.7 13.1 9.5 4.6 15.3 13.7 29.6 14.1 29.5 7.7 15.4 16.2 58.6 16.3 15.1 11.7 11.3 8.7 24.9 7.9 14.8 12.3 25.1 12.4 11.7 9.8 11.3 18.2 4.3 14.4 13.9 12.8 13.5 24.2 7.2 11.0 3.2 1.8 1.1 3.1 1.2 28.4 19.6 6.3 10.7 32.4 25.8 12.4 14.3 21.0 12.5 11.5 15.8 9.8 9.9 3.2 20.9 15.6 20.8 15.6 19.5 8.7 22.6 20.7 16.2 21.5 2.0 24.6 9.2 10.2 21.6 16.5 12.4 18.9 8.0 11.4 8.7 8.1 17.4 7.2 20.4 8.9 2.2 6.9 13.8 8.6 15.8 33.3 20.6 5.4 17.0 10.4 7.6 17.9 21.3 12.3 5.4 5.4 7.7 10.9 21.8 15.7 12.6 21.5 18.1 42.2 38.8 7.1 14.6 13.6 3.2 1.8 0.0 0.6 1.8 0.3 6.4 1.4 0.5 11.0 7.2 0.7 0.6 0.0 1.1 0.4 10.1 3.1 1.2 14.4 26.0 15.0 21.7 13.7 13.1 29.6 14.1 16.3 18.2 0.0 2.6 2.9 3.6 9.7 1.3 1.4 0.0 0.0 1.2 1.8 0.0 0.7 0.0 0.9 0.2 5.0 4.0 0.0 0.0 1.6 17.7 2.9 18.4 0.2 12.4 0.0 1.2 6.7 3.2 1.9 54.1 5.1 6.8 5.4 3.5 1.5 0.7 3.5 27.6 0.1 1.7 109.9 59.0 0.3 2.2 10.3 1.0 6.1 8.8 3.1 ADCY4 AC4 ENSG00000129467 "Adenylate cyclase 4" Q8NFM4 14 24318349-24335093 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 57.3;Ito cells: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "basophil: 5.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.0" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 9.9;TIME: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005070, HPA048344" Approved NA NA "CAB005070: AB_2273639, HPA048344: AB_2680366" "unprognostic (5.59e-2)" "unprognostic (1.34e-1)" "unprognostic (3.47e-4)" "prognostic favorable (8.20e-4)" "unprognostic (4.06e-1)" "unprognostic (2.82e-3)" "unprognostic (1.75e-4)" "unprognostic (8.58e-2)" "unprognostic (2.51e-2)" "unprognostic (7.88e-2)" "unprognostic (6.77e-2)" "unprognostic (7.87e-2)" "prognostic unfavorable (7.01e-4)" "unprognostic (8.02e-2)" "unprognostic (3.88e-2)" "unprognostic (1.57e-1)" "unprognostic (3.47e-2)" 15.8 2.7 2.3 4.6 2.0 1.5 14.2 1.1 2.4 13.3 4.4 1.6 6.3 1.7 16.8 10.0 6.0 7.7 10.9 10.3 1.6 1.4 6.3 2.0 14.7 8.4 2.3 1.5 3.2 2.1 4.7 1.8 17.8 2.7 4.8 2.3 5.8 3.6 8.0 6.2 4.4 3.9 7.0 1.9 9.3 3.4 2.6 1.6 0.0 7.4 7.3 3.3 5.9 12.6 0.0 1.1 5.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.9 0.4 1.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.8 0.0 0.2 0.0 0.0 9.9 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 4.1 0.3 0.1 1.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 5.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.3 2.0 1.1 2.4 1.6 1.4 2.3 1.5 2.7 1.6 0.0 2.6 0.0 0.2 3.2 0.0 8.1 0.0 1.4 1.2 1.8 0.0 0.1 0.0 0.8 1.0 57.3 1.7 0.0 2.8 0.1 1.7 0.2 1.1 0.0 1.3 1.6 1.2 40.5 7.2 5.9 0.0 2.3 6.8 3.6 5.0 0.8 1.4 1.5 0.0 0.0 0.3 6.5 2.3 0.3 0.5 2.5 0.0 2.6 1.6 0.3 ADCY5 AC5 ENSG00000173175 "Adenylate cyclase 5" O95622 3 123282296-123449758 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 69.9" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 56.0;Paneth cells: 59.6;Peritubular cells: 69.3;Sertoli cells: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 18.0;RPMI-8226: 3.1;RPTEC TERT1: 6.5" "Region enriched" "Detected in many" 5 "basal ganglia: 347.3" "Region enriched" "Detected in all" 6 "basal ganglia: 205.1" "HPA017730, HPA077682" Uncertain Enhanced "Intermediate filaments" NA NA "Intermediate filaments" "HPA017730: AB_1844595, HPA077682: AB_2686851" "unprognostic (3.55e-2)" "unprognostic (1.01e-3)" "unprognostic (7.61e-3)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.48e-1)" "unprognostic (7.61e-2)" "unprognostic (2.49e-2)" "unprognostic (2.34e-1)" "unprognostic (7.27e-3)" "unprognostic (2.64e-2)" "prognostic favorable (7.46e-6)" "unprognostic (1.81e-2)" "unprognostic (5.65e-2)" "unprognostic (3.19e-2)" "unprognostic (5.97e-4)" 13.3 3.0 12.5 3.7 32.0 0.6 9.3 2.6 14.4 4.5 11.7 10.4 3.1 4.2 6.2 4.4 13.8 5.3 7.3 69.9 10.4 8.3 5.3 2.4 2.6 2.0 15.0 8.6 10.1 5.7 1.1 7.7 4.8 9.7 13.8 4.6 4.6 3.1 16.3 2.2 1.1 4.8 13.5 8.8 4.7 9.6 5.9 16.0 0.0 1.0 0.2 2.6 9.5 8.5 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.7 1.6 0.1 0.1 0.1 0.4 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.4 0.2 2.7 0.5 0.8 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 18.0 0.0 0.0 1.0 0.0 0.1 0.0 0.4 3.1 6.5 0.6 2.2 2.0 0.0 0.6 0.1 2.2 0.0 0.1 0.0 0.1 1.5 0.1 0.3 0.2 0.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 12.5 32.0 2.6 14.4 10.4 8.3 15.0 8.6 9.7 16.0 0.0 0.0 0.0 0.1 0.2 16.5 56.0 2.5 0.0 0.0 7.0 0.0 1.1 0.0 11.5 0.7 0.4 0.5 0.0 6.3 3.1 2.3 0.1 0.0 0.0 0.2 0.0 0.0 2.5 0.0 1.1 19.0 0.0 0.0 1.8 0.3 0.8 0.6 59.6 69.3 0.7 1.5 64.7 12.2 0.7 5.6 0.6 10.4 0.0 1.2 0.0 ADCY6 AC6 ENSG00000174233 "Adenylate cyclase 6" O43306 12 48766194-48789037 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018365 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB018365: AB_2257941" "unprognostic (1.18e-2)" "unprognostic (2.20e-2)" "unprognostic (6.89e-2)" "unprognostic (1.31e-1)" "unprognostic (3.84e-2)" "unprognostic (3.68e-2)" "prognostic unfavorable (8.23e-4)" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.59e-1)" "unprognostic (1.64e-2)" "unprognostic (5.06e-3)" "unprognostic (5.10e-3)" "unprognostic (1.09e-1)" "unprognostic (3.09e-1)" "unprognostic (2.48e-2)" 25.9 9.6 14.1 12.4 7.5 0.8 19.7 15.0 17.0 9.8 15.2 5.5 16.2 12.3 13.2 12.8 6.2 9.5 17.6 37.5 9.9 8.3 11.3 5.6 8.5 4.7 5.6 11.0 14.6 17.4 15.8 9.1 9.5 8.9 11.1 12.6 11.8 19.9 12.0 7.3 10.2 13.9 9.1 4.7 2.9 13.5 4.0 5.5 0.6 11.1 6.8 3.8 7.8 14.9 1.8 0.4 1.4 0.4 0.5 0.4 0.5 5.9 11.6 13.4 8.4 14.1 7.1 14.5 7.4 7.4 9.0 6.3 20.6 20.2 0.0 16.9 6.4 3.6 4.8 3.9 4.9 3.2 0.0 6.0 5.5 15.8 3.7 8.1 0.0 4.5 9.0 6.1 7.5 2.8 16.5 8.1 0.3 0.7 2.0 6.6 10.3 0.0 0.2 4.6 9.1 5.5 1.9 5.1 3.3 10.1 18.7 2.0 8.3 7.6 30.4 6.6 5.9 23.7 1.5 9.3 8.4 6.1 4.4 3.2 3.1 1.6 0.2 7.6 0.0 3.8 1.4 0.4 0.4 0.3 0.2 0.2 1.1 0.3 0.2 0.3 1.8 0.4 0.3 0.9 0.5 0.4 0.4 0.2 0.5 14.1 7.5 15.0 17.0 9.9 8.3 5.6 11.0 8.9 5.5 0.0 5.4 0.8 2.8 2.4 7.4 6.7 10.2 1.4 5.7 17.4 19.6 5.4 0.0 5.6 0.4 6.0 26.4 0.0 3.5 2.2 5.7 6.2 1.1 6.0 1.9 9.5 8.1 4.9 0.3 0.5 10.6 1.1 6.8 1.0 24.4 5.6 8.0 31.6 8.9 2.9 8.6 19.4 16.7 1.2 1.3 1.8 4.2 0.0 19.7 5.8 ADCY7 "AC7, KIAA0037" ENSG00000121281 "Adenylate cyclase 7" P51828 16 50246137-50318135 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 34.7;granulocytes: 48.6;Hofbauer cells: 30.2;Kupffer cells: 61.4;Macrophages: 41.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 23.3;HMC-1: 65.3;RPMI-8226: 32.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041218, HPA048241" Uncertain Approved Cytosol NA NA Cytosol "HPA041218: AB_2677365, HPA048241: AB_2680326" "unprognostic (1.98e-1)" "prognostic unfavorable (5.31e-4)" "unprognostic (1.24e-1)" "unprognostic (1.78e-1)" "unprognostic (3.77e-1)" "unprognostic (2.80e-1)" "unprognostic (3.90e-2)" "unprognostic (7.75e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.18e-1)" "unprognostic (5.59e-3)" "unprognostic (7.34e-2)" "unprognostic (2.15e-3)" "unprognostic (2.18e-1)" "unprognostic (9.52e-4)" 6.3 4.3 7.0 17.4 9.7 14.9 3.9 1.2 5.2 3.7 5.0 9.8 0.8 2.8 3.7 4.8 13.2 5.3 6.9 7.3 5.3 4.2 3.3 3.6 16.4 16.5 8.8 4.4 17.1 3.7 1.0 3.4 9.7 8.6 3.5 5.9 6.2 6.5 1.6 1.8 7.9 10.4 5.0 12.3 26.9 4.9 2.1 9.2 21.8 3.7 3.1 26.0 6.6 6.1 3.6 12.5 6.5 16.7 8.4 7.0 5.0 4.0 5.5 0.2 0.8 0.6 7.1 0.5 2.8 1.3 2.2 2.0 5.2 8.4 1.6 7.6 11.4 0.1 14.7 5.8 2.4 2.7 15.4 2.0 23.3 4.2 1.5 6.5 4.4 65.3 3.8 2.4 1.6 2.6 1.2 0.6 5.3 8.5 3.2 3.1 2.3 1.7 10.4 1.0 1.9 7.9 1.6 2.1 32.4 1.5 0.4 1.0 2.7 1.5 0.6 1.3 1.4 0.1 13.0 5.2 0.3 7.6 0.8 0.8 0.3 0.1 3.5 2.4 9.5 1.0 6.5 7.8 2.9 7.0 11.7 5.1 3.2 2.8 5.0 12.5 3.6 2.6 3.7 4.4 8.4 16.7 6.5 3.9 5.0 7.0 9.7 1.2 5.2 5.3 4.2 8.8 4.4 8.6 9.2 17.9 34.7 6.9 0.3 3.3 1.0 0.6 0.0 0.0 12.5 0.0 5.9 9.3 0.0 1.6 1.3 1.0 1.7 0.0 0.2 0.9 11.4 0.3 48.6 0.2 30.2 0.0 0.0 1.8 61.4 0.5 0.6 41.8 5.0 3.6 0.5 0.9 3.1 7.0 1.1 0.0 0.4 6.5 1.4 0.0 0.7 3.4 3.3 18.5 2.1 1.0 ADCY8 "AC8, ADCY3, HBAC1" ENSG00000155897 "Adenylate cyclase 8" P40145 8 130780301-131042426 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.6;epididymis: 27.8" "Cell type enhanced" "Detected in some" 22 "Cardiomyocytes: 1.0;Early spermatids: 2.5" "Group enriched" "Detected in some" 5 "glioma: 6.0;ovarian cancer: 1.8;thyroid cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.9;GAMG: 6.3;U-138 MG: 13.7;U-87 MG: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018652, HPA024291" Supported NA NA "CAB018652: AB_633654, HPA024291: AB_1844597" "unprognostic (5.59e-3)" "unprognostic (3.10e-1)" "unprognostic (1.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.05e-1)" "unprognostic (8.22e-3)" "unprognostic (4.91e-2)" "unprognostic (7.39e-3)" "unprognostic (1.92e-1)" "unprognostic (2.44e-2)" "unprognostic (6.67e-2)" 0.2 0.2 8.2 0.2 5.1 0.2 0.9 5.3 9.6 0.8 0.2 1.2 1.4 0.2 0.3 27.8 0.2 4.8 0.2 0.3 6.4 6.2 0.5 0.2 1.6 0.2 7.8 0.6 0.3 0.2 0.2 0.0 0.2 5.7 0.2 0.2 0.0 2.8 2.0 0.2 1.5 0.2 0.9 5.0 0.2 0.3 0.7 1.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.7 0.3 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 5.1 5.3 5.0 6.4 6.2 7.8 0.6 5.7 1.1 0.0 1.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ADCY9 AC9 ENSG00000162104 "Adenylate cyclase 9" O60503 16 3953387-4116185 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 36.4" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 28.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041328, HPA044225" Approved Approved Cytosol NA NA Cytosol "HPA041328: AB_2677414, HPA044225: AB_2678863" "unprognostic (1.78e-1)" "unprognostic (5.54e-2)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (6.62e-2)" "unprognostic (1.30e-2)" "unprognostic (2.52e-1)" "unprognostic (3.61e-2)" "unprognostic (6.93e-2)" "unprognostic (4.76e-3)" "unprognostic (5.40e-2)" "unprognostic (1.37e-1)" "prognostic favorable (5.24e-8)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (1.55e-2)" 5.2 4.8 7.1 3.2 10.9 0.9 5.4 8.5 9.6 7.0 6.4 4.1 4.4 6.5 6.5 4.4 6.8 7.7 6.5 13.3 6.2 3.0 8.0 9.6 11.1 2.5 3.0 6.2 9.4 12.5 12.3 5.8 7.8 7.7 3.6 5.5 9.0 10.1 5.0 36.4 4.4 10.9 6.3 2.2 3.2 5.5 4.4 3.4 0.7 21.8 7.7 3.0 7.9 4.8 0.1 1.0 3.2 1.5 1.0 1.9 0.9 4.9 7.6 2.3 4.3 8.3 10.2 3.5 8.8 9.2 4.9 4.0 6.3 4.4 0.0 13.5 24.0 3.0 4.8 9.1 5.4 3.4 6.1 8.8 0.2 17.4 12.1 9.1 0.6 4.0 10.8 8.5 5.7 3.0 4.1 3.3 1.6 2.7 0.0 5.0 9.1 0.0 2.6 4.2 2.1 4.1 7.8 11.1 0.2 1.8 1.3 5.3 2.3 6.8 8.1 5.9 2.7 20.5 8.9 3.0 9.8 2.7 9.5 3.8 1.9 1.1 1.0 2.1 2.7 3.8 3.2 1.5 1.0 1.9 1.5 1.7 0.0 0.6 0.6 0.1 0.1 0.1 1.1 0.3 1.0 0.0 1.0 0.0 0.9 7.1 10.9 8.5 9.6 6.2 3.0 3.0 6.2 7.7 3.4 11.9 10.9 0.5 1.0 5.7 9.3 15.1 28.1 6.7 7.9 12.2 11.8 1.4 0.0 3.8 0.6 5.2 13.6 0.0 4.6 1.7 6.9 0.6 0.0 17.4 1.4 1.6 1.2 8.0 5.9 1.5 7.8 2.6 6.8 1.0 8.4 7.5 2.8 0.0 7.1 4.7 12.8 0.0 13.8 1.1 5.2 3.3 0.8 4.3 5.2 0.9 ADCYAP1R1 "PAC1, PAC1R, PACAPR" ENSG00000078549 "ADCYAP receptor type I" P41586 7 31052461-31111479 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.2;fallopian tube: 25.1" "Group enriched" "Detected in some" 5 "Leydig cells: 10.6;Peritubular cells: 5.3" "Cancer enriched" "Detected in some" 11 "glioma: 45.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.6;NTERA-2: 7.3;SCLC-21H: 6.2;SH-SY5Y: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030739, HPA049877" Enhanced Enhanced Vesicles NA NA Vesicles "HPA030739: AB_2732461, HPA049877: AB_2680928" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.16e-2)" "prognostic favorable (5.78e-4)" "unprognostic (2.17e-1)" "unprognostic (8.36e-2)" "unprognostic (4.93e-2)" "unprognostic (5.75e-2)" "unprognostic (3.50e-2)" "unprognostic (3.88e-1)" "unprognostic (1.58e-1)" "unprognostic (6.67e-3)" "unprognostic (6.43e-4)" "unprognostic (1.09e-3)" "unprognostic (9.55e-2)" "unprognostic (3.85e-2)" "unprognostic (2.75e-4)" 5.4 10.6 23.6 2.7 24.2 0.9 2.9 13.7 71.2 12.8 2.7 13.4 0.0 1.6 5.4 2.3 3.3 25.1 2.0 2.8 22.1 21.6 1.0 1.1 1.6 1.0 19.0 20.2 1.9 2.2 2.9 4.4 1.0 18.7 2.1 2.0 0.0 2.6 3.7 1.9 1.8 2.0 3.9 6.5 1.3 1.6 2.2 13.3 0.0 2.3 0.9 1.6 1.4 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 11.1 0.0 0.0 0.0 2.2 0.0 0.0 0.3 0.9 1.3 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.6 24.2 13.7 17.3 22.1 21.6 19.0 20.2 18.7 13.3 0.0 0.0 0.0 0.0 0.5 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.2 0.0 1.4 0.0 1.5 0.3 0.0 0.0 0.0 0.0 ADGRA1 "GPR123, KIAA1828" ENSG00000197177 "Adhesion G protein-coupled receptor A1" Q86SQ6 10 133070929-133131675 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.8;brain: 26.6" "Cell type enhanced" "Detected in some" 26 "Cardiomyocytes: 1.1;Cholangiocytes: 2.5;Ito cells: 6.2" "Cancer enriched" "Detected in single" 13 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "RH-30: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042773 Approved NA NA "HPA042773: AB_10794764" "unprognostic (8.31e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (1.09e-2)" "unprognostic (7.51e-3)" "unprognostic (2.48e-2)" "unprognostic (3.33e-1)" "unprognostic (1.66e-1)" 0.8 7.8 9.9 0.7 9.3 0.7 0.7 3.5 26.6 0.7 0.7 3.2 0.0 0.7 0.7 0.7 0.7 4.3 0.7 0.7 11.6 14.6 1.0 1.1 0.9 0.7 7.5 6.6 0.7 0.8 0.7 1.9 0.7 5.3 0.7 0.7 0.3 4.1 0.7 0.7 0.7 0.7 0.7 4.6 1.0 0.8 1.0 1.4 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 9.3 3.5 19.0 11.6 14.6 7.5 6.6 5.3 1.4 0.0 0.0 0.0 0.0 0.0 0.4 1.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 ADGRA2 "DKFZp434C211, DKFZp434J0911, FLJ14390, GPR124, KIAA1531, TEM5" ENSG00000020181 "Adhesion G protein-coupled receptor A2" Q96PE1 8 37784191-37844896 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Wnt signaling pathway" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Ito cells: 27.6;Leydig cells: 52.3;Muller glia cells: 22.3;Peritubular cells: 39.3;Sertoli cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 37.0;ASC TERT1: 24.8;BJ: 16.4;BJ hTERT+: 27.7;fHDF/TERT166: 28.4;HHSteC: 17.5;HSkMC: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012393 Uncertain NA NA 140000 "HPA012393: AB_1849256" "unprognostic (1.63e-1)" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (1.21e-1)" "unprognostic (2.00e-1)" "unprognostic (6.34e-2)" "unprognostic (1.38e-1)" "unprognostic (3.75e-2)" "unprognostic (1.15e-2)" "unprognostic (1.20e-2)" "unprognostic (3.55e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.18e-7)" "unprognostic (2.65e-2)" "unprognostic (4.90e-2)" "unprognostic (6.12e-2)" "unprognostic (4.60e-3)" 14.6 2.5 3.0 13.8 3.2 0.7 15.4 4.9 5.7 38.0 11.3 2.9 21.8 3.8 29.2 17.5 12.4 21.8 28.4 9.1 3.2 2.3 5.7 2.7 8.1 7.3 3.3 3.1 30.1 3.0 0.9 5.6 25.7 3.8 32.9 4.1 30.5 4.8 32.8 3.0 6.7 6.5 40.2 2.0 5.9 6.8 7.1 1.2 1.7 6.2 10.1 6.0 25.9 18.3 0.0 0.5 0.4 1.4 0.1 0.1 0.4 0.1 0.8 0.1 1.7 37.0 24.8 0.2 16.4 27.7 1.8 5.1 0.1 0.0 0.0 2.8 28.4 1.1 0.3 1.3 0.0 0.6 0.6 0.7 0.0 0.7 0.0 17.5 0.0 0.0 17.3 0.1 1.3 0.3 1.2 8.1 1.1 0.0 0.2 0.4 0.4 0.0 3.0 1.3 0.0 0.2 2.5 1.6 0.1 0.0 0.0 0.1 7.8 0.4 0.1 2.3 6.9 0.0 6.5 7.7 2.9 4.1 4.3 1.3 2.5 0.1 0.0 0.3 8.6 3.1 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.4 3.0 3.2 4.9 5.7 3.2 2.3 3.3 3.1 3.8 1.2 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.0 1.1 1.7 0.1 0.1 6.2 0.0 0.0 1.4 0.5 4.1 0.1 0.0 0.0 1.9 0.0 0.0 27.6 2.6 1.3 52.3 0.9 0.0 0.0 0.0 22.3 0.5 0.0 39.3 0.0 0.5 45.3 1.1 0.3 0.7 0.0 1.9 0.0 0.0 0.2 ADGRA3 "FLJ38547, GPR125, PGR21" ENSG00000152990 "Adhesion G protein-coupled receptor A3" Q8IWK6 4 22345071-22516054 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.8" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 93.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "NK-cell: 2.9" "Lineage enriched" "Detected in single" 5 "NK-cells: 2.9" "Cell line enhanced" "Detected in many" "RH-30: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008904 Uncertain "Intracellular and membrane" NA NA 160000 "HPA008904: AB_1849258" "unprognostic (3.70e-1)" "unprognostic (9.01e-2)" "unprognostic (5.32e-3)" "unprognostic (8.27e-3)" "unprognostic (4.58e-2)" "unprognostic (1.55e-1)" "unprognostic (8.15e-2)" "unprognostic (1.81e-2)" "unprognostic (1.02e-1)" "unprognostic (3.91e-2)" "unprognostic (8.77e-2)" "unprognostic (1.88e-1)" "unprognostic (1.78e-3)" "unprognostic (1.76e-1)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.79e-3)" 5.3 6.9 15.5 3.0 14.7 1.2 7.6 5.7 11.6 8.2 11.8 12.8 5.9 5.0 10.9 7.1 3.8 15.6 5.4 7.4 17.8 8.6 7.5 51.8 3.5 2.4 13.1 8.5 6.6 14.6 9.7 5.5 6.4 14.2 8.9 12.3 6.7 5.7 10.6 11.8 3.1 4.8 10.0 12.8 1.8 6.4 4.5 11.8 3.2 17.9 4.1 1.8 4.6 3.6 0.0 0.3 0.0 0.0 2.9 0.6 0.0 8.3 6.3 16.3 13.6 13.3 6.0 14.6 10.3 11.3 7.0 3.8 7.1 16.8 1.3 5.3 4.9 9.7 9.3 10.2 14.7 10.0 0.0 7.2 0.7 4.9 15.8 4.4 7.3 0.0 5.6 18.4 4.5 7.9 13.3 10.4 5.3 7.6 0.2 11.5 3.7 6.4 0.2 18.0 7.9 6.5 30.3 33.5 2.1 8.4 8.7 12.2 14.1 4.3 0.3 7.2 11.8 4.4 6.4 0.2 10.5 7.5 4.7 9.6 1.2 0.0 0.0 5.8 5.2 8.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.9 0.0 0.3 0.0 0.0 15.5 14.7 5.7 11.6 17.8 8.6 13.1 8.5 14.2 11.8 3.0 2.6 0.0 12.1 0.0 13.6 11.5 20.4 4.0 9.1 15.7 19.6 16.6 0.0 14.9 5.8 1.0 4.3 23.3 10.0 7.2 6.6 10.4 0.0 93.3 3.0 0.0 11.7 6.2 4.7 5.5 8.9 0.6 0.0 0.0 26.0 4.8 16.8 7.0 9.2 5.7 12.3 0.0 3.2 1.2 7.7 0.0 6.1 0.7 19.7 8.8 ADGRB1 BAI1 ENSG00000181790 "Adhesion G protein-coupled receptor B1" O14514 8 142449430-142545009 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity, Myogenesis, Neurogenesis, Phagocytosis" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 27.4" "Cell type enriched" "Detected in some" 9 "Horizontal cells: 119.2" "Cancer enhanced" "Detected in many" "glioma: 11.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 11.8;MCF7: 4.3;NB-4: 5.8;RPMI-8226: 16.3;U-2 OS: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (9.57e-4)" "unprognostic (1.28e-1)" "unprognostic (3.87e-3)" "unprognostic (8.50e-3)" "unprognostic (9.98e-2)" "unprognostic (5.87e-2)" "unprognostic (3.39e-1)" "unprognostic (2.14e-2)" "unprognostic (2.76e-1)" "unprognostic (2.55e-1)" "unprognostic (6.48e-2)" "unprognostic (3.43e-1)" "unprognostic (7.30e-11)" "unprognostic (6.27e-2)" "unprognostic (7.42e-2)" "unprognostic (4.52e-3)" "unprognostic (3.29e-2)" 1.0 3.4 13.6 1.4 18.1 0.9 1.1 5.4 27.4 2.0 1.0 3.1 0.1 1.4 1.8 2.3 0.9 1.4 0.9 0.9 11.0 11.9 1.1 0.8 1.2 1.6 8.7 9.2 1.6 1.1 0.9 2.7 2.5 9.1 1.3 0.9 0.9 2.6 1.9 0.7 3.1 1.4 1.0 2.3 3.7 1.5 2.1 3.2 0.0 0.9 0.0 1.0 0.9 0.4 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.1 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.9 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 5.8 1.8 0.2 0.0 0.1 0.0 16.3 0.0 0.0 3.1 3.1 0.0 0.0 0.2 0.2 0.1 0.3 0.0 0.1 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 18.1 5.4 19.5 11.0 11.9 8.7 9.2 9.1 3.2 0.0 0.0 0.0 0.2 0.0 13.1 5.3 2.5 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 119.2 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.0 0.0 3.8 0.1 0.0 12.7 0.0 0.6 6.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 ADGRB2 BAI2 ENSG00000121753 "Adhesion G protein-coupled receptor B2" O60241 1 31727117-31764893 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 52.0" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 18.3;Horizontal cells: 7.9;Late spermatids: 10.3;Muller glia cells: 10.1" "Cancer enhanced" "Detected in many" "glioma: 20.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 20.7;SH-SY5Y: 15.2;T-47d: 17.5;U-2 OS: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069175 Supported "Plasma membrane" NA NA 49000 "Plasma membrane" "HPA069175: " "prognostic favorable (6.46e-4)" "unprognostic (1.74e-1)" "unprognostic (7.98e-2)" "unprognostic (4.34e-2)" "unprognostic (1.90e-1)" "unprognostic (2.40e-1)" "unprognostic (8.17e-4)" "prognostic unfavorable (4.02e-5)" "unprognostic (2.31e-2)" "unprognostic (1.54e-2)" "unprognostic (1.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-3)" "unprognostic (1.63e-1)" "unprognostic (1.23e-1)" "unprognostic (1.75e-3)" "unprognostic (7.98e-2)" 2.2 5.4 15.9 1.3 26.8 1.1 1.4 7.9 52.0 2.4 1.4 7.3 0.0 5.2 2.4 1.2 1.6 2.2 2.1 2.8 18.9 8.0 1.4 0.9 1.3 1.3 7.4 16.5 1.8 1.4 1.3 2.7 3.8 8.4 2.4 1.1 1.3 1.4 3.1 1.1 1.5 5.0 2.4 2.9 1.8 1.8 3.2 6.3 1.5 3.2 0.0 1.1 2.0 0.5 0.4 0.0 0.0 0.0 0.0 0.9 0.3 0.6 4.4 4.2 12.0 1.2 0.7 2.0 2.8 4.5 2.8 4.9 0.2 1.3 0.0 2.8 1.2 4.6 0.4 1.8 0.2 0.4 3.1 1.9 0.0 20.7 0.0 0.1 0.0 1.6 0.7 0.3 3.8 0.0 8.8 0.4 8.8 0.4 0.1 3.1 0.4 7.9 0.1 5.2 0.1 1.3 12.1 0.4 0.4 0.0 5.7 3.2 15.2 6.5 0.4 0.5 1.5 17.5 0.0 0.1 2.1 17.0 0.3 0.7 0.0 0.0 0.4 6.7 0.0 5.1 0.0 0.0 0.0 0.9 0.0 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 15.9 26.8 7.9 37.6 18.9 8.0 7.4 16.5 8.4 6.3 0.0 0.0 0.0 0.5 0.0 18.3 4.1 0.0 0.0 0.0 0.0 5.9 0.7 0.0 0.1 2.9 0.0 0.0 0.0 0.0 1.1 0.4 0.5 0.0 0.0 0.4 7.9 1.2 0.0 0.0 10.3 1.1 0.0 0.0 0.0 0.0 10.1 0.1 0.0 1.8 1.9 4.1 0.0 0.3 0.7 4.5 0.0 0.2 0.0 0.1 0.9 ADGRB3 "BAI3, KIAA0550" ENSG00000135298 "Adhesion G protein-coupled receptor B3" O60242 6 68635367-69389511 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 55.0;pituitary gland: 17.1" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 43.5;Early spermatids: 14.7;Peritubular cells: 8.1" "Cancer enriched" "Detected in single" 10 "glioma: 3.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 6 "dendritic cells: 2.6" "Group enriched" "Detected in some" 5 "SCLC-21H: 9.3;SH-SY5Y: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 9200 "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (2.69e-1)" "unprognostic (3.72e-3)" "unprognostic (3.27e-2)" "unprognostic (1.04e-1)" "unprognostic (2.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (5.08e-5)" "unprognostic (4.93e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-3)" "unprognostic (2.43e-1)" "unprognostic (1.01e-1)" "unprognostic (8.16e-3)" 2.7 8.0 20.0 2.8 22.5 1.5 2.1 46.9 55.0 3.1 3.4 6.2 0.0 2.2 5.2 3.1 2.7 2.4 3.0 3.2 17.6 15.2 2.4 2.4 3.6 1.6 9.0 22.7 4.3 1.9 1.8 17.1 1.8 9.6 2.6 3.6 1.2 3.2 3.9 1.9 1.9 3.2 6.7 10.1 2.4 1.9 4.4 11.1 0.0 2.1 0.0 1.6 2.9 1.8 0.0 2.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.0 0.0 1.2 1.0 0.0 0.0 9.3 20.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 20.0 22.5 46.9 25.1 17.6 15.2 9.0 22.7 9.6 11.1 0.0 0.0 0.0 0.1 0.0 43.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 1.6 1.0 4.6 0.0 0.0 1.8 0.0 0.8 0.1 0.0 8.1 0.0 2.6 0.0 0.0 4.6 2.1 0.0 0.0 0.0 0.0 0.0 ADGRD1 "DKFZp434B1272, GPR133, PGR25" ENSG00000111452 "Adhesion G protein-coupled receptor D1" Q6QNK2 12 130953907-131141469 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 66.1" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 29.1;Cardiomyocytes: 39.1;Fibroblasts: 20.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 4.1;intermediate monocyte: 4.9;myeloid DC: 2.4;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 4.9" "Cell line enhanced" "Detected in some" "BJ: 5.1;fHDF/TERT166: 5.8;HeLa: 10.5;HHSteC: 6.7;HMC-1: 14.5;U-2 OS: 7.1" "Region enhanced" "Detected in some" "basal ganglia: 5.3" "Low region specificity" "Detected in all" "HPA042395, HPA076279" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA 600000 "Plasma membrane" Nucleoplasm "HPA042395: AB_10796906, HPA076279: " "unprognostic (3.21e-1)" "unprognostic (1.49e-4)" "unprognostic (1.32e-2)" "unprognostic (1.63e-1)" "unprognostic (4.40e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (9.27e-4)" "unprognostic (2.55e-3)" "unprognostic (1.63e-2)" "unprognostic (6.94e-2)" "unprognostic (1.11e-2)" "unprognostic (3.98e-2)" "unprognostic (4.79e-5)" "unprognostic (1.31e-3)" "unprognostic (4.58e-1)" "unprognostic (2.15e-2)" "unprognostic (1.77e-3)" 12.7 2.1 2.0 3.2 3.1 0.5 8.9 1.1 3.9 11.2 5.5 2.2 3.9 2.2 13.3 14.0 6.8 8.8 45.6 34.8 1.9 1.5 1.6 5.2 18.6 0.6 4.2 2.2 12.5 11.8 0.3 3.5 26.6 2.4 13.3 2.4 13.0 1.6 2.3 11.6 3.8 6.4 66.1 6.4 1.9 10.2 3.8 2.6 0.0 6.3 7.1 2.1 29.5 30.8 0.2 2.4 0.0 4.9 0.5 0.0 1.2 0.0 0.7 0.0 2.6 0.1 0.0 0.1 5.1 0.0 0.0 0.4 0.0 0.0 0.3 0.0 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.5 0.0 6.7 0.0 14.5 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.9 0.0 0.1 0.2 2.2 0.5 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.4 0.0 0.5 7.1 1.9 0.1 0.1 1.8 0.9 0.1 0.0 0.0 0.0 4.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.5 3.6 0.0 0.0 1.2 2.0 3.1 1.1 3.9 1.9 1.5 4.2 2.2 2.4 2.6 20.8 29.1 0.0 0.0 0.0 0.0 39.1 0.0 4.0 9.1 1.8 0.0 0.9 0.0 0.0 14.7 1.0 0.0 0.0 0.3 0.6 20.1 0.1 1.1 2.6 2.3 0.0 0.0 3.1 2.4 14.7 12.7 0.7 0.0 1.8 0.0 0.0 0.5 0.0 14.9 0.0 0.7 6.5 0.9 2.6 5.7 0.0 0.8 0.0 0.0 0.3 ADGRD2 "GPR144, PGR24" ENSG00000180264 "Adhesion G protein-coupled receptor D2" Q7Z7M1 9 124451425-124478589 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 2.8;pituitary gland: 7.2;seminal vesicle: 5.8" "Group enriched" "Detected in some" 18 "Early spermatids: 27.1;Late spermatids: 64.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SCLC-21H: 1.5" "Group enriched" "Detected in some" 4 "hypothalamus: 0.7;midbrain: 1.9;pons and medulla: 0.7" NA NA "unprognostic (7.39e-4)" "unprognostic (1.34e-2)" "unprognostic (4.21e-2)" "unprognostic (8.01e-3)" "unprognostic (6.29e-2)" "unprognostic (3.23e-6)" "unprognostic (1.15e-1)" "unprognostic (3.15e-1)" "unprognostic (5.82e-2)" "unprognostic (4.22e-2)" "unprognostic (3.63e-2)" "unprognostic (2.25e-1)" "unprognostic (3.00e-1)" "unprognostic (1.65e-1)" "unprognostic (1.41e-1)" 0.0 0.6 0.1 0.0 0.1 0.0 2.8 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.0 0.3 0.0 0.0 5.8 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 64.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.9 ADGRE1 "EMR1, TM7LN3" ENSG00000174837 "Adhesion G protein-coupled receptor E1" Q14246 19 6887566-6940459 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "blood: 64.1;lymphoid tissue: 50.0" "Cell type enriched" "Detected in some" 9 "Kupffer cells: 25.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 64.1" "Group enriched" "Detected in many" 17 "granulocytes: 64.1;monocytes: 20.2" "Cell line enhanced" "Detected in some" "A549: 5.8;BJ hTERT+: 7.9;GAMG: 8.3;HDLM-2: 19.2;HMC-1: 13.7;Karpas-707: 16.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA052809 Uncertain NA NA 9100 "HPA052809: AB_2681959" "unprognostic (2.06e-2)" "unprognostic (3.45e-1)" "unprognostic (1.32e-1)" "unprognostic (7.88e-2)" "unprognostic (1.02e-1)" "unprognostic (6.93e-5)" "unprognostic (6.77e-2)" "unprognostic (1.18e-1)" "unprognostic (5.75e-2)" "unprognostic (1.09e-1)" "unprognostic (2.55e-2)" "unprognostic (1.26e-1)" "unprognostic (1.37e-7)" "unprognostic (6.69e-2)" "unprognostic (3.33e-4)" "unprognostic (1.11e-2)" "unprognostic (1.35e-1)" 1.8 0.5 0.7 7.2 2.4 5.9 0.5 0.3 1.7 0.5 0.6 0.3 0.0 2.8 0.4 0.9 0.4 0.6 0.7 1.3 1.5 0.7 0.7 4.1 4.6 6.6 1.7 0.0 0.3 0.4 0.0 1.0 1.8 0.9 0.5 0.5 0.5 0.5 0.0 0.4 0.3 2.8 1.7 1.9 50.0 0.7 1.2 1.0 6.9 0.5 0.0 1.7 2.8 0.4 0.0 2.4 64.1 20.2 0.1 2.0 1.9 2.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 8.3 0.0 0.0 0.0 0.0 19.2 0.0 0.1 0.0 0.0 0.0 0.4 13.7 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 16.8 0.0 0.1 0.5 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.2 0.3 0.1 0.9 3.0 0.1 3.9 3.7 0.0 27.2 4.3 64.1 0.0 12.0 0.0 0.0 1.5 0.2 2.4 0.0 2.0 0.1 1.6 0.1 20.2 0.1 0.4 1.9 0.7 2.4 0.3 1.7 1.5 0.7 1.7 0.0 0.9 1.0 3.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.8 25.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.1 0.0 0.0 0.0 ADGRE2 "CD312, EMR2" ENSG00000127507 "Adhesion G protein-coupled receptor E2" Q9UHX3 19 14732393-14778541 "CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Cell adhesion, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.7;lymphoid tissue: 38.9" "Cell type enhanced" "Detected in many" 15 "granulocytes: 44.2;Kupffer cells: 60.1;Macrophages: 39.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 19.6;eosinophil: 24.2;intermediate monocyte: 15.7;neutrophil: 19.1;non-classical monocyte: 28.7" "Group enriched" "Detected in many" 8 "granulocytes: 24.2;monocytes: 28.7" "Cell line enhanced" "Detected in some" "HEL: 10.3;HMC-1: 16.6;NB-4: 10.1;RPMI-8226: 7.3;U-937: 13.2" HPA055200 Uncertain Vesicles,Cytosol NA NA Vesicles Cytosol "HPA055200: " "unprognostic (2.46e-2)" "unprognostic (3.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (9.10e-2)" "unprognostic (3.58e-2)" "unprognostic (2.77e-2)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.32e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.35e-6)" "unprognostic (1.46e-1)" "unprognostic (2.45e-3)" "unprognostic (2.50e-1)" "unprognostic (1.01e-1)" 6.3 3.1 1.7 22.9 1.9 7.2 4.4 1.0 1.3 14.9 8.1 2.5 0.9 2.4 12.0 1.0 1.9 2.3 3.3 7.3 2.0 1.8 3.4 4.3 15.6 37.4 2.2 0.0 5.3 3.5 0.7 1.6 10.9 2.4 3.8 2.5 3.2 2.4 3.9 3.5 3.0 3.0 2.0 3.1 38.9 2.0 2.2 1.4 2.8 3.4 5.2 2.8 7.5 2.1 0.1 3.1 24.2 28.7 1.2 0.0 1.8 0.2 1.0 0.1 0.2 0.1 0.3 1.1 0.8 1.1 0.0 0.0 0.2 0.2 0.2 0.1 0.7 2.1 1.7 0.3 0.1 0.0 0.2 0.2 10.3 3.3 0.2 0.5 3.8 16.6 0.8 1.5 3.7 0.6 0.1 0.1 0.9 2.4 0.4 1.2 0.5 1.3 10.1 0.4 0.7 0.2 0.1 1.4 7.3 0.0 0.3 0.1 0.2 2.1 1.8 0.4 0.2 0.3 4.8 0.3 0.3 0.3 0.2 0.1 0.2 0.1 0.2 1.0 13.2 0.6 19.6 4.4 24.2 0.0 15.7 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 19.1 1.2 28.7 0.6 0.0 1.8 1.7 1.9 1.0 1.3 2.0 1.8 2.2 0.0 2.4 1.4 3.0 10.6 5.4 4.4 0.0 0.7 0.6 0.0 4.0 4.5 0.0 0.0 0.1 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.3 0.3 1.7 44.2 0.4 13.5 0.0 1.2 1.3 60.1 2.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.2 0.3 0.0 0.3 0.7 0.0 3.0 ADGRE3 EMR3 ENSG00000131355 "Adhesion G protein-coupled receptor E3" Q9BY15 19 14619117-14690027 "G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 70.7;lung: 26.3" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 3.7;Ciliated cells: 1.4;granulocytes: 2.3;Macrophages: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basophil: 36.3;eosinophil: 69.6;neutrophil: 70.7" "Lineage enriched" "Detected in many" 9 "granulocytes: 70.7" "Cell line enriched" "Detected in single" 38 "HMC-1: 32.5" "Not detected" "Not detected" HPA015638 Uncertain "Secreted to blood" NA NA "HPA015638: AB_1848039" "unprognostic (2.11e-4)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (5.69e-2)" "unprognostic (5.63e-2)" "unprognostic (4.53e-2)" "unprognostic (1.14e-1)" "unprognostic (8.07e-2)" "unprognostic (9.61e-2)" "unprognostic (9.11e-4)" "unprognostic (4.68e-2)" "unprognostic (2.41e-1)" "unprognostic (1.13e-1)" "unprognostic (7.06e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" 1.7 0.2 0.3 8.5 0.8 4.0 0.3 0.2 0.7 0.2 0.4 0.3 0.1 2.1 0.2 0.7 0.4 0.6 1.2 0.6 0.3 0.3 0.4 1.1 26.3 5.9 0.4 0.1 0.5 0.3 0.0 0.3 1.7 0.7 0.6 0.5 0.7 6.2 0.1 0.9 0.2 3.2 0.7 0.6 8.1 0.4 0.8 0.3 0.8 0.5 0.9 3.4 2.6 0.4 0.0 0.7 70.7 8.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 3.2 69.6 0.0 7.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 70.7 0.0 8.0 0.0 0.0 0.9 0.3 0.8 0.2 0.7 0.3 0.3 0.4 0.1 0.7 0.3 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 4.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRE5 "CD97, TM7LN1" ENSG00000123146 "Adhesion G protein-coupled receptor E5" P48960 19 14380501-14408725 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 95.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 102.4;Kupffer cells: 83.8;T-cells: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA013707 Enhanced Approved Cytosol "Secreted to blood" NA Yes 10000000 930000 Cytosol "HPA013707: AB_1846345" "unprognostic (3.16e-1)" "unprognostic (1.80e-1)" "unprognostic (5.10e-2)" "unprognostic (2.30e-1)" "unprognostic (2.85e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (3.73e-5)" "unprognostic (7.51e-2)" "unprognostic (6.06e-3)" "unprognostic (3.14e-2)" "unprognostic (1.08e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.87e-6)" "unprognostic (2.08e-2)" "unprognostic (4.14e-2)" "unprognostic (2.44e-2)" "unprognostic (6.41e-2)" 17.7 8.9 2.5 23.0 4.0 55.3 14.3 1.1 5.2 21.7 15.9 12.9 0.5 12.9 56.9 18.5 11.6 19.1 27.1 16.4 3.0 2.4 10.7 15.5 30.3 41.1 6.3 3.2 10.7 16.2 2.4 3.3 18.2 5.9 11.3 9.0 6.9 17.0 3.6 12.5 6.0 22.2 36.2 4.2 56.9 15.0 6.9 4.9 24.3 8.6 3.7 22.5 34.7 12.4 3.9 13.3 95.3 43.2 22.8 25.8 23.3 30.8 21.9 0.2 21.0 9.3 15.3 3.3 21.4 34.5 15.4 16.9 6.2 31.3 3.5 21.7 27.5 22.0 7.3 5.7 10.4 6.9 19.2 6.4 6.9 32.5 2.7 11.5 14.9 32.3 6.7 0.3 15.7 5.4 5.0 1.5 6.1 9.0 27.7 16.8 6.9 0.9 20.0 0.6 24.5 27.3 2.0 9.2 16.1 5.2 2.7 0.2 0.7 12.2 17.5 15.2 0.5 4.5 13.8 3.7 5.2 8.7 21.7 35.2 0.0 0.1 0.2 18.7 26.7 19.5 42.0 18.6 95.3 25.8 36.7 17.3 3.9 13.1 17.8 13.3 2.6 9.4 12.8 82.7 22.8 43.2 6.4 9.0 23.3 2.5 4.0 1.1 5.2 3.0 2.4 6.3 3.2 5.9 4.9 32.8 102.4 15.9 7.4 0.0 0.2 3.1 12.7 50.9 31.8 0.0 0.0 2.7 0.0 15.1 0.0 4.5 10.2 23.3 19.1 36.8 4.8 9.8 70.9 1.5 47.0 0.0 4.7 26.4 83.8 1.0 6.1 50.6 0.0 2.8 34.7 2.3 17.9 21.0 4.6 0.7 1.2 25.8 17.2 0.5 5.7 0.0 6.6 152.3 31.8 14.1 ADGRF1 "GPR110, hGPCR36, PGR19" ENSG00000153292 "Adhesion G protein-coupled receptor F1" Q5T601 6 46997703-47042363 "G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 27.4" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 102.9;Pancreatic endocrine cells: 59.1;Urothelial cells: 305.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 10.6;CAPAN-2: 40.0;HaCaT: 8.9;PC-3: 13.0;RPTEC TERT1: 18.3;RT4: 45.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038438 Approved "Secreted - unknown location" NA NA "HPA038438: AB_10672645" "unprognostic (4.83e-4)" "unprognostic (1.38e-1)" "unprognostic (1.64e-1)" "unprognostic (6.71e-3)" "unprognostic (1.95e-3)" "unprognostic (3.02e-3)" "unprognostic (7.76e-2)" "unprognostic (2.63e-2)" "unprognostic (2.90e-1)" "unprognostic (4.20e-2)" "unprognostic (3.64e-3)" "unprognostic (1.99e-1)" "prognostic favorable (1.35e-5)" "unprognostic (7.41e-2)" "unprognostic (8.39e-2)" "unprognostic (1.76e-1)" "unprognostic (1.08e-2)" 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 6.5 6.1 0.0 3.7 0.1 1.3 4.2 15.7 0.8 10.0 0.0 0.0 0.0 27.4 0.1 5.4 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.6 0.0 7.5 0.2 0.0 3.2 1.9 0.1 0.1 5.5 2.1 0.1 0.1 1.5 1.3 0.0 0.0 11.3 5.6 12.3 16.2 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.7 0.0 0.0 8.9 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 13.0 0.0 0.0 0.0 18.3 45.7 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.9 0.0 12.6 0.0 0.0 0.4 15.3 26.8 25.0 102.9 0.0 0.0 19.9 25.6 0.0 0.0 0.0 0.0 16.7 0.0 0.0 30.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 59.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.4 305.8 ADGRF2 "GPR111, hGPCR35, PGR20" ENSG00000164393 "Adhesion G protein-coupled receptor F2" Q8IZF7 6 47656436-47697797 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 6.0;lymphoid tissue: 5.0;skeletal muscle: 4.7;skin 1: 6.0;tongue: 7.7" "Cell type enhanced" "Detected in single" 21 "Ciliated cells: 1.4" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.5;U-87 MG: 3.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA035507 Uncertain NA NA "HPA035507: AB_10601809" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (3.74e-2)" "unprognostic (5.95e-1)" "unprognostic (1.59e-1)" "unprognostic (1.53e-1)" "unprognostic (1.38e-1)" "unprognostic (1.25e-1)" "unprognostic (2.51e-4)" "unprognostic (3.05e-2)" "unprognostic (3.86e-2)" "unprognostic (1.20e-1)" "unprognostic (2.24e-1)" "unprognostic (7.99e-2)" 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.4 1.2 0.3 0.1 0.0 0.0 0.0 0.2 0.0 6.0 4.2 0.0 0.5 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.8 0.6 0.3 0.2 0.0 0.0 0.4 0.0 4.7 6.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 7.7 5.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRF3 "GPR113, hGPCR37, PGR23" ENSG00000173567 "Adhesion G protein-coupled receptor F3" Q8IZF5 2 26308173-26346817 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 7.6" "Group enriched" "Detected in some" 8 "Early spermatids: 10.2;Late spermatids: 21.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MOLT-4: 3.9;U-937: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA044500 Uncertain NA NA "HPA044500: AB_10794290" "unprognostic (9.58e-3)" "unprognostic (2.13e-2)" "unprognostic (4.07e-1)" "unprognostic (1.36e-1)" "unprognostic (6.39e-2)" "unprognostic (6.68e-4)" "unprognostic (8.98e-3)" "unprognostic (1.14e-2)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" "unprognostic (9.66e-4)" "unprognostic (2.29e-1)" "unprognostic (8.09e-2)" "unprognostic (3.53e-2)" "unprognostic (2.58e-1)" "unprognostic (4.08e-2)" "unprognostic (8.70e-5)" 0.4 0.5 0.4 1.1 0.9 1.4 0.5 2.1 1.2 1.0 1.2 0.1 0.1 2.0 0.8 0.1 0.8 0.5 0.5 1.3 3.3 0.3 3.4 0.7 2.6 1.8 0.3 0.1 0.8 3.2 0.0 0.8 0.7 1.5 0.6 0.4 0.1 2.7 2.6 0.4 0.8 0.7 0.1 1.5 1.4 0.8 2.8 0.7 2.0 0.9 0.1 0.5 0.7 7.6 1.3 0.0 2.0 0.8 0.5 1.5 0.0 0.5 0.2 0.4 1.5 0.1 0.3 2.1 0.2 0.2 0.0 0.3 0.7 0.0 2.4 1.7 0.2 0.0 0.9 0.0 0.0 0.0 0.5 0.5 1.0 1.7 0.2 0.0 0.9 1.0 0.3 0.0 0.1 0.0 0.0 0.6 1.4 0.1 1.0 0.1 0.1 3.9 1.1 2.8 0.0 0.0 2.3 2.2 1.0 0.2 3.1 1.9 0.9 0.0 1.0 0.0 0.1 0.1 0.2 0.4 0.1 0.5 0.9 0.3 1.8 1.4 2.7 0.1 3.5 0.4 0.0 0.0 2.0 1.1 0.8 0.8 1.3 0.5 0.6 0.0 0.3 0.7 1.5 0.1 0.5 0.3 0.0 1.5 0.0 0.4 0.9 2.1 1.2 3.3 0.3 0.3 0.1 1.5 0.7 0.0 0.0 0.0 0.1 0.0 0.8 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.2 0.0 0.1 1.1 0.4 0.0 0.1 0.0 0.0 0.0 ADGRF4 "FLJ38076, GPR115, PGR18" ENSG00000153294 "Adhesion G protein-coupled receptor F4" Q8IZF3 6 47685864-47722021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8" "Cell type enhanced" "Detected in some" 14 "Extravillous trophoblasts: 9.6;Pancreatic endocrine cells: 12.3;Syncytiotrophoblasts: 6.1;Urothelial cells: 16.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 8.7;HBEC3-KT: 13.8;hTCEpi: 21.5;OE19: 12.0;U-87 MG: 18.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA007131, HPA007158" Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA007131: AB_2667756, HPA007158: AB_1849254" "unprognostic (1.40e-2)" "unprognostic (7.06e-3)" "unprognostic (2.11e-1)" "unprognostic (4.68e-2)" "unprognostic (3.79e-2)" "unprognostic (3.77e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-1)" "unprognostic (3.47e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (2.86e-1)" "unprognostic (1.66e-8)" "unprognostic (1.62e-3)" "unprognostic (2.01e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" 0.0 0.5 0.0 0.1 0.1 0.0 1.9 0.3 0.0 7.0 1.0 0.1 0.0 0.0 1.0 0.0 15.8 0.9 0.5 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 23.9 0.2 1.9 1.2 0.0 1.8 0.0 0.4 30.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 17.8 14.0 2.3 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.5 8.7 0.0 13.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.5 0.2 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.0 0.8 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 1.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.3 0.0 3.3 0.2 0.0 0.0 0.0 3.0 9.6 0.1 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.0 0.0 16.0 ADGRF5 "DKFZp564O1923, GPR116, KIAA0758" ENSG00000069122 "Adhesion G protein-coupled receptor F5" Q8IZF2 6 46852512-46954943 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 54.6" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 271.0;Alveolar cells type 2: 421.7;Club cells: 164.9;Endothelial cells: 125.4;Ito cells: 281.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 13.5;TIME: 40.3" "Low region specificity" "Detected in all" NA NA 23000000 "unprognostic (8.45e-2)" "unprognostic (3.00e-3)" "unprognostic (1.13e-1)" "unprognostic (3.26e-1)" "unprognostic (6.51e-2)" "unprognostic (1.89e-2)" "unprognostic (5.76e-2)" "unprognostic (9.00e-3)" "unprognostic (7.80e-2)" "unprognostic (3.32e-1)" "unprognostic (1.42e-1)" "unprognostic (4.56e-2)" "prognostic favorable (8.84e-5)" "unprognostic (1.43e-2)" "unprognostic (5.91e-2)" "unprognostic (2.82e-2)" "unprognostic (3.78e-2)" 32.6 11.9 5.0 3.4 7.1 0.2 27.5 2.1 5.8 6.6 5.3 4.2 7.0 2.9 10.4 8.9 5.9 6.7 8.5 34.3 6.4 4.9 33.6 8.7 54.6 6.1 7.3 4.7 6.5 3.3 7.0 5.2 25.1 5.9 5.5 3.1 7.5 3.5 5.0 19.4 3.8 4.0 11.1 6.1 26.2 3.8 3.1 3.0 0.1 16.1 8.8 1.7 8.1 13.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.0 7.1 2.1 5.8 6.4 4.9 7.3 4.7 5.9 3.0 271.0 421.7 5.7 0.3 0.0 0.0 8.4 12.7 88.3 164.9 1.8 0.0 0.2 10.0 0.2 8.1 125.4 0.0 0.0 0.0 1.0 0.0 0.4 11.6 1.5 0.2 0.0 0.0 281.1 20.0 3.0 2.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 97.0 1.5 0.1 0.4 0.0 0.2 0.0 0.0 0.5 ADGRG1 "GPR56, TM7LN4, TM7XN1" ENSG00000205336 "Adhesion G protein-coupled receptor G1" Q9Y653 16 57610652-57665580 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein, G-protein coupled receptor, Heparin-binding, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 182.4;Exocrine glandular cells: 149.7;Proximal tubular cells: 129.8;Syncytiotrophoblasts: 156.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 48.1" "Lineage enriched" "Detected in many" 6 "T-cells: 48.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 41.7;SK-BR-3: 54.1;SK-MEL-30: 55.7;TIME: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046065 Uncertain "Secreted to blood" NA NA 22000 "HPA046065: AB_2679521" "unprognostic (4.91e-3)" "unprognostic (1.70e-1)" "unprognostic (2.69e-2)" "unprognostic (1.47e-2)" "unprognostic (2.26e-3)" "prognostic unfavorable (2.53e-4)" "unprognostic (4.87e-2)" "unprognostic (8.35e-2)" "unprognostic (1.82e-2)" "unprognostic (6.77e-2)" "unprognostic (1.52e-1)" "unprognostic (1.36e-2)" "prognostic favorable (5.52e-7)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (3.33e-1)" "unprognostic (1.98e-1)" 18.9 5.6 39.3 5.1 32.3 6.5 19.7 9.1 70.9 15.2 14.2 28.2 14.6 10.3 10.0 34.5 16.8 20.3 26.7 8.7 33.4 15.9 82.1 1.9 15.4 2.2 24.2 22.8 3.1 25.2 13.5 6.7 38.1 27.2 13.0 13.4 6.3 34.3 24.7 5.7 32.6 7.7 7.8 32.0 4.9 18.1 22.1 28.9 12.1 81.4 8.7 7.2 17.8 14.2 0.1 0.1 1.0 0.2 8.7 48.1 8.4 7.7 8.5 2.5 0.1 0.0 0.0 25.0 1.4 0.8 2.5 0.5 6.4 41.7 0.0 20.9 1.3 36.3 28.5 0.0 19.4 1.0 0.3 0.0 0.8 10.4 7.3 0.0 0.0 0.4 0.5 28.0 4.5 1.9 3.1 20.6 0.2 0.0 0.3 0.5 9.7 20.6 0.1 0.3 26.8 8.3 0.7 0.2 5.7 39.2 24.6 7.2 0.2 0.4 54.1 55.7 1.8 23.9 0.1 44.7 4.7 7.7 0.3 17.3 0.0 0.3 0.1 38.7 0.1 11.3 0.6 0.2 0.0 48.1 0.1 0.5 0.1 3.3 18.3 0.0 0.0 1.7 14.1 1.0 8.7 0.1 0.1 0.0 8.4 39.3 32.3 9.1 35.0 33.4 15.9 24.2 22.8 27.2 28.9 8.9 14.0 0.5 24.7 0.0 0.6 2.8 20.4 30.8 39.8 75.0 0.0 182.4 23.2 27.8 68.9 52.5 2.5 0.0 149.7 10.0 3.2 15.7 4.7 0.6 19.2 0.0 19.9 30.7 3.3 24.2 2.8 4.6 0.0 0.0 32.9 3.5 83.2 3.5 0.0 129.8 0.5 0.0 3.9 1.6 0.7 0.0 156.0 24.9 29.5 13.1 ADGRG2 "EDDM6, GPR64, HE6, TM7LN2" ENSG00000173698 "Adhesion G protein-coupled receptor G2" Q8IZP9 X 18989309-19122637 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 202.4" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 5.1;Ciliated cells: 4.0;Glandular cells: 3.0;Horizontal cells: 3.2;Muller glia cells: 4.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.3;BEWO: 7.9;HeLa: 6.5;NTERA-2: 6.8;SH-SY5Y: 7.1;U-2197: 15.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA001478, HPA050029" Enhanced Approved "Plasma membrane,Cytosol" NA NA 7900000 "Plasma membrane, Cytosol" "HPA001478: AB_1078923, HPA050029: AB_2680996" "unprognostic (3.33e-2)" "unprognostic (3.20e-1)" "unprognostic (2.40e-1)" "unprognostic (2.55e-2)" "unprognostic (1.58e-1)" "unprognostic (4.43e-3)" "unprognostic (2.63e-4)" "unprognostic (2.66e-1)" "unprognostic (1.27e-3)" "unprognostic (1.12e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-1)" "unprognostic (3.54e-7)" "unprognostic (6.37e-2)" "unprognostic (3.19e-1)" "unprognostic (2.83e-1)" "unprognostic (1.35e-1)" 4.4 0.3 0.4 0.9 0.2 0.2 2.8 0.1 0.2 0.8 1.0 0.1 6.6 0.2 0.5 202.4 0.9 6.9 1.4 1.8 0.6 0.6 0.7 0.9 1.7 3.1 0.2 0.2 0.9 0.9 24.8 1.9 0.6 0.3 3.2 0.2 1.6 9.6 0.8 0.6 0.3 1.4 0.6 0.2 1.2 3.5 4.7 0.2 2.7 1.8 0.6 1.9 1.1 1.5 0.1 0.2 0.9 0.6 0.0 0.2 0.0 0.2 6.3 0.0 0.0 0.1 1.0 7.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.5 0.0 6.5 0.3 0.9 0.0 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 2.3 6.8 0.0 2.1 0.0 0.1 4.5 0.0 1.3 2.4 7.1 1.6 0.1 0.0 1.2 0.1 0.1 0.1 0.2 0.4 15.7 2.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.9 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.7 0.0 0.6 0.1 0.0 0.0 0.4 0.2 0.1 0.2 0.6 0.6 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.8 5.1 4.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 3.0 0.0 0.4 0.0 3.2 0.0 1.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.5 1.8 0.0 1.4 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 ADGRG3 "GPR97, Pb99, PGR26" ENSG00000182885 "Adhesion G protein-coupled receptor G3" Q86Y34 16 57668187-57689378 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.8;bone marrow: 62.7;lymphoid tissue: 26.4" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 7.9;Ciliated cells: 2.7;Club cells: 3.4;granulocytes: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "eosinophil: 33.3;neutrophil: 42.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 42.8" "Group enriched" "Detected in some" 6 "NB-4: 8.7;SK-MEL-30: 4.8;U-937: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040469 Uncertain NA NA "HPA040469: AB_10794032" "unprognostic (4.41e-3)" "unprognostic (3.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.14e-2)" "unprognostic (8.84e-2)" "unprognostic (1.64e-2)" "unprognostic (1.50e-4)" "unprognostic (5.25e-3)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (1.93e-1)" "unprognostic (1.53e-1)" "unprognostic (2.67e-3)" "unprognostic (4.75e-2)" "unprognostic (3.77e-1)" "unprognostic (1.00e-1)" "unprognostic (2.90e-1)" 4.6 0.4 0.3 7.2 0.9 62.7 1.6 0.2 0.5 1.1 4.1 0.0 0.0 1.4 1.4 2.0 2.9 3.4 1.6 7.7 0.2 0.3 0.7 2.7 11.0 26.4 2.0 0.0 1.7 0.6 0.2 0.3 1.7 0.6 1.6 0.9 1.2 0.4 0.3 2.3 0.7 3.9 1.5 0.3 25.4 1.2 1.7 0.3 1.1 6.5 1.2 0.8 3.4 7.2 0.0 0.0 42.8 0.0 8.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 15.6 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.8 8.8 0.0 0.0 0.0 0.1 0.3 0.9 0.2 0.5 0.2 0.3 2.0 0.0 0.6 0.3 8.9 7.9 0.0 0.0 0.0 0.0 0.6 0.0 2.7 3.4 0.0 0.0 0.3 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.6 0.6 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.0 0.0 ADGRG4 "GPR112, PGR17, RP1-299I16" ENSG00000156920 "Adhesion G protein-coupled receptor G4" Q8IZF6 X 136300963-136416888 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 21 "intestine: 23.6" "Cell type enriched" "Detected in some" 10 "Horizontal cells: 39.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "TIME: 3.3" HPA035324 Uncertain NA NA "HPA035324: AB_10671512" "unprognostic (3.40e-3)" "unprognostic (7.68e-5)" "unprognostic (7.61e-2)" 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.9 0.0 0.0 7.1 0.7 1.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.0 23.6 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 39.7 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRG5 "GPR114, PGR27" ENSG00000159618 "Adhesion G protein-coupled receptor G5" Q8IZF4 16 57542421-57591681 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 37.7;lymphoid tissue: 25.6" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 2.2;Kupffer cells: 1.2;monocytes: 1.8;T-cells: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 37.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HMC-1: 28.1;OE19: 9.2" "Region enhanced" "Detected in single" "thalamus: 0.4" "Not detected" "Not detected" HPA007133 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" Nucleoplasm "HPA007133: AB_1849253" "unprognostic (6.11e-3)" "prognostic favorable (4.25e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (6.14e-2)" "unprognostic (1.14e-2)" "unprognostic (6.43e-2)" "unprognostic (1.42e-2)" "unprognostic (8.09e-4)" "unprognostic (3.80e-3)" "unprognostic (3.02e-3)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (7.69e-3)" "unprognostic (4.52e-1)" "unprognostic (1.62e-3)" "unprognostic (6.32e-3)" 0.7 0.6 2.4 20.2 2.7 1.4 0.8 0.6 2.1 0.6 2.1 2.5 0.0 4.3 0.5 0.2 1.7 0.8 0.8 0.5 1.6 1.1 0.5 0.6 2.9 12.1 2.6 0.9 0.5 0.4 0.2 0.8 0.0 2.9 1.2 1.7 0.5 4.6 0.8 0.4 0.7 7.5 0.3 3.5 12.8 0.5 1.2 3.5 3.4 1.1 0.2 25.6 2.8 0.9 4.0 21.9 37.7 0.0 8.8 11.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.4 2.6 9.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 37.7 11.1 0.0 5.6 4.0 1.6 6.4 0.7 2.8 0.4 4.0 0.1 8.8 0.0 21.9 0.0 2.3 2.4 2.7 0.6 2.1 1.6 1.1 2.6 0.9 2.9 3.5 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.7 0.4 0.0 ADGRG6 "FLJ14937, GPR126" ENSG00000112414 "Adhesion G protein-coupled receptor G6" Q86SQ4 6 142301854-142446266 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 51.9;placenta: 104.9" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 118.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "myeloid DC: 3.5" "Lineage enriched" "Detected in single" 13 "dendritic cells: 3.5" "Cell line enhanced" "Detected in many" "A549: 25.7;Hep G2: 24.0;hTERT-HME1: 24.4;HUVEC TERT2: 47.1;MCF7: 44.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017346 Approved NA NA 70000000 "HPA017346: AB_1849260" "unprognostic (1.04e-2)" "unprognostic (2.72e-2)" "unprognostic (7.37e-2)" "unprognostic (3.00e-2)" "unprognostic (8.64e-4)" "unprognostic (1.67e-1)" "unprognostic (2.98e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.78e-5)" "unprognostic (4.46e-1)" "unprognostic (6.49e-2)" "unprognostic (2.15e-1)" "unprognostic (1.36e-2)" "unprognostic (2.97e-2)" "unprognostic (4.59e-2)" 5.6 1.4 1.1 4.1 1.0 0.0 6.1 0.5 1.1 4.1 14.0 1.0 2.7 8.9 2.2 2.8 9.1 2.6 8.8 4.4 1.4 1.1 5.3 51.9 12.0 2.6 1.9 0.8 1.4 3.1 0.3 0.7 104.9 1.3 7.2 3.3 3.3 6.3 3.6 1.5 7.8 17.5 5.0 2.3 6.1 6.6 1.5 0.9 2.2 2.1 3.9 4.7 11.3 9.2 0.0 3.5 0.0 0.2 0.0 0.1 0.0 4.8 25.7 0.5 2.7 0.1 0.0 0.0 6.7 1.2 5.1 3.2 20.5 14.9 0.0 6.0 3.8 1.4 12.1 0.7 6.4 8.4 0.0 2.0 1.0 4.4 24.0 5.0 4.0 0.0 0.0 10.4 0.1 24.4 2.9 47.1 0.1 0.1 0.0 2.0 44.2 0.0 0.0 0.2 1.7 5.9 0.0 2.3 5.0 2.6 10.9 0.0 0.0 1.9 9.0 4.2 4.4 4.9 0.0 1.6 0.0 2.3 2.2 3.3 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 1.0 0.5 1.1 1.4 1.1 1.9 0.8 1.3 0.9 6.0 5.1 0.5 15.4 0.0 0.0 1.4 15.3 5.3 14.8 8.7 0.0 4.8 0.0 11.5 0.0 4.4 0.8 0.0 4.7 24.6 0.6 11.8 0.0 118.8 2.0 0.0 0.0 16.5 24.7 0.2 0.6 0.6 0.0 1.0 0.9 0.0 22.8 3.6 0.4 10.3 0.0 6.5 0.5 1.6 5.1 0.0 11.3 0.0 1.8 21.0 ADGRG7 "FLJ14454, GPR128" ENSG00000144820 "Adhesion G protein-coupled receptor G7" Q96K78 3 100609589-100695479 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 31 "intestine: 58.4;liver: 26.9" "Cell type enhanced" "Detected in some" 25 "Collecting duct cells: 1.8;Enterocytes: 2.6;Hepatocytes: 10.4;Paneth cells: 4.0" "Cancer enhanced" "Detected in some" "stomach cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 2.9;CACO-2: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA056451 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA056451: " "unprognostic (1.65e-1)" "unprognostic (1.10e-1)" "unprognostic (2.79e-1)" "unprognostic (8.46e-3)" "unprognostic (1.26e-1)" "unprognostic (6.71e-2)" "unprognostic (9.37e-3)" "unprognostic (2.84e-5)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (6.77e-2)" 0.1 0.2 0.1 0.5 0.1 1.2 0.1 0.1 0.1 0.9 17.1 0.1 0.1 25.7 0.3 0.1 0.2 0.9 0.3 0.2 0.1 0.1 0.1 26.9 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.2 0.4 1.7 0.1 0.1 0.1 0.1 0.2 58.4 0.8 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 ADGRL1 "CIRL1, KIAA0821, LEC2, LPHN1" ENSG00000072071 "Adhesion G protein-coupled receptor L1" O94910 19 14147743-14206187 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 59.8;Horizontal cells: 33.4;Muller glia cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 31.8;HMC-1: 23.1;SCLC-21H: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037974 Uncertain NA NA 63000 "HPA037974: AB_10675623" "unprognostic (5.52e-2)" "unprognostic (3.89e-1)" "unprognostic (1.04e-1)" "unprognostic (5.52e-3)" "unprognostic (6.29e-2)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" "unprognostic (5.39e-2)" "unprognostic (2.73e-1)" "unprognostic (5.68e-2)" "prognostic favorable (1.14e-4)" "unprognostic (2.09e-1)" "prognostic favorable (4.45e-4)" "unprognostic (7.65e-3)" "unprognostic (1.32e-1)" "unprognostic (3.06e-2)" "unprognostic (2.18e-1)" 10.5 4.6 12.1 3.5 18.0 1.8 3.9 27.0 30.9 7.7 6.4 12.7 4.3 6.1 9.0 4.1 6.5 10.8 4.1 5.5 12.7 9.3 3.4 0.5 5.4 2.6 8.7 9.0 4.0 5.8 12.8 9.1 3.7 11.8 5.4 3.7 9.4 9.8 8.1 1.6 9.1 5.4 8.1 8.1 4.4 5.0 5.5 6.9 2.8 9.2 2.0 1.8 4.6 3.4 0.4 1.7 1.3 1.3 4.6 1.3 0.6 10.0 3.9 8.9 31.8 2.4 0.7 3.1 0.7 1.0 1.0 0.6 3.4 3.5 0.8 10.7 1.2 2.0 0.6 10.7 3.0 0.3 1.4 9.1 1.8 1.6 0.5 5.4 0.6 23.1 1.9 2.8 0.3 0.5 1.6 0.8 10.0 8.8 0.9 0.1 16.9 0.8 0.9 13.3 5.4 7.6 4.9 1.1 11.2 1.7 3.2 24.6 6.3 1.9 12.7 4.4 3.3 12.6 4.7 1.2 8.4 12.9 2.3 2.9 2.5 2.1 13.8 2.5 11.7 3.0 0.0 1.3 0.5 1.3 1.1 0.9 0.4 0.7 0.4 0.5 0.2 1.0 0.6 1.3 4.6 1.1 1.7 0.7 0.6 12.1 18.0 27.0 27.6 12.7 9.3 8.7 9.0 11.8 6.9 0.0 5.0 0.0 2.8 0.0 59.8 7.3 2.5 0.0 3.4 7.0 9.8 0.3 0.0 3.2 0.3 4.5 3.2 0.0 2.7 0.3 3.3 3.9 4.7 0.0 0.7 33.4 7.0 9.2 2.2 2.0 8.6 0.4 0.0 1.0 3.0 32.9 2.4 7.8 15.2 0.7 22.2 19.4 0.9 0.9 22.6 0.0 0.2 1.9 6.7 1.4 ADGRL2 "KIAA0786, LEC1, LPHH1, LPHN2" ENSG00000117114 "Adhesion G protein-coupled receptor L2" O95490 1 81306160-81992436 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 51.9;Cardiomyocytes: 43.9;Hepatocytes: 33.8;Horizontal cells: 31.8;Ito cells: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 63.8;hTEC/SVTERT24-B: 31.7;NTERA-2: 26.8;SH-SY5Y: 42.7;U-2197: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043447 Approved "Plasma membrane,Cell Junctions" NA NA 280000 "Plasma membrane, Cell Junctions" "HPA043447: AB_2678486" "unprognostic (2.54e-2)" "unprognostic (6.29e-3)" "unprognostic (2.57e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (3.22e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.92e-4)" "unprognostic (3.55e-2)" "unprognostic (9.84e-2)" "unprognostic (2.42e-1)" "unprognostic (7.81e-2)" "unprognostic (8.01e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.00e-4)" "unprognostic (2.76e-1)" "unprognostic (3.38e-3)" "unprognostic (1.41e-2)" 8.9 10.5 21.1 3.6 20.9 0.0 8.8 1.5 45.8 7.5 7.0 1.4 1.2 2.7 6.1 8.6 12.0 12.0 11.5 17.6 12.2 6.6 10.9 18.7 32.7 3.5 3.5 22.8 18.8 4.9 20.3 11.8 24.4 6.2 15.6 5.4 9.4 19.1 10.1 2.0 6.3 6.1 6.0 3.2 10.0 7.6 2.0 3.3 0.6 22.4 15.0 5.0 6.5 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 2.4 63.8 0.0 7.9 9.1 0.8 1.5 3.5 0.6 0.7 0.0 0.0 0.0 17.5 8.1 1.8 2.5 5.0 6.7 0.5 0.1 10.4 0.0 1.8 4.4 3.0 0.0 0.1 7.7 0.4 31.7 3.2 4.4 10.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 26.8 0.0 1.9 0.0 8.8 0.0 14.5 0.9 3.2 42.7 0.0 1.8 0.0 18.9 0.1 18.8 6.8 6.5 7.4 29.2 2.2 0.0 0.0 0.0 3.7 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 20.9 1.5 45.8 12.2 6.6 3.5 22.8 6.2 3.3 3.0 2.1 0.0 6.5 0.0 51.9 43.9 10.2 0.0 5.7 5.2 5.9 0.3 0.0 3.7 1.0 27.2 0.0 0.0 1.5 0.2 9.1 8.9 0.0 33.8 0.7 31.8 0.0 40.5 6.0 1.3 21.6 0.9 0.0 0.0 1.1 20.6 1.0 0.0 16.6 7.0 2.4 19.4 3.7 0.5 3.0 0.0 0.3 0.0 0.7 2.4 ADGRL3 "KIAA0768, LEC3, LPHN3" ENSG00000150471 "Adhesion G protein-coupled receptor L3" Q9HAR2 4 61201258-62078335 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;parathyroid gland: 23.1" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 33.8;Late spermatids: 24.4;Muller glia cells: 39.3" "Cancer enriched" "Detected in some" 8 "glioma: 5.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 30.1;EFO-21: 7.9;HEK 293: 4.6;SCLC-21H: 4.6;SuSa: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015027, HPA015762, CAB022698" Uncertain NA NA "CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245" "unprognostic (2.88e-2)" "unprognostic (1.12e-1)" "unprognostic (6.43e-4)" "unprognostic (1.79e-2)" "unprognostic (1.88e-1)" "unprognostic (7.56e-2)" "unprognostic (8.70e-2)" "unprognostic (5.42e-2)" "unprognostic (1.62e-2)" "unprognostic (1.28e-1)" "unprognostic (6.81e-2)" "unprognostic (1.28e-1)" "unprognostic (1.62e-5)" "unprognostic (1.03e-2)" "unprognostic (1.44e-1)" "unprognostic (9.85e-3)" "unprognostic (4.23e-3)" 4.9 7.6 19.7 1.6 19.0 0.4 2.7 11.3 30.5 7.3 4.8 5.0 0.4 3.3 4.9 2.6 1.6 3.3 2.3 3.2 13.1 12.3 2.4 0.9 3.4 0.8 11.8 11.9 1.8 0.7 23.1 0.9 4.9 9.8 2.0 5.0 0.4 0.8 5.6 0.8 2.6 4.4 3.9 8.5 0.8 3.9 4.8 6.1 0.0 0.9 0.6 0.6 2.2 2.9 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.9 0.0 0.0 0.0 4.2 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.7 0.0 2.8 0.4 0.1 0.1 0.0 3.3 0.1 0.0 4.6 0.2 0.0 0.0 0.0 5.7 0.0 2.3 0.0 0.1 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 19.7 19.0 11.3 23.3 13.1 12.3 11.8 11.9 9.8 6.1 0.0 0.0 0.0 0.0 0.0 3.8 3.3 0.0 0.0 0.0 0.0 3.9 0.2 8.3 0.0 33.8 0.3 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.1 1.6 0.0 1.8 0.0 24.4 0.0 0.0 0.0 0.0 0.0 39.3 0.0 0.0 1.1 0.0 2.2 6.5 0.0 0.5 2.1 0.0 1.8 0.0 0.0 0.1 ADGRL4 "ELTD1, ETL" ENSG00000162618 "Adhesion G protein-coupled receptor L4" Q9HBW9 1 78889764-79006718 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 98.9" "Group enriched" "Detected in some" 7 "Endothelial cells: 232.9;Ito cells: 348.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 19.6;HUVEC TERT2: 64.3;RPTEC TERT1: 14.0;TIME: 78.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025229 Supported NA NA 1800000 "HPA025229: AB_10602493" "unprognostic (2.67e-1)" "unprognostic (2.17e-1)" "unprognostic (2.05e-2)" "unprognostic (2.58e-1)" "unprognostic (5.32e-2)" "unprognostic (8.11e-3)" "unprognostic (2.01e-1)" "unprognostic (1.23e-1)" "unprognostic (7.52e-2)" "unprognostic (2.38e-1)" "unprognostic (2.57e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (5.32e-3)" "unprognostic (1.48e-1)" "unprognostic (3.45e-2)" "unprognostic (3.85e-3)" 98.9 4.7 3.6 5.6 5.7 0.0 43.8 3.2 6.1 14.6 7.8 1.5 6.6 2.8 12.9 7.1 12.4 6.8 12.3 12.3 4.3 3.7 11.3 8.8 16.2 8.5 5.4 1.4 9.3 3.0 5.7 7.8 12.8 6.2 12.2 3.6 5.9 4.8 5.7 16.1 5.3 4.8 16.0 4.7 34.8 4.9 6.8 4.3 1.1 13.9 8.0 3.9 16.0 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 1.6 5.2 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 3.8 0.0 11.1 0.0 19.6 64.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 78.4 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 5.7 3.2 6.1 4.3 3.7 5.4 1.4 6.2 4.3 0.0 8.9 2.2 0.3 0.0 0.0 4.2 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 232.9 0.0 0.0 0.2 0.0 0.3 1.1 0.0 2.0 0.5 1.6 0.0 348.0 29.4 42.9 0.6 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 1.2 1.4 1.1 0.0 0.0 0.0 0.0 0.6 ADGRV1 "DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1" ENSG00000164199 "Adhesion G protein-coupled receptor V1" Q8WXG9 5 90529344-91164437 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Hydrolase, Receptor, Transducer" "Deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 95.3;pituitary gland: 35.4" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 249.4;Rod photoreceptor cells: 90.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 12.2;HAP1: 18.1;NTERA-2: 9.5;SCLC-21H: 8.8;SuSa: 12.4;U-266/70: 10.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067503 Approved Approved "Lipid droplets" NA NA "Lipid droplets" "HPA067503: AB_2685856" "unprognostic (1.29e-1)" "unprognostic (3.02e-1)" "unprognostic (3.69e-2)" "unprognostic (1.38e-1)" "unprognostic (4.01e-2)" "unprognostic (2.61e-1)" "unprognostic (3.76e-2)" "unprognostic (1.62e-3)" "unprognostic (1.48e-2)" "unprognostic (1.87e-1)" "unprognostic (3.95e-3)" "unprognostic (7.50e-3)" "unprognostic (9.73e-7)" "unprognostic (1.87e-2)" "unprognostic (5.24e-2)" "unprognostic (3.48e-2)" "unprognostic (7.14e-2)" 0.5 95.3 21.9 0.6 19.8 0.8 2.2 13.9 14.7 0.7 1.0 3.1 1.2 0.7 0.6 0.9 1.0 0.6 6.3 0.6 26.5 1.5 10.6 19.4 5.5 0.5 1.1 7.0 0.6 1.3 1.1 35.4 2.4 4.9 1.1 1.0 4.9 0.7 2.4 0.6 1.5 0.7 0.6 0.4 0.7 1.0 1.1 5.3 0.0 4.2 0.0 0.7 5.4 0.4 4.1 2.2 8.4 1.7 1.7 3.4 0.4 0.4 1.6 12.2 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 1.3 0.1 0.2 0.3 0.0 0.3 0.1 18.1 0.1 0.0 0.7 3.4 3.1 1.4 1.0 0.0 0.2 0.1 0.0 3.8 0.0 0.1 0.1 0.0 0.1 7.3 2.0 0.0 1.5 0.1 0.1 9.5 2.2 3.2 0.0 0.3 1.6 0.0 0.4 8.8 2.2 2.6 1.7 0.1 12.4 4.7 0.0 0.6 0.3 1.5 0.4 0.8 10.7 3.0 0.4 0.6 0.1 0.0 4.9 1.7 4.8 2.0 1.3 3.2 2.5 2.2 2.6 0.9 4.1 3.4 1.8 8.4 1.7 1.0 2.2 2.7 0.4 21.9 19.8 13.9 14.7 26.5 1.5 1.1 7.0 4.9 5.3 23.8 17.9 0.0 4.8 0.0 26.4 2.0 5.1 13.4 10.3 5.2 249.4 2.3 1.7 1.4 35.8 0.8 0.0 0.0 3.8 1.5 1.2 2.9 0.0 12.4 0.2 9.5 7.0 0.0 0.3 38.5 0.6 0.0 0.0 1.8 0.0 8.6 2.7 0.0 0.4 12.0 90.0 0.0 0.2 1.9 2.8 0.0 3.4 0.0 0.4 8.6 ADIG "MGC39724, RP5-1100H13.2, SMAF1" ENSG00000182035 Adipogenin Q0VDE8 20 38581195-38588463 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 31.4" "Group enriched" "Detected in some" 126 "Early spermatids: 391.1;Late spermatids: 1240.6" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;Hep G2: 1.2;NB-4: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA041124 Uncertain NA NA "HPA041124: AB_10795534" "unprognostic (2.97e-2)" "unprognostic (7.69e-3)" "unprognostic (2.27e-1)" "unprognostic (4.52e-3)" "unprognostic (1.34e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 7.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.1 0.0 31.4 0.1 0.1 3.2 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 391.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1240.6 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 6.5 0.0 5.6 2.7 0.0 0.0 0.0 0.0 0.0 ADIPOR1 "ACDCR1, PAQR1" ENSG00000159346 "Adiponectin receptor 1" Q96A54 1 202940823-202958572 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-1)" "unprognostic (1.58e-1)" "unprognostic (3.81e-2)" "unprognostic (2.74e-1)" "unprognostic (1.59e-1)" "unprognostic (1.22e-1)" "unprognostic (9.95e-2)" "unprognostic (4.32e-2)" "unprognostic (1.47e-1)" "prognostic favorable (5.27e-4)" "prognostic unfavorable (5.50e-4)" "unprognostic (1.13e-1)" "unprognostic (1.79e-3)" "unprognostic (5.90e-2)" "unprognostic (1.75e-1)" "unprognostic (2.84e-1)" "unprognostic (8.63e-2)" 26.8 24.8 20.4 16.4 25.9 65.7 29.6 18.1 29.0 22.2 19.3 33.2 17.1 16.2 18.0 33.7 49.1 24.8 18.5 39.6 19.8 19.5 30.5 56.8 41.5 33.6 20.7 14.3 22.6 66.2 30.4 21.6 63.1 20.2 23.1 21.6 38.3 39.7 17.9 43.5 46.1 24.4 18.2 30.2 36.9 24.8 24.9 18.3 21.9 26.6 28.6 32.1 25.0 29.3 21.6 28.8 112.6 49.9 16.0 23.4 63.8 24.9 23.8 14.6 16.0 30.5 23.5 74.4 28.0 32.7 29.1 27.0 23.7 30.3 16.7 20.8 31.7 23.3 31.0 21.7 38.4 26.4 31.5 24.7 12.8 30.2 18.8 30.1 26.5 19.5 27.8 62.6 31.6 32.3 29.1 28.6 29.5 33.0 35.5 29.3 27.2 21.9 19.5 32.0 22.5 27.3 17.5 35.4 32.3 28.2 30.0 24.0 24.8 29.6 44.2 34.4 40.8 32.1 25.7 25.5 21.5 17.0 10.5 30.8 37.5 50.8 18.9 30.8 15.3 25.1 39.6 49.9 59.9 19.7 33.5 20.4 21.6 21.0 19.3 28.8 21.4 21.0 18.4 112.6 16.0 32.3 19.9 23.4 63.8 20.4 25.9 18.1 29.0 19.8 19.5 20.7 14.3 20.2 18.3 32.8 48.6 40.6 78.1 208.7 24.6 48.9 30.6 50.9 36.4 50.6 27.5 96.5 58.0 65.0 51.8 53.4 41.2 210.2 76.0 142.7 52.5 96.6 35.9 53.5 89.9 11.1 47.2 52.8 115.1 42.9 26.4 67.3 81.0 74.9 43.5 23.3 91.5 45.6 23.0 46.9 35.3 38.8 45.3 11.6 29.6 200.0 169.6 42.7 43.1 136.7 ADIPOR2 "ACDCR2, PAQR2" ENSG00000006831 "Adiponectin receptor 2" Q86V24 12 1688574-1788678 "Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043737 Approved NA NA "HPA043737: AB_10964205" "unprognostic (1.52e-1)" "unprognostic (2.11e-1)" "unprognostic (2.44e-1)" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (1.34e-1)" "unprognostic (5.33e-2)" "unprognostic (7.66e-3)" "unprognostic (4.86e-2)" "unprognostic (1.61e-1)" "unprognostic (5.34e-3)" "unprognostic (2.29e-2)" "unprognostic (1.18e-2)" "unprognostic (1.15e-1)" "unprognostic (9.79e-2)" "unprognostic (2.00e-2)" "unprognostic (5.85e-2)" 30.6 30.5 20.8 9.6 45.6 8.0 16.9 11.7 32.9 9.2 15.7 41.4 19.0 20.2 10.4 8.3 20.1 8.9 9.4 12.2 25.8 17.2 12.3 48.0 17.5 8.5 64.9 15.7 11.5 26.8 17.1 10.8 12.1 39.1 10.8 17.0 11.7 9.0 19.0 19.5 12.2 20.3 11.5 49.5 8.1 23.9 16.6 61.6 5.8 17.2 10.7 11.5 7.8 13.6 1.8 3.2 5.7 2.3 2.0 3.2 1.0 16.0 13.4 11.3 10.4 10.7 13.0 15.1 11.8 13.8 15.5 22.1 20.0 24.9 11.4 3.8 11.0 28.0 12.5 16.7 17.2 22.3 29.3 13.9 22.3 11.3 14.2 10.7 16.8 14.4 11.3 17.4 19.5 22.6 14.2 11.1 12.4 14.6 24.8 11.4 22.8 10.9 15.3 22.6 13.4 7.2 9.1 21.4 8.6 15.4 9.5 3.4 8.1 10.9 21.3 23.9 20.4 11.9 22.0 11.1 8.8 18.8 14.0 17.1 6.0 7.5 19.0 10.7 15.3 11.9 2.0 2.3 5.7 3.2 2.3 2.7 1.6 1.8 2.9 1.8 1.8 2.4 2.5 3.2 2.0 1.9 3.2 2.5 1.0 20.8 45.6 11.7 32.9 25.8 17.2 64.9 15.7 39.1 61.6 11.9 26.7 20.0 21.3 21.1 11.7 17.7 25.5 20.1 37.5 14.0 17.7 12.3 10.0 21.6 43.1 45.1 57.8 0.0 27.2 33.3 16.0 23.5 36.8 102.4 15.9 17.5 35.9 30.1 26.3 57.7 14.7 24.1 25.3 20.8 37.8 27.1 29.0 24.3 21.2 8.9 14.7 6.5 21.7 40.6 40.9 30.1 24.5 22.4 23.0 25.3 ADORA1 RDC7 ENSG00000163485 "Adenosine A1 receptor" P30542 1 203090654-203167405 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.7" "Group enriched" "Detected in some" 4 "granulocytes: 23.0;Muller glia cells: 40.0" "Cancer enhanced" "Detected in many" "glioma: 24.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 19.7;MCF7: 11.9;RH-30: 32.7;RPTEC TERT1: 15.9;SK-BR-3: 17.7;U-138 MG: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044383 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA044383: AB_2678921" "unprognostic (3.93e-3)" "unprognostic (8.16e-2)" "unprognostic (6.16e-2)" "unprognostic (2.38e-3)" "unprognostic (2.25e-2)" "unprognostic (2.34e-1)" "unprognostic (4.64e-2)" "unprognostic (4.17e-2)" "unprognostic (3.04e-1)" "unprognostic (4.80e-3)" "unprognostic (1.42e-1)" "unprognostic (2.98e-1)" "unprognostic (2.96e-3)" "unprognostic (1.54e-1)" "unprognostic (1.27e-1)" "unprognostic (4.13e-2)" "unprognostic (5.76e-4)" 4.5 1.0 19.7 2.6 21.7 0.8 6.1 9.7 38.7 1.1 1.6 27.4 0.0 2.0 2.0 1.6 1.6 2.0 1.8 13.8 19.8 12.1 4.2 1.0 2.8 1.4 22.8 13.4 0.8 15.5 15.5 0.9 8.9 25.0 1.2 1.6 1.8 8.9 1.3 2.0 1.9 1.8 1.3 20.7 7.4 1.6 16.3 15.9 0.0 3.2 0.0 1.4 3.4 0.3 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 1.4 0.3 0.1 0.1 0.8 0.1 1.0 1.5 0.4 0.2 19.7 0.3 0.0 4.5 3.6 2.4 0.0 0.3 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.4 0.0 0.4 0.0 3.2 0.0 3.2 0.0 0.0 3.1 11.9 0.0 0.0 5.1 0.0 0.0 0.0 32.7 1.0 15.9 0.0 0.3 0.4 2.1 17.7 0.2 1.9 1.0 0.4 0.0 10.6 5.4 0.0 5.7 0.0 0.1 0.0 5.3 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 19.7 21.7 9.7 25.7 19.8 12.1 22.8 13.4 25.0 15.9 0.0 0.0 0.0 0.0 0.0 0.5 2.5 5.1 0.0 0.0 3.5 0.0 0.0 0.0 7.2 0.1 0.0 0.0 0.0 3.0 1.0 0.7 0.0 23.0 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.4 1.7 0.0 0.0 40.0 0.5 0.0 0.7 1.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 ADORA2A "ADORA2, RDC8" ENSG00000128271 "Adenosine A2a receptor" P29274 22 24417879-24442360 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 22.8;bone marrow: 28.1;brain: 43.9;lymphoid tissue: 59.0" "Cell type enriched" "Detected in single" 25 "monocytes: 19.0" "Not detected" "Not detected" "Region enriched" "Detected in all" 8 "basal ganglia: 43.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 15.4;Karpas-707: 21.2;RPMI-8226: 15.0;SK-BR-3: 30.4;U-266/70: 21.2;U-266/84: 27.7;U-698: 21.7" "Region enriched" "Detected in some" 10 "basal ganglia: 357.5" "Region enriched" "Detected in single" 92 "basal ganglia: 166.0" "CAB001943, HPA065566, HPA075997" Enhanced Supported NA NA "CAB001943: , HPA065566: , HPA075997: AB_2732298" "unprognostic (7.30e-2)" "unprognostic (2.42e-2)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (7.44e-2)" "unprognostic (1.88e-3)" "unprognostic (9.85e-2)" "unprognostic (3.63e-1)" "unprognostic (2.88e-2)" "unprognostic (4.57e-3)" "unprognostic (2.15e-3)" "unprognostic (1.87e-3)" "unprognostic (6.81e-4)" "unprognostic (1.50e-1)" "unprognostic (9.78e-3)" "unprognostic (1.30e-1)" "unprognostic (7.10e-3)" 1.0 2.4 1.9 10.4 43.9 28.1 1.5 3.4 3.8 0.8 2.0 1.7 0.3 5.4 1.4 1.4 1.0 0.9 2.4 3.5 2.4 1.8 3.5 4.3 5.1 14.8 2.6 1.6 1.2 0.8 0.0 2.1 1.4 2.3 1.6 0.8 3.3 2.7 1.5 1.2 0.9 2.6 0.7 1.3 7.5 2.8 2.0 5.7 59.0 1.3 0.9 8.6 3.8 1.3 17.7 1.1 13.7 9.0 2.2 22.8 11.2 0.2 0.3 0.4 0.1 0.2 0.1 0.4 0.2 9.5 0.5 1.0 1.7 0.1 15.4 1.0 0.3 1.0 0.3 0.9 0.0 0.0 1.8 2.7 0.2 0.0 2.2 0.2 0.3 7.7 0.1 0.0 2.9 0.0 0.2 3.4 2.2 0.1 21.2 0.0 0.2 5.3 1.6 0.6 2.0 0.0 0.2 0.7 15.0 0.0 0.1 1.5 8.9 0.4 30.4 0.1 0.4 0.4 1.5 0.2 0.9 1.5 0.2 0.1 21.2 27.7 21.7 4.8 5.2 0.1 3.0 0.8 4.8 8.6 2.6 20.1 9.6 16.1 16.9 1.1 17.7 22.8 18.3 13.7 2.2 9.0 1.1 21.4 11.2 1.9 43.9 3.4 3.8 2.4 1.8 2.6 1.6 2.3 5.7 0.0 0.3 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADORA2B ENSG00000170425 "Adenosine A2b receptor" P29275 17 15944917-15975746 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 65.4;Suprabasal keratinocytes: 56.2;Urothelial cells: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.8;myeloid DC: 8.4" "Group enriched" "Detected in many" 86 "dendritic cells: 8.4;granulocytes: 12.8;monocytes: 4.5" "Cell line enhanced" "Detected in many" "GAMG: 50.2;HMC-1: 50.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073747 Uncertain Cytosol NA NA Cytosol "HPA073747: " "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (4.68e-1)" "unprognostic (7.88e-3)" "unprognostic (2.64e-4)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "unprognostic (1.38e-1)" "unprognostic (1.66e-9)" "unprognostic (2.07e-1)" "unprognostic (3.49e-1)" "unprognostic (1.50e-2)" "unprognostic (2.84e-1)" 1.5 1.5 7.6 4.5 9.1 1.6 1.8 7.3 8.7 2.9 15.3 2.4 0.0 0.8 1.7 1.5 11.1 2.2 3.8 1.2 6.6 3.0 0.6 0.7 4.1 1.0 1.9 5.4 0.6 2.8 0.4 1.9 9.0 5.2 1.7 12.8 10.5 1.9 0.7 0.7 10.4 1.6 2.8 3.9 0.7 2.6 0.7 2.6 0.1 0.6 4.4 4.5 6.8 5.6 0.0 8.4 12.8 4.5 0.0 0.0 1.5 10.0 5.5 0.1 0.2 1.8 3.5 0.2 1.9 8.7 5.7 7.1 2.6 10.5 1.3 2.4 1.7 50.2 15.8 2.4 14.5 7.6 2.8 5.5 9.7 1.8 3.8 7.1 0.0 50.7 2.0 6.2 8.1 18.9 9.8 2.8 1.5 0.4 0.0 5.6 2.6 0.6 1.9 0.6 21.6 7.8 0.0 0.1 0.0 5.8 2.7 0.2 0.3 4.3 1.0 2.6 4.3 0.0 1.5 2.4 2.0 5.4 5.6 9.0 0.8 0.0 0.0 8.1 0.0 2.8 12.8 4.0 2.6 0.0 4.5 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.4 0.0 2.3 0.1 0.0 1.5 7.6 9.1 7.3 8.7 6.6 3.0 1.9 5.4 5.2 2.6 3.0 3.4 0.0 12.7 65.4 0.0 1.2 2.5 8.1 7.9 0.0 0.0 10.1 0.0 6.2 0.3 0.6 4.9 0.0 0.8 2.8 6.1 11.9 0.0 0.0 4.6 0.0 2.4 0.0 2.7 0.0 0.0 5.1 6.8 0.0 1.4 7.4 0.8 4.8 0.0 0.0 0.5 0.0 1.9 0.5 1.2 56.2 5.1 0.0 3.7 26.7 ADORA3 AD026 ENSG00000282608 "Adenosine A3 receptor" P0DMS8 1 111499429-111503760 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 88.6;brain: 25.5" "Cell type enhanced" "Detected in some" 26 "Hofbauer cells: 17.7;Kupffer cells: 53.6;Late spermatids: 12.4" "Cell type enriched" "Detected in some" 40 "eosinophil: 88.6" "Lineage enriched" "Detected in many" 40 "granulocytes: 88.6" "Cell line enriched" "Detected in some" 9 "HMC-1: 48.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 5.2 13.4 8.7 3.1 12.0 0.0 4.5 1.0 6.7 3.7 5.2 10.3 0.0 3.5 0.5 1.0 1.8 2.8 4.8 1.6 7.5 1.9 2.1 2.8 3.8 17.7 2.2 1.2 1.0 0.9 1.2 2.0 12.1 1.0 4.2 2.7 1.1 1.9 0.5 0.0 7.9 3.8 25.5 1.5 2.2 1.1 13.3 0.4 0.5 0.0 1.9 3.4 0.0 0.0 2.2 88.6 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 88.6 0.0 0.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.3 0.4 0.0 0.3 0.0 0.0 0.9 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 0.0 0.2 0.0 6.9 0.0 17.7 0.0 0.0 2.5 53.6 12.4 0.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 ADPRM "C17orf48, MDS006" ENSG00000170222 "ADP-ribose/CDP-alcohol diphosphatase, manganese dependent" Q3LIE5 17 10697594-10711233 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023265, HPA023820" Approved NA NA "HPA023265: AB_1845590, HPA023820: AB_1845591" "unprognostic (7.58e-3)" "prognostic favorable (1.69e-4)" "unprognostic (1.42e-1)" "prognostic favorable (2.38e-5)" "unprognostic (2.49e-1)" "unprognostic (1.30e-1)" "unprognostic (1.31e-1)" "unprognostic (1.35e-1)" "unprognostic (1.43e-2)" "unprognostic (1.43e-1)" "unprognostic (6.26e-3)" "unprognostic (2.97e-1)" "unprognostic (6.53e-3)" "unprognostic (2.65e-2)" "unprognostic (1.83e-1)" "unprognostic (4.77e-2)" "unprognostic (5.97e-2)" 11.1 8.2 6.4 9.3 13.1 12.9 13.0 9.8 12.2 10.3 8.1 10.1 16.1 6.6 11.3 9.1 7.8 9.0 7.9 6.4 9.6 6.1 7.8 15.2 6.9 23.2 8.1 5.6 14.2 12.4 4.2 11.9 4.9 9.3 16.7 7.5 8.3 8.8 13.4 14.8 9.2 9.9 6.5 7.3 10.5 12.2 9.5 8.2 18.8 14.6 10.4 11.1 8.8 9.0 10.5 4.2 6.1 3.5 4.0 18.7 5.9 4.1 2.2 4.5 5.3 10.5 13.6 2.3 7.9 8.8 5.8 8.7 1.4 2.0 8.1 4.3 8.3 3.0 3.4 1.9 5.7 6.9 5.1 5.3 5.9 3.7 4.5 18.8 3.0 5.5 15.6 10.4 6.1 9.0 10.7 10.1 8.3 4.0 1.5 8.3 1.1 3.9 5.4 3.7 3.0 2.1 3.4 5.3 2.4 10.1 3.1 1.0 6.4 4.2 1.6 9.8 4.9 3.8 6.0 10.3 4.0 2.4 4.5 5.2 2.0 1.4 2.4 7.9 4.5 6.7 3.4 3.5 6.1 3.2 3.0 5.4 8.2 8.8 5.8 4.2 10.5 18.7 12.0 2.5 4.0 3.1 2.4 7.7 5.9 6.4 13.1 9.8 12.2 9.6 6.1 8.1 5.6 9.3 8.2 3.0 1.3 31.2 12.3 4.6 10.4 2.2 2.5 2.7 5.7 1.8 17.7 6.0 3.3 7.7 6.0 6.0 5.1 0.0 7.3 5.7 5.4 10.1 13.9 7.8 5.8 3.2 4.6 4.3 5.1 4.1 14.7 7.9 10.1 10.8 7.4 13.2 7.7 3.5 7.8 6.1 33.4 6.5 10.3 9.2 9.2 4.1 6.9 10.0 4.7 8.9 ADRA1A "ADRA1C, ADRA1L1" ENSG00000120907 "Adrenoceptor alpha 1A" P35348 8 26748150-26867273 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.1" "Group enriched" "Detected in some" 15 "Early spermatids: 50.8;Hepatocytes: 14.0;Late spermatids: 20.6" "Cancer enhanced" "Detected in some" "liver cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 1.3;HAP1: 1.7;JURKAT: 2.0;NTERA-2: 2.3;U-2 OS: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029678, HPA029679, HPA076693" Approved Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: " "unprognostic (1.27e-1)" "unprognostic (1.68e-2)" "unprognostic (1.99e-1)" "unprognostic (3.57e-1)" "unprognostic (5.04e-4)" "unprognostic (1.97e-1)" "unprognostic (9.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.58e-2)" "unprognostic (7.47e-2)" "unprognostic (1.71e-2)" "unprognostic (6.06e-3)" "unprognostic (7.41e-2)" "unprognostic (1.52e-2)" "unprognostic (1.30e-1)" 14.5 0.7 7.1 1.1 3.9 0.3 3.4 6.2 4.9 0.9 1.5 5.9 4.9 1.0 1.8 2.0 0.9 0.6 0.5 10.1 11.6 2.0 0.8 45.1 3.9 1.4 4.7 4.7 1.0 0.5 0.3 0.6 0.3 3.8 10.2 0.7 0.6 4.6 11.2 0.6 0.9 1.3 2.4 1.9 7.0 1.2 0.5 4.2 0.0 0.6 0.1 0.6 0.6 0.7 0.3 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 7.1 3.9 6.2 4.9 11.6 2.0 4.7 4.7 3.8 4.2 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 1.3 0.0 20.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ADRA1B ENSG00000170214 "Adrenoceptor alpha 1B" P35368 5 159865080-159972544 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.6;liver: 20.3;lymphoid tissue: 17.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 13.2;HaCaT: 6.7;TIME: 11.1;U-2 OS: 9.3;U-251 MG: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074416 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA074416: AB_2686688" "unprognostic (4.93e-3)" "unprognostic (2.94e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (6.00e-5)" "prognostic unfavorable (6.98e-4)" "unprognostic (4.08e-3)" "unprognostic (1.67e-3)" "unprognostic (1.68e-1)" "unprognostic (6.12e-2)" "prognostic favorable (2.67e-4)" "unprognostic (2.28e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.40e-6)" "unprognostic (5.24e-4)" "unprognostic (2.54e-1)" "prognostic favorable (3.19e-5)" "unprognostic (1.59e-2)" 5.3 2.9 5.3 0.9 9.0 0.4 2.3 1.3 21.6 0.9 1.2 0.7 0.8 1.2 1.5 3.6 1.1 3.6 1.3 3.3 6.2 5.8 7.4 20.3 4.7 2.3 1.2 13.9 6.2 0.8 1.0 0.8 1.1 5.2 1.6 1.1 0.9 1.0 1.9 1.6 1.3 1.7 1.2 0.9 17.4 0.9 0.8 0.5 0.0 2.0 0.0 1.1 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.7 0.3 0.0 2.4 0.9 0.1 0.5 0.2 0.6 0.3 0.0 4.3 0.0 13.2 3.9 5.2 6.7 0.0 0.6 0.3 0.0 0.3 0.0 1.7 0.0 5.1 0.0 0.0 2.8 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.7 0.0 4.5 0.0 0.4 0.0 0.0 0.3 0.4 2.3 0.1 0.0 11.1 0.1 9.3 0.0 7.1 0.0 0.0 0.0 3.4 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 9.0 1.3 21.6 6.2 5.8 1.2 13.9 5.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADRA1D "ADRA1, ADRA1A, ADRA1R" ENSG00000171873 "Adrenoceptor alpha 1D" P25100 20 4220631-4249074 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7" "Cell type enhanced" "Detected in single" 18 "Smooth muscle cells: 1.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "cerebral cortex: 7.4;hippocampal formation: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.8;BJ: 12.0;CAPAN-2: 5.4;fHDF/TERT166: 7.1" "Group enriched" "Detected in many" 4 "cerebral cortex: 23.5;hippocampal formation: 31.8;olfactory region: 11.0" "Low region specificity" "Detected in many" HPA038789 Uncertain NA NA "HPA038789: AB_10673475" "unprognostic (5.37e-2)" "unprognostic (4.65e-1)" "unprognostic (8.73e-2)" "unprognostic (7.75e-11)" "unprognostic (7.83e-3)" "unprognostic (1.54e-2)" "unprognostic (7.62e-2)" "unprognostic (7.82e-4)" "unprognostic (4.41e-3)" "unprognostic (8.37e-2)" "unprognostic (6.09e-2)" "unprognostic (7.24e-3)" "unprognostic (7.71e-7)" "unprognostic (5.21e-3)" "unprognostic (2.76e-1)" "unprognostic (6.01e-3)" "unprognostic (3.32e-5)" 2.5 1.1 1.9 0.5 2.8 0.3 1.0 0.1 7.4 9.1 2.4 1.4 1.1 0.6 4.7 1.8 0.9 3.5 1.2 0.4 17.7 1.7 0.5 0.4 2.9 1.5 0.5 1.1 1.0 1.2 0.4 0.0 0.7 2.9 8.8 1.0 0.0 0.8 6.0 1.2 0.4 0.8 1.6 0.5 3.6 2.5 1.5 0.0 0.0 0.9 0.0 0.4 3.3 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.0 12.0 2.1 0.8 0.3 0.5 5.4 0.0 0.0 7.1 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.8 0.1 7.4 17.7 1.7 0.5 1.1 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 ADRA2A "ADRA2, ADRA2R, ADRAR" ENSG00000150594 "Adrenoceptor alpha 2A" P08913 10 111077163-111080907 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 84.9" "Cell type enhanced" "Detected in many" 21 "Cholangiocytes: 63.7;Paneth cells: 72.4;Smooth muscle cells: 182.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 8.2;ASC TERT1: 10.1;HEL: 14.8;HeLa: 8.0;HSkMC: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.87e-2)" "unprognostic (1.63e-2)" "unprognostic (1.38e-1)" "prognostic favorable (8.06e-4)" "unprognostic (1.36e-2)" "unprognostic (1.04e-1)" "unprognostic (4.78e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-1)" "unprognostic (4.64e-3)" "unprognostic (5.86e-2)" "unprognostic (5.63e-2)" "unprognostic (3.08e-6)" "unprognostic (1.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.35e-2)" "unprognostic (1.89e-3)" 29.9 1.3 1.4 8.0 1.8 0.2 25.4 4.3 8.1 28.2 7.5 0.7 3.0 8.5 12.4 3.9 2.1 2.6 84.9 5.6 1.7 4.0 3.8 1.1 2.8 18.8 1.5 2.3 15.5 26.2 1.5 1.7 3.4 3.8 10.4 3.5 2.2 4.8 7.4 1.5 6.8 4.9 5.7 1.1 32.2 3.5 3.5 0.0 0.0 5.9 7.1 16.6 9.8 15.9 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 8.2 10.1 0.0 0.0 0.0 0.9 1.9 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 14.8 8.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 1.4 1.8 4.3 8.1 1.7 4.0 1.5 2.3 3.8 0.0 0.0 2.2 0.0 0.4 9.2 0.0 1.4 63.7 0.0 2.3 0.0 0.0 0.1 0.0 1.1 2.6 0.6 5.4 0.0 3.1 0.1 5.2 0.7 6.9 0.0 0.1 0.0 11.9 0.6 0.3 1.0 20.8 0.0 27.0 0.0 1.2 0.0 0.3 72.4 4.6 0.3 0.0 6.5 182.3 2.7 0.1 5.4 0.1 0.0 9.2 0.6 ADRA2B "ADRA2L1, ADRA2RL1, ADRARL1" ENSG00000274286 "Adrenoceptor alpha 2B" P18089 2 96112875-96116245 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.1;EFO-21: 3.3;HAP1: 1.8;NTERA-2: 1.8;SuSa: 3.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA066029, HPA074948" Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA066029: AB_2685599, HPA074948: " "unprognostic (6.16e-2)" "unprognostic (1.31e-2)" "unprognostic (1.76e-2)" "unprognostic (4.93e-4)" "unprognostic (1.84e-2)" "unprognostic (5.24e-2)" "unprognostic (6.80e-5)" "unprognostic (4.85e-2)" "unprognostic (1.69e-1)" "unprognostic (3.16e-2)" "unprognostic (8.34e-2)" "unprognostic (2.54e-1)" "unprognostic (2.21e-1)" "unprognostic (4.43e-2)" "unprognostic (3.39e-1)" "unprognostic (1.36e-1)" "unprognostic (6.55e-2)" 4.9 2.2 0.3 0.4 2.2 1.2 8.1 0.1 0.7 4.5 4.0 1.9 0.2 0.5 1.3 7.5 4.3 0.8 3.2 6.1 0.5 2.9 7.5 0.3 0.2 4.4 0.0 5.0 2.3 1.0 0.0 1.3 3.3 3.3 0.4 0.9 1.8 2.9 8.0 0.3 1.2 2.1 0.6 4.8 0.7 2.6 1.9 0.0 2.1 1.8 0.0 3.8 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.3 0.0 0.3 0.2 1.8 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.7 0.0 0.1 1.8 0.1 0.3 0.0 0.0 0.4 0.0 0.3 1.4 0.0 0.0 1.2 0.0 3.1 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 2.0 0.0 1.4 1.2 1.8 0.0 0.4 0.0 0.2 0.0 0.7 0.0 0.0 0.5 0.1 0.4 0.9 0.0 0.0 0.3 0.0 2.4 3.1 0.3 0.0 1.7 0.9 1.7 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 32.3 8.0 0.0 0.2 1.3 0.3 0.0 0.0 0.3 ADRA2C "ADRA2L2, ADRA2RL2, ADRARL2" ENSG00000184160 "Adrenoceptor alpha 2C" P18825 4 3766348-3768526 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 35.1" "Cell type enhanced" "Detected in some" 13 "Collecting duct cells: 12.2;Muller glia cells: 5.2;Smooth muscle cells: 4.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "basal ganglia: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 11.1;MCF7: 18.4;NTERA-2: 6.5;OE19: 7.3;SCLC-21H: 7.1;SH-SY5Y: 8.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "basal ganglia: 41.4" HPA057688 Uncertain NA NA "HPA057688: AB_2683503" "unprognostic (1.44e-2)" "unprognostic (2.21e-3)" "unprognostic (1.23e-1)" "unprognostic (2.02e-2)" "unprognostic (4.70e-2)" "unprognostic (1.11e-1)" "unprognostic (7.12e-2)" "unprognostic (6.69e-2)" "unprognostic (1.88e-1)" "unprognostic (3.71e-1)" "unprognostic (3.24e-2)" "unprognostic (9.08e-3)" "unprognostic (1.01e-2)" "unprognostic (6.00e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (6.48e-2)" 6.5 2.4 2.1 1.0 9.8 0.4 9.2 0.5 2.6 35.1 1.5 0.6 12.8 1.0 20.3 18.0 2.1 6.4 5.5 3.0 1.2 1.0 9.2 1.3 2.0 1.2 0.7 1.6 7.6 4.1 0.5 4.2 27.6 1.1 7.3 0.6 3.6 0.8 24.6 2.6 2.1 0.9 3.0 0.7 7.5 0.7 6.2 2.0 0.2 0.8 1.9 0.5 2.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.1 0.5 0.0 0.2 0.4 0.0 0.0 0.0 2.0 1.2 0.0 2.1 0.3 0.7 0.0 0.2 0.0 0.0 0.0 5.7 0.0 0.0 11.1 0.6 0.0 0.8 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.7 18.4 0.0 0.0 6.5 7.3 0.0 0.0 6.0 0.0 0.0 0.3 7.1 8.5 2.5 0.0 0.1 1.7 6.1 0.1 0.0 0.0 4.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 9.8 0.5 1.4 1.2 1.0 0.7 1.6 1.1 2.0 0.0 0.0 0.0 0.1 0.0 1.4 0.9 2.5 0.0 0.0 12.2 0.0 0.8 3.3 0.4 0.0 0.5 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.3 3.2 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.2 0.2 0.0 3.5 1.8 0.0 0.0 4.1 0.0 0.7 0.0 1.4 0.0 0.0 0.1 ADRB1 ADRB1R ENSG00000043591 "Adrenoceptor beta 1" P08588 10 114044056-114046908 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.0;placenta: 41.7" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 80.0;Cytotrophoblasts: 56.3;Sertoli cells: 51.8;Syncytiotrophoblasts: 32.2" "Cancer enriched" "Detected in many" 10 "prostate cancer: 12.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 10.2;PC-3: 4.0;THP-1: 6.9;TIME: 8.9;U-937: 5.2" "Group enriched" "Detected in many" 4 "amygdala: 10.0;basal ganglia: 7.3;cerebral cortex: 17.1;hippocampal formation: 11.3;thalamus: 6.9" "Low region specificity" "Detected in many" HPA067972 Enhanced NA NA "HPA067972: AB_2685936" "unprognostic (1.45e-3)" "unprognostic (1.18e-3)" "unprognostic (1.44e-1)" "unprognostic (4.92e-2)" "unprognostic (3.22e-1)" "unprognostic (8.88e-2)" "unprognostic (9.28e-2)" "unprognostic (3.52e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-2)" "unprognostic (2.77e-4)" "unprognostic (1.33e-1)" "unprognostic (7.80e-3)" "unprognostic (1.53e-1)" "unprognostic (1.85e-1)" "unprognostic (1.59e-2)" "unprognostic (1.44e-1)" 4.3 1.0 6.9 1.1 14.0 1.3 5.9 1.0 10.7 0.8 3.1 0.8 0.0 1.8 0.9 0.9 1.9 0.8 0.9 48.0 5.6 2.4 1.7 2.5 18.3 0.9 3.5 4.4 0.8 2.4 0.9 1.2 41.7 2.6 6.5 1.6 4.5 10.7 0.8 3.1 0.9 2.3 0.9 1.3 1.7 1.4 1.0 2.5 0.0 1.0 0.0 1.1 1.1 0.4 1.4 1.9 0.1 1.3 0.0 0.5 0.1 2.1 1.3 0.2 1.3 0.0 0.0 0.3 0.1 0.1 0.2 0.2 0.5 1.6 0.3 0.4 0.0 0.6 0.4 0.1 0.1 0.3 10.2 0.6 0.4 0.2 0.2 0.0 0.4 0.7 0.0 1.1 0.0 2.1 0.2 0.3 1.6 0.1 0.1 0.2 1.2 1.6 1.4 0.5 0.3 4.0 0.3 0.4 0.1 0.0 1.7 0.2 0.4 0.0 0.8 0.1 0.5 0.3 6.9 8.9 0.3 0.1 0.2 0.2 0.0 0.1 0.5 0.0 5.2 0.2 0.0 1.3 0.0 0.5 0.9 0.0 0.6 0.1 0.3 1.9 1.4 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.1 6.9 14.0 1.0 10.7 5.6 2.4 3.5 4.4 2.6 2.5 17.9 8.5 0.0 4.2 0.9 4.7 80.0 5.1 12.0 13.6 0.0 0.0 56.3 1.7 0.0 0.1 0.7 0.0 0.0 0.2 2.1 3.7 7.1 0.0 0.2 3.9 12.7 0.0 0.6 2.4 0.0 0.0 0.6 1.7 0.0 3.1 0.7 0.1 0.3 0.4 0.0 1.2 51.8 0.8 0.5 0.0 0.0 32.2 1.5 0.4 3.1 ADRB2 "ADRB2R, ADRBR, B2AR, BAR" ENSG00000169252 "Adrenoceptor beta 2" P07550 5 148825245-148828687 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.6" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 104.2;Basal keratinocytes: 344.2;granulocytes: 116.5;Suprabasal keratinocytes: 214.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 24.5;hTERT-HME1: 25.4;PC-3: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003431, HPA075322" Uncertain Uncertain Cytosol NA NA Cytosol "HPA003431: AB_1845333, HPA075322: " "unprognostic (2.28e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (9.35e-3)" "unprognostic (5.54e-2)" "unprognostic (2.34e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-2)" "unprognostic (2.23e-1)" "prognostic favorable (3.15e-9)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.49e-1)" "unprognostic (7.65e-2)" 11.7 0.2 0.7 0.9 0.4 4.6 13.8 0.0 0.3 6.1 0.9 0.3 0.9 0.2 6.4 1.4 1.1 2.8 0.7 0.3 0.2 6.0 8.5 1.1 0.9 0.0 0.0 0.5 0.0 4.0 3.8 0.7 3.3 0.1 4.4 15.9 1.3 1.2 1.0 3.7 2.9 0.0 0.5 2.0 2.3 5.4 4.8 6.1 14.0 10.8 7.3 34.6 9.6 7.6 0.0 0.0 0.0 0.3 0.0 0.0 1.5 4.4 2.0 2.3 0.0 3.3 0.0 2.1 0.4 7.4 6.8 0.0 9.2 2.3 0.0 0.2 0.0 1.6 0.0 0.2 0.0 3.8 0.0 24.5 0.6 25.4 1.7 0.9 0.0 0.0 2.9 5.3 0.0 0.0 4.2 0.1 0.0 10.5 2.2 1.4 4.3 1.1 1.9 0.0 0.0 1.8 0.2 0.6 0.9 0.0 2.3 4.1 0.0 1.8 2.5 1.1 0.7 0.0 0.1 0.0 5.0 0.8 3.5 4.7 14.0 34.6 7.8 25.7 4.8 8.2 20.9 5.3 3.0 1.4 12.9 7.6 7.3 10.8 6.1 0.4 9.6 104.2 33.5 11.1 31.2 344.2 0.2 12.4 0.0 8.1 33.0 0.0 0.0 0.3 0.0 1.4 0.2 17.5 0.0 0.0 0.2 0.2 6.1 16.2 116.5 11.9 14.7 0.0 2.9 6.7 12.7 0.4 0.0 16.5 28.7 1.0 1.4 3.5 5.3 0.0 0.0 0.0 4.8 0.0 3.6 0.0 0.0 214.5 0.5 35.5 0.8 48.5 ADRB3 ENSG00000188778 "Adrenoceptor beta 3" P13945 8 37962991-37966965 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 23.9;ovary: 15.7;smooth muscle: 10.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "amygdala: 1.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 2.4;Karpas-707: 1.0;U-2 OS: 1.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA061969 Uncertain NA NA "HPA061969: AB_2732674" "unprognostic (1.70e-1)" "unprognostic (2.24e-1)" "unprognostic (6.64e-3)" "unprognostic (5.41e-1)" "unprognostic (1.07e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (9.49e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-3)" "unprognostic (3.77e-2)" "unprognostic (2.29e-8)" "unprognostic (1.10e-3)" "unprognostic (2.81e-2)" "unprognostic (5.37e-2)" "unprognostic (6.06e-3)" 0.4 0.1 1.3 1.9 0.3 0.3 0.3 0.0 0.8 1.6 2.3 0.0 0.0 0.4 0.9 1.9 1.7 5.3 23.9 0.1 0.2 0.1 0.1 0.0 0.2 1.2 0.0 0.0 15.7 0.0 0.0 0.0 4.7 0.0 4.1 0.4 0.0 0.0 0.1 0.0 0.1 0.9 10.8 0.0 0.0 3.0 0.2 0.0 0.0 0.0 0.0 0.1 9.9 1.5 0.9 0.2 1.2 0.4 0.8 0.5 0.0 0.2 0.2 0.1 0.1 0.3 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 2.4 0.4 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.3 0.2 1.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.2 0.1 0.4 0.4 0.4 1.3 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.0 1.0 0.3 0.3 0.1 0.1 0.4 0.7 0.2 0.1 0.0 0.9 0.2 0.2 1.2 0.8 0.4 0.2 0.5 0.0 1.3 0.3 0.0 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 ADSSL1 FLJ38602 ENSG00000185100 "Adenylosuccinate synthase like 1" Q8N142 14 104724186-104747325 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 200.5;tongue: 53.2" "Cell type enhanced" "Detected in many" 21 "Cardiomyocytes: 119.6;Early spermatids: 397.7;Late spermatids: 83.9;Muller glia cells: 76.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 12.0;MCF7: 10.6;OE19: 17.0;SiHa: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 220000 "unprognostic (2.23e-2)" "unprognostic (3.15e-1)" "unprognostic (1.72e-3)" "unprognostic (5.14e-2)" "unprognostic (2.81e-3)" "unprognostic (3.46e-1)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (2.26e-1)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (2.33e-1)" "unprognostic (2.35e-1)" "unprognostic (2.18e-2)" "unprognostic (2.78e-2)" 2.5 1.1 0.8 0.5 1.8 0.4 0.9 0.3 1.2 0.8 0.7 3.4 0.3 0.8 0.9 3.5 3.9 1.5 2.2 27.8 1.2 1.5 2.9 7.2 0.7 0.5 3.3 0.4 0.8 1.7 1.9 2.2 1.6 2.0 1.9 0.6 4.6 3.2 1.1 200.5 1.3 0.8 1.0 2.1 0.5 1.2 3.4 2.0 0.0 1.7 53.2 2.8 6.1 3.8 0.0 0.4 1.2 2.1 0.0 0.5 0.0 0.1 2.5 1.8 5.5 1.3 0.8 0.6 0.7 1.0 0.2 0.5 0.2 1.9 0.0 12.0 0.6 0.4 1.0 0.1 0.4 0.4 0.8 0.4 0.0 5.9 0.8 1.4 0.0 4.7 2.6 1.8 0.0 2.0 2.1 0.3 0.2 2.1 0.0 0.9 10.6 0.0 0.5 1.6 17.0 1.1 0.1 0.2 0.6 0.4 1.3 1.6 3.3 17.8 0.8 2.4 1.5 5.6 1.5 0.6 0.1 0.5 1.2 0.0 3.5 2.5 0.0 1.7 0.8 1.2 0.0 0.1 1.2 0.5 2.1 0.0 0.0 0.1 0.4 0.4 0.0 0.4 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.8 1.8 0.3 1.2 1.2 1.5 3.3 0.4 2.0 2.0 3.0 0.3 0.0 5.2 4.6 3.5 119.6 2.5 14.7 2.3 3.5 0.0 2.8 6.6 2.1 397.7 3.1 3.2 0.0 4.3 1.4 4.7 3.6 0.0 12.8 3.0 4.8 9.2 7.4 2.2 83.9 8.1 2.6 10.1 1.8 2.5 76.5 2.0 3.5 17.3 14.6 2.6 12.9 3.1 35.8 21.6 5.3 1.3 1.7 1.7 7.1 ADTRP "AIG1L, C6orf105, dJ413H6.1" ENSG00000111863 "Androgen dependent TFPI regulating protein" Q96IZ2 6 11712054-11807046 "Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 109.7;Enterocytes: 113.2;Late spermatids: 127.1;Paneth cells: 73.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "pons and medulla: 12.4" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 10.5;T-reg: 9.8" "Lineage enriched" "Detected in many" 7 "T-cells: 10.5" "Cell line enhanced" "Detected in some" "hTERT-HME1: 10.5;HUVEC TERT2: 35.9;RPMI-8226: 13.5;TIME: 19.4;U-138 MG: 12.9;U-266/84: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA048113 Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA048113: AB_2680268" "unprognostic (6.82e-3)" "unprognostic (1.41e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-3)" "unprognostic (3.04e-3)" "unprognostic (1.41e-2)" "unprognostic (4.00e-2)" "unprognostic (1.77e-1)" "unprognostic (1.85e-2)" "unprognostic (2.72e-1)" "unprognostic (5.41e-3)" "unprognostic (2.90e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (2.61e-2)" "unprognostic (1.40e-1)" "unprognostic (1.95e-2)" "unprognostic (1.26e-1)" 0.8 0.4 0.6 10.6 0.8 0.0 0.9 0.3 2.1 0.4 21.8 1.5 48.3 22.4 0.4 4.0 0.9 0.5 0.3 0.5 1.2 0.4 3.8 1.0 3.9 2.0 0.4 1.1 0.4 0.6 0.8 0.3 0.3 12.4 1.7 16.2 38.0 0.7 48.0 0.4 12.7 61.2 0.5 0.4 1.0 11.4 14.1 0.1 0.8 0.7 0.6 3.2 2.7 0.5 0.2 0.2 1.4 0.3 0.1 10.5 1.5 1.7 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.3 0.5 0.3 1.6 0.8 0.0 0.7 0.3 1.1 0.7 0.0 4.8 0.6 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 8.9 3.6 10.5 7.5 35.9 0.2 8.6 0.0 1.2 0.0 0.0 0.2 0.1 0.0 2.5 0.0 0.1 13.5 0.7 0.1 0.0 0.1 0.6 0.0 0.3 1.3 0.0 0.3 19.4 12.9 0.9 0.3 1.0 0.5 15.2 0.0 2.7 0.5 0.1 1.4 0.1 0.0 0.0 0.3 2.3 0.2 2.8 0.2 0.1 0.1 10.5 0.8 0.2 0.1 0.2 0.2 9.8 1.5 0.6 0.8 0.3 2.1 1.2 0.4 0.4 1.1 12.4 0.1 0.0 1.4 1.5 0.2 4.5 0.0 0.0 0.0 0.0 3.4 5.2 0.0 0.1 44.7 0.7 109.7 0.1 113.2 23.3 2.2 0.1 1.0 0.5 5.7 0.0 8.9 0.0 5.2 0.0 0.3 127.1 1.7 1.3 1.7 47.7 36.6 0.0 5.0 73.7 0.7 0.0 0.0 0.0 1.0 1.5 0.8 5.0 0.1 5.7 46.8 0.4 AF241726.2 ENSG00000250349 X 37349330-38687674 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 17.4;skeletal muscle: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.4;HDLM-2: 1.2;HEK 293: 1.4;JURKAT: 5.6" HPA003140 Uncertain NA NA "HPA003140: AB_1078454" 2.7 1.9 3.3 1.7 10.2 1.8 1.9 2.1 6.1 1.7 1.9 17.4 1.3 1.7 1.7 1.7 1.8 1.7 1.7 2.1 3.7 1.9 2.2 2.0 2.1 1.7 14.9 4.1 1.9 1.8 1.7 1.7 3.7 9.9 1.8 1.7 0.6 1.8 1.7 16.5 1.8 1.8 1.7 12.2 1.9 1.7 1.7 11.1 0.0 2.0 0.5 1.7 1.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 1.4 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 5.6 0.2 0.0 0.3 0.0 0.8 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.4 0.0 1.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.3 10.2 2.1 6.1 3.7 1.9 14.9 4.1 9.9 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AFG3L2 "SCA28, SPAX5" ENSG00000141385 "AFG3 like matrix AAA peptidase subunit 2" Q9Y4W6 18 12328944-12377314 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004479, HPA004480" Enhanced Supported Mitochondria NA NA Mitochondria "HPA004479: AB_1078109, HPA004480: AB_1078108" "unprognostic (1.11e-1)" "unprognostic (7.49e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (1.31e-1)" "unprognostic (5.06e-3)" "unprognostic (1.61e-1)" "unprognostic (2.33e-1)" "unprognostic (5.35e-2)" "unprognostic (1.54e-2)" "unprognostic (4.05e-2)" "unprognostic (3.00e-2)" "prognostic favorable (6.05e-14)" "unprognostic (5.90e-2)" "unprognostic (9.41e-2)" "unprognostic (5.74e-3)" "unprognostic (2.22e-1)" 11.5 15.8 11.8 14.3 14.0 11.7 19.9 17.2 30.3 11.2 25.7 9.5 12.7 33.1 11.4 10.1 18.3 10.4 11.2 77.4 13.2 13.1 27.2 22.9 16.3 23.7 12.0 13.2 12.0 23.1 34.3 12.6 9.9 16.9 10.8 23.5 12.2 14.9 14.8 61.0 17.5 35.0 15.1 14.0 9.9 16.0 8.9 7.1 10.7 16.9 22.4 13.2 14.0 11.6 10.1 15.8 8.5 12.3 19.9 15.2 8.4 15.0 15.4 11.0 12.4 12.7 14.0 14.7 16.9 16.8 24.2 17.8 23.8 9.3 43.4 18.6 15.3 21.5 15.2 27.8 19.4 19.8 10.1 11.9 13.0 16.9 22.3 17.4 48.9 19.5 15.4 21.3 22.9 30.3 13.4 17.6 15.6 29.2 25.7 11.8 23.9 17.5 15.0 15.3 74.6 11.4 19.7 34.8 36.2 20.8 33.5 20.6 14.4 26.5 28.8 23.7 14.8 13.2 22.1 13.3 28.9 24.8 27.4 22.0 18.1 20.8 27.8 15.8 19.3 13.2 2.6 11.5 8.5 8.7 12.3 10.7 10.1 10.4 13.7 15.8 7.7 13.3 15.2 0.8 19.9 10.8 8.1 6.4 8.4 11.8 14.0 17.2 30.3 13.2 13.1 12.0 13.2 16.9 7.1 38.7 35.6 27.6 31.2 19.7 46.8 69.2 40.8 28.1 33.0 33.2 47.1 50.2 61.3 33.0 4.2 23.3 78.3 46.7 32.4 29.6 23.8 24.6 13.9 71.5 32.6 28.6 37.6 18.4 22.3 2.7 30.5 25.6 21.9 20.8 71.9 29.1 36.4 31.7 28.3 54.2 55.2 25.8 20.6 47.7 72.0 27.4 77.6 17.5 75.2 29.8 AGER "RAGE, SCARJ1" ENSG00000204305 "Advanced glycosylation end-product specific receptor" Q15109 6 32180968-32184324 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Inflammatory response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lung: 178.6" "Cell type enriched" "Detected in many" 18 "Alveolar cells type 1: 2224.3" "Cancer enhanced" "Detected in all" "lung cancer: 27.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 4.9;JURKAT: 8.1;MCF7: 4.2;RPTEC TERT1: 5.1;U-266/70: 6.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB011682, HPA064436, HPA069474" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane,Cell Junctions" "Secreted in other tissues" NA NA 5360000 140000 "Plasma membrane, Cell Junctions" "Nucleoli fibrillar center" "CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: " "unprognostic (9.37e-2)" "unprognostic (3.70e-1)" "unprognostic (2.37e-2)" "unprognostic (1.14e-1)" "unprognostic (4.55e-2)" "unprognostic (1.59e-3)" "unprognostic (4.36e-2)" "unprognostic (1.00e-1)" "unprognostic (4.38e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.41e-4)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.01e-7)" "unprognostic (3.57e-1)" "unprognostic (3.70e-2)" "unprognostic (4.44e-2)" "prognostic favorable (2.74e-6)" 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.9 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.6 0.4 0.4 0.2 0.2 0.2 0.0 0.5 0.2 178.6 0.2 0.2 0.2 0.5 0.3 0.1 0.7 0.4 0.4 0.5 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.0 0.2 0.2 0.2 0.2 22.6 0.2 0.2 0.2 0.3 0.7 0.7 1.0 0.3 0.1 0.5 0.1 0.2 0.2 0.0 0.6 0.2 1.9 2.7 0.1 0.2 0.1 0.2 0.1 0.4 0.2 2.1 0.5 0.0 2.2 0.2 1.1 0.3 0.4 4.9 1.3 0.1 0.0 0.0 0.6 2.2 0.3 0.3 0.1 0.2 0.3 0.3 8.1 0.0 0.8 0.2 4.2 0.3 1.5 0.0 0.2 0.0 0.1 0.2 0.3 5.1 0.1 0.1 0.5 0.1 0.0 1.9 0.1 1.2 0.1 0.2 0.0 1.5 1.5 0.1 6.1 3.2 2.2 2.2 0.5 0.5 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.3 0.2 0.0 0.7 0.4 0.3 1.0 0.1 0.2 0.7 0.0 0.1 0.2 0.2 0.9 0.2 0.2 0.0 0.2 0.2 0.4 0.2 2224.3 120.3 1.7 1.1 0.8 4.8 3.4 5.1 8.1 37.5 1.8 0.0 0.9 0.0 1.5 0.0 2.6 0.5 0.0 0.8 0.8 1.6 2.3 16.3 1.8 1.2 6.4 0.0 2.5 9.0 0.2 1.7 4.9 1.7 2.8 1.4 7.4 0.8 2.9 1.1 0.2 4.1 6.5 1.7 0.0 0.7 1.6 1.8 5.0 0.9 0.8 AGMO "FLJ16237, TMEM195" ENSG00000187546 "Alkylglycerol monooxygenase" Q6ZNB7 7 15200318-15562015 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 41.9;liver: 57.9" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 79.7" "Cancer enriched" "Detected in many" 5 "liver cancer: 15.7" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basophil: 3.6;neutrophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "HSkMC: 4.1;Karpas-707: 8.7;NTERA-2: 3.9;SCLC-21H: 3.7;TIME: 4.4;WM-115: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057900 Uncertain Vesicles NA NA Vesicles "HPA057900: " "unprognostic (2.82e-1)" "unprognostic (9.28e-2)" "unprognostic (5.60e-3)" "unprognostic (1.44e-4)" "unprognostic (7.52e-2)" "unprognostic (1.07e-2)" "unprognostic (3.61e-2)" "unprognostic (6.56e-2)" "unprognostic (3.31e-1)" "unprognostic (3.35e-1)" "unprognostic (4.18e-3)" "unprognostic (3.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.04e-2)" "unprognostic (3.45e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" 6.8 0.2 0.8 1.0 1.2 0.1 3.7 0.3 0.5 0.3 16.5 1.1 0.1 4.6 0.3 7.3 0.3 0.3 4.7 0.9 0.7 0.6 5.3 57.9 0.4 0.5 1.1 0.8 0.3 0.3 0.0 0.7 0.4 0.7 0.4 0.3 0.0 0.4 0.1 0.5 0.5 41.9 0.1 1.1 0.3 0.3 1.8 2.0 0.0 0.7 0.1 0.1 1.0 0.4 0.2 0.1 3.6 0.1 0.6 0.1 0.0 0.0 2.5 0.1 2.2 0.2 3.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 1.3 0.0 0.7 3.7 0.0 0.0 0.0 0.0 2.9 0.0 0.0 4.4 1.5 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 17.2 3.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 3.1 0.6 0.0 0.1 0.0 0.0 0.8 1.2 0.3 0.4 0.7 0.6 1.1 0.8 0.7 2.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 15.3 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.7 0.1 2.6 0.0 0.0 0.1 0.7 0.0 0.0 79.7 0.1 0.0 1.7 1.3 1.3 0.9 0.0 0.1 3.3 0.0 0.1 0.0 0.6 0.0 0.0 15.2 0.0 6.5 0.2 0.4 2.5 0.0 0.1 0.0 0.6 0.0 AGPAT1 LPAAT-alpha ENSG00000204310 "1-acylglycerol-3-phosphate O-acyltransferase 1" Q99943 6 32168212-32178096 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048478, HPA073355" Approved Supported "Endoplasmic reticulum,Rods & Rings" NA NA "Endoplasmic reticulum" "Rods & Rings" "HPA048478: AB_2680411, HPA073355: AB_2686596" "prognostic unfavorable (1.93e-4)" "unprognostic (9.35e-3)" "unprognostic (1.87e-3)" "prognostic unfavorable (5.21e-4)" "unprognostic (4.79e-2)" "unprognostic (7.05e-2)" "unprognostic (7.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.79e-1)" "unprognostic (4.24e-3)" "unprognostic (1.84e-3)" "unprognostic (1.77e-1)" "unprognostic (6.58e-2)" "unprognostic (1.97e-2)" "unprognostic (2.16e-1)" "unprognostic (9.92e-3)" "unprognostic (7.00e-2)" 11.7 32.3 21.5 8.3 33.1 7.4 12.1 18.7 32.4 26.9 22.1 19.6 19.6 32.0 25.1 53.3 13.8 26.9 22.3 19.4 22.8 21.1 26.4 20.3 24.3 10.7 20.3 23.6 33.1 18.5 1.3 16.6 18.5 22.4 18.5 24.8 17.5 17.4 19.5 25.5 9.1 46.9 17.9 18.6 11.7 27.8 27.7 17.4 12.1 33.4 9.0 14.6 19.3 12.7 6.7 13.8 13.2 9.6 8.9 10.1 5.7 0.0 0.1 13.5 0.0 35.3 23.8 12.5 0.0 0.0 0.0 0.0 27.5 0.0 0.0 11.6 33.7 9.5 3.3 29.1 9.6 0.0 0.0 22.5 0.0 0.0 29.0 0.0 0.0 27.3 13.3 12.4 0.0 12.6 29.0 8.2 23.0 17.3 17.7 29.2 7.3 0.0 6.3 0.0 0.0 4.2 0.1 0.0 0.1 8.8 0.0 0.0 0.0 13.4 4.3 15.1 14.6 16.9 0.0 5.8 0.0 5.0 0.0 0.0 10.6 10.1 4.4 17.4 0.0 0.0 2.7 5.7 13.2 9.2 9.6 8.7 6.7 5.8 10.1 10.3 5.9 5.0 7.3 11.0 8.9 6.6 13.8 7.8 5.7 21.5 33.1 18.7 32.4 22.8 21.1 20.3 23.6 22.4 17.4 14.9 18.1 19.4 9.5 8.0 26.4 3.1 12.7 12.0 7.9 34.9 11.8 28.8 5.0 16.4 52.8 13.5 30.7 0.0 12.4 25.8 14.4 11.5 12.7 27.1 22.0 30.2 28.3 18.4 17.4 64.8 12.4 17.4 8.5 5.4 24.1 34.1 13.6 21.0 20.1 22.3 17.0 0.0 20.8 45.5 20.6 3.1 12.8 12.1 20.4 10.5 AGPAT2 "BSCL, LPAAT-beta" ENSG00000169692 "1-acylglycerol-3-phosphate O-acyltransferase 2" O15120 9 136673143-136687423 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 71.5;liver: 63.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 930.5;Paneth cells: 350.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 50.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA019544 Uncertain Approved Centrosome NA NA Centrosome "HPA019544: AB_1844646" "unprognostic (3.20e-2)" "unprognostic (1.27e-1)" "unprognostic (5.01e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (9.30e-3)" "unprognostic (5.06e-3)" "unprognostic (8.98e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (2.17e-1)" "unprognostic (5.61e-2)" "unprognostic (2.60e-1)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (4.58e-2)" "unprognostic (2.93e-1)" 71.5 5.3 2.3 8.1 2.2 8.4 35.2 2.0 3.0 7.4 20.2 2.2 5.9 31.3 4.7 7.1 11.7 4.1 15.8 12.4 2.8 2.4 10.9 63.1 12.1 11.1 2.5 2.8 5.3 47.7 2.5 6.2 4.9 2.6 5.5 3.3 8.9 12.9 6.2 9.5 7.0 33.6 4.0 1.9 6.8 11.0 5.2 1.9 5.1 13.4 7.0 8.8 6.6 4.9 7.0 20.3 33.2 28.4 2.1 2.5 9.8 14.7 20.8 2.4 11.5 17.9 5.6 10.5 9.8 7.8 6.7 5.1 23.6 29.2 4.9 22.1 5.6 10.9 40.1 3.5 6.1 0.7 50.5 15.9 7.2 8.6 5.1 12.3 7.5 17.6 5.3 8.5 5.7 3.0 5.8 3.5 6.6 8.7 0.8 2.8 26.6 0.5 23.5 6.3 27.2 37.8 11.1 8.9 26.9 7.9 9.3 5.5 8.9 12.7 13.4 16.1 2.0 8.5 29.8 6.8 8.9 9.2 2.9 6.2 1.2 0.1 3.1 0.1 16.3 8.9 6.0 28.4 33.2 2.2 25.3 2.1 4.1 1.9 2.5 14.9 7.0 1.6 1.8 19.1 2.1 22.2 20.3 2.3 9.8 2.3 2.2 2.0 3.0 2.8 2.4 2.5 2.8 2.6 1.9 14.9 59.7 17.6 50.1 40.2 2.1 34.7 68.8 10.7 18.2 69.8 0.0 6.7 46.4 135.1 138.9 26.4 930.5 0.0 193.7 28.9 36.3 80.5 13.8 203.0 114.8 38.1 34.3 22.1 50.6 271.0 24.7 62.8 129.9 36.9 126.5 13.3 140.9 350.7 19.1 33.5 3.6 45.3 29.6 1.1 36.6 71.0 5.7 20.3 115.8 138.0 AGPAT3 LPAAT-gamma ENSG00000160216 "1-acylglycerol-3-phosphate O-acyltransferase 3" Q9NRZ7 21 43865186-43986536 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 59.1" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 172.8;Early spermatids: 230.1;Late spermatids: 164.7;Rod photoreceptor cells: 181.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.36e-2)" "prognostic unfavorable (8.31e-4)" "unprognostic (5.50e-2)" "unprognostic (4.56e-3)" "unprognostic (4.70e-2)" "unprognostic (8.55e-2)" "unprognostic (4.88e-2)" "unprognostic (9.72e-3)" "unprognostic (2.14e-1)" "unprognostic (3.54e-2)" "unprognostic (1.65e-1)" "unprognostic (2.84e-1)" "prognostic favorable (2.29e-4)" "unprognostic (1.50e-2)" "unprognostic (8.91e-2)" "unprognostic (1.80e-1)" "unprognostic (4.60e-2)" 12.0 10.2 21.5 11.1 23.0 5.8 12.7 14.6 22.7 6.4 20.1 18.9 8.5 27.4 5.1 10.4 13.4 8.1 8.6 11.6 19.9 15.1 33.8 30.2 9.9 9.0 21.7 11.4 5.4 12.7 17.1 7.3 7.6 13.6 7.9 7.6 10.6 24.0 8.0 59.1 10.2 34.6 5.8 25.2 10.2 11.1 11.7 11.4 7.2 14.1 15.0 7.0 9.8 6.6 1.3 4.5 2.4 10.6 0.7 3.5 2.0 26.9 15.4 3.8 10.5 7.8 8.6 3.0 12.5 15.7 15.9 9.8 15.1 19.7 9.1 9.5 14.8 14.9 10.5 6.6 13.8 4.6 43.5 17.6 4.0 9.5 20.2 13.6 14.7 9.1 10.2 11.9 14.0 5.9 14.9 11.9 3.1 22.5 15.1 5.7 11.6 0.1 9.1 1.8 10.7 10.9 15.1 4.4 24.6 12.6 26.6 13.3 9.7 15.2 17.4 11.6 1.6 12.0 16.0 17.6 10.1 0.1 15.1 12.7 12.1 18.0 5.7 13.1 29.4 9.1 0.0 4.1 2.4 1.5 8.9 1.5 1.3 2.1 2.2 4.5 1.2 1.7 1.9 1.0 0.7 10.6 1.1 3.5 2.0 21.5 23.0 14.6 22.7 19.9 15.1 21.7 11.4 13.6 11.4 11.9 23.1 7.5 7.5 7.1 36.1 31.3 20.4 32.1 22.7 24.4 172.8 13.2 8.3 23.9 230.1 11.7 47.3 0.0 25.5 0.7 8.9 14.4 4.7 59.5 16.9 62.0 13.3 15.4 24.3 164.7 7.2 22.0 1.7 27.9 21.9 27.1 23.5 20.1 5.3 42.8 181.7 6.5 7.8 9.0 2.1 9.7 10.1 9.2 19.3 12.2 AGPAT4 "dJ473J16.2, LPAAT-delta" ENSG00000026652 "1-acylglycerol-3-phosphate O-acyltransferase 4" Q9NRZ5 6 161129979-161274061 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.0" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 51.8;Late spermatids: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 19.8;HEL: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053287, HPA060525" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoli, Vesicles" "HPA053287: AB_2682101, HPA060525: AB_2684306" "unprognostic (5.69e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.73e-1)" "unprognostic (3.43e-2)" "unprognostic (4.14e-2)" "unprognostic (6.67e-3)" "unprognostic (1.94e-4)" "unprognostic (1.05e-1)" "unprognostic (3.42e-2)" "unprognostic (2.77e-2)" "unprognostic (1.76e-3)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.08e-4)" "unprognostic (1.82e-2)" "unprognostic (8.87e-2)" "unprognostic (3.63e-4)" "unprognostic (5.51e-2)" 5.6 4.2 10.5 3.5 19.1 8.0 4.5 9.6 26.6 5.3 4.2 35.6 1.0 2.6 10.7 4.5 5.2 7.2 8.0 2.9 14.2 11.8 5.2 2.0 6.1 2.0 25.8 12.4 10.0 2.3 1.3 9.8 14.6 27.4 3.7 4.4 0.7 2.7 4.9 2.1 1.9 2.5 8.5 49.0 5.2 3.0 4.2 19.8 0.6 4.8 2.0 2.2 4.0 3.8 1.1 1.9 0.6 3.5 5.8 7.0 2.1 0.3 0.8 19.8 3.9 3.7 7.6 0.8 0.7 0.2 1.5 2.5 1.1 3.5 0.5 1.4 3.1 9.2 0.3 3.6 3.0 1.4 2.2 6.2 14.8 3.5 0.0 2.9 0.1 2.1 9.1 1.5 4.0 2.1 7.1 4.6 2.3 7.3 6.8 1.8 0.0 1.0 1.6 4.7 0.0 7.5 0.0 0.9 0.4 4.3 0.3 11.5 4.4 3.0 1.6 0.8 8.1 0.8 1.0 5.1 2.1 2.6 1.4 3.3 0.5 0.7 0.0 7.8 0.8 1.3 0.0 3.5 0.0 7.0 2.8 2.3 0.4 3.3 4.1 1.9 1.1 1.7 2.7 0.6 5.8 2.5 1.5 2.9 2.1 10.5 19.1 9.6 15.8 14.2 11.8 25.8 12.4 27.4 19.8 3.0 5.6 5.2 4.6 2.9 1.0 4.0 2.5 10.7 5.7 5.2 0.0 16.0 0.0 4.3 51.8 12.2 0.0 0.0 7.0 10.7 11.3 0.8 10.5 0.4 16.7 0.0 1.7 9.8 7.6 44.8 5.5 15.4 3.3 11.8 0.0 4.0 5.9 0.0 8.1 0.3 0.9 19.4 6.2 3.6 2.9 2.3 18.5 7.4 0.0 3.2 AGPAT5 "FLJ11210, LPAAT-e, LPAAT-epsilon" ENSG00000155189 "1-acylglycerol-3-phosphate O-acyltransferase 5" Q9NUQ2 8 6708357-6759666 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010644, HPA010950, HPA011646" Approved Supported Mitochondria NA NA Mitochondria "HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: " "unprognostic (1.05e-3)" "unprognostic (4.69e-1)" "prognostic favorable (8.82e-4)" "unprognostic (2.05e-2)" "unprognostic (2.99e-1)" "unprognostic (1.44e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (4.92e-1)" "unprognostic (1.82e-1)" "unprognostic (2.98e-2)" "unprognostic (6.33e-2)" "unprognostic (2.91e-1)" "unprognostic (6.62e-2)" "unprognostic (2.83e-1)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" "unprognostic (5.09e-3)" 5.9 12.5 20.0 8.5 20.7 5.1 9.8 10.0 21.2 6.0 12.2 16.5 6.8 9.3 9.3 19.1 8.4 9.7 5.9 4.0 19.3 16.9 14.2 14.3 5.1 16.8 18.7 9.5 6.4 16.2 11.4 18.5 16.3 14.2 11.0 12.3 3.3 5.4 16.0 10.2 5.1 8.4 8.6 30.6 8.6 11.0 30.8 12.7 14.3 7.3 6.8 10.4 7.3 5.7 11.0 8.4 3.0 4.8 5.3 3.9 2.9 9.4 7.6 11.9 7.0 3.1 5.1 10.6 5.0 5.2 7.5 7.3 4.7 7.5 20.7 3.3 3.3 10.5 11.2 9.1 10.1 13.2 4.5 6.2 25.4 5.9 10.6 7.9 10.6 11.1 6.8 8.6 7.3 9.8 6.9 13.1 8.7 18.7 11.1 12.3 6.1 19.2 13.1 20.8 12.7 5.9 13.9 14.3 8.1 6.8 13.3 24.4 12.8 4.8 8.8 9.5 7.3 4.0 14.0 5.4 12.3 5.8 4.7 13.9 4.2 12.8 11.3 7.2 12.8 14.6 3.0 4.1 2.6 1.9 4.8 3.9 8.7 3.0 3.3 2.7 11.0 2.3 2.7 0.4 5.3 4.2 8.4 2.7 2.9 20.0 20.7 10.0 14.6 19.3 16.9 18.7 9.5 14.2 12.7 3.0 4.1 16.6 10.5 8.0 7.7 5.3 12.7 10.7 7.9 7.0 2.0 7.7 3.3 8.4 29.8 15.8 11.4 0.0 8.5 10.7 5.7 13.4 17.4 29.2 11.0 6.4 21.2 8.6 14.0 22.9 14.7 6.4 6.8 1.0 7.9 37.9 8.0 8.6 14.5 17.4 8.8 6.5 13.2 20.9 8.6 9.2 15.4 4.4 20.0 10.6 AGRN AGRIN ENSG00000188157 Agrin O00468 1 1020123-1056118 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Differentiation "Developmental protein" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 79.0;Collecting duct cells: 148.3;Ductal cells: 85.5;Pancreatic endocrine cells: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 46.4;EFO-21: 54.1;HaCaT: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040090 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 15000000 Cytosol "Plasma membrane" "HPA040090: AB_10805603" "unprognostic (8.04e-2)" "unprognostic (8.25e-3)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (2.82e-3)" "unprognostic (1.32e-1)" "unprognostic (3.33e-2)" "unprognostic (9.49e-3)" "unprognostic (1.06e-1)" "unprognostic (8.46e-2)" "unprognostic (8.49e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-1)" "unprognostic (1.31e-2)" 10.2 2.8 13.0 5.3 12.4 2.9 8.3 2.3 24.0 11.3 8.5 20.5 8.9 9.8 8.2 14.5 8.8 11.4 37.2 8.1 10.9 8.3 36.0 9.3 18.1 2.3 9.3 7.0 7.6 25.2 5.7 5.0 11.0 12.7 8.7 2.5 13.6 26.5 10.8 4.7 18.6 11.2 3.9 7.7 7.2 14.1 7.5 8.1 6.4 27.0 9.5 7.6 13.7 6.2 0.0 0.1 0.0 0.5 0.0 1.1 0.1 27.0 16.8 3.3 10.9 0.5 0.7 29.4 13.7 4.4 9.2 5.6 14.1 46.4 0.5 54.1 2.1 4.5 47.1 1.1 16.9 1.1 1.0 6.4 0.0 22.0 14.8 3.9 0.3 5.5 2.4 7.3 2.9 6.4 12.8 1.6 0.4 5.6 0.1 0.7 22.2 0.2 3.8 7.0 8.7 12.3 4.3 6.4 4.0 16.1 12.1 0.8 6.5 27.8 30.1 26.5 3.3 26.5 2.1 23.9 11.3 40.0 1.5 11.0 0.3 0.2 1.0 7.1 2.5 3.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 13.0 12.4 2.3 22.0 10.9 8.3 9.3 7.0 12.7 8.1 23.8 9.1 2.4 7.5 13.4 0.8 2.2 79.0 5.3 14.8 148.3 7.9 1.1 1.7 85.5 0.1 17.9 18.6 0.0 14.5 4.6 5.6 15.4 2.3 8.9 3.9 4.8 6.4 13.5 2.1 0.8 5.2 3.1 23.6 27.1 10.4 10.0 62.9 14.0 2.5 11.3 5.4 6.5 8.5 0.5 9.6 5.3 1.0 1.0 18.4 13.7 AGTR1 "AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R" ENSG00000144891 "Angiotensin II receptor type 1" P30556 3 148697784-148743008 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 29.6;placenta: 44.9" "Group enriched" "Detected in many" 5 "Leydig cells: 134.3;Sertoli cells: 142.3" "Group enriched" "Detected in many" 8 "breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 64.4;ASC TERT1: 9.0;BJ hTERT+ SV40 Large T+: 12.3;HBF TERT88: 19.4;HSkMC: 11.7" "Low region specificity" "Detected in many" HPA003596 Enhanced Uncertain Vesicles NA NA Vesicles "HPA003596: AB_1845163" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.48e-4)" "unprognostic (5.28e-3)" "unprognostic (1.55e-1)" "unprognostic (3.46e-1)" "unprognostic (1.28e-2)" "unprognostic (3.26e-2)" "unprognostic (3.08e-2)" "unprognostic (9.25e-3)" "unprognostic (4.11e-2)" "unprognostic (4.79e-2)" "unprognostic (3.21e-3)" "unprognostic (1.46e-1)" "unprognostic (2.54e-1)" "unprognostic (5.41e-3)" 18.8 11.6 0.0 0.1 0.0 0.0 10.8 0.0 0.0 0.8 5.5 0.0 0.6 0.5 0.5 2.2 1.6 3.1 0.0 0.1 5.7 29.6 2.6 0.0 0.9 0.8 0.6 0.6 0.8 44.9 1.3 1.0 1.0 1.0 2.9 4.4 0.7 1.1 0.0 2.3 1.7 0.2 4.1 0.0 4.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 64.4 9.0 0.0 0.0 1.3 12.3 7.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 1.1 0.6 0.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 3.1 0.0 5.7 5.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.2 0.0 0.0 6.6 0.2 13.7 1.2 0.0 26.8 0.6 0.0 22.7 29.4 0.8 0.2 134.3 0.0 1.7 0.0 0.0 4.5 0.8 0.0 7.1 0.0 0.0 142.3 15.5 0.0 0.4 1.5 0.2 0.0 0.0 0.0 AGTR2 "AT2, MRX88" ENSG00000180772 "Angiotensin II receptor type 2" P50052 X 116170722-116174972 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 20.8;lung: 26.7;smooth muscle: 13.6" "Cell type enriched" "Detected in some" 15 "Alveolar cells type 2: 17.8" "Group enriched" "Detected in some" 12 "endometrial cancer: 3.0;lung cancer: 1.9" "Region enriched" "Detected in single" 10 "cerebellum: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "HSkMC: 1.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 9 "cerebellum: 3.8" NA NA "unprognostic (2.13e-1)" "unprognostic (1.71e-1)" "unprognostic (3.22e-2)" "unprognostic (4.37e-2)" 0.3 1.6 0.1 0.8 0.1 0.0 0.1 1.0 0.1 5.3 0.4 0.1 0.1 0.0 20.8 3.3 0.2 3.6 0.4 1.7 0.1 0.0 0.4 0.1 26.7 0.8 0.1 0.1 1.1 1.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 13.6 0.1 0.1 0.6 0.2 0.1 0.4 0.1 1.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 17.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AGTRAP ATRAP ENSG00000177674 "Angiotensin II receptor associated protein" Q6RW13 1 11736084-11754802 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 96.5" "Cell type enhanced" "Detected in many" 10 "Exocrine glandular cells: 387.3;Kupffer cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044120 Enhanced Supported "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA044120: AB_10960748" "unprognostic (1.08e-3)" "unprognostic (2.98e-3)" "unprognostic (6.10e-2)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (7.92e-3)" "prognostic unfavorable (6.57e-7)" "unprognostic (4.44e-2)" "unprognostic (7.96e-2)" "unprognostic (4.31e-2)" "unprognostic (1.61e-2)" "unprognostic (7.22e-2)" "unprognostic (1.61e-2)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (2.33e-3)" "unprognostic (5.89e-2)" 16.5 19.2 8.7 16.6 10.8 65.5 31.0 3.1 10.0 13.0 9.7 16.7 15.6 6.5 10.3 37.0 19.6 28.4 14.5 22.0 8.9 6.9 29.7 11.0 26.4 35.6 14.2 6.6 15.0 27.2 7.9 12.2 15.2 16.5 33.2 5.6 17.1 22.2 13.5 25.3 13.2 8.4 13.4 12.9 31.0 12.3 15.3 10.7 11.4 25.5 12.6 14.6 15.2 26.0 5.2 35.2 85.3 96.5 7.7 21.7 53.1 15.0 18.7 4.7 10.3 7.9 10.1 8.7 7.9 13.7 9.8 8.6 11.9 36.7 1.6 36.2 9.6 24.7 12.8 7.8 37.7 3.1 0.8 17.1 0.4 11.3 14.1 24.7 7.4 18.3 10.0 29.9 32.0 17.0 12.1 13.1 4.8 19.7 14.9 5.5 12.4 3.6 21.9 8.4 6.5 19.1 1.2 4.2 7.5 16.0 1.4 4.1 6.2 14.6 7.4 13.5 6.6 16.8 15.8 7.4 12.6 8.9 19.8 8.4 5.5 6.5 8.8 32.2 53.7 5.8 45.4 96.5 74.3 21.7 47.6 10.8 5.2 8.2 12.9 35.2 4.0 8.8 11.7 85.3 7.7 39.8 2.9 9.6 53.1 8.7 10.8 3.1 10.0 8.9 6.9 14.2 6.6 16.5 10.7 20.8 27.2 6.9 27.5 10.3 0.3 10.1 30.6 56.2 17.0 34.9 5.9 15.2 8.3 87.9 13.0 31.8 6.4 0.0 387.3 71.9 36.4 56.1 84.5 6.6 107.2 3.2 6.9 45.4 167.4 16.3 35.1 52.2 27.0 8.2 11.0 15.6 91.8 24.6 25.5 44.0 5.5 12.9 6.6 3.3 27.5 11.8 11.0 47.5 19.1 21.8 AIFM1 "AIF, CMTX4, NAMSD, PDCD8" ENSG00000156709 "Apoptosis inducing factor mitochondria associated 1" O95831 X 130129362-130165887 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "DNA-binding, Oxidoreductase" "Charcot-Marie-Tooth disease, Deafness, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 66.8" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 148.9;Proximal tubular cells: 209.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003764, HPA030611" Enhanced Supported Mitochondria NA NA 160000 Mitochondria "CAB003764: AB_289587, HPA030611: AB_2673549" "unprognostic (3.00e-3)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (2.10e-2)" "unprognostic (3.15e-3)" "unprognostic (1.46e-1)" "unprognostic (1.14e-2)" "unprognostic (1.43e-1)" "unprognostic (3.11e-2)" "unprognostic (2.54e-3)" "unprognostic (2.81e-3)" "prognostic favorable (4.42e-10)" "unprognostic (1.76e-2)" "unprognostic (1.14e-1)" "unprognostic (5.04e-2)" "unprognostic (2.11e-2)" 9.9 28.9 7.1 11.3 8.6 5.3 7.1 7.5 8.9 10.4 14.2 8.4 10.0 19.6 9.9 11.7 8.6 13.0 11.4 34.2 7.2 7.0 66.8 50.5 5.8 9.8 8.2 7.1 7.3 14.6 16.8 7.7 6.1 8.8 6.9 14.2 12.3 13.1 9.4 35.7 5.8 23.2 8.9 6.4 8.7 14.9 14.9 7.2 19.5 7.9 16.1 9.7 8.4 6.0 10.8 22.0 9.8 18.3 15.8 12.8 8.0 16.8 31.2 12.8 32.0 14.6 10.4 16.9 10.7 9.3 16.5 13.3 22.1 12.5 36.4 37.3 9.8 19.6 16.3 39.4 13.9 17.6 13.9 24.0 23.1 23.5 30.0 18.6 20.2 24.3 12.9 13.7 17.5 15.0 9.2 13.9 27.5 19.8 16.9 11.6 40.6 20.5 31.7 9.2 34.0 24.2 18.6 14.3 42.1 37.3 17.1 16.5 9.6 12.5 28.9 27.8 15.2 14.9 18.3 10.1 7.9 7.6 21.4 20.3 9.0 14.6 17.0 10.1 33.9 11.8 2.9 14.8 9.8 9.1 18.3 9.6 10.8 9.7 11.2 22.0 8.1 9.6 9.7 2.1 15.8 15.5 10.6 12.8 8.0 7.1 8.6 7.5 8.9 7.2 7.0 8.2 7.1 8.8 7.2 14.9 15.3 20.1 8.0 7.7 17.8 148.9 20.4 21.4 15.9 38.4 21.6 48.7 77.9 21.8 1.3 10.2 33.3 0.0 18.1 22.0 13.9 6.9 10.4 83.4 33.5 14.3 9.2 14.7 15.5 3.9 16.1 14.0 10.1 17.2 17.6 12.2 17.3 17.3 16.3 209.8 36.6 6.5 9.0 3.9 32.1 5.9 33.2 13.1 32.6 8.9 AIFM2 "AMID, FLJ14497, PRG3" ENSG00000042286 "Apoptosis inducing factor, mitochondria associated 2" Q9BRQ8 10 70098223-70132934 "Predicted intracellular proteins" "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 41.9" "Cell type enhanced" "Detected in many" 5 "monocytes: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 57.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028961, HPA042309, HPA075576" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: " "unprognostic (6.62e-2)" "unprognostic (2.73e-1)" "unprognostic (4.29e-1)" "prognostic favorable (2.80e-4)" "unprognostic (7.26e-3)" "unprognostic (2.57e-2)" "unprognostic (7.95e-3)" "unprognostic (2.80e-1)" "unprognostic (5.31e-2)" "unprognostic (8.90e-2)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (4.49e-1)" "unprognostic (4.59e-3)" "unprognostic (2.17e-1)" "unprognostic (1.11e-1)" "prognostic favorable (2.92e-4)" 32.9 7.8 3.1 6.6 5.9 1.3 41.9 5.0 3.7 3.5 9.0 2.1 22.1 7.6 4.5 9.6 9.1 4.0 7.6 19.7 2.8 4.1 10.2 18.2 8.1 4.0 2.9 2.4 7.5 3.6 3.9 3.1 5.2 3.5 6.4 5.9 9.2 5.8 15.2 9.1 2.8 9.9 7.8 3.7 5.9 6.5 3.1 2.1 1.0 10.8 6.4 7.3 11.8 15.7 3.4 0.7 1.5 1.0 7.8 3.5 1.2 8.8 15.4 0.4 4.0 9.3 3.5 0.1 3.5 8.8 7.3 8.3 11.9 17.2 1.3 9.1 4.9 9.7 9.6 4.3 1.2 2.0 17.2 0.7 0.0 9.1 57.7 20.0 0.1 2.2 4.7 2.9 11.7 2.5 4.6 3.2 0.6 6.7 7.6 3.7 11.2 0.4 0.4 1.6 7.1 5.0 0.2 1.4 4.2 3.9 6.5 1.3 0.3 6.5 5.7 10.0 0.6 0.2 2.4 4.0 0.1 9.0 5.4 10.3 5.7 10.6 2.4 4.9 0.3 4.8 1.5 0.9 1.0 3.5 0.8 3.1 3.4 1.2 3.0 0.7 2.9 1.7 2.7 1.0 7.8 1.0 0.5 2.4 1.2 3.1 5.9 5.0 3.7 2.8 4.1 2.9 2.4 3.5 2.1 6.0 13.1 2.2 11.6 2.1 5.5 11.7 10.2 9.4 10.3 17.4 0.0 12.6 3.3 35.2 19.5 2.3 32.9 0.0 19.3 2.5 6.3 12.0 11.5 20.2 10.5 1.6 11.5 2.5 1.8 33.7 4.9 3.5 8.5 59.5 6.0 4.5 31.0 17.5 4.2 11.5 1.7 19.4 13.0 3.2 3.2 1.3 15.6 5.1 9.0 14.8 AIG1 "AIG-1, dJ95L4.1, FLJ10485" ENSG00000146416 "Androgen induced 1" Q9NVV5 6 143060496-143340304 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 115.7" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 202.6;Proximal tubular cells: 212.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060766 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA060766: AB_2684356" "unprognostic (2.70e-2)" "prognostic unfavorable (3.26e-6)" "unprognostic (4.27e-2)" "prognostic unfavorable (3.06e-4)" "unprognostic (5.34e-2)" "prognostic unfavorable (3.25e-7)" "unprognostic (1.91e-2)" "unprognostic (8.75e-3)" "unprognostic (2.17e-1)" "unprognostic (5.53e-2)" "unprognostic (2.75e-1)" "unprognostic (1.93e-1)" "unprognostic (2.74e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (9.11e-2)" "unprognostic (2.75e-1)" 18.4 14.9 20.1 5.6 18.7 13.0 16.8 15.6 22.3 8.1 15.1 26.6 7.9 22.3 7.7 18.8 14.7 16.7 14.2 21.9 21.7 26.0 51.4 115.7 8.6 5.7 23.3 15.7 17.1 14.2 9.7 19.2 6.3 25.7 12.5 9.7 21.1 11.5 12.8 10.1 8.2 25.6 8.9 28.6 9.4 8.7 10.0 14.7 1.7 23.0 11.2 11.3 14.5 10.5 6.4 19.0 8.2 18.7 6.3 10.0 5.7 9.4 7.1 6.7 18.8 9.6 8.5 2.3 8.2 18.3 8.2 20.1 10.5 27.9 6.3 11.8 18.9 12.1 13.5 8.1 27.1 20.4 18.5 17.9 1.5 11.0 43.5 14.3 13.5 0.9 10.1 27.8 10.4 44.5 29.8 3.2 8.7 1.1 22.2 21.0 12.6 4.1 3.4 12.6 10.7 8.2 6.0 18.2 10.5 32.9 21.6 23.7 13.2 10.7 10.1 4.8 12.0 10.6 31.5 1.0 7.9 8.5 7.8 10.1 29.6 23.5 0.5 19.4 3.2 8.1 5.8 3.9 5.9 4.4 16.8 10.0 6.4 8.2 6.7 19.0 4.2 8.8 6.8 8.2 6.3 18.7 1.9 5.7 5.7 20.1 18.7 15.6 22.3 21.7 26.0 23.3 15.7 25.7 14.7 14.9 23.0 21.7 44.8 22.1 63.0 65.1 76.5 57.6 35.2 48.8 23.6 56.8 44.7 47.3 9.7 28.1 17.9 23.3 27.4 6.9 41.9 39.0 36.8 202.6 29.0 50.9 37.9 31.3 26.1 5.6 29.7 27.8 52.3 23.4 25.0 69.0 25.6 26.6 36.0 212.5 31.0 32.3 36.0 3.6 12.3 40.0 90.4 20.4 28.1 43.8 AJAP1 "MOT8, SHREW-1, SHREW1" ENSG00000196581 "Adherens junctions associated protein 1" Q9UKB5 1 4654732-4792534 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9;ovary: 13.1" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 8.7;Early spermatids: 4.6;Peritubular cells: 5.6;Proximal tubular cells: 4.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "eosinophil: 4.8;plasmacytoid DC: 2.1" "Group enriched" "Detected in many" 18 "dendritic cells: 2.1;granulocytes: 4.8" "Cell line enhanced" "Detected in some" "BEWO: 7.0;EFO-21: 6.2;hTERT-HME1: 3.6;RPTEC TERT1: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.11e-1)" "unprognostic (1.40e-1)" "unprognostic (2.35e-2)" "unprognostic (2.75e-2)" "unprognostic (7.52e-2)" "unprognostic (6.81e-2)" "unprognostic (2.57e-2)" "unprognostic (6.54e-2)" "unprognostic (1.16e-1)" "unprognostic (8.87e-2)" "unprognostic (4.04e-2)" "unprognostic (3.58e-1)" "prognostic favorable (1.89e-7)" "unprognostic (2.57e-1)" "unprognostic (1.70e-1)" "unprognostic (2.50e-1)" "unprognostic (5.49e-2)" 1.4 1.8 18.9 1.1 9.9 0.9 1.1 3.8 18.0 3.0 1.2 4.7 1.6 1.4 2.8 2.5 1.3 2.4 1.2 0.8 10.8 6.0 8.2 1.0 1.2 1.2 6.3 13.4 13.1 3.1 0.9 0.7 1.5 5.5 2.3 1.1 2.2 1.3 6.7 1.3 1.2 1.2 1.6 4.1 3.2 1.3 2.6 7.2 0.0 1.2 0.0 1.2 1.3 1.1 0.0 2.1 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 1.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.6 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.8 0.0 0.0 0.0 0.0 0.7 22.7 0.0 1.1 0.6 0.0 2.1 0.0 2.9 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 18.9 9.9 3.8 14.9 10.8 6.0 6.3 13.4 5.5 7.2 0.0 0.0 0.0 0.0 3.3 8.7 0.8 2.5 4.0 2.3 1.8 0.0 1.6 0.0 1.0 4.6 0.7 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.6 0.3 0.0 1.7 0.0 0.0 1.2 0.2 0.0 5.6 4.9 1.1 0.0 1.9 0.2 0.7 2.0 1.5 0.0 0.0 0.0 AKAP1 "AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17" ENSG00000121057 "A-kinase anchoring protein 1" Q92667 17 57085092-57121349 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 80.1;testis: 75.4" "Group enriched" "Detected in many" 9 "Early spermatids: 596.3;Late spermatids: 1760.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008620, HPA008691, CAB019286" Supported Supported Mitochondria NA NA Mitochondria "CAB019286: , HPA008620: AB_2668104, HPA008691: AB_1078119" "unprognostic (5.52e-2)" "unprognostic (1.83e-1)" "unprognostic (6.96e-3)" "unprognostic (1.78e-1)" "unprognostic (1.79e-2)" "unprognostic (6.38e-2)" "unprognostic (7.19e-2)" "unprognostic (1.48e-2)" "unprognostic (8.14e-2)" "unprognostic (2.36e-2)" "unprognostic (3.22e-1)" "unprognostic (3.00e-1)" "prognostic favorable (7.86e-9)" "unprognostic (6.82e-2)" "unprognostic (2.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.38e-1)" 16.4 6.1 13.5 9.2 16.3 2.8 14.7 13.4 12.5 10.3 28.1 8.7 9.3 22.6 10.2 14.3 18.1 12.5 19.2 35.0 10.0 6.6 11.9 26.4 8.3 4.4 13.6 9.9 9.0 16.4 18.8 7.1 3.3 7.9 15.5 20.6 9.3 13.6 13.9 80.1 10.2 25.2 23.5 8.4 4.9 22.2 75.4 10.1 4.7 14.9 19.7 7.4 20.5 9.8 3.3 6.5 2.8 3.3 6.0 7.4 2.1 16.2 20.4 28.3 9.3 7.3 4.8 17.0 6.8 6.6 9.0 6.4 21.8 14.6 26.1 19.4 5.2 9.5 25.9 15.8 14.9 9.0 14.3 23.0 22.2 18.0 41.3 6.9 20.8 8.6 4.2 14.9 9.9 13.9 5.1 9.1 8.0 14.8 10.1 5.2 13.9 26.3 7.9 10.4 34.4 21.9 20.2 12.0 21.3 6.0 19.3 21.7 14.3 5.4 15.8 8.8 6.4 10.9 21.5 6.7 7.9 8.8 10.2 15.3 10.0 12.5 19.7 5.0 16.3 7.0 2.8 1.7 0.6 4.7 3.3 4.1 3.3 3.8 3.8 4.0 2.4 7.4 4.0 0.2 6.0 0.9 6.5 2.8 2.1 13.5 16.3 13.4 12.5 10.0 6.6 13.6 9.9 7.9 10.1 32.8 37.5 15.1 21.0 20.0 35.4 133.6 33.1 6.7 45.5 5.2 45.2 18.0 1.7 15.3 596.3 10.7 60.0 0.0 14.4 10.0 9.5 23.9 3.5 54.6 8.4 35.0 44.1 10.4 8.5 1760.2 18.1 7.7 6.8 6.4 85.1 6.8 10.7 43.2 13.1 5.8 71.0 45.3 45.3 13.9 10.0 17.2 5.7 6.4 92.8 11.8 AKAP6 "ADAP6, AKAP100, KIAA0311, mAKAP, PRKA6" ENSG00000151320 "A-kinase anchoring protein 6" Q13023 14 32329273-32837681 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 47.0;heart muscle: 46.6;skeletal muscle: 37.0" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 44.0;Cardiomyocytes: 96.0;Cone photoreceptor cells: 47.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "naive B-cell: 7.8" "Lineage enriched" "Detected in many" 6 "B-cells: 7.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001983, HPA048741" Enhanced NA NA "CAB001983: , HPA048741: AB_2680506" "unprognostic (1.99e-1)" "unprognostic (9.92e-2)" "unprognostic (1.88e-1)" "unprognostic (1.37e-1)" "unprognostic (2.52e-1)" "unprognostic (4.33e-2)" "unprognostic (1.41e-4)" "unprognostic (1.81e-3)" "unprognostic (1.93e-2)" "unprognostic (4.49e-3)" "unprognostic (1.24e-3)" "unprognostic (3.54e-1)" "unprognostic (3.33e-16)" "unprognostic (8.57e-2)" "unprognostic (1.27e-1)" "unprognostic (5.14e-3)" "unprognostic (1.79e-3)" 2.1 5.9 17.9 2.9 28.0 1.2 4.5 32.5 34.3 2.3 4.1 28.3 0.0 2.3 4.2 5.9 5.6 3.2 4.0 46.6 16.8 13.7 3.4 2.6 2.8 1.3 27.5 22.2 3.0 1.5 5.3 3.1 4.5 47.0 2.5 2.7 2.3 2.6 1.8 37.0 1.8 2.8 7.3 16.5 1.4 2.1 5.5 29.8 0.0 5.0 6.6 1.4 3.2 1.4 7.8 0.8 1.2 0.3 0.3 1.2 0.5 0.6 0.9 1.2 1.1 0.2 2.1 0.3 1.5 4.2 0.2 0.5 1.3 1.2 1.6 1.1 17.7 0.7 0.9 1.3 1.6 0.6 1.4 1.1 1.4 1.9 1.2 0.6 0.1 0.4 2.1 1.5 0.0 0.5 0.7 0.1 2.5 0.3 4.7 1.2 0.9 0.8 0.3 0.2 1.2 1.3 0.8 5.6 0.6 0.5 1.4 6.1 4.8 1.2 0.8 3.8 0.9 3.3 0.1 0.3 0.2 0.9 0.9 0.5 3.0 2.6 0.7 1.8 0.1 6.2 0.5 0.3 0.1 0.1 0.2 0.2 0.5 0.1 0.4 0.4 7.8 0.8 1.2 1.2 0.3 0.2 0.8 0.1 0.5 17.9 28.0 32.5 34.3 16.8 13.7 27.5 22.2 47.0 29.8 6.0 2.4 0.5 2.8 2.1 44.0 96.0 0.0 14.7 7.9 1.8 47.1 0.9 0.0 0.8 18.9 1.0 1.2 0.0 0.5 0.2 9.3 0.9 1.1 2.6 1.0 25.4 1.2 1.3 0.6 9.7 13.6 1.3 6.8 1.0 0.2 2.4 0.4 0.0 31.1 1.1 20.7 19.4 13.7 9.6 1.1 1.4 0.3 0.0 0.6 0.8 AL021546.1 ENSG00000111780 12 120438198-120460006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 9.9;HEK 293: 12.5;U-266/84: 11.1" HPA062394 Uncertain Approved Mitochondria NA NA Mitochondria "HPA062394: AB_2684749" "unprognostic (3.79e-2)" "unprognostic (1.74e-1)" "unprognostic (2.79e-1)" "unprognostic (2.90e-1)" "unprognostic (1.71e-1)" "unprognostic (1.33e-1)" "unprognostic (9.54e-4)" "unprognostic (2.04e-1)" 4.8 6.0 12.8 3.6 11.6 4.7 4.5 8.4 14.8 4.6 16.3 4.2 3.3 3.6 5.1 3.6 6.0 7.1 3.6 6.7 8.9 6.3 11.5 12.1 5.3 4.2 10.5 7.2 9.6 10.3 3.6 4.9 5.8 11.6 6.5 3.6 3.1 5.4 4.3 4.3 4.1 11.4 3.6 5.9 9.2 7.1 4.8 7.7 3.5 6.3 3.8 4.0 6.6 5.1 6.5 12.9 5.8 10.7 2.8 7.4 4.3 2.2 3.1 0.0 0.7 0.0 0.0 0.0 2.1 0.4 0.5 0.0 9.9 0.0 0.6 3.8 0.0 1.0 1.0 0.0 0.5 0.0 1.8 12.5 0.8 0.0 0.0 0.0 4.3 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 1.4 0.3 0.0 0.0 3.6 0.4 0.4 0.0 5.0 2.0 1.4 1.1 0.0 0.0 5.3 0.4 3.3 1.0 0.0 0.0 1.0 0.5 2.8 1.7 0.5 0.0 1.5 1.1 11.1 4.0 0.7 1.5 0.0 2.0 5.8 5.8 6.5 10.7 7.4 6.5 4.0 7.4 12.9 6.0 4.5 4.0 1.7 2.8 8.1 10.0 7.2 4.3 12.8 11.6 8.4 14.8 8.9 6.3 10.5 7.2 11.6 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL034430.1 ENSG00000285508 20 10413520-10431922 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "blood: 31.4" "Group enriched" "Detected in some" 12 "Ciliated cells: 1.4;Club cells: 1.2;granulocytes: 1.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 39.8" "Low region specificity" "Detected in all" NA NA 4.4 1.7 5.0 6.3 0.0 0.6 0.0 2.5 3.2 0.0 0.0 1.2 0.0 0.0 6.2 0.0 2.8 0.0 1.0 0.0 3.7 0.0 0.4 1.3 0.0 1.6 0.0 0.0 0.0 2.3 0.0 0.0 4.3 2.9 0.0 0.0 0.0 8.2 31.4 19.1 16.3 4.3 7.4 5.0 17.7 9.4 5.9 7.6 0.0 1.0 8.1 12.6 3.6 5.2 5.8 6.5 19.4 5.1 8.1 2.8 13.8 13.2 0.0 11.6 10.1 1.4 3.0 9.2 7.8 39.8 3.0 17.9 6.1 1.5 0.0 2.9 6.4 2.4 7.9 2.3 10.8 13.5 7.0 7.3 4.2 20.2 11.1 0.8 8.8 8.1 17.0 11.3 4.4 12.1 2.8 4.4 11.6 20.1 26.0 7.2 9.6 8.6 9.3 12.0 14.4 10.3 16.3 6.8 10.4 12.5 5.9 10.2 11.5 19.1 13.7 15.7 4.7 16.3 5.5 8.2 5.6 7.4 13.4 6.7 5.3 6.4 11.8 4.3 13.7 31.4 6.5 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL110118.2 ENSG00000259066 14 93184973-93218586 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 3.6;MCF7: 1.4;U-698: 1.5" NA NA "unprognostic (5.50e-2)" "unprognostic (9.26e-2)" "unprognostic (2.37e-1)" "unprognostic (4.03e-1)" "unprognostic (2.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.62e-1)" "unprognostic (2.69e-2)" "unprognostic (3.48e-1)" "unprognostic (1.13e-1)" "unprognostic (3.26e-2)" "unprognostic (3.51e-2)" "unprognostic (5.61e-3)" "unprognostic (1.08e-1)" "unprognostic (5.86e-2)" "unprognostic (1.18e-3)" "unprognostic (6.11e-2)" 3.2 3.4 3.4 2.1 2.8 2.8 5.3 2.2 3.0 3.1 3.8 1.9 4.3 4.2 2.1 3.3 2.5 2.6 2.1 5.4 2.9 2.9 4.6 2.3 5.6 4.2 4.1 1.8 2.6 5.5 2.1 3.6 2.2 3.2 2.8 2.9 3.9 4.0 4.0 11.0 2.1 3.8 2.1 3.6 2.1 4.2 3.2 3.0 2.7 3.4 1.8 2.1 2.6 2.5 2.2 0.7 1.6 0.6 0.6 1.3 0.2 0.3 3.6 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.8 1.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 0.9 0.0 1.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.8 0.8 0.0 0.4 1.5 0.6 0.6 0.0 1.0 0.3 1.6 0.7 0.6 1.1 1.0 1.1 0.3 0.5 2.2 0.4 0.4 1.3 0.6 0.5 0.7 1.3 0.2 3.4 2.8 2.2 3.0 2.9 2.9 4.1 1.8 3.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL121845.3 ENSG00000273154 20 63708864-63739103 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 3.2;blood: 2.4;lymphoid tissue: 2.2" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 1.4;monocytes: 1.8" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "THP-1: 3.6;U-266/84: 3.7;U-698: 4.8" NA NA "unprognostic (3.05e-1)" "unprognostic (1.11e-1)" "unprognostic (1.03e-2)" "unprognostic (2.39e-2)" "unprognostic (6.29e-2)" "unprognostic (1.32e-1)" "unprognostic (2.28e-1)" "unprognostic (3.48e-1)" "unprognostic (4.29e-2)" "unprognostic (7.13e-2)" "unprognostic (2.18e-4)" "unprognostic (3.37e-4)" "unprognostic (1.84e-7)" "unprognostic (7.09e-2)" "unprognostic (1.93e-1)" "unprognostic (1.12e-1)" "unprognostic (1.96e-3)" 0.0 3.2 2.2 0.0 0.0 0.0 0.0 0.7 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.1 0.0 1.0 2.0 0.0 0.5 0.8 0.0 1.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 1.8 2.4 0.4 2.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.0 2.3 0.1 2.3 0.0 0.3 0.9 0.5 0.6 0.0 0.7 0.0 0.0 2.4 0.0 1.8 1.2 0.3 1.3 1.5 0.8 0.0 0.0 0.4 0.4 0.0 0.6 0.0 1.2 0.0 2.4 0.4 0.0 0.0 1.6 0.0 0.0 0.0 2.1 0.7 1.9 0.0 0.0 0.2 0.0 1.4 3.6 0.0 3.4 1.3 1.3 0.7 0.4 3.7 4.8 0.0 1.3 0.3 0.0 0.0 0.1 0.9 0.1 0.6 0.0 1.1 2.4 0.0 0.0 1.0 0.7 0.0 1.8 0.0 0.6 1.5 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AL121900.2 ENSG00000284776 20 18567453-18744216 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Ciliated cells: 5.3" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBF TERT88: 22.9" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA040981: AB_10673268" 4.0 5.7 4.0 4.4 5.8 5.8 6.0 4.5 14.1 3.6 6.2 2.0 6.0 5.2 7.4 5.9 4.5 5.4 5.4 7.8 4.4 15.4 6.3 4.7 6.9 4.5 5.4 7.7 16.1 8.3 5.3 4.4 7.6 4.6 6.4 3.1 8.8 8.2 12.2 1.1 5.5 5.9 4.3 5.8 0.9 6.8 5.4 3.6 5.1 9.9 6.8 5.7 6.4 4.9 6.9 2.9 4.8 3.9 5.9 1.7 3.7 1.8 7.9 3.9 2.6 9.1 0.5 2.4 6.5 6.2 0.7 0.9 5.6 0.5 1.9 7.8 3.5 3.5 4.9 15.1 22.9 0.9 0.3 5.1 2.0 2.0 3.1 10.0 6.0 0.0 14.4 4.5 7.4 3.6 8.0 1.5 0.9 7.9 5.3 2.8 1.7 0.8 2.1 3.2 0.0 0.3 4.1 5.5 4.9 4.7 7.8 2.0 0.2 6.4 3.1 6.6 5.0 6.5 0.0 8.5 0.4 7.1 5.3 1.7 8.5 1.5 5.1 1.6 5.6 2.9 3.2 2.7 4.8 4.8 5.9 4.9 5.4 3.6 6.9 2.9 1.7 3.4 1.9 3.9 2.8 1.2 4.5 1.7 8.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL136295.1 ENSG00000254692 14 24189157-24213473 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 6.0;granulocytes: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA059249 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA059249: AB_2683959" "unprognostic (3.45e-2)" 7.6 12.3 11.5 7.0 13.0 2.9 12.0 5.4 9.7 12.0 8.1 8.0 7.9 6.8 7.3 20.6 10.4 9.5 7.1 10.3 10.2 8.8 11.4 11.4 7.0 7.1 13.0 9.1 7.9 7.9 23.2 5.3 9.1 12.1 8.8 10.9 5.3 8.6 10.4 9.0 8.8 9.2 15.3 11.3 7.7 5.9 7.2 10.0 9.4 10.1 4.8 6.6 11.2 8.2 0.0 2.1 2.5 3.3 0.8 3.5 0.6 1.3 5.9 3.7 4.1 18.6 11.5 0.8 0.4 8.6 6.6 8.0 2.2 9.3 0.9 0.3 10.6 7.2 4.4 4.2 4.5 10.8 0.7 0.0 0.3 3.3 9.3 12.6 2.4 2.5 9.3 13.9 5.9 19.1 13.6 4.1 1.3 0.0 7.7 9.9 10.3 1.2 1.9 2.0 18.9 0.0 1.3 1.7 2.4 15.2 5.1 1.2 0.9 1.2 13.2 4.2 5.5 5.8 5.1 2.0 5.8 2.0 2.1 2.9 1.8 1.1 1.4 2.8 1.4 7.5 0.0 1.0 2.2 0.6 2.2 0.0 0.0 0.4 0.6 2.1 0.0 0.5 1.2 2.5 0.8 3.3 1.1 3.5 0.6 11.5 13.0 5.4 9.7 10.2 8.8 13.0 9.1 12.1 10.0 6.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL136295.3 ENSG00000259371 14 24120956-24131829 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "liver: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;HMC-1: 3.0" NA NA "unprognostic (1.38e-1)" "unprognostic (4.35e-3)" "unprognostic (4.81e-2)" "unprognostic (1.87e-2)" "unprognostic (6.61e-5)" "unprognostic (5.64e-2)" "unprognostic (1.61e-1)" "unprognostic (1.29e-1)" "unprognostic (1.78e-1)" "unprognostic (5.39e-2)" "unprognostic (1.53e-2)" "unprognostic (4.52e-4)" "unprognostic (2.37e-1)" "unprognostic (9.36e-2)" "unprognostic (2.23e-1)" 0.2 0.2 0.1 0.2 0.2 1.5 0.3 1.1 0.2 0.3 0.6 1.2 0.2 0.8 0.5 0.1 0.1 0.0 0.1 0.0 0.5 3.0 0.2 0.6 0.1 0.4 0.9 0.6 0.3 0.3 0.4 0.5 0.5 0.7 0.0 1.1 1.5 0.0 0.1 1.1 1.2 1.4 0.5 0.4 0.2 0.3 0.2 0.0 0.1 0.1 0.7 0.4 0.1 0.4 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.6 0.4 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.3 0.5 0.5 1.0 0.0 0.0 0.0 0.0 0.4 3.0 0.0 0.9 0.2 0.3 0.4 0.0 0.8 0.0 0.0 0.0 0.2 0.4 0.4 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.7 0.1 0.5 1.1 0.0 0.8 0.2 0.1 0.0 0.0 0.3 0.6 0.5 0.0 0.5 1.0 0.9 0.4 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL136373.1 ENSG00000282881 "Uncharacterized protein LOC105378696 " 1 46532166-46533614 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.9;testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "BEWO: 3.4" "Group enriched" "Detected in some" 5 "amygdala: 1.2;basal ganglia: 1.6;hypothalamus: 1.4" NA NA 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL162417.1 ENSG00000285245 9 133098121-133163914 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.8;HUVEC TERT2: 2.1;K-562: 1.5;REH: 2.4;TIME: 2.3;U-937: 1.5" HPA025961 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA025961: AB_2671795" 2.4 1.8 2.0 5.1 1.5 3.4 6.0 2.6 2.4 1.6 1.5 1.8 1.0 3.2 2.0 1.5 1.9 0.9 2.0 2.0 2.1 1.2 0.9 2.9 8.2 1.2 0.9 6.5 4.6 0.8 0.9 7.9 2.9 2.7 1.1 6.5 2.2 2.6 1.3 1.3 1.0 3.7 2.2 3.0 1.4 0.9 1.5 0.0 2.6 0.4 4.1 2.0 3.0 0.0 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.6 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 2.1 0.1 1.5 0.5 0.0 0.0 0.6 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL163636.2 ENSG00000259171 14 20684587-20700576 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "liver: 164.0" "Cell type enhanced" "Detected in some" 31 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 2.2;Ciliated cells: 4.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 12.8;memory B-cell: 4.4;myeloid DC: 6.9" "Group enriched" "Detected in many" 12 "B-cells: 4.4;dendritic cells: 6.9;monocytes: 12.8" "Cell line enhanced" "Detected in many" "ASC diff: 11.2;ASC TERT1: 24.0;Hep G2: 14.9;HSkMC: 10.6;OE19: 37.6" NA NA "unprognostic (1.88e-1)" "unprognostic (3.10e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-2)" "unprognostic (1.33e-2)" "unprognostic (2.81e-3)" "unprognostic (1.93e-1)" "unprognostic (1.27e-1)" "unprognostic (2.60e-1)" "unprognostic (8.66e-2)" "unprognostic (6.61e-2)" "unprognostic (6.87e-3)" "unprognostic (8.58e-3)" "unprognostic (2.88e-1)" "unprognostic (2.53e-2)" "unprognostic (5.11e-2)" 34.3 2.1 1.3 6.1 1.6 0.0 33.2 1.0 1.2 29.1 18.6 2.5 13.9 9.8 22.0 21.0 16.8 13.3 26.8 9.1 2.2 1.4 21.5 164.0 14.5 5.5 3.0 1.2 35.6 18.7 1.4 3.0 4.7 2.6 35.2 14.2 11.8 40.5 16.1 7.8 9.9 15.5 19.9 4.0 3.3 22.6 15.0 1.8 0.0 9.3 11.8 8.1 28.9 30.3 4.4 6.9 0.2 12.8 0.0 0.6 3.2 1.3 0.4 1.1 0.0 11.2 24.0 0.0 1.5 3.7 0.0 0.9 0.1 1.6 0.0 0.2 5.6 1.6 0.5 0.3 0.1 0.0 3.5 0.4 0.2 0.0 14.9 0.8 0.0 0.1 10.6 0.8 0.0 0.5 7.3 0.7 1.1 0.0 6.2 1.5 0.0 0.1 0.2 0.0 37.6 0.3 0.2 0.8 1.1 0.4 0.6 0.0 0.1 2.5 0.9 1.0 0.1 1.2 0.0 1.3 1.8 0.5 1.2 0.2 1.2 1.0 0.0 1.9 0.3 1.9 0.0 12.8 0.0 0.0 0.7 0.3 4.4 0.6 0.3 6.9 0.9 0.2 0.1 0.2 0.0 0.0 1.4 0.6 3.2 1.3 1.6 1.0 1.2 2.2 1.4 3.0 1.2 2.6 1.8 11.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL391650.1 ENSG00000236782 1 26169516-26171821 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "retina: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 3.3" "Not detected" "Not detected" NA NA "unprognostic (4.80e-2)" "unprognostic (3.89e-2)" "unprognostic (1.78e-1)" "unprognostic (2.24e-3)" "unprognostic (9.79e-2)" "unprognostic (4.84e-2)" "unprognostic (4.87e-3)" "unprognostic (6.44e-4)" "unprognostic (4.45e-1)" "unprognostic (9.33e-2)" "unprognostic (1.93e-2)" "unprognostic (2.29e-1)" "unprognostic (1.17e-1)" "unprognostic (3.23e-1)" "unprognostic (7.73e-2)" "unprognostic (1.57e-2)" "unprognostic (2.26e-1)" 0.1 0.5 0.1 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.2 0.7 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.3 0.1 0.1 1.1 2.4 0.0 0.1 0.1 0.1 0.2 0.0 18.5 0.3 0.1 3.3 0.3 0.5 0.1 0.1 0.1 0.3 0.6 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.6 0.2 0.0 0.9 0.0 1.4 0.0 1.0 0.4 0.7 0.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.2 1.0 3.3 0.3 0.0 0.7 0.8 0.0 0.0 0.0 1.0 1.9 0.6 0.4 0.7 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.3 1.4 0.0 0.2 0.7 0.4 2.6 0.3 0.0 1.3 0.9 0.4 0.0 0.5 2.3 0.6 0.2 0.7 1.9 1.1 0.6 0.0 0.0 0.1 1.8 1.3 0.3 1.2 0.4 2.3 0.0 1.2 1.3 0.0 0.3 0.0 1.0 0.6 0.1 0.4 0.3 0.6 0.2 0.6 1.4 1.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 AL590132.1 ENSG00000284299 1 210858125-211134146 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "brain: 17.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 2.1;SH-SY5Y: 4.8;SK-MEL-30: 3.1;T-47d: 2.1" NA NA 0.8 1.3 5.3 1.3 11.4 0.6 0.6 16.5 17.5 0.6 0.7 2.6 0.0 0.7 0.7 0.6 0.6 0.6 0.6 0.6 3.1 0.7 0.6 0.6 0.7 0.0 6.3 0.6 0.6 0.8 0.2 0.6 1.2 0.7 0.7 0.0 0.8 0.6 1.5 0.6 0.6 0.6 0.0 0.7 0.7 0.7 1.1 0.0 0.6 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.3 0.0 0.4 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.3 2.1 0.1 0.1 0.0 0.2 4.8 0.0 0.2 3.1 0.0 2.1 0.0 0.0 0.7 0.2 1.2 0.7 0.0 0.0 0.0 0.6 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL592490.1 ENSG00000197991 13 61409858-61427849 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "brain: 1.6;testis: 2.3" "Group enriched" "Detected in some" 32 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062669 Approved "Vesicles,Cytokinetic bridge" NA NA Vesicles "Cytokinetic bridge" "HPA062669: AB_2732687" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL662820.1 ENSG00000285064 6 33321386-33329286 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "retina: 26.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.5;neutrophil: 2.4" "Group enriched" "Detected in many" 4 "B-cells: 2.5;granulocytes: 2.4;T-cells: 1.6" "Cell line enhanced" "Detected in some" "U-266/84: 1.6;U-698: 3.2;U-937: 1.6" NA NA 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 2.5 0.0 2.4 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 2.5 0.3 1.6 2.4 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL662899.1 ENSG00000204422 6 31686962-31714072 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.8;brain: 5.3" "Cell type enriched" "Detected in single" 7 "Club cells: 2.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 2.9;cerebral cortex: 5.3;hippocampal formation: 1.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 25 "HEL: 10.9" NA NA "unprognostic (1.83e-1)" "unprognostic (2.84e-1)" "unprognostic (3.49e-1)" 0.1 0.0 2.9 0.1 0.5 3.8 0.1 0.1 5.3 0.4 0.7 0.1 0.1 0.0 0.5 0.7 0.9 0.2 0.4 0.1 1.8 0.2 0.1 0.1 1.1 0.1 0.1 0.1 0.6 0.1 0.3 0.2 0.1 0.7 0.1 0.5 0.1 0.2 0.1 0.1 2.7 0.1 0.1 0.1 1.7 0.0 0.9 0.1 0.6 2.3 0.1 0.1 0.1 0.8 0.8 1.3 2.9 1.5 0.7 0.9 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 10.9 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 1.3 1.7 0.9 1.5 0.6 0.5 0.6 0.6 1.3 0.8 0.4 0.4 2.9 0.7 1.4 1.1 0.6 1.5 2.9 0.5 0.1 5.3 1.8 0.2 0.1 0.1 0.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL669918.1 ENSG00000250264 6 32813767-32838822 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 17.2;HDLM-2: 11.4;HEL: 12.4" HPA001312 Approved Approved "Nuclear speckles,Endoplasmic reticulum" NA NA "Nuclear speckles, Endoplasmic reticulum" "HPA001312: AB_1080206" "unprognostic (6.13e-2)" "unprognostic (8.76e-3)" "unprognostic (4.62e-1)" "unprognostic (9.88e-2)" "unprognostic (1.99e-1)" "unprognostic (3.39e-2)" "unprognostic (1.72e-1)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.49e-1)" "unprognostic (8.73e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" 6.5 3.6 2.8 25.5 3.1 3.8 3.6 3.1 3.3 4.8 7.7 3.5 1.0 5.7 4.6 2.5 4.8 3.6 5.7 3.5 2.1 2.6 5.3 10.0 8.5 12.6 3.2 2.8 4.7 2.1 1.7 5.0 2.4 3.6 3.8 3.1 3.6 7.0 1.4 2.5 3.3 15.1 2.7 2.8 18.1 12.3 2.5 3.1 14.0 7.5 3.2 10.6 3.8 3.9 8.6 5.5 8.1 4.8 2.3 4.6 5.1 2.1 3.2 0.0 0.7 1.6 1.7 0.5 0.6 0.3 0.0 0.6 0.0 3.3 17.2 2.0 0.2 0.2 7.8 1.6 1.7 0.6 11.4 0.2 12.4 2.1 0.3 0.5 0.0 0.5 0.0 0.9 0.5 0.2 0.0 0.0 1.9 3.1 2.9 0.2 0.6 1.4 0.9 0.2 0.0 2.9 6.0 0.6 5.5 0.0 0.0 0.3 0.3 0.5 5.3 1.4 0.0 5.1 1.3 0.0 1.3 1.9 0.4 0.7 1.4 2.8 7.6 0.7 3.6 0.4 1.6 3.1 6.1 3.5 3.2 3.4 8.0 2.8 3.9 5.5 8.6 2.1 4.6 8.1 2.3 4.8 5.2 4.2 5.1 2.8 3.1 3.1 3.3 2.1 2.6 3.2 2.8 3.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL845331.2 ENSG00000259916 2 94588522-94604573 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "adipose tissue: 12.1" "Cell type enriched" "Detected in single" 10 "Proximal tubular cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "ASC diff: 6.8" NA NA "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (8.07e-3)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.15e-1)" "unprognostic (9.15e-3)" "unprognostic (6.22e-2)" "unprognostic (4.66e-2)" 12.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALCAM "CD166, MEMD" ENSG00000170017 "Activated leukocyte cell adhesion molecule" Q13740 3 105366909-105576900 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Cell adhesion, Immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 122.5" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 684.9;Ciliated cells: 364.1;Club cells: 315.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 20.7" "Lineage enriched" "Detected in many" 6 "dendritic cells: 20.7" "Cell line enhanced" "Detected in many" "hTERT-HME1: 64.5;U-138 MG: 77.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002148, HPA010926" Enhanced "Intracellular and membrane" NA NA 1800000000 "CAB002148: AB_442053, HPA010926: AB_1078449" "unprognostic (6.82e-2)" "unprognostic (2.66e-1)" "unprognostic (2.13e-1)" "unprognostic (2.19e-1)" "unprognostic (9.48e-3)" "unprognostic (2.08e-2)" "unprognostic (1.63e-3)" "unprognostic (3.89e-2)" "unprognostic (1.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.15e-4)" "unprognostic (3.15e-1)" "unprognostic (4.47e-2)" "unprognostic (9.57e-2)" "unprognostic (7.76e-2)" 16.6 14.1 23.6 5.2 31.1 4.2 34.2 4.2 25.3 12.9 8.2 25.0 13.9 7.2 7.0 15.4 4.0 20.6 9.9 4.7 23.2 24.3 9.6 19.4 29.6 4.2 45.1 19.7 24.6 15.3 122.5 11.9 5.3 31.5 14.0 6.6 3.0 17.9 17.5 0.9 5.9 7.3 10.8 35.3 3.0 14.2 2.3 43.8 2.2 25.6 2.7 6.2 9.9 5.5 3.5 20.7 3.7 3.2 0.4 1.6 2.0 38.3 14.8 10.6 5.4 16.2 7.1 0.1 31.4 18.4 20.3 28.5 0.1 8.0 2.7 13.1 44.2 11.2 29.8 1.7 25.0 60.1 2.5 2.6 0.3 11.3 0.7 18.2 15.6 0.1 12.6 18.6 25.9 64.5 56.7 22.2 2.8 0.0 4.6 26.6 2.6 2.2 5.7 2.2 12.4 16.8 1.4 0.9 0.1 30.8 4.3 7.7 21.5 3.2 3.1 2.0 4.4 6.0 10.3 46.1 77.7 26.5 3.3 37.2 0.0 0.0 0.2 17.7 3.3 33.2 0.0 3.2 2.4 0.4 1.5 1.4 3.5 1.1 0.7 20.7 2.2 0.2 0.2 3.7 0.4 0.8 7.4 1.6 2.0 23.6 31.1 4.2 24.6 23.2 24.3 45.1 19.7 31.5 43.8 684.9 108.8 7.2 17.0 10.8 3.0 5.6 61.1 364.1 315.1 15.7 2.0 0.6 1.7 16.4 49.7 10.5 7.5 0.0 36.7 0.6 27.3 97.5 10.5 40.4 60.4 1.6 16.1 3.7 38.7 47.9 3.4 105.6 23.6 140.7 15.0 1.3 39.9 5.8 6.0 23.3 0.5 0.0 19.6 2.1 3.4 17.7 0.7 3.2 9.8 69.3 ALDH3A2 "ALDH10, FALDH, SLS" ENSG00000072210 "Aldehyde dehydrogenase 3 family member A2" P51648 17 19648136-19677598 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 35.6;OE19: 66.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014769, CAB020692" Approved NA NA "CAB020692: , HPA014769: AB_1844728" "unprognostic (1.42e-1)" "unprognostic (7.62e-2)" "unprognostic (7.77e-2)" "unprognostic (2.49e-2)" "unprognostic (4.59e-1)" "unprognostic (1.64e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-2)" "unprognostic (2.23e-1)" "unprognostic (3.93e-3)" "unprognostic (2.40e-1)" "unprognostic (2.63e-1)" "prognostic favorable (3.85e-8)" "unprognostic (4.12e-2)" "unprognostic (1.55e-1)" "unprognostic (1.42e-2)" "unprognostic (1.26e-1)" 22.3 66.4 8.5 9.0 24.6 2.8 10.0 8.8 12.8 13.7 15.9 17.5 7.5 15.6 13.5 19.2 39.6 10.7 26.4 12.5 9.5 6.5 52.5 88.6 17.7 4.3 11.1 10.3 13.5 24.4 10.1 14.9 3.1 14.4 20.7 11.1 16.2 26.0 10.0 18.5 57.1 26.6 10.5 10.2 8.0 18.3 9.8 15.4 4.5 27.3 27.9 22.5 9.8 17.0 3.9 14.3 11.6 14.2 8.6 6.4 5.7 5.7 35.6 3.6 8.9 17.0 14.3 2.5 1.7 4.3 3.4 3.8 11.1 9.2 1.8 4.1 7.0 5.9 12.7 14.0 17.1 2.4 7.9 6.1 0.9 18.7 27.2 3.2 4.2 0.4 7.9 24.3 3.1 1.9 8.9 6.7 4.8 0.2 0.0 8.5 7.7 0.1 5.2 8.5 66.4 19.5 4.1 10.2 5.4 3.9 18.0 6.9 4.9 15.5 6.0 4.9 22.9 10.4 3.9 7.9 2.2 4.0 5.7 5.3 2.4 6.0 2.5 10.5 0.0 7.0 0.0 14.2 11.6 4.2 12.6 6.4 3.9 4.3 3.7 14.3 3.0 4.9 3.4 0.7 8.6 13.7 0.2 5.8 5.7 8.5 24.6 8.8 12.8 9.5 6.5 11.1 10.3 14.4 15.4 163.8 69.7 11.9 106.4 50.7 13.8 39.2 104.4 69.6 113.7 31.4 11.8 10.6 36.5 84.4 78.7 15.8 49.7 0.0 45.0 3.4 27.7 87.9 27.8 102.6 23.4 6.4 15.5 14.1 16.7 14.7 51.8 24.2 6.8 21.6 25.0 98.7 45.1 28.1 75.7 88.8 20.1 12.9 14.6 10.4 22.6 78.9 1.1 13.8 36.8 28.6 ALDH6A1 MMSDH ENSG00000119711 "Aldehyde dehydrogenase 6 family member A1" Q02252 14 74056850-74084493 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 140.0;liver: 134.5" "Cell type enhanced" "Detected in many" 15 "Hepatocytes: 453.8;Proximal tubular cells: 730.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 25.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029072, HPA029073, HPA029074, HPA029075" Enhanced Enhanced Mitochondria No No 9100 Mitochondria "HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005" "unprognostic (1.45e-1)" "unprognostic (5.38e-2)" "unprognostic (6.89e-2)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (7.93e-2)" "unprognostic (1.11e-3)" "prognostic favorable (4.22e-4)" "unprognostic (1.58e-1)" "unprognostic (9.10e-2)" "unprognostic (3.11e-2)" "unprognostic (2.13e-1)" "prognostic favorable (2.00e-15)" "unprognostic (4.59e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-3)" "unprognostic (1.12e-1)" 14.1 6.9 31.3 2.8 30.9 2.3 6.7 11.6 26.4 8.0 11.0 20.1 4.6 11.0 5.5 5.5 5.0 6.2 4.8 15.6 21.1 14.2 140.0 134.5 4.7 3.0 19.4 18.5 12.3 11.8 16.4 3.2 4.0 14.8 11.0 7.2 7.1 7.8 7.8 10.5 3.4 9.3 5.6 13.1 3.1 9.6 7.4 18.7 2.0 12.1 4.0 3.1 6.3 3.3 4.5 5.6 25.5 3.8 5.5 6.7 2.8 4.6 4.0 5.7 12.1 20.9 10.2 9.2 3.2 6.1 3.5 6.0 9.1 5.2 5.4 7.2 6.9 2.9 2.7 13.0 3.6 7.7 4.8 1.8 2.5 4.2 9.9 23.8 1.3 1.2 15.0 6.6 4.5 11.4 9.2 6.2 12.2 4.0 7.5 2.4 17.8 3.7 2.0 4.5 17.2 2.7 7.6 5.9 7.1 5.6 3.5 2.3 3.6 10.7 11.6 2.8 10.1 29.7 4.8 1.9 4.0 4.9 6.2 1.2 5.1 9.2 5.5 5.2 1.6 3.8 13.3 3.8 25.5 4.5 2.9 6.7 4.5 5.1 5.3 5.6 3.6 6.5 4.6 1.5 5.5 2.4 3.2 3.6 2.8 31.3 30.9 11.6 26.4 21.1 14.2 19.4 18.5 14.8 18.7 35.7 48.4 23.6 21.0 8.1 17.6 73.0 48.4 25.4 29.6 62.8 3.9 22.5 170.8 8.1 19.8 13.5 22.3 0.0 2.7 12.8 13.1 38.6 7.0 453.8 14.9 11.1 16.3 58.3 22.2 15.8 26.7 9.0 23.6 20.8 37.9 90.4 5.6 10.5 45.3 730.1 15.1 12.9 21.7 10.5 3.9 6.5 25.6 6.9 37.0 15.2 ALDOA ENSG00000285043 "Aldolase, fructose-bisphosphate A" P04075 16 30053090-30070420 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Glycolysis Lyase "Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 1558.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA004177 Uncertain Approved Cytosol NA NA 1200000000 Cytosol "HPA004177: AB_1078128" 1.8 0.9 2.7 1.1 5.0 2.1 7.2 0.7 7.7 4.9 1.5 2.0 2.4 0.0 2.5 3.9 0.9 3.6 1.6 5.3 2.3 1.3 0.0 2.3 2.0 0.8 4.4 2.2 0.8 0.8 3.0 1.4 4.0 2.4 0.5 2.8 1.6 7.5 10.6 0.6 0.1 1.9 0.4 1.7 1.3 11.6 0.8 1.2 4.7 0.2 2.7 1.2 1.0 7.0 6.6 0.9 6.2 4.2 8.5 12.5 3.8 8.9 1.9 6.2 1.5 5.2 1.5 4.1 7.0 5.5 21.8 3.6 5.1 24.7 6.0 6.8 1.8 6.4 14.1 11.1 3.8 4.4 8.0 6.0 8.3 6.0 11.6 10.6 2.3 5.1 0.5 10.8 12.4 4.5 7.8 4.0 1.2 7.2 13.5 3.9 5.0 8.1 2.1 1.7 5.6 7.7 4.0 22.7 15.3 0.7 6.2 5.1 1.0 1.7 1.5 0.6 5.2 4.0 1.7 8.1 2.5 3.7 5.4 7.4 5.5 8.1 7.7 11.5 3.5 0.1 6.2 0.1 5.3 2.6 7.4 7.0 7.0 5.7 6.6 6.2 8.5 6.6 0.9 4.2 2.3 5.6 5.4 12.5 11.9 25.9 269.9 530.0 703.6 362.0 0.0 315.9 36.1 40.9 40.1 111.9 0.0 94.5 100.6 190.1 242.7 1558.3 46.7 66.6 0.0 38.0 448.8 200.0 94.7 0.0 692.8 311.1 289.1 683.7 930.6 352.7 289.5 877.3 70.3 597.6 553.3 106.3 971.1 380.8 45.3 219.0 478.6 664.3 23.8 81.3 598.3 0.0 258.9 731.1 912.8 ALG1 "CDG1K, HMAT1, HMT-1, Mat-1" ENSG00000033011 "ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase" Q9BT22 16 5033960-5087379 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA060392 Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: AB_2684273" "unprognostic (1.66e-2)" "unprognostic (5.18e-1)" "prognostic favorable (5.79e-4)" "unprognostic (1.55e-2)" "unprognostic (2.10e-2)" "unprognostic (3.22e-2)" "unprognostic (2.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (5.27e-2)" "unprognostic (1.02e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (2.58e-3)" "unprognostic (3.86e-2)" 11.0 22.2 8.7 10.8 12.8 6.6 12.8 9.3 18.8 13.7 16.4 14.9 10.1 14.7 12.1 17.0 11.7 12.4 14.3 8.1 8.8 10.4 18.9 31.6 9.9 12.7 10.5 6.5 10.1 27.9 21.5 13.6 10.7 14.6 10.8 17.2 15.5 20.6 12.0 7.3 9.1 12.8 12.1 9.4 16.2 16.5 19.4 11.4 16.0 15.0 8.7 14.5 12.1 8.7 20.7 24.3 7.8 23.3 20.9 26.5 31.7 6.5 17.8 4.5 8.4 17.2 10.3 8.3 14.7 20.7 19.2 19.3 14.7 24.2 13.9 12.7 18.7 8.0 17.6 12.3 14.5 13.1 11.4 13.9 7.8 14.8 30.3 14.1 13.6 13.7 12.4 11.0 15.1 9.6 7.6 11.4 11.3 9.7 18.2 14.2 17.7 8.7 16.7 17.0 11.9 10.2 16.2 6.2 38.7 12.0 7.1 7.6 7.7 15.7 24.6 8.4 6.3 16.0 11.1 10.9 9.0 8.3 45.5 12.3 13.3 16.0 9.4 7.4 14.6 12.7 3.3 23.3 7.8 26.5 21.6 23.1 19.8 22.9 25.4 24.3 20.7 21.0 23.7 1.5 20.9 21.2 21.2 21.6 31.7 8.7 12.8 9.3 18.8 8.8 10.4 10.5 6.5 14.6 11.4 14.9 6.7 14.0 2.8 2.2 7.1 0.6 12.7 12.0 7.9 7.0 11.8 13.9 3.3 15.9 8.2 4.5 8.4 0.0 24.6 16.8 7.2 3.4 1.1 15.5 19.6 3.2 12.9 9.2 8.2 23.0 8.9 5.9 10.1 6.4 17.7 7.2 18.4 10.5 6.3 8.7 5.0 6.5 1.4 25.9 17.2 1.4 7.1 8.7 18.0 3.5 ALG10 "ALG10A, DIE2, FLJ14751" ENSG00000139133 "ALG10, alpha-1,2-glucosyltransferase" Q5BKT4 12 34022281-34029694 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043329, HPA063387" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA043329: AB_2678432, HPA063387: AB_2685000" "unprognostic (1.71e-1)" "unprognostic (4.98e-2)" "unprognostic (3.16e-3)" "unprognostic (2.80e-2)" "unprognostic (9.23e-2)" "unprognostic (3.49e-2)" "unprognostic (5.88e-4)" "unprognostic (2.13e-1)" "unprognostic (1.73e-2)" "unprognostic (8.01e-2)" "unprognostic (5.41e-2)" "unprognostic (1.16e-1)" "unprognostic (9.29e-2)" "unprognostic (8.99e-2)" "unprognostic (1.53e-1)" "unprognostic (2.43e-1)" "unprognostic (6.45e-2)" 6.2 7.0 2.7 5.4 5.9 6.9 6.9 4.0 5.5 5.3 4.6 3.8 3.6 3.4 10.3 5.5 6.0 6.2 3.7 4.6 2.6 2.9 4.6 5.7 5.4 6.7 4.1 1.7 7.1 7.8 7.5 6.1 7.2 3.5 5.8 4.1 8.7 9.0 4.4 4.6 5.1 5.0 4.0 3.5 6.1 5.1 8.0 3.6 17.2 6.2 3.0 9.8 5.8 4.8 2.7 1.8 4.5 2.7 2.1 3.8 1.6 4.5 5.4 3.5 5.8 4.2 3.3 12.4 4.4 4.1 4.8 8.6 7.9 11.0 6.9 6.5 2.2 7.1 6.9 6.6 5.6 6.5 11.0 6.3 6.4 5.7 3.1 1.7 9.2 6.7 3.6 3.3 10.1 7.7 2.3 3.2 6.2 9.6 11.7 3.9 6.2 5.9 5.1 13.1 2.7 6.8 5.3 12.7 7.0 2.6 6.8 3.1 2.5 7.7 3.3 5.5 10.5 7.9 2.5 6.8 6.6 9.8 8.8 5.5 6.4 11.5 13.3 4.6 3.7 5.2 0.0 2.7 4.5 1.9 1.2 3.0 2.5 2.6 1.1 1.8 2.7 3.1 3.8 0.4 2.1 1.2 1.8 3.0 1.6 2.7 5.9 4.0 5.5 2.6 2.9 4.1 1.7 3.5 3.6 6.0 0.3 3.0 2.5 1.3 3.5 0.8 2.5 4.0 3.4 5.2 3.9 6.4 1.7 1.9 0.6 2.1 1.0 0.0 3.3 4.7 2.1 0.6 1.1 2.4 2.9 1.6 1.2 0.6 2.7 0.0 1.4 2.1 0.0 4.6 1.9 3.7 2.6 0.0 1.1 1.1 4.1 0.0 1.0 7.5 3.0 2.4 2.6 4.3 1.7 1.4 ALG10B KCR1 ENSG00000175548 "ALG10B, alpha-1,2-glucosyltransferase" Q5I7T1 12 38316578-38329728 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 31.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA043329, HPA063387" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA043329: AB_2678432, HPA063387: AB_2685000" "unprognostic (4.55e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-1)" "unprognostic (1.25e-1)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (4.43e-2)" "unprognostic (8.58e-2)" "unprognostic (7.40e-2)" "unprognostic (8.40e-2)" "unprognostic (1.17e-1)" "unprognostic (2.05e-2)" "unprognostic (1.91e-1)" "unprognostic (3.30e-3)" "unprognostic (2.63e-1)" "unprognostic (1.93e-1)" "unprognostic (2.28e-1)" 8.2 8.5 4.3 4.9 7.0 6.6 9.1 5.3 7.2 6.1 4.4 5.4 9.5 4.2 8.5 6.7 6.9 6.4 6.0 5.8 5.0 2.7 5.9 6.6 6.5 7.3 6.6 4.8 8.7 9.6 8.7 7.8 11.6 4.3 6.1 4.5 10.5 9.3 9.7 5.8 7.7 6.5 4.6 4.5 7.5 6.4 8.9 5.0 10.5 7.4 5.6 6.6 7.7 6.8 3.6 2.6 2.0 2.0 1.4 4.1 1.2 5.0 4.7 6.2 6.2 3.1 5.8 6.4 4.0 2.1 5.4 4.8 1.7 15.3 7.7 7.0 2.0 4.0 5.3 5.4 4.4 7.8 5.1 6.9 8.1 8.1 3.4 3.4 10.8 5.7 3.2 5.8 7.6 5.6 4.8 3.9 9.8 9.1 4.7 4.5 3.8 7.2 8.6 7.8 0.5 4.7 2.4 13.3 6.1 4.6 6.3 1.8 6.4 7.0 2.4 4.8 6.9 10.7 4.4 3.3 5.7 6.6 5.0 5.0 3.7 9.5 12.3 4.8 7.6 7.1 1.2 1.5 2.0 1.1 2.0 2.2 1.8 1.1 1.8 1.1 3.6 2.2 2.7 0.6 1.4 1.4 2.6 4.1 1.2 4.3 7.0 5.3 7.2 5.0 2.7 6.6 4.8 4.3 5.0 6.0 11.5 0.5 3.5 1.8 12.9 3.0 0.0 6.7 9.1 3.5 31.4 15.2 6.6 3.6 0.2 4.9 1.2 0.0 5.0 8.2 3.5 2.4 1.1 5.9 4.2 9.5 0.0 6.2 1.5 1.5 3.7 1.9 1.7 0.0 2.5 8.9 3.5 2.0 5.3 2.2 12.4 6.5 1.4 8.3 3.4 1.6 6.8 1.3 2.5 2.3 ALG11 "CDG1P, KIAA0266" ENSG00000253710 "ALG11, alpha-1,2-mannosyltransferase" Q2TAA5 13 52012398-52029664 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 17.9;Ciliated cells: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047214 Approved NA NA "HPA047214: AB_10961640" "unprognostic (9.21e-2)" "unprognostic (1.31e-3)" "unprognostic (2.02e-1)" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (3.04e-2)" "unprognostic (9.15e-3)" "unprognostic (1.69e-1)" "unprognostic (2.28e-1)" "unprognostic (8.97e-3)" "unprognostic (8.89e-3)" "unprognostic (7.47e-2)" "unprognostic (2.30e-4)" "unprognostic (1.87e-2)" "unprognostic (1.60e-1)" "unprognostic (6.03e-2)" "unprognostic (9.71e-3)" 14.7 16.9 11.9 9.6 16.2 14.2 13.8 11.8 17.7 13.9 11.9 12.6 15.9 9.8 15.2 13.0 12.6 12.9 11.3 12.2 13.4 9.5 17.3 20.9 11.5 9.3 13.5 11.5 13.1 15.6 18.4 18.4 19.5 15.7 13.5 13.9 11.4 17.6 13.7 13.0 13.7 15.6 14.2 16.6 11.6 13.1 12.2 12.3 13.8 19.6 7.0 10.3 14.7 11.2 10.4 14.4 14.6 14.1 8.7 13.3 6.4 5.0 7.1 12.3 12.2 11.1 10.9 10.8 13.5 11.4 10.4 9.0 9.5 12.3 10.0 3.7 11.6 10.8 10.7 12.7 8.9 14.2 11.8 9.6 23.9 7.6 8.6 10.7 20.0 24.0 10.0 13.4 9.6 11.4 8.6 9.3 11.5 13.6 9.8 12.6 4.5 9.7 7.4 12.7 15.7 5.9 12.6 8.9 6.1 10.3 9.9 5.2 9.6 10.3 9.6 8.4 10.3 11.7 11.7 13.2 9.6 7.8 9.8 9.8 5.5 7.7 13.2 6.3 7.6 15.8 14.6 7.4 9.8 11.3 6.0 11.2 8.0 10.2 10.5 8.3 10.4 13.1 13.3 4.1 8.7 14.1 14.4 9.8 6.4 11.9 16.2 11.8 17.7 13.4 9.5 13.5 11.5 15.7 12.3 17.9 5.1 1.5 2.3 2.2 5.8 5.5 5.1 17.4 10.3 3.5 5.9 3.0 1.7 2.4 0.7 3.5 2.5 0.0 2.0 2.6 2.2 2.1 3.5 3.0 2.2 4.8 2.9 7.4 2.1 0.2 3.1 3.3 1.7 1.0 1.8 3.6 2.2 1.7 1.1 1.1 6.7 0.0 1.4 4.2 3.3 2.0 4.0 3.1 1.7 3.3 ALG12 "CDG1G, ECM39" ENSG00000182858 "ALG12, alpha-1,6-mannosyltransferase" Q9BV10 22 49900229-49918458 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003076, HPA051665" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA003076: AB_2666777, HPA051665: AB_2681566" "unprognostic (1.66e-1)" "unprognostic (1.26e-1)" "unprognostic (4.39e-3)" "prognostic favorable (6.09e-4)" "unprognostic (2.29e-1)" "unprognostic (3.32e-2)" "unprognostic (4.27e-3)" "unprognostic (3.33e-2)" "unprognostic (1.46e-1)" "unprognostic (3.32e-2)" "unprognostic (1.42e-1)" "unprognostic (2.21e-1)" "prognostic favorable (3.60e-5)" "unprognostic (1.62e-2)" "unprognostic (3.00e-2)" "unprognostic (9.89e-3)" "unprognostic (6.32e-2)" 9.8 13.3 9.6 11.3 11.2 8.5 9.9 16.0 12.7 10.9 11.7 16.2 15.7 18.0 13.2 11.5 12.1 11.4 11.0 12.0 10.0 5.8 14.1 22.8 10.8 9.2 11.6 7.9 11.8 17.5 14.7 10.6 11.3 10.9 13.5 7.1 12.2 19.4 10.2 8.7 11.5 14.8 7.7 8.9 11.5 14.5 6.5 14.9 12.6 24.5 10.5 12.8 12.1 10.3 7.6 7.8 17.7 9.4 16.1 12.7 7.9 7.0 7.1 7.5 12.5 14.5 6.8 8.4 7.4 6.7 8.8 7.1 11.6 10.2 3.8 6.8 6.6 9.6 12.9 9.2 8.8 4.4 6.0 13.5 3.5 11.9 11.7 16.4 8.7 7.7 10.2 9.1 8.6 12.4 9.7 8.4 8.7 4.3 9.6 4.6 16.1 8.4 7.1 7.2 9.4 6.6 14.2 9.5 10.0 9.2 8.1 5.1 8.4 11.8 22.5 9.2 10.6 9.2 7.8 6.5 9.8 7.5 6.8 5.6 8.5 3.9 5.0 10.9 6.7 9.3 17.7 8.8 7.4 12.4 8.2 12.7 5.3 9.8 12.2 7.7 7.6 8.3 9.3 6.9 16.1 9.4 7.8 12.3 7.9 9.6 11.2 16.0 12.7 10.0 5.8 11.6 7.9 10.9 14.9 8.9 1.9 8.1 9.0 3.7 5.4 1.2 2.5 5.3 7.9 17.4 2.0 17.2 3.3 14.4 4.7 6.9 15.5 0.0 11.7 19.0 7.8 8.8 8.1 11.9 15.8 3.2 6.4 7.4 8.6 3.0 8.1 6.1 10.1 10.8 11.2 3.4 10.1 7.0 7.8 5.5 5.1 0.0 3.3 8.6 9.4 5.3 22.0 12.9 13.7 8.1 ALG14 MGC19780 ENSG00000172339 "ALG14, UDP-N-acetylglucosaminyltransferase subunit" Q96F25 1 94974407-95072945 "Disease related genes, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031829 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA031829: AB_2674062" "unprognostic (7.79e-2)" "unprognostic (3.59e-2)" "unprognostic (1.51e-3)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "unprognostic (6.56e-2)" "unprognostic (4.00e-1)" "unprognostic (2.17e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (7.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (9.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.99e-2)" "unprognostic (1.93e-1)" 5.8 13.2 6.8 4.1 8.5 4.6 6.8 5.6 8.0 5.5 7.5 8.5 7.0 8.5 5.4 11.3 5.7 4.8 6.1 6.3 7.0 7.2 8.9 15.1 5.3 7.5 8.2 4.7 5.3 12.6 5.8 6.6 6.3 8.4 5.1 8.7 6.9 14.5 9.8 7.2 5.0 9.2 4.4 9.4 5.8 6.0 10.0 4.2 3.7 8.5 6.2 5.3 4.8 4.2 4.9 5.8 3.1 3.9 2.8 3.8 1.9 5.2 3.3 2.8 2.5 2.2 3.8 2.5 3.8 4.1 3.9 3.3 3.9 1.8 2.7 4.0 4.7 4.7 3.6 3.2 3.6 4.7 5.7 5.5 1.5 3.6 5.9 3.6 3.6 1.0 4.1 3.7 2.9 2.9 3.2 3.3 3.6 2.9 3.6 3.7 2.5 3.8 2.3 1.7 5.2 4.8 2.4 5.7 2.9 4.4 3.0 2.5 3.2 2.1 7.2 6.3 2.2 3.2 3.1 2.6 2.5 2.8 4.4 7.9 2.3 2.2 2.4 1.8 1.8 2.0 3.1 3.2 1.1 2.5 3.9 2.4 4.9 3.1 3.1 4.5 4.4 2.9 3.0 2.7 2.8 1.9 5.8 3.8 1.9 6.8 8.5 5.6 8.0 7.0 7.2 8.2 4.7 8.4 4.2 0.0 12.6 5.2 10.9 10.4 14.8 7.3 10.2 8.1 11.4 15.7 5.9 28.7 16.6 21.4 5.4 8.0 19.2 23.3 46.6 23.6 21.1 9.2 1.1 30.6 17.2 7.9 4.1 14.7 6.3 6.5 13.3 10.8 30.4 11.8 11.1 28.5 21.0 25.9 9.6 34.3 12.9 32.3 12.5 33.6 22.6 7.5 21.1 4.4 24.9 9.1 ALG3 "CDGS4, D16Ertd36e, Not56, NOT56L" ENSG00000214160 "ALG3, alpha-1,3- mannosyltransferase" Q92685 3 184242301-184249548 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.4" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 169.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045103 Enhanced NA NA "HPA045103: AB_10960547" "unprognostic (3.63e-2)" "unprognostic (2.60e-1)" "unprognostic (2.36e-2)" "unprognostic (1.80e-3)" "unprognostic (3.63e-1)" "unprognostic (7.93e-3)" "prognostic unfavorable (1.58e-5)" "prognostic unfavorable (8.67e-5)" "unprognostic (6.18e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-3)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (9.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.64e-1)" "unprognostic (5.02e-2)" 14.2 24.1 7.7 12.2 10.3 11.6 15.4 7.2 12.9 11.5 15.5 13.7 15.2 14.3 12.8 11.2 20.5 11.5 15.4 13.0 7.3 6.5 19.7 74.4 12.9 16.8 11.5 7.3 12.7 37.7 18.4 11.7 26.6 10.2 14.0 16.0 12.4 20.9 13.7 18.9 18.4 16.3 14.0 7.9 14.9 15.0 20.8 10.1 13.9 15.9 14.9 18.8 17.4 15.8 14.2 30.1 6.0 25.4 18.7 18.0 15.5 20.1 17.6 4.8 16.1 19.4 11.1 16.4 10.9 12.4 14.9 12.8 26.9 13.6 17.8 29.7 13.4 30.2 24.3 17.3 23.6 9.3 12.8 20.1 15.9 13.4 21.6 17.8 25.8 14.4 13.1 19.8 17.6 24.9 7.8 8.1 12.2 15.7 36.0 9.6 24.8 12.5 20.9 15.1 40.2 23.0 13.0 7.5 70.6 16.8 6.7 12.1 10.2 10.1 40.0 17.3 6.1 37.9 14.7 6.5 15.8 10.0 13.8 23.1 19.7 34.6 18.8 14.1 33.9 14.1 0.2 25.4 6.0 16.0 25.0 18.0 14.2 17.3 16.2 30.1 12.3 15.6 15.1 0.9 18.7 19.7 27.4 18.0 15.5 7.7 10.3 7.2 12.9 7.3 6.5 11.5 7.3 10.2 10.1 6.0 14.9 23.1 21.9 22.1 9.4 8.4 22.9 10.7 19.4 19.2 9.8 63.5 6.6 48.3 89.2 15.7 30.3 46.7 54.5 79.0 18.5 26.2 12.7 43.7 62.9 7.9 13.9 14.7 21.8 169.9 11.5 18.6 20.3 15.4 27.2 14.3 42.1 21.0 14.2 23.8 9.9 19.4 19.1 28.7 33.6 23.6 55.0 19.3 41.5 24.2 ALG5 bA421P11.2 ENSG00000120697 "ALG5, dolichyl-phosphate beta-glucosyltransferase" Q9Y673 13 36949775-37000261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007989 Approved Approved Cytosol No No Cytosol "HPA007989: AB_1078132" "unprognostic (1.87e-1)" "unprognostic (1.73e-2)" "unprognostic (6.07e-2)" "unprognostic (1.05e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.57e-2)" "unprognostic (5.82e-2)" "unprognostic (5.21e-2)" "unprognostic (7.46e-2)" "unprognostic (3.51e-2)" "unprognostic (3.30e-1)" "prognostic favorable (1.40e-5)" "unprognostic (7.44e-2)" "unprognostic (1.66e-1)" "unprognostic (7.14e-3)" "unprognostic (1.86e-1)" 14.7 18.2 11.8 14.0 14.2 11.3 19.9 10.9 13.7 16.7 16.5 10.3 34.2 13.0 13.5 34.8 11.7 12.4 12.9 13.1 10.0 10.5 18.1 36.7 19.1 28.0 16.1 12.8 11.8 60.4 11.8 11.6 17.0 12.1 12.9 20.8 7.3 30.2 37.0 9.0 11.0 12.6 10.9 15.1 12.9 17.6 7.2 14.2 15.4 25.5 12.1 12.4 12.4 11.1 19.1 45.5 17.7 24.8 22.1 25.2 26.9 9.6 13.0 12.0 12.3 33.1 22.2 8.8 26.8 28.5 22.7 18.6 25.4 33.7 13.9 11.1 16.2 19.3 23.9 14.8 20.4 21.2 14.8 29.0 31.9 10.8 15.9 32.4 27.0 16.7 23.3 30.1 18.1 24.3 14.9 17.3 15.6 14.6 17.3 20.5 17.3 18.2 21.6 12.3 60.8 10.6 22.2 14.8 34.0 24.1 18.3 9.6 18.7 11.3 21.0 15.5 9.5 12.7 26.9 13.2 12.7 7.2 14.0 17.0 14.8 11.4 18.2 19.6 17.2 21.0 17.7 24.1 10.0 24.4 24.8 24.6 19.1 23.0 24.4 23.6 17.0 21.2 23.2 2.7 22.1 20.2 45.5 25.2 26.9 11.8 14.2 10.9 13.7 10.0 10.5 16.1 12.8 12.1 14.2 47.6 44.6 33.5 34.8 30.8 16.4 9.7 81.5 22.7 31.8 50.6 9.8 71.9 19.9 78.2 27.2 40.9 34.9 0.0 121.6 63.8 57.3 47.1 28.8 63.8 63.1 11.1 34.7 32.5 37.8 17.9 37.2 44.2 75.9 39.7 51.8 33.6 80.6 45.6 36.0 43.5 23.5 45.3 44.3 47.0 21.3 26.5 68.0 41.5 66.2 37.2 ALG6 ENSG00000088035 "ALG6, alpha-1,3-glucosyltransferase" Q9Y672 1 63367590-63438562 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062536, HPA076130" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA062536: AB_2684792, HPA076130: " "unprognostic (1.21e-1)" "unprognostic (5.60e-3)" "prognostic favorable (4.86e-4)" "unprognostic (1.59e-1)" "unprognostic (3.45e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (2.07e-1)" "unprognostic (9.81e-3)" "unprognostic (4.65e-2)" "unprognostic (2.00e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (1.84e-3)" "unprognostic (1.07e-1)" "unprognostic (4.61e-2)" "unprognostic (3.41e-1)" 9.7 13.7 9.3 13.5 13.5 8.8 11.6 12.2 12.6 9.9 11.8 10.1 9.0 12.1 11.0 14.3 16.7 9.6 9.1 9.9 11.2 7.1 10.3 14.6 10.0 13.4 8.2 11.1 10.8 11.5 10.6 10.0 14.1 11.6 8.9 14.0 10.2 12.9 11.9 8.0 13.7 13.5 7.5 10.5 14.5 10.0 6.9 8.7 25.9 9.7 8.5 21.7 10.0 11.6 7.5 7.9 24.2 7.4 7.4 10.6 5.6 5.3 4.8 8.5 7.7 10.2 8.8 11.2 6.3 2.2 3.3 3.8 5.6 5.4 13.9 15.2 5.2 14.6 10.3 12.4 10.1 6.0 15.6 9.8 10.7 5.5 4.6 5.0 12.7 9.3 7.3 6.1 8.1 3.0 6.1 12.5 14.2 11.3 11.2 7.7 7.0 12.2 10.7 26.0 14.6 7.2 12.5 12.0 16.4 9.5 7.4 7.9 4.3 16.8 17.5 16.5 16.3 9.7 7.2 6.8 5.5 5.5 11.6 8.1 9.5 13.3 11.5 5.3 12.7 18.4 24.2 7.4 13.6 8.8 6.6 10.6 7.5 7.2 8.5 7.9 5.6 8.7 9.1 4.3 7.4 6.4 6.5 9.4 5.6 9.3 13.5 12.2 12.6 11.2 7.1 8.2 11.1 11.6 8.7 8.9 3.7 7.5 8.0 9.7 5.6 2.8 10.2 4.0 7.9 3.5 3.9 39.5 1.7 10.5 1.9 5.8 5.8 0.0 7.8 23.6 8.2 5.4 9.2 9.2 13.7 6.4 4.1 8.0 5.9 1.7 6.4 7.5 15.1 0.0 7.8 4.9 6.5 0.0 4.6 5.9 5.1 6.5 5.1 12.1 15.9 9.7 22.4 13.8 9.3 6.4 ALG8 MGC2840 ENSG00000159063 "ALG8, alpha-1,3-glucosyltransferase" Q9BVK2 11 78100936-78139660 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051898 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA051898: AB_2681656" "unprognostic (1.37e-1)" "unprognostic (9.24e-2)" "unprognostic (4.60e-2)" "unprognostic (2.69e-2)" "unprognostic (2.65e-1)" "unprognostic (6.49e-2)" "unprognostic (5.38e-3)" "unprognostic (5.91e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (5.29e-2)" "unprognostic (1.20e-1)" "unprognostic (1.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.34e-1)" "unprognostic (3.78e-2)" "unprognostic (6.37e-2)" 20.2 24.5 18.0 11.2 22.3 9.7 23.7 13.8 17.9 16.5 15.0 20.7 23.9 10.3 14.5 30.9 13.3 18.4 12.3 13.0 15.9 16.0 24.9 40.8 12.8 15.7 16.0 11.6 22.9 23.4 24.2 23.6 21.7 17.1 15.5 19.0 17.6 23.2 19.5 8.2 13.3 13.3 14.8 17.6 13.8 13.1 38.9 16.5 18.2 29.7 13.1 17.4 13.2 11.2 21.9 19.4 3.0 20.3 18.2 19.0 14.9 8.9 24.6 23.6 20.2 20.5 14.4 12.7 13.1 19.7 22.5 21.8 46.6 32.7 20.9 24.3 15.7 29.5 25.7 27.5 18.9 36.4 15.0 16.5 25.2 21.7 20.9 13.3 24.0 16.8 11.5 12.2 26.3 13.1 12.9 16.3 19.0 31.2 21.6 30.1 13.0 20.0 27.1 26.3 60.1 12.9 21.4 10.9 49.8 22.6 13.8 6.9 17.4 18.9 30.7 9.5 22.5 34.3 19.0 10.0 15.3 17.8 34.4 11.3 15.5 30.1 30.9 8.5 23.6 26.4 0.3 17.5 3.0 15.7 19.5 17.5 21.9 16.0 16.1 19.4 16.6 19.0 17.2 1.1 18.2 20.3 18.7 13.0 14.9 18.0 22.3 13.8 17.9 15.9 16.0 16.0 11.6 17.1 16.5 11.9 12.3 25.2 20.6 9.3 13.9 6.3 25.5 10.7 13.6 19.2 17.7 44.1 5.0 18.7 10.7 14.3 6.0 0.0 22.1 52.0 15.3 15.6 11.5 36.4 27.9 15.9 7.5 11.1 14.0 9.8 16.7 17.3 25.3 4.6 15.5 8.2 16.4 5.8 14.9 14.6 12.9 0.0 15.2 115.0 39.1 7.9 27.3 14.9 14.0 15.7 ALG9 DIBD1 ENSG00000086848 "ALG9, alpha-1,2-mannosyltransferase" Q9H6U8 11 111782195-111871581 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038575 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA038575: AB_10672718" "unprognostic (1.48e-1)" "unprognostic (5.39e-2)" "unprognostic (6.22e-2)" "unprognostic (5.34e-3)" "unprognostic (8.72e-2)" "unprognostic (2.90e-1)" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (7.07e-3)" "unprognostic (5.11e-2)" "unprognostic (8.75e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (7.29e-5)" "unprognostic (9.15e-2)" "unprognostic (7.76e-2)" "unprognostic (4.20e-2)" "unprognostic (1.10e-2)" 19.9 13.5 11.8 11.4 17.9 9.0 16.8 19.3 19.3 16.9 13.7 15.6 15.7 16.2 19.1 15.7 13.8 12.5 14.0 14.3 11.6 13.7 13.7 17.7 12.3 13.5 12.2 11.2 19.2 29.9 21.0 16.5 20.3 14.6 14.7 14.9 17.5 34.3 20.1 11.7 17.3 13.2 15.8 13.2 13.0 14.1 25.0 9.8 15.3 17.4 10.9 15.2 13.8 14.2 7.8 9.5 7.0 7.9 7.1 12.2 6.5 9.9 10.1 19.8 19.4 12.3 11.8 15.0 13.0 10.6 10.8 11.7 17.2 17.0 16.1 18.5 14.6 13.6 18.7 10.3 15.7 15.2 12.4 8.1 12.2 5.9 12.6 14.3 13.7 8.5 10.2 10.6 11.2 11.1 15.5 10.3 12.5 12.2 25.2 17.6 7.3 13.7 12.2 6.5 13.9 11.2 12.6 17.6 31.3 11.8 8.9 9.7 16.7 11.4 17.5 7.0 14.4 18.9 5.6 10.2 22.7 16.0 11.0 14.0 8.2 6.1 15.1 9.4 17.1 15.3 6.7 5.8 7.0 8.5 7.9 9.4 7.8 8.0 8.8 9.5 6.6 12.2 7.3 2.3 7.1 6.9 9.4 7.7 6.5 11.8 17.9 19.3 19.3 11.6 13.7 12.2 11.2 14.6 9.8 0.0 4.1 2.9 1.2 1.8 9.4 5.0 2.5 1.4 4.5 7.0 7.9 3.0 3.3 6.3 4.3 2.1 3.2 0.0 6.1 11.4 2.8 1.2 0.0 5.8 2.7 14.3 4.1 2.5 1.2 3.5 4.4 2.3 0.0 3.6 3.4 5.4 5.9 3.5 3.5 2.2 10.3 6.5 4.1 3.7 5.5 1.4 7.6 2.5 3.9 0.6 ALOX5AP FLAP ENSG00000132965 "Arachidonate 5-lipoxygenase activating protein" P20292 13 30713478-30764426 "Disease related genes, Predicted membrane proteins" "Leukotriene biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 296.2;bone marrow: 121.8" "Cell type enhanced" "Detected in many" 12 "granulocytes: 589.5;Hofbauer cells: 445.6;Macrophages: 736.5;monocytes: 250.7;T-cells: 298.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 296.2;eosinophil: 148.4;neutrophil: 194.2;plasmacytoid DC: 136.1" "Group enriched" "Detected in all" 7 "dendritic cells: 136.1;granulocytes: 296.2" "Cell line enhanced" "Detected in some" "HDLM-2: 80.1;HL-60: 42.6;HMC-1: 137.8;THP-1: 53.6;U-937: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026592 Enhanced NA NA "HPA026592: AB_10601115" "unprognostic (1.17e-2)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (4.64e-3)" "unprognostic (7.18e-2)" "unprognostic (7.10e-2)" "unprognostic (7.79e-2)" "unprognostic (1.04e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (6.44e-4)" "unprognostic (7.83e-2)" "unprognostic (6.63e-2)" "prognostic unfavorable (5.68e-4)" "unprognostic (1.33e-1)" "unprognostic (3.19e-2)" "unprognostic (2.72e-2)" "unprognostic (2.59e-1)" 16.7 12.7 9.6 27.9 17.0 121.8 8.3 1.9 10.7 6.3 7.5 17.1 0.0 6.4 7.7 3.3 6.4 11.5 11.7 10.4 8.0 9.0 10.6 5.8 55.8 33.4 22.0 2.7 5.1 7.9 1.7 3.3 10.6 14.2 5.9 6.6 5.1 9.9 4.9 2.4 2.8 10.9 12.1 23.0 57.6 7.8 5.2 15.5 42.2 4.3 3.7 29.2 11.9 6.5 18.4 136.1 296.2 12.6 3.6 33.2 24.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 19.1 0.2 0.0 0.6 0.1 0.0 0.5 0.0 80.1 0.0 2.3 0.0 0.1 0.1 42.6 137.8 0.1 0.0 0.0 4.8 1.0 0.1 4.1 0.0 0.4 0.2 0.0 2.3 1.5 0.0 0.0 0.0 0.3 0.5 1.5 0.1 0.0 1.3 0.0 0.0 0.0 0.1 0.3 0.0 53.6 0.1 0.0 0.4 0.0 0.3 8.5 0.0 12.7 0.1 39.4 0.1 296.2 12.6 148.4 22.3 0.6 33.2 16.9 22.3 18.2 7.6 18.4 11.3 11.1 194.2 3.6 0.4 136.1 30.9 24.1 9.6 17.0 1.9 10.7 8.0 9.0 22.0 2.7 14.2 15.5 38.7 140.9 78.7 2.7 21.1 0.0 2.5 17.8 20.1 43.3 0.0 0.0 2.6 13.3 1.9 4.4 5.6 2.8 0.0 0.9 2.8 8.0 1.1 589.5 1.0 445.6 0.0 25.3 9.2 168.8 3.1 4.4 736.5 40.5 250.7 1.0 0.0 3.7 1.5 3.9 1.4 0.0 32.3 4.3 0.3 1.0 21.7 4.1 298.1 1.2 1.3 ALPK1 "FLJ22670, KIAA1527, Lak" ENSG00000073331 "Alpha kinase 1" Q96QP1 4 112285509-112442620 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027435, HPA027443" Approved Approved Centrosome NA NA Centrosome "HPA027435: AB_10599614, HPA027443: AB_10599421" "unprognostic (6.24e-2)" "unprognostic (1.92e-1)" "unprognostic (9.30e-2)" "unprognostic (1.69e-2)" "unprognostic (7.40e-2)" "unprognostic (5.45e-2)" "unprognostic (2.55e-2)" "unprognostic (7.47e-2)" "unprognostic (2.34e-1)" "unprognostic (1.38e-1)" "unprognostic (7.14e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (5.82e-7)" "unprognostic (1.60e-1)" "unprognostic (4.17e-2)" "unprognostic (2.81e-1)" "prognostic favorable (1.17e-4)" 15.1 10.6 5.3 8.3 7.7 17.3 9.3 1.3 5.9 10.8 9.5 5.8 3.0 4.5 9.8 9.2 8.8 9.2 7.5 6.1 6.1 2.3 10.8 13.4 13.2 11.4 9.7 1.0 17.4 9.7 11.0 14.0 11.5 6.6 14.0 7.8 9.6 10.4 6.8 5.0 11.8 12.1 11.3 16.6 16.2 7.4 4.2 8.5 13.7 12.4 4.7 13.7 13.6 11.6 0.9 3.2 16.3 4.3 0.4 0.8 1.2 1.6 5.0 1.6 0.3 6.6 10.6 2.0 1.9 3.5 2.6 3.3 0.5 7.7 5.1 3.3 3.3 5.3 1.1 1.7 3.0 3.9 6.5 1.7 3.6 2.0 0.4 10.6 2.2 2.2 13.1 8.6 3.8 7.9 5.9 1.0 2.7 0.9 8.9 5.0 3.1 1.3 2.0 0.4 3.7 1.3 0.6 1.1 1.6 3.9 1.9 0.5 0.8 1.8 6.6 2.9 0.3 3.0 4.1 1.9 2.4 2.1 3.7 1.3 2.3 0.7 4.4 5.7 4.6 2.1 1.3 3.2 1.4 0.2 4.3 0.6 0.8 0.6 0.1 3.2 0.9 0.8 0.6 16.3 0.4 1.9 0.5 0.0 1.2 5.3 7.7 1.3 5.9 6.1 2.3 9.7 1.0 6.6 8.5 11.9 20.3 0.9 9.4 2.6 0.2 3.1 0.0 20.1 13.6 5.2 0.0 4.0 0.0 5.6 7.5 5.5 7.0 0.0 5.8 2.6 4.1 7.1 5.8 5.8 8.7 0.0 1.2 5.5 14.8 1.6 3.4 14.0 6.8 10.0 8.5 11.3 6.3 8.6 7.1 4.0 0.2 6.5 5.1 0.7 0.5 4.0 6.1 2.2 5.7 10.3 AMELX "AIH1, AMG" ENSG00000125363 "Amelogenin, X-linked" Q99217 X 11293413-11300761 "Disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 3.5;epididymis: 3.0;seminal vesicle: 9.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.9" "Region enhanced" "Detected in single" "amygdala: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.1;OE19: 1.5" "Secreted in other tissues" NA NA "unprognostic (1.76e-1)" "unprognostic (1.00e-1)" "unprognostic (2.00e-1)" 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.1 0.3 3.5 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 9.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.6 0.5 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AMFR "gp78, RNF45" ENSG00000159461 "Autocrine motility factor receptor" Q9UKV5 16 56361452-56425538 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Receptor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 124.0;Hepatocytes: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026381, HPA029018, HPA077835" Approved Supported "Endoplasmic reticulum,Golgi apparatus" NA NA "Endoplasmic reticulum, Golgi apparatus" "CAB026381: , HPA029018: AB_2672869, HPA077835: AB_2686856" "unprognostic (1.72e-2)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (2.43e-2)" "unprognostic (3.60e-3)" "unprognostic (6.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.26e-3)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (4.16e-2)" "unprognostic (5.52e-3)" "unprognostic (1.45e-1)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" "unprognostic (2.28e-1)" 13.9 25.9 21.3 10.6 23.8 14.1 28.7 12.6 25.0 17.2 21.0 24.5 18.5 21.6 16.6 25.2 20.8 15.3 13.7 17.6 20.6 20.2 35.2 50.0 13.3 19.3 22.3 14.3 20.5 14.0 33.3 13.0 41.6 18.9 14.9 11.8 23.8 12.6 18.6 71.6 11.9 18.8 16.0 25.0 14.3 12.2 36.8 17.5 14.6 18.6 10.1 19.3 15.5 16.9 18.3 10.6 21.4 13.1 11.7 9.7 4.0 17.7 24.8 10.8 19.9 33.9 19.1 9.5 19.2 23.8 26.1 20.5 22.0 16.9 46.3 22.2 25.9 15.4 16.6 16.6 14.9 24.9 10.3 17.0 14.0 10.2 23.6 29.7 10.8 16.2 22.1 21.7 20.8 24.9 18.5 15.2 13.6 14.5 6.4 18.9 11.2 16.2 11.6 5.1 9.2 17.0 18.4 21.9 17.4 16.1 18.6 10.9 8.3 45.1 15.8 14.5 11.1 47.6 11.4 19.6 24.6 13.5 12.4 12.9 13.8 12.1 24.6 17.9 7.9 11.2 21.4 8.5 10.9 6.9 9.9 9.7 18.3 8.7 7.1 7.8 15.6 9.1 9.5 10.5 11.7 13.1 10.6 9.0 4.0 21.3 23.8 12.6 25.0 20.6 20.2 22.3 14.3 18.9 17.5 8.9 7.0 28.6 15.3 22.9 17.3 18.2 30.6 1.4 9.1 94.2 37.3 20.9 21.6 18.1 124.0 20.4 37.5 0.0 37.1 5.8 28.2 27.6 8.1 146.0 15.4 30.2 23.8 39.3 62.3 81.3 38.0 22.3 28.7 15.4 25.9 45.2 27.4 21.0 32.2 42.8 41.0 12.9 26.9 32.0 10.8 18.2 20.4 15.2 19.8 17.2 AMHR2 "MISR2, MISRII" ENSG00000135409 "Anti-Mullerian hormone receptor type 2" Q16671 12 53423855-53431534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 27.1;ovary: 38.2;testis: 15.2" "Group enriched" "Detected in some" 4 "granulocytes: 25.4;Ito cells: 12.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "HEL: 28.3;K-562: 15.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "hippocampal formation: 14.3" "HPA060228, HPA069636" Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA060228: AB_2684227, HPA069636: AB_2686163" "unprognostic (5.79e-2)" "unprognostic (3.65e-1)" "unprognostic (3.98e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-3)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.32e-1)" "unprognostic (2.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.97e-1)" 0.3 27.1 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.6 0.4 0.2 0.4 0.8 0.2 0.0 0.2 1.1 0.3 0.2 0.2 0.2 38.2 8.8 0.1 0.2 0.2 0.3 0.4 0.0 0.2 0.2 0.2 2.5 0.0 0.4 0.5 0.2 3.7 0.3 15.2 0.2 0.2 0.2 0.5 0.3 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 28.3 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.8 2.4 0.0 0.0 0.0 1.8 0.0 0.0 0.1 25.4 0.0 0.1 0.0 0.0 12.3 2.2 1.3 4.6 0.0 0.0 0.0 0.0 0.0 4.6 0.0 3.9 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 AMIGO1 "AMIGO, KIAA1163" ENSG00000181754 "Adhesion molecule with Ig like domain 1" Q86WK6 1 109504175-109509738 "Predicted membrane proteins, Transporters" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.9" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 27.9;Rod photoreceptor cells: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "gdT-cell: 1.5;MAIT T-cell: 1.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 2.5;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.9;NK-cell: 1.9;T-reg: 1.5" "Group enriched" "Detected in many" 21 "NK-cells: 1.9;T-cells: 5.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 9.6;SK-BR-3: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046152 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA046152: AB_2679559" "unprognostic (1.35e-1)" "unprognostic (3.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.44e-2)" "unprognostic (9.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.16e-3)" "unprognostic (3.11e-1)" "unprognostic (9.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" 5.3 14.8 11.8 3.7 19.1 1.0 4.7 23.4 33.9 4.8 6.6 4.8 4.0 3.2 5.7 16.4 4.1 4.9 4.3 11.0 12.2 14.3 7.6 3.5 6.4 5.2 9.9 15.0 12.8 9.2 21.1 8.1 3.0 15.6 9.2 3.7 10.3 9.6 11.1 22.4 3.3 4.1 6.5 6.0 4.6 5.0 4.1 5.3 1.7 9.1 1.9 4.6 4.5 3.8 0.1 0.0 0.0 0.1 1.9 5.4 0.9 2.6 1.2 2.7 9.5 3.6 1.5 3.4 4.4 2.2 5.1 2.4 0.5 0.1 0.2 1.2 2.8 1.2 1.4 7.3 0.3 4.3 1.0 0.6 0.0 1.7 0.8 2.9 2.1 5.4 0.7 3.2 1.7 0.0 0.5 1.2 1.5 2.1 0.0 0.1 4.4 0.4 4.4 1.7 2.2 3.0 0.7 0.0 0.4 5.9 1.3 9.6 3.2 1.0 12.6 3.5 1.2 3.6 3.1 1.1 0.2 5.9 3.4 1.8 0.2 0.0 0.0 1.9 0.0 2.7 0.0 0.0 0.0 1.5 0.1 1.6 0.1 2.2 2.5 0.0 0.0 5.4 3.9 0.0 1.9 0.0 0.0 1.5 0.9 11.8 19.1 23.4 33.9 12.2 14.3 9.9 15.0 15.6 5.3 3.0 1.3 0.0 0.4 0.6 27.9 6.7 2.5 0.0 0.0 3.5 3.9 1.0 0.0 1.0 0.0 0.8 1.0 0.0 0.8 0.1 0.6 1.1 0.0 0.8 0.2 4.8 4.6 0.6 0.0 0.0 2.0 0.0 0.0 1.0 0.7 7.1 0.7 0.9 5.3 0.5 8.8 0.0 1.0 0.7 0.9 0.4 0.2 0.0 1.5 0.3 AMIGO2 "ALI1, DEGA" ENSG00000139211 "Adhesion molecule with Ig like domain 2" Q86SJ2 12 47075707-47079951 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.4" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 58.0;Ito cells: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 40.9;fHDF/TERT166: 39.3;hTERT-RPE1: 69.7;LHCN-M2: 39.3;RT4: 53.8;U-2 OS: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054004, HPA059601" Uncertain Approved "Golgi apparatus,Plasma membrane,Cytosol" NA Yes 160000 "Golgi apparatus, Plasma membrane" Cytosol "HPA054004: AB_2682339, HPA059601: AB_2684078" "unprognostic (2.63e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" "unprognostic (3.91e-2)" "unprognostic (3.86e-1)" "unprognostic (1.07e-2)" "unprognostic (3.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-1)" "unprognostic (3.30e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (2.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-2)" "unprognostic (2.95e-1)" "unprognostic (7.47e-2)" "unprognostic (2.29e-3)" 5.6 11.9 5.4 4.0 8.8 1.4 14.5 1.6 6.5 18.3 20.3 3.5 1.9 1.6 19.7 12.4 3.1 21.2 12.4 3.4 2.7 7.5 4.3 2.9 11.9 6.7 2.9 5.1 43.4 2.3 2.0 9.5 7.6 16.2 12.8 5.6 6.7 3.1 7.1 1.5 2.3 7.1 21.0 3.0 9.8 3.5 13.1 3.6 1.6 2.5 4.1 4.5 16.6 15.1 2.8 7.4 0.1 0.2 6.6 14.2 4.3 9.0 22.5 1.4 0.0 0.5 0.0 3.7 3.1 8.5 1.0 0.8 0.0 40.9 0.0 10.3 39.3 25.8 13.6 0.0 25.1 1.2 1.7 0.1 0.0 2.2 0.0 0.8 0.2 0.3 0.2 4.4 26.9 13.3 69.7 3.2 0.2 1.7 0.0 39.3 0.4 0.7 0.0 0.9 4.5 5.7 0.0 10.1 0.0 11.6 53.8 4.1 0.0 16.2 1.9 0.1 0.8 2.4 0.2 0.8 0.5 32.6 0.3 25.1 0.3 0.0 0.0 2.1 0.7 0.6 0.0 0.1 0.0 4.0 0.2 5.4 2.8 6.2 6.2 0.6 1.3 14.2 11.1 0.1 6.6 0.0 7.4 3.6 4.3 5.4 8.8 1.6 6.5 2.7 7.5 2.9 5.1 16.2 3.6 8.9 1.9 5.9 10.4 2.2 21.1 0.8 0.0 2.7 6.8 1.8 0.0 0.7 1.7 4.3 1.2 4.5 0.0 0.0 17.0 23.1 6.7 5.2 6.9 0.8 4.4 0.0 58.0 30.7 3.8 0.9 2.3 2.3 1.7 8.2 2.5 14.9 26.7 0.8 0.7 0.0 4.1 0.0 25.5 0.3 0.7 0.4 7.1 4.4 0.2 13.4 AMIGO3 ENSG00000176020 "Adhesion molecule with Ig like domain 3" Q86WK7 3 49716834-49719695 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 23 "Intestinal endocrine cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 12.6" "Lineage enriched" "Detected in many" 11 "dendritic cells: 12.6" "Cell line enhanced" "Detected in some" "CACO-2: 4.6;HeLa: 5.6;HMC-1: 3.7;SH-SY5Y: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.33e-2)" "unprognostic (5.15e-2)" "unprognostic (2.54e-2)" "unprognostic (4.61e-1)" "unprognostic (2.46e-2)" "unprognostic (4.83e-3)" "unprognostic (3.92e-3)" "unprognostic (3.75e-3)" "unprognostic (1.20e-1)" "unprognostic (2.30e-1)" "unprognostic (7.56e-2)" "unprognostic (7.85e-3)" "unprognostic (3.10e-1)" "unprognostic (2.78e-1)" "unprognostic (2.78e-1)" "unprognostic (2.84e-1)" "unprognostic (3.58e-3)" 2.4 1.3 1.6 1.5 1.7 4.8 1.0 2.8 4.3 1.0 0.9 1.7 5.8 2.0 1.4 4.5 1.8 1.9 1.2 1.6 0.7 2.1 1.0 3.5 1.6 3.6 0.7 0.5 2.0 2.9 0.7 6.6 0.9 1.9 1.9 0.7 1.9 4.1 5.4 11.7 5.3 1.7 0.7 0.9 2.0 1.7 8.7 0.9 8.7 1.7 5.7 3.8 0.8 1.1 0.4 12.6 0.1 0.1 1.1 1.1 0.4 0.2 0.0 0.2 0.0 0.0 0.4 1.2 0.0 0.0 0.1 0.1 4.6 0.5 0.0 0.4 0.0 0.1 2.6 0.0 0.0 0.0 2.5 1.4 0.0 5.6 2.3 0.0 0.8 3.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 0.8 0.0 2.6 2.9 1.6 0.0 0.0 0.0 0.1 0.4 0.2 0.0 2.5 1.4 3.7 0.5 0.2 0.0 0.0 0.3 0.7 0.6 0.4 1.3 0.9 0.2 3.1 2.2 0.4 0.0 1.4 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.2 1.1 0.1 0.1 0.4 0.7 0.1 1.1 0.0 12.6 0.4 0.4 1.6 1.7 2.8 4.3 0.7 2.1 0.7 0.5 1.9 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 AMN amnionless ENSG00000166126 "Amnion associated transmembrane protein" Q9BXJ7 14 102922656-102933596 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 97.6" "Cell type enhanced" "Detected in many" 23 "Enterocytes: 1194.2;Paneth cells: 312.1;Proximal tubular cells: 301.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 11.2;Hep G2: 11.0;U-698: 5.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA000817 Approved NA NA "HPA000817: AB_1078146" "unprognostic (2.02e-2)" "unprognostic (1.67e-1)" "unprognostic (3.94e-3)" "unprognostic (7.39e-3)" "unprognostic (9.32e-2)" "unprognostic (1.88e-3)" "unprognostic (8.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (2.97e-2)" "unprognostic (7.57e-2)" "unprognostic (2.43e-2)" "prognostic favorable (9.62e-5)" "unprognostic (8.02e-2)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (1.66e-1)" 0.4 0.0 0.1 3.3 0.1 0.0 0.7 0.1 0.1 0.6 44.3 0.1 0.2 19.3 0.2 3.1 2.6 0.6 10.4 0.2 0.1 0.0 17.2 17.8 1.8 0.5 0.1 0.0 0.1 0.2 0.0 0.4 0.2 0.1 0.4 2.1 0.2 0.7 0.0 0.0 0.9 97.6 0.1 0.0 0.6 3.9 0.3 0.1 0.7 0.7 0.1 1.1 0.5 1.0 0.3 1.8 0.0 0.0 0.0 0.7 0.1 0.6 0.1 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 11.2 0.3 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.2 0.0 0.8 11.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.2 1.0 1.6 0.2 1.2 0.0 0.2 0.1 0.2 0.0 0.0 1.0 0.7 0.1 0.1 0.1 0.1 0.0 1.5 0.0 0.0 0.0 0.2 0.0 1.0 0.6 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.3 0.7 0.6 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 8.9 0.3 7.8 16.6 11.8 2.6 1.0 94.3 2.7 4.5 19.2 0.0 2.5 28.2 1.6 3.6 0.3 1194.2 0.0 0.6 2.9 0.9 12.4 4.6 44.8 0.6 1.6 18.4 0.6 0.6 4.3 0.6 0.2 6.8 0.0 201.5 0.1 6.5 312.1 0.7 301.0 1.2 0.0 0.5 10.0 13.4 18.2 1.1 1.0 192.4 65.0 ANG "RAA1, RNASE5" ENSG00000214274 Angiogenin P03950 14 20684177-20698971 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Stress response" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 371.4" "Cell type enriched" "Detected in many" 21 "Hepatocytes: 4646.2" "Cancer enriched" "Detected in all" 17 "liver cancer: 279.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "classical monocyte: 18.1;myeloid DC: 10.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Hep G2: 52.5;OE19: 40.2" "Low region specificity" "Detected in many" HPA055896 Approved "Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments" "Secreted to blood" Yes No 308000000 230000000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "Actin filaments" "HPA055896: " "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.77e-2)" "prognostic favorable (6.85e-4)" "unprognostic (5.71e-3)" "unprognostic (6.99e-2)" "prognostic favorable (7.83e-5)" "unprognostic (1.16e-1)" "unprognostic (3.20e-3)" "unprognostic (9.19e-3)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (6.65e-2)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (2.00e-1)" "unprognostic (3.09e-1)" 17.0 0.9 0.7 2.6 0.7 0.7 16.4 0.5 0.7 14.4 9.0 0.7 6.6 3.5 10.7 10.3 8.0 3.8 13.3 3.8 0.8 0.7 10.6 371.4 6.9 2.3 1.0 0.1 17.7 9.0 1.3 1.1 1.9 0.8 17.5 6.5 5.5 20.2 7.7 3.5 4.0 7.4 9.7 1.5 1.5 7.9 7.1 0.4 0.0 4.2 5.5 3.6 14.3 15.0 4.5 10.4 0.3 18.1 0.0 0.9 4.8 1.3 3.4 0.8 0.0 8.6 10.3 0.1 1.4 3.0 0.4 1.4 2.0 1.8 0.1 0.4 4.2 2.9 1.3 0.9 1.0 0.4 5.8 1.3 0.3 1.9 52.5 1.8 1.3 0.1 8.3 0.8 0.5 1.8 4.3 2.0 1.5 0.0 9.6 1.2 0.2 0.2 0.4 0.2 40.2 3.8 0.2 1.3 3.9 0.8 1.0 0.0 0.1 1.5 0.6 2.3 1.9 1.4 0.2 1.7 0.5 1.0 0.5 0.2 2.0 1.6 0.2 1.1 0.6 1.6 0.0 18.1 0.0 0.3 2.1 0.2 4.5 0.9 0.8 10.4 2.4 0.2 0.2 0.3 0.0 0.1 1.6 0.4 4.8 0.7 0.7 0.5 0.6 0.8 0.7 1.0 0.1 0.8 0.4 26.8 12.4 18.0 36.0 24.2 0.0 0.6 219.1 60.2 18.2 10.4 0.0 1.5 10.0 27.6 0.7 12.2 37.1 23.3 27.7 3.3 31.0 52.1 0.0 4646.2 15.9 0.0 68.2 70.0 110.5 1.1 65.9 16.0 21.9 1.0 138.3 9.1 26.8 17.3 22.6 45.5 0.6 12.9 18.6 0.7 1.0 45.8 7.8 12.1 44.2 29.8 ANGPTL1 "ANG3, ANGPT3, AngY, ARP1" ENSG00000116194 "Angiopoietin like 1" O95841 1 178849705-178871052 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Leydig cells: 394.4;Peritubular cells: 199.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.3;naive B-cell: 2.9" "Lineage enhanced" "Detected in single" "B-cells: 2.9" "Group enriched" "Detected in some" 18 "ASC diff: 48.7;ASC TERT1: 19.6;HHSteC: 21.1;HSkMC: 48.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009976 Approved "Secreted to blood" NA NA 100000 "HPA009976: AB_1844822" "unprognostic (2.59e-2)" "unprognostic (1.31e-1)" "unprognostic (5.80e-3)" "unprognostic (2.63e-2)" "unprognostic (3.60e-1)" "unprognostic (1.71e-2)" "prognostic favorable (8.73e-4)" "unprognostic (3.81e-2)" "unprognostic (5.78e-3)" "unprognostic (1.47e-1)" "unprognostic (1.39e-1)" "unprognostic (5.31e-2)" "prognostic favorable (5.11e-4)" "unprognostic (1.49e-2)" "unprognostic (1.30e-1)" "unprognostic (2.85e-2)" "unprognostic (3.61e-3)" 17.7 16.3 1.2 8.5 1.1 0.0 14.4 0.7 1.4 26.3 36.2 0.9 9.6 2.6 34.6 46.5 33.6 29.7 16.6 12.9 1.0 0.6 15.9 7.1 12.4 15.8 0.6 2.5 35.7 6.4 0.0 2.2 42.0 1.6 16.7 8.7 0.9 14.2 4.2 20.0 4.5 28.2 22.7 1.8 7.0 13.1 24.7 0.4 0.9 19.3 57.5 2.8 25.5 13.7 2.9 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 48.7 19.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 21.1 0.0 0.0 48.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.9 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 1.1 0.7 1.4 1.0 0.6 0.6 2.5 1.6 0.4 0.0 0.0 0.5 0.0 3.3 2.2 3.1 30.6 1.4 0.0 1.8 5.9 0.5 1.7 0.7 0.8 2.9 0.0 0.0 0.4 0.6 51.8 0.1 0.0 0.9 1.3 0.0 0.0 11.6 0.0 1.9 394.4 0.0 3.3 0.0 0.0 36.6 0.0 0.0 199.4 0.0 12.4 38.8 35.0 0.7 0.7 3.1 1.1 0.0 0.0 0.1 ANGPTL7 "AngX, CDT6" ENSG00000171819 "Angiopoietin like 7" O43827 1 11189341-11195981 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 22.9" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Cardiomyocytes: 2.2;granulocytes: 1.1;Intestinal endocrine cells: 1.7;Melanocytes: 3.3" "Cancer enriched" "Detected in some" 14 "melanoma: 18.4" "Region enriched" "Detected in single" 6 "cerebellum: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 62 "SCLC-21H: 31.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "Secreted in other tissues" NA NA 490000 "unprognostic (3.23e-2)" "unprognostic (6.95e-2)" "unprognostic (1.22e-1)" "unprognostic (2.67e-3)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.89e-2)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (1.58e-2)" "unprognostic (3.41e-3)" "unprognostic (1.92e-1)" "unprognostic (1.19e-3)" "unprognostic (2.49e-2)" 12.8 3.7 0.1 2.0 0.2 0.0 4.8 3.2 0.2 5.4 8.0 0.3 9.3 1.3 1.4 4.3 7.0 1.7 5.9 10.4 0.1 0.3 6.5 0.4 2.1 1.0 0.1 0.4 1.9 0.6 0.0 7.8 0.9 0.5 4.7 2.4 5.3 4.2 11.4 22.9 5.9 2.6 16.5 3.5 0.4 2.2 3.9 0.5 0.1 0.7 13.8 1.4 6.2 4.5 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.2 0.2 0.1 0.3 0.1 0.4 0.5 0.5 3.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANK1 "ANK, SPH1" ENSG00000029534 "Ankyrin 1" P16157 8 41653220-41896762 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease mutation, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 166.5;tongue: 58.3" "Group enriched" "Detected in many" 10 "Cardiomyocytes: 153.6;Cone photoreceptor cells: 82.5;Erythroid cells: 210.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 20.1" "Group enriched" "Detected in some" 8 "memory B-cell: 10.6;naive B-cell: 9.1;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 7 "B-cells: 10.6;dendritic cells: 3.5" "Group enriched" "Detected in some" 4 "HEL: 38.0;K-562: 39.9;RH-30: 50.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004842, HPA056953" Supported Supported "Intracellular and membrane" NA NA 33000000 "HPA004842: AB_1844827, HPA056953: AB_2683284" "unprognostic (1.05e-1)" "unprognostic (1.30e-1)" "unprognostic (4.22e-3)" "unprognostic (2.31e-3)" "unprognostic (1.76e-7)" "unprognostic (2.03e-1)" "unprognostic (2.15e-1)" "unprognostic (2.52e-1)" "unprognostic (2.95e-1)" "unprognostic (3.21e-2)" "unprognostic (7.90e-2)" "unprognostic (1.57e-1)" "unprognostic (1.40e-1)" "unprognostic (3.86e-1)" "unprognostic (4.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.04e-1)" 1.2 0.3 0.6 0.7 0.6 14.8 0.3 20.1 3.8 0.2 0.2 0.0 0.0 0.4 0.2 2.7 1.8 0.2 0.3 18.0 0.6 1.2 0.3 0.2 0.4 0.9 4.0 0.4 0.2 0.3 4.3 0.3 0.8 8.3 0.9 0.2 0.5 2.9 0.3 166.5 0.2 0.3 0.2 1.0 0.7 1.1 0.3 0.0 0.0 1.0 58.3 3.8 0.3 0.4 10.6 3.5 1.0 0.2 0.1 0.9 0.7 0.0 5.1 0.1 0.0 0.0 0.9 0.0 1.5 10.2 0.5 0.2 0.0 0.0 2.3 0.4 1.0 0.1 0.8 0.2 0.1 0.2 0.9 0.0 38.0 0.2 0.0 0.0 0.1 0.1 1.3 0.2 0.1 0.0 0.2 0.0 0.0 39.9 0.8 0.6 0.1 0.0 0.5 0.5 0.0 0.0 0.3 50.5 0.2 0.2 0.1 0.7 0.4 0.0 0.7 0.0 1.9 0.6 0.9 0.2 0.1 0.2 8.7 0.0 0.0 0.0 1.4 0.9 0.0 0.0 1.0 0.2 0.0 0.1 0.0 0.5 10.6 0.3 0.5 0.1 9.1 0.0 0.0 0.5 0.1 0.0 3.5 0.9 0.7 0.6 0.6 20.1 3.8 0.6 1.2 4.0 0.4 8.3 0.0 0.0 0.0 3.2 1.3 0.6 7.4 153.6 0.0 0.0 0.0 0.0 82.5 0.7 1.7 0.1 6.6 2.1 0.0 210.2 0.0 0.7 0.6 2.2 0.0 0.0 14.9 3.2 1.2 0.0 0.3 2.4 0.3 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.4 0.2 4.7 0.0 3.6 0.2 0.7 0.0 0.3 0.0 0.0 1.5 ANKH "ANK, CCAL2, CMDJ, CPPDD, HANK, SLC62A1" ENSG00000154122 "ANKH inorganic pyrophosphate transport regulator" Q9HCJ1 5 14704800-14871785 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Phosphate transport, Transport" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 119.8;Hofbauer cells: 162.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068104 Approved Cytosol NA NA Cytosol "HPA068104: AB_2685954" "unprognostic (1.15e-1)" "unprognostic (3.35e-1)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (6.58e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (2.83e-2)" "unprognostic (2.11e-1)" "unprognostic (2.38e-2)" "unprognostic (2.99e-1)" "unprognostic (1.54e-3)" "unprognostic (1.76e-3)" "unprognostic (1.71e-1)" "unprognostic (8.66e-2)" "unprognostic (6.46e-2)" 8.5 9.7 15.2 8.0 17.0 5.9 9.2 29.1 25.9 4.4 10.9 19.5 3.4 14.4 6.5 4.7 6.8 7.2 8.4 27.0 15.9 14.9 7.4 18.1 6.3 9.6 19.7 17.1 14.9 13.1 19.6 19.2 7.3 15.4 29.5 10.3 16.1 11.7 8.6 31.0 17.4 14.9 7.6 22.6 6.3 6.5 2.0 15.3 9.3 9.5 12.7 11.8 6.4 6.3 2.5 0.6 0.7 1.4 0.6 7.0 0.7 3.8 2.9 3.8 0.6 7.9 18.8 1.8 3.8 7.6 1.5 1.5 2.3 5.0 9.1 8.9 5.1 3.5 2.5 2.5 4.1 1.7 3.6 6.3 0.2 27.6 6.2 2.6 2.2 0.7 5.9 7.3 4.5 5.2 5.2 3.0 6.8 1.9 19.7 4.8 5.2 3.7 7.1 1.5 5.1 3.3 5.3 1.8 8.2 0.0 1.3 9.3 2.5 18.3 3.0 4.0 3.6 0.1 0.8 3.0 3.9 4.0 6.4 6.8 5.2 4.8 7.1 13.5 8.2 16.1 0.7 0.4 0.1 2.4 0.7 4.0 2.5 5.0 3.9 0.6 2.1 5.7 2.6 0.5 0.6 1.4 0.6 7.0 0.7 15.2 17.0 29.1 25.9 15.9 14.9 19.7 17.1 15.4 15.3 23.8 15.5 11.5 72.4 22.3 53.3 63.0 2.5 9.4 14.8 7.0 119.8 58.3 5.0 1.7 1.1 23.5 47.0 93.5 10.3 3.1 22.5 50.7 17.3 31.4 162.5 19.1 40.1 9.8 59.0 1.4 4.6 30.3 10.1 0.0 31.7 18.8 6.8 28.1 29.7 9.8 47.3 0.0 13.9 2.6 5.9 9.4 35.1 19.1 30.4 13.2 ANKLE1 "ANKRD41, FLJ39369, LEMD6" ENSG00000160117 "Ankyrin repeat and LEM domain containing 1" Q8NAG6 19 17281645-17287646 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.6;brain: 8.3;lymphoid tissue: 12.9" "Group enriched" "Detected in some" 7 "Erythroid cells: 23.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.3" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.3" "Group enriched" "Detected in many" 4 "B-cells: 3.0;dendritic cells: 2.2;monocytes: 4.3" "Cell line enhanced" "Detected in many" "Daudi: 30.8;HEL: 12.6;HL-60: 13.5;NB-4: 17.4;U-937: 24.2" "Low region specificity" "Detected in all" "HPA026789, HPA073498" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026789: AB_10611675, HPA073498: AB_2686612" "unprognostic (5.66e-2)" "unprognostic (2.21e-1)" "unprognostic (6.90e-2)" "prognostic unfavorable (4.86e-5)" "unprognostic (2.73e-1)" "unprognostic (1.72e-3)" "unprognostic (2.19e-2)" "unprognostic (2.09e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "unprognostic (7.89e-4)" "unprognostic (5.86e-2)" "unprognostic (0.00e+0)" "unprognostic (2.03e-1)" "unprognostic (1.61e-1)" "unprognostic (2.00e-3)" "unprognostic (4.30e-2)" 0.6 0.5 1.0 12.9 3.1 22.6 0.6 8.3 1.4 0.7 0.7 0.6 0.2 0.3 0.9 1.3 0.5 0.8 0.5 0.2 1.0 1.2 0.5 0.5 1.3 3.7 1.6 0.7 1.7 0.2 0.6 0.9 1.1 1.4 1.0 0.5 0.4 0.7 0.6 0.9 1.4 1.2 0.9 1.2 5.7 0.3 1.0 0.5 8.9 0.6 0.2 5.3 1.0 0.7 3.0 2.2 0.7 4.3 0.0 0.4 0.8 0.1 0.3 1.5 0.8 0.0 0.3 1.5 0.5 0.1 0.3 0.2 7.0 0.4 30.8 0.3 0.1 0.0 0.6 11.9 0.1 0.3 9.3 1.6 12.6 4.9 0.0 0.1 13.5 5.2 0.1 0.4 1.2 0.0 0.3 0.2 2.6 1.6 3.6 0.1 0.2 9.3 17.4 3.8 0.1 1.1 7.5 0.0 3.1 0.1 0.1 0.4 2.7 3.0 0.2 0.2 0.3 0.0 8.9 0.6 0.1 0.5 0.6 0.3 0.3 0.3 10.9 0.1 24.2 0.6 0.0 1.8 0.7 0.0 4.3 0.0 3.0 0.0 0.4 2.2 1.7 0.1 0.0 0.0 0.0 3.1 1.1 0.0 0.8 1.0 3.1 8.3 1.4 1.0 1.2 1.6 0.7 1.4 0.5 0.0 0.3 0.8 0.8 0.7 2.0 0.8 0.0 1.4 0.0 0.0 0.0 1.5 0.0 0.1 0.1 0.2 0.0 23.3 0.2 0.4 0.4 0.3 1.1 0.0 0.7 0.0 0.0 0.0 0.8 0.0 1.7 1.2 0.0 1.0 0.7 0.2 0.4 0.0 1.4 0.0 1.5 6.5 0.4 0.5 0.9 0.4 0.3 0.0 0.0 0.1 ANKLE2 "KIAA0692, Lem4, LEMD7" ENSG00000176915 "Ankyrin repeat and LEM domain containing 2" Q86XL3 12 132725503-132761888 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 154.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003602, HPA074838" Uncertain Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" "HPA003602: AB_1858349, HPA074838: " "unprognostic (4.43e-2)" "unprognostic (6.92e-2)" "unprognostic (7.97e-2)" "unprognostic (9.84e-3)" "unprognostic (1.97e-2)" "unprognostic (5.81e-2)" "prognostic unfavorable (3.97e-6)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (4.76e-2)" "unprognostic (6.10e-2)" "prognostic unfavorable (1.90e-8)" "unprognostic (1.42e-1)" "unprognostic (1.42e-1)" "unprognostic (6.92e-3)" "unprognostic (2.09e-1)" 20.1 26.4 14.9 21.3 17.6 27.2 21.8 23.3 20.4 15.6 15.4 19.6 15.1 14.6 18.9 16.8 23.7 18.6 17.0 16.5 12.4 10.7 16.3 16.3 21.6 24.1 16.0 11.3 20.7 18.1 17.2 22.3 18.3 15.2 17.2 13.9 16.7 19.1 15.7 19.9 27.3 22.8 18.5 13.4 27.4 16.8 43.7 14.1 31.4 17.4 15.8 27.9 16.4 28.6 4.8 3.3 7.7 2.2 4.7 5.5 1.4 19.7 18.5 19.4 12.0 11.3 17.8 24.3 24.2 18.1 24.3 18.7 21.1 13.6 15.6 12.7 21.2 16.3 23.9 16.9 22.1 23.3 6.6 21.0 19.8 31.1 9.9 12.6 21.2 14.0 16.5 22.6 23.1 17.2 45.1 17.3 12.9 17.8 6.1 24.8 14.2 19.8 35.2 16.4 9.8 17.8 22.8 12.7 6.5 17.5 25.9 23.9 14.7 31.2 13.2 10.6 19.0 23.2 15.4 24.7 29.3 21.1 15.5 26.9 11.5 11.3 19.1 22.7 14.2 16.4 1.4 2.2 7.7 3.6 2.1 4.8 4.8 5.3 5.5 3.3 4.3 5.0 4.1 1.3 4.7 2.2 3.2 4.7 1.4 14.9 17.6 23.3 20.4 12.4 10.7 16.0 11.3 15.2 14.1 68.5 24.5 25.4 82.7 59.8 30.8 22.9 28.1 20.1 55.7 29.6 43.2 25.0 1.7 29.1 63.9 32.7 20.2 0.0 28.1 29.6 26.8 92.4 18.4 12.1 17.7 30.2 20.0 19.0 15.1 14.0 23.3 33.1 32.1 42.3 16.9 24.7 66.6 20.9 26.5 6.4 38.7 25.8 34.8 131.6 52.4 63.7 30.6 37.3 18.6 154.8 ANKRD22 MGC22805 ENSG00000152766 "Ankyrin repeat domain 22" Q5VYY1 10 88822132-88851818 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 40.2;stomach 1: 27.6;tongue: 29.0" "Cell type enhanced" "Detected in many" 16 "Basal keratinocytes: 33.1;Suprabasal keratinocytes: 89.8;Urothelial cells: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 15.4" "Group enriched" "Detected in many" 13 "granulocytes: 15.4;monocytes: 6.8" "Cell line enhanced" "Detected in some" "A-431: 8.5;CAPAN-2: 27.2;HL-60: 8.0;OE19: 20.7;RT4: 18.4;T-47d: 12.5;U-937: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA012922 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA012922: AB_1844838" "unprognostic (1.86e-1)" "unprognostic (1.48e-3)" "unprognostic (9.73e-3)" "prognostic favorable (8.73e-6)" "unprognostic (1.18e-1)" "unprognostic (2.81e-2)" "unprognostic (2.39e-2)" "unprognostic (1.50e-1)" "unprognostic (4.57e-2)" "unprognostic (7.21e-3)" "prognostic unfavorable (6.15e-4)" "unprognostic (1.09e-3)" "unprognostic (1.05e-2)" "unprognostic (4.87e-3)" "unprognostic (4.17e-2)" "unprognostic (3.18e-3)" "unprognostic (1.01e-3)" 0.4 0.5 2.3 8.4 3.6 5.3 2.3 0.3 3.2 6.7 6.7 0.5 0.0 2.0 0.3 0.2 21.9 0.3 4.3 1.1 4.0 0.6 6.0 1.6 1.3 6.1 3.6 0.2 0.3 40.2 0.1 1.6 0.2 2.7 2.0 7.2 0.1 3.7 0.0 0.3 18.5 2.1 1.3 7.4 8.8 27.6 0.3 1.4 7.9 0.3 29.0 14.6 4.4 8.6 0.1 0.4 15.4 6.8 0.5 0.8 1.2 8.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.1 0.1 0.0 0.0 6.7 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 8.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.7 6.4 0.1 20.7 0.1 0.0 0.0 0.0 0.1 18.4 0.0 0.0 0.0 1.3 0.0 0.0 12.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.3 0.1 0.1 4.8 2.5 0.1 6.8 0.0 0.0 0.4 0.1 0.4 0.1 0.8 0.2 15.4 0.5 1.2 0.4 0.0 1.2 2.3 3.6 0.3 3.2 4.0 0.6 3.6 0.2 2.7 1.4 0.0 3.0 0.0 16.2 33.1 0.0 0.1 10.2 0.0 1.2 7.0 0.0 0.0 0.0 2.6 0.0 0.0 6.4 0.0 5.2 0.0 0.7 10.4 0.0 0.0 2.4 0.0 1.7 0.0 7.2 0.0 0.3 12.3 1.7 1.0 11.8 0.0 4.5 20.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 89.8 0.0 0.7 11.2 29.8 ANKRD29 FLJ25053 ENSG00000154065 "Ankyrin repeat domain 29" Q8N6D5 18 23598926-23662885 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 202.5;Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 1.1;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 14 "dendritic cells: 1.6;T-cells: 1.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 12.7;BJ hTERT+: 12.1;hTCEpi: 12.0;PC-3: 11.5;U-2197: 15.0;U-87 MG: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041272, HPA049419" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA041272: AB_2677387, HPA049419: AB_2680757" "unprognostic (4.52e-3)" "unprognostic (8.37e-2)" "unprognostic (7.04e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-3)" "prognostic favorable (1.92e-5)" "unprognostic (3.29e-2)" "prognostic favorable (5.98e-5)" "unprognostic (1.11e-1)" "unprognostic (1.93e-2)" "unprognostic (3.83e-2)" "unprognostic (3.54e-1)" "prognostic favorable (7.20e-5)" "unprognostic (1.10e-2)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" "unprognostic (1.64e-5)" 11.8 6.1 8.9 6.6 6.6 0.2 9.9 1.9 15.1 8.4 3.0 3.7 3.0 1.2 13.1 6.4 6.5 9.6 4.4 4.9 9.8 5.3 2.5 1.6 25.2 14.6 8.7 6.2 12.4 0.8 18.4 6.0 0.3 17.9 7.0 1.8 4.3 5.1 7.5 3.2 3.2 4.5 9.8 3.2 2.0 11.7 2.9 3.1 1.6 2.3 5.5 11.1 4.8 9.1 0.0 1.6 0.0 0.0 0.0 1.1 0.0 1.6 4.8 0.0 0.0 1.2 12.7 0.1 4.8 12.1 1.9 2.4 2.2 0.4 0.0 0.7 2.2 9.5 2.4 0.0 6.3 0.4 0.1 4.4 0.0 3.1 0.1 0.2 0.0 0.3 3.3 12.0 1.9 3.2 1.8 1.2 0.0 0.0 0.2 3.2 0.5 0.0 0.0 0.8 4.0 11.5 0.0 0.3 1.1 3.0 1.7 0.7 5.9 1.2 0.2 0.1 0.2 1.4 0.0 2.8 0.3 1.7 15.0 4.2 0.0 0.0 0.0 15.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 8.9 6.6 1.9 15.1 9.8 5.3 8.7 6.2 17.9 3.1 202.5 27.6 0.0 7.4 4.5 4.2 7.1 5.1 2.7 10.3 1.8 62.8 0.0 5.0 1.8 30.7 19.4 0.4 0.0 1.0 0.0 2.0 4.4 3.5 0.9 2.3 39.7 1.7 9.2 0.6 20.2 6.6 2.4 6.8 0.0 0.5 0.9 6.8 0.2 19.1 8.6 3.7 12.9 38.7 2.7 2.0 2.5 0.0 0.0 0.9 2.7 ANKRD46 ENSG00000186106 "Ankyrin repeat domain 46" Q86W74 8 100509752-100559784 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013758 Approved Approved Cytosol NA NA Cytosol "HPA013758: AB_10962626" "unprognostic (3.71e-3)" "unprognostic (9.01e-2)" "unprognostic (2.03e-1)" "unprognostic (2.22e-2)" "unprognostic (9.82e-2)" "unprognostic (1.16e-1)" "unprognostic (2.63e-1)" "unprognostic (8.84e-2)" "unprognostic (4.79e-2)" "unprognostic (3.56e-1)" "unprognostic (2.98e-2)" "unprognostic (1.51e-1)" "unprognostic (8.08e-3)" "unprognostic (5.29e-2)" "unprognostic (1.82e-1)" "unprognostic (1.81e-2)" "unprognostic (6.29e-3)" 13.0 29.7 25.8 6.0 23.4 1.6 11.1 25.2 34.2 12.2 6.9 13.9 7.6 7.6 9.7 12.8 9.6 8.9 5.9 14.5 24.0 25.9 23.8 29.5 8.0 6.8 21.7 25.2 17.6 13.6 10.7 10.8 15.2 24.5 10.6 7.1 7.7 11.7 10.7 40.3 8.3 8.1 9.5 20.6 7.9 8.4 6.1 14.6 9.4 14.7 6.1 7.9 8.2 7.6 11.3 7.9 10.4 6.0 12.7 15.8 8.7 5.5 7.0 10.6 5.9 8.1 4.8 11.7 7.3 3.3 5.6 4.8 10.1 3.4 17.6 13.8 2.5 1.8 4.3 10.7 5.4 6.0 6.2 9.4 21.9 3.5 7.9 4.8 5.1 2.8 3.4 10.0 3.6 6.0 6.1 6.9 12.3 11.5 5.7 5.3 6.3 23.8 9.5 7.7 14.4 5.2 18.5 3.5 11.7 8.2 6.0 11.6 11.8 3.1 5.8 4.6 13.2 8.6 8.9 5.1 2.6 2.9 3.8 2.8 13.5 12.8 14.5 2.8 16.8 4.1 10.4 6.0 6.1 12.5 3.2 15.2 11.3 12.0 10.9 7.9 9.5 15.8 13.5 1.5 12.7 5.1 7.4 11.2 8.7 25.8 23.4 25.2 34.2 24.0 25.9 21.7 25.2 24.5 14.6 6.0 3.8 12.0 9.0 9.6 28.0 13.7 7.6 4.0 1.2 21.0 17.7 27.0 24.9 7.2 0.8 11.4 8.4 0.0 5.3 11.8 12.0 9.1 4.6 30.4 9.8 63.5 7.0 17.2 7.2 1.1 19.5 3.4 10.1 8.2 8.1 46.0 3.3 8.4 24.8 39.6 28.0 25.8 11.8 8.1 15.1 12.4 19.6 10.0 8.6 7.9 ANO1 "DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A" ENSG00000131620 "Anoctamin 1" Q5XXA6 11 70078302-70189528 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Developmental protein, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 56.2;Hepatocytes: 117.3;Late spermatids: 50.1;Sertoli cells: 45.3;Smooth muscle cells: 42.3;Suprabasal keratinocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 32.9;CAPAN-2: 50.5;HaCaT: 61.6;OE19: 43.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA032148, HPA057356" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA032148: AB_2674180, HPA057356: AB_2732610" "unprognostic (2.73e-1)" "unprognostic (7.91e-2)" "unprognostic (3.66e-2)" "prognostic favorable (4.58e-6)" "unprognostic (1.90e-1)" "prognostic unfavorable (7.28e-5)" "unprognostic (1.16e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (2.13e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.21e-1)" "prognostic unfavorable (4.09e-6)" "unprognostic (1.56e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.81e-1)" 6.9 0.4 1.1 2.1 1.1 0.0 17.2 1.6 1.4 9.7 5.3 1.1 142.4 0.2 14.2 38.5 3.6 11.7 10.6 6.9 1.1 0.2 2.6 24.4 4.4 1.5 1.0 1.0 3.9 4.5 0.5 2.0 6.2 1.5 7.2 1.7 1.7 122.9 93.6 3.4 19.1 1.8 5.7 1.0 1.1 9.5 7.6 0.9 1.1 8.9 8.1 3.8 4.5 5.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 32.9 1.3 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 50.5 0.0 0.6 0.0 0.0 61.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 43.3 4.8 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 10.5 0.2 0.3 3.9 0.1 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 1.6 1.4 1.1 0.2 1.0 1.0 1.5 0.9 0.0 0.0 0.0 18.1 15.8 0.0 2.8 25.5 0.0 1.2 0.0 0.0 1.1 0.0 2.9 56.2 2.2 0.0 0.0 0.0 0.6 3.5 9.1 4.6 117.3 0.2 0.0 0.0 4.9 1.6 50.1 1.7 0.9 5.0 0.0 11.4 1.0 0.6 0.0 1.4 0.4 0.3 45.3 42.3 1.4 1.5 40.8 3.4 0.0 0.2 17.8 ANO10 "FLJ10375, MGC47890, SCAR10, TMEM16K" ENSG00000160746 "Anoctamin 10" Q9NW15 3 43354859-43691594 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016624, HPA051569" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA016624: , HPA051569: AB_2681537" "unprognostic (1.51e-3)" "unprognostic (1.38e-2)" "prognostic favorable (6.70e-4)" "prognostic favorable (1.11e-4)" "unprognostic (4.23e-1)" "unprognostic (2.69e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (7.99e-3)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "prognostic favorable (6.41e-6)" "unprognostic (9.83e-3)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (5.71e-2)" 21.6 12.7 11.8 12.6 13.2 20.6 22.0 18.2 14.1 17.5 27.4 14.3 13.2 42.0 17.9 12.4 19.8 10.4 16.7 10.5 12.3 15.2 22.2 10.5 13.6 10.7 17.3 12.3 12.7 14.4 18.6 14.4 17.5 19.4 10.7 24.4 18.6 23.1 19.5 11.3 24.6 52.9 19.9 23.6 9.4 11.1 9.1 8.8 5.5 17.7 15.8 13.9 13.7 17.0 2.0 8.5 22.4 12.5 6.3 4.6 4.3 9.0 7.2 8.0 8.4 32.6 17.6 9.8 26.5 44.2 13.6 17.3 4.8 8.4 1.0 8.5 34.9 13.4 4.9 6.3 14.5 16.5 10.0 4.5 11.8 9.7 5.2 14.3 2.1 9.6 16.3 11.6 16.7 22.8 24.9 31.7 5.7 8.8 7.7 30.0 6.4 2.3 1.5 9.6 7.0 8.4 1.8 5.7 3.1 26.7 9.5 2.0 5.9 10.5 8.6 6.1 14.8 18.4 4.3 25.8 20.7 7.7 21.7 12.1 5.0 6.5 0.3 18.9 4.5 13.6 4.4 12.5 0.9 4.6 7.1 2.7 1.9 3.2 3.1 8.5 2.0 2.8 4.3 22.4 6.3 7.7 1.5 3.5 4.3 11.8 13.2 18.2 14.1 12.3 15.2 17.3 12.3 19.4 8.8 6.0 2.7 2.2 5.2 4.9 7.1 4.5 10.2 4.0 7.9 14.0 0.0 12.0 104.5 19.0 2.7 14.0 47.9 23.3 15.4 15.5 7.8 5.5 2.3 6.8 10.4 9.5 9.2 19.0 9.2 3.1 5.2 8.2 13.5 1.8 19.1 20.3 11.8 16.5 9.6 14.9 3.6 6.5 12.3 14.7 22.6 5.4 14.3 3.9 24.3 4.6 ANO2 "C12orf3, TMEM16B" ENSG00000047617 "Anoctamin 2" Q9NQ90 12 5531869-5946232 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "placenta: 46.9;retina: 30.6;testis: 13.4" "Group enriched" "Detected in many" 12 "Cone photoreceptor cells: 76.6;Early spermatids: 58.6;Late spermatids: 219.4;Rod photoreceptor cells: 168.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "basophil: 5.1" "Lineage enriched" "Detected in single" 51 "granulocytes: 5.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.6;HUVEC TERT2: 8.5;U-2 OS: 22.5" "Region enriched" "Detected in some" 4 "basal ganglia: 20.0" "HPA036276, HPA057499" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA036276: AB_10670713, HPA057499: AB_2732613" "unprognostic (6.32e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-1)" "unprognostic (1.25e-2)" "unprognostic (1.55e-1)" "unprognostic (4.05e-3)" "unprognostic (2.86e-1)" "unprognostic (2.62e-1)" "unprognostic (1.11e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-3)" "unprognostic (3.78e-3)" "unprognostic (1.04e-2)" "unprognostic (1.10e-2)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (2.17e-1)" 5.8 0.1 1.0 1.3 2.3 0.0 4.3 1.2 1.3 3.3 1.0 1.6 0.9 0.8 1.8 2.1 0.9 1.9 1.5 3.9 1.9 0.9 1.2 0.9 4.7 0.9 1.6 2.0 0.9 0.9 1.4 0.9 46.9 1.2 1.4 0.7 30.6 0.9 1.6 2.3 0.6 0.9 2.1 1.1 1.9 1.0 13.4 0.9 0.9 1.6 1.3 0.9 1.3 2.3 0.0 0.0 5.1 0.0 0.0 0.0 0.2 2.2 0.0 4.0 0.0 0.0 0.2 1.9 0.0 8.6 0.4 0.9 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.6 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.5 0.0 0.0 1.7 0.0 0.8 0.0 0.0 4.1 2.0 0.0 1.7 0.0 0.9 0.1 0.1 0.0 0.0 2.1 1.4 0.0 3.7 1.2 0.0 0.2 0.0 22.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 1.0 2.3 1.2 1.3 1.9 0.9 1.6 2.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 7.4 1.1 0.0 0.0 0.0 0.0 76.6 1.1 0.0 0.0 58.6 3.6 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.2 9.5 0.0 1.8 0.0 219.4 0.3 0.0 0.0 0.0 0.0 10.6 0.0 0.0 1.4 0.0 168.7 0.0 0.4 1.5 1.3 0.1 2.1 0.0 0.0 0.0 ANO3 "C11orf25, DYT23, GENX-3947, TMEM16C" ENSG00000134343 "Anoctamin 3" Q9BYT9 11 26309599-26663288 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "brain: 83.1;epididymis: 47.3" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 13.7;Early spermatids: 7.9;Horizontal cells: 7.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "basal ganglia: 83.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 3.2;HDLM-2: 10.4;U-2 OS: 2.8;U-2197: 7.6" "Region enhanced" "Detected in many" "basal ganglia: 142.2" "Region enriched" "Detected in all" 5 "basal ganglia: 149.8" HPA041629 Uncertain NA NA "HPA041629: AB_10793969" "unprognostic (7.01e-3)" "unprognostic (4.31e-1)" "unprognostic (2.94e-1)" "unprognostic (9.29e-2)" "unprognostic (9.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.35e-1)" "unprognostic (2.75e-2)" "unprognostic (1.66e-1)" "unprognostic (2.45e-2)" "unprognostic (7.02e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-4)" "unprognostic (9.48e-3)" "unprognostic (3.50e-2)" "unprognostic (4.33e-1)" "unprognostic (4.01e-1)" 2.8 1.2 6.4 0.5 83.1 0.4 0.6 0.2 13.3 1.1 0.6 0.1 0.0 0.6 0.6 47.3 0.5 0.7 2.0 0.5 7.0 0.6 1.4 1.4 0.8 0.5 1.1 5.4 0.5 0.7 0.5 0.3 0.5 5.9 0.5 0.6 0.0 0.6 0.6 0.4 0.5 0.5 0.7 0.5 0.8 0.5 1.9 9.0 0.0 1.4 0.0 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 2.1 2.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.2 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.6 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.8 7.6 0.0 0.7 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 83.1 0.2 13.3 7.0 0.6 1.1 5.4 5.9 9.0 0.0 1.3 0.0 0.0 0.0 0.7 0.8 0.0 4.0 0.0 0.0 13.7 0.2 0.0 0.1 7.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.6 0.0 7.9 0.0 3.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.3 2.8 1.1 0.0 0.2 0.0 0.0 0.0 ANO4 "FLJ34221, FLJ34272, FLJ35277, TMEM16D" ENSG00000151572 "Anoctamin 4" Q32M45 12 100717526-101128641 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.3;brain: 19.2;seminal vesicle: 14.0" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 3.9;Early spermatids: 4.4;Intestinal endocrine cells: 4.1;Late spermatids: 1.9;Spermatogonia: 1.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 14.3;LHCN-M2: 6.9;SK-MEL-30: 11.1;TIME: 22.8;WM-115: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053412 Uncertain NA NA "HPA053412: AB_2682140" "unprognostic (1.11e-1)" "unprognostic (3.03e-2)" "unprognostic (4.58e-2)" "unprognostic (1.04e-1)" "unprognostic (1.20e-2)" "unprognostic (2.02e-1)" "unprognostic (3.76e-2)" "unprognostic (1.95e-2)" "unprognostic (1.39e-1)" "unprognostic (1.97e-1)" "unprognostic (4.72e-1)" "unprognostic (6.54e-2)" "prognostic favorable (5.48e-5)" "unprognostic (1.16e-3)" "unprognostic (8.46e-2)" "unprognostic (2.01e-2)" "unprognostic (1.41e-1)" 0.9 20.3 10.3 0.6 16.7 0.6 0.7 2.8 13.0 13.3 0.8 17.2 1.4 1.1 7.9 1.2 0.7 1.0 0.8 0.8 9.5 5.8 0.8 0.6 0.7 0.6 10.9 8.6 13.8 1.6 0.8 2.2 0.7 12.1 8.7 0.9 0.0 3.6 14.0 0.6 0.7 0.9 1.5 4.4 0.6 0.6 2.1 19.2 0.0 0.8 0.0 1.3 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.8 1.1 0.0 5.0 4.5 4.2 2.0 0.0 0.0 0.0 0.0 14.3 0.0 0.2 5.2 4.3 3.9 0.0 0.0 0.0 2.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 6.9 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 11.1 5.8 0.0 0.0 22.8 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 16.7 2.8 13.0 9.5 5.8 10.9 8.6 12.1 19.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.1 0.0 4.1 0.0 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.0 ANO5 "GDD1, LGMD2L, TMEM16E" ENSG00000171714 "Anoctamin 5" Q75V66 11 22193176-22283357 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Limb-girdle muscular dystrophy, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 37.7;parathyroid gland: 26.9;skeletal muscle: 43.7" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 82.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "classical monocyte: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 6.6;HAP1: 7.2;HEK 293: 9.0;NTERA-2: 5.0;U-266/84: 5.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA058857 Uncertain NA NA "HPA058857: AB_2683835" "unprognostic (5.25e-3)" "unprognostic (1.36e-3)" "unprognostic (2.43e-1)" "unprognostic (7.67e-3)" "unprognostic (3.50e-2)" "unprognostic (5.85e-2)" "unprognostic (8.17e-3)" "unprognostic (2.30e-2)" "unprognostic (1.68e-1)" "unprognostic (3.89e-2)" "unprognostic (2.54e-4)" "unprognostic (8.55e-2)" "prognostic favorable (2.50e-7)" "unprognostic (3.65e-3)" "unprognostic (2.84e-1)" "unprognostic (2.77e-4)" "unprognostic (7.94e-2)" 1.0 3.8 3.9 0.9 3.8 0.3 0.9 0.9 7.9 1.7 2.6 1.1 1.0 2.9 1.5 1.6 2.4 1.1 1.6 37.7 4.5 4.2 3.1 2.3 1.4 0.6 3.4 6.3 1.0 3.3 26.9 5.0 0.4 3.5 3.8 2.9 2.7 3.4 3.7 43.7 0.5 3.1 4.1 1.9 1.0 3.0 2.3 1.7 0.0 3.9 14.2 0.6 3.2 1.9 0.0 0.9 0.0 1.5 0.0 0.1 0.1 0.0 6.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 1.7 2.4 4.3 0.0 0.0 0.0 0.0 5.0 3.5 0.0 0.1 0.0 0.0 4.5 0.1 4.0 3.7 0.0 0.0 0.0 3.2 3.3 2.5 0.0 0.0 2.9 0.0 0.0 2.9 5.2 0.0 4.0 0.0 0.9 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 3.8 0.9 7.9 4.5 4.2 3.4 6.3 3.5 1.7 0.0 5.1 0.5 0.3 0.2 7.2 82.0 0.0 1.4 0.0 1.8 0.0 0.0 1.7 0.9 4.8 2.7 2.6 0.0 2.4 0.0 0.2 1.6 0.0 4.9 0.5 1.6 5.2 3.7 0.8 1.9 0.0 1.3 1.7 0.0 7.5 2.4 1.1 3.5 1.1 2.4 0.4 0.0 0.4 4.1 0.5 0.1 0.0 0.0 3.0 0.1 ANO6 "DKFZp313M0720, TMEM16F" ENSG00000177119 "Anoctamin 6" Q4KMQ2 12 45215987-45440404 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Lipid transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 81.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038958 Approved Approved "Plasma membrane,Cytosol" NA NA 1500000 "Plasma membrane, Cytosol" "HPA038958: AB_10672835" "prognostic unfavorable (7.56e-5)" "prognostic unfavorable (3.82e-4)" "unprognostic (2.16e-1)" "unprognostic (1.75e-2)" "unprognostic (1.29e-1)" "unprognostic (9.82e-3)" "unprognostic (7.43e-2)" "unprognostic (3.01e-3)" "unprognostic (7.55e-2)" "unprognostic (2.84e-3)" "unprognostic (1.41e-3)" "unprognostic (3.02e-1)" "unprognostic (2.68e-2)" "unprognostic (1.26e-3)" "unprognostic (1.26e-1)" "unprognostic (4.20e-2)" "unprognostic (1.28e-1)" 40.7 15.3 6.4 17.3 7.0 3.8 42.8 2.5 7.3 22.2 29.7 6.1 34.8 16.5 33.2 16.0 21.2 18.5 20.2 20.7 6.7 5.4 21.6 25.4 25.6 11.7 7.6 4.2 27.4 12.7 20.1 7.1 23.3 8.8 21.6 6.9 14.2 16.8 39.3 40.3 10.0 41.3 42.8 14.6 12.5 13.5 10.4 5.8 21.6 11.2 14.7 9.6 37.6 38.1 2.1 7.1 4.4 9.3 3.1 4.0 5.0 13.6 15.7 8.8 12.0 40.6 21.1 33.7 19.2 24.2 13.3 12.3 23.6 20.7 7.1 18.0 30.0 11.8 18.1 8.0 10.6 15.5 10.4 5.7 8.2 6.4 19.9 12.9 12.7 6.6 17.6 10.6 11.1 16.4 31.7 17.4 14.9 6.2 11.5 14.1 3.6 13.5 4.1 9.8 0.0 5.9 7.8 11.5 7.8 12.2 21.7 4.0 13.7 20.1 12.5 9.2 23.9 14.7 20.1 23.8 14.2 9.1 14.3 9.7 6.1 7.0 8.6 12.8 40.8 11.3 4.4 7.7 1.9 3.3 9.3 3.4 2.1 3.2 2.8 7.1 1.7 2.9 2.0 0.9 3.1 8.6 3.6 4.0 5.0 6.4 7.0 2.5 7.3 6.7 5.4 7.6 4.2 8.8 5.8 56.6 10.2 3.7 20.1 27.1 0.4 20.3 30.6 6.7 13.6 17.4 0.0 29.4 3.3 35.0 1.0 34.4 4.9 0.0 32.0 21.1 32.3 17.2 12.7 81.6 17.8 0.0 8.1 54.0 49.8 1.3 47.5 21.3 16.9 8.2 11.4 9.8 55.0 10.2 38.2 18.0 0.2 38.8 31.6 2.4 4.2 19.3 20.6 6.4 10.7 25.1 ANO7 "IPCA-5, NGEP, PCANAP5, PCANAP5L, TMEM16G" ENSG00000146205 "Anoctamin 7" Q6IWH7 2 241188509-241225377 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 17.3;prostate: 44.7;stomach 1: 15.1" "Group enriched" "Detected in many" 6 "Glandular cells: 15.1;Mucus-secreting cells: 53.7" "Cancer enriched" "Detected in many" 19 "prostate cancer: 32.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "BEWO: 5.6;Hep G2: 5.4;OE19: 5.4" "Low region specificity" "Detected in single" HPA078464 Enhanced "Intracellular and membrane" NA NA "HPA078464: " "unprognostic (1.93e-2)" "unprognostic (3.45e-3)" "unprognostic (1.09e-3)" "unprognostic (5.13e-2)" "unprognostic (1.35e-2)" "unprognostic (8.76e-2)" "unprognostic (3.09e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-2)" "unprognostic (8.45e-2)" "unprognostic (2.90e-2)" "unprognostic (4.94e-2)" "unprognostic (4.82e-3)" "unprognostic (6.09e-2)" "unprognostic (1.61e-1)" "unprognostic (2.14e-1)" "unprognostic (2.53e-2)" 0.2 0.0 0.3 6.5 0.4 1.7 0.2 0.2 0.4 0.3 17.3 0.3 0.2 5.3 0.2 0.2 0.2 0.1 1.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 44.7 4.9 0.2 2.3 0.2 0.2 0.0 17.3 0.5 0.3 0.2 15.1 0.2 0.2 0.2 0.2 0.7 1.0 0.3 0.2 0.0 0.0 0.0 0.8 2.2 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.0 5.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.5 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.0 0.2 5.4 0.3 0.0 0.0 1.1 0.0 0.0 0.4 0.5 0.0 0.1 0.3 0.3 0.3 0.0 1.0 0.0 0.0 1.0 0.5 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.1 0.3 0.4 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.5 0.6 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.1 0.0 1.4 2.4 0.0 3.6 2.8 1.0 15.1 0.0 2.9 1.2 0.0 2.9 4.3 0.3 0.0 3.1 0.9 1.7 0.0 53.7 1.5 6.0 0.0 2.1 1.4 0.5 0.0 0.4 0.0 1.2 0.0 0.6 0.0 2.4 0.7 ANO8 "KIAA1623, TMEM16H" ENSG00000074855 "Anoctamin 8" Q9HCE9 19 17323223-17334829 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.6" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 6.0;Extravillous trophoblasts: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049206 Uncertain NA NA "HPA049206: AB_2680675" "unprognostic (5.12e-2)" "unprognostic (2.79e-1)" "unprognostic (1.59e-1)" "unprognostic (3.07e-1)" "unprognostic (2.91e-1)" "unprognostic (2.20e-3)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (3.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-1)" "unprognostic (5.89e-2)" "unprognostic (3.05e-3)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.48e-2)" "unprognostic (4.59e-2)" 8.5 18.1 19.2 6.6 17.9 3.8 6.6 25.1 30.6 4.3 4.3 11.6 4.9 6.6 5.1 2.2 12.5 4.0 7.9 7.1 15.7 10.6 6.1 6.0 6.6 6.2 13.3 10.3 3.2 7.0 14.4 4.0 5.3 23.3 5.4 4.0 3.2 7.9 4.8 11.1 23.2 6.2 4.5 20.1 5.4 12.2 3.4 14.1 5.3 5.2 5.2 4.4 5.1 5.2 0.1 1.8 0.1 0.1 0.0 0.8 0.1 4.2 3.7 10.4 11.7 3.2 2.2 18.0 4.3 2.5 2.3 2.5 1.7 9.1 0.3 4.7 4.2 3.2 4.0 2.1 3.5 1.3 19.1 5.3 2.9 10.9 2.5 1.6 0.6 4.9 2.5 3.3 2.9 2.1 5.8 1.7 6.9 2.1 4.3 1.4 3.2 3.7 1.1 6.0 4.8 15.6 6.2 2.2 5.1 3.8 7.0 3.9 12.6 4.7 4.5 3.6 3.9 6.4 1.9 1.7 5.3 3.0 16.1 4.7 7.7 6.3 0.7 8.3 5.3 5.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.5 0.5 0.0 0.0 0.1 1.8 0.8 0.1 19.2 17.9 25.1 18.6 15.7 10.6 13.3 10.3 23.3 14.1 6.0 1.7 0.0 0.3 0.8 5.4 1.7 2.5 0.0 1.2 0.0 3.9 2.7 0.0 1.4 0.1 0.3 2.1 0.0 1.4 7.3 0.6 1.2 5.7 3.0 1.5 1.6 0.0 0.6 1.0 0.0 2.0 1.7 0.0 0.0 2.3 2.6 1.5 0.0 0.7 0.5 2.3 0.0 0.9 0.2 0.9 1.3 2.2 0.5 1.5 0.4 ANO9 "PIG5, TMEM16J, TP53I5" ENSG00000185101 "Anoctamin 9" A1A5B4 11 417933-442011 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 69.4" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 72.1;Mucus-secreting cells: 39.0;Paneth cells: 37.1;Undifferentiated cells: 37.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 26.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 41 "B-cells: 2.2;NK-cells: 3.9;T-cells: 7.9" "Cell line enhanced" "Detected in some" "BEWO: 7.0;CAPAN-2: 21.2;HaCaT: 12.3;RPMI-8226: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039948, HPA040112" Approved Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA039948: AB_2676765, HPA040112: " "unprognostic (3.62e-3)" "unprognostic (2.83e-2)" "unprognostic (4.68e-2)" "unprognostic (1.62e-1)" "unprognostic (1.41e-2)" "unprognostic (8.93e-2)" "unprognostic (6.98e-2)" "unprognostic (8.94e-3)" "unprognostic (1.39e-1)" "unprognostic (2.28e-3)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (1.91e-2)" "unprognostic (1.18e-2)" "unprognostic (2.08e-1)" "unprognostic (3.92e-1)" "prognostic favorable (8.81e-4)" 0.7 0.1 0.1 17.4 0.2 0.9 1.4 0.1 0.2 1.4 32.1 0.1 1.3 21.5 0.8 4.7 6.8 1.2 6.2 0.4 0.2 0.1 4.8 0.4 5.8 6.3 0.4 0.1 0.5 5.6 0.0 1.6 0.7 0.3 2.6 5.4 0.6 6.2 0.6 0.1 14.4 69.4 0.5 0.5 4.8 4.4 0.4 0.1 11.3 2.2 6.1 17.2 3.4 2.7 2.2 0.1 0.0 0.0 3.9 7.9 1.5 2.0 0.3 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 1.9 21.2 1.5 1.1 0.0 0.0 12.3 0.0 5.0 0.0 1.7 0.0 0.0 0.3 2.9 0.0 0.3 0.0 0.0 3.4 0.0 0.8 0.0 0.0 3.2 0.1 1.3 0.0 2.4 0.4 0.1 0.0 4.4 0.0 0.1 0.0 14.8 3.2 3.0 0.9 0.1 0.2 5.2 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 5.6 2.2 6.8 3.2 0.1 1.0 3.9 2.9 0.0 3.9 0.0 0.0 7.9 1.5 0.1 0.2 0.1 0.2 0.2 0.1 0.4 0.1 0.3 0.1 0.0 8.9 12.7 4.0 4.6 0.0 2.2 5.1 0.0 3.4 3.5 0.0 0.1 0.0 9.2 0.5 0.0 72.1 0.0 5.6 2.6 0.5 2.7 0.0 0.0 0.3 0.0 14.9 0.6 0.0 0.0 0.0 0.2 3.3 1.8 39.0 0.0 8.6 37.1 0.0 2.6 0.0 0.0 1.0 0.1 0.0 5.5 0.1 10.1 37.3 3.9 ANPEP "CD13, gp150, LAP1, p150, PEPN" ENSG00000166825 "Alanyl aminopeptidase, membrane" P15144 15 89784889-89815401 "CD markers, Enzymes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 195.3;kidney: 78.7;pancreas: 93.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 372.0;Enterocytes: 993.7;Exocrine glandular cells: 328.5;Proximal tubular cells: 388.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 5 "neutrophil: 59.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 59.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 78.5;BJ: 78.2;BJ hTERT+: 111.8;fHDF/TERT166: 67.0;HMC-1: 71.1;HSkMC: 68.7;HUVEC TERT2: 87.5;TIME: 87.4;U-2197: 95.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB002417, HPA004625" Enhanced Supported "Plasma membrane" NA NA 1500000000 "Plasma membrane" "CAB002417: AB_563491, HPA004625: AB_2667199" "unprognostic (6.31e-2)" "unprognostic (7.94e-3)" "unprognostic (6.91e-2)" "unprognostic (2.16e-1)" "unprognostic (2.50e-1)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (7.73e-2)" "unprognostic (5.28e-3)" "unprognostic (3.96e-1)" "unprognostic (4.04e-3)" "unprognostic (3.20e-2)" "unprognostic (2.01e-2)" "unprognostic (4.61e-3)" "unprognostic (1.99e-2)" 21.3 1.1 0.6 2.9 0.8 9.5 17.0 1.0 1.3 8.2 21.2 0.8 0.5 195.3 1.4 8.4 3.6 1.4 27.7 3.7 0.4 0.3 78.7 37.7 9.7 9.3 0.9 0.9 1.8 93.9 0.0 0.7 14.7 1.3 8.6 4.7 4.0 6.6 1.8 1.6 4.9 155.8 4.3 1.2 7.2 0.8 4.7 0.2 5.6 1.5 4.2 3.8 4.7 3.0 0.0 6.9 59.4 12.8 0.0 0.0 5.5 0.0 5.0 0.0 0.0 61.3 78.5 0.5 78.2 111.8 9.6 8.5 0.5 0.0 0.0 0.9 67.0 0.0 0.0 0.6 0.0 3.8 0.0 0.0 14.7 0.4 11.7 36.1 1.0 71.1 68.7 0.1 30.2 0.0 0.4 87.5 0.0 0.4 0.1 3.7 0.0 0.0 34.7 0.2 0.0 5.3 0.0 0.0 0.8 43.7 0.0 0.1 0.7 0.0 0.1 0.0 0.1 0.0 6.8 87.4 42.2 0.0 95.3 0.0 0.0 0.0 0.0 0.1 0.0 2.2 5.7 12.8 10.4 0.0 7.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 59.4 0.0 12.0 0.1 0.0 5.5 0.6 0.8 1.0 1.3 0.4 0.3 0.9 0.9 1.3 0.2 0.0 4.8 8.2 3.1 8.9 0.0 0.8 372.0 2.7 20.5 19.2 0.0 9.7 36.5 10.6 0.1 1.8 993.7 0.0 328.5 12.0 36.3 18.0 24.2 144.7 39.4 0.0 2.9 101.9 51.7 0.0 2.6 46.4 3.3 39.7 10.5 0.0 120.5 201.5 1.4 388.5 0.0 25.8 5.0 0.4 0.1 5.1 5.4 1.0 18.3 1.3 ANTXR1 "ATR, FLJ10601, FLJ21776, TEM8" ENSG00000169604 "Anthrax toxin receptor 1" Q9H6X2 2 69013178-69249327 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor Hypotrichosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 44.0;Fibroblasts: 78.7;Peritubular cells: 63.6;Smooth muscle cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 73.4;RH-30: 39.8;TIME: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054785 Uncertain Vesicles "Intracellular and membrane" NA NA 4100000 Vesicles "HPA054785: " "unprognostic (1.44e-1)" "prognostic unfavorable (5.76e-4)" "unprognostic (8.49e-2)" "unprognostic (4.77e-2)" "unprognostic (3.61e-1)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (4.15e-3)" "unprognostic (9.05e-3)" "unprognostic (1.15e-1)" "unprognostic (3.48e-3)" "unprognostic (2.26e-3)" "unprognostic (9.84e-2)" "prognostic unfavorable (1.22e-5)" "unprognostic (2.09e-2)" 27.5 25.8 10.0 10.1 14.9 0.1 21.1 11.0 9.6 33.4 14.2 23.6 8.5 4.9 35.7 13.5 14.0 20.7 51.5 18.8 17.0 10.1 6.1 3.1 20.1 4.4 19.4 6.5 45.5 3.1 30.5 10.4 32.3 23.6 21.7 8.8 37.2 13.8 23.0 12.4 17.9 8.9 30.4 21.4 11.7 7.4 6.6 16.7 2.6 17.5 10.4 6.7 29.1 24.5 0.0 0.1 0.1 0.0 0.2 0.4 0.0 6.9 8.7 7.7 4.8 35.8 17.5 0.1 11.4 23.2 12.1 9.7 0.0 0.6 0.0 6.7 30.0 7.3 6.6 5.3 6.8 11.4 0.0 4.3 1.8 19.4 2.2 15.8 1.5 1.0 28.4 2.7 12.0 7.5 30.3 3.3 4.0 1.1 0.0 73.4 3.1 4.2 0.1 7.3 0.0 5.7 0.0 39.8 0.1 3.0 6.1 4.4 19.6 22.1 0.1 7.8 4.5 2.3 0.4 49.9 15.4 12.9 15.4 12.0 0.0 0.0 0.0 7.9 1.3 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 10.0 14.9 11.0 9.0 17.0 10.1 19.4 6.5 23.6 16.7 6.0 21.2 0.0 16.2 44.0 0.7 5.1 0.0 5.3 7.9 0.0 0.0 0.7 0.0 1.2 30.7 2.9 0.0 0.0 2.3 0.7 78.7 8.7 1.1 0.0 3.4 0.0 0.0 4.9 0.3 28.8 39.4 2.7 23.6 1.0 0.0 12.0 1.2 0.0 63.6 0.0 0.4 19.4 53.6 5.4 2.0 20.6 1.1 0.0 0.0 8.1 ANTXR2 "CMG-2, CMG2, FLJ31074" ENSG00000163297 "Anthrax toxin receptor 2" P58335 4 79901149-80125454 "Disease related genes, Plasma proteins, Predicted membrane proteins" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 43.4;HHSteC: 37.2;LHCN-M2: 43.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 6600000 "unprognostic (3.01e-1)" "unprognostic (1.79e-2)" "unprognostic (1.95e-2)" "unprognostic (4.87e-2)" "unprognostic (5.63e-2)" "unprognostic (2.30e-2)" "unprognostic (6.75e-2)" "unprognostic (3.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (1.27e-1)" "prognostic unfavorable (3.34e-6)" "unprognostic (1.03e-3)" "unprognostic (2.98e-2)" "unprognostic (1.10e-2)" "unprognostic (1.78e-1)" 18.6 8.8 1.7 14.4 2.0 4.3 16.8 1.0 1.8 30.7 24.6 2.4 10.2 4.1 36.3 11.1 20.1 14.6 22.9 10.0 2.9 1.5 4.1 10.4 9.8 10.1 1.9 2.0 23.5 3.1 16.7 2.5 23.1 2.8 40.2 11.1 6.2 4.6 22.2 8.9 4.8 17.3 56.5 3.9 9.1 19.5 11.1 2.1 4.3 4.3 5.0 8.2 38.0 20.3 9.2 12.4 22.1 6.8 1.5 14.1 5.0 2.6 0.2 6.4 1.1 43.4 25.6 0.6 8.7 25.9 3.8 4.5 0.1 2.1 0.0 0.1 16.0 2.3 0.8 0.9 10.3 14.9 0.3 0.8 2.1 0.1 0.8 37.2 9.0 5.6 30.4 3.0 27.2 14.4 29.0 11.2 0.3 4.9 6.5 43.9 0.0 0.1 4.9 0.8 4.0 12.4 0.4 3.8 1.6 2.1 2.7 6.1 8.4 0.9 0.1 1.1 3.3 0.1 1.8 12.5 28.2 1.5 31.2 15.9 0.3 0.0 0.0 15.8 6.8 8.6 22.1 6.8 21.1 5.1 3.6 5.6 9.2 8.1 5.0 12.4 3.8 4.6 2.0 20.2 1.5 6.8 10.3 14.1 5.0 1.7 2.0 1.0 1.8 2.9 1.5 1.9 2.0 2.8 2.1 11.9 11.4 18.5 14.4 6.3 2.8 20.6 2.5 4.0 14.8 0.0 27.5 10.0 3.3 3.4 1.8 10.5 20.2 0.0 5.8 24.2 36.7 10.6 57.8 18.8 15.6 0.0 17.9 17.8 15.2 4.4 36.2 15.5 1.7 60.5 14.5 8.1 28.0 32.8 60.1 2.9 11.6 38.8 16.4 0.5 1.5 3.8 5.5 17.3 8.1 1.4 ANTXRL ENSG00000274209 "Anthrax toxin receptor like" A6NF34 10 46286345-46330207 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 3.9;testis: 13.2" "Group enriched" "Detected in some" 43 "Early spermatids: 41.7;Late spermatids: 19.0" "Cancer enriched" "Detected in single" 6 "ovarian cancer: 0.7" "Group enriched" "Detected in some" 5 "basophil: 1.9;neutrophil: 3.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.9" "Cell line enhanced" "Detected in some" "MOLT-4: 2.8;NB-4: 3.0;SCLC-21H: 1.7;U-698: 1.2" NA NA "unprognostic (1.09e-1)" "unprognostic (2.67e-2)" "unprognostic (3.65e-3)" "unprognostic (2.59e-2)" "unprognostic (3.40e-1)" "unprognostic (8.11e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.61e-1)" "unprognostic (2.70e-2)" "unprognostic (1.92e-1)" "unprognostic (1.53e-2)" 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.2 0.0 0.0 0.0 0.0 0.5 3.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.8 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.2 1.9 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 AOC2 "DAO2, RAO" ENSG00000131480 "Amine oxidase, copper containing 2" O75106 17 42844600-42850707 "Enzymes, Predicted intracellular proteins" "Catecholamine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "retina: 133.5" "Cell type enriched" "Detected in some" 9 "Early spermatids: 28.8" "Cancer enhanced" "Detected in some" "testis cancer: 3.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "neutrophil: 4.0" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.0" "Cell line enhanced" "Detected in many" "ASC diff: 14.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA057779 Uncertain "Intracellular and membrane" NA NA "HPA057779: " "unprognostic (3.79e-2)" "unprognostic (2.33e-1)" "unprognostic (5.10e-4)" "unprognostic (1.90e-2)" "unprognostic (1.48e-2)" "unprognostic (2.42e-1)" "unprognostic (4.63e-2)" "unprognostic (2.63e-2)" "unprognostic (1.39e-1)" "unprognostic (3.64e-2)" "unprognostic (2.16e-2)" "unprognostic (8.27e-3)" "unprognostic (4.55e-5)" "unprognostic (3.55e-2)" "unprognostic (2.73e-1)" "unprognostic (1.63e-2)" "prognostic favorable (2.47e-4)" 11.6 1.2 0.9 1.3 3.2 1.8 3.1 3.2 1.6 1.5 1.1 0.9 0.9 0.6 1.5 1.2 1.0 1.5 1.5 1.3 1.2 1.8 0.9 3.6 2.2 1.0 0.9 0.9 1.0 1.2 0.8 2.1 0.9 0.9 1.3 0.5 133.5 1.2 1.2 1.4 1.2 1.0 1.3 1.0 1.7 0.7 6.5 0.9 1.0 1.0 0.9 1.2 1.6 0.9 0.1 0.0 4.0 0.0 0.0 0.6 0.0 0.2 2.8 0.6 3.1 14.3 1.4 7.4 0.9 0.9 2.0 2.8 2.2 0.3 1.1 1.4 0.3 0.9 1.2 2.7 0.7 4.1 2.3 7.3 0.4 1.3 2.2 0.9 0.4 2.8 2.2 2.5 1.9 2.9 0.4 0.5 3.8 0.7 2.6 0.6 0.3 0.6 1.1 1.1 0.3 0.9 1.4 2.9 2.3 0.4 4.4 1.0 0.6 0.1 1.0 4.0 6.0 0.5 0.2 0.5 1.9 4.1 2.5 1.2 5.7 5.6 1.1 0.5 2.6 1.0 0.0 0.0 0.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.9 3.2 3.2 1.6 1.2 1.8 0.9 0.9 0.9 0.9 0.0 0.3 0.0 0.5 0.9 0.2 0.3 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.4 28.8 0.7 0.0 0.0 0.3 0.1 0.2 0.7 0.0 0.8 0.1 0.0 0.0 0.6 0.8 3.3 0.3 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.2 0.6 0.0 0.9 2.1 2.7 1.4 0.0 0.0 0.0 0.5 AOC3 "HPAO, VAP-1, VAP1" ENSG00000131471 "Amine oxidase, copper containing 3" Q16853 17 42851184-42858130 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Peritubular cells: 70.4;Sertoli cells: 116.4;Smooth muscle cells: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enriched" "Detected in some" 18 "ASC diff: 85.5" "Low region specificity" "Detected in many" "HPA000980, CAB025797" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted - unknown location" NA NA 240000000 Cytosol "Golgi apparatus" "CAB025797: , HPA000980: AB_1078170" "unprognostic (2.20e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.68e-4)" "unprognostic (2.97e-2)" "unprognostic (1.17e-1)" "unprognostic (2.64e-1)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.48e-1)" "unprognostic (4.00e-2)" "unprognostic (2.95e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.79e-5)" "unprognostic (5.61e-2)" "unprognostic (1.67e-1)" "unprognostic (8.39e-2)" "prognostic unfavorable (6.98e-4)" 97.0 11.5 0.4 18.7 1.0 0.0 67.7 0.5 1.3 26.9 44.3 1.0 16.3 3.6 44.7 34.8 36.1 18.5 50.9 12.1 0.4 0.4 5.8 8.3 48.0 7.9 0.5 1.2 23.8 2.4 2.2 1.3 10.8 2.0 36.5 9.4 32.1 8.0 24.7 7.7 5.5 15.0 79.2 0.6 7.5 17.7 16.2 0.3 1.0 6.6 11.6 2.6 75.9 20.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 85.5 0.1 1.3 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.3 1.5 0.1 0.1 4.7 0.2 0.0 0.2 0.9 0.2 0.1 0.2 0.0 0.0 0.5 0.0 0.4 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.2 0.7 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.7 0.3 0.1 1.2 1.4 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.5 1.3 0.4 0.4 0.5 1.2 2.0 0.3 3.0 8.9 0.8 0.0 2.6 0.0 3.2 0.0 1.4 3.4 0.0 0.0 0.1 0.0 0.1 3.8 4.7 0.0 0.0 0.2 0.1 2.6 0.2 1.1 0.0 1.1 0.0 0.0 22.7 3.0 2.1 3.1 0.5 3.3 0.0 0.0 0.4 0.1 0.0 70.4 0.7 0.5 116.4 56.5 0.9 0.7 1.6 0.2 0.0 0.0 0.3 AP000350.4 ENSG00000251357 22 23862188-23895223 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.1;pancreas: 4.2" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 35.7;Alveolar cells type 2: 85.7;Ciliated cells: 75.0;Club cells: 73.9;granulocytes: 50.0;Melanocytes: 32.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 6.1;SK-MEL-30: 5.0;THP-1: 5.6" HPA042960 Uncertain NA NA "HPA042960: AB_2678241" 0.2 1.9 0.2 0.8 0.3 0.0 0.1 1.8 0.4 0.9 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.1 0.7 1.6 0.2 0.3 0.4 0.2 0.6 4.2 0.0 0.6 0.1 0.3 0.0 1.9 0.5 0.5 0.6 1.2 0.0 0.7 0.1 0.9 0.2 0.1 0.0 0.2 0.2 4.0 5.1 1.1 0.5 0.7 2.2 0.7 2.7 0.0 0.6 0.3 1.0 0.0 0.3 0.6 0.1 0.3 0.0 0.0 1.3 0.2 2.1 0.0 0.0 1.7 0.0 0.5 0.9 2.0 1.8 0.0 0.1 0.3 0.0 0.0 0.6 0.0 1.9 0.0 0.0 0.0 0.0 0.8 0.0 6.1 0.0 0.0 2.2 1.0 1.3 0.1 0.0 1.5 0.1 3.1 0.0 0.0 3.9 3.5 0.0 1.9 5.0 0.4 0.6 5.6 0.0 0.0 1.8 1.8 0.0 3.9 0.5 1.4 1.0 1.3 0.5 0.4 0.1 1.1 0.9 0.5 1.7 1.8 2.2 1.0 0.0 4.0 1.5 1.3 0.0 0.7 0.3 5.1 1.3 0.7 35.7 85.7 0.0 0.0 14.5 0.0 0.0 0.0 75.0 73.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 50.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 32.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 AP000781.2 ENSG00000254979 11 57387365-57424059 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.8;liver: 8.1" "Cell type enriched" "Detected in some" 5 "granulocytes: 5.8" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 7 "basophil: 6.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.3" "Cell line enriched" "Detected in some" 7 "HMC-1: 65.5" HPA038515 Supported NA NA "HPA038515: AB_10675800" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (5.10e-2)" "unprognostic (1.55e-4)" "unprognostic (2.16e-1)" "unprognostic (4.01e-1)" "unprognostic (4.83e-2)" "unprognostic (2.05e-2)" "unprognostic (2.20e-1)" "unprognostic (3.08e-2)" "unprognostic (1.33e-2)" "unprognostic (1.79e-1)" "unprognostic (1.51e-10)" "unprognostic (4.86e-2)" "unprognostic (1.54e-1)" "unprognostic (5.59e-2)" "unprognostic (3.10e-1)" 7.3 0.0 0.0 0.3 0.0 11.8 3.0 0.0 0.5 0.5 0.5 0.5 0.4 0.0 1.2 0.0 0.9 0.6 0.0 0.0 0.1 8.1 1.0 0.7 0.0 0.2 3.0 0.0 0.1 7.9 0.1 0.2 1.6 0.0 0.9 6.6 0.4 0.0 0.0 0.4 0.3 0.0 1.4 0.7 0.8 0.6 0.7 0.9 6.3 0.6 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.3 9.6 65.5 0.6 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.3 3.0 0.1 0.0 0.0 1.3 0.0 2.9 0.0 0.0 0.3 0.1 0.0 0.1 1.0 0.0 0.0 0.3 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.3 0.3 0.3 0.4 6.3 0.6 0.6 0.7 0.3 0.0 0.0 0.5 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.3 0.9 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP001781.2 ENSG00000258529 11 111786286-111879425 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 6.0;HeLa: 4.7;U-698: 4.5" HPA038575 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA038575: AB_10672718" 2.2 0.2 1.7 2.8 2.2 2.9 2.5 0.4 2.7 0.4 3.6 1.9 1.0 2.9 2.0 2.1 0.9 0.9 2.0 0.9 3.0 1.2 0.7 2.6 4.1 1.3 1.1 1.5 1.2 1.7 0.4 0.4 2.2 1.2 2.5 1.5 2.8 0.2 1.2 4.1 0.6 1.3 2.2 3.6 2.1 5.6 1.5 5.7 1.3 0.7 3.7 0.2 0.0 1.6 2.0 1.3 1.6 1.7 3.6 2.9 0.3 0.1 1.3 1.3 0.0 1.8 0.4 1.8 0.1 0.3 0.0 6.0 0.0 0.2 0.9 0.0 1.6 2.3 0.0 0.0 1.3 0.5 0.0 3.4 4.7 0.4 0.0 0.0 0.8 2.5 2.2 1.7 3.4 1.0 0.0 2.0 0.3 2.2 0.0 0.0 1.3 2.6 0.5 0.0 0.0 0.0 0.0 1.7 1.0 1.9 0.0 0.0 1.7 0.0 0.0 0.0 1.2 1.3 0.2 2.4 0.7 1.2 0.0 1.7 1.3 4.5 0.7 3.1 0.4 1.0 1.0 1.3 3.3 1.6 2.2 1.4 2.6 2.1 1.6 1.6 3.6 1.5 0.1 1.7 1.3 2.0 0.9 2.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP002512.3 ENSG00000284732 11 56459221-56473352 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3;bone marrow: 1.9;skin 1: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "K-562: 1.9" NA NA 0.0 0.0 0.1 1.9 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.2 0.0 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.7 0.3 1.3 0.3 0.8 0.5 0.0 0.3 0.5 0.2 0.3 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.1 0.3 0.4 0.2 0.4 0.0 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.9 0.1 0.5 1.9 0.6 0.0 0.0 0.4 0.7 0.6 0.2 1.2 0.0 0.5 0.6 0.1 0.4 0.6 0.8 0.1 0.2 0.1 0.4 0.8 1.1 0.5 0.6 0.7 0.5 0.3 0.7 0.5 0.2 1.0 0.2 0.4 1.2 0.3 0.3 0.3 0.1 0.2 0.4 0.3 0.2 0.1 0.7 0.3 0.5 1.3 0.8 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP003071.5 ENSG00000284713 11 69155478-69159752 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "stomach 1: 19.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;NB-4: 2.4;RH-30: 2.3" "Not detected" "Not detected" NA NA 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.1 0.9 2.6 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.7 19.5 1.0 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.6 0.4 0.1 1.0 0.1 0.5 0.2 0.2 1.7 0.1 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.2 0.2 0.4 0.2 0.0 1.4 0.4 0.3 0.4 0.4 0.2 0.1 0.3 1.2 0.0 1.0 0.5 0.1 0.0 0.9 0.1 2.4 0.3 0.0 1.2 0.5 2.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.3 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP006437.1 ENSG00000186886 11 55723776-55729621 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APCDD1 B7323 ENSG00000154856 "APC down-regulated 1" Q8J025 18 10454628-10489948 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 84.9" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 58.3;Cholangiocytes: 38.2;Melanocytes: 75.9;Peritubular cells: 35.3;Suprabasal keratinocytes: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.3;plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.8;BJ hTERT+: 34.2;HaCaT: 20.8;HHSteC: 9.6;HSkMC: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.21e-1)" "unprognostic (2.85e-2)" "unprognostic (1.11e-1)" "prognostic favorable (6.39e-4)" "prognostic favorable (8.23e-4)" "unprognostic (5.61e-3)" "unprognostic (6.79e-3)" "unprognostic (1.24e-1)" "unprognostic (5.59e-3)" "unprognostic (2.59e-2)" "unprognostic (3.14e-1)" "unprognostic (7.77e-2)" "unprognostic (2.04e-3)" "unprognostic (1.77e-1)" "unprognostic (3.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.43e-2)" 32.9 10.6 21.8 5.3 17.9 1.2 15.9 14.4 26.4 27.0 8.7 22.9 3.9 3.2 23.0 11.9 19.7 23.6 30.6 16.8 29.6 11.2 4.3 1.7 7.3 2.3 12.2 17.4 24.1 8.0 1.5 1.9 18.6 20.8 29.0 10.1 12.0 7.9 11.1 5.2 84.9 7.0 11.2 8.9 4.0 13.7 3.6 17.7 0.0 3.0 16.1 4.0 21.6 18.5 0.7 3.3 2.3 0.9 0.1 0.1 0.8 0.0 0.0 15.8 0.0 2.7 0.0 0.0 1.1 34.2 1.5 2.4 0.0 0.0 0.0 0.0 6.3 0.0 20.8 0.1 0.0 1.6 0.0 0.8 0.0 0.0 0.3 9.6 0.0 0.0 19.9 0.7 3.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 1.0 0.8 0.2 2.6 7.3 0.0 0.4 0.0 0.5 0.0 0.2 0.4 0.1 0.0 0.0 1.8 1.0 0.0 0.2 0.0 1.9 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 2.3 2.3 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.8 0.1 0.0 3.3 0.0 0.8 21.8 17.9 14.4 21.7 29.6 11.2 12.2 17.4 20.8 17.7 0.0 13.0 0.0 4.4 58.3 4.8 3.8 38.2 8.1 3.4 3.5 0.0 1.8 0.0 7.2 0.4 9.5 0.0 0.0 0.3 0.3 31.9 7.7 1.1 0.0 1.2 0.0 3.5 1.3 0.8 0.4 8.1 2.6 75.9 0.0 1.0 0.2 0.2 0.0 35.3 0.0 2.2 25.8 16.7 0.2 0.7 47.0 0.8 0.0 0.2 3.9 APELA "ELA, Ende, tdl" ENSG00000248329 "Apelin receptor early endogenous ligand" P0DMC3 4 164877004-164898965 "Predicted secreted proteins" "Angiogenesis, Differentiation, Gastrulation" "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 7.8;prostate: 8.2" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 22.2;Syncytiotrophoblasts: 34.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "neutrophil: 2.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "NTERA-2: 27.8;SuSa: 17.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (2.97e-2)" "unprognostic (6.97e-2)" "unprognostic (9.83e-4)" "unprognostic (8.92e-3)" "unprognostic (1.43e-3)" "unprognostic (4.50e-2)" "unprognostic (2.21e-1)" "unprognostic (1.71e-1)" "unprognostic (3.38e-3)" "unprognostic (1.68e-1)" "unprognostic (2.18e-2)" "unprognostic (1.89e-1)" "unprognostic (4.34e-1)" "unprognostic (8.35e-2)" "unprognostic (1.95e-4)" 0.0 0.0 0.0 0.1 0.0 0.2 2.8 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 3.9 0.0 1.5 0.1 0.0 2.2 0.7 0.0 0.0 0.0 7.8 0.0 8.2 0.0 0.0 1.9 0.0 0.0 1.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.4 0.0 0.6 0.6 2.5 0.3 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.1 0.1 0.0 0.0 0.1 0.0 0.7 0.3 0.7 0.1 0.1 0.1 0.3 0.2 0.2 0.0 0.6 0.3 0.3 2.5 0.3 0.0 0.6 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 22.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 0.0 0.0 0.0 APH1A "APH-1A, CGI-78" ENSG00000117362 "Aph-1 homolog A, gamma-secretase subunit" Q96BI3 1 150265399-150269580 "Predicted membrane proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037272 Approved NA NA "CAB037272: AB_476776" "unprognostic (1.00e-1)" "unprognostic (5.55e-2)" "unprognostic (8.84e-2)" "unprognostic (1.20e-3)" "unprognostic (4.92e-2)" "unprognostic (3.55e-2)" "unprognostic (2.75e-3)" "unprognostic (4.42e-2)" "unprognostic (1.20e-1)" "unprognostic (1.68e-2)" "unprognostic (2.42e-3)" "unprognostic (1.53e-1)" "unprognostic (6.99e-2)" "unprognostic (4.48e-2)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (1.87e-1)" 31.2 35.7 19.6 38.4 22.5 22.4 65.7 15.1 22.6 29.1 38.4 26.0 41.7 27.5 24.0 51.8 42.5 29.3 55.4 41.2 18.0 16.0 36.2 76.7 68.6 49.3 22.2 17.1 39.0 42.9 30.0 22.3 31.9 15.1 25.2 33.0 30.4 43.0 55.7 22.9 42.9 46.4 23.2 20.6 38.7 31.9 23.4 15.3 24.3 42.0 51.2 34.6 26.2 30.1 11.6 13.1 13.0 13.3 13.9 17.1 10.4 50.7 21.9 26.8 41.1 33.9 28.0 35.0 19.1 39.8 43.4 45.5 17.8 58.3 28.5 27.7 33.4 21.5 41.7 22.9 33.1 30.4 25.6 28.4 21.1 14.8 22.9 42.0 38.7 32.3 34.9 46.8 29.3 35.2 31.6 47.0 29.8 23.1 48.9 27.7 63.3 26.2 22.8 29.9 37.2 36.8 30.7 27.4 45.9 31.9 34.8 22.1 49.9 18.9 31.4 38.9 26.2 40.8 69.2 26.6 25.0 23.9 24.2 33.2 70.4 57.6 25.5 21.3 41.1 27.1 10.2 13.1 10.3 15.8 12.6 17.1 11.6 10.8 10.4 13.1 10.8 10.2 11.4 13.0 13.9 13.3 12.7 5.2 10.4 19.6 22.5 15.1 22.6 18.0 16.0 22.2 17.1 15.1 15.3 20.8 21.0 92.4 68.7 58.4 22.9 21.5 63.7 12.0 20.5 78.5 7.9 113.6 28.2 110.3 3.4 69.7 71.2 0.0 137.8 120.0 70.6 69.6 34.6 57.6 141.6 35.0 72.6 58.3 101.2 4.9 55.8 86.1 59.1 112.8 97.0 51.0 108.9 69.1 38.2 41.9 16.1 25.8 26.7 14.4 17.4 71.5 138.3 63.7 106.4 96.6 APH1B "APH-1B, DKFZp564D0372, PSFL" ENSG00000138613 "Aph-1 homolog B, gamma-secretase subunit" Q8WW43 15 63276018-63309126 "Predicted membrane proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.1;testis: 75.6" "Cell type enriched" "Detected in many" 5 "Early spermatids: 1096.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (9.92e-2)" "unprognostic (1.03e-2)" "unprognostic (1.49e-1)" "unprognostic (1.75e-1)" "unprognostic (3.55e-2)" "unprognostic (3.57e-1)" "unprognostic (7.86e-2)" "unprognostic (1.78e-1)" "unprognostic (3.86e-1)" "unprognostic (4.56e-2)" "prognostic favorable (1.05e-4)" "unprognostic (8.44e-2)" "prognostic favorable (2.25e-4)" "unprognostic (4.29e-3)" "unprognostic (2.54e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" 6.7 8.0 5.3 5.9 7.8 4.5 6.9 6.1 7.1 5.0 3.4 12.6 4.8 2.4 6.3 8.0 3.0 10.4 5.1 5.6 5.6 5.8 5.1 2.2 5.8 15.0 6.8 6.2 9.6 2.9 4.3 5.6 5.0 7.4 7.7 2.9 8.6 5.0 5.4 2.5 3.4 4.5 4.6 7.5 9.2 3.2 75.6 3.4 8.0 12.3 2.0 5.0 5.3 4.2 8.4 5.7 16.6 37.1 2.3 4.9 6.5 0.7 4.8 5.3 4.3 12.2 21.5 1.9 6.3 12.9 4.8 8.1 4.4 7.0 6.2 3.0 7.0 9.0 0.7 9.0 2.5 9.1 4.2 1.4 10.8 1.1 0.1 10.1 2.3 17.9 13.5 4.0 7.1 4.8 8.2 10.1 7.9 3.6 4.7 14.9 2.1 3.2 7.3 5.0 1.5 2.5 3.2 2.9 0.1 2.5 4.9 4.7 2.6 2.6 2.1 0.0 5.9 7.8 14.0 6.7 14.3 5.6 2.3 0.9 11.4 18.9 8.4 10.4 14.1 8.3 10.6 12.0 14.8 4.2 22.9 3.4 8.4 4.4 3.8 5.7 6.4 4.8 4.9 16.6 2.3 37.1 2.1 4.2 6.5 5.3 7.8 6.1 7.1 5.6 5.8 6.8 6.2 7.4 3.4 8.9 19.7 15.7 9.4 4.6 7.0 4.5 7.6 22.7 14.8 21.0 2.0 5.2 1.7 24.3 1096.5 10.0 0.5 0.0 5.5 34.4 12.8 9.1 22.0 1.5 48.6 1.6 19.5 17.2 45.1 235.2 22.7 28.9 10.1 26.2 3.8 23.7 13.2 0.0 15.6 5.6 13.6 12.9 13.3 231.2 16.4 3.0 5.0 10.2 2.4 5.2 APLF "C2orf13, MGC47799, Xip1, ZCCHH1" ENSG00000169621 "Aprataxin and PNKP like factor" Q8IW19 2 68467561-68655862 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 19 "Early spermatids: 110.5;Late spermatids: 132.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 9.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029396, HPA034642, HPA034643" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA029396: AB_10610285, HPA034642: AB_2674259, HPA034643: AB_10602431" "unprognostic (9.37e-2)" "unprognostic (1.04e-1)" "unprognostic (2.14e-1)" "unprognostic (4.29e-3)" "unprognostic (5.18e-3)" "unprognostic (2.39e-3)" "unprognostic (3.24e-1)" "unprognostic (1.46e-1)" "unprognostic (4.00e-2)" "unprognostic (2.78e-1)" "unprognostic (1.25e-3)" "unprognostic (3.28e-1)" "unprognostic (5.02e-3)" "unprognostic (8.44e-2)" "unprognostic (5.95e-2)" "unprognostic (1.35e-2)" "unprognostic (1.85e-3)" 5.2 4.4 3.8 7.3 6.5 2.8 8.2 1.1 5.0 8.0 5.7 3.1 3.8 2.6 8.8 4.0 10.6 3.3 4.1 3.8 4.7 2.0 3.7 5.1 3.4 5.8 3.6 2.1 4.3 3.8 4.1 5.1 6.2 3.2 8.5 2.7 2.3 6.4 4.8 5.4 9.2 3.3 9.2 5.6 5.7 3.6 4.1 6.1 5.1 4.4 7.5 5.8 6.9 6.9 1.1 1.4 9.3 1.2 1.5 2.2 0.9 3.6 0.9 4.1 4.1 5.5 7.4 2.1 3.2 5.8 1.9 2.4 2.3 3.0 6.7 2.6 2.6 4.5 1.2 0.5 4.4 4.6 6.2 0.8 5.5 0.8 1.4 2.6 1.9 4.9 4.1 3.7 2.7 4.1 4.9 1.4 4.2 1.1 4.8 1.9 0.6 2.7 5.0 2.3 3.6 1.6 3.6 1.4 3.0 3.8 2.0 1.2 2.7 3.2 0.4 3.8 6.0 0.3 1.1 3.6 6.7 1.5 3.4 2.5 4.4 2.4 5.2 2.9 2.7 4.4 9.3 0.9 3.1 0.9 1.2 1.0 1.1 1.4 1.3 1.3 1.0 1.5 0.8 0.0 1.5 0.9 1.4 2.2 0.9 3.8 6.5 1.1 5.0 4.7 2.0 3.6 2.1 3.2 6.1 3.0 1.6 0.9 2.2 2.2 0.1 2.6 0.0 1.4 3.4 0.0 2.0 5.3 0.0 2.7 110.5 2.5 0.0 0.0 1.7 2.0 2.3 1.5 0.0 0.8 1.9 3.2 3.4 2.5 0.3 132.8 4.0 1.7 0.0 6.4 0.5 0.5 0.9 0.0 1.8 1.9 0.3 0.0 2.7 5.0 3.9 2.9 4.1 0.0 0.7 1.3 APLN "apelin, XNPEP2" ENSG00000171388 Apelin Q9ULZ1 X 129645259-129654937 "Predicted secreted proteins" "Angiogenesis, Gastrulation, Host-virus interaction" "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;placenta: 52.0" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 2.2;Cardiomyocytes: 5.5;Glandular cells: 1.5;Melanocytes: 1.7" "Group enriched" "Detected in all" 6 "glioma: 44.2;renal cancer: 21.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 106.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (1.50e-1)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (4.50e-2)" "unprognostic (5.94e-2)" "prognostic unfavorable (9.32e-4)" "prognostic unfavorable (6.09e-4)" "unprognostic (4.71e-2)" "unprognostic (2.25e-1)" "unprognostic (3.30e-1)" "unprognostic (9.12e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (1.55e-1)" "unprognostic (1.15e-1)" "unprognostic (2.26e-1)" "unprognostic (8.42e-2)" 3.8 9.7 10.0 2.8 8.0 0.7 2.3 2.0 10.9 0.9 1.2 21.8 0.0 1.5 1.4 1.0 1.3 0.9 1.1 8.3 9.7 10.3 5.2 1.0 13.6 0.8 13.9 7.6 12.5 0.9 0.9 4.3 52.0 14.5 1.5 1.0 0.0 1.3 1.2 2.9 1.2 1.0 2.5 19.3 1.1 1.1 1.6 10.7 0.0 1.6 0.2 0.9 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 0.1 0.4 0.8 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.3 2.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 1.7 0.0 1.5 0.0 0.0 106.9 0.3 0.0 0.4 0.5 0.0 0.0 0.1 0.3 0.0 5.7 0.0 0.1 0.1 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.1 18.1 0.4 0.0 7.8 0.4 0.1 0.0 0.0 7.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 8.0 2.0 8.1 9.7 10.3 13.9 7.6 14.5 10.7 0.0 2.2 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.8 1.2 1.5 1.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 1.0 0.0 0.0 0.0 APLNR "AGTRL1, APJ, APJR, FLJ90771" ENSG00000134817 "Apelin receptor" P35414 11 57233577-57237314 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Angiogenesis, Gastrulation, Host-virus interaction" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 63.8;lymphoid tissue: 44.1;placenta: 40.4" "Group enriched" "Detected in some" 5 "Endothelial cells: 24.9;Ito cells: 12.9" "Cancer enhanced" "Detected in all" "glioma: 50.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "AF22: 10.2;HEL: 8.7;K-562: 2.6;NTERA-2: 3.0;SuSa: 4.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" CAB025842 Approved NA NA "CAB025842: " "unprognostic (5.06e-2)" "unprognostic (3.56e-1)" "unprognostic (2.70e-2)" "unprognostic (1.00e-1)" "unprognostic (2.79e-1)" "unprognostic (6.68e-3)" "unprognostic (1.32e-2)" "unprognostic (2.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "unprognostic (4.72e-1)" "unprognostic (1.77e-3)" "unprognostic (3.27e-2)" "unprognostic (8.13e-2)" "unprognostic (1.13e-1)" "unprognostic (7.13e-3)" 8.4 2.1 26.1 3.8 14.2 0.0 3.3 3.8 21.0 1.2 2.3 30.8 0.0 1.8 1.6 0.0 1.8 1.2 5.7 7.2 24.8 9.3 2.5 8.0 3.5 4.0 17.3 10.2 1.2 1.4 1.9 1.5 40.4 32.8 1.2 2.8 0.2 1.7 0.8 5.8 3.0 1.7 4.7 63.8 44.1 1.5 1.2 18.2 0.1 3.1 0.6 1.8 3.8 1.5 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 26.1 14.2 3.8 16.3 24.8 9.3 17.3 10.2 32.8 18.2 0.0 0.0 0.0 0.0 2.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.9 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 12.9 0.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.8 0.1 0.0 0.0 0.0 APLP1 APLP ENSG00000105290 "Amyloid beta precursor like protein 1" P51693 19 35867899-35879791 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Endocytosis" Heparin-binding Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 147.5" "Group enriched" "Detected in many" 4 "Bipolar cells: 142.9;Horizontal cells: 152.6" "Cancer enhanced" "Detected in many" "glioma: 63.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 25.4;AN3-CA: 47.1;EFO-21: 24.9;HMC-1: 24.3;SCLC-21H: 27.4;SH-SY5Y: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028970, HPA028971" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 3900000 "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA028970: AB_2672847, HPA028971: AB_10601334" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (9.36e-3)" "prognostic unfavorable (3.87e-4)" "unprognostic (7.32e-3)" "unprognostic (1.26e-2)" "unprognostic (1.04e-3)" "unprognostic (2.24e-2)" "unprognostic (4.98e-2)" "unprognostic (6.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.57e-11)" "unprognostic (1.38e-3)" "unprognostic (7.12e-2)" "unprognostic (5.43e-2)" "prognostic unfavorable (2.65e-5)" 2.6 15.6 37.0 2.9 47.9 1.6 1.6 13.1 147.5 2.4 2.6 91.6 0.0 2.0 2.3 2.1 2.2 2.3 4.3 6.0 53.2 37.4 2.4 1.5 2.4 2.1 54.6 24.6 1.9 32.1 5.6 17.6 1.9 38.4 2.3 2.6 3.3 2.4 2.4 1.5 2.0 2.4 2.9 118.2 1.7 9.6 5.7 36.9 0.0 2.2 0.0 2.2 2.1 0.1 1.5 0.4 2.2 0.7 3.0 0.6 0.2 1.4 10.6 25.4 47.1 2.4 1.0 3.3 2.2 1.1 2.5 0.3 2.5 1.4 0.2 24.9 5.5 8.2 0.7 7.8 0.5 1.7 17.7 0.9 0.1 3.1 1.4 0.7 0.0 24.3 1.1 0.6 1.0 0.0 9.4 0.8 1.8 0.9 0.4 7.2 2.3 0.0 0.0 1.2 4.3 6.2 2.4 0.1 0.3 0.4 0.3 27.4 27.8 8.2 1.1 0.3 7.2 6.1 1.3 0.6 17.1 9.8 9.6 1.4 1.1 0.4 0.1 11.2 0.3 8.6 2.2 0.7 0.4 0.4 0.5 0.3 0.7 0.4 0.6 0.2 1.5 0.5 0.6 2.1 3.0 0.7 0.4 0.2 0.2 37.0 47.9 13.1 54.6 53.2 37.4 54.6 24.6 38.4 36.9 6.0 0.0 0.0 2.4 1.1 142.9 4.8 0.0 0.0 0.0 0.0 11.8 0.3 0.0 2.1 25.2 2.8 0.0 0.0 3.8 4.1 2.1 1.8 0.0 0.0 0.4 152.6 33.6 1.3 0.3 8.5 1.1 0.5 5.0 0.0 0.0 11.9 4.4 0.0 0.0 0.0 24.2 0.0 1.7 9.7 22.2 0.5 0.3 0.0 0.0 1.2 APLP2 "APPH, APPL2" ENSG00000084234 "Amyloid beta precursor like protein 2" Q06481 11 130069837-130144811 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 52.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039319 Approved Approved Vesicles NA NA 480000 Vesicles "HPA039319: AB_10673141" "unprognostic (2.83e-2)" "unprognostic (1.29e-1)" "unprognostic (2.06e-1)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.86e-2)" "unprognostic (2.33e-1)" "unprognostic (2.70e-2)" "unprognostic (3.12e-3)" "unprognostic (7.44e-2)" "prognostic favorable (1.33e-9)" "unprognostic (3.20e-3)" "unprognostic (4.95e-2)" "prognostic favorable (2.90e-4)" "unprognostic (4.42e-2)" 72.4 32.9 41.4 29.8 48.5 35.2 43.9 106.0 61.4 39.8 44.9 29.0 31.8 56.6 48.7 42.4 36.2 37.9 51.1 55.6 35.6 49.7 79.2 73.8 82.2 27.3 39.7 43.0 42.0 28.4 76.9 22.3 67.6 48.2 63.4 39.0 105.5 35.4 65.9 17.3 27.3 52.1 46.0 40.9 24.3 33.2 18.2 26.0 12.5 128.7 21.0 17.0 51.0 46.7 12.3 26.0 36.5 52.5 3.6 4.7 25.8 17.6 14.9 26.8 24.0 112.3 74.0 33.5 50.4 61.5 25.2 21.4 110.4 129.2 8.8 132.4 122.7 27.7 45.7 20.6 48.0 14.4 13.7 17.1 15.1 10.9 42.3 17.3 45.5 30.9 49.6 31.4 22.2 42.4 132.3 77.4 2.8 14.4 18.9 41.5 17.5 2.2 20.4 15.6 21.4 25.0 5.8 6.2 8.5 67.2 49.3 9.4 20.5 60.8 32.2 7.8 47.8 49.2 42.2 133.2 27.2 18.5 42.3 24.3 2.9 4.1 20.6 30.7 41.8 19.3 8.7 52.5 14.3 4.5 28.8 3.4 3.4 3.3 4.2 26.0 12.3 2.5 3.3 36.5 3.6 20.8 2.4 4.7 25.8 41.4 48.5 106.0 61.4 35.6 49.7 39.7 43.0 48.2 26.0 875.4 416.5 72.9 138.7 94.7 779.6 197.0 290.4 250.3 447.0 383.8 665.6 678.4 44.7 245.4 11.2 182.9 301.3 46.7 94.3 90.9 217.7 184.7 96.4 435.7 560.4 227.2 89.2 98.8 296.4 9.1 155.1 309.8 91.1 100.0 141.0 413.6 188.5 171.4 201.5 224.3 490.3 187.5 202.8 102.7 283.4 95.7 775.5 52.3 119.9 201.2 APMAP "BSCv, C20orf3" ENSG00000101474 "Adipocyte plasma membrane associated protein" Q9HDC9 20 24962925-24992979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.8;liver: 100.5" "Cell type enhanced" "Detected in all" 11 "Cytotrophoblasts: 255.8;Hepatocytes: 247.3;Syncytiotrophoblasts: 628.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 93.8;NK-cells: 43.2;T-cells: 53.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012863, HPA064700" Uncertain Approved "Plasma membrane" NA NA 80000000 "Plasma membrane" "HPA012863: AB_1845683, HPA064700: AB_2685328" "unprognostic (4.07e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (8.16e-2)" "unprognostic (6.79e-2)" "unprognostic (2.14e-2)" "unprognostic (1.10e-2)" "unprognostic (4.09e-2)" "unprognostic (3.10e-2)" "unprognostic (1.19e-2)" "unprognostic (6.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.99e-3)" "unprognostic (8.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (3.51e-2)" 43.5 13.0 14.8 12.4 16.1 44.5 23.1 47.3 22.7 11.7 12.3 15.7 17.9 8.9 14.8 31.8 7.5 13.0 13.4 10.2 18.2 20.9 12.9 100.5 14.4 15.9 15.4 17.2 12.3 12.2 18.9 20.2 28.3 17.0 12.5 12.4 11.6 10.6 18.7 9.8 14.0 9.3 13.8 13.7 16.9 10.2 19.9 15.4 10.6 57.9 5.7 9.2 13.0 10.6 5.2 13.9 93.8 13.9 43.2 53.4 40.1 22.9 39.8 20.5 30.7 39.9 21.8 20.8 30.0 32.9 29.0 30.1 23.5 40.8 9.5 35.1 36.0 53.0 42.4 18.7 34.9 34.1 12.7 14.6 10.5 14.4 47.7 31.4 20.5 25.3 29.5 49.5 34.0 24.5 40.0 41.2 15.7 12.4 42.9 28.1 34.5 14.1 23.1 12.9 36.7 36.3 11.7 68.1 19.8 30.9 21.1 33.6 13.0 30.9 53.5 33.2 22.3 19.0 17.2 36.1 34.9 31.3 29.5 44.7 24.4 27.0 10.5 18.4 31.2 33.1 7.4 13.9 26.1 53.4 13.4 33.0 5.1 15.1 38.8 13.9 5.2 11.9 30.9 93.8 43.2 9.0 6.8 9.9 40.1 14.8 16.1 47.3 22.7 18.2 20.9 15.4 17.2 17.0 15.4 17.9 28.3 27.4 38.9 21.6 49.0 14.5 45.9 24.1 21.6 47.1 9.8 255.8 14.9 60.3 22.9 34.6 17.0 23.3 39.8 32.6 32.9 31.8 34.7 247.3 84.5 15.9 17.2 38.6 45.7 27.7 60.1 81.5 43.9 161.5 17.3 35.4 35.7 19.9 77.1 13.0 18.3 38.8 34.0 52.1 79.8 17.6 628.2 145.4 24.7 24.2 APOB ENSG00000084674 "Apolipoprotein B" P04114 2 21001429-21044073 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Heparin-binding "Atherosclerosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 145 "intestine: 224.8;liver: 442.2" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 2874.2" "Cancer enriched" "Detected in some" 99 "liver cancer: 295.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "Hep G2: 155.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016070, HPA049793" Supported Supported Vesicles,Cytosol "Secreted to blood" NA NA 1490000000000 89000000000 "Vesicles, Cytosol" "CAB016070: AB_626690, HPA049793: AB_2680885" "unprognostic (1.63e-2)" "unprognostic (2.71e-2)" "unprognostic (1.75e-1)" "unprognostic (1.06e-1)" "unprognostic (1.04e-2)" "unprognostic (7.31e-2)" "unprognostic (1.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.43e-2)" "unprognostic (8.89e-3)" "unprognostic (3.01e-1)" "unprognostic (4.59e-3)" "unprognostic (3.60e-3)" "unprognostic (2.89e-2)" "unprognostic (2.38e-1)" "unprognostic (2.99e-1)" "unprognostic (6.23e-2)" 0.3 0.1 0.1 0.0 0.1 0.0 2.3 0.1 0.1 0.1 68.9 0.0 0.0 24.9 0.1 0.0 0.1 0.1 0.0 1.2 0.1 0.1 0.1 442.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 224.8 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.3 0.9 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 155.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.2 0.2 0.1 0.0 0.4 0.2 0.1 0.9 0.3 0.0 0.3 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 14.6 293.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 0.0 2874.2 0.1 0.0 0.0 51.5 53.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 APOC1 ENSG00000130208 "Apolipoprotein C1" P02654 19 44914247-44919349 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "liver: 702.7" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 27093.4" "Cancer enriched" "Detected in all" 21 "liver cancer: 3253.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "myeloid DC: 8.9" "Lineage enriched" "Detected in single" 13 "dendritic cells: 8.9" "Cell line enhanced" "Detected in many" "Hep G2: 100.3;HSkMC: 62.1;K-562: 26.1;SK-MEL-30: 46.2" "Low region specificity" "Detected in many" HPA051518 Supported "Secreted to blood" NA NA 20300000000 26000000000 "HPA051518: AB_2681519" "unprognostic (3.51e-2)" "unprognostic (3.31e-3)" "unprognostic (1.14e-1)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "prognostic favorable (1.15e-7)" "unprognostic (9.51e-3)" "unprognostic (1.30e-1)" "unprognostic (4.18e-2)" "unprognostic (1.11e-1)" "unprognostic (2.52e-1)" "unprognostic (7.13e-3)" "unprognostic (3.48e-3)" "unprognostic (1.65e-1)" "unprognostic (2.01e-3)" "unprognostic (1.65e-1)" 1.5 58.9 6.6 1.6 30.0 2.4 3.6 0.6 4.4 1.5 1.8 4.9 0.3 0.9 0.6 2.5 0.4 0.8 1.8 0.4 4.1 7.8 0.6 702.7 12.6 6.1 20.2 1.0 4.1 1.1 0.4 2.6 2.3 6.6 0.6 1.1 1.3 2.0 0.4 1.2 1.4 1.0 0.5 11.7 9.6 1.3 1.0 5.2 1.0 0.7 0.5 1.9 1.2 0.3 0.2 8.9 0.0 0.6 0.2 0.0 0.6 0.4 4.7 2.1 0.9 6.9 7.2 20.3 0.2 0.3 0.8 1.3 9.9 8.9 1.4 1.7 0.1 0.6 0.3 2.8 0.3 0.4 0.0 11.4 6.4 0.6 100.3 6.1 4.7 3.3 62.1 0.5 0.8 0.3 1.7 0.2 0.3 26.1 0.1 0.3 0.6 0.2 0.3 20.4 1.8 1.0 1.0 2.9 0.1 1.3 0.3 0.9 0.6 3.3 0.0 46.2 7.2 0.4 17.4 0.7 0.0 0.3 0.0 0.2 0.8 0.8 1.5 0.1 1.3 0.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.9 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.6 6.6 30.0 0.6 3.1 4.1 7.8 20.2 1.0 6.6 5.2 107.2 247.1 115.1 4.2 15.0 1.6 0.7 451.0 44.2 99.0 1.8 0.0 32.3 41.4 3.4 0.9 5.6 0.5 186.9 3.5 299.0 64.1 1.9 139.7 27093.4 5056.0 0.0 2.4 451.8 716.3 1.3 250.8 243.1 28.7 215.6 2.2 120.9 3.3 0.0 244.0 10.9 8.3 19.4 5.9 1.4 3.0 15.6 59.8 137.1 2.1 4.9 APOC2 ENSG00000234906 "Apolipoprotein C2" P02655 19 44945982-44949565 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Disease mutation, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 78 "liver: 506.5" "Cell type enriched" "Detected in some" 26 "Hepatocytes: 936.4" "Cancer enriched" "Detected in some" 17 "liver cancer: 49.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 21 "NK-cell: 6.5" "Lineage enriched" "Detected in single" 21 "NK-cells: 6.5" "Group enriched" "Detected in some" 4 "Hep G2: 84.9;THP-1: 156.9" "Not detected" "Not detected" HPA055877 Supported "Secreted to blood" NA NA 43000000000 110000000000 "HPA055877: AB_2682953" "unprognostic (4.28e-2)" "unprognostic (7.73e-3)" "unprognostic (1.33e-1)" "unprognostic (3.66e-2)" "unprognostic (8.91e-2)" "unprognostic (1.90e-1)" "unprognostic (2.07e-1)" "unprognostic (5.41e-2)" "unprognostic (2.56e-1)" "unprognostic (1.96e-2)" "unprognostic (2.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.14e-8)" "unprognostic (1.32e-1)" "unprognostic (1.45e-1)" "unprognostic (1.77e-2)" "unprognostic (9.80e-3)" 0.2 0.4 2.8 0.3 3.7 0.2 0.5 0.4 1.6 0.4 2.1 3.7 0.0 2.8 0.2 0.5 0.3 0.4 0.4 0.2 2.3 2.2 1.2 506.5 2.2 0.8 4.7 0.5 0.2 0.2 0.3 0.2 0.3 2.2 0.2 0.4 0.0 0.3 0.3 0.3 0.4 6.3 0.2 4.7 0.3 0.3 0.2 2.1 0.0 0.2 0.0 0.7 0.3 0.0 0.1 0.3 0.0 0.0 6.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 14.7 0.2 84.9 0.0 1.8 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 14.1 0.0 0.4 0.0 0.1 0.6 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.9 0.0 0.0 156.9 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 2.8 3.7 0.4 1.6 2.3 2.2 4.7 0.5 2.2 2.1 0.0 2.9 1.5 0.0 0.6 0.0 0.1 12.7 0.0 0.0 3.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 25.4 936.4 35.6 0.0 0.0 18.4 13.7 0.0 0.0 11.1 6.8 3.6 0.0 0.0 0.0 0.0 0.7 11.2 0.0 0.0 0.0 0.1 0.0 0.4 0.2 1.3 0.0 0.0 APOL1 APOL ENSG00000100342 "Apolipoprotein L1" O14791 22 36253010-36267530 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 82.9;Pancreatic endocrine cells: 64.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 63.8;HDLM-2: 41.2;HHSteC: 31.5;RPTEC TERT1: 24.4;RT4: 37.8" "HPA018885, CAB056156" Supported "Secreted to blood" NA NA 1640000000 19000000000 "CAB056156: AB_2665576, HPA018885: AB_1844953" "unprognostic (1.05e-2)" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "unprognostic (8.98e-3)" "unprognostic (1.67e-1)" "unprognostic (8.28e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (5.35e-4)" "unprognostic (4.41e-2)" "unprognostic (1.58e-1)" "unprognostic (4.07e-3)" "unprognostic (5.15e-2)" "prognostic unfavorable (7.43e-6)" "unprognostic (1.93e-1)" "unprognostic (3.15e-2)" "unprognostic (5.05e-3)" "prognostic favorable (2.01e-5)" 22.4 7.1 2.5 16.5 3.2 0.7 11.8 1.7 2.6 16.6 13.0 1.8 11.6 9.1 19.9 15.6 15.9 11.5 25.8 11.5 3.5 2.4 22.8 66.4 23.8 9.9 3.6 2.0 21.6 7.8 1.3 6.5 39.3 4.7 26.4 7.8 13.0 9.5 24.1 6.5 3.1 22.9 17.9 4.6 23.1 17.5 6.1 2.4 9.6 21.9 10.0 9.7 25.9 46.3 2.0 3.3 12.7 7.1 17.2 10.9 4.9 5.3 1.1 0.0 0.1 12.2 11.8 3.6 0.5 2.3 3.4 10.0 0.1 8.6 1.7 63.8 5.9 7.9 1.3 0.0 4.9 0.9 41.2 0.0 1.4 0.8 10.0 31.5 0.6 5.2 2.1 0.4 10.0 0.2 0.5 6.8 0.3 6.1 21.8 0.6 0.0 2.0 0.4 0.1 0.1 0.0 3.3 0.5 0.7 24.4 37.8 0.5 0.0 2.5 1.4 0.5 0.0 0.1 1.9 6.3 7.5 3.2 0.8 0.3 1.7 0.9 0.3 4.2 3.0 1.2 9.8 4.6 3.9 10.9 5.2 8.7 2.0 6.7 9.0 3.3 1.2 4.0 5.4 12.7 17.2 7.1 0.4 4.1 4.9 2.5 3.2 1.7 2.6 3.5 2.4 3.6 2.0 4.7 2.4 53.6 33.0 11.1 14.0 1.4 0.6 3.2 17.8 34.8 22.7 17.4 2.0 9.1 0.0 33.0 0.5 36.5 7.3 0.0 17.5 4.8 20.8 22.5 10.5 82.9 8.3 0.0 7.5 40.5 15.0 0.0 25.3 6.5 0.0 22.6 15.5 0.0 64.3 23.0 22.6 1.2 0.7 6.5 7.1 0.4 0.4 1.9 5.6 15.2 2.3 48.8 APOL2 APOL-II ENSG00000128335 "Apolipoprotein L2" Q9BQE5 22 36226203-36239954 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA001078 Uncertain NA NA 10000000 "HPA001078: AB_10602432" "unprognostic (4.19e-2)" "unprognostic (1.58e-1)" "unprognostic (1.50e-2)" "unprognostic (4.26e-3)" "unprognostic (2.62e-1)" "unprognostic (1.62e-1)" "unprognostic (3.95e-2)" "unprognostic (2.38e-2)" "unprognostic (7.39e-2)" "unprognostic (2.14e-2)" "unprognostic (1.70e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.22e-7)" "unprognostic (1.80e-1)" "unprognostic (6.79e-2)" "unprognostic (2.66e-2)" "prognostic favorable (5.06e-6)" 21.5 14.2 17.4 25.3 12.0 6.9 20.3 26.5 30.1 16.7 15.6 11.1 11.1 25.0 20.3 17.9 10.2 15.3 25.6 17.3 15.1 19.3 18.2 39.7 23.6 22.0 20.2 11.9 12.6 10.1 11.2 57.1 14.6 28.7 19.0 16.1 15.9 15.2 18.8 16.5 9.6 21.7 22.2 16.2 26.2 22.7 7.2 12.0 14.9 23.0 12.7 17.0 25.8 19.4 6.2 6.0 43.0 17.0 9.9 15.5 4.6 7.5 5.6 5.5 4.2 21.5 16.7 10.4 10.2 24.0 27.9 38.0 2.3 6.2 9.1 17.4 18.4 17.3 3.5 6.0 8.2 13.9 30.8 6.8 4.2 11.8 10.6 36.3 9.2 8.4 21.1 5.6 19.6 5.2 11.6 18.2 5.3 7.6 26.0 17.4 2.7 9.2 4.0 2.1 2.7 5.2 9.5 7.1 5.3 28.2 20.0 9.9 2.8 7.0 13.3 5.5 3.9 4.2 1.3 17.6 16.9 8.4 3.5 5.6 15.7 7.8 2.9 14.6 4.8 6.3 8.9 8.6 5.8 15.5 17.0 14.1 6.2 11.2 12.7 6.0 4.1 6.5 10.9 43.0 9.9 11.4 3.7 10.5 4.6 17.4 12.0 26.5 30.1 15.1 19.3 20.2 11.9 28.7 12.0 32.8 15.6 11.9 7.8 5.4 5.1 19.3 20.4 9.4 15.9 12.2 0.0 14.4 14.9 37.9 0.2 22.4 20.7 0.0 53.7 9.4 17.1 18.3 2.3 63.1 22.0 6.4 4.6 20.3 25.9 1.3 15.5 15.2 8.5 27.1 9.4 8.7 48.3 14.0 19.4 18.9 3.4 0.0 21.4 0.3 0.0 5.8 12.7 27.4 6.3 16.6 APOL4 APOLIV ENSG00000100336 "Apolipoprotein L4" Q9BPW4 22 36189124-36204840 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 7.9;Intestinal endocrine cells: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 4.3;intermediate monocyte: 2.3;myeloid DC: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;monocytes: 4.3" "Cell line enhanced" "Detected in some" "BEWO: 8.3;HDLM-2: 46.5;HSkMC: 7.6;K-562: 9.9;SCLC-21H: 21.4" "HPA049797, HPA055435" Uncertain Supported Vesicles "Secreted to blood" NA NA Vesicles "HPA049797: AB_2680887, HPA055435: AB_2682816" "unprognostic (2.73e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" "unprognostic (1.51e-1)" "unprognostic (5.31e-1)" "unprognostic (3.39e-2)" "unprognostic (2.44e-2)" "unprognostic (1.55e-1)" "unprognostic (1.91e-1)" "prognostic favorable (3.45e-4)" "unprognostic (1.33e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (2.00e-5)" "unprognostic (4.26e-2)" "unprognostic (3.69e-1)" "unprognostic (4.18e-2)" "prognostic favorable (2.40e-6)" 2.3 0.8 1.1 2.7 1.3 0.0 2.3 0.9 1.0 2.4 1.2 0.7 0.7 2.2 2.0 0.7 2.4 3.1 3.2 2.8 0.8 1.0 10.3 1.1 7.3 1.7 1.0 0.7 4.2 0.9 0.0 1.9 3.0 1.2 9.0 1.5 1.8 2.9 1.6 1.0 1.6 5.4 2.1 2.3 1.1 2.3 0.7 1.2 7.1 1.1 0.7 2.3 7.4 1.4 0.4 3.8 0.6 4.3 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.9 8.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 46.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.3 0.0 9.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 21.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 4.3 0.0 0.0 2.3 0.0 0.4 0.0 0.0 3.8 0.3 0.0 0.0 0.2 0.8 0.2 0.0 0.0 1.2 1.1 1.3 0.9 1.0 0.8 1.0 1.0 0.7 1.2 1.2 0.0 7.9 0.0 0.9 1.1 0.2 1.1 2.5 4.0 3.4 0.0 0.0 0.4 3.3 0.1 0.0 3.8 0.0 0.0 0.6 0.6 6.3 1.2 2.3 0.0 2.4 1.6 14.3 1.3 4.5 0.0 2.6 5.3 0.0 1.8 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 1.4 0.0 0.0 1.0 5.1 0.0 0.1 1.4 APOL6 "APOL-VI, APOLVI" ENSG00000221963 "Apolipoprotein L6" Q9BWW8 22 35648395-35668409 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB028574, HPA029165, HPA029167" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832" "unprognostic (7.25e-3)" "unprognostic (2.67e-2)" "unprognostic (1.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.76e-1)" "unprognostic (1.55e-1)" "unprognostic (2.32e-2)" "unprognostic (8.29e-2)" "unprognostic (3.76e-2)" "unprognostic (6.26e-3)" "unprognostic (1.46e-3)" "unprognostic (1.46e-1)" "unprognostic (6.65e-3)" "unprognostic (2.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.71e-2)" "prognostic favorable (6.61e-4)" 40.6 9.2 4.8 18.8 5.5 10.1 32.3 1.9 4.2 7.4 17.9 4.1 5.0 14.0 8.8 9.5 9.8 5.9 12.5 9.3 4.0 4.3 15.4 36.9 15.8 17.0 4.6 2.2 17.0 4.7 3.7 5.1 8.9 5.9 11.7 8.9 6.4 10.1 5.6 7.4 3.6 36.6 6.4 7.6 19.5 10.1 2.5 4.5 12.7 24.8 7.7 13.4 8.5 14.1 1.2 2.8 9.2 9.0 5.9 9.1 4.2 7.2 2.3 0.2 0.9 18.1 9.1 10.2 3.1 8.2 10.2 12.9 1.1 8.2 10.0 1.5 8.0 7.5 9.4 0.0 5.0 2.7 18.9 0.1 4.2 1.5 2.3 14.3 5.8 7.4 11.6 3.4 3.5 2.0 2.3 2.1 4.6 0.4 18.3 1.9 0.7 8.1 1.8 0.3 0.5 3.1 3.4 4.0 4.8 4.5 16.6 0.2 0.1 4.9 4.2 5.6 0.7 0.7 6.8 2.2 2.5 1.5 1.7 1.6 9.7 7.7 1.0 4.8 9.3 3.6 6.4 5.6 2.9 9.1 8.9 7.7 1.2 6.1 7.2 2.8 1.0 6.0 6.7 9.2 5.9 9.0 0.3 6.3 4.2 4.8 5.5 1.9 4.2 4.0 4.3 4.6 2.2 5.9 4.5 65.5 29.3 17.5 9.9 7.1 0.1 6.6 38.2 40.2 40.9 12.2 0.0 6.7 8.3 30.0 10.4 23.9 70.1 0.0 36.3 26.7 19.5 29.2 36.8 105.8 31.4 0.0 45.4 41.7 43.9 4.6 24.2 30.8 8.5 23.4 48.8 3.1 38.3 42.1 17.7 23.8 0.0 0.0 13.4 0.2 0.2 4.5 2.1 51.7 25.8 43.1 APOLD1 "DKFZP434F0318, FLJ25138" ENSG00000178878 "Apolipoprotein L domain containing 1" Q96LR9 12 12725917-12829975 "Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 109.5" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 140.0;Erythroid cells: 70.0;Ito cells: 65.7;Muller glia cells: 64.4;Sertoli cells: 109.9;Smooth muscle cells: 101.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 26.2;HDLM-2: 13.2;hTERT-RPE1: 10.9" "Group enriched" "Detected in many" 5 "basal ganglia: 5.8;olfactory region: 24.7" "Low region specificity" "Detected in all" "HPA052462, HPA058882" Approved Approved "Nucleoplasm,Plasma membrane" No No "Nucleoplasm, Plasma membrane" "HPA052462: AB_2681841, HPA058882: AB_2683844" "unprognostic (1.98e-1)" "unprognostic (8.36e-3)" "unprognostic (5.28e-2)" "unprognostic (1.28e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-2)" "unprognostic (5.58e-3)" "unprognostic (8.07e-2)" "unprognostic (3.46e-1)" "unprognostic (4.23e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-2)" "unprognostic (4.30e-3)" "unprognostic (3.42e-3)" "unprognostic (1.81e-1)" "unprognostic (6.18e-2)" "unprognostic (1.15e-2)" 109.5 8.8 11.2 9.2 17.7 0.6 34.4 9.8 17.5 25.5 9.0 7.7 2.9 2.5 7.1 7.0 18.8 14.0 18.7 22.3 13.0 11.8 7.4 9.3 7.1 3.4 16.6 3.3 10.0 12.8 17.2 4.7 44.8 16.7 7.2 7.1 8.1 4.4 3.7 16.6 7.4 6.0 28.0 13.9 4.7 5.3 5.4 12.4 5.7 34.4 9.9 3.3 10.9 7.1 2.3 1.7 4.8 0.9 0.8 2.7 0.3 4.3 0.1 26.2 0.8 0.8 1.5 0.2 4.2 7.0 4.3 6.3 1.7 4.6 1.3 0.4 1.6 1.5 1.4 1.0 0.2 7.3 13.2 1.0 0.4 1.3 0.0 1.6 0.6 0.4 1.0 1.2 1.5 3.4 10.9 3.2 2.4 0.4 1.8 2.2 0.9 0.7 0.7 0.1 1.0 0.8 2.0 0.5 0.6 0.5 0.4 2.3 2.4 4.0 0.4 9.6 0.4 0.1 2.1 3.9 1.0 1.4 5.8 3.8 1.3 0.6 1.0 1.5 2.8 4.9 4.8 0.9 0.7 0.9 0.4 1.1 2.2 2.0 1.3 0.6 2.3 1.6 1.0 4.4 0.8 0.6 1.7 2.7 0.3 11.2 17.7 9.8 17.5 13.0 11.8 16.6 3.3 16.7 12.4 6.0 4.0 21.4 2.2 16.1 4.2 7.0 7.6 8.1 9.1 0.0 3.9 1.5 0.0 0.9 1.6 140.0 1.1 70.0 0.4 1.1 8.4 3.7 7.0 1.6 5.1 3.2 3.5 65.7 14.5 1.1 4.0 5.7 27.0 3.6 4.7 64.4 0.8 0.0 0.4 0.3 3.3 109.9 101.3 3.2 0.7 13.6 0.8 20.8 6.3 2.8 APOO "FAM121B, MGC4825, Mic23, MIC26, My025" ENSG00000184831 "Apolipoprotein O" Q9BUR5 X 23833353-23907934 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 152.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003187 Supported Approved Mitochondria,Cytosol "Secreted to blood" NA NA Mitochondria Cytosol "HPA003187: AB_1079375" "unprognostic (2.53e-2)" "prognostic favorable (3.77e-4)" "unprognostic (4.86e-2)" "unprognostic (6.38e-3)" "unprognostic (3.45e-1)" "unprognostic (2.42e-1)" "unprognostic (6.18e-2)" "unprognostic (2.95e-1)" "unprognostic (6.45e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.22e-1)" "prognostic favorable (2.56e-6)" "unprognostic (2.53e-2)" "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (5.88e-3)" 5.6 13.1 25.5 5.4 21.2 4.4 9.0 18.5 30.9 9.1 10.9 8.5 5.5 9.2 7.2 13.5 7.2 13.6 6.1 38.4 26.0 23.8 29.5 12.2 5.5 6.6 24.9 17.5 7.1 9.0 20.1 15.8 7.1 21.5 9.3 12.5 11.7 14.6 10.4 26.0 4.3 7.6 7.8 18.1 5.4 10.3 10.5 6.8 7.7 13.3 10.4 7.2 6.3 5.8 9.8 14.2 8.5 13.3 7.8 15.0 6.6 14.7 13.5 22.7 15.8 3.8 8.7 3.6 7.4 9.1 15.8 16.7 8.0 7.1 12.8 9.3 6.8 20.6 12.2 28.6 14.8 17.6 13.5 20.3 6.5 13.4 12.6 9.0 16.3 7.3 9.7 8.8 17.4 13.0 8.5 11.0 16.1 9.1 14.5 14.6 13.9 16.4 17.6 20.7 19.4 21.9 12.7 11.3 30.7 30.9 7.6 15.4 11.2 16.1 15.4 15.8 23.3 26.6 7.3 2.7 10.2 6.2 36.5 11.2 11.3 19.8 11.6 16.5 8.1 14.9 8.5 4.2 1.5 11.5 13.3 15.0 9.8 12.7 11.3 12.0 8.3 10.3 10.1 2.5 7.8 12.6 14.2 11.5 6.6 25.5 21.2 18.5 30.9 26.0 23.8 24.9 17.5 21.5 6.8 14.9 7.8 15.6 14.2 12.5 19.3 55.7 25.5 87.0 9.1 22.7 13.7 16.6 152.5 24.6 16.8 8.7 14.4 0.0 14.1 7.3 12.6 14.5 3.5 11.9 20.3 19.1 6.9 9.8 10.1 11.7 10.6 11.2 27.0 55.9 17.6 40.5 12.0 18.4 14.9 67.7 23.7 6.5 6.2 14.0 50.7 6.0 10.4 10.0 20.9 15.4 APP AD1 ENSG00000142192 "Amyloid beta precursor protein" P05067 21 25880550-26171128 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Alzheimer disease, Amyloidosis, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 24.0" "Lineage enriched" "Detected in many" 6 "dendritic cells: 24.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000157, HPA001462" Enhanced Approved "Golgi apparatus,Vesicles" NA NA 15000000 "Golgi apparatus" Vesicles "CAB000157: AB_323833, HPA001462: AB_1078185" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (3.69e-3)" "unprognostic (2.54e-1)" "unprognostic (8.22e-2)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "unprognostic (4.28e-2)" "unprognostic (5.35e-2)" "prognostic favorable (2.79e-6)" "unprognostic (3.77e-2)" "unprognostic (2.46e-1)" "unprognostic (5.23e-2)" "unprognostic (2.08e-3)" 44.8 92.5 89.9 26.3 109.3 21.2 79.9 64.5 139.1 51.7 63.4 86.9 72.0 39.7 52.2 57.2 33.0 57.6 63.4 69.1 104.6 97.7 102.2 54.5 50.2 12.9 97.4 95.8 58.9 57.1 36.4 34.1 79.7 83.2 49.2 59.6 48.9 47.2 66.6 17.2 38.2 34.9 69.3 109.0 26.3 37.9 32.2 67.5 13.9 85.0 21.5 16.7 52.5 58.4 1.5 24.0 0.9 3.9 0.3 1.5 1.8 31.2 40.4 44.3 36.9 60.4 75.0 47.9 63.4 84.6 32.2 37.9 23.2 76.7 0.0 73.9 49.6 42.0 21.4 27.0 74.5 27.3 1.1 21.8 0.0 24.4 16.3 59.0 29.6 1.6 67.5 82.4 37.7 69.3 133.1 144.0 13.0 0.0 3.2 50.5 35.0 0.5 0.3 34.8 51.2 36.1 19.4 42.7 26.0 109.0 22.0 22.6 33.0 68.0 44.8 31.8 63.1 39.6 32.3 153.9 71.7 30.4 26.1 29.9 19.6 0.2 0.3 58.3 0.1 68.8 0.4 3.9 0.0 0.1 1.2 0.2 0.5 1.4 0.5 3.4 1.5 1.5 0.4 0.9 0.3 0.9 24.0 0.3 1.8 89.9 109.3 64.5 124.6 104.6 97.7 97.4 95.8 83.2 67.5 101.3 43.6 31.5 195.4 161.4 26.5 130.8 282.8 120.5 119.4 476.3 27.5 341.9 48.0 308.0 33.6 371.9 139.3 0.0 158.2 112.6 202.6 156.7 8.1 105.8 67.9 79.4 156.1 527.9 77.8 43.7 224.6 45.9 153.5 92.8 307.0 330.4 178.5 181.4 279.0 124.0 22.1 116.4 133.6 37.0 87.7 92.8 461.7 25.5 256.5 110.0 AQP1 "CHIP28, CO" ENSG00000240583 "Aquaporin 1 (Colton blood group)" P29972 7 30911694-30925516 "Blood group antigen proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 156.5" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 218.3;Cholangiocytes: 377.0;Endothelial cells: 221.7;Proximal tubular cells: 281.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 20.9;HeLa: 7.0;SH-SY5Y: 7.8;U-2 OS: 9.8;WM-115: 37.8" "CAB001707, HPA019206" Enhanced Supported "Plasma membrane" NA NA 250000 "Plasma membrane" "CAB001707: , HPA019206: AB_1844965" "unprognostic (4.18e-2)" "unprognostic (7.82e-3)" "unprognostic (1.10e-2)" "unprognostic (1.08e-1)" "unprognostic (1.02e-1)" "prognostic favorable (6.52e-4)" "unprognostic (1.95e-3)" "unprognostic (1.66e-1)" "unprognostic (3.00e-2)" "unprognostic (3.80e-2)" "unprognostic (4.16e-1)" "unprognostic (2.05e-2)" "prognostic favorable (1.32e-8)" "unprognostic (3.43e-2)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (7.21e-2)" 68.2 8.0 9.9 8.7 17.1 9.4 51.9 10.7 13.0 46.5 18.1 62.1 7.7 10.8 28.0 20.8 58.8 29.0 36.3 46.7 18.1 15.4 156.5 4.2 103.2 9.1 36.9 17.8 16.4 49.9 12.9 4.0 9.1 63.2 32.4 10.6 8.3 19.8 22.7 35.2 24.8 18.2 41.2 56.4 2.9 18.2 15.0 17.8 1.9 21.3 33.5 12.5 36.0 76.7 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.6 0.4 1.8 0.4 1.2 0.4 0.0 0.0 0.2 0.3 0.0 20.9 1.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.2 7.0 0.0 0.4 0.1 0.0 3.3 0.0 0.1 0.0 0.0 2.9 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.0 5.2 0.1 0.7 0.0 0.2 7.8 1.2 0.6 0.0 3.9 0.1 0.1 0.0 0.0 9.8 0.8 0.3 0.5 0.3 0.0 0.1 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.9 17.1 10.7 13.0 18.1 15.4 36.9 17.8 63.2 17.8 166.7 218.3 2.9 1.1 81.4 1.1 57.7 377.0 6.7 6.8 29.6 7.9 1.9 24.9 35.6 1.9 221.7 4.2 0.0 2.1 3.0 91.5 1.0 1.1 1.3 3.3 0.0 7.0 154.1 1.8 1.6 1.1 9.8 84.4 2.8 18.2 0.3 2.8 19.2 3.2 281.0 0.2 12.9 92.0 0.3 1.3 68.8 6.1 0.0 71.0 1.0 AQP10 ENSG00000143595 "Aquaporin 10" Q96PS8 1 154321090-154325325 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 59.9" "Group enriched" "Detected in some" 7 "Cholangiocytes: 2.5;granulocytes: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 16.0;HMC-1: 6.7;K-562: 18.3;SH-SY5Y: 4.4" "Low region specificity" "Detected in many" "HPA062621, HPA065947" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA062621: , HPA065947: AB_2685584" "unprognostic (6.84e-2)" "unprognostic (4.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (8.45e-4)" "unprognostic (1.63e-1)" "unprognostic (3.07e-1)" "unprognostic (4.08e-2)" "unprognostic (3.99e-1)" "unprognostic (1.22e-1)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (7.64e-3)" 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 36.0 0.0 0.0 37.2 0.2 0.3 0.1 4.3 0.5 0.7 0.4 0.0 0.0 0.1 2.2 0.4 0.1 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 59.9 0.0 0.0 2.7 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.9 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 7.6 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 AQP11 ENSG00000178301 "Aquaporin 11" Q8NBQ7 11 77589391-77610355 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 60.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 30.5;Late spermatids: 51.4;Muller glia cells: 29.1;Spermatocytes: 35.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3" "Cell line enhanced" "Detected in many" "CACO-2: 7.8;GAMG: 12.3;Hep G2: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042879 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA042879: AB_10794919" "unprognostic (4.95e-2)" "unprognostic (7.61e-2)" "unprognostic (2.15e-2)" "unprognostic (9.62e-5)" "unprognostic (2.42e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (3.48e-2)" "unprognostic (2.65e-1)" "prognostic favorable (9.89e-4)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.73e-2)" "unprognostic (2.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.66e-3)" 1.0 14.5 4.2 0.8 3.5 0.6 1.1 5.0 4.8 0.6 22.4 2.1 0.7 24.7 0.8 1.2 0.5 0.9 2.4 0.7 2.5 4.5 5.2 13.9 0.6 0.9 3.4 3.4 9.3 3.6 0.9 1.8 3.5 3.4 3.9 2.1 3.8 0.8 0.7 1.0 1.0 60.1 0.6 1.5 1.0 2.3 7.4 1.7 0.0 1.6 0.2 0.4 0.8 0.6 2.0 0.1 0.3 0.1 2.0 2.3 0.8 1.0 3.3 1.4 2.2 3.2 0.8 1.4 1.7 0.8 1.6 0.7 7.8 1.6 1.6 0.8 0.7 12.3 1.0 0.5 0.1 0.8 4.8 1.3 1.3 1.1 13.0 1.0 2.7 1.5 0.8 0.3 0.9 0.2 1.9 0.3 0.4 0.8 1.0 1.8 1.6 1.0 1.8 1.4 7.5 3.0 1.4 3.5 0.6 0.9 1.2 1.4 1.0 2.1 0.4 0.8 1.1 1.6 0.4 0.9 1.3 4.1 2.5 1.1 1.1 0.8 1.3 0.4 0.2 1.8 0.0 0.0 0.3 1.9 0.0 1.3 0.3 0.8 1.5 0.1 2.0 2.3 0.7 0.0 2.0 0.1 0.1 0.1 0.8 4.2 3.5 5.0 4.8 2.5 4.5 3.4 3.4 3.4 1.7 0.0 0.0 0.0 0.7 0.1 7.5 0.4 7.6 0.0 0.0 1.8 0.0 6.6 0.0 1.2 30.5 0.3 15.8 0.0 3.4 10.1 0.9 1.2 4.6 21.5 1.0 0.0 4.1 0.0 0.3 51.4 14.4 0.0 1.7 0.0 3.1 29.1 3.7 3.1 10.6 15.3 5.0 0.0 0.7 35.9 5.8 0.1 13.3 0.0 5.6 0.1 AQP2 ENSG00000167580 "Aquaporin 2" P41181 12 49950741-49958881 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Diabetes insipidus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 38 "ductus deferens: 178.6;kidney: 96.5;seminal vesicle: 108.2" "Cell type enriched" "Detected in some" 444 "Collecting duct cells: 3930.9" "Group enriched" "Detected in some" 6 "renal cancer: 1.7;stomach cancer: 1.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "intermediate monocyte: 1.4;non-classical monocyte: 1.3" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.5;EFO-21: 6.9;HEL: 2.0;HMC-1: 4.2;OE19: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA046834 Enhanced NA NA "HPA046834: AB_2679830" "unprognostic (2.10e-1)" "unprognostic (3.77e-2)" "unprognostic (6.96e-3)" "unprognostic (4.48e-3)" "unprognostic (3.60e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "unprognostic (1.43e-2)" "unprognostic (2.65e-2)" "unprognostic (7.38e-3)" "unprognostic (5.92e-2)" "unprognostic (4.60e-2)" "unprognostic (2.01e-2)" "unprognostic (1.11e-1)" 0.1 1.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 178.6 0.0 0.1 3.3 0.1 0.1 0.0 0.6 0.1 0.1 96.5 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.2 108.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 7.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3930.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AQP3 GIL ENSG00000165272 "Aquaporin 3 (Gill blood group)" Q92482 9 33441154-33447633 "Blood group antigen proteins, Plasma proteins, Predicted membrane proteins" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4" "Group enriched" "Detected in many" 6 "Basal glandular cells: 608.6;Basal keratinocytes: 1708.5;Collecting duct cells: 1526.7;Glandular cells: 959.6;Suprabasal keratinocytes: 2172.4;Urothelial cells: 2008.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "hippocampal formation: 2.1;pons and medulla: 6.7" "Group enriched" "Detected in many" 6 "MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1" "Lineage enriched" "Detected in many" 16 "T-cells: 42.1" "Cell line enhanced" "Detected in many" "HaCaT: 28.1;HeLa: 51.2;JURKAT: 28.8;RT4: 47.6;SK-BR-3: 32.9;U-266/70: 34.1;U-266/84: 44.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014924 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA014924: AB_2669120" "unprognostic (4.29e-2)" "prognostic favorable (5.31e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.84e-2)" "unprognostic (1.11e-2)" "unprognostic (9.95e-2)" "unprognostic (1.64e-1)" "unprognostic (3.46e-1)" "unprognostic (9.06e-2)" "unprognostic (4.87e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (3.73e-2)" "unprognostic (4.51e-2)" 1.3 0.4 0.4 2.7 0.2 1.9 5.2 0.9 0.3 29.7 26.7 0.1 1.7 9.9 5.5 3.2 179.6 3.3 2.0 6.0 2.1 0.4 23.9 44.0 16.5 5.7 0.5 0.3 3.6 5.7 0.0 0.7 5.3 6.7 15.5 1.2 0.4 194.2 5.5 0.9 65.2 33.2 5.1 0.3 17.2 3.9 1.2 0.0 70.6 0.6 132.4 156.1 37.6 60.2 2.6 2.4 0.5 0.1 0.5 42.1 10.3 0.1 8.4 0.4 0.0 15.6 2.8 0.2 0.0 0.2 0.2 0.2 4.4 2.6 0.1 2.0 0.0 0.1 28.1 1.3 0.1 0.0 13.4 1.3 0.9 51.2 0.4 0.0 0.2 0.3 0.4 1.4 0.1 0.0 0.0 0.1 28.8 14.3 13.0 1.5 6.2 12.8 5.0 1.1 19.2 0.1 0.2 21.3 2.3 0.2 47.6 0.4 1.1 7.1 32.9 0.0 1.9 0.2 2.2 0.2 0.0 0.2 0.0 0.0 34.1 44.2 3.2 0.1 0.0 0.0 0.3 0.1 0.0 4.5 0.0 41.1 2.6 39.2 12.0 0.0 0.5 22.7 10.8 0.5 0.5 0.1 2.4 42.1 10.3 0.4 0.2 0.9 0.3 2.1 0.4 0.5 0.3 6.7 0.0 35.7 265.4 2.2 608.6 1708.5 1.4 2.1 104.4 136.5 215.0 1526.7 2.0 0.6 0.0 27.2 1.3 40.5 4.2 93.5 41.7 1.3 46.3 959.6 19.7 111.7 2.2 0.0 7.9 16.0 3.8 0.0 30.8 32.1 150.1 1.0 63.7 0.3 32.0 2.9 1.1 28.8 0.4 0.0 42.2 0.0 1.0 2172.4 42.0 43.3 3.5 2008.6 AQP4 MIWC ENSG00000171885 "Aquaporin 4" P55087 18 26852038-26865818 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 185.1;lung: 53.5" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 1: 1024.3" "Cancer enriched" "Detected in some" 22 "glioma: 223.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.9;Karpas-707: 2.0;RPTEC TERT1: 3.9;SCLC-21H: 1.3;U-87 MG: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005079, HPA014784, CAB058689" Enhanced Supported Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967" "unprognostic (7.23e-5)" "unprognostic (1.55e-1)" "unprognostic (3.19e-8)" "unprognostic (3.68e-1)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.34e-1)" "unprognostic (5.38e-3)" "unprognostic (1.64e-3)" "unprognostic (8.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.14e-2)" "unprognostic (1.35e-1)" "unprognostic (4.10e-2)" 1.7 1.7 60.7 1.6 57.1 1.6 1.8 21.8 185.1 1.9 1.6 41.3 0.0 1.6 1.6 2.0 1.9 2.1 1.6 2.7 64.3 27.1 2.7 2.0 53.5 1.7 39.8 36.4 2.8 1.7 2.9 0.8 1.6 39.1 1.8 1.6 0.0 1.8 1.7 25.4 1.6 1.6 1.6 67.2 1.8 6.1 1.7 42.2 0.0 8.4 0.1 1.6 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.2 0.9 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.3 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 57.1 21.8 31.7 64.3 27.1 39.8 36.4 39.1 42.2 1024.3 245.1 0.0 0.6 0.0 2.1 8.5 0.0 37.5 138.8 3.5 5.9 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 3.5 0.5 0.0 1.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 224.7 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 AQP5 ENSG00000161798 "Aquaporin 5" P55064 12 49961870-49965681 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "salivary gland: 217.9;testis: 76.2" "Group enriched" "Detected in many" 8 "Early spermatids: 1235.0;Late spermatids: 3096.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 87.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "OE19: 70.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065008 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA065008: AB_2685401" "unprognostic (4.67e-3)" "unprognostic (5.00e-2)" "unprognostic (3.30e-1)" "unprognostic (6.00e-3)" "unprognostic (1.92e-3)" "prognostic favorable (1.75e-5)" "unprognostic (4.13e-3)" "unprognostic (1.02e-2)" "unprognostic (9.39e-2)" "unprognostic (3.70e-3)" "unprognostic (2.88e-3)" "unprognostic (2.46e-3)" "unprognostic (1.69e-4)" "unprognostic (2.53e-1)" "unprognostic (5.28e-2)" "unprognostic (2.51e-3)" "unprognostic (9.11e-3)" 0.2 0.1 0.4 0.2 1.1 0.0 3.8 0.4 0.3 3.0 0.3 0.4 0.3 3.2 0.6 0.8 3.8 0.1 15.6 1.0 0.3 0.3 0.2 0.2 2.3 0.2 0.7 0.2 0.2 0.8 0.1 0.4 0.2 0.3 0.5 0.0 0.4 217.9 0.6 0.9 23.5 0.3 0.6 0.2 0.2 12.0 76.2 0.3 0.2 0.3 2.8 11.5 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 70.7 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.4 0.3 0.3 0.3 0.7 0.2 0.3 0.3 53.6 1.9 0.0 0.4 1.1 0.5 0.3 0.0 8.1 37.5 7.0 0.0 0.0 0.0 0.0 1235.0 0.0 0.0 0.0 0.2 0.0 0.4 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3096.0 26.4 0.0 280.0 0.0 0.0 45.4 4.3 0.0 18.0 0.0 1.4 19.4 0.3 76.9 15.2 0.6 0.0 0.0 0.0 0.7 AQP6 AQP2L ENSG00000086159 "Aquaporin 6" Q13520 12 49967194-49977139 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "kidney: 40.1" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 4.5;Collecting duct cells: 5.2" "Cancer enriched" "Detected in many" 9 "renal cancer: 9.1" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.0;OE19: 5.1;SH-SY5Y: 2.1" "Region enriched" "Detected in some" 7 "cerebellum: 23.5" "Low region specificity" "Detected in many" HPA015278 Enhanced NA NA "HPA015278: AB_10600982" "unprognostic (1.23e-1)" "unprognostic (1.32e-2)" "unprognostic (9.53e-2)" "unprognostic (2.02e-2)" "unprognostic (6.46e-2)" "unprognostic (4.60e-3)" "unprognostic (3.45e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (1.71e-1)" "unprognostic (2.00e-1)" "unprognostic (1.74e-1)" "unprognostic (6.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.03e-2)" "unprognostic (1.77e-1)" 0.1 0.2 0.6 0.1 1.1 0.0 0.1 0.3 1.6 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.7 0.5 40.1 0.2 0.1 0.1 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 0.1 1.0 0.3 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.7 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.8 0.5 1.2 0.2 0.2 0.4 0.2 0.3 2.0 0.1 0.3 0.1 0.0 0.0 0.4 0.2 0.0 0.0 1.1 1.2 0.0 0.9 0.0 0.0 0.2 0.3 0.0 0.0 0.2 1.4 0.0 0.1 0.7 0.3 0.0 0.1 0.1 0.0 0.0 0.1 1.1 0.0 0.2 0.4 0.6 0.0 0.9 0.0 0.6 0.4 5.1 1.0 1.0 0.1 0.5 0.9 0.0 0.5 2.1 0.7 0.0 0.7 0.3 0.0 0.1 0.0 0.6 0.9 0.0 0.5 0.2 0.2 0.0 0.2 0.2 0.4 1.2 0.2 0.1 0.4 0.1 0.1 0.3 0.1 0.2 0.5 0.8 0.2 0.3 1.1 0.2 0.2 0.2 0.3 0.2 0.6 1.1 0.3 0.3 0.7 0.5 1.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.7 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 AQP7 "AQP7L, AQP9, AQPap" ENSG00000165269 "Aquaporin 7" O14520 9 33383179-33402682 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 72.7;breast: 25.6;heart muscle: 21.5" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 81.4;Early spermatids: 99.6;Enterocytes: 64.2;Proximal tubular cells: 60.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 6 "T-reg: 2.7" "Lineage enriched" "Detected in single" 15 "T-cells: 2.7" "Cell line enriched" "Detected in some" 52 "ASC diff: 79.4" NA NA "unprognostic (3.25e-2)" "unprognostic (3.81e-3)" "unprognostic (1.25e-5)" "unprognostic (7.22e-3)" "unprognostic (1.50e-1)" "unprognostic (3.32e-1)" "unprognostic (4.67e-2)" "unprognostic (3.06e-2)" "unprognostic (9.99e-2)" "unprognostic (4.65e-2)" "unprognostic (8.56e-4)" "unprognostic (1.21e-1)" "prognostic favorable (9.21e-8)" "unprognostic (2.42e-1)" "unprognostic (1.28e-1)" "unprognostic (1.61e-1)" "unprognostic (2.12e-3)" 72.7 1.2 0.6 1.3 0.8 0.0 25.6 2.4 0.9 0.6 3.9 0.6 0.6 3.9 0.6 1.1 1.2 1.2 2.3 21.5 0.6 0.0 5.3 5.9 0.6 0.6 0.6 0.6 1.0 3.0 10.2 0.6 0.9 1.2 1.2 0.8 0.8 2.7 0.6 8.8 0.9 5.7 0.6 1.0 0.6 0.3 5.5 0.6 0.8 1.0 3.0 1.6 1.7 0.6 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.5 0.0 0.0 79.4 1.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.6 0.8 2.4 0.9 0.6 0.0 0.6 0.6 1.2 0.6 6.0 8.2 0.0 0.2 1.3 0.0 81.4 15.3 4.0 1.2 33.2 0.0 0.0 5.0 1.1 99.6 0.8 64.2 0.0 0.2 0.3 0.2 0.4 0.0 16.8 0.1 0.0 0.0 1.8 0.0 14.4 2.0 0.1 0.0 0.0 3.8 0.0 0.3 28.1 1.8 60.8 0.0 6.5 2.1 1.1 0.7 2.3 0.0 0.0 2.1 1.4 AQP8 ENSG00000103375 "Aquaporin 8" O94778 16 25215731-25228940 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 29 "intestine: 40.9;pancreas: 163.4" "Cell type enhanced" "Detected in some" 20 "Enterocytes: 43.3;Exocrine glandular cells: 9.2;granulocytes: 9.2;Intestinal endocrine cells: 12.6;Paneth cells: 16.9" "Group enriched" "Detected in some" 42 "colorectal cancer: 6.4;liver cancer: 3.2;pancreatic cancer: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "Hep G2: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046259 Enhanced NA NA "HPA046259: AB_10960494" "unprognostic (8.75e-2)" "unprognostic (2.91e-3)" "unprognostic (2.20e-3)" "unprognostic (1.93e-2)" "unprognostic (8.67e-2)" "unprognostic (3.34e-3)" "unprognostic (8.47e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-1)" "unprognostic (2.05e-2)" "unprognostic (8.23e-2)" "unprognostic (1.06e-2)" "unprognostic (2.67e-2)" "unprognostic (1.82e-1)" "unprognostic (1.97e-2)" "unprognostic (3.71e-2)" 0.2 0.0 0.2 3.4 0.2 0.0 0.2 0.2 0.2 0.2 40.9 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 163.4 0.0 0.2 0.2 0.2 0.2 19.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.0 5.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 43.3 0.0 9.2 0.1 0.0 0.1 9.2 0.0 0.1 1.6 12.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.2 0.1 2.5 16.9 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.3 0.0 5.4 0.0 AQP9 "HsT17287, SSC1" ENSG00000103569 "Aquaporin 9" O43315 15 58138169-58185911 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 127.8;liver: 147.0" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 258.5" "Cancer enriched" "Detected in many" 30 "liver cancer: 132.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 20 "neutrophil: 127.8" "Lineage enriched" "Detected in many" 20 "granulocytes: 127.8" "Cell line enriched" "Detected in single" 27 "U-87 MG: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA074762, CAB075684" Enhanced NA NA "CAB075684: , HPA074762: AB_2732267" "unprognostic (1.91e-1)" "unprognostic (1.92e-1)" "unprognostic (7.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.24e-2)" "unprognostic (4.15e-2)" "unprognostic (1.36e-3)" "unprognostic (2.28e-2)" "unprognostic (3.82e-2)" "unprognostic (2.03e-1)" "unprognostic (4.80e-3)" "unprognostic (6.98e-2)" "prognostic unfavorable (5.72e-11)" "unprognostic (8.78e-2)" "unprognostic (1.13e-2)" "unprognostic (1.25e-1)" "unprognostic (8.39e-2)" 7.8 0.3 0.6 12.9 0.7 9.8 0.6 0.7 1.4 0.2 0.3 0.1 1.0 0.0 0.2 7.8 0.7 3.0 0.8 2.0 0.4 0.2 0.8 147.0 8.6 12.0 2.4 0.4 1.2 0.3 2.8 0.4 1.4 0.6 0.4 0.0 0.5 0.4 0.8 0.4 6.9 0.3 1.0 0.5 15.8 0.7 2.5 0.4 0.4 0.5 0.1 0.4 1.3 0.6 0.0 0.2 127.8 6.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 25.9 0.1 0.0 0.0 6.2 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 127.8 0.0 2.3 0.0 0.0 1.7 0.6 0.7 0.7 1.4 0.4 0.2 2.4 0.4 0.6 0.4 0.0 19.3 4.3 0.1 0.3 0.0 1.2 5.1 2.7 5.7 0.0 0.0 0.3 0.0 0.1 1.9 0.1 0.0 0.0 0.2 0.5 0.4 0.0 7.0 258.5 43.2 0.0 0.0 8.0 34.5 0.8 0.3 57.7 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.7 1.3 0.0 0.1 AREG "AREGB, SDGF" ENSG00000109321 Amphiregulin P15514 4 74445134-74455009 "Cancer-related genes, Predicted membrane proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 83.5" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 759.9;Basal keratinocytes: 994.1;Enterocytes: 632.3;granulocytes: 633.9;Urothelial cells: 1407.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "basophil: 8.2;eosinophil: 11.6;NK-cell: 3.3" "Group enriched" "Detected in many" 9 "granulocytes: 11.6;NK-cells: 3.3" "Cell line enhanced" "Detected in some" "CACO-2: 42.8;HBEC3-KT: 74.1;hTCEpi: 75.5;hTERT-HME1: 161.4;MCF7: 46.5" "Region enriched" "Detected in single" 4 "olfactory region: 1.5" "Low region specificity" "Detected in all" "HPA008720, CAB023519" Approved Approved Mitochondria NA NA 1520000 Mitochondria "CAB023519: AB_2060673, HPA008720: AB_1844978" "unprognostic (1.44e-2)" "unprognostic (1.84e-3)" "unprognostic (3.36e-2)" "unprognostic (2.26e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (2.61e-5)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.90e-1)" "unprognostic (8.06e-2)" "prognostic unfavorable (8.32e-5)" "unprognostic (2.56e-2)" "unprognostic (2.49e-3)" "unprognostic (2.40e-2)" "unprognostic (1.69e-1)" "unprognostic (1.23e-1)" "unprognostic (6.83e-3)" 19.5 1.1 0.4 9.2 2.1 28.9 20.3 0.3 0.4 5.7 6.7 0.2 0.2 0.7 1.7 1.6 22.3 6.0 34.8 13.6 0.5 0.4 2.5 1.7 14.4 13.3 0.4 0.0 5.8 1.0 0.0 7.8 83.5 1.3 1.9 5.0 1.4 3.9 0.9 9.9 3.4 10.0 1.5 1.0 11.3 5.3 4.6 0.0 1.6 1.2 13.4 13.6 8.7 4.6 0.4 0.8 11.6 0.0 3.3 0.4 0.1 1.7 12.2 0.0 0.0 0.1 0.1 0.0 0.3 0.5 0.0 0.3 42.8 6.8 0.0 0.9 0.0 0.0 1.9 0.0 74.1 0.7 0.0 0.0 0.0 0.3 2.0 23.0 0.2 0.0 0.7 75.5 4.4 161.4 0.1 0.0 0.0 0.1 0.0 1.6 46.5 0.0 0.0 0.0 8.8 4.9 0.0 0.0 0.0 4.2 0.3 0.0 0.0 2.5 0.1 0.0 0.0 1.3 0.0 0.1 0.0 1.7 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 8.2 0.0 11.6 0.0 0.0 0.0 0.3 0.4 0.0 0.8 0.4 0.2 0.0 0.1 3.3 0.0 0.1 0.0 0.1 0.4 2.1 0.3 0.4 0.5 0.4 0.4 0.0 1.3 0.0 184.6 339.4 82.8 759.9 994.1 0.0 30.5 71.4 92.3 310.5 48.8 0.0 1.3 0.0 52.7 45.1 3.9 632.3 0.0 8.6 1.2 28.2 73.6 633.9 2.9 31.8 0.0 39.8 10.4 189.5 5.9 0.3 134.1 32.1 1.8 188.0 0.0 301.5 221.0 1.1 0.5 0.0 19.4 4.4 52.0 45.0 299.4 0.9 149.6 119.9 1407.8 AREL1 "FIEL1, KIAA0317" ENSG00000119682 "Apoptosis resistant E3 ubiquitin protein ligase 1" O15033 14 74653437-74713115 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051306 Uncertain NA NA "HPA051306: AB_2681433" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "unprognostic (1.76e-1)" "unprognostic (1.92e-3)" "unprognostic (1.29e-1)" "unprognostic (2.49e-2)" "unprognostic (1.58e-3)" "unprognostic (9.32e-2)" "unprognostic (1.09e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (2.12e-1)" "prognostic favorable (4.67e-6)" "unprognostic (6.73e-2)" "unprognostic (3.14e-1)" "unprognostic (1.52e-1)" "unprognostic (7.18e-2)" 8.5 13.7 11.8 12.2 22.2 17.6 8.8 14.4 25.7 9.3 11.9 16.5 9.8 13.8 12.8 11.4 14.5 12.6 8.4 12.3 11.3 9.7 17.5 9.8 12.1 12.0 8.6 8.4 11.9 15.7 19.4 9.5 11.9 13.3 10.0 15.0 18.3 14.9 9.8 17.9 10.7 16.0 10.1 11.1 12.3 12.0 20.0 7.2 17.1 18.6 11.2 14.9 11.2 10.8 3.2 7.0 9.7 7.6 4.6 7.3 4.5 12.3 15.5 15.4 15.6 13.5 9.7 13.3 13.1 15.6 16.8 16.2 13.0 15.0 10.6 7.1 18.7 15.0 16.0 17.8 14.3 22.1 18.8 8.7 16.2 10.4 8.1 8.8 11.5 16.1 12.5 10.5 12.1 13.2 20.3 15.8 15.9 12.5 11.8 21.6 15.4 12.1 5.0 10.3 15.4 16.1 12.9 17.9 6.6 12.9 28.3 16.8 22.2 12.0 16.1 8.5 10.8 14.0 12.2 22.1 16.4 19.3 9.7 16.1 14.3 21.0 21.7 19.4 8.7 12.4 2.1 4.8 9.7 7.3 7.6 5.4 3.2 4.2 6.0 7.0 2.1 4.6 3.8 9.7 4.6 4.1 2.3 3.8 4.5 11.8 22.2 14.4 25.7 11.3 9.7 8.6 8.4 13.3 7.2 11.9 2.9 2.2 2.9 3.2 11.2 9.3 2.5 2.7 5.7 10.4 25.5 3.4 1.7 5.9 2.3 3.8 12.3 23.3 8.0 2.7 3.5 5.7 1.1 10.5 6.9 15.9 14.3 6.2 13.9 2.7 8.1 5.5 5.0 6.4 12.0 4.8 8.6 7.0 6.3 3.7 11.3 0.0 3.4 6.6 9.8 2.9 4.9 5.7 8.8 5.1 ARHGAP1 "CDC42GAP, p50rhoGAP, RhoGAP" ENSG00000175220 "Rho GTPase activating protein 1" Q07960 11 46677080-46700615 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004689, HPA008285" Approved Approved Approved Vesicles NA NA 16000000 Vesicles "HPA004689: AB_1078194, HPA008285: AB_1078195" "unprognostic (1.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.05e-3)" "unprognostic (5.19e-2)" "unprognostic (2.48e-2)" "unprognostic (9.07e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (1.34e-3)" "unprognostic (1.24e-1)" "unprognostic (7.96e-2)" "unprognostic (1.35e-2)" "unprognostic (4.94e-1)" "unprognostic (4.79e-2)" "unprognostic (4.13e-2)" "unprognostic (3.49e-2)" "unprognostic (2.55e-1)" "unprognostic (9.24e-2)" 39.9 23.0 17.5 21.3 24.0 17.5 25.8 9.5 30.1 35.6 23.9 42.9 13.1 15.2 43.0 23.9 36.8 31.0 40.2 63.3 23.0 14.8 19.8 19.4 17.9 22.0 17.5 17.7 32.6 17.0 18.6 16.7 32.0 17.1 36.3 20.0 33.8 21.6 39.3 15.1 26.9 19.5 58.5 18.1 29.0 21.4 21.4 24.1 21.0 20.0 16.2 27.2 59.5 27.1 7.9 17.1 18.8 33.4 11.6 14.3 10.3 7.1 18.1 9.1 12.8 45.3 33.4 10.7 15.9 16.3 14.7 13.5 10.8 9.5 10.5 8.7 32.6 13.3 18.0 7.2 24.4 11.1 7.2 7.8 11.5 9.3 12.7 14.9 9.7 17.2 44.1 15.3 11.3 14.2 15.3 12.6 8.7 7.5 9.9 17.9 26.0 6.5 9.7 23.4 24.8 9.4 7.8 13.0 15.4 14.0 27.2 3.3 10.4 14.6 22.8 6.1 13.8 28.6 11.2 15.7 27.3 8.5 32.1 16.0 10.5 11.5 7.9 25.6 16.5 12.7 12.0 16.3 15.6 14.3 28.2 10.2 7.7 11.3 12.1 16.1 7.9 9.9 11.2 18.8 11.6 33.4 17.1 13.4 10.3 17.5 24.0 9.5 30.1 23.0 14.8 17.5 17.7 17.1 24.1 17.9 18.9 18.8 13.8 7.6 11.2 45.2 10.2 2.7 12.5 27.9 25.5 21.6 3.3 19.3 0.3 14.3 20.6 0.0 24.3 27.0 18.9 11.0 18.5 24.6 25.1 15.9 18.7 26.4 23.4 0.9 21.9 15.1 8.5 22.6 29.7 9.4 21.2 17.5 33.2 10.9 14.0 58.2 42.0 3.2 3.4 11.4 13.8 19.1 17.2 14.4 ARHGAP36 FLJ30058 ENSG00000147256 "Rho GTPase activating protein 36" Q6ZRI8 X 131058242-131089883 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 21 "thyroid cancer: 62.5" "Region enriched" "Detected in many" 5 "hypothalamus: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 164 "SH-SY5Y: 64.4" "Region enhanced" "Detected in many" "hypothalamus: 104.3" "Group enriched" "Detected in many" 5 "basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1" "HPA002064, HPA076209" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" Yes NA Nucleoplasm "Vesicles, Plasma membrane" "HPA002064: AB_1078891, HPA076209: " "unprognostic (2.92e-2)" "unprognostic (7.71e-9)" "unprognostic (2.19e-1)" "unprognostic (8.15e-2)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (2.31e-1)" 6.9 58.4 1.4 0.2 3.6 0.1 1.0 0.0 2.7 0.5 0.2 0.0 0.0 0.1 0.1 2.0 0.3 0.2 0.2 0.1 1.0 25.5 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 50.3 0.3 5.4 0.3 0.2 0.6 0.2 0.2 13.7 0.1 0.1 0.1 0.8 0.1 0.2 0.6 0.0 0.5 0.5 4.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 64.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.6 0.0 0.4 1.0 25.5 0.5 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 ARHGAP42 "AD031, FLJ32810, GRAF3, TMEM133" ENSG00000165895 "Rho GTPase activating protein 42" "A6NI28, Q9H2Q1" 11 100687653-100993941 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 38.0" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7;Early spermatids: 72.6;Rod photoreceptor cells: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.1;RH-30: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039924, HPA060528" Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA039924: AB_10674428, HPA060528: AB_2684308" "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.21e-3)" "unprognostic (2.74e-1)" "unprognostic (1.50e-2)" "unprognostic (4.17e-2)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.30e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (1.32e-1)" "unprognostic (1.75e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (8.45e-2)" "unprognostic (1.03e-1)" 11.1 4.9 6.8 8.9 5.8 0.9 10.4 3.0 7.0 9.8 8.3 4.1 2.3 9.9 11.4 7.7 4.3 5.6 9.5 6.5 8.8 3.8 11.9 12.7 13.7 5.1 6.3 5.3 4.8 2.6 9.1 6.0 38.0 5.9 4.8 8.4 25.5 5.1 3.8 9.0 7.2 12.1 5.8 8.7 8.2 11.7 4.1 6.7 12.7 10.9 7.4 3.8 5.5 7.9 1.5 2.5 0.0 0.0 0.7 0.4 0.3 0.5 3.6 4.6 0.1 2.6 3.5 3.2 0.6 0.9 1.1 2.1 4.4 23.1 0.7 6.5 1.7 4.1 7.8 2.3 1.7 1.1 0.0 2.0 11.2 9.1 1.5 4.6 0.1 0.0 3.3 2.2 4.3 0.7 2.6 1.7 2.8 0.4 0.0 3.5 0.6 1.2 0.0 5.6 6.4 5.7 3.4 16.0 0.4 5.4 15.0 2.5 1.6 7.7 0.3 6.1 10.0 0.8 1.4 3.0 3.0 3.7 3.6 1.7 3.3 0.0 4.5 3.5 2.7 13.1 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.3 6.8 5.8 3.0 7.0 8.8 3.8 6.3 5.3 5.9 6.7 44.7 4.0 5.1 4.8 2.2 2.6 4.2 10.2 16.0 21.6 3.5 23.6 0.6 1.7 4.1 72.6 2.9 10.0 23.3 3.3 1.8 4.5 10.0 0.0 5.9 1.3 1.6 1.7 9.2 0.3 27.0 1.1 2.2 10.1 0.0 2.8 31.8 6.5 5.7 2.5 15.8 60.0 38.8 12.3 1.9 1.6 3.0 5.4 0.0 2.4 17.3 ARL10 ARL10A ENSG00000175414 "ADP ribosylation factor like GTPase 10" Q8N8L6 5 176365468-176401865 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 31.9;Horizontal cells: 19.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047044 Approved NA NA "HPA047044: AB_2679915" "unprognostic (2.50e-2)" "unprognostic (4.77e-2)" "unprognostic (6.90e-2)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-1)" "unprognostic (3.00e-3)" "unprognostic (1.37e-1)" "unprognostic (6.31e-2)" "unprognostic (6.00e-3)" "unprognostic (2.78e-1)" "unprognostic (9.29e-2)" "unprognostic (5.92e-3)" "unprognostic (7.96e-2)" "unprognostic (2.69e-1)" "unprognostic (1.68e-2)" "unprognostic (4.33e-2)" 5.0 3.4 11.1 4.4 11.7 7.0 5.5 11.0 15.6 7.6 7.6 10.1 3.3 2.6 8.0 5.9 8.5 4.6 7.0 6.4 8.7 7.7 3.6 1.9 3.5 5.5 9.2 10.9 11.8 3.9 5.7 9.0 5.9 6.7 5.9 2.9 4.3 3.3 6.2 9.8 25.7 4.8 8.2 10.8 5.1 3.8 3.3 7.9 4.3 4.0 3.1 4.5 6.1 7.6 2.5 0.9 1.4 0.4 1.2 2.0 0.3 0.4 0.1 12.1 5.6 6.5 8.0 0.6 3.1 1.5 4.9 5.2 0.3 0.4 1.1 0.6 6.2 0.2 7.9 0.1 0.9 7.3 0.1 4.9 1.1 9.7 1.2 3.9 0.2 1.5 4.7 0.5 6.3 0.0 2.6 8.0 2.2 0.4 1.2 6.5 7.4 1.4 0.3 2.2 0.9 1.3 3.5 3.0 0.0 3.0 4.2 11.1 11.6 2.8 1.7 2.4 5.5 0.4 0.9 6.0 4.6 3.8 3.4 0.6 0.5 0.8 0.4 3.7 0.2 1.5 0.7 0.3 0.4 1.4 0.3 1.3 2.5 1.1 2.0 0.3 2.3 0.8 1.5 1.4 1.2 0.4 0.9 1.3 0.3 11.1 11.7 11.0 15.6 8.7 7.7 9.2 10.9 6.7 7.9 3.0 31.9 1.3 3.6 3.5 12.4 9.8 2.5 9.4 11.4 7.0 5.9 0.4 0.0 1.7 0.8 4.2 0.0 0.0 0.2 0.6 6.0 2.4 16.2 0.6 1.1 19.1 0.0 3.7 1.9 0.0 6.1 1.9 3.3 1.0 0.3 4.3 1.0 0.0 6.7 1.4 5.2 0.0 4.2 1.1 0.7 6.6 0.3 1.7 0.1 2.3 ARL6IP1 "AIP1, ARL6IP, ARMER, KIAA0069, SPG61" ENSG00000170540 "ADP ribosylation factor like GTPase 6 interacting protein 1" Q15041 16 18791667-18801678 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA045307 Uncertain Approved "Endoplasmic reticulum" NA Yes "Endoplasmic reticulum" "HPA045307: AB_10961042" "unprognostic (2.42e-1)" "unprognostic (3.47e-2)" "unprognostic (4.07e-3)" "unprognostic (1.12e-1)" "unprognostic (1.54e-1)" "unprognostic (2.60e-3)" "unprognostic (2.58e-2)" "unprognostic (1.76e-2)" "unprognostic (3.88e-2)" "unprognostic (6.83e-2)" "unprognostic (1.91e-3)" "unprognostic (3.33e-2)" "unprognostic (1.13e-2)" "unprognostic (7.09e-2)" "unprognostic (4.60e-2)" "unprognostic (6.32e-3)" "unprognostic (5.36e-3)" 29.6 40.9 75.9 16.5 62.0 40.2 26.2 76.5 93.0 19.5 31.5 28.6 13.8 31.4 16.7 29.7 19.8 20.5 30.2 8.8 65.7 70.1 35.1 80.7 18.0 27.0 65.2 44.6 24.7 18.6 45.1 13.4 20.3 68.6 18.1 29.0 40.9 18.6 17.4 8.3 14.8 27.5 16.0 43.0 20.4 27.8 28.1 20.4 33.1 26.2 11.3 24.9 27.8 14.2 41.2 57.2 40.1 32.4 44.1 67.7 63.0 48.3 44.2 58.8 45.9 21.1 13.6 52.6 28.3 27.3 44.0 35.2 27.1 117.2 42.3 51.9 27.1 29.6 53.1 42.1 19.9 51.2 54.1 19.0 30.0 27.3 73.7 16.8 42.4 32.1 11.3 19.4 30.4 31.9 32.6 43.9 25.0 32.7 44.1 84.6 43.8 29.8 32.1 72.2 42.4 15.1 50.8 73.8 35.9 47.2 27.3 35.8 40.7 62.2 39.0 27.9 41.4 80.0 42.9 24.2 28.9 27.2 20.5 50.5 15.0 26.6 51.0 25.8 29.0 55.8 40.1 32.4 20.9 48.7 30.0 44.7 41.2 43.2 52.4 32.0 38.3 38.5 45.8 27.7 44.1 30.9 57.2 67.7 63.0 75.9 62.0 76.5 93.0 65.7 70.1 65.2 44.6 68.6 20.4 62.5 47.7 99.8 227.5 331.0 171.8 27.4 341.4 91.0 61.4 272.2 123.7 218.9 147.6 292.3 62.1 144.0 214.0 677.5 180.9 329.7 163.0 191.1 134.8 383.9 223.1 84.2 140.0 177.4 230.1 29.6 78.6 248.9 190.6 385.9 155.5 189.5 210.1 217.5 104.3 161.1 161.3 90.5 101.1 73.5 56.8 285.4 273.1 186.2 246.9 307.2 ARL6IP5 "DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b" ENSG00000144746 "ADP ribosylation factor like GTPase 6 interacting protein 5" O75915 3 69084944-69106066 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015540, CAB019321" Supported Approved "Endoplasmic reticulum" NA NA 19000000 "Endoplasmic reticulum" "CAB019321: , HPA015540: AB_1852061" "unprognostic (8.01e-2)" "unprognostic (1.71e-1)" "unprognostic (8.09e-2)" "unprognostic (1.51e-3)" "unprognostic (2.65e-1)" "unprognostic (3.51e-1)" "unprognostic (1.65e-1)" "unprognostic (1.84e-1)" "unprognostic (3.06e-1)" "unprognostic (3.72e-3)" "unprognostic (1.31e-2)" "unprognostic (7.23e-2)" "unprognostic (2.05e-3)" "unprognostic (3.60e-1)" "unprognostic (4.44e-2)" "unprognostic (3.42e-2)" "unprognostic (1.31e-2)" 53.2 53.2 44.0 37.4 48.5 21.3 51.5 32.9 62.1 48.1 31.9 41.5 16.8 21.1 33.8 40.0 38.5 34.5 37.3 76.0 42.9 51.0 43.3 28.4 44.9 43.7 53.1 30.7 28.9 23.3 18.3 36.3 50.6 81.7 49.2 31.8 32.1 54.9 35.6 69.3 18.5 30.3 37.0 51.6 40.7 27.9 21.4 46.1 32.5 39.9 32.7 45.2 46.9 30.2 57.3 40.4 91.5 57.5 41.4 74.8 114.8 15.2 10.6 13.1 9.6 68.3 64.0 16.6 15.8 35.8 12.3 14.5 5.3 37.4 3.0 5.3 27.1 23.1 12.2 10.7 18.2 10.6 59.8 10.0 10.5 18.0 8.1 17.6 8.9 52.1 46.0 32.9 11.3 14.4 43.7 37.6 10.1 4.6 28.7 29.8 8.8 9.7 11.8 3.4 35.6 10.0 8.6 12.0 28.0 60.7 25.7 3.3 8.7 15.7 17.1 20.6 13.5 11.3 14.3 36.7 8.2 6.5 20.7 17.1 25.8 36.1 5.6 27.2 22.4 13.2 81.4 57.5 91.5 52.3 51.4 40.1 57.3 73.9 66.5 40.4 43.9 63.1 66.2 24.0 41.4 43.0 25.6 74.8 114.8 44.0 48.5 32.9 62.1 42.9 51.0 53.1 30.7 81.7 46.1 163.8 103.0 121.2 73.7 64.7 192.5 338.6 84.1 117.8 116.0 89.0 176.7 275.4 21.6 231.6 8.1 130.0 85.8 70.0 188.9 320.0 170.5 132.5 322.8 62.5 267.8 116.0 40.4 118.4 223.5 12.7 191.8 306.3 258.1 527.6 54.0 207.9 194.4 84.2 246.1 66.8 224.8 187.5 100.4 8.1 2.5 64.5 149.2 256.0 66.9 73.3 ARL6IP6 MGC33864 ENSG00000177917 "ADP ribosylation factor like GTPase 6 interacting protein 6" Q8N6S5 2 152717893-152761253 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.7" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 127.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 50.7;eosinophil: 45.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 50.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014743 Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA014743: AB_1845030" "unprognostic (4.41e-1)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (9.81e-3)" "unprognostic (1.28e-1)" "unprognostic (9.86e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (5.43e-2)" "unprognostic (2.07e-2)" "unprognostic (2.00e-3)" "unprognostic (4.95e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (2.14e-4)" "unprognostic (2.14e-1)" "unprognostic (2.67e-1)" "unprognostic (4.57e-1)" "unprognostic (7.39e-2)" 6.1 5.1 8.4 4.2 10.1 14.5 9.4 6.6 11.4 4.7 5.7 10.1 7.9 6.5 5.6 2.5 7.8 5.1 5.6 3.2 11.4 4.9 3.3 2.3 7.2 7.2 15.9 7.4 6.9 3.3 2.6 8.3 10.2 12.9 4.6 4.1 3.4 4.9 4.8 9.7 8.2 6.1 4.7 12.4 8.7 6.0 7.3 13.5 2.5 4.1 4.6 5.4 6.3 18.9 5.7 7.4 50.7 3.5 2.6 5.6 3.6 8.3 5.1 12.5 3.5 3.1 3.8 19.4 10.2 4.1 8.6 10.8 13.5 12.2 14.7 10.3 4.3 4.1 9.6 6.6 4.5 8.9 23.0 14.0 12.0 5.1 12.0 4.2 9.9 11.3 2.8 5.3 9.3 7.5 3.3 6.4 11.0 13.3 9.5 6.6 6.0 10.2 10.7 12.1 2.6 11.6 11.8 12.4 11.8 3.6 6.2 11.0 11.8 9.3 0.9 8.1 4.5 4.2 7.5 8.8 13.7 9.3 9.5 8.9 9.1 9.1 11.9 6.6 8.5 11.2 50.7 2.8 45.4 4.1 3.0 4.2 5.7 4.2 4.1 3.2 4.9 4.3 3.7 7.5 2.6 3.5 7.4 5.6 3.6 8.4 10.1 6.6 11.4 11.4 4.9 15.9 7.4 12.9 13.5 14.9 10.6 31.2 40.7 94.6 5.6 3.9 20.4 17.4 15.9 10.4 3.9 127.9 14.9 23.8 9.4 27.2 12.3 0.0 16.4 114.2 39.0 25.6 26.5 4.7 35.6 7.9 13.3 21.5 27.9 14.2 18.1 34.9 43.9 56.9 21.6 17.2 18.4 17.5 15.9 7.7 14.7 32.3 26.0 21.3 24.3 93.2 90.6 45.0 22.6 48.9 ARMC10 "MGC3195, SVH" ENSG00000170632 "Armadillo repeat containing 10" Q8N2F6 7 103074881-103099764 "Predicted intracellular proteins, Predicted membrane proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011036, HPA011057" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA011036: AB_1080139, HPA011057: AB_1080137" "unprognostic (7.03e-3)" "unprognostic (2.44e-1)" "unprognostic (8.18e-2)" "unprognostic (3.53e-1)" "prognostic unfavorable (8.90e-6)" "unprognostic (3.85e-3)" "prognostic unfavorable (3.58e-4)" "unprognostic (5.57e-2)" "unprognostic (3.49e-2)" "unprognostic (7.90e-2)" "prognostic unfavorable (2.49e-6)" "unprognostic (1.02e-1)" "unprognostic (5.78e-2)" "unprognostic (1.47e-1)" "unprognostic (2.76e-1)" "unprognostic (1.14e-2)" "unprognostic (5.67e-2)" 21.6 21.7 28.0 12.6 25.0 9.1 24.5 11.4 28.0 24.4 18.6 24.7 20.8 14.0 20.4 24.2 22.2 23.2 20.0 16.7 26.2 26.2 27.4 30.2 15.0 15.7 26.3 24.2 26.5 28.7 26.0 12.0 15.4 19.7 22.2 18.8 17.6 15.7 23.4 15.8 21.6 12.8 20.3 25.5 14.4 19.8 14.1 19.6 21.5 30.7 15.6 15.7 22.3 20.5 5.1 6.8 6.6 5.4 3.9 4.7 2.2 12.6 10.8 6.4 12.4 13.4 12.8 6.4 8.9 9.7 6.4 7.8 5.8 15.0 22.8 19.3 7.8 18.4 11.4 9.0 9.9 9.2 8.5 10.3 8.0 4.6 2.8 13.5 22.0 9.6 8.3 17.5 8.1 13.3 19.6 14.6 12.9 19.6 14.1 11.4 23.4 16.1 17.1 14.3 21.7 11.7 9.8 6.7 29.6 16.3 8.9 7.2 9.9 12.1 18.3 13.4 11.6 7.4 11.0 9.7 10.0 9.5 23.4 13.3 21.7 33.9 18.3 11.3 20.5 12.4 0.0 4.4 6.6 2.6 5.4 4.5 4.0 4.1 4.4 6.8 5.1 4.6 4.7 0.9 3.9 2.8 5.3 4.2 2.2 28.0 25.0 11.4 28.0 26.2 26.2 26.3 24.2 19.7 19.6 23.8 17.0 26.1 49.5 69.9 22.6 15.4 22.9 6.7 15.9 26.2 13.7 38.2 56.3 15.6 10.1 27.0 15.3 0.0 13.3 39.5 28.9 60.5 17.3 34.7 41.8 7.9 14.5 25.2 32.4 6.3 31.4 31.1 43.9 2.8 33.1 24.5 20.4 10.5 32.2 71.6 26.5 32.3 47.6 11.6 30.8 91.1 37.6 30.5 39.3 65.2 ARMCX1 "ALEX1, GASP7" ENSG00000126947 "Armadillo repeat containing, X-linked 1" Q9P291 X 101550531-101554700 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 9.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 26.9;ASC TERT1: 24.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;LHCN-M2: 24.4;RH-30: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000268, HPA005685, CAB020695" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "CAB020695: , HPA000268: , HPA005685: AB_10600781" "unprognostic (2.31e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (2.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.25e-2)" "unprognostic (2.39e-1)" "unprognostic (2.18e-3)" "unprognostic (2.13e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.32e-5)" "unprognostic (1.02e-1)" "unprognostic (2.85e-2)" "unprognostic (2.20e-3)" "unprognostic (8.77e-2)" "unprognostic (2.12e-2)" "unprognostic (1.09e-2)" 17.5 29.8 13.6 7.4 16.5 2.7 18.9 13.4 21.5 24.4 18.7 9.6 15.9 6.2 27.3 19.0 12.3 16.3 14.8 26.6 13.3 18.4 12.1 3.8 11.6 4.4 13.7 14.6 42.6 10.2 20.1 18.0 12.5 16.4 25.8 7.0 13.0 12.0 21.1 22.7 8.1 7.6 26.3 9.1 11.4 10.0 8.1 10.5 3.5 14.0 11.6 3.3 26.8 29.7 0.2 9.9 0.5 4.3 2.1 3.7 2.1 0.7 0.2 5.6 0.0 26.9 24.2 0.0 8.7 17.2 11.0 27.8 0.0 0.1 0.0 7.5 13.4 12.1 0.7 0.0 1.2 6.2 0.0 0.0 5.0 1.7 0.0 14.2 0.0 0.0 20.2 1.7 8.3 0.0 9.1 6.6 0.0 0.1 0.1 24.4 0.3 0.0 0.0 8.0 0.0 0.0 0.0 30.8 0.0 7.5 0.0 5.5 4.6 0.0 0.1 15.0 1.6 0.9 3.7 8.7 6.7 3.5 19.4 0.1 0.0 0.1 0.0 6.5 0.0 4.1 0.0 4.3 0.5 0.0 3.9 0.7 0.0 0.6 0.3 9.9 0.2 1.5 3.7 0.1 2.1 1.1 5.1 0.9 2.1 13.6 16.5 13.4 19.9 13.3 18.4 13.7 14.6 16.4 10.5 23.8 6.1 0.0 23.8 29.5 26.3 54.8 7.6 5.3 5.7 22.7 5.9 1.4 11.6 14.6 0.3 23.2 0.5 0.0 6.0 2.1 52.1 21.0 24.2 0.4 23.6 20.6 5.2 17.8 9.4 0.9 43.7 11.0 55.6 6.4 1.0 31.1 7.5 0.0 41.8 11.4 13.3 45.3 48.4 1.7 0.7 19.1 2.2 1.0 0.6 7.4 ARMCX2 "ALEX2, GASP9, KIAA0512" ENSG00000184867 "Armadillo repeat containing, X-linked 2" Q7L311 X 101655281-101659891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 92.7" "Cell type enhanced" "Detected in many" 7 "Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 48.1;NTERA-2: 34.7;RH-30: 26.6;SuSa: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005761 Enhanced Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA005761: AB_10600782" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (4.25e-2)" "unprognostic (1.48e-1)" "unprognostic (9.59e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (3.41e-2)" "prognostic favorable (3.45e-5)" "unprognostic (9.06e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.69e-4)" "unprognostic (1.12e-1)" "unprognostic (6.73e-2)" "unprognostic (1.25e-1)" 7.7 21.5 12.5 6.7 19.9 1.0 14.2 17.6 17.5 17.1 11.4 8.2 38.8 3.7 18.4 92.7 6.2 16.7 12.5 18.8 13.2 17.1 13.3 2.6 8.3 4.9 11.8 13.3 28.8 9.8 34.1 38.9 15.4 12.4 17.6 5.3 9.7 23.6 41.8 3.8 3.2 6.2 19.3 9.0 10.9 8.3 6.3 10.7 1.4 35.1 3.6 4.3 13.9 18.9 7.6 1.6 0.0 1.4 4.3 4.4 1.9 0.0 0.0 14.9 0.1 13.3 12.1 0.1 16.3 20.5 0.4 0.4 0.0 6.3 0.0 0.0 21.4 0.0 0.4 0.0 0.3 0.1 0.0 0.5 0.0 17.5 0.0 14.1 0.1 0.0 19.1 5.2 12.8 0.1 20.2 17.3 0.0 0.0 0.1 48.1 0.0 0.0 0.2 34.7 0.9 0.1 4.0 26.6 0.0 0.8 0.0 6.0 11.1 0.0 0.0 0.4 27.9 7.6 0.0 3.8 18.4 19.6 11.5 0.1 0.0 0.0 0.0 16.8 0.0 0.3 0.0 0.7 0.0 1.6 1.4 0.7 5.1 1.5 1.5 1.1 7.6 4.2 4.4 0.0 4.3 0.9 1.6 0.9 1.9 12.5 19.9 17.6 17.5 13.2 17.1 11.8 13.3 12.4 10.7 14.9 5.4 4.4 13.8 3.8 11.2 22.2 7.6 2.7 15.9 31.4 7.9 1.0 3.3 8.0 0.1 13.0 0.0 0.0 1.8 0.4 20.2 13.8 2.3 0.4 3.6 1.6 8.7 16.0 2.1 0.4 22.5 4.0 5.0 11.8 2.2 7.0 3.1 0.0 23.0 4.2 9.7 58.2 26.4 1.4 1.1 2.6 4.2 2.5 1.2 6.2 ARMCX3 "ALEX3, GASP6" ENSG00000102401 "Armadillo repeat containing, X-linked 3" Q9UH62 X 101622797-101627843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000325, HPA000967, HPA001530" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: AB_2666349" "unprognostic (1.67e-1)" "unprognostic (2.14e-1)" "unprognostic (5.23e-2)" "unprognostic (8.69e-3)" "unprognostic (1.73e-2)" "unprognostic (1.47e-2)" "unprognostic (9.72e-3)" "unprognostic (2.19e-2)" "unprognostic (4.77e-2)" "unprognostic (6.80e-2)" "unprognostic (3.38e-3)" "unprognostic (2.12e-2)" "prognostic favorable (1.55e-5)" "unprognostic (3.29e-2)" "unprognostic (3.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.55e-2)" 21.0 39.2 26.6 14.8 32.9 8.5 20.5 20.5 36.9 30.6 18.8 21.0 37.1 13.3 26.9 67.8 12.7 17.1 22.0 31.7 28.0 26.6 24.0 17.8 19.1 12.7 27.8 29.6 26.7 38.2 62.0 37.9 28.5 35.4 29.1 14.8 13.6 34.8 31.6 25.5 7.9 13.8 24.6 25.7 24.1 19.0 9.2 22.8 8.2 31.9 17.1 13.7 21.4 21.3 11.6 18.8 25.2 11.8 10.2 14.8 9.4 8.8 6.0 16.4 9.1 37.8 42.2 3.7 19.5 18.8 8.6 24.9 7.1 8.2 3.4 11.2 22.7 17.5 1.7 12.3 7.1 10.5 6.7 7.8 6.3 20.4 10.2 30.0 6.1 15.0 23.3 9.6 10.3 11.1 21.6 16.2 3.8 4.8 30.2 23.3 3.9 5.0 0.2 8.3 16.2 1.3 6.4 21.4 3.0 12.0 3.7 7.6 6.5 9.4 0.6 20.2 23.8 7.1 6.3 22.7 11.4 7.4 25.7 3.8 24.5 6.6 0.0 17.3 4.9 9.6 25.2 11.2 9.5 10.9 11.3 14.8 11.6 10.8 9.5 11.3 7.9 12.2 8.5 4.1 10.2 11.8 18.8 6.6 9.4 26.6 32.9 20.5 36.9 28.0 26.6 27.8 29.6 35.4 22.8 41.7 29.7 51.4 69.7 33.7 60.9 87.7 56.0 14.7 34.2 71.5 55.0 47.1 31.5 41.8 0.5 61.9 17.9 46.7 26.6 17.4 93.4 96.0 76.3 43.1 44.4 58.8 78.9 51.5 46.4 1.1 59.8 60.8 92.8 22.6 46.0 98.2 30.2 24.6 68.2 33.5 12.2 32.3 93.7 1.9 0.4 18.7 96.1 34.6 28.6 71.5 ARMCX4 "CXorf35, GASP4, MGC40053" ENSG00000196440 "Armadillo repeat containing, X-linked 4" X 101418287-101533459 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 10.8" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 24.7;Collecting duct cells: 26.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 9.0;hTEC/SVTERT24-B: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000429, HPA051930" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA000429: AB_1078210, HPA051930: AB_2681665" "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.10e-2)" "unprognostic (6.91e-3)" "unprognostic (2.81e-3)" "unprognostic (7.28e-2)" "unprognostic (3.67e-4)" "unprognostic (2.33e-2)" "unprognostic (4.29e-1)" "prognostic favorable (8.20e-5)" "unprognostic (1.94e-2)" "unprognostic (1.40e-2)" "unprognostic (6.94e-3)" "unprognostic (1.69e-1)" "unprognostic (1.88e-1)" "unprognostic (4.92e-2)" 1.5 4.6 1.9 0.8 2.7 0.3 2.9 3.2 5.7 2.4 1.7 0.6 4.0 2.8 0.7 2.8 1.1 1.2 2.0 2.9 1.2 0.5 1.5 0.5 1.9 8.5 1.4 10.8 4.3 1.6 4.1 1.6 1.2 5.7 1.6 2.1 1.5 2.8 1.4 1.3 1.3 0.4 2.4 0.5 2.1 1.4 0.0 0.1 0.0 0.0 0.0 0.5 0.0 2.3 0.6 8.2 0.0 4.0 4.2 0.8 5.6 4.4 4.6 9.0 1.9 0.8 0.0 2.2 8.3 0.1 1.0 0.0 0.1 7.6 0.0 0.9 0.6 2.3 0.0 2.3 0.0 3.1 2.6 0.4 10.0 0.0 0.0 8.0 0.0 0.0 0.7 2.0 0.0 0.3 0.3 6.0 0.8 0.0 0.4 6.8 0.0 1.2 1.4 5.6 5.1 0.8 0.0 3.0 1.4 0.6 1.2 3.0 2.1 1.3 6.4 0.0 0.0 0.0 0.0 3.9 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 3.0 5.0 0.5 6.3 2.2 24.7 8.7 0.0 14.7 11.4 26.2 7.9 1.4 14.9 2.2 0.2 7.7 2.6 0.0 2.0 0.6 7.0 8.5 3.5 2.1 2.0 22.3 2.9 4.3 4.6 0.4 9.8 2.0 16.9 2.8 2.7 10.8 2.1 3.5 11.7 4.4 7.4 0.0 11.4 1.0 1.2 3.0 1.3 1.8 3.6 3.9 ARMCX6 "FLJ20811, GASP10" ENSG00000198960 "Armadillo repeat containing, X-linked 6" Q7L4S7 X 101615118-101618001 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043030, HPA048125" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear membrane" "HPA043030: AB_2678277, HPA048125: AB_2680275" "unprognostic (1.20e-1)" "unprognostic (2.80e-1)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.80e-2)" "unprognostic (1.73e-3)" "unprognostic (1.92e-3)" "unprognostic (4.13e-2)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (3.31e-1)" "unprognostic (3.74e-1)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (7.82e-3)" "unprognostic (2.38e-2)" 15.1 17.2 11.7 12.1 12.1 7.6 12.7 10.9 12.1 18.7 12.0 15.4 22.6 6.7 17.3 25.9 17.3 14.1 12.4 15.6 11.3 12.6 14.1 12.2 11.2 12.1 13.1 10.3 21.3 27.2 23.4 21.0 16.3 13.1 17.7 9.0 11.8 39.2 23.5 6.5 11.3 10.4 17.1 16.7 22.6 10.6 9.0 11.4 17.9 17.3 9.7 19.3 18.8 13.7 12.8 14.1 10.0 7.0 8.1 8.7 6.4 6.6 7.9 12.4 7.0 25.4 15.1 2.4 14.1 13.7 12.6 24.7 4.8 6.5 7.1 14.4 13.2 13.2 7.0 12.0 5.7 9.9 6.1 7.3 6.7 11.0 6.3 11.7 6.5 8.4 9.4 5.8 7.7 4.0 17.6 12.8 3.7 5.5 9.2 18.9 16.4 9.5 0.0 8.9 8.7 1.6 9.8 16.6 2.6 9.1 0.9 6.8 6.4 8.2 0.0 10.5 9.9 5.8 3.1 9.9 15.4 6.9 21.4 3.2 11.4 6.1 0.0 4.6 1.7 5.0 10.0 3.8 6.3 6.5 7.0 8.7 12.8 7.0 7.3 8.1 9.1 8.4 7.8 0.5 8.1 5.0 14.1 3.9 6.4 11.7 12.1 10.9 12.1 11.3 12.6 13.1 10.3 13.1 11.4 8.9 7.8 28.4 14.8 11.8 4.8 8.1 12.7 1.4 6.8 29.6 15.7 31.9 19.9 36.6 0.4 25.1 3.1 0.0 24.2 14.6 30.1 15.7 13.9 13.4 60.4 9.5 15.7 23.4 19.6 1.3 17.3 28.6 35.4 30.7 15.5 28.2 25.6 14.0 18.7 17.2 4.1 25.8 15.6 2.6 2.2 14.1 28.8 33.1 13.8 15.9 ARSB ENSG00000113273 "Arylsulfatase B" P15848 5 78777209-78986087 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 17.2" "Group enriched" "Detected in many" 7 "dendritic cells: 5.5;granulocytes: 17.2;monocytes: 5.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037770, HPA037771" Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA037770: AB_10671719, HPA037771: AB_10671720" "unprognostic (1.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.97e-2)" "unprognostic (1.09e-2)" "unprognostic (7.34e-2)" "unprognostic (2.65e-1)" "unprognostic (8.69e-3)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (7.20e-2)" "unprognostic (1.74e-1)" "unprognostic (3.59e-2)" "unprognostic (2.48e-2)" "unprognostic (9.57e-3)" "unprognostic (9.88e-2)" "unprognostic (6.54e-3)" "prognostic unfavorable (3.42e-4)" 15.2 8.4 7.7 9.9 8.9 9.4 11.4 6.2 10.4 7.8 8.7 10.8 2.6 4.0 14.1 6.7 8.6 6.7 12.0 13.0 7.7 5.8 23.2 9.3 10.8 17.2 7.1 6.1 6.1 9.6 10.7 6.1 14.7 7.1 7.5 10.5 12.1 5.2 9.3 5.3 3.4 6.0 18.0 8.3 10.9 7.9 4.1 5.6 7.2 6.4 4.0 6.2 10.3 5.6 1.2 5.5 17.2 5.7 0.1 0.6 1.6 2.3 5.6 9.0 2.9 22.0 8.7 8.3 13.1 11.5 9.7 12.0 4.9 4.3 2.7 14.1 12.7 14.8 1.9 3.4 3.7 9.6 23.3 2.6 4.4 5.9 18.7 5.0 4.9 5.3 10.1 1.2 10.2 3.4 8.1 11.4 1.7 0.9 6.4 9.8 4.5 2.3 9.2 2.7 0.5 2.9 3.4 5.4 2.9 6.1 3.0 3.2 7.4 9.8 3.1 5.7 6.6 3.4 12.8 7.5 8.7 5.0 3.9 11.6 5.5 9.9 3.6 10.6 10.6 19.8 10.5 5.7 17.2 0.6 4.6 0.4 1.2 0.3 0.3 5.5 1.1 0.2 0.4 3.3 0.1 3.7 4.0 0.5 1.6 7.7 8.9 6.2 10.4 7.7 5.8 7.1 6.1 7.1 5.6 0.0 1.3 3.0 1.3 0.7 3.0 5.8 2.5 4.0 0.0 3.5 5.9 1.8 3.3 3.1 0.4 4.3 0.6 0.0 7.9 4.0 9.3 1.9 0.0 3.4 15.4 6.4 1.2 13.5 23.4 0.2 4.0 12.6 13.5 15.4 5.6 3.0 4.4 3.5 3.5 17.2 2.7 6.5 3.1 1.1 1.9 1.1 2.2 2.9 1.9 0.9 ARSD ENSG00000006756 "Arylsulfatase D" P51689 X 2903970-2929351 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 98.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 16.5" "Low region specificity" "Detected in many" "HPA004694, HPA063835" Approved Approved "Vesicles,Lipid droplets" NA NA "Vesicles, Lipid droplets" "HPA004694: AB_1078221, HPA063835: AB_2685132" "unprognostic (3.92e-1)" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "prognostic favorable (5.21e-4)" "unprognostic (5.90e-3)" "unprognostic (6.32e-3)" "unprognostic (1.73e-1)" "unprognostic (1.34e-1)" "unprognostic (2.44e-1)" "unprognostic (4.09e-3)" "unprognostic (7.18e-2)" "unprognostic (3.93e-1)" "prognostic favorable (1.97e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (4.99e-2)" "unprognostic (2.11e-3)" 8.1 5.6 3.7 10.1 3.5 2.3 14.2 3.2 5.0 14.7 15.4 5.8 27.4 11.9 8.9 19.2 9.3 16.6 16.8 8.7 5.7 3.6 34.1 23.8 13.1 11.3 3.1 3.3 13.0 48.1 8.5 3.9 16.2 8.7 11.5 8.5 7.8 15.8 30.9 1.6 5.9 22.3 12.0 4.5 5.7 19.5 5.2 3.3 1.8 12.9 5.6 7.1 12.4 6.9 2.1 6.3 5.7 8.5 3.0 2.6 3.2 4.4 7.9 2.2 10.2 9.2 5.3 0.1 2.6 4.7 1.1 0.7 0.5 15.3 0.0 16.5 5.1 12.2 0.0 0.4 1.3 1.0 0.1 0.0 0.0 0.0 2.5 5.1 0.0 6.1 8.4 4.2 2.3 2.4 7.5 7.6 0.0 0.0 0.0 5.0 10.8 0.0 1.1 1.8 13.7 3.3 1.8 0.0 0.1 8.2 0.1 0.0 5.7 3.5 4.2 2.6 5.9 11.3 8.5 6.9 0.0 0.3 0.8 1.2 0.1 0.0 0.0 7.5 5.3 5.8 2.1 8.5 5.7 2.6 7.1 1.0 2.1 1.3 2.0 6.3 1.4 0.3 1.5 1.5 3.0 2.7 4.4 0.4 3.2 3.7 3.5 3.2 5.0 5.7 3.6 3.1 3.3 8.7 3.3 17.9 31.3 2.9 10.8 4.4 4.1 4.8 73.9 25.4 26.1 41.8 0.0 17.6 16.6 29.9 0.6 10.5 39.2 0.0 46.6 19.9 5.8 19.0 16.1 98.3 16.2 0.0 65.3 8.6 12.1 0.7 5.8 11.7 13.5 13.6 55.8 5.4 36.6 35.1 6.3 22.8 1.0 6.5 5.3 1.2 3.0 6.4 21.7 4.3 57.7 14.3 ARSE "CDPX, CDPX1" ENSG00000157399 "Arylsulfatase E (chondrodysplasia punctata 1)" P51690 X 2934632-2968310 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 43.0;pancreas: 99.4" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 43.3;Hepatocytes: 71.2;Proximal tubular cells: 87.6;Undifferentiated cells: 48.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 17 "myeloid DC: 1.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.6" "Cell line enhanced" "Detected in many" "A549: 32.3;CACO-2: 20.0;GAMG: 13.3;Hep G2: 30.0;NTERA-2: 15.0" "Low region specificity" "Detected in all" "HPA060518, HPA070651" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA060518: AB_2684301, HPA070651: AB_2732160" "unprognostic (2.07e-1)" "unprognostic (6.60e-3)" "prognostic favorable (8.95e-4)" "unprognostic (8.74e-3)" "unprognostic (1.14e-3)" "unprognostic (3.48e-2)" "unprognostic (2.38e-1)" "unprognostic (8.27e-2)" "unprognostic (5.45e-2)" "unprognostic (2.25e-1)" "unprognostic (2.27e-1)" "unprognostic (2.37e-1)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (1.28e-1)" "unprognostic (5.94e-2)" "unprognostic (4.76e-2)" 0.2 0.1 0.9 2.4 1.1 0.0 0.4 0.3 0.7 0.8 7.9 0.7 1.3 6.5 1.1 2.3 0.3 1.3 8.4 0.4 0.9 0.8 16.6 43.0 0.8 0.2 0.6 1.0 2.5 99.4 0.0 0.4 0.7 0.7 0.4 6.4 0.6 0.2 0.9 0.2 0.1 7.8 0.5 0.6 0.2 1.2 0.7 0.6 0.2 0.2 0.3 0.2 0.2 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.0 32.3 3.0 0.0 0.9 1.7 0.5 1.3 2.8 1.4 1.7 20.0 0.0 0.0 6.1 0.0 13.3 0.0 0.0 0.2 0.8 0.0 2.1 0.0 0.0 30.0 0.8 0.0 0.0 3.2 0.0 1.1 0.0 2.6 1.3 0.0 0.0 0.0 4.0 0.0 0.0 0.0 15.0 1.1 0.0 0.9 0.4 0.1 3.5 0.0 0.0 0.1 0.0 0.0 0.9 6.6 0.0 0.0 1.9 0.0 0.0 0.0 2.6 0.0 0.0 0.0 3.3 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.3 0.7 0.9 0.8 0.6 1.0 0.7 0.6 0.0 4.1 0.9 0.2 0.1 0.0 0.1 43.3 2.7 0.0 7.0 0.0 0.2 14.9 15.6 0.0 0.3 24.1 23.3 15.0 0.1 0.8 0.1 0.0 71.2 0.2 0.0 19.5 1.3 2.1 0.0 0.3 0.0 3.3 2.8 16.0 0.1 17.1 31.6 3.2 87.6 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 48.8 0.0 ARSF ENSG00000062096 "Arylsulfatase F" P54793 X 3041471-3112726 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3;kidney: 11.5;skin 1: 8.3" "Cell type enhanced" "Detected in some" 31 "Distal tubular cells: 1.7;Proximal tubular cells: 4.6" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.0;U-266/70: 1.1" HPA000549 Uncertain Cytosol "Secreted in other tissues" NA NA Cytosol "HPA000549: AB_1845055" "unprognostic (2.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.87e-1)" "unprognostic (5.41e-3)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (9.72e-2)" "unprognostic (4.70e-1)" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (3.59e-1)" "unprognostic (1.23e-1)" "unprognostic (9.76e-2)" "unprognostic (1.48e-1)" 0.0 4.6 2.7 0.0 5.3 0.0 0.1 0.0 1.9 0.4 0.0 0.0 0.0 2.5 3.1 0.0 0.0 0.0 1.3 0.5 11.5 1.7 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.6 1.5 0.3 0.2 1.9 0.3 0.8 0.3 0.0 0.2 0.4 0.5 0.7 0.0 0.2 2.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.2 0.3 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.3 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.1 0.5 0.1 0.1 1.1 0.1 0.1 0.8 0.4 0.3 1.9 0.3 0.4 0.2 0.3 0.3 0.1 0.3 0.2 0.0 0.3 0.3 0.3 1.2 0.8 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 ARSH ENSG00000205667 "Arylsulfatase family member H" Q5FYA8 X 3006613-3033571 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 3.1;epididymis: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.0;hTERT-RPE1: 1.2;OE19: 1.7;RT4: 1.2;SK-BR-3: 1.2" NA NA "unprognostic (3.43e-1)" "unprognostic (1.95e-1)" "unprognostic (2.01e-2)" "unprognostic (8.90e-2)" "unprognostic (6.79e-2)" "unprognostic (2.56e-2)" "unprognostic (1.83e-1)" "unprognostic (8.56e-4)" "unprognostic (3.48e-2)" "unprognostic (2.39e-1)" "unprognostic (1.63e-1)" "unprognostic (2.65e-2)" "unprognostic (6.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.2 0.0 0.0 0.0 3.7 1.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.9 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARSK "DKFZp313G1735, TSULF" ENSG00000164291 "Arylsulfatase family member K" Q6UWY0 5 95555074-95605064 "Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042384 Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Vesicles Nucleoplasm "HPA042384: AB_10795703" "unprognostic (9.50e-2)" "unprognostic (1.37e-1)" "unprognostic (2.03e-3)" "unprognostic (2.39e-1)" "unprognostic (3.33e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.59e-4)" "unprognostic (3.39e-1)" "unprognostic (1.37e-1)" "unprognostic (5.19e-2)" "unprognostic (7.61e-2)" "unprognostic (2.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.91e-2)" "unprognostic (2.32e-1)" "unprognostic (8.20e-2)" "unprognostic (1.06e-2)" 8.5 10.2 6.9 4.8 7.6 4.7 7.6 14.2 12.3 8.9 8.6 4.3 9.6 5.1 8.5 9.6 6.7 7.4 6.9 8.5 7.9 7.1 11.5 9.7 7.4 5.6 8.4 9.9 12.8 11.7 29.3 14.5 11.2 7.2 10.7 5.9 7.3 6.7 11.2 5.5 8.4 5.4 6.7 8.8 5.5 9.7 4.5 7.5 10.6 15.8 2.8 4.5 9.2 14.0 6.7 2.7 10.0 1.6 3.9 9.2 2.3 3.4 2.2 4.6 4.6 23.2 12.1 6.7 10.9 6.3 4.3 8.8 2.8 5.4 4.7 5.7 3.7 7.7 3.3 4.0 6.9 9.4 5.0 5.9 3.7 5.5 4.5 6.8 2.0 3.0 8.9 6.2 6.5 4.2 9.0 6.9 6.4 3.7 5.1 9.4 1.6 5.6 3.9 6.0 1.1 10.5 3.5 7.4 7.4 9.8 0.8 3.3 3.3 6.7 2.2 6.5 6.7 6.2 2.2 12.4 6.8 5.5 10.5 6.6 4.4 7.4 5.6 6.8 5.5 25.2 10.0 1.6 2.5 5.3 1.5 6.1 5.3 6.0 6.7 0.8 6.7 9.2 6.9 1.5 3.9 1.0 2.7 4.5 2.3 6.9 7.6 14.2 12.3 7.9 7.1 8.4 9.9 7.2 7.5 3.0 2.1 2.7 7.4 3.9 8.1 3.9 2.5 5.3 2.3 7.0 11.8 9.0 3.3 3.0 6.3 5.4 2.5 0.0 2.2 43.9 10.4 4.5 23.0 12.1 3.9 9.5 2.9 3.7 3.1 1.8 10.0 5.2 5.0 6.4 1.8 13.2 1.9 3.5 11.0 4.5 9.1 0.0 8.3 2.2 7.9 6.0 4.2 9.6 3.0 1.6 ART3 ENSG00000156219 "ADP-ribosyltransferase 3" Q13508 4 76011184-76112802 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "brain: 29.1;heart muscle: 55.1;skeletal muscle: 85.2;testis: 42.6;tongue: 27.2" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 65.9;Spermatocytes: 192.9" "Cancer enhanced" "Detected in some" "breast cancer: 2.3" "Region enhanced" "Detected in many" "cerebellum: 29.1" "Cell type enriched" "Detected in single" 5 "gdT-cell: 1.9" "Lineage enriched" "Detected in single" 18 "T-cells: 1.9" "Group enriched" "Detected in some" 8 "NB-4: 6.2;NTERA-2: 16.9;SK-MEL-30: 7.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA011268 Enhanced "Intracellular and membrane" NA NA 45000000 "HPA011268: AB_1845059" "unprognostic (2.45e-1)" "unprognostic (2.84e-2)" "unprognostic (3.12e-2)" "unprognostic (2.77e-3)" "unprognostic (4.53e-2)" "unprognostic (1.34e-1)" "unprognostic (3.34e-1)" "unprognostic (9.85e-4)" "unprognostic (2.35e-1)" "unprognostic (5.10e-2)" "unprognostic (1.64e-2)" "unprognostic (2.95e-1)" "unprognostic (1.73e-2)" "unprognostic (2.53e-1)" "unprognostic (1.48e-1)" "unprognostic (2.58e-2)" "unprognostic (6.61e-3)" 3.5 0.6 4.9 0.9 1.9 0.4 0.7 29.1 9.0 1.0 1.3 6.0 0.0 0.6 0.5 1.1 2.5 0.5 0.5 55.1 3.0 0.9 0.5 0.5 0.6 0.5 3.9 2.0 0.5 3.8 0.4 1.1 0.5 2.7 1.0 1.4 0.4 1.3 1.0 85.2 0.5 0.8 0.6 3.0 1.5 0.9 42.6 7.2 0.0 0.5 27.2 0.5 0.6 0.7 0.0 0.0 0.1 0.0 0.0 1.9 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.2 16.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.9 1.9 29.1 9.0 3.0 0.9 3.9 2.0 2.7 7.2 0.0 0.0 0.0 0.4 0.5 0.4 65.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.4 0.0 0.0 0.0 0.1 0.4 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.0 1.7 0.0 1.7 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.3 0.0 3.1 192.9 19.4 0.3 0.0 0.0 0.0 0.4 ART4 "CD297, DO, DOK1" ENSG00000111339 "ADP-ribosyltransferase 4 (Dombrock blood group)" Q93070 12 14825569-14843533 "Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8" "Cell type enhanced" "Detected in many" 20 "Erythroid cells: 93.5;Hepatocytes: 21.3;Ito cells: 55.3" "Cancer enhanced" "Detected in some" "liver cancer: 3.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 5.2;HEL: 10.3;Hep G2: 6.1;HUVEC TERT2: 23.4" "Region enhanced" "Detected in single" "olfactory region: 2.2" "Low region specificity" "Detected in single" HPA075664 Approved "Rods & Rings" "Secreted to blood" NA NA 11000000 "Rods & Rings" "HPA075664: " "unprognostic (2.50e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-1)" "unprognostic (1.18e-2)" "unprognostic (1.55e-1)" "unprognostic (1.37e-2)" "unprognostic (1.92e-1)" "unprognostic (1.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.64e-1)" "unprognostic (1.37e-1)" "unprognostic (1.90e-2)" "unprognostic (2.62e-3)" "unprognostic (4.33e-3)" "unprognostic (1.25e-3)" "unprognostic (1.05e-1)" "unprognostic (1.71e-1)" 2.7 2.0 0.2 1.7 0.2 2.4 2.1 0.2 0.2 1.4 1.3 0.1 1.9 0.0 1.1 3.7 3.1 1.9 6.1 10.1 0.2 0.2 6.6 33.7 2.1 17.0 0.2 0.0 1.3 1.9 0.0 0.4 17.8 0.3 0.8 0.2 0.0 0.7 0.4 1.9 0.5 0.8 1.5 0.2 17.8 0.5 1.4 0.0 0.1 4.6 1.3 1.3 1.3 1.2 0.6 0.6 1.4 0.4 0.6 1.3 0.3 0.0 0.0 0.2 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 6.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.4 0.5 0.3 0.4 0.5 0.3 0.3 0.2 0.6 0.5 1.3 1.4 0.6 0.2 0.6 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.6 0.0 0.8 0.2 1.8 1.4 12.7 0.0 0.0 1.8 11.8 0.1 0.0 0.7 0.4 2.8 0.0 93.5 1.8 1.4 1.9 0.1 0.0 21.3 0.1 0.0 0.0 55.3 7.5 0.0 1.7 0.6 1.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 12.6 6.5 0.8 0.0 0.0 0.1 0.2 0.0 0.0 0.3 ARV1 ENSG00000173409 "ARV1 homolog, fatty acid homeostasis modulator" Q9H2C2 1 230978981-231000595 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 92.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035709 Approved Uncertain Vesicles NA NA Vesicles "HPA035709: AB_2674744" "unprognostic (2.32e-1)" "unprognostic (4.69e-2)" "prognostic favorable (1.33e-4)" "unprognostic (3.29e-1)" "unprognostic (1.42e-1)" "unprognostic (9.95e-2)" "unprognostic (5.66e-2)" "prognostic favorable (3.27e-5)" "unprognostic (1.37e-1)" "unprognostic (1.12e-2)" "unprognostic (9.57e-2)" "unprognostic (9.82e-2)" "unprognostic (2.31e-1)" "unprognostic (4.82e-1)" "unprognostic (5.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.12e-3)" 8.2 16.3 22.0 10.1 31.0 10.0 16.1 17.1 24.3 11.0 20.0 16.5 13.9 13.8 8.1 20.6 13.6 12.3 17.0 24.2 23.8 21.8 21.0 20.9 12.5 11.0 22.7 17.7 9.8 14.9 18.4 25.8 9.4 22.0 14.0 21.6 15.4 16.9 13.4 15.7 14.6 15.6 10.7 27.1 10.5 13.7 24.6 18.2 11.0 18.4 16.8 11.9 12.7 9.3 15.3 13.9 7.3 17.7 12.5 14.0 8.3 20.0 21.8 10.9 13.0 15.9 13.9 10.2 9.4 17.5 17.4 20.1 8.0 15.7 5.8 11.8 10.9 10.7 16.5 20.5 12.8 20.7 14.7 28.8 17.9 15.8 10.8 16.2 26.3 14.6 15.0 13.5 9.4 10.9 11.3 11.6 18.0 26.3 15.9 11.4 7.0 10.7 8.0 14.0 21.2 14.8 12.7 16.2 16.4 23.2 16.5 11.4 17.3 11.3 13.4 27.8 2.7 24.0 23.5 6.4 6.9 4.4 12.6 22.6 24.6 21.6 14.4 18.9 23.0 18.8 6.4 7.6 7.3 9.8 10.8 13.3 15.3 11.0 11.7 9.1 10.1 13.8 12.7 1.9 12.5 17.7 13.9 14.0 8.3 22.0 31.0 17.1 24.3 23.8 21.8 22.7 17.7 22.0 18.2 14.9 24.8 20.9 19.1 11.4 19.4 26.9 7.6 17.4 18.2 27.9 2.0 32.5 51.4 20.9 26.0 11.9 11.7 46.7 35.3 12.7 17.5 14.6 16.2 17.9 21.8 36.5 7.5 12.3 11.5 14.7 8.6 14.3 23.6 9.0 15.0 28.4 17.4 10.5 15.6 24.2 13.2 0.0 14.4 92.9 16.8 13.2 13.0 7.9 27.4 16.2 ASAH2 ENSG00000188611 "N-acylsphingosine amidohydrolase 2" Q9NR71 10 50182778-50248610 "Enzymes, Predicted intracellular proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "intestine: 43.9" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 6.0;Muller glia cells: 10.2;Sertoli cells: 6.5" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" HPA061171 Supported Approved "Focal adhesion sites" "Intracellular and membrane" NA NA 1200000 "Focal adhesion sites" "HPA061171: AB_2684442" "unprognostic (3.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.66e-1)" "unprognostic (3.84e-2)" "unprognostic (3.66e-1)" "unprognostic (4.48e-2)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-2)" "unprognostic (4.33e-2)" "unprognostic (2.17e-1)" "unprognostic (1.14e-1)" "unprognostic (8.29e-2)" "unprognostic (1.86e-2)" "unprognostic (5.64e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" 0.3 1.1 0.6 0.2 0.9 0.0 0.5 0.5 1.3 1.7 0.5 43.9 0.7 0.3 0.7 0.5 0.2 0.9 0.5 1.4 0.6 1.6 0.4 0.2 1.2 1.4 1.5 0.3 1.0 0.4 0.5 0.3 0.9 0.2 0.8 0.7 33.4 0.7 0.6 0.2 2.5 1.1 0.6 0.1 1.0 0.5 0.9 0.9 0.0 0.0 0.0 2.2 0.1 1.8 1.4 1.6 2.2 2.9 1.1 2.0 2.0 1.3 3.8 3.5 1.0 4.6 0.0 2.2 2.7 3.1 1.7 2.1 0.7 4.7 2.3 3.8 1.3 3.8 2.9 1.8 0.4 0.2 0.4 2.6 6.6 7.5 0.5 0.8 0.0 2.5 1.2 2.5 1.5 1.4 0.1 4.8 0.0 4.1 0.0 6.4 1.6 2.1 0.3 2.7 7.3 2.5 1.8 3.3 3.9 1.5 1.0 2.0 1.9 4.4 4.7 6.1 1.9 0.2 0.0 5.5 0.0 1.7 0.0 0.0 0.0 0.7 0.0 2.2 0.9 0.4 1.7 0.0 0.1 1.4 2.1 0.0 0.0 0.0 0.9 0.6 0.1 0.0 0.0 0.0 0.2 0.3 1.8 3.0 0.0 0.0 1.2 0.0 2.0 0.3 0.0 1.1 4.1 0.1 1.3 0.0 1.3 0.2 0.4 0.2 0.0 1.8 0.2 1.6 0.0 0.6 0.0 6.0 1.1 0.0 0.0 0.0 1.2 10.2 1.4 0.0 1.4 0.6 1.8 6.5 0.9 0.9 0.8 0.1 0.2 0.0 0.6 0.1 ASB11 DKFZp779E2460 ENSG00000165192 "Ankyrin repeat and SOCS box containing 11" Q8WXH4 X 15281697-15315656 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "heart muscle: 51.8;skeletal muscle: 50.7;tongue: 29.8" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 7.7;Melanocytes: 6.8" "Cancer enriched" "Detected in single" 20 "melanoma: 2.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 2.2;basal ganglia: 7.7;cerebral cortex: 5.7;hippocampal formation: 2.9;olfactory region: 5.0" "Not detected" "Not detected" NA NA "unprognostic (5.89e-3)" "unprognostic (1.04e-1)" "unprognostic (9.26e-2)" "unprognostic (3.69e-1)" "unprognostic (4.42e-2)" "unprognostic (5.54e-2)" "unprognostic (2.04e-2)" "unprognostic (2.36e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (6.21e-2)" 2.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 1.2 1.3 0.1 0.0 51.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 5.0 2.2 0.0 50.7 0.5 0.1 0.0 0.1 0.1 2.8 0.1 0.0 0.0 0.3 29.8 2.3 0.1 0.1 0.6 0.6 0.8 0.3 1.4 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.2 0.4 0.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.5 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.4 0.4 0.3 0.1 0.3 0.1 0.2 0.3 0.2 0.2 0.1 0.6 0.3 0.3 0.8 1.4 0.1 0.6 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 7.7 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.3 0.3 6.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.3 ASB18 ENSG00000182177 "Ankyrin repeat and SOCS box containing 18" Q6ZVZ8 2 236194872-236264409 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "heart muscle: 9.8;skeletal muscle: 14.3" "Cell type enriched" "Detected in single" 21 "Cardiomyocytes: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.9;CACO-2: 1.7;HEK 293: 2.4;K-562: 2.8;MCF7: 3.1;PC-3: 1.4;RH-30: 2.5;SiHa: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.12e-1)" "unprognostic (7.33e-3)" "unprognostic (3.07e-1)" "unprognostic (1.78e-6)" "unprognostic (4.75e-2)" "unprognostic (3.22e-1)" 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.3 0.0 0.0 1.9 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.4 0.0 2.5 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.1 0.0 1.4 0.6 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ASB5 ENSG00000164122 "Ankyrin repeat and SOCS box containing 5" Q8WWX0 4 176213673-176277571 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 133.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 229.8" "Cancer enhanced" "Detected in some" "prostate cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "LHCN-M2: 165.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028870 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA028870: AB_10611679" "unprognostic (1.76e-1)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.90e-1)" "unprognostic (7.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" "unprognostic (6.80e-3)" 2.3 0.0 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.3 3.5 0.0 0.0 0.1 0.2 6.3 7.9 0.0 0.4 1.3 0.2 0.2 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.6 1.3 0.0 8.0 0.1 133.4 0.0 0.5 23.5 1.0 0.0 2.0 2.2 0.0 0.0 2.3 31.4 2.2 15.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 3.6 7.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 165.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 229.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 ASGR1 CLEC4H1 ENSG00000141505 "Asialoglycoprotein receptor 1" P07306 17 7173431-7179564 "Predicted intracellular proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 171.0" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 1020.7" "Cancer enriched" "Detected in many" 90 "liver cancer: 131.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7" "Group enriched" "Detected in many" 13 "dendritic cells: 13.7;monocytes: 39.1" "Cell line enriched" "Detected in some" 30 "Hep G2: 104.5" "Region enriched" "Detected in many" 9 "cerebellum: 49.4" "Not detected" "Not detected" "HPA011954, HPA012852" Enhanced Supported "Vesicles,Cell Junctions" "Intracellular and membrane" NA NA Vesicles "Cell Junctions" "HPA011954: AB_1845079, HPA012852: AB_1845080" "unprognostic (3.56e-3)" "unprognostic (3.57e-1)" "unprognostic (8.76e-2)" "unprognostic (4.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-2)" "unprognostic (5.37e-2)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (8.55e-5)" "unprognostic (1.55e-1)" "unprognostic (8.33e-11)" "unprognostic (1.45e-1)" "unprognostic (2.00e-1)" "unprognostic (1.73e-3)" "unprognostic (4.46e-3)" 0.2 0.1 0.8 0.9 0.6 0.6 0.2 2.8 1.8 0.1 0.2 0.2 0.2 0.5 0.2 0.1 0.1 0.1 0.7 0.1 0.8 0.8 0.1 171.0 0.7 0.3 0.4 1.2 0.1 0.3 0.9 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.3 0.7 0.3 0.3 0.3 0.5 0.2 2.9 0.2 0.1 1.4 0.1 0.1 0.3 0.1 0.2 13.7 2.1 39.1 0.1 0.3 10.1 0.0 0.1 2.0 0.9 0.0 0.0 0.1 0.1 0.2 0.2 0.3 3.5 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.3 104.5 0.0 0.1 0.4 0.2 0.0 0.1 0.0 0.1 1.8 1.6 0.2 0.1 0.1 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.1 0.8 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 2.1 39.1 0.1 0.1 17.9 0.3 0.1 0.0 0.0 13.7 0.2 0.1 0.1 1.1 0.1 4.5 0.6 0.1 10.1 0.8 0.6 2.8 1.8 0.8 0.8 0.4 1.2 0.7 0.2 0.0 6.6 13.0 1.0 2.9 31.7 1.2 73.9 1.4 2.3 3.5 151.2 3.2 3.3 0.8 212.5 12.7 0.3 23.3 0.2 3.6 2.0 0.8 0.0 1020.7 41.3 14.3 15.0 23.9 110.6 80.2 2.3 18.3 0.0 0.0 0.7 2.6 0.4 0.6 1.1 1.6 39.8 0.0 0.4 4.5 7.8 4.3 10.4 0.7 1.0 2.4 ASGR2 CLEC4H2 ENSG00000161944 "Asialoglycoprotein receptor 2" P07307 17 7101322-7115700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 154.1" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 660.0" "Cancer enriched" "Detected in many" 66 "liver cancer: 214.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 36.9;myeloid DC: 21.7" "Group enriched" "Detected in many" 52 "dendritic cells: 21.7;monocytes: 36.9" "Cell line enriched" "Detected in some" 8 "Hep G2: 107.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014899, HPA015998" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" NA NA 4700000 "Endoplasmic reticulum, Plasma membrane" "HPA014899: AB_1845085, HPA015998: AB_1845084" "unprognostic (6.76e-2)" "unprognostic (7.45e-7)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (4.99e-2)" "unprognostic (1.16e-3)" "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (9.74e-2)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (9.35e-4)" "unprognostic (1.54e-3)" "unprognostic (6.95e-2)" "unprognostic (1.86e-1)" "unprognostic (7.31e-2)" 0.2 0.0 0.3 1.4 0.1 1.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.1 3.4 0.2 0.2 0.0 0.2 154.1 0.5 4.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.9 0.1 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 21.7 0.5 36.9 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 36.9 0.2 0.0 3.8 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 9.5 0.3 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.0 9.0 14.0 0.0 0.0 0.0 0.0 152.8 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.3 0.0 0.0 23.3 0.0 0.1 0.0 0.1 2.3 660.0 6.9 0.0 6.8 16.0 35.5 0.4 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.5 0.0 0.0 ASIC5 "ACCN5, HINAC, INAC" ENSG00000256394 "Acid sensing ion channel subunit family member 5" Q9NY37 4 155829729-155866273 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "intestine: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014903, HPA029444" Approved NA NA "HPA014903: AB_1844498, HPA029444: AB_10611671" "unprognostic (8.52e-5)" "unprognostic (2.52e-1)" "unprognostic (1.25e-1)" "unprognostic (4.05e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 7.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.3 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASPH "BAH, CASQ2BP1, HAAH, JCTN" ENSG00000198363 "Aspartate beta-hydroxylase" Q12797 8 61500556-61714640 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Dioxygenase, Oxidoreductase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 462.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 102.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055161, HPA059303" Uncertain Enhanced "Endoplasmic reticulum" NA NA 900000 "Endoplasmic reticulum" "HPA055161: AB_2682721, HPA059303: AB_2683973" "unprognostic (8.07e-2)" "prognostic unfavorable (8.07e-5)" "unprognostic (1.73e-2)" "unprognostic (4.48e-2)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.82e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (6.39e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (1.75e-4)" "unprognostic (9.50e-2)" "prognostic unfavorable (1.57e-5)" "unprognostic (8.96e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (2.74e-2)" 104.6 60.4 27.3 15.0 29.5 4.8 84.3 35.2 31.3 22.3 23.8 10.6 18.3 14.0 16.8 17.8 22.4 16.5 19.1 33.9 26.1 22.4 19.0 23.0 22.5 10.9 21.1 22.2 20.5 13.8 12.5 15.7 14.7 20.5 17.3 26.8 23.6 28.8 23.4 103.1 12.0 13.9 26.1 16.7 12.8 30.5 6.4 19.6 2.9 31.7 36.0 13.7 30.0 25.4 3.3 21.0 15.9 5.2 4.9 3.4 2.3 49.9 72.6 10.2 6.2 45.7 43.5 3.5 89.7 83.3 38.4 40.3 12.4 66.6 3.8 6.2 52.5 30.9 18.7 6.3 31.3 65.7 1.4 6.4 8.9 44.1 33.9 29.3 1.3 1.4 35.7 7.0 21.3 27.3 75.4 16.2 2.0 2.4 3.6 33.8 10.6 0.3 1.8 5.8 48.4 42.8 2.4 11.0 0.8 23.4 41.4 10.6 3.6 27.8 13.1 11.1 5.8 5.3 2.4 50.8 38.9 20.0 35.5 31.6 2.3 2.9 0.1 102.4 0.8 26.0 1.1 5.2 0.1 1.6 1.9 3.1 3.3 2.3 1.6 6.1 3.3 3.4 1.6 15.9 4.9 1.0 21.0 2.3 2.3 27.3 29.5 35.2 31.3 26.1 22.4 21.1 22.2 20.5 19.6 181.7 183.4 8.3 108.3 41.8 126.7 192.2 22.9 57.6 137.6 82.0 276.9 97.4 13.3 97.2 1.6 71.6 39.8 0.0 158.3 85.9 64.5 113.1 8.1 51.6 62.4 120.8 111.8 38.6 25.4 0.5 65.6 43.4 40.5 13.6 178.8 462.0 186.9 24.6 54.1 31.9 150.0 45.3 73.9 2.6 16.8 44.0 40.2 10.0 58.7 212.3 ASTL "ovastacin, SAS1B" ENSG00000188886 "Astacin like metalloendopeptidase" Q6HA08 2 96123850-96138436 "Enzymes, Predicted secreted proteins" Fertilization "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 3.0;fHDF/TERT166: 2.1;JURKAT: 2.3;RT4: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA015620 Uncertain "Secreted in female reproductive system" NA NA "HPA015620: AB_1845121" "unprognostic (3.21e-2)" "unprognostic (1.45e-2)" "unprognostic (3.87e-2)" "unprognostic (3.45e-4)" "unprognostic (1.00e-2)" "unprognostic (3.03e-2)" "unprognostic (3.53e-2)" "unprognostic (5.12e-2)" "unprognostic (3.62e-1)" "unprognostic (3.40e-1)" "unprognostic (1.95e-1)" "unprognostic (2.61e-5)" "unprognostic (3.41e-3)" "unprognostic (1.08e-1)" "unprognostic (1.67e-1)" "unprognostic (9.93e-3)" 0.2 0.1 0.2 0.6 0.4 8.5 0.1 1.3 0.8 0.0 0.5 0.1 0.3 0.4 0.5 0.0 0.4 0.0 0.8 0.0 0.1 0.0 0.5 1.1 0.0 0.2 0.0 0.0 0.8 0.0 0.9 0.2 0.6 2.7 0.0 2.3 1.1 0.0 0.0 2.3 0.2 0.7 0.0 0.7 3.2 0.0 0.3 0.0 0.0 0.0 1.9 1.8 0.3 0.0 0.0 0.0 0.1 0.0 0.4 3.0 0.0 0.0 0.0 0.1 1.2 0.1 0.1 1.2 2.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.8 0.0 0.5 1.1 0.9 0.7 0.1 0.0 0.0 0.0 0.4 0.0 3.8 0.8 0.0 0.0 0.3 0.3 0.0 1.4 0.5 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 1.2 0.3 1.8 1.8 0.0 0.0 0.3 0.6 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASTN1 ASTN ENSG00000152092 "Astrotactin 1" O14525 1 176857302-177164973 "Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 19.9;brain: 52.5" "Cell type enhanced" "Detected in some" 20 "Horizontal cells: 22.3;Late spermatids: 9.9;Rod photoreceptor cells: 8.8" "Cancer enriched" "Detected in some" 14 "glioma: 15.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.0;NTERA-2: 4.6;SCLC-21H: 2.8;U-2 OS: 3.7;U-266/84: 20.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074112 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA074112: AB_2686662" "unprognostic (4.41e-3)" "unprognostic (1.48e-2)" "unprognostic (4.03e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "unprognostic (7.61e-2)" "unprognostic (2.03e-4)" "unprognostic (3.86e-3)" "unprognostic (1.08e-1)" "unprognostic (4.36e-1)" "unprognostic (1.67e-3)" "unprognostic (1.98e-1)" "unprognostic (6.77e-2)" "unprognostic (4.74e-3)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (1.16e-1)" 1.4 19.9 21.5 1.6 23.8 1.1 1.7 15.0 52.5 1.3 1.5 7.4 1.9 1.5 2.3 5.4 1.2 3.2 1.9 1.7 17.4 13.7 1.3 1.4 1.4 1.2 8.5 18.8 8.9 1.7 1.2 8.2 1.6 9.8 2.4 1.6 2.2 2.0 3.3 1.3 1.1 1.5 2.2 5.8 3.6 1.2 1.9 7.2 0.0 1.2 0.0 1.5 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 23.8 15.0 27.2 17.4 13.7 8.5 18.8 9.8 7.2 0.0 0.0 0.0 0.0 0.1 4.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 22.3 0.0 1.8 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 8.8 0.0 0.1 4.2 0.2 0.0 0.1 0.0 0.0 0.0 ASTN2 KIAA0634 ENSG00000148219 "Astrotactin 2" O75129 9 116425225-117415070 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Early spermatids: 119.3;Late spermatids: 157.4" "Cancer enhanced" "Detected in all" "prostate cancer: 15.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027035 Uncertain Approved Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA027035: AB_1845122" "unprognostic (3.25e-2)" "unprognostic (2.70e-2)" "unprognostic (7.41e-3)" "unprognostic (5.42e-3)" "unprognostic (1.89e-1)" "unprognostic (2.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.80e-1)" "unprognostic (3.40e-2)" "unprognostic (2.93e-1)" "prognostic favorable (6.66e-16)" "unprognostic (3.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.57e-1)" 4.1 11.9 13.0 3.3 14.9 4.4 5.3 17.2 25.5 5.6 4.6 20.0 5.5 4.6 3.8 5.3 3.2 9.6 3.4 18.6 13.5 16.3 5.5 5.2 3.0 3.0 15.4 19.4 4.0 7.4 5.6 10.7 2.6 16.1 29.2 4.2 6.7 6.1 13.6 7.7 3.5 5.2 3.6 11.3 3.1 4.1 16.7 16.9 1.9 2.4 0.9 2.4 3.6 3.0 2.3 1.3 2.5 0.7 7.8 10.3 1.3 2.5 7.8 3.1 4.7 5.2 4.8 10.4 3.8 1.5 1.7 1.9 5.4 3.0 5.8 4.5 2.5 6.3 0.9 7.6 0.4 2.1 3.1 2.0 2.2 3.7 11.1 2.0 1.4 4.2 6.5 0.7 5.2 0.4 3.7 1.2 6.9 2.7 4.3 5.2 2.6 2.7 1.1 9.1 6.9 4.7 3.3 18.4 1.7 5.3 8.3 4.3 24.9 4.6 1.5 3.2 10.5 10.4 0.9 2.4 4.0 6.5 3.9 3.3 6.3 3.6 5.5 7.1 1.4 16.9 2.5 0.6 0.6 3.9 0.4 4.8 2.0 4.2 3.2 0.3 2.3 4.0 3.3 2.4 7.8 0.7 1.3 10.3 1.3 13.0 14.9 17.2 23.2 13.5 16.3 15.4 19.4 16.1 16.9 6.0 6.2 0.0 3.6 1.1 2.1 19.3 2.5 17.4 7.9 1.8 9.8 0.4 3.3 0.7 119.3 0.7 0.7 0.0 1.0 0.3 3.6 12.1 5.8 1.8 2.5 9.5 12.1 0.6 0.0 157.4 2.6 0.3 0.0 0.0 0.9 3.3 0.7 2.6 5.3 5.7 4.7 0.0 3.8 5.1 13.0 0.5 0.2 2.5 1.7 2.0 ATCAY BNIP-H ENSG00000167654 "ATCAY, caytaxin" Q86WG3 19 3879864-3928079 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 70.1" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 117.5;Cone photoreceptor cells: 21.6;Horizontal cells: 44.5" "Cancer enriched" "Detected in some" 8 "glioma: 15.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 8.3;SCLC-21H: 15.4;SH-SY5Y: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017755 Enhanced NA NA "HPA017755: AB_2669655" "unprognostic (7.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.63e-2)" "unprognostic (1.91e-1)" "unprognostic (7.11e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" "unprognostic (3.05e-2)" "unprognostic (4.89e-2)" "unprognostic (9.83e-4)" "unprognostic (7.22e-2)" "unprognostic (8.78e-3)" "unprognostic (1.78e-1)" "unprognostic (1.36e-1)" "unprognostic (1.24e-2)" "unprognostic (2.67e-1)" 1.3 8.2 19.6 1.8 19.8 1.5 1.3 14.1 70.1 1.8 1.5 3.4 0.1 1.7 1.3 1.3 1.4 1.2 1.4 1.3 16.9 25.5 1.3 1.3 1.3 1.4 12.2 21.4 1.3 1.5 1.2 10.1 1.3 16.0 3.1 1.6 1.1 1.3 4.6 2.3 1.6 1.8 1.4 4.3 1.3 1.6 1.4 4.2 0.0 1.4 0.0 1.2 1.4 0.3 1.4 0.8 3.2 0.7 1.7 0.8 0.6 0.5 0.1 3.2 0.3 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.2 0.7 0.5 0.2 0.0 1.7 0.5 0.2 0.0 0.0 0.2 0.3 0.9 1.1 0.2 0.0 1.1 1.3 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.6 0.6 0.1 0.2 0.2 0.4 8.3 0.1 0.1 0.3 0.5 0.3 0.1 0.2 15.4 10.8 0.2 0.2 0.1 1.5 0.2 0.3 0.5 0.5 0.7 0.5 0.8 0.4 0.3 0.3 0.4 1.6 0.2 2.2 0.7 0.9 0.6 0.5 0.5 0.6 0.7 0.6 0.3 1.4 0.8 0.8 3.2 1.7 0.4 0.8 0.5 0.6 19.6 19.8 14.1 33.0 16.9 25.5 12.2 21.4 16.0 4.2 0.0 4.3 0.0 0.6 0.6 117.5 1.7 2.5 0.0 0.0 0.0 21.6 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.4 6.9 0.0 0.1 44.5 0.0 1.3 1.2 0.0 0.0 0.9 3.3 0.0 0.0 5.2 0.0 0.0 0.4 0.0 18.4 0.0 0.5 0.4 0.9 0.4 0.0 0.5 0.0 0.4 ATF7 ATFA ENSG00000170653 "Activating transcription factor 7" P17544 12 53507856-53626410 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003384 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA003384: AB_1078234" "unprognostic (2.20e-2)" "unprognostic (3.10e-2)" "unprognostic (2.48e-2)" "unprognostic (7.96e-2)" "unprognostic (2.54e-1)" "unprognostic (4.73e-2)" "unprognostic (1.54e-2)" "unprognostic (9.16e-3)" "unprognostic (3.59e-3)" "unprognostic (8.03e-2)" "unprognostic (1.76e-3)" "unprognostic (2.59e-1)" "unprognostic (3.28e-3)" "prognostic unfavorable (2.10e-4)" "unprognostic (2.51e-1)" "unprognostic (3.37e-1)" "unprognostic (1.17e-1)" 22.6 12.2 18.3 14.6 25.3 11.4 21.5 56.1 22.9 17.8 17.7 31.6 12.1 10.5 21.5 13.0 19.7 14.6 15.6 18.8 20.1 9.5 15.1 12.3 18.0 10.3 28.2 12.9 23.5 15.6 15.3 17.3 15.4 22.2 17.1 18.6 15.6 21.9 13.4 23.1 20.9 12.2 24.5 22.3 11.4 16.1 12.4 27.5 11.4 15.2 10.8 13.1 18.1 18.4 11.5 11.4 14.2 19.5 15.5 11.5 9.3 10.0 19.5 10.4 11.4 19.9 25.5 6.9 12.1 12.6 13.5 9.0 14.0 15.7 15.8 16.1 14.9 5.5 12.6 8.1 13.4 12.4 15.2 10.3 13.6 22.5 14.9 13.4 17.4 10.2 19.9 17.6 16.8 19.1 22.5 26.4 8.6 15.5 14.6 20.1 18.6 10.4 12.2 10.3 11.4 10.6 13.9 12.5 15.2 20.3 13.0 8.7 9.3 18.5 13.7 19.2 10.6 18.3 10.8 19.4 16.1 11.4 12.8 10.9 7.2 8.6 10.1 13.2 16.5 14.7 12.9 14.8 14.2 8.6 19.5 8.7 10.8 11.5 8.4 11.4 11.5 8.5 9.9 9.3 15.5 14.3 7.8 10.8 9.3 18.3 25.3 56.1 22.9 20.1 9.5 28.2 12.9 22.2 27.5 11.9 15.9 15.9 19.8 19.7 8.2 13.6 25.5 13.4 10.3 14.0 23.6 19.3 31.5 26.8 29.2 25.1 15.8 0.0 27.5 19.6 17.7 30.9 28.8 12.5 22.3 9.5 17.9 27.6 21.9 26.4 25.0 17.3 23.6 16.2 19.1 22.1 21.8 14.0 23.0 37.9 9.6 25.8 23.7 8.1 16.3 25.2 23.3 17.9 19.9 24.1 ATG9A "APG9L1, FLJ22169" ENSG00000198925 "Autophagy related 9A" Q7Z3C6 2 219219380-219229717 "Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 59.5;Late spermatids: 76.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA059551 Uncertain Supported Vesicles NA NA Vesicles "HPA059551: AB_2684060" "unprognostic (1.53e-2)" "unprognostic (4.03e-1)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (4.80e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (2.18e-5)" "unprognostic (8.99e-3)" "unprognostic (2.07e-1)" "unprognostic (3.55e-3)" "unprognostic (4.67e-2)" "unprognostic (4.21e-1)" "unprognostic (2.23e-2)" "unprognostic (4.84e-2)" "unprognostic (3.15e-1)" "unprognostic (5.61e-2)" "unprognostic (1.95e-2)" 13.9 14.3 15.2 9.0 26.1 23.3 13.2 26.7 37.9 12.2 15.0 23.8 10.0 17.1 14.9 9.4 17.6 10.4 13.3 23.4 14.2 13.2 12.6 21.0 13.6 10.2 18.5 14.0 12.9 16.7 27.0 10.8 20.3 20.6 12.8 14.3 12.5 14.0 14.9 61.3 17.5 19.8 18.0 14.3 13.0 13.0 47.0 16.3 7.8 13.1 16.6 12.6 14.7 12.3 5.0 6.6 8.8 16.8 8.4 7.6 8.5 9.6 12.7 9.9 22.9 20.5 21.6 12.8 18.0 21.3 25.3 23.1 19.2 13.5 2.4 14.5 29.5 20.3 21.5 16.2 20.7 19.3 7.8 24.6 19.4 32.8 22.0 20.4 5.2 14.9 21.6 34.4 26.3 24.7 23.1 25.9 6.3 26.4 9.9 17.5 12.6 4.2 10.8 6.9 9.6 10.1 5.7 13.2 9.8 14.8 14.3 15.3 8.9 18.2 16.9 15.9 21.1 6.2 12.5 17.5 25.2 11.7 10.2 16.2 5.3 5.0 4.0 20.5 12.1 13.6 4.8 9.4 4.3 6.2 14.4 6.6 5.0 4.9 7.6 6.6 3.4 4.7 5.5 8.8 8.4 16.8 2.9 5.6 8.5 15.2 26.1 26.7 37.9 14.2 13.2 18.5 14.0 20.6 16.3 0.0 5.0 9.9 6.8 6.9 16.0 30.7 20.4 1.4 3.4 0.0 13.7 21.5 0.0 0.1 59.5 11.7 32.9 23.3 0.4 19.3 9.8 12.3 10.3 30.8 9.9 20.6 13.3 16.0 11.2 76.7 13.0 2.2 10.1 0.0 15.5 20.3 0.2 23.0 8.1 0.1 13.0 12.9 6.6 21.6 12.5 9.7 29.1 10.2 15.3 5.9 ATG9B "APG9L2, FLJ14885, NOS3AS, SONE" ENSG00000181652 "Autophagy related 9B" Q674R7 7 151012209-151024499 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 67.1" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 27.7;Late spermatids: 21.7;Syncytiotrophoblasts: 96.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 6.0;naive CD4 T-cell: 11.0;naive CD8 T-cell: 4.1;T-reg: 5.9" "Lineage enriched" "Detected in many" 7 "T-cells: 11.0" "Group enriched" "Detected in some" 5 "BEWO: 17.0;CAPAN-2: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.59e-1)" "unprognostic (2.18e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (1.53e-3)" "unprognostic (1.05e-3)" "unprognostic (2.79e-3)" "unprognostic (6.66e-2)" "unprognostic (2.38e-3)" "unprognostic (6.76e-2)" "unprognostic (2.02e-1)" "unprognostic (5.06e-2)" "unprognostic (2.08e-6)" "unprognostic (2.82e-2)" "unprognostic (2.70e-2)" "unprognostic (6.34e-2)" "unprognostic (2.63e-1)" 0.0 0.5 0.0 0.2 8.8 0.1 0.1 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.5 1.2 15.4 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 6.1 67.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 8.8 10.5 0.0 0.1 1.6 0.8 0.2 0.1 0.4 11.0 1.9 0.7 0.0 0.9 0.2 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.1 5.5 0.4 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.7 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 2.0 0.5 0.7 0.0 1.5 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.2 1.3 0.0 1.2 1.1 6.0 1.6 0.0 1.6 11.0 4.1 0.0 0.4 0.1 0.8 5.9 1.9 0.0 0.0 3.2 0.2 0.0 1.7 1.1 0.0 16.0 0.0 0.0 0.0 6.6 0.0 0.3 27.7 1.0 0.0 0.0 0.2 2.3 0.0 0.3 14.9 0.0 1.7 0.0 0.0 3.7 0.0 21.7 0.6 0.2 0.0 0.0 0.0 0.5 2.4 0.0 0.7 0.0 0.4 0.0 0.2 16.9 10.4 0.3 96.6 2.2 0.0 1.1 ATL1 "AD-FSP, FSP1, SPG3, SPG3A" ENSG00000198513 "Atlastin GTPase 1" Q8WXF7 14 50532509-50633068 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 16.0" "Group enriched" "Detected in many" 5 "granulocytes: 16.0;T-cells: 4.3" "Cell line enhanced" "Detected in many" "HDLM-2: 15.0;SCLC-21H: 13.8;SH-SY5Y: 12.6;SiHa: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027550 Enhanced NA NA 9500 "HPA027550: AB_10600983" "unprognostic (2.06e-2)" "unprognostic (7.57e-3)" "unprognostic (1.82e-1)" "unprognostic (7.93e-2)" "unprognostic (2.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.29e-1)" "unprognostic (1.88e-1)" "unprognostic (7.31e-2)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (6.50e-2)" "unprognostic (1.22e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-1)" "unprognostic (4.95e-2)" "unprognostic (1.23e-2)" 3.4 5.7 19.0 3.6 26.8 1.1 10.1 15.9 52.7 5.7 5.4 12.5 0.4 3.6 7.7 3.3 5.3 6.1 4.8 2.0 23.7 19.6 4.0 1.0 4.3 1.9 15.6 23.9 9.7 2.9 2.5 7.7 1.2 24.2 8.0 5.4 0.9 10.6 8.4 1.2 8.8 4.6 13.4 13.9 1.5 3.2 6.6 13.8 0.0 2.7 0.6 2.1 6.3 2.7 1.7 2.0 16.0 0.6 0.3 4.3 1.3 1.1 1.2 4.1 4.2 0.4 0.0 2.5 4.5 7.1 4.6 5.9 0.0 3.0 2.8 2.0 0.1 3.9 1.2 6.4 1.1 2.0 15.0 1.6 1.4 0.8 0.4 0.2 0.2 2.7 3.0 1.6 6.7 1.4 0.2 0.5 2.8 0.0 0.8 6.8 0.4 1.1 0.8 4.0 1.0 1.3 0.7 10.2 0.4 1.1 2.0 13.8 12.6 14.8 0.9 0.4 0.4 0.1 1.7 0.8 5.0 4.0 0.0 2.2 0.7 3.0 1.2 3.1 0.2 0.3 16.0 0.2 3.9 2.7 0.0 0.4 1.7 1.0 1.9 1.1 1.1 1.5 4.3 0.5 0.3 0.6 2.0 0.2 1.3 19.0 26.8 15.9 34.6 23.7 19.6 15.6 23.9 24.2 13.8 6.0 1.6 0.8 5.9 4.5 22.4 1.0 5.1 16.0 2.3 5.2 0.0 0.3 0.0 10.4 20.4 2.8 8.4 0.0 11.7 0.9 7.1 4.3 5.8 0.0 1.7 11.1 6.9 3.1 0.0 2.6 12.4 2.2 8.5 1.8 2.1 25.7 6.8 6.5 15.9 2.9 6.5 19.4 8.1 24.5 5.3 4.8 0.1 1.3 3.3 3.5 ATL2 ARL6IP2 ENSG00000119787 "Atlastin GTPase 2" Q8NHH9 2 38294880-38377285 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029108, HPA075302" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029108: AB_10670557, HPA075302: AB_2732289" "unprognostic (5.80e-2)" "unprognostic (2.23e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (4.51e-4)" "unprognostic (3.64e-2)" "unprognostic (1.18e-1)" "unprognostic (9.10e-2)" "unprognostic (1.42e-2)" "unprognostic (9.81e-3)" "unprognostic (1.09e-2)" "unprognostic (1.27e-3)" "unprognostic (8.22e-2)" "unprognostic (6.86e-2)" "unprognostic (4.28e-2)" "unprognostic (2.09e-1)" "unprognostic (6.33e-2)" "unprognostic (1.84e-1)" 11.9 19.1 14.2 15.2 28.0 15.7 23.4 29.4 17.1 18.2 31.0 7.2 12.3 19.0 21.8 12.3 25.8 18.3 15.5 11.5 12.9 7.9 16.6 25.0 15.0 9.9 10.2 15.9 24.2 14.3 8.8 15.6 10.1 9.8 19.6 15.5 14.0 29.2 19.5 32.8 29.7 23.7 35.3 8.3 13.8 22.9 9.9 12.1 17.9 32.2 24.8 19.0 28.5 20.7 5.4 3.8 13.0 3.8 3.5 6.0 3.5 34.0 17.4 20.6 15.1 19.0 12.2 26.3 12.6 11.1 15.4 15.3 19.7 26.5 28.9 14.2 8.0 18.5 40.9 25.5 12.6 23.7 29.2 22.2 16.9 12.3 27.1 10.7 20.8 15.5 8.6 30.2 13.6 19.4 9.1 14.1 9.5 28.3 15.1 11.9 12.5 21.9 19.3 29.2 36.5 11.9 19.5 23.9 17.6 11.8 18.7 10.7 18.7 15.4 16.6 15.3 17.2 8.8 12.1 8.8 15.2 21.3 14.4 23.9 20.7 18.3 32.3 9.7 20.6 18.3 1.3 3.3 13.0 3.3 2.9 4.7 4.1 4.3 3.5 3.8 5.4 6.0 4.9 4.4 3.5 3.8 2.8 4.6 3.5 14.2 28.0 29.4 17.1 12.9 7.9 10.2 15.9 9.8 12.1 11.9 23.0 18.6 28.2 32.6 19.7 6.7 12.7 14.7 34.2 7.0 13.7 13.6 6.6 8.9 19.2 15.5 11.8 0.0 4.3 12.2 12.2 21.6 4.6 28.0 9.3 20.6 6.3 12.9 7.0 16.1 13.3 7.4 11.8 5.4 11.5 9.5 4.6 10.5 15.6 10.2 18.8 32.3 14.4 17.0 19.0 40.9 12.2 10.0 12.7 29.4 ATL3 DKFZP564J0863 ENSG00000184743 "Atlastin GTPase 3" Q6DD88 11 63624087-63671921 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 242.0;Late spermatids: 574.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065702, HPA076616" Enhanced "Endoplasmic reticulum" NA NA 1600000 "Endoplasmic reticulum" "HPA065702: AB_2685536, HPA076616: AB_2732318" "unprognostic (4.19e-2)" "unprognostic (1.10e-1)" "unprognostic (8.32e-2)" "unprognostic (1.62e-1)" "unprognostic (6.89e-2)" "unprognostic (6.95e-2)" "unprognostic (1.91e-2)" "unprognostic (6.09e-3)" "unprognostic (3.38e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (4.52e-2)" "unprognostic (1.11e-3)" "unprognostic (7.41e-2)" "unprognostic (2.88e-1)" "unprognostic (1.04e-1)" "unprognostic (7.67e-3)" 40.3 17.7 7.9 11.8 10.4 8.2 28.3 5.6 7.4 20.9 15.0 12.4 14.0 6.7 22.5 15.7 23.4 14.5 15.1 9.7 7.0 5.0 15.0 23.6 15.9 24.7 10.9 5.4 22.3 18.4 12.9 8.8 11.8 9.8 17.9 11.7 14.0 17.5 15.4 7.6 20.3 11.0 35.6 12.8 12.0 14.1 43.3 10.7 11.0 18.9 14.2 13.0 32.2 22.3 6.2 9.6 6.6 13.7 7.4 11.8 8.1 13.3 12.9 3.6 8.9 19.3 26.3 0.0 15.9 18.9 16.0 11.0 10.3 21.0 7.8 16.5 27.4 12.3 8.6 6.8 10.7 23.1 11.6 1.8 7.9 14.5 0.0 12.7 15.6 12.0 16.7 18.0 20.5 13.4 10.7 17.2 9.1 8.8 21.9 18.5 14.5 5.7 9.8 4.6 4.4 10.2 12.3 9.1 11.7 13.3 9.6 2.0 5.5 47.6 11.4 15.3 5.0 21.0 6.0 23.7 33.7 16.1 32.9 11.1 6.2 8.5 15.8 18.1 10.5 20.4 6.6 9.1 4.0 10.8 12.4 11.8 6.2 9.0 8.7 9.6 5.2 7.5 10.1 3.9 7.4 13.7 4.8 9.9 8.1 7.9 10.4 5.6 7.4 7.0 5.0 10.9 5.4 9.8 10.7 41.7 22.7 18.0 39.1 38.8 4.3 7.8 30.6 13.4 21.6 31.4 0.0 5.8 1.7 37.0 242.0 45.4 28.8 23.3 43.5 16.5 29.6 47.3 16.2 46.1 35.2 4.8 10.3 47.9 54.0 574.9 50.3 34.8 40.5 40.5 18.4 12.4 59.3 22.9 63.3 18.2 7.0 71.1 60.4 25.8 27.3 35.5 3.3 23.5 15.9 44.8 ATP10A "ATP10C, ATPVA, ATPVC, KIAA0566" ENSG00000206190 "ATPase phospholipid transporting 10A (putative)" O60312 15 25677273-25865172 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 29.8;Early spermatids: 17.6;granulocytes: 15.0;Late spermatids: 14.7;Melanocytes: 16.9;Peritubular cells: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 12 "dendritic cells: 3.0;NK-cells: 4.7;T-cells: 4.0" "Cell line enhanced" "Detected in some" "BJ: 13.0;fHDF/TERT166: 19.1;HMC-1: 12.7;RPTEC TERT1: 10.2;SK-MEL-30: 17.3" "Low region specificity" "Detected in all" "HPA041496, HPA042509" Uncertain NA NA "HPA041496: AB_2677513, HPA042509: AB_2678032" "unprognostic (3.70e-1)" "unprognostic (2.83e-2)" "unprognostic (2.30e-4)" "unprognostic (1.18e-1)" "unprognostic (9.46e-2)" "unprognostic (2.91e-2)" "unprognostic (2.67e-1)" "unprognostic (4.95e-1)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (6.60e-5)" "unprognostic (1.30e-1)" "unprognostic (1.38e-2)" "unprognostic (4.89e-2)" "unprognostic (9.42e-2)" 7.4 14.1 5.3 5.4 9.8 4.7 5.7 3.4 11.0 5.3 3.3 6.2 1.4 1.5 1.9 2.1 3.7 3.1 7.1 2.9 8.0 5.8 6.0 1.0 12.2 14.8 9.3 9.0 1.6 1.9 1.9 2.5 3.6 11.3 3.6 2.3 4.0 14.4 1.5 0.7 3.3 3.6 5.3 6.4 3.5 4.0 6.0 6.2 1.5 3.0 1.6 3.3 4.2 3.3 0.0 3.0 0.0 0.3 4.7 4.0 1.7 0.0 3.4 0.7 0.0 2.7 2.6 0.0 13.0 6.3 4.0 7.1 0.0 0.0 0.0 0.7 19.1 0.0 0.0 6.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.6 0.0 0.5 0.0 1.6 0.0 0.4 0.0 0.0 2.5 0.0 0.5 0.0 0.9 0.0 0.8 2.4 2.4 0.8 10.2 0.0 0.0 0.0 0.0 0.0 17.3 0.0 5.2 0.5 0.0 5.3 0.2 7.6 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.3 0.0 1.9 0.2 1.9 0.0 2.2 2.1 0.4 0.0 4.0 3.7 0.0 4.7 0.1 3.0 0.7 1.7 5.3 9.8 3.4 11.0 8.0 5.8 9.3 9.0 11.3 6.2 29.8 7.5 0.0 0.0 0.9 0.0 1.4 2.5 6.7 7.9 0.0 0.0 0.0 0.0 0.2 17.6 0.8 0.0 0.0 0.0 0.1 2.8 0.9 15.0 0.0 2.2 0.0 0.0 0.6 2.1 14.7 3.7 4.4 16.9 0.0 0.0 0.0 0.6 0.0 16.6 0.0 0.0 0.0 8.1 0.4 0.7 0.4 0.0 4.4 0.0 0.0 ATP10B "ATPVB, FLJ21477, KIAA0715" ENSG00000118322 "ATPase phospholipid transporting 10B (putative)" O94823 5 160563120-160852214 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;intestine: 35.4" "Cell type enhanced" "Detected in some" 11 "Enterocytes: 80.4;Mucus-secreting cells: 52.8;Paneth cells: 67.1;Undifferentiated cells: 77.9" "Group enriched" "Detected in many" 7 "colorectal cancer: 19.0;pancreatic cancer: 4.2;stomach cancer: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "WM-115: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034574 Uncertain NA NA "HPA034574: AB_10669992" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (4.47e-4)" "unprognostic (3.99e-2)" "unprognostic (6.10e-3)" "unprognostic (4.69e-2)" "unprognostic (4.86e-2)" "unprognostic (2.54e-1)" "unprognostic (1.20e-2)" "unprognostic (3.42e-2)" "unprognostic (5.12e-2)" "unprognostic (2.38e-3)" "unprognostic (5.13e-2)" "unprognostic (2.56e-1)" "unprognostic (3.38e-1)" "unprognostic (2.14e-1)" 0.5 0.4 4.3 4.1 9.4 0.4 0.7 5.1 10.0 1.7 33.8 27.8 1.5 18.9 0.4 11.4 8.2 0.7 12.8 0.5 5.5 2.8 0.5 0.4 0.5 0.4 13.8 6.8 0.4 4.2 0.4 0.4 0.4 13.1 0.5 35.4 0.0 2.8 1.0 0.4 8.4 21.1 1.6 20.2 0.4 4.1 0.7 14.0 0.0 0.5 0.0 2.5 1.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.2 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 9.4 5.1 10.0 5.5 2.8 13.8 6.8 13.1 14.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 25.5 0.0 0.0 1.8 0.0 0.0 0.0 11.1 0.1 0.0 80.4 0.0 17.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 12.7 0.0 0.0 0.0 0.0 0.0 1.7 2.8 52.8 0.0 25.1 67.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 77.9 1.0 ATP10D "ATPVD, KIAA1487" ENSG00000145246 "ATPase phospholipid transporting 10D (putative)" Q9P241 4 47485288-47593486 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 55.7" "Cell type enhanced" "Detected in many" 11 "Leydig cells: 57.5;Syncytiotrophoblasts: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "basophil: 31.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 31.5" "Cell line enhanced" "Detected in many" "HAP1: 24.4" HPA050808 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA050808: AB_2681242" "unprognostic (1.62e-1)" "unprognostic (2.97e-1)" "unprognostic (4.93e-2)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "unprognostic (4.23e-2)" "unprognostic (1.65e-2)" "unprognostic (8.05e-2)" "unprognostic (3.48e-2)" "unprognostic (3.54e-2)" "unprognostic (3.04e-1)" "unprognostic (2.43e-1)" "prognostic favorable (5.00e-8)" "unprognostic (3.97e-2)" "unprognostic (4.47e-3)" "unprognostic (1.11e-2)" "unprognostic (3.37e-2)" 8.1 9.7 7.6 6.8 8.0 1.4 6.9 3.9 7.5 10.2 7.4 5.2 10.4 4.5 12.9 10.1 15.2 6.7 8.6 7.4 7.3 4.0 14.5 5.8 9.4 6.7 7.0 4.8 10.0 6.2 16.9 18.6 55.7 8.1 8.1 4.5 7.7 7.5 11.5 2.8 14.8 6.0 11.4 8.9 12.7 7.6 3.9 7.3 3.6 10.7 5.4 9.2 9.9 13.1 3.6 1.8 31.5 2.9 1.0 0.9 0.6 1.4 1.0 2.3 1.6 6.7 7.3 0.4 10.4 12.6 5.0 9.0 5.4 9.0 4.6 3.9 16.8 8.5 2.7 24.4 8.7 7.7 1.8 1.9 3.7 1.7 0.3 6.0 1.1 2.3 6.3 6.7 9.8 6.5 16.5 8.4 2.3 0.0 2.5 13.6 0.5 2.4 0.7 0.8 0.0 1.3 2.8 5.3 0.0 9.1 1.8 1.5 2.9 4.8 1.2 3.1 5.4 2.2 1.2 12.7 12.4 2.5 1.1 4.5 1.1 0.8 0.0 6.1 6.9 3.9 31.5 1.4 0.1 0.6 2.3 0.9 1.3 0.2 0.3 1.8 3.6 0.0 0.4 0.7 1.0 2.9 1.1 0.3 0.6 7.6 8.0 3.9 7.5 7.3 4.0 7.0 4.8 8.1 7.3 8.9 6.9 15.0 7.9 17.1 10.9 3.6 0.0 2.7 2.3 15.7 29.5 27.1 1.7 4.3 1.6 14.0 1.6 0.0 4.1 7.4 11.8 5.8 2.3 4.9 11.7 12.7 9.2 17.8 16.1 0.6 57.5 9.1 6.8 7.2 4.3 28.8 2.7 2.5 23.7 9.1 8.9 25.8 9.8 0.4 2.7 23.6 147.8 11.5 3.7 6.5 ATP11A "ATPIH, ATPIS, KIAA1021" ENSG00000068650 "ATPase phospholipid transporting 11A" P98196 13 112690329-112887168 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 202.5;Alveolar cells type 2: 171.3;Cone photoreceptor cells: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035583, HPA035584" Approved Enhanced Vesicles NA NA Vesicles "HPA035583: AB_10671106, HPA035584: AB_10672096" "unprognostic (1.67e-1)" "unprognostic (5.06e-3)" "unprognostic (1.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.58e-2)" "unprognostic (8.84e-2)" "unprognostic (5.87e-3)" "unprognostic (1.80e-2)" "unprognostic (6.97e-2)" "unprognostic (1.54e-3)" "unprognostic (3.93e-2)" "unprognostic (4.23e-1)" "prognostic favorable (7.44e-4)" "unprognostic (3.85e-2)" "unprognostic (3.69e-1)" "unprognostic (3.26e-2)" "unprognostic (7.40e-3)" 11.1 11.5 7.2 8.3 16.4 15.7 7.9 5.0 12.5 13.6 5.8 24.4 8.7 9.5 13.7 9.2 8.5 10.8 14.6 19.6 7.2 5.4 12.9 12.3 36.9 7.5 17.7 6.9 8.6 13.2 36.1 17.8 11.2 12.8 5.0 3.6 10.0 12.0 9.0 11.2 11.4 8.7 9.1 12.5 10.2 6.1 9.7 16.2 2.1 16.4 6.4 6.0 5.7 11.3 4.2 1.1 6.4 3.1 0.0 1.0 0.6 14.0 7.2 9.1 10.7 4.6 6.3 16.2 6.7 3.9 5.7 4.7 22.6 16.3 7.1 8.2 5.6 7.4 12.0 8.2 5.5 5.6 7.1 7.7 8.2 6.0 11.7 7.3 15.3 13.4 4.2 4.3 6.9 4.2 4.6 15.0 6.5 5.6 1.2 4.0 5.3 6.9 9.7 3.9 16.1 5.1 6.1 3.7 4.0 31.3 3.3 14.6 4.0 6.5 8.5 5.6 12.4 3.2 20.5 9.8 0.0 12.5 7.4 5.0 3.9 7.5 3.0 2.5 14.5 6.3 0.0 2.3 3.1 1.0 3.1 0.6 1.3 0.6 0.5 1.1 4.2 0.7 0.4 6.4 0.0 2.7 1.1 0.1 0.6 7.2 16.4 5.0 12.5 7.2 5.4 17.7 6.9 12.8 16.2 202.5 171.3 5.6 2.8 9.6 29.4 38.0 35.7 16.0 45.5 15.7 221.9 0.6 5.0 31.2 0.7 19.8 4.2 0.0 10.0 26.5 10.6 5.3 11.5 13.2 17.6 12.7 11.5 24.5 33.5 1.4 10.3 21.3 10.1 7.2 3.3 10.4 18.9 5.8 4.6 15.8 44.2 0.0 5.1 3.9 9.0 8.4 7.2 5.7 5.2 3.7 ATP11B "ATPIF, ATPIR, KIAA0956" ENSG00000058063 "ATPase phospholipid transporting 11B (putative)" Q9Y2G3 3 182793500-182921635 "Enzymes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036237, HPA036238" Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA036237: AB_10673123, HPA036238: AB_10670792" "unprognostic (4.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (6.73e-2)" "unprognostic (2.03e-3)" "unprognostic (7.28e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.02e-1)" "unprognostic (1.71e-1)" "unprognostic (1.62e-1)" "unprognostic (3.22e-1)" "unprognostic (8.66e-2)" "unprognostic (1.35e-1)" 16.8 7.9 7.7 19.7 9.8 35.4 17.0 18.4 9.4 20.5 21.6 8.9 14.3 13.6 15.0 11.7 37.3 11.8 12.7 21.1 6.9 5.9 13.7 14.3 19.4 20.3 10.3 5.7 15.2 14.6 21.0 26.0 8.0 8.3 16.8 16.9 9.8 19.7 13.8 13.1 21.8 22.8 16.5 11.3 23.4 27.6 22.8 8.9 49.0 10.8 20.4 21.9 22.7 25.5 3.6 4.2 7.5 1.8 3.0 3.4 1.3 22.7 3.3 7.2 10.0 15.3 16.8 6.6 10.5 14.5 8.2 9.6 8.1 11.8 10.6 18.0 15.1 17.1 13.8 8.5 10.8 14.3 23.4 6.8 25.4 4.4 1.7 8.9 20.0 16.3 11.3 12.3 9.2 13.3 12.1 12.8 16.9 9.0 32.9 13.2 7.7 16.6 6.4 5.1 12.9 6.4 6.9 21.0 12.7 9.9 19.1 4.3 7.7 29.3 3.7 12.8 6.8 4.1 14.9 12.6 12.5 13.5 10.7 18.2 45.0 40.2 19.8 8.6 8.6 7.3 7.5 1.7 7.2 3.1 1.8 3.0 3.6 2.7 3.1 1.9 2.4 2.3 3.4 6.8 3.0 1.7 4.2 2.0 1.3 7.7 9.8 18.4 9.4 6.9 5.9 10.3 5.7 8.3 8.9 14.9 10.4 9.7 20.0 30.5 11.4 15.9 17.8 6.7 11.4 19.2 13.7 9.6 0.0 10.9 27.7 14.5 26.1 46.7 14.4 3.2 14.9 34.3 10.5 13.6 9.2 36.5 6.4 14.1 17.8 19.9 17.8 17.7 13.5 5.4 27.5 8.1 20.8 27.1 19.8 6.2 28.3 19.4 16.5 15.4 10.7 39.0 8.0 24.9 20.4 44.2 ATP11C "ATPIG, ATPIQ" ENSG00000101974 "ATPase phospholipid transporting 11C" Q8NB49 X 139726346-139945276 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 47.7;Spermatogonia: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030830 Approved NA NA "HPA030830: AB_10601336" "unprognostic (8.94e-2)" "unprognostic (1.00e-2)" "unprognostic (3.06e-2)" "unprognostic (3.42e-3)" "unprognostic (3.08e-1)" "unprognostic (3.46e-1)" "unprognostic (1.41e-1)" "unprognostic (3.41e-1)" "unprognostic (1.20e-1)" "unprognostic (1.37e-1)" "unprognostic (4.80e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-1)" "unprognostic (3.65e-2)" "unprognostic (9.75e-2)" "unprognostic (2.73e-1)" "unprognostic (5.18e-2)" 12.8 7.0 4.8 7.6 10.6 4.6 9.6 8.0 5.8 13.1 8.8 5.3 30.2 4.8 12.0 9.5 7.3 9.1 7.4 5.2 6.7 4.5 10.8 41.4 6.7 11.2 9.6 3.2 13.1 4.6 6.8 4.2 4.6 9.5 11.5 6.4 10.7 5.8 21.4 6.6 5.6 7.8 11.3 6.3 14.4 7.1 7.9 9.7 14.9 6.1 4.0 7.4 12.7 12.2 2.8 2.1 5.1 1.7 3.5 2.5 0.5 9.4 4.0 8.4 13.6 12.5 17.0 10.6 11.4 15.3 9.2 12.8 3.6 7.7 13.6 25.7 16.1 6.1 8.0 20.1 5.2 14.5 12.4 11.8 6.9 8.9 7.0 13.9 11.9 4.4 11.2 3.5 10.0 8.6 10.3 15.9 10.6 7.7 10.5 12.1 5.1 10.9 8.1 14.1 0.0 7.7 11.0 9.0 11.3 7.8 15.8 6.5 10.8 4.5 0.5 5.9 8.2 3.4 6.6 17.8 12.6 4.2 15.2 15.4 3.0 2.9 10.8 5.8 15.0 6.3 5.1 1.5 0.4 1.2 1.0 2.5 2.8 1.4 1.1 1.2 2.7 1.4 2.2 2.8 3.5 1.7 2.1 1.0 0.5 4.8 10.6 8.0 5.8 6.7 4.5 9.6 3.2 9.5 9.7 14.9 9.6 13.0 14.5 12.9 1.6 3.9 2.5 5.3 11.4 10.4 0.0 1.7 1.7 4.8 9.9 20.3 4.5 0.0 8.5 10.5 16.6 10.9 9.2 43.9 7.9 0.0 8.7 28.8 29.5 8.5 13.3 8.6 10.1 47.7 6.0 2.8 6.4 5.8 14.5 8.2 3.4 0.0 20.6 23.2 49.4 11.8 5.6 8.7 4.5 13.6 ATP12A "#945, 2, ATP1AL1, HK" ENSG00000075673 "ATPase H+/K+ transporting non-gastric alpha2 subunit" P54707 13 24680411-24712493 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Potassium transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 12.3;lymphoid tissue: 38.4" "Group enriched" "Detected in some" 7 "Ciliated cells: 5.3;Club cells: 18.2" "Cancer enhanced" "Detected in many" "testis cancer: 12.3" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Cell type enriched" "Detected in single" 5 "T-reg: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enriched" "Detected in some" 8 "SuSa: 11.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039526 Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039526: AB_10673534" "unprognostic (8.33e-3)" "unprognostic (3.58e-2)" "unprognostic (2.93e-1)" "unprognostic (5.21e-3)" "unprognostic (2.58e-1)" "unprognostic (1.21e-2)" "unprognostic (8.03e-3)" "unprognostic (2.64e-1)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.78e-1)" "unprognostic (1.67e-1)" "unprognostic (6.80e-2)" "unprognostic (8.22e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.2 1.3 0.4 0.1 0.0 0.0 0.0 0.2 0.2 12.3 0.1 0.0 0.1 0.3 0.2 8.8 0.1 6.1 0.0 0.1 0.0 0.1 1.0 0.0 0.2 5.8 0.4 0.3 2.2 0.0 0.4 0.0 0.1 9.8 0.1 0.0 0.1 0.1 0.1 1.0 0.0 1.2 0.2 2.9 38.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.1 0.2 1.3 0.3 0.2 0.1 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 5.3 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.2 ATP13A1 "ATP13A, CGI-152, FLJ31858, KIAA1825" ENSG00000105726 "ATPase 13A1" Q9HD20 19 19645198-19663693 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031798, HPA049717" Approved Approved Vesicles NA NA Vesicles "HPA031798: AB_2674048, HPA049717: AB_2680858" "unprognostic (2.08e-1)" "unprognostic (4.92e-2)" "unprognostic (4.30e-2)" "unprognostic (7.29e-2)" "unprognostic (3.33e-1)" "unprognostic (4.40e-3)" "unprognostic (3.97e-3)" "unprognostic (1.73e-2)" "unprognostic (3.17e-1)" "unprognostic (2.60e-2)" "unprognostic (1.16e-2)" "unprognostic (9.43e-3)" "prognostic unfavorable (6.51e-4)" "unprognostic (2.26e-3)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.57e-1)" 13.7 20.8 18.6 22.6 20.4 16.0 15.4 19.9 22.4 16.6 15.3 18.9 11.7 20.5 19.1 13.3 17.5 17.4 15.8 11.4 14.4 11.5 17.6 22.9 15.6 23.9 21.6 14.5 24.6 23.4 38.1 21.0 15.4 15.7 16.8 15.0 18.4 18.9 16.8 13.5 17.0 23.2 13.2 16.1 29.9 18.1 16.7 20.7 24.7 23.1 11.0 22.2 15.4 15.6 3.1 8.1 4.1 10.8 1.8 4.5 2.6 12.3 17.4 9.6 20.7 15.4 10.3 26.1 11.2 15.7 9.7 9.9 16.6 21.1 17.1 19.3 13.2 5.5 6.9 14.5 14.3 5.3 6.2 30.1 9.3 17.4 13.0 15.9 17.6 27.8 14.8 13.5 10.5 12.7 10.8 7.0 12.5 16.0 38.3 9.6 20.4 11.8 12.7 17.5 15.4 21.4 9.4 6.8 38.0 10.3 17.2 13.3 22.5 10.3 16.7 11.6 4.7 10.5 19.3 11.1 20.6 3.1 23.3 13.4 31.2 18.6 10.2 14.4 22.7 15.4 0.0 4.2 4.1 3.9 7.4 4.2 3.1 4.5 4.1 8.1 2.7 3.0 3.7 0.1 1.8 10.8 6.3 3.7 2.6 18.6 20.4 19.9 22.4 14.4 11.5 21.6 14.5 15.7 20.7 8.9 8.0 20.4 6.7 5.3 10.5 4.7 10.2 2.7 3.4 14.0 17.7 16.5 1.7 16.9 8.1 6.8 26.2 0.0 15.7 15.4 8.2 10.0 5.7 12.1 18.3 4.8 17.9 11.1 12.1 3.6 13.0 9.2 6.8 11.8 19.8 12.0 14.5 20.4 9.2 6.2 10.7 6.5 5.4 12.1 14.3 5.4 12.8 7.5 17.7 5.5 ATP13A2 "CLN12, HSA9947, PARK9" ENSG00000159363 "ATPase 13A2" Q9NQ11 1 16985958-17011928 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 17.9" "Lineage enriched" "Detected in many" 6 "dendritic cells: 17.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037038, CAB037111, HPA050910, HPA054717" Enhanced NA NA "CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: AB_2681269, HPA054717: AB_2682583" "unprognostic (3.81e-2)" "unprognostic (1.84e-2)" "unprognostic (5.61e-2)" "unprognostic (2.17e-2)" "unprognostic (1.66e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.33e-7)" "unprognostic (1.04e-1)" "unprognostic (9.71e-3)" "unprognostic (4.51e-1)" "unprognostic (9.85e-3)" "unprognostic (1.85e-1)" "unprognostic (5.75e-2)" "unprognostic (3.25e-2)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (6.84e-3)" 9.6 12.3 21.9 16.3 25.8 8.7 6.7 25.5 45.3 6.0 12.5 12.0 4.7 10.4 5.3 6.1 8.9 7.1 7.6 4.5 23.8 34.6 6.5 2.5 9.6 13.2 28.4 20.3 5.3 30.1 7.8 22.2 10.5 52.2 7.2 8.3 9.6 15.6 7.2 7.5 10.0 11.1 7.3 10.9 16.1 10.7 6.2 9.9 5.2 8.6 2.9 8.1 9.2 5.2 2.1 17.9 0.4 2.9 2.2 2.5 1.1 10.2 10.9 6.0 23.1 5.6 4.8 15.8 6.0 5.7 6.6 6.9 19.0 12.0 4.7 25.6 9.9 5.7 16.2 11.9 21.8 2.3 6.2 22.8 15.9 10.2 9.9 7.3 5.8 7.6 3.8 12.1 18.5 13.5 21.4 12.8 12.2 10.2 8.8 26.8 8.4 6.7 3.2 8.8 24.7 7.4 7.4 22.4 18.2 7.4 15.7 16.0 10.3 27.0 35.1 22.7 7.7 11.8 7.1 12.8 7.3 13.8 12.2 12.0 1.8 2.1 4.8 13.8 31.7 11.6 0.0 1.3 0.3 2.4 2.9 2.5 1.2 1.9 2.0 0.4 2.1 1.0 1.4 0.4 2.2 2.7 17.9 1.5 1.1 21.9 25.8 25.5 45.3 23.8 34.6 28.4 20.3 52.2 9.9 0.0 2.1 3.7 6.3 5.8 30.8 3.2 12.7 2.7 1.2 7.0 33.4 5.1 5.0 12.9 0.9 8.4 28.1 0.0 21.6 28.3 4.7 10.7 9.2 3.2 9.2 44.5 7.5 4.3 12.1 0.2 4.9 4.1 5.0 2.8 12.9 37.2 40.5 45.6 6.0 5.7 34.3 0.0 3.8 12.6 14.9 4.5 7.8 8.7 13.3 10.6 ATP13A3 AFURS1 ENSG00000133657 "ATPase 13A3" Q9H7F0 3 194402672-194498364 "Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029471 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA Nucleoli "Plasma membrane, Cytosol" "HPA029471: AB_10600784" "unprognostic (5.07e-2)" "unprognostic (3.53e-2)" "unprognostic (2.94e-1)" "unprognostic (5.31e-2)" "unprognostic (3.20e-2)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (9.87e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.34e-2)" "unprognostic (3.77e-1)" 27.1 14.4 9.0 20.8 12.7 17.5 22.8 15.3 13.8 12.1 13.4 10.8 17.2 11.4 16.2 13.2 12.4 11.3 17.1 37.8 9.6 8.1 29.7 56.9 22.1 11.6 10.1 8.3 13.2 11.4 37.6 10.6 28.9 10.6 11.8 12.6 12.9 16.7 15.9 11.8 7.7 15.0 12.1 9.0 17.1 16.3 8.8 8.4 18.9 37.1 12.0 12.7 17.8 16.1 1.9 2.4 2.3 2.3 2.2 4.7 1.0 49.1 5.6 10.0 9.5 11.4 17.8 24.4 16.9 18.4 18.4 33.5 30.8 12.0 19.4 50.3 24.3 61.0 16.7 9.6 16.8 42.8 64.7 8.3 10.7 7.4 6.5 19.8 34.8 28.1 8.1 7.5 38.2 24.9 30.2 9.5 12.0 12.3 39.3 22.3 8.4 14.0 6.9 9.5 16.1 9.7 12.8 21.6 11.6 15.6 15.7 15.4 8.1 17.9 18.6 12.5 8.8 35.7 24.4 12.4 22.5 18.7 44.6 31.5 25.9 46.7 34.5 44.6 20.7 15.5 1.8 1.7 2.3 1.8 2.3 2.2 1.9 1.7 2.8 2.4 1.1 2.5 2.5 0.3 2.2 0.9 1.6 4.7 1.0 9.0 12.7 15.3 13.8 9.6 8.1 10.1 8.3 10.6 8.4 47.6 35.1 27.9 35.7 73.3 24.1 34.6 96.8 24.1 37.5 47.1 19.6 25.7 3.3 56.7 1.9 46.6 20.8 0.0 60.7 16.3 46.0 62.6 8.1 112.9 37.1 14.3 29.4 49.1 35.1 1.1 9.5 48.5 59.1 8.2 21.5 10.3 76.7 20.4 12.4 39.8 13.3 12.9 36.0 14.0 7.0 62.2 54.0 20.1 19.9 58.3 ATP13A4 "DKFZp761I1011, FLJ37958" ENSG00000127249 "ATPase 13A4" Q4VNC1 3 193402077-193593111 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2" "Cell type enhanced" "Detected in many" 19 "Alveolar cells type 1: 59.6;Alveolar cells type 2: 19.6;Cholangiocytes: 12.7;Ciliated cells: 13.4;Club cells: 22.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 23.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051932 Approved Nucleoplasm NA NA Nucleoplasm "HPA051932: " "unprognostic (4.97e-2)" "unprognostic (1.50e-3)" "unprognostic (4.86e-3)" "unprognostic (2.52e-3)" "unprognostic (2.72e-2)" "prognostic favorable (3.91e-4)" "unprognostic (1.55e-1)" "unprognostic (3.99e-3)" "unprognostic (2.65e-1)" "unprognostic (1.36e-1)" "unprognostic (4.39e-2)" "unprognostic (1.34e-1)" "unprognostic (4.29e-5)" "unprognostic (1.91e-1)" "unprognostic (1.70e-1)" "unprognostic (5.75e-3)" "unprognostic (2.00e-1)" 0.6 0.7 11.2 0.6 11.1 0.6 17.8 2.6 10.1 1.8 2.2 8.4 9.0 0.9 0.6 46.4 11.8 2.7 4.3 0.6 11.1 5.1 0.8 0.7 22.0 0.8 7.5 7.7 0.8 3.9 52.5 3.5 0.6 9.0 0.6 3.2 0.5 4.5 16.7 0.6 11.2 0.6 0.7 6.1 0.7 7.6 0.8 7.5 0.0 51.2 7.8 9.5 0.6 3.7 0.4 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 1.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 9.4 0.2 0.1 1.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 1.9 1.0 1.5 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 11.2 11.1 2.6 10.1 11.1 5.1 7.5 7.7 9.0 7.5 59.6 19.6 0.0 0.0 0.1 1.9 0.4 12.7 13.4 22.7 0.0 0.0 0.8 0.0 2.1 0.3 0.0 0.0 0.0 0.2 0.1 0.2 0.0 1.1 0.0 0.2 1.6 0.0 1.8 0.8 0.8 0.0 0.6 1.7 0.0 1.5 0.6 1.2 1.7 0.4 0.2 0.9 0.0 0.0 0.7 1.2 1.4 0.6 0.8 1.7 0.0 ATP13A5 FLJ16025 ENSG00000187527 "ATPase 13A5" Q4VNC0 3 193274790-193378843 "Predicted membrane proteins" Translocase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 15.2;breast: 17.5;salivary gland: 28.9" "Cell type enhanced" "Detected in some" 25 "Club cells: 2.3;Early spermatids: 1.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Region enriched" "Detected in many" 10 "pons and medulla: 15.2" "Cell type enriched" "Detected in single" 9 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "PC-3: 1.7;SK-BR-3: 5.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA031771, HPA031774" Uncertain NA NA "HPA031771: AB_2674038, HPA031774: AB_2674039" "unprognostic (7.98e-2)" "unprognostic (3.01e-4)" "unprognostic (2.06e-3)" "unprognostic (2.72e-3)" "unprognostic (3.93e-1)" "unprognostic (1.67e-4)" "unprognostic (3.03e-1)" "unprognostic (2.31e-1)" "unprognostic (2.14e-2)" "unprognostic (1.73e-1)" "unprognostic (7.15e-2)" "unprognostic (1.10e-1)" "unprognostic (8.10e-2)" 0.1 0.0 1.4 0.1 1.5 0.1 17.5 0.3 0.9 0.1 0.1 2.8 0.1 0.0 0.3 0.9 0.9 0.0 0.1 0.1 1.0 0.7 0.1 0.1 0.4 0.1 0.9 0.1 0.2 0.1 0.1 0.2 0.1 15.2 0.3 0.0 0.4 28.9 0.1 1.3 5.1 0.1 0.1 0.3 0.1 1.4 0.3 0.1 0.4 1.4 1.3 0.7 0.1 0.1 0.4 0.4 4.1 0.3 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.7 1.0 1.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.6 0.0 0.0 0.0 0.2 0.7 0.0 1.7 0.3 1.0 0.0 0.0 0.4 0.7 0.0 0.0 5.8 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.9 0.3 1.0 0.0 0.3 0.4 0.3 0.4 0.3 0.3 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.2 0.2 4.1 0.3 0.0 0.4 0.1 0.1 1.4 1.5 0.3 0.9 1.0 0.7 0.9 0.1 15.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP1A1 ENSG00000163399 "ATPase Na+/K+ transporting subunit alpha 1" P05023 1 116372668-116410261 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" Translocase "Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Mental retardation, Neurodegeneration, Neuropathy, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 195.4;parathyroid gland: 194.4" "Cell type enhanced" "Detected in all" 5 "Enterocytes: 917.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 254.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018702, CAB069993" Enhanced NA NA 380000 "CAB018702: AB_626713, CAB069993: AB_2060979" "unprognostic (6.18e-2)" "unprognostic (2.18e-1)" "unprognostic (6.91e-2)" "unprognostic (1.42e-2)" "unprognostic (6.80e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.42e-4)" "unprognostic (1.80e-1)" "unprognostic (1.21e-2)" "unprognostic (6.32e-2)" "unprognostic (1.61e-2)" "unprognostic (1.65e-1)" "prognostic favorable (8.98e-8)" "unprognostic (4.75e-2)" "unprognostic (1.17e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (4.01e-4)" 17.4 25.6 22.4 16.2 40.3 10.5 26.9 74.2 67.4 17.8 121.9 14.2 56.1 92.3 13.1 38.3 34.9 17.7 65.8 41.1 26.1 18.7 162.7 34.6 35.1 9.6 19.2 27.6 17.4 78.6 194.4 25.0 19.2 34.1 22.1 65.7 24.1 84.4 53.7 19.0 40.5 195.4 17.7 20.7 13.7 25.0 17.0 13.9 9.1 101.2 13.7 16.2 14.2 23.1 10.3 22.0 6.4 29.7 10.4 30.2 17.2 33.7 12.4 12.9 6.5 26.0 25.3 66.6 20.2 40.3 24.9 35.4 49.8 24.2 26.7 28.6 23.9 25.3 44.1 25.5 42.6 36.3 9.8 28.3 15.5 23.5 42.0 19.9 38.9 21.9 28.1 71.5 29.0 38.3 35.2 30.5 16.3 25.6 25.8 22.0 67.0 15.7 14.1 30.4 53.6 25.0 15.2 30.3 23.6 90.1 34.8 12.7 11.2 31.4 59.6 254.2 33.2 15.7 22.6 26.9 14.2 19.9 36.7 40.9 12.5 9.7 20.5 43.6 22.5 83.4 6.4 13.3 6.1 23.2 20.9 24.8 10.3 26.4 24.9 22.0 5.3 30.2 22.0 1.6 10.4 29.7 11.1 20.3 17.2 22.4 40.3 74.2 67.4 26.1 18.7 19.2 27.6 34.1 13.9 256.1 246.7 58.7 265.3 245.9 76.0 62.7 540.1 113.8 203.6 731.0 375.0 70.1 316.7 432.8 25.0 117.9 917.6 93.5 278.3 130.8 110.9 297.5 43.8 66.4 114.8 96.9 169.4 90.9 77.6 11.5 109.0 130.5 197.4 47.7 304.0 513.0 192.4 264.8 94.7 289.6 141.6 32.3 179.2 17.9 27.5 235.0 56.5 95.6 365.5 236.0 ATP1A2 "FHM2, MHP2" ENSG00000018625 "ATPase Na+/K+ transporting subunit alpha 2" P50993 1 160115759-160143591 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" Translocase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "brain: 109.8;skeletal muscle: 305.8" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 142.4;Muller glia cells: 63.9;Peritubular cells: 37.1;Sertoli cells: 84.1;Smooth muscle cells: 32.5" "Cancer enriched" "Detected in many" 18 "glioma: 91.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 32.9;HHSteC: 9.6;RH-30: 10.7;U-87 MG: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022230 Enhanced NA NA "CAB022230: " "unprognostic (1.08e-2)" "unprognostic (4.42e-2)" "unprognostic (3.41e-2)" "unprognostic (2.83e-1)" "unprognostic (2.83e-1)" "unprognostic (7.98e-2)" "unprognostic (2.16e-2)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (8.85e-2)" "unprognostic (8.63e-4)" "unprognostic (1.70e-2)" "unprognostic (9.40e-3)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (7.16e-2)" "unprognostic (5.32e-3)" 12.6 3.9 61.4 2.8 80.1 2.3 6.5 30.4 109.8 4.7 6.6 27.4 2.4 3.7 4.2 7.4 15.3 6.0 5.3 35.4 42.2 27.0 3.3 2.5 3.8 2.4 45.6 37.9 9.9 2.6 2.4 4.6 3.6 58.0 13.8 5.6 12.5 3.1 14.2 305.8 2.8 4.4 5.4 51.5 2.7 2.8 3.9 28.3 0.0 2.6 17.7 2.5 5.5 1.3 0.6 1.4 1.7 0.4 0.6 0.5 0.3 0.0 0.0 32.9 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 2.9 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 1.3 0.4 0.3 0.3 0.3 0.2 0.4 0.3 0.2 0.7 0.6 0.3 0.5 1.7 0.6 0.2 1.4 0.2 0.3 61.4 80.1 30.4 52.0 42.2 27.0 45.6 37.9 58.0 28.3 0.0 0.0 0.0 0.8 0.5 0.7 142.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 26.7 0.0 0.0 0.0 0.0 63.9 0.0 0.0 37.1 0.0 1.9 84.1 32.5 0.3 0.2 0.5 0.1 0.0 0.0 0.5 ATP1A3 DYT12 ENSG00000105409 "ATPase Na+/K+ transporting subunit alpha 3" P13637 19 41966582-41997497 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" Translocase "Deafness, Disease mutation, Dystonia, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 146.4;heart muscle: 78.3" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 387.3;Cone photoreceptor cells: 161.0;Horizontal cells: 201.8;Late spermatids: 93.3;Rod photoreceptor cells: 178.0" "Group enriched" "Detected in many" 6 "glioma: 21.6;testis cancer: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "Daudi: 20.7;JURKAT: 13.5;Karpas-707: 13.2;REH: 13.0;SCLC-21H: 49.1;SH-SY5Y: 21.1" "CAB033630, HPA045367, HPA056446" Enhanced Approved NA NA "CAB033630: AB_781528, HPA045367: AB_2679297, HPA056446: AB_2683136" "unprognostic (1.90e-1)" "unprognostic (8.65e-2)" "unprognostic (4.57e-2)" "unprognostic (8.20e-3)" "unprognostic (8.94e-2)" "unprognostic (2.52e-1)" "unprognostic (3.16e-2)" "unprognostic (7.66e-2)" "unprognostic (8.02e-2)" "prognostic unfavorable (3.44e-4)" "prognostic favorable (6.15e-5)" "unprognostic (4.02e-3)" "prognostic unfavorable (3.02e-6)" "unprognostic (6.84e-2)" "unprognostic (6.48e-2)" "unprognostic (3.45e-1)" "unprognostic (1.27e-1)" 1.9 12.8 34.0 2.5 30.8 2.1 1.8 42.8 146.4 1.8 2.4 4.8 0.0 2.4 1.8 1.8 2.0 1.8 1.9 78.3 48.3 54.6 1.8 1.8 1.9 2.3 39.9 42.6 1.8 2.3 1.8 3.0 1.8 94.4 1.8 2.3 17.3 2.2 1.8 1.8 2.0 2.7 2.2 18.5 2.1 2.0 18.6 6.9 0.0 1.8 0.0 2.1 1.9 0.1 0.3 0.1 0.0 0.0 0.1 2.2 0.3 0.0 0.8 0.3 8.7 0.0 0.0 0.0 0.1 0.0 0.6 0.6 0.3 1.6 20.7 0.9 0.1 2.0 0.2 6.1 0.0 0.2 3.9 1.1 1.8 0.0 0.1 0.0 0.0 6.8 0.0 0.0 0.0 0.1 0.1 0.0 13.5 0.0 13.2 0.1 0.3 3.7 0.0 1.1 2.9 5.3 13.0 7.1 0.6 0.0 0.2 49.1 21.1 0.1 1.6 0.0 0.0 1.3 0.9 0.0 1.1 1.1 0.0 0.4 1.3 0.9 4.7 1.9 7.2 0.2 0.0 0.0 0.0 2.2 0.0 0.2 0.3 0.6 1.7 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.1 0.7 0.3 34.0 30.8 42.8 66.6 48.3 54.6 39.9 42.6 94.4 6.9 0.0 7.9 0.5 0.3 0.2 387.3 15.7 0.0 0.0 0.0 0.0 161.0 0.0 0.0 0.0 33.6 0.3 0.0 0.0 0.0 0.1 0.6 0.2 1.1 0.0 0.2 201.8 0.0 0.0 0.0 93.3 1.7 0.2 0.0 0.0 0.0 25.9 0.0 0.0 0.4 0.0 178.0 0.0 0.0 21.3 3.2 0.3 0.2 1.9 0.0 0.4 ATP1A4 ATP1AL2 ENSG00000132681 "ATPase Na+/K+ transporting subunit alpha 4" Q13733 1 160151570-160186977 "Enzymes, Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 13.1;seminal vesicle: 19.0;testis: 35.8" "Cell type enhanced" "Detected in some" 20 "Cytotrophoblasts: 20.6;Early spermatids: 67.0;Syncytiotrophoblasts: 31.9" "Group enriched" "Detected in some" 8 "breast cancer: 0.8;urothelial cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "BEWO: 10.8;HDLM-2: 26.8;RT4: 32.4" "Not detected" "Not detected" NA NA "unprognostic (1.33e-1)" "unprognostic (4.01e-3)" "unprognostic (2.20e-1)" "unprognostic (1.94e-1)" "unprognostic (2.09e-1)" "unprognostic (8.55e-2)" "unprognostic (1.22e-1)" "unprognostic (7.48e-3)" "unprognostic (2.45e-1)" "unprognostic (8.77e-3)" "unprognostic (1.98e-2)" "unprognostic (3.17e-2)" "unprognostic (2.43e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.09e-2)" "prognostic favorable (2.20e-4)" 0.4 0.3 0.4 0.8 0.3 0.0 2.2 0.4 0.3 0.3 0.3 0.0 11.2 0.0 0.2 0.3 0.3 0.3 0.8 0.3 0.3 0.3 0.2 0.2 0.3 3.8 0.3 0.0 0.2 0.2 0.0 0.3 13.1 0.0 0.6 0.0 0.4 1.2 19.0 3.2 0.3 0.5 1.6 0.3 1.1 0.3 35.8 0.0 0.9 0.2 0.2 1.6 8.9 5.9 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 1.1 0.0 5.5 0.2 0.0 0.8 0.0 0.0 0.0 1.8 0.0 20.6 0.0 0.0 67.0 0.0 0.0 0.0 0.0 11.9 0.4 0.7 1.1 0.0 2.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.4 0.0 2.1 0.0 0.0 0.2 0.2 0.0 31.9 0.0 0.0 11.2 ATP1B1 ATP1B ENSG00000143153 "ATPase Na+/K+ transporting subunit beta 1" P05026 1 169105697-169132722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 239.7" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 1634.8;Proximal tubular cells: 927.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 10.5;gdT-cell: 2.9;intermediate monocyte: 3.0;memory CD4 T-cell: 3.4;myeloid DC: 8.4;NK-cell: 5.6;T-reg: 9.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 127.3;RPTEC TERT1: 68.9;SH-SY5Y: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012911 Enhanced NA NA 4100000 "HPA012911: AB_1845173" "unprognostic (4.20e-2)" "unprognostic (3.08e-1)" "unprognostic (1.13e-1)" "unprognostic (1.85e-2)" "unprognostic (1.95e-1)" "unprognostic (5.34e-2)" "unprognostic (2.22e-1)" "unprognostic (1.69e-1)" "unprognostic (3.24e-1)" "unprognostic (6.80e-2)" "unprognostic (1.66e-1)" "unprognostic (1.35e-1)" "prognostic favorable (7.08e-7)" "unprognostic (1.11e-1)" "unprognostic (5.48e-2)" "unprognostic (1.97e-3)" "unprognostic (9.39e-2)" 3.9 26.3 48.7 8.6 45.1 1.3 14.9 39.4 92.1 8.7 43.8 34.5 11.3 61.3 19.8 11.2 28.7 9.4 50.1 36.0 86.3 68.2 239.7 30.6 16.9 1.9 82.3 52.6 11.5 33.0 130.6 16.7 8.3 111.5 9.8 34.8 15.5 55.7 15.4 55.1 11.2 51.2 17.8 64.0 9.6 69.5 8.4 25.9 0.9 60.1 23.7 13.9 12.3 9.0 1.4 8.4 10.5 3.0 5.6 9.1 1.4 12.3 30.2 9.8 7.5 2.3 0.4 3.4 6.1 5.0 6.4 6.7 36.8 25.0 0.0 23.1 4.8 7.2 14.6 5.4 11.6 6.6 0.1 2.4 0.7 22.8 17.1 3.7 0.5 1.1 1.3 2.9 4.7 6.1 11.2 5.8 0.9 0.1 0.1 7.3 4.7 1.0 1.9 3.9 127.3 6.5 0.1 11.9 2.1 68.9 15.4 7.8 57.2 36.1 36.4 1.6 12.5 7.5 1.2 12.3 4.9 13.2 8.3 21.8 0.7 0.9 0.2 5.9 1.8 6.6 10.5 1.0 0.1 2.9 3.0 1.5 1.4 3.4 1.1 8.4 0.2 1.0 1.1 0.3 5.6 0.9 0.4 9.1 1.4 48.7 45.1 39.4 92.1 86.3 68.2 82.3 52.6 111.5 25.9 223.4 199.8 17.7 144.1 46.6 22.3 136.8 749.1 187.4 257.0 1634.8 13.7 3.9 782.5 509.0 2.8 15.2 580.2 0.0 519.8 7.5 62.9 68.0 22.0 232.9 298.5 548.2 154.6 46.6 63.5 4.1 83.1 111.4 234.5 43.3 240.2 24.3 309.0 614.7 140.0 927.9 48.2 6.5 23.6 8.6 62.0 27.7 8.2 25.4 319.0 251.2 ATP1B2 AMOG ENSG00000129244 "ATPase Na+/K+ transporting subunit beta 2" P14415 17 7646627-7657768 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 148.8" "Group enriched" "Detected in many" 6 "Bipolar cells: 345.9;Cone photoreceptor cells: 235.6;Muller glia cells: 268.9;Rod photoreceptor cells: 188.4" "Cancer enriched" "Detected in many" 17 "glioma: 200.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 13.5;HAP1: 4.1;K-562: 6.1;SuSa: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010698 Supported NA NA 17000 "HPA010698: AB_1845174" "unprognostic (9.39e-2)" "unprognostic (1.86e-2)" "unprognostic (3.89e-3)" "unprognostic (4.96e-3)" "unprognostic (3.90e-3)" "unprognostic (9.33e-2)" "unprognostic (4.86e-1)" "unprognostic (5.93e-2)" "unprognostic (5.43e-2)" "unprognostic (1.29e-2)" "prognostic favorable (1.05e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.17e-4)" "unprognostic (4.60e-3)" "unprognostic (1.43e-1)" "unprognostic (2.24e-1)" "unprognostic (3.79e-2)" 4.1 6.5 54.7 2.5 61.6 8.1 2.5 62.9 148.8 9.4 3.4 25.1 0.0 2.7 8.0 15.1 3.4 10.9 4.4 5.0 46.1 33.4 6.9 3.4 3.9 2.9 42.4 41.9 23.3 3.3 3.8 10.8 5.0 68.9 4.6 3.8 28.4 3.3 7.6 4.6 2.7 3.0 5.8 58.7 4.8 2.4 4.3 25.7 0.0 4.4 0.0 2.6 3.3 2.0 1.3 0.7 1.5 1.0 1.3 2.0 0.5 0.0 0.0 13.5 0.6 0.4 0.3 0.1 0.2 0.0 0.5 0.3 0.5 0.0 0.4 0.3 0.1 0.2 0.4 4.1 0.2 0.2 0.1 1.7 0.3 0.1 0.1 0.2 0.1 1.3 0.8 0.0 0.5 0.0 0.1 0.0 0.3 6.1 0.8 0.0 0.4 0.3 0.4 2.8 0.1 0.3 0.2 0.0 0.2 0.1 0.1 0.2 2.6 0.0 0.1 0.1 8.2 0.2 0.3 0.0 0.2 1.0 0.1 0.2 0.5 0.2 0.1 1.2 0.3 0.3 0.9 1.0 0.5 2.0 0.3 1.8 1.3 0.7 1.4 0.3 0.8 1.1 1.0 1.5 1.3 0.2 0.7 0.2 0.5 54.7 61.6 62.9 50.8 46.1 33.4 42.4 41.9 68.9 25.7 0.0 0.0 0.0 0.2 1.6 345.9 2.8 5.1 0.0 0.0 0.0 235.6 0.0 0.0 0.0 0.2 1.8 0.5 23.3 0.0 0.1 2.4 0.4 0.0 0.0 0.3 17.5 0.0 5.5 1.5 0.2 17.3 0.6 0.0 0.0 0.0 268.9 0.0 0.0 43.5 0.1 188.4 25.8 22.8 0.4 6.3 1.0 0.2 0.0 0.0 0.1 ATP1B3 "CD298, FLJ29027" ENSG00000069849 "ATPase Na+/K+ transporting subunit beta 3" P54709 3 141876124-141926514 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 712.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020697, HPA048963" Enhanced Supported "Plasma membrane" NA NA 100000 "Plasma membrane" "CAB020697: , HPA048963: AB_2680574" "unprognostic (2.31e-1)" "unprognostic (1.11e-3)" "unprognostic (2.75e-1)" "prognostic favorable (5.19e-5)" "unprognostic (2.60e-2)" "unprognostic (3.31e-2)" "prognostic unfavorable (6.32e-6)" "unprognostic (8.11e-3)" "unprognostic (6.99e-2)" "unprognostic (5.37e-3)" "unprognostic (1.48e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.29e-5)" "unprognostic (5.14e-2)" "unprognostic (2.04e-1)" "unprognostic (7.19e-3)" "unprognostic (6.15e-2)" 50.5 79.9 12.7 26.3 23.3 17.5 105.9 25.7 35.1 17.7 48.2 9.1 16.8 37.3 17.9 14.6 36.9 20.0 47.8 44.0 16.0 18.9 24.9 7.7 44.9 43.4 21.3 12.8 34.7 11.5 6.3 33.8 32.6 43.3 20.5 58.1 23.9 18.4 24.8 7.4 85.4 57.3 24.3 28.4 16.5 13.5 21.1 13.6 14.5 15.6 41.4 18.4 21.9 31.5 10.4 26.8 13.6 60.9 7.8 20.0 22.5 46.4 28.9 27.2 25.5 73.0 21.3 62.3 54.5 49.6 39.7 45.0 44.9 23.4 37.9 49.3 41.4 57.5 102.0 26.9 26.0 45.2 20.6 34.2 33.1 32.5 29.1 28.9 27.2 26.0 22.5 62.3 31.1 30.1 28.4 42.3 26.6 22.7 33.7 40.6 21.1 27.6 45.6 37.8 64.7 13.9 38.0 20.4 38.6 33.3 35.9 22.4 15.3 71.2 33.1 73.1 49.4 25.2 33.2 29.4 34.9 13.4 52.1 31.7 25.1 32.3 61.1 45.5 29.6 28.6 13.6 27.1 8.9 19.2 44.5 14.1 10.4 15.6 20.0 26.8 7.5 9.2 16.7 1.9 7.8 60.9 16.4 16.9 22.5 12.7 23.3 25.7 35.1 16.0 18.9 21.3 12.8 43.3 13.6 53.6 46.5 109.5 333.7 437.8 35.4 16.7 20.4 10.7 43.3 209.3 23.6 255.9 34.9 71.5 391.5 178.3 384.3 140.2 52.8 199.5 109.5 121.1 129.2 6.0 276.1 23.8 53.9 79.8 137.2 712.2 78.6 209.3 210.9 518.4 67.0 42.5 54.6 123.0 64.3 29.8 25.4 122.9 189.2 42.4 191.3 362.3 327.4 66.0 109.6 362.4 ATP1B4 ENSG00000101892 "ATPase Na+/K+ transporting family member beta 4" Q9UN42 X 120362085-120383249 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skeletal muscle: 47.3;tongue: 26.1" "Cell type enriched" "Detected in single" 16 "Cardiomyocytes: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 4 "HSkMC: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.59e-2)" "unprognostic (6.02e-4)" "unprognostic (5.78e-1)" "unprognostic (5.29e-2)" 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.2 1.7 0.1 0.0 2.4 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.4 0.0 47.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 26.1 2.5 0.0 0.0 0.7 0.2 1.4 0.3 0.7 0.3 1.0 0.1 0.1 0.1 0.4 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.2 0.1 0.7 0.3 0.3 0.5 0.1 0.2 0.3 3.1 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.1 0.2 0.2 0.0 0.2 0.2 0.1 0.0 0.1 0.3 0.2 0.1 0.1 0.0 0.2 0.7 0.0 0.6 0.5 0.4 0.3 0.2 0.0 0.0 0.3 0.4 0.4 0.1 1.3 0.3 0.3 0.3 0.1 0.2 0.3 0.1 0.2 0.1 0.7 0.3 0.3 1.4 0.7 0.3 0.2 0.2 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP2A1 "ATP2A, SERCA1" ENSG00000196296 "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1" O14983 16 28878405-28904509 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" Translocase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "skeletal muscle: 456.3;tongue: 209.0" "Cell type enhanced" "Detected in some" 20 "Cone photoreceptor cells: 13.7;Late spermatids: 2.9;Rod photoreceptor cells: 4.6;Spermatogonia: 3.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 19.8" "Region enriched" "Detected in single" 8 "thalamus: 14.3" "Not detected" "Not detected" "CAB002310, CAB032706" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB002310: AB_564139, CAB032706: AB_2061286" "unprognostic (2.37e-1)" "unprognostic (6.81e-2)" "unprognostic (2.23e-5)" "unprognostic (5.35e-2)" "unprognostic (2.27e-1)" "unprognostic (2.04e-1)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (5.24e-2)" "unprognostic (1.87e-1)" "unprognostic (5.22e-2)" "unprognostic (4.94e-2)" "unprognostic (2.72e-4)" "unprognostic (1.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (2.51e-2)" 7.6 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.1 1.1 5.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.6 0.1 12.6 7.0 0.3 456.3 0.2 0.2 0.1 0.1 0.1 0.1 0.9 0.0 0.0 4.2 209.0 6.5 0.2 0.1 1.6 3.1 0.7 0.2 4.7 1.5 0.6 4.8 5.2 9.6 5.8 0.4 1.6 8.9 2.3 1.3 0.4 0.4 2.9 4.4 7.6 2.7 0.4 3.2 5.1 2.4 0.1 0.7 3.8 19.8 2.7 11.8 9.0 0.2 1.1 2.6 4.1 1.1 0.6 0.5 4.9 0.2 14.3 5.2 6.5 0.3 9.7 10.9 6.1 9.7 1.8 7.4 16.9 6.8 5.7 0.0 0.6 6.2 4.9 3.3 4.5 3.4 3.7 3.4 2.7 2.0 3.0 6.3 5.6 2.8 9.5 5.8 7.4 5.9 15.0 2.9 0.0 0.1 0.7 1.0 0.0 1.3 1.6 1.1 1.0 0.0 0.8 1.4 1.3 0.0 4.7 0.2 3.1 1.5 0.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.3 0.0 0.0 0.0 0.0 13.7 0.3 0.0 0.1 1.0 0.0 0.5 0.0 0.2 0.1 0.2 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.3 2.9 0.3 0.0 0.0 0.0 0.1 0.5 0.2 0.3 0.0 0.0 4.6 0.0 0.0 1.8 3.0 0.1 0.6 0.0 0.6 0.0 ATP2A2 "ATP2B, DAR, SERCA2" ENSG00000174437 "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2" P16615 12 110280756-110351093 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 188.3;skeletal muscle: 319.7" "Cell type enriched" "Detected in all" 12 "Cardiomyocytes: 1592.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062605 Enhanced NA NA 38000000 "HPA062605: AB_2684805" "unprognostic (4.81e-2)" "unprognostic (2.16e-2)" "unprognostic (1.87e-1)" "unprognostic (3.41e-3)" "unprognostic (2.50e-1)" "unprognostic (3.98e-3)" "unprognostic (1.91e-2)" "unprognostic (6.20e-2)" "unprognostic (4.69e-2)" "unprognostic (2.42e-1)" "unprognostic (1.20e-2)" "unprognostic (1.00e-1)" "unprognostic (3.47e-2)" "unprognostic (1.36e-3)" "unprognostic (2.26e-1)" "unprognostic (5.62e-2)" "unprognostic (9.93e-2)" 8.4 8.8 7.3 8.5 14.5 5.7 7.5 7.4 20.8 8.2 9.6 8.0 8.3 7.3 9.4 10.3 24.1 9.4 9.3 188.3 10.1 5.0 6.7 11.8 8.9 5.6 5.6 13.1 8.5 7.6 8.7 6.1 8.1 10.2 13.0 11.2 22.3 18.3 9.6 319.7 9.3 9.3 14.3 7.4 5.4 7.9 11.9 7.1 3.1 12.6 51.3 12.7 13.4 11.4 0.8 2.2 0.2 4.4 1.7 1.7 0.7 35.5 70.9 35.9 28.8 23.9 30.6 51.8 44.3 55.8 45.0 30.3 51.2 37.9 43.9 37.5 42.1 34.0 52.0 59.4 70.0 51.2 36.3 29.7 38.3 28.4 29.9 40.6 43.7 37.1 32.1 49.4 57.1 55.4 43.3 34.7 23.0 44.6 21.5 36.6 34.1 23.6 27.1 40.9 36.5 35.9 24.9 32.3 36.2 22.2 73.4 38.0 28.5 55.8 45.8 25.9 34.2 61.6 23.6 37.2 41.7 22.4 27.7 33.8 44.2 53.8 49.2 38.0 18.9 47.2 0.0 1.9 0.0 1.7 4.4 0.9 0.7 1.3 1.1 1.9 0.8 1.3 1.2 0.2 1.7 2.3 2.2 1.2 0.7 7.3 14.5 7.4 20.8 10.1 5.0 5.6 13.1 10.2 7.1 41.7 53.9 23.1 78.3 101.7 60.4 1592.4 45.9 96.4 83.0 48.8 60.9 28.0 1.7 40.8 10.7 37.6 123.8 23.3 60.6 31.5 51.2 89.3 43.9 110.5 56.0 79.4 131.8 41.1 50.1 9.0 28.1 40.7 64.1 19.0 80.6 24.0 82.4 70.2 78.1 23.9 39.0 51.8 126.0 61.6 55.1 95.2 25.6 17.0 66.5 93.6 ATP2A3 SERCA3 ENSG00000074370 "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3" Q93084 17 3923870-3964464 "Enzymes, Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 82.4;salivary gland: 88.1" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 61.6;Intestinal endocrine cells: 94.0;Mucus-secreting cells: 112.7;Paneth cells: 46.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebellum: 10.9;midbrain: 4.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 39.3;HMC-1: 58.2;JURKAT: 32.7;MOLT-4: 52.0;SK-BR-3: 42.3" "Region enriched" "Detected in some" 15 "cerebellum: 75.4" "Low region specificity" "Detected in many" "HPA007180, CAB010882" Approved NA NA 100000000 "CAB010882: AB_258368, HPA007180: AB_1845177" "unprognostic (4.14e-2)" "prognostic favorable (4.69e-5)" "unprognostic (1.21e-2)" "unprognostic (3.68e-2)" "unprognostic (1.02e-2)" "prognostic favorable (2.51e-4)" "unprognostic (8.83e-3)" "unprognostic (2.30e-1)" "unprognostic (8.29e-2)" "unprognostic (3.67e-3)" "unprognostic (3.95e-3)" "unprognostic (1.73e-1)" "unprognostic (1.45e-3)" "unprognostic (1.60e-1)" "unprognostic (3.25e-2)" "unprognostic (1.54e-1)" "unprognostic (1.97e-3)" 2.1 4.9 0.9 36.9 1.6 24.3 2.7 10.9 1.7 2.3 15.4 1.8 48.8 8.1 3.4 2.8 4.5 2.2 16.0 2.6 0.9 0.7 3.4 1.6 7.8 25.6 4.1 1.4 2.1 20.2 0.0 0.8 1.7 1.4 7.4 9.0 8.7 88.1 47.3 0.9 9.4 26.1 3.0 1.0 36.4 25.5 1.6 1.2 82.4 4.2 6.0 47.5 5.4 2.6 8.3 10.8 21.1 1.0 2.5 7.8 3.9 0.0 1.6 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.3 39.3 2.4 0.1 0.0 0.1 0.6 0.0 0.0 4.8 0.4 20.5 1.2 0.0 0.3 22.3 58.2 0.0 0.0 0.1 0.0 0.0 0.0 32.7 4.1 25.4 0.0 24.4 52.0 24.0 0.2 11.1 0.3 5.7 0.0 9.0 0.0 0.7 2.5 0.7 0.3 42.3 0.0 0.2 2.6 5.5 0.1 0.0 0.4 0.1 0.0 9.4 2.8 13.8 0.5 15.9 0.0 9.1 1.0 21.1 7.8 0.6 6.1 6.9 4.8 7.2 1.0 8.3 3.6 4.4 9.0 2.5 0.3 10.8 4.2 3.9 0.9 1.6 10.9 1.7 0.9 0.7 4.1 1.4 1.4 1.2 0.0 3.4 44.0 0.4 0.8 0.0 2.2 5.1 1.4 2.3 22.7 0.0 0.2 0.0 1.7 0.1 3.6 61.6 0.0 10.8 0.2 2.0 6.5 33.4 0.8 2.8 0.0 94.0 7.4 3.5 0.0 0.0 2.6 11.8 0.0 112.7 0.2 17.0 46.0 0.7 0.2 0.1 0.0 3.1 0.0 0.7 0.3 0.0 20.8 41.2 2.5 ATP2B1 PMCA1 ENSG00000070961 "ATPase plasma membrane Ca2+ transporting 1" P20020 12 89588049-89709300 "Enzymes, Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.8" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 311.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 59.7;LHCN-M2: 92.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005605, HPA011166, HPA012945" Enhanced Supported Supported "Plasma membrane" NA NA "Plasma membrane" "CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483" "unprognostic (6.78e-2)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (8.23e-2)" "unprognostic (1.72e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (7.74e-4)" "unprognostic (2.77e-2)" "unprognostic (2.46e-2)" "unprognostic (7.82e-2)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (4.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" 8.7 5.1 23.4 12.5 53.8 40.5 8.8 30.9 44.1 9.0 14.0 4.1 4.0 17.8 8.2 5.8 6.5 8.4 11.3 5.2 29.0 11.8 7.4 10.0 9.2 11.8 7.8 31.5 7.6 7.4 13.7 8.7 11.7 9.2 6.4 14.8 2.9 5.6 6.9 10.9 11.3 12.8 8.7 6.1 12.7 12.4 9.8 16.4 5.7 6.3 6.0 12.3 9.9 7.4 27.1 16.2 41.5 25.6 8.4 16.3 6.2 4.2 21.5 8.5 4.1 12.4 19.7 3.9 13.0 42.9 12.6 20.2 8.6 3.9 8.4 0.9 18.1 14.6 3.8 7.4 3.6 35.5 2.9 8.7 3.0 7.6 7.5 40.3 12.5 5.0 16.3 6.9 39.5 59.7 14.9 3.2 3.2 4.9 3.1 92.7 6.7 3.9 5.4 6.6 5.9 10.3 5.6 27.4 3.5 12.0 19.8 8.0 4.4 15.1 4.3 3.6 18.0 6.3 1.4 2.2 34.5 5.6 12.6 14.2 2.3 3.6 9.0 15.6 3.5 7.6 2.7 13.0 6.7 7.1 13.6 9.0 27.1 12.4 9.0 16.2 27.0 4.6 5.7 41.5 8.4 25.6 2.9 16.3 6.2 23.4 53.8 30.9 44.1 29.0 11.8 7.8 31.5 9.2 16.4 41.7 42.4 79.2 52.7 179.2 311.6 18.9 45.9 29.4 36.4 50.6 145.3 117.8 1.7 21.2 1.8 49.1 113.3 0.0 24.6 36.9 79.9 37.8 30.1 35.8 157.7 286.0 87.9 47.3 100.2 6.0 27.0 213.2 52.3 116.4 24.1 78.6 21.7 48.2 30.1 23.1 99.9 32.3 51.5 12.9 122.1 178.9 191.3 55.4 45.3 59.3 ATP2B2 PMCA2 ENSG00000157087 "ATPase plasma membrane Ca2+ transporting 2" Q01814 3 10324023-10708007 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 55.1;liver: 15.2;salivary gland: 28.6;skeletal muscle: 30.3" "Group enriched" "Detected in some" 5 "Bipolar cells: 85.3;Hepatocytes: 27.0;Horizontal cells: 98.5" "Cancer enhanced" "Detected in some" "liver cancer: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 5.4;RPMI-8226: 15.3;SCLC-21H: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005606 Enhanced NA NA "CAB005606: AB_2243199" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (6.84e-2)" "unprognostic (1.59e-2)" "unprognostic (3.59e-1)" "unprognostic (3.62e-1)" "unprognostic (4.09e-2)" "unprognostic (4.65e-1)" "unprognostic (5.61e-2)" "unprognostic (1.93e-1)" "unprognostic (2.32e-4)" "unprognostic (2.70e-1)" "unprognostic (1.46e-3)" "unprognostic (1.08e-3)" "unprognostic (1.33e-2)" "unprognostic (8.34e-2)" "unprognostic (7.95e-3)" 1.0 1.5 7.6 1.0 23.0 0.9 1.0 39.9 55.1 3.0 1.0 2.4 0.0 1.0 3.2 1.1 1.1 4.3 1.0 1.0 10.0 6.2 1.1 15.2 1.0 1.0 7.9 14.7 1.0 1.1 0.9 1.7 0.9 15.5 1.0 1.0 0.7 28.6 0.9 30.3 1.3 1.0 2.3 2.5 1.0 1.0 1.5 4.2 0.0 0.9 0.0 1.0 0.9 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 15.3 0.0 0.0 5.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 7.6 23.0 39.9 55.1 10.0 6.2 7.9 14.7 15.5 4.2 0.0 0.0 0.0 0.0 0.5 85.3 7.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 27.0 0.0 98.5 0.0 0.6 1.0 5.7 0.0 0.0 3.3 0.0 0.0 14.5 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 ATP2B3 "CFAP39, CLA2, PMCA3, SCAX1" ENSG00000067842 "ATPase plasma membrane Ca2+ transporting 3" Q16720 X 153517676-153582939 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 18.6;brain: 23.2" "Group enriched" "Detected in some" 4 "Bipolar cells: 5.0;Extravillous trophoblasts: 8.3;Rod photoreceptor cells: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 14.6;SH-SY5Y: 4.3;THP-1: 3.5;U-937: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001583 Enhanced Supported NA NA "HPA001583: AB_1079641" "unprognostic (1.35e-1)" "unprognostic (3.07e-2)" "unprognostic (3.28e-1)" "unprognostic (6.82e-2)" "unprognostic (1.30e-1)" "unprognostic (4.32e-2)" "unprognostic (2.67e-1)" "unprognostic (6.34e-2)" "unprognostic (2.68e-2)" "unprognostic (8.58e-2)" "unprognostic (1.38e-3)" "unprognostic (3.44e-1)" "unprognostic (2.71e-12)" "unprognostic (1.44e-3)" "unprognostic (2.04e-1)" "unprognostic (2.42e-2)" 0.8 18.6 5.4 0.9 11.3 0.8 0.8 16.1 23.2 0.8 0.9 3.9 0.0 0.9 0.9 2.6 0.8 3.1 0.8 0.8 7.8 5.5 1.0 0.8 0.8 0.8 4.3 11.5 0.8 0.9 0.8 1.2 1.7 13.6 0.8 0.8 1.4 1.3 1.3 0.8 0.9 0.9 0.9 1.4 0.8 0.8 1.1 0.9 0.0 0.8 0.0 0.8 0.8 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 4.3 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 11.3 16.1 20.7 7.8 5.5 4.3 11.5 13.6 0.9 0.0 0.0 0.0 0.0 0.0 5.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 ATP2B4 "ATP2B2, MXRA1, PMCA4" ENSG00000058668 "ATPase plasma membrane Ca2+ transporting 4" P23634 1 203626561-203744081 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 153.7;Suprabasal keratinocytes: 132.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 59.5;fHDF/TERT166: 45.1;SuSa: 49.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016118, HPA040431" Enhanced Supported "Plasma membrane" NA NA 21000 "Plasma membrane" "CAB016118: AB_2061729, HPA040431: AB_2676980" "unprognostic (7.43e-2)" "unprognostic (1.58e-1)" "unprognostic (1.60e-2)" "unprognostic (8.17e-2)" "unprognostic (2.53e-2)" "unprognostic (9.23e-3)" "unprognostic (8.68e-2)" "unprognostic (3.81e-2)" "unprognostic (9.74e-2)" "unprognostic (1.70e-1)" "unprognostic (1.64e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (3.52e-3)" "unprognostic (2.61e-2)" "unprognostic (1.30e-1)" "unprognostic (2.56e-3)" 23.0 14.0 24.8 10.8 14.2 5.9 11.6 9.4 23.6 32.6 44.2 7.5 12.9 5.3 69.6 13.1 20.4 27.0 13.9 24.0 13.1 8.7 5.0 14.2 16.1 5.3 6.4 19.2 21.9 6.4 8.0 4.8 16.2 9.3 17.0 13.4 11.6 7.5 31.5 5.4 22.0 13.2 74.2 5.7 4.8 16.4 13.1 7.5 9.0 8.3 8.4 7.7 32.8 14.2 1.0 4.2 4.5 2.2 4.2 10.4 2.6 9.2 1.7 3.4 3.2 26.0 38.8 18.0 41.8 59.5 7.1 6.1 0.8 4.7 2.1 6.1 45.1 9.5 9.0 4.9 5.8 7.5 26.5 1.7 6.2 8.3 0.5 9.3 8.8 11.0 28.1 5.7 22.8 3.5 17.3 13.5 12.3 2.7 4.2 5.2 0.5 8.9 2.9 2.0 1.7 5.2 4.7 2.5 3.3 2.4 0.8 1.0 1.4 14.7 2.2 6.6 49.6 1.9 4.3 11.8 17.3 2.5 29.0 10.0 2.8 4.2 1.1 17.3 6.4 5.1 3.0 2.2 0.0 10.4 1.5 7.9 1.0 6.6 8.3 2.4 0.3 1.6 4.2 4.5 4.2 2.2 4.2 6.3 2.6 24.8 14.2 9.4 23.6 13.1 8.7 6.4 19.2 9.3 7.5 83.4 62.7 10.4 15.6 86.3 2.8 64.1 7.6 34.8 40.9 17.4 2.0 22.3 0.0 31.1 4.3 39.1 3.9 23.3 13.2 13.3 48.3 9.5 9.3 15.7 31.0 111.2 23.0 54.6 14.6 1.3 40.6 13.2 25.3 7.2 1.9 153.7 25.2 11.9 35.7 5.0 6.9 19.4 82.4 22.3 2.1 132.0 21.7 45.7 2.6 43.3 ATP2C1 "ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1" ENSG00000017260 "ATPase secretory pathway Ca2+ transporting 1" P98194 3 130850595-131016712 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010207, HPA035116, HPA069684" Supported Supported "Golgi apparatus" NA NA 28000 "Golgi apparatus" "CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169" "unprognostic (1.52e-1)" "unprognostic (1.37e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (2.99e-1)" "unprognostic (1.32e-2)" "prognostic unfavorable (5.06e-6)" "unprognostic (7.66e-2)" "unprognostic (6.52e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (8.44e-2)" "prognostic favorable (1.55e-4)" "unprognostic (2.19e-1)" "unprognostic (1.95e-1)" "unprognostic (3.73e-2)" "unprognostic (3.06e-1)" 18.6 22.9 29.6 14.5 29.4 20.4 36.8 24.5 34.6 22.2 21.6 23.0 14.3 14.4 19.3 18.0 16.9 23.4 16.8 19.2 31.6 32.3 28.0 17.1 30.7 16.0 31.8 25.4 18.5 14.6 47.6 31.0 19.6 26.7 54.0 22.4 18.1 20.3 16.6 16.1 21.3 16.0 19.2 44.6 11.1 18.7 16.0 25.6 20.5 21.7 15.5 15.4 19.3 29.6 4.7 7.6 21.6 7.0 8.7 7.2 4.9 36.6 14.4 14.5 13.9 40.6 32.9 15.6 40.1 53.5 20.2 25.5 23.4 30.3 13.3 27.9 37.9 28.1 43.7 27.2 22.1 29.6 28.7 9.8 35.4 15.3 10.8 25.9 14.1 43.2 25.8 22.3 21.2 24.1 36.9 21.3 16.9 10.2 24.3 24.8 16.3 13.8 11.3 16.4 20.0 15.7 10.0 14.4 20.9 37.2 24.7 22.4 13.4 34.5 10.8 20.2 21.6 16.0 11.6 29.1 21.5 12.0 27.6 18.4 15.7 19.0 19.7 22.2 10.6 17.9 21.6 7.0 12.1 6.3 6.0 5.9 4.7 6.2 5.6 7.6 2.9 4.3 4.3 3.5 8.7 7.0 6.6 7.2 4.9 29.6 29.4 24.5 34.6 31.6 32.3 31.8 25.4 26.7 25.6 35.7 45.2 11.3 32.9 34.9 26.4 27.0 40.8 24.1 23.9 43.6 19.6 13.5 5.0 32.7 12.6 25.1 15.9 0.0 33.1 24.1 29.4 68.4 27.7 24.6 26.6 77.9 34.2 22.7 18.3 14.0 15.0 28.6 20.3 19.8 31.3 22.6 44.4 25.9 13.8 18.6 33.2 6.5 24.2 15.2 14.9 46.2 14.8 13.8 29.3 33.5 ATP2C2 "KIAA0703, SPCA2" ENSG00000064270 "ATPase secretory pathway Ca2+ transporting 2" O75185 16 84368527-84464187 "Enzymes, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.0;salivary gland: 35.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 42.2;Ciliated cells: 72.3;Mucus-secreting cells: 62.9;Undifferentiated cells: 69.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 24 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "MCF7: 14.5;OE19: 26.0;RT4: 11.4;SK-BR-3: 20.2;T-47d: 6.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA052262, HPA075812" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA052262: AB_2681776, HPA075812: AB_2686765" "unprognostic (2.28e-2)" "unprognostic (6.13e-2)" "unprognostic (3.34e-2)" "prognostic favorable (6.20e-6)" "unprognostic (2.04e-1)" "unprognostic (2.41e-2)" "unprognostic (8.36e-2)" "unprognostic (1.72e-1)" "unprognostic (9.92e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-2)" "unprognostic (2.16e-1)" "unprognostic (8.37e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (4.32e-4)" "unprognostic (1.39e-1)" 0.3 0.0 2.1 8.0 1.5 6.1 2.5 0.2 2.0 3.5 23.0 0.5 1.9 16.3 1.8 1.9 2.7 4.0 18.8 0.4 1.8 1.9 2.6 0.2 21.9 0.2 1.3 0.7 1.3 0.5 0.0 2.9 4.8 0.7 7.9 21.9 1.0 35.8 0.2 0.9 15.2 14.5 0.5 0.6 0.2 3.4 0.4 0.4 0.3 8.2 2.2 8.1 4.8 7.8 0.0 0.0 2.7 0.0 0.0 0.1 0.0 3.6 0.2 0.4 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 3.4 3.2 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 26.0 0.1 0.0 0.0 0.1 0.0 11.4 2.9 0.0 0.0 20.2 0.1 0.5 6.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 2.1 1.5 0.2 2.0 1.8 1.9 1.3 0.7 0.7 0.4 29.8 42.2 0.0 12.3 0.6 1.4 0.6 2.5 72.3 29.6 0.0 0.0 1.9 0.0 7.2 3.0 0.6 15.4 0.0 2.3 2.2 0.3 21.6 9.2 0.0 0.2 0.0 32.8 0.0 0.0 1.1 0.0 0.7 1.7 0.0 62.9 1.3 3.1 17.3 0.0 1.9 5.6 0.0 0.5 0.7 0.6 1.0 20.1 0.0 69.5 9.5 ATP4A ATP6A ENSG00000105675 "ATPase H+/K+ transporting alpha subunit" P20648 19 35550043-35563658 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Potassium transport, Transport" Translocase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "stomach 1: 120.1" "Group enriched" "Detected in some" 4 "Early spermatids: 7.3;Late spermatids: 15.2" "Cancer enriched" "Detected in single" 21 "stomach cancer: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "THP-1: 1.2;U-138 MG: 1.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA039154, HPA076684" Enhanced NA NA 790000 "HPA039154: AB_10672772, HPA076684: " "unprognostic (3.54e-2)" "unprognostic (6.98e-3)" "unprognostic (2.77e-2)" "unprognostic (1.43e-1)" "unprognostic (5.84e-3)" "unprognostic (4.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.50e-1)" "unprognostic (9.68e-2)" "unprognostic (1.47e-3)" "unprognostic (3.90e-3)" "unprognostic (3.92e-2)" "unprognostic (4.86e-2)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" 0.1 0.2 0.1 0.1 0.6 0.0 0.1 0.1 0.6 0.1 0.1 3.4 0.1 0.0 0.1 0.1 4.9 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 2.1 0.1 0.1 120.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 1.5 0.3 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.6 0.0 0.0 1.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.6 0.0 0.0 0.0 0.0 0.0 ATP4B ATP6B ENSG00000186009 "ATPase H+/K+ transporting beta subunit" P51164 13 113648804-113658186 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "stomach 1: 156.3" "Cell type enriched" "Detected in single" 6 "Distal tubular cells: 1.7" "Cancer enriched" "Detected in some" 12 "stomach cancer: 8.9" "Region enriched" "Detected in single" 9 "cerebral cortex: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 3.9;RPMI-8226: 1.6;SCLC-21H: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045400, HPA052649" Enhanced NA NA "HPA045400: AB_2679314, HPA052649: AB_2681900" "unprognostic (9.92e-2)" "unprognostic (2.19e-1)" "unprognostic (2.66e-1)" "unprognostic (4.86e-1)" "unprognostic (6.43e-3)" "unprognostic (7.81e-3)" "unprognostic (1.95e-1)" "unprognostic (3.22e-1)" "unprognostic (6.50e-2)" "unprognostic (6.65e-4)" "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (3.78e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 1.0 0.1 0.1 2.0 0.1 0.0 0.1 0.1 1.5 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 6.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 156.3 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.9 0.0 1.6 0.0 0.0 2.6 0.9 0.2 0.7 0.0 0.0 0.1 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP5MC1 "ATP5G, ATP5G1" ENSG00000159199 "ATP synthase membrane subunit c locus 1" P05496 17 48892765-48895871 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 117.9" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 349.4;Distal tubular cells: 1228.5;Proximal tubular cells: 646.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 210.8" "Low region specificity" "Detected in all" NA NA "unprognostic (3.43e-2)" "prognostic favorable (3.88e-4)" "unprognostic (6.60e-2)" "unprognostic (2.09e-1)" "unprognostic (8.73e-2)" "unprognostic (4.92e-2)" "unprognostic (3.04e-2)" "unprognostic (2.53e-1)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (9.42e-3)" "unprognostic (9.78e-2)" "prognostic favorable (8.24e-6)" "unprognostic (2.07e-2)" "unprognostic (5.60e-2)" "unprognostic (1.95e-1)" "unprognostic (2.33e-1)" 11.7 19.2 29.2 16.4 34.2 12.4 17.6 15.8 35.4 13.6 46.8 9.5 11.1 28.3 13.5 24.7 22.2 16.0 13.0 117.9 26.2 21.6 47.9 33.0 11.2 18.3 23.0 28.5 11.0 27.7 15.5 15.0 10.4 27.8 12.3 47.0 10.8 29.5 16.4 103.8 14.3 43.2 19.7 16.1 11.4 21.3 6.1 13.2 8.7 17.3 106.0 21.5 10.4 12.9 67.5 86.3 13.8 52.9 39.3 49.6 49.7 49.3 66.7 21.2 30.9 23.4 28.6 31.3 27.2 22.9 36.4 36.0 44.3 35.6 54.4 65.8 23.5 38.7 45.1 38.0 47.6 54.2 44.7 50.9 52.7 44.1 88.4 16.4 62.8 26.5 23.1 32.5 38.6 42.8 19.6 40.9 44.5 31.4 36.9 41.9 50.8 59.4 29.4 13.2 210.8 65.9 37.9 55.3 87.5 69.2 28.1 31.5 22.9 20.4 43.9 23.1 33.7 64.5 42.9 22.6 23.0 31.6 34.7 34.6 33.7 37.9 72.0 33.1 49.8 27.2 9.1 52.9 13.8 32.2 44.5 38.8 67.5 37.0 34.6 70.1 54.5 49.6 43.1 2.9 39.3 25.7 86.3 31.2 49.7 29.2 34.2 15.8 35.4 26.2 21.6 23.0 28.5 27.8 13.2 44.7 79.4 0.0 0.0 0.0 0.0 0.0 0.0 97.7 91.0 260.0 0.0 349.4 1228.5 161.3 0.0 0.0 0.0 0.0 257.7 210.1 0.0 0.0 67.4 0.0 239.2 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 126.2 0.0 0.0 170.7 0.0 0.0 646.5 0.0 0.0 0.0 0.0 0.0 0.0 185.9 0.0 0.0 0.0 ATP5MC2 ATP5G2 ENSG00000135390 "ATP synthase membrane subunit c locus 2" Q06055 12 53632726-53677408 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 1493.8;Hofbauer cells: 948.2;Proximal tubular cells: 1347.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051469 Approved NA NA "HPA051469: AB_2681496" "unprognostic (1.48e-1)" "unprognostic (1.06e-1)" "unprognostic (3.01e-1)" "unprognostic (3.37e-3)" "unprognostic (1.65e-1)" "unprognostic (8.42e-2)" "unprognostic (2.97e-3)" "unprognostic (2.29e-1)" "unprognostic (2.83e-1)" "unprognostic (3.45e-3)" "unprognostic (3.78e-2)" "unprognostic (5.71e-2)" "unprognostic (3.32e-3)" "unprognostic (3.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.42e-1)" "unprognostic (7.09e-2)" 39.1 60.1 52.8 34.8 48.0 49.7 64.3 47.4 72.1 46.4 57.0 49.5 38.2 50.3 57.0 63.3 52.3 71.2 48.2 107.6 45.9 43.7 60.3 60.1 46.8 105.6 49.3 57.9 67.3 99.2 47.9 50.8 34.0 42.2 46.4 73.3 49.7 69.1 43.1 165.8 50.3 45.4 53.3 51.3 51.6 57.4 38.1 32.9 82.1 46.2 92.9 67.0 47.4 41.7 112.1 133.4 30.2 96.4 71.7 99.0 126.2 27.5 59.0 62.3 56.3 43.0 105.1 29.3 24.3 54.7 72.6 49.8 20.1 65.2 33.4 59.7 47.5 23.6 26.6 79.6 56.3 64.6 55.9 95.3 91.2 47.6 41.4 93.6 69.3 45.5 116.7 83.9 70.3 117.2 117.6 93.2 41.0 64.6 98.9 73.6 72.2 70.7 169.1 53.1 58.4 65.9 71.5 59.1 83.0 88.5 34.7 32.5 59.6 32.8 38.2 81.8 56.9 123.9 126.6 44.5 35.6 49.1 27.3 37.6 51.8 43.3 24.3 53.0 73.2 54.4 30.2 96.4 27.1 68.9 89.6 75.8 112.1 89.2 73.6 133.4 99.5 99.0 81.4 22.0 71.7 79.5 103.0 92.7 126.2 52.8 48.0 47.4 72.1 45.9 43.7 49.3 57.9 42.2 32.9 169.7 211.4 0.0 0.0 0.0 0.0 0.0 0.0 396.2 325.3 500.7 0.0 597.2 1493.8 365.1 0.0 0.0 0.0 0.0 588.0 662.7 0.0 0.0 206.9 0.0 948.2 0.0 0.0 0.0 0.0 0.0 0.0 161.9 0.0 664.6 0.0 0.0 433.3 0.0 0.0 1347.7 0.0 0.0 0.0 0.0 0.0 0.0 424.6 0.0 0.0 0.0 ATP5MC3 ATP5G3 ENSG00000154518 "ATP synthase membrane subunit c locus 3" P48201 2 175176258-175184607 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 189.6" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 786.5;Distal tubular cells: 2259.7;Extravillous trophoblasts: 831.6;Hofbauer cells: 886.9;Proximal tubular cells: 1680.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.45e-3)" "unprognostic (1.67e-1)" "prognostic favorable (9.90e-4)" "unprognostic (1.67e-3)" "unprognostic (3.01e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (3.46e-2)" "unprognostic (6.03e-3)" "unprognostic (1.42e-2)" "unprognostic (7.90e-2)" "unprognostic (4.71e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.31e-6)" "unprognostic (2.86e-1)" "unprognostic (3.93e-1)" "unprognostic (4.55e-2)" "unprognostic (2.31e-2)" 26.1 26.7 26.6 26.3 28.7 19.8 34.3 26.9 50.9 15.7 51.1 11.4 23.6 61.7 17.4 22.2 38.9 15.5 28.7 189.6 25.8 27.4 63.9 60.8 21.2 34.8 31.1 31.5 13.6 28.4 36.7 19.0 16.8 27.6 17.1 53.3 16.6 34.2 25.0 115.7 20.0 47.3 24.6 18.5 17.6 31.9 12.3 15.8 21.8 19.1 95.9 27.7 19.3 20.2 38.5 78.8 22.6 59.9 34.5 37.2 66.1 33.7 30.2 45.6 50.3 39.1 34.8 51.3 31.3 33.0 44.3 38.7 90.2 28.3 84.3 37.0 34.9 49.0 44.7 57.3 54.1 46.9 35.4 52.8 67.7 44.1 114.0 30.1 87.5 41.0 37.4 41.8 50.0 31.9 34.2 44.4 40.8 73.0 40.5 48.4 46.3 67.5 73.9 59.9 81.6 94.6 53.0 42.1 82.7 86.3 76.8 40.9 26.0 25.2 68.6 68.2 68.1 41.3 71.5 29.6 7.4 35.4 0.2 43.0 32.0 40.4 72.9 42.5 52.8 33.0 17.6 53.4 22.6 33.3 59.9 33.6 38.5 35.3 36.1 78.8 30.4 33.5 35.9 6.2 34.5 53.7 58.3 37.2 66.1 26.6 28.7 26.9 50.9 25.8 27.4 31.1 31.5 27.6 15.8 163.8 131.1 0.0 0.0 0.0 0.0 0.0 0.0 238.3 230.9 294.8 0.0 786.5 2259.7 429.4 0.0 0.0 0.0 0.0 326.9 831.6 0.0 0.0 81.4 0.0 886.9 0.0 0.0 0.0 0.0 0.0 0.0 111.5 0.0 358.9 0.0 0.0 350.5 0.0 0.0 1680.5 0.0 0.0 0.0 0.0 0.0 0.0 577.8 0.0 0.0 0.0 ATP5MD "bA792D24.4, DAPIT, MGC14697, USMG5" ENSG00000173915 "ATP synthase membrane subunit DAPIT" Q96IX5 10 103389041-103396466 "Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 1135.7;Ductal cells: 625.1;Exocrine glandular cells: 623.7;monocytes: 754.8;Pancreatic endocrine cells: 789.0;Proximal tubular cells: 951.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044798 Supported Mitochondria NA NA Mitochondria "HPA044798: AB_2679091" "unprognostic (4.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.59e-1)" "unprognostic (7.93e-2)" "unprognostic (1.65e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (5.67e-2)" "unprognostic (1.57e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (3.32e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (7.46e-2)" "unprognostic (1.03e-2)" 48.0 46.2 91.7 26.2 67.0 26.6 56.1 33.5 71.7 38.4 77.9 21.2 29.2 43.8 22.1 72.3 56.3 28.8 31.0 131.5 67.8 57.4 79.3 92.5 24.6 27.7 65.2 44.4 19.7 58.1 21.1 38.2 25.9 46.0 30.0 75.8 23.4 52.7 43.3 146.9 22.4 57.3 39.1 41.4 26.1 40.9 20.2 30.7 22.9 31.3 125.5 39.8 41.2 28.9 71.3 109.1 101.2 85.2 50.7 76.6 66.4 60.6 64.4 61.0 72.7 68.2 85.7 39.9 58.4 73.7 59.7 66.8 103.7 67.7 34.9 33.9 66.0 47.2 62.2 57.1 59.5 82.4 45.8 102.5 36.2 83.0 115.9 66.3 73.8 56.2 69.1 93.4 53.6 84.8 102.3 76.9 56.6 47.4 58.3 99.7 94.1 59.9 127.2 45.3 93.2 109.2 38.9 37.2 54.3 141.9 98.9 23.1 53.5 30.8 47.3 84.0 89.1 42.0 68.6 43.5 29.6 45.3 44.8 76.4 61.5 100.4 58.2 62.5 75.8 22.3 101.2 65.9 88.7 55.9 85.2 63.3 71.3 76.6 65.7 73.3 51.5 65.9 65.6 55.8 50.7 80.6 109.1 71.7 66.4 91.7 67.0 33.5 71.7 67.8 57.4 65.2 44.4 46.0 30.7 196.5 169.5 0.0 0.0 0.0 0.0 0.0 0.0 222.1 167.2 368.2 0.0 256.1 1135.7 625.1 0.0 0.0 0.0 0.0 623.7 361.7 0.0 0.0 109.3 0.0 478.9 0.0 0.0 0.0 0.0 0.0 0.0 129.1 0.0 754.8 0.0 0.0 789.0 0.0 0.0 951.7 0.0 0.0 0.0 0.0 0.0 0.0 255.7 0.0 0.0 0.0 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466331 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 700.3;Distal tubular cells: 1212.0;Hofbauer cells: 681.7;monocytes: 591.5;Proximal tubular cells: 993.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported "Nuclear membrane,Mitochondria" NA NA 1400000 Mitochondria "Nuclear membrane" "HPA067267: AB_2685815, HPA070412: AB_2686266" "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 42.4 49.0 68.0 36.6 52.0 46.4 42.8 37.3 58.8 30.7 62.7 19.0 39.9 62.9 21.2 41.2 57.4 24.8 36.6 94.5 53.9 49.8 59.6 93.5 30.0 35.5 54.6 43.6 20.7 63.6 16.3 36.7 33.4 36.3 35.0 47.3 30.9 57.1 45.2 178.8 27.8 61.5 24.6 33.0 35.6 43.4 58.3 25.5 52.9 37.9 98.0 37.6 27.8 30.2 68.3 129.7 117.2 104.1 58.3 84.0 140.0 86.7 76.6 64.6 104.3 50.9 51.7 40.9 57.6 44.9 61.9 67.1 81.3 80.2 81.4 60.8 35.7 105.4 53.5 71.4 66.0 66.2 58.6 91.7 55.1 122.5 104.8 38.4 93.9 63.1 58.9 63.7 53.8 57.0 54.2 58.9 70.6 111.7 89.7 64.8 203.9 140.4 163.0 91.9 174.2 90.2 62.9 53.9 139.1 130.5 96.5 62.1 68.5 75.4 186.6 54.5 100.7 47.0 121.9 49.9 54.5 87.2 90.0 84.0 51.4 118.1 169.8 63.1 91.9 83.7 90.0 104.0 117.2 54.2 104.1 51.7 68.3 63.5 61.0 129.7 56.9 55.8 59.5 49.7 58.3 79.2 102.7 84.0 140.0 68.0 52.0 37.3 58.8 53.9 49.8 54.6 43.6 36.3 25.5 20.8 44.7 0.0 0.0 0.0 0.0 0.0 0.0 93.7 67.1 366.4 0.0 700.3 1212.0 418.8 0.0 0.0 0.0 0.0 501.7 525.7 0.0 0.0 59.3 0.0 681.7 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 591.5 0.0 0.0 502.5 0.0 0.0 993.9 0.0 0.0 0.0 0.0 0.0 0.0 364.9 0.0 0.0 0.0 ATP5MPL "6.8PL, C14orf2, MLQ, MP68" ENSG00000156411 "ATP synthase membrane subunit 6.8PL" P56378 14 103912288-103928269 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 1357.9;Hofbauer cells: 793.2;Proximal tubular cells: 1064.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058978, HPA060520" Approved Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA058978: AB_2683867, HPA060520: AB_2684302" "unprognostic (1.37e-1)" "unprognostic (1.42e-3)" "unprognostic (1.55e-1)" "unprognostic (2.30e-1)" "unprognostic (2.11e-1)" "unprognostic (1.20e-2)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "prognostic favorable (6.80e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (1.34e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (4.14e-2)" 23.1 34.5 69.4 19.3 64.3 40.2 34.9 31.0 91.7 21.0 43.0 16.0 26.8 44.1 16.5 39.1 27.3 21.3 20.5 87.5 57.5 44.7 43.0 45.2 15.7 28.6 54.0 41.4 22.1 38.2 17.2 29.2 20.5 30.4 22.1 45.6 20.1 28.9 30.3 117.3 17.3 33.6 24.6 28.5 19.5 25.8 17.5 24.4 18.9 23.6 58.9 30.9 18.4 17.2 51.8 63.1 91.6 91.0 32.8 54.6 98.1 37.9 43.8 38.0 36.1 45.5 47.3 37.5 29.7 33.7 37.3 32.7 37.8 27.0 39.8 31.4 30.4 30.1 32.4 48.9 35.8 50.6 32.9 49.3 44.4 37.1 58.1 30.1 53.6 30.9 49.6 48.8 25.3 27.1 42.9 41.9 53.7 26.9 42.7 41.0 112.7 51.8 76.6 29.7 88.5 83.8 33.3 33.2 36.1 56.8 54.0 32.9 39.3 24.9 46.7 56.0 43.9 57.8 63.8 22.5 14.7 23.0 39.6 24.3 32.8 55.7 55.7 34.4 30.6 24.7 54.8 91.0 55.0 37.5 68.0 41.7 51.8 47.8 42.3 63.1 43.6 54.6 48.4 91.6 32.8 65.0 61.2 46.5 98.1 69.4 64.3 31.0 91.7 57.5 44.7 54.0 41.4 30.4 24.4 205.4 192.2 0.0 0.0 0.0 0.0 0.0 0.0 269.0 169.5 392.6 0.0 537.4 1357.9 448.4 0.0 0.0 0.0 0.0 495.8 570.0 0.0 0.0 86.0 0.0 793.2 0.0 0.0 0.0 0.0 0.0 0.0 158.5 0.0 585.3 0.0 0.0 512.8 0.0 0.0 1064.7 0.0 0.0 0.0 0.0 0.0 0.0 593.8 0.0 0.0 0.0 ATP5PB ATP5F1 ENSG00000116459 "ATP synthase peripheral stalk-membrane subunit b" P24539 1 111448864-111462773 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.6" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 297.5;Distal tubular cells: 391.3;Extravillous trophoblasts: 335.0;Hofbauer cells: 328.7;Proximal tubular cells: 348.8;Syncytiotrophoblasts: 290.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046067, HPA057347" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 640000 Mitochondria "HPA046067: AB_10960850, HPA057347: AB_2683416" "unprognostic (4.18e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-3)" "unprognostic (1.73e-2)" "unprognostic (3.56e-2)" "unprognostic (8.18e-2)" "unprognostic (8.52e-3)" "unprognostic (8.82e-2)" "unprognostic (3.67e-2)" "unprognostic (7.18e-3)" "unprognostic (3.29e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.26e-9)" "prognostic favorable (8.07e-4)" "unprognostic (1.60e-1)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" 11.6 16.0 16.8 11.4 22.6 8.0 10.4 30.7 28.8 10.7 30.0 10.4 11.3 16.1 14.4 10.7 21.1 13.7 9.7 57.1 16.4 15.4 30.5 26.2 10.2 14.2 16.1 15.5 12.6 15.3 18.0 13.3 16.3 22.8 13.4 17.8 9.8 20.4 12.4 83.6 9.7 25.4 13.7 13.9 13.7 13.1 11.4 10.1 18.7 18.6 34.0 15.4 15.5 11.5 8.3 10.8 4.3 10.0 5.9 11.9 22.9 15.3 3.5 13.0 10.1 8.4 7.6 8.4 17.0 18.8 17.7 14.7 6.2 7.8 20.9 15.8 11.1 3.8 16.0 18.9 21.0 15.8 16.6 7.4 20.9 4.9 4.1 6.1 26.3 21.1 6.6 9.0 19.4 18.2 4.1 14.1 2.9 18.4 9.2 10.1 7.1 44.9 6.1 9.9 4.0 24.0 11.6 40.6 8.2 14.0 5.2 9.5 3.0 13.2 18.9 13.9 3.1 15.2 9.5 13.6 8.3 14.7 16.2 16.8 12.7 12.1 49.8 20.1 20.0 15.5 1.9 10.0 4.3 9.7 6.4 8.6 7.5 10.8 9.2 10.8 8.3 11.9 7.3 2.9 5.9 5.0 5.9 9.0 22.9 16.8 22.6 30.7 28.8 16.4 15.4 16.1 15.5 22.8 10.1 62.5 73.9 0.0 0.0 0.0 0.0 0.0 0.0 136.5 105.8 118.7 0.0 297.5 391.3 205.2 0.0 0.0 0.0 0.0 172.3 335.0 0.0 0.0 82.5 0.0 328.7 0.0 0.0 0.0 0.0 0.0 0.0 69.8 0.0 172.3 0.0 0.0 151.6 0.0 0.0 348.8 0.0 0.0 0.0 0.0 0.0 0.0 290.7 0.0 0.0 0.0 ATP6AP1 "16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3" ENSG00000071553 "ATPase H+ transporting accessory protein 1" Q15904 X 154428632-154436516 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015218 Uncertain NA NA 160000 "CAB015218: " "prognostic unfavorable (2.40e-4)" "unprognostic (1.95e-2)" "unprognostic (2.06e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (1.84e-3)" "unprognostic (4.99e-3)" "unprognostic (2.57e-1)" "unprognostic (1.10e-2)" "unprognostic (1.84e-1)" "prognostic favorable (7.83e-4)" "unprognostic (1.07e-1)" "prognostic favorable (5.26e-8)" "unprognostic (2.45e-1)" "unprognostic (4.66e-2)" "unprognostic (3.39e-1)" "unprognostic (1.62e-1)" 29.8 37.8 36.6 20.0 50.3 27.5 22.1 59.2 82.7 28.4 26.5 39.4 27.4 24.0 20.6 43.2 29.1 29.6 23.0 35.1 40.8 47.5 42.4 26.9 37.9 21.8 36.5 40.5 24.4 42.6 67.1 41.5 66.1 60.1 41.6 24.7 29.8 35.9 29.4 18.4 30.2 24.2 22.9 39.4 36.4 27.6 21.2 24.2 22.1 39.7 20.9 21.4 27.3 21.1 20.1 68.4 64.0 56.6 23.7 28.9 33.8 22.6 21.5 18.5 31.3 29.9 16.5 34.6 16.7 23.8 26.1 38.0 20.3 28.3 13.4 70.9 35.9 45.2 24.3 27.1 15.5 14.4 12.2 28.0 7.7 27.7 20.1 37.7 12.4 56.9 22.0 26.6 24.5 14.1 28.5 36.1 10.3 9.2 37.9 17.1 33.1 9.0 18.8 6.9 33.4 22.1 13.9 12.3 34.7 27.6 19.0 18.4 19.2 14.6 59.7 31.4 18.0 26.3 30.6 27.9 19.1 17.2 32.4 27.2 54.7 58.8 15.8 22.7 26.9 19.1 37.4 53.9 64.0 28.6 56.6 28.9 17.5 23.7 24.7 68.4 20.1 21.4 23.5 60.0 23.7 43.4 39.0 26.9 33.8 36.6 50.3 59.2 82.7 40.8 47.5 36.5 40.5 60.1 24.2 35.7 60.5 43.2 34.7 26.9 103.3 32.9 58.6 68.3 39.8 92.5 45.2 127.4 16.6 60.6 1.4 40.9 65.9 0.0 45.6 84.9 39.2 41.1 75.1 34.5 216.4 122.3 85.5 57.1 139.0 4.3 38.3 101.8 69.2 65.9 52.9 70.3 39.9 58.6 40.0 42.5 46.1 64.7 33.5 33.9 5.6 28.7 164.3 38.7 44.1 39.7 ATP6AP1L ENSG00000205464 "ATPase H+ transporting accessory protein 1 like" Q52LC2 5 82279462-82386977 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 27.5;Early spermatids: 20.6" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 8 "dendritic cells: 1.3;NK-cells: 1.5;T-cells: 1.2" "Cell line enriched" "Detected in some" 5 "MOLT-4: 15.7" HPA053771 Approved Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA053771: AB_2682257" "unprognostic (1.64e-1)" "unprognostic (8.15e-2)" "unprognostic (5.10e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-1)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (5.09e-1)" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (1.94e-1)" "unprognostic (2.22e-3)" "unprognostic (2.92e-1)" "unprognostic (1.46e-1)" "unprognostic (2.14e-2)" "unprognostic (2.43e-2)" 1.6 1.0 2.6 0.2 2.4 0.6 0.7 2.5 2.1 1.8 1.2 0.1 1.5 0.1 1.4 2.4 1.7 2.0 2.7 1.8 0.8 1.4 1.5 0.7 2.5 4.4 2.4 0.1 2.0 0.7 1.4 0.6 2.6 2.5 3.3 5.1 0.2 0.6 2.7 0.8 1.8 3.8 1.5 0.4 0.9 0.5 0.1 1.3 0.0 0.1 1.5 1.2 0.0 0.1 0.0 0.1 1.0 0.6 0.3 0.0 0.1 0.3 0.4 0.9 0.1 0.0 0.0 0.0 0.9 1.3 0.0 0.3 2.9 0.0 1.3 0.6 0.5 0.2 0.3 2.3 0.2 0.0 2.1 1.1 0.0 2.6 0.2 0.5 0.2 0.7 1.2 0.0 0.2 15.7 0.5 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.2 0.4 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 1.2 0.1 0.7 1.2 0.0 1.5 0.0 1.3 0.0 0.0 0.0 1.6 0.5 2.3 1.9 12.1 2.4 0.0 14.7 1.2 5.2 27.5 6.1 1.7 2.6 20.6 1.8 1.3 0.0 2.9 2.7 3.8 1.2 2.3 1.6 1.2 1.6 1.2 4.9 1.5 16.6 4.4 1.3 0.0 1.0 1.8 10.6 2.6 0.0 2.8 1.1 14.2 0.0 1.4 14.0 5.5 1.3 2.9 1.9 1.1 1.3 ATP6AP2 "APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR" ENSG00000182220 "ATPase H+ transporting accessory protein 2" O75787 X 40579372-40606848 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 176.7" "Cell type enhanced" "Detected in all" 6 "Hofbauer cells: 584.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003156 Approved NA NA "HPA003156: AB_1078245" "unprognostic (1.45e-1)" "unprognostic (3.80e-3)" "unprognostic (1.30e-1)" "unprognostic (7.19e-2)" "unprognostic (8.58e-3)" "unprognostic (1.29e-1)" "unprognostic (1.63e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-1)" "unprognostic (4.15e-2)" "unprognostic (1.45e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.01e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-1)" "unprognostic (1.62e-2)" "unprognostic (2.86e-2)" 25.0 23.8 33.8 17.4 39.3 30.6 31.7 31.5 76.0 35.0 24.0 22.1 13.0 10.0 30.8 25.5 21.4 22.7 23.9 19.3 35.5 36.7 48.7 30.0 30.2 37.9 32.1 34.7 22.3 16.3 176.7 16.1 30.2 37.8 26.4 25.0 21.0 16.8 31.8 8.7 24.0 16.8 35.7 27.8 22.6 15.8 11.9 17.2 16.2 56.1 12.6 19.1 25.7 20.0 16.1 53.2 60.8 78.0 20.0 29.6 85.8 14.7 19.4 14.2 19.1 94.0 59.9 8.8 33.3 51.7 24.6 28.8 11.2 24.3 8.5 16.6 48.6 25.0 15.2 21.8 25.9 33.7 16.6 17.1 10.6 18.9 10.7 34.6 18.9 19.9 51.8 34.7 30.2 24.3 34.7 32.8 8.0 10.7 23.1 37.2 18.6 8.1 16.4 13.1 23.6 21.9 7.7 24.9 28.6 31.8 16.6 10.2 9.5 32.4 20.2 20.3 51.1 26.2 17.4 32.2 31.0 17.0 37.0 11.2 7.2 12.3 8.4 25.6 16.0 24.1 34.4 78.0 60.8 25.9 55.1 27.0 16.1 26.4 26.6 53.2 15.7 29.6 27.0 39.5 20.0 54.1 19.3 24.7 85.8 33.8 39.3 31.5 76.0 35.5 36.7 32.1 34.7 37.8 17.2 53.6 61.1 73.9 115.8 86.4 152.6 26.9 84.1 85.6 72.8 130.9 51.1 152.0 53.0 120.3 3.0 89.3 48.4 70.0 52.6 93.0 160.2 97.5 86.5 55.7 584.5 178.0 54.9 90.9 237.6 4.3 108.7 238.9 141.7 110.0 52.9 170.2 52.8 49.1 142.1 86.4 64.1 103.5 143.2 80.8 23.0 87.3 145.9 82.0 61.8 109.5 ATP6V0A1 "a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1" ENSG00000033627 "ATPase H+ transporting V0 subunit a1" Q93050 17 42458844-42522611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.2;parathyroid gland: 65.6" "Cell type enhanced" "Detected in all" 8 "Cone photoreceptor cells: 276.9;Rod photoreceptor cells: 349.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022144 Enhanced Approved "Nuclear speckles,Golgi apparatus,Vesicles,Cytosol" NA NA 21000 "Golgi apparatus, Vesicles" "Nuclear speckles, Cytosol" "HPA022144: AB_1845189" "unprognostic (3.93e-2)" "unprognostic (2.02e-1)" "unprognostic (4.35e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-2)" "unprognostic (8.69e-2)" "unprognostic (1.84e-2)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.05e-4)" "unprognostic (3.25e-1)" "prognostic favorable (1.28e-4)" "unprognostic (3.07e-1)" "unprognostic (3.68e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (6.90e-4)" 9.4 15.6 19.3 9.3 46.1 9.9 9.1 55.8 66.2 8.0 11.6 25.8 5.1 17.9 11.4 11.1 9.6 9.7 12.2 9.9 23.8 32.8 20.3 11.3 12.7 6.6 23.6 24.8 11.4 9.3 65.6 23.6 11.2 43.3 9.9 11.3 19.7 8.2 10.7 28.9 14.7 12.4 11.7 23.7 11.1 8.8 9.8 13.1 5.2 16.3 6.7 7.8 6.7 6.9 6.3 9.1 14.2 10.5 0.1 2.8 4.2 6.6 13.8 8.5 15.2 14.2 12.4 4.9 4.7 8.8 10.1 13.3 8.8 15.0 1.2 8.7 9.7 13.9 14.5 13.0 8.0 11.8 10.3 13.6 10.7 10.4 6.9 8.8 4.6 19.6 9.1 11.6 16.2 6.9 12.6 7.1 5.0 38.9 42.3 15.0 5.7 1.8 4.1 5.4 8.8 0.1 0.1 8.8 18.6 11.7 5.3 23.4 12.4 7.3 6.7 14.0 11.5 16.3 7.0 4.2 8.6 0.3 12.6 5.6 17.2 23.4 2.5 11.5 0.1 10.0 12.1 10.5 8.0 0.8 3.4 1.2 3.5 0.6 0.1 9.1 6.3 1.0 0.8 14.2 0.1 2.4 4.7 2.8 4.2 19.3 46.1 55.8 65.9 23.8 32.8 23.6 24.8 43.3 13.1 17.9 46.6 27.3 45.1 17.5 158.7 19.5 30.6 6.7 14.8 14.0 276.9 26.4 10.0 14.7 2.4 19.2 44.6 46.7 15.8 13.4 33.9 38.7 23.1 33.6 46.0 90.6 81.5 19.6 33.1 3.1 16.1 25.8 38.8 3.6 23.1 51.9 17.6 38.6 22.3 28.4 349.7 6.5 48.9 38.7 18.5 17.7 83.5 4.4 19.5 10.7 ATP6V0A2 "a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1" ENSG00000185344 "ATPase H+ transporting V0 subunit a2" Q9Y487 12 123712318-123761755 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 71.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 13.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044279 Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA044279: AB_10961274" "unprognostic (2.60e-1)" "unprognostic (8.79e-3)" "unprognostic (3.60e-2)" "unprognostic (1.50e-1)" "unprognostic (2.70e-1)" "unprognostic (2.29e-2)" "unprognostic (2.06e-4)" "unprognostic (1.40e-1)" "unprognostic (3.77e-2)" "unprognostic (1.75e-1)" "unprognostic (8.85e-3)" "unprognostic (1.63e-1)" "unprognostic (1.26e-1)" "unprognostic (7.48e-2)" "unprognostic (1.12e-1)" "unprognostic (3.47e-1)" "unprognostic (1.58e-1)" 13.5 9.4 7.2 13.0 9.9 15.5 11.5 16.2 9.8 8.9 13.1 13.0 9.0 16.0 13.4 8.8 9.1 10.4 10.4 13.6 8.0 7.9 8.9 13.7 13.1 16.6 12.8 6.9 9.7 18.1 8.1 10.4 10.2 9.1 9.8 12.0 9.8 24.5 10.0 13.0 20.5 15.8 12.3 9.4 13.1 15.9 15.9 10.8 24.0 10.3 8.6 17.5 11.0 10.3 2.3 3.4 13.1 1.5 2.1 2.7 0.9 3.3 8.4 8.8 11.8 5.2 5.0 5.4 4.0 4.7 5.2 5.7 6.2 2.7 12.8 2.8 5.4 5.5 7.1 11.4 4.2 3.9 8.7 6.4 18.4 6.7 3.6 8.2 11.7 37.8 4.5 3.7 6.1 6.6 5.2 4.5 10.1 11.1 2.3 5.7 9.2 11.0 14.3 9.2 5.0 5.6 10.6 7.6 4.1 5.0 8.3 5.3 9.0 6.8 4.7 6.0 4.7 4.9 8.5 6.5 6.6 2.5 8.1 6.7 7.6 8.4 11.9 5.5 7.1 5.6 6.4 0.9 13.1 2.1 0.9 1.5 1.3 2.1 1.8 1.1 2.3 1.9 2.7 2.4 2.1 1.5 3.4 1.4 0.9 7.2 9.9 16.2 9.8 8.0 7.9 12.8 6.9 9.1 10.8 6.0 14.1 16.0 6.8 9.0 18.1 7.9 17.8 8.1 9.1 8.7 11.8 4.7 0.0 7.4 7.9 8.9 10.5 0.0 9.5 4.6 8.0 12.1 71.8 9.5 7.4 11.1 12.7 14.1 10.8 3.1 8.1 11.7 1.7 10.0 10.1 12.2 6.7 8.0 8.9 3.7 27.6 6.5 8.9 19.5 11.5 12.4 5.7 13.1 9.9 10.6 ATP6V0A4 "a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2" ENSG00000105929 "ATPase H+ transporting V0 subunit a4" Q9HBG4 7 138706294-138799560 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 40.6;salivary gland: 55.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 15.7;Cytotrophoblasts: 11.7;Distal tubular cells: 26.6;Melanocytes: 6.8" "Cancer enriched" "Detected in many" 8 "renal cancer: 25.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SK-BR-3: 35.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA018029, HPA064555" Enhanced Uncertain Cytosol NA NA Cytosol "HPA018029: AB_1845190, HPA064555: AB_2685284" "unprognostic (1.99e-2)" "unprognostic (8.60e-3)" "unprognostic (1.12e-2)" "unprognostic (3.10e-2)" "unprognostic (1.43e-1)" "unprognostic (6.53e-2)" "unprognostic (4.63e-2)" "unprognostic (4.28e-1)" "unprognostic (1.35e-1)" "unprognostic (9.79e-3)" "unprognostic (1.73e-1)" "prognostic favorable (1.32e-6)" "unprognostic (4.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-2)" 0.1 0.0 0.5 0.0 0.3 0.0 2.2 0.1 0.4 1.7 0.0 0.3 3.1 0.0 0.3 0.5 2.7 0.0 0.0 0.0 0.4 0.3 40.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.2 1.0 0.2 0.5 0.0 0.3 55.4 1.2 0.0 6.5 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 1.8 7.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.4 1.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 3.1 1.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 3.0 0.1 0.0 0.0 0.0 35.9 1.2 2.0 0.1 0.0 0.1 0.4 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.1 0.4 0.4 0.3 0.3 0.0 0.2 0.1 0.0 0.6 0.0 0.8 0.0 0.0 0.3 0.0 1.4 1.2 15.7 2.0 11.7 26.6 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.3 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 4.2 0.0 0.0 1.1 ATP6V0B "ATP6F, HATPL, VMA16" ENSG00000117410 "ATPase H+ transporting V0 subunit b" Q99437 1 43974487-43978295 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 173.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 173.6" "Group enriched" "Detected in all" 4 "dendritic cells: 58.0;granulocytes: 173.6;monocytes: 78.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044281 Approved Cytosol NA NA Cytosol "HPA044281: " "unprognostic (1.38e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (5.69e-2)" "unprognostic (5.31e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (7.23e-2)" "prognostic favorable (3.24e-4)" "unprognostic (6.13e-2)" "prognostic favorable (3.62e-6)" "unprognostic (5.55e-2)" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (8.87e-4)" 20.4 35.7 35.4 21.8 35.3 84.2 28.5 29.1 56.4 23.3 28.3 32.2 26.7 19.2 13.9 35.6 21.9 20.0 22.0 24.8 41.2 44.7 47.6 56.3 25.8 28.5 43.6 31.5 12.9 87.0 32.5 36.3 35.0 33.9 27.0 32.0 32.4 34.8 22.2 27.9 20.1 20.2 19.1 34.8 33.2 25.2 15.3 24.8 16.3 38.7 19.5 24.7 23.2 16.5 23.7 58.0 173.6 78.0 8.8 14.2 87.6 23.7 23.2 19.3 24.2 29.7 15.7 23.6 21.4 31.8 41.6 36.0 24.9 26.0 22.1 19.8 22.6 49.4 19.7 45.0 32.2 19.6 20.7 46.9 27.6 40.1 35.8 47.1 42.9 53.7 19.3 42.5 45.8 40.6 26.7 20.0 31.0 27.5 48.5 34.0 25.1 17.7 71.5 31.8 34.5 49.6 25.1 18.5 60.2 43.3 29.3 45.5 22.5 14.4 57.1 53.6 22.8 23.4 77.2 10.1 21.5 18.3 38.7 51.4 39.3 57.7 24.5 29.2 61.2 33.5 31.9 78.0 64.2 13.2 48.1 13.0 23.7 14.2 12.7 48.1 19.1 10.8 10.9 173.6 8.8 44.0 58.0 13.7 87.6 35.4 35.3 29.1 56.4 41.2 44.7 43.6 31.5 33.9 24.8 74.5 137.9 144.5 130.3 298.3 238.3 92.4 122.3 100.4 66.0 268.7 96.2 165.0 170.8 307.8 2.7 147.4 174.0 23.3 286.0 191.3 151.0 308.8 203.1 213.0 743.7 122.3 214.8 101.3 356.6 8.6 73.1 420.3 266.6 357.1 190.7 203.9 311.9 371.7 61.5 175.0 164.2 77.6 135.2 133.6 224.9 313.3 415.2 116.5 165.6 262.4 ATP6V0C "ATP6C, ATP6L, ATPL, VATL, Vma3" ENSG00000185883 "ATPase H+ transporting V0 subunit c" P27449 16 2513870-2520218 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 11 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 58.3;Ciliated cells: 45.5;Club cells: 33.0;granulocytes: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065100 Approved Cytosol NA NA Cytosol "HPA065100: AB_2685421" "unprognostic (1.30e-1)" "unprognostic (1.30e-1)" "unprognostic (1.12e-1)" "unprognostic (5.96e-2)" "unprognostic (7.67e-2)" "unprognostic (2.31e-1)" "unprognostic (4.20e-3)" "unprognostic (1.44e-2)" "unprognostic (4.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" "prognostic favorable (1.07e-6)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (2.85e-1)" "unprognostic (5.04e-2)" 56.5 68.2 61.2 53.6 83.5 87.2 24.1 76.0 156.7 27.7 42.9 39.2 25.2 55.2 28.0 21.9 48.7 25.6 23.0 32.5 64.3 70.1 78.0 37.3 40.5 37.1 55.4 74.2 27.2 42.7 41.9 52.3 35.1 70.4 35.7 19.5 40.1 54.3 30.3 108.8 38.7 52.8 18.3 41.9 48.3 59.0 30.4 29.4 25.1 25.7 34.7 29.2 20.8 29.6 15.9 28.2 50.6 42.5 13.0 16.1 18.2 29.7 31.9 17.3 24.6 21.9 10.9 41.3 44.1 13.9 18.5 17.8 29.7 38.6 15.0 40.6 21.1 31.7 36.2 18.4 26.2 9.3 38.3 54.8 17.2 25.7 36.3 31.1 27.2 53.0 19.7 19.6 23.4 12.3 18.8 13.2 16.9 40.6 28.8 16.0 58.0 27.4 71.1 33.5 19.6 39.2 44.0 15.0 47.1 32.5 17.7 56.4 45.8 37.1 43.1 35.3 16.1 41.5 34.8 31.5 29.8 35.5 44.8 31.5 53.7 65.5 27.5 26.2 20.1 30.1 22.1 32.6 50.6 14.8 36.3 15.1 15.9 13.4 16.1 20.4 15.4 15.6 13.5 43.7 13.0 42.5 28.2 13.2 18.2 61.2 83.5 76.0 123.3 64.3 70.1 55.4 74.2 70.4 29.4 23.8 58.3 0.5 0.1 0.9 0.5 0.0 0.0 45.5 33.0 1.8 0.0 0.5 0.0 0.5 0.0 0.1 3.2 0.0 0.2 0.7 0.5 0.0 16.3 0.5 0.9 0.0 0.0 1.8 1.8 0.0 0.6 0.7 0.0 0.0 0.4 0.2 0.4 0.0 0.0 0.5 0.7 0.0 0.1 0.4 1.0 0.9 1.0 0.7 0.9 0.1 ATP6V0E1 "ATP6H, ATP6V0E, M9.2" ENSG00000113732 "ATPase H+ transporting V0 subunit e1" O15342 5 172983757-173035445 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.24e-1)" "unprognostic (3.08e-1)" "unprognostic (3.61e-1)" "unprognostic (1.51e-1)" "unprognostic (5.34e-2)" "unprognostic (1.54e-3)" "unprognostic (2.25e-3)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (6.63e-2)" "unprognostic (1.47e-1)" "unprognostic (8.33e-2)" "unprognostic (1.01e-1)" "unprognostic (2.46e-1)" "unprognostic (2.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.02e-1)" 53.2 54.8 22.3 34.4 26.6 18.1 77.1 9.1 21.5 45.3 50.7 30.6 53.2 28.8 41.8 152.2 53.0 35.6 43.5 70.0 20.0 24.9 90.5 78.6 54.4 68.2 33.3 15.5 49.0 53.1 18.3 65.2 83.1 40.5 48.6 36.3 52.6 59.4 54.6 47.6 34.2 54.1 46.3 34.1 61.3 43.8 34.6 21.9 34.8 91.8 42.2 45.6 56.6 43.5 86.8 90.7 183.9 94.9 50.1 69.0 145.1 31.5 34.5 11.3 34.3 105.0 42.3 26.7 62.1 57.9 31.1 48.3 38.7 49.4 13.7 88.9 72.8 83.5 22.8 22.5 44.2 34.8 94.6 22.3 12.9 35.0 36.5 51.3 24.3 45.4 55.7 54.5 35.7 19.8 38.1 37.3 15.3 8.4 40.5 67.8 62.5 15.1 35.2 13.1 25.1 29.8 16.3 16.2 24.6 61.5 40.4 16.5 11.1 27.3 33.7 48.6 33.0 37.3 34.1 56.0 74.5 16.6 52.9 51.8 35.0 71.7 15.0 40.3 40.8 24.3 157.8 94.9 141.6 59.4 69.5 54.4 86.8 68.3 61.8 61.0 72.9 66.5 69.0 183.9 50.1 65.6 90.7 67.8 145.1 22.3 26.6 9.1 21.5 20.0 24.9 33.3 15.5 40.5 21.9 122.1 195.0 243.7 272.1 260.3 17.2 175.6 267.5 147.2 136.5 492.0 5.9 429.9 275.2 586.3 22.7 294.4 265.3 70.0 319.5 476.4 327.8 370.1 248.2 359.4 643.5 35.0 204.6 243.0 435.2 23.0 316.9 443.2 349.2 1058.6 186.8 258.2 473.5 340.1 315.7 579.4 18.7 239.3 199.8 88.1 109.0 248.7 704.7 265.8 182.5 358.6 ATP6V0E2 "ATP6V0E2L, C7orf32" ENSG00000171130 "ATPase H+ transporting V0 subunit e2" Q8NHE4 7 149872968-149880698 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 92.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 112.2;Horizontal cells: 108.1;Muller glia cells: 136.8;Proximal tubular cells: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 51.0" NA NA "unprognostic (8.72e-2)" "unprognostic (4.73e-2)" "unprognostic (3.10e-3)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (1.32e-1)" "unprognostic (1.23e-1)" "unprognostic (2.42e-2)" "unprognostic (5.84e-3)" "unprognostic (3.57e-2)" "prognostic favorable (5.80e-4)" "unprognostic (1.21e-1)" "prognostic favorable (8.26e-7)" "unprognostic (1.96e-1)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (1.48e-3)" 11.8 17.3 60.1 6.5 56.5 3.6 8.6 70.5 92.7 6.4 6.7 26.4 14.2 5.0 4.3 6.2 6.0 13.4 5.9 27.9 73.7 55.3 26.9 27.9 6.8 12.1 61.1 39.7 4.9 11.7 14.0 25.3 3.1 57.1 26.2 5.3 18.7 37.0 24.8 8.7 4.7 4.6 6.3 29.4 8.3 7.3 3.2 12.2 8.4 26.6 2.0 8.1 4.9 1.7 7.0 6.4 1.5 6.9 12.0 30.6 11.2 7.5 21.2 8.8 28.6 3.6 0.6 5.5 3.9 5.4 10.8 11.1 7.4 9.5 15.4 16.6 5.2 11.2 6.7 18.7 6.6 4.6 19.8 20.8 4.8 6.5 42.5 5.3 3.5 10.6 1.2 6.9 11.9 0.7 8.4 8.9 19.5 5.1 7.6 0.7 12.9 2.5 8.0 7.6 9.7 14.9 16.8 0.3 7.2 8.4 8.1 51.0 28.9 5.1 17.8 11.9 2.2 10.0 2.3 1.6 3.1 3.3 32.7 14.5 10.6 13.5 7.4 19.9 6.1 10.1 1.5 3.1 0.7 16.7 5.8 15.4 7.0 21.0 19.5 6.4 6.3 27.5 24.7 0.4 12.0 6.9 3.0 30.6 11.2 60.1 56.5 70.5 66.4 73.7 55.3 61.1 39.7 57.1 12.2 14.9 13.7 15.9 4.7 3.8 112.2 25.4 22.9 6.7 10.3 26.2 23.6 17.3 46.4 40.1 0.1 3.2 0.9 0.0 11.2 2.1 6.7 22.5 10.4 50.4 21.2 108.1 21.4 9.2 6.6 1.3 4.9 9.6 42.2 5.4 16.3 136.8 6.3 0.0 10.6 94.9 61.7 6.5 10.3 0.5 12.4 3.9 4.2 28.7 2.6 3.3 ATP7A MNK ENSG00000165240 "ATPase copper transporting alpha" Q04656 X 77910656-78050395 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" Translocase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012887, HPA048107" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA012887: AB_1845205, HPA048107: AB_2680266" "unprognostic (3.14e-2)" "unprognostic (3.48e-1)" "unprognostic (4.90e-2)" "unprognostic (1.49e-2)" "unprognostic (1.26e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-3)" "unprognostic (2.59e-2)" "unprognostic (3.17e-2)" "unprognostic (2.47e-1)" "unprognostic (2.30e-2)" "unprognostic (1.14e-1)" "prognostic favorable (8.38e-4)" "unprognostic (1.06e-1)" "unprognostic (2.16e-1)" "unprognostic (3.69e-1)" "unprognostic (2.52e-1)" 9.8 7.4 2.6 8.6 4.6 6.4 8.5 2.3 2.9 8.2 7.7 5.9 9.6 4.8 9.5 7.6 10.0 5.7 4.5 5.1 2.9 2.8 9.0 3.3 9.3 9.3 4.1 1.7 7.3 6.3 13.2 15.9 5.0 4.3 8.2 4.4 5.2 12.3 10.3 6.1 15.9 8.5 7.8 6.3 10.8 7.0 2.7 6.0 15.6 6.0 7.1 11.7 11.8 7.0 2.3 1.4 10.7 2.4 1.7 3.0 1.2 2.6 6.8 4.5 4.6 4.3 4.6 0.8 4.0 5.5 2.3 4.8 0.9 3.0 3.8 5.9 3.9 2.9 3.2 5.9 3.2 4.4 5.6 4.0 1.9 6.6 0.7 5.5 3.3 3.6 4.8 1.3 5.0 1.5 5.5 6.2 3.9 15.5 14.7 4.3 2.2 3.6 1.1 1.3 9.1 1.5 3.0 7.6 12.8 3.9 7.3 1.4 17.4 9.8 2.4 5.0 3.0 1.8 1.1 7.8 3.1 3.2 4.4 1.5 4.8 8.4 4.4 5.2 2.0 4.8 8.3 2.0 5.5 2.4 1.9 1.2 2.0 1.7 1.7 1.3 2.3 2.1 3.0 10.7 1.7 2.4 1.4 0.6 1.2 2.6 4.6 2.3 2.9 2.9 2.8 4.1 1.7 4.3 6.0 0.0 5.9 2.0 4.6 6.5 6.1 4.5 0.0 9.4 3.4 8.7 3.9 1.8 1.7 4.3 0.4 7.1 2.8 0.0 12.0 1.9 5.4 5.7 9.2 2.4 12.0 1.6 4.6 9.2 9.9 1.1 6.6 5.4 18.6 1.8 6.2 3.8 6.0 2.9 9.2 5.4 3.6 32.3 4.2 0.9 5.4 14.4 1.8 5.0 4.1 5.5 ATP7B WND ENSG00000123191 "ATPase copper transporting beta" P35670 13 51930436-52012125 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" Translocase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 18.5;liver: 13.5" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 21.6;Early spermatids: 29.4;Late spermatids: 57.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 19.3;CACO-2: 11.1;HEL: 29.3;Hep G2: 10.1;RPTEC TERT1: 17.1" "Low region specificity" "Detected in many" "HPA009137, HPA013187" Supported Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA009137: AB_2668214, HPA013187: AB_1845206" "unprognostic (1.13e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (3.49e-1)" "unprognostic (5.51e-2)" "unprognostic (1.55e-2)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (5.77e-2)" "unprognostic (8.29e-2)" "unprognostic (1.17e-1)" "unprognostic (3.26e-3)" "unprognostic (4.66e-2)" "unprognostic (3.54e-1)" "unprognostic (6.21e-3)" "unprognostic (1.40e-1)" 3.4 0.7 1.8 2.4 2.9 1.8 1.6 7.0 2.8 1.4 6.8 1.1 1.1 10.5 1.6 1.9 1.1 1.9 18.5 1.8 2.1 2.1 2.1 13.5 1.2 1.1 1.6 1.1 2.0 1.7 7.7 1.2 7.1 3.5 1.9 2.6 1.4 3.0 1.1 1.1 0.7 9.6 1.5 1.1 1.6 4.5 7.1 1.6 1.1 1.1 1.1 1.1 2.1 1.1 0.0 0.0 1.0 0.3 0.0 0.5 0.1 0.4 1.6 3.0 2.7 0.6 0.5 19.3 0.8 0.2 0.9 0.7 11.1 0.1 0.0 0.3 1.4 2.1 0.2 2.1 2.4 0.6 0.2 4.1 29.3 0.3 10.1 0.9 0.3 6.9 1.2 2.9 0.1 1.1 1.3 2.1 2.1 7.8 0.0 0.9 0.5 0.1 0.7 1.0 3.7 1.0 1.1 0.8 0.0 17.1 1.9 2.2 1.3 1.1 1.6 1.1 3.4 4.6 0.2 1.1 0.1 1.0 1.6 0.3 0.3 0.4 0.1 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.8 2.9 7.0 2.8 2.1 2.1 1.6 1.1 3.5 1.6 6.0 0.0 1.7 0.7 0.3 3.0 1.8 0.0 5.3 3.4 1.8 21.6 10.2 0.0 1.5 29.4 1.1 6.1 0.0 0.8 4.4 0.6 1.3 0.0 16.3 2.0 0.0 2.4 3.7 1.0 57.4 2.0 0.0 1.7 0.0 4.0 0.5 1.7 2.9 0.7 1.3 6.7 6.5 0.9 1.1 1.9 0.4 3.8 0.0 4.7 1.1 ATP8A1 ATPIA ENSG00000124406 "ATPase phospholipid transporting 8A1" Q9Y2Q0 4 42408373-42657105 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 38.9" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 61.4;Cone photoreceptor cells: 76.6;Horizontal cells: 58.8;Intestinal endocrine cells: 81.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 17.2;Daudi: 28.1;HEL: 9.9;REH: 9.7;SH-SY5Y: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052935 Enhanced Supported Vesicles NA NA 20000 Vesicles "HPA052935: AB_2681992" "unprognostic (8.63e-2)" "unprognostic (3.43e-2)" "unprognostic (1.16e-2)" "unprognostic (7.61e-2)" "unprognostic (6.59e-2)" "unprognostic (6.82e-3)" "unprognostic (7.69e-2)" "unprognostic (2.02e-3)" "unprognostic (3.99e-1)" "unprognostic (2.99e-3)" "unprognostic (4.39e-2)" "unprognostic (9.71e-2)" "prognostic favorable (5.54e-10)" "unprognostic (2.43e-1)" "unprognostic (3.25e-1)" "unprognostic (8.21e-2)" "unprognostic (2.25e-1)" 5.3 8.6 14.2 8.0 29.6 18.5 4.8 7.2 32.0 3.1 11.3 27.3 8.4 4.2 3.4 11.6 2.9 3.5 2.8 8.0 13.7 8.8 4.0 2.1 10.6 12.5 18.0 17.4 15.1 10.0 38.9 6.9 2.6 15.3 7.9 10.7 3.9 4.4 15.2 16.9 3.2 8.1 3.1 23.1 7.8 10.5 2.8 24.9 8.9 34.9 1.9 10.3 4.5 4.0 4.4 3.8 0.9 3.3 3.2 7.3 0.9 0.0 0.1 0.3 17.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.2 28.1 8.0 0.1 0.0 1.4 4.0 0.0 0.0 4.4 2.8 9.9 1.0 0.4 0.0 2.4 0.2 0.3 0.0 0.0 0.0 0.3 0.1 6.3 0.0 3.2 0.0 1.2 3.5 0.8 1.3 1.1 0.3 9.7 0.0 3.1 6.1 0.3 3.1 9.3 0.2 5.9 0.0 0.7 1.9 0.0 0.2 0.0 1.3 0.3 0.0 1.1 0.0 5.7 0.4 3.4 0.1 0.0 1.0 0.9 6.0 0.4 3.2 2.6 1.9 6.5 0.9 4.4 2.9 7.3 0.9 3.2 3.3 3.8 1.4 0.9 14.2 29.6 7.2 22.1 13.7 8.8 18.0 17.4 15.3 24.9 26.8 61.4 5.1 1.7 1.3 17.7 12.8 0.0 0.0 9.1 5.2 76.6 0.0 3.3 0.0 3.0 9.3 46.1 0.0 2.2 0.1 2.2 16.2 8.1 1.1 1.5 58.8 81.2 17.8 7.5 2.3 3.1 3.8 3.3 1.8 23.3 1.0 0.8 7.0 1.8 1.4 41.3 0.0 0.3 1.1 4.1 1.3 0.0 21.8 23.1 2.4 ATP8A2 "ATPIB, ML-1" ENSG00000132932 "ATPase phospholipid transporting 8A2" Q9NTI2 13 25372071-26025851 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 34.9;pituitary gland: 37.0;testis: 10.4" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 90.3;Early spermatids: 29.4;Rod photoreceptor cells: 86.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3;naive CD8 T-cell: 3.3" "Lineage enriched" "Detected in single" 12 "T-cells: 3.3" "Group enriched" "Detected in some" 4 "HMC-1: 21.6;JURKAT: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039926, HPA040033" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA039926: AB_10794205, HPA040033: AB_2676809" "unprognostic (3.79e-2)" "unprognostic (4.28e-2)" "unprognostic (3.32e-2)" "unprognostic (1.95e-4)" "unprognostic (3.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.31e-2)" "unprognostic (2.97e-3)" "unprognostic (2.77e-1)" "unprognostic (3.66e-1)" "unprognostic (4.96e-4)" "unprognostic (1.24e-1)" "unprognostic (1.18e-2)" "unprognostic (4.20e-5)" "unprognostic (9.10e-2)" "unprognostic (2.95e-1)" "unprognostic (7.22e-2)" 1.1 4.9 11.2 1.4 11.4 0.8 2.2 34.9 30.2 1.1 1.3 1.3 0.0 1.4 2.1 4.8 0.9 0.9 1.0 1.0 9.4 11.8 1.3 0.8 2.3 1.9 6.7 10.4 1.2 1.9 0.9 37.0 1.2 19.8 1.1 1.3 3.1 1.0 1.0 1.3 0.9 1.5 1.0 3.5 1.3 1.8 10.4 1.4 0.0 1.0 0.0 1.2 1.2 0.3 0.0 0.0 0.2 0.0 0.2 3.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 21.6 0.2 0.0 0.0 0.0 0.6 0.5 9.6 0.0 0.0 1.7 0.3 3.7 0.0 2.0 0.0 0.7 0.0 2.7 1.0 0.2 0.1 3.3 0.0 0.1 0.3 0.1 0.4 0.0 0.4 0.2 0.1 1.1 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.8 0.6 0.0 0.0 2.3 3.3 0.2 0.2 0.0 0.0 0.7 0.6 11.2 11.4 34.9 18.4 9.4 11.8 6.7 10.4 19.8 1.4 0.0 9.8 0.9 0.1 0.9 20.0 2.2 2.5 0.0 0.0 0.0 90.3 1.2 0.0 0.3 29.4 1.5 0.0 0.0 0.0 0.3 0.4 0.2 4.7 0.0 2.4 20.6 0.0 0.0 0.0 24.5 0.9 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.1 0.6 86.2 12.9 0.0 12.9 9.9 0.4 0.9 0.5 0.0 0.0 ATP8B1 "ATPIC, BRIC, FIC1, PFIC, PFIC1" ENSG00000081923 "ATPase phospholipid transporting 8B1" O43520 18 57646426-57803101 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hearing, Lipid transport, Transport" Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 198.4;Mucus-secreting cells: 179.9;Undifferentiated cells: 138.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.5;HBF TERT88: 24.7;RT4: 58.5" "Low region specificity" "Detected in many" "HPA018673, HPA018674" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA018673: AB_1845207, HPA018674: AB_1845208" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "prognostic favorable (2.60e-4)" "unprognostic (8.81e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (9.62e-3)" "unprognostic (1.97e-1)" "unprognostic (3.30e-3)" "unprognostic (4.55e-3)" "prognostic favorable (6.35e-4)" "unprognostic (1.88e-1)" "unprognostic (2.22e-1)" "unprognostic (3.25e-1)" "unprognostic (8.60e-3)" 3.8 2.3 0.0 1.8 0.0 0.0 3.4 0.0 0.3 4.5 21.3 8.9 2.4 0.8 6.7 2.6 4.8 1.8 0.2 0.0 2.1 3.0 3.6 0.0 0.1 0.7 10.7 2.7 1.1 1.3 6.0 19.3 5.8 2.8 0.4 3.6 11.1 2.0 0.2 1.2 13.3 0.0 5.7 0.2 12.8 5.4 6.0 2.0 4.7 2.1 0.7 1.3 0.3 10.2 3.5 0.1 0.1 3.6 6.6 5.0 19.9 19.4 21.0 13.1 2.6 8.9 0.7 6.0 27.5 8.3 15.2 0.1 4.2 24.7 0.2 0.4 0.1 0.9 0.9 1.1 0.2 0.1 1.0 3.8 6.3 11.1 15.5 11.0 0.2 0.1 0.4 12.1 4.9 0.2 0.2 0.2 11.0 1.0 0.1 0.1 0.2 2.9 58.5 0.4 0.3 0.4 12.3 0.1 0.5 3.8 0.6 12.6 17.1 0.6 2.7 4.6 0.2 0.1 0.2 0.4 0.2 0.9 0.8 2.1 0.5 1.3 0.9 1.0 2.7 1.0 0.7 0.5 6.0 0.9 1.0 4.7 0.7 1.2 2.0 0.4 0.3 17.9 18.2 4.5 44.8 6.9 0.7 4.0 33.1 40.2 48.9 38.4 0.0 17.1 0.0 20.8 2.0 26.8 198.4 0.0 45.9 1.9 5.1 74.4 4.6 16.8 2.3 6.4 65.7 30.1 3.8 0.0 0.3 1.3 6.8 1.0 179.9 0.2 33.7 74.8 0.0 0.1 1.1 12.9 17.6 0.3 1.2 14.3 9.2 1.5 138.5 100.6 ATP8B2 "ATPID, KIAA1137" ENSG00000143515 "ATPase phospholipid transporting 8B2" P98198 1 154325553-154351307 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ito cells: 12.3;Peritubular cells: 13.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 3.1;T-cells: 6.5" "Cell line enhanced" "Detected in many" "ASC diff: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046680 Approved NA NA "HPA046680: AB_2679749" "unprognostic (1.68e-1)" "unprognostic (3.68e-1)" "unprognostic (8.40e-2)" "unprognostic (5.16e-2)" "unprognostic (4.52e-1)" "unprognostic (8.17e-2)" "unprognostic (2.27e-2)" "unprognostic (6.93e-3)" "unprognostic (2.57e-1)" "unprognostic (1.69e-1)" "prognostic favorable (1.60e-4)" "unprognostic (2.82e-1)" "unprognostic (1.89e-3)" "unprognostic (7.77e-3)" "unprognostic (6.58e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (5.29e-5)" 13.6 7.0 5.5 15.0 7.1 3.4 11.9 26.8 8.9 29.1 11.2 7.4 11.5 8.6 28.9 15.2 14.4 21.5 18.4 11.7 7.0 6.8 6.6 2.6 12.2 16.1 6.2 5.8 27.5 5.3 5.1 13.9 10.9 6.1 15.3 6.8 12.5 5.4 16.4 4.3 6.1 11.8 29.4 5.1 14.7 11.4 12.7 5.1 18.9 11.2 8.1 13.6 20.5 24.9 0.6 0.7 3.1 0.0 0.9 6.5 1.0 0.7 5.1 6.5 6.7 41.8 28.3 0.1 15.7 26.2 9.1 10.9 0.1 0.2 0.6 8.3 37.9 6.0 3.2 7.8 1.8 6.4 17.2 6.3 6.5 6.3 5.9 12.7 0.0 5.1 18.2 0.4 13.8 13.2 12.0 14.0 8.3 12.9 15.8 7.7 6.7 12.2 0.8 15.5 0.1 6.5 13.6 4.5 23.4 1.7 0.1 5.8 8.0 4.1 0.9 9.8 9.7 4.8 4.9 12.2 13.8 7.0 17.3 4.7 21.9 26.8 3.9 4.8 0.7 8.4 3.1 0.0 3.0 2.2 0.0 1.5 0.6 3.5 3.7 0.0 0.4 2.9 2.5 0.1 0.9 0.0 0.7 6.5 1.0 5.5 7.1 26.8 8.9 7.0 6.8 6.2 5.8 6.1 5.1 3.0 5.0 2.2 1.5 2.3 0.7 5.1 0.0 6.7 3.4 0.0 2.0 0.1 0.0 1.2 0.4 8.4 0.0 0.0 0.2 0.4 8.1 4.3 7.0 0.9 0.4 7.9 0.0 12.3 1.0 0.4 10.6 0.0 6.8 0.0 0.0 2.6 1.4 0.0 13.8 0.1 0.4 0.0 6.2 2.6 3.6 1.4 0.2 8.2 0.0 0.4 ATP8B3 ATPIK ENSG00000130270 "ATPase phospholipid transporting 8B3" O60423 19 1782075-1812276 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 55.8" "Cell type enhanced" "Detected in many" 17 "Late spermatids: 8.9;Spermatocytes: 26.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "intermediate monocyte: 6.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 10.6;Karpas-707: 18.7;U-266/70: 15.6" "Not detected" "Not detected" NA NA "unprognostic (6.50e-2)" "unprognostic (1.81e-2)" "unprognostic (1.02e-1)" "unprognostic (6.05e-5)" "unprognostic (6.66e-2)" "unprognostic (7.91e-2)" "unprognostic (1.86e-2)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (2.55e-3)" "unprognostic (1.28e-2)" "unprognostic (6.15e-3)" "prognostic unfavorable (4.80e-9)" "unprognostic (8.05e-2)" "unprognostic (3.20e-1)" "unprognostic (3.19e-2)" "unprognostic (1.19e-1)" 0.6 3.1 0.2 3.1 0.2 7.1 0.6 0.2 0.7 1.5 0.7 0.2 0.2 0.4 1.8 4.3 0.6 0.6 1.0 2.2 0.3 0.2 0.4 1.0 1.9 1.1 0.2 0.5 1.9 0.3 0.3 0.6 0.5 0.4 0.5 0.4 1.1 0.5 1.6 0.2 0.8 0.7 1.0 0.7 4.8 0.4 55.8 0.0 5.5 0.7 1.2 1.5 0.8 1.0 0.1 1.2 1.7 6.9 2.2 2.8 1.2 0.6 5.1 0.6 0.8 0.7 0.5 0.0 2.0 3.1 2.0 1.9 0.0 2.1 2.2 2.3 1.6 0.2 0.1 0.4 0.0 0.9 2.1 0.1 0.7 2.5 1.0 0.2 1.3 10.6 0.2 0.2 0.0 2.2 3.0 0.5 6.5 1.6 18.7 3.3 0.0 1.4 3.9 0.1 0.3 2.4 2.2 0.4 0.3 2.7 0.1 0.0 0.7 0.5 0.0 0.3 0.6 0.6 6.5 4.9 0.1 4.1 0.8 2.1 15.6 7.6 0.6 4.0 6.5 2.6 0.0 2.2 1.7 1.9 6.9 0.8 0.0 1.4 1.1 1.2 0.1 0.6 1.9 0.6 2.2 1.8 0.5 2.8 1.2 0.2 0.2 0.2 0.7 0.3 0.2 0.2 0.5 0.4 0.0 0.0 1.1 0.0 0.6 0.7 1.9 1.4 2.5 0.0 0.0 0.0 2.0 0.1 0.0 0.8 6.2 1.0 0.0 0.0 0.2 0.9 1.4 0.3 1.1 0.8 1.3 0.0 0.0 5.5 3.3 8.9 0.3 0.5 1.7 0.0 0.0 0.8 0.2 0.0 0.4 0.0 0.6 0.0 0.9 26.5 3.2 1.3 0.3 2.5 0.0 0.1 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2" "Group enriched" "Detected in many" 4 "Early spermatids: 23.4;granulocytes: 19.6;Hofbauer cells: 12.9;Kupffer cells: 29.9;Late spermatids: 19.9;Macrophages: 17.3;T-cells: 8.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 6.9;NK-cell: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 19.1;NB-4: 7.3;THP-1: 12.3;U-937: 38.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040254 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 2.3 1.2 1.6 1.5 2.1 28.1 1.0 0.6 0.9 26.0 1.5 1.7 1.6 0.4 18.2 3.5 0.6 9.5 3.1 0.8 2.5 0.9 1.0 1.2 3.2 0.7 2.7 0.1 3.9 0.4 0.2 1.1 2.9 2.1 0.7 1.2 0.8 0.9 0.6 0.4 0.5 1.1 2.7 3.1 2.3 0.6 0.9 4.6 0.8 0.5 0.8 2.1 1.3 1.5 0.0 2.2 6.9 1.7 10.6 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 5.2 0.0 3.0 0.6 0.0 0.0 5.3 19.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 38.5 0.0 6.9 1.7 2.4 0.5 0.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.8 10.6 0.3 0.0 0.0 0.8 1.6 2.1 0.6 0.9 2.5 0.9 2.7 0.1 2.1 4.6 0.0 3.4 1.3 0.1 1.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 23.4 0.5 0.4 0.0 0.0 1.6 3.3 0.5 19.6 2.8 12.9 0.0 0.0 1.8 29.9 19.9 1.7 17.3 1.7 1.0 0.3 0.5 0.0 0.0 0.7 0.8 0.0 0.0 4.3 0.4 0.6 0.3 2.4 8.6 0.0 0.1 ATP9A "ATPIIA, KIAA0611" ENSG00000054793 "ATPase phospholipid transporting 9A (putative)" O75110 20 51596514-51768634 "Enzymes, Predicted membrane proteins, Transporters" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.7" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 6.3;NK-cell: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 6.3;NK-cells: 2.2" "Cell line enhanced" "Detected in many" "EFO-21: 29.3;SK-BR-3: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020699, HPA035630" Enhanced NA NA "CAB020699: , HPA035630: AB_10669526" "unprognostic (5.19e-2)" "unprognostic (5.28e-2)" "unprognostic (3.46e-1)" "unprognostic (1.05e-1)" "unprognostic (3.76e-1)" "unprognostic (1.37e-1)" "unprognostic (3.76e-2)" "unprognostic (4.79e-2)" "unprognostic (7.45e-2)" "unprognostic (1.58e-1)" "unprognostic (1.26e-2)" "unprognostic (1.79e-1)" "prognostic favorable (5.67e-5)" "unprognostic (5.82e-2)" "unprognostic (5.81e-1)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" 18.5 8.2 23.7 3.9 31.8 2.0 11.2 29.8 64.7 5.6 12.2 19.9 8.2 9.1 8.6 13.1 8.8 16.9 8.2 7.7 24.3 26.8 6.8 5.4 6.7 2.6 21.1 23.9 13.2 10.0 22.7 8.3 3.6 22.5 14.3 11.3 4.1 14.9 11.3 9.2 4.1 11.5 8.7 18.9 2.2 14.0 12.4 15.8 0.8 18.7 2.9 2.4 7.4 5.6 0.0 0.0 6.3 0.2 2.2 0.8 1.8 9.7 8.3 6.9 15.4 20.3 15.1 0.1 3.5 6.7 2.3 0.7 19.1 20.3 0.0 29.3 14.5 11.7 7.8 9.0 5.1 2.3 7.5 2.7 0.0 9.2 7.7 2.8 0.0 0.0 5.0 10.4 0.5 1.4 5.4 12.5 1.8 0.0 0.0 2.6 13.6 0.7 0.0 1.2 9.9 10.6 1.5 0.0 0.0 4.7 13.7 13.0 9.3 14.0 28.1 5.1 2.5 5.3 0.2 8.1 19.3 5.2 7.5 1.5 0.0 0.1 0.3 5.1 0.0 1.7 6.3 0.0 0.0 0.8 0.2 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.4 2.2 0.1 0.0 0.0 1.8 23.7 31.8 29.8 34.9 24.3 26.8 21.1 23.9 22.5 15.8 14.9 12.8 0.0 10.2 2.6 32.1 11.5 30.6 17.4 14.8 17.4 3.9 0.3 1.7 18.0 0.6 5.4 32.5 0.0 14.8 0.2 7.1 27.0 1.1 10.0 4.5 41.3 53.0 11.1 2.7 1.7 12.4 1.6 3.3 0.0 36.1 4.5 21.7 24.6 21.9 1.2 6.4 6.5 7.1 0.9 1.5 3.6 0.2 0.5 19.7 25.5 ATP9B ATPIIB ENSG00000166377 "ATPase phospholipid transporting 9B (putative)" O43861 18 79069285-79378287 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 119.1;Alveolar cells type 2: 156.1;Ciliated cells: 168.6;Club cells: 95.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029364 Approved NA NA "HPA029364: AB_10602595" "unprognostic (2.84e-3)" "unprognostic (1.66e-1)" "unprognostic (1.88e-1)" "unprognostic (6.51e-3)" "unprognostic (7.32e-2)" "unprognostic (7.66e-4)" "unprognostic (2.45e-2)" "unprognostic (7.43e-2)" "unprognostic (2.55e-2)" "unprognostic (8.21e-2)" "unprognostic (1.61e-1)" "unprognostic (2.93e-1)" "unprognostic (1.92e-3)" "unprognostic (1.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.05e-2)" "unprognostic (1.09e-2)" 14.5 11.0 11.7 16.8 11.6 30.1 11.7 16.8 15.2 14.3 10.7 17.5 15.2 7.1 21.8 17.6 11.3 11.9 14.5 10.7 11.4 8.2 13.1 16.7 13.9 13.2 10.8 9.7 18.2 14.3 25.8 15.5 10.9 11.3 12.8 11.4 12.3 14.2 17.3 18.8 13.3 9.1 14.8 17.1 9.7 11.5 22.1 12.4 19.3 14.6 9.6 16.4 14.6 13.3 9.8 8.4 14.2 16.3 8.6 12.2 6.9 15.2 8.0 11.2 12.4 5.8 9.8 8.7 8.2 5.6 4.9 4.2 8.6 10.9 8.5 13.7 5.9 4.7 6.9 9.2 4.6 8.0 13.1 3.9 10.0 9.2 6.1 7.7 18.2 10.7 7.8 5.8 8.0 4.9 7.3 6.8 10.5 9.6 21.5 6.9 13.3 11.9 7.1 15.9 9.7 10.0 11.4 9.3 11.4 7.0 13.2 8.3 8.7 9.2 9.7 5.6 20.2 11.4 10.8 12.0 10.4 16.9 4.7 5.4 10.8 17.6 19.1 6.0 12.1 10.7 14.2 12.0 9.1 8.4 10.1 9.8 9.0 9.6 8.1 8.4 9.8 12.2 9.5 13.0 8.6 16.3 8.0 7.4 6.9 11.7 11.6 16.8 15.2 11.4 8.2 10.8 9.7 11.3 12.4 119.1 156.1 11.9 6.2 5.0 34.8 10.3 15.3 168.6 95.5 8.7 39.3 5.6 1.7 5.4 19.8 9.8 5.4 0.0 4.9 3.3 7.8 5.5 40.6 6.4 12.9 39.7 11.5 9.2 11.3 34.5 14.7 12.2 6.8 5.4 7.8 17.8 6.6 9.0 10.6 3.1 39.0 6.5 7.3 26.1 16.4 6.4 6.4 16.0 8.1 7.0 ATRAID "APR3, C2orf28, HSPC013, p18" ENSG00000138085 "All-trans retinoic acid induced differentiation factor" Q6UW56 2 27212027-27217178 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051353 Uncertain NA NA "HPA051353: AB_2681451" "unprognostic (4.58e-2)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (1.34e-1)" "unprognostic (3.85e-2)" "unprognostic (4.41e-2)" "unprognostic (1.59e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (1.25e-2)" "unprognostic (5.73e-2)" "unprognostic (5.35e-3)" "unprognostic (2.36e-2)" "unprognostic (4.86e-2)" "unprognostic (1.77e-1)" "unprognostic (3.76e-1)" "unprognostic (1.92e-1)" 33.2 41.3 18.0 24.8 19.7 19.7 51.7 11.8 20.8 38.3 34.2 26.0 47.0 18.6 36.9 119.7 35.4 43.0 37.0 77.9 17.4 17.1 41.5 34.8 41.6 42.9 24.7 13.8 46.5 70.7 34.2 33.0 60.0 23.7 41.0 30.5 41.0 37.5 48.1 39.9 27.9 33.6 41.0 22.4 28.1 32.9 54.1 21.2 22.5 52.7 32.4 29.3 33.5 30.1 63.9 70.8 48.0 59.8 42.4 62.8 92.9 25.0 30.5 17.2 31.2 96.5 57.4 26.5 15.8 51.0 21.3 19.8 24.4 40.3 12.2 27.1 44.8 29.6 23.0 15.8 28.5 17.5 19.3 15.3 14.5 18.8 36.2 43.3 12.7 19.7 45.1 62.4 18.0 40.6 47.6 27.4 22.9 14.7 43.3 32.2 33.7 15.2 34.8 25.9 56.1 24.9 13.8 44.8 59.9 36.0 14.6 18.8 26.9 18.1 24.4 24.4 26.5 20.8 21.2 16.8 32.6 18.5 11.7 15.7 60.6 48.0 31.9 34.4 25.8 31.1 37.5 59.8 48.0 51.2 52.3 52.2 63.9 58.9 57.9 61.0 60.3 62.7 57.5 13.4 42.4 54.1 70.8 62.8 92.9 18.0 19.7 11.8 20.8 17.4 17.1 24.7 13.8 23.7 21.2 56.6 65.5 106.9 140.6 90.8 39.9 149.4 122.3 123.1 101.2 136.1 17.7 233.2 154.2 145.9 121.8 116.3 61.4 0.0 168.7 270.9 177.9 110.4 88.9 70.2 187.5 27.0 88.2 98.2 113.0 171.2 181.8 101.8 167.0 176.7 117.0 126.6 119.3 137.0 132.6 165.6 34.8 51.8 140.1 286.7 168.2 88.1 209.5 96.9 138.2 126.5 ATRN "DPPT-L, MGCA" ENSG00000088812 Attractin O75882 20 3471040-3651122 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008853 Approved Approved Cytosol "Secreted to blood" NA NA 39000000000 Cytosol "HPA008853: AB_1078248" "unprognostic (6.42e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (2.52e-1)" "unprognostic (5.27e-2)" "unprognostic (1.65e-1)" "unprognostic (3.99e-2)" "unprognostic (4.28e-1)" "unprognostic (3.40e-2)" "unprognostic (4.61e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.19e-6)" "unprognostic (3.71e-2)" "unprognostic (9.49e-2)" "unprognostic (2.77e-1)" "unprognostic (3.91e-2)" 12.1 22.8 14.9 7.4 20.7 5.7 13.0 18.4 29.3 13.5 22.8 18.3 7.4 39.9 12.2 12.2 9.3 9.2 12.4 14.8 13.6 14.7 18.4 45.2 10.6 7.1 12.8 18.9 11.5 17.7 40.3 13.4 16.5 16.1 10.1 9.5 12.2 14.0 10.7 11.7 13.6 31.1 11.3 15.2 9.7 17.1 16.2 12.3 5.4 24.1 7.5 7.1 12.0 9.8 3.6 5.7 5.7 6.5 3.0 4.8 1.9 17.9 16.9 10.1 8.4 17.9 29.3 12.9 12.0 17.1 12.7 10.8 7.2 12.3 0.0 8.1 16.8 15.6 25.2 6.8 26.2 17.0 2.0 5.8 5.6 4.7 15.6 10.8 11.9 3.8 15.6 21.3 13.4 13.0 15.9 16.4 3.9 8.8 8.8 12.3 5.1 4.8 4.5 6.7 5.9 10.2 4.0 23.4 13.4 11.6 12.8 6.0 9.3 12.0 22.4 16.4 10.3 12.0 11.4 20.1 13.5 8.0 14.2 11.8 6.2 8.7 0.0 8.3 8.0 13.5 5.7 6.5 3.6 4.8 5.6 2.3 2.8 2.7 3.0 5.7 3.6 4.4 3.7 0.0 3.0 5.7 5.3 3.4 1.9 14.9 20.7 18.4 29.3 13.6 14.7 12.8 18.9 16.1 12.3 14.9 7.2 7.3 3.8 5.7 22.1 10.4 22.9 6.7 5.7 10.4 35.3 6.4 1.7 6.4 6.3 8.4 6.1 0.0 12.5 7.2 9.3 6.1 6.9 39.5 9.6 35.0 9.2 20.9 13.9 2.5 11.5 6.3 6.8 6.4 10.2 12.7 10.7 15.3 7.4 7.9 18.2 32.3 5.2 16.7 21.7 6.4 4.2 5.0 10.5 3.1 ATRNL1 "ALP, FLJ45344, KIAA0534" ENSG00000107518 "Attractin like 1" Q5VV63 10 115093365-115948992 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 40.4;Early spermatids: 37.4;Ito cells: 32.5;Late spermatids: 28.8;Spermatocytes: 41.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enhanced" "Detected in many" "AN3-CA: 20.5;RH-30: 13.7;U-266/70: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038070 Uncertain Approved Nucleoplasm,Mitochondria NA NA 33000000 "Nucleoplasm, Mitochondria" "HPA038070: AB_10697237" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "unprognostic (5.88e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.88e-2)" "unprognostic (5.17e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" "unprognostic (2.50e-2)" "unprognostic (1.04e-3)" "unprognostic (3.10e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (2.08e-3)" 0.9 11.7 8.6 0.7 15.9 0.3 2.1 2.2 26.0 0.9 2.3 2.1 1.1 0.8 12.0 1.1 1.5 1.0 0.8 2.9 9.3 5.8 4.8 2.9 0.6 1.0 4.0 15.7 17.5 2.3 0.3 11.1 3.3 8.4 6.9 0.9 2.0 1.8 8.3 3.8 0.6 1.0 13.4 2.0 0.8 0.9 13.0 2.5 0.0 2.0 0.0 0.9 1.1 1.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.2 20.5 0.0 0.0 0.0 0.1 0.4 3.0 4.4 0.1 0.1 0.0 1.4 0.5 4.2 0.0 1.1 0.0 3.5 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 8.6 0.0 8.6 0.0 6.9 9.4 0.2 8.0 0.0 6.7 0.0 0.1 5.9 13.7 8.9 3.1 0.0 3.4 9.9 0.0 0.0 0.2 3.8 1.2 0.0 0.0 0.0 2.5 0.0 2.9 11.3 0.0 3.3 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 15.9 2.2 26.0 9.3 5.8 4.0 15.7 8.4 2.5 0.0 0.0 0.0 0.1 0.6 40.4 1.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.6 37.4 0.0 0.0 0.0 0.3 0.0 1.1 0.1 0.0 0.0 2.2 9.5 0.0 32.5 3.2 28.8 1.4 0.0 0.0 0.0 0.0 4.0 0.5 0.0 0.7 0.3 4.4 0.0 0.4 41.3 5.3 0.1 0.2 0.0 0.0 0.0 AUP1 ENSG00000115307 "AUP1, lipid droplet regulating VLDL assembly factor" Q9Y679 2 74526645-74529939 "Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007674 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA007674: AB_1078251" "unprognostic (1.09e-1)" "unprognostic (2.95e-2)" "unprognostic (1.97e-2)" "unprognostic (2.11e-2)" "unprognostic (5.97e-2)" "unprognostic (2.96e-3)" "prognostic unfavorable (2.29e-4)" "unprognostic (2.00e-1)" "unprognostic (2.73e-1)" "unprognostic (3.79e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-1)" "prognostic unfavorable (2.97e-9)" "unprognostic (9.68e-2)" "unprognostic (1.59e-1)" "unprognostic (3.35e-1)" "unprognostic (3.96e-2)" 18.8 21.7 13.9 15.5 16.9 9.4 24.2 18.0 16.7 25.7 28.2 14.6 18.4 14.0 14.6 17.8 25.6 15.4 12.5 14.1 11.8 11.2 19.2 44.5 14.4 21.1 18.4 8.0 11.8 44.2 26.4 14.1 20.6 15.1 13.6 25.9 13.5 29.8 17.6 34.6 25.2 31.3 18.0 12.2 18.2 26.0 10.6 14.4 13.5 19.0 11.7 19.9 16.7 13.5 26.3 38.0 30.6 46.3 20.7 31.6 36.4 15.1 22.7 5.8 9.9 34.7 17.3 16.0 11.0 25.3 20.4 10.7 35.4 10.9 15.5 7.8 21.4 38.8 18.6 25.0 19.3 14.5 13.3 23.8 23.0 11.6 29.5 36.7 12.0 11.9 22.9 42.6 30.8 28.6 11.8 21.3 20.2 30.3 21.5 21.7 21.8 12.4 14.4 15.0 58.5 19.5 16.0 24.0 45.5 22.8 12.9 9.3 10.5 10.9 33.7 26.1 9.9 14.8 19.1 8.1 16.5 10.2 4.0 17.4 5.4 8.7 19.0 19.8 16.2 29.1 28.4 39.3 30.6 25.0 46.3 30.2 24.3 26.4 27.3 38.0 26.3 22.1 24.7 19.1 20.7 40.4 35.8 31.6 36.4 13.9 16.9 18.0 16.7 11.8 11.2 18.4 8.0 15.1 14.4 62.5 39.4 71.5 92.4 65.0 32.0 29.5 63.7 32.1 45.5 64.6 13.7 119.5 19.9 114.5 16.9 64.6 148.5 23.3 181.0 166.6 79.4 112.4 86.7 93.6 145.8 35.0 70.9 41.7 72.1 22.0 41.1 89.5 92.8 62.3 95.5 74.6 135.1 112.2 35.7 52.8 33.4 58.2 59.8 85.0 60.7 68.8 187.2 80.9 105.4 119.9 AVPR1A AVPR1 ENSG00000166148 "Arginine vasopressin receptor 1A" P37288 12 63142759-63150942 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 34.9;liver: 71.2" "Group enriched" "Detected in some" 9 "Hepatocytes: 50.5;Sertoli cells: 77.6;Smooth muscle cells: 34.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "ASC diff: 6.9;Karpas-707: 15.4;U-266/84: 10.7" "Group enriched" "Detected in some" 5 "basal ganglia: 7.1;hypothalamus: 4.4" "Low region specificity" "Detected in all" NA NA "unprognostic (1.49e-1)" "unprognostic (2.82e-1)" "unprognostic (9.90e-3)" "unprognostic (2.90e-1)" "unprognostic (1.59e-1)" "unprognostic (1.43e-3)" "unprognostic (3.79e-2)" "unprognostic (2.60e-1)" "unprognostic (3.58e-6)" "unprognostic (1.45e-1)" "unprognostic (7.29e-2)" "unprognostic (1.55e-1)" "unprognostic (1.38e-3)" "unprognostic (4.65e-3)" "unprognostic (1.25e-1)" "unprognostic (4.77e-2)" "unprognostic (4.66e-4)" 26.4 34.9 0.3 2.8 0.3 0.0 6.3 0.2 0.4 9.7 4.2 0.5 1.1 0.2 16.5 2.1 2.5 3.7 3.4 2.5 0.3 0.3 4.2 71.2 0.7 1.5 0.3 0.0 3.8 1.5 1.1 1.0 1.2 0.6 3.2 0.5 0.5 1.1 2.4 4.4 1.3 0.8 7.5 0.3 0.5 1.5 1.8 0.0 0.6 6.1 3.0 0.4 6.2 2.6 0.0 0.0 0.9 0.0 0.0 0.0 1.2 0.2 0.3 0.7 0.0 6.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.3 0.3 0.2 0.4 0.3 0.3 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.0 0.1 3.2 2.5 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.2 0.7 0.0 0.0 50.5 0.2 0.0 0.0 0.6 1.3 0.0 2.6 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.3 77.6 34.1 0.2 0.2 0.3 0.1 0.0 0.0 0.3 AVPR1B AVPR3 ENSG00000198049 "Arginine vasopressin receptor 1B" P47901 1 206109692-206117699 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "pituitary gland: 52.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "renal cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;NTERA-2: 1.0;PC-3: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075404 Enhanced NA NA "HPA075404: AB_2732291" "unprognostic (4.87e-2)" "unprognostic (1.44e-1)" "unprognostic (4.82e-1)" "unprognostic (2.82e-1)" "unprognostic (2.87e-1)" "unprognostic (1.08e-2)" "unprognostic (3.33e-1)" "unprognostic (2.96e-2)" "unprognostic (6.23e-2)" "unprognostic (7.65e-2)" "unprognostic (1.86e-1)" "unprognostic (6.66e-3)" 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.6 0.5 0.1 1.3 0.0 0.0 1.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 52.8 0.1 0.1 0.2 0.8 0.0 0.0 0.4 0.0 0.0 1.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 1.0 0.0 3.6 0.0 0.0 0.2 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AVPR2 "DIR, DIR3, V2R" ENSG00000126895 "Arginine vasopressin receptor 2" P30518 X 153902531-153907166 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Diabetes insipidus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 8.9" "Cell type enriched" "Detected in some" 8 "Collecting duct cells: 47.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 26 "intermediate monocyte: 6.2;non-classical monocyte: 5.3" "Lineage enriched" "Detected in single" 28 "monocytes: 6.2" "Cell line enhanced" "Detected in some" "EFO-21: 5.7;SCLC-21H: 6.6;U-266/84: 6.0;U-698: 6.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "cerebellum: 7.9" NA NA "unprognostic (3.05e-2)" "unprognostic (5.62e-2)" "unprognostic (1.99e-4)" "unprognostic (2.50e-4)" "unprognostic (2.76e-1)" "unprognostic (7.10e-6)" "unprognostic (3.80e-3)" "unprognostic (1.17e-1)" "unprognostic (2.20e-1)" "unprognostic (2.56e-2)" "unprognostic (4.21e-2)" "unprognostic (1.91e-1)" "unprognostic (1.33e-1)" "unprognostic (1.08e-2)" "unprognostic (1.87e-1)" "unprognostic (4.38e-1)" "unprognostic (9.83e-2)" 8.9 0.1 0.0 0.1 0.0 0.9 7.1 1.2 0.0 2.1 1.5 0.7 2.7 0.0 0.8 2.6 1.4 6.3 0.0 0.0 4.7 0.0 1.9 1.1 0.0 0.1 0.6 0.2 0.0 0.1 1.1 0.0 1.2 0.8 4.3 2.2 1.3 1.0 0.0 0.0 1.2 0.0 1.9 0.2 1.8 2.1 0.0 0.2 0.0 6.2 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 2.8 5.7 0.0 0.9 0.0 0.0 0.0 0.0 1.9 0.2 2.2 0.9 0.0 0.1 2.8 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 2.7 0.0 0.1 1.4 1.6 0.2 0.0 0.1 2.5 1.1 2.5 0.1 0.0 6.6 1.2 0.1 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.2 1.1 6.0 6.3 0.0 1.6 0.1 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.2 3.0 2.2 0.0 0.0 0.9 0.0 1.4 0.0 1.4 0.0 47.1 0.0 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.1 AWAT1 DGAT2L3 ENSG00000204195 "Acyl-CoA wax alcohol acyltransferase 1" Q58HT5 X 70234655-70240627 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "breast: 3.8;skin 1: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA063412 Enhanced NA NA "HPA063412: AB_2685009" "unprognostic (1.12e-1)" "unprognostic (1.78e-1)" "unprognostic (1.96e-2)" "unprognostic (4.90e-2)" "unprognostic (2.08e-1)" "unprognostic (6.78e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AWAT2 "DGAT2L4, MFAT" ENSG00000147160 "Acyl-CoA wax alcohol acyltransferase 2" Q6E213 X 70040542-70049938 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "breast: 5.7;skin 1: 14.0" "Cell type enhanced" "Detected in single" 30 "Spermatocytes: 1.2" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 2.4;PC-3: 2.6;SK-BR-3: 1.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA062748 Approved NA NA "HPA062748: AB_2684862" "unprognostic (3.41e-2)" "unprognostic (1.06e-1)" "unprognostic (2.99e-2)" "unprognostic (4.11e-2)" "unprognostic (1.11e-1)" "unprognostic (8.60e-2)" "unprognostic (4.55e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 AXL "ARK, JTK11, Tyro7, UFO" ENSG00000167601 "AXL receptor tyrosine kinase" P30530 19 41219203-41261766 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Differentiation, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Oncogene, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Kupffer cells: 104.4;Sertoli cells: 207.0;Smooth muscle cells: 341.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 8.8;plasmacytoid DC: 18.3" "Group enriched" "Detected in many" 14 "dendritic cells: 18.3;NK-cells: 8.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 67.0;U-251 MG: 71.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032501, HPA037422, HPA037423, HPA075217" Uncertain Supported "Vesicles,Plasma membrane,Actin filaments" NA Yes 12100000 61000000 "Plasma membrane" "Vesicles, Actin filaments" "CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: AB_2675470, HPA075217: " "unprognostic (2.20e-1)" "unprognostic (2.02e-1)" "unprognostic (6.79e-3)" "unprognostic (1.01e-1)" "unprognostic (1.40e-1)" "unprognostic (8.49e-3)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (3.15e-2)" "unprognostic (2.82e-2)" "unprognostic (9.57e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.53e-7)" "unprognostic (1.16e-3)" "unprognostic (1.52e-2)" "unprognostic (5.56e-2)" "unprognostic (4.83e-3)" 38.0 15.4 10.6 11.7 12.7 1.3 27.1 6.3 12.1 26.2 26.8 13.4 8.1 9.1 28.0 19.4 21.8 17.4 17.8 18.5 11.5 6.1 7.8 13.0 20.0 7.6 10.6 9.3 20.9 5.1 9.6 5.6 26.6 10.1 19.5 10.2 16.8 7.8 20.4 14.1 13.8 12.8 29.4 10.7 27.3 16.2 22.4 10.4 3.4 12.0 8.4 5.8 35.6 18.3 0.1 18.3 0.9 0.2 8.8 0.3 0.2 53.3 21.4 1.3 0.1 4.8 4.9 0.0 42.3 38.1 62.2 38.6 1.1 25.1 0.0 17.2 67.0 32.5 4.5 0.0 28.5 53.6 0.0 0.0 0.0 14.2 0.8 17.6 0.0 0.0 3.7 0.5 36.6 56.9 35.3 23.0 0.0 2.0 0.0 38.5 0.0 0.0 0.0 0.5 0.1 10.3 0.0 22.7 0.0 27.8 0.0 0.0 0.0 10.9 0.0 0.2 8.2 0.1 0.9 47.2 44.1 30.1 42.1 71.7 0.0 0.1 0.1 29.4 0.0 32.8 0.9 0.2 0.1 0.1 0.2 0.2 0.1 0.3 0.1 4.2 0.1 0.2 0.2 0.3 8.8 0.1 18.3 0.2 0.2 10.6 12.7 6.3 12.1 11.5 6.1 10.6 9.3 10.1 10.4 8.9 2.2 0.5 72.4 37.1 0.0 4.2 0.0 4.0 5.7 5.2 0.0 2.3 0.0 4.0 8.6 2.9 0.0 0.0 0.2 1.7 91.1 28.0 0.0 0.0 26.7 1.6 0.0 13.5 104.4 2.7 57.0 49.8 25.3 4.6 0.0 28.7 8.9 0.0 75.0 0.0 1.1 207.0 341.9 0.5 2.1 25.5 9.6 2.5 0.0 26.4 B3GALNT1 "B3GALT3, beta3Gal-T3, galT3, GLOB, P1" ENSG00000169255 "Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)" O75752 3 161083883-161105384 "Blood group antigen proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 36.8" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 52.9;Cardiomyocytes: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 4.9;NK-cell: 16.7" "Group enriched" "Detected in many" 7 "granulocytes: 4.9;NK-cells: 16.7" "Cell line enhanced" "Detected in many" "PC-3: 17.2;RT4: 52.6" "Low region specificity" "Detected in all" HPA041204 Approved Vesicles NA NA 290000 Vesicles "HPA041204: AB_10795585" "unprognostic (3.85e-2)" "unprognostic (5.11e-3)" "unprognostic (3.02e-1)" "unprognostic (1.06e-2)" "unprognostic (7.83e-2)" "unprognostic (4.07e-2)" "unprognostic (9.26e-5)" "unprognostic (1.49e-2)" "unprognostic (1.12e-2)" "unprognostic (1.88e-2)" "unprognostic (3.44e-2)" "unprognostic (3.24e-1)" "unprognostic (2.09e-3)" "unprognostic (1.32e-1)" "unprognostic (4.90e-2)" "unprognostic (3.66e-2)" "unprognostic (3.19e-3)" 3.8 5.4 14.0 3.0 24.5 3.1 7.4 17.2 24.7 15.5 2.3 5.5 2.6 1.5 8.3 6.9 5.4 10.4 7.1 36.8 15.4 21.6 14.3 1.0 10.8 3.5 11.3 16.2 13.8 7.8 6.5 8.5 10.0 17.7 8.9 2.0 7.5 14.8 6.7 1.1 2.2 1.9 7.2 7.6 4.2 7.5 6.2 5.0 1.1 19.5 2.3 3.9 10.5 4.7 1.4 1.4 4.9 0.2 16.7 0.7 0.5 6.7 0.2 3.1 0.1 0.3 1.0 0.1 3.7 3.3 8.2 2.8 4.4 5.1 0.0 15.1 3.1 4.9 1.5 0.0 6.6 2.7 0.1 0.0 3.7 2.8 0.0 4.8 0.1 0.1 10.1 2.0 2.2 0.5 6.4 12.1 0.0 0.0 0.0 3.3 10.9 0.0 0.0 7.5 0.1 17.2 0.1 0.0 0.1 3.9 52.6 6.3 0.0 9.5 3.5 2.7 1.4 14.5 5.5 0.0 0.1 6.6 0.2 0.1 1.5 0.0 0.0 5.8 0.0 0.0 4.9 0.2 0.0 0.4 0.1 0.4 1.4 0.2 0.4 1.4 0.3 0.5 0.7 0.4 16.7 0.0 1.0 0.0 0.5 14.0 24.5 17.2 24.7 15.4 21.6 11.3 16.2 17.7 5.0 17.9 2.1 3.4 4.2 4.4 52.9 51.9 0.0 2.7 10.3 14.0 11.8 18.5 10.0 3.0 0.6 6.8 0.0 0.0 7.4 10.2 16.9 4.9 10.3 0.0 8.4 6.4 1.7 6.7 1.3 1.7 6.6 4.6 10.1 7.2 0.0 10.8 7.2 0.0 4.9 13.6 7.2 0.0 13.3 3.7 16.8 2.3 4.2 1.8 0.4 4.1 B3GALT1 beta3Gal-T1 ENSG00000172318 "Beta-1,3-galactosyltransferase 1" Q9Y5Z6 2 167868948-167874041 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 2.4;brain: 5.1;intestine: 5.8;skeletal muscle: 7.1" "Cell type enhanced" "Detected in some" 9 "Enterocytes: 3.1;Mucus-secreting cells: 4.2;Undifferentiated cells: 5.2" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "AN3-CA: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.98e-2)" "unprognostic (4.34e-2)" "unprognostic (1.12e-2)" "unprognostic (7.22e-2)" "unprognostic (1.67e-1)" "unprognostic (4.23e-3)" "unprognostic (2.49e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-1)" "unprognostic (3.94e-2)" "unprognostic (8.72e-2)" "unprognostic (6.44e-2)" "unprognostic (2.30e-3)" "unprognostic (8.34e-2)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (3.79e-1)" 0.1 0.6 0.5 0.0 1.6 0.0 0.3 0.9 5.1 0.2 5.6 0.0 0.2 0.3 0.0 0.8 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.8 0.0 0.1 5.8 0.1 0.9 7.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 1.4 0.8 2.0 0.5 1.0 2.4 0.4 0.0 0.0 2.2 28.6 0.2 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 3.7 0.0 1.0 0.0 0.1 0.0 0.4 0.0 1.9 0.3 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.2 0.1 0.3 0.3 0.0 0.6 0.0 0.5 0.0 2.6 2.0 0.5 0.3 0.6 0.3 0.7 1.1 0.7 0.7 0.2 1.4 2.4 1.3 1.5 1.0 0.3 0.8 0.6 0.4 0.0 2.2 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 3.1 0.0 0.2 0.0 0.2 0.1 1.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 4.2 1.9 0.0 0.0 1.4 0.2 1.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 5.2 0.0 B3GALT2 beta3Gal-T2 ENSG00000162630 "Beta-1,3-galactosyltransferase 2" O43825 1 193179045-193186654 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9;gallbladder: 19.0;heart muscle: 25.1" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 47.7;Cardiomyocytes: 27.8;Cholangiocytes: 15.3;Leydig cells: 29.4;Peritubular cells: 19.8" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 11.9" "Lineage enriched" "Detected in single" 57 "T-cells: 11.9" "Group enriched" "Detected in some" 4 "AF22: 16.4;ASC TERT1: 7.5;LHCN-M2: 11.1;WM-115: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078659 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA078659: AB_2686887" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (1.58e-3)" "unprognostic (2.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (2.44e-1)" "unprognostic (6.14e-4)" "unprognostic (4.41e-2)" "unprognostic (8.10e-3)" "unprognostic (2.72e-1)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-3)" 0.7 2.0 11.3 1.3 8.9 0.7 0.9 1.4 32.9 0.8 1.7 1.2 0.9 1.6 0.6 1.8 1.2 0.7 19.0 25.1 10.1 7.9 1.7 0.8 2.6 0.7 5.7 19.1 13.8 0.8 0.4 0.9 0.9 5.0 6.5 2.0 0.3 0.5 7.1 0.6 0.7 4.1 0.8 6.5 1.4 2.1 1.4 4.7 0.0 1.8 0.0 1.6 2.0 0.7 0.0 0.2 0.1 0.0 0.0 11.9 0.3 0.0 0.0 16.4 0.0 0.4 7.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.4 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.2 0.0 11.9 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.3 0.3 11.3 8.9 1.4 32.9 10.1 7.9 5.7 19.1 5.0 4.7 0.0 0.3 0.0 0.0 0.2 47.7 27.8 15.3 4.0 0.0 1.8 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.3 2.3 0.0 0.2 7.9 2.9 1.3 0.3 0.0 29.4 0.1 0.0 0.0 0.3 1.7 0.4 0.0 19.8 0.0 5.8 0.0 0.4 0.0 0.0 0.3 0.0 5.1 0.4 0.0 B3GALT4 "beta3Gal-T4, GalT4" ENSG00000235863 "Beta-1,3-galactosyltransferase 4" O96024 6 33277132-33284832 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 54.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.1;SCLC-21H: 3.2;SK-BR-3: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043001 Approved NA NA "HPA043001: AB_2678265" "unprognostic (3.71e-2)" "unprognostic (1.33e-2)" "unprognostic (6.02e-2)" "unprognostic (1.00e-1)" "unprognostic (6.10e-3)" "unprognostic (1.66e-2)" "unprognostic (6.00e-2)" "unprognostic (2.17e-1)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (1.98e-2)" "unprognostic (1.96e-1)" "unprognostic (1.17e-3)" "unprognostic (6.83e-2)" "unprognostic (1.94e-1)" "unprognostic (1.22e-2)" "unprognostic (3.75e-2)" 7.0 6.9 3.0 9.8 4.0 3.0 6.7 5.3 6.3 7.6 9.0 6.2 13.1 8.0 6.2 7.0 14.0 6.1 9.4 5.7 3.6 3.4 7.1 1.7 6.7 11.9 3.7 3.0 3.1 3.1 5.3 4.4 7.4 4.0 6.5 4.9 6.7 9.1 15.9 2.7 10.9 12.5 4.3 4.6 11.1 7.7 19.0 2.5 14.7 5.6 5.3 9.8 8.6 7.9 7.3 4.1 12.4 8.4 6.3 9.5 5.2 0.0 0.3 0.6 0.2 0.9 1.6 0.8 0.3 0.4 0.0 0.1 0.0 5.1 0.0 0.0 0.7 1.2 2.6 0.0 0.2 0.0 2.8 0.3 0.9 0.4 0.0 1.0 0.0 2.7 2.1 1.3 0.1 0.1 0.0 0.7 2.4 0.0 0.3 0.0 0.1 1.3 1.2 0.2 1.9 0.3 0.2 0.0 0.0 0.0 0.8 3.2 0.4 0.1 5.2 0.4 0.6 0.0 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.7 12.4 6.9 10.0 9.5 6.7 7.4 6.0 5.9 8.0 4.1 7.3 5.7 5.1 7.3 6.3 8.4 3.3 6.3 5.2 3.0 4.0 5.3 6.3 3.6 3.4 3.7 3.0 4.0 2.5 11.9 4.5 10.4 5.9 2.9 13.7 3.3 17.8 14.7 7.9 14.0 3.9 15.4 5.0 12.9 25.9 9.8 29.5 0.0 16.5 9.9 5.2 9.6 10.3 0.5 18.3 11.1 12.1 11.1 23.0 54.2 7.2 12.7 8.5 30.7 15.3 11.8 14.7 25.9 5.6 5.3 13.9 6.5 3.8 28.9 3.0 4.3 26.8 14.9 10.1 14.6 B3GALT5 "B3GalT-V, B3T5, beta3Gal-T5, GLCT5" ENSG00000183778 "Beta-1,3-galactosyltransferase 5" Q9Y2C3 21 39556442-39673137 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8;intestine: 27.1;lymphoid tissue: 14.8" "Group enriched" "Detected in many" 5 "Enterocytes: 85.3;Intestinal endocrine cells: 27.7;Mucus-secreting cells: 45.4;Paneth cells: 85.2;Undifferentiated cells: 35.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "basal ganglia: 15.8" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "CAPAN-2: 18.6;RPTEC TERT1: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054092, HPA054684" Approved "Intracellular and membrane" NA NA "HPA054092: AB_2682375, HPA054684: AB_2682573" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "prognostic favorable (6.36e-4)" "unprognostic (9.23e-2)" "unprognostic (4.62e-2)" "unprognostic (4.06e-2)" "unprognostic (2.04e-1)" "unprognostic (2.48e-1)" "unprognostic (3.25e-2)" "unprognostic (7.86e-3)" "unprognostic (1.67e-1)" "unprognostic (6.09e-4)" "unprognostic (1.12e-1)" "unprognostic (2.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" 0.1 0.3 0.5 3.1 15.8 0.1 1.8 0.3 1.5 3.0 16.2 0.6 0.0 19.4 1.4 1.6 2.3 1.0 12.9 0.2 1.3 1.5 0.6 0.3 0.2 0.1 0.7 0.1 0.7 6.2 0.1 7.9 0.7 2.2 1.0 27.1 2.2 5.5 0.1 0.2 1.1 23.4 0.7 2.0 0.2 3.8 0.6 3.6 1.8 1.1 0.8 14.8 1.1 5.9 0.2 0.2 1.0 0.2 0.3 0.2 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.6 0.0 0.2 0.1 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.0 0.1 0.5 0.0 2.1 0.1 22.0 1.4 3.7 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.6 0.1 0.8 0.0 0.0 0.0 1.0 0.0 0.3 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 0.3 0.0 0.2 0.0 0.0 0.5 15.8 0.3 1.5 1.3 1.5 0.7 0.1 2.2 3.6 0.0 0.0 0.0 0.2 0.0 6.7 1.7 10.2 1.4 7.9 5.2 0.0 0.0 0.0 6.5 0.3 0.0 85.3 0.0 4.1 0.0 0.0 0.4 4.6 0.0 0.0 0.0 27.7 0.0 0.0 0.6 0.6 0.0 0.0 0.0 45.4 1.4 6.0 85.2 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 35.9 6.7 B3GALT6 beta3GalT6 ENSG00000176022 "Beta-1,3-galactosyltransferase 6" Q96L58 1 1232265-1235041 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease mutation, Dwarfism, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 38.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.76e-2)" "unprognostic (6.97e-2)" "unprognostic (4.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.39e-1)" "unprognostic (4.62e-2)" "unprognostic (2.65e-3)" "unprognostic (1.86e-1)" "unprognostic (1.37e-1)" "unprognostic (2.66e-1)" "unprognostic (3.08e-2)" "unprognostic (2.40e-2)" "unprognostic (1.85e-1)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.28e-1)" "unprognostic (9.89e-2)" 12.2 9.4 13.4 9.9 11.7 3.0 10.2 10.3 17.2 10.0 7.5 11.1 9.5 7.2 11.9 9.3 7.7 11.9 7.1 12.6 13.7 12.9 9.8 19.5 10.1 12.3 9.4 7.9 11.4 14.7 14.1 10.4 12.3 10.4 9.6 6.0 11.4 9.9 8.7 9.6 13.4 7.0 9.3 8.4 12.9 9.2 8.4 10.8 14.7 10.1 7.0 7.7 8.2 9.0 5.2 5.1 2.9 4.1 6.0 6.6 2.2 10.6 5.4 9.3 9.7 9.4 6.4 7.2 11.4 9.7 9.6 7.8 4.8 10.9 8.0 6.8 6.7 8.3 9.6 4.0 6.1 5.9 14.0 15.2 14.8 5.4 4.5 9.7 9.1 9.4 5.9 4.5 6.3 6.2 5.8 7.2 9.3 10.3 7.2 9.7 6.1 12.4 16.5 12.0 11.2 20.5 11.9 3.7 6.5 9.4 3.3 38.3 15.7 8.4 10.0 5.7 5.7 8.4 13.2 7.7 9.9 4.4 6.2 16.3 4.5 3.8 7.3 7.8 20.6 11.2 2.9 2.8 0.9 3.8 3.5 6.6 3.1 3.9 4.5 3.8 5.2 3.4 4.1 1.4 6.0 4.1 5.1 1.6 2.2 13.4 11.7 10.3 17.2 13.7 12.9 9.4 7.9 10.4 10.8 11.9 6.9 8.3 19.2 7.4 12.1 6.4 7.6 2.7 3.4 12.2 3.9 1.4 6.6 7.4 0.4 9.6 1.6 0.0 10.7 3.0 6.2 12.4 0.0 10.5 6.3 19.1 5.8 7.4 7.5 0.9 2.6 7.2 1.7 1.0 3.9 8.2 9.0 0.0 3.9 9.9 8.3 0.0 6.2 1.4 2.7 11.0 1.1 6.9 4.4 9.5 B3GAT1 "CD57, GlcAT-P, HNK-1, LEU7, NK-1" ENSG00000109956 "Beta-1,3-glucuronyltransferase 1" Q9P2W7 11 134378504-134411918 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 76.0" "Cell type enhanced" "Detected in some" 30 "Bipolar cells: 34.2;Horizontal cells: 22.3;Muller glia cells: 119.7" "Group enriched" "Detected in some" 11 "glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.8;naive CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 39 "T-cells: 3.8" "Cell line enhanced" "Detected in some" "AF22: 17.4;HMC-1: 19.3;NTERA-2: 16.7;SH-SY5Y: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002500, CAB010893, HPA069468, HPA074314" Enhanced Enhanced Vesicles "Secreted in brain" NA NA Vesicles "CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: AB_2686138, HPA074314: " "unprognostic (6.72e-2)" "unprognostic (3.97e-4)" "unprognostic (2.13e-2)" "unprognostic (1.40e-3)" "unprognostic (5.52e-2)" "unprognostic (2.60e-3)" "unprognostic (6.30e-2)" "unprognostic (1.96e-2)" "unprognostic (8.74e-2)" "unprognostic (2.72e-1)" "unprognostic (1.57e-3)" "unprognostic (1.58e-1)" "unprognostic (9.34e-3)" "unprognostic (3.87e-3)" "unprognostic (2.42e-1)" "unprognostic (4.07e-2)" "unprognostic (2.26e-2)" 1.5 5.8 38.9 1.7 23.7 2.1 5.6 9.2 76.0 1.7 1.5 25.8 0.0 1.8 1.6 1.7 1.4 1.6 1.7 1.5 43.4 14.9 2.1 6.0 1.8 3.3 30.3 19.5 1.5 1.7 1.4 0.9 1.4 19.7 4.2 1.5 2.1 2.2 1.8 1.4 1.8 1.6 1.5 45.1 2.1 6.0 1.8 25.2 0.0 7.7 0.0 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.4 0.0 0.0 17.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 3.0 0.0 0.7 0.9 1.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 16.7 0.8 0.0 0.3 0.0 1.2 0.0 0.1 2.3 6.4 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.3 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.8 1.9 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.4 38.9 23.7 9.2 33.7 43.4 14.9 30.3 19.5 19.7 25.2 0.0 0.0 0.0 0.0 0.0 34.2 1.0 2.5 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.9 0.1 22.3 1.7 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 119.7 0.0 0.0 0.4 2.3 6.3 0.0 0.0 0.2 0.1 0.0 0.1 3.2 0.0 0.1 B3GAT2 GlcAT-S ENSG00000112309 "Beta-1,3-glucuronyltransferase 2" Q9NPZ5 6 70856679-70957038 "Enzymes, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 27.2" "Cell type enriched" "Detected in many" 9 "Horizontal cells: 301.9" "Group enriched" "Detected in some" 20 "glioma: 4.7;testis cancer: 1.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 20 "SCLC-21H: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012059 Uncertain NA NA "HPA012059: AB_2061050" "unprognostic (7.10e-3)" "unprognostic (7.81e-2)" "unprognostic (1.63e-1)" "unprognostic (1.10e-3)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.96e-2)" "unprognostic (4.88e-2)" "unprognostic (4.22e-2)" "unprognostic (9.16e-4)" "unprognostic (8.09e-2)" "unprognostic (7.43e-3)" "unprognostic (6.88e-7)" "unprognostic (2.72e-2)" "unprognostic (3.35e-2)" "unprognostic (2.53e-2)" "unprognostic (3.45e-3)" 1.8 1.5 9.5 1.9 7.8 1.6 1.1 3.2 27.2 0.8 1.1 26.2 0.0 2.3 1.4 1.1 1.4 1.1 1.4 1.5 19.2 11.5 1.0 1.3 1.2 2.0 9.7 13.6 1.1 2.2 0.8 0.5 1.2 21.0 1.3 0.9 0.4 1.5 0.9 1.5 1.9 2.4 1.1 17.3 2.0 1.5 2.9 16.3 0.0 1.5 0.0 0.9 1.3 0.9 1.2 1.0 2.0 1.2 1.1 2.2 0.2 0.3 0.0 0.6 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.2 1.1 0.1 0.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.5 0.0 0.2 0.0 0.5 0.7 0.1 0.1 0.2 0.3 0.2 0.0 0.2 22.7 0.2 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 1.3 1.2 1.2 1.0 1.0 0.9 1.0 1.5 2.1 0.4 1.2 1.7 1.8 2.0 1.1 1.1 1.0 2.2 0.2 9.5 7.8 3.2 11.2 19.2 11.5 9.7 13.6 21.0 16.3 0.0 2.1 16.6 7.9 22.7 12.4 0.8 7.6 0.0 0.0 15.7 21.6 5.1 0.0 5.0 6.6 7.5 11.0 0.0 3.3 2.8 10.3 14.9 0.0 7.7 7.0 301.9 0.0 3.7 5.3 4.0 18.4 11.1 13.5 11.8 4.1 17.1 7.1 7.0 12.7 0.5 21.5 12.9 8.2 17.4 32.2 17.3 5.9 13.1 3.8 9.9 B3GAT3 GlcAT-I ENSG00000149541 "Beta-1,3-glucuronyltransferase 3" O94766 11 62615296-62622175 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051328 Approved "Intracellular and membrane" NA NA 1600000 "HPA051328: AB_2681444" "unprognostic (1.55e-1)" "unprognostic (3.93e-2)" "unprognostic (8.45e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (4.69e-4)" "unprognostic (3.80e-2)" "prognostic unfavorable (5.11e-6)" "unprognostic (4.94e-2)" "unprognostic (2.42e-1)" "unprognostic (3.66e-2)" "unprognostic (1.08e-3)" "unprognostic (1.40e-1)" "unprognostic (1.58e-3)" "unprognostic (1.46e-3)" "unprognostic (6.00e-2)" "unprognostic (4.48e-2)" "unprognostic (2.58e-2)" 14.4 21.6 24.8 15.9 29.2 15.0 19.7 28.9 29.1 15.4 12.9 24.2 8.1 17.6 14.9 18.8 10.6 21.1 15.3 13.1 25.8 25.6 17.4 21.5 12.8 22.9 30.0 16.8 17.0 22.4 18.5 25.6 19.9 25.7 18.2 6.8 19.0 24.9 20.9 6.4 23.1 16.5 14.2 24.4 17.5 15.5 12.0 24.8 17.5 14.5 5.4 12.9 14.4 17.4 11.2 15.7 15.7 18.9 24.5 14.1 9.4 9.8 16.3 8.9 15.4 12.2 12.1 6.5 8.2 11.6 7.8 8.8 7.2 14.7 8.7 28.4 8.2 21.7 6.4 9.0 8.2 1.7 19.4 17.4 4.1 7.5 9.1 29.6 5.9 9.8 21.4 14.0 10.2 4.2 12.8 6.9 11.3 13.8 22.0 9.2 25.1 10.0 21.0 13.8 5.6 15.3 10.2 6.4 47.9 16.2 1.9 9.4 15.4 9.4 11.1 37.5 3.1 14.9 11.6 5.3 7.9 6.2 21.1 15.7 22.9 7.6 10.1 24.2 10.7 16.6 15.7 18.4 15.5 14.1 18.3 9.3 11.2 9.8 11.4 15.7 9.1 9.8 11.4 5.4 24.5 18.9 9.3 11.7 9.4 24.8 29.2 28.9 27.7 25.8 25.6 30.0 16.8 25.7 24.8 6.0 10.4 30.4 32.3 17.5 51.2 3.2 25.5 6.7 18.2 38.4 31.4 64.6 13.3 30.5 0.4 21.0 25.1 0.0 40.4 49.5 29.4 29.0 1.1 24.6 59.6 46.1 24.2 26.4 39.3 1.9 33.4 30.8 42.2 55.1 20.6 46.3 31.6 28.1 21.2 15.3 38.8 25.8 20.2 6.3 23.5 16.9 36.4 44.6 24.7 17.3 B3GLCT "B3GALTL, B3Glc-T, B3GTL" ENSG00000187676 "Beta 3-glucosyltransferase" Q6Y288 13 31199936-31332276 "Disease related genes, Predicted intracellular proteins" "Carbohydrate metabolism, Fucose metabolism" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 21.8;Cone photoreceptor cells: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 34.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (3.31e-2)" "unprognostic (2.53e-1)" "unprognostic (4.71e-2)" "unprognostic (6.17e-3)" "unprognostic (5.26e-2)" "unprognostic (1.29e-1)" "unprognostic (2.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.00e-1)" "unprognostic (2.91e-1)" "unprognostic (3.28e-3)" "unprognostic (6.74e-2)" "unprognostic (5.51e-3)" "unprognostic (2.26e-1)" "unprognostic (5.70e-2)" "unprognostic (3.81e-2)" "unprognostic (1.51e-1)" 6.7 3.4 8.6 5.1 18.3 4.4 14.0 2.0 10.8 4.6 4.2 8.9 3.8 3.8 17.2 10.1 4.4 8.6 4.8 23.2 6.5 5.8 9.0 4.6 4.9 4.7 4.3 8.8 7.9 7.5 7.5 4.8 9.1 8.3 5.0 4.7 7.2 5.9 8.8 5.6 4.6 4.0 17.1 4.9 4.5 5.1 4.9 7.7 5.6 6.6 2.7 7.1 3.7 6.0 2.5 0.8 3.1 0.8 2.6 6.9 2.6 2.7 3.9 16.1 2.9 3.1 3.1 2.6 6.8 7.7 8.3 5.9 2.0 7.8 11.2 5.0 7.9 15.7 4.6 3.6 4.3 7.8 34.1 6.9 0.7 3.7 2.9 1.9 4.4 6.0 3.6 5.0 4.7 4.1 8.5 7.3 5.6 1.9 1.8 6.5 3.5 6.5 1.3 4.7 4.0 2.4 5.9 5.2 0.4 3.6 3.9 1.5 6.6 5.8 2.8 7.6 4.0 1.3 5.1 10.3 8.4 5.7 3.8 6.7 1.4 3.1 4.3 2.7 3.4 11.1 3.1 0.8 2.4 4.8 0.8 6.9 2.5 3.0 5.3 0.8 1.3 2.5 3.3 0.3 2.6 0.7 0.7 1.6 2.6 8.6 18.3 2.0 10.8 6.5 5.8 4.3 8.8 8.3 7.7 0.0 1.9 1.4 3.2 0.0 5.7 21.8 2.5 2.7 1.2 8.7 15.7 0.3 1.7 4.2 10.1 3.7 0.5 0.0 4.0 1.9 3.1 1.9 0.0 5.3 3.1 0.0 1.2 9.2 3.2 1.9 1.4 1.7 0.0 0.0 1.9 5.6 4.4 2.8 3.2 2.2 4.0 12.9 3.4 1.1 11.8 0.0 0.2 3.2 1.7 1.4 B3GNT10 ENSG00000214654 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 10 (putative)" A8MXE2 9 120792403-120799918 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 2.7;Collecting duct cells: 3.5;Distal tubular cells: 1.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (4.59e-3)" "unprognostic (2.71e-2)" "unprognostic (3.04e-2)" "unprognostic (5.71e-3)" "unprognostic (1.20e-1)" "unprognostic (3.95e-1)" "unprognostic (7.99e-4)" "unprognostic (1.21e-1)" "unprognostic (2.42e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (2.57e-2)" "unprognostic (1.08e-7)" "unprognostic (1.91e-2)" "unprognostic (1.79e-1)" "unprognostic (2.28e-1)" "unprognostic (1.73e-1)" 1.8 1.0 0.9 2.3 3.8 6.5 3.1 0.8 2.6 1.7 2.4 6.3 3.5 1.9 3.1 4.3 1.5 2.6 2.5 1.8 1.4 3.9 1.4 1.3 3.6 3.5 1.5 3.8 5.5 4.3 3.9 1.7 3.3 2.7 3.1 4.1 6.7 2.3 1.9 1.4 3.4 1.5 1.5 2.4 3.2 8.3 3.2 3.6 4.2 0.9 4.2 2.4 1.5 2.8 2.0 3.6 3.1 3.6 4.9 2.3 3.0 3.8 4.3 2.8 3.6 2.8 5.2 2.9 3.1 4.9 3.0 1.2 4.7 5.8 2.6 1.5 5.8 8.1 7.4 5.9 5.7 7.0 2.2 3.3 2.6 1.9 6.1 3.9 1.5 3.0 3.1 3.7 8.8 1.1 0.9 6.8 10.1 8.1 3.1 4.3 2.9 0.9 6.1 6.5 3.7 3.0 8.0 8.8 2.8 3.0 6.1 4.7 5.4 2.6 5.6 2.7 10.5 0.8 1.4 2.5 2.2 5.2 2.9 9.7 14.5 5.6 5.2 2.2 5.0 1.0 1.8 3.6 3.5 1.7 3.6 2.7 3.3 3.9 2.0 2.8 4.9 2.7 1.3 3.6 3.1 1.5 3.6 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 3.5 0.0 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 B3GNT2 "B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT" ENSG00000170340 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2" Q9NY97 2 62196113-62224731 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005997 Approved Approved Vesicles NA NA 43000000 Vesicles "HPA005997: AB_1845234" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (2.64e-2)" "unprognostic (1.23e-2)" "unprognostic (1.67e-1)" "unprognostic (1.51e-1)" "unprognostic (1.55e-2)" "unprognostic (2.13e-2)" "unprognostic (3.76e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.63e-1)" "unprognostic (1.11e-2)" "unprognostic (9.55e-2)" "unprognostic (3.05e-2)" "unprognostic (3.18e-1)" "unprognostic (1.25e-1)" 18.9 14.3 8.6 10.8 23.0 41.6 17.5 3.1 14.1 18.4 17.9 7.4 5.6 17.9 19.8 8.0 24.5 8.7 18.1 20.9 7.6 11.5 24.4 14.2 23.9 13.9 9.7 7.1 9.0 43.2 5.4 25.9 22.8 9.5 7.5 16.3 14.4 17.2 6.0 5.2 13.0 21.7 16.3 7.6 14.6 12.0 7.0 10.6 27.0 15.6 8.5 18.5 11.8 14.7 8.4 6.8 28.3 5.6 20.3 19.3 8.2 7.8 5.4 8.2 3.6 9.0 4.1 23.7 7.6 8.5 6.1 8.2 11.1 12.6 8.5 7.0 7.1 8.6 7.5 5.2 6.4 10.6 17.6 4.2 20.8 2.6 6.5 6.8 12.4 9.4 4.9 12.1 11.7 4.2 4.3 9.1 5.9 11.3 5.3 7.3 5.9 23.6 18.6 7.8 14.2 2.2 43.4 5.7 4.6 11.6 7.7 8.0 5.9 5.4 11.7 8.7 13.8 3.3 14.7 10.3 7.4 6.5 12.5 7.5 15.1 5.3 36.5 5.8 21.6 7.1 7.2 4.5 28.3 11.0 4.4 15.6 7.6 8.2 19.3 5.5 8.4 9.9 14.4 11.3 20.3 5.6 6.8 13.2 8.2 8.6 23.0 3.1 14.1 7.6 11.5 9.7 7.1 9.5 10.6 59.6 9.8 25.1 27.0 63.4 16.0 8.7 17.8 5.3 3.4 17.4 0.0 31.1 19.9 20.8 0.1 21.0 17.3 46.7 50.7 30.1 35.3 23.6 3.5 15.5 51.9 0.0 9.1 37.4 22.7 0.2 2.3 20.4 33.7 24.4 19.1 8.1 37.8 21.8 2.1 18.9 2.4 64.7 52.3 0.2 1.5 56.7 54.6 17.5 11.9 34.6 B3GNT3 "B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3" ENSG00000179913 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3" Q9Y2A9 19 17794828-17813082 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 69.9;intestine: 61.6;placenta: 56.0" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 53.5;Cytotrophoblasts: 51.9;Enterocytes: 58.5;Mucus-secreting cells: 40.2;Paneth cells: 42.5;Syncytiotrophoblasts: 57.1;Urothelial cells: 43.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.1;naive CD4 T-cell: 3.2" "Lineage enriched" "Detected in single" 32 "T-cells: 3.2" "Cell line enhanced" "Detected in some" "A-431: 16.5;BEWO: 16.3;CAPAN-2: 44.2;OE19: 40.5;RT4: 15.8;SK-BR-3: 15.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA024298 Enhanced "Intracellular and membrane" NA NA "HPA024298: AB_1845236" "unprognostic (1.10e-1)" "unprognostic (5.19e-2)" "unprognostic (1.84e-1)" "unprognostic (4.84e-3)" "unprognostic (1.10e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.25e-5)" "unprognostic (3.26e-1)" "unprognostic (4.64e-2)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.91e-1)" "unprognostic (1.44e-2)" "unprognostic (7.38e-2)" "unprognostic (1.26e-1)" "unprognostic (7.10e-2)" "unprognostic (2.57e-2)" 0.4 0.2 0.2 8.7 0.3 0.0 1.8 0.2 0.3 3.5 25.3 0.0 12.0 16.6 0.4 1.2 15.1 0.6 69.9 0.5 0.2 0.3 11.4 2.5 1.0 1.2 0.2 0.0 0.3 9.1 0.0 0.3 56.0 0.0 4.4 22.4 0.3 24.4 12.8 0.3 2.0 61.6 1.9 0.2 0.3 21.8 0.3 0.0 0.3 0.4 2.6 18.3 10.2 5.4 0.0 0.0 0.0 0.0 0.0 3.2 0.6 16.5 4.4 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.2 44.2 0.0 11.3 0.0 0.0 1.6 0.0 5.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.1 40.5 7.1 0.0 0.0 0.4 9.8 15.8 0.0 0.0 0.0 15.0 0.0 0.0 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.1 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.0 2.9 0.5 1.3 0.1 0.0 0.4 53.5 0.0 6.8 15.7 0.0 51.9 1.7 15.2 0.0 0.5 58.5 0.0 24.8 5.9 0.7 7.2 5.7 0.0 5.1 0.0 15.6 0.6 0.0 0.0 0.0 0.0 0.0 1.0 40.2 0.0 23.5 42.5 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 57.1 0.0 20.6 43.1 B3GNT4 "B3GN-T4, beta3Gn-T4" ENSG00000176383 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4" Q9C0J1 12 122203543-122208952 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3;skin 1: 8.5" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 2.6;Proximal tubular cells: 6.1;Spermatogonia: 2.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 8.2;hTCEpi: 9.9;T-47d: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055261 Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA055261: AB_2682765" "unprognostic (1.67e-1)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.60e-2)" "unprognostic (1.32e-3)" "unprognostic (1.98e-1)" "unprognostic (3.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.82e-2)" "unprognostic (3.69e-1)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.24e-1)" "unprognostic (2.79e-1)" "unprognostic (8.97e-2)" "unprognostic (9.47e-2)" 0.7 3.2 7.3 0.8 6.8 4.6 0.8 16.3 9.1 0.5 0.7 0.5 0.0 1.0 0.6 0.7 1.8 1.1 1.1 0.8 4.9 4.0 6.1 0.6 1.1 0.9 1.5 7.3 0.8 0.8 0.8 1.9 0.8 4.0 0.7 0.6 1.0 1.7 0.7 1.1 8.5 1.0 0.6 0.6 1.0 0.7 2.0 0.3 0.0 0.8 0.3 0.8 0.6 0.5 0.8 1.0 0.8 1.7 0.4 1.9 0.4 5.5 1.0 0.4 2.2 0.2 0.1 1.0 0.1 0.0 0.3 0.7 3.5 0.5 0.5 1.0 0.0 0.4 2.0 2.7 2.2 0.2 8.2 2.8 0.2 1.5 0.3 0.6 0.7 1.1 0.7 9.9 0.1 0.5 0.8 0.0 2.0 1.6 0.7 0.2 4.9 0.0 0.7 0.6 0.2 2.0 0.4 0.6 1.0 1.4 0.6 1.4 1.8 1.6 1.0 0.5 0.9 7.6 0.1 0.1 0.5 2.8 0.5 0.3 0.6 5.0 1.2 0.5 0.8 0.3 0.8 0.4 0.2 0.8 0.1 0.4 0.8 1.3 0.2 0.2 0.5 1.9 0.2 0.5 0.4 1.7 1.0 0.6 0.4 7.3 6.8 16.3 8.1 4.9 4.0 1.5 7.3 4.0 0.3 0.0 2.6 0.0 0.7 1.1 0.1 0.4 0.0 1.4 1.2 0.0 0.0 0.4 1.7 1.0 0.2 0.0 0.0 0.0 0.2 0.4 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.6 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.4 0.6 0.0 6.1 0.1 0.0 0.2 0.5 2.6 1.3 0.5 0.5 0.3 0.4 B3GNT5 "B3GN-T5, beta3Gn-T5" ENSG00000176597 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5" Q9BYG0 3 183253244-183298504 "Enzymes, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 80.2" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 101.7;Syncytiotrophoblasts: 132.0;Urothelial cells: 125.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "GAMG: 30.4;HBEC3-KT: 25.2;hTCEpi: 30.7" "Region enriched" "Detected in single" 12 "cerebellum: 16.5" "Low region specificity" "Detected in all" HPA017292 Uncertain Approved Nucleoli NA NA Nucleoli "HPA017292: AB_1845237" "unprognostic (2.17e-1)" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (4.83e-3)" "unprognostic (1.89e-1)" "unprognostic (3.08e-2)" "prognostic unfavorable (5.09e-4)" "unprognostic (7.10e-3)" "unprognostic (7.78e-2)" "unprognostic (8.48e-2)" "prognostic unfavorable (7.23e-6)" "unprognostic (4.20e-1)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.18e-2)" "unprognostic (2.71e-1)" "unprognostic (3.53e-2)" "unprognostic (8.10e-3)" 8.6 1.4 2.2 6.1 2.3 31.6 4.3 1.2 2.5 6.4 29.8 5.4 2.1 17.5 3.2 5.4 23.5 5.4 10.1 3.3 3.0 2.9 3.5 3.0 11.2 5.1 4.0 0.7 4.2 3.5 1.8 5.1 19.8 4.5 3.9 9.2 3.2 8.7 2.5 6.6 8.0 80.2 2.9 6.3 2.3 5.1 2.9 2.3 1.0 4.6 18.9 8.9 5.0 10.6 0.1 1.1 9.0 1.5 0.0 0.3 0.4 16.1 1.5 8.7 5.3 7.3 21.6 7.9 0.2 0.4 1.7 1.4 3.2 8.5 0.0 1.0 0.0 30.4 7.4 8.9 25.2 1.4 0.0 5.5 0.8 0.7 0.0 9.3 8.1 4.0 10.1 30.7 1.3 23.0 2.3 15.7 0.0 9.2 0.0 13.8 0.0 0.0 2.6 3.6 9.5 14.0 2.5 4.4 0.0 5.3 4.5 0.4 8.3 4.5 0.0 1.9 4.1 0.0 9.9 23.1 0.4 3.4 0.5 3.9 0.0 0.0 0.0 3.3 19.2 8.6 0.0 1.5 1.5 0.0 0.3 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.3 0.4 2.2 2.3 1.2 2.5 3.0 2.9 4.0 0.7 4.5 2.3 6.0 17.4 0.0 55.5 57.9 7.1 2.0 12.7 101.7 27.3 5.2 21.6 24.4 1.7 15.7 9.9 10.0 77.7 0.0 10.5 9.4 7.4 42.6 13.9 0.4 25.3 3.2 36.7 3.1 9.7 19.2 1.4 50.1 11.8 11.8 73.1 3.2 25.3 42.1 0.4 4.3 12.7 0.0 3.4 0.9 0.4 74.2 132.0 0.7 26.9 125.2 B3GNT6 B3Gn-T6 ENSG00000198488 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6" Q6ZMB0 11 77034398-77041973 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 15.8;lymphoid tissue: 17.5;stomach 1: 17.9" "Cell type enriched" "Detected in some" 38 "Mucus-secreting cells: 60.5" "Group enriched" "Detected in some" 14 "colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.3;neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 2.0;RPMI-8226: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA039805 Enhanced "Intracellular and membrane" NA NA "HPA039805: AB_2676690" "unprognostic (1.71e-1)" "prognostic favorable (2.31e-4)" "unprognostic (4.79e-2)" "unprognostic (5.42e-2)" "unprognostic (7.64e-2)" "unprognostic (1.95e-1)" "unprognostic (2.72e-1)" "unprognostic (1.23e-2)" "unprognostic (7.77e-2)" "unprognostic (2.19e-1)" "unprognostic (9.30e-2)" "unprognostic (1.71e-1)" 0.2 0.2 0.3 6.6 0.4 0.0 0.2 0.3 0.4 0.5 15.8 0.0 0.0 3.7 0.2 0.0 2.5 0.2 0.9 0.2 0.3 0.3 0.2 0.2 1.4 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 12.4 0.0 1.6 0.0 0.2 0.2 9.4 0.0 0.2 0.2 17.9 0.6 0.0 0.0 0.2 3.4 17.5 0.2 0.3 0.4 0.3 2.3 0.2 0.8 0.5 0.2 0.1 0.0 0.5 0.5 0.0 0.2 0.2 0.1 0.2 0.5 0.1 1.2 0.2 0.7 0.3 0.0 0.5 0.0 0.1 0.6 0.1 0.4 0.2 0.2 0.1 0.2 0.0 0.6 0.2 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 2.0 0.2 0.5 0.7 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.1 0.3 0.4 0.5 0.3 0.1 0.2 0.2 2.3 0.2 0.3 0.4 0.2 0.5 0.2 0.2 0.2 0.0 0.4 0.3 0.3 2.2 0.8 0.0 0.3 0.1 0.2 0.3 0.4 0.3 0.4 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.1 B3GNT7 beta3GnT7 ENSG00000156966 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7" Q8NFL0 2 231395543-231401164 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 93.7;intestine: 41.2" "Cell type enhanced" "Detected in many" 12 "Intestinal endocrine cells: 99.1;Mucus-secreting cells: 119.1;Undifferentiated cells: 275.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 19.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 15.0;HEL: 11.8;THP-1: 10.5;WM-115: 18.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA013881, HPA035625, HPA035626" Enhanced Approved "Golgi apparatus,Mitotic spindle,Cytosol" "Intracellular and membrane" NA NA 2100000 "Golgi apparatus" "Mitotic spindle, Cytosol" "HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-3)" "unprognostic (1.46e-2)" "unprognostic (1.28e-2)" "unprognostic (2.69e-1)" "unprognostic (1.36e-1)" "unprognostic (2.31e-2)" "unprognostic (6.18e-2)" "unprognostic (5.82e-2)" "unprognostic (2.17e-2)" "unprognostic (7.77e-2)" "unprognostic (4.27e-3)" "unprognostic (6.96e-2)" "unprognostic (1.18e-1)" "prognostic favorable (6.00e-4)" "unprognostic (3.57e-1)" 3.0 10.3 5.3 2.3 4.9 5.5 1.9 0.9 3.2 1.2 28.0 3.8 0.8 12.2 1.6 3.5 1.9 3.6 93.7 26.8 4.2 4.4 1.4 1.3 17.7 1.8 4.0 2.0 13.0 18.9 6.7 8.9 10.7 3.2 1.6 35.5 2.0 4.0 2.3 0.4 2.4 41.2 1.1 1.9 6.7 17.1 1.6 2.2 1.2 4.2 1.7 3.9 1.2 0.6 7.1 4.2 0.4 0.3 19.9 2.0 0.5 0.5 2.1 0.2 0.4 0.1 0.2 0.8 0.2 0.8 0.1 0.1 1.0 15.0 1.7 4.6 0.2 0.1 3.9 0.2 0.0 0.1 0.2 0.4 11.8 0.3 0.7 0.1 0.1 0.6 0.1 1.1 0.1 0.2 0.8 0.2 0.3 0.3 0.3 0.1 0.6 0.1 0.5 4.9 5.8 2.6 0.2 0.0 0.2 0.5 1.3 0.4 0.6 0.2 1.3 0.5 5.7 0.5 10.5 0.2 0.3 0.3 0.2 0.1 1.8 0.6 0.5 0.3 0.1 18.2 0.3 0.0 0.4 2.0 0.3 0.4 7.1 0.0 0.2 4.2 5.1 0.1 0.5 0.1 19.9 0.3 2.1 0.1 0.5 5.3 4.9 0.9 3.2 4.2 4.4 4.0 2.0 3.2 2.2 38.7 24.6 2.2 1.2 2.1 0.2 0.8 84.1 75.0 33.0 1.8 2.0 0.4 0.0 13.5 0.3 0.7 75.7 0.0 73.7 52.0 2.2 11.2 9.2 0.0 9.0 0.0 99.1 3.7 7.0 0.9 1.4 13.6 3.3 4.6 119.1 0.5 58.2 46.0 7.8 0.1 1.6 0.0 1.4 0.7 1.3 2.4 1.7 6.9 275.6 13.2 B4GALNT1 "beta1-4GalNAc-T, GALGT, SPG26" ENSG00000135454 "Beta-1,4-N-acetyl-galactosaminyltransferase 1" Q00973 12 57623410-57633355 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.4" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 8.1;Horizontal cells: 20.6;Sertoli cells: 6.5;Smooth muscle cells: 6.6" "Cancer enriched" "Detected in many" 6 "glioma: 10.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Lineage enhanced" "Detected in single" "T-cells: 1.9" "Cell line enhanced" "Detected in many" "EFO-21: 22.0;HDLM-2: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008968 Enhanced "Intracellular and membrane" NA NA 9500 "HPA008968: AB_1078253" "unprognostic (3.18e-1)" "unprognostic (8.34e-2)" "unprognostic (2.05e-2)" "unprognostic (3.33e-3)" "unprognostic (2.54e-1)" "unprognostic (2.70e-3)" "unprognostic (3.73e-5)" "unprognostic (1.26e-2)" "unprognostic (1.72e-1)" "unprognostic (2.66e-1)" "unprognostic (2.00e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.18e-14)" "unprognostic (2.52e-2)" "unprognostic (1.81e-1)" "unprognostic (1.44e-2)" "unprognostic (4.92e-4)" 3.0 2.1 12.9 2.3 16.4 1.0 1.5 26.5 32.4 1.9 2.4 1.0 0.0 1.4 2.2 3.8 1.3 1.4 1.5 3.9 15.3 11.2 1.3 1.3 1.7 1.6 6.5 14.3 1.0 1.2 1.1 1.0 1.3 11.6 4.2 2.2 1.6 3.2 6.8 8.1 1.6 1.9 3.2 2.3 1.3 1.4 1.6 2.3 0.0 1.3 0.6 1.8 1.5 0.9 0.0 0.0 0.0 0.0 0.8 1.9 0.0 2.8 14.7 3.2 5.7 0.2 0.0 0.0 1.4 3.0 6.0 6.4 0.9 7.7 0.8 22.0 4.1 13.6 1.4 2.5 1.1 2.0 18.7 0.9 0.2 3.7 4.8 0.2 0.7 1.4 0.0 0.4 3.6 0.2 2.4 0.1 3.3 2.3 4.6 1.0 3.8 0.6 0.0 3.8 0.3 2.9 0.0 4.4 2.3 0.0 0.0 12.3 3.1 0.8 0.4 0.1 0.2 2.7 1.0 0.0 3.6 8.3 6.9 9.1 11.5 8.6 0.8 8.1 0.9 9.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 12.9 16.4 26.5 25.9 15.3 11.2 6.5 14.3 11.6 2.3 0.0 0.0 0.0 0.0 0.3 8.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.2 0.2 1.1 0.1 0.0 0.0 0.1 20.6 0.0 0.0 0.0 0.4 2.6 0.0 3.3 4.6 0.0 0.8 0.6 0.0 2.8 0.0 1.9 6.5 6.6 0.3 0.9 0.0 0.0 0.0 0.0 0.1 B4GALNT2 "Cad, GALGT2, Sda" ENSG00000167080 "Beta-1,4-N-acetyl-galactosaminyltransferase 2" Q8NHY0 17 49132460-49176840 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.6;lymphoid tissue: 30.9" "Group enriched" "Detected in some" 5 "Collecting duct cells: 5.2;Enterocytes: 5.1;Mucus-secreting cells: 13.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA015721 Approved NA NA "HPA015721: AB_1845245" "unprognostic (4.39e-4)" "unprognostic (3.18e-1)" "unprognostic (8.26e-3)" "unprognostic (2.03e-4)" "unprognostic (1.72e-2)" "unprognostic (2.62e-2)" "unprognostic (3.67e-2)" "unprognostic (7.67e-2)" "unprognostic (4.06e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-1)" "prognostic favorable (1.29e-5)" "unprognostic (3.53e-1)" "unprognostic (1.31e-1)" "unprognostic (7.81e-3)" "unprognostic (2.15e-1)" 0.3 0.8 0.4 30.9 0.5 2.2 0.4 0.3 0.5 0.3 19.6 0.3 0.3 0.7 0.3 0.3 0.5 0.4 4.0 0.3 0.3 0.3 8.3 0.3 1.1 0.8 0.3 0.3 0.3 0.5 0.0 0.4 0.7 0.6 0.3 7.9 0.4 1.7 0.3 0.3 1.8 11.9 1.3 1.1 0.8 5.3 0.7 0.3 0.3 10.3 0.3 0.8 0.3 1.4 2.0 1.2 2.3 0.6 0.6 1.6 0.2 1.5 3.0 2.9 5.2 0.1 0.1 1.5 2.2 1.6 0.1 0.2 6.1 2.4 3.6 3.6 0.1 1.1 1.7 1.1 0.1 0.4 3.1 3.2 3.9 7.3 3.6 0.1 1.9 6.2 0.3 2.1 0.6 0.3 1.3 0.0 2.8 2.2 5.9 0.1 1.8 2.5 2.7 3.6 0.5 1.5 4.2 1.3 1.1 8.4 2.4 2.7 2.6 1.0 1.4 1.2 3.2 3.2 2.6 1.2 3.7 2.3 2.4 1.2 4.5 1.4 3.8 1.3 2.6 1.6 2.3 0.6 0.9 1.1 0.5 0.6 1.3 1.2 0.8 0.5 2.0 1.6 1.5 1.2 0.6 0.3 1.2 0.6 0.2 0.4 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.6 0.3 0.0 1.0 0.0 0.0 0.3 0.0 0.4 0.0 1.4 1.2 5.2 0.0 0.0 1.7 0.4 0.5 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 13.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 B4GALNT3 "B4GalNac-T3, FLJ16224, FLJ40362" ENSG00000139044 "Beta-1,4-N-acetyl-galactosaminyltransferase 3" Q6L9W6 12 460364-563509 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 43.1" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 46.6;Late spermatids: 64.3;Paneth cells: 36.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 26.2;HDLM-2: 9.2;HEK 293: 9.2;NTERA-2: 11.6;U-937: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011404 Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Golgi apparatus" Vesicles "HPA011404: AB_1845242" "unprognostic (2.38e-2)" "unprognostic (9.59e-3)" "unprognostic (1.38e-1)" "prognostic favorable (1.69e-10)" "unprognostic (4.22e-2)" "unprognostic (4.63e-2)" "unprognostic (1.46e-2)" "unprognostic (9.53e-3)" "unprognostic (3.29e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (9.99e-3)" "unprognostic (2.82e-1)" "unprognostic (2.48e-2)" "unprognostic (2.98e-1)" 0.3 5.7 1.4 2.1 3.8 1.5 1.1 0.3 8.2 6.1 12.8 0.6 0.4 0.8 8.5 2.9 6.0 3.4 9.6 16.8 5.6 0.9 4.1 0.3 6.2 0.2 0.9 1.7 2.1 7.9 2.5 14.7 0.1 2.0 1.6 9.8 1.5 3.8 1.1 2.7 11.0 1.7 1.9 0.5 0.4 43.1 8.0 0.1 1.0 2.1 9.1 4.1 1.8 4.0 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 26.2 0.0 0.0 0.0 0.0 6.5 5.0 0.0 0.7 0.0 0.5 2.9 6.5 0.7 0.0 9.2 9.2 0.0 0.0 1.3 0.0 0.1 3.9 0.0 4.6 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 11.6 7.9 0.5 0.4 3.6 0.0 6.3 5.5 3.1 2.0 0.6 0.2 0.7 4.2 0.6 2.0 0.0 0.0 2.0 0.2 0.6 0.0 0.1 0.1 0.0 11.3 4.4 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 3.8 0.3 8.2 5.6 0.9 0.9 1.7 2.0 0.1 0.0 6.5 0.0 4.8 6.6 0.0 11.8 2.5 6.7 5.7 8.7 0.0 0.0 0.0 8.9 25.7 0.0 46.6 0.0 4.2 0.1 0.6 8.9 0.0 0.0 0.6 0.0 9.9 0.0 0.0 64.3 0.0 0.0 0.0 1.0 18.8 0.0 12.7 36.2 0.0 0.0 0.0 0.0 0.9 1.9 1.4 15.2 0.0 1.7 20.2 13.6 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369796-382116 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1;ovary: 18.6" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 17.5;Cardiomyocytes: 11.2;Horizontal cells: 31.8;Muller glia cells: 40.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.2;NTERA-2: 18.0;SCLC-21H: 22.4;SH-SY5Y: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043276, HPA053126" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA No "Nucleoplasm, Cytosol" Vesicles "HPA043276: , HPA053126: AB_2682049" "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 1.6 2.5 20.6 2.8 16.7 1.2 3.5 26.5 35.1 5.9 2.0 8.6 0.8 2.4 8.6 2.4 1.8 8.7 2.1 1.4 17.6 16.8 1.2 1.1 1.3 1.6 11.5 14.9 18.6 1.8 6.3 6.1 1.1 13.0 3.8 1.6 2.3 4.0 3.7 1.1 3.8 2.9 3.1 8.3 1.5 1.5 1.8 11.0 0.0 1.1 0.0 1.7 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 20.2 11.5 0.0 0.0 4.7 3.6 0.9 1.6 0.5 2.0 0.0 0.0 2.7 0.4 3.2 0.7 2.7 4.8 0.5 0.0 6.8 0.0 6.4 6.2 0.2 0.0 4.9 0.4 2.9 0.1 2.2 7.3 0.2 1.0 6.1 0.0 0.0 5.9 0.2 0.0 18.0 0.3 7.9 0.0 0.0 2.6 0.2 0.0 22.4 27.3 1.3 1.0 0.2 2.2 7.9 0.0 4.9 1.1 6.4 1.9 0.2 0.0 0.9 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.6 16.7 26.5 21.2 17.6 16.8 11.5 14.9 13.0 11.0 0.0 0.0 0.0 1.3 0.7 17.5 11.2 0.0 0.0 0.0 1.8 3.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.2 31.8 1.7 0.0 0.0 0.0 2.8 0.0 3.3 0.0 0.0 40.9 0.3 0.0 1.1 0.0 8.1 0.0 0.2 0.0 0.2 0.3 0.2 0.0 0.0 0.4 B4GALT1 "beta4Gal-T1, GGTB2" ENSG00000086062 "Beta-1,4-galactosyltransferase 1" P15291 9 33104082-33167356 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 56.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 56.9;SiHa: 107.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA010806, HPA010807" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA 98000000 "Golgi apparatus" "HPA010806: AB_1078255, HPA010807: AB_1078254" "unprognostic (7.57e-2)" "unprognostic (1.24e-2)" "unprognostic (2.09e-1)" "prognostic favorable (6.85e-7)" "unprognostic (1.83e-2)" "unprognostic (9.94e-2)" "unprognostic (3.08e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.07e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-3)" "unprognostic (2.78e-1)" "unprognostic (7.93e-3)" "unprognostic (4.98e-2)" "unprognostic (3.91e-2)" "unprognostic (7.07e-2)" "unprognostic (3.46e-2)" 32.0 19.5 4.5 22.5 4.5 22.1 35.1 5.9 3.5 25.4 20.4 6.4 29.1 6.5 19.5 34.1 24.7 26.3 24.2 33.1 3.2 2.5 31.7 91.2 34.9 44.9 5.8 2.2 56.8 20.1 30.2 11.9 79.0 5.9 22.6 11.1 32.1 39.1 42.7 15.0 17.6 18.9 17.7 6.4 38.5 19.9 37.6 3.6 23.1 39.3 16.9 41.0 26.4 21.6 24.8 56.4 24.9 9.1 18.2 16.5 5.4 16.2 12.0 2.2 3.1 11.4 20.2 40.7 17.0 21.3 10.3 10.2 7.3 19.0 6.2 10.8 24.7 13.3 8.8 2.3 21.0 10.3 56.9 2.3 3.5 50.2 5.6 22.5 2.9 6.0 22.5 37.7 11.7 14.3 22.2 10.9 1.9 4.0 7.8 9.7 14.2 2.6 5.8 1.3 9.0 3.7 3.4 2.1 4.1 30.7 14.2 1.7 2.1 107.2 20.9 4.2 7.3 26.4 5.3 10.0 7.3 8.7 23.5 6.6 1.3 2.8 3.9 22.8 4.0 2.7 6.2 9.1 5.0 13.0 7.8 16.5 24.8 8.7 11.4 6.1 20.7 5.3 6.7 24.9 18.2 6.0 56.4 5.7 5.4 4.5 4.5 5.9 3.5 3.2 2.5 5.8 2.2 5.9 3.6 80.4 65.7 101.3 48.3 125.9 1.4 29.7 86.6 26.8 59.1 158.7 19.6 74.7 13.3 63.1 9.2 49.6 45.8 23.3 110.1 134.4 71.0 89.2 36.8 170.8 48.5 0.0 8.1 90.9 71.6 5.1 46.9 58.9 91.1 22.6 42.2 7.2 120.8 32.3 41.8 46.1 39.5 51.8 65.3 4.8 13.4 94.7 145.4 44.5 21.7 74.5 B4GALT2 beta4Gal-T2 ENSG00000117411 "Beta-1,4-galactosyltransferase 2" O60909 1 43978943-43991170 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007620, HPA047739" Supported Supported "Golgi apparatus,Vesicles" NA NA 12000 "Golgi apparatus, Vesicles" "HPA007620: AB_2667879, HPA047739: AB_2680141" "unprognostic (1.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (7.59e-2)" "unprognostic (1.19e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (2.96e-5)" "unprognostic (1.12e-2)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" "unprognostic (4.23e-3)" "unprognostic (7.58e-2)" "prognostic unfavorable (3.62e-5)" "unprognostic (6.54e-2)" "unprognostic (1.52e-1)" "unprognostic (7.66e-2)" "unprognostic (3.12e-3)" 18.6 8.6 34.5 10.1 22.4 4.6 15.6 8.1 35.7 18.4 16.1 16.1 10.7 9.4 13.3 8.5 20.2 11.4 11.9 23.3 25.3 18.9 8.4 24.2 7.7 4.4 18.9 15.6 15.3 39.5 9.9 10.6 9.9 12.7 13.5 10.4 8.7 21.4 21.5 41.0 19.5 9.4 21.3 16.1 5.2 11.2 11.4 11.3 1.9 9.0 12.1 10.1 16.5 11.7 1.7 0.4 0.1 0.6 0.2 2.6 0.7 20.1 14.7 15.3 26.1 20.9 18.7 15.4 22.8 18.8 18.2 16.7 9.7 17.7 13.2 11.7 36.4 16.7 14.0 13.7 23.3 8.5 13.3 26.0 8.8 10.2 22.1 16.9 8.4 0.3 16.3 27.3 13.0 26.7 19.2 21.0 5.3 16.6 8.6 14.2 14.5 4.4 8.4 21.4 14.4 18.4 15.7 20.6 20.7 12.9 9.4 27.9 23.2 10.0 31.6 15.3 8.0 13.7 10.0 16.5 31.7 40.6 21.9 25.4 3.1 6.0 5.6 14.2 6.4 21.1 0.0 0.2 0.0 2.6 0.6 2.4 1.7 1.2 2.2 0.4 0.5 0.0 2.0 0.1 0.2 0.1 0.2 1.1 0.7 34.5 22.4 8.1 35.7 25.3 18.9 18.9 15.6 12.7 11.3 0.0 12.0 0.8 8.4 6.9 13.5 12.2 7.6 2.7 4.5 14.0 3.9 1.6 1.7 12.6 14.0 7.4 5.8 0.0 17.4 6.6 10.6 10.5 0.0 17.8 2.1 17.5 15.6 4.3 0.6 5.4 15.3 1.8 3.3 2.8 19.7 7.5 21.8 7.0 11.7 8.6 12.0 6.5 6.1 3.5 13.0 11.0 0.5 1.3 13.3 14.9 B4GALT3 beta4Gal-T3 ENSG00000158850 "Beta-1,4-galactosyltransferase 3" O60512 1 161171310-161177968 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 95.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 74.9" "Low region specificity" "Detected in all" HPA010793 Approved Supported "Golgi apparatus,Cytosol" NA NA 74000 "Golgi apparatus" Cytosol "HPA010793: AB_1078256" "unprognostic (5.67e-3)" "unprognostic (7.68e-3)" "unprognostic (1.20e-2)" "unprognostic (8.15e-3)" "unprognostic (3.91e-1)" "unprognostic (1.10e-2)" "prognostic unfavorable (5.87e-5)" "unprognostic (3.11e-2)" "unprognostic (3.13e-1)" "unprognostic (4.64e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (7.12e-7)" "unprognostic (1.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-1)" 20.7 18.7 16.5 17.2 22.1 17.3 33.4 20.1 23.2 15.0 19.0 12.4 22.2 18.4 13.6 21.0 20.4 17.2 17.5 17.2 13.4 14.7 22.5 21.7 20.8 21.6 16.4 13.4 25.4 37.5 15.8 29.1 41.0 16.6 18.5 19.3 14.8 33.0 27.8 19.5 20.2 15.1 11.7 14.1 26.6 21.5 28.4 16.4 14.8 28.2 10.7 21.4 20.6 22.9 16.7 22.6 7.1 12.6 15.1 25.5 11.9 9.9 6.6 9.8 12.9 14.6 7.5 15.7 5.7 10.2 11.8 10.9 13.0 20.4 9.2 16.3 6.4 11.3 10.2 10.3 6.3 7.0 9.6 12.6 5.3 4.4 10.4 10.5 10.3 14.8 10.4 9.4 10.9 11.9 14.2 13.4 12.1 17.0 20.8 9.6 10.3 6.7 9.9 12.3 20.1 14.1 8.2 5.5 22.7 10.1 6.2 14.0 16.6 5.7 15.1 11.9 13.9 15.1 18.9 5.6 5.9 10.7 6.7 16.6 74.9 40.4 12.3 8.8 8.9 9.4 5.1 8.9 7.1 17.6 10.1 15.7 16.7 16.7 16.8 10.8 13.5 16.4 15.4 5.9 15.1 12.6 22.6 25.5 11.9 16.5 22.1 20.1 23.2 13.4 14.7 16.4 13.4 16.6 16.4 17.9 18.3 36.5 26.3 34.2 12.6 9.5 7.6 10.7 6.8 24.4 2.0 38.4 5.0 25.4 7.0 20.2 14.7 0.0 19.9 75.2 19.5 33.5 9.2 11.6 25.2 25.4 27.6 26.4 16.8 4.0 8.9 13.8 21.9 6.4 22.4 7.4 28.1 14.4 6.7 17.3 6.3 25.8 34.6 9.8 42.9 36.6 95.5 34.6 21.7 45.5 B4GALT4 beta4Gal-T4 ENSG00000121578 "Beta-1,4-galactosyltransferase 4" O60513 3 119211732-119241103 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 111.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 38.8" "Low region specificity" "Detected in all" "HPA046819, HPA063546" Approved Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA046819: AB_2679824, HPA063546: AB_2685036" "unprognostic (4.07e-2)" "unprognostic (1.78e-2)" "unprognostic (3.27e-2)" "unprognostic (1.14e-3)" "unprognostic (4.59e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (6.30e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-1)" "unprognostic (6.10e-3)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" 9.6 7.7 7.0 8.6 8.5 11.6 8.8 5.3 6.6 10.1 20.8 8.2 12.6 14.6 15.1 43.4 13.2 12.6 21.3 11.1 6.0 6.2 15.0 11.8 8.9 8.0 7.7 7.3 13.5 20.8 8.5 16.2 23.7 9.1 9.4 17.9 10.2 10.1 16.1 4.8 10.9 40.4 11.3 9.3 8.2 16.8 5.8 6.5 8.5 10.8 6.5 11.4 13.0 8.7 3.7 4.7 11.2 4.6 11.7 12.2 4.8 17.6 34.3 4.0 2.8 12.5 10.4 20.4 38.8 17.2 18.1 18.2 20.2 5.7 3.8 8.1 20.3 10.9 24.3 6.8 5.2 18.3 7.5 2.3 5.2 5.8 10.7 8.6 3.1 4.7 7.5 7.3 7.7 6.2 6.9 1.7 2.8 3.6 4.0 7.4 6.7 1.4 2.7 5.2 10.2 9.3 1.4 3.7 1.5 9.9 19.4 3.5 8.2 9.3 4.1 8.4 9.0 8.9 1.4 1.2 8.6 7.9 4.3 4.3 8.9 7.0 5.0 7.2 2.9 7.1 11.2 3.7 6.8 12.2 4.6 6.9 3.7 6.0 6.4 4.7 2.9 11.3 6.8 2.2 11.7 4.0 3.1 2.3 4.8 7.0 8.5 5.3 6.6 6.0 6.2 7.7 7.3 9.1 6.5 0.0 6.5 17.8 18.3 9.5 10.5 7.7 40.8 30.8 18.2 7.0 3.9 30.1 1.7 26.8 0.9 8.3 39.8 0.0 29.7 111.2 24.4 21.4 12.7 9.0 12.7 17.5 13.3 4.3 7.5 1.7 13.8 10.8 13.5 13.6 76.6 21.5 28.0 42.1 26.5 21.6 9.4 19.4 12.7 1.6 10.5 9.3 43.7 14.6 21.7 68.6 B4GALT5 beta4GalT-V ENSG00000158470 "Beta-1,4-galactosyltransferase 5" O43286 20 49632945-49713878 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 107.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 10.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (7.98e-2)" "unprognostic (5.27e-2)" "unprognostic (2.62e-1)" "unprognostic (1.88e-2)" "unprognostic (2.76e-1)" "unprognostic (1.61e-2)" "prognostic unfavorable (2.69e-5)" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (1.87e-5)" "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (3.30e-2)" "unprognostic (5.41e-1)" "unprognostic (2.07e-1)" "unprognostic (2.69e-2)" 20.0 37.2 16.2 13.8 15.8 53.3 15.7 22.6 19.0 15.5 16.4 8.5 10.6 16.5 17.2 7.5 27.4 14.6 21.1 32.7 12.4 12.6 16.8 17.3 20.1 7.7 10.4 9.9 19.5 11.7 7.0 14.1 17.8 17.3 12.4 16.1 15.3 15.7 15.7 46.9 6.4 15.5 24.7 13.5 22.6 16.9 16.6 9.3 3.9 9.5 8.0 13.7 19.2 16.0 0.4 1.1 10.2 1.6 1.7 2.4 0.6 15.8 18.3 24.4 10.3 25.5 17.4 21.4 7.8 14.7 36.0 17.3 23.5 19.8 4.8 33.7 13.0 34.1 25.4 15.3 11.7 21.2 14.9 4.2 12.9 10.0 14.0 8.0 16.7 25.3 26.0 11.0 15.6 7.5 33.3 21.8 8.7 20.8 3.0 10.4 7.9 1.0 15.4 12.7 15.7 11.9 8.7 21.1 7.0 17.3 11.3 29.2 14.8 28.0 35.9 15.7 18.8 8.1 23.1 16.7 21.7 17.5 11.5 16.4 3.7 3.2 11.8 11.3 16.1 13.7 1.3 1.6 3.7 2.2 1.6 2.4 0.3 1.0 2.1 1.1 0.4 0.2 1.5 10.2 1.7 1.6 0.9 1.3 0.6 16.2 15.8 22.6 19.0 12.4 12.6 10.4 9.9 17.3 9.3 14.9 45.0 3.2 24.2 16.8 6.2 15.3 30.6 24.1 35.2 34.9 9.8 19.4 1.7 27.9 4.5 43.9 21.4 23.3 17.1 21.5 24.3 41.5 84.0 20.2 21.9 11.1 33.0 47.3 27.6 5.3 18.4 28.0 20.3 9.0 23.7 5.2 29.8 28.6 30.8 31.6 4.8 25.8 26.8 7.5 17.7 15.3 4.7 15.2 16.4 107.6 B4GALT6 beta4GalT-VI ENSG00000118276 "Beta-1,4-galactosyltransferase 6" Q9UBX8 18 31622247-31685836 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3" "Group enriched" "Detected in many" 4 "Bipolar cells: 67.0;Cone photoreceptor cells: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.8" "Group enriched" "Detected in many" 5 "NK-cells: 3.8;T-cells: 1.1" "Cell line enhanced" "Detected in many" "WM-115: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020701, HPA058284" Approved "Intracellular and membrane" NA NA "CAB020701: , HPA058284: AB_2683668" "unprognostic (3.79e-1)" "unprognostic (4.52e-1)" "unprognostic (6.54e-3)" "unprognostic (2.23e-4)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.31e-2)" "unprognostic (4.50e-2)" "unprognostic (5.18e-1)" "unprognostic (1.13e-1)" "prognostic favorable (5.65e-4)" "unprognostic (2.77e-1)" "prognostic favorable (6.40e-5)" "unprognostic (5.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.10e-2)" "unprognostic (4.00e-1)" 3.6 13.8 7.8 2.8 16.0 4.4 2.1 20.6 22.3 2.2 3.5 2.6 0.0 7.7 2.5 2.2 4.8 2.5 7.2 3.8 10.7 7.9 3.7 2.7 1.8 1.2 6.1 10.0 4.3 2.1 7.3 14.8 2.7 16.3 5.8 3.6 13.2 4.6 4.4 3.3 2.2 9.7 1.7 3.1 1.5 3.4 5.4 2.3 5.0 2.1 1.5 1.0 3.6 2.1 0.0 0.5 0.0 0.4 3.8 1.1 0.3 2.3 5.4 9.7 5.4 0.1 0.2 3.6 0.7 0.0 0.1 0.0 10.0 2.0 3.7 4.5 0.9 11.7 0.9 5.1 4.3 0.6 14.5 4.5 4.8 0.5 0.2 1.1 8.8 0.8 1.0 0.9 1.4 3.1 4.9 5.3 8.8 0.7 0.0 0.0 1.4 9.8 0.6 4.2 2.8 2.9 18.4 1.7 0.0 1.1 4.9 5.1 8.1 3.5 0.6 6.3 8.2 0.6 2.7 5.3 11.0 2.3 0.0 5.9 3.6 0.2 7.6 4.5 8.0 51.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.1 0.9 0.5 0.0 0.0 1.1 0.0 3.8 0.4 0.0 0.0 0.3 7.8 16.0 20.6 22.3 10.7 7.9 6.1 10.0 16.3 2.3 0.0 0.3 0.0 0.7 4.8 67.0 6.7 0.0 0.0 1.2 1.8 37.3 0.4 3.3 1.3 3.6 2.3 3.1 0.0 1.0 0.2 1.7 1.5 0.0 1.7 0.6 12.7 2.9 3.7 0.8 3.3 1.1 0.0 0.0 0.0 2.6 3.3 1.7 2.5 2.5 1.1 4.7 0.0 0.9 0.5 10.2 1.5 0.2 0.5 2.9 0.6 B4GALT7 "beta4Gal-T7, XGALT-1" ENSG00000027847 "Beta-1,4-galactosyltransferase 7" Q9UBV7 5 177600100-177610347 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease mutation, Dwarfism, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 110.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042330 Supported NA NA "HPA042330: AB_10796576" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (3.12e-1)" "unprognostic (5.97e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (9.53e-2)" "unprognostic (4.19e-3)" "unprognostic (3.86e-2)" "unprognostic (1.18e-1)" "unprognostic (1.21e-1)" "unprognostic (1.82e-3)" "unprognostic (2.00e-2)" "unprognostic (4.81e-2)" "unprognostic (2.39e-1)" "unprognostic (4.44e-2)" "unprognostic (2.90e-1)" "unprognostic (4.00e-2)" 13.8 33.0 16.0 20.4 14.3 20.7 19.1 10.6 19.6 13.3 12.4 14.9 20.4 16.1 15.5 15.9 11.7 13.3 20.3 17.3 13.7 18.0 16.2 21.3 12.0 21.5 15.1 17.9 16.9 37.0 15.5 23.9 15.3 14.3 16.4 11.7 14.7 22.4 20.9 14.4 12.9 13.7 12.2 10.8 16.3 16.2 16.1 11.7 10.4 16.7 9.8 18.6 13.0 10.2 15.8 16.3 11.2 16.1 8.5 12.5 9.0 8.5 15.2 6.4 16.0 12.8 9.6 28.9 13.4 14.2 12.2 14.0 14.3 13.7 11.1 24.7 13.6 21.4 10.2 4.4 28.6 5.3 36.9 11.6 5.8 11.9 10.0 18.6 6.0 10.2 14.7 10.2 13.1 10.7 11.2 13.5 7.5 5.0 10.7 12.3 20.0 5.1 7.4 6.2 7.7 22.4 10.4 4.6 12.1 9.2 13.1 5.7 6.5 6.6 13.5 11.7 5.3 8.7 7.1 10.4 15.6 9.0 10.2 13.2 13.4 6.2 7.8 13.2 14.5 14.1 11.2 14.6 7.8 12.5 16.1 11.3 12.8 11.6 11.0 16.3 15.8 10.5 10.3 1.0 8.5 15.3 12.8 7.5 9.0 16.0 14.3 10.6 19.6 13.7 18.0 15.1 17.9 14.3 11.7 3.0 6.4 14.9 14.1 6.0 11.8 5.9 10.2 5.3 10.3 15.7 3.9 37.3 6.6 28.8 12.3 11.3 13.7 0.0 34.1 110.0 18.1 23.5 10.3 13.9 28.4 11.1 13.9 10.4 8.8 7.8 13.0 10.6 20.3 33.3 19.6 12.2 26.0 10.5 17.3 15.8 15.1 0.0 11.4 13.0 12.4 7.8 36.7 10.1 20.9 13.9 B4GAT1 "B3GN-T1, B3GNT1, B3GNT6, BETA3GNTI, iGAT, iGNT" ENSG00000174684 "Beta-1,4-glucuronyltransferase 1" O43505 11 66345372-66347692 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 71.1;Horizontal cells: 149.4;Muller glia cells: 83.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015484 Uncertain "Intracellular and membrane" NA NA 48000000 "HPA015484: AB_1845235" "unprognostic (1.80e-1)" "unprognostic (7.20e-2)" "unprognostic (1.70e-1)" "unprognostic (3.81e-2)" "unprognostic (3.96e-2)" "unprognostic (1.45e-1)" "unprognostic (9.23e-2)" "unprognostic (1.59e-1)" "unprognostic (2.65e-2)" "unprognostic (3.43e-3)" "prognostic favorable (3.55e-5)" "unprognostic (2.20e-1)" "unprognostic (3.50e-1)" "unprognostic (1.23e-1)" "unprognostic (2.02e-1)" "unprognostic (1.88e-1)" "unprognostic (2.76e-3)" 8.3 24.8 29.3 3.6 47.1 1.0 5.4 28.5 69.5 7.8 6.5 11.8 4.2 9.5 10.0 9.5 5.2 10.5 6.0 19.6 33.3 57.9 15.0 9.7 9.7 3.7 24.7 32.0 18.9 12.8 11.9 15.6 12.9 31.0 10.2 4.9 10.1 9.1 14.2 12.9 5.8 7.2 8.5 13.2 5.1 7.7 4.4 11.6 1.1 10.7 1.7 2.8 5.5 4.1 5.6 6.8 0.4 1.1 3.9 9.7 4.2 4.0 10.2 11.7 14.2 13.1 11.9 15.5 7.1 16.5 11.1 9.1 7.6 5.8 3.3 30.2 6.5 9.5 6.5 12.4 7.9 5.4 6.6 22.6 0.5 8.4 29.1 7.8 2.6 1.0 11.5 6.1 6.9 2.9 36.8 13.0 5.7 3.1 5.3 5.2 6.8 6.2 7.2 7.9 4.0 10.9 9.0 9.1 5.9 11.5 1.0 7.0 13.3 6.1 4.1 27.5 7.6 16.6 2.6 7.5 8.7 6.4 11.0 3.6 10.3 7.1 1.9 14.7 2.2 10.1 0.0 1.1 0.0 7.1 0.4 9.7 5.6 7.8 7.6 2.8 3.5 9.2 8.4 0.4 3.9 0.2 6.8 5.3 4.2 29.3 47.1 28.5 59.9 33.3 57.9 24.7 32.0 31.0 11.6 20.8 9.6 6.9 1.2 0.0 71.1 36.7 28.1 5.3 3.4 19.2 55.0 47.1 5.0 5.9 0.3 19.1 8.1 0.0 5.3 19.6 10.0 1.2 1.1 22.2 11.1 149.4 4.7 22.7 2.4 0.9 30.2 0.4 0.0 1.8 9.9 83.3 5.0 3.5 38.2 15.1 37.5 25.8 8.6 1.2 2.6 0.0 15.1 2.2 7.6 0.3 BACE1 BACE ENSG00000186318 "Beta-secretase 1" P56817 11 117285207-117316259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 53.0;pancreas: 161.1" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 111.9;Early spermatids: 89.1;Late spermatids: 222.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016358 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB016358: AB_626716" "unprognostic (7.96e-3)" "unprognostic (8.05e-2)" "unprognostic (3.55e-2)" "unprognostic (3.05e-3)" "unprognostic (8.94e-2)" "unprognostic (3.39e-1)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (8.09e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.35e-2)" "unprognostic (1.16e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.76e-4)" 6.5 7.1 12.1 3.8 18.8 2.2 5.5 9.6 22.4 9.8 4.6 42.5 2.7 3.4 9.3 5.6 7.6 8.6 9.1 5.9 16.9 12.4 6.8 12.1 7.3 2.8 28.8 15.0 11.4 161.1 12.8 4.2 6.3 26.4 6.5 4.7 6.9 5.3 9.9 6.2 7.2 3.6 11.7 53.0 5.7 4.9 4.1 21.4 0.0 6.3 2.3 2.8 6.7 5.5 4.0 2.2 0.7 3.2 2.2 6.7 1.1 3.9 4.7 9.7 14.8 32.2 34.7 0.4 21.3 18.6 10.4 8.5 3.6 6.3 0.8 5.2 38.6 7.8 6.9 10.3 6.1 8.5 2.3 5.5 2.4 7.9 4.3 15.9 0.8 0.5 30.0 9.6 13.2 12.9 25.7 8.9 1.4 0.8 0.4 19.0 14.3 0.6 1.9 6.3 4.1 10.4 1.8 4.4 0.8 4.4 2.2 12.6 14.1 7.9 1.0 2.3 8.9 10.2 2.7 12.2 18.7 2.0 19.5 6.8 0.3 0.3 0.4 8.8 1.2 13.0 0.6 2.0 0.7 2.0 3.2 5.2 4.0 6.7 5.3 2.2 1.8 3.1 2.7 0.0 2.2 1.3 1.3 6.3 1.1 12.1 18.8 9.6 21.7 16.9 12.4 28.8 15.0 26.4 21.4 17.9 8.5 0.0 3.8 4.1 53.4 8.1 17.8 4.0 20.5 5.2 111.9 0.8 5.0 4.7 89.1 5.2 1.5 0.0 17.3 0.9 11.5 2.8 2.3 31.6 7.9 54.0 20.8 6.7 12.6 222.6 17.8 5.8 3.3 1.8 2.4 16.6 5.8 4.0 20.8 5.4 48.1 6.5 6.6 3.2 1.7 3.0 0.7 1.0 2.7 2.5 BACE2 "AEPLC, ALP56, CEAP1, DRAP" ENSG00000182240 "Beta-site APP-cleaving enzyme 2" Q9Y5Z0 21 41167801-41282518 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Glandular cells: 265.1;Syncytiotrophoblasts: 430.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 4.8;eosinophil: 8.4" "Lineage enriched" "Detected in many" 8 "granulocytes: 8.4" "Cell line enhanced" "Detected in many" "OE19: 42.8;SK-BR-3: 24.4;SK-MEL-30: 18.9;WM-115: 17.3" "Low region specificity" "Detected in all" HPA035416 Approved "Intracellular and membrane" NA NA "HPA035416: AB_2732467" "unprognostic (1.71e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (5.23e-2)" "unprognostic (8.12e-3)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.52e-2)" "unprognostic (2.58e-2)" "unprognostic (2.64e-3)" "unprognostic (7.24e-2)" "unprognostic (2.49e-1)" "unprognostic (3.46e-2)" "unprognostic (8.50e-2)" "unprognostic (1.22e-1)" "unprognostic (4.04e-1)" "unprognostic (2.10e-1)" "unprognostic (2.76e-2)" "unprognostic (5.83e-2)" 16.1 2.5 1.4 5.9 1.6 0.9 13.8 0.9 2.0 9.0 11.0 3.4 5.6 5.1 10.3 10.7 13.0 6.8 38.9 7.2 1.7 1.6 11.4 4.4 4.9 21.6 2.7 0.5 8.4 29.0 3.3 2.2 17.2 4.4 22.7 7.4 8.7 28.3 4.4 10.6 5.5 5.4 7.8 5.9 7.0 31.6 5.1 1.4 1.3 9.9 7.6 14.3 11.8 33.6 1.0 0.0 8.4 0.0 0.3 0.0 0.0 14.4 1.3 4.8 0.0 1.3 1.3 0.0 3.6 0.0 2.5 2.1 0.0 5.6 0.0 6.8 4.5 3.9 4.5 0.0 8.5 0.8 0.0 7.2 2.8 1.6 0.0 0.6 0.0 6.8 3.5 1.6 0.3 1.8 11.1 7.2 3.3 0.0 0.0 3.4 2.7 1.6 0.0 3.8 42.8 7.4 0.5 0.0 5.4 4.4 0.9 0.2 0.0 0.2 24.4 18.9 0.6 6.8 0.0 7.1 4.0 2.9 3.3 5.1 0.0 0.0 0.0 8.3 0.0 17.3 4.8 0.0 8.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 1.6 0.9 2.0 1.7 1.6 2.7 0.5 4.4 1.4 11.9 15.7 28.2 70.7 16.5 0.3 6.1 124.9 96.4 81.9 19.2 2.0 98.7 79.6 150.6 17.8 58.1 13.6 0.0 91.4 48.8 34.0 265.1 88.9 0.5 22.6 0.0 17.7 36.8 13.4 7.9 13.3 4.8 170.4 4.6 61.8 2.5 75.6 17.3 17.7 1.1 0.2 0.0 30.1 0.5 0.4 10.3 430.4 2.2 37.1 109.5 BAK1 "BAK, BCL2L7, CDN1" ENSG00000030110 "BCL2 antagonist/killer 1" Q16611 6 33572547-33580293 "Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005029 Enhanced NA NA "CAB005029: AB_562051" "unprognostic (3.52e-1)" "unprognostic (2.58e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.71e-4)" "unprognostic (5.67e-2)" "unprognostic (6.58e-3)" "prognostic unfavorable (4.52e-4)" "prognostic unfavorable (5.64e-4)" "unprognostic (2.36e-1)" "unprognostic (1.73e-1)" "unprognostic (2.80e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (1.64e-5)" "unprognostic (6.07e-2)" "unprognostic (3.36e-2)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" 8.9 19.8 6.5 14.5 9.3 15.6 5.2 6.7 10.4 7.0 21.2 8.7 6.2 30.9 7.6 7.1 22.1 6.1 14.0 13.8 6.0 5.0 12.7 8.2 9.6 13.0 6.0 7.2 7.1 9.6 6.2 8.7 9.8 7.7 7.9 16.9 8.1 13.1 6.4 10.9 12.6 29.1 8.9 6.2 21.8 14.0 6.0 7.0 15.4 6.8 9.6 18.2 12.2 7.9 12.1 18.8 35.6 27.9 9.2 24.4 20.3 14.7 8.2 8.7 13.1 5.9 5.9 11.1 7.7 6.2 22.1 17.4 16.8 11.6 12.9 13.5 11.2 10.2 15.5 16.6 31.2 9.8 14.7 17.7 8.1 7.7 13.5 15.4 17.4 13.3 9.6 25.0 18.5 21.8 6.4 12.0 11.6 7.3 11.7 8.1 21.6 15.0 11.6 9.7 10.4 20.3 14.6 8.4 23.6 18.7 12.2 10.8 8.1 9.8 31.7 14.6 11.5 10.4 29.6 11.3 11.8 12.5 7.6 9.8 31.1 38.3 10.9 4.0 20.9 12.9 23.8 19.8 35.6 16.3 27.9 18.6 12.1 15.3 16.3 18.8 8.4 8.6 11.2 13.7 9.2 23.4 6.5 24.4 20.3 6.5 9.3 6.7 10.4 6.0 5.0 6.0 7.2 7.7 7.0 3.0 4.3 29.8 10.0 24.2 6.7 5.5 7.6 1.4 2.3 3.5 7.9 12.3 11.6 18.4 4.0 8.4 69.5 0.0 16.4 29.8 11.0 6.4 11.5 2.9 28.0 4.8 21.2 11.6 19.1 1.3 7.2 17.0 20.3 33.3 25.6 5.5 23.0 49.1 11.0 7.6 5.9 12.9 12.2 0.3 0.9 18.9 8.2 27.4 31.9 13.3 BAMBI NMA ENSG00000095739 "BMP and activin membrane bound inhibitor" Q13145 10 28677342-28682939 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 46.8;seminal vesicle: 52.4" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 40.8;Muller glia cells: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 34.0;SK-MEL-30: 40.6;SuSa: 79.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA010819, HPA010866" Approved Approved "Nucleoli fibrillar center,Vesicles,Lipid droplets" NA NA Vesicles "Nucleoli fibrillar center, Lipid droplets" "HPA010819: AB_2668371, HPA010866: AB_10601686" "unprognostic (7.02e-3)" "unprognostic (4.52e-2)" "unprognostic (1.28e-2)" "unprognostic (3.17e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (9.42e-6)" "unprognostic (1.09e-1)" "unprognostic (6.45e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-3)" "unprognostic (9.29e-2)" "prognostic favorable (5.25e-4)" "unprognostic (1.01e-1)" "unprognostic (3.24e-1)" "unprognostic (2.38e-2)" "unprognostic (2.10e-2)" 2.0 24.7 6.7 1.8 6.9 3.0 13.6 2.2 6.3 3.9 2.3 12.9 15.5 1.1 10.1 2.0 1.1 2.8 3.0 22.8 6.7 6.4 11.2 12.9 5.7 3.1 12.0 2.9 46.8 3.9 7.4 4.5 20.9 10.5 6.5 2.8 30.4 3.8 52.4 1.2 2.7 1.1 12.7 10.8 9.0 2.3 4.8 7.9 0.1 0.6 2.1 1.3 13.8 11.6 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.2 8.6 0.8 0.4 1.0 0.0 5.2 2.1 0.7 3.3 2.1 34.0 3.6 0.1 1.3 1.5 2.0 2.5 2.1 0.3 1.5 2.1 4.7 8.0 1.3 12.9 1.2 0.4 10.7 0.7 0.5 2.2 0.3 20.9 0.5 0.4 4.5 3.9 0.6 14.1 0.0 0.6 15.6 7.2 2.1 0.0 1.6 0.7 2.7 8.2 1.4 1.1 2.8 16.5 40.6 79.5 4.8 0.6 0.0 2.2 1.6 3.6 1.0 0.1 2.9 0.0 0.2 1.8 14.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.7 6.9 2.2 4.8 6.7 6.4 12.0 2.9 10.5 7.9 8.9 5.1 1.7 4.8 3.5 5.1 19.6 40.8 1.4 3.4 10.4 3.9 11.0 1.7 16.1 0.0 3.1 2.0 0.0 0.2 13.7 21.0 16.5 1.1 11.5 5.8 6.4 25.7 19.6 0.6 1.0 3.1 1.4 15.1 1.0 3.4 39.2 7.7 4.3 2.1 13.0 5.2 0.0 4.4 1.7 7.6 1.1 7.1 1.3 1.9 6.4 BAX BCL2L4 ENSG00000087088 "BCL2 associated X, apoptosis regulator" Q07812 19 48954815-48961798 "Cancer-related genes, Predicted intracellular proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 382.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004206, HPA027878" Approved NA NA 1300000 "CAB004206: AB_626729, HPA027878: AB_10601687" "unprognostic (4.11e-2)" "unprognostic (4.70e-2)" "unprognostic (1.50e-1)" "unprognostic (6.23e-2)" "unprognostic (1.70e-1)" "unprognostic (2.82e-1)" "prognostic unfavorable (1.63e-5)" "unprognostic (4.92e-2)" "unprognostic (1.09e-1)" "unprognostic (4.71e-2)" "unprognostic (3.66e-2)" "unprognostic (8.10e-2)" "unprognostic (1.19e-2)" "unprognostic (7.83e-2)" "unprognostic (1.08e-1)" "unprognostic (4.47e-3)" "unprognostic (6.22e-2)" 15.2 20.0 12.3 26.0 13.2 25.3 20.2 7.6 13.6 14.9 33.3 15.1 13.5 30.7 19.3 11.2 21.4 15.5 40.4 14.9 11.3 10.2 19.5 26.1 26.6 25.9 18.7 12.5 16.4 16.2 8.8 10.0 21.5 14.9 16.6 27.8 10.3 16.5 13.3 11.6 17.1 28.7 16.3 15.1 37.8 19.6 10.7 13.2 37.8 17.7 16.3 26.5 19.1 19.5 6.6 10.6 11.1 16.5 9.1 6.4 6.6 34.3 57.2 34.6 30.3 34.6 33.9 57.1 23.5 47.2 31.0 43.4 15.1 33.7 42.1 11.0 35.9 28.9 18.7 15.7 45.8 25.8 32.4 36.2 17.9 11.6 56.0 55.6 18.6 57.5 46.4 32.9 25.7 15.5 37.7 71.3 16.7 17.5 17.3 53.1 24.3 30.1 29.2 26.8 33.6 16.4 21.2 23.0 16.1 32.5 33.5 19.9 23.5 19.8 14.1 10.8 51.5 11.3 33.6 41.7 40.0 43.4 24.4 32.2 20.0 25.4 27.3 24.2 25.3 55.2 4.3 10.4 10.5 6.0 15.3 4.3 6.6 3.4 6.4 10.4 5.8 2.3 5.3 11.1 9.1 16.5 10.6 6.3 6.6 12.3 13.2 7.6 13.6 11.3 10.2 18.7 12.5 14.9 13.2 3.0 4.5 117.5 48.9 48.7 17.5 7.3 79.0 5.3 3.4 57.6 9.8 113.9 63.0 111.1 0.9 69.9 164.3 0.0 84.3 129.6 73.3 76.7 44.8 26.7 232.2 28.6 109.5 54.0 114.6 1.6 44.5 121.4 79.2 382.3 86.5 32.3 116.8 161.4 36.0 172.3 13.7 45.3 56.6 12.6 35.8 49.3 85.2 119.3 131.1 73.4 BBS4 ENSG00000140463 "Bardet-Biedl syndrome 4" Q96RK4 15 72686179-72738476 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 65.6;Cone photoreceptor cells: 113.9;Rod photoreceptor cells: 86.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039418 Approved Supported Cytosol NA NA Cytosol "HPA039418: AB_10672962" "unprognostic (3.47e-1)" "unprognostic (2.83e-1)" "unprognostic (1.35e-1)" "prognostic favorable (2.57e-4)" "unprognostic (3.54e-1)" "unprognostic (2.91e-1)" "unprognostic (8.76e-2)" "unprognostic (5.47e-2)" "unprognostic (5.70e-2)" "unprognostic (2.56e-1)" "unprognostic (3.22e-3)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (4.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.05e-1)" 8.9 15.5 11.1 8.5 16.6 7.3 12.4 10.7 17.9 14.9 10.6 17.2 9.8 5.6 14.1 18.0 8.1 19.9 10.4 11.9 11.2 13.6 17.5 13.6 11.4 8.0 12.1 14.5 14.8 11.1 16.9 31.3 8.6 23.8 23.8 8.8 29.8 7.8 11.0 17.2 10.1 8.0 12.9 13.2 7.6 10.5 25.7 10.2 13.1 18.0 6.0 8.3 12.4 9.6 6.0 3.8 4.8 4.0 13.0 7.9 3.5 3.2 8.5 18.9 8.0 9.3 11.5 5.0 6.4 13.5 6.4 8.3 4.4 11.0 5.2 13.8 5.5 4.9 4.8 4.9 5.3 5.8 5.4 6.0 6.1 7.6 4.9 7.7 5.4 4.8 10.7 7.4 9.1 7.2 9.6 4.9 9.9 13.3 4.6 10.0 5.7 5.0 5.1 26.4 6.6 3.8 3.4 9.4 6.5 10.9 8.1 9.1 10.7 11.4 8.3 16.7 7.6 11.3 6.1 6.9 7.4 5.7 34.8 3.6 9.6 9.3 11.0 8.3 8.1 9.9 4.8 2.4 3.8 6.9 4.0 6.7 5.5 5.8 7.2 2.0 6.0 6.1 7.9 2.0 13.0 2.9 3.8 6.8 3.5 11.1 16.6 10.7 17.9 11.2 13.6 12.1 14.5 23.8 10.2 17.9 19.2 5.4 6.8 2.7 38.9 17.1 5.1 65.6 25.0 12.2 113.9 7.7 5.0 12.8 13.1 4.5 3.9 0.0 9.8 4.9 9.3 9.0 12.8 6.2 6.7 20.6 4.1 7.4 6.3 4.2 14.7 6.7 5.0 4.6 7.1 36.7 7.2 6.5 19.1 7.1 86.0 0.0 10.3 48.3 54.1 2.5 4.5 8.7 4.7 1.7 BCAM "CD239, LU" ENSG00000187244 "Basal cell adhesion molecule (Lutheran blood group)" P50895 19 44809059-44821421 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Blood group antigen, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 101.8" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 519.9;Cytotrophoblasts: 537.1;Syncytiotrophoblasts: 362.4" "Cancer enhanced" "Detected in all" "ovarian cancer: 493.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 31.4;HaCaT: 64.1;SK-BR-3: 60.2;T-47d: 34.1;U-2 OS: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005654 Enhanced Approved "Nucleoli fibrillar center" NA NA 16000000 "Nucleoli fibrillar center" "HPA005654: AB_2667378" "unprognostic (5.63e-2)" "unprognostic (2.98e-2)" "prognostic unfavorable (2.31e-4)" "prognostic unfavorable (1.24e-5)" "unprognostic (1.60e-2)" "unprognostic (1.23e-3)" "unprognostic (2.01e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (6.17e-2)" "unprognostic (2.61e-3)" "unprognostic (1.41e-1)" "prognostic favorable (5.94e-6)" "unprognostic (1.83e-2)" "unprognostic (5.74e-2)" "unprognostic (2.14e-2)" "unprognostic (9.97e-3)" 28.9 7.2 4.9 8.1 5.4 1.4 33.1 3.4 8.7 33.5 8.5 4.4 17.8 5.7 24.8 26.5 15.6 46.3 23.2 23.8 4.5 4.2 101.8 13.2 41.6 5.8 4.4 6.5 30.4 17.8 5.8 9.8 28.7 7.0 42.7 2.4 21.4 17.8 27.3 16.7 12.7 7.4 12.5 3.8 14.2 9.6 13.6 2.6 5.7 93.0 23.7 8.5 14.2 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.2 9.4 0.2 26.2 0.1 0.1 31.4 2.8 1.3 2.3 1.5 14.1 18.0 0.0 14.5 0.3 0.1 64.1 2.3 16.0 0.7 0.0 1.6 0.0 1.9 19.5 5.3 0.0 3.5 2.6 6.2 0.8 0.9 7.5 1.4 0.0 1.5 0.1 0.3 3.7 0.1 0.2 2.9 2.1 3.3 0.1 3.1 0.7 19.6 4.6 0.0 0.1 11.6 60.2 0.7 3.0 34.1 1.0 3.8 0.6 29.5 0.7 1.3 0.1 0.3 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.9 5.4 3.4 8.7 4.5 4.2 4.4 6.5 7.0 2.6 6.0 10.5 0.5 101.3 36.1 0.6 9.0 38.2 2.7 18.2 519.9 0.0 537.1 69.6 23.4 0.8 63.2 5.1 0.0 3.5 27.0 13.6 65.7 0.0 27.0 38.8 0.0 50.0 39.9 5.9 0.8 27.3 8.0 15.1 0.0 4.7 26.3 14.4 17.5 14.2 123.1 0.5 155.2 124.6 2.2 14.9 21.5 362.4 0.0 10.5 34.4 BCAP29 "BAP29, DKFZp686M2086" ENSG00000075790 "B cell receptor associated protein 29" Q9UHQ4 7 107579977-107629170 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 226.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029215, HPA049694" Enhanced Approved Cytosol NA NA Cytosol "HPA029215: AB_10602331, HPA049694: AB_2680854" "unprognostic (3.96e-2)" "unprognostic (9.94e-2)" "unprognostic (1.82e-2)" "unprognostic (1.05e-2)" "unprognostic (5.42e-3)" "unprognostic (4.71e-3)" "prognostic unfavorable (3.62e-4)" "unprognostic (6.43e-2)" "unprognostic (7.22e-2)" "unprognostic (9.64e-2)" "unprognostic (2.31e-2)" "unprognostic (7.36e-2)" "unprognostic (8.34e-2)" "unprognostic (5.40e-2)" "unprognostic (2.78e-2)" "unprognostic (5.28e-3)" "unprognostic (1.81e-1)" 25.6 16.0 17.6 13.7 21.3 11.0 24.0 15.9 33.8 30.5 18.9 10.3 13.6 10.4 27.4 12.3 23.3 13.5 14.7 34.0 18.9 17.0 16.7 24.4 17.3 10.6 20.3 28.7 14.6 12.3 20.8 14.8 23.6 25.7 18.5 19.3 10.0 12.1 17.0 22.9 13.6 13.6 24.0 28.1 12.8 14.6 40.0 13.7 6.3 51.4 13.8 9.8 20.5 20.8 6.6 6.3 20.0 12.4 5.1 6.5 4.3 18.9 5.0 7.9 4.1 17.0 20.2 6.4 21.4 18.6 10.5 11.6 5.5 20.3 3.7 15.2 16.0 18.5 9.5 4.8 10.1 14.6 12.5 5.2 9.1 7.8 5.3 16.8 10.4 12.6 13.0 7.4 13.4 11.0 24.7 28.4 6.8 15.3 10.7 20.7 12.9 6.6 8.8 4.7 6.9 7.8 6.0 10.7 11.7 15.8 9.9 3.4 11.0 20.7 17.9 15.8 10.5 6.8 10.2 30.3 31.0 14.3 27.2 29.6 8.2 21.1 8.8 23.2 9.6 22.6 20.0 6.4 13.0 5.4 7.4 5.5 6.6 4.5 5.7 6.3 5.2 2.7 5.1 2.2 5.1 12.4 6.1 6.5 4.3 17.6 21.3 15.9 33.8 18.9 17.0 20.3 28.7 25.7 13.7 62.5 45.7 19.1 44.3 34.2 31.4 99.3 15.3 32.1 34.2 22.7 9.8 28.2 13.3 40.3 198.1 89.9 22.6 46.7 64.6 44.0 48.3 97.8 56.6 39.4 46.1 7.9 21.5 62.6 29.8 66.5 56.7 40.5 35.4 39.7 32.4 30.9 57.9 31.6 83.8 17.0 22.5 77.6 55.3 226.6 29.8 33.9 59.2 24.5 45.9 62.9 BCAP31 "6C6-Ag, BAP31, CDM, DXS1357E" ENSG00000185825 "B cell receptor associated protein 31" P51572 X 153700492-153724746 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Deafness, Dystonia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003906, CAB015350, CAB015424" Supported Approved Enhanced "Endoplasmic reticulum" NA NA 6800000 "Endoplasmic reticulum" "CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270" "unprognostic (1.02e-2)" "unprognostic (2.14e-2)" "unprognostic (1.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.36e-2)" "prognostic unfavorable (9.87e-4)" "unprognostic (3.25e-3)" "unprognostic (4.20e-2)" "unprognostic (1.27e-1)" "unprognostic (5.75e-2)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.28e-2)" "unprognostic (8.61e-2)" "unprognostic (2.33e-1)" "unprognostic (1.02e-1)" 60.7 43.4 38.3 20.3 38.8 27.4 71.3 22.2 48.1 28.7 31.8 27.1 27.5 28.8 30.2 48.6 42.4 31.0 26.8 26.7 34.1 36.5 41.6 52.4 42.2 50.0 38.1 26.0 29.1 67.6 36.0 27.4 43.6 44.5 34.3 36.6 30.7 44.5 37.7 15.6 37.3 37.8 32.4 33.6 36.7 24.8 31.6 21.1 25.4 53.1 27.2 37.1 38.1 30.8 72.7 109.7 104.4 97.5 68.2 89.8 150.4 55.1 52.0 14.4 72.3 64.2 19.5 33.5 26.8 30.8 31.9 41.1 41.9 40.5 32.3 122.4 43.4 42.5 55.9 36.0 56.3 26.7 15.9 53.7 20.4 41.2 36.0 31.5 33.1 44.2 26.0 48.9 31.1 36.6 33.6 39.0 19.1 27.6 58.9 35.7 57.7 21.2 45.1 16.5 74.8 53.8 23.2 16.1 72.4 50.0 60.5 18.9 26.8 12.0 59.6 40.2 23.7 21.8 37.4 40.7 28.1 27.7 38.0 53.7 60.5 116.6 42.9 54.8 44.9 24.6 80.3 80.6 77.5 89.0 86.1 79.5 71.2 89.8 88.1 69.9 72.7 79.4 86.4 104.4 68.2 97.5 109.7 72.4 150.4 38.3 38.8 22.2 48.1 34.1 36.5 38.1 26.0 44.5 21.1 104.2 111.8 94.7 188.6 125.9 40.7 56.9 135.0 112.4 95.5 122.1 43.2 414.9 31.5 221.9 4.3 139.7 190.7 23.3 182.9 352.4 105.7 160.9 92.5 177.7 341.5 30.2 99.2 204.4 127.2 16.4 97.5 153.8 151.8 150.5 117.5 122.3 207.2 171.9 93.0 136.1 33.7 155.2 85.4 143.9 179.9 114.0 450.0 97.8 147.8 228.6 BCHE "CHE1, CHE2, E1" ENSG00000114200 Butyrylcholinesterase P06276 3 165772904-165837472 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 145.4" "Cell type enriched" "Detected in many" 10 "Hepatocytes: 360.7" "Group enriched" "Detected in many" 6 "glioma: 24.0;liver cancer: 13.7;melanoma: 18.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "Karpas-707: 131.7" "Low region specificity" "Detected in all" HPA001560 Approved "Secreted to blood" NA NA 13000000000 "HPA001560: AB_1078271" "unprognostic (4.74e-2)" "unprognostic (2.00e-1)" "unprognostic (9.21e-4)" "unprognostic (8.19e-8)" "unprognostic (2.66e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (1.44e-1)" "unprognostic (5.04e-2)" "unprognostic (6.15e-2)" "unprognostic (9.59e-2)" "unprognostic (5.15e-2)" "unprognostic (3.65e-2)" "unprognostic (3.18e-3)" "unprognostic (4.46e-5)" "unprognostic (2.17e-2)" "unprognostic (5.92e-2)" "unprognostic (4.26e-4)" 14.0 3.9 6.7 6.2 4.3 0.4 1.9 3.6 9.1 24.4 15.5 4.7 8.3 1.8 20.2 13.4 20.0 18.0 2.2 7.8 6.1 4.4 2.8 145.4 3.7 0.7 5.5 2.7 10.3 1.1 0.4 1.2 0.5 4.7 4.7 5.3 0.7 1.0 10.5 1.1 2.8 6.4 13.9 3.4 3.7 1.9 1.8 6.1 1.0 0.8 0.4 0.5 9.7 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 14.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.9 0.0 1.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 4.2 0.2 0.0 1.4 4.4 0.6 5.2 0.0 131.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 4.8 10.9 0.1 0.0 0.0 0.1 0.0 0.0 7.5 0.0 5.8 0.0 0.0 3.2 0.0 0.0 1.3 0.5 0.0 0.2 1.3 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.3 3.6 4.3 6.1 4.4 5.5 2.7 4.7 6.1 0.0 0.0 0.0 0.3 4.8 0.9 4.3 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 1.5 0.0 0.0 0.0 0.0 2.2 0.2 0.0 360.7 0.1 1.6 0.0 6.2 5.3 5.5 2.0 0.0 18.6 0.0 0.0 34.4 0.0 0.0 0.0 2.9 1.0 0.0 4.6 0.3 0.1 3.0 0.0 0.0 0.0 0.1 BCL2 "Bcl-2, PPP1R50" ENSG00000171791 "BCL2, apoptosis regulator" P10415 18 63123346-63320128 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.3;MAIT T-cell: 7.6;memory B-cell: 5.2;memory CD4 T-cell: 6.3;memory CD8 T-cell: 3.8;naive B-cell: 4.1;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.5;T-reg: 6.7" "Group enriched" "Detected in many" 8 "B-cells: 5.2;T-cells: 7.6" "Cell line enhanced" "Detected in many" "Karpas-707: 22.8;U-266/70: 79.4" "Low region specificity" "Detected in all" "CAB000003, HPA055295" Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB000003: AB_2064429, HPA055295: AB_2682776" "unprognostic (1.11e-3)" "prognostic favorable (5.13e-5)" "unprognostic (5.49e-2)" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (3.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.93e-3)" "unprognostic (4.78e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-2)" "unprognostic (8.51e-2)" "prognostic favorable (1.29e-8)" "unprognostic (6.67e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.47e-4)" "unprognostic (2.63e-1)" 12.9 3.0 10.1 15.7 9.4 5.3 24.6 4.7 8.4 14.8 7.8 7.4 9.1 5.0 17.1 9.3 4.7 12.2 9.2 6.5 10.0 8.1 8.5 2.3 5.0 14.6 10.8 5.6 18.2 2.9 19.6 7.0 22.4 9.2 8.4 5.9 10.8 5.4 15.7 20.0 6.3 10.5 8.6 9.3 17.8 5.4 3.5 10.5 21.0 35.6 2.9 13.4 7.9 16.4 5.2 0.3 0.7 0.2 0.7 7.6 1.9 0.5 0.1 2.3 1.8 2.8 0.4 0.8 0.2 0.2 0.8 0.5 1.1 0.1 0.0 0.4 0.2 1.5 0.1 2.1 0.3 0.4 13.6 0.4 0.1 0.6 0.2 0.5 12.4 1.8 0.5 0.2 0.9 1.9 0.3 0.2 1.4 0.2 22.8 0.4 0.4 2.6 5.4 0.5 0.2 0.4 11.7 0.5 8.8 3.9 1.9 1.9 1.8 0.0 0.0 2.8 0.5 0.1 10.5 0.1 3.0 1.0 0.3 1.5 79.4 10.4 0.9 0.5 8.8 1.7 0.7 0.0 0.0 2.3 0.0 7.6 5.2 6.3 3.8 0.1 4.1 5.1 4.5 0.1 0.7 0.2 0.3 6.7 1.9 10.1 9.4 4.7 8.4 10.0 8.1 10.8 5.6 9.2 10.5 0.0 0.6 41.9 30.2 17.3 1.0 15.4 17.8 0.0 3.4 7.0 0.0 8.5 13.3 2.5 0.2 3.5 0.8 0.0 0.0 0.9 10.3 31.5 15.1 1.5 8.3 0.0 5.2 3.7 10.4 2.1 8.1 16.9 43.9 29.7 9.9 18.9 0.3 0.0 13.1 13.5 0.5 25.8 10.8 0.3 0.6 15.4 41.1 28.7 10.6 39.2 BCL2L1 "Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52" ENSG00000171552 "BCL2 like 1" Q07817 20 31664452-31723989 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Apoptosis, Endocytosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035734, CAB072801" Approved Approved Mitochondria NA NA Mitochondria "CAB072801: , HPA035734: AB_2674757" "unprognostic (2.29e-1)" "unprognostic (5.40e-3)" "unprognostic (1.78e-2)" "prognostic unfavorable (9.10e-4)" "unprognostic (1.37e-1)" "unprognostic (1.09e-1)" "unprognostic (5.04e-2)" "unprognostic (7.82e-3)" "prognostic favorable (9.57e-4)" "unprognostic (1.67e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (1.06e-1)" "prognostic favorable (8.89e-5)" "unprognostic (9.67e-2)" "unprognostic (3.03e-2)" "unprognostic (2.02e-2)" "unprognostic (3.32e-2)" 30.8 21.4 25.1 16.4 34.3 57.0 40.7 27.7 40.7 28.2 22.6 37.0 13.0 31.3 18.7 12.2 36.9 31.5 35.9 26.9 27.0 23.7 42.6 39.3 40.6 17.8 43.4 24.3 11.5 28.5 17.5 22.8 29.0 33.4 24.8 21.4 31.5 33.8 21.5 21.9 26.1 30.4 19.2 28.8 26.6 28.0 30.2 38.4 56.4 25.8 15.4 20.7 24.5 22.4 3.9 7.8 17.0 8.9 12.5 27.2 16.5 64.0 38.2 7.1 6.8 38.0 27.5 22.6 15.3 25.1 16.1 15.4 90.1 31.1 10.5 39.2 22.1 31.2 21.7 9.4 43.4 11.4 11.0 2.4 48.0 8.2 44.8 28.5 4.8 28.5 19.7 18.1 20.3 44.2 21.8 23.0 18.4 29.7 8.0 54.3 18.3 14.1 4.6 9.7 31.8 34.1 8.9 21.3 33.3 65.8 17.9 18.3 8.6 18.8 18.6 8.8 13.5 36.9 5.5 31.8 20.3 23.5 8.1 27.5 5.3 29.7 8.7 29.9 21.1 12.8 17.0 8.1 15.4 27.2 8.2 21.0 3.9 12.4 18.1 7.8 3.7 5.7 13.0 9.8 12.5 8.9 4.7 13.8 16.5 25.1 34.3 27.7 40.7 27.0 23.7 43.4 24.3 33.4 38.4 14.9 11.6 8.2 49.1 16.4 21.1 9.0 101.9 21.4 5.7 36.6 43.2 22.9 72.9 88.0 6.3 31.5 38.7 93.5 56.7 9.6 15.0 56.5 12.7 32.5 33.2 27.0 23.7 20.9 17.2 4.2 17.5 12.2 16.9 127.2 22.5 15.8 125.9 17.5 40.3 57.4 27.1 45.3 20.2 26.5 12.6 8.5 15.8 30.5 18.5 125.1 BCL2L10 "BCL-B, Boo, Diva" ENSG00000137875 "BCL2 like 10" Q9HD36 15 52109263-52112775 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 15.3" "Cell type enhanced" "Detected in some" 9 "Basal keratinocytes: 5.5;Distal tubular cells: 11.6;Proximal tubular cells: 7.5;Suprabasal keratinocytes: 7.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 6.0" "Group enriched" "Detected in some" 6 "basophil: 4.1;memory B-cell: 1.6;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 28 "B-cells: 1.6;dendritic cells: 2.6;granulocytes: 4.1" "Cell line enriched" "Detected in some" 8 "NB-4: 27.5" HPA042222 Approved NA NA "HPA042222: AB_10794271" "unprognostic (5.33e-4)" "unprognostic (1.26e-1)" "unprognostic (1.58e-1)" "unprognostic (3.22e-4)" "unprognostic (1.19e-2)" "unprognostic (1.20e-1)" "unprognostic (5.07e-2)" "unprognostic (4.80e-3)" "unprognostic (8.86e-2)" "unprognostic (3.47e-2)" "unprognostic (9.52e-2)" "unprognostic (3.83e-1)" "unprognostic (2.18e-9)" "unprognostic (9.59e-2)" "unprognostic (1.86e-1)" "unprognostic (1.92e-1)" "unprognostic (3.20e-2)" 1.0 3.5 1.0 2.4 6.0 0.3 2.1 1.4 1.6 2.8 3.6 0.1 0.0 3.9 1.1 1.2 6.1 1.3 3.4 0.1 0.5 1.7 6.5 15.3 0.1 1.2 0.3 1.1 0.9 4.2 0.8 3.7 0.2 0.3 2.5 1.7 0.3 1.8 0.4 0.3 10.0 8.1 0.5 0.3 1.6 1.8 0.9 0.5 0.5 0.8 4.3 1.0 2.3 3.9 1.6 2.6 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.1 3.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 1.0 6.0 1.4 1.6 0.5 1.7 0.3 1.1 0.3 0.5 0.0 0.0 0.0 4.2 5.5 0.9 0.3 2.5 0.0 0.0 0.0 0.0 0.0 11.6 2.0 0.0 0.0 4.6 0.0 1.3 0.2 0.1 1.7 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 1.0 0.6 0.0 0.4 7.5 0.0 0.0 0.0 0.0 0.0 7.5 0.1 0.0 2.2 4.7 BCL2L13 "BCL-RAMBO, MIL1" ENSG00000099968 "BCL2 like 13" Q9BXK5 22 17628855-17730855 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 182.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002052, HPA030994, HPA050377" Uncertain Enhanced Mitochondria NA NA Mitochondria "CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: AB_2681107" "unprognostic (1.59e-1)" "unprognostic (8.17e-2)" "unprognostic (2.18e-3)" "unprognostic (1.86e-1)" "unprognostic (6.27e-2)" "unprognostic (2.69e-2)" "unprognostic (3.38e-1)" "unprognostic (4.97e-2)" "unprognostic (5.04e-2)" "unprognostic (9.46e-2)" "unprognostic (1.45e-2)" "unprognostic (8.21e-2)" "prognostic favorable (1.96e-8)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (4.27e-1)" "unprognostic (2.81e-1)" 15.3 17.4 13.3 7.6 14.2 10.9 17.3 13.0 17.4 9.2 11.9 14.8 8.8 8.3 10.5 10.7 14.5 11.7 10.0 18.9 12.7 12.2 18.9 20.9 10.6 9.3 14.4 13.4 10.4 22.0 25.8 12.3 14.1 12.2 11.1 14.1 15.2 12.4 9.5 61.2 15.5 12.4 11.7 13.0 8.3 11.2 22.9 11.5 12.1 13.5 14.5 12.3 14.6 10.2 6.5 11.3 4.7 17.3 10.4 8.3 9.5 13.8 6.2 9.9 9.4 16.6 15.9 13.2 9.9 17.4 14.7 16.8 7.0 9.2 12.0 7.2 14.2 14.8 19.0 11.4 15.3 15.4 11.5 8.7 11.3 5.6 3.6 20.6 15.7 9.8 12.9 17.9 12.6 34.1 18.4 12.8 10.0 28.1 11.3 16.0 9.3 8.0 5.0 7.8 22.4 7.7 8.4 15.3 4.5 15.3 9.6 14.1 8.8 13.1 13.3 23.7 25.8 9.1 15.6 12.8 8.8 4.5 12.5 9.5 9.7 8.8 10.3 13.1 12.1 15.0 3.8 17.3 4.7 4.6 15.6 5.7 6.5 6.2 5.7 11.3 5.4 5.5 4.5 4.4 10.4 11.0 5.7 8.3 9.5 13.3 14.2 13.0 17.4 12.7 12.2 14.4 13.4 12.2 11.5 20.8 11.8 21.7 29.2 21.9 182.7 38.9 12.7 14.7 29.6 17.4 11.8 42.2 44.7 26.6 26.6 14.3 28.3 23.3 27.5 28.8 15.8 31.6 8.1 30.6 23.9 46.1 22.4 12.9 27.2 9.5 13.0 22.7 15.1 58.7 26.7 45.9 28.7 14.4 14.5 33.8 30.9 0.0 15.5 21.7 21.4 23.7 80.2 19.1 22.9 31.8 BCL2L2 "BCL-W, KIAA0271, PPP1R51" ENSG00000129473 "BCL2 like 2" Q92843 14 23298790-23311759 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB040539, HPA048740" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB040539: , HPA048740: " "unprognostic (8.23e-3)" "unprognostic (9.85e-2)" "unprognostic (1.71e-2)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (1.64e-1)" "unprognostic (3.47e-3)" "unprognostic (1.53e-2)" "unprognostic (1.78e-1)" "unprognostic (2.91e-3)" "unprognostic (1.50e-3)" "unprognostic (2.60e-1)" "prognostic favorable (1.99e-6)" "unprognostic (2.44e-1)" "unprognostic (2.00e-1)" "unprognostic (6.60e-2)" "unprognostic (5.38e-2)" 29.9 22.8 38.2 15.6 33.6 7.4 25.1 27.3 44.8 13.7 32.3 27.4 21.9 19.4 19.0 20.6 32.8 16.6 17.6 23.8 36.2 32.9 22.3 9.0 18.6 8.6 43.3 39.5 17.5 30.6 34.1 16.5 15.1 32.8 31.8 20.4 15.0 36.5 31.9 10.6 29.2 19.0 34.8 40.9 11.3 22.3 14.9 28.1 1.2 25.6 11.8 10.1 23.0 23.2 1.3 1.8 0.6 1.8 0.1 0.3 1.3 11.8 12.8 11.6 8.5 22.4 19.6 10.6 21.5 13.2 10.7 11.8 7.8 18.9 7.7 7.7 11.8 13.6 22.1 7.2 13.5 13.5 3.9 6.8 8.5 17.1 15.4 14.0 9.2 15.1 15.1 26.6 8.0 13.0 13.7 9.0 1.4 8.3 7.6 12.7 8.9 0.7 6.2 4.5 16.4 25.0 5.5 14.3 3.5 9.4 20.3 15.4 9.2 9.7 15.5 17.5 7.5 9.8 7.4 17.5 19.1 12.0 12.9 11.0 9.8 5.8 1.1 12.1 7.6 21.6 0.0 1.8 0.4 0.3 1.8 0.2 1.3 0.0 0.2 1.8 1.0 0.3 0.0 0.6 0.1 1.0 0.9 0.1 1.3 38.2 33.6 27.3 44.8 36.2 32.9 43.3 39.5 32.8 28.1 8.9 13.3 0.5 6.8 7.7 17.1 25.0 2.5 9.4 12.5 5.2 23.6 4.4 11.6 7.4 17.7 9.0 10.1 0.0 15.7 3.4 6.7 14.5 5.7 6.4 4.9 19.1 17.9 9.8 7.3 3.3 10.3 4.0 6.8 4.6 15.5 6.8 18.7 10.5 20.1 7.5 12.0 6.5 16.0 0.0 0.2 9.7 4.7 1.8 9.7 15.2 BCS1L "BCS, BJS, h-BCS, Hs.6719" ENSG00000074582 "BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone" Q9Y276 2 218658764-218663443 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chaperone "Deafness, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037700, HPA037701" Supported NA NA "HPA037700: AB_10794619, HPA037701: AB_10805235" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (6.28e-2)" "unprognostic (4.99e-2)" "unprognostic (6.44e-2)" "unprognostic (4.31e-1)" "unprognostic (4.25e-2)" "unprognostic (2.45e-1)" "unprognostic (8.38e-2)" "unprognostic (1.83e-2)" "unprognostic (1.21e-2)" "unprognostic (6.02e-2)" "unprognostic (3.47e-3)" "unprognostic (1.59e-1)" "unprognostic (3.15e-2)" "unprognostic (8.38e-2)" "prognostic favorable (3.31e-4)" 13.4 19.5 16.4 12.6 19.8 10.5 16.2 15.6 23.4 14.1 15.8 18.3 15.8 15.2 22.0 15.1 18.1 19.7 15.2 26.8 14.3 13.5 18.8 29.1 10.7 13.2 19.5 18.5 21.2 26.6 18.9 18.4 11.4 21.9 17.2 16.6 14.8 17.2 18.3 23.4 18.1 13.0 16.7 14.2 15.9 15.5 7.3 18.9 7.2 16.2 15.8 13.2 14.5 14.9 10.9 19.7 11.5 9.8 5.2 10.2 7.9 6.8 14.2 8.1 11.3 18.6 12.5 12.2 11.8 6.5 19.2 14.0 37.7 11.6 10.3 17.2 11.8 12.9 19.1 26.3 30.4 10.9 15.1 28.7 16.6 18.3 30.9 21.3 14.4 10.2 15.9 23.3 26.0 34.0 7.8 19.1 14.7 23.3 15.0 17.0 23.3 10.7 19.3 10.0 16.3 18.2 15.5 10.1 16.2 16.0 13.1 17.5 7.6 8.3 20.3 14.8 13.5 10.5 14.4 11.1 14.4 11.9 9.3 16.1 11.7 9.0 17.2 9.0 22.1 13.4 11.5 9.8 7.9 8.7 5.8 10.0 10.9 7.0 8.2 19.7 10.1 8.5 10.2 1.2 5.2 0.8 11.1 9.9 7.9 16.4 19.8 15.6 23.4 14.3 13.5 19.5 18.5 21.9 18.9 8.9 6.9 4.5 12.9 9.4 11.6 29.4 12.7 8.1 10.3 5.2 5.9 25.5 18.3 16.4 1.3 12.0 9.3 0.0 8.7 13.3 14.6 10.5 11.5 10.9 15.3 6.4 5.8 9.2 8.7 1.7 8.3 6.3 13.5 13.6 8.6 9.2 10.2 14.0 14.5 17.1 15.4 6.5 22.1 4.1 10.2 8.7 12.1 7.0 14.9 11.1 BDKRB1 "B1BKR, BKR1, bradyb1" ENSG00000100739 "Bradykinin receptor B1" P46663 14 96255824-96268967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 16.1;lymphoid tissue: 17.1" "Cell type enhanced" "Detected in many" 20 "Basal keratinocytes: 36.2;Fibroblasts: 10.8;Suprabasal keratinocytes: 15.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 2.1" "Cell type enriched" "Detected in single" 19 "T-reg: 1.8" "Lineage enriched" "Detected in single" 19 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 11.8;HHSteC: 12.2;hTEC/SVTERT24-B: 11.4;U-2197: 12.6;U-87 MG: 41.9" "Low region specificity" "Detected in single" HPA002935 Approved NA NA "HPA002935: AB_1078274" "unprognostic (6.15e-2)" "unprognostic (2.78e-2)" "unprognostic (9.40e-2)" "unprognostic (3.06e-3)" "unprognostic (6.76e-2)" "unprognostic (1.11e-2)" "unprognostic (3.31e-2)" "unprognostic (2.34e-3)" "unprognostic (2.23e-2)" "unprognostic (2.96e-2)" "unprognostic (4.80e-3)" "unprognostic (2.36e-1)" "unprognostic (9.96e-6)" "unprognostic (2.33e-1)" "unprognostic (8.82e-2)" "unprognostic (2.33e-3)" "unprognostic (4.66e-2)" 7.3 0.0 0.2 17.1 0.2 0.0 0.8 2.1 0.6 5.4 3.7 0.2 0.2 1.8 0.7 2.8 10.4 4.8 16.1 2.3 0.2 0.0 2.4 0.6 3.7 0.2 0.2 0.2 4.5 7.9 0.0 0.2 3.0 0.4 2.2 2.8 0.7 1.5 1.1 0.4 2.4 3.7 5.7 0.2 0.6 3.3 2.3 0.2 0.2 0.8 4.6 2.0 13.7 5.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.6 0.0 0.4 1.1 4.0 0.0 1.0 11.8 1.2 0.2 0.0 0.2 0.0 0.0 6.9 0.6 1.1 0.0 0.1 1.9 0.1 0.0 0.0 1.2 0.0 12.2 0.0 0.0 0.4 1.0 11.4 0.2 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.7 0.1 0.0 3.6 0.0 0.1 0.0 0.4 0.0 3.3 1.1 0.0 0.1 0.0 0.0 0.0 4.5 0.2 12.6 0.7 2.2 4.1 0.0 41.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.2 2.1 0.6 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.3 0.0 1.5 36.2 0.2 0.4 0.0 2.7 0.0 0.0 0.0 0.2 6.6 1.6 0.7 0.1 2.9 0.0 1.1 0.3 10.8 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.5 3.5 0.4 0.0 0.0 0.0 1.0 0.5 1.5 15.1 1.3 0.0 0.0 2.6 BDKRB2 BK-2 ENSG00000168398 "Bradykinin receptor B2" P30411 14 96204679-96244166 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 15.3;Ciliated cells: 13.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 13.5;pons and medulla: 5.7" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 22.8;BJ hTERT+: 41.8;U-87 MG: 18.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003551, HPA050841" Approved Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus, Vesicles" "HPA003551: , HPA050841: AB_2681254" "unprognostic (1.03e-1)" "unprognostic (7.90e-2)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (8.79e-3)" "unprognostic (2.68e-2)" "unprognostic (1.93e-1)" "unprognostic (4.66e-2)" "unprognostic (1.94e-1)" "unprognostic (2.84e-2)" "unprognostic (3.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.32e-3)" "unprognostic (3.11e-2)" "unprognostic (9.40e-2)" "unprognostic (9.90e-2)" "unprognostic (1.49e-2)" 9.0 1.2 1.5 3.7 1.0 0.0 4.7 13.5 1.1 12.2 9.0 1.3 4.4 5.6 8.5 12.7 14.9 5.1 21.1 4.3 0.8 0.7 12.1 0.7 2.2 0.4 0.9 0.3 4.7 6.8 0.9 1.1 2.9 5.7 6.9 9.2 0.9 3.1 11.3 2.7 4.0 10.3 11.3 1.3 0.4 4.2 3.2 0.0 0.6 3.6 13.9 4.4 16.7 13.5 0.0 0.9 0.0 0.0 0.0 1.2 0.0 0.7 2.7 0.0 4.9 7.4 22.8 0.0 2.4 41.8 1.4 1.7 0.1 4.6 0.0 0.1 3.8 1.6 6.5 0.0 1.0 1.2 0.5 0.0 0.0 0.5 0.0 3.6 0.0 0.0 6.9 3.3 4.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 8.8 0.0 0.0 1.0 0.0 1.4 0.0 1.5 0.5 0.8 6.9 0.0 1.0 0.4 0.0 0.0 0.1 0.1 1.4 0.0 0.1 0.0 0.0 18.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.5 1.0 13.5 1.1 0.8 0.7 0.9 0.3 5.7 0.0 3.0 1.9 0.0 0.5 8.1 0.0 0.5 15.3 13.4 9.1 8.7 0.0 0.5 6.6 10.2 0.0 4.2 8.9 0.0 3.5 1.9 6.1 0.8 0.0 0.0 0.2 0.0 6.8 3.1 0.0 0.0 0.9 0.6 5.0 0.0 5.0 0.0 4.5 4.5 1.1 0.0 0.0 0.0 2.0 0.0 0.0 5.1 3.3 0.0 0.7 2.4 BDNF ENSG00000176697 "Brain derived neurotrophic factor" P23560 11 27654893-27722058 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.5;smooth muscle: 10.5" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 35.7;Cardiomyocytes: 9.6;Smooth muscle cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 22.7;BJ hTERT+ SV40 Large T+: 17.4;BJ hTERT+ SV40 Large T+ RasG12V: 13.2;HBF TERT88: 16.7;U-138 MG: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009564, HPA031440, HPA056104" Enhanced Supported "Nuclear speckles,Mitochondria" "Secreted to blood" NA NA 16000000 "Nuclear speckles, Mitochondria" "CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: AB_2683038" "unprognostic (1.25e-2)" "unprognostic (2.84e-1)" "unprognostic (4.35e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-2)" "unprognostic (6.82e-2)" "unprognostic (2.39e-2)" "unprognostic (2.21e-1)" "unprognostic (3.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (3.22e-2)" "unprognostic (3.88e-2)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (2.84e-3)" 0.9 1.3 5.0 0.6 4.5 0.5 0.6 9.4 14.5 1.6 0.8 0.6 0.7 0.8 0.7 8.2 1.4 0.5 2.1 5.8 8.5 5.7 0.9 0.5 4.1 0.4 2.5 4.7 1.2 1.0 0.2 2.3 3.7 12.7 4.9 0.4 3.0 0.9 4.2 1.3 2.1 0.5 10.5 1.0 0.6 0.9 1.3 0.0 0.0 2.3 0.0 0.4 3.2 1.2 0.1 0.4 0.0 0.2 0.1 1.0 0.1 1.6 6.7 0.2 0.0 2.4 1.9 0.0 22.7 4.4 17.4 13.2 0.0 2.6 0.0 2.1 8.2 0.3 1.0 0.1 0.2 16.7 0.1 0.1 0.0 2.2 0.0 10.1 0.1 0.1 5.9 2.2 3.8 2.2 10.6 0.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 2.1 0.0 1.8 0.0 1.3 0.0 2.5 0.0 0.1 0.6 4.3 0.0 0.0 1.0 0.1 0.0 7.5 24.4 4.1 9.4 5.0 0.3 0.0 0.0 9.4 0.6 1.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.1 0.7 0.4 0.0 0.1 0.0 0.4 1.0 0.1 5.0 4.5 9.4 9.4 8.5 5.7 2.5 4.7 12.7 0.0 35.7 0.3 0.0 0.2 0.6 4.7 9.6 0.0 0.0 0.0 1.8 3.9 0.2 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.3 4.1 0.4 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.3 0.0 1.7 0.0 0.0 0.1 0.2 0.0 0.0 0.3 1.5 0.0 6.6 0.4 0.7 0.0 0.6 0.0 0.0 0.0 BEAN1 SCA31 ENSG00000166546 "Brain expressed associated with NEDD4 1" Q3B7T3 16 66427297-66493529 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell type enhanced" "Detected in some" 9 "Cytotrophoblasts: 4.8;Early spermatids: 8.4;Extravillous trophoblasts: 8.9;Late spermatids: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 5.2" "Cell line enhanced" "Detected in some" "AN3-CA: 9.7;BEWO: 4.9;RPTEC TERT1: 8.6;U-87 MG: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053851 Uncertain Uncertain Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA053851: AB_2682280" "unprognostic (1.92e-1)" "unprognostic (5.79e-4)" "unprognostic (3.83e-2)" "unprognostic (3.38e-3)" "unprognostic (1.01e-1)" "unprognostic (4.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.13e-1)" "unprognostic (4.89e-1)" "unprognostic (1.59e-1)" "unprognostic (2.13e-3)" "unprognostic (4.18e-2)" "unprognostic (3.38e-2)" "unprognostic (1.63e-1)" "unprognostic (3.10e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-2)" 1.2 1.2 2.9 1.1 2.5 2.9 1.2 6.9 9.6 1.2 0.7 0.1 0.0 0.6 1.2 1.9 1.8 1.9 1.4 3.0 4.6 4.1 0.9 1.1 1.4 0.9 2.3 3.2 1.4 1.9 0.1 0.4 4.5 11.6 1.0 0.9 5.0 1.9 0.4 3.6 3.2 0.8 0.8 1.7 1.2 1.2 3.1 0.2 0.0 1.9 3.1 0.9 1.0 1.0 0.3 2.4 5.2 0.5 0.4 0.2 0.1 0.8 1.0 1.0 9.7 0.3 0.1 4.9 0.3 0.0 0.1 0.1 0.0 1.0 0.1 0.6 0.3 0.6 0.2 0.1 0.1 0.3 0.0 0.7 0.0 0.2 0.7 0.7 0.1 0.0 0.7 1.9 0.6 0.3 1.4 0.0 0.2 0.1 0.3 0.2 0.5 0.0 0.4 0.3 0.1 0.6 0.1 0.2 0.5 8.6 0.6 0.1 0.2 0.2 0.2 1.4 0.7 0.2 0.1 0.3 0.4 2.7 0.1 0.4 0.5 0.1 0.1 5.6 0.2 1.4 0.4 0.5 1.9 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.2 0.1 5.2 0.4 0.2 2.4 0.1 0.1 2.9 2.5 6.9 9.6 4.6 4.1 2.3 3.2 11.6 0.2 0.0 0.0 0.0 0.2 0.1 0.4 1.2 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.2 8.4 0.3 0.0 0.0 0.0 8.9 0.6 1.0 0.0 0.0 0.9 0.0 0.0 1.3 0.0 8.0 0.3 0.0 3.3 0.0 0.0 0.0 1.0 0.0 2.1 0.0 0.9 0.0 0.5 2.9 0.3 0.1 2.4 0.0 0.0 0.3 BEST1 "BEST, BMD, RP50, VMD2" ENSG00000167995 "Bestrophin 1" O76090 11 61949821-61965515 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 218.0" "Cell type enhanced" "Detected in many" 5 "granulocytes: 70.9;Macrophages: 85.3" "Group enriched" "Detected in some" 6 "glioma: 2.0;melanoma: 6.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "neutrophil: 23.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 23.3" "Cell line enhanced" "Detected in some" "ASC diff: 9.4;SK-MEL-30: 33.5;U-266/70: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057464 Enhanced NA NA "HPA057464: AB_2683444" "unprognostic (2.41e-3)" "unprognostic (3.67e-2)" "unprognostic (5.91e-3)" "unprognostic (1.21e-1)" "unprognostic (1.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.53e-2)" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.07e-3)" "unprognostic (2.06e-1)" "unprognostic (4.27e-10)" "unprognostic (1.38e-1)" "unprognostic (4.93e-2)" "unprognostic (3.59e-3)" "unprognostic (2.72e-3)" 5.2 2.9 7.4 9.5 11.8 26.4 2.3 1.6 12.6 2.0 1.4 16.0 0.7 2.1 2.6 9.6 3.0 2.6 6.2 2.5 9.2 5.3 1.4 1.1 4.7 2.5 14.8 6.0 3.7 2.2 0.5 1.4 2.8 9.4 1.6 1.3 218.0 1.2 1.9 0.7 3.0 2.0 2.1 16.9 5.4 1.3 3.9 13.3 0.3 2.3 0.4 0.6 3.9 2.3 0.3 1.6 23.3 2.8 0.1 0.1 0.9 0.5 0.5 0.2 0.4 9.4 2.0 0.9 0.7 1.2 0.2 0.8 0.3 0.3 0.1 1.3 0.6 1.3 0.7 0.0 0.0 0.1 0.1 0.1 0.0 3.6 0.6 2.9 0.1 0.3 2.7 1.1 1.2 2.6 1.2 0.0 0.5 0.5 5.3 1.2 0.3 0.1 0.4 0.0 0.5 1.3 0.0 0.1 0.2 0.0 1.3 0.7 0.5 1.0 0.1 33.5 0.5 0.5 1.3 0.1 0.6 0.4 0.5 0.2 9.0 0.5 0.5 3.4 0.4 1.0 1.5 2.3 2.1 0.1 2.7 0.1 0.3 0.1 0.1 1.6 0.1 0.1 0.0 23.3 0.1 2.8 0.3 0.1 0.9 7.4 11.8 1.6 5.9 9.2 5.3 14.8 6.0 9.4 13.3 23.8 66.0 6.0 5.8 32.3 1.8 3.2 12.7 37.5 62.6 1.8 0.0 12.7 0.0 2.4 6.6 8.3 19.1 0.0 2.9 18.2 15.0 9.1 70.9 4.7 33.7 0.0 9.9 22.7 60.1 1.8 14.1 85.3 52.3 4.6 10.3 6.0 3.0 14.4 6.3 4.8 9.0 6.5 8.3 1.6 2.8 28.5 17.0 10.2 10.9 5.4 BEST2 "FLJ20132, VMD2L1" ENSG00000039987 "Bestrophin 2" Q8NFU1 19 12751702-12758458 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 25.2;retina: 28.7;skin 1: 11.7" "Cell type enriched" "Detected in some" 62 "Mucus-secreting cells: 105.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.5" HPA046229 Approved NA NA "HPA046229: AB_10966140" "unprognostic (3.19e-1)" "unprognostic (7.58e-2)" "unprognostic (1.54e-2)" "unprognostic (1.02e-1)" "unprognostic (5.74e-2)" "unprognostic (4.02e-3)" "unprognostic (2.77e-1)" "unprognostic (1.87e-1)" "unprognostic (2.18e-1)" "unprognostic (2.43e-1)" "unprognostic (3.46e-3)" "unprognostic (9.18e-6)" "unprognostic (3.45e-2)" "unprognostic (6.95e-2)" "unprognostic (2.90e-1)" "unprognostic (1.64e-5)" 0.2 0.1 0.2 4.1 0.2 1.8 0.3 0.2 1.3 0.4 25.2 0.2 0.2 0.0 0.2 0.7 0.2 0.2 0.3 0.2 0.2 0.1 0.2 0.2 0.2 2.2 0.2 0.2 0.4 0.2 0.4 0.2 0.2 0.2 0.2 12.8 28.7 0.6 0.2 0.2 11.7 11.5 0.5 0.2 0.2 0.1 0.3 0.2 0.2 0.4 1.5 5.2 0.2 1.0 3.1 2.7 2.2 0.8 1.7 2.1 1.2 0.9 0.7 2.3 3.5 0.0 0.4 1.6 1.0 0.0 0.5 0.7 2.6 3.6 2.9 0.9 1.2 0.7 1.8 0.0 0.5 0.6 3.3 1.6 2.4 3.3 0.9 0.4 1.2 5.2 0.5 0.3 0.4 0.3 1.4 0.3 0.6 0.6 1.5 0.5 3.0 0.8 1.9 3.0 0.2 2.6 0.4 1.3 0.5 1.0 1.2 1.9 1.9 1.5 0.7 0.6 2.7 1.8 0.9 2.6 0.9 1.0 1.6 2.1 0.9 1.3 1.1 1.3 2.7 1.9 1.7 0.5 0.4 1.4 0.8 1.1 2.2 1.0 0.8 0.2 3.1 2.1 2.1 2.2 1.7 0.5 2.7 0.7 1.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.6 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 1.6 0.1 BEST3 "MGC13168, MGC40411, VMD2L3" ENSG00000127325 "Bestrophin 3" Q8N1M1 12 69643360-69699476 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 125.0" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 7.9;Late spermatids: 13.0;Muller glia cells: 7.5" "Cancer enriched" "Detected in single" 9 "glioma: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 16 "REH: 18.7;RPMI-8226: 20.1;U-698: 33.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054582 Approved NA NA "HPA054582: AB_2682530" "unprognostic (1.53e-1)" "unprognostic (7.00e-2)" "unprognostic (9.83e-2)" "unprognostic (1.67e-2)" "unprognostic (5.15e-3)" "unprognostic (2.26e-3)" "unprognostic (7.30e-7)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (5.36e-2)" "unprognostic (1.19e-1)" "unprognostic (4.08e-2)" "unprognostic (4.82e-2)" "unprognostic (4.47e-2)" "unprognostic (3.03e-1)" 1.6 0.5 1.7 0.1 1.9 2.4 0.6 6.3 9.3 0.2 0.2 0.9 0.0 0.2 0.2 2.4 1.7 0.1 0.2 0.4 1.8 0.7 0.4 0.3 0.1 0.2 1.8 0.6 0.2 1.0 0.1 0.7 0.3 1.2 1.7 0.2 0.1 1.9 0.1 125.0 0.9 0.1 0.1 1.9 0.1 0.1 2.5 1.0 0.5 0.2 21.9 0.7 0.1 0.0 1.2 0.9 1.7 0.5 0.6 1.0 0.7 0.1 0.2 0.7 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.4 0.1 0.2 1.3 0.3 0.0 1.1 0.1 0.0 0.0 0.4 0.2 0.0 0.5 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.1 0.0 0.2 0.1 0.2 0.0 0.8 0.1 0.0 0.0 0.7 0.3 0.3 18.7 0.6 20.1 1.0 0.1 0.4 0.0 0.1 0.1 0.0 1.3 0.2 0.0 0.1 0.2 0.5 0.1 0.7 0.1 0.2 33.5 1.4 0.0 0.1 0.3 0.5 0.3 0.5 0.4 0.8 1.2 1.0 0.7 0.3 0.8 1.0 1.0 1.7 0.6 0.4 0.9 0.4 0.7 1.7 1.9 6.3 1.5 1.8 0.7 1.8 0.6 1.2 1.0 0.0 0.0 0.0 0.1 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.9 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.0 0.0 0.0 1.7 0.0 0.0 7.5 0.4 0.0 0.0 2.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 BEST4 VMD2L2 ENSG00000142959 "Bestrophin 4" Q8NFU0 1 44783585-44787705 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 34.3" "Cell type enriched" "Detected in some" 35 "Paneth cells: 745.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 7.4;U-698: 5.3" "Low region specificity" "Detected in all" HPA058564 Uncertain NA NA "HPA058564: AB_2683759" "unprognostic (5.76e-2)" "unprognostic (1.22e-1)" "unprognostic (3.15e-2)" "unprognostic (6.20e-2)" "unprognostic (6.51e-3)" "unprognostic (1.09e-1)" "unprognostic (8.39e-2)" "unprognostic (1.45e-3)" "unprognostic (1.04e-1)" "unprognostic (8.97e-2)" "unprognostic (5.72e-2)" "unprognostic (1.29e-1)" "unprognostic (2.69e-5)" "unprognostic (1.43e-1)" "unprognostic (3.72e-1)" "unprognostic (1.28e-1)" "unprognostic (4.13e-3)" 0.5 1.1 0.6 1.4 2.5 0.4 0.5 2.1 0.7 1.2 32.7 0.5 0.5 8.8 0.7 2.6 0.5 7.2 0.5 0.5 1.0 3.2 0.5 0.5 1.1 0.5 0.5 0.5 0.5 0.5 0.4 1.8 0.5 0.5 0.5 15.9 0.5 0.5 0.5 0.5 1.8 34.3 0.5 0.5 0.5 0.2 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 3.0 0.9 0.7 0.1 0.9 2.8 0.4 0.2 0.6 1.1 1.2 0.4 0.4 3.5 0.8 0.4 0.3 0.1 0.4 1.5 0.3 1.5 0.4 0.8 1.6 0.3 0.2 0.4 0.8 0.7 0.2 1.9 7.4 0.4 0.0 0.9 0.7 0.9 0.4 0.7 1.8 1.0 1.3 0.2 0.6 0.2 0.2 0.0 0.5 2.4 0.2 0.2 0.4 0.3 0.7 0.5 0.1 2.5 0.9 0.3 0.2 0.3 0.8 1.2 0.1 1.7 0.5 0.5 0.5 0.5 1.2 0.3 5.3 1.2 0.3 0.2 0.1 0.1 0.5 1.1 0.1 2.7 3.0 1.9 2.8 0.0 2.0 1.0 1.8 0.7 0.9 0.0 0.9 2.2 0.4 0.6 2.5 2.1 0.7 1.0 3.2 0.5 0.5 0.5 0.5 0.0 0.0 0.8 0.7 0.2 0.7 0.4 0.0 21.4 3.4 5.2 0.0 0.3 1.7 0.5 0.0 0.3 15.8 0.0 0.7 0.1 0.2 0.4 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.9 0.3 0.0 0.0 3.4 1.0 0.4 745.7 0.4 0.6 0.1 0.0 0.3 0.5 0.7 0.5 0.2 1.3 5.0 0.4 BET1 hbet1 ENSG00000105829 "Bet1 golgi vesicular membrane trafficking protein" O15155 7 93962762-94004382 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.85e-3)" "unprognostic (1.58e-2)" "unprognostic (3.52e-2)" "unprognostic (2.88e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.60e-2)" "unprognostic (4.19e-2)" "unprognostic (1.51e-2)" "unprognostic (1.90e-1)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" "unprognostic (3.36e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (2.10e-2)" "unprognostic (2.16e-1)" "unprognostic (2.69e-1)" "unprognostic (7.24e-3)" 16.0 26.2 14.3 11.6 15.4 3.1 25.9 13.0 11.7 18.8 15.3 10.5 34.7 16.3 17.0 27.6 13.0 14.2 11.3 12.4 13.6 16.6 18.4 27.5 10.6 16.2 13.0 9.2 19.5 30.8 10.9 36.3 55.0 11.1 16.6 13.2 12.5 27.4 30.6 6.5 10.3 22.7 15.3 13.7 14.5 14.6 11.4 12.1 15.8 16.8 9.3 15.1 17.5 16.0 22.3 21.9 27.8 11.5 12.1 15.7 10.1 9.0 7.8 12.6 11.8 22.5 25.9 8.7 15.5 20.4 13.4 17.8 4.3 10.7 15.4 30.4 8.3 26.0 4.9 6.9 11.3 23.4 8.5 8.9 5.9 8.2 11.0 23.5 10.7 6.2 10.5 20.8 12.1 33.8 19.9 18.8 10.8 12.7 21.6 18.0 7.5 14.4 15.7 12.6 13.3 11.6 9.4 8.3 20.7 27.5 5.7 5.8 10.6 11.5 16.9 30.2 18.3 10.6 11.1 12.1 18.0 9.0 36.2 9.9 14.2 16.2 20.8 25.8 14.7 12.9 27.8 10.2 10.8 11.7 10.3 14.7 22.3 13.2 11.7 9.3 20.2 15.7 12.9 3.3 12.1 11.5 21.9 10.8 10.1 14.3 15.4 13.0 11.7 13.6 16.6 13.0 9.2 11.1 12.1 11.9 18.4 50.2 23.0 17.3 10.1 9.3 25.5 26.8 9.1 40.1 3.9 57.8 86.2 42.6 6.7 29.4 17.4 0.0 30.4 123.5 32.9 48.9 11.5 48.7 31.8 9.5 15.0 27.6 22.5 5.1 33.6 23.4 25.3 74.9 25.9 13.7 34.3 23.2 20.8 74.2 7.7 25.8 14.4 63.2 44.1 22.2 107.3 21.8 18.4 22.0 BET1L "GOLIM3, GS15" ENSG00000177951 "Bet1 golgi vesicular membrane trafficking protein like" Q9NYM9 11 167784-207428 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 91.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039819 Approved Supported "Nucleoplasm,Golgi apparatus" No No "Golgi apparatus" Nucleoplasm "HPA039819: AB_10673020" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "unprognostic (2.14e-3)" "unprognostic (2.56e-3)" "prognostic unfavorable (9.80e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.82e-1)" "unprognostic (1.52e-1)" "unprognostic (3.08e-2)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (9.10e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (8.49e-2)" 18.6 20.3 11.4 23.4 15.2 9.2 19.2 14.4 19.8 22.3 18.0 21.0 34.1 17.0 23.4 28.6 16.2 21.7 25.3 18.7 11.6 12.6 21.4 30.3 20.4 20.4 14.9 13.7 33.8 62.2 29.3 31.4 17.3 15.8 27.3 18.0 24.4 35.1 28.0 11.6 18.6 22.4 26.1 13.4 22.3 21.8 27.4 10.5 18.4 27.0 15.6 22.4 25.8 21.0 18.1 12.3 34.3 15.1 15.1 22.5 15.9 18.5 15.5 9.2 11.4 28.7 25.4 13.4 19.9 26.2 21.4 22.0 19.3 18.0 16.5 9.7 35.9 15.4 17.4 10.6 18.2 16.4 12.7 11.5 15.2 8.2 19.4 26.6 17.2 29.7 28.5 24.5 12.6 33.9 24.9 14.4 11.7 22.1 17.3 13.6 10.1 12.5 10.9 14.1 27.1 17.6 13.1 13.7 11.1 17.6 8.3 10.1 12.2 17.7 28.7 19.3 13.9 14.7 13.6 15.9 16.6 7.7 6.7 9.7 30.5 13.9 14.5 22.5 14.5 15.1 27.0 10.4 34.3 16.7 15.1 20.0 18.1 19.3 17.0 10.5 15.1 22.5 17.3 24.5 15.1 13.2 12.3 14.6 15.9 11.4 15.2 14.4 19.8 11.6 12.6 14.9 13.7 15.8 10.5 11.9 14.2 6.7 14.7 8.2 6.4 14.0 12.7 6.7 4.5 14.0 7.9 13.5 18.3 11.3 46.5 9.2 28.5 0.0 20.3 20.8 15.4 22.9 36.9 33.1 20.4 3.2 7.5 17.8 18.0 91.1 20.4 14.6 6.8 12.6 19.3 8.2 16.7 23.0 17.7 24.5 8.9 6.5 11.7 41.4 14.9 10.2 22.0 15.8 13.3 19.3 BFAR "BAR, RNF47" ENSG00000103429 "Bifunctional apoptosis regulator" Q9NZS9 16 14632815-14669236 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.22e-1)" "unprognostic (1.60e-1)" "unprognostic (4.88e-3)" "unprognostic (2.81e-2)" "unprognostic (3.15e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-2)" "unprognostic (2.11e-1)" "unprognostic (2.09e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (4.74e-5)" "unprognostic (3.22e-1)" "unprognostic (1.07e-2)" "unprognostic (2.31e-2)" "unprognostic (2.65e-1)" "unprognostic (3.42e-2)" "unprognostic (2.51e-2)" 26.5 17.4 11.8 17.0 14.2 16.3 22.4 18.2 14.0 20.5 27.9 18.1 15.8 22.8 26.9 15.9 15.4 15.2 18.7 18.1 12.4 12.7 24.0 19.7 28.2 26.2 12.9 10.3 21.1 46.5 18.4 17.6 23.4 16.8 18.8 23.0 22.7 21.9 15.1 34.2 13.2 23.6 19.5 16.0 22.0 19.6 19.1 12.5 25.8 26.2 15.2 20.9 26.4 16.7 13.5 11.4 11.1 12.1 9.5 18.0 8.9 11.4 12.9 13.3 14.1 15.4 21.2 10.5 17.5 21.6 16.6 17.9 7.8 18.5 16.8 30.0 21.3 15.5 14.6 21.1 17.6 20.4 10.5 11.3 10.9 12.0 24.2 22.2 16.5 13.7 23.5 21.0 16.1 21.2 18.3 26.9 11.7 15.9 15.0 19.4 14.3 11.6 13.4 24.9 11.2 7.6 19.7 17.1 17.5 18.5 12.1 14.7 15.7 18.2 13.7 39.4 13.8 12.8 13.3 23.1 22.8 11.0 11.9 13.7 17.5 19.4 17.7 15.0 15.4 16.8 9.3 10.3 11.1 13.9 12.1 15.9 13.5 13.8 16.7 11.4 10.9 13.8 13.8 7.3 9.5 10.9 9.4 18.0 8.9 11.8 14.2 18.2 14.0 12.4 12.7 12.9 10.3 16.8 12.5 41.7 44.7 38.6 33.1 34.9 32.5 17.3 30.6 21.4 30.7 22.7 35.3 38.5 26.6 44.7 6.9 38.7 31.6 23.3 80.9 59.4 33.9 18.1 46.2 20.2 34.7 23.8 31.7 44.8 36.5 5.7 27.9 39.4 18.6 40.5 46.4 25.4 51.8 38.4 25.1 34.7 33.7 25.8 19.6 28.1 37.5 17.2 36.8 45.0 31.2 32.3 BIK NBK ENSG00000100290 "BCL2 interacting killer" Q13323 22 43110748-43129712 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.8;lymphoid tissue: 26.4" "Cell type enhanced" "Detected in many" 10 "Pancreatic endocrine cells: 75.6;Paneth cells: 122.8;Urothelial cells: 176.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "eosinophil: 28.8;memory B-cell: 7.8;plasmacytoid DC: 24.0" "Group enriched" "Detected in many" 5 "B-cells: 7.8;dendritic cells: 24.0;granulocytes: 28.8" "Cell line enhanced" "Detected in many" "A-431: 29.4;CAPAN-2: 15.0;Daudi: 14.7;U-698: 57.0" HPA051360 Approved NA NA "HPA051360: AB_2681453" "unprognostic (1.18e-3)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (4.09e-1)" "unprognostic (2.06e-3)" "unprognostic (1.64e-1)" "unprognostic (3.86e-3)" "unprognostic (3.27e-1)" "unprognostic (2.71e-2)" "unprognostic (4.36e-3)" "unprognostic (2.36e-1)" "prognostic favorable (7.45e-5)" "unprognostic (1.38e-2)" "unprognostic (2.56e-1)" "unprognostic (4.08e-2)" "unprognostic (3.04e-1)" 0.2 2.2 0.1 23.0 0.9 3.5 4.7 0.1 0.7 3.1 7.7 0.3 8.6 3.5 0.7 2.0 10.5 3.0 19.1 0.6 0.5 0.2 4.2 0.7 2.8 11.1 0.4 0.1 1.8 3.1 0.6 1.1 0.6 0.5 11.9 5.3 0.9 20.9 4.8 0.1 3.1 6.7 0.6 0.6 3.6 13.2 3.0 0.1 4.3 1.8 5.2 26.4 2.7 5.0 7.8 24.0 28.8 1.2 0.3 4.2 2.6 29.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.6 15.0 14.7 1.4 0.0 0.3 6.6 1.6 0.6 0.0 0.2 2.2 0.0 0.1 1.6 0.2 6.9 1.4 0.0 3.0 0.0 0.0 0.1 0.0 3.2 0.1 0.7 0.0 7.5 5.4 9.5 2.3 8.0 2.4 0.0 0.0 6.7 0.3 0.8 0.5 0.0 1.0 2.8 2.0 1.1 0.5 9.6 0.2 0.0 0.8 0.1 0.3 3.6 5.5 57.0 0.0 0.7 0.0 0.7 1.2 28.8 1.2 0.3 1.9 7.8 4.2 1.8 4.3 3.4 2.8 1.5 4.8 0.3 0.3 24.0 2.8 2.6 0.1 0.9 0.1 0.7 0.5 0.2 0.4 0.1 0.5 0.1 0.0 3.4 4.5 21.5 11.2 0.0 0.4 22.9 30.8 14.8 7.0 0.0 0.9 6.6 56.1 0.2 1.4 22.9 23.3 14.5 0.9 1.1 51.8 0.0 0.5 0.9 0.0 48.4 6.7 1.9 0.0 0.0 1.9 33.7 10.0 37.7 0.0 75.6 122.8 0.7 12.3 0.0 0.0 1.9 0.2 12.9 10.3 0.8 7.2 55.7 176.3 BLCAP BC10 ENSG00000166619 "Bladder cancer associated protein" P62952 20 37492472-37527931 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 102.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 72.5" "Low region specificity" "Detected in all" HPA047390 Approved Nucleoli NA NA Nucleoli "HPA047390: AB_2680025" "unprognostic (1.05e-2)" "unprognostic (7.91e-3)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (7.08e-2)" "unprognostic (1.27e-2)" "unprognostic (3.49e-1)" "unprognostic (3.51e-1)" "unprognostic (4.45e-1)" "unprognostic (1.91e-3)" "unprognostic (4.91e-2)" "unprognostic (6.04e-2)" "unprognostic (1.04e-3)" "unprognostic (1.96e-2)" "unprognostic (7.62e-2)" "unprognostic (1.37e-2)" "prognostic favorable (7.28e-5)" 18.9 16.7 31.6 12.9 89.5 10.7 16.4 23.2 40.1 14.3 15.6 13.3 11.4 17.6 9.8 19.9 18.5 50.5 17.9 23.5 26.5 44.4 21.3 23.8 12.2 12.5 22.5 28.3 15.1 7.9 15.4 34.4 26.1 27.6 18.9 18.8 13.4 17.7 21.1 102.5 30.3 18.9 13.4 13.4 14.2 12.4 12.2 10.6 8.5 14.0 27.3 17.8 20.2 12.7 48.0 20.5 26.6 22.2 17.0 28.4 18.7 27.0 8.0 9.4 9.7 18.2 14.0 13.3 13.0 12.6 11.6 9.5 27.8 22.1 14.1 13.0 18.0 11.1 52.5 7.0 53.9 12.1 2.9 6.3 4.6 17.8 25.7 11.7 9.1 6.1 17.8 58.1 11.1 21.1 9.6 16.1 10.3 4.4 10.6 23.3 15.2 7.5 7.2 7.5 15.3 22.5 7.2 35.1 9.4 13.3 72.5 8.6 10.4 15.6 45.3 10.5 10.1 14.9 8.7 15.3 30.1 7.7 10.5 5.5 5.8 7.2 6.8 12.5 8.4 5.3 26.6 22.2 25.9 18.7 21.5 20.4 37.5 21.4 19.8 20.5 48.0 28.4 22.0 23.2 17.0 19.3 8.8 20.6 18.7 31.6 89.5 23.2 40.1 26.5 44.4 22.5 28.3 27.6 10.6 74.5 32.3 42.7 79.2 130.6 42.3 49.4 35.7 64.3 67.1 38.4 21.6 98.9 69.6 30.6 58.8 43.9 49.9 0.0 29.8 68.6 31.1 44.2 29.9 70.6 48.4 39.7 39.3 74.3 36.4 108.7 27.6 35.6 33.7 16.2 50.0 37.9 37.4 28.1 55.9 41.1 33.0 32.3 28.8 23.1 23.8 107.4 54.3 33.2 29.7 128.8 BMP10 ENSG00000163217 "Bone morphogenetic protein 10" O95393 2 68865481-68871517 "Predicted secreted proteins" "Cell adhesion" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "heart muscle: 110.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "T-reg: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Group enriched" "Detected in some" 9 "JURKAT: 6.3;MOLT-4: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 120000 "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.1 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BMP2 BMP2A ENSG00000125845 "Bone morphogenetic protein 2" P12643 20 6767664-6780280 "Cancer-related genes, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 147.9;Basal keratinocytes: 148.5;Suprabasal keratinocytes: 104.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "NK-cell: 2.2" "Lineage enriched" "Detected in single" 7 "NK-cells: 2.2" "Cell line enhanced" "Detected in many" "CACO-2: 21.2;HeLa: 13.8;hTERT-HME1: 12.5;RT4: 16.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA058610, CAB078457" Enhanced Vesicles "Secreted to blood" NA NA 24400 Vesicles "CAB078457: AB_2532532, HPA058610: AB_2683777" "unprognostic (2.22e-2)" "unprognostic (9.32e-2)" "unprognostic (6.12e-2)" "unprognostic (3.56e-2)" "unprognostic (1.94e-2)" "unprognostic (2.48e-1)" "unprognostic (3.70e-3)" "unprognostic (3.12e-3)" "unprognostic (8.51e-2)" "unprognostic (8.46e-2)" "unprognostic (2.53e-3)" "unprognostic (5.39e-3)" "unprognostic (7.81e-2)" "unprognostic (3.76e-1)" "unprognostic (2.77e-1)" "unprognostic (3.01e-2)" "unprognostic (7.49e-2)" 11.1 1.1 1.6 10.5 3.1 0.6 5.3 1.8 7.5 3.7 13.1 2.6 1.9 4.2 3.4 6.7 3.7 3.7 15.6 3.9 2.4 1.6 3.6 3.8 12.8 1.3 2.9 1.3 3.1 9.2 4.7 2.3 7.6 2.7 8.8 9.5 18.3 2.0 1.2 2.6 9.1 13.4 3.4 1.4 8.0 13.8 1.1 2.7 0.3 13.2 6.2 3.1 14.1 9.1 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.5 2.3 0.0 0.0 21.2 0.0 0.0 0.3 0.7 0.0 7.1 4.2 1.8 0.0 0.0 3.8 0.0 13.8 0.0 1.0 0.0 0.6 0.1 6.4 0.0 12.5 2.7 4.3 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.5 2.5 0.5 4.1 0.0 0.3 1.6 16.8 0.8 1.1 5.0 0.0 0.0 4.0 0.0 4.4 1.0 1.2 1.9 0.0 0.6 0.2 0.5 0.0 2.1 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 1.6 3.1 1.8 3.3 2.4 1.6 2.9 1.3 2.7 2.7 74.5 147.9 4.5 34.3 148.5 0.4 4.6 53.5 0.0 13.6 1.8 0.0 0.1 0.0 19.3 0.3 9.7 64.5 0.0 8.3 0.1 15.5 30.2 8.1 2.4 2.7 0.0 10.9 46.1 3.7 0.0 5.5 1.9 8.5 1.0 18.4 4.8 23.9 17.3 0.0 0.7 0.2 19.4 38.9 0.0 0.1 104.4 0.1 0.0 15.1 24.3 BMPR1A "ACVRLK3, ALK3, CD292" ENSG00000107779 "Bone morphogenetic protein receptor type 1A" P36894 10 86756601-86932838 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB019398 Approved Approved Cytosol NA NA Cytosol "CAB019398: " "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (3.34e-1)" "unprognostic (9.61e-2)" "unprognostic (1.05e-3)" "unprognostic (9.34e-2)" "prognostic unfavorable (8.93e-4)" "unprognostic (3.64e-1)" "unprognostic (2.38e-2)" "unprognostic (1.53e-1)" "unprognostic (9.24e-2)" "unprognostic (9.42e-2)" "unprognostic (4.32e-2)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "unprognostic (1.01e-2)" "unprognostic (1.07e-1)" 8.9 7.0 9.4 7.9 12.4 0.9 10.7 14.1 9.2 19.4 20.6 10.9 7.7 6.2 16.3 12.3 8.4 10.9 10.8 11.0 7.7 6.1 8.2 4.6 7.4 2.9 7.3 7.6 16.1 10.6 10.0 14.0 7.4 8.5 12.8 9.3 10.9 12.6 14.2 8.4 11.3 9.8 16.5 12.2 3.4 12.1 7.8 9.2 0.3 19.4 7.8 5.7 16.0 11.4 1.8 1.1 3.6 0.8 0.9 1.4 0.3 7.3 3.7 14.3 12.1 7.5 4.8 2.5 7.4 7.7 4.3 5.1 6.2 6.4 2.2 3.4 9.4 3.1 7.8 6.3 8.0 6.4 2.4 3.6 2.8 3.5 10.3 4.0 3.8 19.7 4.2 3.4 5.8 4.3 6.4 0.0 4.1 4.4 1.5 5.0 3.1 2.6 3.1 7.7 2.6 1.7 0.0 5.6 0.0 8.9 6.9 1.4 4.6 8.2 4.2 4.9 18.2 7.1 1.9 3.7 3.1 5.0 6.4 6.8 0.4 6.8 2.8 2.7 2.6 2.5 2.0 0.8 0.6 1.4 0.5 0.9 1.8 1.4 1.2 0.3 1.5 1.0 1.1 3.6 0.9 0.6 1.1 0.7 0.3 9.4 12.4 14.1 9.2 7.7 6.1 7.3 7.6 8.5 9.2 32.8 24.8 0.0 6.7 10.8 6.0 19.0 10.2 13.4 9.1 10.4 19.6 10.0 1.7 9.8 0.6 2.1 9.0 0.0 8.1 0.7 13.3 12.9 15.0 7.2 2.7 11.1 17.3 8.0 4.0 1.7 31.1 3.5 8.5 1.0 13.6 12.9 7.7 3.5 29.4 4.7 19.0 6.5 14.1 2.3 3.6 8.5 4.2 0.0 10.0 4.2 BMPR1B "ALK6, CDw293" ENSG00000138696 "Bone morphogenetic protein receptor type 1B" O00238 4 94757968-95158448 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Chondrogenesis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 28.0;ductus deferens: 25.1;prostate: 25.3;seminal vesicle: 32.0" "Group enriched" "Detected in many" 5 "Ciliated cells: 14.7;Club cells: 22.7;Collecting duct cells: 57.6;Glandular cells: 28.8;Intestinal endocrine cells: 17.6;Melanocytes: 27.0;Muller glia cells: 44.8" "Cancer enhanced" "Detected in many" "breast cancer: 32.4;prostate cancer: 24.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 18.7;MCF7: 9.4;SH-SY5Y: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.25e-1)" "unprognostic (1.80e-2)" "unprognostic (1.40e-3)" "prognostic favorable (2.84e-4)" "unprognostic (1.57e-1)" "unprognostic (4.22e-2)" "unprognostic (1.92e-1)" "unprognostic (2.86e-2)" "unprognostic (2.95e-2)" "unprognostic (1.01e-1)" "unprognostic (3.97e-2)" "unprognostic (3.93e-1)" "unprognostic (1.62e-3)" "unprognostic (7.89e-4)" "unprognostic (6.22e-2)" "unprognostic (3.81e-3)" "unprognostic (2.63e-2)" 1.1 5.6 12.7 0.8 15.0 0.7 1.7 11.6 12.7 28.0 1.2 5.5 25.1 0.7 5.3 3.2 1.1 14.3 3.4 1.3 13.4 5.9 9.3 1.4 2.4 0.5 5.4 8.6 7.6 1.7 0.6 2.4 1.2 12.1 25.3 0.8 0.7 1.4 32.0 3.3 1.4 0.6 1.2 7.5 1.4 2.8 4.3 11.2 10.8 0.8 0.1 0.6 0.7 0.7 0.4 0.5 1.9 0.9 0.8 1.6 0.3 0.0 18.7 5.0 0.0 2.0 4.6 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.8 0.0 1.0 2.9 6.9 0.0 0.0 4.6 0.0 1.1 0.0 0.5 0.4 0.0 2.8 7.6 2.8 5.7 0.3 0.0 0.0 0.0 0.0 7.2 9.4 0.6 0.1 1.8 0.1 3.2 0.1 2.8 0.1 3.6 0.1 0.2 15.6 0.2 2.5 2.5 0.7 1.9 0.0 0.0 4.0 3.2 0.1 3.4 0.0 0.0 0.0 1.5 0.0 0.4 1.9 0.3 0.5 0.4 0.5 0.7 0.4 0.6 0.3 0.3 0.3 0.5 0.5 0.8 0.8 0.9 0.5 1.6 0.3 12.7 15.0 11.6 11.8 13.4 5.9 5.4 8.6 12.1 11.2 6.0 0.0 0.0 1.3 2.4 0.2 3.6 5.1 14.7 22.7 57.6 0.0 0.0 1.7 2.9 1.1 0.3 0.0 0.0 0.3 0.2 1.4 28.8 0.0 0.0 0.1 0.0 17.6 4.9 0.0 1.6 2.8 0.3 27.0 0.0 0.0 44.8 0.7 0.0 3.5 0.0 1.2 0.0 1.4 1.6 1.3 1.9 0.0 0.0 0.0 1.0 BMPR2 "BMPR-II, BMPR3, BRK-3, PPH1, T-ALK" ENSG00000204217 "Bone morphogenetic protein receptor type 2" Q13873 2 202376936-202567751 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017385, HPA049014" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA017385: AB_1845397, HPA049014: AB_2680599" "unprognostic (2.17e-1)" "unprognostic (9.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.55e-1)" "unprognostic (4.30e-2)" "unprognostic (1.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.13e-2)" "unprognostic (1.97e-1)" "unprognostic (1.29e-2)" "unprognostic (1.21e-3)" "unprognostic (9.20e-2)" "unprognostic (1.18e-1)" "unprognostic (3.40e-1)" 18.1 15.0 12.1 9.8 14.2 1.1 10.2 9.5 17.1 15.7 11.7 8.2 6.5 5.5 12.9 10.2 10.6 10.3 13.2 14.6 10.8 13.5 10.7 11.5 24.9 4.4 10.4 14.5 12.0 7.0 15.5 6.1 21.7 10.8 11.0 7.7 11.4 7.1 9.1 10.6 7.2 8.1 15.3 7.5 8.9 7.2 12.9 3.8 3.9 11.6 5.2 5.4 11.1 8.9 1.6 2.6 0.9 2.7 1.1 3.6 0.9 5.7 5.4 5.6 8.8 14.0 13.6 10.8 12.0 12.1 10.5 10.5 4.7 8.7 2.0 14.0 24.2 9.0 10.9 7.3 9.3 16.5 6.0 5.0 6.1 5.8 7.3 9.7 1.7 4.8 9.9 8.8 7.7 10.3 16.2 30.2 2.5 3.9 10.0 12.9 10.8 1.4 1.6 3.1 2.8 5.0 3.9 11.0 3.0 8.9 12.3 5.7 5.7 12.8 7.6 14.1 14.3 5.9 4.0 33.3 21.4 11.4 7.3 7.2 1.4 1.7 0.6 5.1 3.9 6.2 0.5 2.0 0.9 3.4 1.8 2.5 1.5 1.3 2.2 2.3 1.6 2.7 1.4 0.6 1.1 2.7 2.6 3.6 0.9 12.1 14.2 9.5 17.1 10.8 13.5 10.4 14.5 10.8 3.8 98.3 38.9 17.1 16.1 29.8 51.7 46.4 12.7 21.4 39.8 19.2 76.6 14.0 1.7 27.3 2.4 119.4 12.7 0.0 24.7 19.4 40.9 19.9 23.1 15.5 16.2 33.4 24.1 109.2 20.0 2.3 31.4 17.4 40.5 15.4 16.3 38.7 36.3 20.9 40.3 10.7 29.9 64.7 45.7 17.7 11.1 31.5 16.7 13.8 13.4 22.7 BNIP1 "Nip1, SEC20" ENSG00000113734 "BCL2 interacting protein 1" Q12981 5 173144442-173164387 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, ER-Golgi transport, Host-virus interaction, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008009, HPA008149" Supported Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA008009: AB_1078291, HPA008149: AB_2667993" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (5.89e-2)" "unprognostic (3.08e-1)" "unprognostic (2.57e-1)" "unprognostic (2.94e-2)" "unprognostic (2.71e-2)" "unprognostic (1.50e-1)" "unprognostic (7.38e-2)" "unprognostic (2.70e-2)" "unprognostic (1.84e-2)" "unprognostic (2.28e-1)" "unprognostic (4.40e-3)" "unprognostic (2.10e-1)" "unprognostic (2.13e-1)" "unprognostic (5.61e-2)" "unprognostic (3.07e-2)" 12.0 14.5 13.3 9.5 14.5 34.0 13.7 10.1 16.9 10.5 11.1 13.4 9.0 10.2 10.2 15.0 11.4 10.8 9.4 13.0 12.2 14.9 14.5 14.1 10.1 10.9 13.7 12.0 11.3 22.5 13.6 14.7 13.1 17.5 10.6 13.4 10.8 12.4 9.6 20.9 9.0 9.8 10.8 11.8 11.8 11.5 28.1 9.3 14.4 13.1 9.3 12.4 9.9 10.1 9.9 12.7 3.4 9.3 9.6 14.6 8.5 10.8 9.7 11.6 14.3 7.2 16.8 12.9 9.2 14.5 19.6 19.8 16.7 15.0 11.6 10.9 13.6 20.6 8.6 15.0 26.0 20.1 19.0 12.1 10.4 6.4 8.7 19.0 16.6 13.1 9.4 13.2 18.1 22.9 9.3 14.9 17.0 10.0 14.1 15.9 25.2 18.4 14.7 5.1 13.2 11.6 12.2 9.4 14.2 11.2 6.6 14.7 9.1 8.1 10.4 19.7 8.5 17.5 13.4 11.8 17.0 12.7 14.5 18.5 10.8 12.6 17.8 15.7 17.1 10.9 0.0 8.5 3.4 14.6 9.3 12.4 9.0 12.8 10.5 10.3 9.9 11.0 10.8 0.3 9.6 7.2 12.7 11.1 8.5 13.3 14.5 10.1 16.9 12.2 14.9 13.7 12.0 17.5 9.3 3.0 10.7 5.6 9.0 10.3 13.2 4.5 7.6 10.7 6.8 5.2 3.9 18.5 23.2 12.5 2.2 6.5 7.4 0.0 10.8 15.9 8.2 11.0 1.1 5.7 13.4 9.5 6.9 5.5 6.9 4.8 8.1 9.1 3.3 11.8 10.8 9.8 8.4 7.8 11.0 13.0 9.6 0.0 6.1 19.2 12.5 9.5 25.2 10.4 10.1 7.8 BNIP2 "BNIP-2, Nip2" ENSG00000140299 "BCL2 interacting protein 2" Q12982 15 59659146-59689534 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026843 Approved NA NA "HPA026843: AB_1845403" "unprognostic (3.41e-2)" "unprognostic (2.26e-1)" "unprognostic (4.51e-2)" "prognostic favorable (8.42e-4)" "unprognostic (6.70e-2)" "unprognostic (4.81e-2)" "unprognostic (2.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.44e-2)" "unprognostic (1.26e-1)" "unprognostic (4.72e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (4.68e-3)" "unprognostic (1.81e-1)" "unprognostic (2.10e-2)" "unprognostic (1.01e-1)" 28.5 14.8 11.7 20.1 14.7 58.8 31.5 11.2 9.4 22.7 17.9 11.5 17.8 8.3 22.8 17.3 21.6 18.5 16.6 30.2 11.2 9.0 14.0 23.5 26.2 41.7 13.6 10.0 21.7 13.1 11.5 12.4 21.7 11.7 20.1 12.3 17.1 17.8 21.6 28.6 17.5 16.9 38.1 13.4 31.3 14.9 13.3 13.8 28.0 16.8 21.7 23.8 28.4 31.7 16.6 21.3 40.9 23.2 17.0 18.9 19.4 13.7 12.3 16.0 13.1 25.8 21.3 14.4 21.5 29.2 19.1 21.9 9.9 6.3 24.2 14.4 29.6 26.2 25.4 17.2 24.3 26.0 16.9 10.8 27.9 18.5 10.3 28.4 36.7 32.9 24.6 25.3 17.2 30.7 18.1 31.5 27.2 16.2 24.9 30.8 7.6 17.6 14.8 14.9 2.6 9.0 18.9 21.0 29.4 19.9 29.8 13.4 18.4 14.4 18.9 35.1 24.4 15.6 38.2 24.7 21.2 26.0 13.5 20.3 19.1 38.8 32.0 16.7 34.0 21.1 22.1 22.9 34.5 15.8 23.2 18.9 16.6 16.8 16.8 21.3 15.2 17.6 17.3 40.9 17.0 18.7 17.2 17.8 19.4 11.7 14.7 11.2 9.4 11.2 9.0 13.6 10.0 11.7 13.8 68.5 44.8 41.2 79.0 76.9 30.7 74.9 35.7 37.5 34.2 14.0 45.2 57.5 31.5 26.8 5.9 83.7 20.1 0.0 23.4 66.7 59.6 54.9 94.6 45.2 80.0 47.7 14.9 71.8 107.4 5.1 40.3 102.7 49.0 70.3 18.8 45.2 28.8 19.2 53.7 15.1 45.7 77.6 57.7 23.8 29.6 80.8 162.1 62.8 16.8 113.2 BNIP3 Nip3 ENSG00000176171 "BCL2 interacting protein 3" Q12983 10 131966455-131982013 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 122.7" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 391.8;Proximal tubular cells: 579.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 72.0;hTERT-RPE1: 56.2;U-87 MG: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003015, CAB011676" Supported Uncertain Cytosol NA NA Cytosol "CAB011676: , HPA003015: AB_1078290" "unprognostic (1.01e-3)" "unprognostic (1.42e-3)" "unprognostic (1.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.58e-2)" "unprognostic (1.62e-3)" "unprognostic (6.57e-3)" "unprognostic (1.12e-1)" "unprognostic (2.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (2.37e-3)" "unprognostic (1.04e-1)" "unprognostic (3.29e-2)" "unprognostic (2.98e-1)" 19.3 12.0 18.3 4.0 18.6 3.0 8.7 13.5 28.3 7.7 4.6 13.0 5.1 4.0 6.0 11.4 8.1 6.0 7.9 43.3 16.9 14.6 27.6 53.4 6.7 4.6 16.5 14.2 19.3 122.7 6.0 7.3 13.0 22.6 18.2 2.9 5.2 19.2 6.6 48.0 9.0 4.5 6.0 13.3 4.9 6.4 6.0 11.1 3.3 10.8 6.2 4.0 9.2 7.3 6.1 3.0 5.1 3.5 2.2 23.4 8.9 72.0 5.8 4.2 11.7 11.2 11.9 21.6 17.6 16.3 13.3 38.0 1.2 1.6 0.1 28.6 10.1 15.5 4.4 8.8 25.0 50.1 3.8 6.7 2.5 3.7 16.7 15.0 3.3 2.0 8.2 6.3 12.9 13.1 56.2 9.2 4.5 6.6 0.2 21.7 5.7 1.6 18.4 3.5 0.5 17.5 4.0 2.1 6.1 14.5 1.2 5.5 12.9 3.6 7.4 10.0 18.6 4.5 4.6 10.5 18.8 6.3 7.0 13.9 12.3 10.5 10.0 68.2 0.1 3.2 2.2 3.5 5.1 9.8 2.3 10.4 5.7 13.9 10.3 3.0 6.1 23.4 15.4 0.9 2.2 3.1 2.3 13.2 8.9 18.3 18.6 13.5 28.3 16.9 14.6 16.5 14.2 22.6 11.1 44.7 40.9 23.1 75.3 26.6 87.6 141.4 101.9 89.7 48.9 80.3 37.3 149.9 255.4 174.2 61.9 44.2 3.5 0.0 75.7 295.7 56.6 118.1 0.0 391.8 65.8 314.6 77.8 54.6 21.8 85.4 65.0 16.1 32.1 39.7 6.7 125.3 189.3 1.9 97.2 579.1 50.2 38.8 23.8 33.5 100.7 11.4 206.9 25.4 4.8 42.9 BNIP3L "BNIP3a, Nix" ENSG00000104765 "BCL2 interacting protein 3 like" O60238 8 26382898-26505636 "Cancer-related genes, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Erythroid cells: 467.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015652, CAB025371" Enhanced Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "CAB025371: , HPA015652: AB_1845406" "unprognostic (1.02e-1)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (8.36e-2)" "unprognostic (6.24e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (2.02e-1)" "unprognostic (2.06e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (5.92e-5)" "unprognostic (8.72e-3)" "unprognostic (5.16e-2)" "prognostic unfavorable (3.95e-4)" "unprognostic (7.59e-3)" 61.7 27.8 32.7 18.2 39.1 79.4 40.1 26.1 39.0 35.0 19.9 32.3 30.7 11.5 27.3 34.0 26.7 26.4 28.0 36.0 36.0 27.4 39.9 22.9 31.3 20.7 43.1 31.9 63.4 10.4 26.8 16.0 51.2 41.0 23.7 14.9 20.9 22.1 39.2 21.0 38.1 14.5 26.5 47.9 19.5 16.7 33.0 43.9 17.8 21.5 12.4 25.2 48.3 30.8 14.2 30.4 68.7 53.9 7.8 17.6 36.3 17.9 6.9 16.4 11.1 45.7 28.8 13.9 18.2 53.5 17.1 37.9 3.1 8.7 5.5 17.2 34.2 23.9 9.2 8.1 23.4 57.0 3.6 4.5 22.9 7.1 5.4 25.5 2.0 39.8 34.6 18.4 19.3 11.6 56.7 21.8 13.7 10.3 13.4 35.8 7.8 14.2 7.6 5.3 11.3 7.5 7.6 20.8 10.9 17.7 11.7 17.5 15.6 8.8 1.7 13.8 18.8 9.0 4.3 28.6 32.1 13.9 20.0 4.1 19.7 8.9 7.4 48.9 4.1 7.2 49.9 53.9 32.1 7.6 27.8 6.7 12.4 11.4 8.3 30.4 14.2 17.6 12.8 68.7 7.8 17.4 6.9 15.0 36.3 32.7 39.1 26.1 39.0 36.0 27.4 43.1 31.9 41.0 43.9 80.4 113.7 54.1 47.2 87.7 108.8 31.1 30.6 89.7 69.4 97.7 31.4 24.2 41.4 101.3 153.2 88.4 28.4 467.2 33.9 141.0 136.5 90.8 116.8 23.2 118.2 77.9 115.7 155.9 197.5 155.5 296.6 132.1 101.3 70.3 45.5 412.0 125.0 28.8 326.7 215.8 62.1 142.3 150.4 113.3 98.5 110.7 135.9 55.4 28.1 62.0 BOC CDON2 ENSG00000144857 "BOC cell adhesion associated, oncogene regulated" Q9BWV1 3 113211003-113287459 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 18.8;Leydig cells: 78.6;Peritubular cells: 44.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 8 "B-cells: 1.3" "Cell line enhanced" "Detected in many" "AN3-CA: 31.2;ASC diff: 46.2;BJ hTERT+: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025806 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Intracellular and membrane" NA No 4500000 "Nuclear bodies, Plasma membrane" Nucleoplasm "CAB025806: " "unprognostic (6.89e-3)" "unprognostic (1.34e-2)" "unprognostic (2.62e-3)" "unprognostic (1.03e-2)" "unprognostic (5.03e-3)" "prognostic favorable (4.89e-4)" "unprognostic (8.66e-5)" "unprognostic (1.10e-1)" "unprognostic (1.19e-2)" "unprognostic (4.78e-3)" "unprognostic (3.42e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-3)" "unprognostic (4.94e-3)" "unprognostic (1.11e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.18e-5)" 19.4 4.8 5.3 10.4 8.1 0.4 21.6 4.2 6.0 26.6 23.8 5.4 10.6 3.9 25.8 25.3 19.6 33.2 14.5 20.3 13.3 2.9 4.7 1.0 3.6 3.6 5.5 2.2 26.1 12.0 1.9 12.5 1.9 26.2 21.2 3.9 45.6 17.9 17.4 4.6 25.7 9.6 35.2 36.7 3.5 11.8 9.2 7.6 1.2 13.4 12.9 4.9 28.4 25.0 1.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 2.9 11.0 31.2 46.2 2.4 0.3 5.0 16.5 1.2 1.1 0.0 0.0 0.0 3.1 8.4 0.7 0.0 2.2 1.0 0.4 0.0 1.3 0.0 1.0 0.0 0.2 0.1 0.1 8.0 0.7 0.7 0.1 10.3 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.5 2.8 0.0 2.7 0.0 4.9 0.0 0.3 0.0 3.3 4.7 0.0 0.2 0.1 3.4 1.3 0.1 0.0 1.8 2.9 0.0 1.6 0.0 0.0 0.0 3.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 5.3 8.1 4.2 6.0 13.3 2.9 5.5 2.2 26.2 7.6 0.0 0.3 0.0 2.3 18.8 0.4 0.8 0.0 0.0 1.2 5.2 0.0 4.4 0.0 0.0 1.3 3.3 0.0 0.0 0.0 4.0 12.4 2.8 0.0 0.0 0.7 0.0 1.7 2.5 0.0 1.1 78.6 0.9 10.1 0.0 0.0 14.1 0.5 0.0 44.9 0.0 0.5 0.0 8.3 1.1 3.0 9.7 1.6 0.0 0.0 0.3 BPI BPIFD1 ENSG00000101425 "Bactericidal/permeability-increasing protein" P17213 20 38304123-38337505 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 197.4" "Group enriched" "Detected in some" 6 "Early spermatids: 167.9;Late spermatids: 173.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "classical monocyte: 13.6;neutrophil: 6.4" "Group enriched" "Detected in many" 18 "granulocytes: 6.4;monocytes: 13.6" "Cell line enhanced" "Detected in some" "BJ: 1.3;BJ hTERT+: 2.1;HL-60: 5.2;RPMI-8226: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA061284 Enhanced "Secreted to blood" NA NA 7290000 "HPA061284: AB_2684465" "unprognostic (9.30e-4)" "unprognostic (5.49e-2)" "unprognostic (1.97e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-1)" "unprognostic (1.56e-1)" "unprognostic (4.50e-2)" "unprognostic (1.98e-1)" "unprognostic (3.07e-2)" "unprognostic (1.14e-1)" "unprognostic (2.60e-2)" "unprognostic (1.50e-1)" "unprognostic (8.83e-6)" "unprognostic (2.66e-4)" "unprognostic (9.29e-2)" "unprognostic (2.32e-2)" "unprognostic (9.47e-3)" 0.2 0.1 0.0 0.1 0.1 197.4 0.2 0.1 0.8 1.8 0.1 0.3 0.0 0.1 0.6 0.5 0.1 0.2 0.2 15.3 0.0 0.0 0.6 0.5 6.0 0.1 0.0 0.0 1.7 0.1 0.1 0.5 2.8 0.3 0.2 0.1 0.2 0.3 0.4 0.6 0.3 0.1 0.1 0.1 10.5 0.1 41.7 0.1 5.3 1.3 0.0 0.1 0.1 0.7 0.0 0.5 6.4 13.6 0.0 0.0 6.7 0.0 0.0 0.6 0.0 0.2 0.3 0.0 1.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 13.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.4 0.0 0.5 0.0 0.0 6.7 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.3 0.1 0.0 2.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 8.3 0.0 167.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.1 0.0 0.0 1.3 0.0 173.1 16.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 17.3 27.0 0.0 0.0 0.0 1.8 1.1 0.1 0.0 0.0 0.0 0.0 BPIFB1 "bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP" ENSG00000125999 "BPI fold containing family B member 1" Q8TDL5 20 33273480-33309878 "Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 100.1;lung: 101.0;lymphoid tissue: 115.1;stomach 1: 76.9" "Group enriched" "Detected in some" 16 "Ciliated cells: 887.4;Club cells: 1261.4" "Cancer enhanced" "Detected in many" "stomach cancer: 75.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.0;OE19: 6.6;RT4: 3.9;SK-BR-3: 7.9" "Region enriched" "Detected in single" 7 "olfactory region: 6.2" "Not detected" "Not detected" HPA024256 Enhanced "Secreted in other tissues" NA NA 7500000 "HPA024256: AB_1845664" "unprognostic (2.42e-1)" "unprognostic (5.41e-2)" "unprognostic (3.67e-2)" "unprognostic (3.09e-1)" "unprognostic (6.72e-2)" "unprognostic (3.43e-2)" "unprognostic (9.37e-3)" "unprognostic (1.14e-1)" "unprognostic (2.82e-1)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (1.36e-7)" "unprognostic (3.30e-1)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" 0.1 0.0 0.2 0.2 0.2 0.0 0.2 0.1 0.2 100.1 0.1 0.3 0.1 3.7 0.5 0.2 23.3 0.0 0.3 0.3 0.2 0.0 0.1 0.1 101.0 0.1 0.1 0.1 0.1 0.1 0.0 4.7 0.1 0.1 0.9 0.0 0.1 38.8 0.8 1.0 0.0 0.1 0.1 0.1 0.1 76.9 1.1 0.1 0.2 0.2 29.6 115.1 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.1 6.6 0.0 0.7 0.0 0.3 0.0 3.9 0.0 0.0 0.0 7.9 0.0 0.1 0.6 0.0 0.6 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.1 8.9 17.7 0.0 0.4 1.1 0.0 0.4 5.1 887.4 1261.4 0.0 0.0 0.2 0.0 0.1 66.1 0.2 0.0 0.0 0.2 0.1 0.9 1.9 3.5 0.0 0.2 0.0 0.0 0.0 0.0 66.3 0.3 0.3 1.7 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.1 0.9 0.4 0.4 0.1 0.0 0.0 0.7 BPIFB2 "BPIL1, C20orf184, dJ726C3.2, LPLUNC2" ENSG00000078898 "BPI fold containing family B member 2" Q8N4F0 20 33007600-33023709 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "lymphoid tissue: 218.0;salivary gland: 191.2" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 2.8;Glandular cells: 6.1;Hepatocytes: 1.5;Late spermatids: 7.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 552 "Hep G2: 69.5" "Region enhanced" "Detected in single" "olfactory region: 0.5" "Not detected" "Not detected" "HPA049491, HPA060121" Enhanced Approved Vesicles "Intracellular and membrane" NA NA 68000 Vesicles "HPA049491: AB_2680792, HPA060121: AB_2684207" "unprognostic (1.94e-1)" "prognostic favorable (1.97e-5)" "unprognostic (2.24e-4)" "unprognostic (9.48e-2)" "unprognostic (9.81e-2)" "unprognostic (2.02e-3)" "unprognostic (1.72e-2)" "unprognostic (2.71e-1)" "unprognostic (9.28e-2)" "unprognostic (5.35e-1)" "unprognostic (8.19e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 191.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.6 218.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 7.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 BRCA1 "BRCC1, FANCS, PPP1R53, RNF53" ENSG00000012048 "BRCA1, DNA repair associated" P38398 17 43044295-43170245 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 64.7;Spermatogonia: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "dendritic cells: 9.1;granulocytes: 9.7;monocytes: 12.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB001946, HPA004840, HPA034966, HPA057371" Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes "Nucleoplasm, Nuclear bodies" "CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611" "unprognostic (7.87e-3)" "unprognostic (6.97e-2)" "unprognostic (3.53e-3)" "unprognostic (2.39e-1)" "unprognostic (5.42e-2)" "unprognostic (7.07e-3)" "unprognostic (1.56e-3)" "unprognostic (4.14e-3)" "unprognostic (9.62e-3)" "unprognostic (2.47e-1)" "unprognostic (5.53e-3)" "unprognostic (1.28e-1)" "unprognostic (1.08e-4)" "unprognostic (1.08e-3)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.31e-2)" 4.8 4.3 6.0 9.6 11.3 15.3 5.1 12.9 10.6 5.4 9.2 3.4 6.8 4.3 5.4 5.5 9.1 5.5 3.3 6.5 6.6 5.3 4.2 7.7 4.9 13.0 7.5 5.9 5.1 4.7 4.2 11.0 5.3 10.5 4.1 10.4 3.7 5.4 7.4 7.3 8.3 6.7 5.5 9.2 5.9 5.1 17.6 7.0 10.9 15.6 7.3 14.6 5.5 5.6 2.0 9.1 9.7 12.7 1.4 1.3 10.7 15.7 25.6 14.1 11.2 2.3 5.2 13.8 18.6 8.0 15.6 14.9 15.5 12.3 36.4 3.4 7.1 18.5 18.3 19.1 10.4 26.2 16.6 14.0 17.1 20.1 13.4 0.5 30.5 14.9 1.4 1.7 23.5 7.5 4.0 8.1 17.0 25.8 15.6 14.7 10.5 25.5 10.1 7.7 10.6 6.8 17.6 29.7 14.9 5.8 15.3 9.7 10.4 14.3 4.7 7.0 10.0 12.6 14.1 5.2 14.0 11.4 18.1 19.3 7.3 17.8 28.0 11.3 18.1 14.6 4.6 12.7 1.8 1.3 4.0 1.3 1.1 1.3 1.0 9.1 2.0 1.2 1.3 9.7 1.4 1.5 1.4 0.4 10.7 6.0 11.3 12.9 10.6 6.6 5.3 7.5 5.9 10.5 7.0 0.0 3.2 5.2 3.8 2.6 8.3 10.4 7.6 13.4 5.7 1.8 21.6 7.0 0.0 2.6 11.1 2.9 1.0 0.0 1.0 17.5 2.9 2.4 8.1 16.1 8.6 11.1 0.0 5.5 4.0 5.2 2.3 5.3 0.0 3.6 3.7 2.8 1.6 3.1 1.4 0.8 21.1 6.5 1.4 64.7 61.1 1.9 3.3 2.5 3.5 2.5 BRI3 ENSG00000164713 "Brain protein I3" O95415 7 98252379-98310441 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 23.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042215 Uncertain NA NA "HPA042215: AB_10794790" "unprognostic (1.51e-2)" "unprognostic (5.03e-2)" "unprognostic (7.08e-3)" "unprognostic (3.48e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (3.35e-4)" "unprognostic (2.04e-2)" "unprognostic (1.88e-2)" "unprognostic (3.93e-1)" "unprognostic (4.68e-1)" "unprognostic (1.66e-1)" "unprognostic (6.60e-2)" "unprognostic (1.89e-1)" "unprognostic (1.30e-1)" "unprognostic (1.35e-1)" "unprognostic (1.68e-1)" "unprognostic (3.71e-1)" 41.4 40.9 15.2 17.2 18.2 40.4 97.1 6.9 16.6 22.2 41.1 12.9 16.7 32.5 21.5 22.6 29.6 17.5 25.7 57.2 14.1 13.6 38.5 56.4 56.6 51.1 14.6 11.3 27.5 56.7 6.4 26.7 59.8 14.0 33.4 18.0 38.3 45.9 15.9 86.0 20.5 53.3 28.7 14.8 52.8 41.6 29.3 12.9 11.7 35.9 21.5 13.3 29.2 38.5 0.6 5.5 23.5 12.9 0.1 1.4 1.4 26.3 4.2 7.8 10.0 50.1 22.8 18.7 22.1 25.6 18.5 25.0 3.4 12.5 2.7 46.4 39.4 59.3 9.2 9.8 14.0 12.5 9.2 11.3 1.8 3.2 5.8 49.3 2.0 9.0 17.9 19.7 15.7 28.3 25.6 22.3 3.3 5.3 17.8 34.6 1.8 5.9 6.6 9.6 18.1 11.7 5.9 4.3 8.9 17.7 2.0 6.5 13.4 5.8 23.2 54.3 14.0 2.5 13.4 22.1 36.3 21.3 47.7 17.1 19.0 25.0 7.0 42.1 9.2 19.1 1.2 8.1 11.9 0.5 12.9 0.7 0.5 0.5 0.6 3.9 0.6 0.8 0.7 23.5 0.1 11.8 5.5 1.4 1.4 15.2 18.2 6.9 16.6 14.1 13.6 14.6 11.3 14.0 12.9 77.4 99.5 48.3 226.1 130.0 81.0 100.5 140.1 21.4 33.0 127.4 31.4 104.6 482.4 36.9 537.3 139.8 186.1 46.7 101.1 380.4 110.9 370.7 22.0 237.2 602.5 122.3 75.3 167.0 284.1 88.1 92.9 261.8 158.6 20.8 159.0 187.7 78.8 188.1 114.2 526.3 66.9 109.9 138.1 49.1 54.1 149.8 141.7 34.1 116.0 410.5 BRI3BP "BNAS1, HCCR-2, HCCRBP-3, KG19" ENSG00000184992 "BRI3 binding protein" Q8WY22 12 124993700-125031231 "Predicted membrane proteins, Transporters" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 128.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 38.1;U-698: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014957 Approved Approved Nucleoplasm,Mitochondria NA Yes "Nucleoplasm, Mitochondria" "HPA014957: AB_1845447" "unprognostic (1.62e-2)" "unprognostic (6.82e-2)" "unprognostic (1.53e-2)" "unprognostic (9.95e-2)" "unprognostic (4.66e-2)" "unprognostic (1.20e-2)" "prognostic unfavorable (6.87e-4)" "unprognostic (7.65e-3)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (7.40e-2)" "unprognostic (4.82e-2)" "unprognostic (2.72e-3)" "unprognostic (1.44e-3)" "unprognostic (2.20e-1)" "unprognostic (9.20e-2)" "unprognostic (1.55e-1)" 3.8 3.2 10.8 12.6 13.7 4.7 6.8 13.4 16.0 3.8 16.8 8.8 2.4 22.5 2.9 3.0 10.7 5.0 9.8 3.0 11.0 10.8 8.3 7.5 3.4 14.2 10.9 10.3 2.2 11.2 9.8 4.0 2.6 10.5 3.8 17.8 4.7 4.1 3.1 2.0 8.0 21.8 3.3 12.6 7.3 9.0 2.6 7.7 11.1 5.4 4.5 17.8 3.6 4.3 2.4 5.7 9.5 2.5 1.5 1.2 0.7 9.4 12.5 4.6 4.3 4.0 2.1 5.0 6.7 1.5 4.0 1.9 7.9 6.5 38.1 7.9 1.7 2.8 11.7 10.8 6.0 3.9 7.0 5.9 17.5 5.6 7.1 0.7 25.4 22.0 0.9 3.5 4.7 2.6 1.9 1.7 13.9 6.0 2.2 4.2 10.1 13.0 11.4 2.5 10.3 4.9 8.3 7.7 8.3 6.2 14.5 6.2 4.0 8.2 9.0 3.0 1.6 16.0 21.0 2.0 3.6 3.8 3.8 6.7 7.4 13.3 46.8 3.8 9.5 9.8 4.5 2.5 9.5 1.2 1.7 1.1 1.8 0.9 0.9 2.4 2.4 0.8 1.2 3.8 1.5 1.6 5.7 0.8 0.7 10.8 13.7 13.4 16.0 11.0 10.8 10.9 10.3 10.5 7.7 8.9 7.2 26.7 7.9 10.9 35.5 6.3 45.9 8.1 5.7 8.7 13.7 8.8 3.3 9.0 23.9 3.0 55.2 0.0 9.2 18.3 5.5 8.0 18.4 25.2 17.3 23.8 7.5 3.7 28.3 128.6 1.1 15.5 10.1 3.6 39.6 13.2 14.1 35.1 3.9 10.9 25.6 0.0 5.9 0.9 8.1 15.9 4.3 8.7 67.9 7.8 BRICD5 "C16orf79, MGC21830" ENSG00000182685 "BRICHOS domain containing 5" Q6PL45 16 2209253-2211950 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 29.7;testis: 42.8" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 10.7;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 11.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 29.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA063522 Approved "Nucleoplasm,Actin filaments" NA NA "Actin filaments" Nucleoplasm "HPA063522: AB_2685029" "prognostic favorable (9.74e-4)" "unprognostic (7.12e-3)" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (1.93e-3)" "unprognostic (2.02e-1)" "unprognostic (4.62e-2)" "unprognostic (4.34e-3)" "unprognostic (7.56e-2)" "prognostic favorable (7.01e-4)" "unprognostic (9.84e-3)" "unprognostic (2.65e-2)" "unprognostic (9.79e-2)" "unprognostic (2.88e-1)" "unprognostic (3.57e-1)" "prognostic favorable (8.06e-5)" 2.0 4.0 3.2 3.7 4.9 3.0 2.0 29.7 5.3 2.0 2.0 2.0 2.0 5.4 2.8 2.0 2.0 1.6 2.0 2.9 3.5 4.4 2.9 2.0 2.1 4.6 3.1 2.8 2.0 3.0 2.2 3.6 2.9 2.5 2.4 0.5 9.9 3.7 4.0 9.1 2.7 5.2 2.0 3.3 6.3 2.7 42.8 2.0 2.4 6.1 2.0 2.0 2.0 2.0 0.8 0.6 2.3 0.8 0.8 1.7 0.4 2.8 5.6 7.7 4.4 1.2 1.3 14.1 2.7 0.5 1.5 2.3 7.1 7.0 1.6 1.8 0.5 1.8 7.6 1.0 1.0 1.1 5.2 3.4 1.7 13.4 1.8 0.7 0.7 4.4 1.5 2.1 2.3 0.5 2.3 0.9 6.4 1.9 4.0 0.6 7.6 4.8 10.8 7.5 0.9 3.2 14.8 5.8 5.0 1.7 2.2 5.4 4.9 2.7 3.4 2.6 3.7 3.4 4.0 2.2 7.4 6.0 6.4 2.3 12.1 5.2 4.0 1.4 4.5 3.5 0.4 0.7 2.2 0.6 0.8 0.3 0.3 0.3 0.1 0.6 0.8 1.7 0.4 2.3 0.8 0.2 0.4 0.4 0.4 3.2 4.9 29.7 5.3 3.5 4.4 3.1 2.8 2.5 2.0 3.0 4.1 0.0 0.5 0.3 10.7 0.4 0.0 4.0 0.0 5.2 23.6 1.6 0.0 0.8 2.1 1.1 1.8 0.0 0.5 0.7 1.0 0.8 4.6 1.0 1.1 4.8 1.2 1.8 2.2 5.9 1.1 2.5 1.7 1.0 1.2 4.3 0.7 0.0 2.5 0.3 11.0 0.0 0.5 3.9 1.9 1.0 0.7 0.0 2.3 0.4 BRINP2 "DBCCR1L2, FAM5B" ENSG00000198797 "BMP/retinoic acid inducible neural specific 2" Q9C0B6 1 177171497-177282422 "Predicted secreted proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "adrenal gland: 11.5;brain: 27.9" "Cell type enriched" "Detected in some" 9 "Horizontal cells: 14.3" "Cancer enriched" "Detected in some" 5 "glioma: 11.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 10.7;PC-3: 2.6;REH: 3.0;SCLC-21H: 9.7;SH-SY5Y: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050681 Uncertain "Secreted in other tissues" NA NA "HPA050681: " "unprognostic (7.78e-2)" "unprognostic (4.49e-1)" "unprognostic (2.53e-1)" "unprognostic (1.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.43e-2)" "unprognostic (1.77e-1)" "unprognostic (5.77e-2)" "unprognostic (1.23e-2)" "unprognostic (1.95e-2)" "unprognostic (2.20e-4)" "unprognostic (8.95e-2)" "unprognostic (1.78e-2)" "unprognostic (2.60e-3)" "unprognostic (1.17e-1)" "unprognostic (2.60e-2)" "unprognostic (4.82e-3)" 0.4 11.5 12.2 0.3 8.2 0.3 1.9 0.4 27.9 0.3 0.4 0.6 0.0 0.3 0.5 0.9 0.3 0.6 0.4 0.4 7.0 6.0 0.3 0.4 0.3 0.3 4.5 3.6 0.3 0.3 0.3 2.0 1.0 0.8 0.4 0.3 0.0 0.3 0.4 0.3 0.3 0.3 0.4 1.5 0.5 0.3 1.8 0.3 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 2.6 3.0 0.0 0.0 0.0 0.0 9.7 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 8.2 0.4 15.9 7.0 6.0 4.5 3.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.3 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 BRS3 "BB3, BB3R" ENSG00000102239 "Bombesin receptor subtype 3" P32247 X 136487887-136493780 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 27.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basal ganglia: 3.6;hypothalamus: 2.8" "Cell type enhanced" "Detected in some" "naive B-cell: 1.2;naive CD8 T-cell: 1.0" "Group enriched" "Detected in many" 11 "B-cells: 1.2;T-cells: 1.0" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Group enriched" "Detected in some" 9 "basal ganglia: 1.6;hypothalamus: 7.1" "Low region specificity" "Detected in all" NA NA "unprognostic (1.49e-1)" "unprognostic (1.31e-1)" "unprognostic (2.07e-1)" "unprognostic (1.79e-2)" "unprognostic (3.73e-6)" "unprognostic (1.59e-1)" "unprognostic (1.86e-1)" "unprognostic (5.59e-2)" 0.1 0.1 0.1 0.1 3.6 0.0 0.5 0.4 0.4 0.3 0.1 0.1 0.1 0.0 0.2 27.4 0.1 2.4 0.1 0.1 0.1 2.8 0.1 0.1 0.1 0.1 0.1 0.1 2.9 0.3 0.0 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.2 0.1 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.2 0.1 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 0.4 0.4 0.1 2.8 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 BSCL2 "GNG3LG, SPG17" ENSG00000168000 "BSCL2, seipin lipid droplet biogenesis associated" Q96G97 11 62690275-62709845 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 36.1;Early spermatids: 21.4;Late spermatids: 39.0;Spermatocytes: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 36.0;Karpas-707: 61.7;RPMI-8226: 42.5;SCLC-21H: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042394 Approved NA NA "HPA042394: AB_10794047" "unprognostic (7.78e-2)" "unprognostic (8.74e-2)" "unprognostic (1.24e-1)" "unprognostic (8.17e-2)" "unprognostic (3.08e-2)" "unprognostic (2.01e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (9.30e-2)" "unprognostic (4.44e-2)" "unprognostic (5.13e-3)" "unprognostic (2.41e-1)" "prognostic favorable (7.55e-5)" "unprognostic (3.56e-1)" "unprognostic (1.69e-1)" "unprognostic (1.70e-1)" "unprognostic (1.96e-1)" 6.6 41.6 38.5 3.8 66.3 5.4 13.6 41.0 65.7 20.3 10.6 11.8 13.9 5.4 10.2 77.4 7.6 31.8 11.3 4.7 39.0 81.3 19.0 10.4 11.5 6.6 34.8 27.2 14.1 36.8 35.9 61.0 6.2 32.8 14.2 7.3 12.0 31.1 17.0 6.8 8.8 4.4 7.5 13.2 5.0 10.5 59.5 10.1 9.4 17.2 4.8 5.8 8.9 7.3 19.5 30.8 19.8 33.7 22.1 18.9 25.0 4.1 15.2 10.7 20.6 36.0 12.4 1.8 1.7 9.2 3.5 3.7 2.3 6.4 2.9 3.7 6.6 2.9 14.9 1.3 5.3 1.8 7.1 1.1 2.5 8.7 1.9 7.3 2.2 3.3 8.2 4.3 7.0 2.8 5.3 2.7 8.7 1.8 61.7 5.4 10.7 2.7 5.0 32.1 3.1 2.9 5.1 1.0 42.5 16.4 0.6 44.6 6.9 6.6 3.5 5.9 1.2 10.1 3.3 1.6 4.3 0.9 5.9 0.9 7.7 16.7 3.7 21.3 0.7 3.6 15.4 33.7 19.8 15.8 24.2 17.3 18.2 16.3 16.3 24.8 19.5 17.1 18.1 8.3 22.1 21.7 30.8 18.9 25.0 38.5 66.3 41.0 63.2 39.0 81.3 34.8 27.2 32.8 10.1 14.9 3.5 0.9 1.0 1.4 2.3 0.2 2.5 36.1 1.2 3.5 0.0 1.9 3.3 1.8 21.4 0.3 1.4 0.0 1.0 1.6 2.7 1.2 2.3 2.1 1.8 3.2 0.0 0.6 5.0 39.0 2.3 3.5 11.8 1.0 1.4 0.5 0.4 1.4 2.8 5.0 0.9 6.5 0.8 34.5 18.8 3.4 1.3 1.5 1.4 0.4 BSG "CD147, EMMPRIN, OK" ENSG00000172270 "Basigin (Ok blood group)" P35613 19 571277-583493 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cytotrophoblasts: 1238.9;Syncytiotrophoblasts: 1384.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002427, HPA036048, HPA074870" Enhanced Approved Vesicles NA NA 3400000 Vesicles "CAB002427: AB_563501, HPA036048: AB_2674917, HPA074870: AB_2686719" "unprognostic (1.88e-1)" "unprognostic (4.85e-2)" "unprognostic (9.53e-3)" "prognostic favorable (2.59e-4)" "unprognostic (3.34e-1)" "unprognostic (1.38e-2)" "prognostic unfavorable (5.48e-6)" "unprognostic (1.54e-3)" "unprognostic (1.55e-1)" "unprognostic (9.46e-2)" "unprognostic (4.48e-3)" "unprognostic (2.61e-2)" "prognostic favorable (1.95e-6)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (7.30e-2)" "unprognostic (3.22e-1)" 53.0 74.8 60.0 33.3 73.0 86.3 42.3 36.2 103.0 41.7 93.4 57.8 37.3 50.1 56.0 62.2 35.1 48.8 52.0 205.8 58.5 45.9 78.5 39.1 36.1 22.6 57.6 44.0 51.3 64.2 28.2 48.2 96.2 57.9 49.5 39.6 109.4 44.0 48.4 97.4 38.1 45.5 52.9 34.9 28.3 63.9 76.8 30.4 31.8 61.9 45.9 31.2 48.5 31.5 22.0 43.8 89.4 58.7 30.9 44.5 65.5 63.3 85.6 40.8 91.7 121.6 52.3 86.8 52.8 66.0 63.7 55.5 68.2 68.7 22.7 61.3 47.7 17.4 103.5 41.4 64.1 22.1 47.7 88.7 15.6 72.4 92.2 76.9 37.7 73.6 54.4 65.1 36.6 40.9 76.8 45.7 21.3 73.5 107.6 37.4 113.8 27.4 72.3 95.8 41.1 43.8 55.2 33.4 74.9 75.3 47.6 63.4 57.6 109.6 44.2 78.3 38.1 46.4 116.6 50.2 61.2 38.9 101.3 79.6 69.4 69.8 21.6 116.0 52.3 75.7 32.0 58.7 62.0 44.5 45.2 39.5 22.0 30.2 42.6 39.9 18.3 23.1 29.1 89.4 30.9 48.3 43.8 35.1 65.5 60.0 73.0 36.2 103.0 58.5 45.9 57.6 44.0 57.9 30.4 20.8 26.9 96.8 148.3 185.3 141.6 73.6 104.4 61.6 43.3 272.2 192.4 1238.9 124.3 507.3 196.9 200.0 714.8 607.3 327.4 909.7 249.5 169.5 116.3 84.7 379.2 131.9 245.0 132.0 136.1 473.6 278.2 146.3 480.8 346.3 224.4 452.0 369.5 480.7 316.4 241.2 167.7 200.5 269.3 259.3 553.8 137.0 1384.0 132.0 328.6 155.8 BSND "BART, DFNB73" ENSG00000162399 "Barttin CLCNK type accessory beta subunit" Q8WZ55 1 54998193-55011784 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Bartter syndrome, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 3.9;kidney: 12.3;salivary gland: 4.2" "Group enriched" "Detected in some" 37 "Collecting duct cells: 8.7;Distal tubular cells: 21.6" "Cancer enriched" "Detected in some" 7 "renal cancer: 3.5" "Group enriched" "Detected in some" 5 "basophil: 1.3;neutrophil: 3.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.9" "Cell line enriched" "Detected in single" 20 "RPMI-8226: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053836, HPA060617" Enhanced NA NA "HPA053836: AB_2682277, HPA060617: AB_2732651" "unprognostic (3.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.27e-2)" "unprognostic (6.97e-3)" "unprognostic (3.35e-1)" "unprognostic (8.97e-3)" "unprognostic (2.51e-1)" "unprognostic (1.78e-1)" "unprognostic (4.93e-2)" "unprognostic (6.92e-2)" "unprognostic (2.66e-2)" "unprognostic (1.68e-2)" "unprognostic (1.57e-1)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 3.9 0.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.3 0.2 0.5 0.2 0.4 0.1 0.1 0.1 0.4 0.2 0.2 3.9 0.1 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 8.7 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 BST1 CD157 ENSG00000109743 "Bone marrow stromal cell antigen 1" Q10588 4 15702950-15738313 "CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 59.5;bone marrow: 54.9;intestine: 61.3" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 39.0;Kupffer cells: 36.4;Macrophages: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 52.7;neutrophil: 59.5" "Group enriched" "Detected in many" 105 "dendritic cells: 16.6;granulocytes: 59.5;monocytes: 52.7" "Cell line enhanced" "Detected in many" "THP-1: 37.1;TIME: 20.4;U-937: 24.2;WM-115: 22.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050121 Uncertain "Intracellular and membrane" NA NA 170000000 "HPA050121: AB_2681025" "unprognostic (2.95e-1)" "unprognostic (3.61e-1)" "unprognostic (1.27e-1)" "unprognostic (4.00e-2)" "unprognostic (7.49e-2)" "unprognostic (2.89e-1)" "unprognostic (4.55e-2)" "unprognostic (2.70e-1)" "unprognostic (1.75e-1)" "unprognostic (1.84e-1)" "unprognostic (1.08e-1)" "unprognostic (4.06e-2)" "unprognostic (4.83e-3)" "unprognostic (1.94e-3)" "unprognostic (3.11e-1)" "unprognostic (1.57e-2)" "unprognostic (1.95e-1)" 14.3 2.0 1.1 5.6 2.0 54.9 6.6 0.8 1.5 7.2 33.8 1.5 2.1 20.4 6.4 7.0 4.6 5.6 10.3 14.5 1.8 0.8 6.6 3.7 9.4 9.6 1.3 1.9 5.5 1.0 0.4 1.3 8.0 1.3 7.5 4.0 5.4 2.8 2.2 3.4 3.5 61.3 7.9 1.5 13.6 2.4 2.4 1.2 2.8 3.5 2.9 1.8 7.5 16.1 0.4 16.6 59.5 52.7 0.1 0.3 19.6 0.2 5.5 0.5 0.4 13.5 3.2 0.7 10.5 1.0 9.6 10.8 0.1 5.7 0.3 0.9 5.3 0.2 0.1 1.5 0.2 8.2 0.3 0.2 2.5 0.3 0.2 3.4 3.3 7.3 2.7 0.7 6.1 0.5 0.4 1.5 2.3 0.3 0.2 5.6 0.1 1.0 1.9 1.2 0.4 1.1 0.3 0.7 0.2 0.3 0.3 0.7 2.1 0.2 0.3 7.0 0.5 0.2 37.1 20.4 0.3 0.5 3.7 0.4 0.2 0.0 0.3 1.3 24.2 22.1 7.6 52.7 3.9 0.2 19.8 0.3 0.4 0.1 0.1 16.6 0.2 0.2 0.1 59.5 0.1 13.6 5.5 0.2 19.6 1.1 2.0 0.8 1.5 1.8 0.8 1.3 1.9 1.3 1.2 3.0 3.0 0.0 0.8 4.0 0.2 0.8 5.1 2.7 1.2 1.8 0.0 14.0 1.7 4.1 2.7 2.1 3.2 0.0 2.3 18.7 18.6 0.5 16.1 1.8 39.0 0.0 1.2 3.7 36.4 0.7 2.8 29.9 13.5 0.0 7.0 0.3 0.8 7.0 2.1 6.7 0.0 6.5 10.8 2.3 1.2 2.6 5.9 0.0 16.6 2.7 BST2 "CD317, tetherin" ENSG00000130303 "Bone marrow stromal cell antigen 2" Q10589 19 17402939-17405648 "CD markers, Plasma proteins, Predicted membrane proteins" "Antiviral defense, B-cell activation, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 101.0" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 338.9;Ito cells: 362.2;Leydig cells: 321.0;Peritubular cells: 394.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 79.0;Karpas-707: 76.6" HPA017060 Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA017060: AB_1845467" "prognostic favorable (6.69e-4)" "unprognostic (1.75e-1)" "unprognostic (8.42e-3)" "unprognostic (8.93e-3)" "unprognostic (4.87e-2)" "unprognostic (2.25e-1)" "unprognostic (2.26e-1)" "unprognostic (1.07e-1)" "unprognostic (3.25e-1)" "unprognostic (6.46e-2)" "unprognostic (6.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.56e-9)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" 29.6 72.2 8.4 31.1 9.8 13.6 27.9 2.5 7.6 14.4 12.0 5.6 24.8 6.9 13.4 36.7 8.6 26.8 30.1 13.9 7.9 4.9 24.7 30.8 44.9 16.6 10.0 5.2 101.0 6.9 0.3 8.6 31.5 8.8 15.6 4.8 8.4 11.4 17.5 6.0 3.2 14.0 11.3 9.0 32.9 12.3 8.5 9.4 10.3 10.3 5.9 12.3 14.0 42.4 26.2 74.1 35.8 66.4 57.9 32.6 54.5 39.6 0.0 0.1 18.3 0.0 0.1 6.3 0.1 3.1 58.6 79.0 18.6 35.8 30.8 43.3 24.4 1.8 0.1 26.7 2.9 1.8 33.9 0.2 0.4 64.3 18.1 33.6 14.5 39.0 0.1 0.0 19.4 0.0 0.5 14.9 0.7 17.5 76.6 0.0 10.9 6.9 25.4 20.1 0.0 51.4 12.9 0.1 64.2 13.9 0.1 0.0 0.1 40.5 1.5 48.8 1.6 30.7 20.5 0.1 0.2 1.4 0.0 0.4 39.6 51.6 20.4 0.1 57.4 0.2 35.8 61.6 21.0 32.6 66.4 30.8 21.0 27.5 30.2 50.7 26.2 22.5 25.6 20.3 57.9 59.3 74.1 24.8 54.5 8.4 9.8 2.5 7.6 7.9 4.9 10.0 5.2 8.8 9.4 53.6 16.5 81.0 13.1 29.5 0.0 4.5 50.9 14.7 38.7 47.1 0.0 7.1 31.5 19.8 9.9 239.7 1.6 0.0 1.0 55.9 84.0 7.2 225.9 155.9 338.9 0.0 1.2 362.2 153.7 4.5 321.0 191.2 70.9 239.0 1.4 1.3 2.2 3.5 394.2 0.7 1.9 161.7 150.2 1.4 1.2 22.8 11.0 126.9 2.6 30.3 BTC ENSG00000174808 Betacellulin P35070 4 74744759-74794686 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.5" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 45.5;Club cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 16.4;MCF7: 5.8;RPTEC TERT1: 9.9;SK-BR-3: 6.6" "Not detected" "Not detected" "Secreted to blood" NA NA 314000 "unprognostic (7.36e-2)" "unprognostic (4.99e-2)" "unprognostic (7.04e-2)" "unprognostic (7.76e-3)" "unprognostic (3.87e-3)" "unprognostic (1.01e-3)" "unprognostic (1.05e-1)" "unprognostic (7.17e-3)" "unprognostic (2.68e-2)" "unprognostic (8.81e-2)" "unprognostic (1.50e-2)" "unprognostic (5.35e-1)" "prognostic favorable (6.10e-5)" "unprognostic (2.33e-1)" "unprognostic (2.45e-2)" "unprognostic (3.16e-2)" "unprognostic (2.31e-3)" 3.0 1.2 1.0 5.2 2.2 0.0 3.7 0.3 2.8 2.2 23.5 1.2 3.1 3.0 2.4 5.6 9.9 6.1 10.3 2.5 1.3 1.3 3.7 0.8 3.4 0.2 0.8 1.0 3.6 2.9 5.2 4.5 0.9 2.1 3.7 5.9 7.0 6.8 3.6 0.6 12.4 11.3 8.3 0.6 0.4 6.9 0.8 0.9 0.4 5.2 1.9 2.3 5.6 3.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.0 1.2 0.0 16.4 0.0 3.5 0.0 2.4 0.5 0.0 0.1 0.0 0.0 0.3 0.1 0.6 0.0 0.2 0.0 0.0 0.0 1.2 0.4 0.1 2.7 0.1 0.0 0.0 0.1 0.4 5.8 0.1 0.0 0.1 1.7 2.5 0.0 0.0 0.0 9.9 4.7 0.2 0.0 2.4 6.6 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.3 2.8 0.3 0.0 0.0 2.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.0 2.2 0.3 2.8 1.3 1.3 0.8 1.0 2.1 0.9 8.9 6.7 0.0 3.8 0.6 1.7 0.5 0.0 45.5 17.0 10.4 2.0 0.3 0.0 3.2 1.4 0.2 3.6 0.0 5.1 0.0 0.6 3.9 0.0 0.2 0.1 0.0 11.5 3.1 0.0 0.0 0.3 0.0 0.0 0.0 9.0 10.6 3.4 6.5 0.0 1.1 5.2 0.0 3.8 0.0 0.0 2.6 0.2 0.0 6.8 6.0 BTLA "BTLA1, CD272" ENSG00000186265 "B and T lymphocyte associated" Q7Z6A9 3 112463968-112499561 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 37.2;lymphoid tissue: 30.9" "Cell type enhanced" "Detected in some" 26 "B-cells: 26.7;Melanocytes: 6.8;T-cells: 5.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 22.6;naive B-cell: 37.2" "Lineage enriched" "Detected in many" 4 "B-cells: 37.2" "Cell line enhanced" "Detected in some" "ASC diff: 2.5;Daudi: 2.0;JURKAT: 1.3;U-698: 6.3" "Not detected" "Not detected" "HPA047211, HPA062029" Enhanced NA NA "HPA047211: AB_2679983, HPA062029: AB_2684665" "unprognostic (1.13e-3)" "unprognostic (2.13e-3)" "unprognostic (5.79e-4)" "unprognostic (1.01e-4)" "unprognostic (7.08e-2)" "unprognostic (7.74e-6)" "unprognostic (6.20e-3)" "unprognostic (7.59e-3)" "unprognostic (5.98e-2)" "unprognostic (1.53e-5)" "unprognostic (2.33e-2)" "unprognostic (1.23e-1)" "unprognostic (1.57e-5)" "unprognostic (2.57e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-1)" "unprognostic (1.42e-2)" 0.6 0.3 0.3 20.3 0.4 1.2 1.1 0.4 0.3 0.5 1.2 0.1 0.0 0.9 0.4 0.1 2.3 0.5 1.0 0.4 0.3 0.3 1.0 0.5 1.2 30.9 0.3 0.0 0.4 0.3 0.0 0.4 0.3 0.1 0.5 0.9 0.2 5.7 0.4 0.3 0.5 6.0 0.2 0.4 18.6 1.7 0.6 0.0 14.6 0.9 1.1 19.4 2.8 0.5 37.2 8.6 0.1 0.0 0.1 5.1 2.4 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.4 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.0 3.1 22.6 5.1 2.4 1.5 37.2 4.8 4.7 0.1 0.1 0.0 8.6 1.1 2.4 0.3 0.4 0.4 0.3 0.3 0.3 0.3 0.0 0.1 0.0 0.0 0.3 26.7 0.0 0.1 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.6 1.3 3.0 0.0 1.1 6.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 5.3 0.0 0.0 BTN1A1 "BT, BTN, BTN1" ENSG00000124557 "Butyrophilin subfamily 1 member A1" Q13410 6 26501221-26510422 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "breast: 27.4" "Cell type enhanced" "Detected in single" 32 "B-cells: 1.9" "Cancer enhanced" "Detected in single" "breast cancer: 0.6" "Cell type enhanced" "Detected in some" "memory B-cell: 5.6;naive B-cell: 2.6" "Lineage enriched" "Detected in many" 4 "B-cells: 5.6" "Cell line enriched" "Detected in some" 5 "CACO-2: 10.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011126, CAB037340" Supported "Secreted in female reproductive system" NA NA "CAB037340: , HPA011126: AB_1845491" "unprognostic (4.07e-2)" "unprognostic (1.40e-1)" "unprognostic (1.90e-2)" "unprognostic (1.67e-1)" "unprognostic (2.32e-1)" "unprognostic (1.77e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" "unprognostic (3.24e-3)" "unprognostic (2.85e-1)" "unprognostic (1.88e-1)" "unprognostic (5.35e-10)" "unprognostic (4.62e-2)" "unprognostic (1.38e-1)" "unprognostic (4.14e-2)" "unprognostic (5.31e-4)" 0.0 0.0 0.0 0.2 0.0 0.0 27.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 1.0 1.6 0.0 1.3 0.0 0.6 0.1 0.0 5.6 0.0 0.7 1.2 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 5.6 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 BTN2A1 "BT2.1, BTF1, BTN2.1" ENSG00000112763 "Butyrophilin subfamily 2 member A1" Q7KYR7 6 26457904-26476621 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA019208 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA019208: AB_1845492" "unprognostic (1.86e-1)" "unprognostic (3.48e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-1)" "unprognostic (2.29e-1)" "unprognostic (6.17e-2)" "unprognostic (5.74e-3)" "unprognostic (1.22e-2)" "unprognostic (1.03e-1)" "unprognostic (3.26e-2)" "unprognostic (6.90e-3)" "unprognostic (5.14e-2)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.97e-1)" "unprognostic (4.89e-2)" "unprognostic (7.92e-2)" "prognostic favorable (4.52e-5)" 15.3 16.7 10.8 16.3 13.7 18.5 17.2 42.2 16.2 14.8 15.8 13.2 17.4 12.2 18.8 15.0 11.5 14.9 12.7 15.6 11.2 14.6 13.1 8.5 17.2 16.3 14.4 10.2 15.8 8.9 7.7 16.9 23.2 16.1 16.5 14.6 12.0 11.1 19.3 12.1 9.5 13.9 21.1 15.6 23.5 12.4 13.0 15.0 11.3 10.8 7.3 14.4 21.4 13.4 4.8 4.7 28.8 4.8 4.8 8.1 3.4 7.4 6.8 13.4 8.3 6.0 4.9 0.6 16.3 13.8 20.1 18.4 6.0 5.0 6.1 22.6 11.6 26.5 3.4 10.6 4.2 19.3 8.8 10.4 3.7 7.3 7.4 9.4 5.2 9.8 6.8 4.0 22.4 7.3 11.9 7.2 12.1 5.8 9.7 17.2 3.2 9.2 8.7 4.6 2.1 5.5 7.6 13.2 6.4 7.5 3.7 14.0 7.7 5.2 6.7 11.6 8.7 2.2 4.6 9.5 15.1 8.1 13.1 18.3 7.9 18.2 5.1 6.0 10.4 23.8 16.7 4.8 15.5 6.5 2.7 5.9 4.8 5.4 7.1 4.3 3.9 5.0 6.4 28.8 4.8 4.1 4.7 8.1 3.4 10.8 13.7 42.2 16.2 11.2 14.6 14.4 10.2 16.1 15.0 14.9 14.3 13.4 6.9 7.1 9.0 16.8 10.2 32.1 10.3 8.7 5.9 5.1 3.3 9.6 2.6 19.4 10.6 0.0 11.3 9.3 14.7 9.5 23.2 5.8 10.2 3.2 8.6 19.0 18.7 4.1 11.8 17.0 10.1 16.2 13.7 6.4 12.3 11.2 12.0 4.7 2.2 38.8 21.7 8.8 11.7 7.0 9.8 21.7 12.1 11.1 BTN2A2 "BT2.2, BTF2, BTN2.2" ENSG00000124508 "Butyrophilin subfamily 2 member A2" Q8WVV5 6 26383096-26394874 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 29.0" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 34.7;U-266/70: 28.3" HPA051504 Uncertain Approved Mitochondria NA NA Mitochondria "HPA051504: AB_2681510" "prognostic favorable (1.01e-4)" "unprognostic (4.93e-3)" "unprognostic (1.37e-2)" "unprognostic (6.78e-2)" "unprognostic (9.26e-2)" "unprognostic (2.01e-2)" "unprognostic (1.78e-1)" "unprognostic (8.04e-3)" "unprognostic (1.01e-1)" "unprognostic (1.22e-2)" "unprognostic (6.67e-2)" "unprognostic (1.93e-1)" "unprognostic (1.73e-2)" "unprognostic (3.45e-1)" "unprognostic (6.54e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-3)" 7.0 12.4 3.2 22.6 5.2 2.7 7.5 29.0 5.2 8.5 5.7 5.1 4.8 5.2 10.2 10.6 7.4 6.7 7.9 9.5 4.1 3.7 7.5 6.1 15.6 21.8 4.4 3.3 10.3 5.8 12.9 5.5 2.8 9.7 8.8 8.0 11.5 9.3 7.9 2.7 8.0 9.9 8.2 5.3 18.0 7.2 5.1 4.2 13.0 7.0 6.2 26.0 8.5 7.6 20.2 14.9 7.8 9.1 5.1 6.3 4.7 4.8 3.1 6.3 6.7 2.1 3.3 0.4 5.3 14.0 8.4 14.5 1.9 1.9 4.4 5.8 9.5 6.8 4.5 5.0 4.1 11.2 13.7 8.4 6.9 5.8 3.8 4.4 1.5 2.4 7.1 1.3 16.1 5.5 10.0 7.7 8.7 5.5 34.7 3.7 2.1 5.4 2.0 2.3 0.2 3.1 12.8 9.0 13.5 6.0 2.7 6.0 8.5 3.4 1.3 14.5 3.8 6.4 3.0 9.1 3.1 3.6 2.7 8.1 28.3 17.3 7.7 3.1 6.2 7.7 1.2 8.7 1.5 4.2 9.1 3.9 16.2 3.3 3.7 14.9 20.2 2.8 3.4 7.8 5.1 3.6 6.2 6.3 4.7 3.2 5.2 29.0 5.2 4.1 3.7 4.4 3.3 9.7 4.2 8.9 9.3 13.7 6.2 3.4 0.4 2.2 2.5 4.0 9.1 3.5 0.0 2.0 0.0 8.2 0.2 14.0 1.0 23.3 4.9 0.9 2.1 6.9 18.5 2.5 8.1 0.0 1.7 5.5 8.8 0.0 6.1 18.0 6.8 12.6 7.0 17.3 6.6 0.0 4.6 1.7 0.7 0.0 3.9 0.5 1.3 4.0 0.8 7.5 1.6 3.1 BTN3A1 "BT3.1, BTF5, BTN3.1, CD277" ENSG00000026950 "Butyrophilin subfamily 3 member A1" O00481 6 26402237-26415216 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 24.4;T-cells: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA012565 Approved Uncertain Vesicles NA NA Vesicles "HPA012565: AB_1845494" "unprognostic (2.82e-2)" "unprognostic (6.43e-2)" "unprognostic (1.45e-3)" "unprognostic (4.72e-3)" "unprognostic (1.41e-2)" "unprognostic (1.42e-1)" "unprognostic (3.10e-2)" "unprognostic (9.31e-2)" "unprognostic (9.81e-2)" "unprognostic (8.60e-3)" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "prognostic unfavorable (4.15e-5)" "unprognostic (2.45e-1)" "unprognostic (5.02e-2)" "unprognostic (3.26e-2)" "prognostic favorable (4.81e-4)" 11.3 14.3 6.7 33.5 5.4 10.3 10.2 10.7 5.9 18.5 14.9 10.0 10.1 11.5 22.3 14.1 13.1 9.6 16.5 9.0 5.3 6.1 9.7 11.4 29.9 24.1 7.1 5.4 15.5 9.4 5.6 11.2 8.5 7.8 17.9 12.1 12.3 16.7 10.0 4.8 9.7 20.6 10.2 9.0 45.2 12.5 4.9 6.7 16.5 8.5 9.8 32.9 11.6 12.9 9.8 4.4 17.4 5.9 18.4 23.4 12.1 3.7 3.2 4.7 4.8 13.6 14.5 0.5 3.0 12.0 6.9 20.3 0.1 8.1 9.7 10.6 5.5 10.8 2.5 1.5 4.8 4.0 9.5 3.3 5.1 3.9 2.2 6.1 4.7 4.7 7.8 2.7 6.0 2.7 10.5 9.7 15.7 1.2 12.7 2.8 0.3 8.5 2.9 0.5 1.6 1.0 11.8 2.1 22.0 4.2 4.7 2.5 5.0 1.7 3.6 6.8 0.7 3.3 1.9 2.4 5.3 1.3 1.5 2.9 21.7 22.1 3.5 8.1 10.6 4.0 17.4 5.3 13.5 23.4 5.7 20.9 9.8 14.6 21.7 4.4 5.3 12.7 16.8 11.9 18.4 5.9 2.1 16.9 12.1 6.7 5.4 10.7 5.9 5.3 6.1 7.1 5.4 7.8 6.7 14.9 6.2 15.4 3.5 3.8 4.3 3.5 7.6 5.3 11.4 5.2 0.0 4.5 0.0 5.4 0.1 11.3 9.1 0.0 2.9 3.6 6.6 5.3 24.4 3.4 6.9 0.0 4.6 10.4 11.8 0.4 3.4 8.3 1.7 2.8 14.6 2.9 2.4 7.0 2.5 1.2 0.4 0.0 3.3 0.0 0.1 2.9 1.3 37.4 6.8 4.2 BTN3A2 BTN3.2 ENSG00000186470 "Butyrophilin subfamily 3 member A2" P78410 6 26365159-26378320 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "B-cells: 68.5;T-cells: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 34.9;U-266/70: 34.8" CAB019392 Uncertain NA NA "CAB019392: " "unprognostic (3.77e-2)" "unprognostic (1.17e-2)" "unprognostic (3.73e-2)" "unprognostic (2.86e-2)" "unprognostic (3.66e-2)" "unprognostic (1.60e-1)" "unprognostic (1.40e-1)" "unprognostic (3.89e-1)" "unprognostic (4.04e-2)" "unprognostic (1.30e-3)" "unprognostic (1.12e-1)" "unprognostic (8.45e-2)" "prognostic unfavorable (4.24e-4)" "unprognostic (5.13e-2)" "unprognostic (4.45e-2)" "unprognostic (4.42e-2)" "unprognostic (1.48e-3)" 12.3 19.7 8.5 23.7 8.3 3.6 10.2 3.7 6.4 14.7 15.3 6.7 10.9 12.3 19.7 17.0 9.8 9.9 16.5 7.8 5.3 6.4 10.8 9.9 21.3 17.0 11.4 4.1 14.0 11.7 3.0 14.8 7.8 8.0 11.2 14.0 8.6 12.1 14.2 4.9 10.1 19.2 9.9 12.8 47.0 13.7 4.5 9.0 19.4 10.3 9.5 27.3 14.3 13.4 19.4 6.2 19.6 13.7 30.5 41.5 20.7 4.1 1.8 2.6 2.7 15.2 17.7 0.9 3.9 18.6 7.4 21.0 1.0 14.0 11.4 14.3 5.5 11.3 3.7 3.6 7.1 6.7 6.7 4.9 11.8 7.7 6.9 8.3 7.1 10.9 10.9 2.9 7.0 3.1 17.6 14.2 21.0 3.1 16.0 5.3 0.5 5.9 11.7 0.1 3.1 1.4 9.1 4.6 34.9 6.8 2.1 1.7 4.8 2.8 2.8 9.7 0.8 2.9 5.8 8.7 8.3 1.7 2.9 4.2 34.8 28.9 6.2 13.4 12.7 7.3 19.6 8.0 17.6 41.5 11.2 31.1 19.4 26.8 36.5 6.2 15.3 27.2 33.3 12.6 30.5 13.7 4.4 32.9 20.7 8.5 8.3 3.7 6.4 5.3 6.4 11.4 4.1 8.0 9.0 29.8 20.3 68.5 10.4 9.2 0.5 3.6 12.7 10.7 5.7 12.2 0.0 12.1 1.7 15.8 0.2 28.9 27.3 0.0 12.0 14.8 15.0 14.9 45.2 9.6 17.2 0.0 9.7 28.3 32.3 1.7 10.3 20.3 3.3 20.8 26.2 7.1 11.3 16.9 9.9 3.3 0.9 12.9 6.0 2.1 0.1 11.7 2.7 124.9 13.3 12.7 BTN3A3 "BTF3, BTN3.3" ENSG00000111801 "Butyrophilin subfamily 3 member A3" O00478 6 26440472-26453415 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;T-cells: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 31.6;BJ hTERT+ SV40 Large T+ RasG12V: 21.5" "HPA007904, HPA011871" Enhanced NA NA "HPA007904: AB_1078307, HPA011871: AB_1845496" "unprognostic (1.18e-2)" "unprognostic (6.54e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-2)" "unprognostic (2.30e-2)" "unprognostic (8.60e-2)" "unprognostic (5.13e-3)" "unprognostic (8.08e-2)" "unprognostic (7.88e-2)" "prognostic favorable (1.80e-4)" "unprognostic (4.45e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.42e-5)" "unprognostic (3.49e-2)" "unprognostic (2.14e-2)" "unprognostic (5.26e-2)" "unprognostic (4.54e-3)" 13.3 19.1 6.6 22.5 8.1 2.6 10.6 5.5 8.6 11.8 8.5 5.9 8.8 9.8 19.1 14.9 7.0 12.1 11.8 7.7 5.2 6.8 8.7 11.8 19.5 15.3 5.8 8.4 12.0 3.9 3.1 24.0 5.5 6.6 12.0 8.5 9.8 8.9 7.9 2.9 6.6 15.7 10.2 7.3 29.4 8.9 3.5 6.0 11.7 10.6 8.4 20.1 12.8 10.1 9.0 5.3 16.3 10.0 19.2 25.3 13.0 1.8 0.9 0.8 0.8 16.6 31.6 0.2 2.6 14.1 5.9 21.5 0.0 5.9 11.7 11.9 4.2 5.4 1.3 1.2 4.5 2.9 9.8 2.0 5.4 5.2 0.6 12.1 2.8 1.0 16.7 1.8 5.1 1.9 9.4 11.6 4.4 0.2 1.8 3.2 0.0 7.6 2.3 0.0 0.0 1.4 7.7 1.6 11.2 4.6 1.6 1.0 1.9 1.6 1.5 2.8 0.2 0.4 1.6 7.1 2.9 0.6 3.1 1.8 2.0 0.5 1.1 7.6 5.5 3.0 16.3 6.6 5.5 25.2 9.9 20.4 9.0 17.5 25.3 5.3 6.2 17.1 22.9 5.1 19.2 10.0 2.8 19.6 13.0 6.6 8.1 5.5 8.6 5.2 6.8 5.8 8.4 6.6 6.0 8.9 7.7 13.6 2.1 1.5 0.0 4.4 0.0 2.7 6.8 0.0 0.0 2.2 1.7 3.4 3.2 13.2 6.4 23.3 2.1 1.2 6.7 2.2 3.5 2.4 4.4 0.0 1.2 19.0 14.0 15.2 3.7 8.3 3.3 4.6 6.4 2.0 2.6 3.5 2.1 1.0 0.0 6.5 2.1 0.3 0.1 1.8 0.5 29.9 4.4 1.6 BTNL2 "BTL-II, BTN7, HSBLMHC1" ENSG00000204290 "Butyrophilin like 2" Q9UIR0 6 32393963-32407128 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.0;Karpas-707: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.04e-2)" "unprognostic (1.54e-1)" "unprognostic (1.50e-2)" "unprognostic (8.13e-4)" "unprognostic (3.74e-2)" "unprognostic (1.33e-1)" "unprognostic (1.21e-1)" "unprognostic (3.04e-1)" "unprognostic (9.36e-2)" "unprognostic (2.41e-3)" "unprognostic (2.07e-1)" "unprognostic (3.67e-1)" "unprognostic (8.03e-2)" 0.0 1.0 0.7 0.0 1.3 0.0 0.1 0.2 0.5 0.2 0.0 1.3 0.3 0.2 0.0 0.3 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.1 0.3 1.2 0.0 0.0 0.5 0.0 1.0 0.0 0.1 0.0 3.0 0.1 0.9 0.0 0.3 0.7 0.5 0.4 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BTNL3 "BTN9.1, BTNLR" ENSG00000168903 "Butyrophilin like 3" Q6UXE8 5 180988845-181006727 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 82.5" "Cell type enhanced" "Detected in some" 25 "Enterocytes: 102.3;Mucus-secreting cells: 20.3;Paneth cells: 51.8;Undifferentiated cells: 16.9" "Group enriched" "Detected in some" 7 "colorectal cancer: 5.5;pancreatic cancer: 1.2;stomach cancer: 2.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 178 "neutrophil: 17.8" "Lineage enriched" "Detected in single" 178 "granulocytes: 17.8" "Cell line enhanced" "Detected in some" "BEWO: 1.0;CACO-2: 2.5;HMC-1: 1.0;RPMI-8226: 2.5;U-266/84: 2.4" NA NA "unprognostic (4.07e-2)" "unprognostic (3.64e-2)" "unprognostic (9.21e-2)" "unprognostic (4.00e-1)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.57e-2)" "unprognostic (2.19e-2)" "unprognostic (5.41e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" 0.1 0.0 0.1 2.1 0.1 0.0 0.1 0.1 0.1 0.1 32.5 0.1 0.1 44.2 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 9.4 0.1 0.1 0.1 0.1 0.0 82.5 0.1 0.1 0.5 0.4 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 102.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 2.4 1.8 0.3 1.1 0.0 0.0 0.0 0.0 20.3 0.0 0.0 51.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 BTNL8 "BTN9.2, FLJ21458" ENSG00000113303 "Butyrophilin like 8" Q6UX41 5 180899077-180950906 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "blood: 57.9;intestine: 111.7" "Cell type enriched" "Detected in some" 4 "Enterocytes: 87.2" "Group enriched" "Detected in some" 12 "colorectal cancer: 2.6;liver cancer: 1.5;pancreatic cancer: 2.8;stomach cancer: 3.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 13 "neutrophil: 57.9" "Lineage enriched" "Detected in single" 213 "granulocytes: 57.9" "Group enriched" "Detected in some" 28 "CACO-2: 22.3;OE19: 31.8" HPA039738 Enhanced NA NA "HPA039738: AB_2676656" "unprognostic (4.31e-1)" "unprognostic (6.85e-6)" "unprognostic (6.99e-2)" "unprognostic (1.48e-1)" "unprognostic (6.33e-2)" "unprognostic (1.91e-1)" "unprognostic (6.27e-3)" "unprognostic (6.07e-2)" "unprognostic (3.08e-3)" "unprognostic (3.28e-1)" "unprognostic (1.67e-1)" "unprognostic (9.02e-2)" "unprognostic (4.96e-3)" "unprognostic (2.93e-1)" "unprognostic (1.42e-1)" "unprognostic (4.43e-1)" "unprognostic (1.17e-2)" 1.1 0.2 0.1 2.2 0.4 2.3 0.5 0.3 0.7 0.2 37.6 0.1 0.1 43.8 0.2 0.2 0.2 0.6 9.3 0.3 0.3 0.1 0.4 0.3 1.9 2.0 0.3 0.2 0.2 0.5 0.0 0.2 0.2 0.5 0.1 9.7 0.4 0.1 0.1 0.3 0.1 111.7 0.1 0.5 2.2 2.5 3.5 0.3 0.3 0.9 0.2 0.1 0.1 0.7 0.0 0.0 57.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.2 31.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.1 0.2 0.0 0.0 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.9 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.3 0.7 0.3 0.1 0.3 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 10.2 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 87.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.5 15.4 5.3 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.4 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.2 0.0 BTNL9 "BTN8, FLJ32535" ENSG00000165810 "Butyrophilin like 9" Q6UXG8 5 181040225-181061523 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.2;breast: 76.8" "Cell type enriched" "Detected in many" 5 "Ito cells: 138.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.8" "Group enriched" "Detected in many" 6 "B-cells: 3.8;granulocytes: 1.3" "Group enriched" "Detected in some" 4 "OE19: 7.5;U-698: 28.3" "Not detected" "Not detected" HPA043429 Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane" Vesicles "HPA043429: AB_10961264" "unprognostic (2.69e-1)" "unprognostic (1.44e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (7.51e-4)" "unprognostic (2.07e-1)" "unprognostic (1.43e-1)" "prognostic favorable (1.55e-9)" "unprognostic (2.15e-2)" "unprognostic (8.51e-2)" "unprognostic (1.78e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.71e-2)" "unprognostic (3.43e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-2)" 128.2 2.5 1.5 5.3 1.7 0.3 76.8 1.0 1.8 3.2 11.3 0.8 3.5 0.7 3.9 3.7 2.9 6.0 3.7 11.0 3.4 1.3 3.4 3.0 25.4 2.7 2.5 1.2 1.0 2.0 3.0 1.6 4.3 1.5 3.4 1.5 3.8 3.0 3.5 34.4 2.0 1.9 3.2 2.1 12.7 2.0 3.0 0.9 1.1 6.1 4.0 5.5 3.1 18.3 3.8 0.4 1.3 0.3 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.6 0.1 0.2 1.1 0.0 0.0 0.2 0.5 0.0 0.0 0.2 2.9 1.1 0.2 0.1 0.0 0.5 3.3 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.7 0.3 0.0 0.1 0.1 0.1 0.1 7.5 1.8 0.0 0.2 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.1 4.4 0.1 0.0 0.2 0.1 28.3 0.1 0.0 0.0 1.0 0.3 0.5 0.2 0.1 0.1 3.8 0.2 0.2 0.1 1.9 0.2 0.2 1.3 0.3 0.1 0.4 0.0 0.1 1.5 1.7 1.0 1.8 3.4 1.3 2.5 1.2 1.5 0.9 0.0 6.7 3.0 0.6 2.1 0.4 27.4 0.0 4.0 1.2 0.0 0.0 0.0 3.3 0.0 0.3 29.2 0.0 0.0 0.2 0.1 0.2 0.3 1.1 0.4 0.1 0.0 4.1 138.7 12.7 1.1 2.0 1.0 3.3 0.0 4.0 0.2 0.1 0.0 0.4 0.0 0.3 12.9 2.1 4.3 11.1 1.9 0.1 0.5 1.1 0.6 BVES "HBVES, POP1, POPDC1" ENSG00000112276 "Blood vessel epicardial substance" Q8NE79 6 105096822-105137174 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 29.3;skeletal muscle: 37.1" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 31.1;Early spermatids: 24.1;Late spermatids: 42.6;Sertoli cells: 12.9;Spermatocytes: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Group enriched" "Detected in many" 4 "dendritic cells: 1.2;granulocytes: 2.9" "Cell line enhanced" "Detected in many" "RH-30: 18.7;WM-115: 18.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA014788, HPA018176" Enhanced Supported "Plasma membrane,Cell Junctions" Yes NA "Plasma membrane, Cell Junctions" "HPA014788: AB_1845504, HPA018176: AB_1845503" "unprognostic (2.91e-1)" "unprognostic (2.45e-1)" "unprognostic (2.79e-2)" "unprognostic (1.73e-2)" "unprognostic (5.46e-2)" "unprognostic (3.66e-2)" "unprognostic (5.21e-2)" "unprognostic (2.22e-2)" "unprognostic (8.37e-2)" "unprognostic (4.49e-2)" "unprognostic (2.29e-2)" "unprognostic (8.92e-2)" "unprognostic (5.84e-3)" "unprognostic (3.77e-2)" "unprognostic (1.78e-1)" "unprognostic (2.02e-2)" "unprognostic (3.24e-4)" 2.9 1.0 2.3 2.4 7.6 0.6 8.9 0.7 4.1 2.6 11.5 6.7 6.7 1.7 5.3 2.8 5.3 2.5 2.1 29.3 2.8 2.5 1.5 0.7 2.3 0.9 10.4 1.3 1.2 1.0 0.8 3.5 3.5 6.1 5.4 3.5 3.6 1.6 10.0 37.1 0.8 2.7 19.4 10.7 0.7 5.9 10.0 6.3 0.0 1.6 8.6 0.8 10.3 8.6 0.5 1.2 2.9 0.3 0.4 0.4 0.1 0.8 1.2 4.8 0.8 7.0 9.7 2.1 3.6 2.5 5.6 7.4 0.3 0.0 0.0 0.0 6.7 9.3 0.0 2.0 1.2 5.2 0.0 1.7 0.0 0.6 0.2 1.5 0.0 0.4 5.6 4.3 8.6 0.7 4.2 2.4 2.0 0.1 12.1 12.2 0.1 0.1 0.6 1.0 0.0 0.0 3.4 18.7 0.0 0.0 0.0 6.2 10.8 2.3 0.0 4.8 3.6 0.0 12.2 5.5 8.9 0.0 0.0 9.3 1.1 0.5 0.0 5.3 0.0 18.8 2.9 0.3 0.3 0.2 0.1 0.2 0.3 0.2 0.4 0.0 0.5 0.3 0.3 1.7 0.4 0.1 1.2 0.1 0.1 2.3 7.6 0.7 4.1 2.8 2.5 10.4 1.3 6.1 6.3 0.0 0.0 0.0 0.2 0.2 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 1.9 0.0 0.0 0.0 0.1 1.5 0.6 0.0 0.0 1.7 0.0 0.0 2.5 0.0 42.6 1.1 0.5 0.0 1.8 0.0 0.0 0.2 0.0 3.2 0.0 0.0 12.9 3.9 12.5 5.1 0.6 0.1 0.0 0.0 0.1 BX255925.3 ENSG00000284976 9 137217452-137219361 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 30.6;pancreas: 25.2" "Cell type enhanced" "Detected in some" 15 "Exocrine glandular cells: 21.2;Pancreatic endocrine cells: 23.6;Proximal tubular cells: 6.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA 0.6 3.0 0.4 1.6 0.3 5.0 1.2 0.3 0.8 3.8 7.1 0.3 0.8 5.3 0.6 3.5 30.6 1.1 12.4 2.1 0.3 1.7 1.2 1.5 2.3 0.3 0.3 0.5 25.2 0.7 0.3 1.5 0.3 3.1 0.5 0.3 14.6 1.4 1.1 6.2 8.9 0.9 0.3 1.9 7.0 15.0 0.3 0.3 0.5 15.0 15.1 1.0 0.3 1.8 4.9 3.7 2.3 2.0 2.9 5.6 5.5 9.1 5.4 7.0 2.5 2.5 21.2 6.5 3.5 6.8 4.9 8.4 6.4 8.1 4.6 2.3 5.1 20.2 3.4 4.7 1.5 8.9 9.5 4.7 21.5 7.5 4.2 6.9 15.8 3.3 4.4 7.7 2.1 1.8 3.1 7.9 11.5 6.9 2.3 15.5 6.1 20.0 9.3 12.6 31.6 15.5 7.3 9.4 2.9 5.5 7.0 8.0 5.8 7.1 5.0 2.0 18.3 10.9 3.7 10.5 12.0 16.9 8.0 5.5 9.3 7.0 6.0 8.0 7.8 0.0 1.9 3.7 1.8 2.3 2.9 1.5 1.4 1.1 1.2 1.8 0.8 0.8 3.3 2.0 1.2 4.9 1.4 5.6 6.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 3.5 0.0 0.0 5.0 5.3 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 23.6 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf105 FLJ00245 ENSG00000214688 "Chromosome 10 open reading frame 105" Q8TEF2 10 71711702-71737824 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 20.1;lymphoid tissue: 8.6" "Group enriched" "Detected in some" 13 "Early spermatids: 8.0;Late spermatids: 3.6;Melanocytes: 3.3" "Cancer enriched" "Detected in single" 9 "glioma: 0.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.3;myeloid DC: 1.6;non-classical monocyte: 4.8" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;monocytes: 4.8" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.60e-3)" "unprognostic (6.76e-3)" "unprognostic (5.45e-1)" "unprognostic (4.14e-1)" "unprognostic (1.17e-1)" "unprognostic (1.37e-6)" "unprognostic (5.25e-2)" "unprognostic (2.10e-3)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (3.87e-2)" "unprognostic (1.35e-1)" "unprognostic (7.37e-2)" "unprognostic (4.64e-1)" "unprognostic (1.53e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" 1.2 0.7 6.8 2.8 8.8 1.8 0.5 0.7 5.6 0.7 0.8 20.1 0.0 1.0 0.8 0.3 0.9 0.8 1.2 0.6 8.9 10.6 0.4 0.7 1.1 3.7 11.7 5.2 1.0 0.3 0.4 0.1 0.8 13.7 0.6 0.7 0.0 0.6 0.4 0.8 1.9 1.3 0.6 4.2 8.6 0.5 3.0 8.7 0.5 0.4 0.0 2.0 1.2 0.2 0.0 1.6 0.7 4.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.9 0.0 0.0 0.1 0.0 1.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 4.3 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.0 4.8 0.0 0.0 0.3 6.8 8.8 0.7 4.9 8.9 10.6 11.7 5.2 13.7 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.3 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 C10orf128 Em:AC084727.5 ENSG00000204161 "Chromosome 10 open reading frame 128" Q5T292 10 49154725-49188585 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 61.0" "Cell type enhanced" "Detected in many" 13 "granulocytes: 69.2;Hofbauer cells: 64.2;Macrophages: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "eosinophil: 61.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 61.0" "Cell line enhanced" "Detected in some" "HDLM-2: 61.2;HEL: 14.8;K-562: 28.5;U-87 MG: 30.8;U-937: 26.5" "Low region specificity" "Detected in many" HPA058166 Approved NA NA "HPA058166: AB_2683627" "unprognostic (1.33e-1)" "unprognostic (5.67e-4)" "unprognostic (1.34e-2)" "unprognostic (1.21e-1)" "unprognostic (4.50e-2)" "unprognostic (4.13e-2)" "unprognostic (5.86e-3)" "unprognostic (9.13e-3)" "unprognostic (2.61e-1)" "unprognostic (1.25e-1)" "unprognostic (5.11e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (2.86e-5)" "unprognostic (2.45e-2)" "unprognostic (2.22e-2)" "unprognostic (8.69e-3)" "unprognostic (1.24e-1)" 21.6 2.6 5.9 12.9 15.0 2.8 19.4 1.7 9.2 13.1 9.9 19.2 4.6 7.0 11.0 10.0 8.6 9.4 14.7 14.2 9.2 6.7 4.1 7.3 21.1 18.7 27.6 6.5 3.7 3.3 10.1 3.0 8.6 15.0 6.8 11.8 9.6 7.6 6.6 6.7 5.6 17.4 16.8 33.7 23.3 6.7 4.7 20.6 1.5 8.0 9.7 18.0 15.3 13.7 9.1 4.6 61.0 0.9 0.0 9.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 61.2 0.0 14.8 0.0 0.0 0.0 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 28.5 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 30.8 26.5 0.0 6.0 0.9 61.0 5.5 0.3 9.1 9.1 3.5 5.4 4.6 2.8 0.2 1.6 4.5 0.0 0.1 0.1 2.7 2.3 5.9 15.0 1.7 9.2 9.2 6.7 27.6 6.5 15.0 20.6 3.0 0.3 8.5 0.1 5.5 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.5 0.0 0.0 0.4 20.1 0.0 0.0 0.0 0.7 1.5 0.1 69.2 0.4 64.2 0.0 0.0 9.2 12.1 0.9 0.3 25.7 1.7 0.0 0.0 2.7 0.0 0.0 0.4 0.0 0.0 19.4 1.4 0.7 0.2 4.8 0.9 13.1 0.0 0.3 C10orf99 "AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833" ENSG00000188373 "Chromosome 10 open reading frame 99" Q6UWK7 10 84173738-84185294 "Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Cytokine" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 93.5;intestine: 66.0;lymphoid tissue: 48.4;tongue: 95.1" "Group enriched" "Detected in some" 11 "Enterocytes: 485.1;Mucus-secreting cells: 220.7;Paneth cells: 599.4;Undifferentiated cells: 289.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 32.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA050920 Enhanced "Secreted in other tissues" NA NA "HPA050920: AB_2681274" "unprognostic (3.13e-2)" "unprognostic (1.43e-1)" "unprognostic (6.04e-2)" "unprognostic (1.78e-2)" "unprognostic (7.46e-3)" "unprognostic (2.05e-1)" "unprognostic (7.98e-2)" "unprognostic (2.04e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (3.70e-1)" "unprognostic (4.67e-2)" 0.1 0.0 0.0 48.4 0.0 0.0 0.1 0.0 0.1 22.5 63.5 0.0 0.2 0.0 2.6 0.0 93.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 66.0 0.0 5.9 0.7 0.0 8.8 5.4 3.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 95.1 21.6 17.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 485.1 0.0 0.0 0.0 0.0 0.6 4.6 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 220.7 0.0 0.0 599.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 289.2 36.8 C11orf24 DM4E3 ENSG00000171067 "Chromosome 11 open reading frame 24" Q96F05 11 68261335-68272001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 65.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 99.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 63.4" "HPA012411, HPA012748" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA012411: , HPA012748: AB_1845526" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (2.31e-2)" "unprognostic (7.91e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.56e-1)" "unprognostic (2.68e-2)" "unprognostic (4.99e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.60e-9)" "unprognostic (2.18e-2)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (8.67e-3)" 12.9 9.3 6.6 12.9 10.6 2.7 14.7 6.7 13.7 14.1 32.6 23.3 8.4 35.2 21.8 12.3 8.6 12.2 19.2 19.1 9.1 6.5 10.0 44.3 12.6 14.4 10.3 8.1 14.1 17.5 5.8 8.1 12.6 14.5 12.2 11.8 14.7 22.1 12.6 6.9 8.9 65.7 21.5 13.8 11.3 13.5 7.8 10.3 3.4 9.2 11.4 18.8 14.6 10.5 23.7 16.4 9.3 11.0 5.5 9.2 6.9 12.5 13.0 7.7 15.0 18.7 19.0 9.0 30.3 19.7 15.3 15.8 27.4 7.8 5.7 9.4 37.6 13.9 14.2 11.4 13.6 9.9 6.2 6.7 6.0 13.2 18.3 15.1 5.1 20.3 15.7 10.2 23.2 9.5 9.2 6.1 3.0 10.5 9.4 12.9 15.6 1.2 7.4 12.9 20.4 15.8 2.3 13.2 29.3 6.9 6.0 5.1 9.5 9.9 7.9 63.4 6.7 7.4 4.3 6.7 24.1 14.9 30.3 13.3 11.6 11.3 5.3 19.3 4.0 23.1 9.3 7.2 7.5 9.2 11.0 6.2 17.3 5.3 5.7 12.0 23.7 5.0 5.3 1.1 5.5 8.1 16.4 4.8 6.9 6.6 10.6 6.7 13.7 9.1 6.5 10.3 8.1 14.5 10.3 8.9 2.2 11.5 8.0 12.5 3.7 8.5 12.7 10.7 4.5 8.7 2.0 12.7 1.7 14.5 2.8 6.4 37.3 0.0 27.1 24.7 18.1 10.2 43.9 99.7 14.5 0.0 4.6 9.2 12.1 5.6 13.0 12.4 27.0 21.6 33.5 6.6 21.8 12.4 15.2 8.8 2.9 12.9 17.9 12.7 20.6 9.8 8.8 4.9 12.8 7.9 C11orf87 "LOC399947, LOH11CR1A, NEURIM1" ENSG00000185742 "Chromosome 11 open reading frame 87" Q6NUJ2 11 109422120-109429114 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 32.3" "Cell type enriched" "Detected in some" 17 "Horizontal cells: 19.1" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BJ hTERT+ SV40 Large T+: 4.0;fHDF/TERT166: 15.8;SCLC-21H: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034656 Approved NA NA "HPA034656: AB_10600788" "unprognostic (5.42e-2)" "unprognostic (2.09e-1)" "unprognostic (2.28e-1)" "unprognostic (8.55e-2)" "unprognostic (3.87e-2)" "unprognostic (1.85e-1)" "unprognostic (1.63e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-1)" "unprognostic (2.44e-2)" "unprognostic (2.45e-1)" "unprognostic (5.28e-5)" "unprognostic (8.38e-2)" "unprognostic (9.65e-2)" "unprognostic (2.72e-6)" 0.7 1.0 5.8 0.7 18.1 0.7 0.8 2.7 32.3 2.3 0.8 1.5 0.0 0.8 2.2 1.2 0.8 1.1 0.7 0.7 8.3 3.8 0.8 0.7 0.7 0.7 2.5 12.0 0.7 0.7 0.7 0.3 0.8 11.1 0.9 0.7 0.0 0.8 0.8 0.7 0.8 0.7 0.8 1.2 2.2 0.8 0.8 0.1 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.6 0.0 0.1 0.2 4.0 1.9 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 18.1 2.7 27.7 8.3 3.8 2.5 12.0 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C12orf49 FLJ21415 ENSG00000111412 "Chromosome 12 open reading frame 49" Q9H741 12 116710185-116738070 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 41.4" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 95.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026905 Uncertain "Secreted - unknown location" NA NA 260000 "HPA026905: AB_10603446" "unprognostic (2.74e-3)" "unprognostic (1.41e-1)" "unprognostic (3.66e-2)" "unprognostic (9.19e-2)" "unprognostic (1.30e-1)" "unprognostic (5.76e-2)" "prognostic unfavorable (8.44e-4)" "unprognostic (2.56e-1)" "unprognostic (4.78e-2)" "unprognostic (2.62e-2)" "unprognostic (3.72e-1)" "unprognostic (1.74e-1)" "prognostic favorable (1.91e-11)" "unprognostic (3.28e-2)" "unprognostic (2.25e-1)" "unprognostic (8.46e-2)" "unprognostic (1.73e-1)" 6.2 8.6 10.9 8.6 14.1 6.3 8.6 5.4 16.9 4.7 12.2 10.1 6.1 7.6 5.3 10.4 9.0 4.4 6.8 6.3 8.8 10.0 13.0 9.1 20.4 9.0 10.8 7.2 4.7 7.6 7.3 6.7 5.2 19.6 4.7 9.9 5.9 14.7 5.6 3.6 6.9 8.2 4.8 9.2 7.8 11.9 8.7 7.0 14.0 41.4 5.5 9.7 5.8 4.3 9.4 7.3 6.4 5.4 4.7 8.2 2.6 7.4 10.1 9.4 9.3 11.0 8.8 11.8 5.2 7.0 5.9 5.1 19.9 5.7 19.3 10.3 7.2 8.8 9.7 13.0 8.0 6.7 15.3 10.4 5.5 5.4 18.9 7.7 10.4 17.0 10.6 10.1 7.7 8.7 10.0 8.8 13.0 5.8 4.5 9.4 11.2 9.4 9.7 15.0 11.4 11.8 14.2 6.3 8.4 14.9 20.3 8.7 10.8 8.5 8.6 15.5 11.1 10.4 10.9 11.4 8.8 12.2 12.3 10.2 9.3 27.5 27.0 14.3 10.9 10.3 4.1 4.3 6.4 8.1 5.4 8.2 9.4 6.4 6.5 3.8 8.2 5.7 7.5 3.0 4.7 3.7 7.3 6.4 2.6 10.9 14.1 5.4 16.9 8.8 10.0 10.8 7.2 19.6 7.0 95.3 22.2 23.2 16.8 17.5 10.8 5.4 17.8 5.3 15.9 27.9 11.8 10.3 41.4 55.0 36.4 11.9 30.9 0.0 36.3 30.5 10.3 25.5 6.9 6.4 36.5 28.6 15.5 16.5 15.9 20.7 8.9 14.4 16.9 22.6 16.9 6.7 43.3 34.5 8.9 49.7 12.2 6.5 10.4 12.7 36.3 13.4 15.0 24.9 18.7 49.8 C12orf73 "DKFZp547P055, FLJ13975" ENSG00000204954 "Chromosome 12 open reading frame 73" Q69YU5 12 103950202-103965708 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.8" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038883 Uncertain Approved "Plasma membrane,Centrosome,Mitochondria" "Secreted - unknown location" NA NA "Centrosome, Mitochondria" "Plasma membrane" "HPA038883: AB_10794735" "unprognostic (9.24e-2)" "unprognostic (3.26e-3)" "unprognostic (3.66e-3)" "unprognostic (7.20e-2)" "unprognostic (3.28e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.98e-4)" "unprognostic (8.96e-2)" "unprognostic (1.86e-2)" "unprognostic (3.79e-2)" "unprognostic (3.03e-3)" "unprognostic (2.07e-1)" "unprognostic (1.33e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (6.27e-2)" "prognostic favorable (1.61e-4)" 6.7 11.4 14.3 8.3 14.5 4.4 9.7 15.5 17.5 7.2 7.4 11.4 7.2 7.7 9.5 13.2 7.0 8.9 5.5 11.1 13.0 14.6 9.4 8.3 5.8 10.0 13.3 13.3 11.5 9.7 9.4 21.0 7.3 13.6 10.7 9.5 8.3 8.3 11.1 43.8 9.0 7.7 7.9 14.1 7.0 9.9 10.1 13.8 11.4 11.5 12.9 10.2 6.6 6.9 11.7 11.3 8.6 5.1 12.0 14.5 3.9 5.9 11.1 16.9 10.3 4.9 6.4 11.0 6.4 3.9 7.2 5.9 11.8 5.2 7.0 8.6 3.9 6.3 9.6 10.0 8.2 5.5 10.1 20.3 10.6 16.3 14.8 7.2 15.6 9.7 5.7 9.4 3.6 6.4 17.6 6.6 20.6 13.6 4.8 6.6 6.8 17.3 23.6 8.2 5.7 19.0 10.0 6.3 6.9 9.4 8.0 27.7 9.5 6.5 11.3 14.9 7.6 19.3 8.5 3.3 8.8 4.9 6.5 6.5 13.1 20.1 14.7 10.0 8.9 7.7 7.3 5.1 8.6 10.5 4.2 10.4 11.7 9.8 10.0 7.2 10.7 14.5 13.5 1.4 12.0 3.8 11.3 13.8 3.9 14.3 14.5 15.5 17.5 13.0 14.6 13.3 13.3 13.6 13.8 6.0 5.0 6.7 8.5 5.4 16.5 14.9 7.6 13.4 5.7 8.7 0.0 9.7 23.2 20.3 59.5 6.7 9.2 0.0 10.6 10.4 7.6 8.0 9.2 11.6 14.8 7.9 10.9 6.2 8.3 25.4 8.1 7.1 1.7 11.8 10.9 12.3 16.5 3.5 8.1 17.7 13.1 6.5 7.2 23.1 21.2 4.5 7.4 4.9 11.5 7.0 C12orf76 FLJ40142 ENSG00000174456 "Chromosome 12 open reading frame 76" Q8N812 12 110027028-110073686 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 47.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039713, HPA042013" Uncertain Approved "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA039713: AB_2676640, HPA042013: AB_2677797" "unprognostic (9.20e-2)" "unprognostic (3.31e-2)" "unprognostic (2.35e-3)" "unprognostic (9.54e-2)" "unprognostic (3.50e-2)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "prognostic favorable (6.44e-5)" "unprognostic (1.39e-1)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (5.74e-5)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" 5.7 8.8 34.6 8.4 26.1 11.6 9.4 19.7 47.6 6.6 6.1 32.6 2.5 7.6 8.1 14.0 5.9 12.0 6.7 5.3 36.1 33.5 8.5 7.9 9.7 11.4 36.2 21.2 11.9 8.4 5.1 7.5 9.4 26.1 7.5 6.4 5.9 7.7 7.9 8.3 14.6 7.4 5.3 38.7 11.1 9.2 9.8 27.4 4.8 11.1 1.8 7.9 6.3 5.0 14.0 12.8 31.3 9.4 14.3 16.3 11.1 6.3 9.4 11.4 10.3 8.2 16.9 12.6 5.6 3.2 5.4 4.1 7.7 6.2 7.8 6.7 2.5 4.2 12.6 4.7 4.6 4.1 11.6 10.0 7.8 14.3 15.5 7.8 12.7 15.3 13.5 15.4 4.7 8.7 19.7 8.5 12.7 11.6 20.5 5.6 6.8 6.4 20.9 8.9 4.0 8.6 12.2 7.0 12.6 9.8 6.2 22.9 12.4 7.0 5.2 12.5 12.0 11.4 6.6 10.8 8.3 6.0 6.3 3.3 9.4 10.8 6.4 9.1 7.3 4.7 31.3 9.4 11.2 8.3 6.2 9.2 14.0 13.1 9.3 8.8 11.8 16.3 10.6 12.8 14.3 6.1 12.8 12.6 11.1 34.6 26.1 19.7 35.1 36.1 33.5 36.2 21.2 26.1 27.4 29.8 14.2 10.7 13.8 7.0 23.3 6.3 20.4 36.1 10.3 15.7 2.0 24.1 29.9 10.0 16.2 13.1 6.3 0.0 13.2 8.0 13.6 10.2 4.7 17.3 22.8 30.2 5.8 16.5 19.2 9.0 24.2 16.1 18.6 15.4 11.0 32.3 9.6 7.0 31.8 32.3 20.5 6.5 14.4 26.2 10.1 7.4 10.1 20.8 10.7 5.8 C14orf132 C14orf88 ENSG00000227051 "Chromosome 14 open reading frame 132" Q9NPU4 14 96039324-96093889 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 49.2" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 35.7;Bipolar cells: 42.6;Horizontal cells: 60.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 22.1;SCLC-21H: 24.4;SH-SY5Y: 24.2;U-87 MG: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.82e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-2)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.47e-2)" "unprognostic (2.50e-2)" "unprognostic (1.27e-1)" "unprognostic (1.82e-1)" "unprognostic (4.42e-2)" "prognostic favorable (3.54e-4)" "unprognostic (2.51e-2)" "unprognostic (5.55e-3)" "unprognostic (1.47e-2)" "unprognostic (3.09e-2)" "unprognostic (1.33e-5)" "prognostic unfavorable (4.95e-4)" 4.1 14.3 22.4 3.6 16.6 0.9 5.8 43.5 49.2 20.4 6.2 15.1 10.9 2.8 17.8 14.7 6.8 21.8 5.5 4.2 24.4 16.7 3.9 2.0 12.5 1.5 15.0 16.6 3.9 3.5 1.0 17.5 1.5 13.8 6.3 5.1 4.6 1.9 20.7 1.8 13.5 4.7 21.5 19.8 3.7 5.7 2.0 8.0 0.0 1.8 3.1 1.9 4.5 3.9 1.1 0.6 0.4 0.1 0.1 3.5 0.8 0.0 2.9 14.2 4.4 10.4 10.5 0.0 4.8 10.8 6.3 3.9 0.0 0.0 0.0 1.1 10.7 4.2 0.3 1.7 0.4 5.5 0.0 0.6 0.0 0.5 0.0 1.2 0.0 0.1 5.6 0.5 5.9 0.4 0.0 0.1 1.4 0.0 0.0 2.9 22.1 0.3 0.0 6.9 0.0 0.0 12.6 2.3 0.0 5.1 10.1 24.4 24.2 3.7 0.4 0.6 4.0 13.2 0.6 0.0 5.1 3.0 8.3 0.0 0.0 0.0 0.0 21.5 0.0 2.8 0.2 0.1 0.0 0.0 0.0 0.0 0.1 1.7 0.4 0.0 1.1 3.5 0.7 0.4 0.1 0.0 0.6 0.3 0.8 22.4 16.6 43.5 25.7 24.4 16.7 15.0 16.6 13.8 8.0 35.7 8.8 0.0 2.5 2.4 42.6 1.1 2.5 21.4 5.7 7.0 19.6 0.1 5.0 4.8 3.0 6.5 0.0 0.0 0.2 0.6 12.0 1.8 1.1 3.9 0.2 60.4 8.6 20.3 1.2 2.7 14.7 0.5 8.5 0.0 0.0 3.4 1.6 0.0 12.7 0.0 5.6 0.0 6.1 0.3 0.6 6.8 0.2 0.0 0.0 1.6 C14orf180 "C14orf77, NRAC" ENSG00000184601 "Chromosome 14 open reading frame 180" Q8N912 14 104579684-104590515 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.2;heart muscle: 55.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 2.6;Cardiomyocytes: 6.1;Horizontal cells: 3.2;Ito cells: 3.1" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Region enriched" "Detected in single" 11 "pons and medulla: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "ASC diff: 8.4" NA NA "unprognostic (2.48e-2)" "unprognostic (1.55e-1)" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (3.19e-3)" "unprognostic (1.89e-1)" "unprognostic (3.12e-2)" "unprognostic (3.89e-2)" "unprognostic (2.32e-1)" "unprognostic (9.80e-2)" 23.2 1.2 0.0 1.7 0.2 0.1 9.8 0.0 0.1 0.5 3.8 0.7 6.7 0.3 0.3 4.7 0.2 0.4 0.7 55.1 0.0 0.3 0.7 1.9 0.2 0.3 0.0 0.0 0.3 0.7 0.1 0.6 0.7 3.9 0.4 0.2 2.0 1.7 1.2 2.5 0.1 0.5 0.5 0.0 0.2 0.5 0.4 0.0 0.0 0.2 1.3 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 2.6 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 C14orf37 UT2 ENSG00000139971 "Chromosome 14 open reading frame 37" Q86TY3 14 57999735-58298139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 32.1;Club cells: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 11.2;AN3-CA: 7.0;fHDF/TERT166: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001580, HPA001789" Enhanced Approved "Plasma membrane" NA NA 270000 "Plasma membrane" "HPA001580: AB_2666366, HPA001789: AB_1078328" "unprognostic (2.56e-2)" "unprognostic (2.04e-2)" "unprognostic (1.20e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.97e-3)" "unprognostic (1.94e-1)" "unprognostic (7.84e-3)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (2.42e-1)" "unprognostic (1.01e-1)" "unprognostic (3.87e-8)" "unprognostic (5.22e-6)" "unprognostic (4.93e-2)" "unprognostic (8.74e-4)" "unprognostic (3.01e-4)" 2.8 5.3 11.4 1.5 11.7 1.8 2.4 10.1 14.0 4.1 2.3 3.9 1.1 1.6 6.7 4.0 1.9 4.7 3.9 6.3 8.6 4.6 16.5 2.2 1.8 1.1 5.1 7.8 9.3 2.4 9.2 5.8 1.4 21.5 4.0 2.7 3.9 2.0 3.3 1.2 2.5 1.8 5.0 3.3 1.3 3.0 5.1 5.0 0.0 3.4 0.3 0.9 2.6 3.0 0.3 0.6 0.5 0.3 0.1 0.0 0.0 0.0 0.0 11.2 7.0 5.5 2.3 0.0 2.2 1.7 0.4 0.3 0.5 0.1 0.0 0.7 12.2 1.4 0.1 3.5 0.0 0.5 0.1 1.1 0.0 0.0 0.5 0.2 0.0 5.6 2.4 0.2 0.2 0.2 3.1 0.5 0.9 0.1 0.3 1.4 0.3 0.0 0.0 5.2 0.0 2.3 1.6 0.3 2.7 4.5 0.5 1.3 0.1 0.1 0.0 0.3 3.3 0.3 0.2 0.1 1.7 4.2 0.6 2.9 0.4 0.3 0.0 3.5 0.3 1.2 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 11.4 11.7 10.1 14.0 8.6 4.6 5.1 7.8 21.5 5.0 3.0 6.5 0.0 7.4 1.3 3.5 0.0 0.0 32.1 20.5 0.0 0.0 0.2 0.0 0.0 1.7 3.0 0.0 0.0 0.0 0.3 4.5 1.3 4.7 2.0 0.1 0.0 0.0 3.1 2.6 0.0 9.2 1.1 3.3 0.0 2.3 9.4 0.0 0.0 9.9 0.0 2.7 0.0 1.4 2.3 2.3 1.8 0.2 1.3 0.3 5.4 C15orf48 "MIR147BHG, NMES1" ENSG00000166920 "Chromosome 15 open reading frame 48" Q9C002 15 45430529-45448761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 95.5;lymphoid tissue: 56.1;testis: 47.2" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 2464.8;Exocrine glandular cells: 1795.4;Pancreatic endocrine cells: 2949.0;Paneth cells: 2168.3;Undifferentiated cells: 1451.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "classical monocyte: 3.2;intermediate monocyte: 3.7;myeloid DC: 3.0;neutrophil: 2.1" "Group enriched" "Detected in many" 10 "dendritic cells: 3.0;granulocytes: 2.1;monocytes: 3.7" "Cell line enhanced" "Detected in some" "A-431: 21.6;CAPAN-2: 40.7;GAMG: 41.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA012943 Enhanced NA NA "HPA012943: AB_2668774" "unprognostic (5.29e-3)" "unprognostic (1.76e-1)" "unprognostic (2.08e-1)" "unprognostic (7.83e-2)" "unprognostic (1.17e-1)" "unprognostic (9.74e-3)" "unprognostic (1.48e-3)" "unprognostic (1.28e-3)" "unprognostic (1.59e-1)" "unprognostic (1.15e-1)" "unprognostic (4.93e-3)" "unprognostic (5.95e-2)" "unprognostic (8.86e-2)" "unprognostic (2.37e-1)" "unprognostic (6.51e-2)" "unprognostic (1.39e-1)" "unprognostic (3.66e-1)" 0.6 0.1 0.4 56.1 0.4 7.2 2.9 0.4 0.4 9.0 87.2 0.5 26.0 6.0 0.9 0.9 33.5 0.6 6.0 2.8 0.4 0.1 1.4 1.6 11.2 0.4 0.4 0.4 0.6 3.3 0.0 0.4 10.6 0.5 2.5 95.5 0.8 6.1 21.5 0.5 14.9 54.6 3.1 0.8 0.6 10.8 47.2 0.4 1.6 0.9 33.1 19.6 1.4 10.9 0.0 3.0 2.1 3.7 0.0 0.2 1.6 21.6 5.3 0.0 0.1 0.3 0.0 0.9 1.1 7.8 1.4 4.0 0.8 40.7 0.0 1.0 0.1 41.1 0.5 0.6 0.3 3.4 2.4 0.5 0.0 0.1 0.1 3.7 0.0 9.4 0.4 0.3 7.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 1.0 0.0 0.5 0.0 9.7 0.1 0.0 0.1 0.1 0.8 1.7 0.0 0.2 1.3 2.5 0.1 4.6 0.4 0.5 0.2 0.1 0.5 0.3 0.2 0.7 0.3 0.1 0.7 0.2 0.1 0.0 3.2 0.3 0.2 3.7 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 2.1 0.0 0.4 0.5 0.0 1.6 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.5 0.4 14.9 19.6 4.5 8.9 59.0 0.6 0.8 79.0 9.4 5.7 5.2 0.0 201.6 3.3 743.8 142.7 6.0 2464.8 0.0 1795.4 122.1 24.0 129.7 33.4 0.2 417.3 108.1 620.4 1.8 8.8 208.7 6.6 354.6 55.6 852.2 1284.5 0.4 2949.0 2168.3 7.1 14.2 1.1 0.0 22.1 577.6 53.2 53.4 138.4 4.3 1451.5 477.3 C16orf54 FLJ35681 ENSG00000185905 "Chromosome 16 open reading frame 54" Q6UWD8 16 29742463-29746006 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 95.2;lymphoid tissue: 41.8" "Cell type enhanced" "Detected in some" 12 "B-cells: 44.1;granulocytes: 32.4;Kupffer cells: 20.5;T-cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 13.6;HL-60: 13.7;HMC-1: 8.9;MOLT-4: 11.2;NB-4: 9.3;THP-1: 16.2;U-937: 7.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA060546 Uncertain NA NA "HPA060546: AB_2684317" "unprognostic (2.09e-3)" "unprognostic (1.58e-3)" "unprognostic (1.30e-2)" "unprognostic (1.92e-4)" "unprognostic (2.08e-1)" "unprognostic (1.54e-2)" "unprognostic (1.36e-3)" "unprognostic (2.90e-2)" "unprognostic (2.44e-3)" "unprognostic (1.06e-2)" "unprognostic (1.34e-1)" "unprognostic (2.32e-1)" "unprognostic (9.73e-3)" "unprognostic (2.78e-1)" "unprognostic (3.18e-2)" "unprognostic (1.91e-1)" "unprognostic (2.36e-1)" 2.7 0.9 0.8 19.9 0.8 23.2 1.2 0.6 0.7 2.8 3.8 1.3 0.2 1.7 1.3 1.4 2.4 2.1 4.7 2.2 0.8 1.0 1.9 1.3 7.1 41.8 1.1 0.5 0.8 1.0 0.0 0.8 1.6 0.8 1.8 2.2 1.4 6.8 0.2 1.0 0.9 9.3 0.8 1.2 25.4 3.3 0.7 0.8 35.6 1.3 2.3 27.8 3.1 1.8 26.5 14.7 95.2 20.0 36.1 40.7 26.2 3.9 0.0 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 2.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.6 0.2 0.0 0.0 13.7 8.9 0.3 0.0 0.0 0.0 0.0 0.0 4.9 0.1 3.9 0.0 0.1 11.2 9.3 0.8 0.0 0.0 6.4 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 16.2 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.6 0.2 7.5 0.1 42.6 18.4 61.9 40.7 16.8 38.5 26.5 40.5 35.6 13.0 21.8 33.7 34.7 95.2 36.1 20.0 14.7 21.2 26.2 0.8 0.8 0.6 0.7 0.8 1.0 1.1 0.5 0.8 0.8 3.0 6.6 44.1 0.1 0.5 0.0 0.3 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 32.4 0.4 6.3 0.0 10.4 2.5 20.5 0.0 0.0 14.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.6 1.1 47.3 0.0 0.0 C16orf58 FLJ13868 ENSG00000140688 "Chromosome 16 open reading frame 58" Q96GQ5 16 31489471-31509309 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024406 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA "Nucleoli, Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA024406: AB_1845580" "unprognostic (1.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.25e-2)" "unprognostic (4.22e-1)" "unprognostic (6.21e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (9.89e-2)" "unprognostic (3.20e-1)" "unprognostic (1.58e-1)" "unprognostic (6.34e-3)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "unprognostic (5.69e-2)" "unprognostic (2.24e-2)" 13.5 17.7 15.9 15.3 22.3 11.0 15.7 17.9 30.8 22.6 17.5 16.6 34.2 18.6 24.2 21.4 16.8 21.0 20.0 16.7 12.9 15.3 19.1 51.0 13.9 15.7 13.8 16.4 29.5 49.1 30.7 27.6 23.1 13.1 22.0 11.6 22.9 36.9 26.7 4.8 14.1 22.2 15.6 9.1 12.9 19.7 11.9 14.3 15.1 26.4 14.2 19.3 15.9 17.4 8.9 12.0 8.8 9.8 10.8 11.3 8.4 11.6 15.4 9.7 16.8 22.5 15.0 18.0 14.0 23.9 10.9 13.0 4.6 20.5 10.0 29.7 20.6 14.1 16.3 9.6 12.9 5.1 14.5 9.6 10.1 8.8 11.6 32.7 11.9 12.2 18.2 14.1 14.3 29.5 21.5 10.5 16.1 14.9 17.3 10.6 22.0 5.5 8.0 7.5 17.1 10.1 12.7 14.5 30.2 12.4 7.3 10.6 16.3 10.5 27.7 21.8 9.6 23.9 17.6 9.1 19.1 10.7 12.2 9.1 25.2 14.7 7.5 24.4 18.4 26.2 3.8 6.9 8.8 10.3 9.8 9.6 8.9 10.7 10.2 12.0 8.5 10.8 9.3 1.2 10.8 9.6 11.0 11.3 8.4 15.9 22.3 17.9 30.8 12.9 15.3 13.8 16.4 13.1 14.3 6.0 14.2 9.0 7.9 5.5 22.6 0.8 10.2 6.7 9.1 15.7 2.0 18.1 5.0 17.5 1.5 6.3 17.7 0.0 18.6 17.9 13.1 13.9 18.4 21.9 12.9 12.7 14.3 7.4 8.4 2.5 20.1 6.4 16.9 6.4 20.7 12.4 12.0 10.5 15.2 6.8 22.3 25.8 9.2 13.4 11.7 4.1 18.7 8.3 17.8 7.9 C16orf92 FLJ25404 ENSG00000167194 "Chromosome 16 open reading frame 92" Q96LL3 16 30023334-30027736 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 17.0" "Group enriched" "Detected in some" 27 "Early spermatids: 79.3;Late spermatids: 25.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.3;MCF7: 2.4;NTERA-2: 2.4;RPMI-8226: 3.9;SCLC-21H: 13.1;SH-SY5Y: 3.0" NA NA "unprognostic (2.48e-1)" "unprognostic (4.97e-2)" 0.1 1.8 0.4 0.1 0.2 0.4 0.1 1.2 3.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 17.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 2.3 0.0 2.4 0.5 0.1 2.4 0.0 0.0 0.6 0.1 3.9 0.0 0.0 13.1 3.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.6 0.8 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 1.2 0.4 0.4 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 79.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 25.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 C17orf62 "FLJ90469, MGC4368" ENSG00000178927 "Chromosome 17 open reading frame 62" Q9BQA9 17 82442589-82450829 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045696 Uncertain Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA045696: AB_2679421" "unprognostic (1.87e-2)" "unprognostic (6.92e-3)" "unprognostic (2.25e-1)" "unprognostic (2.15e-3)" "unprognostic (5.75e-2)" "unprognostic (2.05e-3)" "unprognostic (3.81e-3)" "unprognostic (4.86e-2)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-3)" "unprognostic (7.99e-2)" "prognostic unfavorable (6.83e-11)" "unprognostic (1.47e-1)" "unprognostic (5.51e-2)" "unprognostic (7.78e-2)" "unprognostic (9.14e-3)" 19.9 17.3 16.8 35.8 25.2 16.4 20.0 8.6 20.4 16.2 16.2 20.8 10.5 12.1 16.5 13.1 17.1 16.0 22.9 12.1 15.2 12.1 17.5 29.1 20.2 48.3 26.8 12.4 17.6 21.3 12.9 15.7 14.9 20.6 19.5 13.6 12.2 14.7 12.7 6.5 13.9 21.1 20.2 19.0 53.7 16.4 8.3 20.9 26.0 13.8 8.2 42.3 29.2 13.3 30.6 33.0 74.9 44.2 24.2 25.9 34.6 14.2 20.9 11.5 19.0 18.2 19.2 11.2 12.9 15.7 19.0 22.7 7.8 14.5 36.4 11.9 18.3 23.9 14.5 7.9 9.7 13.1 25.9 6.4 9.9 6.9 9.0 18.9 11.1 29.2 22.1 14.1 16.3 9.2 18.4 24.6 28.2 8.3 27.3 16.0 15.9 46.1 9.3 8.7 19.8 11.2 35.2 6.9 27.9 14.0 18.2 9.9 18.7 23.3 27.2 16.6 21.7 28.0 44.7 8.4 14.8 14.5 24.3 13.7 49.9 16.6 26.7 19.4 18.1 13.1 43.8 34.1 44.0 25.9 44.2 20.0 30.2 23.9 25.0 31.4 30.6 20.2 19.6 74.9 24.2 39.6 33.0 24.8 34.6 16.8 25.2 8.6 20.4 15.2 12.1 26.8 12.4 20.6 20.9 29.8 24.8 93.2 8.2 9.8 16.7 0.0 17.8 9.4 13.6 0.0 9.8 23.8 0.0 0.0 1.1 17.6 29.5 23.3 0.0 27.8 22.4 13.1 32.4 21.3 69.8 25.4 24.9 19.0 53.5 1.5 24.7 43.5 18.6 0.0 20.3 22.1 0.0 28.1 17.0 0.0 12.0 0.0 11.4 10.4 7.3 7.8 23.1 58.6 15.2 7.1 C17orf78 FLJ39647 ENSG00000278505 "Chromosome 17 open reading frame 78" Q8N4C9 17 37375986-37392708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 401 "intestine: 83.8" "Cell type enhanced" "Detected in some" 14 "Late spermatids: 1.5;Spermatocytes: 1.4" "Group enriched" "Detected in some" 8 "colorectal cancer: 0.8;stomach cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;NB-4: 1.6;RPMI-8226: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.73e-3)" "unprognostic (1.91e-1)" "unprognostic (8.98e-2)" "unprognostic (4.90e-3)" "unprognostic (5.31e-2)" "unprognostic (7.83e-2)" "unprognostic (2.59e-2)" "unprognostic (2.02e-1)" "unprognostic (7.62e-2)" "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (1.43e-1)" "unprognostic (5.53e-6)" "unprognostic (1.94e-2)" "unprognostic (7.23e-3)" "unprognostic (4.85e-2)" "unprognostic (3.19e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.2 0.0 1.6 0.2 0.0 0.3 0.2 0.1 1.5 0.1 0.0 0.9 0.7 0.2 0.0 0.2 0.0 0.3 0.0 0.3 0.1 0.1 0.8 0.2 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 0.0 C17orf80 "FLJ20721, HLC-8, MIG3, SPEP1" ENSG00000141219 "Chromosome 17 open reading frame 80" Q9BSJ5 17 73232233-73248947 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 128.4;Late spermatids: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012896 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA012896: AB_1850766" "unprognostic (9.22e-2)" "unprognostic (1.62e-1)" "prognostic favorable (1.43e-4)" "unprognostic (5.55e-3)" "unprognostic (8.58e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (9.02e-6)" "unprognostic (1.08e-1)" "unprognostic (1.00e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (6.09e-2)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.52e-1)" "unprognostic (2.36e-3)" "unprognostic (1.37e-1)" 8.0 10.5 12.8 8.5 13.2 2.4 10.6 27.8 15.4 11.3 11.7 8.4 5.3 9.1 13.1 9.0 10.8 11.2 7.8 13.5 13.8 10.0 11.5 8.6 10.2 11.0 11.8 12.7 16.0 10.1 17.2 24.9 10.9 11.8 11.6 9.0 9.4 9.0 11.2 22.2 7.5 10.4 12.4 14.4 9.9 9.7 32.5 11.3 16.1 14.6 8.3 10.3 10.3 13.3 6.5 7.1 14.6 5.0 5.2 8.7 3.9 9.9 10.5 14.6 8.9 10.7 9.2 14.2 13.1 11.4 18.6 17.7 9.9 8.2 18.9 9.3 6.7 12.7 10.0 20.2 7.5 21.8 6.8 13.7 17.4 11.0 11.6 9.4 18.3 10.3 7.2 9.4 12.3 10.2 9.3 15.9 12.8 18.7 11.3 12.3 5.7 21.1 8.7 11.5 11.0 11.3 12.8 40.2 9.6 9.7 7.5 17.9 16.1 6.9 12.8 15.2 24.1 14.0 11.5 8.7 19.5 18.0 6.3 12.4 12.9 15.3 18.3 7.8 8.3 12.3 14.6 4.0 5.7 8.5 5.0 8.7 6.5 6.3 7.5 4.6 5.8 6.0 8.6 1.9 5.2 4.7 7.1 8.6 3.9 12.8 13.2 27.8 15.4 13.8 10.0 11.8 12.7 11.8 11.3 6.0 10.8 3.4 1.6 4.4 8.2 17.9 7.6 25.4 11.4 5.2 19.6 7.3 8.3 4.8 128.4 7.1 5.1 0.0 3.4 4.8 4.1 1.7 7.0 3.9 4.1 7.9 5.2 4.3 5.3 75.5 4.9 5.4 1.7 5.4 3.0 9.8 4.2 4.0 7.1 5.3 14.7 0.0 4.7 23.5 12.3 3.9 14.1 4.1 4.4 1.3 C19orf12 "DKFZP762D096, MGC10922, MPAN, NBIA4, SPG43" ENSG00000131943 "Chromosome 19 open reading frame 12" Q9NSK7 19 29698886-29715789 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 57.4" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046930 Approved Supported Cytosol NA NA Cytosol "HPA046930: AB_10962836" "unprognostic (1.76e-1)" "unprognostic (2.22e-1)" "unprognostic (2.13e-1)" "unprognostic (1.01e-2)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (1.54e-1)" "unprognostic (9.94e-3)" "unprognostic (7.93e-3)" "unprognostic (5.27e-2)" "unprognostic (1.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.23e-1)" "unprognostic (3.22e-1)" "unprognostic (1.22e-3)" 57.4 14.7 11.9 7.6 11.3 2.3 33.9 10.5 14.3 7.2 7.7 5.8 5.4 10.8 7.1 7.6 7.5 6.2 8.7 14.0 9.5 11.6 11.5 36.9 5.6 11.4 10.3 10.7 7.8 9.6 7.7 6.9 7.4 11.1 6.7 5.5 10.5 9.5 7.6 27.5 8.2 9.6 7.6 6.5 7.5 6.0 4.2 5.2 8.9 5.4 9.2 7.4 7.2 11.0 3.7 4.3 2.3 2.1 5.6 14.3 6.0 10.5 20.9 10.3 12.8 25.6 15.9 15.9 12.5 12.5 12.6 16.4 10.0 4.3 8.6 13.4 15.8 11.4 4.6 8.6 5.3 8.5 22.6 15.1 9.6 6.9 17.2 14.4 7.4 12.8 18.1 11.2 7.5 6.1 10.1 11.3 5.4 7.3 11.2 13.0 7.3 5.2 5.4 6.1 9.2 5.2 10.3 10.6 6.6 9.6 10.6 6.3 13.3 7.5 9.8 19.6 11.0 4.1 8.3 11.3 26.7 20.8 10.8 11.3 15.8 14.0 6.4 15.9 4.5 11.1 0.9 2.0 1.0 14.3 2.1 8.2 3.7 8.1 10.2 1.8 3.2 8.5 10.5 2.3 5.6 2.1 4.3 9.7 6.0 11.9 11.3 10.5 14.3 9.5 11.6 10.3 10.7 11.1 5.2 11.9 13.6 13.0 9.8 11.3 15.3 26.8 2.5 8.1 7.9 8.7 5.9 25.1 13.3 15.4 1.3 9.0 12.0 0.0 20.0 23.3 16.7 9.2 16.1 57.8 13.4 4.8 3.5 12.9 11.3 1.5 26.7 10.8 10.1 27.1 6.4 10.3 17.3 10.5 27.6 30.5 8.4 6.5 10.3 3.6 4.1 6.8 18.3 17.0 8.1 7.5 C19orf18 MGC41906 ENSG00000177025 "Chromosome 19 open reading frame 18" Q8NEA5 19 57958437-57974534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 22.6" "Cell type enriched" "Detected in many" 5 "Early spermatids: 83.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 4.6;HEK 293: 6.6;RT4: 4.4" "HPA014527, HPA079195" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA014527: AB_1845612, HPA079195: " "unprognostic (5.38e-2)" "unprognostic (6.36e-3)" "unprognostic (3.70e-2)" "prognostic favorable (5.07e-4)" "unprognostic (4.85e-2)" "unprognostic (9.50e-2)" "unprognostic (2.75e-1)" "unprognostic (5.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.64e-1)" "unprognostic (4.08e-5)" "unprognostic (1.11e-2)" "unprognostic (8.75e-5)" "unprognostic (1.53e-1)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (1.05e-3)" 1.1 1.7 1.4 1.1 1.8 0.4 3.6 1.1 1.1 1.1 1.3 1.1 1.1 0.8 1.4 5.6 1.1 1.8 1.4 4.2 1.9 1.8 1.1 1.1 1.1 1.1 2.1 1.1 1.3 1.1 1.0 3.6 1.1 3.1 2.7 0.8 1.1 1.2 1.6 4.2 1.2 1.1 1.1 2.3 1.1 0.8 22.6 1.1 1.1 1.3 1.1 1.1 1.1 1.1 2.8 1.6 0.7 0.9 0.8 1.2 0.4 0.2 0.0 1.9 4.6 1.1 1.5 1.4 2.2 0.5 0.6 1.4 0.0 0.4 0.5 1.0 0.6 0.5 0.1 0.1 0.0 1.5 0.0 6.6 0.4 0.0 1.5 1.7 0.0 1.1 1.8 2.7 0.1 0.4 1.6 0.3 1.0 0.2 0.0 3.3 0.0 0.9 0.0 0.1 0.0 0.4 1.3 0.0 1.2 1.1 4.4 2.0 0.5 0.9 0.0 0.6 1.5 1.6 1.5 0.9 0.3 0.5 0.6 0.5 0.9 3.9 0.1 0.0 0.0 0.5 0.0 0.6 0.7 0.1 0.2 0.0 2.8 1.0 0.6 1.6 1.3 0.6 1.2 0.5 0.8 0.9 1.0 0.0 0.4 1.4 1.8 1.1 1.1 1.9 1.8 2.1 1.1 3.1 1.1 3.0 2.1 0.0 0.4 0.3 0.5 3.2 0.0 2.7 2.3 0.0 0.0 0.3 0.0 1.7 83.6 1.0 0.4 0.0 0.2 0.5 0.8 0.5 0.0 1.3 0.4 0.0 0.0 3.7 1.0 16.0 2.0 0.0 1.7 1.0 1.8 1.8 0.7 0.0 0.7 0.2 2.8 6.5 1.2 3.5 2.2 0.5 0.2 0.0 1.1 0.3 C19orf24 FLJ20640 ENSG00000228300 "Chromosome 19 open reading frame 24" Q9BVV8 19 1275438-1279249 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA043279, HPA047026" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA043279: AB_10794656, HPA047026: AB_2679906" "unprognostic (1.10e-1)" "unprognostic (3.39e-1)" "unprognostic (1.12e-1)" "unprognostic (1.65e-3)" "unprognostic (7.05e-2)" "unprognostic (4.90e-1)" "unprognostic (4.23e-3)" "unprognostic (3.12e-2)" "unprognostic (1.18e-1)" "unprognostic (3.59e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (2.54e-3)" "unprognostic (2.16e-1)" "unprognostic (1.10e-1)" "unprognostic (2.25e-2)" 20.2 25.3 13.4 20.9 14.9 17.1 65.7 11.3 15.8 11.7 15.6 9.1 17.5 21.8 13.8 22.0 18.7 13.0 26.5 14.3 13.3 10.9 22.6 48.6 17.0 55.0 13.4 7.0 16.6 41.6 5.9 16.9 18.4 9.7 17.6 6.0 11.1 29.6 22.5 6.9 16.6 19.6 10.5 10.9 22.8 16.6 16.8 10.0 23.1 25.7 19.0 15.8 15.5 21.9 40.9 44.8 9.5 27.5 19.0 33.8 21.3 25.7 24.6 2.3 20.3 4.0 9.3 9.5 12.6 6.7 13.4 11.8 28.1 14.4 7.4 17.6 4.4 9.0 13.8 4.1 13.3 1.5 27.1 21.2 8.0 22.0 16.3 16.6 17.0 17.9 11.1 17.2 10.1 4.4 3.9 9.8 23.5 15.3 43.1 5.3 25.8 20.4 25.2 11.9 12.0 24.9 15.2 4.7 46.3 7.4 13.7 16.7 10.8 8.0 19.4 29.0 1.7 14.1 28.7 6.2 24.6 7.8 29.9 29.7 28.3 36.8 9.3 26.6 21.3 22.0 9.5 26.8 9.2 31.2 27.5 30.9 40.9 33.8 32.9 26.7 36.0 31.9 32.3 4.7 19.0 23.1 44.8 31.9 21.3 13.4 14.9 11.3 15.8 13.3 10.9 13.4 7.0 9.7 10.0 11.9 22.9 82.7 40.2 67.5 16.8 7.4 45.9 10.7 5.7 38.4 11.8 75.5 51.4 88.8 46.4 40.0 109.8 0.0 100.0 114.9 38.2 84.3 42.5 125.4 107.8 4.8 59.3 39.9 79.4 237.5 39.4 64.3 65.8 66.7 84.4 22.5 100.5 97.9 28.3 142.5 12.1 19.4 34.8 26.3 98.6 73.5 80.4 49.8 87.4 59.9 C19orf38 HIDE1 ENSG00000214212 "Chromosome 19 open reading frame 38" A8MVS5 19 10836575-10869790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 58.7;bone marrow: 54.4" "Cell type enhanced" "Detected in many" 18 "Kupffer cells: 101.9;Macrophages: 32.6;monocytes: 24.4;Spermatocytes: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 19 "classical monocyte: 44.3;eosinophil: 26.1;intermediate monocyte: 48.7;myeloid DC: 26.2;neutrophil: 37.3;non-classical monocyte: 58.7" "Group enriched" "Detected in many" 19 "dendritic cells: 26.2;granulocytes: 37.3;monocytes: 58.7" "Cell line enriched" "Detected in some" 4 "U-937: 32.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012150, HPA055027" Uncertain "Golgi apparatus,Plasma membrane,Cytosol" No NA Cytosol "Golgi apparatus, Plasma membrane" "HPA012150: AB_10603448, HPA055027: " "unprognostic (6.65e-3)" "prognostic favorable (2.43e-4)" "unprognostic (6.44e-4)" "unprognostic (6.98e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-3)" "unprognostic (3.56e-1)" "unprognostic (8.27e-2)" "unprognostic (5.60e-2)" "unprognostic (6.02e-2)" "unprognostic (9.74e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.75e-7)" "unprognostic (2.31e-1)" "unprognostic (4.00e-2)" "unprognostic (1.03e-2)" "unprognostic (2.11e-2)" 2.7 1.2 2.1 6.9 4.0 54.4 1.8 0.7 3.1 2.0 1.3 4.8 0.0 1.3 0.9 4.0 0.9 2.6 2.1 5.6 2.4 2.1 1.4 2.3 12.8 19.6 4.2 0.6 1.6 1.3 0.3 1.0 1.9 3.8 1.6 1.0 1.5 1.0 0.8 2.3 0.6 1.7 2.3 6.3 22.3 1.2 15.0 3.7 4.1 0.7 0.5 2.0 2.8 3.5 2.1 26.2 37.3 58.7 1.2 0.8 20.7 1.5 0.0 0.1 0.3 1.5 0.8 0.1 0.2 0.0 0.3 0.6 0.1 0.2 3.8 0.3 0.0 0.1 0.1 0.2 0.2 0.2 1.7 0.4 0.2 0.0 0.0 1.1 2.5 0.4 4.1 0.4 0.7 0.2 0.1 0.1 0.4 0.2 8.1 0.1 1.4 0.1 5.9 0.3 0.2 0.3 2.8 0.0 1.9 0.0 0.1 0.2 0.1 0.8 0.0 0.6 0.1 0.1 5.6 0.0 0.0 0.0 0.7 0.0 4.9 2.3 1.1 0.0 32.8 0.0 1.2 44.3 26.1 0.1 48.7 0.2 2.1 0.1 0.1 26.2 1.2 0.8 0.2 37.3 1.2 58.7 0.5 0.3 20.7 2.1 4.0 0.7 3.1 2.4 2.1 4.2 0.6 3.8 3.7 0.0 2.6 12.3 0.3 0.7 0.0 0.6 0.0 2.7 1.2 1.8 2.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 1.1 0.6 1.1 0.4 2.3 0.9 21.2 0.0 0.0 0.0 101.9 5.3 0.9 32.6 1.7 24.4 0.5 2.3 0.2 3.5 0.7 0.4 1.0 6.5 0.1 27.0 15.8 0.6 0.6 0.8 0.3 0.6 C1GALT1 "C1GALT, T-synthase" ENSG00000106392 "Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1" Q9NS00 7 7156934-7248651 "Enzymes, Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 171.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "LHCN-M2: 81.9" "Low region specificity" "Detected in all" "HPA011294, HPA012819" Enhanced Approved "Nuclear bodies,Cytosol" NA NA 10000 "Nuclear bodies, Cytosol" "HPA011294: AB_1845623, HPA012819: AB_1845624" "unprognostic (1.52e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (7.38e-2)" "unprognostic (8.78e-2)" "unprognostic (2.97e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (1.42e-5)" "unprognostic (2.03e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.83e-1)" "unprognostic (3.28e-1)" "unprognostic (8.28e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-1)" 11.4 7.7 10.1 12.4 14.1 23.1 11.0 10.6 14.9 13.9 10.7 21.5 4.0 19.3 5.4 7.1 24.7 12.7 16.1 11.6 12.8 10.8 21.5 14.7 10.9 11.7 23.7 8.9 6.2 6.2 42.3 11.0 30.2 19.2 5.7 12.2 8.1 17.6 5.7 8.1 8.6 15.8 5.3 31.0 13.8 15.3 5.4 21.4 12.9 10.6 6.2 11.6 10.3 8.4 15.9 13.5 33.2 26.0 16.6 17.4 12.2 18.9 8.2 2.5 4.3 7.5 15.8 8.8 21.8 16.3 10.2 15.1 5.6 19.7 8.9 5.6 8.6 27.4 6.1 3.7 8.2 16.1 5.3 3.0 8.4 4.9 15.5 8.2 8.8 3.7 12.9 5.8 25.0 19.3 12.8 8.3 8.9 18.0 5.6 81.9 3.2 2.4 4.3 15.9 12.6 8.9 8.0 14.9 5.4 11.5 8.4 3.1 8.2 13.8 15.6 14.8 16.2 4.9 4.5 8.7 16.3 25.3 23.2 8.8 10.7 9.1 10.1 10.8 11.9 18.1 33.2 11.1 31.2 16.1 16.5 16.9 15.9 15.0 17.4 12.2 13.7 15.7 17.0 24.3 16.6 26.0 13.5 13.0 12.2 10.1 14.1 10.6 14.9 12.8 10.8 23.7 8.9 19.2 21.4 38.7 50.4 35.6 14.0 23.4 22.1 22.0 30.6 18.7 21.6 17.4 31.4 79.2 5.0 23.7 13.7 11.7 21.0 0.0 22.7 66.8 16.9 13.7 11.5 19.5 32.6 44.5 15.0 11.6 19.3 12.2 6.1 21.9 21.9 10.0 20.0 23.0 35.5 17.5 6.0 37.2 32.9 6.5 8.9 15.0 29.3 16.9 171.3 29.2 26.5 17.1 C1GALT1C1 "C1GALT2, COSMC" ENSG00000171155 "C1GALT1 specific chaperone 1" Q96EU7 X 120625793-120630150 "Disease related genes, Predicted membrane proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 83.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 73.1" "Low region specificity" "Detected in all" "HPA010666, HPA015632" Approved Approved Vesicles NA NA Vesicles "HPA010666: , HPA015632: AB_1845625" "prognostic unfavorable (5.66e-4)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (1.98e-1)" "unprognostic (3.07e-2)" "unprognostic (5.26e-3)" "unprognostic (4.34e-2)" "unprognostic (2.50e-1)" "unprognostic (2.18e-2)" "unprognostic (8.10e-2)" "unprognostic (3.85e-2)" "unprognostic (3.07e-1)" "unprognostic (3.98e-2)" "unprognostic (4.48e-2)" "unprognostic (1.55e-1)" "unprognostic (6.05e-3)" "unprognostic (3.78e-2)" 16.5 28.0 8.4 11.1 9.2 3.0 21.1 9.0 9.9 19.2 16.7 10.8 16.5 12.7 13.0 23.1 15.0 15.1 11.6 17.7 9.0 10.9 25.9 35.2 12.4 12.9 11.0 7.5 13.2 18.8 18.7 83.5 13.3 11.5 14.1 19.4 10.9 19.4 15.5 7.4 5.8 20.6 12.4 12.0 16.5 14.6 9.6 10.6 16.3 19.8 12.3 12.4 13.9 12.3 17.2 23.0 31.3 22.3 15.1 23.8 16.2 8.5 8.3 4.6 7.9 73.1 13.9 7.3 15.7 22.2 8.3 15.8 5.4 27.6 5.6 7.9 31.6 16.0 12.1 9.0 7.6 13.3 9.4 10.9 3.6 7.7 7.9 11.4 6.2 5.7 12.1 6.9 10.3 3.5 20.9 26.1 2.8 2.2 6.6 9.7 11.6 2.1 5.9 5.2 28.9 8.4 0.9 3.6 15.2 16.8 5.8 5.1 4.8 14.9 10.2 7.8 8.8 8.9 6.1 23.9 3.8 4.7 15.3 14.6 2.8 4.2 4.4 14.0 12.4 8.4 13.3 17.7 27.0 17.6 22.3 19.4 17.2 22.9 19.0 20.1 10.6 23.8 18.9 31.3 15.1 17.5 23.0 21.0 16.2 8.4 9.2 9.0 9.9 9.0 10.9 11.0 7.5 11.5 10.6 6.0 7.2 13.4 18.7 6.1 8.1 14.1 12.7 26.8 18.2 36.6 2.0 47.7 13.3 34.2 2.5 22.5 15.3 0.0 39.1 41.4 29.1 13.7 2.3 19.2 21.2 19.1 13.3 20.3 15.1 4.4 21.0 19.0 28.7 23.4 19.1 19.0 25.0 17.6 18.0 16.1 8.2 6.5 20.3 4.4 7.9 6.4 16.7 13.8 18.9 20.6 C1GALT1C1L ENSG00000223658 "C1GALT1-specific chaperone 1 like" P0DN25 2 43675151-43676322 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 9.2" "Cell type enhanced" "Detected in some" 19 "Muller glia cells: 4.5;Rod photoreceptor cells: 3.7;Spermatocytes: 17.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 16.0;U-2 OS: 10.1" "Low region specificity" "Detected in all" NA NA "unprognostic (2.18e-1)" "unprognostic (3.71e-2)" "unprognostic (2.50e-2)" "unprognostic (1.02e-2)" "unprognostic (2.32e-1)" "unprognostic (5.71e-3)" "unprognostic (2.19e-3)" "unprognostic (4.91e-2)" "unprognostic (2.78e-2)" "unprognostic (2.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.67e-1)" "unprognostic (7.73e-2)" "unprognostic (3.81e-3)" "unprognostic (8.88e-2)" "unprognostic (1.39e-2)" "unprognostic (8.86e-2)" 1.5 1.2 1.0 0.2 1.7 0.0 5.1 0.0 2.8 1.6 1.6 0.1 1.8 0.0 5.7 9.2 0.6 1.5 1.1 8.0 0.5 2.3 0.0 0.3 0.5 3.9 0.1 1.5 2.9 0.0 0.0 1.0 3.1 3.0 0.7 1.7 1.4 3.5 0.7 0.0 0.4 4.7 1.6 0.4 0.3 7.8 1.4 0.0 1.6 0.8 0.2 1.5 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 3.1 1.6 0.1 0.2 0.5 1.1 1.3 0.6 4.6 0.0 4.6 0.3 4.0 0.3 0.0 0.3 2.5 0.0 3.5 2.0 1.5 0.9 1.1 0.0 0.0 2.0 0.8 3.1 0.1 1.6 3.2 0.0 2.4 0.0 0.3 4.7 0.0 4.3 0.0 0.0 0.0 0.0 1.8 0.0 4.0 1.0 0.2 16.0 0.0 0.2 3.0 0.4 1.1 3.1 0.0 4.1 10.1 0.2 0.9 0.0 2.4 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 1.0 0.4 2.5 2.7 1.2 0.0 0.0 0.2 0.0 0.8 2.0 0.0 0.0 0.0 0.5 0.3 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 0.3 4.5 0.3 0.0 1.8 0.3 3.7 0.0 0.0 17.7 2.3 0.0 0.1 0.0 0.2 0.0 C1orf115 FLJ14146 ENSG00000162817 "Chromosome 1 open reading frame 115" Q9H7X2 1 220689845-220699157 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 32.9;intestine: 32.1" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 168.2;Hepatocytes: 103.9;Syncytiotrophoblasts: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6" "Lineage enhanced" "Detected in single" "B-cells: 3.6" "Cell line enhanced" "Detected in many" "Hep G2: 23.6;HUVEC TERT2: 19.4;TIME: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (5.16e-2)" "prognostic favorable (6.52e-4)" "unprognostic (1.31e-1)" "unprognostic (3.93e-2)" "unprognostic (2.03e-1)" "unprognostic (5.69e-3)" "unprognostic (8.65e-2)" "prognostic favorable (5.12e-5)" "unprognostic (3.11e-1)" "unprognostic (1.33e-1)" "unprognostic (1.74e-2)" "unprognostic (4.24e-1)" "unprognostic (4.54e-2)" "unprognostic (9.21e-3)" "unprognostic (1.07e-1)" 12.4 1.6 16.2 3.2 27.0 0.0 8.9 3.1 32.9 3.9 8.1 2.1 2.4 30.6 3.1 5.8 2.9 3.8 4.6 4.7 9.6 2.9 14.4 27.6 6.2 1.7 2.5 17.8 4.9 3.9 8.5 6.2 19.0 5.7 8.6 6.2 3.3 20.2 2.8 3.3 2.6 32.1 3.2 1.1 12.7 5.5 2.8 3.7 1.0 5.5 1.1 2.2 2.1 2.3 3.6 0.2 0.0 0.6 0.0 0.9 0.3 0.6 2.8 0.1 4.0 0.0 0.0 11.5 0.8 3.1 1.6 7.3 2.8 2.9 0.0 1.2 0.2 3.4 0.1 6.6 1.3 1.5 0.0 6.6 0.1 0.6 23.6 3.8 0.0 0.1 0.5 2.2 0.1 0.8 0.0 19.4 0.0 1.7 0.0 0.1 2.5 0.0 0.1 4.8 7.8 2.0 0.0 0.0 0.2 3.5 3.7 2.1 2.9 0.0 4.8 11.6 7.3 7.9 0.1 36.2 0.0 0.0 0.1 0.6 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.8 0.0 0.3 1.9 0.9 0.2 0.2 3.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 16.2 27.0 3.1 32.9 9.6 2.9 2.5 17.8 5.7 3.7 3.0 7.0 9.9 3.4 3.1 11.4 12.2 10.2 1.4 5.7 29.6 5.9 57.1 33.2 10.0 1.1 33.7 168.2 0.0 14.6 51.0 2.4 13.3 0.0 103.9 5.6 0.0 8.1 11.1 4.7 1.9 2.8 1.1 8.5 7.2 22.1 5.6 13.2 46.0 18.0 52.2 3.9 0.0 3.1 0.3 3.9 1.5 153.8 0.5 13.3 2.1 C1orf159 FLJ20584 ENSG00000131591 "Chromosome 1 open reading frame 159" Q96HA4 1 1081818-1116361 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 48.9;Late spermatids: 101.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA010019, HPA075399" Approved Approved "Nucleoli rim,Mitotic chromosome,Intermediate filaments" Yes No "Nucleoli rim, Mitotic chromosome, Intermediate filaments" "HPA010019: AB_1078885, HPA075399: " "unprognostic (2.79e-1)" "unprognostic (9.46e-2)" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-1)" "unprognostic (2.60e-3)" "prognostic unfavorable (9.58e-6)" "unprognostic (1.34e-1)" "unprognostic (3.09e-1)" "unprognostic (2.04e-2)" "unprognostic (9.29e-2)" "unprognostic (3.26e-3)" "prognostic unfavorable (1.77e-6)" "unprognostic (4.10e-2)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "prognostic favorable (1.62e-4)" 3.7 6.6 8.3 4.9 9.0 5.6 3.1 7.6 10.0 5.5 6.0 11.3 5.4 6.1 6.0 6.9 6.6 4.0 5.9 3.8 8.8 5.8 5.0 5.0 5.6 4.2 6.6 4.9 5.8 5.3 2.2 4.4 5.6 5.0 6.6 1.8 5.8 10.2 6.5 3.6 23.7 5.5 7.5 5.2 7.0 9.0 17.5 5.6 5.2 4.0 5.2 6.4 5.4 4.4 5.0 4.3 9.9 4.9 4.7 5.7 3.9 11.9 9.7 4.5 7.8 1.4 1.4 10.2 6.8 1.6 6.2 4.1 5.2 12.6 3.4 8.4 2.1 5.0 9.9 1.9 6.3 1.8 6.4 14.1 2.3 16.6 5.4 2.9 4.0 5.6 3.1 3.0 3.2 1.2 1.9 3.0 5.5 13.8 2.7 2.2 9.2 7.4 10.2 4.1 4.5 15.6 9.2 5.3 6.2 3.6 4.3 9.4 12.5 5.3 9.5 5.4 1.4 6.6 5.2 5.0 6.7 7.1 9.8 7.0 4.5 6.1 6.0 5.8 10.9 5.4 9.9 4.9 2.6 5.3 4.4 5.4 5.0 4.9 5.7 3.2 4.7 5.3 5.0 1.1 4.7 3.1 4.3 1.7 3.9 8.3 9.0 7.6 10.0 8.8 5.8 6.6 4.9 5.0 5.6 0.0 10.6 1.5 3.4 6.6 6.2 1.8 5.1 9.4 5.7 8.7 3.9 4.7 1.7 7.6 48.9 3.6 5.1 23.3 5.9 11.7 5.0 4.2 5.7 4.7 3.6 12.7 4.1 1.8 1.8 101.9 2.6 2.7 3.3 8.2 7.0 3.0 6.1 2.9 1.4 1.1 7.4 0.0 4.1 11.2 6.6 6.0 4.1 3.8 6.9 4.4 C1orf162 MGC24133 ENSG00000143110 "Chromosome 1 open reading frame 162" Q8NEQ5 1 111473792-111478512 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 119.1;lymphoid tissue: 86.6" "Cell type enhanced" "Detected in many" 18 "granulocytes: 175.8;Hofbauer cells: 198.4;Kupffer cells: 675.1;Macrophages: 367.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "HDLM-2: 45.4;HL-60: 22.1;NB-4: 12.3;THP-1: 17.5;U-937: 36.7" HPA026988 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA026988: AB_10600887" "unprognostic (8.79e-2)" "unprognostic (5.18e-3)" "unprognostic (1.14e-2)" "unprognostic (2.11e-1)" "unprognostic (5.20e-2)" "unprognostic (5.96e-2)" "unprognostic (1.61e-1)" "unprognostic (5.66e-2)" "unprognostic (1.11e-1)" "unprognostic (4.69e-2)" "unprognostic (1.86e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (3.14e-6)" "unprognostic (1.29e-2)" "unprognostic (3.15e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-1)" 39.8 9.3 9.2 25.1 17.9 37.5 20.1 4.6 9.3 5.2 6.3 4.9 0.8 2.7 5.4 7.4 4.9 10.2 11.7 14.8 13.4 4.7 17.3 14.8 40.1 86.6 17.5 1.9 5.8 4.5 1.3 9.7 5.6 15.3 5.0 6.9 5.0 5.9 2.5 7.2 3.6 8.3 13.5 31.0 78.1 5.8 6.1 13.9 10.6 6.2 1.1 20.0 7.2 6.7 24.7 83.3 98.7 119.1 40.1 27.8 74.8 0.1 0.0 0.1 0.3 0.1 0.2 0.2 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 45.4 0.1 0.1 0.1 0.0 0.2 22.1 3.7 0.0 0.9 0.3 0.3 0.3 0.6 0.2 0.2 0.1 0.1 0.1 0.1 12.3 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.1 17.5 0.0 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.1 36.7 0.5 68.4 82.5 98.7 14.2 119.1 4.1 17.5 17.7 8.2 83.3 24.7 27.8 16.8 11.4 40.1 86.3 24.9 5.0 74.8 9.2 17.9 4.6 9.3 13.4 4.7 17.5 1.9 15.3 13.9 20.8 66.7 71.8 0.5 7.0 3.7 3.1 12.7 1.4 7.9 7.0 2.0 1.1 0.0 0.2 33.3 3.7 0.6 0.0 0.2 1.2 5.8 0.7 175.8 6.4 198.4 0.0 1.7 17.8 675.1 60.1 2.6 367.2 11.8 1.0 0.0 0.3 0.2 0.0 0.7 0.6 3.9 32.3 4.2 1.8 1.7 5.6 1.4 95.6 0.6 0.3 C1orf185 FLJ27485 ENSG00000204006 "Chromosome 1 open reading frame 185" Q5T7R7 1 51102234-51148086 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 23.8" "Cell type enriched" "Detected in some" 14 "Early spermatids: 474.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 1.1;THP-1: 1.2" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 474.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 3.0 1.8 0.0 0.0 0.0 0.0 0.0 C1orf210 "MGC52423, TEMP" ENSG00000253313 "Chromosome 1 open reading frame 210" Q8IVY1 1 43281883-43285617 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.0" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 105.5;Paneth cells: 49.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "basophil: 5.4" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "A-431: 7.4;BEWO: 8.3;CACO-2: 7.8;CAPAN-2: 25.2;OE19: 20.3;SK-BR-3: 8.8;T-47d: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA013788 Uncertain Uncertain "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA013788: AB_1845637" "unprognostic (1.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.06e-2)" "unprognostic (1.98e-1)" "unprognostic (3.54e-2)" "unprognostic (2.74e-1)" "unprognostic (2.01e-2)" "prognostic favorable (0.00e+0)" "unprognostic (7.57e-3)" "unprognostic (3.94e-1)" "unprognostic (1.00e-1)" "unprognostic (1.61e-2)" 0.3 0.1 0.3 6.5 0.3 0.0 7.4 0.3 0.3 3.9 28.6 0.4 7.4 20.6 1.0 10.9 11.2 2.6 20.7 0.3 0.3 0.1 25.2 3.3 13.5 0.3 0.3 0.3 1.0 29.8 3.0 9.6 6.1 0.4 4.4 14.4 0.4 25.8 7.2 0.3 10.6 64.0 0.5 0.3 0.3 14.6 1.1 0.3 1.0 32.1 7.8 7.7 3.4 5.2 0.1 0.3 5.4 0.3 0.4 0.2 0.0 7.4 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.0 0.0 7.8 25.2 0.0 0.1 0.0 0.0 5.7 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.1 0.0 20.3 0.0 0.0 0.0 0.2 0.6 4.8 3.0 0.2 0.0 8.8 0.0 1.4 9.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.3 0.4 0.3 0.2 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.4 0.3 20.8 10.7 0.8 5.9 1.0 0.0 0.0 22.9 4.0 4.5 21.0 0.0 11.1 24.9 17.9 0.1 0.0 105.5 0.0 29.5 2.9 0.2 10.4 0.0 0.9 0.6 0.0 32.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 34.2 0.0 16.3 49.1 0.0 39.3 0.0 0.0 0.2 0.1 0.0 2.3 3.9 0.0 31.2 7.8 C1orf43 "DKFZp586G1722, NICE-3" ENSG00000143612 "Chromosome 1 open reading frame 43" Q9BWL3 1 154206706-154220637 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010725 Approved NA NA "HPA010725: AB_1078341" "unprognostic (3.90e-2)" "unprognostic (1.22e-2)" "unprognostic (2.11e-1)" "unprognostic (1.12e-1)" "unprognostic (6.87e-2)" "unprognostic (6.15e-3)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.72e-1)" "unprognostic (2.78e-1)" "unprognostic (2.64e-2)" "unprognostic (3.51e-2)" "unprognostic (1.10e-1)" "unprognostic (1.87e-2)" "unprognostic (1.69e-1)" "unprognostic (2.89e-1)" "unprognostic (1.75e-2)" "unprognostic (1.23e-1)" 36.4 36.5 45.5 20.4 47.7 20.7 43.4 36.0 43.5 29.0 33.7 36.2 28.0 34.9 23.1 36.7 30.9 30.9 31.8 53.5 39.9 35.2 55.5 80.2 30.5 27.6 48.4 29.4 23.4 68.9 28.8 24.2 25.1 31.1 29.8 37.2 25.2 31.0 29.0 124.2 27.0 36.6 27.4 46.1 27.0 30.1 19.5 33.8 22.0 38.4 49.0 28.4 32.7 29.0 29.2 59.0 39.0 56.1 21.2 41.6 56.4 29.2 31.3 26.3 31.0 39.4 39.7 16.3 29.5 51.2 34.4 32.1 21.4 41.7 38.8 45.0 26.5 29.9 30.0 36.1 26.7 24.8 30.5 39.9 29.8 34.8 27.7 61.4 37.4 35.6 32.2 63.6 36.5 76.3 47.0 39.7 43.4 31.3 36.9 44.6 46.8 28.1 34.3 50.7 66.9 48.0 25.8 24.2 70.0 42.9 31.0 42.9 56.5 26.6 71.0 99.6 31.7 70.1 83.1 27.0 26.9 22.6 32.2 37.1 68.1 66.2 37.0 45.0 37.7 71.5 39.0 56.1 35.7 25.4 50.4 30.5 29.2 29.6 27.7 59.0 25.6 31.3 26.1 32.2 21.2 45.3 43.6 41.6 56.4 45.5 47.7 36.0 43.5 39.9 35.2 48.4 29.4 31.1 33.8 107.2 81.5 107.4 106.1 83.7 119.7 121.4 99.3 81.7 92.1 68.0 27.5 74.2 213.9 137.1 214.9 101.4 115.5 23.3 177.2 103.3 70.6 146.8 60.1 134.8 162.0 55.6 117.1 78.0 135.6 130.5 60.1 121.7 118.1 155.1 116.8 73.7 139.3 133.6 70.4 192.0 62.3 71.1 86.3 64.5 69.8 88.0 105.5 73.4 115.3 130.8 C1QB ENSG00000173369 "Complement C1q B chain" P02746 1 22652762-22661538 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 262.8" "Group enriched" "Detected in many" 4 "Hofbauer cells: 1215.3;Kupffer cells: 2993.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 66 "intermediate monocyte: 41.9;non-classical monocyte: 26.9" "Lineage enriched" "Detected in single" 83 "monocytes: 41.9" "Cell line enhanced" "Detected in some" "BEWO: 2.4;HaCaT: 2.8;NB-4: 2.6;SH-SY5Y: 2.9;U-266/70: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052116 Approved "Secreted to blood" NA NA 4700000000 "HPA052116: AB_2681735" "unprognostic (1.42e-1)" "unprognostic (3.36e-2)" "unprognostic (5.61e-3)" "unprognostic (8.20e-2)" "unprognostic (5.93e-2)" "unprognostic (4.09e-1)" "unprognostic (1.25e-1)" "unprognostic (2.35e-1)" "unprognostic (2.87e-2)" "unprognostic (2.21e-1)" "unprognostic (2.63e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (9.58e-6)" "unprognostic (4.14e-2)" "unprognostic (7.76e-3)" "unprognostic (4.83e-2)" "unprognostic (2.35e-2)" 76.7 42.3 30.3 22.0 54.5 7.1 17.6 3.3 27.8 12.1 28.2 27.6 1.4 30.0 9.0 25.5 10.8 21.5 33.2 19.8 19.8 17.0 21.8 51.5 87.9 84.1 45.7 6.8 9.8 11.2 4.2 14.4 41.2 35.7 15.0 24.6 17.2 13.9 9.3 9.2 4.3 30.5 41.9 52.2 262.8 14.4 11.7 38.1 7.4 9.8 3.7 9.5 36.8 6.6 0.0 0.5 0.1 41.9 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 1.2 2.6 1.6 0.0 0.0 1.6 1.1 1.9 0.0 0.0 1.9 2.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.9 0.3 2.9 0.1 0.5 0.5 0.3 0.6 0.0 0.5 0.0 0.0 41.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 26.9 0.0 0.0 1.4 30.3 54.5 3.3 27.8 19.8 17.0 45.7 6.8 35.7 38.1 11.9 23.2 50.8 1.6 5.6 1.0 5.0 35.7 6.7 19.4 3.5 0.0 5.3 0.0 0.0 1.5 5.9 0.3 0.0 0.0 7.3 6.4 1.6 10.5 14.4 1215.3 0.0 0.0 59.5 2993.5 4.2 7.8 520.2 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.7 3.4 58.2 1.4 0.2 1.0 4.0 8.0 25.4 0.0 1.1 C1QTNF1 "CTRP1, FLJ90694, GIP, ZSIG37" ENSG00000173918 "C1q and TNF related 1" Q9BXJ1 17 79022814-79049788 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.5" "Group enriched" "Detected in many" 5 "Ito cells: 145.5;Sertoli cells: 103.5;Smooth muscle cells: 105.0;Syncytiotrophoblasts: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 84.6;BJ hTERT+: 19.8;HHSteC: 32.0;HSkMC: 17.0;U-87 MG: 20.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB025429, HPA051101" Uncertain Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 314000000 30000 "Nucleoplasm, Cytosol" "CAB025429: , HPA051101: AB_2681343" "unprognostic (2.58e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (1.20e-1)" "unprognostic (3.48e-1)" "unprognostic (1.12e-2)" "unprognostic (7.11e-2)" "unprognostic (3.18e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-2)" "unprognostic (7.48e-2)" "unprognostic (9.81e-3)" "unprognostic (5.83e-2)" "prognostic unfavorable (9.09e-9)" "unprognostic (1.93e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-2)" "unprognostic (1.95e-2)" 62.4 18.3 1.7 7.4 4.3 0.4 60.5 1.3 5.1 14.3 10.3 5.2 30.8 2.5 11.0 14.2 10.2 14.4 19.1 77.5 2.0 4.1 9.5 19.4 9.7 16.6 4.8 2.5 25.2 7.5 10.1 4.2 34.0 7.6 13.3 3.3 19.6 13.8 51.8 11.9 8.6 6.1 6.9 2.5 14.3 6.1 8.8 2.8 1.3 26.9 13.3 5.0 14.8 27.5 0.5 0.3 1.9 0.3 1.2 0.4 0.0 0.0 8.2 0.0 0.0 84.6 7.6 0.0 4.2 19.8 1.8 3.5 0.6 4.0 0.0 0.4 1.2 5.2 0.2 0.2 0.1 1.3 0.0 0.9 0.0 3.1 0.4 32.0 0.0 0.0 17.0 0.0 3.8 0.2 2.6 2.4 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.9 8.6 0.0 5.5 0.1 0.0 0.1 0.3 1.6 2.7 0.4 7.9 0.3 0.0 0.0 0.3 9.0 0.2 1.0 1.2 0.0 0.0 0.0 20.0 0.0 0.8 1.9 0.3 0.5 0.3 0.2 0.2 0.2 0.4 0.2 0.1 0.5 0.2 0.4 0.4 1.2 0.2 0.3 0.0 0.0 1.7 4.3 1.3 4.2 2.0 4.1 4.8 2.5 7.6 2.8 0.0 1.1 0.0 0.6 5.8 0.0 9.4 10.2 0.0 0.0 1.8 0.0 17.3 0.0 13.9 0.1 10.5 1.3 0.0 5.3 1.2 14.4 1.2 0.0 1.5 2.3 0.0 4.6 145.5 10.5 0.0 9.8 0.7 3.3 19.0 6.8 0.5 3.2 2.9 3.2 0.0 0.3 103.5 105.0 0.0 0.7 4.0 39.6 0.5 4.5 0.5 C1QTNF12 "ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127" ENSG00000184163 "C1q and TNF related 12" Q5T7M4 1 1242446-1246722 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 11.0;skin 1: 7.8" "Group enriched" "Detected in some" 7 "Extravillous trophoblasts: 10.0;Proximal tubular cells: 37.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.6;NK-cell: 2.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "EFO-21: 8.3;U-2 OS: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024107 Uncertain Approved Vesicles "Secreted to blood" NA NA 38200000 Vesicles "HPA024107: AB_2101207" "unprognostic (1.10e-2)" "unprognostic (5.68e-3)" "unprognostic (3.45e-1)" "unprognostic (1.24e-2)" "unprognostic (6.60e-3)" "unprognostic (2.43e-1)" "unprognostic (2.67e-3)" "unprognostic (1.01e-2)" "unprognostic (2.58e-1)" "unprognostic (1.05e-2)" "unprognostic (8.02e-3)" "unprognostic (1.10e-2)" "unprognostic (9.68e-3)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.09e-1)" "unprognostic (1.20e-1)" 1.0 0.0 0.5 0.2 0.0 0.0 0.5 0.2 0.2 0.1 3.4 11.0 0.1 0.0 1.2 0.2 0.1 0.2 0.0 1.0 3.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 1.2 0.4 0.0 0.1 7.8 10.4 0.1 0.2 0.0 0.3 2.4 0.2 0.1 0.0 0.4 0.3 0.6 2.6 0.3 2.2 0.4 0.2 0.3 0.0 0.0 0.6 0.4 0.1 1.6 1.1 0.0 0.1 0.0 0.6 0.4 0.1 8.3 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.2 0.3 0.1 0.1 0.1 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.5 0.3 0.1 0.9 0.6 0.1 0.3 0.0 1.3 0.0 0.0 1.2 0.3 0.0 0.0 0.7 0.0 0.6 0.1 0.0 0.0 8.2 0.1 0.0 1.7 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.6 0.3 0.4 0.0 2.6 2.2 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.2 0.0 0.0 0.0 0.0 0.7 10.0 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 37.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 C1QTNF6 "CTRP6, ZACRP6" ENSG00000133466 "C1q and TNF related 6" Q9BXI9 22 37180167-37199385 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "endometrium 1: 23.7;placenta: 79.5" "Cell type enriched" "Detected in many" 12 "Extravillous trophoblasts: 349.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 45.0;RT4: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002042 Enhanced Approved Nucleoplasm "Secreted to blood" No No 354000000 Nucleoplasm "HPA002042: AB_1078342" "unprognostic (9.65e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.23e-3)" "unprognostic (1.25e-3)" "unprognostic (3.01e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (9.60e-6)" "unprognostic (6.96e-2)" "unprognostic (5.11e-2)" "unprognostic (2.61e-2)" "unprognostic (1.72e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.61e-2)" "unprognostic (5.36e-2)" "unprognostic (1.08e-3)" "unprognostic (1.52e-2)" 3.3 4.4 1.2 4.2 1.6 0.8 2.5 1.2 1.8 7.8 2.5 1.3 1.6 1.0 23.7 7.2 1.6 5.2 6.2 3.1 1.4 0.7 3.9 7.9 9.2 3.1 1.2 1.3 5.9 2.3 1.4 1.4 79.5 1.7 4.3 2.5 4.4 2.2 3.4 1.5 3.1 3.2 5.7 1.8 4.6 1.8 3.5 1.2 1.6 2.4 1.7 1.8 5.1 2.7 2.4 1.1 1.8 0.5 4.0 3.8 1.0 6.7 8.4 4.4 1.5 0.8 8.9 13.4 1.4 2.8 1.1 0.8 1.5 9.9 0.0 5.7 2.3 0.6 14.0 0.1 3.4 0.5 1.9 1.1 1.1 3.2 1.5 3.1 0.0 0.9 12.3 1.9 0.9 0.2 3.0 10.6 0.3 0.0 3.1 0.4 45.0 0.0 0.2 2.8 1.0 0.1 0.1 0.0 1.1 10.2 20.8 0.7 5.7 0.4 8.1 1.1 2.4 2.8 0.2 3.6 0.4 2.3 0.1 0.0 6.5 0.1 0.0 0.9 0.8 1.2 1.0 0.5 1.5 0.7 0.5 0.8 0.8 1.3 1.0 0.5 2.4 2.9 2.2 1.8 4.0 0.3 1.1 3.8 1.0 1.2 1.6 1.2 1.8 1.4 0.7 1.2 1.3 1.7 1.2 0.0 0.0 3.0 1.4 1.3 0.9 1.1 2.5 4.0 2.3 1.8 0.0 4.2 1.7 1.9 1.7 1.4 2.6 0.0 1.0 349.8 8.9 0.6 1.1 5.0 8.4 0.0 0.0 11.6 1.0 6.2 0.6 0.9 5.0 1.0 2.1 4.2 2.0 3.5 0.4 1.3 0.7 0.0 3.3 7.0 4.0 0.3 28.8 2.5 3.9 1.0 C20orf173 dJ477O4.4 ENSG00000125975 "Chromosome 20 open reading frame 173" Q96LM9 20 35523186-35529652 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 89 "testis: 28.3" "Group enriched" "Detected in some" 80 "Early spermatids: 471.4;Late spermatids: 118.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.1" NA NA "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 471.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 C20orf24 "PNAS-11, RIP5" ENSG00000101084 "Chromosome 20 open reading frame 24" Q9BUV8 20 36605734-36612557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA057387 Uncertain Approved Cytosol NA NA Cytosol "HPA057387: AB_2683425" "unprognostic (2.14e-1)" "unprognostic (4.75e-3)" "unprognostic (6.83e-2)" "unprognostic (1.78e-3)" "unprognostic (3.88e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.56e-6)" "unprognostic (4.47e-3)" "unprognostic (3.89e-1)" "unprognostic (2.90e-1)" "unprognostic (2.37e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "unprognostic (9.98e-2)" 17.0 19.7 15.1 18.5 16.3 25.1 29.1 11.9 21.1 15.8 31.1 10.9 15.2 21.9 11.8 18.1 55.5 10.8 25.1 24.2 14.3 14.0 35.6 71.1 21.4 24.4 15.0 11.7 9.5 27.6 15.4 8.5 19.3 12.6 13.3 26.5 9.8 21.5 17.9 70.0 13.6 26.1 14.6 12.7 26.2 20.0 19.0 11.3 20.4 21.6 42.3 28.3 14.3 20.4 10.0 15.8 41.3 24.2 6.1 11.9 7.7 36.1 27.2 9.0 12.0 21.6 12.4 24.2 22.7 12.4 21.7 19.7 74.4 45.6 15.7 56.2 19.4 40.6 26.9 19.3 35.4 20.7 11.8 20.1 37.4 38.6 81.4 25.3 39.3 18.4 15.5 37.5 31.3 17.8 11.1 19.8 16.5 25.5 37.0 20.4 24.5 23.0 50.8 16.5 35.5 58.1 18.4 23.2 39.4 18.7 27.0 16.7 12.6 32.7 84.8 28.4 14.9 17.9 32.4 22.4 32.4 22.3 33.5 34.3 23.7 38.2 26.5 35.0 45.9 17.2 7.2 24.2 29.9 6.2 12.4 6.2 10.0 7.4 9.6 15.8 8.1 9.0 6.7 41.3 6.1 14.7 10.8 11.9 7.7 15.1 16.3 11.9 21.1 14.3 14.0 15.0 11.7 12.6 11.3 32.8 18.6 61.3 37.0 155.3 30.6 0.0 104.4 17.4 23.9 0.0 23.6 72.8 0.0 0.0 42.7 44.2 136.6 23.3 0.0 105.9 54.2 76.8 47.1 249.1 216.1 12.7 52.7 58.9 146.9 62.8 40.6 64.6 67.4 0.0 79.2 49.6 0.0 118.5 40.3 0.0 29.0 58.2 32.8 171.5 84.7 183.9 113.4 69.2 118.3 184.6 C2CD2 "C21orf25, C21orf258, DKFZP586F0422, TMEM24L" ENSG00000157617 "C2 calcium dependent domain containing 2" Q9Y426 21 41885112-41953890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 56.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 51.0;Cone photoreceptor cells: 78.5;Ito cells: 42.4;Rod photoreceptor cells: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 38.7;SK-BR-3: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030922, HPA030924" Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA030922: AB_2673660, HPA030924: AB_10669873" "unprognostic (3.02e-3)" "unprognostic (3.69e-2)" "unprognostic (2.21e-2)" "unprognostic (9.63e-2)" "unprognostic (3.15e-3)" "unprognostic (2.93e-2)" "unprognostic (2.39e-2)" "unprognostic (3.44e-2)" "unprognostic (3.00e-2)" "unprognostic (4.39e-2)" "unprognostic (2.43e-1)" "unprognostic (2.38e-1)" "prognostic unfavorable (7.68e-5)" "unprognostic (1.99e-1)" "unprognostic (4.56e-2)" "unprognostic (1.06e-2)" "unprognostic (1.48e-1)" 23.9 56.9 5.4 6.1 8.0 1.1 21.0 2.7 7.0 5.8 5.8 7.6 10.9 3.5 6.3 6.1 5.4 4.9 7.8 3.6 5.9 5.1 5.3 4.2 9.6 9.1 12.8 4.5 11.7 10.7 19.4 3.8 4.2 10.9 8.8 4.3 11.8 8.1 9.4 2.7 10.1 4.4 5.6 11.7 20.7 5.7 2.7 9.1 5.7 4.8 3.9 5.3 7.0 23.9 1.1 1.4 0.9 1.3 1.9 2.8 0.7 6.1 2.6 1.8 4.2 38.7 10.7 7.2 4.3 6.8 2.7 2.5 4.0 7.0 0.1 2.4 8.4 6.7 0.7 6.5 4.5 3.5 0.4 2.9 1.1 3.2 3.2 5.2 0.4 0.0 6.8 4.2 14.5 5.7 6.0 12.8 0.3 3.8 0.0 7.2 0.5 0.9 1.2 10.2 2.6 8.9 0.6 2.7 3.7 4.0 13.0 3.0 1.3 4.7 21.3 3.8 3.8 5.6 2.7 4.4 6.5 0.9 2.1 3.5 2.4 3.5 0.5 19.0 3.6 1.3 0.0 1.3 0.0 1.3 0.8 0.5 0.5 1.2 0.5 1.4 1.1 2.8 1.6 0.9 1.9 0.7 0.2 1.5 0.7 5.4 8.0 2.7 7.0 5.9 5.1 12.8 4.5 10.9 9.1 3.0 13.3 6.4 6.8 3.7 51.0 2.0 5.1 4.0 5.7 3.5 78.5 9.6 0.0 5.0 0.1 12.0 2.3 0.0 7.1 3.7 6.1 12.9 0.0 4.5 3.2 1.6 4.7 42.4 7.8 0.0 3.4 2.9 1.7 0.0 7.3 3.5 7.9 6.8 2.1 2.8 35.1 12.9 15.6 0.0 2.3 2.3 7.8 1.7 7.1 12.4 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011044 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Nuclear membrane, Cytosol" "HPA011044: AB_2668414" "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favorable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 5.2 7.0 15.9 7.3 33.1 14.7 4.8 18.2 31.2 5.8 10.3 7.5 8.3 18.7 4.1 6.1 9.4 10.9 6.3 7.9 15.8 13.6 6.3 7.3 8.3 8.5 9.1 12.6 3.9 7.5 7.8 14.2 4.8 11.7 4.8 8.8 5.6 8.7 7.0 8.3 12.5 19.4 6.1 7.3 9.2 5.5 2.6 9.1 7.0 5.5 6.7 6.6 6.6 5.3 0.4 1.1 5.7 4.2 1.7 1.6 1.1 3.4 2.5 3.5 7.2 4.6 1.9 2.2 5.2 4.6 5.2 4.4 4.1 3.6 5.2 13.7 3.6 5.3 7.7 4.4 2.2 2.1 8.1 3.7 20.4 3.3 2.9 6.1 5.8 29.8 2.3 4.6 9.7 3.6 5.7 3.2 7.8 8.4 9.3 4.8 9.1 6.5 14.1 1.3 8.4 6.9 4.1 3.2 5.9 5.1 2.2 11.0 6.2 2.2 11.7 3.3 1.4 20.6 7.8 3.9 4.8 1.6 5.7 9.1 4.1 2.4 2.0 3.0 10.1 5.3 1.1 3.0 5.7 0.6 3.2 1.0 0.4 1.4 1.4 1.1 0.1 1.6 0.8 1.0 1.7 4.2 0.7 1.6 1.1 15.9 33.1 18.2 31.2 15.8 13.6 9.1 12.6 11.7 9.1 6.0 6.2 2.2 1.4 9.5 14.6 2.0 2.5 13.4 4.5 1.8 35.3 0.8 3.3 2.8 2.6 5.0 25.7 0.0 2.4 1.2 2.0 2.9 2.3 4.3 7.9 20.6 1.2 15.4 12.9 1.5 2.0 9.7 6.8 7.2 5.5 4.8 4.2 10.1 1.4 3.3 29.7 6.5 3.1 2.3 1.9 9.5 0.9 8.7 4.5 1.6 C2CD5 "CDP138, KIAA0528" ENSG00000111731 "C2 calcium dependent domain containing 5" Q86YS7 12 22448583-22544546 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 49.1;Early spermatids: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046194 Approved Supported "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA046194: AB_10965327" "unprognostic (2.59e-1)" "unprognostic (1.84e-1)" "unprognostic (1.23e-2)" "unprognostic (1.17e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-3)" "unprognostic (1.08e-3)" "unprognostic (1.17e-2)" "unprognostic (8.47e-2)" "unprognostic (1.71e-1)" "unprognostic (2.69e-2)" "unprognostic (2.50e-2)" "unprognostic (1.51e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (2.05e-1)" "unprognostic (1.87e-3)" 10.2 11.2 18.9 16.3 26.6 11.8 13.6 48.5 30.7 13.1 18.5 10.0 10.0 17.8 15.6 12.3 10.4 15.8 15.4 8.8 14.6 16.5 15.7 7.8 11.2 13.8 13.5 22.8 17.4 12.3 23.3 26.2 9.3 26.9 10.3 20.0 13.3 12.7 10.0 8.0 11.7 14.8 12.7 10.8 15.0 19.2 12.9 12.9 18.7 15.5 4.9 14.3 11.7 11.8 7.3 6.1 15.3 14.1 12.8 8.0 4.3 8.5 8.4 18.8 10.2 12.5 16.6 12.0 9.4 10.2 17.7 21.1 9.3 11.4 9.7 4.2 8.8 9.8 7.6 12.0 7.7 24.7 15.7 12.5 12.0 9.2 8.3 11.5 16.1 14.5 9.5 5.6 11.3 20.0 16.8 12.7 13.5 7.8 6.3 11.4 9.1 15.2 24.8 37.5 16.7 6.4 13.3 20.9 13.1 10.5 7.0 8.7 7.6 8.5 8.4 8.9 29.1 11.1 10.8 11.0 10.6 8.6 9.5 9.9 5.1 3.9 15.6 6.6 12.3 7.8 15.3 6.1 2.9 5.5 13.5 7.2 7.3 8.0 5.4 6.1 5.0 7.2 5.7 6.2 12.8 14.1 3.5 8.0 4.3 18.9 26.6 48.5 30.7 14.6 16.5 13.5 22.8 26.9 12.9 8.9 15.8 5.2 3.6 6.2 28.7 13.9 15.3 22.7 25.0 5.2 49.1 3.1 5.0 3.0 54.5 7.1 12.3 0.0 4.0 1.7 6.8 5.4 17.3 7.4 7.1 17.5 15.5 20.3 28.5 14.0 8.1 12.0 6.8 1.8 19.2 6.7 2.8 10.5 7.4 5.1 45.1 6.5 6.1 10.3 6.1 4.8 2.2 7.0 15.3 3.9 C2orf40 "augurin, ECRG4" ENSG00000119147 "Chromosome 2 open reading frame 40" Q9H1Z8 2 106063246-106078159 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Ciliated cells: 481.8;Early spermatids: 894.2" "Cancer enriched" "Detected in many" 11 "thyroid cancer: 72.8" "Region enriched" "Detected in all" 7 "pons and medulla: 44.8" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 10.0;naive CD8 T-cell: 8.2" "Lineage enriched" "Detected in single" 77 "T-cells: 10.0" "Cell line enhanced" "Detected in some" "BEWO: 2.2;HSkMC: 1.0;NB-4: 1.3" "Group enriched" "Detected in many" 5 "basal ganglia: 44.8;cerebellum: 37.1;hippocampal formation: 85.7;pons and medulla: 114.2;thalamus: 69.1" "Low region specificity" "Detected in many" HPA008546 Uncertain "Secreted to blood" NA NA "HPA008546: AB_2066524" "prognostic favorable (4.58e-4)" "unprognostic (3.91e-1)" "unprognostic (2.44e-2)" "unprognostic (1.34e-2)" "unprognostic (1.09e-1)" "unprognostic (2.32e-1)" "unprognostic (1.61e-3)" "unprognostic (6.56e-3)" "unprognostic (1.82e-2)" "unprognostic (1.25e-1)" "unprognostic (2.35e-3)" "unprognostic (1.36e-2)" "unprognostic (1.06e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (9.11e-3)" "unprognostic (1.30e-4)" 27.5 14.0 1.6 7.6 3.2 0.4 12.7 4.1 4.1 21.8 11.0 18.7 19.9 2.9 19.5 25.8 16.5 15.9 10.3 6.5 3.2 5.1 14.7 1.4 8.4 1.0 6.2 3.7 7.9 3.4 1.0 27.6 4.2 44.8 37.1 3.0 33.9 10.2 50.7 4.1 3.2 6.4 66.8 9.6 12.0 50.6 11.0 1.9 0.1 44.2 8.2 2.5 46.6 26.8 0.1 0.0 0.0 0.0 0.1 10.0 1.7 0.0 0.0 0.7 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 2.4 1.6 0.0 0.0 10.0 8.2 0.0 0.1 0.0 0.0 0.7 1.7 1.6 3.2 4.1 4.1 3.2 5.1 6.2 3.7 44.8 1.9 0.0 1.4 0.0 1.8 7.1 0.1 6.3 0.0 481.8 40.9 19.2 0.0 1.4 0.0 0.6 894.2 5.8 0.0 0.0 0.0 0.7 22.3 1.6 1.1 0.0 2.3 3.2 10.2 11.1 0.3 110.5 19.0 2.7 1.7 0.0 0.0 0.2 0.0 0.0 59.4 0.0 0.2 38.8 97.8 9.7 3.6 0.9 2.6 0.5 0.0 1.8 C2orf66 UNQ6411 ENSG00000187944 "Chromosome 2 open reading frame 66" Q6UXQ4 2 196805002-196810276 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "adipose tissue: 7.0;pituitary gland: 6.4" "Cell type enriched" "Detected in some" 12 "Early spermatids: 27.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 9.4;RT4: 3.5;TIME: 3.9" HPA020869 Uncertain Uncertain Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA020869: AB_1851545" "unprognostic (1.19e-1)" "unprognostic (4.85e-2)" "unprognostic (6.95e-2)" "unprognostic (1.19e-1)" "unprognostic (3.48e-2)" "unprognostic (1.61e-2)" "unprognostic (6.80e-3)" "unprognostic (3.05e-2)" "unprognostic (1.95e-1)" "unprognostic (4.10e-3)" "unprognostic (4.54e-4)" "unprognostic (1.98e-1)" "unprognostic (1.75e-5)" "unprognostic (1.84e-1)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (1.86e-2)" 7.0 4.0 0.4 0.2 0.7 0.2 1.0 0.1 0.4 0.0 0.2 0.0 0.1 1.2 0.1 1.1 0.4 0.7 0.4 2.8 0.3 0.0 0.2 0.0 0.7 0.3 0.6 0.0 6.4 0.1 0.3 0.4 0.0 0.2 0.0 2.8 0.3 0.1 0.0 0.2 0.0 2.6 0.1 0.2 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.4 1.1 0.5 0.3 0.0 0.5 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 1.1 0.2 0.3 0.6 9.4 1.0 0.1 0.0 0.1 0.8 0.7 1.4 0.2 0.2 0.2 0.8 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.2 3.5 0.4 0.2 0.0 0.1 0.1 0.4 0.0 0.0 3.9 0.3 0.3 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 C2orf74 LOC339804 ENSG00000237651 "Chromosome 2 open reading frame 74" A8MZ97 2 61145068-61164829 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Distal tubular cells: 162.5;Early spermatids: 469.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" HPA026826 Approved Approved Centrosome NA NA Centrosome "HPA026826: AB_10671091" "unprognostic (1.20e-1)" "unprognostic (2.44e-1)" "unprognostic (2.03e-2)" "unprognostic (4.54e-2)" "unprognostic (8.10e-2)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (1.28e-3)" "unprognostic (3.57e-2)" "unprognostic (1.87e-1)" "unprognostic (1.54e-1)" "unprognostic (2.69e-2)" "unprognostic (6.65e-2)" "unprognostic (3.52e-1)" "unprognostic (6.22e-2)" 15.8 19.4 32.2 10.7 38.5 2.4 19.1 12.6 33.7 15.4 11.5 13.6 10.0 3.6 12.7 30.2 9.6 13.6 8.6 25.3 25.8 26.1 26.0 22.7 11.4 12.3 26.9 18.4 17.1 8.9 12.5 26.0 11.2 26.0 13.0 6.0 5.8 8.7 12.5 15.0 5.4 5.7 12.7 22.3 13.5 9.9 27.4 22.5 5.7 20.5 12.5 10.1 9.9 10.0 20.1 10.8 17.0 10.4 18.4 20.6 6.8 5.8 10.1 10.5 0.0 22.6 23.1 9.5 15.3 17.6 14.6 12.1 0.0 9.9 7.3 21.3 12.4 9.7 7.9 0.0 12.5 25.2 9.2 6.3 0.0 9.6 11.6 9.1 8.7 8.2 23.6 20.6 10.9 22.3 10.5 8.1 0.1 0.0 5.5 22.3 10.6 0.0 16.7 10.0 4.4 6.4 13.2 13.0 12.2 20.1 4.6 21.9 8.4 1.9 2.0 12.7 9.7 8.0 8.8 4.2 12.4 5.4 7.4 18.5 23.4 10.6 27.6 16.4 6.3 10.9 9.9 4.9 17.0 11.4 10.4 14.5 20.1 12.5 11.6 10.8 13.0 20.6 16.3 1.1 18.4 10.1 8.9 16.1 6.8 32.2 38.5 12.6 33.7 25.8 26.1 26.9 18.4 26.0 22.5 11.9 9.7 18.6 14.5 0.0 9.8 3.2 10.2 21.4 4.5 21.0 7.9 21.1 162.5 20.1 469.7 7.4 0.0 0.0 27.3 21.6 8.2 8.3 13.9 18.7 19.9 11.1 0.0 12.9 15.3 68.5 34.2 20.7 1.7 33.3 0.0 21.8 19.4 0.0 42.5 110.7 18.2 19.4 1.4 18.0 25.6 0.0 5.4 12.5 0.0 6.5 C2orf83 DKFZp547H025 ENSG00000042304 "Chromosome 2 open reading frame 83" Q53S99 2 227610090-227648606 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "placenta: 16.3" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 1.6;Late spermatids: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-2197: 12.6" HPA030319 Approved NA NA "HPA030319: AB_10602112" "unprognostic (1.12e-2)" "unprognostic (1.03e-1)" 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 C2orf92 LINC01125 ENSG00000228486 "Chromosome 2 open reading frame 92" 2 97664217-97703064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 12 "testis: 32.1" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 6.9;Ciliated cells: 2.7;Club cells: 4.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.5;HDLM-2: 5.1" NA NA "unprognostic (5.53e-2)" "unprognostic (8.76e-2)" "unprognostic (1.65e-2)" "unprognostic (2.08e-1)" "unprognostic (4.81e-2)" "unprognostic (3.09e-3)" "unprognostic (9.29e-2)" "unprognostic (1.22e-2)" "unprognostic (1.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.98e-3)" "unprognostic (2.76e-2)" "unprognostic (7.45e-7)" "unprognostic (5.57e-2)" "unprognostic (1.28e-1)" "unprognostic (3.11e-1)" "unprognostic (5.23e-5)" 0.7 0.0 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 2.4 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 1.4 0.3 1.6 2.6 0.2 0.2 0.2 1.4 0.0 32.1 0.2 0.2 0.7 0.2 0.3 0.2 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.0 0.4 0.0 4.5 0.8 2.2 1.6 0.6 0.0 0.2 0.3 0.3 0.0 0.4 1.3 0.7 0.4 0.0 0.0 0.0 0.0 2.0 5.1 0.0 2.0 0.4 0.0 0.0 1.2 0.2 1.5 0.3 0.0 0.0 0.6 0.0 0.4 0.0 0.5 1.2 0.3 0.2 2.6 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 2.5 2.1 1.1 1.6 0.2 1.4 1.8 0.7 2.7 0.0 0.6 0.6 0.1 0.3 0.1 0.4 1.9 2.4 1.4 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.5 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 C3AR1 "AZ3B, C3AR" ENSG00000171860 "Complement C3a receptor 1" Q16581 12 8058302-8066471 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 101.1" "Group enriched" "Detected in many" 4 "granulocytes: 35.8;Hofbauer cells: 141.5;Kupffer cells: 97.6;Macrophages: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 101.1;eosinophil: 56.9;intermediate monocyte: 34.5;non-classical monocyte: 47.0" "Group enriched" "Detected in many" 18 "granulocytes: 101.1;monocytes: 47.0" "Cell line enriched" "Detected in some" 9 "HMC-1: 67.4" "Low region specificity" "Detected in many" CAB009405 Enhanced NA NA "CAB009405: AB_2066739" "unprognostic (1.11e-2)" "unprognostic (5.67e-2)" "unprognostic (5.06e-2)" "unprognostic (4.14e-2)" "unprognostic (6.60e-2)" "unprognostic (1.50e-1)" "unprognostic (4.81e-2)" "unprognostic (2.78e-1)" "unprognostic (6.10e-2)" "unprognostic (8.04e-2)" "unprognostic (1.59e-1)" "unprognostic (3.50e-2)" "unprognostic (8.22e-2)" "unprognostic (4.96e-2)" "unprognostic (9.24e-3)" "unprognostic (2.09e-2)" "unprognostic (8.16e-2)" 34.1 10.0 11.7 35.1 15.5 17.4 10.7 1.9 7.6 7.2 5.8 15.5 0.7 4.9 4.8 6.7 3.8 7.3 15.0 7.3 9.7 7.2 9.2 10.0 21.1 29.7 16.7 3.5 4.9 5.5 2.9 3.5 19.8 13.3 4.8 6.4 5.2 7.8 4.0 3.6 2.7 9.1 13.9 23.4 25.2 4.9 5.8 16.2 1.9 3.2 1.5 4.8 12.9 3.7 0.0 4.0 101.1 47.0 0.5 3.8 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.2 1.9 0.0 0.0 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 5.9 0.0 0.0 0.6 7.8 67.4 0.3 0.0 0.1 0.2 0.1 0.3 0.5 1.6 3.9 0.2 0.0 0.3 2.8 0.0 0.0 0.0 0.0 1.4 7.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.3 0.2 0.2 0.0 0.1 0.1 0.0 0.2 4.3 3.0 0.2 101.1 13.6 56.9 2.9 34.5 3.8 0.0 1.5 2.0 4.0 0.0 0.3 1.2 1.8 0.5 47.0 0.3 1.5 7.8 11.7 15.5 1.9 7.6 9.7 7.2 16.7 3.5 13.3 16.2 0.0 4.8 1.4 0.0 0.5 0.0 0.4 2.5 1.4 4.5 0.0 2.0 0.5 0.0 0.0 1.9 0.3 0.0 0.0 0.2 1.0 0.9 0.0 35.8 0.8 141.5 0.0 0.0 1.8 97.6 2.7 1.1 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 19.4 0.7 0.0 0.1 0.5 1.3 11.7 0.0 0.0 C3orf18 G20 ENSG00000088543 "Chromosome 3 open reading frame 18" Q9UK00 3 50558025-50571027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 26.3;Early spermatids: 47.6;Late spermatids: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;NK-cells: 2.1;T-cells: 7.7" "Cell line enhanced" "Detected in many" "HDLM-2: 29.8" "Group enriched" "Detected in many" 4 "cerebellum: 31.6;olfactory region: 33.8" "Low region specificity" "Detected in all" HPA012105 Approved Approved Cytosol No No Cytosol "HPA012105: AB_1845717" "unprognostic (9.29e-3)" "unprognostic (1.46e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (8.19e-2)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (1.05e-2)" "unprognostic (1.64e-1)" "unprognostic (1.76e-1)" "unprognostic (2.10e-3)" "unprognostic (1.29e-2)" "prognostic favorable (2.80e-9)" "unprognostic (7.65e-2)" "unprognostic (4.49e-1)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" 5.1 6.7 10.0 3.4 12.3 1.2 6.2 34.5 20.1 6.0 6.1 8.0 2.2 2.2 8.0 5.1 5.0 8.4 6.0 25.3 8.1 9.7 6.0 3.0 4.1 3.9 11.4 9.3 14.0 6.1 19.2 7.4 2.6 10.3 8.5 3.2 11.9 7.3 11.0 32.4 2.8 2.9 10.4 6.9 4.1 5.2 9.8 6.1 1.8 6.9 7.2 4.0 6.8 4.9 2.9 0.9 0.8 0.5 2.1 7.7 3.0 1.1 1.7 1.9 0.4 6.6 5.9 0.6 6.9 10.8 6.3 4.6 0.1 1.7 1.4 1.7 9.4 6.0 0.1 0.0 2.7 3.3 29.8 0.2 2.8 3.9 0.5 3.3 0.0 3.8 5.8 0.4 6.1 0.3 5.1 1.2 4.5 0.6 1.3 3.7 0.2 0.2 0.9 2.4 1.2 7.7 0.6 0.2 1.6 0.3 0.2 2.2 10.3 1.8 0.4 0.1 2.3 2.1 0.8 0.3 6.4 5.0 11.5 0.8 1.8 1.5 0.2 9.1 3.1 0.1 0.0 0.5 0.8 6.3 0.2 7.7 2.9 5.5 6.0 0.5 1.8 6.4 7.7 0.0 2.1 0.1 0.9 2.5 3.0 10.0 12.3 34.5 20.1 8.1 9.7 11.4 9.3 10.3 6.1 0.0 0.6 0.0 1.5 1.0 9.2 26.3 0.0 1.4 2.3 1.8 7.9 0.4 3.3 1.8 47.6 1.6 0.0 0.0 1.6 0.5 4.1 0.6 0.0 1.7 1.4 1.6 1.7 2.5 0.3 47.3 4.4 0.4 0.0 15.4 0.3 8.9 0.7 0.0 3.9 1.8 15.9 12.9 3.0 2.8 1.7 0.4 0.1 2.2 0.1 0.1 C3orf52 "FLJ23186, TTMP" ENSG00000114529 "Chromosome 3 open reading frame 52" Q5BVD1 3 112086335-112131004 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 41.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 112.5;Glandular cells: 75.6;Syncytiotrophoblasts: 62.7;Urothelial cells: 119.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 14.9;U-698: 20.8" "HPA007678, HPA008119, HPA011968" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826" "unprognostic (8.86e-2)" "unprognostic (1.71e-1)" "unprognostic (3.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.45e-2)" "unprognostic (3.87e-3)" "unprognostic (3.49e-4)" "unprognostic (2.54e-1)" "unprognostic (1.39e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.71e-2)" "unprognostic (3.76e-6)" "unprognostic (3.14e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-2)" "unprognostic (9.59e-2)" 1.1 1.0 0.3 5.3 0.7 0.4 1.9 0.3 0.4 1.0 9.1 0.0 6.9 2.8 1.7 1.5 2.7 1.0 12.4 3.0 0.4 0.4 7.1 0.5 6.3 0.8 0.3 0.0 0.6 41.2 0.0 8.7 6.1 0.5 5.4 9.0 0.6 3.9 9.6 1.5 22.3 12.7 4.2 0.3 0.8 10.6 1.0 0.0 20.8 10.7 4.3 3.6 6.1 6.1 0.8 0.8 0.0 0.0 0.0 2.7 1.0 8.7 1.4 2.4 0.0 0.3 0.0 3.2 6.9 2.9 4.0 4.6 14.9 4.7 0.3 1.3 2.0 4.6 6.2 2.8 1.7 7.6 0.0 2.3 6.0 2.0 0.7 1.8 0.0 0.0 0.5 3.5 3.6 6.1 2.8 0.9 0.0 1.5 1.5 3.0 0.6 0.2 0.0 5.2 5.6 1.9 0.2 7.9 0.0 7.1 7.7 0.3 0.6 2.6 2.7 2.5 2.9 4.0 0.0 2.2 1.4 2.4 0.0 0.0 5.5 0.0 20.8 1.2 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.4 0.8 2.7 1.3 0.5 0.3 1.5 0.6 0.0 0.0 0.0 0.8 0.0 1.0 0.3 0.7 0.3 0.4 0.4 0.4 0.3 0.0 0.5 0.0 14.9 7.7 0.5 112.5 28.8 0.0 1.4 5.1 13.4 22.7 17.4 0.0 15.2 0.0 29.6 24.4 0.3 14.6 0.0 31.2 16.0 1.7 75.6 0.0 0.0 1.6 0.0 11.3 0.6 0.3 18.2 0.3 0.3 1.7 4.6 32.5 0.0 53.5 5.9 0.4 1.7 0.0 0.0 3.3 1.8 5.5 29.4 62.7 0.8 5.4 119.7 C3orf80 ENSG00000180044 "Chromosome 3 open reading frame 80" F5H4A9 3 160225496-160228213 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.0;intestine: 8.6" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 4.5;Horizontal cells: 6.4;Intestinal endocrine cells: 4.1;Spermatocytes: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HMC-1: 57.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047439 Uncertain NA NA "HPA047439: AB_10965171" "unprognostic (5.34e-2)" "unprognostic (2.31e-1)" "unprognostic (6.35e-2)" "unprognostic (6.62e-3)" "unprognostic (1.92e-3)" "unprognostic (6.70e-3)" "unprognostic (4.28e-3)" "unprognostic (1.69e-1)" "unprognostic (4.64e-3)" "unprognostic (1.51e-1)" "unprognostic (9.20e-2)" "unprognostic (2.65e-1)" "unprognostic (6.09e-10)" "unprognostic (1.32e-2)" "unprognostic (1.78e-2)" "unprognostic (4.11e-3)" "unprognostic (5.00e-2)" 1.3 0.4 5.2 1.6 9.3 1.4 0.7 5.4 25.0 0.5 8.6 0.1 0.0 1.8 1.2 0.5 5.7 0.3 1.4 0.6 4.3 2.0 0.6 0.8 2.0 0.3 1.7 9.3 0.3 0.4 1.4 0.7 0.3 1.2 1.8 3.3 0.0 0.6 0.8 0.2 0.2 1.3 1.8 0.5 2.7 2.5 1.3 0.0 0.0 0.5 0.0 0.4 2.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 1.1 0.7 4.8 1.3 0.0 0.0 0.9 57.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.5 0.0 0.0 0.0 0.1 11.7 0.0 0.0 0.2 0.0 1.4 0.1 0.0 0.0 0.4 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.2 9.3 5.4 25.0 4.3 2.0 1.7 9.3 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.5 0.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 6.4 4.1 1.3 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 2.1 0.5 0.0 0.0 0.0 0.0 0.0 C4orf3 HCVFTP1 ENSG00000164096 "Chromosome 4 open reading frame 3" Q8WVX3 4 119296419-119304445 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Proximal tubular cells: 865.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA026907 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA026907: AB_10600760" "unprognostic (2.97e-1)" "unprognostic (4.68e-2)" "unprognostic (3.32e-1)" "unprognostic (6.85e-3)" "unprognostic (9.30e-2)" "unprognostic (7.15e-3)" "unprognostic (2.04e-1)" "unprognostic (8.85e-2)" "unprognostic (4.90e-2)" "unprognostic (7.11e-2)" "unprognostic (9.94e-3)" "unprognostic (1.84e-1)" "prognostic favorable (3.46e-4)" "unprognostic (8.32e-2)" "unprognostic (2.65e-1)" "unprognostic (3.90e-1)" "unprognostic (1.59e-1)" 51.6 41.9 46.2 39.1 47.2 19.0 31.7 18.2 41.1 46.1 33.5 41.1 25.6 41.3 39.4 49.0 101.3 33.8 37.0 43.4 46.5 45.4 55.8 63.4 33.6 32.2 61.2 31.6 45.1 32.7 19.6 34.7 36.6 47.3 38.7 20.3 33.4 42.6 34.1 70.5 37.7 45.0 41.5 68.7 38.0 26.9 19.4 35.8 30.3 44.2 42.3 39.3 50.0 59.8 60.4 66.8 112.7 53.3 38.0 48.6 65.5 69.1 8.0 23.3 19.3 32.7 24.9 19.0 30.6 8.3 9.0 16.7 8.5 23.1 47.6 23.7 29.2 16.8 13.6 10.3 25.3 14.1 31.9 10.2 19.7 18.5 29.9 9.8 32.3 21.6 26.0 21.2 12.9 5.6 42.0 15.0 13.7 17.5 19.9 33.0 19.9 20.9 30.2 11.8 26.9 8.2 15.0 31.2 12.1 17.0 15.8 14.7 23.8 23.2 30.8 15.9 23.9 16.5 16.9 29.5 33.3 19.8 20.1 12.4 33.6 34.4 22.1 62.6 13.4 18.8 69.3 50.7 60.4 40.1 53.3 38.7 60.4 47.8 45.0 42.7 46.4 48.4 46.9 112.7 38.0 49.0 66.8 48.6 65.5 46.2 47.2 18.2 41.1 46.5 45.4 61.2 31.6 47.3 35.8 145.9 143.1 236.2 239.8 280.2 80.9 421.0 165.6 215.5 144.5 211.1 23.6 289.6 325.0 242.8 18.7 229.5 160.4 23.3 156.7 297.9 248.2 254.6 179.3 378.8 279.6 144.6 65.7 200.7 283.9 15.8 155.1 255.4 189.0 413.8 155.2 139.4 215.9 181.4 202.6 865.1 58.0 194.1 282.9 205.3 54.1 303.0 372.8 183.3 101.9 339.6 C5AR1 "C5A, C5AR, C5R1, CD88" ENSG00000197405 "Complement C5a receptor 1" P21730 19 47290023-47322066 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.8" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 131.1;Kupffer cells: 223.6;Macrophages: 162.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 75.8" "Group enriched" "Detected in many" 42 "granulocytes: 75.8;monocytes: 20.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 6.0;HMC-1: 7.5;U-87 MG: 9.0;U-937: 9.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002720, HPA014520, HPA048012" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "CAB002720: , HPA014520: AB_1846337, HPA048012: " "unprognostic (5.95e-2)" "prognostic favorable (4.71e-4)" "unprognostic (1.70e-2)" "unprognostic (1.25e-1)" "unprognostic (4.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.80e-2)" "unprognostic (4.41e-2)" "unprognostic (5.45e-2)" "prognostic unfavorable (9.55e-4)" "unprognostic (2.02e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.96e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (1.82e-2)" "unprognostic (6.54e-2)" 33.7 8.0 1.9 34.9 7.0 46.2 8.7 0.7 3.0 5.6 6.0 3.7 1.6 1.0 4.1 4.9 3.5 14.3 16.5 11.7 7.6 3.2 5.3 9.1 38.1 26.9 3.8 1.2 7.6 3.6 1.3 27.9 12.8 10.9 4.2 1.9 7.8 2.9 1.1 7.0 1.1 3.0 11.4 11.2 48.8 4.2 6.3 1.3 2.3 2.5 1.7 3.4 12.2 2.7 0.1 1.1 75.8 20.5 0.1 0.1 2.6 1.4 5.4 0.3 0.5 1.0 0.4 1.1 1.0 0.6 0.3 0.1 0.2 6.0 0.5 1.1 1.2 0.7 2.0 0.7 0.8 0.2 1.0 0.7 0.2 5.0 0.8 0.7 2.7 7.5 0.8 3.0 0.6 0.9 0.9 0.0 0.3 0.3 2.6 0.2 1.5 0.3 3.4 1.9 0.3 0.9 0.3 0.2 0.4 1.8 1.3 0.0 0.1 0.5 0.6 0.8 0.9 0.4 3.1 0.0 0.1 3.2 0.4 0.3 0.4 0.4 0.3 9.0 9.1 0.3 7.0 8.9 6.9 0.1 15.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 75.8 0.1 20.5 0.2 0.0 2.6 1.9 7.0 0.7 3.0 7.6 3.2 3.8 1.2 10.9 1.3 3.0 33.4 11.3 0.6 4.5 0.8 2.0 2.5 52.2 26.1 1.8 2.0 0.8 3.3 0.0 0.6 1.7 1.1 0.0 0.0 0.9 2.6 0.5 23.3 3.4 131.1 0.0 0.0 3.1 223.6 0.0 0.6 162.7 5.0 14.4 0.7 0.4 0.1 0.0 0.0 1.1 4.2 12.9 1.7 0.5 1.1 2.6 1.3 0.0 0.9 0.3 C5AR2 "C5L2, GPR77" ENSG00000134830 "Complement component 5a receptor 2" Q9P296 19 47332147-47347327 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.1;lymphoid tissue: 17.3" "Cell type enhanced" "Detected in many" 12 "Ito cells: 31.3;Kupffer cells: 30.9;Macrophages: 18.2" "Cancer enhanced" "Detected in many" "breast cancer: 3.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 9.4;eosinophil: 7.0;neutrophil: 21.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 21.1" "Group enriched" "Detected in some" 5 "MCF7: 17.1;T-47d: 21.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA016629 Uncertain NA NA "HPA016629: AB_1849312" "unprognostic (5.00e-2)" "unprognostic (2.31e-2)" "unprognostic (4.33e-2)" "unprognostic (2.00e-6)" "unprognostic (2.88e-1)" "unprognostic (1.13e-2)" "unprognostic (1.02e-2)" "unprognostic (2.13e-1)" "unprognostic (2.25e-2)" "unprognostic (1.28e-1)" "unprognostic (1.39e-2)" "unprognostic (6.05e-2)" "unprognostic (3.73e-5)" "unprognostic (1.16e-2)" "unprognostic (7.42e-2)" "unprognostic (1.34e-1)" "unprognostic (6.88e-3)" 7.2 1.7 1.1 7.4 1.6 9.2 4.7 0.3 3.5 2.0 1.9 1.7 0.0 0.9 1.5 4.1 3.3 2.8 2.9 3.2 3.6 1.0 2.4 3.1 7.5 6.8 1.3 2.2 2.0 1.4 0.4 1.4 3.9 2.9 0.8 0.9 1.9 1.9 0.6 0.8 2.2 2.0 1.8 4.5 17.3 1.6 3.8 0.3 0.0 1.4 4.4 13.6 5.6 2.0 0.3 0.4 21.1 2.7 0.2 0.4 0.4 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.4 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.1 4.0 0.1 0.0 0.7 1.3 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.0 17.1 0.0 2.0 0.2 0.0 0.0 0.2 0.2 2.2 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.1 21.2 0.2 0.1 0.7 0.2 0.4 0.1 0.3 0.2 0.8 0.7 1.2 0.1 9.4 1.7 7.0 0.2 1.5 0.2 0.2 0.1 0.1 0.4 0.3 0.1 0.1 21.1 0.2 2.7 0.2 0.4 0.4 1.1 1.6 0.3 3.5 3.6 1.0 1.3 2.2 2.9 0.3 3.0 3.4 1.9 2.4 0.3 1.1 1.4 0.0 1.4 4.5 1.8 2.0 0.1 0.0 0.0 4.3 0.7 0.0 0.0 0.0 0.1 0.3 1.7 1.1 0.8 7.1 0.0 0.0 31.3 30.9 2.9 0.0 18.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 3.8 0.0 0.4 0.2 0.4 0.6 0.1 1.3 0.0 2.0 C5orf15 "HTGN29, KCT2" ENSG00000113583 "Chromosome 5 open reading frame 15" Q8NC54 5 133955502-133968787 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011951, HPA039165" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA011951: AB_2668584, HPA039165: AB_10795580" "unprognostic (2.25e-1)" "unprognostic (3.01e-1)" "unprognostic (2.07e-1)" "unprognostic (4.91e-2)" "unprognostic (1.81e-1)" "unprognostic (2.26e-3)" "unprognostic (1.01e-2)" "unprognostic (7.72e-2)" "unprognostic (2.62e-2)" "unprognostic (7.54e-2)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (9.07e-3)" "unprognostic (5.18e-2)" "unprognostic (1.34e-1)" "unprognostic (1.66e-1)" "unprognostic (2.14e-2)" 25.2 36.1 17.4 28.0 24.0 9.2 39.1 18.4 28.9 24.3 19.4 25.7 23.6 27.7 22.3 27.8 20.2 28.3 24.9 53.2 19.4 20.1 56.1 45.2 34.3 36.8 18.9 15.6 32.6 26.6 28.3 25.2 36.0 31.3 23.9 19.5 21.8 24.6 29.6 20.0 21.2 32.0 17.7 41.8 26.8 27.6 26.8 20.2 21.9 31.2 16.4 20.4 27.5 20.4 16.8 24.0 11.0 22.5 13.5 15.6 17.4 17.1 12.8 17.8 20.7 26.6 30.5 22.0 18.1 23.9 27.5 46.1 12.4 51.6 12.2 32.9 21.5 27.9 12.9 14.5 25.9 32.4 13.8 22.2 4.6 9.3 15.7 25.2 7.4 20.6 26.6 16.1 21.5 11.4 39.4 11.5 7.8 9.5 14.6 21.9 10.8 8.6 14.2 10.0 8.4 7.7 8.4 18.5 18.1 44.5 13.3 16.3 12.1 17.9 6.2 28.4 33.8 19.1 22.7 10.6 24.8 23.0 10.0 17.7 11.0 10.6 7.4 29.3 18.0 36.4 11.0 21.2 10.6 10.5 22.5 9.8 16.0 11.9 11.4 24.0 16.8 15.6 12.4 10.8 13.5 20.5 17.5 11.4 17.4 17.4 24.0 18.4 28.9 19.4 20.1 18.9 15.6 31.3 20.2 23.8 28.6 34.0 31.0 27.2 21.3 15.5 33.1 93.7 34.2 47.1 9.8 71.8 14.9 61.8 29.5 20.0 36.5 0.0 41.4 59.2 66.2 31.8 15.0 40.4 47.4 4.8 35.7 23.4 26.4 3.1 47.5 38.1 60.8 140.7 30.1 25.9 43.8 26.0 36.7 66.9 26.7 25.8 30.9 41.2 24.3 28.4 48.5 21.7 22.6 14.9 C5orf46 "MGC23985, SSSP1" ENSG00000178776 "Chromosome 5 open reading frame 46" Q6UWT4 5 147880726-147906538 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "salivary gland: 107.9;skin 1: 42.7" "Group enriched" "Detected in some" 7 "Early spermatids: 262.3;Late spermatids: 107.1" "Cancer enhanced" "Detected in many" "renal cancer: 8.3" "Region enriched" "Detected in single" 5 "cerebellum: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 23.8;PC-3: 39.1;SiHa: 8.7;U-2 OS: 25.5;U-251 MG: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058999, HPA079692" Supported Approved "Nuclear speckles,Mitochondria" "Secreted in other tissues" NA NA "Nuclear speckles" Mitochondria "HPA058999: , HPA079692: " "unprognostic (1.72e-1)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.26e-4)" "unprognostic (9.75e-3)" "unprognostic (2.95e-3)" "unprognostic (1.69e-3)" "unprognostic (1.99e-2)" "unprognostic (3.08e-2)" "unprognostic (2.22e-1)" "unprognostic (4.96e-2)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.75e-9)" "unprognostic (6.48e-3)" "unprognostic (3.47e-2)" "unprognostic (6.01e-2)" "unprognostic (2.79e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 5.2 2.0 0.1 0.6 0.1 0.1 0.1 0.0 0.3 0.6 0.2 0.0 0.2 3.0 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 0.6 0.0 0.1 4.3 0.4 0.4 0.0 0.2 107.9 0.4 0.6 42.7 0.1 1.0 0.1 0.1 0.0 6.5 0.2 0.2 0.1 1.1 0.6 0.2 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 4.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.7 0.1 0.1 5.1 0.0 0.0 0.0 4.6 25.5 0.3 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.1 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.5 0.0 8.7 25.5 0.0 0.0 1.8 0.0 0.1 0.0 12.4 262.3 0.0 0.0 0.0 2.9 0.1 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 107.1 1.7 0.0 3.3 1.0 0.0 6.7 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.8 18.1 1.1 0.0 0.0 0.1 C5orf60 ENSG00000204661 "Chromosome 5 open reading frame 60" A6NFR6 5 179641544-179645046 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 3.7;testis: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 2.2;Karpas-707: 2.5;RT4: 1.6" HPA065431 Enhanced NA NA "HPA065431: " "unprognostic (3.47e-3)" "unprognostic (1.00e-1)" "unprognostic (3.23e-1)" "unprognostic (2.62e-1)" "unprognostic (5.66e-5)" "unprognostic (1.18e-1)" "unprognostic (2.65e-2)" "unprognostic (1.71e-1)" "unprognostic (3.50e-3)" "unprognostic (7.11e-2)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" "unprognostic (9.47e-2)" "unprognostic (2.16e-1)" "unprognostic (8.76e-2)" "unprognostic (1.72e-2)" 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.0 0.0 0.0 1.8 1.1 3.7 1.1 2.4 1.2 0.2 0.3 0.0 0.0 0.0 0.9 0.0 0.2 0.3 0.1 0.0 0.2 0.0 0.1 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 2.2 0.5 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.3 2.5 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 1.6 0.4 0.9 0.0 1.0 0.1 0.7 0.2 0.0 0.0 0.8 0.3 0.3 0.0 1.0 0.6 0.0 0.0 0.2 0.5 3.2 1.1 1.2 0.8 0.5 0.3 1.1 0.6 0.6 0.4 1.8 0.9 1.2 3.7 2.4 0.5 1.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C6orf10 TSBP ENSG00000204296 "Chromosome 6 open reading frame 10" Q5SRN2 6 32288526-32371912 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 28.6" "Cell type enriched" "Detected in some" 12 "Early spermatids: 313.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SuSa: 1.1;U-2197: 1.3" HPA047479 Approved Cytosol NA NA Cytosol "HPA047479: " "unprognostic (1.00e-1)" "unprognostic (2.24e-1)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.55e-1)" "unprognostic (4.32e-4)" "unprognostic (2.42e-1)" "unprognostic (8.19e-2)" "unprognostic (6.56e-2)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 313.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.1 0.0 0.0 0.0 0.0 0.0 C6orf136 Em:AB023049.8 ENSG00000204564 "Chromosome 6 open reading frame 136" Q5SQH8 6 30647039-30653210 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046804 Uncertain NA NA "HPA046804: AB_2679815" "unprognostic (1.94e-2)" "unprognostic (1.71e-3)" "unprognostic (1.26e-1)" "unprognostic (8.01e-3)" "unprognostic (1.65e-2)" "unprognostic (2.76e-2)" "unprognostic (1.61e-1)" "unprognostic (1.79e-1)" "unprognostic (2.13e-1)" "unprognostic (2.62e-2)" "unprognostic (4.72e-3)" "unprognostic (3.43e-1)" "prognostic favorable (9.16e-8)" "unprognostic (2.33e-2)" "unprognostic (4.54e-2)" "unprognostic (6.03e-2)" "prognostic favorable (7.51e-4)" 7.4 13.4 13.5 7.1 19.0 7.5 6.9 22.6 30.0 8.1 22.5 11.9 8.4 24.2 6.2 16.4 9.6 8.4 6.8 16.9 13.5 15.1 14.4 11.7 9.2 8.1 15.8 18.1 5.2 13.3 20.4 12.3 7.0 24.9 7.3 21.3 8.4 8.9 12.1 21.3 14.3 21.5 7.7 11.7 8.2 9.1 7.6 9.5 3.6 10.7 13.0 6.8 10.0 5.8 3.5 2.5 2.2 1.2 1.1 3.9 1.2 3.7 6.2 3.3 2.9 5.1 6.3 5.8 1.4 1.7 3.8 5.3 4.0 2.7 3.2 2.3 1.1 3.2 5.1 0.5 0.2 4.1 2.8 4.7 1.7 4.3 2.4 1.4 5.3 5.5 2.8 5.7 2.8 3.5 3.8 1.5 5.3 4.3 2.4 0.8 6.3 2.3 5.8 3.7 5.9 3.4 4.5 3.1 6.5 8.3 5.5 8.0 1.5 1.9 6.5 4.3 1.3 3.2 1.2 0.7 1.1 5.6 2.2 4.8 6.4 7.4 2.2 2.0 4.7 2.5 0.1 1.2 0.2 2.0 1.0 2.6 3.5 2.4 1.4 1.2 2.3 3.9 2.3 2.2 1.1 1.1 2.5 1.7 1.2 13.5 19.0 22.6 30.0 13.5 15.1 15.8 18.1 24.9 9.5 0.0 4.1 10.4 10.9 8.2 16.6 22.2 12.7 4.0 4.5 34.9 3.9 14.7 49.7 15.7 11.6 9.3 69.1 0.0 15.5 9.0 7.8 8.5 12.7 9.4 13.5 11.1 22.0 6.7 3.5 13.1 7.2 8.6 10.1 11.8 43.6 13.0 14.3 49.1 6.0 20.3 18.9 6.5 5.7 23.6 47.3 9.4 14.1 10.1 40.5 15.5 C6orf89 "BRAP, FLJ25357" ENSG00000198663 "Chromosome 6 open reading frame 89" Q6UWU4 6 36871870-36928964 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 322.9;Late spermatids: 482.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 88.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012548 Uncertain NA NA "HPA012548: AB_1845748" "unprognostic (2.26e-1)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (3.01e-1)" "unprognostic (1.19e-1)" "unprognostic (2.52e-1)" "unprognostic (2.94e-2)" "unprognostic (1.20e-1)" "unprognostic (1.69e-2)" "unprognostic (1.69e-2)" "unprognostic (2.26e-2)" "unprognostic (1.44e-1)" "prognostic favorable (5.77e-5)" "unprognostic (3.75e-3)" "unprognostic (3.85e-1)" "unprognostic (9.94e-3)" "unprognostic (8.42e-3)" 28.0 38.1 26.5 20.9 31.9 24.8 31.2 20.2 34.9 38.2 27.9 33.1 38.6 21.3 34.7 40.0 28.3 30.9 27.2 44.0 33.2 26.4 31.4 42.9 25.9 25.3 30.2 28.8 36.8 47.4 47.7 32.4 29.5 31.6 29.8 29.4 27.1 29.6 60.4 38.3 22.7 25.1 35.2 38.0 20.5 28.3 36.3 25.3 16.1 45.5 21.0 23.3 31.3 28.4 8.6 11.7 21.9 16.5 8.5 15.5 10.2 9.2 5.7 8.0 11.4 29.3 20.2 4.7 18.4 23.3 13.1 14.4 5.9 9.9 8.3 14.4 37.8 14.0 10.2 9.7 11.6 19.1 14.8 8.4 12.0 6.2 6.6 14.6 9.7 12.5 17.3 14.5 16.0 15.4 15.6 11.3 15.2 22.8 23.2 20.2 9.2 10.6 3.6 2.9 10.7 6.4 5.2 7.9 15.0 8.7 8.2 14.2 10.1 12.3 6.0 12.8 7.0 14.3 13.2 13.1 18.8 10.8 14.8 14.3 12.5 15.3 88.2 8.4 13.9 19.6 19.6 13.0 16.0 15.4 12.7 15.5 8.6 12.8 14.2 11.7 7.8 9.0 9.5 21.9 8.5 16.5 7.3 12.9 10.2 26.5 31.9 20.2 34.9 33.2 26.4 30.2 28.8 31.6 25.3 35.7 49.1 35.9 21.5 6.1 14.4 61.4 43.3 18.7 26.1 36.6 9.8 28.5 16.6 34.1 322.9 30.6 29.0 46.7 50.3 35.4 25.1 22.7 29.0 42.3 35.3 22.3 16.7 20.9 25.9 482.3 41.7 21.2 10.1 17.2 24.4 52.6 45.1 26.4 47.7 18.1 10.8 19.4 16.4 20.9 30.5 7.9 38.4 20.0 23.3 22.1 C8B ENSG00000021852 "Complement C8 beta chain" P07358 1 56929210-56966140 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 52 "liver: 240.9" "Cell type enriched" "Detected in some" 11 "Hepatocytes: 251.9" "Cancer enriched" "Detected in some" 181 "liver cancer: 107.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 47 "basophil: 4.6" "Lineage enriched" "Detected in single" 47 "granulocytes: 4.6" "Cell line enriched" "Detected in some" 5 "Hep G2: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023694 Supported "Secreted to blood" NA NA 3600000000 "HPA023694: AB_1847128" "unprognostic (6.65e-2)" "prognostic favorable (9.31e-5)" "unprognostic (2.37e-1)" "unprognostic (2.37e-1)" "unprognostic (1.29e-2)" "unprognostic (6.57e-2)" "unprognostic (5.12e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 240.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 5.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.3 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 23.3 0.6 0.0 0.0 0.0 0.0 251.9 0.1 0.0 0.0 6.2 5.3 8.9 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 C9orf57 ENSG00000204669 "Chromosome 9 open reading frame 57" Q5W0N0 9 72051376-72072721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 114 "testis: 31.4" "Cell type enriched" "Detected in some" 16 "Spermatocytes: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 3.2" NA NA "unprognostic (3.26e-2)" "unprognostic (1.15e-1)" "unprognostic (5.05e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 CA12 HsT18816 ENSG00000074410 "Carbonic anhydrase 12" O43570 15 63321378-63382161 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 103.5" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 155.1;Enterocytes: 240.0;Paneth cells: 157.9;Suprabasal keratinocytes: 220.4" "Cancer enhanced" "Detected in all" "renal cancer: 109.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 39.0;ASC TERT1: 41.1;RT4: 41.3;SK-BR-3: 33.1;T-47d: 53.4;U-138 MG: 57.0;U-87 MG: 68.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008773, CAB025181, CAB062549, CAB068179" Enhanced NA NA 29000 "CAB025181: , CAB062549: AB_2665617, CAB068179: AB_2665616, HPA008773: AB_1078394" "unprognostic (2.01e-1)" "unprognostic (8.38e-3)" "unprognostic (3.47e-1)" "unprognostic (3.25e-3)" "unprognostic (2.73e-2)" "unprognostic (2.47e-2)" "unprognostic (7.48e-2)" "unprognostic (3.43e-3)" "unprognostic (2.29e-1)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.80e-6)" "unprognostic (2.59e-1)" "unprognostic (1.51e-1)" "unprognostic (2.38e-1)" "unprognostic (6.56e-2)" "unprognostic (7.26e-2)" "unprognostic (1.21e-1)" 3.7 0.3 4.7 15.0 27.4 0.3 14.5 3.7 2.3 15.7 32.0 2.6 5.0 0.4 9.8 12.3 42.8 8.5 2.6 1.6 4.9 1.4 103.5 0.3 1.2 0.3 1.8 0.2 2.1 43.8 0.3 3.9 5.9 16.9 3.8 30.3 8.5 8.2 17.9 0.5 44.1 2.4 18.1 0.1 0.4 2.2 1.3 6.7 0.0 1.7 18.4 25.9 10.6 14.5 0.3 0.2 0.6 0.7 0.3 0.2 0.0 0.0 39.0 0.6 0.1 5.2 41.1 2.1 2.8 2.5 0.4 0.7 0.2 0.1 0.0 9.6 2.3 15.4 0.2 0.0 1.9 1.1 0.0 1.4 0.0 2.6 0.0 0.1 0.0 0.0 15.5 2.1 11.9 3.8 0.0 0.5 0.0 0.0 0.0 0.5 22.4 0.0 0.0 0.6 0.0 6.1 0.0 0.0 0.0 0.0 41.3 0.3 0.0 0.1 33.1 0.0 0.4 53.4 0.0 0.0 57.0 3.0 1.8 0.0 0.0 0.0 0.0 68.4 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.7 0.2 0.1 0.0 4.7 27.4 3.7 1.3 4.9 1.4 1.8 0.2 16.9 6.7 0.0 5.8 1.5 18.6 155.1 0.0 0.6 0.0 2.7 3.4 38.4 0.0 0.4 46.4 14.9 12.0 0.0 240.0 0.0 48.3 1.7 5.1 14.8 1.1 0.0 0.6 0.0 8.1 0.0 0.0 3.0 0.0 2.2 21.9 0.0 92.2 2.5 15.0 157.9 0.0 59.0 0.2 0.0 3.9 0.0 0.0 220.4 1.5 0.0 95.7 16.3 CA14 ENSG00000118298 "Carbonic anhydrase 14" Q9ULX7 1 150257159-150265078 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1" "Group enriched" "Detected in some" 16 "Cardiomyocytes: 44.5;Melanocytes: 50.6;Muller glia cells: 123.0" "Group enriched" "Detected in many" 7 "glioma: 4.9;melanoma: 23.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "AF22: 28.7;AN3-CA: 17.0;NTERA-2: 22.3;SK-MEL-30: 57.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008482 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA008482: AB_1078395" "unprognostic (3.06e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (3.25e-2)" "prognostic favorable (8.47e-4)" "unprognostic (7.28e-2)" "unprognostic (4.48e-2)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (2.47e-1)" "unprognostic (5.46e-2)" "unprognostic (1.73e-1)" "unprognostic (5.89e-3)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (1.22e-1)" "unprognostic (5.80e-2)" 0.1 0.3 4.6 0.2 5.2 0.9 0.3 1.4 6.8 0.1 1.7 10.8 0.1 0.3 0.1 0.5 1.6 1.3 0.7 4.4 6.4 4.1 0.3 6.3 0.2 0.2 11.3 3.2 1.4 0.3 0.8 0.1 0.3 4.4 3.2 0.7 29.4 0.6 16.5 24.1 3.7 0.6 0.5 20.9 0.3 0.8 0.5 2.7 0.1 0.9 0.1 0.1 0.2 0.1 2.8 2.2 2.1 2.0 0.2 1.6 0.2 0.2 0.0 28.7 17.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 22.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.1 57.1 4.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 1.3 0.1 0.1 0.1 0.0 0.0 0.9 1.3 1.6 2.0 0.6 2.0 1.0 1.2 0.2 2.8 1.2 1.3 2.1 0.2 0.5 2.2 0.0 0.2 4.6 5.2 1.4 4.7 6.4 4.1 11.3 3.2 4.4 2.7 3.0 0.3 0.0 0.2 1.9 1.4 44.5 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.3 0.0 0.9 0.0 50.6 0.0 0.0 123.0 1.2 0.0 3.2 0.0 4.5 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.4 CA4 "CAIV, Car4, RP17" ENSG00000167434 "Carbonic anhydrase 4" P22748 17 60149936-60170899 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 81.7" "Cell type enriched" "Detected in many" 43 "Paneth cells: 2128.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "cerebellum: 50.1" "Cell type enriched" "Detected in some" 7 "neutrophil: 37.0" "Lineage enriched" "Detected in single" 370 "granulocytes: 37.0" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.5;NTERA-2: 3.4;OE19: 3.9;RPTEC TERT1: 1.9;SuSa: 2.6" "Region enriched" "Detected in all" 5 "cerebellum: 336.9" "Low region specificity" "Detected in many" "HPA011089, HPA017258" Enhanced NA NA 190000 "HPA011089: AB_1845996, HPA017258: AB_1845997" "unprognostic (2.07e-2)" "unprognostic (7.85e-2)" "unprognostic (1.55e-2)" "unprognostic (7.78e-3)" "unprognostic (8.42e-2)" "unprognostic (1.19e-1)" "unprognostic (3.19e-2)" "unprognostic (5.84e-2)" "unprognostic (7.76e-2)" "unprognostic (9.74e-2)" "unprognostic (1.54e-1)" "unprognostic (1.71e-2)" "unprognostic (2.68e-3)" "unprognostic (8.59e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-1)" "unprognostic (4.57e-2)" 32.2 0.9 3.4 9.8 4.4 5.7 46.4 50.1 11.8 2.3 81.7 2.0 31.5 1.4 2.3 17.4 0.9 1.7 12.2 8.8 4.7 2.6 12.0 0.3 33.3 2.4 3.5 5.2 1.9 9.5 3.3 5.1 3.2 3.0 2.4 54.9 20.3 4.8 24.0 10.0 1.0 3.2 1.1 2.1 4.9 2.5 1.2 0.3 0.2 23.1 5.0 0.2 1.7 7.9 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.5 0.8 0.1 0.0 0.3 0.0 0.0 0.3 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 3.9 0.0 0.0 0.2 1.3 1.9 0.0 0.7 0.3 0.2 0.0 0.0 2.6 0.0 0.6 0.0 0.2 0.7 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 3.4 4.4 50.1 11.8 4.7 2.6 3.5 5.2 3.0 0.3 0.0 3.7 0.0 0.2 1.3 0.0 9.2 0.0 1.4 1.2 14.0 0.0 0.0 28.2 3.1 0.2 15.8 49.7 0.0 0.2 0.0 1.5 0.1 11.5 0.0 0.5 0.0 18.6 1.8 0.0 0.0 0.6 0.8 0.0 0.0 27.9 0.0 0.1 2128.8 0.0 18.6 0.0 6.5 17.9 0.0 0.0 1.0 0.0 0.0 32.8 0.3 CA9 "CAIX, MN" ENSG00000107159 "Carbonic anhydrase 9" Q16790 9 35673856-35681159 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8" "Cell type enhanced" "Detected in some" 25 "Cholangiocytes: 53.5;Early spermatids: 178.0;Exocrine glandular cells: 46.4;Pancreatic endocrine cells: 33.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 10 "cerebellum: 7.3" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 40.0;HDLM-2: 20.8;hTERT-RPE1: 25.5;U-87 MG: 83.9" "Region enriched" "Detected in some" 4 "cerebellum: 13.8" "Low region specificity" "Detected in some" "CAB005100, CAB017107, HPA055207" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738" "unprognostic (8.01e-3)" "unprognostic (1.34e-2)" "unprognostic (2.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.59e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (1.47e-2)" "unprognostic (3.90e-2)" "unprognostic (1.29e-1)" "unprognostic (6.24e-3)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.22e-7)" "unprognostic (7.29e-2)" "prognostic favorable (9.50e-4)" "unprognostic (2.97e-3)" "unprognostic (8.67e-2)" 1.0 0.1 0.0 0.1 0.3 0.0 0.0 7.3 0.7 0.5 7.2 0.1 0.2 6.7 0.1 1.5 0.3 0.1 70.4 0.7 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.7 47.4 0.0 0.2 0.7 0.4 0.2 0.0 0.1 0.0 0.0 0.0 2.6 8.0 0.0 0.4 0.0 70.8 1.4 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 1.1 0.0 0.0 0.4 0.1 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.2 0.3 20.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 1.0 0.0 0.0 0.0 83.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.3 7.3 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 3.9 0.0 0.3 53.5 0.0 0.0 0.0 0.0 0.0 0.0 27.8 178.0 0.0 0.0 0.0 46.4 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 12.2 1.4 0.0 0.0 1.0 0.1 1.5 33.9 0.0 0.7 0.0 0.0 0.0 0.4 0.9 2.7 2.8 0.2 0.0 0.2 0.3 CABP7 MGC57793 ENSG00000100314 "Calcium binding protein 7" Q86V35 22 29720084-29731839 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 30.3;pancreas: 9.6" "Cell type enriched" "Detected in some" 24 "Cardiomyocytes: 24.3" "Cancer enhanced" "Detected in some" "pancreatic cancer: 3.9" "Region enhanced" "Detected in all" "hippocampal formation: 30.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "HEL: 12.7;SCLC-21H: 12.6;SH-SY5Y: 4.0;U-2 OS: 4.2" "Group enriched" "Detected in many" 5 "cerebellum: 83.4;hippocampal formation: 224.8;midbrain: 72.1;pons and medulla: 115.1" "Region enhanced" "Detected in all" "hippocampal formation: 65.6" HPA016439 Uncertain NA NA "HPA016439: AB_2669357" "unprognostic (1.88e-1)" "unprognostic (4.75e-2)" "unprognostic (1.18e-1)" "unprognostic (5.37e-2)" "unprognostic (4.55e-1)" "unprognostic (2.29e-4)" "unprognostic (2.05e-3)" "unprognostic (7.96e-2)" "unprognostic (8.69e-3)" "unprognostic (3.32e-2)" "unprognostic (2.61e-1)" "unprognostic (1.22e-1)" "unprognostic (7.44e-7)" "unprognostic (1.25e-4)" "unprognostic (3.60e-2)" "unprognostic (2.71e-1)" "unprognostic (4.72e-3)" 0.4 6.0 2.7 0.5 2.6 0.8 0.3 7.2 6.5 0.3 0.5 1.2 0.0 1.5 0.3 1.8 0.7 0.4 0.5 0.3 30.3 2.0 0.3 0.3 0.4 0.5 3.9 1.2 0.4 9.6 0.3 0.1 0.3 16.9 0.4 0.5 2.4 0.8 0.4 0.6 1.0 3.8 0.4 4.1 0.5 0.4 1.2 2.8 0.0 0.7 0.0 0.3 0.4 0.0 0.6 0.6 1.8 1.6 0.5 1.4 0.6 0.1 0.6 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.7 12.7 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.4 0.0 0.0 12.6 4.0 0.1 0.2 0.1 0.1 0.5 0.0 0.1 0.2 4.2 0.1 0.2 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.8 1.8 0.8 1.3 0.5 0.6 1.1 0.5 0.6 0.4 1.0 1.4 1.3 0.5 1.6 0.6 0.5 0.6 2.7 2.6 7.2 3.0 30.3 2.0 3.9 1.2 16.9 2.8 0.0 0.0 0.0 0.0 0.0 0.2 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CACFD1 "C9orf7, D9S2135, flower" ENSG00000160325 "Calcium channel flower domain containing 1" Q9UGQ2 9 133459965-133470848 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015280 Approved Nucleoplasm NA NA Nucleoplasm "HPA015280: AB_1845833" "unprognostic (3.15e-2)" "unprognostic (4.25e-1)" "unprognostic (1.96e-3)" "unprognostic (4.48e-1)" "unprognostic (2.77e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-2)" "unprognostic (5.49e-2)" "unprognostic (3.97e-1)" "unprognostic (3.17e-1)" "unprognostic (1.67e-3)" "unprognostic (3.91e-2)" "prognostic favorable (2.83e-8)" "unprognostic (5.10e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (3.99e-3)" 2.8 7.0 7.2 7.4 6.9 3.5 11.4 8.5 9.4 5.7 14.0 9.4 5.9 18.9 6.7 16.9 8.4 7.3 15.8 9.1 6.5 5.5 19.1 33.7 9.8 8.6 12.3 6.7 7.7 16.6 10.6 12.6 5.3 8.4 8.3 8.3 6.9 9.9 10.3 5.2 3.3 17.9 6.3 8.7 5.0 22.1 13.7 8.6 4.4 13.7 3.7 3.8 8.7 12.6 4.2 1.3 7.6 1.4 2.7 1.0 1.1 0.8 3.7 8.1 5.0 1.7 0.8 5.1 2.5 3.4 2.3 0.8 8.1 6.7 1.0 8.1 3.4 3.9 1.6 2.5 2.0 0.1 1.4 3.0 0.6 5.3 5.6 4.3 0.0 1.0 1.8 5.5 1.8 1.3 6.6 3.0 1.9 1.4 2.7 2.6 9.4 1.0 1.4 4.9 8.2 3.1 2.1 2.1 7.1 4.7 3.6 10.2 11.4 3.2 13.8 2.0 3.3 15.9 1.8 1.4 5.5 5.2 1.5 0.3 4.6 5.5 3.0 2.1 0.6 1.9 3.7 1.4 7.6 0.8 1.1 0.6 3.5 0.7 1.0 1.3 4.2 0.4 0.7 0.2 2.7 0.9 0.5 0.5 1.1 7.2 6.9 8.5 9.4 6.5 5.5 12.3 6.7 8.4 8.6 17.9 15.8 1.4 4.6 2.5 4.4 7.0 28.1 1.4 6.8 19.2 11.8 1.9 3.3 17.8 10.8 2.3 46.4 0.0 28.6 3.0 5.1 9.4 4.6 38.0 2.9 3.2 27.9 6.2 5.6 6.2 7.5 1.8 5.0 4.6 36.5 6.0 22.8 42.1 7.1 14.4 9.7 0.0 4.2 12.5 6.5 1.4 2.4 1.8 12.8 5.5 CACHD1 "KIAA1573, VWCD1" ENSG00000158966 "Cache domain containing 1" 1 64470792-64693058 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 37.5;Club cells: 18.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 11 "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "AF22: 21.4;NTERA-2: 29.3;SuSa: 19.1;U-2197: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017202 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA017202: AB_1852423" "unprognostic (2.92e-2)" "unprognostic (2.91e-1)" "unprognostic (1.29e-2)" "unprognostic (1.02e-1)" "unprognostic (3.75e-1)" "unprognostic (1.01e-1)" "unprognostic (4.82e-2)" "unprognostic (4.32e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (8.16e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-3)" "unprognostic (2.67e-2)" "unprognostic (3.89e-1)" "unprognostic (3.65e-1)" "unprognostic (2.13e-1)" 5.4 7.6 6.5 0.5 8.4 0.0 4.7 1.2 4.3 7.3 0.8 0.2 6.1 5.2 1.6 8.5 2.1 1.2 3.5 4.2 3.3 0.4 4.7 0.4 2.3 14.2 3.7 5.5 4.5 5.5 4.0 1.0 4.4 4.3 0.8 3.0 0.9 5.3 0.6 1.7 3.3 0.5 2.4 0.2 2.1 4.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.8 21.4 3.1 8.5 3.0 0.0 3.0 3.9 5.1 4.9 12.4 0.1 0.0 8.8 4.8 3.7 1.5 11.9 2.5 5.2 2.3 6.4 4.4 1.3 0.0 0.0 1.9 0.0 2.6 1.7 0.6 3.2 2.9 2.7 3.0 0.0 0.0 0.0 0.3 0.3 0.0 29.3 0.1 2.2 2.3 2.1 0.0 0.0 0.6 0.5 11.2 6.5 0.0 2.6 19.1 0.8 0.2 1.9 0.5 3.8 15.0 2.6 0.0 0.0 0.0 0.4 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 37.5 0.0 6.1 15.3 12.7 1.4 0.0 13.4 18.2 3.5 0.0 0.0 0.0 2.0 7.7 11.8 0.0 0.0 2.5 0.1 4.1 1.2 2.3 0.9 0.2 0.0 0.0 3.1 0.3 2.3 13.3 1.8 1.7 0.0 0.0 5.2 1.3 0.0 2.8 3.1 1.1 6.5 5.7 0.4 0.4 12.9 0.0 0.0 0.1 4.8 CACNA1A "APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6" ENSG00000141837 "Calcium voltage-gated channel subunit alpha1 A" O00555 19 13206442-13633025 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 77.9" "Group enriched" "Detected in many" 8 "Bipolar cells: 68.3;Horizontal cells: 235.2;Intestinal endocrine cells: 205.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 77.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "SCLC-21H: 31.2;U-87 MG: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064258, HPA068138, HPA071902" Enhanced Supported Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA064258: AB_2685229, HPA068138: , HPA071902: " "unprognostic (1.09e-1)" "unprognostic (3.73e-3)" "unprognostic (2.27e-1)" "unprognostic (2.78e-4)" "unprognostic (4.00e-2)" "unprognostic (2.29e-3)" "unprognostic (5.47e-2)" "unprognostic (3.13e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-2)" "prognostic favorable (4.32e-4)" "unprognostic (5.31e-3)" "unprognostic (5.03e-6)" "unprognostic (6.29e-2)" "unprognostic (1.59e-1)" "unprognostic (2.61e-2)" "unprognostic (6.25e-2)" 2.2 5.3 7.6 1.0 12.2 0.7 0.9 77.9 19.7 0.8 1.5 1.8 0.0 3.9 1.2 2.8 0.7 2.2 0.8 1.1 5.7 5.1 0.7 0.5 0.7 1.3 3.9 7.3 1.1 3.0 0.7 1.5 0.6 7.2 0.8 1.7 1.2 0.9 0.8 1.3 0.7 2.8 0.9 3.3 1.3 7.7 1.9 2.8 0.0 0.7 0.0 1.0 0.8 0.3 2.8 0.8 1.9 1.1 0.8 0.8 0.4 0.0 0.1 0.0 3.9 0.1 0.3 0.0 1.6 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.1 3.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 2.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.1 0.9 0.0 0.2 0.4 0.0 0.1 0.0 0.1 31.2 0.0 0.0 0.0 0.2 0.1 0.0 1.2 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.0 17.6 0.0 0.4 1.9 0.4 0.7 0.5 0.5 0.8 2.8 0.5 0.3 0.4 1.7 0.6 0.7 1.6 0.8 1.1 0.8 0.6 0.4 7.6 12.2 77.9 17.4 5.7 5.1 3.9 7.3 7.2 2.8 6.0 2.7 1.3 1.4 0.6 68.3 2.2 0.0 6.7 2.3 1.8 15.7 0.0 0.0 0.6 22.1 4.2 0.0 0.0 0.3 0.1 2.1 0.8 1.1 0.0 0.5 235.2 205.4 1.8 1.3 17.9 1.1 2.1 0.0 1.0 1.1 2.9 1.9 0.0 0.4 2.0 6.2 0.0 4.2 4.1 5.1 0.1 0.2 4.3 0.8 0.9 CACNA1B "CACNL1A5, CACNN, Cav2.2" ENSG00000148408 "Calcium voltage-gated channel subunit alpha1 B" Q00975 9 137877789-138124624 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 6.2;brain: 18.9;fallopian tube: 6.6;pituitary gland: 4.8;testis: 8.1" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 5.9;Horizontal cells: 6.4;Late spermatids: 3.6;Spermatocytes: 5.1;Spermatogonia: 9.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 21.2" "Low region specificity" "Detected in all" "HPA022919, HPA044347" Uncertain Approved Mitochondria NA NA Mitochondria "HPA022919: , HPA044347: AB_10960837" "unprognostic (1.34e-3)" "unprognostic (2.70e-2)" "unprognostic (8.08e-2)" "unprognostic (2.51e-7)" "unprognostic (8.10e-2)" "unprognostic (1.51e-2)" "unprognostic (1.33e-1)" "unprognostic (3.10e-1)" "unprognostic (2.50e-1)" "unprognostic (2.36e-2)" "unprognostic (9.73e-4)" "unprognostic (5.98e-2)" "unprognostic (6.63e-6)" "unprognostic (4.25e-2)" "unprognostic (4.72e-1)" "unprognostic (7.77e-3)" "unprognostic (8.69e-2)" 0.5 6.2 5.7 0.7 8.7 0.5 0.5 18.7 18.9 1.2 0.8 0.2 0.0 0.6 0.6 1.7 0.4 6.6 1.4 1.0 4.5 7.3 0.4 1.2 0.5 0.5 2.9 9.1 0.5 1.2 0.4 4.8 0.4 3.6 1.6 0.8 0.4 0.4 1.3 0.4 0.9 0.7 0.8 4.5 0.6 0.6 8.1 1.4 0.0 0.9 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 4.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 8.7 18.7 10.9 4.5 7.3 2.9 9.1 3.6 1.4 0.0 0.0 0.0 0.0 0.0 5.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.0 0.0 2.4 0.0 0.0 0.4 0.0 1.5 0.0 0.0 5.1 9.3 0.0 0.0 0.0 0.0 0.0 CACNA1C "CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS" ENSG00000151067 "Calcium voltage-gated channel subunit alpha1 C" Q13936 12 1970786-2697950 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Host-virus interaction, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Brugada syndrome, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 32.5" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 284.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 4.2" "Group enriched" "Detected in many" 19 "NK-cells: 4.2;T-cells: 1.2" "Cell line enriched" "Detected in some" 17 "HDLM-2: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039796, CAB079031" Enhanced Approved NA NA "CAB079031: , HPA039796: AB_10673019" "unprognostic (1.76e-1)" "unprognostic (1.19e-1)" "unprognostic (6.29e-2)" "unprognostic (9.35e-2)" "unprognostic (3.71e-2)" "unprognostic (1.60e-2)" "unprognostic (4.68e-2)" "unprognostic (7.99e-2)" "unprognostic (3.07e-2)" "unprognostic (1.03e-5)" "unprognostic (1.93e-2)" "unprognostic (1.01e-1)" "unprognostic (4.02e-7)" "unprognostic (8.85e-2)" "unprognostic (3.60e-2)" "unprognostic (6.90e-2)" "unprognostic (3.39e-2)" 3.8 2.5 8.6 6.0 7.7 1.4 2.4 7.1 11.7 11.2 26.5 1.3 7.4 2.4 29.7 4.5 5.2 4.3 7.1 32.5 5.5 4.0 2.7 1.4 4.7 2.0 2.4 6.6 2.7 3.2 1.5 8.1 5.1 3.9 7.9 3.8 6.5 2.4 8.1 2.3 1.7 5.2 28.8 1.9 3.5 7.2 11.3 1.7 0.0 2.0 1.1 1.7 12.6 5.4 0.0 0.1 0.0 0.1 4.2 1.2 0.2 0.0 0.0 0.0 0.0 1.6 1.1 0.1 1.7 2.0 1.1 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 47.6 0.4 0.6 0.0 0.0 1.2 0.0 0.0 2.7 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.3 2.6 0.0 0.0 0.0 0.0 2.2 0.1 0.6 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.5 0.7 0.0 0.0 0.9 0.7 0.0 4.2 0.1 0.1 0.4 0.2 8.6 7.7 7.1 11.7 5.5 4.0 2.4 6.6 3.9 1.7 0.0 0.0 0.0 1.2 0.6 15.3 42.8 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 27.5 2.9 0.0 0.0 0.0 0.2 2.5 1.4 0.0 0.0 0.2 284.4 35.2 2.5 0.0 64.7 0.9 0.0 0.0 0.0 0.6 6.1 0.3 0.2 3.9 0.0 1.2 12.9 17.5 2.6 5.8 0.1 0.1 0.0 0.4 2.4 CACNA1D "CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2" ENSG00000157388 "Calcium voltage-gated channel subunit alpha1 D" Q01668 3 53328963-53813733 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Cancer-related genes, Deafness, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 45.9;Cone photoreceptor cells: 33.4;Intestinal endocrine cells: 57.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "basophil: 7.2" "Lineage enriched" "Detected in single" 20 "granulocytes: 7.2" "Cell line enhanced" "Detected in some" "HMC-1: 14.4;RPMI-8226: 33.6;SK-BR-3: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA020215 Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA020215: AB_1845860" "unprognostic (5.85e-2)" "unprognostic (4.90e-3)" "unprognostic (5.09e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (1.77e-2)" "unprognostic (1.92e-1)" "unprognostic (2.32e-2)" "unprognostic (2.95e-1)" "unprognostic (4.42e-2)" "unprognostic (3.90e-3)" "unprognostic (1.53e-1)" "prognostic favorable (8.34e-8)" "unprognostic (1.14e-1)" "unprognostic (3.05e-2)" "unprognostic (8.09e-3)" "unprognostic (6.70e-3)" 0.6 13.4 10.0 0.8 12.6 1.4 3.6 12.2 16.5 11.2 2.8 3.7 0.1 3.3 6.8 13.2 1.2 14.9 6.2 1.8 5.3 3.5 4.2 3.0 9.0 0.5 2.5 9.6 1.2 5.3 3.0 13.6 1.4 8.7 5.7 3.1 10.1 1.1 3.5 0.6 1.5 4.2 1.7 2.2 4.4 1.8 3.0 1.6 0.0 5.2 0.0 0.6 2.3 0.6 0.1 0.3 7.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 1.6 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.5 0.0 0.0 0.1 33.6 0.3 2.2 3.1 1.3 0.2 6.3 0.7 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 7.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.0 12.6 12.2 16.5 5.3 3.5 2.5 9.6 8.7 1.6 3.0 45.9 0.0 0.6 0.8 23.0 1.2 12.7 14.7 14.8 1.8 33.4 0.6 0.0 5.5 3.6 0.5 3.3 0.0 2.0 0.1 1.0 2.6 11.6 2.4 0.2 7.9 57.1 0.0 1.0 4.9 4.0 0.3 5.0 0.0 2.7 2.5 2.6 3.5 25.5 1.6 13.0 0.0 2.8 1.1 2.5 0.9 0.2 1.3 4.5 0.6 CACNA1E "BII, CACH6, CACNL1A6, Cav2.3" ENSG00000198216 "Calcium voltage-gated channel subunit alpha1 E" Q15878 1 181317690-181808084 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 30.8" "Cell type enhanced" "Detected in single" 15 "Cardiomyocytes: 1.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042515, CAB079032" Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "CAB079032: , HPA042515: " "unprognostic (3.96e-3)" "unprognostic (1.89e-1)" "unprognostic (1.05e-2)" "unprognostic (1.54e-5)" "unprognostic (6.56e-2)" "unprognostic (3.16e-2)" "unprognostic (4.30e-3)" "unprognostic (1.18e-1)" "unprognostic (2.40e-1)" "unprognostic (9.48e-3)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (9.85e-7)" "unprognostic (1.74e-2)" "unprognostic (2.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.75e-2)" 0.6 3.0 17.9 2.1 19.7 3.1 0.5 3.9 22.5 0.6 0.8 1.3 0.0 0.6 0.6 4.4 1.1 2.3 0.6 0.6 30.8 5.8 3.8 0.6 0.6 1.4 2.4 10.6 0.5 0.6 0.5 0.2 0.8 4.2 0.5 0.8 0.5 0.5 0.5 0.6 0.5 1.1 1.0 5.2 0.9 0.8 2.8 2.4 0.0 0.6 0.0 1.0 0.6 0.1 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.9 0.1 0.0 0.0 0.0 1.1 1.4 0.0 2.3 0.1 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 0.1 0.0 0.0 7.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 17.9 19.7 3.9 22.5 30.8 5.8 2.4 10.6 4.2 2.4 0.0 0.0 0.0 0.0 0.1 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 CACNA1F "AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2" ENSG00000102001 "Calcium voltage-gated channel subunit alpha1 F" O60840 X 49205063-49233371 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Sensory transduction, Transport, Vision" "Calcium channel, Ion channel, Voltage-gated channel" "Cone-rod dystrophy, Congenital stationary night blindness, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "retina: 55.8" "Group enriched" "Detected in some" 15 "Bipolar cells: 66.5;Cone photoreceptor cells: 125.7;Rod photoreceptor cells: 91.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 2.8;U-266/70: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA068379 Enhanced NA NA "HPA068379: AB_2732782" "unprognostic (1.20e-3)" "unprognostic (8.62e-2)" "unprognostic (4.25e-3)" "unprognostic (1.56e-2)" "unprognostic (8.46e-2)" "unprognostic (1.84e-1)" "unprognostic (1.23e-2)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (9.04e-2)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (6.08e-7)" "unprognostic (8.03e-2)" "unprognostic (1.09e-1)" "unprognostic (4.65e-2)" "unprognostic (3.77e-3)" 0.7 0.8 1.8 0.7 1.5 4.0 1.8 5.3 2.0 0.7 1.0 0.7 0.7 1.9 0.7 2.7 0.7 1.0 0.7 0.7 0.8 0.6 0.7 0.7 1.4 2.7 0.7 0.7 0.7 1.4 0.0 0.7 0.7 0.7 0.7 1.5 55.8 1.2 0.9 0.7 2.4 3.7 0.7 0.7 1.8 1.0 0.7 0.7 0.7 1.2 0.7 0.9 0.7 0.7 1.4 4.6 2.0 0.9 0.5 1.0 0.2 0.2 2.5 0.2 0.0 0.6 0.0 2.5 0.4 0.2 0.0 0.0 0.1 0.9 1.4 0.5 0.5 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.7 0.0 0.5 0.6 0.1 0.8 0.6 0.0 0.4 0.0 0.2 0.8 0.8 1.0 0.3 0.0 2.8 1.3 1.5 1.1 1.9 0.0 0.1 0.0 0.5 0.4 1.5 0.6 0.0 0.0 0.1 0.0 0.9 0.9 1.5 1.0 0.2 0.3 0.3 0.1 4.6 1.6 0.1 0.8 0.4 0.0 0.9 0.7 0.6 0.6 0.5 0.5 0.7 0.8 0.4 0.8 1.4 0.5 1.0 2.0 0.5 0.9 4.6 0.7 0.2 1.8 1.5 5.3 2.0 0.8 0.6 0.7 0.7 0.7 0.7 0.0 0.3 0.0 0.1 0.0 66.5 1.2 0.0 0.0 0.0 1.8 125.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 6.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.3 5.5 0.0 0.0 0.4 0.0 91.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 CACNA1G "Cav3.1, NBR13" ENSG00000006283 "Calcium voltage-gated channel subunit alpha1 G" O43497 17 50561068-50627474 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.8;cervix, uterine: 13.6" "Cell type enriched" "Detected in some" 26 "Bipolar cells: 147.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 13.4;GAMG: 5.0;HeLa: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004714 Uncertain NA NA "HPA004714: AB_1078368" "unprognostic (1.90e-2)" "unprognostic (5.83e-2)" "unprognostic (2.85e-2)" "unprognostic (1.08e-1)" "unprognostic (4.00e-1)" "unprognostic (9.89e-2)" "unprognostic (1.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.02e-4)" "unprognostic (1.47e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (4.87e-12)" "unprognostic (3.34e-2)" "unprognostic (1.62e-1)" "unprognostic (1.56e-3)" "unprognostic (6.63e-2)" 1.7 1.0 3.5 0.9 5.2 1.3 2.1 22.8 17.1 13.6 1.0 2.7 0.0 0.9 7.4 1.0 1.6 5.7 1.2 3.8 2.4 8.8 0.7 1.1 0.9 1.2 5.3 7.9 7.1 0.6 0.6 0.4 1.4 6.1 2.5 0.8 4.3 1.1 1.6 0.8 3.9 0.8 2.1 5.9 0.9 0.9 1.7 2.3 0.0 1.2 0.0 1.0 1.0 3.9 1.3 1.3 2.7 0.8 0.7 1.4 0.0 0.0 13.4 3.1 3.5 0.9 0.1 0.2 0.1 0.0 0.1 0.2 2.8 0.5 0.0 1.0 0.1 5.0 0.5 1.6 0.0 0.3 1.8 0.6 0.9 4.6 0.7 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.1 0.7 0.0 0.0 1.2 1.0 0.8 1.4 1.1 0.0 0.0 0.2 4.1 1.8 2.8 0.1 0.0 2.4 0.2 0.1 0.3 1.4 3.9 0.5 0.1 1.0 0.1 0.0 0.6 0.1 0.5 0.5 0.8 0.6 1.4 0.4 0.7 0.8 0.7 0.8 0.2 1.3 0.9 1.0 2.7 0.7 0.4 1.3 0.5 0.0 3.5 5.2 22.8 17.1 2.4 8.8 5.3 7.9 6.1 2.3 0.0 0.0 0.0 0.1 1.6 147.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 3.6 0.4 0.0 0.0 0.4 4.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 5.7 0.0 3.6 0.3 0.2 2.5 0.1 0.0 0.0 0.0 CACNA1H Cav3.2 ENSG00000196557 "Calcium voltage-gated channel subunit alpha1 H" O95180 16 1153121-1221772 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 49.5" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 16.2;Late spermatids: 13.2;Peritubular cells: 24.4;Sertoli cells: 25.8;Smooth muscle cells: 16.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.9;AN3-CA: 15.7;MCF7: 28.9;OE19: 9.6;T-47d: 8.6" "Low region specificity" "Detected in many" HPA039125 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA039125: AB_10795578" "unprognostic (1.66e-3)" "unprognostic (2.10e-1)" "unprognostic (4.07e-2)" "unprognostic (1.21e-3)" "unprognostic (1.37e-2)" "unprognostic (2.15e-1)" "unprognostic (4.39e-2)" "unprognostic (2.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" "prognostic favorable (3.12e-5)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (1.93e-2)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (5.55e-2)" 5.0 6.8 5.1 4.2 12.0 0.3 3.3 0.3 4.3 17.5 28.1 1.6 10.2 5.4 25.7 5.9 16.3 11.7 26.0 2.2 2.5 2.1 4.7 5.5 3.5 0.7 1.0 2.8 31.8 2.1 6.6 14.8 1.9 2.0 21.0 2.2 4.2 1.7 24.9 2.9 4.8 8.5 49.5 1.1 0.5 9.7 11.7 2.1 0.0 5.2 1.4 0.5 34.6 20.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 10.9 1.9 15.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.4 0.0 0.0 6.5 1.9 0.0 2.8 0.2 0.0 0.0 0.0 0.0 0.0 1.9 2.9 0.0 0.0 28.9 0.0 0.0 5.9 9.6 2.2 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.5 0.7 8.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.0 0.3 4.3 2.5 2.1 1.0 2.8 2.0 2.1 0.0 0.0 0.0 0.0 1.3 16.2 1.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.0 1.2 0.0 0.0 0.0 0.0 0.2 3.3 4.6 8.1 0.1 0.0 10.4 0.6 0.0 13.2 7.8 0.0 0.0 0.0 0.3 0.8 0.7 0.0 24.4 0.8 1.0 25.8 16.5 1.8 4.5 3.0 0.0 0.0 0.0 0.5 CACNA1I Cav3.3 ENSG00000100346 "Calcium voltage-gated channel subunit alpha1 I" Q9P0X4 22 39570753-39689737 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.6;brain: 8.1;lymphoid tissue: 4.3;thyroid gland: 4.1" "Cell type enriched" "Detected in some" 6 "Bipolar cells: 18.4" "Cancer enhanced" "Detected in single" "thyroid cancer: 2.1" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "JURKAT: 1.2;SK-BR-3: 6.1;T-47d: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.97e-2)" "unprognostic (1.42e-1)" "unprognostic (1.02e-1)" "unprognostic (4.60e-2)" "unprognostic (3.52e-2)" "unprognostic (1.58e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-1)" "unprognostic (7.21e-2)" "unprognostic (5.20e-3)" "unprognostic (1.64e-2)" "unprognostic (8.64e-2)" "unprognostic (1.62e-2)" "unprognostic (6.14e-3)" "unprognostic (1.57e-1)" "unprognostic (3.78e-2)" "unprognostic (8.27e-4)" 0.0 4.6 3.4 1.9 5.8 1.3 0.2 8.1 7.5 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.0 5.0 3.6 0.0 0.0 0.2 4.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.4 1.3 0.5 1.1 4.1 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 6.1 0.0 0.4 3.6 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.5 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 18.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CACNA1S "CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5" ENSG00000081248 "Calcium voltage-gated channel subunit alpha1 S" Q13698 1 201039512-201112566 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 83.1" "Cell type enhanced" "Detected in some" 21 "Cardiomyocytes: 1.4;Cone photoreceptor cells: 5.9;Early spermatids: 1.4;Late spermatids: 3.3;Rod photoreceptor cells: 1.2" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "BEWO: 5.5;HSkMC: 7.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 13 "olfactory region: 5.3" "CAB009507, HPA048892, HPA056815" Enhanced NA NA "CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242" "unprognostic (2.14e-2)" "unprognostic (1.38e-1)" "unprognostic (1.12e-2)" "unprognostic (1.09e-1)" "unprognostic (3.52e-3)" "unprognostic (4.53e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (2.53e-2)" "unprognostic (1.51e-1)" "unprognostic (4.72e-3)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (7.36e-2)" "unprognostic (1.57e-1)" 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.6 0.0 83.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CACNG1 CACNLG ENSG00000108878 "Calcium voltage-gated channel auxiliary subunit gamma 1" Q06432 17 67044590-67056797 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 126.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HSkMC: 8.3;SH-SY5Y: 2.6" "Region enriched" "Detected in single" 6 "basal ganglia: 3.0" "Not detected" "Not detected" NA NA "unprognostic (1.76e-1)" "unprognostic (9.83e-3)" "unprognostic (1.75e-5)" "unprognostic (2.60e-1)" "unprognostic (6.72e-3)" "unprognostic (2.85e-1)" "unprognostic (1.44e-2)" "unprognostic (4.84e-3)" "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.94e-1)" 5.7 0.4 0.3 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 1.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 126.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.7 25.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 8.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNG2 "MGC138502, MGC138504, stargazin" ENSG00000166862 "Calcium voltage-gated channel auxiliary subunit gamma 2" Q9Y698 22 36563921-36703558 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 30.7" "Group enriched" "Detected in some" 5 "Bipolar cells: 10.8;Horizontal cells: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "SCLC-21H: 7.8;SH-SY5Y: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.54e-2)" "unprognostic (3.06e-1)" "unprognostic (8.80e-3)" "unprognostic (2.34e-2)" "unprognostic (3.07e-2)" 0.7 2.7 5.6 0.8 6.4 0.9 0.7 30.7 21.9 0.6 0.7 0.3 0.0 0.8 0.6 0.6 0.7 0.6 0.6 0.6 3.8 4.7 0.7 0.7 0.7 0.7 2.9 7.8 0.6 1.1 0.6 2.7 0.7 6.9 0.7 0.7 0.1 0.6 0.6 1.0 0.8 0.8 0.7 1.7 0.7 0.7 1.0 0.8 0.0 0.7 0.0 0.6 0.7 0.1 0.3 1.0 1.0 0.3 0.3 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.2 7.8 3.5 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.4 0.4 0.3 0.1 0.3 0.3 0.2 0.0 0.3 0.4 0.4 1.0 0.3 0.2 1.0 0.2 0.1 5.6 6.4 30.7 12.3 3.8 4.7 2.9 7.8 6.9 0.8 0.0 0.0 0.0 0.1 0.0 10.8 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNG3 ENSG00000006116 "Calcium voltage-gated channel auxiliary subunit gamma 3" O60359 16 24255553-24362801 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 32.2" "Cell type enriched" "Detected in some" 46 "Horizontal cells: 166.8" "Cancer enriched" "Detected in single" 15 "glioma: 0.7" "Group enriched" "Detected in many" 6 "amygdala: 12.8;basal ganglia: 13.1;cerebral cortex: 20.0;hippocampal formation: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.3;Karpas-707: 1.0;U-266/70: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077238 Enhanced NA NA "HPA077238: " "unprognostic (5.61e-2)" "unprognostic (3.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.17e-1)" 0.4 1.8 12.8 0.4 13.1 0.5 0.3 0.2 32.2 0.3 0.4 0.1 0.0 0.3 0.3 0.4 0.3 0.4 0.3 0.3 12.7 2.2 0.3 0.4 0.3 0.4 1.8 2.3 0.4 0.3 0.3 0.0 0.4 0.3 0.4 0.4 0.1 0.3 0.4 0.3 0.4 0.3 0.4 0.3 0.4 0.4 0.6 0.0 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.1 0.0 0.2 0.9 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 12.8 13.1 0.2 20.0 12.7 2.2 1.8 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 166.8 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNG4 "MGC11138, MGC24983" ENSG00000075461 "Calcium voltage-gated channel auxiliary subunit gamma 4" Q9UBN1 17 66964910-67033398 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;prostate: 16.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Glandular cells: 3.0;Intestinal endocrine cells: 7.5;Muller glia cells: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 97.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 159.8" "HPA005803, HPA065370" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA005803: AB_2667439, HPA065370: AB_2685480" "unprognostic (1.27e-1)" "unprognostic (3.16e-1)" "unprognostic (8.87e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-2)" "unprognostic (8.64e-3)" "unprognostic (2.91e-1)" "unprognostic (7.08e-2)" "unprognostic (3.37e-2)" "unprognostic (3.85e-2)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (2.38e-10)" "unprognostic (8.57e-3)" "unprognostic (1.23e-1)" "unprognostic (8.71e-2)" "unprognostic (4.28e-1)" 0.7 1.8 16.0 0.8 32.3 0.7 8.1 3.5 37.8 1.2 0.9 11.4 0.2 1.0 1.2 0.8 0.8 6.2 1.2 0.7 9.6 12.9 0.8 0.7 8.0 0.7 7.5 7.1 0.7 1.2 4.9 0.1 1.6 6.8 16.5 0.8 0.1 0.9 2.4 0.8 0.9 0.9 2.0 4.2 0.7 1.7 0.9 10.3 0.0 0.7 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 3.9 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 10.3 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 3.9 1.7 0.0 0.0 0.1 2.1 0.0 2.7 3.9 97.2 0.9 2.5 0.0 10.0 9.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 32.3 3.5 13.0 9.6 12.9 7.5 7.1 6.8 10.3 3.0 2.2 0.0 1.1 0.0 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.0 0.2 0.1 0.2 3.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 CACNG5 ENSG00000075429 "Calcium voltage-gated channel auxiliary subunit gamma 5" Q9UF02 17 66835117-66885486 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 6.5;lymphoid tissue: 3.3;retina: 8.8" "Cell type enriched" "Detected in single" 17 "Horizontal cells: 4.8" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.7;RPMI-8226: 1.5;SH-SY5Y: 3.6;SuSa: 1.3;THP-1: 1.6" "Region enhanced" "Detected in all" "olfactory region: 152.3" "Low region specificity" "Detected in all" HPA050115 Uncertain NA NA "HPA050115: AB_2681022" "unprognostic (1.85e-3)" "unprognostic (3.84e-2)" "unprognostic (1.44e-1)" "unprognostic (2.46e-6)" "unprognostic (4.52e-2)" "unprognostic (1.29e-1)" 0.3 0.3 2.7 0.7 2.6 0.3 0.3 1.7 6.5 0.4 0.7 6.3 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.4 2.1 2.0 1.0 0.3 0.3 3.3 1.1 2.3 0.3 0.7 0.3 0.8 0.3 0.7 0.5 0.5 8.8 0.3 0.3 0.3 0.4 0.7 0.3 1.7 1.3 0.3 0.7 3.8 0.0 0.3 0.0 3.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 3.6 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.6 1.7 6.5 2.1 2.0 1.1 2.3 0.7 3.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNG6 ENSG00000130433 "Calcium voltage-gated channel auxiliary subunit gamma 6" Q9BXT2 19 53992288-54012669 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 11.4;skeletal muscle: 45.4" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 5.3;Horizontal cells: 1.6;Spermatogonia: 1.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 96 "basophil: 11.4;eosinophil: 7.8" "Lineage enriched" "Detected in single" 114 "granulocytes: 11.4" "Cell line enhanced" "Detected in some" "A549: 12.7;EFO-21: 22.3;HHSteC: 5.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056615 Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" Cytosol "HPA056615: AB_2683192" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (7.07e-2)" "unprognostic (8.58e-2)" "unprognostic (2.89e-2)" "unprognostic (2.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.72e-1)" "unprognostic (1.53e-1)" "unprognostic (6.07e-8)" "unprognostic (9.79e-2)" "unprognostic (1.28e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.2 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.4 0.0 45.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 12.7 0.3 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 1.1 0.0 22.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 5.8 0.0 0.1 0.1 0.0 0.0 0.0 2.1 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.2 1.5 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.9 0.0 2.6 0.0 0.0 0.0 3.1 0.1 0.2 0.0 0.0 11.4 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 CACNG7 ENSG00000105605 "Calcium voltage-gated channel auxiliary subunit gamma 7" P62955 19 53909335-53943941 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "brain: 54.4" "Cell type enriched" "Detected in some" 17 "Horizontal cells: 127.1" "Cancer enriched" "Detected in some" 16 "glioma: 29.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 26.8;GAMG: 7.5;HMC-1: 20.9;hTERT-RPE1: 26.3;SH-SY5Y: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.11e-2)" "unprognostic (7.18e-2)" "unprognostic (6.24e-2)" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (1.01e-5)" "unprognostic (1.51e-1)" "unprognostic (7.36e-2)" 1.2 1.8 22.2 1.3 15.6 1.2 1.2 22.7 54.4 1.2 1.3 8.3 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 21.4 13.7 1.2 1.2 1.3 1.2 16.5 10.3 1.2 1.3 1.2 1.8 1.2 9.9 1.2 1.2 0.3 1.2 1.3 1.2 1.2 1.4 1.3 13.5 1.2 1.3 1.5 4.5 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 26.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 20.9 0.2 0.0 0.0 0.0 26.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 5.7 0.0 0.0 0.0 1.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 15.6 22.7 25.9 21.4 13.7 16.5 10.3 9.9 4.5 0.0 0.0 0.0 0.0 0.0 7.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 CACNG8 ENSG00000142408 "Calcium voltage-gated channel auxiliary subunit gamma 8" Q8WXS5 19 53963040-53990215 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 7.9;brain: 22.8" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 47.7" "Cancer enriched" "Detected in single" 5 "glioma: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 9.4;basal ganglia: 9.1;cerebral cortex: 13.6;hippocampal formation: 20.3;hypothalamus: 5.4" "Cell type enriched" "Detected in some" 7 "basophil: 7.9" "Lineage enriched" "Detected in single" 17 "granulocytes: 7.9" "Group enriched" "Detected in some" 5 "AF22: 6.4;HMC-1: 21.3;hTERT-RPE1: 7.6;TIME: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041351 Enhanced NA NA "HPA041351: AB_10796666" "unprognostic (7.01e-2)" "unprognostic (6.27e-2)" "unprognostic (3.06e-1)" "unprognostic (5.29e-4)" "unprognostic (9.66e-2)" "unprognostic (2.17e-2)" "unprognostic (1.38e-1)" "unprognostic (9.40e-3)" "unprognostic (6.13e-2)" "unprognostic (2.03e-1)" "unprognostic (7.63e-2)" "unprognostic (2.58e-1)" "unprognostic (2.82e-8)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" 0.4 0.4 9.4 0.4 9.1 0.6 0.4 0.7 22.8 0.3 0.3 2.1 0.0 0.4 0.5 0.4 0.3 0.4 0.4 0.3 20.3 5.4 0.3 0.3 0.4 0.4 2.3 2.0 0.4 0.3 0.5 0.0 0.3 1.5 0.4 0.4 0.0 0.4 0.3 0.9 0.7 0.4 0.4 0.9 0.4 0.6 1.5 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.4 0.3 7.9 0.2 0.3 0.3 0.1 0.0 2.1 6.4 0.2 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.4 0.3 0.0 0.2 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.9 2.4 0.5 0.0 1.0 0.0 21.3 0.3 0.0 0.0 0.2 7.6 2.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 1.3 0.2 2.6 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.1 0.1 0.0 0.2 0.2 0.0 13.0 0.1 1.2 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.1 7.9 0.2 1.1 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.4 0.3 0.2 0.5 0.3 0.1 0.3 0.1 0.1 9.4 9.1 0.7 13.6 20.3 5.4 2.3 2.0 1.5 0.0 0.0 0.0 0.0 1.0 1.4 0.9 2.8 0.0 4.0 1.2 1.8 0.0 0.0 0.0 1.4 0.4 1.9 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.1 47.7 0.0 3.1 1.5 1.1 0.0 0.0 0.0 0.0 0.4 1.0 0.1 0.0 0.4 0.0 1.5 0.0 0.8 5.0 6.4 1.0 0.1 0.0 0.5 1.0 CADM1 "BL2, IGSF4, IGSF4A, Necl-2, NECL2, RA175, ST17, SYNCAM, SYNCAM1, TSLC1" ENSG00000182985 "Cell adhesion molecule 1" Q9BY67 11 115169218-115504957 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Differentiation, Host-virus interaction, Immunity, Spermatogenesis" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 431.7;Bipolar cells: 552.1;Cone photoreceptor cells: 329.9;Muller glia cells: 546.2;Rod photoreceptor cells: 707.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 10.6;myeloid DC: 10.2" "Group enriched" "Detected in many" 6 "dendritic cells: 10.2;T-cells: 10.6" "Cell line enhanced" "Detected in many" "CACO-2: 69.8;WM-115: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037266 Enhanced Supported "Cell Junctions" NA NA 200000000 "Cell Junctions" "CAB037266: AB_532287" "unprognostic (1.50e-1)" "unprognostic (2.15e-1)" "unprognostic (1.92e-2)" "prognostic favorable (1.32e-4)" "unprognostic (4.11e-3)" "unprognostic (1.50e-1)" "unprognostic (2.75e-3)" "unprognostic (1.13e-2)" "unprognostic (1.77e-1)" "unprognostic (2.67e-1)" "unprognostic (6.61e-3)" "unprognostic (9.22e-2)" "unprognostic (2.92e-3)" "unprognostic (1.77e-2)" "unprognostic (1.54e-1)" "unprognostic (3.67e-2)" "unprognostic (5.40e-2)" 3.5 15.2 31.3 3.0 33.7 0.5 8.3 53.7 24.8 11.5 7.1 16.9 22.9 4.0 9.1 53.1 6.5 11.4 6.2 12.2 21.5 26.5 15.2 31.3 34.3 6.3 14.2 19.0 6.6 8.0 47.6 24.0 18.1 27.8 7.9 4.4 32.9 17.8 15.1 3.9 5.5 4.4 4.5 11.5 3.9 6.6 23.3 17.1 1.0 34.5 1.3 6.9 6.6 3.6 1.8 10.2 0.1 0.0 0.5 10.6 1.8 0.0 5.5 6.2 0.0 0.0 0.0 0.0 5.7 9.9 0.7 0.0 69.8 6.3 0.0 18.6 8.7 6.2 1.2 1.1 6.5 0.4 0.2 9.6 0.0 2.0 26.6 0.0 0.0 13.8 0.0 9.4 0.0 15.6 4.0 0.2 4.1 0.0 0.6 1.0 4.7 4.6 0.1 5.8 0.0 0.0 0.0 0.1 14.2 11.0 0.2 12.2 26.4 0.0 6.1 5.0 26.2 22.3 0.3 0.0 0.5 11.3 5.6 3.0 15.8 22.7 4.4 8.9 0.0 45.0 0.1 0.0 0.0 10.6 0.0 4.7 1.8 3.9 2.8 10.2 0.3 0.1 2.7 0.0 0.5 0.0 0.0 6.3 1.8 31.3 33.7 53.7 24.8 21.5 26.5 14.2 19.0 27.8 17.1 431.7 161.3 9.3 23.5 18.3 552.1 52.3 25.5 13.4 48.9 34.9 329.9 63.6 10.0 33.2 149.6 5.5 0.5 0.0 1.7 3.0 20.1 31.5 23.1 39.0 37.8 28.6 7.5 1.8 4.1 155.9 5.5 11.9 42.2 22.6 1.3 546.2 8.1 0.0 3.9 8.7 707.7 0.0 5.9 52.0 22.1 20.6 26.9 6.7 3.8 10.4 CADM2 "IGSF4D, Necl-3, NECL3, SynCAM2" ENSG00000175161 "Cell adhesion molecule 2" Q8N3J6 3 84958981-86074429 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 52.7" "Group enriched" "Detected in some" 4 "Bipolar cells: 214.8;Cone photoreceptor cells: 488.9;Rod photoreceptor cells: 463.1" "Cancer enriched" "Detected in some" 9 "glioma: 7.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 5.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.0" "Cell line enhanced" "Detected in some" "AF22: 6.4;AN3-CA: 18.4;U-266/70: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010024 Enhanced NA NA 350000 "HPA010024: AB_2068039" "unprognostic (2.23e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (1.90e-4)" "unprognostic (8.64e-2)" "unprognostic (2.27e-1)" "unprognostic (4.76e-3)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (1.90e-1)" "unprognostic (8.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.07e-5)" "unprognostic (9.82e-3)" "unprognostic (1.26e-2)" "unprognostic (4.17e-3)" "unprognostic (1.16e-2)" 5.8 6.3 33.5 2.1 22.7 1.7 3.6 44.8 52.7 2.3 3.0 7.0 0.0 2.0 2.0 2.2 2.7 4.6 2.6 4.2 28.6 11.7 1.9 2.5 2.2 1.8 16.3 31.0 2.3 2.4 3.0 5.5 1.9 24.2 3.4 2.7 8.8 2.3 6.2 4.9 2.0 2.6 2.1 14.0 2.0 3.2 2.2 20.5 0.0 2.1 0.0 1.8 2.0 1.1 1.0 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 6.4 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 2.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.6 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 22.7 44.8 49.5 28.6 11.7 16.3 31.0 24.2 20.5 0.0 0.6 0.0 0.3 0.9 214.8 4.4 0.0 0.0 1.2 0.0 488.9 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.1 1.0 0.7 0.0 0.0 0.3 89.0 1.7 4.9 0.0 1.7 1.7 0.0 3.3 0.0 0.0 62.5 0.2 0.0 0.4 0.0 463.1 0.0 0.8 0.4 1.1 0.9 0.0 0.0 0.0 0.3 CADM3 "BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1" ENSG00000162706 "Cell adhesion molecule 3" Q8N126 1 159171609-159203313 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.5;placenta: 43.1" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 103.2;Fibroblasts: 46.4;Horizontal cells: 33.4;Melanocytes: 23.6;Muller glia cells: 35.4" "Cancer enhanced" "Detected in many" "glioma: 27.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 19.8;HSkMC: 66.3;hTERT-HME1: 35.5;U-2 OS: 9.9;WM-115: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002981, CAB025746" Enhanced Supported Approved Cytosol "Intracellular and membrane" NA NA 790000 Cytosol "CAB025746: , HPA002981: AB_1078916" "unprognostic (1.74e-2)" "unprognostic (8.26e-2)" "unprognostic (1.34e-2)" "unprognostic (1.33e-2)" "unprognostic (9.32e-2)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (6.12e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (5.52e-2)" "unprognostic (2.59e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (5.75e-4)" 8.9 5.4 23.3 8.5 41.0 0.9 6.1 88.4 96.5 18.0 8.8 6.9 0.7 3.2 2.2 1.6 7.2 3.2 4.1 4.3 23.2 27.4 1.1 1.1 2.9 7.8 18.5 22.4 1.2 2.0 1.0 7.4 43.1 30.4 1.7 8.9 4.5 2.6 3.6 2.0 7.7 6.4 4.1 9.6 7.6 2.8 2.4 4.6 0.0 4.8 0.7 5.9 10.2 7.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.3 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 19.8 0.0 0.0 66.3 0.0 0.0 35.5 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.1 0.0 0.0 1.5 0.0 0.0 2.6 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 41.0 88.4 55.6 23.2 27.4 18.5 22.4 30.4 4.6 0.0 0.3 0.0 0.0 6.0 103.2 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.1 4.0 0.0 0.0 0.0 0.4 46.4 0.1 0.0 0.0 1.0 33.4 0.0 4.3 0.0 4.7 0.6 0.0 23.6 0.0 0.0 35.4 0.0 0.0 0.0 0.0 7.5 0.0 3.9 0.9 1.7 3.8 0.6 0.0 0.0 0.0 CADM4 "IGSF4C, Necl-4, SynCAM4, TSLL2" ENSG00000105767 "Cell adhesion molecule 4" Q8NFZ8 19 43622368-43639839 "Predicted membrane proteins" "Cell adhesion" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.9" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 19.9;Proximal tubular cells: 22.7" "Cancer enhanced" "Detected in all" "glioma: 108.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 4.7" "Cell line enriched" "Detected in many" 5 "WM-115: 112.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012612 Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA 5900000 "Nuclear membrane" Nucleoplasm "HPA012612: AB_1851530" "unprognostic (8.80e-3)" "unprognostic (2.57e-2)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (2.87e-1)" "unprognostic (9.29e-3)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (5.03e-1)" "unprognostic (3.19e-3)" "unprognostic (3.81e-1)" "prognostic favorable (2.28e-6)" "unprognostic (1.39e-1)" "unprognostic (3.35e-2)" "unprognostic (2.59e-1)" "unprognostic (3.93e-2)" 3.0 12.6 29.7 3.4 31.0 0.9 6.6 22.2 68.9 4.6 5.3 32.8 2.5 3.0 10.4 6.7 10.8 3.0 3.7 5.5 31.2 26.5 13.2 3.4 3.1 1.8 37.2 20.4 5.2 10.9 26.1 7.5 1.1 29.1 13.7 2.8 4.9 13.3 10.8 5.0 10.8 3.0 6.8 47.8 1.9 4.0 1.9 26.4 0.0 3.3 1.7 3.4 2.9 2.9 0.1 4.7 0.6 0.3 0.0 0.0 0.0 8.8 2.5 13.7 17.9 0.0 0.3 0.7 0.4 0.7 1.2 1.9 3.8 1.5 0.0 3.3 0.1 0.7 2.1 3.0 1.8 1.5 0.1 2.4 0.0 0.6 5.6 1.6 0.0 1.4 0.5 4.0 6.6 0.2 6.5 0.8 0.8 0.9 0.1 0.1 1.3 1.3 0.1 1.5 1.8 0.9 7.1 0.1 0.8 1.8 1.8 1.6 8.8 0.9 2.7 3.5 2.1 2.0 0.4 0.3 0.1 21.2 0.1 0.8 1.3 0.8 0.0 1.0 0.1 112.4 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 4.7 0.0 0.0 29.7 31.0 22.2 34.0 31.2 26.5 37.2 20.4 29.1 26.4 0.0 1.7 0.0 17.0 4.4 16.4 2.8 5.1 1.4 1.2 7.0 2.0 0.2 5.0 10.4 17.6 1.9 0.0 0.0 2.7 0.1 1.1 19.9 0.0 2.6 0.4 19.1 0.0 4.3 0.0 14.7 0.3 0.0 13.5 0.0 0.3 15.4 4.2 0.0 1.4 22.7 3.7 0.0 4.7 0.5 0.8 7.4 0.0 0.5 1.0 12.8 CALCR CTR ENSG00000004948 "Calcitonin receptor" 7 93424487-93574730 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;kidney: 7.5" "Group enriched" "Detected in some" 14 "Early spermatids: 13.2;Late spermatids: 4.4" "Cancer enriched" "Detected in single" 5 "renal cancer: 1.1" "Region enhanced" "Detected in many" "hypothalamus: 10.8" "Cell type enhanced" "Detected in single" "classical monocyte: 1.1" "Lineage enhanced" "Detected in single" "monocytes: 1.1" "Group enriched" "Detected in some" 7 "MCF7: 2.4;RPTEC TERT1: 4.0;SuSa: 7.7;T-47d: 7.7" "Group enriched" "Detected in some" 5 "basal ganglia: 6.7;hypothalamus: 28.7" "Low region specificity" "Detected in all" "HPA028962, HPA061428" Enhanced Supported NA NA "HPA028962: AB_10602339, HPA061428: AB_2732661" "unprognostic (1.95e-1)" "unprognostic (2.43e-1)" "unprognostic (3.88e-2)" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "unprognostic (3.43e-1)" "unprognostic (7.73e-5)" "unprognostic (1.64e-1)" "unprognostic (9.24e-3)" "unprognostic (8.70e-2)" "unprognostic (1.86e-2)" "unprognostic (6.68e-2)" "unprognostic (2.71e-3)" "unprognostic (1.46e-3)" "unprognostic (1.69e-1)" "unprognostic (2.49e-4)" "unprognostic (1.05e-2)" 0.3 0.7 1.4 0.0 2.1 0.0 1.3 0.1 1.5 0.5 0.2 0.0 0.0 0.1 0.1 0.5 0.3 0.1 0.4 0.4 2.1 10.8 7.5 0.1 0.9 0.0 0.8 0.0 0.7 0.1 0.3 3.2 2.1 5.9 0.1 0.2 0.2 1.4 0.0 3.7 0.1 0.2 0.3 2.5 0.1 0.1 2.3 0.7 0.0 0.1 2.5 0.7 0.1 0.1 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 7.7 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 2.1 0.1 1.5 2.1 10.8 0.8 0.0 5.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 4.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 CALCRL "CGRPR, CRLR" ENSG00000064989 "Calcitonin receptor like receptor" Q16602 2 187343129-187448460 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 91.0" "Group enriched" "Detected in many" 9 "Endothelial cells: 183.3;Ito cells: 192.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 3.3;myeloid DC: 11.2;plasmacytoid DC: 3.3" "Group enriched" "Detected in many" 6 "dendritic cells: 11.2;monocytes: 3.3" "Cell line enriched" "Detected in some" 4 "HUVEC TERT2: 62.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008070, HPA046515" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA008070: AB_1845912, HPA046515: AB_2679681" "unprognostic (7.06e-2)" "unprognostic (5.71e-2)" "unprognostic (1.59e-1)" "unprognostic (2.13e-1)" "unprognostic (3.44e-3)" "unprognostic (7.60e-3)" "unprognostic (9.25e-3)" "unprognostic (4.14e-2)" "unprognostic (7.71e-3)" "unprognostic (3.32e-1)" "unprognostic (3.77e-1)" "unprognostic (3.44e-1)" "unprognostic (1.51e-3)" "unprognostic (1.90e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.50e-2)" 42.4 5.2 4.9 6.4 3.8 0.2 19.6 7.3 9.4 21.2 12.6 2.6 4.0 3.1 17.9 6.8 16.3 6.5 13.4 15.1 4.5 3.8 16.5 12.5 91.0 16.9 4.7 3.5 15.2 3.7 8.2 5.3 6.4 7.5 10.7 5.3 7.5 8.4 4.4 5.0 4.2 5.6 14.5 18.1 9.1 5.0 7.9 2.8 2.3 16.9 11.8 4.7 10.6 14.0 0.2 11.2 0.1 3.3 1.2 1.1 1.1 0.0 0.0 3.2 0.0 2.3 0.6 0.0 0.2 0.4 0.0 0.4 0.0 0.3 0.0 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.5 0.0 0.0 1.8 0.0 0.0 1.6 0.1 0.1 0.7 0.2 62.5 0.0 0.0 0.8 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.1 0.1 14.7 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.0 0.2 0.0 0.0 0.1 2.3 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 11.2 0.0 1.1 0.2 0.1 1.2 1.2 3.3 0.0 1.1 4.9 3.8 7.3 3.7 4.5 3.8 4.7 3.5 7.5 2.8 0.0 14.0 0.8 2.3 8.2 0.1 7.0 2.5 2.7 4.5 0.0 0.0 0.3 3.3 0.1 0.5 183.3 0.0 0.0 0.4 0.1 5.4 1.7 4.7 2.1 0.9 0.0 0.0 192.8 14.2 0.4 7.2 7.7 10.1 20.8 0.0 0.0 0.1 0.0 2.5 12.3 0.0 6.5 6.6 1.2 0.4 5.9 0.2 0.0 0.0 1.2 CALHM1 FAM26C ENSG00000185933 "Calcium homeostasis modulator 1" Q8IU99 10 103453387-103458888 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Sensory transduction, Taste, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.7;kidney: 2.4;lymphoid tissue: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 4.2;U-266/70: 4.4;U-266/84: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA061816 Enhanced NA NA "HPA061816: " "unprognostic (2.46e-1)" "unprognostic (2.66e-1)" "unprognostic (2.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.65e-3)" "unprognostic (3.44e-2)" "unprognostic (2.86e-2)" "unprognostic (1.67e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.44e-1)" "unprognostic (2.21e-8)" "unprognostic (1.96e-1)" "unprognostic (1.37e-1)" "unprognostic (1.06e-1)" "unprognostic (1.38e-2)" 0.0 0.0 1.1 0.5 0.3 0.8 0.0 3.4 5.7 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.4 0.1 1.2 2.5 2.4 0.0 0.0 0.4 1.3 0.1 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.2 0.3 0.1 0.2 0.0 2.0 0.2 0.0 1.0 1.6 0.8 1.6 1.3 1.0 0.2 0.4 0.3 0.3 0.4 0.1 0.0 0.5 0.4 0.1 0.1 0.2 0.0 0.2 0.3 0.2 0.0 0.3 0.4 0.1 0.3 0.3 0.4 0.7 0.3 0.9 0.2 0.0 0.0 0.4 0.2 0.2 0.1 0.4 0.5 0.0 0.3 0.2 1.1 0.3 0.5 0.0 0.8 0.4 0.0 0.5 0.4 0.3 4.2 0.3 0.5 0.6 0.3 0.2 1.0 0.1 0.5 0.0 0.0 1.0 0.4 0.3 0.2 0.4 4.4 5.0 0.6 0.5 1.1 0.1 0.6 0.6 0.4 1.0 1.6 0.2 0.5 0.4 1.0 1.6 1.0 0.4 0.9 0.8 1.3 1.4 0.3 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CALHM2 FAM26B ENSG00000138172 "Calcium homeostasis modulator family member 2" Q9HA72 10 103446786-103452402 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 63.7;Hofbauer cells: 47.4;Leydig cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.8;BJ: 18.8;BJ hTERT+: 19.1;fHDF/TERT166: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014706 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA014706: AB_2243916" "unprognostic (2.45e-1)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (2.48e-1)" "unprognostic (3.92e-2)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (8.85e-2)" "unprognostic (5.78e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (8.59e-2)" "unprognostic (2.47e-1)" "unprognostic (3.56e-1)" "unprognostic (4.74e-1)" 24.2 10.5 3.7 10.2 3.8 1.8 28.7 1.9 7.1 34.1 9.2 3.9 8.0 5.6 36.0 18.4 13.4 19.7 18.2 17.0 3.9 2.2 5.7 3.7 11.1 15.9 4.8 5.4 32.5 4.5 1.9 4.0 23.6 4.8 18.2 4.0 10.7 7.6 10.0 8.9 8.9 9.0 19.8 5.5 24.4 7.2 14.1 3.1 3.0 11.0 9.2 10.8 19.9 24.1 7.1 36.6 11.2 47.9 14.0 21.5 17.1 5.3 3.8 0.9 1.2 14.3 23.8 4.6 18.8 19.1 5.8 8.2 1.6 2.6 1.6 2.1 21.5 0.3 2.5 1.9 0.0 1.1 0.2 10.8 3.8 1.1 0.3 6.5 0.6 0.3 8.1 0.0 1.7 0.0 10.8 6.8 4.1 0.8 10.0 3.7 12.3 1.4 1.7 2.4 1.1 3.4 4.5 1.5 3.6 0.5 0.4 2.7 1.2 0.7 3.1 1.0 0.4 0.6 1.2 12.1 1.8 2.3 6.4 1.3 1.5 3.5 1.9 15.9 11.8 0.3 11.2 22.7 0.4 21.5 42.2 17.5 7.1 14.8 17.6 36.6 1.5 2.9 11.2 0.9 14.0 47.9 4.2 18.9 17.1 3.7 3.8 1.9 7.1 3.9 2.2 4.8 5.4 4.8 3.1 3.0 1.1 3.4 2.8 4.7 0.0 2.8 2.5 0.0 0.0 3.5 0.0 2.0 0.0 3.1 0.8 20.4 0.0 0.0 0.2 63.7 23.4 0.8 8.1 0.0 47.4 0.0 1.2 28.3 27.5 0.8 42.3 14.7 8.5 1.8 0.0 0.3 0.2 0.0 15.2 0.3 0.0 19.4 29.8 0.7 0.2 3.3 16.0 17.3 0.0 1.0 CALHM3 "bA225H22.7, FAM26A" ENSG00000183128 "Calcium homeostasis modulator 3" Q86XJ0 10 103472804-103479240 "Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Taste, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.8;pancreas: 2.8;testis: 2.0" "Cell type enhanced" "Detected in some" 23 "Cardiomyocytes: 1.1;Early spermatids: 2.2;Extravillous trophoblasts: 5.4;Late spermatids: 1.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.5" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.8;myeloid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "U-266/84: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA018205 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018205: AB_2069267" "unprognostic (2.88e-1)" "unprognostic (4.00e-1)" "unprognostic (3.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.87e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (7.42e-3)" "unprognostic (1.44e-1)" "unprognostic (4.89e-2)" "unprognostic (3.07e-1)" "unprognostic (5.05e-2)" "unprognostic (1.53e-1)" 0.2 0.1 0.5 0.0 0.6 0.0 0.0 0.2 0.7 0.3 0.1 0.8 0.3 0.9 0.0 0.3 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.4 2.8 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 2.0 0.0 0.0 0.2 0.4 0.0 1.5 0.0 1.8 0.0 0.7 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.3 3.3 0.4 1.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 17.4 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.2 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 CALHM4 "C6orf78, FAM26D, FLJ32239" ENSG00000164451 "Calcium homeostasis modulator family member 4" Q5JW98 6 116529013-116558868 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "placenta: 29.7;skin 1: 9.1" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 45.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "pons and medulla: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 2.8;SuSa: 6.2" "Intracellular and membrane" NA NA "unprognostic (7.95e-2)" "unprognostic (3.44e-4)" "unprognostic (1.99e-1)" "unprognostic (1.44e-2)" 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 29.7 1.4 0.0 0.0 0.2 0.0 0.0 0.5 9.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 0.1 0.0 2.8 0.0 0.3 0.2 0.2 0.3 0.0 0.3 0.6 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 6.2 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.2 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 CALHM5 "C6orf188, dJ493F7.3, FAM26E, MGC45451" ENSG00000178033 "Calcium homeostasis modulator family member 5" Q8N5C1 6 116511646-116524792 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 19 "Alveolar cells type 2: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 6.3;fHDF/TERT166: 6.6;HUVEC TERT2: 6.7;LHCN-M2: 7.1;TIME: 10.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034969, HPA034970" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA034969: AB_10670299, HPA034970: AB_2674390" "unprognostic (2.71e-2)" "unprognostic (1.56e-1)" "unprognostic (8.12e-2)" "unprognostic (1.01e-1)" "unprognostic (1.36e-1)" "unprognostic (3.92e-1)" "unprognostic (1.93e-2)" "unprognostic (5.37e-2)" "unprognostic (4.09e-2)" "unprognostic (4.21e-2)" "unprognostic (1.06e-1)" "unprognostic (9.16e-2)" "unprognostic (1.24e-7)" "unprognostic (1.16e-2)" "unprognostic (2.98e-2)" "unprognostic (7.69e-2)" "unprognostic (6.65e-3)" 11.5 1.7 1.0 2.5 1.6 0.2 8.1 0.6 1.7 5.9 4.3 1.9 0.4 1.4 7.9 6.2 7.6 2.9 3.6 10.1 1.2 1.1 6.0 1.4 4.0 5.8 1.5 2.1 4.6 0.8 1.6 1.4 18.5 1.8 5.3 2.6 14.4 2.1 2.6 4.0 3.2 2.9 11.0 1.3 4.0 2.1 5.2 0.6 0.0 4.4 6.8 1.5 8.2 4.0 0.1 0.0 0.1 0.6 0.3 0.0 0.6 0.0 0.0 5.5 0.0 3.4 5.4 0.0 4.3 6.3 1.7 4.7 0.2 0.0 0.0 0.4 6.6 4.7 0.0 0.0 0.0 1.8 0.0 0.2 0.9 0.0 0.0 0.8 0.0 0.0 3.3 0.0 4.1 0.0 1.3 6.7 0.0 0.0 1.3 7.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 10.6 3.0 1.0 0.3 0.2 0.0 0.0 0.0 2.6 0.0 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.6 1.0 1.6 0.6 1.7 1.2 1.1 1.5 2.1 1.8 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 CALHM6 "C6orf187, dJ93H18.5, FAM26F, INAM, OTTHUMP00000017061, OTTHUMP00000017062, RP1-93H18.5" ENSG00000188820 "Calcium homeostasis modulator family member 6" Q5R3K3 6 116461370-116463779 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 95.3;lymphoid tissue: 58.7" "Cell type enriched" "Detected in some" 7 "Hofbauer cells: 118.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 83.9;non-classical monocyte: 95.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 10.0;Karpas-707: 16.7;RPMI-8226: 56.6;U-937: 21.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (1.14e-2)" "unprognostic (2.31e-2)" "unprognostic (6.46e-3)" "unprognostic (7.15e-3)" "unprognostic (9.53e-3)" "unprognostic (4.10e-2)" "unprognostic (2.69e-1)" "unprognostic (1.68e-1)" "unprognostic (8.19e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (9.31e-10)" "unprognostic (1.69e-1)" "unprognostic (2.12e-2)" "unprognostic (3.85e-3)" "unprognostic (9.25e-3)" 3.0 2.7 2.8 19.6 5.2 12.9 3.1 1.1 2.1 1.5 3.4 1.5 1.7 3.9 1.1 1.3 2.0 1.5 3.9 4.3 3.1 3.2 2.9 8.1 4.2 30.6 2.6 1.8 2.8 1.0 0.4 2.5 4.6 3.4 3.1 2.2 2.7 4.2 0.7 1.0 0.9 8.1 3.7 5.1 58.7 2.2 3.3 1.7 7.3 2.1 1.9 7.5 3.5 1.4 39.6 23.3 13.8 95.3 3.1 3.8 17.8 2.3 0.0 0.2 0.1 0.2 0.7 4.3 0.0 0.4 0.7 0.5 0.0 0.3 0.0 1.3 0.5 0.0 0.0 0.1 0.0 1.6 0.2 0.1 10.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 16.7 2.0 0.0 0.9 1.7 1.3 0.0 0.0 0.8 0.0 56.6 0.8 0.1 1.0 0.0 5.4 0.0 4.0 0.6 0.1 2.6 0.0 0.0 0.0 0.0 0.3 4.3 0.0 0.0 0.1 21.5 1.4 1.8 24.7 5.5 2.1 83.9 2.1 27.0 2.9 1.9 23.3 39.6 3.8 1.9 13.8 3.1 95.3 10.2 0.3 17.8 2.8 5.2 1.1 2.1 3.1 3.2 2.6 1.8 3.4 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.0 9.1 4.9 0.0 0.0 0.0 0.0 118.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 18.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 CALN1 CABP8 ENSG00000183166 "Calneuron 1" Q9BXU9 7 71779491-72447151 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.0;brain: 48.5;lymphoid tissue: 20.0" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 4.8;Early spermatids: 5.1;Spermatocytes: 6.9;Spermatogonia: 11.4;Suprabasal keratinocytes: 8.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "Karpas-707: 31.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036278, HPA036708" Approved Uncertain "Vesicles,Plasma membrane" No No Vesicles "Plasma membrane" "HPA036278: AB_10673125, HPA036708: " "unprognostic (6.38e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (1.32e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-2)" "unprognostic (3.67e-4)" "unprognostic (3.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.57e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (7.72e-4)" "unprognostic (2.99e-1)" 0.8 16.0 10.8 0.8 17.7 1.5 1.0 48.5 39.1 2.3 0.9 5.1 0.0 0.9 1.4 0.8 0.8 1.0 1.3 0.8 9.5 4.4 0.8 1.0 0.9 0.8 6.8 7.3 1.0 1.9 0.8 0.3 0.8 18.6 1.0 0.9 0.0 0.8 2.4 0.9 4.2 0.8 0.9 8.4 0.8 0.8 11.3 3.3 20.0 0.9 0.0 0.8 0.9 1.9 0.3 1.3 0.6 0.4 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 31.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 4.8 0.0 0.5 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 5.0 4.8 0.0 0.2 0.0 0.0 0.6 0.4 0.3 0.2 0.1 0.1 0.2 0.2 0.2 1.3 0.3 0.2 0.2 0.5 0.3 0.1 0.4 0.1 0.1 10.8 17.7 48.5 11.6 9.5 4.4 6.8 7.3 18.6 3.3 0.0 0.0 0.0 0.2 2.1 0.1 4.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 1.8 0.3 3.2 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.7 0.0 0.6 0.0 0.0 6.9 11.4 8.5 0.1 0.0 0.0 0.1 CALY "CALCYON, DRD1IP, NSG3" ENSG00000130643 "Calcyon neuron specific vesicular protein" Q9NYX4 10 133324072-133336935 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "adrenal gland: 26.5;brain: 98.9;pituitary gland: 47.7" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 84.4;Horizontal cells: 68.3;Intestinal endocrine cells: 18.7;Rod photoreceptor cells: 31.1" "Group enriched" "Detected in some" 14 "glioma: 1.7;pancreatic cancer: 7.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.3;naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "SH-SY5Y: 2.7;U-266/70: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042283 Enhanced NA NA "HPA042283: AB_10794417" "unprognostic (1.43e-2)" "unprognostic (7.84e-2)" "unprognostic (3.77e-3)" "unprognostic (1.41e-2)" "unprognostic (7.32e-2)" "unprognostic (9.81e-3)" "unprognostic (2.56e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "prognostic favorable (3.54e-4)" "unprognostic (1.23e-2)" "unprognostic (4.19e-10)" "unprognostic (8.04e-3)" "unprognostic (1.29e-1)" "unprognostic (3.60e-1)" "unprognostic (1.63e-1)" 1.8 26.5 27.1 2.7 57.4 1.8 1.8 12.7 67.1 1.7 2.6 3.6 0.0 5.0 1.7 1.9 1.8 2.0 1.8 1.7 31.8 98.9 1.7 1.7 1.9 2.0 25.1 39.8 1.7 6.3 1.7 47.7 1.7 33.9 1.8 2.4 0.7 2.1 2.0 1.7 1.9 3.8 2.1 14.3 1.9 4.1 4.3 4.8 0.0 1.9 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.1 0.8 0.3 0.0 0.0 0.0 0.3 0.6 0.6 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.8 1.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 1.0 0.0 1.1 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.1 2.7 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 27.1 57.4 12.7 45.9 31.8 98.9 25.1 39.8 33.9 4.8 0.0 0.0 0.0 0.0 0.2 84.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 68.3 18.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 8.1 0.9 0.0 0.4 0.2 31.1 0.0 0.8 1.4 2.6 0.0 0.2 0.0 0.0 0.0 CAMKMT "C2orf34, CLNMT" ENSG00000143919 "Calmodulin-lysine N-methyltransferase" Q7Z624 2 44361950-44772592 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067912 Supported Nucleoplasm NA NA Nucleoplasm "HPA067912: AB_2685922" "unprognostic (2.28e-1)" "unprognostic (6.15e-2)" "unprognostic (1.96e-1)" "unprognostic (2.39e-2)" "prognostic favorable (9.10e-4)" "unprognostic (1.03e-1)" "unprognostic (9.58e-3)" "unprognostic (1.46e-3)" "unprognostic (1.85e-1)" "unprognostic (7.42e-2)" "unprognostic (8.76e-2)" "unprognostic (1.37e-1)" "unprognostic (3.33e-1)" "unprognostic (4.82e-2)" "unprognostic (4.66e-2)" "unprognostic (1.70e-1)" "unprognostic (8.57e-2)" 7.1 8.0 13.9 10.8 21.7 13.9 8.2 15.4 13.1 9.8 10.8 8.2 8.7 8.7 11.0 10.5 8.8 8.1 14.8 7.3 11.8 14.8 11.4 7.0 8.2 8.1 14.1 4.3 6.7 17.6 15.7 17.6 5.2 13.7 5.8 10.9 8.4 12.0 6.4 10.9 9.7 10.8 8.2 10.5 8.4 7.8 19.0 12.6 13.7 12.1 8.1 10.7 7.9 10.0 17.7 9.9 9.3 8.5 7.7 17.2 6.9 7.0 4.4 5.4 4.8 5.7 5.8 11.5 5.9 4.1 3.0 3.9 8.1 6.4 6.8 6.6 3.8 3.9 5.9 7.3 9.1 5.3 25.4 10.5 10.0 9.3 15.2 2.2 6.5 7.1 2.4 5.6 4.1 7.8 4.5 4.4 7.3 7.9 12.1 4.9 7.3 11.8 13.2 9.9 16.7 4.7 7.0 6.4 13.6 14.5 7.9 10.5 9.6 5.6 16.8 6.1 5.3 6.1 5.5 6.0 4.1 4.8 4.9 4.3 9.6 8.0 12.3 4.5 11.5 3.1 9.3 8.5 5.9 11.7 6.7 11.7 17.7 11.2 9.7 9.5 13.4 17.2 13.5 5.1 7.7 7.1 9.9 16.0 6.9 13.9 21.7 15.4 13.1 11.8 14.8 14.1 4.3 13.7 12.6 6.0 1.9 6.5 6.4 4.6 4.2 1.5 7.6 0.0 0.0 8.7 0.0 3.2 19.9 10.2 52.0 3.5 4.7 0.0 13.8 4.1 5.1 4.8 5.7 5.1 5.2 1.6 0.0 1.3 1.8 25.7 7.5 4.0 10.1 7.2 4.8 15.5 7.3 6.5 5.3 11.2 2.3 0.0 5.1 18.0 5.4 6.5 2.2 8.7 7.4 5.2 CAMP "CAP18, FALL-39, FALL39, LL37" ENSG00000164047 "Cathelicidin antimicrobial peptide" 3 48223347-48225491 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 63.7;bone marrow: 201.8;epididymis: 275.0" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 14.1;Glandular cells: 10.4;Late spermatids: 6.8;Spermatogonia: 4.9" "Cancer enhanced" "Detected in many" "testis cancer: 10.1" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 4 "neutrophil: 63.7" "Lineage enriched" "Detected in many" 12 "granulocytes: 63.7" "Cell line enhanced" "Detected in some" "Daudi: 13.6;hTCEpi: 9.5;U-698: 39.4" "Low region specificity" "Detected in single" "CAB015949, CAB016522, HPA029874" Enhanced "Secreted to blood" NA NA 617000000 "CAB015949: , CAB016522: , HPA029874: AB_10600859" "unprognostic (2.14e-2)" "prognostic favorable (5.73e-4)" "unprognostic (4.59e-2)" "unprognostic (2.62e-1)" "unprognostic (9.41e-2)" "unprognostic (4.57e-5)" "unprognostic (3.09e-1)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.65e-2)" "unprognostic (1.32e-1)" "unprognostic (8.08e-4)" "unprognostic (1.23e-2)" "unprognostic (2.55e-1)" "unprognostic (1.71e-1)" "unprognostic (1.80e-2)" "unprognostic (1.03e-2)" 0.2 0.1 0.1 0.1 0.2 201.8 0.2 0.1 0.1 0.1 0.1 0.0 14.7 0.0 0.0 275.0 0.1 0.2 0.0 0.5 0.1 0.1 0.1 0.2 1.5 0.5 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.2 0.0 0.1 1.1 0.1 0.1 0.1 2.6 0.0 0.1 10.1 0.1 4.0 0.0 0.4 0.4 0.1 0.2 0.4 0.1 0.5 1.5 63.7 5.2 0.5 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 39.4 0.0 1.5 0.0 5.5 1.1 15.8 0.0 1.7 0.0 0.5 0.0 0.0 1.5 0.3 0.0 0.0 63.7 0.5 5.2 0.8 0.0 10.9 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.2 0.0 0.2 10.4 0.0 0.0 3.3 0.0 0.0 0.6 0.6 6.8 0.9 0.8 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.9 0.0 0.0 0.0 0.0 0.4 CANT1 "SCAN-1, SHAPY" ENSG00000171302 "Calcium activated nucleotidase 1" Q8WVQ1 17 78991717-79009867 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Mucus-secreting cells: 134.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 92.2;T-47d: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019627, HPA019639, HPA022818" Enhanced Supported "Golgi apparatus" NA NA 2300000 "Golgi apparatus" "HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971" "unprognostic (1.98e-2)" "unprognostic (2.49e-2)" "unprognostic (1.50e-2)" "unprognostic (5.36e-2)" "unprognostic (2.13e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (1.41e-4)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.21e-4)" "unprognostic (7.04e-2)" "unprognostic (5.06e-2)" "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" 13.8 15.3 9.6 13.1 10.2 8.1 13.0 12.2 10.8 17.7 43.8 12.3 25.4 25.5 12.0 14.3 27.5 10.0 19.5 10.8 9.0 6.9 10.3 17.7 11.1 11.5 12.5 7.7 10.4 14.7 13.1 11.8 33.0 12.0 36.7 41.5 7.9 30.3 41.4 9.0 8.9 27.2 8.0 12.4 18.1 25.8 19.0 10.3 14.1 12.4 8.9 14.4 10.3 13.7 4.1 3.8 17.5 4.4 3.1 6.2 4.4 22.2 24.4 6.8 9.9 6.5 7.8 8.8 13.8 12.1 14.8 12.6 11.6 21.1 5.4 8.1 9.6 18.1 11.3 5.8 10.8 14.9 9.0 10.6 7.0 7.4 9.6 5.6 6.7 11.1 8.0 7.0 13.7 7.5 8.8 25.6 9.1 8.8 9.2 9.8 12.1 10.1 4.0 4.7 92.2 26.0 5.7 11.2 6.1 6.5 11.2 9.9 9.9 7.3 48.8 10.4 11.4 60.2 8.0 12.7 22.2 20.1 9.9 17.2 10.9 9.0 5.3 14.2 5.2 13.9 6.1 3.8 8.1 6.2 4.4 6.1 4.1 4.6 5.2 3.8 2.9 4.5 4.4 17.5 3.1 2.9 2.7 3.8 4.4 9.6 10.2 12.2 10.8 9.0 6.9 12.5 7.7 12.0 10.3 26.8 19.4 13.7 13.8 14.7 5.9 11.6 15.3 6.7 10.3 12.2 13.7 30.3 3.3 30.3 11.4 14.3 61.6 23.3 25.4 31.5 12.3 34.8 5.7 12.1 21.5 4.8 49.0 54.6 9.2 10.4 10.9 11.3 13.5 11.8 134.8 6.7 27.4 49.1 7.1 6.1 8.5 6.5 7.2 23.2 5.5 11.4 84.9 10.2 83.2 16.5 CANX "CNX, IP90, P90" ENSG00000127022 Calnexin P27824 5 179678628-179730925 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 109.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004738, HPA009433, HPA009696" Enhanced Enhanced "Endoplasmic reticulum" NA NA 82000000 "Endoplasmic reticulum" "CAB004738: AB_626784, HPA009433: AB_1078380, HPA009696: AB_1078379" "unprognostic (6.56e-2)" "unprognostic (9.34e-3)" "prognostic favorable (1.38e-4)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" "unprognostic (1.41e-2)" "unprognostic (4.66e-3)" "unprognostic (8.57e-2)" "unprognostic (4.34e-2)" "unprognostic (1.25e-2)" "unprognostic (2.17e-3)" "unprognostic (4.48e-2)" "unprognostic (2.28e-1)" "unprognostic (1.87e-1)" "unprognostic (7.12e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.15e-1)" 49.3 35.4 40.0 35.8 40.9 57.6 37.8 27.3 49.1 93.0 33.6 37.1 48.3 44.0 42.7 115.4 31.6 31.7 30.0 51.3 36.9 50.9 61.6 120.8 34.7 30.1 47.5 27.9 41.0 78.2 13.7 33.0 70.5 44.9 33.5 55.1 32.2 121.5 48.5 28.5 23.4 68.5 60.5 48.8 38.2 31.7 34.3 30.0 31.0 113.4 25.9 29.9 41.4 47.6 10.1 26.3 25.9 28.9 18.7 22.6 30.0 8.4 23.8 20.2 12.3 43.5 32.3 10.2 43.5 47.8 50.3 42.7 20.7 19.5 63.9 61.1 34.8 25.6 5.8 31.7 23.7 57.5 16.4 9.6 10.3 59.3 13.4 59.3 19.6 9.7 6.3 43.6 27.0 78.5 15.4 20.8 4.9 8.1 24.9 5.5 7.8 9.9 0.3 4.1 3.6 1.4 10.3 14.7 7.0 37.0 24.9 10.2 2.4 12.2 5.2 109.0 25.3 41.2 8.7 38.6 11.5 19.2 13.0 33.7 7.6 26.2 16.1 17.4 12.8 11.2 25.9 28.9 8.8 17.7 21.2 22.6 10.1 13.9 16.3 26.3 7.7 9.5 10.6 6.1 18.7 18.0 25.3 10.1 30.0 40.0 40.9 27.3 33.3 36.9 50.9 47.5 27.9 44.9 30.0 184.6 236.5 93.5 89.0 131.9 112.0 432.6 180.9 323.9 284.4 172.7 149.2 138.7 41.4 148.7 197.6 180.1 166.6 46.7 132.3 187.5 146.3 221.3 188.7 393.6 206.3 151.0 170.9 163.9 186.1 659.2 147.3 192.4 167.0 120.8 179.5 201.8 157.0 97.9 179.6 160.8 108.3 90.5 152.7 141.2 80.8 141.4 204.7 88.6 178.9 131.5 CAPZA2 "CAPPA2, CAPZ" ENSG00000198898 "Capping actin protein of muscle Z-line alpha subunit 2" P47755 7 116811070-116922049 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007470, HPA007643" Uncertain Approved "Endoplasmic reticulum,Cytosol" No No 19000000 "Endoplasmic reticulum" Cytosol "HPA007470: AB_1845985, HPA007643: AB_2667886" "unprognostic (1.37e-2)" "unprognostic (2.25e-3)" "unprognostic (4.16e-2)" "unprognostic (3.16e-1)" "unprognostic (1.53e-1)" "unprognostic (2.63e-3)" "prognostic unfavorable (9.34e-5)" "unprognostic (1.90e-2)" "unprognostic (1.80e-2)" "unprognostic (2.15e-1)" "unprognostic (2.08e-3)" "unprognostic (2.52e-1)" "prognostic favorable (3.65e-6)" "unprognostic (1.40e-1)" "unprognostic (1.08e-1)" "unprognostic (2.91e-3)" "unprognostic (6.58e-2)" 32.4 17.7 23.6 15.8 22.6 33.6 18.5 17.6 30.2 17.7 26.3 10.7 13.5 16.9 20.6 16.4 25.9 14.9 17.6 36.4 26.7 20.6 40.9 29.2 23.2 16.6 22.1 15.9 17.3 13.8 12.9 16.4 26.1 27.1 21.8 20.6 11.8 14.4 18.3 47.1 11.6 30.6 30.3 19.6 26.0 17.8 12.4 13.7 17.7 24.5 21.0 14.0 31.5 15.0 6.6 14.8 32.0 22.8 7.1 7.8 17.7 13.1 8.9 8.7 11.3 16.6 17.6 4.8 13.1 18.4 13.1 15.0 6.5 16.9 9.0 21.4 18.4 16.8 8.2 8.9 10.7 20.4 9.7 7.1 13.5 8.9 10.8 10.2 8.9 18.2 14.1 12.0 10.7 10.1 15.9 27.6 5.7 8.9 15.6 25.7 6.4 11.6 15.1 12.8 13.5 7.8 8.3 11.7 17.7 30.5 11.2 9.2 10.5 12.1 45.7 12.4 11.5 6.4 10.4 10.2 21.1 6.7 16.6 12.2 12.3 9.0 17.1 12.5 12.7 14.9 19.9 16.4 19.2 5.5 20.1 6.1 6.6 6.5 5.7 14.8 6.0 6.4 6.5 32.0 7.1 22.8 8.2 7.8 17.7 23.6 22.6 17.6 30.2 26.7 20.6 22.1 15.9 27.1 13.7 68.5 67.4 96.3 183.9 215.9 99.6 196.7 68.8 42.8 60.3 162.3 25.5 129.4 437.7 161.9 6.6 193.4 141.9 93.5 141.3 163.7 177.2 113.8 124.6 101.1 274.2 101.7 116.2 221.6 215.0 12.9 69.0 242.4 172.1 184.0 86.3 127.8 150.8 154.3 104.3 362.3 90.2 90.5 201.3 35.1 43.4 191.2 120.5 90.6 83.0 173.2 CARD19 "bA370F5.1, BinCARD, C9orf89, MGC11115" ENSG00000165233 "Caspase recruitment domain family member 19" Q96LW7 9 93096218-93113283 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010921, HPA010990, HPA038297" Approved Supported Mitochondria NA NA Mitochondria "HPA010921: AB_10670295, HPA010990: AB_2668400, HPA038297: AB_2675938" "unprognostic (7.26e-2)" "unprognostic (1.15e-2)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (7.47e-5)" "unprognostic (2.22e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.21e-1)" "unprognostic (1.36e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (9.13e-2)" "unprognostic (6.82e-2)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" 15.1 17.8 9.9 8.1 10.6 6.8 19.6 19.8 15.0 13.5 18.1 13.9 6.4 13.7 13.8 14.2 12.9 12.3 13.0 14.5 9.7 7.5 18.1 12.2 12.0 7.8 14.8 10.7 9.6 9.1 6.1 8.1 7.6 13.7 10.2 7.6 9.9 12.1 10.7 15.5 14.6 12.2 12.5 12.5 12.5 15.7 19.9 10.3 5.3 10.0 13.4 7.1 15.5 12.6 5.6 17.3 23.0 21.7 9.2 11.5 12.3 12.1 11.9 1.4 3.5 1.9 3.7 5.0 10.1 5.0 7.1 3.2 2.9 4.1 2.6 7.1 3.6 5.1 21.2 1.2 8.1 0.6 50.0 4.7 4.6 2.5 6.7 8.1 4.1 4.4 9.3 2.6 5.1 2.0 7.0 8.2 2.3 2.0 4.9 4.8 24.1 4.4 11.1 1.4 7.7 27.1 2.9 8.0 10.6 8.7 4.5 3.7 6.7 5.4 2.6 11.0 0.0 6.0 4.3 8.1 3.6 7.3 6.8 3.1 3.9 3.6 0.5 14.9 4.2 12.4 14.1 21.7 12.8 6.1 16.0 6.2 5.6 6.0 6.5 17.3 3.3 5.5 5.5 23.0 9.2 9.1 6.2 11.5 12.3 9.9 10.6 19.8 15.0 9.7 7.5 14.8 10.7 13.7 10.3 20.8 18.1 6.7 38.6 0.0 10.2 0.0 25.5 4.0 10.3 15.7 15.7 18.5 53.0 70.5 28.5 24.8 23.6 0.0 51.8 27.7 20.8 42.0 27.9 12.4 72.1 4.8 15.2 34.4 46.4 9.3 42.3 64.9 0.0 71.3 25.5 15.1 83.4 7.0 41.1 43.9 21.6 58.2 0.0 75.2 29.6 0.0 18.1 22.4 21.0 66.8 CASC4 "DKFZp459F1927, H63" ENSG00000166734 "Cancer susceptibility 4" Q6P4E1 15 44288729-44415758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043015, HPA049488" Enhanced Enhanced "Golgi apparatus" NA NA 400000 "Golgi apparatus" "HPA043015: AB_2678271, HPA049488: AB_2680790" "unprognostic (2.64e-2)" "unprognostic (2.63e-1)" "unprognostic (3.38e-1)" "unprognostic (1.81e-2)" "unprognostic (8.08e-2)" "unprognostic (1.35e-1)" "unprognostic (1.20e-2)" "unprognostic (2.20e-1)" "unprognostic (2.40e-1)" "unprognostic (1.68e-2)" "unprognostic (4.99e-2)" "unprognostic (2.60e-2)" "prognostic favorable (1.45e-5)" "unprognostic (2.15e-1)" "unprognostic (3.56e-2)" "unprognostic (9.65e-2)" "unprognostic (1.12e-1)" 21.0 48.4 40.2 17.4 40.2 7.8 24.1 29.9 35.6 34.5 24.8 29.6 37.5 15.6 28.8 30.3 13.4 30.7 27.8 23.6 39.5 34.2 30.5 32.6 22.3 15.2 32.4 22.8 32.3 21.2 40.9 42.8 18.7 33.8 38.8 24.4 25.6 24.8 34.0 14.1 9.1 16.2 24.8 40.6 18.5 27.3 18.7 33.2 17.0 46.7 12.1 15.5 21.8 20.8 9.8 9.1 28.2 12.6 8.0 13.5 8.9 13.3 11.5 15.7 27.2 42.5 37.1 9.7 24.5 36.8 13.3 17.1 5.5 23.3 3.9 33.8 34.4 14.9 16.0 10.0 7.3 14.2 20.4 5.6 6.2 13.5 10.0 19.7 12.2 21.4 21.9 8.3 14.8 11.4 38.2 15.4 10.5 9.4 30.2 16.4 6.5 10.3 9.4 4.3 17.6 7.9 8.8 9.0 12.3 17.0 15.6 7.0 16.3 18.6 17.1 7.7 8.7 18.8 14.4 23.0 23.7 12.7 34.9 20.7 24.6 41.9 8.2 27.7 17.1 15.2 10.7 10.6 15.0 12.1 7.7 13.5 9.8 10.1 12.0 9.1 9.5 7.9 8.0 28.2 8.0 12.6 8.2 9.9 8.9 40.2 40.2 29.9 34.0 39.5 34.2 32.4 22.8 33.8 33.2 59.6 49.7 24.4 29.9 21.1 37.1 17.3 38.2 87.0 54.6 61.1 27.5 13.7 8.3 35.5 9.3 39.0 28.8 0.0 49.2 16.2 58.6 84.9 22.0 59.9 23.7 41.3 58.2 39.9 48.5 12.7 61.5 37.7 33.7 88.4 65.4 35.9 36.2 20.1 75.3 28.3 20.7 45.3 38.9 32.5 7.0 16.2 10.6 30.5 46.0 43.0 CASD1 "C7orf12, FLJ21213, FLJ21879" ENSG00000127995 "CAS1 domain containing 1" Q96PB1 7 94509219-94557019 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 54.4;Horizontal cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044404 Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA044404: AB_10964353" "unprognostic (4.02e-2)" "unprognostic (4.16e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (7.04e-2)" "unprognostic (7.90e-2)" "unprognostic (3.66e-2)" "unprognostic (2.18e-2)" "unprognostic (9.83e-2)" "unprognostic (4.74e-2)" "unprognostic (4.95e-3)" "unprognostic (2.16e-2)" "unprognostic (5.24e-2)" "unprognostic (4.01e-3)" "unprognostic (1.93e-1)" "unprognostic (7.07e-2)" "unprognostic (2.59e-3)" 8.6 21.6 16.6 7.1 24.2 4.1 13.2 20.5 24.8 10.0 13.2 10.9 7.5 5.0 11.7 12.5 5.1 9.2 8.1 13.6 25.9 22.2 10.2 7.1 9.0 9.2 13.1 16.6 14.1 7.8 12.7 22.8 9.8 20.0 11.8 15.9 8.4 22.6 8.2 11.3 3.7 6.3 9.7 13.7 8.0 6.0 10.1 11.5 7.3 13.2 2.9 8.3 9.0 6.3 1.8 1.1 0.2 0.7 1.8 4.7 0.7 3.0 5.9 20.3 7.5 6.2 7.5 3.4 4.2 7.4 4.6 6.1 3.7 7.6 7.8 11.0 5.6 8.3 1.7 5.1 1.4 9.2 12.4 4.1 6.9 5.0 6.7 5.3 11.4 0.0 6.8 5.4 4.2 6.1 9.1 7.3 9.2 3.7 17.2 11.4 4.5 15.8 6.5 10.4 4.3 4.7 10.9 16.5 6.0 9.4 8.5 7.7 26.3 6.5 12.1 4.1 15.4 3.1 7.2 3.8 11.6 9.2 9.5 6.0 16.5 15.4 16.3 6.3 2.7 7.5 0.0 0.6 0.2 1.9 0.7 4.7 1.8 2.8 2.3 1.1 1.7 2.9 2.2 0.0 1.8 0.6 1.0 1.7 0.7 16.6 24.2 20.5 24.8 25.9 22.2 13.1 16.6 20.0 11.5 26.8 22.9 6.9 5.2 4.0 54.4 17.1 17.8 18.7 17.0 19.2 17.7 9.7 3.3 4.5 2.7 13.3 12.0 0.0 4.8 4.6 9.3 11.8 10.3 10.9 7.4 63.5 6.9 17.2 11.5 4.7 10.6 5.6 23.6 2.8 27.6 25.0 6.1 8.6 9.2 8.8 28.9 19.4 7.1 6.3 11.9 4.0 14.1 7.2 14.1 3.7 CASK "CAGH39, FGS4, LIN2, TNRC8" ENSG00000147044 "Calcium/calmodulin dependent serine protein kinase" O14936 X 41514934-41923645 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.3" "Lineage enriched" "Detected in many" 11 "granulocytes: 26.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001949, HPA023857" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB001949: , HPA023857: AB_1846035" "unprognostic (6.30e-2)" "unprognostic (3.78e-2)" "unprognostic (1.48e-1)" "unprognostic (2.48e-3)" "unprognostic (1.56e-1)" "unprognostic (1.29e-1)" "unprognostic (1.42e-3)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (5.85e-3)" "prognostic unfavorable (6.11e-5)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (8.72e-2)" "unprognostic (1.15e-2)" "unprognostic (2.13e-2)" "unprognostic (2.85e-2)" 9.1 15.9 13.9 18.8 12.7 9.8 13.2 14.2 15.7 11.1 22.1 20.0 7.1 27.1 12.2 13.7 17.2 9.9 16.0 7.0 12.1 12.8 14.6 10.8 10.3 13.6 16.3 8.5 13.9 14.2 11.1 9.8 13.4 11.9 10.7 23.8 10.4 15.9 7.7 5.8 12.8 32.9 12.1 10.1 9.6 16.2 2.9 14.3 30.9 9.3 8.1 14.0 11.8 13.1 0.6 0.3 26.3 0.8 2.4 2.3 0.3 10.9 14.0 13.4 8.0 9.1 7.4 4.3 9.6 8.0 5.6 5.2 30.1 17.9 0.1 4.9 11.9 10.2 22.0 14.7 9.8 9.4 9.7 8.2 0.0 12.6 10.6 9.4 1.7 1.5 8.4 26.9 10.7 13.7 11.3 4.6 6.4 0.8 8.5 12.2 12.8 3.1 0.7 12.3 15.8 9.1 5.1 33.0 5.2 12.7 23.8 12.3 6.5 18.0 7.2 5.5 22.6 7.7 0.3 5.3 10.5 10.7 9.0 5.3 3.3 2.1 3.7 10.3 1.2 6.7 26.3 0.8 4.8 0.5 0.7 0.5 0.4 0.6 0.8 0.2 0.6 0.7 0.7 1.1 2.4 0.4 0.3 2.3 0.3 13.9 12.7 14.2 14.2 12.1 12.8 16.3 8.5 11.9 14.3 11.9 14.8 0.9 33.3 29.0 40.5 6.5 10.2 20.1 14.8 7.0 21.6 1.6 43.1 13.2 0.8 10.8 22.7 0.0 12.7 0.7 17.5 19.6 0.0 13.0 16.2 47.7 13.3 4.9 3.5 0.2 9.2 6.8 10.1 0.0 30.6 11.9 17.9 28.1 8.9 17.0 26.0 19.4 14.4 1.6 1.9 28.4 1.4 12.5 36.5 26.9 CASR "FHH, GPRC2A, HHC, HHC1, NSHPT" ENSG00000036828 "Calcium sensing receptor" P41180 3 122183683-122291629 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "parathyroid gland: 155.3" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 13.2;Cholangiocytes: 33.1;Ciliated cells: 28.1;Club cells: 10.3;Distal tubular cells: 11.6;Intestinal endocrine cells: 11.1" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 5.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 4.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039686, HPA050335" Enhanced NA NA "HPA039686: AB_10673536, HPA050335: AB_2681092" "unprognostic (1.97e-2)" "unprognostic (7.40e-2)" "unprognostic (8.20e-4)" "unprognostic (3.15e-1)" "unprognostic (8.55e-4)" "unprognostic (1.58e-1)" "unprognostic (7.32e-2)" "unprognostic (7.67e-2)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (1.91e-5)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (1.24e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 21.0 0.0 0.1 0.2 18.1 0.5 0.0 0.0 0.1 0.0 0.6 12.1 155.3 0.6 0.0 0.2 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.6 0.3 0.2 0.2 0.5 0.3 0.0 0.1 1.6 0.0 0.1 0.7 0.0 1.4 0.5 1.1 0.3 0.8 1.1 0.2 0.6 1.3 0.7 1.1 0.3 0.3 0.7 0.7 0.0 0.0 0.1 0.6 0.9 1.1 0.9 0.4 0.8 0.5 0.2 0.2 0.3 0.8 0.1 1.4 1.1 1.1 0.0 0.7 0.8 0.4 0.4 0.5 0.2 0.5 0.2 1.1 0.6 2.0 0.3 0.7 0.5 0.9 1.4 0.8 0.7 0.6 0.5 0.6 4.0 1.5 0.6 0.8 0.9 0.5 0.3 1.7 1.0 0.3 1.3 1.0 1.9 1.0 0.3 1.7 1.1 0.5 0.7 0.6 1.0 1.0 0.3 0.1 0.9 0.2 0.9 0.7 0.9 0.9 0.1 1.4 0.7 0.6 1.1 0.8 0.2 0.5 1.1 0.2 0.0 0.0 0.0 0.6 0.1 0.2 0.1 0.0 0.2 0.0 23.8 13.2 0.0 0.0 0.0 0.0 0.8 33.1 28.1 10.3 3.5 0.0 0.0 11.6 3.7 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 11.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.2 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 CATSPER1 CATSPER ENSG00000175294 "Cation channel sperm associated 1" Q8NEC5 11 66016752-66026517 "Disease related genes, Predicted membrane proteins" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 42 "blood: 12.8;testis: 38.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 28.9;granulocytes: 99.1;Hofbauer cells: 20.8;Kupffer cells: 18.5;Macrophages: 20.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 12.8;classical monocyte: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;EFO-21: 6.6;HEL: 4.4;HMC-1: 8.4;U-2 OS: 3.6" "Low region specificity" "Detected in many" NA NA "unprognostic (2.21e-2)" "unprognostic (3.00e-2)" "unprognostic (2.67e-2)" "unprognostic (1.91e-1)" "unprognostic (3.96e-3)" "unprognostic (1.71e-1)" "unprognostic (6.09e-3)" "unprognostic (1.88e-1)" "unprognostic (3.32e-1)" "unprognostic (2.44e-3)" "unprognostic (5.99e-3)" "unprognostic (1.61e-2)" "unprognostic (2.12e-8)" "unprognostic (8.79e-3)" "unprognostic (9.02e-3)" "unprognostic (2.18e-2)" "unprognostic (1.51e-1)" 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 12.8 5.9 3.3 0.2 2.1 1.6 0.7 0.0 0.0 0.0 0.1 0.1 0.3 1.3 0.6 0.5 0.1 7.2 0.0 6.6 1.3 2.4 0.0 0.0 1.4 0.8 0.0 0.0 4.4 0.3 0.1 0.0 0.0 8.4 0.1 0.0 0.5 0.9 1.6 0.4 0.0 0.0 0.1 1.2 0.0 0.0 0.7 0.0 0.0 0.5 0.0 2.4 0.1 2.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.0 0.3 1.9 3.6 0.2 0.3 0.0 0.0 0.0 1.3 0.5 1.0 12.8 5.9 0.1 0.2 0.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.5 3.3 0.0 0.0 0.0 2.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 28.9 0.0 0.0 0.0 0.6 5.3 0.4 0.0 99.1 0.0 20.8 0.0 0.0 1.8 18.5 2.1 0.9 20.3 1.7 0.0 0.0 0.0 2.2 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.4 0.3 0.3 4.3 0.0 0.3 CATSPER2 ENSG00000166762 "Cation channel sperm associated 2" Q96P56 15 43628503-43668118 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 43.7" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 239.5;Rod photoreceptor cells: 241.8;Spermatocytes: 77.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 9.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 12.8" NA NA "unprognostic (6.88e-3)" "unprognostic (6.79e-2)" "unprognostic (2.08e-2)" "unprognostic (2.65e-2)" "unprognostic (4.05e-1)" "unprognostic (1.05e-2)" "unprognostic (7.11e-3)" "unprognostic (1.48e-2)" "unprognostic (6.35e-2)" "unprognostic (1.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.37e-2)" "unprognostic (3.74e-3)" "unprognostic (1.15e-1)" "unprognostic (6.04e-2)" "unprognostic (8.87e-2)" "unprognostic (8.23e-5)" 1.1 0.9 1.1 1.1 1.4 3.2 1.3 9.0 1.1 1.1 1.7 1.1 1.1 2.7 1.1 5.2 1.9 1.1 1.1 1.1 1.1 1.3 1.1 1.1 1.1 1.3 1.1 1.1 1.4 1.1 4.0 3.0 1.1 1.1 1.3 1.9 1.1 1.1 1.9 1.1 4.8 3.1 1.1 1.6 1.1 1.3 43.7 1.1 1.1 1.7 1.1 1.1 1.2 1.1 3.3 1.8 2.3 1.2 1.8 2.9 0.2 2.5 3.5 1.5 5.6 0.0 0.0 2.6 0.9 2.2 1.6 3.8 0.8 1.4 3.0 1.3 0.6 1.9 5.4 1.4 4.9 1.5 2.5 6.8 8.6 12.8 1.2 2.3 2.0 2.8 0.3 3.9 2.2 5.5 4.2 2.0 5.4 3.4 3.2 0.5 0.6 1.6 3.4 0.5 3.3 1.5 2.3 1.8 1.4 3.1 4.0 3.4 1.2 1.5 2.1 0.1 2.1 4.1 2.0 0.5 4.0 1.7 0.0 2.3 0.6 0.3 5.9 2.7 6.1 1.4 0.4 1.2 0.5 1.3 0.5 1.6 3.3 1.1 1.8 0.8 1.7 1.5 2.9 2.3 1.8 1.2 1.8 0.5 0.2 1.1 1.4 9.0 1.1 1.1 1.3 1.1 1.1 1.1 1.1 0.0 5.0 4.4 7.4 6.3 51.5 2.9 2.5 8.1 7.9 7.0 239.5 4.4 3.3 2.4 53.6 4.5 3.9 0.0 2.3 1.9 2.6 5.8 9.2 3.4 3.7 36.5 20.6 7.4 2.2 22.9 5.8 5.0 1.7 1.8 4.4 11.3 1.8 3.5 6.7 4.2 241.8 0.0 3.1 77.5 8.3 6.9 2.5 3.2 8.2 7.1 CATSPER3 CACRC ENSG00000152705 "Cation channel sperm associated 3" Q86XQ3 5 134967906-135011707 "Predicted membrane proteins, Transporters" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 31.9" "Group enriched" "Detected in some" 39 "Early spermatids: 152.2;Late spermatids: 43.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 7.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (2.59e-2)" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (2.26e-1)" "unprognostic (4.26e-2)" "unprognostic (1.57e-2)" "unprognostic (4.87e-2)" "unprognostic (2.63e-1)" "unprognostic (3.71e-2)" "unprognostic (8.00e-2)" "unprognostic (2.28e-3)" "unprognostic (1.55e-1)" "unprognostic (3.04e-2)" "unprognostic (5.58e-3)" "unprognostic (9.39e-2)" "unprognostic (1.51e-1)" "unprognostic (4.96e-3)" 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.5 0.4 0.5 0.4 0.8 0.4 0.4 0.4 0.4 0.6 1.0 0.4 0.4 0.4 0.4 0.6 0.8 0.2 0.4 0.4 0.4 0.4 0.4 0.4 0.6 0.4 2.7 0.3 0.4 0.4 0.4 0.4 0.3 31.9 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.3 1.4 0.4 0.6 3.2 1.8 0.4 0.4 3.6 1.4 1.6 1.1 0.4 0.8 0.6 0.3 7.2 0.6 2.0 3.1 1.4 1.8 0.3 0.7 1.1 2.3 1.2 0.7 1.9 2.7 0.3 2.0 1.2 0.7 0.9 0.8 0.4 1.8 0.6 2.8 0.7 0.0 0.9 1.5 2.6 0.5 1.6 1.5 2.3 0.4 2.7 1.9 1.9 0.6 0.8 3.1 0.5 1.1 1.1 1.3 1.0 1.1 1.2 1.4 2.2 1.0 0.1 1.3 0.3 1.6 1.2 1.0 0.4 0.7 2.3 0.5 0.0 0.6 0.0 0.4 0.1 0.0 0.8 0.7 0.7 1.4 3.3 1.8 0.7 0.4 3.2 0.1 0.7 0.0 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.5 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 152.2 0.1 0.0 0.0 1.0 0.2 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.3 43.8 1.4 0.0 0.0 1.0 0.0 0.4 0.3 0.0 0.7 1.0 2.5 0.0 0.3 2.1 1.1 0.3 0.1 0.0 0.1 0.0 CATSPER4 ENSG00000188782 "Cation channel sperm associated 4" Q7RTX7 1 26190561-26202968 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 13.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.1;hTCEpi: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA045257 Enhanced NA NA "HPA045257: AB_10968995" "unprognostic (7.20e-2)" "unprognostic (2.06e-2)" "unprognostic (4.56e-2)" "unprognostic (2.69e-2)" "unprognostic (3.49e-1)" "unprognostic (3.86e-2)" "unprognostic (1.52e-2)" "unprognostic (2.16e-1)" "unprognostic (3.06e-1)" "unprognostic (6.78e-2)" "unprognostic (6.98e-2)" "unprognostic (6.67e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 CATSPERB "C14orf161, FLJ14298" ENSG00000133962 "Cation channel sperm associated auxiliary subunit beta" Q9H7T0 14 91580696-91780707 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 15.1" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 11.1;Exocrine glandular cells: 9.3;Pancreatic endocrine cells: 11.1" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;OE19: 4.0;U-937: 3.7" "Not detected" "Not detected" HPA035134 Uncertain Uncertain Vesicles NA NA Vesicles "HPA035134: AB_10671510" "unprognostic (2.69e-2)" "unprognostic (1.95e-1)" "unprognostic (1.16e-3)" "unprognostic (1.93e-1)" "unprognostic (7.04e-3)" "unprognostic (2.72e-5)" "unprognostic (1.81e-1)" "unprognostic (5.01e-3)" "unprognostic (1.81e-3)" "unprognostic (3.52e-3)" "unprognostic (2.30e-2)" "unprognostic (4.34e-1)" "unprognostic (8.99e-3)" "unprognostic (6.85e-2)" "unprognostic (8.31e-2)" "unprognostic (8.88e-2)" "unprognostic (2.71e-3)" 0.6 0.1 0.0 0.6 0.0 0.0 1.4 0.0 0.2 0.4 0.9 0.3 0.4 0.4 0.6 0.7 1.2 0.6 0.0 0.0 0.3 0.2 0.9 1.1 0.0 0.2 15.1 1.0 0.3 0.0 0.9 0.7 3.7 0.0 1.7 4.2 1.2 0.1 0.0 0.8 2.0 2.0 0.9 0.6 0.5 0.3 0.4 0.2 1.1 0.2 0.7 1.6 0.4 0.6 0.0 0.7 1.6 0.0 0.0 1.8 0.2 0.3 0.0 0.0 2.3 3.8 1.1 0.9 0.0 0.1 0.6 0.0 0.5 0.7 1.4 2.0 0.4 1.2 2.2 0.0 1.6 0.8 0.6 0.7 0.4 0.5 1.5 0.0 1.0 0.5 0.2 0.4 2.2 0.6 0.7 0.2 4.0 0.5 0.3 0.0 0.0 0.4 0.9 1.6 0.1 0.0 0.8 1.5 1.7 0.4 2.1 0.9 0.2 0.2 0.0 0.3 0.9 0.8 0.3 0.2 3.7 1.0 1.1 0.2 0.6 1.1 0.0 1.5 0.4 1.6 1.0 0.0 0.2 1.1 1.4 0.4 0.7 0.2 0.2 0.0 0.4 3.0 1.0 0.0 0.2 0.1 0.0 0.1 0.0 1.4 2.3 0.0 0.0 0.0 0.0 1.6 11.1 0.0 0.3 0.0 9.3 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 1.0 2.1 0.0 11.1 0.9 0.0 0.5 0.0 0.0 0.0 0.9 0.2 0.0 0.2 0.0 0.4 0.3 CATSPERD "MGC39581, TMEM146" ENSG00000174898 "Cation channel sperm associated auxiliary subunit delta" Q86XM0 19 5720677-5778734 "Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 32.8" "Group enriched" "Detected in some" 13 "Ciliated cells: 194.1;Early spermatids: 109.5;Late spermatids: 120.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 60 "HEL: 13.2" "Not detected" "Not detected" HPA024056 Enhanced NA NA "HPA024056: AB_1858093" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (3.77e-3)" "unprognostic (9.91e-2)" "unprognostic (3.74e-2)" "unprognostic (6.85e-2)" "unprognostic (2.63e-3)" "unprognostic (2.19e-2)" "unprognostic (5.18e-2)" "unprognostic (2.50e-1)" "unprognostic (5.95e-8)" "unprognostic (2.54e-2)" "unprognostic (9.92e-2)" "unprognostic (2.83e-1)" "unprognostic (3.74e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 32.8 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.5 0.6 0.0 0.1 0.1 0.1 0.1 0.0 2.1 0.0 0.1 0.3 0.0 0.4 0.0 194.1 6.8 0.0 0.0 0.0 0.0 0.0 109.5 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 120.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 11.1 1.1 1.3 0.2 0.0 0.0 0.0 CATSPERE "C1orf101, MGC33370" ENSG00000179397 "Catsper channel auxiliary subunit epsilon" Q5SY80 1 244454377-244641177 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 26.9" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 16.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.7;hTERT-RPE1: 2.6" "Low region specificity" "Detected in many" NA NA "unprognostic (3.22e-1)" "unprognostic (4.50e-2)" "unprognostic (2.02e-1)" "unprognostic (7.31e-2)" "unprognostic (3.32e-1)" "unprognostic (2.50e-3)" "unprognostic (3.76e-3)" "unprognostic (5.39e-4)" "unprognostic (1.96e-2)" "unprognostic (3.41e-2)" "unprognostic (4.37e-4)" "unprognostic (4.43e-2)" "unprognostic (9.09e-2)" "unprognostic (1.76e-1)" "unprognostic (5.79e-2)" "unprognostic (6.74e-3)" "unprognostic (5.85e-2)" 0.9 1.1 1.3 0.5 3.2 1.1 1.2 1.7 2.7 1.2 0.5 4.6 0.4 0.5 1.6 4.1 0.6 2.1 0.9 0.5 3.1 1.3 1.4 1.5 1.0 1.8 1.2 1.3 1.4 2.4 2.6 2.2 0.9 3.2 1.0 0.5 1.3 0.9 1.1 1.0 0.7 0.7 1.5 2.8 0.9 0.7 26.9 0.7 0.5 1.6 0.0 0.6 1.0 0.8 0.8 0.9 0.8 0.1 0.1 0.8 0.1 0.3 0.0 0.6 0.0 1.3 2.7 0.2 1.5 1.5 0.2 0.2 0.0 0.7 0.5 1.8 1.7 0.0 0.7 0.4 0.2 0.5 0.0 1.5 0.0 0.4 0.1 0.9 0.0 1.4 2.2 0.7 0.2 0.0 2.6 0.7 0.7 0.2 0.5 0.2 0.0 0.2 0.3 0.3 0.0 0.2 1.4 0.0 0.0 0.8 0.0 1.6 1.0 0.7 0.0 0.3 0.4 0.1 0.8 1.8 0.1 0.0 0.0 1.0 0.9 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.7 0.0 0.2 0.8 0.1 0.3 0.0 0.6 0.8 0.1 0.0 0.1 0.1 0.9 0.2 0.1 1.3 3.2 1.7 2.7 3.1 1.3 1.2 1.3 3.2 0.7 3.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 16.0 2.3 1.8 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.7" "Group enriched" "Detected in many" 7 "Early spermatids: 23.9;Enterocytes: 14.0;Late spermatids: 27.8;Spermatocytes: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;monocytes: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HMC-1: 5.3;MCF7: 4.3" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.9 0.8 2.9 0.8 7.7 1.1 1.3 4.3 5.8 1.2 1.1 6.5 1.9 1.2 1.2 1.8 0.9 1.4 0.9 0.8 3.9 1.0 1.0 1.0 1.1 1.0 7.4 2.2 1.3 1.0 1.0 1.2 0.8 5.2 1.3 1.0 0.4 2.0 1.1 1.0 2.0 1.1 0.9 3.2 0.9 1.0 35.7 6.5 2.2 1.3 0.0 1.0 0.9 3.3 0.1 0.6 4.8 1.8 0.2 0.5 0.2 0.2 0.5 0.2 1.8 0.8 0.0 4.2 0.2 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.7 0.6 0.5 0.1 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.3 5.3 0.0 0.8 0.0 0.5 0.5 0.1 0.8 0.0 1.4 0.0 4.3 0.0 0.0 0.0 1.1 0.8 0.1 0.0 0.8 2.0 0.1 0.4 0.6 0.4 0.9 0.2 0.7 0.4 0.0 0.3 0.0 1.0 0.7 0.0 0.8 0.9 0.0 0.2 0.2 0.0 0.3 0.8 1.8 0.4 0.9 0.2 0.0 0.1 0.2 0.6 0.1 0.5 0.2 4.8 0.2 1.8 0.4 0.3 0.2 2.9 7.7 4.3 5.8 3.9 1.0 7.4 2.2 5.2 6.5 0.0 2.4 1.7 1.9 2.3 1.1 2.4 2.5 0.0 0.0 1.8 0.0 1.0 0.0 0.8 23.9 1.5 14.0 0.0 0.6 0.2 1.5 1.8 1.1 0.5 2.8 1.6 1.7 1.8 0.8 27.8 1.7 2.6 0.0 1.8 1.5 1.9 0.5 3.5 2.1 1.1 1.1 0.0 1.0 31.9 2.7 1.6 1.1 2.5 2.0 1.4 CAV1 CAV ENSG00000105974 "Caveolin 1" Q03135 7 116524785-116561184 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 1: 3305.3;Basal keratinocytes: 1221.7;Endothelial cells: 1019.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 10.6;memory B-cell: 6.0" "Group enriched" "Detected in many" 37 "B-cells: 6.0;granulocytes: 10.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 145.0;BJ hTERT+: 152.8;HBEC3-KT: 148.8;LHCN-M2: 155.1;U-138 MG: 123.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003791, HPA049326" Enhanced Supported "Golgi apparatus" NA NA "Golgi apparatus" "CAB003791: AB_562068, HPA049326: AB_2680714" "unprognostic (5.98e-2)" "unprognostic (1.35e-3)" "unprognostic (3.35e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-3)" "unprognostic (2.35e-3)" "unprognostic (8.07e-2)" "prognostic unfavorable (7.17e-5)" "unprognostic (1.31e-1)" "unprognostic (2.25e-1)" "unprognostic (1.79e-3)" "unprognostic (7.92e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.65e-3)" "unprognostic (2.72e-1)" "unprognostic (7.40e-2)" "unprognostic (6.14e-3)" 143.9 2.3 2.4 27.5 5.9 0.0 70.5 1.0 3.8 73.8 57.4 2.6 32.3 4.3 84.6 40.9 51.1 31.4 42.0 60.2 2.7 2.3 5.7 4.2 132.7 8.6 7.9 4.5 26.6 3.8 2.0 1.9 92.0 4.2 42.3 13.7 13.6 12.8 26.5 33.3 21.7 18.6 104.0 5.5 28.6 30.1 21.5 5.2 2.8 92.1 34.7 6.6 85.9 33.7 6.0 0.1 10.6 0.0 0.0 0.2 1.1 27.9 22.9 0.6 0.2 94.7 145.0 1.3 66.8 152.8 36.9 38.9 0.1 41.7 0.0 23.6 78.5 32.5 52.9 0.1 148.8 56.2 1.8 1.2 0.0 9.0 0.0 13.1 0.0 0.1 49.4 31.6 53.9 35.7 35.6 111.1 0.0 0.0 1.5 155.1 2.9 0.0 0.0 2.1 0.0 11.0 0.3 1.5 15.9 20.9 0.1 0.0 0.0 20.5 1.3 3.2 9.6 0.1 0.2 85.3 123.8 14.2 47.2 18.4 6.3 0.9 0.1 49.9 0.0 44.7 10.6 0.0 0.0 0.0 0.0 0.0 6.0 0.2 0.1 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 2.4 5.9 1.0 3.8 2.7 2.3 7.9 4.5 4.2 5.2 3305.3 101.8 0.8 331.2 1221.7 5.1 274.0 73.9 30.8 542.6 7.0 2.0 44.7 5.0 68.5 1.7 1019.9 0.4 23.3 0.6 374.1 329.7 54.2 12.8 3.4 12.7 0.0 1.7 373.8 14.3 5.0 349.2 22.2 416.7 6.4 0.1 209.8 27.0 0.0 531.4 0.0 4.5 549.7 544.6 1.9 4.9 534.0 97.8 6.4 0.4 74.0 CAV2 CAV ENSG00000105971 "Caveolin 2" P51636 7 116287380-116508541 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 824.8;Basal keratinocytes: 429.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 82 "basophil: 31.8" "Lineage enriched" "Detected in single" 318 "granulocytes: 31.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 48.8;HBEC3-KT: 55.8;LHCN-M2: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013488, HPA044810" Enhanced Approved Vesicles NA NA Vesicles "CAB013488: AB_2533493, HPA044810: AB_2679098" "unprognostic (4.76e-2)" "unprognostic (3.91e-3)" "unprognostic (4.56e-2)" "unprognostic (2.91e-1)" "unprognostic (5.09e-3)" "prognostic unfavorable (5.80e-5)" "unprognostic (3.66e-2)" "unprognostic (2.27e-2)" "unprognostic (3.81e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (6.32e-2)" "unprognostic (3.44e-3)" "unprognostic (7.84e-3)" "unprognostic (2.88e-1)" "unprognostic (2.42e-1)" "unprognostic (6.34e-3)" 61.9 4.5 3.0 9.5 6.6 0.2 39.9 1.0 3.7 26.3 15.7 3.1 10.3 3.3 23.4 19.6 25.2 10.8 31.3 54.6 4.4 3.1 9.5 17.4 59.4 6.0 7.5 3.8 17.7 16.0 1.4 2.8 35.2 4.6 20.6 5.0 12.1 10.7 10.5 15.3 13.3 8.3 34.0 8.6 25.3 8.9 12.1 5.3 1.7 61.2 23.2 4.9 29.5 15.4 0.0 0.0 31.8 0.0 0.0 0.0 0.2 39.3 10.7 0.5 0.0 18.2 19.6 0.8 27.5 32.8 9.1 8.2 2.0 48.8 0.0 33.0 28.2 29.4 38.2 0.5 55.8 13.2 0.0 2.6 0.3 8.2 0.0 11.2 0.0 0.1 11.5 32.2 12.3 25.5 14.6 29.4 0.0 1.9 1.6 60.2 2.1 0.0 0.0 0.5 1.3 6.9 0.4 13.4 0.5 33.5 1.2 0.0 0.0 21.0 0.7 5.1 5.9 0.0 0.2 41.9 0.0 5.8 18.2 9.0 1.7 0.0 0.1 3.7 0.0 19.7 31.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 3.0 6.6 1.0 3.7 4.4 3.1 7.5 3.8 4.6 5.3 824.8 93.2 3.0 234.5 429.9 3.3 197.7 119.8 33.5 164.9 38.4 3.9 12.5 29.9 203.4 19.4 231.9 2.4 0.0 87.5 115.4 81.9 72.8 2.3 42.7 4.3 0.0 1.7 104.3 4.7 13.0 87.5 7.4 138.3 3.6 4.7 140.5 278.7 0.0 182.5 2.2 6.0 187.5 172.0 2.3 1.3 246.5 10.4 2.5 5.1 133.6 CAV3 "LGMD1C, LQT9, VIP-21, VIP21" ENSG00000182533 "Caveolin 3" P56539 3 8733800-8841808 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 65.8;tongue: 44.6" "Cell type enhanced" "Detected in some" 28 "Cardiomyocytes: 18.9;Early spermatids: 4.4;Sertoli cells: 6.5" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RH-30: 46.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB017518, CAB018557, HPA054488" Enhanced Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504" "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-2)" "unprognostic (6.43e-2)" "unprognostic (8.79e-2)" "unprognostic (3.05e-3)" "unprognostic (8.38e-3)" "unprognostic (9.79e-2)" "unprognostic (1.36e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 6.3 2.3 0.0 0.3 10.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.7 1.3 0.1 65.8 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 44.6 1.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 CBARP "BARP, C19orf26, DOS, MGC40084" ENSG00000099625 "CACN beta subunit associated regulatory protein" Q8N350 19 1228287-1238027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;pituitary gland: 13.1" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 18.9;Early spermatids: 35.1;Late spermatids: 59.2" "Cancer enhanced" "Detected in many" "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 8.7" HPA012777 Approved Nucleoplasm NA NA Nucleoplasm "HPA012777: AB_2067005" "unprognostic (1.31e-1)" "unprognostic (4.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" "unprognostic (3.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (2.17e-1)" "unprognostic (4.58e-2)" "unprognostic (2.86e-3)" "unprognostic (3.03e-1)" "unprognostic (5.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (7.42e-5)" 2.3 8.1 7.2 1.5 12.1 1.0 1.2 3.6 17.9 1.2 1.3 5.2 0.0 1.3 1.8 1.1 1.5 1.1 1.8 1.5 8.5 5.6 1.8 1.5 1.4 1.1 3.3 4.7 2.9 2.1 1.6 13.1 1.4 10.6 1.4 1.0 1.2 1.2 1.5 1.3 4.5 1.1 1.2 6.5 1.2 1.9 3.0 2.2 0.0 1.3 0.0 1.2 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.0 5.3 0.2 0.6 1.5 4.4 1.3 0.9 1.0 2.4 0.2 0.0 5.0 1.0 0.5 2.4 0.8 0.9 0.2 0.9 1.1 0.1 1.7 1.4 2.3 0.1 1.8 1.2 0.5 1.1 0.3 0.9 0.7 1.2 2.8 0.1 0.6 4.0 0.0 1.3 3.7 0.3 2.2 4.4 0.8 0.3 0.2 0.6 3.2 8.7 0.0 0.1 4.5 0.2 0.6 0.9 1.7 1.9 5.6 5.2 1.6 0.5 0.5 0.0 1.5 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 12.1 3.6 17.9 8.5 5.6 3.3 4.7 10.6 2.2 0.0 0.0 0.0 0.2 0.0 18.9 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.2 35.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.2 3.2 0.0 1.3 1.0 59.2 1.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.4 0.1 1.1 0.0 0.0 9.8 4.1 0.0 0.0 0.0 0.0 0.1 CCDC107 MGC31967 ENSG00000159884 "Coiled-coil domain containing 107" Q8WV48 9 35658290-35661511 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016857, HPA050442" Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA016857: AB_10669751, HPA050442: AB_2681128" "unprognostic (3.70e-3)" "unprognostic (7.07e-3)" "unprognostic (3.60e-2)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.09e-2)" "unprognostic (4.13e-1)" "unprognostic (1.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.33e-2)" "unprognostic (1.89e-1)" "unprognostic (5.15e-1)" "unprognostic (1.96e-1)" "unprognostic (5.75e-2)" 42.1 23.4 11.1 15.4 10.3 5.4 50.3 17.2 12.9 17.5 35.2 8.5 18.1 15.0 24.9 28.6 22.4 18.2 31.5 31.3 10.2 11.0 13.0 15.0 14.0 14.1 9.7 7.9 15.3 80.2 7.6 10.5 10.8 8.4 22.8 13.7 11.5 14.6 24.5 29.3 9.6 16.0 44.8 9.7 13.5 24.2 9.2 8.8 19.3 14.0 8.8 10.9 38.9 24.1 20.7 32.5 7.6 11.0 16.4 46.9 18.3 7.9 7.2 6.0 7.5 30.2 19.4 3.5 13.4 12.2 8.6 8.1 3.3 2.4 5.2 6.0 17.6 22.3 2.6 4.4 6.5 6.4 15.3 7.1 2.4 10.9 8.1 7.1 3.7 9.5 11.4 7.7 9.2 7.2 16.1 6.0 8.8 3.2 10.0 10.8 5.1 4.2 5.6 4.4 5.7 22.2 6.1 1.4 4.1 28.6 4.3 3.9 6.5 6.9 9.7 6.6 4.7 5.1 4.7 7.5 13.9 7.7 10.0 12.2 4.5 6.6 10.3 25.6 6.0 12.1 7.6 10.6 5.1 36.1 11.0 46.9 20.7 31.7 31.4 11.8 20.1 15.5 21.3 2.1 16.4 6.4 32.5 35.2 18.3 11.1 10.3 17.2 12.9 10.2 11.0 9.7 7.9 8.4 8.8 62.5 23.5 48.4 32.4 62.4 31.1 0.6 61.1 25.4 15.9 78.5 7.9 12.3 14.9 64.0 5.7 40.2 115.3 0.0 122.5 55.2 43.7 39.9 34.5 68.4 86.5 30.2 84.6 43.0 48.7 20.1 55.0 66.1 108.0 39.7 73.5 46.8 82.6 80.7 96.2 54.7 32.0 116.4 97.8 27.9 59.2 58.5 11.6 95.8 40.0 23.7 CCDC112 MGC39633 ENSG00000164221 "Coiled-coil domain containing 112" Q8NEF3 5 115267188-115296831 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.4" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 227.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 50.4" "Low region specificity" "Detected in all" "HPA045120, HPA050621" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in male reproductive system" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA045120: AB_2679222, HPA050621: AB_2681191" "unprognostic (1.88e-2)" "unprognostic (5.10e-2)" "unprognostic (4.63e-2)" "unprognostic (5.60e-3)" "unprognostic (2.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.32e-6)" "unprognostic (4.30e-2)" "unprognostic (3.24e-1)" "unprognostic (4.41e-2)" "unprognostic (3.33e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (1.51e-6)" "unprognostic (7.00e-2)" "unprognostic (2.79e-2)" "unprognostic (8.61e-2)" "unprognostic (4.10e-3)" 5.5 4.3 9.7 5.7 13.2 7.0 7.7 12.6 12.8 6.5 9.8 7.0 4.3 8.1 6.6 7.3 6.3 4.9 3.9 6.4 11.0 9.0 3.5 1.7 6.1 4.8 9.7 7.6 2.9 13.2 6.5 12.1 3.0 12.6 7.7 10.6 1.9 6.8 8.6 4.5 5.5 6.8 7.7 14.0 5.3 7.0 40.4 11.8 3.7 4.7 3.2 4.7 7.1 4.8 5.3 11.0 11.6 5.5 3.1 3.8 2.1 5.4 2.7 5.5 8.7 3.5 6.8 1.3 4.9 2.6 3.7 4.3 1.2 3.1 6.7 4.1 3.4 5.5 3.5 5.7 2.8 7.8 5.3 4.4 4.4 4.1 1.7 4.7 5.8 2.3 3.1 3.4 4.8 6.4 4.3 5.7 6.1 1.8 5.5 4.9 4.2 8.7 5.0 6.0 5.1 4.8 9.3 6.8 50.4 3.6 2.0 8.3 10.8 5.3 3.4 14.6 3.9 5.7 8.5 5.6 4.9 3.3 9.3 6.8 6.1 5.9 1.4 3.3 4.6 2.9 0.2 5.5 11.6 3.4 4.4 3.8 3.2 2.6 2.9 5.9 5.3 3.4 2.3 3.6 3.1 5.0 11.0 0.1 2.1 9.7 13.2 12.6 12.8 11.0 9.0 9.7 7.6 12.6 11.8 14.9 12.3 12.3 4.6 12.6 28.3 14.6 2.5 12.0 9.1 5.2 9.8 0.6 5.0 24.4 6.8 8.0 11.9 0.0 22.6 1.7 8.5 6.1 9.2 2.6 28.4 9.5 38.9 6.7 23.9 13.4 3.7 28.0 13.5 42.3 28.0 10.3 27.1 14.0 3.9 2.9 24.3 12.9 13.0 227.3 60.7 19.7 0.5 5.3 31.6 3.4 CCDC126 FLJ23031 ENSG00000169193 "Coiled-coil domain containing 126" Q96EE4 7 23597379-23644708 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.4" "Group enriched" "Detected in many" 18 "Early spermatids: 588.1;Late spermatids: 350.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "basophil: 75.4" "Lineage enriched" "Detected in all" 18 "granulocytes: 75.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010969, HPA026883" Uncertain Approved "Golgi apparatus" "Secreted to blood" NA NA 31000000 "Golgi apparatus" "HPA010969: , HPA026883: AB_1846131" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (9.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.18e-1)" "unprognostic (5.96e-3)" "unprognostic (1.16e-2)" "unprognostic (3.90e-1)" "unprognostic (9.30e-2)" "unprognostic (1.42e-2)" "unprognostic (3.44e-2)" "unprognostic (3.29e-2)" "unprognostic (7.35e-3)" "unprognostic (5.90e-2)" "unprognostic (1.20e-1)" "unprognostic (1.62e-1)" "unprognostic (3.28e-1)" 6.7 8.1 8.7 4.4 9.2 6.9 19.5 11.6 13.2 7.4 6.5 5.6 5.8 8.7 8.0 5.3 6.6 6.7 6.2 5.7 13.8 8.9 7.6 11.7 6.5 9.3 10.5 3.9 7.4 9.8 12.2 12.6 4.6 11.1 6.0 6.5 5.8 7.5 6.5 10.0 6.6 9.4 6.7 12.9 6.1 6.8 41.3 8.1 5.4 9.9 5.0 8.6 7.0 7.7 3.8 3.0 75.4 3.6 2.9 4.1 2.9 4.8 3.4 7.5 9.5 12.6 7.1 17.3 6.1 6.0 5.3 7.7 3.6 1.6 10.4 9.7 5.1 10.1 2.8 3.2 2.9 6.9 2.2 4.3 1.8 1.4 4.6 5.1 4.7 9.3 7.5 8.5 1.7 1.6 4.4 7.0 4.4 4.1 3.0 6.3 2.2 3.2 5.7 3.5 6.4 4.3 2.2 11.9 3.1 5.5 2.2 4.6 8.6 6.3 6.1 4.5 12.2 5.1 4.4 8.4 3.1 5.6 7.1 4.8 8.4 8.3 7.4 3.5 6.9 16.9 75.4 3.6 16.4 3.0 3.3 3.7 3.8 3.3 3.5 3.0 3.2 4.1 3.2 6.9 2.9 3.1 0.6 3.6 2.9 8.7 9.2 11.6 13.2 13.8 8.9 10.5 3.9 11.1 8.1 6.0 7.2 7.1 7.0 16.9 12.6 8.3 7.6 9.4 3.4 12.2 7.9 9.0 6.6 10.1 588.1 10.5 5.8 0.0 8.0 5.6 10.4 7.1 6.9 12.7 6.2 7.9 14.5 10.4 5.1 350.6 10.6 7.9 13.5 6.4 8.6 7.2 8.1 6.2 13.4 7.2 12.6 12.9 12.2 26.8 23.8 20.7 16.9 7.5 5.6 5.9 CCDC127 FLJ25701 ENSG00000164366 "Coiled-coil domain containing 127" Q96BQ5 5 196871-218215 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045052 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA045052: AB_10960630" "prognostic unfavorable (7.01e-4)" "unprognostic (4.26e-2)" "unprognostic (1.93e-2)" "unprognostic (9.18e-2)" "unprognostic (2.78e-3)" "unprognostic (2.65e-2)" "prognostic unfavorable (4.04e-6)" "unprognostic (2.41e-1)" "unprognostic (1.57e-1)" "unprognostic (9.62e-2)" "unprognostic (3.43e-3)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.95e-5)" "unprognostic (2.42e-1)" "unprognostic (9.06e-2)" "unprognostic (1.07e-1)" "unprognostic (2.87e-1)" 10.3 14.3 10.3 7.3 13.0 3.8 9.7 14.0 16.2 10.7 10.0 10.6 8.2 8.7 11.6 7.7 13.4 10.5 12.7 16.3 9.8 11.8 8.1 6.8 6.9 12.4 12.0 9.8 15.3 8.6 5.0 14.9 10.2 13.9 10.5 4.1 10.5 8.1 6.1 18.4 12.4 10.1 8.1 9.5 7.2 9.4 11.1 12.2 9.6 23.5 7.4 5.2 9.9 7.9 9.0 8.1 7.2 5.3 8.6 11.0 5.3 4.0 5.3 6.0 10.9 7.3 5.6 5.9 7.8 4.0 3.5 3.5 5.6 8.5 8.5 11.4 3.6 4.6 5.4 3.7 3.0 3.4 21.6 6.6 3.0 25.0 4.9 4.3 2.4 5.5 4.6 4.9 3.3 2.3 8.4 2.9 4.7 4.9 3.0 3.7 3.2 4.2 4.8 5.1 2.4 6.9 5.0 4.4 6.9 6.6 4.1 6.7 10.5 10.8 7.5 7.1 5.0 9.8 4.5 6.6 9.0 5.3 3.6 3.2 5.0 4.2 5.8 5.8 4.2 5.6 4.6 4.5 7.2 8.1 5.3 8.7 9.0 8.3 9.6 4.5 8.8 9.8 11.0 2.9 8.6 4.7 8.1 6.2 5.3 10.3 13.0 14.0 14.7 9.8 11.8 12.0 9.8 13.9 12.2 14.9 7.2 7.0 12.0 12.6 16.5 23.8 7.6 18.7 9.1 5.2 17.7 27.5 3.3 24.3 5.1 15.1 8.1 0.0 13.3 19.7 13.2 13.4 9.2 11.9 17.2 36.5 8.1 15.4 6.9 6.5 19.2 10.3 8.5 29.7 7.7 29.9 13.9 2.9 18.7 7.5 26.8 12.9 9.5 20.9 31.3 6.9 25.2 12.8 6.8 10.6 CCDC134 FLJ22349 ENSG00000100147 "Coiled-coil domain containing 134" Q9H6E4 22 41800679-41826299 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003936 Approved "Secreted to blood" NA NA "HPA003936: AB_1078419" "unprognostic (2.09e-2)" "unprognostic (1.00e-1)" "unprognostic (3.82e-2)" "prognostic favorable (4.09e-4)" "unprognostic (1.73e-1)" "unprognostic (3.85e-2)" "prognostic unfavorable (7.42e-7)" "unprognostic (4.35e-1)" "unprognostic (1.69e-1)" "unprognostic (3.08e-1)" "unprognostic (3.30e-2)" "unprognostic (7.32e-2)" "prognostic favorable (1.36e-5)" "unprognostic (6.24e-3)" "unprognostic (2.52e-2)" "unprognostic (5.47e-1)" "unprognostic (6.63e-2)" 3.8 23.4 3.3 8.1 5.0 15.1 4.4 19.1 5.2 4.6 5.7 7.7 5.7 5.5 5.9 15.0 6.9 7.3 4.8 4.6 4.3 3.1 7.5 6.9 5.6 7.3 4.2 2.4 4.4 8.1 12.2 12.3 6.6 5.6 5.2 4.9 8.6 12.9 9.0 6.5 5.9 5.8 3.4 5.1 7.3 6.1 17.2 5.4 12.6 8.7 3.5 11.8 4.4 4.1 4.2 2.2 9.4 8.2 4.5 7.1 3.4 7.8 6.8 6.1 12.1 3.5 0.9 7.1 6.4 5.3 12.0 14.1 10.3 5.2 7.1 11.1 5.2 7.1 8.7 6.1 6.4 6.7 7.8 9.7 6.6 16.9 7.2 1.6 9.2 9.3 1.9 2.5 13.8 2.8 4.5 6.2 6.8 4.4 14.7 6.6 5.3 5.9 5.5 4.7 11.1 5.0 11.2 9.4 10.0 8.7 7.1 3.6 2.8 11.7 9.4 4.7 3.7 11.9 5.3 3.4 6.3 10.5 4.3 11.0 16.9 10.1 5.4 6.7 5.9 12.5 0.0 4.9 9.4 5.8 8.0 3.6 4.2 3.6 4.4 2.2 2.5 7.1 3.8 2.6 4.5 8.2 2.0 6.0 3.4 3.3 5.0 19.1 5.2 4.3 3.1 4.2 2.4 5.6 5.4 3.0 1.3 0.0 1.5 0.2 1.2 0.7 2.5 1.4 0.0 3.5 2.0 4.0 0.0 4.2 0.6 0.7 3.0 0.0 1.7 15.4 0.9 1.8 0.0 1.7 3.9 0.0 0.0 0.0 0.6 0.4 0.6 0.9 1.7 5.4 1.1 0.9 2.0 1.9 0.4 1.0 2.1 0.0 1.0 4.2 1.6 0.0 2.4 2.9 2.1 1.4 CCDC136 "DKFZP434G156, KIAA1793, NAG6" ENSG00000128596 "Coiled-coil domain containing 136" Q96JN2 7 128790757-128822132 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 34.7;testis: 109.6" "Group enriched" "Detected in many" 4 "Early spermatids: 629.8;Late spermatids: 1449.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 18.6;U-937: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010646, HPA071015" Enhanced Approved Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles" "Plasma membrane" "HPA010646: , HPA071015: AB_2686334" "unprognostic (2.07e-2)" "unprognostic (2.32e-2)" "unprognostic (1.29e-4)" "unprognostic (4.65e-2)" "unprognostic (4.52e-1)" "unprognostic (2.16e-1)" "unprognostic (1.66e-2)" "unprognostic (2.53e-1)" "unprognostic (5.43e-4)" "unprognostic (2.58e-2)" "unprognostic (8.44e-3)" "unprognostic (4.35e-1)" "unprognostic (1.18e-4)" "unprognostic (5.27e-3)" "unprognostic (4.85e-2)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" 2.1 4.0 11.2 2.6 11.7 1.8 2.4 34.7 28.7 2.9 6.5 8.3 2.6 2.4 3.9 2.9 2.5 2.8 2.8 4.9 12.5 20.0 1.5 1.5 1.9 3.0 15.3 16.6 2.8 1.8 1.8 3.8 2.2 11.2 9.9 3.5 13.9 2.0 11.0 3.5 1.6 2.6 17.3 9.7 1.9 2.4 109.6 7.4 0.7 1.7 0.0 2.4 6.4 2.0 0.1 0.6 1.3 0.3 2.7 1.6 0.3 0.7 0.9 7.2 4.8 3.9 3.4 1.2 2.7 3.6 2.8 2.6 1.0 0.6 3.6 0.3 3.7 11.4 1.5 4.6 0.5 2.6 10.2 4.6 6.3 1.7 0.0 1.3 0.7 13.6 3.7 0.5 3.0 0.2 2.5 1.6 6.0 2.2 3.8 1.1 1.4 4.6 1.9 10.0 0.0 2.9 11.4 1.3 1.7 0.2 1.3 4.2 12.6 1.7 2.0 2.8 2.7 0.1 1.7 1.4 4.5 2.6 2.1 2.1 2.2 0.9 3.8 18.6 27.4 1.1 0.0 0.3 1.3 1.4 0.0 1.6 0.0 1.5 1.1 0.6 0.1 0.0 1.0 0.1 2.7 0.1 0.1 0.0 0.3 11.2 11.7 34.7 28.7 12.5 20.0 15.3 16.6 11.2 7.4 0.0 0.3 0.0 0.8 0.5 255.8 6.5 2.5 2.7 1.2 0.0 92.3 0.1 0.0 0.5 629.8 1.6 0.0 0.0 1.3 0.2 0.9 1.2 0.0 0.0 5.0 38.1 0.0 0.6 0.8 1449.2 16.7 0.9 0.0 1.0 0.0 22.8 0.8 0.0 7.1 0.0 16.0 6.5 2.8 193.1 9.4 0.4 0.3 2.2 0.0 0.4 CCDC141 "CAMDI, FLJ39502" ENSG00000163492 "Coiled-coil domain containing 141" 2 178829757-179050086 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 47.5;lung: 17.6" "Cell type enhanced" "Detected in many" 22 "Alveolar cells type 2: 19.8;Cardiomyocytes: 103.0;Early spermatids: 34.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "T-reg: 12.9" "Group enriched" "Detected in many" 9 "B-cells: 7.6;T-cells: 12.9" "Cell line enhanced" "Detected in some" "CACO-2: 6.4;Daudi: 4.1;HEL: 9.5;RH-30: 5.1;U-266/70: 6.1;U-698: 8.5" HPA012718 Approved Nucleoplasm NA NA Nucleoplasm "HPA012718: AB_2072055" "unprognostic (1.58e-1)" "unprognostic (1.85e-2)" "unprognostic (3.10e-2)" "unprognostic (2.37e-1)" "unprognostic (8.62e-3)" "unprognostic (4.25e-2)" "unprognostic (2.98e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (1.74e-2)" "unprognostic (5.33e-2)" "unprognostic (8.03e-3)" "unprognostic (7.71e-8)" "unprognostic (2.50e-2)" "unprognostic (1.52e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-1)" 1.6 0.6 0.5 7.5 0.6 0.9 4.9 0.5 0.5 0.7 1.2 0.1 0.5 0.2 0.8 2.2 2.5 0.6 6.3 47.5 0.6 0.6 0.5 0.5 17.6 4.4 0.6 0.0 0.8 3.8 0.2 0.5 0.8 1.1 1.0 0.3 1.8 0.6 0.3 9.3 0.5 0.7 1.7 0.7 1.8 0.6 1.6 0.0 11.0 0.7 2.1 7.4 1.4 1.2 7.6 0.0 0.4 0.0 1.1 12.9 0.4 0.2 0.0 0.1 0.3 0.0 0.1 2.0 0.0 0.1 0.0 0.2 6.4 0.5 4.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 3.5 0.2 9.5 0.3 0.0 0.0 1.7 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.6 0.1 0.1 0.1 0.3 3.4 0.6 0.7 0.2 5.1 1.6 0.0 0.1 0.2 0.2 0.1 0.3 0.1 1.1 0.3 0.4 0.1 0.3 0.2 0.3 0.0 6.1 0.1 8.5 0.3 0.5 0.6 0.3 0.0 0.2 0.3 0.0 0.2 6.6 2.1 1.4 0.0 7.6 6.4 4.8 0.4 1.1 0.0 0.0 12.9 0.4 0.5 0.6 0.5 0.5 0.6 0.6 0.6 0.0 1.1 0.0 6.0 19.8 0.5 0.0 0.1 1.4 103.0 10.2 2.7 1.2 0.0 0.0 0.0 0.0 2.5 34.6 3.6 0.0 0.0 1.2 0.2 0.4 0.0 5.8 0.0 0.0 6.4 0.0 0.0 0.3 12.9 1.1 0.8 1.7 0.0 0.0 3.8 0.2 0.0 1.8 0.0 0.6 6.5 1.4 0.0 0.2 0.1 0.0 5.0 0.0 0.1 CCDC167 "C6orf129, dJ153P14.2" ENSG00000198937 "Coiled-coil domain containing 167" Q9P0B6 6 37482920-37499922 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 70.0" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 242.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 9 "U-698: 175.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045215 Uncertain Approved Cytosol NA NA Cytosol "HPA045215: AB_10962866" "unprognostic (1.82e-1)" "prognostic favorable (7.59e-4)" "unprognostic (6.99e-2)" "unprognostic (3.66e-1)" "unprognostic (2.86e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (2.73e-1)" "unprognostic (7.67e-2)" "unprognostic (3.41e-3)" "unprognostic (2.71e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (1.71e-7)" "unprognostic (1.57e-1)" "unprognostic (4.06e-1)" "unprognostic (2.44e-1)" "unprognostic (1.95e-1)" 6.4 10.3 16.1 11.6 18.9 12.7 10.2 11.3 15.5 12.6 10.5 12.8 11.4 6.3 8.7 25.2 13.6 11.5 6.2 17.3 13.8 12.1 10.2 29.5 7.0 23.0 18.1 9.1 4.6 14.9 6.9 8.4 9.6 15.8 12.2 13.0 5.0 16.2 7.7 10.5 6.5 8.2 16.7 22.8 15.1 7.5 18.8 16.9 32.1 11.5 11.2 35.5 8.7 8.7 24.8 9.9 23.6 6.0 8.6 70.0 26.4 3.1 7.2 16.6 11.5 4.5 8.0 6.1 3.7 3.0 5.8 6.5 7.6 4.7 17.1 8.5 6.3 11.3 2.4 10.7 8.7 5.9 14.2 19.7 8.1 3.1 19.1 4.8 7.9 3.2 3.7 18.0 6.2 5.7 4.1 18.0 18.0 5.0 14.9 9.9 10.3 14.8 6.5 0.9 9.0 4.6 9.2 5.9 12.6 7.9 6.2 11.3 13.3 5.6 5.5 8.7 15.2 6.0 8.2 4.5 3.9 7.6 2.1 3.8 11.0 10.7 175.0 3.7 17.0 10.9 4.8 6.0 23.6 26.1 5.9 31.1 24.8 43.5 32.8 9.9 17.0 20.1 19.4 1.8 8.6 4.9 6.3 70.0 26.4 16.1 18.9 11.3 15.5 13.8 12.1 18.1 9.1 15.8 16.9 6.0 10.1 32.8 22.2 12.6 8.6 42.5 33.1 16.0 7.9 14.0 7.9 52.7 26.6 58.7 80.7 18.0 15.3 140.2 43.7 96.5 31.5 33.2 15.0 109.5 77.5 14.3 24.2 29.4 18.3 242.2 12.0 25.9 52.3 29.7 18.8 29.8 51.7 14.4 17.7 66.3 8.5 6.5 20.8 95.7 92.0 13.2 24.8 54.9 25.8 27.3 CCDC168 "C13orf40, FLJ40176" ENSG00000175820 "Coiled-coil domain containing 168" Q8NDH2 13 102729369-102759070 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 23.7" "Cell type enriched" "Detected in some" 32 "Early spermatids: 828.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.6;MOLT-4: 1.3;NB-4: 1.0;THP-1: 2.0" "HPA048184, HPA058793, HPA078547" Uncertain Approved Nucleoli,Centrosome,Cytosol NA NA "Nucleoli, Centrosome" Cytosol "HPA048184: AB_2680303, HPA058793: AB_2683823, HPA078547: " "unprognostic (2.06e-1)" "unprognostic (7.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-4)" "unprognostic (2.09e-2)" "unprognostic (3.68e-2)" "unprognostic (2.74e-1)" "unprognostic (5.05e-2)" "unprognostic (3.61e-1)" "unprognostic (2.89e-3)" "unprognostic (1.73e-1)" "unprognostic (1.44e-5)" "unprognostic (2.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.85e-1)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.4 0.2 0.7 0.1 0.0 0.0 1.6 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 1.3 1.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.3 828.1 0.0 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.8 26.2 2.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 1.1 1.4 0.0 0.3 0.0 0.0 0.1 CCDC194 ENSG00000269720 "Coiled-coil domain containing 194" A0A1B0GVG4 19 17390509-17394158 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "ovary: 2.3;placenta: 1.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.4;PC-3: 2.2;U-266/70: 2.3;U-266/84: 1.7" "Not detected" "Not detected" NA NA "unprognostic (1.50e-3)" "unprognostic (1.37e-1)" "unprognostic (1.87e-4)" "unprognostic (2.75e-3)" "unprognostic (1.41e-1)" "unprognostic (1.28e-2)" "unprognostic (3.09e-1)" "unprognostic (9.87e-2)" "unprognostic (3.07e-1)" "unprognostic (5.84e-2)" "unprognostic (1.23e-1)" "unprognostic (2.64e-2)" "unprognostic (5.22e-14)" "unprognostic (1.04e-1)" "unprognostic (6.70e-3)" "unprognostic (2.60e-1)" "unprognostic (1.86e-2)" 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.8 0.7 0.9 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.7 1.4 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.4 0.0 2.2 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.7 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC51 FLJ12436 ENSG00000164051 "Coiled-coil domain containing 51" Q96ER9 3 48432164-48440456 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010980, HPA011408" Supported Supported Nucleoplasm,Centrosome,Mitochondria NA NA "Nucleoplasm, Mitochondria" Centrosome "HPA010980: AB_1846155, HPA011408: AB_2072212" "unprognostic (1.24e-2)" "unprognostic (5.23e-2)" "unprognostic (5.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-1)" "unprognostic (2.75e-3)" "unprognostic (4.71e-3)" "unprognostic (1.26e-2)" "unprognostic (3.04e-1)" "unprognostic (3.26e-2)" "unprognostic (7.70e-2)" "unprognostic (1.47e-3)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" 9.9 14.9 10.1 7.1 12.7 4.5 9.6 10.4 15.9 8.9 12.8 7.5 12.4 11.6 8.2 11.4 15.9 9.7 8.4 12.3 9.2 8.2 15.2 17.8 7.1 9.0 9.9 15.4 8.7 8.5 9.4 7.4 8.5 10.6 7.7 15.1 9.9 11.0 11.2 16.3 10.9 8.8 11.6 8.8 14.7 7.9 10.7 8.9 10.4 11.3 16.1 12.0 8.8 9.7 19.2 18.2 4.8 10.4 10.6 14.8 9.7 9.7 11.9 7.2 8.4 10.6 11.3 19.7 6.5 6.0 13.1 10.7 18.8 16.4 21.2 9.3 5.1 9.8 14.3 17.6 21.2 8.0 9.9 11.6 18.1 18.9 14.1 16.4 8.8 8.3 8.5 48.2 16.1 17.7 7.1 7.4 12.5 10.0 6.2 12.3 9.3 10.2 11.4 15.7 21.0 19.3 7.1 8.4 16.3 17.7 12.2 5.9 12.5 10.7 11.7 17.4 7.0 12.6 13.7 5.6 7.6 10.3 18.8 12.4 10.0 14.6 11.1 10.1 19.1 7.1 2.0 10.4 4.8 12.0 10.2 12.1 19.2 11.2 14.8 18.2 15.4 11.7 13.4 4.5 10.6 6.1 15.2 13.4 9.7 10.1 12.7 10.4 15.9 9.2 8.2 9.9 15.4 10.6 8.9 11.9 1.6 8.9 3.0 4.1 6.8 7.3 22.9 5.3 5.7 8.7 0.0 35.3 19.9 13.2 2.5 5.3 12.6 0.0 10.8 15.3 10.7 3.7 3.5 11.9 14.1 7.9 5.2 3.1 3.8 2.2 11.2 4.1 13.5 13.6 6.3 10.1 12.4 5.8 12.4 27.0 9.5 6.5 3.1 4.8 17.3 4.1 5.6 4.3 12.4 3.1 CCDC80 "DRO1, SSG1, URB" ENSG00000091986 "Coiled-coil domain containing 80" Q76M96 3 112596794-112649530 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 130.0;endometrium 1: 143.8" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 452.4;Fibroblasts: 524.3;Late spermatids: 232.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 48.6;fHDF/TERT166: 113.6;hTERT-RPE1: 221.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA002266 Approved "Secreted to extracellular matrix" NA NA 57000 "HPA002266: AB_1078423" "unprognostic (1.26e-1)" "unprognostic (1.89e-1)" "unprognostic (1.26e-2)" "unprognostic (3.19e-1)" "unprognostic (2.29e-1)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (2.53e-2)" "unprognostic (2.30e-3)" "unprognostic (1.99e-3)" "unprognostic (8.40e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (2.86e-5)" "unprognostic (5.97e-3)" "unprognostic (1.65e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.26e-4)" 49.5 3.3 1.4 16.4 3.1 0.0 39.4 3.1 3.3 130.0 14.9 3.4 54.7 1.1 143.8 94.7 34.2 17.4 39.7 87.6 2.3 2.8 10.7 2.1 17.0 10.1 3.0 1.0 53.3 6.6 2.5 2.7 6.0 7.2 28.6 12.7 8.7 8.7 21.7 4.1 19.2 8.6 81.3 14.0 19.8 12.0 14.0 3.3 4.1 20.4 29.6 10.8 57.3 33.8 2.9 3.0 2.9 1.3 1.3 2.1 0.2 2.2 0.9 11.6 0.5 48.6 38.7 0.6 32.1 9.7 10.8 15.8 0.2 0.1 0.1 1.2 113.6 1.0 3.0 0.4 0.4 11.4 2.1 0.1 0.0 2.6 0.0 10.2 0.0 0.0 38.2 1.3 15.9 1.0 221.6 2.5 0.0 0.0 0.1 31.8 0.0 0.0 0.0 2.8 0.0 0.3 0.0 1.2 0.0 0.3 0.0 0.0 0.2 4.7 0.2 0.1 2.2 0.1 0.0 12.6 31.8 5.2 6.0 13.9 0.1 0.0 0.1 9.4 0.0 5.1 2.9 1.3 0.9 1.6 0.8 1.6 1.7 1.6 1.3 0.5 2.9 2.1 1.9 1.7 1.3 0.8 3.0 1.1 0.2 1.4 3.1 3.1 1.7 2.3 2.8 3.0 1.0 7.2 3.3 6.0 12.8 0.0 3.8 54.1 0.6 19.6 0.0 33.5 9.1 5.2 0.0 40.0 1.7 22.1 452.4 12.8 0.0 0.0 1.1 85.3 524.3 1.2 1.1 0.5 8.3 0.0 0.0 56.4 2.7 232.6 71.4 5.8 136.7 3.6 0.4 119.7 10.8 0.0 32.5 0.0 1.7 19.4 127.8 6.0 3.2 45.2 23.3 0.0 0.0 1.7 CCDC90B "MDS011, MDS025" ENSG00000137500 "Coiled-coil domain containing 90B" Q9GZT6 11 83259097-83286407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 347.8;Spermatocytes: 279.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011130, HPA011931" Supported Enhanced Mitochondria NA NA Mitochondria "HPA011130: AB_1846170, HPA011931: AB_2072332" "unprognostic (5.85e-2)" "unprognostic (1.33e-1)" "unprognostic (7.34e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-1)" "unprognostic (7.48e-2)" "unprognostic (2.99e-1)" "unprognostic (3.57e-3)" "unprognostic (5.76e-3)" "unprognostic (3.53e-2)" "unprognostic (6.01e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-2)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.62e-1)" "unprognostic (2.41e-1)" 15.8 32.0 25.0 11.1 23.3 11.6 18.0 14.3 17.9 15.4 14.5 14.6 17.2 12.1 12.6 29.3 14.3 13.5 15.2 18.2 22.3 25.6 16.4 31.3 11.0 15.0 29.9 14.9 19.4 16.6 15.2 29.5 18.3 24.5 16.3 14.9 8.4 14.5 14.8 12.2 11.6 18.2 14.9 43.9 17.1 13.6 42.2 28.3 15.5 21.6 12.3 13.5 14.8 13.0 18.5 12.7 32.6 19.0 22.5 21.1 12.4 7.2 10.8 18.4 5.9 25.0 18.9 11.3 14.8 12.7 9.4 10.0 12.6 25.3 17.7 19.5 21.9 19.4 9.3 8.1 19.0 12.5 12.4 6.4 10.9 7.3 10.4 21.1 11.0 9.5 21.0 25.7 12.0 34.7 18.5 21.3 19.6 16.1 15.2 34.1 12.9 11.0 14.1 15.2 31.7 13.5 12.8 16.6 15.2 19.4 10.8 9.0 20.8 10.4 8.4 9.6 25.9 21.7 10.3 20.4 18.4 11.6 34.5 10.0 14.8 19.3 18.0 7.4 8.9 18.1 30.8 8.9 32.6 12.3 19.0 15.6 18.5 17.9 17.0 12.7 16.9 15.5 15.5 4.5 22.5 19.0 9.3 21.1 12.4 25.0 23.3 14.3 17.9 22.3 25.6 29.9 14.9 24.5 28.3 11.9 12.5 34.2 43.7 20.9 33.7 49.1 15.3 24.1 15.9 34.9 13.7 62.9 58.0 53.7 347.8 38.6 19.2 0.0 42.7 46.4 36.0 35.2 47.4 39.9 56.5 39.7 32.2 26.4 28.8 188.9 39.4 41.6 20.3 61.3 31.8 23.0 58.7 35.1 24.1 57.7 44.3 25.8 30.1 279.8 83.5 25.3 43.3 28.8 30.4 38.0 CCKAR ENSG00000163394 "Cholecystokinin A receptor" P32238 4 26481400-26490462 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "gallbladder: 47.5;stomach 1: 14.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 4.3;RH-30: 1.3;U-2 OS: 1.3" "Region enhanced" "Detected in some" "hypothalamus: 8.3" "Low region specificity" "Detected in all" NA NA "unprognostic (7.48e-2)" "unprognostic (3.70e-2)" "unprognostic (7.13e-2)" "unprognostic (3.08e-2)" "unprognostic (3.36e-1)" "unprognostic (3.79e-1)" 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.1 0.1 0.6 0.0 0.0 1.3 0.3 0.0 1.3 0.0 47.5 0.1 0.1 1.3 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.6 0.0 14.0 0.2 0.1 0.2 0.0 1.0 7.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.1 1.3 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCKBR ENSG00000110148 "Cholecystokinin B receptor" P32239 11 6259736-6272127 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 12.9;pancreas: 34.7;stomach 1: 21.4" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 1.4;Exocrine glandular cells: 1.2;Spermatogonia: 1.1" "Cancer enriched" "Detected in some" 8 "testis cancer: 9.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 39.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.82e-1)" "unprognostic (4.62e-2)" "unprognostic (1.79e-3)" "unprognostic (2.19e-1)" "unprognostic (1.95e-1)" "unprognostic (6.34e-4)" "unprognostic (8.01e-2)" "unprognostic (3.01e-2)" "unprognostic (9.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.06e-1)" "unprognostic (2.92e-1)" "unprognostic (1.30e-2)" 0.3 0.4 6.5 0.3 5.6 0.3 0.3 10.8 12.9 0.3 0.3 0.0 0.0 0.6 0.4 0.3 0.3 0.6 0.4 0.3 3.3 0.8 0.3 0.3 0.3 0.3 1.0 6.9 0.3 34.7 0.3 0.4 0.4 2.1 0.9 0.3 0.3 0.3 0.4 0.4 0.8 0.3 0.3 0.3 0.3 21.4 0.6 0.0 0.0 0.6 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.5 5.6 10.8 12.9 3.3 0.8 1.0 6.9 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.2 0.0 0.0 0.0 CCL11 "eotaxin, MGC22554, SCYA11" ENSG00000172156 "C-C motif chemokine ligand 11" P51671 17 34285668-34288334 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 31.0;intestine: 29.6;lymphoid tissue: 29.2" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 1.4;Club cells: 2.3;granulocytes: 2.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "BJ hTERT+: 14.3" "Not detected" "Not detected" "Secreted to blood" NA NA 88500 "unprognostic (4.61e-2)" "unprognostic (1.45e-1)" "prognostic favorable (8.70e-4)" "unprognostic (8.18e-2)" "prognostic favorable (1.99e-4)" "unprognostic (9.91e-2)" "unprognostic (8.09e-2)" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "unprognostic (1.45e-1)" "unprognostic (9.64e-8)" "unprognostic (2.66e-2)" "unprognostic (1.05e-3)" "unprognostic (1.61e-1)" "unprognostic (2.72e-2)" 2.6 0.4 0.2 29.2 0.2 0.0 0.2 0.2 0.2 4.5 29.6 0.4 0.6 17.3 3.5 0.0 20.7 0.8 12.0 31.0 0.2 0.2 7.0 1.2 7.3 0.3 0.2 0.0 2.6 11.6 0.2 1.1 0.0 0.2 16.1 8.0 0.0 0.2 0.3 0.5 0.2 18.7 10.2 0.2 1.2 18.2 0.6 0.0 0.7 0.4 0.0 0.8 12.1 5.8 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 14.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCL22 "A-152E5.1, ABCD-1, DC/B-CK, MDC, MGC34554, SCYA22, STCP-1" ENSG00000102962 "C-C motif chemokine ligand 22" O00626 16 57358772-57366190 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 89.8" "Cell type enriched" "Detected in some" 532 "monocytes: 9361.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 18 "HDLM-2: 33.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted to blood" NA NA 617000 "unprognostic (2.67e-2)" "unprognostic (7.68e-3)" "prognostic favorable (2.98e-4)" "prognostic favorable (2.23e-6)" "unprognostic (8.87e-2)" "prognostic favorable (9.17e-5)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (1.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.85e-2)" "unprognostic (2.55e-1)" "unprognostic (1.15e-2)" "unprognostic (7.71e-2)" "unprognostic (3.43e-2)" "unprognostic (3.12e-2)" "unprognostic (3.88e-2)" 10.5 0.6 0.3 27.7 0.5 0.3 1.9 0.2 0.3 1.6 1.3 0.0 0.4 1.0 0.6 0.5 4.6 0.4 2.6 0.4 0.3 0.3 0.6 0.5 4.6 11.9 0.3 0.0 0.3 0.9 0.0 0.3 0.2 0.1 0.7 5.4 0.1 5.9 0.2 0.3 7.1 7.4 0.7 0.3 5.5 1.1 0.3 0.0 89.8 0.7 5.9 31.8 3.6 1.6 3.1 2.6 3.7 0.8 1.4 0.7 0.5 0.4 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.1 0.1 0.0 0.9 0.0 0.0 0.1 33.2 0.1 0.1 0.2 0.3 0.0 0.1 1.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.3 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.1 0.1 1.2 0.0 1.8 0.2 0.1 0.1 1.4 0.0 0.1 0.2 1.6 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 3.6 0.8 0.6 0.6 0.4 0.4 3.1 0.5 0.4 2.6 1.6 0.6 0.7 3.7 1.4 0.4 1.0 0.4 0.5 0.3 0.5 0.2 0.3 0.3 0.3 0.3 0.0 0.1 0.0 3.0 0.6 0.0 0.2 6.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 1.7 4.0 0.0 0.2 0.0 0.0 17.6 0.0 0.7 0.2 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.3 9361.9 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 6.9 0.1 0.0 0.0 0.1 CCL24 "Ckb-6, eotaxin-2, MPIF-2, MPIF2, SCYA24" ENSG00000106178 "C-C motif chemokine ligand 24" O00175 7 75811665-75823356 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 33.1;lung: 23.3;lymphoid tissue: 63.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "colorectal cancer: 67.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 3.3" "Lineage enriched" "Detected in single" 5 "monocytes: 3.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.8;EFO-21: 2.7;HMC-1: 2.7;OE19: 4.1;RH-30: 3.4;U-2 OS: 9.4" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 276000 "unprognostic (4.55e-2)" "unprognostic (1.13e-1)" "prognostic favorable (5.41e-4)" "unprognostic (1.26e-2)" "unprognostic (1.44e-2)" "unprognostic (5.56e-2)" "unprognostic (1.73e-1)" "unprognostic (1.93e-1)" "unprognostic (4.32e-2)" "unprognostic (1.71e-1)" "unprognostic (2.35e-1)" "unprognostic (3.15e-1)" "unprognostic (2.84e-1)" "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" 8.2 0.5 0.3 5.7 0.3 0.0 0.8 0.3 0.3 0.6 12.2 0.3 0.2 9.4 0.4 0.6 1.0 0.4 1.1 0.5 0.3 0.3 0.6 3.8 23.3 21.2 0.3 0.2 0.6 0.4 0.0 0.4 0.3 0.3 0.5 33.1 0.6 0.6 0.5 0.4 0.7 26.8 0.5 0.3 63.3 1.0 1.0 0.2 1.2 0.5 0.9 2.8 13.4 0.7 0.0 0.6 0.0 3.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.0 8.8 0.2 2.7 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.4 0.7 0.2 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.0 4.1 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 9.4 0.0 0.5 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCL4 "Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4" ENSG00000275302 "C-C motif chemokine ligand 4" P13236 17 36103590-36105621 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 69.3;lung: 23.1;lymphoid tissue: 20.8" "Cell type enhanced" "Detected in many" 16 "Hofbauer cells: 716.7;Macrophages: 396.6;T-cells: 809.7" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 69.3;MAIT T-cell: 21.8;memory CD8 T-cell: 40.6;naive CD8 T-cell: 30.5" "Lineage enriched" "Detected in many" 17 "T-cells: 69.3" "Group enriched" "Detected in some" 23 "Karpas-707: 5.2;U-266/70: 11.5;U-266/84: 5.5" CAB007805 Approved "Secreted to blood" NA NA 144000 "CAB007805: AB_598177" "unprognostic (6.03e-2)" "unprognostic (2.48e-2)" "prognostic favorable (3.54e-4)" "prognostic favorable (1.97e-5)" "unprognostic (2.06e-1)" "unprognostic (7.02e-2)" "unprognostic (9.08e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.97e-4)" "unprognostic (3.45e-1)" "unprognostic (8.57e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (3.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-2)" 2.3 2.6 0.0 3.7 0.4 9.3 5.7 0.1 3.6 0.9 2.9 1.4 0.5 0.2 1.6 0.8 1.7 1.6 4.4 3.8 0.0 1.3 5.7 23.1 20.8 1.1 0.0 3.4 0.9 0.0 0.2 4.3 0.9 1.1 1.0 3.9 1.6 1.6 0.5 0.0 0.9 1.4 1.5 10.4 2.3 0.3 0.0 1.0 1.6 2.0 4.3 1.9 0.8 1.8 0.4 4.0 0.6 3.0 69.3 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 5.5 0.3 0.0 0.0 0.0 1.7 0.2 4.0 69.3 0.0 21.8 0.9 7.7 40.6 0.1 1.8 2.3 30.5 1.6 3.0 0.6 0.4 0.0 11.6 0.0 85.1 30.1 1.1 13.9 1.0 10.2 5.1 10.7 12.5 0.0 0.0 7.8 0.0 0.4 21.7 11.3 0.4 0.0 0.3 9.8 13.1 1.2 58.9 4.3 716.7 1.6 1.2 14.7 198.1 23.7 0.9 396.6 49.0 1.8 0.1 1.2 0.1 0.0 0.4 1.8 5.1 0.0 11.3 0.4 0.2 12.7 21.6 809.7 0.0 1.6 CCL4L2 ENSG00000276070 "C-C motif chemokine ligand 4 like 2" Q8NHW4 17 36210924-36212878 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.8;bone marrow: 18.7;lung: 15.2" "Cell type enriched" "Detected in many" 4 "Hofbauer cells: 323.5" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "eosinophil: 41.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 41.8" "Group enriched" "Detected in some" 4 "Daudi: 5.7;HMC-1: 8.2;U-266/70: 12.7" "Secreted to blood" NA NA "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" "unprognostic (2.46e-2)" "unprognostic (1.44e-2)" "unprognostic (1.16e-1)" "unprognostic (6.07e-2)" "unprognostic (3.82e-1)" "unprognostic (3.19e-1)" "unprognostic (1.53e-2)" "unprognostic (1.14e-1)" "unprognostic (3.62e-2)" "unprognostic (1.93e-1)" "unprognostic (1.27e-2)" "unprognostic (2.27e-1)" "unprognostic (2.08e-1)" "unprognostic (8.51e-2)" "unprognostic (1.99e-3)" 0.8 2.4 0.0 4.5 0.6 18.7 8.0 0.3 4.6 0.9 0.4 2.3 0.0 0.6 0.3 0.3 0.1 0.0 4.5 2.1 0.0 0.7 5.0 15.2 8.1 0.6 0.3 0.1 0.1 1.0 0.0 1.0 0.5 0.7 0.8 1.0 1.6 0.0 0.0 0.0 0.5 0.5 0.0 2.6 0.0 0.4 0.4 0.3 0.0 0.9 1.8 1.9 0.0 0.0 0.0 41.8 0.1 0.3 5.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.7 1.9 1.0 0.0 0.1 0.0 0.2 0.1 41.8 5.6 0.0 1.3 0.0 0.2 3.2 0.0 0.0 0.0 3.3 6.3 0.3 0.0 0.0 0.0 1.5 0.0 10.6 0.0 0.2 0.3 0.4 6.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.6 0.0 0.0 0.0 5.4 3.1 0.5 4.7 0.2 323.5 1.6 0.0 4.3 51.8 0.4 0.0 52.5 1.7 0.0 0.0 0.7 0.1 0.0 0.0 0.0 2.3 12.9 0.4 0.0 0.1 0.4 8.0 78.4 0.0 1.5 CCL5 "D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228" ENSG00000271503 "C-C motif chemokine ligand 5" P13501 17 35871491-35880793 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 169.0" "Cell type enriched" "Detected in many" 5 "T-cells: 1814.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 157.7;memory CD8 T-cell: 169.0" "Lineage enriched" "Detected in many" 4 "T-cells: 169.0" "Cell line enriched" "Detected in some" 4 "NB-4: 73.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" CAB078447 Enhanced "Secreted to blood" NA NA 20100000 8200000 "CAB078447: AB_223462" "unprognostic (3.91e-3)" "unprognostic (1.50e-3)" "unprognostic (8.63e-2)" "prognostic favorable (1.34e-5)" "unprognostic (1.36e-3)" "unprognostic (6.37e-3)" "unprognostic (8.70e-2)" "unprognostic (2.64e-2)" "prognostic favorable (2.42e-4)" "unprognostic (3.26e-3)" "unprognostic (1.64e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (1.70e-2)" "unprognostic (7.55e-2)" "unprognostic (8.56e-3)" "unprognostic (3.73e-2)" 3.6 2.4 0.0 28.8 0.1 17.1 2.6 0.0 0.2 6.0 14.7 1.0 0.6 7.1 5.0 7.2 5.2 1.7 20.5 7.5 0.0 2.7 4.7 29.8 33.5 2.8 0.0 5.9 2.3 0.0 0.1 4.8 1.7 7.8 4.0 8.0 5.5 6.4 2.8 0.0 38.7 2.3 2.2 38.8 6.9 1.9 0.0 12.2 1.6 5.5 27.9 11.5 0.0 1.2 1.1 9.9 0.6 40.8 169.0 106.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 2.4 2.9 0.0 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.2 0.0 0.1 11.5 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 73.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.1 1.7 0.1 0.0 17.1 0.0 0.1 0.0 0.1 0.0 2.2 0.8 0.1 0.0 15.7 0.2 9.9 0.6 0.7 157.7 0.4 103.8 1.2 36.7 169.0 1.1 0.7 8.8 99.3 4.6 40.8 0.5 0.9 0.5 106.5 92.3 350.0 25.5 1.0 6.5 1.1 2.5 0.0 52.2 76.2 1.8 0.0 1.4 1.7 0.8 0.8 18.0 2.6 46.7 0.2 0.7 6.0 1.5 74.4 4.7 28.5 0.0 1.7 48.5 34.1 0.0 0.3 29.5 11.8 2.8 0.3 0.8 1.7 3.5 0.4 5.3 0.4 0.0 7.1 1.0 0.7 5.5 13.4 1814.4 1.1 1.6 CCPG1 "CPR8, KIAA1254" ENSG00000260916 "Cell cycle progression 1" Q9ULG6 15 55340032-55408510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 52.9;neutrophil: 59.9" "Group enriched" "Detected in all" 7 "granulocytes: 59.9;monocytes: 15.4" "Cell line enhanced" "Detected in many" "HHSteC: 50.3;Karpas-707: 73.3;U-266/84: 51.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009432, HPA026861" Approved Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Golgi apparatus" "Endoplasmic reticulum" "HPA009432: AB_2668242, HPA026861: AB_1846192" "unprognostic (3.14e-2)" "unprognostic (2.94e-2)" "unprognostic (3.03e-1)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (1.40e-2)" "unprognostic (8.34e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-2)" "unprognostic (2.61e-2)" "prognostic unfavorable (5.07e-4)" "prognostic unfavorable (5.02e-5)" "unprognostic (1.15e-1)" "unprognostic (1.71e-2)" "unprognostic (1.72e-2)" 22.4 20.3 21.1 11.2 34.8 29.5 20.2 27.6 27.7 32.1 16.0 9.9 28.2 11.9 16.0 19.4 12.7 11.7 26.6 29.7 21.2 26.1 27.5 56.2 23.3 19.8 21.8 18.5 17.4 41.6 37.7 56.3 13.4 21.7 21.0 16.5 13.5 33.1 27.4 44.2 7.8 16.9 16.7 23.2 19.5 22.2 13.8 19.7 5.2 41.9 12.9 11.3 20.0 16.7 3.7 5.5 59.9 15.4 4.9 5.6 5.6 2.9 10.5 2.3 5.2 38.7 13.2 3.4 6.3 12.1 3.8 5.8 3.1 5.0 4.4 21.8 20.9 7.4 4.0 2.0 5.3 3.1 11.5 3.1 5.8 13.3 2.7 50.3 8.1 18.4 11.0 12.9 7.9 7.7 31.0 13.8 0.2 9.8 73.3 11.8 4.0 0.0 4.0 1.4 11.5 2.8 1.3 3.8 17.4 7.9 2.1 3.0 4.7 7.4 4.2 32.0 7.9 6.7 17.9 13.9 11.2 2.4 8.4 4.2 14.1 51.7 2.7 20.9 16.3 8.8 34.6 11.5 52.9 5.6 10.1 4.8 3.7 3.6 4.3 5.5 2.8 3.1 4.3 59.9 4.9 15.4 0.9 4.4 5.6 21.1 34.8 27.6 27.7 21.2 26.1 21.8 18.5 21.7 19.7 107.2 100.3 14.1 26.7 13.7 62.1 11.7 48.4 104.4 112.6 83.7 88.4 24.4 5.0 45.7 107.6 39.4 20.9 23.3 127.8 18.8 46.4 51.8 36.0 85.4 45.5 81.0 16.0 63.8 57.2 149.5 52.3 56.5 45.5 79.4 25.9 77.3 67.8 45.6 109.6 32.8 123.2 51.8 41.2 37.2 43.4 14.4 20.6 34.9 15.8 18.6 CCR1 "CD191, CKR-1, CMKBR1, MIP1aR, SCYAR1" ENSG00000163823 "C-C motif chemokine receptor 1" P32246 3 46201709-46208396 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.0;lymphoid tissue: 40.2" "Group enriched" "Detected in many" 17 "Extravillous trophoblasts: 72.1;Hofbauer cells: 97.6;Kupffer cells: 150.1;Macrophages: 66.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 78.3;RPMI-8226: 36.0;U-266/70: 13.8;U-266/84: 40.5" "Low region specificity" "Detected in all" NA NA "unprognostic (3.95e-1)" "unprognostic (2.17e-1)" "unprognostic (1.20e-1)" "unprognostic (2.16e-1)" "unprognostic (1.05e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" "unprognostic (4.91e-3)" "unprognostic (2.20e-3)" "unprognostic (1.09e-1)" "unprognostic (9.60e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (1.08e-1)" "unprognostic (5.52e-3)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" 21.2 6.0 5.1 23.8 8.4 11.2 4.9 1.0 3.7 1.9 2.9 7.2 0.5 3.9 2.0 5.1 2.0 4.5 6.7 4.1 5.4 3.2 4.4 9.6 11.6 26.3 9.0 1.6 2.8 2.3 1.0 2.6 14.9 6.9 2.3 4.1 2.9 3.3 1.3 1.4 1.4 4.5 8.5 11.6 40.2 2.9 1.2 8.7 2.2 1.8 1.0 5.5 6.9 1.5 0.9 15.3 32.5 34.0 22.1 15.3 11.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 36.0 0.0 1.3 0.0 0.0 0.0 0.1 0.3 0.2 0.0 8.2 0.0 0.2 0.0 0.0 0.0 13.8 40.5 0.0 7.0 6.1 0.1 21.5 34.0 6.8 3.1 21.4 15.3 0.9 0.0 2.5 15.3 0.0 0.0 0.4 32.5 22.1 13.1 5.5 0.0 11.8 5.1 8.4 1.0 3.3 5.4 3.2 9.0 1.6 6.9 8.7 3.0 4.0 5.4 0.0 0.8 0.0 0.4 0.0 2.7 2.3 0.0 0.0 0.6 1.7 0.0 0.2 0.5 0.0 0.0 0.0 72.1 1.5 0.0 3.5 0.8 97.6 0.0 0.0 2.5 150.1 0.0 0.0 66.6 5.0 0.0 0.0 0.4 0.1 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 1.5 2.4 5.7 0.0 0.0 CCR10 GPR2 ENSG00000184451 "C-C motif chemokine receptor 10" P46092 17 42678889-42683917 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.1" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 12.0;Sertoli cells: 19.4;Smooth muscle cells: 10.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 31.1" "Group enriched" "Detected in many" 9 "dendritic cells: 10.9;T-cells: 31.1" "Cell line enhanced" "Detected in some" "Karpas-707: 8.8;RPMI-8226: 6.4;U-266/70: 18.1;U-266/84: 8.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011684, HPA048007, HPA069188" Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB011684: AB_731502, HPA048007: AB_2680232, HPA069188: AB_2686100" "unprognostic (3.25e-2)" "unprognostic (2.71e-2)" "unprognostic (5.70e-2)" "unprognostic (2.41e-2)" "unprognostic (5.25e-2)" "unprognostic (2.23e-3)" "unprognostic (5.18e-4)" "unprognostic (1.15e-1)" "unprognostic (9.55e-2)" "unprognostic (1.56e-1)" "unprognostic (1.21e-3)" "unprognostic (1.01e-2)" "unprognostic (2.32e-11)" "unprognostic (2.84e-2)" "unprognostic (1.53e-1)" "unprognostic (1.88e-2)" "unprognostic (1.87e-1)" 10.0 5.4 5.7 4.8 5.3 0.7 3.0 7.3 7.3 3.9 9.7 0.9 1.5 5.1 5.8 1.4 1.5 4.5 1.5 2.5 3.5 5.0 1.6 0.5 2.2 12.5 1.9 5.0 5.2 2.6 0.4 14.0 2.3 4.1 2.1 1.0 1.1 4.0 2.0 9.1 1.1 8.7 1.8 4.4 4.3 5.0 2.2 1.2 0.5 1.5 0.3 3.6 1.0 2.0 2.3 10.9 0.1 0.3 0.0 31.1 0.7 0.5 0.8 1.1 5.0 0.3 0.8 1.2 2.5 0.5 0.2 0.4 0.7 0.3 0.1 0.3 0.3 2.2 0.9 0.0 0.1 0.2 2.3 1.2 0.0 3.2 0.4 0.7 0.0 0.3 0.8 0.0 0.4 0.0 0.9 0.2 0.3 2.6 8.8 0.0 0.3 0.1 2.4 0.6 0.0 1.2 0.6 0.2 6.4 1.1 0.0 0.8 1.1 0.7 0.0 0.2 0.5 0.8 0.9 2.4 2.9 0.6 0.9 0.3 18.1 8.2 2.6 1.4 0.7 0.9 0.0 0.3 0.1 0.2 0.0 0.1 2.3 5.2 2.6 0.2 2.1 0.6 0.8 0.0 0.0 0.1 10.9 31.1 0.7 5.7 5.3 7.3 7.3 3.5 5.0 1.9 5.0 4.1 1.2 0.0 0.0 0.0 0.2 0.7 12.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.3 0.4 1.4 0.0 0.0 0.5 0.2 2.3 0.3 0.0 0.0 1.7 1.6 1.7 1.3 1.8 1.8 5.2 1.2 5.0 5.4 0.1 2.0 0.2 0.0 2.5 0.6 3.1 19.4 10.3 0.7 0.7 0.3 0.0 0.5 0.4 0.1 CCR2 "CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R" ENSG00000121807 "C-C motif chemokine receptor 2" P41597 3 46353734-46360928 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "Host-virus interaction, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 96.3;lymphoid tissue: 36.1" "Cell type enriched" "Detected in some" 6 "Kupffer cells: 61.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "basophil: 96.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Karpas-707: 48.6;THP-1: 23.0;U-266/70: 111.8;U-266/84: 44.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" CAB003793 Approved NA NA "CAB003793: AB_344889" "unprognostic (1.09e-2)" "unprognostic (6.28e-4)" "unprognostic (3.49e-2)" "unprognostic (6.35e-4)" "unprognostic (1.89e-2)" "unprognostic (4.16e-4)" "unprognostic (8.06e-2)" "prognostic favorable (5.87e-4)" "unprognostic (6.33e-2)" "unprognostic (3.27e-2)" "unprognostic (3.12e-1)" "unprognostic (1.56e-1)" "unprognostic (5.52e-3)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (4.88e-2)" "unprognostic (4.19e-1)" 2.5 1.3 0.6 20.7 0.8 0.9 1.9 0.5 0.8 4.3 5.8 0.5 1.5 5.6 2.6 2.4 6.1 2.2 2.5 1.8 0.6 0.6 3.7 1.8 8.6 30.1 1.6 0.1 1.7 1.7 0.0 0.8 2.1 1.8 3.7 4.0 2.6 10.2 3.5 0.8 1.3 7.3 5.6 1.5 36.1 3.7 1.5 0.5 3.6 2.0 3.5 5.9 5.8 1.7 1.6 29.0 96.3 28.4 2.5 19.3 13.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 48.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 111.8 44.5 0.0 0.0 0.8 0.0 96.3 28.4 0.4 2.5 2.6 19.3 1.6 5.2 4.2 29.0 0.3 0.1 0.1 0.7 2.5 0.0 23.0 2.3 13.5 0.6 0.8 0.5 0.8 0.6 0.6 1.6 0.1 1.8 0.5 0.0 2.2 7.8 0.0 0.2 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 3.1 61.3 0.4 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 CCR3 "CC-CKR-3, CD193, CKR3, CMKBR3" ENSG00000183625 "C-C motif chemokine receptor 3" P51677 3 46163604-46266706 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "blood: 175.9" "Cell type enhanced" "Detected in some" 17 "granulocytes: 1.1;Melanocytes: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 22 "basophil: 175.9;eosinophil: 152.0" "Lineage enriched" "Detected in many" 92 "granulocytes: 175.9" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB003795, HPA069514" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "CAB003795: AB_562259, HPA069514: " "unprognostic (1.56e-2)" "unprognostic (6.65e-3)" "unprognostic (1.01e-1)" "unprognostic (3.98e-2)" "unprognostic (1.41e-1)" "unprognostic (3.25e-3)" "unprognostic (3.11e-7)" "unprognostic (4.36e-2)" "unprognostic (3.35e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (3.94e-2)" "unprognostic (3.17e-6)" "unprognostic (1.35e-2)" "unprognostic (1.72e-2)" "unprognostic (2.41e-1)" "unprognostic (9.81e-2)" 0.6 0.2 0.3 2.9 1.1 0.4 0.3 0.2 0.8 0.3 1.3 0.2 0.2 2.9 0.8 0.2 0.4 0.5 1.3 0.3 0.2 0.2 0.5 1.2 5.8 0.6 0.3 0.2 0.2 0.3 0.0 0.3 7.0 0.7 1.0 1.4 0.9 2.4 0.2 3.2 3.6 5.1 1.6 0.5 2.7 2.2 0.4 0.2 0.6 1.8 2.8 0.6 4.0 0.3 0.0 0.2 175.9 0.0 0.0 1.9 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 2.3 0.0 0.7 0.0 0.8 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.2 0.0 25.5 0.0 2.1 0.1 0.0 0.0 0.7 0.0 0.8 0.0 0.6 0.0 0.1 0.2 0.0 0.1 2.8 2.2 0.0 0.0 0.5 0.0 175.9 0.0 152.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.2 1.9 0.3 0.3 1.1 0.2 0.8 0.2 0.2 0.3 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CCR4 "CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5" ENSG00000183813 "C-C motif chemokine receptor 4" P51679 3 32951574-32956349 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 28.9;lymphoid tissue: 57.1" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 1.4;granulocytes: 2.3;Horizontal cells: 4.8;T-cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 28.9" "Lineage enriched" "Detected in single" 48 "T-cells: 28.9" "Cell line enriched" "Detected in some" 17 "HDLM-2: 67.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA031613 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA031613: AB_10601096" "unprognostic (4.63e-3)" "unprognostic (8.70e-3)" "unprognostic (2.82e-3)" "unprognostic (2.64e-3)" "unprognostic (1.18e-1)" "unprognostic (4.59e-7)" "unprognostic (3.02e-1)" "unprognostic (5.05e-3)" "unprognostic (1.53e-2)" "unprognostic (1.69e-2)" "unprognostic (1.75e-1)" "unprognostic (2.17e-1)" "unprognostic (9.88e-3)" "unprognostic (2.04e-1)" "unprognostic (5.53e-4)" "unprognostic (1.54e-1)" "unprognostic (1.40e-1)" 1.5 0.6 0.3 12.6 0.4 1.5 1.1 0.3 0.3 1.1 1.1 0.1 0.7 0.4 1.0 0.6 1.6 0.8 3.8 0.8 0.3 0.3 1.8 0.9 6.0 24.1 0.3 0.0 0.5 0.5 0.5 0.5 0.1 0.1 1.5 1.2 0.8 4.3 0.2 1.8 2.2 5.0 0.4 0.4 10.2 1.3 2.7 0.0 57.1 1.3 2.8 29.7 8.6 1.1 0.2 0.2 0.5 0.1 0.1 28.9 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 67.1 0.0 4.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.9 1.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.2 0.1 0.2 0.1 6.0 1.8 0.0 0.2 0.1 0.1 0.5 0.1 0.1 0.2 28.9 0.8 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.5 0.3 0.1 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 1.0 0.1 0.0 2.2 0.0 0.4 CCR5 "CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22" ENSG00000160791 "C-C motif chemokine receptor 5 (gene/pseudogene)" P51681 3 46370854-46376206 "CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.5" "Cell type enhanced" "Detected in some" 17 "Hofbauer cells: 4.9;Kupffer cells: 4.1;Macrophages: 16.2;T-cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 24.5" "Lineage enriched" "Detected in many" 4 "T-cells: 24.5" "Cell line enhanced" "Detected in some" "JURKAT: 2.5;Karpas-707: 12.0;U-266/84: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.32e-3)" "unprognostic (1.94e-3)" "unprognostic (1.89e-3)" "prognostic favorable (7.42e-5)" "unprognostic (1.80e-2)" "prognostic favorable (9.33e-5)" "unprognostic (3.38e-3)" "unprognostic (9.90e-3)" "unprognostic (7.65e-2)" "unprognostic (6.22e-2)" "unprognostic (1.36e-1)" "unprognostic (5.34e-2)" "unprognostic (1.14e-3)" "unprognostic (8.34e-2)" "unprognostic (4.69e-2)" "unprognostic (3.14e-2)" "unprognostic (2.42e-2)" 7.1 2.3 3.4 13.8 6.1 0.8 2.1 0.8 2.5 2.3 3.0 3.0 0.8 3.8 3.7 4.0 2.6 2.6 5.0 3.6 1.6 2.0 2.7 3.0 9.3 11.9 8.1 0.5 3.0 2.1 0.4 1.9 1.2 4.0 2.8 3.8 3.5 4.4 2.5 0.8 1.1 7.2 2.9 6.1 14.6 6.0 0.9 5.9 2.0 2.6 1.5 13.9 5.7 2.0 0.3 5.5 5.6 2.1 3.2 24.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 12.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.4 5.1 0.0 0.0 0.3 0.0 5.6 1.1 0.0 6.7 2.1 24.5 0.3 2.9 9.7 5.5 0.0 0.3 2.6 0.3 3.2 0.0 5.2 4.5 1.5 3.4 6.1 0.8 2.5 1.6 2.0 8.1 0.5 4.0 5.9 0.0 1.7 0.9 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.2 4.9 0.0 0.0 1.3 4.1 0.0 0.0 16.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 13.1 0.0 0.0 CCR6 "BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22" ENSG00000112486 "C-C motif chemokine receptor 6" P51684 6 167111807-167139696 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 30.7;intestine: 9.9;lymphoid tissue: 33.7" "Cell type enhanced" "Detected in many" 11 "B-cells: 21.0;Late spermatids: 20.6;T-cells: 11.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "MAIT T-cell: 30.7;memory B-cell: 23.8;memory CD4 T-cell: 11.9;naive B-cell: 28.2;T-reg: 20.9" "Group enriched" "Detected in many" 5 "B-cells: 28.2;T-cells: 30.7" "Cell line enhanced" "Detected in some" "HDLM-2: 2.6;Hep G2: 14.1;OE19: 4.9" "Region enriched" "Detected in single" 8 "basal ganglia: 0.9" "Not detected" "Not detected" "CAB006820, HPA014488" Approved NA NA "CAB006820: , HPA014488: AB_1846639" "unprognostic (1.12e-2)" "unprognostic (2.92e-2)" "unprognostic (2.07e-3)" "unprognostic (2.08e-1)" "unprognostic (8.43e-2)" "unprognostic (2.05e-4)" "unprognostic (2.39e-1)" "unprognostic (4.98e-3)" "unprognostic (1.29e-1)" "unprognostic (1.40e-1)" "unprognostic (4.19e-2)" "unprognostic (4.26e-2)" "unprognostic (2.68e-4)" "unprognostic (3.74e-2)" "unprognostic (7.96e-2)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" 0.5 0.3 1.0 24.4 1.5 1.3 1.1 0.3 1.1 0.6 3.0 0.1 0.0 1.4 0.3 0.8 2.1 0.5 3.1 0.3 0.9 0.9 1.0 0.5 3.3 27.3 0.6 0.0 0.3 0.3 0.0 0.4 0.5 0.2 0.5 1.2 0.3 5.0 0.8 0.3 1.1 9.9 0.0 0.4 23.4 2.2 2.7 0.1 3.7 0.6 2.1 33.7 4.8 0.4 28.2 5.4 0.2 0.0 0.4 30.7 2.5 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.2 1.3 0.3 0.0 0.0 0.0 0.3 0.2 0.1 2.6 0.7 0.1 0.3 14.1 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.2 0.1 4.9 0.0 0.2 0.2 0.2 0.4 0.0 0.8 0.4 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.8 0.1 0.3 0.5 0.3 0.4 0.0 0.2 0.6 0.0 0.0 0.1 1.6 0.0 30.7 23.8 11.9 4.7 5.4 28.2 0.1 0.0 0.2 0.4 0.0 0.6 20.9 2.5 1.0 1.5 0.3 1.1 0.9 0.9 0.6 0.0 0.2 0.1 0.0 6.2 21.0 0.3 0.9 0.9 0.0 0.0 1.4 3.4 0.0 2.0 0.0 1.7 0.1 5.7 0.0 0.0 0.0 0.2 0.0 0.7 0.1 2.3 0.8 0.1 0.0 0.0 1.3 0.0 20.6 0.0 5.1 1.7 4.6 0.3 0.4 0.1 0.0 0.4 0.3 3.8 0.0 0.1 2.3 0.4 0.4 0.1 11.4 0.0 0.1 CCR7 "BLR2, CD197, CDw197, CMKBR7, EBI1" ENSG00000126353 "C-C motif chemokine receptor 7" P32248 17 40553769-40565472 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "blood: 252.3;lymphoid tissue: 110.6" "Cell type enriched" "Detected in many" 6 "monocytes: 2758.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 252.3" "Lineage enriched" "Detected in many" 4 "T-cells: 252.3" "Cell line enriched" "Detected in some" 79 "HDLM-2: 175.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB003796, HPA031383, HPA074467" Enhanced Enhanced Mitochondria NA NA Mitochondria "CAB003796: AB_562261, HPA031383: AB_2673854, HPA074467: AB_2686693" "prognostic favorable (3.84e-4)" "prognostic favorable (8.03e-6)" "unprognostic (2.26e-3)" "unprognostic (1.32e-3)" "unprognostic (2.35e-3)" "prognostic favorable (7.61e-7)" "unprognostic (2.71e-4)" "unprognostic (2.58e-2)" "unprognostic (4.48e-2)" "unprognostic (4.68e-4)" "unprognostic (1.10e-2)" "unprognostic (3.11e-1)" "unprognostic (1.08e-3)" "unprognostic (3.12e-1)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.02e-1)" "unprognostic (7.95e-2)" 2.8 0.4 0.2 26.0 0.2 5.2 1.7 0.2 0.3 2.2 1.2 0.3 0.8 0.3 1.2 0.5 1.4 2.3 2.0 1.9 0.2 0.2 1.5 1.7 3.4 110.6 0.3 0.2 1.5 0.3 0.0 1.0 1.0 0.4 1.3 2.1 0.7 8.4 0.2 0.2 1.1 16.2 0.2 0.4 20.3 1.8 1.2 0.3 57.1 2.0 1.2 53.8 4.2 1.3 58.8 2.9 2.3 0.3 44.1 252.3 109.3 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 175.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.1 1.1 0.2 0.0 0.0 1.1 0.3 0.2 3.1 0.1 3.6 37.2 53.3 15.3 0.2 58.8 252.3 133.9 2.3 44.1 0.2 2.9 30.3 109.3 0.2 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.4 0.3 0.0 5.9 116.5 1.4 4.4 0.0 0.3 0.0 0.0 2.3 1.8 0.0 111.5 0.0 0.4 0.1 0.1 0.0 0.0 6.9 6.3 3.3 0.0 2.3 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 12.9 15.1 2758.4 0.0 0.7 0.7 0.0 0.0 0.1 0.0 0.0 3.9 0.2 0.5 3.9 432.7 16.2 0.0 3.3 CCR8 "CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1" ENSG00000179934 "C-C motif chemokine receptor 8" P51685 3 39329706-39333511 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 19.8;lymphoid tissue: 19.3;urinary bladder: 5.3" "Cell type enriched" "Detected in single" 11 "Alveolar cells type 2: 1.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 19.8" "Lineage enriched" "Detected in single" 30 "T-cells: 19.8" "Cell line enriched" "Detected in some" 22 "HDLM-2: 50.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042383 Enhanced NA NA "HPA042383: AB_2732497" "unprognostic (2.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.91e-2)" "unprognostic (1.04e-1)" "unprognostic (2.38e-2)" "unprognostic (7.63e-4)" "unprognostic (3.31e-1)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (3.37e-2)" "unprognostic (7.40e-2)" "unprognostic (2.99e-1)" "unprognostic (4.65e-8)" "unprognostic (7.96e-2)" "unprognostic (2.24e-2)" "unprognostic (2.56e-1)" "unprognostic (4.14e-1)" 0.3 0.2 0.2 3.1 0.2 0.0 0.3 0.2 0.2 0.3 0.5 0.1 0.1 0.0 0.3 0.1 0.8 0.1 2.1 0.2 0.2 0.2 0.5 0.3 1.4 2.8 0.1 0.1 0.2 0.3 0.0 0.2 0.1 0.1 0.4 1.3 0.1 0.5 0.1 0.2 1.0 1.2 0.1 0.4 1.7 0.8 0.3 0.1 19.3 0.4 1.2 3.5 5.3 0.3 0.0 0.0 0.0 0.0 0.6 19.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 19.8 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCR9 "CDw199, GPR-9-6, GPR28" ENSG00000173585 "C-C motif chemokine receptor 9" P51686 3 45886504-45903177 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 130.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 17.5;naive B-cell: 9.2;T-reg: 5.7" "Group enriched" "Detected in many" 42 "B-cells: 17.5;T-cells: 5.7" "Cell line enriched" "Detected in single" 50 "MOLT-4: 49.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB006839 Uncertain NA NA "CAB006839: " "unprognostic (3.08e-3)" "unprognostic (3.37e-1)" "unprognostic (5.56e-2)" "unprognostic (1.78e-1)" "unprognostic (8.65e-3)" "unprognostic (7.88e-3)" "unprognostic (4.54e-1)" "unprognostic (2.94e-2)" "unprognostic (3.00e-1)" "unprognostic (1.77e-1)" "unprognostic (8.06e-2)" "unprognostic (1.16e-1)" "unprognostic (2.59e-2)" "unprognostic (1.88e-1)" "unprognostic (4.34e-1)" "unprognostic (2.27e-1)" "unprognostic (7.20e-3)" 0.1 0.1 0.1 1.8 0.1 0.7 0.1 0.1 0.3 0.1 2.2 0.1 0.1 7.0 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.2 0.1 10.7 0.1 0.2 2.2 0.3 0.1 0.1 130.2 0.1 0.1 0.7 0.1 0.1 17.5 0.2 0.0 0.0 0.0 5.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 49.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 17.5 2.2 1.8 0.2 9.2 0.3 0.1 0.0 0.0 0.0 0.2 5.7 1.8 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CCRL2 "ACKR5, CKRX, CRAM-A, CRAM-B, HCR" ENSG00000121797 "C-C motif chemokine receptor like 2" O00421 3 46407163-46412997 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 31.4" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 16.9;Hofbauer cells: 40.0;Macrophages: 28.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 16.5;OE19: 6.6;PC-3: 12.8;TIME: 12.5;U-266/84: 6.7" "Low region specificity" "Detected in many" HPA043238 Approved NA NA "HPA043238: AB_10794924" "unprognostic (3.94e-1)" "unprognostic (7.02e-2)" "prognostic favorable (3.72e-5)" "unprognostic (1.64e-1)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (1.46e-1)" "unprognostic (1.62e-1)" "unprognostic (4.10e-2)" "unprognostic (4.17e-2)" "unprognostic (9.73e-2)" "unprognostic (1.98e-2)" "unprognostic (5.17e-2)" "unprognostic (1.78e-1)" "unprognostic (3.04e-2)" "unprognostic (2.57e-1)" "prognostic favorable (9.67e-5)" 31.4 1.4 1.3 9.2 1.5 6.0 9.0 0.6 1.2 1.8 9.5 0.9 2.8 9.5 3.5 1.4 1.8 1.3 4.5 2.3 1.5 1.3 2.0 3.4 13.7 4.3 1.9 0.9 2.3 4.8 0.3 1.3 3.9 1.8 2.4 8.8 1.7 1.4 0.7 2.6 1.1 16.9 1.9 2.9 11.2 4.5 2.3 1.2 9.4 1.9 1.3 3.0 3.6 3.5 2.5 7.7 5.6 16.7 5.4 3.9 3.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 1.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.2 0.5 3.8 0.0 16.5 0.0 0.0 0.0 1.0 0.2 0.0 0.0 4.2 0.2 0.0 5.9 3.5 2.2 0.1 4.2 0.0 1.3 2.1 0.0 6.6 12.8 0.3 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 12.5 0.5 0.2 0.6 0.2 0.0 6.7 0.2 6.5 5.1 0.0 5.6 12.1 3.2 2.4 16.7 2.9 1.4 1.4 3.9 7.7 2.5 0.9 2.2 2.0 5.4 7.8 2.4 3.7 3.6 1.3 1.5 0.6 1.2 1.5 1.3 1.9 0.9 1.8 1.2 0.0 6.6 5.1 0.1 1.8 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.2 0.0 0.5 0.0 9.0 16.9 0.0 7.4 0.9 0.9 0.2 9.2 0.4 40.0 0.0 0.0 5.5 16.4 0.0 0.0 28.2 1.7 7.2 14.9 0.0 7.8 6.8 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.0 2.1 6.9 7.2 0.9 CD101 "IGSF2, V7" ENSG00000134256 "CD101 molecule" Q93033 1 117001750-117036476 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;lung: 17.5" "Cell type enhanced" "Detected in some" 9 "Kupffer cells: 6.2;Macrophages: 7.2;Sertoli cells: 6.5;T-cells: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 33.7" "Group enriched" "Detected in many" 17 "dendritic cells: 12.2;granulocytes: 33.7;monocytes: 17.4" "Cell line enriched" "Detected in some" 9 "HMC-1: 25.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA049527, HPA057763" Approved Uncertain Mitochondria NA NA 42000 Mitochondria "HPA049527: , HPA057763: AB_2683519" "unprognostic (1.25e-1)" "unprognostic (7.95e-3)" "unprognostic (5.40e-3)" "unprognostic (4.10e-3)" "unprognostic (2.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.03e-2)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (7.29e-3)" "unprognostic (3.15e-1)" "unprognostic (4.54e-2)" "unprognostic (7.15e-6)" "unprognostic (7.00e-2)" "unprognostic (8.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.28e-2)" 0.9 1.7 0.8 11.3 1.1 5.7 0.8 0.2 1.1 1.3 5.0 0.6 1.2 4.6 1.7 0.4 1.8 1.5 1.4 2.6 1.1 0.5 1.3 0.8 17.5 4.0 1.3 0.2 1.0 2.3 0.0 0.8 0.5 1.1 1.6 3.2 0.7 2.1 1.3 0.5 1.8 10.9 1.6 2.0 7.8 1.8 0.9 1.2 6.4 0.9 2.4 7.4 2.4 1.8 0.1 12.2 33.7 17.4 0.0 1.2 2.5 0.4 0.0 0.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 1.2 1.9 0.1 0.0 0.0 1.1 0.1 0.8 0.0 0.0 0.1 25.3 0.3 1.3 0.0 0.1 0.2 0.2 0.5 0.1 0.6 0.1 1.5 0.0 2.9 0.8 0.0 0.0 0.0 0.5 0.0 0.6 0.7 0.4 0.6 0.4 0.5 0.3 0.6 0.9 0.6 0.5 0.1 0.4 0.5 0.2 0.2 0.1 0.0 0.7 1.9 1.5 0.0 7.6 33.7 0.1 10.0 0.7 0.1 0.2 1.2 12.2 0.0 0.3 1.2 0.3 0.0 17.4 0.0 1.1 2.5 0.8 1.1 0.2 1.1 1.1 0.5 1.3 0.2 1.1 1.2 0.0 1.4 0.5 0.1 1.1 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.5 0.0 0.2 0.1 1.1 0.4 0.7 0.0 1.7 0.0 6.2 1.3 0.3 7.2 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.2 0.0 0.0 1.4 0.0 4.6 0.1 0.1 CD151 "PETA-3, RAPH, SFA-1, TSPAN24" ENSG00000177697 "CD151 molecule (Raph blood group)" P48509 11 832843-839831 "Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Blood group antigen" "Deafness, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 112.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002428, HPA011906" Supported NA NA 680000 "CAB002428: AB_564129, HPA011906: AB_1846245" "unprognostic (1.50e-1)" "unprognostic (1.12e-2)" "unprognostic (5.47e-2)" "unprognostic (5.45e-3)" "unprognostic (4.10e-3)" "unprognostic (2.45e-2)" "prognostic unfavorable (5.58e-4)" "prognostic unfavorable (9.46e-4)" "unprognostic (5.47e-2)" "unprognostic (2.41e-1)" "unprognostic (1.02e-3)" "unprognostic (3.31e-1)" "unprognostic (4.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.24e-1)" "prognostic favorable (6.92e-4)" "unprognostic (7.83e-2)" 63.1 28.1 7.4 19.1 8.1 3.4 133.2 7.9 11.3 39.8 36.0 9.5 37.8 23.2 55.7 45.3 43.1 29.3 63.0 85.2 7.3 7.9 52.8 47.2 45.8 16.3 7.5 10.3 29.8 82.7 27.8 14.1 58.6 10.7 52.0 16.5 31.2 62.9 41.1 19.2 17.1 46.0 62.4 6.7 15.8 31.7 20.8 5.5 2.4 43.2 27.1 16.1 35.9 34.9 2.1 8.1 14.9 14.3 5.2 4.8 6.5 38.1 52.9 7.6 22.8 109.5 45.6 11.9 59.8 40.9 30.2 25.6 27.5 54.6 0.0 24.0 89.4 40.3 34.9 6.7 52.8 7.6 14.3 26.0 10.5 16.3 21.0 41.7 8.5 14.7 44.0 35.3 17.7 31.2 112.1 35.6 1.7 12.9 5.0 45.0 21.4 0.2 10.1 5.0 21.6 63.5 1.9 15.8 8.2 67.2 11.1 10.5 11.8 55.4 30.9 10.4 7.9 12.4 10.3 60.9 41.1 20.4 13.2 33.1 6.6 6.8 0.4 40.5 8.9 22.7 14.9 12.0 9.6 4.2 12.6 4.8 2.1 3.5 3.6 8.1 1.5 1.5 2.2 5.7 5.2 14.3 1.3 2.1 6.5 7.4 8.1 7.9 11.3 7.3 7.9 7.5 10.3 10.7 5.5 193.5 73.9 15.2 121.9 62.7 15.1 156.1 160.5 32.1 73.9 235.5 3.9 213.2 16.6 600.9 2.2 178.4 409.1 0.0 557.1 348.4 135.3 228.7 81.7 50.8 127.0 35.0 122.5 247.9 64.9 8.8 114.5 96.8 121.4 92.8 320.3 85.6 610.0 308.6 266.2 116.1 12.3 207.0 270.6 1.4 13.0 47.6 155.3 44.9 214.1 153.3 CD163 "M130, MM130, SCARI1" ENSG00000177575 "CD163 molecule" Q86VB7 12 7470813-7503893 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Acute phase, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 113.6" "Cell type enriched" "Detected in many" 7 "Kupffer cells: 1509.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 28.2;myeloid DC: 25.3" "Group enriched" "Detected in many" 40 "dendritic cells: 25.3;monocytes: 28.2" "Cell line enhanced" "Detected in some" "ASC diff: 1.8;CACO-2: 1.7;GAMG: 5.4;HSkMC: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB002432, HPA046404, HPA051974" Enhanced Supported "Plasma membrane" "Secreted to blood" NA NA 903000000 1600000000 "Plasma membrane" "CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678" "unprognostic (1.13e-1)" "unprognostic (2.13e-1)" "unprognostic (5.02e-3)" "unprognostic (2.72e-1)" "unprognostic (6.17e-3)" "unprognostic (2.09e-1)" "unprognostic (1.02e-1)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (1.04e-1)" "unprognostic (6.50e-2)" "unprognostic (1.84e-2)" "unprognostic (8.77e-2)" "unprognostic (4.95e-2)" "unprognostic (1.61e-1)" "unprognostic (1.20e-2)" 66.7 23.8 2.1 44.6 7.2 4.1 23.2 2.8 4.9 11.3 25.3 1.6 1.4 3.5 7.2 16.8 11.3 20.1 13.2 15.7 2.8 1.8 43.9 38.9 81.0 99.8 6.9 0.5 10.3 6.7 3.1 11.7 31.9 9.9 6.8 6.5 9.8 8.6 2.2 15.2 4.0 12.5 37.2 5.7 113.6 10.2 19.6 4.3 3.4 15.5 2.9 3.5 20.1 8.3 0.0 25.3 0.6 28.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 1.8 1.0 0.4 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 5.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.5 0.3 5.3 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.5 0.1 0.0 0.1 0.9 0.1 0.0 0.0 0.2 0.5 0.1 0.1 0.0 0.5 0.0 0.3 0.0 0.9 0.3 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.5 28.2 0.1 0.0 2.5 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 6.3 2.1 7.2 2.8 2.4 2.8 1.8 6.9 0.5 9.9 4.3 3.0 8.8 9.3 0.2 1.3 0.0 3.4 10.2 2.7 9.1 0.0 2.0 1.3 0.0 0.0 2.5 1.9 0.0 0.0 0.0 1.5 1.6 0.1 4.7 5.9 221.9 0.0 0.0 28.3 1509.4 3.9 4.6 104.2 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.1 116.4 0.3 3.9 1.7 0.9 2.5 5.0 0.0 0.0 CD163L1 "CD163B, M160, SCARI2, WC1" ENSG00000177675 "CD163 molecule like 1" Q9NR16 12 7346685-7479897 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.4;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 6.9;Melanocytes: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 9.2;HDLM-2: 8.2;HUVEC TERT2: 8.9;TIME: 8.3;U-87 MG: 19.4" HPA015663 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA 170000 "Centrosome, Cytosol" Nucleoplasm "HPA015663: AB_2072575" "unprognostic (1.25e-3)" "unprognostic (1.77e-1)" "unprognostic (1.42e-2)" "unprognostic (7.46e-3)" "unprognostic (2.29e-2)" "unprognostic (7.79e-2)" "unprognostic (9.39e-2)" "unprognostic (4.44e-3)" "unprognostic (1.07e-1)" "unprognostic (8.35e-2)" "unprognostic (1.08e-1)" "unprognostic (3.08e-1)" "unprognostic (1.26e-6)" "unprognostic (8.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.69e-1)" 5.0 1.7 1.2 19.1 1.2 0.0 2.5 0.8 1.6 1.4 9.2 0.3 1.0 5.5 1.2 8.5 1.8 1.3 2.6 3.2 1.2 1.0 1.7 1.5 2.8 14.6 1.1 0.7 1.0 1.0 0.1 1.4 6.8 3.3 1.4 15.1 2.7 2.5 1.4 1.1 1.4 18.4 1.8 1.0 31.2 2.6 4.6 0.2 9.5 1.7 6.4 12.9 4.3 1.2 0.2 0.7 0.7 0.8 0.0 0.0 0.2 0.2 0.4 0.2 0.0 1.0 0.3 0.0 0.8 1.8 0.2 0.8 0.0 1.4 0.0 0.3 0.8 9.2 0.0 0.0 1.1 1.4 8.2 0.0 0.0 0.4 1.2 0.0 0.5 0.0 0.3 0.0 0.2 3.3 0.6 8.9 0.0 0.1 4.7 5.2 0.0 0.0 6.6 0.2 0.0 0.0 1.5 1.5 1.8 0.0 0.0 1.2 5.6 4.3 6.8 0.0 0.3 0.0 5.5 8.3 3.0 2.7 0.3 0.0 0.1 0.1 0.0 19.4 0.4 5.7 0.0 0.8 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 1.2 0.8 1.6 1.2 1.0 1.1 0.7 3.3 0.2 0.0 0.0 0.0 0.0 1.1 2.9 0.7 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 2.2 0.7 0.0 0.0 1.2 0.3 0.5 0.1 0.0 0.4 6.9 0.0 0.0 0.0 4.1 1.1 0.0 3.3 13.5 0.0 0.0 1.0 2.0 1.1 0.0 0.0 1.7 19.4 8.0 3.4 0.7 1.1 0.2 0.0 0.0 0.1 CD164 "DFNA66, MGC-24, MUC-24" ENSG00000135535 "CD164 molecule" Q04900 6 109366514-109382812 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Myogenesis" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010636 Uncertain "Intracellular and membrane" NA NA "HPA010636: AB_1078447" "unprognostic (1.23e-2)" "unprognostic (1.61e-2)" "unprognostic (3.89e-2)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-2)" "unprognostic (1.97e-3)" "unprognostic (1.80e-1)" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (8.88e-2)" "unprognostic (1.38e-1)" "unprognostic (7.11e-2)" "unprognostic (1.29e-1)" "unprognostic (1.84e-1)" "unprognostic (3.01e-1)" "unprognostic (1.51e-1)" 85.0 37.6 17.1 37.2 28.5 38.0 72.9 11.2 19.2 34.2 55.2 31.1 57.4 50.5 35.6 44.4 29.6 31.7 58.1 32.0 18.6 22.6 67.4 66.1 52.5 60.9 45.2 16.7 38.0 49.2 30.4 55.0 106.6 28.2 33.4 57.4 44.1 75.1 49.6 38.5 30.6 100.2 41.5 42.8 43.2 55.8 38.1 30.2 50.7 73.3 25.0 34.7 40.3 37.2 32.6 54.2 66.1 48.9 61.1 46.7 83.2 20.5 11.5 6.1 38.6 88.3 85.3 37.4 38.6 48.7 34.7 50.1 23.0 31.4 16.6 37.4 41.8 34.9 20.3 22.9 24.7 53.7 34.0 22.9 28.2 12.3 27.7 52.4 33.2 67.3 66.8 49.0 34.3 31.4 48.7 32.1 14.7 26.9 44.3 47.9 21.5 31.3 41.5 9.1 46.7 18.8 20.6 18.0 20.9 51.2 27.7 6.5 13.2 23.5 31.5 56.3 31.1 27.5 44.1 32.4 22.7 16.6 32.5 30.5 16.8 23.6 19.1 40.9 39.0 23.3 66.1 47.6 39.9 44.7 48.9 46.4 32.6 36.5 40.9 47.1 28.8 38.3 40.7 32.7 61.1 45.5 54.2 46.7 83.2 17.1 28.5 11.2 19.2 18.6 22.6 45.2 16.7 28.2 30.2 151.8 62.8 154.7 162.8 177.7 29.5 60.1 211.5 374.8 95.5 266.9 23.6 193.9 79.6 146.9 73.7 93.1 381.3 23.3 120.3 352.8 194.4 248.6 124.8 160.3 277.6 31.8 159.9 106.2 314.8 72.5 147.0 269.8 234.5 92.8 363.1 107.0 148.8 273.5 171.1 307.5 42.7 122.9 177.2 153.3 160.8 202.0 564.1 162.5 216.7 229.5 CD164L2 ENSG00000174950 "CD164 molecule like 2" Q6UWJ8 1 27379176-27383380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.8" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 62.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.6;HaCaT: 3.6;HBEC3-KT: 3.9;hTCEpi: 5.4;SK-BR-3: 4.9;T-47d: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062915 Enhanced Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA062915: AB_2684903" "unprognostic (8.97e-3)" "unprognostic (2.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.36e-2)" "unprognostic (1.04e-1)" "prognostic favorable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (4.47e-2)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (4.07e-2)" "unprognostic (5.91e-6)" "unprognostic (1.33e-2)" "unprognostic (6.42e-2)" "unprognostic (1.34e-2)" "unprognostic (2.71e-2)" 0.1 0.1 0.2 0.1 0.5 0.0 2.3 0.1 0.4 3.2 0.4 0.7 1.2 0.0 0.4 12.6 13.4 26.8 0.1 0.1 0.4 0.4 0.4 0.3 7.4 0.1 0.1 0.6 3.3 0.3 0.4 5.8 0.1 1.1 2.4 0.2 1.0 12.9 0.3 0.1 8.1 0.1 0.1 0.1 0.1 0.2 1.0 0.4 0.1 0.9 5.9 6.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 3.6 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.7 2.0 0.1 0.0 0.0 0.1 1.0 0.0 1.0 0.0 0.0 4.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.4 0.4 0.4 0.1 0.6 1.1 0.4 0.0 3.0 0.0 8.0 2.6 0.0 0.6 0.0 62.9 4.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.5 0.0 0.0 0.0 3.1 CD180 "LY64, Ly78, RP105" ENSG00000134061 "CD180 molecule" Q99467 5 67179613-67196799 "CD markers, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.2;lymphoid tissue: 38.7" "Cell type enhanced" "Detected in some" 20 "B-cells: 49.6;Hofbauer cells: 63.1;Kupffer cells: 16.8;monocytes: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 28.7;naive B-cell: 29.2" "Group enriched" "Detected in many" 23 "B-cells: 29.2;dendritic cells: 8.5;monocytes: 11.6" "Group enriched" "Detected in some" 10 "Daudi: 23.3;Karpas-707: 21.9;U-266/70: 17.8;U-266/84: 24.7;U-698: 6.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003740 Enhanced NA NA "HPA003740: AB_1078450" "unprognostic (9.33e-2)" "unprognostic (4.58e-2)" "unprognostic (2.81e-3)" "unprognostic (5.85e-3)" "unprognostic (2.25e-2)" "unprognostic (4.04e-3)" "unprognostic (1.09e-1)" "unprognostic (4.95e-2)" "unprognostic (5.83e-2)" "unprognostic (3.71e-1)" "unprognostic (2.16e-1)" "unprognostic (1.46e-1)" "unprognostic (2.09e-1)" "unprognostic (1.16e-1)" "unprognostic (3.70e-2)" "unprognostic (1.21e-1)" "unprognostic (2.18e-2)" 9.6 1.6 1.4 24.3 3.2 1.9 5.7 0.6 1.3 1.0 2.1 1.6 0.0 1.8 0.9 1.0 1.7 1.3 1.5 4.6 1.2 1.1 2.5 2.7 3.0 30.4 4.1 0.6 1.5 1.0 0.2 1.1 2.9 2.2 1.5 2.5 0.4 3.1 0.4 0.6 0.7 8.4 1.6 3.5 38.7 1.9 0.8 2.8 1.9 1.2 0.2 31.3 4.1 0.8 29.2 8.5 0.3 11.6 0.7 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.1 17.8 24.7 6.5 0.0 1.4 0.0 0.0 4.1 0.3 0.0 7.4 0.0 28.7 0.0 0.0 8.0 29.2 0.0 0.0 0.3 0.7 11.6 8.5 0.0 2.8 1.4 3.2 0.6 1.3 1.2 1.1 4.1 0.6 2.2 2.8 0.0 0.3 49.6 0.1 0.3 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 2.2 0.3 0.0 0.0 0.2 0.2 0.4 0.0 2.3 0.0 63.1 0.0 0.0 0.0 16.8 1.0 0.0 9.7 0.0 13.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.1 CD19 ENSG00000177455 "CD19 molecule" P15391 16 28931939-28939346 "CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 47.6;intestine: 16.7;lymphoid tissue: 40.3" "Cell type enriched" "Detected in some" 6 "B-cells: 94.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 93 "memory B-cell: 36.0;naive B-cell: 47.6" "Lineage enriched" "Detected in single" 106 "B-cells: 47.6" "Cell line enhanced" "Detected in some" "Daudi: 53.4;REH: 28.3;U-698: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB016110 Enhanced NA NA "CAB016110: AB_626952" "unprognostic (3.27e-3)" "unprognostic (1.19e-3)" "unprognostic (6.63e-2)" "unprognostic (1.09e-2)" "unprognostic (8.68e-3)" "unprognostic (3.11e-5)" "unprognostic (2.61e-1)" "unprognostic (6.96e-3)" "unprognostic (1.29e-2)" "unprognostic (4.29e-3)" "unprognostic (1.12e-1)" "unprognostic (1.30e-1)" "unprognostic (5.41e-6)" "unprognostic (2.06e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-1)" "unprognostic (2.07e-1)" 0.4 0.2 0.2 37.0 0.2 2.3 0.2 0.1 0.2 0.2 0.9 0.1 0.0 0.2 0.2 0.1 1.4 0.3 0.2 0.2 0.2 0.2 0.7 0.3 1.4 32.0 0.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.4 0.5 0.1 5.9 0.0 0.1 0.1 16.7 0.0 0.2 40.3 1.3 1.9 0.0 2.4 0.7 0.2 38.7 1.8 0.3 47.6 0.0 0.4 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 47.6 0.1 0.0 0.3 0.0 0.1 0.0 0.0 1.8 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 1.1 94.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.9 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.8 0.6 3.6 0.3 0.4 3.3 0.0 0.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 6.1 3.0 0.0 0.6 0.0 0.4 0.0 CD1A CD1 ENSG00000158477 "CD1a molecule" P06126 1 158254137-158258269 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 105.1" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 6.5;Kupffer cells: 1.6;Macrophages: 2.9;Melanocytes: 1.7;Suprabasal keratinocytes: 6.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "classical monocyte: 5.9;intermediate monocyte: 3.7;memory B-cell: 6.8;myeloid DC: 10.2;naive B-cell: 5.4" "Group enriched" "Detected in many" 35 "B-cells: 6.8;dendritic cells: 10.2;monocytes: 5.9" "Group enriched" "Detected in some" 86 "JURKAT: 21.2;MOLT-4: 33.8" "CAB000009, HPA010734" Enhanced NA NA "CAB000009: AB_2073290, HPA010734: AB_1078452" "unprognostic (7.21e-5)" "prognostic favorable (6.37e-4)" "unprognostic (1.37e-5)" "unprognostic (2.55e-2)" "unprognostic (2.83e-1)" "unprognostic (1.16e-2)" "unprognostic (9.93e-4)" "unprognostic (1.49e-2)" "unprognostic (3.12e-1)" "unprognostic (3.86e-2)" "unprognostic (6.99e-2)" "unprognostic (5.12e-2)" "unprognostic (5.49e-5)" "unprognostic (5.58e-2)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (8.81e-2)" 0.1 0.0 0.1 0.9 0.1 0.0 1.0 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.2 0.1 8.0 0.0 0.6 0.1 0.1 0.0 0.2 0.1 1.8 1.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.2 0.1 0.9 0.1 0.1 20.9 0.3 0.1 0.1 1.4 0.3 0.2 0.1 105.1 0.1 1.0 2.7 0.4 1.1 6.8 10.2 0.0 5.9 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.9 0.0 0.0 3.7 0.2 6.8 0.0 0.0 10.2 5.4 0.1 0.0 0.0 0.0 0.2 0.2 0.0 1.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.0 0.0 2.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.0 0.0 0.0 0.0 0.0 CD1B CD1 ENSG00000158485 "CD1b molecule" P29016 1 158327951-158331531 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 188.8" "Cell type enriched" "Detected in some" 6 "Macrophages: 17.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "myeloid DC: 16.3" "Lineage enriched" "Detected in many" 6 "dendritic cells: 16.3" "Cell line enriched" "Detected in some" 5 "MOLT-4: 112.0" HPA021824 Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" Cytosol "HPA021824: AB_1846262" "unprognostic (7.72e-3)" "unprognostic (1.55e-4)" "unprognostic (1.66e-5)" "unprognostic (1.04e-2)" "unprognostic (1.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.89e-4)" "unprognostic (2.27e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (9.53e-2)" "unprognostic (3.23e-1)" "unprognostic (3.52e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-1)" "unprognostic (3.53e-2)" 0.8 0.1 0.2 1.9 0.2 0.0 0.6 0.2 0.2 0.8 0.6 0.3 0.2 0.0 0.3 0.2 0.9 0.7 1.3 0.2 0.2 0.0 0.6 0.3 1.7 4.0 0.2 0.2 0.3 0.3 0.0 0.2 0.2 0.2 0.2 5.6 0.2 0.6 0.2 0.2 6.2 0.8 0.3 0.2 1.9 0.9 0.2 0.2 188.8 0.4 0.4 2.4 0.5 0.8 0.0 16.3 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.0 112.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.3 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.0 0.0 17.4 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 CD1C CD1 ENSG00000158481 "CD1c molecule" P29017 1 158289786-158293630 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 70.8;lymphoid tissue: 111.4" "Cell type enhanced" "Detected in some" 21 "B-cells: 37.2;Macrophages: 73.3;Melanocytes: 18.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 18.6;myeloid DC: 70.8" "Group enriched" "Detected in many" 8 "B-cells: 18.6;dendritic cells: 70.8" "Group enriched" "Detected in some" 9 "JURKAT: 11.0;MOLT-4: 34.8" NA NA 240000 "unprognostic (2.55e-3)" "prognostic favorable (1.79e-5)" "unprognostic (1.75e-5)" "unprognostic (3.09e-5)" "unprognostic (3.12e-2)" "unprognostic (8.13e-3)" "unprognostic (2.01e-1)" "unprognostic (3.80e-3)" "unprognostic (7.11e-3)" "unprognostic (1.87e-1)" "unprognostic (7.41e-2)" "unprognostic (1.93e-1)" "unprognostic (1.04e-1)" "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (8.05e-2)" "unprognostic (1.99e-1)" 1.8 0.4 0.5 8.2 0.6 0.0 2.2 0.5 0.5 1.1 1.2 0.5 1.3 0.4 1.4 1.2 1.8 1.6 5.1 0.6 0.5 0.3 1.6 1.5 2.8 13.2 0.6 0.5 0.7 0.7 0.0 0.6 0.7 0.6 1.0 4.8 0.9 3.0 1.0 0.6 5.5 11.7 1.3 0.5 24.6 1.2 0.8 0.5 111.4 1.0 2.4 20.5 1.4 1.3 18.6 70.8 0.2 5.9 0.9 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 34.8 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.6 0.0 0.1 5.9 0.0 0.0 5.1 0.0 18.6 0.0 0.0 70.8 9.3 0.0 0.0 0.2 0.9 0.6 0.3 0.1 3.3 0.5 0.6 0.5 0.5 0.5 0.3 0.6 0.5 0.6 0.5 0.0 6.9 37.2 0.0 11.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.1 2.3 0.0 3.5 0.0 4.0 0.0 0.0 0.0 5.9 3.3 0.0 73.3 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 6.5 0.0 0.0 0.0 0.0 CD1D ENSG00000158473 "CD1d molecule" P15813 1 158179947-158184896 "Cancer-related genes, CD markers, Predicted membrane proteins" "Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.5;lymphoid tissue: 17.8" "Cell type enhanced" "Detected in many" 15 "B-cells: 27.5;Kupffer cells: 52.9;Macrophages: 34.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 49.5;intermediate monocyte: 22.4;myeloid DC: 49.5" "Group enriched" "Detected in many" 8 "dendritic cells: 49.5;monocytes: 49.5" "Cell line enriched" "Detected in some" 4 "JURKAT: 45.7" "Low region specificity" "Detected in all" "CAB016107, HPA072662" Enhanced Supported "Endoplasmic reticulum" NA NA 720000 "Endoplasmic reticulum" "CAB016107: AB_626960, HPA072662: AB_2686545" "unprognostic (8.67e-2)" "unprognostic (6.99e-2)" "unprognostic (2.48e-1)" "unprognostic (1.48e-2)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (3.85e-1)" "unprognostic (9.67e-3)" "unprognostic (2.37e-1)" "unprognostic (3.52e-1)" "unprognostic (2.23e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (2.12e-5)" "unprognostic (9.31e-3)" "unprognostic (2.35e-1)" "unprognostic (2.32e-2)" "unprognostic (3.38e-1)" 1.5 1.2 0.0 8.6 0.0 2.6 1.2 0.0 0.0 0.8 2.5 9.5 1.5 0.0 0.4 1.4 2.0 1.4 0.0 0.1 1.6 10.5 2.3 5.5 0.2 0.3 0.7 0.0 0.6 0.0 1.4 3.7 0.7 0.3 0.6 0.0 12.2 2.2 0.4 17.8 1.4 1.4 1.8 3.4 1.6 0.5 6.3 49.5 2.5 49.5 0.1 0.1 23.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.0 2.9 0.0 5.5 0.0 0.0 0.0 0.1 0.0 0.0 8.5 0.1 0.0 3.2 0.4 0.0 0.6 0.0 0.0 45.7 0.0 0.0 0.0 0.0 11.2 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.3 0.0 3.1 0.4 0.0 49.5 0.1 0.0 22.4 0.1 6.3 0.0 0.0 49.5 4.7 0.0 0.0 2.5 0.1 3.6 0.5 0.0 23.5 0.0 5.1 27.5 0.4 0.2 0.4 0.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.5 1.2 2.2 0.0 0.0 0.1 0.2 0.0 1.1 5.3 11.3 1.6 2.4 4.3 52.9 0.9 0.0 34.3 0.0 10.0 2.0 0.3 0.0 3.7 0.0 0.0 0.1 0.0 0.5 0.5 0.9 0.1 0.1 0.0 3.9 0.0 CD1E ENSG00000158488 "CD1e molecule" P15812 1 158353696-158357553 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 308.0" "Cell type enriched" "Detected in some" 9 "Macrophages: 75.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 13 "myeloid DC: 29.7" "Lineage enriched" "Detected in many" 13 "dendritic cells: 29.7" "Cell line enriched" "Detected in some" 42 "MOLT-4: 171.9" "Not detected" "Not detected" HPA057769 Uncertain "Intracellular and membrane" NA NA "HPA057769: AB_2683522" "unprognostic (7.94e-3)" "unprognostic (1.85e-5)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.33e-1)" "unprognostic (1.54e-3)" "unprognostic (1.24e-1)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (8.55e-2)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (8.50e-2)" "unprognostic (2.45e-1)" 1.0 0.2 0.7 2.8 0.7 0.0 1.1 0.7 0.7 1.5 1.0 0.7 0.7 1.2 0.9 0.7 7.0 1.9 3.9 0.7 0.7 0.2 2.0 0.7 2.4 4.7 0.7 0.7 0.7 0.8 0.0 0.7 0.7 0.7 1.8 4.8 0.8 1.9 0.8 0.8 11.5 2.1 0.8 0.7 3.8 3.1 0.9 0.7 308.0 1.0 1.3 8.1 2.4 2.7 0.0 29.7 0.0 2.2 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 171.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.1 0.1 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.7 0.7 0.7 0.7 0.2 0.7 0.7 0.7 0.7 3.0 0.3 0.0 0.0 7.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 1.6 0.0 0.0 0.0 6.4 0.0 0.0 75.9 8.5 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 6.1 0.1 0.0 0.0 0.0 CD2 SRBC ENSG00000116824 "CD2 molecule" P06729 1 116754385-116769228 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 101.7;lymphoid tissue: 164.4" "Cell type enriched" "Detected in many" 11 "T-cells: 299.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "gdT-cell: 44.4;MAIT T-cell: 42.5;memory CD4 T-cell: 65.3;memory CD8 T-cell: 74.2;naive CD4 T-cell: 34.2;naive CD8 T-cell: 52.4;NK-cell: 101.7;T-reg: 62.3" "Group enriched" "Detected in many" 9 "NK-cells: 101.7;T-cells: 74.2" "Group enriched" "Detected in some" 24 "HDLM-2: 58.9;JURKAT: 39.9;MOLT-4: 43.3" "Region enhanced" "Detected in single" "basal ganglia: 0.3" "Low region specificity" "Detected in some" "CAB002430, HPA003883" Enhanced NA NA "CAB002430: AB_442057, HPA003883: AB_1846263" "prognostic favorable (4.36e-4)" "prognostic favorable (1.47e-4)" "unprognostic (3.34e-3)" "prognostic favorable (1.69e-5)" "unprognostic (1.52e-1)" "prognostic favorable (7.46e-5)" "unprognostic (9.32e-3)" "unprognostic (1.61e-2)" "prognostic favorable (3.97e-5)" "prognostic favorable (7.72e-4)" "unprognostic (4.18e-2)" "unprognostic (3.31e-1)" "prognostic unfavorable (4.82e-6)" "unprognostic (6.16e-2)" "unprognostic (6.61e-2)" "unprognostic (2.73e-2)" "unprognostic (7.63e-3)" 3.0 1.1 0.6 14.5 0.5 2.4 1.7 0.5 0.6 2.9 6.0 0.6 0.6 4.8 1.7 2.1 3.8 3.1 4.8 1.4 0.6 0.6 3.3 2.5 8.1 33.0 1.2 0.6 1.9 1.6 0.0 1.0 1.0 1.0 2.9 4.7 2.3 4.1 1.3 1.0 1.2 18.8 0.9 1.8 28.8 6.5 1.1 0.8 164.4 3.5 3.4 30.8 7.7 2.7 0.3 9.3 1.4 0.5 101.7 74.2 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.9 0.0 0.1 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 39.9 0.0 0.1 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.5 0.1 44.4 0.3 42.5 0.3 65.3 74.2 9.3 0.2 34.2 52.4 1.4 101.7 0.2 2.0 62.3 45.9 0.6 0.5 0.5 0.6 0.6 0.6 1.2 0.6 1.0 0.8 3.0 27.0 1.5 0.4 4.4 0.0 0.8 0.0 0.0 4.5 3.5 0.0 0.0 0.0 0.0 13.2 2.4 0.0 0.0 0.0 0.0 2.1 0.1 4.7 0.9 0.7 0.0 2.9 9.8 7.0 4.0 0.6 8.7 1.7 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 4.7 0.2 0.2 3.1 0.0 299.5 0.1 0.1 CD200 "MOX1, MOX2, MRC, OX-2" ENSG00000091972 "CD200 molecule" P41217 3 112332347-112362812 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 63.5" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 82.9;Intestinal endocrine cells: 36.9;Syncytiotrophoblasts: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "memory B-cell: 9.9;naive B-cell: 36.4" "Lineage enriched" "Detected in many" 25 "B-cells: 36.4" "Cell line enhanced" "Detected in some" "AF22: 31.9;HHSteC: 11.7;NTERA-2: 19.9;REH: 17.0;SH-SY5Y: 9.8;SK-MEL-30: 11.7;WM-115: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031149 Approved NA NA "HPA031149: AB_10600694" "unprognostic (1.84e-1)" "unprognostic (5.08e-2)" "unprognostic (1.79e-1)" "unprognostic (2.03e-3)" "unprognostic (4.97e-1)" "unprognostic (1.21e-2)" "unprognostic (9.29e-2)" "unprognostic (2.25e-2)" "unprognostic (3.06e-1)" "unprognostic (3.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "unprognostic (1.06e-2)" "unprognostic (2.80e-1)" "unprognostic (4.49e-2)" "unprognostic (1.22e-2)" 12.8 9.5 18.1 10.9 34.3 1.8 7.1 20.9 38.3 16.0 4.5 11.0 1.5 2.6 21.4 5.7 7.0 20.3 10.1 5.8 17.3 42.4 4.9 1.0 7.2 17.7 12.7 19.3 9.3 3.8 10.9 27.9 63.5 19.6 9.7 6.5 7.5 5.4 13.0 1.4 2.8 4.3 13.9 8.4 4.4 3.4 2.3 6.7 12.7 12.4 1.6 17.6 13.9 3.9 36.4 1.1 1.2 0.1 0.6 1.4 1.3 0.0 0.0 31.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.4 0.0 3.4 0.1 0.1 0.1 0.3 0.0 0.1 0.2 11.7 0.0 0.0 0.2 0.1 0.6 0.0 0.1 4.5 0.0 0.0 0.3 0.0 0.0 0.4 0.1 19.9 0.0 0.0 17.0 0.0 0.2 0.2 0.0 8.4 9.8 0.0 0.1 11.7 6.2 0.0 0.1 0.0 0.1 1.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 34.7 1.2 0.1 0.1 0.1 0.0 1.4 9.9 0.8 0.2 0.5 36.4 0.9 0.5 0.7 0.6 0.1 1.1 0.4 1.3 18.1 34.3 20.9 38.3 17.3 42.4 12.7 19.3 19.6 6.7 3.0 14.5 33.0 11.5 3.8 24.4 0.4 0.0 4.0 2.3 1.8 0.0 2.3 0.0 0.3 20.1 82.9 0.7 0.0 0.0 7.3 5.6 4.6 2.3 0.0 0.8 3.2 36.9 1.8 0.0 21.1 0.3 1.9 8.5 24.4 5.5 5.6 0.3 2.9 0.0 0.0 2.5 0.0 4.1 0.5 0.2 2.9 63.5 0.7 5.8 17.2 CD200R1 "CD200R, HCRTR2, MOX2R, OX2R" ENSG00000163606 "CD200 receptor 1" Q8TD46 3 112921209-112975122 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 46.7;lymphoid tissue: 21.2" "Cell type enhanced" "Detected in some" 11 "Erythroid cells: 23.3;granulocytes: 14.0;Hofbauer cells: 24.1;Ito cells: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 46.7;eosinophil: 12.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 46.7" "Cell line enriched" "Detected in some" 8 "HEL: 25.6" HPA068512 Supported "Plasma membrane" "Intracellular and membrane" NA NA 1500000 "Plasma membrane" "HPA068512: AB_2732784" "unprognostic (1.49e-2)" "unprognostic (1.06e-2)" "unprognostic (2.55e-1)" "unprognostic (1.97e-2)" "unprognostic (1.53e-1)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.06e-3)" "unprognostic (8.30e-2)" "unprognostic (1.85e-1)" "unprognostic (7.98e-2)" "unprognostic (2.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.77e-1)" "unprognostic (7.84e-3)" "unprognostic (1.25e-1)" "unprognostic (5.12e-3)" 3.6 1.6 1.0 9.5 1.4 1.8 3.8 0.8 1.4 5.0 3.5 0.3 1.5 2.0 3.9 5.4 7.5 1.3 2.7 5.8 1.0 1.2 1.4 3.4 4.3 9.0 1.0 0.0 1.0 1.1 0.5 1.0 7.8 0.4 4.2 3.5 2.4 2.5 1.6 0.9 3.4 3.3 1.7 0.9 21.2 1.7 2.5 0.5 15.8 2.0 3.9 17.0 3.8 2.0 2.3 5.8 46.7 0.8 0.6 3.7 1.3 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 25.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 1.2 0.0 46.7 0.8 12.7 1.0 0.4 1.8 2.3 3.7 2.1 5.8 1.2 3.6 1.7 0.2 0.6 0.1 0.1 1.0 1.3 1.0 1.4 0.8 1.4 1.0 1.2 1.0 0.0 0.4 0.5 0.0 1.4 2.9 0.1 1.6 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 23.3 0.0 0.1 1.3 0.0 14.0 0.0 24.1 0.0 0.0 19.6 4.7 0.0 0.0 3.6 5.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.6 0.6 7.5 0.0 0.1 CD200R1L "CD200R2, CD200RLa" ENSG00000206531 "CD200 receptor 1 like" Q6Q8B3 3 112815709-112846856 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 85 "blood: 31.3;testis: 7.8" "Group enriched" "Detected in some" 28 "Early spermatids: 13.7;Late spermatids: 33.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 304 "basophil: 31.3" "Lineage enriched" "Detected in single" 313 "granulocytes: 31.3" "Cell line enhanced" "Detected in some" "A-431: 4.0;CACO-2: 3.6;CAPAN-2: 1.3;RPMI-8226: 1.9" NA NA "unprognostic (3.80e-1)" "unprognostic (1.88e-1)" "unprognostic (2.37e-2)" "unprognostic (1.55e-1)" "unprognostic (1.16e-2)" "unprognostic (1.78e-1)" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.8 0.0 0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.3 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.9 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 31.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 33.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CD207 "CLEC4K, Langerin" ENSG00000116031 "CD207 molecule" Q9UJ71 2 70830214-70835822 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.5;skin 1: 42.3" "Cell type enhanced" "Detected in some" 14 "Basal keratinocytes: 3.5;Macrophages: 1.5;Melanocytes: 5.0;monocytes: 2.8;Suprabasal keratinocytes: 4.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "myeloid DC: 4.0" "Lineage enriched" "Detected in single" 18 "dendritic cells: 4.0" "Cell line enriched" "Detected in some" 4 "AN3-CA: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002222, HPA011216" Enhanced Uncertain Cytosol No NA Cytosol "CAB002222: AB_563850, HPA011216: AB_1078453" "unprognostic (1.45e-2)" "unprognostic (8.28e-3)" "unprognostic (9.34e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "unprognostic (2.23e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-3)" "unprognostic (1.05e-1)" "unprognostic (4.86e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-1)" "unprognostic (7.92e-4)" "unprognostic (2.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" 0.5 0.1 0.1 1.8 0.1 0.0 1.4 0.1 0.1 2.4 1.7 0.1 0.1 1.6 1.1 0.4 9.7 0.3 2.9 0.3 0.1 0.1 0.2 0.9 3.7 0.2 0.1 0.1 0.2 0.2 0.0 1.1 0.1 0.1 1.0 1.1 0.4 1.2 0.2 0.1 42.3 2.6 0.1 0.1 1.5 0.4 0.4 0.1 3.3 0.2 11.3 16.5 0.3 1.9 0.0 4.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 14.1 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 1.9 0.0 0.0 0.0 0.3 2.5 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 CD22 "SIGLEC-2, SIGLEC2" ENSG00000012124 "CD22 molecule" P20273 19 35319261-35347355 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 39.3;lymphoid tissue: 77.8;ovary: 35.4" "Group enriched" "Detected in some" 12 "B-cells: 68.1;granulocytes: 94.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 25 "memory B-cell: 29.8;naive B-cell: 39.3" "Lineage enriched" "Detected in many" 28 "B-cells: 39.3" "Cell line enhanced" "Detected in some" "Daudi: 69.8;REH: 20.6;U-698: 55.5;WM-115: 12.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB002418, HPA024353" Enhanced NA NA "CAB002418: AB_563529, HPA024353: AB_10600695" "unprognostic (2.80e-3)" "unprognostic (3.99e-2)" "unprognostic (6.79e-3)" "unprognostic (9.17e-2)" "unprognostic (3.07e-1)" "unprognostic (6.45e-3)" "unprognostic (3.79e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (2.47e-1)" "unprognostic (1.75e-3)" "unprognostic (1.98e-2)" "unprognostic (1.48e-2)" "unprognostic (9.05e-2)" "unprognostic (3.04e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" 2.1 1.0 5.5 57.9 6.8 3.1 0.5 0.7 3.2 1.4 1.0 0.9 0.5 0.4 1.4 0.9 4.4 7.9 2.9 0.8 9.9 4.2 1.4 0.6 5.5 52.6 9.8 0.5 35.4 0.5 0.0 0.7 1.0 0.9 2.8 1.5 1.1 5.9 1.1 0.5 0.0 11.6 2.0 13.5 64.1 1.4 1.2 0.6 5.0 1.1 2.3 77.8 4.3 0.9 39.3 1.3 0.3 0.3 0.0 0.0 1.4 0.2 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 1.3 69.8 1.4 0.0 3.9 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 3.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.1 20.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.1 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 55.5 0.5 0.2 12.7 0.0 0.0 0.0 0.0 0.3 0.0 29.8 0.0 0.0 1.3 39.3 0.0 0.0 0.3 0.0 0.2 1.1 0.0 1.4 5.5 6.8 0.7 3.2 9.9 4.2 9.8 0.5 0.9 0.6 3.0 4.8 68.1 0.4 0.2 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.4 0.6 0.4 94.6 0.0 7.0 0.0 0.0 1.8 6.4 0.0 3.4 2.3 1.7 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.9 0.4 0.1 0.5 0.0 0.0 CD226 "DNAM-1, DNAM1, PTA1, TLiSA1" ENSG00000150637 "CD226 molecule" Q15762 18 69831158-69961803 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.9;parathyroid gland: 82.5" "Cell type enhanced" "Detected in many" 10 "granulocytes: 12.8;Kupffer cells: 11.2;monocytes: 21.6;T-cells: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 19.4;MAIT T-cell: 7.3;memory CD4 T-cell: 16.1;memory CD8 T-cell: 11.8;naive CD4 T-cell: 9.0;naive CD8 T-cell: 9.7;NK-cell: 14.0;T-reg: 5.5" "Group enriched" "Detected in many" 11 "NK-cells: 14.0;T-cells: 19.4" "Group enriched" "Detected in some" 6 "HEL: 45.3;HMC-1: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA015715, HPA015865" Supported Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" NA No 27000000 "Plasma membrane" "Nucleoplasm, Centriolar satellite" "HPA015715: AB_1846278, HPA015865: " "unprognostic (1.42e-4)" "unprognostic (1.30e-3)" "unprognostic (9.01e-3)" "unprognostic (3.49e-5)" "unprognostic (4.15e-1)" "unprognostic (9.52e-4)" "unprognostic (3.68e-3)" "unprognostic (2.93e-2)" "unprognostic (3.43e-1)" "unprognostic (3.31e-3)" "unprognostic (8.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (2.27e-1)" "unprognostic (3.58e-2)" 1.2 0.6 1.0 7.5 2.0 1.7 0.8 0.7 0.9 1.5 2.9 0.3 0.1 1.1 1.0 1.4 0.8 0.8 1.4 0.9 1.9 1.3 1.3 3.1 5.2 14.0 1.7 0.0 1.0 0.6 82.5 2.4 0.6 1.3 0.9 1.2 2.4 5.4 0.6 1.1 0.4 6.0 1.3 4.2 31.9 1.4 1.8 0.5 6.4 1.8 2.6 10.1 2.0 1.6 0.4 1.5 0.9 0.6 14.0 19.4 6.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 2.4 0.0 45.3 0.1 0.0 0.0 0.3 20.2 0.0 0.5 0.1 0.3 0.0 0.0 0.4 0.1 4.7 0.2 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.1 5.5 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.5 19.4 0.4 7.3 0.4 16.1 11.8 1.5 0.1 9.0 9.7 0.9 14.0 0.6 0.1 5.5 6.6 1.0 2.0 0.7 0.9 1.9 1.3 1.7 0.0 1.3 0.5 3.0 5.1 0.8 0.3 0.0 2.4 1.6 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 6.6 0.1 0.0 0.0 0.3 0.0 0.4 0.2 12.8 0.5 1.4 0.0 0.0 2.5 11.2 7.5 0.9 7.8 0.0 21.6 0.0 1.4 0.2 0.0 0.7 0.0 3.7 0.0 0.3 0.3 0.5 0.4 0.0 25.4 0.0 0.1 CD24 CD24A ENSG00000272398 "CD24 molecule" 6 106969831-106975627 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "kidney: 383.7" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 1347.9;Exocrine glandular cells: 3019.5;Pancreatic endocrine cells: 1516.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 26 "eosinophil: 30.4;memory B-cell: 23.4;naive B-cell: 15.0" "Group enriched" "Detected in many" 202 "B-cells: 23.4;granulocytes: 30.4" "Cell line enhanced" "Detected in many" "NTERA-2: 66.4;RPTEC TERT1: 313.7;SK-BR-3: 91.2" "HPA045879, CAB078471" Approved Enhanced Vesicles "Intracellular and membrane" NA NA Vesicles "CAB078471: AB_10983158, HPA045879: AB_2732523" "prognostic unfavorable (2.44e-5)" "unprognostic (6.64e-2)" "prognostic favorable (3.29e-4)" "unprognostic (1.87e-1)" "unprognostic (1.41e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (7.58e-4)" "unprognostic (2.32e-1)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (2.28e-2)" "unprognostic (1.51e-1)" "unprognostic (5.10e-2)" "unprognostic (2.92e-1)" "unprognostic (1.16e-1)" "unprognostic (2.01e-1)" "unprognostic (3.13e-1)" 0.5 0.5 12.8 2.4 9.9 17.9 25.5 0.5 2.9 69.5 30.6 0.7 1.6 1.2 34.5 5.9 38.1 6.0 25.1 4.2 22.7 383.7 0.8 0.7 0.9 4.8 7.2 15.6 40.0 0.0 5.7 48.2 13.0 3.2 21.2 0.7 15.9 16.6 0.4 0.5 0.8 2.2 4.9 0.7 16.4 0.5 6.5 0.4 48.8 1.2 11.3 4.0 8.1 23.4 0.0 30.4 0.1 0.0 0.0 0.6 23.4 14.5 0.2 1.9 0.0 0.0 27.5 0.0 0.1 0.1 0.0 0.2 0.1 2.3 7.2 0.0 1.0 48.5 8.2 18.3 0.1 0.0 0.1 0.0 17.9 1.0 0.0 0.3 0.1 0.1 21.1 0.2 1.2 1.1 0.1 0.0 0.5 0.0 0.4 29.4 0.1 0.1 66.4 52.2 5.6 54.8 0.0 0.2 313.7 60.5 41.1 30.3 16.6 91.2 0.0 31.1 42.1 0.1 0.0 0.0 0.2 0.2 0.7 0.0 0.1 31.0 0.3 0.1 0.1 0.1 0.0 30.4 0.0 0.0 0.0 23.4 0.0 0.0 0.0 15.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.6 145.9 106.6 139.4 57.2 0.0 6.5 1.1 1003.8 691.9 180.9 1235.3 2.0 679.9 1347.9 1087.4 21.0 2.3 819.9 0.0 3019.5 709.4 9.3 444.2 10.4 3.8 61.3 0.0 552.5 53.4 8.9 32.3 9.5 11.8 0.0 55.9 391.5 1.1 1516.5 703.5 2.1 408.2 0.5 6.5 0.4 0.5 4.9 0.0 466.9 12.5 734.9 281.9 CD244 "2B4, NAIL, NKR2B4, Nmrk, SLAMF4" ENSG00000122223 "CD244 molecule" Q9BZW8 1 160830160-160862855 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 75.8;lymphoid tissue: 22.1" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 9.6;Kupffer cells: 15.1;T-cells: 19.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "basophil: 75.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 75.8" "Cell line enhanced" "Detected in some" "HEL: 10.9;HMC-1: 38.3;NB-4: 7.5;U-937: 15.3" "Not detected" "Not detected" NA NA "unprognostic (6.11e-3)" "unprognostic (1.54e-2)" "unprognostic (1.85e-2)" "unprognostic (6.95e-6)" "unprognostic (5.79e-2)" "unprognostic (1.43e-4)" "unprognostic (1.93e-2)" "unprognostic (7.36e-2)" "unprognostic (3.36e-1)" "unprognostic (2.85e-1)" "unprognostic (1.60e-1)" "unprognostic (2.32e-1)" "unprognostic (5.40e-4)" "unprognostic (1.71e-1)" "unprognostic (1.51e-1)" "unprognostic (1.87e-1)" "unprognostic (1.79e-1)" 2.9 0.4 0.5 3.3 0.5 8.6 0.6 0.3 0.7 0.9 3.1 0.4 1.6 2.8 1.4 0.7 1.0 0.7 1.7 2.0 0.5 0.5 0.7 4.1 5.3 7.4 1.7 0.0 1.6 0.5 0.0 0.5 1.8 1.1 1.6 1.2 1.0 1.6 0.9 1.1 0.5 6.0 2.6 1.5 22.1 0.8 2.8 0.6 0.7 0.6 0.0 4.0 1.5 0.8 0.0 7.9 75.8 13.2 14.0 14.8 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.2 3.5 38.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 15.3 0.0 75.8 8.2 20.1 14.8 11.2 7.3 0.0 0.8 8.1 7.9 0.0 1.1 7.8 0.6 14.0 13.2 0.4 0.0 11.3 0.5 0.5 0.3 0.7 0.5 0.5 1.7 0.0 1.1 0.6 3.0 9.6 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 1.6 0.0 0.2 0.0 3.5 0.0 0.6 0.0 0.0 0.0 15.1 1.9 1.7 3.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.8 0.0 0.0 CD247 "CD3H, CD3Q, CD3Z" ENSG00000198821 "CD247 molecule" P20963 1 167430640-167518610 "CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 62.8;lymphoid tissue: 129.5" "Cell type enriched" "Detected in many" 10 "T-cells: 248.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 26 "gdT-cell: 62.8;MAIT T-cell: 35.4;memory CD4 T-cell: 32.4;memory CD8 T-cell: 36.7;naive CD4 T-cell: 41.3;naive CD8 T-cell: 33.5;NK-cell: 33.4;T-reg: 39.0" "Group enriched" "Detected in many" 31 "NK-cells: 33.4;T-cells: 62.8" "Group enriched" "Detected in some" 25 "HDLM-2: 46.4;JURKAT: 34.6;MOLT-4: 48.9" "Region enhanced" "Detected in single" "thalamus: 0.7" "Low region specificity" "Detected in all" "CAB004651, HPA008750" Enhanced NA NA "CAB004651: AB_425347, HPA008750: AB_1857863" "prognostic favorable (9.12e-4)" "unprognostic (3.21e-3)" "unprognostic (7.09e-3)" "prognostic favorable (8.63e-6)" "unprognostic (1.99e-2)" "prognostic favorable (3.98e-4)" "unprognostic (1.79e-2)" "unprognostic (1.11e-2)" "unprognostic (5.46e-3)" "unprognostic (9.73e-3)" "unprognostic (1.33e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (9.94e-6)" "unprognostic (1.60e-1)" "unprognostic (5.33e-2)" "unprognostic (4.02e-2)" "unprognostic (5.94e-3)" 2.3 0.5 0.9 13.5 2.1 17.8 1.3 1.2 1.1 1.4 4.4 0.7 0.7 2.9 1.5 1.6 1.4 1.2 2.9 1.0 0.8 1.4 1.9 3.2 7.3 24.3 1.0 0.5 1.0 0.5 0.0 0.6 1.3 0.7 2.0 1.8 1.7 3.3 0.4 1.4 0.6 9.8 0.8 0.9 28.6 2.7 0.9 0.5 129.5 1.8 0.9 18.1 3.5 1.4 1.5 0.4 1.4 0.2 33.4 62.8 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.1 0.0 62.8 0.2 35.4 1.5 32.4 36.7 0.2 0.5 41.3 33.5 1.4 33.4 0.1 0.4 39.0 31.4 0.9 2.1 1.2 1.1 0.8 1.4 1.0 0.5 0.7 0.5 3.0 26.0 2.2 0.1 1.3 0.2 0.4 2.5 4.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.1 0.7 0.1 5.8 0.6 0.3 3.2 0.0 5.5 5.9 0.0 0.0 1.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.1 1.5 0.5 0.1 248.3 0.0 0.0 CD248 "CD164L1, TEM1" ENSG00000174807 "CD248 molecule" Q9HCU0 11 66314487-66317044 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.0" "Cell type enhanced" "Detected in many" 14 "Fibroblasts: 70.0;Leydig cells: 69.3;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "naive CD8 T-cell: 17.8" "Lineage enriched" "Detected in single" 122 "T-cells: 17.8" "Cell line enhanced" "Detected in some" "ASC diff: 68.1;ASC TERT1: 67.2;BJ: 29.4;BJ hTERT+: 44.3;fHDF/TERT166: 59.3;HSkMC: 71.6;U-2197: 107.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA051856 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 27000000 "Plasma membrane" Nucleoplasm "HPA051856: AB_2681640" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.95e-2)" "unprognostic (2.77e-2)" "unprognostic (1.14e-2)" "unprognostic (2.61e-1)" "unprognostic (7.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-2)" "unprognostic (6.31e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (2.69e-7)" "unprognostic (1.90e-2)" "unprognostic (2.92e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-2)" 59.2 3.5 0.8 14.4 2.5 0.0 55.2 0.6 2.2 21.2 7.6 1.9 6.3 2.7 14.1 22.9 14.8 17.7 12.3 18.2 1.2 0.5 5.3 1.7 9.3 16.2 1.3 1.6 15.6 4.9 1.4 2.3 71.0 2.1 10.6 2.7 11.5 4.6 8.0 6.7 13.3 7.5 27.6 1.2 1.9 7.5 8.0 0.7 4.1 9.4 6.6 4.5 19.5 17.6 0.1 0.0 0.0 0.0 0.0 17.8 1.9 0.0 0.0 0.6 0.0 68.1 67.2 0.0 29.4 44.3 2.2 2.0 0.0 0.0 0.0 0.7 59.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 13.5 0.0 0.0 71.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.1 107.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.3 0.0 0.1 2.8 17.8 0.0 0.0 0.0 0.0 0.0 1.9 0.8 2.5 0.6 2.2 1.2 0.5 1.3 1.6 2.1 0.7 0.0 0.0 0.0 0.0 11.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.3 2.5 0.0 0.0 0.0 2.5 70.0 0.0 0.0 0.0 5.5 0.0 0.0 4.3 0.0 0.4 69.3 0.0 11.8 1.0 0.0 3.6 0.4 0.0 19.1 0.0 0.0 32.3 12.2 0.1 0.0 7.2 3.7 0.0 0.0 0.0 CD27 "S152, TNFRSF7, Tp55" ENSG00000139193 "CD27 molecule" P26842 12 6444867-6451718 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 82.3;lymphoid tissue: 60.4" "Group enriched" "Detected in some" 10 "B-cells: 95.4;Erythroid cells: 70.0;Melanocytes: 92.8;T-cells: 73.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 82.3" "Group enriched" "Detected in many" 7 "B-cells: 41.8;T-cells: 82.3" "Group enriched" "Detected in some" 141 "Daudi: 65.2;U-698: 36.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB002420, HPA038936" Enhanced NA NA 28000 "CAB002420: AB_563539, HPA038936: AB_2676278" "unprognostic (2.75e-3)" "prognostic favorable (3.77e-5)" "unprognostic (8.87e-3)" "prognostic favorable (2.90e-4)" "unprognostic (2.35e-1)" "prognostic favorable (6.65e-7)" "unprognostic (3.56e-2)" "unprognostic (9.37e-2)" "prognostic favorable (5.50e-4)" "unprognostic (1.31e-3)" "unprognostic (4.32e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (1.19e-6)" "unprognostic (2.80e-1)" "unprognostic (3.15e-1)" "unprognostic (1.28e-1)" "unprognostic (7.35e-2)" 1.1 0.6 0.4 40.8 0.5 2.0 1.2 0.4 0.4 1.7 10.0 0.2 0.5 5.3 0.8 0.6 4.9 1.6 3.7 0.9 0.4 0.4 1.7 1.0 2.9 49.5 0.4 0.1 1.0 0.5 0.0 0.6 0.4 0.2 1.3 2.9 1.2 10.7 1.4 0.4 0.6 19.4 0.2 0.6 45.7 3.7 0.5 0.1 33.5 3.1 2.3 60.4 9.1 1.2 41.8 0.3 0.8 0.1 8.3 82.3 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.8 0.1 0.1 16.7 0.1 28.7 41.8 40.1 37.5 0.1 10.5 55.6 39.1 0.8 8.3 0.1 0.3 82.3 22.1 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.1 0.2 0.1 0.0 8.2 95.4 0.1 2.1 1.0 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 70.0 0.0 0.0 1.9 0.2 1.1 1.0 0.2 0.0 1.2 1.3 2.5 0.0 0.3 0.2 92.8 0.0 0.0 0.3 0.0 0.0 0.4 0.4 1.3 0.0 0.2 0.1 0.0 2.8 0.2 73.4 0.0 0.0 CD274 "B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1" ENSG00000120217 "CD274 molecule" Q9NZQ7 9 5450503-5470566 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 23.9;placenta: 56.0" "Cell type enhanced" "Detected in many" 14 "granulocytes: 26.7;monocytes: 73.9;Syncytiotrophoblasts: 37.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.4" "Group enriched" "Detected in many" 6 "granulocytes: 8.4;T-cells: 2.4" "Cell line enhanced" "Detected in many" "HDLM-2: 34.2;HHSteC: 22.8;U-251 MG: 37.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003528, CAB076385" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" Nucleoplasm "CAB076385: AB_2687655, HPA003528: " "prognostic favorable (8.89e-4)" "unprognostic (4.54e-2)" "prognostic favorable (1.64e-5)" "unprognostic (1.27e-2)" "unprognostic (2.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.61e-2)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (5.67e-4)" "unprognostic (7.39e-3)" "unprognostic (1.69e-2)" "unprognostic (1.24e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-2)" "unprognostic (2.67e-1)" "unprognostic (9.02e-2)" 3.4 2.1 1.7 10.8 3.2 1.4 2.2 2.5 3.3 2.0 2.3 2.5 2.8 2.6 1.7 2.4 3.0 1.9 4.3 9.5 1.4 3.7 3.0 3.6 23.9 6.4 2.3 0.7 1.7 2.7 3.8 7.4 56.0 3.2 2.9 2.2 3.3 1.7 1.6 4.3 1.3 2.7 2.3 2.4 12.8 1.9 1.2 1.0 11.6 3.7 2.1 5.8 3.1 1.9 0.9 0.0 8.4 0.1 0.4 2.4 0.7 5.9 0.1 0.0 0.2 0.0 0.0 0.0 11.9 10.1 3.0 4.2 0.0 1.9 0.0 0.2 0.3 1.5 0.2 0.0 5.2 9.9 34.2 0.0 3.4 0.1 0.0 22.8 0.0 0.0 0.2 0.0 6.3 9.3 3.1 5.9 0.3 0.0 1.1 9.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.3 0.6 0.1 0.0 0.1 0.1 0.9 0.7 0.9 0.0 0.1 10.9 6.5 2.0 0.2 37.9 0.2 0.1 0.1 2.1 0.1 0.0 8.4 0.1 0.3 1.2 0.1 2.1 0.9 2.4 1.8 0.0 0.2 1.3 0.7 5.7 0.4 0.0 0.0 1.1 0.7 1.7 3.2 2.5 3.3 1.4 3.7 2.3 0.7 3.2 1.0 11.9 10.7 0.5 1.2 4.0 1.4 6.5 0.0 4.0 3.4 0.0 0.0 4.9 0.0 6.4 0.2 6.3 0.8 0.0 3.7 20.2 1.9 0.9 26.7 1.0 4.9 0.0 0.0 10.4 1.9 0.0 0.3 7.7 3.3 73.9 0.1 0.6 12.0 0.0 0.4 0.4 0.1 0.0 0.9 0.5 0.7 2.3 37.2 1.3 0.2 2.2 CD276 "B7-H3, B7H3, B7RP-2" ENSG00000103855 "CD276 molecule" Q5ZPR3 15 73683966-73714518 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 186.5;Hofbauer cells: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 4.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.0" "Cell line enhanced" "Detected in many" "HaCaT: 42.2;U-2197: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009285, HPA017139, CAB017826" Enhanced Approved Vesicles NA NA 8900000 Vesicles "CAB017826: , HPA009285: AB_1078258, HPA017139: AB_1845246" "unprognostic (1.05e-1)" "unprognostic (4.74e-3)" "unprognostic (4.57e-3)" "unprognostic (9.62e-2)" "unprognostic (1.26e-2)" "unprognostic (5.50e-3)" "prognostic unfavorable (9.81e-4)" "unprognostic (2.57e-3)" "unprognostic (1.89e-1)" "unprognostic (3.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.29e-2)" "prognostic unfavorable (6.31e-5)" "unprognostic (1.17e-1)" "unprognostic (9.22e-2)" "unprognostic (1.21e-1)" "unprognostic (1.34e-3)" 32.3 16.6 5.8 9.2 3.9 0.6 17.1 3.6 5.3 19.4 8.3 5.1 4.2 8.8 17.2 17.9 6.3 8.1 14.3 12.3 5.6 3.6 7.2 22.9 9.3 6.7 4.6 3.8 16.8 14.3 3.5 5.3 27.7 7.9 16.5 4.2 20.5 12.8 7.8 7.1 12.6 7.0 13.8 4.4 7.4 8.4 9.9 3.9 1.2 7.8 8.3 4.7 12.4 13.6 0.4 0.5 4.0 0.6 0.8 0.2 0.0 9.8 12.2 8.4 18.4 15.4 9.3 25.7 11.5 9.5 7.6 6.9 21.5 20.7 0.1 18.8 10.9 14.6 42.2 9.0 10.3 1.3 7.5 20.4 0.8 12.8 10.3 4.7 0.2 12.3 7.4 5.0 6.9 4.5 5.3 10.0 0.0 3.2 0.2 1.7 15.3 0.1 0.5 20.4 1.9 8.9 0.1 12.3 1.6 6.6 13.7 5.8 14.0 10.7 5.3 20.8 7.1 8.8 5.3 11.5 16.8 15.1 55.2 11.6 0.2 0.2 0.2 27.9 0.9 11.5 0.9 0.3 0.5 0.1 0.6 0.2 0.2 0.1 0.2 0.2 0.4 0.2 0.1 4.0 0.8 0.3 0.5 0.1 0.0 5.8 3.9 3.6 5.2 5.6 3.6 4.6 3.8 7.9 3.9 17.9 7.2 0.5 9.2 13.4 21.2 7.0 5.1 5.3 18.2 10.4 29.5 8.8 1.7 42.7 0.7 8.9 4.0 0.0 16.3 186.5 42.4 15.5 14.9 13.9 70.5 9.5 8.6 5.5 5.8 0.7 9.2 20.9 23.6 7.2 12.1 8.9 22.2 17.3 16.3 2.4 27.5 12.9 41.2 1.2 2.8 8.9 10.3 0.5 8.7 6.5 CD28 ENSG00000178562 "CD28 molecule" P10747 2 203706475-203738912 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.7;lymphoid tissue: 48.6" "Group enriched" "Detected in some" 8 "Hofbauer cells: 25.7;T-cells: 16.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 32.7" "Lineage enriched" "Detected in many" 6 "T-cells: 32.7" "Group enriched" "Detected in some" 14 "Karpas-707: 73.8;RPMI-8226: 33.8;U-266/70: 60.7;U-266/84: 54.2" "Region enhanced" "Detected in single" "olfactory region: 1.3" "Low region specificity" "Detected in all" HPA070003 Enhanced NA NA "HPA070003: AB_2686226" "unprognostic (5.54e-2)" "unprognostic (2.16e-4)" "unprognostic (1.90e-3)" "unprognostic (2.49e-3)" "unprognostic (3.44e-2)" "unprognostic (6.07e-5)" "unprognostic (9.09e-2)" "unprognostic (4.66e-2)" "unprognostic (3.40e-1)" "unprognostic (1.15e-1)" "unprognostic (2.65e-1)" "unprognostic (1.68e-1)" "unprognostic (5.78e-5)" "unprognostic (4.77e-2)" "unprognostic (2.93e-2)" "unprognostic (7.79e-2)" "unprognostic (8.96e-2)" 5.1 0.6 0.4 14.2 0.5 1.9 3.3 0.3 0.4 1.1 1.6 0.4 0.2 0.6 1.1 2.3 1.5 2.1 3.0 4.5 0.4 0.5 1.7 1.5 3.8 23.3 0.5 0.2 1.4 0.6 0.0 0.6 11.0 0.2 1.2 1.3 1.2 3.1 0.8 0.7 1.0 7.2 0.9 0.8 9.0 1.6 0.9 0.0 48.6 1.5 0.8 29.9 4.5 1.4 0.1 0.0 5.1 0.2 0.0 32.7 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 73.8 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 54.2 0.5 0.0 0.0 0.0 0.5 0.2 0.3 3.0 0.1 18.2 0.1 19.4 9.5 0.0 0.1 17.0 6.5 5.1 0.0 0.1 0.0 32.7 4.7 0.4 0.5 0.3 0.4 0.4 0.5 0.5 0.2 0.2 0.0 0.0 2.2 2.2 0.0 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.8 0.0 1.1 0.0 25.7 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 16.6 0.0 0.0 CD300A "CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60" ENSG00000167851 "CD300a molecule" Q9UGN4 17 74466416-74484796 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 81.1;brain: 28.7;lymphoid tissue: 57.8" "Group enriched" "Detected in some" 4 "granulocytes: 57.8;Hofbauer cells: 101.1;Kupffer cells: 71.3;Macrophages: 86.9;T-cells: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 42.2;NB-4: 17.2;RPMI-8226: 33.2" "HPA010971, HPA011645" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 2800000 "Plasma membrane" "Vesicles, Cytosol" "HPA010971: , HPA011645: AB_1846988" "unprognostic (1.99e-1)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.01e-1)" "unprognostic (1.04e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.17e-2)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (5.97e-2)" "unprognostic (5.45e-3)" "unprognostic (1.36e-1)" "unprognostic (5.72e-2)" 8.6 4.5 9.8 16.0 17.7 11.9 4.4 2.2 11.5 2.0 4.8 3.7 0.0 6.0 1.9 1.3 2.1 2.1 7.7 3.4 7.3 4.2 3.0 7.5 10.6 19.0 20.1 0.3 1.5 2.1 0.3 3.0 6.9 12.6 2.8 4.7 2.3 3.0 1.3 1.1 2.3 7.4 6.0 28.7 57.8 2.4 1.5 17.4 4.1 1.9 0.5 6.0 5.4 2.1 2.2 19.4 81.1 45.7 52.1 29.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 2.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.5 17.2 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 81.1 20.4 57.3 29.5 45.7 6.2 2.2 6.1 8.7 19.4 0.6 2.3 7.1 71.6 52.1 44.2 18.1 0.3 19.2 9.8 17.7 2.2 11.5 7.3 4.2 20.1 0.3 12.6 17.4 0.0 11.9 15.7 0.0 0.8 0.0 0.4 2.5 0.0 1.2 0.0 0.0 0.7 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.0 0.5 0.1 57.8 0.8 101.1 0.0 0.0 3.1 71.3 0.0 0.0 86.9 3.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.5 0.5 1.3 25.9 0.0 0.1 CD300C "CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR" ENSG00000167850 "CD300c molecule" Q08708 17 74541108-74546143 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 46.8" "Group enriched" "Detected in some" 12 "granulocytes: 15.0;Hofbauer cells: 29.5;Kupffer cells: 28.1;Macrophages: 33.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 28.6;intermediate monocyte: 46.8;myeloid DC: 32.5;non-classical monocyte: 46.4" "Group enriched" "Detected in many" 5 "dendritic cells: 32.5;monocytes: 46.8" "Cell line enhanced" "Detected in some" "HEL: 5.3;HMC-1: 26.2;THP-1: 4.9;U-937: 12.4" "HPA014523, HPA060349" Approved Uncertain "Golgi apparatus,Vesicles,Mitochondria" NA NA "Golgi apparatus" "Vesicles, Mitochondria" "HPA014523: AB_1846293, HPA060349: " "unprognostic (1.55e-2)" "unprognostic (2.60e-1)" "unprognostic (9.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.21e-1)" "unprognostic (3.47e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.68e-2)" "unprognostic (7.51e-2)" "unprognostic (6.51e-2)" "unprognostic (1.50e-2)" "unprognostic (1.37e-3)" "unprognostic (6.27e-2)" "prognostic unfavorable (8.53e-5)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" 9.8 2.8 3.6 9.0 4.6 10.9 1.8 0.4 2.9 1.2 1.7 2.9 0.0 1.5 1.4 1.9 1.0 1.9 2.8 3.4 2.0 1.7 1.9 2.1 11.2 12.3 5.3 1.3 1.1 1.3 0.5 1.2 3.8 3.9 1.9 1.8 1.8 1.8 0.7 1.1 0.9 2.3 4.1 7.1 14.2 1.6 0.9 2.7 0.1 1.6 0.1 1.4 3.5 1.1 0.4 32.5 8.4 46.8 8.6 0.1 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 2.4 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 12.4 0.0 8.4 28.6 1.4 0.1 46.8 0.1 0.4 0.0 0.0 32.5 0.3 0.0 0.0 1.0 8.6 46.4 2.1 0.0 10.7 3.6 4.6 0.4 2.9 2.0 1.7 5.3 1.3 3.9 2.7 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 15.0 0.0 29.5 0.0 0.0 0.0 28.1 0.0 0.0 33.8 1.7 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 CD300E "CD300LE, CLM2, IREM2" ENSG00000186407 "CD300e molecule" Q496F6 17 74609887-74623738 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.5;bone marrow: 22.5;lymphoid tissue: 21.0" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 2: 25.2;Club cells: 15.9;Kupffer cells: 69.4;Macrophages: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "classical monocyte: 22.7;intermediate monocyte: 36.5;non-classical monocyte: 36.3" "Lineage enriched" "Detected in many" 6 "monocytes: 36.5" "Cell line enhanced" "Detected in some" "HeLa: 1.7;SCLC-21H: 1.5" "Low region specificity" "Detected in single" HPA015570 Uncertain NA NA "HPA015570: AB_1846294" "unprognostic (1.70e-1)" "unprognostic (6.82e-2)" "unprognostic (1.76e-1)" "unprognostic (2.63e-2)" "unprognostic (1.42e-2)" "unprognostic (2.12e-1)" "unprognostic (1.68e-2)" "unprognostic (7.80e-3)" "unprognostic (4.51e-1)" "unprognostic (1.53e-1)" "unprognostic (2.69e-2)" "unprognostic (5.15e-2)" "unprognostic (4.19e-7)" "unprognostic (1.90e-2)" "unprognostic (2.00e-4)" "unprognostic (7.38e-3)" "unprognostic (1.19e-1)" 8.5 0.7 0.5 21.0 0.6 22.5 0.7 1.2 1.0 0.5 1.2 0.3 0.0 0.0 0.7 3.0 0.9 1.5 1.9 2.0 0.5 0.5 2.5 1.1 14.3 9.4 0.5 0.2 1.0 0.8 0.0 0.5 1.7 0.7 0.6 0.2 1.1 0.6 1.6 1.6 0.6 0.7 5.3 0.9 14.3 0.8 0.7 0.3 0.2 1.2 0.8 0.8 1.8 0.6 0.0 5.9 0.5 36.5 0.0 0.0 11.6 0.2 0.0 1.1 0.1 0.0 0.1 0.2 0.2 0.2 0.0 0.1 1.1 0.0 0.5 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.1 0.1 0.0 1.7 0.8 0.0 0.9 0.3 0.1 0.3 0.0 0.0 0.5 0.0 0.5 0.2 0.5 0.0 0.9 0.2 0.8 0.5 0.2 0.4 0.2 0.0 0.2 0.1 0.6 1.5 0.5 0.3 0.0 0.1 1.2 0.6 0.0 0.0 0.5 0.7 0.7 0.2 0.9 0.0 0.1 0.0 0.7 0.5 0.0 22.7 0.1 0.0 36.5 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.5 0.0 36.3 0.1 0.0 11.6 0.5 0.6 1.2 1.0 0.5 0.5 0.5 0.2 0.7 0.3 6.0 25.2 1.4 0.0 0.6 0.2 0.3 0.0 2.7 15.9 1.8 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 3.5 0.2 4.1 0.0 0.0 0.6 69.4 0.0 0.0 16.8 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 CD300LB "CLM7, TREM5" ENSG00000178789 "CD300 molecule like family member b" A8K4G0 17 74521174-74531474 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 20.7;blood: 30.7;bone marrow: 8.8;lymphoid tissue: 10.9" "Group enriched" "Detected in some" 8 "Hofbauer cells: 6.5;Kupffer cells: 10.1;Macrophages: 10.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "eosinophil: 30.7" "Group enriched" "Detected in many" 52 "dendritic cells: 10.5;granulocytes: 30.7;monocytes: 13.0" "Group enriched" "Detected in some" 6 "HL-60: 4.6;NB-4: 6.0;THP-1: 4.7;U-937: 2.8" HPA060449 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA060449: " "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.37e-1)" "unprognostic (4.39e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (7.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.95e-2)" "unprognostic (6.24e-2)" "unprognostic (3.32e-1)" "unprognostic (2.49e-4)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" "unprognostic (7.08e-2)" "unprognostic (4.01e-2)" 20.7 0.9 0.2 10.9 0.5 8.8 2.0 0.4 0.5 0.6 0.8 0.3 0.1 0.7 0.7 1.0 1.1 1.2 2.8 1.6 1.5 0.4 1.2 1.0 4.4 6.5 1.2 0.1 2.0 2.3 0.0 0.7 1.1 1.0 0.8 1.1 1.6 1.2 0.1 0.3 0.4 2.0 2.2 0.6 6.6 0.7 0.7 0.1 0.9 0.6 0.1 2.2 2.6 0.7 0.0 10.5 30.7 13.0 0.3 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 2.8 0.0 0.6 13.0 30.7 0.0 5.6 0.1 0.0 0.0 0.0 10.5 0.0 0.0 0.1 13.8 0.3 0.7 6.6 0.0 4.2 0.2 0.5 0.4 0.5 1.5 0.4 1.2 0.1 1.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.6 10.1 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CD300LD "CD300D, CMRF35A4" ENSG00000204345 "CD300 molecule like family member d" Q6UXZ3 17 74579365-74592283 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 8.5;bone marrow: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 7 "neutrophil: 8.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.5" "Cell line enhanced" "Detected in some" "HMC-1: 4.5;RPMI-8226: 2.7" HPA027756 Uncertain NA NA "HPA027756: AB_10601097" "unprognostic (8.03e-2)" "unprognostic (3.30e-1)" 0.3 0.2 0.1 2.2 0.1 3.2 0.2 0.2 0.3 0.4 0.2 0.0 0.2 0.0 0.2 0.4 0.3 0.3 0.1 0.1 0.1 0.2 0.9 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.1 0.0 0.1 1.6 0.9 0.1 0.1 1.4 0.2 1.7 0.1 0.6 0.4 0.1 0.5 0.7 8.5 0.7 0.8 1.3 0.2 0.4 0.3 0.5 1.1 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.4 0.6 0.3 0.5 0.6 0.5 0.3 0.5 0.0 0.5 0.2 0.2 1.6 0.7 0.0 1.2 4.5 0.6 0.4 0.3 0.5 0.6 0.0 0.5 0.5 1.8 0.2 1.4 0.2 0.6 0.5 0.0 0.6 0.4 0.6 2.7 0.5 0.8 0.5 0.5 0.7 0.5 0.0 0.6 0.6 0.1 0.5 0.6 0.5 1.1 0.0 0.9 0.3 0.6 0.2 0.3 0.4 0.8 0.4 0.4 0.4 0.7 0.2 0.3 0.3 0.2 0.7 0.5 0.5 0.4 8.5 0.8 0.4 0.5 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CD300LF "CD300f, CLM1, IGSF13, IREM1, NKIR" ENSG00000186074 "CD300 molecule like family member f" Q8TDQ1 17 74694311-74712978 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 47.8;bone marrow: 18.2;lung: 24.1;lymphoid tissue: 29.1" "Cell type enhanced" "Detected in some" 13 "granulocytes: 22.0;Hofbauer cells: 21.0;Kupffer cells: 28.8;Macrophages: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 47.8" "Group enriched" "Detected in many" 46 "dendritic cells: 13.5;granulocytes: 47.8;monocytes: 38.1" "Group enriched" "Detected in some" 6 "THP-1: 16.0;U-937: 30.9" HPA013712 Supported NA NA "HPA013712: AB_2668874" "unprognostic (6.51e-2)" "unprognostic (1.49e-3)" "unprognostic (3.81e-2)" "unprognostic (4.00e-2)" "unprognostic (8.51e-2)" "unprognostic (6.74e-2)" "unprognostic (1.79e-1)" "unprognostic (3.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.77e-1)" "unprognostic (9.81e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-1)" "unprognostic (9.60e-2)" "unprognostic (4.14e-2)" "unprognostic (7.75e-2)" "unprognostic (4.79e-2)" 3.3 1.0 1.2 9.8 3.1 18.2 0.9 1.5 1.3 0.8 2.3 3.1 0.0 2.7 0.7 0.7 0.9 1.1 1.9 2.4 1.3 1.2 1.1 1.5 24.1 15.6 3.8 0.5 0.9 0.9 0.0 1.0 2.1 2.6 1.4 2.6 0.8 1.9 0.3 0.5 0.5 3.4 2.3 5.8 29.1 1.0 0.7 2.4 1.1 0.8 0.0 4.2 2.8 0.8 0.0 13.5 47.8 38.1 0.7 0.1 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 30.9 0.0 8.4 20.2 47.8 0.0 34.4 0.1 0.0 0.0 0.0 13.5 0.0 0.0 0.0 15.9 0.7 38.1 1.4 0.0 8.2 1.2 3.1 1.5 1.3 1.3 1.2 3.8 0.5 2.6 2.4 0.0 8.3 0.0 0.0 0.1 0.2 0.1 2.5 0.0 5.7 0.0 2.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.0 0.0 21.0 0.0 0.0 1.3 28.8 0.0 0.0 32.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CD300LG "CLM9, Trem4" ENSG00000161649 "CD300 molecule like family member g" Q6UXG3 17 43847148-43863629 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 76.1;breast: 45.4" "Cell type enhanced" "Detected in some" 19 "Ito cells: 6.7;Leydig cells: 12.0;Peritubular cells: 29.0;Sertoli cells: 12.9" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 2.0;NB-4: 1.1" NA NA 870000 "unprognostic (2.38e-2)" "unprognostic (2.06e-3)" "unprognostic (2.63e-1)" "unprognostic (2.72e-1)" "unprognostic (3.18e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-4)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (2.01e-2)" "unprognostic (4.08e-3)" "unprognostic (8.69e-4)" "unprognostic (2.12e-5)" "unprognostic (1.30e-3)" "unprognostic (1.45e-1)" "unprognostic (1.76e-2)" "unprognostic (1.57e-1)" 76.1 0.9 0.1 2.8 0.2 0.0 45.4 0.1 0.5 2.2 6.1 0.1 1.2 0.0 1.7 5.4 1.5 1.8 1.7 10.5 0.1 0.0 1.9 1.4 4.6 0.5 0.1 0.2 0.8 1.1 0.2 0.1 25.2 0.2 2.6 0.1 1.4 1.7 0.8 8.2 3.1 0.9 0.3 0.1 1.1 1.0 16.0 0.1 2.1 1.2 1.7 0.2 1.5 7.8 0.5 1.6 2.4 0.2 0.6 0.2 0.1 0.1 0.0 0.1 0.3 0.0 0.0 2.0 0.3 0.0 0.6 0.2 0.0 0.2 0.0 1.0 0.0 0.7 0.1 0.0 0.4 0.3 0.4 0.0 0.5 1.0 0.4 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.7 0.0 0.1 0.2 0.8 0.2 0.1 0.0 0.2 0.6 0.4 0.3 0.1 0.6 0.3 0.4 0.1 0.1 2.4 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.2 1.6 0.5 0.2 0.2 1.2 0.6 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.4 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.7 0.3 1.5 12.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 12.9 0.0 0.4 0.6 0.4 0.0 0.0 0.0 0.0 CD302 "BIMLEC, CLEC13A, DCL-1, KIAA0022" ENSG00000241399 "CD302 molecule" Q8IX05 2 159768630-159798255 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 113.8" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 257.0;Kupffer cells: 378.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 190 "dendritic cells: 17.0;granulocytes: 19.1;monocytes: 20.8" "Cell line enriched" "Detected in many" 5 "ASC diff: 77.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 16000 "unprognostic (2.52e-1)" "unprognostic (5.44e-2)" "unprognostic (1.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (6.88e-2)" "unprognostic (1.68e-2)" "unprognostic (9.12e-3)" "unprognostic (5.29e-3)" "unprognostic (2.37e-2)" "unprognostic (4.38e-2)" "unprognostic (2.14e-1)" "unprognostic (4.67e-3)" "unprognostic (1.75e-2)" "unprognostic (6.61e-2)" "unprognostic (7.45e-2)" "unprognostic (3.61e-3)" 27.1 9.4 5.0 6.1 5.9 10.1 28.6 3.3 4.3 13.8 13.8 4.0 2.6 8.7 11.4 11.0 7.9 9.7 11.7 13.7 5.6 3.3 9.3 113.8 22.9 23.3 5.9 2.7 16.3 9.0 4.7 4.0 7.0 6.3 11.5 7.7 13.7 7.7 7.8 6.1 4.9 13.9 12.1 8.7 18.9 8.5 9.2 5.9 0.7 26.6 6.3 3.4 12.4 23.8 0.0 17.0 19.1 20.8 0.0 0.0 7.5 0.0 0.5 0.4 0.0 77.9 16.3 0.0 1.9 7.8 2.3 3.4 0.6 0.7 0.1 0.8 4.1 2.5 0.0 1.6 0.8 3.1 0.5 2.6 3.0 0.5 1.1 3.9 5.8 2.1 12.9 0.4 2.5 0.0 1.9 5.7 0.0 0.2 2.7 2.8 0.2 0.0 4.2 0.7 0.0 2.3 0.0 0.6 0.0 0.4 0.2 0.9 1.0 0.6 1.8 1.8 1.3 1.5 5.6 2.0 4.5 0.0 0.1 1.2 0.3 0.0 0.0 3.1 0.5 1.0 6.2 20.8 19.1 0.0 16.4 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 19.1 0.0 15.6 4.5 0.0 7.5 5.0 5.9 3.3 4.3 5.6 3.3 5.9 2.7 6.3 5.9 41.7 80.3 9.3 14.0 6.0 3.3 3.7 30.6 26.8 45.5 3.5 0.0 2.0 0.0 3.0 26.4 18.4 5.6 0.0 3.1 7.4 29.6 22.5 29.0 257.0 40.0 3.2 9.2 67.5 378.3 12.0 113.6 127.8 18.6 4.6 23.7 1.5 3.1 13.3 88.1 3.3 2.2 64.7 17.5 21.4 11.6 3.9 2.3 7.5 18.6 8.6 CD320 "8D6, 8D6A" ENSG00000167775 "CD320 molecule" Q9NPF0 19 8302127-8308356 "CD markers, Disease related genes, Predicted membrane proteins" "Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 119.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 76.2;RPMI-8226: 69.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014500, HPA073489" Approved Approved Cytosol NA NA 400000 Cytosol "HPA014500: AB_1846295, HPA073489: AB_2686609" "unprognostic (9.97e-2)" "unprognostic (2.62e-1)" "unprognostic (3.51e-1)" "unprognostic (2.54e-3)" "unprognostic (2.17e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (4.19e-2)" "unprognostic (7.13e-2)" "unprognostic (1.31e-1)" "unprognostic (9.35e-3)" "unprognostic (1.25e-1)" "unprognostic (2.03e-1)" "unprognostic (1.07e-1)" "unprognostic (8.92e-2)" "unprognostic (3.14e-1)" "unprognostic (9.90e-2)" 23.1 20.1 13.1 13.4 14.9 6.3 39.0 12.6 19.1 12.0 23.2 9.7 10.5 16.6 15.8 58.1 11.4 14.9 28.9 20.7 13.2 18.7 15.2 16.3 15.1 18.0 18.0 8.5 14.0 27.6 7.6 11.9 38.0 19.9 19.7 14.2 18.6 16.5 12.8 14.0 6.4 17.4 11.9 11.9 32.8 21.3 23.7 9.3 14.3 22.4 9.3 8.6 12.1 19.6 10.3 25.0 0.8 0.6 18.0 51.3 15.0 12.9 13.3 2.9 38.0 9.6 5.0 6.9 6.8 9.2 13.7 10.5 14.2 7.8 11.7 21.3 5.0 10.2 8.3 0.0 10.8 2.6 16.4 40.7 5.6 11.4 20.2 6.4 10.7 14.2 4.7 2.5 7.9 6.6 6.1 13.3 7.9 17.1 40.3 5.3 12.2 11.3 76.2 20.7 11.4 55.5 14.0 4.0 69.2 10.2 0.3 27.5 11.9 14.1 6.0 17.2 2.2 0.4 4.8 7.5 15.7 11.6 23.4 21.4 38.4 24.0 12.7 11.2 39.3 17.0 0.0 0.6 0.0 51.3 0.6 29.2 10.3 34.0 27.4 1.1 9.9 23.1 26.0 0.8 18.0 0.4 25.0 21.7 15.0 13.1 14.9 12.6 19.1 13.2 18.7 18.0 8.5 19.9 9.3 11.9 19.7 29.0 24.5 16.5 50.8 27.1 10.2 12.0 10.3 17.4 31.4 32.9 11.6 46.3 20.5 85.7 13.4 0.0 15.8 39.7 26.8 49.2 11.5 17.1 23.7 20.6 48.9 51.0 3.8 41.6 20.1 5.8 37.1 6.4 31.5 18.4 22.6 66.2 15.9 39.0 37.7 12.9 31.4 119.7 28.0 12.3 29.6 35.5 88.5 19.2 CD33 "FLJ00391, p67, SIGLEC-3, SIGLEC3" ENSG00000105383 "CD33 molecule" P20138 19 51225064-51243860 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.3;lymphoid tissue: 45.4" "Group enriched" "Detected in many" 7 "granulocytes: 73.9;Hofbauer cells: 67.4;Kupffer cells: 119.1;Macrophages: 56.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6" "Group enriched" "Detected in many" 9 "dendritic cells: 49.3;monocytes: 37.6" "Cell line enhanced" "Detected in some" "HEL: 28.5;HL-60: 37.9;HMC-1: 28.4;NB-4: 18.1;RPMI-8226: 20.5;THP-1: 22.2;U-937: 28.0" "CAB011442, HPA035832, HPA064807" Approved Approved "Nucleoplasm,Plasma membrane" NA NA 1400000 "Nucleoplasm, Plasma membrane" "CAB011442: , HPA035832: AB_2674808, HPA064807: AB_2685356" "unprognostic (1.18e-2)" "unprognostic (1.45e-2)" "unprognostic (2.80e-2)" "unprognostic (7.14e-2)" "unprognostic (3.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.59e-1)" "unprognostic (5.90e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-1)" "unprognostic (2.53e-1)" "unprognostic (6.28e-2)" "unprognostic (6.88e-4)" "unprognostic (7.79e-2)" "unprognostic (3.35e-2)" "unprognostic (6.49e-2)" "unprognostic (1.67e-1)" 10.2 4.3 3.6 8.4 6.0 23.0 6.5 0.8 3.5 2.6 2.7 4.4 0.3 2.5 2.3 5.2 1.7 3.9 5.3 7.5 3.1 2.5 4.1 6.4 11.6 45.4 6.4 1.8 1.9 1.9 0.5 1.7 5.4 5.2 2.6 3.4 2.6 2.9 2.1 1.2 2.5 4.0 5.6 9.9 31.6 2.8 1.5 5.8 2.5 1.7 0.2 2.7 4.7 2.3 0.1 49.3 4.6 37.6 3.3 0.2 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 28.5 0.1 0.0 0.0 37.9 28.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 7.2 0.0 0.0 0.0 18.1 0.0 0.0 8.7 0.0 1.5 20.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.2 0.2 4.9 0.4 0.6 0.0 0.1 2.4 0.0 3.3 28.0 0.1 3.3 37.6 2.3 0.0 27.3 0.1 0.0 0.0 0.1 49.3 0.1 0.0 0.0 4.6 3.3 12.6 1.4 0.2 14.7 3.6 6.0 0.8 3.5 3.1 2.5 6.4 1.8 5.2 5.8 0.0 10.7 1.4 0.5 1.5 0.1 0.6 0.0 1.4 1.2 0.0 0.0 0.7 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.4 1.5 0.3 73.9 0.8 67.4 0.0 0.0 8.6 119.1 1.3 0.3 56.4 1.7 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.7 0.5 0.9 0.7 1.7 0.0 0.3 CD34 ENSG00000174059 "CD34 molecule" P28906 1 207880972-207911402 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 214.1;Ito cells: 81.0;Leydig cells: 135.4;Peritubular cells: 115.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 32.6;MOLT-4: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000018, HPA036722, HPA036723" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 69000000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272" "unprognostic (3.82e-1)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.09e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.93e-5)" "unprognostic (1.25e-2)" "unprognostic (7.74e-2)" "unprognostic (7.65e-2)" "unprognostic (3.53e-1)" "unprognostic (1.37e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (1.60e-1)" "unprognostic (1.01e-2)" 61.9 8.8 4.6 12.8 7.6 1.9 37.5 3.1 6.7 38.3 15.9 5.2 20.5 5.0 41.4 40.3 33.8 22.3 20.6 51.2 5.4 4.9 18.8 2.2 25.0 11.9 8.1 6.7 20.7 8.6 7.8 3.6 78.9 6.3 21.0 7.4 12.8 12.4 20.5 39.7 21.2 12.1 42.3 4.7 9.2 11.3 23.1 4.7 3.5 25.8 35.9 11.0 33.6 33.1 0.6 1.7 1.6 0.3 0.6 0.5 1.5 0.0 0.0 0.1 0.0 1.6 0.1 0.1 0.2 1.2 0.3 0.9 0.0 0.0 0.0 3.2 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 32.6 0.5 0.0 0.0 0.8 0.0 32.1 0.1 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.2 1.1 0.0 4.9 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.6 0.2 0.3 0.5 0.2 0.5 0.3 0.3 0.2 0.2 0.6 0.3 0.3 1.1 0.6 0.3 1.7 0.2 1.5 4.6 7.6 3.1 6.7 5.4 4.9 8.1 6.7 6.3 4.7 3.0 8.5 0.0 0.1 14.8 0.4 12.3 2.5 0.0 0.0 3.5 2.0 0.2 0.0 0.2 10.9 214.1 0.0 0.0 0.2 0.3 22.6 0.2 1.1 0.5 0.3 0.0 0.0 81.0 0.3 4.2 135.4 2.2 16.9 0.0 0.0 0.3 0.2 0.0 115.6 0.0 0.0 6.5 4.1 0.7 0.5 11.3 0.1 0.0 0.0 0.3 CD36 "FAT, GP3B, GP4, GPIV, SCARB3" ENSG00000135218 "CD36 molecule" P16671 7 80369575-80679277 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Transport" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 464.3;breast: 156.1" "Cell type enhanced" "Detected in many" 16 "Cardiomyocytes: 491.8;Hofbauer cells: 1111.0;Ito cells: 465.9;Sertoli cells: 685.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9" "Group enriched" "Detected in many" 45 "dendritic cells: 56.9;monocytes: 104.4" "Group enriched" "Detected in some" 5 "ASC diff: 82.7;HEL: 39.3" "Low region specificity" "Detected in many" "HPA002018, CAB025866, HPA071026" Enhanced Enhanced "Golgi apparatus" NA NA 92000000 "Golgi apparatus" "CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170" "unprognostic (7.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.06e-3)" "unprognostic (6.52e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.63e-1)" "unprognostic (9.35e-2)" "unprognostic (2.64e-2)" "unprognostic (1.97e-1)" "unprognostic (1.23e-3)" "unprognostic (1.18e-1)" "unprognostic (1.84e-3)" "prognostic unfavorable (4.47e-4)" "unprognostic (7.05e-3)" "unprognostic (4.87e-2)" "unprognostic (2.73e-3)" 464.3 3.6 1.2 8.9 1.3 10.9 156.1 0.5 0.5 1.8 31.8 0.6 3.3 9.8 1.8 7.5 7.5 3.3 7.2 76.8 1.8 1.9 2.2 13.3 11.5 4.8 0.6 0.3 2.5 3.9 3.1 0.8 37.9 2.9 9.2 3.5 0.8 4.6 2.3 23.6 5.4 23.4 4.7 0.8 42.8 5.0 6.0 0.5 2.7 13.6 15.3 1.4 9.4 19.2 0.3 56.9 1.8 104.4 0.7 0.2 60.2 0.0 0.0 0.2 0.1 82.7 0.8 0.1 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.0 0.1 0.0 0.1 0.1 39.3 0.1 6.3 0.0 0.0 0.0 8.0 3.1 0.0 0.0 1.9 0.2 0.0 1.4 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.1 0.0 0.7 2.7 4.5 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.1 0.0 13.5 10.4 0.9 104.4 0.3 0.2 30.4 0.2 0.3 0.0 0.0 56.9 0.0 0.1 0.0 1.8 0.7 7.5 14.3 0.1 60.2 1.2 1.3 0.5 0.5 1.8 1.9 0.6 0.3 2.9 0.5 6.0 69.8 5.2 0.1 6.5 0.0 491.8 7.6 0.0 5.7 7.0 0.0 8.5 0.0 0.0 9.2 46.6 0.0 163.5 0.0 9.4 14.4 0.7 14.0 12.1 1111.0 0.0 0.0 465.9 196.7 2.3 0.6 68.0 15.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.3 685.6 31.5 4.7 0.7 4.1 15.3 1.3 0.0 0.1 CD37 TSPAN26 ENSG00000104894 "CD37 molecule" P11049 19 49335171-49343335 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 163.4;lymphoid tissue: 109.6" "Cell type enhanced" "Detected in many" 18 "B-cells: 979.0;granulocytes: 262.7;Hofbauer cells: 303.3;Kupffer cells: 224.9;Macrophages: 253.6;T-cells: 359.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 67.2;HMC-1: 66.6;RPMI-8226: 23.9;THP-1: 23.9;U-698: 14.8;U-937: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB002492, HPA032120, HPA032121" Enhanced Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163" "unprognostic (4.30e-3)" "unprognostic (2.39e-3)" "unprognostic (8.85e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.46e-2)" "unprognostic (4.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.23e-2)" "unprognostic (5.34e-2)" "unprognostic (2.23e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-1)" "unprognostic (2.45e-3)" "unprognostic (7.12e-2)" "unprognostic (3.35e-2)" "unprognostic (7.22e-2)" "unprognostic (7.71e-2)" 7.3 3.1 3.4 62.9 4.8 48.7 3.7 1.0 3.1 1.9 4.2 8.5 0.0 3.2 2.0 2.2 5.9 2.9 5.2 10.4 3.8 3.8 4.3 2.7 25.3 109.6 6.9 1.7 2.5 1.6 0.5 1.9 5.4 4.7 3.5 1.7 2.7 10.7 1.4 1.1 2.0 39.3 1.7 14.5 88.1 5.1 2.9 5.0 47.9 3.4 1.7 86.8 10.2 2.4 163.4 53.7 84.4 62.8 27.9 43.5 58.8 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 0.0 11.8 0.0 0.1 0.0 2.0 66.6 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.6 3.7 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.6 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 14.8 0.0 17.8 0.0 42.8 58.2 71.7 34.3 53.4 34.7 137.2 41.8 36.4 41.1 163.4 43.5 36.3 84.4 27.9 62.8 53.7 40.9 58.8 3.4 4.8 1.0 3.1 3.8 3.8 6.9 1.7 4.7 5.0 8.9 20.5 979.0 1.1 10.4 12.4 1.2 2.5 1.4 4.5 1.8 5.9 1.6 0.0 0.3 98.9 4.3 0.4 0.0 0.0 1.5 5.4 0.5 262.7 2.5 303.3 0.0 1.2 14.1 224.9 158.6 2.6 253.6 27.0 43.3 0.5 1.1 0.0 5.3 0.7 2.5 5.2 0.0 0.5 1.1 0.9 10.3 2.4 359.8 0.4 0.9 CD38 ENSG00000004468 "CD38 molecule" P28907 4 15778275-15853230 "Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins" "Hydrolase, Receptor, Transferase" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 94.9;seminal vesicle: 104.1" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 49.5;Erythroid cells: 46.7;granulocytes: 39.1;Kupffer cells: 31.1;T-cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 15.3" "Group enriched" "Detected in all" 4 "B-cells: 9.0;dendritic cells: 5.1;NK-cells: 15.3" "Cell line enhanced" "Detected in some" "Daudi: 50.8;Karpas-707: 14.2;MOLT-4: 12.8;REH: 10.3;U-266/70: 11.0;U-698: 9.6" "Low region specificity" "Detected in all" "CAB002493, HPA022132, CAB025255, HPA052381" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807" "unprognostic (1.27e-2)" "unprognostic (8.06e-3)" "unprognostic (1.06e-2)" "prognostic favorable (9.68e-4)" "unprognostic (1.13e-1)" "unprognostic (1.82e-3)" "unprognostic (2.74e-1)" "unprognostic (8.51e-2)" "unprognostic (5.87e-2)" "unprognostic (6.15e-6)" "unprognostic (5.23e-1)" "unprognostic (4.34e-1)" "unprognostic (6.63e-6)" "unprognostic (1.79e-1)" "unprognostic (5.74e-2)" "unprognostic (2.12e-2)" "unprognostic (2.13e-1)" 4.1 3.3 3.8 17.6 8.5 9.3 2.6 0.7 12.0 1.0 3.2 10.4 14.6 4.3 0.7 0.9 2.3 2.4 1.5 5.0 4.0 4.2 1.2 5.4 4.7 16.1 4.9 3.1 0.6 0.7 0.0 2.5 0.6 3.1 10.8 2.7 4.4 2.8 104.1 14.2 0.5 6.2 0.9 1.8 20.6 2.0 0.7 2.5 94.9 2.8 2.0 13.2 7.6 0.9 9.0 5.1 1.3 2.2 15.3 2.3 3.7 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 50.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 14.2 0.0 0.0 12.8 3.1 0.0 0.0 0.0 10.3 0.0 8.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 2.2 0.2 0.0 0.0 0.0 0.0 11.0 0.1 9.6 0.1 2.4 0.1 0.0 1.7 0.0 1.1 2.2 0.3 9.0 1.4 1.2 4.1 6.6 2.3 1.8 1.3 15.3 1.4 5.1 2.1 3.7 3.8 8.5 0.7 6.2 4.0 4.2 4.9 3.1 3.1 2.5 3.0 10.8 23.4 0.4 0.0 0.0 0.8 0.0 49.5 18.2 0.0 9.8 0.2 0.0 0.0 1.6 0.1 0.0 46.7 0.0 0.0 0.5 10.7 39.1 1.3 4.6 0.0 0.0 3.1 31.1 0.0 0.0 10.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 2.2 1.4 0.0 0.5 30.5 0.7 0.1 CD3D T3D ENSG00000167286 "CD3d molecule" P04234 11 118338954-118342744 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 108.7;lymphoid tissue: 181.4" "Cell type enriched" "Detected in many" 12 "T-cells: 532.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 53 "gdT-cell: 105.6;MAIT T-cell: 68.6;memory CD4 T-cell: 88.1;memory CD8 T-cell: 97.6;naive CD4 T-cell: 78.8;naive CD8 T-cell: 98.6;T-reg: 108.7" "Lineage enriched" "Detected in many" 63 "T-cells: 108.7" "Cell line enhanced" "Detected in some" "JURKAT: 69.9;MOLT-4: 149.5;NB-4: 27.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB013055, HPA071778" Enhanced Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB013055: , HPA071778: " "prognostic favorable (3.00e-4)" "prognostic favorable (8.46e-5)" "unprognostic (1.05e-2)" "prognostic favorable (1.73e-7)" "unprognostic (6.00e-2)" "prognostic favorable (1.70e-4)" "unprognostic (3.82e-1)" "unprognostic (2.40e-2)" "unprognostic (2.24e-3)" "unprognostic (1.01e-2)" "unprognostic (5.69e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (9.00e-2)" "unprognostic (2.02e-1)" "unprognostic (3.66e-2)" "prognostic favorable (6.16e-4)" 2.6 0.8 0.5 17.4 0.7 4.8 1.7 0.5 0.7 1.3 4.1 0.7 0.8 4.1 1.2 1.6 3.2 1.9 2.9 1.0 0.7 0.4 2.6 1.9 6.1 40.8 0.9 0.5 1.0 1.2 0.0 0.7 0.8 0.7 2.2 4.3 1.1 9.0 0.8 0.7 1.3 19.3 1.0 1.5 28.6 4.4 0.8 0.5 181.4 2.7 2.8 32.6 5.7 2.4 0.5 0.3 1.7 0.3 0.2 108.7 64.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.9 5.7 0.0 0.0 0.0 149.5 27.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.2 105.6 0.2 68.6 0.5 88.1 97.6 0.3 0.2 78.8 98.6 1.7 0.2 0.3 0.3 108.7 64.9 0.5 0.7 0.5 0.7 0.7 0.4 0.9 0.5 0.7 0.5 6.0 45.4 3.0 0.3 13.6 0.0 2.5 0.0 2.7 4.5 3.5 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 5.1 0.1 11.6 2.0 0.6 0.0 1.2 9.8 7.6 0.4 0.0 6.1 11.8 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 5.6 0.0 0.0 10.3 0.2 532.0 0.3 0.0 CD3E ENSG00000198851 "CD3e molecule" P07766 11 118304545-118316175 "CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 294.2" "Cell type enriched" "Detected in some" 31 "T-cells: 377.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 36 "gdT-cell: 59.5;MAIT T-cell: 50.2;memory CD4 T-cell: 50.7;memory CD8 T-cell: 55.7;naive CD4 T-cell: 61.3;naive CD8 T-cell: 62.0;NK-cell: 21.8;T-reg: 46.8" "Group enriched" "Detected in many" 29 "NK-cells: 21.8;T-cells: 62.0" "Group enriched" "Detected in some" 67 "JURKAT: 80.1;MOLT-4: 108.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB000010, HPA040957, HPA043955, CAB072863, CAB072864" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" "CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747" "prognostic favorable (1.72e-4)" "prognostic favorable (1.62e-4)" "unprognostic (1.51e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.31e-2)" "prognostic favorable (1.32e-4)" "unprognostic (3.60e-3)" "unprognostic (3.85e-2)" "prognostic favorable (1.18e-4)" "unprognostic (6.11e-3)" "unprognostic (1.59e-1)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.46e-2)" "unprognostic (9.28e-2)" "unprognostic (3.13e-2)" "unprognostic (1.12e-2)" 3.9 1.0 0.5 16.7 0.7 6.8 1.9 0.5 0.7 2.1 4.7 0.9 0.7 4.4 2.0 1.4 3.3 3.0 4.0 1.4 0.5 0.5 3.3 2.6 7.3 40.9 1.3 0.6 1.5 1.3 0.0 0.9 1.2 0.9 2.6 3.9 1.9 6.4 1.1 0.8 1.3 21.1 1.1 1.9 34.5 4.6 1.2 0.5 294.2 3.4 2.1 37.8 6.3 3.0 0.2 0.9 1.4 0.2 21.8 62.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.1 0.1 0.3 0.0 0.0 108.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 1.4 0.0 0.1 0.0 1.3 0.2 0.2 59.5 0.1 50.2 0.1 50.7 55.7 0.1 0.2 61.3 62.0 1.4 21.8 0.2 0.9 46.8 32.9 0.5 0.7 0.5 0.7 0.5 0.5 1.3 0.6 0.9 0.5 0.0 11.3 4.5 0.3 4.6 0.0 0.2 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.1 6.5 0.2 0.0 0.0 0.0 0.0 1.0 0.1 7.0 0.8 0.3 0.0 0.0 12.3 7.3 0.0 0.0 2.5 11.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.5 0.0 0.0 4.6 0.2 377.3 0.2 0.3 CD3G ENSG00000160654 "CD3g molecule" P09693 11 118344344-118355161 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 187.6" "Cell type enriched" "Detected in some" 18 "T-cells: 153.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 30 "gdT-cell: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2" "Lineage enriched" "Detected in many" 37 "T-cells: 46.7" "Group enriched" "Detected in some" 53 "JURKAT: 24.1;MOLT-4: 64.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017520, HPA038494" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB017520: AB_831094, HPA038494: AB_2676044" "prognostic favorable (6.33e-4)" "prognostic favorable (2.61e-4)" "unprognostic (4.58e-3)" "unprognostic (3.12e-5)" "unprognostic (6.30e-2)" "prognostic favorable (3.00e-4)" "unprognostic (1.98e-2)" "unprognostic (1.54e-2)" "unprognostic (8.25e-3)" "unprognostic (1.08e-3)" "unprognostic (1.54e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (9.33e-5)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (4.13e-2)" "unprognostic (2.10e-3)" 1.1 0.6 0.4 7.1 0.4 0.5 0.8 0.3 0.3 0.7 2.3 0.4 0.4 2.0 0.9 0.6 1.5 1.1 1.9 0.6 0.4 0.4 1.2 0.9 2.4 17.2 0.5 0.2 0.7 0.7 0.0 0.5 0.4 0.3 1.0 1.6 0.9 2.9 0.3 5.9 0.6 8.1 0.2 0.8 11.5 2.4 0.5 0.2 187.6 1.4 1.7 19.2 2.5 1.1 0.1 0.2 1.2 0.2 0.2 46.7 14.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.8 0.2 0.0 0.2 64.5 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.6 0.2 0.2 43.5 0.1 25.6 0.1 36.1 37.1 0.1 0.1 37.6 46.7 1.2 0.2 0.1 0.2 34.2 14.1 0.4 0.4 0.3 0.3 0.4 0.4 0.5 0.2 0.3 0.2 3.0 8.6 0.8 0.0 2.1 0.1 0.4 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.8 1.3 0.1 0.0 0.0 6.2 2.8 0.4 0.0 2.8 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.3 0.2 0.0 2.0 0.2 153.8 0.0 0.0 CD4 ENSG00000010610 "CD4 molecule" P01730 12 6786858-6820808 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 111.5;parathyroid gland: 78.4" "Cell type enhanced" "Detected in many" 19 "Hofbauer cells: 121.3;Ito cells: 382.4;Kupffer cells: 192.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 17 "classical monocyte: 42.2;intermediate monocyte: 42.5;memory CD4 T-cell: 29.1;myeloid DC: 29.3;naive CD4 T-cell: 24.8;non-classical monocyte: 33.3;plasmacytoid DC: 46.7;T-reg: 26.4" "Group enriched" "Detected in many" 20 "dendritic cells: 46.7;monocytes: 42.5;T-cells: 29.1" "Group enriched" "Detected in some" 6 "HEL: 34.3;HL-60: 13.8;NB-4: 19.7;THP-1: 39.0;U-937: 36.7" "Region enriched" "Detected in single" 15 "basal ganglia: 41.4" "Not detected" "Not detected" "CAB000011, HPA004252, HPA004472, CAB068180" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465" "unprognostic (1.39e-2)" "unprognostic (1.12e-2)" "unprognostic (2.75e-2)" "prognostic favorable (2.16e-4)" "unprognostic (7.76e-2)" "unprognostic (4.82e-3)" "unprognostic (3.70e-2)" "unprognostic (2.74e-2)" "unprognostic (7.04e-2)" "unprognostic (2.40e-1)" "unprognostic (1.13e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (7.45e-4)" "unprognostic (1.06e-1)" "unprognostic (4.65e-3)" "unprognostic (9.08e-3)" "unprognostic (2.95e-1)" 13.8 5.4 6.1 16.0 5.8 4.4 5.6 1.2 4.3 4.5 5.1 8.6 1.8 3.6 3.5 8.3 3.0 5.5 7.3 5.4 4.9 4.4 6.1 32.2 24.0 30.8 6.3 3.1 3.0 3.1 78.4 3.4 10.9 6.2 4.1 6.5 5.7 5.4 3.9 1.9 3.5 9.5 5.2 10.2 49.1 3.9 2.8 5.7 111.5 3.9 4.1 18.6 8.6 3.2 0.1 46.7 1.9 42.5 0.3 29.1 33.6 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 34.3 0.0 0.2 3.8 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 19.7 0.3 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.1 42.2 0.3 0.3 42.5 1.1 0.0 29.1 0.1 29.3 0.1 24.8 0.1 1.9 0.3 33.3 46.7 26.4 33.6 6.1 5.8 1.2 4.3 4.9 4.4 6.3 3.1 6.2 5.7 0.0 6.9 8.2 0.2 3.1 1.5 1.6 15.3 26.8 3.4 3.5 0.0 0.8 5.0 0.0 0.0 2.8 0.0 0.0 0.3 0.9 5.4 0.1 7.0 7.8 121.3 4.8 0.0 382.4 192.9 0.0 15.5 72.7 5.0 39.7 0.0 14.3 0.0 0.0 14.2 1.1 0.1 12.9 4.2 0.0 0.1 1.9 1.0 28.4 0.0 0.3 CD40 "Bp50, p50, TNFRSF5" ENSG00000101017 "CD40 molecule" P25942 20 46118272-46129863 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Immunity Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "monocytes: 413.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 36.1;naive B-cell: 41.3" "Group enriched" "Detected in many" 6 "B-cells: 41.3;monocytes: 10.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.3;EFO-21: 47.9;U-2 OS: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002495, HPA031567, HPA031568, CAB072868" Enhanced "Secreted to blood" NA NA 705000 16000 "CAB002495: AB_563562, CAB072868: AB_2665719, HPA031567: AB_2673936, HPA031568: AB_2673937" "unprognostic (6.41e-2)" "unprognostic (1.55e-2)" "unprognostic (7.08e-3)" "unprognostic (6.21e-2)" "unprognostic (4.23e-3)" "unprognostic (1.25e-1)" "unprognostic (7.64e-3)" "unprognostic (1.34e-1)" "unprognostic (4.15e-2)" "unprognostic (7.16e-2)" "unprognostic (2.48e-2)" "unprognostic (7.04e-2)" "prognostic unfavorable (4.48e-4)" "unprognostic (1.22e-1)" "unprognostic (4.95e-2)" "unprognostic (1.60e-2)" "unprognostic (2.28e-2)" 13.0 4.6 3.6 38.6 4.7 1.1 11.6 9.7 4.4 11.3 9.2 3.6 7.8 6.5 9.6 8.6 9.9 9.7 8.6 9.5 4.5 2.6 10.0 10.0 18.8 34.7 3.3 3.2 14.8 14.0 12.1 5.9 6.5 5.4 14.7 5.2 13.7 13.0 11.6 7.5 9.0 11.8 10.0 4.6 30.1 8.4 4.4 4.4 11.5 16.5 6.7 46.0 12.5 13.8 41.3 4.1 1.0 10.8 0.6 1.4 4.8 9.2 1.4 0.0 4.6 1.7 1.0 1.8 1.7 0.5 1.4 1.3 0.0 27.3 14.8 47.9 0.3 6.8 1.1 0.8 5.8 1.4 9.9 0.0 3.5 0.0 2.5 13.7 0.0 4.7 6.1 2.2 5.6 0.0 0.0 10.3 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.6 3.2 0.0 0.3 0.3 1.5 12.0 0.1 0.0 0.0 8.1 4.5 0.0 0.0 0.9 4.9 0.0 0.0 15.3 0.0 0.0 0.0 0.0 10.1 3.4 1.8 0.0 1.0 7.7 0.1 1.3 10.8 0.9 36.1 0.7 0.5 4.1 41.3 1.4 1.0 0.7 0.6 7.5 2.1 1.0 4.8 3.6 4.7 9.7 4.4 4.5 2.6 3.3 3.2 5.4 4.4 11.9 15.9 94.5 51.6 38.7 1.0 3.6 40.8 2.7 23.9 14.0 0.0 0.2 0.0 50.8 9.8 40.9 2.4 0.0 26.1 1.1 18.2 33.2 3.5 13.5 37.2 0.0 1.2 39.3 11.9 9.1 23.9 46.8 27.0 413.8 5.3 8.2 33.6 3.6 21.2 4.4 0.0 32.3 36.1 0.9 5.1 29.7 0.3 5.0 5.7 54.0 CD40LG "CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP" ENSG00000102245 "CD40 ligand" P29965 X 136648193-136660390 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Cytokine "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 29.2;intestine: 8.7;lymphoid tissue: 33.7" "Cell type enriched" "Detected in some" 4 "T-cells: 24.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 9.4;MAIT T-cell: 22.9;memory CD4 T-cell: 29.2;naive CD4 T-cell: 28.1" "Lineage enriched" "Detected in single" 58 "T-cells: 29.2" "Cell line enriched" "Detected in some" 14 "MOLT-4: 22.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA045827, HPA072480" Enhanced "Secreted to blood" NA NA 776000 "HPA045827: AB_10959606, HPA072480: " "unprognostic (1.94e-5)" "unprognostic (1.24e-2)" "unprognostic (3.26e-1)" "unprognostic (1.27e-3)" "unprognostic (4.71e-2)" "unprognostic (3.56e-5)" "unprognostic (3.66e-2)" "unprognostic (5.48e-3)" "unprognostic (2.77e-1)" "unprognostic (2.14e-4)" "unprognostic (1.87e-1)" "unprognostic (1.55e-1)" "unprognostic (6.70e-4)" "unprognostic (2.15e-1)" "unprognostic (5.19e-2)" "unprognostic (2.36e-3)" "unprognostic (2.92e-2)" 2.0 0.5 0.3 22.4 0.3 1.4 1.2 0.3 0.3 2.0 3.3 0.1 0.0 1.7 1.5 1.3 1.6 1.6 2.6 1.1 0.4 0.4 1.6 1.1 4.0 14.6 0.4 0.0 0.7 0.6 0.0 0.4 0.2 0.3 1.0 3.1 1.0 4.9 1.3 0.4 1.1 8.7 0.5 0.6 9.9 1.7 0.6 0.1 33.7 1.4 2.0 26.1 3.0 1.4 0.0 0.0 0.5 0.0 0.2 29.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 9.4 0.0 22.9 0.0 29.2 4.1 0.0 0.0 28.1 0.2 0.5 0.2 0.0 0.0 3.3 4.7 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.0 0.3 0.1 0.0 3.7 0.0 0.0 1.1 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.6 5.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 1.8 0.0 24.5 0.0 0.0 CD44 "CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1" ENSG00000026508 "CD44 molecule (Indian blood group)" P16070 11 35138870-35232402 "Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Blood group antigen, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 888.0;Ductal cells: 858.7;Suprabasal keratinocytes: 895.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 139.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000112, CAB000316, HPA005785" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted - unknown location" NA NA 2400000000 "Plasma membrane" "Golgi apparatus" "CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467" "unprognostic (5.33e-2)" "unprognostic (1.85e-1)" "unprognostic (4.97e-2)" "unprognostic (9.90e-3)" "unprognostic (3.50e-3)" "unprognostic (1.46e-2)" "unprognostic (1.56e-2)" "unprognostic (8.12e-2)" "unprognostic (1.57e-1)" "unprognostic (4.18e-2)" "unprognostic (1.51e-3)" "unprognostic (4.63e-2)" "prognostic unfavorable (1.78e-8)" "unprognostic (6.41e-2)" "unprognostic (4.14e-2)" "unprognostic (3.93e-2)" "unprognostic (7.98e-2)" 45.5 9.0 10.5 42.5 21.7 53.0 35.6 4.7 13.4 43.2 19.5 26.3 8.3 10.6 80.5 20.3 66.5 18.6 48.0 11.7 14.9 9.3 12.4 9.1 43.4 48.4 31.5 6.1 12.8 83.9 0.8 3.8 19.4 40.7 30.1 24.5 30.2 148.2 22.4 15.9 107.7 18.9 44.5 100.5 30.9 19.9 7.2 20.3 17.9 20.6 53.9 53.7 55.0 54.2 22.7 41.0 19.1 65.2 54.6 53.1 59.9 39.7 35.9 0.3 0.0 21.7 60.0 0.1 77.9 60.9 43.4 24.2 2.4 12.5 0.0 10.4 110.3 89.3 68.5 0.8 84.7 59.6 8.5 0.4 1.4 17.7 0.0 21.4 20.2 93.5 27.0 66.8 58.3 47.4 139.4 15.1 0.0 0.3 13.0 41.6 0.2 1.8 13.3 0.7 0.7 10.6 0.1 7.4 0.6 63.6 11.5 0.1 0.1 14.7 0.4 35.2 3.4 2.1 1.2 43.5 54.1 9.8 66.3 80.0 22.5 24.3 0.2 82.1 11.4 78.6 19.1 65.2 6.0 26.2 45.7 37.0 22.7 39.8 34.9 41.0 16.2 34.5 28.7 16.4 54.6 59.3 14.2 53.1 59.9 10.5 21.7 4.7 13.4 14.9 9.3 31.5 6.1 40.7 20.3 89.3 339.9 168.9 263.7 888.0 0.0 4.0 25.5 18.7 135.4 19.2 2.0 4.0 1.7 858.7 30.1 53.0 5.0 23.3 741.5 3.7 143.9 293.1 733.4 2.5 234.7 0.0 96.2 20.3 427.0 13.8 20.8 611.7 573.6 514.0 84.8 26.6 787.6 8.6 0.4 0.6 1.6 155.2 254.2 0.4 0.4 895.8 15.0 244.8 66.1 304.0 CD46 "MCP, MGC26544, MIC10, TLX, TRA2.10" ENSG00000117335 "CD46 molecule" P15529 1 207752057-207795513 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 41.7;eosinophil: 63.7;neutrophil: 69.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 69.8" "Low cell line specificity" "Detected in all" "CAB010401, HPA016903" Enhanced Approved "Plasma membrane" NA NA 1000000 "Plasma membrane" "CAB010401: AB_2291289, HPA016903: AB_1846309" "unprognostic (1.42e-2)" "prognostic unfavorable (8.54e-5)" "unprognostic (3.94e-2)" "unprognostic (2.14e-2)" "unprognostic (3.28e-2)" "unprognostic (6.30e-2)" "unprognostic (1.91e-2)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "unprognostic (2.74e-1)" "unprognostic (8.79e-2)" "unprognostic (2.50e-1)" "unprognostic (6.78e-3)" "prognostic favorable (2.38e-4)" "unprognostic (1.76e-1)" "unprognostic (8.23e-2)" "unprognostic (1.49e-2)" 38.0 78.0 13.0 22.9 20.5 18.5 57.0 12.9 17.8 27.5 35.4 25.3 64.3 32.9 39.7 32.6 43.2 30.4 25.2 20.6 16.1 15.5 50.8 57.8 43.6 25.0 21.4 13.2 27.6 47.9 86.6 32.7 119.6 29.1 47.0 28.5 26.7 68.4 60.5 18.8 18.4 39.8 25.0 21.8 26.9 33.9 16.5 20.7 20.3 25.3 21.8 30.3 37.2 27.0 7.7 8.1 69.8 14.1 7.5 13.5 14.9 26.7 15.1 14.2 6.5 44.8 44.4 21.6 20.1 29.2 13.3 18.0 14.8 71.2 4.1 20.5 20.0 18.3 36.3 10.6 27.6 20.3 20.5 15.1 8.9 16.6 26.6 28.5 19.3 31.0 38.1 41.1 20.0 15.8 31.4 37.1 16.3 18.6 17.9 20.4 12.6 9.2 17.0 16.2 16.0 15.1 6.2 22.6 25.2 54.3 53.0 14.4 9.8 25.4 57.2 33.0 29.6 45.0 16.6 31.8 14.3 12.7 30.0 22.8 24.1 29.0 12.4 20.9 12.8 13.4 41.7 13.5 63.7 9.2 14.0 12.5 7.7 11.7 10.1 8.1 6.0 13.5 11.2 69.8 7.5 14.1 4.2 10.1 14.9 13.0 20.5 12.9 17.8 16.1 15.5 21.4 13.2 29.1 20.7 187.6 224.8 34.3 81.1 47.1 61.8 56.5 86.6 227.5 213.9 137.9 62.8 190.0 13.3 67.0 176.4 91.0 82.1 0.0 68.5 62.2 54.2 160.9 108.9 100.2 53.0 38.1 69.8 78.5 81.8 23.7 43.7 72.9 59.1 50.5 91.2 28.9 65.3 92.2 41.4 61.7 79.1 51.8 66.9 13.8 23.3 40.1 287.4 51.1 85.2 127.3 CD47 "IAP, MER6, OA3" ENSG00000196776 "CD47 molecule" Q08722 3 108043094-108091862 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016055, HPA044659" Approved Supported "Vesicles,Plasma membrane" NA NA 2000000 "Plasma membrane" Vesicles "CAB016055: AB_627086, HPA044659: AB_2679040" "unprognostic (3.54e-2)" "unprognostic (4.74e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (4.49e-2)" "unprognostic (2.14e-1)" "unprognostic (2.05e-3)" "unprognostic (8.77e-3)" "unprognostic (7.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.69e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (7.37e-2)" "unprognostic (3.78e-1)" "prognostic favorable (7.29e-5)" "unprognostic (1.83e-1)" 16.2 24.3 23.0 28.8 46.5 58.0 29.0 44.0 55.5 20.5 25.7 42.5 13.4 19.8 16.2 30.4 46.7 31.7 26.0 26.7 24.1 24.4 19.1 22.1 49.6 35.1 27.4 28.8 16.2 25.7 11.5 34.8 23.3 43.6 40.2 29.0 15.7 43.8 18.9 18.1 19.3 21.2 21.0 37.7 29.0 33.4 20.6 25.0 34.4 30.1 22.0 42.5 25.1 29.1 40.1 35.6 44.1 64.4 45.1 65.3 51.7 45.7 8.2 16.6 9.4 23.8 25.6 21.9 17.3 27.1 13.5 23.1 0.4 25.9 21.0 28.1 16.6 31.0 31.4 9.2 17.5 17.6 12.4 6.3 53.5 7.7 0.7 13.8 38.1 72.3 16.4 10.7 12.9 10.4 21.0 13.3 21.8 12.6 50.0 20.0 23.5 46.3 14.3 6.9 42.7 21.0 24.6 12.2 29.7 34.2 18.3 12.6 7.8 10.3 20.5 17.5 8.8 37.1 12.5 12.8 35.0 6.4 19.6 11.7 19.4 13.1 29.5 25.5 19.1 9.6 31.7 24.7 44.1 40.2 48.1 35.0 40.1 47.0 42.0 35.6 39.2 35.4 38.3 30.1 45.1 64.4 27.7 65.3 51.7 23.0 46.5 44.0 55.5 24.1 24.4 27.4 28.8 43.6 25.0 342.4 135.6 141.2 259.6 146.8 90.6 37.8 109.5 58.9 102.4 89.0 90.3 137.8 13.3 418.5 33.5 71.3 35.8 23.3 357.7 75.9 79.2 245.6 56.6 30.2 163.7 116.0 61.4 82.9 78.2 40.6 31.7 105.3 111.3 90.2 60.0 47.2 337.0 107.2 45.6 11.9 214.8 64.7 72.9 25.2 13.2 122.5 101.4 137.1 79.7 264.1 CD48 "BCM1, BLAST, hCD48, mCD48, SLAMF2" ENSG00000117091 "CD48 molecule" P09326 1 160678746-160711851 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.3;lymphoid tissue: 86.3" "Group enriched" "Detected in many" 5 "B-cells: 233.4;granulocytes: 88.9;Hofbauer cells: 87.6;Kupffer cells: 195.5;Macrophages: 131.8;T-cells: 297.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 38.9;HMC-1: 43.5;U-266/70: 92.1;U-266/84: 61.5" "CAB002497, HPA055146" Enhanced Supported "Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 2600000 "Plasma membrane" "Nucleoli fibrillar center, Cytosol" "CAB002497: AB_563586, HPA055146: AB_2682716" "prognostic favorable (3.91e-4)" "unprognostic (1.72e-3)" "prognostic favorable (4.17e-4)" "unprognostic (1.58e-3)" "unprognostic (2.36e-1)" "unprognostic (1.71e-3)" "unprognostic (2.09e-2)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (3.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.36e-4)" "unprognostic (3.21e-1)" "unprognostic (4.69e-2)" "unprognostic (9.38e-2)" "unprognostic (8.51e-2)" 5.5 1.4 1.0 44.6 0.9 23.1 2.8 0.6 0.7 3.2 5.0 0.5 1.1 3.2 1.9 2.5 7.3 2.1 4.8 1.8 1.0 1.0 3.6 3.1 15.4 86.3 1.6 0.3 2.3 1.5 0.0 1.3 2.2 0.8 2.8 5.7 2.4 13.9 1.5 1.3 1.2 21.2 1.7 3.8 66.6 5.0 1.3 0.2 50.8 2.9 3.6 58.0 8.6 2.6 34.6 53.6 35.8 74.1 24.9 57.9 81.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 4.6 43.5 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 14.2 0.0 0.0 13.5 6.7 0.0 0.0 0.0 0.8 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.1 61.5 15.8 0.0 11.7 0.0 28.2 52.2 35.8 42.4 74.1 57.9 34.6 48.3 48.8 53.6 27.9 49.7 52.5 13.4 24.9 73.5 9.4 36.4 81.3 1.0 0.9 0.6 0.7 1.0 1.0 1.6 0.3 0.8 0.2 0.0 14.8 233.4 0.5 4.8 0.0 0.8 5.1 4.0 2.3 3.5 0.0 0.7 1.7 0.1 0.0 0.7 0.0 23.3 0.2 0.7 3.1 0.2 88.9 1.8 87.6 0.0 1.2 8.6 195.5 0.4 1.7 131.8 37.1 8.2 0.0 0.0 0.1 0.0 0.4 1.5 0.0 0.0 0.7 0.4 0.1 2.6 0.3 297.5 0.0 0.3 CD5 "LEU1, T1" ENSG00000110448 "CD5 molecule" P06127 11 61102395-61127852 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.3;lymphoid tissue: 96.2" "Group enriched" "Detected in some" 4 "Muller glia cells: 9.6;T-cells: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 20 "gdT-cell: 12.9;MAIT T-cell: 9.3;memory CD4 T-cell: 31.2;memory CD8 T-cell: 20.6;naive CD4 T-cell: 25.9;naive CD8 T-cell: 19.5;T-reg: 36.3" "Lineage enriched" "Detected in many" 32 "T-cells: 36.3" "Group enriched" "Detected in some" 65 "JURKAT: 12.0;MOLT-4: 38.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB015392, CAB020308, HPA043416, HPA060839" Enhanced NA NA "CAB015392: AB_2075324, CAB020308: , HPA043416: AB_2678472, HPA060839: AB_2684376" "prognostic favorable (4.05e-4)" "prognostic favorable (9.16e-5)" "unprognostic (2.33e-1)" "prognostic favorable (9.00e-5)" "unprognostic (1.02e-2)" "prognostic favorable (7.41e-6)" "unprognostic (2.45e-3)" "unprognostic (1.37e-2)" "prognostic favorable (3.93e-4)" "unprognostic (1.25e-2)" "unprognostic (5.00e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (8.94e-5)" "unprognostic (4.78e-2)" "unprognostic (1.02e-2)" "unprognostic (2.38e-1)" "unprognostic (1.06e-1)" 2.1 0.6 0.5 19.4 0.4 6.5 1.3 0.3 0.6 1.6 2.5 0.3 0.3 1.7 1.1 1.7 1.9 1.4 3.9 0.8 0.6 1.3 1.9 1.1 7.1 28.8 0.4 0.1 1.1 0.9 0.0 0.8 0.4 0.3 1.4 1.5 1.6 15.5 1.3 0.6 1.3 10.2 0.4 0.7 13.8 4.8 1.3 0.1 96.2 1.7 2.4 42.2 5.4 1.5 1.1 1.1 0.4 0.7 0.1 36.3 14.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 12.9 0.1 9.3 0.4 31.2 20.6 0.9 1.1 25.9 19.5 0.4 0.1 0.7 1.1 36.3 14.6 0.5 0.4 0.3 0.6 0.6 1.3 0.4 0.1 0.3 0.1 0.0 1.7 0.5 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.1 0.0 0.1 0.0 0.0 1.3 0.0 0.8 0.0 0.6 3.3 1.8 0.0 9.6 0.1 0.0 0.0 0.0 1.2 0.0 0.3 0.3 0.5 0.3 0.0 18.7 0.0 0.1 CD52 "CDW52, EDDM5, HE5" ENSG00000169442 "CD52 molecule" P31358 1 26317957-26320523 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 495.7;epididymis: 978.9" "Cell type enhanced" "Detected in many" 13 "B-cells: 1214.9;granulocytes: 550.2;Hofbauer cells: 593.7;Macrophages: 676.6;T-cells: 760.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 9 "Daudi: 76.1;REH: 111.3;U-266/84: 111.2;U-698: 123.2" NA NA "prognostic favorable (1.85e-5)" "unprognostic (3.28e-3)" "unprognostic (1.93e-2)" "prognostic favorable (2.06e-4)" "unprognostic (4.18e-2)" "prognostic favorable (4.45e-4)" "unprognostic (9.11e-2)" "unprognostic (2.98e-2)" "unprognostic (7.73e-3)" "unprognostic (6.27e-2)" "unprognostic (4.58e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (3.64e-1)" "unprognostic (6.14e-2)" "unprognostic (7.95e-2)" "unprognostic (1.26e-1)" 9.5 0.9 0.8 23.0 1.4 5.7 4.7 0.3 0.8 0.9 3.7 0.3 93.2 1.0 1.1 978.9 2.9 1.5 2.2 1.5 0.6 0.2 3.5 3.2 43.4 54.6 0.8 0.6 0.8 1.0 0.0 0.7 0.7 0.7 1.7 2.5 1.3 5.7 2.9 0.4 1.9 39.6 1.1 1.2 98.7 2.7 5.3 0.4 24.7 3.2 2.1 30.4 4.3 1.7 292.0 87.6 258.4 194.6 94.3 308.1 495.7 0.2 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 76.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.0 0.7 11.9 0.0 0.0 0.0 0.0 0.0 0.0 4.9 2.5 0.1 0.0 0.5 0.8 6.8 0.3 0.0 0.0 111.3 0.1 1.7 0.0 0.0 0.2 1.0 0.0 0.1 0.1 1.0 0.0 1.3 0.1 0.0 0.2 0.0 0.1 0.3 111.2 123.2 0.0 1.9 0.0 12.4 126.8 258.4 194.7 194.6 155.1 292.0 244.1 190.3 87.6 273.7 166.6 171.2 9.6 94.3 167.6 28.6 308.1 495.7 0.8 1.4 0.3 0.8 0.6 0.2 0.8 0.6 0.7 0.4 62.5 287.6 1214.9 0.7 40.3 0.0 6.0 2.5 32.1 92.1 47.1 0.0 2.7 0.0 0.2 0.7 22.7 0.7 0.0 0.2 4.3 18.8 0.4 550.2 1.5 593.7 0.0 0.0 17.8 203.9 1.3 0.0 676.6 101.3 2.8 1.9 0.0 0.1 2.9 0.0 7.6 0.0 0.0 3.3 0.2 0.2 27.5 4.7 760.6 0.2 0.8 CD53 "MOX44, TSPAN25" ENSG00000143119 "CD53 molecule" P19397 1 110873154-110899928 "CD markers, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 146.7;lymphoid tissue: 103.0" "Group enriched" "Detected in many" 7 "B-cells: 233.1;granulocytes: 158.2;Hofbauer cells: 322.4;Kupffer cells: 293.3;Macrophages: 340.3;T-cells: 289.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 87.2;HDLM-2: 37.5;HMC-1: 54.9;Karpas-707: 34.2;U-266/70: 47.3;U-698: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047216 Enhanced NA NA "HPA047216: AB_2679986" "unprognostic (2.93e-2)" "unprognostic (1.25e-2)" "unprognostic (7.45e-3)" "unprognostic (1.02e-3)" "unprognostic (8.88e-2)" "unprognostic (3.78e-2)" "unprognostic (2.96e-1)" "unprognostic (6.07e-2)" "unprognostic (2.83e-2)" "unprognostic (2.03e-1)" "unprognostic (5.09e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (2.60e-4)" "unprognostic (9.58e-2)" "unprognostic (4.95e-2)" "unprognostic (1.33e-1)" "unprognostic (7.72e-2)" 29.7 8.1 6.1 50.6 10.3 20.4 6.6 1.6 5.8 4.5 9.6 7.6 1.2 6.7 4.3 6.0 5.5 9.9 11.0 6.4 6.4 5.9 9.6 8.8 28.9 93.8 13.3 2.7 4.7 3.8 0.8 3.1 10.6 8.5 5.2 10.5 4.5 10.1 2.3 2.3 2.2 35.2 10.0 14.9 103.0 7.5 4.8 10.0 37.2 4.6 4.1 82.1 15.2 4.0 97.5 74.6 138.0 97.0 59.2 91.8 146.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 37.5 0.0 4.6 0.0 0.0 0.0 10.4 54.9 0.0 0.0 0.0 0.0 0.0 0.0 25.0 1.9 34.2 0.0 0.0 17.7 12.4 0.0 0.0 0.0 17.2 0.1 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 15.7 3.1 0.0 0.0 0.0 0.1 47.3 21.4 27.0 0.2 12.1 0.6 138.0 87.0 54.1 91.8 93.3 82.8 97.5 67.5 80.8 74.6 83.3 49.2 70.8 136.2 59.2 97.0 61.4 85.0 146.7 6.1 10.3 1.6 5.8 6.4 5.9 13.3 2.7 8.5 10.0 14.9 35.6 233.1 0.4 6.3 0.0 0.8 5.1 8.1 15.9 1.8 0.0 1.7 0.0 0.0 0.2 7.2 0.0 23.3 0.2 4.2 5.0 0.3 158.2 1.7 322.4 0.0 0.0 15.4 293.3 0.9 2.0 340.3 37.1 39.7 0.0 0.0 0.2 0.0 0.4 1.1 0.6 6.5 0.7 0.1 0.7 4.8 3.4 289.1 0.0 0.3 CD58 LFA3 ENSG00000116815 "CD58 molecule" P19256 1 116514535-116571039 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Macrophages: 115.4;monocytes: 225.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 46.3" NA NA 7100000 "unprognostic (4.48e-3)" "unprognostic (3.20e-1)" "unprognostic (2.95e-2)" "unprognostic (4.03e-2)" "unprognostic (8.45e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.32e-6)" "unprognostic (9.84e-2)" "unprognostic (7.17e-2)" "unprognostic (4.72e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.82e-1)" "unprognostic (1.66e-2)" "unprognostic (1.86e-1)" "unprognostic (3.68e-2)" "unprognostic (2.17e-2)" "unprognostic (9.66e-2)" 21.5 9.6 5.9 17.6 8.7 29.9 15.2 2.2 7.7 15.8 24.7 5.9 10.4 17.0 12.4 15.3 22.1 11.0 19.2 23.9 7.3 4.8 32.8 11.0 22.4 14.5 9.6 3.7 6.5 6.6 6.5 12.0 10.0 9.3 9.4 17.9 6.4 18.4 15.3 8.8 14.9 48.3 16.3 11.5 23.1 11.1 6.5 8.8 9.3 12.0 22.9 18.2 15.4 16.2 6.0 12.4 47.3 17.1 4.9 17.8 9.5 11.8 6.8 5.0 4.8 8.5 14.3 3.1 6.1 10.6 10.6 10.4 3.0 23.0 2.1 11.3 10.6 12.4 15.4 3.7 10.4 11.3 11.6 4.3 10.7 12.5 4.2 5.4 14.7 14.9 3.9 14.2 8.8 7.9 22.7 6.1 2.8 9.4 46.3 6.4 21.3 6.3 11.2 2.5 17.6 7.5 12.5 17.0 2.8 21.3 9.7 1.7 3.5 12.2 9.1 34.2 5.4 4.7 5.5 11.2 7.7 5.9 10.3 15.5 7.0 12.4 1.4 17.7 7.3 38.0 28.7 14.7 24.4 11.5 14.2 7.9 6.0 10.1 9.5 12.4 2.1 1.4 5.8 47.3 4.9 17.1 1.4 17.8 9.5 5.9 8.7 2.2 7.7 7.3 4.8 9.6 3.7 9.3 8.8 8.9 36.4 11.5 12.8 16.3 0.0 24.6 30.6 33.5 22.7 14.0 0.0 3.6 3.3 34.2 1.7 27.4 41.0 23.3 24.6 1.6 16.2 13.6 49.9 7.8 57.7 1.6 10.4 22.1 34.3 2.1 9.8 115.4 11.8 225.4 14.5 3.9 30.7 42.1 11.0 23.7 0.5 32.3 25.9 3.0 1.4 24.3 1.6 30.5 16.3 33.1 CD6 Tp120 ENSG00000013725 "CD6 molecule" P30203 11 60971680-61020377 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.0;lymphoid tissue: 58.1" "Group enriched" "Detected in some" 5 "B-cells: 10.7;T-cells: 34.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 34 "gdT-cell: 12.4;MAIT T-cell: 11.1;memory CD4 T-cell: 23.0;memory CD8 T-cell: 21.4;naive CD4 T-cell: 15.5;naive CD8 T-cell: 11.1;T-reg: 10.1" "Lineage enriched" "Detected in single" 52 "T-cells: 23.0" "Group enriched" "Detected in some" 12 "JURKAT: 7.8;MOLT-4: 28.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB002489, CAB016252" Enhanced "Secreted to blood" NA NA 5270000 110000 "CAB002489: AB_563605, CAB016252: AB_631163" "prognostic favorable (1.95e-4)" "prognostic favorable (1.57e-5)" "unprognostic (4.47e-2)" "prognostic favorable (2.41e-4)" "unprognostic (2.06e-2)" "prognostic favorable (5.10e-6)" "unprognostic (8.45e-3)" "unprognostic (8.21e-3)" "unprognostic (2.87e-3)" "unprognostic (5.32e-3)" "unprognostic (2.07e-1)" "unprognostic (5.35e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (1.77e-1)" "unprognostic (4.95e-2)" "unprognostic (6.19e-2)" "unprognostic (5.96e-2)" 1.5 0.5 0.8 26.4 0.4 5.5 0.9 0.5 1.4 1.3 3.3 0.6 0.8 2.2 1.4 1.5 1.9 1.3 5.0 1.3 0.7 1.8 1.6 1.1 6.9 25.6 1.7 0.5 0.7 0.8 0.0 0.6 0.6 0.4 1.2 1.6 1.2 7.0 0.3 0.3 0.9 13.0 0.7 0.9 18.4 3.4 0.9 0.1 58.1 1.6 1.9 42.0 3.7 1.3 0.4 0.1 0.3 0.0 0.0 23.0 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.1 0.0 0.0 0.0 28.9 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.4 0.0 11.1 0.4 23.0 21.4 0.1 0.4 15.5 11.1 0.3 0.0 0.0 0.0 10.1 5.1 0.8 0.4 0.5 1.4 0.7 1.8 1.7 0.5 0.4 0.1 0.0 4.5 10.7 0.2 1.8 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.8 0.4 0.0 0.0 0.6 0.1 0.3 0.1 0.0 0.9 2.1 1.6 0.0 1.3 1.2 0.0 0.3 2.0 3.3 1.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.9 0.3 0.8 1.3 0.2 34.6 0.1 0.3 CD63 "ME491, MLA1, TSPAN30" ENSG00000135404 "CD63 molecule" P08962 12 55725323-55729707 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 276.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010088, CAB026356, HPA073506" Supported Supported Vesicles "Intracellular and membrane" NA NA Vesicles "CAB026356: AB_629864, HPA010088: AB_1846323, HPA073506: " "unprognostic (8.76e-3)" "unprognostic (8.81e-2)" "unprognostic (1.27e-1)" "unprognostic (1.28e-3)" "unprognostic (9.48e-2)" "unprognostic (3.66e-3)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.11e-1)" "unprognostic (6.50e-2)" "unprognostic (1.08e-1)" "unprognostic (1.66e-2)" "unprognostic (3.10e-1)" "unprognostic (2.70e-2)" "unprognostic (4.82e-2)" "unprognostic (5.21e-2)" "unprognostic (1.85e-3)" "unprognostic (9.02e-2)" 115.3 88.2 42.5 44.9 37.2 67.4 106.3 13.7 33.1 80.6 84.7 34.4 71.5 39.9 99.7 177.9 70.9 60.4 102.7 154.4 36.9 39.0 106.6 92.5 109.6 113.8 49.8 27.2 93.8 187.1 33.3 49.3 176.9 50.8 82.9 81.8 102.1 105.0 83.7 92.7 38.5 72.4 88.2 43.6 107.7 74.8 52.1 30.5 17.6 108.1 50.7 47.4 96.3 82.2 9.6 40.3 147.4 50.8 58.4 29.8 56.6 22.2 38.8 21.3 20.7 276.2 173.2 28.1 90.7 166.3 53.7 58.5 43.3 44.9 6.4 28.9 134.9 38.3 20.7 15.4 37.5 69.1 18.1 14.5 35.0 30.3 23.9 109.9 15.5 83.4 127.4 37.4 59.6 54.7 111.7 59.1 3.2 19.7 44.8 170.8 35.6 3.1 21.1 19.4 49.2 45.2 7.0 46.8 16.0 90.8 75.9 8.3 21.3 24.8 18.8 162.9 32.5 26.5 51.9 43.9 34.8 25.4 47.9 30.3 18.4 11.3 4.4 99.6 10.0 63.4 89.6 50.8 147.4 29.8 38.5 21.8 9.6 11.9 23.7 40.3 6.5 5.3 18.1 55.7 58.4 26.1 27.0 10.0 56.6 42.5 37.2 13.7 33.1 36.9 39.0 49.8 27.2 50.8 30.5 476.4 590.3 176.4 1219.6 503.8 174.4 555.7 917.2 377.4 564.1 830.5 143.3 558.0 197.3 2170.1 13.3 768.7 766.8 0.0 3001.1 2390.1 1497.1 1539.2 986.0 374.3 3024.5 31.8 557.9 750.1 794.3 26.6 1599.3 1215.7 1891.2 756.6 1108.9 851.5 2709.4 1083.7 1087.6 631.9 181.5 1235.3 1556.4 33.0 71.8 350.0 2264.8 339.0 575.6 1313.8 CD68 "DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1" ENSG00000129226 "CD68 molecule" P34810 17 7579467-7582113 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 179.1;lymphoid tissue: 139.1" "Group enriched" "Detected in many" 6 "Hofbauer cells: 1656.8;Kupffer cells: 486.8;Macrophages: 440.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 155.1;intermediate monocyte: 179.1;non-classical monocyte: 170.1" "Group enriched" "Detected in many" 11 "dendritic cells: 68.4;monocytes: 179.1" "Cell line enhanced" "Detected in many" "ASC diff: 74.5;U-87 MG: 117.4" "Low region specificity" "Detected in all" "CAB000051, CAB000066, HPA048982, CAB072861, CAB072862" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587" "unprognostic (2.16e-2)" "unprognostic (1.47e-2)" "unprognostic (6.46e-2)" "unprognostic (1.49e-3)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (4.75e-4)" "unprognostic (2.83e-2)" "unprognostic (1.31e-1)" "unprognostic (6.85e-2)" "unprognostic (1.04e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (1.14e-5)" "unprognostic (1.58e-1)" "unprognostic (8.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.65e-2)" 118.4 28.5 12.5 46.8 21.6 46.8 40.9 2.9 11.2 27.1 38.1 15.5 2.1 57.0 9.6 24.1 26.9 17.3 33.7 39.0 10.1 6.9 20.9 43.1 84.4 102.5 21.1 4.4 15.8 7.5 2.1 8.5 34.7 15.7 12.1 18.5 12.8 22.2 4.4 16.1 9.4 58.3 15.6 26.0 139.1 17.6 9.4 16.3 13.3 8.8 12.3 21.1 31.4 19.1 3.7 68.4 11.0 179.1 0.9 0.5 125.6 35.7 7.3 0.4 0.5 74.5 28.4 0.3 11.4 31.2 15.2 17.7 1.5 10.8 0.4 13.0 33.1 27.0 1.6 0.1 7.2 10.3 0.3 1.3 5.7 1.8 8.6 6.3 2.8 32.2 9.0 1.5 31.7 23.4 25.1 3.9 0.6 2.2 3.7 14.6 0.2 0.2 2.5 0.4 9.3 5.3 0.4 0.6 21.1 3.1 1.6 0.2 0.4 9.5 4.8 11.1 0.3 0.2 21.9 12.4 19.3 1.2 19.3 14.9 0.2 0.3 0.2 117.4 7.0 9.7 10.1 155.1 0.9 0.4 179.1 0.5 3.7 0.2 0.3 40.9 2.0 0.3 0.2 11.0 0.9 170.1 68.4 0.3 125.6 12.5 21.6 2.9 11.2 10.1 6.9 21.1 4.4 15.7 16.3 0.0 22.4 23.8 26.4 14.0 0.0 0.0 7.6 9.4 13.6 5.2 0.0 7.2 5.0 60.6 0.6 16.8 36.0 0.0 137.4 51.8 33.7 27.3 40.6 16.3 1656.8 0.0 4.7 13.5 486.8 1.1 6.1 440.3 37.1 60.5 7.1 0.2 92.4 25.9 1.8 31.1 1.2 25.8 13.3 0.3 0.2 12.5 27.9 12.5 10.2 68.9 CD69 CLEC2C ENSG00000110848 "CD69 molecule" Q07108 12 9752486-9760901 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 52.1;lymphoid tissue: 56.4" "Cell type enhanced" "Detected in many" 27 "B-cells: 256.7;granulocytes: 1372.7;T-cells: 467.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "NK-cells: 14.8;T-cells: 18.3" "Cell line enhanced" "Detected in some" "HL-60: 12.7;JURKAT: 8.5;K-562: 24.5;MOLT-4: 8.7;U-266/70: 10.0;U-698: 11.3;U-937: 41.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002503, HPA050525" Enhanced NA NA "CAB002503: AB_563625, HPA050525: AB_2681157" "prognostic favorable (3.31e-5)" "unprognostic (1.84e-2)" "unprognostic (1.80e-2)" "unprognostic (1.73e-2)" "unprognostic (1.66e-1)" "unprognostic (7.10e-3)" "unprognostic (4.76e-3)" "unprognostic (9.53e-3)" "unprognostic (9.73e-3)" "unprognostic (1.64e-2)" "unprognostic (1.96e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (7.87e-5)" "unprognostic (2.88e-2)" "unprognostic (3.32e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" 10.1 2.2 1.3 19.9 1.4 52.1 7.0 0.5 0.9 9.0 9.6 4.6 0.8 2.8 5.1 5.1 10.6 6.4 13.6 3.1 2.0 2.2 4.7 6.2 27.0 31.6 4.5 0.6 3.4 1.4 0.9 3.4 1.9 3.5 7.4 8.0 3.3 6.0 2.0 1.5 3.3 14.3 5.0 8.3 43.3 4.3 4.5 1.6 56.4 5.5 6.1 26.7 27.4 5.9 3.9 0.0 3.1 0.1 14.8 18.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.7 12.7 0.6 0.0 0.0 0.0 0.0 0.0 0.2 8.5 24.5 0.0 0.0 0.0 8.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 1.1 11.3 0.0 41.9 0.0 0.7 0.1 3.1 13.7 0.0 18.3 3.3 8.7 9.9 0.0 3.9 12.6 9.2 0.2 14.8 0.0 0.0 4.3 3.8 1.3 1.4 0.5 0.9 2.0 2.2 4.5 0.6 3.5 1.6 38.7 196.1 256.7 1.7 16.5 0.0 0.8 0.0 2.7 9.1 1.8 0.0 0.5 0.0 0.0 0.2 3.9 0.3 23.3 0.0 0.2 14.6 1.2 1372.7 1.0 17.1 0.0 0.0 6.7 6.0 0.0 0.0 57.6 32.1 2.8 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 2.0 0.0 0.2 15.8 1.6 467.3 0.0 1.3 CD7 "GP40, LEU-9, Tp40, TP41" ENSG00000173762 "CD7 molecule" P09564 17 82314868-82317602 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 54.1;lymphoid tissue: 127.6" "Cell type enriched" "Detected in many" 29 "T-cells: 440.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 54.1" "Group enriched" "Detected in many" 21 "NK-cells: 54.1;T-cells: 19.0" "Cell line enhanced" "Detected in some" "BEWO: 5.6;Hep G2: 21.4;JURKAT: 11.4;MOLT-4: 48.7" "CAB002594, HPA039079" Enhanced NA NA "CAB002594: , HPA039079: AB_2676337" "unprognostic (3.14e-3)" "prognostic favorable (5.51e-4)" "unprognostic (1.89e-2)" "prognostic favorable (2.03e-5)" "unprognostic (7.69e-3)" "unprognostic (1.09e-3)" "unprognostic (3.28e-2)" "unprognostic (1.34e-1)" "prognostic favorable (2.69e-4)" "unprognostic (3.16e-2)" "unprognostic (1.03e-1)" "unprognostic (2.24e-1)" "prognostic unfavorable (7.75e-11)" "unprognostic (4.69e-2)" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (1.55e-3)" 4.7 0.7 0.5 23.4 0.4 14.5 1.7 0.4 0.3 1.9 8.0 0.3 0.5 7.7 1.8 1.9 3.4 2.4 3.5 1.4 0.5 0.6 2.8 4.1 9.5 50.2 0.9 0.0 1.6 1.0 0.0 1.0 4.0 0.4 2.7 1.0 1.8 6.0 1.1 0.5 1.0 17.5 0.5 1.6 33.0 4.6 0.9 0.1 127.6 2.2 1.0 33.3 4.6 2.2 0.1 1.7 0.6 0.1 54.1 19.0 7.1 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 21.4 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.1 0.1 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 17.6 0.0 15.1 0.1 7.9 12.8 0.0 0.0 19.0 18.9 0.6 54.1 0.1 1.7 6.8 7.1 0.5 0.4 0.4 0.3 0.5 0.6 0.9 0.0 0.4 0.1 0.0 0.0 5.6 0.5 6.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.9 4.2 0.0 0.5 5.2 6.4 1.7 8.1 2.4 3.2 1.6 0.0 12.9 15.2 0.0 0.0 5.8 11.8 0.0 0.6 0.0 0.2 0.8 0.0 0.6 0.0 0.0 2.2 0.0 0.4 3.9 1.6 440.5 0.9 1.7 CD70 "CD27L, CD27LG, TNFSF7" ENSG00000125726 "CD70 molecule" P32970 19 6583183-6604103 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Cytokine "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.3;lymphoid tissue: 12.7" "Cell type enriched" "Detected in some" 23 "monocytes: 417.4" "Cancer enhanced" "Detected in many" "renal cancer: 24.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 13.9;T-reg: 23.3" "Group enriched" "Detected in many" 38 "B-cells: 13.9;T-cells: 23.3" "Cell line enhanced" "Detected in many" "SiHa: 36.8;THP-1: 30.2;U-251 MG: 44.7;U-266/70: 79.5;U-266/84: 57.5" HPA046582 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046582: " "unprognostic (8.71e-2)" "unprognostic (9.91e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-4)" "unprognostic (1.73e-2)" "unprognostic (1.51e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (2.57e-2)" "unprognostic (1.40e-1)" "unprognostic (2.27e-1)" "unprognostic (2.08e-1)" 5.3 0.2 0.2 9.3 0.2 1.4 2.2 0.9 0.9 1.4 4.1 0.2 0.1 1.0 0.4 1.8 4.0 0.7 0.8 0.4 0.2 0.2 1.7 0.4 1.9 6.1 0.4 0.1 0.3 0.4 0.0 0.3 0.3 0.2 0.9 3.1 0.2 3.1 1.2 1.2 3.3 5.2 0.7 0.5 11.8 1.7 1.9 0.1 3.2 0.8 1.8 12.7 3.1 1.1 13.9 0.1 0.2 0.0 0.4 23.3 0.9 0.2 7.5 0.0 14.8 0.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 14.2 0.8 0.0 16.3 10.4 9.1 0.7 0.0 0.0 0.3 0.0 11.2 0.0 0.0 0.0 0.4 0.1 0.0 8.7 6.2 2.4 0.0 0.0 0.2 0.4 0.2 0.0 0.2 17.8 0.1 0.0 13.7 3.8 0.0 3.0 4.8 0.0 0.0 0.0 36.8 0.0 0.1 0.0 0.1 30.2 0.2 0.1 6.6 0.0 44.7 79.5 57.5 25.6 8.2 4.5 2.8 0.2 0.0 0.0 1.9 0.0 4.8 13.9 3.2 5.0 0.0 4.0 0.4 1.3 0.1 0.4 0.0 0.1 23.3 0.9 0.2 0.2 0.9 0.9 0.2 0.2 0.4 0.1 0.2 0.1 0.0 0.0 18.2 0.1 5.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.1 1.1 0.0 0.3 0.0 1.7 1.3 0.0 0.0 0.0 1.7 3.3 417.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.2 4.6 0.0 10.2 0.0 0.0 CD72 "CD72b, LYB2" ENSG00000137101 "CD72 molecule" P21854 9 35609533-35646810 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "blood: 75.5;lymphoid tissue: 59.7" "Cell type enriched" "Detected in some" 4 "B-cells: 82.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 16 "memory B-cell: 34.3;naive B-cell: 75.5" "Lineage enriched" "Detected in many" 22 "B-cells: 75.5" "Cell line enhanced" "Detected in some" "Daudi: 12.7;Karpas-707: 8.2;REH: 5.3;U-698: 28.3" "Region enriched" "Detected in single" 7 "basal ganglia: 3.6" "Low region specificity" "Detected in single" "CAB002505, HPA044658" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "CAB002505: AB_563629, HPA044658: AB_2679039" "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.21e-2)" "unprognostic (8.82e-2)" "unprognostic (1.87e-2)" "unprognostic (7.81e-2)" "unprognostic (7.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.29e-2)" "unprognostic (2.02e-2)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (2.49e-8)" "unprognostic (1.42e-1)" "unprognostic (2.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.59e-2)" 1.9 1.2 0.8 16.6 1.1 2.6 1.3 0.6 0.6 0.7 0.9 0.2 0.5 0.3 0.8 2.1 0.8 0.7 1.6 0.6 0.8 0.7 1.5 2.3 2.2 26.8 0.8 0.1 0.5 1.4 0.5 1.6 1.5 1.1 0.9 0.3 1.1 3.4 0.1 0.5 0.8 5.2 0.6 1.8 59.7 0.8 0.8 0.2 1.5 1.4 0.3 22.2 4.9 0.6 75.5 3.4 0.2 0.6 1.7 0.7 2.5 0.1 0.0 0.4 0.2 0.7 3.9 0.1 0.2 0.1 0.3 0.5 0.0 0.1 12.7 0.0 0.2 0.1 0.0 0.0 0.1 0.4 1.2 0.3 0.4 0.0 0.0 0.4 0.2 2.8 1.1 0.0 0.2 0.3 0.6 0.0 2.8 0.0 8.2 0.7 0.0 0.2 1.7 0.1 0.0 0.1 5.3 0.0 3.8 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.5 0.1 0.2 0.0 0.1 0.2 28.3 0.5 0.4 0.0 0.0 0.3 0.0 0.5 0.6 0.7 34.3 0.2 0.3 3.4 75.5 0.1 0.4 0.2 1.7 0.0 1.8 0.3 2.5 0.8 1.1 0.6 0.6 0.8 0.7 0.8 0.1 1.1 0.2 0.0 1.1 82.7 0.3 0.9 0.0 0.6 2.5 1.4 0.0 3.5 0.0 0.1 0.0 0.6 0.1 0.5 0.5 0.0 0.6 0.2 0.6 0.4 0.0 0.0 19.7 0.0 1.7 0.6 16.7 0.0 0.9 8.0 0.0 1.8 0.0 0.5 1.2 0.0 0.4 0.3 0.7 0.0 0.8 0.2 1.2 1.0 0.2 4.9 0.3 0.1 CD74 DHLAG ENSG00000019582 "CD74 molecule" P04233 5 150401637-150412929 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 504.7" "Cell type enhanced" "Detected in many" 16 "Hofbauer cells: 4588.2;Macrophages: 7133.7;monocytes: 15196.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 191.6;intermediate monocyte: 303.5;memory B-cell: 467.7;myeloid DC: 437.9;naive B-cell: 504.7;non-classical monocyte: 140.0;plasmacytoid DC: 303.2" "Group enriched" "Detected in all" 5 "B-cells: 504.7;dendritic cells: 437.9;monocytes: 303.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 118.2;Daudi: 181.9;HDLM-2: 261.1;REH: 157.4;RPMI-8226: 107.2;U-266/70: 87.7;U-698: 100.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002506, HPA010592" Enhanced Supported "Golgi apparatus" NA NA 90000 "Golgi apparatus" "CAB002506: AB_563630, HPA010592: AB_1078482" "prognostic favorable (1.06e-4)" "unprognostic (1.48e-2)" "unprognostic (4.80e-3)" "prognostic favorable (6.53e-6)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (2.05e-1)" "unprognostic (3.69e-3)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (2.20e-2)" "unprognostic (2.64e-1)" "unprognostic (5.44e-3)" "unprognostic (1.73e-1)" "unprognostic (4.95e-2)" "unprognostic (2.05e-1)" "unprognostic (4.24e-2)" 137.8 95.7 53.2 177.0 81.4 40.7 104.2 8.4 43.5 89.6 68.2 79.0 30.0 98.3 60.0 73.9 43.6 68.1 81.3 104.1 46.9 43.5 168.3 60.1 222.5 310.1 78.3 23.1 53.4 34.1 15.1 51.0 27.9 79.8 72.6 63.6 72.9 123.0 55.4 40.5 56.6 182.8 55.1 123.1 372.1 77.3 23.7 68.1 201.1 83.4 45.6 288.2 91.7 47.0 504.7 437.9 76.1 303.5 42.2 41.2 238.1 1.9 0.0 0.0 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.0 23.6 118.2 181.9 7.3 0.0 0.5 0.5 0.0 0.0 0.0 261.1 0.0 5.9 0.1 14.4 0.3 0.4 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 72.4 0.0 0.0 0.2 0.8 0.3 0.0 0.0 157.4 0.2 107.2 0.5 7.7 0.3 0.5 0.3 0.2 5.2 1.2 4.8 21.8 0.2 0.6 0.5 0.5 0.2 87.7 9.4 100.8 42.2 8.2 38.5 6.3 191.6 76.1 16.8 303.5 18.7 467.7 14.8 24.8 437.9 504.7 7.8 13.5 16.8 42.2 140.0 303.2 41.2 238.1 53.2 81.4 8.4 43.5 46.9 43.5 78.3 23.1 79.8 68.1 390.1 2012.6 3694.0 133.2 635.9 0.3 57.9 405.1 591.6 683.6 476.3 0.0 29.1 99.5 571.4 6.9 1116.8 170.9 23.3 476.1 19.5 234.4 182.3 395.1 56.2 4588.2 1.6 233.2 353.6 3259.2 11.0 108.4 7133.7 1135.4 15196.0 331.4 14.5 306.9 131.5 16.6 759.6 8.0 161.7 171.2 2.3 7.6 503.4 34.8 370.6 168.2 195.9 CD79A "IGA, MB-1" ENSG00000105369 "CD79a molecule" P11912 19 41877120-41881372 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 125.3;intestine: 43.5;lymphoid tissue: 119.2" "Cell type enriched" "Detected in some" 6 "B-cells: 739.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "memory B-cell: 106.4;naive B-cell: 125.3" "Lineage enriched" "Detected in many" 41 "B-cells: 125.3" "Group enriched" "Detected in some" 24 "Daudi: 159.2;REH: 49.5;U-698: 138.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB000019 Enhanced NA NA "CAB000019: AB_2244527" "prognostic favorable (8.45e-5)" "unprognostic (1.63e-3)" "unprognostic (4.13e-3)" "unprognostic (1.31e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.18e-5)" "unprognostic (1.23e-2)" "unprognostic (8.11e-3)" "unprognostic (9.41e-3)" "unprognostic (1.12e-2)" "unprognostic (2.53e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (6.08e-2)" "unprognostic (3.39e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-1)" 1.3 0.6 0.5 103.8 0.5 5.4 1.3 0.5 0.5 1.8 6.3 0.1 0.1 4.9 0.6 0.2 4.4 1.0 2.3 0.8 0.5 0.5 2.3 0.9 4.3 114.9 0.5 0.1 0.6 0.6 0.0 0.5 0.5 0.1 1.0 3.4 1.8 13.6 1.2 0.5 0.5 43.5 0.2 0.5 108.1 9.7 0.8 0.1 32.0 2.4 1.9 119.2 6.8 1.0 125.3 3.0 0.7 0.3 0.2 2.3 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 49.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.8 0.1 138.6 0.0 4.7 0.0 0.7 0.1 0.5 0.1 0.1 0.0 106.4 0.3 0.1 0.2 125.3 0.4 2.3 0.4 0.2 0.3 3.0 0.8 4.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.1 0.1 0.0 3.7 739.3 0.4 1.5 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 22.3 0.2 0.6 0.2 0.0 0.0 0.8 0.0 0.0 1.8 3.1 0.0 0.3 1.7 131.6 2.8 0.3 0.0 105.8 0.0 0.4 0.6 0.0 0.0 0.4 0.0 0.6 1.3 0.1 6.5 0.6 0.1 CD79B "B29, IGB" ENSG00000007312 "CD79b molecule" P40259 17 63928740-63932354 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 138.8;lymphoid tissue: 56.6" "Cell type enriched" "Detected in many" 8 "B-cells: 486.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 100.6;naive B-cell: 138.8" "Lineage enriched" "Detected in many" 6 "B-cells: 138.8" "Cell line enhanced" "Detected in some" "Daudi: 117.7;REH: 38.7;U-698: 161.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009178, CAB009751, HPA044107" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: " "unprognostic (3.90e-3)" "unprognostic (1.61e-3)" "unprognostic (5.21e-2)" "unprognostic (3.45e-3)" "unprognostic (4.22e-3)" "prognostic favorable (2.35e-4)" "unprognostic (1.82e-1)" "unprognostic (9.25e-3)" "unprognostic (3.89e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (2.87e-2)" "unprognostic (2.50e-3)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (4.28e-2)" "unprognostic (2.75e-1)" 1.7 0.7 0.4 50.6 0.4 11.1 1.2 0.3 0.4 0.6 1.7 0.3 0.3 0.7 0.6 0.5 2.6 0.6 1.4 3.4 0.4 0.2 2.3 1.7 1.3 56.6 0.4 0.3 0.6 1.6 0.0 9.0 0.5 0.3 1.0 1.3 0.8 8.9 0.9 1.2 0.9 22.4 0.5 0.4 56.0 1.8 0.6 0.3 3.7 1.4 1.7 46.6 4.5 0.9 138.8 4.2 0.5 25.0 3.4 9.2 9.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 38.7 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.8 0.1 0.0 0.4 0.0 0.0 5.9 5.7 161.1 0.0 0.2 0.0 0.5 1.1 0.0 4.2 16.5 4.8 100.6 5.4 2.8 4.2 138.8 3.7 2.2 0.5 3.4 25.0 0.6 9.2 9.0 0.4 0.4 0.3 0.4 0.4 0.2 0.4 0.3 0.3 0.3 0.0 2.2 486.9 0.3 3.9 0.0 0.8 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 7.1 0.0 23.3 0.0 0.4 4.3 0.3 15.0 0.5 4.7 0.0 1.2 62.0 14.1 1.1 1.1 3.5 20.3 1.0 0.0 0.0 0.0 0.0 1.8 0.8 0.0 0.0 3.3 0.7 0.1 2.8 0.3 34.6 0.0 0.1 CD80 "B7-1, B7.1, CD28LG, CD28LG1" ENSG00000121594 "CD80 molecule" P33681 3 119524293-119559602 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 17.5" "Cell type enriched" "Detected in some" 22 "monocytes: 113.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 4.3;non-classical monocyte: 1.1;T-reg: 3.3" "Group enriched" "Detected in many" 24 "B-cells: 4.3;monocytes: 1.1;T-cells: 3.3" "Cell line enhanced" "Detected in some" "Daudi: 8.2;HDLM-2: 29.0;Karpas-707: 12.1;U-266/70: 5.2" "Low region specificity" "Detected in all" "CAB025368, HPA050092" Enhanced "Intracellular and membrane" NA NA "CAB025368: , HPA050092: AB_2681012" "unprognostic (2.36e-1)" "unprognostic (1.55e-2)" "unprognostic (5.91e-2)" "unprognostic (1.24e-1)" "unprognostic (3.14e-1)" "unprognostic (1.18e-1)" "unprognostic (1.86e-2)" "unprognostic (4.14e-3)" "unprognostic (1.02e-2)" "unprognostic (4.96e-3)" "unprognostic (1.16e-2)" "unprognostic (1.15e-1)" "unprognostic (9.03e-8)" "unprognostic (3.20e-1)" "unprognostic (3.65e-2)" "unprognostic (7.81e-3)" "unprognostic (1.94e-2)" 0.7 0.6 0.4 11.7 0.3 1.5 1.2 0.3 0.3 0.6 0.7 0.3 0.7 1.3 0.4 0.6 0.7 0.3 1.0 0.5 0.9 0.3 0.7 2.0 6.2 7.4 0.4 0.0 0.3 0.9 0.0 1.1 0.7 0.6 0.6 1.7 0.8 3.9 0.2 0.5 0.4 2.4 0.2 0.8 17.5 0.6 0.4 0.0 5.6 1.6 0.8 17.2 1.8 0.4 4.3 0.1 0.0 1.1 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.2 0.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 4.3 0.5 0.3 0.1 0.6 0.0 0.0 0.0 0.0 1.1 0.0 3.3 0.2 0.4 0.3 0.3 0.3 0.9 0.3 0.4 0.0 0.6 0.0 0.0 1.0 0.5 0.0 0.6 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 3.9 0.0 0.0 5.2 0.0 113.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 CD81 "TAPA-1, TAPA1, TSPAN28" ENSG00000110651 "CD81 molecule" P60033 11 2376177-2397419 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Muller glia cells: 752.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 41.4;naive B-cell: 37.6" "Lineage enriched" "Detected in all" 4 "B-cells: 41.4" "Cell line enhanced" "Detected in many" "ASC diff: 236.1;ASC TERT1: 134.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002507, HPA007234" Supported Supported "Plasma membrane" NA NA 1900000 "Plasma membrane" "CAB002507: AB_563639, HPA007234: AB_1846333" "unprognostic (2.96e-1)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.56e-4)" "unprognostic (1.84e-2)" "prognostic unfavorable (8.21e-5)" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "prognostic favorable (3.86e-4)" "unprognostic (3.07e-3)" "unprognostic (2.08e-1)" "unprognostic (3.55e-2)" "unprognostic (1.67e-1)" "unprognostic (2.06e-1)" "unprognostic (2.06e-1)" 102.5 43.7 52.8 40.1 57.0 9.6 79.3 31.7 63.2 124.7 88.9 75.8 261.4 21.1 143.5 141.5 56.8 123.1 86.8 101.2 46.6 52.8 65.5 123.9 107.4 82.4 70.4 51.3 77.9 62.4 41.4 42.9 61.2 63.0 89.3 34.0 46.6 59.7 263.3 22.6 59.6 39.7 138.9 59.3 64.5 52.1 57.6 53.3 25.3 66.3 38.5 37.9 93.5 80.2 41.4 2.1 5.7 1.8 3.5 9.9 2.7 25.0 26.1 20.9 31.9 236.1 134.3 17.5 47.4 105.1 38.4 38.8 24.4 0.1 21.4 17.1 132.9 24.5 33.0 12.9 33.7 15.8 10.1 39.7 3.2 9.9 0.0 78.1 13.9 28.2 97.5 48.3 15.6 23.8 59.6 36.7 15.6 14.6 37.6 53.6 19.2 11.7 17.7 25.1 22.9 21.1 24.2 10.5 13.6 41.2 16.9 22.6 25.0 15.1 39.8 28.6 17.5 13.2 25.4 48.8 19.6 14.4 36.6 16.2 27.9 6.3 39.1 28.4 8.3 33.4 0.2 0.9 5.7 6.0 1.4 9.9 41.4 4.3 9.4 0.6 37.6 2.6 5.0 0.3 3.5 1.8 2.1 3.0 2.7 52.8 57.0 31.7 63.2 46.6 52.8 70.4 51.3 63.0 53.3 226.3 220.8 55.9 245.9 159.7 80.4 246.3 147.7 72.3 130.8 197.1 25.5 19.0 29.9 103.9 13.1 213.4 6.4 46.7 46.5 23.9 217.2 129.6 79.7 450.6 229.2 139.8 69.1 262.8 169.7 26.3 360.5 166.2 143.4 23.4 40.0 752.2 58.2 11.5 236.2 26.2 63.6 116.4 236.9 12.0 13.4 144.2 16.8 56.5 36.6 204.6 CD82 "IA4, KAI1, R2, ST6, TSPAN27" ENSG00000085117 "CD82 molecule" P27701 11 44564427-44620363 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "granulocytes: 269.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 80.5" "Group enriched" "Detected in all" 6 "B-cells: 51.1;granulocytes: 80.5;T-cells: 25.6" "Cell line enhanced" "Detected in many" "HMC-1: 78.9;LHCN-M2: 46.6;U-87 MG: 55.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002508, HPA028900, HPA061418" Supported Approved Vesicles NA NA Vesicles "CAB002508: AB_563640, HPA028900: AB_10603558, HPA061418: AB_2684510" "unprognostic (5.31e-2)" "unprognostic (4.62e-1)" "unprognostic (2.38e-2)" "unprognostic (1.33e-1)" "unprognostic (2.79e-1)" "unprognostic (1.37e-2)" "unprognostic (1.78e-1)" "unprognostic (7.29e-2)" "unprognostic (3.48e-1)" "unprognostic (2.97e-1)" "unprognostic (2.58e-2)" "unprognostic (1.58e-1)" "unprognostic (3.48e-3)" "unprognostic (1.86e-3)" "unprognostic (2.33e-2)" "unprognostic (2.88e-2)" "unprognostic (6.30e-2)" 14.7 4.9 16.3 21.6 23.1 43.6 13.8 6.3 13.6 17.5 20.7 23.0 53.0 25.9 4.8 13.5 58.3 19.8 21.7 12.7 16.9 13.3 10.2 18.8 38.8 22.8 17.9 9.2 9.0 11.6 2.8 3.9 20.7 14.0 14.3 6.8 18.6 29.8 55.2 10.5 34.6 36.0 8.9 10.2 21.9 22.5 4.5 12.6 23.9 8.3 23.5 33.5 16.3 28.1 51.1 6.7 80.5 9.1 7.2 25.6 9.5 5.1 0.7 6.8 1.3 4.6 17.6 0.2 2.9 24.1 5.2 13.3 0.3 3.5 5.3 3.6 1.5 11.0 19.6 0.9 15.3 12.0 23.7 0.4 33.1 1.6 0.1 3.4 9.1 78.9 24.2 17.9 21.9 11.7 13.4 9.2 4.5 0.2 1.6 46.6 3.7 8.8 17.1 0.2 18.7 0.3 0.2 28.2 7.4 3.1 5.0 0.2 0.3 1.8 28.1 3.9 0.9 26.9 9.0 5.1 16.5 2.2 0.3 28.0 0.6 0.0 0.1 55.8 5.0 8.8 48.4 9.1 16.0 4.9 4.8 8.5 51.1 24.9 11.6 2.2 30.9 8.6 3.8 80.5 7.2 3.4 6.7 25.6 9.5 16.3 23.1 6.3 13.6 16.9 13.3 17.9 9.2 14.0 12.6 44.7 44.6 74.3 91.2 48.9 1.8 6.5 45.9 54.9 87.6 150.1 2.0 1.2 10.0 68.4 1.9 26.6 44.6 46.7 58.6 1.0 26.5 41.9 269.5 23.3 60.0 1.6 12.7 43.0 26.7 1.3 37.4 30.2 60.8 10.0 21.4 35.9 63.0 30.0 7.8 2.0 1.9 12.9 28.8 1.8 4.7 58.7 1.1 35.1 29.6 115.3 CD83 "BL11, HB15" ENSG00000112149 "CD83 molecule" Q01151 6 14117256-14136918 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 70.0;lymphoid tissue: 64.5" "Cell type enhanced" "Detected in many" 22 "granulocytes: 239.5;Macrophages: 184.4;monocytes: 891.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 29.2;HDLM-2: 26.2;U-698: 44.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002509, HPA041454" Enhanced NA NA "CAB002509: AB_563641, HPA041454: AB_2677489" "unprognostic (2.22e-3)" "unprognostic (1.92e-2)" "unprognostic (1.22e-1)" "unprognostic (6.39e-2)" "unprognostic (5.83e-2)" "unprognostic (3.02e-2)" "unprognostic (1.00e-2)" "unprognostic (9.05e-3)" "unprognostic (9.05e-2)" "unprognostic (3.91e-2)" "unprognostic (7.37e-2)" "unprognostic (6.68e-2)" "prognostic favorable (3.49e-4)" "unprognostic (2.30e-1)" "unprognostic (7.07e-2)" "unprognostic (1.40e-2)" "unprognostic (2.46e-2)" 14.0 8.3 6.1 64.5 5.7 70.0 7.5 14.2 11.8 17.0 2.0 24.7 3.4 1.8 3.7 8.3 3.6 1.8 9.9 2.6 7.3 12.7 9.7 6.0 29.0 19.5 7.8 2.2 9.7 1.6 2.2 4.1 3.4 10.8 5.2 3.8 3.5 16.4 7.8 1.8 2.6 6.9 2.7 11.1 16.5 2.2 4.0 2.8 33.8 2.3 6.2 57.5 16.4 9.8 19.1 5.2 1.3 15.4 2.6 3.6 2.3 6.6 0.3 5.0 6.9 7.3 1.7 0.1 1.8 6.8 3.2 5.7 0.5 4.4 29.2 5.6 0.5 6.7 0.7 1.9 2.1 10.8 26.2 2.8 4.0 8.6 0.8 0.2 5.8 6.4 1.9 0.9 3.1 1.0 1.0 0.1 10.1 0.8 0.0 0.3 2.4 4.6 11.0 2.0 1.2 1.3 4.5 10.9 4.1 2.3 6.6 1.1 2.0 0.4 0.2 5.0 3.0 1.2 4.7 0.1 5.0 3.1 0.7 4.5 0.3 0.0 44.9 1.1 8.0 7.5 0.0 1.7 1.1 2.7 10.7 2.9 11.5 2.5 2.2 5.2 19.1 1.8 2.1 1.3 2.6 15.4 1.8 3.6 2.3 6.1 5.7 14.2 11.8 7.3 12.7 7.8 2.2 10.8 2.8 17.9 74.6 42.7 9.5 44.0 3.5 25.4 2.5 5.3 9.1 10.4 5.9 1.4 3.3 0.6 0.4 16.9 2.6 0.0 1.3 2.2 18.7 12.7 239.5 0.8 140.3 1.6 23.1 3.1 66.8 1.1 0.3 184.4 42.2 891.9 3.3 3.1 1.6 0.0 0.0 15.8 2.6 0.0 26.8 0.9 12.1 33.6 2.3 13.8 3.5 2.8 CD84 "hCD84, mCD84, SLAMF5" ENSG00000066294 "CD84 molecule" Q9UIB8 1 160541095-160579516 "CD markers, Predicted membrane proteins" "Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.0" "Cell type enhanced" "Detected in many" 14 "granulocytes: 177.3;Hofbauer cells: 84.2;Kupffer cells: 123.8;Macrophages: 52.0;monocytes: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.6;HEL: 24.3;HL-60: 6.8;HMC-1: 27.7;MOLT-4: 6.7;U-698: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063316, HPA068020, HPA070502" Enhanced Enhanced "Vesicles,Plasma membrane" NA NA 36000000 "Plasma membrane" Vesicles "HPA063316: , HPA068020: , HPA070502: AB_2686274" "unprognostic (4.38e-2)" "unprognostic (6.16e-3)" "unprognostic (1.00e-2)" "unprognostic (8.16e-2)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (3.84e-1)" "unprognostic (2.54e-2)" "unprognostic (8.60e-2)" "unprognostic (1.80e-1)" "unprognostic (8.26e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" 15.9 4.8 3.8 18.5 4.5 6.7 3.7 1.3 3.4 3.3 3.2 7.9 7.7 2.5 2.5 4.3 2.7 3.1 6.4 5.0 3.8 3.0 3.1 5.1 9.2 26.0 6.0 2.2 1.8 4.3 0.9 1.9 7.1 5.3 3.7 4.7 2.4 4.3 9.8 1.6 2.7 9.6 4.1 11.1 25.6 3.5 2.8 5.9 13.8 2.9 2.3 16.3 5.8 2.7 5.1 5.4 21.0 7.3 1.0 8.2 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 6.8 27.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.1 0.0 0.0 6.7 5.1 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 1.5 0.0 21.0 7.3 11.0 6.9 6.3 5.2 5.1 5.9 8.2 5.4 4.7 3.5 6.3 1.0 1.0 2.4 3.2 7.9 6.1 3.8 4.5 1.3 3.4 3.8 3.0 6.0 2.2 5.3 5.9 0.0 8.3 23.1 0.7 2.2 0.2 1.2 5.1 1.4 2.3 0.0 0.0 0.4 0.0 0.0 0.6 2.6 0.0 0.0 0.2 0.3 0.8 0.6 177.3 0.9 84.2 0.0 0.0 5.5 123.8 0.5 0.6 52.0 5.0 78.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 2.0 0.8 42.4 0.0 0.7 CD86 "B7-2, B7.2, CD28LG2" ENSG00000114013 "CD86 molecule" P42081 3 122055366-122121139 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.0;brain: 26.1" "Cell type enriched" "Detected in many" 5 "monocytes: 760.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 25.6;intermediate monocyte: 26.4;memory B-cell: 13.6;myeloid DC: 25.9;naive B-cell: 8.0;non-classical monocyte: 27.0" "Group enriched" "Detected in many" 17 "B-cells: 13.6;dendritic cells: 25.9;monocytes: 27.0" "Cell line enriched" "Detected in some" 7 "HDLM-2: 80.7" "Low region specificity" "Detected in all" "CAB004319, HPA026802" Approved Supported "Plasma membrane" NA NA 220000 "Plasma membrane" "CAB004319: AB_627200, HPA026802: " "unprognostic (1.81e-1)" "unprognostic (3.78e-3)" "unprognostic (3.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-1)" "unprognostic (1.15e-1)" "unprognostic (8.56e-2)" "unprognostic (7.72e-3)" "unprognostic (1.21e-1)" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (9.83e-5)" "unprognostic (9.72e-2)" "unprognostic (1.70e-2)" "unprognostic (9.78e-2)" "unprognostic (8.67e-2)" 10.5 4.7 7.1 23.6 9.5 6.0 3.6 1.5 6.3 2.9 4.3 9.8 0.6 2.5 2.6 5.2 2.8 3.3 10.4 3.5 7.3 6.0 4.0 7.8 13.0 17.8 11.7 3.0 2.5 2.3 2.1 2.6 10.3 8.1 3.1 5.6 3.0 3.6 1.8 1.3 2.4 6.9 5.1 26.1 22.5 3.4 2.4 10.3 7.7 2.3 2.1 15.0 9.2 2.2 13.6 25.9 0.3 27.0 1.2 0.4 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 4.3 0.1 9.6 0.0 0.2 0.0 0.0 25.6 0.2 0.0 26.4 0.0 13.6 0.1 0.1 25.9 8.0 0.0 0.0 0.3 1.2 27.0 2.6 0.4 9.3 7.1 9.5 1.5 6.3 7.3 6.0 11.7 3.0 8.1 10.3 0.0 10.6 25.1 0.0 3.2 0.0 0.2 0.0 0.0 4.5 1.8 0.0 1.6 0.0 0.2 3.0 0.2 0.0 0.0 2.9 0.5 1.7 0.3 2.3 0.8 106.9 0.0 0.0 1.8 111.1 1.3 0.0 155.5 6.8 760.2 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 3.4 1.6 0.0 0.0 0.3 CD8A CD8 ENSG00000153563 "CD8a molecule" P01732 2 86784610-86808396 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 14 "blood: 82.2;lymphoid tissue: 262.3" "Cell type enriched" "Detected in some" 11 "T-cells: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "MAIT T-cell: 36.7;memory CD8 T-cell: 82.2;naive CD8 T-cell: 77.8" "Lineage enriched" "Detected in many" 20 "T-cells: 82.2" "Cell line enhanced" "Detected in some" "JURKAT: 5.0;MOLT-4: 17.5;RPMI-8226: 4.0" "Low region specificity" "Detected in many" "CAB000012, HPA037756, CAB075722" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA 500000 "Plasma membrane" "CAB000012: AB_2075537, CAB075722: AB_2665709, HPA037756: AB_2675648" "unprognostic (1.29e-3)" "prognostic favorable (4.54e-4)" "unprognostic (9.26e-3)" "prognostic favorable (6.15e-6)" "unprognostic (7.28e-2)" "unprognostic (2.79e-3)" "unprognostic (1.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (6.74e-2)" "unprognostic (1.56e-2)" 2.4 1.4 1.4 7.4 2.8 6.8 1.5 1.4 1.2 2.1 5.3 0.8 0.8 4.2 1.5 2.1 2.0 2.1 4.5 1.6 1.2 1.6 1.3 2.1 6.0 23.8 1.0 0.5 1.7 1.2 0.0 0.9 0.6 0.7 2.3 1.9 1.8 3.0 1.1 0.8 0.7 12.2 0.7 1.7 46.4 5.4 1.0 0.5 262.3 2.2 1.6 8.1 3.8 1.9 0.0 0.1 0.6 0.1 4.0 82.2 17.4 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.0 0.0 0.3 0.0 0.8 17.5 1.1 0.6 0.2 0.3 0.1 0.9 4.0 0.0 0.4 0.9 2.4 0.2 0.1 0.0 0.0 0.4 0.5 0.0 0.0 0.6 0.1 0.0 0.1 0.3 0.9 0.0 0.0 0.1 0.1 0.1 0.0 4.8 0.0 36.7 0.0 0.3 82.2 0.0 0.0 0.3 77.8 0.6 4.0 0.1 0.1 0.1 17.4 1.4 2.8 1.4 1.2 1.2 1.6 1.0 0.5 0.7 0.5 0.0 5.8 1.5 0.2 1.8 0.1 2.9 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.5 0.2 2.3 0.8 0.1 0.0 0.0 5.5 1.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.9 0.5 0.4 1.6 0.1 65.4 0.0 0.1 CD8B CD8B1 ENSG00000172116 "CD8b molecule" P10966 2 86815339-86861924 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 132.1;lymphoid tissue: 61.5" "Cell type enriched" "Detected in some" 7 "T-cells: 61.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory CD8 T-cell: 73.5;naive CD8 T-cell: 132.1" "Lineage enriched" "Detected in many" 40 "T-cells: 132.1" "Cell line enriched" "Detected in some" 55 "RPMI-8226: 158.6" "CAB004353, HPA029164" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB004353: AB_627211, HPA029164: AB_2672936" "unprognostic (1.83e-3)" "unprognostic (1.98e-3)" "unprognostic (2.22e-2)" "prognostic favorable (7.88e-7)" "unprognostic (6.23e-2)" "unprognostic (7.05e-3)" "unprognostic (1.11e-2)" "unprognostic (2.59e-2)" "unprognostic (5.50e-3)" "unprognostic (5.91e-2)" "unprognostic (9.25e-2)" "unprognostic (4.60e-1)" "prognostic unfavorable (7.11e-6)" "unprognostic (7.84e-2)" "unprognostic (3.00e-1)" "unprognostic (1.86e-2)" "unprognostic (4.33e-2)" 1.2 0.7 1.0 5.3 1.0 3.9 1.0 1.3 1.3 21.2 1.1 1.0 1.0 2.5 1.2 1.0 1.0 1.1 1.8 1.0 1.0 1.8 1.0 1.0 2.7 14.4 1.7 1.0 1.3 1.0 6.4 7.4 1.0 2.2 1.3 1.3 1.0 1.0 1.0 1.0 0.9 11.4 1.0 1.5 12.7 2.3 1.0 1.0 61.5 1.5 1.0 8.1 1.8 1.3 0.1 0.1 3.2 0.1 0.1 132.1 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 158.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 3.2 0.1 0.0 2.0 0.1 10.0 0.0 0.2 73.5 0.0 0.1 0.5 132.1 0.7 0.1 0.1 0.1 0.2 36.3 1.0 1.0 1.3 1.3 1.0 1.8 1.7 1.0 2.2 1.0 6.0 8.5 0.8 1.7 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.6 0.0 0.2 0.1 0.0 0.0 0.6 1.0 0.0 0.0 1.3 5.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 2.5 0.0 61.8 1.2 0.1 CD8B2 CD8BP ENSG00000254126 "CD8b2 molecule" 2 106487364-106544297 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "blood: 20.6;lymphoid tissue: 35.1" "Group enriched" "Detected in some" 16 "Club cells: 1.2;Proximal tubular cells: 2.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 9 "memory CD8 T-cell: 12.0;naive CD8 T-cell: 20.6" "Lineage enriched" "Detected in many" 15 "T-cells: 20.6" "Cell line enriched" "Detected in some" 7 "RPMI-8226: 93.5" NA NA "unprognostic (9.34e-3)" "unprognostic (7.84e-2)" "unprognostic (2.32e-2)" "unprognostic (3.41e-2)" "unprognostic (2.10e-1)" "unprognostic (5.54e-2)" "unprognostic (1.18e-1)" "unprognostic (5.27e-1)" "unprognostic (1.28e-2)" "unprognostic (1.21e-1)" "unprognostic (2.27e-1)" "unprognostic (2.76e-2)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (6.90e-2)" "unprognostic (9.67e-3)" 0.1 0.0 0.1 1.1 0.4 0.2 0.0 0.6 0.6 1.9 0.3 0.0 0.0 0.4 0.1 0.2 0.2 0.0 0.2 0.0 0.7 2.8 0.4 0.4 5.3 0.0 0.0 0.2 0.0 2.8 0.8 0.1 0.7 1.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.9 1.6 0.0 0.0 35.1 0.0 0.3 9.0 0.3 0.0 0.0 0.0 1.3 0.0 0.2 20.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 9.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.0 1.7 0.0 0.0 12.0 0.0 0.0 0.0 20.6 0.1 0.2 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CD9 "BA2, MIC3, MRP-1, P24, TSPAN29" ENSG00000010278 "CD9 molecule" P21926 12 6199715-6238271 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Fertilization" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Urothelial cells: 2399.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 21 "basophil: 137.8;eosinophil: 98.3" "Lineage enriched" "Detected in many" 24 "granulocytes: 137.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 129.4;RT4: 95.9;TIME: 191.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002490 Supported Supported "Plasma membrane" NA NA 68000000 "Plasma membrane" "CAB002490: AB_563643" "unprognostic (1.38e-1)" "unprognostic (6.36e-3)" "unprognostic (8.27e-3)" "unprognostic (6.98e-3)" "unprognostic (3.89e-1)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "unprognostic (2.08e-2)" "unprognostic (2.90e-1)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.30e-1)" "prognostic favorable (6.49e-5)" "unprognostic (6.10e-2)" "unprognostic (1.77e-1)" "prognostic favorable (8.93e-5)" "unprognostic (9.26e-2)" 38.1 44.5 20.0 24.1 36.2 3.1 48.2 6.8 29.6 55.0 68.3 63.1 151.6 19.5 36.2 43.4 139.8 38.4 23.2 39.2 30.3 15.6 39.9 12.2 61.1 8.2 43.3 23.3 14.1 23.3 89.5 15.2 13.0 28.7 77.9 73.5 25.5 91.6 180.4 11.3 60.1 29.6 62.2 48.9 12.2 27.7 10.4 47.7 6.0 63.6 112.3 85.8 54.5 76.0 1.9 0.9 137.8 5.6 0.2 1.1 5.6 34.3 15.1 0.3 9.3 14.8 15.3 13.1 20.4 40.7 7.0 10.7 11.1 129.4 0.1 5.1 4.3 20.8 75.4 7.9 40.7 5.4 1.7 5.5 0.1 11.5 2.4 6.4 0.1 43.3 0.0 30.3 12.8 11.0 19.7 83.6 2.5 1.6 0.1 4.4 49.2 0.1 3.7 11.7 41.8 15.2 0.3 24.9 43.8 68.4 95.9 0.0 2.9 20.3 16.8 17.5 71.5 7.8 3.5 191.3 0.7 19.1 0.7 2.4 0.1 0.1 5.2 11.9 0.0 18.8 137.8 5.6 98.3 0.1 1.8 0.2 0.5 0.1 0.1 0.9 1.9 0.4 1.1 2.6 0.2 0.0 0.3 0.0 5.6 20.0 36.2 6.8 29.6 30.3 15.6 43.3 23.3 28.7 47.7 738.4 321.6 28.1 1345.7 921.9 3.7 14.2 76.5 519.3 651.7 1020.6 0.0 8.4 116.0 478.4 2.3 477.7 411.2 0.0 155.9 225.1 473.0 1465.7 638.5 36.4 653.0 0.0 166.1 406.4 33.8 7.3 29.7 438.3 892.5 256.1 636.4 386.7 257.1 669.9 66.4 14.0 13.1 653.2 455.3 7.0 76.5 1118.7 45.2 23.0 620.5 2399.6 CD93 "C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4" ENSG00000125810 "CD93 molecule" Q9NPY3 20 23079349-23086340 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 232.0;Ito cells: 170.6;Kupffer cells: 149.3;Macrophages: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 14.4;neutrophil: 17.4" "Group enriched" "Detected in many" 40 "dendritic cells: 5.5;granulocytes: 17.4;monocytes: 14.4" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 58.4;TIME: 73.9;U-937: 98.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA009300, HPA012368" Enhanced Approved "Vesicles,Plasma membrane" NA NA 440000000 "Vesicles, Plasma membrane" "HPA009300: AB_1846342, HPA012368: AB_1846341" "unprognostic (2.05e-1)" "unprognostic (2.85e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (2.31e-1)" "unprognostic (2.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.77e-1)" "unprognostic (4.51e-1)" "unprognostic (3.74e-2)" "unprognostic (2.61e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (2.74e-4)" "unprognostic (8.81e-3)" "unprognostic (6.13e-2)" "unprognostic (4.49e-2)" "unprognostic (3.11e-2)" 50.5 6.1 2.4 15.0 3.4 4.7 31.4 1.0 3.0 13.6 8.1 1.7 3.9 3.2 14.3 12.5 10.0 13.6 14.2 33.3 2.4 2.2 10.8 10.9 34.8 25.3 4.1 1.2 11.6 5.9 5.1 4.3 48.9 5.3 9.7 4.3 4.9 5.9 3.9 16.2 6.8 7.7 15.4 4.3 17.5 7.5 6.9 3.3 6.9 12.3 9.3 4.5 15.6 12.2 0.0 5.5 17.4 14.4 0.0 0.3 4.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 73.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.9 0.0 0.0 14.4 0.2 0.2 10.3 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 17.4 0.0 4.2 0.7 0.3 4.7 2.4 3.4 1.0 3.0 2.4 2.2 4.1 1.2 5.3 3.3 3.0 11.9 3.7 0.6 13.4 0.0 7.3 10.2 5.3 6.8 0.0 0.0 0.2 0.0 0.2 0.4 232.0 0.0 0.0 0.0 0.4 6.5 2.9 4.7 1.3 16.2 0.0 0.0 170.6 149.3 0.2 1.7 59.8 8.5 0.0 0.0 0.1 0.1 0.0 26.2 0.2 0.0 19.4 15.3 0.0 0.2 8.8 0.3 2.9 0.0 0.9 CD96 TACTILE ENSG00000153283 "CD96 molecule" P40200 3 111292719-111665750 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 32.0;lymphoid tissue: 82.4" "Cell type enriched" "Detected in many" 6 "T-cells: 148.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "NK-cells: 20.0;T-cells: 32.0" "Cell line enhanced" "Detected in some" "HEL: 6.8;JURKAT: 7.7;MOLT-4: 29.8;RT4: 27.6;U-937: 24.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066754 Enhanced NA NA 37000 "HPA066754: AB_2685714" "unprognostic (1.06e-3)" "unprognostic (3.95e-3)" "unprognostic (4.16e-3)" "unprognostic (1.91e-5)" "unprognostic (4.72e-3)" "prognostic favorable (5.52e-4)" "unprognostic (2.12e-2)" "unprognostic (3.48e-2)" "unprognostic (6.06e-2)" "unprognostic (4.84e-3)" "unprognostic (2.44e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.02e-6)" "unprognostic (3.12e-1)" "unprognostic (4.42e-2)" "unprognostic (3.90e-2)" "prognostic favorable (5.23e-5)" 5.7 0.9 0.4 18.6 0.5 8.6 3.1 0.6 0.4 2.2 7.1 0.6 0.5 3.6 1.7 1.8 3.4 2.1 3.5 1.3 0.4 0.5 2.3 2.7 9.7 21.9 1.5 0.2 1.4 0.8 0.0 1.1 1.1 1.0 2.6 3.7 2.5 4.0 1.6 0.6 1.3 13.4 1.4 2.0 14.2 3.5 1.0 0.4 82.4 4.8 2.3 23.9 9.9 3.2 5.5 0.1 3.8 0.2 20.0 32.0 11.2 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 6.8 0.1 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.1 0.6 0.0 7.7 0.1 0.9 0.0 0.0 29.8 0.1 0.3 0.0 0.0 0.0 0.9 0.2 0.2 27.6 0.0 0.0 0.1 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 2.7 0.8 0.0 0.1 24.7 5.3 0.5 0.1 3.8 20.2 0.0 32.0 2.8 18.6 23.5 0.1 5.5 19.4 23.6 0.8 20.0 0.2 0.1 11.8 11.2 0.4 0.5 0.6 0.4 0.4 0.5 1.5 0.2 1.0 0.4 17.9 24.2 7.5 0.6 2.9 1.6 0.8 0.0 2.7 17.0 1.8 0.0 0.5 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.1 2.8 0.3 15.1 0.8 0.2 0.0 0.0 0.6 5.1 0.0 0.3 2.5 3.3 0.0 0.0 0.2 0.0 0.2 0.0 0.5 2.2 0.0 0.9 0.5 0.4 2.8 1.6 148.1 0.0 0.4 CD99 MIC2 ENSG00000002586 "CD99 molecule (Xg blood group)" P14209 X 2691133-2741309 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 359.1;breast: 433.0;heart muscle: 347.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 124.8" "Low region specificity" "Detected in all" "CAB000020, HPA035304" Supported Approved "Golgi apparatus" NA NA 34000000 "Golgi apparatus" "CAB000020: AB_2076419, HPA035304: AB_10672861" "unprognostic (3.71e-3)" "unprognostic (2.90e-1)" "unprognostic (5.97e-3)" "unprognostic (7.01e-3)" "unprognostic (2.14e-2)" "unprognostic (6.98e-3)" "unprognostic (3.89e-3)" "unprognostic (1.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.87e-7)" "unprognostic (2.11e-2)" "unprognostic (2.18e-1)" "unprognostic (5.37e-2)" "unprognostic (3.61e-2)" 45.7 14.1 85.8 14.4 100.5 11.1 433.0 45.7 60.9 243.9 31.8 4.5 4.5 19.9 258.4 18.3 26.1 22.2 35.2 347.0 103.4 14.7 66.4 24.6 24.5 16.6 161.0 56.6 187.4 28.9 3.3 67.0 138.7 185.5 30.5 20.6 4.5 18.1 37.7 18.9 28.0 23.8 31.1 359.1 18.5 21.7 23.3 101.3 4.5 15.2 4.5 16.1 24.7 208.8 32.7 62.6 4.3 47.1 32.1 107.1 103.6 23.9 27.5 30.8 41.6 124.8 94.6 18.5 64.2 100.7 40.4 58.9 39.7 16.9 1.6 12.6 89.1 22.5 9.4 12.3 16.1 33.6 32.6 31.0 4.6 19.2 34.5 39.6 7.3 36.7 58.8 20.0 22.1 15.6 28.0 73.6 25.3 5.7 0.0 38.1 18.8 63.9 25.0 10.0 2.7 30.0 10.8 25.7 45.4 23.3 16.4 0.1 13.6 15.4 13.9 38.6 81.3 12.3 22.9 67.9 49.8 8.4 47.6 21.6 0.1 0.0 10.5 33.3 18.4 31.1 1.8 47.1 1.5 107.1 11.6 60.4 32.7 72.6 94.6 44.6 20.2 26.8 57.1 4.3 32.1 2.6 62.6 74.3 103.6 85.8 100.5 45.7 60.9 103.4 14.7 161.0 56.6 185.5 101.3 59.6 70.1 119.1 149.0 222.5 0.9 77.6 76.5 73.6 67.1 68.0 0.0 181.3 11.6 139.8 5.6 366.2 95.9 70.0 121.0 161.2 556.7 292.3 222.0 87.0 661.4 0.0 77.6 437.1 220.0 13.6 597.5 294.4 656.3 138.9 114.0 38.7 162.8 176.3 480.5 50.9 3.0 336.3 416.7 17.9 45.6 194.8 102.9 472.0 184.3 245.6 CD99L2 "CD99B, MIC2L1" ENSG00000102181 "CD99 molecule like 2" Q8TCZ2 X 150766337-150898816 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 72.2" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038782, HPA038783, HPA061400" Enhanced Supported "Plasma membrane" NA NA 790000 "Plasma membrane" "HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: AB_2732660" "unprognostic (2.10e-2)" "unprognostic (2.62e-3)" "unprognostic (3.12e-3)" "unprognostic (6.03e-3)" "unprognostic (1.22e-1)" "unprognostic (2.66e-1)" "unprognostic (5.56e-2)" "prognostic favorable (4.96e-4)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "prognostic favorable (2.74e-5)" "unprognostic (5.50e-2)" "unprognostic (5.13e-2)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (9.23e-2)" "prognostic unfavorable (8.74e-4)" 27.1 16.5 23.3 9.2 30.1 4.5 17.8 27.5 56.7 19.2 12.6 21.0 5.5 6.7 17.6 16.5 9.7 17.6 12.4 32.1 26.3 32.0 14.0 17.0 14.9 9.6 30.5 26.6 26.0 8.4 9.7 8.7 21.5 43.1 13.9 7.4 11.9 8.3 22.0 72.2 6.7 8.0 20.8 31.9 12.5 8.0 7.6 13.3 3.0 7.3 6.9 7.0 10.7 7.7 7.2 10.7 9.4 15.1 8.8 8.9 8.4 2.3 23.0 8.7 10.8 46.3 29.0 2.6 19.0 22.3 9.6 13.8 1.6 2.9 8.3 46.1 33.0 7.2 3.7 11.9 12.9 8.0 19.4 9.3 3.6 5.5 2.3 12.5 6.0 6.9 27.3 4.2 7.1 13.5 15.0 11.2 6.6 2.4 22.0 12.0 4.9 5.3 8.8 3.6 1.9 12.5 5.3 7.1 11.4 9.4 1.5 11.6 5.9 7.4 6.4 8.5 6.7 1.8 10.4 13.2 14.2 4.4 18.4 13.6 18.7 30.9 8.1 17.8 12.1 10.7 9.4 11.2 7.6 8.8 9.9 7.8 6.4 8.2 8.9 10.7 7.2 8.3 8.5 2.8 8.8 15.1 7.8 5.9 8.4 23.3 30.1 27.5 55.2 26.3 32.0 30.5 26.6 43.1 13.3 14.9 8.5 4.5 2.7 2.7 23.3 35.5 12.7 1.4 7.9 12.2 17.7 8.7 5.0 4.0 0.3 11.4 3.4 0.0 4.5 3.8 12.3 3.3 7.0 22.1 9.1 49.3 8.1 14.7 16.2 1.5 19.2 4.7 10.1 9.0 2.4 16.9 3.8 2.9 28.3 9.7 15.5 0.0 9.0 1.5 5.1 1.1 11.3 4.4 3.0 1.1 CDC14B "Cdc14B1, Cdc14B2, CDC14B3, hCDC14B" ENSG00000081377 "Cell division cycle 14B" O60729 9 96490241-96619830 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.9" "Lineage enhanced" "Detected in many" "granulocytes: 9.9" "Cell line enhanced" "Detected in many" "ASC diff: 15.2;ASC TERT1: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013312, HPA064747" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA013312: AB_1846354, HPA064747: AB_2732719" "unprognostic (5.69e-2)" "unprognostic (9.09e-2)" "unprognostic (3.50e-2)" "unprognostic (8.08e-3)" "unprognostic (4.24e-1)" "unprognostic (1.19e-2)" "unprognostic (1.11e-2)" "unprognostic (4.49e-2)" "unprognostic (1.63e-2)" "unprognostic (2.27e-2)" "unprognostic (2.35e-1)" "unprognostic (2.75e-1)" "prognostic favorable (2.97e-10)" "unprognostic (2.01e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (7.40e-2)" 7.3 6.2 6.8 3.0 7.5 4.4 15.7 2.4 6.6 5.3 5.0 14.8 7.1 4.5 4.0 3.7 3.5 7.1 5.9 8.2 6.0 4.6 9.1 16.0 4.9 1.8 9.5 4.0 5.8 7.3 17.1 5.2 3.4 7.1 5.7 5.4 8.3 3.8 7.2 2.2 3.3 7.7 4.2 9.3 2.2 9.3 16.9 8.2 0.2 13.6 2.2 2.1 10.4 10.3 1.6 0.0 9.9 0.0 0.1 2.9 0.8 5.2 2.9 3.1 3.2 15.2 22.8 8.5 3.8 5.1 2.5 4.1 9.9 8.3 0.0 3.7 8.0 6.2 5.9 4.4 3.0 3.0 1.3 4.1 0.8 1.0 7.8 2.5 0.0 0.1 9.4 1.5 2.7 2.5 3.0 0.5 0.0 3.0 0.6 3.5 2.5 0.0 0.8 5.8 5.9 2.5 0.0 1.9 0.1 4.0 8.1 0.9 4.9 2.7 0.8 1.5 11.0 0.7 1.7 1.5 2.5 3.0 6.6 2.8 0.1 0.0 0.0 2.7 0.0 6.0 9.9 0.0 3.1 2.9 0.0 1.6 1.6 1.3 2.3 0.0 0.8 2.3 1.4 0.0 0.1 0.0 0.0 1.6 0.8 6.8 7.5 2.4 6.6 6.0 4.6 9.5 4.0 7.1 8.2 6.0 9.1 2.4 7.4 8.0 6.4 14.5 10.2 16.0 14.8 8.7 7.9 5.3 6.6 4.8 28.7 4.7 8.5 0.0 5.7 2.5 9.3 10.2 13.9 27.2 8.6 7.9 2.4 8.0 1.0 27.6 8.3 4.1 8.5 3.6 7.6 10.9 6.9 6.5 11.0 14.1 11.7 25.8 22.0 3.7 5.5 6.8 2.9 5.0 7.2 8.1 CDCA7L "JPO2, R1, RAM2" ENSG00000164649 "Cell division cycle associated 7 like" Q96GN5 7 21900900-21946084 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.9" "Cell type enhanced" "Detected in many" 7 "Spermatogonia: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 5 "olfactory region: 22.0" "HPA027169, HPA074623" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA027169: AB_1856058, HPA074623: " "unprognostic (5.13e-3)" "unprognostic (5.94e-2)" "unprognostic (1.91e-1)" "unprognostic (4.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.36e-6)" "unprognostic (4.09e-2)" "unprognostic (2.86e-1)" "unprognostic (3.87e-2)" "unprognostic (3.22e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.60e-1)" "unprognostic (1.73e-1)" "unprognostic (2.83e-3)" 6.2 1.2 3.7 19.9 9.6 24.2 8.0 6.5 4.2 8.4 9.0 7.8 3.9 5.2 11.1 3.6 6.0 7.0 5.4 12.5 3.9 2.5 2.7 4.5 7.3 18.7 6.2 4.0 13.9 17.4 1.0 1.6 2.2 3.7 7.6 10.2 5.8 10.5 8.0 2.7 13.6 8.7 6.6 3.0 9.3 12.7 12.6 5.3 47.9 20.0 5.1 16.5 6.0 9.4 38.5 21.8 11.8 1.3 0.8 9.7 3.3 19.7 6.8 6.4 0.1 3.5 4.5 0.0 16.2 13.9 12.6 17.9 2.5 18.0 41.3 5.3 13.9 25.1 12.2 10.1 16.6 25.5 0.0 6.7 9.9 20.1 1.6 4.5 25.9 0.1 8.3 3.0 9.7 28.5 13.0 24.8 32.3 13.6 0.0 9.7 7.4 32.7 9.3 36.5 3.9 8.4 32.9 22.9 27.5 3.5 3.7 23.5 19.2 7.3 4.5 7.4 8.5 11.0 11.7 10.5 13.8 17.0 23.9 19.5 21.3 14.6 53.4 13.2 35.0 13.5 0.3 0.6 11.8 0.6 0.9 0.1 28.6 1.9 0.9 4.3 38.5 9.7 3.9 1.1 0.8 1.3 21.8 2.7 3.3 3.7 9.6 6.5 4.2 3.9 2.5 6.2 4.0 3.7 5.3 17.9 20.3 28.9 22.5 24.2 0.2 26.3 2.5 6.7 31.8 0.0 2.0 0.5 3.3 6.7 2.6 3.7 1.5 0.0 5.3 0.2 4.3 7.7 8.1 3.4 9.6 12.7 10.3 2.5 10.2 3.6 3.7 3.5 8.5 0.0 26.4 2.4 4.9 3.5 2.5 0.0 2.1 12.9 12.3 2.7 61.1 6.8 0.2 2.5 24.4 3.9 CDCP1 "CD318, SIMA135" ENSG00000163814 "CUB domain containing protein 1" Q9H5V8 3 45082278-45146422 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 107.6;Ductal cells: 84.9;Pancreatic endocrine cells: 100.0;Urothelial cells: 90.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 5 "pons and medulla: 5.5" "Group enriched" "Detected in some" 5 "myeloid DC: 4.0;neutrophil: 1.8;NK-cell: 7.1" "Group enriched" "Detected in many" 5 "dendritic cells: 4.0;granulocytes: 1.8;NK-cells: 7.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.8;HBEC3-KT: 27.2;hTEC/SVTERT24-B: 67.5;hTERT-HME1: 45.8;PC-3: 21.1;RPTEC TERT1: 20.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010978, HPA010979, CAB025637" Enhanced "Intracellular and membrane" NA NA "CAB025637: , HPA010978: AB_1846403, HPA010979: AB_1846401" "unprognostic (9.31e-2)" "unprognostic (4.50e-2)" "unprognostic (1.67e-2)" "unprognostic (2.66e-1)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (2.94e-2)" "prognostic unfavorable (1.41e-5)" "unprognostic (2.15e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (9.98e-3)" "unprognostic (3.59e-2)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" "unprognostic (1.34e-1)" 2.3 0.7 0.5 5.6 1.0 0.2 4.4 0.3 0.7 6.9 17.4 1.1 10.1 11.4 3.2 11.1 28.6 2.4 9.8 0.8 1.0 0.5 4.4 0.8 7.1 1.4 0.6 0.3 1.6 13.9 0.0 2.3 4.0 5.5 5.2 11.3 0.5 11.4 13.0 0.6 15.2 29.8 1.8 1.3 0.8 10.8 1.3 0.5 1.0 21.8 19.2 19.1 7.3 11.7 0.2 4.0 1.8 0.9 7.1 0.3 0.3 12.3 3.7 0.0 0.0 0.0 0.6 3.0 2.2 0.4 1.1 1.0 5.2 23.8 0.0 2.8 0.7 0.6 10.0 0.0 27.2 2.3 0.0 0.0 0.0 4.2 0.0 2.0 0.0 0.9 0.9 14.3 67.5 45.8 4.1 0.2 0.0 7.2 0.0 3.4 0.0 0.0 0.2 1.8 6.0 21.1 0.0 0.0 2.1 20.8 10.0 0.8 0.0 4.6 1.2 0.0 1.2 5.8 0.1 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.4 0.9 0.1 0.1 0.1 0.0 0.1 0.3 0.1 4.0 0.2 0.2 0.1 1.8 7.1 0.0 0.1 0.0 0.3 0.5 1.0 0.3 0.7 1.0 0.5 0.6 0.3 5.5 0.5 3.0 13.3 0.0 52.1 107.6 0.0 0.4 12.7 26.8 18.2 8.7 0.0 4.5 0.0 84.9 0.0 0.6 30.4 0.0 61.1 6.7 5.8 52.2 8.1 0.0 10.2 0.0 36.0 0.0 4.8 0.0 2.8 26.8 3.3 18.0 34.1 0.0 100.0 28.8 0.0 0.0 0.0 0.0 3.3 0.0 0.4 65.6 2.7 0.0 22.5 90.5 CDCP2 ENSG00000157211 "CUB domain containing protein 2" Q5VXM1 1 54132968-54153770 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.4" HPA031143 Uncertain "Secreted - unknown location" NA NA "HPA031143: AB_10611819" "unprognostic (1.08e-1)" "unprognostic (5.16e-2)" "unprognostic (1.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.25e-2)" "unprognostic (4.73e-2)" "unprognostic (5.29e-2)" "unprognostic (2.86e-2)" "unprognostic (2.57e-1)" "unprognostic (1.33e-1)" "unprognostic (1.67e-2)" "unprognostic (7.67e-6)" "unprognostic (2.37e-1)" "unprognostic (1.48e-1)" "unprognostic (5.12e-1)" "unprognostic (2.21e-2)" 0.5 0.3 0.1 0.1 0.5 0.3 0.9 0.1 0.6 1.1 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.6 0.3 0.2 0.0 2.2 0.2 0.1 0.6 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.4 0.0 0.7 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDH1 "CD324, UVO, uvomorulin" ENSG00000039068 "Cadherin 1" P12830 16 68737225-68835548 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 125.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "myeloid DC: 2.8;plasmacytoid DC: 8.5" "Lineage enriched" "Detected in single" 18 "dendritic cells: 8.5" "Cell line enhanced" "Detected in some" "BEWO: 107.1;CACO-2: 36.0;CAPAN-2: 50.3;HaCaT: 48.6;hTCEpi: 34.3;MCF7: 29.7;OE19: 31.7;RT4: 37.0;T-47d: 32.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857" Enhanced Supported "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA 22000000 "Plasma membrane, Cell Junctions" "Golgi apparatus" "CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369" "unprognostic (3.95e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-3)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" "unprognostic (5.04e-3)" "unprognostic (1.63e-1)" "unprognostic (5.47e-2)" "unprognostic (2.85e-1)" "unprognostic (1.19e-2)" "unprognostic (3.61e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.21e-1)" "unprognostic (2.62e-1)" "unprognostic (2.51e-1)" "unprognostic (5.92e-2)" 1.1 0.7 1.3 14.8 1.5 0.5 15.3 0.8 1.1 14.4 63.8 1.8 42.4 25.5 4.7 18.6 48.5 9.7 48.9 0.8 1.5 1.0 24.2 64.9 24.4 0.5 1.8 0.9 5.6 71.5 62.2 13.2 55.2 2.8 28.9 25.9 11.8 66.6 43.7 0.8 30.5 125.5 1.5 1.1 3.5 21.6 2.1 1.8 11.7 83.0 26.2 32.6 16.8 21.7 0.0 8.5 0.0 0.0 0.3 0.4 0.1 21.6 2.2 0.0 0.0 0.0 0.0 107.1 0.0 0.0 0.0 0.0 36.0 50.3 0.0 0.4 0.0 0.0 48.6 0.0 24.1 0.0 4.2 0.6 0.0 0.1 7.7 0.0 0.0 0.2 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.0 0.1 0.8 31.7 0.1 0.0 0.0 0.3 8.8 37.0 1.3 0.1 0.2 0.0 9.1 15.2 32.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.8 0.0 0.0 0.0 0.0 0.3 0.0 8.5 0.1 0.1 1.3 1.5 0.8 1.1 1.5 1.0 1.8 0.9 2.8 1.8 122.1 58.7 0.9 101.9 83.6 0.0 0.8 152.8 73.6 64.8 155.3 0.0 97.3 1.7 107.7 0.0 1.2 202.1 0.0 98.3 22.3 4.1 170.0 1.1 44.7 10.1 0.0 83.2 0.6 1.5 0.0 0.3 6.3 50.6 5.4 180.9 0.0 193.9 160.9 0.4 3.3 0.0 0.0 4.7 0.0 0.1 114.9 42.2 0.0 125.1 204.2 CDH10 ENSG00000040731 "Cadherin 10" Q9Y6N8 5 24487100-24644978 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 45.4" "Cell type enhanced" "Detected in single" 14 "Bipolar cells: 1.1" "Group enriched" "Detected in some" 7 "glioma: 5.3;prostate cancer: 1.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 8.8;HAP1: 5.6;hTERT-RPE1: 5.2;SuSa: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010651 Approved NA NA "HPA010651: AB_1078370" "unprognostic (4.31e-3)" "unprognostic (2.77e-1)" "unprognostic (1.88e-1)" "unprognostic (3.66e-2)" "unprognostic (4.48e-1)" "unprognostic (6.11e-3)" "unprognostic (6.27e-2)" "unprognostic (1.59e-7)" "unprognostic (1.65e-2)" "unprognostic (1.41e-1)" "unprognostic (8.74e-3)" 0.9 2.1 9.4 0.8 9.6 0.8 1.0 45.4 34.0 0.9 1.1 1.5 0.0 0.9 0.9 0.8 0.9 0.9 1.2 0.9 9.4 5.2 1.0 0.8 1.1 0.8 3.6 13.4 0.8 0.9 0.8 2.1 0.8 6.0 8.6 1.3 0.0 0.8 1.4 0.8 0.8 1.1 0.9 7.0 0.8 1.0 1.4 3.7 0.0 0.8 0.0 0.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 15.2 0.0 0.0 0.0 1.9 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 9.6 45.4 21.3 9.4 5.2 3.6 13.4 6.0 3.7 0.0 0.0 0.0 0.0 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 CDH11 "CAD11, OB" ENSG00000140937 "Cadherin 11" P55287 16 64943753-65126112 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 71.0" "Group enriched" "Detected in many" 5 "Fibroblasts: 97.0;Ito cells: 32.5;Leydig cells: 48.6;Muller glia cells: 51.3;Peritubular cells: 72.9;Sertoli cells: 25.8;Smooth muscle cells: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 48.0;BJ hTERT+: 27.9;fHDF/TERT166: 65.6;HSkMC: 45.2;PC-3: 56.5;U-2197: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013072 Enhanced NA NA 70000 "CAB013072: AB_2533068" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (6.93e-2)" "unprognostic (6.00e-2)" "unprognostic (1.02e-1)" "unprognostic (6.96e-2)" "unprognostic (1.28e-1)" "unprognostic (2.09e-1)" "unprognostic (2.30e-2)" "unprognostic (3.74e-2)" "unprognostic (6.75e-2)" "prognostic unfavorable (2.48e-9)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (1.26e-1)" "unprognostic (5.07e-3)" 8.1 3.6 5.5 9.2 12.1 0.3 6.1 5.5 8.8 24.1 4.3 7.5 2.4 2.7 25.9 5.9 3.0 6.8 22.4 4.6 7.3 5.1 4.8 1.0 20.8 5.9 7.8 8.5 71.0 1.7 1.2 6.0 44.2 8.3 8.0 4.9 22.2 7.3 9.7 2.5 5.7 3.4 20.5 10.6 35.1 5.1 4.0 5.4 0.1 4.8 1.9 4.9 18.4 11.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.4 0.0 7.4 16.3 0.0 48.0 27.9 12.4 7.1 0.9 0.0 0.0 0.0 65.6 0.0 0.0 0.0 0.3 8.9 0.0 0.4 0.0 0.2 0.0 6.2 0.0 2.9 45.2 0.0 15.1 3.0 0.0 3.5 0.0 0.0 0.0 6.6 0.0 0.0 0.0 3.8 7.2 56.5 0.1 7.5 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 13.7 0.0 0.0 0.0 25.6 3.5 38.6 13.6 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 12.1 5.5 8.8 7.3 5.1 7.8 8.5 8.3 5.4 3.0 0.0 0.0 1.1 3.4 11.0 2.8 2.5 0.0 4.5 0.0 0.0 1.8 0.0 0.0 2.4 9.0 0.0 0.0 0.0 1.4 97.0 0.8 0.0 0.0 4.2 0.0 0.0 32.5 0.0 3.1 48.6 1.1 5.0 0.0 0.0 51.3 0.6 0.0 72.9 1.0 1.1 25.8 24.7 0.6 1.1 2.8 4.7 0.0 0.0 0.4 CDH12 "Br-cadherin, CDHB" ENSG00000154162 "Cadherin 12" P55289 5 21750673-22853622 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;cervix, uterine: 9.3;pituitary gland: 8.6" "Group enriched" "Detected in some" 12 "Bipolar cells: 17.4;Horizontal cells: 19.1;Rod photoreceptor cells: 55.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.5;PC-3: 5.3;SCLC-21H: 7.6;U-2 OS: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029325 Uncertain Uncertain Vesicles NA NA Vesicles "HPA029325: AB_2672998" "unprognostic (2.38e-1)" "unprognostic (3.21e-1)" "unprognostic (4.95e-2)" "unprognostic (8.61e-2)" "unprognostic (3.31e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (3.26e-2)" "unprognostic (1.34e-1)" "unprognostic (3.51e-2)" "unprognostic (3.25e-4)" "unprognostic (7.35e-2)" "unprognostic (3.48e-2)" "unprognostic (5.19e-2)" 0.5 5.2 5.8 0.3 17.7 0.4 1.7 2.0 13.8 9.3 0.5 0.0 0.0 0.5 1.3 1.0 0.4 6.7 0.3 0.5 6.3 3.4 0.7 0.5 0.8 0.3 1.4 4.8 0.5 0.5 0.6 8.6 0.7 4.2 0.5 0.6 1.4 3.1 0.9 0.5 2.5 0.4 0.9 2.5 0.3 0.4 2.9 0.5 0.0 0.4 0.0 0.5 1.5 0.2 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.0 1.1 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 5.3 0.2 0.0 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.0 5.8 17.7 2.0 13.8 6.3 3.4 1.4 4.8 4.2 0.5 0.0 0.0 0.0 0.0 0.1 17.4 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 55.7 0.0 0.0 2.2 1.2 0.0 0.1 0.0 0.0 0.0 CDH15 "CDH14, CDH3" ENSG00000129910 "Cadherin 15" P55291 16 89171767-89195492 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 44.2;skeletal muscle: 60.3" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 1.3;Ito cells: 1.3;Melanocytes: 1.7;Muller glia cells: 1.5;Spermatocytes: 1.6;Spermatogonia: 4.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 24 "cerebellum: 44.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RH-30: 57.9" "Region enriched" "Detected in some" 7 "cerebellum: 17.6" "Region enriched" "Detected in all" 6 "cerebellum: 17.9" "HPA009139, HPA070961" Enhanced Supported Enhanced "Golgi apparatus,Plasma membrane" NA NA 390000 "Golgi apparatus, Plasma membrane" "HPA009139: AB_1078372, HPA070961: AB_2686328" "unprognostic (1.26e-1)" "unprognostic (7.70e-3)" "unprognostic (6.64e-3)" "unprognostic (2.81e-1)" "unprognostic (7.79e-3)" "unprognostic (2.70e-3)" "unprognostic (2.84e-3)" "unprognostic (4.37e-2)" "unprognostic (2.30e-3)" "unprognostic (7.66e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.14e-7)" "unprognostic (3.09e-2)" "unprognostic (3.13e-1)" "unprognostic (5.50e-2)" "unprognostic (2.64e-2)" 0.8 0.2 0.0 0.1 0.0 0.1 0.1 44.2 0.2 0.7 0.1 0.0 0.0 0.2 0.1 2.8 0.6 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.2 0.1 0.0 0.0 0.1 0.9 0.1 0.0 0.8 1.8 0.5 0.1 0.0 0.3 0.2 60.3 0.1 0.1 0.1 0.3 0.6 0.1 0.3 0.0 0.0 0.1 6.5 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 57.9 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 44.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.2 0.2 0.0 0.6 0.3 0.0 0.0 1.3 0.0 0.4 0.0 0.0 1.7 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.3 1.6 4.3 0.0 0.1 0.0 0.0 0.0 CDH16 ENSG00000166589 "Cadherin 16" O75309 16 66908122-66918984 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 139.7" "Cell type enriched" "Detected in some" 6 "Collecting duct cells: 586.2" "Cancer enriched" "Detected in many" 15 "renal cancer: 96.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 96 "RPTEC TERT1: 71.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB013526, HPA036260" Enhanced NA NA "CAB013526: , HPA036260: AB_2675027" "unprognostic (1.07e-1)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (9.81e-2)" "unprognostic (4.24e-3)" "unprognostic (5.81e-2)" "unprognostic (5.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-2)" "prognostic favorable (1.02e-7)" "unprognostic (2.19e-1)" "unprognostic (1.99e-1)" "unprognostic (7.36e-3)" "unprognostic (2.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.0 0.3 0.0 3.5 0.1 3.4 0.2 0.0 0.0 0.0 139.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.3 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 586.2 0.0 0.0 63.0 0.1 2.5 0.0 0.9 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 105.4 0.0 0.0 0.4 0.0 0.1 0.0 0.8 0.0 0.4 0.0 CDH17 "cadherin, HPT-1" ENSG00000079112 "Cadherin 17" Q12864 8 94127171-94217303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 184.4" "Group enriched" "Detected in some" 51 "Enterocytes: 404.8;Intestinal endocrine cells: 104.0;Mucus-secreting cells: 149.4;Paneth cells: 316.3;Undifferentiated cells: 191.5" "Group enriched" "Detected in many" 6 "colorectal cancer: 156.4;stomach cancer: 54.9" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 5 "neutrophil: 12.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.1" "Cell line enhanced" "Detected in some" "CACO-2: 21.9;OE19: 94.0;U-266/70: 36.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023614, HPA023616, CAB025143, HPA026556" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA 3400000 "Cell Junctions" Nucleoplasm "CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897" "unprognostic (2.08e-1)" "unprognostic (5.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (3.02e-1)" "unprognostic (3.06e-2)" "unprognostic (5.60e-2)" "unprognostic (3.38e-3)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.47e-2)" "unprognostic (3.74e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "unprognostic (7.33e-2)" "unprognostic (1.46e-2)" 0.3 0.2 0.2 17.6 0.3 0.3 0.3 0.2 0.2 0.3 88.9 0.2 0.2 54.5 0.4 0.3 0.4 0.4 7.0 0.6 0.2 0.3 0.3 0.3 0.3 0.5 0.2 0.2 0.3 0.4 0.0 0.3 0.2 0.2 0.4 44.0 0.2 0.3 0.2 0.3 0.2 184.4 1.4 0.2 0.6 0.3 0.3 0.2 0.3 0.2 0.2 0.5 0.4 0.3 1.5 0.8 12.1 1.0 1.4 0.6 0.1 0.0 4.0 0.2 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 21.9 1.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.1 0.3 0.1 94.0 0.1 0.2 0.0 0.7 0.1 0.0 0.4 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.3 0.1 36.3 0.0 0.1 0.1 0.1 0.2 2.5 1.0 1.2 0.5 0.8 0.3 0.6 0.5 0.4 0.8 1.5 0.5 0.6 12.1 1.4 0.5 0.7 0.5 0.1 0.2 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 404.8 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 104.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 149.4 0.0 0.0 316.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 191.5 0.0 CDH18 "CDH14, EY-CADHERIN" ENSG00000145526 "Cadherin 18" Q13634 5 19472951-20575873 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 105.4" "Cell type enriched" "Detected in some" 5 "Early spermatids: 68.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 7 "cerebellum: 105.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 5.8;GAMG: 10.1;hTERT-RPE1: 5.3;U-2 OS: 9.1;U-2197: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014416 Uncertain "Intracellular and membrane" NA NA "HPA014416: AB_2668996" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (5.26e-7)" "unprognostic (6.36e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (8.78e-2)" "unprognostic (3.30e-2)" "unprognostic (1.51e-2)" "unprognostic (8.69e-2)" "unprognostic (1.76e-2)" 0.7 9.3 6.9 0.7 7.1 0.7 0.6 105.4 23.2 1.0 0.6 0.0 0.0 0.7 0.6 0.6 0.7 0.7 0.7 0.6 4.6 8.1 0.9 0.6 0.7 0.8 1.8 8.3 0.7 1.2 2.1 11.3 0.6 7.1 0.8 0.7 2.2 0.6 0.8 0.9 0.8 0.7 0.6 2.2 0.7 0.6 3.7 1.3 0.0 0.6 0.0 0.6 0.6 0.3 0.7 0.3 1.2 0.5 0.6 0.4 0.5 1.5 0.0 0.3 0.0 0.9 3.8 3.4 0.2 2.1 0.1 0.6 0.0 0.0 0.0 5.8 0.0 10.1 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 2.3 5.3 0.0 0.1 0.2 0.7 0.4 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.0 1.8 9.1 8.0 0.0 2.2 0.0 0.0 2.6 0.0 0.0 1.1 0.5 0.3 0.4 0.1 0.2 0.3 0.2 0.2 0.2 0.7 0.4 0.4 1.2 0.6 0.4 0.3 0.2 0.5 6.9 7.1 105.4 14.1 4.6 8.1 1.8 8.3 7.1 1.3 0.0 0.0 0.0 0.8 0.0 3.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 68.6 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.3 0.0 0.0 2.1 2.4 0.0 0.2 0.0 0.0 0.0 CDH19 CDH7 ENSG00000071991 "Cadherin 19" Q9H159 18 66501083-66604138 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 37.1" "Group enriched" "Detected in some" 4 "Ito cells: 20.9;Melanocytes: 42.2" "Cancer enriched" "Detected in some" 21 "melanoma: 16.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.3" "Group enriched" "Detected in some" 12 "SK-MEL-30: 20.1;WM-115: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA056332 Uncertain NA NA 160000 "HPA056332: AB_2683102" "unprognostic (1.63e-2)" "unprognostic (2.63e-2)" "unprognostic (4.26e-2)" "unprognostic (4.10e-2)" "unprognostic (2.51e-2)" "unprognostic (3.14e-2)" "unprognostic (1.93e-1)" "unprognostic (3.79e-1)" "unprognostic (1.02e-1)" "unprognostic (4.39e-2)" "unprognostic (9.33e-2)" "unprognostic (2.25e-2)" "unprognostic (4.58e-3)" "unprognostic (8.16e-3)" "unprognostic (8.21e-2)" "unprognostic (1.56e-5)" 4.5 7.5 4.1 5.4 17.4 0.5 2.3 0.9 10.2 6.4 17.9 5.7 4.6 3.8 1.6 3.2 11.7 2.4 4.7 37.1 5.2 2.3 1.1 7.0 2.1 0.5 22.0 5.5 2.0 2.2 0.6 1.1 5.2 13.1 4.7 5.2 6.9 4.5 7.6 6.0 2.6 5.9 7.2 12.5 4.0 5.8 1.9 20.0 0.0 1.7 2.7 0.4 5.7 12.6 0.2 0.0 1.3 0.1 0.2 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 20.1 0.0 0.8 0.0 0.0 0.0 0.2 0.1 0.0 2.3 0.1 0.0 0.1 0.0 35.9 0.0 0.1 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.1 4.1 17.4 0.9 10.2 5.2 2.3 22.0 5.5 13.1 20.0 0.0 0.0 0.0 0.1 1.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.9 1.2 0.0 4.9 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.7 0.3 0.0 0.0 0.0 0.4 CDH2 "CD325, CDHN, NCAD" ENSG00000170558 "Cadherin 2" P19022 18 27950966-28177446 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.6;parathyroid gland: 35.4" "Cell type enhanced" "Detected in many" 15 "Cardiomyocytes: 330.4;Cone photoreceptor cells: 141.4;Hepatocytes: 98.3;Muller glia cells: 175.2;Rod photoreceptor cells: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 4.4;neutrophil: 4.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "AF22: 56.7;BJ: 40.9;fHDF/TERT166: 84.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000141, CAB018580, HPA058574, CAB078686" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 160000000 "Plasma membrane, Cell Junctions" "CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760" "unprognostic (9.42e-2)" "unprognostic (2.69e-3)" "unprognostic (9.07e-3)" "unprognostic (5.45e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" "unprognostic (3.97e-2)" "unprognostic (2.53e-3)" "unprognostic (6.70e-3)" "unprognostic (1.00e-2)" "unprognostic (7.53e-2)" "unprognostic (3.51e-2)" "unprognostic (3.02e-2)" "unprognostic (1.93e-3)" "unprognostic (6.69e-2)" "unprognostic (1.33e-1)" "unprognostic (2.59e-3)" 0.6 29.6 9.8 1.5 9.4 0.5 0.5 5.7 16.1 3.2 2.0 8.0 0.2 0.8 3.1 1.9 0.6 4.7 1.7 77.6 9.9 9.6 9.2 23.3 0.7 1.1 6.0 9.1 3.4 0.7 35.4 5.4 0.5 5.9 1.4 0.8 6.8 0.5 4.6 0.4 0.5 0.9 3.2 6.7 5.9 2.5 19.6 7.4 0.9 2.8 0.0 1.0 1.0 1.3 0.0 0.0 4.4 0.0 0.7 0.9 0.0 0.0 4.5 56.7 0.0 9.0 1.8 0.0 40.9 12.4 16.7 15.3 0.0 0.0 0.0 22.0 84.6 8.0 6.0 9.3 0.0 23.7 0.1 5.9 0.0 15.3 14.0 8.6 0.0 0.0 0.8 0.1 38.3 6.7 38.6 14.6 2.5 0.0 0.0 13.0 0.0 10.3 0.0 7.6 0.0 4.9 0.0 6.7 7.8 0.0 1.8 14.8 25.6 0.0 0.0 4.5 23.2 0.0 0.0 2.3 36.2 11.5 0.5 29.6 0.0 0.0 0.0 6.9 0.0 27.8 4.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.7 0.0 0.0 0.0 0.0 9.8 9.4 5.7 10.1 9.9 9.6 6.0 9.1 5.9 7.4 0.0 1.1 5.0 0.0 0.2 23.9 330.4 58.6 2.7 1.2 10.4 141.4 0.2 0.0 5.6 31.9 3.6 0.0 0.0 0.3 0.0 1.2 0.0 0.0 98.3 0.3 3.2 0.0 18.4 1.9 11.0 2.0 0.4 3.3 0.0 0.0 175.2 12.4 0.0 12.0 40.6 92.8 6.5 5.3 3.3 28.8 0.0 0.2 0.0 0.0 0.1 CDH20 "Cdh7, CDH7L3" ENSG00000101542 "Cadherin 20" Q9HBT6 18 61333582-61555773 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 8.8;brain: 32.8" "Group enriched" "Detected in some" 8 "Bipolar cells: 15.9;Muller glia cells: 13.4" "Cancer enriched" "Detected in single" 15 "glioma: 6.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "basophil: 4.5" "Lineage enriched" "Detected in single" 39 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "AF22: 3.2;ASC diff: 10.1;HHSteC: 4.7;SH-SY5Y: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015490 Uncertain NA NA "HPA015490: AB_1845900" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (1.42e-2)" "unprognostic (3.68e-3)" "unprognostic (2.11e-1)" "unprognostic (5.15e-2)" "unprognostic (2.87e-2)" "unprognostic (1.40e-2)" "unprognostic (1.52e-1)" "unprognostic (3.69e-2)" "unprognostic (1.82e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-1)" "unprognostic (3.82e-2)" "unprognostic (1.27e-1)" "unprognostic (3.01e-2)" "unprognostic (1.93e-1)" 8.8 1.2 13.4 1.1 13.7 1.0 1.2 6.9 32.8 1.5 1.1 16.8 0.0 1.0 1.1 2.3 2.5 1.3 1.1 1.1 16.0 7.3 1.2 1.0 1.0 1.1 20.4 9.8 1.0 1.3 1.0 1.1 1.1 12.6 1.5 1.0 0.5 1.0 1.1 3.4 2.0 1.0 1.1 12.8 1.2 1.1 1.4 18.9 0.0 1.2 0.5 1.0 1.1 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.4 0.0 0.0 3.2 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 13.4 13.7 6.9 14.0 16.0 7.3 20.4 9.8 12.6 18.9 0.0 0.0 0.0 0.0 0.0 15.9 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.4 0.0 1.0 0.0 0.2 0.7 0.7 0.0 0.0 0.0 0.0 0.0 CDH22 "C20orf25, dJ998H6.1" ENSG00000149654 "Cadherin 22" Q9UJ99 20 46173733-46308498 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.8" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 9.4;Cone photoreceptor cells: 5.9;Intestinal endocrine cells: 6.8;Late spermatids: 5.4" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "cerebellum: 55.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012164, HPA012715" Uncertain Supported NA NA "HPA012164: AB_1845902, HPA012715: " "unprognostic (2.41e-4)" "unprognostic (1.72e-2)" "unprognostic (3.10e-1)" "unprognostic (4.32e-3)" "unprognostic (3.39e-2)" "unprognostic (4.73e-1)" "unprognostic (4.32e-1)" "unprognostic (2.54e-2)" "unprognostic (5.54e-2)" "unprognostic (4.50e-4)" "unprognostic (2.62e-1)" "unprognostic (3.09e-1)" "unprognostic (7.26e-3)" "unprognostic (5.93e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (9.83e-2)" 0.7 4.2 10.2 0.5 5.7 0.5 0.8 55.8 15.5 0.7 0.6 1.0 0.0 0.6 0.7 0.7 1.2 4.0 0.5 1.0 3.5 3.7 0.7 0.5 0.6 0.5 1.2 8.7 0.9 4.2 0.5 1.1 0.5 3.0 1.5 0.7 1.8 1.0 1.8 1.2 10.4 0.9 0.5 1.9 0.5 0.9 1.4 1.3 0.0 0.7 0.0 0.5 0.5 0.6 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 10.2 5.7 55.8 14.8 3.5 3.7 1.2 8.7 3.0 1.3 0.0 0.0 0.0 1.1 0.7 9.4 2.8 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 5.4 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 CDH23 "CDHR23, DFNB12, USH1D" ENSG00000107736 "Cadherin related 23" Q9H251 10 71396934-71815947 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Hearing, Sensory transduction, Vision" "Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 28.9" "Group enriched" "Detected in many" 4 "Early spermatids: 60.1;Late spermatids: 52.6;Muller glia cells: 81.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 14.4;non-classical monocyte: 19.9" "Lineage enhanced" "Detected in many" "monocytes: 19.9" "Group enriched" "Detected in some" 4 "RT4: 16.5;SCLC-21H: 6.9" HPA017232 Approved NA NA 14000 "HPA017232: AB_1845903" "unprognostic (6.76e-2)" "unprognostic (2.86e-3)" "unprognostic (3.82e-2)" "unprognostic (3.13e-3)" "unprognostic (1.07e-1)" "unprognostic (5.52e-2)" "unprognostic (7.93e-2)" "unprognostic (2.88e-1)" "unprognostic (6.44e-3)" "unprognostic (4.67e-2)" "unprognostic (2.05e-1)" "unprognostic (9.23e-3)" "unprognostic (2.14e-3)" "unprognostic (2.33e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "prognostic favorable (3.40e-4)" 11.9 3.6 4.9 2.7 6.1 2.6 4.2 12.8 4.7 3.7 1.7 6.5 1.6 1.6 8.4 4.7 2.1 5.7 3.1 3.0 3.4 4.1 0.7 10.3 6.1 2.2 5.6 2.6 25.1 12.1 22.6 0.9 0.9 27.4 5.9 1.8 28.9 1.6 1.3 3.4 2.1 2.0 3.1 3.5 5.1 1.5 6.8 6.2 5.0 1.5 2.0 2.0 4.8 4.0 0.0 5.7 3.2 19.9 0.0 0.4 1.4 0.0 0.9 1.0 1.6 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.5 0.1 0.2 0.1 0.0 1.2 0.6 1.7 0.0 0.0 0.1 1.7 1.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.2 0.1 1.9 0.5 0.0 1.4 0.0 0.1 0.0 16.5 6.9 1.5 0.9 0.2 0.2 1.5 0.2 2.8 0.0 0.0 1.4 0.0 0.0 0.8 0.1 0.2 1.9 1.3 0.0 0.0 3.3 2.9 0.1 14.4 0.3 0.0 0.1 0.0 2.7 0.0 0.1 0.4 3.2 0.0 19.9 5.7 0.0 1.4 4.9 6.1 12.8 4.7 3.4 4.1 5.6 2.6 27.4 6.2 0.0 1.1 0.0 4.1 0.7 1.4 3.1 0.0 0.0 1.2 1.8 0.0 1.1 0.0 0.3 60.1 2.9 1.1 0.0 0.4 2.3 1.9 1.8 0.0 15.8 2.2 0.0 6.9 3.1 9.4 52.6 2.3 6.8 6.8 0.0 0.7 81.1 0.2 3.2 0.7 0.5 3.0 6.5 2.1 3.0 0.9 1.0 0.2 0.5 0.4 2.0 CDH24 CDH11L ENSG00000139880 "Cadherin 24" Q86UP0 14 23047062-23057538 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 5.4;Intestinal endocrine cells: 10.3;Muller glia cells: 4.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 31.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.30e-1)" "unprognostic (3.06e-2)" "unprognostic (4.15e-3)" "unprognostic (6.21e-2)" "unprognostic (1.27e-1)" "unprognostic (9.18e-2)" "unprognostic (6.68e-3)" "unprognostic (2.71e-2)" "unprognostic (5.97e-3)" "unprognostic (3.55e-1)" "unprognostic (4.18e-2)" "unprognostic (5.97e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.37e-2)" "unprognostic (8.85e-2)" 5.8 4.7 8.0 4.3 9.3 2.9 5.0 13.0 12.6 6.2 4.5 4.0 6.1 3.0 13.4 3.2 5.8 5.8 10.1 3.8 10.5 5.1 4.6 1.1 4.7 3.4 4.4 4.8 3.8 3.5 8.3 3.1 5.7 5.3 4.6 4.5 7.9 4.7 4.5 1.8 7.2 5.0 10.2 4.0 5.2 4.1 3.4 6.6 7.8 6.8 3.8 4.1 7.3 6.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 2.5 2.5 10.8 12.3 2.7 1.3 6.0 4.8 3.2 4.1 5.3 3.3 3.5 0.2 3.9 5.3 1.0 14.9 4.6 4.1 3.3 4.0 3.9 0.5 6.6 1.0 3.0 7.4 0.2 10.4 1.3 4.5 3.0 5.1 6.7 2.4 1.6 6.5 3.5 7.3 0.6 4.9 2.7 2.7 6.0 12.9 3.5 4.8 1.2 2.2 31.4 8.4 11.4 6.1 0.6 3.1 5.4 1.0 6.2 4.1 15.8 1.6 3.5 2.1 0.6 0.1 4.3 2.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.0 9.3 13.0 12.6 10.5 5.1 4.4 4.8 5.3 6.6 0.0 0.0 0.0 0.4 1.3 1.4 1.4 0.0 0.0 0.0 1.8 0.0 1.6 1.7 0.6 0.3 5.4 0.4 0.0 0.4 2.1 0.6 0.6 0.0 0.0 0.5 0.0 10.3 1.8 0.0 0.6 0.0 0.0 1.7 0.0 1.4 4.7 0.4 0.0 0.0 0.4 0.5 0.0 1.0 0.7 2.0 1.9 1.6 0.0 1.5 0.9 CDH26 VR20 ENSG00000124215 "Cadherin 26" Q8IXH8 20 59958427-60034011 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.1;prostate: 15.3" "Cell type enhanced" "Detected in some" 19 "Ciliated cells: 45.5;Club cells: 18.2;Glandular cells: 12.1;Syncytiotrophoblasts: 12.5" "Group enriched" "Detected in some" 6 "cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;eosinophil: 1.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "RT4: 34.7" "Low region specificity" "Detected in single" "HPA015722, HPA047578" Uncertain Supported "Plasma membrane,Microtubules" NA NA "Plasma membrane" Microtubules "HPA015722: AB_2077659, HPA047578: AB_2680091" "unprognostic (2.42e-1)" "prognostic favorable (7.62e-4)" "unprognostic (4.71e-4)" "unprognostic (8.17e-2)" "unprognostic (9.40e-2)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "prognostic favorable (3.75e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (3.26e-4)" "unprognostic (8.24e-3)" "unprognostic (9.96e-7)" "unprognostic (1.85e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" 0.8 0.5 0.8 0.7 1.2 1.3 0.8 2.0 1.1 3.8 0.7 0.7 0.7 0.5 1.3 0.7 3.8 2.5 0.7 0.7 1.2 1.0 0.7 0.7 2.9 0.7 1.3 0.7 2.0 0.7 0.7 1.9 0.7 1.4 15.3 0.4 1.4 2.8 0.7 1.0 0.4 0.7 0.7 1.6 0.7 1.9 0.7 0.7 4.2 0.7 0.7 16.1 6.2 1.3 0.0 0.9 1.6 1.4 0.0 0.2 0.4 0.0 0.5 0.1 0.0 0.4 0.2 0.3 0.1 0.0 0.1 0.0 0.6 0.6 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.1 0.0 0.2 0.2 0.1 1.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.2 0.2 0.4 0.4 0.0 0.1 0.0 0.0 0.6 0.0 34.7 0.7 0.1 0.3 0.2 0.1 0.4 0.2 0.4 0.1 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.0 1.4 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.8 1.2 2.0 1.1 1.2 1.0 1.3 0.7 1.4 0.7 6.0 6.7 0.0 0.9 0.1 0.7 0.6 0.0 45.5 18.2 0.0 0.0 1.4 0.0 0.0 2.7 2.1 0.0 0.0 0.0 0.0 0.2 12.1 1.1 0.0 0.5 0.0 0.0 0.0 1.5 1.1 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.2 0.0 12.5 0.0 0.0 6.7 CDH3 "CDHP, PCAD" ENSG00000062038 "Cadherin 3" P22223 16 68636189-68722616 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.0;retina: 40.5" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 49.5;Basal keratinocytes: 54.0;Melanocytes: 57.3;Pancreatic endocrine cells: 60.0;Urothelial cells: 48.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 10 "pons and medulla: 16.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 24.9;HaCaT: 69.1;HBEC3-KT: 33.3;hTCEpi: 26.6;hTERT-HME1: 20.3;RPTEC TERT1: 29.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA001767, CAB002487" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "CAB002487: AB_563446, HPA001767: AB_1078376" "unprognostic (1.55e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-1)" "unprognostic (4.38e-3)" "unprognostic (6.73e-2)" "unprognostic (1.55e-2)" "unprognostic (1.85e-2)" "prognostic unfavorable (8.53e-4)" "unprognostic (1.22e-1)" "unprognostic (3.45e-2)" "prognostic unfavorable (8.43e-4)" "unprognostic (4.30e-2)" "unprognostic (2.41e-5)" "unprognostic (2.11e-1)" "unprognostic (1.09e-1)" "unprognostic (1.33e-3)" "unprognostic (8.56e-2)" 2.2 0.1 1.0 2.5 1.2 0.0 8.7 1.5 1.1 10.5 1.0 2.2 3.0 0.3 9.4 10.3 23.5 8.9 1.4 0.4 1.1 0.8 8.3 0.2 3.6 2.1 0.6 0.4 32.6 0.4 0.5 3.6 6.4 16.0 11.7 0.5 40.5 9.3 4.4 0.1 21.2 0.4 4.1 1.5 10.0 0.7 2.2 0.1 44.0 2.0 26.1 20.1 2.5 6.7 0.9 0.6 1.4 0.5 0.6 0.8 0.2 24.9 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 14.9 9.3 0.0 0.1 0.0 0.0 69.1 0.6 33.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 26.6 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 1.3 0.2 2.1 0.0 0.0 0.0 29.9 11.3 0.1 0.0 0.2 0.0 11.8 12.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.5 0.2 0.4 0.2 0.3 0.6 0.5 0.4 0.1 0.9 0.6 0.8 1.4 0.6 0.2 0.6 0.2 0.2 1.0 1.2 1.5 1.1 1.1 0.8 0.6 0.4 16.0 0.1 14.9 2.9 0.0 49.5 54.0 0.8 1.2 0.0 4.0 13.6 14.0 2.0 21.3 0.0 31.6 0.2 0.5 0.0 0.0 28.5 1.2 3.3 13.1 1.1 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.6 1.2 57.3 1.8 1.4 0.2 60.0 0.0 8.9 0.0 0.4 0.0 1.9 0.2 0.7 26.8 5.3 0.0 0.4 48.9 CDH4 ENSG00000179242 "Cadherin 4" P55283 20 61252426-61940617 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;lymphoid tissue: 10.2;skeletal muscle: 9.8" "Group enriched" "Detected in some" 6 "Horizontal cells: 15.9;Muller glia cells: 21.8" "Group enriched" "Detected in many" 6 "glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enhanced" "Detected in some" "AF22: 8.1;hTERT-HME1: 10.7;U-2 OS: 14.5;U-251 MG: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015613 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA015613: AB_2732414" "unprognostic (1.64e-1)" "unprognostic (1.19e-2)" "unprognostic (3.39e-4)" "unprognostic (2.16e-1)" "unprognostic (2.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.64e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" "unprognostic (6.72e-2)" "unprognostic (6.08e-3)" "unprognostic (1.75e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-2)" "unprognostic (6.78e-2)" 1.0 1.2 17.4 0.7 15.8 0.9 0.9 1.3 13.6 0.9 0.7 4.0 0.0 0.8 0.9 0.7 1.4 2.6 0.9 1.0 10.2 6.9 0.8 0.9 1.0 0.9 2.8 11.8 6.2 2.0 0.7 0.5 0.9 3.3 0.8 0.7 0.6 1.5 3.6 9.8 2.7 0.8 0.7 1.6 10.2 0.8 1.9 3.1 0.0 1.7 0.0 0.7 0.8 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.9 8.1 0.0 0.1 0.6 0.1 2.2 0.0 4.1 0.4 0.2 0.0 0.0 0.2 2.7 2.6 2.9 0.0 4.4 1.7 0.2 0.0 0.0 0.1 0.1 5.6 0.0 0.1 0.8 1.1 0.8 10.7 2.2 0.8 0.3 0.0 0.0 1.6 0.3 0.1 0.0 0.9 0.0 0.0 0.0 0.0 1.1 2.6 0.0 0.8 1.9 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 14.5 0.1 25.3 4.7 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.0 17.4 15.8 1.3 13.6 10.2 6.9 2.8 11.8 3.3 3.1 3.0 0.0 0.0 0.5 0.2 1.2 1.2 0.0 0.0 1.2 0.0 2.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 21.8 0.2 0.0 0.4 0.0 1.8 0.0 0.5 0.1 1.7 0.3 0.0 0.0 0.0 0.1 CDH5 "7B4, CD144" ENSG00000179776 "Cadherin 5" P33151 16 66366622-66404786 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 96.6" "Cell type enhanced" "Detected in many" 15 "Endothelial cells: 155.1;Ito cells: 190.9;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 113.8;TIME: 97.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB028366, HPA075875" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" NA NA 1000000000 "Plasma membrane" "Nucleoplasm, Nuclear membrane" "CAB028366: AB_2276033, HPA075875: " "unprognostic (1.05e-1)" "unprognostic (8.13e-2)" "unprognostic (6.11e-2)" "unprognostic (4.89e-2)" "unprognostic (4.96e-2)" "unprognostic (5.50e-3)" "unprognostic (9.38e-2)" "unprognostic (5.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.33e-2)" "unprognostic (2.32e-1)" "prognostic unfavorable (5.14e-4)" "unprognostic (9.49e-3)" "unprognostic (3.01e-2)" "unprognostic (2.22e-1)" "unprognostic (3.15e-2)" 48.7 5.6 4.0 6.2 5.8 0.6 28.1 2.6 4.8 11.1 6.6 3.4 5.5 3.7 18.7 11.2 8.4 7.2 12.6 21.7 4.5 4.3 7.8 12.7 43.7 9.7 6.5 2.8 7.7 3.6 5.0 3.5 96.6 7.6 9.0 4.8 8.5 5.2 4.4 19.0 7.0 6.8 12.1 5.4 10.8 5.7 6.7 3.3 1.2 16.6 15.7 4.5 11.7 11.3 0.0 0.6 0.4 0.8 0.1 0.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 97.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 1.1 4.0 5.8 2.6 4.8 4.5 4.3 6.5 2.8 7.6 3.3 0.0 10.4 0.0 0.0 3.7 0.0 14.6 7.6 0.0 1.2 1.8 0.0 3.3 0.0 0.1 33.0 155.1 0.0 0.0 0.0 40.7 3.1 0.1 3.5 1.5 2.1 0.0 0.0 190.9 29.5 47.7 5.8 2.3 11.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.1 13.4 0.2 2.6 67.5 0.0 0.0 0.0 CDH6 ENSG00000113361 "Cadherin 6" P55285 5 31193750-31329146 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 73.8" "Cell type enhanced" "Detected in some" 14 "Ductal cells: 30.0;Pancreatic endocrine cells: 38.4;Proximal tubular cells: 100.9;Sertoli cells: 45.3;Smooth muscle cells: 69.4" "Group enriched" "Detected in many" 5 "ovarian cancer: 15.0;renal cancer: 28.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "EFO-21: 106.5" "Low region specificity" "Detected in many" "HPA007047, HPA007403, HPA007456, CAB025274" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 1200000 "Plasma membrane, Cell Junctions" "CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373" "unprognostic (3.87e-2)" "unprognostic (4.69e-2)" "unprognostic (1.35e-1)" "unprognostic (1.92e-3)" "unprognostic (1.58e-2)" "unprognostic (7.61e-3)" "unprognostic (9.04e-2)" "unprognostic (2.68e-1)" "unprognostic (2.74e-2)" "unprognostic (5.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (8.29e-3)" "unprognostic (1.22e-3)" "unprognostic (2.67e-1)" "unprognostic (6.22e-2)" "unprognostic (2.09e-2)" 6.7 1.9 3.4 2.2 7.5 0.6 3.9 1.1 8.4 7.0 2.1 2.4 1.0 2.1 4.5 8.4 3.8 10.0 13.4 3.0 3.3 4.3 73.8 1.4 6.5 1.1 5.0 4.8 3.5 1.3 2.5 2.1 5.3 5.6 2.4 1.7 20.4 1.4 2.9 1.9 1.8 2.0 4.0 6.3 1.4 1.8 0.9 5.5 0.0 3.5 3.3 1.3 4.4 3.4 0.6 0.5 1.7 0.5 0.7 0.4 0.3 0.0 0.4 13.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 106.5 0.0 0.0 0.0 10.6 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.4 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.4 1.3 0.3 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.4 0.4 0.4 0.3 0.3 0.4 0.3 0.3 0.2 0.6 0.3 0.4 1.7 0.7 0.5 0.5 0.3 0.3 3.4 7.5 1.1 6.7 3.3 4.3 5.0 4.8 5.6 5.5 0.0 0.3 0.0 0.0 0.8 7.9 1.7 25.5 0.0 3.4 10.4 0.0 0.0 23.2 30.0 0.2 1.4 0.0 0.0 2.5 0.0 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 1.8 0.0 0.3 38.4 0.0 0.4 100.9 0.7 45.3 69.4 0.0 0.2 0.9 0.0 0.0 0.0 0.0 CDH7 ENSG00000081138 "Cadherin 7" Q9ULB5 18 65750252-65890341 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 16.7" "Cell type enriched" "Detected in some" 7 "Muller glia cells: 44.1" "Cancer enhanced" "Detected in single" "prostate cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 17.3;HEK 293: 3.2;Karpas-707: 6.3;RH-30: 8.3;U-87 MG: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061419 Supported NA NA "HPA061419: AB_2684511" "unprognostic (2.81e-3)" "unprognostic (6.95e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (3.45e-2)" "unprognostic (2.41e-1)" "unprognostic (3.95e-3)" "unprognostic (2.88e-1)" "unprognostic (4.28e-4)" "unprognostic (2.70e-2)" "unprognostic (1.49e-1)" "unprognostic (1.72e-1)" 0.4 0.6 2.6 0.3 4.3 0.6 0.4 15.3 7.5 0.3 0.3 0.0 0.0 0.4 0.3 0.6 0.3 0.3 0.4 0.4 0.5 2.5 0.3 0.6 0.4 0.3 1.5 2.1 1.6 0.3 0.3 1.2 0.3 16.7 3.6 0.5 1.3 0.4 1.9 1.0 0.5 0.3 0.2 1.3 0.4 0.3 1.8 0.1 0.7 0.5 0.0 0.4 0.3 0.2 0.8 0.5 1.9 0.4 0.6 0.4 0.1 0.0 0.2 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.7 0.0 0.3 0.1 8.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.8 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 3.9 0.0 0.0 1.2 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.8 0.4 0.4 1.9 0.6 0.3 0.5 0.2 0.1 2.6 4.3 15.3 5.2 0.5 2.5 1.5 2.1 16.7 0.1 0.0 0.0 0.0 0.5 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 44.1 0.0 0.0 0.0 0.0 4.1 6.5 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.1 CDH8 ENSG00000150394 "Cadherin 8" P55286 16 61647242-62037035 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 29.6;seminal vesicle: 9.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 10.1;Ciliated cells: 4.0;Early spermatids: 3.8;Spermatogonia: 2.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "AF22: 7.0;fHDF/TERT166: 6.1;HaCaT: 13.9;LHCN-M2: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014908, HPA076441" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA014908: AB_1845908, HPA076441: " "unprognostic (1.91e-1)" "unprognostic (2.41e-1)" "unprognostic (4.02e-2)" "unprognostic (7.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.26e-2)" "unprognostic (1.83e-1)" "unprognostic (8.71e-2)" "unprognostic (3.66e-2)" "unprognostic (5.41e-2)" "unprognostic (2.85e-1)" "unprognostic (6.59e-2)" "unprognostic (2.91e-4)" "unprognostic (6.02e-2)" "unprognostic (4.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.06e-1)" 0.9 0.9 13.0 0.7 20.4 0.7 1.2 0.5 29.6 1.4 0.8 5.5 0.0 1.2 0.9 1.1 1.0 0.7 1.1 1.1 10.4 7.7 0.8 0.7 0.9 0.7 9.3 12.2 3.7 0.7 0.8 0.9 1.3 12.8 1.4 0.9 0.0 1.4 9.5 1.4 0.9 1.0 1.4 7.7 0.8 0.8 1.2 5.6 0.0 1.0 0.0 0.8 1.7 0.3 0.0 0.0 1.0 0.2 0.1 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.1 0.0 13.9 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 16.8 0.0 0.0 0.0 1.3 0.0 1.3 0.0 0.0 1.0 0.0 1.8 0.1 0.1 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.0 13.0 20.4 0.5 17.8 10.4 7.7 9.3 12.2 12.8 5.6 0.0 0.3 0.0 0.7 0.1 10.1 1.1 0.0 4.0 1.2 0.0 0.0 0.9 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.2 0.0 0.4 1.2 2.6 0.1 0.2 0.0 0.0 0.6 CDH9 ENSG00000113100 "Cadherin 9" Q9ULB4 5 26880600-27121150 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 46.8" "Cell type enhanced" "Detected in single" 37 "Proximal tubular cells: 3.3" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "amygdala: 46.8;basal ganglia: 24.6;cerebral cortex: 23.7;hippocampal formation: 15.9;olfactory region: 15.6" "Cell type enhanced" "Detected in some" "neutrophil: 8.3" "Group enriched" "Detected in many" 5 "B-cells: 4.1;granulocytes: 8.3" "Cell line enhanced" "Detected in some" "K-562: 9.4;NTERA-2: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007167 Approved Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA007167: AB_1078489" "unprognostic (1.49e-1)" "unprognostic (2.27e-4)" 0.7 0.5 46.8 1.0 24.6 2.8 0.7 0.5 23.7 0.5 0.8 0.0 0.0 0.6 0.9 1.2 0.7 0.5 0.7 0.5 15.9 3.5 10.5 0.5 0.6 1.6 1.2 15.6 0.6 1.1 1.0 0.5 0.8 1.5 1.0 1.2 0.0 0.5 0.1 0.5 1.9 1.5 0.8 0.6 0.8 0.9 3.7 2.6 0.0 1.9 0.0 1.7 0.5 0.5 4.1 0.9 8.3 1.1 0.1 0.8 1.1 2.5 0.9 0.5 0.8 0.4 0.0 1.6 0.0 0.9 0.3 0.7 0.0 0.9 1.3 0.3 0.3 0.2 0.3 0.1 0.6 0.0 0.1 0.3 0.5 0.7 2.5 0.0 0.0 1.6 0.6 0.7 0.0 0.0 0.0 0.2 0.8 9.4 2.3 0.0 1.5 0.8 0.5 13.9 0.2 0.5 0.3 0.3 0.4 0.5 0.5 3.1 0.3 0.0 0.4 0.5 2.7 0.5 0.9 1.7 0.1 0.8 0.8 0.3 2.8 1.0 4.4 1.0 1.0 0.8 1.3 0.2 0.4 0.2 0.7 0.6 4.1 0.4 0.2 0.1 2.5 0.3 0.5 8.3 0.1 1.1 0.9 0.8 1.1 46.8 24.6 0.5 23.7 15.9 3.5 1.2 15.6 1.5 2.6 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDHR1 "CORD15, KIAA1775, PCDH21, RP65" ENSG00000148600 "Cadherin related family member 1" Q96JP9 10 84194635-84219621 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cone-rod dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 31.2;intestine: 22.6;retina: 42.5;skin 1: 86.8" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 357.4;Rod photoreceptor cells: 231.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 13.8" "Region enhanced" "Detected in many" "basal ganglia: 31.2" "Cell type enriched" "Detected in single" 11 "NK-cell: 10.5" "Lineage enriched" "Detected in single" 11 "NK-cells: 10.5" "Cell line enhanced" "Detected in some" "HAP1: 10.5;HEK 293: 5.4;HEL: 6.3;K-562: 4.5;NTERA-2: 4.6;RPTEC TERT1: 17.2" "Region enriched" "Detected in some" 21 "olfactory region: 408.8" "Low region specificity" "Detected in all" HPA036819 Enhanced "Intracellular and membrane" NA NA "HPA036819: AB_10671750" "unprognostic (8.91e-4)" "unprognostic (5.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.71e-2)" "unprognostic (2.63e-2)" "unprognostic (3.03e-2)" "unprognostic (6.40e-2)" "unprognostic (7.77e-2)" "unprognostic (1.41e-1)" "unprognostic (2.67e-1)" "unprognostic (6.69e-4)" "unprognostic (1.90e-1)" "unprognostic (5.51e-3)" "unprognostic (1.26e-1)" "unprognostic (2.27e-1)" "unprognostic (4.56e-3)" "unprognostic (5.07e-2)" 0.3 1.2 1.9 0.7 31.2 0.5 2.3 0.9 7.7 2.8 12.3 2.2 0.0 0.3 0.6 2.2 4.8 0.6 0.5 0.9 3.4 2.1 0.5 0.5 0.4 0.7 1.5 3.1 0.8 0.4 0.3 1.5 0.4 9.3 0.9 22.6 42.5 1.0 2.2 0.7 86.8 5.3 0.9 1.2 3.0 0.4 0.4 3.0 2.4 0.4 3.3 0.9 0.4 1.5 0.0 0.0 0.0 0.0 10.5 0.9 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.5 2.0 0.0 0.0 5.4 6.3 0.0 0.0 0.2 0.0 0.2 0.0 2.3 0.0 0.8 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 1.5 4.6 0.0 0.0 0.0 0.0 1.4 17.2 0.0 3.6 0.8 0.0 0.0 0.0 2.7 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.1 1.9 31.2 0.9 7.7 3.4 2.1 1.5 3.1 9.3 3.0 0.0 0.3 0.0 0.3 45.4 19.5 1.0 0.0 0.0 1.2 0.0 357.4 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 4.8 12.2 0.0 0.3 0.0 0.0 0.0 3.3 0.0 35.5 25.1 0.0 24.6 0.0 0.1 231.3 0.0 0.2 0.0 0.0 59.0 0.0 2.9 47.2 0.1 CDHR2 "FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC" ENSG00000074276 "Cadherin related family member 2" Q9BYE9 5 176542511-176595974 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 179.8" "Group enriched" "Detected in many" 9 "Early spermatids: 170.9;Enterocytes: 298.9;Late spermatids: 532.5;Paneth cells: 175.4" "Group enriched" "Detected in many" 14 "colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "Hep G2: 22.2" "Region enriched" "Detected in single" 6 "hypothalamus: 2.5" "Not detected" "Not detected" "HPA012569, HPA017053" Enhanced NA NA 3600000 "HPA012569: AB_1845298, HPA017053: AB_1845297" "unprognostic (1.34e-2)" "unprognostic (8.90e-4)" "unprognostic (3.82e-2)" "unprognostic (8.51e-2)" "unprognostic (5.10e-4)" "unprognostic (4.24e-3)" "unprognostic (6.66e-2)" "unprognostic (2.06e-3)" "unprognostic (1.54e-1)" "unprognostic (1.99e-1)" "unprognostic (7.66e-3)" "unprognostic (1.75e-1)" "prognostic favorable (9.29e-4)" "unprognostic (6.58e-2)" "unprognostic (3.55e-1)" "unprognostic (2.30e-2)" "unprognostic (1.42e-1)" 0.1 0.0 0.1 2.5 0.3 0.0 0.1 0.1 0.3 0.1 80.0 0.1 0.1 67.2 0.1 0.8 0.1 0.2 7.1 0.1 0.1 0.4 3.0 26.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 2.9 0.5 0.1 0.1 0.1 0.1 179.8 0.1 0.1 0.1 2.8 1.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.3 0.0 0.1 0.1 0.0 0.3 0.3 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.2 0.6 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.3 1.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.1 0.3 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 12.7 0.0 0.0 1.8 0.0 0.0 0.0 2.9 170.9 0.0 298.9 0.0 0.9 0.0 0.0 0.0 0.0 5.6 0.0 0.0 32.2 0.0 0.3 532.5 1.4 0.0 0.0 0.0 34.1 1.5 9.3 175.4 2.1 11.8 0.2 0.0 0.0 4.1 1.9 0.0 0.1 0.0 6.6 0.0 CDHR3 "CDH28, FLJ23834, FLJ44366" ENSG00000128536 "Cadherin related family member 3" Q6ZTQ4 7 105876796-106033773 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 51.9;lung: 28.9;ovary: 22.3" "Cell type enriched" "Detected in many" 6 "Ciliated cells: 341.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 15.9" "Group enriched" "Detected in some" 5 "memory B-cell: 2.9;naive B-cell: 6.9;neutrophil: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 6.9;granulocytes: 1.8" "Cell line enhanced" "Detected in some" "AF22: 7.9;Daudi: 10.1;WM-115: 6.8" "Low region specificity" "Detected in many" HPA011218 Supported Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA011218: AB_1078886" "unprognostic (4.38e-4)" "unprognostic (9.18e-2)" "unprognostic (8.16e-3)" "unprognostic (8.08e-3)" "unprognostic (5.23e-2)" "unprognostic (1.55e-1)" "unprognostic (3.43e-2)" "unprognostic (1.18e-3)" "unprognostic (2.99e-2)" "unprognostic (1.92e-1)" "unprognostic (2.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.18e-1)" "unprognostic (2.77e-2)" "unprognostic (3.70e-3)" "unprognostic (3.51e-3)" 0.4 0.6 2.2 0.6 3.3 0.5 2.5 4.4 1.4 2.4 7.6 4.9 1.1 1.1 2.4 14.9 5.9 51.9 0.2 3.3 3.1 2.1 0.7 0.6 28.9 0.4 1.1 0.3 22.3 0.3 0.1 1.4 0.1 15.9 0.3 0.9 0.1 0.3 0.6 0.5 0.4 12.0 1.7 0.6 0.2 4.6 2.2 1.2 0.1 1.4 0.4 0.7 0.3 0.1 6.9 0.2 1.8 0.2 0.3 0.7 0.1 0.1 0.4 7.9 1.4 2.8 2.7 0.2 0.7 0.6 0.3 0.2 0.0 0.1 10.1 0.0 0.5 1.1 0.1 1.9 0.0 0.3 0.9 1.2 0.0 0.2 0.7 0.0 0.2 0.4 1.0 0.3 0.5 0.0 0.2 0.0 0.0 0.1 0.3 0.3 0.0 0.2 0.1 1.8 2.8 0.6 0.0 0.0 0.4 0.1 0.1 0.6 2.9 0.0 0.8 0.5 1.4 0.0 0.0 0.4 1.4 0.5 1.5 0.0 0.0 0.0 3.3 0.2 0.3 6.8 0.1 0.1 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 6.9 0.3 0.1 1.8 0.3 0.2 0.2 0.7 0.1 2.2 3.3 4.4 1.4 3.1 2.1 1.1 0.3 15.9 1.2 3.0 7.2 0.0 1.6 2.4 4.5 1.2 2.5 341.3 55.7 0.0 0.0 0.5 5.0 0.5 5.4 1.0 2.8 0.0 0.5 0.2 1.5 0.5 3.5 1.7 0.1 0.0 28.7 0.0 0.0 2.5 2.6 0.6 8.5 0.0 3.6 9.5 0.2 2.9 1.4 4.4 1.0 6.5 1.7 1.4 3.1 1.8 0.2 0.7 2.9 0.4 CDHR4 "CDH29, VLLR9392" ENSG00000187492 "Cadherin related family member 4" A6H8M9 3 49790732-49799835 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 37.8;fallopian tube: 42.7" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 132.5" "Cancer enriched" "Detected in some" 6 "endometrial cancer: 6.8" "Region enhanced" "Detected in some" "pons and medulla: 5.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.7;HeLa: 4.5" "Region enhanced" "Detected in many" "basal ganglia: 17.7" "Low region specificity" "Detected in single" HPA076277 Enhanced "Intracellular and membrane" NA NA "HPA076277: AB_2732306" "unprognostic (1.50e-4)" "unprognostic (4.87e-2)" "unprognostic (6.00e-2)" "unprognostic (2.00e-3)" "unprognostic (2.37e-2)" "unprognostic (2.45e-3)" "unprognostic (6.35e-7)" "unprognostic (1.17e-1)" "unprognostic (1.13e-2)" "unprognostic (1.12e-1)" "unprognostic (9.61e-2)" "unprognostic (2.35e-1)" "unprognostic (9.07e-11)" "unprognostic (2.65e-1)" "unprognostic (3.70e-2)" "unprognostic (1.13e-2)" "unprognostic (2.37e-1)" 0.2 0.1 0.4 0.1 1.6 0.3 0.1 0.0 0.0 4.9 0.2 1.9 0.0 0.1 1.3 37.8 0.1 42.7 0.1 0.1 0.7 0.9 0.1 0.1 11.4 0.1 0.0 0.0 8.0 0.0 0.0 0.8 0.6 5.7 0.1 0.1 0.0 0.1 0.2 0.1 0.9 0.1 0.3 0.2 0.0 0.1 3.9 0.0 0.0 0.0 0.5 0.2 0.2 0.1 1.1 1.5 3.0 4.1 1.3 0.4 5.8 0.5 1.8 0.5 0.3 0.5 4.7 0.3 0.4 0.1 1.0 1.0 0.0 2.7 0.0 0.2 1.1 0.6 0.5 0.1 0.0 0.3 0.3 0.3 0.8 4.5 1.0 0.0 0.3 0.5 0.7 1.5 0.8 0.3 1.2 0.0 0.3 0.2 0.7 0.0 0.0 0.0 0.8 0.3 0.6 0.2 0.8 0.2 0.0 0.0 0.3 0.1 0.1 1.6 1.1 0.0 0.1 0.2 0.1 0.0 0.6 0.2 0.7 0.1 0.7 2.4 0.1 2.2 1.3 0.0 3.0 4.1 0.4 0.4 1.6 0.3 0.4 0.3 0.3 1.5 1.1 0.3 0.4 2.5 1.3 0.2 0.5 0.2 5.8 0.4 1.6 0.0 0.0 0.7 0.9 0.0 0.0 5.7 0.0 0.0 4.3 0.0 0.1 0.1 0.0 0.4 0.0 132.5 18.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.4 0.5 0.0 0.0 0.0 0.0 0.1 CDHR5 "FLJ20219, MU-PCDH, MUCDHL, MUPCDH" ENSG00000099834 "Cadherin related family member 5" Q9HBB8 11 616565-626078 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 296.7" "Group enriched" "Detected in many" 6 "Enterocytes: 1223.0;Paneth cells: 645.3" "Group enriched" "Detected in many" 17 "colorectal cancer: 33.2;liver cancer: 61.6;pancreatic cancer: 12.7;renal cancer: 35.4;stomach cancer: 26.7" "Region enriched" "Detected in single" 7 "pons and medulla: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009081, HPA009173, CAB025004" Enhanced "Intracellular and membrane" NA NA 170000000 "CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429" "unprognostic (7.65e-2)" "unprognostic (1.42e-1)" "unprognostic (9.85e-2)" "unprognostic (1.21e-1)" "unprognostic (1.05e-1)" "unprognostic (5.56e-3)" "unprognostic (4.89e-2)" "unprognostic (3.85e-2)" "unprognostic (5.75e-2)" "unprognostic (6.36e-2)" "unprognostic (7.95e-2)" "unprognostic (5.07e-2)" "unprognostic (5.01e-2)" "unprognostic (3.90e-1)" "unprognostic (8.85e-2)" "unprognostic (2.29e-1)" "unprognostic (2.14e-2)" 0.1 0.3 0.1 8.1 0.1 0.0 0.1 0.1 0.1 0.1 118.7 0.4 0.0 34.3 0.1 0.8 0.1 0.2 12.1 0.1 0.2 0.1 10.9 43.8 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.2 0.0 1.6 0.1 21.3 5.1 0.1 0.0 0.1 0.1 296.7 0.8 0.1 0.1 1.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.3 0.4 14.9 0.0 0.1 0.1 2.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.6 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 1.6 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.8 10.2 0.0 0.0 1.8 0.0 0.0 11.6 0.3 2.6 0.0 1223.0 0.0 1.2 0.0 0.0 0.0 13.8 103.1 0.1 0.0 89.1 4.9 5.0 13.1 0.0 0.0 0.0 0.0 152.8 0.0 2.0 645.3 0.0 88.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 129.4 0.0 CDIP1 "C16orf5, CDIP, LITAFL" ENSG00000089486 "Cell death inducing p53 target 1" Q9H305 16 4510675-4538828 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 75.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049352 Approved Supported Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA049352: AB_2680724" "unprognostic (6.38e-3)" "unprognostic (3.70e-3)" "unprognostic (2.95e-2)" "unprognostic (2.50e-3)" "unprognostic (2.74e-2)" "unprognostic (2.56e-2)" "unprognostic (3.48e-1)" "unprognostic (8.26e-2)" "unprognostic (3.68e-2)" "unprognostic (1.03e-2)" "prognostic favorable (2.14e-5)" "unprognostic (9.05e-2)" "prognostic favorable (1.14e-6)" "unprognostic (1.43e-2)" "unprognostic (3.51e-2)" "unprognostic (9.88e-2)" "unprognostic (4.65e-2)" 17.7 14.2 36.8 6.9 41.6 5.1 8.2 36.4 54.6 13.6 9.5 16.3 2.7 30.0 13.4 4.4 8.0 10.9 9.5 25.0 33.8 37.1 23.7 13.2 9.6 8.2 34.2 38.9 18.7 22.9 10.4 19.3 8.5 26.3 13.2 4.1 7.8 10.8 14.7 34.0 9.1 24.2 8.7 20.7 12.0 9.2 10.1 15.7 13.0 10.6 6.7 6.9 7.8 6.3 8.7 9.2 19.3 19.2 14.3 15.9 7.2 3.8 1.6 5.5 1.6 0.4 0.0 0.1 6.0 0.9 5.9 5.1 9.5 1.6 0.2 6.1 4.9 1.8 0.1 5.0 21.2 1.0 13.4 9.5 18.0 6.4 24.6 4.0 8.6 11.3 5.9 11.0 5.3 0.9 1.1 4.7 8.7 0.3 4.9 6.7 0.4 6.7 11.3 12.2 4.3 4.7 25.5 4.9 49.0 1.2 0.1 16.6 7.2 12.0 0.5 7.5 2.5 2.2 4.8 0.2 3.1 9.0 2.1 0.2 13.1 12.1 18.1 0.1 8.8 2.0 3.2 7.9 19.3 15.9 12.5 8.6 8.7 5.7 8.9 7.6 8.3 11.4 9.7 6.2 14.3 19.2 9.2 9.1 7.2 36.8 41.6 36.4 50.3 33.8 37.1 34.2 38.9 26.3 15.7 14.9 6.5 15.6 20.1 26.3 67.6 23.4 2.5 0.0 6.8 15.7 11.8 1.2 44.7 11.0 75.7 16.0 12.0 0.0 7.9 1.3 12.5 12.9 23.0 15.6 16.4 66.7 9.2 24.5 12.4 17.9 16.7 12.3 13.5 2.8 2.3 40.4 9.9 14.4 15.6 47.3 13.1 6.5 13.7 6.4 19.0 13.0 5.6 23.0 3.3 10.6 CDIPT "PIS, PIS1" ENSG00000103502 "CDP-diacylglycerol--inositol 3-phosphatidyltransferase" O14735 16 29858357-29863736 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056597 Enhanced Approved "Nucleoplasm,Nuclear membrane,Plasma membrane" NA NA "Nucleoplasm, Nuclear membrane, Plasma membrane" "HPA056597: AB_2683182" "unprognostic (7.81e-2)" "prognostic favorable (9.40e-4)" "unprognostic (1.93e-3)" "unprognostic (8.08e-3)" "unprognostic (1.50e-2)" "unprognostic (2.84e-2)" "unprognostic (7.60e-2)" "unprognostic (1.09e-2)" "unprognostic (7.03e-2)" "unprognostic (8.75e-2)" "unprognostic (5.56e-3)" "unprognostic (1.61e-1)" "unprognostic (6.17e-2)" "unprognostic (3.36e-2)" "unprognostic (6.95e-2)" "unprognostic (1.56e-1)" "unprognostic (2.48e-1)" 40.4 40.8 24.3 20.2 28.1 15.3 42.9 50.7 39.5 37.1 37.2 21.5 33.9 24.8 33.4 23.0 39.4 30.1 34.5 44.4 23.1 27.9 34.8 66.3 27.1 22.4 24.1 26.4 52.7 40.0 47.1 24.9 43.7 21.8 36.8 16.1 29.3 42.2 38.8 21.0 29.6 32.6 31.8 21.0 25.6 29.5 20.2 16.4 30.4 47.1 19.9 17.3 41.8 42.8 4.8 6.1 20.6 6.5 8.2 8.4 2.7 12.5 27.3 7.7 15.4 42.0 29.1 22.8 22.1 24.8 15.7 15.7 15.9 24.2 8.4 41.9 25.4 13.9 19.8 12.4 14.3 7.2 21.1 25.0 6.0 20.4 23.2 29.3 8.9 15.7 49.2 25.2 21.1 9.7 24.9 19.6 16.1 9.0 21.9 14.1 40.1 12.1 17.7 18.3 13.2 20.3 23.7 9.6 24.5 20.7 12.1 31.7 17.8 11.7 24.9 17.4 14.1 18.6 24.4 17.0 23.3 7.4 18.9 11.3 16.3 18.4 6.0 25.4 14.5 14.0 7.5 6.5 20.6 6.9 4.6 4.6 4.7 6.4 7.3 3.0 4.8 6.3 5.9 16.4 8.2 5.7 6.1 8.4 2.7 24.3 28.1 50.7 39.5 23.1 27.9 24.1 26.4 21.8 16.4 23.8 21.2 20.5 35.7 36.7 46.6 49.2 30.6 18.7 10.3 43.6 43.2 92.1 34.9 59.1 22.5 43.2 44.6 46.7 62.9 107.9 45.5 34.0 13.8 36.5 56.9 55.6 35.8 33.2 37.3 11.0 71.1 25.7 21.9 47.7 34.8 54.4 41.4 37.1 58.0 30.1 42.9 45.3 43.2 8.6 14.0 44.4 61.2 40.6 37.0 35.3 CDKAL1 FLJ20342 ENSG00000145996 "CDK5 regulatory subunit associated protein 1 like 1" Q5VV42 6 20534457-21232404 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "tRNA processing" Transferase "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "SCLC-21H: 67.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.64e-2)" "unprognostic (7.23e-3)" "unprognostic (8.40e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.05e-1)" "unprognostic (1.51e-2)" "unprognostic (3.47e-2)" "unprognostic (4.25e-3)" "unprognostic (6.72e-3)" "unprognostic (1.61e-3)" "unprognostic (1.42e-1)" "unprognostic (3.73e-2)" "unprognostic (5.79e-3)" "unprognostic (3.11e-2)" "unprognostic (1.75e-2)" "unprognostic (1.83e-2)" "unprognostic (2.60e-2)" 18.5 9.8 10.9 18.0 12.2 14.7 13.9 24.1 10.6 16.6 11.4 14.6 9.6 8.1 19.4 12.1 12.1 13.5 11.4 10.8 9.0 7.8 10.8 9.7 11.9 13.4 12.4 7.7 16.6 14.1 12.0 29.9 12.6 11.2 10.8 12.0 14.3 15.7 11.0 22.2 15.0 11.4 13.7 13.4 13.9 11.7 11.4 13.8 22.9 17.1 13.6 19.4 13.2 12.6 8.1 5.4 3.3 11.2 12.0 9.7 3.6 2.9 1.8 4.3 5.5 2.4 3.3 4.6 3.1 2.8 4.6 6.2 3.3 2.7 7.1 7.9 2.6 5.0 3.0 5.8 3.2 6.2 12.6 3.2 6.1 3.2 4.6 3.2 6.0 4.2 3.0 3.3 4.4 4.1 2.9 4.2 4.4 7.8 2.9 3.4 2.5 7.5 7.1 3.0 3.0 2.0 4.4 5.7 6.7 5.9 3.4 67.5 3.9 3.5 5.7 4.5 3.8 4.1 3.0 4.1 5.5 3.8 2.1 5.8 4.6 12.2 6.2 2.0 3.4 9.1 1.5 3.6 3.3 7.8 5.9 6.5 8.1 7.7 7.7 4.9 7.8 9.7 8.6 1.9 12.0 11.2 5.4 8.2 3.6 10.9 12.2 24.1 10.6 9.0 7.8 12.4 7.7 11.2 13.8 6.0 2.9 13.0 8.3 9.3 7.2 8.0 7.6 2.7 7.9 7.0 5.9 8.1 10.0 7.2 12.7 9.0 4.4 0.0 6.8 8.6 7.2 4.1 12.7 4.4 6.4 11.1 32.0 8.0 7.1 5.1 8.1 7.4 3.3 14.4 7.4 5.8 7.7 5.5 4.2 7.4 10.3 6.5 5.7 10.3 12.8 9.3 7.6 10.5 6.9 5.4 CDON "CDO, CDON1, ORCAM" ENSG00000064309 "Cell adhesion associated, oncogene regulated" Q4KMG0 11 125955796-126063335 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 15.7;Muller glia cells: 39.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 26.8" "Cell type enhanced" "Detected in some" "basophil: 2.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 23.1;ASC diff: 29.3;RH-30: 39.9;SuSa: 20.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB012422, HPA017377" Uncertain NA NA 9400000 "CAB012422: AB_2260246, HPA017377: AB_1846453" "prognostic favorable (1.35e-4)" "unprognostic (1.03e-1)" "unprognostic (2.86e-2)" "unprognostic (1.25e-4)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (2.49e-3)" "unprognostic (5.77e-3)" "unprognostic (2.78e-1)" "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (1.78e-7)" "unprognostic (5.39e-2)" "unprognostic (1.51e-1)" "unprognostic (5.83e-3)" "unprognostic (1.86e-4)" 10.4 0.9 1.2 7.9 2.9 0.1 5.3 26.8 4.2 14.6 10.5 2.3 1.5 1.4 16.4 6.3 5.0 14.1 12.6 4.1 1.0 1.5 1.1 1.2 3.7 1.3 0.9 1.9 28.5 1.3 4.1 4.1 3.2 3.6 4.8 2.1 7.2 1.7 4.1 1.2 12.8 3.8 20.6 1.0 0.8 5.6 4.1 1.0 3.0 27.1 2.8 1.8 6.6 6.7 0.5 0.4 2.8 0.3 0.4 0.7 0.1 1.4 1.7 23.1 2.6 29.3 12.4 0.5 0.5 2.8 0.9 0.3 0.7 9.0 1.2 6.5 0.5 2.7 0.3 5.3 1.0 0.8 4.1 4.3 0.4 4.6 2.8 7.0 0.4 1.5 4.0 1.5 0.7 0.2 9.8 0.2 4.8 0.1 1.5 3.0 0.6 2.8 0.8 2.8 0.6 3.6 0.8 39.9 0.9 1.7 0.5 2.2 10.2 2.7 0.4 3.5 20.0 1.9 1.1 0.2 3.0 2.3 5.6 3.5 2.2 3.6 0.3 1.7 1.6 2.9 2.8 0.3 0.3 0.3 0.1 0.2 0.2 0.4 0.4 0.0 0.5 0.7 0.5 1.8 0.4 0.3 0.4 0.3 0.1 1.2 2.9 26.8 4.2 1.0 1.5 0.9 1.9 3.6 1.0 6.0 6.9 0.0 1.3 13.5 3.8 3.9 0.0 4.0 7.9 0.0 15.7 0.3 0.0 0.9 2.2 3.8 0.0 0.0 0.6 0.4 12.7 1.4 0.0 2.4 0.2 0.0 7.5 1.8 0.0 2.3 13.8 0.0 3.3 0.0 0.0 39.8 1.5 0.0 10.6 0.3 4.9 0.0 3.3 1.1 2.5 9.4 0.6 0.0 0.4 1.0 CDRT15L2 ENSG00000214819 "CMT1A duplicated region transcript 15 like 2" A8MXV6 17 20579724-20580911 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 15.3" "Cell type enriched" "Detected in some" 7 "Early spermatids: 54.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.4;AN3-CA: 1.7;Hep G2: 1.3;HMC-1: 1.4;U-138 MG: 2.3" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.4 0.1 1.7 0.0 0.0 1.0 0.3 0.0 0.2 0.0 1.0 0.0 0.7 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.8 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.2 0.7 0.0 2.3 0.0 0.0 0.3 0.9 0.2 0.5 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.5 0.7 0.0 0.0 0.0 0.0 0.0 CDS1 ENSG00000163624 "CDP-diacylglycerol synthase 1" Q92903 4 84582979-84651338 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 48.0" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "myeloid DC: 2.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.5;hTCEpi: 25.6;OE19: 19.7;SK-BR-3: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036187, HPA064546" Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA036187: AB_10601797, HPA064546: AB_2732714" "unprognostic (8.74e-2)" "unprognostic (7.11e-2)" "prognostic favorable (5.22e-4)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-3)" "unprognostic (3.11e-1)" "unprognostic (2.62e-1)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (6.67e-2)" "prognostic favorable (0.00e+0)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-1)" "unprognostic (2.06e-1)" 0.9 4.6 7.4 2.5 10.4 0.4 6.7 13.3 12.9 4.3 16.7 3.3 9.3 24.8 2.0 19.1 17.4 20.5 8.8 0.5 7.4 8.4 11.9 0.6 10.6 0.8 6.4 4.7 5.5 4.5 19.3 7.1 19.7 14.1 6.1 13.6 4.2 11.2 4.3 0.2 12.9 48.0 0.8 2.4 1.0 11.5 5.1 2.3 0.9 19.3 7.9 6.1 3.5 7.4 0.0 2.1 0.0 0.0 0.0 0.4 0.0 11.4 0.2 0.6 0.1 0.0 0.0 12.0 0.0 0.1 0.3 0.2 4.8 20.5 0.0 0.9 0.0 2.4 12.1 3.7 10.2 0.1 0.8 5.7 0.0 1.8 1.1 0.0 0.3 0.8 0.1 25.6 0.0 3.7 0.4 0.0 0.7 0.0 0.0 0.0 8.1 0.1 0.0 1.7 19.7 0.8 0.0 0.0 2.4 5.7 8.7 4.8 0.1 1.3 27.8 0.0 2.3 8.5 0.2 0.0 0.0 0.6 1.2 1.5 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 10.4 13.3 12.9 7.4 8.4 6.4 4.7 14.1 2.3 14.9 36.5 0.5 24.3 25.8 16.5 1.6 17.8 105.7 27.3 38.4 9.8 49.0 3.3 23.6 5.9 2.1 44.6 0.0 20.1 9.6 1.5 29.0 0.0 0.0 10.4 20.6 21.5 1.8 2.2 3.1 0.6 5.6 0.0 1.0 45.1 28.4 30.8 31.6 0.4 14.7 28.1 0.0 1.3 2.3 3.8 47.3 47.9 0.0 47.2 32.3 CDS2 ENSG00000101290 "CDP-diacylglycerol synthase 2" O95674 20 5126786-5197887 "Enzymes, Plasma proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 60.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019698 Approved Approved "Endoplasmic reticulum" No No 200000 "Endoplasmic reticulum" "HPA019698: AB_1846464" "unprognostic (4.59e-2)" "unprognostic (1.98e-1)" "unprognostic (2.39e-1)" "unprognostic (3.37e-2)" "unprognostic (1.15e-1)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (3.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.48e-1)" "unprognostic (3.35e-3)" "unprognostic (1.65e-1)" "prognostic favorable (3.53e-9)" "unprognostic (8.89e-2)" "unprognostic (3.53e-1)" "unprognostic (1.38e-1)" "unprognostic (2.44e-1)" 14.8 16.1 22.2 9.9 25.5 12.1 12.1 36.0 34.5 12.7 11.8 21.4 6.7 5.9 12.9 9.8 10.5 12.5 10.0 26.6 22.0 34.0 16.9 14.2 14.5 10.9 26.7 24.0 10.9 7.2 20.6 15.6 11.1 28.3 15.9 12.3 19.8 8.0 19.7 9.4 6.2 9.9 20.2 16.2 9.8 10.6 13.0 12.5 8.1 14.2 4.6 13.6 11.6 8.2 7.6 7.9 28.3 9.7 6.5 11.1 11.7 9.6 10.8 10.8 5.6 6.4 5.9 4.9 5.3 10.9 8.8 12.7 6.6 9.5 7.3 2.7 9.9 16.0 13.8 8.8 11.1 9.3 7.7 3.0 8.4 3.1 10.1 6.0 5.4 3.2 5.1 6.2 11.5 4.5 7.8 11.7 10.1 4.0 9.5 8.2 1.7 10.8 2.0 5.2 4.7 3.3 9.3 8.7 3.3 5.6 9.4 4.5 6.3 5.9 10.1 13.6 13.7 6.2 2.5 8.5 6.3 5.0 5.6 5.3 8.3 60.6 6.1 2.8 4.3 3.8 24.1 9.7 11.5 10.0 8.0 10.6 7.6 10.2 11.1 7.9 7.4 8.0 7.8 28.3 6.5 7.3 6.3 11.1 11.7 22.2 25.5 36.0 31.6 22.0 34.0 26.7 24.0 28.3 12.5 17.9 14.9 30.8 25.7 15.7 61.3 45.6 25.5 9.4 11.4 31.4 90.3 19.1 5.0 29.0 54.7 32.9 11.8 0.0 19.9 30.4 16.4 18.4 20.7 17.5 51.1 41.3 10.3 27.0 37.0 25.0 15.0 23.1 30.4 28.9 11.5 22.0 25.6 14.8 23.3 13.5 58.9 19.4 53.6 21.6 29.8 13.4 13.6 30.2 12.8 26.9 CDSN D6S586E ENSG00000204539 Corneodesmosin 6 31115090-31120446 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 19.2;skin 1: 109.3;tongue: 29.7" "Group enriched" "Detected in some" 6 "granulocytes: 4.6;Suprabasal keratinocytes: 4.5" "Group enriched" "Detected in some" 8 "head and neck cancer: 2.4;melanoma: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "A-431: 5.9" "Group enriched" "Detected in some" 5 "amygdala: 1.0;cerebral cortex: 1.5;hippocampal formation: 1.0" "Not detected" "Not detected" "HPA044730, HPA054184" Enhanced "Secreted in other tissues" NA NA "HPA044730: AB_10964923, HPA054184: AB_2682409" "unprognostic (1.46e-1)" "unprognostic (6.96e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-1)" "unprognostic (3.44e-2)" "unprognostic (8.80e-2)" "unprognostic (8.13e-2)" "unprognostic (3.92e-4)" "unprognostic (3.92e-3)" "unprognostic (1.74e-4)" "unprognostic (6.34e-2)" "unprognostic (2.75e-1)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 109.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 29.7 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.1 CDYL "CDYL1, DKFZP586C1622" ENSG00000153046 "Chromodomain Y like" Q9Y232 6 4706159-4955551 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Lyase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035578 Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA035578: AB_2674685" "unprognostic (1.25e-1)" "unprognostic (8.99e-2)" "unprognostic (6.03e-2)" "unprognostic (2.38e-3)" "prognostic favorable (1.53e-4)" "unprognostic (1.92e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.62e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (2.06e-1)" "unprognostic (2.05e-2)" "unprognostic (2.09e-1)" "unprognostic (5.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" "unprognostic (2.60e-2)" "unprognostic (3.94e-1)" 18.4 9.2 13.3 14.2 14.4 19.3 16.5 8.1 15.8 19.8 16.2 13.3 20.6 8.2 22.2 15.5 19.6 14.7 11.7 14.5 11.0 8.6 9.9 6.9 11.8 12.7 12.5 10.7 13.3 8.5 12.7 8.3 35.4 12.8 12.5 15.8 11.0 12.8 15.3 24.7 23.2 12.2 17.7 8.5 12.6 13.3 10.1 12.9 11.3 11.7 12.5 15.2 17.7 24.8 1.8 11.2 5.1 2.1 2.3 2.4 1.9 11.8 10.4 15.0 12.6 11.8 8.0 17.4 11.4 9.2 10.8 11.4 8.4 8.3 2.5 11.9 8.8 16.5 10.5 12.2 13.8 13.1 8.3 10.9 10.1 10.2 7.6 15.0 13.1 11.7 6.5 24.8 12.3 18.9 6.6 10.5 9.4 18.3 7.6 5.4 10.6 7.5 12.2 15.5 8.4 11.5 9.3 13.4 20.6 7.2 9.7 12.9 7.8 13.9 12.1 18.0 44.7 7.3 13.0 13.9 12.8 11.3 9.3 13.2 17.6 28.3 9.3 4.3 8.6 13.9 5.1 2.1 0.8 2.4 1.1 1.7 1.4 1.7 1.8 2.5 1.8 1.0 1.7 0.6 2.3 1.2 11.2 0.2 1.9 13.3 14.4 8.1 15.8 11.0 8.6 12.5 10.7 12.8 12.9 17.9 6.5 17.1 15.7 33.2 16.2 16.5 15.3 10.7 10.3 14.0 21.6 10.7 13.3 9.8 56.5 19.6 27.4 70.0 8.8 19.3 13.4 20.9 5.7 9.0 9.0 42.9 31.0 18.4 13.2 47.4 5.5 12.7 8.5 21.6 25.3 22.3 13.6 31.7 7.8 6.6 24.9 6.5 19.6 5.9 24.7 36.6 53.3 12.8 21.7 54.5 CEACAM1 "BGP, BGP1, CD66a" ENSG00000079385 "Carcinoembryonic antigen related cell adhesion molecule 1" P13688 19 42507304-42561234 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 58.7;liver: 46.1;lymphoid tissue: 46.5" "Cell type enhanced" "Detected in many" 16 "Basal glandular cells: 234.8;Enterocytes: 131.5;Glandular cells: 256.0;Urothelial cells: 472.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "eosinophil: 20.6;neutrophil: 12.7" "Lineage enriched" "Detected in many" 11 "granulocytes: 20.6" "Group enriched" "Detected in some" 4 "CAPAN-2: 11.7;Hep G2: 33.3;OE19: 32.1;RT4: 21.9;SK-MEL-30: 24.6" "CAB002146, HPA011041" Enhanced "Intracellular and membrane" NA NA 180000000 "CAB002146: AB_563614, HPA011041: AB_1078481" "unprognostic (7.13e-3)" "unprognostic (2.15e-1)" "unprognostic (2.67e-2)" "prognostic favorable (6.32e-7)" "unprognostic (3.04e-1)" "unprognostic (1.80e-3)" "unprognostic (1.21e-1)" "unprognostic (4.45e-2)" "unprognostic (4.43e-1)" "unprognostic (5.46e-3)" "unprognostic (4.87e-2)" "unprognostic (4.03e-1)" "unprognostic (1.92e-2)" "unprognostic (1.88e-1)" "unprognostic (1.06e-1)" "unprognostic (7.55e-2)" "unprognostic (5.52e-3)" 5.3 5.0 0.4 30.2 0.7 15.8 5.3 0.5 0.5 7.7 58.7 0.9 2.5 11.8 3.5 1.5 35.6 1.7 4.3 3.8 0.5 0.5 24.0 46.1 5.4 8.6 1.8 0.0 2.5 1.0 0.0 3.7 16.8 1.0 8.8 35.6 1.7 20.7 5.4 0.9 1.7 54.9 3.0 1.5 5.5 3.6 1.3 0.7 1.2 2.3 18.5 46.5 7.8 12.7 1.9 0.1 20.6 1.8 0.0 1.5 0.3 0.1 2.2 0.1 0.1 0.0 0.0 5.6 0.0 0.1 0.4 0.2 0.9 11.7 0.7 4.7 0.0 1.2 0.3 0.0 3.1 0.1 0.0 0.2 0.1 0.1 33.3 0.7 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 1.5 0.0 0.4 0.1 0.0 0.1 32.1 0.6 0.6 0.0 0.5 0.2 21.9 0.1 0.0 0.0 0.0 24.6 3.2 0.1 0.0 0.8 0.1 0.2 0.1 0.1 0.7 0.0 1.3 0.0 0.1 0.1 0.4 0.0 20.6 0.0 0.9 0.2 1.9 0.5 0.2 0.1 0.3 0.4 0.1 12.7 0.0 1.8 0.0 1.5 0.3 0.4 0.7 0.5 0.5 0.5 0.5 1.8 0.0 1.0 0.7 6.0 10.9 15.9 234.8 1.1 5.7 1.6 7.6 4.0 7.9 0.0 3.9 0.8 0.0 16.9 2.1 7.1 131.5 0.0 13.8 7.8 1.7 256.0 9.2 32.6 1.1 4.8 16.6 51.5 6.5 0.0 0.0 3.0 6.8 1.0 22.4 1.4 43.2 84.3 0.7 10.5 6.6 0.0 1.8 4.3 2.8 0.9 0.6 4.9 9.8 472.9 CEACAM18 ENSG00000213822 "Carcinoembryonic antigen related cell adhesion molecule 18" A8MTB9 19 51478622-51490952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 62 "intestine: 31.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "pancreatic cancer: 0.8;stomach cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "CACO-2: 8.6;OE19: 7.0;RT4: 2.8" "Not detected" "Not detected" HPA059487 Uncertain Approved Midbody NA NA Midbody "HPA059487: AB_2684036" "unprognostic (1.12e-1)" "unprognostic (1.87e-2)" "unprognostic (1.00e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 16.6 0.0 0.0 14.6 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 31.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 7.0 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CEACAM19 CEAL1 ENSG00000186567 "Carcinoembryonic antigen related cell adhesion molecule 19" Q7Z692 19 44662278-44684359 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 10.7;RPTEC TERT1: 13.7;TIME: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA014462, HPA052865" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA014462: AB_2669006, HPA052865: AB_2681976" "unprognostic (2.91e-1)" "unprognostic (5.29e-3)" "unprognostic (6.96e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-2)" "unprognostic (8.43e-2)" "unprognostic (5.22e-2)" "unprognostic (1.15e-2)" "unprognostic (9.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.77e-1)" "unprognostic (3.26e-9)" "unprognostic (8.01e-3)" "unprognostic (9.62e-2)" "unprognostic (1.31e-1)" "unprognostic (2.70e-1)" 1.6 2.9 1.1 0.8 1.9 1.0 2.4 4.3 1.7 3.1 2.4 2.7 2.7 1.4 2.4 4.3 2.1 4.1 1.2 1.8 3.3 4.3 3.8 0.6 0.6 4.0 4.7 1.2 3.9 1.8 4.1 3.3 2.9 3.0 12.5 10.8 2.9 3.0 0.9 1.8 2.0 3.0 3.4 1.7 1.0 4.4 1.7 0.5 1.7 1.0 1.0 0.7 0.6 4.2 8.8 1.3 0.9 3.1 3.6 3.3 2.4 3.6 0.8 1.6 0.3 1.0 0.1 0.8 3.2 0.9 5.3 2.2 0.9 0.7 1.2 5.0 0.1 4.6 1.4 3.2 0.2 0.8 1.1 8.7 2.2 5.4 10.7 2.0 0.6 0.3 0.2 1.2 1.0 0.0 0.5 0.8 1.1 1.0 0.0 1.6 0.2 13.7 1.0 1.7 0.4 0.9 0.9 0.8 1.3 1.2 0.3 17.7 0.3 6.1 1.3 0.7 0.1 0.3 0.0 0.4 1.7 1.4 1.7 1.0 0.6 0.6 0.4 0.3 0.5 0.3 0.6 0.2 1.7 0.4 0.7 1.6 1.0 0.5 0.5 0.3 0.6 3.0 2.1 0.0 0.9 1.8 2.6 4.1 2.5 1.4 2.3 0.0 0.0 0.0 0.0 1.6 0.7 3.1 1.7 0.0 2.9 0.1 0.9 1.3 0.0 1.9 0.2 0.0 1.7 4.9 1.2 0.2 2.8 0.5 0.0 0.0 2.6 0.1 3.5 3.5 2.5 0.2 0.5 0.0 2.8 3.2 0.4 5.3 0.0 0.0 2.2 0.9 CEACAM20 UNQ9366 ENSG00000273777 "Carcinoembryonic antigen related cell adhesion molecule 20" 19 44501677-44529788 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "intestine: 64.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "liver cancer: 1.2;prostate cancer: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "U-266/70: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.04e-2)" "unprognostic (5.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.92e-1)" "unprognostic (1.23e-2)" "unprognostic (3.75e-1)" "unprognostic (9.89e-2)" "unprognostic (1.07e-2)" "unprognostic (7.58e-2)" "unprognostic (2.14e-5)" "unprognostic (7.13e-2)" "unprognostic (2.51e-2)" "unprognostic (1.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 64.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CEACAM21 "FLJ13540, R29124_1" ENSG00000007129 "Carcinoembryonic antigen related cell adhesion molecule 21" Q3KPI0 19 41549518-41586844 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 19.1;bone marrow: 21.1;lymphoid tissue: 22.7" "Group enriched" "Detected in some" 4 "B-cells: 4.4;Early spermatids: 5.3;granulocytes: 4.6;Hofbauer cells: 7.6;Ito cells: 14.1;Kupffer cells: 6.9;Late spermatids: 7.8;Macrophages: 4.6;T-cells: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 9.8;Karpas-707: 7.8;U-266/70: 8.6;U-937: 6.5" HPA043411 Uncertain NA NA "HPA043411: AB_10794886" "unprognostic (2.55e-1)" "unprognostic (1.61e-3)" "unprognostic (5.73e-2)" "prognostic favorable (1.89e-5)" "unprognostic (2.57e-1)" "unprognostic (8.02e-4)" "unprognostic (3.04e-1)" "unprognostic (2.05e-3)" "unprognostic (1.51e-2)" "unprognostic (2.63e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (3.37e-6)" "unprognostic (2.09e-1)" "unprognostic (3.67e-1)" "unprognostic (1.12e-3)" "unprognostic (1.37e-1)" 1.8 1.2 1.6 18.5 1.7 21.1 1.3 1.0 1.4 3.5 3.8 2.4 0.0 1.2 3.9 1.4 1.5 1.4 1.1 2.1 2.0 7.2 1.4 1.8 7.2 19.2 8.4 0.5 1.1 0.7 0.3 1.0 2.4 1.9 1.2 1.2 2.0 4.3 6.2 0.5 0.6 5.0 0.9 3.3 22.7 1.4 1.5 1.6 11.1 1.2 0.7 22.4 2.9 0.8 6.9 7.0 13.0 4.6 10.3 19.1 10.1 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 7.8 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 8.6 1.5 1.6 0.0 6.5 0.0 0.0 2.6 10.8 19.1 4.6 12.8 6.7 16.5 13.1 2.8 6.9 14.2 13.8 13.0 10.3 2.8 7.0 14.6 10.1 1.6 1.7 1.0 1.4 2.0 7.2 8.4 0.5 1.9 1.6 0.0 0.0 4.4 0.2 0.0 0.0 0.6 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 5.3 1.3 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 7.6 0.0 0.0 14.1 6.9 7.8 0.0 4.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.2 10.0 0.0 0.0 CEACAM3 "CD66d, CGM1" ENSG00000170956 "Carcinoembryonic antigen related cell adhesion molecule 3" P40198 19 41796437-41811553 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 60.0;bone marrow: 35.4" "Cell type enriched" "Detected in some" 12 "Paneth cells: 35.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 7 "neutrophil: 60.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 60.0" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;PC-3: 3.8" HPA011041 Approved NA NA "HPA011041: AB_1078481" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-2)" "unprognostic (2.95e-2)" "unprognostic (2.19e-1)" "unprognostic (8.09e-3)" "unprognostic (1.44e-1)" "unprognostic (2.85e-1)" "unprognostic (1.49e-1)" "unprognostic (3.19e-2)" "unprognostic (1.62e-1)" "unprognostic (8.07e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-1)" "unprognostic (4.68e-2)" "unprognostic (8.44e-2)" "unprognostic (2.83e-1)" 0.9 0.3 0.3 3.6 0.8 35.4 0.7 0.2 0.8 0.6 1.0 0.0 0.0 0.2 0.4 0.2 1.2 0.7 0.4 5.1 0.4 0.3 0.4 1.1 14.0 11.5 1.8 0.1 0.7 1.0 0.2 0.3 4.6 0.5 0.3 0.3 1.4 0.8 0.2 1.5 0.2 0.6 0.4 0.3 10.7 0.4 0.9 0.2 1.6 0.5 0.3 2.7 0.8 0.6 0.0 0.8 60.0 8.9 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.8 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 60.0 0.0 8.9 0.0 0.0 0.6 0.3 0.8 0.2 0.8 0.4 0.3 1.8 0.1 0.5 0.2 3.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.8 0.0 0.0 0.0 1.2 0.9 0.0 1.7 0.0 0.0 0.0 0.0 0.1 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CEACAM4 CGM7 ENSG00000105352 "Carcinoembryonic antigen related cell adhesion molecule 4" O75871 19 41618971-41627074 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 41.5;bone marrow: 22.5;lymphoid tissue: 30.2" "Group enriched" "Detected in some" 7 "Kupffer cells: 39.1;Macrophages: 11.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 4 "neutrophil: 41.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 41.5" "Cell line enriched" "Detected in some" 6 "U-937: 9.5" NA NA "unprognostic (1.10e-2)" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" "unprognostic (4.48e-1)" "unprognostic (3.20e-2)" "unprognostic (3.83e-2)" "unprognostic (9.11e-2)" "unprognostic (5.59e-2)" "unprognostic (1.79e-2)" "unprognostic (1.97e-1)" "unprognostic (1.04e-1)" "unprognostic (2.17e-1)" "unprognostic (2.09e-9)" "unprognostic (3.65e-2)" "unprognostic (2.95e-2)" "unprognostic (1.47e-1)" "unprognostic (4.34e-1)" 1.8 0.5 0.2 5.5 0.5 22.5 0.5 0.1 1.0 0.4 0.5 0.1 0.2 0.4 0.4 3.3 1.0 1.0 1.6 3.4 0.9 0.3 2.2 1.2 6.4 30.2 1.7 0.1 0.5 1.5 0.0 0.7 1.1 0.9 0.9 0.3 1.6 0.9 0.2 0.3 0.3 1.4 1.2 1.2 27.5 0.8 0.6 0.3 1.0 0.4 0.0 1.4 0.9 0.5 0.1 7.9 41.5 10.3 0.0 3.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 10.3 1.8 0.0 7.5 0.0 0.1 0.4 0.0 7.9 0.0 0.2 0.0 41.5 0.0 3.2 0.0 3.5 3.5 0.2 0.5 0.1 1.0 0.9 0.3 1.7 0.1 0.9 0.3 0.0 3.8 0.5 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.6 39.1 0.0 0.0 11.5 1.7 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CEBPZOS CEBPZ-AS1 ENSG00000218739 "CEBPZ opposite strand" A8MTT3 2 37196488-37216193 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053866 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053866: AB_2682283" "unprognostic (2.13e-1)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (1.33e-1)" "unprognostic (8.05e-3)" "prognostic unfavorable (1.72e-6)" "unprognostic (2.34e-2)" "unprognostic (2.40e-2)" "unprognostic (5.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (3.46e-7)" "unprognostic (3.69e-2)" "unprognostic (4.49e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-2)" 16.5 31.3 29.5 16.2 25.4 17.9 18.5 21.0 30.2 16.9 19.8 16.3 19.1 19.0 25.9 33.0 19.3 19.5 14.4 24.5 43.8 23.8 21.5 18.2 13.8 16.5 23.6 31.3 22.8 14.9 18.6 30.2 22.1 25.4 22.3 18.9 16.1 23.9 16.7 38.4 19.0 22.0 17.1 19.4 13.8 15.3 20.3 12.7 12.9 23.7 19.8 15.1 19.4 14.0 20.9 29.4 15.3 15.3 13.1 25.2 13.7 26.2 8.8 18.9 15.3 20.1 21.9 18.3 19.5 17.6 12.7 9.3 8.2 12.0 9.1 10.5 19.4 16.5 15.5 10.3 14.8 15.6 24.6 21.3 24.5 10.2 12.8 17.4 30.5 13.7 23.2 20.5 17.1 19.1 17.2 20.2 9.8 18.4 13.7 20.6 5.3 7.6 30.0 27.8 21.2 13.6 22.8 26.0 20.9 22.3 7.2 20.3 19.9 14.9 24.9 19.0 10.8 11.1 18.6 17.8 13.7 16.9 20.0 16.8 24.6 0.2 19.8 25.5 18.4 19.5 15.3 14.1 12.1 17.7 15.3 20.4 20.9 20.1 18.5 13.5 18.0 25.2 22.4 5.7 13.1 11.5 29.4 13.7 13.7 29.5 25.4 21.0 30.2 43.8 23.8 23.6 31.3 25.4 12.7 50.6 39.2 29.4 42.0 0.0 44.4 41.1 7.6 49.5 38.7 36.6 17.7 70.8 77.9 36.3 30.8 23.3 27.4 0.0 29.4 42.0 27.8 39.9 16.2 24.1 37.6 30.2 16.8 22.1 25.3 9.5 43.7 33.7 0.0 37.9 27.6 46.1 36.7 28.8 41.8 51.9 51.6 45.3 28.5 119.8 51.1 0.0 57.8 34.5 27.5 38.8 CELF4 BRUNOL4 ENSG00000101489 "CUGBP Elav-like family member 4" Q9BZC1 18 37243047-37566037 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 69.1" "Group enriched" "Detected in many" 5 "Bipolar cells: 75.9;Horizontal cells: 278.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013322, HPA037986" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA013322: , HPA037986: AB_10673035" "unprognostic (7.87e-3)" "unprognostic (2.31e-2)" "unprognostic (4.31e-3)" "unprognostic (3.42e-7)" "unprognostic (2.95e-2)" "unprognostic (2.95e-2)" "unprognostic (3.72e-3)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.92e-2)" "unprognostic (1.00e-2)" "unprognostic (3.49e-1)" "unprognostic (1.69e-2)" "unprognostic (2.48e-1)" "unprognostic (8.32e-3)" "unprognostic (6.13e-2)" 1.4 10.7 40.2 1.7 25.2 1.1 1.3 45.3 69.1 1.1 1.6 0.9 0.0 1.6 1.3 1.5 1.4 1.3 2.0 1.7 27.0 26.3 1.4 1.3 1.4 1.6 13.5 26.3 2.0 4.2 1.2 8.1 1.7 13.1 1.5 1.3 0.5 2.5 1.1 8.3 2.0 1.9 1.3 3.7 1.7 1.6 3.9 5.6 0.0 2.3 0.0 1.0 1.2 0.0 0.7 0.5 2.4 0.9 0.9 0.9 0.4 0.1 0.1 0.5 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.2 0.7 0.0 0.1 0.4 0.0 0.1 0.0 0.5 0.3 0.0 1.2 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.6 0.0 0.2 0.1 0.4 1.1 0.0 0.2 0.1 0.0 1.4 0.0 0.1 31.7 7.7 0.8 0.2 0.0 0.2 0.2 0.1 0.0 1.0 0.4 0.2 0.1 2.0 0.3 0.1 0.1 0.1 0.1 2.4 0.5 0.5 0.7 0.6 0.7 0.7 0.4 0.4 0.3 0.7 0.8 0.9 1.3 0.9 0.9 0.5 0.6 0.4 40.2 25.2 45.3 31.1 27.0 26.3 13.5 26.3 13.1 5.6 0.0 0.0 0.0 1.4 0.3 75.9 1.5 0.0 0.0 0.0 0.0 39.3 0.2 0.0 0.2 37.5 0.6 0.3 0.0 0.9 0.1 0.7 2.1 0.0 0.0 6.4 278.1 12.2 1.3 0.0 19.6 0.6 0.0 0.0 0.0 0.0 6.0 4.1 0.0 4.9 1.3 20.9 0.0 0.0 10.0 4.3 0.5 0.2 0.0 0.1 0.8 CELSR1 "ADGRC1, CDHF9, FMI2, HFMI2, ME2" ENSG00000075275 "Cadherin EGF LAG seven-pass G-type receptor 1" Q9NYQ6 22 46360834-46537170 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 38.7;Ciliated cells: 33.5;Club cells: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "memory B-cell: 3.0;naive B-cell: 3.0" "Lineage enriched" "Detected in single" 4 "B-cells: 3.0" "Cell line enhanced" "Detected in many" "A549: 24.1;HaCaT: 15.2;T-47d: 17.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052976, HPA060521" Enhanced "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA052976: AB_2682004, HPA060521: AB_2684303" "unprognostic (5.62e-2)" "unprognostic (4.93e-2)" "unprognostic (4.22e-2)" "unprognostic (1.54e-3)" "unprognostic (2.71e-1)" "unprognostic (1.83e-1)" "unprognostic (3.66e-1)" "unprognostic (3.36e-1)" "unprognostic (5.31e-2)" "unprognostic (1.05e-2)" "unprognostic (1.18e-2)" "unprognostic (8.59e-2)" "unprognostic (2.44e-2)" "unprognostic (1.17e-1)" "unprognostic (2.67e-2)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" 3.4 0.5 0.6 5.0 1.4 0.3 4.1 0.4 0.3 8.7 1.3 0.9 3.6 0.3 5.7 7.5 14.2 11.1 5.3 4.6 0.7 0.7 16.2 0.8 19.3 4.2 0.4 0.0 6.0 2.6 7.5 3.8 3.4 2.2 7.2 0.4 3.8 22.6 3.0 0.3 13.9 2.3 3.1 0.4 1.8 3.6 2.8 0.0 1.8 5.7 12.7 12.8 3.1 5.0 3.0 0.2 0.0 0.0 0.7 0.1 0.0 8.7 24.1 4.6 3.9 0.0 0.0 2.2 0.7 1.5 1.4 0.3 5.7 6.8 0.0 11.9 0.1 9.3 15.2 3.8 11.5 0.5 0.0 4.6 0.0 9.7 0.2 0.2 1.5 0.6 0.0 10.8 0.0 9.6 9.1 0.0 0.6 0.0 0.0 0.0 10.9 0.0 1.7 1.7 2.8 3.8 0.0 0.0 2.8 6.4 5.4 0.2 0.3 7.5 6.0 1.2 1.9 17.3 5.1 0.3 0.0 0.1 0.0 0.1 4.6 0.2 2.4 6.0 0.0 5.2 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.6 1.4 0.4 0.3 0.7 0.7 0.4 0.0 2.2 0.0 38.7 16.8 1.3 3.3 15.1 0.0 10.2 0.0 33.5 27.3 5.2 0.0 1.0 0.0 1.4 1.2 5.5 0.0 0.0 0.6 1.7 1.7 3.6 0.0 1.6 2.4 0.0 1.2 1.3 0.0 5.0 0.0 1.3 5.0 1.8 2.0 1.3 2.6 0.0 0.0 11.0 0.3 0.0 1.0 0.2 0.2 13.7 0.7 0.0 1.5 4.7 CELSR2 "ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3" ENSG00000143126 "Cadherin EGF LAG seven-pass G-type receptor 2" Q9HCU4 1 109250019-109275750 "G-protein coupled receptors, Predicted membrane proteins" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.7;skin 1: 27.8" "Cell type enhanced" "Detected in many" 15 "Horizontal cells: 92.2;Muller glia cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 25.2;HaCaT: 24.9;MCF7: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013952 Uncertain Approved Cytosol NA NA Cytosol "HPA013952: AB_1846518" "unprognostic (4.46e-3)" "unprognostic (1.07e-2)" "unprognostic (3.00e-2)" "unprognostic (4.71e-2)" "unprognostic (2.19e-1)" "unprognostic (5.30e-2)" "unprognostic (3.51e-2)" "unprognostic (2.98e-1)" "unprognostic (1.33e-1)" "unprognostic (1.59e-2)" "unprognostic (1.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.94e-2)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-2)" "unprognostic (5.16e-2)" 1.5 2.3 12.6 1.1 16.0 0.9 5.4 9.2 31.7 6.9 1.8 13.7 3.4 1.4 3.1 4.3 10.9 18.8 1.8 5.3 17.1 8.1 5.6 1.2 1.8 1.3 10.0 15.4 1.2 4.8 7.8 2.3 1.6 8.3 3.5 1.4 5.4 6.4 10.4 9.3 27.8 1.5 2.4 14.1 1.0 2.0 11.0 8.6 0.5 10.9 2.7 3.2 2.3 6.1 0.0 0.1 0.0 0.0 0.0 0.6 0.1 7.0 6.6 25.2 4.6 0.0 0.0 6.8 0.8 0.6 1.5 0.4 1.0 0.2 1.2 5.7 0.5 1.2 24.9 6.5 4.0 0.8 0.1 2.7 0.5 6.0 1.4 0.5 0.3 3.2 0.1 9.8 0.6 0.4 5.7 0.3 4.0 4.1 0.3 0.0 28.7 0.7 0.3 8.1 0.8 1.2 6.4 2.3 0.3 5.5 2.4 10.2 4.8 3.8 8.5 5.4 6.2 8.0 1.6 0.0 0.0 4.6 0.4 6.2 1.6 0.4 0.3 1.4 0.5 2.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 16.0 9.2 31.7 17.1 8.1 10.0 15.4 8.3 8.6 8.9 5.3 0.0 4.8 14.0 7.2 9.4 5.1 2.7 4.5 17.4 3.9 1.9 1.7 2.2 4.9 0.8 0.5 0.0 0.4 1.0 1.0 2.1 1.1 5.9 0.9 92.2 1.7 0.0 0.0 5.3 3.1 0.5 10.1 0.0 0.3 32.3 1.7 0.0 18.0 2.7 5.2 6.5 2.0 0.9 3.4 19.9 0.5 0.0 1.2 5.7 CELSR3 "ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2" ENSG00000008300 "Cadherin EGF LAG seven-pass G-type receptor 3" Q9NYQ7 3 48636469-48662915 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.7;pituitary gland: 11.2" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 16.2;Cone photoreceptor cells: 15.7;Horizontal cells: 28.6;Intestinal endocrine cells: 8.6;Rod photoreceptor cells: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 4 "T-cells: 1.5" "Cell line enhanced" "Detected in many" "HDLM-2: 13.1;SH-SY5Y: 15.0;SiHa: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062866 Approved NA NA "HPA062866: AB_2684886" "unprognostic (7.80e-2)" "unprognostic (3.80e-2)" "unprognostic (4.89e-1)" "unprognostic (9.12e-4)" "unprognostic (1.51e-1)" "unprognostic (1.59e-6)" "unprognostic (3.61e-6)" "unprognostic (1.86e-1)" "unprognostic (1.46e-3)" "unprognostic (5.07e-2)" "unprognostic (2.13e-3)" "unprognostic (2.87e-3)" "unprognostic (3.26e-3)" "unprognostic (9.53e-2)" "unprognostic (1.42e-1)" "unprognostic (3.86e-2)" "unprognostic (1.73e-1)" 0.7 4.0 10.9 1.2 8.3 1.7 0.8 19.7 11.1 0.6 1.3 0.0 0.0 1.2 0.8 1.2 0.6 0.7 0.7 0.5 7.1 1.4 0.6 0.6 0.8 1.4 2.0 10.4 0.9 2.6 1.4 11.2 1.0 3.6 0.7 1.2 1.4 0.6 0.8 0.5 1.2 1.3 0.8 3.3 1.0 2.1 5.4 1.4 0.0 0.9 0.0 1.0 0.7 0.7 0.3 0.1 0.0 0.1 0.2 1.5 0.4 3.9 2.9 4.9 2.9 0.6 0.9 1.3 0.3 0.5 0.6 0.9 5.5 3.0 0.8 0.8 0.2 2.5 0.5 1.5 0.2 0.3 13.1 0.8 1.3 11.3 2.0 0.9 1.3 2.1 0.4 3.9 0.3 7.0 0.2 0.0 2.8 0.5 4.0 1.0 4.2 0.1 0.0 2.7 1.4 1.3 0.3 0.7 4.1 0.0 2.7 11.0 15.0 13.2 0.3 0.5 0.7 6.5 2.5 0.1 4.8 4.7 6.4 2.3 0.3 7.2 3.5 3.4 0.9 7.6 0.0 0.1 0.0 1.0 0.0 0.2 0.3 0.2 0.2 0.1 0.0 0.3 1.5 0.0 0.2 0.0 0.0 1.1 0.4 10.9 8.3 19.7 11.1 7.1 1.4 2.0 10.4 3.6 1.4 0.0 0.3 0.5 0.1 0.3 16.2 2.5 0.0 0.0 0.0 0.0 15.7 0.2 0.0 0.1 2.8 0.0 0.4 0.0 0.0 0.2 0.2 0.1 1.1 0.4 0.2 28.6 8.6 0.6 0.0 1.6 0.3 0.0 0.0 0.0 1.8 0.8 0.2 0.0 0.0 0.0 11.2 0.0 0.0 5.9 3.4 0.4 0.1 0.0 0.2 0.0 CEND1 "BM88, FLJ90066" ENSG00000184524 "Cell cycle exit and neuronal differentiation 1" Q8N111 11 787104-790123 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 85.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 89.3;Horizontal cells: 71.5" "Cancer enriched" "Detected in many" 13 "glioma: 24.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 7.6;Karpas-707: 17.0;SCLC-21H: 30.5;SH-SY5Y: 11.4;U-266/70: 11.9;U-87 MG: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042527 Enhanced Supported Approved Mitochondria NA NA Mitochondria "HPA042527: AB_2678038" "unprognostic (4.62e-3)" "unprognostic (1.34e-4)" "unprognostic (9.66e-3)" "unprognostic (1.27e-2)" "prognostic unfavorable (4.38e-5)" "unprognostic (2.20e-3)" "unprognostic (4.11e-2)" "unprognostic (6.72e-2)" "unprognostic (2.60e-2)" "unprognostic (2.26e-1)" "unprognostic (2.00e-3)" "unprognostic (4.24e-3)" "unprognostic (1.94e-3)" "unprognostic (4.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" 1.9 8.2 28.5 2.9 34.7 1.8 1.8 46.5 85.2 1.8 2.3 8.3 1.3 2.5 1.9 2.0 2.2 1.8 1.9 2.1 34.2 25.3 2.1 1.8 1.8 2.1 32.0 30.7 1.8 1.9 1.9 5.1 1.8 42.4 3.2 1.9 2.1 1.8 3.6 1.8 1.9 2.7 2.3 10.2 1.8 1.9 1.9 5.9 0.0 1.8 0.0 2.0 2.1 0.1 3.6 0.2 0.0 0.7 0.0 1.9 0.3 0.0 0.4 0.4 0.7 0.1 0.1 0.1 0.7 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.3 7.6 0.3 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.1 0.0 2.9 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 17.0 0.3 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 30.5 11.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.5 11.9 3.2 0.7 15.9 0.1 0.2 0.0 0.0 0.0 0.9 0.7 0.3 3.6 1.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.3 28.5 34.7 46.5 65.2 34.2 25.3 32.0 30.7 42.4 5.9 0.0 0.0 0.0 0.1 0.1 89.3 0.4 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 71.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 17.6 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 CEP170 "FAM68A, KAB, KIAA0470" ENSG00000143702 "Centrosomal protein 170" Q5SW79 1 243124428-243255348 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.7" "Group enriched" "Detected in many" 37 "Early spermatids: 1512.0;Late spermatids: 3749.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042151, HPA045597, HPA045787" Uncertain Enhanced "Mitotic spindle,Centrosome,Cytosol" Yes No Centrosome "Mitotic spindle, Cytosol" "HPA042151: AB_2677876, HPA045597: AB_2732522, HPA045787: AB_2679453" "unprognostic (2.97e-1)" "unprognostic (2.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (7.60e-2)" "unprognostic (6.83e-5)" "unprognostic (8.05e-2)" "unprognostic (9.88e-3)" "unprognostic (7.09e-2)" "unprognostic (3.52e-2)" "unprognostic (6.65e-2)" "prognostic unfavorable (1.30e-9)" "unprognostic (2.21e-2)" "unprognostic (2.17e-1)" "unprognostic (6.49e-3)" "unprognostic (9.62e-3)" 9.5 6.1 13.7 10.8 13.2 36.5 6.8 27.7 23.2 7.4 5.4 11.4 3.1 3.1 9.1 5.2 5.5 6.4 11.1 8.6 12.8 11.2 3.8 6.7 8.4 7.3 19.3 13.7 13.3 2.8 2.8 10.8 9.8 20.2 5.0 4.2 3.3 4.2 5.5 9.3 4.2 4.7 7.4 25.8 7.8 4.2 53.7 18.0 11.6 14.4 3.3 8.9 8.6 6.6 9.4 8.4 12.3 10.1 2.8 4.7 2.1 6.0 5.1 13.2 11.1 8.2 15.9 2.9 16.1 9.6 12.1 11.5 3.2 5.9 4.5 9.9 13.7 4.1 3.0 11.3 6.9 17.3 10.0 6.5 4.7 4.8 2.2 7.1 8.2 8.8 10.0 1.9 38.6 16.9 27.7 28.2 2.7 11.3 4.7 15.3 1.3 5.0 4.4 16.6 1.2 14.5 9.0 9.4 1.5 2.5 1.0 19.1 25.7 8.2 0.7 7.7 10.8 2.8 11.2 31.1 22.6 6.7 12.1 18.5 4.6 5.9 9.0 12.0 7.5 51.9 3.5 8.3 7.6 1.9 10.0 2.7 3.6 3.8 1.6 8.4 9.4 4.7 2.7 12.3 2.8 10.1 5.5 2.9 2.1 13.7 13.2 27.7 15.8 12.8 11.2 19.3 13.7 20.2 18.0 17.9 16.6 13.7 4.2 13.5 41.1 19.0 7.6 25.4 11.4 12.2 5.9 3.1 0.0 18.9 1512.0 31.0 0.7 0.0 6.1 6.7 26.8 3.3 22.0 6.8 31.5 42.9 10.4 18.4 34.9 3749.4 40.9 70.8 21.9 31.5 1.9 11.4 19.1 0.0 33.2 2.1 18.3 25.8 15.7 71.0 23.8 10.0 1.6 7.0 1.6 3.1 CEP95 "CCDC45, DKFZp667E1824" ENSG00000258890 "Centrosomal protein 95" Q96GE4 17 64506588-64542461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023654, HPA052426, HPA052428, HPA061371" Approved Approved "Nucleoplasm,Vesicles,Mitotic spindle,Centrosome" Yes No Nucleoplasm "Vesicles, Mitotic spindle, Centrosome" "HPA023654: AB_2072077, HPA052426: AB_2681827, HPA052428: AB_2681829, HPA061371: AB_2684495" "unprognostic (1.28e-2)" "unprognostic (9.12e-2)" "unprognostic (3.66e-3)" "unprognostic (4.09e-2)" "unprognostic (3.30e-2)" "prognostic favorable (5.78e-4)" "prognostic unfavorable (2.52e-5)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (3.57e-3)" "prognostic unfavorable (5.76e-5)" "unprognostic (3.48e-1)" "unprognostic (1.84e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" 13.0 8.6 10.9 17.1 13.1 37.9 15.5 27.9 15.6 16.7 14.2 16.2 11.6 11.9 26.5 16.6 10.7 17.1 12.3 10.6 11.5 7.8 14.1 11.7 13.0 20.7 13.6 7.9 27.3 15.5 11.8 20.4 8.5 13.0 15.2 13.5 15.6 13.8 19.8 14.6 21.7 14.2 15.0 17.4 13.2 13.3 16.9 13.9 26.4 21.0 8.6 14.7 14.3 14.0 5.9 3.7 2.2 3.6 2.1 10.8 2.4 9.9 6.3 12.9 11.1 3.4 8.9 13.0 5.1 5.2 6.3 9.6 7.6 5.7 15.9 3.3 7.1 6.3 12.6 11.1 9.7 13.1 4.2 8.5 14.1 12.2 14.6 11.5 15.3 7.6 10.1 10.2 7.0 15.7 8.4 5.3 16.6 16.2 11.6 6.9 11.6 19.4 9.8 8.0 10.2 7.9 14.0 23.5 11.8 7.4 15.9 8.2 14.8 6.9 10.2 13.1 20.2 11.2 10.3 7.9 14.5 11.3 6.6 6.9 11.9 9.5 16.9 6.2 11.8 8.8 2.2 3.6 2.2 4.5 2.9 10.8 4.5 5.2 4.5 3.4 5.9 8.0 5.4 1.4 2.1 3.4 3.7 4.2 2.4 10.9 13.1 27.9 15.6 11.5 7.8 13.6 7.9 13.0 13.9 38.7 22.9 11.5 23.2 14.3 26.0 16.7 12.7 65.6 39.8 3.5 43.2 7.8 6.6 16.8 45.2 9.8 15.1 0.0 10.2 9.0 11.5 13.9 27.8 6.6 7.4 17.5 7.5 12.3 9.5 14.2 19.2 10.4 11.8 15.4 12.4 22.7 11.6 11.5 20.1 5.0 86.8 12.9 15.0 30.7 28.8 17.8 5.5 19.7 17.0 19.0 CEPT1 ENSG00000134255 "Choline/ethanolamine phosphotransferase 1" Q9Y6K0 1 111139627-111185102 "Enzymes, Predicted membrane proteins, Transporters" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.16e-1)" "unprognostic (2.42e-1)" "unprognostic (1.47e-3)" "unprognostic (1.83e-2)" "prognostic favorable (4.96e-4)" "unprognostic (5.52e-2)" "unprognostic (1.10e-1)" "unprognostic (5.61e-2)" "unprognostic (1.54e-3)" "unprognostic (1.84e-1)" "unprognostic (9.20e-3)" "unprognostic (1.03e-1)" "unprognostic (4.60e-2)" "unprognostic (3.58e-2)" "unprognostic (1.10e-1)" "unprognostic (5.88e-2)" "unprognostic (1.27e-2)" 22.4 22.9 16.0 22.2 19.5 5.6 20.1 20.7 19.8 14.9 13.7 22.2 17.5 19.0 18.3 19.1 21.3 16.6 15.3 12.2 17.9 16.0 22.6 39.4 16.5 31.7 22.9 15.1 22.9 17.8 19.6 25.5 22.5 18.2 13.9 18.1 16.9 19.2 12.0 11.2 17.8 20.2 16.3 23.3 34.5 17.5 12.5 21.3 22.3 19.4 11.5 24.7 19.5 17.8 14.6 9.0 4.2 19.1 5.3 9.0 5.5 14.0 5.3 6.3 6.1 25.0 12.3 15.3 15.6 8.9 7.3 8.8 4.6 16.0 16.8 17.3 8.0 9.3 17.4 9.1 12.2 10.5 12.4 14.1 7.3 9.5 10.2 16.7 17.1 10.5 10.0 23.5 5.3 25.5 13.9 9.6 17.5 15.7 11.0 9.5 10.2 17.5 16.9 9.7 22.6 10.9 9.5 20.0 13.6 11.9 8.9 8.3 4.4 14.4 22.0 16.6 12.8 11.7 18.7 8.4 11.9 7.5 25.7 10.4 10.1 10.9 13.1 16.0 15.4 22.5 3.2 7.6 4.2 6.4 13.6 8.4 14.5 7.2 6.7 9.0 14.6 8.4 9.0 1.9 5.3 19.1 7.0 6.2 5.5 16.0 19.5 20.7 19.8 17.9 16.0 22.9 15.1 18.2 21.3 32.8 12.2 37.9 14.6 11.6 26.0 3.6 20.4 21.4 14.8 34.9 33.4 24.6 5.0 11.7 1.7 9.7 16.0 0.0 7.1 16.3 11.4 13.2 18.5 29.7 25.2 27.0 9.8 22.7 40.9 2.2 13.6 19.4 15.1 9.0 13.6 9.4 8.5 14.7 15.9 12.0 20.7 12.9 7.2 12.0 13.2 13.4 15.9 20.0 13.3 12.4 CERS1 "LAG1, LASS1, UOG1" ENSG00000223802 "Ceramide synthase 1" P27544 19 18868545-18896727 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 86.3" "Cell type enriched" "Detected in some" 5 "Late spermatids: 85.2" "Cancer enhanced" "Detected in many" "glioma: 13.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.7" "Cell line enhanced" "Detected in many" "AN3-CA: 17.7;EFO-21: 13.0;HEK 293: 18.1;NB-4: 19.4;NTERA-2: 13.3" HPA045724 Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA045724: AB_10969762" "unprognostic (8.25e-2)" "unprognostic (8.91e-2)" "unprognostic (2.12e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-2)" "unprognostic (6.47e-2)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "unprognostic (4.02e-1)" "unprognostic (7.04e-3)" "unprognostic (3.52e-3)" "unprognostic (1.92e-1)" "unprognostic (4.59e-2)" "unprognostic (2.99e-2)" "unprognostic (3.15e-2)" "unprognostic (9.15e-2)" "unprognostic (3.49e-1)" 2.4 4.7 28.9 2.3 32.9 1.7 1.7 12.5 86.3 2.2 2.1 40.5 0.0 1.6 2.0 2.1 2.5 2.1 3.9 3.4 29.5 23.2 1.6 1.6 1.9 1.6 31.9 20.5 4.3 2.4 1.7 3.2 1.9 33.8 2.0 1.8 1.8 2.3 2.1 17.8 2.0 1.9 3.0 37.8 1.7 1.8 15.7 22.2 0.0 2.4 0.0 1.6 2.6 0.4 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.1 1.8 10.9 17.7 0.6 0.2 0.3 1.2 0.1 3.1 2.2 8.7 0.6 0.0 13.0 0.8 2.5 0.1 8.0 0.3 1.2 0.0 18.1 0.1 0.4 6.5 1.4 1.8 0.2 0.6 0.1 1.0 0.3 3.5 0.7 0.1 1.1 0.1 2.1 4.5 0.1 19.4 13.3 0.0 0.3 0.0 0.3 0.3 2.4 0.0 9.3 9.3 0.4 0.0 7.9 3.7 3.0 10.8 0.3 0.0 2.5 1.7 2.5 0.3 0.2 0.0 0.0 0.6 6.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 28.9 32.9 12.5 35.7 29.5 23.2 31.9 20.5 33.8 22.2 0.0 0.0 0.0 0.1 0.5 2.0 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 18.9 0.4 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 85.2 1.1 0.0 1.7 0.0 0.0 9.2 0.0 0.0 1.1 0.0 1.2 0.0 0.3 0.9 2.7 0.4 0.2 0.0 0.0 0.0 CERS2 "FLJ10243, LASS2, SP260" ENSG00000143418 "Ceramide synthase 2" Q96G23 1 150960583-150975004 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 142.3" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 187.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027262, HPA078737" Approved Supported "Nuclear membrane,Endoplasmic reticulum" NA NA 24000 "Nuclear membrane, Endoplasmic reticulum" "HPA027262: AB_1852717, HPA078737: " "unprognostic (1.01e-1)" "unprognostic (2.70e-3)" "unprognostic (3.72e-2)" "unprognostic (1.29e-2)" "unprognostic (8.23e-2)" "unprognostic (2.03e-2)" "unprognostic (7.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.34e-1)" "unprognostic (4.05e-2)" "unprognostic (8.17e-3)" "unprognostic (1.11e-1)" "unprognostic (2.63e-2)" "unprognostic (1.56e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" 19.4 65.5 17.0 10.5 36.1 13.9 22.6 9.6 21.3 19.8 21.1 59.3 22.1 19.6 16.9 19.0 12.5 21.1 21.6 14.4 23.0 16.1 60.9 142.3 28.6 14.0 50.1 14.5 21.8 29.7 28.7 17.6 24.0 25.5 18.5 18.8 16.5 12.3 19.2 7.1 9.1 33.3 21.2 63.7 13.2 23.4 10.2 38.7 10.2 35.5 8.8 14.0 17.5 25.6 12.3 23.5 56.6 27.0 19.3 33.6 26.2 25.5 28.0 23.6 50.6 70.5 43.3 17.7 26.1 38.4 49.9 34.3 29.3 45.3 22.5 43.7 41.1 31.2 29.2 32.7 27.9 41.0 30.5 26.7 31.0 19.6 35.4 51.0 35.2 38.4 39.4 36.0 44.0 54.9 60.5 31.1 32.5 33.2 51.5 62.2 38.5 23.0 20.3 36.1 85.2 50.0 26.3 16.0 35.8 54.0 21.7 21.8 34.0 28.8 51.3 29.9 30.7 61.0 53.4 24.1 36.1 16.3 32.6 46.0 33.4 37.5 141.2 40.6 15.1 36.6 56.6 27.0 44.0 28.0 14.6 33.6 12.3 25.7 28.4 23.4 11.4 22.9 22.2 29.2 19.3 10.2 23.5 28.8 26.2 17.0 36.1 9.6 21.3 23.0 16.1 50.1 14.5 25.5 38.7 62.5 51.6 17.2 31.4 21.4 7.0 2.2 101.9 21.4 14.8 50.6 3.9 65.8 11.6 88.6 6.4 42.6 55.1 0.0 80.3 35.9 56.4 34.0 35.8 187.2 49.9 3.2 23.6 32.5 43.8 3.8 52.0 30.4 35.4 20.8 32.1 25.3 90.5 30.8 37.8 65.4 8.2 38.8 25.5 11.8 5.2 13.7 45.3 37.6 28.9 27.6 CERS3 "LASS3, MGC27091" ENSG00000154227 "Ceramide synthase 3" Q8IU89 15 100400395-100544995 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 25.6;skin 1: 29.0;testis: 37.9" "Cell type enhanced" "Detected in some" 16 "Basal keratinocytes: 16.8;Early spermatids: 19.4;Late spermatids: 12.5;Spermatocytes: 33.6;Suprabasal keratinocytes: 43.8" "Cancer enhanced" "Detected in some" "head and neck cancer: 14.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "hTCEpi: 38.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006092, HPA024356" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006092: AB_1079236, HPA024356: AB_1852721" "unprognostic (5.01e-3)" "unprognostic (3.43e-2)" "unprognostic (6.47e-4)" "unprognostic (2.35e-2)" "unprognostic (5.58e-2)" "unprognostic (1.68e-1)" "unprognostic (6.84e-3)" "unprognostic (3.23e-1)" "unprognostic (1.43e-1)" "unprognostic (2.09e-1)" "unprognostic (1.31e-5)" "unprognostic (2.65e-1)" "unprognostic (4.74e-4)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.05e-3)" 0.4 0.0 0.4 0.4 0.4 0.0 1.9 0.4 0.4 6.0 0.4 0.4 0.4 0.0 0.4 0.4 25.6 0.3 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.4 3.6 0.4 0.4 29.0 0.4 0.4 0.4 0.4 0.0 37.9 0.4 0.4 0.4 0.4 8.5 0.4 11.2 0.0 0.0 1.5 0.6 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.1 0.2 0.2 0.0 0.7 0.3 0.0 0.0 3.3 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 3.6 16.8 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 33.6 0.4 43.8 0.0 0.0 0.0 7.4 CERS4 "FLJ12089, LASS4, Trh1" ENSG00000090661 "Ceramide synthase 4" Q9HA82 19 8206736-8262421 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 63.6;Muller glia cells: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 21.6;NB-4: 39.0;U-937: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033734, HPA054729" Uncertain Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB033734: AB_2132977, HPA054729: " "unprognostic (5.96e-2)" "prognostic favorable (2.71e-4)" "unprognostic (2.46e-2)" "unprognostic (2.82e-2)" "unprognostic (1.30e-1)" "prognostic favorable (7.83e-4)" "unprognostic (1.74e-1)" "prognostic favorable (3.45e-5)" "unprognostic (1.48e-2)" "unprognostic (3.32e-1)" "prognostic favorable (8.05e-4)" "unprognostic (1.77e-1)" "prognostic favorable (9.63e-5)" "unprognostic (6.08e-3)" "unprognostic (2.69e-2)" "unprognostic (2.91e-2)" "unprognostic (8.08e-3)" 6.2 6.7 17.5 10.5 22.9 2.5 21.6 14.5 19.3 13.2 6.8 24.3 7.8 4.6 9.9 41.8 26.4 11.9 7.7 9.7 16.1 10.8 16.5 32.4 12.9 12.2 26.9 13.3 13.8 56.7 11.6 10.1 2.2 16.8 22.4 3.2 26.2 34.8 12.8 2.1 20.9 6.1 8.5 20.3 8.6 9.9 8.4 29.0 6.4 38.1 9.5 15.9 9.3 13.2 13.3 2.7 16.9 4.4 13.5 5.2 3.5 0.1 0.9 0.9 10.2 0.3 0.0 0.7 1.3 3.4 1.5 0.7 7.6 0.8 15.9 11.3 0.0 4.0 5.5 6.6 0.1 0.7 14.0 5.2 3.1 0.1 21.6 13.2 0.0 8.7 5.1 8.5 3.6 7.8 4.3 0.1 7.3 2.2 0.5 0.0 0.3 1.2 39.0 10.4 0.0 3.8 19.2 0.2 1.2 2.5 0.0 3.9 5.2 1.7 0.3 5.5 7.2 7.5 3.6 0.0 1.2 3.3 7.6 0.0 10.0 8.0 12.2 0.0 24.4 1.1 5.9 4.4 16.9 5.2 2.3 3.9 13.3 3.0 3.1 2.7 12.1 2.8 2.6 14.0 13.5 1.5 2.6 3.5 3.5 17.5 22.9 14.5 19.3 16.1 10.8 26.9 13.3 16.8 29.0 6.0 12.5 16.4 11.3 16.0 23.7 3.0 12.7 16.0 15.9 1.8 17.7 2.2 6.6 15.6 1.1 6.0 0.0 0.0 26.2 0.4 11.8 36.8 12.7 63.6 12.8 11.1 23.0 6.7 9.8 4.6 13.3 5.6 25.3 29.7 0.2 146.0 15.3 0.0 15.2 35.3 25.4 6.5 10.3 0.7 1.7 22.6 2.4 17.5 0.6 9.8 CERS5 "FLJ25304, LASS5, MGC45411, Trh4" ENSG00000139624 "Ceramide synthase 5" Q8N5B7 12 50129306-50167533 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026589 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA026589: AB_1852727" "unprognostic (1.59e-2)" "unprognostic (9.83e-2)" "unprognostic (5.17e-2)" "unprognostic (3.64e-2)" "unprognostic (3.02e-1)" "unprognostic (2.49e-3)" "prognostic unfavorable (4.63e-5)" "unprognostic (5.56e-2)" "unprognostic (1.65e-2)" "unprognostic (9.26e-2)" "unprognostic (1.88e-3)" "unprognostic (5.67e-2)" "prognostic unfavorable (9.33e-11)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "prognostic favorable (5.76e-5)" "unprognostic (3.26e-1)" 18.0 13.2 18.3 13.3 21.6 10.9 18.0 38.3 19.6 21.1 15.0 17.5 8.9 6.3 22.6 20.9 14.1 17.7 14.9 9.9 16.7 11.6 16.0 7.8 14.7 15.1 13.9 19.1 22.5 13.8 23.9 22.4 19.7 14.3 15.6 11.5 14.9 14.6 16.2 5.0 21.5 12.2 21.8 10.3 15.7 13.3 11.6 14.4 12.7 15.5 7.0 14.9 18.4 18.3 21.0 26.1 33.5 35.1 29.0 26.3 22.3 9.2 10.4 23.0 6.5 12.8 10.8 19.5 20.5 17.7 19.7 18.7 24.5 14.7 14.0 17.2 29.0 10.3 8.7 10.0 7.9 19.6 22.1 10.2 11.7 8.8 14.8 25.6 11.9 16.0 18.5 12.0 16.2 15.1 25.9 17.9 12.3 8.8 13.0 24.7 16.2 10.3 32.4 14.7 5.2 10.1 13.5 15.0 10.0 25.6 12.0 7.0 11.4 17.4 8.2 27.5 15.8 11.2 13.7 17.1 17.0 11.4 12.7 8.9 12.7 12.1 11.3 13.4 8.3 7.8 24.8 19.0 28.1 26.0 25.5 22.9 17.9 22.9 22.4 18.2 21.0 17.9 24.3 33.5 29.0 35.1 26.1 26.3 22.3 18.3 21.6 38.3 19.6 16.7 11.6 13.9 19.1 14.3 14.4 17.9 17.3 12.1 17.3 15.3 41.7 5.6 15.3 9.4 14.8 14.0 19.6 27.6 6.6 19.6 0.6 14.9 9.1 0.0 12.2 48.5 20.0 10.2 15.0 3.8 17.4 30.2 15.0 15.4 17.0 1.1 15.5 16.5 11.8 30.7 7.0 21.7 14.2 7.0 16.3 6.8 36.1 32.3 17.6 8.1 7.5 12.5 28.1 20.0 6.0 11.3 CERS6 LASS6 ENSG00000172292 "Ceramide synthase 6" Q6ZMG9 2 168455862-168775137 "Predicted membrane proteins" "Inflammatory response, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 9.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044683, HPA063527" Approved Uncertain Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA044683: AB_10965059, HPA063527: AB_2685030" "unprognostic (2.17e-2)" "unprognostic (1.87e-1)" "unprognostic (3.92e-3)" "prognostic unfavorable (7.31e-4)" "unprognostic (3.24e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.28e-1)" "unprognostic (1.11e-2)" "unprognostic (9.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.93e-2)" "unprognostic (2.38e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-2)" "unprognostic (2.41e-1)" "unprognostic (4.80e-2)" 12.3 13.5 17.7 12.2 17.5 9.6 14.2 28.0 23.2 12.3 24.4 6.5 19.8 22.4 17.4 17.0 12.7 9.8 9.7 26.9 14.5 15.9 12.1 11.7 9.4 12.5 11.0 15.9 15.6 7.3 15.8 14.6 8.3 9.2 12.2 27.1 13.4 6.9 17.1 9.4 20.0 28.3 11.0 8.5 6.9 21.0 11.0 8.1 25.1 24.1 7.4 7.5 11.8 30.5 0.8 9.0 0.7 1.7 1.1 1.7 0.5 5.9 5.3 9.5 10.9 23.6 17.6 0.0 6.0 6.1 6.4 8.7 8.4 13.2 0.0 8.7 5.4 9.1 11.3 12.2 13.9 10.8 0.0 8.4 10.9 5.7 6.0 20.7 22.9 5.3 19.5 40.1 13.5 10.6 6.4 3.2 16.3 5.8 0.0 13.3 6.5 20.1 6.4 8.8 12.8 7.8 15.6 18.0 10.3 6.1 17.9 13.2 15.9 5.8 15.0 3.1 8.2 13.3 13.1 1.8 16.5 6.9 4.5 10.3 0.1 0.0 0.0 10.8 12.2 11.0 0.7 1.7 0.0 0.3 1.2 0.6 0.2 0.6 0.3 1.3 0.8 1.7 1.3 0.2 1.1 1.0 9.0 0.0 0.5 17.7 17.5 28.0 23.2 14.5 15.9 11.0 15.9 9.2 8.1 6.0 10.1 10.9 40.4 96.7 20.6 40.6 30.6 25.4 18.2 10.4 0.0 0.5 0.0 12.6 4.2 12.7 42.8 0.0 20.1 0.8 10.8 29.9 10.3 41.4 21.3 35.0 99.7 14.7 43.8 2.7 18.4 31.6 10.1 96.4 94.8 31.2 14.0 35.1 37.4 8.4 2.3 64.7 18.6 3.9 3.0 81.1 0.5 8.6 107.7 39.9 CES5A "CAUXIN, CES4C1, CES5, CES7, FLJ31547" ENSG00000159398 "Carboxylesterase 5A" Q6NT32 16 55846154-55956031 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 43.4" "Group enriched" "Detected in some" 4 "Cholangiocytes: 2.5;Collecting duct cells: 5.2;Hepatocytes: 5.5" "Cancer enhanced" "Detected in single" "liver cancer: 0.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 44 "U-266/70: 13.3" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (2.07e-1)" "unprognostic (2.55e-1)" "unprognostic (6.34e-2)" "unprognostic (4.82e-2)" "unprognostic (3.78e-1)" "unprognostic (2.33e-1)" "unprognostic (3.12e-2)" "unprognostic (1.72e-7)" "unprognostic (1.55e-2)" "unprognostic (2.27e-1)" 0.1 0.1 0.7 0.1 0.6 0.0 0.1 0.1 0.8 0.1 0.1 0.1 3.6 0.0 0.1 43.4 0.1 0.0 1.4 0.1 0.8 0.5 0.1 6.6 0.1 0.1 1.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.3 0.1 1.2 0.1 0.1 1.8 0.1 0.0 1.7 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.1 0.8 0.8 0.5 1.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFAP47 "CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1" ENSG00000165164 "Cilia and flagella associated protein 47" Q6ZTR5 X 35919734-36385319 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.4;fallopian tube: 12.8;pituitary gland: 24.5" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 37.5;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 16.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Karpas-707: 4.2;U-266/70: 7.8" "HPA044633, HPA054859" Uncertain NA NA "HPA044633: AB_10960684, HPA054859: AB_2682627" "unprognostic (1.88e-1)" "unprognostic (4.38e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (1.09e-1)" "unprognostic (3.13e-2)" "unprognostic (2.15e-1)" "unprognostic (4.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (5.61e-2)" "unprognostic (1.50e-5)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "unprognostic (1.48e-2)" "unprognostic (5.19e-3)" 0.3 0.3 2.0 0.2 5.9 0.2 0.3 0.3 1.2 0.9 0.3 6.2 1.2 0.2 0.7 7.0 0.3 12.8 0.2 0.3 3.7 1.3 0.4 0.5 3.7 0.2 1.2 1.5 5.3 0.3 2.3 24.5 0.3 12.4 0.3 0.2 2.0 0.3 0.3 0.3 0.3 0.3 0.2 1.1 0.3 0.3 2.1 2.7 0.0 1.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 4.2 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.9 0.3 1.2 3.7 1.3 1.2 1.5 12.4 2.7 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 37.5 4.5 1.8 7.9 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.1 0.0 0.0 2.5 5.1 0.0 0.0 0.0 0.0 0.0 CFAP54 "C12orf55, C12orf63, FLJ31514, FLJ44112" ENSG00000188596 "Cilia and flagella associated protein 54" Q96N23 12 96489571-96875555 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7;testis: 15.1" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 65.5;Alveolar cells type 2: 54.7;Ciliated cells: 195.4;Club cells: 78.5" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "basal ganglia: 16.5;pons and medulla: 30.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 10.8;TIME: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039897 Enhanced Approved Microtubules,Cytosol NA NA Microtubules Cytosol "HPA039897: AB_10674427" "unprognostic (1.87e-4)" "unprognostic (3.63e-2)" "unprognostic (8.07e-2)" "unprognostic (7.89e-2)" "unprognostic (4.66e-2)" "unprognostic (5.55e-2)" "unprognostic (2.75e-2)" "unprognostic (2.91e-2)" "unprognostic (6.16e-2)" "unprognostic (8.40e-2)" "unprognostic (2.86e-1)" "unprognostic (2.36e-1)" "unprognostic (3.55e-5)" "unprognostic (2.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.26e-2)" "unprognostic (8.00e-2)" 1.0 0.9 3.4 1.9 16.5 4.5 1.4 1.0 3.4 2.0 1.4 9.5 1.8 2.3 3.3 8.6 1.2 8.9 1.5 0.9 5.3 3.6 1.4 1.5 8.1 1.9 1.3 3.1 3.8 0.7 1.3 11.7 0.9 30.7 1.7 1.5 0.3 1.8 1.9 1.8 2.9 1.5 1.9 1.7 1.9 1.6 15.1 5.2 0.0 2.4 0.5 1.6 1.0 1.1 2.7 1.6 3.7 1.4 1.5 1.7 0.1 1.6 0.8 1.4 1.8 0.8 1.2 1.2 1.4 0.3 0.4 0.6 0.8 2.4 1.4 2.1 0.5 1.3 1.3 0.7 0.4 0.5 2.3 1.0 1.4 3.1 0.8 0.2 2.7 1.7 0.4 0.5 2.0 0.8 2.9 10.8 1.3 0.7 5.0 1.4 0.7 1.2 2.4 2.4 0.6 1.5 1.5 1.5 1.7 3.1 1.9 2.4 1.7 1.3 0.8 1.5 1.6 2.3 0.7 12.9 2.5 3.0 2.2 2.4 5.6 2.4 1.1 1.7 1.2 1.7 3.7 1.4 1.4 1.7 0.9 1.4 1.4 1.3 1.3 0.4 2.7 1.6 1.5 3.7 1.5 1.1 1.6 1.0 0.1 3.4 16.5 1.0 3.4 5.3 3.6 1.3 3.1 30.7 5.2 65.5 54.7 0.9 0.2 0.0 3.0 0.8 0.0 195.4 78.5 0.0 21.6 0.2 0.0 0.0 22.0 1.6 0.0 0.0 0.0 0.2 0.3 0.2 34.9 0.0 0.2 0.0 1.2 0.0 0.6 12.3 0.3 0.0 0.0 0.0 0.0 10.9 0.2 0.0 0.0 0.0 7.8 0.0 0.0 11.1 6.9 0.0 0.0 0.0 0.0 0.3 CFAP61 "C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156" ENSG00000089101 "Cilia and flagella associated protein 61" Q8NHU2 20 20052514-20360702 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.1;heart muscle: 14.8;pituitary gland: 15.0;skeletal muscle: 23.9;testis: 25.5" "Group enriched" "Detected in some" 4 "Early spermatids: 72.8;Late spermatids: 61.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.3;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 4.3;HMC-1: 4.2;SCLC-21H: 9.7;SK-MEL-30: 3.8;U-87 MG: 7.3" "Low region specificity" "Detected in all" HPA009079 Approved NA NA "HPA009079: AB_1078344" "unprognostic (5.93e-2)" "unprognostic (1.27e-1)" "unprognostic (6.73e-2)" "unprognostic (1.38e-3)" "unprognostic (6.20e-3)" "unprognostic (3.67e-3)" "unprognostic (8.58e-4)" "unprognostic (8.24e-2)" "unprognostic (8.29e-2)" "unprognostic (3.11e-1)" "unprognostic (1.86e-2)" "unprognostic (1.56e-1)" "unprognostic (2.76e-4)" "unprognostic (2.77e-1)" "unprognostic (9.27e-2)" "unprognostic (3.10e-3)" "unprognostic (3.06e-1)" 0.2 1.2 1.0 0.2 9.5 0.1 0.5 0.6 2.6 0.9 0.2 5.3 0.8 0.1 1.1 4.5 0.2 15.1 0.3 14.8 4.0 1.9 1.1 0.2 3.5 0.2 0.9 2.0 3.3 0.5 1.0 15.0 0.2 11.4 0.5 0.2 0.1 0.3 0.4 23.9 0.5 0.3 0.3 0.7 0.2 0.3 25.5 1.1 0.0 1.1 0.0 0.2 0.2 0.2 0.0 1.5 0.0 0.0 0.6 2.3 0.0 0.4 1.3 0.2 0.5 0.0 0.0 0.5 0.1 0.4 0.0 0.4 0.0 0.7 4.3 0.1 0.0 1.8 0.1 0.2 0.0 0.1 1.2 1.5 0.0 0.4 0.0 0.0 0.0 4.2 0.0 0.7 0.0 0.0 0.2 0.0 0.6 0.0 0.3 0.0 1.0 0.0 0.0 0.3 0.4 0.3 0.0 0.3 2.1 0.7 0.0 9.7 0.2 0.3 0.4 3.8 0.0 0.7 0.0 0.7 0.0 0.4 0.6 0.4 1.4 0.4 0.0 7.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.5 0.0 0.0 1.0 9.5 0.6 2.6 4.0 1.9 0.9 2.0 11.4 1.1 0.0 0.3 0.0 0.0 0.0 0.0 9.8 0.0 16.0 4.5 1.8 3.9 0.0 0.0 0.0 72.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 61.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 8.2 5.1 0.0 0.0 0.0 0.0 0.0 CFAP65 "CCDC108, DKFZp434O0527, MGC35338" ENSG00000181378 "Cilia and flagella associated protein 65" Q6ZU64 2 219002846-219041527 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.3;fallopian tube: 29.2;testis: 20.4" "Group enriched" "Detected in many" 4 "Ciliated cells: 53.5;Early spermatids: 163.7;Late spermatids: 138.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.1" "Region enhanced" "Detected in many" "pons and medulla: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 2.4;SCLC-21H: 1.5;SH-SY5Y: 4.0;U-87 MG: 2.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 13.1" "HPA055156, HPA063406" Uncertain Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA055156: AB_2682720, HPA063406: " "unprognostic (3.95e-2)" "unprognostic (1.80e-1)" "unprognostic (9.88e-3)" "prognostic favorable (6.08e-5)" "unprognostic (2.18e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-1)" "unprognostic (3.76e-3)" "unprognostic (3.71e-1)" "unprognostic (3.03e-1)" "unprognostic (5.58e-3)" "unprognostic (1.43e-1)" "unprognostic (6.62e-3)" "unprognostic (8.04e-2)" "unprognostic (2.81e-2)" "unprognostic (9.60e-2)" "unprognostic (6.60e-2)" 0.2 0.4 1.8 0.3 6.4 0.3 0.3 0.0 2.1 2.2 0.4 5.4 0.3 0.3 0.9 6.0 0.2 29.2 0.6 0.2 2.9 3.2 0.5 0.2 3.6 0.3 0.4 1.2 4.2 0.6 0.3 6.1 0.2 16.3 0.3 0.5 2.8 0.4 0.4 0.2 0.2 0.7 0.2 0.6 0.3 0.6 20.4 2.5 0.0 1.3 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.5 0.0 1.1 0.2 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 2.4 0.1 0.0 0.0 0.0 1.2 0.0 1.5 4.0 0.0 0.1 0.7 0.6 1.1 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.8 6.4 0.0 2.1 2.9 3.2 0.4 1.2 16.3 2.5 0.0 3.4 0.0 0.1 0.0 0.7 0.0 7.6 53.5 12.5 0.0 11.8 0.0 0.0 0.4 163.7 0.0 0.5 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.1 0.0 28.1 0.0 0.0 138.9 0.6 0.0 0.0 0.0 25.9 0.8 1.4 0.0 0.7 0.9 20.7 0.0 0.0 15.4 4.1 0.0 0.0 0.0 3.4 0.0 CFTR "ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR" ENSG00000001626 "Cystic fibrosis transmembrane conductance regulator" P13569 7 117465784-117715971 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Isomerase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pancreas: 103.0" "Cell type enriched" "Detected in many" 5 "Ductal cells: 325.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.9;pancreatic cancer: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "CACO-2: 12.8;MOLT-4: 48.1;U-266/70: 26.3" "Low region specificity" "Detected in some" "Region enriched" "Detected in single" 5 "olfactory region: 6.3" "CAB001951, HPA021939, HPA079652" Enhanced NA NA "CAB001951: , HPA021939: AB_1846578, HPA079652: " "unprognostic (6.38e-3)" "unprognostic (9.55e-2)" "unprognostic (1.77e-2)" "unprognostic (1.44e-2)" "unprognostic (8.74e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (9.44e-4)" "unprognostic (3.20e-3)" "unprognostic (1.13e-1)" "unprognostic (8.89e-2)" "unprognostic (1.55e-2)" "unprognostic (2.14e-2)" "unprognostic (4.78e-3)" "unprognostic (1.24e-1)" "unprognostic (2.58e-1)" "unprognostic (9.08e-2)" "unprognostic (6.64e-2)" 0.4 0.2 0.4 10.5 0.4 0.0 0.3 0.3 0.3 2.5 19.8 0.1 0.8 10.5 0.6 2.1 0.4 0.4 15.8 0.3 0.4 0.3 1.1 1.4 5.7 0.1 0.5 0.1 0.3 103.0 0.0 0.3 0.1 0.1 1.5 12.5 0.1 22.4 0.1 0.3 1.1 24.2 0.3 0.7 0.3 0.6 0.9 0.1 0.1 0.3 0.2 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.3 0.4 0.3 0.5 0.1 0.1 0.1 6.0 48.7 0.0 1.7 0.0 0.4 1.2 43.3 9.4 23.9 0.0 0.0 0.0 0.0 325.5 2.9 0.0 19.4 0.0 3.7 0.0 0.1 3.6 1.1 0.2 0.0 0.0 6.9 0.0 0.0 1.6 0.3 0.0 0.0 11.8 11.5 0.6 21.5 37.7 0.0 0.0 0.0 0.0 0.3 1.8 0.4 0.0 0.0 0.0 64.4 3.9 CGA "FSHA, GPHa, GPHA1, HCG, LHA, TSHA" ENSG00000135346 "Glycoprotein hormones, alpha polypeptide" P01215 6 87085498-87095406 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "pituitary gland: 398.8;placenta: 489.3" "Cell type enriched" "Detected in some" 30 "Syncytiotrophoblasts: 71349.9" "Cancer enhanced" "Detected in many" "testis cancer: 13.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 28 "BEWO: 73.5;SuSa: 141.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "hypothalamus: 69.2" "CAB023350, HPA029698" Enhanced "Secreted to blood" NA NA "CAB023350: AB_617281, HPA029698: AB_2673153" "unprognostic (1.66e-1)" "unprognostic (2.10e-1)" "unprognostic (3.22e-5)" "unprognostic (1.46e-2)" "unprognostic (1.51e-1)" "unprognostic (2.69e-2)" "unprognostic (3.17e-1)" "unprognostic (7.04e-3)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (4.32e-2)" "unprognostic (8.32e-2)" "unprognostic (9.15e-3)" 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 398.8 489.3 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.6 0.0 0.1 7.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.2 1.9 3.5 1.5 1.1 2.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 73.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 141.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.3 1.1 1.0 1.7 0.5 0.7 1.3 0.8 1.4 0.6 2.2 1.2 2.1 3.5 1.1 1.5 1.9 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.0 0.0 1223.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2346.5 0.1 1.5 0.0 0.0 567.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 71349.9 0.0 0.0 0.3 CGRRF1 "CGR19, RNF197" ENSG00000100532 "Cell growth regulator with ring finger domain 1" Q99675 14 54509812-54539309 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 105.4;Spermatocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002930 Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA002930: AB_1078507" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (5.61e-2)" "unprognostic (4.38e-1)" "unprognostic (1.01e-1)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.58e-2)" "unprognostic (2.63e-1)" "unprognostic (7.29e-2)" "unprognostic (2.64e-3)" "prognostic favorable (2.57e-8)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (1.48e-1)" "unprognostic (1.74e-1)" 13.3 12.8 18.3 5.7 19.2 10.2 17.3 21.9 18.9 12.7 11.4 16.2 12.7 8.0 14.3 20.1 8.4 12.6 8.3 12.7 15.2 15.4 20.8 10.3 9.9 10.9 16.6 14.6 11.4 19.5 11.2 16.5 10.0 20.1 14.7 9.9 9.8 9.7 16.3 20.7 5.0 9.6 12.4 18.2 8.8 10.2 24.9 16.7 3.0 18.0 6.3 7.2 12.6 9.2 11.9 6.4 31.3 10.7 12.4 13.7 11.7 8.5 7.6 8.0 7.2 13.8 8.6 6.0 8.3 7.5 12.1 11.9 7.0 9.5 4.6 10.5 6.8 13.3 7.5 8.5 7.0 14.3 9.7 7.2 6.5 1.9 8.8 17.2 3.8 3.8 8.5 13.6 9.0 14.8 7.6 8.4 7.8 2.6 5.8 10.9 15.0 3.8 5.8 5.3 7.7 12.0 8.6 9.7 2.8 9.3 11.1 5.7 4.8 6.6 3.5 12.5 7.4 9.4 3.3 7.2 14.9 12.7 6.3 6.9 4.3 5.0 6.7 9.2 4.6 9.9 31.3 7.9 13.4 12.3 9.0 12.3 11.1 13.4 13.5 6.4 11.9 13.7 12.6 8.0 12.4 10.7 5.6 13.5 11.7 18.3 19.2 21.9 18.9 15.2 15.4 16.6 14.6 20.1 16.7 8.9 7.8 12.4 17.2 6.8 17.8 18.5 5.1 18.7 10.3 15.7 9.8 12.5 19.9 19.5 105.4 17.7 12.0 0.0 14.8 9.3 18.6 18.7 28.8 8.6 15.2 11.1 10.3 20.3 11.0 31.0 15.5 13.6 15.1 12.6 8.7 22.4 14.4 12.7 21.2 21.9 12.0 19.4 26.2 79.4 35.5 3.0 10.1 19.2 11.3 11.8 CH25H ENSG00000138135 "Cholesterol 25-hydroxylase" O95992 10 89205629-89207314 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.4" "Group enriched" "Detected in many" 5 "Club cells: 17.0;Smooth muscle cells: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "ASC diff: 7.4;ASC TERT1: 3.8;fHDF/TERT166: 26.3;HSkMC: 6.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (6.07e-3)" "unprognostic (2.96e-3)" "unprognostic (1.57e-1)" "unprognostic (5.11e-2)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "unprognostic (3.15e-2)" "unprognostic (2.13e-1)" "unprognostic (2.54e-1)" "unprognostic (8.65e-3)" "unprognostic (7.74e-2)" "unprognostic (4.76e-2)" "unprognostic (2.62e-5)" "unprognostic (2.47e-2)" "unprognostic (1.40e-1)" "unprognostic (2.32e-2)" "unprognostic (2.29e-2)" 18.5 6.8 5.1 8.5 30.7 4.1 7.9 1.0 15.7 5.2 3.6 22.6 2.4 4.3 1.6 17.6 18.4 7.4 18.3 4.2 11.3 6.5 2.8 4.7 17.0 4.6 9.4 1.6 3.4 1.8 2.2 9.8 5.4 44.4 5.7 7.5 5.3 2.3 2.1 2.1 3.2 6.8 6.9 41.9 2.6 6.2 0.6 2.2 7.2 3.0 8.5 5.7 14.0 2.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 7.4 3.8 0.0 0.0 2.5 0.6 0.7 0.0 0.0 0.0 0.9 26.3 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 6.9 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.5 0.0 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 30.7 1.0 10.6 11.3 6.5 9.4 1.6 44.4 2.2 3.0 4.3 0.0 4.4 6.2 0.0 0.4 0.0 6.7 17.0 0.0 0.0 0.1 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 7.6 0.9 1.1 0.0 7.9 1.6 0.0 3.1 4.7 0.0 0.3 8.7 6.8 0.0 0.0 0.6 0.1 0.0 0.7 0.0 0.3 6.5 61.8 0.0 0.0 5.8 0.1 0.7 0.0 4.7 CHI3L2 "YKL-39, YKL39" ENSG00000064886 "Chitinase 3 like 2" Q15782 1 111200771-111243440 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 86.7;salivary gland: 47.2" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 113.5;B-cells: 47.6;Leydig cells: 69.3" "Cancer enriched" "Detected in many" 8 "glioma: 104.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 36.0" "Group enriched" "Detected in many" 4 "B-cells: 16.8;T-cells: 36.0" "Group enriched" "Detected in some" 5 "JURKAT: 113.5;MOLT-4: 59.4" "Low region specificity" "Detected in all" HPA005443 Approved "Secreted to blood" NA NA 480000 "HPA005443: AB_1078510" "unprognostic (1.02e-2)" "unprognostic (4.34e-2)" "unprognostic (1.37e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (9.10e-5)" "prognostic favorable (2.19e-4)" "unprognostic (7.12e-2)" "unprognostic (1.39e-1)" "unprognostic (1.49e-3)" "unprognostic (1.26e-2)" "unprognostic (1.32e-2)" "unprognostic (2.44e-2)" "prognostic unfavorable (8.59e-7)" "unprognostic (7.15e-3)" "unprognostic (7.68e-2)" "unprognostic (1.39e-3)" "unprognostic (1.20e-1)" 8.3 0.9 3.9 38.7 11.9 0.9 13.4 0.3 11.9 0.7 2.5 5.9 0.3 0.4 0.6 3.7 2.2 0.7 4.4 20.8 8.3 8.3 3.0 0.3 21.0 19.1 5.6 1.2 1.4 0.3 0.1 1.6 5.8 7.3 3.9 1.0 4.2 47.2 0.3 3.0 3.2 2.6 1.2 28.4 18.4 2.5 4.4 2.1 86.7 4.2 4.2 39.4 19.3 1.7 16.8 0.5 0.9 1.2 6.4 36.0 10.1 0.0 0.0 0.0 0.1 16.8 3.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.1 0.6 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.2 0.0 0.3 4.0 0.0 0.0 0.1 0.9 0.0 113.5 0.0 0.2 0.0 0.0 59.4 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.3 0.2 0.0 0.1 0.9 0.1 13.2 4.2 0.0 0.4 0.3 1.2 0.1 8.7 0.3 2.2 14.3 6.1 14.3 0.3 16.8 36.0 13.6 0.9 6.4 0.2 0.5 3.6 10.1 3.9 11.9 0.3 5.4 8.3 8.3 5.6 1.2 7.3 2.1 8.9 113.5 47.6 1.0 2.1 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.2 0.0 9.7 3.7 0.1 0.0 0.0 0.3 0.6 2.6 3.7 2.3 0.0 1.0 0.0 1.2 0.0 1.3 9.4 69.3 1.7 15.1 0.0 0.0 0.0 1.1 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.2 1.1 2.6 6.4 0.0 0.4 CHIC1 BRX ENSG00000204116 "Cysteine rich hydrophobic domain 1" Q5VXU3 X 73563200-73687102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA052062" Uncertain Approved "Nuclear speckles,Vesicles,Cytosol" NA NA "Nuclear speckles, Vesicles" Cytosol "HPA026782: AB_1846654, HPA052062: AB_2681714" "unprognostic (9.85e-3)" "unprognostic (3.91e-2)" "unprognostic (3.10e-2)" "unprognostic (9.95e-2)" "unprognostic (6.22e-2)" "unprognostic (1.91e-1)" "unprognostic (1.57e-1)" "unprognostic (1.36e-2)" "unprognostic (2.43e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-3)" "unprognostic (2.65e-1)" "prognostic favorable (2.75e-4)" "unprognostic (1.37e-2)" "unprognostic (2.19e-1)" "unprognostic (3.51e-1)" "unprognostic (2.76e-2)" 5.6 13.9 11.0 7.1 16.3 1.5 7.5 14.7 17.6 14.6 8.2 8.5 7.7 4.7 11.1 7.9 5.1 8.7 9.2 10.3 11.7 13.2 12.4 3.4 5.6 7.2 11.2 13.8 11.8 4.1 13.3 18.2 4.4 16.8 9.9 8.6 6.8 5.1 13.0 4.6 6.0 5.9 10.7 15.4 7.7 4.9 3.3 12.5 3.7 12.8 2.6 6.8 7.4 10.1 1.1 0.2 1.0 0.3 1.2 3.0 0.6 4.0 4.2 2.1 2.7 6.1 8.3 0.0 4.6 6.1 3.8 4.6 2.8 5.2 1.9 6.4 4.1 7.5 1.2 3.0 2.2 8.4 4.7 3.7 2.8 3.4 0.0 3.9 0.0 5.5 5.7 2.7 7.1 3.8 4.8 5.3 1.9 0.7 18.5 7.3 0.6 1.6 0.0 6.6 0.0 4.1 1.6 5.4 1.2 4.7 2.0 1.2 1.7 5.2 2.5 5.5 3.8 2.0 1.1 6.2 4.4 4.2 8.6 2.8 5.2 13.0 0.0 6.4 3.0 3.3 1.0 0.1 0.0 1.9 0.1 3.0 1.1 1.5 1.9 0.0 1.1 1.5 2.0 0.0 1.2 0.3 0.2 1.2 0.6 11.0 16.3 14.7 17.6 11.7 13.2 11.2 13.8 16.8 12.5 3.0 7.8 2.7 4.2 2.4 10.0 9.8 7.6 2.7 4.5 3.5 5.9 0.0 0.0 3.2 3.3 6.8 1.4 0.0 2.9 0.0 5.0 5.6 4.7 1.7 1.2 12.7 0.0 5.5 1.0 1.6 2.8 1.5 5.0 1.0 6.3 5.0 2.1 5.8 8.5 8.4 6.8 0.0 3.6 2.1 1.9 4.0 0.0 5.7 2.9 3.8 CHIC2 BTL ENSG00000109220 "Cysteine rich hydrophobic domain 2" Q9UKJ5 4 54009789-54064690 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Basal keratinocytes: 309.8;Suprabasal keratinocytes: 326.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA026784, HPA076603" Uncertain Enhanced "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA026782: AB_1846654, HPA026784: AB_2732433, HPA076603: AB_2732317" "unprognostic (4.56e-2)" "unprognostic (2.24e-3)" "unprognostic (3.47e-3)" "unprognostic (9.58e-2)" "unprognostic (1.49e-1)" "unprognostic (2.25e-2)" "unprognostic (7.87e-2)" "unprognostic (1.22e-1)" "unprognostic (3.65e-2)" "unprognostic (7.81e-3)" "unprognostic (2.94e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (2.89e-1)" "unprognostic (1.77e-1)" "unprognostic (4.56e-2)" "unprognostic (9.40e-2)" 17.0 17.5 9.5 14.6 9.7 23.7 17.1 17.9 12.0 12.8 14.2 7.1 11.9 13.0 16.8 14.9 25.3 11.0 22.1 14.3 7.3 7.9 12.3 20.2 17.7 13.5 6.6 10.0 13.2 9.9 5.5 16.7 18.5 9.9 12.3 9.6 15.9 15.3 9.9 10.9 24.7 20.6 10.8 8.1 18.5 12.9 50.1 8.3 32.3 11.8 11.6 20.5 12.9 16.3 8.4 10.9 63.8 15.9 13.6 15.6 13.6 11.6 2.1 6.5 5.7 10.8 8.3 6.3 16.2 17.2 9.7 9.7 8.3 10.4 9.9 14.5 10.4 8.8 3.5 8.7 11.8 10.5 5.4 4.4 5.4 2.0 6.3 32.4 8.7 11.2 11.2 9.7 14.6 22.4 19.6 14.2 10.8 5.8 7.5 19.3 3.2 10.2 14.1 4.3 5.4 8.0 6.7 3.5 3.8 11.1 3.9 9.4 8.9 3.8 5.7 11.8 9.7 3.0 13.1 24.1 12.5 9.7 17.8 10.4 8.9 4.2 8.1 9.2 8.8 8.9 56.0 15.9 32.2 12.6 12.4 12.1 8.4 12.8 14.2 10.9 8.2 11.8 12.7 63.8 13.6 12.5 9.1 15.6 13.6 9.5 9.7 17.9 12.0 7.3 7.9 6.6 10.0 9.9 8.3 6.0 8.2 16.1 80.5 309.8 7.1 4.0 12.7 29.4 7.9 7.0 7.9 24.6 14.9 37.6 40.4 37.2 22.7 23.3 24.6 33.5 50.4 75.8 36.8 21.5 22.8 12.7 24.8 38.6 38.9 11.4 15.8 40.6 64.1 23.4 21.3 8.2 45.8 24.6 23.0 22.8 7.0 19.4 37.6 152.1 82.4 326.7 39.9 39.9 18.0 124.8 CHIT1 "CHI3, CHIT" ENSG00000133063 "Chitinase 1" Q13231 1 203212827-203273641 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 99.9;lymphoid tissue: 106.5" "Cell type enriched" "Detected in single" 44 "Hofbauer cells: 42.8" "Cancer enhanced" "Detected in many" "testis cancer: 31.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "neutrophil: 2.9;non-classical monocyte: 1.1" "Group enriched" "Detected in many" 4 "granulocytes: 2.9;monocytes: 1.1" "Cell line enhanced" "Detected in some" "EFO-21: 2.8;LHCN-M2: 1.7;RH-30: 1.8;U-266/70: 2.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA010575, HPA074844" Enhanced "Secreted to blood" NA NA 26400000 58000000 "HPA010575: AB_1078512, HPA074844: " "unprognostic (5.80e-3)" "prognostic favorable (2.02e-4)" "unprognostic (2.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.87e-2)" "unprognostic (2.28e-2)" "unprognostic (7.55e-2)" "unprognostic (6.36e-3)" "unprognostic (1.17e-1)" "unprognostic (3.25e-2)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (1.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" 99.9 0.2 0.2 0.4 0.3 26.7 5.5 0.1 0.3 5.9 0.6 0.5 0.1 0.0 2.5 0.2 0.3 0.1 0.2 0.6 0.2 0.1 0.1 0.4 22.1 106.5 0.4 0.1 1.4 1.1 0.0 0.2 0.4 0.5 0.6 0.5 0.3 0.3 0.1 0.1 0.3 0.7 0.2 9.4 4.3 0.1 0.1 0.1 2.3 0.9 0.2 0.5 0.1 0.3 0.5 0.2 2.9 1.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 1.7 0.2 0.0 0.0 0.1 0.0 0.2 0.0 1.8 0.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 2.3 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.9 0.0 1.1 0.2 0.0 1.3 0.2 0.3 0.1 0.3 0.2 0.1 0.4 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 42.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CHL1 "CALL, FLJ44930, L1CAM2, MGC132578" ENSG00000134121 "Cell adhesion molecule L1 like" O00533 3 196596-409417 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.9" "Cell type enhanced" "Detected in many" 16 "Basal keratinocytes: 20.4;Ciliated cells: 18.7;Muller glia cells: 74.3" "Cancer enhanced" "Detected in many" "glioma: 15.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 56 "memory B-cell: 4.5;naive B-cell: 6.7" "Lineage enriched" "Detected in single" 67 "B-cells: 6.7" "Group enriched" "Detected in some" 5 "SK-MEL-30: 45.2;WM-115: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003345, CAB026120" Enhanced "Intracellular and membrane" NA NA 6900000000 "CAB026120: , HPA003345: AB_1078516" "unprognostic (5.54e-2)" "unprognostic (2.08e-1)" "unprognostic (7.45e-2)" "unprognostic (7.14e-3)" "unprognostic (1.16e-3)" "unprognostic (1.12e-1)" "unprognostic (3.10e-2)" "unprognostic (2.22e-1)" "unprognostic (5.14e-1)" "unprognostic (1.06e-1)" "unprognostic (7.81e-2)" "unprognostic (3.51e-1)" "prognostic favorable (1.21e-6)" "unprognostic (1.11e-1)" "unprognostic (6.07e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" 12.8 4.7 17.8 7.9 32.1 1.1 8.4 7.3 62.9 2.9 10.8 5.0 0.9 4.6 3.9 2.4 8.8 2.8 5.1 10.0 21.2 19.0 17.2 1.5 5.3 5.8 11.1 28.7 16.5 2.4 2.0 3.7 0.8 17.8 3.1 8.1 2.3 7.1 6.9 0.9 12.1 6.1 5.5 9.9 3.3 3.9 2.2 7.5 0.0 1.7 0.0 3.3 2.4 5.3 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 32.1 7.3 36.1 21.2 19.0 11.1 28.7 17.8 7.5 0.0 0.0 0.0 0.6 20.4 1.0 16.1 2.5 18.7 18.2 10.4 0.0 0.0 10.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 6.5 9.0 1.1 1.0 0.0 1.6 0.0 2.5 0.3 1.1 2.6 0.0 3.3 0.0 0.0 74.3 0.1 0.0 0.0 17.0 1.8 0.0 1.0 3.2 0.1 10.7 0.0 0.0 0.0 0.6 CHML REP-2 ENSG00000203668 "CHM like, Rab escort protein 2" P26374 1 241628853-241640254 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029627, HPA029628, HPA062967" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: AB_2797269" "unprognostic (1.63e-1)" "unprognostic (6.84e-2)" "unprognostic (3.57e-1)" "unprognostic (8.00e-2)" "unprognostic (2.46e-1)" "unprognostic (5.66e-2)" "prognostic unfavorable (9.23e-5)" "unprognostic (1.90e-2)" "unprognostic (3.37e-2)" "unprognostic (8.01e-3)" "unprognostic (3.02e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-2)" "unprognostic (3.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.03e-3)" "unprognostic (1.09e-1)" 6.5 3.8 6.0 5.7 10.5 10.8 7.7 3.6 18.0 6.0 6.4 3.1 1.4 3.8 7.6 5.0 6.1 7.2 5.6 5.1 5.3 5.1 6.5 21.1 12.5 10.0 4.9 13.1 13.3 5.6 8.5 8.2 30.7 4.2 3.7 6.1 2.0 5.8 3.0 7.1 6.5 6.5 5.6 3.7 9.3 5.6 9.9 2.2 14.8 11.0 2.2 5.1 5.2 6.6 1.6 2.9 3.0 1.3 0.5 1.4 0.2 17.6 5.5 8.6 6.8 2.6 7.8 16.8 7.0 3.5 6.1 4.2 10.0 3.3 4.8 10.7 4.6 5.0 3.6 12.0 7.6 11.4 9.3 11.0 6.4 22.4 7.0 5.2 15.2 8.3 6.5 3.4 8.1 8.4 4.3 4.7 13.2 17.2 6.0 7.2 6.9 10.0 10.2 11.4 6.7 17.8 15.3 10.6 16.3 6.1 11.0 11.0 18.2 8.8 6.8 7.6 8.8 7.9 9.9 9.6 12.5 24.3 6.3 13.2 7.0 17.2 5.2 12.2 9.2 19.3 3.0 0.9 0.6 0.5 1.3 0.8 1.3 0.3 0.4 0.8 1.6 1.4 1.1 0.1 0.5 0.8 2.9 0.1 0.2 6.0 10.5 3.6 18.0 5.3 5.1 4.9 13.1 4.2 2.2 44.7 6.5 11.1 3.4 7.6 2.6 16.1 2.5 1.4 9.1 0.0 0.0 19.5 5.0 11.7 10.8 6.8 4.2 0.0 17.8 19.9 5.1 3.9 3.5 1.9 6.4 4.8 6.4 3.1 10.7 16.3 9.8 20.4 16.9 13.6 4.0 2.9 18.3 2.8 17.0 2.1 4.3 12.9 10.3 5.9 12.3 6.4 16.8 4.4 4.3 4.2 CHODL "C21orf68, FLJ12627, MT75, PRED12" ENSG00000154645 Chondrolectin Q9H9P2 21 17901263-18267373 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 59.6" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.5;Early spermatids: 2.2;Late spermatids: 3.1;Leydig cells: 2.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 6.8;hypothalamus: 8.2;pons and medulla: 8.6" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 8 "T-cells: 4.9" "Cell line enhanced" "Detected in some" "U-266/70: 4.1;U-266/84: 10.0;U-87 MG: 11.6" "Group enriched" "Detected in many" 4 "basal ganglia: 4.1;hypothalamus: 14.3;pons and medulla: 11.4" "Region enriched" "Detected in all" 6 "olfactory region: 208.8" "HPA017282, HPA057559" Enhanced Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA017282: AB_1846687, HPA057559: " "unprognostic (3.91e-1)" "unprognostic (3.18e-2)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (6.74e-2)" "unprognostic (6.82e-2)" "unprognostic (1.06e-3)" "unprognostic (6.79e-2)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.87e-1)" "unprognostic (4.83e-2)" "unprognostic (1.02e-1)" 2.3 1.9 0.8 2.1 6.8 0.0 1.1 0.5 0.8 0.3 2.3 0.5 4.0 1.5 0.7 1.1 1.4 0.5 0.8 3.4 1.3 8.2 4.7 0.0 0.3 0.3 1.4 0.8 0.5 0.0 0.5 2.1 1.7 8.6 8.2 3.4 1.4 0.6 1.8 1.3 2.1 0.9 0.4 2.2 12.3 0.7 59.6 1.1 0.1 0.9 4.3 1.1 1.1 1.1 0.4 0.6 0.0 0.1 0.4 4.9 0.3 0.0 0.0 1.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.1 0.0 2.5 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.6 0.1 2.1 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.3 0.0 1.1 0.9 1.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.1 10.0 0.3 11.6 0.0 0.1 0.0 0.0 0.0 0.7 0.0 4.9 0.4 0.3 0.8 0.1 0.2 0.0 1.1 0.0 0.4 0.1 0.6 1.0 0.3 0.8 6.8 0.5 0.8 1.3 8.2 1.4 0.8 8.6 1.1 0.0 0.0 0.0 0.6 3.5 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.2 2.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.2 1.1 1.7 1.9 0.5 1.0 0.0 0.3 CHPT1 CPT1 ENSG00000111666 "Choline phosphotransferase 1" Q8WUD6 12 101696947-101744140 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 497.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 19.4;eosinophil: 9.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 19.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067643 Approved Supported Vesicles NA NA Vesicles "HPA067643: " "unprognostic (1.59e-3)" "unprognostic (1.02e-1)" "unprognostic (1.91e-1)" "unprognostic (9.48e-2)" "unprognostic (3.15e-1)" "unprognostic (9.17e-2)" "unprognostic (5.79e-2)" "unprognostic (4.83e-2)" "unprognostic (1.12e-1)" "unprognostic (4.70e-1)" "unprognostic (5.27e-2)" "unprognostic (1.16e-2)" "unprognostic (1.52e-2)" "unprognostic (3.35e-1)" "unprognostic (1.72e-1)" "prognostic favorable (7.41e-4)" "unprognostic (1.79e-1)" 18.0 21.6 19.3 14.3 20.4 21.4 76.7 12.8 16.7 22.2 40.0 11.0 15.8 36.5 9.3 25.0 10.9 14.7 17.1 71.4 18.5 14.5 30.6 64.6 20.2 30.5 17.8 14.5 11.3 14.2 12.6 7.6 9.6 12.8 16.3 21.0 14.0 53.1 22.8 18.5 13.5 42.9 16.7 17.4 13.0 23.1 28.3 12.6 3.3 26.0 7.4 8.7 17.7 38.7 3.0 2.5 19.4 1.5 3.3 0.8 0.4 3.5 16.5 4.4 9.5 35.8 12.0 12.8 12.9 14.9 13.0 8.4 6.1 2.4 5.4 7.3 17.5 17.9 5.4 27.1 4.5 12.4 8.1 22.9 22.0 8.9 35.7 20.0 10.8 4.4 11.3 1.3 5.8 10.7 19.5 6.4 11.7 31.8 14.0 12.8 8.7 6.4 37.5 11.9 17.1 21.9 5.0 8.8 3.9 5.9 14.0 4.4 3.4 11.9 17.2 32.0 7.3 17.5 7.5 4.7 11.9 6.2 9.3 12.5 8.0 2.4 6.6 9.4 12.6 17.3 19.4 1.5 9.7 0.4 1.2 0.4 3.0 0.8 0.7 2.0 2.0 0.3 0.4 2.2 3.3 1.4 2.5 0.4 0.4 19.3 20.4 12.8 16.7 18.5 14.5 17.8 14.5 12.8 12.6 44.7 22.2 63.5 276.5 33.3 14.2 43.5 114.7 4.0 12.5 61.1 27.5 102.9 59.7 7.2 284.8 18.8 76.4 0.0 11.8 43.5 56.0 122.8 10.4 175.9 50.0 33.4 20.3 18.4 79.5 497.4 79.1 37.8 138.3 1.0 51.0 47.9 10.2 114.8 83.8 145.6 15.2 19.4 33.5 169.9 29.8 37.8 50.5 22.4 79.9 235.4 CHRFAM7A "CHRNA7-DR1, D-10" ENSG00000166664 "CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion" Q494W8 15 30357766-30393849 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 6.2;parathyroid gland: 6.3" "Cell type enhanced" "Detected in some" 15 "Horizontal cells: 11.1;Spermatocytes: 3.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 5.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 6.3;HEL: 6.0;RH-30: 4.8;SH-SY5Y: 6.2;U-937: 6.4" NA NA "unprognostic (3.61e-2)" "unprognostic (1.52e-1)" "unprognostic (5.59e-2)" "unprognostic (2.66e-3)" "unprognostic (2.40e-1)" "unprognostic (2.02e-1)" "unprognostic (3.55e-1)" "unprognostic (7.20e-2)" "unprognostic (3.53e-1)" "unprognostic (7.45e-2)" "unprognostic (2.41e-1)" "unprognostic (4.94e-2)" "unprognostic (1.10e-2)" "unprognostic (1.71e-4)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" 0.9 3.5 1.3 1.1 1.3 6.2 0.4 0.0 2.5 0.6 0.4 0.7 0.3 0.2 0.1 0.8 0.4 2.4 0.9 1.6 0.2 0.0 1.2 0.5 2.8 0.6 0.9 6.3 1.0 0.0 1.0 0.6 0.2 0.5 0.1 0.4 1.8 0.6 1.6 0.8 0.9 5.5 3.2 0.2 0.8 0.5 0.2 2.8 5.2 2.1 1.0 0.3 0.4 0.0 0.6 1.9 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 2.3 0.0 6.3 0.0 0.0 0.0 3.7 6.0 0.2 0.6 0.1 1.2 2.1 0.4 0.0 0.2 0.0 3.1 0.6 1.4 0.6 0.0 1.8 0.0 0.0 0.6 0.7 0.2 0.0 0.0 4.8 0.0 1.5 1.9 0.4 6.2 0.0 0.0 0.0 0.8 0.1 1.3 2.6 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 2.1 5.2 0.3 0.7 0.1 0.2 0.0 0.0 2.8 0.1 0.0 0.3 0.0 1.0 0.1 0.6 0.1 0.4 0.0 0.0 0.0 0.7 0.0 1.1 1.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.3 0.0 1.0 0.0 0.0 0.4 1.1 0.0 0.7 11.1 1.2 0.6 0.3 0.0 0.0 0.0 0.0 1.8 2.5 0.8 0.6 0.0 1.4 0.0 0.0 0.0 0.1 3.0 1.9 0.0 0.0 0.0 1.0 1.5 CHRM1 ENSG00000168539 "Cholinergic receptor muscarinic 1" P11229 11 62908679-62921807 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 34.7;prostate: 28.2;salivary gland: 25.3" "Group enriched" "Detected in some" 6 "Glandular cells: 2.0;Melanocytes: 3.3;Mucus-secreting cells: 2.1" "Cancer enriched" "Detected in some" 16 "prostate cancer: 27.9" "Group enriched" "Detected in many" 10 "amygdala: 13.2;basal ganglia: 22.0;cerebral cortex: 34.7;hippocampal formation: 14.2;olfactory region: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MCF7: 4.9;OE19: 15.2" "Group enriched" "Detected in many" 9 "amygdala: 74.1;basal ganglia: 65.6;cerebral cortex: 83.5;hippocampal formation: 100.4;olfactory region: 36.8" "HPA014101, CAB022366" Enhanced Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB022366: , HPA014101: AB_1854210" "unprognostic (3.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.16e-2)" "unprognostic (2.89e-2)" "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (2.08e-1)" "unprognostic (8.57e-4)" "unprognostic (4.88e-1)" "unprognostic (6.43e-2)" "unprognostic (1.75e-1)" 0.5 3.7 13.2 0.8 22.0 0.5 3.2 0.2 34.7 0.6 1.3 0.5 0.0 1.0 0.7 0.6 0.8 0.8 0.7 0.6 14.2 1.7 0.7 0.6 2.9 0.6 1.4 14.0 0.5 1.2 1.0 0.1 0.8 0.1 28.2 1.3 1.3 25.3 0.6 0.6 2.6 1.3 0.6 0.3 0.6 1.9 0.6 1.8 0.0 0.8 0.0 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.1 0.1 15.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.4 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 22.0 0.2 34.7 14.2 1.7 1.4 14.0 0.1 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 CHRM2 ENSG00000181072 "Cholinergic receptor muscarinic 2" P08172 7 136868669-137020255 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 25.5;heart muscle: 35.0;smooth muscle: 32.8" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 45.4" "Cancer enhanced" "Detected in single" "stomach cancer: 0.8" "Region enhanced" "Detected in many" "pons and medulla: 15.7" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 44.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022338, HPA029795" Approved NA NA "CAB022338: , HPA029795: AB_10601357" "unprognostic (3.51e-2)" "unprognostic (3.73e-4)" "unprognostic (5.77e-2)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (4.00e-1)" "unprognostic (2.69e-1)" "unprognostic (1.43e-2)" "unprognostic (1.80e-1)" "unprognostic (1.35e-3)" 0.8 0.9 3.6 7.2 1.9 0.3 0.8 0.8 6.0 0.9 8.9 0.0 0.0 0.9 0.8 0.3 0.8 0.8 25.5 35.0 0.9 0.9 0.8 1.2 1.0 0.2 0.9 2.2 0.8 0.8 0.2 0.9 1.7 15.7 5.4 3.9 0.0 0.8 0.2 0.8 0.8 3.7 32.8 5.0 0.8 2.7 2.3 1.5 0.0 0.8 0.0 0.2 14.0 1.8 0.0 0.2 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 9.2 0.1 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 0.2 0.0 0.0 3.6 1.9 0.8 6.0 0.9 0.9 0.9 2.2 15.7 1.5 0.0 0.0 0.0 0.0 0.0 4.9 45.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 CHRM3 ENSG00000133019 "Cholinergic receptor muscarinic 3" P20309 1 239386565-239915452 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 39.8" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 17.2;Early spermatids: 14.2;Exocrine glandular cells: 14.9;Paneth cells: 23.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 8.7" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Group enriched" "Detected in many" 18 "monocytes: 1.2;T-cells: 2.3" "Cell line enhanced" "Detected in some" "RPMI-8226: 10.2;SH-SY5Y: 32.5;U-266/70: 13.5;U-266/84: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024106, HPA048036" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA024106: AB_1854211, HPA048036: AB_2680238" "unprognostic (1.63e-1)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (4.11e-3)" "unprognostic (3.48e-3)" "unprognostic (5.81e-2)" "unprognostic (2.30e-3)" "unprognostic (5.18e-2)" "unprognostic (1.71e-1)" "unprognostic (1.27e-1)" "unprognostic (6.29e-2)" "unprognostic (6.44e-2)" "unprognostic (5.34e-4)" "unprognostic (3.04e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (4.88e-2)" 0.8 0.0 2.1 1.4 1.8 0.0 0.8 0.8 8.7 0.8 5.9 0.8 0.8 0.8 1.4 0.8 6.6 0.3 0.8 0.8 2.5 1.8 0.8 0.8 1.5 0.8 0.8 1.1 4.3 8.7 0.2 0.8 0.8 0.8 3.8 2.2 39.8 13.7 2.5 0.8 0.7 1.2 3.3 0.8 1.0 4.8 1.7 0.8 1.3 1.3 0.8 1.6 7.1 0.8 0.0 0.0 0.0 1.2 0.0 2.3 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.5 0.3 2.3 1.6 0.0 2.2 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.6 5.6 0.5 0.8 0.0 0.0 2.9 2.7 5.1 0.0 0.7 10.2 0.4 0.5 0.0 32.5 0.0 0.1 0.1 2.7 1.1 0.0 0.0 1.3 0.5 0.1 0.3 13.5 9.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 1.2 0.7 0.0 0.5 0.4 0.0 0.0 2.3 0.7 0.0 0.0 0.7 0.0 0.5 0.2 2.1 1.8 0.8 8.7 2.5 1.8 0.8 1.1 0.8 0.8 0.0 3.0 0.0 1.4 0.0 17.2 0.8 0.0 2.7 1.2 0.0 0.0 2.6 1.7 0.3 14.2 1.1 2.6 0.0 14.9 0.8 0.5 2.3 1.1 0.0 0.4 0.0 3.4 1.3 0.0 2.6 0.0 0.0 6.8 0.0 2.4 0.2 3.7 23.2 0.4 0.7 0.4 0.0 0.3 5.2 2.0 0.0 0.5 0.0 6.6 0.1 CHRM4 ENSG00000180720 "Cholinergic receptor muscarinic 4" P08173 11 46385098-46386608 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.7;intestine: 8.0;lymphoid tissue: 17.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 5.0;SCLC-21H: 14.5;U-2 OS: 4.2" "Group enriched" "Detected in many" 6 "amygdala: 26.8;basal ganglia: 65.9;cerebral cortex: 30.5;hippocampal formation: 26.4;olfactory region: 36.4" "Group enriched" "Detected in many" 7 "amygdala: 5.5;basal ganglia: 15.3;cerebral cortex: 8.6;hippocampal formation: 7.6;olfactory region: 20.1" "CAB022444, HPA072083" Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "CAB022444: , HPA072083: " "unprognostic (7.11e-2)" "unprognostic (3.79e-1)" "unprognostic (5.31e-2)" "unprognostic (7.38e-2)" "unprognostic (8.63e-3)" "unprognostic (1.38e-1)" "unprognostic (6.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (2.96e-3)" "unprognostic (4.08e-3)" "unprognostic (5.02e-2)" "unprognostic (3.83e-2)" "unprognostic (3.64e-1)" "unprognostic (1.71e-1)" "unprognostic (3.56e-1)" "unprognostic (5.08e-2)" 0.0 0.5 1.1 0.2 11.7 1.6 0.0 0.0 6.0 0.0 0.6 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.2 8.0 0.1 0.0 17.2 0.8 4.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.3 0.1 0.2 0.0 3.0 0.0 0.1 0.2 0.1 1.5 0.2 0.3 0.3 0.0 2.6 0.1 1.8 0.1 0.0 2.2 0.3 0.5 0.2 0.0 0.2 0.5 0.6 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.6 0.2 0.0 1.1 0.2 0.2 0.6 0.1 0.2 0.0 5.0 0.0 0.0 0.1 14.5 0.4 0.4 0.1 0.1 0.3 0.1 2.4 0.0 0.4 4.2 0.0 0.1 0.8 0.6 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRM5 ENSG00000184984 "Cholinergic receptor muscarinic 5" P08912 15 33968720-34067457 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 22.8" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 3.0;Early spermatids: 5.2;Extravillous trophoblasts: 13.6;Late spermatids: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.8" "Group enriched" "Detected in some" 5 "BEWO: 5.5;HMC-1: 19.3" "Region enhanced" "Detected in many" "hypothalamus: 15.4" "Low region specificity" "Detected in many" HPA013172 Uncertain NA NA "HPA013172: AB_1854212" "unprognostic (8.19e-2)" "unprognostic (2.13e-1)" "unprognostic (7.67e-2)" "unprognostic (4.32e-1)" "unprognostic (3.05e-3)" "unprognostic (2.77e-1)" "unprognostic (2.49e-2)" "unprognostic (2.79e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-2)" "unprognostic (4.61e-4)" "unprognostic (7.95e-2)" "unprognostic (1.33e-6)" "unprognostic (1.42e-1)" "unprognostic (4.53e-2)" "unprognostic (1.38e-1)" "unprognostic (9.07e-2)" 0.3 0.5 1.2 0.9 15.7 1.3 2.1 0.8 6.9 0.3 0.4 5.1 0.0 1.1 0.5 0.8 0.5 0.3 0.6 0.3 6.8 4.4 0.6 0.9 0.4 1.0 5.8 4.5 0.5 1.0 0.1 0.5 4.8 17.8 0.6 0.3 0.0 0.5 0.1 0.7 1.8 1.8 0.2 22.8 0.7 0.6 5.2 0.0 0.0 2.3 0.0 0.3 0.4 0.3 0.3 0.9 4.8 0.3 0.2 0.3 0.0 0.1 0.2 0.8 0.3 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.5 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.7 0.3 0.2 0.0 0.5 19.3 0.4 0.0 0.2 0.1 0.2 0.0 0.5 0.6 1.2 0.1 0.2 0.2 2.2 0.2 0.2 0.3 0.1 0.3 0.2 0.0 0.4 0.4 0.3 0.3 0.7 0.2 0.2 0.2 1.2 0.2 0.2 0.2 0.2 0.1 0.9 0.3 0.4 0.1 0.2 0.3 1.5 0.3 0.2 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.3 0.1 0.2 4.8 0.2 0.1 0.9 0.2 0.0 1.2 15.7 0.8 6.9 6.8 4.4 5.8 4.5 17.8 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 1.7 0.0 5.2 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.7 0.0 0.7 0.0 0.0 0.0 CHRNA1 CHRNA ENSG00000138435 "Cholinergic receptor nicotinic alpha 1 subunit" P02708 2 174747592-174787935 "Disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 96.7" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 1.6;Melanocytes: 1.7;T-cells: 1.8" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Region enhanced" "Detected in single" "hippocampal formation: 2.0" "Cell type enriched" "Detected in single" 27 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 27 "dendritic cells: 2.6" "Group enriched" "Detected in some" 18 "LHCN-M2: 89.4;RH-30: 73.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA071554 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA071554: AB_2686416" "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.22e-3)" "unprognostic (2.28e-2)" "unprognostic (2.96e-1)" "unprognostic (8.55e-3)" "unprognostic (5.34e-2)" "unprognostic (5.29e-3)" "unprognostic (9.59e-2)" "unprognostic (9.64e-2)" "unprognostic (9.66e-2)" "unprognostic (6.37e-2)" "unprognostic (4.18e-4)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-2)" 4.5 0.0 0.5 0.5 0.1 0.0 0.6 0.0 0.4 0.7 1.7 0.0 0.1 0.2 0.0 4.6 1.2 0.0 0.0 0.3 2.0 0.1 0.0 0.2 0.7 0.9 0.1 0.0 0.0 0.0 0.0 12.1 0.2 0.0 2.4 1.0 0.0 1.5 0.0 96.7 0.0 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.5 0.0 4.5 1.3 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 89.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.5 0.1 0.0 0.4 2.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 1.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 CHRNA10 ENSG00000129749 "Cholinergic receptor nicotinic alpha 10 subunit" Q9GZZ6 11 3665587-3671384 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 33.6" "Cell type enhanced" "Detected in some" 5 "Ciliated cells: 2.7" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 6 "olfactory region: 8.9" "Not detected" "Not detected" NA NA "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (4.04e-2)" "unprognostic (1.11e-4)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (8.22e-2)" "unprognostic (1.50e-1)" "unprognostic (3.79e-2)" "unprognostic (2.74e-1)" "unprognostic (6.90e-5)" "unprognostic (4.35e-2)" "unprognostic (1.06e-5)" "unprognostic (5.60e-2)" "unprognostic (1.70e-2)" "unprognostic (2.32e-1)" "unprognostic (4.39e-3)" 0.2 0.2 0.2 0.4 0.3 0.2 0.1 1.1 0.1 0.2 0.2 0.4 0.2 0.2 0.4 0.3 0.1 0.2 0.2 0.2 0.3 0.6 0.4 0.3 0.1 0.3 0.1 0.0 0.7 0.1 0.7 0.1 0.3 0.1 33.6 0.4 0.2 0.1 0.0 1.0 0.2 0.3 0.5 0.1 0.1 0.0 0.3 0.3 2.2 0.6 0.2 1.0 0.2 1.4 1.5 2.1 2.8 0.9 0.3 1.4 1.7 0.4 1.3 1.3 1.1 2.5 2.5 1.0 0.8 1.1 3.1 1.6 0.9 1.1 1.6 5.2 0.7 3.9 0.5 1.2 0.6 2.7 0.9 1.0 0.9 0.3 0.5 0.8 3.1 2.0 0.6 1.0 0.4 1.5 4.1 2.9 2.6 2.0 2.8 0.9 0.4 1.0 2.0 1.9 0.8 0.9 0.9 1.5 1.8 0.6 3.2 0.7 1.8 2.3 1.3 2.1 0.7 1.7 1.3 0.9 1.3 1.2 0.0 0.4 0.4 1.0 0.0 0.3 0.0 0.8 0.2 0.1 0.3 0.4 0.5 2.2 0.2 0.6 0.3 0.6 0.2 0.0 0.3 0.0 0.6 1.5 1.6 0.8 0.0 2.7 0.0 0.0 0.0 0.3 0.0 0.2 1.2 0.6 0.7 0.0 0.4 0.2 0.3 0.6 0.0 0.8 0.5 1.6 0.0 1.3 0.8 0.4 0.3 0.0 1.7 1.0 0.7 1.3 0.2 0.0 0.4 0.0 0.7 0.0 0.9 0.2 0.4 1.0 0.2 0.0 0.8 0.6 CHRNA2 ENSG00000120903 "Cholinergic receptor nicotinic alpha 2 subunit" Q15822 8 27459761-27479883 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 11.6;prostate: 33.5" "Cell type enhanced" "Detected in single" 22 "Glandular cells: 1.6" "Cancer enriched" "Detected in single" 421 "prostate cancer: 30.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 1.8;plasmacytoid DC: 1.0" "Group enriched" "Detected in many" 14 "dendritic cells: 1.0;granulocytes: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 1.4;SiHa: 2.0;U-2197: 1.8;U-266/84: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (2.23e-2)" "unprognostic (3.19e-1)" "unprognostic (6.19e-2)" "unprognostic (6.29e-3)" "unprognostic (1.19e-2)" "unprognostic (2.13e-1)" "unprognostic (1.91e-1)" "unprognostic (7.60e-2)" "unprognostic (1.70e-1)" "unprognostic (1.47e-1)" 0.3 0.8 1.2 0.6 2.0 1.2 2.1 2.0 11.6 0.3 0.3 11.3 0.0 0.6 0.3 1.4 0.3 0.4 0.4 0.4 1.6 2.9 0.3 0.4 0.6 0.4 1.6 0.6 0.3 0.6 0.4 0.5 0.3 7.0 33.5 0.3 2.4 0.3 0.4 0.4 0.5 0.6 0.3 0.8 0.4 0.4 0.4 1.0 2.4 0.4 0.0 0.4 0.4 0.1 0.0 1.0 1.8 0.0 0.0 0.1 1.8 0.0 0.0 0.1 0.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.5 0.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.7 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.6 0.5 2.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.7 1.8 0.2 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.0 0.0 1.8 1.2 2.0 2.0 11.6 1.6 2.9 1.6 0.6 7.0 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRNA3 ENSG00000080644 "Cholinergic receptor nicotinic alpha 3 subunit" P32297 15 78593052-78621295 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 33.6;lymphoid tissue: 57.2;retina: 74.1" "Cell type enriched" "Detected in some" 18 "Cone photoreceptor cells: 155.1" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 86.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029430 Enhanced NA NA "HPA029430: AB_10603785" "unprognostic (2.28e-1)" "unprognostic (3.45e-1)" "unprognostic (2.58e-2)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (9.16e-3)" "unprognostic (1.97e-1)" "unprognostic (4.28e-2)" "unprognostic (7.20e-2)" "unprognostic (3.12e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-4)" "unprognostic (2.65e-3)" "unprognostic (2.76e-1)" "unprognostic (1.53e-1)" "unprognostic (4.48e-1)" 0.4 33.6 0.8 4.0 2.4 0.1 0.3 6.0 0.4 0.5 8.2 0.7 0.2 1.2 0.5 0.1 0.5 0.1 0.8 0.4 0.2 0.8 0.1 0.1 0.3 2.8 0.4 0.0 0.1 0.2 0.1 1.5 0.2 1.2 0.6 3.4 74.1 0.2 0.6 0.1 0.6 2.9 2.8 0.2 0.2 3.6 0.9 0.5 57.2 0.2 0.2 0.7 0.8 0.6 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 16.4 86.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.4 6.0 0.4 0.2 0.8 0.4 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 4.2 0.6 0.0 0.0 0.0 0.0 155.1 0.0 1.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 2.7 2.5 0.1 0.0 0.0 0.0 8.5 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.1 CHRNA4 "BFNC, EBN, EBN1" ENSG00000101204 "Cholinergic receptor nicotinic alpha 4 subunit" P43681 20 63343223-63378401 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 16.4;liver: 38.8;parathyroid gland: 21.6" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 131.9" "Cancer enhanced" "Detected in some" "liver cancer: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2 OS: 7.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "midbrain: 22.6;pons and medulla: 19.3;thalamus: 29.6" CAB034064 Uncertain NA NA "CAB034064: AB_2080535" "unprognostic (3.40e-1)" "unprognostic (1.71e-1)" "unprognostic (2.87e-2)" "unprognostic (3.98e-1)" "unprognostic (8.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.22e-1)" "unprognostic (1.74e-1)" "unprognostic (2.10e-3)" "unprognostic (5.72e-4)" "unprognostic (9.02e-3)" "unprognostic (9.79e-4)" "unprognostic (6.77e-2)" "unprognostic (1.08e-1)" "unprognostic (3.81e-2)" 0.6 0.8 5.2 0.6 8.7 0.6 0.6 3.1 14.5 0.6 0.6 11.0 0.0 0.6 0.6 0.6 0.6 2.0 0.6 0.6 5.1 6.8 2.1 38.8 0.7 0.6 11.3 8.2 0.7 0.6 21.6 1.0 0.6 16.4 1.3 0.6 5.7 0.6 0.6 0.6 0.6 0.6 0.6 3.9 4.8 0.6 1.9 3.9 0.0 1.2 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 8.7 3.1 14.5 5.1 6.8 11.3 8.2 16.4 3.9 0.0 0.0 0.0 0.0 0.0 20.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.0 131.9 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.8 2.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 CHRNA5 ENSG00000169684 "Cholinergic receptor nicotinic alpha 5 subunit" P30532 15 78565520-78595269 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 33.9" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 9.6;Spermatogonia: 32.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054381 Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Focal adhesion sites" "Plasma membrane" "HPA054381: AB_2682468" "unprognostic (2.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" "unprognostic (3.20e-3)" "unprognostic (6.66e-2)" "unprognostic (1.29e-3)" "unprognostic (7.03e-5)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.34e-2)" "unprognostic (1.31e-2)" "unprognostic (4.52e-2)" "unprognostic (8.97e-2)" "unprognostic (6.50e-11)" "unprognostic (4.37e-1)" "unprognostic (5.39e-1)" "unprognostic (5.44e-2)" "unprognostic (2.22e-1)" 2.9 3.3 1.7 4.4 1.7 0.6 4.9 1.8 1.7 2.7 6.4 0.4 1.6 7.8 4.7 1.9 4.0 1.1 16.3 2.4 1.7 1.8 0.9 1.8 1.4 2.0 1.9 0.3 1.7 11.8 0.0 0.7 2.1 1.2 3.6 7.1 3.5 1.7 0.7 5.8 1.0 6.8 6.1 1.3 1.9 5.3 9.8 0.6 4.5 1.6 2.9 4.4 5.7 33.9 0.9 1.1 3.4 1.6 1.6 1.4 0.7 6.7 17.4 9.5 5.2 1.1 0.8 3.8 4.9 2.4 5.5 10.0 6.6 32.1 4.0 12.2 1.0 14.8 6.0 18.1 7.3 5.6 8.1 21.7 7.4 13.6 6.6 0.6 5.0 10.5 0.3 1.3 1.5 2.0 2.0 10.2 5.6 7.2 5.2 3.5 14.7 6.3 1.7 7.7 13.3 4.8 8.1 10.9 4.0 6.6 16.1 16.0 23.5 11.9 11.6 5.5 5.6 25.8 1.3 2.2 7.5 9.0 5.5 15.5 6.1 25.0 4.5 4.5 8.1 6.9 3.0 1.6 2.5 0.8 1.6 0.4 0.3 0.8 0.5 0.9 0.9 1.4 1.4 3.4 1.6 1.3 1.1 0.3 0.7 1.7 1.7 1.8 1.7 1.7 1.8 1.9 0.3 1.2 0.6 0.0 0.0 0.0 7.8 2.9 1.9 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 1.0 1.0 0.0 0.0 1.8 9.6 0.4 5.2 0.0 0.0 0.9 4.8 3.4 0.0 0.0 1.2 0.3 0.8 1.7 0.0 6.3 0.2 0.7 0.0 0.4 0.2 0.5 0.0 2.1 3.2 32.1 1.4 0.8 1.3 1.5 2.7 CHRNA6 ENSG00000147434 "Cholinergic receptor nicotinic alpha 6 subunit" Q15825 8 42752620-42796392 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.3;retina: 5.1" "Cell type enhanced" "Detected in single" 19 "Rod photoreceptor cells: 1.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 3.4" "Lineage enriched" "Detected in single" 8 "T-cells: 3.4" "Cell line enhanced" "Detected in some" "Daudi: 7.9;HDLM-2: 5.0;HMC-1: 2.4;JURKAT: 2.3;RPMI-8226: 2.0;U-698: 6.9" "Group enriched" "Detected in some" 7 "midbrain: 24.1;thalamus: 7.0" "Region enriched" "Detected in all" 6 "midbrain: 93.1" NA NA "unprognostic (1.91e-1)" "unprognostic (7.49e-2)" "unprognostic (2.66e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (7.60e-4)" "unprognostic (4.99e-2)" "unprognostic (2.48e-2)" "unprognostic (7.73e-2)" "unprognostic (6.24e-2)" "unprognostic (2.13e-1)" "unprognostic (6.56e-2)" "unprognostic (2.63e-1)" "unprognostic (3.97e-2)" "unprognostic (1.92e-1)" "unprognostic (3.27e-3)" "unprognostic (3.66e-2)" 0.1 2.2 0.6 0.6 0.6 0.0 0.9 8.3 3.8 1.2 0.1 1.7 1.4 0.0 0.9 0.0 0.1 1.7 0.2 0.1 0.8 1.6 1.1 0.1 0.4 0.7 4.3 1.7 0.6 0.3 0.0 0.5 0.2 3.6 0.1 0.1 5.1 1.3 1.5 0.1 0.1 0.2 0.0 0.8 0.2 0.1 1.3 0.0 2.0 0.8 0.0 2.8 0.2 0.1 0.4 0.1 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.3 0.0 0.1 0.0 0.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.1 0.0 0.6 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.6 8.3 3.8 0.8 1.6 4.3 1.7 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRNA7 ENSG00000175344 "Cholinergic receptor nicotinic alpha 7 subunit" P36544 15 31923438-32173018 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 27.2" "Cell type enhanced" "Detected in some" 14 "Cholangiocytes: 5.1;Enterocytes: 7.1;Horizontal cells: 15.9;Spermatogonia: 7.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 6.3;RT4: 12.2;SH-SY5Y: 6.9;SK-BR-3: 13.5;U-2 OS: 11.1" "Low region specificity" "Detected in all" "HPA029422, CAB033624" Enhanced NA NA "CAB033624: AB_784835, HPA029422: AB_10600863" "unprognostic (3.43e-2)" "unprognostic (8.44e-2)" "unprognostic (2.02e-1)" "unprognostic (4.61e-4)" "unprognostic (6.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.14e-2)" "unprognostic (5.08e-2)" "unprognostic (1.63e-1)" "unprognostic (4.31e-2)" "unprognostic (3.22e-1)" "unprognostic (1.05e-1)" "unprognostic (2.40e-2)" "unprognostic (4.36e-3)" "unprognostic (5.44e-2)" "unprognostic (7.41e-3)" "unprognostic (2.43e-1)" 0.8 12.9 4.4 1.5 3.4 2.3 2.0 0.9 8.4 1.1 12.2 1.0 1.1 7.9 1.4 0.8 0.8 0.7 4.6 1.2 2.5 5.6 0.9 0.4 1.2 2.0 3.8 2.7 2.9 4.9 1.8 2.0 0.4 11.8 2.2 4.0 11.7 2.1 1.2 0.8 0.7 27.2 0.9 3.1 5.2 11.2 5.1 0.6 0.1 4.3 0.9 1.4 3.1 2.0 0.3 1.2 3.1 1.1 1.8 0.7 0.4 0.0 1.4 2.3 6.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.4 0.0 2.9 0.0 0.0 0.0 1.8 0.4 0.0 1.9 0.0 0.3 0.6 0.0 0.0 0.1 0.0 0.1 0.1 2.5 0.0 0.2 0.0 0.2 0.0 0.2 1.1 3.5 0.0 0.0 3.8 0.2 0.2 12.2 0.5 6.9 0.2 13.5 0.0 0.7 0.0 0.0 0.7 0.0 11.1 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.5 1.1 3.1 0.7 0.4 0.2 0.3 0.4 0.1 1.2 0.2 0.2 0.3 0.7 1.8 0.6 0.7 0.5 0.4 4.4 3.4 0.9 8.4 2.5 5.6 3.8 2.7 11.8 0.6 0.0 0.0 0.0 2.2 0.2 1.7 1.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 7.1 0.0 2.2 0.0 0.0 0.5 1.1 0.0 0.1 15.9 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.6 0.0 1.5 1.1 0.0 0.0 0.0 0.0 0.4 0.2 7.9 0.0 0.0 0.0 1.5 0.9 CHRNA9 NACHRA9 ENSG00000174343 "Cholinergic receptor nicotinic alpha 9 subunit" Q9UGM1 4 40335329-40355217 "Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.3;fallopian tube: 3.9;pituitary gland: 4.6;salivary gland: 2.7;skin 1: 2.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "glioma: 3.5" "Region enhanced" "Detected in some" "pons and medulla: 2.6" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 4 "T-cells: 1.5" "Cell line enriched" "Detected in some" 7 "U-87 MG: 19.2" "Region enriched" "Detected in single" 6 "basal ganglia: 1.0" "Low region specificity" "Detected in single" NA NA "unprognostic (6.20e-3)" "unprognostic (9.18e-2)" "unprognostic (6.93e-2)" "unprognostic (1.06e-1)" "unprognostic (3.54e-1)" "unprognostic (3.48e-1)" "unprognostic (1.58e-1)" "unprognostic (1.89e-1)" "unprognostic (7.30e-2)" "unprognostic (1.94e-1)" "unprognostic (8.96e-6)" "unprognostic (9.00e-2)" "unprognostic (1.76e-1)" "unprognostic (5.01e-2)" "unprognostic (9.18e-3)" 0.0 0.0 0.9 0.0 0.2 0.0 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.2 4.6 0.7 2.6 0.0 0.0 0.0 2.7 0.0 0.0 2.7 0.0 0.0 3.3 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.4 0.7 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 2.8 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.1 0.1 0.1 0.1 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.4 0.5 0.0 0.3 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.0 1.4 0.2 0.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRNB1 CHRNB ENSG00000170175 "Cholinergic receptor nicotinic beta 1 subunit" P11230 17 7445061-7457707 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.6;tongue: 33.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 18.4;RH-30: 38.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005822, CAB011200" Approved NA NA "CAB011200: AB_262151, HPA005822: AB_1079484" "unprognostic (2.89e-2)" "unprognostic (3.43e-1)" "unprognostic (1.08e-1)" "unprognostic (2.67e-2)" "unprognostic (4.19e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-2)" "unprognostic (3.56e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-1)" "unprognostic (9.13e-2)" "unprognostic (6.91e-2)" "unprognostic (2.49e-1)" "unprognostic (1.90e-1)" "unprognostic (1.59e-1)" 4.5 11.5 5.7 1.9 5.1 6.1 3.7 2.3 4.4 3.4 2.0 4.5 3.7 2.3 2.4 5.5 3.6 2.9 1.6 5.0 4.8 3.9 3.9 5.5 2.4 2.6 6.0 3.5 2.9 18.2 8.3 2.5 5.8 4.0 2.6 2.1 4.5 4.5 2.6 81.6 4.0 2.2 2.6 5.1 3.1 2.0 1.2 4.4 4.5 6.0 33.9 3.2 2.4 2.5 7.8 8.2 15.2 11.1 12.3 11.7 7.1 0.8 1.2 2.0 2.5 3.3 2.2 4.6 0.6 2.0 3.0 2.5 0.8 1.1 3.2 2.2 1.3 1.1 7.3 0.7 13.3 1.1 3.9 2.5 1.8 1.2 4.2 1.4 1.1 4.7 4.9 3.7 1.8 6.0 5.1 2.0 6.4 2.3 1.8 18.4 0.5 3.4 2.1 1.5 0.8 0.6 2.2 38.4 8.1 8.3 0.7 0.3 6.0 1.3 2.2 2.5 3.3 2.1 1.6 1.9 1.3 3.5 0.9 2.6 4.4 4.8 0.9 1.1 2.5 1.1 10.6 6.6 15.2 9.9 7.2 7.7 7.8 11.0 10.0 8.2 7.6 9.0 11.7 2.2 12.3 11.1 6.3 8.9 7.1 5.7 5.1 2.3 4.1 4.8 3.9 6.0 3.5 4.0 4.4 0.0 3.7 9.9 2.9 5.7 3.9 7.5 2.5 9.4 5.7 8.7 2.0 34.2 19.9 14.8 1.2 10.3 6.8 0.0 11.8 7.3 8.0 3.5 12.7 8.3 11.1 14.3 2.4 8.0 6.5 1.5 20.1 8.4 11.8 19.8 4.8 11.2 14.5 6.5 15.9 11.9 7.2 0.0 10.3 2.8 2.1 5.6 25.4 14.6 4.8 3.1 CHRNB2 ENSG00000160716 "Cholinergic receptor nicotinic beta 2 subunit" P17787 1 154567781-154580026 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 28.4" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 12.2;Cone photoreceptor cells: 13.7;Horizontal cells: 39.7;Late spermatids: 8.0;Rod photoreceptor cells: 7.6" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Group enriched" "Detected in some" 6 "SCLC-21H: 20.7;SH-SY5Y: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.13e-1)" "unprognostic (6.33e-2)" "unprognostic (8.15e-3)" "unprognostic (3.32e-1)" "unprognostic (4.37e-3)" "unprognostic (2.25e-1)" "unprognostic (3.51e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.37e-1)" "unprognostic (1.24e-3)" "unprognostic (1.83e-1)" "unprognostic (4.36e-1)" "unprognostic (2.32e-1)" "unprognostic (1.45e-1)" "unprognostic (5.65e-2)" "unprognostic (1.84e-1)" 0.9 3.2 7.8 1.2 16.4 1.0 1.8 8.1 28.4 0.9 1.1 1.6 0.0 1.4 1.0 0.9 1.1 1.0 0.9 0.9 9.4 8.9 0.9 0.9 0.9 0.9 7.9 9.8 1.0 2.1 0.9 3.3 0.9 15.4 0.9 1.2 3.1 1.0 0.9 0.9 1.3 1.2 1.1 1.4 0.9 1.6 2.0 1.7 0.0 0.9 0.0 0.9 0.9 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 20.7 20.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 7.8 16.4 8.1 22.1 9.4 8.9 7.9 9.8 15.4 1.7 0.0 0.0 0.0 0.0 0.1 12.2 1.6 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 39.7 3.5 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.9 0.3 0.3 0.0 0.0 0.0 0.0 CHRNB3 ENSG00000147432 "Cholinergic receptor nicotinic beta 3 subunit" Q05901 8 42697376-42737407 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 19.6;pancreas: 6.8;testis: 5.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.6" "Group enriched" "Detected in many" 5 "cerebellum: 19.6;midbrain: 8.2" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 1.5;T-reg: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Group enriched" "Detected in some" 6 "NTERA-2: 3.3;U-266/84: 7.3" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 32 "cerebellum: 21.0;midbrain: 30.4" HPA045555 Enhanced NA NA "HPA045555: AB_10960891" "unprognostic (8.63e-2)" "unprognostic (4.12e-1)" "unprognostic (7.29e-2)" "unprognostic (1.62e-1)" 0.1 0.1 0.3 0.1 0.8 0.1 0.1 19.6 2.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.4 0.1 0.1 0.1 0.8 8.2 2.3 0.1 6.8 0.1 0.9 0.1 1.1 0.1 0.1 3.4 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 5.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.8 19.6 2.7 0.4 0.4 8.2 2.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 CHRNB4 ENSG00000117971 "Cholinergic receptor nicotinic beta 4 subunit" P30926 15 78624119-78727754 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 6.6;lymphoid tissue: 18.5;retina: 10.6;testis: 10.7" "Group enriched" "Detected in some" 21 "Early spermatids: 41.7;Late spermatids: 39.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 16 "SCLC-21H: 20.7;SH-SY5Y: 26.9" "Group enriched" "Detected in some" 5 "olfactory region: 6.5;pons and medulla: 1.4;thalamus: 4.6" "Low region specificity" "Detected in many" HPA059484 Approved "Endoplasmic reticulum,Cell Junctions" NA NA "Endoplasmic reticulum" "Cell Junctions" "HPA059484: " "unprognostic (4.74e-2)" "unprognostic (4.54e-1)" "unprognostic (1.26e-2)" "unprognostic (8.77e-5)" "unprognostic (8.15e-2)" "unprognostic (6.43e-3)" "unprognostic (1.10e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.19e-1)" "unprognostic (1.40e-1)" "unprognostic (1.49e-1)" "unprognostic (1.45e-4)" "unprognostic (7.00e-3)" "unprognostic (2.58e-1)" "unprognostic (8.50e-2)" "unprognostic (7.76e-2)" 0.2 6.6 2.7 3.9 0.8 0.7 0.2 0.5 0.4 0.6 2.3 0.2 0.0 0.2 0.8 0.7 1.4 0.1 0.1 0.8 1.0 0.3 0.5 0.1 0.1 2.9 0.2 0.0 0.3 0.2 0.0 1.6 0.0 1.3 0.2 1.1 10.6 2.2 2.4 0.6 0.3 1.0 0.9 1.0 1.0 0.8 10.7 0.1 18.5 0.4 0.3 1.1 0.5 0.5 1.5 0.4 1.4 0.8 1.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 26.9 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.3 0.5 0.2 0.6 0.9 0.5 0.6 0.2 1.5 0.8 0.8 1.4 1.0 0.4 0.4 0.3 0.0 2.7 0.8 0.5 0.4 1.0 0.3 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 39.8 0.0 0.0 0.0 1.0 0.0 0.3 0.2 0.0 0.4 0.1 0.0 0.0 0.0 1.6 1.9 0.0 0.0 0.0 0.0 0.1 CHRND ACHRD ENSG00000135902 "Cholinergic receptor nicotinic delta subunit" Q07001 2 232525993-232536667 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 49.1" "Cell type enriched" "Detected in single" 11 "Muller glia cells: 4.3" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 72 "RH-30: 43.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "olfactory region: 1.4" "HPA056404, HPA065404" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA056404: AB_2732603, HPA065404: AB_2732734" "unprognostic (1.69e-2)" "unprognostic (7.93e-2)" "unprognostic (3.28e-3)" "unprognostic (7.75e-3)" "unprognostic (6.04e-2)" "unprognostic (1.10e-1)" "unprognostic (7.25e-2)" "unprognostic (1.90e-1)" "unprognostic (4.97e-8)" "unprognostic (7.52e-2)" "unprognostic (2.86e-1)" "unprognostic (2.46e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 49.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRNE ACHRE ENSG00000108556 "Cholinergic receptor nicotinic epsilon subunit" Q04844 17 4897774-4903074 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 53.3;pituitary gland: 19.0" "Cell type enriched" "Detected in many" 5 "Late spermatids: 132.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "gdT-cell: 5.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "HEL: 6.0;HMC-1: 15.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 13 "basal ganglia: 5.7" NA NA "unprognostic (2.00e-3)" "unprognostic (1.56e-1)" "unprognostic (3.94e-2)" "unprognostic (4.35e-3)" "unprognostic (6.55e-2)" "unprognostic (2.27e-3)" "unprognostic (7.80e-4)" "unprognostic (7.75e-2)" "unprognostic (3.24e-1)" "unprognostic (1.34e-1)" "unprognostic (3.69e-2)" "unprognostic (6.58e-2)" "unprognostic (8.42e-4)" "unprognostic (1.39e-3)" "unprognostic (1.26e-1)" "unprognostic (5.83e-2)" "unprognostic (5.70e-2)" 0.3 0.1 0.1 0.4 0.1 0.4 0.1 0.3 0.4 0.1 0.2 0.1 0.1 0.3 0.4 0.8 0.2 0.1 0.4 53.3 0.1 0.0 0.1 1.3 0.3 0.2 0.3 0.1 0.3 0.6 0.3 19.0 0.4 0.2 0.1 0.0 0.5 0.5 0.1 1.0 0.8 0.1 0.2 0.1 0.7 0.1 0.2 0.1 0.1 0.1 1.4 0.2 0.1 0.1 1.0 0.3 1.0 0.4 1.6 5.9 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 6.0 0.0 0.7 0.5 0.0 15.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.0 5.9 0.2 0.0 0.0 0.0 2.1 0.2 1.0 0.1 1.6 0.2 1.6 0.4 0.3 0.0 1.5 0.1 0.1 0.3 0.4 0.1 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 1.1 1.4 0.8 6.3 2.5 0.0 0.0 1.8 3.9 0.4 1.7 0.1 27.7 1.4 0.0 0.0 0.8 6.2 2.6 0.9 8.1 5.9 3.1 3.2 0.0 3.7 1.8 132.7 0.9 5.7 0.0 8.2 0.0 1.2 0.8 0.0 0.4 1.1 10.0 0.0 0.5 4.3 3.0 1.0 9.3 3.2 0.1 0.6 CHRNG ACHRG ENSG00000196811 "Cholinergic receptor nicotinic gamma subunit" P07510 2 232539727-232546403 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "epididymis: 16.7;skeletal muscle: 40.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 18 "HSkMC: 5.1;RH-30: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.26e-1)" "unprognostic (8.97e-2)" "unprognostic (5.61e-2)" "unprognostic (1.92e-2)" "unprognostic (4.38e-1)" "unprognostic (4.86e-3)" "unprognostic (2.32e-1)" "unprognostic (1.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (4.18e-2)" "unprognostic (4.32e-1)" "unprognostic (4.19e-6)" "unprognostic (6.13e-2)" "unprognostic (8.66e-2)" "unprognostic (1.86e-1)" "unprognostic (3.24e-2)" 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 16.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 40.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.0 0.6 0.3 0.5 0.5 1.1 0.8 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.0 0.0 0.2 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.1 0.2 0.1 0.0 0.1 0.1 14.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.5 0.2 0.2 0.2 0.7 0.2 0.4 0.5 0.2 0.6 0.8 0.8 0.2 1.1 0.2 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHST1 "C6ST, KSGal6ST" ENSG00000175264 "Carbohydrate sulfotransferase 1" O43916 11 45648877-45665622 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.5" "Group enriched" "Detected in some" 4 "Early spermatids: 50.9;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 10.3;TIME: 9.8;WM-115: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.77e-2)" "unprognostic (1.67e-1)" "unprognostic (6.37e-3)" "unprognostic (1.32e-1)" "unprognostic (2.18e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.95e-4)" "unprognostic (6.22e-2)" "unprognostic (1.64e-1)" "unprognostic (1.39e-1)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (4.64e-7)" "unprognostic (5.37e-3)" "unprognostic (1.06e-1)" "unprognostic (1.30e-1)" "unprognostic (9.11e-3)" 2.2 8.6 21.2 2.0 21.5 1.2 4.8 2.3 42.5 2.2 1.6 5.0 0.0 1.9 2.5 1.2 1.3 6.5 2.1 2.8 18.6 15.5 2.6 1.5 2.5 2.0 13.6 17.0 4.4 2.5 17.7 4.9 1.7 10.6 1.4 1.2 1.3 14.8 1.6 3.6 1.7 1.7 2.0 2.5 4.7 1.9 3.2 5.5 0.1 9.0 0.4 1.7 2.3 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 2.3 0.0 0.0 0.3 0.3 10.3 0.1 0.0 0.0 0.9 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.5 0.8 0.2 0.0 9.8 2.0 2.9 0.0 0.0 0.0 0.0 0.0 4.2 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 21.5 2.3 35.8 18.6 15.5 13.6 17.0 10.6 5.5 0.0 0.0 0.0 2.4 0.1 8.6 1.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.9 50.9 4.8 0.0 0.0 0.2 0.0 1.9 0.7 0.0 0.0 0.2 0.0 0.0 4.9 0.0 7.6 5.2 0.0 0.0 0.0 0.0 3.7 0.4 0.0 4.6 0.0 0.2 25.8 0.8 6.2 1.4 0.0 0.0 0.0 0.0 0.9 CHST10 HNK-1ST ENSG00000115526 "Carbohydrate sulfotransferase 10" O43529 2 100391860-100417656 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.2" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 14.9;Bipolar cells: 11.4;Muller glia cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "B-cells: 2.3;dendritic cells: 3.1;T-cells: 3.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012884, HPA051545" Approved Approved Cytosol "Intracellular and membrane" NA NA 290000 Cytosol "HPA012884: AB_1846710, HPA051545: AB_2681529" "unprognostic (5.40e-3)" "unprognostic (3.62e-2)" "unprognostic (3.44e-2)" "unprognostic (2.03e-1)" "unprognostic (3.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.89e-2)" "unprognostic (1.44e-1)" "unprognostic (1.78e-1)" "unprognostic (4.54e-2)" "prognostic favorable (4.05e-4)" "unprognostic (8.02e-2)" "unprognostic (2.18e-1)" "unprognostic (1.78e-2)" "unprognostic (3.73e-2)" "unprognostic (3.06e-2)" "unprognostic (3.27e-1)" 4.1 6.7 14.6 3.9 18.7 2.6 5.0 12.6 28.2 6.2 4.1 12.1 2.4 2.2 11.4 13.5 4.1 9.7 5.3 10.1 12.4 9.5 4.4 1.2 7.8 4.0 9.8 12.2 12.9 5.3 8.8 8.6 7.8 9.3 8.1 2.4 7.3 5.5 5.4 5.1 1.6 2.5 11.7 8.9 3.7 3.4 5.8 7.6 3.1 9.8 1.6 5.1 5.8 4.9 2.3 3.1 0.0 0.0 0.1 3.5 1.0 0.1 7.7 15.3 7.8 4.7 6.6 7.7 8.8 6.3 12.1 7.8 0.1 4.5 10.6 7.7 5.3 21.5 0.0 10.7 1.1 7.8 15.0 11.3 5.4 4.2 11.9 5.6 10.9 14.3 4.8 1.5 5.7 1.0 5.8 9.5 10.3 15.7 0.0 5.1 2.4 9.7 8.7 22.5 0.1 9.4 7.0 9.4 0.1 3.3 3.4 16.5 13.5 0.6 0.0 12.2 11.3 4.1 15.1 8.6 8.4 13.4 6.3 8.1 0.0 0.0 10.9 10.3 9.8 9.9 0.0 0.0 0.0 3.5 0.0 1.3 2.3 0.6 2.9 0.6 1.8 0.8 2.3 0.0 0.1 0.0 3.1 0.0 1.0 14.6 18.7 12.6 24.8 12.4 9.5 9.8 12.2 9.3 7.6 14.9 1.9 0.8 1.0 0.8 11.4 4.7 0.0 1.4 7.9 1.8 0.0 4.2 3.3 3.0 0.4 3.3 0.0 0.0 2.5 8.4 3.1 1.0 0.0 0.0 4.8 6.4 1.7 0.0 1.2 0.0 2.0 1.1 0.0 5.4 0.0 17.6 1.9 0.0 4.9 1.0 4.3 0.0 2.5 1.1 4.5 0.5 1.1 2.5 0.0 0.1 CHST11 "C4ST, C4St-1, C4ST1, HSA269537" ENSG00000171310 "Carbohydrate sulfotransferase 11" Q9NPF2 12 104455295-104762014 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Exocrine glandular cells: 55.7;monocytes: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 13.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052828 Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA 22000 "Golgi apparatus" "HPA052828: AB_2681966" "unprognostic (6.35e-2)" "unprognostic (2.68e-3)" "unprognostic (2.28e-2)" "unprognostic (7.53e-2)" "unprognostic (3.45e-2)" "unprognostic (2.64e-2)" "unprognostic (1.64e-3)" "unprognostic (9.21e-3)" "unprognostic (3.12e-1)" "unprognostic (9.02e-2)" "unprognostic (1.22e-2)" "unprognostic (5.44e-2)" "prognostic unfavorable (7.59e-11)" "unprognostic (1.64e-2)" "unprognostic (5.60e-2)" "unprognostic (5.40e-3)" "prognostic unfavorable (8.42e-4)" 6.7 14.3 14.6 21.6 16.6 37.3 4.9 5.7 16.1 6.6 6.2 8.2 9.7 3.9 15.7 16.1 4.4 5.2 11.1 6.6 13.4 11.9 4.4 4.0 15.3 22.5 11.5 6.7 8.7 6.3 1.9 6.8 17.2 10.0 6.4 5.2 16.1 3.3 13.4 1.7 2.7 7.7 12.6 10.5 17.5 8.3 3.3 11.8 26.5 4.3 2.9 15.6 8.5 5.3 2.0 2.6 13.8 1.3 1.3 2.8 0.6 13.5 6.2 2.9 1.8 7.3 3.6 10.2 1.2 0.4 0.6 0.5 0.0 17.7 0.0 2.0 1.8 14.9 3.4 1.7 7.1 0.7 0.1 2.5 18.0 1.6 0.0 1.1 21.0 21.4 1.3 1.0 11.5 1.9 10.8 4.5 25.8 27.8 4.6 1.2 3.3 16.0 24.7 2.4 0.1 2.3 18.2 9.6 4.5 6.0 0.1 4.9 8.0 0.8 9.2 17.0 2.6 2.7 21.3 10.4 2.0 2.2 10.3 11.2 24.0 25.8 3.4 9.4 14.8 20.1 9.3 1.3 9.4 2.8 1.2 1.6 0.9 1.5 2.1 0.7 2.0 0.7 1.8 13.8 1.3 1.1 2.6 2.8 0.6 14.6 16.6 5.7 10.4 13.4 11.9 11.5 6.7 10.0 11.8 14.9 13.3 17.2 13.2 2.5 1.6 4.5 2.5 4.0 7.9 5.2 0.0 28.8 0.0 5.0 0.6 6.3 0.0 0.0 55.7 12.0 9.1 2.7 41.4 0.4 42.1 9.5 0.0 22.1 23.7 1.1 6.9 35.3 3.3 81.2 0.0 1.6 21.1 0.0 15.9 4.8 0.5 6.5 7.2 0.5 2.7 2.5 22.2 36.2 0.0 2.4 CHST12 "C4S-2, C4ST2" ENSG00000136213 "Carbohydrate sulfotransferase 12" Q9NRB3 7 2403560-2448483 "Enzymes, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Ito cells: 159.0;T-cells: 128.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 26.2;NB-4: 27.1;U-266/70: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041680 Approved Approved "Golgi apparatus" NA NA 430000 "Golgi apparatus" "HPA041680: AB_10959789" "unprognostic (4.12e-2)" "unprognostic (3.56e-1)" "unprognostic (3.04e-3)" "unprognostic (1.59e-1)" "unprognostic (2.05e-3)" "unprognostic (7.15e-2)" "unprognostic (2.01e-3)" "unprognostic (1.34e-1)" "unprognostic (3.20e-2)" "unprognostic (4.88e-2)" "prognostic favorable (1.32e-5)" "unprognostic (9.61e-2)" "unprognostic (1.66e-3)" "unprognostic (4.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" 24.2 12.0 9.4 12.1 10.5 14.5 11.2 17.8 16.5 11.9 10.1 13.2 9.0 13.5 14.4 10.6 5.9 11.7 10.9 12.0 8.8 7.7 9.3 6.8 13.6 10.3 10.4 9.2 9.6 17.5 4.9 14.4 9.6 12.7 11.8 4.2 12.3 14.1 11.6 11.9 11.5 10.1 8.1 9.5 25.0 12.4 10.2 8.6 9.0 11.2 4.4 11.8 10.6 10.3 5.7 21.0 16.4 3.5 37.4 30.2 6.7 3.9 4.0 2.5 4.5 3.7 2.7 12.7 7.2 3.4 3.1 4.3 4.5 1.5 3.5 13.6 3.2 6.8 3.2 1.6 1.9 0.9 4.6 8.5 2.4 3.5 5.0 1.7 8.0 26.2 3.7 1.2 2.8 0.3 3.2 3.2 5.9 6.2 12.7 1.4 3.6 8.4 27.1 8.5 1.2 7.3 3.1 3.3 18.3 1.5 2.1 3.0 12.5 3.5 2.6 1.8 2.5 3.3 10.2 5.4 4.6 12.0 9.0 6.3 38.6 14.9 1.6 3.7 4.1 7.9 15.5 3.5 16.4 30.2 2.8 18.9 5.2 10.7 24.5 6.6 5.7 4.5 13.5 1.0 37.4 1.2 21.0 10.2 6.7 9.4 10.5 17.8 16.5 8.8 7.7 10.4 9.2 12.7 8.6 14.9 44.5 41.3 35.2 16.1 44.3 6.7 10.2 17.4 30.7 17.4 62.8 84.2 1.7 17.6 4.4 44.9 6.7 23.3 13.5 8.5 48.9 15.3 36.9 5.9 22.1 44.5 12.2 159.0 21.8 2.7 88.6 20.1 20.3 17.2 9.4 16.0 13.1 7.0 63.6 10.3 46.4 19.4 19.6 27.6 19.4 13.4 111.7 128.5 13.1 9.1 CHST13 C4ST3 ENSG00000180767 "Carbohydrate sulfotransferase 13" Q8NET6 3 126524283-126543291 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 46.8;liver: 42.5" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 56.2;Hepatocytes: 33.7;Spermatocytes: 29.3" "Cancer enhanced" "Detected in many" "liver cancer: 25.0" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 4 "eosinophil: 46.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 46.8" "Group enriched" "Detected in some" 8 "CACO-2: 12.5;Hep G2: 22.4;NB-4: 14.9;THP-1: 8.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA067960 Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA067960: " "unprognostic (5.68e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-2)" "unprognostic (6.42e-4)" "unprognostic (2.26e-1)" "unprognostic (1.05e-1)" "unprognostic (8.45e-3)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" "unprognostic (1.52e-1)" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (5.75e-2)" "unprognostic (5.16e-2)" "unprognostic (6.68e-2)" "unprognostic (2.26e-1)" "unprognostic (1.59e-2)" 0.5 0.2 0.2 0.5 0.3 0.9 0.0 0.2 0.6 0.1 0.9 0.1 0.0 0.8 0.0 1.1 0.1 0.1 0.2 1.1 0.2 0.1 2.6 42.5 0.6 0.6 0.3 0.2 0.4 0.0 0.0 0.0 0.4 0.4 0.2 0.2 0.6 0.5 0.1 0.3 0.0 1.8 0.0 0.3 2.9 0.6 9.7 0.1 0.5 0.1 0.0 0.2 0.1 0.0 0.0 7.0 46.8 10.6 0.0 0.0 3.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 22.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.7 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 10.6 46.8 0.0 6.4 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 9.8 0.0 5.2 0.0 0.0 3.6 0.2 0.3 0.2 0.6 0.2 0.1 0.3 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 33.7 12.3 0.0 1.2 1.3 7.6 3.8 1.4 3.2 0.0 0.0 0.9 0.0 0.0 2.9 1.1 7.9 0.0 0.0 0.0 29.3 2.7 0.0 0.2 0.0 1.6 0.0 CHST15 "BRAG, GALNAC4S-6ST, KIAA0598" ENSG00000182022 "Carbohydrate sulfotransferase 15" Q7LFX5 10 124007666-124093607 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ito cells: 49.7;Kupffer cells: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.4" "Group enriched" "Detected in many" 10 "granulocytes: 29.4;monocytes: 15.4" "Cell line enhanced" "Detected in many" "Karpas-707: 27.6;REH: 36.3;U-266/70: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017584 Approved Approved Centrosome,Cytosol NA NA 560000 Cytosol Centrosome "HPA017584: AB_1849437" "unprognostic (1.19e-1)" "unprognostic (2.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-2)" "unprognostic (4.12e-2)" "unprognostic (1.18e-2)" "unprognostic (1.90e-1)" "unprognostic (3.02e-2)" "unprognostic (2.40e-2)" "unprognostic (7.62e-3)" "unprognostic (7.90e-2)" "unprognostic (8.16e-2)" "prognostic unfavorable (2.22e-7)" "unprognostic (6.47e-3)" "unprognostic (7.80e-2)" "unprognostic (4.63e-3)" "unprognostic (5.26e-3)" 16.4 10.0 8.7 17.0 20.6 5.7 10.7 3.4 17.9 9.8 15.4 6.6 4.0 8.8 8.6 10.8 11.3 13.1 11.7 6.4 11.3 5.3 9.0 11.9 13.9 35.4 6.5 9.6 35.0 12.6 2.9 7.7 5.9 9.2 8.5 8.3 14.4 8.2 13.4 11.0 8.3 12.5 9.5 9.0 31.5 11.4 4.8 8.7 2.8 19.3 6.1 12.6 12.5 12.0 2.1 2.0 29.4 15.4 0.0 0.1 3.2 12.8 8.7 3.2 0.7 3.2 1.7 0.0 2.6 3.5 1.4 2.0 0.2 7.0 0.0 8.5 10.7 0.9 14.7 0.6 8.5 1.2 0.0 2.4 0.0 3.9 6.4 1.0 0.0 16.6 1.0 9.8 4.0 3.4 3.5 2.8 0.0 0.0 27.6 7.0 7.1 0.0 0.0 2.8 1.9 0.0 36.3 4.4 8.5 7.1 1.2 0.3 0.7 7.0 3.9 0.0 8.4 2.9 0.0 3.3 0.3 0.1 10.1 0.4 25.1 6.0 6.9 0.1 0.0 0.0 0.0 8.8 6.2 0.0 14.0 0.0 2.0 0.0 0.0 1.8 2.1 0.1 0.0 29.4 0.0 15.4 2.0 0.1 3.2 8.7 20.6 3.4 17.9 11.3 5.3 6.5 9.6 9.2 8.7 20.8 11.1 9.7 14.5 14.9 4.4 2.2 7.6 9.4 9.1 19.2 0.0 1.5 0.0 8.2 24.2 10.8 0.0 0.0 0.6 1.9 2.7 14.0 5.7 6.4 9.4 0.0 1.7 49.7 47.8 27.7 9.5 23.2 1.7 1.8 0.0 0.1 5.9 0.0 1.8 0.3 0.3 19.4 11.3 8.4 9.2 10.2 0.8 2.2 0.0 15.2 CHST2 C6ST ENSG00000175040 "Carbohydrate sulfotransferase 2" Q9Y4C5 3 143119331-143124014 "Predicted membrane proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9" "Group enriched" "Detected in many" 4 "Muller glia cells: 106.5;Sertoli cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.4" "Group enriched" "Detected in many" 4 "monocytes: 11.4;NK-cells: 4.8" "Cell line enhanced" "Detected in many" "ASC diff: 20.5;ASC TERT1: 21.0;HEL: 16.2;HHSteC: 42.2;HMC-1: 19.4;HSkMC: 22.1;U-266/70: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013620 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA013620: AB_2668861" "unprognostic (1.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.64e-3)" "unprognostic (2.75e-1)" "unprognostic (8.97e-3)" "unprognostic (2.83e-1)" "unprognostic (2.70e-2)" "unprognostic (2.06e-1)" "unprognostic (2.76e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-3)" "unprognostic (9.15e-2)" "unprognostic (1.31e-2)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.58e-3)" "unprognostic (1.34e-1)" 6.5 2.6 8.2 11.6 16.6 20.0 4.1 9.8 15.1 4.6 3.1 6.5 2.6 3.6 6.4 2.7 2.0 1.6 3.1 2.6 7.3 10.4 4.8 1.6 5.1 10.2 10.6 5.8 3.6 2.0 1.5 5.5 15.3 14.0 7.6 2.3 5.9 4.0 15.9 2.7 3.0 4.9 6.0 32.9 17.0 5.4 2.3 4.8 24.7 5.4 0.1 8.1 7.4 5.4 1.4 1.8 0.8 11.4 4.8 0.8 0.9 0.0 0.1 1.0 0.9 20.5 21.0 0.0 1.1 3.2 0.8 0.7 0.0 0.0 0.2 0.7 0.7 1.1 0.0 0.7 2.7 0.4 0.2 0.5 16.2 0.0 0.0 42.2 0.4 19.4 22.1 3.4 1.0 3.5 1.2 1.2 2.5 1.8 1.0 5.3 0.0 3.0 4.1 5.8 0.0 2.7 0.1 0.3 0.0 0.6 0.7 1.3 0.0 0.2 0.0 1.8 1.0 0.0 0.6 4.2 2.5 1.4 3.3 4.7 18.6 0.2 1.1 4.8 3.1 12.8 0.7 0.6 0.8 0.4 4.5 0.0 1.4 0.1 0.2 1.8 1.0 0.8 0.6 0.3 4.8 11.4 0.1 0.5 0.9 8.2 16.6 9.8 15.1 7.3 10.4 10.6 5.8 14.0 4.8 0.0 0.0 14.2 7.0 2.2 20.1 1.2 0.0 0.0 2.3 3.5 2.0 0.4 0.0 0.3 0.1 6.4 0.0 23.3 0.2 0.3 7.1 9.4 11.5 0.0 2.8 1.6 0.0 4.3 6.4 0.4 11.8 13.0 16.9 9.0 0.0 106.5 3.5 0.0 2.1 0.0 19.2 90.5 5.5 0.0 1.9 0.5 0.8 8.7 0.0 15.6 CHST3 "C6ST, C6ST1" ENSG00000122863 "Carbohydrate sulfotransferase 3" Q7LGC8 10 71964365-72013564 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ito cells: 14.7;Leydig cells: 19.0;Peritubular cells: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 28.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047523, HPA055704" Enhanced Approved "Golgi apparatus,Cytosol" NA NA 510000 "Golgi apparatus, Cytosol" "HPA047523: AB_2680075, HPA055704: AB_2682891" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "unprognostic (1.13e-3)" "unprognostic (1.16e-3)" "unprognostic (2.44e-1)" "unprognostic (4.67e-2)" "unprognostic (4.79e-2)" "unprognostic (7.53e-2)" "unprognostic (7.99e-2)" "unprognostic (3.71e-2)" "unprognostic (2.83e-3)" "unprognostic (5.99e-2)" "unprognostic (1.40e-2)" "unprognostic (2.65e-2)" "unprognostic (7.77e-2)" "unprognostic (2.56e-2)" "unprognostic (2.54e-3)" 22.2 11.6 9.2 7.0 19.4 0.7 12.0 2.9 11.6 10.4 9.0 19.4 4.8 1.7 13.7 7.4 8.4 13.6 6.2 11.9 11.3 5.1 8.6 1.8 6.3 2.2 30.1 5.5 25.0 6.1 1.9 4.0 10.0 15.6 10.7 3.3 5.7 6.3 19.5 13.6 7.1 4.0 21.0 16.2 2.9 11.6 19.4 25.2 0.5 7.3 4.8 2.2 7.5 18.5 0.2 0.3 0.8 0.1 0.1 0.2 0.0 6.8 7.4 3.8 9.3 17.3 6.8 0.1 14.5 13.9 8.9 6.0 6.4 13.7 0.0 10.0 17.0 7.2 8.9 3.3 9.9 7.2 0.2 2.5 0.0 12.8 6.1 8.8 0.0 0.0 9.4 11.5 8.8 12.1 17.4 2.6 0.3 2.0 0.0 9.4 0.2 0.0 0.0 1.6 0.2 2.4 0.0 4.6 0.0 12.6 7.0 0.2 3.8 11.0 0.2 10.6 4.8 0.8 1.4 5.4 11.0 12.7 18.3 28.8 0.0 0.0 0.0 8.0 0.0 7.7 0.3 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.8 0.1 0.0 0.3 0.1 0.0 9.2 19.4 2.9 11.6 11.3 5.1 30.1 5.5 15.6 25.2 0.0 3.4 0.0 4.0 2.5 0.0 8.9 5.1 1.4 3.4 7.0 0.0 3.5 3.3 8.2 0.4 3.6 0.0 0.0 2.4 2.2 5.7 3.7 1.1 0.0 0.7 0.0 0.0 14.7 0.6 2.1 19.0 0.4 8.5 1.0 0.0 6.6 7.7 0.0 20.5 2.8 0.0 6.5 9.6 0.5 0.7 2.0 0.9 0.0 0.0 1.4 CHST4 "HEC-GLCNAC-6-ST, LSST" ENSG00000140835 "Carbohydrate sulfotransferase 4" Q8NCG5 16 71525233-71538746 "Predicted intracellular proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "gallbladder: 46.9" "Cell type enriched" "Detected in some" 40 "Cholangiocytes: 152.8" "Cancer enriched" "Detected in many" 6 "pancreatic cancer: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.2;HL-60: 3.4;NB-4: 6.3;NTERA-2: 9.7;SCLC-21H: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA021955 Enhanced "Intracellular and membrane" NA NA "HPA021955: AB_1846723" "unprognostic (2.22e-3)" "unprognostic (1.41e-1)" "unprognostic (8.87e-2)" "unprognostic (3.35e-2)" "unprognostic (4.76e-3)" "unprognostic (6.86e-2)" "prognostic unfavorable (9.24e-4)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (1.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.27e-6)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (5.46e-2)" "unprognostic (1.73e-1)" 0.6 1.7 0.0 0.7 0.1 0.0 0.1 0.0 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.4 2.9 46.9 0.0 0.3 0.0 0.0 5.9 0.3 0.5 0.0 0.2 0.7 9.6 0.0 0.6 0.0 0.4 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.3 0.1 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.5 0.1 0.0 0.4 0.1 0.0 0.8 0.1 0.0 0.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 9.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.9 0.1 1.9 0.0 0.1 2.2 0.0 0.1 0.1 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 152.8 1.4 1.2 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CHST7 "C6ST-2, C6ST2" ENSG00000147119 "Carbohydrate sulfotransferase 7" Q9NS84 X 46573784-46598408 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "monocytes: 91.0;Peritubular cells: 56.6;Sertoli cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 15.4" "Group enriched" "Detected in many" 10 "granulocytes: 9.4;monocytes: 8.0;T-cells: 15.4" "Cell line enhanced" "Detected in many" "EFO-21: 18.0;HHSteC: 13.4;NTERA-2: 16.1;PC-3: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003919, HPA030503" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA003919: AB_10601258, HPA030503: " "unprognostic (3.16e-1)" "prognostic favorable (7.20e-4)" "unprognostic (1.11e-1)" "unprognostic (2.66e-1)" "unprognostic (1.82e-2)" "unprognostic (7.85e-2)" "unprognostic (9.82e-3)" "unprognostic (3.52e-2)" "unprognostic (2.61e-1)" "unprognostic (2.81e-1)" "unprognostic (2.39e-3)" "unprognostic (6.71e-2)" "unprognostic (1.19e-1)" "unprognostic (8.85e-3)" "unprognostic (8.28e-2)" "unprognostic (1.50e-1)" "unprognostic (4.39e-2)" 13.1 7.5 4.9 3.8 6.6 4.7 12.1 4.7 10.3 10.5 4.4 3.6 2.5 2.2 5.0 4.1 4.2 3.2 10.7 25.6 4.1 4.0 3.6 11.0 5.4 3.7 4.5 4.7 27.0 3.4 2.4 3.4 5.9 3.6 3.9 2.2 1.4 2.7 3.7 4.3 5.4 3.3 3.5 1.9 17.1 3.4 3.6 1.8 2.4 4.2 1.4 2.0 4.1 8.7 1.0 1.0 9.4 8.0 0.4 15.4 1.6 4.1 3.5 3.0 2.7 8.6 6.0 0.1 5.8 4.2 1.5 2.1 0.9 1.6 0.0 18.0 2.4 1.0 3.1 2.9 1.0 1.3 2.4 6.3 0.8 0.3 3.1 13.4 1.4 0.1 2.1 0.9 2.9 2.4 2.7 4.8 1.9 0.0 3.7 1.1 1.9 0.5 1.8 16.1 0.3 13.4 2.7 2.5 7.5 4.2 0.1 6.9 2.7 0.8 0.2 0.7 7.9 1.0 0.3 1.1 4.9 0.5 2.6 2.7 8.7 1.8 1.3 5.4 0.0 0.3 1.2 1.9 0.6 1.4 5.9 1.3 1.0 5.3 2.5 1.0 0.6 1.1 1.0 9.4 0.4 8.0 0.6 15.4 1.6 4.9 6.6 4.7 10.3 4.1 4.0 4.5 4.7 3.6 1.8 0.0 1.9 3.7 1.7 11.0 0.8 5.5 5.1 1.4 1.2 1.8 0.0 3.4 1.7 2.2 0.0 9.8 1.0 0.0 2.2 3.5 12.2 3.3 0.0 2.9 10.3 3.2 0.0 17.2 8.6 0.0 17.5 7.9 13.5 91.0 2.3 3.8 1.9 1.1 56.6 1.1 0.7 51.8 10.3 0.5 1.2 11.5 1.1 7.5 0.7 1.4 CHST8 GALNAC-4-ST1 ENSG00000124302 "Carbohydrate sulfotransferase 8" Q9H2A9 19 33621955-33773509 "Disease related genes, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 27.1;pituitary gland: 36.7" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 12.0;Late spermatids: 40.2;Smooth muscle cells: 7.8" "Cancer enhanced" "Detected in many" "glioma: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RPMI-8226: 18.8;SCLC-21H: 11.0;SH-SY5Y: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016004 Enhanced "Intracellular and membrane" NA NA "HPA016004: AB_1846731" "unprognostic (1.00e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (1.45e-2)" "unprognostic (9.44e-2)" "unprognostic (2.96e-2)" "unprognostic (1.15e-2)" "unprognostic (5.75e-2)" "unprognostic (8.41e-2)" "unprognostic (1.16e-1)" "unprognostic (2.83e-2)" "unprognostic (1.54e-1)" "unprognostic (6.98e-8)" "unprognostic (9.37e-3)" "unprognostic (2.61e-1)" "unprognostic (3.28e-1)" "unprognostic (3.87e-2)" 2.0 3.8 3.6 1.7 2.8 0.4 7.0 16.6 9.2 3.4 1.1 1.0 0.0 0.5 1.3 0.4 0.7 2.0 4.0 0.8 9.2 7.9 0.5 0.7 0.6 2.0 5.3 1.5 1.4 3.4 0.4 36.7 0.4 27.1 1.8 0.5 1.4 0.7 0.8 0.6 0.9 0.8 0.8 7.2 3.3 0.9 2.9 0.9 0.0 0.6 0.3 1.4 0.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 3.9 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.9 0.0 0.0 0.0 0.1 18.8 0.0 0.3 11.0 19.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.6 2.8 16.6 9.2 9.2 7.9 5.3 1.5 27.1 0.9 0.0 0.0 0.0 0.4 0.7 2.7 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.5 0.0 0.0 0.0 1.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 4.8 0.0 7.8 0.5 0.6 0.1 0.0 0.0 0.0 0.7 CHST9 "GALNAC-4-ST2, GALNAC4ST-2" ENSG00000154080 "Carbohydrate sulfotransferase 9" Q7L1S5 18 26906481-27185317 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 23.4" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 422.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.4;Hep G2: 9.5;RPTEC TERT1: 30.0;SCLC-21H: 6.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA011393 Uncertain "Intracellular and membrane" NA NA "HPA011393: AB_1846733" "unprognostic (9.24e-3)" "unprognostic (1.13e-2)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (4.53e-3)" "unprognostic (9.98e-3)" "unprognostic (9.21e-3)" "unprognostic (7.92e-2)" "unprognostic (1.61e-1)" "unprognostic (2.04e-2)" "unprognostic (3.54e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-2)" "unprognostic (1.38e-1)" "unprognostic (3.93e-3)" 0.3 0.4 1.7 0.3 2.4 0.2 3.7 1.0 2.6 4.0 2.1 4.5 0.7 0.4 0.3 0.9 2.2 13.6 4.5 3.4 3.7 2.7 2.4 12.1 8.6 0.1 2.6 0.8 1.2 11.9 0.1 4.3 0.1 4.9 4.8 0.4 5.3 23.4 2.7 0.4 0.4 0.7 0.3 5.3 7.1 1.0 8.5 4.2 0.0 0.3 3.9 7.0 2.6 10.5 0.5 0.1 0.8 0.1 0.3 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 30.0 0.0 6.5 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.5 0.2 0.3 0.5 0.3 0.0 0.1 0.1 0.0 1.7 2.4 1.0 2.6 3.7 2.7 2.6 0.8 4.9 4.2 0.0 2.4 0.0 29.8 0.6 1.3 7.7 38.2 422.9 93.3 5.2 0.0 0.2 10.0 8.9 6.1 0.0 0.0 0.0 0.5 0.1 1.1 6.5 4.7 8.9 0.3 0.0 3.4 0.0 0.0 2.4 0.6 0.0 6.8 0.0 0.0 72.3 2.1 0.0 0.4 0.1 1.8 0.0 0.5 0.7 0.7 0.0 0.2 0.0 0.0 37.1 CHSY1 "CSS1, KIAA0990" ENSG00000131873 "Chondroitin sulfate synthase 1" Q86X52 15 101175723-101251932 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 72.5" "Cell type enhanced" "Detected in many" 4 "Smooth muscle cells: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 69.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (7.28e-2)" "unprognostic (6.39e-2)" "unprognostic (9.24e-2)" "unprognostic (1.55e-1)" "unprognostic (7.60e-2)" "unprognostic (9.51e-3)" "unprognostic (1.46e-1)" "unprognostic (3.02e-3)" "unprognostic (1.77e-1)" "unprognostic (1.32e-2)" "unprognostic (5.97e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (6.33e-5)" "unprognostic (3.44e-2)" "unprognostic (1.02e-1)" "unprognostic (8.91e-3)" "unprognostic (5.58e-3)" 23.2 15.6 14.4 14.6 13.7 15.7 17.7 8.5 11.1 17.7 6.5 9.6 8.6 4.9 15.6 11.6 9.1 14.1 19.0 19.0 11.4 7.5 9.0 8.1 20.6 12.4 15.3 5.5 21.9 6.0 5.9 8.7 72.5 12.9 13.6 7.0 12.1 9.8 10.1 7.3 13.7 6.8 16.4 11.9 18.4 9.3 10.8 13.5 8.3 9.7 9.2 8.7 14.3 20.0 1.9 1.5 8.7 2.4 1.2 3.2 1.0 2.8 3.5 11.9 6.0 6.2 8.4 7.9 6.9 6.1 8.4 8.6 3.0 2.3 6.8 4.1 11.5 5.5 7.9 7.9 8.8 9.3 7.6 3.9 13.5 4.0 3.5 7.7 20.5 14.0 7.7 7.4 7.2 6.6 9.6 9.9 3.1 4.9 69.8 6.3 2.4 2.8 14.1 13.7 5.5 2.5 6.4 12.0 10.1 5.8 5.6 2.1 11.3 7.3 3.6 12.5 10.2 4.1 25.5 8.3 13.8 7.9 6.5 14.5 12.4 28.6 4.0 10.7 19.5 10.2 0.0 2.4 5.1 2.9 1.5 3.1 1.7 1.8 3.1 1.5 1.9 1.0 1.9 8.7 1.2 1.6 0.9 3.2 1.0 14.4 13.7 8.5 11.1 11.4 7.5 15.3 5.5 12.9 13.5 0.0 17.8 6.2 17.2 51.4 9.0 7.1 2.5 10.7 11.4 15.7 5.9 5.6 1.7 4.4 0.7 37.9 0.9 23.3 1.9 19.4 44.1 15.0 24.4 4.9 14.0 36.5 2.9 57.7 14.0 1.3 50.9 17.6 25.3 1.0 3.4 9.1 4.6 3.4 44.2 1.9 7.3 45.3 68.0 3.9 7.2 54.6 11.6 8.7 3.1 8.5 CHSY3 "CHSY-2, CSS3" ENSG00000198108 "Chondroitin sulfate synthase 3" Q70JA7 5 129904472-130186634 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 8.9;Ito cells: 4.9;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 12.7;ASC TERT1: 11.3;HSkMC: 7.4;TIME: 6.8;U-138 MG: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044612 Uncertain "Intracellular and membrane" NA NA "HPA044612: AB_10795883" "unprognostic (3.43e-2)" "unprognostic (6.28e-3)" "unprognostic (1.76e-2)" "unprognostic (5.83e-2)" "unprognostic (5.88e-2)" "unprognostic (8.17e-2)" "unprognostic (3.37e-2)" "unprognostic (1.16e-1)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (9.58e-2)" "unprognostic (3.80e-2)" "unprognostic (1.08e-6)" "unprognostic (5.22e-3)" "unprognostic (9.93e-2)" "unprognostic (4.61e-3)" "unprognostic (1.74e-2)" 11.7 1.6 7.0 2.7 8.9 0.3 5.7 0.4 10.4 12.5 1.7 2.1 0.0 1.5 4.2 1.6 1.8 2.6 7.2 3.0 4.8 2.2 1.0 4.8 4.6 1.4 2.1 8.9 1.1 1.1 2.1 0.9 5.6 1.0 1.4 1.6 6.3 1.3 1.8 2.2 2.8 1.3 5.2 1.5 1.9 1.5 1.9 2.1 0.0 2.9 1.3 1.3 3.9 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.1 0.0 12.7 11.3 1.0 2.8 0.1 0.4 0.4 0.0 0.1 0.0 0.2 4.2 0.0 0.0 0.0 0.1 0.0 0.0 1.5 1.7 5.6 0.4 1.2 0.0 0.0 7.4 0.0 0.1 1.1 0.6 3.0 0.0 0.0 1.8 4.9 0.0 0.0 0.0 0.6 0.0 1.2 0.4 5.4 0.0 0.2 0.0 4.4 0.0 0.0 0.0 0.2 1.1 0.2 0.4 6.8 13.6 2.8 0.1 1.8 0.0 0.0 0.0 0.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.0 8.9 0.4 10.4 4.8 2.2 2.1 8.9 1.0 2.1 8.9 0.6 0.0 0.0 0.5 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.1 2.3 0.0 0.0 2.0 1.4 0.0 0.0 4.9 1.8 0.0 1.1 0.0 3.3 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 6.5 2.5 1.4 0.6 0.3 0.3 0.0 0.0 0.0 CISD1 "C10orf70, MDS029, mitoNEET, ZCD1" ENSG00000122873 "CDGSH iron sulfur domain 1" Q9NZ45 10 58269058-58289586 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 63.1" "Cell type enhanced" "Detected in all" 6 "Distal tubular cells: 606.8;Proximal tubular cells: 437.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074383 Supported Supported Mitochondria NA NA Mitochondria "HPA074383: AB_2686684" "prognostic unfavorable (1.11e-4)" "unprognostic (8.60e-3)" "unprognostic (1.07e-1)" "unprognostic (4.10e-3)" "unprognostic (2.41e-2)" "unprognostic (3.22e-2)" "prognostic unfavorable (4.15e-4)" "unprognostic (1.87e-2)" "unprognostic (2.35e-1)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "unprognostic (7.23e-2)" "unprognostic (1.34e-3)" "unprognostic (4.19e-2)" "unprognostic (7.20e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (6.69e-4)" 4.7 8.9 14.0 5.4 21.6 1.4 5.4 14.8 24.9 6.2 10.3 3.7 3.6 17.8 5.2 3.9 9.5 5.7 6.4 32.1 16.2 17.6 20.8 13.2 4.1 4.9 14.7 19.5 6.4 4.8 63.1 10.5 5.0 16.6 6.9 7.7 5.8 8.0 6.7 43.9 7.2 16.7 8.9 9.0 4.2 6.4 3.0 6.0 3.5 8.7 20.4 5.1 8.3 4.4 7.6 9.5 3.0 5.8 6.1 8.3 5.1 12.1 6.2 4.9 9.0 6.7 7.5 2.9 10.3 11.9 10.3 14.2 14.5 11.5 21.7 8.7 10.6 6.0 8.0 13.4 9.2 9.3 9.7 18.2 5.7 10.3 11.7 7.6 10.0 4.5 9.3 7.6 9.8 15.1 8.8 12.0 11.0 12.5 10.2 7.1 4.1 8.5 10.8 5.3 9.3 19.5 6.6 18.3 11.4 13.9 4.3 15.7 5.6 7.9 21.2 7.3 4.5 14.1 5.4 11.8 4.4 8.0 12.8 12.2 10.4 16.9 16.3 11.9 10.0 4.3 0.0 5.8 0.3 5.7 4.2 6.7 7.6 6.6 6.6 9.5 6.0 7.7 7.5 3.0 6.1 2.6 6.2 8.3 5.1 14.0 21.6 14.8 24.9 16.2 17.6 14.7 19.5 16.6 6.0 56.6 40.8 43.2 69.2 114.4 85.6 290.3 127.4 66.9 55.7 127.4 41.2 139.3 606.8 85.2 163.9 59.9 102.8 23.3 70.7 53.7 53.8 54.1 34.5 218.9 59.2 39.7 216.5 78.0 41.4 266.7 39.1 30.5 173.7 19.8 105.2 33.6 75.5 104.0 37.8 437.6 44.2 32.3 59.0 46.8 59.2 99.9 60.8 26.6 102.8 57.1 CISD2 "ERIS, Miner1, NAF-1, WFS2, ZCD2" ENSG00000145354 "CDGSH iron sulfur domain 2" Q8N5K1 4 102868974-102892807 "Disease related genes, Predicted membrane proteins" Autophagy "Deafness, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015914 Approved Supported "Endoplasmic reticulum" NA NA 80000 "Endoplasmic reticulum" "HPA015914: AB_1846794" "unprognostic (1.65e-1)" "unprognostic (1.45e-1)" "unprognostic (6.54e-3)" "unprognostic (8.02e-2)" "unprognostic (2.78e-2)" "unprognostic (3.56e-2)" "unprognostic (1.17e-3)" "unprognostic (3.48e-3)" "unprognostic (9.12e-3)" "unprognostic (2.04e-1)" "unprognostic (2.54e-1)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" "unprognostic (4.66e-2)" "unprognostic (1.70e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" 8.1 13.8 14.8 13.5 11.3 13.7 11.2 14.5 16.1 13.5 8.3 9.3 9.3 5.0 9.4 14.4 8.5 8.2 11.5 10.6 14.5 17.7 19.8 40.5 8.0 12.8 17.9 8.2 8.2 29.7 13.3 10.7 9.5 15.6 7.8 10.7 9.4 16.3 10.5 4.9 7.7 12.5 8.0 16.7 13.0 7.0 7.6 8.4 11.2 21.2 5.6 8.9 6.8 9.3 5.1 6.9 11.0 5.7 7.9 6.6 4.2 10.6 3.6 3.8 4.8 9.6 10.5 2.4 8.4 3.1 3.6 5.5 4.1 18.0 7.8 7.4 7.8 8.6 5.3 18.3 6.6 16.5 6.8 2.8 6.6 2.5 4.2 7.0 11.9 10.7 3.9 10.1 15.1 11.9 3.4 6.4 4.3 14.5 14.0 9.6 2.9 10.3 3.5 7.5 3.6 2.7 4.3 3.9 14.1 8.7 3.4 8.9 5.3 4.9 8.5 7.8 4.6 5.6 2.5 2.8 10.6 11.8 14.3 5.0 10.8 14.6 15.8 7.6 3.7 8.1 7.2 5.6 11.0 5.4 5.1 5.8 5.1 5.5 5.6 5.3 4.0 3.8 4.9 4.1 7.9 5.7 6.9 6.6 4.2 14.8 11.3 14.5 16.1 14.5 17.7 17.9 8.2 15.6 8.4 23.8 25.0 53.7 38.3 76.1 29.8 24.8 48.4 17.4 23.9 73.3 19.6 67.4 61.3 82.9 9.3 26.3 58.3 210.2 67.5 102.3 44.1 55.3 57.6 142.1 102.4 28.6 41.2 19.0 73.8 4.2 22.2 68.4 65.8 85.6 58.6 24.6 77.7 83.4 31.8 182.4 24.3 32.3 31.1 25.1 30.9 78.7 47.5 45.7 58.6 44.3 CKAP4 "CLIMP-63, ERGIC-63, P63" ENSG00000136026 "Cytoskeleton associated protein 4" Q07065 12 106237877-106304279 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Mucus-secreting cells: 162.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 34.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 34.6" "Cell line enhanced" "Detected in many" "BJ: 74.6;BJ hTERT+: 94.1;fHDF/TERT166: 112.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000278, HPA000792, HPA001225" Enhanced Uncertain "Nuclear speckles,Cytosol,Cytoplasmic bodies" NA NA 11000 "Nuclear speckles, Cytosol" "Cytoplasmic bodies" "HPA000278: AB_1078527, HPA000792: AB_1078526, HPA001225: AB_2666241" "unprognostic (5.25e-2)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (7.13e-2)" "unprognostic (2.44e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (6.61e-5)" "prognostic unfavorable (5.61e-4)" "unprognostic (5.02e-2)" "unprognostic (9.66e-3)" "unprognostic (1.95e-1)" "unprognostic (6.23e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.20e-3)" "unprognostic (6.97e-2)" "unprognostic (1.29e-2)" "unprognostic (3.66e-2)" 13.0 23.8 7.1 15.3 4.9 39.5 27.2 6.9 8.4 42.3 19.2 6.5 24.8 8.1 23.7 35.2 47.3 17.2 26.6 32.9 5.7 8.0 18.3 42.1 22.2 28.5 6.3 5.4 28.6 55.2 12.7 12.0 30.6 6.8 23.9 20.5 13.2 34.4 28.0 11.1 20.8 10.7 20.4 5.8 16.7 23.0 10.3 4.2 4.0 18.6 30.0 27.8 25.8 21.4 4.2 2.3 34.6 7.5 0.1 1.0 2.4 11.4 14.4 17.5 18.9 34.1 30.4 10.1 74.6 94.1 36.5 42.0 6.1 2.6 0.7 13.6 112.3 12.4 20.8 12.7 11.3 26.3 0.4 7.4 0.0 8.3 11.9 25.4 0.1 0.2 29.1 15.5 30.9 22.4 46.3 42.6 0.8 0.0 1.5 34.6 3.8 0.5 0.4 10.1 6.0 17.5 5.3 12.6 0.9 11.1 10.3 5.7 6.4 13.2 9.0 7.1 16.4 10.1 5.2 36.3 28.8 15.9 11.9 21.0 4.0 0.0 8.1 20.7 1.4 25.1 34.6 7.5 8.7 0.5 2.7 0.7 4.2 0.7 0.4 2.3 1.6 1.0 0.9 12.7 0.1 4.1 0.0 0.2 2.4 7.1 4.9 6.9 8.4 5.7 8.0 6.3 5.4 6.8 4.2 20.8 24.5 3.0 33.7 48.7 12.8 42.1 43.3 5.3 21.6 22.7 9.8 24.4 5.0 32.4 0.9 24.8 13.4 0.0 75.4 79.1 87.2 68.6 19.5 49.1 19.2 44.5 39.7 49.7 37.3 1.1 63.3 14.9 32.1 6.4 162.0 23.7 51.4 5.8 57.7 9.1 18.4 12.9 46.7 2.5 12.2 62.9 22.1 3.2 60.8 36.8 CKLF "C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1" ENSG00000217555 "Chemokine like factor" Q9UBR5 16 66552563-66566251 "Predicted membrane proteins, Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 142.0" "Cell type enhanced" "Detected in many" 5 "granulocytes: 334.0;Macrophages: 289.2;Spermatocytes: 349.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 142.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA062779 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA062779: AB_2684867" "unprognostic (1.64e-2)" "unprognostic (2.17e-2)" "unprognostic (1.88e-1)" "unprognostic (4.97e-2)" "unprognostic (3.06e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.67e-5)" "unprognostic (2.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.79e-2)" "unprognostic (8.05e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.06e-9)" "unprognostic (2.36e-1)" "unprognostic (2.65e-1)" "prognostic favorable (2.22e-4)" "unprognostic (1.07e-1)" 18.8 21.1 16.1 27.7 16.9 29.9 18.8 19.0 14.9 14.8 20.6 11.0 9.1 15.7 14.8 15.2 12.5 16.4 22.8 11.0 14.9 13.4 15.0 14.6 28.9 41.2 23.1 11.0 14.5 12.0 11.4 13.5 14.6 15.0 14.6 22.0 10.9 13.0 9.7 6.8 9.0 26.5 16.9 20.8 44.4 12.2 42.5 18.6 40.2 12.3 11.7 24.6 17.6 13.0 9.4 32.2 142.0 39.6 17.7 25.6 34.2 35.7 31.9 6.7 19.3 18.1 14.8 4.9 17.9 13.6 19.6 29.3 29.7 43.9 14.1 22.7 15.3 20.5 19.3 13.3 10.7 27.6 17.4 6.7 10.3 28.4 36.3 10.9 32.0 27.8 10.1 8.7 24.4 8.7 23.5 23.3 43.6 16.4 40.7 24.4 11.9 30.9 31.8 2.2 21.1 51.8 53.1 35.4 39.2 65.4 19.9 9.4 11.4 54.8 3.6 16.6 4.7 10.6 21.7 14.2 28.4 25.7 9.8 21.0 19.3 39.7 71.8 23.9 28.2 22.9 64.6 39.6 74.8 20.6 19.8 25.6 9.4 19.2 20.0 32.2 8.8 10.2 14.1 142.0 17.7 18.6 16.3 22.9 34.2 16.1 16.9 19.0 14.9 14.9 13.4 23.1 11.0 15.0 18.6 17.9 66.2 46.2 20.8 24.3 8.2 0.8 101.9 65.6 35.2 54.1 0.0 40.5 14.9 120.7 24.7 44.8 58.0 23.3 113.2 92.3 41.3 13.1 334.0 34.2 227.1 1.6 31.7 66.9 154.7 20.5 45.8 289.2 38.8 30.7 61.5 19.0 153.7 40.3 28.3 75.1 6.4 32.3 33.5 349.8 69.4 20.1 14.5 215.8 65.0 23.3 CKLF-CMTM1 ENSG00000254788 "CKLF-CMTM1 readthrough" 16 66552587-66579135 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 21 "Ciliated cells: 5.3;granulocytes: 18.6;Late spermatids: 6.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 16.1" HPA017136 Approved NA NA "HPA017136: AB_1846992" "unprognostic (9.28e-3)" "unprognostic (1.62e-1)" "unprognostic (2.10e-1)" "unprognostic (1.66e-2)" "unprognostic (2.19e-2)" "unprognostic (9.65e-2)" "unprognostic (5.90e-3)" "unprognostic (3.16e-2)" "unprognostic (1.73e-1)" "unprognostic (9.69e-2)" "unprognostic (2.41e-4)" "unprognostic (2.46e-2)" "unprognostic (2.98e-2)" "unprognostic (7.51e-2)" "unprognostic (4.45e-2)" "unprognostic (2.12e-1)" "unprognostic (1.44e-1)" 5.7 4.4 9.5 11.4 8.5 3.7 6.8 10.9 10.4 5.0 6.8 3.5 2.7 3.9 8.2 5.4 4.2 6.7 8.6 4.7 8.0 9.1 5.2 4.6 11.1 16.4 8.6 3.5 9.2 6.3 2.5 4.2 5.9 5.2 5.0 3.5 3.5 4.4 4.2 2.0 3.7 10.1 4.8 7.0 14.7 5.5 16.9 6.8 16.0 4.9 3.8 6.5 3.7 4.4 0.7 3.4 12.5 3.9 1.8 3.6 2.6 4.3 5.6 2.2 5.3 2.6 5.1 0.8 5.0 2.7 4.5 6.8 2.0 4.6 1.6 2.8 0.5 1.4 3.3 2.7 0.3 3.0 4.8 1.5 0.4 1.9 0.2 1.9 3.6 2.9 0.2 0.3 2.6 0.5 8.0 2.6 6.0 1.8 4.8 3.4 1.3 8.2 4.6 1.4 0.6 2.3 16.1 7.8 5.4 4.0 1.2 3.4 4.7 8.8 0.6 1.5 0.2 2.1 2.0 1.6 6.2 11.2 4.4 1.9 2.9 5.8 6.4 4.0 3.7 10.0 8.5 3.9 10.8 3.0 1.5 3.1 0.4 1.2 1.8 3.4 0.7 0.5 1.4 12.5 1.8 1.8 1.4 3.6 2.6 9.5 8.5 10.9 9.9 8.0 9.1 8.6 3.5 5.2 6.8 3.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 1.8 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 18.6 0.0 0.1 0.0 0.0 1.3 0.8 6.5 0.3 0.9 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 CLCA2 CLCRG2 ENSG00000137975 "Chloride channel accessory 2" Q9UQC9 1 86424086-86456558 "Predicted membrane proteins" "Cell adhesion, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 42.1;Club cells: 22.7;Early spermatids: 20.6;Suprabasal keratinocytes: 47.9;Urothelial cells: 35.8" "Group enriched" "Detected in many" 6 "cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "hTCEpi: 68.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047192 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 66000 "Plasma membrane, Cell Junctions" Nucleoplasm "HPA047192: AB_2679977" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.96e-3)" "unprognostic (6.99e-2)" "unprognostic (6.33e-2)" "unprognostic (1.40e-1)" "unprognostic (6.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (9.99e-3)" "unprognostic (1.97e-8)" "unprognostic (3.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 2.0 0.1 0.1 27.7 0.2 0.1 0.4 0.1 1.1 0.7 105.2 0.1 0.2 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 1.4 0.3 0.1 5.1 0.1 0.1 36.4 0.3 0.1 0.2 0.1 0.0 0.2 0.1 0.7 0.1 42.1 33.9 6.1 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 12.6 0.5 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 10.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 68.6 0.3 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 6.0 42.1 0.0 0.3 0.0 10.7 22.7 0.0 0.0 0.2 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 47.9 0.1 0.0 0.0 35.8 CLCA4 CaCC2 ENSG00000016602 "Chloride channel accessory 4" Q14CN2 1 86547078-86580754 "Predicted membrane proteins" Transport "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 182.1;intestine: 64.2" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 115.2" "Cancer enhanced" "Detected in many" "cervical cancer: 21.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 988 "RT4: 98.7" "HPA017045, HPA064770" Uncertain Approved "Nucleoplasm,Plasma membrane,Aggresome" "Intracellular and membrane" NA NA 210000 "Plasma membrane" "Nucleoplasm, Aggresome" "HPA017045: AB_2291679, HPA064770: " "unprognostic (1.38e-4)" "unprognostic (1.52e-1)" "prognostic favorable (7.47e-4)" "unprognostic (2.73e-2)" "unprognostic (7.03e-2)" "prognostic favorable (8.63e-4)" "unprognostic (7.59e-2)" "unprognostic (3.35e-1)" "unprognostic (1.26e-1)" "unprognostic (6.01e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-2)" "unprognostic (2.29e-1)" "unprognostic (5.69e-2)" "unprognostic (3.43e-2)" 0.2 0.1 2.2 8.8 3.0 0.1 0.6 0.0 2.0 12.3 64.2 2.0 0.0 0.1 0.3 0.1 182.1 0.1 0.1 0.1 2.2 0.6 0.1 0.1 0.1 0.1 3.2 1.6 0.1 0.0 0.1 0.0 0.1 3.0 1.8 38.4 0.0 5.9 0.1 0.1 4.5 6.1 0.8 2.4 0.1 0.1 0.1 5.0 0.0 0.1 8.6 21.5 9.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.0 0.0 2.0 2.2 0.6 3.2 1.6 3.0 5.0 0.0 0.0 0.0 13.3 3.0 0.0 0.2 0.0 2.7 5.7 1.8 0.0 0.0 0.0 0.0 0.3 0.0 18.6 0.0 0.0 0.0 0.0 3.9 9.2 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 4.1 115.2 CLCC1 MCLC ENSG00000121940 "Chloride channel CLIC like 1" Q96S66 1 108929508-108963457 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009087, HPA013210" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA009087: AB_1078532, HPA013210: AB_1846895" "unprognostic (2.95e-1)" "unprognostic (1.09e-1)" "prognostic favorable (1.33e-5)" "unprognostic (4.32e-2)" "unprognostic (2.55e-1)" "unprognostic (1.48e-1)" "unprognostic (2.40e-2)" "unprognostic (1.45e-1)" "unprognostic (5.30e-2)" "unprognostic (9.23e-2)" "unprognostic (1.14e-1)" "unprognostic (1.36e-1)" "unprognostic (7.50e-2)" "unprognostic (1.74e-1)" "unprognostic (2.04e-1)" "unprognostic (4.68e-3)" "unprognostic (9.65e-2)" 17.4 19.5 17.5 13.2 24.8 7.1 19.1 22.8 26.1 19.0 16.4 28.4 22.9 15.6 22.1 31.2 12.2 16.9 15.8 20.2 19.5 15.2 12.2 23.5 15.1 10.9 24.4 16.3 23.3 28.5 26.6 24.4 20.0 20.5 23.1 15.3 17.7 21.8 24.1 29.3 16.1 14.8 19.3 21.5 13.7 17.9 8.3 24.3 5.1 21.7 10.4 12.9 17.1 16.0 7.7 9.5 9.0 15.4 7.1 9.4 5.5 23.8 10.4 13.5 23.3 18.8 17.1 17.5 19.9 16.4 14.1 15.3 11.2 10.0 5.7 21.4 15.7 9.2 9.2 12.2 7.5 18.1 18.1 10.9 14.1 13.0 10.3 15.1 13.9 15.6 12.5 11.3 16.3 13.4 14.5 12.9 6.7 17.0 23.3 10.3 9.5 1.3 5.5 10.2 8.4 9.4 12.9 6.9 13.6 11.8 14.2 8.1 12.4 23.3 25.2 18.0 10.8 7.9 9.5 13.9 18.9 15.1 18.0 19.5 17.0 13.9 8.8 23.0 11.3 40.6 4.1 9.2 9.0 9.1 11.1 9.4 7.7 7.7 7.2 8.0 5.9 8.7 7.9 1.6 7.1 15.4 9.5 9.2 5.5 17.5 24.8 22.8 26.1 19.5 15.2 24.4 16.3 20.5 24.3 23.8 18.1 4.5 11.7 3.3 13.1 4.5 15.3 18.7 19.4 10.4 27.5 24.4 0.0 15.5 6.1 7.1 5.7 0.0 18.3 10.5 14.6 15.9 11.5 19.2 11.6 20.6 3.5 10.4 4.3 2.1 18.4 5.7 8.5 11.8 8.8 14.5 17.7 0.0 17.7 5.6 15.6 19.4 8.0 4.2 4.6 5.5 15.4 6.4 10.1 8.9 CLCN1 "ClC-1, CLC1" ENSG00000188037 "Chloride voltage-gated channel 1" P35523 7 143316126-143352083 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "skeletal muscle: 38.9;tongue: 21.1" "Group enriched" "Detected in some" 13 "Early spermatids: 20.5;Late spermatids: 67.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 2.4;intermediate monocyte: 2.6;myeloid DC: 1.8;non-classical monocyte: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 1.8;monocytes: 3.8" "Cell line enhanced" "Detected in some" "CACO-2: 1.5;HSkMC: 5.5;NTERA-2: 1.2;PC-3: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.16e-2)" "unprognostic (4.99e-2)" "unprognostic (1.44e-1)" "unprognostic (2.05e-1)" "unprognostic (9.53e-2)" "unprognostic (8.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.56e-4)" "unprognostic (8.71e-3)" "unprognostic (2.35e-1)" "unprognostic (2.90e-3)" "unprognostic (3.12e-1)" "unprognostic (2.35e-1)" "unprognostic (4.30e-2)" "unprognostic (2.47e-1)" "unprognostic (3.55e-3)" "unprognostic (3.57e-2)" 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 38.9 0.0 0.8 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.7 21.1 0.9 0.1 0.0 0.0 1.8 0.5 3.8 0.0 0.2 0.9 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 2.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.5 0.0 3.8 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 67.5 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.0 2.1 CLCN2 "ClC-2, CLC2, EJM6" ENSG00000114859 "Chloride voltage-gated channel 2" P51788 3 184346185-184361651 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 21.0;intestine: 20.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 10.2;Enterocytes: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009397, HPA014545, HPA024108" Approved Approved Cytosol NA NA Cytosol "CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883" "unprognostic (1.13e-1)" "unprognostic (4.01e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (4.67e-8)" "unprognostic (1.72e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (2.10e-1)" "unprognostic (2.50e-3)" "unprognostic (1.19e-1)" "unprognostic (4.40e-2)" "unprognostic (5.88e-2)" "unprognostic (4.60e-2)" "unprognostic (1.35e-1)" 1.6 5.4 4.9 2.6 8.3 1.3 1.6 8.8 6.3 2.8 20.2 16.9 5.1 11.6 4.5 5.0 1.7 2.8 21.0 1.5 6.3 3.1 3.7 1.8 1.3 1.0 15.3 4.1 6.1 5.9 4.4 4.0 1.5 8.9 2.6 14.0 15.6 3.7 9.0 1.2 2.2 11.8 2.4 10.8 1.6 2.7 11.9 9.8 0.1 3.2 1.3 1.3 2.2 2.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 8.0 2.8 2.3 6.2 2.1 1.8 5.4 2.9 1.6 2.9 1.8 15.1 2.7 2.8 8.0 1.4 7.5 14.0 3.3 3.1 0.9 2.5 4.0 2.5 5.8 6.4 1.3 1.0 2.5 3.4 2.5 2.5 2.9 1.3 2.7 3.0 1.0 1.4 1.0 4.4 0.8 1.3 3.5 6.7 4.4 5.0 2.2 9.6 3.5 6.1 3.9 2.3 3.0 10.5 4.7 1.6 8.5 1.1 1.3 1.5 4.4 7.1 7.0 3.8 4.8 1.7 2.6 4.8 6.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 8.3 8.8 6.3 6.3 3.1 15.3 4.1 8.9 9.8 3.0 2.6 0.0 0.7 0.9 2.2 1.1 10.2 4.0 1.2 0.0 0.0 0.9 0.0 3.5 2.4 0.5 30.8 0.0 1.8 0.4 1.0 0.6 1.1 0.4 0.5 1.6 2.9 1.8 0.0 1.3 4.9 0.4 0.0 1.0 3.6 1.8 1.8 7.8 4.6 2.2 2.6 0.0 0.8 3.3 1.6 0.4 1.3 0.0 6.5 0.3 CLCN3 "ClC-3, CLC3" ENSG00000109572 "Chloride voltage-gated channel 3" P51790 4 169612633-169723673 "Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044723 Approved Supported Vesicles NA NA Vesicles "HPA044723: AB_10959733" "unprognostic (1.92e-1)" "unprognostic (3.92e-2)" "unprognostic (1.95e-3)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (2.25e-1)" "unprognostic (3.32e-1)" "unprognostic (1.79e-1)" "unprognostic (5.40e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.10e-4)" "unprognostic (2.49e-2)" "unprognostic (2.49e-1)" "unprognostic (1.45e-1)" "unprognostic (6.38e-3)" 11.6 21.1 27.6 10.9 29.9 5.9 18.4 24.9 37.7 15.0 26.7 32.4 15.5 17.1 11.1 17.7 26.6 15.6 22.0 19.6 29.3 29.7 22.2 14.7 11.9 9.0 32.7 22.7 14.0 23.4 29.4 38.7 14.5 36.1 19.5 30.8 20.6 48.5 13.5 14.6 18.0 16.5 10.4 46.1 9.0 23.2 18.4 25.4 10.8 21.7 18.4 13.5 20.5 16.7 8.6 11.9 6.2 8.1 6.9 11.5 7.9 11.4 11.9 17.8 22.6 36.3 30.5 8.7 15.4 19.3 10.4 12.7 8.4 26.0 14.1 9.6 12.8 12.0 9.8 22.1 9.5 17.5 12.5 8.6 11.9 19.3 9.6 24.7 14.2 19.9 21.2 21.9 18.5 18.3 43.3 18.7 19.7 29.3 32.5 18.4 4.1 19.4 3.3 7.3 19.8 8.1 8.7 7.9 11.0 21.7 23.7 19.3 19.0 13.7 15.0 24.1 15.3 10.2 6.7 15.8 8.4 9.4 13.4 11.9 14.4 21.7 12.6 25.1 5.4 22.0 6.2 6.5 4.7 9.0 8.1 11.5 8.6 6.7 8.2 9.5 7.4 10.4 9.2 5.3 6.9 6.5 11.9 8.1 7.9 27.6 29.9 24.9 36.8 29.3 29.7 32.7 22.7 36.1 25.4 29.8 22.1 14.3 22.7 10.1 84.1 61.8 45.9 71.0 13.6 59.3 123.7 19.6 6.6 32.1 76.3 24.8 82.7 23.3 38.3 14.8 13.8 65.9 112.9 33.3 15.9 57.2 64.2 33.7 32.6 56.4 22.7 13.3 30.4 7.2 61.7 156.2 31.4 48.2 19.8 15.9 109.5 6.5 19.6 16.9 16.4 22.8 59.5 16.0 47.2 30.6 CLCN4 "ClC-4, CLC4" ENSG00000073464 "Chloride voltage-gated channel 4" P51793 X 10156945-10237660 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;epididymis: 22.8;skeletal muscle: 34.6" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 75.3;Cone photoreceptor cells: 96.2;Horizontal cells: 49.3;Rod photoreceptor cells: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.3;memory B-cell: 1.7;naive B-cell: 6.8;neutrophil: 4.4" "Group enriched" "Detected in many" 9 "B-cells: 6.8;granulocytes: 4.4" "Cell line enhanced" "Detected in many" "GAMG: 17.5;HEL: 16.2;SCLC-21H: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031313, HPA063637" Enhanced Approved Approved Vesicles NA NA Vesicles "HPA031313: AB_10601358, HPA063637: AB_2685069" "unprognostic (1.01e-1)" "unprognostic (1.20e-2)" "unprognostic (5.07e-2)" "prognostic unfavorable (2.13e-5)" "unprognostic (2.96e-1)" "unprognostic (3.75e-1)" "unprognostic (1.04e-2)" "unprognostic (3.66e-1)" "unprognostic (1.75e-1)" "unprognostic (5.99e-2)" "prognostic favorable (9.55e-4)" "unprognostic (9.70e-2)" "unprognostic (9.78e-3)" "unprognostic (1.68e-1)" "unprognostic (1.49e-1)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" 3.1 3.4 9.7 2.0 21.3 2.1 1.6 18.6 29.1 2.0 1.4 15.7 0.0 1.2 1.3 22.8 2.3 3.0 2.8 11.4 13.0 10.5 3.4 3.5 3.4 2.9 23.5 10.4 2.2 2.4 8.9 3.9 1.7 18.2 2.1 1.1 6.0 2.3 1.7 34.6 1.2 1.2 1.4 15.2 3.2 2.1 2.2 17.9 0.0 6.8 2.0 2.2 2.3 0.8 6.8 0.6 4.4 0.5 0.0 0.0 0.6 4.8 3.0 2.2 0.0 1.1 2.0 0.0 0.1 0.0 0.0 0.0 5.9 3.3 3.6 8.7 0.9 17.5 1.0 1.4 3.2 0.1 0.0 3.4 16.2 1.6 2.4 5.4 0.0 0.0 9.7 2.6 4.2 1.0 3.4 6.2 0.0 1.2 0.0 2.2 0.5 0.0 0.1 2.8 5.2 10.5 0.0 3.6 0.0 1.5 0.5 16.8 6.3 6.9 0.7 0.0 2.0 1.8 2.0 6.1 2.6 4.4 11.4 0.4 0.4 8.1 1.3 8.3 0.0 3.3 2.3 0.5 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.6 6.8 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.6 9.7 21.3 18.6 26.7 13.0 10.5 23.5 10.4 18.2 17.9 8.9 1.9 3.7 0.7 0.5 75.3 26.7 12.7 5.3 1.2 7.0 96.2 0.1 0.0 2.2 0.0 1.4 0.0 0.0 3.1 0.2 1.0 0.7 1.1 4.2 2.5 49.3 14.5 17.2 4.7 0.0 0.9 0.5 0.0 0.0 0.0 12.8 2.9 0.0 3.5 2.6 37.1 0.0 0.8 0.0 0.2 0.1 0.2 0.0 0.0 0.8 CLCN5 "ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN" ENSG00000171365 "Chloride voltage-gated channel 5" P51795 X 49922615-50099235 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 46.1" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.6" "Group enriched" "Detected in many" 8 "dendritic cells: 6.6;monocytes: 1.8" "Cell line enhanced" "Detected in many" "CACO-2: 25.4;RH-30: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000401, HPA003213" Uncertain Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane" Cytosol "HPA000401: AB_1078531, HPA003213: AB_2666843" "unprognostic (3.33e-2)" "unprognostic (6.15e-2)" "unprognostic (3.13e-1)" "unprognostic (1.57e-1)" "unprognostic (7.59e-2)" "unprognostic (1.27e-1)" "unprognostic (1.54e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-1)" "unprognostic (5.21e-2)" "prognostic favorable (5.20e-4)" "unprognostic (3.59e-2)" "prognostic favorable (2.05e-8)" "unprognostic (7.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" 4.4 4.1 2.5 2.4 2.9 2.1 3.4 9.4 3.4 2.3 3.1 2.6 4.7 5.0 9.8 26.7 3.7 4.6 7.6 2.2 3.1 2.8 46.1 15.8 4.7 3.0 2.6 2.5 10.8 6.7 2.6 8.3 7.3 5.9 2.7 3.7 7.6 4.0 3.5 5.6 6.2 6.4 3.8 4.3 3.0 4.0 5.9 2.3 1.2 3.6 4.0 2.3 2.4 3.1 0.2 6.6 0.5 1.8 0.3 0.4 0.5 1.8 2.8 2.2 3.3 8.4 5.3 4.7 1.5 0.8 1.0 1.2 25.4 1.7 1.8 0.8 1.7 5.6 1.5 6.8 0.8 1.6 0.7 4.6 1.8 1.4 6.6 4.0 2.3 3.4 3.1 1.1 2.6 3.8 0.8 3.6 2.4 2.7 2.7 2.9 1.8 0.8 0.7 3.2 4.2 1.4 1.1 39.3 2.8 3.8 2.9 3.8 2.7 2.2 2.2 3.1 8.7 1.9 1.1 1.8 1.0 2.1 7.8 0.9 2.3 6.9 4.1 1.7 3.8 5.1 0.1 1.8 0.0 0.2 1.5 0.3 0.2 0.4 0.4 3.8 0.2 0.1 0.1 0.5 0.3 0.3 6.6 0.0 0.5 2.5 2.9 9.4 3.4 3.1 2.8 2.6 2.5 5.9 2.3 8.9 5.9 1.5 1.6 6.4 19.5 1.6 5.1 5.3 0.0 12.2 2.0 5.2 10.0 3.7 1.1 3.8 10.9 0.0 2.9 2.2 5.7 3.1 2.3 21.7 8.9 7.9 0.0 0.6 9.5 0.0 4.9 8.9 3.3 5.4 5.7 2.8 5.8 6.2 12.4 32.4 4.3 0.0 3.3 1.0 0.7 8.3 4.2 0.0 6.4 4.6 CLCN6 "CLC-6, KIAA0046" ENSG00000011021 "Chloride voltage-gated channel 6" P51797 1 11806096-11843144 "Plasma proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032097 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA032097: AB_10670827" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" "unprognostic (2.46e-1)" "unprognostic (8.83e-2)" "unprognostic (2.08e-1)" "unprognostic (3.84e-3)" "unprognostic (1.51e-3)" "unprognostic (6.49e-2)" "unprognostic (7.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.71e-3)" "unprognostic (3.44e-1)" "unprognostic (2.13e-2)" "unprognostic (6.91e-2)" "unprognostic (1.45e-1)" "unprognostic (1.69e-1)" "unprognostic (3.65e-2)" 11.2 14.6 18.9 11.5 18.7 12.2 8.6 18.0 27.9 9.2 8.7 22.4 8.6 9.6 12.8 14.2 6.3 10.7 8.1 15.7 15.0 20.6 10.0 9.1 10.6 11.1 16.4 17.8 21.4 6.6 8.4 14.8 9.6 32.4 11.3 7.8 13.1 6.7 8.7 11.2 10.0 9.1 10.8 15.9 10.6 8.5 16.1 14.5 4.3 10.7 5.0 9.5 7.7 8.2 10.1 3.2 4.2 4.6 2.0 3.2 1.1 5.6 5.3 12.0 10.1 12.9 13.4 3.7 4.7 9.2 6.6 10.3 8.1 13.8 8.1 3.9 4.4 16.4 8.4 7.9 8.8 5.9 3.6 4.2 8.4 10.5 10.7 16.7 4.7 7.9 9.2 5.2 12.4 7.0 8.0 5.9 8.4 10.6 11.7 6.7 3.1 4.8 12.7 8.0 2.7 4.2 6.1 6.6 7.4 8.7 4.7 5.2 8.3 3.2 5.1 11.0 8.8 4.5 8.4 7.1 6.2 7.0 10.5 3.3 7.0 4.3 20.8 7.6 9.4 4.5 4.2 4.6 1.5 2.6 3.7 1.5 8.0 2.1 3.2 2.7 10.1 2.3 2.1 3.9 2.0 4.6 3.2 1.4 1.1 18.9 18.7 18.0 27.9 15.0 20.6 16.4 17.8 32.4 14.5 17.9 20.5 11.3 3.3 3.1 18.5 21.8 10.2 8.1 6.8 3.5 13.7 3.2 0.0 3.6 12.5 5.6 5.4 0.0 3.9 2.2 5.2 4.1 2.3 5.5 6.5 25.4 6.3 8.0 8.2 7.4 6.9 10.1 1.7 5.4 2.9 7.8 4.2 3.5 6.7 3.0 16.0 0.0 4.2 9.7 9.4 2.8 3.4 2.5 3.0 3.5 CLCN7 "CLC-7, CLC7, OPTA2, PPP1R63" ENSG00000103249 "Chloride voltage-gated channel 7" P51798 16 1444934-1475580 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 69.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043019, HPA043586" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA043019: AB_10964727, HPA043586: AB_10965322" "unprognostic (2.69e-1)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (5.61e-2)" "unprognostic (1.90e-2)" "prognostic favorable (5.23e-4)" "unprognostic (1.59e-2)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-2)" "unprognostic (1.41e-2)" "unprognostic (3.98e-1)" "unprognostic (3.49e-3)" "unprognostic (5.81e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (2.80e-1)" "unprognostic (2.54e-1)" 19.5 34.7 23.2 18.7 23.0 35.0 19.4 22.9 26.8 16.7 15.5 29.3 15.4 18.3 18.8 16.8 12.5 15.8 17.0 15.0 21.9 17.5 19.5 22.7 17.7 19.6 30.3 18.5 14.2 24.1 30.9 19.5 15.5 22.2 14.6 9.4 34.4 17.5 17.5 22.5 21.7 18.9 17.3 18.0 24.8 18.1 17.6 29.5 16.4 21.8 10.9 14.9 17.2 10.2 2.5 2.3 2.0 6.4 0.5 1.6 1.5 5.0 14.1 8.0 12.6 18.2 9.3 12.6 6.9 15.9 15.1 18.8 11.0 18.9 5.8 14.2 9.3 29.2 10.7 7.2 8.9 4.6 9.2 11.3 4.1 13.2 10.9 31.7 10.6 17.0 18.3 12.3 13.6 11.7 9.3 9.6 14.1 16.7 11.3 7.6 10.1 7.4 18.2 8.0 3.4 8.1 34.8 5.4 16.1 7.5 7.3 9.0 9.2 11.1 14.0 44.3 4.7 12.3 28.4 9.5 13.3 6.1 14.6 6.5 17.2 11.2 6.0 11.1 20.2 8.3 0.0 3.0 2.0 1.6 5.4 0.7 2.2 0.9 0.7 2.3 2.5 0.4 0.6 0.6 0.5 6.4 2.3 0.3 1.5 23.2 23.0 22.9 26.8 21.9 17.5 30.3 18.5 22.2 29.5 0.0 6.9 7.8 4.9 6.5 40.9 2.8 5.1 2.7 5.7 19.2 33.4 8.6 1.7 14.1 8.1 5.7 15.8 0.0 15.2 7.9 8.7 7.7 5.8 13.9 31.5 69.9 11.5 20.3 25.7 7.2 10.6 15.2 37.1 15.4 11.7 24.7 17.3 8.0 7.8 12.3 25.3 0.0 6.9 10.2 9.8 5.9 12.9 9.5 10.0 4.3 CLCNKA hClC-Ka ENSG00000186510 "Chloride voltage-gated channel Ka" P51800 1 16018875-16034050 "Disease related genes, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Bartter syndrome, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 46.9;parathyroid gland: 15.4" "Cell type enriched" "Detected in some" 4 "Late spermatids: 171.7" "Group enriched" "Detected in some" 7 "renal cancer: 4.4;thyroid cancer: 1.6" "Region enriched" "Detected in single" 7 "cerebellum: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/70: 13.0" HPA057717 Approved NA NA "HPA057717: AB_2683509" "unprognostic (2.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.37e-2)" "unprognostic (4.02e-1)" "unprognostic (2.76e-3)" "unprognostic (8.20e-2)" "unprognostic (6.16e-2)" "unprognostic (1.18e-2)" "unprognostic (6.92e-3)" "unprognostic (3.49e-2)" "unprognostic (1.76e-2)" "unprognostic (1.41e-1)" "unprognostic (8.13e-3)" "unprognostic (1.36e-1)" "unprognostic (9.13e-2)" "unprognostic (4.37e-3)" "unprognostic (1.28e-1)" 0.2 0.7 0.2 0.2 0.2 0.0 0.2 2.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.0 46.9 0.2 0.2 0.2 0.2 0.2 0.2 1.2 15.4 5.8 0.2 0.2 0.2 0.0 0.2 4.4 0.2 0.2 0.0 0.2 0.2 0.2 0.2 1.6 1.1 0.2 0.2 6.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.4 3.1 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.3 0.2 0.5 0.0 0.0 0.1 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 0.3 0.0 0.0 0.1 0.6 3.5 0.0 0.0 1.2 24.4 0.0 0.4 21.6 0.1 38.8 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.1 12.7 1.2 0.0 0.0 171.7 0.3 0.0 1.7 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.7 0.7 0.0 0.6 0.0 0.0 0.1 CLCNKB hClC-Kb ENSG00000184908 "Chloride voltage-gated channel Kb" P51801 1 16043736-16057308 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Bartter syndrome, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 58.4;salivary gland: 25.7" "Group enriched" "Detected in some" 10 "Collecting duct cells: 22.7;Distal tubular cells: 49.7;Early spermatids: 20.7;Late spermatids: 76.4" "Cancer enriched" "Detected in some" 9 "renal cancer: 24.9" "Region enriched" "Detected in single" 7 "cerebellum: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 1.9;CAPAN-2: 2.2;EFO-21: 5.1;HeLa: 3.1;K-562: 2.0;SuSa: 2.1" HPA057717 Approved NA NA "HPA057717: AB_2683509" "unprognostic (9.05e-4)" "unprognostic (1.72e-1)" "unprognostic (2.41e-2)" "unprognostic (2.68e-3)" "unprognostic (1.44e-2)" "unprognostic (1.58e-1)" "unprognostic (2.10e-4)" "unprognostic (1.87e-1)" "unprognostic (3.61e-2)" "unprognostic (2.31e-1)" "unprognostic (4.57e-2)" "unprognostic (1.02e-1)" "prognostic favorable (1.27e-7)" "unprognostic (2.04e-2)" "unprognostic (4.62e-1)" "unprognostic (1.78e-2)" "unprognostic (5.14e-2)" 0.1 0.5 0.2 0.1 0.2 0.0 0.1 2.8 0.2 0.7 0.1 0.1 2.2 0.0 0.5 0.5 0.1 0.1 0.4 1.2 0.1 0.1 58.4 0.1 0.3 0.1 0.1 0.1 0.5 0.4 0.9 0.8 0.4 0.3 0.5 0.0 1.2 25.7 0.7 0.1 0.0 0.2 0.3 0.5 0.1 0.1 0.7 0.1 0.1 11.5 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.9 0.0 2.2 0.0 5.1 0.7 0.0 0.1 1.7 0.0 0.3 0.0 0.0 0.0 3.1 0.1 0.6 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.2 2.0 0.0 0.1 0.0 0.0 0.0 0.8 0.2 1.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.1 2.1 0.4 0.8 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.8 0.2 0.1 0.1 0.1 0.1 0.3 0.1 3.0 1.1 0.0 0.0 0.0 0.5 4.3 0.0 1.4 2.3 22.7 0.0 0.3 49.7 0.5 20.7 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 76.4 0.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.1 0.2 0.0 0.0 0.1 1.4 0.6 0.0 0.5 0.0 0.6 0.0 CLDN1 "ILVASC, SEMP1" ENSG00000163347 "Claudin 1" O95832 3 190305701-190322475 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 134.3;skin 1: 73.9" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 390.9;Suprabasal keratinocytes: 730.8;Urothelial cells: 538.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "EFO-21: 107.5;HaCaT: 37.6;hTCEpi: 46.9;RPTEC TERT1: 67.3;RT4: 42.1" "Low region specificity" "Detected in many" "CAB002602, HPA048319" Enhanced NA NA "CAB002602: , HPA048319: AB_2680355" "unprognostic (5.89e-2)" "unprognostic (4.58e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (7.92e-3)" "unprognostic (2.43e-1)" "unprognostic (3.54e-1)" "unprognostic (2.04e-1)" "unprognostic (1.48e-1)" "unprognostic (5.25e-2)" "prognostic unfavorable (5.23e-4)" "unprognostic (3.06e-1)" "unprognostic (1.13e-1)" "unprognostic (4.43e-2)" "unprognostic (9.20e-2)" "unprognostic (1.09e-3)" "unprognostic (1.22e-1)" 11.4 14.7 1.0 4.9 0.5 0.0 5.8 0.2 0.7 10.1 7.2 1.2 11.4 0.1 46.5 18.8 13.8 18.8 9.2 3.2 0.7 0.6 7.2 134.3 5.5 0.0 1.0 0.4 13.3 18.0 0.0 1.3 30.5 2.0 13.0 0.3 0.5 10.6 18.2 0.6 73.9 0.4 31.1 1.3 1.2 0.4 7.1 0.1 6.7 8.5 12.2 19.8 9.7 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 4.7 0.0 0.0 0.0 0.0 0.0 0.4 8.4 0.1 0.3 2.7 11.0 0.0 107.5 0.0 9.5 37.6 0.2 12.3 1.0 0.1 0.2 0.0 1.6 6.4 8.2 0.0 0.0 0.0 46.9 0.9 14.2 0.4 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.3 0.8 0.0 0.1 0.0 67.3 42.1 0.0 0.0 4.9 0.9 2.8 0.6 8.6 0.0 2.0 0.1 1.6 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.2 0.7 0.7 0.6 1.0 0.4 2.0 0.1 11.9 29.6 0.0 214.2 390.9 0.0 0.4 173.3 195.4 155.8 29.6 0.0 1.3 0.0 178.6 0.0 0.8 0.0 0.0 49.1 0.2 10.7 75.9 1.1 165.2 1.0 0.0 1.7 1.8 2.7 0.9 14.4 13.7 30.4 10.0 0.2 0.0 113.1 0.0 33.2 1.9 0.0 0.0 9.2 0.2 0.3 730.8 28.3 0.5 0.0 538.7 CLDN10 "CPETRL3, OSP-L" ENSG00000134873 "Claudin 10" P78369 13 95433604-95579759 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 50.5;lymphoid tissue: 49.4;pancreas: 97.3;salivary gland: 70.0" "Group enriched" "Detected in many" 7 "Cholangiocytes: 247.1;Collecting duct cells: 94.2;Distal tubular cells: 114.4;Ductal cells: 224.8;Exocrine glandular cells: 70.7;Melanocytes: 65.8;Muller glia cells: 75.5;Pancreatic endocrine cells: 89.7;Proximal tubular cells: 232.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 7.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.8" "Group enriched" "Detected in some" 4 "RPTEC TERT1: 19.7;SuSa: 64.9" "Low region specificity" "Detected in all" "CAB012969, HPA042348" Enhanced NA NA "CAB012969: AB_2533386, HPA042348: AB_2677955" "unprognostic (6.45e-2)" "unprognostic (5.72e-2)" "unprognostic (3.35e-1)" "unprognostic (4.60e-2)" "unprognostic (4.73e-2)" "unprognostic (2.46e-3)" "unprognostic (6.91e-2)" "unprognostic (2.60e-1)" "unprognostic (1.88e-1)" "unprognostic (1.91e-3)" "unprognostic (2.59e-3)" "unprognostic (7.93e-2)" "prognostic favorable (7.46e-5)" "unprognostic (1.11e-2)" "unprognostic (9.94e-2)" "prognostic favorable (2.13e-4)" "unprognostic (4.75e-3)" 0.8 0.5 28.3 0.5 17.1 1.9 2.6 5.9 17.7 26.0 0.6 4.3 0.0 1.4 8.1 15.4 2.6 16.0 23.1 0.6 18.1 6.2 50.5 1.7 0.8 0.5 10.8 12.0 1.1 97.3 0.8 1.1 0.7 5.7 1.4 0.6 3.4 70.0 0.6 0.5 4.5 0.5 0.7 2.8 0.7 1.0 0.9 6.3 0.0 0.5 2.1 49.4 0.6 0.2 1.2 0.6 7.8 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.4 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.1 0.0 0.0 0.0 0.0 19.7 0.0 0.1 0.1 0.0 0.0 0.0 64.9 0.2 1.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.6 0.0 0.1 28.3 17.1 5.9 17.7 18.1 6.2 10.8 12.0 5.7 6.3 0.0 0.0 0.5 5.8 0.2 0.1 0.4 247.1 9.4 6.8 94.2 0.0 13.8 114.4 224.8 2.4 2.7 0.0 0.0 70.7 5.3 0.5 10.6 0.0 0.0 1.7 0.0 0.0 1.3 0.0 1.7 0.0 0.1 65.8 2.8 0.0 75.5 89.7 0.0 0.4 232.4 3.9 6.5 1.4 6.7 11.3 0.5 19.3 0.0 0.0 3.0 CLDN11 "OSP, OTM" ENSG00000013297 "Claudin 11" O75508 3 170418865-170454733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.9;ovary: 47.7;testis: 86.1" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 37.5;Ito cells: 49.1;Leydig cells: 97.5;Peritubular cells: 63.6" "Cancer enhanced" "Detected in many" "glioma: 11.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 57.6;ASC TERT1: 72.7;EFO-21: 43.2;HSkMC: 26.6;HUVEC TERT2: 62.3;TIME: 98.4" "CAB009789, HPA013166, HPA013657" Enhanced Supported "Lipid droplets,Cell Junctions" NA NA "Cell Junctions" "Lipid droplets" "CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: " "prognostic favorable (6.31e-4)" "unprognostic (3.18e-1)" "unprognostic (2.32e-2)" "unprognostic (5.28e-4)" "unprognostic (3.45e-2)" "unprognostic (4.60e-1)" "unprognostic (5.25e-2)" "unprognostic (5.40e-2)" "unprognostic (2.52e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" "unprognostic (5.48e-2)" "unprognostic (8.70e-11)" "unprognostic (2.50e-3)" "unprognostic (1.93e-1)" "unprognostic (6.68e-3)" "unprognostic (2.29e-1)" 8.2 1.9 14.1 2.0 40.6 1.7 6.3 3.5 50.3 1.9 3.4 85.9 0.5 2.2 2.7 4.6 4.6 4.2 18.9 4.0 28.7 13.0 3.2 2.8 2.8 2.1 59.5 17.1 47.7 2.1 1.8 5.5 4.2 37.3 5.1 2.5 0.6 4.7 4.2 1.7 3.6 2.6 2.8 80.6 2.6 2.5 86.1 47.9 0.0 2.0 0.9 2.0 6.3 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 57.6 72.7 0.0 0.7 3.7 4.7 7.9 0.0 9.7 0.0 43.2 5.8 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 3.3 17.8 0.0 0.0 26.6 0.0 25.9 0.0 0.2 62.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 14.1 40.6 3.5 25.0 28.7 13.0 59.5 17.1 37.3 47.9 0.0 1.1 0.0 12.0 12.8 0.4 1.4 0.0 0.0 0.0 1.8 0.0 1.0 0.0 0.0 6.5 21.9 0.0 0.0 0.0 1.7 37.5 1.3 0.0 0.8 0.8 0.0 0.0 49.1 0.0 16.0 97.5 1.7 13.5 0.0 0.0 0.3 0.5 0.0 63.6 0.0 0.0 0.0 5.9 7.2 2.6 8.9 0.7 0.0 0.0 1.0 CLDN12 ENSG00000157224 "Claudin 12" P56749 7 90383721-90513402 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 274.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026945 Approved NA NA "HPA026945: AB_10603786" "unprognostic (1.45e-2)" "prognostic unfavorable (6.36e-4)" "unprognostic (3.84e-2)" "unprognostic (4.87e-2)" "unprognostic (7.28e-2)" "unprognostic (1.86e-2)" "unprognostic (6.47e-2)" "unprognostic (3.41e-2)" "unprognostic (3.67e-1)" "unprognostic (9.06e-2)" "unprognostic (1.67e-2)" "unprognostic (1.07e-1)" "unprognostic (2.19e-2)" "unprognostic (7.66e-2)" "unprognostic (2.37e-1)" "unprognostic (9.49e-2)" "unprognostic (1.30e-1)" 7.3 18.2 10.4 5.5 22.5 2.3 17.1 20.5 21.5 11.9 17.2 7.3 9.8 14.9 15.0 16.5 11.6 13.0 15.2 17.2 9.5 13.7 19.7 40.4 9.7 1.5 9.2 12.4 18.4 16.7 16.2 42.4 8.2 14.5 20.1 19.5 19.1 19.3 11.2 15.7 6.7 22.6 11.6 12.3 4.3 16.9 10.4 8.0 3.3 14.0 9.4 7.0 12.1 10.1 1.1 3.6 0.0 0.9 0.0 2.4 0.9 10.9 9.8 11.8 8.0 13.3 10.9 6.5 14.0 15.2 9.5 15.9 9.8 28.8 1.8 11.2 8.3 20.9 9.7 10.9 12.7 18.9 2.5 9.8 1.1 8.6 10.2 12.4 2.2 1.2 13.0 13.6 15.9 26.0 17.0 4.7 2.2 6.6 6.6 14.0 5.3 2.9 5.1 19.9 14.0 6.8 1.4 17.1 2.7 13.9 7.3 9.7 17.7 7.7 6.9 22.2 20.4 8.1 7.0 12.4 22.7 13.6 16.6 14.5 3.5 3.3 0.2 15.6 1.6 10.6 0.0 0.7 0.0 1.4 0.9 1.4 1.1 2.4 0.5 3.6 0.6 1.0 1.2 0.0 0.0 0.1 1.1 1.7 0.9 10.4 22.5 20.5 21.5 9.5 13.7 9.2 12.4 14.5 8.0 29.8 6.4 1.5 13.4 8.8 34.0 12.1 28.1 14.7 9.1 17.4 19.6 6.9 6.6 16.9 274.0 3.8 15.1 0.0 35.2 7.5 12.4 40.7 0.0 44.8 6.0 19.1 16.0 9.8 1.0 13.0 9.8 3.4 18.6 4.6 12.7 52.7 27.4 10.7 9.9 23.8 19.9 12.9 11.4 16.8 5.5 9.5 4.2 0.0 14.0 22.9 CLDN14 DFNB29 ENSG00000159261 "Claudin 14" O95500 21 36460621-36576569 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 7.4;liver: 25.0" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 7.6;Distal tubular cells: 16.6;Ductal cells: 10.3;Exocrine glandular cells: 7.3;Hepatocytes: 19.8;Pancreatic endocrine cells: 13.1" "Cancer enriched" "Detected in many" 6 "liver cancer: 7.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 2.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.1" "Cell line enriched" "Detected in some" 14 "HDLM-2: 70.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA054707 Uncertain Vesicles NA NA Vesicles "HPA054707: " "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.43e-2)" "unprognostic (8.20e-3)" "unprognostic (5.54e-2)" "prognostic favorable (1.53e-4)" "unprognostic (3.50e-4)" "unprognostic (2.28e-1)" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (4.87e-1)" "unprognostic (7.44e-4)" "unprognostic (2.77e-2)" "unprognostic (7.65e-2)" "unprognostic (2.45e-2)" "unprognostic (9.71e-2)" 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.1 0.3 0.0 7.4 25.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 1.8 0.1 0.2 0.1 0.0 0.2 0.0 0.3 0.2 0.4 0.0 0.5 1.4 0.1 0.1 0.0 0.0 0.2 0.0 0.6 0.2 0.0 0.2 0.2 2.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 70.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.8 5.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.3 1.4 0.0 0.2 0.1 1.9 3.7 0.0 0.3 0.1 0.0 0.7 0.2 2.1 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.2 1.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 1.0 0.3 0.0 0.8 7.6 0.0 0.0 1.8 0.0 0.1 16.6 10.3 0.4 0.0 0.0 0.0 7.3 0.9 0.0 0.7 0.0 19.8 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 3.3 1.0 0.0 0.0 13.1 0.0 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.3 0.7 0.0 0.0 1.4 CLDN15 ENSG00000106404 "Claudin 15" P56746 7 101232092-101238820 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "intestine: 194.8" "Cell type enhanced" "Detected in many" 6 "Undifferentiated cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.85e-2)" "unprognostic (1.48e-1)" "unprognostic (4.93e-2)" "unprognostic (3.66e-1)" "unprognostic (1.11e-1)" "unprognostic (6.81e-2)" "unprognostic (1.58e-2)" "unprognostic (1.03e-1)" "unprognostic (6.56e-2)" "unprognostic (1.79e-1)" "prognostic favorable (2.56e-4)" "unprognostic (2.02e-2)" "prognostic unfavorable (5.31e-5)" "unprognostic (9.98e-2)" "unprognostic (2.89e-2)" "unprognostic (9.64e-2)" "prognostic favorable (3.30e-4)" 15.4 0.7 1.0 5.2 1.0 3.9 12.5 1.3 1.1 2.5 172.9 1.1 1.2 76.6 2.4 4.4 1.8 3.2 7.2 2.1 1.7 0.8 3.7 7.0 2.2 2.9 1.7 0.8 4.4 1.3 1.1 1.3 2.0 1.7 2.2 2.4 0.8 1.4 1.2 1.1 2.1 194.8 1.6 2.3 5.7 1.7 2.4 1.4 1.0 1.8 1.3 2.3 2.7 3.0 1.0 1.8 1.7 1.2 0.8 1.9 1.4 2.2 6.9 3.7 5.8 5.8 4.7 2.5 2.2 2.8 2.7 4.0 4.6 2.6 7.4 3.9 1.4 4.5 4.2 6.1 1.3 2.7 9.2 12.9 3.4 3.9 5.9 5.1 3.8 7.5 4.5 6.1 3.6 4.7 5.9 2.2 7.5 16.0 12.1 2.1 7.7 6.0 21.9 2.9 3.3 4.8 8.2 3.2 6.1 1.6 2.8 3.6 12.7 2.0 3.8 10.6 5.3 3.5 7.7 3.2 9.0 7.8 13.6 2.6 12.8 16.0 7.9 2.5 10.0 5.2 0.2 1.2 0.1 1.9 0.7 0.6 0.4 1.9 0.2 0.8 1.0 1.3 1.4 1.7 0.8 0.9 1.8 0.8 1.4 1.0 1.0 1.3 1.0 1.7 0.8 1.7 0.8 1.7 1.4 3.0 1.4 5.2 5.3 6.1 17.9 0.8 12.7 5.3 7.9 21.0 29.5 4.1 11.6 4.4 13.8 6.7 24.5 0.0 5.8 3.2 6.0 5.3 0.0 8.1 2.4 14.3 11.6 4.9 1.9 3.0 14.1 2.9 6.8 3.6 27.6 4.1 4.8 25.4 2.1 2.2 21.1 6.5 2.5 6.0 6.3 4.5 4.2 8.2 51.4 2.7 CLDN16 "HOMG3, PCLN1" ENSG00000113946 "Claudin 16" Q9Y5I7 3 190322541-190412143 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease mutation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "kidney: 55.9" "Cell type enriched" "Detected in many" 7 "Distal tubular cells: 159.2" "Group enriched" "Detected in many" 15 "ovarian cancer: 39.8;thyroid cancer: 29.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 131 "EFO-21: 101.3;RPTEC TERT1: 35.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA056020 Enhanced NA NA "HPA056020: AB_2683011" "unprognostic (5.01e-2)" "unprognostic (7.83e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.99e-5)" "unprognostic (6.06e-4)" "unprognostic (1.30e-1)" "unprognostic (2.07e-1)" "unprognostic (2.39e-2)" "unprognostic (3.31e-1)" "unprognostic (4.20e-1)" "unprognostic (2.76e-3)" "unprognostic (3.70e-1)" "unprognostic (1.96e-1)" "unprognostic (5.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.2 0.8 0.4 0.2 0.3 0.0 0.2 0.2 0.5 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.6 0.2 0.2 0.3 0.4 55.9 1.2 0.2 0.7 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.6 0.5 0.2 1.8 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.4 3.4 0.2 0.4 0.3 0.2 0.5 0.4 1.4 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 1.4 0.1 0.2 0.2 0.2 0.1 0.4 0.2 0.1 0.0 0.5 0.3 0.2 1.2 0.3 0.2 0.4 0.1 0.0 0.4 0.3 0.2 0.5 0.3 0.4 0.3 0.2 0.2 0.2 0.0 0.0 0.0 4.8 6.3 0.2 0.3 5.1 22.7 1.2 8.7 0.0 0.2 159.2 2.2 0.6 0.0 0.0 0.0 0.3 0.1 0.3 1.2 1.1 1.5 0.1 3.2 0.0 0.0 0.3 0.0 0.0 1.0 5.0 0.0 0.0 0.0 0.4 0.0 0.4 0.6 0.1 0.0 0.0 0.1 0.1 11.0 5.1 0.0 0.0 3.1 CLDN17 "MGC126552, MGC126554" ENSG00000156282 "Claudin 17" P56750 21 30165564-30166756 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 12.8;salivary gland: 6.7;tongue: 24.4;vagina: 9.0" "Cell type enriched" "Detected in single" 6 "Early spermatids: 3.5" "Cancer enhanced" "Detected in single" "head and neck cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "HaCaT: 2.2;hTCEpi: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA045903 Enhanced NA NA "HPA045903: AB_2679491" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 24.4 2.8 0.0 9.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN18 SFTPJ ENSG00000066405 "Claudin 18" P56856 3 137998735-138033655 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "gallbladder: 37.4;lung: 91.9;stomach 1: 126.9" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 1488.8" "Group enriched" "Detected in some" 11 "pancreatic cancer: 113.7;stomach cancer: 186.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "OE19: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013010, CAB013243, HPA018446" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866" "unprognostic (1.03e-1)" "unprognostic (1.49e-1)" "unprognostic (2.93e-1)" "unprognostic (1.04e-2)" "unprognostic (1.41e-1)" "unprognostic (8.51e-2)" "unprognostic (5.14e-4)" "unprognostic (2.00e-1)" "unprognostic (1.29e-1)" "unprognostic (2.60e-1)" "unprognostic (9.54e-2)" "unprognostic (1.38e-2)" "unprognostic (4.42e-5)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (8.26e-2)" "unprognostic (2.95e-1)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.1 0.1 0.1 0.3 0.1 37.4 2.0 0.1 0.0 0.1 0.1 91.9 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 126.9 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.4 0.1 0.0 0.1 0.1 0.2 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.9 0.3 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.6 18.9 0.1 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.3 0.5 0.3 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.1 1488.8 318.5 0.0 0.0 0.0 0.8 18.9 0.0 1.4 20.5 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 9.9 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 257.5 0.0 0.0 0.0 1.4 0.0 0.0 6.6 3.8 0.0 0.0 0.0 0.0 0.0 CLDN19 ENSG00000164007 "Claudin 19" Q8N6F1 1 42733093-42740254 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "Disease mutation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0" "Cell type enriched" "Detected in some" 7 "Extravillous trophoblasts: 192.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Group enriched" "Detected in some" 54 "midbrain: 13.8;pons and medulla: 9.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CACO-2: 5.1;Hep G2: 10.6;SuSa: 6.4" "Region enhanced" "Detected in some" "olfactory region: 6.7" "Low region specificity" "Detected in all" NA NA "unprognostic (6.23e-4)" "unprognostic (1.80e-1)" "unprognostic (1.85e-6)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (3.21e-2)" "unprognostic (3.22e-1)" "unprognostic (9.45e-2)" "unprognostic (1.95e-1)" "unprognostic (2.68e-1)" "unprognostic (7.22e-2)" "unprognostic (8.76e-3)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (3.29e-3)" 1.0 0.2 0.1 0.1 0.2 0.2 1.6 0.2 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.9 0.6 0.3 0.1 0.4 0.2 0.1 22.5 0.2 0.2 0.1 13.8 0.0 0.2 0.2 0.1 0.2 20.9 9.5 0.4 0.1 37.0 1.2 2.7 0.4 0.8 0.3 1.0 6.2 0.1 0.5 0.2 0.0 1.3 0.1 2.6 0.1 0.8 1.0 0.5 0.4 1.4 0.3 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.3 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.5 0.5 0.5 1.4 0.2 0.2 0.4 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 13.8 0.0 9.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 1.2 12.2 0.0 9.1 28.2 0.0 0.0 0.0 0.0 0.0 0.0 192.3 0.2 0.1 0.0 0.0 4.4 0.0 0.0 0.6 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.1 0.0 10.4 0.0 0.0 0.0 CLDN2 ENSG00000165376 "Claudin 2" P57739 X 106900164-106930861 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7" "Cell type enhanced" "Detected in some" 21 "Ductal cells: 67.3;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 28.7;Proximal tubular cells: 138.0" "Group enriched" "Detected in many" 5 "colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5" "Region enriched" "Detected in some" 6 "pons and medulla: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "OE19: 81.0" "Group enriched" "Detected in many" 5 "basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5" "Not detected" "Not detected" "CAB002609, HPA051548" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB002609: , HPA051548: AB_2681530" "unprognostic (2.31e-1)" "unprognostic (2.62e-1)" "unprognostic (3.99e-1)" "unprognostic (1.73e-1)" "unprognostic (1.30e-2)" "unprognostic (1.42e-2)" "unprognostic (6.07e-2)" "unprognostic (7.47e-3)" "unprognostic (2.24e-1)" "unprognostic (8.67e-2)" "unprognostic (8.83e-2)" "unprognostic (8.15e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "prognostic favorable (1.70e-4)" "unprognostic (9.76e-2)" 0.4 1.2 0.4 0.4 0.6 0.0 0.4 0.4 3.4 0.4 0.4 19.4 0.4 5.3 0.4 9.6 0.4 0.1 28.4 0.4 5.0 0.1 46.1 25.2 0.4 0.4 0.4 0.4 0.4 7.8 0.0 0.4 0.4 31.7 0.6 1.0 11.0 0.4 27.7 0.4 0.2 11.3 0.4 0.4 0.4 2.1 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.6 0.4 3.4 5.0 0.1 0.4 0.4 31.7 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.2 15.3 0.0 0.0 1.8 0.0 0.0 13.3 67.3 0.0 0.0 1.0 0.0 42.5 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 2.8 0.1 0.9 28.7 2.9 0.0 138.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 CLDN20 ENSG00000171217 "Claudin 20" P56880 6 155264013-155276548 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 24 "Bipolar cells: 1.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 3.5;WM-115: 3.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (3.75e-2)" "unprognostic (1.74e-1)" "unprognostic (1.01e-1)" "unprognostic (1.85e-1)" "unprognostic (2.84e-1)" "unprognostic (4.04e-2)" "unprognostic (2.38e-1)" "unprognostic (2.34e-2)" "unprognostic (1.67e-1)" "unprognostic (5.22e-2)" "unprognostic (6.26e-2)" "unprognostic (6.40e-2)" "unprognostic (7.33e-3)" "unprognostic (1.51e-1)" "unprognostic (1.30e-2)" "unprognostic (3.29e-2)" "unprognostic (2.05e-1)" 0.2 1.0 0.1 0.5 0.2 3.1 0.4 0.8 1.3 0.1 0.3 0.5 1.6 0.0 0.7 0.1 1.2 0.4 0.8 0.2 1.2 0.5 0.4 1.3 0.8 0.6 0.7 0.0 0.4 0.1 0.3 0.0 1.2 0.0 0.7 3.6 1.0 2.4 2.1 1.2 0.6 1.3 1.6 0.0 0.4 0.9 0.9 0.1 0.8 0.3 0.0 0.6 0.0 0.4 1.5 0.6 1.2 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.9 0.6 2.9 0.4 0.0 0.3 1.6 0.0 0.0 0.0 0.3 1.0 1.0 2.1 3.5 0.3 1.7 0.6 1.4 0.0 0.0 0.0 0.2 0.0 0.4 1.3 1.5 0.0 2.5 0.1 1.6 0.1 0.3 0.2 0.9 0.4 0.2 0.0 3.3 0.3 1.1 0.5 0.3 0.5 0.2 0.9 0.2 1.8 1.3 0.7 0.9 1.9 0.7 0.4 2.1 0.8 1.1 3.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.9 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN22 CLDN21 ENSG00000177300 "Claudin 22" Q8N7P3 4 183318194-183320774 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "fallopian tube: 4.2;salivary gland: 7.2" "Group enriched" "Detected in some" 18 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0;Club cells: 3.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HAP1: 1.0;MCF7: 1.0;RT4: 1.3;SCLC-21H: 1.5;THP-1: 1.1" NA NA 0.0 0.4 0.2 0.0 0.4 0.2 0.0 0.3 0.5 0.1 0.1 0.0 1.0 0.0 0.9 4.2 0.0 0.0 0.5 0.2 1.1 1.3 0.1 0.0 0.1 0.0 0.2 0.1 0.4 0.0 0.4 0.0 7.2 0.1 0.5 0.4 0.0 0.1 0.2 0.2 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.3 0.3 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN23 CLDNL ENSG00000253958 "Claudin 23" Q96B33 8 8701938-8704106 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Enterocytes: 128.5;Paneth cells: 76.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "myeloid DC: 3.4;plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.8;Daudi: 7.8;RT4: 8.3;SK-BR-3: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA070578 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA070578: " "unprognostic (1.86e-1)" "unprognostic (1.53e-1)" "prognostic favorable (3.46e-4)" "unprognostic (2.97e-1)" "unprognostic (8.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.44e-1)" "unprognostic (2.05e-2)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.97e-2)" "unprognostic (8.25e-3)" "prognostic favorable (9.65e-8)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.33e-3)" 9.1 1.0 0.3 7.1 1.4 0.3 6.1 0.4 0.6 2.6 14.8 0.5 3.8 5.5 1.0 6.3 2.8 1.4 10.6 1.4 0.9 0.2 6.5 13.3 8.7 3.1 1.1 0.3 2.6 3.2 1.5 0.7 15.7 1.7 3.3 8.8 2.8 6.0 2.5 0.9 10.0 20.0 0.5 0.3 2.4 18.0 1.5 0.5 0.4 8.8 4.3 3.0 6.0 5.3 0.5 3.9 0.8 2.4 0.0 0.0 0.6 0.2 3.2 0.0 0.2 1.0 0.1 9.8 2.4 1.9 2.6 4.0 1.9 5.2 7.8 0.0 0.1 1.0 3.1 0.0 0.1 0.2 1.5 0.0 0.0 1.0 0.1 4.6 0.0 0.1 1.3 1.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.3 4.0 0.1 0.2 2.5 0.4 1.6 0.0 0.0 0.0 1.2 8.3 0.4 1.2 3.2 8.5 0.1 1.0 1.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.8 0.0 2.4 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.6 0.3 1.4 0.4 0.6 0.9 0.2 1.1 0.3 1.7 0.5 8.9 1.9 1.3 6.7 0.1 0.0 0.5 20.4 6.7 1.2 1.8 0.0 15.9 6.6 19.6 0.0 1.0 128.5 0.0 9.5 15.2 3.5 2.8 4.6 6.8 15.3 0.0 7.5 8.0 1.9 0.0 0.3 2.9 3.3 1.0 23.5 0.2 20.1 76.4 0.4 3.8 1.1 6.5 2.1 0.0 0.0 0.5 7.9 0.0 18.9 10.5 CLDN24 CLDN21 ENSG00000185758 "Claudin 24" A6NM45 4 183321764-183322426 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 4.6;salivary gland: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.9;fHDF/TERT166: 3.6;HSkMC: 1.5;SCLC-21H: 1.5;SK-BR-3: 3.1" NA NA "unprognostic (1.49e-1)" "unprognostic (9.27e-2)" "unprognostic (1.89e-1)" "unprognostic (4.93e-3)" 0.1 0.3 0.0 0.5 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 1.0 0.1 0.0 0.2 0.0 0.0 4.6 0.4 0.6 0.0 0.0 0.2 0.3 0.5 0.1 0.0 0.1 0.0 2.1 0.0 0.2 0.4 0.1 0.0 0.0 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.3 1.9 0.7 0.0 0.3 0.0 0.4 3.6 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.8 0.0 0.0 0.0 1.5 0.0 0.0 3.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN25 ENSG00000228607 "Claudin 25" C9JDP6 11 113779747-113780500 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pituitary gland: 2.5;skin 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 34 "T-47d: 3.3" "Not detected" "Not detected" HPA053555 Uncertain NA NA "HPA053555: AB_2682186" "unprognostic (1.02e-2)" "unprognostic (3.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN3 "C7orf1, CPE-R2, CPETR2, HRVP1, RVP1" ENSG00000165215 "Claudin 3" O15551 7 73768997-73770270 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 100.4;thyroid gland: 91.6" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 2133.6;Mucus-secreting cells: 1109.4;Paneth cells: 1932.3;Undifferentiated cells: 955.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 7 "cerebellum: 3.1;pons and medulla: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.6;MCF7: 66.5;PC-3: 14.2;RPMI-8226: 11.4;SCLC-21H: 17.6;T-47d: 31.6" "Not detected" "Not detected" HPA014361 Enhanced Supported "Cell Junctions" NA NA 15000 "Cell Junctions" "HPA014361: AB_2668982" "unprognostic (1.84e-1)" "unprognostic (4.83e-2)" "unprognostic (2.05e-1)" "unprognostic (5.27e-2)" "unprognostic (2.61e-1)" "unprognostic (1.31e-1)" "unprognostic (2.79e-2)" "unprognostic (8.26e-2)" "unprognostic (3.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.28e-3)" "unprognostic (1.42e-1)" "prognostic favorable (3.39e-5)" "unprognostic (1.46e-2)" "unprognostic (1.87e-1)" "unprognostic (5.18e-2)" "unprognostic (6.72e-2)" 0.3 0.1 0.1 11.5 0.1 0.2 7.1 3.1 0.2 3.8 77.9 1.6 21.8 24.3 2.8 8.8 0.3 9.4 11.3 0.1 0.2 0.4 20.7 16.0 6.0 0.2 0.0 0.0 4.3 38.0 0.2 7.4 3.1 3.0 14.6 8.0 1.9 31.1 32.1 0.1 2.1 100.4 0.5 0.0 0.1 0.7 1.2 0.0 2.2 91.6 0.9 3.6 0.8 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.5 0.7 1.0 0.0 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.2 10.6 0.0 3.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.1 0.3 0.6 2.6 14.2 0.0 0.0 11.4 0.6 0.0 17.6 0.2 0.0 10.1 0.0 0.0 31.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 3.1 0.2 0.2 0.4 0.0 0.0 3.0 0.0 35.7 34.4 4.2 34.2 0.1 0.7 0.5 206.4 104.4 48.9 120.4 3.9 47.1 8.3 212.5 0.0 0.0 2133.6 23.3 15.9 8.6 0.5 498.9 28.7 32.7 4.3 0.0 581.8 0.0 0.0 0.0 2.3 0.9 10.1 3.6 1109.4 10.8 59.3 1932.3 0.0 42.3 8.5 0.0 0.4 0.0 0.0 0.0 60.5 2.9 955.0 455.4 CLDN34 ENSG00000234469 "Claudin 34" H7C241 X 9967358-9968352 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 8 "testis: 5.4" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 5.9;Early spermatids: 9.7;Late spermatids: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.2;RT4: 4.2;SuSa: 2.2;U-138 MG: 1.7" NA NA "unprognostic (1.54e-2)" "unprognostic (6.73e-5)" "unprognostic (1.25e-1)" "unprognostic (2.80e-1)" "unprognostic (5.43e-2)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" "unprognostic (6.82e-2)" "unprognostic (2.27e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-3)" "unprognostic (5.39e-1)" "unprognostic (8.13e-2)" "unprognostic (3.23e-1)" "unprognostic (2.89e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.5 0.4 0.1 0.0 0.0 0.1 0.0 0.4 0.4 0.3 0.0 0.0 0.6 0.5 0.0 0.1 0.2 0.5 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.5 4.2 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.8 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.1 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 5.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 CLDN4 "CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8" ENSG00000189143 "Claudin 4" O14493 7 73799542-73832693 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 141.0" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 2545.0;Glandular cells: 2415.4;Urothelial cells: 7943.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 43.3;BEWO: 51.0;CAPAN-2: 95.4;MCF7: 48.6;OE19: 49.3;PC-3: 62.1;RT4: 42.0;SK-BR-3: 80.9" "Not detected" "Not detected" "Not detected" "Not detected" CAB002610 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB002610: " "unprognostic (1.14e-1)" "unprognostic (2.79e-2)" "unprognostic (2.25e-1)" "unprognostic (1.23e-2)" "unprognostic (1.56e-2)" "unprognostic (1.84e-1)" "unprognostic (1.60e-2)" "unprognostic (7.09e-2)" "unprognostic (3.07e-1)" "prognostic unfavorable (3.28e-4)" "unprognostic (2.16e-3)" "unprognostic (5.11e-1)" "prognostic favorable (3.46e-10)" "unprognostic (5.77e-2)" "unprognostic (1.37e-1)" "unprognostic (9.38e-2)" "unprognostic (4.63e-2)" 0.7 0.2 0.4 17.1 0.4 0.0 17.1 0.4 0.5 17.5 53.7 0.7 23.2 25.0 5.1 15.9 62.3 15.4 15.4 0.5 0.4 0.3 30.2 2.0 28.8 0.4 0.4 0.4 5.5 32.4 2.7 3.5 78.1 1.3 31.8 24.7 0.7 52.0 25.7 0.6 35.3 93.3 2.7 0.4 0.4 2.7 2.5 0.4 3.8 141.0 60.9 55.7 38.5 21.0 0.1 0.1 0.2 0.1 0.1 0.6 0.0 43.3 0.5 0.0 0.2 0.0 0.0 51.0 0.4 0.0 0.0 0.0 22.7 95.4 0.0 3.5 0.0 0.3 24.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 15.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.6 0.0 0.2 0.0 49.3 62.1 0.0 0.8 1.0 11.6 42.0 10.1 0.2 0.0 80.9 0.1 2.9 31.6 0.1 0.0 0.1 1.8 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.6 0.2 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.4 0.5 0.4 0.3 0.4 0.4 1.3 0.4 256.1 182.2 2.2 2545.0 14.3 0.2 0.6 242.0 323.9 224.1 207.6 0.0 586.9 11.6 821.2 0.0 2.9 1686.2 0.0 388.8 629.5 21.8 2415.4 27.6 0.8 67.0 0.0 648.6 0.0 0.3 0.0 2.3 10.6 13.5 27.1 955.9 0.9 781.5 1557.1 0.0 10.2 0.0 0.0 2.1 0.0 0.2 47.2 799.6 1.7 627.6 7943.2 CLDN5 "AWAL, BEC1, CPETRL1, TMVCF" ENSG00000184113 "Claudin 5" O00501 22 19523024-19527545 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 101.1" "Group enriched" "Detected in many" 22 "Endothelial cells: 667.5;Ito cells: 611.4" "Cancer enhanced" "Detected in all" "glioma: 32.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "basophil: 7.4;naive CD4 T-cell: 3.4;neutrophil: 4.1" "Group enriched" "Detected in many" 20 "granulocytes: 7.4;T-cells: 3.4" "Group enriched" "Detected in some" 10 "HUVEC TERT2: 41.0;SCLC-21H: 25.8" "Low region specificity" "Detected in all" CAB002607 Approved NA NA 730000 "CAB002607: " "unprognostic (1.26e-1)" "unprognostic (2.05e-3)" "unprognostic (1.77e-2)" "unprognostic (2.07e-1)" "unprognostic (3.05e-3)" "unprognostic (6.00e-2)" "unprognostic (4.98e-2)" "unprognostic (3.24e-3)" "unprognostic (1.33e-1)" "unprognostic (8.95e-2)" "unprognostic (2.29e-3)" "unprognostic (1.15e-1)" "unprognostic (7.31e-2)" "unprognostic (2.01e-2)" "unprognostic (2.47e-2)" "unprognostic (2.22e-1)" "unprognostic (2.96e-2)" 101.1 4.9 13.9 6.8 17.9 1.9 45.5 7.1 20.0 10.6 19.4 10.2 3.0 9.9 10.2 5.1 7.8 9.5 11.7 14.1 16.9 15.0 7.6 6.0 43.6 9.2 19.8 4.5 8.6 5.5 2.4 1.5 13.1 20.0 8.2 5.0 5.4 4.1 5.1 26.2 10.2 10.3 7.6 18.9 13.5 8.8 6.5 11.9 0.3 20.1 7.3 3.7 7.6 34.7 0.1 0.2 7.4 0.2 0.0 3.4 20.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 41.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.4 0.3 0.0 0.0 0.0 25.8 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 3.4 0.1 4.1 0.0 0.0 0.1 0.0 20.9 13.9 17.9 7.1 15.8 16.9 15.0 19.8 4.5 20.0 11.9 3.0 10.6 2.2 1.1 28.7 0.6 15.4 2.5 0.0 1.2 7.0 0.0 0.2 0.0 0.0 3.6 667.5 0.0 0.0 0.7 0.2 7.1 3.4 1.1 1.0 0.7 0.0 2.4 611.4 25.1 2.3 4.9 2.8 13.5 0.0 0.0 2.5 0.0 0.0 0.7 0.0 4.4 0.0 16.5 0.7 0.9 26.7 0.0 5.7 0.0 6.3 CLDN6 ENSG00000184697 "Claudin 6" P56747 16 3014712-3020071 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 9.5;testis: 4.8" "Cell type enhanced" "Detected in some" 28 "Cytotrophoblasts: 21.7;Ductal cells: 18.1;Extravillous trophoblasts: 119.4;Syncytiotrophoblasts: 36.8" "Group enriched" "Detected in many" 8 "endometrial cancer: 25.8;ovarian cancer: 73.6;testis cancer: 112.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Group enriched" "Detected in some" 6 "BEWO: 85.2;CACO-2: 23.1;NTERA-2: 78.4;SuSa: 61.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.59e-1)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.42e-6)" "unprognostic (1.16e-1)" "unprognostic (1.58e-1)" "unprognostic (6.08e-2)" "unprognostic (1.92e-1)" "unprognostic (5.50e-4)" "unprognostic (1.02e-2)" "unprognostic (5.88e-1)" "unprognostic (1.98e-2)" "unprognostic (7.66e-4)" "unprognostic (1.79e-3)" "unprognostic (1.02e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.78e-4)" 0.1 0.9 0.5 0.1 3.7 0.5 0.1 2.5 1.0 0.1 0.6 0.1 0.1 0.5 0.4 0.1 0.1 0.4 0.7 0.2 0.7 0.8 0.2 0.1 0.9 0.1 0.7 0.1 0.1 3.3 0.0 1.2 9.5 1.5 0.1 0.4 0.1 0.1 0.1 0.6 0.0 0.4 0.1 0.3 0.2 0.4 4.8 0.1 1.3 0.2 0.1 0.1 0.3 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 85.2 0.0 0.0 0.0 0.0 23.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 78.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 61.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 3.7 2.5 1.0 0.7 0.8 0.7 0.1 1.5 0.1 3.0 0.0 0.0 1.2 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 21.7 0.0 18.1 0.1 0.0 0.0 0.0 0.0 119.4 0.2 0.5 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.4 0.4 36.8 0.0 0.0 0.1 CLDN7 "CEPTRL2, CPETRL2, Hs.84359" ENSG00000181885 "Claudin 7" O95471 17 7259903-7263983 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 166.7" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 1175.0;Paneth cells: 985.5;Urothelial cells: 711.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 26.8;CACO-2: 27.9;CAPAN-2: 54.3;HaCaT: 114.0;MCF7: 39.7;OE19: 42.8;SK-BR-3: 47.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013063, HPA014703, HPA073662" Enhanced Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "CAB013063: , HPA014703: AB_1846873, HPA073662: " "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (4.12e-2)" "unprognostic (2.90e-1)" "unprognostic (1.05e-1)" "unprognostic (8.67e-2)" "unprognostic (3.41e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-3)" "unprognostic (8.34e-2)" "unprognostic (4.89e-3)" "unprognostic (1.62e-2)" "prognostic favorable (8.96e-11)" "prognostic favorable (4.09e-4)" "unprognostic (1.87e-1)" "prognostic favorable (1.85e-4)" "unprognostic (1.62e-1)" 1.6 2.0 0.4 28.0 0.4 0.0 9.5 0.4 0.4 9.9 71.4 0.4 47.6 47.2 2.4 49.3 73.4 13.4 47.2 0.7 0.4 0.3 30.0 12.1 32.3 0.8 0.4 0.4 3.4 70.9 12.3 7.3 25.0 0.4 9.8 42.5 0.7 40.9 42.2 0.9 2.9 166.7 1.8 0.5 1.4 1.2 1.8 0.4 1.5 40.5 28.3 45.6 12.2 19.3 3.8 1.6 0.0 3.0 2.2 6.7 2.3 3.2 0.3 0.0 0.0 0.0 0.2 26.8 0.0 0.1 0.0 0.0 27.9 54.3 0.0 1.0 0.1 0.1 114.0 0.0 3.5 0.0 0.0 0.6 0.0 0.7 0.0 2.1 0.0 0.2 0.5 5.4 0.0 0.2 0.0 2.5 0.0 0.3 0.1 0.0 39.7 0.0 0.3 0.2 42.8 1.0 0.0 0.0 0.7 0.0 0.0 6.5 0.1 0.3 47.5 0.0 2.2 17.3 0.4 5.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 2.2 3.0 4.8 0.5 1.5 3.3 1.6 3.8 3.7 6.7 0.0 2.2 0.1 0.2 0.9 2.3 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.4 104.2 43.9 5.4 188.2 1.8 0.8 0.5 226.7 123.1 91.0 305.4 7.9 231.4 33.2 701.7 0.0 3.8 1175.0 0.0 684.7 284.5 5.1 310.2 5.7 34.7 29.8 0.0 313.6 3.7 3.1 0.0 1.1 9.1 23.6 18.0 591.9 0.4 632.6 985.5 0.0 47.8 6.8 0.0 2.1 0.2 3.0 2.3 492.5 5.9 501.5 711.9 CLDN8 ENSG00000156284 "Claudin 8" P56748 21 30214006-30216073 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 26.2;kidney: 48.4" "Cell type enriched" "Detected in some" 8 "Collecting duct cells: 212.9" "Cancer enhanced" "Detected in many" "prostate cancer: 31.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "HaCaT: 27.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA060605 Supported NA NA "HPA060605: AB_2684331" "unprognostic (3.74e-2)" "unprognostic (3.12e-2)" "unprognostic (1.33e-1)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.17e-1)" "unprognostic (1.87e-1)" "unprognostic (1.62e-1)" "unprognostic (2.52e-1)" "prognostic favorable (3.32e-4)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" 0.6 0.6 0.6 0.1 0.6 0.0 26.2 0.7 0.6 2.5 10.0 0.0 6.9 0.0 0.7 14.0 4.2 0.8 0.0 0.7 0.6 0.6 48.4 0.9 1.7 0.0 0.6 0.0 0.6 1.5 0.0 1.3 5.9 0.0 4.6 19.5 0.0 14.2 8.7 0.6 2.2 0.8 0.0 0.6 0.6 0.7 1.0 0.0 0.0 12.2 1.2 1.8 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.9 0.0 0.0 0.0 26.8 4.5 212.9 0.0 0.0 10.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.1 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 13.5 0.0 0.0 17.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 6.6 18.2 CLDN9 ENSG00000213937 "Claudin 9" O95484 16 3012456-3014505 "Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2" "Cell type enhanced" "Detected in some" 12 "Cholangiocytes: 10.2;Ductal cells: 8.3;Pancreatic endocrine cells: 5.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 5.7;MCF7: 19.5;SCLC-21H: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076613 Supported "Vesicles,Cell Junctions" NA NA "Cell Junctions" Vesicles "HPA076613: AB_2686808" "unprognostic (7.93e-2)" "unprognostic (1.40e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (2.24e-6)" "unprognostic (4.91e-2)" "unprognostic (6.04e-2)" "unprognostic (1.13e-1)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (5.06e-2)" "unprognostic (8.97e-3)" "unprognostic (4.51e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.55e-2)" 0.3 0.4 0.4 0.5 2.1 5.2 0.3 16.5 1.4 0.6 1.0 0.3 0.3 1.8 0.3 0.9 0.3 2.3 1.1 0.4 0.8 0.8 0.6 2.6 1.5 0.3 1.4 0.3 0.3 9.6 4.8 15.9 10.2 0.5 0.3 0.1 0.3 1.7 0.3 1.5 0.4 1.2 0.3 2.2 1.0 0.3 0.3 0.3 1.2 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.3 0.1 0.0 2.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 5.7 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 19.5 0.0 1.6 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.1 15.3 0.1 0.8 0.8 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 2.1 16.5 1.4 0.8 0.8 1.4 0.3 0.5 0.3 0.0 0.0 0.0 1.8 0.1 1.4 0.3 10.2 2.7 0.0 0.0 0.0 0.2 0.0 8.3 0.0 0.0 0.0 0.0 1.6 0.7 0.0 0.7 0.0 0.0 0.1 0.0 1.7 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 5.9 1.1 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.4 0.9 0.0 0.2 1.7 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 75.9;brain: 227.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 14.7 12.4 61.6 10.7 76.1 11.7 14.1 11.9 77.1 14.1 10.4 100.5 3.3 10.0 16.9 12.6 22.6 10.9 14.3 15.9 85.4 52.3 11.0 14.0 12.2 13.6 133.4 28.9 19.1 5.8 7.0 6.7 20.5 72.7 14.6 13.6 4.9 6.8 15.7 9.7 17.6 9.4 18.5 227.4 11.5 7.5 28.5 95.4 4.3 11.5 4.7 14.8 14.7 11.1 19.9 19.7 28.1 18.6 49.5 75.9 28.6 17.9 7.3 22.9 14.0 27.7 21.6 12.5 14.2 19.6 20.0 27.7 14.8 18.3 9.0 19.2 13.6 38.0 24.3 17.6 10.8 35.1 21.2 7.5 18.7 5.2 13.2 22.2 16.8 18.7 25.2 58.3 15.6 16.8 21.5 21.7 17.9 9.3 27.7 28.1 9.4 12.3 11.1 19.9 7.8 15.6 8.3 30.8 11.4 18.7 8.1 8.3 22.8 19.6 6.6 28.1 32.1 6.6 14.3 20.1 26.1 24.1 17.7 18.4 36.7 15.7 14.5 43.6 16.2 33.3 28.1 18.6 19.8 21.7 10.7 40.8 19.9 40.9 39.8 19.7 16.4 16.6 16.9 13.8 49.5 10.5 12.7 75.9 28.6 61.6 76.1 11.9 38.8 85.4 52.3 133.4 28.9 72.7 95.4 32.8 39.6 30.5 103.2 128.0 19.7 48.0 12.7 16.0 23.9 26.2 23.6 44.0 24.9 18.4 58.8 63.1 19.7 46.7 14.2 132.7 70.7 85.5 35.8 18.7 31.6 14.3 27.5 54.0 25.9 62.2 47.8 38.0 108.0 43.3 18.8 28.6 24.0 11.5 43.9 18.2 31.4 51.8 126.4 168.0 50.6 171.8 80.1 103.6 17.1 110.7 CLDND2 MGC33839 ENSG00000160318 "Claudin domain containing 2" Q8NHS1 19 51367098-51369003 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 31.4" "Cell type enriched" "Detected in many" 15 "Early spermatids: 230.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 11.7" HPA056971 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA056971: AB_2683294" "unprognostic (2.86e-1)" "unprognostic (4.29e-5)" "unprognostic (2.29e-2)" "unprognostic (3.40e-2)" "unprognostic (1.19e-1)" "unprognostic (9.42e-2)" "unprognostic (5.74e-3)" "unprognostic (1.79e-1)" "unprognostic (2.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.25e-3)" "unprognostic (1.13e-2)" "unprognostic (1.94e-9)" "unprognostic (4.00e-2)" "unprognostic (3.95e-1)" "unprognostic (1.85e-1)" "unprognostic (8.70e-2)" 7.7 7.8 6.8 3.2 11.1 13.3 3.3 10.9 16.5 2.6 3.6 1.4 8.4 7.7 3.0 2.5 2.9 2.8 4.5 2.5 9.9 4.7 2.8 3.5 4.0 3.2 19.6 5.2 6.7 9.1 1.5 2.9 1.8 7.4 3.8 2.4 1.7 7.5 6.0 11.9 1.5 7.1 3.8 10.2 7.3 3.3 31.4 10.6 0.0 2.9 2.2 1.2 3.2 3.0 1.7 3.0 5.8 2.0 5.3 4.5 0.7 2.1 6.0 2.2 3.0 3.3 2.9 1.2 1.0 0.5 1.0 1.3 0.7 7.1 5.6 1.2 0.6 0.7 2.7 0.7 0.3 0.2 3.9 9.7 4.9 9.4 11.7 1.3 1.4 1.4 2.2 1.0 0.2 0.6 1.5 0.7 2.8 3.1 4.1 0.9 1.3 1.2 8.1 0.9 6.1 7.6 1.1 5.1 2.2 1.6 1.6 1.3 1.5 2.6 0.5 2.1 1.1 1.5 0.4 1.4 2.2 4.4 2.3 0.9 3.8 4.0 2.0 5.4 5.6 1.3 5.8 0.9 4.1 3.5 2.0 2.0 1.7 0.8 4.5 1.4 1.1 0.6 1.5 0.5 5.3 0.7 3.0 1.2 0.7 6.8 11.1 10.9 16.5 9.9 4.7 19.6 5.2 7.4 10.6 0.0 5.9 7.8 5.0 1.4 5.5 3.6 12.7 9.4 1.2 15.7 0.0 1.9 3.3 0.7 230.3 1.7 6.6 0.0 0.6 1.1 2.3 4.4 15.1 13.4 2.3 3.2 9.9 7.4 2.4 9.1 5.8 4.6 1.7 1.8 14.5 2.3 0.8 5.8 6.0 3.0 1.9 0.0 2.7 2.3 1.3 2.4 0.7 4.5 10.5 4.6 CLEC10A "CD301, CLECSF13, CLECSF14, HML, HML2" ENSG00000132514 "C-type lectin domain containing 10A" Q8IUN9 17 7074537-7080307 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Endocytosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.1;lymphoid tissue: 49.3" "Group enriched" "Detected in some" 6 "Kupffer cells: 53.6;Macrophages: 176.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 12 "myeloid DC: 81.1" "Lineage enriched" "Detected in many" 12 "dendritic cells: 81.1" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.6;NB-4: 4.0" HPA021937 Approved NA NA "HPA021937: AB_1846905" "unprognostic (3.96e-3)" "unprognostic (1.71e-3)" "unprognostic (2.95e-2)" "unprognostic (2.04e-3)" "unprognostic (4.54e-2)" "prognostic favorable (1.26e-5)" "unprognostic (1.07e-1)" "prognostic favorable (9.24e-4)" "unprognostic (2.70e-2)" "unprognostic (1.41e-1)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.12e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (3.23e-1)" "unprognostic (3.65e-1)" 12.7 4.0 0.4 14.3 0.5 0.6 6.6 0.4 0.6 4.9 9.7 0.8 1.7 7.9 6.4 31.3 6.9 6.1 12.2 17.5 0.4 0.4 4.4 6.2 22.0 49.3 0.6 0.6 4.1 3.3 0.4 2.0 1.3 2.0 7.2 9.7 3.8 5.0 5.9 6.1 5.1 14.3 9.6 0.9 10.2 4.4 3.7 0.5 5.4 4.7 9.9 10.4 9.8 4.6 0.0 81.1 0.3 6.6 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.3 0.0 0.0 0.0 4.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.3 0.6 0.0 0.0 0.1 0.0 0.1 0.0 5.5 0.0 0.0 6.6 0.0 0.0 0.0 0.0 81.1 0.0 0.0 0.0 0.3 0.3 0.0 1.6 0.0 3.3 0.4 0.5 0.4 0.6 0.4 0.4 0.6 0.6 2.0 0.5 3.0 3.8 2.2 0.0 11.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.5 0.0 1.1 0.9 17.9 0.0 0.0 0.6 53.6 0.7 0.3 176.8 20.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 6.5 3.9 0.0 2.1 10.3 0.1 0.0 0.0 0.0 CLEC12A "CD371, CLL-1, DCAL-2, MICL" ENSG00000172322 "C-type lectin domain family 12 member A" Q5QGZ9 12 9951316-9995694 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 46.5;bone marrow: 35.4;lung: 36.2;lymphoid tissue: 22.4" "Cell type enhanced" "Detected in some" 18 "granulocytes: 27.9;Kupffer cells: 91.2;Macrophages: 86.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "eosinophil: 46.5" "Group enriched" "Detected in many" 38 "dendritic cells: 17.1;granulocytes: 46.5;monocytes: 32.8" "Group enriched" "Detected in some" 6 "HL-60: 12.1;U-937: 37.8" HPA048515 Enhanced NA NA "HPA048515: AB_2680425" "unprognostic (4.74e-2)" "unprognostic (6.06e-3)" "unprognostic (7.76e-2)" "unprognostic (6.88e-2)" "unprognostic (2.00e-2)" "unprognostic (6.66e-2)" "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (3.29e-1)" "unprognostic (1.44e-2)" "unprognostic (1.70e-1)" "unprognostic (2.74e-2)" "unprognostic (1.10e-3)" "unprognostic (9.67e-3)" "unprognostic (7.43e-2)" "unprognostic (3.78e-2)" "prognostic favorable (9.33e-4)" 4.2 1.2 0.3 6.4 1.2 35.4 1.2 0.6 1.1 0.9 1.5 0.3 0.1 0.2 1.9 3.7 0.9 1.3 2.8 3.5 0.3 0.3 1.9 3.4 36.2 9.6 0.5 0.8 1.0 1.4 0.0 0.6 3.4 1.2 1.3 1.3 1.4 1.5 0.1 0.7 1.1 1.9 3.5 1.5 22.4 1.3 0.9 0.3 2.8 0.7 0.1 1.2 2.1 1.0 0.0 17.1 46.5 32.8 0.8 0.1 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 12.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 37.8 0.0 4.1 32.8 46.5 0.0 26.4 0.1 0.0 0.0 0.0 17.1 0.0 0.0 0.1 10.2 0.8 28.4 1.5 0.0 12.5 0.3 1.2 0.6 1.1 0.3 0.3 0.5 0.8 1.2 0.3 3.0 5.3 4.2 0.0 0.3 0.0 0.4 0.0 2.7 5.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 27.9 0.8 20.0 0.0 0.0 1.3 91.2 0.0 0.0 86.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.5 1.1 3.2 0.0 0.0 CLEC12B ENSG00000256660 "C-type lectin domain family 12 member B" Q2HXU8 12 10010627-10018619 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 30.9" "Cell type enriched" "Detected in some" 6 "Melanocytes: 75.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "GAMG: 5.7;U-937: 12.0" "Region enhanced" "Detected in single" "pons and medulla: 0.8" "Not detected" "Not detected" NA NA "unprognostic (2.08e-2)" "unprognostic (4.81e-2)" "unprognostic (3.60e-1)" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (3.36e-3)" "unprognostic (4.14e-4)" "unprognostic (7.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.02e-5)" "unprognostic (1.41e-2)" "unprognostic (1.99e-1)" "unprognostic (5.48e-1)" "unprognostic (8.95e-4)" 0.4 0.0 0.2 0.5 0.2 5.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.0 0.2 0.2 1.3 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.2 5.4 0.2 0.2 0.2 2.7 0.1 30.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.5 1.3 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 12.0 0.4 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.3 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 2.6 7.2 0.3 0.4 75.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.6 0.0 0.0 0.0 0.0 CLEC14A C14orf27 ENSG00000176435 "C-type lectin domain containing 14A" Q86T13 14 38254103-38256369 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 63.2" "Group enriched" "Detected in some" 45 "Endothelial cells: 217.3;Ito cells: 286.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "myeloid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 17.4;HUVEC TERT2: 94.4;TIME: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039468, HPA048119" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" NA NA 3600000 "Endoplasmic reticulum, Golgi apparatus" "HPA039468: AB_2676524, HPA048119: AB_2680270" "unprognostic (4.02e-1)" "unprognostic (4.26e-2)" "unprognostic (4.20e-3)" "unprognostic (9.44e-2)" "unprognostic (1.35e-1)" "prognostic favorable (4.13e-6)" "unprognostic (2.55e-3)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (6.90e-2)" "unprognostic (5.41e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-2)" "unprognostic (1.75e-2)" "unprognostic (1.55e-1)" "unprognostic (4.97e-2)" "unprognostic (5.28e-2)" 32.2 3.9 3.2 6.8 4.3 0.0 47.8 2.3 3.9 14.5 9.3 3.4 5.9 5.9 18.4 13.3 9.3 9.9 13.6 23.7 3.8 3.4 6.8 11.4 63.2 7.9 4.9 2.2 7.6 3.3 5.0 2.8 15.0 4.4 11.8 4.4 10.8 5.5 6.5 36.5 6.5 7.4 12.1 3.9 9.0 5.9 6.8 2.2 1.4 14.0 21.1 3.8 9.4 14.8 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 4.3 2.3 3.9 3.8 3.4 4.9 2.2 4.4 2.2 0.0 5.6 2.9 0.3 3.1 0.0 5.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.0 217.3 0.0 0.0 0.2 0.1 2.7 0.2 1.1 0.8 0.3 0.0 0.0 286.7 5.6 1.0 0.6 0.7 5.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.5 0.0 4.1 0.6 0.2 2.8 0.1 0.0 0.0 0.0 CLEC17A FLJ45910 ENSG00000187912 "C-type lectin domain containing 17A" Q6ZS10 19 14583084-14611157 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 30.9;intestine: 8.5;lymphoid tissue: 25.1" "Group enriched" "Detected in some" 31 "B-cells: 2.2;Early spermatids: 5.2;Late spermatids: 8.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "memory B-cell: 14.7;naive B-cell: 30.9" "Lineage enriched" "Detected in many" 16 "B-cells: 30.9" "Group enriched" "Detected in some" 10 "Daudi: 10.1;U-698: 18.7" "Low region specificity" "Detected in some" NA NA "unprognostic (4.71e-5)" "unprognostic (1.34e-2)" "unprognostic (9.64e-4)" "unprognostic (5.02e-3)" "unprognostic (3.90e-1)" "unprognostic (9.00e-4)" "unprognostic (3.18e-3)" "unprognostic (1.60e-3)" "unprognostic (1.32e-2)" "unprognostic (7.11e-2)" "unprognostic (3.78e-2)" "unprognostic (4.43e-2)" "unprognostic (9.13e-3)" "unprognostic (1.65e-1)" "unprognostic (5.91e-2)" "unprognostic (2.07e-1)" "unprognostic (1.23e-1)" 0.4 0.3 0.8 23.2 2.2 1.3 0.3 0.3 1.3 0.3 0.6 3.3 0.0 0.4 0.3 0.0 0.4 0.3 0.6 0.3 2.2 1.1 0.6 0.3 0.4 18.7 1.3 0.0 0.3 0.3 0.1 0.5 0.1 1.7 0.4 0.6 0.4 4.7 0.0 0.3 0.3 8.5 0.0 3.7 17.0 0.7 1.4 2.0 1.0 0.5 0.0 25.1 1.5 0.3 30.9 1.8 0.7 0.3 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 14.7 0.0 0.0 1.8 30.9 0.0 0.0 0.7 0.1 0.1 0.2 0.0 1.3 0.8 2.2 0.3 1.3 2.2 1.1 1.3 0.0 1.7 2.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLEC1A "CLEC1, MGC34328" ENSG00000150048 "C-type lectin domain family 1 member A" Q8NC01 12 10069554-10111627 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.8" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 45.1;Endothelial cells: 22.2;Extravillous trophoblasts: 51.1;Ito cells: 14.7;Syncytiotrophoblasts: 43.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 2.2;intermediate monocyte: 1.3;myeloid DC: 5.2;neutrophil: 2.8" "Group enriched" "Detected in many" 14 "dendritic cells: 5.2;granulocytes: 2.8;monocytes: 2.2" "Cell line enhanced" "Detected in some" "BEWO: 18.8;HUVEC TERT2: 15.9;SuSa: 5.1;U-266/70: 4.3;U-266/84: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (5.96e-2)" "unprognostic (2.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.16e-2)" "unprognostic (1.37e-1)" "unprognostic (1.03e-1)" "unprognostic (7.15e-2)" "unprognostic (2.73e-2)" "unprognostic (3.26e-2)" "unprognostic (1.81e-1)" "unprognostic (3.35e-3)" "unprognostic (3.94e-2)" "unprognostic (1.28e-1)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" 27.4 2.1 1.6 4.9 3.0 0.5 14.0 1.2 1.9 9.7 3.1 1.2 2.4 1.4 16.1 6.0 4.3 4.2 4.9 4.8 2.0 1.8 3.6 2.5 19.9 4.5 3.1 0.6 4.9 4.1 1.0 2.6 40.8 3.4 5.2 2.0 2.3 2.0 2.3 4.8 2.9 3.0 7.6 3.5 5.8 2.6 3.3 1.7 20.4 5.6 3.6 3.0 6.4 12.3 0.2 5.2 2.8 2.2 0.2 0.1 0.5 0.0 0.0 0.3 0.2 0.2 0.1 18.8 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 15.9 0.0 0.0 1.6 0.0 0.0 0.0 0.4 2.6 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.2 0.2 0.0 5.1 0.0 0.0 1.2 0.0 0.2 0.2 0.0 4.3 9.5 0.0 0.2 0.0 0.0 0.2 2.2 0.1 0.0 1.3 0.1 0.1 0.0 0.0 5.2 0.2 0.1 0.0 2.8 0.2 0.5 0.2 0.0 0.5 1.6 3.0 1.2 1.9 2.0 1.8 3.1 0.6 3.4 1.7 0.0 0.3 0.0 0.1 1.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.3 22.2 0.0 0.0 0.0 51.1 1.7 0.2 0.0 0.0 4.4 0.0 0.0 14.7 6.5 0.0 6.9 1.8 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 2.4 1.4 43.6 0.0 0.0 0.4 CLEC1B CLEC2 ENSG00000165682 "C-type lectin domain family 1 member B" Q9P126 12 9985642-10013424 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 12.5;liver: 44.1" "Cell type enriched" "Detected in some" 10 "Ito cells: 718.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 7.8" "Group enriched" "Detected in many" 37 "dendritic cells: 2.1;granulocytes: 7.8;monocytes: 4.9" "Group enriched" "Detected in some" 6 "Karpas-707: 10.1;U-266/84: 23.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA 1500000 "unprognostic (2.03e-1)" "unprognostic (2.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.15e-3)" "unprognostic (1.26e-2)" "unprognostic (7.71e-2)" "unprognostic (4.98e-2)" "unprognostic (1.58e-1)" "unprognostic (8.13e-2)" "unprognostic (1.49e-3)" "unprognostic (1.46e-2)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (2.91e-2)" 0.1 0.3 0.0 0.4 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.0 0.0 0.0 0.1 44.1 2.1 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.2 0.0 4.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.1 7.8 4.9 0.1 0.1 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 2.9 0.0 7.8 4.9 6.7 0.0 4.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 3.3 0.1 3.7 1.2 0.0 12.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.9 0.1 0.0 0.0 718.7 73.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 CLEC2A "INPE5792, KACL, PILAR, UNQ5792" ENSG00000188393 "C-type lectin domain family 2 member A" Q6UVW9 12 9898673-9932381 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 37.0" "Group enriched" "Detected in some" 199 "Basal keratinocytes: 16.7;Suprabasal keratinocytes: 32.4" "Cancer enhanced" "Detected in some" "cervical cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 13.5;U-937: 33.7" "HPA048530, HPA072407" Approved Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA048530: AB_2680429, HPA072407: AB_2686518" "unprognostic (3.10e-1)" "unprognostic (5.29e-2)" "unprognostic (2.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.3 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.1 CLEC2B "AICL, CLECSF2, HP10085" ENSG00000110852 "C-type lectin domain family 2 member B" Q92478 12 9852984-9870136 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 58.7;lymphoid tissue: 56.6" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 179.2;Macrophages: 186.4;Suprabasal keratinocytes: 210.5;T-cells: 224.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 58.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 17.2;ASC TERT1: 27.2;HSkMC: 14.9;U-937: 62.1" HPA008194 Enhanced "Intracellular and membrane" NA NA "HPA008194: AB_1078533" "unprognostic (3.14e-2)" "unprognostic (4.27e-2)" "unprognostic (2.14e-2)" "unprognostic (9.69e-3)" "unprognostic (4.83e-2)" "unprognostic (2.51e-1)" "unprognostic (5.99e-2)" "unprognostic (4.45e-1)" "unprognostic (1.79e-1)" "unprognostic (3.58e-1)" "unprognostic (1.15e-3)" "unprognostic (3.50e-1)" "prognostic unfavorable (5.64e-13)" "unprognostic (8.09e-2)" "unprognostic (7.12e-3)" "unprognostic (5.70e-2)" "unprognostic (2.79e-1)" 10.8 1.8 2.0 9.1 2.8 29.8 8.2 2.4 3.0 6.3 3.9 2.7 3.4 1.5 7.2 4.4 6.1 3.6 6.0 4.8 2.0 1.3 2.7 4.5 13.1 8.9 3.0 2.0 12.9 2.0 0.2 2.0 4.8 3.2 4.9 3.7 3.4 4.5 2.0 5.7 24.5 4.9 4.0 3.3 12.6 2.2 3.6 2.4 56.6 3.4 3.6 7.6 5.3 7.9 5.6 9.3 58.7 17.3 17.1 19.1 18.6 0.0 0.8 0.0 0.0 17.2 27.2 0.1 0.4 3.3 0.2 0.9 0.0 0.6 0.3 0.2 13.7 10.3 5.1 2.8 0.0 0.1 0.7 0.0 0.9 0.0 0.0 5.7 0.6 0.1 14.9 5.1 0.6 0.1 0.8 8.6 3.6 0.0 2.3 4.0 0.0 5.3 1.2 0.1 0.0 0.5 7.9 0.1 0.0 0.0 5.5 0.0 0.0 0.2 0.0 3.5 0.0 1.3 0.1 11.4 0.1 3.2 0.4 1.6 4.1 0.3 0.6 3.5 62.1 5.0 9.6 10.3 3.7 18.4 14.7 14.6 3.1 11.6 19.1 9.3 5.6 11.1 16.8 58.7 17.1 17.3 3.5 9.3 18.6 2.0 2.8 2.4 3.0 2.0 1.3 3.0 2.0 3.2 2.4 3.0 33.4 35.1 68.5 179.2 0.0 3.1 12.7 4.0 26.1 0.0 0.0 0.7 0.0 3.8 0.2 130.0 0.2 23.3 0.7 1.4 28.8 14.5 52.1 2.6 77.5 0.0 1.7 145.5 124.7 0.7 46.1 186.4 75.9 10.8 0.0 0.4 1.8 0.0 16.6 0.7 0.2 6.5 37.7 0.2 0.5 210.5 1.6 224.3 0.0 126.6 CLEC2D "CLAX, LLT1, OCIL" ENSG00000069493 "C-type lectin domain family 2 member D" Q9UHP7 12 9664969-9699555 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 45.6;lymphoid tissue: 47.5" "Group enriched" "Detected in many" 5 "B-cells: 129.2;Early spermatids: 83.6;monocytes: 115.4;T-cells: 223.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "gdT-cell: 37.8;MAIT T-cell: 23.0;memory B-cell: 15.9;memory CD4 T-cell: 37.3;memory CD8 T-cell: 41.3;naive B-cell: 24.6;naive CD4 T-cell: 39.4;naive CD8 T-cell: 45.6;T-reg: 31.5" "Group enriched" "Detected in many" 11 "B-cells: 24.6;T-cells: 45.6" "Group enriched" "Detected in many" 4 "Daudi: 27.8;HDLM-2: 21.7;Karpas-707: 13.2;U-698: 42.8" "HPA017649, HPA047584" Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA017649: AB_1846912, HPA047584: " "unprognostic (1.09e-3)" "prognostic favorable (1.37e-4)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (1.29e-1)" "unprognostic (2.77e-4)" "unprognostic (4.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.24e-2)" "unprognostic (1.92e-1)" "unprognostic (6.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.85e-11)" "unprognostic (1.17e-1)" "unprognostic (2.70e-1)" "unprognostic (3.44e-1)" "prognostic favorable (1.68e-7)" 3.8 1.0 1.1 47.5 1.1 7.8 3.7 0.8 1.0 2.9 6.0 0.6 1.4 1.7 3.0 7.0 3.6 3.2 3.0 3.3 1.2 1.1 2.6 1.3 10.4 28.3 1.7 1.2 4.0 1.5 0.2 1.3 1.7 1.1 4.5 2.1 2.5 9.8 3.2 1.2 2.4 11.2 3.2 2.5 21.3 2.7 5.7 1.0 44.7 2.8 2.7 29.4 8.2 2.5 24.6 0.4 1.1 0.4 3.1 45.6 19.2 0.5 1.0 1.5 0.1 0.2 0.6 1.7 0.7 1.0 0.3 0.9 0.8 0.9 27.8 0.1 0.7 0.4 0.3 0.5 0.1 0.5 21.7 0.4 0.8 0.7 1.2 2.5 0.7 0.7 1.0 0.7 0.2 0.9 3.4 0.0 0.5 0.2 13.2 0.6 1.8 0.3 2.4 1.4 0.1 0.2 6.0 0.6 0.8 1.4 1.5 0.3 0.5 0.4 1.2 1.2 2.9 0.2 0.7 0.2 0.5 0.7 0.4 0.5 1.8 0.4 42.8 1.2 1.3 0.8 1.1 0.4 0.2 37.8 0.2 23.0 15.9 37.3 41.3 0.4 24.6 39.4 45.6 1.1 3.1 0.2 0.3 31.5 19.2 1.1 1.1 0.8 1.0 1.2 1.1 1.7 1.2 1.1 1.0 6.0 26.8 129.2 29.8 3.7 0.6 6.9 2.5 10.7 11.4 1.8 3.9 9.1 6.6 2.1 83.6 9.8 0.4 0.0 1.7 5.4 7.0 13.2 18.6 2.1 8.0 4.8 0.0 12.3 20.8 15.6 7.8 18.9 1.7 115.4 2.5 3.7 2.3 2.0 9.2 1.9 2.1 19.4 6.6 4.7 5.1 4.3 4.0 223.7 3.0 25.3 CLEC2L FLJ32986 ENSG00000236279 "C-type lectin domain family 2 member L" P0C7M8 7 139523856-139544984 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.8;parathyroid gland: 15.5" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 2.2;Extravillous trophoblasts: 2.6;Horizontal cells: 4.8;Muller glia cells: 1.7;Rod photoreceptor cells: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 15.3;U-266/70: 3.7;U-266/84: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045050 Enhanced NA NA "HPA045050: AB_10965839" "unprognostic (1.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.20e-4)" "unprognostic (1.24e-2)" "unprognostic (1.33e-2)" "unprognostic (6.17e-2)" "unprognostic (2.29e-6)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (6.73e-2)" "unprognostic (2.68e-1)" "unprognostic (8.31e-2)" "unprognostic (7.94e-4)" "unprognostic (3.57e-3)" "unprognostic (4.03e-2)" "unprognostic (8.42e-3)" "unprognostic (3.02e-2)" 1.1 0.9 9.8 1.0 9.4 1.1 0.8 14.0 24.1 2.3 0.9 1.4 0.0 0.9 2.5 0.5 1.6 0.8 1.9 0.5 13.8 9.2 0.7 0.6 0.7 0.8 15.1 7.2 0.7 0.7 15.5 0.1 0.7 26.8 0.6 0.9 2.2 0.7 0.6 5.5 0.7 1.2 2.2 3.8 0.7 0.6 1.3 0.5 1.8 0.8 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.6 0.0 1.5 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 9.8 9.4 14.0 24.1 13.8 9.2 15.1 7.2 26.8 0.5 0.0 0.0 0.0 0.0 0.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.7 1.7 0.0 0.3 0.0 0.0 0.0 CLEC3A CLECSF1 ENSG00000166509 "C-type lectin domain family 3 member A" 16 78022515-78066761 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 14.6;prostate: 8.6;smooth muscle: 17.1;urinary bladder: 17.2" "Cell type enhanced" "Detected in single" 26 "Glandular cells: 1.4" "Cancer enriched" "Detected in some" 102 "breast cancer: 78.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SK-BR-3: 7.5;T-47d: 21.4" "Region enhanced" "Detected in single" "midbrain: 0.5" "Not detected" "Not detected" HPA051511 Uncertain "Secreted to extracellular matrix" NA NA "HPA051511: AB_2681514" "prognostic unfavorable (1.61e-4)" "unprognostic (1.60e-1)" "unprognostic (2.42e-1)" "unprognostic (1.25e-1)" "unprognostic (4.95e-2)" "unprognostic (3.80e-2)" 0.1 0.1 0.1 1.8 0.3 0.0 14.6 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 4.6 0.3 0.1 1.1 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.4 8.6 0.0 3.3 0.1 0.0 0.1 0.1 0.1 17.1 0.1 0.1 0.8 0.1 0.0 0.0 0.1 1.9 0.0 17.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.8 0.1 1.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLEC4A "CD367, CLECSF6, DCIR, DDB27" ENSG00000111729 "C-type lectin domain family 4 member A" Q9UMR7 12 8123632-8138607 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.6;lung: 30.0" "Cell type enhanced" "Detected in many" 18 "Hofbauer cells: 22.3;Kupffer cells: 81.7;Macrophages: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 29.2;classical monocyte: 54.6;intermediate monocyte: 31.2;myeloid DC: 53.2;neutrophil: 48.8;non-classical monocyte: 19.6" "Group enriched" "Detected in many" 12 "dendritic cells: 53.2;granulocytes: 48.8;monocytes: 54.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.4" HPA007842 Uncertain NA NA "HPA007842: AB_1078534" "unprognostic (9.13e-2)" "unprognostic (2.11e-2)" "unprognostic (1.41e-2)" "unprognostic (3.13e-2)" "unprognostic (2.69e-1)" "unprognostic (9.34e-2)" "unprognostic (5.49e-2)" "unprognostic (8.22e-2)" "unprognostic (1.62e-1)" "unprognostic (7.84e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.42e-3)" "unprognostic (1.42e-1)" "unprognostic (1.35e-2)" "unprognostic (3.05e-1)" "unprognostic (9.79e-2)" 8.3 2.0 2.7 20.1 4.0 14.6 3.3 2.2 2.6 3.7 3.1 3.5 0.6 3.6 2.7 5.2 2.1 2.9 5.6 3.4 2.5 2.5 5.4 4.1 30.0 25.1 2.8 2.4 5.5 2.5 0.5 3.3 6.0 3.2 4.1 4.6 4.0 2.6 2.2 2.2 3.8 4.7 3.3 8.1 16.3 2.0 2.8 3.7 5.7 2.8 3.2 7.4 6.0 3.1 4.5 53.2 48.8 54.6 0.5 0.2 23.7 0.3 0.0 0.7 1.8 3.3 8.4 1.1 2.2 0.9 1.8 2.5 3.0 1.4 1.3 0.3 1.2 0.7 0.4 1.9 0.4 1.1 2.2 2.2 1.4 1.5 0.8 4.1 4.2 5.6 4.2 1.9 0.7 2.3 5.2 0.4 3.0 0.7 1.2 2.3 1.0 1.2 3.1 1.3 1.1 0.8 0.8 1.4 2.1 1.2 2.0 0.3 0.7 0.5 1.6 0.0 2.9 0.2 0.3 0.5 3.1 1.9 1.2 1.4 1.4 0.2 1.7 0.4 1.6 0.1 29.2 54.6 0.1 0.1 31.2 0.1 2.0 0.1 0.2 53.2 4.5 0.1 0.1 48.8 0.5 19.6 7.3 0.1 23.7 2.7 4.0 2.2 2.6 2.5 2.5 2.8 2.4 3.2 3.7 0.0 5.8 5.0 0.6 3.8 0.5 0.8 0.0 4.0 3.4 0.0 3.9 0.2 1.7 0.1 4.1 1.4 0.0 0.0 0.4 0.2 2.2 0.8 2.3 0.9 22.3 0.0 1.7 1.3 81.7 0.9 2.3 93.5 6.8 1.0 0.0 0.4 0.5 0.3 1.4 0.2 0.6 0.0 1.2 0.2 0.5 2.9 0.2 0.5 0.0 0.7 CLEC4C "BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL" ENSG00000198178 "C-type lectin domain family 4 member C" Q8WTT0 12 7729415-7751605 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "blood: 80.0" "Cell type enriched" "Detected in some" 5 "Spermatogonia: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 16 "plasmacytoid DC: 80.0" "Lineage enriched" "Detected in many" 16 "dendritic cells: 80.0" "Cell line enriched" "Detected in some" 4 "HDLM-2: 6.6" HPA029432 Approved NA NA "HPA029432: AB_10601259" "unprognostic (3.55e-3)" "unprognostic (3.01e-2)" "unprognostic (1.03e-1)" "unprognostic (3.70e-2)" "unprognostic (7.37e-5)" "unprognostic (2.36e-2)" "unprognostic (2.06e-1)" "unprognostic (2.55e-2)" "unprognostic (6.98e-2)" "unprognostic (1.39e-1)" "unprognostic (1.88e-3)" "unprognostic (2.82e-2)" "unprognostic (3.18e-3)" "unprognostic (2.36e-2)" "unprognostic (1.25e-1)" 0.3 0.2 0.2 1.6 0.2 1.8 2.0 0.2 0.6 0.2 0.2 0.1 0.1 0.0 0.2 0.1 0.3 0.5 1.2 0.3 0.2 0.2 0.5 0.3 1.5 7.0 0.2 0.1 0.4 0.2 0.0 0.2 0.1 0.1 0.2 0.0 0.4 0.3 2.0 0.2 0.3 0.3 0.1 0.2 4.6 0.3 9.9 0.1 6.7 0.3 0.1 7.1 1.9 0.3 0.5 80.0 4.9 0.1 0.5 0.0 0.5 0.2 0.0 0.3 0.3 0.5 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 6.6 0.2 0.3 0.7 0.2 0.0 0.6 1.3 0.4 0.3 0.0 0.0 0.1 0.1 0.0 0.2 1.0 0.0 0.1 0.1 0.8 1.5 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.2 0.2 0.1 0.2 0.0 0.4 0.9 0.1 0.4 0.4 0.2 0.1 0.1 0.6 0.2 1.4 0.1 0.3 0.3 0.9 0.1 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.5 0.0 0.0 2.6 0.5 0.0 80.0 0.0 0.5 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.3 0.3 0.0 0.0 0.0 0.0 CLEC4D "CD368, CLECSF8, Dectin-3, MCL, Mpcl" ENSG00000166527 "C-type lectin domain family 4 member D" Q8WXI8 12 8509475-8522366 "Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 35.0;bone marrow: 38.4;lymphoid tissue: 15.0" "Cell type enriched" "Detected in some" 5 "Kupffer cells: 13.9" "Cancer enriched" "Detected in single" 50 "testis cancer: 11.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 18 "classical monocyte: 20.9;neutrophil: 35.0" "Group enriched" "Detected in many" 32 "granulocytes: 35.0;monocytes: 20.9" "Cell line enhanced" "Detected in some" "NB-4: 2.9;NTERA-2: 11.6;SuSa: 12.4;U-937: 6.6" "Not detected" "Not detected" HPA004906 Approved NA NA "HPA004906: AB_1078535" "unprognostic (1.10e-1)" "unprognostic (4.94e-2)" "unprognostic (4.78e-2)" "unprognostic (1.27e-1)" "unprognostic (4.39e-1)" "unprognostic (3.84e-2)" "unprognostic (7.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.90e-1)" "unprognostic (2.21e-1)" "unprognostic (2.70e-1)" "unprognostic (3.81e-1)" "unprognostic (7.91e-5)" "unprognostic (1.12e-2)" "unprognostic (8.57e-2)" "unprognostic (7.89e-2)" "unprognostic (2.18e-1)" 1.7 0.2 0.1 4.8 0.6 38.4 0.4 0.1 1.8 2.2 0.3 0.1 0.0 0.0 0.2 0.3 0.3 1.4 0.3 3.6 1.1 0.2 0.4 0.7 6.7 10.4 0.6 0.0 0.4 0.3 0.0 0.4 0.4 0.7 0.2 0.0 0.1 0.3 0.0 1.3 0.1 0.5 0.5 0.5 15.0 0.5 0.5 0.4 0.1 0.7 0.4 0.4 0.5 4.2 0.1 0.8 35.0 20.9 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 11.6 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.3 20.9 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 35.0 0.0 0.3 0.2 0.0 4.4 0.1 0.6 0.1 1.8 1.1 0.2 0.6 0.0 0.7 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.0 0.0 13.9 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CLEC4E "CLECSF9, mincle" ENSG00000166523 "C-type lectin domain family 4 member E" Q9ULY5 12 8533305-8540963 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.7;bone marrow: 37.7;lymphoid tissue: 41.2" "Group enriched" "Detected in some" 8 "Kupffer cells: 144.8;Macrophages: 65.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "classical monocyte: 22.8;neutrophil: 81.7" "Group enriched" "Detected in many" 17 "granulocytes: 81.7;monocytes: 22.8" "Group enriched" "Detected in some" 4 "NB-4: 5.8;RPTEC TERT1: 16.3" "Not detected" "Not detected" HPA004935 Uncertain Uncertain Cytosol NA NA Cytosol "HPA004935: AB_2667299" "unprognostic (3.05e-2)" "unprognostic (2.01e-2)" "unprognostic (8.91e-2)" "unprognostic (3.76e-1)" "unprognostic (1.76e-1)" "unprognostic (9.71e-3)" "unprognostic (1.77e-1)" "unprognostic (1.24e-1)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (1.16e-1)" "unprognostic (2.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.62e-1)" "unprognostic (1.51e-1)" "unprognostic (8.44e-2)" "unprognostic (2.29e-1)" 8.4 3.0 1.1 20.9 2.4 37.7 17.5 1.2 2.2 3.4 1.4 0.0 1.1 0.1 1.2 1.6 1.7 4.2 6.7 5.9 1.3 1.2 6.2 3.5 25.6 41.2 2.8 0.6 1.0 3.3 0.0 1.7 1.7 9.0 1.6 0.5 1.1 1.2 0.6 2.7 0.7 1.9 3.2 5.3 34.2 1.8 3.3 0.8 0.7 12.8 0.9 1.1 2.2 2.2 0.0 2.9 81.7 22.8 0.0 0.0 4.5 0.1 0.6 0.4 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.1 2.0 0.1 0.2 2.6 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.3 0.3 0.0 0.7 0.1 0.0 1.7 0.1 0.6 0.7 0.1 0.2 0.1 0.0 0.1 0.0 5.8 0.5 0.0 0.1 0.1 0.2 0.1 16.3 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.0 0.5 1.3 0.6 0.1 1.1 0.1 0.2 0.1 0.1 1.6 0.5 0.1 0.0 22.8 0.0 0.0 3.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 81.7 0.0 0.1 0.1 0.0 4.5 1.1 2.4 1.2 2.2 1.3 1.2 2.8 0.6 9.0 0.8 0.0 6.6 1.4 0.0 0.0 0.0 0.3 7.6 1.4 3.4 1.8 0.0 0.0 0.0 4.5 0.3 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 5.8 0.0 0.0 11.6 144.8 1.1 0.9 65.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 12.9 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 CLEC4F "CLECSF13, FLJ39110, KCLR" ENSG00000152672 "C-type lectin domain family 4 member F" Q8N1N0 2 70808643-70820600 "Predicted membrane proteins" Endocytosis Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 17 "Cone photoreceptor cells: 9.8;Horizontal cells: 4.8;Rod photoreceptor cells: 7.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 9 "intermediate monocyte: 7.9;non-classical monocyte: 5.8" "Lineage enriched" "Detected in single" 11 "monocytes: 7.9" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;BEWO: 2.1;HAP1: 1.7;SH-SY5Y: 1.4;T-47d: 3.1" "Not detected" "Not detected" HPA056101 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA056101: " "unprognostic (8.14e-3)" "unprognostic (3.73e-2)" "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (4.91e-2)" "unprognostic (5.41e-2)" "unprognostic (3.66e-2)" "unprognostic (2.07e-2)" "unprognostic (9.29e-2)" "unprognostic (3.45e-1)" "unprognostic (2.68e-4)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" "unprognostic (1.91e-1)" "unprognostic (2.44e-2)" "unprognostic (9.59e-2)" "unprognostic (2.44e-1)" 3.1 0.0 0.5 3.2 0.5 0.0 2.1 0.7 0.7 1.8 4.2 0.5 6.8 2.5 2.9 1.4 1.5 1.5 7.0 1.5 0.5 0.1 1.2 2.4 9.0 1.8 1.2 0.5 1.3 0.5 0.0 1.4 0.5 0.5 2.9 1.3 0.8 3.3 2.7 1.4 2.3 7.6 2.0 0.5 6.8 0.7 2.0 0.5 0.9 0.6 0.5 2.0 1.5 2.5 0.0 0.7 0.0 7.9 0.0 0.0 0.6 0.0 0.1 0.1 6.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.6 0.5 0.5 0.7 0.5 0.5 0.1 1.2 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.3 0.7 0.0 1.7 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CLEC4G "LSECtin, UNQ431" ENSG00000182566 "C-type lectin domain family 4 member G" Q6UXB4 19 7728957-7733906 "Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 63.1;lymphoid tissue: 53.5" "Cell type enriched" "Detected in some" 13 "Ito cells: 979.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 11.8" "Cell type enhanced" "Detected in some" "classical monocyte: 13.9;myeloid DC: 11.9" "Group enriched" "Detected in many" 19 "B-cells: 4.1;dendritic cells: 11.9;monocytes: 13.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.3;hTEC/SVTERT24-B: 1.0;RPMI-8226: 1.3;RT4: 1.2;TIME: 2.7;U-937: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB003789, HPA014044" Enhanced NA NA "CAB003789: , HPA014044: AB_1846916" "unprognostic (7.20e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" "unprognostic (3.64e-1)" "unprognostic (4.47e-2)" "unprognostic (1.35e-1)" "unprognostic (7.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.23e-1)" "unprognostic (3.29e-2)" "unprognostic (7.45e-2)" "unprognostic (3.04e-1)" "unprognostic (2.13e-8)" "unprognostic (5.21e-2)" "unprognostic (1.27e-1)" "unprognostic (1.77e-1)" "unprognostic (6.65e-2)" 11.2 0.1 0.9 1.5 1.2 0.9 2.6 11.8 1.6 0.2 1.5 0.2 0.2 0.4 0.2 1.3 5.2 2.7 1.0 7.3 2.6 1.0 0.3 63.1 0.5 53.5 0.8 0.2 0.5 0.8 0.0 0.2 0.8 0.2 0.8 0.7 0.3 4.9 0.5 0.2 0.4 0.7 0.7 0.2 1.3 0.3 0.7 0.2 0.3 0.5 0.6 0.2 2.0 0.6 4.1 11.9 0.5 13.9 0.4 0.1 2.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 1.2 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.7 2.7 0.0 0.1 0.7 0.0 0.1 0.0 0.3 0.0 2.2 0.1 0.0 13.9 0.0 0.0 3.3 0.0 0.3 0.0 0.0 11.9 4.1 0.1 0.0 0.5 0.4 0.4 0.6 0.0 2.8 0.9 1.2 11.8 1.6 2.6 1.0 0.8 0.2 0.2 0.2 0.0 0.0 9.3 0.0 0.1 0.0 0.4 7.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.7 0.0 0.0 979.0 76.3 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.2 0.0 0.0 0.0 CLEC4M "CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN" ENSG00000104938 "C-type lectin domain family 4 member M" Q9H2X3 19 7763149-7769605 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Endocytosis, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "liver: 38.5;lymphoid tissue: 30.1" "Cell type enriched" "Detected in some" 17 "Ito cells: 378.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 18 "B-cells: 1.7" "Group enriched" "Detected in some" 7 "GAMG: 3.5;HUVEC TERT2: 2.3;K-562: 3.1;Karpas-707: 1.2;RPMI-8226: 1.6" "CAB033689, CAB033691, HPA042661" Supported "Intracellular and membrane" NA NA 890000 "CAB033689: AB_831088, CAB033691: AB_2081354, HPA042661: AB_2678101" "unprognostic (1.56e-1)" "unprognostic (3.03e-1)" "unprognostic (1.00e-1)" "unprognostic (1.71e-2)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (6.58e-2)" "unprognostic (1.27e-1)" "unprognostic (4.58e-3)" "unprognostic (4.60e-2)" "unprognostic (5.15e-2)" "unprognostic (1.43e-1)" 0.9 0.9 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.0 0.3 0.1 1.2 0.6 0.1 0.1 0.1 0.0 0.1 38.5 2.5 30.1 0.1 0.1 2.7 0.1 0.0 0.1 4.8 0.2 0.1 0.0 0.1 0.8 0.1 0.1 0.0 0.5 0.1 0.1 0.2 0.0 1.4 0.1 0.1 0.2 0.1 0.2 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 3.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.0 0.0 378.7 22.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.1 CLEC5A "CLECSF5, MDL-1" ENSG00000258227 "C-type lectin domain containing 5A" Q9NY25 7 141927357-141947007 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 35.8" "Group enriched" "Detected in some" 4 "Hofbauer cells: 18.6;Macrophages: 57.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "classical monocyte: 11.5" "Lineage enriched" "Detected in many" 8 "monocytes: 11.5" "Group enriched" "Detected in some" 23 "HL-60: 15.2;U-937: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA054137 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA054137: AB_2732582" "unprognostic (6.89e-2)" "unprognostic (1.07e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" "unprognostic (1.69e-2)" "unprognostic (4.56e-2)" "unprognostic (1.33e-5)" "unprognostic (4.57e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.58e-3)" "unprognostic (1.06e-1)" "unprognostic (1.73e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.23e-2)" "unprognostic (1.64e-1)" 1.4 3.2 1.8 7.3 2.4 35.8 0.8 0.8 2.5 1.7 0.4 1.9 0.6 0.4 0.8 0.5 1.4 1.2 2.0 3.8 7.6 3.1 2.9 2.1 13.9 0.3 2.4 0.5 2.7 2.6 1.4 1.1 2.7 8.2 0.9 0.5 0.8 2.7 0.8 0.3 2.7 0.3 1.5 4.8 2.1 0.4 0.9 4.8 1.1 1.4 4.9 1.4 1.9 1.1 0.0 0.5 1.4 11.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.7 0.0 0.0 11.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 1.9 1.8 2.4 0.8 2.5 7.6 3.1 2.4 0.5 8.2 4.8 0.0 7.4 0.0 0.0 1.6 0.0 0.3 2.5 5.3 9.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 2.3 0.0 18.6 0.0 0.0 0.0 3.8 0.2 0.0 57.4 1.7 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.3 0.2 0.0 0.0 0.0 CLEC6A "CLECSF10, dectin-2" ENSG00000205846 "C-type lectin domain containing 6A" Q6EIG7 12 8455926-8478330 "Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 8.4;heart muscle: 2.3;lung: 6.2;lymphoid tissue: 5.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 8.4;myeloid DC: 3.5" "Group enriched" "Detected in many" 11 "dendritic cells: 3.5;monocytes: 8.4" "Cell line enriched" "Detected in some" 4 "NTERA-2: 8.6" "Low region specificity" "Detected in many" NA NA "unprognostic (1.44e-1)" "unprognostic (9.07e-3)" "unprognostic (5.32e-3)" "unprognostic (1.27e-2)" "unprognostic (2.54e-1)" "unprognostic (4.27e-4)" "unprognostic (6.06e-2)" "unprognostic (2.17e-1)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (7.30e-4)" "unprognostic (8.89e-2)" "unprognostic (3.29e-1)" "unprognostic (2.43e-1)" "unprognostic (2.60e-2)" 0.2 0.2 0.1 4.9 0.2 0.5 0.2 0.1 0.1 0.8 0.2 0.0 0.0 0.0 0.2 0.8 0.2 0.3 0.2 2.3 0.5 0.2 0.4 0.8 6.2 5.0 0.2 0.0 0.1 0.3 0.0 0.2 0.9 0.4 0.1 0.0 0.3 0.2 0.0 0.1 0.1 0.3 0.2 0.4 0.9 0.1 0.5 0.0 0.7 0.2 0.0 1.7 1.1 0.2 0.0 3.5 0.5 8.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.2 0.1 0.1 0.5 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLEC7A "CD369, CLECSF12, dectin-1, hDectin-1, SCARE2" ENSG00000172243 "C-type lectin domain containing 7A" Q9BXN2 12 10116777-10130258 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 53.9;bone marrow: 43.9;brain: 18.7;lung: 32.8;lymphoid tissue: 28.8" "Group enriched" "Detected in many" 11 "Hofbauer cells: 84.0;Kupffer cells: 334.2;Macrophages: 240.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 53.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 16 "Karpas-707: 60.8;U-266/84: 47.3" "Low region specificity" "Detected in many" NA NA "unprognostic (1.79e-1)" "unprognostic (1.88e-2)" "unprognostic (2.98e-2)" "unprognostic (3.64e-1)" "unprognostic (3.03e-2)" "unprognostic (5.49e-2)" "unprognostic (5.19e-2)" "unprognostic (5.88e-3)" "unprognostic (2.10e-1)" "unprognostic (9.87e-2)" "unprognostic (7.46e-2)" "unprognostic (4.40e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.83e-2)" "unprognostic (3.89e-2)" "unprognostic (5.13e-2)" "unprognostic (1.14e-1)" 7.1 5.0 6.3 27.7 7.4 43.9 3.7 0.9 3.4 3.9 4.5 9.5 0.5 3.7 3.2 8.9 8.7 5.3 7.4 5.2 6.2 4.2 8.7 6.9 32.8 24.2 8.9 4.3 2.4 2.8 1.6 2.6 7.8 8.6 2.7 5.0 6.4 6.5 2.4 1.2 3.2 6.5 5.7 18.7 28.8 3.1 1.6 7.3 5.1 2.3 3.2 9.1 5.5 3.8 0.1 13.1 53.9 30.1 0.1 0.1 7.4 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 60.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.5 0.1 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.4 47.3 0.0 0.1 0.3 0.0 0.2 26.4 0.4 0.0 29.5 0.1 0.0 0.0 0.0 13.1 0.1 0.0 0.0 53.9 0.1 30.1 0.2 0.0 7.4 6.3 7.4 0.9 3.4 6.2 4.2 8.9 4.3 8.6 7.3 11.9 20.4 11.3 0.2 3.3 0.0 0.6 0.0 4.0 13.6 0.0 0.0 1.2 0.0 0.0 1.4 3.1 0.0 0.0 0.0 10.7 2.6 0.1 5.8 2.1 84.0 0.0 0.0 8.0 334.2 1.5 0.3 240.6 3.3 8.2 0.0 0.0 0.0 0.0 0.0 0.8 0.3 12.9 0.1 0.0 0.5 2.6 4.5 1.3 0.0 0.4 CLEC9A "CD370, DNGR-1, HEEE9341, UNQ9341" ENSG00000197992 "C-type lectin domain containing 9A" Q6UXN8 12 10030677-10066027 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 17.3;brain: 7.8;lymphoid tissue: 8.9;testis: 21.1" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 2.2;Macrophages: 9.3;Spermatocytes: 7.0" "Cancer enriched" "Detected in some" 5 "testis cancer: 2.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 103 "myeloid DC: 17.3;neutrophil: 6.1" "Group enriched" "Detected in many" 103 "dendritic cells: 17.3;granulocytes: 6.1" "Group enriched" "Detected in some" 5 "GAMG: 2.1;Karpas-707: 1.2;U-266/84: 3.7" "Not detected" "Not detected" NA NA "unprognostic (1.13e-3)" "unprognostic (1.21e-2)" "unprognostic (5.00e-3)" "unprognostic (7.85e-3)" "unprognostic (1.28e-2)" "unprognostic (1.56e-5)" "unprognostic (6.58e-4)" "unprognostic (4.73e-3)" "unprognostic (9.65e-2)" "unprognostic (7.45e-3)" "unprognostic (8.15e-3)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (7.93e-2)" "unprognostic (3.45e-5)" "unprognostic (2.17e-1)" 0.6 0.0 3.3 1.7 2.5 0.3 0.6 0.6 1.1 0.6 0.6 0.6 0.6 0.9 0.6 0.6 0.6 0.0 1.0 0.6 3.2 3.1 0.6 0.8 0.6 8.9 5.0 0.6 0.8 0.6 0.0 0.6 1.0 0.6 0.6 0.6 0.6 1.2 0.6 0.6 0.0 1.8 0.8 7.8 6.4 0.2 21.1 0.6 0.6 0.6 0.6 2.8 0.8 0.6 0.0 17.3 6.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 6.1 0.1 0.0 0.0 0.0 0.3 3.3 2.5 0.6 1.0 3.2 3.1 5.0 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.9 0.0 0.0 0.0 0.0 0.0 CLECL1 DCAL1 ENSG00000184293 "C-type lectin like 1" Q8IZS7 12 9715860-9733299 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 9 "blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6" "Group enriched" "Detected in some" 4 "B-cells: 69.2;Hofbauer cells: 21.8;Kupffer cells: 84.7;Macrophages: 31.4;monocytes: 69.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 42.4" "Lineage enriched" "Detected in many" 5 "B-cells: 42.4" "Group enriched" "Detected in some" 5 "HEL: 16.0;Karpas-707: 22.2;U-698: 56.8;U-937: 31.2" HPA063928 Supported "Plasma membrane,Centriolar satellite" NA NA "Plasma membrane, Centriolar satellite" "HPA063928: " "unprognostic (2.18e-2)" "unprognostic (2.35e-3)" "unprognostic (2.20e-3)" "unprognostic (1.90e-3)" "unprognostic (3.66e-1)" "unprognostic (1.90e-3)" "unprognostic (2.83e-1)" "unprognostic (7.55e-4)" "unprognostic (5.10e-2)" "unprognostic (2.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-5)" "unprognostic (3.31e-1)" "unprognostic (2.45e-1)" "unprognostic (6.10e-2)" "unprognostic (7.39e-2)" 2.7 1.0 0.8 9.8 1.1 0.9 1.1 0.3 0.9 0.6 1.7 1.3 0.1 1.6 0.7 1.3 2.6 0.9 1.5 2.7 1.0 0.9 1.6 1.4 1.9 15.5 1.3 0.7 0.5 1.7 0.0 0.9 0.5 0.9 0.8 2.8 0.8 1.5 0.1 0.5 0.5 11.5 0.9 2.5 20.5 2.6 0.6 0.3 2.2 0.9 0.5 20.6 2.8 2.4 42.4 8.6 0.7 4.6 0.0 3.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 56.8 0.0 31.2 0.0 0.7 2.6 0.1 1.7 4.6 0.0 42.4 1.4 3.5 6.1 14.5 0.0 0.5 0.1 0.0 4.6 8.6 0.1 2.1 0.8 1.1 0.3 0.9 1.0 0.9 1.3 0.7 0.9 0.3 0.0 0.0 69.2 0.1 1.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.4 0.0 4.7 0.2 21.8 0.0 0.0 0.6 84.7 1.1 0.3 31.4 11.8 69.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.5 0.2 0.0 0.0 1.6 0.2 12.5 0.0 0.1 CLGN ENSG00000153132 Calmegin O14967 4 140388455-140427968 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 40.3;pituitary gland: 23.6;testis: 52.6" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 243.4;Early spermatids: 78.2;Muller glia cells: 200.1;Spermatocytes: 280.7" "Cancer enhanced" "Detected in many" "prostate cancer: 19.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 21.7;U-251 MG: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020709, HPA048761, HPA058627" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB020709: , HPA048761: AB_2680514, HPA058627: AB_2683782" "unprognostic (6.74e-2)" "unprognostic (8.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-2)" "unprognostic (2.56e-1)" "unprognostic (3.73e-3)" "unprognostic (6.14e-2)" "unprognostic (4.80e-2)" "unprognostic (3.11e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-2)" "unprognostic (2.45e-3)" "unprognostic (3.00e-3)" "unprognostic (1.29e-1)" "unprognostic (2.59e-1)" "unprognostic (1.01e-1)" 0.4 3.6 2.1 0.7 3.7 1.2 1.6 5.9 3.5 0.8 1.4 0.5 0.0 0.4 1.0 1.6 0.9 7.0 0.4 40.3 0.9 3.4 0.4 3.7 0.5 0.5 1.4 1.6 1.8 1.6 0.2 23.6 0.3 8.6 11.9 0.8 2.4 0.6 0.6 0.4 0.3 0.8 0.9 0.8 0.3 1.6 52.6 0.3 3.1 1.5 0.0 0.8 0.6 0.4 0.5 1.0 3.4 1.1 0.0 0.0 0.1 0.0 4.0 4.2 2.7 1.7 8.8 1.0 0.0 3.7 4.0 7.5 0.1 0.3 0.0 11.5 0.4 3.5 0.1 2.9 0.0 6.6 0.2 3.4 1.1 4.0 2.9 17.5 14.6 0.2 1.0 16.1 0.4 0.4 21.7 0.1 3.9 0.7 0.0 0.0 0.2 18.3 0.2 4.8 0.1 11.4 12.2 0.0 0.1 0.0 0.1 6.8 12.3 2.5 1.6 0.7 1.6 0.8 2.2 0.0 11.0 2.0 4.0 28.9 5.8 12.6 7.9 17.7 0.6 1.2 3.4 1.1 1.5 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 3.7 5.9 3.5 0.9 3.4 1.4 1.6 8.6 0.3 0.0 2.1 0.0 1.0 0.0 8.5 243.4 0.0 28.1 4.5 0.0 3.9 0.3 0.0 0.9 78.2 1.1 0.0 23.3 3.7 0.1 0.5 35.3 0.0 2.6 0.1 23.8 5.1 0.0 0.0 42.6 4.6 0.0 1.7 0.0 0.0 200.1 1.4 0.0 4.2 0.0 11.8 0.0 0.3 280.7 9.8 0.1 0.2 0.0 0.4 0.9 CLMN "FLJ12383, KIAA0500, KIAA1188" ENSG00000165959 Calmin Q96JQ2 14 95181940-95319906 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 153.5;Late spermatids: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 11.9;SK-BR-3: 13.7;T-47d: 11.5;WM-115: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012634 Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "HPA012634: AB_1846973" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (4.20e-2)" "unprognostic (6.07e-2)" "unprognostic (8.88e-2)" "unprognostic (4.31e-1)" "unprognostic (4.18e-2)" "unprognostic (7.24e-2)" "unprognostic (8.31e-2)" "unprognostic (2.64e-1)" "unprognostic (1.29e-3)" "unprognostic (3.09e-2)" "prognostic favorable (2.68e-7)" "unprognostic (8.27e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (9.91e-3)" 14.1 2.3 11.0 5.9 36.3 2.0 13.0 3.1 20.1 7.8 15.3 31.6 5.6 4.6 5.6 11.0 4.3 8.2 8.3 3.7 13.0 5.6 18.9 18.8 5.2 2.3 38.1 8.0 3.5 18.1 4.7 3.4 9.2 17.2 8.0 17.6 7.1 9.4 7.9 4.6 3.5 6.9 4.5 14.5 3.6 10.0 33.4 34.0 0.0 6.6 1.8 2.9 7.3 7.1 3.8 3.0 7.2 8.4 0.0 0.1 2.1 5.2 7.0 1.1 0.2 4.3 1.9 0.4 0.1 0.0 0.3 0.2 0.6 8.8 0.0 0.8 0.0 11.9 4.6 0.5 3.1 0.0 3.5 1.3 0.1 0.2 4.1 0.4 0.0 0.1 2.1 3.1 1.4 5.0 1.7 3.6 1.9 0.0 1.0 2.6 4.5 0.2 0.4 0.4 6.3 1.7 3.9 3.8 2.3 3.4 8.6 1.4 1.4 1.8 13.7 7.0 1.1 11.5 0.3 1.0 0.1 3.2 0.0 0.2 1.4 0.1 4.8 2.5 2.1 13.1 6.0 8.4 0.7 0.0 3.0 0.0 3.8 0.0 0.0 1.8 2.2 0.0 0.1 7.2 0.0 1.8 3.0 0.0 2.1 11.0 36.3 3.1 20.1 13.0 5.6 38.1 8.0 17.2 34.0 14.9 4.3 9.8 28.6 5.6 59.5 42.8 43.3 50.9 12.5 55.8 13.7 1.6 23.2 46.5 153.5 5.6 41.0 0.0 41.2 1.5 4.6 50.7 4.6 61.4 7.5 36.5 22.4 1.8 17.1 245.4 20.8 7.6 3.3 6.4 64.0 3.2 40.2 35.1 10.3 17.9 25.8 103.5 91.4 4.1 16.6 2.3 2.4 2.2 48.8 39.4 CLMP "ACAM, ASAM, FLJ22415" ENSG00000166250 "CXADR like membrane protein" Q9H6B4 11 123069865-123195281 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Extravillous trophoblasts: 14.8;Fibroblasts: 41.4;Leydig cells: 19.2;Peritubular cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 29.9;BJ: 39.5;BJ hTERT+: 37.0;hTEC/SVTERT24-B: 30.2;hTERT-HME1: 36.9;U-138 MG: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 120000 "unprognostic (1.63e-2)" "unprognostic (6.65e-3)" "unprognostic (1.06e-1)" "unprognostic (1.09e-1)" "unprognostic (3.46e-2)" "unprognostic (9.42e-3)" "unprognostic (1.31e-1)" "unprognostic (1.35e-3)" "unprognostic (9.66e-3)" "unprognostic (3.25e-2)" "unprognostic (4.02e-3)" "unprognostic (3.87e-2)" "unprognostic (9.78e-8)" "unprognostic (3.88e-3)" "unprognostic (1.26e-1)" "unprognostic (1.19e-2)" "unprognostic (1.69e-2)" 29.8 3.4 1.2 7.3 0.7 0.0 38.5 5.9 3.3 22.7 19.6 0.2 6.0 3.6 18.8 5.8 16.2 10.0 18.6 8.5 4.2 0.7 4.2 0.5 5.1 5.9 1.0 1.3 8.7 1.4 0.0 1.3 13.5 2.6 11.2 5.7 9.4 3.5 4.6 3.2 3.6 9.3 19.4 4.6 6.2 10.4 4.9 0.1 0.1 1.7 4.8 2.4 17.4 16.4 1.3 0.8 3.2 0.6 1.0 1.2 0.3 0.6 0.7 1.7 3.5 29.9 26.1 10.7 39.5 37.0 5.6 10.4 1.6 0.0 0.0 0.1 28.8 19.4 0.0 0.0 10.4 6.5 0.2 0.0 0.0 1.7 0.0 9.8 0.0 0.0 14.6 7.2 30.2 36.9 14.1 2.7 0.0 0.0 0.0 7.7 0.0 0.0 0.0 4.0 0.0 4.6 0.0 0.6 0.0 2.9 0.0 4.8 11.8 0.0 0.1 0.0 0.8 0.1 0.0 9.9 55.2 0.5 22.4 4.8 0.0 0.0 0.0 14.9 0.0 1.7 1.6 0.6 0.8 0.8 0.3 1.2 0.7 1.1 0.9 0.2 1.3 0.6 0.7 3.2 1.0 0.6 0.8 0.4 0.3 1.2 0.7 5.9 3.3 4.2 0.7 1.0 1.3 2.6 0.1 0.0 3.8 0.0 0.2 1.3 1.5 4.6 0.0 0.0 0.0 0.0 0.0 8.6 0.0 1.2 0.4 1.1 0.0 0.0 1.2 14.8 41.4 1.1 0.0 0.0 3.2 1.6 6.4 3.7 0.0 0.2 19.2 0.0 0.0 0.0 0.0 0.4 0.6 0.0 54.5 0.0 0.9 0.0 3.4 0.1 0.0 0.9 8.7 0.0 0.0 0.1 CLN3 "BTN1, BTS, JNCL" ENSG00000188603 "CLN3, battenin" Q13286 16 28474111-28495575 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 278.0;Syncytiotrophoblasts: 377.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 53.8;SK-BR-3: 52.9" HPA063280 Uncertain NA NA "HPA063280: AB_2684975" "unprognostic (2.38e-3)" "unprognostic (2.41e-2)" "unprognostic (7.06e-2)" "unprognostic (8.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (2.36e-2)" "unprognostic (1.69e-2)" "unprognostic (6.38e-3)" "unprognostic (8.16e-2)" "unprognostic (6.27e-2)" "unprognostic (5.26e-1)" "unprognostic (9.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.05e-2)" 14.0 23.8 10.6 15.7 11.8 9.0 15.8 14.5 10.3 12.5 27.1 14.6 61.5 14.8 11.7 23.0 15.2 10.6 10.1 9.2 10.8 7.1 18.2 22.3 20.6 15.3 14.4 8.0 14.6 18.4 22.2 6.7 26.0 11.4 13.3 20.4 11.9 22.6 45.3 9.3 16.9 17.4 9.6 13.1 15.8 18.6 7.5 16.5 8.9 19.1 9.4 10.0 15.4 14.8 11.6 28.2 39.6 25.0 15.3 24.1 17.6 6.3 10.9 4.5 10.8 12.2 6.0 53.8 4.0 12.4 9.1 11.0 5.4 15.8 4.7 13.5 7.3 16.4 6.8 7.7 7.4 3.9 11.6 10.4 4.5 7.4 16.0 18.7 6.8 19.6 8.1 17.9 7.0 4.5 7.7 10.0 7.5 7.9 14.4 9.1 15.2 6.0 11.1 6.9 9.6 7.1 10.4 4.4 14.7 8.7 14.3 6.1 6.3 1.9 52.9 5.1 4.4 17.0 9.2 5.5 5.4 3.1 7.4 6.7 16.3 18.3 4.5 8.7 14.0 3.8 18.1 25.0 39.6 24.1 19.5 18.0 9.6 19.4 23.3 27.2 11.6 16.1 18.2 9.4 15.3 14.3 28.2 19.7 17.6 10.6 11.8 14.5 10.3 10.8 7.1 14.4 8.0 11.4 16.5 20.8 15.7 9.0 13.8 0.1 9.9 0.0 33.1 2.7 11.4 1.8 11.8 278.0 0.0 1.5 0.9 5.8 37.7 0.0 0.5 81.9 4.1 11.7 2.3 32.7 61.9 12.7 16.4 18.4 38.9 0.5 17.5 7.9 0.0 1.0 51.1 26.6 1.3 59.6 11.7 0.7 10.6 12.9 0.0 2.3 6.8 0.1 377.5 17.3 69.6 13.6 CLN5 ENSG00000102805 "CLN5, intracellular trafficking protein" O75503 13 76990660-77019143 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 114.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA041788 Approved "Intracellular and membrane" NA NA 430000 "HPA041788: AB_10962726" "unprognostic (1.19e-2)" "unprognostic (1.75e-1)" "unprognostic (1.06e-1)" "unprognostic (2.02e-1)" "unprognostic (9.82e-2)" "unprognostic (2.07e-3)" "unprognostic (3.41e-1)" "unprognostic (7.80e-2)" "unprognostic (2.29e-1)" "unprognostic (2.90e-1)" "unprognostic (6.98e-2)" "unprognostic (2.65e-1)" "prognostic favorable (1.52e-9)" "unprognostic (2.35e-1)" "unprognostic (7.04e-2)" "unprognostic (5.64e-2)" "unprognostic (8.15e-2)" 15.7 17.0 10.4 11.0 11.1 8.5 18.2 9.9 9.5 15.7 11.1 12.9 12.7 7.5 13.3 26.0 12.0 15.7 16.4 14.3 10.2 10.0 34.8 21.7 12.7 13.8 16.1 6.8 21.1 15.0 17.5 20.9 22.2 14.2 14.1 10.1 16.7 13.6 15.4 11.4 10.0 13.5 14.0 13.9 12.0 12.9 10.9 13.4 13.5 45.2 7.0 10.8 13.2 11.8 8.1 6.3 24.0 14.4 0.6 13.9 8.0 11.6 5.6 8.2 6.9 36.3 23.7 10.5 11.0 20.0 8.7 15.0 6.3 11.1 5.1 8.7 15.4 10.2 12.9 5.5 12.0 9.6 9.5 11.9 6.4 7.1 5.8 16.3 8.9 9.9 21.1 13.6 4.4 8.9 18.2 15.2 6.7 4.4 9.0 20.3 3.8 5.7 6.1 5.3 22.4 5.3 4.5 7.4 4.4 20.4 6.9 3.7 5.6 7.0 8.5 12.9 11.2 9.1 12.8 14.8 6.7 5.5 7.6 6.7 12.0 14.0 5.7 17.4 6.8 14.8 24.0 8.9 20.9 2.1 12.4 1.8 8.0 10.3 3.6 6.0 8.1 13.3 8.0 6.6 0.6 14.4 6.3 13.9 8.0 10.4 11.1 9.9 9.5 10.2 10.0 16.1 6.8 14.2 13.4 14.9 25.9 17.6 25.9 10.2 19.6 6.7 30.6 33.5 42.1 64.6 9.8 44.5 8.3 32.9 1.5 20.4 16.4 0.0 33.4 114.1 33.4 28.5 21.9 30.6 41.7 6.4 13.3 26.4 21.3 3.0 46.1 26.5 23.6 33.3 12.3 47.7 21.7 13.6 44.6 40.4 24.2 19.4 28.9 19.1 39.4 10.0 38.8 9.2 9.6 18.8 CLN6 "FLJ20561, HsT18960, nclf" ENSG00000128973 "CLN6, transmembrane ER protein" Q9NWW5 15 68206992-68257211 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 161.8;Hofbauer cells: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066046, HPA066759" Approved Approved "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" "Nucleoli, Vesicles" "HPA066046: AB_2685604, HPA066759: " "unprognostic (1.01e-1)" "unprognostic (1.54e-3)" "unprognostic (7.01e-2)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (3.08e-1)" "unprognostic (2.24e-2)" "unprognostic (5.07e-2)" "unprognostic (2.40e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.85e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-1)" "unprognostic (6.78e-2)" 21.2 17.8 11.6 16.5 11.8 29.8 13.9 14.9 20.7 14.4 20.2 13.2 11.6 17.1 11.7 14.3 16.7 12.0 17.1 10.4 11.7 10.8 22.0 29.5 18.8 27.0 11.1 12.2 12.4 19.7 11.7 11.5 18.6 14.3 13.4 18.0 28.6 16.0 17.9 16.3 17.0 18.5 12.4 11.6 26.5 15.7 13.8 9.7 27.7 14.5 18.2 21.7 11.0 10.9 2.9 4.6 9.4 13.4 1.8 4.1 2.7 11.5 28.8 7.5 10.6 4.7 3.8 18.2 11.0 5.3 13.6 11.2 22.2 18.8 18.0 5.5 6.5 10.1 21.5 21.6 10.7 5.4 11.9 26.4 25.9 21.1 16.5 9.6 29.1 18.5 6.7 3.6 10.9 7.5 2.8 9.0 10.3 17.0 36.5 10.4 31.6 13.2 20.9 18.1 20.5 12.3 12.9 23.1 24.5 11.3 30.2 15.5 6.4 12.4 19.4 10.6 5.9 10.4 29.1 5.9 15.3 18.2 11.3 38.9 26.7 29.0 14.7 9.6 35.4 14.8 0.0 7.3 0.4 2.8 11.5 3.8 2.9 2.1 4.1 4.6 2.3 2.7 1.2 9.4 1.8 13.4 3.8 1.9 2.7 11.6 11.8 14.9 20.7 11.7 10.8 11.1 12.2 14.3 9.7 8.9 5.8 12.7 17.8 17.9 161.8 19.9 0.0 0.0 4.5 5.2 15.7 29.2 0.0 3.1 0.2 12.9 13.6 23.3 1.6 44.9 15.2 12.6 9.2 17.7 76.0 20.6 14.6 14.1 18.0 1.3 8.3 11.9 18.6 7.2 15.3 16.9 3.1 20.9 7.8 1.3 31.0 6.5 8.0 0.9 16.8 12.3 18.2 10.9 30.5 14.5 CLN8 "C8orf61, EPMR, FLJ39417" ENSG00000182372 "CLN8, transmembrane ER and ERGIC protein" Q9UBY8 8 1755778-1801711 "Disease related genes, Predicted membrane proteins" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 35.5" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "plasmacytoid DC: 35.5" "Lineage enriched" "Detected in all" 5 "dendritic cells: 35.5" "Low cell line specificity" "Detected in many" NA NA "unprognostic (5.86e-2)" "unprognostic (1.95e-2)" "unprognostic (6.40e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (4.05e-3)" "unprognostic (1.21e-1)" "unprognostic (3.45e-1)" "unprognostic (3.03e-1)" "unprognostic (6.66e-2)" "unprognostic (9.69e-3)" "unprognostic (1.83e-1)" "prognostic favorable (4.36e-8)" "unprognostic (1.36e-1)" "unprognostic (1.70e-1)" "unprognostic (6.24e-2)" "unprognostic (8.38e-2)" 6.4 4.6 10.3 5.2 11.5 12.8 4.2 5.5 11.4 4.2 6.1 22.8 5.1 8.3 5.0 7.7 14.6 5.6 13.3 8.1 12.2 8.7 6.2 12.0 7.5 8.2 21.3 6.1 3.3 11.5 2.2 4.0 8.9 12.1 4.2 5.2 3.0 6.1 7.2 4.8 10.3 6.2 6.8 24.1 8.9 7.3 7.3 14.6 3.9 6.1 6.4 7.6 11.3 4.5 6.8 35.5 2.6 6.0 2.1 3.4 2.7 3.1 7.0 1.7 3.1 3.5 3.4 8.2 5.4 4.3 3.5 5.0 5.1 8.4 4.3 2.5 2.9 3.2 5.9 3.4 6.1 7.0 2.0 1.6 3.5 2.4 1.7 1.4 2.0 11.8 2.0 3.5 3.8 2.0 0.6 6.9 5.5 4.0 2.1 6.9 3.1 6.2 1.9 3.4 8.7 6.6 4.2 2.5 2.4 4.4 5.6 1.0 1.6 2.2 1.7 2.3 4.7 13.3 2.9 9.7 7.4 2.8 0.8 4.0 0.8 4.1 6.1 3.8 4.6 8.5 2.6 4.7 1.9 3.2 6.0 3.4 4.8 3.3 2.1 4.7 6.8 3.3 2.2 1.3 2.1 5.0 35.5 3.2 2.7 10.3 11.5 5.5 11.4 12.2 8.7 21.3 6.1 12.1 14.6 8.9 17.4 41.7 67.0 48.5 25.6 7.1 17.8 17.4 20.5 29.6 29.5 28.5 13.3 22.8 3.3 40.5 18.2 23.3 16.7 15.9 22.8 74.2 27.6 23.7 40.5 38.1 18.9 29.4 36.1 4.9 7.5 56.8 20.3 11.8 14.0 14.7 16.6 18.2 11.3 7.6 25.5 12.9 16.5 14.9 10.9 55.6 110.1 17.3 14.4 48.1 CLPS ENSG00000137392 Colipase P04118 6 35794982-35797344 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Digestion, Lipid degradation, Lipid metabolism" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1551 "pancreas: 4260.9" "Cell type enriched" "Detected in some" 9 "Exocrine glandular cells: 19853.4" "Cancer enriched" "Detected in many" 188 "pancreatic cancer: 1726.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 2.6;HDLM-2: 1.3;T-47d: 3.4;U-2 OS: 3.0;U-266/84: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA010512 Enhanced "Secreted to digestive system" NA NA 1100000 "HPA010512: AB_1846979" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (8.12e-3)" "unprognostic (2.47e-1)" "unprognostic (1.33e-1)" "unprognostic (1.61e-1)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.6 4260.9 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.4 2.7 0.4 1.3 1.1 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 3.0 0.0 1.0 0.0 2.4 1.0 0.0 0.9 0.0 0.5 0.4 1.3 0.1 0.2 0.0 0.3 1.1 0.1 0.4 0.5 0.3 0.0 2.7 1.3 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.4 0.0 0.0 0.0 0.0 19853.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 228.2 0.0 0.0 2154.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 CLPSL1 "C6orf127, dJ510O8.6" ENSG00000204140 "Colipase like 1" A2RUU4 6 35781017-35793675 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "epididymis: 123.5;pancreas: 103.6" "Group enriched" "Detected in some" 40 "Exocrine glandular cells: 32.7;Pancreatic endocrine cells: 14.1" "Group enriched" "Detected in some" 6 "breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "T-47d: 13.9" HPA073155 Enhanced "Secreted in male reproductive system" NA NA "HPA073155: AB_2686576" "unprognostic (7.97e-2)" "unprognostic (1.58e-1)" "unprognostic (4.75e-1)" "unprognostic (2.54e-1)" "unprognostic (3.10e-2)" "unprognostic (2.13e-1)" "unprognostic (1.97e-1)" "unprognostic (6.60e-2)" "unprognostic (7.06e-3)" 0.1 0.1 1.6 0.0 0.2 0.0 0.8 0.1 0.9 0.1 0.1 0.0 9.6 0.0 0.1 123.5 0.1 0.1 0.0 0.1 1.8 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.1 103.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 13.9 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.1 0.9 1.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 CLPSL2 "C6orf126, dJ510O8.5, UNQ3045" ENSG00000196748 "Colipase like 2" Q6UWE3 6 35776594-35779552 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "epididymis: 124.8" "Group enriched" "Detected in some" 6 "Exocrine glandular cells: 3.5;Intestinal endocrine cells: 1.7;Pancreatic endocrine cells: 3.5;Spermatogonia: 1.5" "Cancer enhanced" "Detected in some" "breast cancer: 2.6" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 25 "plasmacytoid DC: 2.4" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.4" "Cell line enriched" "Detected in some" 6 "T-47d: 12.6" HPA051655 Approved "Secreted in male reproductive system" NA NA "HPA051655: " "unprognostic (2.38e-1)" "unprognostic (3.65e-1)" "unprognostic (6.39e-3)" "unprognostic (9.38e-2)" "unprognostic (4.03e-2)" "unprognostic (2.47e-1)" "unprognostic (4.85e-3)" "unprognostic (8.69e-2)" "unprognostic (3.17e-2)" "unprognostic (3.95e-2)" "unprognostic (1.49e-1)" "unprognostic (1.13e-1)" "unprognostic (2.37e-1)" 0.0 0.0 0.4 0.0 0.2 0.0 0.7 0.0 1.1 0.0 0.0 0.0 2.3 0.0 0.0 124.8 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 9.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.3 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.0 0.4 0.5 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.3 1.3 0.0 1.1 0.4 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.6 0.0 0.3 12.6 1.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.4 0.4 0.2 0.0 1.1 0.8 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.1 0.0 0.0 0.0 CLPTM1 ENSG00000104853 "CLPTM1, transmembrane protein" O96005 19 44954585-44993341 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068702, HPA068767" Approved Approved "Nuclear membrane,Centriolar satellite" NA NA "Nuclear membrane, Centriolar satellite" "HPA068702: AB_2686020, HPA068767: " "unprognostic (1.40e-1)" "unprognostic (1.32e-1)" "unprognostic (4.07e-1)" "unprognostic (2.19e-1)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.94e-1)" "unprognostic (5.93e-2)" "unprognostic (6.60e-3)" "unprognostic (2.67e-2)" "unprognostic (1.46e-3)" "unprognostic (2.62e-1)" "unprognostic (1.02e-2)" "unprognostic (3.30e-1)" "unprognostic (2.56e-1)" "unprognostic (7.46e-2)" "unprognostic (1.59e-1)" 29.7 53.4 39.4 20.3 56.2 14.7 20.2 26.7 66.4 25.8 26.6 36.8 17.3 31.5 20.3 24.0 23.7 25.6 22.1 32.2 35.7 35.7 40.6 62.5 23.1 19.1 36.0 33.7 26.9 36.2 53.8 21.1 34.3 37.7 27.1 21.3 30.2 38.0 29.6 37.6 32.9 27.6 23.7 27.2 22.6 25.1 26.7 30.7 13.9 27.3 16.1 26.3 19.5 18.6 18.4 24.1 25.5 28.8 12.5 24.4 11.8 26.5 60.1 14.0 27.7 46.7 18.8 14.9 26.3 29.0 31.1 33.5 26.0 26.9 26.5 29.4 34.8 22.9 31.4 24.9 23.8 21.1 19.4 34.4 20.5 22.7 21.8 33.0 16.3 24.1 29.4 25.3 29.7 19.3 22.2 21.6 15.5 21.3 37.1 27.4 24.0 17.1 9.6 12.6 38.7 20.0 17.8 15.2 25.6 28.9 37.3 16.5 18.2 32.6 48.4 14.2 13.0 26.5 13.1 20.0 35.0 21.8 18.3 32.6 26.1 56.9 20.6 28.9 16.2 32.0 10.4 16.7 25.5 17.0 23.6 14.3 17.5 18.3 24.4 15.4 18.4 14.5 12.2 15.7 12.5 28.8 24.1 15.1 11.8 39.4 56.2 26.7 66.4 35.7 35.7 36.0 33.7 37.7 30.7 6.0 5.6 29.8 29.5 32.5 35.2 10.1 33.1 6.7 10.3 34.9 37.3 80.2 11.6 67.1 41.8 27.0 90.3 0.0 64.6 70.4 35.2 31.5 10.4 43.3 66.9 41.3 39.0 25.8 23.2 42.5 27.9 27.2 32.1 141.5 38.2 56.2 55.1 50.4 28.3 50.1 26.9 25.8 28.3 31.6 29.4 38.5 100.3 22.9 40.1 31.7 CLPTM1L "CRR9, FLJ14400" ENSG00000049656 "CLPTM1 like" Q96KA5 5 1317744-1345099 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 114.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 83.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014791 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA014791: AB_1847250" "unprognostic (2.92e-2)" "unprognostic (1.34e-1)" "unprognostic (9.53e-2)" "unprognostic (8.43e-2)" "unprognostic (5.16e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.75e-4)" "unprognostic (3.42e-2)" "unprognostic (1.41e-1)" "unprognostic (5.47e-3)" "unprognostic (9.14e-3)" "unprognostic (1.06e-1)" "unprognostic (5.77e-3)" "unprognostic (8.57e-2)" "unprognostic (4.92e-2)" "unprognostic (4.54e-2)" "unprognostic (4.17e-2)" 15.8 14.1 10.6 20.5 12.4 13.5 16.3 6.7 16.9 13.8 19.0 11.1 12.1 24.6 12.0 10.6 15.7 11.7 20.7 13.1 11.3 12.2 29.4 56.1 20.0 17.6 14.8 8.3 11.3 57.6 10.0 14.6 15.8 11.6 13.9 11.0 13.1 33.3 14.5 8.3 12.3 23.6 12.1 9.2 22.5 25.6 20.0 9.8 37.2 30.9 11.3 21.1 13.8 9.8 10.4 12.3 12.3 9.6 12.8 9.7 5.2 12.7 21.7 7.4 20.0 12.1 5.2 19.6 13.1 8.7 11.8 11.7 23.6 20.4 12.2 40.5 12.2 26.3 11.2 10.0 10.9 5.4 49.6 27.5 6.4 50.7 15.6 13.6 16.8 16.5 8.3 12.5 10.9 10.2 8.7 9.6 28.1 14.5 41.9 8.9 20.9 18.5 22.1 13.7 14.2 23.6 15.7 12.1 37.4 9.2 12.2 7.8 15.5 22.9 19.9 9.9 6.5 33.5 25.3 7.1 14.2 40.8 9.8 18.8 75.8 83.6 19.7 10.6 25.4 16.1 4.6 6.7 12.3 7.9 6.2 9.3 9.7 8.4 7.8 6.0 10.4 8.0 9.6 5.2 12.8 9.6 12.3 9.7 5.2 10.6 12.4 6.7 16.9 11.3 12.2 14.8 8.3 11.6 9.8 53.6 65.0 17.1 16.0 19.8 9.7 11.3 50.9 32.1 38.7 27.9 13.7 9.6 5.0 15.2 2.0 19.5 35.1 23.3 27.7 17.2 13.6 39.9 24.3 114.3 20.9 20.6 42.9 25.8 37.2 2.6 16.1 17.0 15.1 6.4 46.8 21.2 37.1 28.5 18.0 58.6 10.5 12.9 13.3 18.9 35.7 20.6 9.2 18.1 32.0 28.8 CLRN1 "RP61, USH3, USH3A" ENSG00000163646 "Clarin 1" P58418 3 150926163-150972999 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hearing, Sensory transduction, Vision" "Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 11.2;retina: 16.2" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 150.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 32 "NTERA-2: 8.9" NA NA "unprognostic (1.00e-3)" "unprognostic (1.26e-1)" "unprognostic (5.54e-1)" "unprognostic (9.68e-2)" 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.1 0.0 1.6 0.0 2.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.8 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 8.9 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 150.4 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLRN2 ENSG00000249581 "Clarin 2" A0PK11 4 17515165-17527104 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 1.2;salivary gland: 1.1;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA042407 Uncertain NA NA "HPA042407: AB_10806237" 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.5 1.2 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLRN3 "MGC32871, TMEM12, USH3AL1" ENSG00000180745 "Clarin 3" Q8NCR9 10 127877841-127892947 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 69.3;kidney: 14.7;liver: 25.6" "Group enriched" "Detected in some" 5 "Enterocytes: 118.1;Hepatocytes: 34.8;Intestinal endocrine cells: 39.9;Mucus-secreting cells: 70.4;Paneth cells: 98.2;Proximal tubular cells: 59.1;Undifferentiated cells: 39.3" "Group enriched" "Detected in many" 10 "colorectal cancer: 45.3;liver cancer: 9.4;pancreatic cancer: 10.7;renal cancer: 30.0;stomach cancer: 16.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 40 "OE19: 46.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014482 Approved NA NA "HPA014482: AB_2082885" "unprognostic (7.34e-3)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (1.46e-3)" "unprognostic (1.22e-2)" "unprognostic (1.06e-1)" "unprognostic (5.08e-2)" "unprognostic (2.62e-1)" "unprognostic (6.22e-2)" "unprognostic (4.67e-1)" "unprognostic (8.86e-2)" "prognostic favorable (8.98e-4)" "unprognostic (1.74e-1)" "unprognostic (2.89e-3)" "unprognostic (3.00e-2)" 0.4 0.2 0.3 3.1 0.2 0.0 0.2 0.2 0.3 0.2 27.5 0.3 0.2 23.7 0.2 1.3 0.2 0.1 9.5 0.2 0.3 0.2 14.7 25.6 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 23.5 0.2 0.2 0.2 0.2 0.1 69.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 1.4 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.1 0.3 0.2 0.2 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 118.1 0.0 0.5 0.0 0.0 0.0 0.0 34.8 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.4 0.0 0.2 98.2 0.0 59.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.3 0.0 CLSTN1 "CDHR12, CSTN1, KIAA0911" ENSG00000171603 "Calsyntenin 1" O94985 1 9729026-9824526 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.0" "Cell type enhanced" "Detected in all" 8 "Cone photoreceptor cells: 412.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012412, HPA077705" Enhanced NA NA 70000000 "HPA012412: AB_1846981, HPA077705: " "unprognostic (4.63e-2)" "unprognostic (2.89e-1)" "unprognostic (9.76e-2)" "unprognostic (1.43e-1)" "unprognostic (9.79e-2)" "unprognostic (1.63e-1)" "unprognostic (2.44e-3)" "unprognostic (3.07e-2)" "unprognostic (2.54e-1)" "unprognostic (3.24e-2)" "unprognostic (1.34e-1)" "unprognostic (1.25e-1)" "prognostic favorable (4.10e-7)" "unprognostic (1.12e-1)" "unprognostic (2.65e-1)" "unprognostic (4.05e-2)" "unprognostic (4.72e-2)" 13.6 20.1 38.2 15.0 51.2 5.2 15.4 90.5 102.0 24.2 28.6 25.1 11.7 16.7 35.9 14.2 21.0 35.1 25.6 16.3 32.1 31.2 23.3 4.7 16.0 16.4 25.8 53.8 33.6 31.1 27.8 21.0 22.8 32.3 33.6 26.1 29.8 30.0 24.9 10.3 45.6 18.6 28.8 22.0 14.4 15.1 8.1 21.6 15.3 20.9 12.9 16.1 18.0 23.6 2.5 2.7 8.5 1.7 0.9 6.3 2.5 27.7 16.5 23.9 22.1 25.5 16.9 7.9 17.7 19.9 22.7 20.8 11.6 66.9 21.9 46.4 34.9 21.6 39.7 14.0 62.6 18.2 24.8 17.0 6.5 20.7 12.2 35.4 12.2 10.6 17.2 43.2 29.3 19.9 33.3 31.6 12.7 3.0 17.1 11.1 12.9 13.5 6.4 10.0 16.7 13.3 20.4 8.7 10.5 28.1 8.1 25.4 16.0 25.6 49.2 19.8 15.1 10.0 20.9 47.1 26.9 21.4 17.9 29.3 17.4 16.0 31.7 23.0 19.7 30.3 8.5 1.4 4.3 6.3 1.7 3.3 2.3 4.0 4.7 2.7 2.5 2.9 2.6 0.8 0.9 1.7 1.7 3.6 2.5 38.2 51.2 90.5 99.9 32.1 31.2 25.8 53.8 32.3 21.6 26.8 14.9 18.6 53.3 38.9 198.8 10.5 58.6 40.2 38.7 48.8 412.3 27.6 1.7 25.3 3.7 30.8 111.5 23.3 34.1 12.2 32.6 55.8 11.5 2.0 24.2 170.0 29.6 34.4 22.3 3.2 42.8 12.3 30.4 20.8 86.8 156.4 43.0 51.5 47.4 25.6 134.9 84.1 20.6 13.5 37.1 22.8 16.0 25.3 48.3 36.5 CLSTN2 "CDHR13, CS2, CSTN2, FLJ39113" ENSG00000158258 "Calsyntenin 2" Q9H4D0 3 139935185-140577397 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;ovary: 59.4" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 17.1;Late spermatids: 10.8;Leydig cells: 25.9" "Cancer enriched" "Detected in many" 7 "breast cancer: 15.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 21.0;SCLC-21H: 9.3;SuSa: 28.6;THP-1: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031342, HPA061800" Approved Uncertain "Vesicles,Cytokinetic bridge" Yes No 9100 Vesicles "Cytokinetic bridge" "HPA031342: AB_10602800, HPA061800: AB_2684615" "unprognostic (7.58e-2)" "unprognostic (2.64e-2)" "unprognostic (8.02e-2)" "unprognostic (1.51e-3)" "unprognostic (5.52e-3)" "unprognostic (8.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (5.58e-1)" "unprognostic (6.25e-2)" "unprognostic (2.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-2)" "unprognostic (3.16e-2)" "unprognostic (7.63e-5)" "unprognostic (7.22e-5)" 14.2 5.0 4.9 1.0 9.8 0.8 8.5 1.5 19.7 4.1 1.8 2.4 0.3 1.2 5.2 1.8 1.6 3.6 2.6 5.9 15.4 4.0 4.5 1.5 1.7 2.8 4.1 14.3 59.4 2.0 1.5 1.3 1.5 23.7 5.4 1.4 3.0 1.6 1.8 1.9 2.1 1.5 6.6 1.4 0.8 1.4 1.9 0.5 0.0 2.9 0.5 1.0 1.9 4.7 0.3 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 3.3 0.0 1.4 0.4 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 1.3 0.0 0.0 0.0 28.6 1.4 5.8 0.0 0.7 0.3 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 4.9 9.8 1.5 19.7 15.4 4.0 4.1 14.3 23.7 0.5 0.0 0.0 0.0 0.2 0.5 0.7 5.3 0.0 5.3 1.2 3.5 0.0 0.2 1.7 0.0 17.1 0.7 0.0 0.0 0.2 0.0 1.6 5.3 0.0 0.0 0.1 0.0 0.0 3.1 0.8 10.8 25.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 7.9 3.7 0.0 6.1 0.7 0.7 0.0 0.0 0.0 0.0 0.1 CLSTN3 "CDHR14, CSTN3, KIAA0726" ENSG00000139182 "Calsyntenin 3" Q9BQT9 12 7129698-7158945 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.0" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 150.4;Cone photoreceptor cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 12.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 50000 "prognostic favorable (5.08e-4)" "unprognostic (2.84e-2)" "unprognostic (1.06e-3)" "unprognostic (1.33e-2)" "unprognostic (6.73e-3)" "unprognostic (6.35e-2)" "unprognostic (9.52e-2)" "unprognostic (2.58e-1)" "unprognostic (2.94e-1)" "unprognostic (1.85e-1)" "prognostic favorable (1.19e-5)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.49e-5)" "unprognostic (2.19e-2)" "unprognostic (6.14e-2)" "unprognostic (1.91e-1)" "prognostic favorable (8.07e-4)" 11.0 16.2 22.1 14.9 37.1 14.4 6.8 51.4 64.0 5.9 6.0 5.7 1.7 8.1 8.1 4.2 4.9 7.2 12.2 4.1 19.2 33.3 14.1 14.6 7.8 15.4 13.3 31.6 13.2 6.9 14.4 15.0 4.1 37.6 5.8 6.0 7.6 8.1 5.7 1.4 11.1 7.1 8.9 6.0 14.1 6.1 3.5 4.0 6.7 6.5 1.0 11.3 12.0 5.6 0.3 0.2 2.6 0.0 12.4 7.2 1.9 6.6 11.1 3.8 9.2 4.6 6.7 17.2 3.9 9.2 6.8 11.2 16.1 10.5 10.7 2.9 7.7 7.9 8.7 6.9 7.6 4.0 10.8 6.6 17.7 17.4 15.1 6.3 2.7 32.2 20.1 7.6 8.7 10.7 32.6 8.2 10.2 16.5 6.6 1.6 2.0 6.9 2.9 10.9 0.4 0.7 4.6 0.0 3.1 10.4 12.4 5.0 8.2 9.4 2.3 1.5 9.8 4.5 6.4 4.9 4.3 13.0 9.8 2.1 8.1 1.9 1.4 7.6 3.7 2.6 2.6 0.0 0.0 7.2 0.0 4.1 0.3 3.2 6.1 0.2 0.3 1.1 2.5 0.5 12.4 0.0 0.1 3.3 1.9 22.1 37.1 51.4 64.0 19.2 33.3 13.3 31.6 37.6 4.0 0.0 3.8 0.0 2.3 3.7 150.4 1.2 7.6 0.0 1.2 14.0 58.9 4.9 0.0 8.1 0.8 7.7 1.7 0.0 6.4 6.3 4.3 1.9 5.7 23.1 1.0 25.4 28.2 4.3 3.5 0.6 11.8 1.7 5.0 1.0 3.4 9.5 6.3 2.9 6.0 28.2 36.4 6.5 2.5 0.7 1.1 5.0 2.7 13.6 2.8 1.6 CLTRN "NX17, TMEM27" ENSG00000147003 "Collectrin, amino acid transport regulator" Q9HBJ8 X 15627318-15665031 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "kidney: 204.4" "Cell type enriched" "Detected in some" 15 "Proximal tubular cells: 679.1" "Cancer enriched" "Detected in many" 35 "renal cancer: 106.2" "Region enriched" "Detected in single" 9 "pons and medulla: 5.0" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 10.6;hTERT-HME1: 6.1;RPTEC TERT1: 9.8;SuSa: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048543 Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" "HPA048543: AB_2680436" "unprognostic (1.27e-1)" "unprognostic (4.77e-2)" "unprognostic (2.45e-2)" "unprognostic (2.66e-2)" "unprognostic (5.20e-2)" "unprognostic (5.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-2)" "prognostic favorable (5.65e-4)" "unprognostic (1.05e-2)" "unprognostic (3.03e-1)" "prognostic favorable (6.78e-9)" "unprognostic (1.77e-1)" "unprognostic (2.60e-2)" "unprognostic (2.58e-1)" "unprognostic (1.33e-2)" 0.1 0.2 0.3 0.1 0.4 0.0 0.3 0.1 0.2 0.2 0.2 0.5 0.1 0.1 0.2 1.6 0.2 0.4 0.6 0.2 0.5 0.4 204.4 11.5 0.6 0.1 0.3 0.1 0.8 1.2 4.0 0.2 0.7 5.0 0.3 0.0 11.3 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 2.4 0.3 0.1 0.2 0.7 0.1 0.1 0.4 0.2 0.9 0.6 0.0 0.5 0.0 3.0 0.4 3.0 2.1 1.5 0.6 0.8 1.2 1.0 0.1 0.0 0.1 0.1 0.2 0.5 0.3 2.1 0.1 0.2 10.6 0.9 2.5 0.0 0.4 1.4 0.3 0.0 1.0 1.6 0.0 0.0 0.2 2.4 0.4 6.1 0.7 0.0 2.4 0.7 0.6 0.3 3.5 0.2 0.4 3.5 0.9 3.1 0.3 0.5 1.3 9.8 0.2 1.4 1.3 0.8 0.2 2.0 6.5 1.0 0.3 0.1 0.2 0.5 0.4 0.0 0.5 0.3 0.4 0.9 0.1 0.1 0.0 0.5 0.0 0.6 0.2 1.3 0.4 0.8 0.5 0.6 0.9 3.0 0.9 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.4 0.1 0.2 0.5 0.4 0.3 0.1 5.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 26.2 0.0 1.9 46.4 19.8 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 679.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 CLYBL CLB ENSG00000125246 "Citrate lyase beta like" Q8N0X4 13 99606669-99897134 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 57.7" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 117.7;Hepatocytes: 75.9;Proximal tubular cells: 93.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 29.2;SCLC-21H: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039959, HPA040691" Enhanced NA NA "HPA039959: AB_10793857, HPA040691: AB_10794746" "unprognostic (1.25e-2)" "unprognostic (1.94e-1)" "unprognostic (2.30e-3)" "unprognostic (7.57e-3)" "unprognostic (3.69e-1)" "unprognostic (2.90e-2)" "unprognostic (1.57e-3)" "unprognostic (2.91e-1)" "unprognostic (2.10e-1)" "unprognostic (2.34e-1)" "unprognostic (2.49e-2)" "unprognostic (2.85e-1)" "prognostic favorable (6.66e-16)" "unprognostic (3.74e-2)" "unprognostic (5.41e-2)" "unprognostic (4.78e-2)" "unprognostic (7.82e-2)" 4.2 11.6 6.2 10.4 9.4 2.6 6.0 6.7 6.4 4.6 11.2 3.8 4.8 13.6 5.2 7.6 6.4 4.7 8.3 12.3 5.1 6.3 35.0 57.7 4.7 9.6 7.9 8.6 3.5 15.0 6.1 5.7 2.2 12.5 4.2 12.3 8.9 8.7 5.5 22.2 5.7 12.5 8.6 4.5 5.5 4.8 10.7 4.3 4.6 7.0 13.3 8.2 4.9 4.4 11.0 7.5 1.2 6.7 9.2 16.7 5.5 0.2 1.2 9.0 4.0 4.2 3.9 1.9 0.4 0.8 0.7 1.4 0.2 6.6 1.5 2.6 0.5 1.7 2.0 0.8 1.5 1.0 7.9 1.3 9.9 2.4 6.1 2.9 5.3 0.7 2.1 4.4 0.1 3.4 0.9 1.1 8.3 1.4 5.2 0.8 2.2 2.4 7.4 5.8 29.2 1.8 3.1 0.3 3.6 8.8 0.6 28.8 4.4 1.8 2.0 1.7 3.3 4.3 6.9 0.1 0.4 1.0 0.7 1.4 12.1 2.4 0.3 6.1 7.8 1.2 1.2 3.3 0.3 7.5 6.7 9.0 10.9 13.3 10.6 6.7 11.0 10.3 12.1 0.5 9.2 3.2 7.5 16.7 5.5 6.2 9.4 6.7 6.4 5.1 6.3 7.9 8.6 12.5 4.3 6.0 5.3 4.4 8.9 4.8 1.8 30.3 20.4 4.0 11.4 14.0 2.0 11.2 117.7 9.6 1.2 6.3 18.6 0.0 7.0 2.5 2.6 3.4 5.8 75.9 6.9 0.0 1.2 6.2 7.5 4.0 2.0 7.7 15.1 4.6 8.4 4.5 3.8 14.0 3.9 93.6 4.3 0.0 9.2 3.1 9.1 5.5 6.2 6.9 16.4 5.1 CMKLR1 RVER1 ENSG00000174600 "Chemerin chemokine-like receptor 1" Q99788 12 108288044-108339341 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.6" "Cell type enhanced" "Detected in some" 20 "Hofbauer cells: 25.9;Kupffer cells: 51.2;Macrophages: 10.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 11.9;plasmacytoid DC: 15.2" "Group enriched" "Detected in many" 31 "dendritic cells: 15.2;monocytes: 11.9;T-cells: 6.3" "Cell line enhanced" "Detected in some" "ASC diff: 7.9;ASC TERT1: 33.3;BJ hTERT+: 23.7;hTERT-RPE1: 8.0;LHCN-M2: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047865 Uncertain NA NA "HPA047865: AB_2680191" "unprognostic (1.78e-1)" "unprognostic (2.61e-2)" "unprognostic (8.83e-3)" "unprognostic (7.39e-2)" "unprognostic (2.44e-1)" "unprognostic (3.49e-3)" "unprognostic (1.69e-1)" "unprognostic (2.94e-2)" "unprognostic (1.69e-1)" "unprognostic (6.83e-2)" "unprognostic (1.06e-1)" "unprognostic (8.72e-2)" "unprognostic (2.96e-2)" "unprognostic (1.77e-1)" "unprognostic (1.83e-2)" "unprognostic (5.19e-2)" "unprognostic (1.14e-1)" 11.3 6.3 2.5 8.5 3.5 0.3 5.1 0.9 3.6 6.7 5.2 5.1 1.7 3.1 9.6 12.0 4.1 5.4 6.4 9.3 2.9 2.3 4.3 7.1 10.5 17.2 5.6 1.5 3.9 3.2 1.6 4.1 18.9 4.0 5.3 6.5 10.7 5.6 3.7 2.9 4.6 5.4 12.1 5.1 42.6 3.4 4.6 4.8 3.2 9.9 5.9 5.8 6.9 3.2 0.0 15.2 0.2 11.9 0.3 6.3 3.1 0.0 0.0 0.1 0.0 7.9 33.3 0.1 0.0 23.7 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 8.0 0.4 0.0 0.0 0.0 7.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 3.2 0.0 6.3 11.9 0.0 0.0 1.0 4.2 0.8 0.0 0.4 3.4 0.2 0.3 2.0 15.2 0.3 3.1 2.5 3.5 0.9 2.6 2.9 2.3 5.6 1.5 4.0 4.8 0.0 0.0 0.9 0.0 0.8 0.0 1.2 0.0 1.4 1.2 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.4 6.2 0.0 0.0 0.0 25.9 0.0 0.0 5.5 51.2 0.0 0.3 10.6 3.3 1.8 0.0 0.0 0.0 0.0 4.9 0.0 0.0 6.5 5.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 CMTM1 "CKLFH, CKLFH1a, CKLFSF1" ENSG00000089505 "CKLF like MARVEL transmembrane domain containing 1" Q8IZ96 16 66566393-66579137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 80.7" "Group enriched" "Detected in some" 13 "Early spermatids: 60.6;Late spermatids: 113.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.7" "Cell line enhanced" "Detected in many" "REH: 16.8" "HPA013801, HPA017136" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA013801: AB_1846990, HPA017136: AB_1846992" "unprognostic (2.37e-2)" "unprognostic (7.48e-2)" "unprognostic (3.10e-1)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.32e-2)" "unprognostic (2.97e-3)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.68e-5)" "unprognostic (2.47e-2)" "unprognostic (1.56e-4)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (3.49e-1)" 0.9 0.8 0.8 1.9 1.2 0.0 0.5 2.2 1.3 0.7 0.9 0.5 0.5 1.7 1.3 1.1 0.6 0.8 1.5 0.7 0.8 1.1 0.8 0.5 0.9 1.2 0.8 0.6 1.7 0.5 0.3 1.1 0.9 0.7 0.7 0.2 0.5 0.6 0.5 0.6 0.6 1.2 0.5 0.9 2.8 0.9 80.7 0.7 0.8 0.7 0.5 0.6 0.9 0.6 0.3 1.9 8.7 2.1 1.3 1.9 1.1 4.2 6.7 1.2 5.6 2.4 2.3 1.2 5.6 2.7 4.5 4.7 1.4 2.9 2.0 3.0 1.6 1.4 3.4 1.9 0.3 2.4 7.4 1.3 0.7 3.0 1.4 1.1 3.9 4.9 1.9 0.5 4.0 0.5 6.9 2.3 4.0 3.5 2.8 1.9 1.6 7.4 3.8 1.0 0.6 2.5 16.8 14.4 4.6 4.0 2.0 3.2 4.3 7.8 0.6 2.0 0.2 2.0 2.8 5.7 8.0 12.7 4.8 2.4 2.8 6.7 7.3 3.8 5.3 9.3 8.7 2.1 7.1 1.9 0.6 1.6 0.2 0.6 0.9 1.9 0.3 0.5 0.6 8.4 1.3 1.2 0.5 0.6 1.1 0.8 1.2 2.2 1.0 0.8 1.1 0.8 0.6 0.7 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 113.2 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 6.5 0.0 4.8 0.4 0.3 0.1 0.0 0.0 0.0 CMTM2 "CKLFSF2, FLJ25732, MGC39436" ENSG00000140932 "CKLF like MARVEL transmembrane domain containing 2" Q8TAZ6 16 66579448-66588275 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "testis: 165.2" "Group enriched" "Detected in some" 7 "Early spermatids: 2945.7;Late spermatids: 2467.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 3.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.8" "Cell line enriched" "Detected in some" 20 "REH: 26.7" "Low region specificity" "Detected in many" NA NA "unprognostic (2.81e-1)" "unprognostic (3.75e-2)" "unprognostic (6.94e-2)" "unprognostic (2.20e-1)" "unprognostic (2.18e-1)" "unprognostic (2.23e-1)" "unprognostic (8.71e-2)" "unprognostic (3.31e-1)" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (1.91e-2)" "unprognostic (3.27e-2)" "unprognostic (1.02e-4)" "unprognostic (1.80e-2)" "unprognostic (1.07e-1)" "unprognostic (1.43e-2)" "unprognostic (1.32e-1)" 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 165.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.2 0.0 0.7 2.8 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.4 0.0 0.1 1.3 0.4 0.1 0.0 0.0 26.7 0.2 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.6 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.7 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 11.9 34.0 0.0 0.0 0.0 0.1 0.1 0.0 1.4 9.1 0.0 0.0 0.0 0.0 0.0 2945.7 0.0 0.0 0.0 0.2 0.1 0.1 0.0 17.4 0.0 1.1 0.0 0.0 1.3 0.3 2467.7 33.6 1.5 0.0 0.0 0.0 0.0 0.4 0.0 28.7 0.1 0.6 19.4 0.0 398.0 14.3 0.0 0.1 0.0 0.0 0.0 CMTM3 "BNAS2, CKLFSF3, FLJ31762" ENSG00000140931 "CKLF like MARVEL transmembrane domain containing 3" Q96MX0 16 66603874-66613892 "Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 178.7;granulocytes: 90.0;Hofbauer cells: 108.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013870, HPA072695" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA013870: AB_1847003, HPA072695: AB_2732210" "unprognostic (1.59e-1)" "unprognostic (2.83e-2)" "unprognostic (7.63e-2)" "unprognostic (1.49e-1)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (1.80e-3)" "unprognostic (6.65e-3)" "unprognostic (7.75e-2)" "unprognostic (1.60e-2)" "unprognostic (1.22e-2)" "unprognostic (7.38e-2)" "prognostic unfavorable (4.42e-6)" "prognostic unfavorable (1.85e-4)" "unprognostic (7.56e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" 24.3 8.5 5.4 11.5 6.1 8.0 29.5 1.2 4.6 19.1 7.8 10.0 7.7 3.2 18.0 19.1 10.0 12.2 16.3 15.9 5.9 4.9 8.9 6.1 21.7 34.1 6.7 2.6 25.4 6.5 22.9 5.6 30.8 8.4 16.4 6.0 15.5 9.3 8.7 7.9 11.5 9.1 14.0 8.4 19.0 6.2 61.7 6.9 35.6 8.6 10.4 14.6 13.6 21.1 1.4 19.9 7.0 11.3 6.5 12.0 4.4 1.8 9.6 27.3 19.0 20.4 12.9 16.8 4.9 22.7 10.0 10.0 5.3 6.0 0.0 13.7 13.9 17.5 2.1 18.3 16.4 8.1 9.4 6.5 6.0 1.3 14.9 27.6 17.9 22.2 25.5 1.3 10.6 2.2 41.7 22.8 17.0 9.2 0.2 12.4 2.3 14.5 30.0 13.0 0.1 9.1 45.3 19.1 0.9 4.8 0.2 2.8 9.7 2.4 0.1 15.9 18.5 0.2 16.6 15.1 14.4 17.2 3.4 5.9 1.2 0.1 6.0 9.0 13.9 15.3 6.1 11.3 7.0 7.8 10.9 10.9 1.4 8.8 8.9 9.7 0.8 6.8 8.2 6.6 6.5 6.5 19.9 12.0 4.4 5.4 6.1 1.2 4.6 5.9 4.9 6.7 2.6 8.4 6.9 0.0 10.3 18.2 25.6 13.1 0.6 1.6 5.1 2.7 7.9 5.2 0.0 7.2 0.0 20.2 1.8 33.7 0.0 0.0 5.8 178.7 48.2 33.2 90.0 0.8 108.7 0.0 12.0 41.1 71.2 6.3 36.5 64.5 27.0 11.8 0.5 10.0 25.7 0.0 23.0 2.2 0.6 6.5 19.7 3.9 9.7 7.5 7.9 69.9 0.0 19.4 CMTM4 CKLFSF4 ENSG00000183723 "CKLF like MARVEL transmembrane domain containing 4" Q8IZR5 16 66614750-66696707 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 39.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014704, HPA023890" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles, Plasma membrane" "HPA014704: AB_1847005, HPA023890: AB_1847007" "unprognostic (2.65e-3)" "unprognostic (1.16e-1)" "unprognostic (6.17e-3)" "unprognostic (3.43e-1)" "unprognostic (5.13e-1)" "unprognostic (8.30e-2)" "unprognostic (2.88e-2)" "unprognostic (2.65e-1)" "unprognostic (3.35e-3)" "unprognostic (6.06e-3)" "unprognostic (2.07e-2)" "unprognostic (3.08e-1)" "prognostic favorable (4.72e-9)" "unprognostic (1.41e-1)" "unprognostic (2.31e-1)" "unprognostic (4.94e-2)" "unprognostic (1.00e-1)" 2.7 4.8 18.9 3.3 18.2 2.9 6.6 8.3 22.1 4.8 16.1 13.5 8.7 12.6 3.2 21.8 4.5 11.5 4.8 3.3 20.0 16.2 18.3 2.5 6.5 1.3 17.0 13.0 2.5 15.1 31.7 9.4 4.3 12.5 6.8 13.4 5.2 10.7 6.9 2.7 7.2 15.8 4.2 13.3 1.8 18.5 6.3 10.3 0.0 39.3 0.5 2.1 4.3 2.6 0.2 1.3 0.1 1.2 0.2 0.9 0.2 9.6 8.3 4.8 11.9 1.6 2.4 20.2 4.1 3.5 2.2 3.6 14.6 11.0 0.4 7.1 2.4 3.0 12.3 11.8 4.6 3.3 0.8 10.8 0.9 3.0 8.8 3.5 0.8 1.9 4.0 8.2 2.5 5.2 7.5 1.2 1.3 4.9 2.7 3.2 10.6 0.1 1.9 5.7 17.1 5.4 2.1 6.4 2.9 9.5 8.7 11.5 4.4 16.6 9.2 5.7 3.6 9.8 2.0 2.5 4.0 4.7 1.1 4.1 0.9 1.9 0.5 5.0 2.0 4.9 0.0 1.2 0.0 0.3 0.3 0.0 0.0 0.1 0.9 1.3 0.2 0.1 0.2 0.1 0.2 0.7 1.3 0.7 0.2 18.9 18.2 8.3 22.1 20.0 16.2 17.0 13.0 12.5 10.3 20.8 12.0 0.0 6.0 4.6 10.9 5.9 25.5 21.4 7.9 22.7 7.9 4.2 11.6 14.5 1.6 3.0 26.2 0.0 20.6 27.7 3.1 19.1 4.6 5.0 2.0 28.6 37.5 1.3 3.0 2.1 2.3 1.5 3.3 0.0 24.3 22.6 24.1 11.5 2.8 20.3 9.2 6.5 4.7 4.7 6.8 4.8 2.4 0.0 32.7 12.7 CMTM5 "CKLFSF5, FLJ37521" ENSG00000166091 "CKLF like MARVEL transmembrane domain containing 5" Q96DZ9 14 23376808-23379772 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 19.4;brain: 67.3" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 28.7" "Group enriched" "Detected in some" 37 "glioma: 8.4;melanoma: 3.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 7.6;neutrophil: 2.8" "Lineage enriched" "Detected in single" 11 "granulocytes: 7.6" "Cell line enriched" "Detected in some" 6 "HEL: 42.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052338 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA052338: AB_2681793" "unprognostic (2.73e-3)" "unprognostic (1.51e-1)" "unprognostic (5.24e-1)" "unprognostic (2.43e-3)" "unprognostic (2.63e-1)" "unprognostic (6.40e-2)" "unprognostic (8.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.27e-2)" "unprognostic (8.40e-2)" "unprognostic (6.24e-4)" "unprognostic (3.03e-3)" "unprognostic (1.97e-3)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" 1.7 1.8 14.1 1.3 19.4 6.6 1.3 4.8 55.4 2.6 1.9 47.0 0.0 1.3 1.6 1.6 2.1 1.7 2.5 5.8 19.6 12.1 1.1 1.0 1.7 1.1 26.9 10.3 1.7 1.1 0.9 0.1 1.5 18.4 1.9 1.6 0.6 3.1 4.2 1.4 1.5 2.0 1.7 67.3 1.9 1.1 1.1 12.7 0.0 1.0 0.0 1.0 1.3 0.7 0.1 0.7 7.6 0.4 0.0 0.3 19.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 42.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 7.6 0.4 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.7 0.3 19.4 14.1 19.4 4.8 24.8 19.6 12.1 26.9 10.3 18.4 12.7 0.0 0.0 0.0 0.1 0.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.2 0.0 0.0 0.0 5.0 0.0 0.0 28.7 0.0 0.0 0.0 0.0 1.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 CMTM6 "CKLFSF6, FLJ20396" ENSG00000091317 "CKLF like MARVEL transmembrane domain containing 6" Q9NX76 3 32481312-32503408 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 55.5" "Cell type enhanced" "Detected in many" 6 "monocytes: 520.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026980, HPA063491" Enhanced Supported Vesicles NA NA 390000 Vesicles "HPA026980: AB_10602801, HPA063491: " "unprognostic (1.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.34e-2)" "unprognostic (1.81e-2)" "unprognostic (7.25e-2)" "unprognostic (8.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.99e-1)" "unprognostic (2.44e-3)" "unprognostic (2.95e-1)" "unprognostic (1.04e-3)" "unprognostic (6.79e-2)" "unprognostic (2.27e-1)" "unprognostic (7.23e-2)" "unprognostic (6.58e-2)" "unprognostic (3.74e-2)" "unprognostic (1.55e-3)" 5.5 6.4 2.8 8.2 2.6 10.4 6.7 1.4 1.4 6.6 5.5 2.5 6.7 4.9 9.8 24.4 6.1 4.2 2.4 2.4 5.1 21.6 9.0 5.6 2.8 4.1 6.0 4.0 3.0 8.6 6.0 7.3 9.0 5.0 0.7 12.6 5.9 4.7 3.9 10.5 6.3 5.7 7.7 9.5 9.3 6.1 10.0 12.8 55.5 35.4 11.2 8.1 16.3 22.9 7.4 14.8 11.1 25.7 25.6 65.6 17.0 24.4 17.9 20.7 7.9 38.4 13.7 19.4 22.7 12.1 14.9 10.3 28.2 24.5 61.1 12.6 17.3 5.4 11.7 18.3 28.8 34.5 25.3 18.2 20.6 15.5 28.9 28.7 13.4 8.4 25.8 22.8 7.1 17.3 15.0 13.2 19.2 11.0 14.7 11.6 10.6 24.8 32.2 3.4 10.0 15.5 8.8 16.3 15.7 12.9 28.9 25.7 19.9 13.2 19.4 20.3 13.4 13.3 12.8 13.9 25.3 24.8 24.6 15.1 35.2 5.6 23.3 6.2 10.0 7.5 5.3 12.8 7.1 4.4 4.9 55.5 11.2 35.4 6.9 8.1 16.3 32.8 47.1 95.1 72.5 85.3 9.9 5.1 81.5 112.4 53.4 90.7 11.8 219.6 28.2 87.5 4.6 59.7 40.2 0.0 72.9 81.3 109.6 119.8 124.6 218.5 140.7 47.7 126.8 122.2 288.9 5.4 36.5 262.8 77.6 520.2 93.6 137.9 99.4 49.1 40.3 54.3 17.2 38.8 75.2 34.5 20.2 110.7 218.9 111.7 53.2 91.4 CMTM7 "CKLFSF7, FLJ30992" ENSG00000153551 "CKLF like MARVEL transmembrane domain containing 7" Q96FZ5 3 32391671-32483067 "Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 104.7;Kupffer cells: 102.2;Macrophages: 86.9;monocytes: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 39.8;hTERT-RPE1: 41.0" "Low region specificity" "Detected in all" HPA077409 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077409: AB_2686838" "unprognostic (2.27e-3)" "unprognostic (3.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.15e-1)" "unprognostic (5.42e-2)" "unprognostic (3.16e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (3.03e-2)" "unprognostic (3.92e-2)" "unprognostic (2.60e-1)" "unprognostic (6.55e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.00e-6)" "unprognostic (5.86e-2)" "unprognostic (2.51e-1)" "unprognostic (3.79e-1)" "unprognostic (3.12e-2)" 14.5 6.5 3.3 18.9 5.7 23.8 43.1 4.5 2.2 10.0 6.2 4.3 11.0 3.1 7.7 12.3 4.8 24.5 14.6 8.3 2.8 2.8 14.8 5.9 25.1 47.5 5.9 1.0 9.3 27.6 0.9 2.8 11.4 4.7 12.8 5.9 6.1 8.7 17.6 4.0 6.4 10.9 7.0 10.3 32.4 8.2 5.8 4.6 45.9 24.5 3.3 23.1 16.5 12.4 10.0 24.8 24.4 47.0 4.9 36.2 22.1 0.1 4.5 9.8 11.9 9.2 9.1 27.9 4.4 5.3 8.0 7.4 5.0 39.8 0.0 13.8 5.3 9.9 5.0 12.1 20.5 7.1 0.0 9.6 5.3 0.0 11.6 37.6 1.3 8.5 9.6 2.7 8.2 13.1 41.0 18.0 0.0 4.4 12.0 5.9 0.1 0.0 12.3 11.8 2.0 20.9 25.6 3.7 24.4 11.3 8.8 0.5 10.2 0.6 0.7 22.8 4.4 6.2 13.8 10.3 7.6 7.6 8.3 15.4 3.4 1.2 0.0 2.7 16.7 15.9 5.5 47.0 24.4 5.3 44.1 3.2 10.0 17.9 10.9 24.8 7.0 19.5 13.5 18.0 4.9 37.2 10.5 36.2 22.1 3.3 5.7 4.5 2.2 2.8 2.8 5.9 1.0 4.7 4.6 23.8 14.7 40.7 17.6 8.8 0.2 1.5 15.3 14.7 23.9 17.4 0.0 19.8 0.0 83.6 0.1 15.7 1.3 23.3 13.6 6.7 16.0 11.2 28.9 1.0 104.7 1.6 16.6 18.4 102.2 1.0 1.4 86.9 23.6 120.0 3.4 1.3 59.3 8.6 1.1 24.0 0.2 6.5 14.5 1.2 7.2 4.8 5.7 43.6 3.0 10.2 CMTM8 CKLFSF8 ENSG00000170293 "CKLF like MARVEL transmembrane domain containing 8" Q8IZV2 3 32238679-32370325 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 79.8" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 81.9;Syncytiotrophoblasts: 97.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.2;memory CD4 T-cell: 2.8" "Group enriched" "Detected in many" 7 "granulocytes: 4.2;T-cells: 2.8" "Group enriched" "Detected in many" 4 "BEWO: 68.3;SK-BR-3: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA055077, HPA073258" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA055077: AB_2682691, HPA073258: AB_2686591" "unprognostic (9.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-1)" "unprognostic (1.14e-1)" "unprognostic (3.33e-2)" "unprognostic (9.46e-2)" "unprognostic (5.67e-2)" "unprognostic (8.85e-2)" "unprognostic (1.29e-1)" "unprognostic (7.59e-2)" "unprognostic (2.56e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.78e-2)" "unprognostic (2.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" 9.7 9.9 4.3 4.1 3.5 0.9 27.0 1.5 3.4 4.7 6.8 1.3 10.8 5.2 3.4 13.4 4.2 6.3 5.7 8.2 3.6 3.2 8.8 40.0 19.9 12.6 3.9 3.3 2.1 79.8 2.8 3.1 12.4 2.5 8.8 5.5 4.4 13.5 19.2 4.3 6.2 8.1 2.0 3.1 1.5 10.0 1.1 1.6 5.5 20.7 6.0 11.2 4.7 5.6 0.1 0.0 4.2 0.1 0.4 2.8 0.3 3.3 3.5 0.6 4.3 3.1 4.9 68.3 0.0 0.1 0.3 0.4 4.7 4.8 0.0 7.1 0.0 0.0 1.8 5.5 1.1 0.3 0.0 10.1 2.1 0.7 7.9 0.2 0.8 1.7 9.6 3.5 0.4 3.4 1.7 2.7 3.6 0.0 0.0 3.4 2.4 2.7 0.3 1.4 5.1 3.2 3.9 0.8 0.6 4.2 3.8 1.2 1.0 0.5 19.3 1.7 0.8 5.5 0.4 2.4 0.0 5.2 0.0 1.0 0.1 0.1 0.0 0.0 1.5 1.1 0.0 0.1 4.2 0.3 0.0 0.4 0.0 2.8 0.8 0.0 0.1 1.8 0.3 0.0 0.4 0.0 0.0 0.0 0.3 4.3 3.5 1.5 3.4 3.6 3.2 3.9 3.3 2.5 1.6 35.7 27.6 0.8 29.9 10.3 0.0 1.7 12.7 6.7 19.4 0.0 0.0 81.9 10.0 16.6 7.5 35.8 13.1 23.3 32.2 59.6 6.9 51.8 0.0 67.6 8.5 0.0 21.4 46.1 6.0 1.8 2.3 4.1 5.0 1.0 41.2 30.7 28.4 10.5 1.1 21.6 1.7 0.0 4.7 3.4 2.1 5.6 97.1 15.0 21.1 38.8 CNEP1R1 "C16orf69, FLJ38101, NEP1-R1, TMEM188" ENSG00000205423 "CTD nuclear envelope phosphatase 1 regulatory subunit 1" Q8N9A8 16 50024410-50037088 "Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042815, HPA077906" Uncertain Supported Cytosol NA NA Cytosol "HPA042815: AB_10794765, HPA077906: AB_2686868" "unprognostic (4.11e-2)" "unprognostic (2.45e-1)" "unprognostic (2.79e-2)" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (6.33e-2)" "unprognostic (1.43e-3)" "unprognostic (1.80e-1)" "unprognostic (3.42e-2)" "unprognostic (8.53e-2)" "unprognostic (3.86e-2)" "unprognostic (1.21e-2)" "unprognostic (3.37e-3)" "unprognostic (5.09e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-2)" "unprognostic (6.78e-2)" 15.4 12.7 14.5 16.3 15.0 25.1 17.0 19.1 17.2 10.6 11.3 12.2 4.0 10.9 13.0 17.1 17.2 10.9 13.5 14.3 12.8 12.6 12.5 12.9 14.1 19.7 17.7 11.9 12.9 13.6 11.7 17.3 18.5 14.0 10.6 16.7 14.9 12.2 10.7 10.5 13.9 12.9 13.9 12.9 21.4 11.9 22.4 14.1 12.4 8.4 10.3 18.6 12.8 12.6 5.5 9.6 28.7 18.7 6.3 9.6 7.2 7.6 7.3 8.6 9.2 17.4 16.8 12.9 15.6 11.9 15.1 9.1 7.6 11.0 8.8 11.7 12.8 10.2 12.2 7.1 7.7 19.2 6.3 8.4 4.1 4.4 12.0 11.9 5.5 12.8 12.5 13.0 9.8 7.8 11.8 10.3 11.1 5.0 5.1 19.1 2.2 10.5 13.9 6.5 3.3 9.9 13.3 11.6 8.8 10.1 5.2 6.9 8.0 14.6 6.0 5.5 7.9 5.2 6.7 13.4 14.7 11.7 13.8 5.5 8.3 7.4 10.4 8.2 5.6 11.9 7.4 12.2 8.6 9.6 15.7 8.9 5.5 7.6 7.0 9.6 4.9 7.6 8.9 28.7 6.3 18.7 3.8 7.4 7.2 14.5 15.0 19.1 17.2 12.8 12.6 17.7 11.9 14.0 14.1 3.0 8.5 0.9 3.2 9.4 5.2 9.8 2.5 4.0 7.9 7.0 3.9 15.7 3.3 4.7 1.3 8.7 5.2 0.0 4.7 22.0 11.6 2.4 12.7 5.6 13.1 6.4 4.6 6.7 19.2 2.2 5.5 13.5 15.1 10.0 3.9 10.8 4.5 5.8 7.4 5.0 9.4 6.5 10.3 23.3 17.0 8.5 12.0 10.9 5.2 3.3 CNGA1 "CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49" ENSG00000198515 "Cyclic nucleotide gated channel alpha 1" P29973 4 47935977-48016672 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.7" "Cell type enriched" "Detected in many" 9 "Rod photoreceptor cells: 880.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.4;RT4: 10.7;U-2 OS: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA076168 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA076168: AB_2686781" "unprognostic (2.68e-2)" "unprognostic (4.90e-2)" "unprognostic (1.33e-1)" "unprognostic (8.59e-2)" "unprognostic (2.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-2)" "unprognostic (3.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (3.18e-1)" "unprognostic (2.91e-1)" "unprognostic (5.48e-6)" "unprognostic (1.86e-1)" "unprognostic (1.04e-1)" "unprognostic (4.66e-2)" "unprognostic (8.23e-2)" 4.9 1.1 0.6 2.7 1.0 0.1 2.9 0.3 0.5 5.7 6.1 0.2 1.6 2.1 0.6 12.1 13.7 3.9 1.5 1.0 0.6 0.6 4.9 23.7 0.5 0.0 1.3 0.0 1.6 2.1 5.2 4.2 21.3 0.4 6.2 2.3 14.7 4.9 1.7 4.2 5.3 12.7 0.5 0.9 8.2 2.5 1.4 0.2 0.1 2.2 3.6 2.7 8.2 8.8 0.7 2.7 1.2 0.4 1.9 1.6 0.1 3.2 1.2 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.2 2.9 13.4 0.1 0.7 0.0 3.6 2.1 0.3 0.4 0.1 0.0 0.9 0.0 0.3 1.0 0.0 0.1 0.3 0.1 0.6 0.0 0.1 1.6 0.0 1.1 0.9 0.7 0.2 1.3 0.1 0.2 0.6 2.0 3.1 0.1 0.0 0.1 0.6 10.7 0.3 0.1 0.2 0.6 0.2 0.3 1.2 0.0 0.6 0.3 4.2 0.1 0.1 0.9 1.0 0.1 0.1 0.1 2.4 0.2 0.4 0.0 0.5 0.4 0.1 0.3 0.2 1.6 0.3 0.7 0.3 0.6 1.2 1.9 0.2 2.7 0.1 0.1 0.6 1.0 0.3 0.5 0.6 0.6 1.3 0.0 0.4 0.2 0.0 0.0 0.0 1.4 0.1 78.5 0.4 2.5 0.0 0.0 59.3 86.4 0.0 0.0 7.8 0.4 0.1 8.4 0.0 5.9 0.0 0.2 4.0 0.0 30.0 1.3 42.9 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 3.2 100.9 1.6 10.5 0.0 0.3 880.8 0.0 3.1 0.3 1.3 2.4 0.2 0.0 2.9 15.6 CNGA2 "CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA" ENSG00000183862 "Cyclic nucleotide gated channel alpha 2" Q16280 X 151738451-151745304 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Olfaction, Sensory transduction, Transport" "Calmodulin-binding, Ion channel, Ligand-gated ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 26 "testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.8" "Region enriched" "Detected in single" 4 "olfactory region: 0.6" "Not detected" "Not detected" HPA015065 Uncertain NA NA "HPA015065: AB_1847034" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CNGA3 "ACHM2, CCNC1, CCNCa, CNCG3, CNG3" ENSG00000144191 "Cyclic nucleotide gated channel alpha 3" Q16281 2 98346155-98398601 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pituitary gland: 32.0" "Cell type enriched" "Detected in some" 39 "Cone photoreceptor cells: 41.2" "Cancer enriched" "Detected in some" 9 "glioma: 7.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "U-87 MG: 12.8" "Group enriched" "Detected in some" 6 "basal ganglia: 1.9;hypothalamus: 2.2" "Not detected" "Not detected" "HPA049378, CAB079025" Approved Approved NA NA "CAB079025: , HPA049378: AB_2732551" "unprognostic (2.34e-2)" "unprognostic (1.83e-2)" "unprognostic (4.96e-2)" "unprognostic (4.81e-2)" "unprognostic (1.13e-1)" "unprognostic (2.18e-1)" "unprognostic (4.17e-4)" "unprognostic (4.65e-2)" "unprognostic (1.86e-3)" "unprognostic (2.88e-1)" "unprognostic (3.85e-3)" "unprognostic (8.98e-2)" "unprognostic (5.90e-2)" "unprognostic (3.71e-2)" 0.1 0.0 0.3 1.4 0.7 0.0 0.7 0.1 2.9 0.1 6.1 2.4 0.1 2.8 0.1 0.1 4.6 0.8 0.4 0.1 1.2 4.0 0.1 0.1 0.2 0.1 0.8 0.4 0.1 1.5 0.0 32.0 0.1 4.9 0.1 3.2 1.2 0.2 0.5 0.1 0.0 4.0 2.2 4.3 0.1 3.0 1.1 0.3 0.1 0.1 0.1 0.1 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 1.5 1.2 4.0 0.8 0.4 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CNGA4 "CNCA2, CNG5, CNGB2, OCNC2, OCNCb" ENSG00000132259 "Cyclic nucleotide gated channel alpha 4" Q8IV77 11 6234765-6244429 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Olfaction, Sensory transduction, Transport" "Ion channel, Ligand-gated ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 8.0;fallopian tube: 22.5;ovary: 9.1" "Group enriched" "Detected in some" 7 "Ciliated cells: 5.3;Early spermatids: 3.5;Late spermatids: 2.4" "Cancer enriched" "Detected in single" 6 "endometrial cancer: 2.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 21 "eosinophil: 2.0" "Lineage enriched" "Detected in single" 21 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "ASC diff: 2.5;CAPAN-2: 2.6;HaCaT: 2.3;HMC-1: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "unprognostic (1.11e-2)" "unprognostic (4.32e-2)" "unprognostic (2.69e-3)" "prognostic favorable (1.48e-4)" "unprognostic (4.96e-2)" "unprognostic (1.09e-1)" "unprognostic (2.01e-3)" "unprognostic (1.89e-1)" "unprognostic (8.51e-2)" "unprognostic (5.51e-2)" "unprognostic (1.83e-2)" "unprognostic (8.70e-2)" "unprognostic (1.03e-3)" "unprognostic (3.84e-2)" "unprognostic (3.47e-2)" "unprognostic (8.11e-2)" "unprognostic (3.55e-3)" 0.2 0.3 1.5 0.3 2.0 0.6 0.2 0.6 1.1 1.0 0.4 1.9 0.1 0.5 1.2 8.0 0.4 22.5 0.3 0.1 1.7 1.4 0.3 0.2 6.6 0.4 1.0 0.1 9.1 0.3 0.3 2.3 0.2 3.3 0.3 0.2 0.3 0.2 0.8 0.1 0.4 0.3 0.3 1.3 0.3 0.3 7.4 1.4 0.1 0.3 0.1 0.3 0.2 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.7 2.5 0.1 0.1 0.1 0.0 0.1 0.0 0.0 2.6 0.7 0.3 0.0 0.3 2.3 0.1 0.5 0.0 1.6 0.3 0.0 0.4 0.1 0.1 0.2 3.4 1.6 1.2 0.2 0.1 0.1 0.3 0.5 0.0 0.7 0.0 0.0 0.0 0.1 1.1 0.4 0.0 0.0 0.0 0.4 0.2 0.5 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.3 0.4 0.2 0.6 0.0 1.1 0.6 0.0 0.7 0.3 1.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.0 0.6 1.1 1.7 1.4 1.0 0.1 3.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 CNGB3 "ACHM1, ACHM3, RMCH" ENSG00000170289 "Cyclic nucleotide gated channel beta 3" Q9NQW8 8 86553977-86743675 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 68.9" "Cell type enriched" "Detected in some" 21 "Cone photoreceptor cells: 149.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA057244 Enhanced NA NA "HPA057244: AB_2683380" "unprognostic (5.35e-1)" "unprognostic (1.68e-3)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (3.62e-2)" "unprognostic (2.58e-1)" "unprognostic (6.25e-2)" "unprognostic (1.18e-1)" "unprognostic (2.91e-1)" "unprognostic (2.17e-1)" "unprognostic (3.82e-1)" "unprognostic (9.28e-2)" "unprognostic (2.77e-4)" "unprognostic (1.40e-4)" "unprognostic (1.66e-2)" "unprognostic (8.76e-2)" "unprognostic (1.84e-1)" 0.2 0.1 0.4 0.4 0.2 7.9 0.2 0.2 1.0 0.9 0.1 0.1 0.1 0.9 0.7 0.4 0.2 2.8 0.1 0.3 0.2 0.2 0.2 0.1 0.1 0.3 0.6 0.1 1.0 1.5 0.0 0.6 0.1 1.8 0.1 0.0 68.9 0.3 0.1 0.1 2.4 0.4 0.1 0.8 0.1 0.6 5.4 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.0 1.4 0.1 0.0 0.0 3.1 0.3 0.0 0.0 0.4 0.0 1.6 21.6 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.5 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.2 0.2 1.0 0.2 0.2 0.6 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 149.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.2 0.0 0.1 1.0 0.0 0.3 0.0 0.0 0.0 0.0 CNIH1 "CNIH, CNIL, TGAM77" ENSG00000100528 "Cornichon family AMPA receptor auxiliary protein 1" O95406 14 54423560-54441431 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002544 Approved Uncertain Vesicles NA NA Vesicles "HPA002544: AB_2081856" "unprognostic (1.06e-1)" "unprognostic (1.18e-3)" "unprognostic (7.09e-2)" "unprognostic (5.06e-2)" "unprognostic (1.50e-1)" "unprognostic (8.93e-3)" "unprognostic (1.47e-1)" "unprognostic (2.71e-3)" "unprognostic (4.78e-2)" "unprognostic (4.62e-1)" "unprognostic (1.38e-2)" "unprognostic (1.79e-1)" "unprognostic (4.12e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-1)" "unprognostic (1.71e-2)" "prognostic unfavorable (8.95e-4)" 32.2 32.3 24.3 19.9 24.9 11.7 27.7 20.6 28.0 23.5 31.0 18.9 22.5 35.8 25.4 20.3 28.7 25.2 27.5 31.0 21.6 22.9 29.4 83.6 26.1 36.2 23.5 18.9 22.0 26.3 12.3 31.2 21.0 20.5 26.9 35.8 23.2 20.5 23.2 25.1 14.3 32.1 46.2 25.5 17.1 20.7 16.7 16.2 26.3 24.1 27.3 27.8 40.6 20.0 23.6 31.7 7.6 31.2 15.6 30.7 31.6 41.6 25.5 21.5 24.1 58.1 74.4 20.0 50.7 65.1 44.0 50.5 15.1 58.8 52.6 33.8 38.4 26.9 41.8 38.8 36.9 55.0 20.1 22.7 20.1 16.4 27.4 58.4 24.3 17.0 60.5 46.1 40.9 58.0 45.2 41.2 21.8 19.6 17.9 48.9 23.0 26.9 18.5 15.8 48.4 51.8 20.7 36.1 17.5 49.7 31.2 18.0 20.0 29.6 23.8 56.1 20.8 36.6 26.5 26.4 37.0 36.9 31.0 30.5 11.2 24.2 25.5 44.9 20.9 32.7 1.9 31.2 3.8 12.9 23.7 21.5 23.6 22.8 18.4 31.7 18.9 30.7 20.5 7.6 15.6 18.2 17.8 23.2 31.6 24.3 24.9 20.6 28.0 21.6 22.9 23.5 18.9 20.5 16.2 32.8 55.8 74.2 72.9 93.9 41.9 74.4 43.3 65.6 43.3 43.6 19.6 81.2 76.3 83.7 21.1 62.1 85.5 46.7 54.2 106.7 92.0 77.1 194.9 125.6 106.1 63.5 100.2 65.1 100.9 13.8 55.5 72.8 79.2 77.5 75.5 42.1 62.6 89.2 61.9 125.2 36.3 45.3 68.4 49.2 77.8 96.1 59.3 59.7 96.4 71.6 CNIH2 "CNIH-2, Cnil, MGC50896" ENSG00000174871 "Cornichon family AMPA receptor auxiliary protein 2" Q6PI25 11 66278190-66285301 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 74.5" "Group enriched" "Detected in some" 9 "Early spermatids: 56.3;Horizontal cells: 15.9;Intestinal endocrine cells: 47.6;Late spermatids: 18.6" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.1;AN3-CA: 7.8;MCF7: 7.7;NTERA-2: 8.5;SCLC-21H: 35.5;SH-SY5Y: 16.4;T-47d: 7.7" "Low region specificity" "Detected in all" NA NA "unprognostic (1.84e-2)" "unprognostic (3.53e-3)" "unprognostic (3.40e-3)" "unprognostic (1.04e-2)" "prognostic unfavorable (9.18e-4)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (3.29e-1)" "unprognostic (3.25e-1)" "unprognostic (3.80e-2)" "unprognostic (7.66e-3)" "unprognostic (4.16e-2)" "unprognostic (6.95e-8)" "unprognostic (3.53e-1)" "unprognostic (3.19e-2)" "unprognostic (3.17e-2)" "unprognostic (3.55e-2)" 1.5 6.5 33.9 1.5 37.6 3.2 1.4 8.4 49.5 1.2 1.4 6.2 0.0 2.1 1.5 1.3 1.3 2.0 1.5 1.2 74.5 17.3 1.2 1.2 1.4 1.4 9.6 15.5 1.2 4.2 1.6 8.8 2.0 4.6 1.4 1.6 0.0 1.3 1.2 1.2 3.1 1.6 1.6 2.4 1.6 2.8 2.6 4.7 0.5 1.3 0.0 1.3 1.3 0.0 0.8 0.3 0.0 0.0 0.0 0.8 0.0 0.2 0.4 9.1 7.8 0.1 0.2 1.1 0.5 0.6 1.1 0.1 0.2 0.0 0.0 0.1 0.1 0.5 0.1 2.0 0.0 0.1 0.8 0.7 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.1 1.2 0.5 7.7 1.2 0.1 8.5 0.0 0.6 3.7 0.0 0.0 0.1 0.4 35.5 16.4 0.0 4.4 0.3 0.4 7.7 0.1 0.0 1.0 0.4 0.3 0.3 0.2 0.2 0.3 2.4 0.2 5.9 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.1 0.8 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 33.9 37.6 8.4 36.5 74.5 17.3 9.6 15.5 4.6 4.7 0.0 0.3 0.0 0.2 0.6 1.7 0.8 2.5 4.0 0.0 0.0 0.0 0.6 0.0 0.0 56.3 0.3 0.0 0.0 0.2 1.7 0.2 0.2 0.0 0.0 0.2 15.9 47.6 0.6 0.0 18.6 0.6 0.0 0.0 0.0 1.2 0.5 0.7 0.0 0.4 0.0 2.8 0.0 0.0 0.5 0.7 0.4 1.0 0.8 0.3 0.3 CNIH3 "CNIH-3, FLJ38993" ENSG00000143786 "Cornichon family AMPA receptor auxiliary protein 3" Q8TBE1 1 224434660-224740549 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 16.1;pancreas: 21.7" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 26.6;Early spermatids: 14.0;Late spermatids: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.8;hTEC/SVTERT24-B: 24.9;hTERT-RPE1: 14.1;NTERA-2: 9.2;U-266/70: 13.3;U-87 MG: 29.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.36e-1)" "unprognostic (1.66e-1)" "unprognostic (4.90e-2)" "unprognostic (5.18e-2)" "unprognostic (2.88e-1)" "unprognostic (7.18e-2)" "unprognostic (4.96e-2)" "unprognostic (6.11e-2)" "unprognostic (1.41e-1)" "unprognostic (4.63e-2)" "unprognostic (3.15e-1)" "unprognostic (2.30e-1)" "unprognostic (5.23e-5)" "unprognostic (1.03e-1)" "unprognostic (3.66e-1)" "unprognostic (5.87e-2)" "unprognostic (2.63e-1)" 2.0 0.8 7.0 0.5 5.1 0.2 1.3 1.0 16.1 1.7 0.6 0.6 0.0 0.8 1.5 0.9 0.6 1.9 1.2 0.6 9.8 5.0 1.5 0.6 0.9 0.9 5.4 8.0 3.6 21.7 0.3 0.7 0.4 3.5 0.9 0.7 0.2 0.6 1.1 0.7 0.4 0.6 1.0 1.4 0.6 0.6 3.9 0.1 0.2 1.0 0.0 0.9 0.7 0.9 0.9 0.3 0.0 0.0 1.8 0.9 0.1 0.2 0.2 0.3 0.3 0.3 0.5 0.1 1.8 9.8 0.2 0.5 0.0 2.2 0.0 0.9 4.2 0.7 0.0 0.0 0.0 1.7 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.7 0.3 0.0 24.9 0.3 14.1 0.0 0.1 0.0 0.0 1.4 0.0 0.0 3.0 9.2 0.1 1.1 0.0 0.5 0.0 1.5 0.9 0.3 0.2 0.0 0.0 6.1 1.0 0.0 0.2 0.0 0.0 2.3 0.0 0.2 13.3 0.5 0.0 29.6 0.1 3.7 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.3 0.3 0.0 0.6 0.0 1.8 0.0 0.0 0.9 0.1 7.0 5.1 1.0 11.1 9.8 5.0 5.4 8.0 3.5 0.1 0.0 1.3 0.5 2.4 2.5 3.3 1.2 2.5 13.4 0.0 1.8 0.0 1.5 26.6 0.6 14.0 2.7 0.4 0.0 2.6 0.4 3.2 2.0 2.3 1.7 5.2 0.0 1.2 1.8 0.0 26.2 2.6 1.9 0.0 1.0 2.3 9.2 0.7 0.0 1.1 9.0 0.5 0.0 0.9 2.3 9.6 1.9 4.2 1.8 1.7 1.3 CNIH4 HSPC163 ENSG00000143771 "Cornichon family AMPA receptor auxiliary protein 4" Q9P003 1 224356850-224379459 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044268 Approved NA NA "HPA044268: AB_10965330" "unprognostic (2.01e-1)" "unprognostic (1.34e-3)" "unprognostic (1.56e-1)" "unprognostic (1.66e-1)" "unprognostic (1.40e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (4.47e-3)" "unprognostic (1.02e-1)" "unprognostic (1.62e-1)" "unprognostic (5.96e-3)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.51e-1)" "prognostic unfavorable (4.27e-6)" "unprognostic (3.15e-3)" "unprognostic (2.20e-1)" "unprognostic (1.42e-3)" "unprognostic (1.63e-2)" 19.8 21.1 13.6 12.9 16.3 26.7 42.3 13.9 21.1 15.6 21.2 13.6 12.7 18.5 19.8 14.6 23.9 16.0 13.7 35.4 12.8 13.5 22.4 20.2 29.3 36.3 17.1 11.3 17.2 19.1 12.9 16.2 20.6 19.3 14.5 17.9 18.6 15.2 18.7 22.9 19.2 22.4 27.6 15.3 16.8 17.2 15.7 13.0 8.6 17.7 18.5 12.7 18.0 20.1 8.1 17.3 23.1 47.0 9.7 17.4 18.5 24.9 34.7 17.2 15.3 31.2 20.2 14.0 17.3 16.5 18.3 17.0 35.5 30.8 7.7 28.7 17.6 19.9 31.0 30.8 19.5 19.6 9.1 32.7 6.5 23.1 18.1 26.8 12.6 13.0 20.4 26.4 22.7 30.3 18.6 24.3 13.7 15.1 10.2 21.6 19.3 5.5 11.8 22.7 33.8 20.5 6.0 31.4 8.4 30.5 29.1 4.3 14.7 26.5 29.8 20.9 22.6 22.5 30.0 23.3 17.2 14.9 21.3 35.0 4.5 5.7 7.8 21.1 17.7 18.0 15.2 21.1 23.1 13.2 34.2 12.5 8.1 17.4 14.9 17.3 7.5 14.0 15.4 16.2 9.7 47.0 5.8 11.5 18.5 13.6 16.3 13.9 21.1 12.8 13.5 17.1 11.3 19.3 13.0 116.1 62.1 29.8 106.2 59.1 18.3 111.8 56.0 61.6 76.2 50.6 27.5 126.7 24.9 126.4 12.2 66.8 112.0 93.5 108.9 152.0 90.0 85.1 31.2 66.4 98.6 19.1 15.0 63.3 131.7 9.4 60.9 75.2 55.6 36.9 30.0 44.6 118.2 84.2 61.2 82.7 24.4 84.1 70.7 140.1 52.1 75.9 134.8 42.6 64.1 124.0 CNMD "BRICD3, CHM-I, CHM1, LECT1, MYETS1" ENSG00000136110 Chondromodulin O75829 13 52703264-52739812 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.1;salivary gland: 15.1;thyroid gland: 8.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 33 "NTERA-2: 33.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010510 Uncertain "Secreted to extracellular matrix" NA NA "HPA010510: AB_10602021" "unprognostic (7.52e-3)" "unprognostic (1.34e-1)" "unprognostic (7.36e-2)" "unprognostic (1.45e-2)" "unprognostic (1.15e-1)" "unprognostic (3.22e-1)" "unprognostic (2.84e-2)" "unprognostic (2.63e-2)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-1)" 0.3 0.3 3.1 0.3 11.1 0.3 0.4 0.9 2.5 0.3 0.5 4.3 0.0 0.3 0.3 0.3 0.6 0.4 0.3 0.4 3.0 2.6 0.3 0.3 3.9 0.3 3.7 0.9 0.4 1.1 0.3 2.5 0.5 3.1 1.6 0.5 6.1 15.1 0.4 0.5 0.5 0.4 0.3 4.4 1.0 0.4 4.2 4.1 0.0 8.0 0.0 0.6 0.3 0.0 0.0 0.6 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 3.1 11.1 0.9 2.3 3.0 2.6 3.7 0.9 3.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CNNM2 ACDP2 ENSG00000148842 "Cyclin and CBS domain divalent metal cation transport mediator 2" Q9H8M5 10 102918293-103090221 "Disease related genes, Predicted membrane proteins" "Ion transport, Transport" "Disease mutation, Epilepsy, Mental retardation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 35.6" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 30.2;Syncytiotrophoblasts: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059954, HPA071631" Enhanced Vesicles NA NA Vesicles "HPA059954: AB_2684177, HPA071631: AB_2686427" "unprognostic (2.18e-1)" "unprognostic (6.46e-2)" "unprognostic (1.24e-1)" "unprognostic (2.65e-3)" "unprognostic (3.19e-1)" "unprognostic (2.44e-1)" "unprognostic (1.93e-1)" "unprognostic (4.80e-2)" "unprognostic (4.51e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-2)" "unprognostic (2.39e-1)" "prognostic favorable (2.39e-8)" "unprognostic (2.44e-1)" "unprognostic (1.13e-1)" "unprognostic (2.65e-3)" "unprognostic (1.56e-1)" 5.7 19.8 9.5 6.6 13.8 13.3 5.0 16.8 15.1 6.0 11.8 12.5 8.0 6.9 6.6 5.8 3.3 8.9 9.4 4.1 7.8 10.9 15.6 7.9 6.4 4.1 10.4 8.6 8.8 6.8 35.6 10.6 14.3 9.6 5.0 11.2 7.7 5.2 7.1 3.0 7.2 7.7 6.9 9.3 4.1 5.4 8.0 12.7 3.3 10.0 1.9 3.0 6.2 5.4 1.3 1.3 2.8 0.8 4.5 1.1 0.4 4.7 7.8 3.1 8.2 7.9 3.2 8.4 2.3 9.4 3.1 3.8 5.5 4.2 1.8 3.5 3.3 5.9 6.3 6.6 4.4 2.3 3.1 11.6 2.6 4.3 11.1 4.6 1.8 3.6 4.2 6.4 3.1 10.5 7.8 1.9 5.4 4.5 10.6 1.7 8.0 2.1 2.1 4.9 4.6 4.9 5.2 3.9 2.2 2.4 2.8 4.4 5.7 5.6 1.4 5.9 9.3 10.1 3.5 1.5 4.2 6.3 2.9 4.0 11.6 12.8 3.3 7.4 6.3 1.7 1.9 0.8 0.7 1.0 0.8 0.8 1.3 0.7 0.5 0.6 0.7 0.8 0.7 2.8 4.5 0.4 1.3 1.1 0.4 9.5 13.8 16.8 15.1 7.8 10.9 10.4 8.6 9.6 12.7 6.0 6.7 7.5 2.1 2.2 15.8 3.5 0.0 8.1 7.9 5.2 11.8 13.9 1.7 1.8 8.4 3.8 24.6 0.0 4.8 2.7 2.9 2.2 3.5 5.4 3.3 30.2 6.4 3.1 1.5 10.4 3.1 2.7 6.8 1.0 4.2 6.5 2.7 11.5 3.2 4.4 15.7 12.9 7.8 15.0 5.4 3.6 33.3 3.1 7.4 1.8 CNNM3 ACDP3 ENSG00000168763 "Cyclin and CBS domain divalent metal cation transport mediator 3" Q8NE01 2 96816245-96833911 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016711 Supported Approved Cytosol NA NA Cytosol "HPA016711: AB_1847394" "unprognostic (1.50e-2)" "unprognostic (6.96e-2)" "unprognostic (2.71e-2)" "unprognostic (3.21e-2)" "unprognostic (1.82e-1)" "unprognostic (1.23e-1)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (3.03e-1)" "unprognostic (1.59e-1)" "unprognostic (8.32e-3)" "unprognostic (3.64e-1)" "unprognostic (5.31e-3)" "unprognostic (7.35e-2)" "unprognostic (3.36e-1)" "unprognostic (1.06e-1)" "unprognostic (4.48e-2)" 8.1 10.7 8.6 6.4 11.5 5.2 8.6 25.0 11.2 8.9 13.3 16.9 7.4 17.4 10.7 5.3 7.5 12.0 15.0 5.9 10.0 5.2 8.6 20.7 8.8 7.2 14.5 9.7 11.6 27.9 28.9 15.7 10.3 11.4 8.9 8.3 13.1 11.4 9.9 9.9 7.7 15.1 10.7 7.0 9.5 12.3 11.4 15.9 13.8 10.0 2.4 10.2 9.9 8.2 3.0 1.8 5.5 3.3 2.1 5.4 1.3 6.9 7.3 6.0 9.8 7.5 3.6 18.3 4.9 4.2 4.7 4.7 18.8 11.7 7.8 17.0 3.8 5.3 8.1 9.1 6.4 3.0 7.7 22.0 10.6 9.2 19.0 6.6 9.1 7.8 3.6 7.8 6.3 5.6 5.7 5.7 6.4 9.6 12.5 1.8 9.2 8.5 8.9 8.3 10.2 8.5 10.5 8.4 9.7 7.6 9.5 19.3 11.7 6.3 9.6 5.3 8.6 9.7 6.7 2.7 4.2 11.9 6.1 6.8 12.5 12.1 5.7 2.4 8.7 4.2 2.7 1.4 5.5 5.4 0.6 2.9 3.0 2.8 4.4 0.4 2.8 2.5 2.7 3.0 2.1 3.3 1.8 4.6 1.3 8.6 11.5 25.0 11.2 10.0 5.2 14.5 9.7 11.4 15.9 8.9 3.7 4.2 2.8 1.1 17.9 14.3 10.2 4.0 3.4 0.0 7.9 4.3 0.0 3.6 6.3 2.3 4.9 0.0 3.6 2.0 2.4 5.7 0.0 12.9 2.2 31.8 4.1 4.3 2.6 1.1 2.3 0.8 3.3 1.0 6.4 8.9 2.9 0.0 3.9 1.6 12.9 12.9 3.3 3.4 7.5 1.4 1.4 2.5 6.9 2.2 CNNM4 "ACDP4, KIAA1592" ENSG00000158158 "Cyclin and CBS domain divalent metal cation transport mediator 4" Q6P4Q7 2 96760902-96811891 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Biomineralization, Ion transport, Sensory transduction, Transport, Vision" "Amelogenesis imperfecta, Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 106.0;Enterocytes: 53.8;Rod photoreceptor cells: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-BR-3: 29.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017732 Enhanced Uncertain "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA017732: AB_1847395" "unprognostic (1.98e-3)" "unprognostic (8.95e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (9.14e-4)" "unprognostic (3.42e-2)" "unprognostic (5.28e-2)" "unprognostic (1.54e-3)" "unprognostic (3.36e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.75e-4)" "unprognostic (4.75e-3)" "unprognostic (3.72e-1)" "unprognostic (8.14e-2)" "unprognostic (3.13e-1)" "unprognostic (3.44e-2)" "unprognostic (1.15e-2)" "unprognostic (1.06e-1)" 3.7 4.0 4.8 17.0 9.6 4.5 7.4 24.1 11.1 6.8 31.2 11.3 8.3 6.3 10.4 5.2 7.7 10.8 7.3 11.5 5.4 5.0 5.9 4.9 8.1 4.3 6.0 6.6 6.1 11.4 9.0 10.6 17.1 5.5 7.4 33.5 13.9 10.8 11.3 21.3 7.4 11.1 5.7 5.2 6.1 12.6 11.8 6.1 4.6 9.7 6.1 9.3 6.5 7.4 3.7 2.2 2.8 2.3 0.8 3.2 1.1 6.9 4.6 3.7 6.8 3.9 2.6 10.2 3.0 4.3 4.5 6.1 8.3 7.5 5.0 8.8 3.1 6.2 9.0 9.5 5.2 4.2 10.1 7.5 4.0 3.1 4.5 5.4 1.9 4.0 2.5 6.5 7.2 4.4 3.0 2.4 5.1 2.0 14.4 2.3 9.8 4.0 2.8 4.9 12.9 6.3 6.0 1.7 5.8 4.5 5.4 17.4 5.2 5.8 29.6 4.3 10.8 14.4 3.3 2.2 2.6 5.9 5.7 3.4 5.0 4.0 2.6 3.8 3.8 4.6 2.8 1.6 0.5 3.2 1.8 1.1 3.7 1.7 1.7 2.2 2.1 1.1 2.1 0.7 0.8 2.3 1.7 0.8 1.1 4.8 9.6 24.1 11.1 5.4 5.0 6.0 6.6 5.5 6.1 35.7 7.7 4.7 3.8 5.0 38.8 11.8 7.6 5.3 14.8 7.0 106.0 4.7 0.0 2.6 4.1 2.9 53.8 0.0 3.6 1.4 2.8 3.4 1.1 3.0 3.0 31.8 9.7 3.1 5.4 1.0 0.9 2.4 0.0 0.0 26.3 7.7 3.8 20.9 1.1 1.2 46.8 0.0 4.7 5.5 2.0 3.6 5.6 2.9 21.7 4.9 CNOT1 "AD-005, CDC39, KIAA1007, NOT1, NOT1H" ENSG00000125107 "CCR4-NOT transcription complex subunit 1" A5YKK6 16 58519951-58629886 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046577, HPA049664" Approved Supported Cytosol NA NA 210000 Cytosol "HPA046577: AB_2679706, HPA049664: AB_2680844" "unprognostic (1.30e-2)" "unprognostic (6.86e-2)" "unprognostic (9.25e-3)" "unprognostic (1.66e-1)" "unprognostic (2.39e-2)" "unprognostic (7.11e-2)" "unprognostic (3.58e-2)" "unprognostic (2.19e-1)" "unprognostic (6.43e-2)" "unprognostic (6.99e-2)" "unprognostic (1.83e-2)" "unprognostic (6.63e-2)" "unprognostic (1.33e-3)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (5.53e-2)" "unprognostic (1.52e-1)" 20.4 26.5 14.9 31.5 16.5 18.2 18.8 24.2 16.8 21.3 26.6 16.7 26.6 24.3 22.2 19.1 45.6 19.0 15.4 15.5 14.2 9.0 18.8 20.9 19.6 24.1 19.0 12.3 22.6 21.8 39.6 25.4 23.2 16.1 15.9 26.6 17.3 28.3 27.2 32.6 27.4 31.4 20.0 13.6 25.8 22.7 53.9 18.1 45.1 20.2 22.6 32.6 26.9 26.0 15.4 14.6 18.8 20.9 14.6 19.2 10.6 26.4 31.1 23.8 19.0 11.5 14.7 27.3 20.9 18.3 24.1 18.0 35.2 16.0 40.3 10.1 16.0 14.0 26.1 38.0 21.4 32.7 15.0 20.8 31.3 25.7 40.2 15.7 48.2 35.2 14.2 14.7 28.0 33.0 14.6 18.7 22.8 36.6 11.8 16.2 10.7 37.3 12.6 24.6 17.7 27.1 47.5 41.0 25.6 13.6 37.3 19.7 12.7 71.2 24.1 11.9 22.8 14.5 25.3 21.0 17.7 17.6 13.3 18.3 27.0 27.2 81.8 18.8 20.6 16.4 18.3 11.6 13.0 14.6 15.9 19.2 15.4 14.1 14.6 14.6 14.2 12.6 13.5 18.8 14.6 20.9 7.4 14.8 10.6 14.9 16.5 24.2 16.8 14.2 9.0 19.0 12.3 16.1 18.1 14.9 40.5 34.1 27.4 42.1 27.5 15.5 43.3 46.8 39.8 22.7 27.5 30.8 8.3 26.3 70.8 29.5 51.6 46.7 40.6 26.0 23.4 33.4 30.2 35.2 31.0 38.1 34.7 27.0 46.6 26.6 23.0 34.4 18.6 27.9 57.2 18.1 34.7 23.0 30.4 19.2 22.3 32.3 23.9 105.1 59.6 41.0 31.7 34.6 59.2 59.6 CNPPD1 "C2orf24, CGI-57" ENSG00000115649 "Cyclin Pas1/PHO80 domain containing 1" Q9BV87 2 219171897-219178106 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "monocytes: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049303 Uncertain NA NA "HPA049303: AB_2680703" "unprognostic (9.24e-2)" "unprognostic (4.12e-2)" "unprognostic (1.09e-1)" "unprognostic (9.43e-2)" "unprognostic (3.68e-2)" "unprognostic (5.74e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (1.77e-1)" "unprognostic (4.15e-3)" "unprognostic (5.54e-3)" "unprognostic (8.53e-2)" "unprognostic (2.35e-1)" "prognostic favorable (1.62e-10)" "unprognostic (1.48e-2)" "unprognostic (1.51e-1)" "unprognostic (2.62e-2)" "unprognostic (2.54e-2)" 25.9 41.2 17.2 21.2 21.5 34.6 25.7 21.5 22.5 17.9 30.8 36.1 16.8 30.3 21.2 22.7 40.2 17.0 26.4 24.1 15.4 13.3 61.3 27.3 24.9 27.3 26.1 20.4 22.7 29.1 30.7 11.5 26.2 20.4 22.1 23.1 28.0 24.6 26.7 39.2 29.5 32.6 25.5 24.6 32.9 23.0 22.6 23.4 21.5 32.1 20.6 32.2 28.7 21.4 37.3 38.7 31.1 45.6 21.1 28.3 26.5 15.9 12.0 12.1 22.3 25.0 12.6 17.4 20.7 12.2 17.2 13.8 25.8 19.9 9.1 12.2 20.1 13.8 22.4 16.0 16.7 10.1 23.3 9.3 37.1 12.5 25.6 30.7 21.7 25.9 13.4 21.5 17.0 15.3 15.5 14.4 24.8 29.5 34.4 9.9 29.0 23.7 16.6 7.7 18.5 15.4 35.5 9.0 30.9 26.6 22.5 15.8 18.9 11.9 29.9 21.8 13.8 23.8 25.1 13.5 14.1 13.3 27.6 19.6 27.3 10.6 19.5 19.1 26.1 9.1 28.3 25.1 24.5 22.7 37.3 19.7 34.0 22.2 22.7 38.7 37.3 15.6 17.3 31.1 21.1 45.6 21.4 28.3 26.5 17.2 21.5 21.5 22.5 15.4 13.3 26.1 20.4 20.4 23.4 17.9 15.3 25.9 13.1 11.9 11.4 20.5 35.7 10.7 15.9 40.1 3.9 26.8 48.0 30.2 1.5 21.1 77.8 46.7 28.8 17.9 17.8 21.2 12.7 19.5 33.2 11.1 27.7 25.8 41.2 1.5 20.8 28.2 20.3 113.6 43.1 26.0 33.1 40.3 19.8 48.8 11.0 19.4 21.3 22.6 33.4 13.9 46.0 33.3 35.7 13.6 CNR1 "CANN6, CB-R, CB1, CB1A, CB1K5, CNR" ENSG00000118432 "Cannabinoid receptor 1" P21554 6 88139864-88166359 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Cell type enriched" "Detected in some" 14 "Sertoli cells: 97.0" "Cancer enriched" "Detected in many" 13 "glioma: 12.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.9;naive B-cell: 2.1" "Lineage enriched" "Detected in single" 6 "B-cells: 2.9" "Group enriched" "Detected in some" 7 "ASC diff: 40.3;HSkMC: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042256, HPA069945" Enhanced Supported Supported "Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Actin filaments" "HPA042256: AB_2677917, HPA069945: " "unprognostic (1.28e-1)" "unprognostic (7.04e-2)" "unprognostic (4.61e-2)" "unprognostic (4.08e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-3)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-2)" "unprognostic (2.74e-2)" "unprognostic (2.68e-1)" "unprognostic (1.70e-1)" "unprognostic (5.59e-3)" "unprognostic (2.68e-3)" "unprognostic (5.88e-2)" "unprognostic (7.00e-2)" 19.4 6.4 18.0 5.2 15.8 1.5 14.9 13.8 30.5 3.9 5.5 0.8 0.8 2.3 3.1 4.7 3.7 5.5 3.6 1.4 17.6 7.7 0.9 0.7 6.4 6.5 2.3 14.7 4.1 1.8 1.3 18.3 5.2 4.2 1.5 5.1 0.0 4.3 4.0 1.7 2.4 4.2 5.8 3.2 2.3 2.3 2.7 2.8 0.0 2.6 0.0 9.9 2.7 3.1 2.9 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 40.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.9 1.4 0.0 2.6 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 3.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.7 3.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 18.0 15.8 13.8 21.4 17.6 7.7 2.3 14.7 4.2 2.8 0.0 7.2 2.7 0.4 0.6 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 97.0 2.3 0.0 0.1 0.1 0.1 0.0 0.0 0.7 CNR2 CB2 ENSG00000188822 "Cannabinoid receptor 2" P34972 1 23870526-23913362 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 19.2;lymphoid tissue: 31.1" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 4.6;B-cells: 16.4;T-cells: 5.7" "Cancer enriched" "Detected in single" 6 "testis cancer: 2.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basophil: 19.2;eosinophil: 16.2;memory B-cell: 14.9;naive B-cell: 15.1;NK-cell: 8.7" "Group enriched" "Detected in many" 7 "B-cells: 15.1;granulocytes: 19.2;NK-cells: 8.7" "Cell line enhanced" "Detected in some" "Daudi: 5.0;HEL: 4.2;HMC-1: 19.4;U-698: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" CAB009719 Uncertain NA NA "CAB009719: AB_2082784" "unprognostic (9.45e-4)" "unprognostic (5.40e-3)" "unprognostic (8.50e-3)" "unprognostic (8.19e-3)" "unprognostic (3.55e-3)" "unprognostic (9.34e-6)" "unprognostic (5.58e-3)" "unprognostic (6.96e-3)" "unprognostic (1.74e-1)" "unprognostic (7.87e-2)" "unprognostic (1.53e-1)" "unprognostic (4.93e-2)" "unprognostic (1.04e-3)" "unprognostic (3.67e-1)" "unprognostic (1.80e-1)" "unprognostic (3.75e-2)" "unprognostic (4.91e-2)" 0.3 0.2 0.2 18.5 0.2 1.8 0.2 0.2 0.2 0.2 0.4 0.0 0.0 0.1 0.2 0.1 1.8 0.2 0.3 0.3 0.2 0.2 0.4 0.3 0.6 27.7 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.4 0.3 0.3 3.1 0.0 1.8 0.2 5.5 0.0 0.2 29.7 0.4 0.4 0.0 3.0 0.6 0.6 31.1 1.5 0.3 15.1 0.8 19.2 0.1 8.7 2.0 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.2 0.1 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 13.0 0.0 0.1 0.0 19.2 0.1 16.2 1.7 0.0 2.0 14.9 0.1 1.5 0.2 15.1 0.1 0.9 0.6 8.7 0.1 0.8 0.1 0.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 3.0 4.6 16.4 0.7 0.6 0.7 0.3 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 3.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.8 0.0 0.3 0.3 0.2 0.3 0.2 5.7 0.0 0.6 CNST "C1orf71, FLJ32001, PPP1R64" ENSG00000162852 "Consortin, connexin sorting protein" Q6PJW8 1 246566444-246668584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007225, HPA007226" Approved Supported Vesicles NA NA 4600000 Vesicles "HPA007225: AB_1848869, HPA007226: AB_2667782" "unprognostic (1.55e-2)" "unprognostic (9.75e-2)" "unprognostic (3.33e-2)" "unprognostic (9.76e-2)" "unprognostic (2.78e-1)" "unprognostic (4.28e-2)" "unprognostic (3.72e-2)" "unprognostic (7.28e-3)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (3.52e-2)" "unprognostic (3.47e-2)" "unprognostic (2.73e-3)" "unprognostic (6.17e-2)" "unprognostic (2.63e-1)" "unprognostic (8.77e-3)" "unprognostic (2.26e-1)" 15.5 21.7 10.2 13.7 22.3 21.8 12.8 25.1 22.4 10.6 14.6 8.1 10.2 11.0 14.7 9.4 18.6 10.0 9.7 11.1 9.5 17.6 9.9 25.1 12.4 16.4 11.2 14.1 12.1 11.0 15.2 17.4 11.9 13.7 9.7 13.4 11.6 9.4 9.6 35.5 11.6 15.5 18.4 7.6 12.3 9.6 17.2 9.3 24.6 15.4 10.2 18.6 14.9 11.0 21.1 6.6 21.6 11.1 7.8 19.3 9.0 4.3 5.7 4.2 3.7 6.9 8.1 8.5 14.1 13.9 14.3 10.9 5.5 5.7 12.6 6.3 13.9 4.2 4.5 6.5 4.8 19.5 7.0 2.2 14.8 5.2 4.1 10.1 7.3 28.7 7.6 4.6 13.8 14.8 7.1 4.4 6.8 18.7 5.6 8.0 3.1 8.0 3.4 13.8 6.0 5.0 7.9 7.6 10.3 5.4 12.6 9.7 11.6 6.0 3.5 17.4 5.1 6.5 6.5 6.2 17.8 4.3 7.3 9.5 17.1 21.7 12.8 4.4 11.0 17.1 21.6 4.7 12.9 8.8 5.0 9.6 19.4 15.0 8.1 4.6 21.1 19.3 10.3 6.2 7.8 11.1 6.6 18.1 9.0 10.2 22.3 25.1 22.4 9.5 17.6 11.2 14.1 13.7 9.3 11.9 15.0 6.5 13.5 22.0 28.1 10.4 7.6 32.1 25.0 3.5 13.7 3.1 6.6 5.9 36.0 31.6 39.9 0.0 5.2 5.0 12.2 17.4 38.3 18.1 8.5 15.9 14.5 28.3 13.3 30.0 8.9 11.1 13.5 7.2 16.1 12.2 7.1 17.5 7.4 4.1 21.8 12.9 18.4 12.1 11.9 23.5 7.8 18.4 10.1 17.0 CNTN1 "F3, GP135" ENSG00000018236 "Contactin 1" Q12860 12 40692442-41072418 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.2" "Cell type enhanced" "Detected in many" 14 "Late spermatids: 116.1;Leydig cells: 58.1;Peritubular cells: 56.6" "Cancer enhanced" "Detected in many" "glioma: 17.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "A549: 71.9;HaCaT: 13.0;SCLC-21H: 22.1;SH-SY5Y: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025200, HPA070467" Enhanced Approved "Intracellular and membrane" NA NA 490000000 "CAB025200: , HPA070467: AB_2732156" "unprognostic (3.18e-2)" "unprognostic (5.96e-3)" "unprognostic (3.66e-2)" "unprognostic (7.34e-2)" "unprognostic (2.00e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (2.05e-1)" "unprognostic (9.13e-2)" "unprognostic (1.08e-1)" "unprognostic (1.72e-2)" "unprognostic (1.86e-1)" "unprognostic (1.32e-2)" "unprognostic (8.15e-4)" "unprognostic (6.98e-2)" "unprognostic (5.46e-2)" "prognostic unfavorable (3.75e-4)" 2.9 21.0 27.8 2.1 21.5 0.8 5.7 47.1 81.2 9.9 2.5 14.3 0.7 1.8 7.9 2.2 6.5 2.1 8.2 1.1 27.5 22.1 8.2 1.4 3.3 3.1 23.0 27.7 32.3 4.5 0.8 7.7 0.8 27.0 18.4 3.0 6.9 3.8 18.1 1.1 8.3 2.5 14.4 32.2 5.3 3.0 5.9 17.8 0.0 1.4 0.5 2.9 11.8 3.6 1.6 2.2 6.4 1.4 1.9 1.3 0.2 0.0 71.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 13.0 1.9 3.4 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 22.1 13.4 0.0 0.7 0.8 0.3 0.0 0.2 0.0 0.0 1.4 0.0 2.9 1.0 0.0 0.0 0.1 0.0 0.2 6.4 1.4 1.9 1.1 0.8 1.0 1.3 0.9 0.6 0.2 1.6 1.3 0.9 4.1 1.9 0.9 2.2 0.7 0.2 27.8 21.5 47.1 32.6 27.5 22.1 23.0 27.7 27.0 17.8 0.0 5.1 0.0 0.5 4.6 26.9 0.6 0.0 0.0 6.8 5.2 27.5 0.0 1.7 0.0 29.3 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.1 11.1 0.0 0.0 0.0 116.1 58.1 0.0 10.1 0.0 0.0 31.8 0.7 0.0 56.6 0.0 5.7 0.0 1.9 0.7 0.9 11.8 0.0 0.0 0.0 0.1 CNTNAP1 "Caspr, CNTNAP, NRXN4, p190" ENSG00000108797 "Contactin associated protein 1" P78357 17 42682613-42699814 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.7;smooth muscle: 26.7" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 12.8;Sertoli cells: 6.5;Smooth muscle cells: 4.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "TIME: 30.0;U-138 MG: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011772 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011772: AB_1079541" "unprognostic (4.04e-2)" "unprognostic (3.69e-1)" "unprognostic (2.37e-3)" "unprognostic (1.89e-1)" "unprognostic (5.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" "unprognostic (2.59e-1)" "unprognostic (9.76e-3)" "unprognostic (1.99e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.16e-14)" "unprognostic (9.52e-3)" "unprognostic (2.27e-2)" "unprognostic (3.11e-2)" "unprognostic (7.37e-3)" 6.1 2.5 35.5 5.9 18.8 1.1 1.7 31.7 48.7 4.7 8.5 2.9 1.4 2.3 12.1 7.1 2.9 7.0 7.1 4.0 29.2 14.8 1.7 0.9 3.9 2.8 10.5 23.9 8.7 6.5 1.7 7.2 5.0 18.4 4.2 4.7 2.1 2.0 7.6 3.5 2.5 2.7 26.7 11.5 3.2 3.9 2.3 13.3 0.0 1.7 0.2 2.9 5.8 3.3 0.0 0.7 0.1 0.0 0.1 1.4 0.0 1.8 2.6 5.8 1.9 9.0 18.4 0.4 10.9 19.1 8.1 7.3 0.3 0.4 0.0 0.6 11.9 8.1 2.1 2.8 0.9 6.3 4.2 0.9 0.0 10.8 2.7 4.4 0.0 0.1 17.9 0.0 7.7 1.5 12.9 10.1 0.1 0.5 3.3 3.1 0.3 0.0 1.6 2.0 0.1 2.6 0.3 0.7 1.0 2.1 0.0 1.1 3.4 3.2 0.0 2.1 5.5 2.1 0.9 30.0 34.8 5.9 8.0 3.0 4.0 2.4 0.1 9.6 0.7 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 1.4 0.0 35.5 18.8 31.7 48.7 29.2 14.8 10.5 23.9 18.4 13.3 0.0 2.6 0.0 0.1 0.5 12.8 1.1 0.0 1.4 1.2 0.0 3.9 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 2.5 0.4 0.0 0.0 0.1 1.6 0.0 2.5 0.0 0.0 1.4 0.0 0.0 1.0 0.0 0.8 0.1 0.0 0.7 0.0 2.8 6.5 4.4 0.2 0.2 0.3 0.2 0.0 0.0 0.1 CNTNAP2 "Caspr2, KIAA0868, NRXN4" ENSG00000174469 "Contactin associated protein like 2" Q9UHC6 7 146116002-148420998 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Autism, Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Cell type enriched" "Detected in many" 32 "Horizontal cells: 974.1" "Cancer enhanced" "Detected in many" "prostate cancer: 10.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 31 "memory B-cell: 1.8;naive B-cell: 6.1" "Lineage enriched" "Detected in single" 48 "B-cells: 6.1" "Group enriched" "Detected in some" 4 "AF22: 7.5;CACO-2: 6.3;NTERA-2: 11.2;SCLC-21H: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002739 Enhanced NA NA "HPA002739: AB_1078545" "unprognostic (2.49e-2)" "unprognostic (1.49e-2)" "unprognostic (4.05e-1)" "unprognostic (3.08e-3)" "unprognostic (1.77e-1)" "unprognostic (2.29e-1)" "unprognostic (2.51e-2)" "unprognostic (1.45e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-1)" "unprognostic (3.67e-2)" "unprognostic (2.68e-1)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.00e-3)" 0.9 2.0 14.0 1.2 16.6 0.9 2.2 4.4 25.8 0.7 2.3 1.2 0.0 0.7 0.9 0.7 1.4 2.2 0.8 1.0 9.6 6.4 1.0 3.5 0.8 1.6 7.5 16.2 1.7 1.1 0.7 2.7 1.9 17.0 8.7 1.6 2.5 0.9 1.0 0.7 0.8 2.0 0.8 18.1 1.7 1.2 1.4 0.5 2.4 1.5 0.0 1.3 0.8 0.5 6.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 7.5 1.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.2 0.0 1.8 1.6 0.5 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 1.3 0.0 0.0 0.0 2.1 0.0 0.0 20.2 1.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 14.0 16.6 4.4 25.8 9.6 6.4 7.5 16.2 17.0 0.5 0.0 0.0 2.0 0.2 0.1 29.8 1.1 12.7 0.0 0.0 0.0 2.0 30.0 0.0 0.9 5.7 0.0 1.3 0.0 0.6 2.5 0.6 7.2 0.0 8.9 2.7 974.1 2.4 0.0 1.2 2.1 1.1 0.4 0.0 0.0 3.6 7.0 3.6 2.5 0.0 0.5 13.9 0.0 0.2 1.9 1.5 0.0 5.3 0.0 6.5 0.1 CNTNAP3 "CASPR3, CNTNAP3A, FLJ14195, KIAA1714" ENSG00000106714 "Contactin associated protein like 3" Q9BZ76 9 39072767-39288315 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.6;esophagus: 9.5" "Cell type enhanced" "Detected in many" 11 "Ito cells: 22.1;Muller glia cells: 11.5" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 22 "neutrophil: 10.6" "Lineage enriched" "Detected in single" 107 "granulocytes: 10.6" "Cell line enhanced" "Detected in many" "A549: 12.7;AF22: 15.4;TIME: 9.7;WM-115: 25.7" HPA047731 Uncertain "Intracellular and membrane" NA NA "HPA047731: AB_2680137" "unprognostic (9.06e-3)" "unprognostic (3.07e-2)" "unprognostic (5.74e-2)" "unprognostic (7.89e-2)" "unprognostic (7.03e-2)" "unprognostic (2.33e-3)" "unprognostic (4.58e-2)" "unprognostic (1.34e-2)" "unprognostic (1.51e-1)" "unprognostic (2.94e-2)" "unprognostic (1.11e-1)" "unprognostic (3.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.15e-2)" "unprognostic (1.20e-1)" "unprognostic (1.95e-3)" "unprognostic (1.93e-3)" 2.9 0.1 1.2 0.3 4.8 1.0 2.6 0.4 2.5 0.8 2.4 0.6 0.2 0.2 9.5 1.6 1.1 4.1 1.2 1.3 1.1 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.3 1.7 1.6 1.4 2.8 1.7 0.0 8.3 1.0 2.5 1.1 2.4 0.1 1.9 1.3 0.3 0.5 1.9 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.7 12.7 15.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.9 3.2 1.3 2.9 0.0 0.0 1.1 0.0 3.4 0.3 0.1 0.2 0.0 0.4 2.8 0.0 1.1 6.5 6.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 3.9 0.0 0.4 3.5 0.3 0.5 1.4 0.5 4.5 0.0 2.5 1.7 0.0 2.1 9.7 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 3.0 1.7 0.0 3.4 5.6 0.8 2.5 7.6 2.7 0.0 1.8 2.0 0.7 0.0 0.3 1.3 5.8 0.0 0.0 0.2 0.6 0.9 0.8 0.0 1.8 0.1 0.0 3.4 22.1 1.3 0.8 0.3 0.0 0.0 0.0 0.0 11.5 0.5 0.0 0.0 1.5 0.4 0.0 0.5 0.9 5.8 6.8 0.6 0.0 0.0 2.5 CNTNAP3B ENSG00000154529 "Contactin associated protein like 3B" Q96NU0 9 41890314-42129510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Endothelial cells: 28.1;Ito cells: 77.3;Muller glia cells: 26.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "neutrophil: 7.5" "Lineage enriched" "Detected in single" 76 "granulocytes: 7.5" "Cell line enhanced" "Detected in some" "A549: 18.4;AF22: 26.3;WM-115: 17.7" HPA047731 Uncertain NA NA "HPA047731: AB_2680137" "unprognostic (2.68e-2)" "unprognostic (9.63e-3)" "unprognostic (2.20e-2)" "unprognostic (2.87e-1)" "unprognostic (1.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.20e-3)" "unprognostic (5.70e-2)" "unprognostic (2.27e-1)" "unprognostic (7.20e-2)" "unprognostic (3.74e-3)" "unprognostic (1.64e-1)" "unprognostic (7.74e-2)" "unprognostic (5.78e-3)" "unprognostic (7.93e-3)" "unprognostic (2.90e-2)" "unprognostic (2.05e-4)" 4.1 0.6 1.1 0.3 2.2 0.0 4.7 0.5 2.2 1.5 1.1 0.4 1.3 0.0 7.3 1.9 1.3 2.5 1.3 1.4 4.9 1.0 2.1 0.0 0.9 0.4 0.3 0.0 1.2 2.4 1.0 1.7 1.9 1.1 0.7 6.5 0.6 1.9 0.9 1.6 0.5 1.1 0.8 0.1 2.0 1.4 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 18.4 26.3 0.0 0.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.1 0.4 2.3 1.5 1.4 0.0 0.0 0.9 0.0 3.3 1.6 0.6 0.9 0.0 2.0 2.2 0.2 0.3 6.6 4.3 0.0 0.4 0.1 0.0 0.1 0.0 0.0 2.5 0.6 5.6 0.0 0.5 7.1 0.8 0.5 1.9 0.2 0.7 0.0 3.5 0.8 0.0 2.5 4.5 0.1 1.7 0.1 0.5 0.0 0.0 0.0 0.0 0.8 17.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 6.7 3.8 2.9 6.1 2.5 14.7 0.0 3.5 0.0 2.1 0.0 1.6 1.8 28.1 0.0 0.0 2.8 1.0 1.3 1.5 1.1 7.5 0.1 0.0 1.7 77.3 3.8 0.9 0.9 1.0 5.0 0.0 0.6 26.6 2.0 0.0 0.7 6.0 0.5 0.0 1.0 0.7 2.2 4.5 0.6 0.5 0.0 6.2 CNTNAP4 "CASPR4, KIAA1763" ENSG00000152910 "Contactin associated protein like 4" Q9C0A0 16 76277278-76559238 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "brain: 36.9" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 20.9;Early spermatids: 11.3;Late spermatids: 7.8;Muller glia cells: 4.3" "Cancer enriched" "Detected in single" 5 "glioma: 1.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Daudi: 14.0;HSkMC: 5.6;Karpas-707: 4.8;RPMI-8226: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031859 Enhanced NA NA 73000 "HPA031859: AB_10601360" "unprognostic (7.88e-2)" "unprognostic (7.19e-2)" "unprognostic (6.58e-2)" "unprognostic (2.46e-1)" "unprognostic (1.55e-2)" "unprognostic (1.50e-3)" "unprognostic (9.42e-3)" "unprognostic (1.91e-2)" "unprognostic (5.26e-4)" "unprognostic (1.83e-2)" "unprognostic (2.00e-2)" "unprognostic (4.56e-1)" "unprognostic (1.09e-1)" 0.9 2.4 10.2 0.9 19.1 0.9 0.9 13.2 36.9 1.3 0.9 27.6 0.0 1.2 0.9 0.9 0.9 0.9 0.9 0.9 9.9 2.2 1.0 0.9 0.9 1.0 23.1 15.1 1.0 0.9 0.9 0.8 0.9 25.0 1.3 0.9 0.0 0.9 1.4 0.9 0.9 1.1 1.0 30.9 0.9 0.9 2.2 21.4 0.0 0.9 0.0 1.0 0.9 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.4 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.2 19.1 13.2 14.4 9.9 2.2 23.1 15.1 25.0 21.4 0.0 0.0 0.0 0.0 0.0 20.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 CNTNAP5 "caspr5, FLJ31966" ENSG00000155052 "Contactin associated protein like 5" Q8WYK1 2 124025287-124915287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 22.4" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 5.6;Cardiomyocytes: 1.4;Distal tubular cells: 1.7;Horizontal cells: 1.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.3;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.4" "Low region specificity" "Detected in all" "HPA069095, HPA069356" Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA069095: AB_2686083, HPA069356: AB_2686127" "unprognostic (6.32e-3)" "unprognostic (6.38e-2)" "unprognostic (1.23e-1)" "unprognostic (2.25e-1)" "unprognostic (1.68e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (3.11e-2)" "unprognostic (2.62e-6)" "unprognostic (3.65e-3)" "unprognostic (5.32e-2)" "unprognostic (9.58e-2)" 0.7 2.8 12.9 0.7 7.9 1.0 0.7 3.3 22.4 0.6 0.8 1.5 0.0 1.0 0.7 0.7 0.7 0.6 4.2 0.7 14.0 4.0 1.2 0.7 0.7 0.7 2.2 8.4 0.6 1.1 0.7 0.8 0.7 15.2 0.8 0.8 0.4 0.6 1.0 0.7 0.8 0.9 0.8 1.9 0.7 0.7 0.9 2.8 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.3 7.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 7.9 3.3 22.4 14.0 4.0 2.2 8.4 15.2 2.8 0.0 0.0 0.0 0.0 0.0 5.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 COA1 "C7orf44, FLJ10803, MITRAC15" ENSG00000106603 "Cytochrome c oxidase assembly factor 1 homolog" Q9GZY4 7 43608456-43729717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA011944 Approved Supported Mitochondria NA NA Mitochondria "HPA011944: AB_1848671" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" "unprognostic (2.22e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (2.85e-3)" "prognostic unfavorable (7.84e-5)" "unprognostic (2.21e-1)" "unprognostic (4.42e-2)" "unprognostic (2.22e-2)" "unprognostic (5.22e-2)" "unprognostic (6.74e-2)" "unprognostic (1.52e-1)" "unprognostic (3.52e-1)" "unprognostic (1.02e-2)" "unprognostic (2.56e-2)" "unprognostic (5.39e-2)" 13.8 16.2 22.4 14.4 21.7 17.6 14.5 13.8 24.0 11.8 10.9 14.4 17.4 11.4 14.8 14.3 15.1 9.6 10.9 47.8 19.7 18.5 23.4 14.4 11.9 24.2 23.0 13.2 11.1 23.9 9.4 22.1 11.3 17.4 10.9 14.7 17.9 17.5 17.7 55.5 7.0 12.6 9.7 19.9 16.2 14.5 11.8 14.3 16.2 15.8 22.4 28.3 14.8 8.8 21.0 17.9 24.2 17.2 18.6 21.0 14.4 10.5 28.5 23.6 23.2 6.9 7.8 15.8 14.8 25.4 20.2 21.0 21.7 24.2 20.1 25.1 9.0 42.6 15.4 27.2 22.8 25.6 18.0 25.0 25.0 16.8 19.9 11.4 19.4 11.1 6.4 14.6 14.6 21.8 21.7 18.3 24.4 42.3 17.5 16.4 14.4 28.5 48.8 14.8 22.1 20.6 17.3 21.6 37.1 24.6 11.9 14.5 26.0 14.9 27.7 9.6 35.6 20.7 13.1 13.6 10.0 21.9 9.8 20.9 42.2 34.1 36.1 28.5 25.0 26.6 1.3 15.3 16.0 12.9 17.2 9.5 19.7 12.0 13.2 17.9 21.0 16.9 21.0 24.2 18.6 14.6 16.0 11.5 14.4 22.4 21.7 13.8 24.0 19.7 18.5 23.0 13.2 17.4 14.3 26.8 35.0 59.1 58.9 11.6 42.6 55.7 17.8 29.4 23.9 33.2 43.2 28.3 99.5 49.1 4.8 25.8 16.9 46.7 37.1 43.0 26.0 44.0 25.4 19.2 50.1 31.8 26.6 18.4 33.8 6.6 27.3 34.8 35.4 48.7 20.9 22.3 38.8 10.5 18.4 100.4 53.4 12.9 22.7 54.2 85.2 14.6 15.0 52.2 24.9 37.6 COA3 "CCDC56, COX25, HSPC009, MITRAC12" ENSG00000183978 "Cytochrome c oxidase assembly factor 3" Q9Y2R0 17 42795147-42798704 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 601.8;Proximal tubular cells: 547.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031966, HPA071122" Approved Enhanced Mitochondria NA NA Mitochondria "HPA031966: AB_10602115, HPA071122: " "unprognostic (1.20e-1)" "prognostic favorable (3.40e-4)" "unprognostic (5.65e-2)" "prognostic favorable (8.93e-4)" "unprognostic (7.62e-2)" "unprognostic (2.19e-1)" "unprognostic (4.78e-2)" "unprognostic (1.16e-2)" "unprognostic (1.48e-1)" "unprognostic (2.25e-2)" "unprognostic (8.44e-3)" "unprognostic (1.52e-1)" "prognostic favorable (6.62e-4)" "unprognostic (1.64e-1)" "unprognostic (2.70e-1)" "unprognostic (3.16e-2)" "unprognostic (3.01e-2)" 13.4 17.8 34.5 11.1 26.7 4.6 20.6 19.5 31.8 18.7 33.7 18.0 18.2 35.9 14.0 62.6 30.2 26.2 20.0 26.3 29.3 26.0 57.2 44.1 13.7 14.1 31.2 22.2 17.0 97.0 16.2 15.0 17.8 26.1 22.0 31.6 14.9 30.3 25.1 28.7 12.6 33.5 14.5 21.6 12.2 27.1 9.5 17.1 13.1 22.8 28.6 19.8 14.1 18.1 56.1 49.2 46.0 59.1 46.2 50.5 59.7 16.2 55.2 25.4 13.9 23.5 20.0 15.6 12.8 19.6 30.7 27.8 21.7 20.6 0.9 36.4 15.5 28.9 15.9 19.5 31.3 29.1 15.9 51.3 11.0 26.0 68.6 16.6 14.8 13.3 20.3 23.6 28.9 16.6 15.7 24.3 7.9 17.5 14.1 27.1 26.7 4.8 32.4 11.6 33.5 19.9 19.4 37.1 27.9 31.1 22.5 19.0 15.9 13.1 13.9 22.2 22.9 43.2 19.4 14.8 33.5 17.5 14.1 16.9 16.7 18.0 8.7 25.1 14.8 22.6 46.0 59.1 36.8 39.8 54.9 41.6 56.1 41.4 40.2 49.2 51.2 38.4 38.2 6.3 46.2 45.5 32.9 50.5 59.7 34.5 26.7 19.5 31.8 29.3 26.0 31.2 22.2 26.1 17.1 26.8 53.5 65.9 51.4 32.6 33.1 216.0 178.3 105.7 47.8 253.0 19.6 126.9 601.8 110.3 8.4 56.1 184.6 0.0 208.4 149.1 56.0 56.9 34.6 366.5 106.3 42.9 76.7 73.6 73.2 15.0 51.8 46.4 84.4 81.2 165.8 62.7 139.6 178.9 42.5 547.1 26.6 38.8 61.8 48.1 47.3 48.6 85.5 37.4 224.0 60.3 COL11A2 "DFNA13, DFNB53, HKE5" ENSG00000204248 "Collagen type XI alpha 2 chain" P13942 6 33162681-33192499 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Deafness, Disease mutation, Dwarfism, Non-syndromic deafness, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "pituitary gland: 28.8" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 3.9;Early spermatids: 11.3;Ito cells: 6.7;Muller glia cells: 6.7" "Cancer enriched" "Detected in many" 8 "melanoma: 13.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;HMC-1: 2.1;U-266/70: 2.4;U-698: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" NA NA 720000 "unprognostic (4.62e-1)" "unprognostic (8.69e-2)" "unprognostic (1.65e-4)" "unprognostic (5.15e-3)" "unprognostic (1.14e-1)" "unprognostic (1.69e-1)" "unprognostic (1.04e-2)" "unprognostic (9.67e-2)" "unprognostic (2.05e-2)" "unprognostic (4.47e-2)" "unprognostic (1.22e-1)" "unprognostic (3.41e-3)" "unprognostic (2.26e-6)" "unprognostic (8.27e-2)" "unprognostic (2.17e-1)" "unprognostic (1.88e-1)" "unprognostic (5.96e-2)" 1.6 0.7 0.8 0.6 1.5 0.2 0.4 6.6 2.8 1.2 0.4 2.5 0.1 1.2 0.6 1.2 0.4 0.3 0.5 1.6 1.1 0.9 0.4 0.8 0.7 0.3 2.7 0.1 0.5 1.7 0.2 28.8 0.5 1.7 0.8 0.2 2.6 2.2 0.6 2.5 1.6 1.5 0.9 2.2 0.8 3.5 4.5 1.8 1.1 2.1 0.9 0.6 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.1 0.2 0.1 2.0 0.3 1.6 1.0 0.2 0.7 0.2 0.0 0.0 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.3 2.1 0.3 0.0 0.1 0.1 0.0 0.1 1.5 0.5 0.8 0.2 0.3 0.0 0.6 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 1.4 0.2 1.2 0.4 0.2 0.8 1.5 0.0 0.1 2.4 1.7 2.9 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.4 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.8 1.5 6.6 1.2 1.1 0.9 2.7 0.1 1.7 1.8 0.0 0.0 0.0 0.1 1.3 1.9 2.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 11.3 0.7 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 6.7 1.2 1.0 0.0 0.0 1.7 0.0 0.0 6.7 0.1 0.0 0.4 0.0 1.1 0.0 1.0 0.9 1.5 1.0 0.0 0.0 0.0 0.0 COL14A1 UND ENSG00000187955 "Collagen type XIV alpha 1 chain" Q05707 8 120059780-120372036 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 87.4" "Cell type enhanced" "Detected in many" 21 "Cytotrophoblasts: 32.7;Fibroblasts: 157.1;Smooth muscle cells: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 18.3;hTERT-RPE1: 9.3;RH-30: 48.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023781 Uncertain Approved Vesicles "Secreted to extracellular matrix" NA NA 2000000 Vesicles "HPA023781: AB_1847098" "unprognostic (1.10e-1)" "unprognostic (3.15e-1)" "unprognostic (1.41e-1)" "unprognostic (2.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-3)" "unprognostic (5.96e-2)" "unprognostic (4.29e-2)" "unprognostic (7.61e-2)" "unprognostic (3.77e-2)" "unprognostic (4.36e-1)" "unprognostic (5.07e-2)" "prognostic unfavorable (5.79e-5)" "unprognostic (1.07e-2)" "unprognostic (8.21e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.01e-4)" 20.0 3.3 0.8 20.8 0.9 0.0 21.6 0.7 0.9 87.4 13.9 1.0 9.6 1.3 64.6 39.2 20.0 15.6 38.6 27.8 0.8 1.0 8.3 5.0 8.8 4.5 1.1 1.1 62.1 4.4 1.1 1.8 30.8 3.0 41.7 10.5 4.2 21.8 5.8 7.6 5.4 12.2 45.2 6.5 15.4 10.1 13.3 0.4 1.1 15.7 32.5 9.9 30.4 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 18.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.6 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 5.3 0.1 0.0 4.7 0.1 1.0 0.0 9.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 48.7 0.1 2.1 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.1 0.1 1.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.7 0.9 0.8 1.0 1.1 1.1 3.0 0.4 0.0 1.4 0.0 0.2 10.1 0.0 7.8 0.0 0.0 7.9 1.8 0.0 32.7 0.0 0.0 0.8 2.9 0.0 0.0 0.0 2.9 157.1 0.4 3.5 0.0 5.4 0.0 0.0 25.8 0.0 0.4 13.6 0.8 5.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.2 0.0 54.7 3.5 2.9 8.4 21.2 0.0 0.0 0.4 COL17A1 "BP180, BPAG2" ENSG00000065618 "Collagen type XVII alpha 1 chain" Q9UMD9 10 104031286-104086002 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 85.8;skin 1: 123.2;tongue: 64.0" "Cell type enriched" "Detected in many" 4 "Basal keratinocytes: 520.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 227.4" "Region enriched" "Detected in single" 4 "basal ganglia: 1.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 3.7" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 24.8;HaCaT: 56.6;HBEC3-KT: 90.6;hTCEpi: 117.8;hTERT-HME1: 100.3" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Not detected" "Not detected" "HPA043673, HPA052963" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" "Golgi apparatus" "HPA043673: AB_10960893, HPA052963: AB_2681999" "prognostic favorable (1.38e-4)" "unprognostic (1.33e-1)" "unprognostic (4.01e-1)" "unprognostic (1.01e-1)" "unprognostic (9.65e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (6.82e-3)" "unprognostic (1.63e-1)" "unprognostic (7.85e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.75e-2)" "unprognostic (8.35e-2)" 0.2 0.0 0.2 4.4 1.2 7.5 8.1 0.2 0.2 15.2 9.3 0.2 0.9 2.0 0.6 2.6 31.5 0.1 1.2 0.2 0.2 0.1 0.4 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.6 85.8 0.2 5.0 5.4 0.2 15.5 7.3 0.5 123.2 23.2 0.8 0.2 0.3 3.9 4.0 0.2 18.1 2.0 64.0 24.7 3.0 17.3 0.0 0.0 3.7 0.2 0.0 0.0 0.8 3.1 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.7 0.0 0.5 56.6 0.1 90.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.8 0.0 100.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 5.1 3.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.0 0.8 0.2 1.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.6 0.0 12.4 520.3 0.6 0.8 0.0 2.7 20.5 0.0 0.0 3.5 0.0 0.7 8.5 1.0 105.8 0.0 0.8 8.3 2.1 0.6 0.0 0.0 1.2 0.0 2.4 0.0 0.0 2.6 0.3 1.0 32.1 0.0 5.9 0.4 45.8 16.1 0.7 0.0 0.4 0.0 1.7 8.3 1.1 121.8 4.7 0.0 14.5 8.0 COL24A1 ENSG00000171502 "Collagen type XXIV alpha 1 chain" Q17RW2 1 85729233-86156943 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.0" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 59.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 6.2" "Lineage enriched" "Detected in single" 10 "dendritic cells: 6.2" "Cell line enhanced" "Detected in some" "ASC diff: 3.4;HSkMC: 3.2;Karpas-707: 6.0;NTERA-2: 3.1;RH-30: 4.4;SuSa: 4.6;U-266/70: 11.2" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" NA NA 12000 "unprognostic (3.00e-1)" "unprognostic (6.19e-2)" "unprognostic (2.21e-2)" "unprognostic (6.76e-3)" "unprognostic (1.82e-3)" "unprognostic (2.45e-2)" "unprognostic (2.44e-5)" "unprognostic (1.37e-1)" "unprognostic (4.08e-2)" "unprognostic (6.59e-2)" "unprognostic (3.89e-2)" "unprognostic (1.46e-1)" "unprognostic (3.48e-6)" "unprognostic (2.79e-5)" "unprognostic (5.07e-1)" "unprognostic (1.19e-1)" "unprognostic (9.90e-2)" 1.1 0.4 6.2 3.4 7.1 2.3 1.1 1.7 18.0 7.0 9.5 0.3 0.0 4.1 3.6 2.4 2.2 0.6 4.4 4.1 12.1 1.2 1.5 0.3 1.7 1.0 1.1 5.2 6.9 0.3 0.2 2.0 0.3 1.7 2.3 2.4 2.4 1.2 4.3 1.4 1.6 3.7 2.8 1.0 0.8 3.4 1.9 2.9 0.0 0.8 2.6 0.8 8.3 4.9 0.0 6.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.5 0.0 3.4 0.6 0.0 0.6 0.1 0.2 0.5 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.9 0.0 1.4 0.0 0.8 0.0 1.0 0.1 0.1 0.0 0.0 3.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 6.0 0.9 0.0 0.0 0.2 3.1 0.0 0.0 0.0 4.4 0.5 0.6 1.1 0.1 0.0 0.0 0.2 0.5 4.6 0.0 0.9 0.0 2.0 0.2 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 6.2 0.0 0.0 6.2 7.1 1.7 18.0 12.1 1.2 1.1 5.2 1.7 2.9 0.0 1.1 1.9 0.0 0.3 2.2 1.6 0.0 2.7 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.9 0.3 10.1 0.0 0.0 59.8 0.0 0.0 0.7 0.0 1.1 0.0 0.0 1.1 0.4 0.1 0.0 0.0 0.0 0.0 COL25A1 ENSG00000188517 "Collagen type XXV alpha 1 chain" Q9BXS0 4 108808725-109302752 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Heparin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.4;retina: 22.1;testis: 23.6" "Group enriched" "Detected in some" 16 "Early spermatids: 89.3;Late spermatids: 22.6;Rod photoreceptor cells: 75.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HeLa: 31.5" "Low region specificity" "Detected in many" HPA029107 Approved "Endoplasmic reticulum,Vesicles,Cytosol" NA NA "Vesicles, Cytosol" "Endoplasmic reticulum" "HPA029107: AB_10600802" "unprognostic (1.77e-1)" "unprognostic (2.12e-1)" "unprognostic (1.18e-1)" "unprognostic (8.87e-5)" "unprognostic (2.43e-2)" "unprognostic (3.20e-1)" "unprognostic (7.62e-3)" "unprognostic (6.86e-2)" "unprognostic (2.83e-1)" "unprognostic (3.53e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-1)" "unprognostic (5.30e-3)" "unprognostic (2.82e-3)" "unprognostic (9.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" 9.0 0.8 6.7 0.2 4.4 0.0 5.1 0.8 3.4 1.6 0.9 0.4 0.9 4.0 2.1 3.5 0.8 1.4 3.1 2.0 4.7 2.1 2.9 3.2 0.9 0.1 0.8 0.0 1.6 0.9 3.9 17.4 0.4 2.5 0.9 0.4 22.1 6.7 1.4 1.4 1.1 3.1 1.5 0.9 1.0 0.9 23.6 1.5 0.0 3.7 0.1 0.0 1.6 3.4 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.9 0.0 0.1 0.0 2.3 4.2 31.5 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.2 4.0 0.0 0.5 0.0 1.2 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.4 0.8 3.4 4.7 2.1 0.8 0.0 2.5 1.5 0.0 0.0 0.0 0.0 0.0 1.9 0.8 0.0 0.0 1.2 1.8 3.9 0.0 0.0 0.0 89.3 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.6 0.0 1.3 0.0 22.6 0.6 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 75.2 0.0 3.4 3.2 1.5 0.1 0.0 0.0 0.0 0.0 COL26A1 "EMI6, EMID2, Emu2" ENSG00000160963 "Collagen type XXVI alpha 1 chain" Q96A83 7 101362820-101559024 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.4;brain: 18.3" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 5.2;Hepatocytes: 2.6;Late spermatids: 2.2;Spermatogonia: 2.2" "Group enriched" "Detected in many" 6 "endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7" "Cell type enriched" "Detected in single" 63 "plasmacytoid DC: 11.4" "Lineage enriched" "Detected in single" 63 "dendritic cells: 11.4" "Cell line enhanced" "Detected in some" "AF22: 20.3;BEWO: 16.3;HAP1: 7.2;NTERA-2: 17.1;SuSa: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027059 Approved Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA027059: AB_1848142" "unprognostic (5.94e-3)" "unprognostic (2.16e-2)" "unprognostic (2.19e-2)" "unprognostic (4.67e-2)" "unprognostic (1.66e-1)" "unprognostic (3.35e-1)" "prognostic favorable (2.32e-5)" "unprognostic (1.48e-1)" "unprognostic (1.16e-1)" "unprognostic (2.85e-2)" "unprognostic (1.26e-3)" "unprognostic (1.78e-1)" "unprognostic (4.24e-3)" "unprognostic (3.60e-1)" "unprognostic (1.50e-1)" "unprognostic (7.48e-4)" "unprognostic (2.83e-3)" 0.0 4.1 2.5 0.3 7.0 0.3 0.2 0.4 18.3 0.1 0.0 0.2 0.0 0.1 0.5 0.3 0.0 0.2 0.3 0.1 3.3 3.1 4.8 0.6 0.9 0.0 8.1 0.2 3.1 6.7 0.0 0.5 0.6 3.7 0.0 0.0 0.2 1.1 0.0 0.1 0.1 0.1 0.3 0.4 0.2 0.8 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 20.3 1.2 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 3.2 0.0 0.0 0.0 7.2 0.0 0.0 0.7 0.8 0.0 0.0 5.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 17.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.1 13.7 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.1 1.1 0.0 0.0 0.0 0.5 0.2 0.0 0.5 0.0 2.6 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.3 0.0 0.0 0.5 COL4A2 "DKFZp686I14213, FLJ22259" ENSG00000134871 "Collagen type IV alpha 2 chain" P08572 13 110305812-110513027 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 125.7" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 463.3;Peritubular cells: 165.5;Sertoli cells: 368.7;Smooth muscle cells: 174.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 145.1;WM-115: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010751, HPA029118, HPA069337" Enhanced Supported Vesicles "Secreted to extracellular matrix" NA NA 1900000 Vesicles "CAB010751: AB_476828, HPA029118: , HPA069337: " "unprognostic (2.43e-1)" "unprognostic (4.13e-3)" "unprognostic (8.04e-2)" "unprognostic (6.03e-3)" "unprognostic (2.20e-1)" "unprognostic (2.64e-2)" "unprognostic (3.45e-2)" "unprognostic (1.15e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-1)" "unprognostic (1.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.49e-5)" "unprognostic (1.33e-2)" "unprognostic (1.57e-2)" "unprognostic (6.95e-2)" "prognostic unfavorable (9.25e-4)" 87.2 9.5 4.6 26.1 3.3 0.1 50.1 2.0 3.0 37.2 53.1 1.9 30.3 7.6 48.4 25.5 23.0 26.3 52.4 26.6 3.6 1.4 18.4 5.7 35.9 17.5 3.8 1.7 25.7 8.3 7.3 3.8 125.7 5.0 26.9 5.5 12.2 7.6 29.3 26.3 9.2 16.9 84.1 2.8 58.5 23.4 11.0 1.9 4.2 16.0 8.0 5.7 65.3 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.6 6.6 30.1 0.0 39.2 16.3 47.4 40.8 14.8 24.3 11.4 0.7 0.0 0.0 145.1 9.5 10.7 11.4 0.0 12.2 4.7 1.5 6.3 0.0 11.2 0.3 28.9 0.0 0.1 7.3 0.7 17.0 11.7 31.1 25.4 0.0 0.0 0.1 4.0 0.2 0.0 1.0 4.7 0.2 2.3 0.0 12.4 0.0 26.8 0.2 0.9 4.9 0.0 0.1 12.8 13.5 0.0 0.5 43.7 13.4 34.1 0.3 22.1 0.0 0.2 0.6 0.3 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.6 3.3 2.0 3.0 3.6 1.4 3.8 1.7 5.0 1.9 77.4 8.0 1.4 6.5 8.5 2.0 27.9 25.5 2.7 2.3 50.6 0.0 67.8 1.7 25.5 1.6 98.7 13.4 0.0 3.7 463.3 94.4 2.1 1.1 1.6 26.8 0.0 0.0 139.3 5.4 1.5 56.1 5.8 37.1 3.6 5.1 9.5 2.8 0.0 165.5 16.1 0.2 368.7 174.9 0.2 8.1 6.0 56.2 0.0 3.7 1.2 COLEC11 "CL-K1, MGC3279" ENSG00000118004 "Collectin subfamily member 11" Q9BWP8 2 3594832-3644644 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 61.9;liver: 57.4" "Group enriched" "Detected in many" 6 "Ito cells: 128.3;Peritubular cells: 49.1;Proximal tubular cells: 111.2;Sertoli cells: 71.1" "Cancer enhanced" "Detected in many" "liver cancer: 13.6" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HHSteC: 53.7;SH-SY5Y: 48.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA035241 Uncertain "Secreted to blood" NA NA 30000000 "HPA035241: AB_10600701" "unprognostic (3.35e-1)" "unprognostic (4.73e-2)" "unprognostic (2.44e-3)" "unprognostic (2.31e-3)" "unprognostic (1.53e-2)" "unprognostic (1.40e-2)" "unprognostic (7.95e-3)" "unprognostic (5.85e-3)" "unprognostic (6.96e-2)" "unprognostic (2.04e-1)" "unprognostic (1.41e-1)" "unprognostic (6.96e-2)" "unprognostic (2.26e-1)" "unprognostic (9.27e-3)" "unprognostic (7.54e-2)" "unprognostic (1.46e-1)" "unprognostic (1.60e-1)" 3.7 13.2 0.5 0.5 1.2 0.6 1.7 0.7 1.4 0.5 1.7 1.3 0.8 1.7 0.7 1.0 1.2 1.4 61.9 14.8 0.9 0.1 7.9 57.4 0.9 1.8 0.6 0.5 15.8 6.5 0.2 2.0 2.8 3.6 1.6 0.1 1.0 0.8 0.5 1.0 0.4 3.0 1.6 0.7 1.4 0.7 2.5 0.5 0.7 5.5 0.6 0.5 1.8 1.5 1.2 0.8 4.0 0.8 1.2 1.8 0.2 0.0 0.4 0.2 0.8 0.0 0.0 4.5 0.2 0.0 0.1 0.0 0.3 0.0 0.1 1.3 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.4 1.5 53.7 0.0 0.3 0.6 0.0 0.0 0.0 0.1 0.0 0.2 3.8 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.6 48.5 0.5 0.3 0.2 0.1 0.1 0.3 0.0 0.0 0.2 0.2 0.1 1.0 7.8 0.4 0.1 0.4 0.2 1.9 0.8 1.2 0.6 0.2 0.5 0.6 0.3 0.3 0.3 1.2 1.8 1.0 4.0 1.2 0.4 0.8 0.3 0.2 0.5 1.2 0.7 1.4 0.9 0.1 0.6 0.5 3.6 0.5 0.0 0.0 0.5 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 14.9 0.0 0.3 1.8 0.0 0.0 0.0 0.9 12.4 0.1 0.0 6.8 2.3 0.0 0.0 128.3 3.5 0.4 6.9 0.0 3.3 0.0 0.0 0.3 0.1 0.0 49.1 111.2 0.0 71.1 4.0 0.4 11.1 0.6 1.0 0.0 0.0 0.0 COLEC12 "CL-P1, SCARA4, SRCL" ENSG00000158270 "Collectin subfamily member 12" Q5KU26 18 316740-500722 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 40.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 109.4;Cytotrophoblasts: 115.8;Hofbauer cells: 118.9;Syncytiotrophoblasts: 93.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.7;BJ: 8.6;HSkMC: 14.6;U-2197: 22.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047917, HPA071056" Enhanced Approved "Golgi apparatus,Vesicles,Cell Junctions" NA NA 550000 "Golgi apparatus, Vesicles" "Cell Junctions" "HPA047917: AB_2680208, HPA071056: AB_2686338" "unprognostic (8.67e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (3.60e-2)" "unprognostic (6.94e-2)" "unprognostic (1.09e-2)" "unprognostic (1.14e-4)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "unprognostic (4.86e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (2.61e-1)" "unprognostic (2.24e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (3.01e-3)" 14.2 3.7 6.9 4.6 9.7 1.2 9.4 3.5 6.4 40.8 8.0 7.7 5.1 3.4 13.1 9.9 7.5 6.6 8.1 13.5 7.0 6.3 2.7 1.4 18.7 13.9 8.1 5.8 6.8 2.4 1.5 1.5 32.0 10.5 9.6 5.0 23.5 4.8 3.5 6.3 4.4 5.0 14.3 5.2 1.2 5.0 5.0 4.7 0.7 7.6 3.8 4.9 15.0 7.3 0.9 0.9 3.3 0.8 0.7 0.5 0.3 0.0 0.0 1.5 0.0 1.7 17.7 0.6 8.6 3.0 1.2 2.2 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.8 0.0 0.5 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.1 2.2 0.3 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.8 0.4 0.5 0.3 0.3 0.5 0.5 0.4 0.2 0.9 0.4 0.4 3.3 0.7 0.5 0.9 0.3 0.3 6.9 9.7 3.5 6.4 7.0 6.3 8.1 5.8 10.5 4.7 3.0 109.4 0.0 2.9 3.7 6.1 3.6 0.0 2.7 19.4 3.5 9.8 115.8 0.0 0.1 7.2 3.1 0.0 0.0 0.0 4.3 47.7 8.6 12.8 0.2 118.9 6.4 15.1 1.8 4.1 16.7 57.0 17.9 1.7 27.1 0.2 63.6 0.3 0.0 6.7 0.0 10.8 0.0 1.9 1.1 1.2 3.3 93.0 1.3 0.7 1.6 COLQ EAD ENSG00000206561 "Collagen like tail subunit of asymmetric acetylcholinesterase" Q9Y215 3 15450133-15521751 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Neurotransmitter degradation" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.8;lymphoid tissue: 19.6" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 6.7;Early spermatids: 4.2;Horizontal cells: 6.4;Late spermatids: 11.3;Peritubular cells: 4.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 11.4" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 31.8" "Lineage enriched" "Detected in single" 35 "T-cells: 31.8" "Group enriched" "Detected in some" 5 "BEWO: 17.3;HDLM-2: 5.6;U-937: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045876 Approved "Plasma membrane,Cell Junctions" "Secreted to blood" NA NA "Plasma membrane" "Cell Junctions" "HPA045876: AB_2679479" "unprognostic (4.08e-3)" "unprognostic (2.61e-2)" "unprognostic (2.13e-3)" "unprognostic (2.37e-1)" "unprognostic (2.11e-1)" "unprognostic (4.62e-2)" "unprognostic (1.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (1.28e-3)" "unprognostic (4.68e-1)" "unprognostic (7.00e-5)" "unprognostic (6.58e-2)" "unprognostic (1.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.30e-4)" 2.7 0.7 0.9 0.7 1.1 1.3 0.9 11.4 2.1 2.4 2.3 0.4 0.2 0.8 3.2 2.7 1.3 8.8 1.8 15.9 1.5 1.2 0.5 0.9 2.1 19.6 0.9 1.1 2.3 0.6 10.0 1.1 0.5 2.1 2.0 0.5 2.0 1.1 1.4 14.3 0.9 1.4 1.1 1.5 3.8 1.5 2.0 0.4 3.8 1.0 0.6 3.3 1.3 1.4 0.0 0.2 0.0 0.4 0.9 31.8 1.7 0.1 0.5 2.0 1.2 1.5 1.0 17.3 0.3 0.5 0.4 0.6 0.0 0.3 0.1 0.7 0.3 0.1 0.2 0.3 0.4 0.5 5.6 1.2 0.6 0.7 0.2 0.2 0.4 1.2 0.8 0.4 0.8 0.3 0.8 0.3 1.5 0.0 0.6 0.8 0.3 0.6 1.8 0.2 0.0 0.6 0.8 0.2 0.4 0.4 0.4 0.6 1.8 0.2 0.1 0.4 1.9 1.2 0.8 0.1 0.2 1.1 1.9 0.6 1.7 1.5 0.1 0.1 8.7 0.1 0.0 0.4 0.0 5.5 0.0 31.8 0.0 2.7 3.9 0.0 0.0 0.3 0.3 0.0 0.9 0.0 0.2 0.1 1.7 0.9 1.1 11.4 2.1 1.5 1.2 0.9 1.1 2.1 0.4 0.0 1.1 0.0 0.1 0.2 0.3 0.7 0.0 6.7 2.3 0.0 0.0 0.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.8 0.2 6.4 1.2 2.5 0.0 11.3 1.7 0.0 0.0 0.0 0.0 0.4 0.2 0.0 4.2 0.0 0.6 0.0 0.2 0.7 0.2 0.1 1.9 1.3 0.0 0.0 COMT ENSG00000093010 Catechol-O-methyltransferase P21964 22 19941607-19969975 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" "Methyltransferase, Transferase" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 139.3" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 779.9;Syncytiotrophoblasts: 542.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 118.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001169, CAB011233" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" NA NA 560000 Vesicles "Endoplasmic reticulum" "CAB011233: , HPA001169: AB_1078402" "unprognostic (5.20e-2)" "unprognostic (2.73e-2)" "unprognostic (3.08e-2)" "prognostic favorable (3.68e-4)" "unprognostic (2.99e-2)" "unprognostic (2.32e-3)" "unprognostic (5.54e-3)" "unprognostic (9.14e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (2.14e-3)" "prognostic favorable (5.67e-4)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (3.97e-1)" "unprognostic (1.07e-2)" 18.6 49.0 29.4 14.3 28.8 24.3 27.8 19.6 32.9 22.4 23.4 42.4 36.1 21.0 19.8 33.8 58.1 19.4 36.8 28.1 28.9 22.3 31.1 139.3 30.9 17.0 29.0 18.4 36.3 27.2 14.1 12.7 59.0 23.3 25.7 8.9 24.9 67.3 30.9 21.5 27.7 28.6 15.5 41.0 17.8 24.8 18.2 23.7 11.5 19.2 44.0 32.0 36.3 28.0 11.2 55.1 10.9 60.0 12.9 15.6 28.0 19.1 19.7 2.3 19.5 22.2 19.8 0.8 21.8 27.4 18.7 21.4 16.7 22.4 7.7 9.7 31.1 7.4 26.3 3.7 23.3 5.0 16.7 24.9 13.8 10.5 39.0 41.5 23.0 5.5 25.2 28.9 16.2 16.1 18.0 17.5 12.5 55.7 16.5 15.0 118.8 9.0 41.3 4.8 52.7 6.7 13.6 19.5 10.6 19.7 60.8 9.5 8.4 7.2 61.7 18.0 1.3 13.3 64.7 20.9 33.4 12.8 10.9 16.3 6.1 2.6 6.3 36.0 31.0 23.0 10.2 60.0 10.9 15.6 39.9 12.8 11.2 10.8 12.6 47.7 10.7 9.6 10.6 2.4 12.9 26.6 55.1 13.3 28.0 29.4 28.8 19.6 32.9 28.9 22.3 29.0 18.4 23.3 23.7 116.1 64.8 45.5 189.7 90.7 68.3 29.9 109.5 88.3 85.3 144.8 9.8 779.9 271.9 173.4 3.6 68.7 98.5 0.0 167.1 75.3 99.4 123.4 70.4 231.9 281.1 23.8 81.1 74.9 149.0 7.4 124.3 142.1 227.7 154.1 89.3 151.7 163.3 110.1 169.0 60.7 34.5 135.8 91.5 4.4 5.3 107.9 542.4 36.6 110.1 180.5 COMTD1 FLJ23841 ENSG00000165644 "Catechol-O-methyltransferase domain containing 1" Q86VU5 10 75233969-75236030 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 57.2" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 363.3;Exocrine glandular cells: 216.7;Paneth cells: 207.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 14.9;HEK 293: 22.9;PC-3: 31.9;RPMI-8226: 17.8;U-266/70: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042165 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus" "Plasma membrane, Cytosol" "HPA042165: AB_10794042" "unprognostic (2.53e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (9.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (3.23e-2)" "unprognostic (8.08e-3)" "unprognostic (9.35e-2)" "unprognostic (6.74e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.12e-1)" "unprognostic (2.35e-1)" 2.5 5.2 1.3 5.8 1.4 2.9 5.7 3.6 2.2 4.8 14.1 0.5 9.7 17.9 2.0 5.9 20.0 1.6 6.4 8.0 1.2 1.6 12.6 14.9 4.4 4.1 1.9 1.7 2.2 57.2 3.2 5.3 7.8 2.2 3.1 2.1 3.2 21.2 9.1 19.6 7.3 22.9 1.9 1.0 3.4 16.1 1.5 0.6 2.7 7.0 14.4 6.0 2.4 7.5 6.6 15.7 3.8 9.3 7.3 12.5 7.1 4.9 0.9 0.2 0.9 0.2 0.4 14.9 1.4 0.4 0.1 0.3 1.2 4.4 14.0 2.8 0.3 0.7 7.1 0.4 1.2 0.0 2.1 22.9 0.5 1.3 2.4 0.7 2.7 2.4 0.3 1.9 0.0 1.2 0.3 0.0 1.8 5.6 2.7 0.0 3.3 3.9 8.3 0.7 3.9 31.9 7.3 0.7 17.8 1.0 0.2 5.4 1.3 1.5 11.5 3.0 0.1 6.7 0.3 1.2 0.3 4.3 0.5 1.6 15.3 3.2 6.8 0.3 2.3 0.3 0.0 8.9 3.8 12.1 9.3 12.5 6.6 11.7 12.2 10.1 4.7 3.8 6.7 1.8 7.3 8.9 15.7 9.0 7.1 1.3 1.4 3.6 1.7 1.2 1.6 1.9 1.7 2.2 0.6 17.9 14.4 22.9 33.2 26.2 5.2 26.2 48.4 2.7 4.5 50.6 9.8 24.6 122.7 126.7 1.3 10.8 363.3 0.0 216.7 64.2 12.7 34.1 12.7 75.5 32.8 1.6 38.7 19.0 24.7 2.2 8.9 19.4 35.4 37.9 104.6 5.8 134.6 207.0 6.7 96.3 26.7 32.3 19.1 2.1 2.3 33.4 25.4 25.5 104.0 43.9 COQ2 "CL640, FLJ26072" ENSG00000173085 "Coenzyme Q2, polyprenyltransferase" Q96H96 4 83261536-83284914 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Isoprene biosynthesis, Ubiquinone biosynthesis" Transferase "Disease mutation, Neurodegeneration, Parkinsonism, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 45.2;Kupffer cells: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056599, HPA068727" Approved Approved Cytosol NA NA Cytosol "HPA056599: AB_2683184, HPA068727: AB_2686022" "unprognostic (8.26e-2)" "unprognostic (7.40e-3)" "unprognostic (3.95e-3)" "unprognostic (1.55e-1)" "unprognostic (9.22e-2)" "unprognostic (5.59e-2)" "unprognostic (1.26e-2)" "unprognostic (1.52e-1)" "unprognostic (4.09e-1)" "unprognostic (4.16e-2)" "unprognostic (2.08e-2)" "unprognostic (2.77e-3)" "unprognostic (1.56e-2)" "unprognostic (3.73e-1)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (2.46e-1)" 6.6 25.5 4.9 8.4 7.0 8.9 9.9 1.9 6.0 7.4 12.1 5.8 8.4 7.8 8.0 10.2 13.1 5.4 7.4 17.5 4.3 4.1 8.0 14.9 9.8 9.0 6.5 3.4 8.0 5.9 6.7 12.3 7.2 5.0 6.6 12.5 5.2 12.7 8.5 21.8 13.8 8.2 5.8 6.7 14.1 4.8 6.6 6.7 2.9 10.1 23.9 9.2 6.2 7.4 3.6 11.8 6.0 17.4 3.7 2.0 6.8 11.7 6.9 6.8 12.9 5.3 5.4 4.8 7.6 12.6 14.5 17.0 4.8 17.0 7.9 5.6 13.5 11.5 9.1 11.5 12.4 18.3 8.1 7.3 7.1 9.0 6.7 5.8 14.4 34.2 8.0 7.9 7.0 12.1 4.3 14.4 4.5 4.6 9.5 13.4 12.1 3.8 9.7 5.0 13.9 9.7 6.6 5.3 10.2 21.1 5.7 4.8 3.1 8.7 11.1 3.9 3.2 7.1 7.9 10.0 6.8 7.1 5.1 10.6 2.8 2.3 4.7 13.3 16.9 9.3 1.1 16.3 2.3 1.6 14.4 1.2 3.6 1.8 1.5 11.8 3.5 1.3 2.0 6.0 3.7 17.4 6.2 2.0 6.8 4.9 7.0 1.9 6.0 4.3 4.1 6.5 3.4 5.0 6.7 0.0 3.4 11.8 9.6 6.0 5.2 17.1 5.1 2.7 6.8 8.7 0.0 20.5 26.6 5.8 0.6 3.6 9.6 0.0 9.5 25.6 5.4 9.8 0.0 11.4 45.2 1.6 4.6 12.9 48.6 0.6 3.4 26.3 6.8 1.0 15.2 12.9 4.7 14.0 4.6 8.2 4.2 0.0 4.7 4.3 14.5 11.0 10.4 10.0 23.9 8.9 COQ7 "CAT5, CLK-1" ENSG00000167186 "Coenzyme Q7, hydroxylase" Q99807 16 19067599-19080095 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubiquinone biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 45.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 45.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067252, HPA071922" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA067252: AB_2685813, HPA071922: AB_2686473" "unprognostic (1.37e-1)" "unprognostic (6.89e-3)" "unprognostic (1.59e-2)" "unprognostic (6.08e-2)" "unprognostic (2.44e-2)" "unprognostic (9.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-2)" "unprognostic (1.15e-1)" "unprognostic (7.27e-3)" "unprognostic (2.15e-1)" "unprognostic (8.32e-2)" "prognostic favorable (8.23e-12)" "unprognostic (2.19e-1)" "unprognostic (2.76e-1)" "unprognostic (3.14e-2)" "unprognostic (5.27e-2)" 9.1 14.2 13.5 7.8 12.9 4.0 12.6 11.3 18.5 11.2 12.8 12.8 15.2 11.4 14.7 17.4 11.9 15.0 13.9 21.1 12.1 13.0 13.5 11.4 14.6 11.1 12.2 12.0 19.4 12.2 23.7 15.1 9.4 12.9 17.1 12.5 16.5 11.3 14.7 37.3 7.5 12.1 11.1 12.4 8.7 11.8 34.7 10.7 9.4 15.3 24.7 7.6 12.1 10.0 5.1 5.3 45.2 4.0 4.1 4.4 1.8 12.6 13.6 11.8 6.9 6.7 7.1 9.9 7.4 6.1 10.2 10.5 8.6 10.6 9.6 36.1 5.7 11.0 13.4 16.4 9.3 7.4 8.2 16.6 5.1 12.5 26.4 8.3 12.2 11.3 5.9 8.2 9.4 6.9 8.4 8.2 11.6 14.0 9.0 7.1 22.7 12.7 9.9 9.0 4.9 7.3 15.6 13.1 12.3 8.8 8.5 17.2 9.8 6.9 15.3 8.6 6.0 14.1 16.6 8.9 10.8 6.3 7.9 10.6 8.4 13.6 10.5 11.6 7.1 6.9 10.8 4.0 5.8 3.5 3.5 3.3 5.1 3.2 3.1 4.3 5.0 4.4 3.9 45.2 4.1 3.9 5.3 2.0 1.8 13.5 12.9 11.3 18.5 12.1 13.0 12.2 12.0 12.9 10.7 14.9 9.3 38.9 25.6 9.7 30.8 19.0 22.9 21.4 9.1 15.7 37.3 18.0 38.1 20.5 10.9 11.3 47.3 0.0 15.9 14.6 13.0 14.3 25.3 8.9 20.1 19.1 23.1 13.5 18.7 6.2 17.3 15.3 10.1 9.0 30.7 39.8 11.7 24.3 13.1 19.5 53.8 19.4 15.1 77.6 54.5 10.8 26.9 33.1 29.9 22.2 CORIN "ATC2, CRN, Lrp4, PRSC, TMPRSS10" ENSG00000145244 "Corin, serine peptidase" Q9Y5Q5 4 47593998-47838106 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 11.6;heart muscle: 39.5" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 50.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "pons and medulla: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "ASC TERT1: 32.6" "Region enhanced" "Detected in some" "basal ganglia: 2.7" "Low region specificity" "Detected in single" HPA070941 Approved "Nuclear bodies,Plasma membrane,Actin filaments" "Intracellular and membrane" Yes No "Plasma membrane" "Nuclear bodies, Actin filaments" "HPA070941: AB_2686324" "unprognostic (1.05e-1)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-1)" "unprognostic (3.58e-4)" "unprognostic (3.19e-1)" "unprognostic (3.67e-2)" "unprognostic (8.22e-2)" "unprognostic (9.78e-2)" "unprognostic (6.53e-2)" "unprognostic (1.18e-1)" "unprognostic (2.86e-2)" "unprognostic (5.18e-2)" "unprognostic (7.22e-2)" "unprognostic (1.33e-2)" 0.3 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.1 3.1 0.1 0.1 2.6 0.0 3.4 11.6 0.7 1.2 4.5 39.5 0.0 0.2 2.0 0.0 1.3 0.0 0.2 0.0 0.6 0.1 0.0 1.5 0.6 1.6 1.7 0.0 0.4 0.3 4.6 0.2 5.3 0.4 0.5 0.0 3.5 0.3 3.7 0.0 0.2 0.1 1.7 0.4 0.8 3.2 0.2 0.0 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 7.5 32.6 0.0 1.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.2 0.0 1.6 0.0 0.0 6.9 0.0 0.2 3.4 0.8 50.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 9.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.8 4.4 0.0 5.0 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.1 0.0 4.2 3.0 4.6 2.4 0.0 0.0 0.0 0.2 COX10 ENSG00000006695 "COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor" Q12887 17 14069496-14208677 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 34.9" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 89.2;Late spermatids: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.32e-6)" "prognostic favorable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 5.5 6.9 5.3 5.7 6.5 7.0 5.4 6.5 7.2 4.4 11.8 4.1 2.9 9.7 5.1 3.6 9.4 4.8 3.5 18.9 5.8 3.8 10.0 9.3 5.2 8.4 4.5 2.8 4.9 9.6 7.2 6.4 6.6 5.7 5.2 10.1 5.5 6.7 4.8 34.9 6.0 10.9 7.2 4.0 4.6 7.7 15.5 4.9 5.9 5.2 9.6 7.4 7.2 5.8 11.9 13.6 4.0 14.1 8.8 17.5 9.8 7.3 14.1 5.9 8.4 5.9 5.4 13.3 8.9 6.2 16.3 11.3 12.3 5.4 17.3 7.1 9.0 5.6 14.1 11.9 11.5 13.1 9.3 12.0 10.3 11.3 13.6 10.3 10.6 9.7 7.7 14.5 10.2 13.0 6.5 8.6 12.3 13.9 5.9 7.2 9.1 9.0 7.0 8.9 27.6 7.3 7.6 19.9 12.2 10.2 13.8 4.4 7.4 9.2 12.3 11.0 29.1 6.9 6.0 7.0 7.1 6.0 7.2 11.2 7.2 10.1 7.8 10.7 11.0 8.8 3.0 10.6 4.0 9.9 14.1 10.4 11.9 11.6 10.3 13.6 8.2 12.6 11.9 1.2 8.8 11.9 4.6 17.5 9.8 5.3 6.5 6.5 7.2 5.8 3.8 4.5 2.8 5.7 4.9 0.0 14.3 5.2 7.2 8.7 8.0 89.2 7.6 5.3 4.5 10.4 9.8 16.5 34.9 8.0 33.1 4.9 19.0 0.0 7.5 14.8 5.1 7.4 4.7 8.9 9.4 0.0 12.1 4.9 3.8 61.2 2.0 5.4 5.0 4.6 14.2 2.8 8.6 11.0 6.3 11.4 11.6 0.0 5.1 14.6 15.9 9.2 13.5 5.3 15.1 11.8 COX11 COX11P ENSG00000166260 "COX11, cytochrome c oxidase copper chaperone" Q9Y6N1 17 54951902-54968785 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044020 Approved NA NA "HPA044020: AB_2678777" "unprognostic (1.42e-1)" "unprognostic (6.59e-2)" "prognostic favorable (4.30e-4)" "unprognostic (3.13e-1)" "unprognostic (5.37e-2)" "unprognostic (1.63e-2)" "unprognostic (4.69e-2)" "unprognostic (2.85e-2)" "unprognostic (4.11e-2)" "unprognostic (8.12e-3)" "unprognostic (8.18e-2)" "unprognostic (3.65e-2)" "unprognostic (2.02e-3)" "unprognostic (2.69e-2)" "unprognostic (9.25e-2)" "unprognostic (6.29e-2)" "unprognostic (7.85e-2)" 15.0 15.0 20.2 12.2 28.7 9.0 12.1 20.3 28.1 12.6 17.1 16.1 13.5 45.7 15.2 11.1 12.5 13.5 12.1 21.6 17.7 19.4 28.2 23.0 12.0 13.5 17.8 19.1 16.2 16.1 10.3 18.3 8.7 22.4 15.5 12.3 16.6 16.9 13.0 58.1 10.8 26.0 14.9 15.9 11.3 17.1 10.8 14.9 13.8 18.8 9.4 10.9 18.2 11.4 13.1 12.4 6.9 8.6 8.6 18.6 8.7 16.8 38.9 5.4 13.2 10.4 9.5 12.6 11.7 6.9 9.4 8.2 32.7 5.0 28.8 30.3 6.3 11.0 6.5 5.8 6.7 12.8 51.9 27.2 23.0 18.7 39.3 7.4 24.3 8.3 9.9 5.8 10.0 4.2 8.7 8.2 18.7 14.2 15.6 9.2 20.3 25.0 11.2 6.1 9.8 35.0 16.2 26.2 16.7 17.2 13.0 9.4 17.6 14.1 6.1 12.6 6.5 18.8 6.7 10.2 18.1 10.2 16.9 21.1 20.6 29.5 24.9 17.8 12.1 12.0 6.9 6.8 6.7 13.6 8.6 17.5 13.1 17.1 14.9 12.4 10.5 17.3 17.2 0.7 8.6 4.8 9.9 18.6 8.7 20.2 28.7 20.3 28.1 17.7 19.4 17.8 19.1 22.4 14.9 23.8 18.9 27.2 41.7 27.9 53.7 31.9 33.1 25.4 13.6 19.2 66.8 33.4 137.6 32.0 34.6 26.0 27.3 0.0 38.6 25.6 27.4 18.5 19.7 32.6 23.4 33.4 41.6 35.6 16.4 11.7 50.3 21.8 33.7 29.7 20.2 32.8 25.0 35.1 55.5 92.2 59.6 71.1 50.3 57.5 48.1 23.7 14.6 35.5 56.9 20.7 COX14 "C12orf62, MGC14288" ENSG00000178449 "COX14, cytochrome c oxidase assembly factor" Q96I36 12 50111979-50120457 "Disease related genes, Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Proximal tubular cells: 571.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044618, HPA062014" Approved Supported Mitochondria NA NA Mitochondria "HPA044618: AB_10960419, HPA062014: AB_2684657" "unprognostic (5.71e-2)" "unprognostic (1.86e-2)" "unprognostic (1.43e-1)" "unprognostic (4.04e-1)" "unprognostic (1.87e-2)" "unprognostic (3.66e-2)" "unprognostic (2.20e-2)" "unprognostic (4.20e-3)" "prognostic unfavorable (7.90e-4)" "unprognostic (7.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.09e-3)" "unprognostic (3.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.84e-2)" "unprognostic (3.07e-3)" 33.1 30.2 25.9 16.7 33.7 17.5 27.8 46.4 28.9 18.5 24.0 16.7 29.7 28.1 13.9 34.0 17.6 17.1 22.1 60.1 23.4 24.9 39.5 40.4 18.2 18.6 29.6 28.7 16.6 19.6 19.5 26.1 15.0 27.8 18.5 22.0 25.1 26.4 30.5 75.4 13.1 27.1 20.5 24.8 19.0 20.9 8.4 26.6 8.7 25.4 38.5 16.7 19.3 21.8 56.8 65.7 56.4 52.2 38.7 58.6 52.5 16.7 32.2 7.1 16.2 31.7 19.4 14.3 12.9 16.7 19.1 16.5 30.7 21.8 15.8 37.3 15.7 17.1 16.3 12.1 18.3 16.5 17.3 45.4 31.0 28.6 24.7 13.2 24.2 27.6 24.5 25.3 14.3 16.6 19.8 17.4 16.8 15.0 30.8 19.4 36.7 19.5 34.4 11.7 23.7 43.4 16.1 12.5 36.2 27.6 27.9 19.0 11.4 19.8 35.8 37.6 15.2 23.8 20.5 15.2 11.9 12.9 19.3 11.3 22.6 32.2 19.2 17.3 21.0 6.4 56.4 52.2 46.0 43.2 48.9 45.4 56.8 54.5 47.6 49.5 47.1 52.0 50.9 18.8 38.7 44.3 65.7 58.6 52.5 25.9 33.7 46.4 28.9 23.4 24.9 29.6 28.7 27.8 26.6 56.6 95.2 111.2 77.0 110.9 65.4 464.4 165.6 93.7 63.7 211.1 21.6 164.5 479.1 104.3 5.5 95.2 364.2 46.7 148.2 95.7 85.9 119.9 65.6 322.2 191.9 44.5 149.9 73.6 123.3 17.9 119.7 114.8 141.7 202.0 184.1 64.2 118.9 228.0 102.9 571.4 49.0 103.5 154.3 38.4 50.3 139.3 106.6 109.0 191.6 86.0 COX15 CEMCOX2 ENSG00000014919 "COX15, cytochrome c oxidase assembly homolog" Q7KZN9 10 99711844-99732100 "Disease related genes, Predicted membrane proteins" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037727, HPA037728, HPA066096" Uncertain Supported Mitochondria NA NA Mitochondria "HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: AB_2685616" "unprognostic (9.74e-2)" "unprognostic (1.20e-1)" "unprognostic (1.99e-1)" "unprognostic (6.55e-3)" "unprognostic (1.50e-2)" "unprognostic (1.34e-1)" "unprognostic (5.36e-2)" "unprognostic (2.96e-1)" "unprognostic (6.84e-2)" "unprognostic (1.76e-1)" "unprognostic (3.40e-2)" "unprognostic (8.34e-2)" "prognostic favorable (9.21e-6)" "unprognostic (2.08e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-2)" "unprognostic (3.40e-2)" 14.0 31.6 15.5 13.5 23.8 7.8 15.3 15.2 25.6 13.8 17.9 23.0 14.2 15.5 18.2 15.5 17.3 16.4 16.8 19.3 14.4 15.5 25.3 27.1 11.0 15.4 15.2 16.2 20.7 15.3 17.0 26.7 17.1 22.7 15.9 20.1 21.9 13.5 14.0 28.8 14.4 14.1 16.0 14.6 17.0 15.1 14.2 14.0 21.0 18.9 12.0 23.0 19.4 13.6 17.4 18.0 21.7 23.1 11.7 13.0 12.9 14.6 31.6 13.4 29.3 19.4 15.1 11.0 11.2 14.4 17.0 16.1 23.6 21.0 27.3 18.5 9.8 11.1 21.6 28.7 15.8 18.4 12.6 14.1 15.7 16.1 24.4 20.4 21.1 15.0 16.5 14.7 17.9 29.0 25.9 17.7 24.6 17.7 21.2 15.5 15.4 15.1 15.5 14.9 14.7 15.0 18.8 19.6 17.6 15.7 10.6 11.0 18.2 20.2 11.1 19.0 11.4 42.3 8.8 13.9 8.9 12.6 13.2 16.7 17.3 22.4 18.4 15.6 34.2 7.5 21.7 17.4 16.4 10.7 20.1 12.4 17.4 12.2 12.3 18.0 16.5 12.6 12.9 13.3 11.7 23.1 8.3 13.0 12.9 15.5 23.8 15.2 25.6 14.4 15.5 15.2 16.2 22.7 14.0 20.8 6.7 13.3 8.0 5.5 13.2 21.4 15.3 34.8 14.8 14.0 9.8 20.0 24.9 14.4 1.6 10.6 13.4 0.0 13.8 18.5 7.1 8.1 2.3 22.2 15.6 12.7 16.8 4.9 25.1 1.4 9.8 10.9 11.8 13.6 10.9 12.4 13.3 10.5 9.6 20.3 14.9 0.0 8.2 8.4 9.8 8.2 19.0 8.7 16.6 6.8 COX16 "C14orf112, HSPC203" ENSG00000133983 "COX16, cytochrome c oxidase assembly homolog" Q9P0S2 14 70325081-70359731 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062659 Uncertain Supported Mitochondria NA NA Mitochondria "HPA062659: AB_2684823" "unprognostic (5.44e-2)" "unprognostic (1.31e-1)" "unprognostic (2.68e-1)" "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (6.37e-3)" "unprognostic (1.80e-2)" "unprognostic (8.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-2)" "unprognostic (6.80e-2)" "unprognostic (7.44e-2)" "prognostic favorable (1.03e-12)" "unprognostic (4.08e-1)" "unprognostic (1.73e-1)" "unprognostic (3.97e-1)" "unprognostic (1.72e-1)" 19.3 25.2 23.6 15.4 20.4 10.9 23.5 14.8 23.3 16.2 19.6 16.8 16.8 21.8 12.4 29.6 19.9 18.3 18.5 24.0 19.4 20.1 30.6 40.6 15.3 16.0 20.9 16.2 16.9 32.3 12.3 18.3 19.1 20.3 19.7 21.2 13.4 28.9 16.7 39.7 17.0 24.6 11.3 20.6 23.5 24.4 11.7 15.3 19.9 25.9 29.2 18.4 14.2 14.2 22.3 22.9 11.1 17.2 20.4 19.4 18.0 30.8 14.6 18.5 17.7 11.7 18.0 14.3 16.0 14.1 14.9 15.6 10.5 28.9 10.3 11.9 14.8 9.5 12.7 13.5 16.8 19.5 9.1 14.5 11.6 11.7 10.5 6.8 13.4 14.4 16.0 12.5 9.3 9.2 12.7 16.1 19.6 8.2 16.3 18.3 24.7 20.1 13.9 18.5 32.1 22.0 14.7 18.4 16.9 19.8 14.4 20.3 17.8 15.2 30.1 10.8 13.9 22.6 19.8 15.2 13.8 25.2 14.4 15.2 14.5 12.3 9.4 24.4 5.0 16.3 11.1 16.7 3.9 13.3 17.1 15.5 22.3 17.2 15.2 17.6 17.9 17.3 17.6 1.3 20.4 17.2 22.9 19.4 18.0 23.6 20.4 14.8 23.3 19.4 20.1 20.9 16.2 20.3 15.3 47.6 45.1 20.6 6.7 75.0 8.5 6.1 50.9 77.6 44.3 22.7 2.0 13.2 44.7 40.3 1.6 19.1 23.8 0.0 56.0 16.1 13.5 10.6 31.3 50.0 16.2 1.6 30.0 28.8 37.5 2.5 17.0 50.6 91.1 28.9 36.9 14.6 53.1 24.6 14.9 32.9 8.0 6.5 33.3 15.8 21.3 88.1 9.2 27.4 37.4 11.9 COX18 FLJ38991 ENSG00000163626 "COX18, cytochrome c oxidase assembly factor" Q8N8Q8 4 73052362-73069755 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046772, HPA049489" Approved NA NA "HPA046772: AB_2679799, HPA049489: AB_2680791" "unprognostic (3.32e-3)" "unprognostic (2.01e-1)" "prognostic favorable (6.31e-4)" "unprognostic (9.01e-3)" "unprognostic (2.43e-1)" "unprognostic (2.17e-1)" "unprognostic (3.81e-2)" "unprognostic (6.97e-2)" "unprognostic (2.92e-1)" "unprognostic (5.29e-3)" "unprognostic (1.58e-3)" "unprognostic (2.85e-2)" "prognostic favorable (8.22e-7)" "unprognostic (1.28e-2)" "unprognostic (2.94e-1)" "unprognostic (5.80e-2)" "unprognostic (1.22e-3)" 8.5 20.4 8.9 6.8 11.6 4.4 8.3 8.5 11.7 8.2 10.4 12.3 11.2 9.8 11.0 9.5 7.9 7.3 9.6 16.3 8.2 9.1 14.7 18.9 7.2 12.6 9.1 9.5 8.4 15.9 6.8 9.2 8.2 9.6 9.3 10.2 10.4 16.5 8.4 10.4 7.4 8.4 5.5 10.6 9.8 9.7 15.6 7.8 10.9 10.1 9.0 9.9 8.4 6.1 4.2 6.7 2.1 6.0 2.6 5.4 3.0 4.3 9.4 4.1 7.0 4.8 6.1 6.0 6.2 4.3 2.5 3.0 6.7 7.1 9.2 5.4 4.7 4.5 3.0 7.5 5.2 3.1 8.6 3.7 5.0 5.7 8.3 4.8 8.3 7.3 7.3 4.0 2.8 7.3 4.5 5.8 8.1 8.6 7.0 5.6 6.2 9.9 4.0 6.4 5.5 10.0 6.2 8.0 10.2 4.9 6.1 8.1 5.3 4.9 8.1 3.2 4.1 5.7 3.4 6.8 5.2 2.5 9.2 3.8 16.4 7.8 6.5 6.4 6.3 5.7 2.1 5.9 1.8 3.4 5.6 4.9 3.8 3.5 3.8 4.6 4.2 5.4 5.3 1.5 2.6 6.0 6.7 2.9 3.0 8.9 11.6 8.5 11.7 8.2 9.1 9.1 9.5 9.6 7.8 3.0 4.6 10.0 3.1 2.3 11.3 11.5 5.1 8.1 6.8 8.7 21.6 6.6 11.6 5.6 3.3 5.9 5.3 23.3 6.8 7.2 3.5 5.3 0.0 15.8 7.7 19.1 5.2 14.1 8.3 1.5 8.3 6.9 5.0 8.2 8.5 8.8 7.3 2.9 8.9 11.2 14.8 12.9 5.2 7.7 7.0 1.3 2.5 9.6 9.0 3.0 COX4I1 "COX4, COX4-1" ENSG00000131143 "Cytochrome c oxidase subunit 4I1" P13073 16 85798633-85807044 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002485, CAB004080" Supported Supported Mitochondria NA NA 970000 Mitochondria "CAB004080: AB_2085427, HPA002485: AB_1078559" "unprognostic (4.73e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-1)" "unprognostic (6.18e-3)" "unprognostic (2.47e-1)" "unprognostic (4.52e-2)" "unprognostic (2.65e-1)" "unprognostic (1.46e-1)" "unprognostic (5.97e-2)" "unprognostic (7.82e-3)" "unprognostic (3.32e-2)" "unprognostic (2.29e-1)" "prognostic favorable (2.56e-8)" "unprognostic (4.23e-2)" "unprognostic (4.06e-1)" "unprognostic (1.01e-1)" "unprognostic (2.38e-2)" 41.6 38.6 101.1 54.0 100.2 66.5 60.6 51.6 86.9 38.1 87.1 38.9 43.9 77.6 33.9 69.3 54.7 50.4 59.8 218.6 82.3 73.0 59.7 69.5 29.6 49.1 100.1 65.9 45.4 71.2 55.7 36.3 36.8 57.0 37.6 98.4 40.6 65.9 53.1 172.3 48.0 76.5 51.2 58.4 40.1 56.5 21.8 38.7 46.6 49.1 112.6 70.2 47.1 52.4 123.0 144.1 74.8 130.8 74.7 121.9 222.6 44.7 73.0 49.7 66.3 92.0 86.3 85.7 40.9 83.7 77.5 38.8 123.5 67.9 73.5 50.3 65.1 42.4 90.2 70.6 82.2 69.1 24.9 73.0 41.0 61.8 119.9 83.0 37.2 30.6 100.0 127.6 63.4 86.6 81.2 80.9 60.5 68.9 30.2 65.7 161.5 74.4 115.3 66.6 99.8 86.1 84.6 31.2 64.3 114.9 88.9 59.1 48.0 86.6 55.1 66.2 55.7 80.8 103.9 56.8 38.9 45.1 35.7 43.7 60.9 57.8 168.9 59.4 73.8 43.6 50.9 130.8 74.8 72.5 112.8 88.4 123.0 96.3 85.0 144.1 116.1 121.9 100.0 50.7 74.7 98.6 107.7 102.7 222.6 101.1 100.2 51.6 86.9 82.3 73.0 100.1 65.9 57.0 38.7 256.1 363.9 981.6 971.7 1003.2 230.7 3140.6 1197.4 362.7 382.2 600.2 123.7 1081.3 2332.7 965.7 464.1 701.9 2320.1 280.4 1145.7 924.4 671.8 956.9 507.1 1060.0 1395.9 200.2 970.5 596.0 1378.7 820.3 462.0 1118.7 1086.5 1424.7 1513.6 283.9 1228.5 1740.3 336.3 1959.5 260.3 349.3 760.4 345.7 304.0 1190.3 1239.3 852.8 1984.7 1551.2 COX4I2 "COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2" ENSG00000131055 "Cytochrome c oxidase subunit 4I2" Q96KJ9 20 31637888-31645006 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.7" "Group enriched" "Detected in some" 34 "Sertoli cells: 407.4;Smooth muscle cells: 177.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 11 "naive B-cell: 2.6" "Lineage enriched" "Detected in single" 11 "B-cells: 2.6" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.64e-1)" "unprognostic (2.09e-2)" "unprognostic (2.76e-3)" "unprognostic (2.18e-2)" "unprognostic (4.51e-2)" "prognostic favorable (6.04e-5)" "unprognostic (5.60e-2)" "unprognostic (1.13e-1)" "unprognostic (2.51e-1)" "unprognostic (7.45e-2)" "unprognostic (1.04e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (9.78e-4)" "unprognostic (1.11e-1)" "unprognostic (3.30e-3)" "unprognostic (1.43e-1)" "unprognostic (5.59e-2)" 9.9 0.7 1.6 1.7 1.9 0.1 7.9 0.7 2.5 4.7 2.2 1.5 0.9 1.1 5.9 3.5 7.1 2.6 5.4 15.5 1.7 1.4 2.0 0.5 24.6 4.9 2.4 1.0 1.9 1.9 2.1 1.1 60.7 2.7 5.2 1.6 4.1 2.4 2.8 12.8 2.5 2.7 3.9 1.2 0.8 2.0 1.5 2.1 0.5 8.0 7.5 2.3 3.7 3.7 2.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 1.9 0.7 2.5 1.7 1.4 2.4 1.0 2.7 2.1 0.0 0.0 0.0 0.2 5.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 5.7 0.0 0.0 0.0 0.2 4.3 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 3.4 1.1 8.5 0.0 0.0 1.1 0.1 0.0 0.7 0.0 0.4 407.4 177.5 0.0 0.1 5.8 2.1 0.0 0.0 0.3 COX6A1 COX6A ENSG00000111775 "Cytochrome c oxidase subunit 6A1" P12074 12 120438090-120440742 "Disease related genes, Predicted membrane proteins" Oxidoreductase "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062394 Approved Supported Mitochondria NA NA Mitochondria "HPA062394: AB_2684749" "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (5.10e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-1)" "unprognostic (8.78e-2)" "unprognostic (3.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (3.22e-2)" "unprognostic (2.82e-1)" "prognostic favorable (6.50e-7)" "unprognostic (2.53e-1)" "unprognostic (1.31e-1)" "unprognostic (5.48e-2)" "unprognostic (2.63e-2)" 49.2 48.0 171.0 32.1 103.0 52.6 43.8 44.4 107.5 37.3 96.8 38.5 32.4 102.8 28.0 47.0 59.3 41.8 37.6 41.5 121.5 92.0 85.8 102.6 32.4 39.6 140.0 57.9 27.7 62.7 43.8 38.3 44.4 86.9 43.1 74.3 31.3 63.8 44.2 10.6 37.7 85.7 38.1 67.2 32.1 60.8 28.1 61.2 33.7 48.2 36.0 40.1 42.1 35.0 74.5 102.2 60.5 69.8 47.8 87.4 83.0 47.2 101.2 57.6 60.1 44.4 37.9 70.6 30.1 40.3 53.5 45.7 122.3 48.3 99.6 90.1 42.5 41.4 79.1 56.1 66.1 34.7 59.7 121.0 53.4 57.9 89.5 41.1 58.5 38.4 45.5 81.6 48.8 57.9 44.2 45.0 72.6 52.3 31.2 44.4 132.3 84.4 148.2 52.5 92.1 148.4 57.7 38.6 93.3 84.4 114.0 76.0 66.1 55.2 54.2 70.7 33.5 97.2 66.9 33.9 33.4 41.3 34.4 41.8 48.5 66.6 77.1 52.4 57.4 44.4 38.5 65.5 58.3 54.4 69.5 58.5 74.5 64.3 59.5 95.1 59.2 59.1 59.3 60.5 47.8 69.8 102.2 87.4 83.0 171.0 103.0 44.4 107.5 121.5 92.0 140.0 57.9 86.9 61.2 369.2 267.5 329.6 423.0 340.5 204.2 104.8 682.8 548.7 311.7 734.5 543.9 662.2 1255.0 574.2 113.2 290.2 1336.6 93.5 578.7 601.6 281.6 433.2 262.5 840.8 680.4 138.2 495.4 264.6 384.0 100.3 279.6 388.0 497.7 739.4 694.0 232.4 574.7 1129.3 249.6 1194.5 252.8 336.3 428.1 355.7 331.5 339.1 775.3 316.6 860.7 644.8 COX6C ENSG00000164919 "Cytochrome c oxidase subunit 6C" P09669 8 99873200-99894062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 232.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014295, CAB016244" Enhanced Supported Mitochondria NA NA 53000 Mitochondria "CAB016244: AB_2085703, HPA014295: AB_2668966" "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-2)" "unprognostic (1.58e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-2)" "unprognostic (1.29e-1)" "unprognostic (3.51e-1)" "unprognostic (3.70e-1)" "unprognostic (8.86e-2)" "unprognostic (3.47e-3)" "unprognostic (1.10e-1)" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" 20.5 43.1 66.1 21.6 56.2 44.4 23.3 28.5 63.8 18.7 46.0 14.3 29.4 113.7 38.8 64.1 31.6 27.4 23.5 113.0 54.8 46.9 38.7 66.8 18.2 23.2 58.8 36.7 32.7 26.5 12.1 24.0 30.7 38.8 23.3 38.1 20.6 32.4 30.1 232.1 31.2 55.8 38.7 40.4 23.7 35.1 29.6 23.5 17.9 19.5 80.6 17.8 31.0 21.3 45.9 62.3 55.7 50.6 37.2 73.5 48.0 17.0 6.9 8.0 32.8 18.3 13.3 13.4 5.6 5.3 3.8 4.3 6.9 36.5 41.4 42.4 8.7 6.1 22.7 4.5 46.4 6.4 7.5 11.6 85.9 8.2 20.1 11.9 39.6 26.6 12.3 61.8 3.2 7.1 17.0 5.7 13.0 6.0 74.4 6.4 16.3 41.1 36.5 15.4 25.7 15.9 47.8 2.6 40.5 58.2 90.8 24.9 15.2 3.9 85.1 41.6 8.6 60.0 25.4 4.9 29.1 37.9 30.7 7.9 18.5 14.9 24.6 40.9 16.1 25.7 55.7 29.3 22.1 40.1 42.3 41.8 45.9 61.0 42.5 43.8 41.7 73.5 65.7 3.5 37.2 50.6 62.3 56.9 48.0 66.1 56.2 28.5 63.8 54.8 46.9 58.8 36.7 38.8 23.5 375.2 414.8 374.3 402.8 435.9 194.1 2063.7 626.8 575.5 377.6 574.0 96.2 831.0 1886.7 571.0 645.5 416.6 1532.5 303.7 739.7 730.3 697.7 423.0 347.2 1528.6 904.1 147.8 776.1 376.3 443.5 180.9 615.6 499.6 695.0 943.2 982.6 392.7 687.3 1094.2 552.3 1121.0 205.6 485.0 628.5 756.0 487.0 560.0 1492.7 393.7 1121.0 582.7 COX7A1 "COX7A, COX7AH" ENSG00000161281 "Cytochrome c oxidase subunit 7A1" P24310 19 36150922-36152869 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 114.9;skeletal muscle: 404.3" "Cell type enriched" "Detected in many" 28 "Cardiomyocytes: 19391.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.9" "Group enriched" "Detected in many" 8 "dendritic cells: 1.3;granulocytes: 1.4;monocytes: 1.9" "Cell line enhanced" "Detected in some" "ASC diff: 24.5;ASC TERT1: 18.0;BJ: 16.5;BJ hTERT+: 13.7;fHDF/TERT166: 25.1;HHSteC: 16.3;HSkMC: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.48e-2)" "unprognostic (1.19e-1)" "unprognostic (6.13e-3)" "unprognostic (6.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.87e-2)" "unprognostic (3.77e-2)" "unprognostic (9.93e-2)" "unprognostic (1.92e-1)" "unprognostic (1.41e-1)" "unprognostic (9.49e-2)" "unprognostic (1.46e-1)" "unprognostic (7.84e-3)" "unprognostic (7.27e-3)" "unprognostic (9.44e-2)" "unprognostic (6.23e-2)" "unprognostic (1.54e-2)" 15.7 8.1 5.3 2.5 3.6 1.2 8.8 2.1 13.1 4.1 8.0 0.8 2.6 2.0 3.9 6.1 6.6 3.1 5.0 114.9 3.3 2.4 5.0 1.6 4.0 2.7 2.6 4.6 4.2 3.5 6.0 7.9 2.6 1.7 5.9 2.3 5.9 6.2 7.1 404.3 2.0 2.2 12.3 1.4 3.1 3.6 1.6 1.5 1.6 5.1 59.7 2.6 7.0 4.7 0.0 1.3 1.4 1.9 0.0 0.1 0.3 0.1 2.6 0.2 0.0 24.5 18.0 0.1 16.5 13.7 0.5 0.0 0.0 0.8 0.6 6.9 25.1 0.0 0.3 0.0 0.0 0.1 0.1 0.9 0.1 0.9 0.1 16.3 0.0 0.2 16.9 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.2 0.0 0.3 0.0 0.1 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 3.7 0.0 0.6 0.2 0.1 0.4 0.4 0.3 0.1 0.3 0.5 0.0 1.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 1.4 0.0 0.5 0.4 0.1 0.3 5.3 3.6 2.1 13.1 3.3 2.4 2.6 4.6 1.7 1.5 0.0 9.0 5.9 1.3 23.5 71.7 19391.7 25.5 1.4 3.4 21.0 43.2 1.0 693.0 10.8 13.4 160.8 0.0 0.0 12.2 0.9 86.2 2.4 43.9 4.4 18.4 63.5 0.0 239.4 11.6 76.0 207.9 6.0 269.9 0.0 0.0 16.2 9.2 0.0 264.5 128.7 56.3 181.1 233.8 1.5 3.2 16.7 1.6 2.5 0.0 0.6 COX7A2 "COX7AL, COXVIIa-L" ENSG00000112695 "Cytochrome c oxidase subunit 7A2" 6 75237675-75250323 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 157.6" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 3729.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.49e-2)" "unprognostic (2.56e-1)" "unprognostic (1.98e-2)" "unprognostic (2.15e-2)" "unprognostic (1.34e-1)" "unprognostic (5.67e-3)" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" "unprognostic (7.70e-2)" "unprognostic (2.73e-3)" "unprognostic (7.44e-2)" "unprognostic (1.74e-1)" "prognostic favorable (3.43e-5)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" 26.9 25.3 49.7 18.8 55.3 26.5 30.2 27.0 54.9 19.5 55.9 12.3 37.0 35.3 16.9 41.5 29.7 20.3 23.4 76.3 38.0 32.9 44.8 51.7 17.8 23.9 48.9 34.6 12.6 46.9 19.4 27.2 18.3 36.8 24.0 61.5 18.3 35.7 27.1 38.2 19.1 35.6 29.0 39.4 18.1 36.4 62.8 27.5 17.4 22.4 47.1 27.1 23.4 16.7 109.1 130.5 94.1 108.8 76.9 110.3 157.6 15.3 35.2 46.2 37.9 27.6 31.4 33.5 37.5 34.5 37.5 40.7 63.3 23.5 25.1 33.3 33.8 50.5 33.4 32.1 40.5 47.0 45.8 65.9 37.6 110.1 83.1 28.4 40.0 44.4 33.9 54.3 34.6 22.7 39.5 43.4 57.2 33.2 36.5 50.6 71.4 17.0 43.6 29.0 75.8 64.5 27.8 23.3 66.0 59.7 100.2 31.6 38.3 23.3 42.8 37.6 39.6 26.1 113.0 21.1 16.6 30.3 13.2 42.5 51.7 56.3 27.8 18.9 45.8 32.3 92.9 100.0 94.1 78.3 107.7 83.0 109.1 102.4 93.5 103.6 90.2 101.1 93.4 74.7 76.9 108.8 130.5 110.3 157.6 49.7 55.3 27.0 54.9 38.0 32.9 48.9 34.6 36.8 27.5 282.9 318.7 403.4 476.4 491.8 218.2 2259.4 751.6 480.5 353.8 478.1 113.9 585.5 2205.0 700.7 3729.3 440.0 1510.8 210.2 878.7 682.4 432.2 710.6 290.2 1241.2 769.2 146.2 637.2 364.0 458.4 2761.1 329.4 416.4 803.1 743.0 1103.4 253.8 951.9 1195.4 318.9 1303.8 241.1 401.0 739.2 2380.3 194.6 547.7 684.3 381.3 1038.8 776.7 COX7A2L "COX7AR, COX7RP, EB1, SIG81" ENSG00000115944 "Cytochrome c oxidase subunit 7A2 like" O14548 2 42333546-42425088 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059124, CAB073545" Enhanced Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "CAB073545: , HPA059124: AB_2683912" "unprognostic (3.90e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (5.45e-2)" "unprognostic (4.60e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (4.13e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-1)" "unprognostic (1.66e-2)" "unprognostic (2.43e-1)" "unprognostic (7.07e-3)" "unprognostic (1.54e-2)" "unprognostic (2.76e-1)" "unprognostic (5.53e-2)" "unprognostic (6.19e-2)" "unprognostic (1.02e-1)" 25.1 73.3 47.3 24.4 63.3 47.7 45.4 35.2 58.2 33.4 33.8 21.0 28.8 31.7 30.2 37.9 20.9 31.2 27.1 49.8 40.4 45.3 50.9 48.9 24.0 28.1 42.6 35.6 49.8 49.3 24.9 42.7 24.0 34.9 29.5 36.2 32.3 37.0 30.3 24.4 21.5 32.1 28.4 33.1 23.1 29.4 24.8 20.5 28.0 35.8 35.8 30.9 24.5 31.1 45.1 59.7 57.2 48.7 40.5 53.7 100.9 38.3 24.6 27.3 29.6 46.9 66.9 32.7 31.8 46.5 29.1 37.2 26.9 27.8 34.0 31.9 36.4 37.3 17.2 32.5 33.7 42.6 52.2 25.0 23.0 17.6 47.7 55.3 34.5 25.6 65.6 67.9 28.4 68.8 42.2 40.9 26.7 33.4 58.4 45.0 31.2 41.1 57.4 26.8 45.4 25.6 22.5 47.4 28.8 41.6 31.1 32.5 37.1 13.3 33.6 91.2 31.7 24.1 40.3 30.8 26.4 34.6 31.9 31.0 48.0 53.6 25.5 37.4 37.5 22.4 57.2 48.7 27.2 39.0 42.0 50.0 45.1 47.9 45.3 53.1 37.6 53.7 46.1 21.6 40.5 46.3 59.7 52.8 100.9 47.3 63.3 35.2 58.2 40.4 45.3 42.6 35.6 34.9 20.5 29.8 61.2 171.1 166.3 235.9 115.5 140.5 132.5 96.4 51.2 141.3 35.3 190.2 547.2 206.3 15.8 157.6 103.8 23.3 199.6 263.9 167.1 184.8 86.4 193.0 204.8 123.9 277.2 113.5 243.6 17.7 149.8 177.9 209.2 287.7 202.3 182.8 197.6 161.4 149.2 386.1 95.5 109.9 206.0 195.8 267.6 214.7 275.6 186.4 235.2 168.4 COX8A "COX, COX8, COX8-2, COX8L, VIII, VIII-L" ENSG00000176340 "Cytochrome c oxidase subunit 8A" P10176 11 63974607-63976543 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 275.5" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 1984.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA055942 Supported NA NA "HPA055942: AB_2682979" "unprognostic (6.93e-2)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "unprognostic (7.70e-3)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (3.46e-1)" "unprognostic (6.49e-3)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic favorable (2.51e-6)" "unprognostic (2.70e-2)" "unprognostic (5.41e-2)" "unprognostic (1.13e-1)" "unprognostic (8.44e-2)" 41.4 42.8 54.0 32.8 53.4 50.4 47.4 40.9 60.3 30.2 76.6 18.2 35.5 69.0 23.3 31.2 63.3 35.9 43.9 154.9 41.5 41.0 78.8 61.1 38.1 50.8 54.5 34.0 24.7 43.0 38.7 37.6 32.2 35.7 37.9 51.6 35.9 54.4 50.2 275.5 31.2 66.7 29.9 37.0 31.0 50.8 18.7 24.3 44.6 42.4 121.7 34.8 38.8 29.8 52.7 114.8 87.8 108.6 51.0 75.7 80.3 60.3 80.6 52.0 51.6 22.3 27.3 37.7 32.0 35.9 63.6 49.5 53.8 49.6 28.8 70.9 44.5 60.2 60.3 40.0 55.1 21.8 42.3 69.5 41.9 65.4 63.1 35.8 42.2 54.6 35.2 41.9 50.9 41.1 28.4 39.4 68.6 48.7 62.8 39.9 157.1 59.7 143.7 47.3 72.0 141.6 46.8 41.8 121.1 51.4 51.0 47.2 66.8 38.1 55.4 78.5 23.2 81.4 45.9 24.2 37.0 50.2 79.2 37.3 78.9 61.8 44.4 48.1 41.7 44.3 78.3 101.8 87.8 57.5 108.6 42.4 52.7 63.2 56.4 114.8 46.4 49.0 53.4 71.3 51.0 97.9 113.0 75.7 80.3 54.0 53.4 40.9 60.3 41.5 41.0 54.5 34.0 35.7 24.3 208.4 199.1 288.8 299.8 261.7 169.3 1162.0 458.6 376.1 244.5 415.2 68.7 392.2 1984.5 389.4 7.0 198.9 1123.7 140.2 421.4 448.5 223.4 381.0 221.4 677.3 801.9 101.7 693.6 209.3 461.0 13.2 221.8 429.5 595.5 445.4 846.8 231.3 439.3 874.7 207.9 1094.8 128.1 155.2 347.5 51.9 59.0 324.2 306.9 320.7 910.0 526.5 COX8C COX8-3 ENSG00000187581 "Cytochrome c oxidase subunit 8C" Q7Z4L0 14 93347191-93348356 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 72 "testis: 72.8" "Group enriched" "Detected in some" 11 "Early spermatids: 811.2;Late spermatids: 1407.4;Spermatocytes: 393.6" "Group enriched" "Detected in some" 8 "ovarian cancer: 2.9;testis cancer: 6.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 9 "U-937: 18.0" "Not detected" "Not detected" HPA003127 Approved NA NA "HPA003127: AB_1078560" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (3.76e-3)" "unprognostic (2.11e-1)" "unprognostic (2.77e-2)" "unprognostic (7.71e-2)" "unprognostic (3.83e-1)" "unprognostic (1.99e-2)" "unprognostic (8.28e-2)" "unprognostic (6.33e-2)" "unprognostic (2.64e-2)" "unprognostic (9.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 72.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 811.2 0.0 0.0 0.0 0.0 10.6 0.2 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1407.4 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.0 19.4 0.0 393.6 80.8 0.1 2.9 0.0 0.0 0.1 CPD GP180 ENSG00000108582 "Carboxypeptidase D" O75976 17 30378905-30469989 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 178.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052796, HPA055465" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear speckles" NA NA 930000 "Nucleoplasm, Nuclear speckles" "Nuclear membrane" "HPA052796: AB_2681953, HPA055465: AB_2682823" "unprognostic (1.05e-1)" "unprognostic (1.31e-1)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (6.13e-2)" "unprognostic (1.65e-1)" "unprognostic (7.97e-3)" "unprognostic (4.45e-2)" "unprognostic (2.07e-2)" "unprognostic (2.96e-1)" "unprognostic (1.62e-1)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.25e-2)" "unprognostic (3.36e-1)" "unprognostic (1.08e-1)" 16.4 8.0 9.8 12.3 12.4 18.1 17.9 9.1 13.3 28.6 16.2 18.5 10.1 12.9 12.6 10.1 10.0 15.2 33.6 10.5 12.8 10.4 13.4 26.8 20.0 14.2 22.1 11.4 7.8 14.7 21.2 14.9 22.3 13.9 11.4 13.3 7.5 59.7 7.9 10.0 7.8 22.0 15.1 25.9 7.9 24.6 25.0 13.5 5.8 37.2 7.7 10.0 11.5 11.6 0.4 3.4 19.3 5.5 2.1 3.8 2.5 12.2 18.7 16.2 16.7 16.9 32.2 5.8 16.9 24.8 11.7 14.5 21.9 7.9 1.5 21.6 19.4 14.9 8.8 10.5 21.4 19.9 5.8 15.0 3.5 11.5 13.5 20.6 22.7 9.2 57.4 9.6 15.0 14.6 19.6 23.8 5.3 6.7 18.1 9.4 2.4 7.3 6.2 4.5 28.2 4.3 7.0 18.8 4.7 22.0 14.0 4.1 10.3 20.2 17.5 8.8 19.8 16.5 15.8 28.3 11.7 7.7 18.2 16.1 7.3 15.2 5.2 15.0 14.9 9.9 2.8 5.5 6.4 3.4 2.8 3.8 0.2 1.7 2.8 3.4 0.4 1.4 1.7 19.3 2.1 2.3 0.4 1.1 2.5 9.8 12.4 9.1 13.3 12.8 10.4 22.1 11.4 13.9 13.5 29.8 19.2 7.5 28.1 19.6 23.1 10.4 178.3 18.7 27.3 27.9 43.2 20.5 1.7 21.2 75.9 48.4 31.6 0.0 21.4 9.1 26.2 58.6 24.2 67.2 14.9 44.5 31.0 51.0 34.9 41.5 15.5 20.5 28.7 10.0 69.1 11.1 30.2 20.1 15.2 17.7 35.0 0.0 22.6 15.6 24.2 16.3 20.1 20.8 31.5 38.6 CPED1 "C7orf58, FLJ21986" ENSG00000106034 "Cadherin like and PC-esterase domain containing 1" A4D0V7 7 120988677-121297444 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Fibroblasts: 35.2;Ito cells: 30.7;Peritubular cells: 76.7;Smooth muscle cells: 39.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 7.6;intermediate monocyte: 7.8;myeloid DC: 17.2;non-classical monocyte: 4.8;plasmacytoid DC: 10.3" "Group enriched" "Detected in many" 9 "dendritic cells: 17.2;monocytes: 7.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 28.7;Hep G2: 16.5;K-562: 55.7;LHCN-M2: 19.7;U-138 MG: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA012058 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012058: AB_1845761" "unprognostic (7.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (4.48e-4)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (5.52e-3)" "prognostic favorable (3.00e-4)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.48e-1)" "unprognostic (8.69e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (6.28e-3)" "unprognostic (5.05e-2)" "unprognostic (3.78e-1)" "unprognostic (6.54e-4)" 21.6 8.3 3.2 8.0 3.7 0.1 7.8 1.1 2.7 19.4 16.3 4.1 15.0 3.7 21.8 15.7 10.5 12.2 14.4 10.3 2.9 1.7 3.9 19.4 9.0 1.5 5.1 1.9 36.8 2.0 0.4 4.5 10.6 3.1 20.7 6.7 18.5 2.8 17.1 24.4 2.9 10.6 48.9 8.7 9.9 8.6 7.1 3.8 0.2 4.9 15.9 1.4 34.3 14.6 1.0 17.2 1.4 7.8 0.0 0.1 2.1 1.9 0.0 0.1 0.0 4.7 13.8 0.1 8.1 28.7 2.8 7.7 0.2 0.1 0.3 0.1 4.3 3.2 0.1 0.1 0.0 7.4 0.1 0.3 2.2 0.1 16.5 8.2 0.0 0.0 5.6 0.0 6.6 0.1 2.2 1.4 0.0 55.7 4.2 19.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 11.3 5.5 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.2 0.8 16.8 0.4 14.0 7.7 1.8 0.0 0.2 1.9 0.0 0.8 1.4 7.6 0.0 0.0 7.8 0.1 1.0 0.0 0.0 17.2 0.3 0.0 0.0 0.3 0.0 4.8 10.3 0.0 2.1 3.2 3.7 1.1 2.7 2.9 1.7 5.1 1.9 3.1 3.8 17.9 0.3 1.3 0.5 2.7 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 3.6 0.0 0.0 0.0 1.5 35.2 0.8 0.0 20.2 3.9 3.2 0.0 30.7 11.5 0.0 19.5 25.2 3.3 1.0 0.0 21.5 0.0 0.0 76.7 0.0 0.2 0.0 39.2 0.3 0.4 1.8 0.3 0.0 0.0 1.3 CPT1A "CPT1, CPT1-L, L-CPT1" ENSG00000110090 "Carnitine palmitoyltransferase 1A" P50416 11 68754620-68844410 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008835 Supported Supported Mitochondria NA NA 790000 Mitochondria "HPA008835: AB_1078563" "prognostic unfavorable (3.84e-4)" "unprognostic (1.38e-3)" "unprognostic (3.04e-3)" "unprognostic (2.46e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (2.17e-1)" "unprognostic (4.99e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-2)" "unprognostic (2.92e-2)" "unprognostic (2.34e-1)" "prognostic favorable (2.67e-7)" "unprognostic (9.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.49e-1)" "unprognostic (2.46e-3)" 18.0 18.3 9.9 9.9 12.1 15.8 24.4 7.0 10.3 12.8 31.9 8.2 14.1 33.7 17.0 7.2 11.2 12.8 14.7 14.6 12.0 6.6 30.6 62.0 13.1 10.1 10.5 8.6 17.0 24.4 16.9 13.8 8.7 10.8 15.6 22.0 19.7 12.9 11.4 6.9 10.3 33.4 16.9 8.7 18.9 16.8 10.4 9.0 17.9 13.2 7.5 7.6 11.3 30.2 2.5 11.9 10.6 8.6 5.7 8.8 2.5 8.1 14.5 2.1 14.2 9.3 8.4 0.6 6.5 5.4 5.2 1.0 0.5 27.6 0.0 24.2 17.2 18.2 26.9 18.4 3.9 1.5 13.0 1.8 20.1 15.8 6.7 13.9 11.6 24.3 8.7 1.9 10.4 6.3 7.1 18.3 8.1 2.1 16.5 4.7 23.4 9.4 20.6 0.2 42.2 15.4 26.5 0.3 35.6 12.2 20.4 0.2 9.3 18.0 34.9 5.7 1.4 31.1 11.3 18.4 11.3 0.2 22.6 9.4 12.9 16.4 8.3 11.9 8.6 12.3 9.2 7.8 10.6 8.8 8.6 5.1 2.3 5.5 5.3 5.0 2.5 3.4 7.0 3.8 5.7 7.2 11.9 2.9 2.5 9.9 12.1 7.0 10.3 12.0 6.6 10.5 8.6 10.8 9.0 35.7 36.9 11.5 7.7 8.4 4.9 22.1 28.1 32.1 22.7 22.7 60.9 12.9 16.6 11.2 9.2 25.4 82.1 0.0 8.1 4.1 13.9 7.4 27.8 79.0 14.6 1.6 15.5 37.4 42.3 15.7 8.9 13.5 0.0 11.8 44.9 12.9 9.7 40.3 30.1 9.4 41.0 38.8 16.0 12.1 8.8 6.8 6.5 16.6 59.0 6.4 CPT1B "CPT1-M, M-CPT1" ENSG00000205560 "Carnitine palmitoyltransferase 1B" Q92523 22 50568861-50578465 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 162.2;skeletal muscle: 59.8" "Group enriched" "Detected in many" 6 "Early spermatids: 35.8;Late spermatids: 93.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA079265 Enhanced NA NA "HPA079265: " "unprognostic (1.66e-1)" "unprognostic (2.99e-1)" "unprognostic (6.71e-3)" "unprognostic (2.53e-2)" "unprognostic (1.36e-1)" "unprognostic (1.18e-3)" "unprognostic (8.89e-2)" "unprognostic (7.16e-2)" "unprognostic (5.01e-2)" "unprognostic (9.50e-2)" "unprognostic (1.10e-3)" "unprognostic (9.76e-3)" "unprognostic (7.37e-2)" "unprognostic (4.98e-3)" "unprognostic (1.14e-1)" "unprognostic (8.43e-2)" "unprognostic (3.15e-5)" 4.3 1.5 1.7 2.9 2.7 3.3 2.8 9.1 2.0 1.7 3.1 1.8 1.6 3.8 1.6 2.9 3.7 0.9 1.6 162.2 2.1 1.9 4.0 4.2 1.9 3.5 2.5 1.6 1.6 3.1 17.2 4.5 2.3 2.2 2.5 2.9 5.2 4.3 1.6 59.8 3.8 3.7 1.6 2.2 5.0 3.8 19.7 2.3 1.9 5.2 39.6 4.5 2.0 1.6 0.5 2.3 0.7 0.4 2.3 1.6 0.3 5.3 4.9 15.7 5.8 3.6 2.1 12.4 0.6 2.0 2.6 3.0 2.3 4.7 10.6 1.8 1.2 4.1 8.8 8.3 1.9 2.4 4.3 9.2 5.3 14.3 2.4 0.9 5.5 15.4 1.2 14.3 1.9 3.1 9.9 0.5 7.5 1.8 17.9 2.5 7.5 2.1 10.7 3.4 2.7 3.3 9.7 5.1 2.3 6.7 12.6 4.4 8.5 4.0 6.4 6.5 10.1 7.0 11.6 1.1 7.7 8.2 5.1 1.8 15.3 3.5 5.5 3.6 9.8 5.2 0.0 0.4 0.5 1.0 0.1 0.0 0.5 1.6 0.3 2.3 0.2 0.4 0.2 0.7 2.3 0.2 0.3 0.1 0.3 1.7 2.7 9.1 2.0 2.1 1.9 2.5 1.6 2.2 2.3 0.0 11.2 0.0 0.0 0.2 1.8 2.8 2.5 0.0 1.2 3.5 2.0 0.4 0.0 1.6 35.8 0.4 3.9 0.0 1.8 0.5 0.6 0.0 6.9 1.9 0.5 3.2 0.0 0.6 0.0 93.5 0.3 0.7 1.7 10.8 4.9 0.2 1.1 2.5 0.7 0.3 1.6 0.0 0.3 6.9 1.7 0.3 0.3 1.3 3.7 0.0 CPT1C "CPT1P, CPTIC, FLJ23809" ENSG00000169169 "Carnitine palmitoyltransferase 1C" Q8TCG5 19 49690898-49713731 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.0" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 39.6;Horizontal cells: 30.2;Late spermatids: 17.8;Rod photoreceptor cells: 18.1" "Cancer enhanced" "Detected in many" "glioma: 9.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 18.8;AN3-CA: 15.8;SCLC-21H: 13.1;SH-SY5Y: 33.9;U-87 MG: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014529, HPA063621" Approved Approved Centrosome NA NA Centrosome "HPA014529: AB_1847206, HPA063621: AB_2732706" "unprognostic (1.09e-1)" "unprognostic (6.25e-2)" "unprognostic (1.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.73e-1)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.49e-1)" "prognostic favorable (1.84e-4)" "unprognostic (4.36e-1)" "unprognostic (1.92e-10)" "unprognostic (9.44e-4)" "unprognostic (3.35e-2)" "unprognostic (3.91e-1)" "unprognostic (4.72e-3)" 3.4 9.3 11.2 3.1 18.9 0.8 1.1 16.3 34.0 4.1 1.9 8.9 0.2 2.7 6.4 5.3 1.8 4.1 7.6 2.8 11.9 12.8 1.6 1.6 2.5 2.6 8.0 13.4 3.8 1.2 0.7 15.6 1.9 11.4 2.8 1.7 7.4 1.5 4.8 1.7 1.5 2.4 7.8 6.6 4.2 1.4 4.1 6.3 0.0 1.7 0.2 1.7 4.4 1.9 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 18.8 15.8 6.8 5.4 0.0 6.0 11.9 7.7 10.8 0.3 0.0 0.3 0.0 5.9 0.9 1.4 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 11.1 0.0 0.0 6.2 0.0 6.2 0.0 2.0 10.6 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.8 1.2 3.9 0.0 0.0 0.0 0.4 0.0 13.1 33.9 0.0 0.0 0.0 0.3 0.0 0.0 8.6 0.4 0.1 3.6 3.0 0.1 1.4 0.1 14.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 11.2 18.9 16.3 23.4 11.9 12.8 8.0 13.4 11.4 6.3 0.0 0.0 0.0 3.3 1.9 39.6 1.2 2.5 0.0 0.0 0.0 15.7 0.8 0.0 0.0 7.9 4.5 0.0 0.0 0.0 3.6 3.1 1.5 0.0 0.0 0.3 30.2 0.0 3.1 1.2 17.8 3.1 0.0 0.0 0.0 0.0 14.9 0.5 0.0 12.4 0.0 18.1 0.0 5.3 2.7 6.9 1.6 0.9 0.0 0.0 0.9 CPXM2 "CPX2, UNQ676" ENSG00000121898 "Carboxypeptidase X, M14 family member 2" Q8N436 10 123706207-123940267 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 8 "Early spermatids: 85.6;Late spermatids: 150.5;Peritubular cells: 74.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 16.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "BJ: 9.8;fHDF/TERT166: 38.3;SuSa: 16.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048375 Uncertain "Secreted - unknown location" NA NA "HPA048375: AB_2680377" "unprognostic (1.50e-1)" "unprognostic (3.66e-1)" "unprognostic (2.58e-2)" "unprognostic (4.02e-3)" "unprognostic (2.69e-2)" "unprognostic (6.48e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.57e-2)" "unprognostic (4.42e-2)" "unprognostic (2.14e-1)" "prognostic favorable (9.02e-4)" "unprognostic (3.48e-2)" "unprognostic (2.54e-2)" "unprognostic (1.27e-1)" "unprognostic (1.16e-3)" 17.0 4.1 0.8 5.0 2.1 0.1 12.3 1.3 1.6 6.4 40.9 6.7 5.7 3.8 12.2 37.8 20.0 9.1 9.4 14.3 1.7 4.0 6.6 1.5 4.6 3.7 6.1 0.7 12.8 3.2 1.9 7.1 11.6 16.9 14.7 4.5 26.5 5.6 8.3 5.0 4.5 9.1 45.5 21.6 13.8 14.4 7.7 3.4 2.6 9.5 11.9 4.0 32.5 20.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.4 0.6 0.0 0.0 0.0 0.0 0.0 38.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 16.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 2.1 1.3 1.6 1.7 4.0 6.1 0.7 16.9 3.4 0.0 1.1 0.0 0.0 1.9 0.0 1.4 0.0 0.0 0.0 1.8 0.0 6.6 1.7 0.1 85.6 13.5 0.0 0.0 0.2 0.2 2.3 0.0 0.0 0.0 0.3 1.6 0.0 13.5 0.0 150.5 10.0 0.0 3.3 0.0 0.5 0.0 0.2 0.0 74.3 0.0 0.0 0.0 2.8 1.1 1.9 1.8 4.2 0.0 1.1 0.0 CR1 "CD35, KN" ENSG00000203710 "Complement C3b/C4b receptor 1 (Knops blood group)" P17927 1 207496147-207641765 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.2;lymphoid tissue: 42.3" "Group enriched" "Detected in some" 4 "B-cells: 23.8;Erythroid cells: 46.7;Kupffer cells: 50.8;Macrophages: 12.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "basophil: 23.2;eosinophil: 9.4;neutrophil: 9.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 23.2" "Group enriched" "Detected in some" 9 "HL-60: 9.0;HMC-1: 21.1;NB-4: 8.4" "CAB002491, CAB016271, HPA042455, HPA043579, HPA049348" Enhanced NA NA 27000000 "CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: AB_2680723" "unprognostic (1.74e-1)" "unprognostic (3.16e-2)" "unprognostic (2.75e-2)" "unprognostic (6.12e-2)" "unprognostic (1.58e-2)" "unprognostic (7.14e-2)" "unprognostic (2.84e-1)" "unprognostic (3.86e-2)" "unprognostic (2.02e-1)" "unprognostic (2.80e-1)" "unprognostic (1.32e-1)" "unprognostic (1.84e-1)" "unprognostic (2.29e-3)" "unprognostic (4.38e-2)" "unprognostic (3.32e-2)" "unprognostic (6.45e-2)" "unprognostic (3.50e-3)" 9.0 1.1 0.6 17.0 0.6 5.8 1.5 0.4 0.5 0.6 1.7 0.2 0.0 0.5 0.7 5.6 1.4 2.2 1.1 8.0 0.6 0.5 2.3 3.8 4.0 42.3 0.6 0.0 1.7 1.2 0.0 0.6 5.5 1.0 1.7 0.7 0.5 1.9 0.0 0.8 0.5 5.1 3.6 0.7 42.0 1.1 0.9 0.1 1.3 0.7 0.0 11.1 3.2 1.3 2.8 0.2 23.2 2.3 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 9.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.2 2.3 9.4 0.0 1.4 0.4 2.8 0.6 0.3 0.2 1.4 0.1 0.1 9.1 0.0 1.2 0.0 0.0 0.6 0.6 0.6 0.4 0.5 0.6 0.5 0.6 0.0 1.0 0.1 0.0 6.2 23.8 0.0 0.0 0.0 0.8 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 46.7 0.0 0.1 0.2 0.0 1.1 0.0 8.0 0.0 0.0 0.0 50.8 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CR2 "C3DR, CD21" ENSG00000117322 "Complement C3d receptor 2" P20023 1 207454230-207489895 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 97.2" "Cell type enriched" "Detected in some" 15 "B-cells: 25.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "memory B-cell: 13.3;naive B-cell: 16.2" "Lineage enriched" "Detected in many" 9 "B-cells: 16.2" "Cell line enhanced" "Detected in some" "Daudi: 21.5;JURKAT: 3.7;MOLT-4: 11.8;RPMI-8226: 4.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB002659, HPA052942, HPA060715" Enhanced NA NA 150000000 "CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349" "prognostic favorable (6.90e-4)" "unprognostic (1.22e-1)" "unprognostic (9.95e-2)" "unprognostic (3.64e-2)" "unprognostic (2.65e-1)" "unprognostic (1.27e-3)" "unprognostic (1.18e-1)" "unprognostic (6.62e-3)" "unprognostic (1.91e-2)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (7.95e-2)" "unprognostic (2.14e-1)" "unprognostic (1.12e-1)" "unprognostic (2.19e-1)" "unprognostic (2.09e-2)" "unprognostic (3.35e-2)" 0.5 0.3 0.4 97.2 0.3 0.0 0.4 0.3 0.3 0.3 1.2 0.0 0.0 0.0 0.3 0.0 2.8 0.3 0.3 0.3 0.4 0.4 1.4 0.4 2.0 72.8 0.4 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.5 0.9 0.0 6.0 0.0 0.4 0.3 11.5 0.0 0.4 63.4 1.4 0.5 0.0 6.5 0.7 0.3 56.3 0.6 0.3 16.2 0.0 0.2 0.0 0.0 1.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.3 0.0 0.0 0.1 11.8 0.0 1.9 0.0 0.2 0.0 0.2 4.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 13.3 0.7 0.5 0.0 16.2 1.8 1.6 0.2 0.0 0.0 0.0 0.0 1.1 0.4 0.3 0.3 0.3 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 CRB1 "LCA8, RP12" ENSG00000134376 "Crumbs 1, cell polarity complex component" P82279 1 197268204-197478455 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 155.1;Muller glia cells: 100.9;Rod photoreceptor cells: 136.0" "Cancer enriched" "Detected in single" 12 "glioma: 2.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "basophil: 9.4" "Lineage enriched" "Detected in single" 22 "granulocytes: 9.4" "Cell line enriched" "Detected in some" 8 "HeLa: 17.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA061250, HPA063127" Approved Uncertain Vesicles "Intracellular and membrane" NA NA Vesicles "HPA061250: AB_2684458, HPA063127: AB_2684944" "unprognostic (1.96e-1)" "unprognostic (5.38e-3)" "unprognostic (2.92e-3)" "unprognostic (1.50e-2)" "unprognostic (5.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.38e-1)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (1.48e-3)" "unprognostic (2.59e-1)" "unprognostic (2.01e-3)" "unprognostic (1.78e-3)" "unprognostic (1.56e-1)" "unprognostic (3.36e-2)" "unprognostic (2.96e-1)" 1.1 1.1 11.9 0.9 11.0 1.8 1.2 31.4 20.4 0.9 0.9 10.4 0.0 0.9 0.8 1.2 1.1 2.0 1.0 1.2 11.4 6.2 1.1 0.9 1.0 1.0 4.0 8.9 2.6 1.7 0.7 1.9 0.9 14.1 1.0 0.9 9.0 0.8 0.9 2.4 0.9 0.9 0.8 8.7 0.9 1.5 7.3 9.6 0.0 1.3 0.0 0.8 0.9 0.1 0.1 0.0 9.4 0.0 0.1 0.4 0.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 17.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.3 0.1 0.0 0.0 0.0 0.0 11.9 11.0 31.4 10.5 11.4 6.2 4.0 8.9 14.1 9.6 0.0 0.0 0.0 0.2 0.2 12.7 1.2 0.0 0.0 0.0 0.0 155.1 0.0 0.0 0.0 1.4 0.0 0.0 23.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.0 100.9 0.0 0.0 0.4 0.0 136.0 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 CRB2 "FLJ16786, FLJ38464" ENSG00000148204 "Crumbs 2, cell polarity complex component" Q5IJ48 9 123356170-123380324 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Gastrulation "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Group enriched" "Detected in some" 13 "Bipolar cells: 30.9;Cone photoreceptor cells: 111.9;Rod photoreceptor cells: 97.1" "Group enriched" "Detected in some" 7 "glioma: 9.4;ovarian cancer: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "AF22: 27.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA043674 Approved Supported "Intracellular and membrane" NA NA 240000 "HPA043674: AB_10962974" "unprognostic (1.38e-2)" "unprognostic (2.39e-2)" "unprognostic (1.26e-1)" "unprognostic (2.83e-4)" "unprognostic (2.85e-2)" "unprognostic (1.14e-2)" "unprognostic (2.31e-1)" "unprognostic (3.69e-4)" "unprognostic (1.20e-1)" "unprognostic (7.28e-3)" "unprognostic (4.66e-3)" "unprognostic (3.09e-1)" "unprognostic (5.56e-5)" "unprognostic (1.31e-1)" "unprognostic (1.55e-1)" "unprognostic (4.38e-2)" "unprognostic (3.38e-1)" 1.3 0.6 6.8 1.9 8.7 1.3 1.0 3.0 16.2 0.5 2.4 21.5 0.0 0.9 2.4 0.9 0.7 3.4 0.5 0.6 9.7 3.7 5.7 0.5 0.6 2.4 7.3 17.4 0.9 0.5 0.5 1.3 0.7 7.4 0.6 1.7 5.1 0.6 0.6 0.5 1.0 1.0 1.3 9.5 1.8 1.1 1.1 7.7 0.0 0.6 0.0 2.3 0.7 0.2 0.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 27.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.0 0.0 3.7 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 6.8 8.7 3.0 8.2 9.7 3.7 7.3 17.4 7.4 7.7 0.0 0.0 0.0 0.0 0.2 30.9 2.2 0.0 0.0 0.0 1.8 111.9 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 2.3 0.0 1.1 0.0 0.2 3.2 2.9 0.0 0.0 6.2 1.7 0.0 0.0 0.0 2.8 4.9 0.0 0.0 0.0 0.0 97.1 0.0 0.4 0.1 0.1 0.5 0.2 0.0 3.1 0.1 CRB3 MGC17303 ENSG00000130545 "Crumbs 3, cell polarity complex component" Q9BUF7 19 6463777-6467221 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Pancreatic endocrine cells: 118.0;Suprabasal keratinocytes: 122.0;Urothelial cells: 233.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.3" "Group enriched" "Detected in many" 17 "B-cells: 3.8;T-cells: 11.3" "Cell line enhanced" "Detected in some" "A-431: 26.3;BEWO: 16.9;CACO-2: 17.7;HaCaT: 17.3;hTCEpi: 13.3;OE19: 15.2;SK-BR-3: 14.0;T-47d: 12.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA013835 Enhanced Supported "Cell Junctions" NA NA "Cell Junctions" "HPA013835: AB_1847214" "unprognostic (3.25e-1)" "unprognostic (4.41e-2)" "unprognostic (9.69e-2)" "prognostic favorable (4.54e-4)" "unprognostic (1.24e-1)" "unprognostic (1.95e-2)" "unprognostic (2.81e-1)" "unprognostic (1.03e-2)" "unprognostic (1.86e-1)" "unprognostic (2.57e-2)" "unprognostic (4.98e-2)" "unprognostic (1.11e-1)" "prognostic favorable (0.00e+0)" "unprognostic (8.42e-3)" "unprognostic (1.96e-1)" "unprognostic (1.12e-2)" "prognostic favorable (8.06e-5)" 0.4 0.1 0.4 5.9 0.5 0.0 2.6 0.4 0.4 4.1 24.4 0.6 20.7 19.8 2.2 12.6 24.2 4.3 14.8 0.4 0.5 0.1 24.8 28.5 11.7 1.4 0.4 0.5 1.4 37.2 7.0 7.7 6.5 1.8 5.0 5.5 4.1 19.3 16.9 0.4 18.3 33.6 0.9 0.4 0.6 16.1 1.6 0.4 0.8 19.4 7.7 10.6 5.2 7.0 3.8 0.0 0.4 0.0 0.0 11.3 2.7 26.3 3.3 0.0 0.1 0.0 0.0 16.9 0.0 0.0 0.0 0.0 17.7 11.2 0.1 10.6 0.0 0.1 17.3 0.2 5.8 0.0 0.0 0.2 0.0 0.1 9.7 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 6.9 0.0 0.2 0.6 15.2 0.0 0.0 0.0 0.3 7.9 11.2 0.0 0.0 0.1 14.0 0.0 0.8 12.2 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 1.7 3.8 5.6 2.6 0.0 1.3 11.3 4.5 0.4 0.0 0.0 0.0 3.6 2.7 0.4 0.5 0.4 0.4 0.5 0.1 0.4 0.5 1.8 0.4 32.8 29.4 0.8 51.0 64.1 0.0 0.3 58.6 14.7 23.9 29.6 0.0 23.3 39.7 102.1 0.0 0.5 81.0 0.0 88.0 9.0 3.1 85.4 1.1 29.8 2.1 0.0 16.1 0.6 0.6 0.0 0.0 4.1 6.8 4.6 35.2 1.1 118.0 63.1 0.0 33.6 0.6 0.0 2.3 0.7 0.2 122.0 47.0 2.9 39.7 233.8 CREG1 CREG ENSG00000143162 "Cellular repressor of E1A stimulated genes 1" O75629 1 167529677-167553767 "Predicted secreted proteins" "Growth regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Hofbauer cells: 442.0;Kupffer cells: 417.0;monocytes: 450.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 15.1;classical monocyte: 36.8;eosinophil: 21.7;intermediate monocyte: 21.5;myeloid DC: 26.9;neutrophil: 13.0;non-classical monocyte: 19.9" "Group enriched" "Detected in all" 5 "dendritic cells: 26.9;granulocytes: 21.7;monocytes: 36.8" "Cell line enhanced" "Detected in all" "RPMI-8226: 158.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056390 Approved Vesicles,Microtubules "Secreted to blood" NA NA 550000 Microtubules Vesicles "HPA056390: AB_2683113" "unprognostic (3.25e-1)" "unprognostic (2.00e-1)" "unprognostic (1.91e-1)" "unprognostic (9.65e-3)" "unprognostic (4.64e-2)" "unprognostic (2.35e-2)" "unprognostic (1.55e-1)" "unprognostic (5.02e-2)" "unprognostic (2.07e-3)" "unprognostic (8.54e-2)" "unprognostic (8.65e-2)" "unprognostic (1.21e-1)" "unprognostic (8.24e-3)" "unprognostic (2.99e-1)" "unprognostic (4.63e-2)" "unprognostic (3.78e-3)" "unprognostic (3.16e-1)" 50.9 52.6 15.7 21.0 17.9 29.6 56.7 11.8 15.0 23.0 32.8 21.7 21.3 16.5 22.0 46.8 41.9 25.0 40.8 48.9 15.5 13.6 39.8 81.3 68.5 83.8 16.4 9.6 43.3 41.6 19.1 36.2 46.8 14.7 41.4 23.7 28.7 39.0 22.6 33.0 37.1 30.4 40.9 21.0 98.2 22.7 27.6 15.1 12.6 53.1 32.7 23.7 50.8 40.9 1.3 26.9 21.7 36.8 3.3 5.3 13.9 12.0 5.4 2.8 5.8 44.8 12.5 7.2 5.2 2.3 4.1 5.4 8.8 13.9 13.3 15.2 5.7 7.7 19.1 3.2 11.2 2.8 18.0 11.0 5.4 4.5 4.9 15.4 12.0 40.1 13.0 33.8 4.8 5.3 5.8 1.3 4.7 27.9 54.6 5.7 5.0 2.4 12.4 3.0 27.8 8.5 4.2 7.9 158.5 7.4 8.5 1.9 3.5 13.0 17.8 14.4 9.9 23.6 32.9 2.5 1.1 5.4 17.0 3.3 10.7 21.3 8.7 18.0 12.5 2.1 15.1 36.8 21.7 1.6 21.5 2.5 1.3 2.4 2.0 26.9 0.6 5.3 2.6 13.0 3.3 19.9 1.8 1.1 13.9 15.7 17.9 11.8 15.0 15.5 13.6 16.4 9.6 14.7 15.1 32.8 78.6 17.9 43.5 39.2 16.0 45.9 63.7 22.7 31.8 52.4 84.4 79.1 19.9 26.7 18.6 34.9 20.0 116.8 34.5 36.0 45.2 30.0 29.9 79.5 442.0 14.3 28.2 43.0 417.0 20.2 40.3 100.2 23.6 450.0 40.4 25.3 26.6 24.6 26.9 45.2 30.1 12.9 41.5 32.9 43.2 44.7 106.0 14.6 47.5 37.3 CRELD1 AVSD2 ENSG00000163703 "Cysteine rich with EGF like domains 1" Q96HD1 3 9933822-9945413 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026964 Uncertain Approved Nucleoli,Cytosol "Intracellular and membrane" NA NA 16000000 Cytosol Nucleoli "HPA026964: AB_10602210" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (2.69e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.07e-4)" "unprognostic (3.03e-1)" "unprognostic (3.59e-1)" "unprognostic (2.85e-2)" "unprognostic (1.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.92e-2)" "unprognostic (4.59e-2)" "unprognostic (1.14e-2)" "unprognostic (6.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.89e-1)" "unprognostic (3.78e-2)" 21.8 22.9 31.6 15.3 32.4 7.3 27.3 52.2 45.1 9.9 22.4 12.0 17.1 12.5 15.1 17.8 13.1 20.1 15.8 50.2 25.6 24.9 16.6 23.5 15.8 11.0 17.2 30.7 19.7 15.2 21.9 32.4 15.1 27.2 25.4 11.4 10.0 19.4 32.2 24.4 11.6 13.1 19.5 19.4 11.9 14.8 11.1 22.3 5.9 45.7 7.4 8.2 17.8 15.6 10.5 13.7 11.5 12.5 13.4 14.3 10.4 2.8 5.2 8.5 4.4 14.4 9.4 47.1 10.4 3.1 2.6 4.9 5.0 8.5 3.4 22.9 7.2 12.1 1.8 4.1 7.5 1.8 6.7 3.9 3.1 6.7 11.8 28.8 1.1 12.0 9.6 13.9 6.4 5.9 31.4 11.8 5.2 3.7 4.1 2.5 6.8 2.0 8.4 2.3 11.6 3.5 2.1 1.2 8.1 11.0 4.9 3.4 11.0 4.8 4.5 9.3 11.7 11.5 6.8 8.2 5.0 8.1 6.6 2.5 4.7 6.0 6.3 11.1 3.5 5.3 11.5 11.4 9.4 14.2 11.6 14.3 8.9 10.5 13.7 8.2 10.5 14.2 12.7 1.8 13.4 12.5 13.7 8.0 10.4 31.6 32.4 52.2 45.1 25.6 24.9 17.2 30.7 27.2 22.3 17.9 13.7 10.7 19.5 8.7 20.8 34.7 33.1 8.1 7.9 15.7 15.7 20.0 6.6 17.7 5.8 15.0 14.7 0.0 3.9 9.2 21.7 31.7 20.7 11.5 18.5 30.2 25.9 16.0 7.8 7.9 29.7 10.2 11.8 19.0 14.9 21.0 8.8 15.0 24.8 8.2 15.0 25.8 14.1 49.7 11.9 10.8 18.5 12.1 14.1 16.3 CRHR1 "CRF-R, CRF1, CRHR" ENSG00000120088 "Corticotropin releasing hormone receptor 1" P34998 17 45784280-45835828 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 23.2;pituitary gland: 16.5" "Group enriched" "Detected in some" 13 "Early spermatids: 37.9;Late spermatids: 37.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RT4: 8.1;SH-SY5Y: 5.0" CAB025251 Enhanced "Intracellular and membrane" NA NA "CAB025251: " "unprognostic (4.59e-2)" "unprognostic (1.43e-2)" "unprognostic (2.59e-7)" "unprognostic (1.76e-1)" "unprognostic (2.71e-1)" "unprognostic (3.94e-2)" "unprognostic (2.48e-1)" "unprognostic (4.55e-4)" "unprognostic (1.65e-2)" "unprognostic (2.21e-1)" "unprognostic (3.33e-4)" "unprognostic (2.07e-5)" "unprognostic (3.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" 0.8 0.6 14.7 0.5 5.1 0.5 1.5 23.2 11.5 1.4 0.6 1.1 0.0 0.8 2.7 1.1 0.5 1.6 0.7 0.5 3.2 2.2 0.6 0.5 0.6 0.5 1.8 5.2 0.6 0.5 0.6 16.5 0.6 2.9 1.3 0.6 1.9 1.2 2.5 0.6 1.4 1.0 1.2 1.0 0.5 0.5 1.0 2.8 0.0 0.9 0.0 0.5 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.6 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 5.1 23.2 11.5 3.2 2.2 1.8 5.2 2.9 2.8 0.0 0.0 0.0 1.1 1.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.3 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.5 0.0 0.1 2.3 1.5 2.9 0.0 0.0 0.0 0.5 CRHR2 "CRF-RB, CRF2, HM-CRF" ENSG00000106113 "Corticotropin releasing hormone receptor 2" Q13324 7 30651943-30700129 "G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Cell type enriched" "Detected in single" 13 "Horizontal cells: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;HeLa: 1.8;NTERA-2: 3.0;SCLC-21H: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (7.14e-2)" "unprognostic (4.20e-1)" "unprognostic (1.68e-1)" "unprognostic (1.24e-3)" "unprognostic (5.69e-2)" "unprognostic (8.58e-2)" "unprognostic (6.00e-2)" "unprognostic (1.86e-4)" "unprognostic (2.01e-1)" "unprognostic (3.07e-1)" "unprognostic (5.90e-4)" "unprognostic (4.02e-2)" "unprognostic (8.29e-4)" "unprognostic (3.73e-3)" "unprognostic (2.84e-3)" "unprognostic (1.81e-1)" "unprognostic (3.84e-1)" 1.4 0.7 0.9 0.5 4.1 0.4 1.6 0.5 11.7 0.8 0.6 0.0 3.6 2.1 1.1 0.5 1.7 2.1 1.0 3.2 4.3 3.2 0.8 0.4 0.6 0.6 0.9 3.2 1.0 3.9 0.9 8.0 0.4 3.1 0.9 0.9 1.7 0.7 6.2 5.5 0.8 1.2 1.1 0.8 0.3 1.0 1.8 1.0 0.0 1.7 3.2 0.6 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 1.3 0.0 1.8 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.2 0.2 3.0 0.0 0.4 0.0 0.0 0.6 0.0 0.9 1.7 0.1 0.2 0.0 0.2 0.6 0.1 0.0 0.5 0.4 1.0 0.3 0.2 0.8 0.3 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.1 0.5 11.7 4.3 3.2 0.9 3.2 3.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CRIM1 S52 ENSG00000150938 "Cysteine rich transmembrane BMP regulator 1" Q9NZV1 2 36355926-36551135 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 116.2" "Cell type enhanced" "Detected in many" 5 "Ito cells: 170.0;Syncytiotrophoblasts: 145.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 68.0;fHDF/TERT166: 67.0;TIME: 94.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000556 Enhanced "Intracellular and membrane" NA NA 120000 "HPA000556: AB_1078567" "unprognostic (2.15e-1)" "unprognostic (5.41e-2)" "unprognostic (6.39e-2)" "unprognostic (3.17e-3)" "unprognostic (3.88e-2)" "unprognostic (3.44e-2)" "unprognostic (1.88e-1)" "unprognostic (6.25e-2)" "unprognostic (2.32e-1)" "unprognostic (4.11e-3)" "unprognostic (8.19e-2)" "unprognostic (1.26e-1)" "prognostic favorable (9.51e-4)" "unprognostic (1.98e-2)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (6.67e-2)" 42.4 6.0 9.1 8.7 11.0 1.1 44.6 6.1 9.0 13.8 13.1 6.4 10.2 5.7 14.9 9.8 12.4 14.2 17.3 32.2 8.6 8.7 28.6 6.2 24.7 13.2 7.6 10.2 15.5 9.2 18.0 4.3 116.2 12.0 14.9 9.4 24.7 13.1 13.8 25.9 13.7 9.0 23.1 10.8 17.5 10.2 8.1 6.2 3.0 18.1 7.9 4.5 16.9 22.3 0.8 5.5 3.4 1.4 1.1 1.6 0.2 14.2 10.9 2.2 2.5 10.5 12.0 18.6 68.0 36.1 38.1 20.1 13.7 4.9 0.0 44.4 67.0 24.8 6.2 1.6 11.0 31.3 0.1 1.2 0.4 14.6 7.9 34.0 0.3 0.1 16.8 8.2 15.2 27.5 35.9 53.3 0.2 0.6 0.1 40.0 1.3 0.0 0.1 1.7 0.7 3.2 0.7 2.9 2.2 24.0 5.9 0.2 0.0 11.8 3.9 0.5 8.8 10.6 0.2 94.6 48.2 17.4 5.9 32.8 3.7 0.0 0.1 14.2 0.0 14.8 3.4 0.4 1.2 1.6 0.2 1.2 0.6 0.7 0.9 0.3 0.8 0.2 1.0 0.5 1.1 1.4 5.5 0.5 0.2 9.1 11.0 6.1 9.0 8.6 8.7 7.6 10.2 12.0 6.2 11.9 46.6 5.2 34.8 58.6 7.1 35.8 48.4 26.8 35.2 125.6 2.0 107.1 3.3 29.4 0.9 118.8 18.6 0.0 2.2 34.1 49.4 51.6 1.1 0.9 22.4 0.0 30.5 170.0 6.5 1.3 17.5 10.5 37.1 10.8 41.0 15.6 17.1 31.7 18.7 36.6 37.9 45.3 115.4 2.1 8.7 26.3 145.1 13.8 31.6 40.7 CRISP3 "Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28" ENSG00000096006 "Cysteine rich secretory protein 3" P54108 6 49727384-49744437 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 156.3;fallopian tube: 117.6;salivary gland: 233.3" "Group enriched" "Detected in some" 8 "Cholangiocytes: 38.2;Club cells: 23.9;Melanocytes: 21.9" "Group enriched" "Detected in many" 7 "breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 45 "neutrophil: 6.0;non-classical monocyte: 2.9" "Group enriched" "Detected in many" 45 "granulocytes: 6.0;monocytes: 2.9" "Group enriched" "Detected in some" 20 "HEL: 14.5;RT4: 4.9;SK-BR-3: 11.0;T-47d: 5.4" "Not detected" "Not detected" HPA054392 Supported "Secreted in other tissues" NA NA 390000000 "HPA054392: AB_2682472" "unprognostic (1.28e-2)" "unprognostic (7.01e-2)" "unprognostic (8.93e-2)" "unprognostic (5.56e-2)" "unprognostic (1.02e-1)" "unprognostic (2.22e-4)" "unprognostic (5.30e-2)" "unprognostic (6.70e-2)" "unprognostic (9.16e-2)" "unprognostic (4.34e-3)" "unprognostic (1.91e-1)" "unprognostic (1.93e-1)" 0.2 0.2 0.2 0.0 0.2 33.5 0.2 0.2 0.2 11.1 0.2 0.0 156.3 0.0 0.7 0.0 45.3 117.6 2.0 0.2 0.2 0.2 0.2 0.2 0.6 0.0 0.2 0.0 15.9 1.7 0.0 0.2 0.0 0.0 3.0 0.0 0.0 233.3 17.7 0.2 0.6 0.2 0.0 0.2 0.4 0.2 0.2 0.0 0.0 0.2 56.7 14.8 1.2 14.4 0.0 0.0 6.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 11.0 0.0 0.0 5.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 2.9 0.0 0.0 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 38.2 2.7 23.9 3.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.4 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 CRISPLD2 "DKFZP434B044, LCRISP2, LGL1" ENSG00000103196 "Cysteine rich secretory protein LCCL domain containing 2" Q9H0B8 16 84819984-84920768 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 19 "Leydig cells: 251.5;Peritubular cells: 250.0;Smooth muscle cells: 678.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 36.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 36.0" "Cell line enhanced" "Detected in many" "ASC diff: 15.3;BEWO: 23.8;HHSteC: 56.8;HSkMC: 23.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA030054, HPA030055" Approved Approved Nucleoplasm,Nucleoli "Secreted to blood" No No 219000000000 "Nucleoplasm, Nucleoli" "HPA030054: AB_2732452, HPA030055: AB_10611821" "unprognostic (8.91e-3)" "unprognostic (3.05e-1)" "unprognostic (2.63e-2)" "unprognostic (2.02e-2)" "unprognostic (7.12e-2)" "unprognostic (2.30e-1)" "unprognostic (2.11e-2)" "unprognostic (5.58e-3)" "unprognostic (1.48e-1)" "unprognostic (5.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (1.97e-6)" "unprognostic (7.35e-3)" "unprognostic (3.38e-2)" "unprognostic (2.99e-3)" "unprognostic (5.15e-3)" 29.2 11.6 2.2 41.1 5.0 3.0 57.2 2.1 3.6 44.1 26.0 2.5 10.6 4.2 38.5 58.7 21.1 43.6 107.4 19.1 2.1 2.0 10.1 6.7 31.0 21.4 5.5 1.6 37.1 9.1 1.0 6.4 50.2 7.1 31.6 7.3 21.9 6.8 23.6 15.9 12.0 17.5 48.0 8.6 10.0 22.5 16.8 3.1 0.4 15.9 11.4 3.3 40.3 32.7 0.0 0.5 36.0 7.9 0.0 0.1 1.3 0.3 0.7 0.2 2.0 15.3 5.7 23.8 11.6 10.3 9.3 6.6 1.5 0.9 0.0 1.0 10.1 2.7 0.3 0.0 0.0 9.4 0.0 0.0 0.1 0.2 0.0 56.8 0.0 0.1 23.8 0.0 2.7 0.0 3.1 0.0 0.0 0.1 0.1 1.0 0.4 0.1 0.5 0.6 1.5 0.6 0.0 0.1 0.1 0.1 1.8 2.3 0.1 2.7 1.2 0.2 3.4 4.7 0.3 1.3 0.1 0.6 9.7 0.3 0.1 0.0 1.9 0.0 0.2 1.4 4.4 7.9 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 1.3 2.2 5.0 2.1 3.6 2.1 2.0 5.5 1.6 7.1 3.1 3.0 2.9 0.8 7.9 41.0 0.6 7.6 0.0 1.4 2.3 0.0 0.0 6.0 0.0 1.1 10.8 12.0 0.4 0.0 0.4 24.6 126.1 19.2 6.9 0.0 4.4 1.6 2.9 60.2 40.4 10.7 251.5 12.2 45.5 0.0 4.2 5.0 0.8 0.0 250.0 0.0 0.5 90.5 678.7 0.9 0.9 37.4 7.6 4.8 1.3 5.2 CRLF2 "CRL2, TSLPR" ENSG00000205755 "Cytokine receptor like factor 2" Q9HC73 X 1187549-1212750 "Cancer-related genes, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 7.8" "Cell type enriched" "Detected in some" 9 "monocytes: 174.9" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 43 "plasmacytoid DC: 4.3" "Lineage enriched" "Detected in single" 43 "dendritic cells: 4.3" "Cell line enhanced" "Detected in some" "GAMG: 2.4;HMC-1: 18.5;RPMI-8226: 4.7;U-698: 4.0" "Intracellular and membrane" NA NA "unprognostic (7.84e-2)" "unprognostic (7.99e-4)" "unprognostic (6.02e-3)" "unprognostic (2.01e-2)" "unprognostic (1.15e-3)" "unprognostic (2.31e-6)" "unprognostic (1.72e-1)" "unprognostic (5.10e-2)" "unprognostic (4.59e-3)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (9.72e-3)" "unprognostic (6.88e-5)" "unprognostic (7.09e-3)" "unprognostic (4.81e-2)" "unprognostic (2.89e-2)" "unprognostic (1.62e-1)" 0.8 0.0 0.2 4.1 0.2 4.1 0.6 0.2 0.2 3.0 0.7 0.2 0.2 0.2 7.8 0.2 0.9 0.2 3.7 0.2 0.2 0.1 0.9 0.2 1.9 0.2 0.2 0.2 0.2 0.2 0.0 0.2 1.0 0.2 0.6 0.9 0.2 0.8 0.2 0.2 0.7 1.5 0.3 0.2 0.6 1.0 0.2 0.2 0.2 0.2 0.2 1.4 1.3 0.6 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.6 1.0 0.2 0.3 2.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.5 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.7 1.0 4.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 3.0 3.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 174.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRLS1 "C20orf155, CLS1, dJ967N21.6, GCD10" ENSG00000088766 "Cardiolipin synthase 1" Q9UJA2 20 6006090-6040053 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 84.2" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 167.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 72.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.48e-1)" "unprognostic (2.97e-1)" "unprognostic (2.88e-1)" "unprognostic (8.56e-2)" "unprognostic (9.64e-3)" "unprognostic (1.89e-1)" "unprognostic (1.41e-2)" "unprognostic (2.65e-2)" "unprognostic (1.42e-1)" "unprognostic (2.00e-1)" "unprognostic (9.89e-3)" "unprognostic (2.78e-2)" "unprognostic (1.52e-2)" "unprognostic (1.83e-2)" "unprognostic (1.85e-1)" "unprognostic (9.54e-2)" "prognostic favorable (8.02e-4)" 23.0 30.4 9.1 13.2 9.2 9.9 15.0 6.8 9.9 11.5 30.4 8.2 18.5 24.0 11.6 10.8 11.7 10.5 17.2 84.2 7.9 7.5 32.9 67.4 16.4 8.3 7.9 7.7 12.6 27.0 10.2 10.1 13.3 9.5 14.4 14.8 9.1 18.3 13.4 48.5 7.2 33.1 10.5 6.8 11.0 19.3 12.3 7.1 13.1 17.2 23.7 9.6 11.7 8.6 4.9 3.7 1.1 2.4 3.6 5.2 1.1 19.7 14.9 9.6 12.3 26.7 24.3 10.3 12.5 16.2 12.9 15.4 19.7 13.6 21.5 9.1 16.1 22.4 12.9 18.3 22.5 19.4 6.1 10.8 29.4 6.0 72.0 18.1 28.0 9.7 14.2 18.0 13.5 23.0 12.0 17.3 12.4 20.5 9.8 14.4 7.9 18.5 24.9 16.8 45.6 11.7 12.2 14.0 22.9 19.3 7.7 15.5 13.2 12.6 31.9 21.3 10.6 10.8 17.9 11.1 14.1 9.9 14.3 16.7 9.7 21.2 22.3 5.7 23.7 13.0 0.0 2.4 1.1 2.6 2.0 5.2 4.9 1.7 2.2 2.6 1.9 3.6 1.9 0.1 3.6 1.0 3.7 1.5 1.1 9.1 9.2 6.8 9.9 7.9 7.5 7.9 7.7 9.5 7.1 20.8 47.1 26.8 35.6 30.0 10.8 90.4 68.8 2.7 11.4 34.9 3.9 40.1 54.7 25.2 142.9 23.9 44.6 0.0 24.8 50.7 32.7 86.4 14.9 167.1 31.2 11.1 27.4 25.2 33.0 73.4 28.1 27.8 25.3 10.8 46.4 39.8 24.6 45.6 23.0 104.4 12.9 12.9 24.5 18.2 18.6 24.3 30.3 22.3 71.8 34.1 CRTAM CD355 ENSG00000109943 "Cytotoxic and regulatory T cell molecule" O95727 11 122838500-122872639 "CD markers, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 140.8" "Cell type enhanced" "Detected in some" 25 "Hofbauer cells: 6.2;Kupffer cells: 9.1;Macrophages: 7.2;T-cells: 34.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 24 "cerebellum: 140.8" "Cell type enhanced" "Detected in many" "NK-cell: 25.7" "Group enriched" "Detected in many" 5 "NK-cells: 25.7;T-cells: 16.7" "Cell line enriched" "Detected in single" 34 "SCLC-21H: 17.4" "Region enriched" "Detected in single" 44 "cerebellum: 115.2" "Low region specificity" "Detected in all" NA NA 3200000 "unprognostic (3.51e-3)" "unprognostic (6.73e-4)" "unprognostic (1.33e-2)" "unprognostic (3.73e-3)" "unprognostic (2.40e-2)" "unprognostic (5.25e-4)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (5.27e-2)" "unprognostic (1.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.32e-1)" "unprognostic (1.83e-4)" "unprognostic (6.01e-2)" "unprognostic (4.26e-2)" "unprognostic (3.87e-2)" "unprognostic (6.59e-2)" 0.4 0.3 0.3 2.7 0.4 1.9 0.4 140.8 0.4 0.3 0.4 0.2 0.1 0.4 0.8 0.4 0.3 0.3 1.8 0.3 0.3 0.3 0.3 1.0 2.2 10.6 0.4 0.1 0.3 0.3 0.0 0.3 0.2 5.8 0.3 0.5 0.3 0.7 0.1 0.3 0.3 1.3 0.2 1.2 4.4 0.7 0.3 0.1 3.3 0.3 0.2 4.3 1.1 0.3 0.1 1.7 0.6 4.4 25.7 16.7 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.2 0.2 6.7 2.7 6.5 0.0 0.7 13.5 1.7 0.1 2.2 16.7 0.6 25.7 4.4 0.1 0.0 2.8 0.3 0.4 140.8 0.4 0.3 0.3 0.4 0.1 5.8 0.1 0.0 1.4 0.0 0.4 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.3 1.1 0.0 6.2 0.0 0.0 0.6 9.1 0.6 0.0 7.2 3.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.6 0.1 34.1 0.0 0.3 CRTAP "CASP, LEPREL3, P3H5" ENSG00000170275 "Cartilage associated protein" O75718 3 33113979-33147773 "Disease related genes, Predicted secreted proteins" "Disease mutation, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 172.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 67.8" "Group enriched" "Detected in all" 5 "dendritic cells: 55.8;monocytes: 67.8" "Cell line enhanced" "Detected in many" "ASC diff: 122.6;ASC TERT1: 80.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043598, HPA044150" Approved Approved "Intermediate filaments,Actin filaments,Cytosol" "Secreted to blood" NA NA "Intermediate filaments, Actin filaments, Cytosol" "HPA043598: AB_10960991, HPA044150: AB_10959594" "unprognostic (5.29e-2)" "unprognostic (2.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.85e-3)" "unprognostic (7.36e-2)" "unprognostic (4.73e-3)" "unprognostic (4.28e-2)" "unprognostic (1.87e-1)" "unprognostic (9.97e-2)" "unprognostic (4.62e-2)" "unprognostic (3.70e-1)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-1)" "unprognostic (9.93e-2)" "unprognostic (1.28e-3)" 59.2 33.4 16.3 13.4 22.2 13.6 63.2 5.4 14.1 57.5 39.4 23.3 32.7 12.8 54.2 41.1 42.8 35.1 43.5 37.0 16.8 13.1 25.7 16.8 35.9 37.8 24.2 13.0 48.5 13.3 14.6 7.6 25.4 13.8 54.5 19.7 35.4 16.4 42.2 23.9 24.6 18.8 66.1 22.8 17.6 25.2 26.1 19.0 5.1 34.1 25.8 18.3 62.4 59.7 7.6 55.8 5.5 67.8 6.9 12.9 30.8 9.1 18.1 5.7 17.8 122.6 80.3 33.0 20.0 43.7 24.3 23.2 6.1 5.2 6.4 22.4 38.0 19.6 11.8 10.1 15.3 17.6 15.8 15.7 10.0 14.2 6.3 36.7 6.4 8.2 64.0 31.4 21.9 27.9 47.3 25.5 4.0 8.5 12.3 24.5 7.8 2.3 6.6 6.8 9.8 24.7 8.5 16.7 12.3 19.0 6.1 1.2 9.2 13.5 11.9 28.8 13.8 12.8 15.9 16.6 31.9 13.6 17.3 21.1 8.9 30.1 0.9 25.0 13.0 17.4 2.1 67.8 4.9 6.9 26.3 10.0 7.6 10.1 7.7 55.8 6.8 5.8 5.4 5.5 6.9 7.8 15.0 12.9 30.8 16.3 22.2 5.4 14.1 16.8 13.1 24.2 13.0 13.8 19.0 8.9 42.6 18.6 27.6 53.7 18.7 29.5 25.5 4.0 19.4 36.6 7.9 42.5 10.0 19.9 1.0 55.3 18.1 0.0 27.7 59.7 94.1 20.8 46.2 44.4 93.2 33.4 5.8 103.2 172.9 2.2 132.3 73.7 75.9 27.9 22.6 17.7 20.2 10.5 136.2 43.7 10.5 109.9 117.1 1.4 7.9 40.8 23.5 20.8 33.1 22.1 CRY2 ENSG00000121671 "Cryptochrome circadian regulator 2" Q49AN0 11 45847118-45883248 "Predicted intracellular proteins" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation" "Photoreceptor protein, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 128.4;Horizontal cells: 95.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037577 Supported Supported "Nuclear speckles,Cytosol" "Intracellular and membrane" NA NA "Nuclear speckles" Cytosol "HPA037577: AB_10672497" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "prognostic unfavorable (1.67e-4)" "unprognostic (1.31e-2)" "unprognostic (9.16e-2)" "unprognostic (3.09e-2)" "prognostic favorable (6.82e-5)" "unprognostic (1.48e-3)" "unprognostic (1.67e-1)" "unprognostic (5.07e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.01e-1)" "prognostic favorable (6.44e-15)" "unprognostic (8.13e-3)" "unprognostic (1.89e-1)" "unprognostic (4.24e-2)" "unprognostic (2.24e-1)" 17.4 13.3 18.2 8.8 27.4 17.2 16.7 29.8 36.5 17.7 12.1 15.4 10.5 7.6 16.2 12.4 11.2 20.8 18.7 39.5 15.6 13.1 15.7 27.8 15.7 6.7 12.7 15.0 26.3 23.4 20.6 16.4 9.3 11.5 15.0 7.3 35.5 14.4 17.1 58.2 24.3 8.5 18.7 10.4 9.2 12.2 17.4 9.6 5.9 23.6 22.4 10.3 17.4 10.6 7.8 5.2 7.6 10.6 10.4 10.4 7.1 1.2 3.6 5.6 6.6 15.2 7.7 12.2 4.3 7.8 5.5 4.1 5.8 2.9 8.3 3.4 9.0 5.3 7.4 5.3 4.5 3.8 8.8 4.8 5.5 6.3 8.0 5.8 6.7 7.5 9.0 6.7 4.2 6.8 6.3 3.8 6.5 10.6 14.3 4.9 4.5 5.7 8.0 15.1 15.2 4.3 9.7 8.0 3.9 4.0 6.8 9.0 3.4 7.2 6.6 3.7 7.4 8.8 4.7 4.8 7.8 4.8 11.9 3.0 13.3 9.1 6.9 4.8 2.9 4.7 5.7 5.0 7.6 8.7 7.1 7.2 7.8 8.4 9.3 5.2 7.7 10.3 10.4 2.6 10.4 10.6 3.8 6.9 7.1 18.2 27.4 29.8 36.5 15.6 13.1 12.7 15.0 11.5 9.6 11.9 15.6 3.2 9.8 15.0 128.4 29.0 12.7 14.7 13.6 7.0 25.5 6.2 24.9 3.9 19.1 8.3 11.3 0.0 4.0 4.6 16.6 11.6 14.9 37.0 3.3 95.3 6.8 9.2 9.4 7.2 29.1 7.2 15.1 2.8 5.4 32.7 4.7 6.5 37.4 10.5 25.6 19.4 17.6 21.0 12.7 15.3 7.8 4.5 4.5 9.5 CS ENSG00000062485 "Citrate synthase" O75390 12 56271699-56300392 "Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tricarboxylic acid cycle" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 125.9" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 207.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754" Enhanced Enhanced Mitochondria NA NA 4400000 Mitochondria "CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: AB_2665758, CAB075753: AB_2665759, CAB075754: AB_2665760, HPA038460: AB_2676023, HPA038461: AB_2676024" "unprognostic (7.67e-3)" "unprognostic (3.80e-1)" "unprognostic (2.59e-2)" "unprognostic (2.50e-2)" "unprognostic (2.70e-2)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (3.34e-2)" "unprognostic (2.43e-1)" "unprognostic (5.58e-2)" "unprognostic (2.56e-1)" "unprognostic (1.97e-2)" "prognostic favorable (1.17e-4)" "unprognostic (1.20e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-2)" "unprognostic (2.02e-1)" 37.1 35.5 11.9 16.3 20.4 19.3 55.6 28.5 43.8 17.2 27.4 14.1 11.3 25.3 19.9 10.8 31.7 16.5 14.0 79.2 11.2 14.5 26.7 12.3 17.3 30.8 12.3 14.2 16.9 20.7 28.1 14.3 11.9 24.8 16.2 32.7 19.8 23.1 17.5 125.9 22.8 27.0 21.2 15.0 18.4 21.4 7.9 11.1 20.7 17.9 48.2 26.1 22.9 19.1 19.5 37.1 59.6 27.8 15.9 19.7 18.2 35.8 38.8 31.7 41.1 42.1 39.2 20.6 29.9 29.4 52.7 36.8 54.7 35.2 70.1 29.4 37.7 22.6 38.9 87.5 45.0 50.4 24.3 44.5 48.1 28.2 39.4 23.6 58.8 34.6 43.1 43.0 41.3 50.1 43.4 59.1 36.6 49.8 42.1 45.9 28.8 48.7 18.1 25.2 27.2 56.1 47.5 37.2 52.9 32.6 36.4 41.6 27.3 38.7 46.1 30.3 30.8 64.1 34.3 39.2 26.6 37.3 37.5 31.5 27.8 42.3 45.6 24.5 43.4 24.9 14.5 22.0 59.6 15.2 27.8 19.7 19.5 18.3 14.3 37.1 16.7 19.4 15.4 9.8 15.9 27.0 20.5 19.3 18.2 11.9 20.4 28.5 43.8 11.2 14.5 12.3 14.2 24.8 11.1 14.9 33.2 16.0 18.6 34.7 21.7 207.5 22.9 10.7 19.4 12.2 58.9 15.6 29.9 31.3 5.1 27.0 51.5 0.0 38.6 26.0 18.2 26.3 27.6 26.2 31.0 9.5 16.3 17.2 29.2 3.6 18.7 33.5 10.1 27.1 43.6 15.1 37.2 23.0 18.7 17.3 36.0 12.9 25.9 18.4 24.7 45.7 14.1 18.1 64.8 26.5 CSF1 "M-CSF, MCSF, MGC31930" ENSG00000184371 "Colony stimulating factor 1" P09603 1 109910242-109930992 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 47.6;granulocytes: 111.9;Ito cells: 54.0;Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 7.0;eosinophil: 16.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 16.5" "Cell line enhanced" "Detected in many" "ASC diff: 46.5;ASC TERT1: 29.2;BJ hTERT+: 30.6;GAMG: 29.0;HHSteC: 70.7;HSkMC: 45.2;hTERT-RPE1: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA076624 Supported "Nuclear bodies,Plasma membrane" "Secreted to blood" NA NA 270000 17000000 "Plasma membrane" "Nuclear bodies" "HPA076624: AB_2686810" "unprognostic (2.35e-3)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-1)" "unprognostic (3.60e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (4.25e-5)" "unprognostic (1.04e-1)" "unprognostic (1.75e-2)" "unprognostic (2.18e-1)" "unprognostic (1.72e-1)" "unprognostic (5.10e-2)" "prognostic unfavorable (1.00e-11)" "unprognostic (2.03e-1)" "unprognostic (1.88e-2)" "unprognostic (4.01e-1)" "unprognostic (3.16e-2)" 38.1 21.4 11.5 14.6 16.7 10.1 36.5 4.3 14.6 13.8 12.8 28.2 3.6 8.5 12.0 10.1 11.3 15.7 20.6 16.0 11.4 5.8 10.7 10.3 23.5 16.9 24.3 5.4 16.9 11.3 6.7 5.2 26.0 19.2 16.3 11.0 12.2 12.4 11.6 12.7 10.4 12.7 16.0 21.9 25.8 11.9 7.5 20.3 2.9 12.4 7.8 11.0 20.6 29.2 0.0 0.0 16.5 0.0 0.0 1.0 0.1 1.5 5.7 2.9 1.1 46.5 29.2 1.0 6.6 30.6 5.3 4.9 0.2 0.8 0.0 8.4 16.3 29.0 1.2 1.2 2.2 2.0 18.5 0.9 2.0 3.3 1.9 70.7 0.0 2.6 45.2 0.6 11.6 7.0 32.5 1.0 0.5 0.4 1.1 6.3 0.1 0.0 0.3 0.9 0.4 0.5 0.2 1.5 0.1 2.1 1.5 0.1 0.3 1.9 0.5 2.3 3.7 0.4 0.2 3.5 5.5 1.9 24.4 3.7 0.5 0.2 0.0 14.0 0.0 20.6 7.0 0.0 16.5 0.2 0.0 0.5 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.1 11.5 16.7 4.3 14.6 11.4 5.8 24.3 5.4 19.2 20.3 8.9 47.6 2.4 5.4 6.5 0.2 2.4 22.9 0.0 5.7 3.5 0.0 0.5 0.0 23.8 0.3 19.0 0.6 0.0 2.0 0.4 28.2 4.8 111.9 2.5 9.2 0.0 7.5 54.0 3.5 0.0 23.3 11.7 10.1 2.8 0.8 1.9 8.1 0.9 8.1 1.1 0.1 58.2 25.9 0.6 0.6 4.8 0.7 8.5 0.6 1.8 CSF1R "C-FMS, CD115, CSFR, FMS" ENSG00000182578 "Colony stimulating factor 1 receptor" P07333 5 150053291-150113372 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.5;lymphoid tissue: 82.6" "Group enriched" "Detected in many" 8 "Extravillous trophoblasts: 97.9;Hofbauer cells: 277.3;Kupffer cells: 200.7;Macrophages: 125.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 60.7;non-classical monocyte: 82.5" "Lineage enriched" "Detected in many" 4 "monocytes: 82.5" "Group enriched" "Detected in some" 5 "BEWO: 51.8;SK-BR-3: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008970, HPA012323" Uncertain Supported "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1500000000 "Vesicles, Plasma membrane" "CAB008970: , HPA012323: AB_1848977" "unprognostic (3.82e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-3)" "unprognostic (9.83e-2)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (9.37e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (3.67e-2)" "prognostic unfavorable (4.92e-4)" "unprognostic (1.72e-2)" "unprognostic (4.61e-2)" 20.9 12.4 18.2 28.1 18.9 1.8 7.7 2.8 13.5 9.3 8.3 25.4 1.1 9.2 5.9 13.1 8.4 7.9 16.1 8.7 16.4 13.7 7.8 15.1 13.7 25.4 21.3 6.0 5.3 5.2 5.9 6.4 52.1 17.1 8.5 8.4 16.8 8.0 8.7 3.0 5.8 14.5 16.2 25.8 82.6 9.0 4.9 23.0 3.1 4.2 2.9 8.2 16.4 4.7 0.0 19.1 2.9 82.5 0.0 0.1 13.9 1.7 0.0 0.0 0.0 0.8 0.2 51.8 0.1 0.0 0.0 0.0 1.5 0.0 2.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.1 0.0 19.8 0.0 0.8 0.0 7.4 0.0 0.3 0.0 0.0 1.3 0.0 0.1 0.0 2.6 0.9 0.0 0.4 18.1 0.5 0.1 60.7 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 2.9 0.0 82.5 1.4 0.0 13.9 18.2 18.9 2.8 13.4 16.4 13.7 21.3 6.0 17.1 23.0 0.0 6.7 0.5 0.0 2.5 0.0 2.8 5.1 1.4 0.0 0.0 0.0 2.9 0.0 0.0 3.7 2.2 0.0 0.0 0.0 97.9 3.3 0.0 2.3 0.8 277.3 0.0 0.0 4.9 200.7 3.5 1.7 125.7 3.3 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.4 12.9 1.3 0.5 0.2 1.1 22.1 2.2 0.0 0.0 CSF2RA "alphaGMR, CD116, CSF2R" ENSG00000198223 "Colony stimulating factor 2 receptor alpha subunit" P15509 X 1268800-1310381 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 60.2;placenta: 79.5" "Cell type enhanced" "Detected in many" 26 "Cytotrophoblasts: 215.8;monocytes: 954.0;Syncytiotrophoblasts: 261.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 30.0;eosinophil: 36.0;intermediate monocyte: 17.7;myeloid DC: 31.9;neutrophil: 60.2;plasmacytoid DC: 30.5" "Group enriched" "Detected in many" 28 "dendritic cells: 31.9;granulocytes: 60.2;monocytes: 30.0" "Group enriched" "Detected in some" 7 "BEWO: 60.4;HMC-1: 18.2;SK-MEL-30: 42.3" CAB016148 Uncertain "Secreted to blood" NA NA 9400000 "CAB016148: AB_626868" "unprognostic (4.19e-2)" "prognostic favorable (2.38e-5)" "unprognostic (5.47e-2)" "unprognostic (4.33e-2)" "unprognostic (4.88e-2)" "prognostic favorable (2.81e-4)" "unprognostic (8.24e-2)" "unprognostic (2.17e-1)" "unprognostic (5.55e-2)" "unprognostic (8.48e-2)" "unprognostic (8.89e-2)" "unprognostic (3.80e-1)" "unprognostic (2.89e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (5.53e-4)" "unprognostic (3.60e-1)" "unprognostic (9.44e-2)" 8.7 2.3 11.8 11.1 11.1 8.9 17.7 3.4 9.6 3.1 2.2 0.6 0.6 2.2 4.4 0.6 2.1 2.2 5.7 3.7 15.0 4.7 2.4 1.7 11.2 8.3 18.8 6.5 3.5 1.0 0.2 2.1 79.5 13.2 1.5 3.3 0.6 3.1 1.0 0.6 1.8 3.3 2.9 25.5 12.6 1.7 0.6 16.3 0.6 2.5 0.6 10.4 4.2 1.5 0.3 31.9 60.2 30.0 1.4 0.2 10.1 0.1 3.5 0.2 0.0 0.0 0.0 60.4 0.0 0.1 0.1 0.0 1.2 0.3 0.0 3.9 0.0 3.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.4 0.0 0.0 1.3 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 5.6 0.5 0.5 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 42.3 5.0 2.8 5.0 0.0 0.0 1.7 0.3 0.0 0.1 0.1 0.1 0.0 5.5 0.0 2.4 30.0 36.0 0.0 17.7 0.2 0.3 0.0 0.0 31.9 0.1 0.0 0.0 60.2 1.4 8.4 30.5 0.1 10.1 11.8 11.1 3.4 9.6 15.0 4.7 18.8 6.5 13.2 16.3 0.0 8.2 11.1 1.0 6.9 0.6 1.1 5.1 4.0 5.7 1.8 0.0 215.8 0.0 0.2 0.5 1.4 0.0 0.0 1.5 101.6 5.3 0.5 9.3 0.0 66.0 0.0 0.0 1.3 66.8 0.0 0.9 146.7 8.5 954.0 0.0 0.5 0.3 0.0 0.4 0.0 1.1 6.5 2.1 0.2 0.4 4.5 261.3 0.0 0.0 2.1 CSF2RB "betaGMR, CD131, IL3RB, IL5RB" ENSG00000100368 "Colony stimulating factor 2 receptor beta common subunit" P32927 22 36913628-36940449 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.1;placenta: 73.6" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 32.6;granulocytes: 87.9;Macrophages: 41.6;monocytes: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 53.1;neutrophil: 20.1" "Lineage enriched" "Detected in many" 14 "granulocytes: 53.1" "Group enriched" "Detected in some" 6 "HEL: 27.0;HMC-1: 84.6" "Low region specificity" "Detected in all" HPA078677 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA078677: AB_2732389" "unprognostic (1.67e-2)" "unprognostic (9.44e-3)" "unprognostic (1.03e-2)" "unprognostic (6.66e-3)" "unprognostic (1.51e-1)" "prognostic favorable (7.47e-5)" "unprognostic (1.86e-1)" "unprognostic (1.94e-2)" "unprognostic (4.38e-1)" "unprognostic (9.57e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-1)" "unprognostic (1.82e-3)" "unprognostic (5.76e-2)" "unprognostic (3.65e-2)" "unprognostic (1.95e-1)" "unprognostic (8.52e-2)" 8.5 1.8 1.5 28.9 1.5 21.7 6.0 0.6 1.0 3.0 5.9 2.0 0.4 4.5 2.2 2.8 4.0 3.6 5.5 4.2 1.4 1.4 2.4 3.5 12.6 34.1 2.9 0.2 2.5 1.9 0.3 1.2 73.6 2.4 3.5 3.8 2.8 9.7 1.0 2.6 3.8 10.2 3.0 2.9 25.2 3.9 2.1 1.9 8.2 3.4 4.8 30.5 8.2 4.3 0.4 3.8 53.1 2.1 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 27.0 0.0 0.0 0.0 0.4 84.6 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 3.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 2.7 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.1 0.2 0.0 0.0 0.0 0.4 0.2 1.7 0.0 3.9 0.0 53.1 1.9 5.8 0.0 2.1 0.0 0.4 0.0 0.0 1.2 0.3 0.0 0.0 20.1 0.0 1.7 3.8 0.6 1.8 1.5 1.5 0.6 1.0 1.4 1.4 2.9 0.2 2.4 1.9 0.0 14.5 8.2 0.0 6.4 0.0 0.8 5.1 5.3 3.4 0.0 0.0 2.2 0.0 0.0 11.1 9.0 0.0 0.0 0.2 32.6 4.1 0.0 87.9 0.0 16.8 0.0 0.0 4.3 26.0 26.5 0.0 41.6 11.8 29.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 5.5 13.8 1.3 0.0 0.0 CSF3R "CD114, GCSFR" ENSG00000119535 "Colony stimulating factor 3 receptor" Q99062 1 36466043-36483278 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 167.3;bone marrow: 88.9;lymphoid tissue: 71.4;placenta: 152.7" "Cell type enhanced" "Detected in many" 27 "Alveolar cells type 2: 228.0;Cytotrophoblasts: 271.6;Syncytiotrophoblasts: 999.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 167.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 167.3" "Group enriched" "Detected in some" 18 "BEWO: 34.9;NB-4: 9.4;THP-1: 22.9;U-937: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017116, HPA048086" Enhanced "Intracellular and membrane" NA NA "CAB017116: , HPA048086: AB_2680257" "unprognostic (5.57e-3)" "unprognostic (8.05e-2)" "unprognostic (7.23e-2)" "unprognostic (3.87e-2)" "unprognostic (2.88e-1)" "unprognostic (2.92e-2)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (1.83e-1)" "unprognostic (5.65e-2)" "unprognostic (2.47e-1)" "unprognostic (3.44e-1)" "prognostic unfavorable (5.72e-4)" "unprognostic (6.33e-2)" "prognostic unfavorable (3.79e-4)" "unprognostic (2.03e-1)" "unprognostic (2.31e-2)" 8.5 1.5 2.9 39.5 3.2 88.9 2.4 0.7 2.9 1.1 1.1 4.2 0.4 0.6 0.7 1.1 1.2 6.9 4.3 5.6 2.6 2.0 1.7 4.5 26.9 27.5 7.2 1.1 1.1 1.3 0.3 1.1 152.7 3.8 1.3 0.5 2.1 1.6 0.5 0.6 0.3 1.6 3.1 7.1 71.4 2.2 1.4 3.3 1.1 1.0 0.4 0.9 4.6 3.9 0.0 8.2 167.3 22.1 0.2 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.1 0.0 0.0 22.1 0.6 0.0 4.8 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 167.3 0.2 1.8 0.2 0.0 10.3 2.9 3.2 0.7 2.9 2.6 2.0 7.2 1.1 3.8 3.3 23.8 228.0 2.4 0.6 0.9 0.0 1.4 0.0 12.0 18.2 0.0 0.0 271.6 0.0 0.0 0.4 1.9 0.0 0.0 0.0 49.1 3.0 0.2 17.4 0.8 60.8 0.0 0.0 3.7 146.3 0.4 0.3 62.6 0.0 3.6 0.0 0.2 0.1 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.2 0.1 999.2 0.5 0.0 2.2 CSGALNACT1 "ChGn, CSGalNAcT-1, FLJ11264" ENSG00000147408 "Chondroitin sulfate N-acetylgalactosaminyltransferase 1" Q8TDX6 8 19404161-19758029 "Enzymes, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 57.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 41.5;Endothelial cells: 33.7;Glandular cells: 33.6" "Cancer enhanced" "Detected in all" "prostate cancer: 22.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 20.1;granulocytes: 10.3;T-cells: 25.5" "Cell line enhanced" "Detected in some" "A549: 29.0;BJ hTERT+: 16.3;GAMG: 11.7;RPTEC TERT1: 20.3;U-2197: 18.5;U-87 MG: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068462 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Cytosol" "HPA068462: " "unprognostic (8.90e-2)" "unprognostic (1.57e-2)" "unprognostic (4.66e-2)" "unprognostic (2.58e-1)" "unprognostic (6.03e-2)" "unprognostic (3.17e-3)" "unprognostic (9.78e-2)" "unprognostic (7.76e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-2)" "unprognostic (8.22e-2)" "unprognostic (6.82e-2)" "unprognostic (1.22e-2)" "unprognostic (1.89e-1)" "unprognostic (2.38e-2)" "unprognostic (1.46e-3)" "unprognostic (1.02e-2)" 13.8 8.7 22.7 6.0 15.4 6.8 7.2 3.8 21.4 13.0 3.8 9.2 4.0 2.8 7.1 5.9 21.2 8.7 10.8 23.8 17.7 8.2 5.3 2.3 7.9 10.5 9.1 18.7 38.6 10.9 4.2 5.9 25.1 7.0 21.7 2.1 2.6 5.8 7.3 3.9 4.2 4.2 17.2 8.6 6.3 5.4 2.7 10.3 4.0 57.7 4.5 6.1 18.9 9.7 20.1 1.7 10.3 1.2 3.2 25.5 4.8 0.7 29.0 0.2 0.0 4.8 1.1 3.7 0.6 16.3 0.1 0.1 1.4 0.3 0.0 0.0 0.0 11.7 0.3 0.0 0.0 0.1 3.6 0.2 0.0 8.3 0.7 2.1 0.0 0.0 0.4 0.7 0.1 0.1 0.0 5.5 0.0 0.0 0.0 0.0 1.2 1.1 0.1 0.0 3.6 0.9 0.1 0.0 0.0 20.3 0.7 0.1 0.1 8.5 3.4 1.1 0.6 0.0 0.0 0.3 0.4 0.4 18.5 0.2 0.1 0.0 0.0 13.4 1.6 5.6 0.0 1.2 10.3 2.5 0.0 0.3 20.1 11.5 3.9 1.1 6.2 20.6 5.2 7.1 3.2 0.1 1.7 25.5 4.8 22.7 15.4 3.8 21.4 17.7 8.2 9.1 18.7 7.0 10.3 3.0 1.4 8.2 8.2 3.9 0.4 41.5 0.0 2.7 1.2 12.2 9.8 1.4 1.7 3.7 5.5 33.7 0.0 0.0 1.5 13.5 20.0 33.6 0.0 0.0 12.0 17.5 2.9 20.3 21.2 5.9 4.9 5.1 11.8 0.0 0.0 0.9 3.0 0.0 11.3 0.0 1.0 6.5 7.2 0.1 0.0 2.8 7.0 2.2 0.0 2.1 CSGALNACT2 "GALNACT-2, GALNACT2, MGC40204, PRO0082" ENSG00000169826 "Chondroitin sulfate N-acetylgalactosaminyltransferase 2" Q8N6G5 10 43138486-43185308 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 80.6" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 62.0;Macrophages: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 37.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031540 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA031540: AB_10599943" "unprognostic (1.65e-1)" "unprognostic (2.70e-2)" "unprognostic (9.10e-2)" "unprognostic (6.41e-2)" "unprognostic (1.95e-1)" "unprognostic (8.28e-3)" "unprognostic (2.85e-3)" "unprognostic (4.95e-2)" "unprognostic (2.96e-1)" "unprognostic (3.43e-3)" "unprognostic (7.65e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (3.53e-7)" "unprognostic (2.68e-2)" "unprognostic (1.40e-1)" "unprognostic (2.47e-1)" "unprognostic (4.05e-3)" 18.3 8.2 9.0 16.4 13.0 80.6 11.5 10.0 10.9 11.4 12.5 17.6 4.8 6.8 14.7 7.5 9.8 12.8 18.4 11.5 10.0 9.0 8.2 11.3 24.0 25.7 11.0 6.2 16.2 6.3 7.8 15.0 18.3 11.5 10.4 8.9 19.8 7.9 8.6 12.5 8.1 9.6 15.7 14.4 21.1 8.7 6.7 9.6 24.3 9.2 6.6 12.2 17.8 11.0 2.5 11.6 15.2 16.3 8.7 6.3 5.1 4.9 3.3 6.2 5.9 9.7 16.4 1.5 18.1 24.4 8.0 12.5 1.1 5.1 8.2 4.5 16.3 3.8 4.6 5.1 6.8 13.1 9.8 3.8 4.3 3.1 3.4 21.2 9.9 9.0 16.3 7.5 17.8 37.3 10.1 10.2 12.5 1.8 24.7 16.3 2.6 7.5 5.9 2.7 1.7 4.3 4.7 6.2 3.4 7.1 2.6 5.6 11.1 4.7 4.8 11.3 5.6 6.4 8.2 15.0 6.9 10.9 21.5 12.1 6.4 8.9 4.4 14.6 24.3 3.2 10.7 9.8 15.2 6.3 11.4 5.5 2.5 4.9 4.9 11.6 2.2 5.8 4.8 9.0 8.7 16.3 3.4 5.6 5.1 9.0 13.0 10.0 10.9 10.0 9.0 11.0 6.2 11.5 9.6 14.9 16.0 7.2 10.1 15.8 11.9 9.2 2.5 6.7 14.8 10.4 9.8 1.9 0.0 5.4 2.1 14.0 1.4 0.0 6.0 5.6 26.7 10.2 46.2 10.4 15.8 7.9 8.6 14.1 62.0 0.4 15.8 59.7 8.5 7.2 2.1 4.4 9.8 1.7 11.7 3.4 8.3 25.8 25.1 11.7 17.2 10.7 1.3 32.8 1.6 6.0 CSMD1 "KIAA1890, PPP1R24" ENSG00000183117 "CUB and Sushi multiple domains 1" 8 2935353-4994972 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 29.5;testis: 9.0" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 8.4;Ciliated cells: 17.4;Early spermatids: 38.6" "Cancer enhanced" "Detected in some" "testis cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "K-562: 9.0;U-2 OS: 4.4;U-266/70: 4.3;U-266/84: 3.9;U-698: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074707 Approved Vesicles NA NA Vesicles "HPA074707: AB_2686707" "unprognostic (6.32e-2)" "unprognostic (4.23e-2)" "unprognostic (2.37e-1)" "unprognostic (1.67e-3)" "unprognostic (5.72e-2)" "unprognostic (4.26e-2)" "unprognostic (1.02e-2)" "unprognostic (4.66e-2)" "unprognostic (7.69e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-1)" "unprognostic (7.90e-2)" "unprognostic (1.01e-1)" "unprognostic (2.74e-2)" "unprognostic (5.09e-2)" "unprognostic (1.26e-2)" "unprognostic (1.11e-1)" 1.0 1.1 20.4 0.8 21.1 0.8 1.4 6.3 29.5 2.5 0.8 1.7 0.0 1.0 1.2 0.9 0.8 3.2 0.8 0.7 12.9 4.5 2.7 0.7 1.4 0.9 3.9 18.2 0.9 0.9 0.7 0.7 2.8 3.4 1.1 0.8 0.0 0.7 1.5 1.1 1.0 1.0 1.7 2.4 2.8 0.8 9.0 2.4 0.0 1.1 0.0 0.9 1.1 0.5 0.0 0.9 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.7 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 4.4 0.0 0.0 4.3 3.9 3.7 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 20.4 21.1 6.3 29.5 12.9 4.5 3.9 18.2 3.4 2.4 0.0 0.3 0.0 0.0 0.2 8.4 1.6 0.0 17.4 1.2 1.8 0.0 2.4 0.0 0.0 38.6 0.4 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.6 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.7 0.5 0.0 0.0 7.1 5.4 0.1 3.0 0.0 0.0 0.0 CSMD2 KIAA1884 ENSG00000121904 "CUB and Sushi multiple domains 2" Q7Z408 1 33513999-34165842 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 4.8;Bipolar cells: 10.5" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 4.9;fHDF/TERT166: 6.0;HEL: 9.0;NTERA-2: 7.2;PC-3: 7.4;U-87 MG: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008622 Uncertain NA NA "HPA008622: AB_1078579" "unprognostic (1.33e-2)" "unprognostic (2.98e-1)" "unprognostic (6.47e-2)" "unprognostic (2.14e-1)" "unprognostic (7.03e-2)" "unprognostic (2.77e-1)" "unprognostic (1.31e-3)" "unprognostic (5.90e-2)" "unprognostic (7.44e-2)" "unprognostic (5.36e-2)" "unprognostic (2.32e-2)" "unprognostic (2.97e-1)" "unprognostic (1.25e-5)" "unprognostic (1.03e-3)" "unprognostic (1.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.38e-2)" 2.1 2.3 9.0 2.0 10.6 0.7 0.9 5.9 15.8 1.2 1.1 6.2 1.6 1.7 1.4 1.3 1.1 0.9 6.6 1.5 10.4 7.5 1.0 0.9 1.0 1.9 4.7 9.3 0.9 1.9 0.8 0.8 0.9 10.4 1.4 1.4 2.7 0.9 1.8 0.8 1.6 1.4 2.5 7.4 1.5 1.2 3.4 5.2 0.0 1.3 0.0 2.9 2.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.1 1.3 0.0 2.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 10.6 5.9 15.8 10.4 7.5 4.7 9.3 10.4 5.2 6.0 4.8 0.0 0.3 0.2 10.5 4.3 0.0 0.0 0.0 1.8 2.0 0.0 0.0 3.6 2.8 1.2 0.0 0.0 2.5 0.1 0.6 0.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.0 1.4 0.4 0.0 0.0 0.0 0.2 0.9 0.0 3.5 0.0 1.6 0.0 0.5 0.3 1.8 0.4 0.0 0.0 0.0 0.2 CSMD3 ENSG00000164796 "CUB and Sushi multiple domains 3" Q7Z407 8 112222928-113437099 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 26.6" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 4.8;Bipolar cells: 6.4;Early spermatids: 10.2;Spermatocytes: 15.3;Spermatogonia: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 2.4;hTCEpi: 2.4;hTERT-HME1: 1.7;LHCN-M2: 3.4;RH-30: 2.1;SCLC-21H: 1.5;U-2 OS: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029007 Uncertain NA NA "HPA029007: AB_10601802" "unprognostic (2.26e-1)" "unprognostic (2.16e-2)" "unprognostic (2.83e-2)" "unprognostic (5.97e-2)" "unprognostic (3.44e-2)" "unprognostic (1.26e-2)" "unprognostic (3.54e-4)" "unprognostic (2.48e-1)" "unprognostic (2.54e-1)" "unprognostic (2.89e-2)" "unprognostic (2.33e-2)" "unprognostic (5.03e-10)" "unprognostic (1.95e-1)" "unprognostic (4.14e-3)" "unprognostic (1.91e-2)" "unprognostic (1.74e-3)" 1.0 1.0 26.6 1.0 21.9 1.0 1.0 6.0 18.3 1.6 1.1 2.2 0.0 1.1 1.1 1.1 1.0 2.3 1.0 1.0 14.2 6.7 1.1 1.0 1.1 1.0 3.0 15.8 1.0 1.0 1.0 5.7 1.0 10.9 2.1 1.2 0.0 1.0 2.1 1.0 1.0 1.2 1.1 3.6 2.4 1.3 5.0 7.0 0.0 1.0 0.0 1.0 1.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 2.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.4 0.0 1.7 0.6 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 21.9 6.0 18.3 14.2 6.7 3.0 15.8 10.9 7.0 0.0 4.8 0.0 0.1 0.2 6.4 1.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 10.2 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.8 0.0 0.0 15.3 5.6 0.5 0.0 0.0 0.0 0.2 CSNK1G1 CK1gamma1 ENSG00000169118 "Casein kinase 1 gamma 1" Q9HCP0 15 64165517-64356259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 121.0;Late spermatids: 209.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018209 Supported Cytosol NA NA Cytosol "HPA018209: AB_1847278" "unprognostic (9.10e-2)" "unprognostic (8.09e-2)" "unprognostic (1.20e-1)" "unprognostic (2.65e-2)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (1.61e-2)" "unprognostic (2.02e-1)" "unprognostic (8.63e-2)" "unprognostic (3.75e-2)" "unprognostic (7.51e-2)" "unprognostic (8.16e-3)" "unprognostic (1.31e-1)" "unprognostic (2.59e-2)" "unprognostic (2.41e-1)" 7.2 7.8 10.2 11.9 15.1 11.6 8.7 12.2 10.6 8.7 7.4 7.6 11.6 7.0 11.1 9.9 15.7 10.8 7.8 5.6 8.9 7.6 8.6 6.0 8.4 9.6 6.6 4.7 8.5 8.8 10.4 16.1 7.2 7.2 6.8 7.9 10.1 8.2 14.5 6.5 10.4 6.8 11.1 5.3 8.2 6.8 41.3 7.3 11.8 11.5 5.6 11.2 8.3 10.6 4.1 4.1 8.8 5.1 5.3 8.0 2.4 5.1 10.9 7.9 10.2 6.8 9.3 7.2 6.4 6.6 10.9 9.8 8.7 10.1 8.1 3.5 10.1 11.4 11.9 20.6 12.9 12.8 15.4 5.3 7.6 8.7 5.8 7.8 14.0 9.0 8.2 17.2 11.1 15.9 9.5 11.9 8.4 9.2 8.5 9.8 7.1 7.1 4.4 7.4 6.8 5.7 12.0 9.9 6.5 8.8 20.8 12.8 7.8 8.4 5.1 7.4 13.6 8.9 5.5 12.8 9.9 11.9 7.9 7.9 9.8 18.9 6.9 9.2 10.3 6.1 0.9 3.6 5.6 5.7 5.1 8.0 3.6 5.1 4.1 2.7 4.1 5.1 4.7 8.8 5.3 4.3 4.1 3.9 2.4 10.2 15.1 12.2 10.6 8.9 7.6 6.6 4.7 7.2 7.3 26.8 9.9 7.1 8.7 10.3 44.6 6.5 5.1 16.0 13.6 5.2 64.8 5.8 1.7 8.2 121.0 8.4 8.4 0.0 6.1 7.4 8.9 7.9 3.5 4.0 9.4 9.5 21.9 9.2 9.7 209.9 5.8 10.3 6.8 10.0 10.0 6.9 9.1 7.0 9.6 8.7 29.5 6.5 8.5 27.2 18.4 13.7 3.4 7.7 10.3 10.1 CSPG4 "HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2" ENSG00000173546 "Chondroitin sulfate proteoglycan 4" Q6UVK1 15 75674322-75712848 "Predicted membrane proteins" "Angiogenesis, Differentiation, Tissue remodeling" "Developmental protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Sertoli cells: 116.4;Smooth muscle cells: 29.5" "Cancer enhanced" "Detected in all" "melanoma: 74.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 1.9" "Lineage enriched" "Detected in single" 11 "NK-cells: 1.9" "Cell line enhanced" "Detected in many" "BJ: 20.1;SK-MEL-30: 45.8;U-138 MG: 29.6;WM-115: 43.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001933, HPA002951, CAB016189, HPA042785, HPA050008" Approved Enhanced "Nucleoplasm,Plasma membrane" NA NA 28000000 "Plasma membrane" Nucleoplasm "CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991" "unprognostic (5.21e-2)" "unprognostic (2.17e-3)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.56e-2)" "unprognostic (3.58e-1)" "unprognostic (1.09e-2)" "unprognostic (2.11e-2)" "unprognostic (1.07e-1)" "unprognostic (5.00e-2)" "unprognostic (1.63e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (7.60e-6)" "unprognostic (1.23e-2)" "unprognostic (2.04e-2)" "unprognostic (3.21e-2)" "prognostic unfavorable (4.93e-5)" 36.1 3.1 8.3 10.0 7.9 1.0 19.5 1.6 7.8 15.3 29.2 7.2 6.9 4.6 21.3 14.9 19.9 9.4 18.2 9.2 6.5 5.2 3.5 1.5 10.9 1.4 6.6 5.2 7.0 3.8 3.0 1.6 20.9 6.6 11.4 3.9 10.0 3.4 16.7 25.7 8.0 9.1 37.9 5.4 3.8 14.0 2.5 6.3 0.0 4.7 6.0 1.3 30.3 10.9 0.0 0.1 0.0 0.0 1.9 0.0 0.0 3.6 0.0 0.3 2.2 0.5 3.2 0.0 20.1 9.0 14.1 9.2 0.0 14.0 0.0 0.5 14.0 1.9 0.2 0.0 0.1 4.3 0.1 0.0 0.0 5.9 0.0 3.2 0.0 0.0 1.5 0.0 4.2 0.5 5.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 45.8 0.4 0.3 0.3 0.0 29.6 5.8 1.1 0.2 0.0 0.0 0.0 6.5 0.1 43.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 8.3 7.9 1.6 5.9 6.5 5.2 6.6 5.2 6.6 6.3 0.0 0.0 0.0 0.6 2.5 0.0 9.8 0.0 1.4 1.2 1.8 0.0 0.1 0.0 0.0 0.6 2.8 0.0 0.0 0.0 0.2 6.5 0.6 0.0 0.0 1.1 0.0 0.0 1.3 0.0 0.0 0.3 0.8 11.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 116.4 29.5 0.0 1.3 1.6 0.2 0.0 0.0 0.3 CSPG5 NGC ENSG00000114646 "Chondroitin sulfate proteoglycan 5" O95196 3 47562239-47580792 "Predicted membrane proteins" "Differentiation, Growth regulation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 81.1" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 28.1;Muller glia cells: 86.9;Rod photoreceptor cells: 19.5;Spermatocytes: 17.2" "Cancer enriched" "Detected in many" 19 "glioma: 48.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.8;HEK 293: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049529, HPA067818, HPA071779" Enhanced Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446" "unprognostic (2.68e-1)" "unprognostic (2.11e-1)" "unprognostic (8.87e-2)" "unprognostic (3.12e-2)" "unprognostic (2.88e-1)" "unprognostic (7.66e-2)" "unprognostic (5.05e-4)" "unprognostic (1.40e-1)" "unprognostic (3.82e-1)" "prognostic favorable (2.14e-4)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (3.41e-4)" "unprognostic (8.08e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" 1.8 1.8 30.6 1.3 25.8 1.1 1.6 7.2 81.1 1.3 1.4 6.7 0.0 1.1 1.3 1.2 1.3 1.4 1.2 1.3 20.2 17.1 1.2 1.2 1.7 1.3 12.9 12.6 1.1 1.4 1.1 0.2 1.8 5.6 1.5 1.3 8.0 1.1 1.1 1.5 1.6 1.3 1.4 6.2 1.1 1.2 2.2 4.1 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 26.8 4.7 0.5 0.0 0.7 0.5 0.1 1.0 0.3 0.2 1.6 0.1 2.1 0.0 2.0 0.4 2.2 0.2 0.2 0.0 7.4 0.4 1.1 0.0 0.0 0.3 1.2 0.0 0.9 0.1 0.0 0.7 0.0 0.9 5.2 0.2 0.1 1.2 0.2 0.3 2.6 1.9 2.7 0.4 0.2 0.6 1.1 0.9 2.8 1.3 1.7 3.4 0.1 0.7 1.3 2.4 0.2 0.0 5.6 0.1 1.5 0.6 0.6 0.0 0.4 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 25.8 7.2 22.4 20.2 17.1 12.9 12.6 5.6 4.1 3.0 1.3 0.0 0.1 0.7 28.1 1.2 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.5 0.2 6.4 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 86.9 0.2 0.0 0.0 0.0 19.5 0.0 0.2 17.2 1.0 0.5 0.1 0.0 0.2 0.1 CST11 "CST8L, CTES2, dJ322G13.6" ENSG00000125831 "Cystatin 11" Q9H112 20 23450403-23452857 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "epididymis: 76.3" "Cell type enriched" "Detected in single" 10 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA053399 Enhanced "Secreted in male reproductive system" NA NA "HPA053399: AB_2682136" "unprognostic (9.42e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 76.3 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.0 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CST3 ENSG00000101439 "Cystatin C" P01034 20 23626706-23638473 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Kupffer cells: 3433.6;Macrophages: 4110.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 163.9;intermediate monocyte: 211.0;myeloid DC: 269.6;non-classical monocyte: 135.1;plasmacytoid DC: 153.5" "Group enriched" "Detected in many" 9 "dendritic cells: 269.6;monocytes: 211.0" "Cell line enhanced" "Detected in many" "ASC diff: 163.2;ASC TERT1: 111.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000118, HPA013143" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1040000000 4100000000 "Golgi apparatus, Vesicles" "CAB000118: , HPA013143: AB_1847417" "unprognostic (3.89e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.83e-4)" "unprognostic (8.53e-2)" "unprognostic (4.06e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-2)" "unprognostic (3.46e-2)" "unprognostic (3.72e-1)" "unprognostic (2.29e-3)" "unprognostic (3.51e-2)" "unprognostic (1.85e-1)" "unprognostic (1.16e-1)" "unprognostic (2.97e-1)" "unprognostic (5.01e-2)" "prognostic favorable (8.77e-4)" 95.8 72.6 229.0 37.9 254.7 22.2 68.6 61.4 196.7 76.6 78.2 75.4 39.5 59.4 47.6 143.6 73.8 64.9 89.4 79.7 157.4 96.2 35.9 67.3 58.0 91.2 148.3 90.6 51.4 142.1 34.5 45.6 25.8 69.9 55.2 66.1 195.0 338.2 74.2 44.2 44.9 77.9 57.3 73.3 85.5 105.5 57.4 68.4 40.7 43.2 40.1 31.9 49.4 50.2 0.6 269.6 27.4 211.0 6.4 2.4 106.7 12.9 29.3 6.9 15.8 163.2 111.7 12.8 22.5 31.4 15.5 12.6 55.8 20.0 0.0 21.2 30.7 20.1 43.9 6.3 45.0 4.8 0.0 21.7 13.3 5.8 94.7 58.4 0.6 22.3 86.4 37.9 20.8 22.3 32.8 24.2 1.6 12.1 0.3 21.5 20.6 0.1 14.0 9.2 41.0 64.4 0.5 8.4 17.8 63.6 29.3 7.5 8.6 16.4 4.9 28.0 10.4 13.9 48.7 60.9 14.7 10.6 20.5 8.4 13.9 0.5 0.1 12.5 29.1 16.5 1.4 163.9 1.0 2.4 211.0 0.9 0.6 0.6 1.6 269.6 0.5 0.6 1.2 27.4 6.4 135.1 153.5 0.4 106.7 229.0 254.7 61.4 196.7 157.4 96.2 148.3 90.6 69.9 68.4 107.2 165.4 122.1 459.0 837.5 35.4 213.0 1645.8 65.6 135.4 608.9 27.5 429.7 351.5 407.3 34.7 720.9 2161.2 23.3 692.7 269.5 1051.9 864.5 358.3 2073.4 1660.2 46.1 847.5 528.5 3433.6 95.9 1974.8 4110.2 1482.9 256.1 1276.0 130.5 997.4 2367.2 1683.0 939.5 34.6 2160.2 727.9 82.7 461.4 718.5 392.2 90.0 866.3 802.3 CST9 "CLM, CTES7A" ENSG00000173335 "Cystatin 9" Q5W186 20 23602410-23605876 "Predicted secreted proteins" "Antimicrobial, Protease inhibitor, Thiol protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 11 "breast: 6.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 37 "breast cancer: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA029190 Uncertain "Secreted - unknown location" NA NA "HPA029190: AB_10602804" "unprognostic (2.06e-2)" "unprognostic (2.21e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CST9L "bA218C14.1, CTES7B" ENSG00000101435 "Cystatin 9 like" Q9H4G1 20 23564732-23568749 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 49.8" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 2.4;Late spermatids: 7.3;Leydig cells: 2.3;Peritubular cells: 1.4;Spermatocytes: 1.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "HEL: 5.6" "Secreted in male reproductive system" NA NA "unprognostic (2.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 CT83 "CXorf61, FLJ20611, FLJ22913, KK-LC-1" ENSG00000204019 "Cancer/testis antigen 83" Q5H943 X 116461682-116463003 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 46.8" "Group enriched" "Detected in some" 113 "Early spermatids: 613.3;Late spermatids: 1930.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 28.4;OE19: 26.9;RPMI-8226: 8.7;U-266/70: 40.1;U-266/84: 20.2" "Not detected" "Not detected" NA NA "unprognostic (1.59e-2)" "unprognostic (1.69e-2)" "unprognostic (8.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.3 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 40.1 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 613.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1930.3 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 9.3 5.2 0.0 0.0 0.0 0.0 0.0 CTAGE1 "CT21.1, CT21.2, CTAGE, cTAGE-1, cTAGE-2" ENSG00000212710 "Cutaneous T cell lymphoma-associated antigen 1" "Q96RT6, Q9HC47" 18 22413601-22417915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 12.9" "Cell type enriched" "Detected in some" 11 "Early spermatids: 62.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBF TERT88: 2.3;U-2 OS: 1.8" "HPA000387, HPA000922, CAB016204" Uncertain NA NA "CAB016204: AB_673617, HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.41e-1)" "unprognostic (5.65e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.52e-1)" "unprognostic (1.70e-2)" "unprognostic (3.15e-1)" "unprognostic (1.63e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 4.9 0.5 0.3 0.1 0.0 0.0 0.3 CTAGE15 CTAGE15P ENSG00000271079 "CTAGE family member 15" A4D2H0 7 143571801-143574387 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 8.1" "Cell type enhanced" "Detected in single" 34 "Club cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (2.82e-1)" "unprognostic (8.64e-2)" "unprognostic (3.23e-1)" "unprognostic (3.32e-1)" "unprognostic (2.44e-1)" "unprognostic (2.23e-1)" "unprognostic (4.52e-2)" "unprognostic (9.94e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-2)" "unprognostic (3.72e-1)" "unprognostic (2.47e-1)" "unprognostic (2.33e-1)" "unprognostic (2.91e-2)" "unprognostic (2.39e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAGE4 "cTAGE-4, FLJ43692" ENSG00000225932 "CTAGE family member 4" Q8IX94 7 144183466-144186053 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 9.1" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.5;Ciliated cells: 4.0;Club cells: 2.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.3;T-reg: 2.0" "Lineage enriched" "Detected in single" 5 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "A-431: 13.8;hTCEpi: 12.2;RPTEC TERT1: 10.9;T-47d: 7.7;WM-115: 7.4" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.76e-1)" "unprognostic (3.24e-3)" "unprognostic (2.89e-1)" "unprognostic (5.17e-2)" "unprognostic (2.80e-1)" "unprognostic (3.65e-3)" "unprognostic (1.15e-1)" "unprognostic (1.26e-2)" "unprognostic (4.69e-2)" "unprognostic (1.91e-2)" "unprognostic (9.50e-3)" "unprognostic (1.07e-1)" "unprognostic (2.30e-1)" "unprognostic (8.36e-2)" "unprognostic (2.68e-1)" 1.3 0.9 0.2 0.0 0.7 0.0 3.8 0.1 0.2 0.7 1.2 3.7 1.4 2.5 1.3 1.1 1.9 1.4 0.2 0.4 1.3 1.6 2.0 0.0 0.7 1.9 4.1 0.0 2.1 0.8 1.3 3.5 2.0 0.3 0.3 9.1 1.0 0.0 0.4 1.3 2.4 4.9 7.5 0.0 0.8 1.3 0.4 0.0 0.0 0.0 0.0 2.0 0.0 13.8 0.1 0.0 0.0 0.0 0.0 5.8 0.4 0.2 0.0 0.2 1.3 4.4 0.0 0.0 0.5 0.3 0.4 0.0 2.5 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.3 12.2 0.4 3.8 0.6 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.5 3.9 0.0 0.0 0.0 0.0 10.9 3.6 0.0 0.0 5.0 5.1 0.4 2.3 7.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.0 3.5 0.0 0.1 0.6 0.0 0.4 0.0 4.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 CTAGE5 "cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, MEA6, MGEA, MGEA11, MGEA6" ENSG00000150527 "CTAGE family member 5, ER export factor" "O15320, Q96PC5" 14 39230231-39388513 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 72.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 43.4" "HPA000387, HPA000922, HPA054066, HPA055459" Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819" "unprognostic (2.62e-1)" "unprognostic (7.17e-3)" "unprognostic (2.33e-1)" "unprognostic (5.27e-4)" "unprognostic (3.21e-4)" "unprognostic (2.63e-1)" "unprognostic (2.48e-1)" "unprognostic (7.18e-2)" "unprognostic (1.12e-1)" "unprognostic (1.21e-2)" "unprognostic (4.31e-2)" "unprognostic (1.78e-1)" "prognostic favorable (2.81e-4)" "unprognostic (6.93e-2)" "unprognostic (8.08e-2)" "unprognostic (2.91e-1)" "unprognostic (3.97e-2)" 9.3 16.9 7.3 11.4 7.3 7.3 7.9 5.1 7.9 12.1 22.8 5.8 13.5 28.5 8.5 17.9 18.5 8.4 15.1 7.5 6.4 5.9 34.7 52.2 10.6 9.0 7.8 6.5 8.6 20.6 22.9 20.6 6.0 21.1 8.9 12.6 6.0 22.3 17.0 17.4 6.4 52.4 6.9 9.7 9.7 16.0 8.7 8.6 10.1 17.0 15.9 7.0 8.3 10.9 8.7 12.5 24.5 13.5 9.8 11.6 8.4 7.7 8.6 3.6 6.4 7.4 8.4 5.1 4.6 4.8 3.3 3.4 6.7 43.4 9.3 14.3 5.1 6.7 11.8 4.4 5.1 3.9 7.2 3.7 5.8 4.2 35.8 17.4 7.8 10.8 5.1 29.5 3.2 24.6 20.9 5.3 11.0 5.5 23.9 4.9 7.4 4.9 6.3 4.2 29.6 7.2 5.1 6.4 11.6 15.1 8.4 3.1 1.8 10.6 11.3 6.9 4.8 10.9 8.4 8.3 5.0 3.3 3.6 3.0 13.7 11.7 9.2 2.8 4.9 4.1 22.5 11.8 17.6 11.6 12.3 10.5 8.5 8.9 10.8 12.5 8.7 11.0 10.2 24.5 9.8 13.5 8.7 8.1 8.4 7.3 7.3 5.1 7.9 6.4 5.9 7.8 6.5 21.1 8.6 35.7 36.1 11.6 6.2 3.8 11.5 0.0 43.3 72.3 29.6 0.0 31.4 4.5 0.0 0.0 4.3 3.1 34.6 0.0 0.0 4.0 5.3 11.6 24.4 38.4 6.8 7.9 31.2 11.1 12.4 2.2 11.8 7.6 5.0 0.0 21.2 4.3 0.0 20.1 11.0 0.0 13.0 0.0 3.1 17.9 13.4 3.0 5.8 13.8 14.3 12.8 CTAGE6 "CTAGE6P, MGC41943" ENSG00000271321 "CTAGE family member 6" Q86UF2 7 143755089-143757696 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 40 "testis: 15.0" "Cell type enhanced" "Detected in single" 27 "Early spermatids: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;HeLa: 1.6;U-266/70: 1.0" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.51e-2)" "unprognostic (8.90e-12)" "unprognostic (1.73e-2)" "unprognostic (2.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.8 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 CTAGE8 ENSG00000244693 "CTAGE family member 8" P0CG41 7 144266701-144269288 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 7.7" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.6;Ciliated cells: 1.4;Club cells: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.5;CAPAN-2: 3.1;HaCaT: 2.9;HBEC3-KT: 2.9;OE19: 6.4;RT4: 4.1" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (4.80e-2)" "unprognostic (2.54e-1)" "unprognostic (1.93e-1)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (9.90e-2)" "unprognostic (1.11e-1)" "unprognostic (8.92e-3)" "unprognostic (1.56e-1)" "unprognostic (7.79e-2)" "unprognostic (1.33e-2)" "unprognostic (8.73e-2)" "unprognostic (6.23e-3)" "unprognostic (2.46e-1)" "unprognostic (2.84e-2)" 0.3 0.0 0.0 0.4 0.0 0.2 1.5 0.0 0.0 0.6 1.4 1.8 0.6 0.3 3.9 0.5 0.8 0.0 0.0 0.0 3.3 2.3 1.2 0.2 0.0 0.9 2.5 6.2 1.1 0.4 2.1 1.0 2.4 0.5 0.0 6.9 2.4 0.1 0.0 0.5 2.0 7.7 6.0 0.4 0.6 1.4 0.5 0.6 0.1 0.0 0.1 0.3 0.2 8.5 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.1 0.2 2.5 3.1 0.0 0.0 0.0 0.0 2.9 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.4 0.9 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.2 6.4 0.0 0.0 0.0 0.0 0.9 4.1 0.0 0.0 1.2 1.9 1.5 0.5 1.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.2 0.1 0.0 0.1 0.0 0.6 0.2 0.2 6.0 1.6 0.0 0.0 0.0 0.0 0.4 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CTAGE9 ENSG00000236761 "CTAGE family member 9" A4FU28 6 131708684-131711017 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 29 "testis: 11.6" "Cell type enhanced" "Detected in some" 17 "Club cells: 2.3;Early spermatids: 1.9;Suprabasal keratinocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A-431: 1.3" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (3.92e-2)" "unprognostic (6.84e-2)" "unprognostic (3.48e-2)" "unprognostic (1.92e-1)" "unprognostic (9.89e-3)" "unprognostic (2.36e-1)" "unprognostic (5.55e-2)" "unprognostic (2.34e-1)" "unprognostic (2.52e-2)" "unprognostic (5.74e-4)" "unprognostic (3.15e-2)" "unprognostic (9.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 11.6 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.2 0.2 1.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.4 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 CTDNEP1 "DULLARD, HSA011916, NET56" ENSG00000175826 "CTD nuclear envelope phosphatase 1" O95476 17 7243591-7252491 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 140.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037439, HPA066466" Uncertain Approved "Lipid droplets" NA NA "Lipid droplets" "HPA037439: AB_10601264, HPA066466: AB_2732745" "unprognostic (7.11e-2)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "prognostic favorable (6.45e-4)" "unprognostic (3.12e-1)" "unprognostic (2.13e-1)" "unprognostic (4.61e-2)" "unprognostic (1.50e-2)" "unprognostic (2.98e-1)" "unprognostic (9.90e-2)" "prognostic favorable (1.81e-4)" "unprognostic (3.37e-1)" "unprognostic (2.77e-3)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (9.97e-2)" "unprognostic (2.02e-2)" 27.1 23.1 21.4 22.4 21.0 24.2 38.8 21.8 26.6 25.3 24.8 26.6 16.7 20.8 31.2 22.8 26.6 27.3 18.8 29.0 21.5 12.9 23.8 20.6 26.5 39.4 24.7 17.1 31.1 27.9 30.7 26.1 30.4 20.5 25.2 27.9 20.4 23.0 23.8 140.1 35.5 30.9 26.7 25.6 38.3 24.3 26.6 24.3 43.8 26.0 31.5 34.1 22.4 26.7 13.0 17.3 18.3 11.8 7.2 11.2 3.8 38.9 58.3 32.8 35.2 51.4 63.3 24.9 29.2 48.9 47.1 40.6 27.8 27.3 36.1 31.1 52.1 32.9 32.7 43.0 45.0 52.7 53.6 36.5 25.2 39.2 47.9 47.7 28.6 47.7 51.0 54.8 53.9 57.6 48.5 50.1 35.8 22.5 26.8 44.2 24.6 31.9 30.7 22.8 34.9 24.8 38.9 29.2 28.8 37.4 20.5 12.6 36.2 23.2 23.3 31.1 33.9 22.0 23.6 28.5 34.4 29.6 27.4 54.8 23.2 20.2 18.5 44.2 39.6 35.5 6.3 11.8 18.3 10.5 11.7 8.5 13.0 10.1 11.0 8.4 12.4 7.8 11.2 15.6 7.2 7.7 17.3 9.6 3.8 21.4 21.0 21.8 26.6 21.5 12.9 24.7 17.1 20.5 24.3 23.8 21.0 48.6 41.4 41.9 42.6 10.8 30.6 9.4 25.0 38.4 21.6 54.3 10.0 54.2 3.7 44.4 63.2 0.0 73.6 98.0 42.3 51.3 19.7 33.8 80.8 28.6 70.8 40.5 83.4 5.0 53.5 53.1 27.0 36.9 73.9 45.9 67.9 46.0 44.2 29.3 28.2 25.8 33.0 14.6 35.6 58.6 69.6 36.2 58.8 56.2 CTLA4 "CD, CD152, CELIAC3, GSE, IDDM12" ENSG00000163599 "Cytotoxic T-lymphocyte associated protein 4" P16410 2 203867786-203873960 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Diabetes mellitus, Disease mutation, FDA approved drug targets, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.8;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 2: 5.6;granulocytes: 1.1;T-cells: 1.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 6 "T-reg: 24.8" "Lineage enriched" "Detected in single" 248 "T-cells: 24.8" "Cell line enhanced" "Detected in some" "SK-MEL-30: 3.9;U-266/70: 5.9;U-266/84: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.92e-2)" "unprognostic (9.13e-3)" "unprognostic (1.47e-3)" "unprognostic (9.89e-6)" "unprognostic (1.86e-1)" "prognostic favorable (4.48e-5)" "unprognostic (1.02e-1)" "unprognostic (1.75e-2)" "unprognostic (1.84e-3)" "unprognostic (2.65e-3)" "unprognostic (2.77e-1)" "unprognostic (3.76e-1)" "unprognostic (9.86e-10)" "unprognostic (4.13e-2)" "unprognostic (7.45e-2)" "unprognostic (4.94e-2)" "unprognostic (1.19e-2)" 1.6 0.2 0.2 24.1 0.3 2.9 1.3 0.2 0.6 0.8 1.6 0.1 0.6 0.2 1.1 0.1 2.0 1.2 3.6 0.5 0.3 0.5 1.6 0.6 5.8 27.9 0.3 0.3 0.7 0.3 0.1 0.6 0.1 1.7 1.1 1.7 0.8 1.4 0.6 0.2 1.0 10.3 0.3 1.5 6.7 1.2 1.7 0.1 14.2 1.9 3.3 31.2 4.6 1.3 0.0 0.0 0.0 0.0 0.0 24.8 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.3 0.0 0.5 0.1 0.3 0.0 5.9 16.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 4.0 0.4 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 24.8 0.4 0.2 0.3 0.2 0.6 0.3 0.5 0.3 0.3 1.7 0.1 0.0 5.6 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.6 0.1 1.9 0.0 0.0 CTNS "CTNS-LSB, PQLC4" ENSG00000040531 "Cystinosin, lysosomal cystine transporter" O60931 17 3636468-3661542 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 46.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046947 Supported "Vesicles,Intermediate filaments" NA NA "Vesicles, Intermediate filaments" "HPA046947: AB_2679872" "unprognostic (1.64e-1)" "unprognostic (1.70e-1)" "unprognostic (1.21e-1)" "unprognostic (8.25e-2)" "unprognostic (8.39e-2)" "prognostic favorable (7.33e-4)" "unprognostic (1.28e-2)" "unprognostic (8.02e-2)" "unprognostic (1.94e-1)" "unprognostic (6.62e-3)" "prognostic favorable (6.39e-5)" "unprognostic (8.40e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-1)" "unprognostic (5.64e-2)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 9.6 19.0 8.5 8.2 11.9 8.3 12.1 5.0 9.9 18.8 8.2 16.1 34.8 10.8 10.3 7.2 7.3 8.3 10.6 9.3 7.7 5.9 23.9 16.4 11.4 9.1 12.1 5.6 12.6 32.7 11.3 14.5 13.2 8.5 10.2 6.4 11.4 10.5 46.2 22.6 18.0 9.2 7.9 10.2 12.2 12.9 27.0 13.0 11.7 9.0 6.5 9.0 10.1 9.1 3.5 19.6 13.7 5.6 2.5 3.3 3.7 6.2 14.0 8.2 7.0 13.3 6.8 5.1 6.0 10.2 7.0 8.8 7.8 6.1 3.7 6.4 4.1 19.2 16.0 7.2 4.1 5.4 46.5 12.7 4.2 10.5 6.3 18.0 2.8 29.1 8.4 5.3 7.3 6.0 10.9 7.7 6.0 4.3 5.9 6.5 5.7 2.8 2.7 3.6 4.3 6.1 6.2 3.3 8.8 6.2 6.3 1.6 6.0 7.1 9.5 7.1 7.3 6.7 2.8 9.0 6.9 4.3 15.5 4.9 4.7 6.1 1.8 10.6 3.1 4.7 13.7 5.6 12.1 1.9 3.7 2.7 3.5 2.3 3.3 5.4 3.1 2.9 3.1 2.0 2.5 3.8 19.6 2.6 3.7 8.5 11.9 5.0 9.9 7.7 5.9 12.1 5.6 8.5 13.0 3.0 2.1 0.0 3.2 1.4 1.4 3.6 7.6 2.7 1.2 12.2 9.8 5.1 0.0 5.4 33.5 6.0 2.8 0.0 5.5 5.9 4.8 5.5 8.1 5.8 20.7 4.8 2.4 13.5 7.1 23.4 8.9 8.3 5.0 12.6 2.5 6.6 5.8 2.0 12.0 7.9 3.6 6.5 2.8 11.4 8.5 2.0 7.1 4.3 1.8 2.6 CTRB1 CTRB ENSG00000168925 "Chymotrypsinogen B1" P17538 16 75219000-75226338 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2272 "pancreas: 1908.8" "Cell type enriched" "Detected in some" 12 "Exocrine glandular cells: 26371.2" "Cancer enriched" "Detected in some" 1905 "pancreatic cancer: 962.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;HDLM-2: 5.0;U-2 OS: 2.5;U-251 MG: 1.6" "Secreted to digestive system" NA NA "unprognostic (1.76e-1)" "unprognostic (2.62e-1)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (5.22e-2)" "unprognostic (4.43e-3)" "unprognostic (2.96e-1)" "unprognostic (1.17e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.8 1908.8 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.4 0.0 0.4 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.2 1.6 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.0 26371.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 265.1 0.0 0.0 2264.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTRB2 ENSG00000168928 "Chymotrypsinogen B2" Q6GPI1 16 75204096-75207185 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5240 "pancreas: 3761.5" "Cell type enriched" "Detected in some" 5 "Exocrine glandular cells: 45669.7" "Cancer enriched" "Detected in single" 1696 "pancreatic cancer: 540.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.1;HDLM-2: 1.9;U-2 OS: 9.3;U-251 MG: 1.9;U-266/84: 2.6;U-698: 2.4" "Secreted to digestive system" NA NA "unprognostic (9.41e-4)" "unprognostic (2.20e-1)" "unprognostic (1.28e-2)" "unprognostic (2.10e-1)" "unprognostic (2.92e-2)" "unprognostic (2.77e-1)" "unprognostic (5.95e-2)" "unprognostic (9.56e-2)" "unprognostic (3.54e-3)" "unprognostic (7.06e-2)" "unprognostic (2.17e-1)" "unprognostic (7.57e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.6 3761.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 5.1 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 9.3 0.0 1.9 0.1 2.6 2.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.9 1.0 0.0 0.0 0.0 45669.7 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.3 0.3 0.0 0.0 376.1 0.0 0.0 8606.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTSA "GSL, PPGB" ENSG00000064601 "Cathepsin A" P10619 20 45890144-45898820 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 125.7" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 279.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 113.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024930, HPA031068, HPA072487" Enhanced Enhanced Vesicles "Intracellular and membrane" NA NA 18000000 Vesicles "CAB024930: , HPA031068: AB_10601205, HPA072487: " "unprognostic (8.61e-2)" "unprognostic (3.37e-1)" "unprognostic (4.30e-2)" "unprognostic (2.13e-1)" "unprognostic (6.42e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (6.33e-2)" "unprognostic (9.53e-3)" "unprognostic (7.19e-2)" "unprognostic (1.83e-1)" "unprognostic (6.85e-2)" "unprognostic (7.57e-2)" "unprognostic (1.09e-1)" "unprognostic (6.05e-2)" "unprognostic (1.71e-1)" "unprognostic (8.40e-2)" 29.0 125.7 12.0 22.8 19.5 22.1 35.3 11.4 30.0 14.1 50.6 17.4 16.2 29.4 18.2 19.3 20.7 12.7 28.0 32.6 11.5 11.6 88.2 43.8 28.4 38.9 12.3 16.1 23.9 19.2 28.3 16.5 47.7 15.7 18.2 50.5 30.1 20.5 15.1 19.3 28.2 40.6 19.6 11.9 38.8 19.7 14.3 11.2 8.0 18.1 24.9 22.4 23.3 18.7 7.0 16.6 81.1 46.1 12.0 31.2 50.0 14.1 14.5 2.7 12.4 113.6 58.9 6.3 20.3 54.2 22.3 29.1 27.3 38.1 3.0 23.6 38.1 84.2 22.6 7.3 13.7 14.0 5.9 6.8 8.0 10.2 47.5 25.3 12.7 33.2 46.7 16.5 14.4 3.2 55.8 24.2 3.9 7.9 46.7 24.1 29.1 3.2 11.8 2.8 21.6 34.6 5.1 14.1 16.8 17.8 12.5 5.5 5.2 33.9 59.3 56.7 7.3 14.5 18.3 22.3 44.8 10.5 25.3 15.9 23.1 29.1 2.1 80.6 16.9 18.4 60.6 46.1 81.1 7.5 26.6 31.2 7.0 12.9 13.2 16.6 3.6 4.7 6.9 24.7 12.0 17.7 6.6 23.9 50.0 12.0 19.5 11.4 30.0 11.5 11.6 12.3 16.1 15.7 11.2 32.8 24.6 40.4 31.0 21.5 54.2 10.9 58.6 22.7 26.1 68.0 56.9 86.8 33.2 172.8 2.3 41.6 257.8 0.0 146.8 91.1 44.1 21.0 9.2 53.3 279.4 44.5 51.9 105.0 166.6 3.6 30.5 81.3 106.3 136.1 70.2 92.8 127.7 92.2 25.8 168.1 30.9 25.8 46.4 6.2 32.4 19.9 120.5 54.2 85.6 31.9 CTSZ CTSX ENSG00000101160 "Cathepsin Z" Q9UBR2 20 58995185-59007247 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 945.4;Macrophages: 462.5;monocytes: 1072.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 3.2;intermediate monocyte: 2.7;memory B-cell: 1.0;myeloid DC: 3.9;naive B-cell: 1.9;neutrophil: 3.5;non-classical monocyte: 2.9;plasmacytoid DC: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 119.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025114, HPA049876, HPA053504" Supported Supported Vesicles "Intracellular and membrane" NA NA 85000000 Vesicles "CAB025114: , HPA049876: AB_2680927, HPA053504: AB_2682172" "unprognostic (7.30e-2)" "unprognostic (3.98e-2)" "unprognostic (4.07e-2)" "unprognostic (1.11e-3)" "unprognostic (8.25e-3)" "unprognostic (1.15e-1)" "unprognostic (4.12e-2)" "unprognostic (6.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-1)" "unprognostic (1.33e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (5.72e-5)" "unprognostic (1.96e-1)" "unprognostic (6.92e-2)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" 70.7 27.9 12.4 40.8 20.4 20.7 51.2 14.6 13.5 25.4 52.8 16.0 19.9 40.8 20.6 25.5 20.1 20.7 22.3 50.1 9.8 13.3 34.9 83.7 54.3 61.2 18.8 10.5 29.7 29.0 30.6 27.6 38.6 19.2 28.8 37.8 31.5 40.3 17.7 20.7 12.9 63.6 26.4 22.1 56.5 19.2 13.8 14.9 18.4 42.4 17.5 35.8 29.8 21.5 1.9 3.9 3.5 3.2 0.3 0.6 0.8 27.6 21.5 0.0 0.0 25.4 29.2 15.2 45.5 50.4 34.9 31.2 41.5 46.5 15.2 30.2 119.6 0.0 22.1 13.7 43.1 23.9 48.6 1.8 13.9 34.8 0.0 26.6 1.6 48.4 24.8 26.0 15.2 18.2 11.6 55.2 0.0 10.0 7.7 23.3 0.0 0.1 15.0 1.7 12.1 21.5 0.3 0.1 18.2 25.5 6.5 0.4 0.3 35.4 41.0 0.1 14.2 18.9 23.6 60.6 0.0 23.6 30.7 0.2 36.7 22.3 2.9 0.4 33.5 0.0 0.0 3.2 0.3 0.6 2.7 0.0 1.0 0.4 0.1 3.9 1.9 0.4 0.1 3.5 0.3 2.9 2.2 0.2 0.8 12.4 20.4 14.6 13.5 9.8 13.3 18.8 10.5 19.2 14.9 14.9 4.0 130.0 51.2 44.8 4.6 17.5 53.5 8.1 5.7 68.0 0.0 34.5 19.9 168.0 2.8 62.8 285.7 23.3 37.2 91.0 58.0 41.9 10.4 307.7 945.4 11.1 26.0 44.2 260.7 3.3 12.0 462.5 96.2 1072.2 50.0 45.9 72.3 98.2 13.1 68.2 4.9 45.3 59.0 1.7 4.5 36.3 34.6 29.9 76.8 46.2 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924485-7926166 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 91.1" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 14.7;Late spermatids: 13.4;Spermatogonia: 10.4" "Cancer enhanced" "Detected in all" "ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 33.9;HEK 293: 23.6;NTERA-2: 25.7;REH: 19.5;SCLC-21H: 20.0;SH-SY5Y: 33.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 2.1 4.8 47.7 2.5 91.1 1.6 2.1 0.0 74.2 5.2 6.1 5.0 3.6 2.6 17.5 5.1 2.4 16.4 1.8 1.6 49.4 16.8 3.1 1.5 3.0 1.6 15.7 20.1 2.7 2.1 2.3 6.5 2.0 4.0 5.5 2.1 0.0 2.1 16.5 1.6 2.8 2.1 7.1 1.5 2.0 2.2 6.1 8.3 0.0 1.8 0.0 1.6 2.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 2.8 7.3 33.9 0.0 0.1 1.7 2.9 0.8 1.4 0.8 0.8 1.7 0.0 5.8 0.7 0.8 12.3 1.6 0.3 0.0 1.0 23.6 0.2 1.9 0.5 0.3 0.6 0.6 0.0 0.9 0.5 0.3 3.5 1.9 3.2 7.1 0.1 0.1 13.7 6.2 4.6 25.7 0.8 11.9 19.5 0.0 2.2 5.2 0.5 20.0 33.6 1.8 0.9 3.1 0.6 7.4 0.2 2.8 0.7 11.9 1.3 1.6 0.2 0.3 1.6 2.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 91.1 0.0 63.8 49.4 16.8 15.7 20.1 4.0 8.3 0.0 0.0 0.0 3.6 1.0 0.2 0.2 0.0 0.0 0.0 8.7 3.9 0.1 3.3 5.0 7.3 0.5 0.0 0.0 0.3 0.4 0.9 14.7 0.0 0.0 0.2 0.0 8.7 0.6 0.0 13.4 1.1 0.1 1.7 0.0 0.0 0.1 2.0 0.2 1.8 7.2 0.4 0.0 4.2 3.6 10.4 1.8 0.2 0.0 0.0 5.9 CTXN2 ENSG00000233932 "Cortexin 2" P0C2S0 15 48178122-48203756 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "brain: 11.3;pituitary gland: 5.7;testis: 4.9" "Group enriched" "Detected in some" 6 "Early spermatids: 29.9;Late spermatids: 26.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 1.0;SCLC-21H: 3.6;SH-SY5Y: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053168 Uncertain NA NA "HPA053168: AB_2682066" "unprognostic (1.90e-1)" "unprognostic (3.85e-3)" "unprognostic (7.43e-2)" "unprognostic (2.18e-4)" "unprognostic (6.81e-3)" "unprognostic (1.72e-1)" "unprognostic (2.80e-1)" "unprognostic (4.61e-2)" 0.5 1.2 6.4 0.7 6.7 0.5 0.6 8.4 9.0 0.5 0.8 0.0 0.0 0.7 0.5 0.6 0.6 1.3 0.7 0.5 4.0 11.3 0.9 0.5 0.6 0.6 7.3 2.9 0.5 1.4 0.6 5.7 0.5 8.8 0.6 0.9 0.0 0.5 0.6 0.6 0.5 1.1 0.6 1.9 0.5 0.6 4.9 1.2 0.0 0.6 0.0 0.6 0.5 0.0 0.0 0.1 0.3 1.5 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.0 3.6 1.0 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 0.1 0.0 0.0 6.4 6.7 8.4 9.0 4.0 11.3 7.3 2.9 8.8 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 26.0 0.9 0.0 0.0 0.0 0.0 1.7 0.2 2.9 0.0 0.3 0.3 0.0 0.0 1.4 1.6 0.0 0.0 0.0 0.1 0.0 CTXN3 ENSG00000205279 "Cortexin 3" Q4LDR2 5 127649044-127658630 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 21.9;kidney: 58.1" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 121.0" "Cancer enriched" "Detected in single" 8 "renal cancer: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 4.5;NTERA-2: 1.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 4 "olfactory region: 50.2" NA NA "unprognostic (7.32e-2)" "unprognostic (9.88e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-1)" "unprognostic (6.20e-3)" 0.6 0.6 2.2 0.5 9.4 0.5 0.6 0.2 19.1 0.6 0.6 0.7 0.0 0.5 0.6 0.5 0.6 0.6 0.6 0.6 7.9 4.8 58.1 0.6 0.6 0.6 12.6 4.6 0.5 0.5 0.5 5.9 0.5 21.9 0.9 0.6 0.0 0.7 0.6 9.1 0.5 0.5 0.5 0.5 0.5 0.6 0.6 1.0 0.0 0.5 0.3 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 9.4 0.2 19.1 7.9 4.8 12.6 4.6 21.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 19.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CTXND1 LINC01314 ENSG00000259417 "Cortexin domain containing 1" 15 80195484-80252213 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 20.8;epididymis: 9.1;liver: 14.7" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 4.6;Ciliated cells: 1.4;Collecting duct cells: 1.8;Distal tubular cells: 1.7;Proximal tubular cells: 5.6" "Group enriched" "Detected in many" 7 "glioma: 3.4;liver cancer: 2.7;melanoma: 9.1;thyroid cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 1.7;SK-MEL-30: 3.4;WM-115: 10.2" "Region enriched" "Detected in many" 4 "hippocampal formation: 38.5" NA NA "unprognostic (4.15e-5)" "unprognostic (8.42e-2)" "unprognostic (6.08e-2)" "unprognostic (1.86e-3)" "unprognostic (5.59e-2)" "unprognostic (3.48e-1)" "unprognostic (1.90e-2)" "unprognostic (2.61e-1)" "unprognostic (2.41e-1)" "unprognostic (7.04e-2)" "unprognostic (3.90e-4)" "unprognostic (2.43e-1)" "unprognostic (1.72e-2)" "unprognostic (1.92e-3)" "unprognostic (1.06e-1)" "unprognostic (5.14e-3)" "unprognostic (1.34e-1)" 0.3 4.2 12.8 0.3 5.7 0.1 0.2 4.4 8.2 0.2 0.5 2.2 0.0 0.7 0.2 9.1 0.2 0.4 0.2 6.6 20.8 3.5 14.7 2.6 0.4 1.9 1.9 0.4 0.7 0.0 0.0 0.1 4.5 0.2 0.5 1.1 0.2 0.3 0.6 1.3 0.8 0.2 3.3 2.0 3.3 0.3 7.1 0.0 0.8 0.0 0.5 0.2 0.0 0.4 0.1 0.5 0.1 0.3 0.6 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 1.2 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 3.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.1 0.2 0.2 10.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.4 0.6 0.1 0.5 0.3 0.0 0.1 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.8 0.0 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTXND2 ENSG00000283324 "Cortexin domain containing 2" 1 150887136-150913292 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "fallopian tube: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "BEWO: 5.2" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.1 0.1 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CUTA "ACHAP, C6orf82" ENSG00000112514 "CutA divalent cation tolerance homolog" O60888 6 33416442-33418317 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016787, HPA064369" Uncertain Approved "Plasma membrane,Focal adhesion sites" "Secreted to blood" NA NA 35000000 "Plasma membrane, Focal adhesion sites" "CAB016787: , HPA064369: AB_2685248" "unprognostic (7.03e-2)" "unprognostic (5.44e-2)" "unprognostic (4.56e-2)" "unprognostic (8.91e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.98e-2)" "prognostic favorable (8.50e-4)" "unprognostic (1.87e-1)" "unprognostic (2.78e-2)" "unprognostic (1.27e-3)" "unprognostic (1.91e-1)" "unprognostic (5.55e-2)" "unprognostic (9.90e-2)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (2.74e-1)" 26.6 65.6 47.9 28.3 60.1 33.5 47.6 37.7 73.7 47.7 37.9 36.8 53.9 42.1 40.1 78.5 30.5 46.0 48.8 49.6 45.2 44.9 46.3 61.6 39.0 77.4 46.5 37.8 57.7 66.6 43.8 86.1 45.7 39.8 38.8 28.9 34.2 74.3 69.7 34.6 32.7 37.2 32.4 47.0 36.0 38.7 27.3 31.6 52.2 69.7 30.3 31.3 42.6 28.9 56.5 31.4 27.1 32.0 49.9 69.8 60.8 43.8 26.3 42.1 53.3 31.7 31.2 20.4 40.1 75.1 77.6 82.7 26.2 27.4 31.0 31.2 45.9 56.4 26.8 27.3 40.8 43.8 26.2 60.5 32.3 43.6 68.6 41.3 25.1 24.6 41.3 34.5 37.3 31.5 54.0 20.8 32.9 39.6 63.1 56.7 34.1 38.0 53.5 37.7 38.0 34.7 41.8 25.1 81.9 53.4 19.1 82.4 42.0 24.0 41.8 72.8 25.2 30.7 52.8 22.9 42.0 35.7 29.8 41.8 62.0 61.6 33.9 36.3 55.6 34.1 27.1 32.0 16.5 45.7 22.9 63.2 56.5 67.6 52.7 31.4 44.2 68.5 53.2 4.6 49.9 16.8 27.1 69.8 60.8 47.9 60.1 37.7 73.7 45.2 44.9 46.5 37.8 39.8 31.6 122.1 105.5 178.5 242.5 204.8 84.5 113.4 239.5 131.2 121.7 300.1 64.8 309.8 240.4 162.1 64.8 93.9 157.7 23.3 122.9 203.5 204.8 237.5 167.3 299.7 277.3 73.1 280.4 131.3 162.9 285.6 185.2 150.2 300.3 80.2 266.0 150.8 114.3 196.4 180.0 440.5 69.0 90.5 220.1 100.6 65.6 201.4 203.1 245.2 291.8 203.9 CUX1 "CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6" ENSG00000257923 "Cut like homeobox 1" "P39880, Q13948" 7 101815904-102283958 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Transport" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "non-classical monocyte: 21.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003277, HPA003317" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA003277: AB_10601804, HPA003317: AB_2666891" "unprognostic (5.86e-2)" "unprognostic (5.39e-3)" "unprognostic (9.62e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (7.51e-4)" "unprognostic (5.85e-2)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (2.89e-3)" "unprognostic (2.20e-1)" "unprognostic (2.50e-1)" "prognostic favorable (5.72e-7)" "unprognostic (1.12e-1)" "unprognostic (8.85e-2)" "unprognostic (1.97e-2)" "unprognostic (2.97e-1)" 19.3 12.7 22.9 19.2 24.4 19.5 12.3 48.6 29.9 31.6 26.4 23.1 17.3 22.2 52.1 17.4 23.9 24.5 23.2 53.8 18.8 18.3 27.4 16.0 22.0 11.8 20.4 11.7 33.0 41.4 34.4 30.2 24.4 16.9 22.8 17.2 26.8 26.3 16.9 31.0 15.9 25.3 27.5 31.6 15.0 23.4 8.3 17.1 44.0 33.5 23.2 24.1 31.8 21.9 2.0 12.1 4.7 21.0 3.0 2.2 4.5 14.5 15.6 11.0 13.7 9.0 18.6 6.9 14.7 15.6 6.2 4.1 9.3 9.4 18.9 23.6 14.5 11.5 12.0 7.0 11.8 3.7 9.0 7.8 6.6 11.6 7.7 23.9 8.5 3.6 12.9 24.1 4.8 10.9 17.9 8.0 12.2 15.3 16.0 5.8 30.0 27.8 10.5 4.5 22.5 16.4 18.4 9.2 22.3 10.2 16.7 10.2 30.3 12.8 32.2 12.5 9.6 6.3 10.3 11.9 26.3 17.8 19.8 8.3 10.5 4.9 40.8 24.3 7.9 18.3 2.1 8.6 1.5 2.1 8.8 2.2 2.0 1.6 2.2 7.0 1.7 1.6 2.2 4.7 3.0 21.0 12.1 1.5 4.5 22.9 24.4 48.6 29.9 18.8 18.3 20.4 11.7 16.9 17.1 92.3 45.5 28.3 27.6 23.4 53.5 101.2 28.1 46.8 45.5 38.4 64.8 44.1 8.3 29.7 7.2 31.1 49.5 0.0 20.8 48.4 40.9 44.0 11.5 30.9 29.9 50.9 40.8 32.5 70.3 7.4 38.3 36.4 16.9 25.2 44.2 49.6 28.5 54.3 57.3 53.1 57.1 25.8 24.5 12.0 13.8 37.9 73.6 20.8 37.2 42.8 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832149-122850793 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 200 "pancreas: 650.6" "Group enriched" "Detected in some" 23 "Exocrine glandular cells: 224.1;Pancreatic endocrine cells: 71.0" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 6 "B-cells: 1.1;T-cells: 3.2" "Cell line enhanced" "Detected in many" "hTERT-HME1: 7.2;LHCN-M2: 8.0" "Low region specificity" "Detected in single" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles No No Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663" "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 650.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.2 0.0 3.2 0.2 1.6 1.7 1.7 0.0 0.5 0.8 1.0 2.5 0.7 0.3 1.7 1.8 3.7 0.9 0.7 1.1 0.0 1.7 0.0 1.5 2.6 2.3 2.2 3.6 4.7 0.8 0.3 0.0 3.8 1.2 0.3 1.5 7.2 0.2 1.8 1.5 1.3 1.5 8.0 0.4 2.0 2.7 1.7 0.9 1.3 0.0 4.0 0.6 1.4 1.3 1.9 0.7 0.9 0.4 1.1 2.0 1.3 1.9 3.6 0.0 2.4 0.9 0.0 1.9 1.4 3.2 1.3 5.9 0.0 0.0 0.1 0.3 0.8 0.1 1.3 0.6 0.9 1.1 0.1 1.1 1.4 0.7 0.0 0.0 0.2 0.2 3.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.1 0.0 0.0 0.0 224.1 0.0 0.1 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 4.5 0.3 0.0 0.0 6.4 0.0 0.0 71.0 0.0 0.4 0.0 0.5 0.0 0.0 0.5 0.2 0.1 0.0 0.5 0.0 0.0 CWH43 "CWH43-C, FLJ21511" ENSG00000109182 "Cell wall biogenesis 43 C-terminal homolog" Q9H720 4 48986247-49062081 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 26.1;seminal vesicle: 22.9" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 22.7;Collecting duct cells: 7.0;Glandular cells: 8.2;Paneth cells: 11.5;Suprabasal keratinocytes: 8.0;Undifferentiated cells: 8.9" "Cancer enhanced" "Detected in many" "prostate cancer: 20.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;NB-4: 1.4;SH-SY5Y: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA042814, HPA048140" Uncertain NA NA "HPA042814: AB_2678182, HPA048140: AB_2680280" "unprognostic (9.38e-3)" "unprognostic (6.23e-2)" "unprognostic (3.14e-2)" "prognostic favorable (1.32e-4)" "unprognostic (2.14e-1)" "unprognostic (5.00e-2)" "unprognostic (1.94e-1)" "unprognostic (2.49e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-1)" "unprognostic (2.49e-4)" "unprognostic (1.24e-1)" "prognostic favorable (2.29e-11)" "unprognostic (5.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.82e-2)" "unprognostic (2.51e-2)" 0.1 0.0 0.1 9.3 0.1 0.0 1.0 0.1 0.2 5.1 9.7 0.2 11.1 0.0 2.0 2.2 19.8 8.6 0.4 0.1 0.1 0.1 7.6 1.1 0.8 0.1 0.1 0.1 0.2 0.1 0.0 0.4 0.1 0.1 26.1 9.1 0.4 2.7 22.9 0.1 16.9 0.1 1.9 0.1 0.1 5.2 0.7 0.1 0.3 10.6 12.6 3.6 3.7 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.1 1.6 0.0 0.3 0.0 22.7 2.3 7.0 0.0 0.0 1.7 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 11.5 0.0 3.4 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 8.9 0.3 CX3CL1 "ABCD-3, C3Xkine, CXC3, CXC3C, fractalkine, neurotactin, NTN, SCYD1" ENSG00000006210 "C-X3-C motif chemokine ligand 1" P78423 16 57372458-57385048 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Chemotaxis" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 39.3;Endothelial cells: 39.1;Glandular cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "EFO-21: 13.7;HDLM-2: 37.3;Hep G2: 27.8;RPTEC TERT1: 16.6;SK-BR-3: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026192, HPA040361" Approved Supported "Plasma membrane" "Secreted to blood" NA NA 1870000 "Plasma membrane" "CAB026192: , HPA040361: AB_10796453" "unprognostic (6.89e-3)" "prognostic favorable (9.46e-4)" "unprognostic (1.52e-2)" "unprognostic (3.20e-2)" "unprognostic (1.73e-1)" "unprognostic (1.82e-1)" "unprognostic (7.12e-2)" "unprognostic (2.08e-3)" "unprognostic (4.49e-2)" "unprognostic (3.70e-1)" "unprognostic (2.59e-2)" "unprognostic (2.06e-2)" "prognostic favorable (8.52e-7)" "unprognostic (5.19e-2)" "unprognostic (2.72e-1)" "unprognostic (1.11e-2)" "unprognostic (9.33e-2)" 24.3 3.6 13.4 4.7 26.6 0.7 42.5 3.8 45.1 12.4 5.9 6.9 8.7 4.2 12.1 7.0 10.7 11.7 14.9 12.0 16.4 13.8 14.5 11.2 35.3 6.0 9.2 18.0 5.2 9.6 3.8 4.5 3.4 11.7 22.3 4.5 12.2 39.9 34.4 9.2 9.9 5.0 21.7 6.6 1.5 5.0 3.8 3.9 0.8 12.0 5.7 4.9 19.7 6.7 1.0 0.8 2.1 0.7 0.8 0.6 0.2 0.0 0.3 3.6 3.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 13.7 0.0 1.9 0.1 0.0 0.0 0.0 37.3 0.2 0.0 0.0 27.8 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.5 0.0 16.6 0.1 0.1 3.2 0.0 9.7 0.8 2.4 0.0 0.1 0.0 0.1 2.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.7 0.5 0.6 0.4 0.3 0.6 0.4 0.3 0.2 1.0 0.4 0.6 2.1 0.8 0.4 0.8 0.2 0.2 13.4 26.6 3.8 37.3 16.4 13.8 9.2 18.0 11.7 3.9 3.0 5.8 0.0 39.3 3.9 5.4 7.0 25.5 10.7 25.0 3.5 3.9 0.0 0.0 25.9 0.3 39.1 0.2 0.0 1.6 0.0 3.3 28.6 1.1 10.0 0.0 4.8 1.7 3.1 0.6 0.0 4.4 0.0 0.0 1.0 0.0 0.8 6.6 0.0 26.2 10.2 1.7 12.9 14.4 0.1 0.1 2.3 0.2 0.0 0.7 24.6 CX3CR1 "CCRL1, CMKBRL1, CMKDR1, GPR13, V28" ENSG00000168329 "C-X3-C motif chemokine receptor 1" P49238 3 39263494-39281735 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Age-related macular degeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 69.2;brain: 51.6" "Cell type enhanced" "Detected in some" 17 "Kupffer cells: 14.4;Macrophages: 26.4;Sertoli cells: 6.5;T-cells: 15.2" "Cancer enhanced" "Detected in many" "glioma: 21.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 69.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 20 "RPMI-8226: 114.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032478, HPA046587" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "CAB032478: AB_638830, HPA046587: AB_2679708" "unprognostic (2.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.65e-1)" "unprognostic (2.42e-2)" "unprognostic (6.52e-2)" "unprognostic (3.01e-3)" "unprognostic (2.64e-1)" "unprognostic (1.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.57e-3)" "unprognostic (1.13e-2)" "unprognostic (1.04e-1)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (8.59e-2)" "unprognostic (7.71e-3)" "unprognostic (1.12e-1)" 2.3 3.8 14.9 6.0 17.3 0.9 4.8 2.5 34.1 2.7 1.2 51.6 0.0 1.2 2.7 4.2 1.4 5.9 2.5 2.2 12.4 11.9 2.5 1.9 9.0 1.8 21.8 7.4 1.8 1.8 5.2 2.5 4.3 21.8 3.7 1.2 3.5 6.4 7.0 5.2 2.4 1.2 3.3 33.5 10.3 1.5 1.8 16.3 0.8 2.4 0.7 4.7 2.8 1.3 0.1 15.7 3.5 69.2 6.5 46.5 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 114.8 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.6 0.0 1.2 15.9 0.2 46.5 43.3 0.5 0.1 10.4 25.2 15.7 0.1 3.7 22.7 3.5 6.5 69.2 1.1 0.2 29.8 14.9 17.3 2.5 19.9 12.4 11.9 21.8 7.4 21.8 16.3 0.0 0.3 0.0 0.0 0.5 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.7 0.0 3.5 0.0 0.0 0.6 14.4 0.0 0.3 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.5 0.0 0.7 0.2 0.5 0.0 15.2 0.0 0.0 CXADR CAR ENSG00000154639 "CXADR, Ig-like cell adhesion molecule" P78310 21 17512382-17593579 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.4" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 287.2;Suprabasal keratinocytes: 300.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 32.2;Hep G2: 20.8;NTERA-2: 37.3;RT4: 36.0" "HPA003342, CAB005103, HPA030411, HPA030412" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 11000 "Plasma membrane, Cell Junctions" "CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992" "unprognostic (3.75e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favorable (3.50e-4)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (1.94e-1)" "unprognostic (2.15e-1)" "unprognostic (3.48e-3)" "unprognostic (1.04e-1)" "unprognostic (9.35e-2)" "unprognostic (3.89e-3)" "unprognostic (2.20e-1)" "unprognostic (8.27e-2)" "unprognostic (5.71e-3)" 4.0 3.1 6.4 3.2 9.4 1.3 5.8 2.0 15.4 6.3 27.1 12.5 9.0 24.9 3.3 9.3 15.0 6.5 17.2 10.8 7.9 5.5 5.1 28.6 9.9 4.2 9.2 5.6 1.1 12.0 5.2 11.1 0.3 11.6 9.2 15.4 3.7 16.3 15.8 0.6 30.0 41.4 2.1 13.0 1.4 17.6 8.5 6.9 0.9 13.1 4.9 3.8 14.7 10.0 0.8 0.4 2.6 0.5 0.9 2.7 0.9 5.6 3.1 15.4 0.0 0.0 0.0 9.3 0.0 0.0 0.2 0.9 32.2 4.9 2.0 6.9 0.0 4.6 9.8 7.8 2.0 0.3 3.1 6.6 0.0 9.2 20.8 1.0 0.6 0.0 0.0 8.5 0.4 0.1 3.7 3.0 1.9 0.1 0.1 0.0 0.3 1.2 0.0 37.3 5.0 0.0 0.0 5.2 4.0 12.9 36.0 6.2 4.2 3.6 4.1 2.1 16.5 8.6 0.1 0.1 0.0 9.3 0.1 2.2 1.5 2.5 0.1 1.2 0.0 0.2 2.6 0.5 0.4 0.5 0.2 1.0 0.3 2.6 0.6 0.1 0.8 2.7 0.8 1.4 0.9 0.2 0.4 0.5 0.9 6.4 9.4 2.0 15.4 7.9 5.5 9.2 5.6 11.6 6.9 131.0 63.6 1.5 156.7 287.2 15.2 27.4 137.6 50.9 55.7 97.7 25.5 1.0 5.0 109.2 4.3 2.0 199.0 0.0 81.3 0.2 6.8 133.1 5.7 114.1 0.6 0.0 77.6 70.6 23.6 4.0 2.0 5.3 21.9 1.0 96.0 11.6 81.7 112.0 0.0 4.4 10.0 6.5 3.8 4.2 22.3 300.5 0.6 3.8 81.0 165.3 CXCL10 "C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10" ENSG00000169245 "C-X-C motif chemokine ligand 10" P02778 4 76021117-76023497 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 36.2;lymphoid tissue: 34.8;prostate: 34.6" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 9.7;Glandular cells: 10.1;Hofbauer cells: 18.2;Macrophages: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 10.6;intermediate monocyte: 25.5;non-classical monocyte: 15.9" "Lineage enriched" "Detected in many" 15 "monocytes: 25.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 3.4;BJ hTERT+ SV40 Large T+ RasG12V: 3.4;GAMG: 7.9;RPMI-8226: 6.3;RT4: 3.6;THP-1: 4.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 253000 "unprognostic (1.94e-1)" "unprognostic (5.32e-2)" "unprognostic (9.98e-3)" "unprognostic (6.30e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-1)" "unprognostic (7.59e-2)" "prognostic favorable (1.12e-5)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.75e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (1.03e-1)" "unprognostic (4.95e-2)" "unprognostic (1.73e-2)" "unprognostic (1.66e-2)" 4.3 2.1 2.7 34.8 2.5 0.0 7.3 1.8 4.8 8.1 3.5 0.9 0.2 3.8 2.3 6.7 4.7 1.2 3.8 7.6 1.2 1.2 7.5 10.6 36.2 21.7 3.2 1.6 3.9 1.2 0.0 2.3 5.6 3.0 34.6 6.0 2.6 9.1 2.1 7.3 2.1 4.1 5.5 11.3 15.8 6.4 1.3 0.9 15.0 25.7 5.4 9.2 9.2 2.2 0.5 1.6 0.6 25.5 0.0 0.1 3.7 0.7 0.0 0.0 0.3 0.0 0.2 0.0 0.0 9.2 3.4 3.4 0.3 0.1 3.0 0.3 0.0 7.9 0.0 0.0 0.2 0.2 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 6.3 0.1 3.6 0.0 0.0 0.0 0.7 2.0 0.0 0.2 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.8 0.0 0.0 10.6 0.0 0.0 25.5 0.0 0.5 0.1 0.0 1.6 0.0 0.0 0.0 0.6 0.0 15.9 0.0 0.0 3.7 2.7 2.5 1.8 4.8 1.2 1.2 3.2 1.6 3.0 0.9 0.0 2.1 0.5 9.7 0.8 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 1.1 0.0 0.0 0.0 0.8 10.1 1.1 0.0 18.2 0.0 0.0 0.0 5.6 3.5 0.3 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 CXCL11 "b-R1, H174, I-TAC, IP-9, SCYB11, SCYB9B" ENSG00000169248 "C-X-C motif chemokine ligand 11" O14625 4 76033682-76041415 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 20.1" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 3.0;Basal glandular cells: 2.5;Cholangiocytes: 2.5;Exocrine glandular cells: 3.0;Kupffer cells: 4.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 2.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "BJ hTERT+: 5.3;BJ hTERT+ SV40 Large T+: 8.3;BJ hTERT+ SV40 Large T+ RasG12V: 8.8;GAMG: 2.3" "Not detected" "Not detected" CAB009921 Uncertain "Secreted to blood" NA NA 187000 "CAB009921: AB_2088137" "unprognostic (2.00e-1)" "unprognostic (3.62e-1)" "unprognostic (6.94e-3)" "unprognostic (1.87e-2)" "unprognostic (9.95e-2)" "unprognostic (5.85e-2)" "unprognostic (1.89e-1)" "unprognostic (1.04e-1)" "unprognostic (1.73e-1)" "prognostic favorable (4.31e-7)" "prognostic unfavorable (8.18e-5)" "unprognostic (2.90e-1)" "prognostic unfavorable (3.29e-6)" "unprognostic (1.53e-1)" "unprognostic (4.17e-2)" "unprognostic (4.48e-2)" "unprognostic (5.32e-2)" 3.6 0.3 3.8 10.5 3.1 0.0 3.4 1.3 2.0 3.3 1.4 0.6 0.1 0.6 1.3 2.0 2.3 1.4 2.0 3.3 2.2 2.8 2.5 2.1 13.7 10.0 3.1 1.5 1.3 8.9 0.0 0.7 3.5 2.8 8.5 4.5 0.3 2.9 1.1 6.4 0.6 1.0 1.4 9.8 7.0 5.6 0.6 1.5 4.3 20.1 3.6 1.4 3.2 0.7 0.0 0.9 0.0 2.1 0.0 0.1 0.6 1.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 5.3 8.3 8.8 0.0 0.2 1.0 0.0 0.0 2.3 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 2.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.6 3.8 3.1 1.3 2.0 2.2 2.8 3.1 1.5 2.8 1.5 3.0 0.0 0.0 2.5 0.1 0.0 0.0 2.5 1.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.7 0.0 3.0 0.0 0.0 1.7 0.0 0.0 1.9 0.0 0.0 0.6 4.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 CXCL14 "BMAC, bolekine, BRAK, Kec, KS1, MIP-2g, NJAC, SCYB14" ENSG00000145824 "C-X-C motif chemokine ligand 14" O95715 5 135570679-135579279 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 140.1" "Group enriched" "Detected in many" 6 "Basal keratinocytes: 3051.6;Fibroblasts: 4090.0;Proximal tubular cells: 2046.8;Suprabasal keratinocytes: 1848.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.2" "Group enriched" "Detected in many" 6 "dendritic cells: 3.2;granulocytes: 1.1" "Group enriched" "Detected in some" 12 "HAP1: 17.2;hTCEpi: 22.8;RPTEC TERT1: 61.9;SuSa: 34.3;U-2 OS: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB029996 Uncertain "Secreted to blood" NA NA 800000 "CAB029996: AB_2086070" "unprognostic (1.82e-3)" "prognostic favorable (1.71e-4)" "prognostic favorable (4.52e-4)" "unprognostic (2.75e-2)" "unprognostic (2.71e-3)" "unprognostic (2.94e-2)" "unprognostic (1.33e-1)" "unprognostic (9.05e-2)" "unprognostic (2.22e-2)" "unprognostic (5.34e-2)" "unprognostic (1.26e-1)" "unprognostic (9.89e-2)" "unprognostic (2.09e-1)" "unprognostic (3.48e-1)" "unprognostic (1.85e-1)" "unprognostic (1.49e-1)" "unprognostic (2.54e-1)" 59.5 0.9 19.4 25.8 14.9 0.2 44.1 0.6 20.7 40.7 30.0 1.5 4.5 38.8 6.8 26.1 16.7 5.2 3.8 11.2 10.8 4.6 79.2 10.3 1.7 13.9 6.3 9.3 2.1 2.8 0.3 25.4 30.5 7.6 7.0 34.3 14.3 44.2 3.7 17.2 140.1 59.2 8.6 1.0 15.1 18.7 5.1 2.4 1.5 10.0 30.2 22.9 12.7 17.0 0.2 3.2 1.1 0.3 0.3 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.8 0.2 0.0 0.0 0.0 2.6 0.0 0.8 0.0 1.1 0.0 17.2 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.3 61.9 0.0 0.3 0.2 0.1 0.0 0.0 34.3 0.0 0.0 0.0 0.0 25.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.9 0.3 0.2 0.2 0.1 0.3 0.1 0.2 0.1 3.2 0.2 0.3 0.2 1.1 0.3 0.2 0.2 0.2 0.1 19.4 14.9 0.6 20.7 10.8 4.6 6.3 9.3 7.6 2.4 0.0 0.6 0.9 12.3 3051.6 249.2 2.0 0.0 0.0 0.0 268.7 0.0 28.7 477.5 0.0 0.6 4.8 0.0 0.0 0.0 24.5 4090.0 8.5 0.0 0.0 56.4 6.4 0.0 74.3 0.0 1.1 19.2 3.2 416.7 0.0 0.0 3.7 0.1 0.0 0.4 2046.8 14.0 0.0 20.0 0.5 4.1 1848.7 64.5 0.0 0.0 8.1 CXCL16 "CXCLG16, SR-PSOX, SRPSOX" ENSG00000161921 "C-X-C motif chemokine ligand 16" Q9H2A7 17 4733526-4739922 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 22 "Early spermatids: 715.4;Late spermatids: 3190.9;monocytes: 938.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 18.3;intermediate monocyte: 29.3;myeloid DC: 10.7;neutrophil: 25.9;non-classical monocyte: 37.7" "Group enriched" "Detected in many" 7 "dendritic cells: 10.7;granulocytes: 25.9;monocytes: 37.7" "Cell line enhanced" "Detected in many" "A-431: 35.0;CACO-2: 24.1;CAPAN-2: 19.0;HaCaT: 39.2;T-47d: 18.9" "HPA053253, HPA066315" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1100000 4000000 "Golgi apparatus" Vesicles "HPA053253: AB_2682091, HPA066315: AB_2685657" "unprognostic (4.64e-3)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (3.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (4.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.78e-2)" "unprognostic (4.74e-2)" "unprognostic (2.37e-2)" "unprognostic (2.48e-2)" "unprognostic (2.60e-1)" 32.5 9.5 8.2 18.7 9.7 16.3 9.7 2.0 6.6 8.0 17.2 15.8 3.4 19.1 4.8 10.5 13.1 9.5 23.0 5.2 9.9 6.9 12.5 34.8 41.9 28.8 13.3 5.1 10.6 11.0 34.6 8.6 9.7 10.0 9.8 8.3 12.7 26.6 5.9 3.3 11.3 29.5 5.2 16.5 34.1 18.7 51.9 10.0 4.5 8.1 8.5 10.1 9.7 7.4 3.4 10.7 25.9 37.7 0.0 0.3 6.9 35.0 4.8 0.0 11.3 0.1 0.9 4.5 0.4 3.4 3.4 4.6 24.1 19.0 0.0 4.2 0.2 2.1 39.2 5.6 4.0 1.2 3.6 6.4 0.0 0.5 10.6 2.4 0.0 5.2 0.2 6.7 1.8 0.2 1.3 0.9 0.1 0.0 0.2 0.3 7.4 0.1 0.6 0.0 10.1 3.0 0.4 0.0 5.2 7.2 5.8 0.0 0.4 7.1 2.9 1.8 0.4 18.9 0.4 0.1 0.5 2.5 0.8 2.0 1.2 1.6 0.0 0.1 0.1 0.9 0.0 18.3 4.0 0.1 29.3 0.1 2.9 0.3 0.2 10.7 3.4 0.1 0.3 25.9 0.0 37.7 4.6 0.0 6.9 8.2 9.7 2.0 6.6 9.9 6.9 13.3 5.1 10.0 10.0 68.5 50.1 21.2 107.8 62.3 2.0 0.7 40.8 14.7 37.5 38.4 2.0 2.4 3.3 146.2 715.4 13.4 32.3 0.0 129.6 1.8 13.6 179.9 71.7 5.9 190.7 3.2 29.6 160.8 160.8 3190.9 22.7 246.0 25.3 938.6 23.4 6.8 134.1 45.6 28.3 6.8 0.8 19.4 18.9 20.7 11.8 66.9 2.4 10.0 19.3 257.2 CXCL8 "3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1" ENSG00000169429 "C-X-C motif chemokine ligand 8" P10145 4 73740506-73743716 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 79.4;bone marrow: 300.7;lung: 106.1" "Group enriched" "Detected in many" 4 "Basal glandular cells: 9866.5;Glandular cells: 5032.8;Urothelial cells: 12569.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 428 "neutrophil: 79.4" "Lineage enriched" "Detected in single" 794 "granulocytes: 79.4" "Group enriched" "Detected in many" 4 "BJ hTERT+: 291.3;GAMG: 80.6" "Not detected" "Not detected" HPA057179 Supported "Secreted to blood" NA NA 7260 "HPA057179: AB_2683362" "unprognostic (3.42e-1)" "prognostic unfavorable (1.18e-5)" "unprognostic (3.91e-3)" "unprognostic (8.49e-2)" "unprognostic (3.29e-2)" "unprognostic (3.03e-3)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.37e-3)" "unprognostic (3.19e-1)" "unprognostic (4.46e-1)" "unprognostic (7.19e-3)" "unprognostic (7.16e-2)" "prognostic unfavorable (3.13e-6)" "unprognostic (4.73e-2)" "unprognostic (8.57e-2)" "unprognostic (1.64e-2)" "unprognostic (6.15e-2)" 13.4 1.6 1.8 21.9 1.9 300.7 1.7 0.4 1.5 6.5 1.4 0.8 0.0 0.5 4.5 0.9 6.7 3.9 18.9 17.7 1.3 1.1 2.4 8.4 106.1 2.3 2.4 0.9 4.4 4.3 0.3 1.1 9.6 7.8 4.3 1.0 1.9 7.4 0.3 2.9 0.5 1.6 1.4 5.5 1.6 2.8 13.5 1.1 1.0 1.1 9.3 7.7 27.9 1.5 0.0 0.0 79.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 1.4 0.0 1.8 291.3 2.6 8.6 0.0 0.9 0.0 39.9 0.0 80.6 3.4 0.0 0.0 41.6 0.1 0.0 0.0 0.0 0.4 0.5 2.6 0.1 0.9 0.1 8.7 0.2 0.9 9.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.0 1.4 0.0 0.0 0.0 23.1 1.2 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.3 22.4 4.2 0.3 1.1 3.8 0.0 0.0 0.1 18.8 2.1 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.4 0.0 0.0 0.0 0.0 0.0 1.8 1.9 0.4 1.5 1.3 1.1 2.4 0.9 7.8 1.1 47.6 287.8 4.2 9866.5 0.0 0.2 22.2 150.3 327.9 783.7 0.0 0.0 3.4 0.0 1020.3 1.4 16.9 1.6 0.0 220.3 4.9 10.8 5032.8 48.7 2.5 332.1 0.0 18.3 23.9 507.0 0.5 0.6 391.0 0.0 2049.7 1.0 0.4 645.9 0.0 0.4 0.4 1.1 38.8 17.7 0.0 1.2 0.0 17.8 4.3 1.6 12569.9 CXCL9 "CMK, crg-10, Humig, MIG, SCYB9" ENSG00000138755 "C-X-C motif chemokine ligand 9" Q07325 4 76001275-76007488 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 70.6;thyroid gland: 28.6" "Cell type enhanced" "Detected in some" 15 "Hofbauer cells: 6.6;Kupffer cells: 11.9;Macrophages: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.2;non-classical monocyte: 2.6" "Lineage enriched" "Detected in single" 27 "monocytes: 2.6" "Cell line enriched" "Detected in single" 8 "RPMI-8226: 4.9" "Region enhanced" "Detected in single" "olfactory region: 0.6" "Low region specificity" "Detected in some" "Secreted to blood" NA NA 902000 "prognostic favorable (6.36e-4)" "unprognostic (6.86e-3)" "unprognostic (1.25e-2)" "prognostic favorable (2.07e-4)" "unprognostic (2.97e-1)" "unprognostic (3.78e-3)" "unprognostic (8.79e-2)" "unprognostic (4.93e-2)" "unprognostic (1.46e-2)" "prognostic favorable (8.06e-4)" "unprognostic (2.18e-3)" "unprognostic (1.88e-1)" "prognostic unfavorable (5.15e-6)" "unprognostic (4.76e-2)" "unprognostic (4.14e-2)" "unprognostic (1.57e-2)" "unprognostic (6.54e-2)" 6.3 0.4 0.5 30.8 0.8 0.0 4.4 0.4 0.4 6.0 2.4 0.4 1.0 0.5 1.1 3.6 2.5 0.5 2.1 5.3 0.5 0.4 9.9 5.9 16.4 70.6 0.3 0.5 4.5 1.0 0.0 1.5 2.1 1.3 5.0 7.3 2.9 4.9 0.6 7.0 2.2 6.6 3.4 2.6 18.6 4.1 1.9 0.4 17.3 28.6 3.5 15.7 4.3 1.6 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 4.9 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.5 0.8 0.4 0.4 0.5 0.4 0.3 0.5 1.3 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.8 6.6 0.0 0.0 0.0 11.9 1.4 0.6 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 2.7 0.3 0.1 0.0 0.0 0.1 CXCR1 "CD181, CDw128a, CKR-1, CMKAR1, IL8RA" ENSG00000163464 "C-X-C motif chemokine receptor 1" P25024 2 218162845-218166995 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 144.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 9.0;granulocytes: 2.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 16 "neutrophil: 144.6" "Lineage enriched" "Detected in many" 59 "granulocytes: 144.6" "Cell line enriched" "Detected in single" 26 "HMC-1: 11.6" "Not detected" "Not detected" HPA031991 Uncertain NA NA "HPA031991: AB_2674103" "unprognostic (2.80e-1)" "unprognostic (2.91e-2)" "unprognostic (3.53e-2)" "unprognostic (5.74e-2)" "unprognostic (1.19e-1)" "unprognostic (1.68e-1)" "unprognostic (2.14e-2)" "unprognostic (3.36e-2)" "unprognostic (2.32e-1)" "unprognostic (1.57e-1)" "unprognostic (8.27e-2)" "unprognostic (2.15e-2)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-1)" "unprognostic (8.85e-2)" 11.5 0.4 0.8 21.1 0.7 7.3 0.6 0.9 2.6 0.6 0.6 0.2 0.0 0.0 0.5 0.1 1.3 2.8 3.6 3.8 0.9 0.6 0.7 2.9 20.3 33.4 5.9 0.0 1.7 1.2 0.0 0.8 2.1 2.3 0.9 0.1 1.4 0.6 0.0 1.0 0.5 0.6 1.4 3.4 33.7 1.0 1.4 0.7 0.1 0.9 0.6 0.4 4.5 4.1 0.0 0.0 144.6 0.2 0.1 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.2 0.2 2.4 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.9 144.6 0.1 0.2 0.0 0.0 0.7 0.8 0.7 0.9 2.6 0.9 0.6 5.9 0.0 2.3 0.7 0.0 9.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 CXCR2 "CD182, CMKAR2, IL8RB" ENSG00000180871 "C-X-C motif chemokine receptor 2" P25025 2 218125289-218137253 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 216.1" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 17.5;Club cells: 3.4;granulocytes: 5.8;Kupffer cells: 5.0;Macrophages: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 59 "neutrophil: 216.1" "Lineage enriched" "Detected in many" 109 "granulocytes: 216.1" "Group enriched" "Detected in some" 11 "BEWO: 12.4;HL-60: 6.9;HMC-1: 14.4;THP-1: 13.1;U-937: 12.9" "Low region specificity" "Detected in single" "CAB016268, HPA031999, HPA032017" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle" NA NA "Plasma membrane" "Nucleoplasm, Microtubules, Mitotic spindle" "CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112" "unprognostic (4.89e-2)" "unprognostic (2.01e-1)" "unprognostic (5.63e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (3.13e-1)" "unprognostic (1.33e-1)" "unprognostic (2.13e-1)" "unprognostic (5.96e-2)" "unprognostic (1.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-1)" "unprognostic (7.54e-2)" "unprognostic (1.04e-1)" "unprognostic (7.23e-2)" "unprognostic (8.18e-2)" "unprognostic (5.48e-2)" 9.3 0.9 1.3 25.6 1.5 4.0 0.6 1.2 1.3 5.2 0.6 0.5 2.5 0.0 0.8 1.1 18.1 3.3 5.2 4.3 1.5 0.6 0.7 4.6 16.7 40.5 6.6 0.0 1.2 1.7 0.0 0.7 4.5 1.7 1.9 0.3 1.8 3.3 2.6 0.6 3.0 0.7 1.4 4.1 30.6 1.0 1.1 0.7 0.6 0.6 4.8 10.1 5.4 6.4 0.0 1.6 216.1 1.9 0.4 1.9 1.0 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.9 14.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 1.1 0.2 0.0 0.0 0.3 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.0 13.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 12.9 0.0 3.6 1.9 3.2 1.9 0.5 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.7 216.1 0.4 0.2 1.6 0.0 1.0 1.3 1.5 1.2 1.3 1.5 0.6 6.6 0.0 1.7 0.7 0.0 17.5 0.0 0.9 0.0 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.2 5.8 0.0 1.6 0.0 0.0 0.0 5.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.0 1.8 CXCR3 "CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR" ENSG00000186810 "C-X-C motif chemokine receptor 3" P49682 X 71615916-71618517 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "Angiogenesis, Apoptosis, Chemotaxis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 61.7;lymphoid tissue: 24.5" "Cell type enriched" "Detected in some" 4 "T-cells: 31.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 61.7" "Group enriched" "Detected in many" 4 "dendritic cells: 61.7;NK-cells: 38.1;T-cells: 26.6" "Cell line enriched" "Detected in some" 15 "RPMI-8226: 32.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA045942 Enhanced NA NA "HPA045942: AB_2679507" "unprognostic (4.84e-3)" "unprognostic (3.05e-3)" "unprognostic (1.61e-1)" "prognostic favorable (3.44e-6)" "unprognostic (3.93e-2)" "prognostic favorable (3.35e-4)" "unprognostic (1.01e-2)" "unprognostic (5.24e-2)" "prognostic favorable (2.90e-4)" "unprognostic (6.32e-2)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.67e-6)" "unprognostic (4.67e-2)" "unprognostic (2.18e-1)" "unprognostic (2.91e-2)" "unprognostic (5.76e-2)" 0.9 0.9 0.4 9.0 0.4 6.0 0.6 0.3 0.3 1.9 2.4 0.4 0.5 5.4 3.3 1.4 1.3 1.1 2.6 2.4 0.3 0.4 1.9 0.8 4.5 19.0 0.4 0.1 1.6 0.8 0.0 0.6 0.7 0.5 2.9 0.8 1.5 3.9 1.0 0.4 0.5 9.1 0.3 0.7 13.9 2.6 0.6 0.0 14.0 1.9 1.7 24.5 1.7 1.8 9.8 61.7 0.4 0.0 38.1 26.6 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 17.3 0.0 8.9 9.8 19.6 26.6 1.6 1.8 1.2 11.1 0.4 38.1 0.0 61.7 17.8 6.3 0.4 0.4 0.3 0.3 0.3 0.4 0.4 0.1 0.5 0.0 0.0 0.0 7.5 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.7 1.8 1.1 0.0 0.1 5.8 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.5 0.1 31.9 1.7 0.0 CXCR4 "CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R" ENSG00000121966 "C-X-C motif chemokine receptor 4" P61073 2 136114349-136118165 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "Host-virus interaction" "G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 149.9;lymphoid tissue: 186.3" "Cell type enhanced" "Detected in many" 14 "B-cells: 772.9;Macrophages: 299.5;monocytes: 255.1;T-cells: 588.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 76.4;JURKAT: 43.5;Karpas-707: 41.0;MOLT-4: 69.2;REH: 36.7;U-266/70: 88.9;U-698: 89.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.19e-1)" "unprognostic (1.46e-2)" "unprognostic (2.69e-1)" "unprognostic (5.97e-2)" "unprognostic (1.29e-2)" "unprognostic (1.12e-2)" "unprognostic (4.99e-2)" "unprognostic (9.25e-2)" "unprognostic (6.06e-2)" "prognostic favorable (2.05e-4)" "unprognostic (1.23e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.41e-7)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.57e-1)" "unprognostic (3.47e-2)" "unprognostic (9.33e-2)" 15.4 26.5 3.0 39.1 3.4 149.9 9.7 0.8 2.1 7.7 8.7 6.8 1.5 1.6 8.3 3.8 16.4 9.1 12.0 5.4 4.1 4.7 8.2 7.1 29.3 94.5 6.5 1.3 6.3 3.1 0.7 8.1 7.8 6.1 6.8 7.0 10.0 10.6 2.2 3.2 2.3 57.8 3.8 22.9 82.4 8.0 7.2 3.4 186.3 9.2 4.6 97.5 50.0 6.6 47.3 16.8 37.8 7.2 4.0 32.0 11.9 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 76.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.9 4.6 12.1 0.0 0.0 10.5 8.3 0.0 0.0 0.0 0.0 0.0 7.3 43.5 0.1 41.0 0.0 0.2 69.2 9.4 1.2 5.9 0.4 36.7 8.5 13.3 0.6 0.0 4.2 3.5 0.0 0.2 0.0 0.4 0.0 20.7 1.0 0.0 0.2 0.0 0.0 88.9 15.0 89.4 0.0 17.4 0.0 17.9 7.2 29.6 22.9 3.8 18.7 30.1 21.1 21.7 6.6 47.3 32.0 30.1 37.8 4.0 2.1 16.8 18.9 11.9 3.0 3.4 0.8 2.1 4.1 4.7 6.5 1.3 6.1 3.4 14.9 64.2 772.9 4.0 36.5 4.4 3.6 2.5 4.0 6.8 3.5 0.0 1.4 11.6 3.6 0.9 19.0 0.0 46.7 0.8 2.2 30.2 4.8 11.6 5.5 168.4 0.0 1.7 22.7 175.5 1.7 1.4 299.5 108.0 255.1 0.1 1.0 1.6 0.0 2.5 2.1 0.6 45.3 16.3 0.5 5.5 31.1 5.3 588.4 0.4 3.2 CXCR5 "BLR1, CD185, MDR15" ENSG00000160683 "C-X-C motif chemokine receptor 5" P32302 11 118883766-118897799 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "B-cell activation" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 35.5;lymphoid tissue: 45.6" "Cell type enriched" "Detected in some" 26 "B-cells: 71.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 4.0" "Group enriched" "Detected in some" 8 "memory B-cell: 24.2;naive B-cell: 35.5" "Lineage enriched" "Detected in many" 9 "B-cells: 35.5" "Group enriched" "Detected in some" 10 "Daudi: 10.6;U-698: 37.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026149, HPA042432" Enhanced NA NA "CAB026149: , HPA042432: AB_2677995" "unprognostic (8.51e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-1)" "unprognostic (1.19e-1)" "unprognostic (4.02e-5)" "unprognostic (2.08e-2)" "unprognostic (3.23e-3)" "unprognostic (1.19e-2)" "unprognostic (3.66e-1)" "unprognostic (2.41e-3)" "unprognostic (1.52e-5)" "unprognostic (4.21e-1)" "unprognostic (2.03e-3)" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" 0.4 0.8 0.6 31.8 0.6 7.3 0.1 4.0 0.9 0.1 3.6 0.2 0.1 0.1 0.2 0.1 2.6 0.0 0.5 0.9 0.7 0.5 0.8 1.0 0.9 31.5 0.3 0.1 0.3 0.5 0.0 0.9 0.1 0.2 2.9 0.3 0.3 3.6 0.1 1.3 0.9 8.6 0.1 0.3 45.6 1.3 0.1 0.1 1.9 0.7 1.3 41.8 3.9 0.9 35.5 0.0 0.0 0.0 0.0 3.9 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 10.6 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.5 0.4 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.4 0.1 0.1 0.5 0.0 0.2 0.5 0.0 0.0 0.2 0.0 37.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.3 24.2 3.9 1.0 0.0 35.5 0.4 0.3 0.0 0.0 0.0 0.0 0.5 1.9 0.6 0.6 4.0 0.9 0.7 0.5 0.3 0.1 0.2 0.1 0.0 2.6 71.5 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.5 0.0 0.0 CXCR6 "BONZO, CD186, STRL33, TYMSTR" ENSG00000172215 "C-X-C motif chemokine receptor 6" O00574 3 45940933-45948353 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 81.3" "Group enriched" "Detected in some" 7 "Extravillous trophoblasts: 66.4;T-cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 4 "MAIT T-cell: 81.3" "Lineage enriched" "Detected in many" 6 "T-cells: 81.3" "Cell line enhanced" "Detected in some" "BEWO: 4.1;CAPAN-2: 15.7;JURKAT: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.05e-3)" "prognostic favorable (4.92e-4)" "unprognostic (1.77e-3)" "prognostic favorable (6.74e-6)" "unprognostic (6.67e-2)" "prognostic favorable (2.16e-4)" "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (1.93e-2)" "unprognostic (3.65e-4)" "unprognostic (8.57e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.42e-5)" "unprognostic (2.25e-2)" "unprognostic (4.42e-2)" "unprognostic (3.46e-2)" "unprognostic (1.57e-2)" 2.5 1.1 0.5 7.6 0.5 0.5 2.1 0.4 0.5 2.3 9.9 1.1 1.5 3.0 2.7 3.2 3.0 2.4 5.2 1.7 0.6 0.6 2.5 2.5 9.2 10.4 0.6 0.2 3.7 1.6 0.0 0.9 18.9 1.0 2.6 2.6 3.0 3.3 0.2 7.7 1.1 10.8 1.0 1.3 22.3 6.0 2.3 0.2 5.2 4.1 5.3 14.6 5.2 2.6 0.0 0.1 0.1 0.0 13.4 81.3 3.8 0.3 0.1 0.0 0.3 0.0 0.0 4.1 0.2 0.0 0.0 0.0 1.1 15.7 0.3 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.2 0.5 0.0 0.2 0.8 0.2 0.3 0.0 0.6 0.1 0.0 0.0 0.0 1.7 0.0 0.1 0.3 0.9 0.0 2.1 0.2 0.8 0.4 1.5 0.7 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.0 17.3 0.0 81.3 0.0 4.9 20.3 0.0 0.0 0.2 3.1 0.1 13.4 0.0 0.1 14.5 3.8 0.5 0.5 0.4 0.5 0.6 0.6 0.6 0.2 1.0 0.2 0.0 0.0 0.0 0.0 0.9 0.7 0.7 0.0 0.0 0.0 0.0 2.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.4 0.5 0.1 1.1 0.8 0.7 0.0 0.0 1.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.0 0.0 1.0 8.6 54.5 0.0 0.0 CXorf66 "RP11-35F15.2, SGPX" ENSG00000203933 "Chromosome X open reading frame 66" Q5JRM2 X 139955725-139965520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 17.8" "Cell type enriched" "Detected in some" 12 "Early spermatids: 95.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.87e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 CYB561 "CYB561A1, FRRS2" ENSG00000008283 "Cytochrome b561" P49447 17 63432304-63446378 "Predicted membrane proteins, Transporters" "Electron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 86.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 90.7;SK-BR-3: 43.4;T-47d: 35.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014753 Enhanced NA NA "HPA014753: AB_1847364" "prognostic unfavorable (8.89e-5)" "unprognostic (2.90e-1)" "unprognostic (4.01e-1)" "prognostic favorable (2.95e-5)" "unprognostic (1.81e-3)" "unprognostic (3.82e-1)" "unprognostic (1.37e-2)" "unprognostic (8.47e-2)" "unprognostic (2.07e-1)" "unprognostic (3.91e-2)" "unprognostic (8.97e-2)" "unprognostic (6.38e-2)" "unprognostic (8.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.17e-2)" "unprognostic (1.50e-2)" "unprognostic (2.89e-1)" 4.7 46.3 7.0 5.6 12.4 1.0 16.6 2.4 12.3 16.6 11.8 3.7 43.7 12.4 5.2 20.9 16.8 19.8 13.2 9.9 7.1 14.5 10.1 12.0 14.6 9.1 4.7 7.8 8.8 86.9 21.8 26.3 12.2 9.9 22.8 7.3 6.2 26.0 32.0 2.7 11.9 13.7 3.4 3.7 2.8 16.9 4.7 1.8 1.2 17.1 8.3 8.3 5.3 8.6 0.4 1.2 3.4 4.4 12.6 16.2 3.1 19.6 6.7 0.5 4.2 2.4 11.3 8.9 1.9 2.4 2.5 1.0 6.0 19.9 0.0 4.6 15.3 0.7 17.2 4.2 1.6 1.0 5.0 1.6 2.5 4.2 0.4 4.6 0.2 0.8 1.8 17.4 2.3 0.3 3.7 4.9 0.0 7.7 3.7 0.8 28.1 0.0 0.9 4.1 16.2 9.9 0.0 0.0 6.2 8.2 10.1 15.4 90.7 5.1 43.4 2.0 1.6 35.0 1.2 0.7 5.5 6.0 12.8 0.6 0.0 0.1 0.0 4.8 1.0 2.9 0.1 1.1 0.1 12.6 3.4 16.2 0.4 9.6 8.5 1.2 0.4 0.8 2.8 3.4 12.6 4.4 0.0 0.0 3.1 7.0 12.4 2.4 12.3 7.1 14.5 4.7 7.8 9.9 1.8 26.8 31.5 1.9 20.2 14.5 3.6 9.6 22.9 60.2 43.3 22.7 0.0 20.6 3.3 36.2 4.3 10.0 21.5 0.0 44.2 24.7 8.9 51.0 16.1 9.6 4.4 0.0 20.7 8.0 4.0 4.1 3.4 4.5 3.3 6.4 26.8 5.6 29.3 5.8 3.2 10.5 26.5 6.5 4.1 8.4 5.8 24.3 20.7 11.7 23.3 15.7 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348745-61362299 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.7;blood: 98.8" "Cell type enhanced" "Detected in many" 10 "Melanocytes: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8" "Group enriched" "Detected in all" 10 "B-cells: 50.1;dendritic cells: 98.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 10.0 113.7 4.0 22.5 6.4 7.1 7.5 4.7 6.9 6.6 10.9 10.9 14.4 6.1 10.9 9.9 8.8 11.0 11.0 5.7 5.1 4.1 9.7 30.6 12.4 21.7 8.3 3.5 14.5 17.9 9.0 6.6 21.0 6.8 9.2 9.6 10.7 10.9 8.1 10.2 24.8 15.8 7.6 5.6 24.0 8.5 8.0 7.0 16.8 10.0 8.4 33.3 10.7 7.3 50.1 98.8 3.8 7.4 3.3 3.8 8.7 18.2 30.8 4.9 14.2 23.4 15.5 4.2 9.2 14.0 11.1 11.1 8.3 20.4 35.5 16.6 16.2 9.0 25.5 4.7 25.6 6.8 23.7 10.5 6.1 20.8 5.6 11.0 8.4 15.9 21.8 36.2 24.1 11.1 9.2 16.5 16.1 20.0 21.3 18.6 19.6 15.8 3.6 9.2 16.3 17.7 19.2 4.8 26.5 12.8 18.1 6.1 10.1 18.8 27.1 21.2 3.4 22.0 9.8 10.9 13.1 6.8 12.7 13.2 13.3 17.6 19.9 18.0 14.7 16.4 1.6 7.4 3.8 3.8 6.0 3.4 40.5 2.7 3.4 7.4 50.1 2.8 3.0 2.5 3.3 6.4 98.8 2.6 8.7 4.0 6.4 4.7 6.9 5.1 4.1 8.3 3.5 6.8 7.0 6.0 28.1 119.0 16.1 25.1 15.4 1.4 7.6 29.4 25.0 12.2 29.5 43.5 10.0 22.6 55.7 11.9 46.6 0.0 34.2 35.0 17.5 17.4 8.1 18.7 49.1 17.5 18.5 11.6 20.3 10.6 19.2 29.8 303.7 77.5 27.1 16.9 21.9 38.6 19.4 12.9 51.6 12.9 12.3 5.4 11.1 21.0 33.1 21.8 26.6 12.9 CYB561D1 "FLJ39035, FLJ44753" ENSG00000174151 "Cytochrome b561 family member D1" Q8N8Q1 1 109494052-109502932 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027028 Uncertain NA NA "HPA027028: AB_1847365" "unprognostic (2.15e-2)" "unprognostic (3.49e-1)" "unprognostic (1.04e-2)" "unprognostic (1.98e-1)" "unprognostic (2.27e-1)" "prognostic favorable (4.68e-4)" "unprognostic (4.53e-4)" "unprognostic (1.32e-1)" "unprognostic (3.45e-1)" "unprognostic (5.29e-2)" "prognostic favorable (5.16e-6)" "unprognostic (4.30e-1)" "prognostic favorable (2.22e-4)" "unprognostic (1.20e-3)" "unprognostic (2.75e-1)" "unprognostic (4.95e-3)" "unprognostic (5.82e-2)" 6.1 10.5 8.7 10.7 12.0 9.1 7.0 21.7 13.4 4.2 8.4 7.9 13.4 7.1 6.9 14.8 9.3 7.0 6.7 4.6 9.6 5.6 8.2 4.2 7.4 12.8 9.7 10.2 9.4 19.4 11.1 11.2 7.0 8.8 6.8 7.7 4.6 10.8 8.4 7.8 22.5 12.2 6.8 7.8 12.1 9.0 3.9 11.1 10.6 10.3 6.6 12.8 7.0 12.2 4.5 3.0 10.8 4.5 8.7 8.3 3.5 8.3 5.0 3.6 4.2 12.6 9.3 9.3 7.3 5.7 8.4 6.0 4.9 3.8 7.6 7.9 9.4 5.5 9.7 4.8 6.0 5.5 6.2 4.4 5.1 6.8 3.8 5.9 10.3 16.0 9.9 15.0 8.3 4.4 5.3 6.0 7.5 3.2 3.5 5.4 10.6 3.7 5.5 1.7 6.4 7.7 6.1 14.8 3.0 7.7 14.3 5.4 4.7 8.3 8.2 7.7 5.3 5.6 5.6 7.8 8.4 9.9 11.3 5.9 4.0 2.9 3.8 8.5 8.6 9.2 3.8 3.8 5.6 6.3 4.2 5.5 3.5 6.6 5.6 2.7 4.5 8.3 5.8 10.8 8.7 4.5 3.0 4.7 3.5 8.7 12.0 21.7 13.4 9.6 5.6 9.7 10.2 8.8 11.1 0.0 6.6 4.9 1.5 2.1 7.6 3.4 5.1 2.7 3.4 3.5 2.0 2.2 0.0 2.8 0.0 2.1 7.4 0.0 6.9 1.0 2.1 1.5 1.1 1.8 1.1 3.2 4.1 1.3 3.8 0.0 2.3 2.3 1.7 1.0 2.7 2.4 4.5 0.0 3.9 2.3 5.5 0.0 2.8 1.1 1.5 2.6 0.9 6.9 3.4 2.3 CYB561D2 "101F6, TSP10" ENSG00000114395 "Cytochrome b561 family member D2" O14569 3 50350695-50358460 "Predicted membrane proteins" "Electron transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA071862 Approved NA NA "HPA071862: " "unprognostic (4.89e-2)" "unprognostic (3.25e-1)" "unprognostic (2.02e-1)" "unprognostic (6.98e-2)" "unprognostic (5.15e-2)" "unprognostic (2.72e-2)" "unprognostic (2.28e-3)" "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (5.41e-2)" "prognostic favorable (1.86e-4)" "unprognostic (3.26e-1)" "prognostic favorable (6.16e-5)" "unprognostic (4.33e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-1)" "unprognostic (7.57e-2)" 8.7 16.6 9.8 11.9 11.6 14.8 12.0 10.9 12.2 8.5 14.6 11.5 12.8 16.4 6.3 20.5 11.1 7.8 16.0 7.6 8.8 6.9 15.2 42.2 11.2 16.6 12.2 10.0 5.9 27.3 13.6 14.8 12.2 8.0 12.6 13.9 8.9 15.2 18.2 7.1 6.9 19.0 6.2 11.5 19.7 16.4 7.4 12.4 12.3 16.1 6.5 11.2 9.7 6.9 29.9 31.0 58.3 46.9 34.4 53.2 33.8 7.4 16.6 4.2 7.9 8.9 7.7 9.9 13.4 10.0 12.4 14.2 11.6 12.3 11.9 14.2 16.7 15.3 8.1 6.2 12.4 5.4 17.9 15.5 11.0 19.5 10.5 12.8 12.1 25.9 11.6 5.6 14.9 7.1 6.4 10.3 9.4 4.8 15.8 9.8 14.2 7.7 10.9 6.7 11.9 26.2 5.5 2.9 23.7 12.9 12.8 4.2 11.8 6.6 27.3 8.2 4.6 9.7 14.4 11.1 11.2 9.6 18.7 16.5 12.1 11.3 7.6 15.5 15.2 12.0 42.4 41.1 58.3 53.2 46.9 34.8 29.9 36.1 42.0 30.0 27.4 25.6 38.0 39.0 34.4 44.1 31.0 37.1 33.8 9.8 11.6 10.9 12.2 8.8 6.9 12.2 10.0 8.0 12.4 6.0 23.7 4.5 12.5 4.4 5.8 0.0 0.0 9.4 5.7 24.4 5.9 30.2 10.0 36.4 10.5 4.1 40.7 0.0 59.2 35.9 11.9 18.5 20.8 0.0 51.2 7.9 30.5 0.0 0.0 5.2 8.1 24.4 18.6 37.9 39.9 23.0 38.7 49.1 7.4 20.3 5.2 12.9 4.1 5.0 13.0 6.5 46.1 13.1 23.6 13.9 CYB5A CYB5 ENSG00000166347 "Cytochrome b5 type A" P00167 18 74250847-74292016 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 266.8" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 1827.0;Hepatocytes: 3445.7;Proximal tubular cells: 3021.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 154.8;RT4: 67.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006333, HPA047548, HPA058547" Enhanced Enhanced Vesicles,Cytosol No No 780000 "Vesicles, Cytosol" "CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750" "unprognostic (1.88e-1)" "unprognostic (1.28e-1)" "prognostic favorable (5.23e-4)" "unprognostic (1.08e-2)" "unprognostic (1.41e-1)" "unprognostic (9.14e-2)" "prognostic favorable (4.15e-4)" "unprognostic (7.79e-3)" "unprognostic (1.11e-1)" "unprognostic (3.33e-2)" "unprognostic (2.68e-2)" "unprognostic (1.65e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (4.64e-2)" "unprognostic (8.54e-2)" 25.0 13.2 4.3 11.0 5.8 1.5 39.4 6.9 5.9 7.5 68.2 4.3 38.5 37.7 4.9 16.0 8.3 7.0 34.8 14.5 4.1 3.7 76.2 266.8 67.0 9.2 6.5 3.4 25.1 75.3 10.1 6.5 7.2 5.2 13.5 9.0 6.2 7.6 54.9 4.3 11.4 70.7 21.2 11.5 10.3 18.0 12.2 5.5 4.6 4.6 7.9 4.3 21.6 18.8 34.9 16.9 2.1 12.9 10.2 38.0 13.5 10.0 17.2 9.0 0.0 154.8 27.5 12.0 6.9 15.1 14.8 22.3 20.3 11.0 12.3 4.9 12.7 7.3 22.5 0.0 9.5 11.8 22.9 11.9 4.5 9.4 53.8 24.0 8.6 5.9 46.1 7.6 8.4 4.3 8.9 8.1 11.0 7.3 4.6 12.4 18.1 4.8 10.3 4.0 14.2 11.2 12.0 2.9 0.2 14.8 67.5 25.7 10.7 6.7 18.4 8.2 8.0 36.4 8.2 7.6 0.0 11.6 3.5 8.8 3.2 13.3 3.8 9.1 2.4 8.5 1.1 9.6 2.1 16.7 10.8 38.0 28.5 18.7 19.6 16.9 34.9 18.4 23.1 1.1 10.2 12.9 14.8 14.4 13.5 4.3 5.8 6.9 5.9 4.1 3.7 6.5 3.4 5.2 5.5 592.6 899.4 80.0 70.0 87.0 10.0 73.8 919.7 746.8 1341.0 799.1 3.9 200.0 1827.0 177.8 6.0 109.5 224.5 0.0 443.4 144.1 156.3 120.6 38.2 3445.7 88.8 7.9 157.7 172.5 116.8 12.6 146.4 67.3 86.0 370.7 201.7 22.6 370.4 256.3 140.7 3021.0 12.1 51.8 70.7 13.6 36.0 195.7 37.2 60.9 256.7 159.2 CYB5B CYB5-M ENSG00000103018 "Cytochrome b5 type B" O43169 16 69424525-69466266 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 130.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007893 Approved Approved "Endoplasmic reticulum,Centriolar satellite,Cytosol" NA NA 1600000 "Endoplasmic reticulum" "Centriolar satellite, Cytosol" "HPA007893: AB_1847369" "unprognostic (1.13e-1)" "unprognostic (4.47e-2)" "unprognostic (9.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (2.87e-3)" "unprognostic (4.35e-3)" "unprognostic (3.87e-1)" "unprognostic (1.44e-2)" "unprognostic (1.52e-2)" "unprognostic (3.10e-1)" "prognostic favorable (6.38e-5)" "unprognostic (9.69e-3)" "unprognostic (4.66e-2)" "unprognostic (3.78e-2)" "unprognostic (1.30e-2)" 21.3 130.7 29.6 15.4 33.1 5.9 17.1 12.0 37.9 16.6 29.0 22.8 12.6 21.9 20.5 24.6 21.4 19.2 14.7 18.0 23.1 22.0 26.9 26.5 18.3 20.1 21.6 24.4 19.9 12.8 26.3 16.2 24.6 34.3 17.1 38.2 20.2 14.8 16.7 19.9 16.0 31.2 19.9 20.8 20.7 15.4 14.0 16.0 26.0 19.9 17.6 23.5 24.3 16.0 24.8 44.2 35.8 28.3 32.3 46.0 32.4 29.6 94.4 38.9 24.0 18.0 24.0 16.6 26.6 37.1 44.6 42.2 65.8 36.4 27.1 26.8 25.7 36.3 35.3 37.0 38.5 50.8 14.4 14.1 13.0 17.0 76.7 26.6 26.8 29.0 20.6 19.4 52.8 25.3 18.9 42.0 31.3 21.0 13.1 27.3 38.6 43.9 32.6 28.8 27.6 12.9 41.6 21.5 29.7 59.5 34.0 22.8 11.7 70.8 13.6 22.5 20.9 26.3 21.5 18.9 25.7 21.2 17.0 23.4 15.9 35.1 82.9 26.5 22.3 29.7 35.8 20.3 24.3 39.3 28.3 32.2 24.8 29.6 30.8 24.8 22.6 24.6 29.2 6.1 32.3 20.1 44.2 46.0 32.4 29.6 33.1 12.0 37.9 23.1 22.0 21.6 24.4 34.3 16.0 41.7 38.5 39.4 44.1 44.3 21.6 21.7 25.5 52.2 42.1 59.3 5.9 140.9 66.3 51.1 13.9 49.6 69.8 23.3 62.0 75.3 41.2 33.1 58.9 43.3 55.7 28.6 22.5 36.2 27.6 17.2 41.1 44.4 59.1 64.9 68.4 45.7 54.3 63.1 41.8 46.7 30.4 45.3 42.2 31.1 48.5 36.9 50.0 71.0 55.0 45.3 CYB5D2 MGC32124 ENSG00000167740 "Cytochrome b5 domain containing 2" Q8WUJ1 17 4143168-4187310 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011032, HPA042299" Approved Approved "Endoplasmic reticulum,Plasma membrane" "Secreted - unknown location" NA NA "Endoplasmic reticulum, Plasma membrane" "HPA011032: , HPA042299: AB_10793879" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (4.16e-2)" "prognostic favorable (6.19e-4)" "unprognostic (1.88e-2)" "unprognostic (1.75e-2)" "prognostic favorable (4.98e-6)" "unprognostic (1.57e-1)" "unprognostic (2.47e-1)" "unprognostic (9.71e-3)" "prognostic favorable (7.76e-5)" "unprognostic (2.04e-1)" "prognostic favorable (2.03e-10)" "unprognostic (2.01e-3)" "unprognostic (8.73e-2)" "unprognostic (1.82e-1)" "unprognostic (2.97e-1)" 13.1 17.3 18.7 5.1 26.4 3.6 15.0 20.6 27.5 15.0 8.1 21.8 14.6 13.3 13.9 27.1 9.8 17.4 14.5 10.3 17.8 21.6 22.9 25.3 8.6 7.4 19.7 26.1 19.5 17.0 28.5 18.5 9.9 19.1 12.0 6.8 17.3 17.5 16.8 12.2 11.7 10.3 7.8 21.7 7.9 12.3 54.1 17.1 4.8 20.6 7.1 6.8 12.0 8.6 9.4 13.0 14.7 12.7 5.9 12.5 9.0 7.9 10.7 6.2 6.5 40.1 11.8 2.6 7.7 16.7 5.7 5.8 3.1 5.3 2.6 7.0 8.9 4.8 11.3 2.6 3.6 2.3 8.5 12.9 2.4 6.7 5.3 7.3 1.0 4.9 15.4 8.6 3.1 6.2 11.9 10.2 5.8 2.5 15.8 4.3 9.8 3.7 1.6 2.2 6.8 5.8 4.5 5.5 6.3 13.1 4.2 5.0 4.2 8.7 5.1 11.4 7.2 13.5 1.6 13.7 8.3 2.1 7.6 4.0 3.0 2.3 2.0 10.2 2.2 3.2 0.6 12.7 14.7 7.2 10.4 8.1 9.4 11.4 8.8 12.0 9.4 10.8 9.7 11.7 5.9 9.4 13.0 12.5 9.0 18.7 26.4 20.6 27.5 17.8 21.6 19.7 26.1 19.1 17.1 11.9 9.3 19.5 18.9 47.7 26.3 8.5 56.0 45.5 11.4 29.6 55.0 44.7 44.7 26.6 19.7 31.6 18.6 0.0 23.9 24.3 20.3 8.4 10.5 31.1 17.8 38.1 13.3 29.4 21.3 23.3 26.7 17.5 13.5 14.4 13.8 34.2 24.3 17.3 26.9 34.9 30.0 0.0 21.2 83.1 23.6 37.5 32.3 15.2 15.8 7.8 CYB5R1 "humb5R2, NQO3A2" ENSG00000159348 "Cytochrome b5 reductase 1" Q9UHQ9 1 202961869-202967280 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 119.2" "Cell type enhanced" "Detected in all" 6 "Basal keratinocytes: 166.3;Syncytiotrophoblasts: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010641, HPA014147" Enhanced Approved Mitochondria,Cytosol NA NA 860000 Mitochondria Cytosol "HPA010641: AB_1078600, HPA014147: AB_1847370" "unprognostic (6.36e-2)" "unprognostic (8.51e-2)" "unprognostic (1.16e-2)" "prognostic favorable (1.14e-4)" "unprognostic (1.86e-2)" "unprognostic (4.34e-2)" "unprognostic (8.46e-2)" "unprognostic (1.28e-1)" "unprognostic (4.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (2.89e-1)" "unprognostic (1.73e-2)" "unprognostic (2.33e-1)" "unprognostic (6.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.69e-1)" 9.6 14.5 7.8 5.0 8.4 3.9 16.9 6.2 11.0 11.6 7.5 8.7 10.6 4.4 10.1 32.3 13.7 16.4 9.2 33.9 7.3 9.2 15.5 18.4 10.1 11.7 10.0 9.1 10.8 11.1 16.3 11.1 63.8 11.9 10.5 5.0 15.7 14.4 10.1 119.2 28.5 6.9 10.6 7.4 10.8 18.6 20.1 6.7 11.7 13.5 26.4 10.0 13.6 10.1 20.2 21.9 25.7 33.3 17.2 26.5 28.8 8.5 5.3 4.7 9.6 43.9 10.1 46.1 17.1 16.2 11.2 10.0 4.4 10.1 5.3 14.6 17.1 6.2 47.3 3.8 14.7 7.4 7.6 9.7 3.0 6.5 5.0 15.8 2.6 7.6 16.2 48.7 12.3 6.7 9.5 7.3 6.6 8.9 9.6 40.2 10.0 3.2 2.3 3.1 7.7 10.3 5.4 22.7 11.3 10.6 10.2 4.0 5.0 9.6 32.0 13.9 10.7 14.8 5.8 7.1 12.8 5.4 4.8 9.5 9.0 10.6 2.5 14.1 4.0 9.5 11.6 33.3 25.6 16.7 24.2 22.2 13.6 19.3 17.8 21.9 20.2 26.5 18.8 25.7 17.2 15.7 15.1 19.1 28.8 7.8 8.4 6.2 11.0 7.3 9.2 10.0 9.1 11.9 6.7 20.8 24.3 13.0 30.5 166.3 19.6 98.7 33.1 58.9 20.5 27.9 27.5 100.3 6.6 35.7 4.3 29.5 11.9 23.3 41.7 159.6 29.6 19.2 27.7 36.0 54.2 9.5 18.4 23.4 39.9 5.4 27.6 33.5 60.8 9.0 10.9 56.4 53.6 10.5 29.4 32.1 25.9 12.9 34.0 24.6 2.7 137.6 245.4 17.5 14.2 47.8 CYB5R2 ENSG00000166394 "Cytochrome b5 reductase 2" Q6BCY4 11 7665100-7677222 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 58.8" "Group enriched" "Detected in many" 5 "Early spermatids: 205.4;Late spermatids: 439.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 5.9;memory B-cell: 12.2" "Group enriched" "Detected in many" 9 "B-cells: 12.2;granulocytes: 5.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 42.5;BJ hTERT+ SV40 Large T+: 22.7;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 18.2;NTERA-2: 23.9;WM-115: 32.7" "Low region specificity" "Detected in many" "HPA038962, HPA061707" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038962: AB_10675954, HPA061707: AB_2732668" "unprognostic (1.47e-1)" "unprognostic (2.56e-2)" "unprognostic (8.90e-3)" "unprognostic (4.41e-2)" "unprognostic (4.13e-3)" "unprognostic (1.60e-2)" "unprognostic (4.02e-2)" "unprognostic (2.48e-1)" "unprognostic (3.41e-2)" "unprognostic (1.30e-2)" "unprognostic (2.64e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.40e-1)" "unprognostic (8.16e-2)" "unprognostic (1.70e-1)" "unprognostic (7.01e-2)" 3.3 1.9 9.3 2.8 12.1 1.9 7.7 3.1 12.3 6.6 2.3 26.1 4.2 1.3 10.0 13.1 8.0 5.2 3.4 2.0 11.2 5.3 2.4 2.5 4.6 3.8 22.3 7.3 14.9 2.2 23.1 0.6 6.7 11.6 7.8 2.7 12.2 12.8 11.6 0.8 23.4 1.7 6.8 12.4 2.0 2.2 58.8 14.5 0.2 2.6 6.7 4.9 5.9 7.1 12.2 0.0 5.9 1.0 0.0 0.2 0.7 2.3 1.2 0.5 0.0 0.1 0.6 7.9 14.8 42.5 22.7 20.7 0.2 3.2 0.0 3.5 7.6 7.0 0.2 0.0 0.1 18.2 0.0 0.0 0.0 1.3 0.3 12.3 0.1 2.3 6.2 0.5 0.1 1.2 0.0 1.9 0.0 2.2 0.0 0.1 0.0 0.0 0.0 23.9 2.4 1.1 11.2 0.0 0.0 0.0 1.5 0.0 0.2 0.1 9.5 0.6 4.0 1.6 3.1 0.0 2.1 0.0 0.1 1.1 0.0 0.0 3.5 0.1 0.0 32.7 0.0 1.0 5.9 0.0 0.5 0.0 12.2 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.7 9.3 12.1 3.1 12.3 11.2 5.3 22.3 7.3 11.6 14.5 20.8 3.2 0.0 7.4 6.3 0.8 1.9 0.0 8.1 2.3 3.5 19.6 4.6 0.0 1.4 205.4 1.0 0.0 0.0 4.2 16.5 7.1 4.8 2.3 1.1 2.3 0.0 0.0 0.0 0.0 439.8 4.4 1.4 5.0 0.0 1.4 0.8 4.6 0.9 5.6 0.0 37.7 12.9 12.6 63.0 5.9 8.8 3.8 0.0 1.4 10.5 CYBA p22-PHOX ENSG00000051523 "Cytochrome b-245 alpha chain" P13498 16 88643283-88651152 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Transport" Oxidoreductase "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 116.7;lymphoid tissue: 129.2" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 1995.7;Kupffer cells: 1785.0;Macrophages: 1690.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 94.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 141.2;THP-1: 117.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009492 Enhanced NA NA "CAB009492: AB_2090309" "prognostic favorable (8.19e-4)" "unprognostic (1.05e-1)" "unprognostic (8.32e-2)" "prognostic favorable (4.75e-5)" "unprognostic (2.42e-1)" "unprognostic (4.77e-2)" "unprognostic (4.88e-2)" "unprognostic (9.16e-2)" "unprognostic (1.72e-1)" "unprognostic (1.11e-1)" "unprognostic (3.08e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.91e-1)" "unprognostic (5.22e-2)" "unprognostic (2.57e-2)" "unprognostic (1.63e-2)" 31.4 12.6 9.7 60.1 14.9 116.7 16.5 2.0 8.6 16.1 40.5 11.5 25.8 35.7 11.4 20.0 19.6 19.2 43.6 18.0 7.8 8.0 49.3 19.8 46.7 120.1 15.7 3.4 14.8 37.4 0.9 8.2 19.3 11.8 14.7 15.2 15.1 21.7 22.5 6.7 7.1 41.0 9.0 16.7 129.2 41.1 7.4 12.7 31.0 25.6 14.0 60.4 27.0 13.6 15.3 28.4 94.1 20.7 5.2 11.9 5.7 0.2 55.2 0.2 0.1 0.1 0.0 29.8 13.5 7.4 3.9 2.2 36.8 78.7 42.3 40.1 5.6 0.0 23.0 2.1 0.0 0.5 13.4 45.6 8.3 20.7 58.7 7.4 14.0 37.5 7.8 0.0 0.1 0.0 0.1 2.1 9.6 23.7 57.8 0.3 85.6 13.6 66.7 10.1 23.9 0.1 39.7 0.1 141.2 32.1 46.3 7.9 7.0 40.4 7.9 12.7 6.4 0.1 117.9 11.2 0.1 0.5 0.1 0.2 34.5 41.4 46.5 19.2 40.2 5.1 15.9 14.7 94.1 11.9 20.7 8.7 14.5 5.8 11.0 15.7 15.3 4.6 5.7 28.5 5.2 19.3 28.4 5.8 5.7 9.7 14.9 2.0 8.6 7.8 8.0 15.7 3.4 11.8 12.7 14.9 14.3 1206.4 193.9 106.1 0.0 11.3 382.1 38.8 34.2 270.4 2.0 56.0 107.8 589.8 3.5 108.2 700.4 256.9 138.1 250.5 228.6 131.9 281.8 17.4 1995.7 0.0 221.3 360.3 1785.0 7.4 46.3 1690.4 1093.2 1012.7 382.5 1.5 573.4 1045.1 20.1 714.0 2.1 58.2 83.9 0.6 17.7 74.9 98.9 597.7 722.2 321.4 CYBB "CGD, GP91-PHOX, NOX2" ENSG00000165168 "Cytochrome b-245 beta chain" P04839 X 37780011-37813461 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.3;lung: 49.4;lymphoid tissue: 74.5" "Group enriched" "Detected in many" 6 "Hofbauer cells: 133.2;Kupffer cells: 479.9;Macrophages: 227.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 50.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 16.5;NB-4: 19.8;REH: 16.9;RPMI-8226: 65.1" "Not detected" "Not detected" HPA051227 Enhanced NA NA 640000 "HPA051227: AB_2681395" "unprognostic (5.83e-2)" "unprognostic (1.77e-2)" "unprognostic (2.15e-3)" "unprognostic (1.48e-2)" "unprognostic (1.27e-1)" "unprognostic (5.65e-2)" "unprognostic (2.29e-2)" "unprognostic (4.45e-2)" "unprognostic (9.14e-2)" "unprognostic (2.32e-2)" "unprognostic (5.73e-2)" "unprognostic (5.18e-2)" "unprognostic (5.92e-2)" "unprognostic (3.02e-1)" "unprognostic (2.48e-2)" "unprognostic (1.32e-1)" "unprognostic (9.72e-2)" 16.4 11.0 9.7 44.2 13.2 42.6 8.1 2.5 6.7 3.7 6.0 10.4 0.2 5.2 3.4 6.3 3.2 6.0 7.5 10.1 6.8 6.5 6.2 11.8 49.4 74.5 12.6 2.9 5.3 4.5 1.4 4.9 16.1 10.3 4.8 8.9 4.5 6.0 2.7 2.5 2.2 16.1 15.3 20.3 49.9 4.9 2.3 10.3 5.4 3.4 3.5 20.2 13.9 3.1 8.1 17.5 20.0 50.3 0.1 0.1 22.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 16.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.1 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 19.8 0.0 0.0 0.1 16.9 0.0 65.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.0 0.0 2.8 0.0 0.3 45.5 20.0 0.0 50.3 0.1 8.1 0.0 0.0 12.1 7.2 0.0 0.0 3.7 0.1 42.7 17.5 0.1 22.0 9.7 13.2 2.5 6.7 6.8 6.5 12.6 2.9 10.3 10.3 23.8 33.4 47.7 0.1 0.9 0.0 9.6 2.5 13.4 23.9 1.8 0.0 0.9 0.0 0.0 0.1 1.6 0.9 0.0 0.3 0.9 4.3 0.0 7.0 2.1 133.2 1.6 0.0 7.4 479.9 0.4 0.6 227.9 1.7 3.6 0.7 0.1 0.2 0.0 0.0 0.5 0.5 12.9 0.9 0.0 0.3 1.1 1.5 2.5 1.2 0.0 CYBRD1 "CYB561A2, DCYTB, FLJ23462, FRRS3" ENSG00000071967 "Cytochrome b reductase 1" Q53TN4 2 171522247-171558133 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 205.4;Leydig cells: 187.0;Peritubular cells: 208.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.0;intermediate monocyte: 12.4;myeloid DC: 11.7;neutrophil: 6.7;non-classical monocyte: 9.4" "Group enriched" "Detected in many" 4 "dendritic cells: 11.7;granulocytes: 6.7;monocytes: 12.4" "Cell line enhanced" "Detected in many" "ASC diff: 144.2;ASC TERT1: 62.7;BJ hTERT+: 54.3;HSkMC: 44.4;hTERT-RPE1: 37.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014757 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014757: AB_1847374" "unprognostic (1.35e-1)" "unprognostic (1.57e-1)" "unprognostic (2.89e-2)" "unprognostic (4.87e-2)" "unprognostic (2.97e-2)" "unprognostic (3.11e-2)" "unprognostic (2.86e-1)" "unprognostic (5.44e-3)" "unprognostic (8.90e-3)" "unprognostic (3.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.71e-1)" "unprognostic (1.02e-3)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (2.77e-2)" "unprognostic (1.51e-2)" 75.2 26.0 10.1 9.3 13.2 4.0 78.9 6.1 8.0 44.5 56.3 14.7 16.3 49.5 44.3 28.5 29.6 26.1 38.8 43.1 12.1 5.5 8.6 6.2 35.6 10.6 11.0 11.2 49.5 5.4 2.0 9.5 9.5 11.4 41.7 10.2 32.0 21.5 21.1 17.5 26.7 111.3 41.1 12.8 7.3 18.1 20.1 11.7 2.1 103.8 23.9 10.0 43.8 56.0 0.0 11.7 6.7 12.4 2.5 1.2 4.4 3.2 2.4 1.3 2.6 144.2 62.7 0.2 11.8 54.3 6.2 7.8 0.1 4.5 0.0 2.0 27.7 6.3 1.6 1.1 0.9 7.3 2.4 0.3 2.7 3.7 0.0 30.3 2.8 0.2 44.4 9.2 9.6 1.8 37.0 3.9 1.6 0.9 0.0 16.9 0.0 0.9 2.6 0.7 0.0 0.6 0.3 17.0 0.1 0.9 0.1 0.1 0.6 13.7 0.0 7.3 0.5 4.8 1.7 7.8 13.9 2.0 12.9 5.0 0.0 0.0 0.0 6.6 2.4 7.4 0.0 12.0 0.5 1.2 12.4 0.2 0.0 0.2 0.1 11.7 0.0 0.0 0.0 6.7 2.5 9.4 0.5 0.0 4.4 10.1 13.2 6.1 8.0 12.1 5.5 11.0 11.2 11.4 11.7 205.4 82.9 0.0 33.8 107.6 0.0 17.1 28.1 8.1 48.9 24.4 0.0 1.6 0.0 1.0 0.9 40.3 13.6 46.7 5.8 1.3 122.8 21.6 2.3 2.1 39.6 0.0 0.0 57.7 57.5 2.1 187.0 28.5 42.2 12.6 3.8 29.3 1.3 8.6 208.2 0.3 1.8 19.4 57.5 0.9 1.3 52.6 1.1 2.5 4.8 13.8 CYHR1 "CHRP, KIAA0496, MGC13010" ENSG00000187954 "Cysteine and histidine rich 1" Q6ZMK1 8 144449582-144465677 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053653, HPA059543" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053653: AB_2682219, HPA059543: AB_2684056" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.58e-2)" "unprognostic (8.28e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.90e-4)" "unprognostic (4.02e-2)" "unprognostic (2.63e-1)" "unprognostic (2.13e-1)" "unprognostic (7.08e-3)" "unprognostic (1.46e-1)" "unprognostic (5.33e-2)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (1.54e-2)" 18.7 26.9 30.3 10.9 30.2 10.3 15.8 49.5 29.5 19.4 16.6 21.4 40.6 14.7 17.1 25.3 15.3 24.3 17.2 33.4 26.4 20.3 16.4 17.2 14.1 13.9 22.0 21.5 19.3 40.2 29.1 28.2 11.2 22.3 28.3 9.5 16.9 40.4 41.6 35.3 22.9 14.5 17.2 16.1 14.7 16.3 26.9 25.6 10.1 19.5 13.8 11.7 19.6 15.8 10.1 19.1 4.8 8.7 3.3 17.4 7.0 11.4 14.8 9.5 12.1 17.0 11.9 12.3 8.4 8.5 7.9 10.6 6.5 16.3 5.3 17.1 12.5 10.3 17.6 7.8 12.7 3.2 12.7 13.1 11.8 17.3 11.3 24.7 3.1 6.5 20.9 16.3 10.2 12.7 17.2 9.3 14.8 17.9 14.6 7.8 27.4 14.9 8.6 6.4 17.9 30.2 14.4 4.0 13.9 12.1 10.6 14.3 8.6 17.8 14.2 18.7 7.8 19.5 12.8 10.8 10.4 11.4 11.3 8.5 7.4 4.9 4.2 14.8 10.8 7.8 2.1 8.7 4.8 7.2 5.6 11.6 9.7 8.9 5.9 9.0 10.1 17.4 9.6 4.4 3.3 6.2 19.1 3.5 7.0 30.3 30.2 49.5 29.5 26.4 20.3 22.0 21.5 22.3 25.6 32.8 21.6 16.6 38.3 27.1 79.2 16.5 38.2 34.8 27.3 55.8 23.6 26.6 36.5 23.2 7.8 28.7 37.7 0.0 24.8 16.3 32.4 46.0 4.7 42.0 22.3 85.8 32.4 36.8 20.6 29.7 46.9 19.0 25.3 32.5 43.9 110.9 24.4 42.1 37.4 30.5 50.8 38.8 24.7 39.5 25.6 33.9 14.0 19.5 43.5 27.8 CYP19A1 "ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM" ENSG00000137869 "Cytochrome P450 family 19 subfamily A member 1" P11511 15 51208057-51338610 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 49 "placenta: 440.1" "Cell type enriched" "Detected in some" 36 "Syncytiotrophoblasts: 1678.9" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 8 "basal ganglia: 5.9" "Cell type enriched" "Detected in single" 17 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 45.7;HDLM-2: 7.9;HSkMC: 15.3;SuSa: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000355, HPA051194" Enhanced Uncertain Mitochondria NA NA Mitochondria "CAB000355: , HPA051194: AB_2681381" "unprognostic (9.41e-2)" "unprognostic (7.44e-2)" "unprognostic (9.52e-5)" "unprognostic (6.81e-2)" "unprognostic (2.72e-1)" "unprognostic (4.25e-4)" "unprognostic (5.18e-5)" "unprognostic (1.54e-3)" "unprognostic (2.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.97e-1)" "unprognostic (5.37e-2)" "unprognostic (1.54e-5)" "unprognostic (2.52e-3)" "unprognostic (2.11e-1)" "unprognostic (1.40e-2)" "unprognostic (1.11e-1)" 9.0 4.6 0.2 0.2 5.9 0.1 2.1 0.2 0.3 0.9 0.3 0.3 0.2 0.4 0.2 0.3 0.3 0.2 0.3 1.3 0.2 0.7 0.3 0.2 0.6 0.2 0.2 0.2 4.4 0.6 0.1 0.2 440.1 0.2 0.5 0.1 0.2 0.9 1.4 0.8 2.3 0.2 0.7 0.5 0.5 0.1 3.0 0.2 0.3 3.0 0.2 0.2 1.2 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 45.7 2.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.3 0.1 3.7 0.3 0.0 0.0 15.3 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 8.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.4 0.6 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 5.9 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 6.9 1.4 0.0 0.0 0.0 13.4 0.0 0.0 0.0 1.6 4.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 6.5 0.3 7.7 0.2 0.0 1678.9 0.0 0.0 0.0 CYP1A1 "CP11, CYP1, P1-450, P450-C, P450DX" ENSG00000140465 "Cytochrome P450 family 1 subfamily A member 1" P04798 15 74719542-74725610 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Lyase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "liver: 38.3;lung: 144.1;urinary bladder: 40.0" "Cell type enhanced" "Detected in some" 21 "Glandular cells: 1.5;Hepatocytes: 6.0;Urothelial cells: 3.2" "Group enriched" "Detected in some" 24 "liver cancer: 18.6;urothelial cancer: 54.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 22.0;hTCEpi: 12.0;HUVEC TERT2: 11.5;SK-BR-3: 9.0;SuSa: 23.3" "Not detected" "Not detected" "Not detected" "Not detected" CAB018654 Uncertain NA NA "CAB018654: AB_2088699" "unprognostic (1.71e-2)" "unprognostic (7.86e-2)" "unprognostic (2.57e-2)" "unprognostic (2.89e-1)" "unprognostic (5.45e-3)" "unprognostic (6.34e-2)" "unprognostic (3.08e-1)" "unprognostic (6.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (4.21e-2)" "unprognostic (6.70e-2)" "unprognostic (2.20e-1)" "unprognostic (4.77e-1)" "unprognostic (1.28e-1)" 9.3 0.4 0.1 0.4 0.2 0.2 7.7 0.2 0.5 2.3 0.7 0.4 3.9 0.5 3.8 4.4 1.2 0.2 11.3 3.0 0.1 0.0 0.7 38.3 144.1 0.2 0.1 0.1 0.5 0.5 0.2 0.1 3.5 0.3 0.2 0.2 0.8 2.1 0.5 1.5 8.1 10.7 5.9 0.2 0.2 0.4 0.3 0.1 0.1 0.8 0.8 8.0 40.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.3 0.1 0.0 0.3 0.0 7.2 0.0 0.0 0.4 0.2 22.0 0.9 0.2 5.9 0.0 5.4 6.9 0.4 4.4 0.2 0.0 0.6 0.3 1.5 3.2 0.1 0.2 7.1 0.0 12.0 0.1 0.9 0.2 11.5 0.2 1.3 0.2 0.0 0.4 0.0 0.2 0.1 7.2 1.8 0.7 0.0 0.2 0.0 1.4 0.3 0.1 1.0 9.0 2.3 23.3 0.3 0.1 0.6 1.0 0.3 3.2 0.0 0.4 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.2 0.3 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 3.2 CYP1A2 "CP12, P3-450" ENSG00000140505 "Cytochrome P450 family 1 subfamily A member 2" P05177 15 74748844-74756202 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 143.0" "Cell type enriched" "Detected in some" 18 "Hepatocytes: 44.0" "Group enriched" "Detected in some" 22 "liver cancer: 25.3;urothelial cancer: 6.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" CAB016531 Enhanced NA NA "CAB016531: AB_629359" "unprognostic (1.54e-4)" "unprognostic (1.29e-1)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.17e-2)" "unprognostic (5.48e-2)" "unprognostic (2.33e-2)" "unprognostic (7.41e-2)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.7 1.1 4.5 1.2 1.1 0.7 0.3 1.1 0.9 2.7 2.1 0.2 0.0 1.6 0.7 0.0 0.0 0.2 0.6 1.3 2.2 0.5 0.0 1.8 1.2 0.1 0.2 0.1 0.5 1.2 2.8 1.6 0.8 0.1 1.9 1.1 0.4 0.3 0.1 0.0 0.7 0.2 3.9 1.9 4.0 0.0 0.8 2.5 1.3 1.7 0.9 0.6 2.6 2.4 0.9 0.0 2.2 2.2 1.1 2.1 6.0 0.4 2.3 1.6 1.0 0.4 1.1 1.4 1.1 1.2 1.0 0.7 1.6 1.1 2.4 1.2 3.2 1.2 1.2 0.6 0.6 0.5 0.8 0.7 0.5 0.4 1.7 0.7 0.7 4.5 1.1 0.8 1.1 0.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 44.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 CYP1B1 "CP1B, GLC3A" ENSG00000138061 "Cytochrome P450 family 1 subfamily B member 1" Q16678 2 38066973-38109902 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Disease mutation, Glaucoma, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.0;lung: 39.2" "Cell type enhanced" "Detected in many" 11 "Glandular cells: 345.6;Leydig cells: 147.9;Peritubular cells: 160.5;Urothelial cells: 295.9" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "classical monocyte: 45.0" "Lineage enriched" "Detected in many" 22 "monocytes: 45.0" "Cell line enhanced" "Detected in many" "ASC diff: 24.6;ASC TERT1: 26.4;HSkMC: 105.7;hTERT-RPE1: 24.4;SiHa: 49.2;U-87 MG: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB011705, HPA026863" Approved Uncertain Mitochondria NA NA Mitochondria "CAB011705: AB_731810, HPA026863: AB_10600900" "unprognostic (7.25e-3)" "unprognostic (2.28e-1)" "unprognostic (1.24e-3)" "unprognostic (2.27e-1)" "unprognostic (2.04e-2)" "unprognostic (1.68e-1)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (9.69e-2)" "unprognostic (4.20e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.39e-6)" "unprognostic (1.87e-3)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (2.76e-4)" 9.1 3.1 0.5 9.4 1.2 0.0 11.4 1.0 1.2 11.4 2.1 0.7 4.5 0.0 12.8 5.9 3.5 15.0 6.9 17.5 1.2 8.8 3.5 39.2 26.3 3.1 1.0 6.1 3.6 0.0 1.3 0.8 3.3 10.7 0.0 19.3 0.0 13.0 4.8 0.5 1.4 10.6 5.1 15.7 0.3 3.9 0.5 5.1 2.5 1.1 4.2 6.9 2.1 0.0 0.4 2.0 45.0 0.0 0.0 16.2 1.2 13.2 0.4 0.0 24.6 26.4 0.0 0.1 0.8 0.2 2.3 0.0 5.5 0.0 3.6 3.2 0.5 10.8 0.0 0.7 0.4 1.0 0.7 0.0 4.0 0.0 6.8 0.0 0.0 105.7 10.3 5.7 0.2 24.4 0.0 0.0 0.1 0.0 0.1 5.2 0.0 4.0 1.4 1.8 2.5 0.0 0.0 0.0 2.5 0.1 0.1 0.4 49.2 7.2 0.0 1.4 9.1 1.9 0.0 0.2 0.0 20.2 0.0 0.0 0.0 0.0 26.8 0.0 2.2 0.4 45.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.0 5.5 0.2 0.0 16.2 17.9 50.6 0.5 98.2 15.8 0.9 2.7 0.0 12.0 35.2 43.6 0.0 0.4 13.3 5.0 11.7 36.8 0.0 0.0 0.5 0.7 41.1 345.6 3.5 9.7 12.6 0.0 1.7 5.5 116.2 8.6 147.9 28.1 16.9 39.7 0.3 0.5 0.4 0.0 160.5 0.8 0.3 19.4 20.8 1.0 1.8 12.4 0.2 0.0 0.8 295.9 CYP20A1 CYP-M ENSG00000119004 "Cytochrome P450 family 20 subfamily A member 1" Q6UW02 2 203238940-203305611 "Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055872, HPA058461" Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions,Actin filaments" No No "Plasma membrane, Cell Junctions, Actin filaments" Nucleoplasm "HPA055872: AB_2682951, HPA058461: AB_2683725" "unprognostic (4.72e-2)" "unprognostic (2.06e-2)" "unprognostic (1.20e-2)" "unprognostic (2.14e-2)" "unprognostic (1.42e-1)" "unprognostic (3.06e-2)" "unprognostic (5.21e-2)" "unprognostic (2.58e-2)" "unprognostic (4.21e-2)" "unprognostic (2.62e-2)" "unprognostic (4.53e-2)" "unprognostic (4.42e-2)" "unprognostic (7.64e-3)" "unprognostic (9.39e-2)" "unprognostic (2.18e-1)" "unprognostic (1.23e-2)" "unprognostic (1.95e-3)" 11.1 14.9 5.0 9.1 6.4 2.8 7.6 6.8 6.1 9.3 8.6 8.6 9.2 6.0 10.8 7.1 8.0 8.0 9.1 7.0 4.5 4.8 13.5 12.5 8.4 7.8 8.1 2.1 13.4 17.3 9.1 13.6 9.4 6.5 9.0 7.8 10.9 9.8 8.8 5.3 6.3 10.5 9.0 6.5 10.1 8.8 10.8 8.1 13.8 16.9 4.3 9.1 7.7 9.7 13.0 13.6 6.8 11.3 8.8 15.5 9.1 5.2 4.9 2.5 4.9 14.6 3.1 5.2 8.9 4.5 3.8 3.9 14.1 7.6 3.8 7.3 5.6 6.4 5.8 3.2 4.0 5.3 5.1 3.8 8.2 3.1 6.4 11.3 9.0 5.2 6.9 3.1 6.1 6.4 2.8 7.5 7.0 12.7 13.1 6.9 7.1 7.5 4.7 9.7 3.8 10.9 5.1 5.7 7.4 4.5 10.4 3.7 5.1 0.3 4.6 7.3 4.6 2.8 4.9 8.5 12.3 4.8 6.1 5.6 8.9 9.7 4.6 7.6 3.6 5.7 5.2 10.4 6.8 14.4 11.3 15.5 11.1 14.9 12.7 7.8 13.0 12.5 9.2 2.2 8.8 10.5 13.6 13.4 9.1 5.0 6.4 6.8 6.1 4.5 4.8 8.1 2.1 6.5 8.1 14.9 28.6 32.8 34.8 11.0 38.9 22.7 35.7 28.1 43.3 15.7 55.0 28.0 10.0 15.4 79.1 37.9 32.7 23.3 17.9 19.0 33.8 32.0 27.8 42.9 33.5 47.7 43.6 74.3 32.1 14.0 113.9 25.8 6.8 21.6 29.9 37.0 13.8 28.1 78.8 22.1 69.0 64.7 26.8 43.2 28.1 11.7 34.1 33.1 28.6 27.5 CYP26A1 "CP26, CYP26, P450RAI, P450RAI1" ENSG00000095596 "Cytochrome P450 family 26 subfamily A member 1" O43174 10 93073475-93077890 "Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "liver: 23.2;retina: 7.3" "Cell type enriched" "Detected in some" 9 "Muller glia cells: 70.3" "Cancer enhanced" "Detected in many" "testis cancer: 5.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "AF22: 37.6" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 6.8" NA NA "unprognostic (2.80e-1)" "unprognostic (4.21e-3)" "unprognostic (5.65e-2)" "unprognostic (2.94e-1)" "unprognostic (2.16e-1)" "unprognostic (4.90e-1)" "unprognostic (4.17e-2)" "unprognostic (6.22e-2)" "unprognostic (3.35e-1)" "unprognostic (4.89e-1)" "unprognostic (1.11e-2)" "unprognostic (6.24e-2)" "unprognostic (2.04e-11)" "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (4.11e-1)" 0.1 0.3 0.3 0.0 0.6 0.1 0.3 0.4 1.8 0.3 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 23.2 0.1 0.0 0.2 1.4 0.1 0.0 0.0 0.2 0.8 0.3 0.1 0.0 7.3 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.2 1.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 37.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.4 1.8 0.6 0.3 0.2 1.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 8.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.5 1.1 0.0 6.4 0.0 0.0 0.0 CYP26B1 P450RAI-2 ENSG00000003137 "Cytochrome P450 family 26 subfamily B member 1" Q9NR63 2 72129238-72148038 "Disease related genes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.4" "Group enriched" "Detected in many" 8 "Leydig cells: 70.2;Peritubular cells: 216.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 8.2;HaCaT: 12.1;RH-30: 15.6;U-2 OS: 17.3;U-2197: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012567 Uncertain Approved Cytosol "Intracellular and membrane" No No Cytosol "HPA012567: AB_1847429" "unprognostic (1.70e-1)" "unprognostic (1.05e-1)" "unprognostic (8.76e-2)" "unprognostic (2.19e-4)" "unprognostic (3.46e-2)" "unprognostic (4.40e-1)" "unprognostic (2.17e-4)" "unprognostic (8.41e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (7.55e-3)" "unprognostic (1.52e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-1)" "unprognostic (1.55e-1)" "unprognostic (9.44e-3)" "unprognostic (2.04e-2)" 16.6 2.6 8.3 2.1 7.8 0.1 7.7 25.0 23.9 5.8 2.4 1.2 1.6 3.6 1.5 1.6 3.4 2.7 1.2 6.0 2.5 1.5 4.2 0.7 2.7 4.4 3.4 10.0 4.9 0.2 0.9 5.2 3.2 35.4 1.3 1.2 1.2 5.1 7.5 7.6 20.5 2.4 1.5 0.6 1.9 0.5 13.8 1.1 4.9 9.2 2.2 2.8 1.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.9 0.0 0.1 8.2 3.1 4.9 0.7 0.1 0.2 0.2 1.5 0.4 0.0 0.4 0.6 2.4 12.1 6.9 0.0 0.1 0.0 2.2 0.0 4.9 0.6 0.1 0.0 0.2 0.0 0.4 0.0 0.2 2.5 0.9 3.3 0.4 0.1 0.7 2.3 0.0 0.1 0.0 0.1 0.8 0.0 15.6 0.0 0.0 1.2 0.5 0.1 2.7 0.0 2.9 1.0 0.2 0.7 0.0 1.3 17.3 7.6 2.6 0.0 0.9 0.0 5.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 7.8 25.0 23.9 2.5 1.5 3.4 10.0 35.4 1.1 0.0 0.0 2.9 1.1 13.1 0.1 1.1 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.1 1.6 0.0 0.0 0.0 0.7 3.7 0.3 0.0 0.2 0.1 0.0 1.7 17.2 4.5 4.9 70.2 0.0 6.8 0.0 0.0 5.4 0.2 0.0 216.0 0.0 0.0 0.0 5.6 1.4 3.0 8.4 0.1 0.0 0.0 0.1 CYP26C1 ENSG00000187553 "Cytochrome P450 family 26 subfamily C member 1" Q6V0L0 10 93060808-93069536 "Disease related genes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 1.3;lymphoid tissue: 2.0;testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;SiHa: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.39e-2)" "unprognostic (3.41e-2)" "unprognostic (3.88e-1)" "unprognostic (5.05e-2)" "unprognostic (3.25e-2)" "unprognostic (3.43e-2)" "unprognostic (4.97e-2)" "unprognostic (1.70e-1)" "unprognostic (8.85e-2)" "unprognostic (5.29e-2)" "unprognostic (2.47e-1)" "unprognostic (1.10e-1)" "unprognostic (2.02e-2)" "unprognostic (1.74e-4)" "unprognostic (8.59e-3)" "unprognostic (3.10e-3)" "unprognostic (1.17e-1)" 0.1 1.3 0.2 0.1 0.1 0.0 0.1 0.1 0.8 0.3 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 2.0 0.1 1.8 0.1 1.7 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.3 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 CYP2A13 "CPAD, CYP2A" ENSG00000197838 "Cytochrome P450 family 2 subfamily A member 13" Q16696 19 41088472-41096195 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 30.7" "Cell type enriched" "Detected in single" 7 "Early spermatids: 3.0" "Cancer enriched" "Detected in single" 5 "liver cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.1;NTERA-2: 1.6" "HPA046713, HPA047262" Supported "Intracellular and membrane" NA NA "HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (9.79e-2)" "unprognostic (1.00e-1)" "unprognostic (4.51e-3)" "unprognostic (4.92e-2)" "unprognostic (1.99e-1)" "unprognostic (1.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 30.7 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 CYP2A6 "CPA6, CYP2A, CYP2A3" ENSG00000255974 "Cytochrome P450 family 2 subfamily A member 6" P11509 19 40843538-40850447 "Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 165 "liver: 199.5" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 161.7" "Cancer enriched" "Detected in some" 12 "liver cancer: 281.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.3;HL-60: 2.9;K-562: 1.4;RH-30: 4.4;SiHa: 2.2;TIME: 1.0;U-698: 1.0;U-937: 1.0" "HPA046713, HPA047262" Supported "Intracellular and membrane" NA NA "HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (1.21e-1)" "unprognostic (4.10e-1)" "unprognostic (5.05e-2)" "unprognostic (2.64e-2)" "prognostic favorable (5.38e-5)" "unprognostic (4.98e-3)" "unprognostic (4.86e-2)" "unprognostic (6.23e-2)" "unprognostic (5.20e-2)" "unprognostic (1.95e-1)" "unprognostic (2.25e-2)" "unprognostic (8.83e-3)" "unprognostic (2.46e-1)" "unprognostic (3.07e-2)" "unprognostic (2.55e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 199.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.1 5.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 161.7 0.0 0.0 0.0 12.9 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 CYP2A7 CYP2A ENSG00000198077 "Cytochrome P450 family 2 subfamily A member 7" P20853 19 40875439-40882752 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 134 "liver: 53.7" "Cell type enhanced" "Detected in some" 29 "Hepatocytes: 29.0;Ito cells: 12.3;Kupffer cells: 5.7" "Group enriched" "Detected in some" 238 "breast cancer: 9.2;liver cancer: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 2.0" "CAB033510, HPA046713, HPA047262" Enhanced "Intracellular and membrane" NA NA "CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (2.18e-1)" "unprognostic (3.60e-2)" "unprognostic (2.65e-3)" "unprognostic (8.89e-2)" "unprognostic (1.39e-2)" "unprognostic (3.95e-1)" "unprognostic (9.21e-2)" "unprognostic (8.71e-2)" "unprognostic (3.99e-2)" "unprognostic (1.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 29.0 0.0 0.0 0.0 12.3 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 CYP2C8 CPC8 ENSG00000138115 "Cytochrome P450 family 2 subfamily C member 8" P10632 10 95036772-95069497 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 131 "liver: 247.5" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 1616.5" "Cancer enriched" "Detected in some" 82 "liver cancer: 102.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "gdT-cell: 1.8" "Lineage enriched" "Detected in single" 9 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "Daudi: 1.8;HL-60: 2.7;SiHa: 3.0;U-266/70: 3.0;U-266/84: 2.3" "HPA013547, HPA013970, HPA015066" Enhanced "Intracellular and membrane" NA NA "HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433" "unprognostic (3.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (4.41e-2)" "unprognostic (1.09e-2)" "unprognostic (1.80e-3)" "unprognostic (4.29e-2)" "unprognostic (1.03e-1)" "unprognostic (3.38e-1)" "prognostic favorable (9.82e-4)" "unprognostic (2.85e-1)" "unprognostic (1.44e-3)" "unprognostic (2.63e-1)" "unprognostic (7.88e-2)" "unprognostic (1.39e-1)" "unprognostic (4.05e-4)" 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.1 0.1 0.2 0.3 247.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.1 1.1 0.2 0.0 0.2 0.0 0.7 1.0 0.0 1.0 0.5 2.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.3 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 3.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 2.3 1.2 0.0 0.9 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 21.0 0.0 0.0 0.9 0.2 155.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 70.0 0.2 0.0 0.0 0.1 0.0 1616.5 0.0 4.8 1.7 61.4 65.7 5.1 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.6 0.0 0.0 2.1 0.6 0.0 0.0 0.0 0.0 0.1 CYP2D6 "CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D" ENSG00000100197 "Cytochrome P450 family 2 subfamily D member 6" P10635 22 42126499-42130906 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 78.0" "Cell type enriched" "Detected in many" 38 "Hepatocytes: 435.9" "Cancer enriched" "Detected in many" 35 "liver cancer: 90.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 4.4;HMC-1: 6.2;Karpas-707: 1.9;REH: 3.6;T-47d: 2.3;U-266/70: 4.3" HPA045223 Enhanced Approved "Golgi apparatus" No No "Golgi apparatus" "HPA045223: AB_10962927" "unprognostic (4.40e-3)" "unprognostic (7.68e-3)" "unprognostic (5.45e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (1.29e-4)" "unprognostic (3.83e-2)" "unprognostic (7.27e-3)" "unprognostic (1.13e-1)" "unprognostic (1.71e-1)" "unprognostic (4.03e-4)" "unprognostic (2.11e-2)" "unprognostic (5.61e-5)" "unprognostic (3.01e-1)" "unprognostic (2.23e-1)" "unprognostic (4.08e-1)" "unprognostic (4.82e-5)" 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.2 0.1 0.1 3.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 78.0 0.1 0.1 0.1 0.1 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 11.2 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.3 0.2 0.0 0.6 0.0 0.2 3.6 0.0 1.1 0.0 0.0 0.1 0.3 1.2 0.1 0.0 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.3 4.3 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.5 0.5 6.5 0.3 2.5 1.4 0.0 1.8 2.0 0.1 1.7 0.6 2.9 0.3 3.9 0.0 0.5 0.1 0.2 0.5 0.0 435.9 0.1 11.1 1.2 6.7 6.2 11.4 0.0 0.0 0.0 0.0 1.0 0.9 0.5 2.9 1.4 0.5 2.0 0.0 0.2 0.7 0.3 1.0 0.3 0.5 0.8 0.2 CYP2E1 CYP2E ENSG00000130649 "Cytochrome P450 family 2 subfamily E member 1" P05181 10 133520406-133561220 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 87 "liver: 802.4" "Cell type enriched" "Detected in many" 65 "Hepatocytes: 5979.1" "Cancer enriched" "Detected in some" 278 "liver cancer: 265.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.9;myeloid DC: 9.1" "Group enriched" "Detected in many" 17 "dendritic cells: 9.1;T-cells: 3.9" "Cell line enhanced" "Detected in many" "HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009128, HPA029564" Enhanced Approved "Endoplasmic reticulum,Mitochondria" "Intracellular and membrane" NA NA "Endoplasmic reticulum, Mitochondria" "HPA009128: AB_1078613, HPA029564: AB_10602213" "unprognostic (6.32e-2)" "unprognostic (1.51e-2)" "unprognostic (3.83e-5)" "unprognostic (1.27e-1)" "unprognostic (3.37e-2)" "unprognostic (1.26e-1)" "unprognostic (2.92e-3)" "unprognostic (6.36e-3)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.70e-4)" "unprognostic (1.72e-1)" "unprognostic (8.36e-2)" "unprognostic (3.78e-1)" "unprognostic (9.59e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.6 0.3 0.1 0.1 0.2 0.7 0.0 0.1 0.3 0.8 0.2 1.3 0.1 0.1 0.1 0.3 802.4 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.1 0.3 0.1 0.0 0.2 0.1 1.1 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.3 0.1 0.1 0.2 0.2 1.5 0.1 0.1 0.0 9.1 0.0 0.3 0.2 3.9 0.3 0.1 0.0 0.3 0.9 3.2 1.8 0.7 1.4 4.0 0.0 0.3 0.0 2.4 1.3 0.2 0.4 0.0 9.8 0.0 0.2 0.3 0.2 1.4 1.5 0.1 1.1 0.5 7.6 8.1 0.9 0.2 0.0 0.6 1.7 0.0 2.8 0.5 0.4 0.9 0.6 0.5 20.6 5.6 3.7 0.4 0.3 5.5 0.0 1.8 0.0 0.0 0.0 3.7 0.0 0.6 0.1 0.2 0.8 0.0 1.3 0.4 2.0 0.9 2.0 0.8 2.8 1.3 6.4 0.1 0.0 0.0 0.0 0.1 0.0 3.9 0.0 1.7 1.0 9.1 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.6 21.0 0.2 2.1 4.5 2.2 50.9 2.7 2.3 0.0 2.0 0.0 0.0 0.3 1.3 0.4 0.0 23.3 1.2 0.1 0.4 0.5 1.1 5979.1 0.0 7.9 0.0 68.2 91.8 1.9 1.4 0.0 0.0 0.0 0.0 1.0 2.6 0.0 2.5 0.0 5.2 0.0 0.5 3.6 2.2 6.6 0.1 8.7 0.0 0.0 CYP2F1 CYP2F ENSG00000197446 "Cytochrome P450 family 2 subfamily F member 1" P24903 19 41114432-41128366 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 10.4;lymphoid tissue: 6.1;pituitary gland: 4.6;testis: 4.9" "Cell type enhanced" "Detected in some" 29 "Ciliated cells: 22.7;Club cells: 48.9;Spermatocytes: 9.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "basophil: 1.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 7 "HMC-1: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Intracellular and membrane" NA NA "unprognostic (2.04e-1)" "unprognostic (8.79e-2)" "unprognostic (4.63e-1)" "unprognostic (4.60e-2)" "unprognostic (2.54e-1)" "unprognostic (7.29e-3)" "unprognostic (6.23e-3)" "unprognostic (2.87e-2)" "unprognostic (3.91e-2)" "unprognostic (1.58e-6)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (9.90e-2)" "unprognostic (1.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 3.1 6.1 0.0 2.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 22.7 48.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 4.8 0.0 0.0 0.0 0.0 0.0 CYP2J2 ENSG00000134716 "Cytochrome P450 family 2 subfamily J member 2" P51589 1 59893308-59926790 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 44.9;intestine: 46.6;liver: 74.6" "Cell type enhanced" "Detected in many" 15 "Cardiomyocytes: 84.7;Cytotrophoblasts: 107.4;Syncytiotrophoblasts: 201.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.0;naive CD8 T-cell: 5.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "OE19: 9.9;RT4: 36.0;SK-BR-3: 9.7" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (3.53e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-2)" "unprognostic (1.99e-2)" "unprognostic (2.51e-2)" "unprognostic (2.28e-1)" "unprognostic (1.61e-1)" "unprognostic (3.16e-1)" "unprognostic (1.15e-1)" "unprognostic (2.84e-2)" "unprognostic (7.29e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (5.54e-7)" "unprognostic (4.96e-1)" "unprognostic (8.45e-2)" "unprognostic (4.25e-1)" "unprognostic (9.70e-2)" 0.8 0.9 8.8 1.2 12.0 0.7 5.8 7.9 8.5 1.2 13.1 22.1 0.0 17.9 1.2 1.1 7.2 1.1 1.7 44.9 9.1 6.9 2.2 74.6 1.4 0.8 13.2 6.3 0.7 1.8 0.6 0.7 11.9 12.3 2.4 12.0 0.5 7.2 1.0 12.2 5.3 46.6 1.6 10.1 0.7 3.0 0.9 15.5 0.0 0.7 0.5 2.3 5.8 1.8 1.8 1.2 0.0 0.0 0.7 6.0 1.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.7 0.2 1.6 0.0 0.5 0.0 2.1 0.5 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 1.8 0.0 0.0 0.9 9.9 1.6 0.0 3.8 0.0 2.0 36.0 0.5 2.3 0.0 9.7 0.3 0.1 2.4 0.0 0.0 1.2 1.5 0.0 0.5 1.1 0.1 0.0 0.4 0.0 4.0 0.0 0.0 0.0 0.2 0.0 1.2 1.8 0.7 0.4 0.1 0.9 6.0 5.2 0.0 0.7 0.0 1.2 0.0 1.0 8.8 12.0 7.9 8.5 9.1 6.9 13.2 6.3 12.3 15.5 3.0 2.6 0.5 1.2 0.3 0.0 84.7 12.7 29.4 35.2 0.0 0.0 107.4 0.0 9.1 16.8 0.0 23.8 0.0 0.8 7.3 1.0 0.8 0.0 44.3 6.1 0.0 8.6 0.0 0.6 19.0 0.0 0.0 0.0 1.0 21.4 11.9 1.8 21.0 0.0 2.9 1.0 0.0 0.0 0.3 0.1 1.9 201.5 0.0 23.6 0.9 CYP2R1 ENSG00000186104 "Cytochrome P450 family 2 subfamily R member 1" Q6VVX0 11 14877440-14892252 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 132.6;Late spermatids: 84.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 21.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042949 Approved "Intracellular and membrane" NA NA "HPA042949: AB_2678237" "unprognostic (1.62e-2)" "unprognostic (1.82e-2)" "unprognostic (5.90e-2)" "unprognostic (1.63e-3)" "unprognostic (2.67e-1)" "unprognostic (2.19e-1)" "unprognostic (3.23e-2)" "unprognostic (7.73e-2)" "unprognostic (1.70e-1)" "unprognostic (3.90e-2)" "unprognostic (2.25e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.86e-4)" "unprognostic (1.01e-1)" "unprognostic (1.81e-1)" "unprognostic (1.46e-1)" "unprognostic (1.44e-2)" 5.4 4.4 3.5 7.4 6.5 6.4 10.1 7.7 6.8 5.4 8.6 4.2 4.6 10.8 4.6 7.9 10.3 4.3 6.9 6.9 4.3 3.4 6.4 9.1 6.3 6.7 5.3 5.8 4.9 12.0 5.1 7.7 2.7 4.7 8.1 8.0 5.6 10.2 5.5 6.2 15.8 12.6 8.7 5.4 9.3 9.5 14.9 6.2 9.3 5.2 9.7 9.1 7.7 6.8 5.6 3.5 4.2 3.8 3.2 8.8 2.0 4.8 3.0 2.9 1.2 1.3 2.1 0.0 1.7 0.9 1.0 1.0 3.5 5.5 6.1 1.4 0.3 3.9 0.0 1.0 2.2 0.4 5.0 4.7 2.7 3.4 0.2 4.5 4.6 2.8 2.0 8.7 0.0 3.6 0.9 1.1 7.6 4.0 21.4 0.7 1.2 5.0 9.4 2.8 3.5 2.8 3.6 2.2 9.0 1.1 0.5 2.5 3.9 3.6 4.5 4.1 2.0 3.3 1.8 3.1 3.0 3.7 1.8 2.2 10.6 12.3 7.2 4.2 6.1 2.7 4.2 3.7 2.7 5.9 3.2 8.8 3.0 4.7 3.5 3.0 5.6 6.8 5.6 0.6 3.2 3.8 3.5 5.6 2.0 3.5 6.5 7.7 6.8 4.3 3.4 5.3 5.8 4.7 6.2 11.9 3.7 8.1 12.1 5.3 2.7 3.9 7.6 1.4 4.5 5.2 5.9 0.2 5.0 6.6 132.6 4.9 8.4 0.0 14.6 0.1 3.6 6.3 3.5 4.9 5.2 1.6 6.4 6.2 6.3 84.5 2.0 7.9 13.5 5.4 5.4 4.6 9.3 3.5 3.9 5.0 4.2 12.9 4.2 8.9 14.0 5.8 0.0 20.3 7.3 5.8 CYP2S1 ENSG00000167600 "Cytochrome P450 family 2 subfamily S member 1" Q96SQ9 19 41193049-41207539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Lyase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.1;gallbladder: 29.1;intestine: 62.7;stomach 1: 45.9" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 16.5;Enterocytes: 23.2;Mucus-secreting cells: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 9.5;myeloid DC: 33.1" "Group enriched" "Detected in many" 121 "dendritic cells: 33.1;monocytes: 9.5" "Cell line enhanced" "Detected in many" "A549: 31.3;CACO-2: 16.1;HaCaT: 16.8;NTERA-2: 23.7;OE19: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA049227, HPA069248" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA049227: AB_2680681, HPA069248: AB_2732128" "unprognostic (1.49e-2)" "unprognostic (7.45e-2)" "unprognostic (2.45e-2)" "unprognostic (6.03e-2)" "unprognostic (3.93e-2)" "unprognostic (7.46e-2)" "unprognostic (1.27e-2)" "unprognostic (4.85e-2)" "unprognostic (2.18e-1)" "unprognostic (1.54e-2)" "unprognostic (6.25e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.60e-6)" "unprognostic (1.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.02e-1)" "unprognostic (7.66e-2)" 1.2 0.8 0.8 2.3 1.0 0.5 0.6 0.1 1.0 1.7 18.3 1.2 0.5 37.6 0.3 0.9 10.1 2.4 29.1 1.0 1.4 1.6 0.9 2.1 3.8 3.3 5.6 0.4 0.8 0.6 0.0 0.9 1.6 4.5 0.9 7.2 1.1 3.8 0.3 0.1 2.0 62.7 0.6 1.1 4.0 45.9 0.5 1.2 2.6 0.4 15.8 21.0 3.2 2.7 0.0 33.1 0.0 9.5 0.0 0.1 3.9 1.2 31.3 0.0 0.0 0.0 0.0 1.5 0.2 0.2 0.3 0.0 16.1 4.5 0.0 3.7 0.2 0.0 16.8 5.5 8.5 0.1 0.0 0.1 4.2 1.7 5.8 6.6 0.0 0.1 0.2 0.4 0.4 0.2 0.0 0.2 1.4 1.9 0.1 0.0 0.6 0.1 0.0 23.7 51.4 4.1 0.0 0.0 0.3 0.5 6.7 0.0 0.2 3.1 0.0 0.0 9.7 4.1 1.6 3.6 0.0 1.3 0.6 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 9.5 0.0 0.0 2.3 0.1 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 3.9 0.8 1.0 0.1 1.0 1.4 1.6 5.6 0.4 4.5 1.2 0.0 8.6 0.0 1.6 2.3 0.0 0.8 0.0 8.1 7.9 1.8 0.0 16.5 0.0 0.8 0.3 0.0 23.2 0.0 0.9 0.6 1.3 0.4 1.1 0.0 12.8 0.0 0.0 0.6 4.7 0.0 0.0 11.5 0.0 8.2 29.0 0.0 13.8 14.8 0.0 0.0 0.0 0.0 0.3 0.1 0.4 2.5 8.6 0.0 13.9 0.1 CYP2U1 SPG49 ENSG00000155016 "Cytochrome P450 family 2 subfamily U member 1" Q7Z449 4 107931369-107953457 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 122.7" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 18.6;Peritubular cells: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041622, HPA046754, HPA064827" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362" "unprognostic (3.54e-1)" "unprognostic (2.45e-1)" "unprognostic (3.08e-1)" "unprognostic (2.84e-1)" "unprognostic (5.16e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (1.20e-3)" "unprognostic (3.19e-1)" "unprognostic (8.97e-3)" "unprognostic (5.41e-3)" "unprognostic (3.02e-1)" "prognostic favorable (2.75e-5)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.19e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.6 7.9 7.7 4.4 9.1 0.4 7.3 11.3 9.2 7.8 7.3 7.0 4.1 4.0 9.5 4.6 6.3 9.8 6.6 8.8 7.1 7.9 6.4 6.8 6.6 6.7 8.3 5.2 12.0 2.6 10.3 8.1 2.7 7.8 12.4 4.7 8.6 4.5 11.0 4.3 3.1 6.0 12.3 7.0 8.5 4.6 3.9 7.4 122.7 4.7 3.5 5.4 7.3 5.3 2.6 2.7 0.7 5.9 1.6 1.7 0.4 2.5 1.2 3.4 6.3 18.8 9.0 0.5 10.8 16.3 6.6 10.5 0.0 1.7 6.9 0.8 6.4 5.2 0.1 5.3 4.0 10.4 1.9 1.6 1.4 2.4 0.3 7.5 2.0 0.0 10.1 3.4 3.1 2.1 13.5 2.5 7.8 0.1 3.3 5.5 1.8 7.4 0.0 3.5 0.2 3.0 4.2 4.1 0.0 2.1 4.3 6.7 5.0 2.7 4.7 11.5 3.0 2.3 1.0 6.8 4.3 0.5 6.1 4.3 14.0 13.2 2.2 3.5 0.0 4.8 0.0 0.3 0.7 1.2 1.1 0.9 2.0 0.9 1.0 2.2 2.6 1.7 1.3 0.0 1.6 5.9 2.7 0.0 0.4 7.7 9.1 11.3 6.9 7.1 7.9 8.3 5.2 7.8 7.4 3.0 3.8 3.2 3.2 1.0 4.3 3.4 2.5 13.4 3.4 8.7 3.9 0.4 0.0 0.9 9.6 5.8 2.6 0.0 1.7 0.3 5.1 1.7 4.6 6.8 1.9 1.6 2.9 6.7 6.1 6.1 16.4 4.6 18.6 3.6 1.1 9.9 0.4 0.0 16.6 2.4 3.3 0.0 5.2 0.9 4.3 1.3 0.2 1.3 1.6 0.7 CYP39A1 ENSG00000146233 "Cytochrome P450 family 39 subfamily A member 1" Q9NYL5 6 46549580-46652830 "Enzymes, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 52.2" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 58.9" "Cancer enhanced" "Detected in many" "prostate cancer: 11.9" "Region enriched" "Detected in many" 8 "cerebellum: 19.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 6.9;hTCEpi: 15.5;OE19: 6.7;SiHa: 9.3;U-698: 10.9" "Region enhanced" "Detected in many" "olfactory region: 24.1" "Low region specificity" "Detected in all" NA NA "unprognostic (1.33e-1)" "unprognostic (1.62e-2)" "unprognostic (8.46e-3)" "unprognostic (5.89e-2)" "unprognostic (1.06e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (5.78e-2)" "unprognostic (1.61e-1)" "unprognostic (4.99e-2)" "unprognostic (7.33e-2)" "unprognostic (6.11e-2)" "prognostic favorable (1.86e-4)" "unprognostic (1.54e-1)" "unprognostic (5.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" 2.6 2.0 1.7 2.9 1.9 0.0 2.9 19.3 1.9 3.6 1.9 1.5 6.4 0.4 1.9 12.0 4.9 2.3 3.4 4.8 1.6 1.1 3.3 52.2 2.6 0.2 2.3 0.9 6.5 8.7 8.6 8.3 0.2 2.3 8.2 1.9 8.0 21.0 1.8 0.5 8.5 1.4 1.7 2.2 0.6 2.7 3.3 0.9 0.0 9.4 2.3 2.1 2.5 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.3 2.0 0.3 0.0 0.0 0.0 1.2 0.4 0.1 0.0 0.6 6.9 5.0 0.0 1.0 1.9 0.9 1.6 0.0 0.0 3.0 0.0 1.8 2.0 4.7 0.0 0.0 0.5 15.5 0.0 1.8 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.7 1.7 0.5 1.3 0.1 3.3 4.4 0.8 0.0 9.3 0.0 0.2 0.5 1.7 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.9 19.3 1.9 1.6 1.1 2.3 0.9 2.3 0.9 14.9 1.0 0.0 7.1 3.5 0.2 4.6 10.2 8.1 4.5 3.5 2.0 0.0 5.0 1.6 11.8 2.3 0.5 0.0 0.3 0.9 1.7 12.3 0.0 58.9 0.2 0.0 0.0 0.0 1.9 15.3 5.8 0.2 3.3 0.0 3.1 8.0 0.9 2.9 8.9 4.1 1.5 0.0 2.1 0.7 0.1 13.4 0.0 0.0 2.3 6.0 CYP3A4 CYP3A3 ENSG00000160868 "Cytochrome P450 family 3 subfamily A member 4" P08684 7 99756960-99784265 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 45 "intestine: 145.3;liver: 464.6" "Cell type enriched" "Detected in some" 45 "Hepatocytes: 2276.5" "Cancer enriched" "Detected in some" 240 "liver cancer: 351.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.2;NB-4: 4.5;RPMI-8226: 6.7;SCLC-21H: 2.6;SH-SY5Y: 5.0" "CAB033671, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "CAB033671: AB_782375, HPA072245: , HPA075539: " "unprognostic (4.55e-2)" "unprognostic (8.95e-2)" "unprognostic (8.08e-2)" "unprognostic (1.63e-1)" "unprognostic (5.89e-2)" "unprognostic (5.37e-2)" "unprognostic (7.07e-3)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" "unprognostic (4.92e-2)" "unprognostic (3.78e-2)" "unprognostic (6.42e-2)" "unprognostic (1.89e-8)" "unprognostic (2.59e-1)" "unprognostic (1.75e-2)" "unprognostic (9.79e-2)" "unprognostic (6.82e-2)" 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 145.3 0.1 0.1 56.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 464.6 0.1 0.1 0.1 0.1 0.1 6.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 126.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.6 0.2 0.6 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.0 1.9 0.4 0.0 1.2 0.0 0.4 0.0 0.0 0.1 0.5 0.0 0.5 0.0 0.1 4.5 0.3 0.0 0.0 0.0 2.2 6.7 0.0 0.5 2.6 5.0 0.5 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.4 0.0 0.7 0.1 0.7 0.1 0.7 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.6 0.6 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.3 1.0 0.3 0.0 0.3 40.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 2.6 46.7 0.8 0.0 0.0 0.5 0.0 2276.5 0.0 0.0 0.0 39.3 50.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.4 0.9 CYP3A43 ENSG00000021461 "Cytochrome P450 family 3 subfamily A member 43" Q9HB55 7 99828013-99866102 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 32.5" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 6.3;granulocytes: 2.3;Hepatocytes: 6.8;Late spermatids: 2.5" "Cancer enriched" "Detected in single" 18 "liver cancer: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "HPA066463, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA066463: AB_2685670, HPA072245: , HPA075539: " "unprognostic (1.20e-3)" "unprognostic (4.74e-2)" "unprognostic (3.64e-3)" "unprognostic (7.24e-2)" "unprognostic (2.52e-1)" "prognostic favorable (3.41e-4)" "unprognostic (1.68e-2)" "unprognostic (1.44e-1)" "unprognostic (2.38e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.23e-2)" "unprognostic (6.46e-2)" "unprognostic (5.90e-2)" "unprognostic (3.10e-1)" "unprognostic (6.37e-4)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.9 0.1 0.0 0.1 0.1 0.1 0.0 0.2 32.5 0.1 0.1 0.1 0.1 0.1 8.0 0.0 2.2 0.1 0.1 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.5 1.6 0.6 0.3 0.6 0.2 0.1 0.0 0.9 0.3 1.1 0.2 0.2 0.0 0.2 0.2 0.2 1.2 0.7 1.5 0.3 0.3 0.1 1.3 0.2 0.0 0.7 0.2 0.5 0.9 1.5 1.3 0.3 0.9 1.3 0.0 0.7 0.0 0.0 0.6 0.5 0.1 1.0 1.0 0.0 0.0 0.0 0.6 0.4 0.3 0.0 0.9 0.0 0.2 0.8 1.6 0.5 0.4 0.6 1.7 0.0 0.7 0.5 0.0 1.6 0.5 0.2 1.1 0.7 1.1 1.2 0.1 0.8 0.4 0.2 1.5 0.6 0.4 0.6 0.2 0.3 0.3 0.3 0.2 0.1 0.6 0.5 0.5 1.6 0.3 0.2 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.3 6.8 0.1 1.6 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.9 0.2 0.3 0.0 0.0 0.0 0.0 CYP3A5 "CP35, P450PCN3, PCN3" ENSG00000106258 "Cytochrome P450 family 3 subfamily A member 5" P20815 7 99648194-99680026 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 72.9;liver: 73.4;stomach 1: 21.3" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 346.5;Enterocytes: 640.5;Hepatocytes: 330.1;Urothelial cells: 352.8" "Cancer enhanced" "Detected in many" "liver cancer: 38.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 8.3;CAPAN-2: 5.6;Hep G2: 5.7;OE19: 23.6" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (2.13e-1)" "unprognostic (4.36e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "unprognostic (2.73e-1)" "prognostic favorable (3.72e-5)" "unprognostic (1.37e-3)" "unprognostic (1.21e-2)" "unprognostic (7.29e-3)" "unprognostic (3.85e-1)" "unprognostic (4.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" "unprognostic (2.39e-4)" "unprognostic (6.58e-3)" 1.0 3.3 0.4 2.0 0.5 0.0 1.3 0.6 0.6 1.9 32.6 0.6 1.0 30.3 0.7 0.5 5.2 0.5 8.2 0.4 0.4 0.0 6.8 73.4 2.4 0.8 0.4 0.4 0.6 12.1 0.0 1.8 0.6 0.8 4.9 5.1 0.4 0.6 1.3 0.4 4.3 72.9 0.6 0.5 0.4 21.3 0.7 0.4 0.5 0.4 2.2 4.0 3.0 2.7 0.0 0.2 0.1 0.6 0.0 0.7 0.2 0.0 2.1 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 8.3 5.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.3 0.2 23.6 0.0 0.1 0.0 0.6 0.5 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.4 0.5 0.6 0.6 0.4 0.0 0.4 0.4 0.8 0.4 11.9 11.3 11.2 107.3 41.0 13.1 1.0 346.5 14.7 12.5 3.5 11.8 1.3 0.0 58.0 1.7 2.5 640.5 46.7 44.6 1.0 3.8 166.5 9.3 330.1 0.6 7.9 52.5 9.8 8.3 0.0 2.3 4.6 3.3 7.2 117.1 6.0 69.5 210.5 2.5 4.2 20.2 0.0 3.5 6.8 4.2 51.6 1.3 12.9 85.2 352.8 CYP3A7 "CP37, P450-HFLA" ENSG00000160870 "Cytochrome P450 family 3 subfamily A member 7" P24462 7 99684957-99735196 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 82.6" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 135.0" "Cancer enriched" "Detected in some" 43 "liver cancer: 38.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 1.9;BJ hTERT+: 3.3;Hep G2: 6.4;HHSteC: 3.7;RT4: 1.9" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (8.10e-3)" "unprognostic (1.45e-1)" "unprognostic (3.12e-1)" "unprognostic (5.47e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.34e-2)" "unprognostic (8.28e-2)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-11)" "unprognostic (2.02e-2)" "unprognostic (5.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.34e-3)" 0.1 0.4 0.1 0.1 0.0 0.0 2.6 0.1 0.1 0.0 0.7 0.0 0.0 0.1 0.3 0.1 0.2 0.0 3.9 0.0 0.1 0.0 2.8 82.6 0.6 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.4 3.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 135.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 18.4 0.1 0.0 0.0 4.9 3.7 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 CYP3A7-CYP3A51P ENSG00000282301 "CYP3A7-CYP3A51P readthrough" P24462 7 99685226-99735093 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 73.9" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 7.6" "Cell type enhanced" "Detected in single" "eosinophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.3;U-87 MG: 2.6" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.1 73.9 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 1.1 0.0 0.0 0.5 0.0 0.3 0.5 1.6 0.5 0.2 4.3 0.0 0.6 0.2 0.0 0.0 0.0 1.3 0.1 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.9 1.4 1.9 0.0 0.0 0.5 0.3 0.4 0.4 0.0 0.4 0.5 0.0 0.8 0.5 1.1 0.1 0.2 1.2 0.5 0.2 0.5 0.2 0.1 0.4 1.5 0.0 0.0 0.4 0.2 0.0 0.5 0.6 0.6 0.0 0.1 0.4 0.3 0.5 0.5 0.6 0.9 0.7 0.1 2.6 0.7 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP4A11 "CYP4A2, CYP4AII" ENSG00000187048 "Cytochrome P450 family 4 subfamily A member 11" Q02928 1 46929177-46941484 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 78 "kidney: 36.5;liver: 141.0" "Group enriched" "Detected in some" 6 "Hepatocytes: 433.3;Proximal tubular cells: 109.9" "Cancer enriched" "Detected in some" 5 "liver cancer: 73.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.4;HL-60: 1.2;RH-30: 1.3;SiHa: 1.6;U-698: 2.3;U-937: 1.6" NA NA "unprognostic (9.05e-2)" "unprognostic (4.98e-2)" "unprognostic (4.43e-2)" "unprognostic (4.11e-1)" "unprognostic (7.81e-5)" "unprognostic (5.10e-3)" "unprognostic (1.16e-2)" "unprognostic (1.83e-2)" "unprognostic (1.92e-2)" "unprognostic (1.90e-1)" "unprognostic (1.12e-1)" "unprognostic (4.59e-2)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (3.00e-3)" "unprognostic (1.68e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.3 0.1 0.1 0.0 36.5 141.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.4 0.0 0.3 0.4 0.0 0.2 0.1 1.1 0.0 1.4 0.0 0.4 0.0 1.2 0.5 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.5 1.3 0.6 0.0 0.0 0.0 0.4 1.6 0.1 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.1 0.0 0.0 0.0 2.3 0.0 1.6 0.1 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.2 0.0 0.2 0.8 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 43.3 0.0 0.0 7.0 0.0 0.0 14.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 433.3 0.0 0.0 0.0 6.2 6.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP4A22 ENSG00000162365 "Cytochrome P450 family 4 subfamily A member 22" Q5TCH4 1 47137435-47149741 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 71.0" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 99.2" "Cancer enriched" "Detected in some" 13 "liver cancer: 20.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 5.1;SuSa: 2.6" NA NA "unprognostic (5.34e-2)" "unprognostic (1.24e-1)" "unprognostic (3.19e-2)" "unprognostic (2.88e-3)" "unprognostic (2.76e-3)" "unprognostic (1.50e-3)" "unprognostic (2.21e-1)" "unprognostic (2.75e-1)" "unprognostic (1.93e-2)" "unprognostic (5.29e-3)" "unprognostic (1.02e-1)" "unprognostic (1.71e-1)" "unprognostic (8.59e-4)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 1.2 0.1 0.0 0.1 0.1 0.1 0.0 14.4 71.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.4 0.2 0.1 0.6 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.4 0.5 0.5 0.2 0.1 0.0 0.2 0.3 0.0 0.1 0.2 0.2 0.1 0.5 0.0 0.0 0.6 0.6 0.2 0.0 0.1 0.2 0.0 0.1 0.3 0.2 0.5 0.1 0.1 0.4 0.4 0.4 0.0 0.0 0.0 5.1 0.0 0.0 0.4 0.5 0.2 0.3 0.1 0.0 2.6 0.4 0.6 0.7 0.2 0.1 0.2 0.0 0.0 0.5 0.6 0.2 1.1 0.0 0.0 0.2 0.4 0.5 0.0 0.4 0.5 0.5 0.6 0.1 0.6 0.5 0.6 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.2 0.0 0.0 0.0 1.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP4B1 ENSG00000142973 "Cytochrome P450 family 4 subfamily B member 1" P13584 1 46757838-46819413 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 92.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 1140.4;Ciliated cells: 602.3;Club cells: 304.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 56.9" "Region enhanced" "Detected in single" "midbrain: 1.7" "Cell type enriched" "Detected in single" 11 "memory CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enriched" "Detected in some" 8 "RT4: 81.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA004331 Approved Supported Vesicles NA NA Vesicles "HPA004331: AB_1078616" "unprognostic (2.29e-2)" "prognostic favorable (5.99e-4)" "unprognostic (7.01e-2)" "unprognostic (1.11e-1)" "unprognostic (2.28e-1)" "unprognostic (8.31e-2)" "unprognostic (1.16e-2)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "unprognostic (2.59e-1)" "unprognostic (6.12e-2)" "unprognostic (5.46e-2)" "unprognostic (7.33e-2)" "unprognostic (1.80e-1)" "unprognostic (1.15e-1)" "unprognostic (1.22e-3)" "unprognostic (6.69e-3)" 41.6 2.2 0.0 0.6 0.1 0.3 45.5 0.1 0.3 9.5 6.7 0.1 7.2 0.7 2.1 2.8 17.9 18.5 0.8 13.5 0.0 0.0 1.4 0.2 92.0 1.5 1.7 0.1 3.3 0.9 0.5 4.8 0.9 0.8 15.4 0.5 2.8 5.0 6.9 14.4 10.4 3.4 6.8 3.5 0.5 3.0 1.7 0.1 0.7 12.7 4.5 5.7 36.5 18.9 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.5 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 1.7 0.1 0.8 0.1 1140.4 70.0 0.0 114.6 0.5 0.0 4.8 0.0 602.3 304.8 0.0 0.0 0.9 0.0 0.0 0.5 2.1 0.0 0.0 0.0 0.2 4.7 3.9 5.8 0.0 0.6 0.0 0.0 2.5 0.0 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 3.6 0.7 0.0 0.0 142.5 CYP4F11 ENSG00000171903 "Cytochrome P450 family 4 subfamily F member 11" Q9HBI6 19 15912367-15934867 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 88.6" "Cell type enhanced" "Detected in many" 17 "Ductal cells: 13.3;Hepatocytes: 48.8;Urothelial cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 7.6;CAPAN-2: 30.3;EFO-21: 11.4;Hep G2: 14.7;RPMI-8226: 7.9;RT4: 9.1" "HPA017265, CAB033648, HPA058960" Enhanced "Intracellular and membrane" NA NA "CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862" "prognostic favorable (4.05e-4)" "unprognostic (4.12e-2)" "unprognostic (1.79e-1)" "unprognostic (5.99e-2)" "unprognostic (5.92e-3)" "unprognostic (1.06e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-1)" "unprognostic (2.33e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (9.28e-4)" "unprognostic (4.44e-2)" "unprognostic (9.50e-3)" "unprognostic (2.14e-2)" "unprognostic (2.24e-1)" "unprognostic (2.78e-2)" "unprognostic (4.64e-2)" 0.4 2.2 3.6 0.5 4.4 0.5 1.7 1.8 5.4 1.1 2.5 4.4 0.0 7.5 0.5 11.8 7.9 2.2 12.9 0.4 3.9 1.4 4.9 88.6 2.4 0.4 2.1 3.8 0.3 3.5 0.2 0.6 0.2 8.3 2.4 1.9 0.6 2.6 3.4 0.5 0.8 15.7 0.2 9.7 0.9 2.7 1.0 3.0 0.0 2.2 2.8 1.8 4.8 2.0 0.1 0.1 0.8 1.2 0.0 0.2 0.1 7.6 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 0.1 11.4 0.0 6.5 0.9 0.0 3.9 0.0 0.0 0.0 0.0 2.3 14.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 1.1 0.0 0.1 0.0 6.7 0.0 0.0 0.1 7.9 2.1 9.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.1 0.1 0.1 0.1 0.3 0.1 0.2 0.9 0.0 0.8 0.5 0.0 0.1 1.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.7 0.1 0.0 0.1 3.6 4.4 1.8 5.4 3.9 1.4 2.1 3.8 8.3 3.0 0.0 0.0 0.0 7.8 0.1 0.0 0.3 0.0 4.0 1.2 8.7 0.0 0.0 1.7 13.3 0.0 0.0 5.3 0.0 9.9 0.0 0.0 7.8 0.0 48.8 0.0 0.0 1.2 0.0 1.6 0.0 0.3 0.0 0.0 0.0 3.0 2.5 7.5 2.9 0.0 5.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 1.7 13.3 CYP4F12 ENSG00000186204 "Cytochrome P450 family 4 subfamily F member 12" 19 15672757-15697174 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 53.0;liver: 24.2" "Cell type enhanced" "Detected in many" 16 "Enterocytes: 95.3;Paneth cells: 35.4;Undifferentiated cells: 26.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 39 "basophil: 5.3;eosinophil: 13.2" "Lineage enriched" "Detected in single" 76 "granulocytes: 13.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.6;HaCaT: 18.7;Hep G2: 5.2;Karpas-707: 12.6;OE19: 27.1" HPA058960 Approved NA NA "HPA058960: AB_2683862" "unprognostic (4.30e-4)" "prognostic favorable (1.21e-4)" "unprognostic (1.86e-1)" "unprognostic (1.48e-2)" "unprognostic (1.37e-2)" "unprognostic (5.32e-3)" "unprognostic (1.84e-3)" "unprognostic (9.13e-2)" "unprognostic (9.11e-2)" "unprognostic (2.50e-1)" "unprognostic (4.32e-2)" "unprognostic (1.47e-1)" "unprognostic (1.66e-3)" "unprognostic (6.20e-2)" "unprognostic (5.45e-2)" "unprognostic (3.17e-1)" "prognostic favorable (2.33e-4)" 1.9 0.7 1.6 6.1 0.9 0.6 3.5 0.0 1.9 3.9 24.6 5.6 1.4 24.6 1.4 1.8 11.5 2.1 10.8 1.7 1.9 0.3 1.1 24.2 0.9 0.3 3.0 3.5 1.9 0.2 0.1 0.3 0.4 2.7 4.4 5.1 1.4 3.0 1.5 0.4 12.9 53.0 5.1 0.8 0.7 8.0 0.4 4.8 0.2 0.6 8.9 6.3 10.1 6.5 0.0 0.0 13.2 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.3 0.0 0.0 0.1 18.7 0.0 0.0 0.0 1.0 0.0 0.0 0.7 5.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 13.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.9 0.0 1.9 1.9 0.3 3.0 3.5 2.7 4.8 0.0 2.6 0.8 10.1 12.5 0.0 1.0 5.1 2.7 0.0 0.0 0.0 0.1 0.0 0.3 1.1 1.5 95.3 0.0 0.0 0.1 3.0 2.8 0.0 24.2 0.4 0.0 7.5 0.6 0.3 2.2 3.7 0.0 1.7 0.0 24.4 2.7 1.1 35.4 1.1 2.1 0.0 0.0 0.8 0.1 0.0 18.4 0.2 0.7 26.0 18.3 CYP4F2 ENSG00000186115 "Cytochrome P450 family 4 subfamily F member 2" P78329 19 15878023-15898120 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 69.1;liver: 102.9" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 132.0" "Cancer enriched" "Detected in some" 9 "liver cancer: 29.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "basophil: 8.5" "Lineage enriched" "Detected in single" 86 "granulocytes: 8.5" "Cell line enriched" "Detected in some" 4 "Hep G2: 9.0" "HPA014048, HPA017265, HPA058960" Supported "Intracellular and membrane" NA NA "HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862" "unprognostic (7.46e-3)" "unprognostic (3.58e-1)" "unprognostic (3.01e-1)" "unprognostic (9.39e-2)" "unprognostic (1.74e-1)" "unprognostic (2.87e-2)" "unprognostic (4.55e-3)" "unprognostic (6.52e-2)" "unprognostic (2.05e-1)" "unprognostic (4.64e-2)" "unprognostic (9.82e-2)" "unprognostic (2.92e-1)" "unprognostic (8.69e-4)" "unprognostic (3.24e-1)" "unprognostic (1.89e-1)" "unprognostic (7.79e-3)" 0.1 0.1 0.2 0.5 0.1 0.0 0.2 0.1 0.2 0.2 10.1 0.2 0.1 24.5 0.1 8.8 0.2 0.1 1.8 0.1 0.2 0.1 11.9 102.9 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.2 1.9 0.0 0.1 0.1 0.2 0.1 0.5 69.1 0.1 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.4 0.3 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.7 0.1 0.3 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.2 9.0 0.0 1.0 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 1.6 0.1 0.0 0.1 0.3 0.6 0.8 0.1 0.4 0.4 0.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.5 5.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 6.2 0.0 16.2 0.0 0.3 0.0 0.0 0.6 0.0 132.0 0.0 0.0 1.7 0.6 3.9 11.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 5.8 0.0 14.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.0 0.1 CYP4F22 FLJ39501 ENSG00000171954 "Cytochrome P450 family 4 subfamily F member 22" Q6NT55 19 15508493-15552317 "Disease related genes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" Ichthyosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 44.6;skin 1: 29.0" "Cell type enhanced" "Detected in some" 21 "Glandular cells: 1.9;granulocytes: 6.9;Spermatogonia: 1.5;Suprabasal keratinocytes: 2.6" "Group enriched" "Detected in many" 7 "breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "intermediate monocyte: 6.1;MAIT T-cell: 4.6;non-classical monocyte: 13.2" "Group enriched" "Detected in many" 9 "monocytes: 13.2;T-cells: 4.6" "Cell line enhanced" "Detected in some" "HEL: 1.3;JURKAT: 2.8;MCF7: 5.1;RT4: 2.5;T-47d: 3.1;U-2 OS: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA058960 Uncertain NA NA "HPA058960: AB_2683862" "unprognostic (2.32e-3)" "unprognostic (1.17e-2)" "unprognostic (6.81e-2)" "unprognostic (2.47e-2)" "unprognostic (1.03e-1)" "unprognostic (7.02e-2)" "unprognostic (1.30e-1)" "unprognostic (2.43e-1)" "unprognostic (3.33e-1)" "unprognostic (1.89e-2)" "unprognostic (9.33e-2)" "unprognostic (3.00e-2)" "unprognostic (2.21e-5)" "unprognostic (8.10e-2)" "unprognostic (3.16e-1)" "unprognostic (7.25e-3)" "unprognostic (2.03e-2)" 0.5 0.0 0.0 0.1 0.0 0.1 3.6 0.0 0.0 5.4 0.1 0.0 10.3 0.2 0.6 0.2 12.1 0.1 0.6 0.0 0.0 0.0 0.0 19.3 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 5.2 0.0 0.0 1.6 44.6 1.2 29.0 0.1 1.0 0.0 0.3 0.5 0.7 0.0 0.4 0.0 14.7 6.7 5.5 10.3 0.0 0.2 0.0 13.2 1.0 4.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.8 0.0 0.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 1.8 6.1 4.6 0.0 0.6 1.5 0.2 0.0 0.0 0.4 0.0 1.0 13.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 6.9 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.6 0.0 0.9 0.0 0.2 CYP4F3 "CYP4F, LTB4H" ENSG00000186529 "Cytochrome P450 family 4 subfamily F member 3" Q08477 19 15640897-15662825 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 159.2" "Cell type enriched" "Detected in many" 6 "Hepatocytes: 506.3" "Cancer enhanced" "Detected in many" "liver cancer: 30.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 68 "neutrophil: 33.1" "Lineage enriched" "Detected in single" 166 "granulocytes: 33.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 20.0;HaCaT: 9.1;Hep G2: 10.9;OE19: 29.3" HPA058960 Approved NA NA "HPA058960: AB_2683862" "unprognostic (1.73e-2)" "unprognostic (9.70e-3)" "unprognostic (1.21e-1)" "unprognostic (1.16e-3)" "unprognostic (5.40e-1)" "unprognostic (1.57e-1)" "unprognostic (7.15e-3)" "unprognostic (5.19e-2)" "unprognostic (2.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-2)" "unprognostic (2.32e-1)" "unprognostic (1.59e-3)" "unprognostic (2.36e-1)" "unprognostic (1.12e-1)" "unprognostic (1.07e-2)" "unprognostic (2.07e-1)" 0.4 0.1 0.3 0.3 1.5 24.8 0.1 0.1 2.2 2.1 3.4 6.5 0.0 3.1 0.1 0.4 8.6 0.3 19.8 0.2 0.8 0.2 23.7 159.2 0.7 0.0 0.4 1.9 0.1 0.2 0.0 0.2 0.0 1.6 0.3 0.5 0.0 1.3 0.1 0.1 1.2 13.4 0.1 1.0 2.6 1.7 0.2 1.8 0.0 0.1 1.1 0.8 1.8 2.7 0.0 0.0 33.1 0.1 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 20.0 0.0 0.1 0.0 0.0 9.1 0.0 0.1 0.0 0.3 0.0 0.1 1.9 10.9 0.0 0.1 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.1 2.2 0.8 0.2 0.4 1.9 1.6 1.8 8.9 5.9 5.1 2.3 0.9 0.0 0.8 91.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 13.5 23.3 0.2 0.1 0.3 1.7 1.1 506.3 0.0 0.0 50.9 6.2 10.2 0.4 0.0 0.4 0.0 0.0 5.6 0.0 2.5 7.0 0.0 31.2 0.0 0.0 0.2 0.0 0.1 5.6 0.0 0.8 8.3 10.8 CYP4F8 ENSG00000186526 "Cytochrome P450 family 4 subfamily F member 8" P98187 19 15615218-15630638 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 155 "ductus deferens: 265.6;seminal vesicle: 360.6" "Cell type enhanced" "Detected in some" 14 "Glandular cells: 1.7;granulocytes: 1.1;Urothelial cells: 2.4" "Group enriched" "Detected in some" 31 "breast cancer: 2.5;prostate cancer: 3.3;urothelial cancer: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "OE19: 2.1;RT4: 1.6;SK-BR-3: 4.4" HPA058960 Approved NA NA "HPA058960: AB_2683862" "unprognostic (1.70e-2)" "unprognostic (5.46e-3)" "unprognostic (3.21e-2)" "unprognostic (3.97e-6)" "unprognostic (3.51e-3)" "unprognostic (2.72e-1)" "unprognostic (1.15e-1)" "unprognostic (8.25e-2)" "unprognostic (1.15e-2)" "unprognostic (1.02e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 265.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 360.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.4 CYP4V2 CYP4AH1 ENSG00000145476 "Cytochrome P450 family 4 subfamily V member 2" Q6ZWL3 4 186191520-186213456 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sensory transduction, Vision" "Monooxygenase, Oxidoreductase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 92.7;Muller glia cells: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 13.1;SK-MEL-30: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029122 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA029122: AB_10601806" "unprognostic (1.65e-1)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "prognostic favorable (5.86e-4)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.66e-2)" "unprognostic (5.84e-2)" "unprognostic (2.05e-1)" "unprognostic (6.49e-2)" "unprognostic (9.89e-2)" "prognostic favorable (1.49e-7)" "unprognostic (3.25e-2)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" 6.6 16.6 7.8 5.0 12.4 1.6 5.5 8.9 7.5 6.7 8.0 8.9 4.9 11.4 5.7 4.2 5.2 6.2 13.7 7.4 7.7 4.6 21.6 64.7 7.3 4.1 7.7 9.0 6.3 12.1 30.8 16.1 3.0 6.7 5.6 8.2 19.1 6.2 9.1 3.3 2.8 14.7 6.4 7.0 7.5 5.2 3.2 7.4 4.4 11.9 2.1 3.8 8.0 5.1 2.3 2.5 0.0 6.2 1.3 4.0 1.5 2.6 1.8 0.6 0.0 11.3 4.6 0.1 3.8 8.1 1.4 2.0 0.0 10.9 1.0 0.5 2.5 5.7 1.3 1.3 1.2 0.4 6.5 1.3 4.1 0.4 0.5 3.4 2.2 2.0 4.2 0.5 1.4 0.7 4.7 0.1 4.2 1.6 13.1 4.7 2.3 2.5 0.6 1.4 1.1 0.0 2.1 0.5 1.1 4.6 5.2 2.8 4.1 0.9 0.0 19.4 0.2 1.9 3.5 4.2 3.0 0.7 3.3 1.6 0.0 0.0 0.5 9.0 8.3 3.6 0.0 1.2 0.0 4.0 4.1 2.5 1.0 2.5 3.4 1.5 2.3 2.7 2.3 0.0 1.3 6.2 2.5 2.1 1.5 7.8 12.4 8.9 7.5 7.7 4.6 7.7 9.0 6.7 7.4 6.0 7.8 8.3 3.1 2.3 31.1 15.3 45.9 12.0 10.3 14.0 29.5 1.8 8.3 16.1 2.4 5.5 19.2 0.0 19.5 1.7 8.4 5.5 6.9 92.7 11.5 4.8 16.3 9.2 11.2 1.7 4.6 7.1 3.3 0.0 19.1 64.2 11.0 10.5 6.0 31.8 27.1 0.0 10.2 8.1 5.4 2.8 0.8 10.7 8.9 5.0 CYP4X1 MGC40051 ENSG00000186377 "Cytochrome P450 family 4 subfamily X member 1" Q8N118 1 47023568-47050751 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 38.1" "Cell type enriched" "Detected in many" 6 "Ciliated cells: 156.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.7;CACO-2: 6.2;NTERA-2: 2.9;SCLC-21H: 3.8;T-47d: 13.5" "Low region specificity" "Detected in all" HPA017661 Approved NA NA "HPA017661: AB_2669633" "unprognostic (1.19e-1)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (1.78e-2)" "unprognostic (9.88e-2)" "unprognostic (1.56e-3)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" "unprognostic (1.10e-2)" "unprognostic (2.35e-2)" "unprognostic (1.46e-1)" "unprognostic (2.76e-2)" "unprognostic (3.03e-2)" "unprognostic (1.79e-3)" "unprognostic (3.65e-2)" "unprognostic (8.56e-2)" "unprognostic (5.03e-2)" 7.9 3.6 9.0 1.1 14.9 0.5 16.0 7.1 16.9 38.1 2.0 1.6 2.5 2.1 3.6 3.2 12.0 9.7 2.0 6.7 4.8 10.6 6.3 10.0 8.9 2.0 3.3 13.5 1.7 2.0 2.0 4.1 1.5 7.8 8.0 2.3 17.6 23.7 3.4 4.5 5.0 1.8 2.4 2.0 1.0 14.3 4.2 0.9 0.0 4.0 6.9 8.8 3.9 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.9 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.9 1.0 0.0 0.0 0.5 0.0 0.6 0.2 3.8 0.0 0.0 0.3 0.0 0.2 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 14.9 7.1 16.9 4.8 10.6 3.3 13.5 7.8 0.9 20.8 10.5 0.0 23.5 2.3 0.9 1.0 0.0 156.6 27.3 0.0 0.0 0.0 0.0 0.3 6.0 2.3 0.0 0.0 0.6 0.0 1.9 10.7 0.0 2.5 2.9 0.0 0.0 0.6 0.3 5.6 9.8 0.6 5.0 0.0 0.0 0.0 0.2 0.0 19.4 1.3 0.7 0.0 14.5 0.0 1.5 1.3 0.1 0.0 0.6 26.2 CYP4Z1 CYP4A20 ENSG00000186160 "Cytochrome P450 family 4 subfamily Z member 1" Q86W10 1 47067488-47118319 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "breast: 23.1" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9" "Cancer enriched" "Detected in some" 50 "breast cancer: 42.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 39 "HDLM-2: 13.7;SK-BR-3: 5.9" NA NA "unprognostic (4.11e-2)" "unprognostic (2.57e-2)" "unprognostic (2.46e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (4.33e-4)" "unprognostic (1.10e-1)" "unprognostic (3.53e-3)" "unprognostic (7.76e-3)" "unprognostic (1.21e-1)" "unprognostic (3.53e-1)" "unprognostic (6.82e-3)" "unprognostic (5.09e-3)" "unprognostic (3.88e-2)" "unprognostic (6.46e-2)" "unprognostic (3.49e-3)" 2.5 0.2 0.4 0.4 0.9 0.0 23.1 0.4 2.0 1.0 0.4 0.4 0.4 0.0 0.4 0.8 0.8 0.7 0.4 0.4 0.4 1.8 0.4 1.5 2.1 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.7 1.3 0.0 0.4 1.5 0.8 0.5 2.2 0.4 0.4 0.4 0.4 0.2 1.0 0.4 0.6 0.4 0.4 0.5 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 2.0 0.4 1.8 0.4 0.4 0.7 0.4 8.9 0.6 0.0 0.4 0.1 0.0 0.2 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 CYP51A1 "CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1" ENSG00000001630 "Cytochrome P450 family 51 subfamily A member 1" Q16850 7 92112151-92142952 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.9" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 62.5;Alveolar cells type 2: 133.7;Club cells: 77.3;Early spermatids: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 96.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041325, HPA043508" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA041325: AB_2677411, HPA043508: AB_2678520" "unprognostic (6.68e-2)" "prognostic unfavorable (6.12e-4)" "unprognostic (3.48e-2)" "unprognostic (1.18e-2)" "unprognostic (7.82e-2)" "unprognostic (3.60e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.84e-2)" "unprognostic (1.36e-1)" "unprognostic (9.75e-2)" "unprognostic (1.34e-1)" "unprognostic (1.59e-9)" "unprognostic (1.82e-1)" "unprognostic (2.73e-1)" "unprognostic (5.13e-2)" "unprognostic (1.09e-3)" 10.3 27.0 16.7 8.1 22.1 10.5 15.5 13.3 32.0 11.8 21.1 32.9 6.3 33.1 9.1 15.3 23.4 7.1 10.3 9.9 18.6 20.8 18.6 80.9 22.2 5.0 17.2 13.7 21.0 20.2 32.4 11.9 8.8 47.1 18.2 16.9 17.1 11.0 7.7 4.3 12.8 28.8 8.3 43.7 7.3 18.1 35.7 19.5 2.3 14.1 18.7 10.0 9.0 13.2 14.2 14.1 3.5 13.9 6.7 10.7 7.1 21.4 10.5 26.6 17.0 18.7 30.7 3.8 7.3 22.1 9.5 26.0 25.3 39.3 18.7 11.6 12.6 96.2 18.8 23.1 46.1 11.1 7.8 16.4 5.4 11.2 19.0 25.6 11.0 8.1 22.2 21.0 37.1 39.0 8.4 9.7 3.8 20.2 43.2 11.1 22.0 2.3 10.2 19.8 8.8 10.5 7.6 5.5 42.2 43.0 36.4 18.7 12.5 15.5 30.9 22.6 12.6 11.2 13.2 11.5 13.0 14.6 18.8 9.5 14.7 13.1 17.1 10.0 14.6 16.6 1.8 9.7 3.5 10.7 13.9 7.1 14.2 7.6 8.4 14.1 10.7 7.2 9.2 1.5 6.7 8.3 12.4 5.8 7.1 16.7 22.1 13.3 32.0 18.6 20.8 17.2 13.7 47.1 19.5 62.5 133.7 7.5 1.0 2.3 2.1 1.2 7.6 28.1 77.3 1.8 2.0 1.3 1.7 9.2 70.7 2.1 14.4 23.3 17.0 0.8 1.8 1.3 27.7 4.2 1.3 0.0 10.4 8.6 6.6 27.7 3.4 2.1 0.0 1.0 12.0 1.9 12.3 10.4 1.4 1.7 1.8 0.0 2.8 3.2 1.5 4.6 3.7 1.0 11.5 2.1 CYP7A1 CYP7 ENSG00000167910 "Cytochrome P450 family 7 subfamily A member 1" P22680 8 58490178-58500236 "Enzymes, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 70 "liver: 50.4" "Cell type enriched" "Detected in single" 12 "Hepatocytes: 4.7" "Cancer enriched" "Detected in single" 96 "liver cancer: 28.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BJ hTERT+: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (5.20e-2)" "unprognostic (1.93e-2)" "unprognostic (1.77e-2)" "prognostic favorable (3.19e-4)" "unprognostic (7.60e-2)" "unprognostic (5.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-1)" "unprognostic (8.43e-3)" "unprognostic (3.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.51e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.5 0.0 0.0 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.9 0.0 0.2 0.5 0.0 0.4 0.1 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CYP7B1 SPG5A ENSG00000172817 "Cytochrome P450 family 7 subfamily B member 1" O75881 8 64587763-64798761 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Disease mutation, Hereditary spastic paraplegia, Intrahepatic cholestasis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 16.9;Smooth muscle cells: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 36 "basophil: 6.4;eosinophil: 6.2" "Lineage enriched" "Detected in single" 36 "granulocytes: 6.4" "Cell line enhanced" "Detected in some" "HSkMC: 16.9;NTERA-2: 3.2;SH-SY5Y: 6.2;WM-115: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017761 Uncertain NA NA "HPA017761: AB_1847455" "unprognostic (3.19e-2)" "unprognostic (1.91e-1)" "unprognostic (1.50e-1)" "unprognostic (6.89e-3)" "unprognostic (1.07e-1)" "unprognostic (5.80e-3)" "unprognostic (3.80e-1)" "unprognostic (5.50e-2)" "unprognostic (6.11e-3)" "unprognostic (2.46e-1)" "unprognostic (1.61e-1)" "unprognostic (3.19e-2)" "unprognostic (1.87e-2)" "unprognostic (2.38e-3)" "unprognostic (4.00e-1)" "unprognostic (3.04e-3)" "unprognostic (6.75e-3)" 10.1 8.5 5.0 7.5 12.2 0.8 9.8 2.1 10.8 8.7 3.8 20.7 3.5 2.4 4.1 3.9 10.8 5.4 8.0 6.6 5.8 4.2 10.0 24.6 11.0 5.7 5.0 7.8 5.6 8.2 31.0 4.4 1.7 13.5 5.8 4.8 7.3 6.6 7.1 1.8 6.7 3.5 6.1 12.6 19.1 3.9 3.2 7.5 0.2 16.2 5.5 3.8 8.4 10.1 0.0 0.1 6.4 0.0 0.0 0.1 0.0 1.9 0.8 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.1 6.2 0.0 0.1 2.6 1.1 0.0 1.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 6.4 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 12.2 2.1 10.8 5.8 4.2 5.0 7.8 13.5 7.5 0.0 4.3 0.0 6.1 9.4 5.5 2.0 0.0 1.4 1.2 7.0 2.0 0.0 3.3 3.3 6.0 1.4 0.0 0.0 4.4 0.1 7.2 3.7 12.7 7.8 0.2 3.2 1.7 2.5 0.3 5.7 5.5 0.0 16.9 1.8 0.0 8.1 1.4 0.0 4.6 2.9 0.5 12.9 16.1 1.7 3.0 11.0 0.0 1.0 0.0 2.6 CYP8B1 CYP12 ENSG00000180432 "Cytochrome P450 family 8 subfamily B member 1" Q9UNU6 3 42856005-42876165 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 132.7" "Cell type enriched" "Detected in some" 57 "Hepatocytes: 737.2" "Cancer enriched" "Detected in some" 46 "liver cancer: 69.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "Group enriched" "Detected in some" 5 "BEWO: 6.8;HEL: 1.7;Hep G2: 2.6;SK-BR-3: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.58e-2)" "unprognostic (5.41e-2)" "unprognostic (6.38e-2)" "unprognostic (1.15e-2)" "unprognostic (8.95e-2)" "unprognostic (1.42e-3)" "unprognostic (4.47e-3)" "unprognostic (1.49e-1)" "unprognostic (9.85e-2)" "unprognostic (4.04e-3)" "unprognostic (5.86e-3)" "unprognostic (2.74e-1)" "unprognostic (3.37e-1)" "unprognostic (1.03e-1)" "unprognostic (3.63e-1)" "unprognostic (3.19e-1)" "unprognostic (1.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 6.7 132.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.4 0.2 0.1 0.2 0.1 0.4 0.7 0.3 0.2 0.0 0.0 6.8 0.1 0.0 0.0 0.0 0.5 0.3 0.2 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 1.7 0.2 2.6 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.2 0.0 0.4 0.2 0.0 0.3 0.1 0.4 0.5 0.6 0.3 0.3 0.5 0.1 0.0 0.6 3.1 0.3 0.4 0.3 0.1 0.3 0.3 0.6 0.3 0.2 0.4 0.1 0.3 0.3 0.4 0.1 1.4 0.2 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 737.2 0.1 0.0 0.0 10.4 10.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CYSLTR1 "CysLT(1), CysLT1, CYSLT1R" ENSG00000173198 "Cysteinyl leukotriene receptor 1" Q9Y271 X 78271464-78327691 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.9;esophagus: 24.6" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 62.5;Alveolar cells type 2: 54.8;Ciliated cells: 65.6;Club cells: 67.1;granulocytes: 76.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 33.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 11.6;Karpas-707: 7.5;NB-4: 16.2;RPMI-8226: 24.7;THP-1: 15.2;U-937: 16.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA010546 Approved NA NA "HPA010546: AB_1078268" "unprognostic (9.48e-2)" "unprognostic (6.01e-5)" "unprognostic (4.72e-3)" "unprognostic (3.04e-1)" "unprognostic (6.30e-2)" "unprognostic (2.80e-3)" "unprognostic (2.52e-1)" "unprognostic (8.19e-2)" "unprognostic (1.19e-1)" "unprognostic (2.53e-2)" "unprognostic (4.55e-1)" "unprognostic (2.43e-1)" "unprognostic (4.41e-4)" "unprognostic (5.82e-2)" "unprognostic (3.56e-2)" "unprognostic (9.87e-2)" "unprognostic (8.94e-2)" 7.3 2.0 1.7 7.8 1.7 2.8 5.4 0.8 2.2 3.0 3.3 1.7 2.9 2.2 2.3 4.4 24.6 2.3 5.6 3.1 2.3 1.9 4.8 2.7 6.9 19.5 3.8 0.8 1.7 2.0 1.7 1.5 3.3 2.9 3.7 4.8 3.1 5.4 0.8 1.7 3.1 7.1 4.2 5.1 22.8 5.2 2.3 4.0 4.7 4.5 4.8 11.3 9.8 3.5 8.1 7.4 33.9 11.9 4.1 3.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 11.6 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 16.2 0.0 0.0 0.0 3.3 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 16.8 0.0 5.8 6.3 33.9 0.0 10.9 0.0 8.1 2.4 0.1 4.8 5.8 3.7 0.0 18.4 4.1 11.9 7.4 0.5 2.8 1.7 1.7 0.8 2.2 2.3 1.9 3.8 0.8 2.9 4.0 62.5 54.8 40.4 3.9 3.3 2.9 0.6 0.0 65.6 67.1 0.0 5.9 0.3 0.0 0.1 0.0 9.0 0.0 0.0 0.2 0.2 1.4 1.2 76.2 0.0 23.3 0.0 0.0 3.7 30.2 0.0 0.6 32.2 6.8 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.2 3.1 0.7 17.5 0.5 1.4 CYSLTR2 "CysLT(2), CYSLT2R" ENSG00000152207 "Cysteinyl leukotriene receptor 2" Q9NS75 13 48653711-48711226 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.2;ductus deferens: 25.1;placenta: 22.6;seminal vesicle: 22.4" "Cell type enhanced" "Detected in some" 12 "Macrophages: 4.3;Melanocytes: 5.0;Sertoli cells: 12.9;Smooth muscle cells: 5.1" "Group enriched" "Detected in many" 6 "melanoma: 1.8;renal cancer: 6.6;thyroid cancer: 7.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 12 "eosinophil: 37.2" "Lineage enriched" "Detected in many" 12 "granulocytes: 37.2" "Cell line enriched" "Detected in some" 43 "HDLM-2: 44.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA046528 Approved NA NA "HPA046528: AB_2679687" "unprognostic (9.83e-3)" "unprognostic (2.72e-3)" "unprognostic (1.05e-2)" "unprognostic (6.81e-2)" "unprognostic (2.94e-2)" "unprognostic (3.11e-2)" "unprognostic (1.11e-1)" "unprognostic (7.41e-3)" "unprognostic (8.33e-2)" "unprognostic (1.83e-1)" "unprognostic (5.44e-2)" "unprognostic (5.93e-2)" "unprognostic (1.88e-3)" "unprognostic (3.79e-2)" "unprognostic (4.44e-2)" "unprognostic (2.35e-2)" "unprognostic (1.18e-2)" 2.0 11.4 3.4 3.9 4.2 0.7 1.0 1.6 8.0 0.9 1.0 1.1 25.1 2.1 1.3 1.7 0.7 3.4 1.6 11.5 4.1 3.4 1.8 1.0 1.5 4.4 3.3 1.5 5.4 0.5 0.7 2.3 22.6 3.7 3.4 1.1 2.9 0.7 22.4 0.5 1.3 2.5 0.7 2.3 6.9 1.1 1.0 2.9 1.0 1.1 0.5 1.5 1.0 1.2 0.0 0.9 37.2 3.2 0.4 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 1.0 37.2 0.2 3.2 0.0 0.0 0.4 0.0 0.9 0.0 0.5 0.1 0.1 0.4 2.0 0.0 0.3 0.4 3.4 4.2 1.6 8.0 4.1 3.4 3.3 1.5 3.7 2.9 0.0 1.4 0.5 0.1 0.5 0.0 0.8 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.2 0.8 0.0 0.0 0.0 1.0 4.1 0.0 1.1 0.0 0.6 0.0 0.0 3.1 2.1 0.0 0.3 4.3 5.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 5.1 0.0 0.1 0.0 2.4 1.9 0.0 0.0 CYYR1 C21orf95 ENSG00000166265 "Cysteine and tyrosine rich 1" Q96J86 21 26466209-26573284 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "breast: 59.8" "Group enriched" "Detected in many" 6 "Endothelial cells: 113.7;Ito cells: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 38 "plasmacytoid DC: 21.1" "Lineage enriched" "Detected in single" 73 "dendritic cells: 21.1" "Cell line enhanced" "Detected in some" "AF22: 9.0;NTERA-2: 25.2;PC-3: 6.9;RH-30: 10.7;SCLC-21H: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034921, HPA067685" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB034921: AB_2089315, HPA067685: AB_2685887" "unprognostic (5.64e-2)" "unprognostic (2.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (2.63e-2)" "unprognostic (2.88e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.46e-1)" "unprognostic (2.44e-3)" "unprognostic (9.29e-3)" "unprognostic (2.26e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" 30.9 28.9 3.8 7.7 4.4 4.0 59.8 2.1 4.3 19.0 8.4 2.7 13.4 3.5 15.1 14.7 13.1 8.6 10.8 29.1 4.7 3.9 10.6 7.1 23.8 13.4 5.6 2.5 9.8 4.5 5.1 3.5 21.7 3.9 11.7 4.0 11.6 5.4 10.5 14.5 4.8 6.8 14.6 5.0 34.1 5.9 9.2 2.5 3.6 11.2 9.1 2.7 11.2 23.9 0.0 21.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.0 0.2 0.0 3.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 25.2 0.0 6.9 0.0 10.7 0.0 1.0 0.0 21.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 21.1 0.0 0.0 3.8 4.4 2.1 4.3 4.7 3.9 5.6 2.5 3.9 2.5 0.0 1.1 0.9 1.1 10.4 0.0 5.6 0.0 1.4 2.3 14.0 0.0 0.1 3.3 0.0 0.6 113.7 0.0 0.0 0.0 0.2 6.1 0.4 0.0 0.0 0.3 0.0 0.0 60.8 2.7 0.9 2.0 1.2 6.8 1.0 0.0 0.5 0.1 0.0 0.0 2.6 0.0 0.0 3.3 0.2 1.1 4.6 0.2 0.0 0.0 0.7 DAD1 OST2 ENSG00000129562 "Defender against cell death 1" P61803 14 22564905-22589269 "Cancer-related genes, Predicted membrane proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028882 Uncertain Approved Cytosol NA NA 14000 Cytosol "HPA028882: AB_10602214" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (1.97e-2)" "unprognostic (2.02e-1)" "unprognostic (1.18e-3)" "prognostic unfavorable (7.73e-4)" "unprognostic (9.43e-3)" "unprognostic (3.06e-2)" "unprognostic (6.09e-2)" "unprognostic (1.99e-2)" "unprognostic (9.64e-2)" "unprognostic (6.62e-3)" "unprognostic (1.19e-1)" "unprognostic (3.08e-1)" "unprognostic (1.93e-1)" "unprognostic (1.37e-3)" 48.1 64.7 47.9 36.4 49.4 26.4 61.2 19.3 39.5 59.0 46.7 55.9 93.6 39.7 49.8 118.7 61.2 56.5 54.9 55.2 45.9 43.1 85.1 123.6 48.4 54.6 51.5 25.1 55.4 114.1 35.6 57.0 54.6 51.9 48.3 51.5 43.5 81.9 100.1 39.7 35.6 73.4 49.6 65.3 57.4 48.0 56.7 33.6 84.6 107.0 50.7 52.2 49.3 43.4 80.2 121.1 75.3 65.9 61.5 95.6 122.5 47.9 45.1 37.1 50.3 101.4 72.9 32.1 51.4 62.3 45.6 64.6 28.3 69.1 30.3 33.0 59.0 51.9 44.0 38.4 49.3 73.2 41.1 35.1 29.6 26.4 112.8 70.7 41.3 43.0 54.1 66.3 47.7 61.5 52.1 66.5 29.4 22.3 71.7 67.1 58.8 19.6 50.5 22.8 106.4 73.8 27.5 31.4 39.5 67.1 39.7 28.5 35.7 39.0 55.9 56.6 46.6 33.7 42.2 50.3 39.8 31.9 48.3 32.3 53.7 62.2 39.1 36.0 29.0 57.4 66.0 65.9 68.1 86.7 56.2 85.1 80.2 90.9 81.7 62.0 71.2 95.6 83.8 75.3 61.5 47.8 121.1 83.5 122.5 47.9 49.4 19.3 39.5 45.9 43.1 51.5 25.1 51.9 33.6 148.9 165.4 142.8 161.3 176.2 21.8 136.5 170.7 219.5 109.2 242.5 25.5 222.0 182.4 458.8 135.7 237.6 168.9 23.3 362.6 309.7 253.7 161.4 292.5 226.5 313.4 20.6 130.4 183.0 140.5 70.6 198.5 173.2 313.8 230.0 162.7 174.4 363.0 131.9 187.0 354.4 32.8 148.8 195.7 167.4 132.2 188.6 241.7 163.9 144.2 147.6 DAG1 "156DAG, A3a, AGRNR, DAG" ENSG00000173402 "Dystroglycan 1" Q14118 3 49468703-49535618 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 62.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001960, CAB016353, HPA070563" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 70000000 "Vesicles, Plasma membrane" Nucleoplasm "CAB001960: , CAB016353: AB_627292, HPA070563: " "unprognostic (1.58e-1)" "unprognostic (5.14e-1)" "unprognostic (6.71e-3)" "unprognostic (3.32e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" "unprognostic (1.67e-1)" "unprognostic (3.27e-2)" "unprognostic (8.18e-2)" "unprognostic (3.91e-2)" "unprognostic (5.70e-3)" "unprognostic (1.10e-1)" "prognostic favorable (2.59e-4)" "unprognostic (9.22e-2)" "unprognostic (1.99e-2)" "unprognostic (7.43e-2)" "unprognostic (1.57e-2)" 19.2 17.4 16.5 10.1 21.1 2.8 16.2 17.3 27.1 17.3 23.9 24.1 13.1 14.1 23.4 14.3 19.1 19.6 19.7 40.9 19.9 10.3 22.7 31.7 18.9 6.3 16.7 15.7 22.6 35.0 32.7 15.8 45.6 18.1 18.6 18.9 22.2 19.9 24.3 57.3 18.7 17.5 27.9 14.0 7.3 22.2 29.4 16.3 6.0 15.3 24.0 14.3 20.4 15.0 3.2 3.6 1.8 6.1 1.9 3.7 3.3 19.5 19.5 13.6 33.6 18.2 8.9 62.0 13.8 20.5 23.7 15.3 16.0 20.8 2.7 14.1 22.5 20.1 36.7 11.8 17.9 14.7 2.6 3.9 1.8 19.6 18.2 8.1 2.4 3.9 7.8 16.2 22.5 7.5 21.7 21.2 3.3 2.8 2.1 6.4 15.7 2.0 1.6 14.6 24.1 6.5 1.2 13.2 4.6 18.6 27.5 4.8 9.9 16.6 45.8 22.4 41.3 38.6 4.8 11.1 9.0 14.3 16.7 19.7 2.4 4.9 1.7 10.9 2.6 54.3 1.8 2.8 1.1 3.3 3.5 3.7 3.2 2.8 2.5 1.8 2.6 3.0 2.4 0.6 1.9 6.1 3.6 1.9 3.3 16.5 21.1 17.3 27.1 19.9 10.3 16.7 15.7 18.1 16.3 50.6 13.6 9.0 8.0 12.7 7.8 50.0 30.6 10.7 11.4 33.2 3.9 95.1 1.7 26.2 25.8 16.8 20.6 0.0 69.3 96.3 24.2 13.2 6.9 48.8 18.3 3.2 31.7 17.8 7.2 13.6 19.8 4.0 32.1 5.4 27.5 30.3 50.2 25.1 34.6 6.8 8.7 45.3 23.7 7.0 18.6 14.9 80.2 5.0 26.4 9.0 DAGLA "C11orf11, DAGLALPHA, KIAA0659, NSDDR" ENSG00000134780 "Diacylglycerol lipase alpha" Q9Y4D2 11 61680433-61747001 "Disease related genes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0" "Cell type enhanced" "Detected in many" 5 "Mucus-secreting cells: 5.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;intermediate monocyte: 1.9;non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.2;T-47d: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062497, CAB078793" Approved Supported NA NA "CAB078793: , HPA062497: AB_2684784" "unprognostic (2.53e-3)" "unprognostic (1.85e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.13e-7)" "unprognostic (1.23e-1)" "unprognostic (1.70e-1)" "unprognostic (1.14e-4)" "unprognostic (2.22e-2)" "unprognostic (2.29e-3)" "unprognostic (3.99e-3)" "unprognostic (1.55e-1)" "unprognostic (1.09e-1)" "unprognostic (1.11e-3)" "unprognostic (1.53e-1)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.14e-2)" 3.7 2.5 7.2 2.8 13.3 1.1 3.0 12.0 22.0 3.1 6.0 3.6 3.1 4.4 2.7 3.8 4.7 3.8 2.9 3.8 8.6 6.0 2.3 0.5 3.2 1.3 3.7 7.4 1.2 8.8 1.7 3.3 1.7 4.5 3.5 3.7 2.5 7.9 4.0 3.1 1.1 5.2 3.2 1.4 3.4 2.9 3.3 2.7 0.0 1.6 2.0 1.0 1.7 1.4 0.0 0.8 0.0 1.9 0.0 0.1 0.3 5.4 6.2 4.8 1.0 1.1 1.8 0.8 2.6 0.7 2.9 3.1 3.6 11.2 0.0 2.6 2.3 4.5 3.2 0.8 0.0 1.2 0.0 3.2 0.0 4.6 5.5 1.8 0.0 1.0 0.9 0.3 3.7 0.0 1.7 0.8 0.4 0.0 0.0 1.3 2.6 0.0 0.0 9.9 1.9 6.0 0.0 0.7 0.0 1.0 1.3 10.0 5.5 1.4 2.4 1.7 1.2 12.3 3.1 3.4 1.9 8.7 5.2 3.0 0.0 0.0 0.0 5.2 1.4 3.0 0.0 1.4 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.3 7.2 13.3 12.0 21.5 8.6 6.0 3.7 7.4 4.5 2.7 3.0 0.3 0.0 0.3 0.3 1.1 0.7 0.0 0.0 2.3 3.5 0.0 0.0 0.0 1.5 0.0 0.6 3.1 0.0 1.9 0.1 0.5 0.7 0.0 0.0 2.2 0.0 4.1 2.5 3.3 0.0 1.7 2.7 0.0 0.0 5.6 1.7 2.4 0.0 3.9 0.4 0.3 0.0 0.4 1.2 2.9 0.3 0.0 0.0 4.5 0.0 DAGLB "DAGLBETA, KCCR13L" ENSG00000164535 "Diacylglycerol lipase beta" Q8NCG7 7 6409126-6484190 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069377 Supported "Nucleoplasm,Plasma membrane" No No "Plasma membrane" Nucleoplasm "HPA069377: AB_2686132" "unprognostic (2.39e-1)" "unprognostic (4.61e-2)" "unprognostic (2.13e-3)" "unprognostic (1.42e-1)" "unprognostic (9.04e-3)" "unprognostic (3.68e-2)" "unprognostic (1.78e-3)" "unprognostic (2.36e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (7.18e-5)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (2.18e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (1.81e-2)" 20.1 28.2 12.6 12.7 20.3 25.8 29.8 18.4 26.1 19.1 18.0 11.4 19.4 15.1 14.3 17.5 16.2 12.5 26.6 18.9 12.4 13.8 24.0 88.0 18.4 25.2 11.6 5.8 22.5 47.0 14.2 19.0 45.7 7.5 14.6 10.6 14.6 34.1 22.3 22.0 22.1 31.3 16.0 13.2 15.1 14.0 27.1 7.9 7.2 23.1 15.1 16.8 15.6 20.8 5.6 18.9 13.6 14.7 2.4 8.4 7.5 10.9 12.5 5.4 7.0 8.2 6.4 4.3 15.4 10.5 13.3 14.4 6.6 12.0 5.9 6.7 7.4 32.5 16.2 8.8 8.1 7.6 2.7 6.1 3.1 14.3 4.5 8.8 8.9 5.0 5.7 13.5 8.9 8.8 5.3 5.7 7.6 8.9 2.9 7.8 7.7 3.1 12.6 19.7 5.4 9.5 27.4 6.2 12.7 8.4 4.0 7.0 4.2 8.7 13.4 2.5 9.0 9.3 16.7 7.0 11.5 21.9 14.4 7.1 3.1 5.6 5.0 5.7 14.0 13.9 6.2 14.7 13.6 4.4 13.9 3.9 5.6 3.5 2.9 18.9 3.6 8.4 4.8 7.3 2.4 12.2 3.2 2.9 7.5 12.6 20.3 18.4 23.4 12.4 13.8 11.6 5.8 7.5 7.9 8.9 13.0 3.9 2.8 14.9 4.2 2.4 2.5 2.7 3.4 5.2 2.0 4.4 0.0 6.2 0.4 6.7 10.9 0.0 5.3 7.7 4.6 4.6 3.5 6.2 14.7 0.0 2.4 8.0 15.4 0.9 5.8 15.3 5.0 11.8 4.7 0.9 9.2 5.8 2.1 1.8 4.5 0.0 5.7 7.2 6.8 11.7 10.4 5.3 6.3 3.2 DAPL1 ENSG00000163331 "Death associated protein like 1" A0PJW8 2 158795317-158862781 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 522.1" "Group enriched" "Detected in all" 7 "cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HaCaT: 3.7;hTCEpi: 22.1;SCLC-21H: 5.7;U-87 MG: 8.1" "Not detected" "Not detected" "HPA046937, HPA058635" Enhanced Approved "Nucleoplasm,Nuclear bodies,Microtubules" NA NA "Nucleoplasm, Nuclear bodies, Microtubules" "HPA046937: AB_2679870, HPA058635: AB_2732625" "unprognostic (3.95e-5)" "prognostic favorable (8.43e-4)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (4.63e-2)" "unprognostic (8.59e-2)" "unprognostic (5.24e-2)" "unprognostic (4.59e-2)" "unprognostic (2.44e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-3)" "unprognostic (4.09e-2)" "unprognostic (6.68e-2)" "unprognostic (3.00e-2)" "unprognostic (2.30e-3)" 0.3 14.7 1.4 0.4 1.3 0.0 7.4 0.4 1.0 11.7 1.0 0.8 1.6 0.0 2.1 53.5 75.6 21.1 0.6 0.2 1.5 3.6 1.3 0.2 0.8 0.4 2.8 0.3 3.8 5.7 0.0 5.6 0.2 1.5 2.3 0.0 63.9 6.8 0.4 0.2 61.3 0.5 1.1 0.4 0.2 0.2 2.1 0.8 0.8 21.5 37.3 16.9 2.0 21.1 1.4 4.0 2.9 2.6 2.8 1.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.2 22.1 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.3 5.7 0.0 0.0 0.0 0.6 0.0 0.6 1.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 8.1 0.0 0.0 2.9 2.6 1.6 0.5 1.9 1.0 1.2 0.8 0.4 1.0 1.4 0.4 0.5 2.2 2.8 0.6 4.0 1.3 0.5 1.4 1.3 0.4 1.0 1.5 3.6 2.8 0.3 1.5 0.8 0.0 0.0 14.6 31.4 94.9 6.8 0.0 5.1 1.4 17.0 8.7 5.9 5.5 3.3 8.0 10.6 0.5 2.5 0.0 5.1 10.7 4.1 10.8 4.6 12.1 12.9 3.2 2.9 0.6 7.9 43.8 3.7 5.5 11.8 2.8 1.6 522.1 5.7 3.5 2.1 5.8 16.3 0.0 5.1 9.8 4.1 110.7 3.8 1.9 2.5 25.5 DBH DBM ENSG00000123454 "Dopamine beta-hydroxylase" P09172 9 133636360-133659344 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adrenal gland: 86.6;brain: 36.2;liver: 35.6" "Cell type enriched" "Detected in single" 43 "Ito cells: 17.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 45 "pons and medulla: 36.2" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.0" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Cell line enriched" "Detected in single" 340 "SH-SY5Y: 206.1" "Region enriched" "Detected in some" 6 "pons and medulla: 23.2" "Region enriched" "Detected in single" 38 "pons and medulla: 25.1" "HPA002130, HPA005960, HPA070789" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA 2000000000 Vesicles "Endoplasmic reticulum" "HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312" "unprognostic (1.93e-3)" "unprognostic (7.52e-3)" "unprognostic (8.53e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-3)" "unprognostic (3.38e-3)" "unprognostic (3.39e-3)" "unprognostic (3.97e-2)" "unprognostic (1.71e-1)" "unprognostic (8.99e-2)" "unprognostic (5.80e-2)" "unprognostic (7.69e-2)" "unprognostic (2.81e-7)" "unprognostic (9.31e-2)" "unprognostic (6.77e-2)" "unprognostic (1.49e-2)" "unprognostic (5.06e-3)" 0.7 86.6 0.1 0.3 0.1 0.0 0.0 0.1 0.8 0.3 0.0 1.9 0.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.5 35.6 0.3 0.6 0.0 0.0 0.1 1.3 0.0 0.6 0.4 36.2 0.8 0.0 1.0 0.2 5.9 0.0 0.0 0.2 0.0 1.4 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.2 206.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.0 0.0 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCAKD FLJ22955 ENSG00000172992 "Dephospho-CoA kinase domain containing" Q8WVC6 17 45023340-45061109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060997 Approved Nucleoplasm NA NA Nucleoplasm "HPA060997: AB_2797262" "unprognostic (1.32e-2)" "unprognostic (4.79e-3)" "unprognostic (9.71e-2)" "prognostic favorable (7.16e-6)" "unprognostic (1.13e-1)" "unprognostic (8.24e-3)" "unprognostic (7.57e-2)" "unprognostic (6.05e-3)" "unprognostic (4.10e-2)" "unprognostic (1.12e-1)" "unprognostic (2.97e-3)" "unprognostic (4.00e-2)" "unprognostic (6.55e-2)" "unprognostic (5.10e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" "unprognostic (1.82e-2)" 14.6 26.9 25.1 10.3 28.1 6.5 14.9 20.3 32.6 18.8 11.8 31.2 17.8 10.0 18.7 23.7 19.6 28.2 13.6 29.0 28.0 30.0 13.6 15.9 9.9 11.3 28.7 22.9 26.5 16.5 21.1 25.0 11.8 28.6 21.3 10.5 23.7 38.1 22.5 12.7 21.5 10.2 15.6 24.6 11.2 9.8 11.6 23.6 21.8 27.0 8.7 14.8 17.9 15.6 5.7 13.2 2.2 6.5 4.7 9.4 3.9 7.7 14.8 14.3 21.8 12.3 13.0 7.9 6.9 4.7 8.8 8.9 3.5 8.3 13.9 15.0 6.7 7.7 9.9 9.9 6.7 7.6 43.6 19.0 14.3 7.1 17.5 14.9 6.0 8.3 16.1 15.7 9.8 2.9 8.2 7.5 21.4 13.3 9.7 10.3 17.3 18.7 6.7 7.6 14.0 12.7 11.3 11.7 11.4 7.9 10.2 17.8 22.7 4.7 3.7 8.2 12.9 11.1 8.8 11.3 11.5 7.8 16.4 7.2 12.2 5.8 6.3 20.1 6.2 13.4 1.0 4.5 2.2 7.5 6.5 9.4 5.7 7.6 6.6 7.0 5.1 7.0 7.3 0.8 4.7 4.6 13.2 6.9 3.9 25.1 28.1 20.3 28.1 28.0 30.0 28.7 22.9 28.6 23.6 6.0 8.6 5.4 11.2 6.8 11.1 14.5 10.2 6.7 4.5 19.2 3.9 15.9 19.9 4.0 1.6 4.5 3.4 0.0 4.2 9.1 9.1 8.4 0.0 9.5 6.5 15.9 11.6 6.7 4.6 2.7 8.6 4.6 15.1 25.2 9.2 20.7 3.3 9.0 10.3 12.1 10.5 12.9 7.2 4.6 4.3 6.9 9.4 5.7 12.9 7.9 DCBLD1 "dJ94G16.1, MGC46341" ENSG00000164465 "Discoidin, CUB and LCCL domain containing 1" Q8N8Z6 6 117453817-117569858 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA059667 Approved Approved Cytosol NA NA 11000000 Cytosol "HPA059667: AB_2684099" "unprognostic (1.00e-1)" "prognostic unfavorable (6.44e-5)" "unprognostic (1.08e-1)" "unprognostic (3.23e-3)" "unprognostic (2.47e-1)" "unprognostic (2.29e-3)" "unprognostic (1.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.74e-2)" "unprognostic (8.99e-2)" "unprognostic (5.69e-3)" "unprognostic (6.33e-2)" "prognostic unfavorable (8.57e-8)" "unprognostic (6.99e-2)" "unprognostic (4.72e-2)" "unprognostic (7.44e-2)" "unprognostic (1.36e-1)" 15.5 5.2 6.6 7.9 5.6 0.7 12.2 5.1 8.9 12.9 10.6 4.2 10.4 9.0 7.9 6.2 7.9 3.9 12.8 8.2 4.8 3.7 6.1 13.2 15.6 6.3 4.7 3.2 3.2 13.1 12.2 12.6 12.1 7.0 7.6 8.7 4.5 7.1 9.6 17.8 4.3 12.7 7.1 10.2 5.8 10.5 7.6 3.2 1.2 8.8 7.0 5.1 10.5 12.2 0.0 1.2 0.0 0.7 1.0 3.5 1.2 3.1 7.3 2.6 2.9 4.6 5.8 7.4 18.2 24.0 15.5 11.8 15.3 6.9 0.0 9.1 7.8 19.3 7.3 5.0 8.1 16.4 1.4 3.8 2.7 7.6 24.9 20.0 3.9 2.3 6.6 19.0 14.0 13.3 17.9 21.5 2.7 5.8 2.8 20.2 2.5 0.0 2.6 1.9 8.6 3.0 0.0 0.5 1.8 3.4 3.8 7.9 0.1 13.4 1.5 2.1 3.9 1.9 5.2 15.9 0.0 18.8 5.2 7.9 7.8 2.1 2.1 7.8 3.9 6.8 0.0 0.5 0.0 1.7 0.7 0.3 0.0 2.4 3.5 0.6 0.0 3.0 3.5 0.0 1.0 0.3 1.2 2.2 1.2 6.6 5.6 5.1 8.9 4.8 3.7 4.7 3.2 7.0 3.2 14.9 13.1 5.2 2.9 4.6 5.6 3.2 12.7 5.3 15.9 5.2 5.9 23.0 1.7 5.2 22.6 7.8 9.7 0.0 4.2 4.8 5.1 3.1 1.1 7.9 5.0 4.8 4.1 13.5 5.1 7.0 0.9 6.3 8.5 1.0 7.1 1.2 7.9 7.8 0.4 2.1 3.0 12.9 17.6 1.5 13.6 5.3 15.2 6.1 9.3 5.3 DCBLD2 "CLCP1, ESDN" ENSG00000057019 "Discoidin, CUB and LCCL domain containing 2" Q96PD2 3 98795941-98901689 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 66.0;Cone photoreceptor cells: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 59.8;hTERT-RPE1: 84.9;LHCN-M2: 99.6;RPTEC TERT1: 62.4;U-87 MG: 76.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016909 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 1800000 "Plasma membrane, Cytosol" "Golgi apparatus" "HPA016909: AB_1847510" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (4.46e-2)" "unprognostic (2.64e-1)" "unprognostic (5.97e-3)" "unprognostic (9.29e-3)" "unprognostic (8.31e-3)" "unprognostic (1.06e-3)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.32e-5)" "prognostic unfavorable (2.87e-4)" "unprognostic (7.76e-2)" "unprognostic (3.93e-2)" "unprognostic (1.59e-3)" 13.1 14.6 4.5 6.4 7.2 1.1 19.3 9.7 9.6 12.0 13.1 5.1 8.1 2.7 16.8 9.2 8.8 13.9 11.7 24.2 4.5 6.2 11.3 9.2 13.1 3.2 6.7 3.5 19.0 6.4 17.6 12.7 9.9 6.5 11.2 6.8 19.3 11.1 14.7 6.6 7.7 5.2 16.7 7.1 2.1 8.6 33.8 7.3 8.1 18.7 6.3 3.6 15.1 6.8 0.6 1.2 1.7 0.5 0.1 1.1 0.2 6.8 50.2 6.7 5.3 9.0 21.4 2.9 15.5 7.4 10.6 12.0 4.2 21.9 0.0 48.8 26.6 32.5 6.4 3.0 25.2 24.4 0.1 1.0 2.4 1.6 6.4 5.5 1.1 1.1 8.4 3.9 30.4 59.8 84.9 6.9 0.9 0.4 0.6 99.6 1.8 0.9 0.6 4.7 0.0 17.4 1.0 12.7 0.6 62.4 1.8 1.8 3.1 4.2 0.8 18.1 4.8 3.4 0.9 11.4 27.3 21.9 6.9 54.2 0.8 1.1 0.9 76.2 0.4 11.8 1.2 0.5 1.7 0.0 0.1 0.0 0.6 0.1 0.1 0.5 0.2 1.1 0.1 0.9 0.1 0.3 1.2 0.0 0.2 4.5 7.2 9.7 9.6 4.5 6.2 6.7 3.5 6.5 7.3 29.8 44.4 4.5 12.4 20.3 11.2 66.0 12.7 18.7 20.5 17.4 72.6 9.6 0.0 20.3 2.5 7.1 0.9 0.0 7.0 8.2 18.1 10.1 36.9 18.7 3.5 12.7 3.5 4.9 1.6 3.6 20.4 2.6 8.5 1.8 7.3 44.0 17.8 3.5 47.4 6.9 49.1 0.0 19.1 15.8 23.3 13.7 3.3 0.0 10.7 5.9 DCC "IGDCC1, NTN1R1" ENSG00000187323 "DCC netrin 1 receptor" P43146 18 52340172-53535903 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 22.0;testis: 16.5" "Group enriched" "Detected in some" 27 "Early spermatids: 183.2;Late spermatids: 131.3" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 15.4;U-266/70: 47.9;U-266/84: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055376, HPA069552" Enhanced Approved "Golgi apparatus" NA NA 25000 "Golgi apparatus" "HPA055376: AB_2682798, HPA069552: AB_2686151" "unprognostic (1.96e-3)" "unprognostic (1.69e-2)" "unprognostic (3.13e-1)" "unprognostic (3.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.35e-3)" "unprognostic (2.59e-1)" "unprognostic (5.59e-2)" "unprognostic (2.00e-1)" "unprognostic (2.58e-1)" "unprognostic (8.22e-4)" "unprognostic (4.14e-2)" "unprognostic (1.27e-4)" "unprognostic (7.21e-2)" "unprognostic (1.84e-2)" "unprognostic (1.42e-1)" "unprognostic (2.69e-3)" 0.5 1.9 6.3 0.8 22.0 0.4 0.6 0.7 10.1 0.8 0.9 1.3 0.0 0.5 0.4 1.0 0.7 0.7 0.5 0.5 18.4 2.0 0.9 0.5 3.8 0.4 1.5 9.9 0.7 1.2 0.6 1.1 0.4 5.3 1.3 0.8 0.0 0.8 3.5 0.4 0.8 0.7 0.5 2.4 0.8 0.8 16.5 6.5 0.7 0.5 0.0 1.1 0.8 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 47.9 22.5 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 22.0 0.7 10.1 18.4 2.0 1.5 9.9 5.3 6.5 0.0 5.9 0.0 0.1 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 183.2 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 131.3 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.1 0.4 0.0 0.0 1.4 1.9 0.0 0.1 0.0 0.0 0.0 DCHS1 "CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16" ENSG00000166341 "Dachsous cadherin-related 1" Q96JQ0 11 6621323-6655854 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 22 "Endothelial cells: 12.7;Fibroblasts: 17.1;Ito cells: 63.3;Melanocytes: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 19.2;HUVEC TERT2: 26.7;REH: 12.9;SH-SY5Y: 18.7;TIME: 11.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017970, HPA050246" Approved Approved "Plasma membrane" NA NA 75000 "Plasma membrane" "HPA017970: AB_2669718, HPA050246: AB_2681062" "unprognostic (2.42e-1)" "unprognostic (1.13e-1)" "unprognostic (8.93e-2)" "unprognostic (3.52e-2)" "unprognostic (1.83e-1)" "unprognostic (1.38e-3)" "unprognostic (2.52e-2)" "unprognostic (4.55e-3)" "unprognostic (2.63e-2)" "unprognostic (2.93e-2)" "unprognostic (5.96e-2)" "unprognostic (6.87e-2)" "prognostic unfavorable (9.32e-4)" "unprognostic (5.62e-2)" "unprognostic (2.28e-1)" "unprognostic (1.60e-2)" "unprognostic (1.24e-3)" 9.0 2.0 4.1 7.7 4.7 0.5 6.8 5.2 4.4 26.1 12.9 4.4 9.0 3.8 23.9 4.7 5.0 10.4 9.1 8.0 4.0 4.5 3.4 5.6 7.7 3.9 2.5 3.4 13.7 3.3 1.6 2.7 9.7 3.3 12.0 3.4 9.7 3.3 12.0 3.5 3.4 6.0 16.0 1.6 10.2 6.8 2.6 2.5 5.8 3.3 2.6 2.6 10.9 11.9 0.0 1.4 0.1 0.0 0.0 0.9 0.4 0.0 0.0 19.2 0.1 0.0 0.0 0.1 0.6 4.9 3.1 3.5 0.1 0.0 0.1 2.9 5.5 0.2 0.0 1.5 0.0 2.1 0.0 0.5 0.4 0.0 0.0 0.2 0.1 0.0 0.6 0.1 1.4 0.0 0.0 26.7 0.0 0.1 0.0 1.1 0.0 0.6 0.3 2.8 0.0 0.0 12.9 0.0 0.0 0.0 0.0 1.4 18.7 0.0 0.1 0.1 2.1 0.0 0.7 11.4 0.0 5.9 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.8 0.9 0.1 0.0 0.0 1.4 0.0 0.4 4.1 4.7 5.2 4.4 4.0 4.5 2.5 3.4 3.3 2.5 0.0 0.3 0.0 0.2 2.6 0.4 2.8 5.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 2.2 12.7 0.0 0.0 0.3 0.3 17.1 0.2 0.0 0.0 1.8 0.0 0.0 63.3 6.0 2.9 1.1 0.4 15.1 0.0 0.7 0.5 0.2 0.0 1.8 0.0 0.3 0.0 2.2 2.7 0.5 1.5 0.2 0.0 1.0 0.0 DCHS2 "CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ" ENSG00000197410 "Dachsous cadherin-related 2" 4 154231742-154495570 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "endometrium 1: 8.6" "Group enriched" "Detected in some" 7 "Early spermatids: 20.6;Horizontal cells: 23.8;Intestinal endocrine cells: 6.4;Late spermatids: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-2 OS: 8.0" "Low region specificity" "Detected in many" HPA064159 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA064159: AB_2685201" "unprognostic (1.38e-2)" "unprognostic (1.51e-1)" "unprognostic (5.74e-3)" "unprognostic (5.93e-2)" "unprognostic (7.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.27e-4)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (1.61e-1)" "unprognostic (2.53e-3)" "unprognostic (1.62e-1)" "unprognostic (1.06e-3)" "unprognostic (3.13e-1)" "unprognostic (2.62e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-3)" 0.9 1.6 3.4 1.3 7.0 1.1 1.0 0.6 4.8 2.6 4.0 1.9 1.1 1.3 8.6 1.5 1.0 2.0 1.6 0.8 3.5 2.6 0.9 0.7 1.1 0.8 3.0 2.3 1.9 0.6 1.1 1.7 0.8 4.6 1.6 1.5 2.7 0.8 3.6 1.0 2.1 1.0 3.0 7.0 0.8 4.9 2.6 2.9 0.0 1.0 0.0 0.9 2.3 1.2 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.4 7.0 0.6 4.8 3.5 2.6 3.0 2.3 4.6 2.9 0.0 0.0 0.0 0.2 0.3 0.0 1.7 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 23.8 6.4 0.0 0.0 14.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.3 0.0 0.0 0.0 0.0 DCST1 FLJ32785 ENSG00000163357 "DC-STAMP domain containing 1" Q5T197 1 155033824-155050930 "Enzymes, Predicted membrane proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "retina: 18.2;skin 1: 6.8;testis: 10.7" "Cell type enhanced" "Detected in some" 19 "Cone photoreceptor cells: 11.8;Early spermatids: 23.4;Late spermatids: 15.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 4.9;HeLa: 4.1;RPMI-8226: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA060314 Uncertain NA NA "HPA060314: AB_2684250" "unprognostic (1.44e-1)" "unprognostic (7.66e-2)" "unprognostic (3.77e-2)" "unprognostic (1.05e-4)" "unprognostic (3.58e-2)" "unprognostic (8.75e-4)" "unprognostic (1.46e-2)" "unprognostic (2.66e-1)" "unprognostic (6.01e-3)" "unprognostic (2.22e-1)" "unprognostic (6.62e-2)" "unprognostic (1.89e-2)" "unprognostic (8.33e-15)" "unprognostic (7.77e-2)" "unprognostic (2.22e-1)" "unprognostic (2.38e-1)" "unprognostic (1.23e-1)" 0.2 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.1 1.7 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 18.2 0.7 0.1 0.1 6.8 1.6 0.1 0.1 0.2 0.4 10.7 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.8 0.8 0.9 1.2 0.0 1.0 0.1 1.5 0.7 2.7 1.5 0.1 0.0 1.0 0.6 0.0 0.0 0.0 0.7 3.3 1.6 0.5 0.0 0.7 4.9 0.0 0.0 0.0 1.2 0.4 0.4 4.1 0.3 0.0 1.2 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.2 1.1 2.3 0.0 1.0 0.0 0.3 0.2 0.2 2.2 0.0 1.1 5.6 0.0 0.8 0.9 1.8 0.6 1.8 0.2 1.1 3.5 0.1 0.0 0.4 0.2 0.8 0.4 1.0 0.8 0.3 0.7 1.6 0.0 0.0 0.2 0.9 0.1 0.0 0.0 0.8 0.4 0.2 0.3 0.0 1.0 0.2 0.2 0.0 1.2 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.2 0.6 0.0 1.4 2.3 0.0 11.8 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 DCST2 FLJ32934 ENSG00000163354 "DC-STAMP domain containing 2" Q5T1A1 1 155018520-155033781 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 8.6;testis: 20.8" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 15.7;Early spermatids: 43.0;Late spermatids: 21.0;Rod photoreceptor cells: 17.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.0;Karpas-707: 3.7;U-266/70: 4.9" "Low region specificity" "Detected in some" NA NA "unprognostic (8.08e-2)" "unprognostic (5.67e-2)" "unprognostic (6.04e-4)" "unprognostic (1.63e-2)" "unprognostic (3.34e-2)" "unprognostic (1.88e-3)" "unprognostic (8.25e-2)" "unprognostic (2.65e-2)" "unprognostic (2.94e-1)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (8.92e-2)" "unprognostic (2.78e-10)" "unprognostic (6.95e-3)" "unprognostic (9.05e-2)" "unprognostic (1.40e-1)" "unprognostic (5.60e-3)" 0.8 0.2 0.5 0.5 0.5 0.1 2.2 0.7 0.5 1.8 0.6 0.5 0.5 2.5 0.7 0.5 1.2 1.5 0.5 0.5 0.5 0.1 0.5 0.8 0.5 0.5 0.5 0.5 0.8 0.5 0.0 0.5 0.5 0.5 1.9 0.7 5.3 3.0 1.2 0.5 8.6 1.5 0.5 0.5 0.5 0.6 20.8 0.5 0.5 0.7 0.5 0.5 0.5 2.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.3 0.4 1.2 1.6 0.9 0.8 0.9 0.1 0.5 0.3 0.0 0.0 1.2 0.2 1.0 0.2 0.3 3.0 0.4 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.3 0.2 0.1 0.9 2.2 0.1 0.4 0.5 0.0 0.1 0.1 3.7 0.0 1.1 0.0 0.1 0.2 1.3 0.2 0.3 0.1 1.3 0.4 0.1 0.6 0.3 1.1 0.6 0.8 0.8 0.7 0.0 0.0 0.0 1.0 0.0 0.0 4.9 1.9 0.0 0.0 0.4 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.7 0.5 0.5 0.1 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.8 0.8 1.1 0.4 0.0 0.0 0.0 0.0 15.7 0.3 0.0 0.0 43.0 0.1 1.1 0.0 0.2 9.8 0.2 0.2 0.0 0.0 0.4 1.6 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.7 0.3 0.3 0.0 0.7 0.5 17.6 0.0 0.8 2.6 1.6 1.1 0.7 0.0 0.6 0.4 DCSTAMP "DC-STAMP, FIND, TM7SF4" ENSG00000164935 "Dendrocyte expressed seven transmembrane protein" Q9H295 8 104339087-104356689 "Predicted membrane proteins, Transporters" "Differentiation, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adipose tissue: 28.8;lung: 18.2" "Group enriched" "Detected in some" 4 "Hofbauer cells: 7.5;Macrophages: 2.5" "Cancer enriched" "Detected in some" 46 "thyroid cancer: 45.3" "Region enriched" "Detected in single" 4 "amygdala: 3.5" "Cell type enriched" "Detected in single" 8 "non-classical monocyte: 1.5" "Lineage enriched" "Detected in single" 16 "monocytes: 1.5" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.1;RPMI-8226: 1.2;SuSa: 1.4;U-87 MG: 4.5;U-937: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.11e-2)" "unprognostic (1.22e-2)" "unprognostic (8.41e-2)" "unprognostic (2.96e-2)" "unprognostic (8.48e-4)" "unprognostic (2.14e-1)" "unprognostic (5.40e-2)" "unprognostic (1.51e-2)" "unprognostic (3.08e-2)" "unprognostic (1.18e-2)" "unprognostic (5.26e-2)" "unprognostic (2.45e-1)" "unprognostic (1.61e-3)" "unprognostic (8.84e-2)" "unprognostic (1.36e-1)" "unprognostic (8.05e-2)" "unprognostic (8.34e-3)" 28.8 0.1 3.5 0.3 0.2 0.4 1.2 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.3 0.3 0.0 0.8 0.2 0.1 1.0 18.2 0.8 0.2 0.0 0.8 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.5 1.6 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.9 3.5 0.2 0.0 0.6 0.8 0.2 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 7.5 0.0 0.0 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCT TYRP2 ENSG00000080166 "Dopachrome tautomerase" P40126 13 94436808-94479682 "Enzymes, Predicted membrane proteins" "Melanin biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 58 "retina: 151.5;skin 1: 54.2" "Cell type enriched" "Detected in some" 25 "Melanocytes: 3369.1" "Cancer enriched" "Detected in some" 215 "melanoma: 155.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 259 "SK-MEL-30: 76.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010742, HPA010743, HPA010800, CAB017634" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520" "unprognostic (5.99e-2)" "unprognostic (1.67e-2)" "unprognostic (1.54e-2)" "unprognostic (3.17e-2)" "unprognostic (2.45e-2)" "unprognostic (3.35e-2)" "unprognostic (2.15e-2)" "unprognostic (2.81e-2)" "unprognostic (6.07e-2)" "unprognostic (1.81e-1)" "unprognostic (3.64e-3)" "unprognostic (1.06e-2)" "unprognostic (6.18e-5)" "unprognostic (6.97e-2)" "unprognostic (9.87e-2)" "unprognostic (1.22e-3)" "unprognostic (2.42e-1)" 0.2 0.2 0.5 0.1 1.5 0.1 1.7 0.2 0.6 0.2 0.1 0.3 0.1 0.0 0.2 0.5 0.1 0.8 0.1 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 1.4 0.1 0.3 0.2 0.0 151.5 1.4 0.2 0.2 54.2 0.2 0.1 0.8 0.1 0.0 0.3 0.4 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 76.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.5 0.2 0.6 0.4 0.5 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.1 135.3 0.7 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 12.6 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.9 0.0 3369.1 0.0 0.0 2.4 0.0 0.0 0.7 0.0 0.2 0.0 0.9 0.5 0.2 29.2 0.0 0.0 0.0 0.0 DCUN1D5 "FLJ32431, MGC2714" ENSG00000137692 "Defective in cullin neddylation 1 domain containing 5" Q9BTE7 11 103062076-103092215 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050863 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA050863: AB_2681259" "unprognostic (4.47e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.62e-4)" "prognostic unfavorable (2.01e-7)" "unprognostic (1.92e-3)" "unprognostic (1.21e-2)" "prognostic favorable (9.52e-5)" "unprognostic (2.08e-2)" "prognostic unfavorable (4.12e-4)" "unprognostic (2.64e-3)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-2)" "unprognostic (1.43e-3)" 20.9 18.3 18.9 17.2 24.5 13.4 19.1 22.5 28.8 12.9 13.5 15.9 11.5 11.4 15.9 13.7 26.5 12.9 10.6 24.2 20.3 16.6 14.4 19.0 13.9 21.5 15.6 21.0 12.2 17.7 14.5 17.0 17.3 23.6 15.4 13.9 9.9 15.6 13.5 38.7 14.0 11.3 18.4 17.5 15.7 16.0 24.0 21.0 19.4 13.2 24.2 21.3 14.4 14.7 14.4 17.3 11.8 13.1 20.5 17.0 13.4 22.3 12.4 13.7 21.0 11.2 14.2 15.2 22.2 12.1 18.3 18.9 47.5 26.2 10.8 39.3 15.8 19.0 21.3 28.8 28.1 18.9 19.0 19.4 28.9 10.7 18.4 19.0 41.4 15.0 12.4 25.0 24.5 25.4 9.6 22.7 26.4 47.2 0.0 17.3 20.2 27.3 32.4 26.7 19.5 31.7 11.6 21.9 27.4 13.9 23.0 18.6 19.7 20.7 21.2 18.4 14.7 24.8 17.4 18.4 14.9 18.1 26.4 19.8 9.1 14.4 36.0 10.6 40.7 15.4 11.8 11.1 10.2 13.8 13.1 16.3 14.4 16.3 14.2 13.7 14.1 14.0 16.3 4.0 20.5 10.0 17.3 17.0 13.4 18.9 24.5 22.5 28.8 20.3 16.6 15.6 21.0 23.6 21.0 14.9 8.3 25.2 44.6 70.6 11.0 26.6 15.3 14.7 14.8 8.7 7.9 51.2 41.4 60.4 3.0 19.7 6.9 23.3 48.3 76.2 37.5 35.6 15.1 21.3 40.1 6.4 13.8 20.9 29.7 5.9 13.3 22.6 28.7 25.2 16.1 14.8 51.7 14.0 18.4 31.1 12.3 25.8 31.1 118.2 114.7 73.1 36.6 24.5 23.4 57.0 DDOST "GATD6, KIAA0115, OST, OST48, WBP1" ENSG00000244038 "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit" P39656 1 20651767-20661544 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009746, HPA046841, HPA052867" Supported Supported "Endoplasmic reticulum" NA NA 3300000 "Endoplasmic reticulum" "CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977" "unprognostic (8.57e-3)" "unprognostic (1.35e-2)" "unprognostic (1.57e-2)" "prognostic favorable (5.99e-4)" "unprognostic (1.62e-1)" "prognostic unfavorable (4.88e-4)" "prognostic unfavorable (2.64e-5)" "unprognostic (1.33e-1)" "unprognostic (5.51e-3)" "unprognostic (2.70e-2)" "unprognostic (3.59e-2)" "unprognostic (3.72e-1)" "prognostic unfavorable (9.05e-7)" "unprognostic (1.07e-1)" "unprognostic (2.98e-1)" "unprognostic (1.69e-2)" "unprognostic (1.07e-1)" 25.7 42.7 17.0 28.7 21.6 37.1 42.5 13.9 26.7 32.8 35.3 16.4 52.0 27.3 37.1 54.7 33.2 32.7 40.0 53.2 13.9 15.7 36.0 59.8 37.2 84.7 16.5 18.3 42.4 146.9 25.4 37.2 71.6 16.1 24.9 39.1 29.5 51.3 58.3 25.5 25.1 35.6 32.2 12.8 49.8 36.5 35.1 15.0 32.5 51.5 28.7 34.5 26.7 30.0 45.6 80.1 50.1 57.1 49.7 58.9 80.7 46.3 29.8 26.0 77.0 51.8 54.2 54.3 39.1 78.7 63.7 65.8 39.6 97.2 38.6 65.3 63.4 35.0 40.3 35.8 47.9 47.2 30.5 36.8 33.3 19.4 52.0 77.2 51.8 86.3 55.5 53.5 53.3 64.5 76.8 72.7 25.9 16.1 64.3 38.2 35.5 24.5 42.8 26.8 74.4 31.6 21.6 34.9 68.4 52.0 20.5 18.9 33.0 42.2 43.0 58.1 39.2 34.4 80.3 37.3 36.8 38.7 63.4 36.0 76.3 82.0 25.9 60.6 69.2 49.3 44.7 55.7 50.1 55.7 57.1 58.9 45.6 48.2 51.3 80.1 39.6 44.1 46.6 14.2 49.7 48.5 65.4 49.2 80.7 17.0 21.6 13.9 26.7 13.9 15.7 16.5 18.3 16.1 15.0 32.8 59.5 70.0 69.0 44.6 15.7 18.9 58.6 75.0 70.5 33.2 27.5 298.3 33.2 141.7 21.4 50.9 44.9 23.3 130.8 225.3 93.6 64.6 76.3 67.1 126.3 15.9 69.0 62.0 66.8 12.2 69.0 83.0 81.0 115.4 106.2 51.5 92.2 91.2 57.3 44.9 19.3 45.3 41.9 107.7 187.2 46.9 292.5 81.2 128.2 58.0 DDR1 "CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6" ENSG00000204580 "Discoidin domain receptor tyrosine kinase 1" Q08345 6 30876421-30900156 "CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lactation, Pregnancy" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 145.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 31.8;HBEC3-KT: 24.5;RT4: 32.5;T-47d: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010162, CAB025656, HPA057194" Approved Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA 2100000 "Nucleoplasm, Cell Junctions" "CAB010162: AB_2092090, CAB025656: , HPA057194: " "unprognostic (2.11e-2)" "unprognostic (9.31e-2)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (7.75e-3)" "unprognostic (6.43e-2)" "unprognostic (1.92e-1)" "unprognostic (1.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.50e-1)" "unprognostic (4.41e-2)" "prognostic favorable (3.31e-10)" "unprognostic (1.42e-1)" "unprognostic (2.53e-1)" "unprognostic (5.49e-3)" "unprognostic (4.09e-2)" 6.7 11.3 23.5 7.9 36.2 2.2 12.5 6.8 42.2 9.7 25.2 57.4 17.6 16.8 7.7 10.5 30.5 31.7 18.9 8.7 27.8 20.8 19.8 3.5 13.2 3.1 55.7 19.8 11.3 20.9 28.2 14.6 13.3 34.7 17.7 14.9 4.0 28.3 20.5 9.1 41.3 32.1 3.1 43.2 5.1 52.2 5.1 37.0 8.7 20.9 10.5 7.6 16.3 16.6 1.8 0.4 0.0 0.2 0.0 1.8 0.9 19.7 6.5 9.2 1.9 0.6 0.9 5.7 0.5 0.1 0.3 0.0 8.7 10.5 0.1 11.0 1.7 9.6 31.8 2.0 24.5 0.1 10.9 3.5 0.0 6.0 2.3 1.8 0.0 0.4 1.2 12.7 0.1 0.2 5.8 0.7 0.5 5.7 0.2 1.4 12.5 0.7 0.0 1.6 10.9 1.3 1.3 6.9 0.7 4.7 32.5 1.6 0.9 1.8 14.7 7.1 3.2 36.5 0.2 1.5 4.6 4.3 0.4 4.6 0.2 0.0 0.8 3.0 0.0 4.0 0.0 0.2 0.0 1.1 0.0 0.8 0.4 0.2 0.7 0.4 1.8 1.2 1.8 0.0 0.0 0.0 0.4 0.0 0.9 23.5 36.2 6.8 25.0 27.8 20.8 55.7 19.8 34.7 37.0 32.8 24.0 2.2 62.3 47.2 5.2 19.9 38.2 33.5 31.8 85.5 0.0 53.4 5.0 115.9 10.8 4.9 88.3 23.3 66.9 19.7 6.5 54.7 1.1 0.4 5.4 6.4 44.4 1.8 0.8 16.6 7.8 2.2 15.1 22.6 55.1 145.4 62.4 74.8 4.9 5.6 7.4 6.5 8.9 0.7 4.5 45.4 38.9 0.0 54.4 76.8 DDR2 "NTRKR3, TKT, TYRO10" ENSG00000162733 "Discoidin domain receptor tyrosine kinase 2" Q16832 1 162631373-162787400 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Osteogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 84.7;Leydig cells: 58.4;Peritubular cells: 83.1;Smooth muscle cells: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;MAIT T-cell: 1.3" "Lineage enriched" "Detected in single" 5 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 61.7;ASC TERT1: 61.0;BJ hTERT+: 45.1;fHDF/TERT166: 32.3;HSkMC: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070112 Supported "Plasma membrane,Actin filaments" Yes No 850000 "Plasma membrane, Actin filaments" "HPA070112: AB_2686229" "unprognostic (4.12e-2)" "unprognostic (2.73e-1)" "unprognostic (6.97e-3)" "unprognostic (4.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.16e-2)" "unprognostic (1.81e-1)" "unprognostic (1.19e-1)" "unprognostic (6.62e-2)" "unprognostic (2.24e-2)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.73e-7)" "unprognostic (1.56e-3)" "unprognostic (8.26e-3)" "unprognostic (7.57e-2)" "unprognostic (4.10e-3)" 42.1 43.5 4.7 10.9 6.9 0.2 15.6 7.9 7.1 30.3 30.4 9.0 18.6 3.3 24.2 17.7 25.0 13.4 16.6 15.4 7.9 4.7 4.0 3.3 8.9 5.1 12.9 3.4 26.4 2.2 2.1 4.0 6.6 12.7 21.8 9.1 30.7 6.4 19.3 5.2 6.1 10.1 34.3 19.7 3.4 14.1 8.3 7.5 0.0 8.6 12.8 4.1 29.0 18.3 0.1 0.2 0.0 0.0 0.2 1.3 0.0 0.1 0.0 0.0 16.3 61.7 61.0 0.2 24.0 45.1 10.5 15.1 0.0 0.0 0.0 0.0 32.3 2.1 0.0 0.0 0.1 14.4 12.9 0.1 0.0 0.1 0.0 26.8 0.0 0.0 43.3 0.1 18.5 0.5 17.0 12.1 0.1 0.1 5.1 9.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 6.9 0.1 0.0 0.0 0.0 9.9 0.0 0.0 0.8 0.9 0.0 0.0 0.6 16.8 3.7 8.5 3.3 0.7 1.3 0.0 15.2 0.0 17.0 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 4.7 6.9 7.9 7.1 7.9 4.7 12.9 3.4 12.7 7.5 3.0 2.9 0.0 2.4 11.2 3.1 23.3 2.5 4.0 1.2 0.0 0.0 0.5 0.0 0.5 6.9 21.3 2.0 0.0 1.5 0.4 84.7 4.1 1.1 3.0 1.1 0.0 1.2 24.5 2.1 4.0 58.4 1.5 21.9 0.0 0.7 19.0 1.5 1.7 83.1 0.9 2.9 38.8 68.4 0.9 0.9 7.5 0.8 1.3 0.6 3.3 DDRGK1 "C20orf116, dJ1187M17.3, UFBP1" ENSG00000198171 "DDRGK domain containing 1" Q96HY6 20 3190350-3204685 "Predicted intracellular proteins" "Ubl conjugation pathway" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013373, HPA013705" Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoli "HPA013373: AB_2091955, HPA013705: AB_2668872" "unprognostic (2.99e-1)" "unprognostic (1.55e-1)" "unprognostic (3.42e-2)" "unprognostic (1.60e-1)" "unprognostic (6.54e-3)" "unprognostic (2.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.63e-1)" "unprognostic (4.10e-3)" "unprognostic (8.16e-2)" "unprognostic (5.44e-3)" "unprognostic (7.29e-2)" "prognostic favorable (2.01e-5)" "unprognostic (6.80e-3)" "unprognostic (1.43e-2)" "unprognostic (2.48e-2)" "unprognostic (6.90e-2)" 29.5 47.3 28.5 18.6 45.7 17.8 20.5 33.4 38.2 22.1 23.9 29.8 23.7 35.3 21.5 17.8 21.1 21.0 24.3 17.7 27.0 21.8 28.5 54.0 27.0 17.5 47.9 22.9 23.9 43.6 37.5 17.7 31.3 30.9 27.3 16.6 20.6 48.5 29.3 29.5 22.2 31.9 17.1 36.8 20.2 31.5 14.7 39.3 12.6 34.0 14.2 16.2 20.8 29.4 15.1 32.0 24.4 20.2 12.3 21.0 12.9 29.9 37.8 9.4 17.4 21.3 8.1 13.5 19.1 9.2 11.8 13.0 29.7 21.9 18.0 15.7 10.6 22.8 33.7 9.6 28.6 4.4 12.2 18.0 15.2 12.6 51.5 29.2 17.1 16.5 12.7 28.1 22.6 16.2 13.1 10.8 13.0 21.1 21.7 7.5 16.4 11.7 32.0 11.6 20.6 17.5 15.5 8.3 27.3 19.2 28.3 20.8 12.8 19.6 55.7 17.8 5.9 23.6 10.5 16.2 19.1 8.5 13.4 29.1 16.2 18.2 7.6 5.3 14.5 11.1 11.7 20.2 24.4 19.6 13.3 19.5 15.1 20.9 21.0 20.5 15.1 18.7 18.2 5.4 12.3 12.1 32.0 18.6 12.9 28.5 45.7 33.4 38.2 27.0 21.8 47.9 22.9 30.9 39.3 41.7 48.8 26.8 54.1 23.4 43.2 27.9 104.4 44.2 40.9 66.3 60.9 110.7 16.6 129.1 42.5 50.1 133.4 0.0 154.4 53.3 42.9 64.4 27.6 109.1 106.6 49.3 51.3 39.3 55.8 12.9 51.8 50.8 37.1 61.3 57.4 61.1 136.8 122.8 64.7 61.9 91.7 64.7 41.2 35.6 20.7 33.9 122.1 30.5 77.9 57.1 DDX3X "DBX, DDX14, DDX3, HLP2" ENSG00000215301 "DEAD-box helicase 3, X-linked" O00571 X 41333284-41364472 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 631.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059585" Supported Supported Approved Nucleoplasm,Cytosol NA NA 110000 Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073" "unprognostic (2.42e-2)" "unprognostic (1.11e-1)" "unprognostic (8.01e-3)" "unprognostic (1.66e-1)" "unprognostic (8.12e-2)" "unprognostic (6.43e-2)" "unprognostic (1.17e-3)" "unprognostic (1.88e-1)" "unprognostic (9.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.25e-2)" "unprognostic (2.05e-1)" "unprognostic (1.51e-1)" "unprognostic (2.95e-1)" "unprognostic (4.77e-1)" "unprognostic (9.44e-2)" "unprognostic (2.93e-2)" 80.9 49.3 26.1 40.0 34.5 49.3 46.5 31.1 36.2 52.4 43.3 35.1 21.3 29.5 56.4 25.9 53.5 56.3 42.6 47.6 30.8 24.5 55.6 77.9 45.3 40.4 41.4 29.0 60.1 30.9 68.7 60.2 79.9 37.9 30.0 29.2 30.8 37.4 26.5 63.4 42.2 54.0 57.2 53.9 46.1 43.0 27.0 39.0 49.2 45.6 44.0 42.6 55.8 50.2 13.1 20.5 32.0 21.6 17.3 21.5 17.9 45.8 51.1 47.7 26.2 56.2 47.7 29.1 33.5 47.1 34.4 27.6 52.5 30.9 0.5 23.9 37.4 41.4 31.0 58.3 47.1 57.3 27.2 45.4 29.2 50.8 31.5 29.2 54.7 52.5 34.5 33.4 57.9 56.0 38.5 53.9 25.7 53.6 28.9 31.9 34.7 34.4 17.1 45.9 24.4 20.6 40.4 50.8 37.4 32.4 61.9 32.6 49.4 75.8 38.9 40.1 50.2 35.0 37.2 48.6 35.5 37.9 37.9 39.7 33.7 40.0 45.3 35.7 33.2 33.6 22.5 20.2 17.5 14.8 21.1 21.5 13.1 14.5 16.3 20.5 9.0 16.3 15.1 32.0 17.3 21.6 6.9 14.3 17.9 26.1 34.5 31.1 36.2 30.8 24.5 41.4 29.0 37.9 39.0 80.4 161.8 98.4 138.2 234.8 74.1 130.3 81.5 65.6 85.3 55.8 123.7 79.4 36.5 59.8 317.8 170.8 178.1 116.8 73.8 80.3 155.2 122.4 162.7 142.1 107.7 57.2 176.3 120.3 200.6 631.6 61.5 160.4 121.4 72.1 136.1 88.8 86.2 143.8 59.1 71.7 117.4 71.1 155.5 15.7 55.7 291.5 144.6 132.3 100.9 182.7 DDX59 "DKFZP564B1023, ZNHIT5" ENSG00000118197 "DEAD-box helicase 59" Q5T1V6 1 200623896-200669969 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047166 Approved Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA047166: AB_2679966" "unprognostic (1.99e-1)" "unprognostic (1.60e-1)" "unprognostic (3.44e-2)" "unprognostic (4.87e-2)" "unprognostic (1.18e-2)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" "unprognostic (4.83e-2)" "unprognostic (3.40e-3)" "unprognostic (2.43e-3)" "unprognostic (4.16e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (9.02e-4)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (6.66e-2)" "unprognostic (5.98e-2)" 14.0 14.4 12.1 16.4 14.8 23.7 22.7 16.7 11.2 14.5 11.6 10.8 12.6 8.1 15.8 17.6 12.0 13.8 11.4 18.0 12.0 9.9 13.6 15.1 11.8 15.1 15.1 6.7 17.1 21.6 13.9 10.7 46.5 12.8 14.1 12.5 15.0 19.4 12.9 28.6 21.5 12.4 14.0 17.2 20.9 10.4 9.9 14.5 18.5 15.1 10.1 13.2 12.8 12.7 12.2 9.5 23.1 16.2 12.4 15.6 7.9 9.4 10.9 12.7 10.6 5.7 10.0 28.3 10.6 9.5 11.4 9.3 3.4 11.1 9.6 5.4 8.4 9.3 9.0 7.1 10.8 8.1 30.3 7.3 7.3 14.0 10.1 11.5 10.5 13.6 10.7 16.4 8.6 23.5 9.5 8.7 13.8 9.2 14.3 11.0 10.9 6.3 15.8 13.4 5.7 8.9 5.3 8.8 18.5 12.2 11.0 7.7 20.0 16.8 17.5 18.6 17.2 15.1 14.8 7.8 9.6 5.4 9.5 10.9 10.9 14.2 12.7 9.2 6.6 16.4 23.1 10.3 19.0 13.0 8.9 10.6 12.2 10.9 11.7 8.5 11.5 11.3 10.3 18.2 12.4 16.2 9.5 15.6 7.9 12.1 14.8 16.7 11.2 12.0 9.9 15.1 6.7 12.8 14.5 17.9 19.0 14.5 11.1 14.3 3.3 15.9 5.1 10.7 7.9 7.0 2.0 18.5 13.3 7.5 2.0 15.9 7.4 0.0 7.3 22.7 10.8 10.1 19.7 6.4 11.5 6.4 1.2 10.4 8.6 0.2 7.5 11.7 5.0 17.2 10.7 8.5 7.9 8.0 12.7 8.4 6.0 0.0 12.3 12.1 19.0 13.7 36.6 13.1 8.8 8.6 DEAF1 "NUDR, SPN, ZMYND5" ENSG00000177030 "DEAF1, transcription factor" O75398 11 644233-706715 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.1" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030302 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Intracellular and membrane" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA030302: AB_2673421" "unprognostic (1.32e-2)" "unprognostic (3.32e-2)" "unprognostic (3.58e-3)" "unprognostic (5.90e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (2.42e-2)" "unprognostic (2.65e-1)" "unprognostic (2.48e-1)" "unprognostic (2.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.39e-2)" "unprognostic (2.79e-1)" "unprognostic (3.03e-1)" "unprognostic (1.20e-1)" "unprognostic (5.15e-2)" 4.8 5.9 36.1 6.5 19.9 4.5 16.9 19.4 26.2 5.4 4.3 5.3 5.2 4.8 7.5 6.3 6.8 9.8 6.0 8.3 30.2 15.7 4.5 2.8 5.3 4.4 18.3 3.4 6.0 13.2 5.9 14.5 5.2 9.7 6.7 2.2 3.6 11.8 4.7 7.8 6.6 4.0 7.2 8.1 4.0 7.2 5.7 9.8 15.2 12.0 2.7 5.3 7.0 20.3 1.2 4.4 3.3 3.0 3.5 5.9 1.6 7.5 4.6 7.4 3.9 7.3 9.5 5.8 5.6 7.2 11.9 8.7 4.9 6.5 2.1 6.1 5.5 3.2 5.0 7.1 5.1 1.7 9.1 42.1 5.0 2.6 3.7 13.2 11.0 8.2 8.0 7.0 2.1 6.0 7.6 9.4 5.8 11.1 8.8 4.4 3.8 4.1 10.1 17.4 7.8 9.7 10.1 2.6 8.2 8.4 0.9 10.6 11.1 4.0 6.0 4.0 1.9 3.7 3.2 10.8 3.9 2.2 1.6 4.8 9.8 3.6 3.9 4.4 7.3 7.7 0.0 3.0 3.3 2.4 1.7 2.6 1.2 4.7 2.7 4.4 0.8 5.9 3.2 1.8 3.5 1.9 0.5 1.7 1.6 36.1 19.9 19.4 26.2 30.2 15.7 18.3 3.4 9.7 9.8 0.0 3.8 9.0 22.8 11.7 18.3 6.1 10.2 5.3 4.5 33.2 9.8 11.6 44.7 17.9 3.0 13.5 11.1 0.0 9.7 5.1 14.9 30.4 0.0 10.4 8.8 57.2 10.5 4.9 7.0 5.1 18.4 9.0 16.9 12.6 8.6 20.4 12.8 10.7 28.3 22.3 17.1 12.9 15.5 6.7 11.7 13.6 12.9 8.7 8.9 26.8 DEFB103A "DEFB-3, DEFB103, DEFB3, HBD-3, HBD3, HBP-3, HBP3" ENSG00000176797 "Defensin beta 103A" P81534 8 7881204-7882664 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.6;tongue: 16.7;vagina: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 5.6;LHCN-M2: 1.2;U-2197: 2.2" "Secreted in other tissues" NA NA 0.3 0.0 0.1 0.1 0.1 0.0 1.0 0.1 0.1 2.2 0.1 0.1 0.1 0.0 0.1 0.5 3.3 0.0 0.1 0.1 0.1 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 3.5 0.1 0.1 1.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 16.7 6.6 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB103B ENSG00000177243 "Defensin beta 103B" P81534 8 7428888-7430348 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 4.1;lymphoid tissue: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 5.6;LHCN-M2: 1.2;U-2197: 2.2" "Secreted in other tissues" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 4.1 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB105A "DEFB-5, DEFB105" ENSG00000186562 "Defensin beta 105A" Q8NG35 8 7821966-7823889 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 438 "epididymis: 227.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.4;GAMG: 1.3;NB-4: 12.8;SH-SY5Y: 2.6" "Secreted in male reproductive system" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 227.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB105B ENSG00000186599 "Defensin beta 105B" Q8NG35 8 7487669-7489593 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 396 "epididymis: 150.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "NB-4: 2.2" "Secreted in male reproductive system" NA NA 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.1 150.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB107A "DEFB-7, DEFB107" ENSG00000186572 "Defensin beta 107A" Q8IZN7 8 7811720-7815716 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 100 "epididymis: 77.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.1;NB-4: 1.8" HPA045626 Approved "Secreted in male reproductive system" NA NA "HPA045626: AB_2679396" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.1 0.0 0.3 77.2 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB107B HsT21816 ENSG00000198129 "Defensin beta 107B" Q8IZN7 8 7495846-7509311 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 95 "epididymis: 78.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.1;NB-4: 1.8" HPA045626 Approved "Secreted in male reproductive system" NA NA "HPA045626: AB_2679396" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.0 0.3 78.7 0.1 0.8 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB114 DEFB-14 ENSG00000177684 "Defensin beta 114" Q30KQ6 6 49960249-49964105 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 67 "epididymis: 39.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 39.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB115 DEFB-15 ENSG00000215547 "Defensin beta 115" Q30KQ5 20 31257664-31259632 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 22 "epididymis: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "U-2 OS: 6.0" HPA053160 Uncertain "Secreted in male reproductive system" NA NA "HPA053160: AB_2682062" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB126 "bA530N10.1, C20orf8, DEFB-26" ENSG00000125788 "Defensin beta 126" Q9BYW3 20 142369-145751 "Disease related genes, Predicted secreted proteins" Fertilization "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "epididymis: 255.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.0;OE19: 5.9;RPMI-8226: 1.1;SH-SY5Y: 1.0;SK-BR-3: 1.2" "Secreted in male reproductive system" NA NA "unprognostic (1.16e-1)" "unprognostic (1.21e-1)" "unprognostic (3.16e-2)" "unprognostic (2.41e-2)" "unprognostic (2.32e-1)" "unprognostic (1.47e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.0 18.2 0.0 0.1 255.5 0.3 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.2 5.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 1.2 0.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 DEFB133 ENSG00000214643 "Defensin beta 133" Q30KQ1 6 49946021-49950265 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 30 "epididymis: 18.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 43 "K-562: 4.2" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB134 ENSG00000205882 "Defensin beta 134" Q4QY38 8 11993174-11996312 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "epididymis: 24.4" "Group enriched" "Detected in some" 43 "Early spermatids: 38.2;Late spermatids: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.6;NTERA-2: 1.3;U-87 MG: 1.2;WM-115: 1.3" "Secreted in male reproductive system" NA NA "unprognostic (3.80e-2)" "unprognostic (2.20e-1)" 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.0 0.2 0.0 0.0 0.0 1.6 0.3 0.0 24.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 DEFB4A "DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1" ENSG00000171711 "Defensin beta 4A" O15263 8 7894629-7896711 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 44.1;lymphoid tissue: 15.7;tongue: 50.4" "Group enriched" "Detected in some" 32 "Exocrine glandular cells: 31.8;Pancreatic endocrine cells: 27.9" "Group enriched" "Detected in many" 6 "head and neck cancer: 32.2;melanoma: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "EFO-21: 6.9;NTERA-2: 2.6" "Secreted in other tissues" NA NA "unprognostic (6.96e-2)" "unprognostic (1.17e-2)" "unprognostic (2.72e-2)" "unprognostic (4.37e-1)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.75e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.0 0.2 0.2 0.2 0.0 0.3 0.2 44.1 0.0 8.6 0.2 0.2 0.0 0.2 0.2 2.9 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 7.3 0.2 0.2 1.3 0.2 0.2 0.2 0.2 2.9 0.2 0.2 0.2 0.2 50.4 15.7 0.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DEFB4B DEFB4P ENSG00000177257 "Defensin beta 4B" O15263 8 7414860-7416863 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 14.3;lymphoid tissue: 8.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "CAPAN-2: 1.4;JURKAT: 1.2" "Secreted in other tissues" NA NA "unprognostic (1.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEGS1 "DEGS-1, Des-1, DES1, FADS7, MLD" ENSG00000143753 "Delta 4-desaturase, sphingolipid 1" O15121 1 224175756-224193441 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 164.4" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 218.5;Cytotrophoblasts: 229.8;Suprabasal keratinocytes: 280.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076422 Supported Mitochondria NA NA Mitochondria "HPA076422: AB_2686799" "unprognostic (2.34e-2)" "unprognostic (6.91e-2)" "unprognostic (2.48e-2)" "prognostic unfavorable (7.74e-5)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.29e-5)" "unprognostic (7.70e-2)" "unprognostic (2.31e-1)" "unprognostic (3.20e-1)" "unprognostic (3.63e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.83e-7)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (3.86e-2)" "prognostic unfavorable (2.53e-4)" 19.2 10.7 14.7 14.1 15.7 20.0 28.6 11.9 17.8 17.8 17.0 19.9 15.8 15.0 17.2 13.4 16.1 13.1 13.5 16.6 15.1 16.4 12.8 17.3 16.1 24.5 22.0 17.4 14.4 9.3 11.8 15.1 40.1 17.9 27.6 9.4 15.9 14.8 20.1 7.6 164.4 12.1 23.3 22.1 13.0 14.6 9.2 19.3 7.7 19.7 12.3 15.7 15.5 24.9 31.7 39.5 43.6 25.7 16.1 24.4 16.8 14.9 10.6 14.0 10.4 61.0 39.4 10.9 42.0 47.3 29.5 35.5 9.8 11.5 11.9 54.6 38.0 17.9 15.9 16.3 14.3 32.8 17.4 29.1 8.6 11.7 5.9 37.1 17.2 18.7 39.2 32.0 27.1 15.3 30.9 29.1 6.6 12.6 13.2 37.8 5.5 8.7 9.3 17.4 8.2 15.7 8.0 19.8 7.7 37.5 4.1 9.1 14.7 22.3 35.2 22.2 26.8 11.9 25.1 26.5 28.4 9.0 32.6 40.9 9.4 11.1 11.0 30.6 8.6 31.8 32.3 22.3 43.6 12.7 25.7 24.4 23.9 21.5 17.5 39.5 31.7 17.1 15.0 26.1 16.1 17.4 13.2 22.0 16.8 14.7 15.7 11.9 17.8 15.1 16.4 22.0 17.4 17.9 19.3 77.4 27.7 37.9 37.6 218.5 30.5 15.7 12.7 22.7 20.5 10.4 13.7 229.8 11.6 30.3 15.3 49.6 4.2 23.3 38.8 36.5 83.9 44.4 103.9 18.1 85.9 17.5 14.3 60.2 49.3 8.5 58.4 80.4 65.8 75.7 5.0 21.7 25.8 5.8 74.6 25.8 15.9 103.5 85.6 67.0 42.8 280.0 166.4 61.0 5.6 12.9 DEGS2 "C14orf66, DES2, FADS8" ENSG00000168350 "Delta 4-desaturase, sphingolipid 2" Q6QHC5 14 100143957-100160163 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.5;skin 1: 30.6" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 77.6;Collecting duct cells: 78.5;Intestinal endocrine cells: 53.2;Undifferentiated cells: 46.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 22.9" "Cell type enhanced" "Detected in many" "memory B-cell: 11.9" "Group enriched" "Detected in many" 5 "B-cells: 11.9;granulocytes: 6.4" "Group enriched" "Detected in some" 16 "OE19: 29.1;T-47d: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA046644 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA046644: AB_2797231" "unprognostic (8.18e-2)" "unprognostic (3.83e-3)" "unprognostic (2.33e-1)" "unprognostic (1.32e-2)" "unprognostic (3.55e-1)" "unprognostic (4.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "prognostic favorable (7.94e-7)" "unprognostic (1.03e-3)" "unprognostic (1.26e-1)" "unprognostic (1.14e-1)" "prognostic favorable (1.66e-4)" 0.4 0.3 2.0 2.3 4.6 0.5 5.8 22.9 6.4 5.3 20.2 1.8 0.6 20.8 3.4 4.6 20.9 1.9 13.3 0.3 2.0 1.5 8.7 17.2 2.6 0.8 2.4 1.4 0.8 13.0 0.3 1.6 0.6 2.7 2.5 4.2 0.8 4.5 2.3 0.5 30.6 44.5 0.7 1.9 0.5 17.9 0.7 0.7 0.0 2.4 7.3 11.1 7.1 5.2 11.9 0.7 6.4 0.5 0.2 1.8 0.8 0.0 0.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.7 0.1 0.1 0.0 29.1 0.0 0.1 0.0 1.5 0.0 0.7 2.2 0.0 0.0 1.3 0.0 0.0 45.3 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 0.5 6.4 1.8 0.0 0.0 11.9 0.1 0.8 0.7 5.9 0.0 1.2 0.2 0.2 0.0 0.1 0.0 0.8 2.0 4.6 22.9 6.4 2.0 1.5 2.4 1.4 2.7 0.7 3.0 5.3 0.0 2.8 1.5 4.4 0.4 38.2 77.6 11.4 78.5 0.0 5.9 1.7 13.4 1.0 0.9 31.3 0.0 1.3 1.5 0.3 1.1 9.2 0.2 1.6 0.0 53.2 0.6 1.9 1.5 0.3 1.0 0.0 0.0 43.3 1.2 2.8 43.8 0.0 0.1 24.4 0.0 0.2 0.9 1.9 13.4 31.2 1.3 46.7 17.4 DENND1B "C1orf218, FAM31B, FLJ20054, MGC27044" ENSG00000213047 "DENN domain containing 1B" Q6P3S1 1 197504748-197775696 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042586 Uncertain Supported "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "HPA042586: AB_2678064" "unprognostic (8.79e-2)" "unprognostic (1.58e-1)" "unprognostic (4.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.39e-1)" "unprognostic (7.13e-3)" "unprognostic (2.69e-1)" "unprognostic (9.54e-2)" "unprognostic (7.79e-3)" "unprognostic (3.99e-2)" "unprognostic (3.13e-2)" "unprognostic (5.36e-2)" "unprognostic (6.11e-2)" "unprognostic (5.61e-3)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-2)" 5.9 3.9 6.2 12.7 8.3 6.4 8.7 3.9 5.6 5.7 13.0 1.4 8.8 7.5 3.6 6.4 9.0 3.1 5.4 7.3 4.9 4.9 7.9 6.6 7.3 7.8 4.0 2.7 5.6 8.7 9.9 15.9 3.6 3.7 7.5 7.8 6.4 9.9 15.8 6.5 3.8 21.6 4.1 3.5 7.7 6.1 4.4 2.6 17.9 8.2 6.5 11.7 6.9 6.8 2.3 2.0 5.0 0.6 5.8 3.6 0.7 6.0 1.5 1.7 2.9 0.8 4.5 2.7 4.6 3.2 2.9 1.7 1.6 3.9 11.0 2.4 7.1 1.7 3.1 2.7 3.4 2.5 8.3 3.0 4.0 3.0 0.8 2.4 12.9 4.9 1.5 4.6 1.1 3.2 8.8 1.2 6.4 3.0 17.1 2.8 1.1 6.9 6.6 0.6 1.5 1.5 4.3 1.5 8.6 7.1 5.7 3.0 4.7 7.1 4.8 1.2 2.9 2.0 11.3 3.4 0.3 2.8 0.1 2.7 8.7 0.0 5.6 3.0 5.3 5.3 5.0 0.3 2.3 2.1 0.6 1.1 2.3 1.4 3.3 1.5 0.7 0.8 1.5 1.0 5.8 0.6 2.0 3.6 0.7 6.2 8.3 3.9 5.6 4.9 4.9 4.0 2.7 3.7 2.6 38.7 11.5 19.6 20.9 7.4 19.3 24.6 12.7 4.0 12.5 14.0 23.6 8.1 14.9 8.1 25.6 4.8 51.6 0.0 19.9 7.7 8.9 21.4 63.5 14.3 17.9 4.8 13.8 8.0 21.7 19.7 22.2 29.4 15.1 13.6 24.1 7.1 17.6 42.1 12.4 13.2 13.8 0.0 2.9 8.0 13.3 10.7 6.2 33.8 22.4 47.8 DENND5A "FLJ22354, FLJ33829, FLJ43455, KIAA1091, RAB6IP1" ENSG00000184014 "DENN domain containing 5A" Q6IQ26 11 9138825-9265390 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052923, HPA055009" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA052923: AB_2681989, HPA055009: AB_2682669" "unprognostic (5.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" "unprognostic (1.28e-2)" "unprognostic (4.03e-1)" "unprognostic (3.48e-1)" "prognostic unfavorable (5.05e-6)" "unprognostic (1.84e-1)" "unprognostic (2.96e-1)" "unprognostic (1.02e-1)" "unprognostic (5.15e-2)" "unprognostic (3.10e-1)" "prognostic unfavorable (1.14e-6)" "unprognostic (9.86e-3)" "unprognostic (1.03e-1)" "unprognostic (4.32e-1)" "unprognostic (1.40e-2)" 26.7 13.0 36.6 18.6 37.2 22.9 15.8 23.7 43.8 20.0 16.8 56.8 9.3 4.4 23.2 16.7 13.8 18.1 19.8 35.2 36.3 31.6 13.1 11.4 22.8 13.4 44.4 20.4 18.2 17.5 18.1 9.2 22.1 35.3 14.5 10.2 13.6 9.0 26.6 12.1 7.3 8.0 32.8 51.0 21.9 10.5 10.4 34.9 7.3 11.5 5.9 12.4 17.9 20.3 1.8 5.1 14.7 9.9 1.7 5.5 2.0 6.5 8.9 24.3 21.7 35.4 32.5 24.3 21.3 31.3 29.4 34.6 8.3 4.9 0.0 9.2 39.1 25.9 5.4 21.7 7.1 36.2 22.4 11.8 2.3 13.5 12.0 20.1 11.2 4.8 25.2 4.9 17.5 25.2 20.5 26.3 7.3 10.7 0.2 30.7 5.0 6.2 7.6 6.9 1.0 9.5 10.6 14.5 0.1 14.0 5.0 5.5 11.4 19.9 9.5 10.6 25.1 5.2 7.3 18.6 23.2 13.8 27.8 15.6 0.5 0.1 5.5 22.6 5.8 17.5 5.3 5.2 6.1 0.3 7.8 0.8 1.8 1.9 1.6 5.1 0.5 5.5 2.6 14.7 1.7 9.9 1.6 0.0 2.0 36.6 37.2 23.7 33.9 36.3 31.6 44.4 20.4 35.3 34.9 17.9 16.4 6.4 16.3 19.3 8.2 29.5 15.3 2.7 7.9 14.0 56.9 13.4 0.0 6.6 0.8 27.9 0.0 0.0 5.8 14.1 32.8 23.5 2.3 9.6 19.2 12.7 6.3 20.9 36.7 1.4 19.8 42.5 18.6 26.2 1.6 10.6 9.4 0.6 19.4 7.7 9.2 25.8 38.1 5.6 10.4 7.2 9.4 4.3 0.6 12.1 DENND5B MGC24039 ENSG00000170456 "DENN domain containing 5B" Q6ZUT9 12 31382223-31591097 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 41.3;Cardiomyocytes: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 4.0;naive B-cell: 4.1;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 5 "B-cells: 4.1;dendritic cells: 2.2" "Cell line enhanced" "Detected in many" "SuSa: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038865 Approved Approved Nucleoli,Microtubules NA NA Microtubules Nucleoli "HPA038865: AB_2676245" "unprognostic (5.41e-2)" "unprognostic (2.23e-2)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "unprognostic (1.24e-1)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (7.23e-2)" "unprognostic (2.13e-1)" "unprognostic (1.16e-2)" "unprognostic (4.96e-2)" "unprognostic (3.14e-1)" "unprognostic (8.27e-2)" "unprognostic (5.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.26e-1)" "unprognostic (2.60e-2)" 6.0 9.5 9.9 9.3 16.6 3.1 5.9 24.5 17.8 6.5 8.1 7.9 2.7 12.4 9.7 3.4 3.9 6.0 6.2 14.4 9.3 12.4 10.7 17.0 4.6 9.3 8.7 10.9 30.5 7.9 6.0 12.8 6.9 16.0 4.7 6.3 7.7 3.2 5.0 10.9 2.8 14.6 10.2 6.4 8.9 6.8 20.3 8.4 0.4 4.6 3.2 11.1 6.6 7.3 4.1 2.2 0.6 0.3 0.4 0.2 0.2 1.5 15.2 11.2 4.3 4.1 5.1 1.7 3.7 4.1 9.5 6.9 10.2 6.1 5.6 6.2 8.0 10.4 0.4 2.2 1.0 9.5 0.0 4.7 0.1 12.0 6.1 3.8 5.1 0.1 3.1 3.3 6.3 10.5 8.7 8.7 3.2 2.1 11.5 5.9 1.4 3.0 5.3 11.4 3.5 2.7 2.9 15.5 0.1 8.0 2.0 3.6 5.4 9.3 1.0 8.1 33.8 1.6 2.8 9.0 3.6 9.1 6.4 7.8 6.1 6.8 5.7 6.1 0.6 6.0 0.3 0.3 0.3 0.2 0.1 0.1 4.0 0.1 0.1 0.6 4.1 0.1 0.1 0.6 0.4 0.2 2.2 0.0 0.2 9.9 16.6 24.5 17.8 9.3 12.4 8.7 10.9 16.0 8.4 3.0 0.3 20.1 2.6 2.6 41.3 39.9 20.4 2.7 3.4 7.0 29.5 0.5 3.3 1.4 15.1 5.8 9.9 0.0 8.0 2.5 8.9 2.1 0.0 29.2 3.6 27.0 8.1 23.4 4.3 6.4 7.8 2.5 21.9 3.6 2.3 12.5 6.9 3.4 9.9 11.1 23.4 6.5 8.0 29.0 14.3 1.3 0.6 0.5 2.3 0.9 DERL1 "DER-1, DER1, derlin-1, FLJ13784, MGC3067, PRO2577" ENSG00000136986 "Derlin 1" Q9BUN8 8 123013164-123042423 "Plasma proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Protein transport, Transport, Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 135.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016562, CAB037269" Supported Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB037269: AB_609868, HPA016562: AB_1847611" "prognostic unfavorable (2.43e-4)" "unprognostic (4.30e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (5.66e-5)" "unprognostic (9.48e-2)" "unprognostic (4.21e-3)" "unprognostic (2.76e-1)" "unprognostic (1.28e-3)" "unprognostic (4.42e-2)" "unprognostic (5.38e-2)" "unprognostic (1.41e-3)" "unprognostic (4.35e-1)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.88e-3)" "unprognostic (2.51e-1)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" 31.2 34.3 12.7 24.5 14.6 43.4 31.6 18.6 19.5 17.3 23.9 16.6 21.4 22.9 21.3 17.0 23.4 17.5 20.2 23.8 11.7 12.4 25.4 73.3 23.4 42.3 14.1 11.5 23.5 33.6 11.7 23.0 25.0 14.9 16.4 21.5 17.9 21.9 24.4 48.0 16.3 32.6 16.9 14.4 35.3 18.1 22.4 13.0 17.9 25.2 20.9 31.2 23.3 18.3 34.0 26.6 32.8 35.1 34.6 47.3 35.1 20.5 15.3 9.2 11.9 16.6 12.6 7.6 17.3 11.8 11.6 14.3 9.7 20.7 23.8 21.7 14.2 13.5 17.3 8.6 11.2 16.4 27.6 9.6 24.8 10.7 8.1 15.2 9.6 18.6 11.3 14.7 12.6 15.2 10.5 10.2 9.8 14.8 31.8 12.9 41.0 10.5 6.0 6.9 26.6 13.7 10.9 7.6 39.9 29.3 14.8 10.0 14.7 17.5 135.8 11.0 10.4 16.0 8.7 11.8 13.8 26.0 12.1 16.2 40.1 67.1 21.4 22.7 12.1 12.9 27.3 28.8 32.8 45.1 35.1 47.3 34.0 30.6 37.1 23.4 26.2 21.6 33.3 19.8 34.6 34.2 26.6 36.6 35.1 12.7 14.6 18.6 19.5 11.7 12.4 14.1 11.5 14.9 13.0 29.8 23.4 47.9 34.8 37.5 21.5 25.5 12.7 10.7 21.6 27.9 19.6 36.4 8.3 77.0 57.1 33.4 43.9 46.7 65.5 54.9 36.5 51.0 42.6 68.3 62.7 17.5 29.2 42.4 44.8 14.7 22.7 41.9 57.3 51.3 45.8 25.2 57.9 42.1 24.1 23.1 22.1 45.3 37.1 43.5 36.8 44.4 65.2 61.8 30.5 53.3 DERL2 "CGI-101, derlin-2, F-LAN-1, F-LANa, FLANa" ENSG00000072849 "Derlin 2" Q9GZP9 17 5471251-5486811 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 180.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037287, HPA048957, HPA056551" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB037287: AB_1078641, HPA048957: AB_2680570, HPA056551: AB_2683171" "unprognostic (2.54e-1)" "unprognostic (5.30e-2)" "unprognostic (5.83e-2)" "prognostic favorable (7.26e-4)" "unprognostic (1.51e-2)" "unprognostic (4.70e-2)" "unprognostic (1.36e-1)" "unprognostic (2.63e-1)" "unprognostic (2.17e-1)" "unprognostic (1.12e-3)" "unprognostic (1.73e-3)" "unprognostic (5.23e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (3.73e-1)" "unprognostic (2.91e-2)" 12.2 18.9 8.8 11.6 10.7 22.4 13.5 8.1 9.7 11.9 10.7 10.5 17.0 10.9 12.4 23.6 13.4 11.5 13.2 9.6 10.6 6.8 18.1 28.7 12.8 18.8 12.5 4.4 13.1 49.1 12.2 14.7 16.6 11.5 11.0 9.5 10.7 30.3 19.4 9.5 9.5 15.9 11.3 11.0 14.9 13.5 21.0 11.3 11.4 22.1 7.6 16.7 13.8 10.5 33.4 36.6 39.3 36.3 29.5 40.6 53.3 16.8 21.9 10.3 17.4 17.8 13.4 13.3 24.0 19.7 16.6 20.3 14.9 15.2 11.7 21.9 15.3 18.7 18.9 7.1 13.9 16.7 15.5 15.0 5.7 14.3 16.0 24.5 4.2 14.0 12.4 11.6 22.4 19.5 14.7 17.1 12.2 6.2 20.6 22.4 8.8 9.0 6.5 10.0 11.1 8.7 11.0 14.7 8.6 17.8 8.7 4.4 12.8 14.7 10.2 25.2 11.9 13.5 6.3 12.9 19.7 13.3 12.0 22.9 14.4 15.9 10.4 20.6 10.6 15.5 31.4 34.4 39.3 36.5 36.3 37.8 33.4 35.4 38.6 25.7 29.3 28.1 34.8 32.3 29.5 27.8 36.6 40.6 53.3 8.8 10.7 8.1 9.7 10.6 6.8 12.5 4.4 11.5 11.3 11.9 25.8 37.1 44.0 30.5 17.1 26.9 33.1 36.1 26.1 41.8 21.6 60.0 13.3 71.9 180.2 34.2 29.0 23.3 78.4 83.8 58.7 59.6 47.4 52.3 67.1 11.1 17.7 27.6 34.8 40.2 40.6 40.1 43.9 79.4 23.7 29.0 76.1 28.1 33.2 37.4 20.7 58.2 30.9 77.5 49.8 27.1 80.4 41.7 25.9 52.1 DERL3 "C22orf14, derlin-3, FLJ43842, IZP6, MGC71803" ENSG00000099958 "Derlin 3" Q96Q80 22 23834503-23839128 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.7;pancreas: 80.8" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 88.6;Late spermatids: 121.3;Melanocytes: 212.6;Spermatocytes: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "plasmacytoid DC: 77.7" "Lineage enriched" "Detected in many" 9 "dendritic cells: 77.7" "Cell line enhanced" "Detected in some" "Karpas-707: 33.9;RPMI-8226: 19.9;U-266/70: 36.4;U-698: 8.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB037234, HPA049306" Approved Uncertain Vesicles NA NA Vesicles "CAB037234: AB_1840802, HPA049306: " "unprognostic (2.01e-3)" "prognostic favorable (8.70e-5)" "unprognostic (9.72e-3)" "unprognostic (7.47e-2)" "unprognostic (9.77e-3)" "prognostic favorable (8.01e-4)" "unprognostic (2.23e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (4.74e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (7.76e-13)" "unprognostic (1.53e-2)" "unprognostic (4.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.95e-1)" 1.3 1.8 1.2 27.3 2.1 4.1 2.8 1.7 1.6 3.7 21.5 1.1 20.2 18.7 1.9 2.9 4.1 3.4 5.7 3.9 1.2 1.9 2.9 4.7 7.2 25.5 1.3 1.2 1.1 80.8 0.6 4.0 7.9 2.4 1.6 6.9 1.9 44.8 29.3 1.3 0.4 14.9 0.3 1.0 28.5 21.8 12.6 1.6 1.0 9.5 3.4 36.1 15.5 1.2 8.4 77.7 0.1 0.0 0.0 0.1 1.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.1 3.5 0.6 0.0 0.6 0.0 0.3 0.6 0.0 0.7 1.8 0.1 2.0 0.0 0.4 3.8 0.9 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.5 33.9 0.0 0.0 0.5 2.0 0.5 1.4 0.1 2.6 0.0 19.9 0.7 0.1 0.3 0.0 0.1 0.0 0.2 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.0 36.4 4.4 8.6 0.4 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.0 0.0 77.7 0.0 1.3 1.2 2.1 1.7 1.6 1.2 1.9 1.3 1.2 2.4 1.6 0.0 1.4 39.4 1.5 1.5 1.1 2.8 2.5 14.7 3.4 0.0 2.0 0.7 0.0 0.3 88.6 0.5 1.3 0.0 5.0 4.3 1.1 2.3 2.3 3.2 2.9 0.0 1.7 6.7 2.4 121.3 2.3 1.7 212.6 0.0 4.0 0.8 1.6 0.0 3.9 0.3 0.5 0.0 1.2 55.6 36.8 1.8 12.9 5.7 4.3 0.9 DEUP1 "CCDC67, FLJ25393" ENSG00000165325 "Deuterosome assembly protein 1" Q05D60 11 93329971-93438487 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 6.0;pituitary gland: 13.0;testis: 19.9" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 40.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.4;Karpas-707: 1.0;NTERA-2: 4.0;SCLC-21H: 1.6;SuSa: 1.2;U-2 OS: 2.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (4.68e-1)" "unprognostic (3.25e-1)" "unprognostic (3.93e-1)" "unprognostic (7.24e-3)" "unprognostic (2.09e-1)" "unprognostic (4.13e-1)" "unprognostic (2.29e-1)" "unprognostic (1.79e-2)" "unprognostic (1.16e-1)" "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (1.41e-3)" "unprognostic (1.33e-1)" "unprognostic (6.03e-3)" "unprognostic (8.59e-2)" "unprognostic (2.25e-1)" 0.0 0.7 0.2 0.0 0.8 0.0 0.4 0.0 0.2 0.1 0.1 0.8 0.8 0.0 0.2 1.5 0.2 6.0 0.1 0.0 0.3 1.0 1.0 0.0 0.6 0.0 0.3 0.0 1.6 0.9 0.1 13.0 0.0 0.7 1.1 0.1 0.1 1.6 1.8 1.3 0.2 0.1 0.1 1.0 0.0 0.1 19.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.2 4.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 2.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.2 0.3 1.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 3.4 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEXI MYLE ENSG00000182108 "Dexi homolog" O95424 16 10928891-10942460 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041511 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA041511: AB_10796675" "unprognostic (4.14e-1)" "unprognostic (8.52e-2)" "unprognostic (1.29e-1)" "unprognostic (9.70e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (1.19e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "unprognostic (1.47e-2)" "prognostic favorable (4.23e-4)" "unprognostic (5.21e-2)" "unprognostic (1.33e-3)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.75e-2)" "unprognostic (1.83e-2)" 15.0 25.2 15.7 8.0 20.8 4.1 10.7 14.0 27.5 12.2 13.9 9.8 12.7 11.1 11.7 18.5 12.9 14.5 11.6 32.2 13.1 13.6 13.3 26.3 9.5 9.9 18.8 12.3 15.9 18.0 22.1 12.9 13.3 21.3 13.6 6.6 13.7 15.4 16.6 81.6 10.3 11.1 12.1 9.4 12.7 10.6 8.9 11.9 13.7 18.4 10.6 8.1 10.9 10.5 4.0 2.4 8.2 0.7 3.9 7.0 1.2 9.5 13.9 7.5 13.2 30.6 16.9 6.9 14.7 15.4 9.7 9.2 6.5 10.0 11.3 22.2 16.6 10.5 12.4 8.8 15.8 8.3 26.6 19.8 5.6 9.1 27.5 17.6 9.6 10.7 17.1 18.3 9.4 11.0 15.7 13.9 16.2 12.8 11.4 10.7 16.8 11.9 10.5 10.5 11.8 14.5 11.1 9.9 17.3 11.9 7.1 15.5 13.6 14.0 15.5 11.7 6.6 12.3 16.8 15.2 9.8 10.5 23.0 9.6 15.1 11.6 3.3 8.6 20.7 11.0 1.7 0.6 8.2 6.0 0.7 5.6 0.6 5.2 7.0 0.4 4.0 6.4 6.0 0.7 3.9 0.3 2.4 3.9 1.2 15.7 20.8 14.0 27.5 13.1 13.6 18.8 12.3 21.3 11.9 6.0 8.9 13.4 27.4 29.7 18.1 0.0 48.4 8.1 2.3 26.2 11.8 20.0 64.6 22.3 6.3 18.5 9.7 0.0 31.5 17.9 28.6 35.2 1.1 87.3 33.0 22.3 14.3 38.1 12.3 11.5 69.6 8.7 15.1 16.2 13.5 38.1 25.7 13.9 80.6 56.2 12.9 19.4 35.5 2.4 2.7 28.4 9.7 18.1 16.8 37.0 DGAT1 "ARGP1, DGAT" ENSG00000185000 "Diacylglycerol O-acyltransferase 1" O75907 8 144314584-144326910 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "intestine: 161.0" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 291.1;Paneth cells: 112.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 15.8;PC-3: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB032853 Enhanced Approved "Nucleoli,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoli "CAB032853: AB_2090798" "unprognostic (9.24e-3)" "unprognostic (1.61e-1)" "unprognostic (1.75e-2)" "unprognostic (2.23e-1)" "unprognostic (3.49e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (5.10e-2)" "unprognostic (2.78e-2)" "unprognostic (6.88e-2)" "unprognostic (3.52e-1)" "unprognostic (2.65e-3)" "unprognostic (3.83e-2)" "unprognostic (1.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.67e-3)" 11.8 18.5 3.6 5.7 4.7 6.4 6.8 6.6 5.6 3.3 60.2 4.0 6.4 44.7 3.9 3.6 5.5 3.1 7.9 6.3 3.7 2.7 6.7 14.4 3.8 3.1 4.1 2.7 3.3 3.9 5.0 4.0 4.3 3.6 3.4 6.3 4.1 5.9 4.3 10.0 4.8 161.0 3.6 2.6 5.3 5.7 10.7 4.2 5.1 3.8 6.2 5.0 4.7 3.4 0.7 2.2 2.8 2.0 0.3 1.7 0.8 3.8 4.2 2.0 3.6 3.2 1.3 2.3 2.8 2.7 2.6 1.8 9.7 2.6 1.5 10.7 1.7 1.3 3.3 1.6 3.8 0.6 2.8 4.0 2.8 3.4 15.8 2.3 0.7 2.9 1.8 2.9 1.7 1.9 1.8 2.0 4.9 2.2 3.6 1.7 3.2 4.8 3.1 0.9 9.2 17.6 6.3 0.8 2.5 2.4 2.1 2.0 3.4 3.6 4.4 1.8 0.8 2.5 2.7 1.6 1.4 4.9 2.8 2.2 2.1 0.4 0.6 1.5 4.9 2.3 0.0 2.0 2.8 1.2 1.3 1.7 0.7 0.9 1.1 2.2 0.5 0.7 0.3 2.3 0.3 1.7 1.1 0.7 0.8 3.6 4.7 6.6 5.6 3.7 2.7 4.1 2.7 3.6 4.2 14.9 21.3 6.5 9.8 7.1 24.2 17.9 15.3 4.0 7.9 17.4 27.5 10.2 1.7 6.8 13.4 13.5 291.1 0.0 10.4 8.3 7.1 8.8 6.9 49.5 16.5 17.5 22.4 10.4 25.4 16.4 6.4 15.0 5.0 1.0 70.1 18.1 11.4 112.2 6.3 6.8 21.9 0.0 10.5 25.1 15.9 8.2 13.7 8.5 84.8 18.4 DGAT2 ENSG00000062282 "Diacylglycerol O-acyltransferase 2" Q96PD7 11 75759512-75801535 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 104.3;blood: 68.9;liver: 81.3" "Cell type enhanced" "Detected in many" 19 "Early spermatids: 192.0;Hepatocytes: 104.6;Late spermatids: 49.3;Spermatocytes: 45.4;Spermatogonia: 49.4" "Cancer enhanced" "Detected in many" "liver cancer: 19.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "eosinophil: 26.3;neutrophil: 68.9" "Lineage enriched" "Detected in many" 16 "granulocytes: 68.9" "Cell line enhanced" "Detected in many" "ASC diff: 30.3;HDLM-2: 22.0;Hep G2: 22.9;OE19: 44.2" "Low region specificity" "Detected in all" HPA013351 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA013351: AB_1847630" "unprognostic (2.28e-1)" "unprognostic (3.69e-1)" "unprognostic (9.38e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (3.63e-1)" "unprognostic (4.99e-2)" "unprognostic (1.10e-2)" "unprognostic (7.59e-2)" "unprognostic (4.46e-1)" "unprognostic (4.12e-3)" "unprognostic (2.87e-1)" "unprognostic (2.99e-1)" "unprognostic (1.49e-7)" "unprognostic (2.03e-1)" "unprognostic (2.85e-1)" "unprognostic (2.74e-2)" "unprognostic (5.60e-2)" 104.3 1.3 1.9 12.5 6.8 1.7 30.4 0.1 4.2 1.0 11.8 0.6 0.4 3.6 0.5 0.6 6.3 0.7 6.3 6.0 1.0 1.2 1.0 81.3 1.8 16.1 0.6 1.2 0.6 1.3 0.4 0.6 0.5 1.0 1.0 1.4 1.2 9.9 0.6 1.3 34.1 8.1 0.9 0.6 3.7 3.3 13.6 0.5 1.0 2.4 3.9 4.5 4.0 2.7 1.5 1.1 68.9 4.2 0.0 0.0 0.9 4.6 2.3 0.1 4.0 30.3 2.4 0.3 0.4 0.5 0.6 0.3 16.7 4.9 7.4 6.2 0.1 4.4 0.1 0.6 2.3 1.6 22.0 0.4 0.5 1.6 22.9 0.3 2.6 2.6 10.1 12.4 2.7 3.9 1.6 0.4 7.5 0.4 10.1 0.2 3.0 1.7 5.7 1.3 44.2 10.9 0.0 0.0 8.7 0.4 12.9 8.3 0.5 4.2 0.7 1.0 1.0 1.6 9.3 0.5 5.3 2.6 0.1 3.2 5.9 13.2 9.9 3.8 8.4 9.0 3.0 4.2 26.3 0.0 0.8 0.0 1.5 0.0 0.0 1.1 1.2 0.0 0.0 68.9 0.0 0.8 0.3 0.0 0.9 1.9 6.8 0.1 4.2 1.0 1.2 0.6 1.2 1.0 0.5 6.0 4.8 3.4 0.8 1.0 0.6 3.4 0.0 1.4 1.2 0.0 2.0 0.5 0.0 1.4 192.0 0.3 0.4 0.0 0.4 0.1 0.8 2.0 0.0 104.6 2.3 1.6 1.2 1.3 5.6 49.3 2.0 1.7 1.7 0.0 5.0 0.5 2.1 2.6 0.7 1.7 0.0 6.5 0.3 45.4 49.4 6.9 0.7 0.0 3.4 4.2 DGAT2L6 "DC3, FLJ25989" ENSG00000184210 "Diacylglycerol O-acyltransferase 2 like 6" Q6ZPD8 X 70177483-70205545 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "breast: 6.9;skin 1: 10.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "NB-4: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.90e-2)" "unprognostic (3.08e-1)" "unprognostic (1.43e-3)" "unprognostic (3.47e-3)" "unprognostic (8.60e-2)" "unprognostic (5.82e-2)" "unprognostic (1.63e-3)" 0.0 0.0 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DGCR2 "DGS-C, IDD, KIAA0163, LAN, SEZ-12" ENSG00000070413 "DiGeorge syndrome critical region gene 2" P98153 22 19036282-19122454 "Predicted membrane proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000873 Uncertain NA NA "HPA000873: AB_1847632" "unprognostic (1.68e-1)" "unprognostic (4.27e-2)" "unprognostic (4.03e-2)" "unprognostic (1.33e-2)" "unprognostic (6.28e-2)" "unprognostic (8.51e-2)" "unprognostic (1.05e-1)" "unprognostic (6.86e-2)" "unprognostic (2.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.25e-1)" "unprognostic (2.06e-2)" "prognostic favorable (8.72e-7)" "unprognostic (3.63e-2)" "unprognostic (2.29e-1)" "unprognostic (6.27e-2)" "unprognostic (6.28e-3)" 20.3 21.0 28.6 19.0 30.0 7.2 29.5 30.0 40.0 22.1 26.2 23.3 19.0 26.3 21.7 21.0 27.6 26.0 24.2 24.3 28.7 30.7 19.6 17.8 24.7 29.8 24.3 29.7 30.5 44.5 27.5 21.6 16.9 23.2 25.9 16.9 16.6 31.7 26.3 17.2 46.4 26.3 16.7 19.2 18.5 24.4 19.5 21.6 19.3 28.3 25.0 16.9 20.4 19.2 4.8 5.8 19.8 7.6 4.2 8.0 7.5 16.6 10.5 13.2 23.4 24.2 9.7 12.9 11.2 14.1 11.0 11.0 17.9 19.1 8.9 15.8 12.2 7.9 31.7 9.8 10.8 4.7 7.5 17.8 5.9 6.6 14.3 14.6 11.1 13.6 13.9 25.2 8.5 10.1 9.7 12.2 5.6 44.1 7.8 5.6 17.5 5.8 12.0 11.0 26.7 7.7 10.3 13.9 3.4 18.9 18.4 18.1 13.3 20.7 14.5 12.6 7.6 13.5 10.1 10.7 20.5 10.6 10.6 9.0 8.7 3.2 5.8 9.7 6.5 15.5 7.3 7.6 12.8 5.5 4.5 4.8 3.9 5.8 5.5 5.8 4.8 7.2 5.5 19.8 4.2 3.2 3.5 8.0 7.5 28.6 30.0 30.0 40.0 28.7 30.7 24.3 29.7 23.2 21.6 17.9 27.7 7.5 11.0 8.7 25.1 12.6 22.9 4.0 21.6 26.2 13.7 14.7 0.0 21.5 11.5 13.6 34.8 0.0 19.0 16.5 10.8 17.7 8.1 23.8 10.3 35.0 19.1 22.7 20.2 17.3 15.8 8.0 8.5 5.4 31.7 14.7 25.6 23.0 21.2 8.4 23.2 12.9 10.8 10.3 12.9 10.8 9.0 10.9 23.8 10.5 DGKE "DAGK6, DGK" ENSG00000153933 "Diacylglycerol kinase epsilon" P52429 17 56834099-56869567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 167.4;Cone photoreceptor cells: 178.7;Rod photoreceptor cells: 165.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 43.5;MOLT-4: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017167 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017167: AB_1847638" "unprognostic (1.19e-2)" "unprognostic (2.11e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.92e-5)" "unprognostic (4.20e-2)" "unprognostic (4.87e-2)" "unprognostic (3.37e-1)" "unprognostic (4.27e-2)" "unprognostic (1.19e-3)" "unprognostic (4.75e-2)" "unprognostic (6.07e-3)" "unprognostic (2.68e-1)" "unprognostic (2.55e-2)" "unprognostic (1.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-1)" "unprognostic (3.69e-3)" 7.8 4.9 7.8 8.3 17.7 5.5 5.2 21.3 18.6 9.5 7.4 4.4 5.6 5.4 13.3 8.9 5.0 8.2 9.4 4.9 7.4 9.2 4.2 4.9 8.1 9.3 5.6 10.0 7.3 6.5 9.5 14.5 5.5 9.9 8.9 7.0 17.4 4.3 7.3 2.4 3.4 7.1 9.3 6.8 12.7 6.4 12.5 5.4 14.5 8.3 2.5 8.6 6.5 15.3 2.4 2.4 1.2 0.8 1.9 4.5 0.8 1.7 1.6 1.5 0.1 0.3 0.5 0.7 2.9 2.3 2.0 2.3 3.8 2.1 2.5 3.6 1.5 1.0 2.1 3.6 1.6 4.1 8.0 4.7 3.2 4.0 2.5 1.7 6.2 4.5 0.9 2.0 2.1 4.2 1.8 2.7 7.4 2.6 43.5 2.4 2.5 14.5 3.5 1.1 2.2 4.9 4.5 6.3 5.9 2.0 3.8 2.4 1.6 2.3 1.2 0.1 1.0 2.7 3.0 2.4 0.5 2.7 0.8 0.4 5.7 11.7 1.7 1.7 3.6 0.1 0.3 0.5 0.0 2.7 0.4 2.0 2.4 1.9 2.3 0.6 0.9 1.9 2.5 1.2 1.9 0.8 2.4 4.5 0.8 7.8 17.7 21.3 18.6 7.4 9.2 5.6 10.0 9.9 5.4 3.0 5.9 2.2 10.2 7.9 167.4 5.5 15.3 1.4 4.5 15.7 178.7 3.2 0.0 6.5 13.1 23.3 3.4 0.0 4.0 2.2 4.3 13.9 0.0 3.8 1.9 7.9 10.9 32.5 5.6 7.4 4.0 4.1 3.3 2.8 7.1 13.8 4.9 5.5 4.9 0.0 165.4 6.5 10.3 25.4 18.5 5.8 2.9 13.8 4.6 8.8 DHCR24 "DCE, KIAA0018, seladin-1" ENSG00000116133 "24-dehydrocholesterol reductase" Q15392 1 54849633-54887218 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 164.5;liver: 119.6" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 733.4;Hepatocytes: 888.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 132.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017981, CAB037247, HPA063005" Enhanced NA NA "CAB037247: AB_796187, HPA017981: AB_2732422, HPA063005: AB_2684919" "unprognostic (2.88e-1)" "unprognostic (1.80e-2)" "unprognostic (4.99e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (1.69e-1)" "unprognostic (2.61e-1)" "unprognostic (1.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.68e-1)" "unprognostic (1.86e-1)" "unprognostic (6.18e-3)" "unprognostic (3.35e-1)" "unprognostic (7.82e-3)" "unprognostic (5.48e-2)" "unprognostic (1.83e-1)" "unprognostic (1.70e-1)" "unprognostic (3.97e-2)" 10.6 164.5 6.6 3.9 22.1 0.7 22.0 6.5 27.5 7.7 11.1 43.8 1.2 11.9 2.2 1.1 40.8 12.3 8.6 3.7 12.0 9.2 6.4 119.6 40.9 2.0 36.2 13.0 7.8 4.6 28.4 2.6 4.4 47.9 26.1 8.3 4.8 20.2 2.1 24.6 47.6 7.3 2.7 71.7 24.3 17.6 14.1 31.1 1.7 4.3 17.1 14.3 2.5 13.0 5.4 7.0 7.3 3.1 3.7 9.0 5.5 40.5 7.5 26.5 32.0 132.8 28.6 6.2 11.7 20.3 16.9 34.9 41.6 25.7 6.5 23.6 10.2 53.9 39.0 31.7 61.7 15.1 0.9 19.9 36.1 17.7 49.7 21.6 15.0 8.4 20.8 53.9 52.2 9.7 8.3 8.3 15.3 26.3 0.0 6.2 17.0 3.2 13.2 73.3 11.0 20.5 0.0 6.7 19.9 92.9 32.9 18.3 6.7 22.2 42.0 15.3 29.3 54.7 17.5 7.6 5.6 16.5 8.1 22.1 2.8 6.4 11.2 4.1 25.9 7.3 7.3 2.4 1.1 9.0 3.1 0.5 5.4 4.0 4.2 7.0 2.4 3.9 4.7 0.1 3.7 1.0 4.2 0.7 5.5 6.6 22.1 6.5 27.5 12.0 9.2 36.2 13.0 47.9 31.1 276.9 733.4 19.9 13.4 27.9 4.4 9.0 165.6 95.0 154.7 64.6 0.0 33.0 3.3 46.7 12.8 10.6 64.2 93.5 65.4 27.5 19.8 70.0 30.2 888.0 22.6 4.8 23.1 154.7 70.4 40.3 13.0 6.1 13.5 10.8 30.6 3.7 38.4 26.0 7.4 11.2 4.4 0.0 4.7 1.7 14.0 70.3 25.6 7.0 24.8 34.0 DHCR7 SLOS ENSG00000172893 "7-dehydrocholesterol reductase" Q9UBM7 11 71428193-71452868 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.8" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 43.9;Hepatocytes: 67.2;Syncytiotrophoblasts: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044280 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044280: AB_10794893" "unprognostic (1.76e-1)" "unprognostic (1.50e-3)" "unprognostic (1.32e-2)" "unprognostic (7.16e-3)" "unprognostic (2.69e-1)" "unprognostic (2.18e-3)" "unprognostic (8.57e-3)" "unprognostic (3.02e-2)" "unprognostic (4.91e-2)" "unprognostic (1.13e-1)" "unprognostic (1.08e-2)" "unprognostic (5.45e-2)" "prognostic favorable (6.93e-7)" "unprognostic (1.73e-1)" "unprognostic (1.01e-1)" "unprognostic (8.15e-2)" "prognostic unfavorable (5.67e-4)" 8.0 40.1 12.1 5.6 14.5 19.0 16.8 5.3 22.8 5.5 9.3 27.9 8.8 20.8 4.0 27.3 14.6 5.2 5.8 10.7 13.7 13.2 7.1 64.8 12.0 2.7 20.6 12.3 21.5 7.3 14.0 7.0 3.7 23.4 10.0 6.6 16.6 10.0 3.9 5.4 22.9 15.8 4.5 20.5 5.9 8.5 17.7 15.5 2.8 5.4 12.1 7.7 4.3 7.4 6.3 6.2 3.5 1.9 4.6 12.1 5.7 21.2 19.3 18.9 20.9 8.9 13.8 5.9 8.8 23.5 7.5 20.5 71.9 70.0 14.9 14.0 8.4 67.3 41.0 22.5 47.6 7.9 5.6 16.9 5.7 16.3 30.7 22.8 10.6 2.7 15.9 21.1 28.2 19.4 6.2 11.1 19.5 26.6 31.8 7.5 57.2 8.7 12.0 27.1 21.1 11.5 7.9 26.6 64.0 28.2 32.2 25.7 9.6 8.4 27.8 20.0 9.6 26.9 5.8 10.4 2.0 11.4 0.6 10.5 10.5 12.7 15.9 6.0 18.9 8.5 3.5 1.9 1.7 9.7 1.2 11.8 6.3 8.2 9.0 2.5 5.4 10.5 12.1 1.0 4.6 1.2 6.2 5.1 5.7 12.1 14.5 5.3 22.8 13.7 13.2 20.6 12.3 23.4 15.5 3.0 12.6 6.7 7.1 0.7 6.8 11.3 10.2 5.3 9.1 21.0 11.8 13.8 6.6 29.1 0.1 6.6 7.8 0.0 43.9 21.8 9.3 14.2 0.0 67.2 9.8 0.0 9.1 6.2 3.7 0.0 7.8 3.0 5.0 9.0 11.8 20.9 19.8 7.0 4.6 2.9 8.0 12.9 2.5 0.6 5.9 1.0 45.3 10.2 14.5 7.1 DHODH ENSG00000102967 "Dihydroorotate dehydrogenase (quinone)" Q02127 16 72008588-72027664 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Pyrimidine biosynthesis" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 72.4" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010123, HPA011942" Approved Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA010123: AB_1847648, HPA011942: AB_1847649" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.41e-3)" "unprognostic (2.10e-1)" "unprognostic (4.27e-2)" "unprognostic (1.31e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-1)" "unprognostic (2.14e-1)" "unprognostic (6.40e-2)" "unprognostic (9.26e-3)" "unprognostic (1.98e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" 5.9 4.2 4.7 8.8 5.1 2.9 5.0 2.7 5.0 5.9 4.4 6.1 1.4 3.4 6.6 2.3 5.1 5.2 2.3 11.5 4.3 3.0 6.6 72.4 3.4 5.5 4.8 2.7 6.2 9.9 7.1 4.0 2.6 5.2 3.9 4.8 5.9 6.0 4.4 11.7 4.0 3.0 7.5 4.0 3.5 3.4 4.3 5.4 4.0 3.6 7.1 5.1 3.5 3.3 11.2 13.4 3.9 8.1 9.3 12.9 6.8 7.4 15.5 4.5 7.5 2.4 3.2 8.6 6.4 2.6 9.7 7.5 12.2 6.8 16.8 8.7 3.5 5.4 7.9 8.9 6.9 11.5 3.8 8.4 9.2 7.5 12.0 6.8 12.7 6.8 3.1 7.1 11.7 12.3 3.1 7.0 11.4 14.0 3.1 5.9 19.8 12.0 12.2 10.2 12.7 6.1 15.2 5.9 17.7 5.8 4.9 5.4 6.3 8.6 9.2 4.2 5.8 8.2 6.4 3.0 8.9 5.5 8.4 9.3 5.9 10.9 28.4 4.6 14.0 8.1 3.9 8.1 0.9 9.3 7.7 12.7 11.2 8.9 9.0 13.3 10.6 12.4 12.9 2.1 9.3 5.6 13.4 7.1 6.8 4.7 5.1 2.7 5.0 4.3 3.0 4.8 2.7 5.2 5.4 3.0 9.6 9.5 6.4 4.9 5.7 12.1 7.6 9.4 1.2 7.0 3.9 12.0 5.0 6.6 2.1 6.7 0.7 0.0 4.4 9.6 6.0 5.0 8.1 106.1 6.9 3.2 1.2 2.5 5.3 2.3 2.6 3.4 11.8 3.6 4.4 4.8 5.2 2.9 2.1 20.1 4.2 0.0 9.9 7.9 8.0 3.3 2.4 5.0 6.2 4.1 DHRS11 "MGC4172, SDR24C1" ENSG00000278535 "Dehydrogenase/reductase 11" Q6UWP2 17 36591798-36600806 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "intestine: 88.0" "Cell type enhanced" "Detected in many" 16 "Cone photoreceptor cells: 121.7;Enterocytes: 380.9;Paneth cells: 114.5;Undifferentiated cells: 112.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041226, HPA048236, HPA053623" Enhanced Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 11000 Cytosol "Golgi apparatus" "HPA041226: AB_2677372, HPA048236: AB_2680322, HPA053623: AB_2682209" "unprognostic (2.00e-3)" "unprognostic (1.22e-2)" "unprognostic (1.06e-2)" "unprognostic (3.74e-1)" "unprognostic (1.61e-3)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (1.80e-2)" "unprognostic (3.67e-1)" "unprognostic (5.94e-2)" "unprognostic (1.33e-2)" "unprognostic (4.11e-2)" "prognostic favorable (3.24e-4)" "unprognostic (1.45e-1)" "unprognostic (1.70e-1)" "unprognostic (2.16e-2)" "unprognostic (9.35e-2)" 1.3 0.6 1.2 4.1 2.4 0.4 0.7 0.5 5.7 0.4 38.7 0.4 0.4 42.7 0.4 0.1 1.2 1.1 1.4 2.0 0.5 2.5 1.7 0.1 0.0 0.0 2.4 0.1 2.8 1.5 0.2 0.0 1.6 0.5 12.4 2.8 2.1 0.8 2.0 0.8 88.0 0.9 0.1 0.0 1.1 2.2 0.3 0.0 1.3 1.3 1.0 0.4 0.0 0.9 0.2 0.9 0.7 0.1 2.7 0.1 6.7 6.0 2.9 7.6 0.6 1.8 5.6 2.0 1.4 6.5 5.9 9.8 5.4 0.7 1.4 2.0 2.7 7.0 6.1 4.2 6.6 3.5 11.6 1.7 5.8 18.9 3.1 2.0 0.6 0.9 3.9 4.5 3.3 1.4 5.0 6.9 15.8 5.9 3.5 5.9 6.5 3.6 2.2 7.9 2.3 8.1 7.1 11.2 6.6 5.7 6.1 2.6 7.2 7.4 16.6 4.7 10.2 1.8 1.8 0.9 9.3 4.9 5.1 9.7 8.1 2.3 3.3 4.8 2.9 0.4 0.5 0.9 1.0 0.7 0.1 0.4 1.0 0.6 0.1 0.9 1.3 0.9 0.5 0.1 0.1 0.2 2.7 0.1 0.0 1.0 1.9 6.8 3.8 17.5 8.4 0.0 1.4 0.0 7.0 121.7 6.4 49.7 8.1 18.9 4.8 380.9 23.3 9.9 3.7 2.7 10.9 0.0 11.5 3.0 15.9 11.6 3.1 2.2 23.8 3.7 2.3 18.6 4.6 59.2 11.6 6.1 114.5 4.9 26.7 62.6 0.0 3.5 26.3 5.2 5.3 5.8 1.3 112.5 13.2 DHRS13 "MGC23280, SDR7C5" ENSG00000167536 "Dehydrogenase/reductase 13" Q6UX07 17 28897781-28903071 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 29.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 29.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022991 Uncertain Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA022991: AB_1853865" "unprognostic (8.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.35e-1)" "unprognostic (1.21e-2)" "unprognostic (6.37e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (2.38e-1)" "unprognostic (4.74e-2)" "unprognostic (5.65e-2)" "unprognostic (1.20e-2)" "unprognostic (7.57e-2)" "unprognostic (1.73e-2)" "unprognostic (3.72e-2)" "unprognostic (2.63e-1)" "unprognostic (7.22e-3)" "unprognostic (2.55e-1)" 2.3 6.0 5.9 5.1 7.9 31.7 5.9 24.9 5.7 6.4 4.5 6.4 9.0 4.1 2.6 6.5 6.7 4.0 3.0 2.7 5.3 10.9 6.9 27.0 4.1 8.6 6.7 5.4 3.6 9.5 8.5 5.3 9.5 9.9 14.9 3.5 5.0 11.8 10.9 1.1 6.8 3.0 3.2 5.6 8.0 5.5 2.8 3.6 4.4 5.5 1.2 8.1 9.2 5.1 4.0 3.1 29.7 3.5 4.6 6.3 3.1 5.6 3.6 8.5 10.8 1.3 1.9 8.3 3.1 4.0 5.7 8.8 11.2 3.4 15.6 5.3 0.6 6.6 5.1 12.0 3.4 2.4 15.7 11.6 8.8 6.7 6.1 3.2 4.4 1.0 1.4 3.1 3.6 3.8 4.0 1.7 11.0 19.7 5.4 1.1 10.2 9.7 7.4 5.2 14.9 0.5 15.5 8.1 12.0 10.5 9.6 12.3 10.3 4.9 34.0 6.6 4.7 22.6 7.2 0.5 1.8 5.6 4.4 4.2 12.6 11.8 9.7 5.4 5.6 4.5 0.4 2.3 1.6 4.8 3.5 5.9 3.6 6.1 6.0 3.1 4.0 6.3 4.6 29.7 4.6 3.3 1.7 5.7 3.1 5.9 7.9 24.9 5.7 5.3 10.9 6.7 5.4 9.9 3.6 3.0 3.4 3.0 11.5 1.3 5.4 0.4 2.5 0.0 3.4 7.0 2.0 21.6 8.3 7.8 10.7 2.9 2.4 46.7 2.4 18.2 1.9 9.4 1.1 3.8 5.2 4.8 2.9 6.7 0.8 3.8 1.1 2.7 5.0 24.4 2.7 6.9 3.2 2.9 0.4 2.9 5.0 6.5 1.4 1.5 12.6 1.5 11.3 5.3 5.7 4.3 DHRS2 "HEP27, SDR25C1" ENSG00000100867 "Dehydrogenase/reductase 2" Q13268 14 23630115-23645639 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1" "Cell type enhanced" "Detected in some" 11 "Extravillous trophoblasts: 10.3;Spermatogonia: 8.5;Syncytiotrophoblasts: 20.7;Urothelial cells: 11.9" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 141.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 49.9;RT4: 59.8;SK-BR-3: 292.6;U-2 OS: 95.8" "Region enriched" "Detected in single" 4 "cerebellum: 2.7" "HPA053915, HPA069551" Enhanced Supported Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA053915: AB_2682307, HPA069551: AB_2686150" "unprognostic (3.07e-1)" "unprognostic (4.91e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (9.97e-2)" "unprognostic (5.03e-3)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-1)" "unprognostic (6.91e-2)" "unprognostic (6.66e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (3.75e-5)" "unprognostic (1.83e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "prognostic favorable (6.45e-4)" 0.1 0.3 0.3 0.0 0.2 0.0 79.9 0.1 0.2 0.5 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.8 1.8 5.0 0.2 0.0 0.2 0.0 9.0 5.9 0.3 0.5 5.0 0.1 40.2 0.0 0.1 20.1 0.6 0.1 0.7 0.1 23.1 0.3 3.7 0.8 0.9 0.0 0.0 0.1 0.0 0.0 120.7 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.4 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.1 20.1 1.5 0.1 0.0 49.9 0.0 0.2 1.8 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.4 2.2 0.1 0.4 0.1 0.0 59.8 0.2 0.3 0.4 292.6 0.3 0.0 0.2 0.0 0.0 0.1 95.8 0.5 0.3 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.3 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 5.9 6.6 0.0 3.4 0.0 0.0 0.0 0.2 10.3 0.3 0.2 0.0 0.8 1.6 0.0 3.4 0.0 0.8 3.0 0.0 0.0 0.0 1.0 0.0 0.0 6.7 0.0 1.1 0.1 1.0 6.5 0.0 0.0 8.5 0.1 20.7 0.0 0.5 11.9 DHRS3 "RDH17, retSDR1, Rsdr1, SDR1, SDR16C1" ENSG00000162496 "Dehydrogenase/reductase 3" O75911 1 12567910-12617731 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8" "Group enriched" "Detected in many" 9 "dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5" "Cell line enhanced" "Detected in many" "A549: 27.6;CAPAN-2: 56.6;hTERT-RPE1: 55.9;SK-BR-3: 30.4;WM-115: 52.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010844 Supported Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA010844: AB_1847653" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.74e-3)" "unprognostic (1.87e-1)" "unprognostic (3.68e-2)" "unprognostic (2.25e-3)" "unprognostic (5.06e-2)" "unprognostic (3.40e-2)" "unprognostic (5.18e-2)" "unprognostic (1.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.80e-1)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "prognostic favorable (2.65e-4)" "unprognostic (5.48e-2)" 22.7 4.4 6.3 6.2 8.6 2.5 30.6 4.0 7.9 16.7 16.3 3.4 9.2 13.6 7.6 15.5 19.0 12.2 11.2 16.1 6.8 8.6 12.3 45.6 11.6 8.3 9.0 4.5 11.8 20.3 0.5 8.9 11.5 9.8 16.3 5.6 20.3 11.8 14.3 10.2 5.6 18.9 11.1 9.8 4.2 12.3 5.2 4.2 3.1 40.5 5.4 5.2 21.0 9.4 0.2 8.6 2.1 0.3 13.8 33.5 15.6 4.8 27.6 0.0 12.2 16.0 1.3 3.2 1.6 0.0 0.0 0.1 3.3 56.6 0.0 1.3 16.2 4.9 22.3 6.0 3.1 0.0 0.0 9.9 4.3 2.8 15.4 2.4 0.0 0.0 8.1 3.7 0.0 0.1 55.9 5.2 0.1 6.5 0.0 0.1 0.8 1.1 0.2 1.8 5.2 11.2 0.1 0.0 5.6 0.0 9.5 0.3 0.5 9.3 30.4 1.7 3.9 2.9 1.2 3.8 0.1 0.6 8.5 0.1 0.8 0.0 0.0 6.4 0.3 52.5 2.1 0.2 0.0 33.5 0.1 24.2 0.2 18.3 15.7 8.6 0.2 31.6 19.7 1.7 13.8 0.3 1.0 0.5 15.6 6.3 8.6 4.0 7.9 6.8 8.6 9.0 4.5 9.8 4.2 89.3 49.3 3.7 141.7 22.8 0.8 31.9 38.2 58.9 55.7 19.2 17.7 22.8 19.9 81.6 86.2 36.5 70.9 23.3 142.3 39.4 26.7 66.3 15.1 157.8 60.3 0.0 24.1 62.0 40.2 235.9 21.0 19.3 6.8 17.2 30.8 13.7 112.0 49.1 9.2 39.4 2.0 0.0 30.1 1.4 1.4 23.6 22.0 22.3 29.9 124.6 DHRS7 "retDSR4, SDR34C1" ENSG00000100612 "Dehydrogenase/reductase 7" Q9Y394 14 60144120-60169856 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 123.5" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 5 "prostate cancer: 199.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031121, HPA078401" Enhanced Approved Nucleoplasm,Mitochondria No No 63000 "Nucleoplasm, Mitochondria" "HPA031121: AB_10600803, HPA078401: " "prognostic favorable (6.42e-4)" "unprognostic (5.20e-2)" "unprognostic (6.70e-3)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (4.65e-2)" "unprognostic (4.31e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (7.99e-4)" "unprognostic (1.73e-1)" "unprognostic (1.59e-1)" "prognostic favorable (1.92e-10)" "unprognostic (8.35e-3)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" 15.0 24.6 12.3 10.1 10.9 10.5 17.9 10.6 12.4 11.1 30.6 10.7 57.3 20.7 11.7 19.4 12.3 9.9 15.3 17.4 11.0 11.4 22.6 27.9 13.1 13.9 14.1 8.8 13.4 17.2 40.2 17.2 6.1 17.8 83.4 13.4 9.1 113.7 93.0 123.5 9.8 48.7 9.6 15.5 11.1 32.6 4.9 11.0 6.4 24.8 16.7 10.1 12.4 15.6 26.0 56.6 121.4 32.2 37.3 50.8 54.0 52.6 15.9 9.2 20.2 47.7 18.7 11.7 17.0 43.8 6.2 13.8 8.8 35.7 5.5 10.2 15.9 15.8 22.7 12.0 23.9 9.1 38.3 11.2 13.6 7.8 14.4 25.1 16.1 0.4 13.9 28.8 9.8 33.3 11.1 11.9 14.0 4.1 11.9 15.5 15.9 9.3 15.3 4.3 31.1 16.1 9.7 12.4 6.4 27.7 18.0 19.8 24.8 17.2 26.1 37.7 11.8 18.3 7.1 8.3 30.9 10.5 8.4 9.7 4.2 1.9 9.8 16.8 15.6 21.2 80.1 32.2 71.6 50.8 22.6 49.9 26.0 36.0 43.9 27.1 21.8 20.2 38.9 121.4 37.3 29.0 56.6 29.0 54.0 12.3 10.9 10.6 12.4 11.0 11.4 14.1 8.8 17.8 11.0 50.6 96.5 40.4 57.0 30.2 23.6 16.5 147.7 46.8 59.1 82.0 78.5 22.0 16.6 184.7 1.5 65.9 155.6 0.0 145.2 76.8 60.2 242.6 172.3 147.5 88.2 39.7 44.6 30.1 58.9 2.0 76.2 101.1 102.9 178.5 77.9 88.0 174.5 89.2 79.2 41.6 54.4 84.1 70.6 1.1 3.1 22.2 17.4 135.7 66.0 41.6 DHRS7B "CGI-93, DKFZp566O084, MGC8916, SDR32C1" ENSG00000109016 "Dehydrogenase/reductase 7B" Q6IAN0 17 21123364-21193265 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012132, HPA016873" Uncertain Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "HPA012132: AB_1847658, HPA016873: AB_1847657" "unprognostic (1.90e-1)" "unprognostic (3.16e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.98e-8)" "unprognostic (9.83e-2)" "unprognostic (1.18e-1)" "unprognostic (3.46e-1)" "unprognostic (1.45e-1)" "unprognostic (5.02e-3)" "unprognostic (2.76e-1)" "unprognostic (1.70e-1)" "unprognostic (2.81e-1)" "prognostic favorable (3.95e-5)" "unprognostic (1.20e-2)" "unprognostic (6.26e-2)" "unprognostic (9.20e-2)" "unprognostic (3.97e-1)" 15.9 17.8 14.0 10.3 14.5 2.5 16.2 11.1 15.2 17.6 14.2 11.9 16.7 14.4 13.5 25.3 12.8 15.4 16.3 17.9 11.8 13.2 23.1 18.4 13.9 14.0 14.5 14.8 11.8 18.9 31.2 11.4 14.2 12.9 14.8 15.2 16.5 17.5 10.5 23.7 15.7 18.3 12.7 11.1 11.5 14.7 30.5 9.1 8.0 19.7 15.8 10.9 10.7 12.8 4.2 11.7 15.0 20.4 4.1 5.7 7.5 8.6 10.2 3.7 8.1 10.0 6.8 6.5 8.2 4.6 6.0 11.0 12.8 9.1 3.6 12.6 7.0 4.7 12.2 5.4 13.5 8.5 6.9 17.6 5.0 7.5 11.0 5.5 2.7 3.7 5.3 9.0 7.7 11.7 3.0 5.8 6.4 3.0 4.5 7.0 17.7 3.0 10.8 5.2 28.1 4.4 5.0 9.9 6.3 20.0 10.5 2.0 4.4 10.2 9.1 8.8 31.4 6.1 5.7 2.9 5.0 3.5 15.1 9.3 2.5 3.8 6.7 7.9 10.3 7.5 9.7 18.9 15.0 3.8 17.9 3.4 4.2 3.8 2.5 11.7 3.6 4.1 3.6 13.5 4.1 20.4 5.0 5.7 7.5 14.0 14.5 11.1 15.2 11.8 13.2 14.5 14.8 12.9 9.1 14.9 14.9 16.4 24.6 14.4 20.5 12.2 25.5 28.1 14.8 27.9 29.5 44.8 14.9 40.1 48.5 21.9 30.7 23.3 34.3 26.4 19.3 22.8 8.1 16.3 25.9 17.5 6.9 28.8 12.3 16.2 20.8 11.7 18.6 19.8 19.0 29.9 27.5 22.4 32.9 21.4 35.7 6.5 16.9 44.2 20.3 16.3 43.1 16.6 21.2 17.9 DHRS7C SDR32C2 ENSG00000184544 "Dehydrogenase/reductase 7C" A6NNS2 17 9771434-9791297 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "heart muscle: 44.0;skeletal muscle: 87.4;tongue: 40.1" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 62.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "BJ hTERT+: 4.5;HeLa: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (6.83e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 44.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 2.7 0.0 87.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 40.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 DHRS9 "3alpha-HSD, RDH15, RDHL, RETSDR8, SDR9C4" ENSG00000073737 "Dehydrogenase/reductase 9" Q9BPW9 2 169064789-169096167 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.0;blood: 53.1;heart muscle: 32.2;intestine: 30.9" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 118.1;granulocytes: 85.8;Syncytiotrophoblasts: 223.7;Urothelial cells: 225.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 16.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 53.1;eosinophil: 23.9;neutrophil: 19.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 53.1" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 10.1;HUVEC TERT2: 8.9;NB-4: 14.7;THP-1: 42.9;TIME: 19.1;U-2197: 14.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA036491, HPA036667" Approved "Intracellular and membrane" NA NA "HPA036491: AB_10673498, HPA036667: AB_10670237" "unprognostic (1.15e-1)" "unprognostic (3.82e-3)" "unprognostic (1.15e-1)" "unprognostic (1.85e-1)" "unprognostic (4.80e-2)" "unprognostic (2.35e-1)" "unprognostic (3.24e-2)" "unprognostic (1.40e-1)" "unprognostic (3.18e-1)" "unprognostic (3.62e-4)" "prognostic unfavorable (2.73e-4)" "unprognostic (2.72e-1)" "unprognostic (3.23e-1)" "unprognostic (1.85e-2)" "unprognostic (1.34e-2)" "unprognostic (1.12e-1)" "unprognostic (1.41e-1)" 40.0 0.1 1.3 14.9 1.0 3.3 2.2 0.3 1.9 4.0 30.9 1.1 0.8 0.6 1.3 0.9 12.8 0.6 2.3 32.2 1.2 0.8 0.4 1.0 9.6 8.0 2.5 1.1 1.2 1.4 0.0 0.3 4.9 1.1 3.5 20.9 0.6 2.9 0.3 1.0 1.5 2.7 3.5 2.4 4.0 4.6 12.3 0.6 0.9 0.5 23.2 12.0 3.7 4.6 1.7 5.4 53.1 6.1 0.0 0.1 1.3 0.0 0.3 0.0 0.0 1.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.4 0.2 0.2 0.6 2.7 10.1 8.9 0.0 0.4 0.0 0.0 0.0 0.0 14.7 0.0 0.1 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 19.1 0.0 0.1 14.1 0.1 0.0 0.0 0.0 0.3 7.7 0.0 53.1 5.4 23.9 0.0 6.1 0.1 1.7 0.0 0.0 5.4 1.0 0.0 0.0 19.5 0.0 1.2 0.4 0.0 1.3 1.3 1.0 0.3 0.7 1.2 0.8 2.5 1.1 1.1 0.6 0.0 2.2 0.9 6.8 1.4 0.0 26.4 0.0 57.6 10.3 0.0 0.0 1.7 0.0 0.3 118.1 0.6 34.9 0.0 21.0 1.1 1.1 5.5 85.8 0.5 25.7 0.0 1.7 0.0 5.7 33.8 1.1 6.4 0.0 0.0 38.5 3.5 40.1 9.5 0.4 0.0 0.0 6.5 0.1 0.7 0.6 1.3 223.7 0.0 1.3 225.8 DIABLO "DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC" ENSG00000184047 "Diablo IAP-binding mitochondrial protein" Q9NR28 12 122207663-122226568 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Cytotrophoblasts: 9.3;Extravillous trophoblasts: 9.1;Hofbauer cells: 5.7;Syncytiotrophoblasts: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA001825, CAB003857, CAB016688" Supported Enhanced Mitochondria NA Yes 21000 Mitochondria "CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247" "unprognostic (3.67e-2)" "unprognostic (1.90e-1)" "unprognostic (1.11e-1)" "unprognostic (3.10e-3)" "unprognostic (1.64e-1)" "unprognostic (2.38e-3)" "unprognostic (1.40e-3)" "unprognostic (5.06e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (5.35e-4)" "unprognostic (6.68e-2)" "unprognostic (2.36e-1)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" 17.2 29.7 21.9 15.5 24.0 26.7 24.8 21.9 30.1 20.4 25.9 29.0 14.3 20.6 22.2 36.6 23.5 21.8 19.2 20.3 21.2 26.8 31.7 37.2 15.8 20.9 28.3 23.6 22.4 32.6 22.9 30.6 28.5 27.0 21.1 24.2 22.4 22.2 20.2 25.8 18.2 21.3 21.8 29.2 18.5 19.8 62.7 21.8 23.2 26.9 23.0 22.8 20.5 17.9 32.8 35.0 27.5 29.1 29.9 32.1 26.8 19.2 38.3 27.1 18.4 19.5 19.1 20.8 20.1 19.8 23.7 21.3 33.1 10.1 23.6 18.9 18.1 17.6 19.2 29.5 24.0 28.1 20.4 23.0 25.9 15.8 30.3 27.7 27.8 10.8 26.3 17.1 27.9 41.9 26.9 27.3 23.6 29.6 10.0 23.0 28.8 22.7 40.9 21.8 27.7 36.0 20.7 27.0 25.9 26.7 30.1 25.7 26.2 26.8 10.8 21.8 31.9 36.3 19.6 18.6 18.3 22.5 20.7 18.1 21.9 36.6 33.8 23.3 21.5 24.0 23.6 28.9 27.5 30.4 29.1 29.1 32.8 28.4 28.4 35.0 26.0 27.9 28.2 12.7 29.9 26.5 26.8 32.1 26.8 21.9 24.0 21.9 30.1 21.2 26.8 28.3 23.6 27.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 DIABLO "DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC" ENSG00000284934 "Diablo IAP-binding mitochondrial protein" Q9NR28 12 122207662-122227534 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.7;intestine: 5.3;lymphoid tissue: 3.8" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 17.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 21.4" HPA001825 Uncertain Approved Mitochondria NA NA 21000 Mitochondria "HPA001825: AB_1857247" 0.1 8.7 0.0 3.8 0.0 0.0 0.0 0.0 0.5 0.2 5.3 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 2.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.9 2.4 0.0 1.2 0.6 1.1 0.6 0.6 2.3 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.5 0.4 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.3 0.1 0.1 0.2 0.0 0.1 0.7 0.0 0.4 1.9 21.4 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.7 0.5 0.3 1.4 0.6 1.0 0.3 1.0 2.3 0.6 1.2 0.3 1.3 1.1 0.6 0.2 0.4 2.2 0.5 0.0 1.1 2.9 4.0 4.4 7.1 0.0 10.2 0.0 1.2 0.0 3.9 0.0 0.0 0.2 4.3 1.9 8.8 0.0 0.0 0.0 2.4 3.1 4.6 2.8 0.0 3.2 7.0 4.3 1.9 3.9 5.2 0.8 3.3 0.0 7.8 7.2 0.2 9.7 3.2 0.0 9.1 6.5 4.1 17.0 15.2 4.3 0.0 5.0 9.3 3.3 DIO1 TXDI1 ENSG00000211452 "Iodothyronine deiodinase 1" P49895 1 53891239-53911086 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "kidney: 36.1;liver: 50.8;thyroid gland: 67.7" "Cell type enhanced" "Detected in some" 22 "Cholangiocytes: 17.8;Hepatocytes: 52.9;Proximal tubular cells: 83.0" "Group enriched" "Detected in many" 8 "liver cancer: 44.7;thyroid cancer: 43.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 26 "Hep G2: 17.0;SK-BR-3: 41.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (4.89e-2)" "unprognostic (4.86e-2)" "unprognostic (1.81e-2)" "unprognostic (1.21e-2)" "unprognostic (1.06e-1)" "unprognostic (2.68e-2)" "unprognostic (3.91e-3)" "unprognostic (6.96e-4)" "unprognostic (6.94e-2)" "unprognostic (4.83e-2)" "unprognostic (8.81e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-3)" "unprognostic (9.99e-3)" "unprognostic (3.78e-2)" "prognostic unfavorable (5.44e-4)" "unprognostic (3.59e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.0 36.1 50.8 0.4 0.1 0.2 0.1 0.4 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 67.7 0.1 0.1 0.1 0.1 0.0 1.5 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.0 17.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 41.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 13.7 17.8 0.0 0.0 0.0 0.0 0.2 10.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 52.9 0.4 0.0 0.0 0.6 2.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 0.0 0.0 DIO2 "SelY, TXDI2" ENSG00000211448 "Iodothyronine deiodinase 2" Q92813 14 80197527-80387757 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 67.7;thyroid gland: 128.7" "Group enriched" "Detected in many" 14 "Extravillous trophoblasts: 495.6;Muller glia cells: 220.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 34.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 26.7;fHDF/TERT166: 14.7;HeLa: 30.6;HHSteC: 15.2;SiHa: 55.9;SK-BR-3: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048002 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "HPA048002: AB_2680230" "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "prognostic favorable (1.67e-4)" "prognostic favorable (4.62e-6)" "unprognostic (2.76e-1)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (2.07e-1)" "unprognostic (8.78e-2)" "unprognostic (3.68e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-3)" "unprognostic (5.08e-2)" "unprognostic (3.43e-1)" "unprognostic (8.40e-2)" "unprognostic (7.15e-2)" 1.3 1.8 13.0 0.9 12.3 0.7 6.1 1.0 19.7 67.7 1.2 1.6 1.9 1.2 15.6 1.1 36.1 0.9 2.5 4.7 14.2 2.7 2.4 0.7 1.2 1.0 4.1 7.6 0.7 1.3 0.9 35.9 5.9 13.2 5.0 1.3 13.1 17.7 12.4 3.0 3.3 1.2 2.4 1.2 0.9 2.5 2.5 1.4 0.0 128.7 15.8 12.0 2.6 13.7 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.4 0.0 26.7 5.7 2.4 0.3 0.0 0.1 0.0 0.1 14.7 0.1 0.5 0.9 0.0 1.9 0.0 0.0 0.0 30.6 0.0 15.2 0.0 0.0 1.7 0.0 0.5 0.0 1.3 0.5 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.5 0.0 0.1 0.2 1.2 0.0 0.0 0.2 0.0 0.0 55.9 11.7 0.1 2.5 0.0 0.0 0.3 0.1 2.4 5.6 6.7 0.9 0.0 0.0 2.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 13.0 12.3 1.0 19.7 14.2 2.7 4.1 7.6 13.2 1.4 0.0 0.3 0.0 0.1 2.6 2.9 1.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 18.5 1.4 0.0 0.0 0.0 495.6 26.0 0.2 0.0 0.0 8.2 1.6 0.0 0.6 1.0 9.6 3.1 0.3 5.0 0.0 0.0 220.7 0.6 0.0 3.9 0.0 6.2 0.0 8.2 3.3 0.6 2.6 23.6 0.0 0.0 0.0 DIO3 TXDI3 ENSG00000197406 "Iodothyronine deiodinase 3" P55073 14 101561351-101563452 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 40.9;placenta: 17.6" "Group enriched" "Detected in some" 4 "Fibroblasts: 8.0;Leydig cells: 10.0;Muller glia cells: 6.6;Peritubular cells: 7.1;Syncytiotrophoblasts: 23.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "AF22: 35.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA073684 Supported Vesicles NA NA Vesicles "HPA073684: " "unprognostic (4.52e-3)" "unprognostic (1.80e-1)" "unprognostic (3.04e-3)" "unprognostic (3.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.50e-1)" "unprognostic (4.24e-2)" "unprognostic (8.11e-2)" "unprognostic (2.58e-1)" "unprognostic (6.24e-2)" "unprognostic (2.34e-1)" "unprognostic (2.52e-1)" "unprognostic (7.46e-5)" "unprognostic (4.82e-3)" "unprognostic (2.43e-1)" "unprognostic (1.11e-4)" "unprognostic (9.80e-3)" 4.5 0.2 0.2 1.7 1.8 0.0 3.5 0.1 0.8 40.9 1.6 0.1 1.0 0.0 3.4 2.2 1.9 3.5 2.9 1.6 0.7 0.0 0.9 2.7 1.4 7.1 0.1 0.1 9.2 4.1 0.0 0.6 17.6 0.3 1.6 0.4 12.6 0.8 2.5 2.2 1.9 0.7 0.9 0.1 2.5 0.7 1.0 0.1 0.1 3.6 1.1 0.4 6.9 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 35.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.9 0.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.1 0.6 0.7 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.1 0.0 0.9 0.0 0.0 2.1 8.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 1.0 0.0 6.6 0.6 0.0 7.1 0.0 0.1 0.0 1.2 0.0 0.0 0.1 23.7 0.0 0.0 0.1 DIRC2 "FLJ14784, RCC4" ENSG00000138463 "Disrupted in renal carcinoma 2" Q96SL1 3 122794795-122881139 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Syncytiotrophoblasts: 189.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "neutrophil: 4.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072579 Supported Vesicles NA NA Vesicles "HPA072579: AB_2686536" "unprognostic (1.40e-1)" "unprognostic (8.53e-3)" "unprognostic (1.20e-1)" "unprognostic (1.09e-1)" "unprognostic (1.16e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (9.74e-2)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.87e-1)" "prognostic favorable (8.81e-11)" "unprognostic (2.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-1)" "unprognostic (7.13e-2)" 7.6 7.8 6.5 4.0 7.7 7.9 6.8 5.2 8.8 5.0 6.2 10.0 4.4 3.0 4.2 6.1 8.8 5.0 5.9 9.9 6.4 6.3 7.5 9.2 8.0 6.9 7.5 4.5 4.9 12.9 18.4 7.6 34.8 6.7 7.8 6.9 11.9 7.7 6.0 27.0 9.7 6.1 6.7 7.8 5.8 5.9 4.2 3.8 3.1 8.0 11.2 7.4 7.4 5.4 0.6 0.3 4.2 0.8 0.0 0.5 0.1 5.6 4.7 4.7 2.6 6.1 5.0 15.7 2.4 5.3 3.9 4.0 11.1 6.4 0.8 3.1 2.7 8.8 8.3 3.4 4.4 3.8 1.2 2.5 0.9 2.6 4.7 4.5 0.5 0.6 4.1 12.0 2.8 4.8 6.1 4.4 1.6 0.5 1.0 5.0 2.5 0.7 0.6 4.2 1.9 7.8 1.5 10.6 1.2 5.6 6.6 4.9 3.8 7.1 3.3 6.3 3.1 3.8 1.2 6.2 6.1 2.3 3.7 2.0 1.1 0.9 0.3 3.1 1.0 3.3 0.0 0.7 0.1 0.5 0.8 0.0 0.1 0.0 0.0 0.3 0.6 0.5 0.3 4.2 0.0 0.7 0.0 0.1 0.1 6.5 7.7 5.2 8.8 6.4 6.3 7.5 4.5 6.7 3.8 11.9 5.9 2.7 17.9 9.4 4.8 11.8 7.6 6.7 7.9 14.0 3.9 38.7 1.7 19.4 2.9 3.9 4.4 0.0 22.2 50.7 5.1 13.3 2.3 3.9 11.3 1.6 14.3 4.3 12.7 1.0 3.1 12.2 8.5 21.6 5.6 20.3 18.6 6.8 4.2 5.7 5.4 6.5 3.8 4.7 4.1 10.2 189.5 1.8 4.7 14.5 DISP1 "DISPA, DKFZP434I0428, MGC13130, MGC16796" ENSG00000154309 "Dispatched RND transporter family member 1" Q96F81 1 222872271-223005995 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 12.7;Collecting duct cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 15.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051411 Uncertain Approved "Nuclear bodies" No No "Nuclear bodies" "HPA051411: AB_2681475" "unprognostic (2.10e-2)" "unprognostic (3.31e-1)" "unprognostic (7.00e-2)" "unprognostic (7.81e-2)" "unprognostic (7.82e-2)" "unprognostic (2.88e-1)" "unprognostic (2.71e-1)" "unprognostic (1.27e-1)" "unprognostic (2.28e-1)" "unprognostic (3.28e-1)" "prognostic favorable (5.00e-4)" "unprognostic (4.13e-1)" "prognostic favorable (3.86e-5)" "unprognostic (5.24e-2)" "unprognostic (2.38e-1)" "prognostic favorable (4.16e-4)" "unprognostic (9.69e-3)" 8.3 7.7 2.7 3.8 8.5 0.1 3.9 2.5 2.9 3.8 10.3 4.2 6.7 3.3 5.9 11.5 6.9 3.1 24.0 4.9 3.3 3.1 7.9 8.1 33.3 1.5 2.6 2.1 6.5 3.2 6.9 3.9 6.9 6.6 14.2 2.9 9.2 2.5 4.0 4.7 4.2 4.8 18.8 2.1 4.9 6.9 28.1 2.7 0.7 7.5 5.1 2.5 12.3 3.3 3.1 1.4 0.1 1.2 2.5 4.4 1.1 0.6 2.2 5.8 3.8 11.5 7.9 2.6 3.9 2.7 1.6 2.3 2.6 1.8 0.3 4.3 1.7 2.7 0.5 1.7 1.0 1.8 7.2 2.8 1.0 8.4 1.2 5.2 0.8 0.9 5.3 3.4 2.7 1.4 7.0 2.4 1.4 0.1 0.1 3.8 1.3 1.1 1.1 3.5 7.3 1.3 1.8 15.9 0.2 8.7 1.0 1.5 2.6 1.7 0.9 2.1 3.0 3.4 1.9 2.2 2.3 1.6 4.1 4.2 1.1 0.6 0.4 3.7 0.7 5.3 0.0 0.7 0.1 2.6 1.2 4.4 3.1 1.5 2.9 1.4 2.4 2.0 1.3 0.0 2.5 0.9 0.7 0.7 1.1 2.7 8.5 2.5 2.9 3.3 3.1 2.6 2.1 6.6 2.7 6.0 1.7 0.9 0.5 0.5 2.8 3.3 12.7 4.0 4.5 10.4 0.0 1.2 0.0 1.6 1.7 1.4 1.7 0.0 2.3 1.5 4.9 0.5 0.0 3.4 4.8 0.0 0.0 8.0 1.0 3.1 1.4 3.5 0.0 1.0 1.7 1.2 1.3 1.7 3.2 4.6 2.0 0.0 1.4 1.9 1.5 1.0 0.7 1.3 1.1 0.1 DISP2 "C15orf36, DISPB, HsT16908, KIAA1742, LINC00594" ENSG00000140323 "Dispatched RND transporter family member 2" A7MBM2 15 40358235-40378639 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 37.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 15.6;Enterocytes: 12.9;Horizontal cells: 17.5;Mucus-secreting cells: 14.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 5.2;HaCaT: 8.1;SCLC-21H: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059903 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059903: AB_2684156" "unprognostic (3.43e-4)" "unprognostic (7.65e-3)" "unprognostic (4.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.90e-1)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (3.08e-2)" "unprognostic (1.98e-1)" "unprognostic (2.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" "unprognostic (4.47e-8)" "unprognostic (1.96e-1)" "unprognostic (3.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" 0.8 2.5 9.0 1.5 7.6 1.3 0.6 37.2 14.5 0.7 4.0 1.0 0.0 3.4 0.9 0.9 0.7 1.1 1.1 0.8 9.0 7.0 0.5 0.7 0.9 1.5 2.9 14.0 1.3 1.4 0.6 2.8 1.0 11.4 0.8 3.9 0.3 1.2 1.8 0.8 1.3 3.0 1.4 2.0 1.1 3.9 2.4 1.8 0.0 3.4 0.0 0.6 1.2 0.4 0.9 1.1 2.9 0.4 1.1 0.6 0.2 1.5 0.6 0.4 2.5 0.1 0.1 0.9 0.2 0.1 1.0 1.5 2.3 0.7 0.2 1.7 0.9 5.2 8.1 0.3 1.3 0.6 0.2 0.5 0.4 0.5 0.1 0.0 0.5 1.5 1.8 0.0 0.3 0.2 0.3 0.5 0.9 0.6 1.0 1.3 0.3 0.2 0.4 0.4 2.0 1.1 0.2 0.4 0.5 0.3 2.1 16.7 2.4 0.3 0.2 0.2 0.5 0.4 0.2 0.5 1.2 0.9 0.2 0.2 0.3 0.2 0.3 0.4 0.7 2.3 2.1 0.4 0.5 0.6 0.3 0.4 0.5 0.4 0.4 0.2 0.9 0.5 0.6 2.9 1.1 0.4 1.1 0.4 0.2 9.0 7.6 37.2 14.5 9.0 7.0 2.9 14.0 11.4 1.8 3.0 5.1 0.0 2.0 0.0 15.6 1.4 2.5 4.0 7.9 3.5 9.8 0.2 0.0 0.3 0.9 1.0 12.9 0.0 0.3 0.2 0.8 1.1 8.1 0.0 0.8 17.5 9.2 0.6 0.0 1.5 1.1 0.9 0.0 0.0 14.1 1.7 0.2 2.9 0.0 0.0 7.2 0.0 0.4 4.2 6.6 0.0 0.2 0.0 4.8 1.0 DISP3 "KIAA1337, PTCHD2" ENSG00000204624 "Dispatched RND transporter family member 3" Q9P2K9 1 11479166-11537584 "Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;testis: 7.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;NTERA-2: 3.4;SCLC-21H: 3.2;SH-SY5Y: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054579 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054579: AB_2682529" "unprognostic (4.93e-2)" "unprognostic (2.23e-2)" "unprognostic (1.61e-1)" "unprognostic (9.55e-3)" "unprognostic (1.80e-1)" "unprognostic (2.73e-1)" "unprognostic (6.12e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.08e-1)" "unprognostic (4.34e-3)" "unprognostic (4.86e-2)" "unprognostic (3.80e-2)" "unprognostic (3.88e-1)" "unprognostic (7.06e-2)" "unprognostic (1.79e-4)" "unprognostic (1.34e-1)" 0.9 1.9 7.3 1.1 10.0 0.9 0.9 4.1 17.4 0.9 1.0 9.0 0.0 1.3 1.1 0.9 0.8 1.0 0.8 0.8 7.3 5.7 0.9 0.8 0.9 1.2 4.0 6.5 0.9 1.6 0.8 4.2 0.8 5.1 1.6 0.9 5.4 0.9 0.8 0.8 0.8 1.3 1.0 2.1 1.1 1.2 7.5 6.8 0.0 0.9 0.0 1.0 0.9 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 7.9 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.0 0.8 0.0 2.0 0.0 0.2 3.2 11.0 2.4 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 10.0 4.1 12.9 7.3 5.7 4.0 6.5 5.1 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DKC1 "Cbf5, DKC, dyskerin, NAP57, NOLA4, XAP101" ENSG00000130826 "Dyskerin pseudouridine synthase 1" O60832 X 154762742-154777689 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Isomerase, Ribonucleoprotein, RNA-binding" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 114.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000166, HPA000447, HPA001022, CAB033086" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA 40000 "Nucleoli fibrillar center" Nucleoplasm "CAB033086: AB_2091314, HPA000166: AB_1078669, HPA000447: AB_1078667, HPA001022: AB_2666175" "unprognostic (9.87e-3)" "unprognostic (1.14e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (2.66e-5)" "unprognostic (2.86e-1)" "prognostic unfavorable (2.94e-4)" "prognostic unfavorable (1.39e-5)" "unprognostic (7.02e-2)" "prognostic unfavorable (9.13e-4)" "unprognostic (2.53e-2)" "unprognostic (2.35e-2)" "unprognostic (2.63e-2)" "prognostic unfavorable (1.46e-9)" "unprognostic (5.28e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-1)" "unprognostic (2.55e-1)" 17.6 18.1 17.2 22.5 17.3 42.3 25.8 19.6 20.7 16.6 20.3 14.8 20.7 17.4 19.7 17.1 33.6 18.5 15.9 16.9 15.4 16.3 15.2 22.5 15.2 26.8 15.6 16.6 23.9 38.7 22.6 24.6 19.1 17.0 17.1 26.2 13.7 20.8 18.7 40.8 25.5 18.5 18.3 20.9 25.8 17.6 33.1 16.7 31.3 26.6 28.7 33.2 16.4 20.8 23.5 18.5 16.7 15.5 20.8 26.8 14.8 36.7 20.5 12.7 18.0 7.9 8.2 18.8 14.0 9.9 21.0 19.9 25.8 18.4 70.3 37.0 11.8 19.6 19.8 38.6 23.1 31.6 16.9 21.5 35.9 21.5 22.4 11.2 47.1 21.6 7.8 22.2 23.2 52.9 7.7 14.5 23.5 32.3 17.7 14.2 21.4 31.7 36.3 21.1 36.8 25.7 27.7 28.5 36.4 13.2 20.9 27.9 13.8 12.4 21.7 19.1 12.9 11.0 19.0 11.6 15.1 22.7 19.4 46.3 32.7 45.2 114.9 10.3 49.9 16.4 4.8 13.1 16.7 21.4 15.5 26.8 23.5 17.6 22.7 18.5 17.1 23.3 22.2 4.0 20.8 14.9 13.4 13.4 14.8 17.2 17.3 19.6 20.7 15.4 16.3 15.6 16.6 17.0 16.7 23.8 28.8 32.8 45.8 88.6 31.1 28.6 17.8 37.5 38.7 24.4 13.7 49.0 34.9 41.0 1.9 32.1 7.5 23.3 39.2 59.7 35.2 32.7 53.4 20.8 39.9 22.3 32.7 14.7 19.2 6.2 23.9 30.6 47.2 38.7 31.9 25.7 36.3 8.6 26.9 18.8 27.3 12.9 41.0 35.3 81.7 85.9 28.6 30.5 47.6 46.7 DKKL1 "CT34, SGY-1" ENSG00000104901 "Dickkopf like acrosomal protein 1" Q9UK85 19 49361783-49375116 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 91.5" "Group enriched" "Detected in some" 39 "Early spermatids: 1802.9;Late spermatids: 1817.6" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory B-cell: 4.1" "Lineage enriched" "Detected in single" 42 "B-cells: 4.1" "Cell line enhanced" "Detected in many" "AF22: 7.3;AN3-CA: 13.8" "Group enriched" "Detected in many" 17 "amygdala: 27.1;basal ganglia: 15.6;cerebral cortex: 50.1;hippocampal formation: 25.1;olfactory region: 20.8" "Low region specificity" "Detected in all" "CAB025410, HPA047194" Enhanced Approved Vesicles "Secreted in male reproductive system" NA NA Vesicles "CAB025410: , HPA047194: AB_2679979" "unprognostic (1.64e-1)" "unprognostic (5.30e-1)" "unprognostic (5.39e-4)" "unprognostic (1.85e-4)" "unprognostic (3.79e-2)" "unprognostic (4.30e-2)" "unprognostic (5.52e-4)" "unprognostic (1.00e-1)" "unprognostic (6.76e-2)" "unprognostic (4.08e-1)" "unprognostic (1.90e-1)" "unprognostic (5.65e-2)" "unprognostic (2.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.13e-1)" "unprognostic (1.18e-1)" "unprognostic (5.57e-2)" 0.2 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.4 0.5 0.3 0.4 0.2 0.3 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.2 0.1 0.3 0.0 0.3 0.3 0.1 0.0 0.0 0.3 0.4 0.0 0.1 0.0 91.5 0.0 0.0 0.0 0.2 0.1 0.3 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.3 13.8 0.1 0.5 0.6 1.4 0.0 0.2 0.4 0.0 0.6 0.0 1.0 0.3 0.5 0.1 0.2 0.0 0.0 0.0 2.6 0.0 3.5 0.3 0.0 0.0 1.2 1.0 0.4 0.2 0.5 1.3 1.2 0.0 1.4 0.6 0.1 0.6 0.0 0.1 2.9 0.7 1.5 0.1 0.1 0.1 0.0 0.0 0.0 3.0 1.2 0.0 0.7 1.5 1.4 2.7 1.7 1.6 0.9 1.0 0.0 0.6 0.8 0.3 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 1802.9 1.0 0.0 0.0 0.5 0.1 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1817.6 15.5 0.0 1.7 0.0 0.1 2.2 0.4 0.0 11.3 0.0 0.1 6.5 0.3 46.8 10.9 0.0 0.0 0.0 0.0 0.1 DLK1 "Delta1, FA1, pG2, Pref-1, ZOG" ENSG00000185559 "Delta like non-canonical Notch ligand 1" P80370 14 100725705-100738224 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 157.6;pituitary gland: 143.1;placenta: 244.9" "Group enriched" "Detected in many" 5 "Exocrine glandular cells: 527.9;Leydig cells: 1256.4" "Cancer enhanced" "Detected in many" "liver cancer: 28.1" "Group enriched" "Detected in some" 5 "hypothalamus: 2.6;pons and medulla: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 23.1;Hep G2: 77.0;SH-SY5Y: 91.7" "Region enhanced" "Detected in some" "hypothalamus: 65.4" "Region enhanced" "Detected in many" "midbrain: 159.6" "CAB005872, HPA062262" Enhanced Approved "Golgi apparatus" NA NA 160000 "Golgi apparatus" "CAB005872: AB_731965, HPA062262: AB_2684729" "unprognostic (2.16e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (4.89e-3)" "unprognostic (5.75e-2)" "unprognostic (1.87e-2)" "unprognostic (1.12e-1)" "unprognostic (5.24e-1)" "unprognostic (3.11e-2)" "unprognostic (6.57e-2)" 0.3 157.6 0.2 0.7 0.8 0.0 0.9 0.0 0.1 0.5 0.0 1.8 0.2 0.2 0.2 4.4 0.3 0.3 0.8 2.7 0.1 2.6 0.1 0.1 0.1 0.1 0.8 0.0 34.9 4.6 0.0 143.1 244.9 6.0 0.2 0.0 0.2 8.2 0.0 2.0 0.1 0.2 0.2 0.3 0.2 0.2 14.2 0.0 0.5 0.0 10.0 1.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 77.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.1 6.5 91.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.8 0.0 0.0 0.1 2.6 0.8 0.0 6.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 52.1 0.0 2.9 4.0 0.0 0.0 0.0 527.9 35.4 1.3 0.5 0.0 0.0 73.1 0.0 0.0 0.0 0.0 11.5 1256.4 0.0 0.0 0.0 0.0 0.0 6.5 0.0 162.3 0.0 0.0 58.2 0.0 6.5 56.6 0.4 88.4 0.0 0.0 0.1 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 19.3" "Cell type enriched" "Detected in some" 7 "Basal glandular cells: 79.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 16.5;HBEC3-KT: 9.0;hTCEpi: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles No No Nucleoplasm "Nucleoli, Vesicles" "HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 1.0 1.1 4.5 1.4 7.9 1.7 4.3 12.2 8.2 2.2 0.7 0.9 6.4 1.1 1.4 3.8 10.5 1.1 0.9 1.8 4.1 4.6 0.7 0.7 1.1 1.7 1.5 4.8 1.7 1.5 0.4 0.5 1.3 0.9 10.4 0.5 0.3 12.4 13.0 0.7 19.3 1.0 0.6 1.5 1.5 1.1 1.1 1.2 1.3 0.8 4.7 3.9 2.2 5.3 0.8 1.8 1.0 0.5 2.5 3.2 0.3 5.2 1.9 0.5 7.9 0.0 0.4 1.8 1.9 2.1 2.2 1.0 1.8 0.2 1.0 1.2 0.4 2.7 16.5 5.6 9.0 0.5 1.0 2.1 0.4 0.9 2.8 0.6 0.3 1.1 0.9 27.2 0.6 5.1 0.7 0.0 3.1 0.4 0.8 0.8 2.0 0.4 0.4 0.7 2.0 2.0 1.1 1.0 0.5 0.3 1.8 5.9 0.6 0.6 0.2 0.3 0.4 0.5 1.6 0.5 0.8 2.5 0.6 3.8 1.2 0.3 1.7 0.1 0.7 0.5 0.9 0.4 0.4 0.7 0.3 3.2 0.6 2.2 2.2 0.1 0.8 0.9 0.4 1.0 2.5 0.5 1.8 0.3 0.3 4.5 7.9 12.2 8.2 4.1 4.6 1.5 4.8 0.9 1.2 0.0 0.3 0.0 79.5 9.0 0.6 0.5 0.0 0.0 7.9 0.0 0.0 0.8 0.0 0.1 0.2 0.3 0.0 0.0 0.0 2.1 0.2 4.3 0.0 0.0 0.1 11.1 1.2 0.0 0.0 0.2 0.3 0.0 1.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.9 0.0 0.3 1.2 5.5 2.3 0.2 0.0 0.0 3.9 DLL1 ENSG00000198719 "Delta like canonical Notch ligand 1" O00548 6 170282206-170306565 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.9" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 59.4;Intestinal endocrine cells: 49.7;Mucus-secreting cells: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 7.3" "Lineage enriched" "Detected in single" 8 "NK-cells: 7.3" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;HBEC3-KT: 10.8;NB-4: 17.8;THP-1: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078298 Uncertain Nucleoplasm NA NA 210000 Nucleoplasm "HPA078298: " "unprognostic (1.03e-1)" "unprognostic (9.22e-2)" "unprognostic (2.17e-3)" "unprognostic (1.95e-1)" "unprognostic (2.89e-2)" "unprognostic (6.35e-2)" "unprognostic (1.63e-2)" "unprognostic (1.89e-1)" "unprognostic (9.22e-2)" "unprognostic (1.14e-2)" "unprognostic (1.39e-2)" "unprognostic (2.64e-2)" "unprognostic (5.23e-3)" "unprognostic (3.50e-1)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.66e-1)" 8.9 5.7 4.1 5.5 9.0 3.2 8.6 2.5 13.8 7.4 10.3 18.5 2.6 8.1 6.0 3.0 11.1 5.7 11.4 7.2 5.2 4.0 5.8 13.5 6.8 5.6 5.5 5.2 2.5 13.8 2.2 3.1 5.0 10.0 14.5 5.2 14.3 8.9 7.1 3.8 14.3 13.1 3.9 4.6 36.9 5.9 1.6 7.3 0.9 6.1 5.3 6.3 4.5 11.0 0.0 0.0 0.1 0.9 7.3 0.5 0.2 0.9 0.1 4.3 2.7 0.3 0.2 2.3 0.2 0.6 0.3 0.5 1.1 0.1 0.0 0.2 0.1 0.7 7.0 2.7 10.8 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 3.1 0.1 2.0 0.0 1.1 0.2 1.1 0.1 0.0 0.0 0.4 3.0 0.0 17.8 0.6 0.4 0.0 0.8 4.3 0.1 0.0 1.3 1.9 0.1 0.3 0.0 0.0 1.6 0.7 14.7 0.5 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.8 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.3 0.1 7.3 0.9 0.0 0.0 0.2 4.1 9.0 2.5 11.2 5.2 4.0 5.5 5.2 10.0 7.3 0.0 0.3 0.0 15.5 59.4 0.7 4.6 0.0 10.7 10.3 1.8 21.6 2.4 0.0 0.3 0.3 18.9 1.6 0.0 1.5 5.2 8.9 3.8 5.7 0.0 1.0 0.0 49.7 20.9 3.9 1.2 0.3 2.5 6.8 0.0 76.5 1.0 0.9 2.9 1.1 0.0 0.6 12.9 9.0 0.5 1.9 11.2 3.1 0.0 2.6 0.9 DLL3 SCDO1 ENSG00000090932 "Delta like canonical Notch ligand 3" Q9NYJ7 19 39498895-39508481 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 38.5" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 37.2" "Group enriched" "Detected in many" 11 "glioma: 29.2;melanoma: 15.5;testis cancer: 8.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4;naive CD8 T-cell: 3.3" "Group enriched" "Detected in many" 13 "B-cells: 5.4;T-cells: 3.3" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 42.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA056533 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA056533: " "unprognostic (2.52e-1)" "unprognostic (3.81e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (9.85e-2)" "unprognostic (1.41e-2)" "unprognostic (1.65e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.82e-4)" "unprognostic (4.94e-2)" "unprognostic (5.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.97e-1)" 0.6 0.6 8.9 0.7 10.1 0.6 0.6 1.4 38.5 0.5 0.6 10.3 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.6 6.5 6.8 0.5 0.6 0.6 0.7 4.5 1.9 0.6 0.5 0.6 3.2 0.5 4.3 0.6 0.5 0.0 0.6 0.5 0.5 0.6 0.6 0.5 3.6 0.6 0.6 1.2 2.3 0.0 0.7 0.0 0.6 0.6 0.0 5.4 0.3 0.0 0.0 0.0 3.3 0.4 0.0 2.0 0.4 1.0 0.0 0.0 0.3 0.5 0.0 0.3 0.1 0.3 0.4 0.0 2.0 0.0 0.8 0.0 1.2 0.5 0.1 0.6 3.1 0.1 0.0 0.2 0.1 0.5 2.4 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.5 0.0 0.2 0.0 0.1 0.0 0.4 0.0 3.2 0.3 0.1 0.1 0.1 0.1 7.4 7.6 1.5 0.0 42.1 0.1 0.0 0.1 0.0 0.0 1.4 0.1 0.5 0.7 0.0 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.9 0.0 0.4 5.4 0.2 1.3 0.3 1.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.4 8.9 10.1 1.4 4.8 6.5 6.8 4.5 1.9 4.3 2.3 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 0.0 0.0 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.2 0.0 2.9 0.0 0.0 1.6 1.1 0.0 1.7 0.0 0.0 0.5 0.2 0.0 1.4 0.0 0.6 6.5 0.0 5.4 37.2 0.1 0.2 0.0 0.0 0.0 DLL4 ENSG00000128917 "Delta like canonical Notch ligand 4" Q9NR61 15 40929340-40939072 "Disease related genes, Predicted membrane proteins" "Angiogenesis, Differentiation, Neurogenesis, Notch signaling pathway, Sensory transduction, Vision" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Endothelial cells: 33.6;Intestinal endocrine cells: 16.7;Ito cells: 24.5;Mucus-secreting cells: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BJ hTERT+: 34.6;HUVEC TERT2: 9.1;SCLC-21H: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023392 Uncertain NA NA "HPA023392: AB_1847740" "unprognostic (1.92e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (7.52e-2)" "unprognostic (4.71e-2)" "unprognostic (2.72e-1)" "unprognostic (4.16e-2)" "unprognostic (3.56e-2)" "unprognostic (1.60e-2)" "unprognostic (2.49e-1)" "unprognostic (2.73e-1)" "unprognostic (3.51e-2)" "unprognostic (6.10e-2)" "unprognostic (2.56e-3)" "unprognostic (9.92e-2)" "unprognostic (2.93e-1)" "unprognostic (1.51e-2)" "unprognostic (5.51e-3)" 34.1 3.4 5.9 4.2 8.0 0.9 16.8 5.8 12.6 9.5 8.4 2.7 2.3 5.9 12.0 3.3 5.9 5.6 5.6 15.3 9.4 3.7 6.5 6.0 27.0 6.6 7.7 0.1 8.1 3.9 4.8 5.2 27.4 11.2 8.8 4.7 11.9 3.2 4.4 12.5 4.5 5.3 6.6 5.8 5.9 4.0 3.9 7.8 4.7 13.0 6.1 3.4 9.4 10.8 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 34.6 0.1 0.2 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.1 0.0 0.2 0.6 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.8 0.2 0.8 0.0 0.1 18.7 0.0 0.1 0.4 0.0 0.0 0.0 2.0 0.5 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.9 8.0 5.8 12.6 9.4 3.7 7.7 0.1 11.2 7.8 0.0 2.4 0.0 0.1 1.1 4.5 2.1 0.0 0.0 1.2 0.0 0.0 1.3 0.0 0.1 0.2 33.6 9.1 0.0 0.2 0.6 1.1 1.5 2.3 0.0 0.2 0.0 16.7 24.5 2.2 0.0 0.0 0.0 1.7 0.0 15.7 0.0 0.2 8.7 0.0 0.0 1.3 0.0 2.3 0.7 2.7 1.4 1.6 0.0 4.3 0.7 DMAC1 "C9orf123, MGC4730, TMEM261" ENSG00000137038 "Distal membrane arm assembly complex 1" Q96GE9 9 7796490-7888380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Distal tubular cells: 424.4;Hofbauer cells: 180.4;Proximal tubular cells: 165.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014585 Approved NA NA "HPA014585: AB_1845803" "unprognostic (1.48e-2)" "unprognostic (3.74e-2)" "unprognostic (7.23e-3)" "prognostic favorable (4.15e-4)" "unprognostic (2.78e-2)" "unprognostic (2.79e-3)" "unprognostic (1.33e-1)" "unprognostic (1.28e-1)" "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (3.26e-3)" "unprognostic (3.65e-1)" "prognostic favorable (1.96e-11)" "unprognostic (1.75e-1)" "unprognostic (4.19e-1)" "unprognostic (2.35e-1)" "unprognostic (7.41e-2)" 13.7 16.0 17.8 14.1 20.1 7.9 17.1 17.9 20.9 13.6 15.1 14.4 12.4 13.5 12.5 16.9 15.9 15.6 16.5 30.7 16.8 16.2 18.8 17.1 9.5 13.2 17.7 14.1 18.8 17.1 15.6 14.9 11.3 15.4 16.8 13.9 14.4 19.9 17.1 49.4 10.2 11.7 14.1 17.5 13.0 12.4 11.9 12.0 35.6 18.6 26.5 12.7 13.0 10.0 16.0 8.6 2.8 7.6 12.7 14.7 11.5 9.8 11.9 11.0 6.9 8.9 11.1 7.5 6.0 4.3 6.4 5.9 5.3 6.3 14.7 3.1 5.4 8.4 5.4 11.8 10.3 6.6 8.8 13.5 26.6 18.8 17.0 9.0 9.2 3.7 13.9 7.4 5.1 7.9 6.0 6.1 13.4 4.8 3.1 6.8 8.4 13.3 21.2 9.8 8.4 5.8 10.2 6.2 8.7 7.4 9.6 17.8 9.9 6.6 4.4 7.3 7.9 5.8 5.7 7.7 5.0 8.0 6.5 4.1 3.9 6.3 7.8 4.2 7.7 4.9 0.8 6.8 2.8 8.1 7.6 12.1 16.0 11.0 8.5 8.2 13.8 14.7 11.6 1.1 12.7 5.9 8.6 12.3 11.5 17.8 20.1 17.9 20.9 16.8 16.2 17.7 14.1 15.4 12.0 65.5 40.3 0.0 0.0 0.0 0.0 0.0 0.0 129.8 44.3 96.0 0.0 97.3 424.4 77.8 0.0 0.0 0.0 0.0 78.5 76.3 0.0 0.0 25.6 0.0 180.4 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 45.1 0.0 0.0 59.8 0.0 0.0 165.4 0.0 0.0 0.0 0.0 0.0 0.0 46.3 0.0 0.0 0.0 DMRT2 ENSG00000173253 "Doublesex and mab-3 related transcription factor 2" Q9Y5R5 9 1049858-1057552 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 27.3;lymphoid tissue: 18.4;parathyroid gland: 52.9" "Cell type enriched" "Detected in some" 23 "Distal tubular cells: 97.8" "Cancer enhanced" "Detected in many" "renal cancer: 9.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.9;RH-30: 5.3;RPMI-8226: 19.8;SCLC-21H: 3.1;SK-MEL-30: 5.4;THP-1: 3.8;WM-115: 3.8" "Region enhanced" "Detected in some" "cerebral cortex: 1.8" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" HPA029297 Uncertain NA NA "HPA029297: AB_10600905" "unprognostic (5.67e-2)" "unprognostic (2.20e-3)" "unprognostic (3.24e-2)" "unprognostic (8.88e-2)" "unprognostic (1.32e-1)" "unprognostic (7.10e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (3.13e-1)" "unprognostic (7.43e-2)" "unprognostic (1.74e-1)" "unprognostic (1.43e-3)" "unprognostic (8.93e-2)" "unprognostic (8.62e-2)" "unprognostic (4.93e-2)" "unprognostic (1.27e-3)" 3.8 0.5 1.9 0.5 6.5 0.4 4.5 0.5 4.5 0.5 1.6 11.0 2.6 0.4 0.5 1.3 0.6 0.6 0.4 0.5 3.2 1.3 27.3 0.4 2.4 0.6 7.0 2.5 0.4 0.4 52.9 0.7 0.6 3.6 0.6 1.1 0.0 1.4 1.5 9.0 0.6 0.4 0.5 3.0 0.4 0.4 0.9 6.2 18.4 0.4 6.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3.9 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 5.3 19.8 0.0 0.9 3.1 0.0 0.0 0.0 5.4 0.3 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 3.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 6.5 0.5 4.5 3.2 1.3 7.0 2.5 3.6 6.2 0.0 0.0 0.0 0.4 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 97.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.3 0.0 0.7 0.3 0.0 2.3 0.0 0.0 1.7 0.0 0.0 4.2 1.5 0.1 0.1 0.0 1.5 0.1 DNAH10 FLJ43808 ENSG00000197653 "Dynein axonemal heavy chain 10" Q8IVF4 12 123762188-123936206 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.0;epididymis: 10.1;fallopian tube: 9.5;lung: 11.8;testis: 16.4" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 104.4;Club cells: 20.5;Early spermatids: 27.9;Late spermatids: 49.5" "Cancer enhanced" "Detected in single" "testis cancer: 1.0" "Group enriched" "Detected in many" 4 "basal ganglia: 4.8;pons and medulla: 10.0" "Cell type enhanced" "Detected in some" "gdT-cell: 1.6;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 13 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3;ASC diff: 3.9;SuSa: 2.4" HPA039066 Enhanced NA NA "HPA039066: AB_10673237" "unprognostic (1.37e-1)" "unprognostic (1.78e-1)" "unprognostic (6.08e-3)" "unprognostic (9.90e-3)" "unprognostic (2.16e-1)" "unprognostic (8.91e-2)" "unprognostic (3.39e-2)" "unprognostic (1.86e-1)" "unprognostic (5.59e-2)" "unprognostic (1.08e-2)" "unprognostic (7.28e-3)" "unprognostic (5.25e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-1)" "unprognostic (7.23e-2)" "unprognostic (1.22e-2)" "unprognostic (9.11e-3)" 0.4 0.2 0.7 0.2 4.8 3.1 0.3 1.2 0.6 1.9 0.7 3.9 0.5 0.5 0.6 10.1 0.2 9.5 0.2 0.2 1.4 1.7 0.4 0.2 11.8 0.2 0.5 0.0 6.2 0.2 0.1 0.2 0.4 10.0 1.1 0.2 0.0 0.2 0.2 0.1 0.2 1.1 0.2 1.5 0.3 0.2 16.4 0.3 0.0 0.5 0.0 0.2 0.4 0.9 0.1 0.0 0.1 0.0 0.0 1.6 0.2 0.0 0.0 0.1 2.3 3.9 1.7 0.6 1.0 0.3 0.0 0.2 0.0 0.4 0.1 0.2 1.2 0.4 0.4 0.0 0.0 0.0 0.4 0.8 0.6 0.0 0.0 0.4 0.0 1.1 1.3 0.0 0.3 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.8 2.4 0.0 0.2 0.3 1.1 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 4.8 1.2 0.5 1.4 1.7 0.5 0.0 10.0 0.3 0.0 5.6 0.0 0.0 0.0 0.2 2.0 0.0 104.4 20.5 0.0 0.0 0.0 1.7 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 1.4 0.8 12.9 0.0 7.6 1.9 0.0 0.0 0.0 0.0 0.1 DNAJB11 "EDJ, ERdj3, HEDJ" ENSG00000090520 "DnaJ heat shock protein family (Hsp40) member B11" Q9UBS4 3 186567403-186585800 "Predicted intracellular proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA010814, HPA017051" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 18000 "Endoplasmic reticulum" "HPA010814: AB_1078691, HPA017051: AB_1847792" "unprognostic (4.29e-1)" "unprognostic (1.07e-1)" "unprognostic (2.98e-2)" "unprognostic (2.24e-2)" "unprognostic (8.53e-2)" "unprognostic (1.07e-3)" "unprognostic (3.86e-2)" "unprognostic (6.52e-2)" "unprognostic (7.95e-2)" "unprognostic (2.14e-3)" "unprognostic (2.58e-2)" "unprognostic (1.05e-3)" "prognostic unfavorable (3.44e-9)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" "unprognostic (1.82e-1)" 18.8 16.4 14.0 27.7 21.2 26.4 22.3 12.4 14.4 18.7 21.6 15.9 21.5 19.7 20.0 28.1 19.9 18.1 18.2 27.3 14.7 14.9 29.5 83.5 21.7 31.5 17.4 10.2 13.9 67.4 20.6 18.0 26.2 19.6 14.4 22.7 13.3 37.2 18.4 13.2 13.9 25.4 17.3 17.4 25.6 21.3 16.1 19.6 17.9 47.6 15.7 20.3 19.0 26.0 19.3 42.2 19.0 21.6 22.6 23.7 16.8 33.2 13.1 19.3 33.4 15.9 12.3 33.2 37.7 21.6 31.2 33.0 40.4 22.2 24.3 76.4 24.7 45.3 31.0 22.0 19.5 32.9 27.2 19.4 21.5 13.0 29.8 37.0 25.2 34.0 10.9 19.9 17.5 30.8 17.2 26.0 13.4 11.9 58.6 20.6 25.3 16.9 20.7 18.9 45.7 17.7 17.0 21.9 40.8 23.3 14.4 16.7 23.3 24.2 40.5 26.1 24.8 46.6 38.5 19.6 17.4 22.5 22.5 53.4 46.8 34.4 38.4 23.0 30.8 37.3 16.6 18.3 19.0 23.7 21.6 19.9 19.3 12.2 19.2 22.9 11.5 11.8 16.0 8.4 22.6 15.8 42.2 16.7 16.8 14.0 21.2 12.4 14.4 14.7 14.9 17.4 10.2 19.6 19.6 17.9 18.1 40.2 176.4 129.0 21.7 133.1 73.9 14.7 21.6 14.0 17.7 80.7 3.3 86.5 28.0 75.2 81.9 46.7 74.8 136.3 69.6 91.0 55.2 85.7 131.5 22.3 136.1 66.3 76.0 7.2 29.1 64.3 97.8 20.8 37.6 45.1 80.8 43.8 24.4 17.2 21.3 64.7 67.3 102.4 77.5 98.1 163.2 65.0 43.1 144.4 DNAJB12 "DJ10, FLJ20027" ENSG00000148719 "DnaJ heat shock protein family (Hsp40) member B12" Q9NXW2 10 72332830-72355230 "Predicted membrane proteins, Transporters" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 160.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010642, HPA072702" Approved Supported "Nuclear membrane,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nuclear membrane" "HPA010642: AB_1078692, HPA072702: " "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (4.79e-4)" "unprognostic (6.01e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.17e-4)" "unprognostic (5.73e-2)" "unprognostic (5.60e-2)" "unprognostic (8.85e-3)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (4.05e-2)" "unprognostic (4.73e-1)" "unprognostic (1.16e-2)" "unprognostic (1.87e-1)" 24.9 31.7 18.6 20.1 20.6 27.2 32.6 24.0 28.3 24.1 21.8 29.9 26.4 25.0 26.8 31.0 23.8 21.1 28.7 25.3 18.0 17.3 25.6 34.3 26.8 27.5 19.9 19.4 25.4 33.1 38.4 26.2 36.0 20.2 24.5 17.5 27.5 32.4 44.8 40.3 28.6 27.4 22.8 22.3 26.9 24.3 29.2 18.2 20.8 25.5 25.8 23.5 21.1 21.2 7.6 15.5 23.3 19.8 8.3 8.7 9.9 15.6 16.3 10.3 17.2 13.5 13.8 13.0 15.8 27.4 21.8 20.3 19.1 27.4 11.6 12.8 19.0 13.6 26.4 9.5 14.2 11.5 12.6 13.0 6.2 9.7 12.3 29.8 12.6 23.8 17.7 29.5 19.2 24.4 19.7 15.1 11.2 9.7 17.5 18.0 15.2 10.7 10.7 4.8 12.0 4.8 9.9 7.8 8.0 16.0 9.2 7.1 10.2 8.6 32.0 15.4 5.8 12.2 14.4 16.9 10.9 15.0 12.2 19.8 14.8 11.0 6.8 18.0 13.9 7.4 9.1 18.1 11.0 8.7 19.8 7.8 7.6 8.6 6.5 15.5 7.3 7.2 7.1 23.3 8.3 16.8 10.5 8.7 9.9 18.6 20.6 24.0 28.3 18.0 17.3 19.9 19.4 20.2 18.2 26.8 27.7 36.1 25.5 11.8 32.1 20.2 53.5 20.1 22.7 22.7 21.6 34.5 10.0 30.2 95.9 21.5 37.6 46.7 56.5 35.4 21.6 25.1 39.3 26.0 34.3 28.6 28.3 17.8 36.2 160.7 33.6 33.3 10.1 33.3 24.0 31.9 29.4 31.7 32.9 30.0 34.0 51.8 25.0 20.2 9.0 13.6 56.9 20.3 21.7 29.8 DNAJB9 MDG1 ENSG00000128590 "DnaJ heat shock protein family (Hsp40) member B9" Q9UBS3 7 108569568-108574850 "Predicted intracellular proteins" "Unfolded protein response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Melanocytes: 322.2;Syncytiotrophoblasts: 476.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 34.1;Karpas-707: 31.1;U-266/70: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040967, HPA041553" Supported Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA "Endoplasmic reticulum, Cytosol" "HPA040967: AB_10794430, HPA041553: AB_10794300" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (4.75e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (5.37e-2)" "unprognostic (5.13e-2)" "unprognostic (3.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.76e-1)" "unprognostic (1.05e-1)" "unprognostic (2.68e-3)" "unprognostic (1.91e-1)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (8.76e-2)" 13.7 28.9 11.6 9.7 14.1 16.7 14.6 8.6 15.4 18.2 11.1 10.0 33.7 11.1 12.6 31.4 8.7 12.8 10.8 24.2 11.6 18.7 29.2 54.3 16.1 13.3 14.0 11.4 14.6 47.9 6.9 31.0 51.2 15.7 14.2 9.6 10.1 32.2 29.5 29.4 7.6 10.8 10.7 14.7 10.8 11.9 18.5 10.6 5.4 37.4 7.2 14.2 18.1 13.5 10.0 30.1 25.8 7.7 9.9 24.0 11.4 2.5 2.9 4.0 4.6 11.2 8.1 8.9 9.4 11.4 5.2 6.3 2.9 4.9 3.4 10.5 2.9 16.4 3.1 4.5 2.3 5.4 3.6 2.4 1.8 2.1 9.0 34.1 2.7 3.6 5.7 18.0 3.0 16.9 11.8 5.4 2.0 2.6 31.1 8.1 3.7 2.5 3.1 4.0 3.0 1.6 1.6 4.1 17.7 4.3 1.6 2.8 5.9 3.5 15.8 17.3 11.8 2.9 3.7 6.2 5.5 2.6 6.8 3.3 54.8 17.5 3.9 4.8 3.5 5.0 25.8 7.7 3.5 14.1 5.8 24.0 10.0 15.4 14.1 5.7 8.1 8.9 10.2 2.1 9.9 6.2 30.1 8.9 11.4 11.6 14.1 8.6 15.4 11.6 18.7 14.0 11.4 15.7 10.6 3.0 24.5 55.9 74.7 164.9 35.2 49.9 33.1 12.0 26.1 50.6 7.9 92.1 41.4 36.7 250.3 25.6 26.9 46.7 40.0 74.4 81.3 107.9 93.2 138.2 37.2 19.1 63.8 27.0 30.2 167.7 35.4 38.7 322.2 17.2 22.8 79.9 42.7 35.1 43.5 139.7 27.0 38.8 75.0 129.5 59.0 138.6 476.2 51.1 13.6 74.9 DNAJC1 "DNAJL1, ERdj1, MTJ1" ENSG00000136770 "DnaJ heat shock protein family (Hsp40) member C1" Q96KC8 10 21756537-22003769 "Predicted membrane proteins, Transcription factors" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013432 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA013432: AB_1847797" "unprognostic (7.00e-2)" "unprognostic (9.81e-2)" "unprognostic (3.61e-1)" "unprognostic (5.12e-2)" "unprognostic (5.51e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (3.81e-2)" "unprognostic (1.21e-1)" "unprognostic (3.46e-2)" "unprognostic (1.09e-1)" "unprognostic (9.36e-2)" "prognostic favorable (2.33e-4)" "unprognostic (4.44e-3)" "unprognostic (4.88e-2)" "unprognostic (1.45e-2)" "unprognostic (2.22e-2)" 14.8 16.0 8.6 13.5 13.4 11.1 14.6 8.3 11.2 14.5 17.8 9.6 16.2 19.9 15.5 14.0 14.1 10.9 16.4 14.2 10.2 7.2 22.1 41.3 20.5 9.5 13.5 6.8 13.4 33.7 27.1 34.3 16.6 13.8 29.2 13.6 12.6 28.5 14.3 10.6 11.6 18.5 22.8 15.0 13.7 19.9 7.7 13.9 12.2 21.8 11.6 11.5 25.9 28.8 6.5 21.5 5.4 15.2 17.9 21.1 7.7 12.7 8.3 18.7 6.9 17.6 12.5 8.1 17.4 7.6 7.3 11.5 11.4 11.3 5.6 7.7 10.6 10.9 12.3 4.2 8.7 4.0 29.4 14.1 13.4 6.8 6.8 42.7 1.0 5.7 12.7 16.2 8.6 9.9 10.7 9.5 5.6 14.0 32.4 8.1 13.0 3.1 4.3 2.4 11.1 7.0 4.6 6.5 20.6 10.0 3.0 3.9 6.0 12.8 21.5 12.6 21.5 6.8 14.4 14.5 7.1 15.6 11.9 9.8 10.4 3.2 3.9 10.6 42.7 4.2 5.4 9.2 3.6 20.9 8.7 21.1 4.9 12.0 16.6 8.3 6.5 7.8 9.9 5.2 17.9 15.2 21.5 8.4 7.7 8.6 13.4 8.3 11.2 10.2 7.2 13.5 6.8 13.8 13.9 32.8 26.9 21.2 53.6 34.5 28.0 12.9 56.0 21.4 22.7 29.6 43.2 13.3 23.2 67.3 35.8 46.6 45.3 23.3 64.6 86.2 53.4 72.0 40.5 79.1 47.8 36.5 36.8 46.6 37.7 15.6 87.8 31.8 64.1 40.5 54.8 41.6 73.1 46.5 62.9 69.2 144.0 58.2 37.3 70.7 72.9 38.6 29.5 94.8 50.0 63.1 DNAJC10 "ERdj5, PDIA19" ENSG00000077232 "DnaJ heat shock protein family (Hsp40) member C10" Q8IXB1 2 182716041-182794464 "Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 74.8" "Cell type enhanced" "Detected in all" 4 "Ciliated cells: 156.6;Early spermatids: 164.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031111 Approved NA NA "HPA031111: AB_10601211" "unprognostic (3.29e-2)" "unprognostic (5.20e-3)" "unprognostic (3.10e-3)" "prognostic favorable (6.42e-5)" "unprognostic (1.89e-1)" "unprognostic (1.18e-1)" "unprognostic (4.34e-3)" "unprognostic (1.82e-2)" "unprognostic (1.54e-2)" "unprognostic (4.34e-2)" "unprognostic (2.29e-1)" "unprognostic (9.76e-2)" "prognostic unfavorable (2.19e-7)" "unprognostic (2.91e-1)" "unprognostic (8.96e-2)" "prognostic unfavorable (7.27e-4)" "unprognostic (2.87e-2)" 10.4 8.6 10.2 21.2 12.1 2.8 14.8 11.2 14.5 17.2 10.9 7.4 28.9 8.3 18.5 74.8 8.1 18.8 17.0 17.7 10.8 12.8 14.5 14.0 12.2 17.3 10.7 8.9 14.4 21.9 16.1 17.7 11.5 10.5 12.4 11.8 9.0 19.7 31.5 7.6 6.6 11.7 11.8 11.4 16.3 15.1 14.5 7.7 13.5 17.8 8.2 15.0 10.9 10.3 22.0 13.1 2.1 12.2 6.6 7.3 6.9 10.6 8.2 14.0 7.2 23.0 30.6 14.5 23.3 30.3 14.7 16.5 14.9 20.2 32.2 22.8 21.7 18.0 11.7 12.1 18.5 26.9 15.6 10.9 11.3 12.3 12.1 19.9 25.3 21.8 16.0 20.4 18.1 30.2 23.8 32.7 6.8 10.9 16.7 15.4 4.6 8.9 7.0 22.7 14.2 20.3 10.0 14.2 38.6 24.4 12.2 12.6 11.9 14.7 13.8 14.0 22.1 6.6 8.5 30.0 25.9 18.8 14.6 16.9 11.7 24.1 18.0 35.9 16.9 22.3 2.1 12.2 0.9 5.8 10.8 7.3 22.0 6.3 6.3 13.1 20.2 6.1 6.3 1.2 6.6 7.7 7.7 5.9 6.9 10.2 12.1 11.2 14.5 10.8 12.8 10.7 8.9 10.5 7.7 41.7 19.5 54.5 15.2 15.2 33.5 38.3 38.2 156.6 45.5 54.1 17.7 9.8 5.0 42.2 164.5 36.8 7.7 23.3 54.2 34.9 31.0 39.6 29.0 22.1 32.9 22.3 31.2 39.3 29.9 40.9 33.6 30.3 18.6 10.0 110.7 20.3 38.0 14.8 41.8 19.0 26.1 45.3 35.3 87.4 41.1 12.9 9.0 20.8 19.8 17.3 DNAJC14 "DNAJ, DRIP78, FLJ32792, HDJ3, LIP6" ENSG00000135392 "DnaJ heat shock protein family (Hsp40) member C14" Q6Y2X3 12 55820960-55830824 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA017653 Approved NA NA "HPA017653: AB_1847799" "unprognostic (2.54e-2)" "unprognostic (1.77e-2)" "unprognostic (1.47e-1)" "unprognostic (1.90e-1)" "unprognostic (6.04e-2)" "unprognostic (3.14e-2)" "unprognostic (6.91e-3)" "unprognostic (6.92e-2)" "unprognostic (3.45e-2)" "unprognostic (1.80e-1)" "unprognostic (3.63e-1)" "unprognostic (4.34e-2)" "unprognostic (3.89e-3)" "unprognostic (4.73e-2)" "unprognostic (7.98e-2)" "unprognostic (9.17e-2)" "unprognostic (8.92e-2)" 18.0 20.6 17.0 15.8 17.8 16.5 17.6 19.5 24.7 19.4 16.8 20.0 15.7 15.2 23.5 18.7 18.4 21.0 18.3 19.1 17.6 14.5 21.7 26.2 17.8 19.0 17.7 13.8 17.9 29.7 31.4 22.0 26.6 15.1 17.7 16.9 18.6 18.2 20.2 14.9 17.7 20.9 18.4 17.7 23.3 17.1 32.5 19.3 37.8 24.9 14.3 20.8 18.7 14.4 16.0 16.5 22.6 14.1 14.8 19.7 12.8 14.3 17.9 20.2 19.0 19.5 18.6 21.6 16.8 22.3 21.0 15.2 14.8 26.2 17.9 32.1 17.7 14.8 18.1 15.7 19.3 18.4 32.2 12.3 26.9 19.9 14.1 18.5 14.9 23.6 15.5 15.7 21.0 18.8 33.4 22.3 25.5 20.6 23.2 23.5 21.8 27.7 14.8 14.6 15.5 15.1 21.8 17.6 16.3 17.9 15.5 26.5 24.4 14.5 19.9 12.6 19.2 39.6 22.5 21.7 20.1 19.8 18.9 13.7 26.7 25.2 18.2 20.8 14.6 25.9 22.6 12.3 18.7 19.7 10.9 15.2 16.0 13.8 16.4 11.3 12.3 12.8 15.0 13.3 14.8 14.1 16.5 11.6 12.8 17.0 17.8 19.5 24.7 17.6 14.5 17.7 13.8 15.1 19.3 6.0 7.7 2.2 3.2 3.5 7.1 0.8 5.1 2.7 7.9 10.4 9.8 8.4 3.3 8.4 3.6 6.6 6.4 0.0 6.8 11.2 6.0 4.2 1.1 6.4 8.7 1.6 6.9 4.3 8.6 3.6 8.9 7.6 6.8 7.2 6.0 7.0 7.0 8.5 8.5 6.5 4.3 6.5 3.8 5.6 8.8 3.6 10.9 5.7 6.6 2.7 DNAJC15 "DNAJD1, MCJ" ENSG00000120675 "DnaJ heat shock protein family (Hsp40) member C15" Q9Y5T4 13 43023203-43114224 "Disease related genes, Predicted membrane proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.12e-1)" "unprognostic (2.89e-2)" "unprognostic (1.09e-2)" "unprognostic (2.97e-2)" "unprognostic (1.53e-2)" "unprognostic (3.07e-3)" "unprognostic (3.91e-2)" "unprognostic (1.49e-1)" "unprognostic (1.25e-1)" "unprognostic (3.23e-1)" "unprognostic (2.38e-2)" "unprognostic (3.40e-1)" "unprognostic (2.50e-1)" "unprognostic (2.51e-2)" "unprognostic (2.90e-1)" "unprognostic (5.92e-3)" "unprognostic (3.17e-1)" 11.9 18.4 19.1 15.1 17.2 7.7 12.0 5.8 17.1 14.8 22.2 12.6 21.8 19.3 8.0 9.3 11.1 8.3 9.6 22.4 18.9 17.4 30.9 21.5 12.1 13.5 24.0 7.3 5.0 12.8 10.8 9.4 13.2 16.0 8.2 14.8 10.0 15.0 28.7 16.2 8.4 42.2 13.9 36.4 13.6 11.7 16.7 9.4 13.4 15.5 13.9 13.3 11.9 7.4 8.2 11.3 6.0 6.6 5.0 6.7 3.9 0.0 0.0 1.9 1.6 6.9 10.4 1.5 7.6 7.4 9.2 4.9 9.0 8.0 5.7 0.0 9.5 4.6 5.6 0.8 6.5 9.8 12.6 0.0 5.5 4.0 6.5 8.0 0.0 3.9 10.6 12.8 4.6 4.4 4.8 7.3 3.4 0.0 1.0 7.5 3.1 0.1 1.4 0.0 6.6 0.0 2.1 1.9 8.5 14.3 2.9 2.4 2.8 0.0 4.1 5.5 3.4 3.0 7.7 7.6 3.7 1.7 6.2 1.9 0.3 1.0 0.0 8.0 0.0 3.6 6.0 6.2 3.0 4.2 6.6 3.8 8.2 5.1 4.8 11.3 6.8 4.2 4.7 0.4 5.0 5.2 7.2 6.7 3.9 19.1 17.2 5.8 12.6 18.9 17.4 24.0 7.3 16.0 9.4 77.4 40.6 107.9 20.8 37.5 21.4 149.3 101.9 71.0 40.9 125.6 23.6 66.1 97.8 219.1 351.7 63.7 176.2 0.0 287.5 257.2 63.4 14.3 37.1 203.8 126.0 28.6 128.3 66.9 112.5 81.3 14.1 110.9 84.4 180.3 107.4 40.7 252.0 147.9 11.3 275.4 21.0 25.8 60.8 195.3 97.0 39.9 77.5 57.3 129.9 26.5 DNAJC16 KIAA0962 ENSG00000116138 "DnaJ heat shock protein family (Hsp40) member C16" Q9Y2G8 1 15526813-15592379 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043643 Approved Approved Vesicles NA NA Vesicles "HPA043643: AB_10796794" "unprognostic (1.77e-1)" "unprognostic (4.95e-2)" "prognostic favorable (6.77e-4)" "unprognostic (4.52e-2)" "unprognostic (5.51e-2)" "unprognostic (2.05e-2)" "unprognostic (1.91e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (4.28e-2)" "unprognostic (2.35e-2)" "unprognostic (3.74e-2)" "prognostic favorable (7.24e-4)" "unprognostic (3.67e-2)" "unprognostic (3.74e-1)" "unprognostic (5.38e-2)" "unprognostic (4.70e-2)" 9.6 11.5 9.8 9.5 18.7 3.9 12.3 13.2 24.3 10.2 10.9 18.4 14.2 12.0 12.9 14.7 11.5 13.0 11.2 9.1 11.0 10.8 22.1 20.0 8.9 10.5 11.1 10.8 13.1 13.4 20.1 20.3 13.9 17.2 10.8 11.2 12.0 12.1 10.8 19.2 10.2 11.2 11.9 10.7 11.3 9.9 11.1 11.0 11.4 13.9 8.9 12.5 10.3 9.4 6.9 4.1 3.8 4.1 3.2 8.0 3.6 7.5 7.2 6.0 10.9 16.4 13.3 5.6 9.0 9.2 9.1 9.8 6.2 11.1 6.5 6.1 9.0 11.9 9.4 7.3 8.0 12.9 7.7 3.4 6.7 8.3 10.7 16.3 10.3 7.8 9.6 9.5 14.7 8.2 11.4 10.1 5.5 14.1 6.0 10.4 3.0 5.2 5.3 5.7 6.8 5.1 6.2 7.7 7.3 11.2 5.2 6.7 6.3 9.3 8.9 7.6 9.0 5.6 4.2 13.7 16.1 5.8 14.8 4.9 8.2 11.5 5.9 10.0 6.0 7.6 3.8 4.1 3.0 5.6 4.0 8.0 6.8 5.8 5.0 4.1 6.9 7.4 6.3 2.3 3.2 2.9 3.7 5.3 3.6 9.8 18.7 13.2 24.3 11.0 10.8 11.1 10.8 17.2 11.0 0.0 8.3 11.2 4.1 4.5 13.4 12.0 20.4 21.4 11.4 24.4 21.6 10.5 1.7 8.1 7.1 8.7 8.6 0.0 6.0 6.3 8.6 10.7 8.1 15.3 9.4 17.5 11.1 16.5 19.9 5.4 11.5 5.8 6.8 5.4 11.3 12.4 8.2 7.0 10.6 13.8 15.0 6.5 4.6 22.7 14.5 5.1 18.4 4.3 11.5 5.2 DNAJC18 MGC29463 ENSG00000170464 "DnaJ heat shock protein family (Hsp40) member C18" Q9H819 5 139408588-139444491 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 51.4" "Group enriched" "Detected in many" 20 "Early spermatids: 425.4;Late spermatids: 1065.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036538, HPA060154" Approved Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions" Cytosol "HPA036538: AB_10670802, HPA060154: AB_2684212" "unprognostic (2.03e-1)" "unprognostic (1.16e-1)" "unprognostic (1.13e-1)" "unprognostic (1.19e-3)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (2.73e-3)" "unprognostic (8.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "prognostic favorable (5.89e-4)" "unprognostic (8.09e-2)" "unprognostic (1.69e-2)" "unprognostic (3.55e-2)" "unprognostic (1.81e-1)" "unprognostic (6.96e-2)" "unprognostic (1.97e-2)" 4.1 4.0 8.2 2.9 15.7 1.9 4.3 10.7 19.5 4.7 3.3 12.4 0.7 1.8 7.6 4.9 3.9 4.9 4.2 6.3 8.7 8.7 4.5 1.2 4.5 3.3 8.8 11.7 10.7 2.3 6.5 7.1 4.1 16.2 4.9 3.0 3.4 2.1 5.9 8.4 2.2 2.4 6.8 9.0 2.9 2.4 51.4 7.5 1.2 5.1 1.7 2.6 3.4 3.3 3.5 2.0 2.1 2.0 6.0 6.7 1.4 1.6 1.8 11.3 10.4 6.3 6.7 1.2 3.4 7.5 6.0 11.0 4.0 1.3 7.5 9.3 5.3 13.3 2.9 6.3 10.2 6.3 17.0 8.4 5.1 3.8 1.9 5.0 0.6 2.5 9.0 1.3 10.0 6.1 10.2 8.2 2.9 2.2 7.3 8.9 0.9 2.2 2.4 7.8 0.6 2.5 6.2 12.3 1.2 3.6 1.8 10.5 11.0 3.5 1.4 7.7 15.2 1.6 3.8 10.5 8.0 0.0 2.4 7.2 8.7 11.4 4.0 4.3 3.8 3.4 1.9 2.0 2.1 2.2 1.3 3.2 3.5 3.2 4.1 1.5 3.5 3.2 2.0 0.6 6.0 0.7 2.0 6.7 1.4 8.2 15.7 10.7 19.5 8.7 8.7 8.8 11.7 16.2 7.5 3.0 4.6 2.2 8.0 1.3 29.0 8.8 0.0 2.7 7.9 1.8 9.8 3.8 1.7 4.8 425.4 11.3 0.5 0.0 0.9 3.3 5.4 2.7 9.2 0.0 2.4 15.9 12.1 12.9 3.1 1065.4 13.0 2.6 5.0 4.6 2.5 14.5 2.5 1.4 17.7 2.9 18.4 19.4 8.5 37.2 4.9 1.0 3.9 3.2 1.2 2.6 DNAJC19 "Pam18, Tim14, TIMM14" ENSG00000205981 "DnaJ heat shock protein family (Hsp40) member C19" Q96DA6 3 180983709-180989774 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone Cardiomyopathy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 399.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037782 Approved NA NA "HPA037782: AB_10672611" "unprognostic (4.52e-2)" "unprognostic (3.55e-3)" "unprognostic (3.08e-2)" "unprognostic (2.45e-3)" "unprognostic (1.41e-1)" "unprognostic (5.54e-2)" "unprognostic (1.39e-1)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "prognostic favorable (8.53e-5)" "unprognostic (6.19e-2)" "unprognostic (1.76e-2)" "unprognostic (2.14e-2)" "unprognostic (1.75e-1)" "unprognostic (4.66e-1)" "unprognostic (3.33e-1)" "unprognostic (4.20e-3)" 14.6 32.0 24.5 11.0 23.1 8.5 23.8 12.0 25.8 17.1 17.0 14.0 15.6 18.9 13.9 30.9 15.8 17.2 15.7 53.2 21.4 23.3 44.1 38.1 11.8 13.4 22.3 17.9 24.6 22.0 22.2 24.7 12.8 19.9 19.4 16.4 15.1 23.3 17.7 45.5 11.5 16.9 19.2 17.9 14.0 17.2 9.8 14.5 13.3 22.9 30.9 13.5 18.4 12.6 20.6 19.6 16.8 14.1 13.6 24.9 16.4 21.0 5.5 15.9 12.1 19.1 11.6 14.3 12.1 7.4 12.1 10.6 19.6 10.6 8.9 25.6 10.3 29.4 10.7 15.3 14.7 15.1 14.2 19.6 10.6 9.5 19.2 20.5 25.4 11.3 10.8 12.3 10.0 18.0 15.9 13.9 22.0 16.3 14.6 9.4 17.4 18.8 21.2 21.0 30.0 17.8 11.9 10.9 26.8 17.7 9.9 15.9 8.4 12.5 30.9 30.5 19.1 34.3 17.5 6.6 7.6 11.3 10.5 21.4 19.3 23.0 30.9 7.7 19.6 9.1 13.2 11.5 16.8 20.0 11.4 23.6 20.6 23.3 20.7 15.8 17.2 24.9 24.8 2.4 13.6 14.1 19.6 18.6 16.4 24.5 23.1 12.0 25.8 21.4 23.3 22.3 17.9 19.9 14.5 35.7 48.6 66.8 59.9 50.4 31.2 138.0 79.0 53.5 51.2 73.3 13.7 99.1 399.6 71.6 5.8 54.0 53.5 0.0 94.7 95.3 70.0 81.0 105.4 133.3 59.2 46.1 43.5 49.7 30.2 7.9 78.9 50.7 70.9 62.3 81.2 47.0 73.4 66.6 68.2 169.2 52.1 84.1 69.7 70.5 59.6 52.6 57.4 61.8 84.7 48.6 DNAJC22 "FLJ13236, wus" ENSG00000178401 "DnaJ heat shock protein family (Hsp40) member C22" Q8N4W6 12 49346917-49357546 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 10.0;intestine: 10.0;liver: 18.9" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 40.8;Enterocytes: 38.0;Exocrine glandular cells: 37.8;Hepatocytes: 39.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 15.7;EFO-21: 16.9;MCF7: 13.8;OE19: 28.8;T-47d: 12.5" "Region enhanced" "Detected in single" "midbrain: 1.4" "Not detected" "Not detected" HPA039953 Approved Vesicles NA NA Vesicles "HPA039953: AB_2676770" "unprognostic (5.23e-2)" "unprognostic (1.24e-1)" "unprognostic (9.01e-2)" "prognostic favorable (4.56e-5)" "unprognostic (4.77e-3)" "unprognostic (2.74e-1)" "unprognostic (1.28e-1)" "unprognostic (4.05e-2)" "prognostic unfavorable (7.54e-4)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-2)" "unprognostic (9.35e-2)" "unprognostic (1.58e-1)" "unprognostic (3.83e-2)" 1.1 0.3 0.5 0.4 1.0 0.0 0.4 0.4 2.2 1.5 5.4 0.8 0.4 10.0 2.2 1.3 0.4 0.8 10.0 0.4 0.7 0.5 5.2 18.9 0.4 0.4 1.0 1.2 0.4 5.2 2.7 0.4 0.9 4.6 0.4 5.2 0.8 1.2 0.4 0.4 0.2 8.3 0.4 0.8 0.4 4.4 0.6 0.4 0.4 6.6 0.4 0.4 0.4 0.7 0.7 0.8 2.7 0.5 0.5 0.5 0.4 1.4 9.4 0.0 10.0 0.0 0.0 3.3 0.3 3.0 1.0 2.2 15.7 9.9 0.0 16.9 0.3 0.9 0.1 1.4 0.0 1.7 0.1 2.3 0.3 0.2 7.8 2.4 0.0 1.7 0.1 0.0 1.5 0.3 4.0 1.4 0.0 0.1 0.3 0.7 13.8 0.0 0.0 0.0 28.8 4.8 0.0 4.8 0.0 0.2 0.0 1.6 0.8 0.3 0.5 3.1 0.2 12.5 0.2 0.2 1.0 3.1 0.1 1.3 0.0 0.0 0.0 2.3 0.0 2.0 2.3 0.5 0.5 0.5 0.3 0.3 0.4 0.4 0.3 0.1 0.7 0.3 0.3 2.7 0.5 0.4 0.8 0.2 0.4 0.5 1.0 0.4 2.2 0.7 0.5 1.0 1.2 4.6 0.4 0.0 0.6 0.0 1.8 0.6 0.1 0.3 40.8 8.1 1.2 1.8 0.0 0.1 0.0 13.9 3.9 0.3 38.0 0.0 37.8 0.2 1.3 0.5 1.1 39.4 0.1 3.2 20.2 1.3 0.3 1.3 0.0 0.0 3.3 1.0 24.6 0.6 20.2 23.0 0.7 18.0 0.3 0.0 0.3 0.0 0.4 0.3 0.3 0.0 23.4 0.1 DNAJC25 bA16L21.2.1 ENSG00000059769 "DnaJ heat shock protein family (Hsp40) member C25" Q9H1X3 9 111631352-111654351 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 41.9" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019122 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019122: AB_1853155" "unprognostic (3.07e-1)" "unprognostic (7.42e-2)" "unprognostic (8.94e-3)" "prognostic favorable (3.73e-4)" "unprognostic (2.08e-2)" "unprognostic (5.66e-2)" "unprognostic (1.60e-2)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (9.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.09e-2)" "unprognostic (2.52e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-1)" "unprognostic (8.30e-2)" "unprognostic (5.19e-2)" 5.1 10.2 3.3 3.9 4.6 1.9 5.8 4.5 4.2 3.4 5.1 2.5 5.7 4.6 4.1 7.7 3.4 3.8 3.6 6.7 4.3 3.8 7.8 41.9 3.5 4.1 2.7 2.3 5.7 7.0 7.4 9.0 4.4 3.3 5.9 3.0 3.6 9.7 4.0 3.6 2.4 6.9 5.0 2.9 2.9 3.7 4.2 1.9 1.4 4.3 2.4 2.2 6.4 4.5 0.6 1.1 1.2 1.9 0.4 0.8 0.3 2.6 2.0 1.4 2.4 14.7 6.6 5.4 10.2 4.9 4.0 4.0 3.9 1.7 2.3 4.0 7.0 6.3 8.6 1.5 2.9 3.9 1.9 2.0 2.3 0.0 7.9 4.8 4.3 3.4 5.7 8.3 3.1 5.9 3.2 3.3 1.3 4.6 2.0 5.1 2.9 1.3 0.2 2.5 5.1 4.8 2.2 7.5 2.1 8.4 2.9 2.4 1.3 5.7 8.0 3.6 2.6 4.2 1.1 6.4 4.9 2.2 13.1 5.8 3.7 5.6 1.3 8.4 2.1 4.3 0.0 0.1 1.2 0.6 1.9 0.2 0.3 0.5 0.0 0.5 0.6 0.5 0.2 0.8 0.4 1.0 1.1 0.8 0.3 3.3 4.6 4.5 4.2 4.3 3.8 2.7 2.3 3.3 1.9 6.0 11.0 14.5 13.2 9.4 7.7 9.0 7.6 13.4 12.5 10.4 19.6 11.8 11.6 13.6 7.8 4.9 17.6 0.0 14.1 18.7 13.1 26.6 1.1 75.4 10.9 12.7 16.6 6.7 5.0 1.4 9.5 7.9 11.8 4.6 14.9 3.9 11.0 7.4 9.6 10.7 20.2 12.9 11.3 29.8 11.9 8.2 11.6 7.9 10.9 17.1 DNAJC30 WBSCR18 ENSG00000176410 "DnaJ heat shock protein family (Hsp40) member C30" Q96LL9 7 73680969-73683453 "Predicted membrane proteins" "ATP synthesis" Chaperone "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 179.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017318 Supported NA NA "HPA017318: AB_1858788" "unprognostic (1.86e-2)" "unprognostic (1.85e-1)" "unprognostic (2.16e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (5.37e-2)" "unprognostic (1.50e-1)" "unprognostic (2.66e-2)" "unprognostic (4.53e-1)" "unprognostic (3.93e-2)" "unprognostic (2.85e-3)" "unprognostic (4.60e-2)" "prognostic favorable (4.91e-8)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (2.51e-1)" "unprognostic (1.20e-2)" 13.3 20.6 14.7 8.3 15.8 6.4 8.9 8.5 23.4 10.2 8.9 11.1 11.7 9.2 10.2 15.3 7.4 12.0 14.8 18.6 13.4 14.2 14.7 22.1 8.2 9.5 11.8 14.1 14.9 12.2 11.1 14.5 10.3 15.0 12.6 8.2 10.6 14.3 12.3 12.9 7.2 9.2 7.5 7.9 10.0 10.3 24.4 7.3 12.7 16.5 9.7 8.1 9.4 6.0 12.5 7.5 4.6 7.3 6.7 11.9 5.7 6.2 6.2 4.5 9.1 7.2 5.1 4.8 9.8 7.3 7.6 7.5 5.9 6.5 5.5 2.5 7.7 11.2 8.8 4.1 5.5 4.3 6.4 8.3 3.2 5.7 6.2 7.5 5.4 4.5 5.7 4.5 7.0 6.0 5.4 6.6 7.1 6.4 5.0 7.5 12.5 8.6 10.8 3.9 5.7 10.6 5.9 3.5 13.3 9.8 7.3 12.4 6.6 10.0 17.6 7.1 4.8 16.0 3.5 6.4 8.1 5.8 8.4 6.9 5.3 3.6 5.2 6.5 3.7 9.9 4.6 7.3 4.6 8.1 6.7 10.0 9.0 9.8 9.7 7.3 12.5 11.9 9.9 1.0 6.7 5.1 7.5 6.7 5.7 14.7 15.8 8.5 23.4 13.4 14.2 11.8 14.1 15.0 7.3 17.9 3.8 14.7 14.1 5.3 34.8 15.1 15.3 6.7 13.6 17.4 13.7 34.8 48.0 26.0 87.9 5.7 9.5 0.0 24.5 14.7 11.1 12.4 12.7 22.1 19.6 19.1 16.7 12.9 9.4 179.1 22.7 9.2 13.5 36.1 11.8 22.1 17.9 7.0 17.3 60.7 28.3 19.4 8.0 32.1 14.1 7.2 30.1 11.8 15.7 10.5 DNAJC4 "HSPF2, MCG18" ENSG00000110011 "DnaJ heat shock protein family (Hsp40) member C4" Q9NNZ3 11 64230278-64234286 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 2560.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011947 Uncertain NA NA "HPA011947: AB_1847803" "unprognostic (8.99e-3)" "unprognostic (2.28e-2)" "prognostic unfavorable (3.12e-4)" "unprognostic (2.95e-2)" "unprognostic (1.15e-1)" "unprognostic (5.20e-2)" "unprognostic (8.99e-2)" "unprognostic (1.56e-2)" "unprognostic (7.69e-2)" "unprognostic (5.44e-3)" "unprognostic (1.73e-3)" "unprognostic (1.07e-1)" "prognostic favorable (6.21e-4)" "unprognostic (2.47e-1)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (2.69e-1)" 16.7 26.5 16.5 15.6 17.3 22.5 15.8 14.5 26.6 22.9 24.7 15.3 24.4 23.3 22.1 25.6 28.6 15.2 26.5 26.5 15.0 13.3 25.2 26.4 16.5 22.5 16.4 9.6 29.3 55.1 22.5 19.5 14.7 19.0 28.7 14.1 19.7 50.0 22.8 31.0 19.1 28.2 13.7 15.0 28.1 18.9 72.5 8.6 26.4 33.2 18.0 28.7 22.9 20.3 18.8 46.6 14.8 20.6 14.5 12.2 12.0 4.5 4.4 10.4 15.3 12.7 22.3 7.3 6.7 11.5 4.2 5.8 4.3 6.7 5.5 22.5 12.0 2.5 3.6 5.1 6.1 2.4 11.6 6.0 6.9 4.5 11.7 15.4 5.0 16.4 23.1 16.5 6.6 7.8 20.1 9.9 6.2 4.6 29.3 2.7 11.2 2.0 12.2 2.9 10.8 8.5 14.3 2.7 36.9 17.4 3.1 9.0 14.7 6.8 7.7 25.2 10.4 18.7 9.2 9.1 4.9 4.9 7.4 3.8 29.0 11.6 6.7 4.3 6.4 14.0 14.8 20.6 14.6 8.3 18.2 10.5 17.5 8.4 9.7 28.7 18.8 12.2 9.4 11.4 14.5 14.4 46.6 7.8 12.0 16.5 17.3 14.5 26.6 15.0 13.3 16.4 9.6 19.0 8.6 11.9 32.8 67.7 44.8 38.8 19.6 20.4 22.9 14.7 23.9 26.2 7.9 65.2 135.9 28.7 574.0 28.9 54.9 0.0 33.4 50.6 35.0 55.4 46.1 29.9 46.7 23.8 78.1 30.7 62.3 2560.6 58.1 54.9 45.5 123.6 63.7 20.3 28.0 59.6 43.9 75.2 13.6 19.4 29.9 26.0 24.9 44.7 45.5 42.7 59.3 49.1 DNAJC5 "CLN4, DNAJC5A, FLJ00118, FLJ13070" ENSG00000101152 "DnaJ heat shock protein family (Hsp40) member C5" Q9H3Z4 20 63895182-63936031 "Disease related genes, Predicted membrane proteins" Chaperone "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012139, HPA012737, HPA013154" Approved Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Vesicles "HPA012139: , HPA012737: AB_1847293, HPA013154: AB_1847292" "unprognostic (9.96e-3)" "unprognostic (2.75e-1)" "unprognostic (3.91e-1)" "unprognostic (3.61e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (8.82e-6)" "unprognostic (3.04e-2)" "unprognostic (2.73e-1)" "unprognostic (2.65e-2)" "unprognostic (1.78e-3)" "unprognostic (1.51e-1)" "prognostic favorable (7.70e-6)" "unprognostic (2.24e-2)" "unprognostic (3.54e-2)" "unprognostic (4.28e-3)" "unprognostic (1.08e-2)" 13.0 14.2 30.5 12.1 36.6 16.4 8.5 38.0 48.6 7.3 12.3 11.2 9.6 14.2 7.2 7.8 29.9 10.8 8.7 22.6 28.1 31.6 9.3 9.6 12.3 14.5 23.8 26.7 5.9 23.7 20.7 15.1 10.7 23.4 11.2 8.9 12.8 14.9 14.3 10.2 16.5 14.7 9.9 12.8 11.7 11.4 8.2 9.2 8.1 14.7 8.4 10.1 11.8 8.2 3.2 9.0 7.5 7.6 2.6 6.7 4.5 11.9 11.3 9.6 9.2 9.7 7.6 7.0 13.3 12.7 23.4 11.3 26.3 14.3 4.8 14.7 13.0 11.3 16.9 7.7 25.1 8.8 3.6 6.1 9.1 8.5 14.6 9.0 8.9 20.7 8.8 19.2 10.8 5.8 9.5 11.7 8.0 8.9 4.2 10.7 8.6 9.5 15.1 3.5 10.4 13.6 9.5 5.4 4.9 8.6 11.6 10.5 6.7 14.4 24.3 8.2 6.3 11.4 36.1 20.5 20.9 6.8 9.8 10.1 4.9 2.4 6.5 20.9 12.0 12.4 2.2 7.5 4.8 6.7 7.6 4.4 3.2 4.4 6.1 5.2 2.9 5.2 5.6 7.5 2.6 5.7 9.0 5.9 4.5 30.5 36.6 38.0 43.5 28.1 31.6 23.8 26.7 23.4 9.2 6.0 16.2 5.3 10.4 18.4 55.1 25.2 15.3 6.7 14.8 22.7 58.9 15.2 11.6 18.8 39.2 18.0 53.6 23.3 32.2 14.9 9.5 25.8 1.1 24.1 37.2 74.7 31.2 26.4 43.4 86.4 6.6 20.5 13.5 20.8 27.7 20.9 42.5 35.1 11.7 19.2 43.4 12.9 10.8 12.0 13.8 19.9 25.3 10.2 23.4 59.6 DNAJC5G "CSP-gamma, FLJ40417" ENSG00000163793 "DnaJ heat shock protein family (Hsp40) member C5 gamma" Q8N7S2 2 27275421-27281499 "Predicted membrane proteins" Chaperone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "epididymis: 35.8;testis: 58.0" "Group enriched" "Detected in some" 6 "Early spermatids: 52.3;Late spermatids: 63.1;Spermatocytes: 116.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 2.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 2.8;HAP1: 3.6;JURKAT: 3.7;SH-SY5Y: 1.9" "Not detected" "Not detected" HPA041445 Approved NA NA "HPA041445: AB_2677485" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" "unprognostic (2.61e-2)" "unprognostic (2.26e-1)" "unprognostic (3.99e-1)" "unprognostic (2.77e-1)" "unprognostic (1.56e-2)" "unprognostic (1.48e-2)" "unprognostic (1.13e-1)" "unprognostic (4.06e-1)" "unprognostic (1.75e-4)" "unprognostic (2.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" "unprognostic (7.67e-2)" "unprognostic (1.97e-2)" 0.1 0.7 0.5 0.1 0.1 0.0 0.1 0.1 2.1 0.4 0.1 0.1 0.1 0.0 0.3 35.8 0.1 0.2 0.1 1.3 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 58.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.5 0.9 2.4 0.9 0.4 0.7 0.8 2.8 1.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 1.0 0.3 0.0 1.4 0.1 0.9 1.6 0.0 0.0 0.0 0.6 0.5 0.5 3.7 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 1.5 1.5 0.4 0.0 0.4 0.2 1.9 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 1.6 0.9 0.6 0.3 0.5 0.2 0.2 0.3 0.3 0.1 0.5 0.7 0.3 2.4 0.4 0.6 0.9 0.2 0.8 0.5 0.1 0.1 2.1 0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 116.2 14.0 0.0 0.0 0.0 0.0 0.0 DNASE1 DNL1 ENSG00000213918 "Deoxyribonuclease 1" P24855 16 3611728-3680143 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Actin-binding, Endonuclease, Hydrolase, Nuclease" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 26.7" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA010703 Enhanced Supported Vesicles "Secreted in other tissues" NA NA 160000 Vesicles "HPA010703: AB_10600806" "unprognostic (5.18e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-1)" "unprognostic (1.74e-1)" "unprognostic (2.38e-1)" "unprognostic (1.90e-2)" "unprognostic (3.73e-2)" "unprognostic (3.82e-1)" "unprognostic (3.20e-1)" "unprognostic (9.91e-2)" "unprognostic (1.69e-3)" "unprognostic (5.37e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.74e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.14e-4)" 1.5 1.4 1.5 2.6 1.6 1.7 1.5 3.8 2.5 2.2 12.2 1.8 1.5 14.9 1.5 2.2 3.4 1.2 2.5 1.5 1.5 1.2 11.4 1.5 1.5 4.4 1.5 1.5 2.0 13.7 1.6 12.2 1.9 3.1 5.1 2.1 1.5 3.3 1.5 1.5 3.9 26.7 1.5 1.5 2.3 6.0 2.7 1.5 1.5 1.6 2.6 3.8 1.9 2.3 4.5 2.2 9.2 2.0 1.9 3.4 1.0 2.5 5.8 10.2 5.3 3.0 2.6 4.8 4.0 0.7 3.3 4.8 6.9 6.1 10.7 3.3 0.6 7.0 4.2 3.6 1.1 3.5 4.6 5.6 3.7 8.6 4.5 1.5 2.6 8.7 2.1 4.3 4.4 1.1 5.2 2.2 9.0 9.3 4.7 2.8 10.4 5.3 11.5 6.2 7.4 3.1 12.6 4.6 5.2 2.8 2.2 7.2 6.7 3.0 9.2 1.7 5.3 9.1 6.6 3.0 6.1 4.5 3.8 2.3 4.3 6.1 18.5 1.7 4.9 5.8 4.3 2.0 5.3 3.0 1.3 1.9 2.5 2.3 2.4 1.0 4.5 2.7 3.4 9.2 1.9 1.2 2.2 2.4 1.0 1.5 1.6 3.8 2.5 1.5 1.2 1.5 1.5 3.1 1.5 8.9 10.1 2.4 8.5 2.4 27.4 4.8 5.1 9.4 11.4 15.7 21.6 6.6 48.0 4.5 16.1 4.5 12.7 0.0 9.7 3.3 5.1 9.8 2.3 1.5 3.2 23.8 13.7 4.9 2.7 34.9 7.8 3.8 1.7 11.8 11.3 12.8 4.3 11.2 7.4 1.4 18.3 0.0 4.2 15.1 17.5 3.3 5.1 10.5 15.3 5.3 DNASE2B DLAD ENSG00000137976 "Deoxyribonuclease 2 beta" Q8WZ79 1 84398532-84415018 "Enzymes, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "salivary gland: 98.7" "Cell type enhanced" "Detected in some" 17 "Ciliated cells: 1.4;Early spermatids: 1.6;Glandular cells: 2.3;Hofbauer cells: 5.7;Late spermatids: 2.4;Paneth cells: 1.7" "Cancer enhanced" "Detected in some" "prostate cancer: 9.3" "Region enhanced" "Detected in single" "basal ganglia: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;HL-60: 1.0;HUVEC TERT2: 2.1;SK-MEL-30: 2.6;U-266/70: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (2.24e-1)" "unprognostic (3.57e-2)" "unprognostic (2.77e-1)" "unprognostic (1.22e-1)" "unprognostic (4.70e-2)" "unprognostic (3.70e-1)" "unprognostic (2.86e-1)" "unprognostic (1.62e-2)" "unprognostic (9.87e-2)" "unprognostic (7.90e-2)" "unprognostic (2.72e-1)" "unprognostic (1.15e-1)" "unprognostic (3.82e-5)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" "unprognostic (6.79e-2)" "unprognostic (3.08e-3)" 16.2 0.1 0.2 0.1 2.2 0.1 0.3 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.6 0.1 0.2 13.0 1.2 0.3 0.0 0.3 0.4 0.0 0.4 0.1 0.2 2.9 0.3 0.0 98.7 0.1 1.8 0.0 0.1 0.1 1.7 0.5 0.6 0.3 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 2.1 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.6 0.2 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.3 0.3 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 5.7 0.0 1.2 0.0 0.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 DNER "bet, UNQ26" ENSG00000187957 "Delta/notch like EGF repeat containing" Q8NFT8 2 229357629-229714558 "Cancer-related genes, Predicted membrane proteins" "Notch signaling pathway" "Activator, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 45.6;brain: 85.2;salivary gland: 46.1" "Cell type enhanced" "Detected in many" 18 "Bipolar cells: 121.0;Intestinal endocrine cells: 27.5;Muller glia cells: 53.3;Rod photoreceptor cells: 35.9" "Cancer enriched" "Detected in many" 32 "glioma: 73.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "Group enriched" "Detected in some" 7 "GAMG: 71.3;hTERT-HME1: 29.1;hTERT-RPE1: 79.5;U-138 MG: 49.2;U-87 MG: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017320 Enhanced NA NA 2700000 "HPA017320: AB_1847808" "unprognostic (4.39e-2)" "unprognostic (1.83e-1)" "unprognostic (3.25e-1)" "unprognostic (1.00e-3)" "unprognostic (8.73e-2)" "unprognostic (6.23e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.23e-3)" "unprognostic (2.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.60e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (3.42e-4)" "unprognostic (2.59e-2)" "unprognostic (7.32e-2)" "unprognostic (5.63e-2)" "unprognostic (5.13e-3)" 1.7 45.6 25.4 2.2 26.8 1.3 3.1 19.5 85.2 2.2 2.3 38.4 0.0 1.6 2.1 5.7 1.5 4.1 1.5 6.8 23.9 36.8 9.7 1.3 2.0 1.5 39.8 15.2 1.6 1.9 1.7 9.6 1.5 30.0 2.8 2.2 2.5 46.1 1.6 1.3 2.5 1.9 2.2 26.4 1.3 8.3 2.0 30.4 0.0 1.4 0.0 2.1 1.4 0.2 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.1 0.1 0.0 0.0 0.2 1.6 0.5 0.0 0.2 0.0 0.0 0.0 71.3 0.0 0.0 0.2 0.8 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.5 1.7 1.2 29.1 79.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 2.6 0.0 0.3 0.0 2.8 0.0 5.8 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 49.2 0.0 1.6 7.3 0.0 0.0 0.0 29.1 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 25.4 26.8 19.5 26.6 23.9 36.8 39.8 15.2 30.0 30.4 0.0 0.0 0.0 5.8 0.3 121.0 10.3 0.0 14.7 0.0 3.5 13.7 0.0 1.7 0.2 6.8 0.0 0.0 0.0 1.2 0.1 0.8 3.8 0.0 0.0 0.1 11.1 27.5 0.0 0.0 1.3 5.5 1.0 18.6 0.0 0.0 53.3 0.5 0.0 5.6 0.8 35.9 0.0 0.5 0.7 1.1 0.0 0.1 0.0 0.0 0.4 DOLK "DK1, KIAA1094, TMEM15" ENSG00000175283 "Dolichol kinase" Q9UPQ8 9 128945530-128947619 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066767, HPA068706" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA066767: AB_2732751, HPA068706: AB_2732118" "unprognostic (6.35e-2)" "unprognostic (2.69e-1)" "unprognostic (2.63e-1)" "unprognostic (1.30e-3)" "unprognostic (3.55e-1)" "unprognostic (2.81e-3)" "unprognostic (8.90e-3)" "unprognostic (3.26e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-2)" "prognostic favorable (5.53e-4)" "unprognostic (3.20e-2)" "unprognostic (1.06e-1)" "prognostic favorable (6.88e-5)" "unprognostic (6.13e-3)" 11.0 20.2 7.9 7.8 13.8 1.4 9.5 7.0 18.6 9.8 8.6 14.9 7.1 8.8 12.4 16.8 10.9 10.8 10.8 12.0 7.6 9.9 17.5 22.0 10.6 10.6 8.1 6.7 13.2 16.9 19.2 8.0 19.5 16.3 12.3 8.0 14.2 15.5 12.8 7.9 11.4 10.9 11.1 5.9 11.6 12.4 22.4 6.0 12.5 11.0 11.9 12.1 10.4 7.3 9.4 14.2 5.6 16.4 9.8 13.7 9.0 5.1 19.3 6.8 10.1 20.2 10.7 9.3 10.8 17.5 13.3 9.9 15.1 8.2 2.8 5.7 15.6 18.8 36.7 9.3 13.5 6.9 4.7 8.1 3.5 13.3 10.9 20.5 3.8 6.3 14.8 12.5 14.3 7.9 7.8 12.9 4.1 8.6 4.6 14.3 25.4 3.1 3.2 8.8 14.8 12.0 3.2 9.0 11.2 11.9 7.8 6.3 7.0 14.3 11.8 6.3 6.7 20.6 5.1 10.7 12.0 4.3 15.1 8.8 4.4 10.8 2.9 11.3 3.5 9.1 2.3 13.5 5.6 10.2 13.3 9.1 9.4 9.2 11.2 14.2 9.2 12.1 12.3 2.1 9.8 16.4 8.1 13.7 9.0 7.9 13.8 7.0 18.6 7.6 9.9 8.1 6.7 16.3 6.0 6.0 2.6 1.5 3.2 1.5 9.0 3.0 7.6 6.7 3.4 7.0 7.9 21.7 0.0 14.1 10.7 8.3 6.2 0.0 12.3 14.0 5.6 3.1 1.1 8.3 11.4 4.8 1.2 17.2 6.9 2.8 11.2 2.7 3.3 1.8 3.8 11.2 10.4 5.8 5.6 7.2 6.5 0.0 4.1 24.0 14.9 1.1 15.2 1.9 5.5 1.7 DOLPP1 LSFR2 ENSG00000167130 "Dolichyldiphosphatase 1" Q86YN1 9 129081100-129090438 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019179 Approved Approved "Vesicles,Intermediate filaments" NA NA Vesicles "Intermediate filaments" "HPA019179: AB_1847827" "unprognostic (1.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.89e-1)" "unprognostic (6.12e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-2)" "unprognostic (3.18e-1)" "unprognostic (3.10e-2)" "unprognostic (6.96e-2)" "unprognostic (7.12e-2)" "unprognostic (1.65e-1)" "unprognostic (4.37e-3)" "unprognostic (7.59e-3)" "unprognostic (2.38e-2)" "unprognostic (1.35e-1)" "unprognostic (4.69e-2)" "unprognostic (5.34e-2)" 6.4 12.8 10.0 6.8 10.6 7.7 6.8 11.7 19.3 8.3 17.1 17.7 8.6 28.6 6.0 7.4 18.8 6.6 9.2 4.1 10.1 10.7 9.4 21.8 6.7 6.6 13.2 10.6 7.7 10.5 10.4 6.9 11.6 12.5 10.0 14.2 6.1 10.3 5.8 5.2 10.3 27.7 6.3 15.2 8.5 11.8 12.2 11.0 9.4 6.3 8.5 9.1 7.8 8.0 8.8 12.5 9.8 8.3 7.9 21.7 7.2 4.1 16.0 15.7 14.4 5.3 4.5 18.2 10.3 6.0 19.6 11.0 20.6 13.9 8.1 9.1 6.4 15.0 30.3 16.1 8.6 8.3 9.4 9.9 10.6 10.8 15.7 9.4 11.0 13.2 4.9 12.1 12.8 10.2 4.5 8.7 15.1 17.5 8.1 5.5 21.0 12.5 11.4 13.5 30.9 13.0 14.8 12.7 14.5 7.1 6.7 18.0 11.8 13.0 11.8 4.3 9.6 21.7 7.3 7.1 16.9 8.1 15.9 13.9 10.1 19.4 12.3 7.5 2.2 11.1 4.4 6.8 9.8 8.9 8.1 21.7 8.8 10.9 10.8 8.5 6.0 11.1 10.5 1.4 7.9 8.3 12.5 10.1 7.2 10.0 10.6 11.7 19.3 10.1 10.7 13.2 10.6 12.5 11.0 6.0 4.6 3.7 2.9 2.1 3.2 1.6 5.1 0.0 2.3 1.8 5.9 16.9 1.7 5.9 0.5 2.4 26.6 0.0 8.4 11.4 3.3 2.7 5.7 17.0 6.5 3.2 3.5 6.2 3.8 0.4 2.0 2.3 5.0 4.6 9.0 9.1 5.4 13.3 3.9 3.8 3.4 0.0 3.1 4.5 8.7 3.4 13.7 3.8 12.2 3.4 DPAGT1 "ALG7, CDG-Ij, D11S366, DGPT, DPAGT, DPAGT2, GPT" ENSG00000172269 "Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1" Q9H3H5 11 119096503-119108331 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053878 Approved NA NA "HPA053878: AB_2682288" "unprognostic (1.66e-2)" "unprognostic (3.14e-3)" "unprognostic (1.76e-1)" "unprognostic (7.83e-3)" "unprognostic (6.50e-2)" "unprognostic (8.53e-3)" "prognostic unfavorable (2.03e-5)" "unprognostic (2.52e-1)" "unprognostic (3.95e-1)" "unprognostic (9.05e-2)" "unprognostic (2.08e-2)" "unprognostic (7.12e-2)" "unprognostic (2.19e-3)" "unprognostic (1.87e-3)" "unprognostic (1.08e-2)" "unprognostic (2.52e-2)" "unprognostic (4.57e-2)" 13.0 20.0 6.8 9.7 6.7 5.5 10.0 5.2 9.3 13.2 13.1 8.5 13.0 11.0 10.9 12.0 14.5 11.6 11.3 8.3 5.9 5.8 12.5 53.0 10.0 6.9 7.5 3.6 11.6 32.1 18.4 5.8 12.5 7.4 10.6 11.1 8.1 26.3 13.6 8.0 6.9 15.3 10.6 6.4 12.2 11.9 5.4 8.0 7.7 11.8 7.2 12.4 16.1 8.3 10.1 16.4 9.2 14.4 7.6 11.8 8.0 5.2 13.4 4.7 14.4 18.0 10.8 6.4 9.7 10.2 6.5 9.8 13.1 22.4 11.3 15.3 13.8 16.1 17.1 13.1 17.6 7.5 6.2 7.1 20.1 4.3 16.0 14.9 12.7 10.1 13.9 14.7 17.7 24.7 6.9 15.1 5.4 12.4 21.8 14.6 16.8 3.1 7.7 5.3 37.8 15.0 5.2 6.4 15.7 16.8 12.5 6.3 6.4 7.1 23.7 3.9 9.2 32.0 5.2 7.7 16.2 6.1 7.2 5.1 3.1 8.4 3.7 3.0 16.3 12.5 9.2 14.4 1.4 9.8 13.2 11.8 10.1 7.5 9.7 16.4 7.3 6.0 6.0 1.4 7.6 11.5 15.2 6.7 8.0 6.8 6.7 5.2 9.3 5.9 5.8 7.5 3.6 7.4 8.0 6.0 7.2 16.2 12.6 11.7 6.2 4.5 25.5 21.4 7.9 14.0 13.7 29.2 3.3 26.6 0.9 13.6 12.9 0.0 11.6 36.9 7.2 12.6 12.7 21.2 25.7 3.2 9.8 14.7 12.3 1.1 13.0 11.7 8.5 20.8 18.1 6.7 14.5 13.6 7.8 10.0 3.5 0.0 8.6 4.4 11.3 10.9 19.7 8.7 18.3 11.9 DPCR1 "bCX105N19.6, C6orf37, PBLT" ENSG00000168631 "Diffuse panbronchiolitis critical region 1" Q3MIW9 6 30934523-30954221 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "gallbladder: 53.4;stomach 1: 70.9" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 42.0;Cholangiocytes: 48.4" "Group enriched" "Detected in some" 9 "pancreatic cancer: 56.8;stomach cancer: 55.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.6;OE19: 4.7;RPTEC TERT1: 1.3" HPA014036 Enhanced NA NA "HPA014036: AB_1847841" "unprognostic (2.81e-1)" "unprognostic (4.49e-2)" "unprognostic (9.13e-4)" "unprognostic (6.74e-2)" "unprognostic (4.29e-2)" "unprognostic (8.06e-2)" "unprognostic (3.08e-1)" "unprognostic (1.03e-1)" "unprognostic (3.32e-3)" "unprognostic (2.79e-1)" "prognostic unfavorable (6.58e-4)" "unprognostic (1.13e-1)" "unprognostic (5.97e-2)" "unprognostic (4.76e-2)" "unprognostic (9.80e-2)" "unprognostic (3.20e-2)" "unprognostic (3.58e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 1.9 0.0 0.0 0.0 0.0 4.8 0.0 53.4 0.0 0.0 0.0 0.0 2.5 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.9 42.0 0.0 0.2 0.0 0.0 0.0 48.4 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 DPEP2 ENSG00000167261 "Dipeptidase 2" Q9H4A9 16 67987394-68000586 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 105.1" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 29.3;Kupffer cells: 40.0;Macrophages: 33.7;Syncytiotrophoblasts: 45.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 43.5;eosinophil: 105.1;neutrophil: 47.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 105.1" "Cell line enhanced" "Detected in some" "HEL: 4.4;HMC-1: 19.9;NB-4: 4.3;U-937: 6.6" "Low region specificity" "Detected in many" HPA035644 Approved NA NA 260000000 "HPA035644: AB_10670164" "unprognostic (8.81e-2)" "unprognostic (7.84e-5)" "unprognostic (1.35e-1)" "unprognostic (1.42e-2)" "unprognostic (1.92e-1)" "unprognostic (6.66e-3)" "unprognostic (1.03e-1)" "unprognostic (5.47e-2)" "unprognostic (3.69e-2)" "unprognostic (1.68e-1)" "unprognostic (6.01e-2)" "unprognostic (1.46e-1)" "unprognostic (3.91e-2)" "unprognostic (5.75e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (7.78e-3)" "unprognostic (3.91e-2)" 7.8 0.9 1.3 7.1 2.4 13.0 3.5 0.7 2.5 1.5 2.6 2.4 1.1 1.7 4.1 4.1 1.8 2.0 6.8 2.4 1.6 1.3 2.0 2.0 11.4 10.4 2.1 2.0 0.7 0.9 0.1 0.9 19.4 2.7 2.4 2.4 5.1 2.8 0.4 1.6 1.2 10.1 2.3 3.3 26.4 1.6 2.5 1.6 3.5 2.5 3.8 11.1 6.3 1.5 5.0 4.3 105.1 15.3 5.6 4.9 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.4 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 4.4 0.0 0.1 0.0 0.1 19.9 0.0 0.1 0.0 0.0 0.1 0.1 1.4 0.3 0.1 0.0 0.0 0.1 4.3 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.6 0.0 0.0 0.0 0.0 1.1 0.5 0.3 0.0 6.6 0.0 43.5 10.7 105.1 2.3 13.0 2.7 4.1 4.0 1.9 4.3 5.0 4.9 2.5 47.3 5.6 15.3 0.6 4.0 5.7 1.3 2.4 0.7 2.5 1.6 1.3 2.1 2.0 2.7 1.6 0.0 12.2 15.6 0.0 1.8 0.0 1.1 0.0 2.7 2.3 0.0 0.0 7.7 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.6 1.6 0.0 2.3 0.0 29.3 0.0 0.0 17.2 40.0 0.9 0.0 33.7 3.3 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 6.5 6.1 1.1 45.2 13.8 0.0 0.1 DPM2 "MGC111193, MGC21559" ENSG00000136908 "Dolichyl-phosphate mannosyltransferase subunit 2, regulatory" O94777 9 127935099-127938484 "Disease related genes, Predicted membrane proteins" "Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064623 Approved NA NA "HPA064623: AB_2685303" "unprognostic (8.30e-3)" "unprognostic (1.07e-2)" "unprognostic (9.84e-3)" "prognostic favorable (2.20e-4)" "unprognostic (3.67e-1)" "unprognostic (2.06e-2)" "prognostic unfavorable (7.08e-4)" "unprognostic (1.91e-1)" "unprognostic (1.37e-1)" "unprognostic (6.62e-2)" "unprognostic (5.55e-3)" "unprognostic (1.35e-1)" "unprognostic (1.51e-2)" "unprognostic (5.71e-3)" "unprognostic (3.23e-1)" "unprognostic (2.21e-1)" "unprognostic (2.48e-1)" 9.6 13.6 15.2 6.9 18.0 8.5 12.3 8.4 19.4 14.3 11.3 9.7 14.7 10.4 8.0 18.7 12.2 19.8 12.9 6.8 15.4 12.1 16.9 17.9 11.1 9.5 14.4 11.5 10.3 27.2 15.6 10.9 16.0 11.3 10.3 8.9 14.3 21.0 13.4 5.1 9.7 8.9 10.8 9.4 9.4 31.9 13.6 8.4 7.9 22.1 11.9 13.9 7.4 7.9 25.2 25.0 15.4 20.6 17.7 22.5 14.7 6.6 14.3 4.9 4.5 13.4 8.8 5.3 9.0 7.7 7.3 4.7 7.9 9.5 4.5 5.1 15.6 13.1 8.2 4.8 15.2 3.9 10.2 11.5 5.4 15.4 8.4 17.1 9.9 7.3 9.8 11.0 12.2 16.9 7.0 10.5 12.2 11.2 6.3 10.8 29.2 3.7 11.3 7.5 30.9 10.8 3.4 5.8 28.0 13.3 5.7 3.5 11.2 9.0 9.2 6.3 4.4 12.3 7.8 5.8 4.1 4.4 4.9 7.5 14.5 18.6 2.9 16.8 5.7 6.5 11.6 17.4 15.4 22.5 20.6 19.5 25.2 16.7 21.0 20.0 23.3 13.8 17.2 7.3 17.7 16.6 25.0 14.0 14.7 15.2 18.0 8.4 19.4 15.4 12.1 14.4 11.5 11.3 8.4 26.8 31.5 25.3 30.5 24.0 23.8 11.1 40.8 25.4 30.7 38.4 15.7 72.6 38.1 50.5 5.6 29.0 35.6 163.5 51.4 89.2 38.5 52.1 28.8 27.0 72.2 36.5 31.2 35.0 23.0 9.4 24.5 25.5 30.4 60.5 41.7 24.6 49.5 34.5 19.1 39.2 18.6 6.5 28.8 14.9 20.7 30.2 54.3 30.5 40.4 32.7 DPM3 "MGC125904, MGC125905, MGC34275" ENSG00000179085 "Dolichyl-phosphate mannosyltransferase subunit 3" Q9P2X0 1 155139891-155140595 "Disease related genes, Predicted membrane proteins" "Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014667 Approved NA NA 160000 "HPA014667: AB_1847848" "unprognostic (6.47e-2)" "unprognostic (1.49e-2)" "unprognostic (1.18e-1)" "prognostic favorable (7.09e-5)" "unprognostic (7.07e-2)" "unprognostic (1.07e-1)" "unprognostic (2.67e-2)" "unprognostic (6.83e-3)" "unprognostic (4.71e-1)" "prognostic favorable (8.97e-5)" "unprognostic (1.42e-3)" "unprognostic (8.83e-2)" "unprognostic (1.75e-1)" "unprognostic (1.50e-2)" "unprognostic (1.71e-1)" "unprognostic (1.28e-1)" "prognostic favorable (8.64e-4)" 21.6 32.2 18.8 14.6 21.3 21.8 28.4 13.0 20.7 25.9 36.1 14.6 43.4 31.0 23.4 42.9 19.6 25.1 31.7 26.1 17.4 18.0 23.9 42.5 19.2 17.9 18.1 15.3 19.9 62.6 9.2 32.7 12.4 14.3 22.3 9.9 23.7 42.1 44.8 29.6 13.4 23.4 23.3 15.1 20.0 24.2 21.5 12.2 13.1 47.0 22.2 11.9 17.3 18.1 43.3 49.6 40.4 45.2 36.4 42.1 37.6 22.6 25.3 7.9 18.6 14.6 13.6 8.5 7.5 9.5 10.1 10.6 8.0 26.8 7.3 23.0 6.1 3.4 16.3 3.0 8.7 1.2 10.4 52.3 8.1 37.6 27.1 13.8 7.2 10.8 13.4 16.1 7.3 3.1 4.9 11.7 18.5 9.0 39.4 7.5 54.9 15.9 16.6 19.6 26.6 19.7 13.8 9.0 43.7 12.1 15.7 13.9 28.7 17.0 20.3 27.0 3.0 14.0 35.2 9.3 6.3 15.2 8.9 10.8 33.5 16.9 21.9 16.5 15.7 4.7 20.3 45.2 40.4 38.8 27.8 42.1 43.3 41.4 37.9 43.7 41.8 39.7 37.9 25.0 36.4 27.6 49.6 32.6 37.6 18.8 21.3 13.0 20.7 17.4 18.0 18.1 15.3 14.3 12.2 47.6 64.3 56.3 56.1 24.4 27.7 97.4 104.4 92.3 59.1 167.5 9.8 59.1 56.3 50.1 36.1 63.7 136.5 0.0 141.2 58.3 64.6 65.2 69.3 221.9 77.0 12.7 95.4 77.3 64.8 9.5 85.7 58.5 92.8 28.9 187.9 74.4 61.4 155.6 91.9 122.9 22.5 38.8 60.8 23.6 10.6 29.5 34.1 44.9 139.7 53.3 DPP10 "DPL2, DPPY, DPRP3" ENSG00000175497 "Dipeptidyl peptidase like 10" Q8N608 2 114442299-115845752 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 15.6;brain: 30.3;pancreas: 23.4" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 5.1;Early spermatids: 10.4;Extravillous trophoblasts: 7.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.1;HAP1: 7.6;HMC-1: 5.4;JURKAT: 4.1;NTERA-2: 4.6;RT4: 8.1;SCLC-21H: 12.0;SH-SY5Y: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048767 Uncertain NA NA "HPA048767: AB_2680515" "unprognostic (1.19e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" "unprognostic (1.77e-2)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (6.59e-2)" "unprognostic (2.92e-1)" "unprognostic (5.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-2)" "unprognostic (8.33e-2)" "unprognostic (7.61e-2)" "unprognostic (4.22e-2)" 0.7 15.6 13.4 1.1 15.9 0.9 0.9 1.9 30.3 1.3 3.6 7.9 0.0 2.4 1.4 0.8 0.8 0.9 1.9 0.8 17.5 9.9 1.1 0.9 1.0 0.7 7.1 21.3 0.9 23.4 0.7 1.5 1.8 10.8 0.8 4.6 0.0 1.0 0.8 0.7 0.9 2.4 1.9 12.7 0.7 1.5 2.1 10.3 0.0 1.6 0.0 0.8 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 12.0 4.8 0.0 0.0 0.0 1.5 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 15.9 1.9 30.3 17.5 9.9 7.1 21.3 10.8 10.3 0.0 0.0 0.0 0.0 0.0 2.7 1.4 5.1 0.0 1.2 0.0 0.0 1.1 0.0 0.0 10.4 0.0 0.4 0.0 2.3 7.3 0.2 0.0 0.0 0.0 0.3 4.8 4.1 0.6 0.0 4.3 0.3 0.0 1.7 0.0 1.3 1.4 1.2 0.0 0.0 0.0 0.5 0.0 0.0 1.7 1.1 0.0 3.7 0.0 2.9 0.0 DPP4 "ADCP2, CD26, DPPIV" ENSG00000197635 "Dipeptidyl peptidase 4" P27487 2 161992241-162074542 "CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 133.1;parathyroid gland: 75.5" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 134.1;Proximal tubular cells: 80.1;Syncytiotrophoblasts: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "MAIT T-cell: 26.7" "Lineage enriched" "Detected in many" 10 "T-cells: 26.7" "Cell line enhanced" "Detected in many" "ASC diff: 42.8;ASC TERT1: 43.4;BJ hTERT+: 39.8;RPTEC TERT1: 58.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB045970, HPA068778, HPA071236" Enhanced "Secreted in other tissues" NA NA 170000000 "CAB045970: AB_11140529, HPA068778: , HPA071236: " "unprognostic (4.47e-2)" "unprognostic (4.47e-2)" "unprognostic (8.89e-2)" "unprognostic (3.36e-1)" "unprognostic (7.25e-2)" "unprognostic (5.40e-2)" "unprognostic (2.78e-1)" "unprognostic (3.54e-2)" "unprognostic (3.58e-1)" "unprognostic (4.73e-1)" "unprognostic (2.36e-1)" "prognostic unfavorable (1.98e-4)" "prognostic favorable (1.35e-6)" "unprognostic (4.68e-2)" "unprognostic (6.33e-2)" "prognostic favorable (4.99e-4)" "unprognostic (1.21e-2)" 9.5 2.9 0.3 3.2 0.5 0.0 5.0 0.3 1.4 2.2 50.0 0.2 36.9 19.1 2.2 3.5 1.2 1.2 5.2 2.1 0.4 0.3 29.1 12.2 5.4 2.1 0.4 0.2 2.7 1.8 75.5 0.3 24.0 0.2 21.1 2.8 0.6 46.9 38.8 2.4 4.4 133.1 0.9 0.8 5.0 1.2 0.6 0.1 6.2 1.0 1.4 1.1 1.0 2.6 0.1 2.1 0.3 0.0 2.6 26.7 2.5 0.0 0.0 0.1 0.0 42.8 43.4 0.1 7.9 39.8 2.2 7.7 8.0 0.2 0.0 3.0 13.7 7.4 0.2 0.1 0.0 1.3 2.5 0.1 0.0 0.0 11.9 17.4 0.0 0.0 4.9 0.0 13.4 0.1 2.0 1.3 0.1 0.0 0.0 0.7 0.0 0.7 0.1 0.4 0.3 16.4 0.0 0.0 0.1 58.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 7.1 4.6 0.2 0.2 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 3.2 0.0 26.7 0.1 8.3 5.2 0.6 0.0 8.3 3.3 0.3 2.6 0.0 2.1 0.9 2.5 0.3 0.5 0.3 1.4 0.4 0.3 0.4 0.2 0.2 0.1 6.0 17.5 0.0 0.3 3.7 1.7 4.0 12.7 4.0 4.5 14.0 9.8 134.1 1.7 3.1 13.0 3.9 21.3 0.0 0.0 52.7 45.7 38.3 12.8 39.9 12.7 0.0 53.0 12.3 1.6 6.2 0.0 4.6 5.0 1.0 11.0 0.0 0.9 11.4 0.0 80.1 0.0 0.0 1.0 2.1 0.8 3.6 143.8 11.4 12.8 0.3 DPP6 "DPL1, DPPX" ENSG00000130226 "Dipeptidyl peptidase like 6" P42658 7 153887097-154894285 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.7;endometrium 1: 24.5;thyroid gland: 24.1" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 13.3;Horizontal cells: 30.2;Late spermatids: 16.0;Melanocytes: 15.1;Muller glia cells: 18.7" "Cancer enriched" "Detected in some" 11 "glioma: 12.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 9 "NTERA-2: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050509 Enhanced Supported NA NA "HPA050509: AB_2681150" "unprognostic (1.29e-1)" "unprognostic (3.55e-2)" "unprognostic (5.68e-2)" "unprognostic (5.86e-2)" "unprognostic (1.53e-2)" "unprognostic (2.28e-1)" "unprognostic (2.73e-1)" "unprognostic (5.83e-4)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (7.45e-3)" "unprognostic (4.04e-3)" "unprognostic (2.94e-3)" "unprognostic (1.85e-4)" "unprognostic (1.05e-1)" "unprognostic (4.61e-3)" "unprognostic (6.11e-2)" 1.6 7.2 15.4 1.4 32.5 1.3 1.5 26.6 45.7 2.3 6.8 8.7 0.0 1.6 24.5 3.1 1.5 4.6 1.3 1.4 26.6 15.2 3.6 1.2 2.2 1.3 14.0 22.7 1.3 4.0 1.2 4.9 1.3 18.8 1.5 2.4 0.4 1.3 8.1 4.6 3.7 2.0 15.8 7.2 4.2 3.5 7.9 10.0 0.0 24.1 0.0 1.2 1.3 0.4 0.6 0.6 1.9 0.9 0.9 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 11.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 1.2 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.9 0.4 0.7 0.4 0.6 0.7 0.6 0.6 0.4 0.4 0.6 0.7 0.7 1.6 0.9 0.9 0.6 0.5 0.3 15.4 32.5 26.6 32.4 26.6 15.2 14.0 22.7 18.8 10.0 0.0 0.0 0.0 0.4 3.0 9.3 5.9 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.1 13.3 0.0 0.0 0.0 3.6 0.0 0.3 0.1 0.0 0.0 0.2 30.2 9.9 0.0 0.0 16.0 1.1 0.0 15.1 0.0 0.2 18.7 0.5 0.0 3.5 0.3 6.0 0.0 0.3 0.9 1.7 1.4 0.0 0.0 0.0 0.1 DPP7 "DPP2, DPPII" ENSG00000176978 "Dipeptidyl peptidase 7" Q9UHL4 9 137110542-137115177 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 751.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 57.2;THP-1: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021282, CAB025541, HPA059381" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 1300000 "Golgi apparatus, Vesicles" "CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999" "unprognostic (1.15e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (6.07e-6)" "unprognostic (6.78e-3)" "unprognostic (1.25e-1)" "unprognostic (8.33e-2)" "unprognostic (7.49e-2)" "unprognostic (6.10e-2)" "unprognostic (2.28e-2)" "unprognostic (5.71e-3)" "prognostic favorable (8.31e-5)" "unprognostic (7.99e-2)" "unprognostic (1.46e-2)" "unprognostic (2.56e-2)" "unprognostic (1.72e-1)" "unprognostic (2.15e-1)" "unprognostic (1.02e-1)" 28.1 45.2 23.7 23.4 35.3 31.8 20.8 23.5 27.5 21.5 22.0 24.9 40.7 23.2 17.5 35.8 19.1 27.0 30.2 44.7 24.6 29.2 21.0 29.9 25.6 34.8 29.7 25.9 14.3 55.4 23.3 42.5 21.9 24.2 28.8 6.9 32.8 73.1 41.6 25.3 26.9 17.8 22.8 21.7 29.1 24.4 30.9 26.8 18.9 41.2 17.5 24.7 21.3 16.6 20.0 60.8 12.2 43.1 19.2 36.8 38.2 6.9 11.0 0.9 0.9 13.6 10.9 1.4 10.5 17.2 7.0 4.6 10.4 5.7 13.7 11.5 6.9 0.3 15.0 8.0 2.1 0.3 13.4 0.5 6.3 15.2 0.3 30.5 16.9 35.2 13.4 8.3 3.0 6.3 10.2 9.1 17.0 13.8 10.7 4.6 19.2 8.5 16.2 3.7 25.2 10.8 12.5 0.1 57.2 11.1 7.7 17.6 12.2 12.1 31.9 29.7 0.2 11.4 54.9 11.0 17.9 6.1 11.3 7.2 13.2 7.5 3.7 21.4 10.3 8.0 6.8 43.1 12.2 34.4 37.6 35.5 19.7 31.1 29.6 41.7 20.0 28.1 25.1 2.6 19.2 22.6 60.8 36.8 38.2 23.7 35.3 23.5 27.5 24.6 29.2 29.7 25.9 24.2 26.8 50.6 79.4 78.5 85.1 59.5 68.6 52.7 58.6 42.8 46.6 50.6 33.4 44.8 31.5 93.8 230.4 57.3 44.4 23.3 59.4 85.7 82.6 106.0 74.8 62.7 275.2 114.4 84.6 55.3 148.6 751.7 143.8 125.9 158.6 165.1 27.0 123.1 65.3 48.9 159.1 69.0 73.5 51.8 56.5 57.7 46.0 56.8 43.0 127.1 37.4 74.0 DPP8 "DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141" ENSG00000074603 "Dipeptidyl peptidase 8" Q6V1X1 15 65442463-65517704 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008706 Approved Supported Cytosol NA NA Cytosol "HPA008706: AB_1078665" "unprognostic (3.65e-1)" "unprognostic (2.38e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" "unprognostic (1.24e-1)" "unprognostic (8.60e-2)" "unprognostic (2.98e-1)" "unprognostic (2.46e-1)" "unprognostic (2.52e-2)" "unprognostic (1.81e-1)" "unprognostic (4.09e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-2)" "unprognostic (1.01e-1)" "unprognostic (7.58e-2)" "unprognostic (8.56e-2)" "unprognostic (2.59e-1)" 15.6 16.1 16.4 14.9 18.8 16.2 13.9 22.9 24.9 15.5 14.5 15.0 12.7 18.0 15.9 13.9 13.1 11.1 12.4 18.8 15.1 14.6 16.0 9.9 13.3 16.0 15.4 11.8 16.2 11.7 22.2 14.5 15.9 21.7 13.5 15.8 13.9 15.6 20.8 30.5 14.2 16.5 16.2 17.5 17.2 13.2 29.9 15.8 22.5 17.4 12.5 16.0 16.2 13.2 10.7 8.1 20.0 10.8 6.1 10.3 5.3 9.6 15.6 10.3 10.3 11.6 16.6 8.8 15.5 18.4 13.9 13.4 6.7 8.3 17.0 12.2 19.4 9.5 17.9 19.8 11.2 17.1 14.3 12.3 16.3 12.0 6.4 12.1 21.0 16.1 12.4 10.7 11.3 10.7 11.7 15.2 13.2 11.1 15.8 17.1 7.8 11.2 7.7 7.0 9.8 8.0 14.9 19.0 16.5 11.4 21.0 7.3 12.9 10.1 10.2 15.6 10.6 9.4 12.6 19.2 18.7 13.0 8.8 16.5 20.5 26.8 17.2 14.1 21.2 13.4 20.0 9.1 11.1 9.9 9.2 10.3 9.2 8.6 9.5 8.1 10.7 8.6 9.2 18.3 6.1 10.8 7.5 8.9 5.3 16.4 18.8 22.9 24.4 15.1 14.6 15.4 11.8 21.7 15.8 32.8 24.7 23.1 12.5 11.8 24.3 36.8 25.5 22.7 27.3 14.0 35.3 16.6 19.9 19.2 44.1 27.4 20.3 0.0 26.0 12.3 17.3 17.3 25.6 14.7 18.7 27.0 24.9 43.0 34.3 48.6 27.0 25.3 21.9 30.7 28.3 29.5 29.2 21.0 27.6 24.1 27.0 19.4 17.5 62.7 22.3 17.7 14.8 26.2 24.3 20.9 DPY19L1 KIAA0877 ENSG00000173852 "Dpy-19 like C-mannosyltransferase 1" Q2PZI1 7 34928876-35038271 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 183.8;Late spermatids: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059139 Uncertain Approved Vesicles NA NA Vesicles "HPA059139: AB_2683921" "unprognostic (4.66e-2)" "unprognostic (1.11e-3)" "unprognostic (8.53e-3)" "unprognostic (2.47e-3)" "unprognostic (2.50e-2)" "unprognostic (3.80e-3)" "unprognostic (2.02e-3)" "unprognostic (3.57e-2)" "unprognostic (1.14e-1)" "unprognostic (4.84e-2)" "prognostic unfavorable (2.99e-4)" "unprognostic (3.21e-1)" "unprognostic (1.88e-2)" "unprognostic (3.99e-1)" "unprognostic (2.69e-2)" "unprognostic (1.37e-1)" "unprognostic (4.12e-2)" 9.7 12.2 11.0 10.2 13.0 9.0 13.7 16.9 27.0 15.6 9.3 13.5 4.5 4.8 17.7 4.3 7.1 10.3 13.8 18.1 11.8 13.4 7.2 25.2 13.0 9.9 16.3 12.0 8.6 6.7 5.0 11.2 19.0 23.6 8.6 11.3 10.3 6.4 8.4 4.0 4.5 6.8 17.5 38.1 14.1 9.0 31.7 5.8 2.3 10.4 3.6 8.4 11.5 11.3 1.6 1.6 2.8 2.3 1.6 4.1 1.0 5.3 21.0 12.0 15.2 23.7 18.9 2.5 11.9 10.8 7.4 10.6 5.0 14.0 7.7 17.5 12.3 30.8 9.5 9.1 6.5 16.8 4.0 7.3 11.3 13.3 8.2 8.6 10.5 10.5 9.7 5.4 10.1 6.7 21.3 30.6 3.8 8.4 31.6 26.0 3.0 0.1 10.5 7.7 12.5 9.5 7.8 15.8 11.0 28.2 18.5 5.5 14.5 10.6 1.5 6.1 19.7 10.7 12.7 35.3 14.9 18.0 10.2 16.0 14.3 30.8 8.7 18.4 9.8 41.3 2.8 1.7 0.1 3.9 2.3 4.1 1.3 1.7 3.1 1.5 1.6 0.6 1.8 0.3 1.6 0.8 1.6 1.0 1.0 11.0 13.0 16.9 27.0 11.8 13.4 16.3 12.0 23.6 5.8 26.8 16.0 1.9 5.0 6.4 7.2 12.0 5.1 10.7 14.8 7.0 17.7 10.8 0.0 6.4 183.8 10.5 4.5 0.0 14.0 3.5 8.7 7.7 26.5 13.9 7.4 11.1 14.3 21.5 8.2 52.5 8.6 4.0 5.0 0.0 5.0 7.2 16.9 5.8 9.6 1.5 13.3 0.0 6.6 8.3 3.4 4.3 17.7 5.3 6.3 9.5 DPY19L2 "FLJ32949, SPATA34" ENSG00000177990 "Dpy-19 like 2" Q6NUT2 12 63558913-63668939 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 44.0" "Group enriched" "Detected in many" 6 "Early spermatids: 300.2;Late spermatids: 304.6;Spermatocytes: 171.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.4;naive CD8 T-cell: 2.7" "Lineage enriched" "Detected in single" 19 "T-cells: 3.4" "Cell line enhanced" "Detected in many" "U-266/84: 10.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA071264, HPA078305" Enhanced Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA071264: AB_2686375, HPA078305: " "unprognostic (1.97e-1)" "unprognostic (4.08e-1)" "unprognostic (4.46e-3)" "unprognostic (2.50e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-4)" "unprognostic (2.28e-2)" "unprognostic (2.14e-3)" "unprognostic (1.53e-1)" "unprognostic (3.64e-1)" "unprognostic (3.99e-3)" "unprognostic (1.97e-1)" "unprognostic (6.31e-3)" "unprognostic (4.22e-3)" "unprognostic (5.88e-2)" "unprognostic (8.90e-3)" "unprognostic (1.79e-1)" 5.7 4.3 2.6 1.6 5.2 2.1 2.4 5.2 4.5 5.6 2.6 1.4 3.1 0.7 7.8 3.4 1.3 3.7 2.4 12.9 1.8 2.4 6.0 0.3 1.1 0.8 1.7 3.1 7.3 2.3 7.4 10.9 1.2 3.0 5.7 1.2 5.1 2.3 6.3 0.5 1.4 0.9 4.3 0.7 1.1 1.5 44.0 0.9 0.5 8.4 1.4 0.7 2.7 3.1 0.1 0.0 0.1 0.0 0.1 3.4 0.4 1.2 3.1 2.8 6.6 0.7 0.0 0.3 2.1 2.2 2.9 3.8 0.4 1.0 3.4 2.2 0.9 3.6 0.5 3.3 0.3 4.4 1.7 2.0 5.4 1.4 2.0 0.6 3.9 1.7 1.5 0.1 1.4 0.0 7.4 0.8 2.6 2.2 3.4 4.7 2.1 0.2 1.6 2.5 0.5 2.5 0.1 2.3 0.0 5.6 0.5 8.5 0.9 0.8 0.3 1.2 1.2 2.4 1.1 0.6 4.0 5.2 0.6 5.4 9.1 10.4 0.0 4.3 1.9 3.6 0.1 0.0 0.0 0.6 0.0 3.4 0.0 0.1 0.6 0.0 0.1 1.0 2.7 0.0 0.1 0.0 0.0 0.0 0.4 2.6 5.2 5.2 4.5 1.8 2.4 1.7 3.1 3.0 0.9 3.0 0.0 0.0 2.9 0.5 41.9 24.2 2.5 16.0 6.8 12.2 13.7 1.1 5.0 0.4 300.2 2.3 0.0 0.0 0.0 1.1 1.0 3.0 2.3 0.0 0.3 3.2 0.0 0.0 0.0 304.6 6.6 0.0 6.8 0.0 0.0 11.1 0.2 0.0 8.1 5.6 6.2 25.8 15.6 171.9 4.1 0.4 1.1 0.0 0.0 0.9 DPY19L3 ENSG00000178904 "Dpy-19 like C-mannosyltransferase 3" Q6ZPD9 19 32405543-32485895 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 74.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008325 Approved Approved Microtubules NA NA Microtubules "HPA008325: AB_1847853" "unprognostic (9.58e-3)" "unprognostic (3.89e-1)" "unprognostic (2.24e-1)" "unprognostic (3.60e-1)" "unprognostic (5.21e-2)" "prognostic favorable (5.55e-4)" "unprognostic (2.00e-2)" "unprognostic (3.76e-2)" "unprognostic (1.28e-3)" "unprognostic (3.27e-1)" "prognostic favorable (1.70e-4)" "unprognostic (3.26e-1)" "unprognostic (1.02e-2)" "unprognostic (6.34e-2)" "unprognostic (1.87e-1)" "unprognostic (1.75e-1)" "unprognostic (9.72e-3)" 8.4 10.9 20.7 8.1 23.0 11.5 10.1 11.2 18.5 12.8 6.2 15.2 9.9 4.2 10.7 9.3 6.1 8.9 9.7 6.4 17.9 14.1 8.6 7.4 7.6 7.1 15.3 11.0 19.3 11.3 15.0 13.3 11.7 14.5 16.1 6.7 9.8 10.2 8.7 3.6 4.9 5.9 7.6 15.7 10.8 9.8 12.3 10.2 6.8 15.3 4.5 6.9 8.3 7.5 2.9 2.2 9.0 2.7 1.3 2.2 0.8 3.0 5.8 22.0 9.7 22.6 11.7 11.0 9.4 6.7 3.9 7.0 6.8 3.4 11.9 6.0 6.7 2.8 1.6 8.9 4.1 7.4 6.0 5.8 15.9 5.9 6.2 14.9 8.2 9.2 12.1 2.3 4.8 4.6 7.5 9.2 5.7 11.4 3.8 10.1 5.1 2.1 4.1 9.2 5.8 2.3 5.8 8.8 3.5 7.4 7.5 4.9 13.2 4.6 4.5 5.0 12.8 3.4 9.7 10.1 8.0 5.7 4.8 9.9 5.9 12.0 8.0 11.2 10.0 12.8 6.0 2.5 7.4 1.8 1.9 1.0 2.0 1.7 1.7 2.2 2.9 1.4 1.6 9.0 1.3 2.7 1.6 2.2 0.8 20.7 23.0 11.2 15.0 17.9 14.1 15.3 11.0 14.5 10.2 6.0 10.0 3.2 3.5 1.8 11.0 3.1 0.0 6.7 5.7 14.0 9.8 5.5 1.7 1.9 1.7 6.5 3.9 0.0 3.5 4.5 7.7 14.9 1.1 4.9 4.7 74.7 3.5 26.4 14.8 2.2 10.0 2.1 1.7 0.0 8.7 25.9 3.2 4.3 11.0 3.3 12.0 0.0 3.1 10.4 21.2 2.6 12.5 2.1 3.6 3.1 DPY19L4 ENSG00000156162 "Dpy-19 like 4" Q7Z388 8 94719703-94793836 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ito cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024780 Approved NA NA "HPA024780: AB_10600869" "unprognostic (1.45e-1)" "unprognostic (2.89e-3)" "unprognostic (3.41e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.28e-1)" "unprognostic (5.54e-2)" "unprognostic (4.94e-2)" "unprognostic (7.17e-2)" "unprognostic (3.18e-2)" "unprognostic (1.04e-1)" "unprognostic (4.72e-2)" "unprognostic (9.38e-2)" "unprognostic (2.25e-1)" "unprognostic (1.48e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-2)" "unprognostic (1.55e-1)" 13.2 18.3 14.5 10.8 16.3 5.7 17.3 9.0 13.6 18.5 10.4 21.6 16.8 8.3 20.0 13.6 11.6 14.4 16.3 18.3 14.9 12.7 18.5 19.1 11.3 12.9 21.5 13.8 21.7 11.5 29.3 16.9 15.3 14.8 16.5 11.4 16.5 13.2 16.8 11.0 11.6 10.3 15.8 21.6 12.9 15.2 12.2 16.0 11.2 20.1 7.4 9.7 13.6 14.4 2.7 3.4 1.5 1.6 3.7 4.6 2.2 14.9 9.7 16.7 10.5 17.0 22.1 9.2 13.5 12.8 12.8 12.6 4.5 22.1 3.3 16.7 13.0 8.5 15.9 10.1 10.7 21.3 7.5 8.1 15.6 9.3 7.5 19.8 6.7 3.3 14.6 9.0 10.8 10.5 15.0 15.4 10.1 10.9 5.7 14.8 9.3 12.6 12.6 6.5 17.3 10.9 9.1 11.5 6.7 12.3 11.8 8.2 18.6 10.8 2.3 10.3 10.7 14.5 8.4 15.1 13.3 8.2 14.8 11.2 6.4 7.9 8.9 10.0 11.6 18.8 1.5 1.6 0.1 2.9 1.5 4.1 2.7 3.0 4.6 2.7 1.0 3.2 4.2 1.2 3.7 1.6 3.4 1.2 2.2 14.5 16.3 9.0 13.6 14.9 12.7 21.5 13.8 14.8 16.0 14.9 12.3 0.8 12.5 8.8 17.2 20.7 7.6 14.7 10.3 38.4 3.9 13.7 1.7 8.2 1.7 14.6 7.1 0.0 8.6 9.5 17.8 15.7 3.5 25.1 8.2 12.7 7.0 68.7 13.2 3.2 16.1 7.9 10.1 1.8 11.7 11.8 10.2 2.9 17.3 9.8 16.1 6.5 8.2 11.4 7.9 10.7 7.7 4.4 10.2 11.7 DRAM1 "DRAM, FLJ11259" ENSG00000136048 "DNA damage regulated autophagy modulator 1" Q8N682 12 101877351-102012130 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 52.5;lung: 73.9" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 271.2;Early spermatids: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "BJ hTERT+: 103.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (8.82e-2)" "unprognostic (1.80e-1)" "unprognostic (7.19e-2)" "prognostic favorable (6.52e-8)" "unprognostic (1.15e-2)" "unprognostic (2.35e-3)" "unprognostic (1.29e-3)" "unprognostic (1.23e-2)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "unprognostic (6.17e-3)" "unprognostic (5.02e-2)" "prognostic unfavorable (3.91e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-3)" "unprognostic (3.58e-2)" "unprognostic (2.07e-2)" 13.1 11.0 3.6 9.9 3.8 16.7 52.5 1.2 2.6 9.2 8.3 2.3 3.6 3.4 8.0 9.2 8.1 6.9 11.2 13.8 3.6 3.6 16.7 7.2 73.9 20.9 4.3 2.3 10.9 13.7 4.3 6.6 15.2 4.4 13.2 4.8 5.4 8.8 5.4 6.6 4.6 6.4 10.8 4.4 14.8 10.0 8.6 2.2 4.9 10.4 4.3 6.4 12.4 22.1 2.6 3.0 9.2 9.8 3.5 2.2 2.5 2.0 4.0 1.4 0.4 18.8 4.3 8.0 15.0 103.6 15.1 23.6 1.3 3.9 0.3 1.7 24.6 5.8 3.0 0.3 6.2 21.0 2.1 1.3 0.5 3.5 5.1 8.7 0.6 1.1 5.1 2.7 5.2 5.7 13.0 8.0 0.5 1.8 0.7 3.9 1.6 0.3 1.7 1.0 5.0 0.9 0.7 1.0 0.3 16.0 9.5 0.3 0.3 8.3 0.9 3.8 4.2 2.9 2.2 4.9 10.6 1.9 1.8 2.7 2.2 1.0 0.2 3.6 5.1 2.8 9.2 8.8 5.8 1.9 9.8 2.2 2.6 1.4 2.0 3.0 1.7 1.1 1.3 8.8 3.5 5.6 0.8 1.9 2.5 3.6 3.8 1.2 2.4 3.6 3.6 4.3 2.3 4.4 2.2 50.6 271.2 17.1 18.3 18.5 1.0 4.5 5.1 6.7 36.4 27.9 0.0 23.3 1.7 10.2 116.0 15.0 0.2 0.0 18.2 25.9 19.4 16.1 23.1 1.3 54.5 0.0 0.0 8.6 37.3 53.8 13.0 40.8 8.5 26.2 1.0 2.5 22.0 0.0 9.9 19.6 0.0 12.9 8.0 0.9 2.5 5.4 18.4 6.5 1.0 16.9 DRAM2 "MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154" ENSG00000156171 "DNA damage regulated autophagy modulator 2" Q6UX65 1 111117333-111140216 "Predicted membrane proteins" "Apoptosis, Autophagy" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 18.0;THP-1: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018036, HPA061701" Supported Enhanced "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA018036: AB_1858134, HPA061701: AB_2684590" "unprognostic (9.38e-3)" "unprognostic (1.58e-2)" "unprognostic (2.16e-3)" "unprognostic (5.22e-2)" "unprognostic (1.12e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (3.45e-5)" "unprognostic (6.57e-3)" "prognostic unfavorable (6.43e-4)" "unprognostic (2.69e-1)" "unprognostic (4.37e-3)" "unprognostic (2.66e-1)" "prognostic unfavorable (7.45e-4)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (2.29e-1)" "unprognostic (1.77e-3)" 21.8 10.1 5.9 14.4 6.6 7.9 18.4 13.5 6.9 8.4 12.0 7.5 5.7 10.6 8.6 11.1 10.0 12.7 9.1 11.7 5.3 6.0 13.0 9.2 11.5 19.9 9.3 4.2 12.3 8.2 5.7 9.9 14.1 8.4 10.1 8.7 8.8 10.7 7.1 10.6 7.0 15.2 10.1 15.1 24.9 9.5 6.1 8.3 15.0 10.6 6.7 14.7 16.8 7.7 16.1 11.2 3.0 10.9 6.2 10.4 11.4 2.1 0.1 3.4 2.1 8.7 7.4 6.2 8.3 3.2 2.0 4.7 2.5 1.1 7.5 5.5 4.1 2.9 2.4 4.9 1.3 4.0 9.0 3.5 4.2 2.6 1.2 6.6 0.7 1.9 5.2 6.2 3.4 1.3 3.4 1.0 4.8 2.3 3.3 2.4 1.4 4.0 5.4 6.6 3.7 4.2 3.8 3.9 3.2 7.5 2.2 6.6 2.5 0.9 2.8 18.0 2.4 4.8 19.8 3.6 0.6 0.8 4.2 5.5 4.3 1.2 12.7 1.5 8.3 1.3 2.7 10.3 3.0 6.5 10.9 10.4 13.6 9.0 8.1 11.2 16.1 9.5 7.9 2.1 6.2 7.6 11.2 5.4 11.4 5.9 6.6 13.5 5.4 5.3 6.0 9.3 4.2 8.4 8.3 11.9 11.8 165.2 43.6 41.8 11.3 21.7 28.1 46.8 10.3 41.8 2.0 75.5 36.5 45.2 6.8 30.1 51.2 23.3 40.9 73.1 42.1 53.3 24.1 20.8 163.1 19.1 12.7 38.6 143.2 5.9 31.1 92.1 77.6 53.3 43.0 19.9 40.7 48.4 23.3 58.6 7.4 38.8 31.9 4.2 7.4 46.3 61.3 39.9 38.8 55.3 DRAXIN "C1orf187, Draxin, FLJ34999, Neucrin" ENSG00000162490 "Dorsal inhibitory axon guidance protein" Q8NBI3 1 11691729-11725857 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.6;brain: 9.5" "Cell type enhanced" "Detected in some" 6 "Basal glandular cells: 2.5;T-cells: 3.5" "Group enriched" "Detected in some" 6 "glioma: 5.1;testis cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 5.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NTERA-2: 25.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA014302 Uncertain "Secreted in brain" NA NA "HPA014302: AB_1853084" "unprognostic (5.28e-2)" "unprognostic (2.73e-1)" "unprognostic (6.58e-2)" "unprognostic (4.95e-2)" "unprognostic (2.51e-1)" "unprognostic (1.85e-1)" "unprognostic (1.37e-2)" "unprognostic (1.84e-2)" "unprognostic (1.49e-1)" "unprognostic (1.17e-1)" "unprognostic (1.51e-2)" "unprognostic (7.47e-2)" "unprognostic (5.16e-6)" "unprognostic (4.65e-2)" "unprognostic (1.15e-1)" "unprognostic (8.52e-2)" "unprognostic (5.08e-1)" 0.7 0.4 9.5 1.0 4.4 2.8 1.4 4.1 4.7 0.3 0.4 4.9 0.0 0.6 1.0 0.8 0.6 0.7 0.6 0.4 8.9 0.9 0.5 0.2 1.2 1.0 2.7 3.0 0.5 0.7 0.4 0.2 0.4 2.4 0.4 0.5 0.0 3.6 0.7 0.6 1.3 0.7 0.3 1.9 0.9 0.4 1.5 2.5 0.0 0.7 0.8 0.5 0.4 0.2 1.2 0.6 5.6 1.1 0.9 1.9 0.5 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.4 0.0 0.9 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 5.1 0.0 0.2 0.0 0.1 0.0 0.1 1.8 0.3 25.0 0.0 0.0 5.5 0.2 0.0 0.0 0.0 1.7 0.7 0.0 0.0 0.1 4.3 0.0 0.1 0.2 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 5.6 1.1 0.7 1.9 0.6 0.7 0.6 0.5 1.1 0.3 1.2 0.8 1.0 2.9 0.9 0.7 0.6 0.8 0.5 9.5 4.4 4.1 4.2 8.9 0.9 2.7 3.0 2.4 2.5 0.0 0.3 0.9 2.5 0.5 0.8 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.6 0.9 0.0 0.0 0.2 0.1 0.7 1.6 1.1 0.0 0.4 0.0 0.0 0.0 0.3 1.8 0.6 1.5 1.7 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.9 0.6 1.9 0.3 0.0 3.5 0.0 2.0 DRD1 ENSG00000184845 "Dopamine receptor D1" P21728 5 175440039-175444208 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 34.5" "Group enriched" "Detected in some" 13 "Bipolar cells: 40.8;Horizontal cells: 31.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 24.2" "Region enriched" "Detected in many" 9 "basal ganglia: 147.4" "Region enriched" "Detected in many" 13 "basal ganglia: 95.6" "HPA013393, HPA017304" Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA013393: AB_1847833, HPA017304: " "unprognostic (2.74e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-3)" "unprognostic (1.28e-1)" "unprognostic (1.15e-6)" "unprognostic (6.69e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (8.60e-4)" "unprognostic (5.86e-2)" "unprognostic (5.43e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" 0.7 1.5 1.9 0.2 34.5 0.0 0.1 0.1 12.0 0.7 0.7 0.4 0.0 0.5 0.4 0.7 0.7 0.6 1.1 0.3 1.0 0.6 0.7 2.6 1.8 0.1 0.5 1.6 0.3 0.0 0.0 0.1 2.5 0.3 2.7 0.9 2.1 0.1 1.2 0.1 0.1 0.3 0.4 0.1 0.4 0.4 0.1 6.8 0.1 0.1 0.0 0.4 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 24.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 34.5 0.1 5.3 1.0 0.6 0.5 1.6 0.3 6.8 0.0 0.0 0.0 0.0 0.1 40.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 31.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 2.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DRD2 ENSG00000149295 "Dopamine receptor D2" P14416 11 113409615-113475691 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 17.3;brain: 52.0;pituitary gland: 51.6" "Cell type enriched" "Detected in some" 12 "Horizontal cells: 57.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 52.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 45.2" "Region enriched" "Detected in many" 10 "basal ganglia: 183.8" "Group enriched" "Detected in many" 8 "basal ganglia: 126.7;midbrain: 41.7" "HPA015139, HPA015691" Supported Supported NA NA "HPA015139: , HPA015691: AB_1847834" "unprognostic (8.49e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-4)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (1.97e-2)" "unprognostic (5.89e-2)" "unprognostic (4.40e-2)" "unprognostic (8.33e-4)" "unprognostic (1.10e-1)" "unprognostic (6.65e-3)" "unprognostic (2.29e-1)" "unprognostic (1.71e-1)" "unprognostic (4.82e-2)" "unprognostic (8.49e-3)" 0.6 17.3 0.9 0.5 52.0 0.2 2.1 0.2 3.3 1.3 0.6 1.5 0.0 0.3 2.3 0.4 0.9 2.1 0.6 0.5 0.3 4.1 0.3 0.2 0.6 0.2 9.9 0.2 0.3 0.4 0.3 51.6 0.2 2.4 1.5 0.9 3.9 5.1 1.7 1.7 0.3 0.5 3.2 0.2 0.2 0.5 1.6 9.5 0.0 0.2 0.0 0.3 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.5 0.0 0.0 0.0 4.8 0.0 0.0 0.0 45.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.9 52.0 0.2 3.3 0.3 4.1 9.9 0.2 2.4 9.5 0.0 0.0 0.0 0.0 0.0 4.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DRD3 ENSG00000151577 "Dopamine receptor D3" P35462 3 114128652-114199407 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.0;brain: 8.3;testis: 4.2" "Group enriched" "Detected in some" 39 "Early spermatids: 5.5;Late spermatids: 12.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.0;T-reg: 1.4" "Lineage enriched" "Detected in single" 6 "T-cells: 2.0" "Cell line enhanced" "Detected in single" "HAP1: 1.0" "Region enriched" "Detected in some" 5 "basal ganglia: 7.5" "Region enriched" "Detected in many" 12 "basal ganglia: 25.2" NA NA "unprognostic (2.32e-1)" 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 2.0 0.6 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 DRD4 ENSG00000069696 "Dopamine receptor D4" P21917 11 637293-640706 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 86.1" "Group enriched" "Detected in some" 7 "Bipolar cells: 115.9;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 193.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 14 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 14 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "HaCaT: 2.7;Hep G2: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.83e-2)" "unprognostic (2.99e-2)" "unprognostic (4.98e-4)" "unprognostic (3.81e-2)" "unprognostic (7.52e-2)" "unprognostic (7.89e-3)" "unprognostic (3.14e-2)" "unprognostic (2.96e-1)" "unprognostic (8.45e-2)" "unprognostic (5.07e-2)" "unprognostic (3.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.05e-4)" "unprognostic (1.26e-2)" "unprognostic (8.21e-2)" "unprognostic (2.36e-2)" "unprognostic (1.85e-1)" 0.9 0.6 1.8 0.5 1.9 1.2 0.7 3.5 1.6 1.2 1.4 4.3 0.5 1.5 1.5 0.5 0.5 1.5 0.6 0.7 2.3 2.0 1.0 0.7 1.1 1.4 1.0 1.1 3.4 1.4 0.5 4.2 1.1 7.3 1.6 0.5 86.1 1.6 0.5 10.2 3.5 2.8 0.8 1.2 1.0 0.6 1.8 0.7 0.7 1.3 0.5 1.0 0.5 1.2 0.0 3.2 0.2 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 2.7 0.0 0.1 0.0 0.3 1.3 0.2 0.4 2.7 0.0 0.7 0.3 0.0 0.3 0.0 0.3 0.0 0.0 0.1 1.0 0.0 0.0 0.8 0.6 0.1 0.6 0.2 0.0 0.2 0.3 0.0 0.0 0.3 0.0 1.0 0.5 0.3 0.1 0.0 0.3 1.0 0.0 0.7 0.7 0.1 0.9 1.0 0.9 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 1.8 1.9 3.5 1.6 2.3 2.0 1.0 1.1 7.3 0.7 0.0 0.3 0.0 0.3 0.0 115.9 1.1 0.0 0.0 0.0 1.8 82.5 0.4 0.0 0.1 0.4 0.0 1.3 0.0 0.3 0.2 0.4 0.7 0.0 0.0 0.2 6.4 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 1.1 19.0 0.3 0.0 0.7 1.2 193.4 0.0 0.3 0.2 1.0 0.4 0.1 0.0 1.1 0.3 DRD5 "DRD1B, DRD1L2" ENSG00000169676 "Dopamine receptor D5" P21918 4 9781680-9784009 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Dystonia, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 8.4;lymphoid tissue: 3.5;stomach 1: 10.9" "Cell type enhanced" "Detected in single" 41 "Horizontal cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 3.6;THP-1: 2.0;U-2 OS: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048930 Supported NA NA "HPA048930: AB_2680562" "unprognostic (2.03e-2)" "unprognostic (2.63e-1)" "unprognostic (9.73e-2)" "unprognostic (4.27e-2)" "unprognostic (4.44e-3)" "unprognostic (1.98e-2)" "unprognostic (1.32e-4)" "unprognostic (5.09e-4)" "unprognostic (6.51e-2)" "unprognostic (1.46e-1)" "unprognostic (7.36e-3)" 0.2 0.2 2.8 3.5 4.1 0.1 0.2 0.0 8.4 0.1 0.9 0.0 0.0 0.9 0.1 0.1 0.3 0.3 0.1 0.1 3.2 3.2 0.2 0.1 0.4 0.2 1.9 0.8 0.1 0.2 0.1 1.0 0.1 7.4 0.6 0.2 0.4 0.2 0.2 0.1 0.2 0.2 0.2 0.6 0.1 10.9 1.3 1.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 3.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.4 0.0 2.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.1 0.0 8.4 3.2 3.2 1.9 0.8 7.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DSC1 CDHF1 ENSG00000134765 "Desmocollin 1" Q08554 18 31129236-31162856 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 78.4" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 145.5" "Group enriched" "Detected in some" 17 "head and neck cancer: 7.3;melanoma: 4.1" "Region enriched" "Detected in single" 13 "cerebral cortex: 7.0" "Group enriched" "Detected in some" 8 "naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.2" "Lineage enriched" "Detected in single" 8 "T-cells: 5.7" "Cell line enriched" "Detected in single" 4 "hTERT-RPE1: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075379 Enhanced NA NA 18000000 "HPA075379: AB_2732290" "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (2.12e-1)" "unprognostic (1.10e-1)" "unprognostic (6.95e-2)" "unprognostic (2.48e-2)" "unprognostic (3.71e-2)" "unprognostic (8.19e-3)" "unprognostic (1.56e-1)" "unprognostic (1.89e-1)" "unprognostic (1.27e-1)" "unprognostic (1.78e-1)" "unprognostic (5.65e-6)" "unprognostic (5.08e-2)" "unprognostic (2.91e-1)" "unprognostic (6.99e-2)" "unprognostic (4.74e-5)" 0.2 0.1 0.1 0.3 0.5 0.0 3.5 0.1 7.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 2.8 0.1 0.0 9.1 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.4 0.1 1.3 0.0 0.1 0.0 1.3 1.2 0.0 0.2 78.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 1.1 0.1 16.6 1.5 0.1 0.2 0.0 0.0 0.7 0.0 0.0 5.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 5.7 5.2 0.7 0.0 0.0 0.0 0.0 0.9 0.1 0.5 0.1 7.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 12.6 0.4 29.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 145.5 0.3 0.0 0.0 0.1 DSC2 "CDHF2, DSC3" ENSG00000134755 "Desmocollin 2" Q02487 18 31058840-31102415 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 127.5;lymphoid tissue: 68.2;tongue: 163.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 156.0;Extravillous trophoblasts: 157.3;Paneth cells: 155.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 48.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "eosinophil: 20.4;neutrophil: 5.7" "Lineage enriched" "Detected in many" 14 "granulocytes: 20.4" "Cell line enhanced" "Detected in many" "BEWO: 15.3;CAPAN-2: 19.8;HaCaT: 28.6;hTCEpi: 30.9;OE19: 24.0;SK-BR-3: 18.1;SuSa: 18.6" "Not detected" "Not detected" "HPA011911, HPA012615" Enhanced NA NA 14000000 "HPA011911: AB_1847618, HPA012615: AB_1847619" "unprognostic (3.28e-2)" "unprognostic (3.20e-1)" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (1.90e-1)" "unprognostic (3.04e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (7.66e-2)" "unprognostic (4.07e-2)" "unprognostic (1.22e-3)" "unprognostic (2.10e-1)" "unprognostic (1.43e-3)" "unprognostic (1.60e-1)" "unprognostic (1.75e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (3.01e-4)" 3.3 1.1 1.1 9.8 1.1 0.0 6.3 0.7 0.9 38.1 23.6 0.6 0.2 12.1 3.0 2.4 127.5 1.5 1.1 9.5 1.0 0.9 4.7 4.3 3.3 6.3 1.1 0.6 1.0 3.8 11.8 0.7 20.0 1.1 4.5 13.3 1.3 22.4 0.0 0.7 4.4 33.5 0.8 1.7 6.1 12.6 0.9 0.7 4.8 2.5 163.9 68.2 1.0 39.6 0.0 0.0 20.4 1.5 0.0 0.0 0.3 7.1 0.7 1.1 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 3.6 19.8 0.0 0.3 0.0 0.3 28.6 4.8 2.0 0.0 0.0 2.8 10.6 3.4 6.3 0.1 0.0 0.2 0.1 30.9 0.0 3.0 2.5 0.0 0.0 5.1 0.0 0.0 5.7 0.0 0.4 4.6 24.0 7.1 5.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 18.1 0.0 18.6 4.9 7.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 20.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.3 1.1 1.1 0.7 0.9 1.0 0.9 1.1 0.6 1.1 0.7 26.8 6.4 0.9 29.2 74.4 0.7 29.9 22.9 0.0 3.4 7.0 0.0 77.6 0.0 76.8 0.1 5.3 156.0 0.0 28.7 157.3 3.7 131.3 0.0 14.0 21.2 0.0 66.7 9.8 50.9 0.0 0.3 31.7 13.5 34.3 68.2 7.3 108.4 155.6 0.7 8.6 0.6 0.0 3.3 0.1 0.6 48.1 70.1 3.2 63.7 69.4 DSC3 "CDHF3, DSC, DSC1, DSC2, DSC4" ENSG00000134762 "Desmocollin 3" Q14574 18 30990008-31042815 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" Hypotrichosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 444.8;Suprabasal keratinocytes: 602.1" "Cancer enhanced" "Detected in many" "cervical cancer: 78.6;head and neck cancer: 107.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 71.0;HBEC3-KT: 16.3;hTCEpi: 42.0;hTERT-HME1: 30.9;REH: 11.9" "Group enriched" "Detected in some" 4 "basal ganglia: 1.3;hippocampal formation: 3.6" "Low region specificity" "Detected in some" "CAB037328, HPA049265, HPA073937" Enhanced Enhanced "Plasma membrane,Cell Junctions" NA NA 2700000 "Plasma membrane, Cell Junctions" "CAB037328: , HPA049265: AB_2680695, HPA073937: AB_2686645" "unprognostic (4.44e-3)" "unprognostic (6.28e-2)" "unprognostic (1.46e-1)" "unprognostic (3.02e-3)" "unprognostic (2.38e-1)" "unprognostic (1.32e-2)" "unprognostic (6.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-2)" "unprognostic (3.92e-3)" "unprognostic (3.13e-1)" "unprognostic (4.13e-4)" "unprognostic (1.22e-2)" "unprognostic (7.85e-2)" "unprognostic (3.47e-1)" "prognostic unfavorable (1.04e-5)" 1.5 0.0 0.0 0.6 0.0 0.0 10.4 0.0 0.0 11.9 1.0 0.0 0.4 0.1 2.1 1.4 73.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 2.4 0.1 16.0 0.1 4.5 0.0 0.0 7.2 0.3 0.2 99.1 0.2 0.1 0.0 0.0 0.0 0.5 0.0 2.2 0.0 92.4 28.4 1.0 14.4 0.7 0.2 1.0 0.5 0.4 0.4 0.1 4.5 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 71.0 0.0 16.3 0.0 0.0 3.9 0.2 1.4 0.1 2.7 0.0 0.0 2.8 42.0 0.0 30.9 5.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 5.8 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.3 0.2 0.2 0.4 0.3 0.2 0.0 0.7 0.3 0.4 1.0 0.4 0.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 1.4 0.0 43.5 444.8 0.0 1.2 0.0 2.7 19.4 0.0 0.0 62.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.1 7.5 19.6 0.0 0.0 4.6 0.0 2.4 0.0 0.0 0.0 0.0 0.6 37.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 602.1 20.9 0.0 0.0 96.7 DSCAM "CHD2-42, CHD2-52" ENSG00000171587 "DS cell adhesion molecule" O60469 21 40010999-40847139 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.2;pituitary gland: 9.1" "Group enriched" "Detected in some" 5 "Bipolar cells: 15.0;Horizontal cells: 15.9" "Cancer enriched" "Detected in single" 14 "glioma: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.6;MCF7: 12.3;NTERA-2: 3.4;SCLC-21H: 5.1;T-47d: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019324, HPA057493" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA019324: AB_2670118, HPA057493: " "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (7.59e-2)" "unprognostic (1.99e-2)" "unprognostic (9.98e-2)" "unprognostic (5.49e-4)" "unprognostic (1.78e-1)" "unprognostic (9.58e-2)" "unprognostic (7.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.85e-3)" "unprognostic (2.12e-2)" "unprognostic (2.00e-3)" "unprognostic (2.17e-2)" "unprognostic (2.29e-1)" "unprognostic (8.75e-2)" "unprognostic (5.46e-3)" 0.9 1.1 12.7 0.9 10.3 0.9 1.2 3.0 22.2 0.9 1.0 8.2 0.0 1.0 0.9 2.8 0.9 1.1 1.0 0.9 10.1 8.6 0.9 1.4 1.0 0.9 6.8 10.1 0.9 1.2 0.9 9.1 2.9 9.5 1.0 1.0 0.7 0.9 1.0 0.9 0.9 1.0 0.9 3.7 2.9 0.9 2.0 6.9 0.0 0.9 0.0 0.9 1.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 3.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.1 0.0 0.0 0.1 0.0 0.5 3.4 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.7 10.3 3.0 14.7 10.1 8.6 6.8 10.1 9.5 6.9 0.0 0.0 0.0 0.0 0.0 15.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 15.9 0.0 0.6 1.0 3.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.3 0.0 0.0 1.8 1.5 0.0 0.7 0.0 0.0 0.0 DSCAML1 KIAA1132 ENSG00000177103 "DS cell adhesion molecule like 1" Q8TD84 11 117427773-117817525 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Group enriched" "Detected in some" 10 "Bipolar cells: 78.3;Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 127.6" "Group enriched" "Detected in some" 5 "glioma: 1.9;ovarian cancer: 0.9;pancreatic cancer: 0.6;renal cancer: 2.5;thyroid cancer: 0.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "memory B-cell: 1.7;naive B-cell: 2.0;T-reg: 2.4" "Group enriched" "Detected in many" 22 "B-cells: 2.0;T-cells: 2.4" "Group enriched" "Detected in some" 4 "EFO-21: 9.2;RPTEC TERT1: 6.8;T-47d: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035230 Uncertain NA NA "HPA035230: AB_2674527" "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" "unprognostic (1.07e-2)" "unprognostic (6.27e-5)" "unprognostic (8.48e-2)" "unprognostic (1.56e-2)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (7.96e-2)" "unprognostic (2.89e-2)" "unprognostic (2.39e-3)" "unprognostic (8.37e-2)" "prognostic favorable (8.37e-4)" "unprognostic (1.64e-1)" "unprognostic (1.86e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-2)" 1.5 1.7 10.4 1.3 14.5 1.1 1.3 3.4 19.5 1.7 2.2 26.0 0.0 1.8 4.2 2.2 1.3 4.3 3.5 2.1 12.0 5.8 5.6 1.2 2.0 1.4 14.9 11.1 9.9 2.6 1.0 5.0 1.0 12.1 1.7 2.3 10.8 3.6 1.5 2.1 1.0 1.9 2.9 12.2 3.3 1.9 4.2 17.4 0.0 1.5 0.0 1.7 1.7 0.9 2.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 9.2 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.1 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.3 6.8 0.0 1.2 0.2 0.0 0.0 0.0 0.4 12.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 10.4 14.5 3.4 14.4 12.0 5.8 14.9 11.1 12.1 17.4 0.0 0.0 0.0 0.0 0.1 78.3 2.8 0.0 5.3 0.0 0.0 39.3 0.0 0.0 0.4 5.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 3.2 6.4 0.6 0.0 8.6 1.1 0.0 0.0 0.0 2.5 2.5 0.0 0.0 1.8 2.1 127.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 DSE "DS-Epi1, DSEPI, SART2" ENSG00000111817 "Dermatan sulfate epimerase" Q9UL01 6 116254173-116444860 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 85.3;Macrophages: 81.1;monocytes: 97.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 8.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014764, HPA052151" Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA014764: AB_1856587, HPA052151: AB_2681746" "unprognostic (1.28e-1)" "prognostic unfavorable (3.36e-4)" "unprognostic (1.38e-1)" "unprognostic (3.23e-3)" "unprognostic (1.21e-1)" "unprognostic (1.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.02e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (6.34e-4)" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (6.19e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "unprognostic (1.10e-2)" 32.3 10.6 7.4 22.3 10.7 13.1 34.8 5.4 7.7 16.0 12.8 4.9 9.9 5.3 11.7 18.5 13.5 15.3 12.9 16.1 8.1 4.3 11.2 10.4 17.7 13.1 9.8 4.5 21.0 4.0 15.4 20.9 21.7 13.1 13.0 7.1 14.3 9.3 9.4 8.5 16.9 10.7 12.8 16.1 24.9 7.6 10.9 9.0 8.3 8.7 10.9 8.3 14.6 29.4 3.6 8.9 2.5 3.9 0.2 1.1 1.2 10.5 2.3 7.9 7.4 21.5 14.2 9.0 12.5 29.4 15.7 23.1 0.0 3.0 0.3 1.1 21.8 15.8 20.3 1.1 29.4 20.6 10.9 4.8 0.7 3.4 0.1 24.0 0.5 0.5 30.1 12.7 17.4 17.1 8.2 9.2 2.7 0.2 4.8 7.5 0.3 1.4 0.6 4.2 0.0 0.6 1.8 7.3 5.0 10.4 0.7 2.6 2.0 12.1 0.0 0.3 5.7 0.1 1.2 3.4 15.9 4.6 3.9 10.0 1.0 0.3 0.5 8.4 1.3 1.8 0.7 3.1 0.1 1.0 3.9 0.6 3.2 0.9 0.4 8.9 3.6 1.1 0.4 2.5 0.2 2.2 4.2 0.2 1.2 7.4 10.7 5.4 7.7 8.1 4.3 9.8 4.5 13.1 9.0 14.9 2.6 18.6 20.6 46.1 4.1 7.0 5.1 18.7 18.2 3.5 0.0 2.0 6.6 4.0 39.9 11.9 0.0 0.0 7.5 3.7 35.5 14.2 22.0 3.8 39.5 1.6 1.2 57.7 85.3 19.2 50.9 81.1 10.1 97.4 0.7 3.9 9.5 0.0 28.3 6.1 3.0 32.3 29.2 2.6 5.1 34.9 4.1 6.5 1.0 42.4 DSEL "C18orf4, DE-epi2, FLJ11477, NCAG1" ENSG00000171451 "Dermatan sulfate epimerase-like" Q8IZU8 18 67506582-67516980 "Predicted membrane proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 43.3;Extravillous trophoblasts: 69.4;Fibroblasts: 40.8" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Cell line enhanced" "Detected in many" "BJ: 19.9;BJ hTERT+: 11.5;LHCN-M2: 24.9;U-138 MG: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060942 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060942: AB_2684392" "unprognostic (2.49e-1)" "unprognostic (5.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.19e-5)" "unprognostic (1.56e-1)" "unprognostic (2.71e-1)" "unprognostic (2.40e-3)" "unprognostic (7.11e-2)" "unprognostic (4.91e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-2)" "unprognostic (2.47e-1)" "unprognostic (7.95e-3)" "unprognostic (3.25e-2)" "unprognostic (1.24e-1)" "unprognostic (9.70e-3)" "unprognostic (1.16e-4)" 10.2 3.4 8.8 3.2 15.5 1.6 9.4 7.9 12.8 10.9 4.5 15.7 2.5 2.2 5.7 4.0 3.1 7.1 8.3 5.1 8.6 8.4 9.0 7.1 6.0 1.9 13.2 4.5 7.6 3.6 3.6 1.3 11.5 9.7 4.8 3.5 2.4 2.3 4.9 1.9 3.2 2.7 7.4 11.1 4.5 3.1 3.4 10.9 0.0 2.8 1.1 1.6 3.6 8.4 0.2 0.1 0.6 0.1 0.3 3.2 0.3 0.0 0.0 2.4 0.0 4.7 7.0 0.3 19.9 11.5 5.1 2.2 0.0 0.0 0.0 0.0 10.1 1.3 0.1 0.4 0.9 4.9 0.0 0.0 0.0 2.2 0.0 4.0 0.0 0.0 7.0 1.3 3.1 7.4 1.9 1.0 0.0 0.0 0.2 24.9 0.0 0.0 0.0 0.3 0.0 2.1 0.2 5.3 0.0 2.3 0.0 0.9 1.1 1.8 0.0 0.0 1.1 0.0 0.0 1.7 25.9 0.8 1.8 2.2 0.1 0.0 0.0 5.4 0.0 2.2 0.6 0.1 0.2 0.2 0.0 1.7 0.1 0.8 1.2 0.0 0.2 0.5 3.2 0.5 0.3 0.1 0.1 0.2 0.3 8.8 15.5 7.9 9.9 8.6 8.4 13.2 4.5 9.7 10.9 6.0 14.4 2.0 8.0 10.3 9.4 14.3 43.3 0.0 2.3 10.4 3.9 2.4 0.0 7.9 1.1 11.3 0.5 0.0 2.0 69.4 40.8 6.6 4.6 12.9 2.2 3.2 6.3 16.0 2.1 1.4 22.7 2.9 6.8 0.0 0.1 14.3 5.4 0.0 34.6 18.8 4.2 12.9 12.3 13.1 11.7 11.5 7.4 2.5 0.6 5.4 DSG2 CDHF5 ENSG00000046604 "Desmoglein 2" Q14126 18 31498043-31549008 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.7" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 208.8;Mucus-secreting cells: 176.4;Pancreatic endocrine cells: 177.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 7 "pons and medulla: 6.9" "Cell type enriched" "Detected in single" 10 "basophil: 9.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 9.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 36.3;HaCaT: 56.6;HBEC3-KT: 42.0;hTERT-HME1: 45.7;OE19: 47.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA004896, CAB025122" Enhanced Supported "Cell Junctions" NA NA 94000000 "Cell Junctions" "CAB025122: , HPA004896: AB_1078643" "unprognostic (1.56e-3)" "prognostic unfavorable (8.22e-4)" "prognostic favorable (7.81e-4)" "unprognostic (8.77e-3)" "unprognostic (3.53e-4)" "prognostic unfavorable (5.63e-4)" "unprognostic (2.86e-3)" "prognostic unfavorable (2.43e-4)" "unprognostic (5.21e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (4.94e-5)" "unprognostic (3.40e-1)" "prognostic favorable (3.14e-10)" "unprognostic (1.76e-1)" "unprognostic (1.51e-1)" "unprognostic (3.72e-1)" "unprognostic (8.57e-3)" 17.3 1.1 0.6 11.6 0.7 0.0 21.1 0.7 0.7 3.9 50.2 1.3 4.0 18.1 3.8 5.6 6.3 4.9 14.2 15.7 0.7 0.6 22.4 10.8 7.0 2.4 0.6 0.9 8.8 15.5 39.9 2.7 39.8 6.9 10.4 23.8 4.5 27.3 1.5 2.2 5.3 70.7 3.1 0.5 0.6 17.3 2.3 0.5 13.6 20.8 3.2 5.8 18.5 7.7 0.1 0.9 9.5 0.0 0.0 0.3 0.0 24.2 9.4 0.8 0.0 0.1 1.5 30.5 0.0 0.0 0.0 0.0 6.5 36.3 0.0 13.8 0.0 11.6 56.6 11.5 42.0 0.0 0.0 7.1 0.0 10.8 7.3 4.4 3.0 0.0 2.1 29.2 0.9 45.7 22.0 0.0 7.2 9.6 0.0 0.0 6.4 6.4 0.4 11.7 47.1 4.8 10.8 0.0 15.5 14.1 12.1 5.1 0.0 18.4 13.1 0.0 26.3 9.3 2.6 0.0 0.0 5.4 0.0 6.0 1.2 0.0 0.0 4.3 0.0 5.3 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.6 0.7 0.7 0.7 0.7 0.6 0.6 0.9 6.9 0.5 50.6 38.4 0.5 64.3 11.9 0.2 51.1 89.2 42.8 50.0 12.2 0.0 70.4 3.3 82.4 0.6 8.7 208.8 23.3 65.2 91.9 9.5 96.7 4.6 22.1 9.0 1.6 76.9 2.5 1.5 1.6 1.4 1.8 16.9 10.8 176.4 4.2 177.3 149.7 0.4 10.0 0.2 0.0 9.5 3.0 8.1 5.3 50.1 1.3 168.5 163.4 DSG4 "CDHF13, LAH" ENSG00000175065 "Desmoglein 4" Q86SJ6 18 31376777-31414912 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 7.3;testis: 2.6" "Group enriched" "Detected in some" 4 "Early spermatids: 1.0;Urothelial cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 143 "HaCaT: 31.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA059456 Enhanced NA NA 300000 "HPA059456: AB_2684025" "unprognostic (9.86e-2)" "unprognostic (8.61e-2)" "unprognostic (2.17e-2)" "unprognostic (2.61e-1)" "unprognostic (5.55e-2)" "unprognostic (5.61e-2)" "unprognostic (2.11e-2)" "unprognostic (6.00e-2)" "unprognostic (1.06e-1)" "unprognostic (2.58e-1)" "unprognostic (2.14e-1)" "unprognostic (1.79e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.0 0.0 7.3 0.7 0.0 0.0 0.0 1.0 2.6 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 DST "BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2" ENSG00000151914 Dystonin Q03001 6 56457987-56954628 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Basal glandular cells: 1024.4;Basal keratinocytes: 2104.0;Cone photoreceptor cells: 1319.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 5 "dendritic cells: 5.3;monocytes: 1.7;NK-cells: 2.1" "Cell line enhanced" "Detected in many" "hTCEpi: 94.5;hTERT-HME1: 70.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030200 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules" Cytosol "HPA030200: AB_10601901" "unprognostic (4.87e-3)" "unprognostic (1.29e-1)" "unprognostic (3.40e-1)" "unprognostic (1.54e-1)" "unprognostic (1.25e-2)" "unprognostic (3.60e-2)" "unprognostic (5.78e-2)" "unprognostic (2.35e-2)" "unprognostic (1.09e-1)" "unprognostic (2.75e-2)" "unprognostic (1.13e-1)" "unprognostic (3.69e-1)" "unprognostic (4.39e-2)" "unprognostic (5.13e-3)" "unprognostic (1.46e-1)" "unprognostic (2.66e-1)" "unprognostic (7.62e-2)" 26.5 29.2 43.4 11.7 57.1 2.5 59.2 43.6 52.4 53.8 31.5 32.1 11.5 15.1 53.6 21.7 37.1 19.4 16.8 28.1 41.2 36.2 18.0 26.6 29.4 5.4 56.5 28.9 30.3 14.0 32.1 28.2 15.1 53.9 22.6 17.4 8.4 23.6 25.3 57.5 81.8 16.9 53.6 54.9 12.8 14.8 11.7 66.5 6.1 7.6 33.6 7.7 19.7 23.7 0.6 5.3 0.3 1.7 2.1 0.4 0.3 12.2 5.9 7.9 4.4 13.1 20.7 4.5 16.5 15.8 6.8 7.6 3.4 3.2 1.9 6.8 37.2 6.8 8.6 6.7 29.0 13.5 11.6 9.9 3.4 10.6 6.2 11.8 3.3 0.0 9.1 94.5 16.6 70.1 11.9 12.9 1.9 2.8 8.1 17.7 3.4 1.0 1.3 6.0 6.8 4.3 0.0 6.1 2.8 20.6 15.8 10.5 7.9 7.0 2.4 11.2 14.1 3.7 5.3 34.5 15.1 12.7 7.2 13.6 9.1 6.4 1.0 10.7 1.8 7.2 0.3 1.7 0.0 0.3 1.3 0.1 0.2 0.4 0.0 3.2 0.6 0.1 0.2 0.1 2.1 1.0 5.3 0.0 0.3 43.4 57.1 43.6 52.4 41.2 36.2 56.5 28.9 53.9 66.5 312.7 10.2 2.2 1024.4 2104.0 540.0 729.3 79.0 49.5 257.0 52.4 1319.4 36.7 6.6 171.1 26.9 93.9 163.1 23.3 56.2 11.1 132.5 139.6 16.2 67.6 21.5 290.8 43.1 50.3 48.7 7.9 123.4 67.7 204.1 62.3 71.1 216.1 150.7 84.2 143.2 6.7 103.8 64.7 142.4 7.1 9.1 749.3 22.2 6.1 19.2 121.2 DTNA "D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3" ENSG00000134769 "Dystrobrevin alpha" Q9Y4J8 18 34493290-34891844 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2" "Cell type enhanced" "Detected in many" 18 "Cardiomyocytes: 121.0;Muller glia cells: 42.7" "Cancer enriched" "Detected in many" 9 "glioma: 28.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;T-cells: 6.7" "Cell line enhanced" "Detected in many" "MCF7: 17.7;NTERA-2: 19.8;SCLC-21H: 27.8;U-87 MG: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015196, HPA071177" Enhanced Approved "Nucleoplasm,Cell Junctions,Intermediate filaments" NA NA "Cell Junctions, Intermediate filaments" Nucleoplasm "CAB015196: AB_2261797, HPA071177: " "unprognostic (1.57e-1)" "unprognostic (4.57e-2)" "unprognostic (3.13e-3)" "unprognostic (7.82e-6)" "unprognostic (5.03e-1)" "unprognostic (2.43e-3)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (1.23e-1)" "unprognostic (6.27e-2)" "unprognostic (1.35e-4)" "unprognostic (6.89e-2)" "prognostic favorable (2.64e-7)" "unprognostic (6.08e-3)" "unprognostic (3.93e-2)" "unprognostic (1.12e-1)" "unprognostic (7.27e-5)" 9.3 5.3 51.5 4.0 47.6 1.6 7.3 37.7 69.1 4.5 5.4 38.7 0.9 3.4 4.3 13.9 13.9 7.6 7.1 82.8 42.3 46.5 2.7 2.5 4.8 2.3 44.7 21.0 5.4 12.3 1.4 6.1 3.6 51.0 14.6 5.6 3.4 5.7 15.9 90.2 1.8 3.9 15.2 106.3 3.9 3.6 4.7 39.5 0.0 9.3 6.5 2.4 12.8 1.7 1.4 7.0 0.4 1.3 1.0 6.7 1.7 0.3 0.1 7.6 0.0 4.9 13.6 1.2 2.0 7.4 0.3 0.9 1.7 0.0 0.0 4.5 0.8 7.0 0.6 0.9 3.9 0.7 0.0 5.3 0.0 0.4 3.5 3.9 0.1 0.1 10.3 0.8 6.4 2.2 7.3 3.3 0.0 1.1 1.0 2.1 17.7 0.1 0.0 19.8 0.3 4.0 0.0 3.7 12.1 0.3 0.1 27.8 3.2 0.0 0.7 2.0 12.5 10.9 2.6 0.1 8.8 4.8 0.1 2.7 0.6 0.9 0.4 28.4 0.0 3.8 0.4 1.3 0.0 1.4 0.0 1.9 1.4 2.7 1.9 7.0 1.1 2.8 2.0 0.1 1.0 0.0 0.2 6.7 1.7 51.5 47.6 37.7 35.7 42.3 46.5 44.7 21.0 51.0 39.5 0.0 1.4 0.0 0.0 1.3 10.2 121.0 22.9 4.0 1.2 0.0 5.9 0.0 5.0 9.9 3.1 0.7 0.0 0.0 21.8 0.1 2.8 0.9 0.0 0.0 7.1 1.6 0.0 0.0 4.1 1.9 5.5 8.8 5.0 0.0 0.0 42.7 12.5 0.0 0.4 1.5 4.2 12.9 22.8 0.5 1.5 0.9 0.0 0.0 0.0 0.1 DUOX1 "LNOX1, NOXEF1, THOX1" ENSG00000137857 "Dual oxidase 1" Q9NRD9 15 45129933-45165576 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 48.7" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 77.4;Alveolar cells type 2: 116.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HaCaT: 34.6;hTCEpi: 16.8;RT4: 19.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.5" HPA023544 Approved NA NA "HPA023544: AB_1847878" "unprognostic (2.85e-2)" "prognostic favorable (4.31e-6)" "unprognostic (2.49e-2)" "unprognostic (8.84e-3)" "unprognostic (1.44e-2)" "unprognostic (3.27e-2)" "unprognostic (1.23e-1)" "unprognostic (2.57e-2)" "unprognostic (5.87e-2)" "unprognostic (6.02e-3)" "unprognostic (5.13e-2)" "unprognostic (1.19e-1)" "unprognostic (8.91e-3)" "unprognostic (2.23e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (3.03e-1)" 0.4 5.2 0.5 0.4 0.8 0.0 2.0 1.2 0.9 18.9 0.6 2.4 43.3 0.1 2.2 37.8 38.3 6.0 6.2 1.1 0.6 0.1 0.2 0.1 48.7 0.1 1.0 0.5 1.2 0.1 1.8 0.9 2.5 0.9 4.8 0.0 4.3 9.8 19.2 0.8 34.2 0.3 1.6 0.5 0.1 18.0 1.0 1.1 0.7 31.9 35.9 31.9 6.2 13.1 0.2 1.5 0.5 0.5 0.1 0.4 0.0 4.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.6 0.0 3.2 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 16.8 0.0 1.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 19.3 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.5 0.0 0.1 0.3 0.0 1.1 0.2 0.2 0.0 0.0 0.1 0.1 1.5 0.2 0.0 0.5 0.8 1.2 0.9 0.6 0.1 1.0 0.5 0.9 1.1 77.4 116.2 6.7 13.0 9.8 20.8 2.0 10.2 38.8 34.2 3.5 7.9 3.8 0.0 3.4 0.5 2.9 2.7 0.0 4.8 0.6 5.2 5.8 8.1 1.7 1.1 6.4 20.8 8.6 5.1 0.0 3.1 5.8 15.1 1.8 3.4 4.1 3.3 4.2 3.5 0.3 2.6 0.0 2.7 2.8 2.3 15.7 3.1 10.1 2.3 23.7 DUOX2 "LNOX2, P138-TOX, P138(TOX), THOX2" ENSG00000140279 "Dual oxidase 2" Q9NRD8 15 45092650-45114344 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 151.5;gallbladder: 80.4" "Cell type enhanced" "Detected in many" 18 "Ductal cells: 151.4;Exocrine glandular cells: 106.5;Pancreatic endocrine cells: 346.5;Urothelial cells: 98.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 60.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "basophil: 1.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.3" "Cell line enriched" "Detected in some" 8 "HaCaT: 11.8" "Region enhanced" "Detected in single" "basal ganglia: 1.3" "Not detected" "Not detected" NA NA "unprognostic (3.19e-1)" "unprognostic (7.51e-2)" "unprognostic (3.77e-2)" "unprognostic (5.99e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (7.93e-2)" "unprognostic (3.32e-1)" "unprognostic (1.42e-1)" "unprognostic (4.49e-2)" "unprognostic (9.59e-3)" "unprognostic (7.11e-2)" "unprognostic (5.32e-5)" "unprognostic (1.71e-1)" "unprognostic (1.62e-2)" "unprognostic (4.12e-2)" "unprognostic (1.63e-2)" 0.1 0.6 0.1 8.4 0.3 0.0 0.1 0.1 0.2 5.1 3.2 0.2 151.5 0.3 0.4 0.8 10.9 0.0 80.4 0.3 0.1 0.0 0.3 0.8 1.2 0.1 0.1 0.1 0.2 0.8 0.0 0.1 0.2 0.2 3.4 1.4 0.4 7.3 1.2 0.6 2.1 3.5 0.6 0.1 0.1 14.9 0.5 0.1 0.1 29.0 6.1 6.6 20.4 9.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.6 0.0 0.0 11.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.3 0.2 0.4 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 44.7 41.2 0.0 1.9 1.6 0.4 1.6 68.8 21.4 37.5 0.0 0.0 0.0 0.0 151.4 0.5 0.0 4.3 0.0 106.5 0.0 0.5 3.8 30.2 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.3 0.9 0.0 9.0 4.1 0.1 346.5 4.2 0.0 0.0 0.3 0.0 3.1 0.7 0.3 1.6 0.0 0.0 2.1 98.5 DUOXA1 "FLJ32334, mol, NIP, NUMBIP" ENSG00000140254 "Dual oxidase maturation factor 1" Q1HG43 15 45117367-45129938 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 48.0" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 56.6;Alveolar cells type 2: 90.0;Ciliated cells: 38.8;Club cells: 36.4;Urothelial cells: 33.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 30.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "MAIT T-cell: 2.1" "Lineage enriched" "Detected in single" 12 "T-cells: 2.1" "Cell line enriched" "Detected in some" 7 "HaCaT: 48.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041578 Approved NA NA "HPA041578: AB_10795691" "unprognostic (1.28e-1)" "unprognostic (1.32e-3)" "unprognostic (1.88e-1)" "unprognostic (2.66e-2)" "unprognostic (2.71e-1)" "unprognostic (6.87e-3)" "unprognostic (1.03e-1)" "unprognostic (4.45e-2)" "unprognostic (6.69e-2)" "unprognostic (3.68e-2)" "unprognostic (5.82e-2)" "unprognostic (1.86e-1)" "unprognostic (2.17e-5)" "unprognostic (8.11e-2)" "unprognostic (1.12e-2)" "unprognostic (4.69e-2)" "unprognostic (5.36e-2)" 0.5 1.2 0.4 0.9 0.5 0.0 1.4 0.4 0.6 8.5 0.4 0.7 18.8 0.1 2.0 18.9 48.0 1.9 1.8 0.4 0.4 0.0 0.6 0.4 23.7 0.4 0.4 0.4 0.4 0.4 1.0 0.4 1.0 0.5 5.7 0.0 1.6 7.5 9.5 0.4 32.8 0.5 1.7 0.4 0.4 9.1 0.6 0.4 0.4 30.3 34.1 26.2 10.0 17.9 0.1 0.0 0.0 0.1 0.1 2.1 0.3 4.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.5 0.4 0.6 0.4 0.0 0.4 0.4 0.5 0.4 56.6 90.0 0.0 16.5 8.4 0.4 0.4 0.0 38.8 36.4 0.0 2.0 1.6 0.0 1.1 0.1 0.6 0.0 0.0 2.7 0.1 1.5 6.6 1.1 0.0 0.2 0.0 2.9 0.0 0.0 0.0 0.3 1.1 0.0 1.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 19.2 2.5 0.0 0.0 33.5 DUOXA2 ENSG00000140274 "Dual oxidase maturation factor 2" Q1HG44 15 45114321-45118421 "Disease related genes, Predicted membrane proteins" "Protein transport, Transport" "Congenital hypothyroidism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 78.3;gallbladder: 38.9" "Group enriched" "Detected in some" 4 "Ductal cells: 452.7;Pancreatic endocrine cells: 814.2;Urothelial cells: 638.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.4;EFO-21: 1.9;HDLM-2: 1.1;U-2 OS: 3.9;U-266/84: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA063548 Enhanced NA NA "HPA063548: AB_2685037" "unprognostic (1.87e-1)" "unprognostic (9.88e-2)" "unprognostic (7.37e-2)" "unprognostic (6.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.00e-3)" "unprognostic (6.73e-2)" "unprognostic (2.03e-1)" "unprognostic (2.10e-1)" "unprognostic (3.15e-2)" "unprognostic (1.26e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-4)" "unprognostic (9.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.37e-1)" "unprognostic (5.54e-2)" 0.0 0.3 0.0 3.2 0.0 0.0 0.4 0.0 0.0 3.6 1.9 0.0 78.3 0.2 0.1 0.2 5.6 0.0 38.9 0.5 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 3.2 0.0 0.0 5.4 0.0 0.0 0.0 1.5 0.2 0.0 0.0 16.5 0.1 0.0 0.0 20.2 3.9 2.9 12.9 7.8 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.6 0.6 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.6 0.0 4.2 0.0 0.0 0.6 17.8 0.0 2.3 0.0 0.0 0.0 0.0 452.7 0.0 0.0 1.7 0.0 151.7 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 1.7 0.0 814.2 0.8 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.6 638.1 DUSP13 "BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP" ENSG00000079393 "Dual specificity phosphatase 13" "Q6B8I1, Q9UII6" 10 75094432-75109221 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 75.2;testis: 18.6;tongue: 26.0" "Cell type enriched" "Detected in some" 6 "Early spermatids: 345.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 39 "neutrophil: 3.9" "Lineage enriched" "Detected in single" 39 "granulocytes: 3.9" "Cell line enhanced" "Detected in some" "BEWO: 5.0;EFO-21: 5.9;Hep G2: 12.2;K-562: 4.7;LHCN-M2: 10.9;RH-30: 9.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (1.79e-1)" "unprognostic (2.39e-2)" "unprognostic (2.39e-1)" "unprognostic (7.07e-2)" "unprognostic (1.66e-3)" "unprognostic (2.47e-3)" "unprognostic (8.63e-2)" "unprognostic (1.97e-1)" "unprognostic (2.63e-2)" "unprognostic (1.27e-1)" "unprognostic (3.92e-1)" "unprognostic (2.22e-7)" "unprognostic (1.93e-2)" "unprognostic (1.54e-1)" "unprognostic (4.81e-1)" "unprognostic (2.09e-2)" 0.8 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.3 1.2 0.0 0.0 5.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 2.3 0.0 75.2 0.1 0.0 0.0 0.0 0.1 0.0 18.6 0.0 0.0 1.0 26.0 1.9 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 12.2 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 10.9 0.6 0.0 0.0 0.7 0.1 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 1.4 0.0 10.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 345.5 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 54.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.0 0.0 2.6 2.7 1.8 2.5 0.0 0.0 0.1 DWORF ENSG00000240045 "DWARF open reading frame" 3 155290229-155293775 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 173.0" "Cell type enriched" "Detected in some" 4 "Proximal tubular cells: 7.9" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "basophil: 2.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.9" "Low cell line specificity" "Detected in some" "Region enriched" "Detected in some" 8 "basal ganglia: 19.5" NA NA "unprognostic (6.77e-4)" "unprognostic (1.60e-2)" "unprognostic (6.62e-2)" "unprognostic (1.58e-1)" "unprognostic (7.82e-3)" "unprognostic (1.33e-2)" 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.2 2.9 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 173.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.7 23.7 0.9 0.0 0.0 0.5 0.4 2.9 0.2 0.4 0.2 0.0 0.2 0.0 0.6 0.0 0.0 2.3 0.7 0.3 0.0 0.0 0.6 0.0 1.3 0.0 0.4 0.0 0.4 0.5 0.3 0.5 0.0 0.3 0.6 0.4 0.5 0.5 0.0 1.8 0.4 2.1 0.0 0.0 0.5 0.4 0.8 0.0 0.6 1.3 1.2 0.4 0.2 1.7 1.2 0.7 0.6 0.3 0.2 0.3 0.0 0.0 1.0 0.9 0.0 0.7 0.1 1.0 0.9 1.1 1.9 1.8 1.3 0.8 0.2 0.2 0.3 0.8 0.8 0.3 0.0 2.9 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.5 0.2 0.2 0.8 0.4 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DYNAP "C18orf26, FLJ39106" ENSG00000178690 "Dynactin associated protein" Q8N1N2 18 54587757-54599493 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 23.9;tongue: 50.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "Karpas-707: 16.9" HPA011148 Uncertain NA NA "HPA011148: AB_1845609" "unprognostic (9.88e-2)" "unprognostic (2.51e-2)" "unprognostic (1.75e-3)" "unprognostic (1.45e-1)" "unprognostic (8.09e-3)" 0.2 0.2 0.1 0.1 0.1 1.1 0.1 0.1 0.2 0.8 0.1 0.1 0.1 0.1 0.5 1.4 23.9 0.2 0.2 0.3 0.1 0.1 0.3 0.2 0.1 0.4 0.1 0.1 0.3 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.1 2.1 0.1 0.2 0.5 0.2 0.3 0.1 1.4 0.2 0.4 0.1 0.2 0.1 50.3 6.7 0.1 0.3 1.8 1.0 3.1 2.9 0.7 1.0 0.0 1.0 0.3 1.8 0.8 0.9 2.1 1.8 0.4 0.7 1.3 1.4 0.9 0.7 0.9 0.6 0.9 1.4 0.6 1.2 0.0 0.7 0.3 0.3 0.3 1.1 0.6 0.7 0.8 0.8 0.9 0.2 1.3 0.4 0.5 0.3 0.8 1.3 16.9 0.2 0.3 0.6 0.5 2.7 0.3 0.5 0.6 2.0 0.8 0.5 0.9 0.7 1.0 0.3 0.3 2.9 1.3 0.5 1.1 2.9 0.6 3.3 0.7 0.5 0.6 0.5 1.3 0.9 0.4 0.4 1.2 1.3 2.1 1.0 1.1 0.7 1.0 0.6 0.4 0.4 1.8 0.7 0.7 3.1 0.7 2.9 1.0 0.3 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DYRK2 ENSG00000127334 "Dual specificity tyrosine phosphorylation regulated kinase 2" Q92630 12 67648338-67665406 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 72.1;Horizontal cells: 76.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027230, HPA056902" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA027230: AB_1847925, HPA056902: AB_2683271" "unprognostic (5.86e-3)" "unprognostic (4.18e-1)" "unprognostic (4.08e-3)" "unprognostic (2.56e-3)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.37e-3)" "unprognostic (7.83e-2)" "unprognostic (2.83e-2)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (2.12e-2)" "unprognostic (2.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "unprognostic (1.35e-1)" 12.2 5.3 4.5 20.1 4.8 8.6 8.1 4.4 6.6 10.1 21.3 4.1 8.3 13.7 14.6 9.6 9.6 9.1 16.9 26.1 4.7 3.2 6.3 4.6 10.1 17.9 4.0 3.3 7.6 8.5 3.6 4.4 13.0 5.0 7.1 15.3 6.6 7.2 6.6 23.7 9.4 26.0 11.2 5.3 10.3 14.0 4.4 3.9 34.3 7.6 12.5 17.2 11.1 12.2 2.7 1.9 5.9 1.3 6.9 6.8 1.6 13.8 7.8 11.7 8.4 5.9 8.1 9.4 14.1 9.2 6.9 3.9 10.3 7.7 25.8 17.4 20.3 4.2 16.1 9.3 5.5 7.4 11.1 12.2 4.1 5.2 3.9 2.3 9.4 9.1 6.6 7.9 18.6 14.9 11.7 3.8 11.0 5.1 13.5 8.8 7.9 8.0 4.6 10.1 9.0 12.6 21.5 11.6 11.4 8.0 17.4 15.5 18.3 5.9 7.9 8.1 8.3 5.4 7.9 5.7 11.0 10.4 7.5 11.1 6.5 1.0 14.3 10.5 6.4 11.3 3.2 0.5 5.9 5.2 1.3 4.0 2.7 3.9 6.8 1.9 2.7 3.3 6.1 0.7 6.9 1.3 0.8 3.1 1.6 4.5 4.8 4.4 6.6 4.7 3.2 4.0 3.3 5.0 3.9 8.9 12.2 6.4 9.1 10.1 17.2 33.5 22.9 12.0 10.3 1.8 21.6 2.7 0.0 17.2 0.4 10.5 72.1 0.0 15.8 6.4 18.2 11.3 5.7 4.7 14.1 76.3 23.6 6.2 11.6 1.6 10.6 9.8 8.5 6.4 50.5 15.3 15.6 48.2 12.4 7.5 21.9 12.9 21.1 2.5 8.7 14.2 3.8 21.0 26.7 28.1 DYSF "FER1L1, LGMD2B" ENSG00000135636 Dysferlin O75923 2 71453722-71686768 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 39.9;skeletal muscle: 53.3" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 20.1;Endothelial cells: 22.1;Ito cells: 34.4;Kupffer cells: 20.6;Syncytiotrophoblasts: 55.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 19.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 19.9" "Group enriched" "Detected in some" 5 "hTERT-RPE1: 12.8;HUVEC TERT2: 32.9;LHCN-M2: 29.9;RH-30: 31.6;TIME: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002510, HPA017071, HPA021945" Enhanced Supported "Plasma membrane,Centriolar satellite" Yes No "Plasma membrane, Centriolar satellite" "CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928" "unprognostic (1.04e-1)" "unprognostic (7.66e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (1.14e-1)" "unprognostic (2.70e-1)" "unprognostic (3.21e-1)" "unprognostic (2.93e-1)" "unprognostic (6.43e-2)" "unprognostic (4.88e-3)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (1.36e-1)" "unprognostic (5.97e-3)" 6.6 2.1 1.1 7.2 1.3 18.6 7.9 1.2 2.0 1.9 6.4 0.0 3.9 1.6 4.2 4.9 5.1 3.6 3.3 20.8 1.2 2.0 4.7 13.4 9.1 17.8 2.1 0.7 4.1 1.4 2.0 2.1 39.9 7.0 4.8 1.9 3.3 1.9 3.6 53.3 1.7 3.3 12.1 1.4 26.5 3.2 1.5 0.3 0.8 4.9 8.3 1.0 8.7 11.9 0.0 0.0 19.9 2.6 0.3 0.3 0.7 0.4 0.0 1.3 1.1 0.0 0.0 2.4 0.0 0.3 0.9 0.6 0.1 0.3 0.0 4.9 0.0 1.3 1.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.9 4.2 12.8 32.9 0.0 3.1 0.0 29.9 0.0 0.0 2.2 3.2 0.0 0.3 0.0 31.6 0.0 1.0 0.0 0.0 0.0 1.5 0.2 0.0 3.3 0.1 0.3 21.5 0.1 1.5 0.1 0.4 0.0 0.0 0.0 0.0 5.2 0.0 0.0 2.6 0.0 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 19.9 0.3 0.1 0.0 0.0 0.7 1.1 1.3 1.2 2.0 1.2 2.0 2.1 0.7 7.0 0.3 3.0 13.8 0.5 0.0 2.2 0.8 20.1 0.0 1.4 2.3 0.0 0.0 5.4 0.0 0.4 4.4 22.1 0.0 0.0 0.2 2.8 1.4 0.2 2.3 9.9 11.0 0.0 0.0 34.4 20.6 4.1 0.6 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.7 0.1 6.5 3.1 0.5 0.0 1.4 55.4 0.9 0.0 0.0 E2F5 ENSG00000133740 "E2F transcription factor 5" Q15329 8 85177225-85217158 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "B-cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 13.3;naive B-cell: 7.6" "Lineage enriched" "Detected in many" 9 "B-cells: 13.3" "Cell line enhanced" "Detected in many" "AF22: 27.5;Daudi: 54.2;U-698: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055723, HPA065441" Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA055723: AB_2682897, HPA065441: " "unprognostic (8.73e-2)" "unprognostic (3.45e-1)" "unprognostic (3.15e-2)" "unprognostic (1.02e-3)" "unprognostic (6.73e-3)" "unprognostic (1.62e-1)" "unprognostic (3.36e-5)" "unprognostic (1.23e-1)" "unprognostic (9.53e-2)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (2.88e-2)" "unprognostic (3.25e-2)" "unprognostic (3.64e-1)" "unprognostic (2.95e-3)" 3.0 9.0 6.4 22.2 8.1 1.5 5.9 2.6 5.3 5.0 5.9 4.0 3.4 4.6 5.4 7.4 4.7 7.2 6.6 3.2 5.6 5.6 9.0 4.5 5.1 22.4 4.6 2.7 8.3 14.6 12.7 10.6 4.3 3.8 5.1 7.2 3.4 5.7 5.9 1.1 1.7 7.3 3.8 4.5 9.9 5.1 10.5 3.2 13.6 10.2 3.0 26.0 6.0 7.6 13.3 1.4 0.0 0.0 1.1 0.6 0.6 4.9 5.3 27.5 10.2 0.5 0.7 8.8 1.0 2.2 0.8 2.4 3.2 5.8 54.2 3.8 1.1 9.9 1.0 16.0 1.3 1.0 5.6 7.3 5.5 3.0 7.4 4.4 1.6 0.0 1.0 2.2 1.1 3.9 5.4 0.8 5.7 11.5 0.4 1.5 3.2 5.5 3.6 8.8 9.2 4.7 4.4 1.1 5.8 8.9 3.5 3.4 10.6 0.6 1.9 8.1 11.5 11.6 1.7 0.0 1.3 1.0 1.6 3.6 10.2 6.8 25.9 1.5 1.4 2.7 0.0 0.0 0.0 0.1 0.0 0.0 13.3 0.0 0.0 0.1 7.6 0.2 0.4 0.0 1.1 0.0 1.4 0.6 0.6 6.4 8.1 2.6 4.5 5.6 5.6 4.6 2.7 3.8 3.2 0.0 6.2 16.3 2.8 2.1 0.4 1.0 2.5 9.4 3.4 5.2 9.8 2.7 0.0 2.9 5.2 1.5 1.3 0.0 2.1 0.6 3.0 2.7 1.1 2.4 0.4 0.0 7.5 0.6 1.0 2.9 1.4 0.4 3.3 0.0 3.4 4.3 2.8 0.0 1.8 4.9 1.1 0.0 1.7 11.1 3.4 2.5 0.9 1.9 3.7 1.6 EBP "CDPX2, CHO2, CPX, CPXD" ENSG00000147155 "Emopamil binding protein (sterol isomerase)" Q15125 X 48521158-48528716 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Isomerase "Cataract, Disease mutation, Dwarfism, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.1" "Cell type enhanced" "Detected in all" 7 "Hepatocytes: 389.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003130 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA003130: AB_1078717" "unprognostic (1.90e-1)" "unprognostic (2.64e-2)" "unprognostic (2.80e-1)" "unprognostic (6.27e-2)" "unprognostic (3.41e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" "unprognostic (4.72e-2)" "unprognostic (1.47e-1)" "unprognostic (5.14e-2)" "unprognostic (4.04e-2)" "unprognostic (5.39e-2)" "unprognostic (4.13e-1)" "unprognostic (1.36e-1)" 3.7 33.2 5.3 4.3 5.7 10.5 10.5 10.1 6.3 8.6 19.6 2.8 3.4 17.2 4.0 3.7 20.6 3.9 4.5 21.7 4.7 4.3 12.8 74.1 14.9 13.0 3.5 8.0 4.8 11.7 6.0 3.7 4.2 8.8 8.6 15.7 5.2 8.7 4.8 3.5 9.1 30.0 5.6 7.0 7.9 8.1 5.4 2.8 9.0 4.6 9.8 10.4 5.0 10.0 17.1 22.9 21.5 12.6 13.3 29.9 18.1 33.6 7.1 18.9 11.3 10.5 7.8 6.1 8.6 7.2 11.5 16.6 14.1 56.2 18.2 6.1 6.0 11.3 37.9 31.6 46.7 8.7 14.0 15.8 9.2 9.5 12.1 7.7 33.8 22.8 7.6 17.0 15.3 11.4 2.9 7.6 12.9 11.7 17.3 9.4 14.7 18.8 20.7 19.0 9.7 23.4 13.0 1.9 51.6 28.1 6.0 16.1 8.1 31.8 16.4 4.5 12.6 18.0 8.1 8.0 5.9 10.0 22.7 9.4 7.4 11.6 18.4 13.7 34.1 5.6 17.4 8.9 21.5 29.9 11.7 25.1 17.1 22.2 27.5 12.3 12.6 20.1 25.5 1.8 13.3 12.6 22.9 22.4 18.1 5.3 5.7 10.1 6.3 4.7 4.3 3.5 8.0 8.8 2.8 29.8 39.6 41.7 45.2 33.0 23.7 36.3 81.5 22.7 21.6 50.6 7.9 40.6 33.2 80.2 5.4 24.3 135.6 46.7 207.1 93.9 32.6 42.4 40.3 389.0 57.0 7.9 28.8 28.8 26.6 7.8 12.4 34.4 35.4 47.7 72.4 13.4 126.3 129.8 13.8 76.4 15.9 12.9 20.6 8.6 20.0 39.6 31.4 74.7 134.2 61.7 EBPL EBRP ENSG00000123179 "Emopamil binding protein like" Q9BY08 13 49660723-49691475 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 285.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA049891 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA049891: AB_2680937" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (4.23e-2)" "unprognostic (3.06e-2)" "unprognostic (2.81e-1)" "unprognostic (8.63e-3)" "unprognostic (3.91e-2)" "unprognostic (1.57e-1)" "unprognostic (6.91e-2)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.63e-2)" "unprognostic (2.67e-2)" "prognostic unfavorable (7.18e-8)" "unprognostic (1.11e-2)" "unprognostic (1.11e-1)" "unprognostic (3.03e-1)" "unprognostic (1.95e-2)" 10.2 32.6 5.8 13.4 5.7 11.1 17.1 4.5 8.6 21.5 13.9 4.7 8.8 10.1 21.1 7.0 32.9 13.0 7.2 6.8 4.8 7.1 12.8 64.8 14.5 17.9 6.1 5.0 21.8 46.4 6.6 5.9 7.3 9.4 22.4 11.7 8.2 21.0 14.6 4.9 15.5 8.8 13.5 6.0 13.7 13.6 8.4 3.7 11.1 22.2 21.8 19.7 14.7 22.6 7.0 6.7 9.3 4.8 5.5 10.4 1.7 14.3 11.6 7.5 30.8 9.5 23.1 12.2 14.9 11.1 11.4 8.3 22.4 21.0 17.6 6.9 8.1 9.8 30.3 13.7 15.9 15.5 13.9 39.0 15.2 8.1 31.8 26.8 22.1 11.4 26.9 33.0 8.3 23.5 17.5 18.5 20.9 10.8 7.7 14.0 9.6 8.6 41.9 24.5 51.4 24.3 18.1 4.3 28.3 22.8 4.8 6.5 17.0 5.8 20.9 6.8 8.0 18.0 17.9 9.1 7.8 7.9 6.6 12.4 4.8 11.9 14.8 3.4 22.1 7.2 2.8 4.0 1.1 3.4 4.7 10.0 5.8 7.3 7.2 6.7 7.0 10.4 5.8 9.3 5.5 4.8 4.5 4.9 1.7 5.8 5.7 4.5 8.6 4.8 7.1 6.1 5.0 9.4 3.7 32.8 17.2 59.6 137.3 96.5 6.8 3.8 76.5 5.3 14.8 22.7 7.9 26.0 34.9 55.4 11.6 57.3 12.7 0.0 44.5 33.3 44.2 104.1 18.4 285.3 33.1 1.6 26.8 65.7 45.6 8.4 87.2 31.9 43.9 3.6 79.1 13.6 42.9 21.0 65.7 52.5 8.0 19.4 53.6 31.6 14.1 135.1 12.7 39.8 112.1 100.9 ECE1 ECE ENSG00000117298 "Endothelin converting enzyme 1" P42892 1 21217247-21345504 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 114.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 21.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 103.3;TIME: 91.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001490, HPA013616" Enhanced NA NA 2100000 "HPA001490: AB_1078718, HPA013616: AB_1847963" "unprognostic (7.90e-2)" "unprognostic (1.01e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-2)" "unprognostic (1.49e-2)" "unprognostic (1.46e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (6.20e-2)" "unprognostic (1.92e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (7.70e-2)" "unprognostic (3.55e-2)" "unprognostic (9.10e-2)" "unprognostic (1.97e-2)" "unprognostic (1.97e-2)" 44.0 49.9 10.3 18.7 14.5 17.3 33.7 3.6 15.6 29.5 27.5 19.2 11.2 12.4 24.0 10.5 15.6 19.1 23.0 30.9 12.4 8.0 14.9 41.8 30.1 14.4 13.9 13.4 34.2 42.1 114.4 21.6 27.0 14.6 27.9 14.6 26.5 14.7 11.4 15.2 14.8 23.2 24.1 13.2 23.5 18.9 19.1 14.7 9.5 23.2 10.7 19.1 34.2 37.0 4.6 2.0 21.5 7.5 1.0 6.1 4.2 13.8 9.3 12.0 6.0 17.4 18.6 6.9 20.7 36.1 11.3 10.4 6.7 42.8 5.0 52.1 20.8 24.4 5.9 4.9 9.9 9.9 12.6 4.1 7.2 14.4 5.4 23.2 1.0 1.8 9.7 11.6 17.4 8.7 30.9 103.3 4.1 1.4 2.7 9.5 2.9 2.1 1.6 3.6 3.9 7.3 2.5 6.9 7.2 17.6 2.5 4.1 10.0 20.5 12.1 8.9 6.8 8.7 3.0 91.7 25.5 12.4 11.2 11.9 4.1 7.0 5.8 52.9 2.4 30.7 0.1 5.8 2.2 2.2 7.5 3.3 4.6 4.6 3.5 0.5 3.1 3.1 1.9 21.5 1.0 5.2 2.0 6.1 4.2 10.3 14.5 3.6 15.6 12.4 8.0 13.9 13.4 14.6 14.7 17.9 9.8 18.9 17.1 18.0 1.9 16.1 7.6 10.7 28.4 22.7 0.0 3.6 5.0 21.9 1.1 83.9 51.8 23.3 49.4 26.8 34.3 33.0 18.4 32.5 3.1 0.0 24.2 95.8 8.2 1.7 40.3 5.1 6.8 27.9 10.9 57.2 80.7 84.2 51.9 7.4 4.7 38.8 42.9 1.1 4.7 14.1 8.8 10.7 20.9 38.3 ECE2 "KIAA0604, MGC2408" ENSG00000145194 "Endothelin converting enzyme 2" O60344 3 184276011-184293031 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "adrenal gland: 14.4;brain: 25.1;pancreas: 29.0;pituitary gland: 7.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 60.4;Late spermatids: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "REH: 14.3" NA NA "unprognostic (2.70e-2)" "unprognostic (1.44e-2)" "unprognostic (1.91e-2)" "prognostic unfavorable (8.41e-5)" "unprognostic (1.37e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (5.80e-4)" "unprognostic (1.47e-2)" "unprognostic (3.69e-1)" "unprognostic (2.65e-3)" "unprognostic (1.70e-2)" "unprognostic (5.95e-2)" "unprognostic (1.63e-9)" "unprognostic (3.66e-2)" "unprognostic (6.16e-2)" "unprognostic (2.19e-1)" "unprognostic (1.25e-2)" 0.7 14.4 9.1 0.9 17.1 0.7 0.7 17.6 10.5 0.7 1.1 2.2 0.0 0.8 0.7 1.6 0.8 0.9 0.7 1.5 4.6 25.1 0.7 0.7 0.7 0.7 10.3 3.0 0.7 29.0 0.7 7.6 0.7 7.5 1.6 0.9 1.4 1.1 1.1 0.7 0.7 0.8 0.9 2.9 0.7 1.0 0.8 3.3 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 17.1 17.6 5.2 4.6 25.1 10.3 3.0 7.5 3.3 0.0 0.0 2.2 6.7 34.0 1.3 1.7 7.6 0.0 0.0 0.0 2.0 18.6 0.0 0.0 60.4 2.8 7.7 0.0 0.0 41.9 6.7 11.2 0.0 31.4 15.8 25.4 11.7 4.3 4.8 84.4 2.8 0.8 8.5 0.0 11.8 2.3 0.0 3.5 2.1 0.0 0.7 6.5 3.1 38.6 9.8 34.3 18.0 0.0 13.4 15.3 ECEL1 "DINE, XCE" ENSG00000171551 "Endothelin converting enzyme like 1" O95672 2 232479827-232487828 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;ovary: 57.1" "Group enriched" "Detected in some" 19 "Muller glia cells: 76.3;Peritubular cells: 19.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.9" "Region enriched" "Detected in many" 5 "hypothalamus: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 30.1;HeLa: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA067560, HPA069756, HPA077424" Approved Supported Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA067560: , HPA069756: , HPA077424: " "unprognostic (1.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.39e-1)" "unprognostic (4.62e-3)" "unprognostic (2.80e-1)" "unprognostic (9.96e-4)" "unprognostic (7.56e-3)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.49e-2)" "unprognostic (1.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.24e-5)" "unprognostic (3.09e-2)" "unprognostic (3.68e-1)" "unprognostic (7.84e-2)" "unprognostic (5.45e-2)" 0.9 2.6 0.5 0.9 4.0 0.2 0.4 0.7 1.2 0.3 0.4 0.5 0.1 0.3 0.6 4.9 0.3 1.7 1.0 1.1 0.1 28.6 1.0 0.7 0.2 1.2 0.3 0.1 57.1 0.6 0.3 8.9 0.4 5.5 0.3 0.2 11.5 0.3 1.2 1.8 0.3 0.3 1.1 4.5 2.0 0.3 0.8 1.6 0.1 0.5 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.7 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.0 0.7 1.2 0.1 28.6 0.3 0.1 5.5 1.6 0.0 0.0 0.0 0.0 0.0 2.6 1.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.0 0.0 0.0 76.3 0.2 0.0 19.8 0.0 1.7 0.0 2.1 0.2 1.7 0.0 0.0 0.0 0.0 0.0 ECHDC1 dJ351K20.2 ENSG00000093144 "Ethylmalonyl-CoA decarboxylase 1" Q9NTX5 6 127288710-127343609 "Enzymes, Plasma proteins, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035445, HPA035446" Uncertain Approved Vesicles NA NA Vesicles "HPA035445: AB_10669860, HPA035446: AB_2732468" "unprognostic (9.57e-2)" "unprognostic (1.63e-2)" "unprognostic (2.46e-3)" "unprognostic (1.34e-1)" "unprognostic (4.09e-1)" "unprognostic (3.68e-2)" "unprognostic (5.03e-3)" "unprognostic (4.89e-3)" "unprognostic (4.97e-2)" "unprognostic (1.76e-1)" "unprognostic (3.99e-1)" "unprognostic (9.97e-2)" "unprognostic (8.21e-3)" "unprognostic (6.83e-2)" "unprognostic (2.86e-1)" "unprognostic (1.39e-1)" "unprognostic (1.40e-2)" 40.1 16.8 20.8 16.5 23.1 6.8 21.9 16.6 21.4 18.6 27.2 12.0 12.8 21.9 13.7 15.5 20.6 11.4 16.1 20.0 19.4 18.0 44.4 44.3 26.8 17.8 27.3 16.5 11.9 14.2 14.5 16.1 17.0 23.1 19.8 26.3 15.1 22.2 14.5 22.0 13.3 25.8 30.1 27.3 14.1 18.1 8.3 20.9 20.7 42.4 14.2 19.4 24.2 22.6 13.2 29.6 13.4 31.2 6.4 11.6 16.9 15.9 12.8 18.4 16.9 27.3 26.0 15.6 26.2 31.8 22.6 28.8 22.2 12.2 24.3 22.5 24.8 25.6 13.2 0.0 19.6 28.6 14.4 12.3 32.3 17.2 35.2 24.3 43.1 18.2 29.3 23.7 21.0 17.9 20.5 20.4 17.9 40.0 14.7 30.0 15.1 28.5 20.0 15.1 8.0 15.9 13.4 22.6 19.9 41.1 19.8 21.1 20.6 14.7 0.5 35.9 14.6 0.5 50.5 21.1 13.9 22.3 35.0 29.1 19.0 38.0 31.9 25.4 37.8 32.6 6.2 31.2 10.0 11.0 25.6 11.6 12.8 9.5 10.8 29.6 13.2 11.6 11.6 13.4 6.4 17.9 22.6 9.6 16.9 20.8 23.1 16.6 21.4 19.4 18.0 27.3 16.5 23.1 20.9 89.3 91.1 32.9 31.3 23.2 25.4 53.7 25.5 48.2 87.6 29.6 29.5 92.5 107.8 66.8 54.2 29.5 50.2 0.0 69.9 70.0 41.4 25.3 42.7 52.3 76.6 27.0 13.3 22.1 48.0 20.2 30.5 56.1 33.7 19.0 31.2 28.6 47.4 28.1 29.4 160.1 37.1 25.8 25.6 26.9 22.6 19.9 54.8 31.9 50.3 46.0 ECM1 ENSG00000143369 "Extracellular matrix protein 1" Q16610 1 150508062-150513789 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Biomineralization, Mineral balance, Osteogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 80.6;Ito cells: 56.4;Melanocytes: 70.9;Pancreatic endocrine cells: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.2;myeloid DC: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 77.4;BJ hTERT+: 53.9;fHDF/TERT166: 50.8;hTEC/SVTERT24-B: 36.5;LHCN-M2: 39.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA027241, HPA076029" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 12000000000 Cytosol Nucleoplasm "HPA027241: AB_1847976, HPA076029: " "unprognostic (2.89e-2)" "unprognostic (1.17e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-2)" "unprognostic (1.09e-1)" "unprognostic (6.79e-3)" "unprognostic (8.42e-2)" "unprognostic (2.15e-2)" "unprognostic (4.90e-2)" "unprognostic (7.50e-2)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.33e-2)" "prognostic unfavorable (1.51e-9)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.20e-5)" 16.1 2.5 0.9 1.8 1.3 0.1 11.0 0.9 4.2 37.9 2.8 0.1 7.4 1.5 10.5 133.2 257.1 3.3 30.7 11.6 0.9 1.0 2.5 16.7 3.8 0.2 1.0 1.7 3.0 0.8 0.3 2.0 20.2 4.2 2.6 3.1 1.6 28.7 2.9 3.5 11.5 2.0 5.3 0.8 3.6 2.1 5.9 0.0 0.0 1.8 45.5 107.2 6.0 46.6 0.0 1.8 0.0 1.2 0.0 0.4 1.3 6.2 0.6 2.3 0.0 14.0 77.4 2.1 22.7 53.9 14.2 18.6 0.3 3.5 0.1 0.2 50.8 1.6 13.1 0.0 2.7 14.9 0.1 0.1 0.9 0.8 0.1 3.9 0.0 23.5 6.8 0.1 36.5 1.3 20.9 3.9 0.1 4.8 0.1 39.5 0.0 0.0 0.7 0.2 26.5 0.7 0.3 17.0 0.1 0.5 0.0 0.1 0.0 5.2 0.1 19.4 1.1 0.0 6.0 1.0 30.1 4.5 3.4 4.9 0.1 0.2 0.2 15.8 2.1 4.0 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 1.3 0.9 4.2 0.9 1.0 1.0 1.7 4.2 0.0 0.0 0.6 1.4 1.8 13.1 0.7 1.1 12.7 0.0 2.3 3.5 0.0 1.3 0.0 4.8 0.2 4.4 0.2 0.0 3.7 26.0 80.6 1.0 10.3 0.6 16.0 1.6 0.0 56.4 2.1 0.0 9.2 4.8 70.9 0.0 0.3 0.8 42.0 0.0 20.8 0.0 1.1 12.9 16.1 0.5 0.4 16.7 9.2 0.0 0.2 5.8 ECSCR "ARIA, ECSM2" ENSG00000249751 "Endothelial cell surface expressed chemotaxis and apoptosis regulator" Q19T08 5 139448556-139462743 "Predicted membrane proteins" "Angiogenesis, Apoptosis, Chemotaxis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 20 "Endothelial cells: 271.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.7" "Lineage enhanced" "Detected in single" "T-cells: 2.7" "Group enriched" "Detected in some" 121 "EFO-21: 49.7;HUVEC TERT2: 125.6;TIME: 92.7" HPA063337 Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA063337: AB_2732701" "unprognostic (5.91e-2)" "unprognostic (2.37e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.69e-2)" "unprognostic (2.15e-3)" "unprognostic (3.95e-2)" "unprognostic (1.12e-1)" "unprognostic (2.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.78e-2)" "unprognostic (1.91e-1)" "unprognostic (1.83e-3)" "unprognostic (2.41e-3)" "unprognostic (1.36e-1)" "unprognostic (9.90e-2)" "unprognostic (2.91e-1)" 14.8 1.9 0.8 5.7 1.6 0.0 17.5 0.4 0.7 13.7 6.1 1.0 5.1 1.9 14.3 14.4 11.0 7.9 8.6 26.9 0.8 5.6 4.3 23.4 26.9 1.4 0.7 7.9 1.0 1.3 0.4 19.6 2.9 9.3 4.3 6.8 3.6 5.5 13.4 2.9 3.4 14.3 4.3 12.1 1.1 6.8 1.1 0.1 11.5 14.5 4.6 13.2 13.1 0.6 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 49.7 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 125.6 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 92.7 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.6 1.1 1.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 4.6 0.0 0.2 13.3 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.5 0.0 271.3 0.0 0.0 1.0 0.1 2.6 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 5.8 10.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 12.2 0.2 0.0 0.0 0.7 EDA "ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED" ENSG00000158813 "Ectodysplasin A" Q92838 X 69616067-70039469 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 11.2;Early spermatids: 15.7;Ito cells: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.0" "Group enriched" "Detected in many" 6 "monocytes: 3.0;T-cells: 4.0" "Cell line enhanced" "Detected in many" "EFO-21: 5.7;Hep G2: 18.4;OE19: 5.3;RPMI-8226: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037972, HPA037973" Supported "Vesicles,Lipid droplets" "Intracellular and membrane" NA NA Vesicles "Lipid droplets" "HPA037972: AB_2675761, HPA037973: AB_2675762" "unprognostic (3.76e-2)" "unprognostic (8.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.59e-3)" "unprognostic (7.85e-2)" "unprognostic (1.25e-4)" "unprognostic (4.33e-4)" "unprognostic (5.03e-2)" "unprognostic (1.53e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-2)" "unprognostic (2.01e-1)" "prognostic favorable (1.04e-9)" "unprognostic (8.63e-4)" "unprognostic (7.64e-2)" "unprognostic (9.85e-2)" "unprognostic (2.79e-1)" 6.8 11.7 2.2 3.1 3.0 0.3 3.9 0.9 2.4 10.3 3.4 3.9 7.4 0.9 6.3 5.7 5.0 4.4 7.0 13.3 2.6 2.1 6.9 3.1 4.3 5.8 4.3 2.0 7.9 6.3 18.4 1.9 2.7 2.9 8.3 1.7 5.0 5.4 10.4 3.3 5.4 1.6 5.4 4.6 2.0 4.7 2.7 2.3 0.8 8.9 5.0 1.2 4.4 8.1 0.0 0.0 0.0 3.0 0.6 4.0 0.3 0.0 0.6 0.3 3.0 0.6 0.1 0.2 0.0 0.1 0.0 0.0 1.4 0.1 0.3 5.7 0.2 0.2 0.4 4.1 1.5 0.0 0.0 4.7 0.0 0.1 18.4 1.1 0.0 1.2 2.4 1.5 0.0 1.0 0.0 0.5 3.7 0.0 5.2 0.0 1.2 0.0 0.0 3.0 5.3 0.4 0.0 1.3 6.2 0.1 0.0 1.6 0.0 0.1 0.4 0.1 2.3 0.3 0.1 0.5 1.9 2.5 2.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 3.0 4.0 0.0 1.8 0.9 0.0 0.0 1.1 0.2 0.0 0.6 2.0 0.0 0.0 0.3 2.2 3.0 0.9 2.4 2.6 2.1 4.3 2.0 2.9 2.3 3.0 0.3 0.0 2.3 3.4 0.2 11.2 0.0 1.4 0.0 5.2 0.0 0.1 0.0 1.2 15.7 1.4 0.4 0.0 1.2 0.1 2.0 2.2 0.0 0.9 3.1 0.0 1.7 14.7 5.4 5.3 4.4 1.5 1.7 0.0 0.3 1.5 1.0 0.0 2.1 2.7 0.0 6.5 3.8 0.7 2.7 3.6 0.0 0.0 0.2 1.0 EDA2R "EDA-A2R, EDAA2R, TNFRSF27, XEDAR" ENSG00000131080 "Ectodysplasin A2 receptor" Q9HAV5 X 66595637-66639298 "Predicted membrane proteins" Differentiation "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 6 "Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Muller glia cells: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;naive B-cell: 1.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 14.0;HSkMC: 19.1;LHCN-M2: 17.6;SuSa: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA054522 Approved "Cell Junctions" NA NA "Cell Junctions" "HPA054522: AB_2682516" "unprognostic (1.31e-3)" "unprognostic (3.17e-3)" "unprognostic (2.19e-1)" "unprognostic (8.49e-3)" "unprognostic (4.15e-3)" "unprognostic (3.63e-3)" "unprognostic (2.48e-2)" "unprognostic (3.37e-2)" "unprognostic (2.82e-1)" "unprognostic (7.17e-2)" "unprognostic (6.04e-2)" "unprognostic (2.74e-1)" "unprognostic (1.01e-1)" "unprognostic (2.12e-2)" "unprognostic (8.23e-2)" "unprognostic (4.92e-2)" "unprognostic (3.08e-1)" 4.7 9.4 2.3 1.9 3.2 0.0 5.6 1.2 3.0 9.7 3.7 5.7 4.6 0.4 13.5 6.3 3.6 6.5 4.8 2.8 2.9 1.2 3.0 1.2 3.7 0.6 5.7 1.1 12.9 4.9 7.4 16.0 4.8 4.5 14.5 7.6 5.5 6.1 8.3 11.0 2.5 1.8 7.5 8.2 2.0 1.6 2.7 4.0 1.5 8.2 1.9 1.2 6.3 7.4 1.1 0.3 0.0 0.5 0.0 1.1 0.0 0.0 9.0 8.3 0.0 12.0 14.0 0.1 12.3 13.4 1.2 1.8 0.0 0.0 4.4 0.0 8.0 0.0 0.0 0.0 4.7 4.1 0.0 4.3 0.0 0.2 5.9 2.1 0.0 0.0 19.1 11.2 9.3 8.5 11.4 0.3 0.2 0.4 4.6 17.6 1.0 0.2 0.0 3.1 0.0 0.0 0.0 1.1 0.0 0.8 0.0 0.0 1.5 0.0 0.0 0.0 14.8 0.2 0.1 9.4 0.0 6.8 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.3 1.1 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 2.3 3.2 1.2 2.6 2.9 1.2 5.7 1.1 4.5 4.0 3.0 0.0 0.0 1.0 0.2 0.0 0.5 2.5 0.0 0.0 1.8 0.0 1.0 0.0 0.1 0.0 0.3 0.0 0.0 0.5 1.1 1.0 0.8 0.0 0.0 0.2 0.0 1.2 0.6 0.0 0.0 1.7 0.0 1.7 0.0 0.3 2.3 0.7 0.0 0.4 0.2 0.0 0.0 1.9 0.0 0.1 0.5 0.6 0.0 0.4 0.6 EDAR "DL, ED1R, ED3, ED5, EDA1R, EDA3, Edar" ENSG00000135960 "Ectodysplasin A receptor" Q9UNE0 2 108894471-108989372 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Developmental protein, Receptor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.2;esophagus: 9.2;lymphoid tissue: 11.3" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 1.4;Club cells: 1.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "naive CD4 T-cell: 10.2;naive CD8 T-cell: 4.8" "Lineage enriched" "Detected in single" 102 "T-cells: 10.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.6;HaCaT: 14.2;OE19: 3.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042292 Approved NA NA "HPA042292: AB_10794648" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (2.22e-2)" "unprognostic (1.24e-2)" "unprognostic (4.68e-2)" "unprognostic (1.21e-2)" "unprognostic (2.30e-1)" "unprognostic (2.53e-2)" "unprognostic (3.70e-1)" "unprognostic (1.31e-1)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (8.83e-7)" "unprognostic (9.21e-2)" "unprognostic (5.61e-2)" "unprognostic (2.29e-1)" "unprognostic (5.03e-3)" 0.3 0.2 0.3 1.9 0.4 0.5 1.8 0.4 0.3 2.8 2.9 0.1 0.0 2.2 1.1 2.6 9.2 0.4 6.8 0.5 0.3 0.4 1.9 1.9 2.4 6.6 0.3 0.0 0.3 0.5 0.0 0.2 0.2 0.3 1.6 4.5 0.1 3.2 0.1 0.3 3.5 2.5 1.3 1.2 0.5 1.8 0.6 0.2 3.2 0.3 1.7 11.3 4.6 3.5 0.0 0.0 0.0 0.0 0.0 10.2 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 6.6 0.0 0.5 0.0 0.0 14.2 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 10.2 4.8 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.4 0.4 0.3 0.3 0.4 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 EDDM3A "FAM12A, HE3-ALPHA" ENSG00000181562 "Epididymal protein 3A" Q14507 14 20745892-20748380 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "ductus deferens: 61.8;epididymis: 129.9" "Cell type enriched" "Detected in some" 22 "Collecting duct cells: 27.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 13 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "BEWO: 2.9;NB-4: 3.4;SH-SY5Y: 1.5" HPA049952 Approved "Secreted in male reproductive system" NA NA "HPA049952: AB_2680970" "unprognostic (1.42e-1)" "unprognostic (9.88e-2)" "unprognostic (8.56e-3)" "unprognostic (2.10e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 61.8 0.0 0.1 129.9 0.1 0.2 0.0 0.1 0.1 0.1 1.5 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.2 14.7 0.1 0.1 0.1 0.0 0.1 0.4 0.4 4.7 0.0 0.0 0.1 0.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 EDDM3B "FAM12B, HE3-BETA" ENSG00000181552 "Epididymal protein 3B" P56851 14 20768427-20770948 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "epididymis: 261.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.8;NB-4: 7.2;RPMI-8226: 1.7;SH-SY5Y: 2.1" HPA001323 Enhanced "Secreted in male reproductive system" NA NA "HPA001323: AB_1848377" "unprognostic (2.40e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.1 0.1 0.2 0.1 0.0 12.9 0.0 0.2 261.1 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.8 0.9 0.2 0.4 0.1 0.0 0.2 0.1 0.1 3.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EDEM1 "EDEM, KIAA0212" ENSG00000134109 "ER degradation enhancing alpha-mannosidase like protein 1" Q92611 3 5187646-5219957 "Plasma proteins, Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 57.5;lymphoid tissue: 89.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 96.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029565 Uncertain Enhanced "Endoplasmic reticulum,Aggresome" NA NA "Endoplasmic reticulum" Aggresome "HPA029565: AB_10602032" "unprognostic (3.03e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-3)" "unprognostic (4.30e-3)" "unprognostic (1.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.29e-2)" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (5.72e-3)" "unprognostic (1.51e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "unprognostic (2.34e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" 6.5 7.6 5.3 13.1 6.7 26.3 7.0 4.8 6.3 6.7 7.6 4.5 5.1 5.9 8.4 6.4 10.5 7.0 6.2 4.8 4.3 3.1 6.6 57.5 14.2 16.9 3.9 5.0 8.6 20.3 10.2 6.5 14.2 4.2 6.6 7.6 5.5 9.7 5.7 3.7 10.1 11.8 5.4 3.7 15.4 7.8 7.8 4.0 89.4 7.8 5.5 23.5 8.8 8.1 9.9 10.3 4.3 5.8 2.9 8.9 2.8 4.7 4.8 3.0 3.0 4.0 9.0 9.7 7.8 10.6 5.4 7.1 2.2 6.3 25.5 4.2 7.7 11.8 3.7 3.3 10.7 8.3 48.9 1.9 8.7 4.5 4.9 18.8 10.2 25.5 8.1 13.1 11.5 12.7 7.3 10.7 33.3 2.2 35.3 6.6 2.8 20.5 3.9 1.5 2.2 3.6 29.9 5.4 23.4 6.2 10.0 0.4 4.0 5.6 8.1 11.5 2.8 4.1 32.9 10.4 10.4 7.3 8.8 8.9 20.8 12.6 43.9 17.3 9.9 8.6 3.5 3.8 4.0 5.8 5.0 8.4 9.9 8.8 6.5 4.6 6.8 7.9 6.2 4.3 2.9 5.8 10.3 8.9 2.8 5.3 6.7 4.8 6.3 4.3 3.1 3.9 5.0 4.2 4.0 56.6 96.8 35.0 6.3 18.3 4.1 2.8 17.8 6.7 20.5 15.7 9.8 8.0 0.0 6.0 9.1 11.3 14.8 0.0 10.5 26.0 8.7 10.9 23.1 65.7 15.8 1.6 8.1 14.7 33.3 37.6 7.8 35.8 15.1 47.7 22.7 3.5 14.0 0.0 8.5 7.0 3.5 0.0 12.2 6.7 2.0 23.8 34.2 21.4 10.1 16.1 EDNRA ENSG00000151617 "Endothelin receptor type A" P25101 4 147480917-147544954 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 62.6;seminal vesicle: 52.3" "Cell type enhanced" "Detected in some" 14 "Leydig cells: 40.6;Peritubular cells: 64.0;Sertoli cells: 51.8;Smooth muscle cells: 84.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 7.3;ASC TERT1: 14.5;HHSteC: 7.4;LHCN-M2: 17.2;SH-SY5Y: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013774, CAB018957" Uncertain Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB018957: AB_2039838, HPA013774: AB_1847994" "unprognostic (3.08e-2)" "unprognostic (6.28e-2)" "unprognostic (1.78e-1)" "unprognostic (3.42e-1)" "unprognostic (1.07e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-2)" "unprognostic (7.20e-2)" "unprognostic (2.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.34e-3)" "unprognostic (2.88e-1)" "prognostic unfavorable (1.50e-7)" "prognostic unfavorable (3.93e-4)" "unprognostic (6.20e-3)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" 7.6 2.6 1.3 1.4 1.8 0.0 7.2 0.6 2.4 62.6 2.6 1.0 21.7 1.5 37.3 14.2 4.7 13.3 7.3 15.1 1.3 1.3 3.1 1.4 12.7 2.0 1.8 1.0 23.5 0.9 1.9 2.2 5.9 2.7 21.5 1.5 10.3 4.1 52.3 4.8 3.2 1.8 19.4 1.6 11.5 4.4 9.1 1.4 2.9 5.0 6.0 2.6 14.7 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 4.2 0.0 7.3 14.5 0.0 2.2 2.9 0.4 0.1 0.2 0.0 0.0 0.0 0.7 0.5 0.0 0.3 0.6 0.2 0.0 1.5 0.0 2.5 0.0 7.4 0.0 0.0 5.6 0.5 0.4 0.0 2.7 0.0 0.0 0.0 1.1 17.2 0.2 0.0 0.1 1.2 0.0 0.9 0.0 0.7 0.1 1.1 0.8 0.0 13.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.9 0.6 0.0 0.0 1.1 0.3 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.8 0.6 2.4 1.3 1.3 1.8 1.0 2.7 1.4 3.0 4.0 0.0 0.6 2.7 0.0 17.1 0.0 0.0 7.9 0.0 0.0 0.2 0.0 0.0 2.0 2.7 0.0 0.0 0.0 0.1 11.8 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.1 40.6 0.3 3.3 0.0 0.0 0.0 0.2 0.0 64.0 0.0 0.0 51.8 84.6 0.6 0.6 2.4 0.1 0.0 0.0 0.2 EDNRB "ETB, HSCR, HSCR2" ENSG00000136160 "Endothelin receptor type B" P24530 13 77895481-77975529 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 67.5" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 97.7;Ito cells: 106.8;Melanocytes: 104.6;Muller glia cells: 142.7;Sertoli cells: 213.4;Smooth muscle cells: 110.2" "Group enriched" "Detected in all" 7 "glioma: 41.1;melanoma: 127.7;renal cancer: 28.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 2.0;intermediate monocyte: 2.1" "Lineage enriched" "Detected in single" 21 "monocytes: 2.1" "Cell line enhanced" "Detected in some" "AF22: 25.2;ASC diff: 19.2;SK-MEL-30: 23.1;U-266/70: 15.1;WM-115: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017842, HPA027546" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "CAB017842: , HPA027546: AB_2672327" "unprognostic (7.75e-2)" "unprognostic (6.73e-2)" "unprognostic (1.41e-3)" "unprognostic (2.59e-2)" "unprognostic (8.37e-2)" "unprognostic (2.45e-3)" "unprognostic (4.17e-3)" "unprognostic (5.43e-2)" "unprognostic (1.02e-1)" "unprognostic (1.38e-2)" "unprognostic (3.40e-2)" "unprognostic (3.01e-2)" "prognostic favorable (7.20e-5)" "unprognostic (1.59e-2)" "unprognostic (3.86e-2)" "unprognostic (4.58e-2)" "unprognostic (6.77e-3)" 25.4 23.2 22.2 10.3 29.8 0.8 23.1 10.3 30.7 8.1 7.2 13.6 2.3 10.9 7.7 3.6 4.9 6.0 8.5 23.7 16.7 16.4 22.3 26.5 28.4 15.6 24.2 8.1 4.9 6.4 7.7 6.3 67.5 33.2 14.9 7.7 51.0 13.4 4.4 6.7 5.1 11.9 7.4 33.4 16.0 5.8 3.1 12.4 0.0 17.6 2.0 2.9 10.9 8.2 0.0 0.0 0.0 2.1 0.0 0.0 0.4 2.0 0.0 25.2 0.0 19.2 0.7 0.3 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 23.1 3.4 0.0 0.1 0.1 0.2 0.0 0.0 0.1 15.1 8.5 0.0 0.4 0.0 48.1 0.0 2.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.2 29.8 10.3 11.9 16.7 16.4 24.2 8.1 33.2 12.4 11.9 38.2 0.0 1.0 13.2 3.2 7.3 0.0 2.7 4.5 0.0 5.9 14.3 0.0 0.0 2.4 97.7 0.0 0.0 0.0 10.2 27.8 2.5 5.8 0.5 10.9 0.0 0.0 106.8 21.3 1.8 73.9 9.2 104.6 0.0 0.0 142.7 0.1 0.0 2.5 0.0 3.4 213.4 110.2 0.3 1.4 6.4 4.8 0.0 0.0 1.4 EEF1AKMT4-ECE2 ENSG00000284917 "EEF1AKMT4-ECE2 readthrough" O60344 3 184249695-184293031 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "REH: 5.1" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 1.2 6.6 0.0 2.1 0.1 0.3 0.3 0.0 1.5 0.6 2.9 0.0 1.5 0.9 0.3 0.3 2.8 0.5 0.6 2.1 0.0 2.8 22.6 1.3 1.5 0.0 0.0 0.9 6.0 1.5 2.0 6.1 0.2 1.4 0.6 0.2 4.0 1.6 3.8 0.3 2.9 0.4 0.0 2.4 0.3 9.7 0.0 3.3 4.9 3.1 2.5 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EEF1E1 "AIMP3, P18" ENSG00000124802 "Eukaryotic translation elongation factor 1 epsilon 1" O43324 6 8073360-8102578 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 233.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA027901, HPA057866" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA027901: AB_10611960, HPA057866: AB_2683547" "unprognostic (9.39e-3)" "prognostic favorable (3.16e-4)" "unprognostic (2.23e-1)" "unprognostic (2.36e-2)" "unprognostic (1.42e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.55e-7)" "unprognostic (1.79e-1)" "unprognostic (5.67e-2)" "prognostic favorable (3.24e-4)" "unprognostic (1.13e-1)" "unprognostic (1.76e-2)" "unprognostic (1.52e-2)" "unprognostic (1.37e-1)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" 10.5 21.8 20.1 14.2 26.9 34.0 18.5 20.0 24.6 10.8 12.2 13.5 12.3 8.2 13.6 19.2 15.9 10.3 9.5 12.5 19.4 27.0 34.9 19.2 9.9 19.7 26.9 16.2 10.8 26.6 19.8 28.6 11.7 41.2 12.5 15.2 9.6 13.5 13.4 14.4 8.4 8.4 13.3 21.3 11.8 14.8 36.3 19.4 9.9 13.9 15.8 20.3 11.6 9.3 20.9 29.6 6.8 15.0 14.0 21.3 13.5 28.1 14.9 24.0 16.5 7.9 13.3 14.6 23.7 15.0 21.4 22.1 24.3 11.8 30.9 52.3 15.4 39.2 11.7 27.1 27.3 36.1 17.3 35.3 24.9 19.7 42.2 14.7 49.3 18.4 11.1 25.8 25.5 26.5 15.0 30.2 25.5 59.5 8.6 20.4 11.8 21.1 40.1 21.6 27.5 24.0 25.9 14.1 48.5 35.0 21.7 35.7 11.1 10.1 22.8 28.2 33.9 18.1 17.0 15.6 17.9 17.7 16.2 34.3 13.5 61.1 43.9 10.0 20.9 28.4 6.2 11.0 6.8 13.5 15.0 19.1 20.9 18.1 17.8 29.6 20.5 20.3 20.6 1.1 14.0 11.2 13.0 21.3 13.5 20.1 26.9 20.0 24.6 19.4 27.0 26.9 16.2 41.2 19.4 14.9 28.8 28.9 35.2 58.5 35.8 20.7 15.3 33.5 37.5 57.6 9.8 71.1 119.3 54.7 233.2 31.6 7.7 23.3 76.4 54.8 31.5 42.5 15.1 26.4 44.1 28.6 38.5 23.4 30.6 155.8 24.5 35.1 40.5 22.6 35.3 32.1 63.6 7.0 22.3 129.8 16.8 12.9 36.0 118.9 83.7 66.6 27.0 27.3 39.8 36.5 EFCAB14 KIAA0494 ENSG00000159658 "EF-hand calcium binding domain 14" O75071 1 46675159-46719064 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011224, HPA011938" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA 58000 Cytosol "Nucleoli, Golgi apparatus" "HPA011224: AB_1852314, HPA011938: AB_1852317" "unprognostic (2.44e-1)" "unprognostic (5.90e-2)" "unprognostic (7.53e-2)" "unprognostic (2.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.39e-2)" "unprognostic (6.06e-2)" "unprognostic (1.73e-1)" "unprognostic (1.66e-1)" "unprognostic (1.21e-2)" "unprognostic (3.00e-1)" "unprognostic (1.13e-3)" "unprognostic (1.00e-2)" "unprognostic (5.77e-2)" "unprognostic (1.94e-1)" "unprognostic (2.46e-1)" 29.4 17.4 29.4 14.3 29.5 6.7 22.5 16.2 24.8 25.3 26.0 40.6 15.6 17.2 23.7 27.3 30.0 22.0 19.7 20.2 27.2 20.5 27.8 24.9 24.0 16.4 31.0 15.2 25.2 16.0 107.1 17.2 25.2 27.3 24.4 24.0 23.0 19.9 24.9 24.7 20.4 26.9 22.5 36.1 24.0 36.4 21.9 30.6 28.7 30.1 13.2 20.2 25.7 20.0 16.6 16.0 30.3 21.1 17.1 28.5 18.3 14.5 8.3 7.1 11.2 34.0 21.4 16.3 15.8 23.3 17.5 18.1 9.9 9.9 11.7 16.5 21.4 23.7 17.6 12.1 17.4 23.8 22.2 7.8 14.6 9.2 4.0 11.7 18.8 28.8 18.9 29.2 13.9 11.6 16.8 21.3 11.4 9.0 16.7 18.0 5.7 12.4 8.5 10.1 17.2 9.4 9.5 19.9 10.2 18.5 29.6 3.7 5.1 19.5 27.6 14.8 20.1 12.3 16.5 19.6 15.0 7.3 17.4 16.0 17.2 23.8 9.4 19.2 16.2 11.0 15.6 18.6 30.3 23.6 21.1 28.5 16.6 20.6 20.2 16.0 16.2 18.0 19.5 12.5 17.1 18.3 12.9 17.8 18.3 29.4 29.5 16.2 24.8 27.2 20.5 31.0 15.2 27.3 30.6 68.5 69.2 34.6 40.1 28.2 30.1 33.2 45.9 45.5 45.5 108.2 29.5 31.8 26.6 31.3 50.1 52.8 51.8 0.0 33.7 27.6 35.0 57.4 96.2 51.2 37.0 44.5 36.2 46.1 67.7 14.4 43.7 41.1 25.3 34.3 62.6 50.2 37.9 57.5 46.7 30.6 17.7 25.8 28.8 37.2 23.3 38.0 49.3 41.5 41.9 98.2 EFNA5 "AF1, EPLG7, LERK7" ENSG00000184349 "Ephrin A5" P52803 5 107376889-107670895 "Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.5;memory CD8 T-cell: 3.0" "Group enriched" "Detected in many" 7 "NK-cells: 2.5;T-cells: 3.5" "Cell line enhanced" "Detected in many" "AF22: 19.6;RPTEC TERT1: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013282, HPA054047" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB013282: AB_2533353, HPA054047: AB_2682355" "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.15e-3)" "unprognostic (3.98e-3)" "unprognostic (2.74e-2)" "unprognostic (8.91e-4)" "unprognostic (9.46e-3)" "unprognostic (4.92e-1)" "unprognostic (2.28e-3)" "unprognostic (1.26e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.92e-7)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (1.27e-1)" 5.3 1.9 1.9 2.3 6.0 0.0 7.3 10.1 22.2 15.0 4.2 0.9 2.5 1.2 1.6 2.8 9.1 3.9 3.6 8.3 2.5 5.3 5.3 0.6 7.0 3.2 2.1 8.9 5.5 0.7 6.9 18.5 3.1 4.8 6.2 3.6 3.3 11.2 6.8 1.1 13.3 2.3 2.8 3.5 6.3 3.1 1.8 1.1 0.1 2.5 6.0 3.3 4.0 8.1 0.0 0.0 0.4 0.1 2.5 3.5 0.4 6.3 11.3 19.6 0.0 9.4 8.2 1.8 0.2 3.4 2.5 6.1 0.1 7.1 0.0 10.7 1.2 3.7 6.6 10.8 9.3 2.3 0.0 6.6 0.0 6.2 0.0 1.8 0.3 0.0 8.8 8.9 0.0 7.9 2.3 7.8 0.0 0.0 0.0 4.7 6.1 0.0 0.0 2.4 0.0 0.9 0.0 8.8 0.2 29.9 8.2 3.0 7.8 3.0 4.6 1.9 7.1 2.0 1.2 0.1 14.9 2.6 9.0 3.5 0.6 0.0 4.1 6.5 0.5 16.0 0.2 0.0 0.1 3.5 0.0 0.0 0.0 0.8 3.0 0.0 0.0 0.3 1.4 0.4 2.5 0.1 0.0 0.1 0.4 1.9 6.0 10.1 22.2 2.5 5.3 2.1 8.9 4.8 1.1 8.9 19.5 0.0 20.5 14.2 0.2 27.7 12.7 16.0 27.3 14.0 0.0 12.5 19.9 1.9 1.5 1.6 0.0 0.0 1.2 3.9 23.9 10.3 0.0 0.0 1.5 6.4 11.5 3.7 0.3 2.7 17.0 0.6 8.5 6.4 10.3 3.7 9.3 0.0 20.5 0.0 1.0 0.0 3.9 0.1 1.9 21.1 3.2 0.0 7.0 19.2 EFNB1 "CFNS, Elk-L, EPLG2, LERK2" ENSG00000090776 "Ephrin B1" P98172 X 68828997-68842147 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 104.2;Ito cells: 108.6;Suprabasal keratinocytes: 105.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 7.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 35.3;hTCEpi: 27.6;PC-3: 26.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB031489, HPA067188" Uncertain Supported "Plasma membrane" NA NA 790000 "Plasma membrane" "CAB031489: AB_631414, HPA067188: AB_2685799" "unprognostic (2.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (3.32e-5)" "unprognostic (1.04e-1)" "unprognostic (2.48e-2)" "unprognostic (8.05e-3)" "unprognostic (2.15e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (4.29e-4)" "unprognostic (1.29e-1)" "unprognostic (2.17e-3)" "unprognostic (2.76e-2)" "unprognostic (8.03e-2)" "unprognostic (1.72e-3)" "unprognostic (1.86e-2)" 36.5 13.2 5.0 11.5 4.5 1.3 26.5 2.3 4.7 19.5 21.1 4.7 13.1 14.0 15.2 14.9 17.4 15.2 33.7 16.0 3.6 2.7 25.5 15.3 23.0 5.2 4.7 3.5 21.6 4.5 15.0 6.4 34.3 3.9 15.9 10.1 14.9 7.0 13.2 9.1 26.4 24.0 12.3 2.6 15.3 13.3 7.4 4.2 4.8 11.9 22.0 11.2 16.7 14.8 0.5 7.1 0.6 3.4 1.3 1.0 1.0 3.6 1.9 15.5 5.7 8.3 5.1 8.2 3.2 3.5 1.4 1.0 1.7 6.9 0.9 21.2 1.2 1.8 19.8 14.7 35.3 0.8 1.5 3.7 0.9 0.8 3.0 7.6 0.7 7.9 9.5 27.6 3.5 15.9 1.3 10.8 1.9 1.0 0.0 1.2 3.0 1.5 0.7 10.7 22.8 26.1 6.6 1.6 5.9 5.9 13.1 5.8 2.8 2.4 0.7 0.9 12.4 0.6 1.3 18.1 2.7 3.3 7.2 1.2 0.0 0.8 0.9 1.3 4.0 1.7 0.0 1.3 0.6 1.0 3.4 0.6 0.5 0.9 0.9 7.1 0.4 0.8 0.4 0.3 1.3 2.1 1.0 0.4 1.0 5.0 4.5 2.3 4.7 3.6 2.7 4.7 3.5 3.9 4.2 3.0 1.4 5.2 58.4 104.2 2.1 8.1 22.9 0.0 7.9 21.0 0.0 9.2 0.0 17.1 0.3 33.4 38.3 0.0 13.8 68.8 20.1 10.6 4.6 3.8 10.6 1.6 8.1 108.6 9.1 0.9 25.3 7.5 20.3 3.6 26.2 14.6 28.9 46.1 7.8 6.3 1.3 12.9 11.8 1.0 3.0 105.3 9.4 4.9 22.1 71.6 EFNB2 "EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228" ENSG00000125266 "Ephrin B2" P52799 13 106489731-106535662 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Ito cells: 134.4;Muller glia cells: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Lineage enhanced" "Detected in single" "NK-cells: 1.5" "Cell line enhanced" "Detected in many" "AF22: 48.7;OE19: 27.9;SH-SY5Y: 24.4;U-87 MG: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008999, CAB009368" Supported Supported Nucleoplasm,Cytosol NA NA 760000 Nucleoplasm Cytosol "CAB009368: AB_2095700, HPA008999: AB_1078721" "unprognostic (1.70e-1)" "unprognostic (1.95e-3)" "unprognostic (1.72e-1)" "unprognostic (5.22e-3)" "unprognostic (4.52e-3)" "prognostic unfavorable (3.11e-6)" "unprognostic (2.32e-2)" "prognostic unfavorable (8.43e-4)" "unprognostic (2.09e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (8.70e-5)" "unprognostic (1.60e-1)" "unprognostic (1.09e-2)" "unprognostic (1.30e-1)" "unprognostic (3.07e-1)" "unprognostic (4.62e-2)" "unprognostic (2.27e-3)" 15.7 4.9 11.2 8.2 11.0 0.8 21.8 8.3 14.0 13.2 23.1 5.8 13.1 13.9 10.8 5.2 11.4 13.6 11.2 11.8 10.4 6.5 9.3 11.8 50.1 7.8 6.2 11.5 8.4 3.7 5.7 6.1 27.7 5.2 11.8 18.4 15.2 12.7 20.6 6.6 14.3 20.6 10.5 5.0 9.3 21.3 7.2 5.9 7.3 11.2 8.8 5.9 7.7 12.4 0.2 0.0 0.4 0.0 1.5 0.0 0.0 11.6 1.1 48.7 0.0 0.1 0.3 0.1 5.3 3.3 5.3 3.0 11.8 17.8 0.0 5.1 1.6 0.4 13.9 1.8 6.8 5.7 0.0 10.4 0.0 4.0 0.0 1.0 3.8 0.3 2.2 12.2 0.2 10.4 2.6 6.6 0.1 0.0 0.0 5.7 2.0 0.1 0.0 2.6 27.9 2.3 9.8 1.9 0.0 7.5 1.5 3.4 24.4 2.0 1.0 0.0 14.3 0.6 0.1 5.2 10.4 0.0 0.3 11.9 0.1 0.0 0.0 21.9 0.2 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 11.2 11.0 8.3 14.0 10.4 6.5 6.2 11.5 5.2 5.9 6.0 29.4 1.9 48.4 73.8 9.4 7.4 7.6 9.4 12.5 24.4 0.0 1.1 0.0 6.9 0.4 80.4 63.8 0.0 1.2 2.6 17.1 25.9 18.4 0.4 1.0 6.4 48.6 134.4 8.6 0.5 0.3 1.3 30.4 0.0 38.0 92.0 27.1 53.7 0.4 0.0 2.8 0.0 20.3 0.6 3.2 75.2 1.6 3.2 27.5 75.5 EFNB3 "EPLG8, LERK-8" ENSG00000108947 "Ephrin B3" Q15768 17 7705202-7711378 "Cancer-related genes, Predicted membrane proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.6" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 6.7;Early spermatids: 6.8;Intestinal endocrine cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 30.0;AN3-CA: 17.8;hTERT-RPE1: 18.3;SH-SY5Y: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001623 Approved NA NA "HPA001623: AB_1848026" "unprognostic (5.17e-2)" "unprognostic (7.15e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (5.52e-4)" "unprognostic (3.27e-1)" "unprognostic (1.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.61e-1)" "unprognostic (2.64e-2)" "unprognostic (1.14e-1)" "prognostic favorable (8.21e-4)" "unprognostic (3.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.56e-2)" "unprognostic (3.00e-1)" "unprognostic (8.56e-2)" "unprognostic (2.20e-2)" 1.7 2.8 10.6 1.1 26.5 0.4 4.3 1.1 34.6 4.8 1.0 4.0 0.0 0.8 12.3 1.0 2.2 6.7 1.8 1.1 10.9 19.0 1.4 2.3 1.5 0.7 3.0 11.8 3.2 1.8 1.1 3.0 1.8 4.3 2.7 1.1 1.4 1.7 1.0 0.8 6.9 1.0 4.7 1.3 0.5 1.3 2.1 2.1 0.0 1.2 0.1 1.4 2.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 30.0 17.8 0.5 0.4 0.2 0.3 3.9 2.6 1.7 1.1 1.8 0.0 0.6 1.1 0.2 0.2 7.6 3.7 1.5 0.0 3.7 0.1 0.0 0.0 0.8 0.0 0.0 1.7 0.7 0.8 0.6 18.3 0.2 0.3 0.0 0.0 0.5 2.8 0.0 0.0 2.7 0.0 0.5 0.1 0.1 0.0 4.1 0.4 1.9 15.7 0.0 0.0 0.6 5.5 1.6 0.0 0.0 1.8 5.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.6 26.5 1.1 26.3 10.9 19.0 3.0 11.8 4.3 2.1 0.0 0.0 0.0 4.1 3.7 0.4 1.6 0.0 6.7 1.2 0.0 0.0 0.2 0.0 0.8 6.8 0.1 0.0 0.0 0.2 0.8 2.7 1.3 1.1 0.0 0.4 4.8 6.4 3.7 0.0 4.2 4.4 0.0 0.0 0.0 0.0 1.3 0.3 0.0 3.2 0.0 0.6 0.0 0.8 0.2 0.2 2.5 0.2 0.0 0.0 0.6 EGF ENSG00000138798 "Epidermal growth factor" P01133 4 109912884-110012266 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 48.4;pancreas: 41.2;skeletal muscle: 19.8" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 38.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "EFO-21: 8.2;SK-BR-3: 14.9;U-251 MG: 4.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA 209000 25000 "unprognostic (2.83e-2)" "unprognostic (1.02e-2)" "unprognostic (8.50e-3)" "unprognostic (1.88e-3)" "unprognostic (4.24e-2)" "unprognostic (1.64e-3)" "unprognostic (5.06e-4)" "unprognostic (8.30e-2)" "unprognostic (2.21e-3)" "unprognostic (4.25e-2)" "unprognostic (1.80e-2)" "unprognostic (2.95e-1)" "unprognostic (7.72e-3)" "unprognostic (4.64e-5)" "unprognostic (2.63e-1)" "unprognostic (9.80e-5)" "unprognostic (3.92e-3)" 0.8 0.1 0.4 0.0 0.4 0.0 5.9 0.1 0.9 0.2 0.2 0.3 0.3 0.0 0.3 2.6 0.9 0.2 0.3 2.3 0.8 0.3 48.4 0.0 0.6 0.0 1.2 0.7 0.0 41.2 0.0 0.4 0.0 1.4 0.6 0.4 3.9 8.4 0.1 19.8 0.5 0.2 1.9 0.6 0.2 0.0 0.2 0.2 0.0 1.2 4.5 0.4 0.4 0.5 0.0 0.4 1.7 0.0 0.0 0.0 2.6 0.2 0.3 2.4 0.1 0.0 0.1 0.0 0.6 1.5 0.8 0.5 0.1 0.1 0.0 8.2 0.8 2.1 0.0 0.3 0.0 0.6 0.1 0.4 0.1 0.9 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 1.6 0.2 0.8 0.1 0.0 0.0 2.9 0.0 0.6 0.2 0.1 0.7 0.7 0.2 0.0 0.0 0.0 14.9 0.5 1.8 3.5 0.0 0.0 1.3 2.0 0.0 4.7 0.0 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 2.6 0.4 0.4 0.1 0.9 0.8 0.3 1.2 0.7 1.4 0.2 0.0 0.0 0.0 0.1 0.9 0.6 6.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.2 2.2 0.0 0.4 0.0 4.9 0.0 0.0 1.5 0.0 0.0 0.1 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 38.3 1.6 0.0 0.0 1.2 1.1 0.0 0.0 0.5 0.3 1.3 0.0 0.0 1.6 0.1 EGFLAM "AGRINL, AGRNL, FLJ39155, PIKA" ENSG00000164318 "EGF like, fibronectin type III and laminin G domains" Q63HQ2 5 38258409-38465021 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 54.7" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 113.9;Leydig cells: 143.8;Sertoli cells: 84.1;Smooth muscle cells: 78.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 7.2;HBEC3-KT: 8.7;hTERT-HME1: 11.6;HUVEC TERT2: 11.1;LHCN-M2: 25.6;U-2 OS: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA066577 Approved "Secreted - unknown location" NA NA "HPA066577: " "unprognostic (2.05e-1)" "unprognostic (4.81e-2)" "unprognostic (1.01e-1)" "unprognostic (1.38e-3)" "unprognostic (1.08e-2)" "unprognostic (3.63e-3)" "unprognostic (6.31e-2)" "unprognostic (2.83e-1)" "unprognostic (2.08e-2)" "unprognostic (1.71e-3)" "unprognostic (1.12e-1)" "unprognostic (5.80e-2)" "prognostic unfavorable (4.47e-5)" "unprognostic (7.02e-6)" "unprognostic (2.60e-1)" "unprognostic (9.90e-2)" "unprognostic (1.04e-2)" 18.6 10.4 0.8 3.1 2.6 0.0 25.9 1.5 0.7 7.8 4.0 1.5 5.1 0.8 9.3 9.2 6.3 3.9 4.0 7.8 0.6 1.1 4.8 3.5 1.5 11.0 1.3 0.6 16.6 1.4 2.1 3.0 25.7 3.5 9.9 1.5 19.8 6.6 11.1 54.7 2.9 2.3 3.5 2.2 8.1 1.8 9.1 1.3 4.9 4.6 19.4 4.2 6.0 6.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 4.6 0.1 0.5 0.1 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.1 7.2 0.0 0.1 0.0 0.0 8.7 0.0 0.0 1.1 0.0 4.1 0.0 2.0 0.0 0.0 3.9 0.0 0.0 11.6 0.0 11.1 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 2.7 0.0 2.6 0.1 1.0 0.0 0.1 0.0 0.1 11.2 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 2.6 1.5 0.7 0.6 1.1 1.3 0.6 3.5 1.3 0.0 0.0 0.0 0.2 2.4 1.0 2.0 0.0 0.0 0.0 0.0 113.9 0.4 3.3 0.4 41.7 3.3 0.0 0.0 0.9 0.4 12.7 0.2 0.0 0.0 0.6 0.0 0.0 1.3 0.0 39.1 143.8 0.6 5.0 0.0 0.0 1.5 0.9 0.0 29.0 2.9 30.1 84.1 78.8 8.1 3.1 1.8 0.5 0.0 0.0 0.3 EGFR "ERBB, ERBB1" ENSG00000146648 "Epidermal growth factor receptor" P00533 7 55019021-55211628 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Host-virus interaction" "Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 102.3" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 207.2;Syncytiotrophoblasts: 315.1" "Cancer enhanced" "Detected in all" "glioma: 136.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 12 "A-431: 345.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000035, HPA001200, HPA018530, CAB068186, CAB073534" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Secreted to blood" NA NA 4740000 93000000 "Plasma membrane, Cell Junctions" "CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044" "unprognostic (2.62e-2)" "unprognostic (9.56e-3)" "unprognostic (1.59e-1)" "unprognostic (7.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (6.11e-2)" "unprognostic (4.88e-2)" "unprognostic (2.85e-2)" "unprognostic (3.30e-3)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" "unprognostic (1.93e-3)" "unprognostic (6.98e-3)" "unprognostic (1.72e-1)" "unprognostic (6.62e-2)" "prognostic unfavorable (2.04e-5)" 16.2 8.4 4.9 7.5 6.8 0.1 39.8 5.1 8.5 13.8 7.8 3.3 10.7 3.6 8.2 11.7 15.6 8.8 8.5 4.8 6.8 2.7 7.6 23.5 14.2 2.3 4.1 3.9 10.4 10.1 1.8 2.1 102.3 5.6 10.9 6.7 9.2 15.4 12.9 10.7 32.5 6.3 15.5 3.5 3.3 7.8 5.5 5.9 3.2 12.8 15.5 8.0 10.2 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 345.9 4.4 1.1 1.5 7.1 4.4 1.2 3.4 4.6 2.1 1.6 0.8 3.7 0.2 0.8 2.9 9.0 13.9 0.0 15.3 2.5 0.1 0.2 0.0 1.9 0.2 1.8 0.0 0.0 2.1 14.0 5.3 28.6 3.1 0.2 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.3 1.3 2.2 0.0 0.6 0.0 2.6 3.7 0.0 1.3 2.9 3.5 0.7 1.2 0.3 0.8 1.0 1.9 0.5 14.9 3.2 0.0 0.3 0.2 2.6 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 6.8 5.1 6.6 6.8 2.7 4.1 3.9 5.6 5.9 89.3 37.5 4.2 67.7 76.2 1.5 7.3 53.5 16.0 59.1 21.0 5.9 207.2 0.0 30.6 4.6 10.9 15.9 23.3 21.0 36.6 45.3 37.8 0.0 77.4 24.2 0.0 4.1 6.7 7.0 2.2 118.8 1.3 16.9 2.8 25.3 106.1 41.7 17.3 125.5 14.0 2.3 77.6 23.1 1.6 2.7 78.5 315.1 0.0 20.0 46.4 EI24 "EPG4, PIG8, TP53I8" ENSG00000149547 "EI24, autophagy associated transmembrane protein" O14681 11 125569216-125584687 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 164.6" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 494.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 117.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047165, HPA051029" Approved Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Golgi apparatus" "HPA047165: AB_2679965, HPA051029: AB_2681317" "unprognostic (2.04e-3)" "unprognostic (2.69e-2)" "unprognostic (1.25e-2)" "unprognostic (3.43e-2)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.02e-2)" "unprognostic (6.38e-2)" "unprognostic (6.74e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (3.50e-2)" "unprognostic (1.35e-1)" "unprognostic (4.58e-2)" "unprognostic (8.35e-2)" "unprognostic (2.07e-1)" "unprognostic (3.01e-1)" 13.4 10.2 13.3 8.9 16.2 4.6 16.7 11.2 22.1 12.7 17.0 14.4 13.8 11.3 13.6 12.9 22.7 12.1 15.8 16.4 10.6 10.7 14.6 55.5 12.1 11.2 12.0 11.1 13.1 34.2 164.6 9.2 11.9 11.0 13.7 18.9 13.2 20.9 14.3 26.5 17.2 16.1 15.9 9.2 10.5 17.7 10.4 10.5 9.9 12.0 14.2 13.0 16.2 12.9 8.5 15.5 5.4 7.3 6.5 10.0 4.9 24.5 18.7 21.4 25.8 35.2 26.8 26.8 25.2 19.1 17.4 15.7 28.4 49.7 24.7 42.9 23.7 18.5 28.4 32.5 53.0 22.6 6.5 20.6 117.9 13.4 26.6 26.2 26.6 12.8 25.0 48.6 26.1 38.7 17.2 36.7 13.5 53.5 10.1 24.4 17.3 12.1 13.6 28.2 63.6 20.5 17.8 25.3 21.0 29.0 44.0 20.0 19.2 29.5 35.2 9.5 37.0 71.9 26.5 30.5 22.4 15.2 15.7 20.4 6.3 12.7 32.2 9.8 40.8 29.8 4.1 7.3 5.4 8.2 7.0 8.1 8.5 6.5 10.0 11.6 7.3 9.4 7.6 0.9 6.5 5.1 15.5 9.0 4.9 13.3 16.2 11.2 22.1 10.6 10.7 12.0 11.1 11.0 10.5 29.8 34.7 29.8 114.2 107.2 57.4 55.7 129.9 9.4 27.3 104.7 35.3 140.6 122.7 154.4 19.7 84.2 53.8 0.0 158.4 174.0 83.1 141.9 27.6 494.9 92.4 77.9 94.5 65.1 44.4 33.9 66.2 50.8 86.0 34.3 100.9 68.5 153.1 52.6 67.8 102.8 30.5 45.3 89.6 92.8 109.0 158.6 117.2 35.1 116.3 136.4 EIF2AK3 "PEK, PERK" ENSG00000172071 "Eukaryotic translation initiation factor 2 alpha kinase 3" Q9NZJ5 2 88556741-88627576 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Stress response, Translation regulation, Unfolded protein response" "Kinase, Serine/threonine-protein kinase, Transferase" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Daudi: 38.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009204, HPA015737" Approved NA NA "CAB009204: AB_2230863, HPA015737: AB_1848062" "unprognostic (7.25e-3)" "unprognostic (5.35e-2)" "unprognostic (3.03e-3)" "unprognostic (9.32e-2)" "unprognostic (9.39e-3)" "unprognostic (3.25e-2)" "unprognostic (2.27e-2)" "unprognostic (3.46e-3)" "unprognostic (9.84e-2)" "unprognostic (3.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.31e-1)" "unprognostic (2.06e-1)" "unprognostic (2.92e-1)" "unprognostic (9.80e-2)" "unprognostic (3.60e-3)" "unprognostic (2.90e-3)" 12.7 10.3 7.2 12.3 7.6 18.6 10.7 8.8 6.6 15.8 10.7 6.1 20.9 7.3 9.6 12.4 9.5 8.9 8.5 11.1 5.7 5.5 11.5 15.9 10.4 9.3 7.9 5.0 8.8 36.7 18.5 18.4 14.4 8.3 11.4 12.6 7.3 28.0 20.9 12.7 8.9 10.8 7.0 7.5 11.1 19.0 4.6 7.3 8.7 15.7 6.3 17.3 21.5 19.2 6.6 2.6 1.5 0.7 1.6 2.4 0.6 4.9 3.3 7.2 4.7 13.3 9.3 11.5 7.1 9.2 5.1 7.5 7.4 3.6 38.2 4.3 4.9 7.9 4.5 5.2 4.0 7.5 13.4 3.4 4.1 3.3 7.5 8.3 5.0 9.7 3.5 6.4 4.7 10.2 7.6 5.5 4.5 2.4 13.7 3.9 5.6 4.7 4.0 5.3 9.3 3.8 18.5 10.0 6.8 6.3 9.4 5.6 7.7 4.2 10.9 7.2 9.1 4.0 3.0 4.3 4.4 4.7 9.9 4.4 25.7 12.9 27.0 6.2 4.6 5.9 1.1 0.7 1.5 1.7 0.6 1.9 4.7 1.7 2.4 0.9 6.6 1.5 1.1 0.2 1.6 0.2 2.6 1.4 0.6 7.2 7.6 8.8 6.6 5.7 5.5 7.9 5.0 8.3 7.3 8.9 6.9 11.2 8.5 18.0 6.0 4.8 17.8 4.0 1.2 12.2 7.9 3.7 0.0 3.3 0.1 7.7 8.6 0.0 5.5 5.9 13.0 14.2 1.1 11.3 4.1 1.6 13.1 9.8 5.7 0.4 6.9 6.4 30.4 1.0 26.4 2.9 8.4 8.5 5.3 2.6 1.8 0.0 10.3 2.6 3.4 15.9 5.6 7.5 5.1 12.1 ELANE "ELA2, HLE, HNE, NE" ENSG00000197561 "Elastase, neutrophil expressed" P08246 19 851014-856247 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "bone marrow: 244.3" "Cell type enhanced" "Detected in some" 9 "Basal keratinocytes: 7.7;Fibroblasts: 5.7;Kupffer cells: 5.6;Leydig cells: 5.8;Melanocytes: 6.8;Suprabasal keratinocytes: 6.5" "Group enriched" "Detected in some" 7 "pancreatic cancer: 3.5;stomach cancer: 3.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "classical monocyte: 3.2;neutrophil: 6.9" "Group enriched" "Detected in many" 9 "granulocytes: 6.9;monocytes: 3.2" "Cell line enriched" "Detected in some" 65 "THP-1: 197.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB015409, HPA066836" Enhanced "Secreted to blood" NA NA 59000 "CAB015409: AB_831596, HPA066836: AB_2685733" "unprognostic (3.46e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-3)" "unprognostic (2.09e-2)" "unprognostic (1.80e-3)" "unprognostic (3.43e-2)" "unprognostic (3.92e-1)" "unprognostic (6.38e-3)" "unprognostic (5.80e-1)" "unprognostic (2.54e-2)" "unprognostic (4.06e-2)" "unprognostic (3.48e-2)" "unprognostic (1.19e-10)" "unprognostic (6.27e-3)" "unprognostic (4.00e-2)" "unprognostic (2.76e-2)" "unprognostic (4.75e-3)" 1.5 0.3 0.1 0.3 0.1 244.3 1.6 0.2 0.6 0.3 0.6 0.7 0.0 0.3 0.3 0.7 0.5 0.6 0.8 31.2 0.0 0.0 0.3 1.5 17.8 1.6 0.0 0.0 0.3 1.8 0.3 0.4 4.7 0.5 1.4 0.3 1.0 0.7 0.3 1.1 2.1 0.5 0.5 0.0 22.5 0.5 0.3 0.0 23.0 2.3 0.9 0.3 1.0 0.2 0.0 0.0 6.9 3.2 0.0 0.5 11.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 11.2 0.1 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 5.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 5.6 0.0 5.8 0.0 6.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.7 0.2 0.0 6.5 0.0 0.0 0.0 0.0 ELFN1 PPP1R28 ENSG00000225968 "Extracellular leucine rich repeat and fibronectin type III domain containing 1" P0C7U0 7 1688119-1747954 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 13.3" "Cell type enhanced" "Detected in some" 10 "Cone photoreceptor cells: 5.9;Hepatocytes: 7.8;Ito cells: 9.8;Rod photoreceptor cells: 6.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 19.5;U-138 MG: 12.3;U-2 OS: 18.0;U-2197: 20.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066382 Approved "Nucleoplasm,Cell Junctions" NA NA 11000 "Nucleoplasm, Cell Junctions" "HPA066382: AB_2732744" "unprognostic (8.45e-2)" "unprognostic (3.39e-3)" "unprognostic (6.54e-4)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "prognostic favorable (9.68e-4)" "unprognostic (4.60e-3)" "unprognostic (1.63e-3)" "unprognostic (6.60e-2)" "unprognostic (4.14e-3)" "unprognostic (1.11e-2)" "unprognostic (2.31e-2)" "unprognostic (7.47e-3)" "unprognostic (8.63e-2)" "unprognostic (2.78e-1)" "unprognostic (4.07e-1)" 1.8 0.8 2.2 0.6 1.4 0.0 0.6 0.0 4.2 3.2 0.3 0.2 2.2 0.3 0.3 0.8 0.8 3.3 1.8 2.2 2.8 13.3 0.3 0.1 2.7 0.0 0.2 0.2 0.2 0.7 0.6 0.0 0.5 0.2 1.2 0.6 0.3 0.5 1.7 1.7 0.2 0.7 0.2 0.0 0.5 0.9 0.5 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 3.0 6.3 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.1 0.3 0.0 3.0 1.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.5 0.0 2.9 1.2 0.0 0.7 19.5 0.0 1.9 0.0 0.0 2.8 1.3 0.1 0.1 0.0 0.3 0.0 0.2 0.0 12.3 18.0 20.9 0.0 0.0 0.2 5.3 0.0 0.0 1.5 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.5 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.4 0.1 1.0 1.6 0.0 0.0 0.0 0.0 5.9 0.0 3.3 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 7.8 0.1 0.0 0.0 9.8 0.6 0.0 0.9 0.0 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 6.7 0.0 0.9 0.0 2.7 0.0 0.0 0.0 0.0 0.0 ELFN2 "dJ63G5.3, KIAA1904, LRRC62, PPP1R29" ENSG00000166897 "Extracellular leucine rich repeat and fibronectin type III domain containing 2" Q5R3F8 22 37367960-37427470 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 30.0" "Cell type enriched" "Detected in some" 11 "Bipolar cells: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.7;CAPAN-2: 8.4;GAMG: 9.4;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000781 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA000781: AB_1079280" "unprognostic (2.74e-1)" "unprognostic (6.81e-2)" "unprognostic (2.80e-2)" "unprognostic (1.31e-5)" "unprognostic (3.28e-1)" "unprognostic (2.51e-2)" "unprognostic (7.76e-2)" "unprognostic (4.25e-2)" "unprognostic (6.05e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (4.51e-1)" "prognostic unfavorable (7.21e-4)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" 1.0 2.1 26.8 0.9 10.9 0.9 0.9 0.7 30.0 0.9 0.9 1.9 0.0 0.9 0.9 0.9 0.9 1.0 1.9 0.8 16.2 8.7 1.2 0.8 2.0 1.0 6.7 15.0 0.8 1.1 0.8 0.1 0.8 5.8 2.2 0.9 0.9 0.9 0.9 0.9 1.5 0.9 0.8 3.8 0.9 1.1 4.2 3.9 0.1 0.8 0.0 0.9 0.9 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.7 3.7 0.0 0.0 0.0 0.7 0.0 4.0 2.1 0.9 0.0 1.4 8.4 0.2 5.2 2.8 9.4 6.1 0.4 0.8 0.1 0.2 0.0 0.0 3.9 0.0 0.2 0.0 0.1 0.7 0.1 0.3 1.2 3.5 0.3 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.2 5.2 8.0 0.1 0.0 8.4 16.4 0.0 0.7 0.0 3.6 4.6 0.0 0.0 0.0 0.1 0.4 0.0 18.7 0.1 2.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 10.9 0.7 16.8 16.2 8.7 6.7 15.0 5.8 3.9 0.0 3.2 0.0 0.0 0.1 43.2 0.0 2.5 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.3 1.6 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 ELN "SVAS, WBS, WS" ENSG00000049540 Elastin P15502 7 74027789-74069907 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 53.4;Ito cells: 49.1;Leydig cells: 102.4;Peritubular cells: 139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 16.9;BJ: 23.4;fHDF/TERT166: 33.6;U-2197: 133.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB010750, HPA018111, HPA056941" Supported Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 2900000 "Plasma membrane" "CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280" "unprognostic (1.51e-2)" "unprognostic (4.86e-2)" "unprognostic (2.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-2)" "unprognostic (2.72e-2)" "unprognostic (3.70e-3)" "unprognostic (1.23e-1)" "unprognostic (3.33e-2)" "unprognostic (2.00e-3)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.62e-3)" 35.0 8.8 4.3 14.9 3.6 0.0 24.8 27.8 5.8 23.3 12.1 12.9 9.1 3.2 22.3 26.0 30.1 17.1 30.8 41.5 5.4 3.0 8.3 3.7 49.7 7.5 4.4 9.2 10.6 35.3 0.7 6.1 22.5 13.7 25.1 4.6 34.3 16.8 14.5 6.0 23.6 9.2 34.7 9.9 10.7 16.0 8.1 6.4 0.9 11.9 10.3 4.4 34.0 21.7 0.4 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.3 0.1 0.0 16.9 0.1 0.1 23.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.3 0.1 0.1 0.0 9.0 0.1 0.0 0.0 4.6 11.0 0.0 0.2 0.0 1.7 0.1 0.0 0.0 0.0 0.0 133.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.3 3.6 27.8 5.8 5.4 3.0 4.4 9.2 13.7 6.4 0.0 8.3 0.0 13.2 9.7 0.9 8.9 2.5 4.0 5.7 7.0 2.0 0.1 0.0 0.2 2.5 26.4 0.0 0.0 3.5 0.2 53.4 1.2 0.0 2.1 0.4 6.4 1.7 49.1 0.3 4.2 102.4 1.0 13.5 0.0 1.3 17.8 1.5 0.0 139.3 0.0 0.7 0.0 31.5 0.9 1.1 9.5 0.1 0.0 0.0 0.8 ELOVL1 Ssc1 ENSG00000066322 "ELOVL fatty acid elongase 1" Q9BW60 1 43363397-43368074 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 101.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033426, HPA056557" Enhanced Supported "Endoplasmic reticulum" NA Yes "Endoplasmic reticulum" "CAB033426: AB_2099896, HPA056557: AB_2683173" "unprognostic (5.23e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (8.00e-2)" "unprognostic (8.45e-2)" "unprognostic (7.60e-2)" "unprognostic (7.40e-2)" "prognostic unfavorable (2.79e-7)" "unprognostic (4.74e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-1)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" "unprognostic (1.73e-1)" "unprognostic (9.00e-2)" 21.2 15.6 16.2 15.3 25.3 18.3 24.1 6.8 32.5 16.1 23.6 101.5 11.7 20.7 14.1 13.0 46.6 15.1 17.3 11.5 30.3 18.3 26.6 23.8 22.9 22.7 51.4 14.1 9.3 18.3 16.7 8.4 20.9 45.6 21.6 20.1 8.6 20.6 21.6 6.8 54.0 21.7 20.7 99.5 17.2 22.8 8.4 37.2 7.2 23.9 15.6 21.7 20.4 22.6 30.9 61.1 46.9 54.8 30.5 32.3 48.8 23.8 26.9 5.2 10.3 35.6 33.5 16.3 28.3 35.7 36.1 29.1 23.8 41.9 16.5 22.0 44.3 31.2 27.5 18.4 34.8 22.2 21.2 12.4 21.4 18.6 17.2 30.9 18.4 22.9 25.6 39.6 42.6 47.1 27.1 36.1 6.5 14.8 12.6 41.3 17.6 4.3 15.5 7.6 31.1 27.9 9.7 13.9 20.1 45.5 29.1 6.4 6.7 16.7 59.7 23.8 16.2 28.1 18.4 29.8 30.6 19.4 37.0 35.8 6.3 6.8 7.9 29.8 18.9 27.5 29.0 54.8 46.9 32.3 50.6 28.6 30.9 30.7 31.4 61.1 25.5 20.1 28.1 38.2 30.5 48.1 42.9 31.4 48.8 16.2 25.3 6.8 32.5 30.3 18.3 51.4 14.1 45.6 37.2 17.9 8.4 18.1 20.4 13.9 5.4 3.6 45.9 5.3 7.9 38.4 9.8 79.2 6.6 86.7 2.5 28.7 74.3 70.0 86.6 103.3 20.2 33.0 20.7 13.7 66.2 3.2 18.4 23.4 47.0 3.4 18.7 37.1 11.8 129.8 30.5 12.4 99.9 40.7 24.1 21.3 8.4 19.4 15.3 6.7 8.6 27.0 80.2 24.6 36.9 43.7 ELOVL2 Ssc2 ENSG00000197977 "ELOVL fatty acid elongase 2" Q9NXB9 6 10980759-11044314 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.6;liver: 43.1;parathyroid gland: 19.9;placenta: 28.4" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 27.5;Extravillous trophoblasts: 17.8;Hepatocytes: 13.2;Sertoli cells: 19.4" "Group enriched" "Detected in many" 8 "breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 17.0;GAMG: 17.5;HBF TERT88: 16.4;Hep G2: 12.5;RH-30: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "prognostic favorable (6.73e-5)" "unprognostic (4.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.28e-5)" "unprognostic (4.06e-2)" "unprognostic (4.09e-3)" "unprognostic (1.89e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-1)" "unprognostic (2.56e-1)" "unprognostic (6.92e-3)" "unprognostic (1.78e-2)" "unprognostic (1.04e-12)" "unprognostic (9.98e-4)" "unprognostic (8.86e-2)" "unprognostic (3.41e-1)" "unprognostic (9.47e-2)" 1.4 1.3 10.7 1.7 11.5 0.6 4.7 5.8 12.2 0.6 0.6 8.8 0.0 0.7 0.9 2.5 0.8 0.6 1.1 3.1 6.4 4.8 0.7 43.1 0.7 0.9 7.1 7.1 0.7 2.6 19.9 2.8 28.4 8.0 5.0 0.6 5.9 1.1 0.9 1.3 0.7 0.8 1.1 18.6 0.5 0.6 9.3 4.0 0.0 2.0 0.0 1.3 1.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 11.2 0.0 0.0 0.0 6.4 0.2 0.5 9.9 17.0 0.0 0.0 0.0 0.0 0.6 17.5 0.0 11.7 0.0 16.4 0.0 10.1 0.1 0.2 12.5 0.5 0.2 2.7 0.1 0.0 7.6 0.0 0.6 0.0 0.5 0.6 0.0 0.2 0.0 6.4 0.1 2.1 0.0 9.6 8.9 17.8 0.0 0.0 0.1 4.5 5.1 0.0 0.0 4.1 9.5 2.0 5.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.7 11.5 5.8 10.9 6.4 4.8 7.1 7.1 8.0 4.0 0.0 0.0 0.0 0.0 0.1 1.8 0.6 5.1 0.0 0.0 0.0 27.5 1.6 0.0 4.8 8.6 0.7 0.0 0.0 0.8 17.8 7.2 2.1 0.0 13.2 1.1 0.0 0.0 0.0 0.0 12.4 0.9 0.0 0.0 0.0 0.0 3.9 1.1 0.0 0.4 0.0 10.2 19.4 0.3 12.1 7.9 0.0 1.4 0.0 0.0 0.0 ELOVL3 CIG-30 ENSG00000119915 "ELOVL fatty acid elongase 3" Q9HB03 10 102226328-102229589 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 24.6" "Cell type enhanced" "Detected in some" 11 "Ito cells: 1.3;Kupffer cells: 2.4;Smooth muscle cells: 2.0;Spermatogonia: 2.7" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 11 "classical monocyte: 9.4;intermediate monocyte: 3.1;myeloid DC: 2.6;non-classical monocyte: 6.6" "Group enriched" "Detected in many" 12 "dendritic cells: 2.6;monocytes: 9.4" "Cell line enhanced" "Detected in some" "ASC diff: 8.3;ASC TERT1: 8.3;HSkMC: 12.2;NB-4: 9.4;SiHa: 18.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036236 Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA036236: AB_10601550" "unprognostic (1.52e-2)" "unprognostic (6.76e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (6.25e-5)" "unprognostic (8.23e-3)" "unprognostic (9.82e-2)" "unprognostic (2.17e-4)" "unprognostic (4.27e-2)" "unprognostic (2.28e-1)" "unprognostic (5.56e-2)" "unprognostic (1.84e-2)" "unprognostic (5.36e-3)" "unprognostic (2.66e-9)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (1.97e-1)" "unprognostic (1.79e-1)" 6.3 1.1 1.2 2.1 2.4 3.6 7.3 0.4 0.9 0.2 0.2 0.0 0.0 0.0 0.9 0.3 0.3 0.3 2.5 2.5 0.6 0.2 0.5 0.2 1.8 0.1 0.7 0.0 0.2 0.2 0.0 1.8 2.4 1.1 0.3 0.2 1.6 3.4 1.7 1.7 24.6 0.3 0.0 0.2 0.8 0.2 6.8 0.0 0.0 0.2 2.8 0.0 0.6 2.6 0.0 2.6 0.5 9.4 0.0 0.0 1.9 2.6 0.2 0.1 6.6 8.3 8.3 2.4 0.1 0.2 0.3 0.4 0.4 2.5 0.0 0.3 0.0 0.0 0.0 5.0 0.1 0.4 0.0 0.0 0.1 0.3 0.6 0.3 0.0 0.1 12.2 1.4 3.0 0.0 0.0 0.0 0.8 0.1 3.0 0.7 0.0 0.0 9.4 0.1 0.9 0.9 0.0 4.3 0.0 1.7 0.0 0.0 0.3 18.9 0.8 0.6 0.5 6.9 2.2 0.0 1.3 0.0 0.3 0.2 0.4 5.8 0.0 3.0 5.4 0.0 0.0 9.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.5 0.0 6.6 0.0 0.0 1.9 1.2 2.4 0.4 0.9 0.6 0.2 0.7 0.0 1.1 0.0 0.0 0.6 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.9 0.1 0.0 0.0 0.2 0.0 0.0 1.3 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.7 0.1 0.2 0.0 0.0 0.0 ELOVL4 "CT118, SCA34, STGD2, STGD3" ENSG00000118402 "ELOVL fatty acid elongase 4" Q9GZR5 6 79914812-79947580 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease mutation, Ichthyosis, Mental retardation, Neurodegeneration, Spinocerebellar ataxia, Stargardt disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 92.6;skin 1: 41.9" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 139.4;Rod photoreceptor cells: 278.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 19.1" "Lineage enriched" "Detected in single" 191 "T-cells: 19.1" "Cell line enhanced" "Detected in many" "JURKAT: 25.2;MOLT-4: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-2)" "unprognostic (8.58e-3)" "unprognostic (2.38e-2)" "unprognostic (3.08e-6)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (1.27e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (3.46e-1)" "unprognostic (6.91e-3)" "unprognostic (3.39e-1)" "unprognostic (1.38e-2)" "unprognostic (3.45e-3)" "unprognostic (1.66e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.27e-4)" 1.2 2.6 6.0 1.6 8.8 0.6 4.7 16.0 15.5 2.2 1.4 2.3 0.2 1.1 2.8 1.6 11.0 0.9 2.2 0.9 8.4 10.4 1.9 0.6 0.7 0.9 6.3 4.8 2.3 1.0 10.7 7.6 2.2 19.3 4.7 1.6 15.5 3.0 2.3 0.7 41.9 1.3 3.2 3.5 1.0 1.0 5.8 2.3 92.6 2.0 4.4 2.2 1.8 2.6 0.0 0.0 0.0 0.0 0.0 19.1 0.6 0.0 0.5 6.7 7.4 5.6 5.4 1.0 3.4 3.8 2.9 6.4 0.9 0.0 0.0 0.6 4.7 12.1 0.7 8.6 4.8 2.2 0.0 11.2 0.2 1.4 0.0 5.2 2.6 1.0 4.4 1.8 3.0 3.1 4.2 4.8 25.2 0.0 0.0 6.1 1.1 19.2 0.0 6.4 0.0 3.5 0.0 9.6 0.0 0.1 0.0 8.9 2.6 3.7 5.9 1.0 4.8 2.3 0.2 0.4 1.3 2.6 2.0 2.6 4.5 8.9 0.0 3.1 0.0 2.0 0.0 0.0 0.0 1.8 0.0 19.1 0.0 2.6 3.1 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.2 0.6 6.0 8.8 16.0 13.5 8.4 10.4 6.3 4.8 19.3 2.3 0.0 0.0 0.0 2.3 10.1 47.3 0.4 0.0 0.0 4.5 0.0 139.4 0.8 0.0 0.1 4.5 0.8 0.0 0.0 0.0 1.6 3.2 2.0 0.0 0.0 0.2 39.7 8.5 0.0 0.0 1.8 1.1 0.0 3.3 0.0 0.0 35.8 0.0 0.0 3.2 2.3 278.2 0.0 5.3 13.5 7.8 33.1 0.8 0.5 0.0 0.7 ELOVL5 "dJ483K16.1, HELO1, SCA38" ENSG00000012660 "ELOVL fatty acid elongase 5" Q9NYP7 6 53267398-53349179 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 250.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017042, HPA047752, HPA054197" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413" "unprognostic (7.33e-2)" "unprognostic (5.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.92e-2)" "unprognostic (1.16e-1)" "unprognostic (5.01e-2)" "unprognostic (3.06e-1)" "unprognostic (2.19e-1)" "unprognostic (4.38e-2)" "unprognostic (1.43e-2)" "unprognostic (3.23e-1)" "unprognostic (6.40e-2)" "prognostic unfavorable (1.94e-6)" "unprognostic (1.58e-1)" "unprognostic (5.12e-2)" "prognostic unfavorable (6.80e-4)" "unprognostic (2.76e-2)" 75.7 48.7 17.9 24.2 22.0 33.9 78.8 13.3 22.1 18.2 13.9 38.3 91.2 9.7 15.7 18.0 10.8 16.5 18.0 14.6 18.3 17.5 13.5 36.8 24.4 33.6 41.1 12.3 13.1 5.7 8.1 11.6 13.6 26.4 45.2 6.7 16.1 9.4 88.4 3.6 11.4 17.3 18.0 46.4 18.5 9.5 34.8 29.1 28.7 17.6 5.6 33.6 16.6 19.4 23.8 18.1 60.7 11.3 8.4 25.3 10.4 25.3 18.5 32.5 59.3 86.2 50.1 13.8 29.6 33.3 23.9 33.6 16.4 29.4 28.8 21.5 30.7 37.6 15.0 32.0 27.1 35.9 24.2 22.5 28.4 17.3 22.8 47.4 22.4 20.8 46.2 21.3 23.9 30.1 24.2 26.5 57.5 35.4 16.8 17.2 2.7 66.5 19.9 17.5 0.9 14.2 26.0 22.3 10.0 45.0 15.2 30.3 20.8 24.5 12.8 24.8 22.1 29.2 21.0 25.1 26.3 23.4 46.8 38.9 14.1 13.0 21.9 13.7 32.6 18.6 9.0 11.3 40.7 8.8 8.1 14.2 21.6 14.7 10.6 18.1 23.8 7.2 6.7 60.7 8.4 9.6 4.8 25.3 10.4 17.9 22.0 13.3 20.2 18.3 17.5 41.1 12.3 26.4 29.1 74.5 46.1 107.2 78.7 46.5 7.7 20.2 22.9 49.5 31.8 12.2 2.0 21.5 13.3 32.0 79.1 51.7 5.1 0.0 31.8 46.1 52.2 250.9 98.0 83.9 32.1 7.9 24.0 41.1 61.4 135.1 19.2 53.0 45.5 16.2 0.6 75.7 19.7 0.6 30.1 34.2 5.2 64.7 88.4 20.7 10.4 53.2 26.1 87.3 4.3 62.0 ELOVL6 "FLJ23378, LCE, MGC5487" ENSG00000170522 "ELOVL fatty acid elongase 6" Q9H5J4 4 110045846-110199199 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 43.9" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 35.3;Hepatocytes: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.8;MAIT T-cell: 4.9;memory CD4 T-cell: 2.1;memory CD8 T-cell: 3.2;naive CD8 T-cell: 2.3;NK-cell: 5.6" "Group enriched" "Detected in many" 20 "NK-cells: 5.6;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042355 Uncertain NA NA "HPA042355: AB_10796577" "unprognostic (3.92e-2)" "unprognostic (9.47e-2)" "prognostic favorable (6.74e-4)" "unprognostic (8.09e-2)" "unprognostic (2.06e-2)" "unprognostic (1.08e-3)" "unprognostic (4.16e-1)" "unprognostic (3.01e-3)" "unprognostic (4.03e-1)" "unprognostic (1.47e-1)" "unprognostic (2.33e-1)" "unprognostic (1.90e-2)" "unprognostic (2.28e-2)" "unprognostic (1.21e-1)" "unprognostic (2.12e-1)" "unprognostic (1.86e-1)" "unprognostic (5.32e-2)" 7.6 9.8 7.7 7.9 9.4 3.7 7.9 10.9 12.3 4.0 14.5 8.6 0.9 11.8 3.4 2.7 16.6 2.9 11.1 8.1 6.6 5.9 6.4 43.9 3.3 2.2 7.5 9.4 2.0 2.5 10.6 7.1 2.6 15.7 3.0 14.1 4.3 6.9 3.2 1.4 12.3 10.2 5.7 20.0 1.9 16.9 1.3 7.3 1.1 2.3 7.9 4.0 6.0 5.0 0.1 0.0 0.2 0.1 5.6 4.9 0.8 13.4 8.0 29.3 7.3 19.7 20.7 15.0 9.4 4.6 3.3 7.4 3.9 23.7 1.1 0.8 7.2 11.3 12.6 22.2 27.5 7.7 4.6 6.4 15.2 8.7 10.2 12.2 14.8 9.9 18.0 6.4 16.8 8.0 10.9 6.5 1.6 18.1 31.5 7.3 7.1 3.4 1.5 13.4 8.2 4.8 2.3 11.5 3.9 21.4 10.1 5.2 11.2 4.8 32.0 4.1 13.9 5.4 0.1 2.4 6.7 7.9 11.2 11.4 1.5 4.9 24.9 10.2 0.0 1.7 0.2 0.1 0.1 4.8 0.0 4.9 0.1 2.1 3.2 0.0 0.1 0.7 2.3 0.2 5.6 0.0 0.0 0.2 0.8 7.7 9.4 10.9 12.3 6.6 5.9 7.5 9.4 15.7 7.3 0.0 5.6 0.0 2.3 1.5 22.3 2.4 7.6 1.4 6.8 10.4 35.3 1.2 5.0 6.1 3.7 1.1 16.0 0.0 7.3 21.6 3.9 2.4 5.8 43.3 1.6 25.4 2.9 4.3 2.7 2.7 1.1 0.7 0.0 0.0 12.4 4.4 12.1 24.6 1.1 5.6 15.9 6.5 3.8 0.2 1.2 6.0 1.7 12.8 12.4 4.4 ELOVL7 FLJ23563 ENSG00000164181 "ELOVL fatty acid elongase 7" A1L3X0 5 60751791-60844389 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 27.6;Suprabasal keratinocytes: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.8;neutrophil: 2.9" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.8" "Cell line enhanced" "Detected in many" "GAMG: 24.0;HEL: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036337 Approved NA NA "HPA036337: AB_10670797" "unprognostic (6.34e-2)" "unprognostic (1.96e-2)" "unprognostic (1.51e-2)" "prognostic unfavorable (3.87e-5)" "unprognostic (3.84e-1)" "unprognostic (1.66e-1)" "unprognostic (1.60e-2)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (2.37e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.54e-9)" "unprognostic (6.95e-2)" "unprognostic (1.01e-3)" "unprognostic (2.94e-1)" "unprognostic (6.30e-3)" 9.9 5.3 11.4 2.1 15.2 1.1 21.4 7.5 12.4 4.0 7.9 15.0 1.4 10.5 2.8 2.1 5.0 2.4 17.5 1.1 13.8 10.9 15.0 1.2 3.7 2.3 19.0 7.7 0.8 7.6 17.2 3.3 3.1 16.7 20.4 10.8 4.2 3.9 1.5 0.9 23.0 18.9 3.6 26.2 0.9 2.9 1.0 11.7 0.0 15.4 5.0 3.7 5.7 5.0 0.1 0.1 3.8 0.2 0.1 0.1 5.8 11.0 4.1 0.0 0.3 0.0 0.0 10.4 0.0 2.3 1.4 4.9 5.3 11.8 0.0 5.0 0.0 24.0 0.6 7.0 4.5 2.1 15.2 3.7 20.0 0.4 1.7 0.1 1.6 8.5 0.1 8.2 0.1 7.2 0.5 0.0 3.5 3.1 4.0 0.0 9.6 0.0 0.1 1.3 1.0 0.0 0.8 1.2 0.6 10.9 10.6 4.4 0.7 6.1 4.9 2.7 1.2 8.1 0.3 0.1 0.9 5.1 0.1 3.8 10.5 10.4 0.1 7.5 0.4 0.2 3.8 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 2.9 0.1 0.1 0.1 0.0 5.8 11.4 15.2 7.5 12.4 13.8 10.9 19.0 7.7 16.7 11.7 11.9 1.9 0.0 8.3 27.6 3.0 0.7 20.4 2.7 7.9 12.2 0.0 0.1 5.0 6.7 0.0 2.6 11.9 0.0 2.7 0.0 1.5 15.5 12.7 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.9 10.1 2.8 15.9 2.9 5.8 9.9 0.0 7.5 7.3 0.0 1.0 0.1 1.3 33.4 2.4 0.0 11.5 7.8 ELSPBP1 "E12, EDDM12, HE12" ENSG00000169393 "Epididymal sperm binding protein 1" Q96BH3 19 47994651-48025153 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "epididymis: 279.8" "Cell type enhanced" "Detected in some" 20 "Cone photoreceptor cells: 15.7;Early spermatids: 23.3;Horizontal cells: 17.5;Late spermatids: 14.5;Muller glia cells: 16.0;Rod photoreceptor cells: 68.3" "Cancer enhanced" "Detected in single" "melanoma: 0.9" "Region enriched" "Detected in single" 11 "hypothalamus: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HMC-1: 14.6;NB-4: 7.9" "Not detected" "Not detected" "HPA044256, HPA050341" Enhanced "Secreted in male reproductive system" NA NA "HPA044256: AB_2678879, HPA050341: AB_2681097" "unprognostic (1.51e-1)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.1 279.8 0.0 0.0 0.0 0.0 0.1 1.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 17.5 0.0 0.0 0.0 14.5 0.6 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.4 0.0 68.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 EMB MGC71745 ENSG00000170571 Embigin Q6PCB8 5 50396192-50443248 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.3;intestine: 42.2;lymphoid tissue: 44.1" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 62.5;Cone photoreceptor cells: 102.1;T-cells: 112.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 70.3;U-937: 30.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.01e-3)" "unprognostic (8.65e-2)" "unprognostic (1.66e-2)" "unprognostic (1.15e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-2)" "unprognostic (8.31e-2)" "unprognostic (2.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.33e-1)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (2.76e-5)" "unprognostic (4.96e-3)" "unprognostic (1.79e-1)" "unprognostic (1.22e-2)" "unprognostic (8.86e-3)" 15.0 16.4 1.7 21.7 2.0 43.3 8.4 1.1 2.9 2.7 18.9 1.4 0.5 21.7 1.6 5.6 6.5 4.7 6.1 16.7 2.2 4.7 4.2 1.9 10.6 44.1 3.8 1.4 2.7 1.8 15.2 8.0 6.6 4.5 9.5 3.6 4.0 7.4 6.9 2.7 15.9 42.2 2.5 3.3 20.6 3.7 10.5 1.8 15.9 13.7 3.6 17.0 5.3 2.9 9.9 11.4 16.4 14.7 16.4 26.1 16.1 8.6 0.7 1.7 0.0 0.7 2.3 0.1 0.4 0.0 0.7 0.0 0.0 22.7 17.3 0.4 0.8 0.0 13.1 3.9 11.1 0.1 5.3 8.8 8.2 2.8 0.0 0.1 16.4 0.0 0.1 6.1 1.8 7.5 11.8 0.0 6.9 0.0 23.1 13.5 10.0 10.1 9.7 6.6 0.0 4.4 16.1 0.0 22.6 0.0 7.7 5.2 4.7 0.0 2.6 0.2 3.6 1.0 70.3 0.0 0.0 8.3 0.0 0.0 0.2 0.0 14.3 0.0 30.5 2.1 3.7 14.7 16.4 21.5 1.9 26.1 9.9 19.4 19.3 9.7 6.5 11.5 15.5 13.7 16.4 0.6 11.4 23.4 16.1 1.7 2.0 1.1 2.9 2.2 4.7 3.8 1.4 4.5 1.8 62.5 15.9 38.9 1.7 16.3 3.3 1.5 2.5 32.1 40.9 0.0 102.1 10.9 0.0 0.8 0.4 3.6 2.6 46.7 0.8 7.9 5.8 13.2 18.5 1.3 19.1 1.6 7.0 24.5 40.6 0.5 2.6 44.9 10.1 18.0 6.4 0.9 9.3 2.9 6.3 0.2 9.0 0.0 5.9 0.9 1.9 11.0 7.1 112.1 9.7 1.6 EMC10 "C19orf63, HSM1, HSS1, INM02" ENSG00000161671 "ER membrane protein complex subunit 10" Q5UCC4 19 50476400-50490870 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 147.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 52.1;PC-3: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053905 Uncertain "Secreted to blood" NA NA "HPA053905: AB_2682303" "unprognostic (2.48e-1)" "unprognostic (1.93e-2)" "unprognostic (9.86e-3)" "unprognostic (1.65e-1)" "unprognostic (6.94e-2)" "unprognostic (8.38e-3)" "unprognostic (3.23e-2)" "unprognostic (9.87e-2)" "unprognostic (2.77e-1)" "unprognostic (2.99e-1)" "prognostic favorable (4.39e-4)" "unprognostic (5.01e-2)" "prognostic favorable (6.64e-6)" "unprognostic (2.81e-1)" "unprognostic (3.49e-2)" "unprognostic (1.28e-1)" "unprognostic (2.44e-1)" 17.8 24.4 21.9 12.4 21.2 17.2 11.1 10.8 32.1 14.5 22.4 41.1 23.1 23.4 17.4 24.9 14.4 22.7 24.9 21.9 21.8 19.2 33.8 43.2 15.3 19.8 23.0 20.0 22.4 25.6 32.5 48.2 21.1 22.2 20.5 8.7 29.8 29.4 19.0 147.8 13.9 28.7 8.5 31.4 14.6 33.1 24.3 19.1 15.4 34.0 13.7 16.4 12.6 11.7 12.2 10.8 11.2 10.5 4.7 10.3 6.8 17.2 21.4 0.8 8.3 2.4 3.0 0.2 16.8 3.1 1.5 1.6 0.2 11.9 5.7 0.2 3.0 2.7 14.5 1.0 2.7 0.5 22.0 52.1 1.2 9.5 0.0 4.1 4.9 33.5 3.7 3.1 1.5 1.2 1.4 3.6 5.0 11.0 12.2 3.0 12.1 7.8 0.1 0.0 6.8 37.2 13.5 2.6 18.4 6.8 15.8 13.3 29.6 24.8 8.0 8.8 1.0 8.4 9.1 6.9 1.0 23.0 6.3 9.1 13.6 33.8 4.7 6.8 3.5 8.3 7.8 10.5 11.2 8.1 8.0 6.9 9.4 8.6 8.6 7.7 12.2 10.3 10.0 4.5 4.7 5.9 10.8 6.8 6.8 21.9 21.2 10.8 32.1 21.8 19.2 23.0 20.0 22.2 19.1 59.6 135.5 78.7 47.6 26.4 78.3 8.1 86.6 29.4 64.8 66.3 76.6 114.1 19.9 150.7 157.7 33.8 118.0 0.0 98.3 126.3 46.9 69.4 51.9 61.8 121.6 35.0 203.6 53.4 97.1 29.5 63.9 74.5 79.2 85.6 93.3 93.2 107.1 129.8 108.2 56.1 61.3 6.5 41.2 14.0 52.6 27.4 126.3 73.4 108.6 54.5 EMC3 TMEM111 ENSG00000125037 "ER membrane protein complex subunit 3" Q9P0I2 3 9962537-10011116 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 287.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042372 Approved Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA042372: AB_10795609" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (2.50e-2)" "unprognostic (1.51e-1)" "unprognostic (2.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.59e-3)" "unprognostic (2.90e-2)" "unprognostic (2.05e-3)" "unprognostic (2.46e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-1)" "prognostic favorable (2.81e-6)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.71e-2)" "unprognostic (5.58e-2)" 41.8 31.5 19.8 17.2 27.1 35.4 24.7 17.2 28.0 17.6 25.0 18.6 23.5 23.2 19.4 19.6 31.3 18.8 17.7 28.3 18.6 21.5 33.0 47.2 22.3 12.7 23.6 20.6 16.3 27.2 25.5 15.9 19.6 27.9 20.8 23.2 16.3 26.0 21.9 54.7 25.4 24.8 20.2 21.9 17.1 23.1 52.6 19.2 15.0 37.7 22.4 20.3 27.3 25.4 25.0 35.1 41.6 46.1 28.1 40.2 51.4 13.5 28.8 10.8 6.5 69.2 27.2 36.4 27.9 24.2 17.5 19.0 19.7 21.7 10.8 20.4 31.6 33.7 19.1 18.4 16.5 18.1 29.3 18.5 17.7 21.9 12.8 29.9 19.9 20.0 31.9 29.8 30.5 17.6 22.4 21.7 11.9 22.5 31.7 25.8 33.4 10.5 9.9 12.0 28.9 19.7 13.7 15.2 32.1 21.2 24.6 7.7 15.5 19.9 29.9 17.9 11.9 25.3 16.3 24.8 17.5 14.7 18.9 28.3 17.1 44.3 21.9 37.0 14.7 21.9 38.4 46.1 41.3 27.4 36.2 28.3 24.9 27.2 31.2 35.1 25.0 19.9 26.8 41.6 28.1 34.7 31.5 40.2 51.4 19.8 27.1 17.2 27.9 18.6 21.5 23.6 20.6 27.9 19.2 50.6 63.5 44.0 48.5 45.0 39.0 97.2 56.0 62.9 61.4 43.6 37.3 43.1 39.7 83.4 287.9 55.4 60.4 256.9 103.9 42.9 46.8 56.5 32.4 82.2 88.7 22.3 20.3 42.4 51.0 67.2 46.6 55.9 55.6 120.8 32.8 60.4 90.0 70.2 35.3 57.8 53.0 58.2 48.9 135.1 54.3 53.1 71.7 50.4 50.0 70.1 EMC4 "FLJ90746, MGC24415, PIG17, TMEM85" ENSG00000128463 "ER membrane protein complex subunit 4" Q5J8M3 15 34224999-34230156 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026868, HPA053440" Approved Supported "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA026868: AB_2672032, HPA053440: AB_2682151" "unprognostic (8.99e-2)" "unprognostic (1.59e-1)" "unprognostic (7.68e-2)" "unprognostic (3.29e-2)" "unprognostic (9.23e-2)" "unprognostic (1.29e-3)" "unprognostic (3.25e-1)" "unprognostic (3.61e-2)" "unprognostic (1.65e-1)" "unprognostic (1.78e-3)" "unprognostic (1.33e-1)" "unprognostic (2.20e-2)" "unprognostic (2.52e-1)" "unprognostic (5.42e-2)" "unprognostic (4.20e-2)" "unprognostic (2.96e-1)" "unprognostic (1.97e-2)" 36.3 34.3 43.5 23.4 48.3 25.4 35.2 34.9 54.3 33.5 32.2 31.0 25.7 27.5 33.5 54.3 36.2 35.4 28.4 38.5 39.4 40.6 39.1 47.5 27.1 24.5 41.7 42.8 35.3 45.2 29.1 29.5 41.5 48.6 32.5 30.1 32.8 38.9 34.7 95.1 29.6 27.9 30.1 36.7 27.2 31.2 26.4 32.0 26.9 34.6 41.2 29.0 28.9 32.6 71.6 53.3 65.7 59.4 60.3 65.9 78.0 31.9 67.2 28.3 36.6 36.9 33.6 26.0 36.7 42.2 45.4 39.5 43.7 28.5 12.7 48.6 42.4 39.9 61.6 28.7 36.0 32.6 38.7 27.8 24.0 62.0 40.1 44.7 36.3 24.1 33.7 34.4 33.0 37.2 32.4 37.5 38.9 29.9 50.6 39.5 36.4 28.8 38.9 31.7 43.2 44.1 26.7 25.8 35.9 43.2 50.4 37.3 45.6 27.3 40.1 19.4 21.5 26.8 43.2 28.5 41.7 28.6 35.8 37.3 44.9 63.5 32.4 50.8 43.4 35.2 65.7 52.3 54.5 53.0 54.0 57.9 71.6 59.5 63.4 52.2 54.6 60.8 59.8 29.1 60.3 59.4 53.3 65.9 78.0 43.5 48.3 34.9 54.3 39.4 40.6 41.7 42.8 48.6 32.0 50.6 63.2 53.6 84.9 81.4 33.7 52.6 50.9 116.4 81.9 62.8 17.7 127.8 106.1 146.0 74.2 81.8 39.4 0.0 149.7 140.0 89.5 80.2 84.5 75.5 101.4 17.5 50.0 54.0 38.3 16.6 93.2 68.5 96.2 106.4 60.1 89.7 146.5 66.8 85.2 85.7 30.5 84.1 115.4 137.4 96.5 96.1 118.5 65.3 63.0 96.2 EMC6 "MGC2963, TMEM93" ENSG00000127774 "ER membrane protein complex subunit 6" Q9BV81 17 3668815-3669668 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062681 Uncertain Approved Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA062681: AB_2684831" "unprognostic (2.21e-1)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.21e-2)" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" "unprognostic (6.20e-3)" "unprognostic (4.03e-2)" "prognostic unfavorable (9.39e-5)" "unprognostic (1.86e-1)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (7.58e-3)" "unprognostic (4.17e-2)" "unprognostic (1.94e-1)" "unprognostic (6.37e-2)" "unprognostic (3.27e-1)" "unprognostic (6.32e-2)" 14.6 18.5 15.5 12.2 15.5 21.4 12.5 9.9 21.2 8.9 15.9 14.9 10.0 16.9 9.8 10.8 15.6 9.5 12.1 26.2 14.5 12.3 19.8 42.1 10.2 10.7 14.2 11.0 8.7 24.5 7.6 9.3 16.6 12.2 12.9 9.7 14.6 17.8 10.5 100.1 10.6 16.8 10.1 13.6 12.5 18.8 27.4 11.1 14.3 14.9 31.5 14.3 9.7 9.1 34.5 56.1 40.7 42.0 25.2 43.4 38.5 31.2 30.8 13.5 14.1 9.7 7.8 26.0 22.5 11.0 18.5 17.1 18.6 11.8 19.7 32.8 10.5 16.3 30.2 15.6 15.8 13.4 19.0 58.3 14.3 21.6 25.8 14.1 9.9 14.7 9.8 18.0 17.0 11.9 14.6 14.0 23.7 17.9 14.3 13.5 19.0 20.2 29.2 19.4 19.1 34.8 18.9 12.6 18.6 25.9 8.9 11.1 20.2 18.4 14.5 23.9 14.1 16.9 10.7 15.3 15.5 19.2 23.3 32.8 14.0 15.4 12.9 24.3 13.0 18.6 34.5 42.0 40.7 34.9 39.7 32.0 34.5 39.0 38.3 35.8 32.3 40.6 36.7 31.6 25.2 27.9 56.1 43.4 38.5 15.5 15.5 9.9 21.2 14.5 12.3 14.2 11.0 12.2 11.1 14.9 23.4 62.6 99.3 79.0 40.5 0.3 94.3 53.5 23.9 55.8 33.4 102.2 140.9 117.4 202.1 52.2 55.0 23.3 123.7 126.4 43.1 113.2 54.3 108.8 90.3 31.8 49.3 39.3 53.3 121.5 35.6 54.6 64.1 101.0 61.0 85.4 129.4 63.1 32.2 149.9 38.8 38.8 51.5 146.4 87.0 89.1 107.9 52.2 68.0 156.9 EMC7 "C11orf3, C15orf24" ENSG00000134153 "ER membrane protein complex subunit 7" Q9NPA0 15 34084017-34101948 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010029, HPA047572" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA010029: AB_1078335, HPA047572: AB_2680090" "unprognostic (2.16e-1)" "unprognostic (8.16e-3)" "unprognostic (5.28e-2)" "prognostic favorable (4.68e-5)" "unprognostic (7.75e-2)" "prognostic unfavorable (9.25e-5)" "unprognostic (1.35e-1)" "unprognostic (3.68e-2)" "unprognostic (1.18e-1)" "unprognostic (5.65e-3)" "unprognostic (4.67e-2)" "unprognostic (3.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.31e-1)" "unprognostic (2.58e-1)" "unprognostic (2.49e-2)" "unprognostic (2.47e-3)" 31.2 45.1 36.8 22.4 41.6 31.8 29.7 22.5 36.8 25.1 30.1 30.9 38.2 25.1 27.1 53.1 25.0 23.0 24.5 36.5 34.0 45.3 52.5 62.3 26.5 24.4 44.0 38.7 24.1 46.7 35.5 33.5 57.6 35.2 31.8 32.3 29.8 29.6 46.0 44.8 28.2 28.1 29.0 42.2 28.5 28.5 39.3 30.8 18.8 35.3 26.7 21.8 26.3 26.2 37.8 68.8 66.6 54.7 32.6 53.7 49.1 14.3 39.6 14.4 18.3 56.4 32.3 15.1 41.2 43.0 38.6 40.1 36.0 17.3 8.5 42.8 40.2 40.1 28.0 20.9 20.7 28.9 20.9 20.7 21.1 59.2 30.7 51.6 21.1 30.1 35.7 39.5 27.6 40.1 26.3 24.2 16.4 20.5 57.0 37.2 16.6 11.7 24.1 12.8 33.8 26.3 14.8 16.7 29.4 40.6 25.5 23.6 17.5 24.5 33.2 20.4 17.9 24.0 34.2 20.3 41.4 16.0 27.3 30.7 38.6 46.6 19.0 41.8 32.4 33.5 66.6 47.3 49.0 42.7 51.0 41.6 37.8 42.9 43.4 43.1 28.9 31.6 39.0 41.3 32.6 54.7 68.8 53.7 49.1 36.8 41.6 22.5 36.8 34.0 45.3 44.0 38.7 35.2 30.8 26.8 26.0 38.7 50.2 77.2 49.7 83.2 45.9 48.2 40.9 97.7 43.2 105.5 33.2 106.2 83.3 62.5 52.0 0.0 149.7 127.4 78.3 46.4 44.9 78.4 102.1 28.6 43.8 56.4 57.1 65.1 83.4 60.8 97.8 64.1 51.6 111.7 112.9 52.6 97.9 61.9 46.3 116.4 76.2 178.6 21.7 75.5 133.9 64.0 55.9 50.3 EMCN MUC14 ENSG00000164035 Endomucin Q9ULC0 4 100395341-100880126 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 11 "Endothelial cells: 203.6;Ito cells: 143.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005928 Approved "Intracellular and membrane" NA NA "HPA005928: AB_1078735" "unprognostic (8.01e-2)" "unprognostic (2.13e-4)" "unprognostic (1.36e-1)" "unprognostic (2.42e-1)" "unprognostic (2.96e-3)" "unprognostic (2.00e-2)" "prognostic favorable (1.03e-4)" "unprognostic (3.65e-1)" "unprognostic (5.94e-2)" "unprognostic (9.02e-2)" "unprognostic (2.39e-2)" "unprognostic (3.10e-2)" "prognostic favorable (2.25e-4)" "unprognostic (4.75e-3)" "unprognostic (2.36e-1)" "unprognostic (3.23e-1)" "unprognostic (9.75e-2)" 26.3 10.8 3.1 6.2 7.5 0.1 24.0 3.8 6.8 26.4 9.7 1.4 13.1 3.5 28.2 19.7 16.3 10.4 16.4 31.5 4.2 3.9 45.5 4.6 25.1 5.3 5.4 3.5 12.9 3.3 8.3 10.5 0.4 6.7 17.1 4.3 19.8 5.8 16.5 16.8 6.1 5.5 20.4 9.1 1.9 5.5 7.3 3.5 1.0 28.1 20.9 2.5 23.5 21.7 0.2 0.1 1.6 0.4 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.1 0.0 26.5 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.6 0.2 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.7 1.2 0.4 0.1 0.0 0.0 3.1 7.5 3.8 6.8 4.2 3.9 5.4 3.5 6.7 3.5 6.0 8.9 0.9 0.4 14.7 0.0 9.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 203.6 0.0 0.0 0.0 0.0 6.1 0.8 0.0 0.6 0.2 0.0 0.0 143.6 8.2 0.9 1.1 1.7 15.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 13.2 0.2 0.2 12.8 0.2 0.0 0.0 0.6 EMD "LEMD5, STA" ENSG00000102119 Emerin P50402 X 154379197-154381523 "Disease related genes, Predicted membrane proteins" Actin-binding "Cardiomyopathy, Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000609, CAB001545, CAB002029, CAB058694, CAB062552" Supported Enhanced "Nuclear membrane,Endoplasmic reticulum" NA NA 520000 "Nuclear membrane" "Endoplasmic reticulum" "CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: AB_2665587, CAB062552: AB_2665586, HPA000609: AB_1078736" "unprognostic (2.92e-1)" "unprognostic (6.59e-3)" "unprognostic (4.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.16e-1)" "unprognostic (9.12e-3)" "unprognostic (3.58e-2)" "unprognostic (6.06e-3)" "unprognostic (7.74e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-2)" "unprognostic (1.49e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (7.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.99e-1)" 25.0 17.5 14.0 17.6 16.0 21.0 26.5 15.8 21.8 24.8 21.3 13.7 22.3 14.0 32.3 25.7 22.9 27.2 28.7 29.5 13.1 14.1 18.2 21.2 22.0 37.4 13.3 16.5 35.9 29.4 20.5 22.8 15.4 11.9 25.5 11.4 20.7 24.5 29.1 62.0 18.1 13.7 40.4 13.1 17.6 20.1 16.1 9.7 16.6 28.1 24.4 18.3 31.7 20.6 23.2 30.5 24.5 19.7 14.7 26.9 15.8 30.6 11.6 8.0 8.8 7.3 14.6 14.4 15.1 16.2 19.3 20.3 10.3 6.0 24.4 23.0 15.5 40.7 17.1 15.3 18.7 8.2 14.3 33.4 11.4 17.0 6.0 19.8 11.0 12.6 12.8 14.9 17.2 21.5 13.0 13.4 10.4 9.4 10.5 13.1 13.0 19.2 20.2 13.4 17.9 36.2 16.0 12.0 23.3 10.4 5.9 10.2 12.6 7.8 13.1 18.4 8.1 9.2 8.3 12.1 9.6 18.3 21.6 21.6 34.4 25.5 44.0 11.7 18.6 10.4 16.6 16.9 24.5 26.9 19.7 25.0 22.5 25.7 25.7 13.5 23.2 23.1 22.4 18.1 14.7 14.0 30.5 23.9 15.8 14.0 16.0 15.8 21.8 13.1 14.1 13.3 16.5 11.9 9.7 29.8 39.9 28.9 65.6 63.7 31.2 18.5 30.6 20.1 30.7 26.2 11.8 50.6 59.7 39.0 13.8 27.2 18.0 0.0 47.4 56.3 49.5 56.7 53.2 33.5 46.5 28.6 23.0 27.0 17.1 11.2 37.7 46.4 64.1 59.5 33.9 40.7 39.0 28.8 42.1 35.0 29.9 25.8 51.0 10.7 34.1 67.2 104.6 47.8 27.5 59.3 EMID1 "EMI5, EMU1, hEmu1" ENSG00000186998 "EMI domain containing 1" Q96A84 22 29205851-29259597 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.0" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 23.3;granulocytes: 11.5;Ito cells: 14.7" "Cancer enhanced" "Detected in all" "endometrial cancer: 23.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 2.3" "Lineage enriched" "Detected in single" 8 "NK-cells: 2.3" "Group enriched" "Detected in some" 4 "HEL: 13.2;NB-4: 45.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000592 Uncertain "Secreted in other tissues" NA NA "HPA000592: AB_1078737" "unprognostic (2.20e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-2)" "unprognostic (7.80e-3)" "unprognostic (2.40e-2)" "unprognostic (1.42e-1)" "unprognostic (3.46e-1)" "unprognostic (6.25e-3)" "unprognostic (3.75e-2)" "unprognostic (2.33e-1)" "unprognostic (5.24e-3)" "unprognostic (1.18e-1)" "unprognostic (1.36e-3)" "unprognostic (1.59e-1)" "unprognostic (1.76e-1)" "unprognostic (3.09e-2)" "unprognostic (1.08e-1)" 2.6 19.3 17.8 3.6 12.7 11.7 2.4 3.5 17.9 2.9 5.4 14.2 2.2 4.8 10.5 2.5 0.9 10.4 4.8 1.3 12.6 6.1 7.7 2.1 7.0 13.3 5.6 14.7 4.8 12.7 4.5 1.2 4.7 3.8 5.2 3.4 2.9 4.7 4.2 0.7 3.6 7.4 2.3 2.6 31.0 7.0 2.1 6.9 4.6 8.4 0.5 2.2 5.0 1.4 0.1 0.0 0.0 0.0 2.3 0.3 0.1 0.0 0.1 2.3 4.9 0.0 0.0 0.3 0.0 0.0 0.2 0.1 2.6 0.3 0.0 2.2 0.0 0.0 0.0 1.2 0.0 0.0 5.2 4.1 13.2 0.0 0.5 0.3 1.8 1.0 0.1 0.1 0.1 0.0 0.0 0.0 3.0 1.1 0.0 0.0 3.6 0.1 45.9 0.5 0.0 0.2 0.0 0.1 5.0 0.0 0.0 6.3 3.0 0.2 0.0 0.0 0.4 1.9 2.4 0.0 0.0 3.9 0.0 0.0 0.2 0.0 0.0 0.0 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 17.8 12.7 3.5 17.9 12.6 6.1 5.6 14.7 3.8 6.9 0.0 4.5 0.0 0.8 2.5 0.1 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.1 2.2 0.0 23.3 1.2 0.1 3.1 2.4 11.5 0.2 0.3 0.0 0.0 14.7 0.8 0.2 2.8 0.0 0.0 1.0 0.0 1.2 0.7 0.0 1.8 1.4 0.5 0.0 2.8 0.0 1.5 1.8 0.2 0.5 0.0 0.4 EML2 "ELP70, EMAP-2, EMAP2" ENSG00000125746 "Echinoderm microtubule associated protein like 2" O95834 19 45606994-45645629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 151.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012757 Approved Approved Vesicles NA NA 140000 Vesicles "HPA012757: AB_1848145" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.61e-3)" "unprognostic (2.12e-1)" "unprognostic (1.81e-3)" "unprognostic (1.13e-1)" "unprognostic (1.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.85e-1)" "unprognostic (3.05e-3)" "unprognostic (3.72e-1)" "unprognostic (2.75e-3)" "unprognostic (1.77e-1)" "unprognostic (2.85e-2)" "unprognostic (9.44e-2)" "unprognostic (7.48e-2)" "unprognostic (7.03e-2)" 7.7 23.0 13.0 9.4 25.3 9.5 10.0 11.3 20.7 12.6 15.5 32.8 13.5 8.6 5.9 6.4 26.8 9.3 9.9 14.7 15.8 18.9 11.0 5.4 9.6 9.3 32.4 12.0 3.6 15.6 47.9 9.7 16.9 26.6 11.2 11.1 12.4 21.2 17.5 4.1 22.0 7.9 8.9 24.1 8.6 13.5 2.9 25.5 9.9 15.7 6.2 10.6 15.6 14.3 7.8 8.8 10.6 7.0 3.7 9.7 4.9 17.6 6.0 1.2 0.4 9.8 5.4 6.7 11.1 14.4 5.0 5.7 2.3 14.8 4.5 6.6 5.9 1.5 14.9 2.2 22.1 1.7 20.0 5.5 2.3 6.6 4.1 18.6 6.7 4.9 8.3 29.1 5.8 28.5 4.0 3.6 10.5 6.8 13.3 3.8 17.5 3.7 1.3 0.7 28.2 5.4 0.7 2.1 6.6 12.9 21.7 6.5 1.2 6.1 12.1 8.2 6.7 7.1 7.3 5.7 0.0 2.1 1.8 0.1 25.1 15.4 2.8 7.9 7.5 14.5 10.6 4.9 7.1 9.6 6.2 7.0 7.8 6.5 9.7 5.9 3.4 4.2 5.7 1.3 3.7 7.0 8.8 7.7 4.9 13.0 25.3 11.3 20.7 15.8 18.9 32.4 12.0 26.6 25.5 3.0 12.5 10.2 36.5 16.6 27.3 8.1 17.8 13.4 9.1 33.2 13.7 59.6 31.5 13.9 55.8 11.6 22.7 0.0 18.1 16.7 6.9 20.3 19.5 5.9 14.0 27.0 16.8 14.1 6.7 19.4 3.7 7.6 18.6 18.0 32.1 12.5 16.5 26.0 6.7 5.9 151.2 0.0 13.3 2.6 5.9 12.5 84.4 24.5 25.5 40.6 EMP1 "CL-20, TMP" ENSG00000134531 "Epithelial membrane protein 1" P54849 12 13196716-13219939 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 240.9;lymphoid tissue: 129.3" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 616.6;Fibroblasts: 489.5;Melanocytes: 448.7;Suprabasal keratinocytes: 601.1;Urothelial cells: 926.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 28.6" "Cell type enriched" "Detected in some" 7 "myeloid DC: 7.0" "Lineage enriched" "Detected in single" 14 "dendritic cells: 7.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 132.0;fHDF/TERT166: 91.8;HaCaT: 82.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA051931, HPA056250" Approved Nucleoplasm NA NA Nucleoplasm "HPA051931: , HPA056250: " "unprognostic (1.40e-2)" "unprognostic (7.30e-2)" "unprognostic (8.01e-2)" "unprognostic (1.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (8.41e-3)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" "prognostic unfavorable (2.26e-8)" "prognostic unfavorable (7.46e-4)" "unprognostic (2.98e-1)" "unprognostic (4.84e-2)" "unprognostic (3.05e-2)" "unprognostic (3.45e-2)" "unprognostic (3.25e-1)" "prognostic unfavorable (9.69e-8)" 63.3 5.0 2.7 8.0 10.4 2.1 20.8 0.8 3.9 51.3 11.6 5.5 4.0 4.6 14.0 10.4 240.9 9.9 25.2 16.1 7.3 2.8 8.9 4.4 18.1 5.9 5.3 0.9 5.7 10.2 2.9 2.8 10.6 28.6 6.3 6.9 17.8 45.4 2.8 12.0 16.8 10.7 17.6 9.7 8.5 6.0 5.2 3.0 0.6 22.5 99.1 129.3 14.1 80.6 0.0 7.0 0.0 0.5 0.1 0.1 0.0 38.9 2.0 1.0 0.2 63.1 132.0 0.1 28.8 52.9 14.9 19.0 0.2 66.0 0.2 20.6 91.8 6.5 82.1 1.1 3.8 20.2 0.7 0.0 0.1 6.9 0.0 15.2 0.2 0.2 41.4 5.6 47.3 13.9 11.8 34.0 0.0 0.2 0.6 35.0 0.1 0.0 0.8 0.7 7.3 6.7 0.1 4.0 0.3 43.5 0.4 0.0 0.0 12.9 1.9 21.5 7.7 0.3 0.2 37.2 33.5 11.8 31.4 15.5 0.1 0.4 0.2 48.8 0.2 39.3 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.1 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 2.7 10.4 0.8 3.9 7.3 2.8 5.3 0.9 28.6 3.0 190.6 90.0 2.7 198.6 616.6 0.0 9.5 2.5 87.0 247.9 17.4 0.0 0.8 13.3 17.9 0.7 293.7 59.6 0.0 3.9 1.5 489.5 352.1 46.5 2.0 41.5 0.0 45.6 127.7 32.1 0.5 64.5 93.9 448.7 7.2 4.0 2.5 37.6 27.1 102.9 0.2 0.0 6.5 173.1 0.7 0.5 601.1 0.9 5.1 5.6 926.6 EMP2 XMP ENSG00000213853 "Epithelial membrane protein 2" P54851 16 10528422-10580698 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 118.7" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 3868.0;Suprabasal keratinocytes: 1026.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 59.5;RT4: 40.9;SK-BR-3: 58.8;T-47d: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014711, HPA070816" Approved Approved Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA014711: AB_1848147, HPA070816: " "unprognostic (1.75e-1)" "unprognostic (4.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (9.27e-2)" "unprognostic (8.90e-2)" "unprognostic (2.41e-2)" "unprognostic (4.40e-1)" "unprognostic (1.86e-1)" "unprognostic (6.24e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (2.85e-8)" "unprognostic (9.54e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (9.52e-2)" 16.5 2.0 5.0 7.9 5.1 0.0 26.2 3.4 4.7 14.8 10.4 3.4 6.1 4.2 7.3 13.8 35.7 7.4 7.3 14.0 5.5 3.0 3.1 47.5 118.7 5.7 5.4 2.5 14.0 3.2 19.9 3.2 23.5 5.3 11.1 10.0 10.8 9.9 5.8 7.7 40.2 6.6 12.8 3.4 5.3 9.3 5.6 4.1 2.2 7.5 26.4 18.4 10.6 16.3 1.3 1.1 4.1 1.1 1.4 1.0 0.4 6.3 8.8 3.6 4.3 8.2 7.1 7.2 9.1 8.4 5.5 8.3 28.8 22.3 0.0 2.9 10.9 4.0 28.3 9.3 11.2 7.3 0.0 5.9 0.0 18.5 15.7 1.4 0.0 0.1 4.3 3.0 7.3 0.7 1.2 2.3 0.0 2.1 0.6 15.2 59.5 0.1 0.1 4.2 10.3 2.1 1.6 4.2 13.8 1.2 40.9 5.1 5.8 11.2 58.8 3.3 11.0 35.9 1.4 1.2 17.6 7.6 5.9 5.0 0.1 0.2 0.0 7.7 0.1 17.2 3.4 1.0 1.0 0.8 0.8 1.0 1.0 0.8 0.7 0.5 1.3 0.9 0.9 4.1 1.4 1.1 1.1 0.8 0.4 5.0 5.1 3.4 4.7 5.5 3.0 5.4 2.5 5.3 4.1 3868.0 343.3 4.5 123.1 317.0 1.8 48.0 109.5 153.9 326.4 40.1 0.0 59.0 0.0 2.5 4.2 191.2 51.9 0.0 60.2 16.3 121.0 91.1 34.8 181.1 8.8 0.0 100.6 112.3 14.0 5.0 176.6 42.0 82.7 58.7 141.3 5.2 27.3 172.1 259.6 0.0 1.1 51.8 141.5 2.3 13.2 1026.6 40.2 4.3 139.9 220.6 EMP3 YMP ENSG00000142227 "Epithelial membrane protein 3" P54852 19 48321509-48330553 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 165.9" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 530.6;Hofbauer cells: 548.3;Kupffer cells: 540.8;Macrophages: 782.1;Melanocytes: 1059.5" "Cancer enhanced" "Detected in all" "melanoma: 195.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 116.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062030 Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA062030: " "unprognostic (5.06e-3)" "unprognostic (4.41e-1)" "unprognostic (1.83e-1)" "unprognostic (9.28e-3)" "unprognostic (1.33e-2)" "unprognostic (4.83e-3)" "unprognostic (1.49e-2)" "unprognostic (1.02e-1)" "unprognostic (9.31e-2)" "unprognostic (4.72e-2)" "unprognostic (3.41e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.31e-7)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.16e-1)" "unprognostic (2.41e-1)" "unprognostic (2.90e-3)" 27.6 23.4 10.4 26.5 12.6 66.2 28.7 7.2 8.4 50.6 40.3 9.2 14.6 8.4 45.9 22.6 26.9 26.1 21.1 37.9 10.8 6.9 15.6 7.0 36.1 48.0 15.2 6.7 41.4 6.4 2.2 6.1 29.9 12.7 30.7 15.4 24.7 11.3 23.1 13.2 16.3 20.8 46.7 19.1 27.8 19.2 18.2 8.2 16.2 11.6 13.4 25.6 36.8 30.6 44.9 54.8 165.9 91.0 59.7 119.1 124.8 5.6 63.2 3.5 10.1 56.2 87.8 0.1 39.0 71.1 51.7 45.8 6.1 20.4 0.7 8.8 86.6 26.7 1.0 3.7 4.2 31.8 18.6 1.6 27.0 16.6 3.7 47.2 13.3 28.3 47.6 0.8 53.0 36.6 38.4 22.1 6.1 17.8 46.4 79.0 0.9 2.0 116.0 4.7 1.2 16.0 1.6 12.2 27.4 44.3 0.0 0.1 0.2 17.7 0.1 10.1 6.8 0.2 20.4 36.4 46.8 20.3 36.9 30.6 24.5 30.4 1.7 27.7 17.6 31.7 165.9 77.2 105.6 109.2 91.0 90.4 44.9 114.8 106.6 54.8 35.4 65.7 78.2 85.7 59.7 86.6 40.8 119.1 124.8 10.4 12.6 7.2 8.4 10.8 6.9 15.2 6.7 12.7 8.2 0.0 5.0 254.5 67.7 246.9 2.2 3.9 15.3 5.3 11.4 31.4 0.0 10.5 5.0 62.4 5.0 137.6 1.3 0.0 9.8 19.7 530.6 38.3 254.8 4.7 548.3 0.0 5.8 114.8 540.8 9.1 310.7 782.1 1059.5 206.4 2.9 65.0 72.6 17.3 204.0 6.5 3.3 103.5 237.6 9.8 4.5 166.0 16.9 200.3 2.6 22.6 ENDOD1 KIAA0830 ENSG00000149218 "Endonuclease domain containing 1" O94919 11 95089810-95132645 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 62.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008932, HPA010517" Enhanced Approved "Nuclear membrane" "Secreted - unknown location" NA NA 19000000 "Nuclear membrane" "HPA008932: AB_2262252, HPA010517: AB_1852351" "unprognostic (8.81e-3)" "unprognostic (1.92e-2)" "unprognostic (2.22e-2)" "unprognostic (1.43e-1)" "unprognostic (6.34e-2)" "unprognostic (2.78e-2)" "unprognostic (4.43e-2)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (3.65e-1)" "prognostic unfavorable (8.86e-4)" "unprognostic (2.84e-1)" "prognostic favorable (6.64e-7)" "unprognostic (5.92e-2)" "unprognostic (2.35e-1)" "unprognostic (5.62e-3)" "prognostic unfavorable (3.27e-4)" 14.9 13.8 20.3 7.9 27.9 4.1 15.0 14.3 31.0 17.6 25.4 52.6 9.7 8.4 13.7 12.2 19.0 13.1 12.2 14.4 24.0 22.3 18.9 4.9 10.6 7.3 33.5 20.1 12.0 4.7 48.8 11.8 12.1 40.6 36.5 29.4 15.5 12.5 22.9 34.4 20.6 14.5 16.2 40.4 22.9 8.3 9.3 25.5 0.5 12.6 12.3 6.7 9.0 16.5 7.3 2.9 1.3 5.4 3.1 5.9 6.1 1.1 1.7 2.2 1.3 62.5 20.0 9.2 8.3 1.8 2.2 2.3 8.6 15.1 8.0 10.3 6.6 5.0 11.1 2.1 11.4 0.8 6.3 1.6 17.3 0.8 3.6 6.8 3.1 22.4 18.1 14.9 1.3 4.2 15.3 7.7 7.7 3.5 5.2 8.3 2.9 1.3 0.1 0.5 12.4 5.6 5.8 0.0 3.3 6.6 9.3 1.1 0.9 3.5 3.5 6.2 3.1 3.6 0.9 5.5 12.2 3.6 8.1 3.5 4.3 3.2 0.6 3.7 1.7 27.2 1.3 1.3 0.9 5.9 3.2 5.5 7.2 3.9 5.0 2.9 7.3 3.2 3.8 0.6 3.1 5.4 1.3 2.2 6.1 20.3 27.9 14.3 31.0 24.0 22.3 33.5 20.1 40.6 25.5 8.9 14.2 11.5 14.8 7.1 2.1 4.4 17.8 1.4 11.4 10.4 0.0 4.6 1.7 4.5 2.5 22.4 35.5 23.3 7.7 6.5 8.6 20.7 13.9 2.9 2.9 0.0 15.5 38.1 4.3 2.6 9.5 5.5 27.0 1.0 22.5 1.9 6.1 40.2 14.2 9.3 0.6 38.8 19.1 0.3 3.6 10.9 10.4 5.1 18.4 8.6 ENG "CD105, END, HHT1, ORW, ORW1" ENSG00000106991 Endoglin P17813 9 127815012-127854756 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Endothelial cells: 336.5;Ito cells: 724.3;Leydig cells: 451.1;Peritubular cells: 1336.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.2;intermediate monocyte: 17.7;myeloid DC: 6.4;NK-cell: 4.6;non-classical monocyte: 13.0" "Group enriched" "Detected in many" 4 "dendritic cells: 6.4;monocytes: 17.7;NK-cells: 4.6" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 36.6;HUVEC TERT2: 68.4;TIME: 139.4;U-138 MG: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000096, HPA011862, HPA067440, CAB072873" Enhanced Supported "Nuclear bodies,Plasma membrane" NA NA 260000000 "Plasma membrane" "Nuclear bodies" "CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-2)" "unprognostic (2.96e-2)" "unprognostic (1.77e-1)" "prognostic favorable (6.61e-4)" "prognostic favorable (5.62e-6)" "unprognostic (2.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.87e-2)" "unprognostic (2.20e-2)" "unprognostic (8.98e-2)" "prognostic unfavorable (4.26e-4)" "unprognostic (3.33e-3)" "unprognostic (7.35e-2)" "unprognostic (2.84e-1)" "unprognostic (1.27e-1)" 40.3 19.3 6.4 26.6 10.5 5.5 52.7 3.9 8.6 26.3 14.0 7.6 18.5 11.2 27.0 25.2 17.2 23.2 28.3 105.4 8.0 5.0 40.8 26.8 66.7 44.1 10.6 7.0 66.4 9.6 8.6 12.5 60.2 10.1 23.1 6.4 35.5 9.9 51.7 24.1 10.1 14.5 23.1 8.7 52.4 11.6 37.2 7.7 6.7 35.4 19.3 11.0 20.3 44.8 1.1 6.4 0.3 17.7 4.6 2.3 4.6 0.1 0.1 1.0 0.0 17.2 11.8 30.3 19.9 14.3 10.6 6.2 0.0 0.1 0.1 9.7 36.6 8.0 0.3 0.0 3.2 3.5 0.0 0.0 5.6 11.3 0.6 13.3 2.6 0.0 20.1 0.7 13.8 5.0 0.1 68.4 0.1 0.0 0.1 12.4 0.1 0.0 0.2 0.2 0.0 0.5 8.8 1.7 0.1 0.0 0.0 0.1 0.2 10.5 9.2 2.7 0.7 1.8 4.0 139.4 34.9 1.9 22.7 0.0 0.7 0.1 0.1 9.4 7.0 11.4 0.0 12.2 0.3 1.3 17.7 0.4 0.4 2.1 2.3 6.4 1.1 1.3 2.0 0.3 4.6 13.0 2.4 0.8 4.6 6.4 10.5 3.9 8.6 8.0 5.0 10.6 7.0 10.1 7.7 3.0 23.1 25.1 2.3 10.6 2.5 16.5 22.9 8.1 3.4 3.5 3.9 24.4 0.0 8.3 7.0 336.5 0.0 23.3 1.0 249.8 36.6 1.4 15.0 5.1 119.5 0.0 2.4 724.3 66.8 29.3 451.1 50.7 23.6 46.9 1.1 3.1 2.0 0.0 1336.5 0.0 4.1 71.1 20.8 3.7 4.9 7.3 314.8 5.7 0.2 1.1 ENHO "C9orf165, UNQ470" ENSG00000168913 "Energy homeostasis associated" Q6UWT2 9 34521040-34523041 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 79.6" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 53.5" "Cancer enhanced" "Detected in many" "glioma: 44.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "myeloid DC: 19.4" "Lineage enriched" "Detected in many" 7 "dendritic cells: 19.4" "Cell line enhanced" "Detected in many" "AN3-CA: 13.4;NTERA-2: 18.5;SCLC-21H: 9.4;SH-SY5Y: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042575 Approved "Secreted to blood" NA NA 4240000 "HPA042575: AB_10794914" "unprognostic (2.63e-2)" "unprognostic (9.53e-3)" "unprognostic (2.46e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.30e-1)" "unprognostic (7.51e-2)" "unprognostic (9.93e-2)" "unprognostic (1.34e-2)" "unprognostic (5.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.78e-4)" "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.47e-2)" "unprognostic (1.87e-1)" "unprognostic (5.50e-2)" "unprognostic (8.76e-2)" 1.5 1.9 58.0 1.9 59.3 1.7 3.7 15.5 79.6 2.9 3.9 13.9 0.0 3.0 1.4 1.4 1.5 3.6 1.8 1.8 36.3 37.5 1.5 12.0 2.0 1.4 52.0 27.1 1.5 2.6 1.2 1.0 1.3 13.7 5.2 3.2 0.1 1.8 1.7 1.6 3.8 3.6 1.3 17.1 1.6 5.3 6.4 13.4 0.0 1.4 0.0 1.4 1.5 0.0 0.0 19.4 0.0 2.5 2.7 0.0 0.4 0.1 1.0 5.3 13.4 0.1 0.0 0.3 0.0 0.0 2.1 2.2 0.5 0.2 2.2 3.7 0.0 4.3 0.2 6.1 0.4 0.4 0.3 5.9 0.0 0.1 1.2 0.2 0.0 3.0 0.0 0.1 0.0 0.2 0.0 0.0 4.3 0.0 1.9 0.5 0.3 0.0 0.0 18.5 1.0 3.7 0.1 0.0 0.3 0.5 0.0 9.4 8.9 0.7 4.1 0.4 0.7 0.3 1.7 0.0 0.4 2.1 0.1 0.1 1.1 1.3 0.1 0.5 0.0 3.1 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 2.7 0.7 1.0 0.0 0.4 58.0 59.3 15.5 37.0 36.3 37.5 52.0 27.1 13.7 13.4 0.0 0.3 0.0 2.5 2.5 4.3 0.4 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.7 0.7 0.0 0.0 0.0 0.2 0.2 1.0 10.2 0.0 2.6 2.6 4.8 1.7 1.3 0.3 2.7 0.3 3.2 1.7 1.0 0.0 53.5 0.0 0.0 0.4 0.3 2.8 0.0 0.1 0.5 5.9 2.8 0.0 0.0 0.0 0.5 ENPEP "CD249, gp160" ENSG00000138792 "Glutamyl aminopeptidase" Q07075 4 110365733-110565285 "CD markers, Enzymes, Plasma proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 165.1;kidney: 63.8" "Cell type enhanced" "Detected in many" 14 "Proximal tubular cells: 153.4;Sertoli cells: 155.2;Smooth muscle cells: 60.8;Syncytiotrophoblasts: 49.0" "Cancer enriched" "Detected in many" 8 "renal cancer: 41.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HEK 293: 11.4;MOLT-4: 2.7;SuSa: 8.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA005128 Enhanced NA NA 37000000 "HPA005128: AB_1844795" "unprognostic (2.73e-3)" "unprognostic (2.84e-3)" "unprognostic (5.16e-3)" "unprognostic (3.48e-1)" "unprognostic (2.90e-1)" "unprognostic (8.74e-2)" "unprognostic (3.34e-2)" "unprognostic (1.03e-1)" "unprognostic (1.35e-2)" "unprognostic (1.22e-1)" "unprognostic (1.93e-1)" "unprognostic (9.47e-2)" "unprognostic (4.49e-3)" "unprognostic (3.43e-3)" "unprognostic (1.52e-2)" "unprognostic (8.46e-2)" "unprognostic (2.49e-3)" 5.8 1.0 0.4 0.4 0.6 0.0 2.8 0.3 1.0 1.1 54.4 0.4 0.7 11.1 5.3 2.4 0.8 1.4 1.1 2.3 0.5 0.3 63.8 14.5 2.7 0.5 0.4 0.3 1.0 1.0 33.3 0.8 4.4 0.5 1.4 0.0 0.8 0.6 0.5 2.3 0.4 165.1 3.1 0.5 4.7 0.7 0.4 0.4 1.4 2.4 2.0 0.4 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.1 0.0 0.1 0.2 4.2 0.6 0.0 0.2 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.5 2.7 0.5 0.5 0.1 0.0 0.2 0.0 0.4 0.0 0.4 0.1 0.2 0.0 2.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.3 1.0 0.5 0.3 0.4 0.3 0.5 0.4 0.0 1.3 0.0 0.1 1.4 0.0 3.3 0.0 0.0 0.0 10.4 0.0 33.0 14.9 0.0 0.4 1.4 2.6 0.0 0.0 2.7 19.7 0.1 0.0 24.1 2.4 0.0 1.7 1.8 0.3 0.0 0.6 0.6 0.0 0.0 0.8 0.0 0.0 0.8 0.4 153.4 0.0 155.2 60.8 0.0 0.2 0.9 49.0 1.3 1.1 0.1 ENPP1 "M6S1, NPPS, PC-1, PCA1, PDNP1" ENSG00000197594 "Ectonucleotide pyrophosphatase/phosphodiesterase 1" P22413 6 131808016-131895155 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins" Biomineralization Hydrolase "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Hepatocytes: 80.9;Peritubular cells: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "NK-cell: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 23.1;LHCN-M2: 13.8;U-138 MG: 18.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB032904, HPA062066" Enhanced "Secreted - unknown location" NA NA 2500000 "CAB032904: AB_2099635, HPA062066: AB_2684674" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.60e-3)" "unprognostic (2.40e-1)" "unprognostic (1.11e-1)" "unprognostic (2.00e-1)" "unprognostic (1.60e-2)" "unprognostic (7.22e-3)" "unprognostic (8.96e-2)" "unprognostic (1.95e-1)" "unprognostic (3.00e-1)" "unprognostic (2.61e-2)" "unprognostic (1.41e-1)" "unprognostic (1.96e-1)" "unprognostic (1.84e-1)" "unprognostic (3.28e-3)" 17.2 2.1 0.5 1.9 0.5 0.0 30.5 0.6 0.4 8.5 2.8 1.6 8.3 1.1 25.7 7.1 1.5 6.4 2.6 1.9 0.5 0.7 10.9 19.4 2.0 0.7 1.1 0.0 7.3 17.5 22.2 27.0 28.9 0.8 3.3 1.2 13.4 5.4 6.5 2.1 1.7 2.6 6.8 2.0 1.2 1.7 4.6 0.3 2.0 13.2 6.9 1.4 3.2 7.7 0.6 2.2 1.4 0.3 4.6 1.7 0.1 0.0 0.8 0.8 0.0 23.1 3.6 0.0 6.0 6.1 2.3 6.4 2.6 0.7 0.0 0.5 3.8 4.8 0.0 0.8 0.1 9.9 0.2 1.1 0.0 0.7 7.7 0.7 0.0 2.8 5.9 0.2 6.4 0.2 2.7 2.8 0.5 0.0 1.2 13.8 1.6 0.0 0.0 5.2 1.0 0.9 0.0 6.7 0.1 0.1 0.3 2.3 0.0 0.1 0.8 2.7 4.0 2.5 0.0 1.8 18.5 0.7 1.3 5.8 2.2 0.0 0.0 8.4 0.0 2.3 1.4 0.2 0.3 0.3 0.2 1.7 0.3 0.3 0.3 2.2 0.6 0.3 0.3 1.0 4.6 0.3 0.3 0.2 0.1 0.5 0.5 0.6 0.4 0.5 0.7 1.1 0.0 0.8 0.3 0.0 1.7 1.5 10.5 1.3 4.0 2.8 5.1 0.0 0.0 1.8 0.0 2.0 5.0 0.1 3.9 1.9 7.7 0.0 8.8 1.3 25.4 3.4 0.0 80.9 4.3 1.6 0.0 2.5 3.3 4.7 23.3 1.3 1.7 0.0 8.6 4.4 7.9 3.5 65.7 15.6 0.3 12.9 10.5 1.4 1.3 1.1 5.1 0.0 1.7 1.6 ENPP2 "ATX, PD-IALPHA, PDNP2" ENSG00000136960 "Ectonucleotide pyrophosphatase/phosphodiesterase 2" Q13822 8 119557086-119673453 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 103.7;placenta: 79.0" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 38.2;Fibroblasts: 51.0;Hofbauer cells: 50.0;Intestinal endocrine cells: 51.9;Melanocytes: 43.9;Proximal tubular cells: 45.6" "Cancer enhanced" "Detected in all" "renal cancer: 46.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 26.8" "Cell line enhanced" "Detected in some" "AF22: 25.2;ASC diff: 34.5;ASC TERT1: 73.7;BJ hTERT+: 42.4;fHDF/TERT166: 27.3;HSkMC: 33.8;U-2197: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023700, HPA053652" Approved Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Intracellular and membrane" NA NA 1100000000 "Nucleoplasm, Golgi apparatus" "Actin filaments" "HPA023700: AB_1848170, HPA053652: AB_2682218" "unprognostic (1.17e-2)" "unprognostic (6.29e-2)" "unprognostic (3.63e-2)" "unprognostic (3.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-1)" "unprognostic (9.70e-3)" "unprognostic (7.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "prognostic favorable (2.07e-5)" "unprognostic (5.54e-2)" "unprognostic (3.14e-1)" "unprognostic (2.37e-1)" "unprognostic (5.18e-2)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" 29.9 15.4 24.0 18.2 42.0 0.7 26.2 4.4 33.3 19.6 8.1 103.7 1.7 20.8 44.8 6.4 2.9 18.7 12.7 3.6 39.8 21.5 24.9 8.9 13.5 31.0 71.5 20.9 5.3 5.2 0.9 4.1 79.0 59.7 8.5 10.6 67.6 3.4 9.2 3.0 5.4 12.1 28.9 102.4 17.3 8.3 9.7 63.9 3.6 3.7 0.8 26.1 13.4 5.7 0.2 3.8 26.8 0.1 0.2 1.8 0.3 0.0 0.0 25.2 0.0 34.5 73.7 0.0 23.2 42.4 10.0 9.6 0.0 0.0 0.0 0.3 27.3 0.0 0.0 0.5 0.0 7.1 1.8 0.7 0.0 0.0 0.6 15.4 0.0 0.1 33.8 0.2 20.4 1.0 0.1 0.1 0.0 0.0 4.1 0.5 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 20.3 0.4 24.4 0.1 0.2 0.0 0.0 17.1 0.1 0.5 26.8 0.1 5.2 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 1.8 0.6 0.3 0.2 0.0 3.8 0.0 0.3 24.0 42.0 4.4 33.3 39.8 21.5 71.5 20.9 59.7 63.9 11.9 5.1 3.2 0.5 9.4 1.1 1.2 38.2 6.7 1.2 1.8 0.0 3.4 1.7 0.0 34.3 16.3 0.9 0.0 0.0 1.5 51.0 0.1 5.8 0.4 50.0 0.0 51.9 19.0 12.5 3.6 2.8 8.9 43.9 0.0 0.6 3.3 1.2 0.3 3.2 45.6 1.2 0.0 5.1 1.1 0.4 4.5 5.4 0.5 0.6 0.9 ENPP3 "B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3" ENSG00000154269 "Ectonucleotide pyrophosphatase/phosphodiesterase 3" O14638 6 131628442-131747418 "CD markers, Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 29.0;intestine: 45.4;seminal vesicle: 70.7" "Cell type enhanced" "Detected in many" 20 "Enterocytes: 9.0;granulocytes: 33.7;Proximal tubular cells: 8.2" "Cancer enriched" "Detected in many" 8 "renal cancer: 49.6" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 74 "basophil: 18.2" "Lineage enriched" "Detected in single" 74 "granulocytes: 18.2" "Group enriched" "Detected in some" 18 "HEL: 5.2;Hep G2: 17.0;HMC-1: 7.6" "Low region specificity" "Detected in some" HPA043772 Enhanced "Secreted - unknown location" NA NA 480000 "HPA043772: AB_10795616" "unprognostic (2.74e-1)" "unprognostic (1.99e-2)" "unprognostic (1.84e-1)" "unprognostic (5.41e-3)" "unprognostic (6.07e-2)" "unprognostic (4.86e-5)" "unprognostic (1.13e-1)" "unprognostic (7.20e-3)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (2.21e-3)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.96e-4)" "unprognostic (2.80e-2)" "unprognostic (7.85e-2)" "unprognostic (2.29e-1)" "unprognostic (1.31e-3)" 0.8 7.9 0.5 2.0 0.5 0.0 4.0 2.1 0.4 19.0 18.5 0.2 29.0 9.3 6.2 7.2 0.5 2.3 1.8 0.2 0.4 0.7 11.9 2.7 1.7 0.2 0.5 0.2 0.9 0.2 0.0 0.5 0.4 0.2 3.7 4.8 0.6 14.9 70.7 0.2 0.8 45.4 1.9 0.4 0.5 0.7 1.0 0.2 4.1 0.5 1.2 0.5 0.9 1.2 0.0 0.0 18.2 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 5.2 0.0 17.0 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.5 2.1 0.4 0.4 0.7 0.5 0.2 0.2 0.2 0.0 1.4 0.0 2.8 0.0 0.0 0.2 0.0 2.7 1.2 0.0 0.0 0.0 1.7 0.0 1.3 0.3 9.0 0.0 0.0 0.0 0.5 4.6 33.7 1.7 0.1 0.0 0.0 0.6 0.6 0.0 1.1 0.2 1.7 0.0 1.1 0.0 0.0 2.3 0.7 8.2 0.0 0.0 0.0 1.8 0.8 0.5 0.1 0.5 5.2 1.1 ENPP4 "AP3Aase, KIAA0879, NPP4" ENSG00000001561 "Ectonucleotide pyrophosphatase/phosphodiesterase 4" Q9Y6X5 6 46129993-46146699 "Enzymes, Predicted membrane proteins" "Blood coagulation, Hemostasis" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 71.5;Ciliated cells: 57.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 15.0;U-266/84: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016594 Approved NA NA "HPA016594: AB_1848171" "unprognostic (9.87e-2)" "unprognostic (1.74e-1)" "unprognostic (2.75e-2)" "unprognostic (2.01e-1)" "unprognostic (2.92e-1)" "unprognostic (1.90e-1)" "unprognostic (8.13e-2)" "unprognostic (5.51e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-1)" "unprognostic (8.51e-2)" "unprognostic (4.36e-1)" "prognostic favorable (6.95e-7)" "unprognostic (1.82e-2)" "unprognostic (1.83e-1)" "unprognostic (2.62e-2)" "unprognostic (2.56e-1)" 12.7 12.5 14.8 6.2 21.9 30.2 14.3 10.1 20.6 9.8 10.5 19.3 31.9 9.5 3.8 10.9 4.8 9.9 7.3 12.9 19.8 15.7 16.8 9.0 17.9 6.9 30.8 15.6 3.4 10.4 22.2 14.1 3.2 23.9 15.0 11.6 7.1 17.5 30.8 20.9 3.6 8.7 8.6 43.2 11.5 12.3 7.1 22.2 4.8 11.3 7.3 5.6 8.0 5.9 3.1 1.8 0.9 2.7 4.6 11.0 3.1 0.0 0.7 0.5 1.0 0.0 0.0 0.0 1.1 1.1 2.7 0.2 1.2 9.0 10.0 8.8 1.4 6.8 0.1 2.8 0.4 0.5 12.0 7.5 5.5 0.0 0.0 0.4 6.8 10.2 1.4 0.0 0.0 0.0 0.7 0.9 7.1 0.0 0.0 1.0 1.1 5.0 0.6 1.8 11.1 0.3 3.8 1.8 3.7 5.7 1.1 12.3 0.0 0.0 1.9 0.0 2.9 5.1 2.8 0.0 0.0 4.7 0.2 7.4 15.0 17.1 3.4 7.1 0.0 0.9 0.0 0.4 0.9 11.0 1.3 6.4 3.1 4.1 7.9 1.7 1.5 4.0 7.0 0.3 4.6 2.7 1.8 1.4 3.1 14.8 21.9 10.1 20.6 19.8 15.7 30.8 15.6 23.9 22.2 71.5 24.8 5.1 2.8 0.8 8.7 16.9 10.2 57.6 38.7 27.9 13.7 0.3 0.0 13.0 12.6 6.7 16.0 0.0 10.7 0.2 3.5 18.9 15.1 7.3 5.4 25.4 15.1 1.8 15.8 21.4 1.1 10.5 3.3 22.6 14.4 23.1 8.0 16.5 10.6 11.4 6.1 0.0 4.2 8.6 8.7 0.5 0.2 13.8 8.9 6.8 ENPP5 ENSG00000112796 "Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)" Q9UJA9 6 46159187-46170971 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "epididymis: 116.5" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 68.3;Muller glia cells: 94.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 13.4" "Lineage enriched" "Detected in many" 6 "T-cells: 13.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.7;HSkMC: 7.8;SuSa: 6.9;T-47d: 9.2;U-266/84: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016902 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 300000 Cytosol Nucleoplasm "HPA016902: AB_1848172" "unprognostic (1.12e-1)" "unprognostic (5.19e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-1)" "unprognostic (7.61e-2)" "unprognostic (1.63e-1)" "unprognostic (5.01e-2)" "prognostic favorable (4.57e-4)" "unprognostic (1.96e-1)" "unprognostic (9.89e-2)" "prognostic favorable (4.04e-4)" "unprognostic (7.00e-2)" "prognostic favorable (4.44e-13)" "unprognostic (4.40e-2)" "unprognostic (2.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.60e-1)" 1.5 4.8 6.5 1.3 10.3 0.8 7.1 9.2 16.1 6.9 2.0 3.3 28.7 1.5 1.6 116.5 1.6 7.9 3.9 3.9 6.6 9.4 12.1 1.0 4.7 1.2 14.2 10.5 5.4 6.2 21.8 23.3 1.5 14.4 14.6 2.3 11.8 6.9 27.5 6.9 1.3 1.6 5.1 5.5 3.2 3.5 16.2 3.5 1.0 24.3 0.9 1.4 5.7 1.7 0.4 0.0 1.0 0.1 2.2 13.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.6 0.1 0.3 11.7 1.9 3.9 0.2 4.0 0.0 0.6 1.6 0.1 0.0 2.6 0.8 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 1.9 0.0 0.5 2.5 5.5 0.0 0.0 0.3 0.2 4.9 0.6 5.1 0.2 0.0 4.9 0.0 6.9 9.2 0.0 0.0 0.0 1.3 0.0 0.1 5.8 7.9 0.0 3.1 0.0 0.1 0.0 0.0 0.0 13.4 0.1 7.2 0.4 2.7 8.6 0.0 0.4 0.8 8.2 1.0 2.2 0.0 0.0 0.0 2.6 6.5 10.3 9.2 16.1 6.6 9.4 14.2 10.5 14.4 3.5 11.9 9.8 0.0 4.7 0.8 11.0 8.1 7.6 68.3 9.1 22.7 3.9 4.2 1.7 6.9 0.8 0.1 1.4 0.0 6.5 2.4 3.3 16.0 4.6 0.0 0.3 9.5 7.9 0.6 0.0 1.5 2.6 0.7 0.0 1.0 3.4 94.1 2.7 2.9 11.3 16.2 2.9 6.5 0.7 0.2 2.3 0.5 0.2 3.8 2.5 2.6 ENTPD1 "ATPDase, CD39, NTPDase-1, SPG64" ENSG00000138185 "Ectonucleoside triphosphate diphosphohydrolase 1" P49961 10 95711779-95869695 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Hydrolase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 59.4" "Cell type enhanced" "Detected in many" 8 "B-cells: 45.3;Endothelial cells: 46.6;Kupffer cells: 77.1;Macrophages: 80.4;monocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 37.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HDLM-2: 57.3;Karpas-707: 47.1" "CAB002494, HPA014067" Enhanced Uncertain Microtubules NA NA Microtubules "CAB002494: AB_563557, HPA014067: AB_1848178" "unprognostic (1.14e-1)" "unprognostic (1.01e-2)" "unprognostic (3.11e-1)" "unprognostic (5.67e-2)" "unprognostic (9.68e-3)" "unprognostic (3.45e-3)" "unprognostic (6.31e-2)" "unprognostic (5.26e-3)" "unprognostic (2.73e-1)" "unprognostic (1.28e-2)" "unprognostic (6.40e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.33e-5)" "unprognostic (9.79e-2)" "unprognostic (2.30e-1)" "prognostic favorable (7.89e-4)" "unprognostic (5.09e-2)" 10.4 7.5 7.4 16.2 8.4 15.6 8.8 7.6 6.9 18.9 12.7 13.1 8.7 5.8 59.4 12.8 13.2 15.6 22.2 6.8 7.4 7.4 6.2 3.9 14.8 14.5 8.5 4.9 10.3 2.8 3.0 4.3 24.0 9.9 14.7 9.1 10.8 6.7 12.7 3.3 5.5 12.2 37.2 17.9 25.3 7.5 5.4 7.2 3.5 13.4 12.5 21.1 25.2 12.4 6.0 11.8 37.4 15.2 0.5 5.1 4.6 0.1 0.3 0.9 0.8 0.0 0.0 0.5 0.5 0.4 0.0 0.0 0.5 0.1 1.0 0.6 0.0 1.4 0.3 0.0 0.0 0.0 57.3 0.7 0.6 0.4 0.7 0.0 1.5 0.2 0.0 0.0 0.2 0.0 0.3 7.5 0.3 0.6 47.1 0.0 0.6 0.4 1.5 0.6 0.6 0.2 2.4 0.4 0.7 0.5 0.2 0.7 1.1 0.3 1.1 0.8 0.6 0.5 1.6 0.8 0.4 0.2 0.6 0.6 6.7 0.9 0.0 0.6 3.1 0.2 0.1 15.2 37.4 0.1 10.7 0.3 6.0 0.6 0.3 11.8 4.6 0.1 0.1 26.7 0.5 2.4 0.7 5.1 4.6 7.4 8.4 7.6 6.9 7.4 7.4 8.5 4.9 9.9 7.2 0.0 1.4 45.3 0.3 7.9 1.4 8.5 0.0 1.4 1.2 1.8 2.0 0.4 1.7 0.0 5.9 46.6 0.0 0.0 1.8 1.7 8.7 0.4 3.5 0.0 23.2 0.0 0.0 11.6 77.1 6.1 0.6 80.4 15.1 46.9 0.0 0.7 0.2 0.2 2.8 0.3 0.7 6.5 32.0 6.2 4.3 9.8 13.2 14.6 0.4 0.2 ENTPD2 "CD39L1, NTPDase-2" ENSG00000054179 "Ectonucleoside triphosphate diphosphohydrolase 2" Q9Y5L3 9 137048098-137054045 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.6" "Group enriched" "Detected in many" 4 "Leydig cells: 178.1;Peritubular cells: 90.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "eosinophil: 2.6" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.6" "Cell line enhanced" "Detected in some" "Hep G2: 15.9;hTCEpi: 8.8;MCF7: 11.0;OE19: 17.7;SK-BR-3: 14.8;T-47d: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017676 Approved NA NA "HPA017676: AB_1848179" "unprognostic (1.64e-1)" "unprognostic (3.35e-2)" "unprognostic (1.76e-1)" "unprognostic (3.33e-2)" "unprognostic (2.15e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (2.71e-2)" "unprognostic (4.97e-2)" "unprognostic (3.23e-1)" "unprognostic (2.99e-1)" "unprognostic (1.89e-1)" "prognostic favorable (3.51e-6)" "prognostic favorable (1.38e-4)" "unprognostic (2.51e-1)" "unprognostic (8.43e-2)" "unprognostic (1.12e-3)" 1.7 1.6 18.8 1.5 10.1 0.6 7.0 4.0 10.4 9.8 9.1 21.9 1.7 17.6 2.8 4.4 3.3 9.4 10.7 2.7 22.6 9.6 4.5 1.0 1.0 0.5 6.1 12.8 0.8 2.6 1.2 3.1 3.9 11.9 11.2 5.8 2.5 6.2 2.9 3.0 9.3 11.1 1.9 7.5 0.5 9.5 6.8 11.7 0.0 0.7 2.6 1.0 0.9 3.5 0.0 0.0 2.6 0.1 0.0 0.0 0.0 4.2 1.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.9 0.0 0.0 3.4 0.3 2.5 0.0 0.0 0.1 0.0 0.4 15.9 0.0 0.0 0.2 0.0 8.8 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 17.7 2.4 0.0 0.7 1.6 1.9 0.4 2.4 0.0 0.2 14.8 0.0 0.1 16.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.8 10.1 4.0 9.8 22.6 9.6 6.1 12.8 11.9 11.7 0.0 0.0 0.0 1.1 1.4 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.3 0.0 6.1 1.1 0.7 31.6 0.0 3.9 0.9 1.7 5.9 0.0 0.9 0.2 0.0 24.2 0.6 0.0 2.1 178.1 0.0 5.0 1.0 8.1 7.2 4.5 31.7 90.9 8.4 0.0 0.0 0.4 1.2 4.3 1.3 0.8 0.0 12.8 1.0 ENTPD3 "CD39L3, HB6, NTPDase-3" ENSG00000168032 "Ectonucleoside triphosphate diphosphohydrolase 3" O75355 3 40387156-40428619 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 26.2;pancreas: 37.3" "Group enriched" "Detected in many" 4 "Exocrine glandular cells: 19.8;Pancreatic endocrine cells: 5.7;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 7.4" "Lineage enriched" "Detected in many" 5 "dendritic cells: 7.4" "Cell line enhanced" "Detected in some" "HaCaT: 3.8;HBEC3-KT: 12.7;hTCEpi: 8.6;RT4: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.00e-1)" "unprognostic (1.54e-2)" "unprognostic (2.75e-2)" "unprognostic (9.84e-3)" "unprognostic (2.27e-2)" "unprognostic (2.04e-1)" "unprognostic (1.80e-1)" "unprognostic (1.18e-2)" "unprognostic (8.40e-2)" "unprognostic (9.88e-3)" "unprognostic (4.72e-2)" "unprognostic (2.08e-1)" "unprognostic (3.25e-1)" "unprognostic (6.53e-2)" "unprognostic (5.99e-2)" "unprognostic (1.68e-1)" "unprognostic (1.23e-1)" 4.6 2.2 5.7 1.7 25.9 0.5 2.1 5.4 15.8 26.2 3.3 0.6 1.9 1.7 4.0 4.4 7.5 1.3 3.6 1.4 4.9 6.3 3.6 0.5 4.8 0.9 4.0 6.3 2.6 37.3 1.7 4.2 2.9 14.5 5.3 3.6 2.8 21.2 5.1 1.7 3.2 1.6 2.5 1.7 5.1 8.8 1.3 4.8 0.0 7.0 5.6 4.8 13.7 2.9 0.5 7.4 1.4 0.3 0.9 0.8 0.1 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.1 3.8 0.0 12.7 0.3 0.7 0.4 0.7 0.5 0.2 0.0 0.0 0.0 0.1 8.6 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.0 0.5 0.0 0.1 0.1 0.3 1.1 0.1 0.0 0.3 1.6 18.3 1.9 0.4 0.8 1.4 0.3 0.4 0.7 0.0 0.4 0.2 0.1 0.0 0.0 0.2 0.4 0.0 1.1 0.1 0.1 1.4 0.2 0.0 0.2 0.3 0.8 0.3 0.2 0.3 0.0 0.5 0.6 0.6 0.0 0.9 0.2 7.4 0.6 0.1 5.7 25.9 5.4 15.8 4.9 6.3 4.0 6.3 14.5 4.8 3.0 3.4 0.0 1.0 2.1 0.0 0.4 0.0 1.4 2.3 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.0 19.8 0.0 0.2 2.3 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.3 5.7 0.0 0.7 0.0 0.6 19.4 3.1 0.3 0.1 1.9 0.0 0.0 0.0 3.7 ENTPD4 "KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase" ENSG00000197217 "Ectonucleoside triphosphate diphosphohydrolase 4" Q9Y227 8 23385783-23457695 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA017655 Supported Approved Vesicles NA NA 28000 Vesicles "HPA017655: AB_1848181" "unprognostic (2.83e-2)" "unprognostic (1.50e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (5.06e-2)" "unprognostic (7.86e-3)" "unprognostic (2.00e-2)" "unprognostic (2.99e-3)" "unprognostic (2.07e-2)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.39e-1)" "unprognostic (1.11e-1)" "unprognostic (6.62e-2)" "unprognostic (3.72e-2)" 16.3 11.5 15.0 21.9 19.8 25.7 15.3 20.3 27.4 15.2 18.5 14.7 15.7 17.0 18.8 17.9 13.3 12.7 14.4 21.0 14.5 12.8 13.0 14.4 19.9 26.0 16.2 12.2 14.7 26.5 30.4 25.2 19.3 20.6 17.6 20.2 18.0 19.5 13.7 14.9 12.2 26.1 16.1 14.5 26.9 19.1 18.7 15.8 17.0 15.8 9.3 30.7 16.7 16.7 9.7 8.0 15.9 9.5 4.4 10.7 6.8 9.3 12.9 16.3 11.2 14.2 18.1 16.6 15.0 14.3 10.2 16.0 18.5 12.5 15.9 10.9 15.1 15.7 11.4 7.3 13.6 19.6 3.8 5.1 8.4 8.0 6.4 11.6 4.4 16.7 11.1 16.6 13.5 14.5 24.9 14.6 12.4 5.8 14.6 17.2 4.2 6.4 5.4 9.5 12.0 4.7 6.4 16.3 4.8 13.0 11.1 13.0 12.4 5.6 8.2 11.0 33.9 6.0 6.3 18.0 18.6 18.4 20.8 11.0 11.7 4.9 20.7 24.9 5.3 18.6 14.9 6.0 13.7 8.5 9.5 10.0 9.7 8.3 9.1 8.0 6.7 10.7 8.3 15.9 4.4 6.9 7.3 6.5 6.8 15.0 19.8 20.3 27.4 14.5 12.8 16.2 12.2 20.6 15.8 17.9 34.6 17.1 9.5 5.8 30.2 20.4 7.6 14.7 28.4 14.0 13.7 12.6 0.0 13.8 6.9 13.7 17.8 23.3 14.7 13.0 12.7 14.2 16.3 10.5 10.5 44.5 16.6 11.1 11.0 15.7 6.6 15.2 11.8 12.6 15.2 18.9 18.1 11.9 8.1 3.7 34.2 12.9 12.3 20.7 21.1 4.8 16.9 15.0 10.5 13.9 ENTPD5 "CD39L4, NTPDase-5, PCPH" ENSG00000187097 "Ectonucleoside triphosphate diphosphohydrolase 5" O75356 14 73958010-74019399 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 52.0;kidney: 43.1;liver: 71.4" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 99.9;Hepatocytes: 120.9;Mucus-secreting cells: 67.4" "Cancer enhanced" "Detected in all" "prostate cancer: 39.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 15.0;eosinophil: 8.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.0" "Cell line enhanced" "Detected in all" "RT4: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002927 Enhanced "Secreted to blood" NA NA 5000000 "HPA002927: AB_1078744" "unprognostic (4.19e-1)" "unprognostic (9.63e-3)" "unprognostic (3.11e-2)" "unprognostic (2.06e-2)" "unprognostic (1.98e-1)" "unprognostic (3.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.19e-1)" "unprognostic (3.34e-1)" "unprognostic (6.01e-2)" "unprognostic (6.20e-2)" "unprognostic (2.55e-1)" "prognostic favorable (3.95e-5)" "unprognostic (1.25e-1)" "unprognostic (5.06e-2)" "unprognostic (1.76e-1)" "unprognostic (6.92e-3)" 3.0 3.6 2.8 9.4 3.8 1.7 3.5 3.0 4.0 2.4 25.8 5.8 3.1 19.3 3.0 2.7 4.5 2.4 6.6 2.6 2.8 2.3 43.1 71.4 2.3 1.3 3.5 2.3 3.3 5.9 1.8 2.7 2.2 5.5 10.2 29.6 3.2 4.7 1.5 3.8 2.7 52.0 3.9 5.5 3.2 11.8 4.5 2.5 2.1 2.7 3.0 3.3 9.5 3.0 1.6 1.6 15.0 2.1 0.6 2.5 1.2 5.4 4.4 5.0 9.3 10.0 9.5 5.8 5.7 4.7 3.8 4.4 3.3 6.6 6.2 2.9 7.8 3.7 6.5 5.0 8.3 4.3 5.2 2.4 4.6 3.2 18.1 9.7 2.7 5.4 7.7 8.4 5.4 11.2 5.4 7.6 10.2 5.1 9.4 5.6 7.7 3.1 3.3 1.5 4.9 9.6 3.5 4.8 3.0 6.7 34.5 3.6 3.7 9.7 7.7 5.5 4.0 11.1 2.5 6.4 7.7 8.0 4.6 4.2 6.1 9.5 5.0 4.9 5.1 6.9 15.0 1.2 8.3 2.5 2.1 1.3 1.3 1.3 1.7 1.6 1.6 2.1 2.1 0.2 0.6 1.3 0.8 1.4 1.2 2.8 3.8 3.0 4.0 2.8 2.3 3.5 2.3 5.5 2.5 14.9 7.9 6.7 4.8 3.3 6.1 4.8 12.7 5.3 10.3 7.0 3.9 6.4 21.6 5.1 13.9 5.4 99.9 0.0 11.3 5.7 4.9 39.5 1.1 120.9 5.5 9.5 15.5 11.6 7.0 8.7 2.6 5.1 5.0 6.4 67.4 4.8 7.4 54.7 5.3 50.1 12.0 12.9 4.1 20.1 18.3 3.0 2.7 4.9 41.0 12.3 ENTPD6 "CD39L2, dJ738P15.3, IL6ST2, NTPDase-6" ENSG00000197586 "Ectonucleoside triphosphate diphosphohydrolase 6 (putative)" O75354 20 25195693-25226729 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 76.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015491, HPA069555" Approved Supported "Golgi apparatus" "Secreted to blood" NA NA 18000 "Golgi apparatus" "HPA015491: AB_2669200, HPA069555: AB_2686152" "unprognostic (3.24e-1)" "unprognostic (1.27e-2)" "unprognostic (5.91e-2)" "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (4.44e-1)" "unprognostic (2.10e-3)" "unprognostic (7.41e-3)" "unprognostic (2.74e-3)" "unprognostic (1.17e-1)" "unprognostic (2.14e-1)" "unprognostic (1.03e-1)" "unprognostic (8.14e-3)" "unprognostic (1.78e-2)" "unprognostic (2.74e-1)" "unprognostic (4.86e-2)" "unprognostic (4.48e-2)" 12.7 19.7 21.8 11.3 46.5 6.7 12.8 33.1 49.1 9.8 31.3 12.1 12.8 31.6 9.4 10.1 9.0 12.5 18.3 27.5 24.9 25.0 13.4 12.9 11.0 7.4 15.1 29.2 16.1 25.6 11.7 20.5 13.2 15.4 25.5 24.5 9.0 36.8 9.7 15.1 6.8 32.2 9.9 8.2 8.3 24.7 16.1 10.5 9.4 10.4 6.1 8.3 10.2 7.1 7.2 17.1 3.0 16.0 8.8 17.9 12.9 20.7 32.9 9.0 17.3 11.4 14.3 19.4 17.1 12.4 14.8 13.7 17.6 16.1 12.6 25.8 16.4 29.0 27.2 11.0 26.0 9.9 7.7 9.8 10.2 5.0 39.7 17.1 13.6 15.8 13.4 14.5 18.7 14.2 10.9 11.9 12.3 13.3 22.0 11.0 19.9 12.7 8.4 5.7 17.3 25.8 7.2 28.2 28.8 18.6 13.0 14.4 7.5 4.7 28.9 76.8 8.7 21.1 11.5 12.8 17.3 18.0 14.2 20.1 13.8 11.1 5.5 12.4 9.0 32.5 0.0 16.0 3.0 12.7 10.7 17.9 6.1 11.4 10.4 17.1 7.2 12.2 10.6 0.7 8.8 4.8 12.0 10.6 12.9 21.8 46.5 33.1 49.1 24.9 25.0 15.1 29.2 15.4 10.5 17.9 31.6 13.4 14.5 8.8 16.7 4.3 28.1 8.1 7.9 17.4 9.8 53.2 8.3 33.5 18.1 5.8 66.6 0.0 35.1 18.5 10.3 22.0 3.5 13.0 22.9 23.8 32.6 17.2 15.4 46.1 19.0 16.9 10.1 17.2 55.2 3.9 28.8 57.5 39.6 11.0 7.9 6.5 5.9 3.2 9.1 5.3 50.0 8.4 60.2 10.1 ENTPD7 "FLJ30978, LALP1" ENSG00000198018 "Ectonucleoside triphosphate diphosphohydrolase 7" Q9NQZ7 10 99659506-99706240 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 46.1" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 14.1;Urothelial cells: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014351 Uncertain Approved Nucleoplasm NA NA 24000 Nucleoplasm "HPA014351: AB_1848183" "unprognostic (1.82e-1)" "unprognostic (7.26e-2)" "unprognostic (1.11e-2)" "unprognostic (6.01e-3)" "unprognostic (6.22e-2)" "unprognostic (3.32e-3)" "unprognostic (9.35e-2)" "unprognostic (3.77e-3)" "unprognostic (3.83e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (5.59e-2)" "unprognostic (2.98e-1)" "unprognostic (1.22e-1)" "unprognostic (2.99e-2)" "unprognostic (3.39e-1)" 3.1 5.6 2.2 5.1 2.1 6.4 2.7 2.4 3.3 4.4 15.7 1.3 11.3 18.6 3.9 5.7 9.1 3.1 9.1 3.2 2.0 1.7 6.0 14.5 4.2 7.1 1.4 1.9 3.2 23.9 3.6 8.6 8.5 1.5 5.6 4.9 3.4 9.0 13.2 1.6 4.4 46.1 5.6 1.4 5.4 5.1 3.5 0.5 2.5 3.5 6.0 6.3 11.4 5.0 0.9 7.7 3.7 2.2 2.7 2.2 1.3 5.2 6.0 8.0 14.8 4.0 4.0 9.7 9.9 20.6 12.9 10.8 11.0 5.9 4.5 5.8 13.3 3.9 13.9 6.7 4.0 10.6 1.9 5.3 3.4 4.7 10.1 6.0 12.0 7.8 3.7 6.9 16.2 15.4 15.0 13.0 4.8 6.4 4.4 5.1 4.7 2.4 2.5 4.7 6.5 2.6 0.0 6.2 2.4 14.1 17.0 3.3 6.4 6.9 2.6 8.6 5.7 7.2 6.1 8.2 11.2 7.2 7.2 8.3 4.5 7.5 4.1 10.9 3.7 3.0 0.3 2.2 3.7 2.2 2.2 2.0 0.9 0.8 1.8 5.0 0.3 1.4 0.9 2.0 2.7 1.2 7.7 0.6 1.3 2.2 2.1 2.4 3.3 2.0 1.7 1.4 1.9 1.5 0.5 0.0 0.0 0.0 14.1 7.2 0.4 0.6 0.0 4.0 2.3 5.2 2.0 4.5 0.0 1.9 1.4 1.0 6.5 0.0 4.3 4.4 1.5 1.8 0.0 3.4 1.7 0.0 5.2 0.6 1.2 2.2 0.9 1.3 0.0 6.4 2.7 0.7 3.4 2.9 0.7 1.3 1.8 0.0 1.4 1.4 0.7 6.5 4.2 0.0 1.4 22.1 ENTPD8 "NTPDase-8, UNQ2492" ENSG00000188833 "Ectonucleoside triphosphate diphosphohydrolase 8" Q5MY95 9 137434364-137441816 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 48.1" "Group enriched" "Detected in some" 6 "Enterocytes: 107.0;Mucus-secreting cells: 160.6;Paneth cells: 49.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.1;OE19: 3.0;RPMI-8226: 8.8;T-47d: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA021509 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA021509: AB_1848185" "unprognostic (3.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.30e-1)" "unprognostic (1.40e-1)" "unprognostic (6.46e-3)" "unprognostic (8.70e-2)" "unprognostic (3.87e-2)" "unprognostic (8.48e-2)" "unprognostic (1.69e-1)" "unprognostic (2.34e-2)" "unprognostic (1.08e-5)" "prognostic favorable (7.17e-4)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-1)" 0.4 0.0 0.4 2.6 0.4 0.0 0.4 0.4 0.4 0.4 19.2 0.4 0.4 18.5 0.4 0.4 0.4 0.3 2.2 0.4 0.5 0.0 2.1 9.8 0.8 0.4 0.4 0.4 0.4 1.8 0.0 4.2 0.5 0.4 0.4 7.5 0.8 4.1 0.4 0.4 0.0 48.1 0.4 0.4 0.4 6.1 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.0 9.1 0.0 0.6 0.0 0.7 0.1 0.0 0.0 0.0 1.5 0.2 0.0 0.6 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 1.6 0.0 0.2 0.1 3.0 0.4 0.0 0.0 8.8 1.4 0.0 0.3 0.9 0.2 0.0 0.1 0.7 4.8 0.2 0.1 0.0 2.4 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.5 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 12.7 0.0 0.0 19.2 0.0 0.0 0.0 0.8 0.0 0.0 107.0 0.0 6.8 0.1 0.0 1.0 0.0 8.2 0.1 0.0 3.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 160.6 0.0 0.5 49.1 0.0 4.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 12.7 0.6 EOGT "AER61, C3orf64, FLJ33770" ENSG00000163378 "EGF domain specific O-linked N-acetylglucosamine transferase" Q5NDL2 3 68975214-69013961 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 39.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019460 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA019460: AB_1844628" "unprognostic (2.62e-1)" "unprognostic (3.72e-1)" "unprognostic (1.07e-1)" "unprognostic (1.95e-2)" "unprognostic (8.96e-2)" "unprognostic (6.30e-2)" "unprognostic (2.18e-3)" "unprognostic (6.66e-2)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" "unprognostic (1.68e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (8.97e-5)" "unprognostic (7.41e-2)" "unprognostic (4.67e-1)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" 14.9 5.8 3.4 10.1 4.4 3.0 11.9 2.5 4.8 16.8 12.1 4.4 10.2 4.8 23.3 10.4 15.1 11.4 18.1 18.2 3.9 3.6 6.6 5.5 15.8 9.6 4.2 5.0 12.7 7.8 3.9 5.5 15.2 5.1 18.9 5.8 8.7 14.0 24.0 28.0 6.1 7.7 29.4 4.9 10.2 10.1 7.4 2.4 8.3 5.4 14.2 7.3 27.0 9.8 1.7 3.4 5.5 2.2 3.3 9.2 1.8 8.2 2.8 5.4 6.6 7.7 15.2 4.0 11.2 13.7 7.1 9.4 3.7 4.7 0.4 1.7 12.1 6.1 2.7 3.7 14.6 9.0 26.7 2.6 8.6 6.3 5.3 8.6 4.8 3.6 12.6 12.4 9.2 11.7 8.7 39.1 0.3 2.3 5.1 23.8 2.1 0.7 1.5 6.3 2.7 1.3 0.3 5.7 3.5 6.1 19.0 0.5 3.0 12.9 1.0 10.1 6.0 2.8 6.6 20.7 20.1 6.1 2.3 10.8 2.6 8.4 4.0 8.0 7.5 11.2 5.5 2.2 0.0 3.0 1.9 3.5 1.7 4.8 6.4 3.4 1.2 4.1 4.1 0.3 3.3 0.7 0.6 9.2 1.8 3.4 4.4 2.5 4.8 3.9 3.6 4.2 5.0 5.1 2.4 11.9 10.1 1.5 10.1 6.4 2.2 13.7 7.6 8.1 14.8 1.8 15.7 0.8 0.0 4.0 13.9 15.0 2.5 0.0 7.0 3.8 7.5 7.5 0.0 3.8 5.9 0.0 5.8 21.5 5.1 12.0 2.8 7.7 8.5 9.0 3.4 1.3 9.0 2.9 38.2 1.5 4.8 0.0 23.8 1.1 2.4 4.0 0.7 4.4 2.5 5.8 EPB41 "4.1R, EL1" ENSG00000159023 "Erythrocyte membrane protein band 4.1" P11171 1 28887091-29120046 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Actin-binding, Calmodulin-binding" "Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 129.6;Erythroid cells: 116.8;Rod photoreceptor cells: 166.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 39.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 11 "cerebellum: 375.3" "HPA028076, HPA028096, HPA028412, HPA028414" Supported Supported "Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes No 3400000 "Plasma membrane, Cell Junctions" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366" "unprognostic (2.16e-1)" "unprognostic (1.96e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (4.58e-4)" "unprognostic (5.00e-2)" "prognostic favorable (5.87e-4)" "unprognostic (5.01e-3)" "unprognostic (5.40e-3)" "unprognostic (2.52e-2)" "unprognostic (6.65e-2)" "unprognostic (7.81e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (1.75e-6)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 9.2 9.6 3.3 19.4 10.2 28.0 9.6 59.7 11.6 8.2 12.4 2.0 9.8 9.3 10.5 5.7 10.8 5.5 7.9 7.5 3.3 4.8 10.0 13.2 11.0 25.4 3.9 3.0 12.3 10.4 9.1 9.0 8.7 10.3 8.3 12.5 14.6 10.1 10.8 15.0 8.9 14.6 9.2 5.8 13.5 14.0 7.9 6.9 42.2 8.1 8.8 19.8 11.3 12.4 9.9 3.0 30.1 2.1 5.7 15.9 7.7 7.4 1.8 18.6 8.8 1.5 0.2 6.2 1.9 2.8 2.3 2.9 4.9 9.0 13.8 5.0 2.5 3.8 3.4 23.2 1.8 2.5 24.8 7.1 39.5 5.6 8.0 2.9 13.4 26.4 0.5 5.4 2.2 4.0 5.7 4.1 22.1 37.2 11.0 0.0 2.5 21.7 8.8 19.5 12.3 2.9 33.4 8.2 19.8 2.2 9.5 25.1 18.6 5.8 5.5 12.6 6.6 4.2 5.2 0.4 0.1 3.9 3.6 3.8 16.5 21.4 24.7 3.5 13.8 2.1 17.2 2.1 12.6 8.5 0.7 9.6 9.9 12.4 9.3 2.4 9.3 14.8 8.9 30.1 5.7 0.8 3.0 15.9 7.7 3.3 10.2 59.7 11.6 3.3 4.8 3.9 3.0 10.3 6.9 17.9 64.9 30.6 6.3 9.3 105.3 20.1 30.6 22.7 21.6 15.7 129.6 2.3 14.9 15.8 13.9 14.5 25.2 116.8 16.1 3.2 3.3 11.2 23.1 28.8 6.5 20.6 40.0 20.3 22.1 13.3 2.0 11.5 0.0 11.8 25.9 13.2 25.6 22.4 2.1 10.5 166.4 12.9 4.7 8.6 53.0 14.6 3.4 42.8 28.3 11.5 EPCAM "17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1" ENSG00000119888 "Epithelial cell adhesion molecule" P16422 2 47345158-47387601 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 303.2" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 1952.6;Mucus-secreting cells: 1256.8;Paneth cells: 2168.3;Undifferentiated cells: 1330.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "A-431: 55.5;CACO-2: 71.9;CAPAN-2: 101.2;OE19: 96.3;RPTEC TERT1: 43.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB003809, HPA026761, CAB030012, CAB055098, HPA067463" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: AB_2685846" "unprognostic (6.79e-2)" "unprognostic (2.28e-1)" "unprognostic (1.59e-2)" "unprognostic (1.16e-2)" "unprognostic (1.61e-1)" "unprognostic (3.49e-2)" "unprognostic (2.01e-1)" "unprognostic (3.61e-2)" "unprognostic (3.40e-1)" "prognostic favorable (3.30e-4)" "unprognostic (5.27e-2)" "unprognostic (3.28e-2)" "prognostic favorable (1.04e-6)" "unprognostic (6.38e-3)" "unprognostic (1.28e-1)" "unprognostic (6.45e-3)" "unprognostic (6.08e-2)" 0.4 2.1 1.8 49.8 3.0 0.2 8.9 0.6 1.0 10.8 155.8 0.7 31.5 66.8 4.4 35.2 2.8 10.2 41.6 0.4 1.7 2.7 60.2 1.2 22.6 0.4 1.2 0.4 3.8 54.1 19.8 38.7 2.2 0.9 9.0 70.5 0.7 47.2 25.0 0.5 2.0 303.2 1.7 1.4 0.5 15.3 5.5 0.9 1.7 83.6 4.2 4.1 4.1 2.1 0.2 1.9 0.4 0.2 0.0 0.0 0.6 55.5 0.6 0.0 0.1 0.0 0.0 35.2 0.0 0.0 0.0 0.0 71.9 101.2 0.0 15.6 0.1 0.0 26.2 0.5 6.6 0.2 0.0 6.4 0.0 0.3 28.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 16.6 0.0 0.0 28.3 0.0 2.6 18.2 96.3 3.6 0.0 0.0 14.1 43.2 24.5 39.1 0.3 0.4 20.7 0.0 15.5 17.4 0.1 0.0 0.0 0.7 0.2 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.6 1.8 3.0 0.6 1.0 1.7 2.7 1.2 0.4 0.9 0.9 288.8 113.7 7.2 161.4 8.2 0.1 1.7 236.9 180.7 188.8 425.7 0.0 14.0 64.6 814.0 5.0 2.3 1952.6 0.0 356.0 2.6 1.9 182.8 33.3 0.4 2.4 0.0 478.4 0.0 0.0 3.2 19.0 5.0 33.7 19.8 1256.8 11.8 505.0 2168.3 17.7 160.0 0.7 12.9 0.4 67.3 135.0 9.2 5.0 2.5 1330.8 202.8 EPDR1 "EPDR, MERP-1, MERP1, UCC1" ENSG00000086289 "Ependymin related 1" Q9UM22 7 37683843-37951941 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6;skeletal muscle: 55.8" "Cell type enhanced" "Detected in many" 10 "Peritubular cells: 93.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.4" "Group enriched" "Detected in many" 9 "dendritic cells: 5.4;NK-cells: 1.9;T-cells: 1.9" "Cell line enhanced" "Detected in many" "U-937: 36.5;WM-115: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026298, HPA072321" Enhanced "Intracellular and membrane" NA NA "CAB026298: AB_425991, HPA072321: " "unprognostic (1.99e-2)" "unprognostic (9.30e-2)" "unprognostic (4.44e-3)" "unprognostic (3.07e-2)" "unprognostic (1.38e-1)" "unprognostic (4.85e-2)" "prognostic unfavorable (6.97e-4)" "unprognostic (2.53e-2)" "unprognostic (2.75e-1)" "unprognostic (3.13e-1)" "unprognostic (7.23e-2)" "unprognostic (1.85e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (3.43e-4)" "unprognostic (4.13e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.00e-4)" 11.2 23.3 21.9 2.2 16.0 2.1 4.8 30.5 30.5 21.5 4.9 7.5 1.6 7.0 22.4 7.4 4.6 15.5 5.3 13.9 20.3 34.3 8.6 6.0 13.8 2.9 25.3 18.8 18.6 5.7 5.8 4.6 2.8 57.6 18.5 4.7 8.0 7.3 22.6 55.8 1.5 6.8 16.4 13.9 8.3 3.4 6.7 5.2 5.2 16.1 7.7 1.7 4.7 8.5 0.0 5.4 0.2 0.3 1.9 1.9 0.4 0.0 23.8 2.0 0.0 18.8 6.8 0.0 1.8 0.0 0.9 2.9 2.3 1.5 0.0 27.0 26.5 28.2 0.0 0.5 0.2 0.0 0.0 3.0 10.4 3.2 14.5 0.1 8.6 0.0 11.4 0.0 6.7 0.1 6.4 0.0 10.6 0.0 7.9 15.9 1.5 3.3 7.3 7.4 0.0 3.5 10.6 6.9 9.1 14.7 5.8 2.6 9.2 0.0 1.2 8.3 5.1 0.0 6.1 0.0 5.2 8.9 14.4 11.0 10.6 4.5 0.1 24.1 36.5 35.6 0.0 0.3 0.2 1.7 0.3 0.0 0.0 0.0 1.9 1.0 0.0 0.1 1.1 0.2 1.9 0.0 5.4 0.0 0.4 21.9 16.0 30.5 30.5 20.3 34.3 25.3 18.8 57.6 5.2 29.8 37.4 1.3 9.3 1.1 5.1 16.9 7.6 5.3 20.5 1.8 0.0 0.5 14.9 8.1 0.2 1.4 6.8 0.0 7.1 0.1 8.4 9.6 2.3 11.9 3.1 11.1 3.5 6.7 1.3 0.9 26.2 2.2 27.0 24.4 4.7 10.5 13.6 5.3 93.0 11.3 5.3 6.5 12.8 0.0 0.6 0.3 0.1 0.5 4.7 2.0 EPGN "ALGV3072, EPG, epigen, PRO9904" ENSG00000182585 "Epithelial mitogen" Q6UW88 4 74308473-74315307 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.3;esophagus: 39.6;tongue: 25.7" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 3.2;Basal keratinocytes: 5.4;Early spermatids: 1.7;Late spermatids: 2.2;Melanocytes: 1.7;Urothelial cells: 2.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 7.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "hTCEpi: 62.6;U-2197: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014420 Approved Nucleoplasm,Vesicles,Cytosol "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" Vesicles "HPA014420: AB_10601551" "unprognostic (7.51e-2)" "unprognostic (8.08e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-4)" "unprognostic (2.20e-1)" "unprognostic (2.01e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (4.06e-4)" "unprognostic (3.84e-1)" "unprognostic (7.89e-2)" "prognostic unfavorable (2.40e-4)" 1.1 0.0 0.0 1.3 0.0 0.1 1.0 0.0 0.0 7.9 0.3 0.0 1.0 0.0 0.0 14.3 39.6 1.2 0.3 0.6 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.7 0.0 0.3 0.0 0.0 2.5 2.8 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 25.7 5.4 0.6 6.5 0.4 0.1 0.0 0.6 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.1 1.2 0.0 1.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.1 0.0 62.6 1.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.3 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 28.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.2 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 2.2 EPHA1 "EPH, EPHT, EPHT1" ENSG00000146904 "EPH receptor A1" P21709 7 143390289-143408892 "Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 104.4" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 16.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 3.4;naive CD4 T-cell: 6.9;naive CD8 T-cell: 5.1" "Lineage enriched" "Detected in single" 9 "T-cells: 6.9" "Cell line enhanced" "Detected in some" "CACO-2: 10.5;HaCaT: 9.8;HBEC3-KT: 8.0;MCF7: 8.7;NTERA-2: 32.7" "Not detected" "Not detected" CAB026144 Uncertain NA NA 24000000 "CAB026144: " "unprognostic (1.54e-2)" "unprognostic (3.04e-2)" "unprognostic (2.07e-1)" "unprognostic (4.58e-3)" "unprognostic (5.82e-3)" "unprognostic (2.45e-2)" "unprognostic (9.56e-2)" "unprognostic (1.81e-2)" "unprognostic (5.09e-1)" "unprognostic (7.59e-3)" "unprognostic (6.54e-2)" "unprognostic (3.24e-3)" "prognostic favorable (1.14e-6)" "unprognostic (3.73e-2)" "unprognostic (3.28e-2)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" 0.4 0.4 0.0 2.0 0.1 0.5 1.2 0.9 0.3 5.7 7.9 0.0 3.3 3.3 0.9 1.4 29.3 1.6 7.9 0.4 0.0 0.0 2.8 10.6 2.9 5.8 0.0 0.0 1.2 2.9 104.4 1.3 5.5 1.1 2.1 0.9 1.3 5.8 3.9 0.3 9.5 12.3 0.4 0.2 0.5 1.8 0.8 0.0 5.1 6.0 16.4 17.2 1.6 11.8 0.0 0.7 0.2 0.1 0.2 6.9 1.6 5.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 10.5 4.2 0.0 0.0 0.0 0.0 9.8 0.0 8.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 8.7 0.0 1.1 32.7 5.1 0.0 0.0 0.0 0.0 0.7 4.0 0.1 0.0 0.0 4.9 0.0 2.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 3.4 0.9 0.4 0.0 6.9 5.1 0.2 0.2 0.0 0.7 0.2 1.6 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.1 0.0 5.0 1.8 0.0 0.8 2.5 0.0 3.4 7.0 0.0 1.5 0.0 3.9 16.5 0.0 6.5 0.0 3.7 2.0 0.4 2.1 0.0 7.6 0.4 0.0 1.2 0.0 0.0 7.5 0.6 0.0 0.0 0.0 3.7 0.3 5.1 6.8 0.0 1.1 0.0 0.0 0.0 0.2 1.2 3.1 0.8 0.0 6.0 5.0 EPHA10 "FLJ16103, FLJ33655" ENSG00000183317 "EPH receptor A10" Q5JZY3 1 37713880-37765133 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.6;intestine: 12.6;testis: 24.8" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 86.4;Early spermatids: 49.4;Late spermatids: 147.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 5.2;HDLM-2: 19.6;SCLC-21H: 9.1" HPA027497 Uncertain "Intracellular and membrane" NA NA "HPA027497: AB_10601158" "unprognostic (9.27e-2)" "unprognostic (1.21e-1)" "unprognostic (2.94e-2)" "unprognostic (1.24e-6)" "unprognostic (1.06e-1)" "unprognostic (1.11e-2)" "unprognostic (5.39e-2)" "unprognostic (1.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.40e-1)" "unprognostic (7.06e-3)" "unprognostic (1.50e-1)" "unprognostic (8.81e-5)" "unprognostic (2.55e-2)" "unprognostic (2.97e-2)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 0.4 1.1 5.8 1.7 15.6 0.7 1.9 1.3 10.5 0.6 12.6 3.6 0.2 5.8 0.5 6.8 0.8 1.8 2.1 0.4 4.6 7.4 0.5 0.4 0.5 0.6 3.5 5.0 0.4 5.1 1.1 10.8 0.4 6.4 1.4 10.3 1.6 2.4 0.7 0.4 0.6 7.3 1.0 2.3 0.5 5.3 24.8 2.1 0.0 1.0 0.0 0.5 0.6 0.3 0.4 0.3 1.5 0.3 0.8 0.7 0.1 1.5 1.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 1.7 2.8 0.0 0.4 0.0 0.3 0.1 0.1 0.0 0.0 19.6 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.7 0.0 1.1 0.0 0.2 0.7 2.1 0.6 0.0 0.0 0.4 0.3 1.7 9.1 0.4 1.1 0.0 0.0 0.2 2.9 0.1 0.0 0.0 1.0 0.1 0.0 1.8 1.2 0.0 0.0 0.0 0.1 1.4 0.2 0.1 0.7 0.1 0.4 0.4 0.3 0.3 0.1 0.4 0.6 0.7 1.5 0.8 0.3 0.3 0.2 0.1 5.8 15.6 1.3 10.5 4.6 7.4 3.5 5.0 6.4 2.1 0.0 0.3 0.0 0.0 0.1 5.0 1.4 0.0 0.0 0.0 0.0 86.4 0.0 0.0 0.4 49.4 0.0 9.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.0 11.1 18.0 0.0 0.0 147.5 1.7 0.0 0.0 0.0 9.3 0.3 2.1 23.5 0.4 0.0 3.0 0.0 0.0 8.2 2.5 0.0 0.0 0.0 8.3 0.1 EPHA2 ECK ENSG00000142627 "EPH receptor A2" P29317 1 16124337-16156087 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 51.2" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 179.7;Suprabasal keratinocytes: 217.2;Urothelial cells: 155.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 115 "plasmacytoid DC: 11.4" "Lineage enriched" "Detected in single" 115 "dendritic cells: 11.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.4;EFO-21: 40.9;PC-3: 48.6;U-251 MG: 49.8;WM-115: 54.6" "Low region specificity" "Detected in all" CAB010464 Supported "Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nuclear speckles, Golgi apparatus" "CAB010464: AB_631436" "unprognostic (9.41e-2)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.67e-2)" "unprognostic (6.22e-2)" "unprognostic (9.12e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-3)" "unprognostic (2.52e-2)" "unprognostic (7.05e-3)" "unprognostic (1.52e-3)" "unprognostic (2.77e-1)" "unprognostic (2.65e-2)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (4.77e-3)" "unprognostic (4.40e-2)" 6.7 3.4 1.3 3.1 2.6 0.0 5.2 0.5 2.1 12.1 4.9 1.6 1.9 4.3 7.8 3.8 51.2 4.6 16.7 6.4 1.1 0.8 5.7 8.2 6.6 4.7 2.7 1.3 4.5 10.2 2.2 2.8 8.9 3.4 5.8 2.6 5.4 31.0 2.8 3.4 12.7 13.1 2.7 3.0 2.8 6.8 2.4 1.2 1.2 5.7 21.8 25.5 15.2 18.5 0.0 11.4 0.0 0.0 0.0 0.0 0.0 15.6 31.7 8.8 4.2 0.6 0.7 5.2 9.5 13.4 17.2 10.9 13.2 42.4 0.0 40.9 5.4 21.3 6.4 2.1 21.9 6.0 0.0 1.4 0.0 9.2 8.4 11.3 0.0 0.0 1.0 8.2 9.3 20.7 27.0 18.3 0.0 0.0 0.0 10.9 5.0 0.0 0.0 4.2 11.8 48.6 0.0 8.0 0.0 18.2 8.1 0.0 1.3 18.4 4.5 1.2 4.8 0.6 0.1 22.6 6.1 16.5 0.4 49.8 0.0 0.1 0.1 4.7 0.0 54.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 1.3 2.6 0.5 2.1 1.1 0.8 2.7 1.3 3.4 1.2 50.6 28.9 0.5 100.5 179.7 0.6 5.8 40.8 37.5 33.0 8.7 3.9 8.1 0.0 31.3 5.4 17.5 57.1 0.0 12.5 0.9 7.0 56.8 5.7 19.8 1.6 0.0 2.9 32.5 2.8 0.0 3.1 4.6 25.3 1.8 19.6 5.8 62.9 20.1 0.0 1.4 2.0 32.3 17.6 0.0 0.7 217.2 6.3 0.0 17.7 155.0 EPHA3 "ETK, ETK1, HEK, HEK4, TYRO4" ENSG00000044524 "EPH receptor A3" P29320 3 89107524-89482134 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 39.0" "Group enriched" "Detected in some" 5 "Fibroblasts: 12.2;Horizontal cells: 19.1;Peritubular cells: 7.8;Rod photoreceptor cells: 16.9;Sertoli cells: 6.5;Smooth muscle cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 66.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010462, HPA069390" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane, Plasma membrane, Cytosol" "Nucleoplasm, Actin filaments" "CAB010462: AB_2099218, HPA069390: " "unprognostic (1.48e-3)" "unprognostic (2.30e-2)" "unprognostic (4.95e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (1.47e-2)" "unprognostic (2.03e-1)" "unprognostic (9.10e-3)" "unprognostic (1.24e-3)" "unprognostic (7.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (3.28e-7)" "unprognostic (3.63e-2)" "unprognostic (1.88e-2)" "unprognostic (4.05e-2)" "unprognostic (1.20e-2)" 9.7 1.1 2.3 1.7 4.5 0.2 5.1 1.3 8.7 12.3 5.8 0.6 1.4 2.2 13.9 1.3 6.3 2.6 17.2 10.0 2.2 2.5 1.5 4.4 2.7 3.0 2.5 3.4 4.2 2.8 1.2 3.4 17.5 11.9 39.0 5.9 5.4 3.8 6.8 1.7 1.7 3.5 17.3 2.9 1.2 3.7 1.3 2.0 0.0 16.3 6.0 3.0 11.8 12.2 0.3 0.1 0.5 0.1 0.3 0.2 0.0 0.0 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.8 0.0 0.2 0.0 0.8 0.0 0.0 4.1 0.0 0.0 0.6 0.7 0.0 1.3 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.8 0.0 0.0 0.0 0.6 0.0 0.5 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 2.3 4.5 1.3 8.7 2.2 2.5 2.5 3.4 11.9 2.0 0.0 0.0 0.0 0.3 0.5 1.5 2.1 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 1.3 1.1 0.0 0.0 0.0 0.1 12.2 0.1 0.0 0.0 0.1 19.1 0.0 0.6 0.0 1.3 2.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 7.8 0.0 16.9 6.5 20.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 EPHA4 "Hek8, TYRO1" ENSG00000116106 "EPH receptor A4" P54764 2 221418027-221574202 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.6" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 25.0;Pancreatic endocrine cells: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 3.0;gdT-cell: 3.4;MAIT T-cell: 3.4;memory B-cell: 2.5;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.3;naive B-cell: 1.8;naive CD4 T-cell: 1.9;NK-cell: 6.0;T-reg: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 35.8;ASC diff: 15.8;CACO-2: 26.2;U-2197: 17.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB028368 Enhanced NA NA 8400000 "CAB028368: AB_2099353" "unprognostic (1.28e-1)" "unprognostic (5.87e-2)" "unprognostic (2.28e-1)" "unprognostic (2.46e-2)" "unprognostic (5.99e-2)" "unprognostic (1.33e-1)" "unprognostic (7.05e-4)" "unprognostic (1.80e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.56e-4)" "unprognostic (1.12e-1)" "unprognostic (2.85e-2)" "prognostic favorable (5.67e-4)" "unprognostic (3.12e-2)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (8.66e-2)" 7.1 1.8 8.1 1.9 18.3 3.5 5.2 14.7 29.6 4.9 5.9 3.1 3.2 1.1 6.5 3.1 5.0 6.6 3.3 16.7 19.9 4.4 5.2 0.9 3.7 2.5 2.4 16.4 11.7 1.2 2.0 1.2 1.7 4.9 5.9 4.7 0.8 3.7 6.7 3.1 12.8 4.1 8.2 2.1 3.3 4.0 11.4 2.6 0.5 9.8 3.7 3.2 4.6 4.9 2.5 0.2 3.0 0.0 6.0 5.0 0.7 1.1 1.1 35.8 0.0 15.8 9.8 0.0 8.5 3.7 7.7 2.8 26.2 0.4 0.0 0.0 11.8 0.0 3.1 5.5 0.0 3.2 4.2 3.0 0.0 0.3 0.0 0.4 0.0 0.6 3.9 1.9 2.4 0.0 4.8 7.2 0.0 0.0 0.0 2.0 4.2 0.1 0.0 2.5 2.6 0.8 0.0 3.9 0.0 12.0 1.9 6.3 0.0 2.8 0.6 0.6 3.0 1.3 0.0 0.0 0.8 1.5 17.5 0.4 0.0 0.0 0.0 3.2 0.0 1.6 3.0 0.0 0.0 3.4 0.0 3.4 2.5 5.0 3.3 0.0 1.8 1.9 0.3 0.2 6.0 0.0 0.2 2.1 0.7 8.1 18.3 14.7 29.6 19.9 4.4 2.4 16.4 4.9 2.6 0.0 5.4 0.8 0.4 5.5 10.2 25.0 7.6 1.4 3.4 8.7 0.0 0.0 6.6 0.2 2.0 11.7 0.1 0.0 0.2 0.0 3.9 1.2 1.1 0.0 0.3 1.6 3.4 12.3 0.0 4.3 1.1 0.2 6.8 0.0 14.0 6.3 18.0 0.0 8.1 1.5 2.7 0.0 7.2 6.7 1.3 10.9 0.0 1.0 6.8 1.8 EPHA5 "CEK7, EHK1, Hek7, TYRO4" ENSG00000145242 "EPH receptor A5" P54756 4 65319563-65670495 "Enzymes, Predicted membrane proteins" Neurogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.5" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 12.1;Late spermatids: 12.5;Muller glia cells: 6.4" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 7.8;PC-3: 7.1;TIME: 9.5;U-138 MG: 19.9;U-2197: 12.1;U-251 MG: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.02e-2)" "unprognostic (4.22e-2)" "unprognostic (2.38e-1)" "unprognostic (4.89e-4)" "unprognostic (7.43e-4)" "unprognostic (1.60e-1)" "unprognostic (6.68e-3)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-2)" "unprognostic (9.25e-2)" "unprognostic (5.88e-3)" "unprognostic (2.55e-2)" "unprognostic (5.97e-4)" "unprognostic (3.81e-3)" 0.9 2.7 17.6 1.0 9.0 0.8 0.8 1.9 25.5 5.9 1.2 1.5 1.8 0.9 1.9 0.9 1.1 1.0 0.9 2.7 17.3 6.8 0.9 0.8 1.1 0.9 5.4 13.2 6.2 0.8 0.8 6.5 2.7 10.2 4.2 1.1 2.6 1.2 4.1 0.8 1.2 0.9 1.4 17.7 1.5 1.1 2.2 0.7 0.0 3.0 0.0 0.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.6 0.3 0.0 0.3 0.9 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 3.3 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.8 0.2 0.0 0.0 1.2 1.9 0.0 0.0 0.0 0.0 0.0 7.1 0.0 2.2 0.4 0.0 0.0 0.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 9.5 19.9 2.5 12.1 15.3 0.0 0.0 0.0 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 9.0 1.9 24.7 17.3 6.8 5.4 13.2 10.2 0.7 0.0 0.0 0.0 0.0 0.5 0.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.1 1.6 0.0 0.0 0.0 12.5 0.9 0.0 3.3 0.0 0.0 6.4 0.0 0.0 0.0 0.0 1.4 0.0 0.4 1.0 0.2 0.1 0.0 0.0 0.0 0.0 EPHA6 FLJ35246 ENSG00000080224 "EPH receptor A6" Q9UF33 3 96814581-97752460 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.9;ovary: 13.2;testis: 15.5" "Group enriched" "Detected in some" 67 "Early spermatids: 305.1;Late spermatids: 156.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEK 293: 8.2;U-266/70: 24.9" "Low region specificity" "Detected in many" "HPA007397, HPA058047" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA007397: AB_2667821, HPA058047: AB_2683588" "unprognostic (9.87e-2)" "unprognostic (1.67e-2)" "unprognostic (3.42e-4)" "unprognostic (7.21e-5)" "unprognostic (8.51e-2)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (3.14e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (1.71e-4)" "unprognostic (1.93e-3)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (7.14e-3)" 0.8 0.5 8.7 0.5 9.8 0.3 0.8 27.9 9.9 2.2 5.8 1.1 0.3 0.6 2.2 1.0 2.1 4.2 2.1 1.1 15.4 1.3 1.3 0.5 0.5 0.4 1.1 6.8 13.2 1.4 0.7 0.6 0.5 5.7 2.5 1.8 0.2 0.6 1.7 0.4 0.5 1.1 3.2 0.8 0.4 1.7 15.5 2.8 0.0 4.3 0.0 0.5 2.1 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 8.2 0.0 2.1 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.8 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 2.1 0.0 0.8 24.9 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 9.8 27.9 9.9 15.4 1.3 1.1 6.8 5.7 2.8 0.0 0.0 0.0 0.1 0.2 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 305.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 156.3 2.8 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.4 0.6 0.2 0.0 0.1 3.4 2.3 0.0 0.1 0.0 0.0 0.0 EPHA7 Hek11 ENSG00000135333 "EPH receptor A7" Q15375 6 93240020-93419547 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "parathyroid gland: 110.4" "Group enriched" "Detected in some" 4 "Bipolar cells: 14.1;Cardiomyocytes: 10.8;Early spermatids: 3.7;Horizontal cells: 11.1;Proximal tubular cells: 11.5" "Cancer enhanced" "Detected in many" "renal cancer: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 8.9;HEK 293: 25.5;RH-30: 24.4;THP-1: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010496 Approved "Intracellular and membrane" NA NA 340000 "CAB010496: AB_2099673" "unprognostic (3.34e-1)" "unprognostic (7.82e-2)" "unprognostic (1.41e-1)" "unprognostic (9.32e-2)" "unprognostic (1.19e-1)" "unprognostic (3.56e-2)" "unprognostic (1.62e-2)" "unprognostic (4.07e-1)" "unprognostic (4.16e-2)" "unprognostic (3.19e-2)" "unprognostic (5.69e-2)" "unprognostic (1.69e-1)" "unprognostic (1.74e-2)" "unprognostic (1.35e-1)" "unprognostic (1.56e-2)" "unprognostic (4.82e-2)" 1.3 1.3 6.0 1.7 24.6 1.2 2.2 21.6 8.6 2.4 24.6 0.0 0.1 2.5 2.0 7.5 14.7 1.7 3.1 4.2 13.8 2.9 6.9 1.3 1.5 1.3 2.4 5.8 3.0 1.3 110.4 5.6 1.6 6.7 17.9 3.6 0.4 8.2 1.9 1.3 1.4 6.5 20.2 4.8 4.7 14.9 2.1 4.4 0.0 1.3 0.0 1.3 9.7 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 25.5 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.5 0.0 0.6 4.5 24.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 20.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 24.6 21.6 8.6 13.8 2.9 2.4 5.8 6.7 4.4 0.0 0.0 0.0 0.4 0.3 14.1 10.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.7 0.7 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.1 11.1 0.0 0.0 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 11.5 0.9 0.0 0.8 0.2 0.7 0.9 0.0 0.0 0.0 0.0 EPHA8 "EEK, Hek3" ENSG00000070886 "EPH receptor A8" P29322 1 22563564-22603594 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 9.4;brain: 5.3;lymphoid tissue: 10.3;pancreas: 8.3;testis: 3.5" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 5.2;Early spermatids: 2.5;Horizontal cells: 3.2;Late spermatids: 3.9;Rod photoreceptor cells: 8.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "SCLC-21H: 37.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 25.0" "CAB009660, HPA031433" Uncertain "Intracellular and membrane" NA NA "CAB009660: AB_2099696, HPA031433: AB_10601371" "unprognostic (8.58e-2)" "unprognostic (8.59e-2)" "unprognostic (3.72e-1)" "unprognostic (1.15e-2)" "unprognostic (4.69e-4)" "unprognostic (3.58e-1)" "unprognostic (7.14e-2)" "unprognostic (1.52e-1)" "unprognostic (4.75e-2)" "unprognostic (9.80e-2)" "unprognostic (2.10e-1)" "unprognostic (9.84e-14)" "unprognostic (2.14e-3)" "unprognostic (1.69e-1)" "unprognostic (2.76e-1)" "unprognostic (8.68e-2)" 0.2 9.4 1.6 0.2 3.1 0.2 0.1 1.8 3.9 0.2 0.2 2.2 0.0 1.7 0.1 0.3 0.2 0.1 0.2 0.2 2.0 2.6 0.1 0.1 0.2 0.2 2.1 4.1 0.1 8.3 0.2 1.7 0.1 5.3 0.2 0.2 1.6 0.8 0.2 0.3 0.4 0.2 0.1 1.3 10.3 0.2 3.5 0.6 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.3 3.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 3.1 1.8 3.9 2.0 2.6 2.1 4.1 5.3 0.6 0.0 0.0 0.0 0.0 0.0 5.2 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.4 0.0 8.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 EPHB1 "EPHT2, Hek6" ENSG00000154928 "EPH receptor B1" P54762 3 134597801-135260467 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 74.7" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 9.8;Early spermatids: 30.2;Late spermatids: 26.8;Muller glia cells: 16.2" "Cancer enriched" "Detected in many" 6 "glioma: 7.0" "Region enhanced" "Detected in all" "cerebellum: 74.7" "Group enriched" "Detected in some" 33 "neutrophil: 15.9;plasmacytoid DC: 15.4" "Group enriched" "Detected in many" 33 "dendritic cells: 15.4;granulocytes: 15.9" "Group enriched" "Detected in some" 4 "HDLM-2: 34.7;HMC-1: 20.6;RPTEC TERT1: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067740 Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA067740: AB_2685895" "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.52e-1)" "unprognostic (1.41e-6)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (8.15e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-2)" "unprognostic (1.78e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-4)" 2.0 1.5 9.0 1.8 16.6 1.5 5.5 74.7 23.6 3.6 3.4 3.4 3.1 2.8 4.1 2.0 3.8 2.8 3.3 1.1 9.4 5.3 2.3 2.9 1.0 3.3 2.8 7.0 1.7 1.1 0.6 3.8 0.9 7.1 3.3 1.4 1.9 3.9 5.1 7.4 6.0 1.7 1.7 6.0 3.4 1.3 16.7 6.0 0.0 11.6 2.9 3.3 4.5 2.6 0.0 15.4 15.9 0.0 0.0 0.4 0.1 0.0 0.0 4.8 0.0 0.1 0.0 0.1 3.6 0.0 0.2 0.0 0.0 0.0 0.6 1.0 1.9 0.3 0.0 3.2 0.0 0.7 34.7 0.4 2.6 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.2 2.6 0.1 0.1 0.1 1.4 0.6 0.0 0.0 0.5 0.1 9.4 0.0 0.6 0.1 0.0 0.0 0.0 0.7 0.1 0.4 0.2 0.6 2.0 0.3 4.3 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 15.4 0.0 0.1 9.0 16.6 74.7 19.0 9.4 5.3 2.8 7.0 7.1 6.0 0.0 0.0 0.9 0.0 3.3 1.2 1.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.8 30.2 0.6 0.0 0.0 0.3 0.0 0.2 0.1 0.0 5.8 0.4 0.0 0.0 0.0 0.0 26.8 0.6 0.0 1.7 0.0 0.0 16.2 0.6 0.0 0.0 0.0 0.9 0.0 0.8 0.4 0.9 5.1 0.0 0.0 0.0 0.1 EPHB2 "DRT, EPHT3, ERK, Hek5, Tyro5" ENSG00000133216 "EPH receptor B2" P29323 1 22710839-22921500 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.0" "Cell type enhanced" "Detected in many" 11 "Ductal cells: 42.3;Intestinal endocrine cells: 46.8;Mucus-secreting cells: 53.6;Pancreatic endocrine cells: 38.4;Undifferentiated cells: 82.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;intermediate monocyte: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "GAMG: 34.4;HUVEC TERT2: 29.7;TIME: 29.4;U-251 MG: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013647, HPA071200" Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" No No 290000 "Plasma membrane" Nucleoplasm "CAB013647: , HPA071200: AB_2686360" "unprognostic (2.47e-2)" "unprognostic (2.43e-2)" "prognostic favorable (4.98e-4)" "prognostic unfavorable (1.05e-5)" "unprognostic (3.99e-2)" "unprognostic (8.91e-3)" "unprognostic (1.23e-1)" "unprognostic (2.33e-3)" "unprognostic (1.56e-1)" "unprognostic (7.73e-2)" "unprognostic (1.23e-2)" "unprognostic (2.15e-2)" "unprognostic (2.16e-4)" "unprognostic (1.45e-1)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (3.46e-2)" 3.7 2.9 3.4 15.4 5.4 0.9 2.5 1.9 8.2 3.8 23.9 16.2 4.6 21.6 2.5 3.2 1.1 5.4 4.4 5.4 5.6 6.5 3.5 1.1 3.0 5.5 12.7 3.8 17.9 5.4 6.1 5.4 12.0 8.2 3.3 25.0 2.2 6.6 4.0 0.7 1.8 22.6 4.0 12.1 3.3 2.3 2.9 9.3 0.1 8.4 1.0 2.1 5.3 3.3 0.1 0.6 0.3 2.5 0.1 0.1 0.4 15.9 6.7 6.5 10.4 0.6 0.6 0.0 3.7 0.2 11.3 2.4 2.3 6.4 0.2 8.0 1.6 34.4 15.1 4.4 21.7 3.0 0.0 1.6 0.0 0.7 0.0 6.8 0.0 1.6 2.2 7.0 20.2 0.1 10.0 29.7 0.9 0.6 0.0 2.2 2.3 0.3 0.1 1.5 17.8 4.4 1.9 6.7 0.3 5.5 1.5 7.1 7.4 6.5 0.2 0.0 0.6 0.4 0.2 29.4 4.5 11.8 11.4 25.5 0.0 0.1 0.0 8.4 0.3 0.1 0.3 2.5 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.4 3.4 5.4 1.9 8.2 5.6 6.5 12.7 3.8 8.2 9.3 3.0 0.0 0.0 1.5 0.7 11.6 1.2 12.7 1.4 3.4 0.0 0.0 0.4 0.0 42.3 2.3 0.5 6.8 0.0 6.8 2.2 1.5 1.4 0.0 0.5 9.1 6.4 46.8 0.6 7.5 0.4 0.9 3.7 0.0 0.0 53.6 20.9 38.4 3.5 0.7 0.0 1.7 0.0 1.7 0.5 2.6 0.4 0.9 0.0 82.9 1.0 EPHB3 "ETK2, Hek2, Tyro6" ENSG00000182580 "EPH receptor B3" P54753 3 184561784-184582409 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Angiogenesis, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 49.3" "Cell type enhanced" "Detected in many" 10 "Intestinal endocrine cells: 68.8;Mucus-secreting cells: 39.5;Suprabasal keratinocytes: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 1.1;myeloid DC: 3.1" "Group enriched" "Detected in many" 5 "dendritic cells: 3.1;monocytes: 1.1" "Cell line enhanced" "Detected in many" "BEWO: 17.0;HaCaT: 23.4;OE19: 16.1;SK-BR-3: 18.1;T-47d: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007698, HPA008184, CAB034350" Enhanced NA NA 20000 "CAB034350: AB_2262377, HPA007698: AB_1848205, HPA008184: AB_1848206" "unprognostic (2.94e-2)" "unprognostic (5.88e-2)" "unprognostic (2.17e-2)" "unprognostic (7.80e-2)" "unprognostic (1.52e-1)" "unprognostic (9.19e-2)" "unprognostic (8.35e-2)" "unprognostic (1.94e-1)" "unprognostic (5.51e-2)" "unprognostic (1.76e-1)" "unprognostic (7.42e-2)" "unprognostic (3.31e-1)" "prognostic unfavorable (7.88e-5)" "unprognostic (8.83e-3)" "unprognostic (3.03e-2)" "unprognostic (9.59e-3)" "unprognostic (2.10e-3)" 1.4 0.9 4.5 5.0 2.6 0.5 9.0 9.7 5.7 22.7 8.8 2.3 1.7 5.7 10.0 1.9 19.9 3.0 9.7 1.6 4.7 1.8 1.7 1.0 4.7 1.0 3.3 3.7 9.0 49.3 1.1 1.7 6.3 7.2 7.7 9.7 3.8 27.7 3.5 0.7 32.3 5.6 3.5 1.3 1.2 16.0 1.1 4.0 0.2 1.0 15.7 8.4 4.0 13.6 0.0 3.1 0.3 1.1 0.0 0.4 0.4 3.7 1.3 8.8 0.9 2.7 0.2 17.0 0.6 1.1 1.3 0.7 1.2 0.1 0.0 1.7 3.6 0.6 23.4 3.1 1.1 0.3 0.1 0.7 0.0 0.2 0.0 0.2 0.0 0.2 0.7 7.7 1.0 0.1 0.4 0.0 0.0 0.0 0.0 0.6 9.9 0.0 3.8 0.9 16.1 1.4 0.8 5.3 0.0 0.0 3.4 1.1 1.3 0.7 18.1 0.8 4.8 12.0 0.1 0.0 2.1 3.1 1.1 1.4 0.0 0.0 0.1 0.2 0.0 8.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.1 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.4 4.5 2.6 9.7 5.7 4.7 1.8 3.3 3.7 7.2 4.0 3.0 2.4 0.0 6.9 21.4 0.0 1.4 2.5 1.4 2.3 0.0 0.0 8.1 1.7 0.3 0.4 0.6 3.5 0.0 1.4 14.8 8.4 5.5 4.6 0.0 17.9 14.3 68.8 3.1 0.3 0.0 2.6 1.0 0.0 1.0 39.5 0.1 2.4 7.0 5.6 0.1 0.8 0.0 2.1 0.5 0.6 31.2 13.6 0.0 27.1 19.5 EPHB4 "HTK, Tyro11" ENSG00000196411 "EPH receptor B4" P54760 7 100802565-100827521 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 50.1;Endothelial cells: 43.5;Ito cells: 106.8;Syncytiotrophoblasts: 172.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 3.6;neutrophil: 7.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013537 Uncertain NA NA 1000000 "CAB013537: " "prognostic unfavorable (8.56e-4)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.33e-4)" "unprognostic (1.33e-1)" "unprognostic (5.23e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.73e-1)" "unprognostic (1.84e-1)" "unprognostic (8.16e-3)" "unprognostic (1.43e-1)" "unprognostic (9.51e-3)" "unprognostic (6.63e-2)" "unprognostic (3.13e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (8.84e-4)" 14.0 20.7 1.8 4.2 2.9 2.2 17.1 1.9 3.0 29.1 9.5 2.9 14.6 4.1 28.8 10.3 11.0 13.1 35.0 19.0 3.4 1.1 16.8 29.8 16.5 12.0 2.2 0.9 24.6 11.6 5.6 3.1 35.5 3.2 13.7 5.4 11.6 10.8 14.7 5.1 14.2 7.0 12.4 2.2 50.5 8.6 12.2 2.1 2.3 10.2 13.1 7.0 7.7 21.5 0.0 1.6 7.4 3.6 0.0 0.0 1.2 12.6 11.2 11.2 32.6 7.2 4.6 33.3 5.0 10.8 7.8 10.2 9.2 9.7 1.6 22.7 5.1 10.9 13.2 4.9 13.1 4.1 2.1 9.1 0.4 6.5 14.3 4.2 0.2 0.3 5.4 19.7 4.9 11.6 8.6 29.1 0.5 23.9 0.6 6.3 22.1 0.2 4.9 19.2 18.7 16.9 17.2 5.5 2.9 9.9 6.7 0.0 9.7 7.6 3.6 7.4 16.3 9.0 2.2 24.4 9.7 15.4 17.9 7.3 0.1 0.2 0.5 1.4 4.1 17.6 0.0 3.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 7.4 0.0 0.2 0.3 0.0 1.2 1.8 2.9 1.9 3.0 3.4 1.1 2.2 0.9 3.2 2.1 8.9 13.0 6.4 8.7 18.2 0.0 3.6 10.2 1.4 5.7 5.2 0.0 50.1 0.0 9.9 20.9 43.5 2.4 0.0 5.7 7.3 7.4 8.7 1.1 18.1 8.1 0.0 2.9 106.8 5.6 8.1 7.5 1.1 3.3 1.0 14.8 1.5 17.1 7.0 3.9 3.7 0.0 6.5 5.0 1.0 12.4 15.6 172.7 1.7 17.9 7.1 EPHB6 HEP ENSG00000106123 "EPH receptor B6" 7 142855061-142871094 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.1;lymphoid tissue: 26.7;skin 1: 32.1" "Cell type enhanced" "Detected in many" 16 "Muller glia cells: 270.3;Sertoli cells: 103.5;Suprabasal keratinocytes: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "MOLT-4: 18.2;RT4: 34.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035784 Uncertain "Nuclear speckles" "Intracellular and membrane" NA NA "Nuclear speckles" "HPA035784: AB_2674781" "unprognostic (1.90e-2)" "prognostic favorable (1.80e-4)" "unprognostic (7.08e-3)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (2.53e-3)" "unprognostic (3.15e-2)" "unprognostic (4.39e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.06e-3)" "unprognostic (3.18e-1)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (4.93e-2)" "unprognostic (3.16e-1)" "prognostic favorable (4.68e-5)" 3.3 1.7 7.4 3.0 30.1 3.3 2.6 3.1 29.3 9.0 1.5 0.8 3.4 0.9 3.0 4.5 7.5 6.4 2.8 1.4 5.4 4.2 1.7 1.3 2.4 3.6 3.3 14.4 3.9 7.8 0.8 1.1 2.9 1.7 6.8 0.9 1.5 4.7 8.1 1.8 32.1 1.6 2.0 1.4 2.6 3.3 3.8 3.6 26.7 6.6 2.5 3.3 5.1 6.5 4.1 0.9 1.0 1.3 0.0 3.1 1.4 0.1 0.0 0.0 0.4 2.0 1.0 0.0 0.2 0.4 0.1 0.0 0.6 1.3 0.0 0.0 0.1 0.0 4.5 0.2 0.0 0.0 1.0 0.1 0.3 0.0 0.2 0.6 4.3 0.2 0.3 0.0 1.2 0.0 0.0 0.2 3.0 0.6 0.0 0.0 0.0 18.2 3.3 3.1 0.7 1.3 0.4 0.0 0.0 0.0 34.6 0.0 0.0 1.2 0.9 0.0 0.4 2.9 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 1.3 0.5 0.1 1.0 0.6 4.1 2.5 1.4 0.9 1.0 3.1 1.5 1.0 0.0 0.4 0.1 1.9 1.4 7.4 30.1 3.1 29.3 5.4 4.2 3.3 14.4 1.7 3.6 3.0 1.7 4.5 25.1 48.3 4.3 2.0 38.2 6.7 10.3 7.0 2.0 0.2 5.0 25.0 0.7 1.4 0.0 0.0 5.7 0.0 12.3 11.7 0.0 1.8 4.3 0.0 1.7 1.3 11.5 4.0 27.9 5.3 11.8 0.0 0.0 270.3 19.6 0.0 9.2 0.4 5.0 103.5 18.4 0.2 8.3 103.5 0.2 8.3 0.0 23.4 EPHX3 "ABHD9, FLJ22408" ENSG00000105131 "Epoxide hydrolase 3" Q9H6B9 19 15226919-15233435 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 34.8;lymphoid tissue: 29.6;skin 1: 33.1;tongue: 39.6" "Group enriched" "Detected in many" 4 "Suprabasal keratinocytes: 37.9;Urothelial cells: 18.6" "Cancer enhanced" "Detected in many" "cervical cancer: 30.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2;non-classical monocyte: 4.9" "Group enriched" "Detected in many" 18 "dendritic cells: 2.8;monocytes: 4.9" "Cell line enhanced" "Detected in some" "EFO-21: 4.0;NTERA-2: 3.7;OE19: 12.9;SuSa: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012842 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA012842: AB_10601648" "unprognostic (1.39e-1)" "unprognostic (1.16e-2)" "unprognostic (1.54e-2)" "unprognostic (1.74e-1)" "unprognostic (8.24e-2)" "prognostic favorable (2.27e-5)" "unprognostic (8.83e-3)" "unprognostic (1.50e-1)" "unprognostic (3.90e-1)" "unprognostic (4.36e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.43e-1)" "unprognostic (3.68e-2)" "unprognostic (1.48e-1)" "unprognostic (1.30e-2)" "unprognostic (6.01e-2)" 0.2 0.1 0.1 0.2 0.3 0.1 1.0 0.1 0.3 12.5 0.2 0.2 0.4 0.1 0.9 0.3 34.8 1.1 1.7 0.1 0.5 0.1 1.6 0.2 1.6 0.0 0.2 0.0 0.6 0.0 2.2 2.4 0.2 0.4 1.5 0.1 0.6 3.4 0.6 0.2 33.1 0.2 0.2 0.2 1.2 0.5 2.7 0.2 2.4 0.2 39.6 29.6 2.8 13.6 0.0 2.8 0.2 4.9 0.0 0.0 0.5 0.1 0.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.5 0.3 4.0 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.6 0.0 0.5 3.7 12.9 0.5 0.0 0.0 0.0 0.1 0.8 1.6 0.2 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.1 0.0 1.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 4.9 2.8 0.0 0.5 0.1 0.3 0.1 0.3 0.5 0.1 0.2 0.0 0.4 0.2 0.0 0.6 0.0 1.5 6.3 0.2 0.3 2.5 1.4 0.0 5.2 0.0 1.5 1.7 0.5 0.3 0.1 0.0 0.0 0.0 2.5 0.7 2.0 0.0 0.0 0.6 0.0 0.0 1.3 1.3 0.0 0.0 1.4 0.0 1.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 1.2 2.1 2.1 37.9 2.2 0.0 0.0 18.6 EPHX4 "ABHD7, EPHXRP, FLJ90341" ENSG00000172031 "Epoxide hydrolase 4" Q8IUS5 1 92029982-92063536 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 13.3;brain: 20.7" "Cell type enhanced" "Detected in some" 11 "Endothelial cells: 2.9;Melanocytes: 3.3;Muller glia cells: 8.1;Pancreatic endocrine cells: 3.0;Spermatocytes: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 13.3" "Lineage enriched" "Detected in single" 24 "T-cells: 13.3" "Cell line enhanced" "Detected in some" "A-431: 10.0;CAPAN-2: 8.8;EFO-21: 17.9;RPTEC TERT1: 24.8;U-251 MG: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035067 Uncertain Approved Vesicles NA NA Vesicles "HPA035067: AB_10601465" "unprognostic (1.27e-1)" "unprognostic (4.17e-2)" "unprognostic (6.76e-3)" "unprognostic (6.10e-8)" "prognostic unfavorable (9.43e-4)" "unprognostic (5.36e-3)" "unprognostic (2.72e-4)" "unprognostic (4.85e-2)" "unprognostic (9.44e-3)" "unprognostic (7.93e-2)" "prognostic unfavorable (2.00e-4)" "unprognostic (2.53e-1)" "unprognostic (6.36e-6)" "unprognostic (6.93e-3)" "unprognostic (1.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" 1.0 1.3 5.8 1.3 14.1 0.3 3.2 1.7 20.7 2.4 1.0 0.3 0.1 1.6 1.7 1.3 2.1 1.3 1.2 1.2 3.3 2.4 0.9 0.4 1.5 0.7 3.1 9.8 0.6 0.3 0.5 1.3 1.9 4.4 2.2 1.4 1.5 0.4 4.1 0.4 0.6 0.9 2.5 1.1 0.4 0.5 2.6 2.1 0.0 3.9 0.0 0.7 1.9 0.4 0.1 0.0 0.0 0.0 0.5 13.3 1.4 10.0 0.3 2.0 0.0 0.0 0.0 0.5 0.2 3.7 0.3 0.2 0.0 8.8 0.0 17.9 0.0 2.7 0.1 0.3 0.8 0.3 0.0 5.4 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.4 0.0 0.0 6.5 3.1 0.0 0.0 0.0 0.3 0.6 1.4 0.3 1.9 0.0 3.5 0.3 0.2 0.0 24.8 2.0 1.2 1.5 6.1 0.0 1.8 0.1 0.0 1.4 0.1 0.0 0.0 0.0 7.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.3 0.0 2.3 0.1 1.7 3.3 0.0 0.0 0.4 3.4 0.0 0.5 0.0 0.0 0.0 1.4 5.8 14.1 1.7 20.7 3.3 2.4 3.1 9.8 4.4 2.1 0.0 0.0 0.0 0.1 0.1 0.8 1.2 0.0 0.0 1.2 0.0 2.0 0.4 0.0 0.3 1.3 2.9 0.0 0.0 0.7 0.6 0.5 0.2 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 8.1 3.0 0.0 0.0 0.0 1.8 0.0 0.8 3.8 0.7 0.4 0.0 0.0 0.0 0.3 EPO EP ENSG00000130427 Erythropoietin P01588 7 100720800-100723700 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted secreted proteins" "Erythrocyte maturation" Hormone "Cancer-related genes, Congenital erythrocytosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.9;endometrium 1: 8.7;liver: 29.3" "Cell type enhanced" "Detected in some" 16 "Exocrine glandular cells: 3.6;Extravillous trophoblasts: 12.2;Hepatocytes: 8.5;Pancreatic endocrine cells: 6.1" "Group enriched" "Detected in many" 5 "liver cancer: 2.7;renal cancer: 5.4" "Region enriched" "Detected in single" 9 "cerebral cortex: 4.4" "Cell type enriched" "Detected in single" 13 "non-classical monocyte: 1.2" "Lineage enriched" "Detected in single" 13 "monocytes: 1.2" "Group enriched" "Detected in some" 7 "BEWO: 3.6;Hep G2: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" CAB010336 Supported "Secreted to blood" NA NA 12300 "CAB010336: AB_2098408" "unprognostic (2.93e-1)" "unprognostic (1.57e-2)" "unprognostic (1.08e-3)" "unprognostic (7.30e-2)" "unprognostic (1.09e-1)" "unprognostic (1.78e-3)" "prognostic unfavorable (5.67e-5)" "unprognostic (3.52e-2)" "unprognostic (5.16e-2)" "unprognostic (9.70e-2)" "unprognostic (2.44e-3)" "unprognostic (3.31e-1)" "prognostic unfavorable (2.18e-6)" "unprognostic (4.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.59e-2)" "unprognostic (3.34e-1)" 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 4.4 10.9 0.0 0.0 0.0 0.0 8.7 0.6 0.4 0.0 0.0 0.1 0.0 0.0 2.8 29.3 0.0 0.0 0.0 0.0 0.1 7.8 0.0 0.0 0.7 0.0 1.6 0.0 0.7 0.9 1.6 0.0 0.7 0.0 0.6 0.0 0.0 0.0 2.4 0.4 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.2 0.0 0.0 13.4 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.6 0.4 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.3 0.4 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 12.2 0.0 0.1 0.0 8.5 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.1 2.4 0.0 0.0 0.0 EPOR ENSG00000187266 "Erythropoietin receptor" P19235 19 11377205-11384342 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted membrane proteins" Receptor "Cancer-related genes, Congenital erythrocytosis, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Ito cells: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA077654 Supported "Nuclear speckles,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA077654: " "unprognostic (9.13e-2)" "unprognostic (7.14e-2)" "unprognostic (1.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (1.11e-1)" "unprognostic (3.70e-1)" "unprognostic (1.50e-2)" "unprognostic (5.60e-2)" "unprognostic (9.00e-2)" "prognostic favorable (3.17e-5)" "unprognostic (6.37e-3)" "unprognostic (1.59e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-1)" "unprognostic (7.48e-2)" "unprognostic (1.01e-3)" 5.5 8.6 2.1 1.1 2.9 14.7 2.6 1.3 1.7 3.9 3.3 2.8 13.3 1.0 3.6 11.6 2.4 3.2 1.8 11.2 1.9 1.4 12.1 8.4 8.5 6.9 1.9 1.6 1.9 9.2 28.1 5.2 12.7 2.3 3.1 1.4 3.3 8.7 18.3 2.0 1.1 1.7 1.5 4.0 8.0 3.7 2.2 1.0 1.6 21.5 1.0 1.5 1.9 2.1 2.6 2.5 12.2 7.7 0.9 4.8 2.9 3.5 1.2 3.5 4.1 5.4 3.4 2.1 2.2 6.8 3.6 4.6 1.2 1.3 2.4 3.9 4.0 5.0 0.9 2.7 1.4 4.2 2.0 1.6 13.1 1.1 2.0 3.8 2.7 5.5 2.5 0.5 4.8 3.3 8.4 8.3 5.1 11.6 11.7 4.0 3.1 2.5 3.3 1.9 1.9 9.4 6.7 6.0 5.3 3.3 1.8 1.4 11.0 1.4 2.0 6.1 3.9 3.6 4.7 3.4 1.9 2.7 6.5 2.0 6.0 4.3 2.6 10.5 2.7 2.0 8.1 4.2 3.3 2.1 5.1 4.5 2.6 4.2 3.1 2.5 1.6 4.8 2.8 12.2 0.9 7.7 0.1 3.7 2.9 2.1 2.9 1.3 1.7 1.9 1.4 1.9 1.6 2.3 1.0 17.9 16.8 5.3 3.5 2.1 2.5 5.1 7.6 2.7 4.5 19.2 0.0 1.8 3.3 2.0 0.7 6.5 0.3 70.0 2.9 11.5 7.6 2.4 26.5 1.9 32.5 1.6 8.1 78.5 15.6 0.0 2.6 3.1 8.5 1.0 2.3 11.1 3.8 0.0 3.9 0.8 2.2 19.4 20.8 3.3 6.4 0.9 2.5 8.7 1.4 1.1 EPSTI1 "BRESI1, MGC29634" ENSG00000133106 "Epithelial stromal interaction 1" Q96J88 13 42886388-42992271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 42.2" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 146.8;monocytes: 201.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 36.9;BJ hTERT+ SV40 Large T+ RasG12V: 38.7;HDLM-2: 27.2;RPMI-8226: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017362 Approved NA NA "HPA017362: AB_1848226" "unprognostic (2.06e-1)" "unprognostic (3.51e-1)" "unprognostic (1.80e-1)" "unprognostic (3.59e-2)" "unprognostic (2.35e-1)" "unprognostic (9.55e-2)" "unprognostic (2.31e-1)" "unprognostic (2.49e-2)" "unprognostic (1.02e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.02e-5)" "unprognostic (7.90e-2)" "unprognostic (3.91e-2)" "unprognostic (1.05e-3)" "unprognostic (8.13e-2)" 22.4 11.9 3.9 42.2 5.5 18.2 7.1 1.4 3.7 6.5 14.1 5.1 5.9 20.3 7.0 9.7 6.8 5.4 11.2 7.5 3.8 3.9 14.8 7.9 14.6 18.7 5.4 3.9 5.4 2.9 5.1 4.7 18.1 6.4 6.5 6.8 6.6 10.5 16.8 3.0 2.7 22.2 5.8 7.4 28.3 9.2 5.8 4.0 28.5 7.6 4.3 18.0 10.1 5.4 12.7 14.4 19.3 26.8 10.2 26.4 9.7 1.0 0.0 0.0 0.0 0.0 2.0 1.1 0.9 9.8 36.9 38.7 8.6 2.1 1.3 0.3 1.2 3.9 4.3 0.0 1.4 4.7 27.2 0.0 4.3 0.0 0.0 9.0 0.0 0.7 6.8 2.0 2.9 0.2 0.5 0.5 2.1 0.0 6.8 0.9 0.0 6.8 1.0 0.2 0.7 0.0 0.0 0.0 13.0 6.1 0.2 0.7 0.0 0.1 0.0 0.7 0.1 0.2 0.7 1.4 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.7 0.0 0.4 19.3 16.2 13.0 5.5 26.8 5.7 12.7 11.1 6.0 14.4 10.9 5.3 4.0 7.8 10.2 16.6 1.7 26.4 9.7 3.9 5.5 1.4 3.7 3.8 3.9 5.4 3.9 6.4 4.0 17.9 10.4 22.5 1.3 3.8 0.0 2.4 12.7 4.0 9.1 5.2 0.0 8.1 1.7 29.5 48.9 12.4 65.2 0.0 34.8 146.8 15.4 3.9 10.4 5.9 77.7 0.0 23.6 15.4 21.0 17.6 13.8 49.5 10.1 201.0 13.5 0.2 43.1 16.5 4.6 28.0 0.0 0.0 4.2 2.1 1.9 3.3 12.1 22.4 16.6 3.1 EQTN "AFAF, C9orf11, equatorin, SPACA8" ENSG00000120160 Equatorin Q9NQ60 9 27284659-27297139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 39.9" "Cell type enriched" "Detected in some" 26 "Early spermatids: 558.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.0;BEWO: 2.2;HaCaT: 1.2;HAP1: 1.3;HSkMC: 1.8;K-562: 1.3;RT4: 1.1" "HPA015089, HPA015504" Enhanced "Intracellular and membrane" NA NA "HPA015089: AB_1845795, HPA015504: AB_2067598" "unprognostic (7.83e-2)" "unprognostic (1.55e-1)" "unprognostic (5.64e-2)" "unprognostic (8.12e-3)" "unprognostic (1.34e-3)" "unprognostic (4.41e-2)" "unprognostic (3.21e-1)" "unprognostic (1.06e-1)" "unprognostic (4.32e-1)" "unprognostic (1.89e-1)" "unprognostic (5.67e-2)" "unprognostic (1.14e-1)" "unprognostic (4.59e-2)" "unprognostic (8.46e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.1 0.1 39.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 1.3 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.6 1.1 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 558.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 21.8 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.1 1.9 0.3 0.1 0.0 0.2 0.1 ERBB2 "CD340, HER-2, HER2, NEU, NGL" ENSG00000141736 "Erb-b2 receptor tyrosine kinase 2" P04626 17 39687914-39730426 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 129.1;Enterocytes: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 8.8" "Lineage enriched" "Detected in many" 4 "T-cells: 8.8" "Group enriched" "Detected in many" 41 "OE19: 366.2;SK-BR-3: 179.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 430000 "Plasma membrane" Cytosol "CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500" "unprognostic (1.97e-1)" "unprognostic (6.60e-3)" "unprognostic (6.21e-2)" "prognostic unfavorable (8.99e-8)" "unprognostic (2.96e-2)" "unprognostic (1.40e-2)" "unprognostic (1.97e-2)" "unprognostic (9.04e-2)" "unprognostic (1.79e-2)" "unprognostic (1.20e-3)" "prognostic unfavorable (9.17e-4)" "unprognostic (3.92e-1)" "prognostic favorable (2.41e-14)" "unprognostic (9.29e-2)" "unprognostic (1.40e-1)" "unprognostic (3.75e-2)" "unprognostic (1.96e-1)" 5.8 2.4 5.2 10.4 7.0 0.1 20.1 4.2 7.0 19.1 46.5 9.1 55.2 21.6 14.9 18.7 40.9 22.7 26.6 24.8 6.3 3.1 37.5 21.5 17.6 3.7 5.1 5.6 19.3 16.2 27.7 8.1 60.8 7.5 23.6 16.6 15.9 28.7 58.1 8.9 35.3 47.2 10.9 4.5 4.0 17.1 6.5 3.7 2.8 35.7 20.8 22.9 19.7 20.3 1.3 0.3 2.1 0.4 0.9 8.8 2.2 2.1 2.5 2.9 1.8 3.5 2.4 3.9 1.5 2.5 3.3 2.8 1.9 5.8 0.1 3.1 3.5 1.8 6.7 0.1 3.4 1.5 0.2 2.2 0.1 2.0 3.1 2.0 0.0 0.0 2.4 3.2 2.0 1.2 3.2 1.3 0.1 0.3 0.1 2.4 3.3 0.3 0.1 5.2 366.2 0.6 0.2 1.1 0.3 3.4 6.7 0.5 0.1 2.9 179.8 0.9 3.7 5.0 0.1 0.1 1.7 2.2 2.1 0.9 0.3 0.1 0.1 0.1 0.0 5.6 1.6 0.4 0.8 8.8 0.3 0.7 0.9 0.5 2.5 0.3 1.3 1.0 2.5 2.1 0.9 0.2 0.2 0.4 2.2 5.2 7.0 4.2 7.0 6.3 3.1 5.1 5.6 7.5 3.7 38.7 34.4 1.3 21.0 12.5 4.3 13.5 30.6 10.7 15.9 129.1 11.8 9.7 6.6 27.1 0.3 4.6 93.2 0.0 22.3 75.4 11.0 33.4 0.0 10.4 3.5 6.4 15.0 12.3 2.4 0.7 17.0 1.8 10.1 1.0 56.6 30.9 26.2 42.1 21.5 20.7 5.9 0.0 10.3 7.1 5.3 16.6 19.0 2.2 63.0 28.1 ERBB3 "HER3, LCCS2" ENSG00000065361 "Erb-b2 receptor tyrosine kinase 3" P21860 12 56076799-56103505 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 180.9;Enterocytes: 163.1;Paneth cells: 165.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.3" "Cell line enhanced" "Detected in many" "Hep G2: 30.9;MCF7: 20.2;OE19: 31.8;RT4: 24.2;SK-BR-3: 28.4;SK-MEL-30: 37.9;T-47d: 31.5;WM-115: 40.2" "Low region specificity" "Detected in many" "CAB025331, HPA045396" Uncertain Supported "Plasma membrane,Actin filaments" "Secreted - unknown location" NA NA 420000 "Plasma membrane" "Actin filaments" "CAB025331: , HPA045396: AB_2679312" "unprognostic (2.97e-1)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" "unprognostic (8.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.07e-3)" "unprognostic (2.31e-3)" "unprognostic (2.66e-2)" "unprognostic (9.89e-2)" "unprognostic (4.30e-2)" "unprognostic (4.76e-3)" "unprognostic (5.77e-2)" "unprognostic (1.06e-2)" "unprognostic (4.56e-2)" "unprognostic (1.57e-1)" "unprognostic (6.72e-3)" "unprognostic (2.07e-2)" 1.1 1.4 11.6 12.6 16.5 0.6 26.8 2.0 16.7 6.8 40.5 40.3 12.0 37.7 2.8 7.5 29.4 5.7 22.9 3.4 18.6 9.0 16.5 33.9 13.4 0.5 23.5 9.3 0.9 21.5 11.4 1.0 15.4 14.9 16.8 29.7 5.5 36.8 22.3 1.1 30.7 41.3 3.2 27.4 0.5 32.9 1.2 23.8 0.0 4.5 7.4 8.5 11.8 14.4 0.9 0.7 5.3 0.6 1.2 1.2 0.2 10.0 0.6 0.8 0.3 0.0 0.0 16.4 0.8 1.9 1.1 1.1 5.5 18.2 0.0 0.2 0.2 0.1 8.6 1.2 1.9 0.6 0.2 0.8 0.0 0.3 30.9 0.0 0.0 0.1 0.4 2.5 0.2 0.0 0.2 0.0 0.1 0.7 0.3 0.1 20.2 0.1 0.3 2.8 31.8 0.4 0.1 1.9 0.5 2.1 24.2 0.9 0.3 0.7 28.4 37.9 2.7 31.5 0.1 0.0 0.1 1.1 0.6 0.1 0.2 0.1 0.1 0.1 0.0 40.2 5.3 0.4 0.8 0.9 0.4 0.4 0.4 0.7 0.3 0.3 0.9 0.6 1.2 3.3 1.2 0.6 0.7 0.8 0.2 11.6 16.5 2.0 16.7 18.6 9.0 23.5 9.3 14.9 23.8 110.2 61.2 1.3 13.0 16.3 1.5 1.4 180.9 21.4 61.4 33.2 2.0 44.4 1.7 41.9 0.9 2.2 163.1 0.0 77.1 73.6 2.7 83.4 1.1 83.9 5.5 0.0 89.5 6.7 1.9 0.0 1.4 1.7 52.3 2.8 134.3 11.3 75.9 165.5 0.0 31.8 1.1 6.5 1.7 2.4 2.3 32.2 84.1 1.5 124.3 62.5 ERBB4 "ALS19, HER4" ENSG00000178568 "Erb-b2 receptor tyrosine kinase 4" Q15303 2 211375717-212538841 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Lactation, Transcription, Transcription regulation" "Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.5" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 11.2;Cardiomyocytes: 15.3;Ciliated cells: 26.8;Club cells: 17.0;Collecting duct cells: 12.2;Muller glia cells: 12.4" "Cancer enhanced" "Detected in many" "breast cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.6;EFO-21: 7.2;HEK 293: 5.3;RPTEC TERT1: 7.8;SCLC-21H: 4.4;T-47d: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000276, HPA012016, CAB025522" Enhanced NA NA 140000 "CAB000276: , CAB025522: , HPA012016: AB_1846541" "unprognostic (1.48e-1)" "unprognostic (3.28e-1)" "unprognostic (4.31e-3)" "unprognostic (1.76e-3)" "unprognostic (3.59e-1)" "unprognostic (2.75e-1)" "unprognostic (2.88e-1)" "unprognostic (9.56e-2)" "unprognostic (2.07e-1)" "unprognostic (4.67e-3)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" "unprognostic (7.14e-3)" "unprognostic (1.49e-3)" "unprognostic (1.41e-1)" "unprognostic (1.14e-1)" "unprognostic (4.11e-2)" 1.6 1.9 15.1 1.2 15.0 1.0 13.4 18.6 14.1 7.8 1.1 7.6 8.8 1.1 1.5 1.2 1.3 24.5 1.2 7.0 14.3 6.5 11.9 1.1 2.9 1.2 7.8 10.7 1.3 2.4 10.8 5.1 1.3 8.8 1.7 1.1 2.0 9.7 18.1 3.8 1.8 1.2 1.1 7.3 1.2 1.5 7.6 12.0 0.0 4.5 1.1 1.2 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.6 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 7.2 1.0 0.0 0.4 0.2 0.0 0.0 0.1 5.3 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.8 0.0 0.0 0.5 0.0 7.8 0.4 4.4 0.2 0.0 0.1 0.1 0.1 7.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 15.0 18.6 14.1 14.3 6.5 7.8 10.7 8.8 12.0 0.0 9.3 0.0 0.8 0.6 11.2 15.3 0.0 26.8 17.0 12.2 0.0 0.0 5.0 0.4 4.1 0.1 0.0 0.0 0.4 0.1 0.2 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 1.7 0.0 3.3 0.0 0.0 12.4 0.0 0.0 0.4 0.0 1.4 6.5 3.1 1.9 1.5 1.1 0.0 0.0 0.0 1.0 EREG ER ENSG00000124882 Epiregulin O14944 4 74365143-74388751 "Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 52.1;tongue: 44.0" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 44.2;Kupffer cells: 56.9;Macrophages: 122.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 60.3;CAPAN-2: 17.1;hTEC/SVTERT24-B: 19.0;U-2197: 41.1;U-87 MG: 70.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054373 Approved Vesicles "Secreted to blood" NA NA 46000 Vesicles "HPA054373: " "unprognostic (1.26e-2)" "prognostic unfavorable (1.67e-7)" "unprognostic (4.56e-3)" "unprognostic (3.94e-2)" "unprognostic (2.24e-3)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (1.45e-5)" "unprognostic (1.07e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (6.57e-5)" "unprognostic (2.94e-1)" "unprognostic (1.70e-6)" "unprognostic (2.42e-2)" "unprognostic (1.13e-2)" "unprognostic (6.59e-3)" "unprognostic (3.16e-3)" 2.2 0.0 0.1 4.6 0.3 52.1 1.2 0.0 0.1 5.0 1.2 0.1 0.0 0.0 0.1 0.5 15.3 1.2 7.3 0.8 0.0 0.0 0.4 0.2 6.7 1.1 0.0 0.2 0.5 0.1 0.0 0.0 2.0 0.3 0.2 1.6 0.1 1.6 0.0 0.5 10.7 1.0 1.3 0.1 1.9 0.3 0.3 0.0 0.2 0.0 44.0 7.2 4.1 4.6 0.6 1.3 2.6 1.2 0.4 0.3 0.3 0.3 9.1 0.0 0.0 0.9 1.5 0.0 2.0 60.3 0.6 0.3 7.1 17.1 0.0 10.1 0.0 4.6 0.5 0.0 13.1 0.6 0.0 0.0 0.2 0.3 0.2 0.2 0.0 0.0 0.9 4.6 19.0 10.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 41.1 0.0 0.0 0.0 0.0 70.5 0.0 0.0 1.9 1.2 2.6 0.3 1.0 0.2 0.2 0.2 0.2 1.3 0.6 0.3 0.2 1.0 0.4 0.2 0.4 0.2 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 6.0 11.1 1.9 4.9 4.7 0.0 15.7 2.5 4.0 29.6 0.0 0.0 0.5 0.0 0.0 3.1 2.2 44.2 0.0 0.2 0.7 6.1 2.0 6.9 0.0 28.2 0.0 3.5 0.6 56.9 0.4 0.3 122.8 6.8 29.7 24.7 0.0 0.4 17.5 0.0 0.1 0.0 0.0 2.2 0.5 0.2 8.2 0.6 1.0 27.7 6.7 ERF "PE-2, PE2" ENSG00000105722 "ETS2 repressor factor" P50548 19 42247572-42255157 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 139.4;Suprabasal keratinocytes: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058532, HPA067952" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA058532: AB_2683744, HPA067952: AB_2685932" "prognostic favorable (8.07e-4)" "unprognostic (2.86e-1)" "unprognostic (1.47e-2)" "unprognostic (9.07e-2)" "unprognostic (5.21e-2)" "unprognostic (6.66e-2)" "unprognostic (2.21e-1)" "unprognostic (7.27e-3)" "unprognostic (3.61e-2)" "unprognostic (2.20e-1)" "unprognostic (8.63e-3)" "unprognostic (3.24e-1)" "unprognostic (6.41e-2)" "unprognostic (1.63e-1)" "unprognostic (2.85e-1)" "unprognostic (1.91e-2)" "unprognostic (1.54e-2)" 29.0 18.1 17.8 17.5 22.0 11.2 20.4 8.3 29.6 27.0 23.5 48.3 14.9 28.4 29.8 15.5 18.4 34.6 42.1 21.5 17.6 12.0 20.2 27.2 22.8 15.2 26.7 13.7 41.0 24.1 14.1 25.0 15.5 22.7 21.0 8.8 23.7 15.2 15.7 10.1 23.3 28.1 17.4 17.7 19.0 17.5 20.8 25.2 18.0 22.9 18.4 16.2 25.0 18.1 0.6 1.0 3.1 0.2 0.0 0.5 0.1 18.4 44.9 19.4 21.8 4.3 11.2 5.4 17.5 12.5 18.1 18.4 20.3 21.6 15.3 11.1 16.1 16.2 20.3 14.0 40.9 13.3 7.5 9.6 9.2 25.2 25.8 11.8 10.6 15.3 12.6 13.9 13.9 15.4 23.6 15.0 12.5 19.5 12.8 9.8 37.4 12.0 8.0 16.2 17.6 9.7 15.0 7.0 6.4 11.1 16.0 8.9 18.3 19.6 14.5 20.2 13.8 14.5 19.1 17.8 26.7 38.5 9.2 32.2 14.6 16.3 12.2 26.0 11.4 36.0 0.0 0.2 1.7 0.2 0.1 0.2 0.0 0.1 0.1 1.0 0.6 0.3 0.3 3.1 0.0 0.0 0.1 0.5 0.1 17.8 22.0 8.3 29.6 17.6 12.0 26.7 13.7 22.7 25.2 3.0 1.7 8.3 24.0 139.4 14.4 6.5 25.5 1.4 1.2 8.7 21.6 6.2 6.6 16.4 8.0 29.2 22.0 0.0 13.8 4.2 11.4 20.6 11.5 25.3 10.2 9.5 25.3 41.7 13.2 3.1 10.3 15.5 52.3 2.8 21.1 23.4 12.4 25.8 9.6 19.2 11.9 12.9 30.3 2.6 15.6 95.9 12.4 14.9 19.1 12.2 ERFE "C1QTNF15, CTRP15, FAM132B, FLJ37034" ENSG00000178752 Erythroferrone Q4G0M1 2 238158982-238168900 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 12.4;testis: 13.8;thyroid gland: 25.6" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 7.5;Ciliated cells: 4.0;Club cells: 4.5;Distal tubular cells: 3.3;granulocytes: 4.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.2" "Region enhanced" "Detected in many" "cerebellum: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 14.1;hTEC/SVTERT24-B: 13.7;REH: 14.0;RH-30: 17.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted to blood" NA NA 277000 "unprognostic (1.66e-1)" "unprognostic (9.14e-2)" "unprognostic (3.64e-4)" "prognostic unfavorable (3.75e-4)" "unprognostic (2.84e-1)" "unprognostic (9.61e-4)" "unprognostic (4.68e-3)" "unprognostic (3.16e-3)" "unprognostic (9.63e-2)" "unprognostic (9.11e-2)" "unprognostic (1.31e-4)" "unprognostic (7.13e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (4.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.33e-2)" 1.6 0.0 2.4 2.5 1.0 3.5 0.1 9.2 2.5 2.1 0.5 0.4 0.1 0.6 0.9 3.0 0.8 0.1 0.3 3.2 1.9 0.1 3.3 0.3 0.5 0.1 0.1 0.7 0.4 0.3 0.2 0.1 3.5 0.5 0.4 0.3 0.4 1.5 1.6 12.4 0.0 1.1 0.5 0.1 0.5 0.7 13.8 0.1 0.4 25.6 4.8 0.4 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.9 2.1 0.6 0.9 1.9 0.1 3.4 0.2 1.4 2.0 3.5 5.8 0.1 5.2 0.0 4.0 0.3 6.9 0.2 9.3 0.4 3.1 0.0 14.1 0.0 0.2 0.1 1.2 0.0 1.0 7.3 1.0 13.7 9.8 0.4 0.1 4.5 3.0 0.0 9.0 2.8 0.0 5.8 1.5 0.6 0.9 14.0 17.9 0.6 7.3 0.0 0.3 5.4 2.1 0.4 7.9 1.8 0.3 10.5 0.8 5.5 5.1 2.1 7.2 0.0 0.0 0.6 9.3 2.9 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.4 1.0 9.2 2.5 1.9 0.1 0.1 0.7 0.5 0.1 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 1.8 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 ERG28 "C14orf1, NET51" ENSG00000133935 "Ergosterol biosynthesis 28 homolog" Q9UKR5 14 75649791-75661189 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 130.3;Ductal cells: 84.3;Exocrine glandular cells: 97.0;Extravillous trophoblasts: 121.7;Syncytiotrophoblasts: 97.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043172, HPA063568" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043172: AB_10793942, HPA063568: AB_2685043" "unprognostic (2.68e-3)" "unprognostic (2.11e-2)" "unprognostic (4.55e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-1)" "unprognostic (1.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.66e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" "unprognostic (2.47e-1)" "unprognostic (3.01e-2)" "prognostic favorable (4.30e-5)" "unprognostic (1.28e-1)" "unprognostic (2.77e-1)" "unprognostic (9.58e-3)" "unprognostic (2.20e-1)" 6.4 20.0 14.2 6.3 16.3 8.1 12.6 9.2 25.5 11.8 11.7 16.3 10.5 14.9 11.3 29.6 23.7 12.4 11.8 9.4 13.6 15.5 17.6 48.3 19.3 9.4 11.9 10.4 15.0 12.4 16.5 13.2 15.6 17.9 15.5 11.2 26.2 15.4 10.6 6.6 15.6 16.9 10.5 18.2 7.1 9.5 52.2 9.6 7.5 24.3 21.3 15.6 9.2 13.5 18.1 18.2 11.8 6.0 14.2 22.0 13.9 14.2 8.0 16.3 12.6 11.0 20.6 10.1 5.8 18.0 11.3 19.5 12.3 34.1 6.0 8.5 7.2 22.7 15.8 14.3 24.8 13.0 11.3 9.5 6.5 8.2 17.4 16.1 7.1 9.8 25.7 21.4 16.2 9.1 9.1 13.1 16.7 5.8 14.8 7.8 28.0 10.8 7.9 15.8 22.8 13.0 8.7 11.0 12.0 37.1 18.5 14.0 7.8 14.7 12.6 8.7 15.0 21.0 10.6 9.4 6.2 12.5 5.9 5.8 9.7 11.3 13.1 9.9 10.5 10.4 11.8 6.0 8.9 20.1 5.9 19.8 18.1 22.0 20.9 14.2 15.3 20.2 20.1 3.2 14.2 5.9 18.2 19.4 13.9 14.2 16.3 9.2 25.5 13.6 15.5 11.9 10.4 17.9 9.6 20.8 41.5 0.0 0.0 0.0 0.0 0.0 0.0 33.5 20.5 57.6 0.0 130.3 41.4 84.3 0.0 0.0 0.0 0.0 97.0 121.7 0.0 0.0 4.7 0.0 53.6 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 65.9 0.0 0.0 61.2 0.0 0.0 38.9 0.0 0.0 0.0 0.0 0.0 0.0 97.3 0.0 0.0 0.0 ERGIC1 "ERGIC-32, ERGIC32, KIAA1181, NET24" ENSG00000113719 "Endoplasmic reticulum-golgi intermediate compartment 1" Q969X5 5 172834275-172952685 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 213.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018666, HPA018900" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA018666: AB_1848241, HPA018900: AB_1848242" "unprognostic (8.86e-2)" "unprognostic (3.50e-2)" "unprognostic (3.44e-2)" "unprognostic (5.71e-2)" "unprognostic (7.96e-2)" "unprognostic (2.46e-2)" "unprognostic (9.53e-3)" "unprognostic (7.02e-3)" "unprognostic (2.06e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "unprognostic (1.74e-2)" "unprognostic (1.67e-1)" "unprognostic (3.86e-2)" "unprognostic (9.28e-2)" "unprognostic (3.22e-2)" 30.2 56.5 14.2 20.6 13.8 12.0 44.6 25.5 18.1 42.9 30.5 12.3 35.6 24.6 26.4 24.9 22.6 23.7 30.3 20.7 14.2 11.4 36.4 120.8 28.6 29.3 14.5 11.4 22.5 55.5 15.6 18.9 25.5 13.5 48.1 32.9 19.2 51.5 29.3 27.1 16.7 32.6 22.0 10.8 30.8 36.5 15.8 13.2 29.1 41.5 20.9 25.8 21.3 45.8 6.6 4.2 20.8 9.2 8.5 3.8 3.0 20.6 19.8 17.0 37.8 65.2 48.8 9.4 42.2 32.0 19.0 17.8 28.1 21.3 19.9 30.2 71.1 32.8 7.6 12.4 56.0 22.4 15.8 12.3 12.3 29.1 15.0 47.8 5.7 3.9 41.3 23.4 28.0 26.3 31.5 30.5 20.9 7.3 28.0 31.5 25.9 16.3 9.8 10.1 49.3 18.3 56.3 11.3 61.2 44.5 12.0 9.6 17.3 14.7 42.0 21.1 17.2 17.5 6.5 23.2 31.1 12.7 29.8 17.1 44.5 49.7 8.3 43.3 13.7 13.6 2.1 4.9 12.1 2.3 7.1 3.8 6.6 1.2 1.5 4.2 4.9 1.0 1.6 20.8 8.5 9.2 2.1 0.7 3.0 14.2 13.8 25.5 18.1 14.2 11.4 14.5 11.4 13.5 13.2 53.6 29.3 64.1 27.9 20.3 36.1 28.5 68.8 20.1 17.0 47.1 15.7 17.7 18.3 91.9 9.5 25.1 68.5 0.0 52.8 71.8 28.5 108.1 23.1 213.3 39.2 20.6 25.0 42.4 73.2 21.3 60.1 52.3 6.8 111.0 176.8 39.2 69.9 52.6 54.8 35.9 11.1 38.8 23.7 1.4 8.9 23.5 7.6 26.1 58.7 42.7 ERGIC2 "Erv41, PTX1" ENSG00000087502 "ERGIC and golgi 2" Q96RQ1 12 29337352-29381189 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 351.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049695 Approved Supported "Nucleoli rim,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "Nucleoli rim" "HPA049695: AB_2680855" "unprognostic (1.62e-2)" "unprognostic (3.50e-2)" "unprognostic (5.53e-2)" "unprognostic (3.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.19e-3)" "prognostic unfavorable (8.06e-6)" "unprognostic (3.70e-2)" "unprognostic (2.32e-2)" "prognostic favorable (8.18e-4)" "prognostic unfavorable (7.02e-6)" "unprognostic (2.67e-1)" "prognostic unfavorable (3.76e-6)" "unprognostic (6.02e-2)" "unprognostic (2.08e-1)" "unprognostic (3.19e-2)" "unprognostic (2.64e-1)" 26.6 21.0 24.4 21.9 32.8 5.5 29.9 28.1 36.1 25.4 22.7 14.6 25.8 21.2 23.1 33.1 32.5 16.6 21.2 33.7 25.3 22.6 27.7 36.2 18.6 18.9 29.8 24.2 24.9 32.6 27.3 40.1 40.9 31.2 29.5 21.4 12.1 28.8 23.8 29.2 15.6 24.3 31.4 31.0 25.6 21.1 32.8 30.7 25.7 28.6 21.6 25.8 33.4 20.6 27.0 39.0 59.2 30.1 22.1 40.8 27.5 24.5 22.5 18.5 12.4 26.8 31.5 45.1 40.0 33.7 25.1 27.1 29.7 41.4 13.5 39.8 31.7 45.3 25.7 17.6 26.4 40.1 28.9 18.9 22.0 32.3 17.2 15.7 30.5 18.6 22.2 21.3 31.6 32.0 46.6 19.4 18.5 17.9 38.5 33.3 13.2 15.2 33.1 26.1 26.1 63.8 14.1 51.0 27.4 21.2 35.9 7.1 11.6 20.3 23.1 23.6 41.1 44.7 25.1 21.4 34.1 29.1 45.1 43.0 28.3 35.8 27.0 28.5 22.9 27.6 24.2 17.0 22.1 29.7 25.3 35.8 27.0 38.1 34.8 17.8 22.3 38.4 32.3 59.2 22.1 30.1 39.0 40.8 27.5 24.4 32.8 28.1 36.1 25.3 22.6 29.8 24.2 31.2 30.7 26.8 22.9 45.6 61.3 51.4 54.1 50.9 35.7 38.8 36.4 50.6 51.1 98.6 41.4 61.1 351.1 42.1 17.7 46.7 54.6 97.9 61.2 75.0 54.3 44.3 50.6 46.1 40.1 33.7 17.2 29.1 48.6 35.9 59.1 46.9 30.8 66.0 56.1 21.0 56.3 38.6 50.8 32.3 70.7 51.7 35.3 58.1 130.7 44.8 32.4 68.7 ERGIC3 "C20orf47, CGI-54, Erv46, NY-BR-84, PRO0989, SDBCAG84" ENSG00000125991 "ERGIC and golgi 3" Q9Y282 20 35542021-35557634 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015242, HPA015968" Approved NA NA "HPA015242: AB_1848238, HPA015968: AB_1848239" "unprognostic (4.36e-2)" "unprognostic (3.43e-2)" "unprognostic (1.18e-1)" "unprognostic (1.16e-1)" "unprognostic (1.93e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (2.20e-7)" "unprognostic (2.61e-1)" "unprognostic (2.90e-2)" "unprognostic (9.59e-2)" "unprognostic (8.59e-2)" "unprognostic (2.37e-1)" "prognostic unfavorable (9.81e-5)" "unprognostic (9.53e-2)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" "unprognostic (8.64e-2)" 35.5 43.7 23.7 29.5 25.7 29.9 38.3 18.9 35.2 45.3 45.2 28.6 52.7 26.5 42.1 104.8 43.2 72.4 52.2 31.1 22.1 23.8 45.6 60.6 33.2 33.3 20.7 19.3 54.2 86.8 36.0 22.8 59.0 21.4 43.9 42.1 33.6 86.1 46.1 31.7 36.5 42.1 32.1 21.6 28.4 37.1 55.8 13.7 37.8 74.4 40.8 46.2 35.0 34.2 43.9 62.0 27.6 50.5 36.9 46.2 54.4 22.5 43.5 22.3 38.4 79.2 60.1 29.3 31.2 69.4 53.0 52.8 103.3 47.8 16.8 30.5 67.3 47.0 33.9 18.8 51.1 39.2 8.3 35.0 35.5 32.5 63.0 40.9 30.8 26.5 66.2 80.8 32.9 42.2 61.1 34.6 22.4 24.5 54.7 42.4 52.0 24.4 48.0 12.7 87.3 42.5 18.6 51.7 48.1 44.9 40.1 21.8 31.3 47.6 39.1 37.0 23.2 38.1 52.7 27.7 60.3 23.7 24.1 27.3 22.7 13.6 13.6 63.7 17.0 31.9 22.2 50.5 27.6 33.9 47.8 40.8 43.9 40.3 37.2 62.0 38.5 40.1 40.5 16.8 36.9 40.3 61.5 46.2 54.4 23.7 25.7 18.9 35.2 22.1 23.8 20.7 19.3 21.4 13.7 32.8 66.3 102.7 179.9 163.6 23.9 33.5 142.7 238.3 89.9 59.3 17.7 420.3 99.5 172.9 606.7 121.2 183.0 46.7 236.4 415.6 175.9 199.9 76.2 125.4 184.0 15.9 108.1 114.2 133.9 507.4 97.5 142.0 180.5 106.4 209.4 65.9 186.0 249.5 88.4 176.5 23.3 116.4 130.8 355.1 184.2 175.4 492.9 102.2 221.4 226.5 ERLIN1 "C10orf69, Erlin-1, KE04, SPFH1, SPG62" ENSG00000107566 "ER lipid raft associated 1" O75477 10 100150094-100188334 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 81.4" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011252 Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA011252: AB_1853965" "unprognostic (3.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.57e-1)" "unprognostic (6.98e-3)" "unprognostic (2.69e-1)" "unprognostic (1.70e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (7.63e-4)" "unprognostic (1.26e-1)" "unprognostic (9.68e-2)" "unprognostic (1.99e-3)" "unprognostic (9.09e-2)" "unprognostic (1.32e-3)" "unprognostic (6.10e-3)" "unprognostic (1.76e-1)" "unprognostic (2.97e-1)" "unprognostic (1.93e-1)" 12.9 8.0 5.4 6.9 10.1 23.2 13.9 6.7 6.1 11.3 18.6 5.7 7.0 13.8 11.9 6.6 17.9 11.2 6.8 6.8 6.2 3.7 12.3 81.4 8.7 10.1 7.3 3.8 13.9 17.7 5.9 8.8 24.2 4.7 9.2 13.5 8.2 9.8 5.7 5.5 10.8 18.9 7.7 4.1 9.7 12.7 17.4 5.4 8.6 11.8 10.3 14.3 14.7 14.6 6.2 12.6 18.2 16.0 7.5 9.0 7.0 23.5 23.4 12.0 21.8 28.9 28.4 24.5 37.5 34.8 31.0 35.8 15.7 27.5 10.5 15.2 34.7 25.4 24.6 10.7 22.1 43.0 6.3 9.5 9.0 10.5 19.8 12.0 31.5 10.0 16.1 13.4 27.1 32.9 29.2 22.4 10.8 8.9 6.4 32.6 9.5 8.1 11.5 8.5 15.8 9.8 6.9 19.7 7.6 13.3 9.4 4.9 7.9 21.3 6.0 13.2 14.4 15.0 26.1 25.3 31.1 23.9 18.5 39.4 5.0 8.4 14.3 27.3 49.9 15.3 4.3 16.0 18.2 8.5 11.7 7.6 6.2 6.6 7.0 12.6 5.5 6.8 9.0 11.6 7.5 8.6 2.9 3.8 7.0 5.4 10.1 6.7 6.1 6.2 3.7 7.3 3.8 4.7 5.4 0.0 8.6 8.0 9.7 14.1 4.7 3.7 2.5 34.8 12.5 14.0 5.9 17.0 0.0 8.5 15.7 14.3 24.4 23.3 9.6 54.3 14.0 10.1 8.1 68.9 12.5 3.2 12.7 11.1 15.9 10.0 14.1 7.2 10.1 10.0 23.4 5.6 8.4 17.5 7.4 10.3 5.3 0.0 6.6 35.7 16.8 17.8 20.7 5.0 23.6 11.9 ERMAP "BTN5, RD, SC" ENSG00000164010 "Erythroblast membrane associated protein (Scianna blood group)" Q96PL5 1 42817088-42844993 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 21.6;Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 24.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA042573, HPA054672" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA042573: AB_10794282, HPA054672: " "unprognostic (9.46e-2)" "unprognostic (4.47e-2)" "unprognostic (2.56e-3)" "unprognostic (1.15e-1)" "unprognostic (6.09e-2)" "unprognostic (2.11e-3)" "unprognostic (2.82e-1)" "unprognostic (7.48e-2)" "unprognostic (2.71e-3)" "unprognostic (6.46e-2)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "unprognostic (8.28e-2)" "unprognostic (4.81e-2)" "unprognostic (1.48e-1)" "unprognostic (9.48e-2)" 10.0 14.1 9.3 6.7 10.4 25.7 8.4 2.5 9.3 9.3 7.9 12.4 12.2 6.4 9.4 16.7 8.3 10.2 7.4 4.7 9.3 6.3 7.8 13.1 9.8 4.4 10.4 8.3 6.2 11.7 9.8 12.3 12.0 10.8 9.4 8.3 11.8 10.2 8.0 4.0 9.2 9.4 6.5 14.6 8.6 7.8 4.2 11.9 4.8 13.1 3.2 8.1 9.7 8.0 2.4 8.1 3.0 7.1 3.5 5.0 2.9 3.5 4.7 1.5 4.7 5.3 15.5 1.3 7.0 11.7 6.2 6.2 1.9 6.4 3.1 2.5 7.3 2.9 4.4 1.6 2.1 5.7 5.1 5.6 24.9 3.4 1.5 6.6 3.6 12.9 9.4 7.9 2.9 6.8 11.4 4.0 3.8 16.9 3.1 5.7 2.3 1.7 1.3 3.6 2.2 2.6 1.7 2.1 2.9 5.3 5.4 3.3 2.4 6.0 2.2 2.6 2.6 4.4 13.3 6.3 4.7 2.8 3.9 3.2 1.4 2.7 1.3 3.8 3.8 3.0 0.5 6.8 3.0 2.1 7.1 1.2 2.4 2.3 2.2 8.1 1.3 2.0 2.3 2.1 3.5 4.5 2.3 5.0 2.9 9.3 10.4 2.5 9.3 9.3 6.3 10.4 8.3 10.8 11.9 11.9 10.4 0.8 3.1 3.4 1.2 1.7 7.6 6.7 7.9 3.5 21.6 2.5 1.7 3.0 3.2 3.5 2.6 23.3 6.2 1.1 3.6 2.6 2.3 11.6 7.0 11.1 5.2 2.5 11.9 18.9 2.6 6.6 5.0 1.8 5.6 5.0 4.1 3.5 3.9 2.9 3.8 0.0 1.9 0.0 0.9 3.3 2.4 0.9 6.6 0.9 ERMARD "C6orf70, dJ266L20.3, FLJ11152" ENSG00000130023 "ER membrane associated RNA degradation" Q5T6L9 6 169751622-169781584 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 35.6;Late spermatids: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041741 Approved Approved Cytosol NA NA Cytosol "HPA041741: AB_10804116" "unprognostic (2.66e-3)" "unprognostic (2.75e-1)" "unprognostic (2.33e-1)" "unprognostic (2.28e-2)" "unprognostic (1.18e-1)" "unprognostic (3.18e-1)" "unprognostic (2.24e-2)" "unprognostic (7.41e-3)" "unprognostic (1.96e-1)" "unprognostic (8.14e-2)" "unprognostic (1.66e-3)" "unprognostic (4.74e-2)" "unprognostic (3.06e-2)" "unprognostic (3.08e-1)" "unprognostic (1.88e-1)" "unprognostic (2.71e-1)" "unprognostic (1.31e-2)" 12.6 14.4 11.9 16.6 15.6 10.6 13.2 12.4 16.0 10.9 10.1 17.5 18.6 8.6 21.8 25.0 10.1 13.3 11.0 7.2 10.0 9.3 12.1 16.4 9.9 16.6 10.9 14.6 18.7 13.3 14.1 17.7 13.6 12.1 12.0 11.1 16.1 15.4 15.6 13.0 21.8 12.4 12.8 11.7 16.7 10.1 27.4 11.8 15.5 14.8 12.1 15.8 11.2 9.9 7.1 7.0 2.2 13.4 7.3 9.8 6.3 4.0 5.0 9.3 14.2 10.7 12.3 3.7 5.3 10.5 6.4 6.8 3.3 9.4 7.7 5.4 7.7 7.9 11.7 4.3 11.8 6.7 8.1 4.7 10.2 7.4 3.3 15.0 12.6 6.8 12.9 13.0 6.5 18.1 10.8 7.2 13.1 9.6 10.3 10.5 7.4 5.9 11.3 3.1 9.0 4.0 7.4 6.3 11.9 10.0 4.6 3.3 6.2 8.3 10.1 4.1 8.1 6.4 14.1 5.5 5.1 3.0 8.0 5.7 11.0 12.5 6.8 7.8 10.4 8.1 2.2 5.7 1.9 6.9 11.1 6.9 6.2 7.2 7.5 7.0 7.1 8.1 7.5 0.9 7.3 13.4 5.3 9.8 6.3 11.9 15.6 12.4 16.0 10.0 9.3 10.9 14.6 12.1 11.8 3.0 12.0 3.0 3.8 3.7 11.1 2.0 0.0 18.7 5.7 5.2 9.8 10.7 10.0 8.2 35.6 3.6 3.3 0.0 7.4 7.0 5.6 2.3 2.3 7.4 5.2 4.8 5.8 7.4 7.1 38.1 4.0 4.0 3.3 4.6 2.8 12.8 4.6 2.9 4.2 6.8 10.5 6.5 5.2 27.7 15.3 2.8 5.9 3.8 3.9 3.1 ERMP1 "FLJ23309, FXNA, KIAA1815" ENSG00000099219 "Endoplasmic reticulum metallopeptidase 1" Q7Z2K6 9 5765076-5833117 "Enzymes, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 57.6" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 69.8;Urothelial cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 27.5;RT4: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055582 Approved NA NA "HPA055582: " "unprognostic (1.93e-2)" "unprognostic (3.40e-1)" "unprognostic (2.76e-2)" "unprognostic (5.93e-2)" "unprognostic (2.97e-1)" "unprognostic (8.59e-2)" "unprognostic (4.30e-3)" "unprognostic (2.81e-1)" "unprognostic (5.46e-2)" "unprognostic (4.83e-3)" "unprognostic (3.14e-2)" "unprognostic (2.88e-2)" "prognostic favorable (5.83e-10)" "unprognostic (1.41e-1)" "unprognostic (4.00e-1)" "unprognostic (5.77e-2)" "unprognostic (1.36e-1)" 4.0 12.0 5.3 3.6 13.8 1.6 4.8 7.3 12.3 8.5 8.2 20.5 1.5 3.4 4.9 2.9 12.7 4.9 8.8 7.1 6.8 5.8 18.8 3.5 4.7 2.7 18.3 7.0 5.6 4.4 57.6 3.3 5.7 17.0 4.8 8.4 6.9 12.8 3.4 5.2 6.8 4.8 3.2 15.9 2.5 9.1 5.9 11.5 4.6 19.1 4.6 7.2 18.7 8.1 0.2 0.3 0.9 0.5 4.7 2.0 0.3 15.3 15.0 0.6 1.8 7.8 7.5 8.0 1.7 3.9 0.8 0.7 3.6 9.4 3.6 6.8 2.9 9.2 11.0 3.2 10.2 1.2 18.9 2.6 19.1 7.9 7.0 1.7 5.4 7.5 3.8 4.5 0.7 4.5 10.3 10.6 1.6 2.3 3.4 0.9 7.0 0.2 2.1 2.3 9.6 2.9 0.5 1.9 4.8 27.5 53.7 3.5 1.1 2.5 18.1 2.8 9.0 12.0 6.9 6.3 0.5 1.8 1.1 5.5 3.2 4.5 1.8 2.3 4.5 1.4 0.6 0.3 0.9 1.3 0.5 2.0 0.2 0.6 0.3 0.0 0.0 0.5 0.5 0.0 4.7 0.2 0.3 0.5 0.3 5.3 13.8 7.3 12.3 6.8 5.8 18.3 7.0 17.0 11.5 6.0 0.6 0.0 11.5 2.6 3.5 12.6 20.4 5.3 4.5 69.8 9.8 5.8 0.0 3.6 19.1 5.0 9.1 0.0 2.6 5.6 2.6 6.9 9.2 5.1 5.4 3.2 10.9 3.1 1.3 31.7 2.8 3.3 1.7 1.0 10.0 3.5 3.4 27.9 4.6 2.8 2.1 6.5 1.9 7.2 4.1 4.0 3.4 4.4 10.3 55.0 ERN1 "IRE1, IRE1P" ENSG00000178607 "Endoplasmic reticulum to nucleus signaling 1" O75460 17 64039142-64130819 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation, Unfolded protein response" "Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 76.4;Melanocytes: 70.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.9;MAIT T-cell: 12.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 41.3;RPMI-8226: 18.5;U-266/70: 39.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB009495, HPA027730" Supported NA Yes "CAB009495: AB_2098712, HPA027730: AB_10602494" "unprognostic (2.52e-1)" "unprognostic (1.16e-2)" "unprognostic (1.89e-1)" "unprognostic (4.05e-3)" "unprognostic (3.63e-2)" "unprognostic (2.81e-2)" "unprognostic (9.14e-2)" "unprognostic (2.72e-2)" "unprognostic (4.55e-1)" "unprognostic (6.17e-2)" "unprognostic (2.95e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (4.65e-1)" "unprognostic (1.89e-1)" "unprognostic (1.36e-2)" "unprognostic (3.11e-2)" 5.5 24.9 2.2 10.6 1.6 8.0 7.7 2.3 1.8 15.8 10.0 3.5 36.1 5.1 11.9 15.0 7.4 7.9 10.6 4.1 1.9 1.7 6.4 21.5 12.3 12.6 2.1 1.6 14.7 44.1 2.9 32.8 10.1 1.8 6.6 3.9 5.0 23.2 34.9 4.2 6.6 11.5 4.1 2.2 9.9 8.8 2.8 1.6 11.6 7.5 5.9 16.7 10.0 7.7 0.1 5.7 12.9 0.7 3.0 12.2 1.0 2.2 1.8 0.9 2.4 2.2 1.8 4.5 1.9 4.3 1.3 1.2 1.2 1.2 2.9 1.3 1.4 2.1 1.5 1.2 1.9 3.3 0.8 1.1 2.6 0.9 1.8 13.9 1.2 0.9 2.1 5.3 3.7 11.8 1.9 2.5 2.8 1.8 41.3 1.2 1.5 1.8 0.5 0.4 2.1 1.6 2.0 2.0 18.5 1.1 3.0 3.2 2.0 1.8 3.1 4.5 1.8 1.7 2.7 2.4 1.1 2.7 2.6 1.2 39.0 10.2 2.2 2.1 1.4 1.9 12.9 0.7 0.2 4.6 0.4 12.2 0.1 3.0 3.2 0.3 0.1 0.7 1.3 3.3 3.0 0.2 5.7 0.7 1.0 2.2 1.6 2.3 1.8 1.9 1.7 2.1 1.6 1.8 1.6 0.0 42.2 9.0 42.2 19.6 3.2 5.6 15.3 6.7 7.9 12.2 5.9 6.5 1.7 9.4 1.8 10.8 7.1 0.0 24.0 6.6 16.0 38.4 8.1 21.3 7.7 3.2 76.4 14.1 12.1 1.1 4.4 18.6 70.9 8.2 7.8 4.0 16.0 7.6 5.6 3.7 26.0 0.0 15.1 3.9 4.1 39.4 45.9 42.7 7.6 52.1 ERP29 "C12orf8, ERp28, ERp29, ERp31, PDI-DB, PDIA9" ENSG00000089248 "Endoplasmic reticulum protein 29" P30040 12 112013316-112023451 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039363, HPA039456" Enhanced Uncertain Nucleoplasm,Microtubules "Intracellular and membrane" NA NA 4900000 Microtubules Nucleoplasm "HPA039363: AB_10673422, HPA039456: AB_10672963" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (1.96e-1)" "prognostic favorable (7.43e-5)" "unprognostic (1.13e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (1.21e-1)" "unprognostic (5.10e-3)" "unprognostic (2.58e-1)" "unprognostic (3.21e-1)" "unprognostic (2.74e-3)" "unprognostic (3.34e-1)" "unprognostic (1.76e-1)" "unprognostic (6.26e-2)" 19.1 37.1 20.2 32.4 19.8 55.1 39.7 29.5 30.8 23.3 45.8 16.8 66.5 32.0 23.1 38.3 30.6 24.6 39.0 24.2 18.6 24.9 34.9 67.5 33.8 61.2 22.5 19.7 28.5 111.2 33.3 35.9 46.1 23.4 30.9 29.6 23.2 61.5 58.8 13.0 37.0 35.6 27.2 21.4 41.6 39.5 31.7 16.3 35.8 53.8 28.3 37.6 24.4 30.9 49.2 83.9 60.6 43.3 14.8 37.7 46.6 20.3 19.9 14.6 28.4 55.4 22.2 31.2 20.0 24.6 16.3 21.0 30.9 23.7 21.8 15.7 34.8 17.3 25.4 27.2 25.9 13.3 18.6 15.2 24.7 22.6 34.7 37.5 60.3 24.2 31.6 34.0 26.3 30.7 43.4 22.6 23.4 28.1 40.7 12.3 23.6 19.7 109.7 23.8 72.3 15.0 16.4 17.8 70.1 33.4 31.4 13.3 17.9 24.9 20.7 60.1 28.9 25.9 83.2 16.8 13.8 21.4 13.1 14.8 45.2 51.8 18.4 23.3 38.1 10.7 14.8 43.3 60.6 25.5 32.0 27.6 47.9 33.8 31.6 41.9 49.2 37.7 30.7 8.7 14.8 29.0 83.9 31.5 46.6 20.2 19.8 29.5 30.8 18.6 24.9 22.5 19.7 23.4 16.3 77.4 153.2 311.9 160.1 125.5 118.0 81.5 201.2 108.4 83.0 176.2 104.1 416.0 79.6 181.9 5.0 100.2 238.7 46.7 186.3 318.9 107.4 199.9 87.6 289.4 332.4 76.3 189.9 117.9 288.1 11.5 119.3 206.5 160.3 143.3 207.8 130.1 146.6 273.5 100.4 213.5 151.3 51.8 107.2 40.1 200.2 140.8 369.3 228.4 248.2 181.2 ERVFRD-1 "envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2" ENSG00000244476 "Endogenous retrovirus group FRD member 1, envelope" P60508 6 11102489-11111732 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "placenta: 66.9" "Cell type enriched" "Detected in some" 52 "Syncytiotrophoblasts: 481.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "SuSa: 30.4" NA NA "unprognostic (1.99e-1)" "unprognostic (3.29e-4)" "unprognostic (4.75e-2)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (2.19e-3)" "unprognostic (3.35e-1)" "unprognostic (6.44e-2)" "unprognostic (1.24e-1)" "unprognostic (1.99e-1)" "unprognostic (1.30e-2)" "unprognostic (2.78e-3)" "unprognostic (5.80e-4)" "unprognostic (3.40e-2)" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" "unprognostic (1.37e-2)" 1.4 2.0 0.1 0.1 0.1 0.1 0.8 0.2 0.2 0.5 0.8 0.1 0.1 0.3 1.3 0.8 0.7 0.2 0.5 0.5 0.1 0.0 1.5 0.7 1.5 1.0 0.1 0.1 0.1 0.1 15.8 0.1 66.9 0.1 1.2 0.2 0.7 0.9 0.5 0.1 0.9 1.9 0.8 0.1 0.1 1.0 0.3 0.1 0.6 0.2 0.9 0.3 1.5 2.2 0.5 0.0 0.3 0.1 2.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.7 0.4 0.3 2.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.6 0.0 0.0 0.0 0.9 0.4 0.0 0.0 1.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 9.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 481.3 0.0 0.0 0.0 ERVMER34-1 envMER34 ENSG00000226887 "Endogenous retrovirus group MER34 member 1, envelope" Q9H9K5 4 52722618-52751640 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "parathyroid gland: 32.0;placenta: 26.9" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 66.3;Extravillous trophoblasts: 80.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 28.2;hTCEpi: 20.3;RPTEC TERT1: 15.1" "HPA011423, HPA024053" Approved Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 5000000 Nucleoplasm Cytosol "HPA011423: AB_2668510, HPA024053: " "unprognostic (5.34e-2)" "unprognostic (1.29e-1)" "unprognostic (1.91e-3)" "unprognostic (5.86e-2)" "unprognostic (4.08e-4)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.88e-4)" "unprognostic (5.28e-2)" "unprognostic (2.99e-2)" "unprognostic (2.39e-3)" "unprognostic (2.62e-3)" "unprognostic (4.23e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-2)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" "unprognostic (1.82e-1)" 0.3 1.3 1.2 0.4 0.7 0.2 2.8 0.5 3.0 1.3 0.5 0.0 1.4 0.5 0.9 1.3 3.7 0.7 0.4 6.2 0.8 1.0 4.4 0.3 1.8 1.9 0.6 0.2 3.9 1.7 32.0 0.2 26.9 0.8 0.7 0.7 0.8 1.3 3.0 0.2 1.0 0.5 0.4 1.5 1.9 1.1 1.7 0.3 0.0 2.5 3.7 1.2 1.0 1.8 0.6 0.4 1.2 0.1 0.4 0.3 0.0 4.5 0.2 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 28.2 6.0 0.0 0.6 0.1 0.4 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 1.3 20.3 0.0 3.0 0.0 0.0 0.0 1.6 0.0 0.1 0.3 0.0 0.0 1.9 1.8 0.8 0.0 0.0 0.0 15.1 0.4 1.2 0.3 1.9 0.8 0.0 3.0 2.5 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.1 0.5 0.3 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.3 0.2 1.1 0.4 0.1 0.4 0.2 0.0 1.2 0.7 0.5 3.0 0.8 1.0 0.6 0.2 0.8 0.3 0.0 0.0 0.0 1.1 0.5 0.0 2.4 0.0 0.0 0.0 7.0 0.0 66.3 0.0 2.3 3.2 0.1 0.0 0.0 0.7 80.6 1.3 1.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.5 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.3 0.2 0.4 0.1 14.5 0.0 0.4 1.1 ERVV-2 ENVV2 ENSG00000268964 "Endogenous retrovirus group V member 2, envelope" B6SEH9 19 53044738-53051076 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 105 "placenta: 85.9" "Cell type enriched" "Detected in single" 5 "Syncytiotrophoblasts: 3.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 19.1;SuSa: 12.9;T-47d: 5.4" HPA076115 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA076115: " "unprognostic (3.14e-3)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (4.33e-9)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" "unprognostic (2.60e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 85.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 ERVW-1 "envW, ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW" ENSG00000242950 "Endogenous retrovirus group W member 1, envelope" Q9UQF0 7 92468380-92477986 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 83.4" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 179.3;Syncytiotrophoblasts: 714.1" "Cancer enriched" "Detected in single" 143 "testis cancer: 31.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 34 "BEWO: 43.6;SuSa: 13.9" NA NA "unprognostic (2.85e-1)" "unprognostic (1.29e-1)" "unprognostic (2.23e-1)" "unprognostic (1.34e-2)" "unprognostic (1.79e-1)" "unprognostic (1.48e-4)" "unprognostic (4.80e-1)" "unprognostic (1.01e-1)" "unprognostic (3.11e-2)" "unprognostic (1.60e-1)" "unprognostic (1.62e-1)" "unprognostic (2.21e-1)" "unprognostic (1.76e-2)" "unprognostic (1.13e-1)" "unprognostic (2.33e-1)" "unprognostic (3.96e-2)" "unprognostic (8.02e-2)" 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 2.0 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 83.4 0.2 0.2 0.1 0.2 0.4 0.2 0.4 0.4 0.2 0.2 0.3 0.3 0.5 10.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.0 2.2 0.8 0.1 0.2 0.0 0.1 0.2 0.3 0.2 0.0 0.3 43.6 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.6 0.3 0.2 0.1 0.1 0.1 0.2 0.2 0.5 0.1 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.7 0.0 0.2 0.2 0.3 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.3 0.0 0.6 0.0 13.9 0.1 0.2 0.1 0.0 0.8 0.2 0.1 0.7 0.3 0.1 0.1 0.2 0.0 0.0 0.4 2.2 0.2 0.8 0.1 0.5 0.1 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.6 0.0 0.1 0.0 0.2 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.2 3.0 1.9 0.0 0.5 0.7 2.2 0.2 0.0 9.4 2.3 0.0 0.0 179.3 0.0 0.0 28.9 0.1 0.0 0.0 0.0 79.7 2.8 0.2 2.3 0.0 23.6 0.0 0.0 0.0 1.0 5.3 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 1.4 0.0 0.0 0.5 0.4 1.8 714.1 0.0 0.0 0.5 ESAM W117m ENSG00000149564 "Endothelial cell adhesion molecule" Q96AP7 11 124752583-124762290 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 93.0" "Cell type enhanced" "Detected in many" 12 "Endothelial cells: 198.2;Ito cells: 127.7;Sertoli cells: 148.8;Smooth muscle cells: 94.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.7;neutrophil: 5.5" "Group enriched" "Detected in many" 9 "B-cells: 6.7;granulocytes: 5.5;T-cells: 1.8" "Group enriched" "Detected in some" 10 "HEL: 53.4;HUVEC TERT2: 69.5;TIME: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051043, HPA056293" Uncertain Approved Microtubules NA NA 64000000 Microtubules "HPA051043: AB_2681323, HPA056293: AB_2683089" "unprognostic (1.52e-1)" "unprognostic (2.03e-1)" "unprognostic (1.05e-2)" "unprognostic (3.56e-1)" "unprognostic (1.41e-2)" "unprognostic (4.49e-3)" "unprognostic (2.61e-1)" "unprognostic (1.10e-1)" "unprognostic (9.05e-2)" "unprognostic (2.99e-2)" "unprognostic (3.08e-1)" "unprognostic (3.60e-1)" "unprognostic (1.54e-1)" "unprognostic (1.24e-2)" "unprognostic (5.10e-2)" "unprognostic (2.29e-1)" "unprognostic (5.06e-2)" 37.1 6.0 6.6 5.3 9.6 1.3 44.6 3.8 8.2 11.8 6.1 5.4 3.7 4.3 14.5 9.5 10.7 10.3 11.5 20.1 7.5 6.6 15.5 10.2 38.4 6.9 9.1 3.9 8.4 6.4 5.4 5.5 93.0 9.0 10.9 5.0 12.4 5.1 9.8 14.6 5.9 6.4 17.2 7.2 8.2 7.6 5.4 5.9 0.9 44.9 10.9 5.0 11.4 25.4 6.7 0.3 5.5 0.5 0.0 1.8 19.4 0.2 0.4 0.1 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 3.5 0.2 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.3 53.4 0.0 1.9 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 69.5 0.0 0.0 1.5 0.1 0.4 0.0 0.0 0.1 5.0 0.5 0.0 0.2 0.2 0.0 0.5 0.0 0.2 0.0 4.0 0.0 2.0 0.8 0.2 34.8 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.1 0.5 0.0 0.1 0.2 0.0 1.4 1.3 0.1 0.3 6.7 1.8 0.6 5.5 0.0 0.0 0.3 0.4 19.4 6.6 9.6 3.8 8.2 7.5 6.6 9.1 3.9 9.0 5.9 35.7 59.6 0.8 0.6 13.5 1.3 10.6 0.0 2.7 4.5 14.0 3.9 0.9 5.0 3.3 4.0 198.2 0.0 0.0 2.1 13.5 8.5 1.1 3.5 0.8 0.9 0.0 0.0 127.7 5.6 13.6 0.9 2.6 11.8 1.0 0.2 0.8 27.0 2.6 0.4 0.0 1.0 148.8 94.7 0.0 0.3 9.5 31.0 0.0 1.7 1.7 ESYT1 "FAM62A, KIAA0747, MBC2" ENSG00000139641 "Extended synaptotagmin 1" Q9BSJ8 12 56118250-56144671 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016858, HPA076926" Approved Supported "Endoplasmic reticulum" NA NA 2600000 "Endoplasmic reticulum" "HPA016858: AB_1848404, HPA076926: AB_2686819" "unprognostic (5.02e-2)" "unprognostic (3.62e-2)" "unprognostic (6.26e-3)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (8.44e-2)" "unprognostic (5.41e-2)" "unprognostic (1.55e-1)" "unprognostic (1.39e-2)" "unprognostic (1.77e-1)" "unprognostic (6.85e-3)" "unprognostic (1.29e-1)" "prognostic favorable (3.86e-4)" "unprognostic (3.04e-2)" "unprognostic (8.43e-3)" "unprognostic (1.52e-2)" "unprognostic (3.98e-2)" 49.8 25.9 10.8 17.6 11.5 7.8 40.3 14.3 16.5 22.8 25.1 15.9 13.7 8.3 33.7 16.4 21.7 24.4 21.1 15.2 10.1 11.3 17.8 27.6 21.8 20.2 11.3 10.8 28.9 25.8 24.7 8.6 19.1 28.1 25.4 18.4 15.9 18.4 24.7 23.4 15.7 18.5 36.6 9.2 23.6 19.1 19.7 12.7 24.3 17.9 18.1 23.5 27.1 22.0 11.7 15.2 70.9 13.4 13.6 29.2 26.3 22.7 16.8 13.8 34.8 20.4 15.3 11.8 25.8 28.3 30.2 21.1 15.4 25.0 8.7 20.6 43.2 11.2 25.9 16.1 25.9 27.1 12.4 11.8 52.7 13.1 12.2 28.3 41.1 83.5 17.3 27.4 32.5 18.2 32.3 25.5 8.4 32.3 58.2 26.9 16.9 14.6 24.0 17.4 9.3 22.4 22.5 19.0 22.6 25.1 19.3 11.6 12.1 38.3 11.5 17.2 16.4 24.5 27.0 33.9 23.5 21.6 13.2 18.3 13.9 20.7 12.7 21.9 17.1 24.5 63.2 6.2 70.9 23.4 12.0 29.2 11.7 24.2 23.7 15.2 9.5 19.5 22.5 1.7 13.6 13.4 5.1 23.9 26.3 10.8 11.5 14.3 16.5 10.1 11.3 11.3 10.8 28.1 12.7 8.9 9.4 28.3 15.0 14.4 4.9 7.2 10.2 2.7 10.3 29.6 9.8 25.2 0.0 30.2 1.6 24.5 2.3 0.0 22.8 13.7 14.6 18.2 61.2 28.0 40.0 0.0 24.2 27.0 18.1 1.9 16.1 21.3 33.7 60.5 11.2 5.8 24.0 0.0 23.7 4.2 5.8 51.8 24.5 3.7 2.6 10.5 31.7 34.6 9.2 13.7 ESYT2 "CHR2SYT, FAM62B, KIAA1228" ENSG00000117868 "Extended synaptotagmin 2" A0FGR8 7 158730995-158830253 "Plasma proteins, Predicted membrane proteins, Transporters" "Endocytosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002132 Approved Uncertain Cytosol NA NA 130000 Cytosol "HPA002132: AB_1078807" "unprognostic (2.30e-1)" "unprognostic (1.06e-2)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (5.72e-2)" "unprognostic (5.43e-2)" "unprognostic (9.01e-2)" "unprognostic (9.94e-2)" "unprognostic (1.72e-1)" "unprognostic (8.71e-3)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.13e-1)" "unprognostic (7.54e-2)" "unprognostic (6.70e-2)" "unprognostic (4.58e-2)" "unprognostic (3.70e-3)" "prognostic unfavorable (2.81e-5)" 33.3 25.6 15.3 16.2 23.5 19.6 27.3 21.7 26.3 26.7 27.9 17.8 21.6 15.8 31.2 31.0 32.5 28.3 31.1 28.4 16.1 17.5 20.6 16.7 26.1 18.0 15.6 16.7 41.6 23.2 29.7 22.0 35.2 20.6 21.1 22.6 23.4 26.7 31.4 34.5 24.5 22.5 37.8 14.9 13.2 19.4 13.3 12.1 29.0 30.5 24.3 23.2 30.5 27.6 1.4 3.6 2.0 2.3 6.6 8.5 2.9 29.6 17.8 5.7 6.0 19.2 22.3 19.0 14.0 14.3 11.2 12.6 9.9 39.0 9.1 16.2 25.1 23.1 14.8 8.2 14.7 10.8 9.4 8.4 7.5 14.2 10.5 19.6 26.9 17.2 16.1 18.3 12.6 16.9 22.5 13.2 24.8 16.1 30.8 18.2 24.9 27.9 19.5 9.1 20.0 17.2 23.8 11.0 11.2 19.0 12.7 16.7 9.2 44.6 36.1 20.3 13.9 13.1 29.5 20.4 12.4 6.5 54.7 17.8 21.1 5.4 8.9 30.7 28.0 36.5 2.0 1.9 1.5 8.5 2.3 4.7 1.4 7.1 6.0 3.6 1.0 6.7 7.9 1.2 6.6 1.5 2.4 5.8 2.9 15.3 23.5 21.7 26.3 16.1 17.5 15.6 16.7 20.6 12.1 35.7 32.5 9.0 10.9 41.0 15.1 25.8 22.9 36.1 33.0 45.4 15.7 24.1 3.3 13.5 11.2 41.4 27.1 23.3 17.1 22.4 41.1 18.3 11.6 17.4 18.3 12.7 20.3 25.2 23.8 3.0 32.5 22.6 49.0 10.8 29.5 15.2 24.1 5.8 51.2 8.2 10.6 32.3 52.8 10.9 10.0 45.2 34.1 25.9 22.5 21.4 ESYT3 "CHR3SYT, FAM62C" ENSG00000158220 "Extended synaptotagmin 3" A0FGR9 3 138434586-138481686 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;skin 1: 13.7" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 35.7;Alveolar cells type 2: 30.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Region enriched" "Detected in all" 5 "cerebellum: 28.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.3;NTERA-2: 7.5;SCLC-21H: 8.1;SiHa: 3.3;SK-MEL-30: 4.0;SuSa: 3.7" "Region enhanced" "Detected in many" "hypothalamus: 8.5" "Low region specificity" "Detected in all" HPA039200 Approved NA NA "HPA039200: AB_10805356" "unprognostic (4.48e-2)" "unprognostic (3.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.38e-4)" "unprognostic (2.23e-1)" "unprognostic (8.22e-2)" "unprognostic (3.55e-3)" "prognostic favorable (8.30e-4)" "unprognostic (3.38e-1)" "unprognostic (5.57e-2)" "unprognostic (6.19e-3)" "unprognostic (4.88e-3)" "unprognostic (3.16e-5)" "unprognostic (3.46e-1)" "unprognostic (1.12e-1)" "unprognostic (2.13e-1)" "unprognostic (6.43e-2)" 0.6 0.8 5.7 0.6 5.8 0.5 2.6 28.5 5.9 1.3 4.9 0.6 0.2 0.7 5.3 0.8 0.9 1.0 2.8 1.1 5.3 3.0 1.8 0.5 12.4 0.5 1.9 4.0 0.9 2.0 3.5 3.0 1.5 4.2 1.0 1.1 0.7 0.8 0.7 0.8 13.7 0.7 4.8 1.2 0.5 2.7 1.4 1.2 0.0 11.5 1.8 1.6 2.5 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 1.2 0.4 0.0 2.0 1.8 0.2 0.6 3.0 0.2 0.0 0.5 0.1 0.2 1.0 1.1 0.3 0.1 0.3 0.1 1.3 0.1 0.1 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.2 0.7 7.5 0.0 0.5 0.0 0.1 0.0 0.8 0.2 8.1 0.0 3.3 0.4 4.0 3.7 0.8 0.3 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.7 5.8 28.5 5.9 5.3 3.0 1.9 4.0 4.2 1.2 35.7 30.7 0.0 0.7 0.7 1.8 2.0 2.5 1.4 7.9 1.8 3.9 0.8 0.0 0.6 0.2 0.0 0.0 0.0 0.8 0.4 1.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.2 0.5 0.0 0.0 0.2 2.3 0.0 0.5 2.1 0.5 1.4 0.6 0.0 0.1 0.0 ETFDH ETFQO ENSG00000171503 "Electron transfer flavoprotein dehydrogenase" Q16134 4 158672125-158709623 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 72.8" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 138.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041978 Enhanced NA NA "HPA041978: AB_10795605" "unprognostic (7.19e-2)" "unprognostic (2.28e-1)" "unprognostic (2.90e-2)" "unprognostic (5.92e-3)" "unprognostic (1.91e-1)" "unprognostic (8.45e-2)" "unprognostic (1.23e-3)" "unprognostic (7.17e-2)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" "unprognostic (1.71e-2)" "unprognostic (5.76e-2)" "prognostic favorable (5.76e-10)" "unprognostic (2.51e-1)" "unprognostic (2.07e-1)" "unprognostic (8.85e-3)" "unprognostic (1.74e-1)" 11.3 20.1 7.0 3.9 8.6 2.8 12.9 10.3 8.2 5.1 12.5 6.5 6.1 23.0 5.7 6.4 10.9 4.3 5.2 47.8 7.2 5.0 17.3 72.8 4.3 2.9 8.0 5.3 5.0 8.9 11.4 8.8 9.0 8.5 5.2 10.5 7.4 7.2 5.6 33.7 7.7 20.4 8.5 4.8 4.8 9.2 4.1 8.4 4.9 6.0 17.5 5.4 5.8 6.1 5.8 11.0 24.5 13.5 6.2 9.2 5.4 5.7 3.6 6.0 10.8 25.9 15.5 2.9 10.1 10.2 7.5 7.3 2.0 12.7 14.0 2.2 12.2 7.8 6.7 11.5 10.1 10.6 22.2 8.4 12.8 8.2 3.4 11.3 11.0 12.3 14.3 12.7 8.1 6.9 11.5 14.6 9.5 7.1 26.5 12.0 5.9 10.7 5.5 2.3 16.9 8.8 8.6 2.0 9.8 11.2 5.0 9.1 3.5 10.1 20.2 9.6 5.7 13.7 8.5 6.5 6.1 3.1 8.9 5.2 14.9 18.5 9.5 12.6 9.3 6.5 2.5 13.5 24.5 6.7 13.3 8.1 5.8 6.3 6.8 11.0 5.4 7.8 6.6 4.6 6.2 11.7 8.4 9.2 5.4 7.0 8.6 10.3 8.2 7.2 5.0 8.0 5.3 8.5 8.4 11.9 9.3 20.1 42.9 29.3 26.0 138.5 12.7 10.7 12.5 17.4 60.9 18.8 24.9 11.1 2.6 18.0 45.5 46.7 10.2 7.3 20.8 16.4 4.7 70.6 11.7 23.8 17.2 12.3 7.8 3.6 21.3 13.7 8.5 7.2 18.2 11.7 10.7 23.7 22.3 23.7 43.8 32.3 23.1 37.2 33.4 32.2 35.9 18.3 21.5 33.8 ETNK1 "EKI, EKI1" ENSG00000139163 "Ethanolamine kinase 1" Q9HBU6 12 22625075-22690665 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 201.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010712, HPA029407" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA010712: AB_2668349, HPA029407: AB_2673026" "unprognostic (2.06e-1)" "unprognostic (7.48e-2)" "unprognostic (1.23e-3)" "unprognostic (2.19e-1)" "unprognostic (8.79e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (3.98e-3)" "unprognostic (8.30e-2)" "unprognostic (7.97e-3)" "unprognostic (2.01e-1)" "unprognostic (1.64e-2)" "unprognostic (4.53e-3)" "unprognostic (2.77e-1)" "unprognostic (2.91e-1)" "unprognostic (3.01e-1)" "prognostic favorable (1.75e-4)" 15.7 17.7 15.2 41.1 19.4 13.7 16.9 19.7 22.2 12.9 33.2 16.4 14.6 27.2 16.6 24.1 14.7 13.1 27.3 10.4 15.6 23.9 22.0 30.2 19.6 18.5 17.2 15.8 17.2 14.9 15.8 30.6 13.4 18.9 13.8 19.5 15.9 16.7 14.7 8.2 17.8 24.5 10.0 17.1 18.3 53.7 22.3 17.5 33.4 17.6 8.2 16.5 14.2 18.6 16.2 10.7 28.1 17.6 14.0 15.7 13.4 6.7 14.0 15.6 14.4 11.3 11.4 11.6 8.0 6.0 8.3 8.6 10.8 17.1 20.1 7.2 5.2 8.7 5.1 13.7 3.8 15.0 16.7 11.1 16.6 6.2 9.3 10.8 15.9 15.3 7.4 3.7 11.2 9.5 13.3 10.3 7.9 19.9 8.5 11.0 4.6 17.3 32.4 30.2 8.7 9.2 15.6 13.8 16.1 13.8 9.2 5.0 8.8 8.7 7.6 12.5 22.4 11.8 15.4 8.8 6.6 10.6 8.9 12.0 6.2 7.7 21.6 8.4 10.4 11.0 28.1 11.7 12.1 12.9 17.5 12.7 16.2 14.1 11.9 10.7 13.0 15.7 15.5 11.5 14.0 17.6 9.7 15.3 13.4 15.2 19.4 19.7 22.2 15.6 23.9 17.2 15.8 18.9 17.5 44.7 25.1 40.9 63.3 128.1 40.4 11.0 53.5 72.3 35.2 41.8 47.1 27.9 23.2 26.3 201.9 28.7 55.0 0.0 39.6 20.3 28.6 70.5 33.5 38.4 37.5 25.4 103.9 27.6 78.9 26.1 22.5 44.7 64.1 22.6 52.6 21.4 29.0 46.1 20.1 26.4 35.5 38.8 44.3 47.7 15.1 148.8 63.0 39.2 36.0 60.2 ETV6 TEL ENSG00000139083 "ETS variant 6" P41212 12 11649854-11895402 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 39.7;NB-4: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA000264 Enhanced Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA000264: AB_611466" "unprognostic (4.03e-3)" "unprognostic (3.08e-2)" "unprognostic (7.54e-3)" "unprognostic (2.60e-1)" "unprognostic (2.07e-1)" "unprognostic (1.35e-3)" "unprognostic (2.74e-2)" "unprognostic (4.02e-2)" "unprognostic (3.16e-1)" "unprognostic (9.46e-2)" "prognostic unfavorable (9.38e-5)" "unprognostic (1.15e-1)" "prognostic unfavorable (4.66e-8)" "unprognostic (1.33e-2)" "unprognostic (5.99e-2)" "unprognostic (8.92e-2)" "prognostic favorable (1.54e-5)" 17.2 8.9 5.1 20.0 7.6 32.8 20.4 1.6 9.1 10.5 14.5 6.0 9.8 7.2 10.8 14.2 11.3 8.9 15.3 6.7 5.6 3.8 9.2 9.6 16.0 13.4 6.0 3.1 10.5 10.4 8.4 8.7 7.7 7.4 14.9 11.0 8.0 41.9 12.4 6.9 23.9 14.6 25.0 9.4 17.8 9.7 4.7 5.7 30.6 10.0 10.0 19.9 19.0 15.8 2.9 6.2 11.4 7.1 2.4 2.2 1.3 2.6 3.5 3.2 5.6 2.5 2.3 3.9 1.9 3.3 2.5 3.0 0.2 12.4 2.2 1.9 3.3 3.0 3.4 1.4 5.9 3.1 39.7 0.7 14.0 1.9 1.3 3.1 14.7 15.3 4.6 3.7 2.5 5.2 4.9 7.6 10.2 1.0 7.4 2.3 1.7 8.3 21.1 5.3 2.7 0.9 2.3 3.1 5.7 5.8 16.5 0.6 3.3 3.8 3.7 3.6 5.4 1.2 9.3 8.6 5.7 4.9 1.9 4.1 3.3 2.5 1.2 3.7 0.1 6.5 5.6 5.7 6.6 1.5 6.6 2.0 2.9 2.2 1.4 4.1 2.3 1.3 0.8 11.4 2.4 7.1 6.2 1.4 1.3 5.1 7.6 1.6 9.1 5.6 3.8 6.0 3.1 7.4 5.7 6.0 8.1 21.4 28.1 13.3 1.9 7.5 17.8 28.1 22.7 14.0 5.9 11.8 1.7 15.2 4.5 23.5 22.5 0.0 30.8 3.6 10.8 33.7 10.4 9.3 17.1 0.0 31.2 38.6 48.1 3.6 7.2 48.8 27.0 40.5 26.8 4.8 31.2 24.9 10.3 7.9 4.0 19.4 28.8 0.6 7.0 19.6 7.2 14.6 20.4 60.6 EVA1A "FAM176A, FLJ13391, TMEM166" ENSG00000115363 "Eva-1 homolog A, regulator of programmed cell death" Q9H8M9 2 75469302-75569722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 69.4;pancreas: 32.3" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 71.0;Proximal tubular cells: 53.7;Syncytiotrophoblasts: 104.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.2;U-138 MG: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008055 Approved Supported "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA008055: AB_1080308" "unprognostic (2.72e-1)" "unprognostic (2.61e-2)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.60e-2)" "unprognostic (5.02e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "prognostic favorable (5.67e-4)" "unprognostic (7.33e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.80e-4)" "unprognostic (8.19e-2)" "unprognostic (4.37e-2)" "unprognostic (2.43e-2)" "unprognostic (9.07e-2)" 0.6 0.3 0.3 0.7 0.5 0.0 1.2 0.3 0.2 3.7 0.6 0.1 11.4 0.5 1.6 5.1 0.5 1.3 0.4 0.6 0.3 0.3 23.6 69.4 15.2 0.1 0.8 0.0 0.8 32.3 0.8 0.8 26.6 0.5 0.6 0.2 5.7 14.3 13.5 0.9 1.5 1.1 0.7 0.4 5.9 0.4 2.2 0.3 3.3 1.2 0.8 0.8 0.3 0.6 0.8 0.0 0.0 0.0 0.0 1.1 0.7 0.3 4.6 0.5 0.1 1.0 7.1 0.5 21.7 14.6 19.4 9.9 0.1 0.4 0.0 2.0 27.2 17.8 3.0 0.5 4.6 12.2 0.0 0.3 0.0 0.8 14.4 0.7 0.0 0.0 5.0 2.7 23.9 11.0 19.5 12.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 1.0 0.0 7.5 2.4 0.0 0.0 10.7 0.1 0.3 0.5 2.0 0.1 16.6 0.7 0.0 0.1 9.8 36.5 15.3 0.6 22.6 0.2 0.0 0.0 20.7 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.5 0.3 0.2 0.3 0.3 0.8 0.0 0.5 0.3 38.7 30.7 2.7 9.2 2.5 0.8 0.2 0.0 1.4 36.4 10.4 0.0 33.7 23.2 27.0 11.0 1.3 0.0 0.0 14.2 17.5 2.1 5.2 0.0 71.0 3.2 0.0 1.7 3.7 0.6 8.2 0.3 0.8 27.0 0.0 0.0 0.0 15.1 0.0 0.7 53.7 0.0 0.0 1.0 1.7 0.4 0.6 104.4 0.0 0.0 10.0 EVA1B "C1orf78, FAM176B, FLJ10647" ENSG00000142694 "Eva-1 homolog B" Q9NVM1 1 36322031-36324154 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 229.9;Ito cells: 91.4;Syncytiotrophoblasts: 134.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 20.0;NB-4: 24.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041928, HPA043537" Approved Approved Cytosol NA NA Cytosol "HPA041928: AB_2677752, HPA043537: AB_2678538" "prognostic favorable (4.58e-4)" "unprognostic (5.66e-3)" "unprognostic (1.04e-3)" "unprognostic (3.20e-2)" "unprognostic (1.22e-2)" "unprognostic (4.00e-3)" "prognostic unfavorable (4.82e-4)" "unprognostic (1.45e-1)" "unprognostic (8.33e-2)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (4.79e-5)" "unprognostic (1.87e-2)" "unprognostic (3.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.02e-1)" 7.2 5.9 3.3 5.0 2.6 3.1 10.6 1.7 3.7 9.4 4.4 2.5 4.1 8.9 9.8 3.8 4.1 5.1 4.2 7.7 2.4 1.1 10.5 2.8 6.3 8.1 3.4 1.7 8.9 1.9 1.3 2.0 23.3 3.2 7.4 0.5 2.9 7.8 4.3 3.6 6.9 8.1 6.4 3.4 10.4 3.9 5.1 2.9 2.6 9.2 1.7 2.5 5.4 8.3 0.0 1.1 5.8 2.1 3.5 2.2 0.3 2.8 1.7 1.4 2.6 5.2 14.7 7.6 20.0 13.6 3.4 3.8 2.9 2.0 0.4 6.6 5.8 0.7 4.4 0.1 0.7 0.7 2.3 4.9 2.6 1.8 2.3 11.1 0.1 1.5 13.1 0.0 4.2 0.4 5.3 5.2 0.7 0.9 1.0 2.2 3.3 0.1 24.7 1.6 0.2 7.7 1.6 0.3 4.2 2.7 0.6 1.1 3.4 2.0 2.2 7.9 2.2 0.3 1.8 8.8 5.4 0.6 7.9 2.2 1.1 0.3 0.6 3.2 1.6 4.4 5.8 2.1 0.0 0.4 0.8 1.4 0.0 0.8 1.2 1.1 0.0 0.0 0.1 3.7 3.5 0.3 0.0 2.2 0.3 3.3 2.6 1.7 3.7 2.4 1.1 3.4 1.7 3.2 2.9 0.0 0.0 6.9 16.7 14.3 0.0 1.6 2.5 0.0 1.2 7.0 0.0 44.7 1.7 17.7 5.6 44.2 0.2 0.0 12.8 229.9 52.8 37.6 4.6 0.4 40.9 0.0 0.0 91.4 28.8 20.1 46.9 15.6 11.8 6.4 0.0 10.9 23.2 0.0 45.6 6.3 0.5 25.8 41.1 9.3 2.4 10.8 134.9 9.5 0.2 17.8 EVA1C "B18, B19, C21orf63, C21orf64, FAM176C, PRED34" ENSG00000166979 "Eva-1 homolog C" P58658 21 32412006-32515397 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 77.7;Late spermatids: 136.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "granulocytes: 1.8;NK-cells: 3.8;T-cells: 5.2" "Cell line enhanced" "Detected in many" "A549: 13.4;CAPAN-2: 13.5;HBEC3-KT: 9.6;hTCEpi: 10.7;HUVEC TERT2: 10.4;SK-MEL-30: 11.7;TIME: 9.4;U-87 MG: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015720, HPA029944, CAB034174" Enhanced NA NA "CAB034174: AB_1564317, HPA015720: AB_1845705, HPA029944: AB_10601092" "unprognostic (7.55e-3)" "unprognostic (8.91e-3)" "unprognostic (5.51e-2)" "unprognostic (2.55e-1)" "unprognostic (3.16e-2)" "prognostic favorable (5.06e-4)" "unprognostic (1.40e-3)" "unprognostic (4.24e-3)" "unprognostic (3.39e-1)" "unprognostic (2.65e-2)" "unprognostic (1.65e-1)" "unprognostic (3.84e-2)" "unprognostic (3.29e-2)" "unprognostic (1.08e-1)" "unprognostic (2.73e-1)" "unprognostic (5.95e-3)" "unprognostic (4.25e-3)" 17.1 3.9 5.0 4.5 11.9 1.7 28.1 5.0 7.9 11.9 9.3 12.2 19.5 2.6 18.8 12.8 13.1 23.9 14.3 12.6 4.8 4.2 5.1 2.6 14.3 8.0 9.4 4.1 12.0 5.9 7.5 6.7 8.3 9.8 16.4 3.5 7.4 11.8 25.8 5.8 14.2 5.3 17.2 7.2 5.3 8.2 10.5 8.5 0.5 9.1 10.5 10.7 14.2 14.9 0.0 0.1 1.8 0.5 3.8 5.2 1.8 0.0 13.4 0.1 0.5 2.9 2.0 0.3 2.9 0.5 0.9 0.2 0.0 13.5 0.1 0.3 0.1 1.4 0.0 0.5 9.6 0.2 1.5 0.0 0.0 6.3 0.4 3.6 0.0 0.0 0.9 10.7 1.9 7.5 2.1 10.4 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.6 3.0 0.0 0.3 0.0 0.3 0.2 4.0 0.6 8.4 0.7 11.7 0.1 0.5 0.0 9.4 1.2 0.4 1.6 0.6 0.2 0.0 0.1 11.6 0.1 3.0 1.8 0.0 0.0 4.6 0.2 5.2 0.0 4.9 4.5 0.1 0.0 1.0 2.5 0.0 3.8 0.5 0.0 0.6 1.8 5.0 11.9 5.0 7.9 4.8 4.2 9.4 4.1 9.8 8.5 17.9 19.4 0.0 77.7 37.9 6.0 6.1 45.9 28.1 30.7 8.7 0.0 0.3 0.0 70.1 70.4 46.2 4.5 0.0 9.2 0.2 9.5 39.2 5.8 1.0 0.5 6.4 1.7 22.1 1.5 136.2 13.6 4.7 21.9 4.6 4.5 25.1 6.1 3.5 13.8 1.7 1.7 19.4 29.7 2.2 1.6 25.7 0.6 13.1 6.6 38.9 EVC DWF-1 ENSG00000072840 "EvC ciliary complex subunit 1" P57679 4 5711197-5814305 "Disease related genes, Predicted membrane proteins" "Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 8.0;Melanocytes: 5.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 26.4;hTERT-HME1: 26.4;hTERT-RPE1: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008703, HPA016046" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008703: AB_1078765, HPA016046: AB_1848299" "unprognostic (1.69e-1)" "unprognostic (5.39e-2)" "unprognostic (1.15e-1)" "unprognostic (6.58e-2)" "unprognostic (6.61e-2)" "unprognostic (9.37e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (2.30e-1)" "unprognostic (2.56e-2)" "unprognostic (9.63e-2)" "unprognostic (2.82e-1)" "prognostic favorable (5.60e-9)" "unprognostic (3.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-2)" "prognostic unfavorable (9.47e-5)" 5.0 2.9 2.5 4.6 2.7 0.0 4.1 1.9 2.3 13.2 4.3 1.8 8.4 0.6 17.2 10.1 6.0 8.1 16.0 3.8 2.2 2.2 26.5 3.7 6.4 1.0 2.3 1.4 20.2 9.2 14.9 2.3 1.8 2.9 10.2 1.6 12.0 9.1 5.7 2.4 4.2 2.8 15.8 2.4 2.1 3.6 5.3 1.0 1.0 6.9 3.9 3.8 7.5 9.0 0.1 0.3 1.2 0.1 0.1 0.5 0.0 3.0 3.9 2.2 5.7 14.3 20.7 0.8 6.9 26.4 8.0 10.4 0.0 0.0 0.0 2.2 10.9 13.4 3.7 2.3 5.7 6.6 5.1 1.5 0.0 2.2 1.0 10.6 0.0 0.6 10.2 8.4 10.7 26.4 22.9 5.5 0.0 0.0 0.0 18.5 0.0 0.0 0.0 2.4 0.0 3.6 4.7 6.0 0.0 2.8 0.5 1.2 3.7 0.0 0.0 2.8 2.2 1.4 0.2 9.6 6.8 1.3 4.8 6.0 4.2 3.4 0.3 19.6 0.0 6.4 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.3 0.5 0.0 2.5 2.7 1.9 2.3 2.2 2.2 2.3 1.4 2.9 1.0 3.0 2.9 0.0 1.6 3.1 0.0 1.6 2.5 1.4 1.2 3.5 0.0 0.0 1.7 0.4 0.4 0.0 0.0 0.0 0.0 0.0 8.0 0.7 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.9 0.0 5.0 0.0 0.0 2.1 0.2 0.0 0.7 1.1 0.0 0.0 1.7 0.0 0.0 2.5 0.1 0.0 0.0 1.1 EVC2 LBN ENSG00000173040 "EvC ciliary complex subunit 2" Q86UK5 4 5542772-5709548 "Disease related genes, Predicted membrane proteins" "Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 5.5;Fibroblasts: 5.3;Leydig cells: 10.6;Peritubular cells: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 9.0;BJ hTERT+: 8.9;HHSteC: 12.4;hTERT-HME1: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040910, HPA048122" Uncertain Approved Mitochondria NA NA Mitochondria "HPA040910: AB_2677195, HPA048122: AB_2680272" "unprognostic (6.56e-2)" "unprognostic (6.74e-2)" "unprognostic (5.10e-2)" "unprognostic (2.25e-1)" "unprognostic (8.23e-3)" "unprognostic (2.80e-1)" "unprognostic (2.05e-2)" "unprognostic (1.22e-2)" "unprognostic (1.71e-1)" "unprognostic (1.28e-1)" "unprognostic (8.57e-2)" "unprognostic (9.37e-2)" "prognostic favorable (1.58e-4)" "unprognostic (2.51e-2)" "unprognostic (3.14e-1)" "unprognostic (5.61e-2)" "unprognostic (6.29e-5)" 6.9 1.2 1.2 7.6 1.6 0.3 15.7 1.6 1.0 13.2 5.2 1.1 3.4 1.3 14.1 8.5 5.1 6.3 8.2 4.7 1.9 0.7 8.0 1.4 4.1 3.7 1.6 0.5 14.4 5.0 8.1 2.5 2.6 1.3 8.6 1.3 7.7 5.0 4.2 2.8 5.6 2.9 14.2 1.7 3.6 3.5 4.5 0.6 1.1 12.4 3.7 7.9 7.2 24.6 0.8 0.0 0.0 0.1 0.0 1.2 0.0 0.0 2.5 0.0 6.1 8.0 9.0 0.0 3.7 8.9 3.3 5.6 0.0 0.0 4.6 0.0 2.9 1.9 2.6 0.0 1.5 3.2 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 5.6 4.2 4.3 9.9 0.0 3.5 0.0 0.0 0.2 4.8 0.0 0.0 0.0 3.6 0.0 0.0 7.6 7.6 0.0 0.3 0.0 0.4 0.6 0.0 0.0 0.0 1.5 0.0 0.5 6.0 0.0 0.0 2.2 0.0 3.8 4.1 1.1 2.4 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.8 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.2 1.6 1.6 1.0 1.9 0.7 1.6 0.5 1.3 0.6 0.0 0.3 0.0 3.9 1.9 0.0 0.9 2.5 0.0 1.2 0.0 0.0 5.5 0.0 1.3 1.4 1.0 0.0 0.0 0.4 0.2 5.3 2.2 2.3 0.0 0.5 0.0 0.0 1.8 0.0 0.4 10.6 0.0 0.0 0.0 0.0 1.7 0.8 0.0 7.4 0.6 0.0 0.0 1.9 1.6 2.0 0.6 1.1 0.0 0.0 1.2 EVI2A "EVDA, EVI2" ENSG00000126860 "Ecotropic viral integration site 2A" P22794 17 31317560-31321884 "Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.7;brain: 74.0" "Group enriched" "Detected in many" 4 "granulocytes: 75.5;Hofbauer cells: 100.8;Kupffer cells: 231.8;Macrophages: 127.6;T-cells: 130.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 20.2;Karpas-707: 33.4;RPMI-8226: 51.6" "HPA045033, HPA057051" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA045033: AB_2679191, HPA057051: AB_2683321" "unprognostic (7.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" "unprognostic (8.49e-2)" "unprognostic (4.89e-2)" "unprognostic (1.88e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.55e-4)" "unprognostic (1.90e-1)" "unprognostic (3.54e-2)" "unprognostic (3.15e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (7.64e-2)" "unprognostic (4.95e-2)" "unprognostic (5.87e-2)" "unprognostic (2.90e-2)" 6.4 4.7 26.8 25.8 36.0 15.1 4.7 3.8 30.0 5.2 6.2 16.5 0.0 6.3 2.2 1.6 3.5 2.1 10.6 2.6 42.5 21.8 2.2 5.3 12.5 27.4 64.7 13.9 1.6 1.6 1.0 1.6 11.6 33.7 2.4 8.2 0.0 3.0 2.0 1.2 1.5 6.8 4.1 74.0 20.4 6.9 1.2 59.7 32.1 2.0 0.6 22.6 14.2 2.2 8.6 17.9 51.7 26.5 8.9 19.2 23.9 0.0 0.0 0.0 0.0 1.7 10.6 0.0 1.3 2.2 1.7 6.1 0.0 0.5 9.0 0.0 1.7 9.9 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.0 20.2 10.4 11.4 13.1 0.0 2.4 7.0 2.6 0.6 8.3 0.3 33.4 13.2 0.1 7.4 11.4 0.0 0.0 0.0 7.8 1.3 51.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.4 4.3 7.3 0.2 0.3 4.8 15.0 0.0 10.1 5.9 7.6 6.0 1.3 26.5 1.0 11.3 12.7 13.7 8.6 16.1 13.1 17.9 4.2 19.2 16.8 51.7 8.9 9.6 5.9 17.1 23.9 26.8 36.0 3.8 24.0 42.5 21.8 64.7 13.9 33.7 59.7 0.0 6.4 31.5 0.3 3.5 0.2 0.3 0.0 2.7 2.3 0.0 0.0 0.6 0.0 0.0 2.0 1.3 0.0 0.0 0.0 0.5 2.6 0.2 75.5 0.8 100.8 0.0 0.0 7.4 231.8 0.0 0.3 127.6 13.5 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.7 0.0 1.6 0.1 0.2 2.8 1.1 130.3 0.0 0.3 EVI2B "CD361, D17S376, EVDB" ENSG00000185862 "Ecotropic viral integration site 2B" P34910 17 31303766-31314112 "CD markers, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 133.6;lymphoid tissue: 72.8" "Cell type enhanced" "Detected in many" 16 "B-cells: 217.4;Kupffer cells: 447.5;Macrophages: 274.7;T-cells: 178.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 133.6" "Group enriched" "Detected in all" 4 "granulocytes: 133.6;monocytes: 34.3" "Cell line enhanced" "Detected in many" "Daudi: 24.2;HHSteC: 19.9;HL-60: 27.3;HMC-1: 38.5;Karpas-707: 27.3;NB-4: 21.6;RPMI-8226: 39.9;THP-1: 34.4" "Low region specificity" "Detected in all" HPA007436 Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA007436: AB_1848307" "unprognostic (1.07e-2)" "unprognostic (1.20e-2)" "unprognostic (5.97e-2)" "unprognostic (4.09e-3)" "unprognostic (2.99e-2)" "unprognostic (1.41e-2)" "unprognostic (3.06e-1)" "unprognostic (3.36e-2)" "unprognostic (1.93e-2)" "unprognostic (1.48e-1)" "unprognostic (1.78e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.56e-2)" "unprognostic (3.32e-2)" "unprognostic (8.64e-2)" "unprognostic (2.73e-2)" 15.0 3.6 4.4 37.7 5.8 44.0 4.2 1.7 4.4 3.7 10.7 6.5 0.3 6.0 2.8 4.8 7.1 4.7 8.1 6.7 6.4 4.4 7.8 7.1 38.5 37.5 10.2 2.6 3.8 2.7 0.4 2.1 4.8 7.8 5.3 8.1 2.5 6.6 1.5 2.3 2.4 23.3 4.2 22.0 72.8 8.0 3.7 6.7 26.1 4.0 3.0 43.0 13.0 7.6 18.6 14.6 133.6 34.3 4.1 16.4 19.8 0.1 0.1 0.0 0.0 1.9 2.5 0.0 0.2 1.7 2.0 3.7 0.0 0.9 24.2 0.0 1.5 7.5 0.1 0.0 0.3 2.2 0.0 0.0 0.5 0.0 0.0 19.9 27.3 38.5 4.6 0.0 1.1 1.5 0.6 1.9 2.0 0.3 27.3 5.7 0.0 7.9 21.6 0.0 0.0 0.0 13.9 0.1 39.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.4 2.1 0.5 0.0 0.2 1.9 5.3 0.2 5.3 2.5 9.4 0.6 78.9 30.5 74.5 8.2 23.2 7.9 18.6 12.6 10.6 14.6 14.3 9.7 9.1 133.6 4.1 34.3 8.4 16.4 19.8 4.4 5.8 1.7 4.4 6.4 4.4 10.2 2.6 7.8 6.7 0.0 17.9 217.4 0.6 4.7 0.2 0.4 2.5 4.0 11.4 1.8 0.0 0.5 0.0 0.0 5.3 2.7 0.2 0.0 0.0 0.5 2.8 0.3 78.7 1.7 88.8 0.0 0.0 9.8 447.5 4.7 0.0 274.7 35.4 10.8 0.0 0.0 0.7 0.0 0.4 0.7 0.8 19.4 4.1 0.3 0.5 3.1 0.2 178.5 0.0 1.1 EVI5L ENSG00000142459 "Ecotropic viral integration site 5 like" Q96CN4 19 7830233-7864976 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 30.8;Horizontal cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043099, HPA043563" Approved Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA043099: AB_10796685, HPA043563: AB_2678556" "unprognostic (3.90e-2)" "unprognostic (4.69e-2)" "unprognostic (9.29e-3)" "unprognostic (2.18e-2)" "unprognostic (1.74e-1)" "unprognostic (1.34e-2)" "unprognostic (2.06e-3)" "unprognostic (1.90e-2)" "unprognostic (7.66e-2)" "unprognostic (3.00e-1)" "unprognostic (7.48e-3)" "unprognostic (1.97e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (1.37e-2)" "unprognostic (2.04e-2)" 7.7 7.8 22.8 6.0 20.0 3.7 4.2 18.7 31.6 7.6 6.6 23.5 5.3 6.2 6.8 6.2 11.6 6.0 6.6 13.3 25.7 20.5 9.0 4.9 6.9 5.0 21.4 17.3 6.6 7.8 11.9 9.6 9.7 18.3 9.9 5.5 5.4 8.9 12.1 21.8 12.3 5.3 10.7 20.3 7.2 7.1 24.0 18.5 5.3 7.3 4.0 5.5 8.6 4.8 0.4 0.5 0.8 3.9 0.3 1.2 0.2 7.2 1.5 5.9 8.7 10.9 9.2 16.7 10.9 11.5 7.9 8.4 0.6 2.8 1.9 13.2 14.8 4.1 5.0 2.1 7.4 7.2 10.6 7.1 1.4 3.4 1.2 13.8 1.6 3.8 8.5 9.0 3.8 18.3 6.5 9.4 9.8 1.7 10.0 8.0 7.5 5.8 3.7 2.2 5.4 15.9 7.0 4.9 5.3 4.7 6.2 2.5 5.9 10.1 4.5 3.2 4.1 3.8 5.4 9.2 5.4 2.5 30.2 4.0 14.6 3.2 2.4 9.1 4.1 4.6 0.0 0.4 0.3 0.8 0.8 1.0 0.2 0.5 0.5 0.3 0.4 1.0 1.2 0.8 0.3 3.9 0.5 0.8 0.2 22.8 20.0 18.7 25.8 25.7 20.5 21.4 17.3 18.3 18.5 0.0 6.1 0.0 1.7 3.4 30.8 3.7 5.1 0.0 0.0 8.7 17.7 2.8 0.0 2.1 12.0 2.1 4.1 0.0 2.1 15.1 2.5 2.4 0.0 1.5 3.2 31.8 5.2 5.5 1.5 22.2 3.7 1.8 3.3 0.0 3.4 7.5 2.4 3.2 4.2 2.4 19.4 6.5 3.5 17.9 4.2 3.6 2.9 1.0 2.4 3.8 EXD2 "C14orf114, EXDL2, FLJ10738" ENSG00000081177 "Exonuclease 3'-5' domain containing 2" Q9NVH0 14 69191511-69244020 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002906, HPA005848" Uncertain Approved "Intermediate filaments,Mitochondria" NA NA Mitochondria "Intermediate filaments" "HPA002906: AB_1078767, HPA005848: AB_1078768" "unprognostic (3.36e-2)" "unprognostic (1.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (9.91e-2)" "unprognostic (8.03e-2)" "unprognostic (2.46e-1)" "unprognostic (4.64e-2)" "unprognostic (8.97e-2)" "prognostic favorable (2.08e-9)" "unprognostic (1.16e-1)" "unprognostic (3.06e-2)" "unprognostic (8.75e-2)" "unprognostic (2.14e-2)" 8.1 7.7 14.3 5.0 19.0 2.3 10.6 20.4 20.1 15.8 8.8 21.7 10.2 7.2 14.4 13.6 10.7 14.5 8.6 8.9 13.8 12.0 11.5 6.0 9.0 4.0 13.7 13.3 12.4 24.9 21.9 13.2 8.0 13.9 11.4 10.0 9.6 17.0 12.1 10.3 7.0 6.8 11.0 20.7 5.8 8.7 20.0 12.6 5.0 12.4 5.2 5.9 10.5 7.9 4.1 7.4 10.9 3.4 3.6 6.0 3.1 19.1 9.0 7.0 10.3 4.3 5.2 8.9 9.6 8.1 9.0 11.9 7.6 13.6 0.0 7.1 10.0 5.5 10.9 7.7 9.7 10.2 4.8 9.2 5.6 3.4 4.5 16.9 4.1 5.4 10.5 16.1 9.1 6.0 5.5 12.6 4.9 3.5 7.4 8.5 9.7 2.3 6.3 7.6 10.3 9.1 0.0 6.7 6.7 13.2 7.1 13.7 12.2 7.2 15.0 7.0 7.9 20.1 3.6 10.0 8.4 6.0 6.7 4.9 5.7 7.6 0.0 0.0 4.5 6.2 10.9 3.4 2.9 3.3 1.9 6.0 4.1 3.5 3.3 7.4 2.4 4.2 6.0 0.4 3.6 1.7 5.8 2.4 3.1 14.3 19.0 20.4 20.1 13.8 12.0 13.7 13.3 13.9 12.6 11.9 7.5 3.2 4.2 2.9 9.4 10.3 5.1 9.4 9.1 0.0 7.9 7.1 5.0 10.0 2.4 4.4 3.2 0.0 7.6 3.8 4.6 4.8 1.1 4.7 5.6 9.5 5.8 10.4 5.9 1.8 5.8 1.8 3.3 9.0 8.7 6.8 9.0 7.0 11.3 4.8 8.7 0.0 3.9 31.0 8.7 3.8 2.4 0.5 6.9 3.0 EXOG "ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b" ENSG00000157036 "Exo/endonuclease G" Q9Y2C4 3 38496127-38542161 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 52.2;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 77.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012531, HPA071050" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA012531: AB_2732403, HPA071050: " "unprognostic (2.88e-1)" "unprognostic (5.81e-3)" "unprognostic (3.55e-3)" "unprognostic (2.77e-1)" "unprognostic (8.32e-3)" "unprognostic (8.90e-3)" "unprognostic (4.78e-4)" "unprognostic (3.59e-2)" "unprognostic (3.99e-2)" "unprognostic (3.10e-2)" "prognostic favorable (1.92e-5)" "prognostic unfavorable (4.90e-4)" "unprognostic (6.51e-2)" "unprognostic (1.64e-2)" "unprognostic (4.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" 7.4 9.9 14.1 12.8 14.2 8.1 6.6 18.5 14.1 8.2 8.0 10.5 6.6 5.4 9.7 8.9 5.2 7.4 9.0 22.8 11.7 9.1 7.2 5.8 7.2 12.9 11.1 11.0 8.0 7.4 7.6 16.8 7.3 8.7 9.4 8.2 6.8 5.9 9.3 9.5 4.8 8.1 11.2 8.0 10.8 6.6 9.7 11.2 11.5 8.7 4.0 11.0 9.0 6.4 24.5 6.8 2.1 5.2 12.0 13.6 2.6 3.7 6.7 7.7 6.7 5.2 7.7 3.1 12.0 7.7 10.5 11.8 6.1 3.7 13.0 3.2 4.9 2.9 3.8 9.7 4.2 8.9 14.5 8.7 9.8 10.1 6.3 6.3 10.6 8.2 5.9 4.6 9.3 4.9 4.9 14.1 7.3 4.5 8.6 16.6 2.5 7.4 3.5 7.4 3.2 8.5 4.8 4.3 5.8 5.5 5.1 3.5 1.8 7.4 1.8 3.2 3.6 2.6 5.0 11.7 8.7 6.2 9.3 9.7 4.8 8.2 11.9 6.6 9.1 6.3 0.4 5.0 2.1 13.6 4.4 11.9 24.5 13.0 13.0 3.4 22.4 13.1 13.0 0.2 12.0 5.2 6.8 5.8 2.6 14.1 14.2 18.5 14.1 11.7 9.1 11.1 11.0 8.7 11.2 6.0 5.0 24.1 5.1 2.6 52.2 29.9 12.7 8.1 1.2 10.4 53.0 9.3 0.0 7.6 3.0 9.0 3.9 0.0 4.6 1.1 10.8 4.4 1.1 5.4 5.9 38.1 16.3 8.6 7.0 2.9 25.0 5.6 11.8 8.2 6.9 18.4 5.5 10.1 16.6 2.8 77.1 12.9 11.2 37.0 22.8 0.9 1.6 25.4 9.0 5.0 EXT1 "LGCR, LGS, ttv" ENSG00000182197 "Exostosin glycosyltransferase 1" Q16394 8 117794490-118111853 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease mutation, Hereditary multiple exostoses, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 55.5;fHDF/TERT166: 56.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044394 Uncertain NA Yes 9600000 "HPA044394: AB_10963838" "unprognostic (1.29e-2)" "prognostic unfavorable (7.04e-4)" "unprognostic (2.73e-2)" "unprognostic (2.02e-3)" "unprognostic (2.19e-1)" "unprognostic (7.55e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.70e-1)" "unprognostic (3.01e-2)" "unprognostic (1.31e-2)" "unprognostic (6.58e-2)" "unprognostic (1.27e-2)" "unprognostic (9.84e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (1.85e-1)" 13.8 11.9 5.8 20.5 4.6 2.1 16.5 7.3 7.4 13.3 17.1 4.1 8.7 23.2 11.5 12.5 11.2 8.8 19.3 14.4 4.6 3.1 8.8 66.4 19.9 8.3 3.0 6.8 10.4 17.9 7.1 6.4 15.6 4.8 9.8 16.0 13.2 9.8 13.3 4.2 12.3 32.0 16.8 4.3 20.1 11.5 5.0 2.7 8.7 12.0 10.3 7.2 11.0 18.5 0.8 1.7 1.2 4.5 0.7 2.4 1.0 17.3 5.0 7.6 3.0 13.7 11.1 3.5 32.5 55.5 24.0 22.1 5.2 1.7 0.3 14.6 56.1 17.9 11.0 3.3 19.1 33.8 6.5 5.6 0.7 4.7 4.1 6.4 0.0 1.2 6.9 5.1 29.1 26.8 30.1 14.7 1.6 0.4 4.8 11.1 1.4 0.8 0.0 2.4 9.2 6.5 0.0 2.8 0.5 9.4 6.3 2.4 2.2 5.0 2.3 4.8 20.2 3.2 0.2 19.5 20.2 18.6 18.6 9.5 2.8 2.7 1.6 18.8 0.0 5.4 0.3 4.4 0.2 0.2 4.5 1.3 0.8 0.5 0.6 1.0 0.1 0.5 0.9 1.2 0.7 2.2 1.7 2.4 1.0 5.8 4.6 7.3 7.4 4.6 3.1 3.0 6.8 4.8 2.7 17.9 5.9 1.4 18.7 48.7 21.1 6.2 28.1 5.3 6.8 7.0 13.7 5.2 0.0 34.9 1.3 16.6 42.3 0.0 17.2 3.2 32.1 10.0 6.9 22.6 2.2 9.5 4.6 17.8 28.9 1.6 16.1 5.4 18.6 5.4 20.7 6.0 21.6 14.0 33.9 5.0 24.5 0.0 28.1 0.5 4.3 41.4 10.2 2.2 21.2 17.9 EXT2 SOTV ENSG00000151348 "Exostosin glycosyltransferase 2" Q93063 11 44095549-44245429 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease mutation, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078409 Supported "Golgi apparatus" NA NA 20000000 "Golgi apparatus" "HPA078409: AB_2686884" "unprognostic (5.87e-2)" "unprognostic (3.05e-3)" "unprognostic (3.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.77e-3)" "unprognostic (2.22e-2)" "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (1.74e-3)" "unprognostic (3.70e-2)" "prognostic unfavorable (5.36e-6)" "unprognostic (7.07e-3)" "unprognostic (2.97e-1)" "unprognostic (3.85e-1)" "unprognostic (1.36e-2)" 24.5 19.5 11.6 17.2 18.5 6.6 25.8 14.5 23.0 26.8 25.0 15.5 17.5 17.6 37.1 25.5 16.7 26.0 23.4 22.7 11.7 13.0 19.2 36.3 22.3 16.8 11.8 12.3 29.3 21.8 25.7 17.3 58.0 16.2 23.7 20.6 22.9 24.7 22.8 16.9 20.2 34.0 35.0 12.2 18.7 19.3 20.0 11.4 16.2 24.7 16.7 13.0 20.2 23.2 6.7 14.9 13.0 12.0 17.8 17.6 9.8 13.1 18.2 9.9 30.7 45.6 33.6 13.6 40.8 51.1 24.2 33.0 12.9 9.1 9.1 18.6 47.8 25.6 21.0 10.5 29.0 29.3 18.2 14.5 8.4 9.6 9.9 18.0 8.4 18.1 26.0 19.2 14.6 22.9 28.5 34.3 8.7 11.2 16.4 17.6 10.1 5.8 5.1 10.6 16.8 13.0 7.3 28.2 4.6 14.0 12.5 7.1 7.9 25.8 10.6 6.8 18.3 17.6 9.0 31.0 32.7 21.4 32.0 26.2 7.4 9.7 6.7 21.5 6.5 34.9 9.3 11.9 13.0 15.6 12.0 17.6 6.4 12.5 14.4 14.9 6.7 11.9 11.7 2.6 17.8 8.5 5.1 9.6 9.8 11.6 18.5 14.5 23.0 11.7 13.0 11.8 12.3 16.2 11.4 14.9 8.8 10.5 13.2 13.5 11.5 9.2 5.1 5.3 10.3 12.2 13.7 27.3 5.0 28.2 30.2 16.7 20.5 0.0 20.6 30.2 24.4 17.7 5.8 15.5 16.2 12.7 1.7 21.5 11.9 17.4 25.3 7.7 5.0 10.0 14.0 16.6 21.7 14.0 26.9 7.0 14.3 19.4 16.9 36.9 21.7 11.0 29.5 7.5 13.3 14.6 EXTL1 "EXTL, MGC70794" ENSG00000158008 "Exostosin like glycosyltransferase 1" Q92935 1 26019884-26036464 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 21.1;heart muscle: 6.0;skeletal muscle: 20.5" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 6.2;Cardiomyocytes: 2.9;Horizontal cells: 9.5;Melanocytes: 6.8" "Cancer enriched" "Detected in some" 13 "melanoma: 21.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "WM-115: 58.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA010726, HPA037749" Approved Approved Vesicles,Centrosome "Intracellular and membrane" NA NA 68000 Centrosome Vesicles "HPA010726: , HPA037749: AB_10805350" "unprognostic (2.00e-1)" "unprognostic (1.10e-2)" "unprognostic (8.16e-3)" "unprognostic (1.47e-2)" "unprognostic (2.47e-2)" "unprognostic (6.14e-3)" "unprognostic (3.78e-2)" "unprognostic (1.99e-1)" "unprognostic (1.99e-1)" "unprognostic (6.70e-2)" "unprognostic (1.44e-2)" "unprognostic (3.46e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-3)" "unprognostic (2.27e-2)" "unprognostic (2.91e-1)" "unprognostic (1.35e-2)" 0.6 2.1 15.3 0.6 9.5 0.5 2.0 1.1 21.1 1.3 0.6 1.4 0.0 0.7 2.5 0.7 1.5 1.7 1.2 6.0 12.7 3.7 0.7 0.5 0.7 0.8 3.7 7.9 2.3 1.0 0.5 0.5 1.0 2.9 1.2 0.6 2.7 0.8 0.9 20.5 1.6 0.7 2.9 2.7 2.2 0.6 1.0 0.8 0.0 0.9 3.2 0.6 0.9 0.2 0.1 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 58.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.1 15.3 9.5 1.1 21.1 12.7 3.7 3.7 7.9 2.9 0.8 0.0 0.0 0.0 0.0 0.1 6.2 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 0.4 1.4 0.0 6.8 0.0 0.0 0.6 0.0 0.0 2.5 0.0 1.4 0.0 0.3 0.2 0.2 0.0 0.8 0.0 0.0 0.0 EXTL2 ENSG00000162694 "Exostosin like glycosyltransferase 2" Q9UBQ6 1 100872372-100895998 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 175.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020716, HPA068921" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 83000000 Nucleoplasm Cytosol "CAB020716: , HPA068921: AB_2686058" "unprognostic (3.14e-1)" "unprognostic (6.34e-2)" "unprognostic (1.50e-2)" "unprognostic (8.20e-2)" "unprognostic (9.07e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (1.10e-2)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (3.00e-1)" "unprognostic (3.17e-2)" "unprognostic (6.84e-2)" "unprognostic (7.83e-2)" "unprognostic (1.24e-2)" "unprognostic (4.34e-2)" 7.5 23.0 9.8 4.1 19.9 1.7 10.4 14.7 22.8 13.4 8.7 8.1 9.9 4.5 16.7 13.1 6.0 10.1 10.3 8.2 9.5 13.3 11.2 10.0 7.6 3.4 14.0 12.0 18.8 7.7 17.5 18.7 21.8 20.1 12.3 7.1 8.6 6.0 11.4 5.3 5.9 4.6 15.4 11.4 5.4 6.2 9.7 16.3 6.4 9.3 5.0 3.4 9.0 6.2 2.1 7.4 3.3 1.1 5.3 5.6 1.9 5.2 2.7 20.1 21.0 22.3 16.5 12.8 9.0 14.9 7.1 15.9 2.6 4.0 5.8 8.8 8.3 5.6 5.1 7.3 7.7 14.4 11.8 5.1 7.1 9.7 7.2 7.3 11.0 3.8 19.5 2.7 14.2 2.8 15.0 25.9 7.4 8.9 0.7 17.9 2.7 5.8 6.1 25.3 4.7 6.1 4.2 20.7 4.7 7.6 4.0 8.3 23.6 6.9 1.8 16.2 15.3 4.3 5.0 10.8 17.8 10.5 11.4 9.5 6.2 5.5 3.6 28.3 11.4 5.8 3.3 0.8 0.0 5.6 1.1 2.8 1.9 1.9 3.7 2.5 2.1 2.1 4.8 0.2 5.3 0.9 7.4 0.0 1.9 9.8 19.9 14.7 22.8 9.5 13.3 14.0 12.0 20.1 16.3 11.9 5.9 2.2 11.4 7.6 20.3 9.7 10.2 29.4 14.8 14.0 33.4 175.5 10.0 5.2 19.7 10.8 2.0 0.0 1.8 25.1 33.5 5.4 17.3 14.7 21.3 3.2 9.1 15.4 7.0 27.2 23.3 3.6 21.9 10.0 3.9 18.6 2.5 2.9 32.5 10.8 17.8 12.9 16.5 29.8 8.1 7.0 62.1 6.9 6.3 3.0 EXTL3 "botv, REGR" ENSG00000012232 "Exostosin like glycosyltransferase 3" O43909 8 28600469-28755599 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025387 Approved NA NA "CAB025387: " "unprognostic (1.35e-1)" "unprognostic (1.31e-1)" "unprognostic (5.53e-2)" "unprognostic (1.19e-3)" "unprognostic (9.83e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.14e-5)" "unprognostic (4.25e-2)" "unprognostic (9.29e-3)" "unprognostic (1.05e-1)" "unprognostic (5.10e-3)" "unprognostic (1.19e-3)" "prognostic favorable (2.47e-5)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (8.91e-2)" "unprognostic (1.39e-2)" 12.1 19.0 15.4 7.9 19.5 4.0 11.6 14.8 26.9 11.3 10.5 16.2 8.8 6.3 15.0 7.9 14.0 13.7 9.6 34.6 15.4 13.4 8.5 6.7 10.1 5.9 11.6 18.1 12.2 13.0 26.1 13.8 15.7 12.9 10.2 6.5 15.2 8.8 14.8 20.7 13.5 6.8 19.8 11.7 9.3 9.6 14.3 10.8 5.4 9.2 8.7 5.9 12.2 9.5 0.8 2.4 10.0 2.3 1.0 3.6 1.5 19.4 14.7 32.9 16.9 9.0 9.3 7.2 14.7 14.9 9.4 7.9 12.5 7.0 5.3 21.3 17.9 13.4 13.1 15.1 24.2 10.1 3.8 8.3 7.4 7.4 6.3 5.2 3.6 21.3 10.4 16.4 7.1 6.6 8.4 20.0 8.0 6.8 6.8 7.3 3.7 6.5 2.4 22.3 6.5 6.0 7.9 14.1 3.0 16.1 12.6 7.0 12.3 6.2 3.9 8.4 10.8 3.7 4.5 15.2 12.3 29.0 11.3 12.4 3.7 7.3 6.0 10.3 4.5 10.9 4.0 2.0 3.3 3.6 2.3 2.1 0.6 1.3 1.9 2.4 0.8 1.1 0.9 10.0 1.0 2.3 2.3 0.8 1.5 15.4 19.5 14.8 26.9 15.4 13.4 11.6 18.1 12.9 10.8 3.0 4.1 0.8 2.1 4.4 14.9 21.3 5.1 2.7 2.3 1.8 23.6 3.3 3.3 9.0 14.8 6.4 2.8 0.0 9.2 15.1 5.8 4.1 5.7 6.6 3.7 7.9 4.1 6.2 5.3 6.4 9.2 3.3 5.0 1.8 2.2 5.8 9.7 3.1 13.4 3.2 14.7 25.8 6.2 4.3 7.0 2.6 1.8 5.0 2.4 2.1 F10 ENSG00000126218 "Coagulation factor X" P00742 13 113122814-113149529 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 116.7" "Cell type enhanced" "Detected in many" 12 "Hepatocytes: 174.9;Leydig cells: 199.9;Peritubular cells: 222.0" "Cancer enriched" "Detected in many" 11 "liver cancer: 95.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 8.5;BJ hTERT+: 6.8;CACO-2: 7.2;fHDF/TERT166: 7.6;Hep G2: 33.5;HHSteC: 7.0;SH-SY5Y: 16.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 16000000000 "unprognostic (4.18e-2)" "unprognostic (1.07e-1)" "unprognostic (7.62e-2)" "unprognostic (9.88e-2)" "unprognostic (9.44e-2)" "unprognostic (1.15e-2)" "unprognostic (4.90e-2)" "unprognostic (1.02e-2)" "unprognostic (2.54e-1)" "unprognostic (1.24e-1)" "prognostic favorable (1.82e-5)" "unprognostic (6.39e-2)" "prognostic unfavorable (5.14e-5)" "unprognostic (6.60e-2)" "unprognostic (1.21e-1)" "unprognostic (3.87e-2)" "unprognostic (2.23e-3)" 8.1 3.7 0.3 2.9 0.7 0.0 5.4 0.4 0.8 20.3 5.9 0.6 7.6 4.5 12.6 21.4 4.5 9.9 10.0 18.4 0.5 0.5 2.3 116.7 4.9 1.6 0.5 0.7 18.2 3.0 0.0 1.7 3.6 1.0 18.1 0.7 6.9 2.0 6.1 2.6 7.8 7.6 11.7 0.6 1.3 3.2 9.5 0.6 0.6 3.1 5.6 1.8 7.8 10.3 0.0 0.0 0.0 0.0 0.9 1.0 0.3 0.0 0.0 1.5 0.2 4.9 5.0 0.0 8.5 6.8 0.5 0.2 7.2 0.0 0.0 0.3 7.6 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 33.5 7.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.6 16.6 0.0 0.3 0.0 0.3 0.3 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.9 0.0 0.0 0.0 0.3 0.3 0.7 0.4 0.8 0.5 0.5 0.5 0.7 1.0 0.6 0.0 0.0 0.0 0.0 14.0 1.0 4.8 7.6 0.0 0.0 1.8 0.0 0.6 0.0 0.0 2.6 2.1 0.3 0.0 0.0 0.6 66.0 0.1 1.1 174.9 1.2 6.4 17.1 9.8 4.5 5.6 199.9 0.3 18.6 1.0 1.4 3.8 0.5 2.9 222.0 5.6 1.1 51.8 54.2 2.1 1.1 13.4 0.9 2.5 0.9 0.2 F11R "CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1" ENSG00000158769 "F11 receptor" Q9Y624 1 160995211-161021348 "CD markers, Plasma proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 235.2;Urothelial cells: 227.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 44.5;neutrophil: 32.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 44.5" "Cell line enhanced" "Detected in many" "HaCaT: 45.8;OE19: 44.1;SuSa: 54.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004671, HPA043616, HPA061700" Enhanced Supported "Cell Junctions,Microtubules" NA NA 41000000 Microtubules "Cell Junctions" "CAB004671: AB_425964, HPA043616: , HPA061700: AB_2684589" "unprognostic (1.60e-2)" "unprognostic (5.78e-3)" "unprognostic (1.78e-3)" "unprognostic (2.24e-1)" "unprognostic (4.99e-2)" "unprognostic (4.89e-2)" "unprognostic (2.28e-1)" "unprognostic (2.55e-1)" "unprognostic (6.35e-2)" "unprognostic (1.98e-3)" "unprognostic (1.87e-2)" "unprognostic (1.24e-1)" "unprognostic (1.78e-1)" "unprognostic (2.50e-1)" "unprognostic (1.59e-1)" "unprognostic (9.72e-3)" "unprognostic (5.01e-2)" 20.7 13.3 3.0 9.6 3.6 6.4 11.8 2.0 3.5 14.5 36.3 3.9 21.4 20.5 8.6 11.2 41.5 12.3 30.5 10.0 3.4 3.2 35.9 69.8 55.0 10.4 3.6 1.8 10.9 37.9 18.5 16.3 61.8 5.3 17.8 19.5 5.7 59.3 23.7 9.0 22.0 59.8 4.9 4.0 27.0 18.8 11.0 3.3 8.1 52.2 25.8 29.9 16.8 19.7 1.3 7.0 44.5 8.9 2.2 3.8 6.6 26.4 3.4 1.0 0.3 0.7 0.0 21.5 0.1 0.0 0.9 0.9 24.5 35.0 1.9 18.0 0.0 5.2 45.8 5.4 22.7 1.4 1.5 4.0 5.5 1.4 11.1 1.1 5.1 16.5 0.3 28.7 0.1 7.6 5.5 21.5 4.2 7.5 0.5 0.1 11.4 1.6 2.9 18.2 44.1 4.9 2.4 0.0 8.5 15.4 20.1 7.6 2.0 6.4 27.5 5.7 54.5 29.9 9.2 12.9 0.0 0.6 0.1 0.2 6.4 12.6 0.6 4.1 5.1 1.7 7.6 8.9 44.5 3.8 4.5 2.0 1.3 3.5 2.3 7.0 0.9 3.4 2.7 32.2 2.2 3.4 5.3 1.5 6.6 3.0 3.6 2.0 3.5 3.4 3.2 3.6 1.8 5.3 3.3 235.2 115.8 3.7 97.8 31.3 0.8 3.0 61.1 163.3 161.5 73.3 2.0 64.9 6.6 66.4 6.8 40.7 78.8 0.0 61.9 148.6 11.0 102.0 17.4 55.2 27.9 0.0 59.7 24.5 14.6 1.5 2.0 22.4 8.5 63.1 64.1 1.4 68.6 75.0 0.7 11.9 2.5 0.0 3.1 12.9 1.2 44.3 52.7 8.7 42.7 227.3 F2R "CF2R, PAR-1, PAR1, TR" ENSG00000181104 "Coagulation factor II thrombin receptor" P25116 5 76716043-76735781 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.5" "Cell type enriched" "Detected in many" 9 "Ito cells: 323.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 17.6" "Lineage enriched" "Detected in many" 4 "T-cells: 17.6" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 39.1;HUVEC TERT2: 71.3;WM-115: 67.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB008973, CAB012962" Approved NA NA "CAB008973: , CAB012962: AB_2533198" "unprognostic (3.03e-1)" "unprognostic (7.76e-2)" "unprognostic (5.55e-2)" "unprognostic (7.76e-2)" "unprognostic (7.14e-2)" "unprognostic (3.46e-1)" "unprognostic (2.51e-1)" "unprognostic (3.75e-2)" "unprognostic (5.37e-2)" "unprognostic (1.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (2.21e-7)" "unprognostic (2.72e-3)" "unprognostic (1.30e-1)" "unprognostic (1.12e-1)" "unprognostic (6.74e-3)" 12.3 11.2 1.5 7.5 2.2 1.1 8.9 0.8 3.5 11.7 14.0 3.3 20.1 5.9 17.6 8.6 9.3 3.5 20.8 19.2 1.4 1.7 19.5 22.6 24.4 10.4 1.5 1.8 6.2 4.0 1.6 4.7 32.0 2.5 9.6 5.1 9.6 26.4 14.0 7.2 23.7 15.5 8.4 3.5 67.5 4.5 16.6 1.4 4.0 9.1 11.4 13.5 10.7 4.7 0.4 0.2 0.8 0.3 4.2 17.6 6.4 1.0 3.3 10.5 1.7 19.8 34.7 0.5 5.8 20.0 3.8 13.9 0.7 9.1 0.0 9.9 2.5 17.4 2.5 4.5 3.5 7.3 0.8 3.7 22.8 0.7 2.8 29.9 0.1 0.9 19.5 11.9 7.3 2.0 39.1 71.3 4.1 4.2 4.3 7.8 0.4 1.7 0.0 3.3 0.0 18.2 3.2 6.3 0.8 18.1 0.1 1.2 5.7 1.7 0.0 8.5 9.9 0.1 0.2 32.6 24.3 5.4 0.2 10.8 11.7 3.4 0.0 6.4 0.4 67.2 0.5 0.2 0.3 17.6 0.3 4.4 0.4 4.1 12.1 0.0 0.1 0.7 9.1 0.8 4.2 0.1 0.2 0.4 6.4 1.5 2.2 0.8 2.1 1.4 1.7 1.5 1.8 2.5 1.4 0.0 11.6 1.5 0.5 15.2 2.5 2.0 10.2 4.0 3.4 7.0 0.0 0.1 0.0 1.9 8.8 22.6 0.2 0.0 1.9 0.3 28.8 1.2 5.8 2.5 1.6 0.0 6.3 323.5 25.7 3.6 0.9 1.3 11.8 0.0 3.2 0.0 6.7 0.0 9.9 2.2 1.6 0.0 17.5 6.7 4.1 35.0 0.2 30.2 1.0 0.4 F2RL1 "GPR11, PAR2" ENSG00000164251 "F2R like trypsin receptor 1" P55085 5 76818933-76835315 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.1" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 97.5;Enterocytes: 75.9;Suprabasal keratinocytes: 147.0;Urothelial cells: 93.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 7.8" "Cell type enriched" "Detected in many" 4 "neutrophil: 24.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 24.9" "Cell line enhanced" "Detected in many" "PC-3: 34.7;RPTEC TERT1: 57.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB012989, HPA014091" Approved Approved "Plasma membrane" NA Yes "Plasma membrane" "CAB012989: AB_2533199, HPA014091: AB_2668939" "unprognostic (1.29e-2)" "unprognostic (4.05e-2)" "prognostic favorable (3.88e-4)" "unprognostic (1.98e-2)" "unprognostic (8.22e-2)" "prognostic unfavorable (5.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (8.92e-4)" "unprognostic (6.13e-2)" "unprognostic (4.07e-1)" "unprognostic (2.16e-3)" "unprognostic (1.52e-2)" "prognostic favorable (5.86e-7)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (3.76e-2)" "unprognostic (9.73e-2)" 0.6 1.1 1.0 7.2 1.4 0.1 2.9 0.4 0.8 2.4 34.0 1.1 25.3 17.4 1.0 2.2 6.4 2.9 13.6 3.6 1.1 0.9 28.9 7.4 2.8 3.7 0.8 0.4 1.2 16.6 1.3 3.2 2.8 7.8 6.0 21.4 1.1 7.1 23.7 0.3 24.8 64.1 0.7 1.5 3.5 16.8 0.8 0.5 0.6 9.6 5.8 3.1 5.3 3.9 0.3 2.7 24.9 5.7 0.3 2.3 2.0 8.7 14.4 1.2 0.0 0.4 1.1 9.3 0.4 4.8 0.2 0.7 12.4 22.6 0.0 19.5 1.0 22.3 15.0 7.6 6.7 0.4 0.0 7.1 0.2 0.3 8.8 3.1 0.0 0.0 1.6 19.2 2.2 14.4 2.3 23.9 2.2 0.1 0.0 0.0 4.7 1.0 0.0 1.6 4.9 34.7 0.0 0.0 0.2 57.6 16.2 0.6 0.1 3.4 3.5 0.0 14.5 1.5 0.0 15.7 0.0 9.1 0.0 0.0 1.3 0.2 0.0 5.1 0.0 0.4 4.6 5.7 1.0 0.3 1.9 1.2 0.3 2.3 1.2 2.7 0.1 2.2 1.3 24.9 0.3 0.3 0.3 0.6 2.0 1.0 1.4 0.4 0.8 1.1 0.9 0.8 0.4 7.8 0.5 8.9 3.0 2.0 18.2 97.5 0.0 0.3 35.7 18.7 11.4 29.6 0.0 4.8 1.7 20.1 0.0 0.6 75.9 0.0 13.1 6.2 3.7 19.6 2.3 8.5 0.7 0.0 12.6 1.8 2.4 0.0 0.0 1.1 1.7 0.0 43.8 0.0 29.3 35.1 0.0 20.2 1.6 0.0 1.0 0.0 1.4 147.0 1.7 0.0 39.6 93.4 F2RL2 PAR3 ENSG00000164220 "Coagulation factor II thrombin receptor like 2" O00254 5 76615482-76623434 "G-protein coupled receptors, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 34.2" "Cell type enhanced" "Detected in some" 21 "Collecting duct cells: 1.8;Ito cells: 9.2;Kupffer cells: 2.7;Rod photoreceptor cells: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "basophil: 10.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 20.8;HBF TERT88: 13.4;HEL: 28.0;hTEC/SVTERT24-B: 13.7;hTERT-RPE1: 29.0;U-138 MG: 21.5;WM-115: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.35e-3)" "unprognostic (5.71e-3)" "prognostic favorable (4.69e-4)" "unprognostic (6.71e-2)" "unprognostic (4.16e-3)" "unprognostic (3.56e-2)" "unprognostic (9.71e-2)" "unprognostic (8.49e-2)" "unprognostic (3.78e-2)" "unprognostic (1.43e-1)" "unprognostic (1.14e-1)" "unprognostic (3.20e-1)" "unprognostic (2.24e-8)" "unprognostic (7.64e-2)" "unprognostic (8.98e-2)" "unprognostic (1.29e-1)" "unprognostic (1.73e-2)" 0.7 0.7 0.4 2.7 1.3 0.3 6.1 0.1 0.8 2.3 6.7 0.5 0.0 2.5 5.9 0.5 5.9 0.6 11.4 2.6 0.9 3.8 1.0 5.1 1.1 0.1 4.7 0.7 0.3 4.2 0.2 1.5 0.4 7.0 0.9 2.9 34.2 7.4 0.2 0.3 4.6 6.3 6.3 1.1 0.5 2.9 0.4 0.1 4.1 0.6 10.2 3.1 2.1 0.8 0.3 1.6 10.2 0.7 1.8 1.2 0.1 0.0 0.8 0.0 0.0 0.9 4.9 0.0 12.0 20.8 3.3 12.0 0.0 0.0 0.0 0.7 0.0 9.7 0.0 0.0 0.0 13.4 0.0 0.0 28.0 0.2 0.1 1.9 0.0 0.0 2.6 0.0 13.7 0.0 29.0 1.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 21.5 6.5 0.9 0.1 1.0 0.0 0.0 2.5 0.0 26.8 10.2 0.7 0.2 1.2 0.3 1.0 0.1 1.1 0.6 0.2 0.3 0.5 1.2 1.4 1.8 0.2 1.6 1.2 0.1 0.4 1.3 0.1 0.8 0.9 3.8 4.7 0.7 7.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 9.2 2.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 F2RL3 PAR4 ENSG00000127533 "F2R like thrombin or trypsin receptor 3" Q96RI0 19 16888860-16892606 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 69.4;breast: 30.7;lung: 33.0" "Group enriched" "Detected in some" 5 "Endothelial cells: 5.8;granulocytes: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "HEL: 24.9;HMC-1: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031401, HPA042340" Supported "Plasma membrane" NA NA "Plasma membrane" "HPA031401: , HPA042340: " "unprognostic (6.17e-2)" "unprognostic (1.08e-1)" "unprognostic (2.64e-2)" "unprognostic (3.83e-1)" "unprognostic (3.27e-1)" "unprognostic (8.31e-3)" "unprognostic (2.97e-1)" "unprognostic (3.28e-2)" "unprognostic (6.52e-2)" "unprognostic (2.60e-1)" "unprognostic (6.30e-2)" "unprognostic (3.00e-3)" "prognostic favorable (6.25e-4)" "unprognostic (2.37e-2)" "unprognostic (1.43e-1)" "unprognostic (3.53e-1)" "unprognostic (2.11e-2)" 69.4 3.3 0.2 2.6 0.4 1.3 30.7 0.2 0.6 1.3 16.9 0.4 0.5 1.9 1.3 1.9 4.3 1.0 4.5 9.7 0.5 0.2 5.0 0.8 33.0 2.6 0.2 0.3 3.9 12.3 0.5 2.3 1.1 1.4 1.4 1.5 1.3 1.0 0.8 6.5 2.2 4.4 1.1 0.2 3.0 5.4 2.5 0.2 0.3 27.1 2.3 1.5 3.4 1.9 5.3 4.3 5.8 2.5 3.9 3.3 3.2 0.2 0.2 0.7 0.3 0.1 0.2 0.7 0.4 0.1 0.2 0.1 0.4 0.7 0.5 0.5 0.2 0.3 0.7 0.1 0.2 0.2 0.3 0.4 24.9 0.9 0.4 0.2 0.3 10.0 0.0 0.1 0.3 0.2 0.3 0.8 0.5 2.0 1.0 0.1 0.3 0.3 2.4 0.3 0.3 0.2 0.2 0.2 0.8 0.2 0.5 0.4 0.2 0.2 0.2 0.1 0.6 0.5 1.7 1.0 0.6 0.5 0.3 0.3 0.5 0.3 0.5 0.2 0.4 0.4 5.8 2.5 1.6 2.2 1.4 2.1 3.9 2.4 1.9 0.8 5.3 3.3 3.1 5.3 3.9 1.8 4.3 1.7 3.2 0.2 0.4 0.2 0.6 0.5 0.2 0.2 0.3 1.4 0.2 0.0 0.6 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.5 0.0 0.5 0.3 6.9 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.5 0.0 0.0 0.3 F3 "CD142, TF" ENSG00000117525 "Coagulation factor III, tissue factor" P13726 1 94529225-94541800 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 636.0;Exocrine glandular cells: 410.4;Muller glia cells: 389.7;Pancreatic endocrine cells: 1078.7;Peritubular cells: 498.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 117.4;HaCaT: 55.6;HBEC3-KT: 144.4;U-2197: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009438, HPA049292, HPA069132" Uncertain Approved Vesicles "Secreted to blood" NA NA 603000 Vesicles "CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092" "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (8.04e-2)" "unprognostic (1.64e-1)" "unprognostic (2.69e-2)" "unprognostic (1.23e-3)" "unprognostic (4.93e-2)" "unprognostic (8.00e-2)" "unprognostic (5.88e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.07e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.02e-8)" "unprognostic (4.84e-2)" "unprognostic (4.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.08e-1)" 45.5 9.8 27.0 14.1 42.9 2.1 55.1 3.4 27.9 14.8 18.7 20.9 18.7 18.3 30.5 23.7 21.3 25.4 30.9 18.8 26.9 14.5 6.6 2.8 31.4 5.8 14.1 20.3 41.6 35.0 6.1 28.8 65.4 39.2 29.7 22.2 49.9 29.2 33.0 2.4 17.7 19.2 5.9 46.3 2.9 18.2 16.4 16.0 0.0 21.8 17.3 11.9 24.7 22.3 0.5 0.9 2.8 0.8 0.7 0.4 0.2 117.4 0.2 0.2 0.0 12.8 6.3 6.6 16.7 10.0 18.1 19.7 2.1 25.2 0.0 8.6 20.7 3.9 55.6 1.5 144.4 29.9 0.1 0.1 0.0 3.6 0.3 4.2 0.0 0.0 10.9 3.2 8.5 41.9 34.4 0.1 0.1 0.1 0.1 12.6 0.2 0.1 2.4 1.1 0.7 0.2 0.1 1.2 0.0 2.2 0.3 0.1 0.3 13.3 5.5 0.4 3.6 0.1 1.6 0.0 11.0 0.3 54.8 5.0 0.1 0.1 0.1 8.4 0.6 0.4 1.7 0.8 0.1 0.3 0.3 0.4 0.2 0.3 0.2 0.2 0.5 0.3 0.3 2.8 0.7 0.2 0.9 0.2 0.2 27.0 42.9 3.4 27.1 26.9 14.5 14.1 20.3 39.2 16.0 122.1 188.9 0.5 636.0 14.4 1.5 21.1 7.6 72.3 238.8 14.0 0.0 13.6 0.0 120.9 5.6 10.5 10.3 0.0 410.4 4.8 48.3 85.3 2.3 0.6 5.4 3.2 12.6 12.3 4.0 9.8 260.4 4.9 3.3 3.6 40.9 389.7 1078.7 11.0 498.9 0.3 13.3 6.5 7.2 1.1 3.4 6.6 6.4 0.8 9.5 358.5 FA2H "FAAH, FAXDC1, FLJ25287, SPG35" ENSG00000103089 "Fatty acid 2-hydroxylase" Q7L5A8 16 74712955-74774831 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Oxidoreductase "Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.2;stomach 1: 45.5" "Cell type enhanced" "Detected in many" 20 "Mucus-secreting cells: 34.0;Paneth cells: 56.1;Urothelial cells: 163.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 24 "memory B-cell: 3.0" "Lineage enriched" "Detected in single" 24 "B-cells: 3.0" "Cell line enhanced" "Detected in some" "A549: 16.0;HAP1: 20.7;JURKAT: 38.1;OE19: 25.5;SK-BR-3: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056614, HPA077840" Approved Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA056614: AB_2683191, HPA077840: AB_2686858" "unprognostic (1.33e-1)" "unprognostic (4.97e-2)" "unprognostic (9.19e-2)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.85e-2)" "unprognostic (1.48e-2)" "unprognostic (2.47e-2)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.74e-4)" "unprognostic (6.01e-2)" "prognostic favorable (5.01e-6)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.83e-2)" "unprognostic (2.11e-3)" 0.7 0.7 11.8 3.4 27.7 0.7 2.6 2.8 25.3 2.0 16.2 62.4 0.0 8.1 0.7 2.2 3.7 1.8 14.3 0.7 22.3 11.0 3.7 0.7 1.5 0.9 40.5 16.5 0.6 6.8 7.1 0.8 1.0 28.5 1.9 15.4 0.0 8.4 1.0 0.6 3.5 11.3 1.4 78.2 0.8 45.5 2.4 44.6 2.6 2.0 0.0 4.7 3.8 1.2 3.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 16.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 8.7 8.9 0.0 0.0 0.0 0.9 1.5 20.7 0.2 0.0 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0 0.0 6.3 0.3 0.0 0.4 25.5 1.0 0.0 0.0 0.7 10.1 6.5 2.8 0.0 0.0 12.3 0.0 0.5 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.8 27.7 2.8 16.1 22.3 11.0 40.5 16.5 28.5 44.6 0.0 2.2 0.0 4.2 0.5 0.0 0.3 10.2 4.0 2.3 0.0 0.0 0.2 6.6 11.5 6.3 0.0 25.4 0.0 12.9 0.1 0.0 20.7 0.0 0.0 0.1 0.0 6.4 0.0 0.0 2.7 0.0 0.0 3.3 0.0 34.0 0.0 26.4 56.1 0.4 0.0 0.0 0.0 0.1 0.5 2.1 0.6 0.1 0.0 16.8 163.9 FAAH FAAH-1 ENSG00000117480 "Fatty acid amide hydrolase" O00519 1 46394265-46413848 "Enzymes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 68.0;Late spermatids: 88.3;Spermatocytes: 73.1" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 19.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 22.2;OE19: 10.7;RT4: 23.9;SK-BR-3: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007425 Approved Approved Cytosol NA NA Cytosol "HPA007425: AB_1078820" "unprognostic (6.12e-2)" "unprognostic (2.04e-1)" "unprognostic (2.51e-2)" "prognostic favorable (1.51e-4)" "unprognostic (1.72e-1)" "unprognostic (4.97e-2)" "unprognostic (2.00e-1)" "unprognostic (6.64e-3)" "unprognostic (2.91e-2)" "unprognostic (2.33e-1)" "unprognostic (4.39e-3)" "unprognostic (9.86e-2)" "prognostic favorable (4.25e-5)" "prognostic favorable (3.63e-5)" "unprognostic (2.66e-1)" "unprognostic (9.97e-2)" "unprognostic (5.00e-3)" 6.1 7.7 11.2 2.5 22.0 7.9 7.9 20.4 21.9 6.9 15.0 40.7 10.1 18.0 3.1 8.2 4.9 10.6 4.6 2.9 14.7 11.7 12.0 18.3 6.7 2.1 19.1 19.3 2.7 18.2 15.1 10.6 3.5 17.6 33.3 12.8 7.4 12.8 8.6 7.1 10.1 17.8 2.3 23.6 2.0 14.3 30.9 18.8 5.6 24.9 3.5 3.5 5.7 4.2 0.1 6.0 19.1 4.7 0.3 0.4 0.9 2.8 0.7 0.4 0.5 0.7 0.5 22.2 0.6 0.3 0.3 0.5 4.1 6.6 0.2 2.3 0.4 0.2 9.4 0.4 1.3 0.1 1.2 3.1 0.0 0.1 1.9 0.5 0.8 1.6 0.4 6.4 0.2 0.8 0.2 0.0 0.5 0.1 0.5 0.0 5.9 0.4 1.2 1.8 10.7 0.2 0.5 0.2 0.1 5.2 23.9 2.8 2.1 3.2 12.4 0.1 0.6 8.5 8.2 0.0 0.0 0.3 0.6 0.4 1.2 0.5 0.3 0.1 7.6 0.2 0.0 4.7 19.1 0.3 1.2 0.1 0.0 0.3 0.1 5.7 0.1 0.4 0.4 0.2 0.3 0.6 6.0 0.1 0.9 11.2 22.0 20.4 21.9 14.7 11.7 19.1 19.3 17.6 18.8 20.8 10.4 4.2 27.1 4.6 12.6 2.2 25.5 4.0 10.3 21.0 41.2 14.4 0.0 12.8 35.5 1.8 68.0 0.0 5.6 6.3 2.4 27.0 0.0 29.2 2.6 1.6 14.9 0.6 3.2 88.3 6.9 2.9 5.0 0.0 33.1 6.3 5.0 40.4 4.2 19.5 11.4 0.0 2.7 73.1 7.7 5.3 10.4 0.0 48.5 12.3 FAAH2 "AMDD, FAAH-2, FLJ31204, RP11-479E16.1" ENSG00000165591 "Fatty acid amide hydrolase 2" Q6GMR7 X 57286706-57489196 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 43.6;pituitary gland: 42.8" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 24.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 18.0" "Cell type enhanced" "Detected in many" "T-reg: 13.6" "Lineage enriched" "Detected in many" 8 "T-cells: 13.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 10.7;HDLM-2: 9.6;RPMI-8226: 19.4;U-266/70: 16.3;U-266/84: 8.3" NA NA "unprognostic (1.37e-1)" "unprognostic (1.78e-2)" "unprognostic (7.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.02e-1)" "unprognostic (4.51e-2)" "unprognostic (7.93e-3)" "unprognostic (4.47e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.99e-4)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" "prognostic favorable (2.47e-13)" "unprognostic (9.16e-3)" "unprognostic (2.27e-1)" "prognostic favorable (2.66e-4)" "prognostic favorable (6.83e-5)" 1.0 1.4 1.0 6.8 1.5 0.0 6.7 18.0 1.0 3.5 3.9 0.2 3.8 2.6 1.4 4.7 5.5 5.8 2.4 0.6 1.2 2.3 9.7 20.1 3.5 5.7 1.1 0.5 1.9 43.6 12.7 42.8 1.4 1.8 9.3 3.6 3.8 9.1 5.3 0.3 10.0 6.4 0.6 1.1 2.3 4.1 0.6 0.3 8.5 15.3 2.7 11.0 3.0 3.6 1.8 1.0 0.3 0.0 0.7 13.6 1.5 2.5 0.2 0.0 0.1 0.1 0.1 2.4 0.0 0.0 0.0 0.0 1.8 10.7 0.1 3.1 0.0 0.0 0.4 0.8 1.9 0.0 9.6 5.2 0.3 2.5 0.7 0.0 1.1 0.0 0.0 3.2 0.0 0.0 0.1 0.0 1.0 1.2 4.8 0.0 1.0 0.5 0.0 1.8 2.2 0.0 0.0 1.8 19.4 6.3 3.4 1.8 0.1 0.1 3.0 0.0 4.6 3.0 0.0 0.0 0.0 0.2 0.0 0.1 16.3 8.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 4.7 1.8 7.7 3.2 0.0 0.6 7.5 0.9 0.3 0.7 0.0 1.0 13.6 1.5 1.0 1.5 18.0 1.0 1.2 2.3 1.1 0.5 1.8 0.3 3.0 5.6 0.0 11.2 2.4 3.1 0.3 2.5 24.1 6.8 5.2 17.7 4.4 8.3 8.3 0.0 0.0 3.9 0.0 12.2 2.1 0.5 10.4 0.0 9.0 0.6 1.6 12.7 0.6 0.0 0.0 0.6 0.0 3.3 1.0 5.6 1.2 11.6 3.4 0.4 4.5 12.2 0.0 0.1 0.0 0.0 5.8 4.7 2.5 4.7 9.0 FADS1 "D5D, FADS6, FADSD5, LLCDL1, TU12" ENSG00000149485 "Fatty acid desaturase 1" O60427 11 61799625-61829318 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 82.0;Rod photoreceptor cells: 89.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 99.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042705 Approved NA NA "HPA042705: AB_10795709" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.29e-1)" "unprognostic (1.99e-1)" "unprognostic (8.17e-3)" "unprognostic (1.40e-1)" "unprognostic (1.99e-2)" "unprognostic (3.23e-3)" "unprognostic (7.88e-2)" "unprognostic (1.94e-2)" "unprognostic (4.10e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (1.95e-9)" "unprognostic (2.29e-2)" "unprognostic (3.59e-2)" "prognostic unfavorable (2.79e-4)" "prognostic unfavorable (1.33e-4)" 15.1 51.6 26.7 14.4 21.8 6.6 7.6 12.5 41.4 9.6 4.8 46.1 12.9 4.6 14.8 5.6 4.6 8.5 11.1 16.6 23.2 21.8 6.5 38.3 14.9 11.5 16.2 25.4 23.2 7.8 34.4 11.3 15.3 27.1 15.2 4.3 23.0 4.9 13.5 8.9 7.7 3.8 15.4 18.6 6.1 5.7 9.0 21.8 3.3 4.5 1.9 6.9 8.7 7.8 4.2 14.9 3.8 21.1 3.6 6.6 7.3 11.8 31.1 29.7 7.4 58.5 99.0 8.7 7.5 36.6 13.0 21.8 9.5 26.4 0.4 8.2 11.0 32.6 15.5 23.8 20.9 9.6 2.1 3.4 18.6 35.7 17.0 31.4 4.1 1.9 44.5 6.9 29.0 14.1 13.5 11.6 19.2 10.2 22.0 12.8 3.2 13.9 4.1 17.2 0.9 11.5 15.4 29.3 41.2 14.9 5.3 15.1 16.7 18.9 0.3 16.4 11.1 7.0 17.9 10.9 13.5 13.7 13.5 9.0 21.1 19.0 9.5 8.0 19.2 11.0 3.8 18.0 3.2 6.6 21.1 1.4 1.3 2.3 2.7 14.9 4.2 1.3 3.2 1.4 3.6 8.9 12.5 1.4 7.3 26.7 21.8 12.5 25.5 23.2 21.8 16.2 25.4 27.1 21.8 6.0 65.1 11.5 1.6 2.4 73.3 30.9 5.1 5.3 22.7 12.2 25.5 4.8 0.0 12.9 6.7 9.5 0.0 0.0 29.6 42.1 29.7 6.9 35.9 30.1 30.3 65.2 9.4 8.0 17.1 11.3 27.6 19.4 30.4 41.5 0.2 82.0 7.9 0.0 20.1 0.9 89.8 0.0 23.3 7.0 10.4 1.3 7.8 6.4 0.4 1.0 FADS2 "D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13" ENSG00000134824 "Fatty acid desaturase 2" O95864 11 61792980-61867354 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 204.5;seminal vesicle: 98.8" "Cell type enhanced" "Detected in many" 5 "monocytes: 34.3;Muller glia cells: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 151.3;HBEC3-KT: 90.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006741 Approved NA NA "HPA006741: AB_1078796" "unprognostic (2.37e-2)" "unprognostic (1.02e-1)" "unprognostic (8.34e-2)" "unprognostic (4.33e-3)" "unprognostic (4.63e-2)" "unprognostic (2.42e-2)" "unprognostic (4.51e-2)" "unprognostic (4.35e-3)" "unprognostic (2.01e-1)" "unprognostic (4.21e-2)" "unprognostic (8.95e-3)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (6.19e-2)" "unprognostic (1.34e-1)" "unprognostic (1.41e-2)" "prognostic unfavorable (3.42e-4)" 7.1 85.9 34.3 10.0 31.7 7.5 20.2 10.1 48.5 23.7 4.9 28.6 204.5 9.3 19.9 10.3 3.2 8.9 6.6 8.2 24.4 29.9 3.8 38.0 9.7 6.7 28.1 20.1 8.6 3.1 41.5 11.8 12.8 26.4 32.0 4.3 16.7 5.0 98.8 3.0 26.1 3.6 39.3 17.9 3.3 3.6 10.4 24.0 8.4 2.5 3.2 9.2 10.6 6.5 3.5 13.3 6.9 9.0 6.3 9.4 3.8 1.4 53.2 79.1 43.7 72.0 151.3 20.6 8.9 80.5 13.1 35.8 3.3 17.8 0.3 1.2 19.6 19.9 1.5 51.7 90.4 5.6 0.6 1.1 30.2 10.6 7.8 56.8 1.8 1.7 56.8 2.7 47.6 4.3 19.6 38.7 28.4 1.7 24.5 6.0 1.3 17.0 10.0 34.5 0.0 14.0 23.0 1.4 74.4 52.0 0.4 23.5 28.6 5.8 0.1 2.3 19.5 2.2 22.3 15.6 1.4 14.2 0.9 1.2 11.4 10.0 4.0 1.4 10.1 16.0 4.5 5.7 6.9 9.4 9.0 2.2 1.6 3.5 5.0 10.5 3.5 2.0 4.4 3.1 6.3 7.5 13.3 3.0 3.8 34.3 31.7 10.1 25.2 24.4 29.9 28.1 20.1 26.4 24.0 8.9 13.1 0.0 1.0 1.4 6.9 3.6 2.5 0.0 6.8 3.5 3.9 1.6 0.0 5.8 1.5 2.9 0.0 0.0 15.7 18.4 8.5 18.5 4.7 12.9 16.1 4.8 5.2 3.1 3.2 3.5 23.9 3.8 8.5 34.3 0.0 29.9 4.9 0.0 22.3 0.2 13.0 0.0 10.8 0.9 0.5 0.5 2.6 4.4 0.6 0.7 FADS3 "CYB5RP, LLCDL3" ENSG00000221968 "Fatty acid desaturase 3" Q9Y5Q0 11 61873519-61892051 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 63.1" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 109.7;Rod photoreceptor cells: 109.4;Smooth muscle cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 8.9;naive B-cell: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 63.4;HHSteC: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045224 Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA045224: AB_10967570" "unprognostic (4.69e-3)" "unprognostic (1.31e-2)" "unprognostic (5.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.91e-2)" "prognostic unfavorable (9.54e-5)" "unprognostic (1.76e-3)" "unprognostic (3.46e-1)" "unprognostic (6.45e-2)" "unprognostic (1.49e-1)" "unprognostic (1.28e-3)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.50e-9)" "unprognostic (1.14e-1)" "unprognostic (3.92e-2)" "unprognostic (1.53e-1)" "unprognostic (2.37e-1)" 63.1 25.9 15.7 17.5 17.9 4.1 23.5 8.7 16.5 9.3 8.3 13.8 5.9 4.3 9.8 25.4 7.4 9.0 9.9 22.7 14.4 11.6 16.6 8.5 16.3 15.4 16.9 10.0 12.7 12.1 12.4 5.0 48.2 15.1 7.1 4.4 16.8 5.5 11.3 15.7 4.2 9.0 14.9 13.3 9.7 8.3 6.0 15.6 1.1 6.1 7.3 15.7 10.4 9.9 10.6 0.7 5.7 1.2 0.6 2.4 0.7 7.7 2.4 0.7 4.9 63.4 12.8 15.8 15.8 38.6 16.9 16.4 3.4 2.8 5.8 10.3 31.4 13.2 4.3 2.9 42.9 9.0 1.6 1.6 4.8 10.3 6.9 54.9 0.4 0.9 14.0 18.7 20.3 38.8 10.3 19.5 3.1 4.6 11.0 28.7 9.0 1.7 2.4 2.3 0.8 6.4 9.7 31.3 16.1 18.9 2.7 1.2 1.6 18.0 2.4 16.0 6.8 3.5 1.0 13.2 16.5 11.5 4.8 6.9 3.4 1.6 7.0 13.8 2.3 11.9 0.0 0.7 5.7 1.8 1.2 1.6 8.9 1.6 2.4 0.7 10.6 0.1 0.6 0.3 0.6 0.8 0.0 0.4 0.7 15.7 17.9 8.7 15.4 14.4 11.6 16.9 10.0 15.1 15.6 29.8 6.9 31.8 7.1 6.1 10.3 18.6 7.6 2.7 1.2 5.2 7.9 34.9 1.7 39.5 16.2 27.8 7.0 23.3 17.7 109.7 19.7 8.5 6.9 8.5 17.2 1.6 6.4 18.4 3.7 8.3 26.4 14.0 33.7 12.6 3.6 57.1 21.1 3.5 16.6 9.1 109.4 19.4 106.1 2.1 3.8 4.8 56.9 4.3 4.8 3.3 FADS6 ENSG00000172782 "Fatty acid desaturase 6" 17 74877299-74893781 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.2;epididymis: 22.6;intestine: 20.0" "Cell type enhanced" "Detected in some" 8 "Cytotrophoblasts: 1.7;Hepatocytes: 3.4;Spermatogonia: 2.2;Syncytiotrophoblasts: 3.2" "Cancer enhanced" "Detected in some" "liver cancer: 2.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016802 Uncertain NA NA "HPA016802: AB_2669448" "unprognostic (2.41e-2)" "unprognostic (6.80e-3)" "unprognostic (2.64e-1)" "unprognostic (4.68e-3)" "unprognostic (4.73e-2)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (1.07e-1)" "unprognostic (6.41e-2)" "unprognostic (6.98e-4)" "unprognostic (3.38e-2)" "unprognostic (7.53e-2)" "unprognostic (1.14e-2)" "unprognostic (6.71e-2)" "unprognostic (2.27e-1)" "unprognostic (8.45e-2)" "unprognostic (1.79e-1)" 0.4 6.3 1.7 0.7 3.3 1.7 0.7 13.2 5.9 0.5 9.7 0.4 1.2 9.2 0.4 22.6 2.7 0.3 0.2 0.4 1.7 3.4 1.4 5.2 0.3 0.7 4.5 1.9 0.4 0.6 0.6 0.1 0.4 12.5 0.6 1.0 0.6 2.3 0.5 0.7 6.5 20.0 0.3 0.8 4.7 0.4 1.0 0.4 0.3 0.6 2.2 1.1 1.7 0.9 1.1 0.8 5.3 2.9 1.3 0.5 0.0 0.7 0.7 1.8 1.7 0.0 2.7 3.0 3.3 0.2 0.4 0.8 2.3 1.3 1.2 0.5 1.5 1.4 1.0 2.5 0.0 0.4 0.4 0.1 1.4 3.9 1.7 0.9 1.3 1.5 1.0 0.2 3.4 1.2 0.8 0.0 1.2 1.5 4.3 2.0 2.2 0.9 3.0 1.1 1.1 1.5 0.8 1.0 1.5 1.0 0.7 1.6 1.3 2.5 1.0 0.5 2.1 1.0 2.0 1.0 1.7 2.5 1.9 1.7 1.7 0.7 1.3 3.3 1.1 2.2 2.1 1.3 1.0 0.4 1.2 0.2 0.4 0.3 0.4 0.2 1.1 0.4 0.5 5.3 1.3 2.9 0.8 0.3 0.0 1.7 3.3 13.2 5.9 1.7 3.4 4.5 1.9 12.5 0.4 0.0 0.0 0.0 1.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.9 0.0 0.2 0.0 0.2 1.0 0.0 3.4 0.3 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.3 0.0 0.0 0.0 2.2 0.5 3.2 0.0 0.1 1.4 FAIM2 "KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2" ENSG00000135472 "Fas apoptotic inhibitory molecule 2" Q9BWQ8 12 49866896-49904217 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 138.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 136.4;Early spermatids: 135.6;Horizontal cells: 219.3" "Cancer enriched" "Detected in many" 8 "glioma: 21.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 1.7;T-reg: 6.2" "Lineage enriched" "Detected in single" 9 "T-cells: 6.2" "Cell line enhanced" "Detected in some" "HHSteC: 9.1;OE19: 11.7;SH-SY5Y: 4.9;U-87 MG: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018790, HPA048800" Enhanced Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA018790: AB_1852822, HPA048800: AB_2680526" "unprognostic (1.74e-1)" "unprognostic (5.98e-4)" "unprognostic (2.22e-1)" "unprognostic (9.75e-3)" "unprognostic (3.36e-2)" "unprognostic (2.61e-4)" "unprognostic (2.62e-1)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (1.75e-2)" "unprognostic (5.66e-2)" "unprognostic (1.30e-2)" "unprognostic (3.28e-6)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.47e-1)" "unprognostic (6.78e-4)" 3.9 27.2 35.6 4.1 57.5 1.4 2.5 42.4 138.5 3.2 4.7 29.1 0.2 2.7 4.2 6.4 3.9 5.8 7.5 7.4 38.8 51.0 2.0 1.5 2.5 3.5 35.9 33.7 2.6 2.8 14.7 7.8 1.5 65.6 8.8 3.5 3.9 3.0 7.1 2.0 1.8 4.0 8.7 36.9 2.5 2.6 12.1 20.5 0.0 1.7 0.0 3.1 4.7 2.0 0.0 0.0 0.0 0.4 0.6 6.2 0.2 0.0 0.3 0.4 0.5 2.0 1.3 0.1 0.5 2.6 0.5 0.3 0.3 0.0 0.0 0.1 3.6 0.2 0.2 1.2 0.0 0.3 0.0 0.0 2.0 0.0 0.0 9.1 0.1 0.0 0.8 0.2 1.9 0.0 0.0 0.0 0.2 1.1 0.3 0.5 0.0 0.1 0.0 0.0 11.7 0.0 0.0 0.1 0.0 0.0 0.0 3.2 4.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 28.4 0.0 0.2 0.0 0.1 0.0 1.7 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 6.2 0.2 35.6 57.5 42.4 99.5 38.8 51.0 35.9 33.7 65.6 20.5 0.0 0.0 0.0 0.1 0.2 136.4 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 135.6 0.0 0.0 0.0 0.2 0.0 1.4 0.6 26.4 0.0 0.4 219.3 0.0 0.0 0.0 31.4 4.6 0.0 0.0 0.0 2.0 34.2 0.1 0.0 4.9 0.1 14.5 0.0 0.9 1.2 2.1 0.3 0.1 0.0 0.2 0.1 FAM105A "FLJ11127, NET20" ENSG00000145569 "Family with sequence similarity 105 member A" Q9NUU6 5 14581775-14615007 "Enzymes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 35.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 89.3;Hofbauer cells: 83.6;Intestinal endocrine cells: 59.1;Kupffer cells: 69.4;Spermatogonia: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 14.0;HMC-1: 44.0;OE19: 12.3;THP-1: 12.2;U-937: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046638 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA046638: AB_2679731" "unprognostic (1.47e-1)" "unprognostic (6.64e-3)" "unprognostic (1.92e-2)" "unprognostic (1.15e-3)" "unprognostic (6.26e-2)" "unprognostic (1.13e-3)" "unprognostic (2.33e-2)" "unprognostic (2.27e-2)" "unprognostic (6.44e-2)" "unprognostic (2.42e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.38e-2)" "prognostic unfavorable (7.62e-4)" "unprognostic (3.14e-1)" "unprognostic (8.79e-3)" 5.1 3.5 4.0 7.9 4.9 35.4 5.2 3.1 5.1 6.3 15.4 9.0 4.5 8.3 3.0 5.6 2.9 3.1 4.1 3.0 3.9 4.3 5.2 1.9 28.8 16.7 6.1 3.8 4.0 13.3 1.9 8.7 6.7 7.9 12.6 17.3 10.3 3.1 13.5 1.3 2.6 13.7 3.3 10.8 13.2 5.4 4.4 4.1 3.5 27.2 3.0 6.2 7.1 5.8 0.1 26.7 6.9 26.2 14.1 9.6 16.2 0.0 0.6 1.2 0.0 0.2 0.0 5.3 1.5 1.4 0.4 0.7 1.9 1.4 0.0 0.8 0.7 2.2 0.1 2.6 1.2 0.6 0.8 3.6 3.4 14.0 0.3 1.3 0.0 44.0 0.1 0.3 0.2 0.0 0.0 0.0 2.2 0.0 5.5 0.1 1.1 0.0 1.2 1.9 12.3 9.4 0.4 0.5 1.6 0.0 10.5 4.6 5.1 0.7 0.5 0.0 1.3 0.5 12.2 0.0 0.6 3.4 0.2 1.1 0.0 0.0 0.0 0.8 20.8 0.2 0.0 26.2 0.1 4.5 12.4 6.0 0.1 5.7 6.1 26.7 0.1 7.8 7.5 6.9 14.1 9.4 19.7 9.6 16.2 4.0 4.9 3.1 5.1 3.9 4.3 6.1 3.8 7.9 4.1 89.3 8.2 0.9 4.4 7.4 0.7 0.0 2.5 0.0 3.4 0.0 0.0 0.7 0.0 0.0 1.1 6.3 22.2 0.0 0.0 1.5 5.9 7.8 49.6 0.2 83.6 0.0 59.1 4.3 69.4 2.0 4.0 37.7 11.8 0.0 39.6 2.5 0.0 37.1 3.2 0.0 0.9 0.0 3.8 20.5 57.7 5.9 1.1 30.5 41.5 2.7 FAM151A "C1orf179, MGC27169" ENSG00000162391 "Family with sequence similarity 151 member A" Q8WW52 1 54609182-54623556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "intestine: 45.8;kidney: 59.3" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 116.1" "Group enriched" "Detected in many" 5 "liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "eosinophil: 2.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.4" "Cell line enriched" "Detected in single" 45 "CACO-2: 41.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA016840 Approved NA NA "HPA016840: AB_2669461" "unprognostic (1.89e-1)" "unprognostic (6.90e-3)" "unprognostic (3.73e-2)" "unprognostic (1.97e-6)" "unprognostic (1.71e-2)" "unprognostic (4.84e-3)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (2.87e-1)" "unprognostic (1.05e-2)" "unprognostic (4.91e-3)" "unprognostic (9.99e-2)" "prognostic favorable (4.09e-5)" "unprognostic (5.85e-2)" "unprognostic (8.97e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-3)" 0.1 0.0 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.6 0.1 0.1 0.2 0.0 0.1 0.8 0.1 0.0 59.3 5.6 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 45.8 0.1 0.1 0.5 0.0 0.3 0.1 0.3 0.1 0.1 0.9 0.1 0.1 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 41.7 0.5 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.9 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 0.0 0.4 0.0 0.0 0.8 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 7.0 0.0 0.0 11.6 0.0 4.1 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.3 9.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.8 0.0 116.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 FAM162A "C3orf28, E2IG5" ENSG00000114023 "Family with sequence similarity 162 member A" Q96A26 3 122384176-122412334 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035856, HPA058113" Approved Enhanced Mitochondria,Cytosol NA NA 29000 "Mitochondria, Cytosol" "HPA035856: AB_10611965, HPA058113: AB_2683609" "unprognostic (1.17e-2)" "unprognostic (1.42e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" "unprognostic (3.99e-1)" "unprognostic (7.84e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (5.91e-3)" "unprognostic (8.74e-2)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (4.10e-2)" "prognostic favorable (3.93e-4)" 13.6 32.8 24.9 18.6 49.9 14.1 18.7 10.7 44.8 21.8 57.8 11.5 19.6 22.7 17.0 25.5 58.7 13.8 25.4 54.2 40.2 21.7 35.9 78.1 12.2 16.5 23.6 27.7 30.2 71.5 24.6 16.1 7.3 31.0 27.3 61.3 16.2 17.7 23.1 56.6 29.2 21.2 27.2 24.4 10.9 25.7 16.9 18.8 8.6 17.9 48.6 16.7 34.6 36.0 26.8 29.4 25.3 24.4 16.4 33.1 12.9 28.8 6.2 9.2 17.1 16.9 15.7 4.7 11.8 10.6 11.3 28.8 15.4 13.3 31.4 20.6 4.0 9.3 20.2 16.6 28.8 30.2 16.2 12.4 25.4 10.7 27.5 11.1 24.8 9.1 18.1 15.1 10.7 22.7 38.0 14.9 31.0 17.1 12.6 16.1 11.3 25.2 30.2 13.6 65.2 32.8 15.2 13.2 40.9 32.7 70.4 13.8 11.0 8.8 21.0 24.1 14.4 13.1 12.2 10.5 11.2 8.0 6.5 12.2 25.0 8.5 31.8 33.2 24.3 5.1 2.6 9.3 25.3 21.7 23.0 32.1 26.8 29.8 27.1 29.4 23.9 32.6 33.1 3.0 16.4 24.4 24.6 27.1 12.9 24.9 49.9 10.7 44.8 40.2 21.7 23.6 27.7 31.0 18.8 26.8 42.4 71.1 131.6 113.8 30.4 312.0 96.8 46.8 43.3 123.9 45.2 42.9 457.6 109.5 73.0 47.4 279.5 23.3 152.7 35.4 52.8 85.5 85.3 207.9 83.9 36.5 102.7 38.1 49.4 23.4 124.5 76.0 99.5 146.9 326.4 45.5 161.9 325.6 139.7 345.2 28.5 103.5 89.6 141.1 55.3 116.1 39.5 54.9 245.2 156.6 FAM162B "bA86F4.2, C6orf189" ENSG00000183807 "Family with sequence similarity 162 member B" Q5T6X4 6 116752197-116765723 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 51.6" "Group enriched" "Detected in some" 4 "Sertoli cells: 64.7;Smooth muscle cells: 58.7" "Cancer enriched" "Detected in many" 18 "testis cancer: 32.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 7.0;BJ hTERT+: 19.0;BJ hTERT+ SV40 Large T+ RasG12V: 18.3;HHSteC: 5.3;HSkMC: 6.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "olfactory region: 6.9" "HPA036112, HPA060342" Enhanced NA NA "HPA036112: AB_10696649, HPA060342: AB_2684258" "unprognostic (1.81e-1)" "unprognostic (5.65e-3)" "unprognostic (1.54e-1)" "unprognostic (3.38e-1)" "unprognostic (5.45e-2)" "unprognostic (1.86e-5)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-2)" "unprognostic (2.44e-2)" "unprognostic (7.32e-2)" "unprognostic (6.27e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.22e-2)" "unprognostic (1.72e-1)" "unprognostic (2.73e-3)" "unprognostic (4.34e-2)" 11.4 12.5 2.2 1.0 4.0 0.5 11.2 0.5 8.6 13.0 3.8 1.1 4.8 1.1 7.8 7.0 6.5 6.7 4.9 7.7 2.0 1.8 4.3 1.0 14.6 2.4 2.7 5.8 7.7 1.5 2.5 6.1 51.6 1.9 9.7 2.2 6.0 6.5 11.8 7.3 2.5 1.9 3.7 1.3 0.5 3.0 2.9 0.5 0.0 8.7 5.2 1.4 5.7 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 7.0 19.0 3.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.0 0.5 8.6 2.0 1.8 2.7 5.8 1.9 0.5 0.0 0.0 0.0 0.1 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 13.9 4.5 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.0 2.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 4.9 0.0 0.0 64.7 58.7 3.5 6.0 0.6 0.5 0.0 0.0 0.0 FAM163A "C1orf76, MGC16664, NDSP" ENSG00000143340 "Family with sequence similarity 163 member A" Q96GL9 1 179743163-179816198 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 19.2;lymphoid tissue: 25.5;pituitary gland: 24.2" "Group enriched" "Detected in some" 12 "Early spermatids: 27.4;Late spermatids: 35.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 9 "pons and medulla: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 36 "SH-SY5Y: 51.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (8.74e-3)" "unprognostic (3.42e-2)" "unprognostic (1.32e-2)" "unprognostic (3.24e-1)" "unprognostic (2.62e-1)" "unprognostic (1.66e-1)" "unprognostic (5.67e-6)" "unprognostic (5.56e-2)" "unprognostic (1.52e-1)" "unprognostic (2.40e-2)" "unprognostic (3.81e-3)" "unprognostic (9.14e-2)" "unprognostic (7.75e-5)" "unprognostic (1.67e-2)" "unprognostic (2.83e-1)" "unprognostic (1.60e-1)" "unprognostic (4.98e-2)" 0.2 10.9 0.7 2.1 1.5 0.0 0.0 0.4 2.1 0.0 1.3 0.7 0.0 1.9 0.1 1.7 0.0 0.6 5.5 0.3 0.4 0.8 0.1 0.4 0.0 1.0 1.2 1.0 0.4 0.6 0.0 24.2 0.4 19.2 0.4 0.9 0.2 0.0 0.1 0.1 0.1 1.3 0.6 0.2 0.4 1.7 9.0 0.0 25.5 1.5 0.0 1.2 0.1 0.1 0.0 0.1 0.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 51.2 0.0 0.0 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.7 1.5 0.4 2.1 0.4 0.8 1.2 1.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 FAM163B C9orf166 ENSG00000196990 "Family with sequence similarity 163 member B" P0C2L3 9 133578415-133586197 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 41.7" "Cell type enriched" "Detected in some" 4 "Late spermatids: 15.1" "Cancer enriched" "Detected in some" 6 "glioma: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "SH-SY5Y: 40.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067336 Enhanced Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nuclear bodies, Plasma membrane, Cytosol" "HPA067336: AB_2685825" "unprognostic (2.94e-2)" "unprognostic (6.87e-3)" "unprognostic (2.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.23e-2)" "unprognostic (9.05e-2)" "unprognostic (1.02e-2)" "unprognostic (3.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (5.75e-4)" "unprognostic (1.07e-1)" "unprognostic (9.54e-2)" "unprognostic (1.65e-1)" "unprognostic (4.73e-4)" 0.1 8.2 10.0 0.0 2.7 0.0 0.0 3.2 41.7 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.4 1.2 6.1 3.9 0.1 2.7 0.0 1.3 3.3 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.8 40.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM171A1 "C10orf38, FLJ12884" ENSG00000148468 "Family with sequence similarity 171 member A1" Q5VUB5 10 15211643-15371062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.9" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 104.4;Ito cells: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.6;MAIT T-cell: 6.8;memory CD4 T-cell: 3.8;memory CD8 T-cell: 3.3;naive CD4 T-cell: 7.4;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 23 "T-cells: 7.4" "Cell line enhanced" "Detected in many" "TIME: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051345 Approved Approved "Nucleoplasm,Plasma membrane" NA NA 96000 "Plasma membrane" Nucleoplasm "HPA051345: AB_2681449" "unprognostic (3.60e-2)" "unprognostic (7.15e-2)" "unprognostic (2.21e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (4.11e-2)" "unprognostic (9.84e-2)" "unprognostic (9.19e-2)" "unprognostic (2.28e-1)" "unprognostic (3.97e-2)" "unprognostic (3.09e-2)" "unprognostic (1.87e-1)" "prognostic favorable (2.71e-5)" "unprognostic (3.08e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (4.90e-6)" "unprognostic (3.28e-2)" 6.9 3.7 22.1 5.5 37.9 0.2 4.6 11.1 31.8 8.8 16.1 25.3 6.5 13.7 9.7 4.8 4.7 11.8 9.3 7.0 24.1 17.5 17.8 6.2 5.3 3.7 25.1 14.3 10.9 13.8 8.9 1.9 2.9 21.5 8.4 12.9 2.5 10.0 9.4 5.1 2.4 8.9 9.0 43.9 8.5 10.3 2.4 21.9 0.6 4.3 1.1 4.6 6.0 6.2 0.0 0.0 0.0 0.0 0.3 7.4 1.3 0.0 6.3 13.0 5.0 5.3 10.1 0.1 7.9 1.5 4.0 3.5 1.1 7.4 0.0 9.6 20.5 9.1 0.6 9.3 0.1 4.5 2.6 14.6 18.4 2.0 18.2 5.8 0.0 14.9 7.9 1.9 10.9 1.6 14.6 20.0 2.7 7.2 0.0 12.7 0.5 3.1 0.0 12.5 3.5 3.5 12.4 6.9 1.9 5.0 0.0 9.0 11.5 4.4 0.1 0.0 14.5 0.0 0.2 42.6 5.5 23.2 19.9 8.3 2.7 0.7 0.0 12.2 0.0 4.2 0.0 0.0 0.0 2.6 0.0 6.8 0.0 3.8 3.3 0.0 0.0 7.4 3.7 0.0 0.3 0.0 0.0 0.7 1.3 22.1 37.9 11.1 23.1 24.1 17.5 25.1 14.3 21.5 21.9 0.0 0.0 0.0 3.3 1.1 3.8 5.1 104.4 2.7 2.3 14.0 0.0 0.1 3.3 17.1 0.6 18.9 12.0 0.0 10.5 0.1 8.9 13.8 1.1 18.3 0.3 6.4 20.2 41.1 4.4 1.0 4.9 0.0 1.7 1.0 25.9 1.5 15.9 8.6 5.3 4.1 1.1 0.0 6.2 2.3 3.5 1.6 0.1 1.3 31.1 2.1 FAM171A2 MGC34829 ENSG00000161682 "Family with sequence similarity 171 member A2" A8MVW0 17 44353215-44363875 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5" "Group enriched" "Detected in some" 7 "Bipolar cells: 39.1;Horizontal cells: 41.3;Muller glia cells: 149.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 10.6;REH: 18.4;SCLC-21H: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019770 Uncertain NA NA "HPA019770: AB_1848383" "unprognostic (1.28e-2)" "unprognostic (2.07e-2)" "unprognostic (4.14e-3)" "unprognostic (8.47e-2)" "unprognostic (9.98e-2)" "unprognostic (1.92e-1)" "unprognostic (1.62e-4)" "unprognostic (5.76e-2)" "unprognostic (1.98e-2)" "unprognostic (1.01e-1)" "unprognostic (7.01e-3)" "unprognostic (3.00e-1)" "unprognostic (2.43e-3)" "unprognostic (1.06e-1)" "unprognostic (1.38e-1)" "unprognostic (2.36e-2)" "unprognostic (4.76e-2)" 3.1 3.3 10.3 1.2 12.8 1.0 1.0 13.9 26.5 6.4 1.2 1.7 1.1 1.1 4.1 7.9 2.1 5.4 2.6 1.3 8.6 8.8 1.7 1.0 1.4 1.3 3.7 13.2 5.5 1.1 2.3 7.3 1.8 4.6 2.2 0.9 3.1 1.5 3.2 1.1 2.0 1.2 1.6 1.7 1.4 1.2 1.3 2.2 0.0 2.6 0.0 1.2 1.5 1.9 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 1.8 5.6 7.7 0.9 1.1 3.9 2.1 0.3 1.8 2.2 0.2 0.1 2.5 4.9 0.6 1.0 0.1 2.0 0.5 0.2 2.0 10.6 0.7 0.1 1.0 0.6 0.1 0.4 1.3 0.2 0.7 0.0 3.1 2.7 5.7 1.7 0.0 0.6 6.3 5.7 1.0 8.3 0.0 4.0 18.4 3.6 1.5 0.3 0.4 13.2 9.9 0.7 0.1 0.9 1.4 2.1 1.3 1.7 2.6 5.0 4.3 0.7 0.8 0.2 0.9 0.2 0.9 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.8 13.9 26.5 8.6 8.8 3.7 13.2 4.6 2.2 0.0 0.0 0.0 0.0 0.0 39.1 1.1 0.0 0.0 0.0 3.5 11.8 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.2 41.3 0.0 0.6 0.3 0.0 1.7 0.0 0.0 0.0 0.0 149.9 0.4 0.0 0.7 0.0 7.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 FAM171B "FLJ34104, KIAA1946" ENSG00000144369 "Family with sequence similarity 171 member B" Q6P995 2 186693971-186765965 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.0" "Cell type enriched" "Detected in many" 6 "Bipolar cells: 137.0" "Cancer enriched" "Detected in many" 5 "glioma: 15.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 25.4;U-138 MG: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010639, HPA013434" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA010639: AB_1852447, HPA013434: AB_2262499" "unprognostic (2.52e-1)" "unprognostic (7.75e-3)" "unprognostic (1.27e-1)" "unprognostic (1.04e-2)" "unprognostic (4.03e-2)" "unprognostic (9.43e-2)" "unprognostic (6.78e-3)" "unprognostic (2.68e-1)" "unprognostic (1.88e-2)" "unprognostic (1.52e-1)" "unprognostic (4.24e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (9.51e-7)" "unprognostic (4.63e-3)" "unprognostic (1.52e-1)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.03e-4)" 3.1 13.1 32.0 2.0 32.6 1.1 3.7 12.7 62.0 6.7 2.1 5.8 0.1 1.6 7.1 2.6 2.4 3.2 4.9 1.9 25.5 13.1 1.8 1.1 2.0 1.6 9.1 23.0 9.7 1.6 11.4 13.4 3.5 9.7 3.2 2.5 1.4 17.8 2.8 1.3 3.8 1.9 4.5 8.4 2.0 2.4 1.6 10.4 0.0 2.7 0.0 1.7 2.9 1.8 0.3 1.3 1.1 1.7 2.4 1.1 0.5 2.3 2.8 4.2 13.1 12.5 9.5 0.1 2.6 4.6 3.2 4.6 7.7 12.6 0.0 0.9 7.3 5.5 0.3 5.7 2.5 4.6 0.0 3.3 2.8 1.3 0.0 1.0 0.8 1.0 12.1 1.0 2.5 2.0 4.2 7.0 2.2 0.0 25.4 6.1 1.6 1.6 0.0 5.6 0.0 2.8 0.0 8.1 0.6 5.0 9.0 13.2 7.2 1.3 0.8 3.5 2.6 1.0 0.6 4.1 17.6 2.3 0.3 1.6 6.8 6.5 0.0 5.4 0.0 2.4 1.1 0.7 0.3 0.8 1.7 0.7 0.3 1.0 0.9 0.6 0.2 0.6 1.1 0.4 2.4 1.6 1.3 0.1 0.5 32.0 32.6 12.7 30.4 25.5 13.1 9.1 23.0 9.7 10.4 0.0 0.0 0.0 2.1 7.9 137.0 0.8 10.2 0.0 2.3 0.0 13.7 7.9 0.0 0.7 1.4 10.5 0.0 0.0 0.3 0.8 6.6 1.2 0.0 0.0 1.7 22.3 4.6 8.0 0.3 2.5 7.2 1.1 3.3 1.0 0.0 16.5 0.5 0.0 13.1 0.1 15.5 0.0 4.1 0.1 1.4 4.5 6.9 0.0 0.0 0.5 FAM173A "C16orf24, MGC2494" ENSG00000103254 "Family with sequence similarity 173 member A" Q9BQD7 16 720581-722601 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 314.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046262 Approved Approved Cytosol NA NA Cytosol "HPA046262: AB_10963070" "unprognostic (3.94e-2)" "unprognostic (8.78e-2)" "unprognostic (1.55e-1)" "unprognostic (2.61e-1)" "unprognostic (6.54e-2)" "prognostic favorable (8.88e-4)" "unprognostic (2.11e-1)" "unprognostic (4.49e-1)" "unprognostic (9.54e-2)" "unprognostic (5.68e-2)" "unprognostic (4.02e-2)" "unprognostic (5.70e-2)" "prognostic favorable (4.24e-5)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (9.28e-2)" "unprognostic (3.60e-3)" 16.0 10.4 15.6 10.3 9.1 7.3 9.6 8.9 21.5 4.8 15.5 8.2 9.3 19.1 6.5 8.3 6.1 5.2 10.6 11.1 13.6 11.5 18.6 15.8 7.5 7.5 11.3 12.2 4.3 10.2 8.5 13.4 5.8 9.2 8.4 3.5 6.5 15.1 8.6 37.3 6.2 14.5 5.6 9.5 15.0 19.3 21.8 7.9 8.6 7.8 11.1 7.1 5.9 8.9 9.0 6.0 5.3 6.8 6.3 18.0 4.2 6.4 4.3 0.8 2.3 0.1 0.3 10.3 5.6 1.4 1.3 1.6 4.3 5.4 8.3 10.1 0.6 2.4 10.1 0.8 2.8 0.4 18.3 11.4 3.5 4.5 4.5 2.0 5.8 4.8 0.7 2.1 0.6 1.7 2.9 0.5 5.8 7.3 3.8 1.2 10.5 0.9 14.0 3.3 3.6 14.1 3.5 2.1 15.5 3.6 2.3 3.7 9.7 2.9 4.8 9.3 0.5 5.3 5.2 4.7 1.2 10.0 3.6 3.9 33.6 15.0 8.9 2.5 4.3 3.2 0.0 6.8 5.3 7.3 3.9 16.5 9.0 5.8 12.9 4.4 9.0 5.9 18.0 0.8 6.3 4.8 6.0 12.5 4.2 15.6 9.1 8.9 21.5 13.6 11.5 11.3 12.2 9.2 7.9 6.0 5.4 49.9 28.1 9.0 86.9 11.2 50.9 1.4 0.0 61.1 33.4 40.1 99.5 47.3 182.0 14.5 140.4 0.0 56.0 31.2 20.0 36.4 28.7 74.6 77.3 50.9 50.1 27.6 51.9 314.4 23.6 43.6 45.5 55.1 53.9 57.8 49.3 73.7 17.7 139.1 71.7 25.8 27.8 65.4 88.0 8.3 21.4 60.6 62.2 31.4 FAM173B JS-2 ENSG00000150756 "Family with sequence similarity 173 member B" Q6P4H8 5 10226330-10249897 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SiHa: 40.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074513 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA074513: AB_2686698" "prognostic unfavorable (1.32e-6)" "unprognostic (8.87e-3)" "unprognostic (1.23e-3)" "unprognostic (1.20e-1)" "unprognostic (9.24e-2)" "unprognostic (1.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-2)" "unprognostic (6.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-1)" "unprognostic (9.06e-2)" "unprognostic (5.61e-2)" "unprognostic (1.03e-1)" 10.1 14.6 17.7 10.4 16.2 3.3 9.0 20.1 18.6 7.9 9.7 12.2 8.8 7.7 9.3 12.6 7.9 9.2 9.9 8.8 14.9 18.1 12.1 13.1 7.5 8.9 18.8 9.9 8.6 6.8 19.2 22.8 5.3 18.6 12.2 12.4 10.3 8.8 12.3 7.3 7.4 7.1 10.1 13.2 5.6 7.8 6.5 18.9 8.4 12.7 6.2 8.7 11.6 13.9 5.7 8.9 11.6 9.7 5.1 8.6 4.5 7.3 8.1 8.0 7.6 8.8 6.7 2.8 11.4 5.7 6.1 4.8 8.5 12.2 9.5 20.5 8.1 15.4 5.5 12.2 10.4 9.9 15.8 7.5 7.9 27.6 6.3 5.9 12.2 9.5 6.1 11.6 10.1 3.4 6.9 11.8 9.4 11.0 9.7 17.2 6.9 6.0 10.8 4.9 17.1 9.8 8.3 5.5 8.4 15.6 9.7 6.4 6.4 40.2 14.2 6.4 6.3 14.5 12.7 6.5 13.0 7.7 7.9 8.3 6.6 7.2 10.6 8.2 14.0 5.3 5.0 9.3 11.6 7.0 9.7 8.4 5.7 6.7 8.5 8.9 4.2 6.8 8.6 3.4 5.1 7.7 3.1 7.8 4.5 17.7 16.2 20.1 18.6 14.9 18.1 18.8 9.9 18.6 18.9 3.0 1.4 3.0 5.1 1.3 8.4 5.9 5.1 14.7 3.4 10.4 2.0 5.0 5.0 6.0 4.1 4.9 3.6 0.0 3.7 3.9 6.3 5.8 9.2 7.4 6.9 9.5 2.4 1.8 4.5 2.5 3.4 2.3 3.3 5.4 3.9 7.8 3.4 6.0 6.3 6.3 12.2 6.5 2.5 10.0 15.8 1.6 2.2 5.0 5.3 3.4 FAM174A "NS5ATP6, TMEM157, UNQ1912" ENSG00000174132 "Family with sequence similarity 174 member A" Q8TBP5 5 100535305-100586741 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 211.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 8 "neutrophil: 28.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 28.0" "Cell line enhanced" "Detected in many" "U-266/84: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019539 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA019539: AB_2293743" "unprognostic (2.34e-1)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (9.02e-3)" "prognostic unfavorable (2.57e-6)" "unprognostic (5.55e-3)" "unprognostic (3.06e-1)" "unprognostic (2.60e-1)" "unprognostic (3.60e-2)" "unprognostic (1.30e-2)" "unprognostic (1.73e-2)" "unprognostic (7.69e-2)" "prognostic favorable (5.48e-4)" "unprognostic (1.74e-1)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.45e-1)" 15.6 24.6 18.8 8.3 21.0 3.0 15.3 14.2 26.8 11.1 12.0 16.5 14.0 11.8 11.3 15.2 18.0 35.9 9.5 17.3 22.0 25.0 18.3 15.2 17.6 5.5 19.3 18.2 9.1 26.8 23.6 21.9 15.6 24.1 19.5 9.1 16.6 16.5 13.7 38.8 20.4 10.7 9.6 19.4 10.1 15.5 37.3 12.2 4.4 14.3 17.0 9.6 9.9 11.7 1.5 2.2 28.0 2.7 2.5 2.7 1.6 5.0 5.3 2.2 6.9 5.3 4.3 7.7 11.6 6.5 4.8 6.5 1.1 6.6 0.9 23.6 5.0 8.3 4.3 1.8 7.5 3.4 6.1 5.5 0.6 9.2 3.1 7.2 2.6 6.4 5.6 18.0 3.6 2.8 10.8 7.1 2.7 1.8 6.9 7.8 10.1 0.7 5.4 1.1 0.6 14.5 1.7 8.3 8.7 8.3 6.1 4.4 11.7 8.1 7.3 6.4 2.6 7.1 5.7 8.1 6.0 3.8 9.6 9.1 22.0 28.7 1.1 7.5 3.5 5.2 3.6 2.5 3.4 1.8 2.7 2.7 1.4 1.8 2.2 2.2 1.5 1.6 2.1 28.0 2.5 2.7 2.2 2.2 1.6 18.8 21.0 14.2 26.8 22.0 25.0 19.3 18.2 24.1 12.2 29.8 25.6 12.6 27.4 78.3 24.0 14.9 20.4 211.5 31.8 27.9 3.9 33.9 36.5 26.0 16.2 23.7 14.7 0.0 26.4 32.0 28.2 31.9 12.7 27.2 20.9 28.6 33.5 31.9 14.3 4.0 16.7 17.1 47.2 19.0 31.7 63.9 27.0 20.1 23.0 32.2 36.9 12.9 22.6 86.9 16.8 100.6 42.1 13.1 19.9 34.6 FAM174B "LOC400451, MGC102891" ENSG00000185442 "Family with sequence similarity 174 member B" Q3ZCQ3 15 92617443-92809884 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 57.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 98.3;Mucus-secreting cells: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Group enriched" "Detected in many" 7 "dendritic cells: 4.5;granulocytes: 3.7;T-cells: 10.9" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;MCF7: 25.6;OE19: 21.5;RPMI-8226: 30.0;RT4: 63.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015306 Approved Approved "Intermediate filaments" No No "Intermediate filaments" "HPA015306: AB_2669182" "unprognostic (3.00e-3)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "prognostic favorable (9.03e-5)" "unprognostic (4.68e-2)" "unprognostic (1.63e-1)" "unprognostic (8.35e-2)" "unprognostic (8.23e-3)" "unprognostic (7.67e-3)" "unprognostic (5.05e-3)" "unprognostic (6.60e-2)" "unprognostic (1.33e-1)" "unprognostic (4.67e-2)" "unprognostic (2.01e-1)" "unprognostic (6.64e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-2)" 6.1 3.5 5.9 3.3 6.3 0.7 17.9 3.9 8.6 10.9 6.2 2.9 21.5 3.6 5.1 4.9 5.2 14.6 6.4 4.2 7.4 8.3 3.3 4.0 16.3 5.5 6.5 6.2 10.2 57.6 2.5 15.9 4.6 6.7 19.4 9.2 7.7 47.7 10.8 16.3 4.9 5.0 4.6 4.9 3.2 17.3 9.7 3.6 4.2 28.9 3.9 4.8 24.4 15.3 0.4 4.5 3.7 0.9 0.7 10.9 0.7 0.0 3.6 2.3 0.7 0.0 0.0 0.3 1.3 6.3 0.0 0.0 21.3 2.4 0.3 6.1 0.1 1.7 0.1 4.0 0.1 0.0 0.1 1.8 0.2 0.4 0.2 0.4 0.3 0.9 0.3 0.1 0.0 0.0 0.1 3.0 2.0 0.3 15.8 3.5 25.6 0.7 0.0 11.5 21.5 0.0 2.4 6.6 30.0 1.5 63.4 1.4 1.1 1.8 12.2 3.9 7.0 9.8 2.2 0.0 0.0 0.5 0.1 2.9 0.5 4.7 0.7 0.0 0.2 1.5 1.1 0.8 0.9 0.2 0.9 0.4 0.4 2.5 0.0 0.6 0.3 2.8 3.3 3.7 0.7 0.0 4.5 10.9 0.7 5.9 6.3 3.9 8.6 7.4 8.3 6.5 6.2 6.7 3.6 98.3 20.3 0.0 14.7 2.1 5.3 4.1 10.2 14.7 18.2 7.0 7.9 1.1 6.6 4.4 19.8 5.8 2.3 0.0 12.4 15.9 4.1 29.2 18.4 5.8 4.2 11.1 40.5 30.7 4.3 39.0 5.5 1.8 11.8 0.0 61.2 3.5 17.4 0.0 1.8 1.1 2.7 0.0 5.3 1.0 3.4 2.6 0.6 2.1 4.7 23.7 FAM180B LOC399888 ENSG00000196666 "Family with sequence similarity 180 member B" 11 47586693-47589194 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 4.6;breast: 6.9;skin 1: 5.2;thyroid gland: 3.9" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 6.5;Leydig cells: 2.3;Melanocytes: 5.0;Peritubular cells: 3.9;Suprabasal keratinocytes: 5.5" "Cancer enhanced" "Detected in some" "melanoma: 1.7" "Cell type enriched" "Detected in single" 5 "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HEL: 2.2;MCF7: 2.0;NB-4: 2.1;SK-MEL-30: 4.2;U-937: 3.1" "Not detected" "Not detected" HPA029408 Uncertain NA NA "HPA029408: AB_10601319" "unprognostic (1.28e-2)" "unprognostic (4.99e-3)" "unprognostic (7.48e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.64e-2)" "unprognostic (1.21e-3)" "unprognostic (1.04e-1)" "unprognostic (2.69e-1)" "unprognostic (3.87e-2)" "unprognostic (3.16e-2)" "unprognostic (1.03e-5)" "unprognostic (5.65e-2)" "unprognostic (1.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" 4.6 0.4 0.2 0.0 1.4 0.3 6.9 0.7 1.2 0.5 0.4 0.1 0.1 0.3 0.0 0.7 0.8 0.6 0.2 0.9 0.0 0.0 0.1 0.1 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 1.1 5.2 0.0 0.1 1.2 0.0 0.3 0.7 3.9 0.2 0.5 0.1 0.0 0.0 0.0 0.2 0.1 1.2 0.0 0.1 0.0 1.9 0.0 1.3 1.3 0.3 0.2 0.1 0.0 0.0 0.2 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.3 2.2 0.4 0.7 0.1 0.4 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.2 2.0 0.1 2.1 0.3 0.1 0.2 0.6 0.4 0.0 0.0 0.1 0.0 0.3 0.3 0.0 4.2 0.4 0.2 0.7 1.2 0.5 0.3 0.2 0.0 0.3 0.2 0.1 0.0 3.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 2.3 0.0 5.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.1 0.0 0.0 0.0 FAM187B "FLJ25660, TMEM162" ENSG00000177558 "Family with sequence similarity 187 member B" Q17R55 19 35224800-35228729 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 108 "testis: 56.0" "Group enriched" "Detected in some" 117 "Early spermatids: 555.2;Late spermatids: 1683.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA079535 Enhanced NA NA "HPA079535: " "unprognostic (3.34e-1)" "unprognostic (4.96e-1)" "unprognostic (2.40e-1)" "unprognostic (2.84e-1)" "unprognostic (2.72e-1)" "unprognostic (2.12e-1)" "unprognostic (1.25e-3)" "unprognostic (2.71e-1)" "unprognostic (2.49e-1)" "unprognostic (1.47e-1)" "unprognostic (1.76e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 56.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 555.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1683.5 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 7.6 4.2 0.0 0.0 0.0 0.0 0.0 FAM189A1 "KIAA0574, TMEM228" ENSG00000104059 "Family with sequence similarity 189 member A1" O60320 15 29120254-29570723 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.3;parathyroid gland: 6.5" "Cell type enhanced" "Detected in some" 7 "Cardiomyocytes: 3.1;Ductal cells: 3.7;Enterocytes: 2.3;Intestinal endocrine cells: 2.9;Paneth cells: 3.5;Undifferentiated cells: 2.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;HDLM-2: 15.6;Karpas-707: 2.0;REH: 3.7" "Low region specificity" "Detected in many" "HPA009410, HPA010637" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA009410: AB_1852332, HPA010637: AB_1852333" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (5.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.71e-2)" "unprognostic (4.85e-3)" "unprognostic (2.21e-1)" "unprognostic (1.27e-1)" "unprognostic (3.39e-1)" "unprognostic (7.97e-2)" "unprognostic (5.00e-1)" "unprognostic (6.70e-3)" "unprognostic (2.39e-2)" "unprognostic (9.03e-2)" "unprognostic (2.50e-2)" "unprognostic (3.12e-1)" 0.8 1.5 12.8 0.6 7.9 0.4 0.6 4.2 9.5 0.4 4.0 1.5 0.0 1.0 1.1 0.8 0.6 1.5 0.5 0.7 15.3 4.7 1.7 0.5 1.5 0.5 3.5 3.4 0.4 3.3 6.5 0.0 0.7 4.0 0.8 3.0 0.0 1.1 0.5 0.4 0.8 3.2 1.0 0.7 1.3 0.6 2.3 0.3 0.0 1.9 0.0 1.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.3 0.0 0.0 0.0 0.2 15.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 2.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 3.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 12.8 7.9 4.2 9.5 15.3 4.7 3.5 3.4 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.7 0.0 2.3 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.5 0.9 0.0 0.0 0.0 1.7 0.1 0.2 3.5 1.4 0.8 0.3 0.0 0.2 0.5 1.2 0.0 0.0 0.0 2.9 0.5 FAM189A2 "C9orf61, X123" ENSG00000135063 "Family with sequence similarity 189 member A2" Q15884 9 69324567-69392558 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 40.1;thyroid gland: 38.0" "Cell type enhanced" "Detected in many" 23 "Alveolar cells type 1: 145.9;Club cells: 48.9;Muller glia cells: 40.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 22.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.4;NTERA-2: 8.4;RPTEC TERT1: 3.1;RT4: 3.7;SK-MEL-30: 8.1;SuSa: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029411, HPA057207" Approved NA NA "HPA029411: AB_10602338, HPA057207: AB_2683369" "unprognostic (2.04e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.16e-6)" "unprognostic (2.24e-1)" "unprognostic (3.93e-2)" "unprognostic (3.47e-2)" "unprognostic (2.89e-2)" "unprognostic (2.09e-1)" "unprognostic (2.71e-3)" "unprognostic (7.84e-2)" "unprognostic (1.07e-2)" "prognostic favorable (1.75e-5)" "unprognostic (3.42e-1)" "unprognostic (2.41e-1)" "unprognostic (4.82e-2)" "unprognostic (1.14e-1)" 3.2 3.1 9.2 1.5 11.6 0.8 13.2 4.5 12.2 25.6 3.9 11.4 8.3 1.8 5.6 2.5 5.3 6.0 2.9 11.5 10.3 4.1 2.0 0.8 21.4 1.3 7.2 4.9 15.0 5.2 8.5 4.7 2.2 20.0 8.9 1.9 6.7 6.4 5.0 40.1 6.7 2.3 6.0 17.1 1.1 9.0 1.5 9.3 3.7 38.0 6.0 1.6 4.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.4 1.1 1.1 0.0 0.0 1.0 2.7 0.1 2.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 8.4 0.5 0.0 0.0 0.2 0.0 3.1 3.7 0.0 0.1 0.0 0.0 8.1 3.4 0.2 0.0 1.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 11.6 4.5 12.2 10.3 4.1 7.2 4.9 20.0 9.3 145.9 21.8 0.0 5.1 3.0 0.6 11.3 0.0 4.0 48.9 1.8 0.0 0.9 0.0 0.8 0.1 6.8 0.1 0.0 0.6 0.1 0.8 4.4 0.0 0.0 0.3 0.0 0.0 1.8 0.3 0.0 0.0 0.0 18.6 0.0 0.3 40.4 2.8 0.3 0.0 0.1 0.8 0.0 2.1 0.1 0.4 2.0 0.2 0.0 0.6 1.3 FAM189B "C1orf2, cote1" ENSG00000160767 "Family with sequence similarity 189 member B" P81408 1 155247205-155255483 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006659, HPA050674" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA006659: AB_1078339, HPA050674: AB_2681213" "unprognostic (1.56e-2)" "prognostic unfavorable (4.98e-4)" "unprognostic (1.44e-2)" "prognostic unfavorable (9.59e-5)" "unprognostic (1.46e-2)" "unprognostic (4.86e-3)" "prognostic unfavorable (3.43e-4)" "unprognostic (2.70e-2)" "unprognostic (3.49e-2)" "unprognostic (2.73e-1)" "unprognostic (5.15e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.43e-7)" "unprognostic (4.16e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-3)" "unprognostic (3.25e-2)" 18.7 13.5 18.8 12.0 17.3 6.4 20.1 18.3 18.4 11.2 16.9 5.6 16.6 14.4 14.8 6.9 14.7 10.9 13.9 10.3 15.2 11.0 11.0 10.1 10.1 7.8 10.1 16.3 11.6 11.8 15.9 13.2 11.0 19.7 12.3 8.1 7.2 13.9 18.7 41.1 12.9 12.5 17.1 13.0 9.7 13.6 10.3 11.2 3.8 8.9 10.8 7.2 18.6 19.3 0.2 0.2 0.1 0.3 1.2 0.8 0.3 12.6 9.5 8.6 16.2 8.2 11.3 2.5 10.8 8.1 8.1 7.0 10.7 6.8 10.9 16.8 8.2 4.7 12.8 10.2 10.3 3.8 15.5 23.0 7.8 8.0 6.2 11.0 2.5 9.1 10.4 6.5 8.2 7.7 9.4 10.7 6.6 6.5 4.6 6.3 6.8 11.2 3.9 10.8 10.6 23.0 11.6 6.4 12.3 5.5 3.4 12.3 16.5 5.0 18.0 12.6 5.5 14.8 9.8 9.1 7.5 10.4 8.6 11.6 9.9 9.8 5.8 9.1 4.6 6.2 0.0 0.3 0.0 0.1 0.3 0.8 0.1 0.4 0.2 0.2 0.2 0.0 0.2 0.1 1.2 0.0 0.2 0.0 0.3 18.8 17.3 18.3 18.4 15.2 11.0 10.1 16.3 19.7 11.2 3.0 2.1 7.5 10.8 5.4 15.2 10.7 5.1 5.3 2.3 12.2 17.7 10.6 1.7 12.3 3.2 12.6 7.1 0.0 9.0 13.3 7.3 10.3 5.7 5.9 6.9 38.1 6.4 14.1 9.7 4.2 8.9 4.0 6.8 4.6 8.6 7.2 9.9 3.5 8.5 4.8 16.5 0.0 9.8 17.7 6.6 7.2 12.0 3.8 9.2 10.4 FAM198A "C3orf41, DKFZP434B172" ENSG00000144649 "Family with sequence similarity 198 member A" Q9UFP1 3 42979267-43060211 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 11.9;Leydig cells: 9.2;Muller glia cells: 17.2;Peritubular cells: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 5.9;RPMI-8226: 6.2;SK-BR-3: 4.2;T-47d: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047726 Approved Supported Vesicles "Secreted - unknown location" NA NA 440000 Vesicles "HPA047726: AB_10960554" "unprognostic (2.16e-3)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (2.93e-2)" "unprognostic (7.48e-2)" "unprognostic (2.18e-2)" "unprognostic (1.65e-2)" "unprognostic (5.79e-2)" "unprognostic (2.69e-1)" "unprognostic (6.21e-2)" "unprognostic (2.02e-1)" "unprognostic (1.50e-1)" "unprognostic (1.57e-4)" "unprognostic (4.45e-2)" "unprognostic (2.09e-2)" "unprognostic (3.49e-2)" "unprognostic (3.81e-1)" 8.9 3.5 6.2 3.7 8.3 0.1 5.4 4.1 6.8 10.8 3.5 6.1 2.4 1.3 11.7 9.4 4.0 13.8 13.0 2.0 7.2 2.6 1.3 12.1 3.8 1.1 5.1 5.5 9.4 3.0 0.3 2.6 3.2 11.2 2.7 1.8 4.0 4.1 3.8 1.4 1.8 2.5 9.2 5.2 1.2 4.3 3.1 6.8 0.0 2.0 1.1 0.6 3.8 4.2 0.0 1.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 5.9 0.2 0.0 1.7 0.3 0.6 0.0 0.0 0.2 1.8 0.0 1.8 0.0 2.8 0.0 0.7 0.0 0.0 0.0 2.5 0.9 0.0 0.0 1.3 0.5 2.1 1.2 0.0 0.6 1.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.4 0.0 3.4 0.0 0.0 0.0 0.0 6.2 0.0 0.8 0.1 0.4 0.0 4.2 0.0 0.3 11.9 1.4 0.0 0.8 1.2 2.4 0.0 0.4 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.2 1.2 0.0 0.0 6.2 8.3 4.1 6.8 7.2 2.6 5.1 5.5 11.2 6.8 0.0 0.0 0.0 0.1 0.1 1.2 0.6 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.1 0.6 0.3 0.0 0.0 0.2 1.9 3.1 0.2 0.0 11.9 3.1 3.2 0.0 1.8 0.3 0.0 9.2 0.0 0.0 1.0 0.0 17.2 0.3 0.0 18.7 0.3 1.6 6.5 1.4 0.9 0.9 0.5 2.3 0.0 0.0 0.0 FAM198B "C4orf18, DKFZp434L142, ENED, FLJ38155" ENSG00000164125 "Family with sequence similarity 198 member B" Q6UWH4 4 158124474-158173318 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 83.8" "Cell type enhanced" "Detected in many" 13 "Endothelial cells: 51.3;Hofbauer cells: 56.1;Ito cells: 49.7;Kupffer cells: 140.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 23.8;intermediate monocyte: 14.8;myeloid DC: 7.6;non-classical monocyte: 6.8" "Group enriched" "Detected in many" 37 "dendritic cells: 7.6;monocytes: 23.8" "Cell line enhanced" "Detected in many" "ASC diff: 21.5;ASC TERT1: 40.6;HSkMC: 46.6;HUVEC TERT2: 52.0;WM-115: 20.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007227 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA007227: AB_1847689" "unprognostic (4.87e-2)" "unprognostic (7.79e-2)" "unprognostic (6.60e-3)" "unprognostic (9.42e-3)" "unprognostic (2.37e-2)" "unprognostic (7.47e-2)" "unprognostic (2.13e-2)" "unprognostic (7.49e-2)" "unprognostic (9.20e-3)" "unprognostic (1.71e-1)" "unprognostic (1.60e-1)" "unprognostic (1.89e-1)" "unprognostic (3.25e-3)" "unprognostic (3.74e-3)" "unprognostic (3.85e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-2)" 24.1 83.8 13.9 12.9 12.6 0.9 15.9 22.9 16.0 16.7 8.9 12.1 6.2 4.5 27.5 13.2 6.0 10.6 12.6 25.8 24.2 9.0 4.2 2.9 6.9 7.1 18.6 20.2 50.1 4.8 4.4 2.7 9.5 12.4 8.3 8.1 4.2 7.9 10.8 3.8 3.5 6.3 23.9 25.9 15.7 7.5 7.0 17.5 0.0 8.2 3.1 2.3 14.2 7.3 0.0 7.6 0.4 23.8 0.0 0.0 7.3 3.2 2.6 1.6 0.3 21.5 40.6 3.1 0.8 0.6 0.1 1.0 3.5 1.3 0.0 0.1 1.3 1.4 0.0 19.0 5.0 0.5 0.0 0.0 0.2 0.0 9.7 14.4 0.1 0.0 46.6 1.2 6.6 0.7 2.2 52.0 0.0 3.3 0.0 9.6 0.2 0.0 0.0 0.1 11.3 0.0 0.0 0.1 0.0 0.0 7.3 0.1 0.0 0.0 7.5 2.1 9.6 1.4 0.0 2.5 4.4 4.8 2.6 1.6 0.0 0.0 11.8 0.6 0.0 20.0 0.0 23.8 0.0 0.0 14.8 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.4 0.0 6.8 0.3 0.0 7.3 13.9 12.6 22.9 16.0 24.2 9.0 18.6 20.2 12.4 17.5 8.9 3.8 1.7 1.7 8.1 0.0 30.3 0.0 2.7 2.3 3.5 0.0 3.6 0.0 0.5 2.4 51.3 2.6 0.0 5.0 0.9 14.8 2.4 1.1 0.8 56.1 6.4 1.7 49.7 140.4 4.3 32.5 27.2 8.5 0.0 6.5 0.0 3.2 1.9 39.6 0.0 0.0 6.5 10.3 4.4 0.5 6.5 4.9 2.2 2.9 1.0 FAM19A1 "TAFA-1, TAFA1" ENSG00000183662 "Family with sequence similarity 19 member A1, C-C motif chemokine like" Q7Z5A9 3 68004216-68545625 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 13.9;brain: 28.0" "Cell type enriched" "Detected in some" 12 "Early spermatids: 14.9" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 13.9;MAIT T-cell: 10.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 7.5;naive CD4 T-cell: 8.2;naive CD8 T-cell: 11.5;T-reg: 5.0" "Lineage enriched" "Detected in many" 6 "T-cells: 13.9" "Cell line enriched" "Detected in single" 9 "REH: 6.1" "Low region specificity" "Detected in many" HPA013407 Approved "Secreted in brain" NA NA "HPA013407: AB_1848386" "unprognostic (5.19e-2)" "unprognostic (4.64e-3)" "unprognostic (1.97e-2)" "unprognostic (1.86e-2)" "unprognostic (7.95e-2)" "unprognostic (6.40e-2)" "unprognostic (3.42e-3)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (2.41e-1)" "unprognostic (1.41e-2)" "unprognostic (7.87e-2)" "unprognostic (1.35e-3)" "unprognostic (2.11e-1)" "unprognostic (1.99e-1)" "unprognostic (3.50e-4)" "unprognostic (5.77e-2)" 0.7 2.0 10.6 0.8 9.0 0.4 0.5 0.4 28.0 0.5 0.7 0.1 0.3 2.3 0.8 2.0 0.5 0.5 1.4 0.5 18.4 4.8 0.8 0.8 0.5 1.2 4.4 10.4 0.4 0.4 0.4 0.6 0.4 25.2 2.6 0.6 0.0 0.6 6.2 0.6 0.4 0.5 0.9 1.3 0.9 0.5 0.7 0.2 0.0 0.6 0.0 0.7 0.7 0.3 0.0 0.0 0.2 0.1 2.1 13.9 2.6 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.9 0.0 10.7 0.0 11.5 7.5 0.0 0.0 8.2 11.5 0.2 2.1 0.0 0.0 5.0 2.6 10.6 9.0 0.4 24.4 18.4 4.8 4.4 10.4 25.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 FAM19A2 "TAFA-2, TAFA2" ENSG00000198673 "Family with sequence similarity 19 member A2, C-C motif chemokine like" Q8N3H0 12 61708259-62279150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.7;brain: 25.8" "Group enriched" "Detected in many" 7 "Early spermatids: 155.9;Late spermatids: 77.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 17.7;neutrophil: 9.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 17.7" "Cell line enhanced" "Detected in some" "hTCEpi: 9.8;SCLC-21H: 3.7;WM-115: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (3.89e-3)" "unprognostic (9.33e-2)" "unprognostic (1.02e-1)" "unprognostic (1.37e-2)" "unprognostic (2.78e-1)" "unprognostic (4.83e-1)" "unprognostic (6.62e-2)" "unprognostic (4.16e-3)" "unprognostic (4.08e-1)" "unprognostic (1.80e-1)" "unprognostic (3.22e-5)" "unprognostic (1.05e-1)" "unprognostic (2.22e-2)" "unprognostic (3.31e-2)" "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (1.28e-1)" 1.7 1.7 16.7 1.3 10.1 3.8 1.5 1.3 25.8 3.1 1.7 1.1 0.0 1.8 1.9 1.0 0.9 1.3 1.2 0.7 13.1 7.0 0.9 0.8 0.9 1.4 5.8 12.7 4.3 1.8 0.9 5.7 4.9 9.9 2.4 1.5 0.2 1.2 11.1 0.6 1.3 1.3 1.0 2.1 1.8 1.2 5.3 0.0 0.0 1.0 0.0 0.7 1.5 2.5 0.4 0.4 17.7 1.9 0.4 2.8 0.4 0.2 0.0 1.9 0.4 1.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.3 0.8 0.1 0.0 0.3 0.3 0.3 0.7 0.4 1.3 3.0 0.0 0.3 1.4 2.2 0.1 9.8 0.0 0.0 0.3 0.0 2.7 1.9 1.1 0.0 0.0 2.5 0.5 0.8 0.3 0.0 0.5 0.0 0.0 0.0 0.0 3.7 0.3 0.8 0.0 0.6 0.7 0.4 0.4 0.1 0.4 1.1 0.2 0.5 0.8 0.9 0.5 0.0 0.6 8.1 17.7 1.9 3.8 0.3 0.6 0.1 0.4 0.8 0.4 0.2 0.2 0.7 0.2 9.2 0.4 0.2 0.4 2.8 0.4 16.7 10.1 1.3 25.8 13.1 7.0 5.8 12.7 9.9 0.0 0.0 0.0 3.7 1.0 1.6 1.7 2.5 0.0 4.0 0.0 0.0 2.0 1.3 5.0 0.5 155.9 1.6 1.5 0.0 1.0 1.1 3.2 0.6 1.1 2.4 1.6 0.0 2.4 0.6 10.4 77.3 3.7 1.2 1.7 0.0 1.5 2.5 0.9 1.9 0.4 1.3 1.7 6.5 0.8 17.3 5.6 0.5 2.2 2.5 1.7 1.4 FAM19A3 "TAFA-3, TAFA3" ENSG00000184599 "Family with sequence similarity 19 member A3, C-C motif chemokine like" Q7Z5A8 1 112720419-112727235 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "adrenal gland: 19.6;brain: 5.2;testis: 8.8" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 44.6;Cone photoreceptor cells: 64.8;Muller glia cells: 15.8;Rod photoreceptor cells: 17.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.7;BJ hTERT+: 9.5;HEL: 3.7;U-87 MG: 3.8" HPA055927 Approved "Secreted in other tissues" NA NA "HPA055927: AB_2682972" "unprognostic (9.96e-2)" "unprognostic (4.30e-1)" "unprognostic (3.36e-2)" "unprognostic (5.63e-4)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.66e-1)" "unprognostic (3.40e-2)" "unprognostic (1.13e-1)" "unprognostic (6.43e-2)" "unprognostic (1.32e-1)" "unprognostic (9.82e-2)" "unprognostic (2.51e-1)" "unprognostic (5.14e-6)" "unprognostic (2.10e-4)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-1)" 0.1 19.6 0.4 0.1 0.0 0.0 0.3 5.2 0.4 0.1 0.0 0.0 0.1 0.9 0.2 0.4 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.4 3.9 0.6 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.0 1.2 0.0 0.0 8.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.2 0.0 0.0 0.6 0.8 0.2 9.5 0.7 0.6 0.0 0.3 0.0 0.1 0.1 0.7 0.0 0.1 0.5 0.4 1.6 0.3 3.7 0.0 0.1 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.5 0.0 0.2 0.0 0.4 0.4 0.4 0.1 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.3 0.6 0.1 0.0 1.1 0.0 1.4 1.3 0.2 0.5 0.1 0.0 0.0 3.8 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 44.6 0.4 0.0 0.0 0.0 0.0 64.8 0.0 0.0 0.3 8.1 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 17.9 0.0 0.1 0.6 0.9 0.0 0.1 0.0 0.0 0.0 FAM19A4 TAFA-4 ENSG00000163377 "Family with sequence similarity 19 member A4, C-C motif chemokine like" Q96LR4 3 68731766-68953297 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.0;brain: 10.9" "Cell type enriched" "Detected in some" 7 "Cone photoreceptor cells: 31.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.7;NTERA-2: 13.9;SuSa: 4.1" "Region enriched" "Detected in some" 5 "thalamus: 14.7" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (1.92e-1)" "unprognostic (9.97e-3)" "unprognostic (2.28e-1)" "unprognostic (8.19e-3)" "unprognostic (8.78e-2)" "unprognostic (2.00e-2)" "unprognostic (3.01e-2)" "unprognostic (1.22e-1)" "unprognostic (3.66e-2)" "unprognostic (8.06e-2)" "unprognostic (2.50e-1)" 0.5 26.0 2.3 0.9 7.3 0.5 0.6 0.4 7.5 0.5 0.7 10.8 0.0 0.6 0.5 0.5 1.1 0.6 2.7 0.5 2.9 4.2 0.7 0.5 0.6 0.6 10.9 1.8 1.0 0.5 0.5 1.8 1.8 8.7 2.2 0.6 5.0 0.7 1.1 0.5 0.5 0.5 1.0 10.4 0.6 8.3 2.1 8.2 0.0 0.6 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 7.3 0.4 7.5 2.9 4.2 10.9 1.8 8.7 8.2 0.0 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 FAM19A5 TAFA-5 ENSG00000219438 "Family with sequence similarity 19 member A5, C-C motif chemokine like" Q7Z5A7 22 48489460-48850912 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.2" "Cell type enhanced" "Detected in many" 17 "Bipolar cells: 15.0;Muller glia cells: 37.6;Peritubular cells: 8.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 13.8;HEK 293: 9.3;Hep G2: 21.3;NTERA-2: 12.0;SCLC-21H: 6.1;U-2 OS: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025629 Approved "Secreted in brain" NA NA "CAB025629: " "unprognostic (2.86e-1)" "unprognostic (2.98e-1)" "unprognostic (3.42e-2)" "unprognostic (2.19e-1)" "unprognostic (3.57e-1)" "unprognostic (1.80e-1)" "unprognostic (2.82e-3)" "unprognostic (2.41e-2)" "unprognostic (6.80e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-2)" "unprognostic (1.26e-1)" "unprognostic (9.31e-3)" "unprognostic (2.64e-2)" "unprognostic (2.55e-2)" "unprognostic (1.06e-1)" "unprognostic (5.94e-2)" 1.9 2.5 22.7 1.7 18.7 0.7 2.7 19.1 40.2 12.2 1.8 8.5 0.1 2.0 8.1 6.9 1.1 3.4 3.4 1.4 23.6 22.8 1.9 3.0 2.2 1.2 18.1 12.9 8.3 2.4 0.8 1.9 0.8 8.7 4.0 1.0 0.7 7.3 5.7 1.5 1.9 2.6 1.8 9.9 1.1 3.7 2.5 7.3 1.3 1.1 0.0 1.0 2.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 0.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.8 0.1 0.0 0.9 0.0 0.0 0.0 9.3 0.0 0.1 21.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.2 12.0 0.4 0.0 0.5 0.0 5.1 0.0 0.0 6.1 0.1 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 16.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 18.7 19.1 21.9 23.6 22.8 18.1 12.9 8.7 7.3 3.0 2.9 0.0 0.0 1.6 15.0 1.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.6 0.0 0.0 0.3 0.0 5.6 1.0 0.0 0.0 0.2 3.2 0.0 0.6 0.0 0.0 6.4 0.2 5.0 0.0 0.0 37.6 0.7 0.0 8.9 1.8 1.5 0.0 0.9 0.5 3.4 1.4 0.0 0.0 0.0 0.0 FAM200A "C7orf38, DKFZp727G131, FLJ36794" ENSG00000221909 "Family with sequence similarity 200 member A" Q8TCP9 7 99546308-99558536 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017855 Uncertain NA NA "HPA017855: AB_1847703" "unprognostic (3.98e-3)" "unprognostic (2.36e-2)" "unprognostic (2.67e-1)" "unprognostic (6.44e-2)" "unprognostic (1.60e-1)" "unprognostic (4.63e-2)" "prognostic unfavorable (9.24e-4)" "unprognostic (2.38e-3)" "unprognostic (4.12e-3)" "unprognostic (1.38e-1)" "unprognostic (5.42e-3)" "unprognostic (1.85e-1)" "prognostic favorable (2.17e-7)" "unprognostic (8.38e-2)" "unprognostic (3.46e-2)" "unprognostic (7.84e-2)" "unprognostic (2.41e-2)" 5.5 13.1 10.2 7.2 14.2 2.6 10.4 23.2 13.1 11.4 6.0 7.1 10.9 5.9 9.1 11.5 7.1 8.8 6.2 8.9 11.0 12.4 11.1 6.0 6.6 9.2 15.1 8.8 18.2 8.4 11.7 21.3 8.5 10.0 12.1 5.5 6.1 10.4 9.5 9.2 8.9 6.0 5.6 10.7 7.7 7.8 16.1 13.9 12.3 12.6 5.9 8.5 8.1 10.6 6.7 3.5 6.6 3.1 3.3 10.3 3.3 7.7 4.7 11.1 13.1 9.9 9.6 7.2 7.1 7.5 6.3 7.8 4.5 6.6 4.7 7.5 4.6 10.1 6.2 8.8 6.7 10.4 6.8 7.8 5.3 6.4 5.5 8.0 6.1 6.2 6.7 12.0 5.9 11.6 8.4 6.4 8.0 11.4 4.2 11.3 5.7 11.3 12.1 10.0 2.1 7.7 5.7 9.4 4.8 5.8 5.3 8.6 16.5 4.2 6.9 11.8 13.9 5.4 6.8 5.0 9.5 11.4 13.5 6.2 5.6 4.9 5.7 7.5 5.2 14.8 6.6 3.1 4.0 5.8 2.2 8.4 4.8 5.7 7.0 3.4 6.7 10.3 8.4 2.0 3.3 1.9 3.5 7.5 3.3 10.2 14.2 23.2 13.1 11.0 12.4 15.1 8.8 10.0 13.9 8.9 4.0 2.7 3.7 1.6 14.2 5.8 2.5 6.7 5.7 7.0 0.0 6.3 6.6 3.9 67.1 4.9 2.0 0.0 3.0 4.4 3.1 3.0 0.0 1.7 3.7 12.7 0.0 1.8 1.8 9.6 8.3 2.1 1.7 5.4 2.7 12.3 3.7 4.3 5.6 4.1 9.4 0.0 2.1 17.4 7.6 2.9 6.8 4.9 2.9 1.1 FAM205A C9orf144B ENSG00000205108 "Family with sequence similarity 205 member A" Q6ZU69 9 34723055-34729467 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 243 "testis: 24.3" "Cell type enriched" "Detected in some" 6 "Early spermatids: 99.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;THP-1: 2.3" HPA071267 Enhanced Uncertain "Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoli fibrillar center" "HPA071267: AB_2686376" "unprognostic (2.25e-1)" "unprognostic (3.66e-3)" "unprognostic (6.29e-3)" "unprognostic (1.90e-1)" "unprognostic (2.73e-3)" "unprognostic (7.82e-2)" "unprognostic (9.61e-2)" "unprognostic (6.41e-2)" "unprognostic (4.78e-1)" "unprognostic (7.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 FAM205C FAM205CP ENSG00000187791 "Family with sequence similarity 205 member C" A6NFA0 9 34889064-34895778 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 23.2" "Group enriched" "Detected in some" 80 "Early spermatids: 294.6;Late spermatids: 336.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 97 "THP-1: 18.1" NA NA "unprognostic (1.29e-1)" "unprognostic (1.90e-1)" "unprognostic (3.64e-2)" "unprognostic (8.64e-2)" "unprognostic (2.63e-1)" "unprognostic (1.84e-1)" "unprognostic (7.73e-2)" "unprognostic (1.85e-4)" "unprognostic (1.48e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 1.7 0.0 294.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 336.5 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.6 0.5 0.0 0.0 2.6 1.0 0.0 0.0 0.0 0.0 0.0 FAM209A "C20orf106, dJ1153D9.3" ENSG00000124103 "Family with sequence similarity 209 member A" Q5JX71 20 56517187-56526142 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 40.3" "Cell type enriched" "Detected in some" 15 "Early spermatids: 1951.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.9;neutrophil: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 5.5;Karpas-707: 3.0;U-266/84: 3.9" NA NA "unprognostic (1.03e-1)" "unprognostic (1.01e-2)" "unprognostic (2.19e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (8.58e-3)" "unprognostic (1.06e-2)" "unprognostic (2.12e-1)" "unprognostic (2.10e-1)" "unprognostic (9.83e-2)" "unprognostic (5.56e-3)" "unprognostic (7.68e-2)" "unprognostic (1.86e-9)" "unprognostic (2.98e-2)" "unprognostic (2.07e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-2)" 0.2 0.0 0.0 0.3 0.0 8.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.1 40.3 0.0 0.5 0.0 0.1 0.6 0.3 2.3 0.2 0.0 1.9 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.4 0.0 0.3 0.3 0.3 0.2 1.9 0.3 0.5 0.2 0.2 0.5 0.2 0.2 0.3 0.3 0.6 0.4 0.0 0.2 1.5 5.5 0.3 1.6 0.0 0.2 0.2 0.0 1.7 0.0 3.0 0.0 1.3 0.2 1.9 0.2 0.1 0.2 1.0 0.9 1.2 0.0 0.7 0.5 0.0 0.0 2.1 0.5 0.0 0.4 0.9 0.0 0.5 0.3 0.8 0.3 1.4 3.9 2.0 0.0 0.2 0.1 0.0 0.2 0.6 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.1 2.3 0.0 0.2 0.3 0.0 0.0 0.0 2.9 0.0 0.1 0.1 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1951.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 1.1 0.0 0.1 0.0 1.2 1.8 0.3 132.6 8.1 0.8 0.0 0.0 0.0 0.0 0.4 0.0 6.0 0.0 0.0 0.0 0.0 7.5 4.1 0.0 0.2 0.0 0.1 0.1 FAM209B "C20orf107, dJ1153D9.4" ENSG00000213714 "Family with sequence similarity 209 member B" Q5JX69 20 56533246-56536520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 40.8" "Cell type enriched" "Detected in some" 10 "Early spermatids: 1427.6" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 5.0" HPA042144 Enhanced NA NA "HPA042144: AB_10794414" "unprognostic (2.93e-1)" "unprognostic (6.90e-2)" "unprognostic (9.49e-3)" "unprognostic (4.96e-3)" "unprognostic (1.72e-1)" "unprognostic (3.77e-1)" "unprognostic (1.72e-1)" "unprognostic (7.77e-2)" "unprognostic (3.63e-2)" "unprognostic (1.43e-1)" "unprognostic (4.59e-4)" "unprognostic (3.47e-1)" "unprognostic (2.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.55e-1)" "unprognostic (7.13e-2)" "unprognostic (1.48e-4)" 0.2 0.0 0.0 0.2 0.1 4.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.3 0.3 0.2 0.0 0.0 0.9 0.1 40.8 0.0 0.3 0.0 0.0 1.0 0.8 3.4 1.1 0.0 2.1 0.4 0.0 2.7 0.7 0.0 0.0 0.3 0.4 1.1 1.9 2.4 0.9 1.7 0.1 0.3 1.8 1.2 0.6 1.4 1.2 0.7 2.1 0.4 1.1 1.2 0.0 1.1 0.0 2.2 4.2 1.3 2.0 0.2 1.5 0.0 0.0 1.9 0.2 1.9 0.0 2.6 0.8 2.0 0.5 0.2 1.5 0.7 0.8 0.2 1.5 0.9 1.7 0.4 0.9 3.4 0.6 0.8 1.5 0.6 0.0 0.3 0.7 1.7 0.1 5.0 4.5 0.9 0.4 1.0 0.3 0.0 1.1 3.4 2.1 0.4 0.3 0.0 0.1 1.3 0.8 1.0 0.7 0.0 1.8 0.0 0.7 0.0 0.0 0.4 0.0 3.4 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 1427.6 0.0 0.0 0.0 1.4 0.4 0.0 0.3 1.1 0.0 0.5 0.0 1.2 0.0 0.3 148.4 10.6 0.7 0.0 1.0 0.0 0.0 0.6 0.0 7.8 0.5 0.0 0.0 0.5 6.9 6.8 0.0 0.0 0.0 0.0 0.6 FAM20A DKFZp434F2322 ENSG00000108950 "FAM20A, golgi associated secretory pathway pseudokinase" Q96MK3 17 68535113-68601389 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 59.2;salivary gland: 50.4" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 68.0;Early spermatids: 61.3;Hepatocytes: 58.2;Hofbauer cells: 72.2;Late spermatids: 140.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "pons and medulla: 3.8" "Cell type enhanced" "Detected in some" "non-classical monocyte: 2.1" "Group enriched" "Detected in many" 4 "dendritic cells: 1.0;granulocytes: 1.8;monocytes: 2.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.8;BJ hTERT+: 27.3;HSkMC: 22.8;U-2197: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA048964 Approved "Secreted in other tissues" NA NA 10000000 "HPA048964: AB_2680575" "unprognostic (3.68e-2)" "unprognostic (3.14e-2)" "unprognostic (3.35e-2)" "unprognostic (4.49e-3)" "unprognostic (6.56e-2)" "unprognostic (5.29e-2)" "unprognostic (3.90e-3)" "unprognostic (2.39e-2)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (9.16e-10)" "unprognostic (1.25e-3)" "unprognostic (1.06e-1)" "unprognostic (4.55e-2)" "unprognostic (2.39e-2)" 4.9 1.1 0.2 4.7 0.4 1.0 3.7 0.2 1.5 12.1 3.2 0.7 0.7 1.4 7.6 9.9 2.2 4.1 2.3 6.5 0.3 0.4 19.6 59.2 17.6 14.7 0.3 0.8 6.8 1.0 0.6 4.8 4.2 3.8 3.5 1.0 8.7 50.4 1.7 2.8 1.5 1.2 4.7 2.4 7.3 9.5 9.1 0.2 0.9 8.2 4.0 2.5 3.7 3.4 0.2 1.0 1.8 2.1 0.1 0.3 0.0 0.0 0.1 0.0 0.1 1.3 11.8 0.0 0.5 27.3 0.0 0.0 0.0 0.0 0.0 2.4 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 22.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.9 0.3 0.2 0.0 0.0 0.3 0.1 0.0 0.1 1.8 0.1 2.1 1.0 0.0 0.0 0.2 0.4 0.2 1.5 0.3 0.4 0.3 0.8 3.8 0.2 14.9 68.0 0.0 0.1 2.1 3.1 4.8 7.6 1.4 37.5 41.8 0.0 0.5 0.0 0.3 61.3 1.3 0.0 0.0 0.4 2.0 5.8 0.0 1.1 58.2 72.2 39.7 0.0 7.4 20.3 140.0 10.3 11.6 1.7 1.8 0.0 0.2 0.6 0.0 13.8 13.0 2.9 6.5 0.7 1.2 0.2 1.6 2.3 0.0 0.0 0.0 FAM20B "GXK1, KIAA0475" ENSG00000116199 "FAM20B, glycosaminoglycan xylosylkinase" O75063 1 179025804-179076562 "Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007409 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 280000 "Golgi apparatus" Nucleoplasm "HPA007409: AB_10601649" "unprognostic (7.58e-2)" "unprognostic (1.12e-1)" "unprognostic (4.97e-2)" "unprognostic (6.23e-3)" "unprognostic (3.29e-1)" "unprognostic (3.07e-1)" "unprognostic (4.76e-2)" "unprognostic (7.70e-3)" "unprognostic (7.85e-2)" "unprognostic (3.93e-2)" "unprognostic (5.36e-2)" "unprognostic (1.58e-1)" "unprognostic (3.76e-1)" "unprognostic (2.03e-1)" "unprognostic (1.76e-1)" "unprognostic (3.67e-2)" "unprognostic (3.74e-1)" 18.2 21.3 17.7 12.8 20.9 8.8 26.0 16.1 26.4 15.8 20.8 10.8 13.3 8.7 18.5 14.7 17.5 14.7 17.3 32.9 17.1 17.2 16.2 14.8 14.6 9.1 16.1 19.9 19.0 10.1 22.5 16.9 15.2 15.2 15.6 13.4 14.5 9.9 18.8 19.0 11.4 10.6 25.9 13.6 10.5 14.4 6.8 9.4 7.3 16.5 7.7 9.4 17.6 28.7 4.9 3.6 2.3 2.3 4.4 4.1 1.5 17.9 16.5 12.8 13.5 22.9 24.2 14.2 15.0 17.2 10.6 9.5 8.2 18.0 9.3 19.8 26.4 8.7 13.2 13.0 11.0 15.6 11.8 8.8 29.7 15.6 10.4 11.4 19.6 18.8 14.0 12.1 14.4 11.2 16.2 13.0 13.1 33.0 13.7 16.9 10.0 8.5 7.1 16.8 20.3 3.5 10.5 13.5 12.4 8.9 20.4 17.1 42.1 15.8 18.0 15.3 19.0 15.5 14.4 13.7 16.9 14.9 23.2 20.2 11.2 20.4 8.2 16.8 9.6 16.7 2.3 2.0 0.6 3.8 1.7 4.1 4.2 2.4 3.5 2.2 4.9 3.5 3.2 1.9 4.4 2.3 3.6 2.7 1.5 17.7 20.9 16.1 26.4 17.1 17.2 16.1 19.9 15.2 9.4 6.0 10.7 11.2 8.9 13.9 12.3 31.9 17.8 8.1 7.9 17.4 23.6 8.0 3.3 8.2 4.2 11.2 4.1 0.0 11.0 5.7 12.4 14.8 16.2 12.2 6.9 36.5 13.8 10.4 8.9 2.5 16.4 6.9 15.1 10.0 7.6 7.8 11.0 0.0 20.1 5.4 20.2 12.9 20.3 12.9 15.8 11.3 6.3 6.9 6.6 23.8 FAM20C "DKFZp547D065, DMP4, G-CK, IMAGE:4942737" ENSG00000177706 "FAM20C, golgi associated secretory pathway kinase" Q8IXL6 7 192969-260745 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" Biomineralization "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 80.6" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 52.4;Hepatocytes: 80.0;Hofbauer cells: 49.0;Peritubular cells: 53.0;Proximal tubular cells: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HSkMC: 50.3;hTERT-RPE1: 39.1;U-87 MG: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019823 Approved "Nucleoplasm,Golgi apparatus" "Secreted in other tissues" NA NA 160000000 "Golgi apparatus" Nucleoplasm "HPA019823: AB_1848389" "unprognostic (1.94e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (3.15e-2)" "unprognostic (1.03e-2)" "unprognostic (3.33e-3)" "unprognostic (2.47e-2)" "unprognostic (7.86e-2)" "unprognostic (2.45e-3)" "unprognostic (3.35e-2)" "prognostic unfavorable (9.40e-6)" "unprognostic (1.97e-3)" "unprognostic (2.49e-1)" "unprognostic (3.08e-3)" "unprognostic (1.94e-2)" "unprognostic (3.92e-2)" "unprognostic (2.16e-2)" "unprognostic (3.83e-3)" 27.5 10.2 10.8 19.3 16.6 3.3 25.6 7.4 14.9 8.3 20.1 13.5 15.1 12.9 9.5 6.9 11.1 9.7 15.0 15.0 8.8 7.2 31.8 31.6 12.7 5.1 16.9 5.6 11.8 14.8 2.6 9.2 7.2 15.8 15.0 4.6 8.8 80.6 11.8 20.4 6.8 16.5 17.0 17.0 6.9 20.0 5.9 14.8 0.4 9.6 8.4 4.4 20.5 17.5 0.0 0.6 0.0 1.6 0.2 0.0 0.0 13.3 6.5 0.2 9.3 11.9 19.7 0.0 11.9 20.2 6.5 5.2 0.7 8.2 0.0 6.6 17.8 8.8 11.6 1.0 0.5 1.6 2.8 0.6 0.0 3.1 3.5 9.0 0.0 0.9 50.3 1.5 0.2 0.7 39.1 4.5 0.0 0.0 0.1 1.7 1.8 0.0 0.7 6.3 0.1 0.4 1.5 0.3 0.0 4.8 0.0 3.1 0.1 12.4 0.0 1.8 1.2 8.8 6.1 12.5 8.1 4.0 6.9 3.6 0.0 0.0 0.0 31.0 0.8 23.1 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.8 16.6 7.4 14.9 8.8 7.2 16.9 5.6 15.8 14.8 6.0 3.2 2.4 1.9 9.0 20.6 8.1 33.1 5.3 0.0 52.4 0.0 0.5 5.0 1.3 0.0 2.4 3.5 0.0 4.1 0.6 13.5 6.8 3.5 80.0 49.0 1.6 11.3 9.8 15.6 1.1 15.0 14.7 1.7 11.8 4.2 16.6 6.5 3.5 53.0 46.8 8.0 12.9 15.3 0.2 0.7 7.0 0.5 0.0 7.3 1.4 FAM210A "C18orf19, HsT2329, MGC24180" ENSG00000177150 "Family with sequence similarity 210 member A" Q96ND0 18 13663347-13726663 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014324, HPA051564" Uncertain Approved "Nucleoplasm,Golgi apparatus,Mitochondria" NA NA "Nucleoplasm, Golgi apparatus, Mitochondria" "HPA014324: AB_2668972, HPA051564: AB_2681536" "unprognostic (1.32e-1)" "unprognostic (6.98e-2)" "unprognostic (5.78e-2)" "unprognostic (9.18e-3)" "unprognostic (4.13e-2)" "prognostic unfavorable (8.14e-4)" "unprognostic (2.23e-3)" "unprognostic (1.11e-2)" "unprognostic (2.26e-1)" "unprognostic (5.53e-3)" "unprognostic (6.79e-3)" "unprognostic (2.98e-2)" "unprognostic (3.27e-3)" "unprognostic (7.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" "unprognostic (4.82e-2)" 10.5 8.1 7.5 8.9 7.1 4.0 9.4 8.3 8.8 5.8 9.9 7.2 5.8 11.5 6.6 4.4 13.5 5.7 5.4 27.5 6.4 7.8 12.0 17.6 5.6 7.4 7.4 6.4 8.7 5.6 7.8 7.5 9.3 8.2 7.1 8.5 6.5 7.0 7.6 27.9 5.6 10.9 8.2 9.1 6.4 6.1 10.2 7.3 5.9 8.4 16.3 8.9 14.7 7.9 9.2 8.6 4.3 10.7 7.6 9.7 5.0 12.2 7.0 4.9 4.6 5.8 6.1 7.2 8.5 7.9 9.6 11.2 9.4 6.0 12.7 10.7 6.0 17.8 6.0 9.4 10.6 15.7 8.7 4.4 8.9 5.1 6.8 6.9 15.1 8.4 5.2 8.4 9.2 32.6 6.7 6.1 7.7 12.0 7.0 11.1 8.4 9.3 9.8 5.5 24.1 7.0 7.6 11.7 14.7 7.9 7.8 3.2 5.5 7.4 11.0 20.3 7.4 5.8 7.2 6.7 24.7 24.2 15.2 10.4 7.9 9.8 14.7 13.1 7.9 9.8 3.4 7.0 4.3 8.9 10.7 9.7 8.1 7.6 7.7 8.6 9.2 9.6 9.0 1.2 7.6 5.3 5.6 7.2 5.0 7.5 7.1 8.3 8.8 6.4 7.8 7.4 6.4 8.2 7.3 8.9 8.8 20.4 10.4 49.1 53.0 60.1 5.1 1.4 11.4 7.0 19.6 19.1 18.3 16.3 6.1 15.8 11.7 0.0 7.8 31.2 17.4 9.1 6.9 19.0 18.1 28.6 10.9 5.5 8.4 3.1 8.6 16.6 8.5 11.8 8.4 17.4 10.7 0.0 9.6 21.9 29.7 6.5 16.0 27.0 29.8 50.1 21.5 11.4 17.7 10.4 FAM210B "C20orf108, dJ1167H4.1, DKFZP434A1114" ENSG00000124098 "Family with sequence similarity 210 member B" Q96KR6 20 56358915-56368663 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Erythrocyte maturation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 233.6;Peritubular cells: 146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 73.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042652 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA042652: AB_2678098" "unprognostic (3.29e-1)" "prognostic favorable (5.44e-4)" "unprognostic (3.24e-2)" "unprognostic (1.66e-3)" "unprognostic (1.26e-1)" "unprognostic (3.34e-2)" "unprognostic (9.45e-2)" "prognostic favorable (4.26e-4)" "unprognostic (1.77e-1)" "unprognostic (2.24e-2)" "unprognostic (7.60e-2)" "unprognostic (2.90e-1)" "prognostic favorable (1.44e-10)" "unprognostic (1.08e-1)" "unprognostic (3.27e-2)" "unprognostic (1.84e-1)" "unprognostic (3.00e-1)" 19.8 47.7 13.2 9.3 22.8 30.5 29.0 13.4 12.3 23.4 18.1 10.9 24.0 10.7 22.3 24.7 24.4 18.5 29.5 48.1 13.0 12.9 15.2 43.2 16.3 11.8 15.2 9.3 50.5 21.8 13.1 15.1 17.6 13.7 30.9 13.8 21.4 29.0 33.5 54.2 17.5 15.0 19.9 11.1 12.2 16.3 11.1 9.7 5.9 19.8 25.7 12.3 22.8 30.9 1.9 2.8 10.3 5.6 2.2 4.0 1.5 4.8 1.9 7.5 18.2 21.7 24.6 14.6 6.0 13.4 10.9 12.6 3.4 2.4 0.4 3.1 10.2 6.3 14.1 4.0 17.2 18.4 0.7 6.3 3.0 4.4 32.5 14.3 0.3 1.9 21.0 19.3 6.2 8.8 12.7 17.5 2.6 22.5 3.2 13.3 5.0 2.5 1.3 6.3 7.1 11.8 0.0 15.5 3.8 5.6 5.7 10.4 18.7 14.5 31.7 73.1 16.7 14.0 2.7 12.1 9.8 6.5 15.6 3.6 2.5 2.6 0.1 7.8 1.9 6.3 3.3 3.8 10.3 2.9 5.6 2.2 1.9 3.4 4.0 2.8 1.8 3.6 3.4 1.7 2.2 2.4 2.4 3.7 1.5 13.2 22.8 13.4 12.3 13.0 12.9 15.2 9.3 13.7 9.7 14.9 21.1 2.2 74.0 22.0 7.6 52.5 68.8 1.4 14.8 15.7 37.3 61.4 54.7 24.7 0.6 24.8 25.3 233.6 16.9 19.6 25.7 58.3 19.5 106.8 25.0 1.6 48.9 44.2 41.8 2.6 61.9 18.3 35.4 32.5 26.7 25.1 32.5 7.0 146.3 38.9 16.9 19.4 28.4 1.2 10.4 28.4 35.0 13.1 32.1 44.8 FAM213A "Adrx, C10orf58, MGC4248, PAMM" ENSG00000122378 "Family with sequence similarity 213 member A" Q9BRX8 10 80407829-80437115 "Predicted intracellular proteins, Predicted membrane proteins" Antioxidant "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 120.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "plasmacytoid DC: 48.5" "Lineage enriched" "Detected in all" 10 "dendritic cells: 48.5" "Cell line enhanced" "Detected in many" "ASC diff: 140.5;HaCaT: 39.5;HUVEC TERT2: 62.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009025, HPA024565" Enhanced "Intracellular and membrane" NA NA "HPA009025: AB_1078312, HPA024565: AB_1845519" "unprognostic (1.73e-2)" "unprognostic (2.96e-2)" "unprognostic (6.96e-3)" "unprognostic (2.15e-2)" "unprognostic (3.02e-2)" "unprognostic (4.31e-2)" "unprognostic (3.14e-1)" "unprognostic (6.68e-2)" "unprognostic (2.58e-1)" "unprognostic (7.01e-2)" "unprognostic (3.54e-2)" "unprognostic (2.83e-3)" "unprognostic (3.32e-3)" "unprognostic (3.55e-1)" "unprognostic (6.78e-2)" "unprognostic (1.80e-1)" "prognostic favorable (6.11e-4)" 120.6 9.3 42.3 6.5 47.7 1.7 64.1 9.8 44.0 33.0 21.1 17.8 11.2 28.0 18.4 75.3 22.5 11.3 10.8 22.5 36.2 33.7 38.2 65.6 7.4 7.6 36.6 26.2 11.4 22.3 34.6 23.3 15.5 26.5 25.0 15.1 31.7 17.4 16.6 15.4 27.1 25.4 7.9 29.6 4.4 7.3 17.1 16.3 5.0 19.2 24.3 11.4 19.1 13.0 4.6 48.5 3.3 1.0 1.9 4.4 1.5 3.5 8.9 15.2 0.0 140.5 0.0 1.0 0.5 3.1 0.2 0.0 8.4 10.9 2.3 11.9 0.0 6.8 39.5 1.3 1.5 0.0 0.1 2.5 4.6 3.4 12.3 13.6 0.0 1.3 10.5 2.9 0.9 0.0 36.5 62.5 13.5 3.6 0.0 0.0 12.4 5.7 0.6 7.3 5.4 0.0 16.3 7.0 0.1 32.2 14.9 15.7 11.1 1.5 21.4 23.0 12.0 9.5 6.4 16.8 0.1 0.1 0.0 0.0 1.3 2.9 0.0 9.6 0.0 1.0 0.2 1.0 3.3 2.1 0.2 1.7 4.6 1.1 1.7 1.0 3.5 4.4 4.4 0.7 1.9 0.0 48.5 0.0 1.5 42.3 47.7 9.8 44.0 36.2 33.7 36.6 26.2 26.5 16.3 11.9 50.5 16.1 75.8 154.2 6.5 138.5 66.2 64.3 94.4 97.7 188.5 13.2 134.3 70.7 6.8 96.0 160.8 23.3 57.1 4.9 53.1 76.2 34.7 150.8 61.4 60.4 146.2 122.8 34.6 11.5 196.2 17.8 30.4 14.4 55.9 89.2 48.7 48.9 115.6 124.6 24.9 291.1 47.4 18.8 66.6 118.3 3.1 6.9 70.5 111.2 FAM234A "C16orf9, DKFZP761D0211, FLJ32603, ITFG3" ENSG00000167930 "Family with sequence similarity 234 member A" Q9H0X4 16 234546-268971 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria NA NA 3700000 Mitochondria Nucleoplasm "HPA011651: , HPA071871: AB_2732188" "unprognostic (1.00e-1)" "unprognostic (1.85e-2)" "unprognostic (3.49e-1)" "unprognostic (4.80e-2)" "unprognostic (5.51e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-2)" "unprognostic (2.55e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.16e-1)" "unprognostic (3.28e-2)" "unprognostic (2.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (3.68e-1)" 20.2 19.1 11.3 11.7 24.3 6.4 16.5 12.2 16.2 11.6 20.3 56.0 13.7 36.3 17.4 12.6 26.4 14.0 16.0 31.1 8.3 7.3 18.3 15.6 11.4 10.5 39.8 9.0 13.4 29.6 24.3 19.2 15.4 37.8 16.8 12.4 15.5 14.1 15.4 51.4 14.9 26.8 29.0 42.0 9.7 18.8 13.0 27.2 7.2 16.6 16.2 6.3 19.0 11.7 10.3 17.8 12.5 17.4 14.2 11.5 12.5 9.0 18.7 23.4 54.2 36.4 21.7 12.3 22.0 27.9 13.4 17.3 18.9 26.1 8.2 35.8 27.7 11.9 18.3 7.4 13.2 11.2 11.3 13.1 11.5 11.7 15.2 22.2 6.1 6.9 22.5 20.5 18.9 15.5 37.1 21.6 10.8 12.7 2.1 14.5 37.2 6.9 6.8 29.5 13.2 9.5 20.9 16.5 40.8 23.1 8.8 29.7 24.0 35.6 20.9 18.6 20.5 26.7 10.6 21.5 28.3 8.3 15.1 6.7 5.0 2.0 10.8 19.9 9.8 38.5 11.3 17.4 12.5 10.8 16.9 5.6 8.0 9.6 10.2 17.8 10.3 11.1 11.5 7.6 14.2 16.5 6.3 9.3 12.5 11.3 24.3 12.2 16.2 8.3 7.3 39.8 9.0 37.8 27.2 8.9 13.0 2.2 9.1 0.0 8.6 0.0 10.2 12.0 9.1 29.6 23.6 49.9 6.6 41.4 21.8 13.9 34.2 0.0 23.0 42.1 9.7 12.0 8.1 19.8 22.9 9.5 33.9 20.9 14.5 52.2 15.5 11.9 0.0 57.7 30.3 9.3 17.1 51.6 20.5 15.1 11.9 19.4 0.0 16.4 28.1 0.0 55.4 6.9 42.9 9.8 FAM234B KIAA1467 ENSG00000084444 "Family with sequence similarity 234 member B" A2RU67 12 13044284-13142521 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 17.4;Erythroid cells: 23.3" "Cancer enhanced" "Detected in all" "breast cancer: 16.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010803, HPA010850" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA010803: AB_1079200, HPA010850: AB_2732402" "unprognostic (1.85e-3)" "unprognostic (1.99e-1)" "unprognostic (1.93e-3)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (8.03e-3)" "unprognostic (3.34e-2)" "unprognostic (1.37e-1)" "unprognostic (9.55e-2)" "unprognostic (3.40e-2)" "unprognostic (3.62e-2)" "unprognostic (1.63e-1)" "unprognostic (1.85e-3)" "unprognostic (5.22e-2)" "unprognostic (1.06e-1)" "unprognostic (4.06e-3)" "unprognostic (7.62e-2)" 4.4 3.6 9.6 2.3 17.5 3.5 21.2 21.3 28.5 3.4 1.6 4.4 4.2 2.6 3.6 4.4 2.8 4.0 2.4 1.9 10.8 12.4 7.3 3.0 3.6 2.1 9.1 16.7 3.5 3.4 4.8 5.2 7.1 13.6 8.1 1.9 3.4 3.4 5.0 2.8 15.5 2.5 3.2 5.1 2.9 1.7 6.8 5.0 0.5 10.9 0.1 2.2 3.6 2.8 6.8 4.3 1.9 6.9 2.7 4.5 1.4 2.9 3.0 9.2 6.5 7.3 7.1 7.2 2.0 2.3 4.5 8.9 3.1 4.4 12.0 2.5 2.4 7.9 4.5 11.5 2.2 9.5 1.4 6.4 7.1 3.3 2.5 3.9 6.2 4.1 5.4 4.7 6.5 5.0 6.8 5.9 8.4 1.8 4.4 4.9 9.8 5.2 4.0 12.1 2.3 1.7 6.8 12.0 1.3 2.8 7.2 12.9 4.2 4.4 2.9 3.5 16.5 3.7 3.5 3.0 3.0 5.1 5.5 2.1 2.4 3.1 7.8 9.6 2.8 3.7 0.3 2.7 1.9 2.6 4.5 3.4 4.6 2.9 2.5 2.3 6.8 4.3 4.5 0.7 2.7 6.9 4.3 2.3 1.4 9.6 17.5 21.3 28.5 10.8 12.4 9.1 16.7 13.6 5.0 3.0 3.5 0.9 1.7 0.0 11.3 0.0 2.5 0.0 0.0 17.4 2.0 5.6 1.7 1.9 7.0 0.0 0.0 23.3 1.2 2.7 1.0 3.8 0.0 2.0 3.1 3.2 11.7 4.9 1.3 2.7 5.2 0.5 0.0 2.8 0.1 3.8 1.2 0.0 4.9 1.0 2.9 0.0 0.0 8.8 10.9 0.0 3.0 0.0 0.0 1.1 FAM241A "C4orf32, FLJ39370" ENSG00000174749 "Family with sequence similarity 241 member A" Q8N8J7 4 112145397-112195256 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 49.5" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 56.6;Alveolar cells type 2: 52.1;Ciliated cells: 77.6;Club cells: 67.1;Collecting duct cells: 31.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 26.5;HUVEC TERT2: 18.3" "Low region specificity" "Detected in all" "HPA062443, HPA069294" Approved Enhanced "Golgi apparatus" No No "Golgi apparatus" "HPA062443: AB_2684765, HPA069294: AB_2686111" "unprognostic (3.07e-1)" "unprognostic (1.11e-2)" "unprognostic (2.42e-2)" "unprognostic (5.58e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (1.61e-2)" "unprognostic (3.16e-1)" "unprognostic (1.21e-1)" "unprognostic (5.05e-2)" "unprognostic (4.81e-2)" "unprognostic (5.25e-2)" "unprognostic (9.20e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (4.08e-1)" "unprognostic (7.16e-2)" "unprognostic (1.39e-2)" 43.2 4.8 3.3 11.9 3.0 7.0 49.5 3.6 3.1 6.9 9.5 4.6 10.7 3.1 8.9 6.0 7.6 5.2 6.2 18.5 4.3 3.0 6.4 6.9 10.2 7.2 5.6 1.8 5.2 3.8 7.1 6.3 12.6 3.4 9.7 3.2 2.8 22.3 17.2 11.6 7.2 4.7 9.0 4.3 9.7 8.3 7.7 3.6 6.3 8.5 7.3 6.0 9.3 24.7 2.7 2.8 5.7 1.7 1.7 1.7 0.7 4.0 1.6 1.6 1.3 8.6 4.9 2.5 3.4 0.8 0.6 1.1 1.2 5.1 26.5 3.2 1.8 2.3 1.9 2.6 3.6 1.2 12.4 4.3 2.9 3.9 2.1 5.1 6.5 1.7 5.3 5.8 1.0 6.2 1.3 18.3 3.8 5.3 12.8 2.1 4.1 2.4 4.7 2.1 6.6 3.8 5.4 2.7 5.4 2.7 3.9 3.0 2.5 3.2 5.9 1.6 2.5 4.2 2.8 11.5 2.1 6.3 1.4 1.2 5.4 7.0 12.2 4.9 3.2 2.7 5.7 1.7 1.6 1.5 1.3 1.3 1.5 1.6 1.1 0.9 2.7 1.5 1.7 4.2 1.7 1.6 2.8 1.7 0.7 3.3 3.0 3.6 2.4 4.3 3.0 5.6 1.8 3.4 3.6 56.6 52.1 0.0 0.0 0.0 0.0 0.0 0.0 77.6 67.1 31.4 0.0 1.4 6.6 11.8 0.0 0.0 0.0 0.0 14.9 2.2 0.0 0.0 30.2 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 8.2 0.0 0.0 21.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 FAM241B C10orf35 ENSG00000171224 "Family with sequence similarity 241 member B" Q96D05 10 69630251-69633599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5" "Cell type enhanced" "Detected in some" 10 "Collecting duct cells: 15.7;Distal tubular cells: 10.0;Ductal cells: 23.4;Exocrine glandular cells: 15.9;Pancreatic endocrine cells: 15.7;Proximal tubular cells: 10.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.2" "Lineage enriched" "Detected in single" 25 "T-cells: 14.2" "Cell line enhanced" "Detected in many" "PC-3: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034591 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA034591: AB_10670572" "unprognostic (1.12e-1)" "unprognostic (6.37e-2)" "unprognostic (3.13e-2)" "unprognostic (1.17e-1)" "unprognostic (7.17e-3)" "prognostic unfavorable (8.64e-4)" "prognostic unfavorable (1.03e-4)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.63e-1)" "unprognostic (3.37e-2)" "unprognostic (3.12e-2)" "unprognostic (5.23e-2)" "unprognostic (2.52e-1)" "prognostic favorable (9.72e-4)" 1.4 3.3 13.1 2.0 13.5 1.1 5.3 34.5 23.9 1.3 3.0 3.2 0.6 3.0 2.7 13.0 4.0 4.8 2.1 6.9 15.0 17.8 4.7 2.3 4.1 2.7 10.8 14.4 2.0 7.9 5.6 5.3 1.3 8.3 7.8 2.6 5.1 5.6 5.6 1.6 2.4 2.2 4.5 4.6 0.8 4.2 11.4 2.4 0.7 6.0 0.1 2.4 2.6 1.6 0.3 0.0 0.5 0.0 0.2 14.2 2.8 13.3 14.5 1.8 14.9 0.0 0.0 6.5 1.3 0.3 2.4 2.6 10.5 11.0 0.0 20.4 0.3 8.6 5.5 7.8 4.5 3.4 13.2 10.7 0.0 3.2 4.0 3.9 0.0 4.8 0.0 4.4 0.1 2.3 1.8 0.0 20.1 4.9 0.0 0.2 17.9 0.1 0.0 9.0 5.4 26.9 0.0 0.0 0.1 5.1 7.6 7.6 10.4 5.5 14.0 8.5 3.9 9.6 2.3 0.6 0.3 9.3 0.0 3.9 2.4 6.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 3.4 0.0 8.9 0.1 8.5 5.6 0.0 0.3 14.2 4.9 0.5 0.2 0.0 0.0 5.3 2.8 13.1 13.5 34.5 23.9 15.0 17.8 10.8 14.4 8.3 2.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 5.7 15.7 0.0 5.6 10.0 23.4 0.0 0.0 0.0 0.0 15.9 4.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 15.7 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 FAM24A AC073585.4 ENSG00000203795 "Family with sequence similarity 24 member A" A6NFZ4 10 122910701-122913111 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 95 "testis: 20.9" "Cell type enriched" "Detected in some" 17 "Early spermatids: 125.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.9;LHCN-M2: 1.2" HPA052490 Supported "Secreted in male reproductive system" NA NA "HPA052490: AB_2681851" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 1.2 0.0 0.0 0.5 0.6 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 125.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 0.0 FAM24B "AC073585.2, MGC45962" ENSG00000213185 "Family with sequence similarity 24 member B" Q8N5W8 10 122849078-122879641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 24.5" "Cell type enriched" "Detected in many" 4 "Distal tubular cells: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 6 "hTERT-HME1: 43.9;LHCN-M2: 55.2;TIME: 17.8" HPA052490 Supported "Intracellular and membrane" NA NA "HPA052490: AB_2681851" "unprognostic (4.03e-2)" "unprognostic (4.27e-2)" "unprognostic (3.13e-3)" "unprognostic (8.40e-5)" "unprognostic (2.55e-2)" "unprognostic (3.31e-2)" "unprognostic (6.42e-7)" "unprognostic (2.99e-1)" "unprognostic (7.06e-3)" "unprognostic (3.00e-1)" "unprognostic (5.89e-2)" "unprognostic (3.59e-2)" "unprognostic (1.78e-1)" "unprognostic (2.58e-1)" "unprognostic (9.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.81e-3)" 2.2 2.4 6.9 13.5 6.4 3.9 4.0 6.7 7.4 2.3 4.1 5.1 2.2 2.8 3.4 3.8 3.1 3.8 3.7 1.5 5.8 5.9 24.5 1.7 3.7 6.5 6.9 3.4 5.0 12.5 2.6 11.4 1.1 6.6 3.2 5.9 1.9 2.7 2.6 1.7 4.5 4.1 3.0 6.8 4.7 4.4 11.4 5.6 9.8 2.9 2.0 6.3 2.4 2.5 5.9 11.3 3.0 2.2 2.7 5.3 1.9 2.2 3.8 0.7 0.0 0.4 1.1 1.0 3.3 3.3 1.5 1.1 3.8 4.2 0.8 1.1 1.8 0.4 1.1 0.0 1.7 3.9 4.1 1.5 6.3 3.6 2.0 3.4 0.0 3.7 1.3 0.2 3.1 43.9 0.2 3.4 4.7 2.7 1.5 55.2 2.1 3.9 3.6 1.3 2.3 3.9 0.0 5.6 0.8 2.5 1.7 2.5 1.0 1.5 0.7 4.5 2.2 1.2 3.8 17.8 0.3 1.7 1.4 0.3 1.8 2.0 5.2 2.9 6.1 0.0 3.0 2.2 1.4 2.6 1.9 0.9 5.9 5.0 3.4 3.0 3.7 5.3 3.4 1.4 2.7 1.8 11.3 4.9 1.9 6.9 6.4 6.7 7.4 5.8 5.9 6.9 3.4 6.6 5.6 0.0 0.3 6.9 1.3 6.0 3.6 0.2 2.5 0.0 0.0 8.7 0.0 0.1 43.1 3.7 1.6 0.7 1.5 0.0 6.2 0.1 0.8 1.8 9.2 0.5 1.1 1.6 4.6 1.3 3.2 1.6 3.4 1.9 1.7 2.8 2.8 2.3 7.6 3.5 3.9 1.4 4.5 0.0 2.1 9.8 4.9 4.6 0.0 8.6 2.8 1.0 FAM3A "2-19, DXS560S, XAP-7" ENSG00000071889 "Family with sequence similarity 3 member A" P98173 X 154506159-154516242 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025016, HPA035268, HPA056991" Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" "Secreted - unknown location" Yes No "Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "CAB025016: , HPA035268: , HPA056991: AB_2683303" "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (3.19e-2)" "unprognostic (4.73e-2)" "unprognostic (5.19e-2)" "unprognostic (2.54e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (6.27e-2)" "unprognostic (3.42e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (2.74e-1)" "unprognostic (1.41e-1)" "unprognostic (4.04e-1)" "unprognostic (9.71e-2)" 18.9 18.9 18.9 14.7 20.9 13.7 17.3 13.4 25.7 22.3 21.2 31.1 16.3 37.0 18.2 16.2 19.3 19.1 25.3 31.4 21.3 18.7 19.8 28.5 16.1 16.7 23.0 16.4 29.1 35.5 18.2 22.1 21.0 18.5 20.6 9.9 17.3 29.4 34.7 33.4 15.3 33.7 14.4 25.4 18.4 23.6 10.7 16.8 13.5 28.8 16.1 12.2 16.9 16.9 8.0 13.3 21.2 11.5 8.5 13.3 8.9 16.6 16.0 4.0 13.5 12.2 6.2 11.4 8.5 5.9 5.9 7.0 7.3 10.1 10.8 43.4 14.2 11.5 12.1 6.3 7.5 1.4 8.8 8.6 4.2 14.0 5.1 19.1 2.8 6.8 7.7 6.8 12.1 8.5 7.0 4.1 7.0 8.0 8.0 6.7 17.4 5.2 12.3 1.7 18.1 20.1 6.5 4.0 29.7 6.4 6.9 8.0 6.1 3.9 9.5 14.0 3.1 7.2 4.4 4.5 7.9 4.8 21.4 11.5 30.8 16.8 13.2 14.6 7.4 8.1 21.2 9.9 12.5 13.3 11.5 12.9 6.2 8.2 9.3 9.9 8.0 10.2 11.9 5.0 8.5 9.5 13.3 8.5 8.9 18.9 20.9 13.4 25.7 21.3 18.7 23.0 16.4 18.5 16.8 11.9 14.7 8.0 19.3 14.4 23.0 20.5 25.5 8.1 6.8 21.0 13.7 39.7 23.2 22.8 0.6 17.7 66.7 23.3 37.0 40.6 24.2 23.6 5.7 27.2 26.3 20.6 16.8 20.3 14.9 1.6 31.1 13.9 32.1 19.0 45.1 25.5 24.3 49.1 27.6 26.2 15.2 6.5 16.0 3.7 8.6 18.4 59.6 19.3 33.2 20.3 FAM3B "2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44" ENSG00000183844 "Family with sequence similarity 3 member B" P58499 21 41304212-41357431 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.8;pancreas: 120.3;salivary gland: 67.9" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 242.6;Exocrine glandular cells: 349.6;Pancreatic endocrine cells: 184.9;Syncytiotrophoblasts: 134.9" "Cancer enhanced" "Detected in many" "prostate cancer: 40.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 3.0;neutrophil: 6.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.9" "Cell line enhanced" "Detected in some" "CACO-2: 9.3;CAPAN-2: 6.0;Hep G2: 15.3;OE19: 13.2;RPMI-8226: 42.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015885, HPA029777, CAB034131" Enhanced Approved Vesicles "Secreted to blood" NA NA 2080000 57000 Vesicles "CAB034131: AB_2231472, HPA015885: AB_1848396, HPA029777: AB_2673194" "unprognostic (2.88e-1)" "unprognostic (3.31e-3)" "unprognostic (5.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "unprognostic (6.32e-3)" "unprognostic (1.41e-1)" "unprognostic (8.79e-3)" "unprognostic (9.38e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "unprognostic (3.78e-1)" "unprognostic (5.60e-3)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (1.78e-1)" "unprognostic (1.55e-3)" 0.6 0.2 0.2 4.5 0.4 0.0 4.3 0.2 0.3 1.8 38.5 0.4 29.9 38.2 0.2 8.8 17.4 4.5 6.9 0.4 0.2 0.2 5.2 0.6 2.0 0.7 0.3 0.2 0.7 120.3 0.0 1.9 7.9 0.4 10.0 0.0 0.2 67.9 36.0 0.2 0.9 83.8 2.0 0.3 0.5 30.8 2.0 0.2 2.3 3.9 7.4 17.6 17.5 4.7 0.2 1.3 6.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.3 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 13.2 0.0 0.0 0.0 42.4 0.0 2.8 0.2 0.2 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 6.9 0.0 0.6 1.3 0.0 0.0 0.2 0.4 0.2 0.3 0.2 0.2 0.3 0.2 0.4 0.2 20.8 18.8 0.0 11.2 1.1 0.0 0.1 81.5 22.7 50.0 62.8 0.0 242.6 21.6 113.7 19.2 1.0 0.0 0.0 349.6 6.2 5.7 99.4 1.1 0.0 23.0 0.0 0.0 0.0 2.5 7.0 0.6 8.1 5.0 3.6 0.9 0.0 184.9 0.0 0.4 0.4 0.0 0.0 0.9 26.7 7.2 1.1 134.9 0.0 0.0 104.8 FAM3C "GS3876, ILEI" ENSG00000196937 "Family with sequence similarity 3 member C" Q92520 7 121348851-121396364 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Urothelial cells: 398.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 13.9;naive B-cell: 11.9" "Lineage enriched" "Detected in many" 6 "B-cells: 13.9" "Cell line enhanced" "Detected in all" "CAPAN-2: 167.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043376, HPA050548" Enhanced Enhanced "Golgi apparatus" "Secreted in other tissues" NA NA 59000000 "Golgi apparatus" "HPA043376: AB_2678452, HPA050548: AB_2681169" "unprognostic (9.44e-2)" "unprognostic (3.91e-1)" "unprognostic (1.75e-1)" "unprognostic (8.11e-3)" "unprognostic (1.26e-2)" "unprognostic (3.09e-3)" "unprognostic (3.38e-3)" "unprognostic (2.44e-1)" "unprognostic (2.95e-1)" "unprognostic (1.22e-2)" "unprognostic (2.15e-3)" "unprognostic (1.90e-1)" "unprognostic (1.58e-1)" "unprognostic (1.48e-1)" "unprognostic (9.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.06e-2)" 18.1 18.0 38.0 13.7 29.8 3.2 16.3 26.5 46.6 38.6 27.1 8.2 12.8 65.6 20.9 23.0 15.5 14.3 13.7 24.6 23.4 20.0 24.3 20.7 15.9 15.3 20.6 42.0 15.7 35.5 20.6 15.8 21.7 30.6 12.3 21.2 11.1 20.4 13.2 9.0 14.5 60.8 16.9 14.1 16.8 21.9 9.0 12.7 6.4 42.8 11.4 16.2 17.3 15.9 13.9 1.1 0.6 0.9 2.3 1.8 0.7 16.8 4.3 8.0 8.5 13.6 22.6 7.3 18.2 8.1 5.5 7.0 3.4 167.0 16.0 8.6 9.4 15.6 11.2 4.6 10.1 11.8 1.9 9.1 4.4 2.6 3.4 9.9 7.4 8.4 22.6 6.9 7.8 7.7 14.8 9.8 3.2 2.9 20.3 43.1 2.8 2.8 5.8 14.4 5.8 6.0 4.4 8.2 6.5 34.3 9.8 5.2 5.1 5.4 22.3 9.9 17.6 3.1 4.1 23.5 14.4 4.7 31.3 12.4 19.4 8.6 6.3 15.5 7.7 25.7 0.0 0.9 0.6 1.8 0.9 1.7 13.9 0.8 1.4 0.8 11.9 1.0 0.8 0.2 2.3 0.7 1.1 0.4 0.7 38.0 29.8 26.5 46.6 23.4 20.0 20.6 42.0 30.6 12.7 8.9 32.3 73.0 174.8 63.7 109.7 59.0 40.8 38.8 47.8 52.4 21.6 74.8 51.4 169.6 2.5 40.5 66.5 23.3 169.6 170.2 99.2 134.9 19.6 32.1 40.3 42.9 50.3 46.1 27.3 4.5 88.9 38.7 94.5 40.5 46.7 50.7 269.6 77.2 90.2 60.6 51.8 71.1 82.5 23.9 18.5 58.1 100.7 42.4 72.4 398.1 FAM3D "EF7, OIT1" ENSG00000198643 "Family with sequence similarity 3 member D" Q96BQ1 3 58633946-58666848 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 61.2;intestine: 69.2;salivary gland: 146.0;seminal vesicle: 88.6" "Group enriched" "Detected in some" 6 "Enterocytes: 558.6;Mucus-secreting cells: 1112.4;Paneth cells: 854.0;Undifferentiated cells: 821.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 151.0" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 6.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.7" "Cell line enriched" "Detected in single" 72 "OE19: 38.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA013844 Approved "Secreted to digestive system" NA NA 8200 "HPA013844: AB_2668897" "prognostic favorable (7.51e-4)" "unprognostic (1.07e-1)" "unprognostic (2.08e-2)" "unprognostic (9.67e-2)" "unprognostic (5.51e-2)" "prognostic favorable (1.89e-4)" "unprognostic (7.97e-2)" "unprognostic (6.54e-2)" "unprognostic (7.43e-2)" "unprognostic (5.48e-2)" "unprognostic (2.23e-2)" "unprognostic (1.42e-1)" "unprognostic (8.68e-2)" "unprognostic (1.64e-1)" "unprognostic (2.00e-1)" "unprognostic (6.97e-4)" "unprognostic (2.34e-2)" 0.3 0.2 0.3 8.5 0.3 0.0 2.2 0.2 0.2 4.4 48.2 0.3 26.1 11.2 0.5 0.3 61.2 0.3 20.0 0.2 0.2 0.2 0.5 0.2 1.5 0.2 0.3 0.2 0.2 0.8 0.0 0.3 0.5 0.3 3.3 69.2 0.3 146.0 88.6 0.4 0.8 26.1 0.8 0.2 0.3 9.5 0.3 0.2 0.3 0.6 15.2 47.1 2.2 13.1 0.0 0.7 6.7 1.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 38.6 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 6.7 0.0 0.5 0.0 0.0 0.9 0.3 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.0 0.6 0.0 7.9 0.0 0.0 0.2 56.0 28.1 9.1 14.0 0.0 0.0 0.0 0.6 0.4 0.6 558.6 0.0 0.0 0.0 0.0 70.7 9.2 0.0 0.3 0.0 146.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1112.4 0.0 1.9 854.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.0 821.7 144.0 FAM57A "CT120, FLJ22282" ENSG00000167695 "Family with sequence similarity 57 member A" Q8TBR7 17 732412-742972 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 43.8" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 47.3;Suprabasal keratinocytes: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "B-cells: 1.6;T-cells: 3.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.46e-1)" "unprognostic (6.16e-2)" "unprognostic (5.64e-2)" "prognostic favorable (3.53e-6)" "unprognostic (1.11e-1)" "unprognostic (1.66e-1)" "unprognostic (1.32e-3)" "unprognostic (2.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.59e-2)" "unprognostic (9.40e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (4.88e-2)" "unprognostic (1.60e-1)" "unprognostic (8.05e-2)" "unprognostic (1.39e-2)" 5.5 2.2 3.8 3.6 3.3 1.4 8.7 4.7 5.1 8.0 9.1 2.7 23.7 7.0 4.7 5.8 15.3 4.6 15.3 3.6 3.1 3.6 3.8 3.5 4.3 3.7 2.9 1.7 7.0 14.3 3.3 5.8 4.7 6.2 6.9 6.0 4.9 7.8 17.8 3.0 43.8 13.6 5.1 3.0 2.1 10.7 7.2 1.8 2.5 6.3 16.6 11.8 8.4 9.5 1.6 0.4 0.0 0.0 0.0 3.4 0.4 22.1 14.7 11.1 14.5 14.7 18.7 10.3 17.5 16.1 18.1 20.5 7.1 4.0 5.6 10.4 19.7 6.8 22.5 21.9 15.5 19.6 13.8 16.0 5.2 9.7 17.2 11.6 4.8 7.9 15.3 15.6 10.4 24.7 10.7 13.7 8.0 4.5 0.7 10.9 8.8 2.0 1.2 5.0 16.9 4.6 9.0 4.3 0.6 15.9 19.3 5.4 9.3 10.7 1.0 6.6 8.2 4.2 5.8 9.6 18.4 9.0 23.3 21.3 1.4 4.5 5.9 18.0 8.4 10.9 0.0 0.0 0.0 3.2 0.0 3.0 0.3 0.6 1.3 0.4 1.6 0.2 0.8 0.0 0.0 0.0 0.4 3.4 0.4 3.8 3.3 4.7 5.1 3.1 3.6 2.9 1.7 6.2 1.8 0.0 9.8 0.5 34.2 47.3 1.8 0.8 10.2 5.3 4.5 8.7 3.9 0.9 0.0 17.3 27.2 5.2 2.9 0.0 15.5 16.1 9.4 20.2 8.1 0.0 8.0 0.0 6.4 6.7 1.5 14.5 3.4 1.8 10.1 6.4 10.1 0.9 16.6 3.5 2.8 0.7 1.1 0.0 4.1 0.9 0.7 62.0 2.1 0.7 6.8 30.4 FAM57B DKFZP434I2117 ENSG00000149926 "Family with sequence similarity 57 member B" Q71RH2 16 30024427-30052978 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;retina: 20.8;testis: 51.7" "Group enriched" "Detected in some" 6 "Bipolar cells: 45.7;Cone photoreceptor cells: 170.8;Early spermatids: 100.4;Late spermatids: 48.9;Rod photoreceptor cells: 171.7;Spermatocytes: 57.2" "Cancer enriched" "Detected in some" 5 "glioma: 2.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 8.2;SCLC-21H: 44.0;SH-SY5Y: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.31e-2)" "unprognostic (9.72e-4)" "unprognostic (7.78e-3)" "unprognostic (1.13e-1)" "unprognostic (8.06e-2)" "unprognostic (2.45e-1)" "unprognostic (1.54e-2)" "unprognostic (9.72e-2)" "unprognostic (2.60e-2)" "unprognostic (3.56e-2)" "unprognostic (1.12e-2)" "unprognostic (4.51e-2)" "unprognostic (2.40e-11)" "unprognostic (1.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.85e-2)" "unprognostic (1.09e-3)" 1.2 3.8 12.0 1.4 14.2 2.6 1.5 36.4 35.7 1.1 1.3 1.7 0.0 1.5 1.2 1.1 1.5 1.3 1.2 1.2 11.8 7.9 1.2 1.2 1.2 1.6 7.6 9.5 1.2 1.3 1.2 10.4 1.2 29.4 1.3 1.3 20.8 1.4 1.2 13.9 1.5 1.3 1.2 3.9 1.2 1.4 51.7 2.8 0.0 1.2 1.8 1.4 1.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.3 1.6 0.7 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 1.1 0.5 0.0 0.0 0.2 0.3 0.1 0.0 0.4 1.3 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 4.7 0.0 4.7 0.1 0.3 1.3 0.3 8.2 0.1 0.4 3.4 0.6 0.5 0.0 0.0 44.0 16.7 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 1.2 0.2 0.2 4.3 0.1 0.1 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 12.0 14.2 36.4 35.7 11.8 7.9 7.6 9.5 29.4 2.8 0.0 0.0 0.0 0.2 0.1 45.7 0.6 0.0 0.0 0.0 0.0 170.8 0.0 0.0 0.0 100.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 15.9 0.0 0.0 0.3 48.9 2.6 0.0 0.0 0.0 0.0 15.2 0.2 0.0 1.1 0.0 171.7 0.0 0.3 57.2 1.7 0.0 0.0 0.0 0.0 0.1 FAM69A FLJ23493 ENSG00000154511 "Family with sequence similarity 69 member A" Q5T7M9 1 92832737-92961522 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 25.6;Syncytiotrophoblasts: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015718, HPA017281" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA015718: AB_1848405, HPA017281: AB_1848406" "prognostic favorable (8.96e-4)" "unprognostic (1.00e-1)" "unprognostic (6.17e-2)" "unprognostic (1.50e-3)" "unprognostic (1.43e-1)" "unprognostic (3.77e-3)" "unprognostic (3.63e-3)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.10e-1)" "unprognostic (2.19e-1)" "unprognostic (5.04e-2)" "prognostic unfavorable (1.45e-7)" "unprognostic (1.26e-2)" "unprognostic (5.99e-2)" "unprognostic (2.57e-1)" "unprognostic (1.66e-2)" 13.3 3.4 20.7 10.4 22.5 7.0 7.8 19.4 22.2 7.3 13.2 15.9 4.2 8.8 15.7 3.8 9.3 8.3 11.1 5.3 22.6 18.0 6.1 24.7 4.5 10.1 25.0 12.2 6.0 3.5 20.5 4.1 12.8 17.7 9.5 12.4 5.4 5.5 11.3 7.5 5.6 8.2 19.4 24.7 7.6 8.8 6.4 24.4 9.6 6.2 3.6 8.8 12.2 6.0 22.5 7.1 0.2 0.9 11.8 14.2 6.7 4.3 4.8 2.0 4.8 7.5 14.1 2.4 13.6 28.1 7.7 15.7 2.7 0.9 14.8 2.5 25.0 15.4 5.6 0.3 10.2 12.8 5.9 4.8 0.5 3.8 6.9 2.7 1.3 0.9 8.4 8.2 17.0 3.9 13.1 0.1 9.1 5.2 15.7 9.7 1.6 4.9 1.2 3.5 7.3 1.9 4.4 14.5 4.5 1.1 4.5 4.9 3.8 3.8 3.8 5.0 4.6 1.8 0.4 0.5 9.1 7.0 17.7 4.8 23.8 22.7 17.3 4.3 0.9 0.8 0.0 0.9 0.0 10.5 0.4 8.1 22.5 12.1 8.2 4.3 13.6 14.2 12.1 0.2 11.8 0.2 7.1 10.7 6.7 20.7 22.5 19.4 22.0 22.6 18.0 25.0 12.2 17.7 24.4 0.0 2.4 9.3 3.5 10.1 1.3 3.6 7.6 10.7 1.2 5.2 2.0 25.6 3.3 1.6 1.5 3.0 1.3 0.0 2.1 4.9 9.9 3.7 0.0 13.2 3.7 7.9 0.0 4.9 3.7 2.3 0.9 2.2 6.8 16.2 3.2 0.7 2.8 0.0 7.1 4.4 1.3 0.0 9.2 0.7 1.6 8.2 21.2 5.7 2.5 1.8 FAM69B "C9orf136, MGC20262" ENSG00000165716 "Family with sequence similarity 69 member B" Q5VUD6 9 136712570-136724050 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 15.8;Horizontal cells: 25.4;Ito cells: 20.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "naive B-cell: 7.3;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 34 "B-cells: 7.3;dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "EFO-21: 28.7;HEK 293: 25.7;HUVEC TERT2: 31.9;REH: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054443 Approved "Nucleoplasm,Nuclear bodies,Vesicles" No No "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA054443: AB_2682489" "unprognostic (2.78e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (1.77e-5)" "unprognostic (3.82e-1)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (6.80e-2)" "unprognostic (2.10e-2)" "prognostic favorable (9.48e-5)" "unprognostic (2.77e-1)" "unprognostic (6.67e-3)" "unprognostic (4.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.84e-1)" "unprognostic (2.78e-1)" 8.0 3.8 12.3 3.6 14.2 8.2 5.6 19.8 21.4 6.1 4.6 4.9 2.3 4.7 9.6 5.0 4.7 11.0 5.9 18.8 12.3 14.6 6.6 5.5 11.0 4.5 12.4 15.9 5.4 11.9 7.9 11.4 24.5 14.2 6.5 1.3 17.5 11.2 4.5 9.9 13.0 4.4 4.1 5.3 7.9 3.5 7.5 3.2 1.6 7.6 4.1 2.1 3.2 3.1 7.3 1.9 0.0 0.1 0.0 0.0 0.7 0.5 3.4 9.6 9.4 0.0 0.0 8.6 0.3 0.0 0.4 0.4 9.7 1.6 0.8 28.7 0.0 3.1 2.9 4.9 0.1 0.0 1.3 25.7 5.4 0.4 0.3 0.1 0.8 2.9 0.1 0.0 0.1 0.0 1.4 31.9 6.9 6.4 0.9 0.0 4.2 3.7 8.6 14.8 2.1 2.1 20.5 0.2 9.6 0.5 1.0 16.4 17.7 0.4 1.9 7.1 3.1 5.3 5.0 16.3 0.8 7.1 1.3 0.6 5.7 0.5 2.5 0.6 0.8 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.7 12.3 14.2 19.8 21.4 12.3 14.6 12.4 15.9 14.2 3.2 0.0 5.3 1.4 1.3 0.9 10.5 4.4 0.0 0.0 1.2 0.0 9.8 0.5 3.3 0.6 1.2 15.8 0.0 0.0 0.0 5.3 2.1 1.3 1.1 3.9 0.4 25.4 0.0 20.3 0.6 3.7 4.4 0.2 11.8 0.0 0.0 9.7 0.2 0.0 2.5 1.1 8.3 0.0 0.8 1.2 5.5 0.3 0.2 0.0 0.0 0.0 FAM69C C18orf51 ENSG00000187773 "Family with sequence similarity 69 member C" Q0P6D2 18 74434099-74457944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;heart muscle: 10.8" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 197.8" "Group enriched" "Detected in some" 18 "glioma: 11.1;melanoma: 6.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SK-MEL-30: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048928 Enhanced NA NA "HPA048928: AB_2680560" "unprognostic (6.35e-2)" "unprognostic (1.13e-2)" "unprognostic (8.09e-2)" "unprognostic (3.32e-2)" "unprognostic (4.08e-2)" "unprognostic (3.19e-1)" "unprognostic (1.43e-2)" "unprognostic (1.10e-1)" "unprognostic (3.31e-1)" "unprognostic (8.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.10e-2)" "unprognostic (1.91e-4)" "unprognostic (2.16e-1)" "unprognostic (6.73e-2)" "unprognostic (3.23e-2)" "unprognostic (4.40e-3)" 1.1 0.9 13.8 0.7 20.5 0.6 1.1 3.5 29.1 3.4 1.0 9.5 0.0 0.7 0.9 0.8 0.8 1.0 1.3 10.8 11.0 9.0 0.8 1.1 0.6 0.7 15.5 5.2 0.7 0.9 0.8 0.1 0.9 9.9 1.1 0.9 3.7 0.9 1.7 2.3 7.0 0.9 0.9 5.3 0.8 3.0 7.3 18.8 0.0 0.8 0.0 0.7 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 20.5 3.5 10.3 11.0 9.0 15.5 5.2 9.9 18.8 0.0 0.0 0.0 0.0 1.1 1.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.1 0.0 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.4 38.1 0.0 2.5 0.8 2.0 0.0 0.0 30.4 0.0 0.0 197.8 0.8 0.0 0.0 0.0 3.7 12.9 1.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 FAM76B MGC33371 ENSG00000077458 "Family with sequence similarity 76 member B" Q5HYJ3 11 95768942-95790409 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 212.1;Late spermatids: 286.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036608 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA036608: AB_2675215" "unprognostic (8.17e-2)" "unprognostic (2.26e-1)" "unprognostic (8.21e-2)" "unprognostic (2.39e-2)" "unprognostic (3.12e-2)" "unprognostic (1.43e-2)" "unprognostic (2.30e-1)" "unprognostic (2.64e-2)" "unprognostic (1.01e-2)" "unprognostic (1.65e-2)" "unprognostic (1.22e-1)" "unprognostic (3.90e-3)" "prognostic unfavorable (7.17e-5)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.43e-1)" "prognostic favorable (2.72e-4)" 10.1 6.2 5.3 12.1 9.3 35.7 9.3 12.3 9.7 8.5 10.8 6.2 6.1 9.5 8.2 7.5 7.8 7.3 10.1 4.9 6.1 4.4 5.2 13.6 8.2 16.8 10.5 5.6 8.3 6.7 6.3 9.5 8.2 7.1 9.0 5.7 6.3 9.1 8.2 5.6 8.7 9.0 9.8 8.9 8.8 6.6 28.2 10.1 12.0 8.4 4.1 17.8 8.6 7.9 3.0 7.3 8.7 3.0 4.5 7.6 2.8 4.4 3.5 13.1 7.1 2.2 2.2 10.9 7.7 3.8 5.7 6.6 13.0 8.9 17.1 9.9 3.8 7.4 8.7 7.6 2.6 6.1 9.1 5.6 20.0 6.3 6.8 5.5 14.0 11.5 2.8 4.4 6.6 5.9 3.8 5.4 10.2 11.8 9.5 3.2 3.3 15.7 16.5 7.3 4.9 3.2 17.1 9.8 10.0 4.3 5.1 5.5 15.8 9.5 5.4 5.8 4.6 7.2 6.1 5.5 8.0 8.6 9.3 7.0 5.2 11.0 26.3 1.9 13.7 11.2 0.1 2.9 5.2 5.4 3.0 4.4 3.0 4.9 5.4 2.0 2.6 4.5 6.7 8.7 4.5 2.8 7.3 7.6 2.8 5.3 9.3 12.3 9.7 6.1 4.4 10.5 5.6 7.1 10.1 6.0 13.9 22.8 11.5 12.2 15.0 6.9 7.6 10.7 18.2 5.2 25.5 7.4 0.0 6.2 212.1 15.5 9.1 46.7 6.5 8.4 10.6 12.1 10.4 14.7 7.2 11.1 19.5 16.5 14.8 286.0 15.8 16.0 15.1 9.0 12.1 15.6 7.1 11.5 14.5 2.1 13.2 25.8 15.5 20.5 19.2 14.1 6.4 19.2 9.9 9.0 FAM8A1 AHCP ENSG00000137414 "Family with sequence similarity 8 member A1" Q9UBU6 6 17600355-17611719 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 685.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044698, HPA073675" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA044698: AB_2679051, HPA073675: AB_2732236" "unprognostic (4.06e-1)" "unprognostic (2.32e-1)" "unprognostic (9.11e-2)" "unprognostic (6.90e-2)" "unprognostic (1.99e-2)" "unprognostic (5.17e-3)" "unprognostic (6.13e-2)" "unprognostic (1.93e-2)" "unprognostic (2.04e-2)" "unprognostic (1.09e-3)" "unprognostic (4.44e-2)" "unprognostic (3.50e-1)" "unprognostic (1.56e-2)" "unprognostic (3.85e-2)" "unprognostic (3.71e-1)" "unprognostic (7.59e-2)" "unprognostic (2.98e-1)" 14.7 13.0 19.8 8.3 21.1 21.1 15.2 23.7 22.6 17.2 16.2 10.8 23.8 12.9 21.4 15.4 11.1 16.7 16.4 11.8 17.7 17.8 18.8 58.7 14.5 14.6 17.3 16.5 22.6 17.8 19.0 16.2 11.5 17.5 16.9 18.1 8.7 16.3 31.4 17.5 13.1 15.9 19.7 17.9 10.5 12.0 28.4 16.4 15.1 18.3 10.5 6.4 15.0 16.2 0.2 0.4 9.0 0.6 2.6 2.0 0.5 4.8 1.9 7.2 17.1 25.0 23.6 5.9 7.9 10.8 4.0 7.1 11.1 1.6 4.2 19.0 13.3 4.4 4.0 10.8 6.8 5.4 3.5 15.4 5.0 6.8 23.7 11.1 3.1 5.2 12.4 11.1 4.6 3.3 13.1 9.0 4.7 10.1 8.6 6.4 5.9 2.3 9.8 3.0 6.0 3.0 6.2 7.0 12.6 13.8 3.9 2.2 11.5 6.1 13.3 12.0 13.0 15.4 4.9 6.9 5.2 1.8 8.0 2.8 7.2 6.0 4.1 4.7 3.7 7.1 4.2 0.5 1.5 1.9 0.6 2.0 0.0 0.9 1.6 0.3 0.2 1.2 1.9 9.0 2.6 0.4 0.4 0.6 0.5 19.8 21.1 23.7 22.6 17.7 17.8 17.3 16.5 17.5 16.4 17.9 19.0 3.0 8.6 11.8 26.8 12.2 15.3 12.0 14.8 27.9 13.7 8.4 5.0 7.4 685.5 9.3 26.4 0.0 6.8 10.4 12.6 10.7 1.1 67.4 5.4 14.3 11.5 23.9 20.0 149.2 33.9 6.5 5.0 1.0 11.3 17.4 7.3 17.5 29.0 11.4 15.3 32.3 17.5 30.6 16.8 13.9 10.2 10.2 13.4 7.0 FAM9C TEX39C ENSG00000187268 "Family with sequence similarity 9 member C" Q8IZT9 X 13035618-13044682 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 29.8;testis: 12.0" "Cell type enhanced" "Detected in some" 16 "Spermatocytes: 13.5;Spermatogonia: 8.1" "Cancer enriched" "Detected in single" 22 "testis cancer: 4.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "eosinophil: 3.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 3.0" "Cell line enriched" "Detected in some" 55 "AN3-CA: 65.1" NA NA "unprognostic (2.28e-1)" "unprognostic (7.35e-2)" "unprognostic (1.90e-1)" "unprognostic (1.66e-1)" "unprognostic (3.35e-2)" "unprognostic (2.06e-4)" "unprognostic (3.96e-2)" "unprognostic (1.00e-1)" "unprognostic (1.89e-1)" 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.2 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 1.3 0.0 2.0 0.0 0.1 0.0 0.1 29.8 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.0 0.1 0.0 0.3 0.0 0.1 0.1 0.3 65.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.6 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.4 0.0 0.1 0.5 0.0 0.6 0.1 0.0 0.2 0.5 0.0 0.0 0.3 0.3 0.1 0.5 0.0 0.2 0.4 0.4 0.2 0.3 0.2 0.2 1.1 0.2 0.1 0.3 0.4 0.2 0.2 0.3 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.5 1.4 0.3 2.5 1.4 1.2 0.0 2.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.2 0.4 0.2 1.1 0.0 0.4 0.0 0.0 0.0 0.3 3.1 0.9 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.6 0.0 0.0 13.5 8.1 0.5 0.1 0.0 0.0 0.0 FANCM "FAAP250, KIAA1596" ENSG00000187790 "Fanconi anemia complementation group M" Q8IYD8 14 45135940-45200890 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 55.9;Late spermatids: 151.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055144 Supported Nucleoplasm NA NA Nucleoplasm "HPA055144: AB_2682715" "unprognostic (8.40e-2)" "unprognostic (6.70e-2)" "unprognostic (3.99e-2)" "unprognostic (4.32e-2)" "unprognostic (2.15e-1)" "unprognostic (2.31e-3)" "unprognostic (2.66e-2)" "unprognostic (1.18e-1)" "unprognostic (1.57e-2)" "unprognostic (8.52e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-2)" "unprognostic (7.55e-2)" "unprognostic (2.90e-1)" "unprognostic (1.71e-1)" "unprognostic (8.94e-2)" "unprognostic (1.13e-2)" 4.7 3.9 3.9 4.4 8.4 9.8 5.7 8.2 7.9 5.7 3.5 4.9 4.9 2.6 6.7 4.8 4.5 4.2 3.7 3.8 3.4 3.3 4.1 3.1 3.3 6.6 3.2 3.6 6.2 3.3 4.5 4.5 4.4 9.3 3.5 3.8 4.8 4.1 4.8 4.2 5.2 3.5 3.8 3.4 8.9 3.2 15.4 4.2 15.2 3.3 2.9 6.4 3.8 4.3 6.7 3.2 7.6 3.6 2.0 4.1 1.1 7.8 6.8 8.1 7.5 6.4 4.0 6.5 10.3 4.0 8.1 10.5 11.0 6.0 10.3 5.9 2.4 4.6 10.6 9.5 4.4 11.1 7.5 5.2 4.7 7.7 6.0 1.2 12.3 6.1 2.3 1.6 8.1 5.1 1.8 6.9 6.7 8.5 9.1 6.7 7.8 9.0 8.8 3.2 6.0 11.5 8.4 12.6 4.7 3.3 5.6 7.4 1.9 9.1 7.5 3.8 5.4 8.0 5.7 5.4 11.8 11.1 10.8 7.7 4.6 8.3 10.3 2.3 7.6 7.0 7.6 1.3 4.6 4.0 3.6 2.2 6.7 2.5 1.5 1.0 4.2 4.1 3.5 2.1 2.0 1.7 3.2 1.7 1.1 3.9 8.4 8.2 7.9 3.4 3.3 3.2 3.6 9.3 4.2 0.0 1.9 1.5 1.2 2.4 5.2 6.7 2.5 0.0 3.4 1.8 2.0 6.7 0.0 1.6 55.9 2.7 1.0 0.0 2.3 2.8 2.3 0.8 1.1 1.7 3.0 3.2 0.0 5.5 3.7 151.5 8.3 2.7 3.3 4.6 1.6 4.4 1.5 0.0 4.9 1.5 6.1 6.5 4.1 23.6 14.4 1.6 1.9 3.3 2.6 0.3 FAP DPPIV ENSG00000078098 "Fibroblast activation protein alpha" Q12884 2 162170684-162245151 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Apoptosis, Cell adhesion" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 30.0" "Group enriched" "Detected in many" 6 "Fibroblasts: 25.9;Muller glia cells: 68.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 45.4;ASC TERT1: 48.2;BJ hTERT+: 38.0;hTERT-RPE1: 48.7;U-138 MG: 38.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA059739 Uncertain "Secreted to blood" NA NA 34000000 "HPA059739: AB_2684117" "unprognostic (7.48e-3)" "unprognostic (7.87e-3)" "unprognostic (4.10e-2)" "unprognostic (5.04e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.82e-4)" "unprognostic (2.01e-2)" "unprognostic (1.05e-2)" "unprognostic (3.30e-2)" "unprognostic (4.89e-2)" "unprognostic (4.59e-2)" "unprognostic (3.52e-1)" "unprognostic (7.32e-11)" "unprognostic (1.72e-3)" "unprognostic (9.84e-3)" "unprognostic (7.97e-2)" "unprognostic (4.49e-3)" 19.8 0.7 2.6 3.2 1.2 0.0 7.5 0.6 3.7 17.6 4.5 0.4 4.0 0.1 30.0 13.7 4.1 5.1 14.9 5.2 3.1 0.9 2.0 0.9 4.7 0.8 2.6 1.2 4.1 2.3 0.5 1.0 17.0 1.9 4.1 1.5 2.4 5.3 3.9 8.1 2.9 1.4 17.9 2.2 0.9 1.7 9.8 3.4 0.0 3.5 9.0 0.8 12.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.4 48.2 0.0 18.5 38.0 3.9 5.9 0.0 0.0 0.0 0.1 7.0 0.0 0.0 0.0 1.2 1.9 0.0 0.0 0.0 0.2 0.0 4.6 0.0 0.0 15.5 0.2 6.4 1.2 48.7 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 1.9 0.0 0.0 0.0 19.0 38.7 0.7 9.4 0.0 0.0 0.0 0.0 8.7 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.2 0.6 3.7 3.1 0.9 2.6 1.2 1.9 3.4 0.0 0.0 0.0 0.1 3.9 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 3.9 2.9 0.0 0.0 0.2 1.6 25.9 0.1 0.0 0.0 0.8 1.6 4.7 2.5 0.0 2.3 7.8 0.3 3.3 0.0 0.0 68.0 1.6 0.0 0.0 0.6 1.5 0.0 1.4 0.2 0.0 3.8 1.5 0.0 0.0 0.0 FAR1 "FLJ22728, MLSTD2, SDR10E1" ENSG00000197601 "Fatty acyl-CoA reductase 1" Q8WVX9 11 13668670-13732346 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Cataract, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 125.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017322 Approved Supported Peroxisomes NA NA Peroxisomes "HPA017322: AB_1848424" "unprognostic (3.96e-2)" "unprognostic (1.92e-1)" "prognostic favorable (2.27e-4)" "unprognostic (1.38e-1)" "unprognostic (1.34e-1)" "unprognostic (4.62e-2)" "unprognostic (3.66e-1)" "unprognostic (3.30e-1)" "unprognostic (2.79e-1)" "unprognostic (3.60e-2)" "unprognostic (2.59e-2)" "unprognostic (1.84e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-1)" "unprognostic (2.22e-1)" "unprognostic (2.22e-1)" "unprognostic (2.37e-3)" 16.3 11.1 19.0 14.2 28.2 42.7 13.7 24.4 24.0 17.3 20.9 33.8 11.1 24.7 17.4 17.1 38.1 12.7 9.2 13.9 20.4 16.1 9.7 3.3 13.9 12.2 32.8 24.0 16.7 15.8 25.1 16.5 15.8 30.0 14.1 25.1 10.0 14.6 10.9 11.4 8.0 13.4 20.2 47.8 13.9 39.4 12.8 32.2 13.2 13.2 17.2 15.0 16.7 22.1 2.8 15.8 21.8 13.7 5.0 4.5 4.0 27.0 17.7 17.5 13.6 16.8 19.4 9.6 24.2 9.7 17.9 19.1 18.5 23.4 34.8 10.9 19.3 26.7 29.6 25.8 24.5 27.6 10.2 21.0 14.9 16.1 0.1 16.2 29.8 12.1 14.7 25.3 12.9 38.9 13.3 17.5 17.7 23.2 10.4 14.7 13.7 22.0 9.0 9.1 34.5 25.7 19.5 22.4 9.7 17.3 44.0 13.5 9.8 22.9 21.9 11.9 21.1 13.4 18.7 21.7 24.8 21.1 22.7 20.2 5.8 19.8 29.5 15.7 9.1 14.9 4.6 13.7 15.0 4.5 11.9 3.1 2.1 2.2 3.8 15.8 2.8 2.0 3.4 21.8 5.0 9.4 2.4 2.8 4.0 19.0 28.2 24.4 24.0 20.4 16.1 32.8 24.0 30.0 32.2 32.8 19.7 8.2 20.6 28.6 44.7 23.2 5.1 9.4 21.6 21.0 39.3 21.4 5.0 12.6 98.3 26.3 45.7 23.3 22.2 15.2 24.6 24.0 38.1 1.6 29.3 44.5 34.5 35.0 52.6 125.1 24.7 35.6 33.7 16.2 26.0 22.1 23.3 37.4 24.1 7.0 50.8 25.8 27.8 36.7 26.8 17.3 8.2 16.6 38.8 32.4 FAR2 "FLJ10462, MLSTD1, SDR10E2" ENSG00000064763 "Fatty acyl-CoA reductase 2" Q96K12 12 29149103-29340980 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Syncytiotrophoblasts: 162.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 26.3;HUVEC TERT2: 30.8;NB-4: 26.4;SK-BR-3: 32.5;TIME: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015884 Approved Approved "Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" Nucleoli "HPA015884: AB_1853998" "unprognostic (6.32e-2)" "unprognostic (2.40e-2)" "unprognostic (1.50e-3)" "unprognostic (3.33e-3)" "unprognostic (2.41e-1)" "unprognostic (4.13e-3)" "unprognostic (4.30e-2)" "unprognostic (1.18e-1)" "unprognostic (3.11e-2)" "unprognostic (6.37e-2)" "unprognostic (5.70e-3)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.33e-1)" "unprognostic (5.22e-3)" 9.4 7.2 9.8 6.9 17.4 12.0 7.6 5.1 18.2 4.6 25.7 3.2 6.1 13.3 6.2 29.4 6.0 3.7 4.2 5.4 12.8 10.9 4.0 3.1 8.6 6.7 9.4 10.4 2.1 2.6 1.0 2.9 19.2 6.6 2.8 22.3 4.1 4.8 1.7 4.5 8.7 14.0 6.0 5.1 12.3 3.7 8.4 5.9 7.2 3.5 4.5 2.3 6.6 4.3 0.9 4.0 23.7 11.5 1.8 7.6 4.4 0.9 1.8 1.8 0.4 2.6 10.1 0.8 7.6 9.0 2.1 2.0 3.0 10.3 1.3 2.0 1.0 1.5 0.5 4.7 0.0 0.5 0.6 11.8 26.3 4.2 0.9 5.4 10.5 8.8 2.8 0.0 3.2 4.1 5.4 30.8 1.0 2.3 1.0 0.3 0.3 6.7 26.4 7.1 0.5 20.1 5.6 2.9 1.1 9.5 2.6 3.1 2.8 1.7 32.5 12.9 3.8 1.5 9.9 25.0 5.7 1.7 2.0 3.3 1.6 1.7 0.6 9.1 13.8 4.9 1.3 11.5 23.7 2.7 6.9 1.8 0.9 4.5 3.2 4.0 0.7 1.5 1.7 20.7 1.8 3.7 1.5 7.6 4.4 9.8 17.4 5.1 18.2 12.8 10.9 9.4 10.4 6.6 5.9 0.0 3.5 0.0 0.1 1.1 1.9 8.7 0.0 4.0 2.3 0.0 0.0 14.0 0.0 0.0 16.3 11.1 22.3 0.0 0.2 16.9 4.3 0.4 10.4 0.0 16.4 4.8 6.9 3.7 19.8 4.2 1.1 7.2 15.1 1.0 19.9 0.4 1.9 31.9 0.4 0.3 1.1 0.0 3.3 0.2 0.9 0.3 162.1 4.4 19.4 0.1 FASLG "APT1LG1, CD178, FasL, TNFSF6" ENSG00000117560 "Fas ligand" P48023 1 172659018-172666874 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Apoptosis, Transcription, Transcription regulation" "Cytokine, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.6;lymphoid tissue: 13.4" "Cell type enriched" "Detected in some" 7 "T-cells: 30.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "gdT-cell: 25.6" "Group enriched" "Detected in many" 12 "NK-cells: 16.0;T-cells: 25.6" "Cell line enhanced" "Detected in some" "ASC diff: 1.0;LHCN-M2: 2.5;NB-4: 1.2;RPTEC TERT1: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054959 Approved "Secreted to blood" NA NA 73600 "HPA054959: AB_2682650" "unprognostic (1.09e-3)" "unprognostic (1.41e-2)" "unprognostic (8.69e-2)" "unprognostic (1.54e-7)" "unprognostic (3.29e-1)" "unprognostic (2.23e-3)" "unprognostic (5.44e-2)" "unprognostic (1.84e-2)" "unprognostic (4.67e-2)" "unprognostic (4.76e-2)" "unprognostic (8.88e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (1.59e-6)" "unprognostic (3.49e-2)" "unprognostic (1.22e-1)" "unprognostic (1.15e-2)" "unprognostic (3.82e-3)" 0.9 1.1 0.5 1.9 0.7 3.6 1.8 0.5 0.8 0.7 2.6 0.6 0.0 3.0 3.9 1.2 1.0 0.8 1.6 1.2 0.5 0.5 1.2 2.2 6.8 7.7 1.4 0.0 1.5 0.6 0.0 0.7 2.4 0.6 4.7 1.2 2.8 1.9 0.3 0.4 0.5 3.8 1.9 1.7 13.4 2.1 0.4 0.0 1.2 1.1 0.0 10.1 1.4 0.9 0.0 0.0 1.6 0.0 16.0 25.6 5.5 0.0 0.0 0.3 0.1 1.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.5 0.5 0.1 0.0 0.0 0.8 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.2 0.4 0.7 0.1 0.0 0.1 0.3 0.6 2.5 0.0 0.0 1.2 0.4 0.2 0.0 0.0 0.0 0.1 1.0 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.8 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 25.6 0.0 15.8 0.0 5.4 13.7 0.0 0.0 1.1 11.7 0.8 16.0 0.0 0.0 0.1 5.5 0.5 0.7 0.5 0.8 0.5 0.5 1.4 0.0 0.6 0.0 0.0 4.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 30.5 0.0 0.0 FAT1 "CDHF7, CDHR8, FAT" ENSG00000083857 "FAT atypical cadherin 1" Q14517 4 186587783-186726722 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 76.4" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 64.9;LHCN-M2: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001869, HPA023882" Enhanced "Intracellular and membrane" NA NA 120000 "HPA001869: AB_1078818, HPA023882: AB_1848429" "unprognostic (1.98e-1)" "unprognostic (4.91e-2)" "unprognostic (2.50e-2)" "unprognostic (1.86e-1)" "unprognostic (1.53e-2)" "unprognostic (5.82e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (6.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.15e-3)" "unprognostic (6.80e-2)" "unprognostic (3.57e-2)" "unprognostic (8.03e-3)" "unprognostic (9.41e-2)" "unprognostic (6.25e-3)" "unprognostic (4.27e-2)" 15.5 1.3 7.9 12.3 9.8 0.4 15.4 11.9 8.4 15.9 40.4 11.8 8.1 17.9 20.6 14.0 9.7 9.6 28.2 21.1 10.0 6.0 29.1 13.3 10.9 1.4 11.4 6.2 9.7 13.8 7.5 10.5 14.6 24.7 15.9 22.9 5.0 13.9 18.2 3.0 13.1 76.4 18.3 12.8 1.7 11.5 7.0 11.2 1.3 10.5 10.2 6.7 17.5 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 19.0 18.9 0.0 18.9 22.8 4.6 25.4 41.9 12.4 7.9 11.3 11.2 0.0 6.1 64.9 8.0 9.2 7.4 31.3 16.9 0.0 3.0 0.0 6.7 11.4 9.4 8.2 6.8 8.2 11.3 23.0 15.0 17.0 0.2 10.3 0.1 0.0 47.7 6.0 14.6 0.0 4.2 9.5 3.2 0.0 5.2 0.4 18.6 17.9 2.0 7.6 4.4 7.5 3.0 13.5 0.0 3.0 5.4 35.4 13.7 0.4 15.7 0.1 0.0 0.1 8.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 9.8 11.9 8.4 10.0 6.0 11.4 6.2 24.7 11.2 14.9 4.1 0.0 25.5 75.6 5.2 20.3 35.7 16.0 25.0 50.6 0.0 1.1 5.0 21.9 0.6 5.1 58.5 0.0 23.2 3.5 24.9 37.8 16.1 22.9 0.3 0.0 13.9 1.8 1.0 0.4 13.6 3.1 11.8 0.0 54.8 4.2 24.0 23.0 35.0 21.4 0.3 38.8 54.6 1.8 7.7 40.9 1.4 0.0 38.7 20.0 FAT2 "CDHF8, CDHR9, HFAT2, MEGF1" ENSG00000086570 "FAT atypical cadherin 2" Q9NYQ8 5 151504093-151568944 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 61.0;skin 1: 35.1" "Group enriched" "Detected in some" 7 "Basal glandular cells: 5.4;Basal keratinocytes: 16.0;Early spermatids: 12.8;Extravillous trophoblasts: 18.5;Late spermatids: 5.5;Melanocytes: 6.8;Suprabasal keratinocytes: 17.1;Urothelial cells: 13.7" "Group enriched" "Detected in many" 6 "cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6" "Region enriched" "Detected in some" 34 "cerebellum: 61.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "BEWO: 17.3;EFO-21: 10.4;HaCaT: 25.0;HBEC3-KT: 11.4;hTCEpi: 34.7" "Region enriched" "Detected in single" 18 "cerebellum: 35.9" "Region enriched" "Detected in some" 66 "cerebellum: 442.8" CAB033680 Enhanced NA NA "CAB033680: AB_2100956" "unprognostic (8.06e-3)" "unprognostic (6.01e-2)" "unprognostic (3.47e-1)" "unprognostic (4.80e-3)" "unprognostic (1.33e-1)" "unprognostic (4.43e-1)" "unprognostic (9.78e-3)" "unprognostic (2.28e-1)" "unprognostic (8.25e-2)" "unprognostic (2.65e-1)" "unprognostic (2.96e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-7)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (6.77e-2)" "unprognostic (3.64e-3)" 0.4 0.0 0.4 0.4 1.7 0.0 2.2 61.0 0.4 2.4 0.4 0.4 0.4 0.0 0.4 1.0 11.8 0.5 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 1.3 0.4 0.0 0.4 0.4 0.9 0.9 0.0 0.4 3.8 3.2 0.4 35.1 0.4 0.4 0.4 0.4 0.0 2.7 0.4 0.4 0.4 0.4 1.9 1.0 4.9 0.2 0.6 0.1 0.4 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 17.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.1 25.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 1.7 61.0 0.4 0.4 0.0 0.4 0.4 0.9 0.4 0.0 0.0 0.0 5.4 16.0 0.0 1.6 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 12.8 0.0 0.0 0.0 0.0 18.5 0.4 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.5 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 17.1 0.8 0.0 0.0 13.7 FAT3 "CDHF15, CDHR10, KIAA1989" ENSG00000165323 "FAT atypical cadherin 3" Q8TDW7 11 92352096-92896470 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.5;seminal vesicle: 6.0" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 11.2;Collecting duct cells: 14.0;Peritubular cells: 7.1;Spermatogonia: 5.1" "Cancer enriched" "Detected in single" 6 "glioma: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.1;fHDF/TERT166: 2.4;NTERA-2: 2.7;SuSa: 2.6;U-2 OS: 2.3;U-251 MG: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026878 Uncertain NA NA "HPA026878: AB_1848430" "unprognostic (5.00e-2)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (4.76e-6)" "unprognostic (1.27e-1)" "unprognostic (1.79e-1)" "unprognostic (1.56e-1)" "unprognostic (9.32e-2)" "unprognostic (1.08e-1)" "unprognostic (3.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (5.79e-2)" "unprognostic (3.66e-4)" "unprognostic (8.83e-2)" "unprognostic (7.72e-2)" "unprognostic (2.25e-1)" 0.5 0.1 2.6 0.1 10.5 0.1 0.3 1.4 7.3 0.4 0.2 0.1 0.4 1.0 0.1 0.4 0.2 0.2 1.8 2.2 0.4 0.1 1.4 0.0 2.2 0.8 0.0 0.0 1.8 0.2 3.2 0.2 0.1 6.0 0.2 0.1 0.1 0.2 0.2 0.2 1.2 0.8 0.0 0.4 1.3 0.3 0.2 0.2 0.7 0.0 0.2 0.3 0.0 0.0 0.3 8.1 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.4 0.0 0.0 0.0 1.6 2.4 0.0 1.3 0.0 0.0 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 2.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.1 11.2 1.2 0.0 0.0 0.0 14.0 0.0 0.1 0.0 0.5 3.6 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 1.1 0.0 0.0 0.0 0.0 0.7 0.3 0.0 7.1 0.0 0.9 0.0 3.3 0.4 5.1 0.0 0.0 0.0 0.0 0.0 FAT4 "CDHF14, CDHR11, FAT-J" ENSG00000196159 "FAT atypical cadherin 4" Q6V0I7 4 125316399-125492932 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Endothelial cells: 11.1;Fibroblasts: 9.3;Ito cells: 30.7" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 12 "NK-cells: 1.1" "Cell line enhanced" "Detected in many" "ASC diff: 12.3;ASC TERT1: 9.1;fHDF/TERT166: 8.9;HSkMC: 10.5;HUVEC TERT2: 11.1;TIME: 17.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052819 Approved Approved Cytosol NA NA 7900000 Cytosol "HPA052819: AB_2681963" "unprognostic (1.18e-1)" "unprognostic (1.77e-1)" "unprognostic (7.99e-2)" "unprognostic (1.09e-1)" "unprognostic (2.31e-1)" "unprognostic (2.81e-4)" "unprognostic (6.17e-3)" "unprognostic (1.28e-1)" "unprognostic (1.77e-2)" "unprognostic (2.78e-2)" "unprognostic (1.63e-1)" "unprognostic (1.39e-1)" "prognostic favorable (1.89e-4)" "unprognostic (2.38e-2)" "unprognostic (1.71e-1)" "unprognostic (1.30e-2)" "unprognostic (2.49e-3)" 3.8 0.5 0.9 0.8 0.7 0.0 3.2 0.0 0.5 4.4 7.1 0.3 2.7 0.6 1.9 2.1 4.1 5.0 1.0 0.4 2.6 2.0 5.3 0.1 0.9 5.3 0.5 6.7 0.4 2.5 3.6 1.9 1.0 2.3 1.1 1.4 2.4 3.3 0.6 2.1 2.4 0.1 3.9 0.2 3.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 6.0 0.6 12.3 9.1 0.0 2.0 2.4 1.0 1.0 0.0 0.3 0.0 2.5 8.9 1.2 0.0 2.2 2.5 0.6 0.0 1.0 1.3 2.5 0.0 4.0 0.8 0.0 10.5 1.4 0.5 5.5 7.2 11.1 0.0 0.0 1.6 5.0 0.1 0.4 0.0 0.4 0.0 0.2 0.7 1.2 0.0 0.1 0.0 0.1 1.2 0.3 0.0 0.0 0.3 0.0 0.0 17.3 6.1 1.7 2.1 0.9 0.2 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.1 1.4 1.3 5.3 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.7 0.8 11.1 0.0 0.0 0.2 0.0 9.3 0.1 0.0 6.8 0.2 0.0 0.0 30.7 2.4 0.0 5.5 0.0 3.3 0.0 0.0 1.2 0.2 0.0 4.6 0.6 0.1 0.0 3.9 0.0 0.6 0.5 0.0 0.0 0.0 0.0 FATE1 "CT43, FATE" ENSG00000147378 "Fetal and adult testis expressed 1" Q969F0 X 151716035-151723194 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 155 "testis: 100.9" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 16.5;Late spermatids: 42.8;Sertoli cells: 12.9;Spermatocytes: 7.9" "Group enriched" "Detected in some" 9 "renal cancer: 1.2;testis cancer: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.2;U-2197: 1.7;U-266/70: 1.5;U-87 MG: 1.3" "Not detected" "Not detected" HPA034604 Enhanced NA NA "HPA034604: AB_10602318" "unprognostic (1.82e-2)" "unprognostic (7.13e-2)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.40e-5)" "unprognostic (2.10e-1)" "unprognostic (3.70e-3)" "unprognostic (2.58e-1)" "unprognostic (1.16e-1)" "unprognostic (5.07e-3)" "unprognostic (1.55e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (4.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.68e-1)" "unprognostic (5.34e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 100.9 0.0 0.6 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 42.8 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 12.9 0.0 7.9 5.2 0.0 0.0 0.0 0.0 0.0 FAXDC2 "C5orf4, FLJ13758" ENSG00000170271 "Fatty acid hydroxylase domain containing 2" Q96IV6 5 154818491-154859252 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 77.9;parathyroid gland: 112.1" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 38.7;Leydig cells: 43.7;Muller glia cells: 45.6;Peritubular cells: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 21.4;ASC TERT1: 16.1;HSkMC: 14.3;hTERT-RPE1: 15.3;SK-MEL-30: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (6.38e-3)" "unprognostic (2.88e-2)" "unprognostic (6.26e-2)" "unprognostic (5.11e-2)" "unprognostic (3.12e-2)" "unprognostic (2.70e-2)" "prognostic favorable (3.87e-5)" "unprognostic (8.29e-2)" "unprognostic (2.52e-2)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (3.42e-2)" "prognostic favorable (9.71e-10)" "unprognostic (1.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.07e-3)" "unprognostic (3.94e-1)" 15.9 15.7 14.5 2.9 25.1 12.2 12.9 7.7 31.6 11.9 19.9 77.9 6.7 4.1 14.9 23.7 7.7 16.8 12.7 13.7 19.8 12.3 11.2 55.3 15.3 3.4 29.0 15.3 25.8 6.7 112.1 6.6 5.7 35.9 12.6 8.1 25.6 16.7 14.1 5.0 10.1 7.2 16.9 38.7 5.6 9.0 8.8 33.6 0.0 29.7 5.6 3.1 11.4 8.3 1.9 1.4 6.7 1.2 4.3 0.9 8.8 0.9 0.8 3.0 6.1 21.4 16.1 2.4 2.1 6.2 0.9 3.9 0.8 7.8 1.1 1.3 3.7 0.2 0.8 0.0 1.0 0.8 0.6 0.9 11.8 1.9 4.6 3.2 1.6 1.1 14.3 4.1 2.1 0.5 15.3 4.7 0.8 7.0 0.4 5.3 0.3 1.0 2.4 1.4 2.9 0.2 1.0 2.0 0.4 1.5 0.9 0.3 5.2 0.9 0.5 13.4 6.8 0.4 0.4 1.7 2.2 1.3 0.9 0.6 0.9 0.6 0.7 2.9 0.9 1.3 4.4 1.2 2.2 0.7 0.9 0.6 0.7 0.8 0.7 1.4 1.9 0.7 0.9 6.7 4.3 0.7 1.1 0.4 8.8 14.5 25.1 7.7 31.6 19.8 12.3 29.0 15.3 35.9 33.6 38.7 10.2 0.0 10.9 2.6 1.2 16.9 12.7 20.1 11.4 8.7 0.0 2.8 8.3 2.2 9.9 16.7 1.7 0.0 0.6 0.4 9.7 3.7 5.8 35.5 1.8 3.2 2.9 20.9 8.8 7.3 43.7 5.8 5.0 1.0 17.3 45.6 7.6 5.8 47.7 2.2 1.6 0.0 9.0 1.9 0.9 3.1 1.1 1.3 1.1 3.5 FBN2 "CCA, DA9" ENSG00000138829 "Fibrillin 2" P35556 5 128257909-128659185 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "placenta: 175.9" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 251.0;Syncytiotrophoblasts: 136.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;non-classical monocyte: 5.0" "Lineage enriched" "Detected in many" 5 "monocytes: 5.0" "Cell line enhanced" "Detected in many" "HHSteC: 38.0;HSkMC: 27.1;hTERT-HME1: 59.9;HUVEC TERT2: 33.7" "Region enhanced" "Detected in single" "olfactory region: 2.6" "Low region specificity" "Detected in some" "HPA012853, CAB026401" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 4600000 Cytosol Nucleoplasm "CAB026401: , HPA012853: AB_1848588" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (7.29e-3)" "unprognostic (1.79e-3)" "unprognostic (6.74e-2)" "unprognostic (2.33e-1)" "unprognostic (4.92e-3)" "unprognostic (9.41e-2)" "unprognostic (1.06e-2)" "unprognostic (4.66e-1)" "unprognostic (1.12e-1)" "unprognostic (8.69e-2)" "unprognostic (8.60e-5)" "unprognostic (1.04e-2)" "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (7.41e-5)" 0.3 7.9 0.3 1.0 0.3 1.6 0.1 0.2 0.3 1.5 0.7 0.4 1.0 0.2 2.9 0.6 1.1 0.6 0.2 6.7 0.2 0.5 0.2 0.2 0.2 1.3 0.2 0.4 0.9 0.1 0.0 1.3 175.9 0.4 1.0 0.8 6.2 0.4 0.9 0.2 0.3 0.5 0.8 0.4 0.6 0.5 4.6 0.2 0.3 0.9 0.4 0.7 0.4 1.2 0.0 1.1 0.6 5.0 0.0 0.0 0.4 0.0 4.5 16.4 0.0 2.7 4.7 3.4 17.9 0.0 15.9 11.9 0.0 0.0 0.0 0.0 23.9 0.0 2.7 10.6 2.7 14.9 0.0 4.2 0.0 7.5 0.0 38.0 2.3 0.0 27.1 1.4 6.7 59.9 5.1 33.7 0.0 0.0 0.0 9.8 0.0 0.0 0.9 7.1 0.0 5.4 5.1 5.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 14.0 0.0 5.0 0.0 6.4 12.2 18.3 0.0 0.0 0.0 0.0 1.9 0.0 6.7 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.0 5.0 0.0 0.0 0.4 0.3 0.3 0.2 0.3 0.2 0.5 0.2 0.4 0.4 0.2 0.0 0.3 0.0 0.1 0.0 0.0 11.3 0.0 0.0 2.3 0.0 0.0 251.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 27.7 3.3 1.5 0.0 0.0 29.6 0.0 0.0 0.0 12.9 5.3 1.1 1.8 1.7 0.0 0.0 3.1 0.1 0.0 2.1 0.0 0.0 6.5 0.2 12.7 3.8 0.4 136.7 0.0 0.0 0.1 FBXL17 "DKFZP434C1715, Fbl17, Fbx13, FBXO13" ENSG00000145743 "F-box and leucine rich repeat protein 17" Q9UF56 5 107859035-108382098 "Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036410, HPA036411" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA036410: AB_2675109, HPA036411: AB_10669603" "unprognostic (8.15e-2)" "unprognostic (3.77e-2)" "unprognostic (2.18e-2)" "unprognostic (1.21e-1)" "unprognostic (4.58e-2)" "unprognostic (2.72e-2)" "unprognostic (2.08e-2)" "unprognostic (2.65e-1)" "unprognostic (6.67e-2)" "unprognostic (3.08e-2)" "unprognostic (5.98e-2)" "unprognostic (6.30e-2)" "prognostic favorable (4.60e-8)" "unprognostic (1.86e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (3.35e-2)" 13.7 13.8 22.2 7.8 27.4 5.4 13.3 18.0 27.4 11.5 9.8 7.9 12.0 10.3 10.1 9.3 12.0 9.3 10.4 25.1 18.5 19.0 16.8 13.6 9.8 12.0 16.8 17.1 9.7 9.8 27.5 12.5 6.1 11.7 12.0 10.5 12.4 9.6 14.4 46.1 9.6 10.5 11.6 12.3 10.4 9.6 8.2 8.9 16.8 23.8 9.7 10.0 10.8 9.0 2.0 1.9 3.3 1.3 1.0 2.3 0.5 6.5 6.5 7.5 13.7 12.6 13.3 5.0 8.0 18.1 6.6 9.0 1.3 13.9 7.3 12.7 12.9 10.2 2.9 6.0 9.2 10.3 7.3 5.4 6.9 7.6 3.2 6.6 4.6 8.0 9.5 13.8 6.1 4.5 12.9 7.8 3.0 1.0 9.5 14.4 4.9 4.0 5.9 1.0 5.0 6.1 5.7 10.1 9.4 9.2 9.1 6.5 11.1 10.4 9.3 9.8 5.5 7.3 11.1 8.4 15.0 4.7 4.6 10.3 7.5 10.4 5.5 13.3 7.1 9.7 0.4 0.9 3.3 2.1 1.3 2.2 1.1 1.9 2.3 1.1 2.0 2.0 1.6 1.7 1.0 0.7 1.9 1.3 0.5 22.2 27.4 18.0 27.4 18.5 19.0 16.8 17.1 11.7 8.9 17.9 16.4 11.5 6.7 14.9 34.9 31.5 10.2 2.7 6.8 27.9 53.0 3.9 14.9 5.4 3.7 11.2 14.7 0.0 11.2 5.4 7.7 10.1 16.1 18.4 7.4 28.6 28.7 21.5 18.4 2.9 13.0 9.7 15.1 1.0 24.2 19.3 10.7 17.3 15.6 11.2 49.7 0.0 7.8 8.6 4.3 21.5 3.8 12.1 14.3 7.0 FBXO31 "FBX14, Fbx31, FBXO14, MGC15419" ENSG00000103264 "F-box protein 31" Q5XUX0 16 87326987-87392142 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA030150 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA030150: AB_10670559" "unprognostic (4.85e-1)" "unprognostic (5.76e-3)" "unprognostic (1.67e-1)" "unprognostic (1.53e-2)" "unprognostic (4.04e-1)" "unprognostic (2.25e-1)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.65e-2)" "prognostic favorable (9.16e-5)" "unprognostic (3.00e-2)" "unprognostic (1.47e-3)" "unprognostic (1.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.57e-3)" "unprognostic (2.26e-3)" 25.7 11.5 10.5 6.1 12.1 5.4 22.3 39.7 18.7 10.4 14.1 5.9 9.3 9.0 13.3 7.4 10.8 11.1 6.7 17.2 8.3 8.2 5.3 11.3 5.6 6.3 6.9 10.4 13.9 13.5 8.8 16.6 5.4 8.5 9.4 6.4 7.9 10.3 12.0 50.4 8.9 11.4 14.8 4.6 5.3 8.3 9.1 5.6 4.5 6.0 7.0 5.4 12.2 22.6 2.4 0.9 1.4 0.7 0.2 3.7 1.4 4.9 9.4 3.1 8.5 16.2 9.8 9.2 8.6 8.6 8.6 4.5 8.5 4.2 11.5 9.5 9.1 4.3 7.6 6.0 7.2 5.8 5.3 11.1 3.9 5.7 23.9 9.1 3.7 3.3 11.6 6.1 11.2 10.6 5.6 5.2 6.0 11.0 4.5 4.5 7.1 8.7 5.0 6.1 5.1 8.4 11.3 3.7 4.9 3.8 3.5 14.6 7.1 19.2 3.9 5.9 2.4 6.1 3.2 7.2 8.3 6.3 7.8 6.7 10.5 8.1 14.3 6.6 6.9 5.1 1.4 0.6 0.2 1.0 0.6 1.8 2.4 1.7 2.4 0.4 1.6 1.8 1.9 0.9 0.2 0.7 0.9 3.7 1.4 10.5 12.1 39.7 18.7 8.3 8.2 6.9 10.4 8.5 5.6 0.0 2.9 3.7 4.3 13.1 12.3 19.4 0.0 4.0 1.2 5.2 31.4 8.8 0.0 3.1 6.9 8.4 17.0 0.0 4.3 2.7 7.1 3.8 0.0 23.7 3.5 0.0 8.6 3.7 5.1 22.2 7.5 1.9 3.3 4.6 10.4 3.9 3.7 11.5 10.6 4.4 11.8 19.4 9.0 13.5 5.1 11.3 6.1 5.0 13.6 3.5 FBXW7 "AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10" ENSG00000109670 "F-box and WD repeat domain containing 7" Q969H0 4 152320544-152536063 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 60.1;skin 1: 45.0" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 179.3;Suprabasal keratinocytes: 152.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 38.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013793, CAB029987" Supported Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB013793: AB_2533451, CAB029987: AB_2246842" "unprognostic (3.32e-1)" "unprognostic (9.02e-2)" "unprognostic (1.84e-2)" "unprognostic (3.08e-2)" "unprognostic (3.87e-1)" "unprognostic (1.36e-3)" "unprognostic (4.37e-1)" "unprognostic (1.94e-1)" "unprognostic (8.28e-2)" "unprognostic (3.29e-1)" "unprognostic (5.32e-3)" "unprognostic (3.19e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (3.38e-2)" "unprognostic (1.41e-1)" "unprognostic (5.49e-3)" "unprognostic (2.17e-3)" 9.2 6.8 27.0 8.9 27.9 11.1 9.8 27.2 60.1 5.5 6.1 3.6 3.8 4.9 6.0 18.3 9.8 10.6 6.3 10.9 21.4 10.1 4.1 7.3 6.9 9.8 9.1 40.5 6.4 8.0 6.4 7.3 6.2 37.2 5.1 6.9 2.8 7.6 5.3 15.8 45.0 6.5 6.1 6.4 10.1 8.0 13.7 5.7 6.5 6.8 10.6 12.3 7.9 6.5 2.9 2.2 16.6 3.4 7.8 5.0 1.3 4.9 4.0 10.3 7.5 7.2 5.2 8.6 7.2 6.6 4.5 4.2 8.0 6.4 12.9 2.0 6.9 3.4 3.0 8.9 16.2 6.3 7.3 4.2 6.0 4.9 5.7 7.3 14.6 5.5 8.2 25.8 7.7 13.1 4.7 7.8 10.5 9.4 13.8 5.6 7.0 16.8 5.8 5.0 4.2 3.2 16.9 4.4 2.5 5.5 8.6 6.6 5.7 4.6 6.3 3.9 12.2 3.4 6.9 8.2 6.1 6.9 3.1 4.0 38.0 21.7 12.6 4.9 4.8 4.3 16.6 3.1 1.7 5.0 3.4 3.3 2.9 3.7 3.2 1.8 2.4 3.9 3.2 5.5 7.8 2.5 2.2 3.3 1.3 27.0 27.9 27.2 60.1 21.4 10.1 9.1 40.5 37.2 5.7 8.9 18.5 27.6 32.1 179.3 67.8 54.1 7.6 8.1 13.6 8.7 29.5 9.7 3.3 11.6 13.1 26.4 13.5 0.0 11.7 33.1 24.6 28.4 15.1 15.6 9.4 11.1 13.9 17.8 16.2 7.4 14.1 20.2 27.0 16.2 11.7 30.1 15.8 15.8 10.6 6.0 40.5 12.9 25.6 57.9 80.3 152.9 26.1 34.6 11.3 48.9 FCAMR "CD351, FCA/MR, FKSG87" ENSG00000162897 "Fc fragment of IgA and IgM receptor" Q8WWV6 1 206957965-206970625 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 23.9;liver: 7.6;lymphoid tissue: 23.0" "Cell type enriched" "Detected in some" 8 "Proximal tubular cells: 26.5" "Cancer enhanced" "Detected in some" "renal cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.9;HMC-1: 1.0" HPA056505 Enhanced NA NA 3600000 "HPA056505: AB_2732604" "unprognostic (2.94e-1)" "unprognostic (1.06e-1)" "unprognostic (8.53e-2)" "unprognostic (2.92e-1)" "unprognostic (7.44e-2)" "unprognostic (4.55e-3)" "unprognostic (2.69e-3)" "unprognostic (1.08e-4)" "unprognostic (3.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.82e-1)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (1.29e-1)" "unprognostic (3.88e-2)" "unprognostic (2.08e-1)" "unprognostic (1.26e-1)" 0.1 0.1 0.1 23.0 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.6 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 23.9 7.6 0.1 8.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 2.4 0.1 0.1 0.1 1.0 0.1 0.5 0.6 0.1 0.2 0.1 0.2 0.2 0.1 9.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.9 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.4 0.1 0.3 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 FCAR CD89 ENSG00000186431 "Fc fragment of IgA receptor" P24071 19 54874248-54890472 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "IgA-binding protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;lung: 19.5;lymphoid tissue: 15.9" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 3.7;Cardiomyocytes: 1.4;Ciliated cells: 1.4;Kupffer cells: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 2.6;neutrophil: 6.1" "Group enriched" "Detected in many" 44 "granulocytes: 6.1;monocytes: 2.6" "Cell line enhanced" "Detected in single" "THP-1: 1.7" "Low region specificity" "Detected in all" HPA014050 Approved Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA014050: AB_1846338" "unprognostic (1.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.30e-1)" "unprognostic (4.71e-3)" "unprognostic (3.46e-1)" "unprognostic (2.02e-1)" "unprognostic (7.99e-2)" "unprognostic (1.54e-2)" "unprognostic (1.59e-2)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (7.05e-2)" "unprognostic (4.19e-6)" "unprognostic (9.23e-2)" "unprognostic (8.10e-3)" "unprognostic (8.04e-3)" "unprognostic (9.81e-2)" 4.0 0.6 0.4 1.5 4.4 28.1 0.8 0.1 1.0 0.6 0.6 0.7 0.0 0.6 0.6 0.6 0.6 3.8 0.6 8.2 2.0 0.4 0.6 1.8 19.5 15.9 1.2 0.0 2.2 0.6 0.6 0.3 1.5 4.3 0.6 0.6 0.9 0.6 0.6 0.6 0.6 0.6 0.7 2.7 14.9 0.9 2.1 0.0 1.0 0.6 0.3 0.6 4.4 4.8 0.0 0.0 6.1 2.6 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.7 0.4 4.4 0.1 1.0 2.0 0.4 1.2 0.0 4.3 0.0 0.0 3.7 0.0 0.2 0.1 0.1 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 1.1 0.0 1.0 0.0 0.0 0.0 5.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 FCER1A FCE1A ENSG00000179639 "Fc fragment of IgE receptor Ia" P12319 1 159289714-159308224 "FDA approved drug targets, Predicted membrane proteins" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "blood: 494.6" "Group enriched" "Detected in some" 4 "granulocytes: 258.2;Macrophages: 206.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "basophil: 494.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 494.6" "Cell line enriched" "Detected in some" 94 "HEL: 100.1" "Low region specificity" "Detected in all" "CAB022102, HPA036051, CAB055526" Approved NA NA "CAB022102: , CAB055526: , HPA036051: AB_2674919" "unprognostic (1.78e-2)" "unprognostic (2.26e-2)" "unprognostic (7.32e-2)" "unprognostic (7.51e-2)" "unprognostic (1.32e-2)" "unprognostic (1.44e-3)" "unprognostic (7.19e-2)" "unprognostic (1.97e-3)" "unprognostic (2.44e-1)" "unprognostic (7.20e-2)" "unprognostic (8.54e-2)" "unprognostic (2.74e-1)" "prognostic favorable (1.20e-4)" "unprognostic (1.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.70e-1)" "unprognostic (3.39e-2)" 5.8 1.4 1.6 3.6 0.8 6.0 9.2 0.9 1.3 8.0 3.4 1.1 3.4 3.2 10.6 5.6 12.1 2.0 25.4 4.1 4.3 1.3 3.6 2.4 27.8 0.6 1.0 5.3 1.5 2.6 0.5 1.9 0.5 2.7 9.4 5.4 6.5 5.9 4.7 1.2 17.9 4.1 6.0 2.8 3.5 2.3 1.5 6.8 2.4 2.5 19.7 16.2 3.8 4.9 0.0 75.4 494.6 0.3 0.4 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 494.6 0.3 0.9 0.0 0.1 0.1 0.0 0.1 0.0 75.4 0.0 0.0 0.1 0.4 0.4 0.2 10.4 0.0 3.0 1.6 0.8 0.9 1.3 4.3 1.3 1.0 5.3 2.7 6.8 6.0 53.5 20.1 0.0 33.5 0.0 0.2 0.0 2.7 3.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 7.2 0.0 258.2 0.0 6.6 0.0 0.0 0.0 2.5 0.6 0.0 206.7 43.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.6 0.0 0.2 29.7 0.0 0.0 0.0 0.0 FCER1G ENSG00000158869 "Fc fragment of IgE receptor Ig" P30273 1 161215234-161220699 "FDA approved drug targets, Predicted membrane proteins" "Immunity, Innate immunity" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 262.7;lymphoid tissue: 176.3" "Group enriched" "Detected in many" 6 "granulocytes: 677.9;Hofbauer cells: 2071.1;Kupffer cells: 1979.2;Macrophages: 2000.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 262.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 17.5;HMC-1: 71.6;THP-1: 63.0;U-266/84: 19.4;U-937: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022108, HPA026872" Supported NA NA 9800000 "CAB022108: , HPA026872: AB_1848473" "unprognostic (3.71e-2)" "unprognostic (2.52e-2)" "unprognostic (2.40e-2)" "unprognostic (8.73e-3)" "unprognostic (1.46e-1)" "unprognostic (4.28e-2)" "unprognostic (3.10e-3)" "unprognostic (1.84e-1)" "unprognostic (3.25e-1)" "unprognostic (9.63e-2)" "unprognostic (2.28e-2)" "unprognostic (5.67e-2)" "prognostic unfavorable (1.83e-6)" "unprognostic (1.99e-1)" "unprognostic (6.28e-2)" "unprognostic (2.04e-2)" "unprognostic (7.87e-2)" 62.6 20.5 12.1 49.5 22.4 71.5 17.6 2.4 10.8 10.6 14.6 14.1 1.3 8.0 7.2 15.9 6.9 20.5 18.8 21.2 15.3 11.2 18.9 35.9 71.2 124.8 23.4 4.5 11.4 7.4 2.9 7.9 38.1 17.0 9.7 21.3 9.7 12.8 7.4 11.9 5.7 13.6 28.5 33.3 176.3 10.9 11.6 16.0 6.5 11.5 6.7 14.7 22.4 10.5 0.9 135.4 73.5 262.7 66.6 2.0 132.1 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.1 0.2 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 17.5 0.1 3.3 0.0 3.6 71.6 1.4 0.7 0.5 0.0 0.1 0.1 0.4 0.0 1.7 0.5 0.1 0.3 8.5 0.3 0.0 0.0 0.0 1.5 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.6 0.3 0.0 63.0 0.1 0.4 0.1 0.2 0.2 0.7 19.4 0.2 0.4 19.7 0.1 64.3 129.8 12.1 0.5 210.3 0.6 0.9 0.4 0.4 97.1 0.3 0.7 2.0 73.5 66.6 262.7 135.4 0.8 132.1 12.1 22.4 2.4 10.8 15.3 11.2 23.4 4.5 17.0 16.0 80.4 219.7 81.8 1.4 35.1 0.0 4.0 20.4 28.1 50.0 17.4 0.0 11.9 0.0 0.5 1.4 15.7 0.6 46.7 0.8 13.5 26.5 1.8 677.9 7.6 2071.1 0.0 1.7 49.7 1979.2 4.7 4.9 2000.4 75.9 55.9 0.0 0.2 0.7 0.9 1.1 3.9 2.6 71.1 23.6 0.9 2.6 31.5 19.8 270.2 0.2 1.6 FCER2 "CD23, CD23A, CLEC4J, FCE2" ENSG00000104921 "Fc fragment of IgE receptor II" P06734 19 7688758-7702146 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "IgE-binding protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 87.2;lymphoid tissue: 38.4" "Cell type enriched" "Detected in some" 57 "B-cells: 110.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "memory B-cell: 28.2;naive B-cell: 87.2" "Lineage enriched" "Detected in many" 34 "B-cells: 87.2" "Cell line enriched" "Detected in some" 14 "HDLM-2: 99.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB002624, HPA008928, HPA067430" Enhanced "Secreted to blood" NA NA 59000 "CAB002624: , HPA008928: AB_1846285, HPA067430: " "unprognostic (3.20e-4)" "unprognostic (1.87e-3)" "unprognostic (1.95e-2)" "unprognostic (2.44e-2)" "unprognostic (4.77e-2)" "unprognostic (1.77e-3)" "unprognostic (1.64e-1)" "unprognostic (1.89e-3)" "unprognostic (2.71e-1)" "unprognostic (1.88e-1)" "unprognostic (2.04e-2)" "unprognostic (8.55e-2)" "unprognostic (2.46e-4)" "unprognostic (2.99e-1)" "unprognostic (1.80e-1)" "unprognostic (4.89e-2)" "unprognostic (5.17e-2)" 2.4 0.3 0.5 17.1 0.5 2.3 1.2 0.3 1.1 0.3 1.0 0.1 0.4 1.3 0.3 2.3 1.0 0.4 0.5 0.8 0.3 0.3 0.6 0.6 0.8 21.1 0.3 0.0 0.4 0.3 0.0 0.3 0.3 0.1 0.3 0.8 0.0 7.5 0.7 0.4 0.6 7.7 0.4 0.3 38.4 0.8 0.5 0.0 6.3 0.7 0.0 33.8 2.0 0.5 87.2 0.7 0.2 2.5 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.5 0.0 0.0 2.5 0.0 28.2 0.0 0.0 0.7 87.2 0.0 0.0 0.2 0.0 0.7 0.1 0.0 3.0 0.5 0.5 0.3 0.3 0.3 0.3 0.3 0.0 0.1 0.0 0.0 1.1 110.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.3 0.6 0.0 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FCGR1A "CD64, CD64A" ENSG00000150337 "Fc fragment of IgG receptor Ia" P12314 1 149782671-149792518 "CD markers, FDA approved drug targets, Predicted membrane proteins" "Immunity, Innate immunity" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.6;epididymis: 33.2" "Cell type enhanced" "Detected in many" 21 "Hofbauer cells: 235.7;Kupffer cells: 121.8;Late spermatids: 48.6;Macrophages: 101.0" "Cancer enhanced" "Detected in many" "glioma: 10.3" "Group enriched" "Detected in some" 7 "classical monocyte: 35.6;intermediate monocyte: 14.0;myeloid DC: 9.5;neutrophil: 25.5" "Group enriched" "Detected in many" 80 "dendritic cells: 9.5;granulocytes: 25.5;monocytes: 35.6" "Cell line enriched" "Detected in some" 5 "THP-1: 61.0" HPA026910 Uncertain "Golgi apparatus,Vesicles,Plasma membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA026910: " "unprognostic (5.27e-2)" "unprognostic (2.89e-2)" "unprognostic (2.34e-2)" "unprognostic (7.97e-2)" "unprognostic (8.44e-3)" "unprognostic (1.73e-1)" "unprognostic (7.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (6.18e-2)" "prognostic unfavorable (4.83e-8)" "unprognostic (1.28e-1)" "unprognostic (4.51e-2)" "unprognostic (9.99e-2)" "unprognostic (9.03e-2)" 3.9 2.4 6.7 14.1 4.4 5.0 0.7 0.3 3.5 1.1 0.3 0.0 0.1 33.2 0.3 0.7 2.4 0.7 5.3 4.9 1.0 1.1 8.9 3.4 10.1 0.3 1.0 0.5 1.2 10.8 0.4 0.3 0.7 0.2 0.0 0.0 0.1 5.5 14.3 7.0 0.3 0.9 0.3 0.0 3.3 0.0 0.2 9.5 25.5 35.6 0.0 0.2 11.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 61.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.5 35.6 0.4 0.0 14.0 0.2 0.2 0.0 0.1 9.5 0.0 0.0 0.0 25.5 0.0 2.8 0.2 0.1 11.2 0.0 1.9 3.5 0.0 0.1 1.5 1.2 2.5 1.4 2.3 0.0 2.0 2.1 0.0 0.0 28.2 0.1 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 235.7 0.0 0.0 1.3 121.8 48.6 0.3 101.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 6.5 0.0 0.7 0.4 0.0 3.4 0.0 0.0 0.0 FCGR1B CD64b ENSG00000198019 "Fc fragment of IgG receptor Ib" Q92637 1 121087345-121096310 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.8;epididymis: 36.9" "Group enriched" "Detected in some" 5 "Hofbauer cells: 68.7;Kupffer cells: 38.3;Macrophages: 36.3;Sertoli cells: 19.4" "Cancer enhanced" "Detected in single" "glioma: 1.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 19.2;neutrophil: 21.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "NB-4: 10.7;THP-1: 40.9" HPA026910 Uncertain "Golgi apparatus,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA026910: " "unprognostic (3.21e-2)" "unprognostic (4.35e-2)" "unprognostic (1.13e-2)" "unprognostic (2.84e-1)" "unprognostic (1.85e-1)" "unprognostic (9.60e-2)" "unprognostic (1.56e-2)" "unprognostic (6.42e-2)" "unprognostic (3.10e-2)" "unprognostic (8.17e-2)" "unprognostic (1.91e-1)" "unprognostic (3.65e-1)" "unprognostic (3.24e-10)" "unprognostic (8.99e-2)" "unprognostic (2.85e-2)" "unprognostic (7.86e-3)" "unprognostic (8.93e-2)" 4.2 2.3 6.6 13.2 6.2 3.9 1.3 0.8 3.2 0.8 0.5 3.0 0.2 0.5 0.9 36.9 0.5 0.8 1.5 7.4 5.0 4.2 1.0 1.1 4.8 7.9 8.9 0.2 1.1 1.9 0.4 1.5 8.1 6.4 0.6 0.6 0.4 1.3 0.5 0.2 0.0 0.4 4.2 11.3 6.8 0.5 0.5 6.2 0.4 1.8 0.2 0.4 1.5 0.2 0.0 5.2 21.8 19.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 40.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 19.2 0.2 0.0 11.3 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 21.8 0.0 6.2 0.1 0.0 5.3 6.6 6.2 0.8 3.0 5.0 4.2 8.9 0.2 6.4 6.2 0.0 1.3 0.8 0.0 0.0 0.8 2.0 0.0 0.0 1.2 0.0 2.0 0.5 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 68.7 3.2 0.0 0.0 38.3 8.2 1.1 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 19.4 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 FCGR2A "CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2" ENSG00000143226 "Fc fragment of IgG receptor IIa" P12318 1 161505430-161524013 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Immunity "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 182.8" "Cell type enhanced" "Detected in many" 17 "Hofbauer cells: 145.9;Kupffer cells: 155.0;Macrophages: 311.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 182.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 182.8" "Cell line enhanced" "Detected in some" "HEL: 14.3;HMC-1: 28.9;K-562: 8.4;NB-4: 8.1;THP-1: 30.7;U-937: 13.2" "HPA010718, HPA010776, HPA014730" Enhanced Supported "Golgi apparatus,Plasma membrane" NA NA 55000000 "Plasma membrane" "Golgi apparatus" "HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074" "unprognostic (2.57e-2)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (4.12e-2)" "unprognostic (5.89e-2)" "unprognostic (6.17e-2)" "unprognostic (1.24e-2)" "unprognostic (1.17e-1)" "unprognostic (7.63e-2)" "unprognostic (1.17e-3)" "unprognostic (2.43e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (6.49e-7)" "unprognostic (8.85e-3)" "unprognostic (6.47e-3)" "unprognostic (1.54e-1)" "unprognostic (3.42e-2)" 36.8 12.6 13.2 44.6 19.2 18.6 8.2 2.2 10.1 9.1 7.1 10.0 0.0 3.8 4.7 6.6 5.5 11.6 17.0 11.3 17.0 8.9 11.5 7.1 44.1 50.0 25.9 1.7 8.0 5.8 2.8 6.1 47.5 19.6 7.0 9.9 10.8 8.3 4.8 7.3 3.0 7.3 17.6 30.9 43.4 5.9 4.8 19.2 3.2 6.3 2.5 4.4 19.3 4.5 0.2 7.0 182.8 27.2 0.0 0.0 10.6 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.2 0.0 0.3 4.1 28.9 0.3 0.0 0.0 0.0 0.4 0.0 0.0 8.4 0.2 0.0 0.0 0.2 8.1 0.0 0.0 0.6 0.1 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 30.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 13.2 3.6 0.1 27.2 31.6 0.0 20.7 0.0 0.2 0.0 0.0 7.0 0.1 0.0 0.0 182.8 0.0 16.7 0.2 0.0 10.6 13.2 19.2 2.2 10.1 17.0 8.9 25.9 1.7 19.6 19.2 20.8 63.3 13.7 0.4 7.7 0.0 1.2 5.1 6.7 21.6 0.0 0.0 0.8 8.3 0.2 37.5 2.6 0.0 0.0 0.5 1.1 5.8 0.3 29.0 0.8 145.9 0.0 0.0 4.3 155.0 35.2 1.4 311.2 16.9 1.8 0.0 0.3 0.7 0.0 0.0 7.9 0.1 6.5 5.8 0.3 0.4 6.8 1.4 4.1 0.0 0.3 FCGR2B "CD32, CD32B, FCG2, FCGR2" ENSG00000072694 "Fc fragment of IgG receptor IIb" P31994 1 161663147-161678654 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Host-virus interaction" "IgG-binding protein, Receptor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 53.3;placenta: 83.2" "Group enriched" "Detected in many" 5 "Ito cells: 479.4;Macrophages: 138.2" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 53.3;memory B-cell: 42.2" "Group enriched" "Detected in many" 18 "B-cells: 42.2;dendritic cells: 14.5;granulocytes: 53.3" "Cell line enhanced" "Detected in some" "Daudi: 18.7;HMC-1: 23.5;NB-4: 5.2;RPMI-8226: 8.4" "CAB007796, HPA014730" Enhanced NA NA "CAB007796: AB_562288, HPA014730: AB_2669074" "unprognostic (1.58e-1)" "unprognostic (5.14e-2)" "unprognostic (3.32e-3)" "unprognostic (3.12e-2)" "unprognostic (6.79e-3)" "unprognostic (4.05e-3)" "unprognostic (1.27e-1)" "unprognostic (4.65e-3)" "unprognostic (1.91e-1)" "unprognostic (4.72e-2)" "unprognostic (2.89e-2)" "unprognostic (3.49e-1)" "prognostic unfavorable (8.82e-4)" "unprognostic (3.51e-2)" "unprognostic (6.36e-2)" "unprognostic (4.31e-1)" "unprognostic (3.37e-1)" 11.3 2.4 0.0 2.0 0.2 0.0 4.1 0.0 0.0 1.9 3.4 0.2 0.9 0.2 2.1 2.1 2.3 3.7 0.0 0.2 2.0 9.5 5.6 2.5 0.5 0.8 0.6 0.0 0.3 83.2 0.3 2.0 3.3 0.2 0.5 2.0 4.6 3.1 4.7 6.7 1.5 0.1 1.7 5.6 3.3 1.2 42.2 14.5 53.3 1.9 0.1 0.3 2.4 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 5.2 0.1 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 2.2 0.0 53.3 1.8 5.4 0.3 1.9 0.1 42.2 0.1 0.2 14.5 34.3 0.0 0.3 11.2 0.1 1.7 0.0 0.0 2.4 0.0 4.6 57.3 0.0 4.7 0.0 1.9 5.1 0.0 2.3 0.0 0.0 0.2 0.0 0.0 4.2 1.4 0.0 23.3 0.0 0.2 2.7 0.0 2.3 2.5 7.6 0.0 0.0 479.4 63.3 2.3 0.6 138.2 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.3 0.2 2.8 0.3 4.9 0.0 0.0 FCGR3A "CD16, CD16a, FCG3, FCGR3" ENSG00000203747 "Fc fragment of IgG receptor IIIa" P08637 1 161541759-161550737 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 223.6;lymphoid tissue: 60.8" "Cell type enhanced" "Detected in many" 22 "Hofbauer cells: 191.4;Kupffer cells: 556.1;Macrophages: 266.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 109.4;non-classical monocyte: 223.6" "Group enriched" "Detected in many" 4 "granulocytes: 73.0;monocytes: 223.6" "Cell line enhanced" "Detected in some" "BEWO: 1.0;HaCaT: 1.7;SH-SY5Y: 1.3;U-2197: 1.1;U-266/70: 1.8" "CAB032435, HPA055431" Supported "Secreted to blood" NA NA 2500000000 "CAB032435: AB_626925, HPA055431: AB_2682815" "unprognostic (5.27e-2)" "unprognostic (9.95e-2)" "unprognostic (2.37e-2)" "unprognostic (1.66e-1)" "unprognostic (1.39e-1)" "unprognostic (1.82e-1)" "unprognostic (2.24e-2)" "unprognostic (6.06e-2)" "unprognostic (2.41e-1)" "unprognostic (1.64e-1)" "unprognostic (1.98e-2)" "unprognostic (7.52e-2)" "prognostic unfavorable (3.22e-6)" "unprognostic (1.14e-1)" "unprognostic (4.66e-2)" "unprognostic (1.03e-2)" "unprognostic (7.51e-2)" 11.9 9.7 7.5 20.5 12.4 4.4 4.1 1.6 7.0 1.9 2.1 5.5 0.8 0.8 1.1 2.4 1.0 2.4 5.1 6.4 6.3 7.3 2.6 22.5 43.2 8.0 12.7 1.9 1.4 2.9 1.8 3.9 14.6 6.8 2.6 2.3 2.2 2.7 1.3 1.3 0.3 1.2 14.3 25.7 60.8 1.3 1.2 8.0 1.4 1.8 1.3 1.3 6.3 2.3 0.1 11.7 73.0 223.6 7.9 33.9 35.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.5 1.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.5 0.5 0.0 0.0 0.8 0.5 0.4 0.0 0.0 0.5 1.3 0.4 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.1 1.1 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.3 1.6 0.5 33.9 109.4 0.3 0.1 0.3 13.2 11.7 0.0 0.2 12.2 73.0 7.9 223.6 0.2 0.1 35.8 7.5 12.4 1.6 7.0 6.3 7.3 12.7 1.9 6.8 8.0 20.8 30.6 13.0 0.0 0.5 0.1 0.4 7.6 10.7 19.4 3.5 2.0 1.1 0.0 0.0 0.9 0.8 0.0 0.0 0.0 1.1 0.3 0.0 17.4 3.4 191.4 0.0 0.0 9.2 556.1 1.5 0.3 266.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 1.3 19.4 0.0 0.0 0.5 0.0 1.7 99.7 0.0 0.1 FCGR3B "CD16, CD16b, FCG3, FCGR3" ENSG00000162747 "Fc fragment of IgG receptor IIIb" O75015 1 161623196-161631963 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "blood: 334.5" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 11.1;Ciliated cells: 4.0;Club cells: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 95 "neutrophil: 334.5" "Lineage enriched" "Detected in many" 95 "granulocytes: 334.5" "Cell line enhanced" "Detected in single" "K-562: 1.5" "Secreted to blood" NA NA "unprognostic (1.60e-1)" "unprognostic (1.36e-1)" "unprognostic (1.59e-3)" "unprognostic (4.16e-2)" "unprognostic (1.15e-1)" "unprognostic (6.52e-2)" "unprognostic (3.97e-2)" "unprognostic (6.96e-3)" "unprognostic (2.53e-2)" "unprognostic (1.02e-1)" "unprognostic (1.07e-1)" "unprognostic (8.67e-2)" "unprognostic (5.16e-2)" "unprognostic (1.35e-1)" "unprognostic (8.37e-3)" "unprognostic (2.28e-1)" "unprognostic (9.24e-2)" 9.9 0.8 1.8 30.8 1.5 13.8 1.5 0.9 1.8 0.9 0.8 0.5 0.2 0.0 0.4 0.5 1.7 2.8 6.8 4.6 1.2 0.9 0.9 2.9 15.2 16.9 5.0 0.5 1.2 1.2 0.0 0.6 4.5 1.9 1.5 0.0 1.3 0.9 0.9 0.8 1.4 0.8 2.0 4.0 44.3 1.3 1.5 0.9 0.6 0.8 0.2 0.9 11.1 4.7 0.0 0.1 334.5 3.5 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.5 1.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 334.5 0.1 3.5 0.0 0.0 0.5 1.8 1.5 0.9 1.8 1.2 0.9 5.0 0.5 1.9 0.9 3.0 11.1 0.0 0.0 0.0 0.0 0.3 0.0 4.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 FCGRT "alpha-chain, FCRN" ENSG00000104870 "Fc fragment of IgG receptor and transporter" P55899 19 49506816-49526333 "Predicted intracellular proteins, Predicted membrane proteins" "IgG-binding protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 164.3" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 863.1;Hofbauer cells: 1128.9;Paneth cells: 837.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 164.3" "Group enriched" "Detected in all" 16 "dendritic cells: 70.7;granulocytes: 164.3;monocytes: 100.2" "Cell line enhanced" "Detected in many" "ASC diff: 40.8;Hep G2: 34.8;OE19: 42.6;THP-1: 45.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012122, HPA015130" Enhanced NA NA 17000000 "HPA012122: AB_1848474, HPA015130: AB_1848475" "unprognostic (2.19e-3)" "unprognostic (2.05e-2)" "unprognostic (1.89e-1)" "unprognostic (1.69e-2)" "unprognostic (2.39e-1)" "unprognostic (1.26e-1)" "unprognostic (8.58e-2)" "unprognostic (3.87e-3)" "unprognostic (2.81e-1)" "unprognostic (3.49e-2)" "unprognostic (2.00e-3)" "unprognostic (3.64e-1)" "unprognostic (3.67e-3)" "unprognostic (3.40e-1)" "unprognostic (1.40e-1)" "unprognostic (1.29e-2)" "unprognostic (2.18e-3)" 55.6 25.4 10.9 30.0 10.7 20.9 68.7 5.3 9.6 41.7 104.2 14.3 15.3 54.7 30.8 41.7 19.8 28.7 49.3 42.9 12.0 5.8 32.4 87.4 41.7 51.6 15.8 8.7 41.0 32.2 16.1 17.3 32.0 13.2 28.0 30.3 27.5 20.9 19.4 19.9 22.1 125.2 23.8 14.2 66.3 24.1 24.6 10.2 14.1 28.5 15.3 13.1 20.1 27.9 4.4 70.7 164.3 100.2 2.0 7.0 72.1 0.0 8.5 1.5 30.5 40.8 20.7 1.3 6.5 18.1 5.2 5.7 12.0 5.4 0.0 13.5 10.6 2.9 2.1 0.3 0.2 3.3 0.0 11.5 16.9 0.1 34.8 24.3 0.2 3.0 24.6 0.4 4.1 0.0 20.7 20.3 12.1 2.8 2.8 13.7 0.2 0.1 3.3 0.4 42.6 5.5 0.6 7.8 0.8 23.5 2.3 0.5 5.8 1.4 0.0 0.9 5.3 6.5 45.8 6.5 13.2 2.4 0.2 0.2 0.6 3.2 2.3 2.0 15.3 1.8 29.3 100.2 63.3 1.9 65.6 2.3 4.1 3.1 3.0 70.7 4.4 7.0 3.9 164.3 2.0 42.3 40.1 1.9 72.1 10.9 10.7 5.3 9.6 12.0 5.8 15.8 8.7 13.2 10.2 62.5 86.1 44.6 103.6 112.0 0.4 24.1 104.4 41.5 50.0 69.8 3.9 11.0 51.4 65.2 5.3 238.2 863.1 46.7 54.3 21.5 241.8 68.4 70.3 290.5 1128.9 0.0 151.9 518.1 657.4 9.4 335.4 492.4 177.2 40.5 328.3 12.3 84.6 837.7 172.5 259.8 5.3 213.4 73.9 20.6 16.4 93.6 17.3 43.6 442.9 92.8 FCMR "FAIM3, TOSO" ENSG00000162894 "Fc fragment of IgM receptor" O60667 1 206904386-206923247 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9" "Group enriched" "Detected in many" 11 "B-cells: 125.3;T-cells: 41.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 99.6;T-cells: 60.0" "Group enriched" "Detected in some" 5 "RPMI-8226: 53.0;U-266/70: 26.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA003910 Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Secreted to blood" NA NA 2400000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA003910: AB_1078798" "prognostic favorable (4.23e-4)" "unprognostic (1.16e-3)" "unprognostic (7.48e-2)" "unprognostic (3.06e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-3)" "unprognostic (1.15e-1)" "unprognostic (4.85e-3)" "unprognostic (1.03e-1)" "unprognostic (3.97e-1)" "unprognostic (3.23e-2)" "unprognostic (2.01e-1)" "unprognostic (8.15e-3)" "unprognostic (8.06e-2)" "unprognostic (2.12e-2)" "unprognostic (3.74e-2)" "unprognostic (5.05e-3)" 15.5 0.6 0.5 42.9 0.5 2.9 1.5 0.4 0.4 0.8 2.5 0.4 0.3 1.2 1.2 0.8 3.4 1.3 2.6 1.0 0.5 0.5 2.4 1.5 3.9 77.2 0.5 0.0 1.3 0.7 0.0 0.9 0.8 0.2 1.4 2.3 1.3 10.1 0.3 1.9 0.6 30.1 0.4 0.6 78.8 2.8 0.5 0.0 51.8 1.8 1.2 84.9 8.5 1.2 99.6 1.4 5.3 0.4 18.4 60.0 28.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.1 0.0 0.0 3.4 0.0 0.1 0.3 0.1 0.0 0.4 0.2 0.0 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 2.7 0.0 7.4 0.0 0.1 1.0 0.1 0.0 0.0 0.0 1.7 0.2 53.0 0.0 0.1 0.0 0.0 1.0 0.2 5.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 26.7 1.9 7.4 0.3 0.0 0.2 0.5 0.2 0.2 20.3 0.4 26.4 80.3 28.1 26.2 0.2 99.6 49.5 33.3 5.3 18.4 0.3 1.4 60.0 28.2 0.5 0.5 0.4 0.4 0.5 0.5 0.5 0.0 0.2 0.0 0.0 4.6 125.3 3.9 0.0 0.0 3.0 7.6 1.4 2.3 0.0 0.0 0.0 0.0 1.3 0.1 0.1 0.0 0.0 2.6 0.1 0.6 2.6 0.0 1.1 3.8 0.0 0.0 5.5 5.1 0.0 0.3 1.2 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.3 0.1 1.0 0.0 0.0 41.7 1.2 7.1 FCN2 "EBP-37, FCNL, ficolin-2, P35" ENSG00000160339 "Ficolin 2" Q15485 9 134880812-134887520 "Plasma proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 77.4" "Cell type enriched" "Detected in some" 16 "Ito cells: 1725.4" "Group enriched" "Detected in some" 8 "breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 6.0;intermediate monocyte: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RH-30: 1.3;SCLC-21H: 1.1;T-47d: 1.3;U-698: 1.2" "Secreted to blood" NA NA 8100000000 1800000000 "unprognostic (1.91e-1)" "unprognostic (1.07e-1)" "unprognostic (6.96e-4)" "unprognostic (3.73e-2)" "unprognostic (2.09e-2)" "unprognostic (3.81e-1)" "unprognostic (2.82e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" "unprognostic (1.05e-1)" "unprognostic (3.07e-1)" 2.0 11.4 0.2 0.2 0.2 0.0 4.0 0.2 0.3 0.2 0.3 0.3 0.5 0.0 0.3 0.6 0.2 0.0 0.2 0.5 0.2 0.0 2.2 77.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.5 0.2 0.3 1.5 0.0 0.2 1.4 0.2 0.2 0.0 0.2 0.2 0.2 1.4 0.0 0.3 0.2 0.2 0.9 0.2 0.2 0.3 0.2 0.0 3.3 1.3 6.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.9 0.0 0.0 6.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.3 0.0 2.5 0.0 0.0 7.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.9 0.0 0.0 0.0 1725.4 106.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FCRL1 "CD307a, FCRH1, IFGP1, IRTA5" ENSG00000163534 "Fc receptor like 1" Q96LA6 1 157794403-157820105 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 31.6;lymphoid tissue: 55.1" "Cell type enriched" "Detected in some" 60 "B-cells: 69.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 51 "memory B-cell: 16.8;naive B-cell: 31.6" "Lineage enriched" "Detected in single" 66 "B-cells: 31.6" "Group enriched" "Detected in some" 33 "Daudi: 5.7;U-698: 19.4" "Low region specificity" "Detected in all" HPA013323 Enhanced NA NA 120000 "HPA013323: AB_1848480" "unprognostic (6.52e-4)" "unprognostic (3.49e-3)" "unprognostic (8.68e-3)" "unprognostic (8.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.01e-5)" "unprognostic (1.47e-2)" "unprognostic (5.48e-3)" "unprognostic (1.40e-2)" "unprognostic (4.30e-2)" "unprognostic (1.81e-1)" "unprognostic (2.85e-2)" "unprognostic (1.44e-3)" "unprognostic (1.96e-1)" "unprognostic (1.65e-2)" "unprognostic (4.80e-2)" "unprognostic (6.74e-2)" 0.5 0.2 0.2 55.1 0.2 6.2 0.3 0.2 0.2 0.2 0.7 0.0 0.0 0.0 0.2 0.1 2.4 0.3 0.2 0.3 0.2 0.2 0.7 0.5 1.9 19.2 0.2 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.5 0.3 0.3 5.4 0.7 0.2 0.2 10.1 0.0 0.2 25.3 0.4 0.2 0.0 1.1 0.7 0.4 49.0 4.5 0.8 31.6 0.0 0.4 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 16.8 0.0 0.0 0.0 31.6 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 69.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FCRL2 "CD307b, FCRH2, IRTA4, SPAP1" ENSG00000132704 "Fc receptor like 2" Q96LA5 1 157745733-157777132 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 20.2;intestine: 14.9;lymphoid tissue: 27.0" "Cell type enriched" "Detected in some" 17 "B-cells: 57.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 50 "memory B-cell: 20.2;naive B-cell: 10.8" "Lineage enriched" "Detected in single" 65 "B-cells: 20.2" "Group enriched" "Detected in some" 4 "Daudi: 15.0;U-698: 12.2" NA NA "unprognostic (3.94e-3)" "unprognostic (1.47e-3)" "unprognostic (3.49e-2)" "unprognostic (3.69e-3)" "unprognostic (5.11e-5)" "unprognostic (1.67e-2)" "unprognostic (4.77e-3)" "unprognostic (8.19e-2)" "unprognostic (8.66e-3)" "unprognostic (1.20e-2)" "unprognostic (4.19e-2)" "unprognostic (4.60e-7)" "unprognostic (2.89e-1)" "unprognostic (2.29e-1)" "unprognostic (7.92e-2)" "unprognostic (2.48e-1)" 0.4 0.2 0.2 22.6 0.2 1.5 0.2 0.1 0.2 0.2 1.3 0.1 0.1 1.2 0.3 0.1 1.4 0.2 0.4 0.2 0.2 0.2 0.5 0.9 0.7 15.6 0.3 0.1 0.5 0.2 0.0 0.2 0.1 0.2 0.4 1.7 0.6 2.8 0.7 0.1 0.2 14.9 0.1 0.2 27.0 0.8 0.2 0.1 0.3 0.5 0.1 23.3 1.4 0.2 20.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.2 0.0 12.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.1 0.2 0.1 0.0 1.4 57.3 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.1 0.4 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.3 FCRL3 "CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e" ENSG00000160856 "Fc receptor like 3" Q96P31 1 157674321-157700857 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 20.3;lymphoid tissue: 32.2" "Cell type enhanced" "Detected in some" 28 "B-cells: 38.7;Early spermatids: 7.0;Late spermatids: 7.6;T-cells: 14.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive B-cell: 20.3" "Group enriched" "Detected in many" 56 "B-cells: 20.3;NK-cells: 10.7;T-cells: 10.8" "Cell line enriched" "Detected in some" 7 "Daudi: 14.6" "Low region specificity" "Detected in single" HPA048022 Enhanced NA NA "HPA048022: AB_2732541" "unprognostic (6.73e-3)" "unprognostic (5.06e-4)" "unprognostic (1.13e-2)" "unprognostic (2.08e-4)" "unprognostic (3.86e-1)" "unprognostic (1.74e-5)" "unprognostic (1.09e-2)" "unprognostic (4.29e-3)" "unprognostic (3.69e-3)" "unprognostic (2.46e-4)" "unprognostic (1.13e-1)" "unprognostic (2.55e-2)" "unprognostic (2.01e-4)" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (2.21e-1)" "unprognostic (6.69e-2)" 0.4 0.2 0.2 29.4 0.2 0.4 0.3 0.2 0.2 0.3 0.6 0.0 0.0 0.0 0.5 0.2 1.5 0.3 0.6 0.3 0.2 0.2 0.5 0.6 0.9 26.4 0.4 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.5 0.6 0.2 5.6 0.0 0.4 0.2 8.7 0.1 0.2 22.4 0.6 0.2 0.0 5.2 0.6 0.6 32.2 1.2 0.3 20.3 0.0 0.2 0.0 10.7 10.8 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 1.0 16.1 1.4 7.2 0.0 20.3 0.1 4.7 0.2 10.7 0.0 0.0 5.6 3.5 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.6 0.0 0.0 FCRL4 "CD307d, FCRH4, IGFP2, IRTA1" ENSG00000163518 "Fc receptor like 4" Q96PJ5 1 157573749-157598080 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 5.4;lymphoid tissue: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 12 "B-cells: 1.1" "Cell line enriched" "Detected in single" 104 "U-266/70: 10.4" "Not detected" "Not detected" HPA054030 Approved NA NA "HPA054030: " "unprognostic (6.06e-2)" "unprognostic (3.41e-3)" "unprognostic (2.57e-1)" "unprognostic (5.08e-2)" "unprognostic (4.69e-4)" "unprognostic (2.06e-2)" "unprognostic (6.38e-2)" "unprognostic (1.99e-1)" "unprognostic (2.14e-1)" "unprognostic (3.37e-1)" "unprognostic (6.77e-2)" 0.1 0.1 0.1 15.6 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 5.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 2.5 0.0 0.1 0.1 5.4 0.0 0.1 2.2 0.3 0.1 0.0 1.1 0.1 1.9 14.9 0.4 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FCRL5 "BXMAS1, CD307e, FCRH5, IRTA2" ENSG00000143297 "Fc receptor like 5" Q96RD9 1 157513377-157552520 "CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.3;lymphoid tissue: 39.1;salivary gland: 12.4" "Group enriched" "Detected in some" 7 "B-cells: 61.9;Early spermatids: 51.2;Melanocytes: 21.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "memory B-cell: 11.4;naive B-cell: 13.3" "Lineage enriched" "Detected in single" 19 "B-cells: 13.3" "Group enriched" "Detected in some" 5 "U-266/70: 5.8;U-698: 12.3" "Secreted to blood" NA NA 169000000 36000000 "unprognostic (1.30e-3)" "unprognostic (3.51e-2)" "unprognostic (7.59e-3)" "unprognostic (1.57e-2)" "unprognostic (9.41e-3)" "unprognostic (4.32e-5)" "unprognostic (2.61e-2)" "unprognostic (6.93e-2)" "unprognostic (7.40e-2)" "unprognostic (7.66e-3)" "unprognostic (4.01e-1)" "unprognostic (1.39e-1)" "unprognostic (9.51e-10)" "unprognostic (1.20e-1)" "unprognostic (4.40e-1)" "unprognostic (8.99e-2)" "unprognostic (2.78e-1)" 0.7 0.4 0.3 33.9 0.3 1.1 1.3 0.3 0.3 1.6 7.4 0.1 0.0 3.6 0.5 0.1 4.6 0.8 0.8 0.4 0.3 0.3 1.6 0.8 1.6 17.4 0.3 0.0 0.6 0.4 0.0 0.3 0.0 0.0 0.5 2.7 1.0 12.4 0.8 0.3 0.3 6.4 0.1 0.3 29.5 2.5 0.9 0.0 3.1 1.1 0.7 39.1 5.3 0.6 13.3 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.1 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 4.5 61.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 51.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 0.3 0.0 0.0 0.6 0.3 4.4 0.3 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 1.1 0.0 0.0 0.6 0.5 0.0 0.0 FCRL6 "FcRH6, FLJ16056, IFGP6" ENSG00000181036 "Fc receptor like 6" Q6DN72 1 159800511-159816251 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 39.4;lymphoid tissue: 15.5" "Cell type enriched" "Detected in some" 37 "T-cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "gdT-cell: 39.4;memory CD8 T-cell: 36.0;naive CD8 T-cell: 29.2;NK-cell: 13.2" "Group enriched" "Detected in many" 27 "NK-cells: 13.2;T-cells: 39.4" "Cell line enhanced" "Detected in some" "HSkMC: 2.4;hTCEpi: 2.6;Karpas-707: 1.8;U-937: 1.7" "Low region specificity" "Detected in all" NA NA "unprognostic (2.64e-3)" "unprognostic (1.30e-2)" "unprognostic (1.97e-2)" "unprognostic (1.62e-3)" "unprognostic (1.85e-1)" "unprognostic (1.84e-3)" "unprognostic (5.79e-3)" "unprognostic (6.65e-3)" "unprognostic (2.76e-2)" "unprognostic (3.91e-1)" "unprognostic (1.98e-1)" "unprognostic (1.61e-1)" "unprognostic (1.52e-5)" "unprognostic (3.98e-1)" "unprognostic (1.13e-1)" "unprognostic (8.78e-2)" "unprognostic (9.18e-2)" 2.2 1.5 0.6 7.0 0.6 6.8 1.6 1.1 0.8 1.3 0.7 0.7 0.0 0.8 4.6 2.4 0.8 1.2 7.2 3.6 0.6 0.6 1.5 4.0 7.5 9.0 0.7 2.4 1.4 0.9 0.0 0.9 1.3 1.0 3.2 0.3 2.7 2.8 0.1 1.1 0.9 2.5 0.7 1.8 15.5 1.1 1.2 0.0 3.2 1.3 1.2 3.4 2.0 1.0 0.0 0.9 0.3 0.3 13.2 39.4 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.2 0.4 0.0 0.0 2.4 2.6 0.0 0.5 0.0 0.1 0.3 0.0 1.8 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.3 0.5 0.0 0.2 0.0 0.3 0.0 0.5 0.2 0.0 0.2 1.7 0.9 0.0 0.0 0.0 39.4 0.0 0.8 0.0 7.3 36.0 0.9 0.0 3.3 29.2 0.3 13.2 0.3 0.0 0.0 11.1 0.6 0.6 1.1 0.8 0.6 0.6 0.7 2.4 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 0.0 FCRLA "FCRL, FCRLa, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRLM1, FCRLX, FREB, MGC4595" ENSG00000132185 "Fc receptor like A" Q7L513 1 161706972-161714352 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 66.3;lymphoid tissue: 51.8" "Group enriched" "Detected in some" 57 "B-cells: 105.0;Melanocytes: 64.1" "Cancer enriched" "Detected in many" 21 "melanoma: 38.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "memory B-cell: 66.3;naive B-cell: 61.9" "Lineage enriched" "Detected in many" 9 "B-cells: 66.3" "Group enriched" "Detected in some" 6 "Daudi: 94.0;SK-MEL-30: 38.7;U-698: 52.0" "Not detected" "Not detected" "Not detected" "Not detected" CAB016545 Enhanced "Intracellular and membrane" NA NA "CAB016545: AB_2247037" "unprognostic (5.46e-4)" "unprognostic (7.19e-2)" "unprognostic (3.69e-3)" "unprognostic (4.75e-4)" "unprognostic (4.69e-2)" "unprognostic (1.48e-4)" "unprognostic (1.45e-2)" "unprognostic (4.15e-3)" "unprognostic (8.66e-2)" "unprognostic (3.58e-4)" "unprognostic (2.19e-2)" "unprognostic (2.89e-1)" "unprognostic (6.84e-5)" "unprognostic (3.21e-2)" "unprognostic (1.55e-1)" "unprognostic (1.56e-1)" "unprognostic (2.08e-2)" 0.4 0.2 0.6 31.7 0.7 1.3 0.3 0.2 0.3 0.2 0.9 0.2 0.0 0.2 0.2 0.0 2.4 0.2 0.2 0.6 0.5 0.3 0.6 0.4 0.4 26.3 0.4 0.0 0.2 0.2 0.0 0.2 0.1 0.2 0.5 0.9 0.6 4.8 0.0 0.4 0.6 13.9 0.0 0.7 42.4 1.3 0.2 0.1 2.0 0.5 0.3 51.8 1.9 0.4 66.3 6.9 0.0 0.0 0.0 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.1 0.0 0.0 94.0 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.7 10.8 0.0 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 52.0 0.6 0.0 9.3 0.0 0.0 0.0 0.1 0.0 0.0 66.3 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 6.9 0.0 2.7 0.6 0.7 0.2 0.3 0.5 0.3 0.4 0.0 0.2 0.1 0.0 1.1 105.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 64.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 FDCSP "C4orf7, FDC-SP" ENSG00000181617 "Follicular dendritic cell secreted protein" Q8NFU4 4 70226071-70235252 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "lymphoid tissue: 176.5;salivary gland: 452.5" "Cell type enriched" "Detected in single" 38 "Ductal cells: 37.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 336.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.2;GAMG: 10.9;HL-60: 2.0;RH-30: 3.0;U-87 MG: 8.0" "HPA014326, CAB014890" Enhanced "Secreted in other tissues" NA NA "CAB014890: , HPA014326: AB_1845719" "unprognostic (1.26e-3)" "unprognostic (2.32e-1)" "unprognostic (8.73e-3)" "unprognostic (9.62e-2)" "prognostic favorable (2.38e-4)" "unprognostic (5.99e-3)" "prognostic favorable (1.32e-4)" "unprognostic (2.04e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (3.79e-1)" "unprognostic (1.96e-1)" "unprognostic (3.68e-2)" "unprognostic (2.80e-1)" "unprognostic (7.83e-2)" 0.4 0.4 0.4 95.4 0.4 0.0 9.7 0.4 0.4 0.4 1.0 0.0 0.0 0.0 0.4 0.0 1.9 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.5 124.7 0.4 0.0 0.4 0.4 0.0 0.4 0.0 0.0 0.4 0.7 0.0 452.5 0.0 0.5 0.4 3.7 0.0 0.4 12.1 0.4 0.4 0.0 0.4 0.5 35.9 176.5 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.2 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.1 0.0 0.0 0.0 0.2 8.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FDPS ENSG00000160752 "Farnesyl diphosphate synthase" P14324 1 155308748-155320666 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 149.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028200 Approved Approved Nucleoplasm,Cytosol NA NA 2000000 Cytosol Nucleoplasm "HPA028200: AB_10612109" "unprognostic (1.23e-1)" "unprognostic (8.46e-3)" "unprognostic (2.47e-2)" "unprognostic (6.57e-2)" "unprognostic (4.58e-2)" "unprognostic (2.84e-2)" "prognostic unfavorable (7.35e-4)" "unprognostic (4.21e-2)" "unprognostic (6.78e-3)" "unprognostic (1.64e-3)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (1.11e-2)" "unprognostic (8.25e-2)" "unprognostic (2.07e-1)" "unprognostic (5.65e-2)" "unprognostic (8.44e-2)" 21.0 57.8 19.3 17.6 26.5 16.5 19.8 12.8 32.2 19.0 25.0 22.6 14.5 45.9 18.0 21.7 41.4 16.7 18.8 19.6 18.6 23.4 23.7 100.8 25.7 19.2 19.5 24.3 15.2 27.5 15.6 12.3 20.2 47.3 16.5 29.7 20.5 29.2 12.9 15.7 29.3 32.3 18.9 23.0 17.7 23.4 15.1 16.5 25.1 19.5 41.7 27.3 13.7 20.8 41.1 39.7 49.4 37.1 45.3 45.5 48.3 36.0 19.6 72.1 26.0 16.9 62.0 25.7 17.2 34.1 27.5 44.8 31.7 85.9 27.5 41.9 15.0 65.7 40.3 42.9 149.6 25.8 15.0 30.7 15.9 35.0 38.3 27.8 25.8 18.3 44.1 23.7 43.7 22.0 12.5 47.9 40.8 28.5 74.2 28.6 38.7 33.0 25.1 43.3 26.8 28.7 28.5 31.3 76.3 72.5 24.1 28.1 24.0 17.7 32.3 29.7 42.9 23.3 70.2 34.8 15.4 18.9 9.5 31.4 31.5 24.2 49.1 15.0 27.6 24.2 30.5 36.0 49.4 39.4 37.1 35.0 41.1 34.8 39.8 39.7 34.2 31.5 39.3 16.5 45.3 27.2 31.4 45.5 48.3 19.3 26.5 12.8 32.2 18.6 23.4 19.5 24.3 47.3 16.5 68.5 144.0 64.8 78.5 32.6 65.5 1.4 107.0 85.6 83.0 50.6 58.9 177.4 116.0 154.2 171.3 113.0 197.2 93.5 286.2 162.6 57.3 89.5 62.2 111.9 95.6 52.4 68.5 133.8 57.6 52.3 56.4 56.4 91.1 217.4 74.5 75.0 194.9 143.8 66.1 113.5 78.0 71.1 63.8 41.9 15.5 52.2 120.0 77.8 106.3 110.3 FER1L5 DKFZp434I0121 ENSG00000249715 "Fer-1 like family member 5" A0AVI2 2 96642737-96704887 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 17.9" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 15.5;Late spermatids: 4.2;Spermatocytes: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.4;AF22: 2.0;BJ hTERT+ SV40 Large T+ RasG12V: 1.4;HSkMC: 1.5;NTERA-2: 1.1;U-87 MG: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.11e-2)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" "unprognostic (3.34e-3)" "unprognostic (5.81e-3)" "unprognostic (2.06e-1)" "unprognostic (1.12e-4)" "unprognostic (4.49e-4)" "unprognostic (1.39e-2)" "unprognostic (6.10e-2)" "unprognostic (1.27e-1)" "unprognostic (1.40e-1)" "unprognostic (2.95e-2)" "unprognostic (2.68e-2)" "unprognostic (2.30e-1)" "unprognostic (2.37e-2)" "unprognostic (1.16e-3)" 0.2 0.2 2.8 0.2 3.7 0.2 1.2 2.0 3.2 0.4 0.2 1.5 1.9 0.2 0.4 1.5 0.3 0.8 0.5 0.3 1.6 0.6 0.2 0.5 0.2 0.0 3.8 0.7 1.3 0.3 3.2 0.5 0.4 1.0 0.2 2.0 0.4 3.0 0.2 0.2 0.2 0.3 0.2 0.3 0.3 17.9 0.6 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 1.4 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.0 1.1 0.0 0.0 1.1 0.0 2.7 1.2 0.0 0.0 0.0 1.7 0.4 15.5 0.0 0.0 0.0 0.6 0.0 0.0 0.5 1.1 0.0 0.1 0.0 0.0 0.6 0.0 4.2 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.4 0.0 0.0 0.0 0.1 3.3 1.0 0.0 0.2 0.0 0.0 0.3 FER1L6 C8ORFK23 ENSG00000214814 "Fer-1 like family member 6" Q2WGJ9 8 123851987-124120061 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "stomach 1: 29.3" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 12.4;Late spermatids: 25.1;Pancreatic endocrine cells: 6.3" "Group enriched" "Detected in some" 6 "pancreatic cancer: 4.2;stomach cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.8;ASC TERT1: 5.0;BJ hTERT+: 3.3;PC-3: 4.4;U-87 MG: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA054117 Enhanced NA NA "HPA054117: AB_2682387" "unprognostic (1.90e-1)" "unprognostic (3.08e-3)" "unprognostic (2.06e-3)" "unprognostic (3.91e-2)" "unprognostic (2.09e-1)" "unprognostic (9.49e-3)" "unprognostic (1.36e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (3.32e-2)" "unprognostic (3.23e-6)" "unprognostic (7.09e-2)" "unprognostic (8.43e-2)" "unprognostic (2.79e-3)" "unprognostic (6.39e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.1 1.7 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.4 0.0 3.8 0.0 0.0 0.0 29.3 3.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.8 0.0 0.2 5.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.3 1.3 4.4 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.1 0.0 4.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 0.9 0.0 0.0 0.0 3.9 0.0 6.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 FFAR1 "FFA1R, GPR40" ENSG00000126266 "Free fatty acid receptor 1" O14842 19 35351552-35353862 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.7;brain: 4.1;ovary: 4.8;pancreas: 9.6" "Group enriched" "Detected in some" 4 "granulocytes: 1.1;Intestinal endocrine cells: 1.7" "Cancer enriched" "Detected in single" 13 "pancreatic cancer: 2.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 2.9;HMC-1: 1.4;U-698: 5.5;WM-115: 2.1" "Not detected" "Not detected" NA NA "unprognostic (9.49e-2)" "unprognostic (2.08e-1)" "unprognostic (1.59e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" "unprognostic (4.51e-2)" "unprognostic (1.03e-2)" "unprognostic (4.46e-2)" "unprognostic (6.19e-2)" "unprognostic (9.56e-3)" 0.0 0.0 1.2 0.2 1.6 5.7 0.0 0.0 0.6 0.0 0.0 0.8 0.1 0.0 0.0 0.8 0.0 0.0 1.9 0.9 0.0 0.0 0.1 0.7 1.7 4.8 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 4.1 0.3 1.6 0.1 0.0 0.2 0.0 0.0 1.2 0.5 1.9 0.3 0.7 0.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.4 0.1 0.2 0.4 0.0 0.0 0.1 0.3 0.3 0.9 0.2 0.0 0.1 0.4 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.1 0.7 0.1 0.1 0.0 1.1 0.2 0.0 0.0 0.3 0.1 0.4 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 5.5 0.1 0.2 2.1 1.6 0.3 0.7 0.4 0.2 0.4 0.3 0.3 0.2 0.0 1.2 0.3 0.4 1.9 0.7 0.2 0.5 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 FFAR2 "FFA2R, GPR43" ENSG00000126262 "Free fatty acid receptor 2" O15552 19 35443907-35451767 "G-protein coupled receptors, Predicted membrane proteins" "Immunity, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 60.2;lymphoid tissue: 22.9" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 5.6;Intestinal endocrine cells: 23.2;Kupffer cells: 6.2" "Cancer enhanced" "Detected in many" "prostate cancer: 6.0" "Region enhanced" "Detected in many" "midbrain: 7.0" "Group enriched" "Detected in some" 27 "eosinophil: 18.9;neutrophil: 60.2" "Lineage enriched" "Detected in many" 42 "granulocytes: 60.2" "Cell line enhanced" "Detected in some" "HMC-1: 8.7;OE19: 3.9;SK-BR-3: 2.5;THP-1: 2.7;U-937: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023985 Approved NA NA "HPA023985: AB_1849302" "unprognostic (7.75e-3)" "unprognostic (5.65e-2)" "unprognostic (4.33e-3)" "unprognostic (1.68e-1)" "unprognostic (2.18e-1)" "unprognostic (2.55e-2)" "unprognostic (6.16e-2)" "unprognostic (2.04e-1)" "unprognostic (1.92e-2)" "unprognostic (9.04e-2)" "unprognostic (2.30e-2)" "unprognostic (4.60e-2)" "unprognostic (5.17e-4)" "unprognostic (1.48e-1)" "unprognostic (4.76e-2)" "unprognostic (9.42e-2)" "unprognostic (1.03e-2)" 4.3 0.3 1.1 16.5 0.8 16.7 9.2 0.3 1.8 0.4 1.6 0.2 0.0 3.0 0.5 0.9 1.5 1.3 1.2 1.4 0.9 0.3 0.5 1.6 8.9 15.2 7.0 0.5 0.8 0.4 0.3 0.3 1.9 1.3 1.1 0.5 0.8 0.7 0.0 0.3 0.8 4.1 1.0 1.2 22.9 1.0 0.9 0.3 0.8 0.6 1.2 0.7 2.3 4.6 0.0 0.2 60.2 1.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.3 0.1 8.7 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.8 0.0 1.3 0.1 3.9 0.1 0.1 0.0 0.0 0.0 0.2 1.7 0.1 0.0 2.5 0.1 0.0 0.3 2.7 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.0 3.5 0.0 0.6 0.4 18.9 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 60.2 0.0 1.4 0.0 0.0 0.1 1.1 0.8 0.3 1.8 0.9 0.3 7.0 0.5 1.3 0.3 0.0 5.6 0.0 0.4 0.1 0.0 0.0 0.0 4.0 4.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 5.4 4.7 0.0 4.6 0.0 23.2 0.6 6.2 0.0 0.0 4.9 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.4 1.0 FFAR3 "FFA3R, GPR41" ENSG00000185897 "Free fatty acid receptor 3" O14843 19 35358460-35360485 "G-protein coupled receptors, Predicted membrane proteins" "Immunity, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 6.5;blood: 5.6;lymphoid tissue: 6.1" "Cell type enhanced" "Detected in single" 19 "Macrophages: 1.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 4.7;neutrophil: 5.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.6" "Group enriched" "Detected in some" 5 "ASC diff: 1.2;HHSteC: 3.9;HSkMC: 3.4;U-937: 1.5" HPA044681 Uncertain NA NA "HPA044681: AB_2679043" "unprognostic (1.15e-1)" "unprognostic (5.16e-3)" "unprognostic (1.45e-1)" "unprognostic (3.08e-2)" "unprognostic (1.03e-3)" "unprognostic (2.21e-2)" "unprognostic (4.46e-2)" "unprognostic (1.34e-1)" "unprognostic (1.92e-4)" "unprognostic (3.80e-1)" "unprognostic (1.11e-3)" "unprognostic (1.04e-3)" "unprognostic (2.18e-2)" "unprognostic (3.41e-1)" "unprognostic (3.22e-2)" 6.5 0.0 0.1 6.1 0.3 1.7 3.8 0.0 0.2 0.0 2.1 0.7 0.0 0.0 0.0 0.5 1.1 0.2 0.4 0.2 0.0 0.5 0.6 0.4 0.5 0.3 1.0 0.4 0.5 0.9 0.2 0.1 0.0 0.0 0.0 0.0 0.9 3.7 1.5 2.4 1.3 0.0 0.9 0.0 0.7 0.0 0.0 0.1 5.6 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.4 0.0 0.1 4.7 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FFAR4 "GPR120, GPR129, O3FAR1, PGR4" ENSG00000186188 "Free fatty acid receptor 4" Q5NUL3 10 93566665-93604480 "G-protein coupled receptors, Predicted membrane proteins" "Differentiation, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 15.8;lung: 11.7;pituitary gland: 39.2" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 18.7;Intestinal endocrine cells: 20.1;Mucus-secreting cells: 63.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "OE19: 16.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042563 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA042563: AB_10794762" "unprognostic (1.96e-1)" "unprognostic (1.06e-2)" "unprognostic (1.14e-2)" "unprognostic (4.21e-2)" "unprognostic (2.12e-1)" "unprognostic (4.98e-4)" "unprognostic (1.41e-3)" "unprognostic (1.20e-2)" "unprognostic (2.34e-2)" "unprognostic (7.87e-2)" "unprognostic (9.51e-2)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (5.32e-2)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" 5.2 0.6 1.8 2.8 1.7 0.2 1.9 0.1 2.6 0.2 11.3 1.1 0.0 0.7 0.1 0.1 0.4 1.4 2.6 1.2 0.9 1.6 0.3 0.6 11.7 1.3 0.6 1.0 0.3 1.1 0.1 39.2 0.4 0.8 0.2 15.8 0.3 0.9 0.1 0.5 1.3 1.0 0.3 2.6 0.2 0.7 2.0 0.9 0.7 0.2 0.0 0.6 0.3 0.2 0.5 3.4 1.3 3.0 0.7 0.3 0.8 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.4 0.4 0.1 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.1 16.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 3.0 0.2 0.3 0.6 0.2 0.4 0.2 0.2 3.4 0.5 0.2 0.3 1.3 0.7 0.4 0.4 0.1 0.8 1.8 1.7 0.1 2.6 0.9 1.6 0.6 1.0 0.8 0.9 0.0 0.3 0.0 0.4 0.0 0.0 0.3 12.7 0.0 1.2 0.0 0.0 0.1 0.0 0.6 18.7 0.1 6.5 0.0 0.0 0.5 0.2 0.3 0.0 0.0 7.8 0.0 20.1 0.0 3.2 12.2 0.6 3.8 1.7 0.0 63.6 0.0 1.4 9.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.2 FGF10 ENSG00000070193 "Fibroblast growth factor 10" O15520 5 44303544-44389706 "Disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Disease mutation, Ectodermal dysplasia, Lacrimo-auriculo-dento-digital syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 26.4" "Group enriched" "Detected in some" 8 "Leydig cells: 7.8;Muller glia cells: 5.2;Peritubular cells: 9.9" "Cancer enriched" "Detected in some" 6 "breast cancer: 5.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "AF22: 34.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB010315 Uncertain "Secreted in other tissues" NA NA "CAB010315: AB_2262731" "unprognostic (1.40e-1)" "unprognostic (1.25e-1)" "unprognostic (8.54e-2)" "unprognostic (1.08e-1)" "unprognostic (3.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.54e-2)" "unprognostic (4.06e-3)" "unprognostic (2.72e-2)" "unprognostic (6.73e-2)" "unprognostic (5.59e-2)" "unprognostic (4.55e-2)" "unprognostic (1.24e-2)" "unprognostic (1.11e-2)" "unprognostic (2.14e-2)" "unprognostic (5.23e-4)" 10.5 1.8 0.2 3.4 1.2 0.0 13.1 0.6 1.9 15.5 6.1 0.4 2.1 0.2 3.1 17.2 3.8 5.4 5.0 4.2 0.2 0.5 0.9 0.1 2.5 1.8 1.0 0.3 26.4 5.4 0.0 5.4 7.7 1.4 11.7 2.0 3.2 6.8 4.2 0.7 0.9 2.5 11.0 1.7 0.1 4.4 6.2 0.4 0.2 5.0 8.6 0.8 9.3 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.7 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.6 1.9 0.2 0.5 1.0 0.3 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 5.2 0.5 0.0 9.9 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FGF19 ENSG00000162344 "Fibroblast growth factor 19" O95750 11 69698232-69704642 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "gallbladder: 62.4" "Cell type enriched" "Detected in some" 5 "Cholangiocytes: 38.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "CAPAN-2: 47.6" "Region enhanced" "Detected in single" "basal ganglia: 0.8" "Region enriched" "Detected in single" 19 "basal ganglia: 0.9" HPA036082 Approved "Secreted to blood" NA NA 133000 "HPA036082: AB_10669665" "unprognostic (7.46e-3)" "unprognostic (2.43e-3)" "unprognostic (5.52e-3)" "unprognostic (1.22e-1)" "unprognostic (4.68e-3)" "unprognostic (6.45e-2)" "unprognostic (5.72e-3)" "unprognostic (2.26e-1)" "unprognostic (6.39e-3)" "unprognostic (1.66e-2)" "unprognostic (8.82e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.4 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.4 38.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 1.1 0.0 0.0 0.1 1.6 FGF4 "HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF" ENSG00000075388 "Fibroblast growth factor 4" P08620 11 69771016-69775403 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6;intestine: 1.6;testis: 2.4;tongue: 2.0" "Cell type enhanced" "Detected in single" 28 "Early spermatids: 2.3" "Cancer enriched" "Detected in some" 5 "testis cancer: 13.9" "Group enriched" "Detected in some" 19 "midbrain: 2.6;pons and medulla: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 64 "NTERA-2: 18.6;SuSa: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA011209 Uncertain "Secreted in other tissues" NA NA 326000 "HPA011209: AB_1848527" "unprognostic (1.47e-2)" "unprognostic (6.22e-2)" "unprognostic (7.77e-2)" "unprognostic (8.56e-2)" 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 1.2 0.8 0.1 2.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 FGF6 ENSG00000111241 "Fibroblast growth factor 6" P10767 12 4428155-4445614 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "skeletal muscle: 24.6;tongue: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NB-4: 1.7;NTERA-2: 6.2;REH: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (4.29e-2)" 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.9 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.7 6.2 0.0 0.0 6.6 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 FGF7 KGF ENSG00000140285 "Fibroblast growth factor 7" P21781 15 49423096-49488775 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 101.2;Fibroblasts: 91.0;Leydig cells: 77.1;Smooth muscle cells: 82.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 24.2;ASC TERT1: 22.3;fHDF/TERT166: 10.0;HSkMC: 22.6;RH-30: 18.0;U-138 MG: 12.2" "Region enriched" "Detected in single" 9 "cerebellum: 9.7" HPA043605 Uncertain Approved Nucleoplasm,Nucleoli "Secreted in other tissues" NA NA "Nucleoplasm, Nucleoli" "HPA043605: AB_10960215" "unprognostic (4.65e-1)" "unprognostic (7.62e-2)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (3.62e-2)" "unprognostic (5.74e-3)" "unprognostic (2.56e-2)" "unprognostic (7.30e-2)" "unprognostic (5.79e-2)" "unprognostic (1.91e-3)" "unprognostic (1.22e-3)" "unprognostic (7.59e-2)" "unprognostic (1.98e-3)" "unprognostic (1.63e-3)" 39.7 2.7 0.6 9.9 0.6 0.0 16.5 0.6 2.4 73.3 22.2 0.0 10.1 1.1 13.1 16.1 25.2 14.1 25.4 19.1 0.6 0.6 5.9 1.2 44.8 5.5 2.1 0.0 43.7 2.5 2.9 2.8 9.1 0.8 42.5 4.5 2.7 6.4 8.1 25.6 3.6 4.2 38.3 1.4 1.0 6.6 12.7 0.0 0.0 23.2 24.7 2.9 72.2 32.4 0.2 0.1 1.6 0.2 0.3 0.5 0.0 0.1 0.0 0.1 0.1 24.2 22.3 0.0 7.3 4.5 0.0 0.0 0.0 0.1 0.0 0.1 10.0 0.2 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.1 0.0 22.6 0.4 1.9 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 18.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 0.1 0.1 0.1 0.1 12.2 0.2 0.4 0.0 0.2 0.1 0.0 3.3 0.0 0.2 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.5 0.2 0.0 0.3 0.2 0.1 0.4 0.0 0.6 0.6 0.6 0.6 0.6 0.6 2.1 0.0 0.8 0.0 11.9 13.4 0.9 13.5 12.8 7.9 40.0 5.1 0.0 0.0 8.7 2.0 4.7 101.2 1.1 2.8 5.3 0.0 0.0 0.6 3.8 91.0 9.0 1.1 2.5 1.8 3.2 0.0 0.0 1.0 3.1 77.1 3.1 6.8 0.0 0.0 7.3 0.6 0.0 4.6 24.5 6.0 6.5 82.4 0.3 0.1 11.0 2.4 1.0 0.0 7.1 FGFR1 "BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM" ENSG00000077782 "Fibroblast growth factor receptor 1" P11362 8 38411138-38468834 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Transcription, Transcription regulation" "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease mutation, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 177.8;Muller glia cells: 106.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 111.2;BJ hTERT+: 50.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033614, HPA056402" Approved NA NA 120000000 "CAB033614: AB_783377, HPA056402: AB_2683118" "unprognostic (9.53e-2)" "unprognostic (7.33e-2)" "unprognostic (2.44e-1)" "unprognostic (1.35e-2)" "unprognostic (4.23e-3)" "unprognostic (7.02e-2)" "unprognostic (6.59e-2)" "unprognostic (2.77e-1)" "unprognostic (1.81e-1)" "unprognostic (3.99e-2)" "unprognostic (7.97e-3)" "unprognostic (4.59e-2)" "unprognostic (7.69e-2)" "unprognostic (6.87e-3)" "unprognostic (5.60e-2)" "unprognostic (4.59e-3)" "unprognostic (1.05e-3)" 41.1 8.6 12.5 14.5 12.2 7.2 39.5 45.0 10.5 36.0 31.5 10.1 11.6 5.5 29.3 20.6 22.9 29.4 32.4 31.7 12.8 10.1 11.8 5.4 18.6 9.7 11.4 14.3 42.0 51.2 11.5 22.3 28.4 20.0 28.2 10.8 35.8 14.0 31.6 12.0 12.9 14.4 52.4 15.6 4.5 16.4 16.4 8.5 11.3 12.6 13.0 9.8 39.6 41.2 1.6 0.7 1.8 1.1 0.8 5.7 0.7 2.4 9.4 41.1 111.2 25.5 18.2 27.1 25.3 50.7 17.6 18.4 6.1 1.4 0.3 7.0 24.2 22.6 0.0 19.4 1.2 20.4 6.6 4.3 0.0 1.6 6.0 14.4 5.9 0.1 16.5 0.1 14.3 2.9 9.5 16.9 1.4 2.3 0.1 8.3 2.9 17.4 2.0 28.9 0.3 3.9 16.0 4.3 0.0 8.5 0.0 1.6 3.6 4.5 0.2 1.0 21.5 2.3 1.1 10.6 11.5 6.4 31.8 6.0 0.4 0.8 0.0 13.6 0.3 6.0 1.4 1.1 0.4 5.7 0.3 3.9 0.7 2.7 3.7 0.1 1.6 1.5 4.1 1.8 0.8 0.5 0.7 2.2 0.7 12.5 12.2 45.0 10.5 12.8 10.1 11.4 14.3 20.0 8.5 3.0 12.0 0.0 68.4 27.9 1.3 48.2 17.8 1.4 9.1 8.7 3.9 6.5 0.0 23.4 14.2 57.3 0.0 0.0 56.3 69.1 85.6 80.3 8.1 0.9 19.7 20.6 24.0 47.3 3.2 9.3 177.8 7.5 32.1 2.8 0.0 106.2 29.8 0.0 93.7 8.0 2.4 12.9 68.0 1.4 11.3 17.2 8.7 6.4 0.4 8.4 FGFR2 "BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25" ENSG00000066468 "Fibroblast growth factor receptor 2" P21802 10 121478334-121598458 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.8" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 191.1;Club cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 10.8;eosinophil: 4.6" "Lineage enriched" "Detected in single" 35 "granulocytes: 10.8" "Cell line enhanced" "Detected in some" "AN3-CA: 58.9;BEWO: 19.8;CACO-2: 15.4;HaCaT: 17.8;HAP1: 19.1;NTERA-2: 18.9;T-47d: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010886, HPA035305" Uncertain Supported "Nucleoplasm,Vesicles,Cell Junctions" "Secreted - unknown location" NA NA 500000 "Cell Junctions" "Nucleoplasm, Vesicles" "CAB010886: AB_259379, HPA035305: AB_10672862" "unprognostic (5.53e-2)" "prognostic favorable (8.79e-4)" "unprognostic (1.08e-1)" "unprognostic (5.23e-2)" "unprognostic (1.73e-1)" "prognostic favorable (9.32e-4)" "unprognostic (1.53e-1)" "unprognostic (4.96e-3)" "unprognostic (1.74e-1)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "unprognostic (2.54e-1)" "unprognostic (6.93e-2)" "unprognostic (2.25e-1)" 2.1 8.8 16.4 3.0 30.3 0.0 9.9 15.8 21.3 6.8 14.1 55.7 5.6 4.2 22.0 6.6 10.2 12.5 12.5 1.4 20.6 11.1 11.4 16.1 13.1 1.0 41.2 13.3 7.4 12.8 25.5 2.5 6.2 30.2 11.7 8.7 16.4 23.8 24.3 0.4 45.4 4.7 18.3 74.8 0.5 9.3 2.9 32.1 0.8 23.4 1.6 3.4 6.9 8.5 0.1 0.1 10.8 0.1 0.1 0.3 0.0 2.2 0.1 9.2 58.9 0.0 0.0 19.8 0.1 0.0 0.0 0.0 15.4 0.3 0.0 4.2 0.9 0.0 17.8 19.1 4.0 0.0 0.0 4.1 0.0 0.0 0.3 0.4 0.0 3.8 0.0 8.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 18.9 2.7 0.0 0.0 0.0 2.3 5.7 5.0 0.1 0.1 0.1 10.8 0.0 11.5 15.8 0.0 0.0 0.1 2.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 10.8 0.1 4.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 16.4 30.3 15.8 21.3 20.6 11.1 41.2 13.3 30.2 32.1 17.9 31.8 0.0 29.5 35.6 0.0 2.7 191.1 18.7 52.4 34.9 0.0 12.6 0.0 4.0 2.9 0.5 2.6 0.0 0.2 2.7 17.5 9.8 0.0 4.3 2.0 0.0 2.4 3.1 0.3 6.5 1.1 1.3 5.0 1.0 32.0 1.6 0.6 1.4 5.6 11.5 0.1 0.0 2.1 0.9 7.7 24.2 3.3 1.5 3.0 27.7 FGFR3 "ACH, CD333, CEK2, JTK4" ENSG00000068078 "Fibroblast growth factor receptor 3" P22607 4 1793293-1808872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Apoptosis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skin 1: 131.7" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 92.2;Cholangiocytes: 94.3;Suprabasal keratinocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 19.3;HaCaT: 15.1;Hep G2: 32.5;NTERA-2: 15.8;RT4: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004231, HPA067204" Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 670000 "Endoplasmic reticulum" "CAB004231: AB_627596, HPA067204: AB_2685804" "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (5.90e-2)" "unprognostic (1.24e-3)" "unprognostic (7.22e-2)" "unprognostic (2.54e-1)" "unprognostic (1.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.38e-1)" "unprognostic (2.88e-2)" "unprognostic (1.30e-1)" "unprognostic (9.11e-3)" "unprognostic (1.98e-1)" "unprognostic (4.74e-2)" "unprognostic (1.97e-1)" 1.5 1.5 24.7 1.7 30.3 1.6 4.2 10.2 22.0 4.1 4.9 15.8 3.4 9.9 1.8 2.7 26.9 2.0 5.0 2.0 21.6 11.7 9.6 7.4 4.5 1.3 17.6 21.5 1.1 23.0 1.2 3.0 5.6 15.1 3.7 3.8 1.7 3.8 9.0 1.7 131.7 7.4 1.3 9.0 2.1 4.9 8.1 10.6 0.1 1.3 8.5 7.3 8.5 10.1 0.1 0.6 0.1 0.1 0.2 0.3 0.0 0.0 1.5 9.2 2.6 0.0 0.1 9.4 1.1 0.1 0.4 0.2 19.3 0.4 0.0 7.7 0.3 0.4 15.1 2.6 0.1 0.1 0.1 9.7 6.0 1.5 32.5 0.0 0.0 0.2 0.0 5.1 0.1 0.0 0.0 0.0 0.9 6.5 0.0 0.0 9.6 0.4 0.2 15.8 8.8 0.0 0.5 0.5 0.1 1.3 19.3 2.7 0.7 0.8 1.6 0.0 11.1 9.0 1.1 0.4 0.0 0.9 0.2 0.6 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.6 0.1 0.0 24.7 30.3 10.2 22.0 21.6 11.7 17.6 21.5 15.1 10.6 0.0 23.8 2.4 3.6 92.2 0.0 2.0 94.3 0.0 21.6 14.0 0.0 0.4 0.0 4.8 5.4 0.9 20.6 0.0 0.6 9.2 7.0 3.3 0.0 27.0 0.5 0.0 4.1 14.7 1.2 0.4 0.6 1.2 11.8 1.0 20.7 0.2 0.4 17.3 0.4 7.5 0.6 0.0 2.8 0.4 17.9 77.5 0.7 0.0 13.0 11.8 FGFR4 "CD334, JTK2" ENSG00000160867 "Fibroblast growth factor receptor 4" P22455 5 177086886-177098144 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 33.6;kidney: 37.7;liver: 45.3" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 50.9;Hepatocytes: 23.7;Proximal tubular cells: 19.5;Sertoli cells: 19.4;Undifferentiated cells: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "CACO-2: 43.0;Hep G2: 43.0;RH-30: 69.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005196, HPA027273, HPA027369, HPA028251" Approved "Intracellular and membrane" NA NA 4300000 "CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221" "unprognostic (1.96e-1)" "unprognostic (2.10e-2)" "unprognostic (1.12e-1)" "unprognostic (9.06e-3)" "unprognostic (2.87e-1)" "unprognostic (1.95e-2)" "unprognostic (7.85e-3)" "unprognostic (9.19e-2)" "unprognostic (4.25e-1)" "unprognostic (4.46e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (1.78e-1)" "unprognostic (1.71e-3)" "unprognostic (2.41e-1)" "unprognostic (5.75e-2)" "unprognostic (4.68e-2)" 0.5 5.7 0.7 14.3 0.6 0.1 1.6 2.6 0.5 2.8 10.4 0.9 0.7 13.5 0.9 4.8 1.6 1.7 33.6 0.7 0.8 0.3 37.7 45.3 25.3 2.5 0.7 1.0 13.6 26.0 0.0 0.7 1.3 0.8 4.0 3.7 2.0 1.6 0.3 4.3 0.5 17.3 1.6 0.8 11.2 5.4 2.9 0.4 0.3 0.8 2.3 0.7 1.9 3.6 1.1 0.9 3.0 1.1 0.4 0.4 0.0 0.7 12.1 0.2 2.9 0.0 0.0 5.9 0.0 0.0 0.0 0.0 43.0 1.6 1.3 5.6 0.0 0.6 0.6 2.4 0.4 0.0 0.7 2.8 0.1 0.6 43.0 1.3 0.1 1.0 0.2 0.0 2.1 0.0 0.0 0.0 0.8 4.0 0.1 0.9 9.8 0.0 0.8 7.3 7.6 1.0 1.9 69.1 7.2 5.8 0.1 0.4 0.7 0.4 3.1 1.4 1.6 2.9 0.6 0.2 0.0 5.8 0.0 0.1 0.4 0.4 0.7 0.0 0.2 0.5 1.5 1.1 0.4 0.4 0.3 0.3 1.1 0.4 0.0 0.1 0.6 0.4 0.4 3.0 0.4 0.3 0.9 0.2 0.0 0.7 0.6 2.6 0.5 0.8 0.3 0.7 1.0 0.8 0.4 0.0 0.0 0.8 0.6 0.6 0.4 0.8 50.9 0.0 0.0 3.5 0.0 1.1 3.3 8.4 0.1 0.1 10.6 0.0 4.4 3.2 1.7 0.3 0.0 23.7 0.3 0.0 4.1 2.5 0.8 0.0 0.6 0.0 0.0 1.0 5.2 0.9 3.6 2.9 1.4 19.5 0.1 19.4 0.5 1.6 12.8 0.4 7.3 0.0 33.6 0.6 FGFRL1 ENSG00000127418 "Fibroblast growth factor receptor like 1" Q8N441 4 1009936-1026897 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 51.1" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 29.6;Muller glia cells: 87.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.5;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;monocytes: 3.6;T-cells: 1.2" "Cell line enhanced" "Detected in many" "U-251 MG: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB026019, HPA068828" Approved Supported Vesicles No No Vesicles "CAB026019: , HPA068828: AB_2686043" "unprognostic (1.30e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "unprognostic (2.80e-2)" "unprognostic (1.23e-2)" "unprognostic (1.48e-1)" "unprognostic (2.62e-2)" "unprognostic (9.79e-2)" "unprognostic (4.87e-3)" "unprognostic (8.46e-2)" "unprognostic (2.01e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-3)" "unprognostic (1.49e-1)" "unprognostic (7.80e-2)" "unprognostic (1.06e-2)" "unprognostic (1.96e-2)" 21.8 22.9 16.0 6.1 20.5 5.8 21.5 13.8 20.6 8.1 6.6 9.1 5.3 6.6 6.6 5.0 4.7 19.7 9.8 12.2 16.6 3.6 11.5 25.1 6.4 4.0 8.8 8.4 14.0 51.1 12.6 9.0 3.1 17.0 7.6 4.8 12.7 29.3 3.1 9.6 3.7 6.0 4.1 14.0 5.3 15.0 3.2 11.1 1.0 33.8 3.9 3.6 6.2 11.5 0.4 0.3 1.2 3.6 0.1 1.2 0.4 8.5 11.6 4.2 12.8 4.5 4.7 1.1 15.2 2.3 4.9 3.2 8.4 17.7 0.9 19.8 23.2 22.0 2.2 8.1 5.1 4.5 3.2 7.9 0.1 15.2 22.1 9.2 4.9 2.1 9.9 4.4 8.4 3.6 18.3 4.6 3.4 9.3 3.3 2.9 11.1 5.7 13.5 5.3 14.4 31.6 9.4 6.2 6.0 8.5 1.3 0.4 0.8 14.1 0.3 5.6 5.3 8.4 4.3 9.9 26.2 10.7 13.2 36.8 3.6 4.8 1.3 6.9 5.7 8.4 1.2 0.1 0.0 0.7 3.5 0.1 0.4 1.2 0.2 0.3 0.1 0.2 0.5 0.0 0.1 3.6 0.3 0.1 0.4 16.0 20.5 13.8 20.6 16.6 3.6 8.8 8.4 17.0 11.1 3.0 5.5 0.5 2.9 5.8 4.7 7.5 7.6 9.4 4.5 7.0 0.0 1.2 0.0 8.0 0.2 2.2 3.2 0.0 8.9 16.2 4.6 8.6 1.1 29.6 2.6 0.0 1.7 4.9 2.1 1.0 4.0 2.9 6.8 1.0 8.1 87.5 15.6 3.5 3.2 6.2 5.1 0.0 4.2 0.2 2.2 4.1 1.3 2.5 3.2 5.1 FGG ENSG00000171557 "Fibrinogen gamma chain" P02679 4 154604134-154612967 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 495 "liver: 2225.7" "Cell type enriched" "Detected in many" 15 "Hepatocytes: 7797.1" "Cancer enriched" "Detected in many" 19 "liver cancer: 1503.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 55 "Hep G2: 128.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027529, CAB033120, HPA074638" Supported Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 267000000000 68000000000 "Endoplasmic reticulum" "CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: " "unprognostic (1.26e-2)" "unprognostic (4.77e-3)" "unprognostic (6.33e-3)" "unprognostic (3.69e-3)" "unprognostic (2.18e-3)" "unprognostic (9.63e-2)" "unprognostic (7.57e-3)" "prognostic unfavorable (1.00e-6)" "unprognostic (1.75e-3)" "unprognostic (3.21e-1)" "unprognostic (1.14e-1)" 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 2.7 2225.7 4.4 0.0 0.0 0.0 0.2 0.7 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 128.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 17.9 218.6 146.9 0.0 0.0 0.0 0.2 507.0 2.7 4.5 0.0 0.0 0.0 0.0 3.8 2.8 0.0 0.0 327.1 40.0 0.1 0.0 0.0 10.5 7797.1 0.2 0.0 0.0 232.7 240.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 266.1 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.6 0.0 0.3 20.1 0.0 0.0 FIBCD1 FLJ14810 ENSG00000130720 "Fibrinogen C domain containing 1" Q8N539 9 130902438-130939286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;parathyroid gland: 10.7;testis: 9.5" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 14.5;Exocrine glandular cells: 27.4;Late spermatids: 25.9;Mucus-secreting cells: 12.2;Pancreatic endocrine cells: 16.7;Spermatogonia: 15.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 11 "hippocampal formation: 19.2" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 5.7" "Lineage enriched" "Detected in single" 11 "monocytes: 5.7" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 9.4;MCF7: 21.2;OE19: 15.0;RPTEC TERT1: 16.5;THP-1: 8.2;U-2 OS: 11.3;U-251 MG: 9.2" "Group enriched" "Detected in many" 4 "basal ganglia: 18.2;hippocampal formation: 75.0" "Region enriched" "Detected in many" 4 "hippocampal formation: 81.5" HPA055353 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA055353: AB_2682791" "unprognostic (1.18e-3)" "unprognostic (2.70e-1)" "unprognostic (4.69e-2)" "unprognostic (5.63e-2)" "unprognostic (9.11e-2)" "unprognostic (1.62e-1)" "unprognostic (4.16e-5)" "unprognostic (1.83e-3)" "unprognostic (3.14e-1)" "unprognostic (1.28e-1)" "unprognostic (2.05e-2)" "unprognostic (4.45e-2)" "unprognostic (1.42e-6)" "unprognostic (1.66e-1)" "unprognostic (5.53e-2)" "unprognostic (6.68e-3)" "unprognostic (2.77e-1)" 0.0 8.5 1.7 0.1 1.1 0.0 1.1 0.1 3.0 0.0 1.8 0.3 0.0 0.5 0.0 1.4 0.4 0.0 5.0 2.0 19.2 1.2 0.0 0.0 5.3 0.0 0.6 0.0 0.4 0.0 10.7 0.0 1.7 1.5 1.0 1.4 1.1 1.6 0.0 0.0 0.0 1.6 2.1 0.0 0.8 0.1 9.5 0.8 0.0 0.3 0.0 0.0 2.9 0.0 0.0 0.5 0.0 5.7 0.0 0.0 0.2 0.2 2.3 0.8 0.0 0.0 0.0 0.0 5.0 5.9 0.3 0.8 0.0 2.5 0.0 1.8 0.2 4.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.2 0.2 0.0 0.1 2.7 0.0 9.4 0.0 0.0 0.6 0.0 0.0 21.2 0.0 2.2 1.5 15.0 0.5 0.0 4.4 0.3 16.5 0.0 0.1 0.0 0.7 0.0 0.5 0.7 1.3 8.2 0.0 0.9 11.3 0.1 9.2 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.2 1.7 1.1 0.1 1.0 19.2 1.2 0.6 0.0 1.5 0.8 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 1.8 0.0 7.7 0.0 0.3 14.5 0.1 4.7 0.0 27.4 0.4 1.8 0.7 0.0 0.0 0.9 3.2 0.0 0.0 0.0 25.9 0.6 0.0 0.0 0.0 12.2 0.8 16.7 3.5 3.2 0.0 0.1 0.0 0.3 1.1 15.1 0.0 3.3 0.0 4.7 1.7 FICD "HIP13, HYPE" ENSG00000198855 "FIC domain containing" Q9BVA6 12 108515185-108525837 "Enzymes, Predicted intracellular proteins" "Unfolded protein response" "Hydrolase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 65.6;Late spermatids: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021390, HPA071134" Approved Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA021390: AB_1851340, HPA071134: AB_2686347" "unprognostic (1.00e-1)" "unprognostic (8.76e-2)" "unprognostic (1.76e-2)" "prognostic favorable (4.61e-5)" "unprognostic (6.92e-2)" "unprognostic (2.68e-2)" "unprognostic (5.73e-2)" "unprognostic (2.84e-2)" "unprognostic (8.68e-2)" "unprognostic (2.57e-1)" "unprognostic (3.15e-2)" "unprognostic (1.19e-1)" "unprognostic (7.66e-2)" "unprognostic (1.56e-2)" "unprognostic (6.22e-2)" "unprognostic (3.12e-2)" "unprognostic (3.65e-2)" 4.2 9.6 5.6 6.1 8.2 3.0 4.5 4.0 6.7 8.5 3.8 7.3 10.5 3.9 4.6 15.8 2.3 4.1 4.1 3.5 5.4 5.9 5.2 16.4 5.0 4.9 8.9 5.1 4.8 27.9 4.8 15.3 7.9 6.0 6.1 3.6 10.2 19.7 7.9 2.6 3.4 3.3 4.6 7.5 4.8 5.1 8.5 6.6 5.4 13.6 1.0 6.2 4.1 4.5 5.0 15.2 10.9 5.4 3.1 8.0 1.8 1.9 4.8 2.0 3.9 4.7 3.3 5.4 12.7 6.7 6.0 4.2 3.0 1.9 2.7 4.8 6.0 7.1 2.5 2.1 1.4 5.3 4.5 3.1 1.5 3.7 4.2 18.5 2.2 5.7 1.5 3.0 8.4 12.1 7.4 4.3 2.5 1.0 9.1 5.3 4.4 2.9 2.3 2.1 2.0 8.0 1.7 2.6 6.5 2.8 3.8 1.9 1.3 5.7 2.7 6.2 3.0 4.2 2.2 4.8 6.2 2.2 10.8 4.8 18.2 2.9 0.9 8.5 2.0 4.3 10.9 2.8 4.2 6.8 4.8 8.0 5.0 5.0 6.2 2.7 3.3 2.9 5.6 5.5 3.1 5.4 15.2 3.1 1.8 5.6 8.2 4.0 6.7 5.4 5.9 8.9 5.1 6.0 6.6 0.0 3.0 1.5 2.9 0.7 5.2 1.7 5.1 2.7 0.0 7.0 2.0 4.9 5.0 3.7 65.6 3.7 1.6 0.0 8.1 3.9 4.7 7.7 13.8 4.9 5.7 12.7 1.7 4.9 1.8 37.2 3.1 4.7 6.8 3.6 2.5 14.7 7.6 0.8 9.2 1.8 8.3 12.9 2.7 7.2 6.8 2.9 26.0 4.5 1.6 4.2 FIG4 "ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3" ENSG00000112367 "FIG4 phosphoinositide 5-phosphatase" Q92562 6 109691312-109825428 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017823, HPA068859" Approved Supported "Vesicles,Lipid droplets" NA NA "Vesicles, Lipid droplets" "CAB017823: , HPA068859: AB_2686049" "prognostic unfavorable (5.91e-4)" "unprognostic (4.12e-2)" "prognostic favorable (8.42e-4)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.73e-4)" "unprognostic (7.06e-2)" "unprognostic (2.69e-1)" "unprognostic (8.67e-2)" "unprognostic (3.44e-3)" "unprognostic (4.22e-2)" "prognostic favorable (8.19e-4)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (5.45e-2)" "unprognostic (2.00e-2)" 11.0 13.5 14.5 12.2 30.3 14.0 14.4 13.5 35.3 12.4 13.2 11.0 5.0 8.3 11.3 17.0 11.7 10.5 13.4 10.1 14.5 18.5 13.2 8.7 19.2 16.6 17.6 17.7 12.2 9.9 25.4 15.4 12.6 19.0 11.6 14.6 9.7 17.0 12.0 12.1 9.2 10.7 14.7 16.0 17.3 11.4 12.6 12.9 18.1 12.6 8.5 15.0 12.5 10.5 15.5 15.9 12.8 20.0 8.0 7.7 9.8 6.2 6.5 9.8 11.7 10.4 14.4 6.2 8.1 11.7 6.7 18.0 4.8 6.6 16.8 5.2 13.1 12.4 4.7 9.6 6.4 15.6 10.2 11.7 9.4 6.5 4.8 9.6 8.8 8.4 7.4 8.4 11.4 7.9 17.2 13.6 11.1 5.5 7.2 9.4 5.8 9.0 7.6 5.1 9.3 3.2 6.3 4.5 5.8 11.3 15.5 10.9 10.2 5.3 7.8 16.4 12.5 5.6 14.7 9.5 4.2 3.6 6.1 6.9 3.4 2.4 8.1 22.3 6.3 3.8 11.5 20.0 12.8 7.7 19.7 6.0 14.6 5.7 7.3 15.9 15.5 7.0 6.8 8.7 8.0 13.5 6.9 6.6 9.8 14.5 30.3 13.5 35.3 14.5 18.5 17.6 17.7 19.0 12.9 14.9 7.0 5.9 6.5 4.0 6.1 5.1 5.1 9.4 4.5 8.7 2.0 11.5 5.0 8.9 13.3 5.0 5.3 0.0 9.9 5.8 4.4 4.5 8.1 3.8 20.0 1.6 9.8 6.2 20.5 13.8 3.1 13.5 8.5 9.0 8.8 7.5 6.8 6.8 6.3 6.3 6.0 0.0 6.6 4.9 11.7 3.9 10.3 10.7 6.1 7.6 FIS1 "CGI-135, Fis1, H_NH0132A01.6, TTC11" ENSG00000214253 "Fission, mitochondrial 1" Q9Y3D6 7 101239458-101252316 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017430 Approved Supported Mitochondria NA NA 590000 Mitochondria "HPA017430: AB_1848608" "unprognostic (1.45e-2)" "unprognostic (8.20e-2)" "unprognostic (4.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.48e-2)" "unprognostic (1.63e-1)" "unprognostic (7.73e-2)" "unprognostic (6.54e-2)" "unprognostic (5.33e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-3)" "unprognostic (3.47e-2)" "prognostic favorable (1.08e-7)" "unprognostic (1.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" 35.1 46.8 53.4 22.3 49.9 32.7 35.8 26.0 60.0 30.3 34.4 57.9 38.0 30.0 31.1 42.7 35.6 47.0 39.4 78.6 52.6 44.8 39.6 58.3 27.8 23.6 65.3 37.8 41.2 56.6 39.5 37.1 34.0 45.1 29.3 26.3 28.8 45.2 43.8 120.5 29.7 29.2 32.4 87.9 28.1 31.1 30.4 44.1 21.3 47.1 48.8 22.6 30.5 29.3 73.0 73.4 63.6 67.4 55.6 72.8 87.9 25.0 29.5 22.1 31.7 25.6 34.2 15.1 27.2 33.1 24.9 21.5 20.3 41.2 24.5 36.3 37.3 22.8 14.8 15.4 43.9 13.9 19.0 22.4 11.1 42.9 26.9 30.5 20.7 17.3 32.6 41.4 17.3 26.7 28.0 44.9 13.6 23.3 33.7 37.4 115.0 32.2 37.4 24.5 50.6 28.7 15.8 12.4 53.8 37.6 29.0 28.7 33.6 13.0 62.5 18.4 20.3 20.8 23.5 36.8 29.2 18.8 30.2 28.9 28.6 21.8 14.1 27.1 23.6 38.1 58.9 67.4 63.6 63.2 65.5 65.1 72.2 61.0 59.7 73.4 73.0 60.7 63.5 51.4 55.6 59.0 61.4 72.8 87.9 53.4 49.9 26.0 60.0 52.6 44.8 65.3 37.8 45.1 44.1 95.3 100.9 113.2 110.6 93.2 42.7 311.2 216.6 109.7 67.1 218.1 15.7 209.3 475.9 225.3 158.1 164.5 399.5 537.3 254.1 253.9 149.0 192.6 133.9 365.3 254.4 33.4 210.7 152.2 158.6 575.1 179.5 136.4 207.5 212.0 223.3 159.0 210.6 475.1 168.3 613.6 43.3 97.0 162.7 157.3 182.7 118.6 271.1 129.8 226.8 173.1 FITM1 FIT1 ENSG00000139914 "Fat storage inducing transmembrane protein 1" A5D6W6 14 24131275-24132849 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 56.1;skeletal muscle: 94.7;tongue: 79.9" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 228.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 17 "RH-30: 27.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA019842 Uncertain NA NA "HPA019842: AB_1853025" "unprognostic (1.81e-2)" "unprognostic (4.29e-7)" "unprognostic (2.77e-1)" "unprognostic (2.02e-3)" "unprognostic (2.24e-2)" "unprognostic (6.68e-2)" "prognostic favorable (1.00e-3)" "unprognostic (1.20e-4)" "unprognostic (4.57e-1)" "unprognostic (2.12e-2)" "unprognostic (2.84e-2)" "unprognostic (3.68e-2)" "unprognostic (2.47e-1)" "unprognostic (2.86e-2)" "unprognostic (5.62e-1)" "unprognostic (1.96e-1)" "unprognostic (2.12e-3)" 0.8 1.7 0.0 0.2 0.0 0.6 0.3 0.4 0.2 0.2 0.3 0.0 0.0 0.5 0.2 2.2 1.2 0.2 0.2 56.1 0.0 0.0 0.2 13.1 0.2 0.3 0.0 0.0 0.2 11.9 0.2 0.2 0.2 0.0 0.7 0.2 0.1 2.9 0.3 94.7 0.5 0.4 0.2 0.0 2.5 0.3 0.3 0.0 0.0 0.5 79.9 3.6 0.3 0.0 0.8 0.3 0.0 1.1 0.4 1.5 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.6 0.1 0.0 0.7 0.7 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.2 0.3 0.0 0.0 0.3 0.2 27.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.5 1.1 0.3 0.2 1.1 1.5 0.3 0.8 0.6 0.6 0.0 0.4 0.4 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.4 228.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 1.9 0.3 2.0 0.0 2.6 0.1 0.5 0.4 0.0 26.1 0.2 0.0 1.2 0.6 1.5 2.7 0.0 0.1 0.0 1.0 1.0 0.8 1.1 0.0 0.7 0.1 0.3 0.0 0.4 1.2 0.2 0.5 0.6 0.8 0.8 0.1 FITM2 "C20orf142, dJ881L22.2, FIT2" ENSG00000197296 "Fat storage inducing transmembrane protein 2" Q8N6M3 20 44302838-44311169 "Predicted membrane proteins" "Deafness, Disease mutation, Dystonia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "heart muscle: 56.7" "Cell type enriched" "Detected in many" 9 "Cardiomyocytes: 134.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.92e-2)" "unprognostic (7.61e-2)" "unprognostic (2.27e-2)" "unprognostic (2.10e-3)" "unprognostic (1.02e-1)" "unprognostic (3.57e-3)" "unprognostic (1.63e-2)" "unprognostic (3.90e-2)" "unprognostic (8.43e-2)" "unprognostic (5.19e-2)" "unprognostic (6.56e-3)" "unprognostic (1.19e-1)" "prognostic favorable (8.98e-12)" "unprognostic (2.07e-1)" "unprognostic (2.54e-1)" "unprognostic (3.38e-3)" "unprognostic (2.49e-3)" 8.8 9.9 5.0 2.6 5.7 1.2 9.5 7.1 8.2 4.0 4.5 4.3 3.8 3.8 3.7 7.7 3.1 3.5 3.3 56.7 4.9 5.1 7.7 8.0 3.6 2.0 4.7 5.5 4.3 7.8 13.0 4.5 1.9 6.6 5.8 5.3 4.7 5.3 4.2 6.9 4.5 3.7 4.6 4.7 2.5 3.8 3.6 5.1 0.2 5.5 4.4 2.4 3.9 3.8 2.0 2.7 1.7 3.0 3.8 6.2 2.5 4.5 7.0 3.0 4.3 21.2 8.7 3.0 7.4 5.4 5.9 3.2 8.6 3.3 3.1 4.3 8.3 9.3 10.2 3.7 5.0 6.4 0.9 1.7 1.0 4.4 14.4 4.4 2.0 2.6 6.6 11.3 4.1 3.1 3.2 4.2 2.0 1.7 9.3 5.9 14.1 0.7 2.1 0.7 6.8 9.1 1.2 5.5 3.1 3.3 4.3 1.8 2.1 15.7 8.9 6.5 1.4 10.8 1.5 5.1 18.8 8.4 10.8 4.3 3.4 8.8 0.8 8.3 3.1 9.3 1.4 3.0 1.7 3.4 2.7 3.5 1.8 3.6 2.8 2.7 2.0 6.2 4.8 1.4 3.8 2.1 1.7 3.2 2.5 5.0 5.7 7.1 8.2 4.9 5.1 4.7 5.5 6.6 5.1 6.0 8.9 7.3 3.1 6.2 5.8 134.0 15.3 4.0 3.4 5.2 5.9 1.9 1.7 4.5 3.6 3.6 4.3 0.0 7.4 2.7 4.7 2.9 0.0 12.1 3.0 6.4 8.7 9.8 4.0 0.4 7.2 1.7 6.8 1.8 5.6 5.3 5.4 5.3 7.1 5.1 5.7 0.0 4.7 7.5 5.2 7.0 1.3 3.8 8.0 2.0 FJX1 "FLJ22416, FLJ25593" ENSG00000179431 "Four jointed box 1" Q86VR8 11 35618419-35620868 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 15.5;Cytotrophoblasts: 18.7;Extravillous trophoblasts: 14.0;Ito cells: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059220 Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA059220: AB_2683950" "unprognostic (8.99e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-3)" "unprognostic (5.20e-2)" "unprognostic (5.72e-2)" "unprognostic (9.56e-3)" "unprognostic (5.16e-2)" "unprognostic (1.06e-2)" "unprognostic (1.74e-1)" "unprognostic (4.39e-3)" "unprognostic (5.28e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (9.24e-9)" "unprognostic (1.64e-2)" "unprognostic (9.64e-2)" "unprognostic (8.35e-2)" "prognostic unfavorable (6.56e-4)" 6.0 3.5 7.8 3.5 10.3 0.7 3.6 6.6 25.4 8.8 1.4 7.9 0.0 1.1 10.1 3.4 3.1 6.1 4.5 2.4 8.0 4.9 3.8 4.9 2.2 2.3 5.7 5.7 12.2 17.0 1.7 1.8 6.6 7.7 4.1 1.1 2.7 2.6 4.7 1.1 10.3 1.1 3.4 5.1 7.8 1.7 1.2 3.3 1.7 2.2 3.0 3.4 3.7 2.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 9.8 4.9 5.2 1.6 1.8 5.8 1.6 11.1 7.5 10.6 7.7 6.2 3.1 0.0 2.5 4.3 22.0 10.5 1.8 18.3 9.1 0.1 14.5 0.9 1.9 0.2 4.4 1.1 0.0 2.1 14.0 5.5 16.9 1.7 4.8 0.5 5.2 0.0 10.2 2.3 0.3 0.0 7.2 0.0 14.7 0.6 11.7 2.2 8.1 12.2 5.0 2.8 1.2 0.9 3.1 4.0 21.1 0.2 9.4 8.5 15.7 1.6 26.1 0.0 0.0 0.0 15.2 0.4 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 10.3 6.6 12.3 8.0 4.9 5.7 5.7 7.7 3.3 0.0 0.0 0.0 9.3 15.5 0.4 1.0 0.0 4.0 3.4 0.0 11.8 18.7 1.7 7.9 0.0 5.6 0.0 0.0 0.2 14.0 4.5 1.5 0.0 0.0 3.1 0.0 0.0 16.0 0.6 0.0 0.6 1.5 0.0 0.0 0.0 10.3 1.1 0.0 0.7 6.7 0.3 0.0 5.3 0.4 1.1 8.3 10.0 0.0 0.0 2.6 FKBP11 FKBP19 ENSG00000134285 "FK506 binding protein 11" Q9NYL4 12 48921518-48926474 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 175.6;salivary gland: 62.0" "Cell type enhanced" "Detected in all" 7 "Exocrine glandular cells: 145.3;Melanocytes: 258.1;T-cells: 152.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 37.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 44.0;Karpas-707: 40.1;OE19: 56.1;RPMI-8226: 40.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041709 Enhanced Approved Centrosome NA NA Centrosome "HPA041709: AB_10794487" "unprognostic (7.45e-3)" "unprognostic (8.62e-2)" "unprognostic (2.40e-1)" "prognostic favorable (7.09e-4)" "unprognostic (1.70e-2)" "unprognostic (2.00e-1)" "unprognostic (3.46e-2)" "unprognostic (1.75e-1)" "unprognostic (7.64e-2)" "unprognostic (3.49e-3)" "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.15e-1)" "unprognostic (4.51e-1)" "unprognostic (2.79e-1)" "unprognostic (1.54e-1)" 5.6 4.6 1.1 8.2 1.4 3.7 3.7 0.9 2.2 7.5 6.9 0.9 21.6 9.2 4.4 12.9 4.4 4.8 8.1 3.4 1.3 2.4 4.8 38.4 5.8 16.6 1.0 1.3 3.7 175.6 0.2 12.3 3.3 1.6 4.8 6.3 1.9 62.0 20.9 1.4 1.7 7.6 2.9 1.0 18.7 10.0 1.9 0.9 2.2 4.7 4.9 14.5 8.2 4.3 11.1 8.3 1.1 0.3 5.1 37.6 7.3 2.0 2.7 0.5 0.7 12.0 18.2 1.0 15.9 22.8 17.6 20.8 10.2 11.4 30.9 0.5 25.9 0.2 8.5 5.5 7.0 9.1 6.5 1.1 1.1 2.9 0.1 44.0 0.6 0.8 20.3 13.5 13.5 25.1 7.5 9.9 10.5 0.4 40.1 6.4 5.8 4.6 1.1 1.4 56.1 5.1 12.7 0.7 40.1 2.2 0.4 6.5 1.9 5.3 7.9 3.5 0.6 0.4 0.9 7.9 3.4 0.6 0.3 0.3 23.5 19.4 15.7 2.1 0.7 5.6 0.9 0.2 0.6 22.5 0.3 37.6 11.1 15.6 17.7 0.3 4.8 9.4 14.4 1.1 5.1 0.1 8.3 6.4 7.3 1.1 1.4 0.9 2.2 1.3 2.4 1.0 1.3 1.6 0.9 14.9 18.4 30.6 44.0 25.1 4.9 1.7 35.7 28.1 19.4 8.7 37.3 19.0 6.6 17.0 15.1 19.7 11.7 46.7 145.3 59.9 74.1 89.1 12.7 90.3 9.7 1.6 24.1 49.1 14.2 13.2 25.6 9.7 258.1 5.4 84.9 1.5 80.1 7.0 13.1 12.2 15.0 6.5 22.1 8.0 6.8 18.6 35.4 152.0 40.1 37.6 FKBP1A "FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE" ENSG00000088832 "FK506 binding protein 1A" P62942 20 1368978-1393172 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Isomerase, Rotamase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 63.6;granulocytes: 88.4;monocytes: 94.3" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 152.2;TIME: 176.4" "CAB004639, HPA051798" Uncertain NA NA 16000000 "CAB004639: AB_425434, HPA051798: AB_2681615" "unprognostic (4.09e-2)" "unprognostic (2.29e-1)" "unprognostic (5.22e-3)" "unprognostic (1.28e-2)" "unprognostic (2.66e-1)" "unprognostic (7.18e-3)" "prognostic unfavorable (3.44e-7)" "unprognostic (7.05e-3)" "unprognostic (2.76e-1)" "unprognostic (8.81e-2)" "unprognostic (5.12e-3)" "unprognostic (6.65e-2)" "prognostic unfavorable (6.69e-5)" "unprognostic (1.97e-2)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (1.47e-1)" 106.0 42.4 67.3 55.0 114.8 44.4 63.5 15.8 55.8 33.2 39.7 22.1 33.8 32.7 45.5 45.9 42.7 33.8 32.0 36.4 51.7 30.6 41.9 41.7 59.2 84.1 26.0 36.5 41.7 57.7 20.6 21.7 65.0 22.5 34.4 49.4 21.4 30.8 40.6 38.9 31.5 37.1 56.0 23.3 68.0 33.0 21.1 28.4 47.4 62.2 39.7 48.3 48.1 37.0 13.3 63.6 88.4 94.3 14.5 18.6 84.3 71.4 19.8 15.8 22.8 53.5 67.2 20.8 45.4 30.8 36.4 33.8 19.8 27.8 29.3 14.6 42.3 52.9 32.9 20.4 83.1 47.9 8.4 22.1 30.0 9.3 37.6 32.9 34.8 16.7 39.0 26.5 33.7 34.8 42.5 152.2 33.0 27.4 15.1 42.8 8.9 34.0 48.0 33.9 25.3 38.8 29.2 27.6 35.4 47.0 18.1 26.3 19.9 22.4 45.3 75.2 22.1 17.7 29.7 176.4 135.4 22.7 28.8 33.5 7.5 16.3 30.6 23.3 35.4 29.9 23.9 79.4 88.4 11.5 94.3 10.2 12.8 13.9 13.2 63.6 13.3 14.8 14.2 77.9 14.5 90.3 31.6 18.6 84.3 67.3 114.8 15.8 55.8 51.7 30.6 26.0 36.5 22.5 28.4 80.4 70.6 192.2 178.9 233.8 16.6 52.9 173.3 66.9 58.0 164.0 0.0 249.8 202.2 393.2 31.1 486.6 196.8 23.3 297.3 496.2 197.8 189.6 142.9 99.4 651.5 33.4 317.5 445.0 487.0 41.0 185.2 363.6 229.5 390.5 244.5 40.1 382.3 768.7 153.1 245.7 11.0 135.8 189.1 153.9 133.6 261.7 193.6 124.6 263.1 202.2 FKBP7 FKBP23 ENSG00000079150 "FK506 binding protein 7" Q9Y680 2 178463664-178478600 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 116.0;Fibroblasts: 67.2;Leydig cells: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 52.8;ASC TERT1: 32.8;HSkMC: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008707 Approved Supported Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA008707: AB_1848624" "unprognostic (1.33e-1)" "unprognostic (1.89e-2)" "unprognostic (1.43e-1)" "unprognostic (1.67e-1)" "unprognostic (5.61e-2)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (1.48e-1)" "unprognostic (1.34e-2)" "unprognostic (1.83e-2)" "unprognostic (6.05e-2)" "unprognostic (8.96e-3)" "prognostic unfavorable (4.61e-6)" "unprognostic (3.50e-3)" "unprognostic (1.34e-2)" "unprognostic (4.19e-3)" "unprognostic (1.10e-1)" 9.6 4.6 1.5 4.3 4.1 0.7 11.1 3.5 2.3 20.5 6.9 1.0 10.0 1.8 21.4 21.9 8.4 12.4 12.8 12.1 1.5 1.5 5.5 7.4 6.8 5.2 4.0 1.8 34.6 4.3 1.5 11.1 8.2 2.9 19.5 4.2 7.1 4.9 9.7 4.4 4.0 3.9 19.9 3.9 3.0 5.3 8.3 2.2 2.2 8.7 8.0 2.3 15.5 9.9 2.8 5.8 0.2 1.6 1.2 2.8 0.8 0.0 0.6 6.1 9.0 52.8 32.8 0.5 10.9 18.1 2.0 6.4 0.1 0.6 1.7 2.4 19.9 1.8 0.1 2.3 0.9 3.5 1.4 1.3 1.7 2.5 1.7 8.1 1.1 1.3 22.0 0.5 8.0 1.1 14.7 6.5 2.1 0.8 1.1 8.4 0.1 1.9 1.9 1.2 1.1 0.9 2.5 10.7 2.3 2.7 0.2 3.2 10.6 2.3 0.0 1.8 4.5 0.1 2.1 6.0 3.7 2.3 4.3 1.0 2.1 2.2 0.8 6.8 2.7 8.0 0.0 1.1 0.1 2.3 1.6 2.8 2.8 2.0 1.6 5.8 1.7 2.2 2.4 0.2 1.2 0.0 4.5 2.2 0.8 1.5 4.1 3.5 2.3 1.5 1.5 4.0 1.8 2.9 2.2 6.0 2.6 2.2 6.7 6.3 4.6 12.6 2.5 2.7 3.4 7.0 0.0 6.2 1.7 9.1 116.0 18.6 0.1 0.0 7.4 18.5 67.2 3.6 13.9 9.8 5.3 4.8 1.2 13.5 4.3 22.0 59.2 4.8 16.9 1.8 4.8 3.7 4.0 0.0 45.6 3.5 3.3 6.5 39.2 3.7 5.5 5.1 4.2 5.0 2.6 3.4 FKBP8 "FKBP38, FKBPr38" ENSG00000105701 "FK506 binding protein 8" Q14318 19 18531751-18544077 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Host-virus interaction" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 972.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 32.5;neutrophil: 31.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 32.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025346, HPA045177" Supported Supported "Endoplasmic reticulum,Mitochondria,Cytosol" NA NA Mitochondria "Endoplasmic reticulum, Cytosol" "CAB025346: , HPA045177: AB_2679244" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.24e-4)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (9.22e-2)" "unprognostic (2.54e-2)" "unprognostic (2.26e-1)" "unprognostic (2.10e-2)" "unprognostic (1.49e-1)" "prognostic favorable (7.76e-4)" "unprognostic (8.51e-2)" "unprognostic (1.61e-1)" "unprognostic (2.97e-1)" "unprognostic (6.89e-2)" "unprognostic (1.12e-2)" "unprognostic (2.32e-1)" 44.3 38.1 75.9 27.5 82.1 82.5 26.5 43.4 113.7 35.2 31.9 41.2 34.6 31.1 31.4 27.2 48.7 39.3 34.5 43.4 69.6 62.1 28.9 42.7 34.3 31.1 55.3 54.3 56.1 60.4 28.8 42.2 36.6 51.2 36.5 12.9 31.9 73.1 46.1 56.7 35.1 31.6 34.6 46.3 36.7 31.9 49.5 26.9 32.1 38.8 24.2 30.7 36.3 45.8 4.3 4.3 32.5 6.9 3.1 6.6 9.1 36.9 26.5 20.8 39.5 21.5 33.8 52.2 29.9 31.9 22.9 31.8 25.1 50.5 21.2 48.7 36.7 15.4 20.1 12.8 41.7 6.5 25.8 60.9 19.8 34.6 30.2 37.0 19.6 43.6 44.1 40.2 20.6 13.1 44.1 23.5 41.3 41.4 50.5 19.9 61.6 35.6 58.7 42.5 33.2 38.5 37.4 17.3 72.4 30.8 24.2 23.1 42.1 21.0 17.3 37.3 16.5 20.4 57.2 27.4 28.7 26.2 55.9 22.7 38.6 22.2 24.6 64.8 31.5 25.4 6.3 5.6 32.5 6.0 5.8 5.5 4.1 6.1 6.6 4.3 4.3 4.7 5.3 31.0 3.1 6.9 4.3 6.0 9.1 75.9 82.1 43.4 113.7 69.6 62.1 55.3 54.3 51.2 26.9 8.9 1.4 107.1 128.1 84.6 57.2 2.0 71.4 2.7 5.7 96.0 13.7 219.4 210.5 151.9 314.6 76.6 289.8 233.6 111.8 173.9 174.8 132.3 54.0 55.9 208.7 93.8 197.7 79.8 159.9 972.7 188.7 127.3 192.3 254.3 108.6 104.6 130.6 224.5 155.6 222.1 41.3 97.0 149.9 203.6 97.7 103.1 261.7 163.0 127.0 126.6 FKRP "LGMD2I, MDC1C" ENSG00000181027 "Fukutin related protein" Q9H9S5 19 46746046-46776988 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Cardiomyopathy, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043115, HPA060454" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA043115: AB_2678324, HPA060454: AB_2684281" "unprognostic (4.44e-2)" "unprognostic (5.20e-2)" "unprognostic (2.19e-2)" "unprognostic (8.37e-3)" "unprognostic (1.83e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (3.85e-1)" "unprognostic (2.99e-2)" "unprognostic (4.59e-3)" "prognostic favorable (8.98e-4)" "unprognostic (3.53e-1)" "unprognostic (2.30e-2)" "unprognostic (2.53e-1)" "unprognostic (2.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.53e-2)" 13.7 10.7 12.4 12.5 17.5 12.6 9.6 7.4 25.2 10.5 11.5 12.8 13.7 7.8 15.7 8.7 8.3 12.7 10.1 13.1 9.8 12.2 10.7 10.8 11.6 11.0 11.5 11.1 13.3 13.2 12.9 16.9 16.5 14.1 13.6 7.3 13.0 17.8 13.2 23.6 9.6 9.7 13.4 9.1 14.7 10.3 13.0 11.1 8.8 13.5 7.8 7.9 12.3 10.2 6.9 5.0 5.4 4.2 5.6 4.5 2.4 8.4 18.1 12.4 8.7 11.0 12.2 11.1 21.6 14.6 8.9 14.0 11.5 14.7 7.6 12.1 12.4 14.7 9.0 4.6 10.1 8.2 14.9 15.4 8.0 8.7 7.2 9.7 6.2 13.8 13.5 8.7 10.9 10.7 10.4 11.6 4.2 8.0 7.7 8.9 3.8 4.5 15.2 12.1 5.3 4.5 12.3 7.7 2.8 5.6 18.1 8.5 16.2 10.8 5.3 7.1 8.6 6.4 4.9 11.9 13.2 14.0 4.8 17.3 8.2 9.8 7.2 10.7 5.0 17.6 3.4 4.2 2.5 4.1 2.5 2.8 4.6 3.0 4.5 2.6 6.9 3.7 4.5 5.4 5.6 2.6 5.0 1.6 2.4 12.4 17.5 7.4 25.2 9.8 12.2 11.5 11.1 14.1 11.1 8.9 6.1 0.8 4.3 0.7 9.7 13.7 7.6 10.7 6.8 5.2 5.9 7.9 5.0 4.3 7.3 3.9 3.5 23.3 2.1 4.7 4.1 3.6 1.1 13.4 6.3 3.2 7.5 9.2 11.4 9.9 5.2 1.8 5.0 4.6 4.6 6.8 4.9 3.1 3.9 5.8 10.7 6.5 4.7 9.1 4.3 1.4 15.7 5.0 3.6 3.4 FKTN "FCMD, LGMD2M" ENSG00000106692 Fukutin O75072 9 105558130-105641118 "Disease related genes, Predicted intracellular proteins" Transferase "Cardiomyopathy, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012820 Approved NA NA "HPA012820: AB_1848478" "unprognostic (3.48e-2)" "unprognostic (1.84e-2)" "unprognostic (7.54e-2)" "unprognostic (2.47e-1)" "unprognostic (1.78e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (2.41e-2)" "unprognostic (4.24e-2)" "unprognostic (8.76e-2)" "unprognostic (3.17e-1)" "unprognostic (3.10e-2)" "unprognostic (4.30e-3)" "unprognostic (1.18e-1)" "unprognostic (1.84e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (3.02e-4)" 7.7 9.7 8.5 7.4 15.9 1.2 10.6 13.6 18.0 8.9 9.7 13.1 11.5 7.5 11.4 9.9 8.3 9.1 7.4 8.0 12.1 9.0 10.5 8.0 7.4 9.1 10.2 16.0 12.0 12.3 21.1 14.6 10.0 15.7 8.7 11.4 7.3 7.9 9.3 7.3 9.3 7.3 9.0 10.6 7.7 9.8 7.7 12.5 7.2 12.6 8.7 6.9 7.9 7.9 1.9 3.3 0.1 1.9 0.6 1.9 1.1 6.5 6.7 6.8 6.1 10.7 16.8 8.2 12.3 11.5 8.3 8.3 4.4 11.5 4.2 6.5 12.4 8.9 11.3 6.8 8.8 11.3 7.8 4.7 3.1 7.3 2.9 8.6 6.4 2.9 13.6 7.9 11.1 15.9 10.7 7.0 4.8 3.7 4.9 15.3 7.0 4.6 3.3 6.3 6.2 8.2 2.9 17.8 2.8 7.3 2.3 7.5 5.2 10.5 8.1 6.3 7.1 17.3 4.5 9.1 8.3 4.8 15.8 10.6 7.4 11.8 2.9 7.9 6.3 11.9 0.1 1.6 0.0 0.9 1.9 1.2 1.9 1.7 1.9 3.3 1.5 1.7 1.5 0.0 0.6 0.6 1.6 0.9 1.1 8.5 15.9 13.6 18.0 12.1 9.0 10.2 16.0 15.7 12.5 6.0 7.7 2.2 3.8 2.9 20.1 8.5 12.7 8.1 5.7 7.0 7.9 2.2 1.7 4.2 2.2 4.9 2.8 0.0 2.9 2.9 6.2 4.2 2.3 5.1 3.7 22.3 4.1 9.2 3.8 0.4 5.8 2.4 8.5 1.8 8.1 8.0 2.7 3.5 8.5 3.3 13.7 6.5 4.7 9.8 4.1 3.4 0.7 4.3 6.9 2.8 FLRT1 "MGC21624, SPG68" ENSG00000126500 "Fibronectin leucine rich transmembrane protein 1" Q9NZU1 11 64103188-64119173 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.6;brain: 13.0" "Group enriched" "Detected in some" 7 "Bipolar cells: 7.3;Muller glia cells: 7.2;Rod photoreceptor cells: 2.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 4.2;Karpas-707: 4.5;SCLC-21H: 6.1;SH-SY5Y: 15.2;THP-1: 12.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054589 Uncertain "Intracellular and membrane" NA NA "HPA054589: AB_2682533" "unprognostic (5.13e-3)" "unprognostic (1.55e-1)" "unprognostic (1.63e-1)" "unprognostic (8.65e-2)" "unprognostic (2.89e-1)" "unprognostic (9.55e-2)" "unprognostic (2.61e-3)" "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (2.98e-1)" "unprognostic (4.64e-3)" "unprognostic (6.02e-2)" "unprognostic (1.79e-1)" "unprognostic (2.62e-2)" "unprognostic (5.62e-2)" "unprognostic (1.29e-3)" "unprognostic (4.37e-2)" 0.2 7.6 3.6 0.4 5.3 0.0 0.0 2.7 13.0 4.6 2.5 0.7 2.6 0.0 0.6 1.0 0.7 0.9 3.6 3.2 3.0 0.2 0.0 0.0 2.7 0.1 0.3 0.0 0.6 0.1 0.5 0.5 0.9 1.6 0.3 1.6 1.1 0.9 2.7 0.0 0.5 0.2 3.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 3.1 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.5 0.0 1.0 0.7 4.2 0.0 0.0 0.8 0.2 0.0 1.0 0.1 0.0 2.3 0.3 4.5 0.0 0.6 0.1 0.6 1.3 0.1 0.2 0.9 0.3 0.1 0.0 0.3 6.1 15.2 0.3 0.3 0.5 0.1 0.4 12.2 0.1 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.2 3.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FLRT2 ENSG00000185070 "Fibronectin leucine rich transmembrane protein 2" O43155 14 85530144-85654426 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 34.8;retina: 50.6" "Cell type enhanced" "Detected in many" 17 "Leydig cells: 202.8;Peritubular cells: 117.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 27.1;HUVEC TERT2: 17.0;TIME: 24.1;U-138 MG: 26.5;U-2197: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 18000 "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "unprognostic (8.13e-3)" "unprognostic (4.59e-3)" "unprognostic (3.57e-2)" "unprognostic (1.46e-2)" "unprognostic (4.75e-2)" "unprognostic (9.46e-2)" "unprognostic (1.32e-1)" "unprognostic (2.59e-1)" "unprognostic (5.34e-2)" "unprognostic (8.02e-6)" "unprognostic (1.98e-3)" "unprognostic (8.03e-2)" "unprognostic (1.50e-2)" "unprognostic (1.50e-5)" 10.5 5.1 6.5 4.6 13.2 0.4 3.9 0.8 16.1 12.2 3.8 1.6 2.3 1.2 6.7 4.3 3.9 7.4 9.5 6.6 4.7 3.6 2.1 1.5 2.6 6.5 3.7 5.8 31.7 34.8 1.4 2.6 1.5 1.4 5.8 3.5 50.6 2.2 3.9 6.7 6.4 2.3 7.3 4.2 5.9 2.6 9.2 0.8 0.0 6.5 2.2 2.9 6.9 12.3 0.6 0.3 2.3 0.2 0.4 0.3 0.0 0.0 0.1 3.9 0.0 3.6 6.7 0.0 4.2 2.8 4.0 3.8 0.0 0.0 0.0 0.0 12.3 0.4 0.9 5.9 8.1 9.8 0.0 3.4 0.0 2.2 0.0 11.5 0.9 0.0 3.6 4.7 3.3 27.1 1.2 17.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 1.8 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.9 0.0 1.0 0.0 1.4 5.5 0.0 0.0 24.1 26.5 4.5 19.1 7.5 0.0 0.0 0.0 8.3 0.0 2.5 2.3 0.2 2.0 0.2 0.1 0.1 0.3 0.2 0.2 0.0 0.6 0.3 0.3 1.0 0.4 0.2 0.3 0.1 0.0 6.5 13.2 0.8 16.1 4.7 3.6 3.7 5.8 1.4 0.8 0.0 2.2 0.0 1.2 19.1 0.4 3.5 2.5 2.7 0.0 1.8 0.0 0.3 0.0 43.3 2.3 12.8 0.0 0.0 37.5 0.2 24.6 0.4 0.0 0.0 2.4 9.5 0.0 31.3 0.6 4.5 202.8 1.2 1.7 1.0 0.0 14.3 31.9 0.0 117.4 0.0 1.4 12.9 3.8 1.2 0.2 21.0 0.7 0.0 0.0 0.1 FLRT3 ENSG00000125848 "Fibronectin leucine rich transmembrane protein 3" Q9NZU0 20 14322988-14337616 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.1" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 202.5;Alveolar cells type 2: 116.8;Basal glandular cells: 129.3;Club cells: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.6;hTCEpi: 29.4;RPTEC TERT1: 9.9;WM-115: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056033 Enhanced Supported "Plasma membrane,Cell Junctions,Cytosol" "Intracellular and membrane" NA NA 240000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA056033: AB_2683016" "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.98e-1)" "unprognostic (1.14e-3)" "unprognostic (2.30e-1)" "unprognostic (6.00e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.85e-5)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (3.05e-1)" "prognostic favorable (1.49e-7)" "unprognostic (1.54e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-3)" "unprognostic (3.65e-1)" 7.3 4.3 3.4 2.2 7.4 0.1 2.7 27.5 18.9 3.8 5.0 0.7 3.2 12.4 2.6 5.5 2.5 2.7 5.6 1.6 9.3 4.1 43.1 28.9 26.2 0.2 2.3 5.3 11.9 2.3 4.6 2.1 2.0 2.9 12.7 1.0 1.9 1.5 16.4 2.1 6.9 6.0 3.9 2.3 0.8 9.7 1.7 0.7 4.8 8.5 1.8 0.4 12.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 15.6 0.0 0.0 0.0 0.0 1.5 0.4 0.1 0.0 8.5 3.1 0.0 0.5 0.3 0.0 4.4 0.0 4.6 0.1 0.0 1.0 0.0 0.2 0.1 1.3 0.0 0.0 2.7 29.4 0.0 5.5 0.0 0.0 0.1 0.0 0.1 3.0 0.2 1.9 0.0 5.1 3.4 0.0 0.0 0.1 0.0 9.9 1.9 0.3 3.2 0.0 0.0 4.9 9.2 0.2 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 7.4 27.5 18.9 9.3 4.1 2.3 5.3 2.9 0.7 202.5 116.8 0.0 129.3 7.7 13.3 0.9 17.8 22.7 126.3 21.0 5.9 0.3 11.6 18.8 0.0 1.6 2.0 0.0 13.0 0.0 5.4 11.3 4.7 7.8 0.2 6.4 10.9 1.8 0.0 0.2 3.4 0.9 5.0 2.8 1.0 0.5 9.4 2.9 0.4 41.7 2.9 0.0 0.1 0.0 0.0 14.4 0.0 0.5 1.5 9.0 FLT3 "CD135, FLK2, STK1" ENSG00000122025 "Fms related tyrosine kinase 3" P36888 13 28003274-28100592 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.9;brain: 19.3;lymphoid tissue: 15.0" "Cell type enhanced" "Detected in some" 25 "Kupffer cells: 29.6;Macrophages: 12.4;monocytes: 55.9" "Cancer enhanced" "Detected in some" "breast cancer: 1.8" "Region enhanced" "Detected in many" "cerebellum: 19.3" "Group enriched" "Detected in some" 11 "myeloid DC: 29.9;plasmacytoid DC: 12.1" "Lineage enriched" "Detected in many" 16 "dendritic cells: 29.9" "Group enriched" "Detected in some" 11 "REH: 28.5;THP-1: 17.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047539 Approved "Endoplasmic reticulum" NA NA 180000 "Endoplasmic reticulum" "HPA047539: AB_2680080" "unprognostic (2.19e-3)" "unprognostic (3.16e-3)" "unprognostic (6.54e-3)" "unprognostic (9.96e-2)" "unprognostic (3.88e-1)" "unprognostic (3.96e-7)" "unprognostic (7.99e-3)" "unprognostic (1.65e-2)" "unprognostic (5.37e-2)" "unprognostic (1.01e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" "unprognostic (3.65e-1)" "unprognostic (3.91e-2)" "unprognostic (2.51e-1)" "unprognostic (2.22e-1)" 0.9 0.6 0.6 7.2 1.1 7.5 2.6 19.3 3.5 0.9 1.2 0.1 0.1 0.4 0.8 0.8 1.0 1.2 4.6 0.5 0.9 1.7 2.8 0.7 2.7 15.0 1.8 1.1 0.5 5.7 0.0 0.4 0.0 7.4 0.6 1.4 0.1 2.3 0.6 0.4 1.2 3.0 1.3 4.4 8.8 0.9 1.2 0.0 8.2 0.6 0.0 5.8 2.4 0.7 0.1 29.9 1.4 1.8 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.1 0.5 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 1.4 0.0 0.3 0.0 0.1 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.8 0.0 12.1 0.0 1.2 0.6 1.1 19.3 3.5 0.9 1.7 1.8 1.1 7.4 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.3 29.6 1.6 0.0 12.4 1.7 55.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.5 0.0 0.0 0.0 0.0 FLT3LG ENSG00000090554 "Fms related tyrosine kinase 3 ligand" P49771 19 49474207-49486231 "Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 49.8" "Cell type enhanced" "Detected in many" 9 "T-cells: 36.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 18.2;MAIT T-cell: 33.7;memory CD4 T-cell: 37.3;memory CD8 T-cell: 23.7;naive CD4 T-cell: 41.1;naive CD8 T-cell: 32.0;T-reg: 35.9" "Lineage enriched" "Detected in all" 7 "T-cells: 41.1" "Cell line enhanced" "Detected in many" "HDLM-2: 17.9;U-266/70: 17.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.29e-3)" "prognostic favorable (2.17e-5)" "unprognostic (2.12e-3)" "unprognostic (9.16e-2)" "unprognostic (3.05e-1)" "unprognostic (3.81e-3)" "unprognostic (2.58e-1)" "unprognostic (1.55e-1)" "unprognostic (1.03e-2)" "unprognostic (6.07e-2)" "unprognostic (1.16e-2)" "unprognostic (2.88e-1)" "unprognostic (7.78e-6)" "unprognostic (2.17e-1)" "unprognostic (5.25e-2)" "unprognostic (8.22e-3)" "unprognostic (5.68e-2)" 12.8 5.9 4.5 21.0 6.7 14.0 11.1 1.9 4.0 14.1 12.4 5.1 6.6 9.4 12.1 8.0 11.3 9.2 14.8 6.8 3.4 2.7 8.6 4.8 10.5 32.7 4.3 2.6 16.3 4.5 2.2 5.7 3.5 4.7 12.9 3.4 6.6 9.6 7.7 7.1 8.8 11.0 10.8 4.9 17.0 8.1 5.5 6.3 49.8 8.5 9.0 32.7 11.6 16.0 3.1 1.2 4.9 6.0 6.0 41.1 10.4 4.2 0.4 0.6 1.5 7.2 11.9 0.4 3.3 6.8 7.0 11.7 0.3 4.7 4.2 1.7 4.6 2.1 4.7 1.1 3.8 1.7 17.9 1.7 3.0 1.8 1.6 12.6 2.7 10.6 8.1 0.6 4.8 1.0 4.2 2.4 5.7 1.3 14.1 2.1 2.7 2.8 4.5 0.2 0.7 0.8 2.2 2.2 4.7 1.0 2.6 0.3 1.0 1.0 1.2 1.9 0.2 1.7 2.1 2.0 8.9 1.9 5.2 4.7 17.9 5.5 1.7 4.3 5.8 2.5 1.1 1.6 4.9 18.2 4.5 33.7 3.1 37.3 23.7 1.2 2.6 41.1 32.0 1.7 6.0 6.0 0.5 35.9 10.4 4.5 6.7 1.9 4.0 3.4 2.7 4.3 2.6 4.7 6.3 0.0 3.0 1.4 6.3 4.5 1.5 0.3 2.5 0.0 9.1 3.5 5.9 0.6 0.0 1.5 0.1 3.5 0.3 0.0 1.6 0.7 9.8 2.6 5.7 1.5 1.9 7.9 1.7 5.5 1.9 0.0 15.3 4.8 8.5 3.6 1.3 3.5 1.3 0.9 7.4 2.2 2.4 6.5 5.2 0.3 1.8 4.1 0.2 36.3 0.8 3.8 FLT4 "PCL, VEGFR3" ENSG00000037280 "Fms related tyrosine kinase 4" P35916 5 180601506-180649624 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 56.3" "Group enriched" "Detected in some" 5 "Extravillous trophoblasts: 31.7;Ito cells: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.7" "Lineage enriched" "Detected in single" 35 "T-cells: 7.7" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;BEWO: 10.1;HEK 293: 12.5;HUVEC TERT2: 8.1;JURKAT: 10.0;T-47d: 11.9;TIME: 12.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000099, HPA046519, HPA067906, HPA074389" Approved Supported "Nuclear speckles,Plasma membrane,Cell Junctions" "Secreted to blood" NA NA 270000000 "Nuclear speckles, Plasma membrane" "Cell Junctions" "CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: " "unprognostic (7.35e-2)" "unprognostic (1.63e-1)" "unprognostic (9.45e-3)" "unprognostic (3.81e-1)" "unprognostic (9.26e-2)" "unprognostic (3.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-1)" "unprognostic (1.88e-2)" "unprognostic (9.41e-3)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (1.32e-1)" 14.8 7.1 1.6 4.9 6.0 0.7 28.5 1.3 2.7 6.3 7.3 1.9 2.1 3.1 7.3 6.2 5.7 9.2 5.3 6.4 1.7 0.9 11.7 10.2 14.1 23.6 2.0 0.8 5.8 2.3 2.3 6.2 56.3 2.1 4.9 1.4 6.7 3.3 4.4 4.8 2.8 4.7 4.7 1.5 14.5 2.4 3.5 2.0 0.3 19.4 4.4 2.3 6.1 14.7 0.0 0.1 0.2 0.0 0.0 7.7 0.2 0.1 2.0 2.7 8.3 0.0 0.0 10.1 0.2 0.1 0.0 0.0 0.3 0.3 0.2 0.8 0.1 0.5 0.3 2.8 0.1 0.2 0.1 12.5 1.0 0.4 0.4 0.1 7.4 0.2 0.2 0.0 0.1 0.3 0.3 8.1 10.0 0.3 0.3 1.7 4.5 0.1 0.4 5.8 0.2 0.5 6.5 0.0 0.1 0.1 0.2 0.2 0.9 0.1 0.2 0.0 2.7 11.9 0.2 12.6 0.1 5.9 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.9 0.0 7.7 0.0 0.4 1.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 1.6 6.0 1.3 2.7 1.7 0.9 2.0 0.8 2.1 2.0 0.0 1.7 0.9 0.2 0.8 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.2 9.2 0.0 0.0 0.0 31.7 0.6 0.2 2.3 0.4 1.1 0.0 0.0 65.1 5.7 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 4.3 1.0 0.8 0.7 0.0 0.1 FLVCR1 "AXPC1, FLVCR, MFSD7B, PCA" ENSG00000162769 "Feline leukemia virus subgroup C cellular receptor 1" Q9Y5Y0 1 212858255-212899363 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Erythrocyte maturation, Transport" Receptor "Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 40.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NTERA-2: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046646 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA046646: AB_2679735" "unprognostic (2.09e-1)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (1.01e-1)" "unprognostic (2.83e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (1.03e-1)" "unprognostic (1.21e-1)" "unprognostic (3.88e-2)" "prognostic favorable (3.50e-4)" "unprognostic (1.89e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (7.15e-2)" "unprognostic (2.25e-1)" "unprognostic (3.91e-2)" "unprognostic (7.29e-3)" 3.2 3.8 4.6 4.5 7.2 7.8 4.8 11.3 5.9 4.4 12.9 4.7 3.3 13.5 4.0 7.5 3.2 3.6 3.6 2.5 5.0 7.5 3.5 3.1 3.7 4.1 5.3 5.9 4.0 5.1 7.0 16.8 3.5 7.2 5.3 4.4 4.0 2.9 4.3 1.6 4.3 40.6 3.8 4.8 4.2 7.1 4.0 5.5 5.4 3.6 2.1 3.3 4.0 5.0 1.2 1.6 4.7 0.8 0.7 1.4 0.2 4.8 6.4 10.0 3.0 1.7 2.1 18.9 1.4 1.1 2.9 1.8 9.4 9.0 5.3 2.7 1.0 6.2 7.4 10.8 3.2 2.9 3.1 4.7 3.1 6.3 8.5 2.0 8.3 5.1 1.6 2.1 3.1 4.0 1.5 2.2 3.7 8.3 4.4 1.9 1.8 2.3 4.1 33.1 6.4 4.6 5.2 9.2 6.1 3.6 4.7 10.9 7.7 6.6 6.6 6.0 8.7 10.8 3.9 1.3 1.4 3.4 4.6 6.5 2.7 5.5 6.3 2.1 4.8 1.7 1.6 0.8 4.7 0.8 0.6 0.9 0.9 1.2 1.0 0.5 1.2 1.2 1.1 2.6 0.7 0.8 1.6 1.4 0.2 4.6 7.2 11.3 5.9 5.0 7.5 5.3 5.9 7.2 5.5 11.9 13.6 12.6 8.8 12.7 22.7 3.3 7.6 9.4 15.9 19.2 33.4 3.0 1.7 3.8 3.2 7.7 17.9 0.0 11.7 5.3 7.8 10.1 6.9 4.9 5.5 15.9 31.2 10.4 10.3 5.3 5.8 9.0 5.0 8.2 8.6 6.3 7.3 10.5 2.5 4.1 31.2 6.5 7.2 10.1 5.9 8.2 2.1 8.9 6.5 3.7 FLVCR2 "C14orf58, FLJ20371, MFSD7C" ENSG00000119686 "Feline leukemia virus subgroup C cellular receptor family member 2" Q9UPI3 14 75578617-75663214 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 45.7" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 60.5;Late spermatids: 110.7;Syncytiotrophoblasts: 45.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 11.3;intermediate monocyte: 12.1;myeloid DC: 6.2;non-classical monocyte: 8.9" "Group enriched" "Detected in many" 7 "dendritic cells: 6.2;monocytes: 12.1" "Cell line enhanced" "Detected in many" "ASC diff: 27.1;ASC TERT1: 11.8;BEWO: 36.2;MCF7: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA037984 Enhanced NA NA "HPA037984: AB_10672733" "unprognostic (2.42e-1)" "unprognostic (4.85e-2)" "unprognostic (4.19e-2)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "unprognostic (4.44e-2)" "unprognostic (8.72e-2)" "unprognostic (2.78e-1)" "unprognostic (3.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.22e-1)" "unprognostic (4.80e-2)" "prognostic favorable (2.53e-5)" "unprognostic (6.69e-2)" "unprognostic (9.94e-2)" "unprognostic (9.38e-2)" "unprognostic (1.16e-1)" 5.6 11.6 1.4 6.5 2.6 3.0 2.4 0.7 2.4 2.5 24.1 1.9 0.9 12.5 1.4 2.9 2.4 2.0 2.6 3.0 1.7 1.0 8.3 19.0 11.5 7.7 4.8 0.7 2.4 0.8 0.8 4.1 25.6 5.0 2.3 5.2 30.9 8.7 2.5 7.6 5.1 45.7 2.8 6.0 17.5 1.1 15.6 2.6 1.1 3.2 5.6 3.3 2.2 4.2 0.1 6.2 0.5 12.1 0.3 1.3 3.0 1.7 1.3 0.4 1.9 27.1 11.8 36.2 0.3 1.5 1.6 1.3 3.0 0.2 0.0 0.1 0.1 2.7 0.2 4.7 0.1 0.6 9.1 0.3 0.0 1.3 6.3 2.2 0.0 0.3 5.5 3.7 1.9 1.1 0.0 0.4 0.1 0.1 0.2 4.9 12.5 0.0 0.9 0.8 0.5 2.1 0.0 1.2 0.0 1.7 2.4 0.0 0.0 0.9 3.9 0.7 2.4 2.2 4.8 4.2 2.0 0.7 1.0 0.0 0.3 0.5 0.0 5.7 1.2 0.3 0.0 11.3 0.5 0.3 12.1 1.0 0.0 0.9 0.3 6.2 0.1 0.7 0.1 0.3 0.3 8.9 0.1 1.3 3.0 1.4 2.6 0.7 2.1 1.7 1.0 4.8 0.7 5.0 2.6 6.0 5.4 0.8 0.2 0.6 0.0 0.5 0.0 0.0 5.7 3.5 0.0 20.2 0.0 0.1 60.5 1.9 16.9 0.0 0.2 26.2 2.2 1.1 1.1 16.1 15.9 0.0 0.0 2.5 32.4 110.7 3.1 17.3 0.0 1.8 0.9 1.3 0.1 1.9 1.8 5.9 0.1 0.0 0.0 1.2 1.2 0.6 45.5 0.0 2.1 0.1 FMNL1 "C17orf1, C17orf1B, FMNL" ENSG00000184922 "Formin like 1" O95466 17 45221444-45247320 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 107.4;lymphoid tissue: 56.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 52.5;Kupffer cells: 54.4;Macrophages: 116.9;monocytes: 95.6;T-cells: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 50.4;MOLT-4: 34.6;U-266/70: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008129, HPA028288" Enhanced Approved Cytosol NA NA Cytosol "HPA008129: AB_1848963, HPA028288: AB_10612110" "unprognostic (1.90e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (8.60e-2)" "unprognostic (1.95e-2)" "unprognostic (1.24e-2)" "unprognostic (2.01e-1)" "unprognostic (1.58e-1)" "unprognostic (5.44e-2)" "unprognostic (6.06e-2)" "unprognostic (2.37e-1)" "unprognostic (4.07e-1)" "prognostic unfavorable (4.23e-8)" "unprognostic (1.29e-1)" "unprognostic (3.01e-2)" "unprognostic (3.46e-2)" "unprognostic (2.16e-1)" 8.6 3.8 10.7 29.7 9.6 107.4 7.5 8.1 16.1 4.6 5.2 4.2 0.8 5.8 2.6 5.8 4.5 6.1 9.1 5.8 13.4 6.0 4.2 3.6 22.2 38.1 6.1 6.4 3.1 3.6 3.6 7.4 7.4 7.2 4.3 4.1 3.3 8.4 2.3 2.5 4.2 14.9 4.3 6.2 45.9 6.6 2.7 3.3 56.6 3.9 4.1 22.8 11.3 4.6 3.5 4.3 22.3 5.6 5.4 7.6 3.5 4.2 8.3 0.0 0.4 0.0 1.9 0.4 0.5 1.1 3.1 2.3 0.4 1.9 13.1 4.3 0.1 3.3 0.7 0.0 0.1 1.0 22.9 1.1 7.6 12.3 0.6 8.9 19.7 26.8 1.4 0.3 4.1 1.8 4.3 0.0 14.6 0.6 50.4 2.3 2.7 34.6 20.4 0.4 0.5 0.2 21.9 2.9 23.4 0.8 0.5 2.6 1.2 2.5 0.4 1.0 0.7 2.4 16.1 1.0 0.2 3.0 0.5 18.5 42.1 18.5 13.4 0.3 16.1 0.6 6.8 5.1 8.2 7.0 5.6 4.7 3.5 5.5 7.6 4.3 3.3 3.6 4.8 22.3 5.4 4.2 2.5 6.0 3.5 10.7 9.6 8.1 16.1 13.4 6.0 6.1 6.4 7.2 3.3 3.0 4.8 52.5 2.8 5.5 4.0 1.9 2.5 1.4 1.2 1.8 0.0 0.4 0.0 1.1 2.0 2.9 0.0 0.0 0.8 1.0 10.7 1.9 23.0 0.5 43.3 3.2 1.2 8.6 54.4 0.7 4.9 116.9 42.2 95.6 0.1 0.9 0.4 0.0 0.0 0.6 1.2 6.5 3.8 0.5 1.7 5.4 2.1 97.0 0.2 1.4 FMO2 ENSG00000094963 "Flavin containing monooxygenase 2" Q99518 1 171185208-171211230 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.0;esophagus: 35.3;lung: 53.0" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 428.8;Club cells: 348.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 57 "ASC diff: 24.6;ASC TERT1: 11.2;HSkMC: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028261 Approved NA NA "HPA028261: AB_10601012" "unprognostic (1.85e-2)" "unprognostic (3.14e-2)" "unprognostic (7.44e-2)" "unprognostic (3.75e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-3)" "unprognostic (3.00e-2)" "unprognostic (2.74e-1)" "unprognostic (1.58e-2)" "unprognostic (1.16e-1)" "unprognostic (4.28e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (3.83e-2)" 40.0 11.8 1.2 1.7 4.4 0.0 22.5 1.5 0.6 7.6 5.0 0.6 2.9 0.3 1.9 3.5 35.3 6.7 2.0 17.4 1.8 1.2 9.4 1.8 53.0 5.7 3.9 1.2 6.1 2.1 1.8 7.0 0.0 2.4 6.0 0.7 8.3 14.0 1.3 7.6 1.7 1.5 2.5 1.9 0.4 2.4 3.3 1.3 0.4 5.8 6.8 5.5 5.0 10.2 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 29.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 4.4 1.5 0.6 1.8 1.2 3.9 1.2 2.4 1.3 428.8 20.8 0.0 5.3 0.3 0.2 6.9 0.0 62.9 348.1 1.8 0.0 0.0 0.0 0.0 2.7 5.3 0.0 0.0 0.0 0.0 0.6 3.0 3.5 0.0 0.0 0.0 0.0 4.3 0.0 2.3 0.9 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 8.4 0.2 0.0 3.4 0.3 0.0 0.0 0.0 0.0 0.0 1.1 FMO3 ENSG00000007933 "Flavin containing monooxygenase 3" P31513 1 171090877-171117819 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 170.2" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 378.8" "Cancer enriched" "Detected in many" 13 "liver cancer: 94.9" "Region enriched" "Detected in single" 5 "pons and medulla: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 25.4;ASC TERT1: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA013750 Enhanced NA NA "HPA013750: AB_1848968" "unprognostic (1.87e-2)" "unprognostic (6.30e-2)" "unprognostic (1.00e-1)" "unprognostic (6.81e-3)" "unprognostic (2.64e-1)" "unprognostic (1.31e-3)" "prognostic favorable (3.46e-4)" "prognostic favorable (5.60e-5)" "unprognostic (2.95e-1)" "unprognostic (9.34e-2)" "unprognostic (3.02e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (3.45e-1)" "unprognostic (7.27e-2)" 9.5 2.0 0.0 0.8 0.2 0.0 1.3 0.1 0.1 0.2 0.8 0.1 0.1 0.3 0.6 1.2 1.7 2.3 0.3 0.8 0.0 0.1 6.4 170.2 3.7 1.5 0.2 0.0 0.9 0.7 0.3 2.7 0.0 1.4 0.2 0.1 3.6 0.9 0.1 1.9 0.8 0.4 0.2 0.1 0.1 0.6 0.5 0.1 0.0 0.8 1.2 2.6 0.2 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.4 19.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 5.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.2 0.0 1.4 0.1 11.9 0.3 0.9 0.3 0.3 0.0 0.3 5.1 32.1 27.3 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.9 0.1 0.0 378.8 0.0 0.0 0.0 4.9 6.9 0.0 0.3 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 6.5 3.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 FMO4 FMO2 ENSG00000076258 "Flavin containing monooxygenase 4" P31512 1 171314208-171342084 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 33.8;liver: 42.2" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 24.9;Hepatocytes: 19.8;Proximal tubular cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 7.9;HSkMC: 9.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA049100, HPA072438" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA049100: AB_2680629, HPA072438: " "unprognostic (1.83e-2)" "unprognostic (1.17e-1)" "unprognostic (6.18e-2)" "unprognostic (3.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.13e-1)" "prognostic favorable (1.09e-4)" "prognostic favorable (7.45e-4)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (5.99e-2)" "unprognostic (2.90e-1)" "prognostic favorable (6.96e-4)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-3)" "unprognostic (1.95e-1)" 5.3 3.6 1.4 5.1 4.8 0.9 4.5 0.6 2.7 4.5 6.0 4.8 3.1 4.2 3.0 10.0 4.6 3.8 4.6 6.3 2.3 1.5 33.8 42.2 3.4 2.8 7.5 2.8 4.1 3.2 5.5 5.0 2.3 3.7 3.9 3.7 6.7 2.7 2.0 1.6 2.9 16.1 2.0 7.0 3.8 3.9 2.0 6.2 2.7 4.5 3.3 3.4 2.9 3.7 5.3 2.9 0.9 4.0 3.9 4.9 2.0 0.1 0.0 0.4 0.6 5.5 5.0 0.2 1.1 5.0 1.6 1.7 0.8 7.2 4.4 7.9 0.0 2.6 0.3 0.8 1.3 2.2 2.1 1.1 0.0 0.0 0.1 0.8 0.9 1.0 9.3 3.2 0.6 1.3 0.6 0.3 2.2 0.2 3.3 0.7 1.0 2.1 1.9 0.5 1.3 1.6 0.4 0.5 2.5 3.5 0.0 0.2 0.0 1.5 1.5 3.0 5.7 3.1 1.3 0.1 1.3 0.4 1.4 1.0 4.0 1.3 2.7 2.4 1.5 1.1 0.6 2.6 0.9 2.5 4.0 1.8 3.1 2.4 3.3 2.2 5.3 3.3 2.5 0.5 3.9 2.7 2.9 4.9 2.0 1.4 4.8 0.6 2.7 2.3 1.5 7.5 2.8 3.7 6.2 0.0 1.6 0.5 3.8 2.5 0.0 3.5 2.5 6.7 0.0 8.7 0.0 2.1 24.9 1.6 4.0 0.9 8.6 0.0 1.2 1.2 3.1 1.1 1.1 19.8 3.2 0.0 1.2 1.8 5.7 0.4 1.4 2.3 5.0 1.8 1.9 1.5 0.9 0.0 0.4 33.2 0.0 0.0 1.2 0.2 0.2 1.4 1.6 0.5 1.4 1.7 FMO5 ENSG00000131781 "Flavin containing monooxygenase 5" P49326 1 147175351-147243050 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 61.1;liver: 119.4;stomach 1: 38.6" "Cell type enhanced" "Detected in many" 17 "Cholangiocytes: 117.2;Hepatocytes: 260.8" "Cancer enriched" "Detected in many" 7 "liver cancer: 43.0" "Group enriched" "Detected in many" 6 "basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Hep G2: 29.0;HMC-1: 6.6;THP-1: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012373 Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA012373: AB_1848975" "unprognostic (2.70e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (3.96e-2)" "unprognostic (2.43e-2)" "unprognostic (2.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-2)" "unprognostic (2.93e-1)" "unprognostic (1.13e-1)" "prognostic favorable (1.34e-6)" "unprognostic (3.77e-1)" "unprognostic (1.38e-1)" "unprognostic (1.85e-1)" "unprognostic (4.11e-2)" 1.1 2.4 1.1 1.9 5.5 0.2 8.6 0.6 4.5 1.3 61.1 1.5 0.8 12.5 1.0 1.3 0.7 1.1 8.5 1.0 1.3 0.5 9.0 119.4 17.0 0.8 17.1 0.5 1.0 11.9 8.8 4.9 0.6 5.2 1.9 8.2 0.5 9.7 0.6 0.4 4.2 53.6 0.9 7.1 1.2 38.6 1.2 6.0 0.2 1.1 1.5 0.5 1.9 0.8 9.2 4.9 6.2 12.1 1.0 2.0 3.6 0.1 0.7 0.5 0.1 1.9 0.5 0.7 0.4 0.4 0.2 0.6 0.4 1.5 0.3 0.5 0.4 0.1 0.3 0.0 0.0 0.0 1.0 0.1 1.2 0.0 29.0 0.6 1.0 6.6 0.9 0.1 0.3 0.0 0.3 0.4 0.2 0.1 0.1 1.1 1.0 0.2 0.5 2.1 3.6 0.5 0.3 0.3 0.2 2.4 0.4 0.4 0.2 0.6 2.0 0.9 1.0 1.4 7.4 0.7 0.0 0.2 0.6 0.0 0.2 0.0 0.2 0.7 0.3 0.2 6.2 12.1 3.5 2.0 5.6 0.3 3.6 0.5 0.6 4.9 9.2 0.3 1.3 1.2 1.0 1.6 2.4 1.4 3.6 1.1 5.5 0.6 4.5 1.3 0.5 17.1 0.5 5.2 6.0 8.9 48.6 8.5 3.5 1.4 2.0 1.4 117.2 21.4 13.6 14.0 0.0 1.2 6.6 4.3 5.9 2.7 52.0 0.0 5.1 0.9 1.3 4.1 5.7 260.8 3.2 3.2 6.4 3.1 10.1 4.1 2.6 2.6 27.0 0.0 25.3 0.3 5.7 28.1 1.4 41.5 1.3 0.0 0.8 1.8 0.7 1.4 1.1 4.3 16.4 6.2 FMR1NB "CT37, FLJ25736, NY-SAR-35" ENSG00000176988 "FMR1 neighbor" Q8N0W7 X 147981329-148026667 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 87 "testis: 38.0" "Group enriched" "Detected in some" 7 "Spermatocytes: 302.9;Spermatogonia: 264.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "U-266/70: 35.2;U-266/84: 27.5" "HPA011284, CAB026403" Enhanced NA NA "CAB026403: , HPA011284: AB_1078898" "unprognostic (2.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.83e-1)" "unprognostic (4.38e-2)" "unprognostic (4.11e-3)" "unprognostic (2.85e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 38.8 0.0 302.9 264.0 0.0 0.2 0.0 0.0 0.0 FNDC10 C1orf233 ENSG00000228594 "Fibronectin type III domain containing 10" F2Z333 1 1598012-1600096 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.9;brain: 17.2" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 1.3;Distal tubular cells: 3.3;Hofbauer cells: 4.5;Pancreatic endocrine cells: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 19.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-1)" "unprognostic (1.11e-1)" "unprognostic (3.22e-2)" "unprognostic (8.35e-2)" "unprognostic (7.32e-3)" "unprognostic (4.33e-2)" "unprognostic (3.33e-1)" "unprognostic (3.12e-1)" "unprognostic (2.72e-2)" "unprognostic (1.97e-1)" "prognostic favorable (1.11e-4)" "unprognostic (2.09e-2)" "unprognostic (1.50e-1)" "unprognostic (6.00e-2)" "unprognostic (5.76e-2)" 1.6 16.9 10.2 2.6 7.6 4.0 2.7 6.3 17.2 2.2 2.0 2.1 0.0 3.9 1.0 1.3 8.5 1.6 3.9 1.6 10.1 16.3 2.1 0.7 3.8 3.3 9.4 8.6 2.2 1.7 0.4 6.2 2.0 17.1 0.9 1.1 4.5 2.7 1.0 0.6 10.4 2.8 1.2 5.6 3.7 3.1 6.3 1.5 0.1 6.3 2.0 2.0 3.3 1.6 0.1 2.1 4.5 2.4 0.1 1.0 0.6 0.0 2.8 2.7 8.4 5.6 1.3 3.8 6.6 1.3 10.6 0.6 2.5 11.8 0.0 7.9 3.2 0.0 1.7 0.6 1.4 0.9 0.0 2.4 0.1 2.9 6.1 1.3 2.0 19.6 1.8 6.7 0.5 0.0 1.3 0.6 7.6 5.3 0.0 1.2 12.6 1.5 6.1 11.6 3.9 4.1 0.0 0.0 6.4 3.7 0.6 12.6 10.4 7.0 10.5 6.9 1.8 0.0 6.3 1.1 0.0 2.1 4.5 0.0 2.0 0.2 0.1 0.0 4.2 3.0 0.0 2.4 4.5 0.4 1.7 0.5 0.1 0.9 1.0 2.1 0.1 1.0 0.6 0.2 0.1 2.0 0.0 0.7 0.6 10.2 7.6 6.3 17.2 10.1 16.3 9.4 8.6 17.1 1.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 1.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FNDC3A "bA203I16.5, FNDC3, KIAA0970" ENSG00000102531 "Fibronectin type III domain containing 3A" Q9Y2H6 13 48975912-49209779 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008927, HPA012555, HPA012825" Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Centrosome" Cytosol "HPA008927: AB_1078899, HPA012555: , HPA012825: AB_1848985" "unprognostic (1.54e-1)" "unprognostic (1.34e-3)" "unprognostic (8.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (2.91e-2)" "unprognostic (5.71e-2)" "unprognostic (6.17e-2)" "unprognostic (3.16e-2)" "unprognostic (1.87e-2)" "unprognostic (4.03e-2)" "prognostic favorable (4.25e-4)" "unprognostic (8.93e-3)" "unprognostic (1.03e-1)" "unprognostic (9.60e-2)" "unprognostic (6.14e-2)" 13.9 27.2 16.9 14.8 24.9 10.0 17.4 19.4 15.0 25.3 22.3 14.6 32.0 17.8 22.4 32.2 10.6 18.2 17.9 14.0 15.0 23.1 20.4 43.0 18.1 12.0 14.6 14.8 25.0 37.4 14.1 59.0 79.8 15.7 15.6 16.2 15.1 22.5 31.6 9.1 9.2 24.7 17.5 14.8 16.2 18.5 18.8 16.6 13.2 34.2 11.6 12.7 17.8 15.4 6.6 7.6 8.7 6.9 3.9 7.9 3.2 4.5 5.2 19.2 5.0 24.3 30.8 3.7 21.3 28.5 20.6 15.0 7.1 11.1 3.4 4.0 16.0 8.9 4.9 11.4 7.2 30.0 8.6 8.8 5.6 15.0 13.0 14.8 5.2 0.9 15.7 10.1 18.2 21.2 19.3 21.2 4.8 6.9 8.5 22.3 1.8 5.1 10.4 9.4 9.8 4.4 4.9 7.6 6.3 17.3 8.4 7.3 12.0 8.0 7.2 15.2 12.7 3.8 10.2 16.6 10.7 7.4 9.9 15.0 10.4 5.4 3.2 8.1 6.7 11.0 3.4 5.7 3.6 5.2 4.0 7.5 6.6 6.1 4.4 3.6 4.9 7.9 6.7 8.7 3.9 6.9 7.6 4.7 3.2 16.9 24.9 19.4 14.5 15.0 23.1 14.6 14.8 15.7 16.6 50.6 43.5 17.9 23.8 16.4 46.2 21.6 25.5 32.1 30.7 34.9 35.3 10.1 11.6 24.5 39.5 33.8 23.2 0.0 31.5 29.4 31.7 42.8 30.1 63.7 22.7 33.4 41.8 27.6 26.5 7.9 31.4 34.7 35.4 25.2 35.7 64.1 29.0 25.4 37.1 38.9 46.7 6.5 26.9 73.8 28.1 10.5 27.0 19.3 22.5 24.4 FNDC3B "DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421" ENSG00000075420 "Fibronectin type III domain containing 3B" Q53EP0 3 172039628-172401665 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 22.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007859 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA007859: AB_1078900" "unprognostic (7.18e-2)" "prognostic unfavorable (2.41e-5)" "unprognostic (6.03e-2)" "unprognostic (6.38e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (3.25e-2)" "prognostic unfavorable (9.85e-4)" "unprognostic (2.17e-3)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (9.06e-5)" "unprognostic (3.50e-2)" "prognostic unfavorable (5.65e-7)" "unprognostic (4.35e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-2)" 39.6 22.1 4.0 16.5 5.7 18.2 27.3 2.9 5.1 20.8 18.4 4.2 20.9 7.5 28.9 21.7 13.2 12.3 18.3 18.9 4.9 4.2 17.6 35.6 23.1 10.9 6.7 2.3 26.4 30.7 12.3 21.4 64.1 5.9 15.1 11.5 13.4 27.7 19.8 22.0 8.1 13.1 17.8 6.6 17.5 15.0 10.5 5.0 4.8 21.2 10.5 12.8 25.4 25.8 0.6 2.7 22.7 5.0 2.4 2.6 1.8 12.2 14.2 9.9 12.0 31.0 21.4 24.0 17.6 19.9 11.9 16.3 7.8 27.1 1.2 47.2 26.5 23.7 7.3 3.4 14.3 21.0 7.0 2.5 1.7 9.1 21.4 31.2 15.7 27.6 21.6 7.3 22.2 21.2 28.6 31.7 2.2 2.8 8.9 12.5 3.8 0.6 6.9 5.7 4.7 5.8 1.4 10.2 5.9 13.1 10.9 0.6 3.0 16.8 8.7 14.6 14.3 8.2 8.1 45.8 16.8 7.8 21.2 13.8 18.7 20.7 2.4 17.7 9.1 16.5 7.8 5.0 11.4 2.6 3.0 1.1 0.6 0.8 1.4 2.7 0.0 0.9 1.6 22.7 2.4 1.5 0.4 0.7 1.8 4.0 5.7 2.9 5.1 4.9 4.2 6.7 2.3 5.9 5.0 80.4 43.5 12.0 47.6 56.7 7.5 43.1 50.9 13.4 35.2 43.6 11.8 35.6 13.3 62.0 7.7 56.2 22.4 0.0 39.5 90.0 84.5 54.9 15.0 60.6 44.9 0.0 16.1 62.0 65.2 5.3 53.2 61.1 65.8 50.5 28.4 16.6 73.1 40.8 51.2 30.5 12.2 51.8 50.5 2.4 2.7 29.4 29.1 19.2 20.0 74.5 FNDC4 "FLJ22362, FRCP1" ENSG00000115226 "Fibronectin type III domain containing 4" Q9H6D8 2 27491883-27495245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.9;liver: 57.6" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 165.4;Hepatocytes: 113.4;Late spermatids: 388.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 17.0;ASC diff: 17.4;HUVEC TERT2: 20.9;SH-SY5Y: 16.3;TIME: 19.0;U-87 MG: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051804, HPA063581" Uncertain Approved Nucleoplasm,Aggresome,Cytosol "Intracellular and membrane" NA NA Nucleoplasm "Aggresome, Cytosol" "HPA051804: AB_2681617, HPA063581: AB_2685048" "unprognostic (2.57e-1)" "unprognostic (1.19e-3)" "unprognostic (3.87e-2)" "prognostic unfavorable (5.07e-4)" "unprognostic (1.46e-3)" "unprognostic (1.27e-1)" "unprognostic (4.77e-3)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (9.64e-2)" "unprognostic (8.28e-3)" "unprognostic (4.41e-2)" "unprognostic (1.28e-2)" "unprognostic (1.13e-2)" "unprognostic (5.74e-3)" "unprognostic (2.40e-3)" "prognostic unfavorable (6.11e-4)" 18.5 45.9 13.4 2.7 13.7 0.7 9.1 10.8 29.5 3.8 2.0 4.0 0.5 1.5 2.8 2.8 11.8 1.5 10.0 3.1 15.6 8.5 2.3 57.6 2.0 1.4 12.0 8.6 16.5 4.6 18.6 2.8 2.5 22.2 6.3 2.1 1.9 2.1 3.3 1.3 2.4 1.4 4.7 5.4 3.5 3.2 10.2 3.8 0.0 1.8 0.7 2.7 4.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 17.0 17.4 10.7 0.1 3.9 7.8 2.8 2.5 0.7 0.2 0.0 0.4 12.3 3.7 0.0 6.5 2.3 2.5 0.0 1.0 0.8 0.0 8.7 6.5 0.0 0.1 9.1 1.1 4.9 1.0 12.9 20.9 0.0 0.9 0.0 10.3 0.0 0.0 0.0 6.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.1 16.3 0.1 0.0 0.1 1.3 0.0 0.0 19.0 2.7 1.2 1.0 3.0 0.0 0.0 0.0 14.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.7 10.8 29.5 15.6 8.5 12.0 8.6 22.2 3.8 0.0 0.3 0.0 2.8 3.1 8.2 2.5 10.2 0.0 0.0 0.0 3.9 0.1 3.3 68.5 165.4 5.8 0.0 0.0 41.6 0.1 8.1 14.7 5.7 113.4 0.5 0.0 0.0 6.2 1.3 388.8 14.4 0.6 3.3 1.8 0.0 12.3 60.5 0.0 11.0 0.2 11.8 0.0 11.3 4.9 3.6 2.0 0.0 0.0 0.0 1.0 FNDC5 FRCP2 ENSG00000160097 "Fibronectin type III domain containing 5" Q8NAU1 1 32862268-32872482 "Predicted membrane proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 110.0;tongue: 33.3" "Group enriched" "Detected in some" 7 "Bipolar cells: 68.2;Cardiomyocytes: 56.9;Early spermatids: 25.8;Muller glia cells: 40.4" "Group enriched" "Detected in many" 7 "glioma: 4.2;liver cancer: 10.0;testis cancer: 14.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RH-30: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051290 Enhanced "Intracellular and membrane" NA NA "HPA051290: AB_2681422" "unprognostic (4.36e-2)" "unprognostic (9.08e-3)" "unprognostic (7.62e-4)" "unprognostic (1.03e-2)" "unprognostic (3.77e-2)" "unprognostic (6.26e-2)" "unprognostic (5.68e-2)" "unprognostic (2.76e-2)" "unprognostic (1.45e-2)" "unprognostic (1.83e-1)" "unprognostic (3.15e-3)" "unprognostic (1.63e-1)" "unprognostic (9.07e-2)" "unprognostic (7.07e-3)" "unprognostic (1.13e-1)" "unprognostic (3.37e-3)" "unprognostic (1.33e-2)" 1.2 6.3 3.4 0.6 5.1 0.6 0.9 26.7 13.6 1.0 0.8 1.7 0.0 0.9 2.1 1.5 4.9 2.6 1.4 15.9 3.6 4.1 0.9 8.6 1.0 0.6 5.0 3.7 3.0 0.8 2.5 2.3 0.8 9.5 2.0 0.7 8.2 12.3 1.0 110.0 0.6 1.0 1.5 2.8 0.6 2.3 1.3 1.7 0.0 1.0 33.3 1.3 0.9 0.4 0.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.9 0.2 0.0 1.3 0.1 0.4 0.1 0.5 0.1 0.9 0.2 0.1 0.6 0.3 0.2 0.0 3.9 0.0 0.1 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.0 2.4 0.0 0.3 0.0 0.5 0.0 0.2 0.7 0.1 0.9 0.1 0.1 0.1 1.4 0.0 0.1 0.4 32.7 0.2 0.0 0.0 5.6 0.9 0.3 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.6 1.5 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 5.1 26.7 13.6 3.6 4.1 5.0 3.7 9.5 1.7 0.0 0.0 0.0 0.1 0.1 68.2 56.9 0.0 0.0 0.0 1.8 3.9 0.0 1.7 0.0 25.8 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 1.0 0.7 0.0 0.0 0.0 0.0 2.6 4.9 0.0 0.0 0.0 0.0 40.4 0.2 0.0 5.3 0.1 7.3 0.0 1.0 0.5 0.9 0.0 0.2 0.0 0.3 0.1 FNDC9 "C5orf40, MGC27121" ENSG00000172568 "Fibronectin type III domain containing 9" Q8TBE3 5 157341600-157345721 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "adrenal gland: 9.4;brain: 24.0;pituitary gland: 10.0" "Cell type enriched" "Detected in single" 5 "Bipolar cells: 3.4" "Cancer enriched" "Detected in single" 16 "glioma: 0.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 1.7;HeLa: 1.8;Karpas-707: 3.0;U-266/70: 1.6" "Group enriched" "Detected in many" 5 "basal ganglia: 21.9;hypothalamus: 28.4" "Low region specificity" "Detected in all" HPA011115 Uncertain NA NA "HPA011115: AB_1079374" "unprognostic (2.35e-3)" "unprognostic (3.80e-2)" "unprognostic (2.93e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-3)" "unprognostic (3.40e-1)" "unprognostic (1.95e-1)" "unprognostic (1.68e-1)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (6.35e-6)" "unprognostic (3.63e-2)" "unprognostic (6.39e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" 0.6 9.4 3.9 1.5 21.1 2.0 0.6 9.1 24.0 0.5 1.1 0.0 0.0 0.6 0.6 0.9 0.5 0.6 0.6 0.7 1.9 22.0 0.7 0.6 0.5 0.9 1.3 3.8 0.5 0.5 0.5 10.0 0.6 5.8 0.6 1.2 0.0 0.5 0.6 0.6 0.6 0.8 0.8 1.3 0.6 0.6 0.5 0.4 0.0 0.6 0.0 0.5 0.6 0.0 0.5 0.3 0.8 0.8 0.0 1.9 0.1 0.0 0.2 0.4 0.4 0.0 0.0 0.4 1.0 0.0 0.2 0.0 0.2 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 3.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.4 0.1 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.6 1.0 0.3 0.3 1.6 0.0 1.0 0.4 0.0 0.1 0.0 0.0 0.8 1.9 0.2 0.1 0.0 0.6 1.3 0.0 0.5 0.8 1.5 0.2 0.0 0.8 0.3 0.0 0.1 3.9 21.1 9.1 13.3 1.9 22.0 1.3 3.8 5.8 0.4 0.0 0.0 0.0 0.0 0.0 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FO681492.1 ENSG00000277758 10 47750864-47763592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.2;brain: 6.7;lung: 10.6" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 37.0" "HPA036971, HPA036972, HPA064559" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (2.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-2)" "unprognostic (5.70e-2)" "unprognostic (4.59e-1)" "unprognostic (2.51e-1)" "unprognostic (2.06e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (2.69e-2)" "unprognostic (1.97e-1)" "unprognostic (3.49e-5)" "unprognostic (4.52e-2)" "unprognostic (5.13e-2)" "unprognostic (6.35e-2)" "unprognostic (1.11e-2)" 0.5 0.0 0.1 0.0 0.0 6.7 0.3 0.0 0.0 0.1 0.0 2.4 1.1 0.4 0.4 0.0 0.0 10.6 2.3 0.3 1.4 0.0 1.1 0.0 0.0 1.4 0.4 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.9 0.7 2.5 0.4 5.2 0.9 1.1 0.4 0.5 4.2 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.1 0.0 2.7 3.0 0.0 0.2 1.2 0.8 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.2 2.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 3.3 37.0 0.1 0.2 3.2 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.3 2.3 0.3 0.7 2.8 1.1 0.7 1.1 0.8 2.5 0.3 0.5 0.7 0.4 0.9 5.2 1.0 0.7 0.4 3.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOLH1 "FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA" ENSG00000086205 "Folate hydrolase 1" Q04609 11 49146635-49208670 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.7;intestine: 111.2;prostate: 33.8" "Cell type enhanced" "Detected in some" 16 "Glandular cells: 41.1;Hepatocytes: 24.1;Muller glia cells: 17.3;Proximal tubular cells: 22.6" "Cancer enriched" "Detected in many" 27 "prostate cancer: 142.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 5.4;RPMI-8226: 3.8;SK-BR-3: 4.5;TIME: 2.9;U-2 OS: 2.7;WM-115: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001451, HPA010593" Enhanced NA NA "CAB001451: AB_563979, HPA010593: AB_1079685" "unprognostic (1.33e-1)" "unprognostic (1.19e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.24e-5)" "unprognostic (2.55e-1)" "unprognostic (8.31e-2)" "prognostic favorable (4.25e-4)" "unprognostic (1.32e-1)" "unprognostic (2.09e-2)" "unprognostic (2.67e-3)" "unprognostic (2.13e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (1.30e-6)" "unprognostic (4.81e-2)" "unprognostic (7.27e-2)" "unprognostic (4.74e-3)" "unprognostic (4.04e-1)" 1.2 1.0 10.4 0.9 16.4 0.8 2.5 1.4 12.7 1.4 67.6 37.7 0.0 111.2 1.3 0.8 1.2 2.1 5.0 0.7 16.9 8.7 6.1 15.7 1.1 0.9 19.0 9.1 1.0 0.7 0.7 0.4 0.7 17.7 33.8 0.8 0.6 20.7 0.8 0.6 1.2 61.1 1.0 33.0 1.5 1.0 0.9 16.2 0.0 1.0 0.0 0.8 1.2 0.5 0.9 0.1 0.3 0.8 1.4 1.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.7 0.0 0.2 0.2 5.4 0.5 0.0 1.3 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 1.1 0.0 0.0 0.0 1.1 1.0 0.2 0.0 0.4 0.3 3.8 0.0 0.0 0.4 1.7 0.0 4.5 1.0 0.6 1.0 0.0 2.9 0.2 2.7 0.4 0.3 0.1 0.5 0.1 0.0 0.9 5.4 0.1 0.8 0.3 0.9 0.6 0.2 0.6 1.2 0.5 0.0 0.9 0.7 0.3 0.2 1.4 0.5 0.1 0.4 0.0 10.4 16.4 1.4 12.7 16.9 8.7 19.0 9.1 17.7 16.2 0.0 1.1 0.0 0.8 0.2 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 6.6 0.0 3.5 0.3 0.0 0.0 0.0 0.0 0.4 41.1 0.0 24.1 0.1 0.0 0.0 3.1 0.0 1.0 1.4 0.0 3.3 0.0 0.0 17.3 0.0 0.0 0.4 22.6 0.2 0.0 0.3 0.2 1.6 0.6 0.0 0.0 0.0 0.5 FOLR1 FOLR ENSG00000110195 "Folate receptor 1" P15328 11 72189558-72196323 "Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" Transport Receptor Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 157.6;salivary gland: 101.2" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 461.6;Club cells: 316.2;Collecting duct cells: 301.8;Cytotrophoblasts: 307.8;Proximal tubular cells: 286.0;Syncytiotrophoblasts: 216.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 259.5" "Region enriched" "Detected in many" 20 "pons and medulla: 157.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HeLa: 83.6;RPTEC TERT1: 88.8" "Group enriched" "Detected in many" 5 "basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0" "Low region specificity" "Detected in all" HPA077030 Approved "Nuclear membrane" "Secreted to blood" NA NA 81000 "Nuclear membrane" "HPA077030: " "unprognostic (3.30e-1)" "unprognostic (2.19e-1)" "unprognostic (6.55e-2)" "unprognostic (3.49e-2)" "unprognostic (7.67e-3)" "unprognostic (1.98e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.18e-2)" "unprognostic (8.13e-2)" "unprognostic (2.47e-2)" "unprognostic (2.58e-2)" "unprognostic (2.87e-3)" "unprognostic (1.67e-1)" "unprognostic (2.52e-1)" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (2.69e-1)" 0.0 0.7 1.3 0.2 1.7 0.0 6.6 0.6 3.5 31.4 0.1 21.4 2.8 0.0 1.0 3.5 1.6 46.7 1.0 0.2 7.9 1.8 38.8 0.2 47.0 0.0 0.8 0.4 8.9 1.8 0.4 3.5 24.5 157.6 1.5 0.0 17.0 101.2 4.0 0.1 0.9 0.1 0.0 0.7 0.0 7.4 0.4 0.2 0.0 12.7 2.6 3.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 7.8 7.9 0.0 8.1 0.1 0.0 0.1 0.4 0.3 0.0 0.0 0.2 0.1 83.6 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.7 0.0 88.8 0.0 0.0 0.5 0.2 1.2 0.0 7.3 11.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.3 1.7 0.6 3.5 7.9 1.8 0.8 0.4 157.6 0.2 461.6 156.4 0.0 7.8 0.8 0.0 0.3 35.7 178.0 316.2 301.8 0.0 307.8 112.7 15.6 0.0 0.0 0.0 0.0 1.2 101.0 3.8 4.7 4.7 0.0 26.1 0.0 1.7 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 1.4 4.1 0.0 0.0 286.0 0.0 0.0 0.1 0.0 0.1 0.1 216.6 0.0 0.0 8.6 FP565260.3 ENSG00000277117 21 5022493-5040666 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell type enriched" "Detected in single" 22 "monocytes: 8.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 5.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 16.3;REH: 12.7;SiHa: 10.9" HPA029179 Approved "Plasma membrane,Cytoplasmic bodies" NA NA "Plasma membrane, Cytoplasmic bodies" "HPA029179: AB_2732445" "unprognostic (3.34e-2)" "unprognostic (1.52e-1)" "unprognostic (2.82e-1)" "unprognostic (3.58e-4)" "unprognostic (6.66e-4)" "unprognostic (1.24e-2)" "unprognostic (1.12e-1)" "unprognostic (3.36e-1)" "unprognostic (2.46e-1)" "unprognostic (6.63e-2)" "unprognostic (1.14e-1)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (3.17e-1)" "unprognostic (3.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-1)" 1.5 0.2 0.6 3.4 4.5 2.4 1.9 0.4 7.0 2.6 2.0 9.2 0.6 4.3 0.8 1.7 1.4 2.1 2.6 2.9 2.2 2.5 2.3 1.2 4.5 4.2 3.1 0.2 1.8 0.0 0.0 1.9 4.3 1.3 1.6 0.1 1.3 1.0 0.7 3.1 2.8 0.7 2.6 2.3 4.1 0.5 3.6 0.0 1.0 1.9 5.7 1.6 1.2 5.3 0.9 0.0 3.0 0.0 1.1 0.8 0.2 0.6 0.0 1.1 0.3 0.7 16.3 1.3 1.0 0.2 0.0 3.9 0.7 8.7 2.6 0.0 2.1 3.1 1.0 1.2 0.2 0.2 0.8 0.0 0.5 2.1 0.2 6.7 6.4 0.1 1.7 0.9 0.8 0.0 0.9 0.0 1.0 0.3 0.1 2.2 0.0 4.0 0.6 10.8 5.3 12.7 0.4 8.9 0.4 5.5 0.7 0.0 10.9 9.6 0.1 0.6 2.9 9.0 0.3 0.0 2.5 0.0 0.2 6.0 6.1 5.7 6.9 3.8 1.5 0.0 0.6 0.0 0.0 3.0 0.3 2.9 0.5 0.2 0.7 5.3 0.1 0.5 0.0 0.0 0.6 0.9 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FPR1 "FMLP, FPR" ENSG00000171051 "Formyl peptide receptor 1" P21462 19 51745172-51804110 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 213.3;lymphoid tissue: 64.4" "Cell type enhanced" "Detected in many" 21 "Hofbauer cells: 97.2;Kupffer cells: 262.0;Macrophages: 111.7" "Cancer enhanced" "Detected in all" "glioma: 23.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 213.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 213.3" "Cell line enriched" "Detected in some" 5 "U-87 MG: 35.0" "Not detected" "Not detected" "HPA046550, HPA061744" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA046550: AB_2679694, HPA061744: AB_2684600" "unprognostic (5.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-1)" "unprognostic (5.48e-3)" "unprognostic (4.59e-2)" "unprognostic (8.34e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.03e-2)" "unprognostic (4.52e-3)" "unprognostic (1.54e-2)" "unprognostic (1.70e-3)" 22.6 3.7 5.2 52.2 12.4 54.5 2.9 1.1 6.3 2.6 2.4 5.9 0.0 1.1 2.3 2.3 3.3 8.4 9.6 11.2 15.7 4.3 6.0 7.5 28.8 58.4 15.5 0.8 1.9 3.5 0.8 2.3 13.0 9.7 1.8 1.2 2.4 2.4 0.9 3.2 1.1 2.2 12.8 14.3 64.4 3.2 2.9 10.1 0.9 2.7 0.7 3.2 7.9 4.6 0.0 8.9 213.3 36.3 0.0 0.0 16.9 0.3 0.5 0.2 0.3 0.4 1.1 0.3 0.2 0.0 0.3 1.0 0.2 0.3 0.6 0.3 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 2.8 0.2 0.4 2.4 0.1 0.9 0.8 4.2 0.0 0.2 0.1 0.4 7.1 0.5 0.1 0.2 0.2 0.2 0.4 0.2 0.4 0.0 0.6 0.3 0.1 0.2 0.4 0.1 0.3 0.1 0.6 0.6 0.5 1.2 0.3 0.0 1.7 0.1 0.0 0.3 35.0 0.9 0.1 13.0 36.3 10.0 0.0 15.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 213.3 0.0 9.5 0.3 0.0 16.9 5.2 12.4 1.1 6.3 15.7 4.3 15.5 0.8 9.7 10.1 14.9 40.8 6.2 0.2 0.6 0.4 0.2 0.0 16.0 28.4 0.0 0.0 0.9 0.0 0.0 1.2 0.4 0.0 0.0 0.0 1.2 0.9 0.2 24.4 1.7 97.2 0.0 0.0 4.3 262.0 1.3 0.3 111.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 6.5 1.0 0.5 0.6 0.0 2.5 0.0 0.0 0.0 FPR2 "ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R" ENSG00000171049 "Formyl peptide receptor 2" P25090 19 51752026-51770526 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 128.2;lymphoid tissue: 32.2" "Cell type enhanced" "Detected in some" 13 "Hofbauer cells: 10.2;Kupffer cells: 24.7;Late spermatids: 14.9;Macrophages: 25.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "neutrophil: 128.2" "Lineage enriched" "Detected in many" 10 "granulocytes: 128.2" "Cell line enriched" "Detected in some" 18 "U-937: 26.0" HPA029154 Approved NA NA "HPA029154: AB_10602133" "unprognostic (3.11e-1)" "unprognostic (5.20e-2)" "unprognostic (1.71e-2)" "unprognostic (1.44e-1)" "unprognostic (1.07e-1)" "unprognostic (1.65e-1)" "unprognostic (1.81e-1)" "unprognostic (1.19e-1)" "unprognostic (1.00e-1)" "unprognostic (1.23e-1)" "unprognostic (5.04e-2)" "unprognostic (3.90e-4)" "unprognostic (3.41e-5)" "unprognostic (1.08e-2)" "unprognostic (4.69e-2)" "unprognostic (5.10e-2)" "unprognostic (1.90e-1)" 7.9 1.1 0.6 30.7 2.1 8.7 0.8 0.4 1.9 0.6 0.8 0.8 0.0 0.4 0.6 0.2 1.0 2.6 3.3 5.0 1.9 0.6 1.3 2.4 17.3 32.2 2.8 0.0 1.6 1.1 0.0 1.1 4.4 2.3 0.6 0.1 1.1 1.0 0.0 1.1 0.4 1.1 3.3 3.0 29.1 1.2 2.5 1.6 0.8 1.0 0.9 0.3 4.4 2.2 0.0 1.7 128.2 12.7 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.7 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.8 26.0 0.0 0.4 12.7 0.6 0.0 11.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 128.2 0.0 7.5 0.3 0.0 3.9 0.6 2.1 0.4 1.9 1.9 0.6 2.8 0.0 2.3 1.6 0.0 5.3 0.8 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.4 10.2 0.0 0.0 0.6 24.7 14.9 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 FPR3 "FMLPY, FPRH1, FPRL2, RMLP-R-I" ENSG00000187474 "Formyl peptide receptor 3" P25089 19 51795163-51826189 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.9" "Group enriched" "Detected in some" 10 "Hofbauer cells: 59.4;Kupffer cells: 71.5;Macrophages: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 20 "classical monocyte: 3.2;intermediate monocyte: 9.6;myeloid DC: 3.4" "Group enriched" "Detected in many" 43 "dendritic cells: 3.4;monocytes: 9.6" "Group enriched" "Detected in some" 4 "HEL: 14.7;hTERT-RPE1: 4.2" NA NA "unprognostic (3.77e-2)" "unprognostic (1.54e-1)" "unprognostic (1.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.15e-1)" "unprognostic (1.84e-1)" "unprognostic (8.41e-2)" "unprognostic (1.39e-1)" "unprognostic (1.37e-2)" "unprognostic (7.14e-2)" "unprognostic (3.17e-1)" "unprognostic (9.37e-2)" "unprognostic (1.02e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (9.13e-4)" "unprognostic (1.96e-1)" "unprognostic (4.28e-2)" 35.9 10.0 1.5 12.9 2.1 0.0 6.2 0.6 1.8 3.2 6.6 1.8 0.5 5.9 3.1 7.0 3.4 3.0 10.7 6.3 1.7 1.2 6.8 13.0 25.9 15.1 2.8 0.9 5.4 3.2 0.7 2.2 5.2 2.4 5.0 10.3 4.9 5.1 1.3 4.6 2.3 10.9 4.6 5.2 10.8 3.4 3.3 1.1 8.0 2.7 6.4 10.1 9.3 2.6 0.0 3.4 0.1 9.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 14.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 4.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 3.2 0.0 0.0 9.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.6 1.5 2.1 0.6 1.8 1.7 1.2 2.8 0.9 2.4 1.1 0.0 1.7 2.4 0.0 4.9 0.0 0.3 0.0 2.7 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.0 0.2 0.0 0.5 59.4 0.0 0.0 1.8 71.5 0.0 0.3 66.8 6.8 4.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 4.0 0.7 0.0 0.0 0.0 FRAS1 "FLJ14927, FLJ22031, KIAA1500" ENSG00000138759 "Fraser extracellular matrix complex subunit 1" Q86XX4 4 78057570-78544269 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 17.9" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 29.8;Cholangiocytes: 22.9;Collecting duct cells: 27.9;Cytotrophoblasts: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 23.4;Hep G2: 14.1;RH-30: 13.5;SiHa: 14.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051601 Approved "Intracellular and membrane" NA NA "HPA051601: AB_2681547" "unprognostic (1.33e-2)" "unprognostic (1.04e-2)" "unprognostic (9.37e-2)" "unprognostic (8.91e-2)" "unprognostic (2.97e-1)" "unprognostic (2.04e-1)" "unprognostic (1.45e-3)" "unprognostic (2.02e-2)" "unprognostic (1.07e-1)" "unprognostic (2.69e-2)" "unprognostic (2.09e-2)" "unprognostic (4.02e-2)" "prognostic favorable (4.69e-4)" "unprognostic (2.56e-1)" "unprognostic (1.10e-1)" "unprognostic (4.78e-3)" "unprognostic (6.09e-2)" 2.0 1.2 6.2 5.0 10.1 0.1 1.3 0.9 6.4 3.6 2.7 0.7 0.1 0.6 3.3 3.1 2.0 1.5 4.1 2.6 2.3 2.3 11.6 0.8 5.2 0.3 1.2 1.8 0.9 7.9 0.7 5.5 8.3 3.8 3.2 2.2 1.3 1.8 1.3 3.7 2.1 1.4 2.2 0.9 1.1 1.6 1.4 1.0 2.1 17.9 1.9 0.4 1.3 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.9 4.4 1.8 0.0 4.8 2.0 3.2 0.7 2.7 0.4 0.2 3.5 6.5 0.0 5.5 23.4 0.0 0.9 2.5 1.4 0.1 0.0 2.5 2.7 5.3 14.1 0.5 0.0 0.0 9.7 1.5 0.0 3.5 3.7 0.1 0.2 0.0 0.0 2.7 0.1 0.1 0.0 5.7 2.3 0.9 0.0 13.5 0.0 5.9 6.4 3.3 6.5 14.1 4.5 0.8 8.6 0.0 0.0 0.0 0.0 3.1 1.9 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 10.1 0.9 6.4 2.3 2.3 1.2 1.8 3.8 1.0 29.8 0.0 0.0 2.3 1.6 9.0 6.9 22.9 1.4 14.8 27.9 0.0 22.8 3.3 4.7 1.9 2.1 0.4 0.0 1.6 1.0 5.4 1.4 0.0 0.0 3.9 0.0 1.2 0.6 0.0 2.0 0.6 0.3 1.7 0.0 1.1 0.3 1.9 0.0 0.0 3.9 2.6 0.0 3.2 0.0 1.3 1.1 13.0 0.0 1.0 0.2 FREM1 "C9orf143, C9orf145, C9orf154, DKFZp686M16108, FLJ25461, TILRR" ENSG00000164946 "FRAS1 related extracellular matrix 1" Q5H8C1 9 14734666-14910995 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Developmental protein" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 33.3;epididymis: 30.8" "Group enriched" "Detected in some" 7 "Early spermatids: 69.1;Late spermatids: 99.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 22.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HEL: 63.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "unprognostic (1.13e-5)" "unprognostic (2.59e-3)" "unprognostic (2.89e-1)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (6.27e-3)" "unprognostic (2.50e-1)" "unprognostic (4.66e-3)" "unprognostic (4.43e-1)" "unprognostic (1.31e-1)" "unprognostic (3.62e-2)" "unprognostic (6.23e-2)" "unprognostic (8.95e-13)" "unprognostic (2.28e-3)" "unprognostic (8.53e-2)" "unprognostic (3.41e-2)" "unprognostic (2.86e-1)" 4.4 2.5 1.5 3.2 1.4 0.2 4.0 22.2 2.5 10.9 7.5 5.0 22.9 1.8 33.3 30.8 0.9 4.5 3.1 7.3 1.8 2.0 10.4 0.8 2.6 0.1 1.1 1.0 2.3 14.2 6.0 1.2 4.6 4.0 3.1 1.5 5.0 1.0 11.4 0.7 2.6 9.3 12.8 2.7 0.4 1.3 3.5 0.6 1.7 0.8 3.4 1.1 2.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 22.2 2.5 1.8 2.0 1.1 1.0 4.0 0.6 0.0 1.1 0.0 0.2 1.1 0.7 2.0 5.1 0.0 0.0 1.8 0.0 0.4 0.0 0.2 69.1 0.0 0.7 0.0 0.0 0.2 11.3 0.1 4.7 0.0 0.4 0.0 0.0 6.2 1.2 99.8 0.6 0.0 0.0 1.0 0.1 4.0 0.3 0.0 1.4 1.0 0.0 0.0 1.0 0.7 0.6 1.0 0.2 0.0 0.2 0.0 FREM2 DKFZp686J0811 ENSG00000150893 "FRAS1 related extracellular matrix protein 2" Q5SZK8 13 38687129-38887131 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 13.9;lung: 11.2;thyroid gland: 12.2" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 19.8;Cholangiocytes: 7.6;Proximal tubular cells: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.2;HAP1: 8.2;MCF7: 5.9;RT4: 5.5;SK-BR-3: 5.0;SuSa: 24.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA028831 Uncertain Approved Cytosol NA NA 170000 Cytosol "HPA028831: AB_10603668" "unprognostic (1.71e-2)" "unprognostic (3.72e-1)" "unprognostic (1.92e-1)" "unprognostic (1.10e-1)" "unprognostic (4.69e-1)" "unprognostic (6.24e-2)" "unprognostic (1.62e-1)" "unprognostic (8.42e-3)" "unprognostic (8.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.25e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.23e-7)" "unprognostic (7.21e-2)" "unprognostic (1.40e-1)" "unprognostic (9.92e-2)" "unprognostic (3.14e-1)" 0.6 0.4 1.3 0.1 1.7 0.1 0.5 1.5 6.4 0.7 1.3 1.2 1.1 0.4 1.1 0.5 0.2 0.9 1.5 0.2 2.8 0.4 13.9 3.4 11.2 0.1 0.4 0.8 1.8 5.2 0.1 1.1 2.6 0.8 3.5 0.4 2.9 0.4 1.5 6.3 0.6 0.7 0.7 0.4 0.3 2.2 1.8 1.5 0.1 12.2 4.1 0.1 1.5 0.3 0.3 0.3 0.9 0.2 0.2 0.2 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 8.2 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.8 0.0 0.1 0.0 1.1 0.1 1.8 5.5 0.1 0.1 0.0 5.0 0.2 24.6 0.9 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.6 0.9 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.2 0.7 0.2 0.2 0.3 0.1 0.0 1.3 1.7 1.5 6.4 2.8 0.4 0.4 0.8 0.8 1.5 0.0 19.8 0.0 0.1 0.6 0.1 2.0 7.6 5.3 2.3 1.8 0.0 5.1 5.0 1.7 0.6 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 1.3 0.0 0.0 22.4 0.2 0.0 0.0 0.1 0.4 0.1 1.6 0.0 0.0 0.0 FRMD3 "EPB41L4O, MGC20553" ENSG00000172159 "FERM domain containing 3" A2A2Y4 9 83242990-83538546 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.5;skeletal muscle: 42.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 102.0;Cardiomyocytes: 66.5;Cone photoreceptor cells: 74.6;Early spermatids: 112.3;Horizontal cells: 95.3;Late spermatids: 100.0;Sertoli cells: 71.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 27.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1" "Group enriched" "Detected in many" 6 "granulocytes: 3.8;monocytes: 4.7" "Cell line enhanced" "Detected in some" "HEL: 11.2;OE19: 23.5;RPMI-8226: 37.7;SCLC-21H: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017285 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA017285: AB_2669569" "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.93e-1)" "unprognostic (6.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.93e-1)" "unprognostic (3.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.23e-1)" "unprognostic (5.87e-2)" "prognostic favorable (7.24e-4)" "unprognostic (3.12e-1)" "unprognostic (1.88e-1)" "prognostic favorable (1.79e-4)" "unprognostic (1.68e-3)" 12.7 4.6 3.5 2.8 2.3 3.0 16.8 2.0 3.0 4.6 7.1 1.7 14.3 1.9 5.5 9.8 4.1 1.9 2.9 48.5 3.2 4.5 11.7 0.7 2.9 0.9 3.6 1.7 1.4 1.4 8.9 6.1 8.7 2.9 5.1 4.1 5.3 2.1 35.3 42.1 1.6 10.9 3.5 2.8 4.3 2.2 6.1 0.8 0.0 8.8 11.1 0.7 3.8 5.0 0.6 0.6 3.8 4.7 0.4 0.6 9.2 0.0 2.1 1.8 0.1 0.3 0.1 0.1 2.0 0.1 0.0 0.0 0.2 2.5 0.4 2.3 0.9 0.4 0.1 0.1 0.0 0.0 0.1 0.1 11.2 2.4 1.3 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.2 23.5 3.5 0.0 1.5 37.7 3.1 4.9 13.9 6.7 0.7 0.1 0.4 0.3 0.8 0.4 2.1 0.1 0.3 0.0 1.4 0.2 0.1 0.0 0.5 3.6 1.4 0.0 2.8 0.0 0.4 4.7 0.6 0.5 0.2 0.1 0.4 0.6 0.1 0.0 3.8 0.4 2.1 0.6 0.0 9.2 3.5 2.3 2.0 3.0 3.2 4.5 3.6 1.7 2.9 0.8 20.8 0.6 0.0 1.0 0.9 102.0 66.5 10.2 0.0 2.3 1.8 74.6 0.3 14.9 2.5 112.3 13.1 26.2 0.0 1.7 0.9 2.1 1.0 0.0 0.2 0.8 95.3 1.2 3.1 4.6 100.0 2.0 1.5 0.0 0.0 19.4 2.0 2.0 7.0 4.6 8.7 4.7 71.1 28.9 1.6 1.4 1.1 0.1 0.0 1.6 1.3 FRMD5 MGC14161 ENSG00000171877 "FERM domain containing 5" Q7Z6J6 15 43870761-44195252 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 24.5;heart muscle: 48.9" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 12.9;Early spermatids: 10.3;Muller glia cells: 14.6;Pancreatic endocrine cells: 7.2" "Cancer enhanced" "Detected in many" "glioma: 6.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "B-cells: 1.6;T-cells: 1.6" "Cell line enhanced" "Detected in many" "hTERT-HME1: 11.9;HUVEC TERT2: 14.8;WM-115: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.54e-2)" "unprognostic (2.16e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (7.26e-7)" "unprognostic (3.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" "unprognostic (5.00e-3)" "prognostic unfavorable (5.89e-4)" "unprognostic (7.01e-2)" "unprognostic (2.92e-4)" "unprognostic (1.21e-1)" "unprognostic (7.31e-2)" "unprognostic (1.18e-1)" "unprognostic (3.31e-1)" 1.0 7.2 8.9 1.4 12.3 1.6 1.3 8.2 15.1 1.0 1.7 24.5 0.0 1.0 0.9 1.3 1.2 2.0 1.3 48.9 10.9 6.9 1.2 0.8 1.0 1.1 14.7 4.8 1.0 1.1 1.1 1.6 0.9 10.7 1.2 1.8 2.9 2.0 1.2 0.8 1.2 1.3 1.1 13.4 1.2 2.2 4.3 11.5 0.0 1.2 0.0 0.8 1.1 0.2 1.6 0.3 0.0 0.0 0.0 1.6 0.0 3.3 1.9 1.2 0.7 1.5 0.1 0.2 0.7 1.1 2.1 4.2 5.6 3.7 0.2 0.7 0.5 5.6 4.0 1.8 3.9 1.9 0.2 2.0 0.5 1.7 2.4 0.1 0.0 0.2 0.0 0.4 5.9 11.9 4.3 14.8 3.0 0.1 0.4 2.3 0.3 0.5 0.0 1.0 11.4 1.9 0.0 2.7 0.0 2.0 1.2 7.8 2.7 0.4 0.0 8.0 1.0 0.1 0.1 0.5 4.1 7.1 1.0 10.5 0.2 1.0 0.4 5.9 0.2 33.8 0.0 0.0 0.0 0.8 0.0 1.6 1.6 1.2 0.4 0.0 0.5 0.6 0.9 0.0 0.0 0.0 0.3 1.6 0.0 8.9 12.3 8.2 12.4 10.9 6.9 14.7 4.8 10.7 11.5 0.0 0.0 0.0 0.0 0.3 6.2 12.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 2.2 10.3 0.0 0.0 0.0 5.3 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.2 0.0 0.0 4.1 0.3 0.0 0.0 0.0 0.3 14.6 7.2 0.0 0.0 0.6 4.1 0.0 0.0 5.8 2.5 0.0 0.0 0.0 0.6 0.0 FRRS1 "SDFR2, SDR2" ENSG00000156869 "Ferric chelate reductase 1" Q6ZNA5 1 99708632-99766631 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 27.1" "Cell type enhanced" "Detected in some" 5 "Syncytiotrophoblasts: 3.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "eosinophil: 5.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 5.5" "Cell line enhanced" "Detected in many" "HEL: 27.8;K-562: 18.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA017883 Approved NA NA "HPA017883: AB_2294223" "unprognostic (3.97e-2)" "unprognostic (8.02e-2)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (8.34e-2)" "unprognostic (1.68e-1)" "unprognostic (8.54e-3)" "unprognostic (7.00e-2)" "unprognostic (2.64e-1)" "unprognostic (8.25e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (2.65e-2)" "unprognostic (1.83e-2)" "unprognostic (3.56e-2)" "unprognostic (3.54e-2)" 10.3 6.2 0.6 2.7 1.2 1.5 5.1 0.5 1.2 6.4 6.1 1.2 14.5 2.6 10.7 6.5 11.2 2.0 3.4 2.9 0.6 0.6 1.9 27.1 3.8 1.7 2.1 0.0 5.3 2.0 1.5 2.3 9.8 0.9 4.4 4.0 1.6 8.4 13.4 2.0 7.2 8.0 3.3 3.1 1.5 4.2 2.9 1.3 1.4 5.6 5.4 6.0 5.1 7.0 0.3 0.5 5.5 0.8 0.0 0.1 0.1 5.5 1.0 2.4 2.1 7.7 4.1 12.3 1.4 2.7 1.7 6.5 6.7 7.3 3.2 5.8 1.6 2.3 12.8 3.8 5.9 2.2 6.5 2.5 27.8 2.7 7.3 1.1 3.1 7.5 6.1 7.6 3.4 1.3 0.4 0.3 2.1 18.6 0.2 1.4 1.7 1.0 1.2 1.7 12.5 5.1 0.0 9.1 1.3 1.1 13.9 0.5 0.1 2.3 10.5 5.4 1.9 3.8 4.0 0.6 3.0 4.1 2.6 1.5 2.3 0.0 5.5 6.7 1.3 1.4 0.5 0.4 5.5 0.0 0.8 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.6 1.2 0.5 1.2 0.6 0.6 2.1 0.0 0.9 1.3 0.0 0.0 0.0 1.7 1.6 0.0 0.7 0.0 2.7 0.0 1.8 0.0 2.1 0.0 0.2 0.1 0.1 1.3 0.0 0.0 1.6 1.3 1.0 0.0 2.5 1.0 0.0 0.0 0.0 2.2 0.0 0.9 0.0 0.0 1.0 0.0 0.8 0.3 0.9 0.0 0.1 0.0 0.0 0.3 0.0 0.3 2.4 3.1 0.0 0.2 2.2 FRRS1L "C9orf4, CG-6" ENSG00000260230 "Ferric chelate reductase 1 like" Q9P0K9 9 109130293-109167295 "Disease related genes, Predicted membrane proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.0;ovary: 15.2" "Group enriched" "Detected in many" 5 "Bipolar cells: 51.6;Horizontal cells: 92.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 3.8;SH-SY5Y: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071086 Enhanced NA NA "HPA071086: AB_2686342" "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (2.21e-1)" "unprognostic (9.01e-2)" "unprognostic (3.10e-1)" "unprognostic (8.12e-2)" "unprognostic (1.84e-1)" "unprognostic (9.94e-2)" "unprognostic (1.51e-1)" "unprognostic (9.21e-4)" "unprognostic (7.35e-3)" "unprognostic (7.02e-2)" "unprognostic (5.78e-3)" "unprognostic (5.89e-2)" "unprognostic (2.85e-1)" "unprognostic (5.38e-3)" 0.9 10.9 10.2 1.1 26.6 1.2 1.1 19.3 38.0 2.4 1.2 2.3 0.1 1.3 2.7 4.4 3.2 2.2 2.0 2.0 10.5 12.5 0.8 0.9 1.0 1.0 6.1 13.1 15.2 1.5 4.4 6.0 0.8 6.6 4.9 1.2 3.0 1.1 3.0 0.9 1.1 1.4 2.5 3.5 1.0 1.1 1.7 3.4 0.0 1.0 0.0 0.9 0.9 0.3 1.3 0.8 2.7 1.6 1.3 0.8 0.3 0.1 0.6 3.8 0.2 0.2 0.2 0.5 0.1 0.0 0.1 0.3 0.2 0.3 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.2 0.2 0.2 0.5 0.5 0.3 0.0 0.2 0.3 0.5 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.5 0.2 0.1 0.2 0.7 1.7 0.1 0.1 0.4 0.1 0.2 0.1 0.3 1.5 9.3 0.0 0.2 0.1 0.3 0.2 0.3 0.4 0.2 0.4 0.2 0.1 0.3 0.1 0.1 0.1 0.2 0.2 2.6 0.9 0.6 0.6 1.2 0.5 0.8 0.6 0.5 0.3 1.3 0.8 0.7 2.7 1.3 1.6 0.8 0.4 0.3 10.2 26.6 19.3 25.8 10.5 12.5 6.1 13.1 6.6 3.4 3.0 1.1 0.0 1.2 0.3 51.6 2.0 0.0 0.0 1.2 0.0 2.0 0.2 0.0 0.0 3.8 0.4 1.7 0.0 0.0 0.1 0.7 0.9 1.1 0.0 0.1 92.2 1.2 0.0 0.0 3.1 12.0 0.5 1.7 0.0 0.2 13.1 0.1 0.0 15.9 0.0 5.8 0.0 0.4 0.3 1.1 0.5 0.2 0.0 1.2 0.9 FSD1L "CCDC10, CSDUFD1, FSD1CL, FSD1NL" ENSG00000106701 "Fibronectin type III and SPRY domain containing 1 like" Q9BXM9 9 105447796-105552433 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 20 "Cone photoreceptor cells: 398.6;Early spermatids: 84.6;Rod photoreceptor cells: 118.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035138 Approved NA NA "HPA035138: AB_10601324" "unprognostic (9.28e-2)" "unprognostic (4.04e-3)" "unprognostic (1.73e-1)" "unprognostic (1.88e-3)" "unprognostic (3.93e-2)" "unprognostic (1.82e-2)" "unprognostic (3.17e-5)" "unprognostic (4.20e-2)" "unprognostic (5.65e-2)" "unprognostic (9.64e-3)" "unprognostic (2.66e-3)" "unprognostic (3.32e-2)" "unprognostic (8.28e-2)" "unprognostic (2.92e-1)" "unprognostic (1.87e-1)" "unprognostic (8.07e-2)" "unprognostic (1.22e-3)" 2.5 6.9 9.5 3.9 15.2 4.1 3.2 11.1 19.6 3.6 4.9 8.3 6.7 8.6 4.3 6.3 2.2 14.5 3.0 7.4 10.0 13.0 4.2 1.8 4.3 3.0 11.3 8.7 2.8 3.2 7.6 18.9 2.0 20.6 3.2 4.8 7.6 2.3 3.8 11.1 2.4 6.7 3.3 15.5 2.8 4.2 12.2 7.4 2.0 4.1 6.0 3.1 2.4 2.3 5.5 2.1 1.2 2.9 1.7 2.5 0.9 3.6 4.1 6.5 3.7 1.7 3.6 2.2 3.2 2.1 3.1 2.8 2.0 1.4 9.5 1.3 3.1 3.3 1.4 4.9 1.8 4.3 11.5 1.6 1.6 5.3 2.4 2.3 5.6 3.7 1.8 1.6 4.3 6.7 3.8 2.4 4.7 1.9 5.6 2.3 1.2 8.9 3.0 4.0 0.4 2.6 11.4 4.3 0.7 2.5 0.8 13.2 6.3 3.6 0.9 2.6 2.7 4.2 1.6 2.8 5.0 3.1 4.2 4.5 3.1 10.4 2.5 3.3 3.1 1.6 1.2 2.9 0.1 1.7 1.6 0.8 5.5 2.5 1.8 1.8 2.3 0.3 1.1 1.2 1.7 1.5 2.1 0.6 0.9 9.5 15.2 11.1 14.8 10.0 13.0 11.3 8.7 20.6 7.4 3.0 0.6 6.0 1.5 0.9 21.4 4.9 2.5 46.8 4.5 7.0 398.6 0.3 1.7 11.6 84.6 2.8 4.7 0.0 3.4 1.1 3.1 1.3 13.9 1.0 3.5 49.3 10.3 0.6 1.6 45.5 4.6 5.0 10.1 28.9 5.5 11.8 5.4 2.9 6.3 1.5 118.5 12.9 3.3 24.5 26.0 0.6 0.0 2.9 4.5 0.1 FSHR "FSHRO, LGR1, ODG1" ENSG00000170820 "Follicle stimulating hormone receptor" P23945 2 48962157-49154537 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 5.3;ovary: 6.5;testis: 16.3" "Group enriched" "Detected in some" 24 "Early spermatids: 1.6;Late spermatids: 4.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basal ganglia: 1.5;cerebral cortex: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "SuSa: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (5.94e-2)" "unprognostic (4.06e-3)" "unprognostic (5.78e-2)" 0.1 0.1 0.1 0.0 1.5 0.1 0.1 0.1 2.9 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.3 5.3 1.0 0.1 0.4 0.3 0.1 0.1 0.0 0.1 0.1 6.5 0.1 0.0 0.1 0.0 0.5 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 16.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.3 0.0 3.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.1 2.9 0.1 0.4 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FTHL17 CT38 ENSG00000132446 "Ferritin heavy chain like 17" Q9BXU8 X 31071241-31072053 "Predicted intracellular proteins" "Iron storage" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 12.7" "Cell type enriched" "Detected in single" 23 "Spermatocytes: 14.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "hTERT-HME1: 1.4;T-47d: 1.2" NA NA "unprognostic (5.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.5 0.0 0.0 0.0 0.0 0.0 FTO "ALKBH9, KIAA1752, MGC5149" ENSG00000140718 "FTO, alpha-ketoglutarate dependent dioxygenase" Q9C0B1 16 53701692-54158512 "Disease related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase, Transferase" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 315.8;Club cells: 92.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017123, HPA041086, HPA068695" Enhanced Supported Vesicles,Cytosol No No 130000 Cytosol Vesicles "CAB017123: , HPA041086: AB_2677293, HPA068695: AB_2732117" "unprognostic (9.74e-2)" "unprognostic (2.49e-1)" "unprognostic (9.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.88e-2)" "unprognostic (6.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-1)" "unprognostic (4.30e-3)" "unprognostic (6.11e-3)" 17.5 25.4 19.7 8.7 37.4 5.6 27.1 29.7 37.5 20.2 13.5 30.1 11.4 5.8 22.7 16.8 13.2 19.5 16.2 19.5 19.9 25.9 19.0 13.0 27.3 10.1 21.8 19.6 21.2 15.2 42.0 31.6 14.7 28.9 15.8 10.9 18.9 13.4 19.1 19.9 13.6 8.1 22.6 23.8 11.5 10.1 6.2 22.2 10.0 20.7 7.8 10.6 16.1 12.5 12.3 15.3 8.1 14.8 16.3 22.1 14.0 6.7 12.2 16.2 16.6 32.0 24.2 5.3 16.2 14.8 13.7 4.0 7.6 8.9 15.4 17.9 20.9 7.8 10.0 15.0 16.0 20.1 7.1 11.7 6.9 16.5 14.1 22.1 5.5 7.9 26.6 16.9 12.4 15.3 17.2 20.2 11.5 6.7 3.9 22.0 5.2 12.2 8.4 8.4 7.0 8.0 18.8 24.6 14.4 20.7 5.7 20.0 13.9 18.4 10.9 5.0 16.4 14.4 13.2 19.2 17.2 11.4 9.2 9.9 7.4 5.9 15.8 15.9 10.3 13.1 8.1 11.6 6.0 17.7 14.8 22.1 12.3 17.0 17.7 15.3 11.7 16.0 17.2 2.0 16.3 10.0 6.1 16.5 14.0 19.7 37.4 29.7 37.5 19.9 25.9 21.8 19.6 28.9 22.2 74.5 43.6 3.7 8.0 11.0 22.7 19.6 17.8 315.8 92.1 7.0 11.8 7.9 6.6 7.4 35.1 11.7 4.2 0.0 4.9 6.2 13.6 6.4 24.4 12.1 7.9 15.9 6.3 11.1 6.3 45.9 13.3 9.3 10.1 2.8 6.0 17.6 5.5 6.8 14.2 12.4 14.2 12.9 11.9 2.5 3.8 8.0 4.2 5.1 6.0 7.1 FURIN "FUR, PACE, PCSK3, SPC1" ENSG00000140564 "Furin, paired basic amino acid cleaving enzyme" P09958 15 90868592-90883458 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "liver: 118.4;placenta: 158.9;salivary gland: 337.9" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 102.2;Hepatocytes: 114.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009499, HPA067869" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 41000 "Golgi apparatus" Nucleoplasm "CAB009499: AB_2105095, HPA067869: " "unprognostic (2.46e-1)" "unprognostic (2.73e-2)" "unprognostic (7.33e-2)" "unprognostic (2.30e-2)" "unprognostic (4.11e-3)" "unprognostic (4.37e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (9.92e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (4.52e-3)" "unprognostic (4.57e-2)" "unprognostic (4.46e-2)" "unprognostic (4.27e-3)" "unprognostic (8.20e-2)" 8.3 3.3 3.0 7.5 3.6 16.6 5.9 5.0 4.4 4.1 6.6 2.8 3.5 5.7 4.9 10.8 4.7 4.4 3.9 6.9 3.1 1.8 6.4 118.4 9.5 3.1 2.8 2.7 4.2 22.5 3.8 7.2 158.9 3.5 9.3 2.2 3.0 337.9 4.7 8.7 9.0 5.9 3.1 3.0 8.2 6.0 5.3 2.9 4.8 8.9 5.5 4.1 4.4 4.3 1.5 3.3 10.3 3.3 3.1 1.9 2.0 14.4 8.8 2.0 8.9 14.5 9.4 22.7 18.2 13.9 7.5 5.3 12.9 15.8 0.5 46.8 13.2 13.5 26.0 4.0 9.4 1.6 41.6 10.3 25.3 15.8 16.8 7.7 3.5 41.7 10.6 10.6 8.5 3.9 18.3 24.0 4.2 19.3 2.5 5.0 9.9 1.3 11.4 6.3 12.2 2.6 2.2 7.7 3.3 11.7 11.0 4.0 2.7 15.4 8.4 12.8 9.9 3.0 9.2 35.4 8.5 18.2 13.0 26.6 4.5 25.6 1.2 16.2 11.4 17.2 7.5 3.3 10.3 1.9 1.1 1.4 1.5 1.2 1.2 2.1 1.0 0.6 0.8 7.4 3.1 0.7 3.3 0.9 2.0 3.0 3.6 5.0 4.4 3.1 1.8 2.8 2.7 3.5 2.9 3.0 30.9 6.7 7.5 17.2 11.9 15.0 10.2 1.4 5.7 21.0 23.6 16.5 0.0 44.3 0.4 25.5 23.8 23.3 102.2 11.4 12.3 26.5 15.1 114.9 22.3 7.9 36.4 23.4 26.1 0.2 10.3 24.1 15.1 7.2 27.3 11.7 83.4 21.8 10.3 5.6 25.2 25.8 12.5 2.3 3.4 20.1 70.5 11.7 16.1 13.9 FUT1 "H, HSC" ENSG00000174951 "Fucosyltransferase 1 (H blood group)" P19526 19 48748011-48755390 "Blood group antigen proteins, Enzymes, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 19.5" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 5.1;Endothelial cells: 5.1;Ito cells: 8.6;Melanocytes: 5.0;Pancreatic endocrine cells: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 8.2;HEL: 10.2;hTCEpi: 8.1;RT4: 9.8" "Not detected" "Not detected" NA NA "unprognostic (2.90e-2)" "unprognostic (3.09e-2)" "unprognostic (8.05e-3)" "unprognostic (4.65e-3)" "unprognostic (2.92e-3)" "unprognostic (8.73e-2)" "unprognostic (2.58e-2)" "unprognostic (3.34e-2)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "prognostic favorable (3.99e-4)" "unprognostic (1.33e-1)" "unprognostic (3.22e-2)" "unprognostic (8.67e-3)" "unprognostic (3.98e-2)" 2.5 0.8 0.9 0.9 0.9 1.5 1.6 3.5 1.4 0.9 0.9 0.9 0.9 1.0 0.9 0.9 1.5 1.2 0.9 1.4 0.9 0.2 1.1 0.9 6.8 0.9 0.9 0.9 0.9 19.5 1.0 1.7 2.8 0.9 0.9 0.0 0.9 0.9 0.9 0.9 0.8 0.9 0.9 0.9 3.4 7.6 0.9 0.9 0.9 1.0 0.9 0.9 0.9 0.9 0.9 0.9 3.3 0.7 1.5 0.6 0.3 3.3 0.1 0.1 0.2 0.0 0.0 1.7 0.2 0.1 0.2 0.2 8.2 4.8 0.3 0.4 0.2 0.8 5.5 1.6 5.1 0.1 0.0 0.8 10.2 0.4 0.1 2.4 0.4 4.5 0.0 8.1 0.4 3.7 0.1 3.6 1.8 0.5 1.5 0.0 3.8 0.2 6.2 1.0 6.5 0.5 0.3 0.0 1.6 0.3 9.8 7.7 0.5 0.4 7.1 0.1 0.4 4.6 0.2 3.5 0.3 2.5 0.2 0.3 1.4 3.6 1.0 0.1 0.3 0.3 3.3 0.7 0.5 0.5 0.3 0.3 0.8 0.6 0.4 0.3 0.9 0.6 0.5 2.1 1.5 0.3 0.9 0.2 0.3 0.9 0.9 3.5 1.4 0.9 0.2 0.9 0.9 0.9 0.9 3.0 1.7 0.0 0.6 2.3 0.3 0.8 5.1 0.0 1.2 0.0 2.0 0.3 1.7 1.1 0.0 5.1 0.0 0.0 1.9 0.2 1.0 0.9 1.1 0.0 0.3 0.0 1.2 8.6 1.0 0.0 0.9 1.5 5.0 0.0 0.4 0.0 4.9 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.1 1.5 0.3 0.0 0.0 0.4 FUT10 ENSG00000172728 "Fucosyltransferase 10" Q6P4F1 8 33370824-33473422 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 187.5;Late spermatids: 217.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053970, HPA058655" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA "Nucleoplasm, Endoplasmic reticulum, Golgi apparatus" "HPA053970: AB_2682327, HPA058655: AB_2683789" "unprognostic (6.02e-2)" "unprognostic (4.61e-2)" "unprognostic (2.85e-3)" "unprognostic (6.24e-2)" "unprognostic (1.01e-1)" "unprognostic (4.80e-2)" "unprognostic (5.40e-3)" "unprognostic (6.07e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (9.10e-3)" "unprognostic (2.76e-4)" "unprognostic (3.06e-3)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-3)" "unprognostic (6.01e-3)" 5.6 7.2 7.9 3.9 10.9 2.0 8.9 18.8 8.6 10.9 6.3 6.9 5.0 6.4 10.5 5.3 5.8 8.4 4.8 5.4 7.4 4.5 8.3 5.2 6.0 4.1 5.8 7.2 13.6 10.9 14.5 11.7 8.2 6.8 6.0 6.9 12.4 6.7 5.9 2.4 9.7 6.1 7.3 5.1 3.8 5.7 4.1 4.6 5.8 6.9 2.2 6.0 6.6 7.2 2.4 3.5 1.9 1.5 3.8 4.1 2.1 2.2 4.4 7.1 8.4 11.1 11.3 3.7 4.5 7.3 4.4 5.9 6.7 3.9 2.5 5.5 5.6 3.7 6.1 10.2 4.1 4.4 5.7 3.9 8.4 3.7 7.3 5.1 1.8 3.0 7.9 7.4 1.1 5.4 9.4 8.7 4.6 7.6 3.4 4.1 1.3 6.5 2.8 10.0 6.3 2.9 4.9 5.5 1.4 6.2 5.5 2.4 2.3 2.5 3.8 4.9 7.8 3.8 1.9 7.1 3.3 1.5 8.5 3.5 1.4 2.2 1.7 2.0 5.4 3.4 1.1 1.5 1.9 3.7 0.7 4.0 2.4 2.2 3.5 3.5 1.0 2.5 2.4 1.1 3.8 0.5 2.0 4.1 2.1 7.9 10.9 18.8 8.6 7.4 4.5 5.8 7.2 6.8 4.6 3.0 1.3 0.0 2.6 2.4 3.1 2.2 5.1 1.4 3.4 3.5 9.8 9.6 1.7 4.1 187.5 3.0 2.6 0.0 3.5 5.8 4.1 1.1 5.7 3.9 3.0 3.2 3.5 4.3 1.8 217.3 6.4 1.9 1.7 2.8 2.9 31.7 3.1 0.0 4.6 2.8 10.8 0.0 2.8 1.6 2.4 1.5 5.0 0.5 2.9 1.3 FUT2 "SE, Se2, SEC2, sej" ENSG00000176920 "Fucosyltransferase 2" Q10981 19 48695971-48705950 "Blood group antigen proteins, Enzymes, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.3;salivary gland: 58.1" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 43.3;Enterocytes: 109.6;Exocrine glandular cells: 41.1;Mucus-secreting cells: 39.5;Paneth cells: 73.7;Undifferentiated cells: 44.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebellum: 8.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "CAPAN-2: 34.7;OE19: 38.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA014402 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014402: AB_1849194" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (2.80e-3)" "unprognostic (4.63e-3)" "unprognostic (2.63e-1)" "prognostic favorable (5.83e-4)" "unprognostic (6.30e-3)" "unprognostic (6.55e-3)" "unprognostic (1.58e-1)" "unprognostic (8.44e-2)" "unprognostic (7.89e-2)" "unprognostic (5.11e-1)" "unprognostic (4.04e-2)" "unprognostic (6.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" 0.4 0.6 0.7 5.3 0.8 0.0 0.8 8.7 1.6 9.3 25.0 0.3 13.9 24.1 1.3 0.1 16.0 1.2 23.3 0.5 0.7 0.7 0.8 0.4 1.1 0.1 0.7 0.1 1.0 7.5 0.0 1.5 0.2 0.7 1.2 10.9 0.1 58.1 14.5 0.5 2.6 41.3 0.4 0.7 0.6 15.8 0.7 0.2 0.5 0.6 16.1 19.3 3.1 5.4 1.7 1.8 3.5 1.0 1.4 2.5 0.6 0.9 0.9 0.2 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.1 34.7 0.3 0.2 0.0 0.2 6.1 0.0 0.0 0.0 0.3 0.2 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.4 0.0 0.4 0.4 0.8 0.2 38.7 0.3 0.3 0.1 1.5 0.0 0.3 1.8 0.2 0.1 0.3 0.0 0.2 5.2 0.0 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.0 0.1 0.2 0.1 3.5 0.8 0.4 2.0 0.7 1.1 1.5 2.3 1.0 0.5 1.7 2.1 0.7 3.4 1.4 1.0 1.8 2.5 0.6 0.7 0.8 8.7 1.6 0.7 0.7 0.7 0.1 0.7 0.2 0.0 1.1 0.0 2.5 0.8 2.7 0.4 43.3 12.0 10.3 19.2 2.0 0.0 1.7 5.5 0.5 0.3 109.6 0.0 41.1 0.0 0.2 2.5 0.0 0.0 0.1 0.0 10.9 0.0 0.3 0.0 0.0 0.0 1.7 0.0 39.5 0.8 25.6 73.7 0.0 0.0 3.8 0.0 0.2 0.2 0.2 1.3 0.1 2.2 44.3 14.7 FUT3 "CD174, LE" ENSG00000171124 "Fucosyltransferase 3 (Lewis blood group)" P21217 19 5842888-5851474 "Blood group antigen proteins, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.6;intestine: 49.3;lymphoid tissue: 38.4" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 106.6;Mucus-secreting cells: 61.1;Paneth cells: 66.6;Undifferentiated cells: 39.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 41.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 29.9;hTCEpi: 4.7;OE19: 13.4;RH-30: 10.1;SK-BR-3: 4.8" HPA046966 Supported NA NA "HPA046966: AB_2679879" "prognostic unfavorable (6.86e-4)" "unprognostic (2.59e-1)" "unprognostic (1.06e-1)" "unprognostic (9.12e-2)" "unprognostic (8.58e-3)" "unprognostic (1.63e-3)" "unprognostic (3.88e-2)" "unprognostic (2.03e-2)" "unprognostic (4.02e-2)" "unprognostic (3.98e-2)" "unprognostic (4.21e-2)" "unprognostic (2.99e-1)" "prognostic favorable (8.22e-7)" "unprognostic (5.66e-3)" "unprognostic (9.56e-2)" "unprognostic (4.30e-2)" "unprognostic (1.07e-1)" 0.2 0.1 0.2 14.5 0.2 0.0 0.4 0.2 0.2 10.9 40.4 0.2 32.5 18.8 0.4 0.5 53.6 0.7 21.5 0.1 0.2 0.2 3.8 0.9 5.1 0.1 0.2 0.1 0.5 4.7 0.0 0.3 0.6 0.1 1.0 18.1 0.2 27.5 31.6 0.1 1.0 49.3 1.0 0.2 0.1 8.1 1.3 0.1 0.3 0.1 14.9 38.4 2.9 16.1 0.2 1.6 0.8 0.6 0.0 0.5 0.0 29.9 0.0 0.1 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.4 0.0 0.0 1.3 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 13.4 0.0 0.0 10.1 1.0 0.0 0.5 0.0 0.1 0.0 4.8 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.8 0.0 0.0 1.6 0.5 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 4.5 0.0 1.8 0.0 1.4 0.3 12.7 2.7 2.3 0.0 0.0 0.0 0.0 33.7 4.3 0.0 106.6 0.0 12.8 0.1 0.0 0.5 9.2 0.2 0.0 0.0 13.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 61.1 1.4 29.6 66.6 0.0 12.0 32.6 0.0 0.1 0.0 0.2 0.0 0.2 0.0 39.4 16.0 FUT4 "CD15, ELFT, FCT3A, FUC-TIV" ENSG00000196371 "Fucosyltransferase 4" P22083 11 94543840-94549898 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "bone marrow: 71.3" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 20.4;Mucus-secreting cells: 20.8;Pancreatic endocrine cells: 18.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 20.8;NB-4: 13.5;THP-1: 26.3;U-937: 18.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB000014, CAB016129" Enhanced Approved Vesicles NA NA Vesicles "CAB000014: , CAB016129: AB_626918" "unprognostic (6.36e-2)" "unprognostic (7.53e-2)" "unprognostic (4.70e-3)" "unprognostic (2.46e-3)" "unprognostic (1.46e-2)" "unprognostic (2.29e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (3.64e-4)" "unprognostic (7.26e-2)" "unprognostic (4.14e-1)" "unprognostic (4.81e-3)" "unprognostic (1.27e-1)" "unprognostic (9.08e-3)" "unprognostic (8.17e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (3.10e-3)" 5.5 2.4 5.5 6.1 6.2 71.3 6.3 3.0 6.0 4.4 8.3 6.7 4.7 10.9 5.9 2.5 3.0 4.6 7.5 3.7 6.2 2.2 4.1 3.0 6.0 5.4 8.1 2.5 4.9 11.4 1.4 2.9 3.4 4.8 3.4 8.3 3.8 6.3 2.9 1.7 1.9 10.1 5.8 5.7 6.5 9.7 2.9 4.5 10.4 2.9 1.9 3.1 4.4 3.0 0.7 1.9 2.5 3.9 0.8 1.9 0.8 1.6 0.8 1.0 0.0 3.2 2.9 5.3 1.5 0.7 1.3 1.5 7.1 2.3 0.0 3.6 2.5 0.7 0.8 1.7 0.1 1.3 10.7 1.7 5.3 1.2 0.1 1.6 20.8 4.7 2.5 0.0 1.7 0.0 0.3 2.1 4.8 5.3 0.0 1.6 0.8 4.3 13.5 2.0 6.5 2.0 3.9 0.0 0.0 1.4 1.1 1.4 0.5 0.9 2.1 0.8 3.1 1.2 26.3 1.9 1.1 2.9 0.0 0.5 0.6 0.3 0.0 0.9 18.7 0.6 2.0 3.1 2.5 1.1 1.5 0.7 0.6 1.0 1.3 1.8 0.7 1.1 0.7 1.7 0.8 3.9 1.9 1.9 0.8 5.5 6.2 3.0 6.0 6.2 2.2 8.1 2.5 4.8 4.5 0.0 0.0 0.0 2.3 1.4 0.6 0.8 20.4 2.7 2.3 1.8 3.9 12.9 0.0 12.8 0.2 1.3 12.1 0.0 15.5 2.0 4.6 1.6 0.0 0.8 7.7 0.0 9.8 2.5 10.6 0.2 4.0 3.3 3.3 10.0 20.8 0.5 18.4 3.5 1.1 1.9 8.8 0.0 1.4 0.9 3.2 0.5 1.8 2.5 14.4 1.2 FUT5 FUC-TV ENSG00000130383 "Fucosyltransferase 5" Q11128 19 5865826-5870540 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 1.8;SH-SY5Y: 3.0;U-266/70: 1.7" HPA046966 Uncertain NA NA "HPA046966: AB_2679879" "unprognostic (7.72e-2)" "unprognostic (3.59e-1)" "unprognostic (5.03e-2)" "unprognostic (1.20e-1)" 0.2 0.1 1.0 0.1 0.5 3.6 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.5 0.3 0.3 1.1 0.4 0.3 0.2 1.1 0.1 0.2 0.9 0.2 0.5 0.1 0.3 0.1 0.1 0.1 0.4 0.1 1.2 0.5 0.1 0.1 0.8 0.2 0.1 1.6 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 FUT6 "FCT3A, FLJ40754, FT1A, FucT-VI" ENSG00000156413 "Fucosyltransferase 6" P51993 19 5830610-5839731 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.8;intestine: 44.4;lymphoid tissue: 33.9;salivary gland: 37.0" "Cell type enhanced" "Detected in some" 13 "Enterocytes: 54.8;Mucus-secreting cells: 33.5;Proximal tubular cells: 29.8;Undifferentiated cells: 19.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 3.7;neutrophil: 1.2;NK-cell: 2.1" "Group enriched" "Detected in many" 7 "granulocytes: 3.7;NK-cells: 2.1" "Group enriched" "Detected in some" 5 "Hep G2: 14.9;RPMI-8226: 5.6" "HPA043707, HPA046966" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA043707: AB_2678628, HPA046966: AB_2679879" "unprognostic (3.65e-2)" "unprognostic (3.00e-3)" "unprognostic (2.13e-3)" "unprognostic (2.78e-3)" "unprognostic (6.35e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.02e-2)" "unprognostic (6.68e-3)" "unprognostic (4.01e-2)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (4.94e-2)" "prognostic favorable (3.17e-8)" "unprognostic (1.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" 0.2 0.2 0.2 7.2 0.2 0.1 0.8 0.2 0.2 9.2 26.4 0.0 9.5 15.6 0.7 7.6 40.8 0.6 25.4 0.2 0.2 0.2 27.2 6.5 1.3 0.2 0.2 0.0 0.2 2.2 0.0 0.8 0.0 0.0 0.3 6.9 0.0 37.0 19.1 0.2 0.2 44.4 0.2 0.2 0.2 2.8 0.3 0.0 0.0 0.2 16.4 33.9 0.2 12.4 0.4 0.3 3.7 0.3 2.1 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.2 14.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 1.2 5.6 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.3 0.1 3.7 0.3 0.4 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.4 0.3 0.2 1.2 2.1 0.1 0.3 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.3 0.3 15.3 1.4 0.0 1.8 0.0 0.1 3.3 4.7 0.2 0.0 54.8 0.0 0.3 0.1 0.3 0.2 0.0 4.9 0.1 0.0 4.7 0.6 0.0 0.0 0.3 0.0 0.0 0.0 33.5 0.5 1.6 15.6 0.0 29.8 12.1 0.0 0.1 0.6 0.5 0.1 0.0 0.0 19.9 1.4 FUT7 ENSG00000180549 "Fucosyltransferase 7" Q11130 9 137030174-137033010 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 40.4;lymphoid tissue: 10.5" "Cell type enhanced" "Detected in some" 24 "Kupffer cells: 7.0;monocytes: 19.8;T-cells: 5.7" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 3.2" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 40.4" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 10 "NB-4: 14.4;THP-1: 18.5;U-937: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA042780 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA042780: AB_2678162" "unprognostic (1.33e-2)" "unprognostic (4.20e-4)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (5.42e-2)" "unprognostic (5.01e-6)" "unprognostic (2.50e-1)" "unprognostic (2.35e-2)" "unprognostic (6.75e-4)" "unprognostic (4.68e-1)" "unprognostic (1.72e-2)" "unprognostic (3.20e-1)" "unprognostic (6.69e-6)" "unprognostic (3.99e-2)" "unprognostic (4.14e-2)" "unprognostic (1.03e-1)" "unprognostic (8.75e-2)" 0.4 0.1 0.2 2.5 0.2 5.9 0.2 3.2 0.3 0.2 0.2 0.2 0.2 0.0 1.4 0.2 0.4 0.5 4.4 0.2 0.3 0.3 0.2 0.2 1.5 6.2 1.7 0.2 0.2 0.2 0.0 0.4 0.2 0.9 0.2 0.0 0.2 0.2 0.2 0.2 0.4 0.6 0.2 0.4 10.5 0.3 0.2 0.2 0.2 0.3 0.2 4.6 0.5 0.2 4.2 40.4 18.3 1.5 22.1 16.3 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.4 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.3 1.5 0.3 2.1 0.3 10.5 4.2 10.3 5.7 4.4 1.2 0.2 0.8 18.3 22.1 0.0 40.4 16.3 3.4 0.2 0.2 3.2 0.3 0.3 0.3 1.7 0.2 0.9 0.2 0.0 0.0 3.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 7.0 0.0 0.0 2.9 0.0 19.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 5.7 0.2 0.0 FUT8 ENSG00000033170 "Fucosyltransferase 8" Q9BYC5 14 65410592-65744121 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 13.5;NK-cells: 12.0;T-cells: 8.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017129, HPA043410" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB017129: , HPA043410: AB_2678467" "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (3.28e-2)" "unprognostic (1.65e-3)" "unprognostic (2.10e-1)" "unprognostic (5.61e-2)" "unprognostic (1.41e-1)" "unprognostic (8.81e-2)" "unprognostic (2.00e-2)" "unprognostic (1.33e-3)" "unprognostic (8.09e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-3)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" 7.2 7.6 16.2 12.0 21.1 3.3 9.4 24.1 18.1 6.7 9.8 29.1 16.1 15.4 8.7 5.0 6.5 14.0 10.1 5.2 19.8 12.9 6.2 2.9 7.0 11.2 20.5 11.2 7.2 10.5 6.2 5.2 18.8 17.3 5.4 10.4 7.1 33.7 13.7 3.5 4.9 15.1 9.5 39.8 8.5 27.6 13.1 23.6 8.4 7.5 2.4 15.2 14.4 5.6 13.5 2.2 0.5 1.7 12.0 8.2 2.5 34.4 6.8 3.3 30.3 14.6 11.0 20.5 11.1 17.0 7.7 8.6 5.3 12.7 9.2 9.5 10.9 21.2 2.6 7.8 3.0 11.8 34.0 3.4 9.2 2.5 6.9 7.5 2.0 7.6 27.7 2.0 10.6 5.0 33.8 19.5 4.5 3.4 7.8 5.5 17.7 9.8 5.1 4.4 16.0 23.9 6.7 2.9 5.3 13.8 9.7 7.0 5.3 5.9 2.8 2.4 20.7 2.8 3.3 42.5 10.1 10.9 4.5 8.9 15.7 6.0 21.9 20.5 3.6 3.2 0.5 1.7 0.5 3.5 0.6 3.5 13.5 5.6 5.1 2.2 6.8 6.1 6.0 0.2 12.0 1.1 2.2 8.2 2.5 16.2 21.1 24.1 17.3 19.8 12.9 20.5 11.2 17.3 23.6 11.9 33.3 42.9 6.7 10.8 10.6 5.6 10.2 16.0 22.7 12.2 3.9 38.8 0.0 7.7 28.3 11.3 6.8 0.0 28.1 24.2 15.8 5.7 7.0 3.2 11.0 7.9 5.2 15.4 12.1 10.9 11.8 7.0 1.7 1.8 17.5 35.8 36.1 8.5 12.7 7.8 8.0 0.0 10.3 31.6 26.2 8.5 11.8 13.8 9.4 4.6 FUT9 Fuc-TIX ENSG00000172461 "Fucosyltransferase 9" Q9Y231 6 96015984-96215612 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 37.7;stomach 1: 35.4" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 2.9;Exocrine glandular cells: 1.6" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "MCF7: 4.2;OE19: 4.1;RT4: 9.5;SCLC-21H: 9.7;SK-BR-3: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070923 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA070923: AB_2686323" "unprognostic (1.60e-1)" "unprognostic (2.48e-1)" "unprognostic (5.99e-3)" "unprognostic (1.33e-1)" "unprognostic (2.40e-1)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (6.43e-3)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" 1.1 1.7 18.5 1.1 22.5 1.1 1.9 37.7 28.6 1.1 1.1 10.7 0.0 4.1 1.4 1.2 1.1 1.4 1.1 1.1 20.0 6.2 1.2 1.1 1.1 1.1 10.2 24.0 1.1 8.0 1.1 0.9 1.7 13.8 1.5 1.2 0.0 1.1 1.5 1.2 1.1 1.1 1.1 10.2 1.1 35.4 1.1 16.5 0.0 1.2 0.0 1.1 2.2 0.4 0.3 0.2 1.5 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 2.1 4.1 0.0 0.0 0.0 0.0 0.0 9.5 9.7 0.2 0.0 5.5 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.8 0.2 0.0 0.2 0.0 0.0 18.5 22.5 37.7 28.6 20.0 6.2 10.2 24.0 13.8 16.5 0.0 0.0 0.0 0.6 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 FXR1 ENSG00000114416 "FMR1 autosomal homolog 1" P51114 3 180868141-180982753 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Myogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 215.4" "Group enriched" "Detected in all" 4 "Early spermatids: 827.9;Late spermatids: 1326.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018246, HPA055475" Approved Enhanced Cytosol NA NA Cytosol "HPA018246: AB_1849204, HPA055475: AB_2682828" "unprognostic (1.38e-1)" "unprognostic (1.59e-2)" "unprognostic (5.23e-2)" "prognostic unfavorable (5.96e-4)" "unprognostic (1.04e-2)" "unprognostic (1.90e-3)" "prognostic unfavorable (2.70e-4)" "unprognostic (7.77e-3)" "unprognostic (9.20e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (7.30e-4)" "unprognostic (3.28e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (7.85e-2)" "unprognostic (2.06e-1)" "unprognostic (2.02e-1)" "unprognostic (2.84e-2)" 12.4 13.8 13.0 7.6 16.1 13.7 11.7 14.8 15.0 11.5 14.3 10.5 11.4 7.5 14.7 10.1 13.4 11.7 8.9 36.1 13.7 14.3 10.1 11.3 8.5 9.4 19.4 9.6 16.9 11.4 11.4 17.3 12.7 18.1 13.1 7.4 6.5 10.2 11.8 215.4 7.7 7.9 12.3 23.4 9.1 10.5 39.1 19.4 17.2 16.2 22.7 10.0 15.6 28.8 13.8 14.9 11.4 14.0 11.0 21.8 9.4 36.1 16.8 36.4 28.2 28.0 32.0 16.5 28.8 29.5 32.4 32.1 24.7 18.3 18.5 47.6 19.8 51.2 17.5 29.3 17.6 45.4 24.4 19.7 18.8 22.2 28.2 29.9 11.6 15.5 33.7 20.2 16.3 39.1 48.6 32.6 18.2 15.0 22.5 40.7 13.0 22.1 19.6 41.0 22.4 18.5 15.4 46.5 19.7 24.9 11.3 15.4 19.7 24.9 29.0 37.2 53.4 40.3 22.4 25.9 24.4 27.3 15.2 56.5 21.0 26.3 22.0 25.5 16.8 31.1 8.9 12.9 10.0 12.9 14.0 13.6 13.8 13.8 11.7 14.9 9.5 17.6 14.4 11.4 11.0 10.2 10.5 21.8 9.4 13.0 16.1 14.8 15.0 13.7 14.3 19.4 9.6 18.1 19.4 59.6 64.8 54.7 82.6 69.6 69.6 196.5 38.2 131.2 89.9 33.2 53.0 80.5 49.7 73.6 827.9 71.9 29.3 93.5 65.6 84.4 66.3 54.2 121.5 58.7 58.6 82.6 51.6 52.2 63.0 1326.2 77.9 61.8 47.2 139.7 33.0 89.6 70.5 35.1 71.5 67.7 82.8 32.3 61.4 245.3 103.5 61.7 51.1 57.5 38.5 60.3 FXYD1 PLM ENSG00000266964 "FXYD domain containing ion transport regulator 1" O00168 19 35138808-35143109 "Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8" "Group enriched" "Detected in many" 4 "Fibroblasts: 170.5;Hepatocytes: 393.6;Leydig cells: 398.4;Muller glia cells: 148.5;Peritubular cells: 120.6;Sertoli cells: 116.4;Smooth muscle cells: 231.4" "Cancer enhanced" "Detected in many" "liver cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 11.7" "Group enriched" "Detected in many" 5 "B-cells: 11.7;T-cells: 7.1" "Cell line enhanced" "Detected in some" "ASC diff: 31.0;ASC TERT1: 9.0;HSkMC: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026873 Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Cytosol" Nucleoli "HPA026873: AB_1855471" "unprognostic (5.58e-3)" "unprognostic (6.60e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.91e-4)" "unprognostic (1.54e-2)" "unprognostic (1.72e-2)" "unprognostic (3.54e-3)" "unprognostic (8.13e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (7.59e-8)" "unprognostic (9.97e-3)" "unprognostic (2.25e-1)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" 28.2 8.1 35.7 5.2 40.7 2.0 21.8 16.8 34.7 46.5 16.9 25.5 7.1 5.0 26.3 17.9 18.8 31.1 14.8 134.1 23.8 19.9 4.5 137.1 14.1 3.0 36.1 23.7 34.0 6.2 2.1 4.3 8.6 21.5 21.6 7.9 14.1 6.4 20.7 299.8 5.8 7.5 27.7 19.0 6.2 8.4 7.5 14.8 0.0 3.9 29.0 3.5 12.7 23.7 11.7 0.7 1.2 0.7 2.0 7.1 0.7 0.7 0.0 0.0 0.1 31.0 9.0 0.8 3.7 0.1 0.0 0.0 0.0 0.2 2.4 1.0 0.0 0.1 0.6 0.7 0.4 0.0 2.2 0.9 0.4 0.0 1.2 3.5 0.2 0.2 12.8 0.0 0.1 0.3 0.3 0.1 0.1 0.6 2.5 0.1 0.0 0.0 0.5 0.1 1.8 0.4 0.0 0.1 0.6 0.0 0.0 0.2 0.1 0.4 0.1 1.0 0.2 0.1 4.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.6 0.4 5.1 1.2 0.3 0.0 1.4 0.7 0.9 11.7 4.1 1.7 0.3 6.6 0.8 1.0 0.6 2.0 0.7 0.7 7.1 0.7 35.7 40.7 16.8 34.7 23.8 19.9 36.1 23.7 21.5 14.8 0.0 0.0 3.7 5.1 26.2 1.4 0.3 2.5 5.3 0.0 24.4 3.9 1.3 0.0 0.1 1.2 6.0 1.3 0.0 4.2 1.5 170.5 2.1 0.0 393.6 4.2 0.0 0.0 49.1 11.0 5.1 398.4 4.1 50.6 0.0 0.4 148.5 1.6 2.5 120.6 0.0 7.0 116.4 231.4 3.8 11.7 23.8 2.4 4.9 0.6 2.3 FXYD2 "ATP1G1, HOMG2, MGC12372" ENSG00000137731 "FXYD domain containing ion transport regulator 2" P54710 11 117800844-117828698 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Disease mutation, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 258.1;pancreas: 68.9;salivary gland: 91.7" "Group enriched" "Detected in many" 5 "Cholangiocytes: 1434.4;Distal tubular cells: 2501.8;Proximal tubular cells: 3101.2" "Cancer enriched" "Detected in some" 8 "renal cancer: 49.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 14.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 25 "MOLT-4: 141.0;RPTEC TERT1: 323.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA064218, HPA068838" Supported Approved Mitochondria NA NA 26000 Mitochondria "HPA064218: AB_2685214, HPA068838: AB_2686047" "unprognostic (4.11e-4)" "unprognostic (1.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-3)" "unprognostic (1.09e-3)" "unprognostic (2.30e-2)" "unprognostic (3.65e-2)" "unprognostic (4.62e-1)" "unprognostic (4.01e-2)" "unprognostic (4.91e-2)" "unprognostic (1.24e-2)" "unprognostic (2.64e-1)" "prognostic favorable (3.23e-9)" "unprognostic (3.22e-3)" "unprognostic (4.38e-2)" "unprognostic (4.62e-1)" "unprognostic (3.00e-2)" 0.3 0.2 0.2 0.2 0.1 0.0 0.7 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.3 2.8 0.3 0.3 54.7 0.2 0.1 0.2 258.1 2.2 0.2 0.6 0.1 0.0 0.4 68.9 0.0 0.3 0.6 0.1 0.3 0.0 0.1 91.7 0.1 0.1 0.2 0.3 0.1 0.1 0.4 0.2 0.2 0.0 9.5 0.2 0.3 0.4 0.2 0.6 0.4 3.2 0.0 1.1 8.4 14.1 2.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.2 0.0 0.0 0.0 0.0 141.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 323.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 1.1 0.2 1.8 14.1 0.2 0.4 5.1 4.1 0.0 8.4 0.0 3.2 1.6 2.0 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.0 1.1 0.0 0.0 1.0 0.1 0.8 1434.4 0.0 0.0 413.5 0.0 0.1 2501.8 465.3 14.4 1.3 0.0 0.0 8.3 0.1 1.1 0.1 0.0 2.4 2.9 0.0 14.6 5.5 4.3 15.4 8.6 2.6 0.0 14.4 0.0 0.5 33.3 0.0 7.1 3101.2 3.5 6.5 3.9 0.4 0.2 0.6 0.2 0.0 0.0 0.0 FXYD3 "MAT-8, PLML" ENSG00000089356 "FXYD domain containing ion transport regulator 3" Q14802 19 35115879-35124324 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 160.2;salivary gland: 141.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 1850.8;Mucus-secreting cells: 1977.6;Paneth cells: 3546.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "HaCaT: 70.3;hTCEpi: 128.0;OE19: 239.6;RT4: 66.8;SK-BR-3: 65.8;WM-115: 47.1" HPA010856 Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Plasma membrane" "HPA010856: AB_1078915" "unprognostic (2.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.37e-3)" "unprognostic (3.31e-3)" "unprognostic (6.38e-2)" "unprognostic (3.02e-1)" "unprognostic (2.64e-3)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (1.15e-6)" "unprognostic (4.17e-2)" "unprognostic (2.08e-1)" "unprognostic (5.06e-2)" "unprognostic (7.69e-3)" 0.4 0.1 1.6 29.5 2.3 0.0 20.4 1.7 2.1 30.0 133.2 1.1 2.3 8.6 3.9 2.9 82.1 9.0 56.6 0.8 1.4 0.3 2.1 0.5 35.8 0.3 2.1 0.8 1.9 28.9 0.0 3.7 41.9 2.2 58.4 160.2 15.8 141.7 3.5 0.5 64.2 36.4 7.5 1.8 0.4 50.6 0.7 1.0 2.5 0.5 93.2 49.8 48.7 42.5 0.3 3.2 0.6 0.1 0.0 0.2 0.5 12.6 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.4 18.5 0.0 0.0 0.0 0.1 70.3 0.0 26.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 128.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.1 0.0 239.6 0.1 0.0 0.0 0.0 0.0 66.8 15.7 0.1 0.0 65.8 4.8 0.1 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.2 0.6 0.0 0.0 3.2 0.0 0.5 1.6 2.3 1.7 2.1 1.4 0.3 2.1 0.8 2.2 1.0 708.7 211.8 0.0 720.0 512.4 2.3 1.3 239.5 860.6 417.5 127.4 0.0 696.6 1.7 18.8 0.1 3.8 1850.8 0.0 640.2 148.4 41.3 1079.2 23.0 0.6 70.8 1.6 937.0 0.0 0.0 0.0 0.0 12.2 391.4 2.8 1977.6 233.2 377.2 3546.9 0.0 0.6 8.5 0.0 25.8 0.2 0.2 756.6 1264.5 0.7 1253.7 1183.0 FXYD4 CHIF ENSG00000150201 "FXYD domain containing ion transport regulator 4" P59646 10 43371642-43376335 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 27 "kidney: 119.5" "Cell type enriched" "Detected in some" 120 "Collecting duct cells: 4780.5" "Group enriched" "Detected in many" 5 "renal cancer: 10.7;urothelial cancer: 20.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "SuSa: 15.9" "Not detected" "Not detected" HPA058421 Enhanced NA NA "HPA058421: AB_2683714" "unprognostic (2.92e-3)" "unprognostic (5.25e-1)" "unprognostic (9.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (5.17e-2)" "unprognostic (2.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-1)" "unprognostic (2.09e-2)" 0.1 0.0 0.4 0.0 2.2 0.0 0.0 0.1 1.0 0.0 0.1 2.0 0.1 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.6 0.3 119.5 0.0 1.3 0.0 1.6 0.4 0.0 0.0 0.0 0.1 0.0 1.0 0.6 0.0 0.0 4.4 1.5 0.6 0.0 0.0 0.0 0.5 0.0 2.4 0.2 1.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.2 0.1 1.0 0.6 0.3 1.6 0.4 1.0 1.4 6.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4780.5 0.0 0.4 39.7 0.0 1.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.1 0.9 FXYD5 OIT2 ENSG00000089327 "FXYD domain containing ion transport regulator 5" Q96DB9 19 35154730-35169883 "Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 407.2;Kupffer cells: 403.3;Macrophages: 433.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA010817 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA010817: AB_1849214" "unprognostic (3.97e-3)" "unprognostic (5.49e-2)" "unprognostic (6.37e-3)" "unprognostic (3.01e-1)" "unprognostic (2.50e-3)" "unprognostic (4.39e-3)" "unprognostic (4.68e-2)" "unprognostic (1.56e-3)" "unprognostic (3.85e-1)" "unprognostic (5.66e-3)" "unprognostic (4.78e-2)" "unprognostic (4.75e-2)" "prognostic unfavorable (3.71e-9)" "unprognostic (6.07e-2)" "unprognostic (7.88e-2)" "unprognostic (3.61e-2)" "unprognostic (1.74e-1)" 58.8 10.6 6.0 47.4 9.0 72.4 66.9 2.7 7.1 44.3 15.6 14.4 10.4 8.8 33.6 25.9 31.3 26.0 28.6 29.1 7.0 7.9 13.7 13.2 39.5 110.7 12.0 7.6 18.9 8.0 3.4 11.7 56.9 11.8 27.3 14.0 19.8 19.7 16.7 17.0 22.7 27.0 18.7 18.2 80.3 20.8 10.8 9.3 33.9 16.0 26.9 97.4 36.6 59.8 73.3 91.4 66.5 76.9 99.6 109.0 94.6 98.9 23.7 0.0 0.1 35.4 44.9 23.8 56.9 75.9 40.7 30.4 6.7 29.1 22.8 15.6 68.7 14.6 23.3 14.6 35.1 26.3 28.1 9.6 42.6 13.1 0.0 27.9 24.2 42.5 26.6 15.7 29.5 51.1 24.0 38.3 6.3 39.9 110.3 25.3 0.1 2.8 10.1 7.3 92.0 13.8 13.6 5.0 28.8 14.9 0.5 4.3 0.0 31.4 16.5 33.2 13.5 8.6 19.5 54.0 50.3 19.1 54.5 4.3 0.1 1.6 5.8 76.6 56.4 76.7 66.5 73.5 13.4 60.3 76.9 56.8 73.3 102.5 62.8 91.4 66.7 68.0 55.0 18.1 99.6 74.5 41.9 109.0 94.6 6.0 9.0 2.7 7.1 7.0 7.9 12.0 7.6 11.8 9.3 3.0 14.9 263.7 53.6 95.1 0.3 2.4 22.9 1.4 7.9 94.2 0.0 9.5 0.0 153.7 1.1 336.6 0.8 0.0 176.3 377.4 156.4 26.1 356.4 4.3 407.2 0.0 10.3 249.2 403.3 2.7 6.1 433.0 199.1 27.9 5.1 0.0 365.9 7.0 0.7 2.5 0.2 64.7 75.9 1.1 7.0 60.5 42.6 318.2 5.2 88.0 FXYD6 ENSG00000137726 "FXYD domain containing ion transport regulator 6" Q9H0Q3 11 117836976-117877486 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 142.8" "Group enriched" "Detected in many" 4 "Ito cells: 132.6;Leydig cells: 220.4;Peritubular cells: 341.9;Sertoli cells: 349.3" "Cancer enriched" "Detected in all" 6 "glioma: 71.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "classical monocyte: 21.9" "Lineage enriched" "Detected in many" 6 "monocytes: 21.9" "Cell line enhanced" "Detected in some" "AF22: 37.9;HAP1: 25.0;RH-30: 15.7;SCLC-21H: 57.4;SH-SY5Y: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041334, HPA042284" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041334: AB_10970752, HPA042284: AB_2677931" "unprognostic (2.18e-3)" "unprognostic (2.70e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (1.05e-5)" "unprognostic (3.31e-2)" "unprognostic (1.15e-1)" "prognostic favorable (5.87e-4)" "unprognostic (4.51e-2)" "unprognostic (3.78e-2)" "unprognostic (1.07e-2)" "prognostic favorable (5.97e-4)" "unprognostic (3.44e-2)" "prognostic favorable (4.38e-5)" "unprognostic (4.64e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.60e-4)" 12.9 38.7 41.2 9.5 46.2 3.1 8.1 49.1 142.8 24.3 52.0 30.2 9.2 7.6 54.8 19.0 9.8 26.7 29.0 25.6 35.4 51.6 12.3 10.4 21.5 8.5 18.4 59.5 82.8 9.5 3.5 28.5 5.6 20.2 35.6 11.7 11.9 9.8 22.9 11.0 3.9 16.3 58.5 12.8 42.8 17.6 23.2 18.5 2.9 15.9 6.4 5.9 38.1 13.9 0.0 3.6 0.5 21.9 0.0 0.3 5.1 0.0 0.2 37.9 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 1.4 0.1 25.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.4 1.6 0.1 7.6 0.0 0.0 0.0 15.7 0.2 0.9 0.0 57.4 32.7 0.0 0.1 1.3 10.9 0.6 0.6 0.0 0.0 9.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 21.9 0.0 0.0 5.3 0.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 5.1 41.2 46.2 49.1 78.8 35.4 51.6 18.4 59.5 20.2 18.5 6.0 2.1 0.0 2.7 6.0 2.1 4.8 2.5 2.7 1.2 0.0 2.0 0.8 1.7 5.2 2.2 57.8 0.0 0.0 0.3 1.1 30.7 2.3 0.0 0.4 57.8 1.6 12.0 132.6 22.4 8.6 220.4 9.7 15.1 3.6 0.0 51.6 0.6 0.0 341.9 0.0 3.0 349.3 63.8 1.4 3.2 3.3 1.1 0.0 0.0 1.4 FXYD6-FXYD2 ENSG00000255245 "FXYD6-FXYD2 readthrough" 11 117820163-117876667 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "Distal tubular cells: 82.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "MOLT-4: 9.8;RPTEC TERT1: 11.2" "HPA068838, HPA075209" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA068838: AB_2686047, HPA075209: AB_2732285" 2.8 2.7 7.4 1.8 12.4 1.8 2.7 4.2 22.2 6.0 4.5 7.9 1.4 1.8 11.4 5.2 2.5 3.9 6.6 3.0 4.8 2.9 23.0 2.8 3.1 2.1 2.5 16.5 10.2 9.6 2.4 4.2 2.5 4.6 9.4 2.0 2.2 19.5 2.2 2.9 2.5 3.0 13.7 2.5 4.2 2.9 3.6 4.3 0.0 2.9 0.5 2.3 10.1 2.8 0.0 0.5 0.0 1.1 0.8 1.3 0.7 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 9.8 0.0 0.7 0.0 0.0 0.0 0.5 0.0 11.2 0.0 0.6 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.3 0.0 0.4 0.3 0.0 0.8 0.0 0.5 0.0 0.7 7.4 12.4 4.2 22.2 4.8 2.9 2.5 16.5 4.6 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 10.4 0.0 0.0 82.9 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 9.0 0.0 6.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FXYD7 ENSG00000221946 "FXYD domain containing ion transport regulator 7" P58549 19 35143250-35154301 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "blood: 24.4;brain: 76.1" "Cell type enhanced" "Detected in some" 8 "Melanocytes: 3.3;Sertoli cells: 6.5;Spermatogonia: 5.5;T-cells: 5.0" "Cancer enhanced" "Detected in some" "glioma: 4.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 24.4" "Group enriched" "Detected in many" 22 "B-cells: 8.1;NK-cells: 24.4;T-cells: 12.9" "Cell line enhanced" "Detected in some" "HAP1: 3.2;HMC-1: 9.8;Karpas-707: 3.4;NTERA-2: 2.8;WM-115: 5.7" "Low region specificity" "Detected in all" HPA026916 Approved NA NA "HPA026916: AB_1849217" "unprognostic (1.25e-3)" "unprognostic (8.73e-3)" "unprognostic (4.64e-2)" "unprognostic (6.95e-4)" "unprognostic (8.47e-2)" "unprognostic (1.73e-2)" "unprognostic (2.13e-2)" "unprognostic (1.91e-1)" "unprognostic (1.90e-1)" "unprognostic (3.08e-2)" "unprognostic (5.70e-2)" "unprognostic (1.16e-1)" "unprognostic (6.90e-5)" "unprognostic (1.51e-2)" "unprognostic (3.32e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" 1.5 1.7 46.9 2.8 31.6 1.8 1.6 3.0 76.1 1.7 1.5 4.7 0.0 1.9 1.9 1.2 1.7 1.8 1.7 1.5 41.9 20.1 1.3 1.4 1.6 3.7 19.8 26.2 1.8 1.5 1.2 0.1 1.4 10.1 1.4 1.5 0.0 1.8 1.6 2.9 1.9 1.7 1.5 8.7 3.2 1.7 1.7 1.6 0.0 1.4 0.0 2.8 1.8 0.4 8.1 0.6 0.3 0.0 24.4 12.9 2.4 1.2 0.4 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.3 0.0 0.6 1.0 0.3 0.0 0.0 0.4 3.2 0.0 0.4 0.5 0.2 0.4 0.8 0.0 0.2 0.0 9.8 0.9 0.0 0.0 0.0 0.2 0.1 0.3 0.8 3.4 0.0 0.0 0.1 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.2 0.2 0.0 0.7 0.5 0.0 0.0 0.5 0.4 1.3 0.2 0.0 0.1 0.0 0.0 0.8 0.2 5.7 0.0 0.0 0.0 8.1 0.0 5.0 8.1 12.9 9.2 0.0 7.3 4.2 7.2 0.3 24.4 0.0 0.6 3.6 2.4 46.9 31.6 3.0 76.1 41.9 20.1 19.8 26.2 10.1 1.6 0.0 2.2 3.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 1.0 0.0 1.1 0.0 0.1 1.6 0.0 0.6 0.0 0.0 1.1 0.3 3.3 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 6.5 0.8 1.0 5.5 1.0 0.2 5.0 0.0 0.0 FZD1 DKFZp564G072 ENSG00000157240 "Frizzled class receptor 1" Q9UP38 7 91264364-91271326 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 61.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 61.1;Horizontal cells: 133.5;Peritubular cells: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2;non-classical monocyte: 5.4" "Lineage enriched" "Detected in many" 4 "monocytes: 5.4" "Cell line enhanced" "Detected in many" "AF22: 16.6;HSkMC: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013008 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB013008: " "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (1.15e-1)" "unprognostic (3.16e-2)" "unprognostic (4.51e-3)" "unprognostic (2.09e-1)" "unprognostic (5.29e-3)" "unprognostic (3.70e-2)" "unprognostic (2.36e-2)" "unprognostic (5.48e-3)" "unprognostic (2.14e-1)" "unprognostic (7.39e-3)" "prognostic favorable (8.87e-7)" "unprognostic (1.05e-2)" "unprognostic (4.16e-2)" "unprognostic (5.53e-2)" "unprognostic (4.13e-2)" 5.8 4.6 2.6 4.9 3.5 0.9 10.7 8.2 2.8 17.6 8.5 4.1 9.3 4.9 10.1 9.9 7.8 6.1 11.0 12.3 6.1 1.8 15.3 3.9 10.5 1.4 2.0 3.2 15.0 7.9 2.5 4.6 10.0 5.7 12.3 3.7 11.1 9.2 17.5 3.1 10.7 8.3 7.2 4.6 3.4 4.5 4.4 3.5 1.4 61.2 6.5 2.9 10.4 13.9 0.1 1.3 0.2 5.4 0.0 0.0 0.4 0.5 1.6 16.6 1.7 13.5 11.7 3.0 6.0 3.8 2.2 1.6 0.7 2.8 0.0 1.5 3.8 2.8 3.0 2.5 1.3 1.5 0.0 3.2 0.1 3.2 0.8 1.0 2.7 0.7 22.1 2.4 5.1 1.6 8.5 0.5 1.8 0.9 2.4 6.4 3.9 0.5 0.7 4.2 0.8 2.8 3.3 10.2 0.3 3.5 7.7 2.3 4.3 4.5 3.7 0.9 4.0 1.9 2.4 2.5 9.4 7.1 10.0 2.4 2.2 1.5 0.2 10.1 2.3 10.9 0.0 1.4 0.0 0.0 4.2 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 5.4 0.1 0.0 0.4 2.6 3.5 8.2 2.8 6.1 1.8 2.0 3.2 5.7 3.5 3.0 1.0 1.3 30.9 3.8 0.8 12.1 61.1 0.0 4.5 12.2 2.0 3.0 0.0 4.5 0.2 3.6 4.6 0.0 1.8 1.6 12.0 11.7 12.7 0.5 3.6 133.5 3.4 10.4 14.3 0.4 30.8 11.2 16.9 0.0 3.2 3.7 2.1 3.4 42.5 10.8 3.1 0.0 9.4 0.4 2.0 4.4 1.7 0.5 3.5 5.9 FZD10 CD350 ENSG00000111432 "Frizzled class receptor 10" Q9ULW2 12 130162459-130165740 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 26.9;lymphoid tissue: 18.6" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 3.9;Basal keratinocytes: 7.4;Smooth muscle cells: 14.4;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 8.6;BEWO: 9.9;hTCEpi: 5.7;RPTEC TERT1: 3.0;RT4: 4.8" "Region enhanced" "Detected in some" "thalamus: 7.6" "Low region specificity" "Detected in many" "HPA014484, HPA014485" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA014484: AB_1849132, HPA014485: AB_1849134" "unprognostic (2.41e-3)" "unprognostic (3.29e-1)" "unprognostic (4.74e-2)" "prognostic favorable (5.05e-7)" "unprognostic (2.81e-2)" "unprognostic (4.63e-2)" "unprognostic (8.62e-3)" "unprognostic (6.33e-2)" "unprognostic (5.41e-2)" "unprognostic (3.77e-2)" "unprognostic (2.70e-1)" "unprognostic (2.24e-3)" "unprognostic (2.66e-9)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (1.49e-2)" "unprognostic (1.07e-1)" 1.1 0.4 1.0 0.5 1.9 0.2 1.5 5.4 2.1 11.6 0.6 2.1 1.6 0.4 5.1 3.4 26.9 2.2 7.1 0.5 1.0 1.0 0.4 0.2 2.0 0.9 1.6 1.2 3.4 1.1 0.2 1.4 9.2 1.9 3.7 0.6 3.0 5.4 3.1 1.2 10.2 0.7 0.9 1.2 0.3 1.0 0.7 2.0 0.6 1.7 9.0 18.6 5.1 7.2 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 8.6 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 1.5 0.7 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 3.0 4.8 0.1 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 1.9 5.4 2.1 1.0 1.0 1.6 1.2 1.9 2.0 0.0 0.3 0.0 3.9 7.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 1.1 0.0 0.0 0.2 0.3 2.5 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 14.4 0.0 0.4 7.4 0.7 0.0 0.0 1.1 FZD2 ENSG00000180340 "Frizzled class receptor 2" Q14332 17 44557459-44559570 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 17.9;Kupffer cells: 11.1;Leydig cells: 21.6;Peritubular cells: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 3.5;myeloid DC: 5.6;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 6 "dendritic cells: 5.6;monocytes: 3.5" "Cell line enhanced" "Detected in many" "A549: 25.9;BJ hTERT+ SV40 Large T+: 25.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057667 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Nucleoplasm, Nuclear bodies" "Cell Junctions" "HPA057667: AB_2683497" "unprognostic (6.94e-2)" "unprognostic (1.12e-2)" "unprognostic (3.04e-2)" "unprognostic (8.83e-3)" "unprognostic (2.04e-1)" "unprognostic (5.29e-3)" "unprognostic (1.44e-2)" "unprognostic (2.29e-1)" "unprognostic (9.45e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-2)" "unprognostic (1.86e-1)" "unprognostic (5.10e-3)" "unprognostic (1.19e-2)" "unprognostic (6.35e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 2.3 2.8 2.3 3.9 5.8 0.9 3.2 0.7 3.1 16.1 2.9 2.1 3.0 2.9 10.8 7.6 2.4 6.6 7.7 5.8 3.2 1.5 5.0 0.5 6.9 3.1 2.1 2.9 12.1 2.7 1.6 1.9 8.4 4.9 4.2 0.8 14.3 2.9 7.9 1.8 1.1 3.6 3.3 2.0 3.7 2.1 6.5 1.8 1.1 5.3 2.4 3.1 3.8 4.3 0.2 5.6 0.0 3.5 0.0 0.8 0.6 7.6 25.9 14.9 8.5 3.3 2.9 0.3 21.5 13.1 25.8 18.6 20.0 4.4 0.0 6.8 5.3 7.8 3.6 1.7 1.8 6.2 1.9 5.0 0.8 4.2 0.1 4.3 0.1 4.4 5.5 1.4 6.2 4.2 15.2 1.1 2.7 1.6 0.2 6.5 4.0 3.4 2.0 16.3 0.0 4.8 9.9 4.5 1.3 3.3 0.3 1.9 6.4 2.7 0.7 1.6 9.7 8.3 3.6 0.4 13.9 12.4 2.6 12.6 0.6 0.4 1.9 2.6 1.4 6.3 0.0 3.5 0.0 0.1 0.2 0.0 0.0 0.0 0.8 5.6 0.2 0.0 0.2 0.0 0.0 0.2 2.6 0.0 0.6 2.3 5.8 0.7 2.1 3.2 1.5 2.1 2.9 4.9 1.8 17.9 0.0 0.0 0.2 0.6 0.0 1.7 0.0 0.0 0.0 1.8 0.0 1.4 0.0 0.3 0.4 0.6 0.0 0.0 1.6 0.4 5.1 0.1 0.0 0.0 4.5 0.0 1.2 1.3 11.1 0.0 21.6 4.2 0.0 2.8 0.0 6.4 0.5 0.0 17.0 0.1 0.2 0.0 1.0 0.3 0.9 0.4 1.9 0.0 0.0 0.0 FZD3 ENSG00000104290 "Frizzled class receptor 3" Q9NPG1 8 28494205-28574268 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 92.3;Rod photoreceptor cells: 82.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.8" "Group enriched" "Detected in many" 5 "dendritic cells: 11.8;T-cells: 3.1" "Cell line enhanced" "Detected in many" "AF22: 31.1;Karpas-707: 16.0;SCLC-21H: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024995, HPA042320" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB024995: , HPA042320: AB_2677948" "unprognostic (1.21e-1)" "unprognostic (1.73e-1)" "prognostic favorable (1.17e-4)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.57e-4)" "unprognostic (1.69e-2)" "unprognostic (4.26e-4)" "unprognostic (2.11e-1)" "prognostic favorable (3.71e-4)" "unprognostic (2.86e-2)" "unprognostic (1.68e-2)" "unprognostic (1.09e-2)" "unprognostic (1.38e-1)" "unprognostic (4.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.09e-3)" 2.2 6.4 13.3 3.4 21.1 3.2 5.4 14.4 20.9 5.3 4.4 5.2 8.7 3.2 7.5 15.6 4.4 7.8 3.2 3.0 9.1 7.8 5.7 1.9 2.6 4.3 4.4 14.4 15.0 7.1 8.2 12.5 3.1 9.6 9.6 3.1 4.3 7.0 12.4 2.7 3.3 2.5 5.8 5.4 1.8 5.1 9.9 4.3 1.3 7.4 0.3 3.3 5.2 3.7 1.6 11.8 0.9 0.3 1.1 3.1 0.9 8.2 1.7 31.1 5.8 0.0 0.4 4.8 0.3 0.6 1.7 0.8 1.7 1.7 4.1 1.5 0.2 3.8 2.9 4.7 4.9 1.2 5.1 3.6 2.6 0.6 1.1 0.0 1.4 4.6 0.3 2.6 0.1 1.3 0.3 0.3 4.1 1.9 16.0 0.1 2.0 0.1 3.2 7.8 3.5 2.6 1.8 4.6 3.7 2.4 2.4 22.9 6.2 1.6 4.3 4.8 4.2 4.2 2.2 0.0 0.0 8.4 1.1 2.1 2.9 3.3 3.7 2.4 0.0 1.5 0.9 0.3 0.0 2.2 0.2 2.8 1.6 1.6 3.1 1.2 0.9 2.2 2.3 0.2 1.1 0.0 11.8 0.0 0.9 13.3 21.1 14.4 20.9 9.1 7.8 4.4 14.4 9.6 4.3 8.9 8.1 7.8 6.9 6.0 26.0 5.2 2.5 12.0 15.9 8.7 92.3 9.6 1.7 10.9 12.8 3.0 1.0 0.0 12.8 7.4 7.3 12.2 5.7 2.4 3.3 20.6 27.5 11.6 1.8 11.0 44.5 2.9 32.1 0.0 4.2 15.3 14.2 3.5 48.1 10.2 82.4 25.8 13.9 23.2 29.3 4.1 4.0 2.5 5.5 6.4 FZD4 "CD344, EVR1" ENSG00000174804 "Frizzled class receptor 4" Q9ULV1 11 86945679-86955391 "CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 75.7" "Cell type enhanced" "Detected in many" 18 "Collecting duct cells: 34.9;Endothelial cells: 26.3;Ito cells: 108.6;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 25.9;Hep G2: 32.6;HSkMC: 18.8;HUVEC TERT2: 36.8;TIME: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042328, HPA074833" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA042328: AB_10962494, HPA074833: AB_2686716" "unprognostic (6.49e-2)" "unprognostic (1.49e-2)" "unprognostic (1.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.87e-2)" "unprognostic (5.51e-2)" "unprognostic (1.82e-1)" "unprognostic (6.97e-2)" "unprognostic (3.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.36e-2)" "unprognostic (2.22e-1)" "prognostic favorable (8.60e-5)" "unprognostic (1.05e-2)" "unprognostic (9.96e-2)" "unprognostic (9.22e-2)" "unprognostic (1.97e-1)" 75.7 5.3 3.4 6.0 4.8 0.5 57.8 1.5 4.3 11.5 9.0 1.4 32.6 2.0 13.1 13.5 6.3 9.6 8.7 12.5 3.1 2.2 17.0 8.9 19.0 4.7 2.9 3.2 12.8 6.0 4.4 10.1 7.3 5.5 9.3 4.3 20.0 7.1 56.0 17.9 3.7 5.4 8.6 2.8 8.6 8.2 5.5 1.6 0.5 11.4 11.1 3.0 8.3 20.7 0.4 0.2 0.8 0.4 1.4 0.3 0.0 0.5 0.4 1.1 2.0 25.9 6.8 1.5 3.2 2.9 1.2 1.3 2.7 0.3 0.0 0.7 1.0 1.7 1.1 1.2 0.5 1.0 0.1 0.8 1.0 0.8 32.6 7.7 0.0 0.0 18.8 0.2 1.1 0.2 3.0 36.8 0.0 1.4 0.1 0.8 0.8 0.0 0.0 1.5 2.8 7.4 0.0 1.9 0.0 3.6 5.3 0.2 0.3 1.3 0.4 0.5 2.3 4.7 0.0 18.0 3.1 2.1 3.6 0.6 0.1 0.5 0.0 0.4 0.0 0.8 0.7 0.3 0.1 0.3 0.2 0.1 0.2 0.3 0.2 0.1 0.4 0.2 0.3 0.8 1.4 0.4 0.2 0.0 0.0 3.4 4.8 1.5 4.3 3.1 2.2 2.9 3.2 5.5 1.6 0.0 2.2 1.9 0.4 1.3 0.7 7.8 7.6 1.4 1.2 34.9 9.8 0.1 3.3 0.6 0.4 26.3 0.8 0.0 1.4 0.1 4.3 0.8 0.0 10.4 0.2 0.0 0.0 108.6 11.2 1.7 8.6 0.9 0.0 0.0 1.1 0.3 1.0 0.0 6.3 6.9 0.1 32.3 5.1 0.2 3.0 0.5 0.2 0.0 0.6 0.1 FZD5 "C2orf31, DKFZP434E2135, HFZ5" ENSG00000163251 "Frizzled class receptor 5" Q13467 2 207762586-207769563 "G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.2;liver: 36.5" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 70.9;Hepatocytes: 53.8;Muller glia cells: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 48.3;CACO-2: 11.8;Hep G2: 16.2;NTERA-2: 14.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA052361 Approved NA NA "HPA052361: AB_2681799" "unprognostic (4.97e-2)" "unprognostic (6.94e-2)" "unprognostic (2.20e-1)" "unprognostic (2.56e-1)" "unprognostic (1.53e-1)" "unprognostic (2.82e-1)" "unprognostic (4.80e-3)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.48e-3)" "unprognostic (1.29e-1)" "unprognostic (8.00e-2)" "unprognostic (7.72e-2)" "unprognostic (2.51e-1)" "unprognostic (9.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.15e-3)" 5.3 5.9 1.7 5.8 3.9 3.3 6.5 0.6 2.0 4.3 25.4 7.2 8.5 17.5 2.8 1.0 3.9 1.6 5.3 1.9 1.7 2.2 12.1 36.5 12.4 0.9 3.9 1.4 4.5 20.8 1.2 6.1 6.5 2.6 6.4 14.4 6.6 3.7 3.9 2.5 1.4 35.2 2.5 1.9 2.8 10.8 0.8 4.2 1.3 18.5 1.8 2.9 2.6 3.4 0.3 1.4 0.5 1.1 0.2 0.4 0.4 1.4 2.6 0.1 1.4 1.2 0.0 48.3 0.2 0.3 0.4 0.3 11.8 2.7 0.2 3.2 0.1 0.9 2.2 4.1 1.7 0.3 0.1 3.1 3.3 1.2 16.2 0.9 0.6 0.9 0.1 1.7 0.5 1.4 0.9 0.4 0.5 6.7 0.5 0.3 1.0 0.3 0.8 14.1 6.3 0.9 0.8 1.5 0.6 3.4 5.1 2.3 0.3 0.6 0.2 0.6 6.9 0.7 0.6 0.1 0.7 1.4 1.4 1.1 0.8 1.7 0.6 1.0 0.7 0.2 0.3 1.1 0.2 0.1 0.8 0.4 0.1 0.0 0.0 1.4 0.3 0.1 0.2 0.5 0.2 0.4 0.1 0.1 0.4 1.7 3.9 0.6 2.0 1.7 2.2 3.9 1.4 2.6 4.2 29.8 24.6 0.9 5.2 4.5 1.9 5.7 25.5 4.0 4.5 1.8 31.4 13.9 0.0 13.5 0.4 3.4 70.9 0.0 21.0 5.2 3.1 10.1 0.0 53.8 8.8 6.4 12.1 2.5 6.5 0.0 1.7 2.2 1.7 1.0 47.7 56.2 16.8 34.5 0.4 13.4 6.9 0.0 3.6 1.4 0.9 3.6 3.3 0.0 45.3 5.0 FZD6 Hfz6 ENSG00000164930 "Frizzled class receptor 6" O60353 8 103298433-103332866 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 41.7;Suprabasal keratinocytes: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017991 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA017991: AB_1849138" "unprognostic (8.22e-3)" "unprognostic (2.64e-1)" "unprognostic (4.75e-2)" "unprognostic (2.57e-1)" "unprognostic (1.22e-2)" "unprognostic (6.99e-2)" "unprognostic (4.01e-2)" "unprognostic (2.74e-1)" "unprognostic (2.43e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.20e-6)" "unprognostic (3.62e-2)" "unprognostic (1.83e-1)" "unprognostic (2.86e-1)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" "unprognostic (7.54e-2)" 13.1 9.2 3.4 5.2 3.8 0.5 13.3 4.3 5.9 12.1 10.7 3.5 8.6 4.0 12.0 16.4 17.9 17.8 12.3 9.6 3.7 3.8 17.4 5.8 17.1 4.7 4.2 2.9 11.6 14.4 21.3 27.2 14.1 10.0 12.4 4.9 11.6 15.3 8.8 4.3 16.9 7.7 12.7 4.2 6.1 8.0 7.2 1.5 10.9 21.2 18.7 14.7 15.9 11.3 1.7 1.0 0.2 0.0 7.9 2.2 0.5 19.6 4.0 9.5 0.0 2.2 7.0 5.9 10.5 11.5 9.3 6.1 2.1 15.1 0.0 17.9 9.2 2.9 29.1 5.3 21.7 16.6 4.4 6.5 10.4 4.6 2.6 31.3 0.0 0.0 7.9 41.8 9.9 30.6 22.2 19.1 2.2 1.0 8.6 10.0 8.1 9.2 0.8 2.2 1.4 6.9 0.7 4.5 0.0 19.0 12.4 3.3 2.7 14.6 7.7 19.0 5.3 0.0 3.5 1.5 2.2 11.0 8.4 10.6 2.2 1.1 4.2 6.1 0.0 13.5 0.0 0.0 0.2 0.6 0.0 0.0 0.9 2.1 0.9 1.0 1.7 2.2 1.0 0.0 7.9 0.0 0.2 0.6 0.5 3.4 3.8 4.3 5.9 3.7 3.8 4.2 2.9 10.0 1.5 23.8 16.1 0.8 13.5 41.7 3.7 4.7 7.6 26.8 25.0 12.2 2.0 17.8 0.0 10.9 7.8 28.9 3.2 0.0 7.2 6.6 6.9 11.0 0.0 3.2 2.1 6.4 5.1 11.1 0.6 2.1 1.1 1.7 13.5 1.0 6.9 15.5 8.1 3.5 1.4 8.2 4.4 0.0 4.1 7.2 0.7 39.0 12.2 2.5 5.2 19.2 FZD7 FzE3 ENSG00000155760 "Frizzled class receptor 7" O75084 2 202034587-202038445 "G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 17.3;Fibroblasts: 22.1;Smooth muscle cells: 12.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "eosinophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 25.5;CAPAN-2: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059979, HPA069165, HPA076183" Approved Supported Vesicles NA NA Vesicles "HPA059979: , HPA069165: AB_2686096, HPA076183: " "unprognostic (3.44e-2)" "unprognostic (6.89e-2)" "unprognostic (9.30e-3)" "unprognostic (2.44e-3)" "unprognostic (4.92e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (7.71e-5)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" "unprognostic (8.22e-2)" "unprognostic (2.73e-2)" "unprognostic (1.10e-1)" "unprognostic (1.87e-3)" "unprognostic (8.16e-3)" "unprognostic (1.43e-1)" "unprognostic (4.16e-2)" "unprognostic (2.05e-3)" 4.8 1.6 3.2 4.7 6.5 0.0 9.9 23.3 4.5 8.5 17.8 2.0 3.3 3.9 9.7 9.4 9.1 8.6 3.7 8.7 10.8 0.7 4.1 0.8 3.0 4.0 0.8 6.2 17.4 0.8 0.0 4.9 3.2 3.8 12.4 3.4 6.1 13.4 16.2 13.5 5.3 5.6 17.3 3.0 2.0 3.1 3.2 3.0 0.8 2.6 4.3 3.2 13.1 8.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 4.6 2.6 17.3 5.5 5.8 4.3 7.4 19.8 25.5 6.4 7.4 16.3 31.8 0.0 11.8 13.6 4.1 5.1 3.1 0.7 7.4 2.3 4.1 0.5 1.1 1.3 3.9 0.9 1.0 4.1 0.5 3.4 2.0 5.1 0.0 0.3 1.3 1.3 5.1 2.1 0.0 2.8 18.1 1.0 1.7 1.9 3.2 0.5 1.0 3.1 2.8 6.2 2.6 0.2 3.2 14.9 1.8 1.2 0.0 12.4 4.4 7.5 2.5 1.2 0.9 0.0 2.5 0.2 8.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 6.5 23.3 4.5 10.8 0.7 0.8 6.2 3.8 3.0 0.0 7.2 0.0 7.2 9.2 0.0 17.3 2.5 1.4 0.0 1.8 0.0 0.4 1.7 0.8 0.1 0.6 7.8 0.0 0.2 0.7 22.1 3.8 1.1 0.0 1.2 0.0 1.2 1.3 0.6 0.0 4.9 1.4 3.3 0.0 6.4 6.1 0.4 2.3 4.6 0.0 0.4 6.5 12.6 1.1 0.5 8.5 0.7 0.0 3.8 1.6 FZD8 ENSG00000177283 "Frizzled class receptor 8" Q9H461 10 35638249-35642278 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 17.9;Muller glia cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 10.8;PC-3: 27.5;U-138 MG: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA045025, HPA071142" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA045025: AB_10795888, HPA071142: AB_2686349" "unprognostic (1.20e-1)" "unprognostic (4.42e-3)" "unprognostic (1.85e-2)" "unprognostic (1.97e-1)" "unprognostic (2.21e-2)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (1.08e-3)" "unprognostic (1.11e-1)" "unprognostic (1.53e-1)" "prognostic favorable (8.21e-4)" "unprognostic (4.92e-2)" "unprognostic (2.25e-1)" "unprognostic (4.85e-2)" "unprognostic (1.68e-1)" "unprognostic (7.34e-3)" "unprognostic (1.19e-1)" 8.9 2.6 7.4 2.7 5.1 0.7 4.9 0.5 8.5 5.2 10.4 4.9 0.6 1.8 3.4 2.2 2.1 7.9 3.9 12.5 12.0 1.7 13.1 5.0 9.5 4.3 2.7 3.8 4.9 9.5 6.0 4.0 1.8 7.1 3.4 4.6 14.2 4.5 3.5 5.8 4.6 2.6 3.6 1.4 21.3 10.4 4.1 5.5 3.3 14.7 2.4 3.0 2.8 5.4 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 2.9 0.5 0.0 1.2 0.0 1.8 3.2 0.1 0.1 0.1 0.3 0.5 0.0 0.5 1.4 3.3 1.0 0.3 1.0 0.0 0.0 8.4 0.0 0.3 0.1 0.6 0.0 0.2 1.0 4.1 6.7 2.6 10.8 2.3 0.0 0.1 0.0 0.9 1.2 0.0 0.0 2.7 0.2 27.5 2.7 1.7 0.0 5.2 0.2 8.3 0.2 0.6 0.2 0.0 4.0 0.0 0.4 5.5 10.3 1.6 5.0 8.8 0.0 0.0 0.0 5.9 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.4 5.1 0.5 8.5 12.0 1.7 2.7 3.8 7.1 5.5 17.9 3.5 0.0 0.6 0.2 0.2 8.9 2.5 1.4 0.0 0.0 2.0 0.1 0.0 2.2 0.0 4.4 5.3 0.0 2.7 0.1 1.1 0.8 0.0 3.4 0.5 0.0 1.2 9.2 0.6 0.0 1.1 0.8 0.0 0.0 2.9 31.4 2.6 0.0 2.1 3.1 1.0 6.5 2.3 0.1 1.1 1.0 0.1 0.0 3.5 0.1 FZD9 "CD349, FZD3" ENSG00000188763 "Frizzled class receptor 9" O00144 7 73433783-73436120 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 14.4" "Group enriched" "Detected in some" 5 "Early spermatids: 7.3;Late spermatids: 10.0;Muller glia cells: 4.8;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "melanoma: 6.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 8.4;MCF7: 3.6;NTERA-2: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (9.60e-2)" "unprognostic (4.03e-2)" "unprognostic (3.16e-2)" "unprognostic (9.15e-3)" "unprognostic (1.10e-1)" "unprognostic (6.91e-2)" "unprognostic (2.29e-2)" "unprognostic (2.26e-1)" "unprognostic (2.04e-1)" "unprognostic (7.17e-3)" "unprognostic (1.20e-1)" "unprognostic (7.24e-2)" "unprognostic (5.90e-5)" "unprognostic (8.99e-2)" "unprognostic (4.57e-2)" "unprognostic (1.22e-1)" "unprognostic (5.21e-2)" 4.4 1.2 6.8 0.7 4.7 2.4 1.1 3.3 7.0 1.1 1.3 4.5 0.0 1.9 0.9 0.9 1.3 0.9 0.7 0.8 7.1 6.3 0.9 0.8 0.9 0.9 7.0 4.5 0.9 3.8 1.6 4.3 1.9 5.0 3.0 0.8 1.4 4.4 1.4 14.4 1.7 2.9 0.9 3.6 1.0 1.0 5.4 6.7 0.3 0.9 1.7 0.8 0.7 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.6 2.7 2.8 3.1 0.0 0.1 0.0 1.9 0.0 0.4 0.1 0.7 0.0 0.0 0.9 0.1 1.2 0.2 1.4 0.0 0.0 0.0 8.4 0.0 0.6 0.9 1.2 0.0 0.3 0.3 0.0 0.1 0.0 0.1 0.2 0.0 2.8 0.0 0.2 3.6 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.7 2.4 1.7 1.8 0.4 1.7 0.9 0.1 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 6.8 4.7 3.3 7.0 7.1 6.3 7.0 4.5 5.0 6.7 0.0 0.0 0.0 0.7 0.6 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.3 0.6 0.0 0.0 0.3 0.2 0.3 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 1.0 0.0 4.8 0.2 0.0 0.4 0.0 0.7 6.5 0.5 0.4 0.3 1.0 0.0 0.0 0.0 0.3 G0S2 ENSG00000123689 "G0/G1 switch 2" P27469 1 209675420-209676388 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 203.9;liver: 154.7" "Cell type enhanced" "Detected in many" 6 "Pancreatic endocrine cells: 558.7;Urothelial cells: 443.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 62 "neutrophil: 89.5" "Lineage enriched" "Detected in single" 197 "granulocytes: 89.5" "Group enriched" "Detected in some" 6 "ASC diff: 77.1;HBEC3-KT: 116.4;PC-3: 29.2;RPMI-8226: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-3)" "unprognostic (1.99e-3)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (3.82e-1)" "unprognostic (2.21e-1)" "unprognostic (5.04e-3)" "unprognostic (3.03e-1)" "unprognostic (1.38e-1)" "unprognostic (2.32e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (7.57e-3)" "unprognostic (1.53e-2)" "unprognostic (4.78e-2)" "unprognostic (2.64e-1)" 130.1 23.3 1.1 18.5 1.1 203.9 85.2 2.0 0.9 2.0 11.3 1.4 29.9 1.6 6.1 9.3 2.0 4.0 13.5 43.7 1.1 0.8 22.2 154.7 51.6 6.4 1.8 0.0 18.4 5.3 0.5 1.2 2.6 1.3 8.7 1.1 3.1 49.2 73.5 97.9 3.0 3.5 3.8 1.5 6.3 7.1 5.3 1.1 0.0 3.1 14.3 6.1 12.6 13.1 0.0 0.0 89.5 0.1 0.0 0.4 0.0 0.0 0.6 0.0 0.0 77.1 2.7 0.0 0.1 0.2 0.3 0.3 3.0 2.4 0.0 0.6 0.5 0.4 0.0 0.0 116.4 0.7 0.1 0.2 0.0 0.2 0.1 6.3 0.0 0.0 8.0 0.2 5.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 29.2 0.0 0.0 37.1 0.2 0.0 0.1 0.2 2.6 0.0 0.6 0.0 0.0 8.9 11.7 0.0 0.8 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.1 1.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 89.5 0.0 0.0 0.0 0.0 0.0 1.1 1.1 2.0 0.9 1.1 0.8 1.8 0.0 1.3 1.1 8.9 93.3 5.6 295.9 206.4 0.2 325.1 12.7 41.5 55.7 10.4 0.0 1.1 253.7 40.5 12.3 26.3 16.9 0.0 123.5 3.9 183.7 312.4 36.0 83.1 183.0 0.0 28.2 14.1 41.0 7.4 106.2 375.5 310.4 50.5 30.7 19.9 558.7 40.3 67.1 223.2 0.0 32.3 88.6 21.4 1.1 141.0 3.5 4.8 37.5 443.6 G6PC "G6PT, GSD1a" ENSG00000131482 "Glucose-6-phosphatase catalytic subunit" P35575 17 42900797-42913369 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Gluconeogenesis Hydrolase "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "liver: 305.4" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 125.4" "Cancer enriched" "Detected in some" 72 "liver cancer: 151.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RH-30: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA052324 Enhanced NA NA "HPA052324: AB_2681790" "unprognostic (4.23e-2)" "unprognostic (1.49e-2)" "prognostic favorable (5.42e-5)" "unprognostic (8.37e-2)" "prognostic favorable (3.79e-5)" "unprognostic (4.79e-2)" "unprognostic (6.46e-2)" "unprognostic (2.56e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 5.0 0.0 0.0 5.8 0.1 0.0 0.1 0.1 1.9 0.1 0.1 0.1 23.7 305.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 33.7 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 2.2 0.5 1.1 0.2 0.5 0.4 0.0 0.4 0.2 0.2 0.5 0.6 0.0 0.7 0.2 0.2 0.0 0.1 0.2 0.3 0.7 0.2 0.3 0.2 0.4 0.0 0.0 0.2 0.3 0.1 0.1 0.5 0.8 0.0 1.3 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.5 0.7 0.0 0.1 0.5 1.2 0.3 0.0 0.3 0.6 2.2 0.2 0.1 0.7 0.4 0.6 0.7 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.7 0.2 1.0 0.3 1.4 0.2 1.1 0.2 0.1 0.3 0.1 0.2 1.0 0.2 0.2 0.0 2.2 0.4 0.4 1.1 0.5 0.1 0.5 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 22.9 0.0 0.0 1.8 0.0 0.0 1.7 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 125.4 0.1 0.0 0.0 3.7 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 G6PC2 IGRP ENSG00000152254 "Glucose-6-phosphatase catalytic subunit 2" Q9NQR9 2 168901240-168910000 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Gluconeogenesis Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 35 "pancreas: 28.8;retina: 12.1" "Cell type enriched" "Detected in some" 13 "Muller glia cells: 70.6" "Cancer enriched" "Detected in single" 92 "pancreatic cancer: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;SCLC-21H: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (6.42e-2)" "unprognostic (2.39e-2)" "unprognostic (6.04e-2)" "unprognostic (9.05e-2)" "unprognostic (2.97e-1)" "unprognostic (3.10e-2)" "unprognostic (1.54e-2)" "unprognostic (1.87e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.0 0.1 0.0 0.0 12.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 70.6 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 G6PC3 UGRP ENSG00000141349 "Glucose-6-phosphatase catalytic subunit 3" Q9BUM1 17 44070735-44076344 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Gluconeogenesis Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067052 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA067052: AB_2685771" "unprognostic (9.13e-2)" "unprognostic (2.28e-1)" "unprognostic (3.61e-1)" "prognostic favorable (1.11e-4)" "unprognostic (1.88e-3)" "unprognostic (3.16e-1)" "prognostic unfavorable (9.61e-4)" "unprognostic (2.79e-1)" "unprognostic (2.43e-1)" "unprognostic (1.15e-2)" "unprognostic (2.59e-2)" "unprognostic (1.85e-3)" "unprognostic (1.87e-3)" "unprognostic (4.53e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (4.49e-2)" 25.4 38.1 25.8 15.6 25.4 11.1 23.4 12.9 35.3 25.3 17.8 37.8 28.3 21.1 22.0 50.9 14.4 27.7 20.5 22.2 25.4 37.8 42.8 15.3 18.7 29.8 32.9 21.3 28.1 29.1 38.4 37.7 22.2 34.0 26.1 15.2 37.4 27.7 33.8 22.9 9.9 17.7 17.8 33.1 19.7 18.2 20.7 16.0 18.5 35.1 11.4 14.8 21.4 14.0 5.9 33.4 3.1 19.0 7.2 6.1 6.5 10.2 61.3 21.4 34.5 22.8 17.0 15.1 11.7 24.2 27.6 18.5 25.3 16.6 23.6 17.0 26.2 19.0 17.7 16.3 25.1 13.2 12.1 25.2 13.0 41.5 46.1 23.7 11.6 16.4 22.3 12.1 26.1 18.4 16.8 22.8 10.1 13.3 30.1 20.6 28.6 5.7 18.0 26.8 13.4 39.9 11.9 13.4 54.7 37.4 24.1 25.8 22.8 13.0 15.6 15.0 25.3 43.0 11.8 22.8 27.3 14.5 7.3 16.3 20.1 14.3 6.7 30.4 10.2 34.7 1.2 15.2 3.1 4.6 19.0 5.6 5.5 3.6 4.4 24.6 5.9 4.6 6.1 0.5 7.2 11.1 33.4 3.5 6.5 25.8 25.4 12.9 35.3 25.4 37.8 32.9 21.3 34.0 16.0 3.0 11.7 11.1 13.2 2.3 9.0 5.9 15.3 16.0 13.6 38.4 11.8 55.8 11.6 46.4 3.3 15.6 15.1 0.0 43.1 32.6 15.4 16.0 17.4 5.0 51.3 4.8 22.1 18.4 20.6 4.0 18.7 18.3 13.5 22.6 12.2 34.1 31.2 14.0 21.5 29.3 7.9 12.9 8.6 27.2 28.1 2.3 35.6 8.2 16.9 12.9 GAA ENSG00000171298 "Glucosidase alpha, acid" P10253 17 80101556-80119879 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, FDA approved drug targets, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 125.7;Syncytiotrophoblasts: 139.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 23.8;eosinophil: 8.4;intermediate monocyte: 20.0;myeloid DC: 15.6;neutrophil: 10.8;non-classical monocyte: 24.7" "Group enriched" "Detected in all" 9 "dendritic cells: 15.6;granulocytes: 10.8;monocytes: 24.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026970, HPA029126" Enhanced Approved Vesicles NA NA 3000000 Vesicles "HPA026970: AB_2672065, HPA029126: AB_2672918" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (7.66e-4)" "unprognostic (2.94e-2)" "unprognostic (1.14e-2)" "unprognostic (7.96e-2)" "unprognostic (2.05e-2)" "unprognostic (1.19e-1)" "unprognostic (2.90e-1)" "unprognostic (1.43e-1)" "unprognostic (1.29e-2)" "unprognostic (2.76e-1)" "unprognostic (1.46e-1)" "unprognostic (7.02e-2)" "unprognostic (2.38e-1)" "unprognostic (1.78e-2)" "unprognostic (1.18e-1)" 27.5 19.6 13.8 17.0 14.8 11.3 18.6 14.3 23.0 14.9 16.5 23.4 21.7 19.4 20.1 50.9 13.9 18.2 23.5 21.4 13.5 17.6 27.9 44.2 34.0 30.2 18.1 16.1 14.6 29.4 28.8 24.7 84.1 14.9 22.3 7.2 21.9 27.5 22.1 26.3 18.3 15.4 17.2 16.6 35.8 17.4 30.7 14.6 13.9 21.9 14.9 13.5 24.0 13.4 1.4 15.6 10.8 24.7 1.1 1.8 9.8 11.4 22.4 4.4 14.5 13.9 14.0 28.9 7.2 13.3 5.5 4.5 6.6 18.7 4.1 19.2 5.6 4.7 4.9 1.4 8.3 1.3 5.3 16.7 0.0 3.8 23.7 24.2 0.5 13.7 30.1 12.0 10.3 3.6 11.2 9.7 11.2 4.1 17.3 4.1 26.5 1.9 2.7 9.2 2.8 15.7 10.0 15.2 7.0 4.4 12.0 5.1 14.7 9.4 10.5 12.9 2.8 30.0 16.4 6.2 20.4 11.0 14.7 2.6 41.4 11.5 1.2 6.5 10.7 12.8 0.1 23.8 8.4 1.5 20.0 1.8 1.3 1.2 1.6 15.6 1.4 1.4 0.9 10.8 1.1 24.7 3.8 0.8 9.8 13.8 14.8 14.3 23.0 13.5 17.6 18.1 16.1 14.9 14.6 17.9 45.3 3.9 14.4 10.0 15.6 14.3 30.6 5.3 17.0 14.0 7.9 106.8 5.0 23.0 42.5 17.4 18.6 0.0 13.8 125.7 30.3 19.9 8.1 23.1 92.2 11.1 5.8 29.4 107.0 25.5 22.2 64.5 23.6 31.5 14.3 28.7 9.4 17.5 18.0 18.2 16.5 6.5 10.3 18.4 26.8 7.3 139.0 7.7 15.5 10.8 GABBR1 "GPRC3A, hGB1a" ENSG00000204681 "Gamma-aminobutyric acid type B receptor subunit 1" Q9UBS5 6 29555629-29633976 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.8" "Cell type enhanced" "Detected in many" 4 "Ito cells: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8;plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 8.1;HEL: 7.9;U-2 OS: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050483, HPA058459" Uncertain Approved Centrosome "Intracellular and membrane" NA NA Centrosome "HPA050483: AB_2681140, HPA058459: " "unprognostic (1.01e-1)" "unprognostic (2.07e-3)" "unprognostic (3.22e-3)" "unprognostic (2.93e-3)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (7.95e-4)" "unprognostic (5.44e-2)" "unprognostic (4.24e-2)" "unprognostic (1.14e-1)" "prognostic favorable (2.54e-5)" "unprognostic (1.23e-3)" "prognostic unfavorable (3.77e-10)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.87e-2)" "unprognostic (2.55e-2)" 14.0 7.4 33.6 7.0 47.2 8.2 4.2 29.1 53.8 6.9 5.6 17.3 3.0 2.3 18.1 1.9 2.9 7.9 4.1 4.6 24.8 21.4 2.9 2.0 6.9 6.6 15.6 33.7 7.8 5.1 1.8 5.8 5.0 22.3 12.8 3.2 4.4 13.0 13.3 8.5 18.3 6.1 5.5 14.9 24.2 6.1 4.3 15.4 0.0 3.9 0.1 5.2 4.0 5.9 1.8 1.7 0.0 0.5 0.0 0.4 0.3 3.0 0.0 1.9 8.1 0.9 2.1 2.1 2.0 0.9 1.8 0.5 2.4 0.1 1.4 2.0 0.0 0.5 2.5 0.9 0.0 0.0 7.3 3.4 7.9 3.5 0.0 1.2 0.3 4.0 0.0 0.0 1.6 0.0 2.3 1.0 4.3 6.7 0.0 0.3 2.0 0.8 0.1 0.6 0.0 1.1 3.5 0.7 0.1 0.3 0.0 0.5 1.3 0.5 0.0 3.3 0.6 1.5 1.2 4.6 3.3 8.4 0.3 3.8 7.1 0.8 0.0 1.8 3.6 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.3 1.8 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.3 33.6 47.2 29.1 53.8 24.8 21.4 15.6 33.7 22.3 15.4 11.9 19.8 5.2 6.1 10.5 22.1 8.9 2.5 1.4 18.2 3.5 0.0 0.4 0.0 1.2 2.4 11.9 0.0 0.0 0.7 0.2 9.6 5.4 7.0 0.0 1.1 22.3 6.9 28.8 7.2 1.7 14.1 10.5 0.0 5.4 3.8 9.7 2.2 1.5 24.1 0.7 13.8 12.9 15.5 1.1 1.5 9.7 0.5 1.0 1.2 1.8 GABBR2 "GABABR2, GPR51, GPRC3B, HG20" ENSG00000136928 "Gamma-aminobutyric acid type B receptor subunit 2" O75899 9 98288082-98709197 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 52.7" "Group enriched" "Detected in some" 11 "Bipolar cells: 87.5;Early spermatids: 83.9;Late spermatids: 26.5" "Group enriched" "Detected in many" 10 "glioma: 7.2;thyroid cancer: 11.6;urothelial cancer: 3.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 11.1;fHDF/TERT166: 5.5;HUVEC TERT2: 23.0;U-138 MG: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013820, HPA031684, CAB079065" Enhanced Approved NA NA "CAB079065: , HPA013820: AB_1849364, HPA031684: AB_2673993" "unprognostic (2.00e-1)" "unprognostic (7.56e-2)" "unprognostic (3.75e-1)" "unprognostic (3.09e-5)" "unprognostic (2.52e-1)" "unprognostic (1.16e-1)" "unprognostic (2.81e-2)" "unprognostic (1.42e-1)" "unprognostic (2.66e-1)" "unprognostic (4.43e-2)" "unprognostic (1.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.76e-2)" "unprognostic (3.52e-2)" "unprognostic (1.91e-1)" "unprognostic (2.68e-2)" "unprognostic (3.45e-2)" 0.9 4.4 13.6 1.0 14.6 0.8 0.9 19.7 52.7 0.8 0.9 2.1 0.0 0.8 1.1 1.1 0.9 0.8 0.9 0.9 14.6 11.1 0.9 0.9 1.0 0.9 7.6 17.6 0.8 0.8 0.9 0.3 0.9 10.3 0.9 0.8 0.6 0.9 0.9 3.2 0.9 0.8 1.0 2.2 0.9 1.0 1.3 0.2 0.0 2.3 0.0 1.1 1.5 0.1 0.7 0.7 1.7 1.1 1.7 1.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 1.0 11.1 2.2 2.4 4.3 0.0 0.1 0.0 0.7 5.5 0.5 0.0 0.1 0.2 0.8 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.8 0.2 0.0 23.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.6 3.1 0.0 0.0 2.8 0.0 0.0 0.0 0.1 1.0 9.0 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 1.7 0.4 0.8 0.6 0.7 1.0 0.7 0.7 0.7 0.4 0.6 0.8 0.9 1.2 1.7 1.1 0.7 1.0 0.4 13.6 14.6 19.7 35.0 14.6 11.1 7.6 17.6 10.3 0.2 0.0 0.0 0.0 0.0 0.1 87.5 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 83.9 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 26.5 0.3 0.0 1.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 5.8 0.0 0.5 0.6 0.7 0.1 0.3 0.0 0.0 0.0 GABRA1 EJM5 ENSG00000022355 "Gamma-aminobutyric acid type A receptor alpha1 subunit" P14867 5 161847063-161899981 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 58.6" "Cell type enriched" "Detected in some" 24 "Bipolar cells: 209.5" "Cancer enriched" "Detected in single" 5 "glioma: 1.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.7;SCLC-21H: 1.1;U-2 OS: 1.6;U-87 MG: 2.3;WM-115: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022502, HPA029363, HPA055746" Enhanced Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022502: , HPA029363: , HPA055746: AB_2682904" "unprognostic (2.58e-2)" "unprognostic (4.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.31e-1)" "unprognostic (2.43e-1)" 1.0 2.6 8.5 1.0 21.9 1.0 1.0 35.2 58.6 1.0 1.0 1.8 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 10.5 8.8 1.0 1.0 1.0 1.0 6.7 22.0 1.0 1.0 1.0 0.1 1.0 7.4 1.2 1.0 0.2 1.0 1.1 1.0 1.0 1.0 1.0 1.3 1.1 1.5 1.1 0.0 0.0 1.0 0.0 1.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 21.9 35.2 49.8 10.5 8.8 6.7 22.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 209.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRA2 ENSG00000151834 "Gamma-aminobutyric acid type A receptor alpha2 subunit" P47869 4 46248427-46475230 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 52.6" "Group enriched" "Detected in some" 4 "Collecting duct cells: 38.4;Enterocytes: 16.9;Intestinal endocrine cells: 30.6" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-2 OS: 9.6;U-87 MG: 4.5;WM-115: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029363, CAB079061" Supported Uncertain "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" Nucleoplasm "CAB079061: , HPA029363: " "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (2.45e-4)" "unprognostic (6.87e-3)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.09e-1)" "unprognostic (6.90e-3)" "unprognostic (8.83e-2)" "unprognostic (2.22e-5)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 2.2 1.3 38.5 1.4 34.4 1.2 1.9 10.4 52.6 1.7 4.5 4.9 0.0 2.0 1.4 11.7 1.7 1.0 1.6 1.0 38.9 7.7 8.8 1.4 1.0 1.4 3.7 31.0 1.9 1.0 0.9 0.6 1.5 10.5 1.0 3.5 0.0 1.2 1.9 1.0 1.3 7.7 1.3 6.9 2.3 1.6 1.5 7.1 0.0 1.1 0.0 1.4 1.2 0.8 0.2 0.3 1.0 0.1 0.1 0.1 0.0 0.5 0.5 0.1 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 2.1 0.6 0.2 0.5 0.0 0.1 0.8 0.0 0.0 0.2 0.5 0.5 0.1 0.7 0.3 0.8 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.8 0.2 0.0 0.4 0.0 0.3 0.9 1.8 0.1 0.0 0.6 0.4 0.1 0.6 0.2 0.0 0.1 0.3 0.0 0.6 0.4 0.4 0.1 0.5 9.6 0.5 0.1 0.8 1.2 0.2 4.5 0.4 5.1 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.1 0.3 0.0 0.0 38.5 34.4 10.4 31.4 38.9 7.7 3.7 31.0 10.5 7.1 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 0.0 0.0 38.4 3.9 0.0 3.3 0.0 6.4 0.2 16.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 30.6 0.0 0.0 6.9 0.6 0.0 1.7 0.0 1.9 0.3 0.0 0.9 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.0 GABRA3 ENSG00000011677 "Gamma-aminobutyric acid type A receptor alpha3 subunit" P34903 X 152166234-152451358 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 30.1" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 12.1" "Cancer enriched" "Detected in many" 7 "testis cancer: 16.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 9.1;HMC-1: 7.7;Karpas-707: 13.0;PC-3: 7.6;U-266/70: 7.0;U-266/84: 11.6;U-87 MG: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000839, HPA029363" Approved Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA000839: AB_1078929, HPA029363: " "unprognostic (9.63e-3)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (1.18e-2)" "unprognostic (7.07e-2)" "unprognostic (5.42e-2)" "unprognostic (2.34e-6)" "unprognostic (1.24e-1)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" "unprognostic (2.63e-2)" "unprognostic (1.73e-1)" "unprognostic (7.29e-6)" "unprognostic (7.42e-3)" "unprognostic (6.20e-2)" "unprognostic (8.13e-2)" 0.7 0.7 7.7 0.6 15.2 0.7 0.7 1.3 30.1 2.2 0.8 3.3 0.0 0.8 1.2 0.8 1.3 0.7 0.7 0.7 10.9 15.9 0.7 0.7 0.7 0.7 4.7 10.5 0.6 0.7 0.6 0.9 5.2 6.2 0.8 0.8 0.4 0.7 1.8 0.8 1.1 0.9 0.8 2.1 0.7 0.7 1.8 1.1 0.0 0.7 0.0 0.9 1.8 0.4 0.0 0.1 1.5 0.3 0.3 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 13.0 0.0 0.0 0.0 0.0 2.4 5.5 7.6 0.0 0.0 0.0 0.0 0.0 0.2 4.7 0.0 4.8 0.4 0.3 0.1 1.2 0.0 4.9 6.5 0.3 1.4 7.0 11.6 0.0 7.7 0.0 4.9 1.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.1 0.2 0.0 7.7 15.2 1.3 28.4 10.9 15.9 4.7 10.5 6.2 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.0 1.6 0.0 0.0 0.3 GABRA4 ENSG00000109158 "Gamma-aminobutyric acid type A receptor alpha4 subunit" P48169 4 46918900-46994407 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 16.1" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 11.0;Muller glia cells: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 177 "REH: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.78e-2)" "unprognostic (6.57e-3)" "unprognostic (2.46e-1)" "unprognostic (2.23e-1)" "unprognostic (3.17e-1)" "unprognostic (1.11e-1)" "unprognostic (6.91e-2)" 0.0 0.1 2.7 0.1 8.9 0.0 0.0 0.3 16.1 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.1 4.0 1.9 1.4 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GABRA5 ENSG00000186297 "Gamma-aminobutyric acid type A receptor alpha5 subunit" P31644 15 26866363-26949207 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 52.6" "Cell type enhanced" "Detected in single" 18 "Spermatogonia: 1.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "A549: 26.4;HAP1: 9.1;NTERA-2: 10.9;U-2 OS: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029363, HPA077031, CAB079022" Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB079022: , HPA029363: , HPA077031: AB_2686825" "unprognostic (6.33e-2)" "unprognostic (8.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (9.50e-3)" "unprognostic (2.57e-1)" "unprognostic (7.63e-2)" "unprognostic (8.50e-2)" "unprognostic (1.44e-2)" 0.8 0.8 12.0 0.8 48.2 0.8 0.8 0.1 52.6 0.8 0.8 0.8 0.0 0.8 0.8 0.7 2.5 0.8 1.5 0.9 20.9 6.0 0.9 0.8 0.8 0.8 2.3 15.2 0.7 0.7 0.7 0.1 0.8 1.0 1.0 0.7 0.0 0.7 0.9 0.7 0.8 0.7 1.4 0.3 0.8 1.1 1.4 2.0 1.3 0.9 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 9.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 48.2 0.1 26.0 20.9 6.0 2.3 15.2 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 GABRA6 ENSG00000145863 "Gamma-aminobutyric acid type A receptor alpha6 subunit" Q16445 5 161547063-161702593 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "brain: 96.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 36 "cerebellum: 96.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 1.0;PC-3: 1.5;TIME: 1.1;U-266/70: 2.5" "Region enriched" "Detected in some" 40 "cerebellum: 1204.9" "Region enriched" "Detected in some" 44 "cerebellum: 189.6" CAB022462 Approved NA NA "CAB022462: " "unprognostic (3.79e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRB1 ENSG00000163288 "Gamma-aminobutyric acid type A receptor beta1 subunit" P18505 4 46993723-47426444 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 34.5;pituitary gland: 14.7" "Cell type enriched" "Detected in some" 25 "Muller glia cells: 39.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.4;REH: 4.2;SCLC-21H: 1.1;U-87 MG: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.11e-2)" "unprognostic (7.56e-3)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-1)" "unprognostic (4.98e-3)" "unprognostic (8.16e-3)" "unprognostic (6.22e-2)" "unprognostic (2.72e-2)" "unprognostic (2.34e-1)" 1.0 1.3 19.9 1.0 34.5 0.9 1.0 14.7 27.9 1.0 1.2 2.7 0.0 1.6 1.2 1.0 1.0 1.2 1.2 6.0 16.3 4.2 1.8 1.1 1.1 0.9 2.8 18.5 1.1 0.9 0.9 14.7 1.3 5.6 1.0 1.2 0.0 0.9 0.9 0.9 0.9 1.3 1.0 3.4 1.0 1.0 1.1 6.7 0.0 1.3 0.0 0.9 0.9 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.7 0.0 0.0 0.0 6.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 34.5 14.7 16.6 16.3 4.2 2.8 18.5 5.6 6.7 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 1.4 0.0 0.1 0.0 0.0 0.0 GABRB2 ENSG00000145864 "Gamma-aminobutyric acid type A receptor beta2 subunit" P47870 5 161288429-161549044 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 48.7" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 17.4;Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 9.0" "Cancer enriched" "Detected in some" 20 "thyroid cancer: 10.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001964, HPA067632" Enhanced NA NA "CAB001964: , HPA067632: AB_2685874" "unprognostic (5.46e-2)" "unprognostic (1.03e-1)" "unprognostic (3.29e-1)" "unprognostic (2.26e-6)" "unprognostic (2.33e-2)" "unprognostic (6.65e-2)" "unprognostic (3.58e-2)" "unprognostic (1.82e-1)" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (2.24e-4)" "unprognostic (1.22e-1)" "unprognostic (1.33e-2)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.04e-2)" 1.2 3.6 7.7 0.8 19.2 0.7 0.9 48.7 45.4 1.3 1.5 0.9 0.0 2.0 0.9 5.8 0.8 1.2 0.8 0.9 8.1 4.6 2.8 0.7 1.8 0.8 3.7 16.3 0.9 0.9 0.8 0.5 1.0 4.3 0.9 2.2 0.1 1.3 1.5 0.8 0.8 1.4 0.9 1.1 3.4 1.2 1.5 1.8 0.0 1.3 0.0 0.8 0.8 0.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.2 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.7 19.2 48.7 34.1 8.1 4.6 3.7 16.3 4.3 1.8 0.0 0.0 0.0 0.0 0.2 17.4 1.6 0.0 0.0 0.0 0.0 25.5 0.0 5.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 1.4 0.0 0.0 0.4 2.6 9.0 0.0 0.4 2.7 1.5 0.4 0.0 0.0 3.0 0.0 GABRB3 ENSG00000166206 "Gamma-aminobutyric acid type A receptor beta3 subunit" P28472 15 26543546-26939539 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.6" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 136.2;Cone photoreceptor cells: 37.3;Horizontal cells: 71.5;Rod photoreceptor cells: 48.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 32.3;HAP1: 13.3;NTERA-2: 23.2;OE19: 10.0;SCLC-21H: 21.5;U-2 OS: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.72e-1)" "unprognostic (4.91e-2)" "unprognostic (3.20e-2)" "unprognostic (4.25e-2)" "unprognostic (1.66e-1)" "unprognostic (7.07e-2)" "unprognostic (1.00e-1)" "unprognostic (8.87e-2)" "unprognostic (1.02e-1)" "unprognostic (2.44e-1)" "unprognostic (1.44e-2)" "unprognostic (3.62e-1)" "unprognostic (3.56e-3)" "unprognostic (2.99e-2)" "unprognostic (1.49e-1)" "unprognostic (3.33e-2)" "unprognostic (4.05e-1)" 1.2 6.2 16.8 1.1 22.6 0.7 1.5 12.7 48.6 3.0 1.8 1.6 0.1 1.4 2.4 1.6 1.9 3.0 13.9 7.4 14.3 11.7 7.8 1.5 1.5 0.7 4.6 13.7 2.5 5.2 1.2 12.2 0.7 3.7 5.7 1.6 3.2 1.2 1.9 0.7 1.3 1.2 2.0 2.5 1.2 6.0 4.4 3.4 0.0 9.1 0.0 0.9 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 32.3 5.1 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.6 1.6 0.0 0.0 0.0 0.0 0.0 7.0 0.9 0.0 0.0 0.0 2.2 0.0 23.2 10.0 1.6 0.0 0.0 0.0 2.3 0.0 21.5 8.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 16.8 22.6 12.7 25.7 14.3 11.7 4.6 13.7 3.7 3.4 11.9 2.2 0.0 1.0 0.0 136.2 8.9 17.8 18.7 2.3 5.2 37.3 0.4 0.0 3.3 9.0 1.3 0.5 0.0 0.4 0.0 0.2 3.6 0.0 0.5 0.0 71.5 9.9 1.3 0.0 4.9 1.7 0.0 0.0 0.0 1.8 6.7 1.4 0.0 3.2 6.3 48.7 0.0 0.9 5.1 15.1 0.1 0.2 0.0 0.4 0.3 GABRD ENSG00000187730 "Gamma-aminobutyric acid type A receptor delta subunit" O14764 1 2019298-2030758 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 87.0" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 9.3;Ciliated cells: 8.1;Club cells: 11.4;Horizontal cells: 12.7;Spermatogonia: 13.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 87.0" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "EFO-21: 2.9;HMC-1: 2.5;MCF7: 8.3;NB-4: 5.3;NTERA-2: 2.1;SH-SY5Y: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044371 Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA044371: AB_2678916" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-8)" "unprognostic (6.34e-3)" "unprognostic (2.66e-3)" "unprognostic (1.04e-2)" "unprognostic (3.44e-3)" "unprognostic (2.14e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (4.12e-8)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "unprognostic (5.16e-2)" 1.2 3.4 8.8 0.9 16.8 1.0 1.0 87.0 40.0 1.0 1.2 1.7 0.0 0.9 1.3 1.2 1.3 1.0 1.5 1.7 6.0 1.7 1.1 0.9 1.4 1.3 3.3 11.1 0.9 0.9 1.4 0.7 1.2 17.1 1.0 1.0 0.0 1.1 0.9 1.3 1.4 1.0 1.4 1.4 1.0 1.0 3.3 1.5 0.0 1.6 0.0 1.0 1.2 0.1 0.0 1.2 0.2 0.1 0.0 0.0 0.8 0.0 0.7 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 5.3 2.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.1 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.8 8.8 16.8 87.0 40.0 6.0 1.7 3.3 11.1 17.1 1.5 3.0 5.1 0.0 0.0 0.5 9.3 0.8 0.0 8.1 11.4 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.2 0.0 0.1 2.3 0.0 0.1 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.0 3.1 0.1 13.5 0.0 0.2 0.0 0.0 0.0 GABRE ENSG00000102287 "Gamma-aminobutyric acid type A receptor epsilon subunit" P78334 X 151953124-151974680 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 36.4;vagina: 27.7" "Cell type enhanced" "Detected in many" 9 "Syncytiotrophoblasts: 51.4;Urothelial cells: 32.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "hypothalamus: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 4.4;EFO-21: 14.9;HeLa: 6.7;SiHa: 7.0" "Low region specificity" "Detected in many" HPA045918 Uncertain NA NA "HPA045918: AB_10961281" "unprognostic (1.33e-2)" "unprognostic (6.75e-2)" "unprognostic (3.50e-3)" "unprognostic (1.39e-3)" "unprognostic (2.43e-1)" "unprognostic (7.52e-2)" "unprognostic (5.06e-3)" "unprognostic (1.27e-1)" "unprognostic (3.58e-2)" "unprognostic (1.55e-1)" "unprognostic (6.44e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (4.05e-11)" "unprognostic (1.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-2)" "unprognostic (5.28e-2)" 14.8 1.0 1.5 2.2 2.8 0.3 16.5 1.0 1.6 8.9 5.8 0.0 2.2 1.4 6.0 4.1 5.0 1.5 4.2 16.3 1.0 21.8 1.1 0.9 2.3 0.7 1.1 0.6 1.6 2.5 0.4 4.1 36.4 4.5 5.9 0.8 3.8 2.0 6.3 0.9 5.6 10.1 2.5 1.1 0.9 1.0 0.9 0.4 0.0 2.5 5.9 3.5 2.9 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 4.4 0.0 0.0 0.6 0.0 1.1 0.5 2.3 0.8 0.0 14.9 3.1 0.0 2.4 0.0 0.8 0.7 0.0 0.5 1.7 6.7 0.9 0.2 0.0 0.2 1.0 0.7 1.2 0.3 1.4 0.6 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.0 1.0 0.0 1.0 0.0 0.0 1.3 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.8 1.0 1.3 1.0 21.8 1.1 0.6 4.5 0.4 14.9 5.7 0.0 20.6 15.2 0.0 6.4 12.7 2.7 14.8 1.8 0.0 17.3 0.0 3.6 1.7 7.9 9.3 0.0 0.3 2.0 9.7 14.0 0.0 0.8 2.7 0.0 1.7 4.3 0.6 1.8 1.4 0.2 1.7 0.0 1.8 0.5 3.7 8.6 2.1 0.0 0.3 0.0 4.7 1.1 1.7 9.5 51.4 0.5 2.3 32.0 GABRG1 ENSG00000163285 "Gamma-aminobutyric acid type A receptor gamma1 subunit" Q8N1C3 4 46035769-46124081 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 35.7" "Group enriched" "Detected in some" 5 "Early spermatids: 5.9;Muller glia cells: 15.1;Sertoli cells: 6.5" "Cancer enriched" "Detected in single" 8 "glioma: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.3;THP-1: 2.6;U-2 OS: 1.8;U-266/70: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035622, HPA058102" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA035622: AB_10603669, HPA058102: " "unprognostic (2.50e-1)" "unprognostic (2.20e-1)" "unprognostic (6.06e-2)" "unprognostic (1.46e-2)" "unprognostic (7.39e-4)" "unprognostic (1.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.99e-1)" 1.5 1.5 20.3 1.2 25.9 1.2 1.3 26.4 35.7 1.3 1.3 12.2 0.0 1.4 1.4 1.3 1.3 1.7 1.3 1.2 26.0 14.6 1.4 1.4 1.2 1.3 10.2 14.0 3.9 1.2 1.3 1.6 1.2 17.9 1.2 1.3 0.0 1.2 1.3 1.2 1.2 1.4 1.4 17.8 1.4 1.3 1.8 17.8 0.0 1.5 0.0 1.2 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.3 1.8 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 25.9 26.4 18.5 26.0 14.6 10.2 14.0 17.9 17.8 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 1.8 6.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GABRG2 ENSG00000113327 "Gamma-aminobutyric acid type A receptor gamma2 subunit" P18507 5 162000057-162162977 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.1" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 81.7" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.3" "Group enriched" "Detected in many" 5 "B-cells: 2.9;granulocytes: 7.3;T-cells: 3.2" "Cell line enhanced" "Detected in many" "CACO-2: 10.6;RPMI-8226: 10.2;SuSa: 11.4;U-266/70: 17.8;U-266/84: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079060 Supported NA NA "CAB079060: " "unprognostic (2.88e-2)" "unprognostic (1.56e-2)" "unprognostic (6.31e-3)" "unprognostic (3.07e-3)" "unprognostic (1.52e-1)" 1.1 5.7 9.7 1.2 28.8 3.3 0.9 21.7 47.1 0.7 1.5 1.1 0.0 2.2 1.2 1.3 1.3 1.3 3.8 1.6 10.6 19.6 1.0 1.2 1.9 1.2 7.5 19.1 1.5 1.0 0.8 5.3 2.9 17.6 1.0 1.3 0.6 1.3 0.8 1.2 3.3 1.9 1.6 2.6 1.2 3.3 1.7 1.8 0.0 1.8 0.0 1.3 1.5 0.3 2.9 0.7 7.3 0.3 0.9 3.2 0.2 3.6 1.7 1.9 0.3 0.0 0.0 2.0 0.6 0.0 0.0 0.0 10.6 4.7 0.7 5.2 0.0 0.4 1.6 1.2 0.0 0.0 0.8 1.1 0.0 2.1 1.3 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.5 0.0 1.0 1.8 8.5 0.0 2.5 0.4 0.1 6.1 3.4 2.9 0.4 0.1 10.2 0.0 3.4 0.9 0.8 0.3 0.6 3.4 11.4 5.6 5.7 0.2 0.3 4.5 0.3 0.5 17.8 14.1 0.5 0.2 0.4 0.4 7.3 0.3 0.6 0.4 0.3 2.7 2.9 0.7 0.6 0.0 2.5 3.2 0.7 1.6 0.9 0.2 0.7 0.6 0.2 9.7 28.8 21.7 38.1 10.6 19.6 7.5 19.1 17.6 1.8 17.9 19.7 0.0 0.0 0.0 81.7 0.2 0.0 12.0 19.4 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.1 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 8.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 GABRG3 ENSG00000182256 "Gamma-aminobutyric acid type A receptor gamma3 subunit" Q99928 15 26971282-27541991 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.3;prostate: 13.5;testis: 16.6" "Group enriched" "Detected in some" 36 "Early spermatids: 81.6;Late spermatids: 207.6;Muller glia cells: 241.7" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 5.0;PC-3: 6.5;SK-MEL-30: 4.2;U-2 OS: 3.0;U-266/70: 3.8;U-87 MG: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054010 Approved NA NA "HPA054010: AB_2682342" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-2)" "unprognostic (3.50e-2)" "unprognostic (2.61e-1)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (4.41e-1)" "unprognostic (1.43e-5)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" "unprognostic (2.03e-2)" "unprognostic (1.83e-1)" 0.5 1.3 2.2 0.8 10.4 0.5 1.2 3.1 15.3 2.2 0.5 0.8 0.0 0.4 0.7 4.4 0.5 1.3 0.5 0.4 3.0 5.8 1.0 0.6 0.5 1.5 1.0 7.8 0.5 0.4 0.4 6.4 0.5 2.7 13.5 0.5 4.0 1.5 3.4 0.5 0.9 0.4 0.6 0.8 2.3 0.4 16.6 0.5 0.3 3.3 0.0 1.9 0.4 0.7 0.8 0.3 0.9 0.4 0.3 0.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 6.5 0.0 0.0 1.2 0.0 0.0 0.1 1.1 0.0 0.0 4.2 0.1 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.8 0.0 0.0 17.1 0.1 0.0 0.4 0.4 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.0 0.8 0.3 0.1 0.9 0.3 0.1 0.3 0.1 0.0 2.2 10.4 3.1 15.3 3.0 5.8 1.0 7.8 2.7 0.5 0.0 0.0 0.0 0.1 0.0 3.0 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 81.6 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 207.6 0.9 0.0 0.0 0.0 0.0 241.7 0.0 0.0 0.7 0.2 2.6 0.0 0.0 1.4 4.9 0.0 0.0 0.0 0.0 0.1 GABRP ENSG00000094755 "Gamma-aminobutyric acid type A receptor pi subunit" O00591 5 170763350-170814047 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.0;lymphoid tissue: 57.7" "Cell type enhanced" "Detected in some" 23 "Cholangiocytes: 48.4;Pancreatic endocrine cells: 33.1;Urothelial cells: 141.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 10.1" "Group enriched" "Detected in many" 6 "granulocytes: 10.1;monocytes: 6.1" "Cell line enhanced" "Detected in many" "A-431: 39.5;EFO-21: 46.1;HeLa: 27.7;PC-3: 63.2;SuSa: 85.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB014883 Uncertain NA NA "CAB014883: " "unprognostic (3.98e-3)" "prognostic favorable (3.37e-4)" "unprognostic (8.34e-2)" "unprognostic (1.57e-1)" "unprognostic (8.90e-2)" "unprognostic (1.27e-1)" "unprognostic (7.89e-2)" "unprognostic (4.97e-3)" "unprognostic (3.72e-1)" "unprognostic (4.93e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.82e-1)" "unprognostic (5.92e-3)" "unprognostic (6.52e-3)" 1.5 0.5 0.5 1.3 0.5 1.1 31.6 0.5 1.1 18.5 1.7 0.6 2.6 2.6 30.4 9.9 37.0 2.2 8.6 1.0 0.5 0.4 6.9 3.8 2.5 0.5 0.5 0.5 1.1 4.3 0.0 2.4 5.5 0.6 6.8 0.4 0.8 25.5 3.2 2.0 10.0 3.9 0.5 0.5 0.8 5.0 1.0 0.5 2.5 0.6 3.1 57.7 1.2 20.0 0.9 1.1 10.1 6.1 0.2 1.3 3.1 39.5 1.8 1.9 1.3 0.1 0.8 4.6 0.7 0.2 0.1 0.1 7.1 4.5 0.6 46.1 0.2 0.4 14.3 1.2 0.0 0.1 0.6 1.4 2.6 27.7 1.0 0.1 0.9 2.2 0.3 0.5 0.5 0.3 1.5 0.2 2.5 10.6 5.0 0.0 1.2 1.7 0.8 16.2 0.7 63.2 2.5 1.2 1.5 2.6 2.2 1.6 0.7 14.6 0.7 0.4 85.1 0.8 0.4 1.6 3.7 13.5 3.0 2.9 1.9 1.2 1.1 0.5 2.6 0.5 10.1 2.3 6.8 0.5 1.7 1.3 0.3 0.5 0.4 0.7 0.9 0.7 0.6 5.4 0.2 6.1 1.1 0.7 3.1 0.5 0.5 0.5 0.6 0.5 0.4 0.5 0.5 0.6 0.5 3.0 1.1 0.0 14.6 0.0 0.0 0.4 48.4 12.0 15.9 1.8 0.0 3.6 0.0 0.8 0.0 0.0 0.0 0.0 12.6 0.1 0.8 15.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.4 141.9 GABRQ THETA ENSG00000268089 "Gamma-aminobutyric acid type A receptor theta subunit" Q9UN88 X 152638183-152657534 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 28.9;cervix, uterine: 16.2" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 3.5;Spermatogonia: 1.1;Suprabasal keratinocytes: 1.6" "Cancer enhanced" "Detected in many" "testis cancer: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 9.0;SiHa: 8.7;SuSa: 4.1;U-87 MG: 28.8" "Region enriched" "Detected in many" 5 "hypothalamus: 61.6" "Region enhanced" "Detected in many" "midbrain: 24.9" NA NA "unprognostic (3.68e-3)" "unprognostic (7.78e-2)" "unprognostic (9.16e-2)" "unprognostic (1.17e-4)" "unprognostic (3.38e-1)" "unprognostic (1.41e-1)" "unprognostic (1.45e-4)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (1.41e-1)" "unprognostic (3.73e-1)" "unprognostic (3.76e-2)" "unprognostic (3.10e-5)" "unprognostic (3.43e-3)" "unprognostic (1.84e-1)" "unprognostic (6.42e-2)" "unprognostic (7.70e-2)" 0.2 4.4 10.5 0.2 5.7 0.1 0.1 0.0 7.5 16.2 0.2 1.5 1.0 0.2 2.6 0.5 1.1 0.3 0.1 0.2 23.4 0.2 0.1 0.1 0.2 0.0 13.6 0.1 0.1 0.1 0.0 0.3 28.9 0.9 0.2 0.0 0.1 1.7 0.1 0.7 0.5 1.6 7.2 0.2 0.1 4.7 1.0 0.0 0.3 1.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.2 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 1.2 8.7 1.6 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 1.6 0.7 0.0 0.0 0.3 GABRR1 ENSG00000146276 "Gamma-aminobutyric acid type A receptor rho1 subunit" P24046 6 89177501-89231278 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "retina: 12.3;testis: 4.6" "Cell type enriched" "Detected in some" 11 "Bipolar cells: 53.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "amygdala: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 3.3;OE19: 6.7;SuSa: 4.6" "Not detected" "Not detected" NA NA "unprognostic (5.75e-2)" "unprognostic (3.92e-2)" "unprognostic (1.12e-1)" "unprognostic (2.90e-2)" "unprognostic (5.78e-2)" "unprognostic (4.90e-2)" "unprognostic (8.32e-3)" "unprognostic (2.52e-3)" "unprognostic (1.74e-1)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (1.62e-5)" "unprognostic (1.18e-1)" "unprognostic (9.90e-2)" "unprognostic (2.12e-2)" "unprognostic (2.29e-1)" 0.4 0.0 2.2 0.1 0.1 0.0 0.2 0.3 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.2 1.0 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 1.0 0.3 0.2 0.1 12.3 0.2 0.1 0.7 0.6 0.7 0.1 0.1 0.1 0.0 4.6 0.1 0.1 0.1 0.1 0.2 0.6 0.2 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 6.7 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.6 0.0 1.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.2 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 53.4 0.3 0.0 0.0 0.0 0.0 3.9 0.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 3.8 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.1 GABRR2 ENSG00000111886 "Gamma-aminobutyric acid type A receptor rho2 subunit" P28476 6 89257208-89315299 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "retina: 18.8" "Cell type enriched" "Detected in some" 13 "Bipolar cells: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Lineage enhanced" "Detected in single" "dendritic cells: 1.0" "Cell line enhanced" "Detected in some" "U-266/70: 4.4;U-266/84: 1.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA "unprognostic (2.05e-2)" "unprognostic (1.47e-4)" "unprognostic (1.56e-1)" "unprognostic (1.88e-4)" "unprognostic (4.19e-1)" "unprognostic (1.07e-1)" "unprognostic (2.24e-2)" "unprognostic (9.13e-2)" "unprognostic (2.87e-1)" "unprognostic (1.10e-2)" "unprognostic (2.65e-1)" "unprognostic (1.41e-1)" "unprognostic (1.54e-6)" "unprognostic (3.69e-2)" "unprognostic (7.81e-2)" "unprognostic (5.79e-2)" "unprognostic (7.15e-3)" 0.2 0.6 0.2 0.5 0.4 0.3 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.0 0.7 0.5 0.2 0.1 0.4 0.2 0.3 0.2 0.3 0.4 0.1 0.9 0.3 0.1 0.1 0.8 0.0 0.2 0.1 0.1 0.3 0.0 18.8 0.6 0.2 1.5 0.5 0.1 0.1 0.2 0.4 0.1 0.6 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.3 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.6 0.3 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.9 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.4 0.0 0.0 0.0 4.4 1.6 0.0 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.4 0.3 0.3 0.3 0.2 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 19.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRR3 ENSG00000183185 "Gamma-aminobutyric acid type A receptor rho3 subunit (gene/pseudogene)" A8MPY1 3 97986673-98035304 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "retina: 18.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 10.5;Rod photoreceptor cells: 11.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 25 "plasmacytoid DC: 2.4" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.4" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;U-266/70: 2.0;U-698: 4.7" "Not detected" "Not detected" NA NA "unprognostic (3.22e-2)" "unprognostic (2.06e-3)" "unprognostic (5.65e-2)" "unprognostic (2.82e-1)" "unprognostic (1.43e-4)" "unprognostic (2.84e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 18.2 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAL "GAL-GMAP, GALN, GLNN, GMAP" ENSG00000069482 "Galanin and GMAP prepropeptide" P22466 11 68683779-68691175 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Hormone, Neuropeptide" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "pituitary gland: 149.9" "Cell type enhanced" "Detected in many" 10 "Ductal cells: 39.1;Exocrine glandular cells: 43.2;Extravillous trophoblasts: 33.3;Glandular cells: 54.2;Pancreatic endocrine cells: 30.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 8 "hypothalamus: 18.8" "Cell type enriched" "Detected in single" 15 "intermediate monocyte: 1.5" "Lineage enriched" "Detected in single" 15 "monocytes: 1.5" "Cell line enhanced" "Detected in some" "CACO-2: 48.0;HEK 293: 22.4;K-562: 24.8;NB-4: 88.7;SH-SY5Y: 35.8" "Region enhanced" "Detected in many" "hypothalamus: 111.6" "Low region specificity" "Detected in many" "HPA049864, CAB079779" Enhanced Supported Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 60000 "Golgi apparatus" Vesicles "CAB079779: , HPA049864: AB_2680922" "unprognostic (8.56e-2)" "unprognostic (1.45e-2)" "unprognostic (7.50e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (8.07e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (5.98e-2)" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (7.42e-2)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.38e-2)" "unprognostic (3.24e-2)" 2.8 0.2 0.1 14.8 0.5 0.4 4.5 0.6 2.0 0.2 6.0 0.1 0.4 1.7 0.2 0.7 0.7 0.2 0.3 0.6 1.3 18.8 0.3 0.2 0.2 0.1 0.2 0.6 0.2 2.9 0.0 149.9 0.9 2.2 0.7 4.1 0.6 0.5 1.8 0.3 4.5 2.2 9.7 0.3 0.2 1.5 0.5 0.4 0.7 0.2 0.4 0.3 1.5 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 4.5 6.8 0.0 0.1 0.0 48.0 1.8 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 22.4 1.1 14.4 0.0 0.2 0.6 0.0 0.3 0.7 0.0 0.0 0.0 1.1 0.0 24.8 0.0 0.0 13.6 0.0 88.7 11.4 0.5 4.3 0.0 0.0 9.1 0.1 0.0 9.4 35.8 4.7 0.2 0.0 5.3 0.2 10.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.7 1.3 18.8 0.2 0.6 2.2 0.4 0.0 0.0 0.0 15.3 1.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 39.1 0.0 0.2 0.0 0.0 43.2 33.3 2.4 54.2 4.6 0.0 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.0 13.7 0.4 11.4 3.0 1.6 0.0 0.6 11.9 GAL3ST1 CST ENSG00000128242 "Galactose-3-O-sulfotransferase 1" Q99999 22 30554635-30574587 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 38.2;Enterocytes: 17.4;Muller glia cells: 29.4;Proximal tubular cells: 18.9" "Cancer enriched" "Detected in many" 6 "renal cancer: 38.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 22.7;CACO-2: 6.3;EFO-21: 12.3;K-562: 5.3;OE19: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001220, HPA077138" Approved Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Vesicles Nucleoplasm "HPA001220: AB_1078933, HPA077138: " "unprognostic (2.69e-2)" "unprognostic (3.12e-4)" "unprognostic (5.93e-2)" "unprognostic (1.08e-2)" "unprognostic (2.32e-1)" "unprognostic (6.50e-3)" "unprognostic (1.53e-2)" "unprognostic (2.23e-1)" "unprognostic (2.89e-1)" "unprognostic (5.18e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (2.33e-1)" "unprognostic (4.23e-2)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" 0.8 0.6 8.4 0.7 9.6 1.2 0.8 1.4 12.3 1.4 11.3 25.8 0.0 24.2 1.3 2.3 0.8 2.2 13.4 0.5 12.1 8.3 13.3 1.6 1.5 0.9 14.0 2.6 1.2 2.9 0.6 0.5 1.3 12.4 1.2 2.8 0.3 1.0 1.9 1.9 2.1 25.1 0.7 28.7 0.7 7.2 2.5 7.8 0.0 0.6 0.0 0.4 1.0 0.7 2.3 2.8 2.3 0.7 0.3 0.8 0.0 0.1 22.7 0.4 0.2 0.0 0.0 1.7 0.0 0.1 0.0 0.0 6.3 3.1 0.3 12.3 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.8 0.3 0.2 4.1 0.5 0.1 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.3 5.3 0.6 0.0 0.1 0.3 0.9 3.3 8.5 0.3 0.2 0.1 0.6 0.9 0.1 0.3 1.5 0.0 0.4 0.2 0.6 0.1 0.1 0.6 0.2 0.1 0.2 0.0 2.0 1.2 0.3 0.1 0.1 0.2 0.9 0.7 0.1 0.4 0.5 0.7 1.8 0.7 0.8 0.2 2.3 0.5 0.8 2.3 0.3 0.3 2.8 0.1 0.0 8.4 9.6 1.4 10.3 12.1 8.3 14.0 2.6 12.4 7.8 0.0 0.0 0.0 0.1 0.3 0.7 0.6 38.2 0.0 0.0 3.5 0.0 0.0 13.3 5.6 0.9 0.1 17.4 0.0 9.7 0.0 0.0 0.2 0.0 1.3 0.1 0.0 10.5 0.0 0.8 0.6 1.4 0.0 0.0 0.0 7.4 29.4 4.6 7.0 2.1 18.9 1.1 0.0 0.0 3.1 7.5 0.3 0.2 0.0 8.0 0.0 GAL3ST2 GP3ST ENSG00000154252 "Galactose-3-O-sulfotransferase 2" Q9H3Q3 2 241776825-241804208 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 8.6;intestine: 16.0;lymphoid tissue: 11.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "colorectal cancer: 6.7;ovarian cancer: 4.9;stomach cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 1.8;Hep G2: 6.5;HMC-1: 2.0" HPA071809 Enhanced "Intracellular and membrane" NA NA "HPA071809: AB_2686450" "unprognostic (5.22e-3)" "unprognostic (6.52e-2)" "unprognostic (1.85e-2)" "unprognostic (4.04e-3)" "unprognostic (3.04e-4)" "unprognostic (3.45e-2)" "unprognostic (2.48e-2)" "unprognostic (2.87e-1)" "unprognostic (4.13e-2)" "unprognostic (2.25e-3)" "unprognostic (2.58e-1)" "unprognostic (4.99e-2)" "unprognostic (2.87e-11)" "unprognostic (4.32e-2)" "unprognostic (1.55e-1)" "unprognostic (5.99e-3)" "unprognostic (3.49e-1)" 1.0 0.6 0.5 11.6 0.7 0.1 0.1 0.1 0.5 1.9 16.0 0.0 0.0 0.1 0.1 0.1 0.1 1.0 8.6 0.1 0.4 0.6 0.4 0.9 1.3 0.1 0.2 0.0 1.7 0.1 0.1 0.4 0.1 0.0 0.3 6.6 0.0 3.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.2 0.1 0.9 11.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.1 0.5 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAL3ST3 GAL3ST2 ENSG00000175229 "Galactose-3-O-sulfotransferase 3" Q96A11 11 66041952-66049180 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.4;retina: 14.2;thyroid gland: 28.0" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 9.8;Horizontal cells: 4.8;Rod photoreceptor cells: 14.0" "Cancer enhanced" "Detected in many" "thyroid cancer: 10.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "naive CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 4 "T-cells: 1.8" "Group enriched" "Detected in some" 5 "NTERA-2: 12.6;SH-SY5Y: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "prognostic unfavorable (6.53e-6)" "unprognostic (1.24e-1)" "unprognostic (3.30e-1)" "unprognostic (1.57e-2)" "unprognostic (2.62e-1)" "unprognostic (6.08e-2)" "unprognostic (2.01e-3)" "unprognostic (7.26e-2)" "unprognostic (2.07e-2)" "unprognostic (1.40e-1)" "unprognostic (5.29e-1)" 0.8 0.7 6.3 0.7 15.4 0.7 0.7 7.5 14.5 5.4 0.8 2.4 0.3 0.8 8.0 1.0 0.8 2.5 0.8 5.9 6.1 4.3 4.0 0.7 0.7 0.9 2.9 5.0 0.9 1.5 1.9 3.5 0.7 3.7 2.2 0.7 14.2 0.8 5.9 1.3 1.0 0.8 9.7 1.2 0.7 0.7 2.6 2.0 0.0 28.0 0.0 0.8 0.7 0.2 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 12.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.3 15.4 7.5 14.5 6.1 4.3 2.9 5.0 3.7 2.0 0.0 0.0 0.0 0.0 0.0 2.9 2.4 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.1 0.0 14.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 GAL3ST4 FLJ12116 ENSG00000197093 "Galactose-3-O-sulfotransferase 4" Q96RP7 7 100159244-100168750 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.8" "Cell type enriched" "Detected in some" 6 "Hofbauer cells: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 26 "dendritic cells: 4.3;T-cells: 15.0" "Cell line enhanced" "Detected in many" "WM-115: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038137, HPA038138" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038137: AB_10697239, HPA038138: AB_2675854" "unprognostic (4.22e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (5.44e-4)" "unprognostic (8.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.57e-4)" "unprognostic (2.80e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (4.14e-4)" "unprognostic (3.98e-2)" "unprognostic (9.67e-2)" "unprognostic (1.89e-2)" "unprognostic (5.36e-2)" 3.9 5.4 8.4 4.2 9.4 1.0 4.1 1.5 10.9 7.8 6.5 18.6 0.4 4.1 9.0 3.7 8.4 6.3 5.9 4.9 8.0 3.8 1.8 1.0 5.3 2.9 11.9 4.7 7.6 1.5 1.6 4.6 9.8 8.1 6.5 7.0 4.2 24.9 4.3 1.9 27.8 8.9 10.6 14.9 2.7 2.8 4.4 10.2 37.8 2.0 2.4 3.9 7.3 10.6 0.1 4.3 0.3 0.1 0.2 15.0 2.2 0.0 0.6 4.0 1.8 3.6 7.1 7.6 2.2 2.2 1.3 1.8 0.4 0.2 0.7 0.5 7.4 2.3 8.6 0.2 1.3 0.4 0.0 0.4 0.2 0.1 0.2 2.4 0.4 2.4 8.7 3.4 3.9 0.4 2.8 2.5 3.1 1.1 0.1 2.4 0.3 2.7 0.1 1.3 8.2 0.9 2.2 1.8 0.1 0.0 0.3 0.2 1.7 0.6 0.0 4.6 0.7 0.0 0.2 2.2 0.2 1.2 0.3 0.1 0.1 0.1 1.7 1.4 0.4 29.6 0.0 0.1 0.0 0.5 0.0 0.0 0.0 4.4 0.3 0.0 0.1 15.0 4.5 0.3 0.2 0.1 4.3 1.1 2.2 8.4 9.4 1.5 10.9 8.0 3.8 11.9 4.7 8.1 10.2 0.0 0.3 0.0 2.0 3.8 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.3 0.0 0.5 0.1 0.5 0.0 0.0 0.0 0.2 6.0 0.3 0.0 0.0 38.9 0.0 0.0 1.8 0.3 0.0 4.4 0.7 5.0 1.0 0.6 0.5 0.5 2.9 4.9 0.0 0.0 0.0 2.2 0.4 0.2 7.0 0.7 0.0 6.0 0.9 GALC ENSG00000054983 Galactosylceramidase P54803 14 87837820-87993665 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism, Sphingolipid metabolism" "Glycosidase, Hydrolase" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 66.9;Kupffer cells: 62.6;Late spermatids: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 35.4;HMC-1: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022196 Approved "Intracellular and membrane" NA NA 16000 "CAB022196: " "unprognostic (1.27e-1)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (2.16e-2)" "unprognostic (9.39e-2)" "unprognostic (3.08e-1)" "unprognostic (9.70e-2)" "unprognostic (1.73e-1)" "unprognostic (6.56e-2)" "unprognostic (8.44e-3)" "unprognostic (8.08e-2)" "unprognostic (1.84e-2)" "unprognostic (6.00e-2)" "unprognostic (2.13e-1)" "unprognostic (6.80e-2)" "unprognostic (2.72e-2)" 13.8 17.7 21.2 13.2 32.2 18.9 15.4 16.3 25.5 12.3 15.8 28.8 9.6 30.3 10.7 12.1 6.5 20.1 17.4 19.6 22.0 19.5 20.5 11.1 23.0 18.0 30.7 20.1 17.3 13.6 14.4 12.6 15.6 24.9 14.1 16.9 13.3 8.9 10.1 9.3 9.4 30.2 9.3 33.8 14.3 14.9 21.6 26.1 8.6 23.5 5.8 7.3 12.6 11.4 1.7 5.7 20.8 10.5 9.4 16.3 6.4 0.0 8.3 3.1 0.0 10.3 9.3 0.0 3.8 7.7 3.6 4.3 4.5 35.4 2.2 11.5 3.7 0.0 0.5 0.0 0.4 4.4 1.1 0.2 12.2 0.3 0.0 8.5 0.0 33.5 9.1 2.8 2.4 0.0 1.5 9.7 0.0 4.0 1.7 6.0 0.8 0.0 1.8 2.8 14.5 0.9 0.0 0.2 0.1 5.7 3.3 2.9 6.7 10.4 1.7 0.0 7.7 8.6 8.4 8.2 0.0 5.6 2.4 0.0 1.8 3.3 0.0 1.0 2.8 8.0 12.8 9.5 20.8 7.5 10.5 16.3 1.7 5.7 7.2 5.7 0.8 4.2 4.9 7.8 9.4 8.0 1.0 3.2 6.4 21.2 32.2 16.3 25.5 22.0 19.5 30.7 20.1 24.9 26.1 23.8 21.3 10.5 4.6 7.4 10.4 9.9 15.3 9.4 7.9 14.0 11.8 4.7 3.3 8.0 38.1 11.3 12.4 0.0 9.9 9.6 10.8 7.8 66.9 5.0 23.9 3.2 5.8 18.4 62.6 61.8 15.0 19.6 10.1 27.1 13.0 9.0 11.8 14.8 9.6 5.8 10.6 0.0 7.2 10.0 8.7 10.0 5.5 20.0 12.9 5.7 GALNS "GALNAC6S, GAS" ENSG00000141012 "Galactosamine (N-acetyl)-6-sulfatase" P34059 16 88813734-88856970 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Dwarfism, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 7.1;granulocytes: 19.3;monocytes: 11.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026404, HPA042433, HPA074225" Supported Approved Cytosol "Intracellular and membrane" NA NA 2400000 Cytosol "CAB026404: , HPA042433: AB_2732499, HPA074225: " "unprognostic (3.16e-1)" "unprognostic (9.98e-2)" "unprognostic (4.03e-3)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (3.66e-4)" "unprognostic (4.15e-3)" "unprognostic (1.32e-1)" "unprognostic (4.84e-3)" "unprognostic (2.00e-1)" "unprognostic (3.53e-2)" "unprognostic (4.12e-3)" "unprognostic (4.24e-2)" "unprognostic (5.54e-2)" "unprognostic (3.59e-2)" "unprognostic (6.84e-2)" 11.9 14.9 9.3 11.2 11.1 25.0 14.8 12.9 15.4 11.1 15.5 11.5 8.8 13.3 9.0 19.9 10.2 14.8 12.7 12.5 11.2 13.9 13.7 17.8 14.7 10.6 11.8 5.2 11.9 7.3 9.9 13.2 15.6 11.6 10.5 8.3 7.1 10.6 9.0 7.1 10.0 17.2 9.4 9.4 10.4 9.5 27.4 8.8 7.9 14.5 6.1 9.0 11.1 13.0 2.1 7.1 19.3 11.2 2.4 3.1 4.7 2.5 19.6 2.8 20.1 22.7 10.9 19.7 8.2 12.8 9.0 7.0 10.2 17.0 3.2 17.4 13.4 13.6 15.1 4.1 6.5 5.5 2.1 6.5 2.0 8.0 5.8 15.3 1.5 13.3 15.2 12.7 10.1 2.8 12.9 7.7 3.5 4.4 1.9 5.3 15.0 4.1 6.5 6.6 6.5 9.1 8.7 2.5 5.4 5.6 6.0 7.4 5.7 19.5 1.8 9.7 7.2 12.7 14.4 14.4 19.8 15.1 20.2 4.5 2.0 1.9 5.5 21.5 13.3 11.7 0.9 11.2 19.3 3.1 8.0 2.6 2.1 1.8 2.7 7.1 0.9 1.7 2.1 14.2 2.4 5.6 3.0 3.0 4.7 9.3 11.1 12.9 15.4 11.2 13.9 11.8 5.2 11.6 8.8 14.9 4.5 1.9 6.4 5.8 3.9 6.7 2.5 26.8 7.9 3.5 5.9 7.9 3.3 5.3 14.3 4.9 12.3 0.0 3.0 11.4 10.2 5.7 1.1 5.7 17.8 23.8 11.5 7.4 13.9 28.0 6.6 8.0 6.8 20.8 6.9 8.5 5.4 12.4 6.3 4.5 9.7 6.5 9.2 49.5 33.7 5.0 13.3 5.7 8.6 5.1 GALNT1 GalNAc-T1 ENSG00000141429 "Polypeptide N-acetylgalactosaminyltransferase 1" Q10472 18 35581117-35711834 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 83.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012628 Uncertain "Intracellular and membrane" NA NA 1600000 "HPA012628: AB_1849439" "unprognostic (9.81e-2)" "unprognostic (1.01e-1)" "unprognostic (4.39e-2)" "unprognostic (2.73e-1)" "unprognostic (2.08e-1)" "unprognostic (2.83e-2)" "unprognostic (1.96e-2)" "unprognostic (7.06e-2)" "unprognostic (2.03e-2)" "unprognostic (1.51e-2)" "unprognostic (3.00e-2)" "unprognostic (1.00e-1)" "unprognostic (3.47e-2)" "unprognostic (4.38e-2)" "unprognostic (2.74e-2)" "unprognostic (1.07e-2)" "unprognostic (8.60e-2)" 15.0 14.2 11.3 11.4 16.0 9.7 24.2 14.3 12.3 15.1 18.7 11.3 8.3 18.9 10.3 13.7 31.8 8.9 13.0 18.4 15.3 9.7 12.9 21.8 12.0 27.4 14.9 13.3 10.5 22.2 4.6 15.0 22.9 12.5 11.7 18.7 15.7 28.3 8.4 19.9 27.6 24.7 15.8 13.7 17.9 11.9 9.8 12.6 13.8 13.5 16.0 17.3 32.3 19.3 6.2 6.7 11.1 9.1 6.6 5.8 2.0 7.9 8.7 10.3 9.5 20.5 19.5 13.7 8.3 8.9 7.8 7.1 5.1 15.5 9.4 9.0 8.9 7.4 6.1 5.0 15.9 12.4 10.9 4.6 11.9 17.0 11.9 10.3 25.8 15.9 13.2 15.3 12.1 13.5 23.2 83.6 7.7 3.5 12.5 30.1 6.3 7.6 9.8 10.6 8.2 4.1 9.5 13.5 4.5 31.9 37.0 5.6 11.0 14.8 10.9 8.8 20.6 8.3 20.4 29.0 14.4 5.8 9.4 9.1 18.0 8.5 18.0 10.1 17.7 7.4 8.4 5.4 11.1 5.1 6.7 5.8 6.2 3.6 4.7 6.1 3.8 3.4 4.9 6.4 6.6 9.1 6.7 3.6 2.0 11.3 16.0 14.3 12.3 15.3 9.7 14.9 13.3 12.5 12.6 74.5 36.1 27.6 22.2 26.6 29.5 34.2 53.5 32.1 38.7 15.7 11.8 24.2 6.6 34.8 1.0 29.2 87.1 0.0 34.3 79.6 43.7 55.6 19.7 61.0 64.0 81.0 37.4 37.4 52.6 1.5 17.5 39.7 18.6 13.6 54.1 102.4 42.0 48.9 17.0 17.6 23.9 12.9 21.7 3.7 14.3 71.8 27.8 22.0 69.9 39.7 GALNT10 GalNAc-T10 ENSG00000164574 "Polypeptide N-acetylgalactosaminyltransferase 10" Q86SR1 5 154190730-154420984 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.7" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 74.0;TIME: 40.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007525 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 830000 "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA007525: AB_1849443" "unprognostic (6.99e-2)" "unprognostic (4.33e-2)" "unprognostic (9.85e-2)" "prognostic favorable (3.33e-6)" "unprognostic (1.63e-1)" "unprognostic (6.98e-2)" "unprognostic (6.95e-3)" "unprognostic (2.38e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (5.69e-4)" "unprognostic (2.88e-3)" "unprognostic (2.63e-1)" "unprognostic (1.54e-1)" "unprognostic (7.76e-3)" "unprognostic (1.22e-1)" "unprognostic (1.61e-2)" "unprognostic (3.08e-1)" 9.5 13.5 8.4 15.4 9.1 10.1 8.7 3.2 6.2 15.9 10.6 14.4 1.0 8.8 4.9 11.5 5.9 9.2 17.8 7.7 6.9 7.5 6.8 3.4 10.1 11.5 7.2 5.2 43.7 9.2 14.1 9.7 5.2 10.1 8.3 9.4 31.6 11.6 2.4 5.6 4.0 12.4 14.1 7.7 16.7 13.8 4.3 9.2 5.6 10.6 4.2 9.3 7.5 10.0 4.7 3.1 5.7 3.8 3.9 7.5 2.1 6.2 21.4 5.2 4.5 11.1 9.9 4.0 18.1 10.1 7.2 6.9 3.0 14.4 4.1 12.8 30.4 12.9 1.1 2.4 14.1 6.6 10.6 1.7 11.2 4.1 4.0 8.5 2.4 10.9 12.3 3.3 5.8 8.6 74.0 13.8 3.1 2.5 13.0 12.3 6.5 0.2 1.6 2.0 17.6 4.4 1.2 2.7 4.1 10.0 4.3 0.7 1.7 8.0 30.0 2.3 8.0 11.6 1.8 40.5 17.6 4.2 4.3 19.2 3.7 3.6 2.2 11.5 4.8 5.3 3.4 2.7 5.3 7.5 3.6 6.6 4.5 4.3 4.8 3.1 4.7 1.9 5.3 5.7 3.9 3.8 2.7 3.5 2.1 8.4 9.1 3.2 6.2 6.9 7.5 7.2 5.2 10.1 9.2 8.9 36.1 12.3 3.5 4.2 3.5 4.1 5.1 0.0 12.5 14.0 3.9 0.6 8.3 9.3 10.6 13.4 15.5 23.3 26.2 1.2 9.1 9.9 10.3 4.7 7.2 0.0 2.9 19.0 15.4 16.0 35.4 9.7 0.0 6.4 16.1 20.8 26.5 11.5 47.0 2.9 11.4 6.5 7.3 1.7 3.1 3.1 0.7 13.8 9.3 2.8 GALNT11 GalNAc-T11 ENSG00000178234 "Polypeptide N-acetylgalactosaminyltransferase 11" Q8NCW6 7 152025674-152122347 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Notch signaling pathway" "Glycosyltransferase, Transferase" Heterotaxy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 82.0" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 116.5;Proximal tubular cells: 163.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039330 Uncertain NA NA "HPA039330: AB_10795249" "unprognostic (6.09e-2)" "unprognostic (1.22e-1)" "unprognostic (4.98e-2)" "unprognostic (3.48e-2)" "prognostic unfavorable (9.54e-4)" "unprognostic (1.76e-1)" "unprognostic (9.10e-3)" "unprognostic (1.56e-3)" "unprognostic (1.38e-1)" "unprognostic (3.65e-1)" "unprognostic (3.82e-2)" "unprognostic (1.64e-1)" "prognostic favorable (2.24e-6)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "unprognostic (2.97e-1)" "unprognostic (9.51e-2)" 10.7 9.4 11.1 5.1 18.7 3.8 10.4 20.8 21.8 9.1 7.5 11.4 7.1 5.1 9.6 9.2 9.8 8.3 9.3 9.2 11.4 9.3 82.0 7.1 9.6 4.9 7.0 13.4 10.6 29.7 19.3 10.5 15.9 34.1 12.0 6.5 21.7 7.8 9.8 8.8 8.3 6.9 9.5 6.5 8.5 7.6 7.3 4.4 4.6 12.5 5.6 6.4 9.4 8.1 6.3 8.3 8.2 12.5 15.7 19.3 8.7 10.6 9.6 14.2 15.8 32.9 32.5 14.6 8.5 9.8 7.2 6.8 7.7 11.3 0.0 22.3 13.8 20.1 5.0 6.7 12.1 8.9 8.8 10.0 2.1 8.7 6.7 10.8 9.6 11.4 28.6 15.6 6.0 5.0 12.6 13.0 7.5 10.7 0.1 18.0 9.2 8.2 8.7 11.6 16.8 7.7 0.0 6.2 0.3 23.7 16.5 12.6 16.8 14.2 6.9 11.5 15.8 10.3 8.3 11.7 9.7 3.4 12.2 9.3 3.2 4.0 0.1 20.2 9.4 33.0 5.8 8.3 8.2 19.3 9.4 19.0 6.3 10.7 17.7 8.3 3.8 9.2 14.0 4.4 15.7 12.5 2.5 7.9 8.7 11.1 18.7 20.8 21.8 11.4 9.3 7.0 13.4 34.1 4.4 11.9 18.5 17.9 21.5 9.3 116.5 24.0 10.2 20.1 11.4 33.2 25.5 66.9 51.4 15.4 3.0 20.7 7.7 0.0 16.2 11.7 25.1 24.5 13.9 13.5 21.9 71.5 21.9 25.8 16.5 2.9 18.4 11.5 16.9 15.4 9.0 30.9 11.9 7.0 33.9 163.9 35.9 0.0 21.7 17.7 13.8 10.3 30.3 22.0 8.5 15.4 GALNT12 GalNAc-T12 ENSG00000119514 "Polypeptide N-acetylgalactosaminyltransferase 12" Q8IXK2 9 98807699-98850081 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 34.7" "Cell type enhanced" "Detected in many" 13 "Mucus-secreting cells: 122.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 17.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 41.8;U-2197: 54.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA048292 Enhanced "Intracellular and membrane" NA NA 15000 "HPA048292: AB_2680343" "unprognostic (7.85e-3)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (1.47e-2)" "unprognostic (2.97e-3)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (1.97e-1)" "unprognostic (2.61e-2)" "unprognostic (7.71e-2)" "prognostic favorable (3.24e-4)" "unprognostic (9.05e-2)" "unprognostic (1.92e-1)" "unprognostic (1.60e-3)" "unprognostic (6.87e-2)" 7.5 1.7 1.0 9.5 2.3 0.6 3.7 17.7 1.6 4.0 29.6 1.7 7.4 14.6 1.8 34.7 15.2 3.2 20.5 1.1 1.4 1.6 2.9 0.4 13.8 1.1 3.3 1.0 1.0 9.2 4.0 3.1 1.0 2.7 4.2 24.8 4.0 15.2 6.6 1.1 2.6 22.4 15.4 1.3 1.5 23.5 3.4 1.1 2.8 9.3 8.1 23.9 9.0 3.4 0.8 0.4 1.6 0.0 2.2 2.5 0.4 1.7 1.3 1.1 4.5 3.4 2.7 0.0 0.4 0.7 0.7 1.5 0.2 7.2 0.0 1.7 0.3 4.1 12.6 1.0 0.4 0.5 8.4 0.6 0.8 0.0 0.0 0.1 0.5 0.1 1.3 0.3 2.1 0.0 0.9 0.8 6.4 9.6 0.0 0.2 4.5 0.8 1.5 5.6 41.8 1.8 2.1 0.1 0.0 0.8 2.5 4.2 0.4 0.1 10.3 1.0 2.7 1.5 1.4 1.4 0.0 0.1 54.3 0.0 0.7 1.5 0.7 12.7 0.0 0.3 0.0 0.0 1.6 1.4 0.0 2.5 0.1 1.9 0.8 0.2 0.8 2.3 1.5 0.1 2.2 0.0 0.4 0.1 0.4 1.0 2.3 17.7 1.6 1.4 1.6 3.3 1.0 2.7 1.1 3.0 22.6 0.9 1.3 2.2 0.9 0.5 25.5 13.4 14.8 10.4 15.7 0.9 0.0 6.4 1.4 0.7 29.9 0.0 21.7 1.5 5.6 10.5 2.3 0.0 2.1 0.0 19.1 0.0 0.3 1.1 2.0 1.7 0.0 0.0 122.4 0.3 23.8 31.7 7.1 3.0 0.1 0.0 1.2 4.7 12.1 1.1 0.9 3.8 33.7 8.2 GALNT13 "GalNAc-T13, KIAA1918" ENSG00000144278 "Polypeptide N-acetylgalactosaminyltransferase 13" Q8IUC8 2 153871913-154453849 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 23.8;Bipolar cells: 15.1;Cone photoreceptor cells: 49.1;Horizontal cells: 68.3" "Cancer enriched" "Detected in some" 5 "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SH-SY5Y: 28.2;U-251 MG: 7.4;WM-115: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060775 Approved NA NA "HPA060775: AB_2684358" "unprognostic (1.97e-1)" "unprognostic (3.43e-3)" "unprognostic (2.47e-2)" "unprognostic (1.00e-3)" "unprognostic (4.21e-3)" "unprognostic (7.73e-3)" "unprognostic (6.50e-2)" "unprognostic (8.17e-2)" "unprognostic (3.57e-1)" "unprognostic (9.15e-2)" "unprognostic (3.83e-2)" "unprognostic (3.09e-2)" "unprognostic (5.17e-2)" "unprognostic (2.05e-5)" "unprognostic (8.61e-3)" "unprognostic (1.52e-1)" "unprognostic (2.05e-1)" 3.0 7.7 8.5 0.7 6.2 0.6 1.4 39.0 29.1 3.1 0.9 7.9 0.6 0.7 3.1 2.3 0.7 1.0 1.1 0.6 7.8 8.9 0.6 0.4 3.4 0.4 8.3 3.1 1.1 1.0 0.5 3.1 1.0 10.5 3.6 1.0 1.1 10.9 2.6 1.7 0.8 0.8 2.0 10.4 0.5 1.1 1.3 4.3 0.0 0.4 0.0 0.5 1.5 0.2 0.2 0.6 2.2 0.9 0.2 0.8 0.0 0.0 3.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.4 0.0 0.0 0.0 1.8 0.0 3.3 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.1 4.7 0.1 4.4 0.0 0.2 0.6 0.0 0.0 4.8 28.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.1 7.4 0.3 0.0 0.0 4.6 0.0 21.1 0.0 0.9 2.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.8 0.1 0.2 0.0 0.6 0.4 0.0 8.5 6.2 39.0 7.4 7.8 8.9 8.3 3.1 10.5 4.3 23.8 1.4 0.0 0.0 0.1 15.1 0.8 0.0 0.0 2.3 0.0 49.1 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.1 68.3 3.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.4 0.1 0.0 0.0 0.0 0.0 GALNT14 "FLJ12691, GalNac-T10, GalNac-T14" ENSG00000158089 "Polypeptide N-acetylgalactosaminyltransferase 14" Q96FL9 2 30910467-31155202 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 42.7" "Cell type enhanced" "Detected in some" 18 "Distal tubular cells: 11.6;Ito cells: 11.1;Proximal tubular cells: 39.7" "Cancer enriched" "Detected in many" 7 "renal cancer: 45.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "neutrophil: 10.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.6" "Cell line enhanced" "Detected in many" "A549: 13.1;RPMI-8226: 15.2;RPTEC TERT1: 22.4;RT4: 16.6;SCLC-21H: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030138 Approved "Nucleoplasm,Golgi apparatus" NA NA 9400 "Golgi apparatus" Nucleoplasm "HPA030138: AB_2673332" "unprognostic (5.69e-2)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (2.82e-3)" "unprognostic (3.85e-2)" "unprognostic (2.10e-2)" "unprognostic (3.32e-1)" "unprognostic (7.58e-2)" "unprognostic (1.96e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (5.18e-3)" "unprognostic (2.67e-2)" "unprognostic (2.56e-1)" "unprognostic (9.51e-3)" 1.2 1.5 1.5 0.9 3.7 4.3 1.1 1.8 9.6 1.4 0.6 1.8 0.3 0.6 0.6 1.0 10.2 1.1 3.7 0.4 1.6 1.5 42.7 1.2 0.6 2.6 1.2 2.3 0.9 2.7 7.6 5.7 0.2 0.9 1.7 0.2 2.1 1.7 0.2 0.4 1.9 3.1 0.7 0.8 1.8 0.6 1.6 0.3 0.1 1.1 1.0 4.2 2.0 1.4 1.4 0.0 10.6 0.0 0.0 0.0 0.1 11.1 13.1 0.0 0.0 0.0 0.0 0.0 3.7 2.0 2.5 0.3 0.0 0.0 10.4 3.8 0.2 0.0 0.0 0.4 0.5 0.4 0.3 1.3 5.8 0.0 0.0 0.0 8.4 0.0 0.1 2.3 0.0 8.6 0.1 0.0 0.3 0.0 9.3 0.0 5.1 0.0 0.0 6.2 0.0 0.0 7.3 0.0 15.2 22.4 16.6 12.3 8.9 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 9.8 0.0 0.2 0.9 2.8 0.0 0.0 5.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.1 1.5 3.7 1.8 9.6 1.6 1.5 1.2 2.3 0.9 0.3 0.0 0.0 0.8 3.8 2.5 0.2 0.4 0.0 0.0 1.2 8.7 0.0 0.0 11.6 2.5 5.3 0.6 0.4 0.0 0.3 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 11.1 0.6 5.8 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 39.7 0.3 6.5 0.8 0.4 3.4 0.6 0.0 0.0 0.0 1.0 GALNT15 "GALNT7, GALNTL2, pp-GalNAc-T15" ENSG00000131386 "Polypeptide N-acetylgalactosaminyltransferase 15" Q8N3T1 3 16174649-16231992 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 66.7;brain: 52.3" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 19.5;Endothelial cells: 15.2;Ito cells: 39.9;Muller glia cells: 48.3" "Cancer enriched" "Detected in many" 5 "glioma: 21.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 44.9;ASC TERT1: 44.3;HSkMC: 33.7" "Group enriched" "Detected in many" 4 "cerebellum: 10.7;pons and medulla: 6.7" "Low region specificity" "Detected in all" HPA017076 Uncertain Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 25000 "Golgi apparatus" Cytosol "HPA017076: AB_1849458" "unprognostic (3.87e-1)" "unprognostic (4.84e-4)" "unprognostic (6.39e-2)" "unprognostic (8.77e-3)" "unprognostic (2.77e-1)" "unprognostic (2.52e-1)" "unprognostic (7.40e-4)" "unprognostic (4.24e-1)" "unprognostic (2.24e-1)" "unprognostic (8.28e-6)" "unprognostic (5.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.66e-2)" "unprognostic (1.37e-3)" "unprognostic (1.88e-1)" "unprognostic (8.51e-2)" "unprognostic (1.78e-3)" 66.7 5.3 7.6 2.6 17.4 1.1 22.8 2.3 31.5 3.9 8.6 28.1 1.1 2.8 3.5 3.3 11.4 5.3 5.2 7.3 14.8 6.6 8.3 2.8 3.1 3.4 38.9 8.4 8.4 3.2 1.6 1.0 35.5 24.8 4.9 3.8 1.3 8.0 4.1 17.3 11.6 5.3 10.5 52.3 12.8 4.6 8.1 19.9 0.0 6.3 1.6 1.5 16.6 23.5 0.6 0.9 0.9 0.3 0.3 0.4 0.3 0.0 0.0 0.0 0.0 44.9 44.3 0.0 1.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 33.7 0.0 0.4 0.5 0.3 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.2 7.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.5 0.2 0.3 0.2 0.2 0.1 0.4 0.2 0.3 0.0 0.6 0.4 0.2 0.9 0.3 0.3 0.9 0.3 0.3 7.6 17.4 2.3 13.6 14.8 6.6 38.9 8.4 24.8 19.9 0.0 1.7 0.0 0.5 0.5 0.8 1.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 19.5 15.2 0.0 0.0 0.0 0.0 2.9 1.2 1.1 0.2 0.1 0.0 0.0 39.9 0.6 10.6 1.7 0.2 0.0 0.0 0.0 48.3 0.2 0.0 0.7 0.0 3.1 0.0 1.2 10.2 0.5 0.6 0.0 0.0 0.0 0.1 GALNT16 "GalNAc-T16, GALNTL1, KIAA1130" ENSG00000100626 "Polypeptide N-acetylgalactosaminyltransferase 16" Q8N428 14 69259277-69357033 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 38.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 7.4;ASC diff: 9.8;hTEC/SVTERT24-B: 13.9;hTERT-RPE1: 14.2;SCLC-21H: 7.3;U-2 OS: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059136, HPA075325" Approved Approved Vesicles,Cytosol NA NA 250000 "Vesicles, Cytosol" "HPA059136: AB_2683919, HPA075325: " "unprognostic (9.71e-3)" "unprognostic (7.47e-2)" "unprognostic (4.02e-1)" "unprognostic (2.30e-2)" "unprognostic (6.71e-2)" "unprognostic (5.72e-3)" "unprognostic (3.18e-3)" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (1.28e-2)" "unprognostic (3.62e-4)" "unprognostic (1.31e-2)" "prognostic favorable (5.23e-6)" "unprognostic (5.38e-3)" "unprognostic (3.34e-2)" "unprognostic (3.93e-2)" "unprognostic (7.96e-5)" 13.6 15.5 20.0 2.9 17.9 0.8 14.5 16.1 21.7 7.8 4.1 5.0 4.0 3.2 6.4 6.0 5.1 6.5 4.8 27.6 18.3 27.2 5.6 3.0 4.2 4.2 6.6 25.2 2.8 5.6 4.0 4.1 1.2 13.0 4.6 3.4 1.7 28.9 6.6 5.3 7.0 5.0 11.3 8.7 14.3 2.4 3.3 3.3 0.0 3.5 6.3 2.2 5.0 3.8 0.5 0.2 1.3 0.5 0.3 0.3 0.2 0.0 0.6 7.4 0.2 9.8 4.5 0.0 1.0 0.0 1.3 1.9 0.4 0.0 0.0 0.2 1.2 0.6 0.0 2.4 0.0 0.2 0.1 5.1 0.0 0.1 0.3 0.1 0.0 0.5 0.4 0.0 13.9 0.0 14.2 0.8 0.0 0.0 0.0 2.3 0.3 0.0 0.0 1.4 0.0 0.1 0.0 3.9 0.0 0.5 0.0 7.3 2.4 1.6 0.3 0.0 0.3 0.2 0.0 0.1 1.5 16.7 1.9 1.5 0.0 0.0 0.0 1.5 0.0 0.0 0.9 0.5 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 0.5 0.3 0.2 1.3 0.3 0.1 0.2 0.1 0.2 20.0 17.9 16.1 16.2 18.3 27.2 6.6 25.2 13.0 3.3 0.0 0.0 0.0 0.5 3.7 1.9 38.2 0.0 0.0 0.0 0.0 2.0 0.1 3.3 0.0 6.4 0.1 0.0 0.0 0.0 0.0 5.2 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.4 0.9 0.0 3.3 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.6 6.5 9.2 0.7 1.9 2.9 0.0 0.0 0.0 0.4 GALNT17 "GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17" ENSG00000185274 "Polypeptide N-acetylgalactosaminyltransferase 17" Q6IS24 7 71132169-71713600 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.9" "Cell type enhanced" "Detected in single" 28 "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.6;NTERA-2: 7.2;RPMI-8226: 8.0;SK-BR-3: 30.5;SuSa: 10.0" "Low region specificity" "Detected in all" "HPA013624, HPA047986" Approved Uncertain "Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "Nucleoli, Nuclear bodies" "HPA013624: AB_1858787, HPA047986: " "unprognostic (2.79e-2)" "unprognostic (6.83e-2)" "unprognostic (5.54e-2)" "unprognostic (3.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.62e-1)" "unprognostic (6.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.00e-1)" "prognostic favorable (4.60e-4)" "unprognostic (2.00e-1)" "unprognostic (4.73e-1)" "unprognostic (1.96e-2)" "unprognostic (9.63e-3)" "prognostic favorable (3.91e-4)" "unprognostic (1.92e-1)" "unprognostic (7.94e-3)" 1.8 7.8 8.2 2.1 13.9 0.5 1.2 25.7 42.9 2.3 4.9 1.7 1.9 0.8 7.9 4.6 8.9 4.4 2.7 19.4 13.2 4.6 2.3 0.6 3.5 0.5 2.1 12.0 22.3 9.4 0.6 4.1 0.7 4.5 9.1 1.4 1.2 1.7 8.3 1.9 0.8 1.5 12.3 1.2 3.3 1.1 3.8 0.8 0.3 9.4 0.0 1.8 10.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.5 0.0 0.0 30.5 0.0 10.0 0.0 0.0 0.0 0.0 2.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 13.9 25.7 22.5 13.2 4.6 2.1 12.0 4.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GALNT18 "GalNAc-T18, GALNT15, GALNTL4, MGC71806" ENSG00000110328 "Polypeptide N-acetylgalactosaminyltransferase 18" Q6P9A2 11 11270876-11622005 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 41.7;Cytotrophoblasts: 37.3;Endothelial cells: 34.9;Muller glia cells: 44.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "gdT-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "A-431: 18.9;HaCaT: 24.2;HBEC3-KT: 16.9;PC-3: 17.0;RPMI-8226: 17.7;SK-BR-3: 22.1;U-87 MG: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012955, HPA070681" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA 200000 "Golgi apparatus" "Vesicles, Cytosol" "HPA012955: AB_1849460, HPA070681: " "unprognostic (1.26e-1)" "unprognostic (2.80e-1)" "unprognostic (3.69e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (7.37e-2)" "unprognostic (1.22e-1)" "unprognostic (6.42e-3)" "unprognostic (6.68e-2)" "unprognostic (6.04e-2)" "unprognostic (2.05e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-1)" "unprognostic (2.66e-3)" "unprognostic (3.54e-2)" "unprognostic (1.63e-1)" "unprognostic (2.10e-1)" "unprognostic (1.81e-2)" 18.6 6.0 15.5 4.9 13.5 0.8 9.1 21.3 16.2 7.0 13.3 5.8 8.3 3.9 15.0 6.4 7.8 7.6 12.6 21.9 13.1 7.0 19.7 6.6 31.2 5.8 10.0 12.1 3.8 9.5 9.1 4.3 26.6 12.8 8.2 4.3 7.1 10.4 11.5 6.1 7.6 4.9 15.0 6.5 4.0 4.1 13.3 8.4 0.7 39.2 5.6 4.2 10.3 9.1 0.0 0.0 0.0 0.0 0.0 1.7 0.3 18.9 6.9 0.9 4.2 0.0 0.0 0.1 2.1 5.2 0.2 0.0 0.7 2.5 0.0 1.5 0.0 2.6 24.2 4.6 16.9 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 7.0 0.0 6.4 0.0 0.0 8.6 0.0 0.0 0.9 4.6 0.2 0.0 0.7 0.0 17.0 0.0 0.0 17.7 13.1 2.3 0.3 1.9 3.5 22.1 0.1 0.6 4.6 0.0 0.0 0.3 3.8 0.1 0.1 0.0 0.0 0.0 16.0 0.0 4.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 15.5 13.5 21.3 16.2 13.1 7.0 10.0 12.1 12.8 8.4 41.7 5.8 0.0 5.8 4.9 0.8 7.3 22.9 12.0 14.8 19.2 2.0 37.3 13.3 18.3 2.1 34.9 0.0 0.0 3.4 2.2 2.8 9.8 1.1 2.6 2.3 0.0 0.0 22.1 1.5 0.7 1.4 0.5 1.7 0.0 0.0 44.1 5.8 0.0 2.8 28.1 1.8 12.9 5.2 0.5 1.0 4.6 12.9 0.0 0.8 1.0 GALNT2 GalNAc-T2 ENSG00000143641 "Polypeptide N-acetylgalactosaminyltransferase 2" Q10471 1 230057990-230282124 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 140.3" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 114.0;Extravillous trophoblasts: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 90.9" "Low region specificity" "Detected in all" HPA011222 Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA 11000000 "Golgi apparatus" "HPA011222: AB_1849446" "unprognostic (1.26e-1)" "prognostic unfavorable (1.22e-6)" "unprognostic (1.15e-2)" "unprognostic (1.35e-2)" "unprognostic (8.70e-3)" "unprognostic (7.77e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (8.48e-8)" "unprognostic (2.93e-1)" "unprognostic (1.93e-1)" "unprognostic (1.70e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.79e-13)" "unprognostic (3.79e-3)" "unprognostic (1.49e-1)" "unprognostic (3.64e-2)" "unprognostic (1.89e-1)" 19.5 25.6 11.1 19.6 10.1 6.9 20.4 7.7 12.5 11.7 12.7 9.1 10.5 11.3 13.7 11.5 11.5 13.2 17.0 13.9 12.5 8.5 17.5 140.3 13.2 20.4 8.4 9.0 24.8 35.9 4.3 7.3 16.6 12.6 10.8 7.5 10.5 11.1 9.6 42.2 8.4 11.3 14.6 13.6 9.5 18.0 12.7 8.2 28.4 10.7 10.7 7.0 14.9 13.1 6.7 13.5 3.5 10.1 2.7 5.3 6.3 16.2 21.7 12.8 15.1 24.6 21.0 26.4 30.7 19.1 12.5 12.0 9.3 30.9 4.1 22.9 16.2 29.2 31.7 8.4 25.8 10.5 41.0 11.0 12.5 48.5 10.4 13.4 4.7 24.6 30.0 12.8 16.7 6.7 27.5 14.6 23.2 15.5 6.3 13.8 4.4 24.6 4.8 17.5 10.9 20.7 27.5 18.3 12.6 12.3 19.3 4.0 15.1 31.1 1.6 18.7 7.1 9.9 9.0 34.6 12.3 23.7 27.7 24.3 21.0 12.0 9.2 31.6 9.6 90.9 1.1 10.1 3.5 4.7 9.6 3.6 3.8 2.9 4.7 7.9 6.7 2.8 5.3 3.2 2.7 9.6 13.5 3.4 6.3 11.1 10.1 7.7 11.8 12.5 8.5 8.4 9.0 12.6 8.2 14.9 14.7 24.2 16.5 13.6 27.5 13.9 22.9 9.4 15.9 22.7 31.4 5.3 5.0 41.3 43.0 13.8 16.1 0.0 114.0 106.1 24.4 21.9 12.7 80.2 23.0 27.0 16.1 15.4 38.3 19.2 33.1 18.8 23.6 47.7 17.9 11.2 87.4 17.6 27.6 18.9 69.7 12.9 11.3 3.6 10.6 6.9 13.8 15.2 15.3 14.0 GALNT3 "GalNAc-T3, HFTC, HHS" ENSG00000115339 "Polypeptide N-acetylgalactosaminyltransferase 3" Q14435 2 165747591-165794682 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Glandular cells: 138.4;Pancreatic endocrine cells: 131.2;Urothelial cells: 275.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.6;HaCaT: 31.9;HBEC3-KT: 21.5;hTCEpi: 30.4;OE19: 67.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA007613 Enhanced Supported "Golgi apparatus" NA NA 88000 "Golgi apparatus" "HPA007613: AB_1078941" "unprognostic (1.95e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (1.16e-3)" "unprognostic (2.78e-1)" "unprognostic (3.22e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (4.13e-2)" "unprognostic (4.47e-2)" "unprognostic (2.74e-1)" "unprognostic (6.44e-2)" "unprognostic (3.62e-3)" "unprognostic (1.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-1)" "unprognostic (1.28e-1)" "unprognostic (1.57e-1)" 1.5 1.7 1.5 6.3 1.7 14.6 12.0 2.2 1.7 11.9 21.3 3.6 6.5 15.5 2.4 8.8 23.4 15.7 26.4 0.9 1.9 2.1 15.1 2.1 15.3 0.6 4.2 1.2 6.4 31.2 3.0 23.0 7.0 4.2 13.8 21.2 1.7 35.7 5.4 0.7 6.7 37.4 0.5 4.8 23.3 28.9 17.6 3.3 1.5 37.6 15.1 20.8 11.7 9.3 3.3 7.5 21.1 5.7 5.8 5.3 2.3 17.1 0.0 0.1 0.0 0.0 0.6 11.4 3.7 1.5 1.5 3.9 10.6 27.6 0.1 0.0 0.0 0.0 31.9 0.0 21.5 3.2 0.2 3.0 0.0 3.1 0.0 0.1 3.2 0.1 0.1 30.4 0.0 8.1 0.7 0.0 0.5 0.0 14.3 1.2 12.3 0.0 1.3 0.0 67.1 1.7 0.0 0.0 0.5 5.7 14.3 1.7 0.0 0.0 15.5 3.4 0.7 6.9 0.1 0.1 0.0 0.2 0.0 0.0 7.3 3.6 0.3 0.0 3.3 0.1 21.1 3.1 13.8 5.3 4.5 4.1 3.3 1.7 3.3 5.3 3.1 0.6 1.9 10.5 5.8 5.7 7.5 2.9 2.3 1.5 1.7 2.2 1.7 1.9 2.1 4.2 1.2 4.2 3.3 11.9 24.2 0.5 78.9 33.8 0.3 0.3 22.9 61.6 27.3 62.8 0.0 7.8 3.3 50.9 60.2 2.4 50.9 0.0 99.9 18.6 2.9 138.4 45.0 0.5 6.4 0.0 22.5 1.3 1.6 5.0 2.3 7.1 15.1 7.2 119.6 18.4 131.2 40.3 0.4 2.5 1.0 6.5 2.1 30.9 1.1 36.1 9.4 13.8 47.7 275.5 GALNT4 GalNAc-T4 ENSG00000257594 "Polypeptide N-acetylgalactosaminyltransferase 4" Q8N4A0 12 89519408-89524806 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 2: 1.1;Ciliated cells: 5.3;Club cells: 3.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 18.8" HPA076116 Approved "Golgi apparatus" NA NA 270000 "Golgi apparatus" "HPA076116: AB_2686778" "unprognostic (2.96e-2)" "unprognostic (7.65e-3)" "unprognostic (8.76e-2)" "unprognostic (3.94e-5)" "unprognostic (3.50e-1)" "unprognostic (4.87e-2)" "unprognostic (2.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.78e-1)" "unprognostic (4.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.24e-1)" "unprognostic (5.81e-6)" "unprognostic (2.34e-1)" "unprognostic (1.91e-1)" "unprognostic (9.65e-2)" "unprognostic (2.52e-1)" 5.0 2.4 4.0 5.8 3.2 3.9 2.6 1.4 3.4 11.1 14.3 3.7 2.7 11.1 9.5 1.9 3.7 7.7 15.8 2.9 1.9 1.7 8.3 5.6 3.2 1.7 4.4 1.1 4.3 8.6 1.1 5.9 2.9 3.7 2.9 11.4 3.3 22.6 1.2 1.1 1.8 20.8 2.0 2.6 7.5 21.0 1.4 3.7 0.2 2.7 2.0 8.2 4.1 2.8 2.8 3.4 5.9 7.5 7.3 5.8 2.7 2.5 7.8 2.7 15.1 5.6 8.1 1.9 6.3 2.9 2.6 2.7 3.0 4.9 0.0 1.5 4.7 0.9 4.0 0.8 4.1 4.4 6.6 1.7 3.2 1.4 2.4 2.6 2.9 7.1 3.6 1.8 5.3 2.3 5.8 8.2 0.4 1.9 1.4 4.0 2.0 0.2 5.6 1.8 5.6 18.8 0.6 0.5 1.2 7.7 8.1 0.1 1.2 0.8 4.3 5.7 2.7 8.4 2.8 7.6 5.4 1.9 3.3 2.0 1.3 2.3 1.2 2.7 1.4 3.1 5.9 5.2 2.4 3.2 7.4 5.8 1.9 1.8 2.4 3.4 2.8 2.6 2.3 5.0 7.3 7.5 1.2 1.9 2.7 4.0 3.2 1.4 3.4 1.9 1.7 4.4 1.1 3.7 3.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GALNT5 GalNAc-T5 ENSG00000136542 "Polypeptide N-acetylgalactosaminyltransferase 5" Q7Z7M9 2 157257598-157314211 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 145.9;Mucus-secreting cells: 66.8;Urothelial cells: 121.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "cerebellum: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 23.6;BJ: 15.5;BJ hTERT+: 27.8;CAPAN-2: 13.6;fHDF/TERT166: 32.4;HaCaT: 27.7;K-562: 16.0;LHCN-M2: 27.7;U-138 MG: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008963, HPA009035" Approved Approved "Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA 630000 "Golgi apparatus, Cytosol" "Nucleoli, Vesicles" "HPA008963: AB_1078942, HPA009035: AB_1078943" "unprognostic (6.34e-3)" "unprognostic (9.31e-2)" "unprognostic (2.11e-2)" "unprognostic (9.89e-2)" "unprognostic (3.19e-2)" "unprognostic (2.46e-2)" "unprognostic (4.63e-3)" "unprognostic (1.88e-1)" "unprognostic (1.09e-1)" "unprognostic (6.93e-2)" "unprognostic (4.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-2)" "unprognostic (6.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-3)" 0.4 0.2 0.2 1.5 0.2 0.5 1.1 28.2 0.2 7.5 12.0 0.7 0.0 2.3 0.5 0.5 9.0 0.2 17.1 0.9 0.4 0.2 0.3 0.2 15.5 0.0 0.2 0.0 0.3 1.5 0.0 6.8 0.1 4.4 1.6 16.1 0.3 18.9 0.2 0.2 0.5 8.4 0.8 0.3 0.3 15.2 0.5 0.0 0.1 0.3 12.2 11.7 2.3 6.6 0.2 0.1 0.2 0.1 0.1 0.5 0.0 23.6 2.6 0.0 0.0 1.0 8.3 0.0 15.5 27.8 0.2 0.6 1.1 13.6 0.0 0.0 32.4 0.0 27.7 0.5 5.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.5 0.0 0.0 0.0 16.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.1 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.5 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.2 0.2 28.2 0.2 0.4 0.2 0.2 0.0 4.4 0.0 145.9 29.7 0.0 10.3 0.7 0.0 0.4 2.5 5.3 36.4 0.0 0.0 0.0 0.0 0.8 5.1 0.0 18.6 23.3 2.9 0.0 2.1 7.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.6 3.3 2.8 66.8 0.0 31.4 31.7 0.0 0.0 0.0 0.0 0.1 2.6 0.2 0.1 0.0 0.0 20.7 121.3 GALNT6 GalNAc-T6 ENSG00000139629 "Polypeptide N-acetylgalactosaminyltransferase 6" Q8NCL4 12 51351247-51392867 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 35.4" "Cell type enriched" "Detected in many" 4 "granulocytes: 164.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 33.6;CACO-2: 33.2;OE19: 28.5;SK-BR-3: 33.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011762, HPA017086" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 2900000 "Nucleoplasm, Golgi apparatus" "HPA011762: AB_1849450, HPA017086: AB_1849452" "unprognostic (2.03e-1)" "unprognostic (6.65e-2)" "unprognostic (2.26e-2)" "prognostic favorable (9.85e-4)" "unprognostic (1.35e-2)" "unprognostic (1.18e-1)" "unprognostic (7.15e-3)" "unprognostic (2.05e-1)" "unprognostic (2.27e-2)" "prognostic favorable (5.40e-4)" "unprognostic (1.88e-2)" "unprognostic (5.25e-2)" "unprognostic (7.13e-4)" "unprognostic (5.65e-3)" "unprognostic (3.18e-1)" "unprognostic (2.16e-2)" "unprognostic (1.18e-2)" 3.1 1.8 4.0 4.1 9.5 4.4 10.6 1.0 5.1 19.5 13.4 15.4 0.5 11.8 0.9 14.4 2.8 3.7 6.8 0.8 7.1 3.6 2.5 0.8 4.1 4.0 14.4 3.6 1.4 6.3 0.4 1.6 9.9 5.8 1.3 3.9 0.9 23.8 6.3 0.6 5.5 16.9 0.8 8.3 5.5 35.4 0.8 9.7 6.6 1.8 2.3 6.6 2.2 2.2 2.9 3.7 23.8 6.5 10.8 3.4 2.8 11.5 1.2 0.2 0.0 0.0 0.1 18.5 19.3 33.6 8.3 5.6 33.2 6.1 0.1 1.8 10.9 0.0 11.1 0.6 8.4 5.2 2.6 1.2 7.3 0.2 0.2 0.3 3.9 26.1 0.7 7.8 7.4 7.1 0.0 20.3 4.2 1.6 0.3 0.0 22.6 12.4 2.9 1.6 28.5 20.9 0.0 0.0 3.3 6.5 0.8 0.1 7.4 0.1 33.8 0.0 3.9 18.8 1.7 23.9 0.0 4.2 0.0 0.0 0.6 0.1 1.0 2.3 8.7 0.1 4.5 4.4 23.8 3.4 3.7 1.4 0.8 1.7 2.6 3.7 2.9 2.7 2.3 0.8 10.8 6.5 3.1 1.1 2.8 4.0 9.5 1.0 5.1 7.1 3.6 14.4 3.6 5.8 9.7 3.0 3.7 15.2 2.7 2.6 0.4 0.8 2.5 10.7 14.8 1.8 0.0 11.3 3.3 2.7 1.6 1.4 20.4 0.0 9.8 40.7 1.7 5.0 164.7 0.0 13.2 0.0 0.0 2.5 12.0 1.0 0.0 11.8 1.7 1.0 14.2 0.0 15.6 26.2 0.4 1.8 0.0 0.0 0.9 0.2 1.2 8.2 4.0 8.7 9.2 5.4 GALNT7 GALNAC-T7 ENSG00000109586 "Polypeptide N-acetylgalactosaminyltransferase 7" Q86SF2 4 173168753-173323967 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.4" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 70.2;Glandular cells: 85.7;Mucus-secreting cells: 125.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064243, HPA065317" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 5000000 "Golgi apparatus" Nucleoplasm "HPA064243: AB_2685223, HPA065317: AB_2685465" "unprognostic (1.81e-1)" "unprognostic (2.11e-1)" "prognostic favorable (4.53e-4)" "unprognostic (1.37e-3)" "unprognostic (1.48e-1)" "unprognostic (6.86e-3)" "unprognostic (2.72e-2)" "unprognostic (1.77e-1)" "unprognostic (2.85e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (7.65e-4)" "unprognostic (1.33e-1)" "unprognostic (4.66e-3)" "unprognostic (3.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.34e-3)" "unprognostic (5.97e-2)" 3.7 4.4 8.4 7.4 8.4 5.0 12.0 27.6 8.0 13.4 23.3 9.4 2.8 14.1 9.3 5.5 12.0 4.9 9.5 3.5 6.5 5.2 4.9 1.2 4.5 5.2 10.8 7.0 7.2 14.9 5.3 5.6 6.3 11.2 20.3 26.7 6.2 20.1 4.2 1.4 3.1 16.2 8.4 16.3 5.7 32.8 6.4 8.8 67.4 6.6 4.4 9.6 9.4 4.8 5.0 9.8 16.8 11.4 5.5 6.8 4.7 20.4 10.7 10.6 3.3 5.7 8.4 15.2 5.4 6.1 5.1 7.0 3.3 32.5 11.4 4.0 4.8 13.7 17.5 4.4 9.5 6.9 44.2 8.7 13.9 22.3 0.1 3.8 20.4 9.9 5.4 8.6 11.3 5.7 19.3 33.5 8.3 9.2 17.8 25.7 6.7 15.0 11.3 10.4 20.4 7.1 15.0 9.8 2.9 37.2 9.6 8.5 6.5 2.5 15.0 7.4 14.4 6.0 6.1 40.0 3.6 16.2 0.1 11.6 5.2 0.0 6.1 14.8 12.3 13.0 9.6 11.4 14.6 4.3 6.0 6.2 5.0 4.9 4.6 9.8 3.1 3.9 3.0 16.8 5.5 6.1 4.1 6.8 4.7 8.4 8.4 27.6 8.0 6.5 5.2 10.8 7.0 11.2 8.8 6.0 29.4 4.7 7.8 1.5 36.4 5.9 12.7 14.7 30.7 19.2 2.0 0.9 0.0 12.2 1.8 6.9 70.2 0.0 43.4 2.9 6.6 85.7 23.1 0.0 9.6 9.5 21.9 8.0 21.3 3.1 8.6 8.8 8.5 8.2 125.7 7.5 33.8 50.7 4.9 8.6 23.6 12.9 6.8 2.3 4.4 1.0 0.7 4.4 37.4 15.7 GALNT8 GALNAC-T8 ENSG00000130035 "Polypeptide N-acetylgalactosaminyltransferase 8" "Q9NY28, P17658" 12 4720341-4851927 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Glycosyltransferase, Ion channel, Potassium channel, Transferase, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 12.7;intestine: 33.2;testis: 18.5" "Group enriched" "Detected in some" 6 "Early spermatids: 74.9;Late spermatids: 88.4;Mucus-secreting cells: 32.6" "Cancer enhanced" "Detected in some" "testis cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 26.1;NTERA-2: 9.3;SuSa: 11.2;U-266/84: 7.5" "Not detected" "Not detected" "HPA012638, HPA073461" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" Yes No "Golgi apparatus, Vesicles" "HPA012638: AB_2294503, HPA073461: AB_2686604" "unprognostic (2.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.13e-2)" "unprognostic (1.75e-2)" "unprognostic (6.24e-2)" "unprognostic (2.87e-1)" "unprognostic (2.59e-2)" "unprognostic (3.79e-1)" "unprognostic (2.72e-1)" "unprognostic (5.76e-2)" "unprognostic (8.06e-5)" "unprognostic (1.16e-2)" "unprognostic (6.67e-5)" "unprognostic (5.18e-2)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-2)" 1.1 2.2 5.3 2.2 6.5 0.5 3.1 1.4 12.7 1.0 15.5 9.4 0.0 7.2 0.9 0.4 0.7 1.2 1.1 3.7 8.0 1.7 1.2 0.8 0.9 1.0 5.7 9.6 1.6 0.9 0.2 3.7 0.5 6.0 1.1 33.2 0.1 1.0 0.9 0.7 0.9 14.7 2.1 3.5 1.2 1.3 18.5 11.5 0.0 0.8 0.5 0.9 1.2 0.9 1.0 0.7 0.1 0.1 0.9 3.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 26.1 0.0 0.0 0.2 0.1 9.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 11.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.3 7.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.3 0.7 1.2 0.0 1.0 0.0 0.1 0.1 0.9 0.0 0.7 3.0 0.0 5.3 6.5 1.4 12.7 8.0 1.7 5.7 9.6 6.0 11.5 6.0 0.3 0.0 0.0 0.0 1.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.9 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 6.3 0.0 0.0 88.4 1.4 0.0 0.0 0.0 32.6 0.1 0.3 0.0 2.5 1.0 0.3 6.5 0.0 11.6 3.6 0.0 0.0 0.0 1.8 0.0 GALNT9 GALNAC-T9 ENSG00000182870 "Polypeptide N-acetylgalactosaminyltransferase 9" Q9HCQ5 12 132196372-132329349 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 52.4" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 7.3;Collecting duct cells: 26.2;Proximal tubular cells: 5.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 2.6;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 9 "B-cells: 2.6" "Cell line enriched" "Detected in some" 4 "U-87 MG: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075016 Approved Vesicles NA NA Vesicles "HPA075016: AB_2686729" "unprognostic (1.13e-1)" "unprognostic (3.47e-2)" "unprognostic (1.47e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (6.53e-2)" "unprognostic (2.65e-1)" "unprognostic (1.32e-2)" "unprognostic (2.03e-1)" "unprognostic (1.64e-3)" "unprognostic (2.85e-1)" "unprognostic (6.62e-2)" "unprognostic (5.17e-2)" "unprognostic (1.89e-1)" "unprognostic (1.71e-1)" "unprognostic (3.89e-2)" "unprognostic (5.69e-2)" 2.6 2.2 9.3 1.0 6.7 0.6 0.5 52.4 27.9 1.1 0.8 0.8 0.0 1.1 1.8 7.7 0.5 1.9 0.7 0.6 12.9 6.8 3.2 0.5 0.9 1.3 4.3 10.8 1.3 0.4 1.9 2.7 0.5 6.9 1.0 0.6 0.3 1.2 1.7 0.5 0.9 1.0 0.6 1.7 1.2 0.7 0.9 1.1 0.0 6.1 0.0 0.4 0.7 0.1 2.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.6 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.7 0.0 6.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 26.6 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 2.6 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.3 6.7 52.4 20.2 12.9 6.8 4.3 10.8 6.9 1.1 0.0 1.1 0.0 0.4 0.0 7.3 0.8 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.4 1.1 0.0 0.2 3.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.8 5.0 2.1 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.8 GALNTL5 "GalNAc-T5L, GALNT15" ENSG00000106648 "Polypeptide N-acetylgalactosaminyltransferase like 5" Q7Z4T8 7 151956379-152019934 "Disease related genes, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 45.0" "Group enriched" "Detected in some" 89 "Early spermatids: 360.6;Late spermatids: 297.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011140 Enhanced NA NA "HPA011140: AB_1078944" "unprognostic (2.33e-2)" "unprognostic (2.09e-1)" "unprognostic (1.55e-1)" 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 1.9 1.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 360.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 297.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.7 1.5 0.0 0.0 0.0 0.0 0.0 GALNTL6 "GalNAc-T6L, GALNT17" ENSG00000174473 "Polypeptide N-acetylgalactosaminyltransferase like 6" Q49A17 4 171812254-173041559 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 7.3;testis: 6.4" "Group enriched" "Detected in some" 5 "Club cells: 3.4;Early spermatids: 11.9;Exocrine glandular cells: 3.7;Late spermatids: 13.6;Melanocytes: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 4.5;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 8 "B-cells: 4.5" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 3.2;Karpas-707: 2.2;SCLC-21H: 2.3;SK-MEL-30: 1.8;U-266/70: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031019 Uncertain "Intracellular and membrane" NA NA "HPA031019: AB_10601653" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (2.01e-2)" "unprognostic (5.73e-2)" "unprognostic (7.50e-2)" "unprognostic (8.32e-2)" "unprognostic (3.25e-1)" "unprognostic (9.55e-2)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (2.06e-1)" "unprognostic (2.80e-1)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.11e-2)" "unprognostic (4.84e-3)" "unprognostic (1.73e-2)" 0.2 0.7 3.9 1.2 8.3 1.1 0.7 1.0 9.5 3.3 1.0 0.6 0.0 0.7 0.3 0.3 0.2 0.3 0.5 0.5 3.6 4.1 0.3 0.5 0.5 1.3 7.6 2.4 0.1 0.5 0.1 0.0 0.1 1.8 2.2 0.7 1.3 0.3 0.2 0.5 0.6 1.2 0.3 0.5 7.3 2.9 6.4 1.2 0.0 0.5 1.1 0.4 0.5 0.6 4.5 0.5 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.5 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.7 1.1 0.0 1.2 0.0 0.3 0.6 0.0 0.0 0.0 3.2 0.0 0.3 0.7 2.2 0.2 1.0 0.3 0.5 1.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.9 0.0 0.5 1.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 2.6 0.0 0.0 0.3 0.1 1.6 0.0 0.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 8.3 1.0 5.9 3.6 4.1 7.6 2.4 1.8 1.2 0.0 1.0 0.0 0.0 0.2 0.6 1.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 3.7 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.6 13.6 0.3 0.0 5.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.9 0.3 0.0 0.0 0.1 0.1 GALR1 "GALNR, GALNR1" ENSG00000166573 "Galanin receptor 1" P47211 18 77250549-77277896 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.3;brain: 3.5;pituitary gland: 4.9" "Group enriched" "Detected in some" 6 "Ciliated cells: 21.4;Early spermatids: 46.5;Intestinal endocrine cells: 16.9" "Cancer enriched" "Detected in single" 6 "glioma: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Region enhanced" "Detected in some" "hypothalamus: 6.1" "Low region specificity" "Detected in many" HPA074584 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA074584: " "unprognostic (1.65e-1)" "unprognostic (1.56e-2)" "unprognostic (2.85e-1)" "unprognostic (3.00e-1)" "unprognostic (2.11e-1)" "unprognostic (2.77e-3)" "unprognostic (1.31e-2)" "unprognostic (5.34e-3)" "unprognostic (7.33e-3)" "unprognostic (9.49e-2)" "unprognostic (2.18e-1)" 1.1 5.3 1.2 0.3 0.8 0.7 0.5 0.0 3.5 0.0 0.3 0.4 0.2 0.5 0.0 0.3 0.1 0.1 0.7 2.0 0.1 0.5 0.0 0.1 0.8 0.1 0.5 0.0 4.9 0.0 0.8 0.5 0.5 0.7 0.1 0.4 0.5 0.1 0.9 0.0 0.3 0.4 0.3 0.0 0.0 0.1 0.4 0.4 1.6 0.2 0.5 0.3 0.0 0.3 0.4 0.6 0.8 0.5 1.2 0.6 0.2 0.5 0.1 0.1 0.8 1.1 0.8 0.2 0.4 0.2 0.4 0.4 0.3 0.1 1.1 0.6 1.1 0.8 0.5 0.3 0.5 0.8 0.8 0.4 0.3 0.3 0.5 0.3 0.5 0.4 1.6 0.1 0.9 0.4 0.9 0.6 0.1 0.5 0.5 0.4 0.4 0.2 0.6 1.5 0.5 0.2 0.4 0.4 0.9 0.5 0.4 0.6 0.6 0.7 1.1 0.1 0.6 0.3 0.4 0.8 0.3 0.4 1.0 0.2 0.3 0.3 0.2 0.3 0.3 0.3 0.2 0.1 0.4 0.2 0.2 1.6 0.5 0.2 0.4 0.1 0.0 0.0 5.1 0.0 0.7 0.0 1.8 0.4 0.0 21.4 1.2 1.8 0.0 0.0 0.0 0.0 46.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.1 0.0 16.9 0.0 0.0 3.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 GALR2 GALNR2 ENSG00000182687 "Galanin receptor 2" O43603 17 76074794-76077541 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 3.5;intestine: 13.1;lymphoid tissue: 9.8;smooth muscle: 6.4" "Cell type enhanced" "Detected in single" 15 "B-cells: 2.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 3.1;NTERA-2: 4.7;PC-3: 3.0;THP-1: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA044513 Approved NA NA "HPA044513: AB_10962510" "unprognostic (1.26e-2)" "unprognostic (1.04e-2)" "unprognostic (1.16e-1)" "unprognostic (1.37e-2)" "unprognostic (2.62e-2)" "unprognostic (3.54e-1)" "unprognostic (3.49e-2)" "unprognostic (3.43e-1)" "unprognostic (7.62e-2)" "unprognostic (1.39e-1)" "unprognostic (9.32e-5)" "unprognostic (2.31e-1)" "unprognostic (2.11e-3)" "unprognostic (1.24e-1)" "unprognostic (2.39e-1)" "unprognostic (4.04e-2)" "unprognostic (8.14e-2)" 0.3 0.1 0.0 9.8 0.1 3.5 0.0 0.0 0.3 0.3 13.1 0.0 0.0 0.6 0.0 0.0 1.1 0.1 0.5 0.1 1.4 0.8 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.3 0.0 0.1 0.4 0.6 0.2 0.1 0.0 0.1 0.0 0.0 0.3 9.0 6.4 1.4 0.2 0.4 0.3 0.0 0.0 0.0 1.1 1.2 1.0 0.2 0.0 1.1 1.4 0.9 0.5 0.4 0.7 0.2 1.9 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.4 0.0 2.2 0.5 0.6 0.3 0.0 0.2 3.1 0.0 0.1 0.0 0.3 2.6 0.0 1.6 2.8 0.3 0.6 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.1 0.5 0.1 1.1 0.2 0.3 4.7 0.0 3.0 0.1 0.6 0.8 0.0 0.2 0.2 0.1 1.7 0.7 0.3 0.1 0.6 6.9 0.2 0.2 0.7 0.2 0.4 0.7 0.4 2.6 0.0 0.1 0.0 0.0 0.9 0.0 0.4 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.4 0.5 0.4 1.1 0.0 0.7 0.0 0.1 0.0 0.3 1.4 0.8 0.2 0.0 0.6 0.0 0.0 0.0 2.4 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.5 0.1 0.2 0.0 0.0 0.3 GALR3 ENSG00000128310 "Galanin receptor 3" O60755 22 37823382-37825495 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.0;skeletal muscle: 2.5" "Cell type enhanced" "Detected in single" 21 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.9;HEK 293: 2.3;Hep G2: 3.0;REH: 1.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (4.45e-2)" "unprognostic (1.45e-2)" "unprognostic (4.60e-3)" "unprognostic (7.07e-2)" "unprognostic (7.63e-2)" "unprognostic (8.17e-2)" "unprognostic (4.18e-2)" "unprognostic (2.16e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (2.07e-1)" "unprognostic (1.66e-2)" "unprognostic (7.37e-2)" "unprognostic (8.35e-2)" "unprognostic (4.45e-2)" 0.0 0.0 0.6 0.0 1.3 0.7 0.0 2.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.0 0.0 0.9 0.0 0.0 0.2 0.4 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.1 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.9 0.4 0.0 0.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.0 1.2 0.0 1.0 0.4 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.4 0.3 1.2 0.0 0.1 0.0 0.9 1.3 0.0 0.1 0.4 0.3 0.0 0.3 0.4 0.3 0.1 0.7 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 GANAB "G2AN, GIIA, GluII, KIAA0088" ENSG00000089597 "Glucosidase II alpha subunit" Q14697 11 62624826-62646726 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026874, HPA061426" Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA 37000000 "Endoplasmic reticulum" "HPA026874: AB_1849745, HPA061426: AB_2684516" "unprognostic (2.12e-1)" "unprognostic (5.95e-3)" "unprognostic (4.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-2)" "unprognostic (3.65e-2)" "prognostic unfavorable (1.27e-5)" "unprognostic (5.80e-3)" "unprognostic (1.09e-1)" "unprognostic (1.79e-1)" "unprognostic (1.68e-3)" "unprognostic (5.91e-2)" "unprognostic (1.01e-3)" "unprognostic (3.81e-2)" "unprognostic (1.82e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (9.54e-4)" 33.6 34.6 16.2 23.3 20.7 17.9 30.1 19.9 31.0 38.9 31.5 29.8 43.4 26.0 44.0 38.6 29.2 34.2 33.8 32.6 17.2 16.5 35.9 91.5 31.4 30.2 21.7 19.5 49.0 51.4 56.6 27.3 61.1 20.0 29.4 32.6 33.7 43.5 40.7 28.2 24.5 39.8 37.4 19.5 37.4 31.2 27.7 20.2 41.8 45.6 25.2 34.0 36.0 29.4 14.6 17.5 16.5 18.8 22.5 20.0 17.6 42.5 37.3 46.7 84.6 72.1 63.1 50.6 48.0 72.1 66.5 57.5 31.1 79.2 29.2 97.1 84.8 52.9 58.2 56.3 53.9 68.9 23.5 24.3 28.8 51.2 12.9 53.3 44.6 36.3 61.2 35.0 66.1 69.4 84.2 61.6 30.0 40.8 52.7 59.7 37.4 23.2 14.5 39.5 35.0 30.3 31.0 56.0 73.3 32.6 34.8 24.7 33.5 68.6 44.5 51.1 52.5 58.3 38.1 46.3 66.6 42.6 52.2 44.6 52.9 61.2 22.3 73.1 24.0 64.7 16.5 15.0 14.4 20.0 18.8 20.0 14.6 13.8 15.9 17.5 13.1 17.9 16.3 7.0 22.5 16.4 11.6 13.0 17.6 16.2 20.7 19.9 31.0 17.2 16.5 21.7 19.5 20.0 20.2 11.9 26.8 19.7 22.3 25.1 29.5 6.5 61.1 10.7 7.9 64.6 56.9 71.8 5.0 43.0 15.3 31.5 35.1 0.0 36.9 114.6 43.7 31.3 10.5 80.2 51.7 33.4 30.6 51.5 41.2 11.0 54.1 24.9 33.7 36.9 50.5 40.2 38.3 25.9 64.0 24.2 33.9 32.3 26.7 18.4 48.6 27.4 67.1 24.2 55.2 26.0 GAPT "C5orf29, FLJ33641" ENSG00000175857 "GRB2 binding adaptor protein, transmembrane" Q8N292 5 58491435-58497090 "Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 117.8" "Group enriched" "Detected in some" 9 "B-cells: 29.7;granulocytes: 52.1;Hofbauer cells: 15.1;Kupffer cells: 25.6;Macrophages: 34.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "eosinophil: 117.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 117.8" "Cell line enhanced" "Detected in some" "HEL: 27.4;HL-60: 15.8;NB-4: 16.5;THP-1: 13.0;U-937: 45.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011048, HPA011070" Uncertain Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus, Vesicles" "HPA011048: , HPA011070: AB_1848887" "unprognostic (9.79e-2)" "unprognostic (5.67e-3)" "unprognostic (2.39e-2)" "unprognostic (3.26e-2)" "unprognostic (3.36e-2)" "unprognostic (8.09e-4)" "unprognostic (4.32e-1)" "unprognostic (1.23e-3)" "unprognostic (4.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.28e-2)" "unprognostic (2.93e-1)" "unprognostic (3.52e-3)" "unprognostic (3.74e-2)" "unprognostic (2.42e-2)" "unprognostic (2.33e-2)" "unprognostic (1.40e-2)" 1.4 0.8 1.4 15.5 2.7 8.5 1.0 0.6 1.2 1.8 1.4 1.6 0.4 1.8 1.3 2.2 3.3 1.2 3.1 1.1 1.5 1.7 1.6 1.0 7.2 19.4 4.5 0.9 0.7 1.2 0.0 1.5 0.8 4.4 2.6 2.0 1.4 2.3 0.4 0.5 0.9 8.2 2.4 5.9 25.8 1.7 0.8 3.2 5.2 1.1 0.5 23.5 5.1 1.2 12.0 25.4 117.8 8.2 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 15.8 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 16.5 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.7 0.0 12.3 8.2 117.8 0.0 5.7 0.0 12.0 0.0 0.0 9.4 11.9 0.0 0.0 10.1 0.1 6.6 25.4 0.0 3.4 1.4 2.7 0.6 1.2 1.5 1.7 4.5 0.9 4.4 3.2 3.0 3.4 29.7 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.1 0.0 15.1 0.0 0.0 0.6 25.6 0.0 0.0 34.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 GBGT1 "A3GALNT, FS, MGC44848, UDP-GalNAc" ENSG00000148288 "Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)" Q8N5D6 9 133152948-133163945 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "granulocytes: 11.5;Hofbauer cells: 19.5;Kupffer cells: 23.4;Macrophages: 13.6;monocytes: 11.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 30.7;HMC-1: 28.7;HUVEC TERT2: 11.9;NB-4: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051298 Approved "Intracellular and membrane" NA NA "HPA051298: AB_2681428" "unprognostic (4.63e-3)" "unprognostic (8.03e-2)" "prognostic unfavorable (6.22e-4)" "unprognostic (2.70e-1)" "unprognostic (8.87e-2)" "unprognostic (4.38e-1)" "unprognostic (2.97e-2)" "unprognostic (7.43e-2)" "unprognostic (9.04e-2)" "unprognostic (2.27e-3)" "unprognostic (2.35e-1)" "unprognostic (9.50e-2)" "prognostic unfavorable (3.46e-5)" "unprognostic (2.92e-2)" "unprognostic (1.01e-1)" "unprognostic (3.41e-2)" "unprognostic (6.35e-2)" 10.2 12.9 6.7 13.7 5.7 10.3 15.5 8.1 7.8 5.8 5.6 6.3 4.7 4.1 8.5 5.7 6.7 7.8 9.0 7.2 7.0 4.6 7.7 2.0 11.2 20.4 6.7 4.3 15.8 4.4 5.6 5.6 19.7 8.8 8.4 3.9 16.7 6.3 8.2 2.9 4.2 7.3 8.2 7.2 11.2 21.7 4.3 5.7 1.7 8.1 3.2 11.5 8.3 9.0 3.4 3.2 5.2 11.2 0.9 0.5 2.5 0.0 0.8 0.8 0.0 0.5 0.6 0.2 2.3 1.8 1.3 0.0 0.0 0.4 0.6 7.8 2.3 0.9 8.6 5.1 0.5 0.0 0.0 0.2 30.7 0.5 0.0 6.3 1.1 28.7 2.7 0.8 0.3 0.0 5.4 11.9 0.4 8.9 0.1 0.4 0.1 0.1 13.8 2.5 0.2 0.2 2.2 0.2 0.8 0.8 0.1 0.2 0.9 0.0 1.2 0.0 1.0 0.0 6.8 7.4 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.1 4.9 0.4 4.7 11.2 5.2 0.2 7.7 0.5 1.7 0.4 0.0 3.2 3.4 0.1 0.1 2.0 0.9 6.4 2.3 0.2 2.5 6.7 5.7 8.1 7.8 7.0 4.6 6.7 4.3 8.8 5.7 0.0 1.7 0.9 2.6 0.7 0.1 2.0 0.0 0.0 1.2 1.8 0.0 2.0 0.0 3.6 0.0 1.1 0.0 0.0 0.5 0.8 3.7 1.2 11.5 0.0 19.5 0.0 0.0 0.6 23.4 0.0 6.9 13.6 0.0 11.8 0.0 2.4 1.2 10.4 1.8 1.4 0.3 0.0 3.5 0.0 0.1 1.0 3.0 1.0 1.2 1.0 GCGR GGR ENSG00000215644 "Glucagon receptor" P47871 17 81804132-81814013 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 68.8" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 60.2" "Cancer enhanced" "Detected in many" "liver cancer: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 3.9;MCF7: 6.1;SK-BR-3: 5.3;U-87 MG: 6.1" "Region enriched" "Detected in single" 5 "cerebellum: 0.9" "Not detected" "Not detected" HPA071228 Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA071228: AB_2686368" "unprognostic (3.28e-4)" "unprognostic (9.30e-2)" "unprognostic (2.20e-1)" "unprognostic (1.53e-4)" "unprognostic (1.11e-1)" "unprognostic (2.30e-3)" "unprognostic (4.38e-2)" "unprognostic (1.79e-3)" "unprognostic (2.18e-1)" "unprognostic (2.77e-1)" "unprognostic (3.09e-1)" "unprognostic (2.61e-1)" "unprognostic (6.42e-2)" "unprognostic (5.99e-3)" "unprognostic (1.71e-1)" "unprognostic (1.17e-3)" "unprognostic (8.36e-3)" 0.2 3.9 0.1 0.6 0.3 0.0 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.0 11.4 68.8 0.1 0.1 0.1 0.1 0.1 0.5 3.9 0.1 0.1 0.5 0.2 0.0 1.4 0.3 0.1 0.1 0.9 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.2 0.6 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.9 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.6 0.0 5.3 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.8 0.2 0.6 0.0 0.0 0.0 3.5 2.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.2 0.1 0.0 0.0 1.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 GCNT1 "C2GNT, NACGT2, NAGCT2" ENSG00000187210 "Glucosaminyl (N-acetyl) transferase 1, core 2" Q02742 9 76419850-76507416 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 32.0;parathyroid gland: 57.8" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 26.5;Kupffer cells: 29.1;Undifferentiated cells: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 16.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 26.3;HSkMC: 22.3;U-2197: 18.7" "Group enriched" "Detected in some" 6 "cerebellum: 8.2;olfactory region: 30.1" "Low region specificity" "Detected in all" "HPA003522, HPA003523, HPA031151" Uncertain Supported "Nuclear speckles" NA NA 72000 "Nuclear speckles" "HPA003522: , HPA003523: , HPA031151: AB_10602904" "unprognostic (3.14e-1)" "unprognostic (2.01e-1)" "unprognostic (2.19e-1)" "prognostic favorable (8.44e-4)" "unprognostic (5.53e-2)" "unprognostic (2.41e-1)" "unprognostic (1.65e-2)" "unprognostic (3.37e-2)" "unprognostic (2.40e-1)" "unprognostic (2.63e-1)" "unprognostic (1.90e-1)" "unprognostic (3.06e-1)" "unprognostic (3.02e-3)" "unprognostic (4.21e-1)" "unprognostic (2.00e-1)" "unprognostic (2.80e-1)" "prognostic unfavorable (4.96e-4)" 5.6 1.1 1.6 7.9 3.9 2.2 8.2 10.9 2.7 5.3 24.5 0.7 3.0 23.2 5.2 1.2 2.1 1.8 4.1 3.1 2.1 1.4 1.4 1.0 4.5 9.2 1.6 2.1 0.9 2.0 57.8 1.9 3.9 1.0 4.9 4.6 0.5 9.1 1.8 0.8 1.5 32.0 2.5 1.2 7.6 18.6 1.4 0.6 2.8 16.9 1.2 6.4 2.4 3.3 9.4 4.7 16.8 6.4 4.7 1.9 1.6 2.4 0.2 0.1 0.0 3.1 15.2 3.7 10.2 4.6 8.3 5.9 2.5 0.6 1.7 1.0 7.6 1.6 2.2 5.2 4.2 9.3 1.2 0.8 4.3 0.2 0.4 26.3 3.1 1.5 22.3 1.1 8.0 8.7 6.8 7.6 2.2 0.0 1.8 8.2 3.8 1.7 5.1 4.8 6.4 0.6 2.8 5.1 0.8 9.7 4.5 1.1 0.0 1.2 1.4 0.0 3.8 0.0 2.2 3.1 5.2 3.4 18.7 4.4 2.6 0.5 0.0 10.5 5.4 1.3 4.3 2.7 16.8 1.3 6.4 0.4 1.3 1.5 1.3 4.7 9.4 0.2 1.0 0.9 4.7 5.7 2.3 1.9 1.6 1.6 3.9 10.9 2.7 2.1 1.4 1.6 2.1 1.0 0.6 0.0 1.7 2.2 3.5 0.8 0.0 0.8 0.0 9.4 9.1 3.5 0.0 1.6 0.0 1.3 19.4 4.2 16.9 0.0 22.1 17.9 4.1 9.1 10.4 0.0 7.4 0.0 26.5 6.2 29.1 9.7 0.0 11.2 1.7 1.0 12.5 0.0 8.5 15.6 1.1 1.3 0.1 0.0 1.0 1.8 2.4 0.3 15.9 4.3 26.5 0.9 GCNT2 "bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3" ENSG00000111846 "Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)" Q8N0V5 6 10492223-10629368 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.1" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 71.5;Melanocytes: 47.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 26.4;Hep G2: 11.0;SuSa: 10.2" "Region enriched" "Detected in many" 4 "basal ganglia: 54.8" "Low region specificity" "Detected in all" HPA026776 Approved Approved "Golgi apparatus" No No 560000 "Golgi apparatus" "HPA026776: AB_1849573" "unprognostic (2.47e-1)" "unprognostic (6.87e-3)" "unprognostic (3.12e-1)" "unprognostic (1.42e-2)" "unprognostic (9.31e-2)" "unprognostic (2.51e-1)" "unprognostic (4.11e-2)" "unprognostic (2.39e-1)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (6.28e-4)" "unprognostic (3.96e-2)" "unprognostic (1.58e-3)" "unprognostic (6.54e-2)" "unprognostic (6.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" 2.0 0.9 2.5 7.9 2.8 0.7 12.7 7.6 1.9 6.0 13.0 2.0 0.9 7.8 5.6 1.3 3.7 1.7 2.8 11.8 2.2 2.4 19.6 14.3 10.4 3.3 2.4 0.4 0.9 5.5 1.0 6.2 3.1 4.0 21.9 3.7 8.1 7.4 0.9 2.3 2.5 25.1 2.6 2.2 4.2 8.3 9.0 2.9 0.9 2.4 1.2 7.2 2.0 3.0 2.1 2.5 4.2 3.1 0.5 0.4 0.7 4.2 3.5 1.2 2.9 0.0 0.0 3.5 0.0 3.1 0.8 0.2 6.2 3.2 2.4 26.4 0.0 1.8 0.1 0.3 3.2 1.8 1.6 0.9 0.5 1.9 11.0 0.0 1.1 3.0 0.0 0.0 0.3 0.0 1.7 7.0 0.0 0.3 0.0 0.3 0.0 0.0 2.3 4.0 0.0 2.4 0.1 2.4 3.8 9.4 2.3 2.6 1.8 0.0 9.2 8.9 10.2 0.1 0.4 5.9 0.5 0.4 0.0 3.4 0.0 0.0 1.7 0.6 0.2 1.4 4.2 3.1 1.3 0.3 2.3 0.1 2.1 0.3 0.4 2.5 1.3 0.4 0.4 0.2 0.5 0.8 0.6 0.2 0.7 2.5 2.8 7.6 1.9 2.2 2.4 2.4 0.4 4.0 2.9 71.5 26.7 12.3 5.5 4.0 4.3 14.9 2.5 30.8 28.4 7.0 0.0 22.4 10.0 2.4 3.3 5.8 28.4 23.3 22.4 1.0 1.1 21.1 2.3 31.1 12.9 3.2 2.4 8.6 6.3 6.0 0.3 6.9 47.2 9.0 2.8 2.9 9.0 1.7 0.0 8.8 0.5 0.0 0.4 1.9 20.4 1.5 9.2 0.0 7.2 7.0 GCNT3 "C2/4GnT, C2GnT-M, C2GnT2" ENSG00000140297 "Glucosaminyl (N-acetyl) transferase 3, mucin type" O95395 15 59594875-59640239 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 29.6;intestine: 103.3;salivary gland: 27.4" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 99.5;Ductal cells: 59.9;Enterocytes: 119.9;Pancreatic endocrine cells: 45.2;Paneth cells: 59.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 29.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 54.4;EFO-21: 9.4;Hep G2: 10.9;OE19: 27.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011154 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA011154: AB_1078961" "unprognostic (5.09e-2)" "unprognostic (2.39e-1)" "unprognostic (5.92e-2)" "prognostic favorable (1.78e-4)" "unprognostic (3.99e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (6.49e-5)" "unprognostic (1.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.34e-1)" "unprognostic (1.64e-2)" "unprognostic (1.63e-1)" "unprognostic (4.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-2)" "unprognostic (4.65e-2)" "unprognostic (2.43e-1)" 0.3 0.5 0.3 8.8 0.4 0.0 0.3 0.3 0.3 5.3 37.6 0.3 0.3 25.4 1.3 0.4 8.7 0.7 29.6 0.3 0.3 0.2 9.9 0.4 0.7 0.3 0.3 0.3 1.1 1.7 0.0 0.4 1.0 0.5 1.0 33.4 0.3 27.4 0.3 0.3 0.2 103.3 0.9 0.3 0.3 6.5 1.7 0.3 0.5 0.7 5.2 15.5 0.7 14.0 1.2 1.4 3.4 0.8 1.1 0.7 0.1 0.0 54.4 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 2.3 2.2 0.2 9.4 0.0 3.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 10.9 0.0 0.1 0.1 0.1 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.1 27.6 0.1 0.1 0.0 0.2 3.8 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.1 0.1 0.2 3.4 0.1 0.0 2.6 0.8 0.6 0.7 0.4 0.4 0.6 0.5 0.3 0.2 1.2 0.4 0.6 3.4 1.1 0.4 1.4 0.5 0.1 0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.5 0.3 0.0 2.1 0.0 6.7 0.0 0.0 0.5 12.7 0.0 0.0 99.5 0.0 0.0 0.0 59.9 7.6 0.0 119.9 0.0 13.4 0.0 0.0 4.7 0.0 0.0 0.1 0.0 7.5 0.0 0.3 13.3 0.0 0.0 0.0 1.8 18.6 0.0 45.2 59.6 0.0 3.3 0.0 6.5 0.0 0.9 0.1 0.0 0.0 0.0 30.8 43.7 GCNT4 C2GNT3 ENSG00000176928 "Glucosaminyl (N-acetyl) transferase 4, core 2" Q9P109 5 75025346-75030899 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.6;intestine: 13.1;stomach 1: 10.4" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 35.7;Cytotrophoblasts: 27.4;Syncytiotrophoblasts: 20.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 13.6" "Group enriched" "Detected in many" 54 "granulocytes: 13.6;T-cells: 11.6" "Cell line enriched" "Detected in some" 5 "RT4: 26.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037431 Approved Supported "Nucleoplasm,Golgi apparatus" No NA "Golgi apparatus" Nucleoplasm "HPA037431: AB_10670382" "unprognostic (1.88e-2)" "unprognostic (5.63e-2)" "unprognostic (6.05e-2)" "unprognostic (1.28e-1)" "unprognostic (1.12e-1)" "unprognostic (4.98e-2)" "unprognostic (4.11e-3)" "unprognostic (1.63e-2)" "unprognostic (3.47e-1)" "unprognostic (2.20e-2)" "unprognostic (4.49e-3)" "unprognostic (6.04e-2)" "prognostic favorable (1.93e-7)" "unprognostic (8.39e-2)" "unprognostic (1.93e-1)" "unprognostic (6.06e-2)" "unprognostic (5.82e-2)" 0.6 0.6 0.3 1.0 0.7 0.0 0.9 0.0 2.3 1.1 1.1 13.1 1.4 0.6 1.3 1.1 2.5 0.3 0.3 0.1 1.8 0.4 1.0 1.7 0.1 0.9 3.0 8.4 0.1 3.0 1.0 0.2 0.5 2.4 1.0 1.5 10.8 0.7 0.0 0.6 10.4 1.0 0.5 1.1 6.4 2.0 0.0 0.0 13.6 0.1 0.2 11.6 1.6 0.2 0.1 1.0 1.6 1.8 0.6 0.1 2.0 5.2 1.0 0.9 2.5 0.1 0.0 0.2 1.5 0.6 0.7 1.0 1.8 0.2 0.0 0.0 0.8 0.2 0.2 0.8 0.0 0.0 0.3 2.9 0.1 0.4 0.0 0.0 1.5 0.0 0.3 0.1 0.0 1.4 0.0 0.4 5.7 0.0 0.0 0.0 2.6 0.2 26.6 0.0 0.0 0.2 0.0 0.0 5.4 0.0 0.0 0.0 0.5 0.1 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.1 13.6 0.0 0.0 0.9 0.0 3.5 0.0 8.1 2.6 0.0 0.0 8.1 5.9 0.1 0.2 0.1 0.0 11.6 1.6 3.0 5.3 0.0 5.5 0.6 0.0 0.4 35.7 0.0 4.5 12.2 0.0 27.4 8.3 6.1 0.1 1.0 6.7 0.0 3.7 0.7 1.1 1.5 7.0 0.8 2.1 0.0 0.0 4.9 0.8 0.0 3.7 0.0 0.0 1.0 0.5 0.0 4.9 1.7 2.5 0.6 0.0 6.5 0.9 0.0 0.2 0.1 20.4 0.0 0.6 4.1 GCSAML-AS1 ENSG00000284824 "GCSAML antisense RNA 1" Q8N628 1 247524679-247532613 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.1;hTERT-HME1: 1.0;SK-MEL-30: 1.2" HPA058578 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA058578: AB_2683761" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 GDAP1 "CMT2K, CMT4, CMT4A" ENSG00000104381 "Ganglioside induced differentiation associated protein 1" Q8TB36 8 74321130-74488872 "Disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.3" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 42.1;Cone photoreceptor cells: 45.2;Horizontal cells: 44.5;Rod photoreceptor cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014266, HPA024334" Enhanced Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA014266: AB_1849581, HPA024334: AB_1849583" "unprognostic (3.19e-2)" "unprognostic (1.52e-3)" "unprognostic (2.72e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (3.31e-1)" "unprognostic (4.36e-2)" "unprognostic (1.72e-2)" "prognostic favorable (2.68e-4)" "unprognostic (3.88e-1)" "unprognostic (4.17e-1)" "unprognostic (9.44e-3)" "unprognostic (2.44e-1)" "unprognostic (5.40e-2)" "unprognostic (3.29e-1)" "unprognostic (6.99e-2)" "prognostic unfavorable (4.54e-4)" "unprognostic (2.73e-1)" 2.8 11.2 19.2 3.8 25.9 2.1 5.6 24.9 48.3 3.2 2.9 7.6 1.1 3.2 5.4 5.7 5.3 3.7 3.4 2.8 17.6 21.4 5.3 2.0 3.2 3.7 16.5 19.2 8.2 10.8 12.3 16.4 2.3 23.3 5.6 3.6 3.7 2.9 5.4 2.6 2.1 3.0 3.9 14.6 2.9 3.2 5.4 9.6 0.7 7.5 0.5 3.4 3.8 1.8 2.7 1.7 2.8 7.2 1.9 4.6 1.4 2.3 7.7 12.0 2.7 1.0 0.9 1.2 1.0 5.7 6.1 7.0 4.1 2.7 9.2 1.4 1.3 6.4 4.0 6.4 3.9 11.9 7.9 2.0 4.8 4.3 7.9 1.3 3.9 9.9 2.9 1.3 2.9 6.2 0.7 0.7 3.9 2.3 0.1 3.6 2.9 8.0 0.6 13.9 12.5 10.6 4.1 5.7 1.7 2.0 7.2 11.8 28.9 7.1 2.7 6.0 3.6 11.9 1.3 0.1 8.9 4.1 2.0 2.8 6.1 5.7 4.5 4.0 0.2 9.3 0.0 1.7 2.8 1.5 4.3 1.8 2.7 1.6 1.9 1.7 1.9 1.3 1.6 0.0 1.9 7.2 0.0 4.6 1.4 19.2 25.9 24.9 25.8 17.6 21.4 16.5 19.2 23.3 9.6 6.0 3.2 3.5 6.4 1.5 42.1 4.8 5.1 4.0 3.4 3.5 45.2 0.4 8.3 4.1 4.4 6.4 2.4 0.0 5.2 0.3 2.9 3.7 17.3 1.6 4.1 44.5 19.5 5.5 4.0 0.5 3.7 4.9 1.7 1.0 2.0 18.0 3.6 0.3 5.3 5.0 45.4 0.0 6.6 14.2 11.7 1.1 0.0 1.5 1.4 3.3 GDAP1L1 ENSG00000124194 "Ganglioside induced differentiation associated protein 1 like 1" Q96MZ0 20 44247099-44280917 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.4" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 8.8;Early spermatids: 7.1;Horizontal cells: 14.3;Late spermatids: 21.0" "Cancer enriched" "Detected in single" 14 "glioma: 6.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 9.8;SCLC-21H: 24.2;SH-SY5Y: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054182, HPA063265" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA054182: , HPA063265: AB_2684972" "unprognostic (6.58e-3)" "unprognostic (2.58e-1)" "unprognostic (2.30e-1)" "unprognostic (2.23e-4)" "unprognostic (3.69e-1)" "unprognostic (5.15e-1)" "unprognostic (6.45e-2)" "unprognostic (7.69e-2)" "unprognostic (1.53e-1)" "unprognostic (5.07e-1)" "unprognostic (4.74e-3)" "unprognostic (2.41e-1)" "unprognostic (3.81e-5)" "unprognostic (8.57e-2)" "unprognostic (1.87e-1)" "unprognostic (3.21e-2)" "unprognostic (1.13e-1)" 1.1 3.9 18.9 1.3 14.9 1.2 1.1 17.8 47.4 1.2 1.2 1.4 0.0 1.0 1.5 1.1 1.1 1.2 1.1 1.3 13.1 14.3 1.1 1.0 1.0 1.0 9.1 12.2 3.0 1.8 2.4 7.1 1.0 10.6 1.1 1.1 0.9 1.0 1.1 1.1 1.5 1.3 1.2 2.6 1.0 1.9 2.8 1.6 0.0 1.1 0.0 1.0 1.1 0.0 0.1 0.0 0.7 0.1 0.5 0.8 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.6 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 11.8 0.0 0.1 1.0 0.2 0.0 3.1 0.1 0.9 0.5 0.2 0.0 0.0 0.1 0.6 0.8 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.7 0.5 0.1 0.0 0.0 0.0 18.9 14.9 17.8 25.7 13.1 14.3 9.1 12.2 10.6 1.6 0.0 0.0 0.0 0.0 0.0 8.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.3 0.0 0.0 0.0 21.0 0.6 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.4 0.0 4.1 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 GDE1 MIR16 ENSG00000006007 "Glycerophosphodiester phosphodiesterase 1" Q9NZC3 16 19501689-19522145 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 226.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077420 Approved Vesicles NA NA Vesicles "HPA077420: " "unprognostic (1.69e-1)" "unprognostic (5.13e-2)" "prognostic favorable (3.12e-4)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (7.52e-5)" "unprognostic (2.10e-2)" "unprognostic (1.40e-2)" "unprognostic (4.31e-2)" "unprognostic (2.60e-3)" "unprognostic (9.92e-2)" "prognostic favorable (3.12e-5)" "unprognostic (8.36e-2)" "unprognostic (9.69e-3)" "unprognostic (1.88e-1)" "unprognostic (3.36e-2)" 20.3 18.5 30.6 11.7 34.3 17.5 23.9 13.5 32.2 18.1 31.0 24.5 23.0 22.7 15.0 22.6 19.0 13.4 17.5 40.7 31.1 17.5 21.1 21.3 22.1 13.1 29.2 20.6 9.9 28.3 35.3 13.9 15.5 20.8 21.4 32.5 12.5 20.4 24.9 42.4 18.5 20.8 27.2 25.3 10.1 22.8 14.8 23.8 9.6 17.9 21.7 12.7 22.8 12.4 4.6 7.4 23.9 12.4 3.7 7.4 4.6 14.8 17.9 9.8 11.7 47.6 17.6 14.2 15.4 26.4 12.0 14.9 10.2 26.6 11.1 19.8 22.3 13.2 12.9 13.7 18.1 14.6 12.1 21.2 9.3 17.6 21.9 28.9 12.2 8.7 18.5 29.4 12.8 15.0 22.3 16.1 14.5 5.1 11.6 13.0 26.8 10.7 11.3 11.5 23.3 13.9 15.4 18.1 16.1 29.7 22.8 11.5 10.5 14.9 17.9 14.2 15.9 18.3 14.7 16.9 10.2 9.1 13.4 9.4 10.9 10.2 7.8 15.6 18.2 9.0 23.9 11.8 6.4 5.7 10.5 7.3 4.6 6.8 6.6 7.4 3.7 3.6 5.7 19.8 3.7 12.4 4.6 7.4 4.6 30.6 34.3 13.5 32.2 31.1 17.5 29.2 20.6 20.8 23.8 35.7 72.1 27.9 29.4 20.8 14.8 63.5 35.7 26.8 26.1 8.7 25.5 63.8 19.9 79.5 27.6 16.8 94.2 23.3 143.1 66.0 28.2 77.4 3.5 20.0 53.4 30.2 32.1 17.8 30.7 51.5 26.4 32.5 23.6 22.6 50.6 19.8 66.9 87.7 35.7 39.2 21.5 12.9 25.5 71.0 39.2 25.7 226.1 21.8 61.0 49.4 GDF9 ENSG00000164404 "Growth differentiation factor 9" O60383 5 132861181-132866884 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 6.6;testis: 11.1" "Cell type enhanced" "Detected in some" 15 "Cone photoreceptor cells: 3.9;Early spermatids: 10.3;Late spermatids: 4.0;Spermatocytes: 13.6" "Cancer enriched" "Detected in some" 5 "breast cancer: 2.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "JURKAT: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069146 Supported "Secreted in female reproductive system" NA NA "HPA069146: AB_2686094" "unprognostic (4.64e-1)" "unprognostic (1.22e-1)" "unprognostic (1.25e-2)" "unprognostic (5.11e-2)" "unprognostic (1.58e-2)" "unprognostic (2.39e-2)" "unprognostic (1.55e-1)" "unprognostic (4.61e-2)" "unprognostic (4.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.70e-3)" "unprognostic (1.04e-1)" "unprognostic (1.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (4.75e-3)" "unprognostic (3.10e-2)" 0.1 0.7 1.3 0.1 1.9 0.1 1.1 0.4 1.1 0.4 0.2 0.4 0.3 6.6 0.1 1.1 0.1 0.1 1.0 1.4 1.5 0.7 0.1 0.5 1.1 0.6 1.0 1.4 2.0 0.1 0.7 0.3 1.0 0.6 0.6 1.4 0.3 0.1 0.8 0.4 0.8 11.1 1.4 0.4 0.7 0.1 0.1 0.8 1.2 0.6 0.0 1.1 0.3 0.4 0.4 1.1 2.3 1.7 0.7 0.4 0.0 0.2 0.4 0.3 0.8 1.8 0.6 1.5 0.2 2.1 0.5 0.9 1.0 0.4 0.8 1.7 1.1 0.9 0.3 0.4 0.2 0.1 0.8 1.3 0.1 0.8 0.2 0.0 8.8 0.2 2.8 0.6 0.6 1.5 1.7 0.4 0.2 0.2 1.4 0.1 0.4 0.7 0.5 2.1 2.0 0.4 0.3 1.1 1.7 1.1 0.3 0.2 2.1 0.9 0.4 0.3 3.0 3.6 0.2 0.5 0.4 0.2 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.8 0.1 0.8 0.1 1.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.9 0.4 3.3 0.0 10.3 0.0 0.4 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.6 0.3 4.0 0.6 0.0 0.0 0.0 0.5 1.2 0.1 0.0 0.4 0.2 0.9 0.0 0.0 13.6 1.1 0.1 0.6 0.0 0.5 0.1 GDNF "ATF1, ATF2, HFB1-GDNF" ENSG00000168621 "Glial cell derived neurotrophic factor" P39905 5 37812677-37839686 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes, Disease mutation, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;skeletal muscle: 12.4" "Cell type enhanced" "Detected in single" 9 "Fibroblasts: 1.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 14.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 25.0;SuSa: 7.8;U-87 MG: 7.6;WM-115: 27.5" "Region enhanced" "Detected in single" "basal ganglia: 2.5" "Low region specificity" "Detected in many" "CAB005210, HPA070283" Supported Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Vesicles Nucleoplasm "CAB005210: AB_2247684, HPA070283: AB_2686246" "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (3.54e-2)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (5.33e-2)" "unprognostic (1.92e-1)" "unprognostic (3.71e-2)" "unprognostic (2.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.10e-1)" "unprognostic (1.16e-4)" "unprognostic (2.04e-1)" "unprognostic (8.86e-2)" "unprognostic (1.05e-1)" "unprognostic (4.42e-2)" 1.9 0.3 0.6 1.9 2.3 0.0 0.4 14.1 1.3 0.8 9.4 0.4 0.4 1.6 1.7 3.4 1.0 0.9 0.9 0.9 0.6 0.4 1.0 0.7 0.4 0.4 0.6 1.2 4.5 0.4 0.0 0.4 6.3 1.4 1.6 3.1 1.1 0.4 6.3 12.4 1.4 2.5 2.5 0.5 0.4 1.9 3.9 2.4 0.4 0.4 1.5 0.4 0.6 1.1 0.8 0.4 1.2 0.3 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 3.4 2.1 0.6 0.9 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.2 0.3 0.1 0.1 0.0 1.0 0.1 25.0 0.0 0.8 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.2 0.0 0.1 0.1 1.7 7.8 0.0 0.0 0.0 3.4 0.0 0.8 3.9 2.3 0.0 0.0 7.6 0.0 27.5 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.8 0.2 0.4 1.2 0.9 0.2 0.4 0.1 0.0 0.6 2.3 14.1 1.3 0.6 0.4 0.6 1.2 1.4 2.4 0.0 0.0 0.0 0.0 0.8 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.5 0.0 0.0 0.6 0.0 0.8 0.3 0.1 0.0 0.0 0.5 GDPD1 "FLJ37451, GDE4" ENSG00000153982 "Glycerophosphodiester phosphodiesterase domain containing 1" Q8N9F7 17 59220467-59275967 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 28.4;Spermatocytes: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 22.6;K-562: 12.8;SCLC-21H: 14.3" "Low region specificity" "Detected in all" NA NA "unprognostic (8.33e-2)" "unprognostic (6.63e-3)" "unprognostic (2.68e-2)" "unprognostic (5.98e-3)" "unprognostic (7.12e-2)" "unprognostic (5.35e-2)" "unprognostic (4.85e-6)" "prognostic favorable (2.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.36e-2)" "unprognostic (1.24e-3)" "unprognostic (2.73e-1)" "unprognostic (1.15e-1)" "unprognostic (2.25e-3)" "unprognostic (4.72e-2)" "unprognostic (1.32e-2)" "unprognostic (6.28e-3)" 1.5 3.6 9.4 1.8 13.1 2.3 3.5 16.6 22.3 2.5 3.9 9.2 0.9 10.7 2.8 1.9 1.7 3.2 3.8 2.2 10.6 13.2 4.2 2.0 4.3 1.7 9.3 10.3 2.2 2.3 14.8 3.1 9.2 15.1 4.4 3.1 2.0 4.1 3.0 2.6 2.8 7.8 2.9 7.1 2.8 10.4 13.0 8.9 3.2 5.5 0.3 2.0 3.6 1.7 1.5 2.9 4.5 3.0 3.0 3.5 1.0 0.8 1.4 4.8 3.5 0.6 0.5 3.6 0.5 1.9 0.7 3.6 0.0 1.7 2.2 5.2 0.1 2.9 0.7 8.1 1.0 2.1 4.0 8.4 22.6 0.5 3.2 1.8 1.3 4.4 0.8 4.9 2.0 0.5 2.3 2.6 5.2 12.8 1.3 0.8 0.8 3.9 0.3 1.0 7.0 1.2 2.7 0.4 2.1 2.5 1.4 14.3 4.2 1.4 0.4 5.4 1.7 4.0 1.4 3.0 0.2 1.6 0.1 0.5 4.3 3.1 0.8 1.2 1.5 2.1 4.5 1.9 0.8 2.2 3.0 1.7 0.7 2.2 3.2 0.9 1.5 3.0 3.5 2.0 3.0 2.3 2.9 1.2 1.0 9.4 13.1 16.6 17.7 10.6 13.2 9.3 10.3 15.1 8.9 3.0 5.1 0.0 1.1 0.5 5.8 2.4 0.0 6.7 12.5 5.2 9.8 0.2 0.0 1.6 28.4 1.1 1.3 0.0 1.6 4.9 0.4 1.2 0.0 0.4 1.6 6.4 1.2 0.6 1.0 5.1 0.6 1.8 1.7 2.8 1.2 1.7 1.5 2.0 1.4 0.3 3.8 0.0 1.2 31.7 4.3 0.4 1.9 1.5 0.9 1.4 GDPD2 "FLJ20207, GDE3, OBDPF" ENSG00000130055 "Glycerophosphodiester phosphodiesterase domain containing 2" Q9HCC8 X 70423031-70433390 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 22.5;intestine: 19.5;lymphoid tissue: 37.5;skin 1: 33.2" "Cell type enhanced" "Detected in some" 16 "Basal keratinocytes: 50.5;Enterocytes: 47.9;Muller glia cells: 24.7" "Cancer enhanced" "Detected in many" "glioma: 10.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "AF22: 9.4;NTERA-2: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.53e-3)" "unprognostic (5.79e-2)" "unprognostic (5.37e-2)" "unprognostic (5.00e-7)" "unprognostic (3.15e-3)" "unprognostic (3.65e-2)" "unprognostic (2.86e-2)" "unprognostic (4.66e-2)" "unprognostic (1.19e-1)" "unprognostic (8.40e-2)" "unprognostic (8.45e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.41e-2)" "unprognostic (5.52e-2)" "unprognostic (2.22e-1)" "unprognostic (8.91e-2)" 0.4 0.4 6.8 0.6 5.7 0.4 1.0 1.1 4.0 0.3 13.0 8.2 8.3 8.0 0.4 22.5 0.4 0.5 0.5 0.8 7.6 4.0 0.6 0.3 0.4 0.4 4.3 5.6 0.4 0.4 0.3 2.6 0.4 8.4 0.3 3.0 0.2 1.1 0.6 0.6 33.2 19.5 0.4 1.5 37.5 1.6 0.3 4.9 0.0 0.4 0.6 0.3 1.0 0.3 0.4 0.1 1.4 0.2 0.1 0.2 0.0 0.0 0.0 9.4 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 20.2 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.4 0.1 0.1 1.4 0.1 0.1 0.1 0.0 0.0 6.8 5.7 1.1 4.0 7.6 4.0 4.3 5.6 8.4 4.9 0.0 0.0 0.0 0.0 50.5 0.1 1.4 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 47.9 0.0 0.0 3.1 0.5 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 24.7 0.1 2.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 2.7 0.0 1.5 0.1 GDPD3 MGC4171 ENSG00000102886 "Glycerophosphodiester phosphodiesterase domain containing 3" Q7L5L3 16 30104810-30113856 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 50.9;Extravillous trophoblasts: 52.5;Late spermatids: 201.8;Proximal tubular cells: 62.4" "Cancer enhanced" "Detected in all" "urothelial cancer: 21.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "eosinophil: 1.6;neutrophil: 5.1" "Lineage enriched" "Detected in single" 19 "granulocytes: 5.1" "Group enriched" "Detected in many" 5 "MCF7: 13.7;OE19: 16.9;SK-BR-3: 48.5" "Region enhanced" "Detected in single" "cerebellum: 0.9" "Low region specificity" "Detected in many" "HPA041148, HPA041470" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041148: AB_10794545, HPA041470: AB_10795121" "unprognostic (4.12e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (9.99e-2)" "unprognostic (2.53e-1)" "unprognostic (4.57e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.53e-1)" "unprognostic (8.86e-3)" "unprognostic (6.59e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.89e-9)" "unprognostic (3.11e-1)" "unprognostic (3.13e-1)" "unprognostic (1.12e-1)" "unprognostic (8.79e-3)" 3.0 0.9 1.2 10.5 1.2 0.5 2.5 5.7 1.3 9.4 11.3 1.2 1.2 4.0 2.8 3.4 30.8 2.1 3.6 1.7 1.2 0.7 5.9 1.2 3.7 2.3 1.2 1.2 3.3 1.2 0.4 2.3 12.9 2.5 2.4 7.4 1.2 4.9 1.2 1.3 5.3 8.6 2.4 1.2 4.1 8.3 1.2 1.2 1.9 2.3 36.6 40.8 2.7 9.2 0.1 0.0 5.1 0.2 0.0 0.2 0.0 5.3 0.0 1.9 0.5 0.5 2.8 1.6 0.5 0.4 0.5 0.6 0.6 3.7 0.6 0.7 0.3 0.1 0.5 0.5 0.2 0.5 1.0 1.5 0.1 0.8 2.5 0.5 0.2 0.4 0.1 0.7 1.5 0.1 1.5 2.1 2.0 0.4 0.9 0.7 13.7 0.4 0.9 1.1 16.9 0.2 2.5 0.6 2.9 1.1 2.4 0.5 0.9 0.0 48.5 0.3 0.5 0.9 1.0 1.5 0.5 0.5 1.1 0.5 1.6 0.3 0.6 1.4 0.8 0.3 0.1 0.0 1.6 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 5.1 0.0 0.1 0.0 0.1 0.0 1.2 1.2 5.7 1.3 1.2 0.7 1.2 1.2 2.5 1.2 6.0 0.6 0.0 0.6 1.1 1.1 0.9 0.0 1.4 1.2 5.2 0.0 20.4 5.0 1.0 50.9 4.0 43.6 0.0 1.2 52.5 2.1 1.4 0.0 0.0 2.8 1.6 3.4 3.7 3.0 201.8 3.1 0.7 1.7 1.0 28.5 0.2 11.2 12.9 2.8 62.4 1.7 6.5 1.4 1.2 1.2 1.8 7.8 1.5 4.7 3.9 GDPD4 GDE6 ENSG00000178795 "Glycerophosphodiester phosphodiesterase domain containing 4" Q6W3E5 11 77216558-77301687 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 7.6" "Group enriched" "Detected in some" 14 "Early spermatids: 8.8;Late spermatids: 13.7;Spermatocytes: 12.7;Spermatogonia: 4.5" "Cancer enriched" "Detected in single" 10 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.6;HEL: 3.5;U-937: 1.1" "Region enriched" "Detected in single" 24 "olfactory region: 2.8" NA NA "unprognostic (6.73e-6)" "unprognostic (3.30e-1)" "unprognostic (2.01e-2)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (3.55e-4)" "unprognostic (4.13e-2)" "unprognostic (5.41e-2)" "unprognostic (1.53e-1)" "unprognostic (2.63e-2)" "unprognostic (3.10e-2)" "unprognostic (4.75e-2)" "unprognostic (1.05e-4)" "unprognostic (1.68e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-2)" "unprognostic (1.64e-2)" 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 13.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.7 4.5 0.0 0.2 0.0 0.0 0.0 GDPD5 "GDE2, PP1665" ENSG00000158555 "Glycerophosphodiester phosphodiesterase domain containing 5" Q8WTR4 11 75434640-75525903 "Predicted membrane proteins" Neurogenesis Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.2;placenta: 41.7" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 64.5;Cone photoreceptor cells: 139.4;Late spermatids: 125.5;Rod photoreceptor cells: 81.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Group enriched" "Detected in many" 5 "granulocytes: 9.3;T-cells: 3.1" "Cell line enhanced" "Detected in many" "EFO-21: 17.4;fHDF/TERT166: 16.6;HDLM-2: 34.0;U-2 OS: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065257, HPA066762, HPA069281" Uncertain Approved "Golgi apparatus" No No "Golgi apparatus" "HPA065257: AB_2685447, HPA066762: AB_2685715, HPA069281: AB_2686107" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.48e-1)" "unprognostic (6.12e-2)" "unprognostic (9.97e-3)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-1)" "unprognostic (3.07e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.59e-9)" "unprognostic (8.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.65e-1)" 16.5 6.0 3.3 3.3 4.6 7.8 8.0 23.2 7.9 3.3 3.0 3.3 1.6 2.0 6.4 3.1 1.6 3.2 3.6 2.8 3.0 1.8 2.3 2.7 5.4 4.3 3.0 2.6 2.9 13.4 0.4 7.0 41.7 4.2 3.1 1.3 18.8 15.5 4.1 5.9 2.3 3.2 4.9 3.4 37.2 1.4 11.9 5.5 2.0 2.6 1.4 3.4 3.5 11.5 1.1 1.1 9.3 1.2 0.0 3.1 0.7 1.0 3.8 1.7 1.9 1.1 0.6 5.8 1.2 1.6 0.6 0.4 5.1 2.3 7.3 17.4 16.6 4.3 2.4 2.1 1.9 0.3 34.0 1.6 1.3 5.9 10.6 1.7 0.8 5.7 1.3 1.0 0.4 0.8 1.7 13.9 6.6 2.3 3.3 0.7 2.2 1.9 3.6 3.0 1.8 5.5 2.2 0.5 1.9 0.4 1.8 0.9 0.6 2.5 9.6 4.6 2.3 1.4 3.2 4.1 3.9 16.2 3.1 1.3 0.8 0.1 1.3 0.9 4.3 0.4 9.3 1.2 0.7 2.0 0.6 2.9 1.1 2.3 1.6 0.3 0.4 1.2 1.5 0.1 0.0 0.0 1.1 3.1 0.7 3.3 4.6 23.2 7.9 3.0 1.8 3.0 2.6 4.2 5.5 6.0 0.0 0.0 0.2 0.9 64.5 2.8 0.0 1.4 1.2 0.0 139.4 2.3 0.0 3.7 37.5 1.8 0.3 0.0 8.0 0.9 3.3 0.9 4.6 1.9 1.8 4.8 0.0 21.5 4.1 125.5 5.5 3.4 5.0 1.8 0.5 5.6 5.4 0.0 2.5 0.0 81.6 0.0 1.3 4.7 7.7 1.0 38.4 2.2 0.2 0.4 GFRAL "bA360D14.1, C6orf144, GRAL, UNQ9356" ENSG00000187871 "GDNF family receptor alpha like" Q6UXV0 6 55327469-55402493 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.9;blood: 2.2;liver: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.6;Karpas-707: 1.5" "Region enriched" "Detected in single" 10 "pons and medulla: 0.3" "Low region specificity" "Detected in many" HPA047372 Uncertain NA NA "HPA047372: AB_2680017" "unprognostic (2.31e-1)" 1.9 0.0 0.1 0.3 0.1 0.4 0.6 0.2 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.9 0.0 0.1 0.0 0.0 1.2 0.7 2.2 0.6 0.6 0.3 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.3 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.5 0.3 0.1 0.8 0.6 0.2 0.2 0.1 0.1 0.8 0.2 0.1 0.0 1.2 0.3 0.3 2.2 0.6 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GFY Goofy ENSG00000261949 "Golgi associated olfactory signaling regulator" I3L273 19 49423749-49428818 "Predicted membrane proteins" "Olfaction, Sensory transduction" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "brain: 2.1;testis: 4.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 3.9;SCLC-21H: 9.2;T-47d: 2.5;U-266/84: 5.6" "Region enriched" "Detected in single" 14 "olfactory region: 1.8" "Region enriched" "Detected in many" 7 "cerebellum: 14.5" NA NA "unprognostic (8.04e-2)" "unprognostic (8.21e-2)" "unprognostic (1.16e-1)" "unprognostic (2.43e-1)" "unprognostic (4.50e-2)" "unprognostic (8.99e-2)" "unprognostic (8.85e-2)" "unprognostic (1.42e-1)" "unprognostic (1.82e-1)" "unprognostic (9.62e-3)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.7 0.0 0.1 0.1 0.0 0.0 3.9 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.9 0.0 0.1 2.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 5.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 GGCX VKCFD1 ENSG00000115486 "Gamma-glutamyl carboxylase" P38435 2 85544723-85561547 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 74.8" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 132.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018284 Enhanced NA NA "HPA018284: AB_1849641" "unprognostic (4.88e-3)" "unprognostic (1.13e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.82e-6)" "unprognostic (5.67e-2)" "unprognostic (1.85e-3)" "unprognostic (2.96e-2)" "unprognostic (3.77e-2)" "unprognostic (5.64e-2)" "unprognostic (2.18e-2)" "unprognostic (6.45e-3)" "unprognostic (5.23e-2)" "unprognostic (8.17e-3)" "unprognostic (7.85e-2)" "unprognostic (2.59e-1)" "unprognostic (7.63e-3)" "unprognostic (9.38e-2)" 7.1 7.8 4.8 4.2 6.3 1.6 10.8 6.3 6.6 6.4 4.9 5.4 8.3 4.0 6.3 8.1 6.5 5.9 7.0 6.8 5.4 3.6 9.0 74.8 8.1 5.4 5.4 5.0 7.0 11.4 15.1 5.6 13.8 5.9 6.3 5.5 5.8 7.4 7.9 6.8 4.9 5.5 7.2 5.1 4.5 6.0 3.6 5.7 3.4 8.5 5.3 5.4 7.3 6.0 0.9 4.9 6.0 7.2 2.2 3.2 3.2 6.8 11.2 8.0 8.9 40.4 11.5 17.8 12.3 14.6 9.1 13.0 19.3 8.5 2.5 12.6 20.2 11.4 11.3 5.7 15.5 10.1 4.4 7.8 4.5 7.5 18.2 15.0 2.8 4.2 14.3 9.2 18.5 12.6 15.1 12.9 4.4 5.3 3.6 26.4 9.0 1.4 2.1 3.7 19.4 9.7 2.6 18.8 6.2 12.7 13.3 3.0 5.1 11.0 21.9 11.4 14.2 10.7 2.7 11.8 11.7 10.3 11.4 8.4 2.9 7.9 2.1 11.3 2.9 16.4 6.0 7.2 3.6 3.2 7.2 3.0 0.7 1.3 1.2 4.9 0.9 3.2 3.0 3.2 2.2 4.4 4.0 1.9 3.2 4.8 6.3 6.3 6.6 5.4 3.6 5.4 5.0 5.9 5.7 26.8 38.9 20.9 16.3 16.7 19.1 20.2 35.7 14.7 17.0 27.9 15.7 51.8 6.6 24.1 3.2 18.0 14.4 23.3 34.3 40.8 26.7 15.3 15.1 132.3 27.6 7.9 13.8 24.5 21.6 1.3 18.7 22.6 20.3 28.9 15.2 19.0 23.2 12.4 19.1 21.4 28.4 6.5 16.5 16.9 8.1 13.2 45.0 14.9 15.8 18.8 GGT1 "CD224, D22S672, D22S732, GGT" ENSG00000100031 "Gamma-glutamyltransferase 1" P19440 22 24583750-24629005 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Protease, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.1;seminal vesicle: 41.7" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 74.5;Alveolar cells type 2: 21.4;Cholangiocytes: 40.8;Ductal cells: 54.8;Enterocytes: 80.7;Hepatocytes: 34.1;Pancreatic endocrine cells: 33.5;Paneth cells: 23.0;Proximal tubular cells: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 35.6;Karpas-707: 52.5;OE19: 37.9;RPMI-8226: 51.6;RPTEC TERT1: 48.0" "HPA045635, HPA047534, HPA065444" Supported Uncertain Vesicles "Intracellular and membrane" NA NA 4600000 Vesicles "HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491" "unprognostic (8.13e-3)" "unprognostic (4.76e-1)" "unprognostic (8.29e-2)" "unprognostic (1.28e-2)" "unprognostic (3.70e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-3)" "unprognostic (1.68e-1)" "unprognostic (2.21e-1)" "prognostic favorable (7.44e-4)" "unprognostic (4.55e-2)" "unprognostic (2.55e-2)" "prognostic favorable (4.83e-4)" "unprognostic (1.44e-2)" "unprognostic (5.37e-2)" "unprognostic (1.74e-1)" "unprognostic (6.10e-2)" 1.6 0.5 1.7 1.7 2.2 2.7 8.2 2.3 2.6 7.3 7.9 1.6 23.7 22.3 1.4 19.9 1.2 0.8 12.2 2.0 1.8 1.2 54.1 29.2 14.3 3.2 1.7 1.6 1.3 17.3 0.0 1.6 1.4 2.2 14.7 2.4 1.4 8.7 41.7 0.9 1.1 20.9 1.7 1.9 4.7 6.6 5.0 2.1 2.4 4.8 1.6 5.5 2.1 1.1 3.3 7.5 15.9 14.6 6.6 8.6 6.6 0.2 19.3 0.2 0.0 0.0 0.1 0.5 0.1 0.6 0.2 0.2 2.6 4.2 0.2 4.3 0.0 3.8 2.8 1.4 0.2 0.1 35.6 2.9 0.1 8.6 14.0 1.5 0.3 11.9 0.4 0.2 0.6 0.4 0.3 0.1 5.3 2.0 52.5 0.2 0.4 0.3 14.6 1.4 37.9 0.2 0.2 2.2 51.6 48.0 0.6 0.2 0.3 0.1 9.3 0.2 5.5 9.3 11.1 2.2 3.5 2.3 10.8 0.3 15.8 5.9 0.2 7.4 15.0 0.1 5.2 14.6 0.4 1.4 6.8 5.2 3.3 7.7 3.4 7.5 0.3 1.0 1.9 15.9 6.6 5.5 0.1 8.6 6.6 1.7 2.2 2.3 2.6 1.8 1.2 1.7 1.6 2.2 2.1 74.5 21.4 3.4 0.1 0.7 0.4 0.4 40.8 2.7 7.9 1.8 0.0 0.9 1.7 54.8 1.1 0.1 80.7 0.0 7.2 0.3 1.3 3.0 5.7 34.1 4.7 0.0 1.2 2.5 3.0 4.1 0.0 2.9 1.7 5.4 2.5 2.0 33.5 23.0 0.4 32.7 0.0 0.0 0.2 0.6 0.7 0.4 0.7 3.2 4.2 0.0 GGT2 GGT ENSG00000133475 "Gamma-glutamyltransferase 2" P36268 22 21207973-21227637 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 7.4;Early spermatids: 3.8;Late spermatids: 14.7" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.4;HeLa: 4.6;Karpas-707: 2.0;U-2197: 13.9" "HPA045635, HPA047534, HPA065444" Supported Uncertain Vesicles NA NA Vesicles "HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491" "unprognostic (4.27e-1)" "unprognostic (6.91e-2)" "unprognostic (7.03e-2)" "unprognostic (8.13e-2)" "unprognostic (1.01e-2)" "unprognostic (2.38e-5)" "unprognostic (1.05e-3)" "unprognostic (5.85e-4)" "unprognostic (7.97e-3)" "unprognostic (8.84e-2)" "unprognostic (1.16e-1)" "unprognostic (6.39e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-2)" "unprognostic (3.46e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 0.2 0.0 1.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.1 2.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 5.5 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.3 1.0 8.4 0.0 0.0 0.0 0.1 0.2 0.4 0.4 0.4 0.5 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.1 0.0 0.0 1.0 0.0 1.5 0.0 0.0 0.1 0.5 0.6 13.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.1 0.5 0.0 0.2 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.5 0.3 3.0 7.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 GGT5 "GGT-REL, GGTLA1" ENSG00000099998 "Gamma-glutamyltransferase 5" P36269 22 24219654-24245142 "Enzymes, Predicted intracellular proteins" "Glutathione biosynthesis, Leukotriene biosynthesis" "Acyltransferase, Hydrolase, Protease, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Ito cells: 44.2;Sertoli cells: 181.1;Smooth muscle cells: 82.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 4.0;eosinophil: 7.5;neutrophil: 1.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 7.5" "Group enriched" "Detected in some" 4 "ASC diff: 39.5;ASC TERT1: 30.1;HHSteC: 56.4;HSkMC: 65.0;TIME: 25.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008121, CAB032489" Uncertain Approved "Nucleoli fibrillar center" "Intracellular and membrane" NA NA 18000000 "Nucleoli fibrillar center" "CAB032489: AB_2111010, HPA008121: AB_1078965" "unprognostic (8.14e-2)" "unprognostic (2.53e-1)" "unprognostic (5.66e-2)" "unprognostic (9.94e-2)" "unprognostic (8.13e-2)" "unprognostic (8.21e-2)" "unprognostic (2.33e-2)" "unprognostic (2.90e-1)" "unprognostic (1.81e-2)" "unprognostic (1.07e-1)" "unprognostic (8.37e-2)" "unprognostic (7.94e-2)" "prognostic unfavorable (6.36e-5)" "prognostic unfavorable (4.06e-4)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.79e-1)" "unprognostic (8.33e-2)" 20.2 14.8 2.0 5.2 3.5 0.0 13.2 0.5 4.2 10.7 4.0 5.7 7.9 3.6 2.1 10.2 12.1 14.0 2.4 3.4 13.1 13.7 5.1 12.4 4.7 3.9 5.0 2.2 6.0 3.2 6.5 3.4 5.4 6.8 2.5 5.3 7.2 10.1 2.7 4.8 5.6 1.2 17.2 5.2 6.3 9.3 0.1 0.4 7.5 0.9 0.8 0.1 0.4 0.0 0.3 0.0 0.0 39.5 30.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.1 5.2 56.4 0.6 1.4 65.0 0.0 0.7 0.7 0.0 10.6 0.1 0.1 0.1 10.1 0.1 0.0 4.9 0.6 0.1 0.0 0.0 0.9 0.1 1.1 0.0 0.0 1.4 0.0 1.7 0.0 5.6 0.2 0.3 25.2 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.9 1.1 0.0 4.0 0.9 7.5 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.9 0.8 0.0 0.1 0.0 0.4 3.0 16.5 0.5 3.1 6.3 0.0 4.8 0.0 2.7 11.4 0.0 0.0 0.2 0.0 0.1 0.5 37.5 0.0 0.0 0.2 0.1 8.7 1.3 1.1 0.0 1.6 0.0 0.0 44.2 1.2 2.6 33.6 2.9 3.3 5.4 0.0 0.2 0.3 0.0 22.3 0.0 0.4 181.1 82.1 0.3 0.4 3.9 0.2 0.0 0.0 0.9 GGT7 "D20S101, dJ18C9.2, GGTL3, GGTL5" ENSG00000131067 "Gamma-glutamyltransferase 7" Q9UJ14 20 34844720-34872860 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 38.6;Horizontal cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013204, HPA013339" Approved Approved Nucleoplasm,Vesicles NA NA 1500000 Vesicles Nucleoplasm "HPA013204: AB_1850347, HPA013339: AB_2668816" "unprognostic (1.32e-3)" "unprognostic (2.33e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (1.26e-5)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.46e-3)" "unprognostic (2.49e-2)" "unprognostic (3.49e-1)" "unprognostic (1.16e-2)" "unprognostic (3.34e-3)" "unprognostic (3.61e-2)" "unprognostic (5.00e-3)" "unprognostic (1.81e-1)" "unprognostic (1.63e-1)" "unprognostic (5.50e-2)" "unprognostic (2.00e-1)" 6.8 6.7 21.6 6.7 23.7 2.9 8.5 42.6 29.1 9.5 11.5 9.7 14.3 9.8 12.3 19.5 6.4 10.5 11.4 13.8 19.7 17.0 9.9 7.2 9.0 10.3 11.2 32.1 13.4 19.5 20.8 18.3 8.5 19.2 11.4 9.6 6.9 18.8 15.3 31.6 11.1 9.0 9.6 11.0 8.3 12.9 5.0 15.6 4.9 16.3 4.3 8.2 9.3 8.5 6.1 2.6 1.5 3.0 3.2 12.8 1.8 2.2 3.3 17.0 17.4 13.4 12.0 15.1 9.4 9.6 7.8 11.6 17.4 11.1 0.0 11.2 7.3 7.9 1.5 7.3 4.1 5.1 0.7 13.1 6.7 5.9 9.1 12.0 0.3 11.1 17.4 4.7 8.7 4.0 23.3 0.6 8.9 5.0 1.2 5.3 3.8 1.7 3.4 3.9 3.8 1.7 0.0 11.6 10.7 11.3 3.3 9.9 11.6 4.8 7.7 12.1 6.7 5.9 6.1 0.2 26.8 10.7 2.5 5.3 13.1 1.7 0.8 31.5 0.6 9.8 1.5 3.0 1.4 7.4 2.0 2.1 5.6 6.3 2.8 2.6 6.1 12.8 8.9 0.3 3.2 0.7 1.4 4.8 1.8 21.6 23.7 42.6 29.1 19.7 17.0 11.2 32.1 19.2 15.6 3.0 2.4 0.9 17.1 6.5 38.6 1.6 22.9 1.4 3.4 17.4 11.8 18.6 0.0 13.9 2.1 2.1 10.5 0.0 4.9 9.8 11.9 9.2 2.3 10.2 4.0 38.1 10.4 0.6 1.9 0.5 11.5 2.4 10.1 3.6 16.0 9.4 6.7 14.0 7.4 5.1 16.9 6.5 8.6 11.1 10.6 3.8 14.1 4.1 17.8 12.0 GHITM "DERP2, HSPC282, My021, PTD010, TMBIM5" ENSG00000165678 "Growth hormone inducible transmembrane protein" Q9H3K2 10 84139440-84153245 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 1967.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016464, HPA061664" Approved Supported Mitochondria NA NA Mitochondria "HPA016464: AB_1849656, HPA061664: AB_2684579" "unprognostic (6.26e-3)" "unprognostic (1.85e-1)" "unprognostic (2.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.61e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (5.71e-2)" "unprognostic (4.56e-2)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (8.14e-2)" "unprognostic (5.71e-2)" "prognostic favorable (2.32e-10)" "unprognostic (2.46e-2)" "unprognostic (2.09e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" 28.7 50.7 46.0 21.9 53.3 25.3 26.0 30.9 62.7 21.4 45.5 20.2 23.9 43.3 21.2 24.5 30.0 19.9 21.8 94.9 40.8 42.8 80.5 71.6 19.2 23.2 45.2 42.4 20.7 25.1 29.9 24.0 20.9 62.8 22.6 46.0 24.3 26.0 24.5 87.6 19.9 35.6 28.9 24.6 20.1 30.1 41.7 17.5 21.5 29.3 47.6 26.6 26.1 19.1 46.8 63.7 60.6 67.5 44.4 51.6 106.0 42.0 43.7 18.7 42.8 32.2 28.7 33.3 29.0 51.3 37.7 35.4 53.1 35.0 33.3 32.7 38.3 33.2 38.0 39.7 38.0 36.5 33.2 30.1 23.6 45.7 52.3 61.0 73.5 38.8 32.3 74.7 38.9 113.5 39.3 32.5 28.6 54.7 62.3 34.6 36.7 26.0 58.8 18.9 34.4 39.0 23.7 17.2 50.0 52.3 33.9 15.3 17.9 29.3 25.7 58.6 22.6 52.5 47.3 27.5 18.4 24.7 26.7 46.7 44.1 48.0 37.4 48.3 68.2 12.7 52.6 64.3 60.6 42.2 67.5 47.1 46.8 44.2 44.9 63.7 37.2 41.5 44.4 51.3 44.4 59.6 33.0 51.6 106.0 46.0 53.3 30.9 62.7 40.8 42.8 45.2 42.4 62.8 17.5 89.3 83.5 136.2 153.4 151.3 140.5 659.4 145.2 87.0 79.6 150.1 66.8 215.6 490.7 245.2 963.4 127.2 319.8 303.7 203.3 204.3 113.7 156.4 99.3 296.0 241.3 95.3 120.5 81.0 150.4 1967.2 102.1 154.3 155.3 237.2 171.1 217.8 200.8 261.9 128.7 653.0 105.3 142.3 188.3 222.7 145.0 148.9 322.8 152.2 238.2 177.5 GHR GHBP ENSG00000112964 "Growth hormone receptor" P10912 5 42423777-42721878 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4" "Cell type enhanced" "Detected in many" 19 "Hepatocytes: 103.6;Syncytiotrophoblasts: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HSkMC: 13.6;T-47d: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045339, HPA057705" Enhanced Supported "Plasma membrane,Cytosol,Cytoplasmic bodies" "Secreted to blood" NA NA 2200000 21000000 "Plasma membrane, Cytosol, Cytoplasmic bodies" "HPA045339: AB_2679294, HPA057705: AB_2683507" "unprognostic (2.18e-2)" "unprognostic (5.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.96e-2)" "unprognostic (3.12e-1)" "unprognostic (1.57e-1)" "prognostic favorable (2.73e-6)" "unprognostic (1.06e-1)" "unprognostic (3.92e-2)" "unprognostic (3.73e-2)" "unprognostic (6.15e-3)" "unprognostic (2.67e-2)" "unprognostic (1.67e-3)" "unprognostic (4.29e-4)" "unprognostic (7.82e-2)" "unprognostic (7.33e-4)" "unprognostic (8.35e-6)" 44.4 2.8 0.7 5.4 1.3 0.3 31.5 0.4 1.4 4.0 6.9 0.5 1.7 0.6 5.7 3.9 2.4 2.5 3.9 6.0 1.3 1.6 5.3 82.4 2.3 2.2 1.2 1.4 5.0 1.3 3.6 2.0 4.0 2.0 8.7 2.5 2.4 2.3 7.4 23.4 3.0 2.4 5.2 1.0 2.6 3.5 1.6 0.2 0.1 2.9 4.3 0.5 3.8 8.4 0.6 0.3 1.8 0.5 0.4 0.3 0.1 0.0 0.0 0.3 3.1 2.1 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 2.6 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 13.6 4.4 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 2.1 0.4 34.7 0.0 1.8 3.0 1.3 1.6 0.3 0.3 0.0 0.0 0.3 0.0 1.6 1.8 0.3 0.4 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.6 0.2 0.3 1.7 0.4 0.5 0.3 0.2 0.1 0.7 1.3 0.4 1.4 1.3 1.6 1.2 1.4 2.0 0.2 0.0 0.3 0.0 2.8 4.1 0.6 13.6 2.5 0.0 0.0 1.8 0.0 8.6 1.7 0.0 3.3 2.9 0.0 0.0 0.2 0.9 9.3 3.5 0.0 103.6 1.6 0.0 2.9 4.9 1.9 1.8 17.3 0.3 1.7 0.0 2.0 0.8 0.2 0.0 11.3 8.8 0.2 12.9 4.4 0.0 0.3 3.1 33.6 0.0 1.5 0.9 GHRHR ENSG00000106128 "Growth hormone releasing hormone receptor" Q02643 7 30938669-30993254 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "pituitary gland: 108.9" "Cell type enhanced" "Detected in single" 31 "Spermatogonia: 2.4" "Cancer enhanced" "Detected in single" "liver cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (8.32e-2)" "unprognostic (1.45e-1)" "unprognostic (9.30e-2)" "unprognostic (1.39e-1)" "unprognostic (7.23e-2)" "unprognostic (4.15e-1)" "unprognostic (2.28e-2)" "unprognostic (1.54e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (1.43e-2)" "unprognostic (1.47e-1)" "unprognostic (5.87e-3)" 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 108.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.0 GHRL "ghrelin, MTLRP, obestatin" ENSG00000157017 "Ghrelin and obestatin prepropeptide" Q9UBU3 3 10285675-10292947 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.8;stomach 1: 64.9" "Cell type enhanced" "Detected in many" 5 "B-cells: 8.2;Bipolar cells: 7.7;Cone photoreceptor cells: 9.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 6.2;classical monocyte: 6.0;eosinophil: 6.0;myeloid DC: 21.8;neutrophil: 13.5;plasmacytoid DC: 15.0" "Group enriched" "Detected in many" 7 "dendritic cells: 21.8;granulocytes: 13.5;monocytes: 6.0" "Cell line enhanced" "Detected in many" "Karpas-707: 16.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA014246, CAB022731" Enhanced "Secreted to blood" NA NA 2580000 69000 "CAB022731: , HPA014246: AB_1849659" "unprognostic (1.74e-2)" "unprognostic (3.01e-4)" "unprognostic (3.75e-1)" "unprognostic (1.05e-2)" "unprognostic (2.94e-2)" "unprognostic (1.60e-3)" "unprognostic (2.12e-1)" "unprognostic (1.06e-3)" "unprognostic (3.85e-1)" "unprognostic (5.45e-3)" "unprognostic (1.54e-3)" "unprognostic (2.71e-2)" "unprognostic (1.64e-3)" "unprognostic (4.52e-2)" "unprognostic (8.56e-2)" "unprognostic (2.14e-1)" "unprognostic (1.79e-4)" 1.2 0.6 1.8 4.2 1.7 1.5 0.6 0.7 1.5 0.6 1.2 1.8 2.2 7.4 0.9 2.3 1.1 1.0 1.7 1.3 1.6 0.7 0.8 0.8 1.8 14.5 0.9 0.4 1.0 1.7 0.2 0.8 0.2 1.1 1.2 0.2 0.7 3.2 0.1 0.7 0.8 1.4 0.3 0.9 4.9 64.9 0.7 1.3 1.7 1.2 0.0 4.3 0.7 0.5 0.8 21.8 13.5 6.0 2.1 0.1 2.0 0.7 0.3 3.0 2.3 2.2 0.0 5.5 2.8 0.0 0.8 0.2 3.2 0.6 1.6 1.0 0.1 2.4 0.4 0.0 0.7 0.0 0.5 3.3 3.4 1.8 6.8 0.0 3.5 6.1 0.4 0.0 0.1 0.1 0.2 0.6 2.1 1.4 16.6 0.0 0.7 1.3 4.8 1.5 0.5 6.0 0.9 0.3 0.9 0.0 3.6 2.1 0.3 1.8 1.2 0.1 2.1 1.7 4.2 2.9 1.4 0.9 1.3 1.8 2.0 2.8 3.5 0.5 3.9 0.6 6.2 6.0 6.0 0.1 2.8 0.0 0.8 0.1 0.0 21.8 0.5 0.1 0.0 13.5 2.1 0.2 15.0 0.1 2.0 1.8 1.7 0.7 1.5 1.6 0.7 0.9 0.4 1.1 1.3 0.0 1.4 8.2 3.3 1.1 7.7 0.0 0.0 0.0 0.0 1.8 9.8 1.3 0.0 1.0 0.2 1.1 0.0 0.0 1.2 1.0 1.0 2.1 0.0 0.0 1.5 3.2 0.0 0.6 2.8 0.4 0.3 7.1 1.7 4.6 0.0 2.9 0.6 0.0 0.4 0.0 5.4 6.5 1.2 1.2 0.8 0.5 0.2 5.2 0.6 1.7 GHSR ENSG00000121853 "Growth hormone secretagogue receptor" Q92847 3 172445133-172448456 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.4;blood: 2.4;pituitary gland: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 25 "NK-cell: 2.4" "Lineage enriched" "Detected in single" 25 "NK-cells: 2.4" "Cell line enriched" "Detected in single" 4 "HMC-1: 1.8" "Region enhanced" "Detected in some" "hypothalamus: 3.8" "Low region specificity" "Detected in all" NA NA "unprognostic (1.27e-1)" "unprognostic (3.31e-2)" 0.0 2.4 0.0 0.8 0.5 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 7.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GIMAP1 "HIMAP1, IAN2, IMAP1, IMAP38" ENSG00000213203 "GTPase, IMAP family member 1" Q8WWP7 7 150716557-150724284 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 75.5;Hofbauer cells: 34.2;Ito cells: 91.4;Kupffer cells: 83.8;T-cells: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 16.9;MOLT-4: 9.7;TIME: 4.3" "Low region specificity" "Detected in all" "HPA044887, HPA053441" Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044887: AB_10960351, HPA053441: AB_2682152" "unprognostic (1.60e-2)" "unprognostic (6.58e-3)" "unprognostic (8.21e-3)" "unprognostic (2.54e-3)" "unprognostic (1.10e-1)" "unprognostic (2.33e-3)" "prognostic favorable (1.09e-4)" "unprognostic (1.66e-2)" "unprognostic (3.54e-2)" "unprognostic (3.44e-1)" "unprognostic (4.60e-3)" "unprognostic (7.89e-2)" "unprognostic (1.77e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (7.49e-2)" "unprognostic (1.96e-1)" 18.9 3.6 3.5 11.5 4.9 1.3 10.3 1.2 4.1 8.5 4.1 2.8 3.6 4.2 12.4 5.5 6.2 5.5 5.9 7.4 3.8 2.9 5.3 4.6 11.2 23.8 4.1 2.1 2.6 3.7 1.8 2.2 8.3 4.4 6.3 3.0 5.2 3.6 2.8 6.4 3.6 8.2 4.9 4.6 28.9 3.8 2.9 3.8 6.7 7.9 5.4 12.0 4.9 11.5 0.2 5.1 1.0 11.5 14.6 27.4 11.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 16.9 2.2 0.0 0.0 0.0 0.0 9.7 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.9 11.5 0.0 17.2 10.4 20.3 0.1 18.8 21.4 5.1 0.2 27.4 22.2 1.0 14.6 10.4 0.3 11.8 11.4 3.5 4.9 1.2 4.1 3.8 2.9 4.1 2.1 4.4 3.8 3.0 1.0 6.5 0.5 4.8 0.2 4.8 2.5 0.0 1.2 0.0 0.0 0.3 0.0 0.1 0.1 75.5 0.0 0.0 0.3 0.2 1.8 0.5 8.1 1.6 34.2 0.0 0.0 91.4 83.8 0.8 1.4 15.8 8.5 2.8 0.0 0.2 0.1 0.0 0.0 0.5 0.9 0.0 3.8 0.2 0.2 2.8 0.3 81.2 0.0 0.5 GIMAP1-GIMAP5 ENSG00000281887 "GIMAP1-GIMAP5 readthrough" 7 150716668-150743646 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "monocytes: 15.5;NK-cells: 21.5;T-cells: 37.5" "Group enriched" "Detected in some" 8 "HUVEC TERT2: 8.4;JURKAT: 5.0;MOLT-4: 13.1;THP-1: 3.2;TIME: 6.2" HPA053441 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA053441: AB_2682152" 12.2 2.1 1.8 12.9 2.7 1.0 6.4 0.0 2.2 5.2 2.2 1.3 1.8 7.0 7.8 3.1 3.6 2.1 3.3 3.8 1.9 3.0 2.5 6.2 15.5 2.0 0.8 1.6 1.9 0.7 0.0 4.6 2.3 3.6 0.5 2.9 2.2 0.9 4.4 0.2 3.1 2.7 2.5 16.4 3.0 1.3 2.0 3.9 4.7 3.0 7.6 2.5 7.2 0.2 4.8 1.5 15.5 21.5 37.5 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 5.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 15.5 0.0 23.3 13.5 27.9 0.2 26.4 34.0 4.8 0.2 37.5 30.2 1.5 21.5 9.8 0.3 16.4 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GIMAP2 "DKFZp586D0824, HIMAP2, IAN12, IMAP2" ENSG00000106560 "GTPase, IMAP family member 2" Q9UG22 7 150685697-150693641 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.8;lymphoid tissue: 38.1" "Cell type enhanced" "Detected in many" 13 "Hofbauer cells: 34.8;Ito cells: 35.6;Kupffer cells: 100.1;T-cells: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 28.0;JURKAT: 15.5;MOLT-4: 33.8;REH: 14.7;U-937: 14.1" "Low region specificity" "Detected in many" HPA013589 Approved NA NA "HPA013589: AB_1849666" "prognostic favorable (3.50e-4)" "unprognostic (4.73e-2)" "unprognostic (2.53e-1)" "unprognostic (3.56e-3)" "unprognostic (6.60e-2)" "unprognostic (6.64e-3)" "unprognostic (4.60e-2)" "unprognostic (5.97e-2)" "unprognostic (3.39e-2)" "unprognostic (3.91e-1)" "unprognostic (5.52e-2)" "unprognostic (8.06e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.54e-1)" "unprognostic (1.88e-2)" "unprognostic (2.56e-2)" "unprognostic (3.08e-2)" 13.0 7.3 4.8 21.3 7.1 4.6 8.3 2.6 4.2 7.6 7.8 3.3 4.0 5.7 7.8 7.1 5.5 4.5 8.1 7.8 6.7 4.2 6.6 7.7 14.9 35.4 7.3 3.3 8.7 2.7 0.9 3.3 9.2 6.2 6.5 7.6 4.6 7.7 3.0 3.9 2.9 12.7 5.4 12.3 38.1 5.3 2.5 6.5 26.7 6.3 4.4 26.7 9.4 9.6 3.9 11.6 10.0 28.3 31.4 44.8 28.0 0.7 0.0 0.0 0.0 0.3 0.3 0.3 0.0 8.0 1.0 2.3 0.0 10.5 1.8 0.1 0.6 4.4 0.4 0.0 0.4 0.1 8.5 0.0 5.6 0.0 0.2 1.3 4.2 5.7 3.1 0.8 0.7 0.0 2.4 28.0 15.5 0.1 2.2 0.4 0.0 33.8 10.7 0.0 0.0 0.0 14.7 0.3 4.2 0.0 2.6 0.0 0.0 0.0 0.0 2.6 0.0 0.4 11.0 6.2 0.4 0.1 0.1 0.0 2.5 2.3 0.0 1.0 14.1 1.5 2.7 20.7 1.7 24.6 28.3 31.0 3.8 32.2 29.7 11.6 3.9 44.8 32.6 10.0 31.4 27.6 1.4 25.6 28.0 4.8 7.1 2.6 4.2 6.7 4.2 7.3 3.3 6.2 6.5 11.9 2.1 8.7 1.7 3.0 0.0 1.2 2.5 4.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 17.5 2.0 0.0 0.6 0.3 2.1 1.9 19.6 3.8 34.8 0.0 0.0 35.6 100.1 0.0 3.7 21.0 1.7 12.6 3.9 0.3 0.7 3.5 0.7 0.8 0.0 6.5 0.8 0.0 0.2 2.8 0.3 62.3 3.3 2.0 GIMAP5 "HIMAP3, IAN4L1, IAN5" ENSG00000196329 "GTPase, IMAP family member 5" Q96F15 7 150722253-150750033 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 61.0;lymphoid tissue: 58.3" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 9.8;Endothelial cells: 18.8;Ito cells: 11.6;Suprabasal keratinocytes: 9.4;T-cells: 17.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "NK-cells: 17.3;T-cells: 61.0" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.9" NA NA "unprognostic (6.77e-2)" "unprognostic (8.83e-3)" "unprognostic (1.61e-1)" "unprognostic (4.68e-2)" "unprognostic (2.49e-1)" "unprognostic (2.34e-3)" "unprognostic (2.21e-3)" "unprognostic (6.42e-2)" "unprognostic (2.12e-1)" "unprognostic (1.61e-2)" "unprognostic (2.96e-2)" "unprognostic (9.87e-2)" "unprognostic (2.77e-3)" "unprognostic (4.13e-1)" "unprognostic (7.15e-3)" "unprognostic (1.86e-1)" "unprognostic (1.47e-2)" 26.8 6.6 4.7 23.3 5.8 1.7 26.6 1.9 4.3 9.3 9.2 3.4 4.5 2.4 15.2 12.0 7.1 8.7 7.9 12.4 5.5 3.7 8.2 9.2 25.8 58.3 5.2 2.1 4.1 5.2 2.0 3.8 10.3 6.1 7.0 7.9 8.4 9.1 4.2 8.7 5.6 11.7 14.2 5.7 28.7 6.6 3.3 5.6 5.5 12.8 9.2 30.7 10.4 10.2 0.1 0.4 0.7 9.5 17.3 61.0 51.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 1.1 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.4 4.7 0.1 30.2 9.5 37.9 0.1 52.1 35.0 0.4 0.0 61.0 30.8 0.7 17.3 3.0 0.1 17.1 51.1 4.7 5.8 1.9 4.3 5.5 3.7 5.2 2.1 6.1 5.6 0.0 1.7 0.5 0.2 9.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.3 0.2 0.2 2.3 0.8 2.4 0.0 0.0 11.6 3.5 0.0 0.0 3.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.1 9.4 0.2 17.3 0.0 0.1 GINM1 "C6orf72, dJ12G14.2" ENSG00000055211 "Glycoprotein integral membrane 1" Q9NU53 6 149566294-149591748 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 261.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017210, HPA041679" Approved Approved "Nucleoli fibrillar center,Plasma membrane" NA NA 8700 "Nucleoli fibrillar center, Plasma membrane" "HPA017210: AB_1845743, HPA041679: AB_2677611" "unprognostic (6.09e-3)" "unprognostic (2.19e-2)" "unprognostic (2.38e-1)" "unprognostic (2.48e-1)" "unprognostic (7.24e-2)" "unprognostic (1.32e-3)" "unprognostic (3.18e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (2.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.64e-2)" "unprognostic (4.87e-2)" "unprognostic (4.79e-3)" 32.1 26.3 21.3 17.8 34.7 20.0 51.5 26.1 27.6 28.8 25.7 22.4 29.0 14.2 29.3 36.9 21.5 24.1 24.3 48.2 20.3 18.3 51.3 29.6 28.4 32.9 43.6 21.4 31.7 28.3 27.1 17.5 34.0 23.0 23.6 19.8 21.7 20.7 40.1 29.2 20.9 17.3 36.7 31.3 18.6 22.8 31.0 30.2 11.5 41.5 21.6 13.1 28.6 22.6 16.8 12.6 23.7 16.0 8.0 8.1 7.7 7.9 5.7 9.3 12.5 50.2 30.1 15.2 27.2 31.9 20.7 26.0 7.4 10.7 5.9 15.0 25.7 19.1 16.4 6.0 13.6 27.1 9.8 13.4 5.6 5.5 8.8 19.2 11.0 5.4 33.4 11.8 17.5 12.1 22.7 22.2 8.1 7.2 9.8 19.4 10.2 6.9 8.3 3.2 11.7 6.1 7.4 16.7 4.4 29.4 7.0 5.9 5.7 27.1 16.1 5.6 10.7 10.1 11.2 15.5 11.2 11.8 28.5 17.9 9.7 11.2 7.3 20.8 9.9 10.3 11.9 13.7 17.1 6.8 13.2 7.9 16.8 8.1 7.4 10.0 11.7 7.9 6.4 23.7 8.0 16.0 12.6 7.5 7.7 21.3 34.7 26.1 27.6 20.3 18.3 43.6 21.4 23.0 30.2 74.5 47.2 33.3 50.3 41.6 20.9 44.8 30.6 33.5 43.3 62.8 27.5 69.7 33.2 80.6 144.2 73.7 38.6 0.0 70.5 63.5 82.2 48.5 27.8 35.6 40.9 15.9 25.7 88.4 45.9 261.3 120.0 45.3 40.5 82.0 22.0 80.5 55.4 29.4 106.1 117.9 21.9 97.0 65.6 141.4 88.4 41.0 102.6 28.7 25.1 50.0 GIPR ENSG00000010310 "Gastric inhibitory polypeptide receptor" P48546 19 45668244-45683724 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3;stomach 1: 26.1" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 33.5;Club cells: 13.6;Intestinal endocrine cells: 28.7;Rod photoreceptor cells: 18.6" "Cancer enriched" "Detected in many" 5 "pancreatic cancer: 4.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.1;HMC-1: 18.4;SCLC-21H: 12.2;U-266/70: 15.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" CAB022710 Uncertain NA NA "CAB022710: " "unprognostic (2.40e-2)" "unprognostic (9.03e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-2)" "unprognostic (2.65e-1)" "unprognostic (3.70e-4)" "unprognostic (1.82e-2)" "unprognostic (2.94e-2)" "unprognostic (1.42e-1)" "unprognostic (1.72e-2)" "unprognostic (4.85e-3)" "unprognostic (2.78e-1)" "unprognostic (1.72e-2)" "unprognostic (1.19e-1)" "unprognostic (1.37e-1)" "unprognostic (3.37e-2)" "unprognostic (2.59e-2)" 8.0 0.4 2.3 4.5 8.4 2.4 6.6 1.8 10.5 2.9 4.5 9.4 0.1 4.3 0.7 1.5 1.8 10.0 1.8 12.3 3.7 2.6 1.7 0.5 4.8 3.6 21.3 1.4 1.0 8.5 9.0 2.0 0.4 6.3 5.3 5.8 2.6 5.8 0.6 0.4 3.3 3.6 0.5 4.6 4.1 26.1 0.4 16.2 0.2 1.8 0.8 4.4 3.0 3.3 2.3 1.2 2.5 0.8 4.1 2.3 0.7 0.7 0.4 1.2 0.7 0.5 0.0 0.2 0.9 0.7 0.1 0.7 0.4 3.4 1.6 0.5 0.6 0.6 1.8 0.3 0.1 0.1 8.1 0.3 1.4 0.8 0.3 0.1 0.5 18.4 0.0 0.3 0.2 0.2 1.6 0.1 1.8 3.7 1.9 0.0 0.2 0.2 1.2 0.1 2.4 0.9 0.5 0.3 3.6 0.4 0.9 12.2 1.2 0.1 0.8 0.1 0.5 1.7 2.6 0.3 0.0 0.6 0.3 0.3 15.0 0.2 0.3 0.5 1.4 0.3 2.5 0.7 2.0 2.3 0.8 0.8 0.9 0.9 1.6 0.9 2.3 1.1 1.8 2.2 4.1 0.5 1.2 1.8 0.7 2.3 8.4 1.8 10.5 3.7 2.6 21.3 1.4 6.3 16.2 3.0 4.6 0.5 3.1 0.8 0.4 3.6 5.1 33.5 13.6 5.2 0.0 0.0 0.0 1.6 0.3 0.3 2.6 0.0 3.1 0.1 0.2 1.1 1.1 0.0 0.1 0.0 28.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 4.4 0.5 3.6 7.0 0.0 0.0 18.6 12.9 0.5 0.0 0.2 0.4 0.1 0.7 1.2 2.0 GJA1 "CX43, GJAL, ODD, ODDD, ODOD, SDTY3" ENSG00000152661 "Gap junction protein alpha 1" P17302 6 121435692-121449727 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cancer-related genes, Cataract, Disease mutation, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 232.3;Basal keratinocytes: 208.6;Cardiomyocytes: 174.1;Fibroblasts: 139.5;Suprabasal keratinocytes: 330.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 73.4;HUVEC TERT2: 56.2;NTERA-2: 57.2;SuSa: 74.9;U-87 MG: 55.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010753, HPA035097, HPA047551, HPA069245" Enhanced Supported Supported "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" Nucleoplasm "CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: " "unprognostic (3.37e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-1)" "unprognostic (4.18e-2)" "unprognostic (1.48e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (2.89e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.00e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (4.99e-5)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (3.00e-3)" 19.7 65.2 78.6 5.5 69.7 0.4 14.2 32.4 44.4 64.5 4.0 23.8 6.1 4.2 23.5 5.5 17.3 7.8 23.0 36.0 87.3 25.5 3.6 2.5 15.2 4.4 42.9 39.9 10.5 4.5 94.7 5.7 63.8 53.7 20.0 4.8 26.3 7.1 35.7 3.4 86.3 4.4 25.6 38.7 1.1 6.4 8.3 64.3 0.5 38.9 9.9 7.6 14.8 32.2 0.5 0.5 0.4 0.5 0.0 0.4 0.0 0.0 6.6 29.3 0.0 16.0 9.9 0.0 21.9 44.6 7.4 18.1 0.1 0.0 0.0 2.4 8.5 6.3 2.8 0.7 13.4 24.1 0.0 8.0 0.3 2.7 0.0 20.0 0.0 0.0 26.4 14.5 27.1 9.8 73.4 56.2 0.0 0.0 0.6 1.4 1.2 0.0 11.7 57.2 0.0 7.3 0.0 0.0 0.5 29.6 3.2 0.0 0.4 0.0 0.0 0.0 74.9 2.3 0.0 41.3 22.8 6.3 19.2 14.1 0.0 0.0 0.0 55.7 0.0 3.2 0.4 0.5 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.2 0.5 0.4 0.4 0.0 0.0 0.1 0.5 0.1 0.0 78.6 69.7 32.4 42.8 87.3 25.5 42.9 39.9 53.7 64.3 232.3 73.8 0.0 121.0 208.6 0.2 174.1 0.0 5.3 14.8 1.8 2.0 46.7 0.0 69.9 0.3 111.0 0.0 0.0 3.5 8.1 139.5 19.9 8.1 0.0 7.5 0.0 0.0 22.7 0.3 1.1 2.3 2.8 42.2 1.0 0.0 0.1 17.0 0.0 3.9 0.0 0.2 0.0 27.8 0.3 0.1 330.6 16.7 0.0 0.0 45.0 GJA10 CX62 ENSG00000135355 "Gap junction protein alpha 10" Q969M2 6 89894469-89921760 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 2.3" "Cell type enriched" "Detected in single" 148 "Horizontal cells: 17.5" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 2.8;NTERA-2: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA021145 Uncertain NA NA "HPA021145: AB_2670600" "unprognostic (1.09e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJA3 "CX46, CZP3" ENSG00000121743 "Gap junction protein alpha 3" Q9Y6H8 13 20138255-20161049 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 23.1;parathyroid gland: 6.2" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 12.5" "Cancer enhanced" "Detected in some" "melanoma: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 5.6;CAPAN-2: 10.2;HL-60: 8.4;U-266/84: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA014821 Supported NA NA "HPA014821: AB_2669097" "unprognostic (2.32e-1)" "unprognostic (1.01e-1)" "unprognostic (4.37e-2)" "unprognostic (2.58e-3)" "unprognostic (2.98e-2)" "unprognostic (1.04e-2)" "unprognostic (6.87e-3)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" "unprognostic (7.52e-2)" "unprognostic (7.70e-2)" "unprognostic (4.02e-2)" "unprognostic (9.65e-8)" "unprognostic (2.87e-1)" "unprognostic (1.91e-1)" "unprognostic (2.55e-2)" "unprognostic (8.04e-3)" 0.2 0.0 0.1 0.1 0.9 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.3 0.1 0.8 0.1 0.5 23.1 0.1 0.0 1.2 0.1 0.2 0.1 0.1 0.1 0.1 0.3 6.2 0.1 3.9 0.2 0.4 0.0 0.2 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.2 0.0 4.2 0.1 0.2 0.1 1.0 1.6 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.4 0.0 5.6 0.3 0.0 5.0 0.2 1.5 0.0 0.7 4.7 0.8 1.0 0.5 10.2 0.0 0.2 1.7 1.7 0.1 3.3 2.8 0.7 0.2 2.6 2.4 0.0 0.0 0.1 8.4 0.0 0.3 1.6 0.2 0.5 0.0 0.0 3.8 0.6 0.0 0.2 0.0 0.0 0.0 0.7 0.1 2.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 5.0 0.2 1.1 1.9 0.0 0.0 0.0 2.0 0.3 2.3 5.9 0.0 0.0 0.1 4.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 GJA4 CX37 ENSG00000187513 "Gap junction protein alpha 4" P35212 1 34792998-34795747 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Ito cells: 227.8;Sertoli cells: 653.2;Smooth muscle cells: 352.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "EFO-21: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047981 Approved NA NA "HPA047981: AB_2680228" "unprognostic (2.22e-2)" "unprognostic (2.05e-1)" "unprognostic (1.12e-2)" "unprognostic (2.67e-2)" "unprognostic (4.48e-1)" "unprognostic (5.24e-3)" "prognostic favorable (3.28e-4)" "unprognostic (2.01e-2)" "unprognostic (2.23e-1)" "unprognostic (8.17e-2)" "unprognostic (6.83e-2)" "unprognostic (8.81e-2)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.47e-2)" "unprognostic (3.74e-2)" "unprognostic (3.82e-3)" "unprognostic (7.96e-3)" 36.1 7.9 2.9 6.7 6.8 0.6 35.9 2.4 3.6 16.2 8.1 2.8 2.0 2.4 18.8 9.7 13.8 23.1 12.7 33.6 4.2 2.8 10.9 17.4 15.3 15.9 4.9 1.8 17.0 3.0 5.7 2.7 45.6 6.3 10.8 3.2 13.3 6.5 9.0 19.4 5.7 5.2 12.0 3.0 7.3 5.3 10.3 3.2 1.5 16.5 10.8 5.8 13.5 13.3 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.9 6.8 2.4 3.6 4.2 2.8 4.9 1.8 6.3 3.2 0.0 0.0 0.0 1.4 8.7 0.0 2.0 0.0 1.4 1.2 3.5 0.0 0.1 0.0 5.8 0.0 63.9 0.0 0.0 0.0 0.1 5.9 2.3 0.0 0.8 0.2 0.0 15.0 227.8 7.5 0.4 0.9 4.7 18.6 1.0 0.0 0.0 1.6 0.0 12.0 0.0 0.6 653.2 352.3 0.2 0.7 7.5 0.0 0.0 0.0 2.6 GJA5 CX40 ENSG00000265107 "Gap junction protein alpha 5" P36382 1 147756199-147773362 "Disease related genes, Predicted membrane proteins" "Atrial fibrillation, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "placenta: 60.6" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 113.4;Extravillous trophoblasts: 273.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SK-BR-3: 55.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB013080, HPA071370" Enhanced NA NA "CAB013080: AB_2533263, HPA071370: " "unprognostic (1.25e-1)" "unprognostic (6.34e-2)" "unprognostic (1.22e-2)" "unprognostic (2.94e-2)" "unprognostic (3.88e-2)" "unprognostic (8.95e-2)" "unprognostic (1.23e-3)" "unprognostic (5.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (7.57e-2)" "unprognostic (1.97e-2)" "unprognostic (2.44e-1)" "unprognostic (4.41e-2)" "unprognostic (3.43e-2)" "unprognostic (8.93e-2)" 8.8 0.2 0.6 1.5 1.1 0.0 2.1 0.7 0.7 2.1 2.2 0.8 2.8 0.6 1.2 1.6 1.2 2.6 1.7 15.1 0.9 7.0 0.2 9.3 0.3 0.9 0.0 2.2 0.7 0.8 0.0 60.6 1.2 1.6 0.9 2.0 0.2 3.1 1.7 0.0 1.4 2.5 0.9 1.9 0.0 1.3 0.3 0.0 2.1 0.4 0.5 2.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.1 0.0 0.0 0.0 2.3 1.8 0.9 0.9 0.2 0.0 0.1 0.0 0.6 0.3 0.0 0.1 0.0 3.8 1.5 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.1 55.6 0.0 5.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.0 6.2 0.5 0.0 0.0 0.0 9.4 0.0 1.4 0.0 3.5 0.0 113.4 0.0 0.0 6.1 2.1 0.0 0.0 0.0 273.7 2.1 0.0 0.0 0.0 13.6 0.0 0.0 30.1 0.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 4.7 1.4 0.4 0.3 26.0 0.0 0.0 0.0 GJA8 "CAE, CAE1, CX50, CZP1" ENSG00000121634 "Gap junction protein alpha 8" P48165 1 147907956-147909257 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 76 "testis: 18.0" "Group enriched" "Detected in some" 4 "Collecting duct cells: 1.8;Early spermatids: 6.8;Late spermatids: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "RPTEC TERT1: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014715, HPA062940" Enhanced NA NA "HPA014715: AB_2732411, HPA062940: AB_2732693" "unprognostic (3.73e-2)" "unprognostic (2.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 GJA9 "CX58, CX59, GJA10" ENSG00000131233 "Gap junction protein alpha 9" P57773 1 38874451-38881587 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 4.3" "Low region specificity" "Detected in all" HPA067850 Uncertain NA NA "HPA067850: AB_2685910" "unprognostic (2.00e-1)" "unprognostic (8.78e-2)" "unprognostic (4.55e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-2)" "unprognostic (1.20e-2)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (2.75e-2)" "unprognostic (1.90e-2)" "unprognostic (2.63e-1)" "unprognostic (4.11e-3)" "unprognostic (2.32e-2)" 1.1 0.1 0.7 0.4 0.9 0.2 0.4 0.9 1.0 0.4 0.7 0.7 0.4 0.9 0.4 0.4 1.4 0.6 0.8 2.3 1.2 0.6 0.4 0.4 0.4 0.4 1.2 0.4 0.4 0.4 0.0 0.9 0.4 0.7 0.5 1.3 1.8 0.8 0.4 0.6 1.9 0.5 0.4 1.8 0.4 1.2 15.8 0.4 0.4 1.1 0.4 0.4 1.2 0.7 1.5 1.0 1.8 1.2 0.4 1.5 0.4 0.5 0.8 0.7 0.5 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.2 1.7 0.4 0.1 0.0 4.3 0.2 0.0 0.3 0.2 0.7 0.7 0.3 0.6 1.1 0.0 0.8 0.6 0.0 0.4 0.3 0.0 0.2 0.0 0.9 0.3 1.2 0.1 0.2 0.4 0.1 0.3 0.3 0.4 0.6 0.2 0.1 0.0 1.3 0.7 0.7 0.0 0.5 1.4 1.1 0.3 0.4 1.8 1.6 0.4 0.4 0.1 0.3 0.6 0.4 1.6 0.5 0.7 0.0 1.1 0.0 0.6 1.2 0.4 0.9 0.5 0.3 1.0 1.5 1.1 0.6 1.8 0.4 0.3 0.3 1.5 0.4 0.7 0.9 0.9 1.0 1.2 0.6 1.2 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJB1 "CMTX, CMTX1, CX32" ENSG00000169562 "Gap junction protein beta 1" P08034 X 71215194-71225516 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.4;liver: 114.4;pancreas: 37.1" "Cell type enhanced" "Detected in many" 15 "Cholangiocytes: 112.1;Enterocytes: 72.8;Hepatocytes: 237.9" "Cancer enhanced" "Detected in many" "liver cancer: 163.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 46.8;SK-MEL-30: 51.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012994 Uncertain NA NA "CAB012994: AB_2533228" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (8.78e-2)" "unprognostic (2.71e-3)" "unprognostic (2.70e-1)" "unprognostic (4.11e-1)" "unprognostic (2.92e-1)" "unprognostic (3.68e-1)" "unprognostic (2.63e-2)" "unprognostic (2.22e-2)" "unprognostic (7.36e-3)" "unprognostic (1.80e-1)" "prognostic favorable (2.85e-6)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (7.79e-2)" "unprognostic (4.97e-2)" 0.4 0.4 7.2 2.5 9.3 0.3 2.6 1.9 14.4 3.3 12.0 46.3 2.5 14.6 0.9 8.1 0.5 9.5 19.8 0.4 13.4 8.0 14.8 114.4 1.2 0.4 22.4 5.6 0.4 37.1 0.3 0.4 0.4 23.0 4.3 8.3 0.5 19.6 8.7 0.4 0.6 11.7 1.0 52.4 0.4 5.7 3.1 12.1 0.0 0.4 0.0 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.0 51.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 9.3 1.9 14.4 13.4 8.0 22.4 5.6 23.0 12.1 0.0 3.7 3.4 0.5 0.6 0.0 0.0 112.1 0.0 2.3 8.7 0.0 0.0 8.3 19.1 0.1 0.0 72.8 0.0 50.9 0.0 0.0 3.9 4.6 237.9 0.0 0.0 9.2 3.1 3.7 0.0 0.3 0.0 21.9 1.0 23.0 0.0 47.9 51.0 0.4 59.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 56.4 2.4 GJB2 "CX26, DFNA3, DFNB1, NSRD1" ENSG00000165474 "Gap junction protein beta 2" P29033 13 20187463-20193010 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease mutation, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 62.0;Hepatocytes: 24.2;Suprabasal keratinocytes: 25.1" "Cancer enhanced" "Detected in all" "head and neck cancer: 447.5" "Region enhanced" "Detected in some" "pons and medulla: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 43.7;hTCEpi: 32.6;OE19: 22.7;RT4: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013093, HPA014362" Uncertain Approved Mitochondria NA NA Mitochondria "CAB013093: AB_2533903, HPA014362: " "unprognostic (2.21e-1)" "unprognostic (1.25e-3)" "unprognostic (2.43e-2)" "unprognostic (6.14e-2)" "prognostic unfavorable (4.45e-4)" "unprognostic (9.77e-2)" "unprognostic (2.92e-1)" "prognostic unfavorable (6.25e-4)" "unprognostic (1.33e-1)" "unprognostic (3.69e-3)" "prognostic unfavorable (2.90e-4)" "unprognostic (3.22e-2)" "prognostic unfavorable (2.53e-6)" "unprognostic (5.78e-3)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (8.93e-3)" 0.2 0.0 0.2 1.5 0.3 0.5 0.7 1.0 0.5 52.8 3.9 0.4 0.4 2.4 4.2 0.6 128.1 0.1 2.7 0.1 0.5 0.1 3.5 9.1 0.1 0.0 1.3 0.7 0.1 0.1 0.0 0.5 0.2 4.5 0.3 3.4 0.3 19.7 0.2 0.2 10.3 1.9 0.4 3.7 0.0 1.5 0.2 0.2 3.2 0.2 129.0 71.1 2.3 64.9 0.0 0.0 0.4 0.6 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.4 43.7 0.0 0.2 0.0 0.3 8.7 1.6 4.3 0.0 3.6 0.5 0.0 0.0 0.1 0.0 0.0 1.5 0.7 32.6 0.5 6.0 0.0 0.0 0.6 0.0 3.2 0.0 0.4 0.3 0.0 0.1 22.7 4.3 0.0 0.0 2.4 0.0 50.8 0.0 0.0 0.0 0.0 0.1 0.6 0.6 0.1 0.0 0.0 0.0 0.7 6.5 2.6 2.7 0.0 5.3 0.0 0.6 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 1.0 0.5 0.5 0.1 1.3 0.7 4.5 0.2 3.0 0.0 0.8 8.0 62.0 0.0 0.4 5.1 0.0 3.4 1.8 0.0 0.0 0.0 3.5 0.7 0.2 19.0 0.0 8.8 0.2 1.6 7.8 0.0 24.2 0.7 0.0 4.1 0.0 0.8 0.9 0.0 1.2 1.7 8.2 3.9 0.0 8.1 15.0 0.0 14.7 0.0 0.0 2.0 0.2 0.4 25.1 0.1 0.0 19.7 15.6 GJB3 "CX31, DFNA2, EKV" ENSG00000188910 "Gap junction protein beta 3" O75712 1 34781189-34786369 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1" "Group enriched" "Detected in many" 7 "Basal glandular cells: 49.4;Basal keratinocytes: 123.0;Pancreatic endocrine cells: 70.6;Suprabasal keratinocytes: 149.2;Urothelial cells: 169.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 26.3;CAPAN-2: 37.4;HaCaT: 30.4;HBEC3-KT: 26.0;hTCEpi: 42.7;OE19: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA074472 Supported "Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" "HPA074472: AB_2686694" "unprognostic (1.34e-3)" "unprognostic (2.30e-1)" "unprognostic (2.84e-2)" "unprognostic (5.22e-3)" "unprognostic (3.82e-2)" "unprognostic (2.00e-2)" "unprognostic (1.21e-4)" "prognostic unfavorable (4.56e-4)" "unprognostic (2.30e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (4.50e-2)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (1.22e-1)" "unprognostic (1.27e-2)" "unprognostic (2.46e-2)" 0.1 0.1 1.0 2.4 0.4 0.0 3.4 1.4 1.2 6.3 2.2 0.0 0.6 0.0 0.7 3.0 40.1 0.5 4.1 0.1 0.2 0.1 0.5 0.8 0.6 0.4 0.1 0.1 0.2 0.2 0.0 0.1 11.3 0.0 3.7 2.8 0.0 3.7 0.9 0.2 49.3 0.6 0.2 0.1 0.1 3.2 0.5 0.0 0.7 0.2 32.1 25.0 4.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.4 0.0 3.6 0.0 0.0 30.4 0.0 26.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 42.7 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 16.3 6.8 0.0 0.0 0.0 12.7 10.0 0.0 0.0 4.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 1.4 1.2 0.2 0.1 0.1 0.1 0.0 0.0 3.0 0.0 0.0 49.4 123.0 0.0 0.3 2.5 1.4 2.3 5.2 0.0 0.0 0.0 15.7 0.0 0.1 3.1 0.0 6.3 0.1 3.1 16.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 13.5 0.0 1.9 0.0 70.6 7.0 0.0 0.0 0.0 0.0 3.1 0.0 0.2 149.2 0.1 0.0 16.1 169.4 GJB4 CX30.3 ENSG00000189433 "Gap junction protein beta 4" Q9NTQ9 1 34759741-34763724 "Disease related genes, Predicted membrane proteins" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 11.1;skin 1: 26.2" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 91.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.7;HaCaT: 9.9;HBEC3-KT: 6.4;hTCEpi: 4.2;OE19: 3.7;RPTEC TERT1: 3.9;RT4: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055112, HPA073904" Enhanced Supported "Cell Junctions" NA NA "Cell Junctions" "HPA055112: AB_2682699, HPA073904: " "unprognostic (3.30e-2)" "prognostic favorable (5.48e-4)" "unprognostic (1.57e-1)" "unprognostic (2.70e-2)" "unprognostic (4.21e-2)" "unprognostic (2.22e-1)" "unprognostic (2.16e-2)" "unprognostic (2.18e-2)" "unprognostic (5.40e-2)" "unprognostic (3.65e-1)" "prognostic unfavorable (3.24e-5)" "unprognostic (3.73e-2)" "unprognostic (5.81e-3)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (3.52e-4)" "unprognostic (5.42e-2)" 0.1 0.1 0.1 1.2 0.1 0.0 1.5 0.1 0.1 1.7 0.3 0.0 2.9 0.0 0.1 11.1 2.9 0.1 8.3 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 3.4 0.0 2.0 0.2 0.0 0.8 2.0 0.1 26.2 0.3 1.2 0.1 0.1 0.2 0.7 0.0 0.1 0.1 1.6 2.4 3.2 6.3 0.0 0.0 0.0 0.0 0.0 0.3 0.2 6.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 1.0 0.0 0.1 9.9 0.0 6.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 3.9 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 22.7 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 21.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.0 91.2 GJB5 CX31.1 ENSG00000189280 "Gap junction protein beta 5" O95377 1 34755047-34758512 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.0;lymphoid tissue: 26.1;skin 1: 37.7;tongue: 28.0" "Group enriched" "Detected in some" 16 "Basal glandular cells: 21.6;Basal keratinocytes: 43.0;Suprabasal keratinocytes: 73.0;Urothelial cells: 70.5" "Group enriched" "Detected in many" 5 "cervical cancer: 36.7;head and neck cancer: 57.5;lung cancer: 13.7;urothelial cancer: 21.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.9;HaCaT: 31.8;HBEC3-KT: 14.2;hTCEpi: 52.7;hTERT-HME1: 8.4;RT4: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA038146 Uncertain NA NA "HPA038146: AB_10697242" "unprognostic (2.62e-1)" "unprognostic (1.63e-1)" "unprognostic (3.48e-1)" "unprognostic (5.71e-2)" "unprognostic (8.26e-2)" "unprognostic (3.12e-1)" "unprognostic (7.89e-2)" "unprognostic (2.76e-2)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.30e-2)" "unprognostic (1.09e-3)" "unprognostic (2.36e-1)" "unprognostic (2.41e-3)" "unprognostic (5.59e-2)" "unprognostic (5.67e-3)" 0.0 0.1 0.7 0.0 0.5 0.1 2.6 0.6 2.3 7.5 0.1 0.0 0.5 0.0 0.1 2.1 39.0 0.4 3.3 0.1 0.8 0.1 0.1 0.1 0.3 0.0 0.2 0.5 0.1 0.6 0.0 0.4 7.0 0.2 3.0 0.1 0.0 5.6 2.1 0.2 37.7 0.1 0.3 0.1 0.0 0.1 0.8 0.0 0.6 0.6 28.0 26.1 3.4 11.7 0.0 0.0 0.0 0.8 0.0 0.1 0.8 9.9 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.1 31.8 0.0 14.2 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 52.7 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 17.7 0.0 0.0 1.2 0.5 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.8 0.7 0.5 0.6 2.3 0.8 0.1 0.2 0.5 0.2 0.0 0.0 0.6 0.0 21.6 43.0 0.0 0.4 0.0 1.4 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 73.0 0.3 0.0 0.0 70.5 GJB6 "CX30, DFNA3, ED2, EDH, HED" ENSG00000121742 "Gap junction protein beta 6" O95452 13 20221962-20232395 "Disease related genes, Predicted membrane proteins" Hearing "Deafness, Disease mutation, Ectodermal dysplasia, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 50.5;esophagus: 97.1;tongue: 43.6" "Cell type enhanced" "Detected in some" 21 "Basal keratinocytes: 10.9;Early spermatids: 3.4;Late spermatids: 4.4;Suprabasal keratinocytes: 3.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 145.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Lineage enhanced" "Detected in many" "T-cells: 5.7" "Cell line enriched" "Detected in some" 9 "RT4: 64.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014846 Supported "Cell Junctions" NA NA "Cell Junctions" "HPA014846: AB_1847135" "unprognostic (5.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.90e-4)" "unprognostic (7.90e-2)" "unprognostic (2.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.83e-1)" "unprognostic (8.96e-2)" "unprognostic (9.64e-2)" "unprognostic (2.82e-2)" "unprognostic (2.82e-2)" "unprognostic (3.54e-2)" "unprognostic (1.14e-11)" "unprognostic (8.99e-2)" "unprognostic (1.16e-1)" "unprognostic (6.35e-3)" "unprognostic (5.04e-2)" 1.2 1.0 15.3 1.1 17.0 50.5 3.3 9.0 15.9 16.9 1.0 1.9 0.0 1.0 1.6 1.1 97.1 1.2 1.8 1.0 16.3 7.9 1.0 1.0 1.1 1.4 11.1 11.3 1.0 1.0 1.0 0.7 1.0 9.2 1.1 1.1 0.0 8.7 1.0 1.0 18.7 1.0 1.0 3.7 1.1 1.2 1.7 6.0 7.9 4.1 43.6 15.7 6.3 30.9 1.4 0.0 1.2 0.0 0.0 5.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 64.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 1.4 2.7 1.5 1.2 0.0 0.0 0.0 5.7 0.6 15.3 17.0 9.0 15.9 16.3 7.9 11.1 11.3 9.2 6.0 0.0 0.0 0.0 1.0 10.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 3.3 0.0 0.0 0.0 2.0 GJB7 "bA136M9.1, CX25" ENSG00000164411 "Gap junction protein beta 7" Q6PEY0 6 87282978-87329278 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "fallopian tube: 12.3;pituitary gland: 10.0;placenta: 4.5" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 29.4;Cytotrophoblasts: 7.7;Extravillous trophoblasts: 4.4;Syncytiotrophoblasts: 6.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.5;HDLM-2: 10.5;MCF7: 5.8;OE19: 6.7;RT4: 5.2;SuSa: 3.6" "Low region specificity" "Detected in many" HPA014392 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014392: " "unprognostic (8.30e-2)" "unprognostic (2.45e-1)" "unprognostic (3.06e-1)" "unprognostic (4.20e-1)" "unprognostic (2.84e-1)" "unprognostic (4.07e-3)" "unprognostic (2.61e-1)" "unprognostic (5.13e-3)" "unprognostic (6.69e-3)" "unprognostic (1.59e-1)" "unprognostic (3.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.24e-1)" "unprognostic (5.64e-2)" "unprognostic (2.09e-2)" "unprognostic (3.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 12.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.0 4.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.1 0.5 0.0 0.7 0.1 1.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 5.8 0.0 0.1 1.8 6.7 0.0 0.2 0.0 0.0 0.0 5.2 0.1 0.0 1.2 0.0 0.0 3.6 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.1 0.6 1.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 29.4 0.0 0.0 0.0 7.7 0.0 0.0 0.6 0.0 0.0 0.0 0.2 4.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.1 0.0 6.1 0.0 0.2 0.1 GJC1 "CX45, GJA7" ENSG00000182963 "Gap junction protein gamma 1" P36383 17 44798448-44830816 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 23 "Sertoli cells: 155.2;Smooth muscle cells: 65.3;Spermatogonia: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071788 Uncertain "Nucleoli,Cell Junctions,Cytosol" NA NA Nucleoli "Cell Junctions, Cytosol" "HPA071788: " "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (2.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (7.02e-2)" "unprognostic (4.01e-1)" "unprognostic (1.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.02e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.55e-8)" "unprognostic (5.18e-2)" "unprognostic (2.20e-1)" "unprognostic (8.52e-2)" "prognostic unfavorable (7.83e-4)" 7.3 0.8 2.2 4.1 3.4 1.0 4.7 8.2 4.2 14.8 23.0 2.8 7.0 1.6 24.2 3.1 3.2 5.0 5.4 10.0 3.3 1.8 1.5 0.9 6.5 2.3 2.5 4.0 2.2 1.3 2.6 0.7 28.5 3.4 8.2 2.8 3.7 1.7 17.0 5.4 1.9 4.8 27.5 2.2 0.9 7.8 8.0 2.9 1.4 5.3 2.9 1.7 12.6 10.4 1.2 1.0 4.7 1.0 1.9 1.0 0.4 17.4 9.0 22.7 7.8 3.0 4.7 8.9 19.4 15.3 20.9 22.5 5.2 9.7 0.1 1.0 18.1 28.6 4.5 11.8 6.0 29.4 0.1 8.8 0.1 4.8 0.5 1.8 0.1 0.7 3.2 0.6 15.9 5.3 7.8 7.1 3.9 0.8 0.2 12.1 0.1 2.8 1.7 10.2 0.0 7.7 16.5 28.8 0.1 5.0 7.3 4.3 9.9 2.2 0.1 6.5 15.3 4.7 2.7 5.9 18.5 17.9 8.4 16.5 0.1 4.5 12.9 6.4 0.1 17.3 4.7 1.0 1.1 0.9 0.6 0.8 0.9 0.7 0.6 0.3 1.2 0.9 1.0 3.9 1.9 0.7 1.0 0.6 0.4 2.2 3.4 8.2 4.2 3.3 1.8 2.5 4.0 3.4 2.9 0.0 0.0 0.0 1.6 1.8 1.0 18.1 0.0 0.0 0.0 1.8 2.0 0.3 0.0 1.3 1.3 11.7 0.0 0.0 0.0 2.1 5.7 1.2 0.0 0.0 1.2 12.7 0.0 6.2 0.8 0.0 1.4 0.0 3.3 1.0 0.0 0.4 0.6 0.0 2.1 0.3 1.0 155.2 65.3 10.2 32.0 2.6 0.5 0.0 0.0 1.4 GJC2 "CX46.6, CX47, GJA12, SPG44" ENSG00000198835 "Gap junction protein gamma 2" Q5T442 1 228149852-228159826 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 34.3" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 11.8;Peritubular cells: 3.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.6" "Cell line enhanced" "Detected in many" "EFO-21: 9.9;SCLC-21H: 5.2;TIME: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069619 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA069619: " "unprognostic (2.67e-1)" "unprognostic (1.81e-2)" "unprognostic (6.42e-2)" "unprognostic (8.19e-3)" "unprognostic (4.24e-1)" "unprognostic (1.57e-1)" "unprognostic (6.94e-2)" "unprognostic (2.56e-1)" "unprognostic (4.99e-2)" "unprognostic (7.09e-2)" "unprognostic (7.88e-3)" "unprognostic (9.67e-2)" "unprognostic (6.09e-3)" "unprognostic (2.53e-2)" "unprognostic (7.36e-2)" "unprognostic (1.54e-1)" "unprognostic (2.02e-1)" 2.4 1.9 4.6 1.2 10.0 0.5 2.0 2.2 14.8 2.8 2.6 34.3 0.0 0.6 4.5 2.0 1.7 4.8 1.4 1.6 9.3 5.3 0.6 0.5 3.1 1.2 27.2 5.6 3.4 0.9 2.9 0.6 1.2 18.3 2.1 0.8 0.0 1.5 4.0 1.5 2.4 1.2 3.8 32.6 1.9 1.2 1.0 15.7 0.0 0.9 0.0 0.7 1.3 1.8 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.2 0.5 1.4 0.7 1.9 1.4 0.4 0.6 0.8 0.9 1.2 0.2 9.9 2.6 0.8 1.0 0.3 0.3 0.3 0.4 1.6 0.3 2.5 2.2 2.5 0.0 0.0 0.4 0.2 0.8 0.5 1.2 0.2 1.7 1.1 0.3 0.4 0.6 1.9 0.6 0.6 0.0 2.0 0.4 0.3 0.1 0.8 0.0 5.2 3.0 0.4 0.1 0.3 0.1 0.1 0.3 4.6 1.4 3.8 4.5 1.6 0.3 0.6 0.2 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 4.6 10.0 2.2 10.4 9.3 5.3 27.2 5.6 18.3 15.7 0.0 1.1 0.0 1.2 3.1 1.5 1.4 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.4 0.0 1.2 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.6 0.0 2.3 0.0 1.7 0.0 0.0 0.3 0.7 0.0 3.9 0.0 0.6 0.0 1.7 0.0 0.0 1.5 0.0 0.0 0.1 0.9 GJC3 "CX30.2, GJE1" ENSG00000176402 "Gap junction protein gamma 3" Q8NFK1 7 99923269-99929620 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 9.1;pancreas: 12.1;salivary gland: 9.0" "Cell type enhanced" "Detected in many" 11 "Exocrine glandular cells: 20.9;Glandular cells: 18.1;Pancreatic endocrine cells: 8.3;Proximal tubular cells: 8.2;Urothelial cells: 9.7" "Group enriched" "Detected in many" 5 "breast cancer: 3.8;melanoma: 3.0;prostate cancer: 3.6" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.5;T-reg: 2.1" "Lineage enriched" "Detected in single" 22 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "OE19: 3.3;SK-MEL-30: 5.7;U-2197: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA015024 Uncertain NA NA "HPA015024: AB_1847132" "unprognostic (9.31e-2)" "unprognostic (6.43e-2)" "unprognostic (6.94e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-2)" "unprognostic (2.54e-1)" "unprognostic (2.88e-2)" "unprognostic (7.68e-2)" "unprognostic (9.14e-2)" "unprognostic (6.71e-2)" "unprognostic (4.78e-2)" "unprognostic (1.20e-1)" "unprognostic (3.88e-3)" "unprognostic (1.14e-1)" "unprognostic (4.17e-1)" "unprognostic (3.49e-1)" "unprognostic (5.81e-3)" 1.0 0.5 0.1 0.0 0.3 0.0 9.1 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 1.1 2.8 0.1 0.1 0.6 0.3 12.1 0.0 0.1 1.2 4.3 0.0 9.0 0.0 0.0 2.0 0.0 0.1 0.7 0.0 0.8 1.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.4 0.6 0.8 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.4 1.2 2.6 0.0 0.0 1.0 0.5 0.5 0.0 0.0 0.2 0.3 0.9 0.2 2.3 0.0 0.4 0.3 0.4 0.0 0.1 0.6 0.2 1.1 1.8 1.4 1.7 0.3 1.3 0.5 1.2 3.0 3.3 0.2 0.0 1.2 0.8 0.0 1.1 0.5 0.6 0.3 1.0 5.7 1.5 1.8 0.2 0.8 0.2 1.0 4.8 0.3 0.4 1.4 0.1 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 2.1 0.4 3.0 3.0 0.0 4.8 0.2 0.0 0.0 2.5 0.0 1.2 1.8 0.0 0.0 1.7 0.3 0.2 0.6 0.0 0.0 20.9 0.0 0.0 18.1 4.6 3.9 0.1 0.0 1.2 0.0 0.0 0.5 0.3 0.0 0.0 1.0 0.0 3.7 8.3 0.0 0.0 8.2 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 9.7 GJD2 "CX36, GJA9" ENSG00000159248 "Gap junction protein delta 2" Q9UKL4 15 34751032-34754965 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 13.8;pancreas: 8.7;pituitary gland: 23.9;retina: 9.1" "Cell type enhanced" "Detected in some" 27 "Bipolar cells: 11.5;Cone photoreceptor cells: 37.3;Horizontal cells: 6.4;Rod photoreceptor cells: 12.7" "Cancer enriched" "Detected in single" 32 "pancreatic cancer: 4.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "SuSa: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (4.30e-2)" "unprognostic (2.87e-2)" "unprognostic (1.28e-3)" "unprognostic (1.15e-1)" 0.3 13.8 1.3 0.3 2.1 0.3 0.2 1.4 4.5 0.4 0.3 0.1 0.0 0.2 0.4 0.2 0.2 0.2 0.3 7.0 1.1 1.6 0.9 0.2 0.3 0.2 0.8 2.8 0.2 8.7 0.2 23.9 0.3 3.4 0.2 0.3 9.1 0.2 0.2 0.3 0.3 0.3 0.3 0.2 0.3 0.4 0.4 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.5 0.6 2.1 1.1 1.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 7.1 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.4 0.8 0.5 0.6 0.7 0.5 0.5 0.3 0.5 0.5 0.6 0.6 2.1 1.0 1.1 0.6 0.5 0.4 1.3 2.1 1.4 4.5 1.1 1.6 0.8 2.8 3.4 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.7 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJD3 "Cx30.2, CX31.9, GJA11, GJC1" ENSG00000183153 "Gap junction protein delta 3" Q8N144 17 40362931-40363815 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 7.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Cell type enriched" "Detected in single" 8 "NK-cell: 1.4" "Lineage enriched" "Detected in single" 8 "NK-cells: 1.4" "Cell line enhanced" "Detected in many" "BEWO: 13.3;HaCaT: 11.8;HEK 293: 9.8;MCF7: 10.0;T-47d: 9.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (5.54e-4)" "unprognostic (4.53e-2)" "unprognostic (1.69e-2)" "unprognostic (6.07e-3)" "unprognostic (5.84e-2)" "unprognostic (8.01e-3)" "unprognostic (3.75e-3)" "unprognostic (7.89e-2)" "unprognostic (5.35e-2)" "unprognostic (2.23e-1)" "unprognostic (8.43e-3)" "unprognostic (9.91e-3)" "unprognostic (1.01e-3)" "unprognostic (1.90e-1)" "unprognostic (1.73e-4)" 1.9 0.6 0.1 1.2 0.2 0.0 0.8 0.1 0.2 1.1 3.4 1.8 1.3 0.0 2.1 0.5 0.0 0.7 0.1 0.3 1.6 1.0 1.8 0.3 0.1 0.2 0.8 0.0 0.4 0.3 1.7 0.0 1.3 1.1 2.0 2.7 2.2 0.0 0.0 7.2 4.0 0.4 1.7 0.0 2.2 1.1 0.0 0.0 0.0 0.1 1.4 0.1 0.0 3.6 7.7 0.1 1.5 0.0 0.0 13.3 4.0 0.0 0.1 0.1 0.3 1.0 0.0 3.8 0.0 0.0 11.8 0.0 0.0 0.0 4.3 9.8 0.7 0.8 6.2 3.3 1.7 5.5 0.2 0.0 0.0 0.0 0.3 0.0 1.1 7.5 0.0 0.0 10.0 0.8 3.3 0.9 0.2 2.7 5.0 0.0 0.3 0.0 7.5 0.5 3.4 5.1 0.0 1.6 0.0 9.9 2.6 3.9 0.0 0.1 2.9 0.0 1.5 0.0 1.5 0.7 0.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJD4 "CX40.1, FLJ90023" ENSG00000177291 "Gap junction protein delta 4" Q96KN9 10 35605410-35608935 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.4;brain: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 5.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.4" "Cell line enhanced" "Detected in many" "RH-30: 5.9" "Not detected" "Not detected" HPA038266 Uncertain NA NA "HPA038266: AB_10672741" "unprognostic (2.05e-1)" "unprognostic (2.58e-1)" "unprognostic (5.74e-6)" "unprognostic (2.00e-1)" "unprognostic (8.96e-2)" "unprognostic (3.92e-2)" "unprognostic (8.49e-2)" "unprognostic (7.70e-2)" "unprognostic (1.67e-2)" "unprognostic (2.44e-1)" "unprognostic (1.19e-10)" "unprognostic (3.06e-1)" "unprognostic (1.43e-1)" "unprognostic (2.27e-1)" "unprognostic (1.31e-1)" 0.2 0.2 0.7 0.2 1.0 2.5 0.2 0.2 3.5 0.5 0.2 0.2 0.2 1.0 0.7 0.2 0.3 0.2 1.3 0.3 0.6 1.3 0.2 0.3 0.2 0.4 0.8 0.2 0.2 0.4 0.3 0.5 0.4 0.2 0.3 0.3 0.2 0.8 0.2 1.5 2.6 0.8 0.2 0.3 0.4 0.8 0.9 0.2 0.2 0.9 0.2 0.2 0.4 0.2 0.7 0.9 5.4 0.6 0.6 0.8 0.2 0.9 0.9 0.5 1.5 0.2 0.0 1.4 0.2 0.0 0.0 0.3 0.7 1.4 1.0 0.6 0.1 0.6 1.5 0.1 0.3 0.3 1.1 0.8 0.9 0.4 0.6 0.0 0.2 0.9 0.3 0.3 0.4 0.1 1.2 0.2 0.9 1.8 2.0 0.2 1.3 1.4 1.0 0.9 0.6 2.4 0.8 5.9 0.4 0.1 1.6 1.2 0.8 0.8 0.6 1.3 0.7 1.0 1.4 1.4 1.1 2.0 0.8 0.6 1.0 0.6 0.3 0.9 0.8 1.0 1.8 0.6 0.7 0.5 0.2 0.4 0.6 0.5 0.4 0.4 0.7 0.8 0.7 5.4 0.6 0.2 0.9 0.2 0.2 0.7 1.0 0.2 3.3 0.6 1.3 0.8 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 GJE1 CX23 ENSG00000203733 "Gap junction protein epsilon 1" A6NN92 6 142133090-142135151 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014916 Uncertain NA NA "HPA014916: AB_1847134" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.5 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GKN1 "AMP18, BRICD1, CA11" ENSG00000169605 "Gastrokine 1" Q9NS71 2 68974573-68980974 "Plasma proteins, Predicted secreted proteins" Mitogen "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 41 "stomach 1: 918.9" "Cell type enriched" "Detected in some" 61 "Pancreatic endocrine cells: 201.5" "Cancer enriched" "Detected in some" 116 "stomach cancer: 255.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 5.2;HMC-1: 14.2;MOLT-4: 9.9;NTERA-2: 13.5;REH: 5.8;U-2 OS: 8.8;U-266/70: 8.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA047684 Enhanced "Secreted to digestive system" NA NA 26000000 "HPA047684: AB_2680120" "unprognostic (5.40e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.54e-1)" "prognostic favorable (4.53e-4)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.4 0.0 2.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 918.9 0.0 0.0 1.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.9 0.0 13.5 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 8.8 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 201.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GLB1L2 ENSG00000149328 "Galactosidase beta 1 like 2" Q8IW92 11 134331874-134378341 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 36.2" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 158.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 11.2" "Cell type enhanced" "Detected in many" "gdT-cell: 5.8;NK-cell: 5.8" "Group enriched" "Detected in many" 23 "NK-cells: 5.8;T-cells: 5.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.6;HaCaT: 20.7;OE19: 47.6;SCLC-21H: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA054808, HPA059955" Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA Nucleoplasm Vesicles "HPA054808: AB_2682608, HPA059955: AB_2684178" "unprognostic (2.63e-2)" "unprognostic (9.77e-3)" "unprognostic (2.32e-2)" "unprognostic (2.20e-2)" "unprognostic (8.07e-2)" "unprognostic (1.54e-1)" "unprognostic (5.98e-2)" "unprognostic (2.08e-2)" "unprognostic (1.51e-1)" "unprognostic (8.31e-2)" "unprognostic (1.67e-1)" "unprognostic (1.48e-1)" "unprognostic (4.73e-2)" "unprognostic (1.22e-2)" "unprognostic (2.64e-1)" "unprognostic (3.88e-3)" "unprognostic (1.01e-1)" 0.8 1.2 1.6 4.4 4.2 0.1 4.5 0.3 2.5 6.0 13.5 4.5 8.7 3.6 20.5 6.6 3.0 17.1 15.7 0.8 2.2 2.7 13.8 0.3 4.1 1.3 0.9 1.4 9.5 6.5 22.7 8.6 5.4 11.2 23.5 7.8 36.2 5.2 17.4 0.8 5.9 2.7 5.6 0.7 0.2 5.7 7.0 0.3 1.4 15.0 5.2 2.6 5.1 2.9 0.2 0.0 0.0 0.0 5.8 5.8 0.8 6.0 0.6 3.3 1.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 5.1 19.6 0.0 6.5 0.0 2.7 20.7 9.9 0.1 0.0 0.0 9.4 0.0 2.6 0.2 0.9 0.0 11.4 0.1 0.3 0.0 0.0 0.0 0.0 3.0 9.9 0.0 0.0 5.8 1.6 1.1 1.8 47.6 7.2 0.0 0.0 0.5 5.6 4.3 14.0 5.2 4.4 5.6 0.0 0.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.2 0.0 0.0 0.0 5.8 0.0 2.3 0.0 1.3 2.3 0.0 0.2 1.6 2.6 0.0 5.8 0.0 0.0 0.0 0.8 1.6 4.2 0.3 2.5 2.2 2.7 0.9 1.4 11.2 0.3 0.0 2.6 0.0 4.2 1.9 6.1 1.0 2.5 8.1 3.4 0.0 39.3 0.2 0.0 2.0 1.7 0.6 9.7 0.0 2.1 0.9 1.5 7.6 0.0 0.0 0.2 4.8 8.6 0.0 0.0 4.9 1.1 0.0 5.0 0.0 5.8 8.1 1.7 8.2 0.7 8.1 158.9 0.0 1.9 2.3 4.2 0.6 0.1 1.3 10.7 2.6 GLCE "HSEPI, KIAA0836" ENSG00000138604 "Glucuronic acid epimerase" O94923 15 69160584-69272217 "Enzymes, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 58.4" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 4.0;monocytes: 4.4;T-cells: 4.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040481, HPA048216" Uncertain Approved Mitochondria "Intracellular and membrane" NA NA 78000 Mitochondria "HPA040481: AB_2677004, HPA048216: AB_2680317" "unprognostic (1.30e-1)" "unprognostic (2.39e-1)" "unprognostic (1.20e-3)" "unprognostic (7.77e-2)" "unprognostic (1.58e-1)" "unprognostic (5.55e-3)" "unprognostic (1.00e-1)" "unprognostic (2.84e-1)" "unprognostic (1.48e-1)" "unprognostic (2.56e-1)" "unprognostic (7.47e-2)" "unprognostic (1.41e-1)" "unprognostic (2.40e-2)" "unprognostic (1.53e-1)" "unprognostic (6.00e-2)" "unprognostic (5.23e-1)" "unprognostic (4.07e-2)" 8.3 12.2 6.5 4.9 14.2 0.6 8.8 58.4 12.1 8.4 12.1 12.4 7.8 13.5 6.3 6.9 10.2 5.9 7.2 5.5 5.8 8.5 13.3 16.0 8.4 5.3 9.4 8.1 12.9 5.9 9.0 12.0 12.6 14.4 5.7 14.0 10.8 11.7 8.9 4.1 9.8 11.2 6.8 10.2 4.0 8.8 6.1 7.6 5.4 4.1 8.4 5.8 6.3 5.6 0.6 4.0 0.1 4.4 0.5 4.0 1.9 3.9 3.5 2.4 4.2 8.2 7.8 0.8 7.4 9.9 5.8 11.0 2.9 10.0 2.4 3.7 6.0 7.3 6.0 5.2 4.8 11.8 0.9 5.7 4.0 6.7 3.0 7.9 1.7 8.2 5.3 3.3 7.1 8.1 4.2 50.9 1.8 1.6 2.6 10.8 2.4 1.0 3.0 1.2 4.0 2.5 2.4 9.8 3.0 5.3 4.2 7.7 1.6 7.6 4.7 15.7 1.7 3.4 2.4 17.7 5.6 6.9 6.1 6.5 1.1 1.5 0.5 5.6 2.9 8.0 0.0 4.4 0.1 0.7 3.4 1.2 0.6 1.8 0.8 3.6 0.5 1.2 1.5 0.1 0.5 4.4 4.0 4.0 1.9 6.5 14.2 58.4 12.1 5.8 8.5 9.4 8.1 14.4 7.6 0.0 12.5 5.7 9.1 4.2 10.3 6.2 7.6 25.4 5.7 10.4 9.8 20.3 5.0 10.4 3.2 13.9 15.7 0.0 12.1 9.9 5.9 4.9 2.3 24.6 13.5 7.9 19.5 16.5 14.6 3.3 5.8 7.7 8.5 11.8 26.4 12.9 12.9 23.4 16.6 14.0 15.4 12.9 3.9 13.0 13.4 5.6 27.6 4.4 26.5 12.1 GLDN "CLOM, COLM, colmedin, CRG-L2, UNC-112" ENSG00000186417 Gliomedin Q6ZMI3 15 51341629-51408013 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.3" "Group enriched" "Detected in many" 4 "Paneth cells: 30.0;Syncytiotrophoblasts: 84.0" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HHSteC: 5.7;SuSa: 3.9;U-266/70: 6.8;U-266/84: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059441 Uncertain "Secreted to extracellular matrix" NA NA 190000 "HPA059441: AB_2684018" "unprognostic (5.04e-2)" "unprognostic (2.57e-2)" "unprognostic (5.15e-5)" "unprognostic (3.21e-3)" "unprognostic (2.82e-2)" "unprognostic (2.33e-1)" "unprognostic (2.07e-4)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (3.30e-2)" "unprognostic (3.15e-1)" "unprognostic (2.14e-2)" "unprognostic (9.89e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-1)" "unprognostic (3.80e-3)" "unprognostic (1.37e-1)" 16.6 3.3 8.1 2.9 22.8 1.5 5.2 1.8 22.7 2.3 5.7 42.8 0.0 0.9 0.9 1.4 1.2 1.5 5.5 7.7 14.2 8.3 0.9 0.7 10.4 0.7 43.3 10.1 0.7 1.1 1.1 0.6 16.0 20.1 1.6 10.3 1.3 1.1 1.6 1.0 4.5 1.0 1.4 26.8 2.6 3.8 0.7 25.4 0.0 0.8 0.8 0.8 2.4 1.0 0.1 1.9 1.0 0.8 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.3 0.1 1.4 0.0 0.0 0.1 0.6 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 5.7 0.0 0.1 2.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 2.6 0.3 0.0 0.2 1.0 1.7 0.1 0.0 0.0 0.0 2.2 0.4 0.1 0.0 2.1 0.0 3.9 0.0 1.1 0.0 0.0 0.0 0.3 0.0 6.8 5.5 0.0 0.8 0.0 0.0 1.0 0.2 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.4 0.1 0.8 1.9 0.1 0.0 8.1 22.8 1.8 12.4 14.2 8.3 43.3 10.1 20.1 25.4 0.0 1.6 0.0 0.0 5.6 1.2 3.0 0.0 1.4 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.5 2.3 0.1 0.0 0.0 5.1 0.0 1.2 0.0 13.7 0.0 0.3 8.1 3.3 0.0 1.6 0.3 0.1 30.0 0.0 0.0 0.8 0.0 4.4 0.0 0.0 3.4 84.0 0.0 3.1 0.5 GLG1 "CFR-1, ESL-1, MG-160" ENSG00000090863 "Golgi glycoprotein 1" Q92896 16 74447427-74607144 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010815 Supported Supported "Golgi apparatus" NA NA 1600000 "Golgi apparatus" "HPA010815: AB_2232486" "unprognostic (3.70e-2)" "prognostic unfavorable (1.99e-4)" "unprognostic (7.42e-2)" "unprognostic (3.30e-2)" "unprognostic (1.90e-1)" "unprognostic (5.02e-3)" "unprognostic (5.13e-3)" "unprognostic (9.45e-3)" "unprognostic (8.46e-2)" "unprognostic (1.61e-1)" "unprognostic (1.29e-1)" "unprognostic (8.85e-2)" "prognostic favorable (1.56e-7)" "unprognostic (3.54e-2)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.97e-4)" 30.8 30.4 24.0 23.9 38.8 13.9 29.9 25.8 35.9 40.2 27.3 43.4 27.2 22.2 44.1 29.7 22.8 33.3 40.8 38.1 23.3 26.3 37.5 28.2 28.3 28.9 32.0 28.9 55.7 44.9 72.8 28.0 55.9 31.8 32.8 24.7 27.0 27.5 36.3 38.3 25.3 25.1 41.2 31.4 25.9 26.0 37.5 31.8 35.6 37.0 17.2 25.1 30.6 30.7 10.2 15.6 11.5 14.2 13.8 25.7 13.4 18.0 21.1 19.1 20.6 63.1 47.2 16.2 22.8 30.5 20.9 28.7 19.4 44.8 9.6 32.0 51.0 16.1 27.4 13.0 27.8 27.9 4.6 7.9 6.8 14.8 25.0 28.0 11.1 5.6 34.0 16.0 29.2 26.0 40.5 42.9 21.3 7.7 12.4 20.4 29.7 6.3 9.6 18.3 24.5 6.9 15.4 12.8 24.2 14.8 9.0 8.3 12.0 35.6 11.8 10.3 20.8 15.5 14.1 41.8 23.4 19.6 18.1 14.3 17.7 15.1 18.6 34.6 10.9 20.5 2.2 14.1 11.5 17.0 13.6 17.2 9.2 22.4 19.0 15.0 10.2 25.7 19.8 7.5 13.8 14.2 15.6 17.6 13.4 24.0 38.8 25.8 35.9 23.3 26.3 32.0 28.9 31.8 31.8 59.6 42.4 41.3 22.9 24.2 67.4 64.7 81.5 53.5 43.3 48.8 137.4 62.6 6.6 32.9 32.2 57.5 29.0 23.3 36.8 37.6 63.0 30.0 3.5 37.8 45.2 66.7 37.2 73.1 63.8 21.3 89.8 36.7 40.5 32.5 40.9 72.9 37.3 28.1 107.5 55.3 59.9 90.5 41.2 75.7 97.9 18.9 62.9 54.2 34.3 19.2 GLIPR1 "GliPR, RTVP1" ENSG00000139278 "GLI pathogenesis related 1" P48060 12 75480680-75503853 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.8" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 303.3;Hofbauer cells: 220.1;Kupffer cells: 261.5;Macrophages: 237.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 40.8;U-138 MG: 79.5;U-87 MG: 31.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011014 Approved "Intracellular and membrane" NA NA "HPA011014: AB_1849714" "unprognostic (2.32e-3)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.41e-2)" "unprognostic (2.19e-1)" "unprognostic (3.31e-1)" "unprognostic (2.32e-3)" "unprognostic (4.09e-1)" "unprognostic (7.58e-2)" "unprognostic (3.10e-1)" "unprognostic (7.23e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (8.69e-9)" "unprognostic (9.06e-3)" "unprognostic (5.08e-2)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" 32.0 12.5 6.7 30.4 7.5 10.9 11.8 2.5 10.2 14.7 13.1 5.2 6.0 4.5 28.8 19.2 8.0 20.2 23.1 12.7 6.3 5.4 10.3 8.2 18.6 45.4 9.3 6.6 18.3 4.5 1.4 5.6 24.2 11.1 12.3 9.0 7.2 13.7 12.5 3.3 3.7 16.2 27.0 19.6 32.0 15.4 7.2 8.1 8.9 7.3 4.3 20.9 20.6 8.9 15.2 39.7 76.8 55.1 3.0 20.0 34.7 1.4 1.5 1.2 0.1 4.8 10.3 0.2 19.7 20.8 16.6 12.1 0.8 0.6 4.9 4.1 21.3 14.7 0.2 0.0 8.1 27.2 7.9 0.3 0.2 1.8 1.2 5.5 1.7 0.2 9.5 3.0 40.8 9.0 26.8 13.4 0.3 0.3 6.2 31.0 0.0 0.8 4.1 0.1 0.0 0.6 0.2 0.9 0.1 1.7 0.3 0.0 0.0 8.1 0.0 0.0 2.8 0.2 1.4 21.6 79.5 7.5 8.4 30.0 1.1 0.1 0.4 31.5 2.0 1.1 2.8 55.1 6.3 20.0 38.0 13.5 12.0 14.3 15.7 39.7 15.2 4.3 9.1 76.8 3.0 40.6 33.4 14.6 34.7 6.7 7.5 2.5 10.2 6.3 5.4 9.3 6.6 11.1 8.1 11.9 16.5 78.6 66.6 12.0 2.5 0.7 7.6 12.0 4.5 3.5 3.9 3.6 0.0 94.4 10.2 6.3 0.0 0.0 71.1 303.3 25.7 70.6 9.3 3.4 220.1 6.4 3.4 13.5 261.5 4.5 13.3 237.2 15.1 13.6 0.3 2.0 65.0 2.9 50.5 1.4 2.8 12.9 27.4 1.9 1.1 8.5 14.1 117.9 0.1 23.7 GLIPR1L2 MGC39497 ENSG00000180481 "GLIPR1 like 2" Q4G1C9 12 75391070-75432688 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 44.0" "Group enriched" "Detected in many" 13 "Early spermatids: 154.8;Spermatocytes: 290.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 5.8;SK-BR-3: 8.5;U-2 OS: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039795, HPA039866" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA039795: AB_10805595, HPA039866: AB_10795235" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (3.32e-1)" "unprognostic (2.27e-1)" "unprognostic (7.74e-2)" "unprognostic (1.33e-1)" "unprognostic (8.78e-3)" "unprognostic (2.29e-2)" "unprognostic (1.48e-1)" "unprognostic (2.82e-1)" "unprognostic (7.68e-3)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (5.91e-2)" "unprognostic (2.57e-2)" 1.3 3.1 5.5 1.2 10.4 0.8 3.0 2.9 5.8 2.2 1.2 4.2 2.9 1.0 2.7 4.2 1.4 3.5 1.5 2.5 5.5 4.6 2.5 1.9 2.7 1.1 6.6 3.9 7.7 3.0 7.3 5.2 1.3 6.2 2.3 0.8 2.0 1.4 3.6 2.4 2.2 1.2 1.5 8.1 1.9 1.0 44.0 5.0 1.4 2.8 0.5 0.8 1.7 1.4 1.4 2.6 2.0 0.7 1.0 3.4 0.6 0.3 0.6 0.3 0.6 4.4 2.6 0.7 0.6 0.5 0.2 0.3 0.1 0.4 0.3 1.5 0.4 1.1 0.2 0.1 0.1 0.4 0.8 0.3 0.1 0.6 5.8 3.3 0.6 0.1 0.9 1.4 0.6 2.3 3.8 0.2 0.2 0.3 0.7 1.1 0.1 0.6 0.4 0.3 1.2 0.2 0.1 0.1 0.3 0.1 0.4 1.1 0.6 0.7 8.5 2.5 0.4 2.5 0.2 1.2 1.0 11.3 1.2 0.4 1.0 1.0 0.3 0.4 0.3 0.8 1.8 0.3 0.5 1.1 0.2 0.7 1.1 1.2 2.0 0.4 1.4 2.2 3.3 2.0 1.0 0.7 2.6 3.4 0.6 5.5 10.4 2.9 5.8 5.5 4.6 6.6 3.9 6.2 5.0 0.0 1.9 0.0 3.9 0.8 4.6 3.6 0.0 14.7 1.2 0.0 0.0 1.3 8.3 0.4 154.8 1.0 0.0 0.0 0.0 0.2 1.1 0.8 1.1 0.0 0.5 1.6 0.0 0.0 0.0 14.7 6.9 0.1 0.0 0.0 0.0 5.6 0.2 0.0 5.3 1.0 2.0 6.5 1.0 290.6 16.8 0.4 0.3 0.0 0.0 2.3 GLMP "C1orf85, MGC31963, NCU-G1" ENSG00000198715 "Glycosylated lysosomal membrane protein" Q8WWB7 1 156290089-156295689 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 163.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 61.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029121 Uncertain NA NA "HPA029121: AB_10600794" "unprognostic (2.46e-2)" "unprognostic (1.19e-2)" "unprognostic (5.68e-2)" "unprognostic (4.22e-3)" "unprognostic (3.71e-2)" "unprognostic (8.28e-2)" "prognostic unfavorable (6.35e-5)" "unprognostic (4.74e-2)" "unprognostic (2.17e-1)" "unprognostic (9.21e-3)" "unprognostic (1.33e-1)" "unprognostic (7.66e-3)" "unprognostic (7.68e-3)" "unprognostic (3.90e-2)" "unprognostic (1.96e-1)" "unprognostic (1.13e-1)" "unprognostic (4.20e-3)" 22.6 44.5 9.0 9.4 10.3 10.0 16.7 5.1 14.1 21.5 21.3 13.5 15.7 18.4 15.6 26.3 17.3 13.4 26.7 19.2 6.7 7.6 43.9 34.8 24.1 27.7 8.6 7.9 13.9 18.3 12.3 12.3 46.5 11.2 36.3 12.7 37.5 22.6 13.4 6.0 17.3 26.7 14.7 8.9 20.9 16.7 10.8 8.0 8.9 17.1 12.5 16.5 22.6 15.7 6.1 13.7 11.4 31.7 6.9 18.3 14.2 5.7 10.5 1.0 7.4 61.5 33.5 7.3 10.5 44.9 15.5 21.5 12.9 17.8 0.0 22.3 15.3 0.5 3.9 0.1 7.6 5.0 1.2 10.7 2.0 6.3 15.0 27.7 4.8 15.4 34.1 9.7 14.6 4.8 23.8 23.2 4.7 8.1 0.9 9.0 7.1 2.5 0.0 12.0 14.3 5.3 4.4 0.0 18.5 14.2 6.4 3.4 11.2 7.4 19.8 31.4 12.5 10.5 13.7 12.4 7.8 1.4 12.5 7.0 7.0 11.4 2.9 12.8 4.0 10.0 11.4 29.7 5.0 10.7 31.7 10.0 6.1 10.8 9.4 13.7 3.7 11.0 10.1 8.9 6.9 22.1 9.0 18.3 14.2 9.0 10.3 5.1 14.1 6.7 7.6 8.6 7.9 11.2 8.0 3.0 18.4 9.3 10.4 0.0 2.1 5.8 22.9 10.7 9.1 29.6 0.0 61.3 23.2 40.6 0.6 10.8 16.4 0.0 33.6 52.4 11.3 35.0 8.1 62.3 163.3 1.6 10.5 43.0 45.3 0.0 15.3 23.2 0.0 19.0 25.2 18.4 30.4 26.4 13.1 50.1 1.5 12.9 13.4 0.2 2.1 0.0 58.2 10.2 14.5 14.6 GLP1R GLP-1R ENSG00000112164 "Glucagon like peptide 1 receptor" P43220 6 39048798-39087743 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 19.0" "Cell type enhanced" "Detected in single" 37 "Cardiomyocytes: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.6;HAP1: 1.3;HMC-1: 1.5;NTERA-2: 3.3;SCLC-21H: 8.1;SH-SY5Y: 1.8" "Group enriched" "Detected in some" 5 "basal ganglia: 16.1;hypothalamus: 4.8" "Low region specificity" "Detected in some" NA NA "unprognostic (4.06e-3)" "unprognostic (5.38e-6)" "unprognostic (1.80e-2)" "unprognostic (4.16e-2)" "unprognostic (4.98e-2)" "unprognostic (3.55e-1)" "unprognostic (2.11e-1)" "unprognostic (1.38e-1)" "unprognostic (9.76e-2)" "unprognostic (3.29e-1)" "unprognostic (1.73e-1)" "unprognostic (8.60e-3)" "unprognostic (2.47e-1)" "unprognostic (1.15e-2)" "unprognostic (1.42e-2)" 0.2 0.1 0.1 0.0 1.8 0.0 0.9 0.1 2.2 0.1 0.1 0.8 0.0 2.4 0.1 0.6 0.1 0.0 3.5 4.8 1.4 1.4 0.1 0.0 0.5 1.0 0.1 2.3 0.0 19.0 0.0 0.1 0.0 2.0 0.1 0.0 0.0 4.1 0.0 0.4 0.3 0.1 0.0 1.4 0.1 1.8 0.4 0.0 0.4 0.8 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.1 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 1.8 0.1 0.7 1.4 1.4 0.1 2.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLP2R ENSG00000065325 "Glucagon like peptide 2 receptor" O95838 17 9822206-9892102 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "gallbladder: 32.7" "Cell type enriched" "Detected in some" 6 "Rod photoreceptor cells: 24.5" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.1" "Group enriched" "Detected in some" 4 "basal ganglia: 2.9;cerebral cortex: 4.1;olfactory region: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HeLa: 42.8" "Group enriched" "Detected in some" 6 "cerebral cortex: 2.1;hippocampal formation: 2.6" "Low region specificity" "Detected in some" "CAB022690, HPA049244" Supported Supported "Plasma membrane" NA NA "Plasma membrane" "CAB022690: , HPA049244: AB_2680690" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (2.66e-3)" "unprognostic (2.21e-2)" "unprognostic (3.81e-3)" "unprognostic (2.09e-1)" "unprognostic (1.39e-2)" "unprognostic (5.15e-2)" "unprognostic (7.63e-2)" "unprognostic (7.14e-2)" "unprognostic (2.19e-1)" "unprognostic (6.16e-3)" "unprognostic (3.40e-8)" "unprognostic (9.53e-5)" "unprognostic (5.51e-2)" "unprognostic (3.92e-1)" "unprognostic (6.48e-3)" 7.9 0.7 0.6 2.0 2.9 0.0 2.6 0.3 4.3 6.6 14.5 0.0 1.7 12.4 1.9 0.4 5.3 1.4 32.7 0.9 0.6 0.5 0.4 3.2 1.4 0.7 0.6 1.6 0.8 2.1 0.0 0.3 1.5 0.5 8.4 7.5 0.8 0.4 0.2 0.3 0.3 15.4 15.6 0.6 0.3 4.9 1.1 0.2 0.0 0.5 0.1 0.4 13.5 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 42.8 0.3 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.3 4.1 0.6 0.5 0.6 1.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLRA1 STHE ENSG00000145888 "Glycine receptor alpha 1" P23415 5 151822513-151924842 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 31.7" "Cell type enhanced" "Detected in some" 26 "Basal glandular cells: 1.1;Bipolar cells: 4.9;Horizontal cells: 1.6" "Not detected" "Not detected" "Region enriched" "Detected in many" 10 "pons and medulla: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.4" "Group enriched" "Detected in many" 4 "hypothalamus: 11.0;midbrain: 18.1;pons and medulla: 27.6" "Region enhanced" "Detected in all" "pons and medulla: 54.9" CAB079042 Supported NA NA "CAB079042: " "unprognostic (3.17e-1)" "unprognostic (2.47e-1)" "unprognostic (3.85e-7)" "unprognostic (8.24e-2)" "unprognostic (9.45e-3)" 0.3 3.2 1.2 0.1 0.7 0.2 0.1 3.2 0.9 0.1 0.2 0.0 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.3 0.1 2.7 0.2 0.1 0.1 0.1 2.7 0.0 0.1 2.2 0.1 0.1 0.2 31.7 0.1 0.1 1.6 0.1 0.1 0.6 0.1 0.1 0.1 12.6 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 3.2 0.9 0.1 2.7 2.7 0.0 31.7 0.0 0.0 0.0 0.0 1.1 0.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 GLRA2 GLR ENSG00000101958 "Glycine receptor alpha 2" P23416 X 14529298-14731812 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "brain: 21.0;intestine: 11.1" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 1.2;Horizontal cells: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 33 "AN3-CA: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB070422 Approved NA NA "CAB070422: AB_11153055" "unprognostic (2.52e-1)" "unprognostic (3.13e-1)" "unprognostic (5.52e-2)" "unprognostic (1.90e-1)" "unprognostic (5.74e-2)" "unprognostic (1.81e-2)" "unprognostic (3.39e-1)" "unprognostic (5.82e-2)" "unprognostic (7.95e-3)" "unprognostic (1.13e-1)" "unprognostic (2.76e-1)" "unprognostic (6.69e-2)" 0.4 0.5 14.5 0.7 13.2 0.7 0.5 21.0 10.8 0.4 4.1 0.1 0.0 0.7 0.5 0.5 0.4 0.8 0.7 0.4 3.6 13.9 0.5 0.5 0.4 0.5 1.6 8.4 0.9 0.5 0.4 0.5 0.8 10.1 0.4 11.1 1.1 0.8 0.5 0.5 0.8 0.9 0.7 6.5 0.5 0.5 0.9 0.8 0.0 0.5 0.0 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 20.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 13.2 21.0 10.4 3.6 13.9 1.6 8.4 10.1 0.8 0.0 0.0 0.0 0.0 0.1 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 GLRA3 ENSG00000145451 "Glycine receptor alpha 3" O75311 4 174636914-174829314 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 15.2;breast: 6.1;pituitary gland: 12.5" "Group enriched" "Detected in some" 9 "Early spermatids: 18.4;Late spermatids: 13.2" "Cancer enhanced" "Detected in single" "breast cancer: 1.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HEL: 2.7;Karpas-707: 6.3;U-698: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.75e-3)" "unprognostic (3.14e-1)" "unprognostic (1.78e-2)" "unprognostic (1.36e-1)" "unprognostic (9.02e-2)" "unprognostic (3.82e-2)" "unprognostic (2.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.12e-2)" "unprognostic (4.26e-2)" "unprognostic (1.64e-5)" "unprognostic (4.61e-4)" "unprognostic (2.24e-1)" "unprognostic (1.15e-2)" 0.5 2.6 13.3 0.6 7.3 0.6 6.1 0.7 15.2 0.5 0.5 0.3 0.0 0.5 0.7 0.5 0.5 0.4 0.6 0.4 2.7 7.4 0.5 0.4 0.5 0.9 4.6 8.7 0.4 1.4 0.5 12.5 0.5 4.4 0.5 0.5 0.0 0.5 0.5 0.4 0.7 0.5 0.8 2.1 0.6 0.5 1.7 0.0 0.0 0.5 0.0 0.9 0.4 0.2 2.7 0.1 1.1 0.0 0.3 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.6 0.0 0.7 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 2.3 0.1 0.1 0.1 0.6 0.0 0.4 0.1 0.0 0.5 2.7 0.2 0.1 0.0 0.5 0.2 0.2 1.1 0.3 0.0 0.1 0.1 0.0 13.3 7.3 0.7 14.5 2.7 7.4 4.6 8.7 4.4 0.0 0.0 1.1 0.0 1.0 0.0 0.7 1.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.6 0.0 0.4 0.2 1.5 0.1 0.0 0.0 0.0 0.3 GLRA4 ENSG00000188828 "Glycine receptor alpha 4" Q5JXX5 X 103707224-103728655 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.5;endometrium 1: 5.1;smooth muscle: 6.7" "Cell type enriched" "Detected in single" 21 "Enterocytes: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "SCLC-21H: 7.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044759 Uncertain NA NA "HPA044759: AB_10795885" "unprognostic (4.96e-2)" "unprognostic (2.09e-2)" "unprognostic (3.95e-1)" "unprognostic (2.24e-1)" "unprognostic (1.28e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (4.94e-7)" "unprognostic (4.49e-1)" "unprognostic (1.94e-1)" "unprognostic (1.87e-1)" 0.0 0.0 0.9 0.1 1.5 0.0 0.3 2.8 3.5 1.9 1.4 0.9 0.0 2.2 5.1 0.1 0.2 0.6 0.1 0.1 1.5 1.8 0.0 0.0 0.0 0.0 0.5 1.0 1.2 0.0 2.4 0.2 0.0 1.2 0.5 1.8 0.0 0.0 0.4 0.1 0.3 2.3 6.7 1.5 0.0 0.1 1.4 0.0 2.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.5 7.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 1.5 2.8 3.5 1.5 1.8 0.5 1.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLRB ENSG00000109738 "Glycine receptor beta" P48167 4 157076057-157172090 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.1;parathyroid gland: 37.0" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 12.6;Cholangiocytes: 7.6;Ciliated cells: 8.1;Muller glia cells: 11.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 18 "dendritic cells: 1.7" "Cell line enhanced" "Detected in many" "AN3-CA: 17.5;hTERT-RPE1: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052363 Approved NA NA "HPA052363: AB_2681800" "unprognostic (7.36e-2)" "unprognostic (6.53e-2)" "unprognostic (1.44e-1)" "unprognostic (2.59e-3)" "unprognostic (5.65e-2)" "unprognostic (1.18e-1)" "unprognostic (9.47e-2)" "unprognostic (1.52e-1)" "unprognostic (1.19e-2)" "unprognostic (2.99e-2)" "unprognostic (6.81e-2)" "unprognostic (1.48e-1)" "prognostic favorable (4.89e-4)" "unprognostic (4.32e-3)" "unprognostic (1.85e-1)" "unprognostic (5.61e-2)" "unprognostic (1.66e-2)" 4.5 7.2 12.6 1.5 20.9 0.7 10.3 15.9 43.1 9.4 2.3 2.8 0.1 1.1 3.3 5.4 1.5 7.4 3.5 9.9 18.3 17.3 4.1 1.6 3.4 0.8 11.1 21.3 1.8 14.2 37.0 6.7 2.9 16.5 6.5 1.4 0.7 16.7 5.2 3.3 1.5 1.2 4.0 6.1 0.6 2.2 1.9 4.5 0.0 1.5 0.5 0.7 1.9 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 4.8 2.0 5.8 17.5 11.3 4.6 0.0 9.6 6.2 4.7 8.9 0.0 14.8 0.0 2.3 9.7 5.8 0.0 4.4 1.5 8.9 0.0 5.8 2.9 2.2 0.2 5.2 3.7 0.0 4.1 1.3 8.2 1.2 23.3 4.2 3.1 0.0 0.0 8.5 0.0 0.4 0.0 0.3 0.0 1.3 0.0 7.9 0.0 12.7 0.8 6.3 3.8 0.0 4.5 0.7 0.9 4.1 0.9 6.2 2.8 8.3 4.7 9.3 0.0 0.0 0.0 6.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 12.6 20.9 15.9 43.1 18.3 17.3 11.1 21.3 16.5 4.5 0.0 0.6 0.0 0.7 1.0 6.9 12.6 7.6 8.1 3.4 0.0 2.0 0.3 0.0 6.9 0.2 1.0 0.0 0.0 1.5 0.0 2.6 0.6 1.1 0.0 0.1 1.6 0.0 1.8 0.0 0.0 0.3 0.0 3.3 1.0 0.0 11.6 1.9 0.0 3.2 0.4 1.6 0.0 1.1 1.1 3.0 0.3 0.1 0.0 0.0 0.1 GLT8D1 "AD-017, FLJ14611" ENSG00000016864 "Glycosyltransferase 8 domain containing 1" Q68CQ7 3 52694488-52706032 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010588 Approved Approved Mitochondria NA NA Mitochondria "HPA010588: AB_1078098" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (1.38e-2)" "prognostic favorable (2.76e-4)" "unprognostic (3.17e-2)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (1.82e-3)" "unprognostic (7.12e-2)" "unprognostic (9.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.07e-1)" "unprognostic (5.82e-3)" "unprognostic (2.42e-3)" "unprognostic (3.97e-1)" "unprognostic (3.34e-2)" "unprognostic (6.21e-2)" 18.6 23.7 16.1 14.5 20.9 4.7 21.0 15.3 19.9 29.3 17.3 18.3 22.1 14.6 23.5 26.8 14.1 31.9 19.9 19.3 16.6 17.0 23.2 39.4 16.8 16.0 17.9 14.4 32.4 23.6 24.3 40.8 34.7 18.1 21.1 18.9 19.7 22.0 25.2 11.5 13.0 15.2 18.7 17.4 14.8 16.0 43.3 21.6 17.5 37.8 11.6 14.7 21.8 16.8 8.6 15.7 20.5 8.4 20.1 16.3 6.6 8.1 9.7 19.7 15.5 43.7 55.6 11.0 20.6 31.9 18.2 20.9 4.5 15.5 6.9 5.9 35.7 22.0 9.3 12.4 21.1 24.1 12.4 9.0 6.5 17.8 20.6 21.0 9.7 20.5 31.9 18.8 15.6 20.2 42.3 27.0 12.0 8.3 16.0 23.8 8.3 6.5 14.9 10.0 14.4 18.2 5.0 11.2 23.3 21.2 8.9 8.1 13.9 17.1 8.4 13.9 19.2 14.1 12.8 19.7 13.2 10.3 19.1 11.4 18.1 20.5 7.7 23.1 15.5 16.6 20.5 8.4 14.1 13.3 5.7 13.2 8.6 16.0 14.3 8.1 6.4 16.3 11.5 4.8 20.1 6.0 15.7 10.6 6.6 16.1 20.9 15.3 19.9 16.6 17.0 17.9 14.4 18.1 21.6 0.0 8.1 11.5 17.3 10.8 37.5 11.3 7.6 33.5 15.9 17.4 11.8 47.2 19.9 28.5 40.0 19.6 13.1 0.0 23.8 55.2 49.3 12.9 5.7 29.3 23.5 20.6 17.9 35.0 14.5 13.6 49.8 10.6 23.6 34.3 18.6 33.9 21.1 19.2 45.6 19.8 17.9 25.8 15.9 90.1 50.7 6.9 21.9 21.5 17.5 6.7 GLT8D2 FLJ31494 ENSG00000120820 "Glycosyltransferase 8 domain containing 2" Q9H1C3 12 103988984-104064183 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 28.7;Fibroblasts: 28.3;Ito cells: 20.9;Leydig cells: 51.8;Peritubular cells: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.9;BJ hTERT+: 34.4;HSkMC: 25.8;hTERT-RPE1: 20.6;RPTEC TERT1: 17.6" "Group enriched" "Detected in many" 5 "amygdala: 8.0;cerebral cortex: 20.1;hippocampal formation: 16.6" "Low region specificity" "Detected in many" "HPA012740, HPA026904, HPA070791" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA012740: , HPA026904: AB_1849731, HPA070791: " "unprognostic (4.02e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (9.53e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" "unprognostic (1.71e-1)" "unprognostic (4.34e-3)" "unprognostic (2.57e-1)" "unprognostic (1.25e-1)" "unprognostic (7.55e-2)" "unprognostic (5.03e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (1.58e-6)" "prognostic unfavorable (7.92e-4)" "unprognostic (7.15e-2)" "unprognostic (7.70e-3)" "unprognostic (7.03e-3)" 10.2 5.2 2.2 9.9 3.3 0.2 12.0 0.7 2.4 32.8 10.3 1.4 8.8 2.5 24.5 23.1 13.5 13.3 19.1 18.8 2.2 1.8 3.4 2.8 6.9 2.2 2.1 2.1 25.5 2.5 5.9 12.5 6.9 3.5 19.6 5.3 21.8 6.7 8.3 4.0 2.7 6.7 17.3 2.2 1.0 5.5 7.8 0.8 1.0 26.0 10.9 5.7 11.2 13.1 0.8 0.9 0.2 0.6 0.0 2.1 0.0 0.1 0.2 0.2 8.7 11.4 27.9 0.2 12.5 34.4 3.2 4.2 0.1 0.0 0.3 0.7 14.3 0.1 0.0 0.1 4.6 2.8 0.6 3.9 0.2 4.6 0.0 5.1 0.3 0.2 25.8 0.2 3.9 5.5 20.6 1.7 0.2 0.1 0.5 14.1 0.1 0.2 0.1 1.0 0.0 2.6 0.3 13.4 0.1 17.6 0.1 0.5 0.7 13.1 0.3 0.1 1.0 2.3 0.2 0.2 5.3 2.5 0.5 0.7 1.5 0.3 0.1 0.4 0.2 0.4 0.0 0.0 0.0 2.1 0.6 0.7 0.8 0.3 1.3 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.9 0.0 0.0 2.2 3.3 0.7 2.4 2.2 1.8 2.1 2.1 3.5 0.8 0.0 5.8 0.0 3.5 2.5 0.8 2.4 0.0 0.0 0.0 0.0 2.0 3.5 0.0 0.0 28.7 5.9 0.0 0.0 0.0 0.8 28.3 0.5 0.0 0.2 0.5 0.0 1.7 20.9 0.6 9.6 51.8 0.0 3.3 1.0 0.4 0.3 0.5 0.0 48.8 0.0 0.3 6.5 17.0 1.1 0.9 2.0 1.1 0.5 0.0 0.0 GLTPD2 ENSG00000182327 "Glycolipid transfer protein domain containing 2" A6NH11 17 4788959-4790390 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 13.0;kidney: 9.8;liver: 44.4" "Group enriched" "Detected in some" 6 "Hepatocytes: 65.2;Proximal tubular cells: 128.9" "Cancer enriched" "Detected in many" 5 "liver cancer: 25.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 3.2" "Lineage enriched" "Detected in single" 6 "monocytes: 3.2" "Cell line enhanced" "Detected in some" "BEWO: 4.7;CACO-2: 11.8;Hep G2: 15.5;MCF7: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA058295, HPA065267" Uncertain Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA058295: AB_2683671, HPA065267: AB_2685451" "unprognostic (4.00e-1)" "unprognostic (1.93e-1)" "unprognostic (1.95e-3)" "unprognostic (1.70e-1)" "unprognostic (3.03e-2)" "unprognostic (1.79e-4)" "unprognostic (1.40e-1)" "unprognostic (1.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.33e-2)" "unprognostic (5.62e-4)" "unprognostic (7.80e-2)" "unprognostic (2.62e-1)" "unprognostic (4.25e-1)" "unprognostic (4.79e-1)" "unprognostic (1.71e-4)" "unprognostic (7.59e-3)" 0.2 0.3 0.5 0.2 0.7 0.8 0.2 0.8 1.8 0.2 8.0 0.3 0.2 8.6 0.3 0.2 0.4 0.3 0.2 0.2 0.5 0.7 9.8 44.4 0.6 0.2 0.5 0.4 0.2 0.5 0.2 0.5 0.2 0.4 0.2 0.0 0.5 0.8 0.2 0.8 1.4 13.0 0.2 0.4 0.8 0.9 0.2 0.2 0.4 0.2 1.6 0.3 0.4 0.3 0.0 0.5 0.0 3.2 0.0 0.2 0.2 0.6 2.5 0.2 2.1 0.0 0.0 4.7 0.4 0.0 0.0 0.0 11.8 0.9 1.2 1.3 0.0 0.4 2.3 0.0 0.1 0.0 2.2 1.8 0.1 1.0 15.5 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.7 0.6 0.0 5.4 0.2 0.2 0.3 0.6 1.0 0.9 0.6 0.3 0.0 0.9 1.6 1.0 2.2 0.4 0.6 0.1 1.4 0.1 2.5 0.8 1.0 0.5 0.4 0.2 0.6 0.1 0.3 0.7 0.9 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.2 0.5 0.7 0.8 0.7 0.5 0.7 0.5 0.4 0.4 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.3 0.0 65.2 0.1 0.0 0.0 1.8 1.3 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 128.9 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.5 GNL2 "HUMAUANTIG, Ngp-1, Nog2, Nug2" ENSG00000134697 "G protein nucleolar 2" Q13823 1 37566816-37595935 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027163, HPA060026" Approved Enhanced "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA027163: AB_10601655, HPA060026: AB_2684191" "unprognostic (1.38e-2)" "unprognostic (5.23e-2)" "unprognostic (2.61e-1)" "unprognostic (9.49e-2)" "unprognostic (2.00e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.86e-9)" "unprognostic (2.28e-1)" "unprognostic (7.80e-2)" "prognostic favorable (7.89e-4)" "unprognostic (1.01e-2)" "unprognostic (8.19e-2)" "prognostic unfavorable (2.90e-11)" "unprognostic (3.36e-2)" "unprognostic (7.33e-3)" "unprognostic (3.37e-1)" "unprognostic (1.87e-1)" 24.1 17.4 13.8 24.1 15.0 30.7 21.9 11.2 14.2 15.9 15.7 11.7 16.8 12.4 20.2 18.3 21.8 16.4 14.8 17.9 12.5 11.3 18.0 26.9 18.7 19.6 21.2 11.5 19.6 17.4 15.2 21.6 24.5 15.8 16.4 18.7 10.1 19.4 18.9 40.3 22.2 16.3 17.4 15.0 21.8 17.8 21.4 15.2 24.3 17.1 27.5 22.2 20.5 19.8 18.4 25.2 14.4 22.7 20.7 17.4 12.2 19.3 10.0 19.4 20.3 15.6 18.0 31.6 29.5 20.5 27.3 27.9 27.3 22.9 31.8 19.3 21.7 15.4 18.3 31.7 24.0 37.7 18.0 24.8 31.9 20.1 21.9 20.9 41.8 22.9 11.3 22.1 37.2 44.6 13.0 19.6 13.9 42.3 22.9 26.4 17.1 22.5 25.3 50.9 14.0 19.6 24.1 35.3 36.1 22.8 21.2 23.8 21.9 22.3 22.5 21.9 30.2 16.1 24.4 15.7 18.5 26.1 39.1 40.9 21.5 19.3 55.3 21.3 33.7 23.5 10.3 17.1 14.4 15.3 22.7 17.4 18.4 14.3 16.5 25.2 13.5 15.1 14.5 1.8 20.7 20.7 18.5 16.9 12.2 13.8 15.0 11.2 14.2 12.5 11.3 21.2 11.5 15.8 15.2 14.9 47.4 26.7 52.5 56.2 7.6 18.2 5.1 73.6 79.6 7.0 9.8 32.5 23.2 37.6 45.3 20.2 13.4 0.0 54.2 43.6 26.3 29.5 46.2 16.2 28.9 6.4 16.6 11.6 17.1 7.8 22.2 29.8 8.5 36.1 16.0 19.1 39.6 17.8 18.0 12.9 8.6 0.0 33.0 50.5 54.9 46.2 38.6 26.7 19.7 42.6 GNPTAB "GNPTA, KIAA1208, MGC4170" ENSG00000111670 "N-acetylglucosamine-1-phosphate transferase alpha and beta subunits" Q3T906 12 101745497-101830938 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Cancer-related genes, Disease mutation, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014558, HPA042343" Approved Supported "Golgi apparatus" NA NA 47000 "Golgi apparatus" "HPA014558: AB_2732409, HPA042343: " "unprognostic (6.72e-2)" "unprognostic (1.66e-1)" "unprognostic (8.71e-3)" "prognostic favorable (8.48e-4)" "unprognostic (1.39e-1)" "unprognostic (8.37e-2)" "unprognostic (2.73e-1)" "unprognostic (8.57e-2)" "unprognostic (3.73e-2)" "unprognostic (1.09e-2)" "unprognostic (2.28e-2)" "unprognostic (2.00e-1)" "unprognostic (6.86e-2)" "unprognostic (3.44e-1)" "unprognostic (1.02e-1)" "unprognostic (5.44e-2)" "unprognostic (4.98e-2)" 15.2 6.5 21.9 11.9 23.0 15.2 12.2 13.9 25.6 14.0 21.3 10.3 5.9 10.3 9.0 6.5 11.7 7.1 11.0 15.9 17.9 13.7 11.0 7.3 19.6 20.3 14.4 13.0 6.6 11.4 29.9 9.0 10.8 10.9 15.6 22.5 11.3 37.6 10.2 10.8 18.1 14.5 11.7 13.1 15.4 15.2 7.4 10.8 24.5 10.5 8.6 12.6 14.7 14.8 3.9 5.8 5.9 3.4 14.2 16.4 2.7 8.2 8.0 3.0 5.1 25.3 12.0 9.3 11.8 24.3 11.7 15.4 6.1 5.8 17.3 8.5 16.1 9.6 10.8 13.8 15.1 18.3 8.1 7.3 7.4 7.4 8.7 4.7 6.7 15.0 9.3 8.4 11.1 6.6 29.2 20.4 13.9 11.5 5.2 10.9 12.5 20.2 9.5 10.3 10.2 5.8 4.8 15.4 23.2 18.8 21.5 6.5 5.3 19.5 14.0 27.7 11.7 14.3 4.4 20.1 11.1 6.0 9.2 6.5 14.2 14.5 9.9 12.6 10.0 6.8 5.9 3.1 3.4 16.4 2.9 5.4 2.4 3.6 8.9 5.8 3.9 4.6 7.1 1.2 14.2 3.4 5.8 2.6 2.7 21.9 23.0 13.9 25.6 17.9 13.7 14.4 13.0 10.9 10.8 56.6 54.2 24.1 31.6 14.9 24.2 36.8 20.4 9.4 29.6 21.0 23.6 20.7 6.6 9.5 0.4 12.7 22.0 0.0 13.2 12.5 11.8 33.9 118.0 8.3 40.7 7.9 17.3 8.0 31.8 2.2 15.8 35.6 40.5 40.5 27.1 29.3 13.7 74.8 12.0 13.3 35.5 0.0 10.3 8.9 30.9 12.5 7.3 61.8 37.4 40.8 GNRHR "GRHR, LHRHR" ENSG00000109163 "Gonadotropin releasing hormone receptor" P30968 4 67739328-67754360 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "pituitary gland: 56.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "K-562: 3.0" "Not detected" "Not detected" HPA013424 Enhanced NA NA "HPA013424: AB_2668840" "unprognostic (2.77e-1)" "unprognostic (1.58e-1)" "unprognostic (4.05e-1)" "unprognostic (1.78e-1)" "unprognostic (4.65e-1)" "unprognostic (8.75e-3)" "unprognostic (3.09e-2)" "unprognostic (1.34e-1)" "unprognostic (1.90e-1)" "unprognostic (1.01e-1)" "unprognostic (6.84e-2)" "unprognostic (1.63e-1)" "unprognostic (9.03e-2)" "unprognostic (3.23e-2)" "unprognostic (9.67e-2)" "unprognostic (1.22e-3)" "unprognostic (3.99e-2)" 0.1 3.9 0.1 0.4 0.2 0.2 0.1 0.3 1.7 0.3 0.1 0.1 0.1 0.7 0.1 0.1 1.6 0.0 0.2 0.2 0.2 0.2 0.1 0.1 0.1 1.1 0.1 0.1 0.2 0.3 0.0 56.6 0.1 0.5 0.2 0.0 0.1 0.3 0.1 0.2 0.9 0.1 0.1 0.1 0.2 0.3 0.3 0.1 0.2 1.0 0.1 0.4 0.1 0.5 1.3 0.2 0.0 0.0 0.4 0.3 0.0 0.2 1.5 1.5 1.6 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.5 1.7 1.3 0.2 0.0 0.6 0.5 0.0 0.0 0.0 0.3 0.5 0.3 0.3 0.7 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.7 0.0 1.2 3.0 0.0 0.0 0.8 0.6 0.4 1.0 0.5 0.0 0.6 1.3 0.6 0.0 0.0 0.9 2.1 0.0 0.3 0.0 0.3 0.3 0.2 1.0 0.1 0.2 0.6 0.2 1.2 0.3 0.6 1.4 0.8 0.9 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.1 0.0 0.0 1.3 0.1 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.2 0.3 0.3 0.2 0.2 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GNS ENSG00000135677 "Glucosamine (N-acetyl)-6-sulfatase" P15586 12 64713445-64759447 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "non-classical monocyte: 50.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013695, CAB026011, HPA048508" Enhanced "Intracellular and membrane" NA NA 940000 "CAB026011: , HPA013695: AB_1849741, HPA048508: AB_2680423" "unprognostic (8.07e-2)" "unprognostic (2.39e-1)" "unprognostic (2.76e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (7.76e-4)" "unprognostic (9.33e-2)" "prognostic unfavorable (1.94e-5)" "unprognostic (1.26e-1)" "unprognostic (4.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.04e-2)" "unprognostic (3.30e-2)" "unprognostic (3.28e-3)" "unprognostic (1.42e-1)" "unprognostic (3.77e-2)" "unprognostic (1.09e-1)" "unprognostic (3.04e-1)" 57.0 96.7 9.0 18.2 10.1 7.4 47.5 7.7 11.6 22.6 19.1 15.4 17.7 11.5 27.1 27.4 14.3 18.7 21.9 33.0 9.0 10.7 48.9 36.7 26.6 48.8 9.6 8.7 32.7 16.0 32.2 16.6 43.5 15.5 18.6 12.8 38.2 17.9 17.1 18.2 13.5 21.6 23.6 10.8 33.6 16.5 19.3 8.4 9.1 31.4 10.4 11.7 23.9 18.2 3.0 18.2 12.9 50.0 3.9 7.0 19.0 7.8 12.1 10.0 16.4 50.3 30.3 21.3 18.2 42.5 21.7 24.0 11.1 10.7 3.3 23.8 23.2 25.6 6.5 9.9 10.4 24.6 9.9 7.2 7.9 9.9 7.1 22.9 5.9 70.9 29.0 12.9 22.1 10.1 68.8 40.0 4.6 5.5 23.8 31.7 6.3 1.4 3.4 3.9 19.9 10.3 4.6 15.6 10.3 18.9 23.1 6.8 7.3 23.7 11.5 16.5 13.8 20.6 7.9 36.9 21.4 11.3 20.7 10.6 22.6 26.9 2.9 30.8 11.5 14.5 8.8 30.3 5.9 7.0 37.0 5.2 3.0 3.8 5.3 18.2 2.4 4.0 4.0 12.9 3.9 50.0 4.3 2.8 19.0 9.0 10.1 7.7 11.6 9.0 10.7 9.6 8.7 15.5 8.4 44.7 34.3 16.7 7.2 14.7 9.2 56.5 25.5 21.4 18.2 97.7 17.7 15.9 1.7 27.2 23.8 39.4 30.9 0.0 12.9 14.7 22.9 22.9 46.2 54.2 72.6 15.9 40.3 68.7 167.4 19.5 32.2 65.5 15.1 24.4 18.5 23.6 21.5 16.4 35.0 61.7 6.0 6.5 18.9 10.9 7.8 11.3 24.4 10.1 15.8 16.1 GOLGA5 "golgin-84, GOLIM5, ret-II, rfg5" ENSG00000066455 "Golgin A5" Q8TBA6 14 92794231-92839963 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000992, HPA063876" Enhanced Supported Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA000992: AB_1079009, HPA063876: AB_2685140" "unprognostic (2.06e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-1)" "unprognostic (2.77e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-1)" "unprognostic (1.78e-1)" "unprognostic (5.02e-2)" "unprognostic (1.15e-2)" "unprognostic (2.83e-2)" "unprognostic (7.67e-2)" "unprognostic (6.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.06e-2)" "unprognostic (2.49e-2)" 20.8 20.3 16.8 15.7 17.3 6.5 24.4 11.6 17.5 24.9 20.4 17.2 25.5 16.5 18.2 41.7 21.2 15.3 17.5 18.3 17.5 15.6 21.5 51.0 16.6 18.2 18.6 14.6 18.9 26.8 23.6 27.2 44.4 16.4 23.4 23.7 12.7 24.3 30.2 20.6 18.9 25.6 18.9 19.4 16.9 23.0 23.5 17.6 13.5 24.8 17.8 16.4 20.7 15.8 9.7 9.7 22.2 12.7 8.1 12.4 6.3 12.6 11.7 10.6 9.6 22.2 30.1 18.2 17.6 32.4 17.2 20.3 8.6 17.4 8.2 14.5 27.9 12.0 13.4 9.3 14.3 23.4 10.0 4.5 7.8 5.9 11.5 25.8 9.0 13.1 23.1 26.1 12.0 25.0 19.0 16.9 8.7 6.8 11.1 18.8 23.5 6.9 7.8 6.6 27.7 12.6 5.4 15.5 8.2 17.5 15.5 7.5 10.7 16.0 12.0 17.9 15.3 20.6 10.1 13.9 9.9 6.5 12.8 8.7 13.7 10.5 7.2 22.7 7.2 16.4 9.1 9.8 22.2 10.9 12.7 12.3 9.7 11.1 11.1 9.7 9.2 9.9 8.6 8.7 8.1 10.8 9.1 12.4 6.3 16.8 17.3 11.6 17.5 17.5 15.6 18.6 14.6 16.4 17.6 26.8 19.9 6.7 9.6 6.9 7.5 23.8 12.7 17.4 15.9 14.0 11.8 20.5 24.9 22.5 25.9 13.5 17.1 0.0 28.6 27.4 17.9 21.7 9.2 30.6 13.9 23.8 21.5 11.6 11.6 13.3 21.3 11.3 11.8 17.2 31.9 14.3 22.7 10.5 23.7 17.8 10.9 25.8 17.6 22.4 28.3 9.9 42.1 11.8 16.1 11.2 GOLGB1 "GCP, GCP372, giantin, GOLIM1" ENSG00000173230 "Golgin B1" Q14789 3 121663199-121749767 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011008, HPA011555" Enhanced Enhanced "Golgi apparatus" NA NA 35000 "Golgi apparatus" "HPA011008: AB_1079011, HPA011555: AB_1079010" "unprognostic (2.56e-2)" "unprognostic (7.69e-2)" "unprognostic (1.46e-1)" "unprognostic (6.57e-2)" "unprognostic (5.34e-2)" "unprognostic (5.96e-2)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (6.58e-2)" "unprognostic (7.49e-2)" "unprognostic (3.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.37e-1)" "unprognostic (9.90e-3)" "unprognostic (9.05e-2)" 16.7 22.3 17.6 12.5 24.0 12.8 25.7 22.3 28.0 24.6 16.8 8.2 27.1 12.7 16.5 35.0 15.9 14.0 14.0 16.6 16.8 10.3 19.7 17.2 13.4 8.5 26.1 14.5 20.9 23.4 26.2 39.4 24.4 17.7 28.0 18.4 12.5 21.5 29.3 11.7 20.5 20.6 21.3 30.6 14.8 16.6 12.1 20.7 9.0 19.3 12.9 10.1 17.2 13.6 3.6 5.8 16.4 4.4 3.9 5.0 1.5 12.4 10.1 10.0 6.5 19.4 21.0 6.3 8.1 17.9 7.9 8.9 8.8 4.6 2.7 6.9 15.1 7.9 5.8 5.9 8.8 9.3 3.9 11.4 7.7 12.1 12.1 11.6 8.5 10.6 17.1 21.0 4.9 12.4 17.1 9.9 4.7 3.5 6.3 8.3 9.0 2.5 6.2 6.5 12.1 10.6 3.4 7.9 6.4 11.7 12.9 7.1 7.9 10.0 7.1 10.5 11.9 8.9 9.6 13.8 7.6 4.6 3.3 5.8 11.7 6.9 4.6 10.2 4.2 2.8 1.7 4.4 4.3 5.0 2.2 4.0 3.6 4.0 3.6 2.7 3.2 3.7 4.0 16.4 3.9 1.7 5.8 3.8 1.5 17.6 24.0 22.3 28.0 16.8 10.3 26.1 14.5 17.7 20.7 271.0 217.5 57.3 76.1 45.8 96.8 233.9 61.1 235.5 260.5 50.6 115.8 64.0 10.0 92.8 49.3 75.2 103.8 0.0 97.4 43.0 46.5 79.1 109.0 56.8 29.9 65.2 88.1 67.5 38.4 14.5 183.8 42.9 32.1 73.9 106.8 82.0 80.8 76.4 187.0 23.3 194.7 84.1 52.3 117.3 42.8 40.0 126.1 28.8 70.0 79.9 GOLIM4 "GIMPC, GOLPH4, GPP130, P138" ENSG00000173905 "Golgi integral membrane protein 4" O00461 3 168008677-168095975 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Muller glia cells: 383.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 11.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001677, HPA002315" Enhanced Enhanced "Golgi apparatus" NA NA 730000 "Golgi apparatus" "HPA001677: AB_1079017, HPA002315: AB_1079018" "unprognostic (6.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.19e-1)" "unprognostic (6.27e-2)" "unprognostic (2.11e-1)" "unprognostic (4.76e-2)" "unprognostic (2.44e-1)" "unprognostic (5.17e-2)" "unprognostic (1.39e-1)" "unprognostic (6.46e-2)" "unprognostic (1.10e-1)" "unprognostic (6.31e-2)" "unprognostic (1.84e-3)" "unprognostic (9.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (9.62e-3)" 13.0 7.1 25.5 10.8 25.6 4.2 9.3 12.4 24.2 11.3 28.0 18.6 7.4 34.8 15.6 7.1 9.3 9.7 16.2 28.5 31.3 13.8 17.1 31.7 15.6 5.5 24.6 23.2 11.6 8.8 13.3 10.3 12.0 26.8 10.2 28.0 13.3 8.9 7.9 15.5 6.1 44.2 14.6 36.2 11.7 13.0 4.9 30.9 1.8 11.0 12.0 5.0 10.7 12.2 2.0 4.5 11.7 3.3 6.0 0.8 0.7 6.6 9.9 14.1 8.9 24.1 17.9 4.2 39.4 21.2 10.8 9.9 11.0 8.2 14.7 47.4 23.7 17.3 12.3 12.9 11.6 16.4 22.9 16.6 23.8 29.8 13.6 9.7 22.6 13.6 18.6 6.1 9.9 9.8 9.6 12.3 0.0 12.1 42.9 12.1 11.1 0.0 6.1 13.8 12.6 10.7 0.0 14.2 20.4 6.0 2.4 12.7 16.5 24.2 7.3 7.9 9.8 9.0 10.3 22.8 34.4 13.2 23.9 31.4 16.7 11.9 31.7 17.0 13.6 15.3 3.0 3.0 11.7 0.8 3.3 0.2 1.5 0.2 0.6 3.7 2.0 0.0 0.3 0.1 6.0 2.5 4.5 0.0 0.7 25.5 25.6 12.4 24.2 31.3 13.8 24.6 23.2 26.8 30.9 44.7 105.2 7.5 21.5 36.9 14.2 142.4 53.5 13.4 34.2 34.9 35.3 9.2 14.9 18.7 1.3 65.5 167.7 23.3 25.9 12.0 109.4 20.4 56.6 158.4 37.0 15.9 60.8 43.0 34.5 1.5 36.8 47.8 35.4 18.0 109.7 383.7 19.8 168.4 48.1 30.0 58.3 45.3 104.0 5.0 38.5 31.5 4.6 20.1 119.7 6.8 GOLM1 "bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73" ENSG00000135052 "Golgi membrane protein 1" Q8NBJ4 9 86026146-86100173 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 83.7;stomach 1: 114.2" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 319.9;Paneth cells: 285.1" "Cancer enhanced" "Detected in all" "prostate cancer: 343.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 79.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010638, HPA011929, CAB015341" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA 70000000 "Golgi apparatus" "CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888" "unprognostic (1.47e-1)" "unprognostic (2.31e-2)" "unprognostic (1.10e-1)" "prognostic favorable (8.14e-5)" "unprognostic (1.97e-1)" "unprognostic (4.40e-3)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.89e-3)" "unprognostic (2.81e-1)" "unprognostic (1.44e-1)" "unprognostic (1.20e-1)" "unprognostic (1.34e-2)" "unprognostic (5.59e-3)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (2.87e-3)" "unprognostic (1.23e-1)" 6.1 53.6 23.3 15.6 18.2 1.9 11.6 23.1 27.7 21.0 53.1 16.5 6.0 62.8 11.9 9.3 4.2 11.1 83.7 4.0 24.7 26.3 22.0 6.6 4.4 2.8 17.4 20.4 11.1 19.5 7.8 15.1 5.3 22.3 39.9 45.5 10.9 43.0 3.5 2.6 4.6 16.5 8.4 25.5 11.3 114.2 5.0 16.4 5.0 19.5 7.9 36.6 11.6 11.0 1.2 2.2 7.2 5.9 1.2 5.7 2.5 29.5 29.0 21.8 24.6 28.1 16.3 23.0 13.5 9.8 21.3 17.3 14.2 59.3 0.6 13.4 26.1 20.6 22.9 13.3 13.3 15.5 1.0 21.2 9.2 19.3 0.7 16.7 13.6 7.4 24.7 7.2 20.0 7.3 26.8 36.3 4.4 5.7 0.9 12.0 13.9 1.6 10.2 34.3 38.7 21.0 8.7 24.9 4.5 35.5 12.7 24.6 15.4 18.4 40.0 15.1 14.7 22.5 14.0 23.1 5.6 15.7 16.8 16.0 79.6 7.5 0.2 24.1 6.1 12.1 2.1 5.5 0.8 5.7 3.9 0.7 1.1 0.5 0.8 0.7 1.2 0.7 1.3 7.2 1.2 5.9 2.2 0.3 2.5 23.3 18.2 23.1 20.8 24.7 26.3 17.4 20.4 22.3 16.4 8.9 11.7 0.0 9.8 2.1 16.9 4.3 71.4 69.6 61.4 33.2 7.9 5.4 21.6 148.1 319.9 21.5 193.3 0.0 197.4 30.2 20.6 130.5 1.1 12.5 9.8 63.5 70.2 9.8 7.5 196.5 17.0 3.3 21.9 1.0 76.8 15.7 203.7 285.1 12.4 11.5 6.1 0.0 10.3 8.9 34.3 0.9 5.4 4.3 129.2 17.6 GOLT1A "CGI-141, FLJ42654, GOT1, MGC62027, YMR292W" ENSG00000174567 "Golgi transport 1A" Q6ZVE7 1 204198160-204214092 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 35.9;liver: 74.9" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 38.2;Hepatocytes: 109.9" "Cancer enriched" "Detected in many" 6 "liver cancer: 80.7" "Group enriched" "Detected in many" 5 "basal ganglia: 8.8;cerebellum: 3.8;hypothalamus: 3.8" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.5" "Lineage enriched" "Detected in single" 12 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "CACO-2: 9.3;CAPAN-2: 10.8;Hep G2: 13.3;MCF7: 22.5;OE19: 8.5;RT4: 14.7;SK-BR-3: 14.8" "Not detected" "Not detected" NA NA "unprognostic (3.43e-1)" "unprognostic (1.13e-1)" "unprognostic (2.22e-3)" "unprognostic (2.66e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (6.20e-3)" "unprognostic (2.14e-1)" "unprognostic (8.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.26e-2)" "unprognostic (7.33e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (6.35e-5)" "unprognostic (1.37e-1)" "unprognostic (5.96e-2)" "unprognostic (1.18e-3)" "prognostic favorable (1.51e-4)" 0.3 0.0 1.2 0.8 8.8 0.0 1.7 3.8 0.8 3.5 13.7 0.4 1.7 15.5 0.3 3.6 0.3 1.0 3.4 0.3 1.0 3.8 5.9 74.9 3.1 0.3 0.8 0.4 0.4 12.5 7.1 8.7 1.0 0.9 2.9 1.6 0.5 1.0 3.7 0.6 0.0 35.9 1.6 0.6 0.3 1.9 0.5 0.3 0.4 0.6 0.3 0.4 10.9 2.5 0.1 0.0 0.0 0.0 0.0 1.5 0.6 0.2 4.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 9.3 10.8 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 2.1 8.5 0.1 0.0 0.0 0.2 4.6 14.7 0.7 1.0 0.4 14.8 0.0 0.4 4.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.1 1.4 1.4 0.0 0.0 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.6 1.2 8.8 3.8 0.8 1.0 3.8 0.8 0.4 0.9 0.3 0.0 17.9 0.0 11.9 0.0 2.5 0.3 38.2 0.0 5.7 15.7 0.0 11.4 11.6 24.4 0.6 0.0 13.1 0.0 16.1 0.2 0.4 10.6 1.1 109.9 1.1 1.6 9.9 3.1 2.8 0.0 0.0 0.0 1.7 0.0 3.2 0.0 18.5 1.7 0.0 10.4 0.1 0.0 0.1 2.3 0.9 0.1 22.1 0.0 7.4 12.9 GOLT1B "CGI-141, GOT1, YMR292W" ENSG00000111711 "Golgi transport 1B" Q9Y3E0 12 21501781-21518408 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055909, HPA066383" Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA055909: AB_2682967, HPA066383: AB_2685667" "unprognostic (1.22e-2)" "unprognostic (3.07e-3)" "unprognostic (1.84e-1)" "unprognostic (3.65e-1)" "unprognostic (3.45e-1)" "unprognostic (5.37e-3)" "prognostic unfavorable (1.99e-8)" "unprognostic (2.24e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.83e-10)" "unprognostic (3.13e-1)" "unprognostic (2.14e-1)" "unprognostic (6.78e-2)" "unprognostic (1.04e-1)" 21.1 26.0 18.3 18.2 24.4 23.4 20.4 31.9 30.4 22.3 14.7 18.9 13.8 12.0 16.9 18.9 15.3 14.6 16.4 17.0 19.1 22.4 23.2 40.1 19.9 16.0 20.1 16.2 14.1 30.9 11.3 34.9 31.1 23.8 19.0 16.8 16.1 17.4 15.3 15.9 14.5 13.0 19.6 22.2 17.8 15.3 11.6 17.5 13.5 19.1 11.6 15.6 22.5 14.2 17.7 22.2 26.7 22.9 14.8 21.1 19.4 11.4 12.1 10.0 12.9 20.2 31.5 17.0 45.1 17.2 14.3 23.4 15.8 17.0 6.9 11.6 23.4 26.6 11.1 8.3 9.3 25.1 10.1 7.9 10.1 7.9 11.0 22.5 13.0 13.0 15.9 18.2 17.1 31.5 24.6 12.9 8.6 6.3 7.7 21.9 10.7 5.8 21.6 27.6 9.9 8.7 5.0 24.4 14.5 11.8 7.0 2.7 8.4 18.4 7.2 24.6 33.8 10.0 14.7 14.4 16.9 18.4 20.8 24.5 7.5 16.3 18.3 23.1 12.5 22.7 26.7 20.6 14.8 17.9 22.9 21.1 17.7 21.1 19.5 20.2 16.5 19.3 19.2 5.6 14.8 20.9 22.2 20.4 19.4 18.3 24.4 31.9 30.4 19.1 22.4 20.1 16.2 23.8 17.5 8.9 14.1 38.8 20.4 41.4 28.9 15.5 15.3 8.1 25.0 15.7 9.8 25.0 23.2 28.8 2.7 27.1 10.5 0.0 29.2 54.0 45.6 35.7 20.8 21.7 37.8 17.5 12.6 17.8 21.3 3.6 16.1 35.7 50.6 22.6 22.7 17.8 30.7 14.4 18.7 17.4 6.7 12.9 30.7 22.9 31.0 55.8 53.5 33.1 13.2 20.5 GOSR1 "GOLIM2, GOS-28, GOS28, GS28, P28" ENSG00000108587 "Golgi SNAP receptor complex member 1" O95249 17 30477362-30527592 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020590 Uncertain NA NA "HPA020590: AB_1850374" "unprognostic (1.54e-1)" "unprognostic (4.02e-1)" "unprognostic (4.59e-3)" "unprognostic (1.08e-1)" "unprognostic (3.41e-1)" "unprognostic (2.83e-2)" "unprognostic (4.98e-2)" "unprognostic (1.16e-2)" "unprognostic (1.71e-1)" "unprognostic (4.34e-2)" "unprognostic (9.93e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.26e-4)" "unprognostic (8.64e-2)" "unprognostic (3.68e-1)" "unprognostic (7.56e-2)" "unprognostic (1.14e-2)" 22.5 23.4 24.8 19.8 26.4 12.9 26.2 30.6 29.3 24.9 23.1 27.0 21.9 18.8 29.9 18.7 29.2 28.6 19.2 21.4 24.5 19.1 30.4 35.5 19.7 18.7 22.6 21.6 26.1 30.6 40.6 36.9 27.7 23.7 26.3 27.7 22.7 26.1 24.9 27.5 24.3 23.6 24.8 22.7 21.4 23.4 33.5 25.7 30.4 29.9 20.5 27.7 25.4 20.9 29.2 25.6 23.4 22.3 28.2 30.6 15.2 16.4 27.4 18.0 12.8 14.0 14.2 13.7 18.4 17.7 25.8 23.3 23.8 11.1 18.4 17.4 18.7 23.2 15.2 22.2 18.2 29.2 10.6 16.8 18.3 20.3 15.0 19.0 28.6 20.3 14.2 14.6 25.2 28.3 14.5 16.9 17.3 28.8 16.8 17.1 10.4 21.0 13.4 18.8 27.2 11.4 19.9 26.4 14.9 13.1 23.9 16.2 15.3 19.2 39.9 22.2 20.6 29.8 19.9 20.3 17.2 15.0 15.8 23.7 20.4 27.9 32.3 17.0 13.2 23.2 19.7 18.7 23.4 26.4 22.3 30.4 26.9 25.4 24.7 25.2 29.2 30.6 29.5 21.7 28.2 21.0 25.6 26.5 15.2 24.8 26.4 30.6 29.3 24.5 19.1 22.6 21.6 23.7 25.7 26.8 38.7 29.5 32.9 24.0 58.6 41.8 43.3 75.0 66.0 40.1 58.9 40.7 43.1 33.8 63.5 31.3 23.4 0.0 35.2 34.3 27.4 26.0 59.0 42.9 24.6 98.5 40.3 30.7 26.6 32.0 27.3 20.5 15.1 30.7 29.1 65.5 32.0 17.5 26.5 33.5 63.9 19.4 30.7 66.9 38.6 23.7 61.1 26.2 27.6 27.0 GOSR2 "Bos1, GS27" ENSG00000108433 "Golgi SNAP receptor complex member 2" O14653 17 46923075-46975524 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Early spermatids: 276.4;Late spermatids: 609.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB017456, HPA048956, HPA054472" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "CAB017456: AB_10532285, HPA048956: AB_2680569, HPA054472: AB_2682499" "unprognostic (3.28e-2)" "unprognostic (1.18e-1)" "unprognostic (1.49e-2)" "unprognostic (3.54e-2)" "unprognostic (1.30e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (2.41e-2)" "unprognostic (7.23e-3)" "unprognostic (2.41e-1)" "unprognostic (2.46e-3)" "unprognostic (4.50e-1)" "unprognostic (3.07e-1)" "unprognostic (2.84e-3)" "unprognostic (4.29e-2)" 22.4 24.6 27.9 18.7 27.8 12.5 22.6 22.2 31.1 24.1 25.3 28.9 38.0 43.9 25.9 30.0 19.7 19.6 21.4 28.7 25.2 26.5 37.4 39.7 21.0 23.8 27.0 22.8 27.5 33.6 26.8 40.6 27.6 23.5 22.0 25.1 25.8 28.4 29.8 34.4 19.2 38.2 27.1 27.8 31.5 20.6 38.8 18.4 23.6 24.9 15.2 30.7 20.9 21.0 16.9 15.5 15.1 37.0 13.9 17.6 15.5 18.3 20.8 14.8 18.0 25.3 18.2 17.2 26.4 26.1 28.8 26.1 26.3 11.5 16.4 15.1 33.3 30.3 13.4 19.2 21.5 35.7 35.0 14.7 24.7 17.1 25.7 28.0 19.2 20.0 19.0 21.1 23.5 33.6 22.2 23.6 19.0 24.1 22.2 20.8 20.3 20.8 10.4 13.7 25.8 29.6 17.9 28.8 19.0 18.2 15.8 13.1 27.6 14.5 8.7 20.4 27.1 24.3 13.4 27.6 27.3 17.6 21.2 25.2 28.9 16.2 25.9 25.8 12.4 29.9 15.1 15.5 13.1 16.8 28.9 15.5 14.8 15.0 13.8 15.5 16.9 14.9 13.0 1.8 13.9 37.0 14.0 17.6 15.5 27.9 27.8 22.2 31.1 25.2 26.5 27.0 22.8 23.5 18.4 23.8 18.9 31.8 12.9 14.7 15.9 13.2 17.8 13.4 9.1 31.4 5.9 25.2 19.9 30.2 276.4 16.2 24.0 23.3 37.2 27.0 16.9 16.6 13.9 19.8 38.2 22.3 6.9 20.9 22.6 609.8 15.5 16.8 10.1 24.4 14.3 15.6 42.8 20.1 13.4 42.5 18.6 0.0 15.6 29.6 24.5 14.8 44.1 16.0 10.2 20.7 GP1BA "CD42b, GP1B, GPIbalpha" ENSG00000185245 "Glycoprotein Ib platelet alpha subunit" P07359 17 4932297-4935030 "CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation, von Willebrand disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 37.8" "Cell type enhanced" "Detected in some" 6 "Distal tubular cells: 3.3;Ito cells: 3.7;Rod photoreceptor cells: 3.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 7 "basophil: 7.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 7.5" "Cell line enriched" "Detected in some" 24 "HEL: 40.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002496, HPA013316" Supported NA NA 2000000000 "CAB002496: AB_563748, HPA013316: AB_1855459" "unprognostic (4.87e-4)" "unprognostic (8.21e-2)" "unprognostic (2.81e-2)" "unprognostic (6.11e-3)" "unprognostic (1.50e-2)" "unprognostic (1.59e-3)" "unprognostic (7.30e-3)" "unprognostic (5.58e-2)" "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "unprognostic (6.54e-4)" "unprognostic (1.27e-1)" "unprognostic (4.85e-3)" "unprognostic (4.58e-3)" "unprognostic (2.56e-1)" "unprognostic (3.53e-4)" "unprognostic (8.35e-2)" 0.7 0.1 0.4 15.8 1.2 5.3 0.7 1.9 0.7 0.7 1.0 0.2 0.2 1.5 0.6 0.7 5.7 0.8 0.3 4.2 0.5 0.4 1.0 1.6 3.5 37.8 0.4 0.2 0.7 0.4 0.0 0.4 1.1 0.4 0.7 0.6 0.3 7.7 0.2 3.0 4.6 3.7 0.2 0.4 13.0 0.9 0.6 0.2 2.0 0.8 0.8 17.6 0.9 1.1 0.0 0.3 7.5 0.2 0.0 0.2 3.6 0.0 1.3 0.3 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 1.2 0.1 1.2 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.4 1.0 40.2 0.5 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.4 0.4 0.0 0.4 0.3 0.2 0.1 0.1 0.2 0.7 0.3 0.2 0.0 0.7 0.0 0.2 0.5 0.0 0.2 0.4 1.7 0.7 0.2 0.2 0.2 0.9 0.1 0.7 0.2 1.0 0.6 0.6 0.4 7.5 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 1.0 0.0 0.1 0.3 0.0 3.6 0.4 1.2 1.9 0.4 0.5 0.4 0.4 0.2 0.4 0.2 0.0 0.0 0.0 0.4 1.3 1.9 0.8 0.0 0.0 0.0 0.0 2.0 0.3 3.3 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.8 0.1 0.0 0.0 3.7 1.9 0.2 0.3 1.1 0.0 1.0 0.0 0.4 0.0 0.0 1.8 0.6 3.1 0.0 0.3 0.9 0.6 1.6 0.2 0.5 0.0 0.3 GP1BB "CD42c, GPIbbeta" ENSG00000203618 "Glycoprotein Ib platelet beta subunit" P13224 22 19722945-19724771 "CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.7;brain: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 6.3;neutrophil: 11.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.0" "Cell line enhanced" "Detected in some" "HEK 293: 5.8;K-562: 10.3;NB-4: 8.6;REH: 10.5;SH-SY5Y: 5.0;U-2 OS: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA 110000000 0.9 0.5 16.7 1.2 19.6 0.5 0.5 7.3 9.0 0.5 1.7 1.2 0.7 0.5 1.8 0.5 0.7 2.9 15.0 4.1 0.5 0.9 0.6 0.6 2.7 0.5 0.5 0.5 2.5 0.6 1.3 0.7 1.9 0.5 1.2 10.4 0.5 1.0 0.2 1.8 1.9 0.5 0.7 0.7 0.5 0.2 0.1 1.7 11.0 1.2 0.1 0.3 61.7 0.0 0.9 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 1.7 5.8 2.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.3 0.1 0.1 0.4 0.4 8.6 0.4 0.0 3.2 10.5 0.0 0.1 0.0 0.0 3.8 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.0 6.3 1.2 1.1 0.2 0.3 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.1 11.0 0.1 0.0 1.7 0.3 61.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GP2 ZAP75 ENSG00000169347 "Glycoprotein 2" P55259 16 20309572-20327808 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 354 "pancreas: 1812.8" "Cell type enhanced" "Detected in some" 30 "Cholangiocytes: 117.2;Exocrine glandular cells: 424.3;Glandular cells: 76.3" "Cancer enriched" "Detected in many" 14 "pancreatic cancer: 320.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015739, HPA016668" Enhanced "Intracellular and membrane" NA NA 27000 "HPA015739: AB_1849905, HPA016668: AB_1849907" "unprognostic (2.14e-2)" "unprognostic (1.97e-2)" "unprognostic (5.68e-2)" "unprognostic (4.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.84e-1)" "unprognostic (6.35e-2)" "unprognostic (8.17e-3)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.1 0.0 5.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.4 1812.8 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.4 1.4 2.3 0.9 0.6 0.8 0.3 0.5 0.3 0.6 1.0 0.0 0.2 1.3 0.3 0.0 0.5 0.2 1.3 0.7 1.3 1.4 0.4 0.6 0.7 0.1 0.4 0.7 0.3 0.2 0.4 1.3 0.2 0.0 0.4 0.9 0.0 0.3 0.2 0.0 0.5 0.0 0.5 0.8 0.8 0.5 0.0 0.5 0.6 0.1 0.1 1.2 0.8 0.8 1.8 0.1 0.2 0.7 0.5 0.6 1.4 0.2 0.7 0.5 0.5 0.0 1.1 2.2 0.8 1.0 0.7 0.8 0.3 0.3 0.6 0.3 2.0 0.9 0.7 0.8 0.3 0.5 0.6 0.7 0.7 0.1 1.4 0.7 0.7 2.3 0.6 0.2 1.4 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.1 117.2 0.0 0.0 0.0 0.0 0.0 8.3 0.8 6.1 0.0 0.6 0.0 424.3 0.0 0.0 76.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 0.0 7.2 2.0 0.2 32.3 13.9 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.0 1.4 GP5 CD42d ENSG00000178732 "Glycoprotein V platelet" P40197 3 194394821-194398354 "CD markers, Plasma proteins, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;naive CD8 T-cell: 2.2" "Group enriched" "Detected in many" 6 "dendritic cells: 1.1;T-cells: 2.2" "Cell line enriched" "Detected in some" 9 "HEL: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA072646 Approved Cytosol NA NA 400000000 Cytosol "HPA072646: " "unprognostic (3.74e-2)" "unprognostic (3.40e-1)" "unprognostic (5.22e-2)" "unprognostic (2.96e-2)" "unprognostic (1.74e-2)" "unprognostic (1.35e-3)" "unprognostic (1.69e-3)" "unprognostic (1.68e-1)" "unprognostic (3.41e-1)" "unprognostic (2.80e-2)" "unprognostic (1.65e-1)" "unprognostic (5.51e-2)" "unprognostic (1.21e-2)" "unprognostic (4.18e-2)" "unprognostic (3.14e-1)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" 0.3 0.0 0.4 2.1 0.5 1.6 0.3 0.3 0.3 0.6 0.3 0.3 0.3 0.0 0.3 0.3 0.3 2.5 0.3 0.3 0.4 0.6 0.3 0.6 0.9 3.7 0.3 0.3 0.8 0.3 0.0 0.4 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.1 0.9 0.3 0.3 1.7 0.2 0.3 0.3 0.3 1.0 0.3 1.9 0.3 0.5 0.1 1.1 0.2 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.4 0.1 0.1 2.0 2.2 0.1 0.0 0.0 1.1 0.0 0.4 0.4 0.5 0.3 0.3 0.4 0.6 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GP6 GPVI ENSG00000088053 "Glycoprotein VI platelet" Q9HCN6 19 55013705-55038264 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.9" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 5.9;Early spermatids: 10.5;Late spermatids: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "HEL: 13.9;K-562: 5.9;U-2 OS: 4.0" HPA066482 Approved Approved Nucleoplasm "Intracellular and membrane" NA NA 28000000 Nucleoplasm "HPA066482: AB_2685674" "unprognostic (3.06e-3)" "unprognostic (4.58e-2)" "unprognostic (1.74e-5)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (7.50e-4)" "unprognostic (2.81e-1)" "unprognostic (1.00e-1)" "unprognostic (4.18e-2)" "unprognostic (3.04e-1)" "unprognostic (1.12e-1)" "unprognostic (1.53e-1)" "unprognostic (2.62e-1)" "unprognostic (3.32e-2)" "unprognostic (5.44e-3)" "unprognostic (2.70e-2)" 0.3 0.3 0.8 0.4 1.4 4.4 0.9 4.6 1.6 1.3 0.4 0.3 0.3 0.1 1.1 0.3 2.1 0.5 0.5 5.4 0.7 0.9 0.4 1.5 1.4 0.3 0.3 0.3 0.6 0.3 0.6 0.3 2.8 0.3 0.6 0.4 2.0 0.7 3.0 0.3 3.2 0.3 0.3 0.3 8.9 0.1 4.2 1.0 0.3 0.6 0.3 0.3 0.7 1.8 0.0 0.3 1.3 0.2 0.0 0.1 4.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.6 0.2 0.0 0.2 0.2 0.5 13.9 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.3 5.9 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.4 0.2 0.2 0.1 4.0 0.1 0.0 0.3 0.0 0.4 0.1 0.4 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 4.0 0.8 1.4 4.6 1.6 0.7 0.9 0.3 0.3 0.3 1.0 0.0 0.0 0.0 0.1 0.0 1.5 0.4 0.0 1.4 0.0 0.0 5.9 0.1 0.0 0.0 10.5 0.3 0.3 0.0 0.3 0.2 0.2 0.3 1.1 0.0 0.1 3.2 0.0 2.5 1.2 6.4 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 2.4 0.0 0.0 1.1 0.9 0.1 0.5 0.0 0.0 0.7 GP9 "CD42a, GPIX" ENSG00000169704 "Glycoprotein IX platelet" P14770 3 129060767-129062406 "CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 27.1;bone marrow: 10.0;lymphoid tissue: 24.5" "Group enriched" "Detected in some" 11 "Early spermatids: 14.0;Late spermatids: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 8.8;neutrophil: 7.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.8" "Cell line enriched" "Detected in some" 14 "HEL: 43.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063182 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 68000000 "Plasma membrane, Cytosol" Nucleoplasm "HPA063182: AB_2684956" "unprognostic (1.70e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (3.80e-2)" "unprognostic (2.50e-2)" "unprognostic (3.24e-1)" "unprognostic (2.53e-2)" "unprognostic (8.47e-2)" "unprognostic (8.70e-2)" 0.2 0.1 0.1 0.1 0.1 10.0 0.1 0.0 0.6 0.4 0.5 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.1 5.0 0.8 0.1 0.1 0.4 4.8 0.0 0.8 0.2 0.5 0.1 0.0 0.3 1.5 0.4 0.1 0.4 0.2 0.0 0.6 0.2 0.0 0.1 0.0 0.1 24.5 0.3 2.2 0.0 0.0 0.6 0.6 0.0 0.6 3.0 0.1 1.5 8.8 0.6 0.0 0.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.6 0.1 0.1 0.3 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.0 7.5 0.0 0.0 1.5 0.0 27.1 0.1 0.1 0.0 0.6 0.8 0.1 0.8 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 13.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPA33 A33 ENSG00000143167 "Glycoprotein A33" Q99795 1 167052836-167166479 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 101.1" "Group enriched" "Detected in some" 10 "Enterocytes: 384.9;Mucus-secreting cells: 185.3;Paneth cells: 288.3;Undifferentiated cells: 97.5" "Cancer enriched" "Detected in many" 6 "colorectal cancer: 84.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 17.8;T-reg: 13.0" "Lineage enriched" "Detected in many" 7 "T-cells: 17.8" "Cell line enriched" "Detected in some" 12 "OE19: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018858, CAB025943" Enhanced NA NA "CAB025943: , HPA018858: AB_1849909" "unprognostic (2.41e-2)" "unprognostic (1.71e-3)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (8.39e-4)" "unprognostic (1.55e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-2)" "unprognostic (9.63e-2)" "unprognostic (2.10e-2)" "unprognostic (9.44e-2)" "unprognostic (6.75e-2)" "unprognostic (5.22e-3)" "unprognostic (3.13e-1)" "unprognostic (9.68e-3)" "unprognostic (2.96e-3)" 0.2 0.2 0.2 12.1 0.2 0.0 0.2 0.2 0.2 0.2 46.9 0.2 0.1 31.6 0.2 0.1 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 1.2 1.6 0.2 0.1 0.2 0.2 0.0 0.2 0.3 0.2 0.2 43.5 0.2 0.3 0.1 0.2 0.2 101.1 1.4 0.2 0.6 0.2 0.2 0.1 0.6 0.2 0.1 0.6 0.2 0.2 1.7 1.7 0.1 2.5 0.1 17.8 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.4 1.4 17.2 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 2.5 1.1 0.1 7.6 3.9 1.7 1.7 17.8 2.4 0.1 0.1 1.6 0.0 13.0 4.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 384.9 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.5 0.0 25.1 0.0 2.6 1.3 0.3 0.9 0.0 0.0 185.3 0.7 0.1 288.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 97.5 0.1 GPAA1 "GAA1, hGAA1" ENSG00000197858 "Glycosylphosphatidylinositol anchor attachment 1" O43292 8 144082590-144086216 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 70.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077224 Approved Approved "Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Centrosome, Mitochondria" "HPA077224: " "unprognostic (2.53e-3)" "unprognostic (1.39e-1)" "unprognostic (3.06e-2)" "unprognostic (2.57e-2)" "unprognostic (2.49e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-3)" "unprognostic (2.64e-1)" "unprognostic (8.92e-2)" "unprognostic (1.67e-2)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (3.89e-1)" "unprognostic (1.27e-1)" "unprognostic (2.73e-2)" 25.2 35.3 23.0 15.9 25.5 32.1 20.0 19.9 43.7 23.6 24.4 27.1 32.3 28.2 26.3 38.3 23.2 24.0 31.1 35.0 20.3 17.4 29.3 47.2 24.9 31.4 19.9 19.0 23.8 46.6 36.4 17.1 32.9 25.1 23.1 10.7 27.4 46.0 35.4 28.5 23.3 31.0 16.3 22.3 21.9 23.0 24.6 16.1 24.0 29.0 22.2 18.6 19.3 18.6 17.2 41.0 21.7 33.3 24.7 34.5 26.1 16.4 29.1 6.8 21.3 15.8 13.5 23.7 16.9 16.8 14.2 14.8 12.0 27.3 9.0 24.7 18.3 6.7 20.5 4.5 16.8 2.1 15.1 15.3 14.1 13.6 8.8 15.3 6.9 21.3 14.8 15.7 14.5 10.1 11.5 11.7 15.3 10.2 31.9 13.6 57.9 13.3 6.4 6.8 19.4 70.8 9.3 8.6 42.8 12.3 11.6 11.8 16.2 22.1 28.5 12.4 3.9 18.3 19.5 7.7 13.2 23.0 7.5 18.9 17.8 13.7 5.9 23.4 8.5 17.9 11.8 24.8 21.7 34.5 29.9 23.7 15.5 17.4 27.1 23.1 17.2 17.3 24.1 5.8 24.7 33.3 41.0 15.0 26.1 23.0 25.5 19.9 43.7 20.3 17.4 19.9 19.0 25.1 16.1 35.7 40.2 43.2 39.6 25.5 57.0 39.1 40.8 26.8 11.4 41.8 60.9 106.7 21.6 110.5 4.7 29.4 99.5 0.0 78.8 116.9 52.6 52.7 65.6 67.2 78.9 52.4 54.6 43.0 45.7 6.6 37.4 40.2 69.2 59.5 47.2 94.2 69.6 80.7 35.3 71.5 53.5 58.2 37.1 132.9 51.7 19.4 91.4 48.0 73.6 37.1 GPAT3 "AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324" ENSG00000138678 "Glycerol-3-phosphate acyltransferase 3" Q53EU6 4 83535914-83605875 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.2;kidney: 43.7" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 41.3;Early spermatids: 68.5;Proximal tubular cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 42.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 51.6;GAMG: 39.2;HMC-1: 19.0;U-87 MG: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029414, CAB033749" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB033749: AB_2224941, HPA029414: AB_10601562" "unprognostic (9.51e-2)" "unprognostic (1.43e-2)" "unprognostic (5.67e-2)" "unprognostic (1.70e-1)" "unprognostic (3.50e-3)" "unprognostic (2.61e-2)" "unprognostic (2.05e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (2.92e-1)" "prognostic favorable (2.71e-9)" "unprognostic (3.74e-1)" "unprognostic (3.45e-2)" "unprognostic (2.53e-3)" "prognostic unfavorable (8.21e-4)" 7.9 0.7 0.7 5.2 1.4 5.2 17.5 4.2 2.9 3.7 18.0 1.2 1.3 20.2 3.0 2.1 5.1 2.1 6.0 24.8 1.2 2.2 43.7 9.0 3.2 4.5 1.9 0.8 12.9 1.7 11.8 5.8 1.2 9.5 2.6 5.7 1.3 3.6 1.9 35.9 1.9 47.2 3.7 3.0 4.3 7.4 4.6 1.4 0.9 26.6 14.6 3.4 4.5 7.2 0.0 23.2 42.0 9.7 0.5 1.8 2.9 9.8 9.7 0.0 0.1 0.5 1.2 0.2 0.7 1.4 0.2 0.2 0.7 51.6 0.0 1.1 1.8 39.2 2.2 4.6 0.9 0.1 0.6 2.2 0.0 3.1 9.5 1.4 2.8 19.0 0.6 0.0 0.3 1.1 3.8 4.8 2.7 7.9 7.8 0.2 1.0 0.7 0.7 0.2 14.5 4.2 0.1 2.2 3.7 9.8 0.6 0.2 0.0 1.9 2.0 5.4 0.5 0.4 0.5 0.2 2.3 4.2 2.3 9.3 0.4 0.6 0.0 22.6 5.6 17.2 42.0 9.7 1.0 0.2 7.7 1.8 0.0 1.0 0.6 23.2 0.0 0.7 0.3 26.4 0.5 6.1 0.1 0.6 2.9 0.7 1.4 4.2 2.9 1.2 2.2 1.9 0.8 9.5 1.4 6.0 5.0 0.0 41.3 0.0 0.0 0.0 7.6 2.7 9.1 10.4 0.0 0.2 13.3 1.6 68.5 0.6 21.6 0.0 5.9 1.0 0.1 25.8 7.0 11.9 15.3 4.8 1.2 5.5 16.7 17.2 1.1 28.3 0.0 5.4 4.8 0.0 6.6 8.0 0.7 50.3 0.2 6.5 0.0 8.8 1.7 0.0 0.8 0.0 2.1 25.4 GPAT4 "AGPAT6, DKFZp586M1819, LPAAT-zeta, TSARG7" ENSG00000158669 "Glycerol-3-phosphate acyltransferase 4" Q86UL3 8 41577187-41625001 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016471 Approved NA NA "HPA016471: AB_1844649" "unprognostic (3.05e-2)" "unprognostic (4.05e-2)" "unprognostic (4.24e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (7.45e-2)" "unprognostic (2.99e-3)" "unprognostic (5.08e-2)" "unprognostic (5.11e-2)" "unprognostic (3.79e-2)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.98e-2)" "prognostic favorable (4.15e-4)" "unprognostic (1.73e-3)" "unprognostic (3.16e-2)" "unprognostic (3.35e-1)" "unprognostic (2.04e-2)" "prognostic favorable (5.65e-4)" 15.7 27.4 14.4 17.8 17.2 16.6 28.1 43.8 21.9 16.9 14.0 23.1 22.7 13.0 22.8 12.0 13.1 14.6 15.8 14.1 14.0 13.1 20.8 26.7 18.7 13.8 18.5 13.6 16.6 17.3 35.7 22.3 23.3 20.5 15.1 15.1 21.0 20.8 15.5 42.1 14.5 14.6 23.0 18.0 17.5 17.8 15.5 16.6 15.2 14.5 12.4 19.4 16.6 14.9 9.1 18.9 10.8 15.0 4.9 12.1 11.1 14.7 16.4 19.7 15.4 21.6 26.3 17.3 32.2 27.7 24.4 25.6 11.0 29.8 20.6 22.6 26.5 30.1 8.6 23.0 14.5 31.7 22.0 12.7 24.0 18.3 10.1 12.6 2.5 34.7 16.5 10.7 25.4 9.2 21.0 25.1 20.6 17.9 24.3 25.0 6.3 22.4 6.5 21.0 27.3 8.8 13.2 19.7 11.1 14.8 22.2 12.9 17.8 12.5 17.3 34.5 23.6 24.0 16.3 18.2 25.3 17.8 28.9 24.0 13.1 17.6 22.5 20.8 14.2 24.7 10.8 15.0 6.6 12.1 14.3 11.3 8.3 9.3 11.9 18.9 9.1 8.5 8.2 3.5 4.9 12.0 7.1 8.7 11.1 14.4 17.2 43.8 21.9 14.0 13.1 18.5 13.6 20.5 16.6 3.0 37.7 8.0 11.2 0.0 15.6 0.0 30.6 10.7 25.0 10.4 9.8 29.1 3.3 35.3 36.6 18.0 10.2 70.0 34.4 34.1 9.3 25.6 2.3 53.8 22.9 14.3 16.4 20.9 29.5 44.4 11.8 16.4 0.0 37.9 19.7 12.7 36.5 14.0 9.9 23.5 12.1 6.5 0.0 3.0 13.4 0.0 33.8 10.2 13.3 13.6 GPBAR1 "BG37, GPCR, GPCR19, GPR131, M-BAR, MGC40597, TGR5" ENSG00000179921 "G protein-coupled bile acid receptor 1" Q8TDU6 2 218259496-218263859 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 85.6;gallbladder: 73.8" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 14.0;Intestinal endocrine cells: 44.2;Kupffer cells: 42.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 3.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 85.6;non-classical monocyte: 78.5" "Lineage enriched" "Detected in many" 5 "monocytes: 85.6" "Cell line enhanced" "Detected in some" "ASC diff: 3.1;HHSteC: 5.1;SCLC-21H: 2.6;U-937: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA062890 Enhanced NA NA "HPA062890: AB_2684896" "unprognostic (8.47e-2)" "unprognostic (3.72e-3)" "unprognostic (1.88e-2)" "unprognostic (9.49e-2)" "unprognostic (1.44e-2)" "unprognostic (4.66e-2)" "unprognostic (2.54e-1)" "unprognostic (2.63e-1)" "unprognostic (8.76e-3)" "unprognostic (4.32e-2)" "unprognostic (4.64e-2)" "unprognostic (1.55e-1)" "unprognostic (7.40e-7)" "unprognostic (4.18e-2)" "unprognostic (4.14e-2)" "unprognostic (2.27e-1)" "unprognostic (2.29e-1)" 19.9 1.1 0.3 2.6 0.4 1.8 11.4 0.2 0.4 0.7 2.7 0.5 0.8 1.0 1.1 1.4 1.3 0.9 73.8 3.8 0.2 0.0 3.2 1.7 2.2 3.8 0.4 0.2 1.4 1.5 0.0 0.7 8.9 0.4 2.0 0.5 0.9 0.5 0.9 0.8 0.8 3.2 10.3 0.2 6.5 5.5 1.5 0.2 1.0 1.5 1.8 0.6 3.2 0.7 0.0 17.4 0.8 85.6 0.0 0.1 15.8 0.2 0.1 0.4 0.0 3.1 0.1 0.9 0.0 0.4 0.0 0.1 0.8 0.4 0.2 0.3 0.3 0.2 0.1 0.1 0.3 0.0 0.0 0.8 0.3 0.5 0.4 5.1 0.4 1.4 0.0 2.5 0.0 0.0 0.2 0.2 0.4 0.3 0.5 0.6 0.3 0.2 0.7 0.2 0.0 0.0 0.2 0.0 0.2 1.6 1.1 2.6 2.3 0.3 0.7 0.4 0.2 0.0 0.8 0.0 0.1 0.3 0.3 0.2 0.3 0.7 0.1 0.3 5.1 0.3 0.0 36.4 0.0 0.1 85.6 0.1 0.0 0.0 0.1 17.4 0.0 0.0 0.0 0.8 0.0 78.5 0.7 0.1 15.8 0.3 0.4 0.2 0.4 0.2 0.0 0.4 0.2 0.4 0.2 0.0 4.3 0.9 0.1 0.2 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.4 10.0 0.0 2.6 0.5 0.0 0.0 0.4 2.8 1.9 0.1 1.1 0.0 14.0 0.0 44.2 3.1 42.9 1.6 3.1 6.8 0.0 1.0 0.3 0.0 0.4 0.8 2.5 0.0 0.0 0.0 0.8 0.0 0.0 0.4 1.4 0.0 0.1 0.2 GPD2 ENSG00000115159 "Glycerol-3-phosphate dehydrogenase 2" P43304 2 156435290-156613735 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 81.5;Late spermatids: 75.7;Urothelial cells: 62.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.5;eosinophil: 3.1;intermediate monocyte: 3.3;myeloid DC: 5.1;neutrophil: 2.3;non-classical monocyte: 4.3" "Group enriched" "Detected in many" 5 "dendritic cells: 5.1;granulocytes: 3.1;monocytes: 6.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008012, HPA045506" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 7600000 Mitochondria "HPA008012: AB_1079013, HPA045506: AB_2679355" "unprognostic (1.30e-1)" "unprognostic (2.50e-1)" "unprognostic (1.08e-1)" "unprognostic (4.79e-3)" "unprognostic (3.25e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (1.44e-4)" "unprognostic (1.75e-1)" "unprognostic (1.57e-1)" "unprognostic (1.86e-1)" "unprognostic (2.60e-3)" "unprognostic (6.67e-2)" "unprognostic (6.02e-3)" "unprognostic (1.73e-1)" "unprognostic (1.89e-1)" "unprognostic (2.41e-1)" "unprognostic (1.01e-2)" 12.7 5.5 19.6 12.4 21.4 11.4 15.2 23.1 16.3 10.9 17.6 8.8 8.1 13.7 9.1 5.0 23.1 18.4 8.6 6.2 18.7 12.7 7.7 3.4 11.4 9.0 11.3 11.8 9.0 7.4 26.6 11.0 7.9 10.3 10.8 17.8 6.8 21.5 7.5 21.2 12.0 24.9 5.9 9.4 10.6 17.1 9.5 8.3 6.7 11.8 17.6 14.0 10.1 10.5 0.5 5.1 3.1 6.5 0.7 0.9 2.7 17.5 11.3 7.1 10.7 14.9 19.0 0.0 22.5 13.8 14.4 17.3 22.2 16.1 3.1 14.6 11.7 5.9 20.2 13.0 20.1 18.4 10.8 4.6 2.6 20.6 0.0 5.2 4.8 5.9 9.0 6.4 24.8 12.4 9.1 10.9 1.6 5.5 0.8 18.0 10.3 0.1 0.4 12.7 6.6 15.0 5.5 4.5 4.1 16.9 22.0 12.6 4.5 20.0 15.1 13.1 11.9 5.1 12.6 10.6 2.8 12.0 12.2 15.8 0.6 0.1 0.1 15.5 1.3 21.5 0.6 6.5 3.1 0.5 3.3 0.9 0.3 0.3 0.9 5.1 0.5 0.7 0.5 2.3 0.7 4.3 0.5 0.9 2.7 19.6 21.4 23.1 16.3 18.7 12.7 11.3 11.8 10.3 8.3 17.9 10.5 5.1 17.9 17.7 4.3 11.3 10.2 10.7 10.3 21.0 5.9 7.0 1.7 8.3 81.5 8.4 22.3 0.0 11.6 12.6 7.8 44.4 12.7 1.8 19.2 4.8 16.7 11.6 14.5 75.7 11.2 13.3 23.6 6.4 14.3 4.3 13.0 20.4 6.7 3.4 9.5 0.0 5.7 1.6 2.0 18.7 9.3 6.9 16.6 62.5 GPER1 "CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR" ENSG00000164850 "G protein-coupled estrogen receptor 1" Q99527 7 1082208-1093815 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 22.2;Kupffer cells: 13.5;Paneth cells: 8.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 4.3;intermediate monocyte: 4.2;myeloid DC: 8.4" "Group enriched" "Detected in many" 18 "dendritic cells: 8.4;monocytes: 4.3" "Cell line enhanced" "Detected in many" "AN3-CA: 10.1;Daudi: 10.6;Hep G2: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA016718, HPA027052" Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol NA NA Nucleoli "Nucleoplasm, Vesicles, Cytosol" "HPA016718: , HPA027052: AB_10612112" "unprognostic (4.74e-2)" "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "prognostic favorable (1.17e-4)" "unprognostic (2.17e-1)" "unprognostic (6.17e-2)" "unprognostic (3.45e-1)" "unprognostic (6.38e-2)" "unprognostic (2.40e-1)" "unprognostic (1.23e-1)" "unprognostic (1.42e-2)" "unprognostic (2.49e-1)" "unprognostic (2.37e-2)" "unprognostic (1.79e-2)" "unprognostic (1.58e-1)" "unprognostic (7.26e-2)" "unprognostic (7.78e-2)" 14.2 10.9 12.1 3.6 13.2 1.2 11.5 5.1 11.1 6.4 7.1 5.6 3.5 2.0 5.4 1.8 5.5 4.8 3.2 6.0 8.3 6.2 7.4 19.5 25.6 6.4 8.6 8.7 3.3 4.0 1.8 4.7 13.3 6.1 6.8 3.7 5.2 4.2 11.8 8.6 2.8 2.6 5.5 4.1 6.5 23.9 2.2 8.6 1.3 16.5 2.3 2.8 6.4 7.2 0.3 8.4 0.0 4.3 0.0 0.0 1.6 0.9 0.4 0.2 10.1 2.5 2.4 1.0 5.8 3.9 1.8 3.3 0.2 0.2 10.6 1.0 7.3 0.1 0.5 0.1 0.0 0.2 2.2 1.8 0.0 1.3 19.4 0.3 0.1 0.7 1.3 0.0 1.1 0.0 1.4 0.5 0.2 0.1 0.1 0.4 0.7 0.0 0.3 1.9 2.0 6.9 0.9 0.0 0.0 0.2 0.0 0.1 4.0 0.0 0.4 2.1 0.8 0.2 0.1 1.4 0.4 2.6 6.1 1.8 0.0 0.0 3.6 3.4 0.2 0.2 0.0 4.3 0.0 0.0 4.2 0.0 0.3 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 1.6 12.1 13.2 5.1 11.1 8.3 6.2 8.6 8.7 6.1 8.6 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 2.2 1.3 0.0 2.8 0.5 1.4 0.7 0.0 22.2 0.5 0.0 1.2 0.6 13.5 0.6 2.6 1.7 0.0 0.0 2.5 4.3 0.8 8.2 1.1 3.0 0.4 0.0 4.1 0.3 3.1 0.3 0.0 0.0 1.5 0.0 GPHB5 "GPB5, ZLUT1" ENSG00000179600 "Glycoprotein hormone beta 5" Q86YW7 14 63312835-63318879 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AF22: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPM6A GPM6 ENSG00000150625 "Glycoprotein M6A" P51674 4 175632934-176002664 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 249.7" "Cell type enhanced" "Detected in many" 21 "Alveolar cells type 1: 89.3;Bipolar cells: 197.8;Horizontal cells: 117.6;Muller glia cells: 415.5" "Cancer enriched" "Detected in many" 107 "glioma: 110.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 22.2;naive B-cell: 9.1" "Lineage enriched" "Detected in many" 12 "B-cells: 22.2" "Group enriched" "Detected in some" 10 "AF22: 26.8;Daudi: 22.3;HAP1: 9.2;U-251 MG: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017338 Supported NA NA "HPA017338: AB_1849933" "unprognostic (1.36e-4)" "unprognostic (3.35e-3)" "unprognostic (2.96e-2)" "unprognostic (1.34e-2)" "unprognostic (9.45e-2)" "unprognostic (1.34e-1)" "unprognostic (3.82e-5)" "unprognostic (2.24e-1)" "unprognostic (9.13e-3)" "unprognostic (1.06e-1)" "unprognostic (3.69e-2)" "unprognostic (7.73e-2)" "unprognostic (2.24e-2)" "unprognostic (3.53e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-3)" "unprognostic (2.60e-3)" 2.4 3.1 81.8 2.0 51.1 1.8 2.5 83.3 249.7 4.1 4.1 15.9 0.0 2.2 4.3 2.7 2.3 4.4 3.1 2.3 54.4 31.2 4.3 6.2 8.8 2.4 23.5 39.4 6.5 2.2 2.0 1.0 1.7 13.1 3.7 3.8 6.3 1.9 4.2 1.8 1.9 2.3 5.5 9.6 6.9 2.0 2.1 17.0 0.0 5.9 0.0 2.0 2.4 0.5 22.2 1.7 0.3 0.1 0.0 0.0 0.4 0.1 0.4 26.8 0.2 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.5 0.4 22.3 0.1 0.1 0.9 0.4 9.2 0.7 0.0 0.1 2.1 0.2 1.8 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.9 0.0 0.6 0.8 0.3 0.6 0.0 0.3 0.1 0.1 0.1 0.0 1.1 0.2 0.2 0.1 0.4 0.1 0.2 0.3 0.0 0.1 0.5 0.3 0.3 26.5 0.8 0.0 1.3 0.9 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.1 9.1 0.0 0.0 0.1 0.0 0.1 1.7 0.0 0.4 81.8 51.1 83.3 79.7 54.4 31.2 23.5 39.4 13.1 17.0 89.3 8.3 7.5 4.6 1.5 197.8 0.6 0.0 0.0 1.2 0.0 13.7 0.0 1.7 0.0 6.9 10.3 0.0 0.0 0.2 0.1 0.2 6.5 0.0 0.8 0.3 117.6 0.0 71.2 4.1 2.5 3.1 0.6 0.0 0.0 0.0 415.5 0.0 0.0 1.4 0.9 24.7 0.0 0.7 0.2 0.0 0.6 0.1 0.0 0.0 4.2 GPM6B "M6B, MGC17150, MGC54284" ENSG00000046653 "Glycoprotein M6B" Q13491 X 13771031-13938638 "Predicted membrane proteins" "Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 219.5" "Cell type enriched" "Detected in many" 6 "Muller glia cells: 1904.1" "Group enriched" "Detected in many" 14 "glioma: 192.5;melanoma: 41.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 222 "plasmacytoid DC: 33.4" "Lineage enriched" "Detected in single" 240 "dendritic cells: 33.4" "Cell line enhanced" "Detected in some" "AF22: 42.8;AN3-CA: 42.4;ASC TERT1: 21.8;HSkMC: 32.1;SK-MEL-30: 42.1" "Low region specificity" "Detected in all" HPA002913 Approved NA NA "HPA002913: AB_2263553" "unprognostic (1.56e-2)" "unprognostic (3.42e-1)" "unprognostic (1.83e-1)" "unprognostic (3.70e-2)" "unprognostic (8.55e-2)" "unprognostic (2.75e-3)" "unprognostic (2.12e-2)" "unprognostic (1.92e-2)" "unprognostic (4.27e-2)" "prognostic favorable (2.67e-4)" "unprognostic (1.79e-2)" "unprognostic (4.78e-2)" "unprognostic (2.38e-3)" "unprognostic (8.34e-2)" "unprognostic (2.12e-1)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" 4.6 5.5 68.4 3.9 55.1 2.0 12.4 24.1 219.5 10.2 5.7 68.7 1.1 3.6 4.3 6.7 6.4 4.2 3.9 5.9 62.6 33.1 4.5 2.0 6.7 2.6 68.9 47.3 3.1 2.9 1.9 2.6 2.1 44.1 9.9 4.9 3.2 7.4 16.9 2.1 7.1 4.3 3.8 109.4 7.2 3.3 3.0 64.8 0.0 3.5 0.0 2.3 3.3 2.7 0.1 33.4 0.1 0.0 0.1 0.1 0.2 0.1 0.1 42.8 42.4 12.1 21.8 0.1 0.2 1.9 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.3 2.1 0.2 0.0 0.1 7.0 0.1 2.8 0.1 0.4 0.1 0.2 32.1 0.2 0.0 0.5 0.1 0.0 0.8 0.1 1.9 0.4 0.1 0.9 0.1 13.4 0.0 0.7 0.5 3.8 6.5 0.0 0.1 2.1 1.2 0.2 1.2 42.1 12.3 0.2 0.9 0.0 0.2 0.3 0.1 0.5 0.1 0.0 0.1 0.4 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 33.4 0.0 0.2 68.4 55.1 24.1 43.1 62.6 33.1 68.9 47.3 44.1 64.8 0.0 3.2 20.4 22.0 29.3 74.8 1.1 0.0 13.4 5.7 21.0 82.5 3.8 0.0 3.2 0.4 6.3 3.8 0.0 3.3 2.8 24.2 20.1 4.6 0.4 1.0 25.4 1.2 16.5 1.0 1.5 22.5 1.8 339.1 2.8 2.6 1904.1 1.9 3.2 30.1 0.6 143.8 45.3 22.6 4.3 9.4 14.9 11.4 15.2 2.9 12.6 GPNMB "HGFIN, NMB" ENSG00000136235 "Glycoprotein nmb" Q14956 7 23235967-23275108 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 137.7" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 290.6;Hofbauer cells: 788.7;Melanocytes: 566.8;Suprabasal keratinocytes: 314.4" "Cancer enhanced" "Detected in all" "melanoma: 354.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.8;intermediate monocyte: 7.1" "Lineage enriched" "Detected in many" 6 "monocytes: 7.1" "Cell line enriched" "Detected in many" 5 "ASC diff: 329.4" "Region enhanced" "Detected in some" "olfactory region: 12.1" "Low region specificity" "Detected in single" "Intracellular and membrane" NA NA 41000000 "unprognostic (3.37e-2)" "unprognostic (1.18e-1)" "unprognostic (6.65e-2)" "unprognostic (1.82e-1)" "unprognostic (5.14e-2)" "unprognostic (4.16e-1)" "unprognostic (1.39e-1)" "unprognostic (3.89e-2)" "unprognostic (7.13e-2)" "unprognostic (2.79e-1)" "unprognostic (2.83e-1)" "unprognostic (6.40e-2)" "unprognostic (2.08e-3)" "unprognostic (1.24e-2)" "unprognostic (3.46e-2)" "unprognostic (4.82e-1)" "unprognostic (6.95e-2)" 137.7 4.3 7.7 9.5 5.9 0.7 33.8 1.0 5.5 56.0 20.7 7.9 9.2 3.5 56.5 34.6 32.6 17.3 45.8 50.0 5.5 2.8 10.8 8.9 58.7 24.1 4.4 5.0 39.7 4.0 0.3 3.7 52.7 18.2 24.8 15.7 115.7 18.1 9.8 11.3 97.2 12.1 26.2 15.7 8.4 11.2 19.8 1.5 20.6 14.0 31.7 26.7 33.4 41.9 0.4 0.8 1.2 7.1 0.3 0.2 0.8 1.1 0.0 0.0 0.0 329.4 60.0 0.0 2.1 35.7 1.7 7.6 0.0 0.0 0.0 0.0 6.8 3.2 7.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 41.3 8.6 2.9 0.3 47.8 0.0 0.0 0.0 0.0 9.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.5 27.8 0.1 0.0 0.0 11.1 51.4 0.0 0.1 0.1 0.0 10.5 1.2 19.1 0.3 0.3 0.5 0.0 3.6 0.1 10.5 0.9 3.8 0.1 0.2 7.1 0.1 0.2 0.0 0.0 0.8 0.4 0.2 0.1 1.2 0.3 0.3 0.8 0.1 0.8 7.7 5.9 1.0 5.5 5.5 2.8 4.4 5.0 18.2 1.5 17.9 28.2 2.7 6.4 290.6 0.4 176.6 2.5 2.7 14.8 71.5 0.0 5.9 3.3 0.4 2.4 9.6 0.0 0.0 0.7 2.7 76.6 1.8 20.9 3.8 788.7 1.6 0.0 6.2 136.5 2.1 120.3 119.7 566.8 4.6 0.0 0.2 0.7 0.0 101.5 0.7 0.5 0.0 64.0 3.8 1.2 314.4 24.1 0.0 0.0 10.9 GPR1 ENSG00000183671 "G protein-coupled receptor 1" P46091 2 206175316-206218047 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.1" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 10.0;Muller glia cells: 4.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 10.7;pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HHSteC: 53.7;hTCEpi: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010525 Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles" "HPA010525: AB_1078919" "unprognostic (5.32e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (2.25e-2)" "unprognostic (3.27e-5)" "unprognostic (1.36e-1)" "unprognostic (4.00e-3)" "unprognostic (1.49e-2)" "unprognostic (7.89e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-3)" "unprognostic (5.65e-2)" "unprognostic (4.29e-4)" "unprognostic (8.48e-4)" "unprognostic (1.21e-1)" "unprognostic (2.68e-2)" "unprognostic (3.06e-3)" 2.3 5.0 0.5 0.6 10.7 0.1 1.7 0.4 1.2 4.1 0.6 4.8 1.6 0.2 1.3 0.7 6.6 1.1 2.7 3.8 1.6 0.5 0.7 0.0 0.5 3.1 0.2 0.3 3.2 0.1 0.0 0.4 19.1 6.6 0.7 0.6 1.1 1.5 0.4 1.5 6.7 0.5 2.3 0.3 0.2 0.2 1.6 1.0 0.0 0.7 2.2 1.2 3.1 7.7 0.5 0.1 1.4 0.2 0.5 0.2 0.6 0.8 0.1 0.7 0.0 0.1 3.0 0.2 5.5 9.5 3.4 2.9 0.0 0.0 0.0 0.3 2.7 0.2 0.1 0.2 0.0 1.1 0.0 0.1 0.0 1.8 0.0 53.7 0.0 0.0 2.2 24.2 4.9 7.9 4.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 2.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 2.4 1.1 0.0 0.0 0.6 0.0 0.0 0.1 4.1 1.9 4.8 0.4 0.0 0.0 0.0 1.5 0.0 0.1 1.3 0.2 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.5 0.2 0.2 1.4 0.5 0.1 0.1 0.2 0.6 0.5 10.7 0.4 1.2 1.6 0.5 0.2 0.3 6.6 1.0 0.0 0.0 0.0 0.6 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.9 0.6 0.0 0.0 0.3 GPR101 ENSG00000165370 "G protein-coupled receptor 101" Q96P66 X 137030148-137031674 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "brain: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 1.6;JURKAT: 2.3" "Region enhanced" "Detected in many" "hypothalamus: 44.7" "Low region specificity" "Detected in many" HPA001084 Uncertain NA NA "HPA001084: AB_1078920" 0.0 0.0 0.0 0.0 11.1 0.1 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR107 "FLJ20998, KIAA1624, LUSTR1, RP11-88G17" ENSG00000148358 "G protein-coupled receptor 107" Q5VW38 9 130053426-130140169 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031704 Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA031704: AB_10601018" "prognostic unfavorable (3.56e-5)" "unprognostic (7.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (8.72e-2)" "unprognostic (1.10e-3)" "unprognostic (1.35e-2)" "unprognostic (2.18e-1)" "unprognostic (3.39e-2)" "unprognostic (2.59e-1)" "unprognostic (1.85e-1)" "prognostic favorable (1.87e-5)" "unprognostic (4.10e-2)" "unprognostic (5.83e-2)" "unprognostic (6.50e-2)" "unprognostic (1.34e-3)" 21.0 21.6 24.2 16.6 26.8 12.5 23.7 28.1 28.0 25.0 24.0 35.9 20.5 13.3 24.0 19.1 22.5 26.2 20.9 20.6 22.3 26.6 24.4 22.9 23.0 17.4 29.5 23.1 21.8 26.6 34.4 21.6 40.7 29.9 28.4 26.3 29.3 23.0 24.4 20.5 25.6 15.4 26.7 28.8 17.2 18.9 23.9 22.9 17.3 40.0 15.4 19.7 19.4 17.3 2.0 3.4 6.3 6.3 1.4 2.4 2.3 12.7 18.7 17.9 14.1 19.2 20.4 17.9 20.4 23.0 17.3 17.3 17.9 17.4 7.1 15.1 22.5 20.3 32.2 13.7 12.6 14.9 11.0 9.2 7.5 23.0 10.2 18.6 15.6 11.0 17.0 19.7 17.2 17.4 19.7 15.9 8.6 10.6 7.1 14.8 15.7 8.3 6.3 12.0 26.0 14.2 7.9 26.3 11.2 14.5 17.8 6.3 13.8 26.7 19.0 14.4 16.3 33.3 8.2 18.7 22.0 11.8 17.9 15.4 4.5 15.0 6.8 19.6 7.5 20.7 2.8 5.7 3.4 1.5 6.1 2.1 1.8 1.6 1.7 3.4 2.0 1.0 2.4 6.3 1.4 6.3 2.1 1.5 2.3 24.2 26.8 28.1 27.6 22.3 26.6 29.5 23.1 29.9 22.9 23.8 17.1 3.9 4.2 5.7 15.8 20.6 25.5 13.4 12.5 15.7 37.3 11.3 0.0 11.0 5.3 9.0 11.9 0.0 15.2 14.5 12.6 12.8 5.8 11.5 13.2 17.5 9.2 24.5 18.1 4.9 17.5 8.3 13.5 13.6 17.2 12.0 17.7 10.5 18.0 6.1 15.2 0.0 8.9 11.7 9.5 9.5 22.3 6.5 13.2 7.3 GPR108 LUSTR2 ENSG00000125734 "G protein-coupled receptor 108" Q9NPR9 19 6729914-6737603 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041924, HPA041951, HPA063863" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: AB_2685135" "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "prognostic favorable (1.04e-7)" "unprognostic (1.58e-1)" "unprognostic (5.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (4.23e-2)" "unprognostic (3.01e-2)" "unprognostic (7.89e-2)" "unprognostic (3.57e-2)" "prognostic favorable (1.29e-9)" "unprognostic (8.68e-3)" "unprognostic (2.95e-2)" "unprognostic (4.96e-3)" "unprognostic (4.13e-3)" 17.6 29.7 15.4 13.8 17.9 14.2 20.1 15.2 23.1 22.2 24.3 24.3 27.0 20.4 20.6 20.8 25.1 26.1 23.5 14.0 14.6 12.3 35.4 33.9 19.6 17.1 20.5 12.9 22.6 41.5 30.9 15.1 27.1 17.2 24.0 17.7 31.3 35.4 27.4 10.6 19.1 29.2 16.9 15.7 20.9 20.6 26.3 19.4 17.2 38.8 14.7 23.1 21.4 19.8 14.8 25.8 54.3 36.3 23.1 26.7 35.5 11.7 12.8 7.9 15.5 31.1 16.9 9.0 9.2 27.9 12.8 13.6 7.9 13.5 5.6 17.1 18.7 15.3 10.1 8.9 19.1 6.6 22.5 10.3 9.1 13.5 10.4 30.6 5.8 12.4 18.3 36.7 12.3 24.9 17.0 14.9 13.7 9.1 37.5 12.9 8.1 10.2 8.4 5.7 21.3 11.4 8.3 9.0 21.2 26.6 11.6 0.0 8.6 9.3 15.2 14.0 7.1 14.5 14.1 12.3 7.3 4.7 23.2 9.7 24.3 13.1 3.9 25.2 18.7 7.8 20.4 35.8 35.7 26.7 32.7 24.3 14.8 21.4 22.5 25.8 14.1 15.5 17.7 54.3 23.1 36.3 9.2 23.4 35.5 15.4 17.9 15.2 23.1 14.6 12.3 20.5 12.9 17.2 19.4 8.9 12.6 24.2 35.3 23.6 27.7 7.3 35.7 17.4 7.9 34.9 21.6 51.9 31.5 69.1 25.9 30.8 74.1 0.0 96.9 31.1 27.5 30.8 25.4 22.9 52.7 20.6 20.8 38.6 25.1 69.5 21.9 38.9 28.7 56.9 51.5 33.6 68.5 77.2 17.3 45.7 33.2 38.8 26.8 22.1 14.0 27.9 49.0 40.7 43.6 33.9 GPR119 "GPCR2, hGPCR2" ENSG00000147262 "G protein-coupled receptor 119" Q8TDV5 X 130384440-130385447 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.5;pancreas: 8.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 11 "pancreatic cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "CACO-2: 2.7;Hep G2: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "prognostic favorable (6.93e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR12 "GPCR21, PPP1R84" ENSG00000132975 "G protein-coupled receptor 12" P47775 13 26755200-26760785 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 29.4;salivary gland: 7.7" "Group enriched" "Detected in some" 5 "Hofbauer cells: 13.2;Horizontal cells: 31.8;Intestinal endocrine cells: 9.4" "Group enriched" "Detected in some" 7 "breast cancer: 0.5;glioma: 0.8;ovarian cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "basophil: 2.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.4" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 18.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050972 Uncertain NA NA "HPA050972: AB_2681295" "unprognostic (2.37e-2)" "unprognostic (9.64e-3)" "unprognostic (3.75e-1)" "unprognostic (3.30e-1)" "unprognostic (1.40e-2)" "unprognostic (4.65e-2)" "unprognostic (1.42e-1)" "unprognostic (7.35e-2)" "unprognostic (5.53e-2)" "unprognostic (3.83e-2)" "unprognostic (2.40e-1)" 1.1 0.7 4.9 0.5 29.4 0.9 4.6 17.7 14.6 1.4 0.7 1.6 0.0 0.7 0.6 0.5 0.8 2.5 0.7 0.7 5.6 2.6 0.6 0.5 0.7 0.6 2.2 4.8 0.6 0.5 0.5 0.7 1.6 1.1 0.6 0.7 1.9 7.7 0.6 0.9 4.4 0.9 0.9 0.7 0.8 0.7 0.8 6.6 0.0 0.6 0.0 0.6 0.6 0.0 0.3 0.2 2.4 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.3 0.1 0.5 0.1 0.1 0.2 0.0 0.1 4.9 29.4 17.7 8.4 5.6 2.6 2.2 4.8 1.1 6.6 0.0 0.0 0.0 0.2 0.1 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 13.2 31.8 9.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.2 GPR132 G2A ENSG00000183484 "G protein-coupled receptor 132" Q9UNW8 14 105049389-105065445 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Stress response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.0;lymphoid tissue: 20.2" "Cell type enhanced" "Detected in some" 11 "B-cells: 8.9;granulocytes: 12.7;Macrophages: 18.8;monocytes: 22.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "HDLM-2: 20.3;Karpas-707: 21.0;THP-1: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA029694, HPA029695" Supported NA NA "HPA029694: AB_10600213, HPA029695: AB_10601984" "unprognostic (2.71e-3)" "prognostic favorable (3.21e-4)" "unprognostic (1.68e-2)" "unprognostic (1.07e-3)" "unprognostic (1.16e-1)" "prognostic favorable (6.44e-4)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "unprognostic (3.35e-2)" "unprognostic (8.54e-2)" "unprognostic (1.10e-1)" "unprognostic (4.18e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (6.71e-2)" "unprognostic (4.60e-2)" "unprognostic (1.23e-3)" "unprognostic (2.72e-1)" 2.9 1.2 1.8 11.5 2.7 9.3 1.5 0.7 1.8 1.5 2.4 3.3 0.0 1.3 1.0 1.6 1.4 3.0 2.9 1.4 1.6 1.2 4.5 0.8 5.9 20.2 3.3 1.0 1.1 0.8 0.4 0.9 2.0 2.2 1.4 1.2 1.5 3.0 0.7 0.8 3.5 6.6 1.0 3.7 15.4 2.1 0.6 2.5 4.3 6.5 0.7 17.4 3.1 1.9 8.6 9.1 9.8 14.0 9.3 10.6 6.6 0.0 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 2.7 0.5 0.0 0.0 0.6 0.0 0.0 0.0 20.3 0.3 0.5 0.1 0.0 0.0 1.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.5 0.0 2.0 0.1 0.0 0.0 1.6 0.1 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.3 6.3 0.3 0.0 0.1 0.0 0.2 0.5 1.9 0.2 0.0 1.8 0.0 9.8 9.0 8.6 10.6 12.5 9.9 7.2 8.2 9.2 9.1 8.6 8.6 8.9 7.9 9.3 14.0 5.2 5.8 6.6 1.8 2.7 0.7 1.8 1.6 1.2 3.3 1.0 2.2 2.5 0.0 3.4 8.9 0.1 1.4 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.4 0.1 12.7 0.0 3.8 0.0 0.0 0.0 7.9 0.0 0.0 18.8 5.0 22.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 7.5 0.0 1.0 GPR135 "HUMNPIIY20, PAFR" ENSG00000181619 "G protein-coupled receptor 135" Q8IZ08 14 59429022-59465342 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 34.1" "Group enriched" "Detected in many" 15 "Early spermatids: 121.5;Late spermatids: 153.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045337 Uncertain NA NA "HPA045337: AB_10960528" "unprognostic (1.55e-1)" "unprognostic (3.00e-1)" "unprognostic (6.09e-3)" "unprognostic (1.14e-1)" "unprognostic (4.20e-2)" "unprognostic (8.47e-2)" "unprognostic (3.22e-1)" "unprognostic (3.91e-2)" "unprognostic (4.64e-2)" "unprognostic (1.09e-1)" "unprognostic (2.47e-2)" "unprognostic (1.55e-1)" "unprognostic (2.75e-5)" "unprognostic (1.33e-2)" "unprognostic (1.90e-1)" "unprognostic (2.71e-2)" "unprognostic (2.68e-3)" 2.1 3.7 2.0 1.2 3.4 0.4 1.2 3.2 2.7 2.9 1.8 2.1 2.3 0.5 3.8 3.4 1.6 6.7 2.7 3.0 2.0 3.3 1.5 0.9 1.3 1.1 1.2 3.7 4.4 4.7 6.8 12.3 1.3 4.7 4.3 1.2 1.7 0.7 6.2 1.0 0.7 1.1 2.7 0.9 1.0 1.4 34.1 1.8 0.4 3.6 0.2 0.7 2.7 2.4 0.1 0.4 0.0 0.4 0.3 1.6 0.1 1.1 1.2 2.1 2.5 1.8 2.6 1.7 2.2 1.3 1.5 1.6 0.5 2.3 1.0 1.7 2.7 0.7 1.3 1.0 0.9 2.1 2.1 0.8 0.7 5.7 0.8 1.5 1.3 1.0 1.5 1.6 2.2 1.0 3.3 1.0 1.1 1.3 1.7 2.2 0.7 0.4 3.1 1.5 0.2 4.6 1.5 1.6 1.1 1.5 1.0 2.7 3.3 5.2 0.9 0.2 1.1 1.1 0.5 3.7 3.8 3.1 1.1 2.5 0.4 0.0 0.9 1.3 1.5 1.7 0.0 0.3 0.0 0.2 0.0 0.3 0.0 0.7 0.0 0.4 0.1 0.2 0.4 0.0 0.3 0.4 0.0 1.6 0.1 2.0 3.4 3.2 2.6 2.0 3.3 1.2 3.7 4.7 1.8 0.0 0.3 0.0 0.8 0.2 3.5 2.0 0.0 9.4 4.5 3.5 2.0 0.3 0.0 0.6 121.5 0.4 0.0 0.0 0.6 0.2 1.5 0.5 0.0 0.0 0.1 1.6 2.9 1.3 0.0 153.7 2.8 0.1 0.0 0.0 0.0 3.0 0.5 0.0 3.5 0.6 2.5 0.0 1.0 6.7 1.1 0.1 0.1 0.0 0.4 0.2 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 157.3;Late spermatids: 445.6;Spermatocytes: 157.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" NA NA "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: AB_2684889" "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favorable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 10.3 12.2 18.6 12.8 21.8 10.4 12.0 20.0 23.1 8.9 10.5 13.2 13.8 11.2 9.0 10.4 10.5 13.3 10.3 9.7 18.5 14.3 14.0 14.1 9.3 10.8 15.4 9.1 7.3 9.4 16.4 10.1 28.9 16.5 10.5 5.8 12.4 13.9 12.8 9.9 15.9 11.4 7.1 12.7 11.3 13.6 64.8 14.4 9.9 14.3 5.5 9.3 9.5 16.2 3.9 3.4 15.7 3.0 1.9 3.4 1.4 9.0 20.3 7.0 20.2 13.7 7.3 29.7 10.8 9.1 10.8 7.0 14.9 12.8 9.3 18.8 6.8 19.4 18.2 9.8 6.0 3.1 29.5 12.3 8.9 20.8 9.5 7.8 5.8 17.3 9.1 9.5 9.4 7.2 7.4 5.8 11.2 7.9 22.8 6.4 23.0 6.5 15.8 9.5 7.4 20.2 13.2 7.5 15.1 7.5 12.4 11.2 13.6 13.1 18.0 11.7 7.4 19.7 2.5 9.3 30.0 20.8 22.6 7.8 18.3 33.5 7.8 21.4 5.0 18.2 1.7 3.0 5.3 2.7 2.8 3.4 2.8 2.3 2.0 3.1 3.9 2.6 2.2 15.7 1.9 2.3 3.4 1.6 1.4 18.6 21.8 20.0 23.1 18.5 14.3 15.4 9.1 16.5 14.4 3.0 9.1 11.8 16.0 12.8 13.4 4.4 10.2 9.4 4.5 12.2 11.8 40.6 13.3 33.8 157.3 14.0 21.2 0.0 23.3 58.9 21.7 17.8 2.3 8.9 21.4 19.1 15.5 9.8 9.1 445.6 17.8 11.8 13.5 20.8 13.8 33.6 24.9 14.0 15.2 15.2 6.0 25.8 12.5 157.6 37.2 13.2 100.0 12.8 13.4 18.0 GPR137B TM7SF1 ENSG00000077585 "G protein-coupled receptor 137B" O60478 1 236142505-236221865 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "monocytes: 130.8;Muller glia cells: 234.3;Rod photoreceptor cells: 135.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 27.3;SK-MEL-30: 67.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026422 Approved NA NA "HPA026422: AB_1849338" "unprognostic (1.59e-3)" "unprognostic (6.89e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (6.49e-2)" "unprognostic (2.42e-1)" "unprognostic (1.96e-1)" "unprognostic (5.54e-2)" "unprognostic (1.41e-1)" "unprognostic (5.06e-2)" "unprognostic (2.73e-2)" "unprognostic (5.53e-2)" "unprognostic (4.77e-2)" "unprognostic (2.83e-2)" "unprognostic (3.16e-1)" "unprognostic (7.02e-2)" "unprognostic (3.61e-1)" "unprognostic (1.44e-1)" 12.6 6.0 26.3 11.6 32.0 4.5 11.3 12.1 23.2 16.3 7.8 18.4 5.6 7.6 14.9 31.8 7.5 5.1 15.8 19.7 24.1 16.3 51.2 16.7 12.7 18.8 23.4 16.7 10.2 3.3 2.0 3.1 22.4 18.9 8.7 8.8 31.1 5.5 12.2 1.7 13.2 6.8 12.7 26.5 16.2 8.4 3.1 20.0 3.8 11.9 1.7 12.7 19.0 10.4 0.5 1.2 11.7 6.8 0.1 2.7 0.4 1.7 2.4 2.0 1.8 27.3 15.5 0.6 3.9 8.7 2.4 3.3 0.5 2.1 0.2 6.3 4.1 5.4 1.4 2.6 2.4 2.3 1.7 5.1 1.0 0.3 0.4 3.8 1.3 9.7 10.0 8.2 1.8 0.9 7.6 3.8 2.4 0.1 0.0 4.0 2.0 1.1 0.5 1.0 0.7 0.9 1.9 3.2 0.7 3.5 6.3 1.5 3.0 1.4 5.4 67.0 1.6 7.0 2.3 3.3 3.6 2.5 8.5 3.8 0.3 2.1 0.2 2.2 0.9 5.5 11.7 0.9 9.2 0.9 4.0 0.5 0.5 0.7 2.7 1.2 0.3 0.4 0.9 0.2 0.1 6.8 0.3 1.8 0.4 26.3 32.0 12.1 17.6 24.1 16.3 23.4 16.7 18.9 20.0 0.0 1.7 13.7 19.2 22.9 31.8 21.6 5.1 0.0 0.0 12.2 33.4 32.4 14.9 10.9 0.0 5.1 0.8 0.0 9.1 8.0 22.8 18.1 20.7 3.9 78.6 49.3 8.2 13.5 52.0 0.0 8.3 34.3 65.8 130.8 3.6 234.3 10.4 2.9 5.6 77.4 135.9 0.0 10.3 0.1 0.2 17.3 34.1 17.5 2.3 23.0 GPR137C "DKFZp762F0713, TM7SF1L2" ENSG00000180998 "G protein-coupled receptor 137C" Q8N3F9 14 52553148-52637713 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.1;epididymis: 16.6" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 19.6;Rod photoreceptor cells: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 3.9;T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003640, HPA030763" Uncertain Approved Vesicles NA NA Vesicles "HPA003640: AB_2667025, HPA030763: AB_10602352" "unprognostic (1.39e-1)" "unprognostic (1.45e-1)" "unprognostic (1.23e-1)" "unprognostic (6.84e-2)" "unprognostic (8.50e-3)" "unprognostic (7.34e-3)" "unprognostic (5.95e-3)" "unprognostic (2.32e-2)" "unprognostic (4.41e-2)" "unprognostic (8.42e-4)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" "unprognostic (7.88e-2)" "unprognostic (4.08e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.60e-1)" 1.4 2.2 7.1 1.0 11.0 3.3 1.9 31.1 20.2 1.4 1.2 7.5 0.2 2.0 2.5 16.6 1.7 1.2 2.8 2.4 5.9 10.6 1.2 1.3 1.7 2.1 6.3 7.5 1.6 0.7 2.3 1.8 1.8 13.3 1.6 1.5 3.2 1.7 1.5 1.3 1.8 1.2 1.5 7.0 2.5 1.4 6.5 8.3 0.0 2.1 0.0 1.2 2.1 0.7 0.7 0.5 2.4 0.5 3.9 4.1 0.8 0.8 0.3 8.2 7.5 2.4 0.7 3.3 3.4 2.3 3.6 8.6 1.5 1.6 0.8 2.5 2.8 7.6 1.9 2.7 0.5 5.3 1.2 1.9 0.9 2.3 0.9 0.3 0.5 1.9 0.4 0.0 3.3 0.2 0.8 1.8 1.8 1.2 3.6 5.1 4.0 0.3 1.1 2.0 1.5 4.8 1.8 5.1 0.3 1.1 5.7 8.3 10.5 1.7 0.5 0.2 3.6 5.1 0.0 0.3 8.2 8.7 5.9 2.8 0.8 2.0 1.8 2.0 0.4 2.4 1.2 0.5 0.5 3.1 0.1 4.1 0.3 2.0 3.9 0.2 0.7 1.5 1.8 2.4 3.9 0.4 0.5 1.4 0.8 7.1 11.0 31.1 14.1 5.9 10.6 6.3 7.5 13.3 8.3 0.0 2.2 0.0 0.7 0.6 19.6 2.2 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 1.3 3.0 0.0 0.0 0.2 0.2 1.5 2.4 0.0 0.4 0.4 6.4 1.2 3.7 1.0 1.5 0.6 0.6 1.7 0.0 0.5 5.1 0.0 0.0 0.7 0.1 19.2 0.0 2.1 4.1 2.8 0.6 0.1 0.0 0.0 0.3 GPR139 PGR3 ENSG00000180269 "G protein-coupled receptor 139" Q6DWJ6 16 20031485-20073917 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 2.8;endometrium 1: 2.1;smooth muscle: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA046596 Uncertain NA NA "HPA046596: AB_2679713" "unprognostic (2.94e-1)" 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR141 PGR13 ENSG00000187037 "G protein-coupled receptor 141" Q7Z602 7 37683796-37833788 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 27.6;brain: 18.1" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 2: 4.8;granulocytes: 22.0;Kupffer cells: 8.5;Macrophages: 4.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 11.4;eosinophil: 8.1;gdT-cell: 4.8;memory CD8 T-cell: 4.5;myeloid DC: 5.8;naive CD8 T-cell: 3.3;neutrophil: 10.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 7.8;HMC-1: 30.8;NTERA-2: 16.6;THP-1: 4.9;U-937: 13.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (4.91e-2)" "unprognostic (3.44e-1)" "unprognostic (3.26e-4)" "unprognostic (4.70e-3)" "unprognostic (8.67e-2)" "unprognostic (2.00e-2)" "unprognostic (3.01e-1)" "unprognostic (2.51e-2)" "unprognostic (7.93e-3)" "unprognostic (1.44e-1)" "unprognostic (1.51e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-3)" "unprognostic (1.39e-2)" "unprognostic (4.14e-2)" "unprognostic (1.79e-1)" "unprognostic (1.60e-1)" 1.7 0.9 2.5 4.4 3.3 27.6 0.9 1.0 3.2 1.9 1.4 0.6 0.0 1.0 1.9 2.0 1.8 1.5 3.7 1.7 3.2 1.4 1.2 1.3 4.3 10.0 5.3 0.7 0.6 1.5 0.3 1.0 2.8 5.8 2.0 2.0 2.7 1.7 0.5 0.6 1.2 1.8 1.8 18.1 10.0 1.2 1.5 5.1 2.9 1.1 1.0 2.1 4.8 2.3 0.0 5.8 10.7 11.4 0.6 4.8 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 7.8 0.6 0.0 0.0 0.1 30.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 4.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 13.0 0.0 0.0 11.4 8.1 4.8 0.9 0.0 0.0 1.2 4.5 5.8 0.0 0.5 3.3 10.7 0.6 0.1 0.2 0.0 3.4 2.5 3.3 1.0 3.2 3.2 1.4 5.3 0.7 5.8 5.1 3.0 4.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.8 0.0 0.0 0.0 8.5 0.6 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.2 0.5 0.0 0.0 GPR142 PGR2 ENSG00000257008 "G protein-coupled receptor 142" Q7Z601 17 74367407-74372622 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.3;lymphoid tissue: 1.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-937: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA031392 Uncertain Uncertain "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA031392: AB_10601935" "unprognostic (6.81e-2)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (6.54e-5)" "unprognostic (4.16e-2)" "unprognostic (4.85e-7)" "unprognostic (3.95e-2)" "unprognostic (7.72e-4)" "unprognostic (1.93e-1)" "unprognostic (1.68e-3)" 0.2 0.0 0.0 1.3 0.1 0.0 0.1 1.3 0.2 0.3 0.1 0.8 0.6 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.2 0.0 0.1 0.8 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR143 OA1 ENSG00000101850 "G protein-coupled receptor 143" P51810 X 9725346-9786297 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "retina: 51.5" "Group enriched" "Detected in many" 9 "Cytotrophoblasts: 34.8;Melanocytes: 119.8" "Cancer enriched" "Detected in all" 9 "melanoma: 84.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "basophil: 5.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 5.0" "Cell line enriched" "Detected in some" 6 "SK-MEL-30: 58.4" "Not detected" "Not detected" HPA003648 Enhanced NA NA "HPA003648: AB_2667028" "unprognostic (4.60e-2)" "prognostic favorable (8.73e-4)" "unprognostic (7.43e-3)" "unprognostic (5.41e-2)" "unprognostic (4.62e-3)" "unprognostic (2.00e-2)" "unprognostic (3.05e-1)" "unprognostic (2.64e-3)" "unprognostic (3.78e-1)" "unprognostic (5.89e-2)" "unprognostic (8.18e-2)" "unprognostic (8.40e-2)" "prognostic favorable (2.45e-5)" "unprognostic (2.75e-1)" "unprognostic (2.07e-1)" "unprognostic (8.76e-2)" "unprognostic (1.59e-2)" 0.8 1.3 4.2 0.0 7.6 0.0 2.1 1.5 4.5 2.0 1.6 3.0 3.6 0.6 3.9 7.0 2.8 3.7 1.1 0.4 3.4 3.7 6.6 2.0 1.2 0.4 5.7 3.1 4.5 2.1 3.0 2.0 7.9 6.3 3.4 1.8 51.5 4.1 6.3 0.2 11.5 0.5 1.2 4.3 0.2 0.9 1.0 2.2 1.0 4.2 1.0 1.8 1.8 1.1 0.5 0.1 5.0 0.3 0.1 0.3 0.0 0.7 0.1 1.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.2 0.9 0.0 1.3 0.0 0.6 0.0 0.0 9.5 2.5 0.0 0.0 0.0 0.0 4.4 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 8.4 1.2 0.3 0.0 0.1 0.0 58.4 4.3 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.3 0.2 0.3 0.1 0.1 0.4 0.1 0.1 0.1 0.5 0.1 0.2 0.8 0.1 0.1 0.0 0.0 0.0 4.2 7.6 1.5 4.5 3.4 3.7 5.7 3.1 6.3 2.2 0.0 0.0 0.0 1.0 4.8 0.4 0.6 0.0 4.0 5.7 7.0 0.0 34.8 1.7 4.6 0.2 0.7 0.2 0.0 0.6 1.3 1.0 1.5 0.0 0.0 4.0 0.0 0.0 3.7 0.0 1.3 1.7 0.0 119.8 0.0 0.4 1.4 1.3 0.0 6.0 3.9 0.0 0.0 0.3 0.2 1.2 0.5 8.5 0.0 1.9 1.4 GPR146 PGR8 ENSG00000164849 "G protein-coupled receptor 146" Q96CH1 7 1044576-1059261 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 26 "Endothelial cells: 40.7;Extravillous trophoblasts: 225.4;Syncytiotrophoblasts: 68.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 36.2" "Group enriched" "Detected in many" 4 "granulocytes: 36.2;T-cells: 11.4" "Cell line enhanced" "Detected in many" "BEWO: 22.8;NB-4: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.39e-2)" "unprognostic (7.83e-2)" "unprognostic (6.27e-4)" "unprognostic (5.51e-3)" "unprognostic (1.78e-1)" "unprognostic (2.33e-1)" "unprognostic (2.30e-1)" "unprognostic (2.69e-1)" "unprognostic (2.99e-2)" "unprognostic (3.48e-3)" "unprognostic (2.51e-2)" "unprognostic (1.70e-1)" "unprognostic (1.14e-1)" "unprognostic (3.27e-3)" "unprognostic (1.41e-1)" "unprognostic (4.19e-2)" "unprognostic (1.03e-2)" 37.2 4.2 7.4 3.0 7.2 10.3 35.1 10.8 10.3 6.9 8.5 6.2 4.0 4.2 8.2 4.3 6.0 9.2 9.8 10.2 6.9 5.6 5.0 17.8 16.8 5.7 8.7 3.4 8.5 8.1 2.6 2.1 13.7 11.1 7.3 2.0 6.4 12.0 8.2 9.9 7.0 4.7 5.1 7.9 4.2 9.6 4.9 10.5 0.4 6.0 5.0 2.2 8.5 8.5 0.0 5.6 36.2 0.1 0.4 11.4 2.1 1.2 1.2 0.4 1.1 1.2 0.3 22.8 0.1 0.8 0.2 1.1 0.9 1.0 0.4 0.9 0.1 3.3 0.7 0.0 0.2 0.1 0.8 1.2 1.6 0.7 1.8 1.5 0.1 0.2 0.5 0.0 0.7 0.0 2.3 1.6 0.5 1.1 1.2 0.2 0.9 0.0 6.4 1.6 1.1 0.7 5.2 0.0 1.6 0.3 0.2 1.2 1.7 1.7 0.2 1.8 0.9 1.1 2.0 0.5 0.9 1.3 1.6 0.8 2.0 2.0 0.1 6.0 2.0 2.0 0.0 0.0 36.2 0.3 0.0 0.5 0.0 3.9 0.3 0.7 0.0 11.4 2.2 0.0 0.4 0.1 5.6 6.1 2.1 7.4 7.2 10.8 10.3 6.9 5.6 8.7 3.4 11.1 10.5 0.0 3.2 0.5 0.8 1.5 2.4 0.3 0.0 0.0 3.4 1.8 0.0 6.0 1.7 0.8 0.0 40.7 0.0 0.0 0.5 225.4 1.8 0.6 2.3 16.8 9.2 3.2 4.1 7.4 0.3 0.4 2.8 0.7 3.3 0.0 0.0 22.9 1.0 0.0 3.2 2.5 4.7 0.0 0.6 0.5 1.1 1.9 68.9 0.0 1.0 0.3 GPR148 PGR6 ENSG00000173302 "G protein-coupled receptor 148" Q8TDV2 2 130729070-130730336 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 2.6;pancreas: 1.1;pituitary gland: 2.2;stomach 1: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "CACO-2: 2.5;SCLC-21H: 2.5" "Low region specificity" "Detected in all" HPA060527 Uncertain NA NA "HPA060527: AB_2684307" "unprognostic (7.16e-4)" "unprognostic (3.38e-1)" 0.0 0.2 0.1 0.0 0.4 0.0 0.0 2.6 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR149 "IEDA, PGR10, R35" ENSG00000174948 "G protein-coupled receptor 149" Q86SP6 3 154337672-154429715 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "brain: 23.5;pituitary gland: 6.5;seminal vesicle: 8.7" "Cell type enhanced" "Detected in single" 37 "Cardiomyocytes: 2.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basal ganglia: 23.5;pons and medulla: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.1" "Region enhanced" "Detected in many" "basal ganglia: 15.0" "Low region specificity" "Detected in all" HPA018020 Uncertain NA NA "HPA018020: AB_1849334" 0.2 0.3 0.2 0.2 23.5 0.2 0.2 0.0 0.8 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.9 0.2 0.2 0.2 0.2 0.8 0.0 0.2 0.2 0.2 6.5 0.2 6.5 0.3 0.3 0.4 0.2 8.7 0.2 0.3 0.3 0.2 0.6 0.2 0.5 1.1 2.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 23.5 0.0 0.8 0.2 1.9 0.8 0.0 6.5 2.1 0.0 0.0 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPR15 ENSG00000154165 "G protein-coupled receptor 15" P49685 3 98531899-98533150 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 12.9;intestine: 27.1;lymphoid tissue: 26.3;urinary bladder: 9.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 4.4;memory CD4 T-cell: 12.9;memory CD8 T-cell: 6.1;T-reg: 12.9" "Group enriched" "Detected in many" 30 "B-cells: 4.4;T-cells: 12.9" "Cell line enhanced" "Detected in some" "GAMG: 2.1;HDLM-2: 11.1;U-266/70: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA013775 Approved NA NA "HPA013775: AB_1849264" "unprognostic (8.03e-2)" "unprognostic (1.04e-2)" "unprognostic (3.72e-3)" "unprognostic (5.66e-2)" "unprognostic (9.48e-3)" "unprognostic (5.60e-5)" "unprognostic (5.17e-1)" "unprognostic (6.77e-3)" "unprognostic (3.96e-1)" "unprognostic (3.03e-2)" "unprognostic (2.82e-1)" "unprognostic (2.83e-1)" "unprognostic (4.04e-3)" "unprognostic (4.23e-3)" "unprognostic (1.89e-1)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" 0.9 0.1 0.1 13.4 0.1 0.0 2.5 0.1 0.2 1.1 15.3 0.1 0.1 1.8 0.1 0.1 2.6 0.2 2.1 0.2 0.1 0.1 0.3 0.4 1.9 24.9 0.1 0.4 0.4 0.1 0.0 0.2 0.1 0.3 1.4 27.1 0.3 4.6 0.7 0.1 0.4 11.8 1.5 0.2 4.3 1.1 0.2 0.1 3.6 0.7 2.0 26.3 9.4 2.4 4.4 0.2 0.2 0.0 0.0 12.9 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 11.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.9 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.4 4.4 12.9 6.1 0.0 0.7 0.6 1.0 0.2 0.0 0.0 0.2 12.9 2.8 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR150 PGR11 ENSG00000178015 "G protein-coupled receptor 150" Q8NGU9 5 95620078-95622142 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.5;pancreas: 13.4" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 3.0;Extravillous trophoblasts: 2.8;granulocytes: 5.7;Hofbauer cells: 2.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.3;memory CD4 T-cell: 2.5;NK-cell: 2.1" "Group enriched" "Detected in many" 12 "NK-cells: 2.1;T-cells: 2.5" "Cell line enhanced" "Detected in some" "ASC diff: 3.8;SiHa: 3.1;TIME: 6.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA026635 Uncertain NA NA "HPA026635: AB_1849266" "unprognostic (3.03e-2)" "unprognostic (6.88e-3)" "unprognostic (1.01e-1)" "unprognostic (1.01e-2)" "unprognostic (5.95e-2)" "unprognostic (5.34e-4)" "unprognostic (1.98e-2)" "unprognostic (6.36e-2)" "unprognostic (3.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.94e-3)" "unprognostic (1.88e-2)" "unprognostic (1.76e-1)" "unprognostic (3.23e-2)" "unprognostic (4.42e-2)" "unprognostic (3.55e-2)" "unprognostic (1.26e-1)" 1.5 0.7 4.3 0.4 2.6 0.4 1.2 0.4 11.5 0.6 0.9 0.3 0.4 0.5 0.4 0.6 0.3 0.5 0.5 0.5 2.3 1.3 0.3 0.4 1.2 1.0 0.6 8.0 0.3 13.4 3.8 1.0 0.6 0.2 0.7 0.7 1.4 0.3 1.1 0.4 1.0 0.6 0.4 0.2 0.8 2.1 0.6 0.0 0.0 0.3 0.0 0.7 0.6 0.3 0.2 0.0 0.0 0.0 2.1 2.5 0.2 0.0 0.0 0.1 0.0 3.8 1.7 0.1 1.2 0.3 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 1.4 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.6 0.0 0.0 2.0 1.5 0.0 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 2.1 1.3 3.1 0.0 0.6 0.1 0.0 1.0 6.9 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.5 0.0 2.3 0.2 2.5 0.0 0.0 0.0 1.0 0.2 0.0 2.1 0.0 0.0 0.0 0.2 4.3 2.6 0.4 11.5 2.3 1.3 0.6 8.0 0.2 0.0 0.0 1.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.2 2.8 0.0 0.3 5.7 0.5 2.8 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.8 0.0 GPR151 "GALR4, PGR7" ENSG00000173250 "G protein-coupled receptor 151" Q8TDV0 5 146513103-146516190 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 1.5;brain: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Region enriched" "Detected in single" 19 "thalamus: 36.8" "Region enriched" "Detected in many" 7 "thalamus: 4.6" HPA065728 Supported NA NA "HPA065728: " "unprognostic (2.09e-1)" "unprognostic (2.30e-1)" "unprognostic (1.14e-1)" "unprognostic (1.32e-2)" 0.0 0.1 0.4 0.0 0.5 0.1 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.1 0.4 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR152 PGR5 ENSG00000175514 "G protein-coupled receptor 152" Q8TDT2 11 67451301-67452729 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.7;lymphoid tissue: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "RPMI-8226: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA035078 Uncertain NA NA "HPA035078: AB_10670286" "unprognostic (3.81e-2)" "unprognostic (1.69e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (3.76e-3)" 0.1 0.0 0.0 0.6 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.1 1.7 0.0 0.1 1.6 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.1 1.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.5 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR153 PGR1 ENSG00000158292 "G protein-coupled receptor 153" Q6NV75 1 6247346-6260975 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 31.4;Horizontal cells: 60.4;Mucus-secreting cells: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "granulocytes: 1.3;monocytes: 1.0;T-cells: 1.7" "Cell line enhanced" "Detected in many" "ASC diff: 14.2;PC-3: 36.4;RH-30: 17.2;SCLC-21H: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007159 Approved NA NA "HPA007159: AB_1849268" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (5.74e-3)" "unprognostic (3.33e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.75e-4)" "unprognostic (8.54e-2)" "unprognostic (1.02e-2)" "unprognostic (1.31e-1)" "unprognostic (1.51e-2)" "unprognostic (1.53e-3)" "unprognostic (2.00e-1)" "unprognostic (2.93e-1)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" 11.0 2.9 11.9 3.8 5.2 0.5 16.1 1.3 10.6 16.1 19.9 3.7 4.6 5.4 8.3 15.9 7.0 7.1 5.8 7.7 5.8 5.1 2.7 6.3 12.6 2.3 2.0 2.7 14.8 2.1 5.9 10.2 9.2 4.2 6.8 7.1 7.2 2.6 4.9 1.4 8.7 18.3 6.6 1.2 8.8 3.0 2.9 2.5 1.8 1.6 5.5 3.5 6.1 9.6 0.0 0.3 1.3 1.0 0.3 1.7 0.1 3.1 0.5 7.7 9.2 14.2 5.6 0.6 2.1 1.9 0.8 0.9 1.3 1.2 0.0 3.2 2.2 1.8 4.0 0.4 9.0 0.3 2.0 1.9 0.0 1.2 0.2 2.8 0.3 1.2 3.4 2.4 0.6 0.4 1.4 0.6 2.8 0.4 0.0 2.6 3.4 1.0 2.4 0.6 1.8 36.4 3.8 17.2 0.2 0.3 1.7 17.5 6.3 1.4 5.3 4.3 2.2 2.0 1.6 1.8 1.9 1.8 0.2 0.9 0.1 0.1 0.7 0.9 4.1 0.7 1.3 0.0 0.9 1.4 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.3 1.0 0.3 0.0 0.1 11.9 5.2 1.3 10.6 5.8 5.1 2.0 2.7 4.2 2.5 0.0 0.0 0.0 1.1 3.1 0.6 3.9 5.1 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.9 1.4 4.5 0.0 0.0 0.2 15.5 0.6 1.1 31.4 0.9 60.4 3.4 1.3 1.0 1.5 4.4 2.8 5.0 3.6 39.4 2.0 0.4 4.8 7.1 1.4 1.8 0.0 3.9 0.0 1.5 6.5 0.3 0.5 1.8 13.5 GPR155 "DEP.7, DEPDC3, FLJ31819, PGR22" ENSG00000163328 "G protein-coupled receptor 155" Q7Z3F1 2 174431571-174487094 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5;stomach 1: 43.2" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 117.8;Melanocytes: 145.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 16.3;WM-115: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036159, HPA057384" Approved Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA036159: AB_10671835, HPA057384: AB_2683424" "unprognostic (3.91e-2)" "unprognostic (7.93e-2)" "unprognostic (3.14e-2)" "unprognostic (4.11e-4)" "unprognostic (5.03e-2)" "unprognostic (2.48e-1)" "unprognostic (8.49e-2)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (4.82e-2)" "unprognostic (2.59e-2)" "unprognostic (9.90e-2)" "unprognostic (1.82e-2)" "unprognostic (4.54e-2)" 4.5 10.1 9.3 6.6 34.5 2.6 3.0 15.1 17.3 3.2 11.4 6.1 2.2 4.0 2.6 13.1 6.7 2.5 5.9 6.8 15.5 9.4 19.8 7.3 3.3 5.9 7.7 11.5 3.0 16.9 8.0 3.2 4.7 27.4 8.0 4.2 4.9 3.7 8.8 5.1 13.4 5.1 7.8 6.9 5.3 43.2 2.6 9.9 1.6 8.3 0.8 3.8 6.6 3.6 1.5 0.8 9.6 6.8 4.7 7.0 1.9 0.7 0.4 1.0 2.5 5.7 3.2 0.6 4.3 1.5 0.7 2.4 0.3 0.4 2.4 1.4 3.0 1.5 0.4 1.4 1.3 2.4 0.9 1.7 2.6 1.4 0.2 1.1 0.9 1.4 4.6 3.6 2.1 0.7 4.6 1.1 3.4 0.4 6.2 4.8 0.7 1.7 1.2 0.6 2.6 1.7 2.1 6.2 1.2 2.4 1.6 6.7 5.7 1.3 1.0 2.2 3.1 0.4 0.4 3.1 3.1 1.2 4.5 0.6 16.3 2.3 0.4 3.6 0.8 10.8 1.5 2.9 0.1 2.4 5.4 2.2 1.3 4.4 4.0 0.8 1.5 3.5 5.4 9.6 4.7 6.8 0.5 7.0 1.9 9.3 34.5 15.1 16.2 15.5 9.4 7.7 11.5 27.4 9.9 11.9 2.2 11.7 2.9 37.9 30.8 21.8 2.5 0.0 10.3 10.4 117.8 1.2 1.7 2.0 0.3 9.0 0.3 0.0 5.0 1.0 7.7 3.4 1.1 16.1 5.9 47.7 12.2 20.9 36.6 0.9 13.8 21.7 145.1 1.8 0.2 15.6 5.6 0.0 30.1 34.6 22.9 0.0 10.8 3.3 2.6 25.0 0.7 17.9 1.1 1.5 GPR156 "GABABL, PGR28" ENSG00000175697 "G protein-coupled receptor 156" Q8NFN8 3 120164645-120285094 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 7.7" "Group enriched" "Detected in some" 8 "Early spermatids: 6.5;Late spermatids: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.1;PC-3: 3.0;SiHa: 8.1;U-2 OS: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028642, HPA028644" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA028642: AB_10599711, HPA028644: AB_10600441" "unprognostic (2.85e-3)" "unprognostic (1.02e-1)" "unprognostic (3.53e-3)" "unprognostic (2.02e-3)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.62e-4)" "unprognostic (2.03e-1)" "unprognostic (4.54e-4)" "unprognostic (5.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (4.03e-5)" "unprognostic (2.43e-2)" "unprognostic (3.43e-2)" "unprognostic (4.91e-3)" "unprognostic (6.71e-2)" 0.9 0.5 0.8 1.6 2.2 0.0 1.0 0.1 1.0 1.4 0.7 0.0 0.0 0.0 1.2 0.0 1.9 3.4 1.3 0.2 0.4 0.3 0.3 0.0 0.2 0.0 0.3 0.0 1.4 0.0 0.0 1.4 1.2 0.7 1.9 0.2 0.4 2.4 1.5 0.1 0.3 0.2 1.6 1.5 0.1 0.3 7.7 1.2 0.0 0.1 0.0 0.4 2.5 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.2 0.8 0.1 0.9 1.3 0.1 0.6 0.0 0.9 3.1 0.7 0.1 0.1 0.1 0.5 0.0 0.0 0.0 2.0 0.0 0.8 0.2 0.0 2.0 0.2 0.5 0.0 0.2 0.0 0.1 0.0 0.3 1.0 0.0 0.0 0.0 1.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 1.0 1.6 8.1 0.0 1.0 0.4 1.1 0.1 0.2 0.2 4.5 0.0 0.3 1.0 0.4 0.1 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 2.2 0.1 1.0 0.4 0.3 0.3 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 0.0 GPR157 FLJ12132 ENSG00000180758 "G protein-coupled receptor 157" Q5UAW9 1 9100305-9129170 "G-protein coupled receptors, Predicted membrane proteins" Differentiation "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.2" "Cell type enriched" "Detected in many" 5 "monocytes: 184.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 17.3;SK-BR-3: 34.0;U-266/70: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028697 Uncertain Uncertain "Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions" NA NA "Nucleoli, Nucleoli rim" "Plasma membrane, Cell Junctions" "HPA028697: AB_10601810" "unprognostic (2.83e-3)" "unprognostic (1.13e-2)" "unprognostic (5.91e-2)" "unprognostic (5.42e-2)" "unprognostic (2.13e-4)" "unprognostic (7.11e-2)" "unprognostic (7.52e-3)" "unprognostic (3.60e-2)" "unprognostic (9.20e-2)" "unprognostic (1.26e-1)" "unprognostic (9.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.02e-2)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-3)" 3.5 3.1 0.3 3.7 0.6 0.5 3.5 0.5 0.4 6.2 2.8 0.9 3.9 2.2 2.1 2.1 23.4 2.1 6.9 10.7 0.8 0.4 2.9 6.9 5.5 3.1 0.3 0.1 4.5 4.3 9.8 1.2 19.0 1.4 2.9 1.2 5.2 14.7 7.1 32.2 14.2 3.3 4.0 0.4 2.4 2.2 2.1 0.8 3.6 4.8 25.2 16.2 4.4 8.3 2.4 1.1 4.6 1.5 1.2 2.6 0.7 4.7 2.7 0.8 2.2 0.7 0.7 4.4 1.5 1.0 1.2 1.7 2.1 1.8 0.6 1.9 1.5 1.6 10.1 2.4 1.0 1.8 13.1 4.0 0.0 7.8 3.2 2.7 0.0 1.1 0.7 2.1 2.1 1.3 1.2 1.0 2.0 0.7 17.3 0.5 3.4 1.9 1.0 0.9 2.3 3.4 0.3 0.7 2.3 0.8 3.2 1.2 3.3 5.8 34.0 2.8 1.7 4.8 0.6 7.1 4.3 1.1 11.1 0.7 16.7 2.7 0.0 3.2 6.7 1.8 1.9 1.5 0.4 2.6 1.2 2.0 1.5 1.9 2.3 0.8 2.4 1.9 2.2 4.6 1.2 0.6 1.1 0.8 0.7 0.3 0.6 0.5 0.4 0.8 0.4 0.3 0.1 1.4 0.8 6.0 9.9 0.5 6.4 12.0 0.2 12.1 5.1 2.7 6.8 5.2 2.0 25.6 0.0 3.0 0.0 2.9 5.6 0.0 3.3 9.1 3.8 4.4 0.0 12.9 3.8 1.6 0.0 0.0 1.2 0.0 1.7 4.5 6.8 184.0 4.3 1.4 9.2 4.8 4.9 1.4 1.5 0.0 3.9 0.5 2.5 21.2 40.3 2.1 4.3 13.7 GPR158 KIAA1136 ENSG00000151025 "G protein-coupled receptor 158" Q5T848 10 25175062-25602226 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.4;seminal vesicle: 11.2" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 136.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 21.2;T-47d: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013185 Uncertain NA NA "HPA013185: AB_2113957" "unprognostic (4.43e-2)" "unprognostic (3.14e-2)" "unprognostic (7.42e-2)" "unprognostic (2.66e-5)" "unprognostic (5.67e-2)" "unprognostic (9.37e-2)" "unprognostic (4.73e-2)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (4.37e-2)" "unprognostic (8.09e-3)" "unprognostic (1.72e-1)" "unprognostic (2.60e-6)" "unprognostic (8.36e-2)" "unprognostic (1.78e-1)" "unprognostic (1.21e-3)" "unprognostic (3.90e-1)" 0.9 2.4 3.6 1.0 16.2 0.8 0.8 28.4 25.2 0.8 1.1 1.6 6.1 0.9 0.8 1.0 0.8 0.8 0.8 0.8 1.9 2.8 0.8 0.9 0.9 0.8 2.4 4.8 0.8 0.9 1.5 8.9 1.5 14.9 1.2 1.1 1.4 0.8 11.2 0.8 0.8 1.2 0.8 4.0 0.9 1.1 1.9 2.9 0.0 1.0 0.0 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 21.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.2 0.0 0.0 1.2 0.0 0.5 1.1 1.9 0.0 5.8 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 16.2 28.4 11.6 1.9 2.8 2.4 4.8 14.9 2.9 0.0 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.1 136.7 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.8 0.7 0.0 0.2 0.0 0.0 0.0 GPR160 "GPCR1, GPCR150" ENSG00000173890 "G protein-coupled receptor 160" Q9UJ42 3 170037929-170085403 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 71.0" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 186.9;Rod photoreceptor cells: 156.5;Undifferentiated cells: 149.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 31.0;SK-BR-3: 24.8;THP-1: 48.9;U-266/70: 54.0;U-266/84: 31.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA006970 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA006970: AB_1849275" "unprognostic (1.70e-1)" "unprognostic (5.08e-3)" "unprognostic (2.96e-2)" "unprognostic (2.39e-3)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (5.21e-2)" "prognostic favorable (1.21e-4)" "unprognostic (5.71e-3)" "unprognostic (1.35e-1)" "unprognostic (4.35e-2)" "unprognostic (1.77e-1)" "prognostic favorable (4.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.25e-1)" "unprognostic (1.43e-1)" "prognostic favorable (3.61e-4)" 7.0 1.4 3.1 21.7 2.5 23.6 8.2 0.9 1.8 2.6 31.2 1.5 7.9 18.0 1.9 21.5 2.6 1.8 16.2 3.0 1.9 1.7 27.4 2.1 23.2 25.6 2.7 0.4 1.6 14.7 71.0 3.5 2.9 1.8 10.7 18.1 11.8 14.2 4.7 2.0 1.8 43.2 0.9 4.7 17.9 18.0 2.9 2.4 6.6 3.8 1.0 10.7 9.1 6.9 11.2 2.9 10.1 1.1 0.3 3.0 1.2 15.9 0.3 0.0 0.1 0.1 0.1 4.0 0.1 0.1 0.1 0.5 2.9 2.0 7.4 3.4 0.1 1.0 0.1 2.2 0.1 0.2 11.3 4.4 4.8 0.2 6.0 0.0 9.4 6.5 0.0 0.2 0.5 0.6 0.7 0.3 3.5 1.5 19.2 0.1 10.2 0.7 2.0 2.6 9.8 0.6 1.3 0.3 31.0 8.4 22.1 1.6 0.4 0.2 24.8 1.1 2.2 14.5 48.9 0.5 0.0 0.1 1.8 1.2 54.0 31.0 12.9 0.2 10.2 0.7 1.5 1.1 8.1 0.5 0.4 0.9 6.8 0.9 0.4 2.2 11.2 3.0 1.1 10.1 0.3 0.1 2.9 0.3 1.2 3.1 2.5 0.9 1.8 1.9 1.7 2.7 0.4 1.8 2.4 8.9 39.0 27.8 3.1 0.3 7.9 1.0 25.5 18.7 18.2 59.3 37.3 2.6 46.4 10.6 24.4 4.5 103.3 0.0 63.8 15.0 0.4 47.4 1.1 0.5 7.0 14.3 186.9 16.0 9.2 32.2 0.6 10.0 27.0 97.4 129.6 7.7 48.2 137.8 0.4 121.7 156.5 0.0 0.3 6.4 11.9 0.6 22.8 2.5 149.6 25.7 GPR161 RE2 ENSG00000143147 "G protein-coupled receptor 161" Q8N6U8 1 168079543-168137667 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 27.1;smooth muscle: 21.0" "Cell type enriched" "Detected in many" 8 "Horizontal cells: 149.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015576, HPA072047" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA015576: AB_1849283, HPA072047: AB_2686484" "unprognostic (1.45e-1)" "unprognostic (3.78e-2)" "unprognostic (2.68e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (3.24e-3)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (5.04e-2)" "unprognostic (5.45e-2)" "unprognostic (1.31e-2)" "unprognostic (5.57e-6)" "unprognostic (3.93e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" 2.4 0.9 2.1 3.6 1.7 0.0 1.9 1.2 4.0 7.3 4.9 3.1 8.5 0.8 27.1 8.2 7.4 7.7 5.6 2.4 2.8 1.5 1.1 0.4 2.8 0.4 3.0 1.2 7.6 11.0 4.9 1.3 1.3 3.0 8.2 2.3 3.4 2.3 9.4 0.8 1.5 2.1 21.0 3.0 1.2 2.2 3.0 0.8 1.4 1.2 1.7 0.7 2.8 6.8 0.3 1.2 1.5 0.5 0.2 0.3 0.2 6.1 3.8 15.5 9.9 3.7 6.6 0.0 5.9 6.5 5.1 5.4 24.0 1.0 0.0 3.3 8.9 9.6 18.4 3.7 5.8 3.0 2.3 4.8 2.2 3.0 0.1 1.6 0.6 1.5 2.3 3.8 4.4 7.1 11.9 10.2 1.9 2.0 0.1 7.7 0.5 0.7 0.1 6.3 10.3 6.0 1.8 6.7 0.0 2.7 1.7 3.1 13.7 6.5 0.2 17.8 6.1 3.4 0.7 13.7 10.5 5.5 14.1 6.7 0.0 0.0 0.0 2.8 0.0 2.7 1.5 0.3 0.2 0.1 0.3 0.1 0.1 0.1 0.0 1.2 0.3 0.1 0.3 1.3 0.2 0.5 0.3 0.0 0.2 2.1 1.7 1.2 4.0 2.8 1.5 3.0 1.2 3.0 0.8 3.0 0.6 0.0 5.0 1.9 1.7 2.0 0.0 1.4 1.2 0.0 0.0 0.4 0.0 3.6 0.4 6.3 0.0 0.0 7.2 0.2 6.3 4.6 0.0 0.0 0.7 149.4 0.0 4.3 1.8 0.6 6.9 1.3 1.7 1.8 1.7 2.7 2.9 0.0 15.9 0.0 1.5 19.4 12.2 0.0 0.7 1.3 0.3 0.0 2.3 2.3 GPR162 "A-2, GRCA" ENSG00000250510 "G protein-coupled receptor 162" Q16538 12 6821545-6829972 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.6" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 75.9;Ciliated cells: 49.5;Horizontal cells: 38.1;Muller glia cells: 46.3" "Cancer enriched" "Detected in many" 6 "glioma: 16.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.3;intermediate monocyte: 3.7;neutrophil: 14.7" "Group enriched" "Detected in many" 6 "granulocytes: 14.7;monocytes: 6.3" "Cell line enhanced" "Detected in many" "AF22: 13.0;AN3-CA: 15.4;hTERT-RPE1: 13.4;NTERA-2: 14.5;SH-SY5Y: 9.9;U-2 OS: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055135 Enhanced Approved "Centriolar satellite" "Intracellular and membrane" NA NA "Centriolar satellite" "HPA055135: AB_2682710" "unprognostic (4.76e-2)" "unprognostic (8.00e-2)" "unprognostic (8.24e-3)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (2.38e-1)" "unprognostic (4.78e-2)" "unprognostic (2.25e-2)" "unprognostic (5.83e-3)" "unprognostic (1.18e-1)" "prognostic favorable (4.29e-5)" "unprognostic (3.82e-3)" "prognostic unfavorable (1.37e-6)" "unprognostic (3.10e-3)" "unprognostic (1.77e-1)" "unprognostic (3.22e-1)" "unprognostic (3.64e-2)" 2.7 6.7 19.6 4.2 13.2 1.5 2.4 41.3 47.6 2.1 3.4 4.7 0.8 3.1 3.8 2.8 1.9 16.9 5.7 4.2 25.9 18.4 1.4 3.7 6.0 1.7 9.9 17.7 2.0 1.7 5.3 8.4 4.3 10.2 2.1 3.0 3.6 1.3 2.1 1.6 1.7 4.2 5.7 5.3 2.8 2.0 1.2 3.6 0.1 1.1 0.0 1.1 2.4 0.5 0.0 1.8 14.7 6.3 0.0 0.0 1.7 0.0 2.9 13.0 15.4 1.4 1.0 0.0 1.0 3.4 2.9 1.7 0.2 0.0 0.0 0.1 1.8 0.1 0.0 2.0 0.0 1.4 0.0 0.9 1.5 0.1 0.0 2.2 0.3 0.0 2.4 0.0 4.4 0.2 13.4 7.9 1.1 0.7 0.1 1.0 0.0 0.4 1.1 14.5 0.0 0.1 0.0 1.6 2.6 1.0 0.0 1.1 9.9 0.0 0.0 0.4 9.3 0.1 3.8 5.2 2.0 12.3 1.0 1.7 0.0 0.9 0.0 2.2 2.7 0.2 0.0 6.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 14.7 0.0 1.3 1.6 0.0 1.7 19.6 13.2 41.3 32.4 25.9 18.4 9.9 17.7 10.2 3.6 0.0 0.0 0.0 0.1 0.7 75.9 1.1 0.0 49.5 1.2 1.8 3.9 0.1 1.7 0.0 0.0 2.4 0.0 0.0 0.0 0.1 2.1 0.5 0.0 0.4 2.2 38.1 0.0 5.5 3.4 0.4 6.9 3.2 0.0 0.0 0.0 46.3 0.1 0.0 13.8 0.3 7.8 0.0 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 GPR17 ENSG00000144230 "G protein-coupled receptor 17" Q13304 2 127645864-127652639 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 43.8" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 32 "glioma: 16.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "naive B-cell: 4.0" "Lineage enriched" "Detected in single" 11 "B-cells: 4.0" "Cell line enhanced" "Detected in some" "HeLa: 4.6;REH: 7.7;TIME: 7.6;U-2 OS: 3.2;U-2197: 3.6;U-251 MG: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029766 Enhanced Supported Approved Vesicles NA NA Vesicles "HPA029766: AB_10612114" "unprognostic (8.10e-2)" "unprognostic (1.73e-1)" "unprognostic (2.61e-1)" "unprognostic (1.42e-2)" "unprognostic (1.54e-1)" "unprognostic (5.19e-2)" "unprognostic (2.77e-5)" "unprognostic (8.40e-3)" "unprognostic (2.92e-1)" "unprognostic (3.25e-2)" "unprognostic (1.61e-3)" "unprognostic (6.60e-2)" "unprognostic (2.11e-3)" "unprognostic (3.33e-2)" "unprognostic (2.19e-1)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" 7.0 2.2 23.7 6.8 21.3 0.8 5.4 4.1 25.6 2.4 16.4 43.8 0.0 3.3 11.2 3.3 5.0 4.0 4.3 12.5 20.6 1.2 2.3 1.6 9.3 2.4 9.1 9.9 1.4 4.6 0.5 0.4 2.7 18.8 3.9 0.8 0.1 1.7 0.5 13.1 6.7 3.8 0.5 6.3 12.6 5.0 1.8 22.6 0.0 2.8 0.0 0.5 6.1 3.9 4.0 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.3 0.6 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.6 0.9 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.4 0.0 0.3 0.0 0.0 0.6 0.3 0.1 0.0 0.2 7.7 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.0 2.3 0.3 0.0 7.6 0.0 3.2 3.6 4.5 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.7 21.3 4.1 25.6 20.6 1.2 9.1 9.9 18.8 22.6 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR171 H963 ENSG00000174946 "G protein-coupled receptor 171" O14626 3 151197832-151203201 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.2;intestine: 19.5;lymphoid tissue: 33.0" "Cell type enhanced" "Detected in many" 26 "Horizontal cells: 20.6;monocytes: 22.6;T-cells: 87.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "MAIT T-cell: 45.2" "Lineage enriched" "Detected in many" 18 "T-cells: 45.2" "Cell line enriched" "Detected in single" 26 "U-266/70: 25.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA067323 Supported NA NA "HPA067323: " "unprognostic (6.82e-6)" "unprognostic (4.90e-3)" "unprognostic (7.10e-2)" "unprognostic (6.85e-4)" "unprognostic (2.80e-3)" "unprognostic (1.04e-3)" "unprognostic (4.19e-4)" "unprognostic (6.09e-2)" "unprognostic (4.93e-3)" "unprognostic (1.01e-3)" "unprognostic (8.84e-2)" "unprognostic (1.08e-1)" "unprognostic (4.72e-6)" "unprognostic (1.31e-1)" "unprognostic (4.17e-2)" "unprognostic (4.58e-2)" "unprognostic (1.02e-2)" 4.1 0.9 0.4 15.1 0.4 0.4 1.6 0.3 0.3 4.0 6.8 0.3 0.6 3.5 1.4 1.6 2.7 3.9 4.6 1.3 0.4 0.4 4.3 2.7 10.7 33.0 0.7 0.5 1.9 1.0 0.0 0.7 0.8 1.5 2.2 3.8 1.7 2.4 1.2 1.0 1.1 19.5 1.1 2.7 20.7 4.0 1.0 0.5 19.9 2.2 1.8 8.5 7.0 2.4 0.1 0.8 1.0 0.1 2.5 45.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.0 11.6 0.0 45.2 0.0 16.2 21.5 0.8 0.1 9.9 8.4 0.3 2.5 0.1 0.7 8.0 3.4 0.4 0.4 0.3 0.3 0.4 0.4 0.7 0.5 1.5 0.5 0.0 2.1 2.4 0.3 1.0 3.6 0.3 0.0 0.0 2.3 0.0 2.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 2.3 1.1 0.1 20.6 0.0 3.1 3.1 0.0 0.0 6.9 0.0 22.6 0.0 5.6 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.9 0.1 0.5 0.6 87.7 0.0 0.3 GPR173 SREB3 ENSG00000184194 "G protein-coupled receptor 173" Q9NS66 X 53049091-53080615 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 6.4;Horizontal cells: 6.4;Intestinal endocrine cells: 3.4;Peritubular cells: 4.2" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 1.8" "Cell line enhanced" "Detected in many" "HAP1: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003905 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA003905: AB_1078922" "unprognostic (2.68e-1)" "unprognostic (2.33e-1)" "unprognostic (4.95e-3)" "prognostic unfavorable (2.88e-6)" "unprognostic (3.87e-2)" "unprognostic (8.58e-2)" "unprognostic (2.73e-1)" "unprognostic (1.47e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-2)" "prognostic favorable (2.33e-5)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.47e-4)" "unprognostic (1.08e-4)" "unprognostic (2.83e-1)" "unprognostic (3.92e-2)" "unprognostic (6.95e-2)" 2.5 5.2 8.2 3.0 9.4 2.2 3.1 15.4 23.2 4.2 2.8 11.6 0.8 1.8 6.4 5.0 2.4 7.7 3.3 4.2 7.9 10.0 2.4 1.1 2.8 2.1 7.3 11.2 15.0 1.3 1.3 14.6 4.5 9.7 3.2 2.6 6.4 2.0 5.4 4.6 3.9 2.1 4.5 6.5 4.0 2.1 2.4 9.6 0.7 3.1 0.1 1.5 3.3 2.8 0.9 0.7 5.7 0.4 1.8 0.7 0.0 0.0 0.0 8.1 0.5 4.6 2.7 0.0 1.3 2.9 2.1 2.5 0.8 0.1 0.2 2.0 2.8 6.4 0.6 10.2 0.0 1.9 0.6 1.0 0.5 8.3 0.3 6.7 0.5 0.1 6.6 0.0 3.3 4.6 7.5 3.5 0.0 0.0 5.7 3.2 4.2 0.0 0.0 6.3 0.4 3.6 0.1 2.4 0.3 0.5 0.4 5.9 8.3 0.0 0.4 0.0 5.5 1.1 0.1 6.4 3.5 5.1 2.3 1.1 0.2 0.3 0.7 2.5 0.0 1.9 5.7 0.2 0.3 0.7 0.1 0.5 0.3 0.2 0.1 0.1 0.9 0.5 0.4 1.2 1.8 0.4 0.7 0.0 0.0 8.2 9.4 15.4 15.1 7.9 10.0 7.3 11.2 9.7 9.6 0.0 0.0 0.0 0.4 0.2 6.4 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.2 6.4 3.4 1.8 0.3 0.0 2.8 0.0 1.7 0.0 0.1 2.7 0.1 0.0 4.2 0.0 2.8 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 GPR174 FKSG79 ENSG00000147138 "G protein-coupled receptor 174" Q9BXC1 X 79144663-79175315 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 73.8" "Group enriched" "Detected in some" 20 "Alveolar cells type 2: 3.7;Club cells: 1.2;Collecting duct cells: 1.8;T-cells: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "JURKAT: 24.1;MOLT-4: 39.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA041025 Enhanced Uncertain Vesicles NA NA Vesicles "HPA041025: AB_10794260" "unprognostic (6.38e-3)" "unprognostic (9.87e-3)" "unprognostic (4.36e-2)" "unprognostic (1.18e-2)" "unprognostic (1.84e-1)" "unprognostic (8.48e-4)" "unprognostic (7.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.75e-1)" "unprognostic (2.02e-1)" "unprognostic (2.46e-1)" "unprognostic (1.05e-1)" "unprognostic (6.53e-5)" "unprognostic (2.27e-1)" "unprognostic (2.64e-2)" "unprognostic (1.21e-1)" "unprognostic (1.78e-2)" 2.2 0.5 0.4 20.3 0.4 2.6 1.3 0.3 0.4 2.4 5.1 0.0 0.5 2.1 1.6 0.9 2.6 0.9 1.9 1.0 0.4 0.4 1.9 1.7 8.2 16.6 0.5 0.0 1.0 0.7 0.0 1.1 0.3 0.2 1.7 2.0 1.6 3.8 0.1 0.5 0.7 9.1 0.2 1.0 21.0 2.2 0.5 0.0 73.8 2.5 1.6 28.1 5.1 1.8 4.0 1.8 6.0 9.1 6.5 8.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.7 0.0 0.0 39.8 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 6.0 0.0 4.7 5.7 3.4 1.7 4.0 7.5 8.6 0.1 3.9 6.1 6.8 0.4 6.5 9.1 1.8 7.6 2.7 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 GPR176 Gm1012 ENSG00000166073 "G protein-coupled receptor 176" Q14439 15 39799032-39920892 "G-protein coupled receptors, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.6" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 9.4;Early spermatids: 17.9;Late spermatids: 11.5;Muller glia cells: 13.2;Pancreatic endocrine cells: 8.3;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "eosinophil: 2.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 69.8;fHDF/TERT166: 47.0;U-138 MG: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039943, HPA039979" Approved NA NA "HPA039943: AB_10697711, HPA039979: AB_2676782" "unprognostic (4.02e-2)" "unprognostic (2.65e-1)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (4.24e-1)" "unprognostic (1.04e-2)" "unprognostic (2.75e-2)" "unprognostic (1.38e-3)" "unprognostic (9.32e-2)" "unprognostic (3.23e-2)" "unprognostic (2.74e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (9.38e-7)" "prognostic unfavorable (6.84e-5)" "unprognostic (2.23e-1)" "unprognostic (1.95e-1)" "unprognostic (3.26e-2)" 9.8 9.6 9.7 5.9 18.4 0.5 8.9 22.6 16.0 8.0 2.9 2.5 1.3 2.8 5.6 3.1 2.9 3.8 10.5 5.4 8.4 12.7 4.7 2.8 5.4 8.0 7.2 7.4 2.5 2.3 3.3 4.1 3.6 11.3 10.9 3.5 3.2 2.5 5.7 3.1 3.0 2.5 6.9 3.0 5.6 2.5 9.9 2.0 1.2 5.1 3.1 8.0 9.5 4.5 0.0 0.5 2.8 0.0 0.0 0.0 0.0 12.6 0.6 0.8 0.1 9.2 16.7 0.0 27.0 69.8 16.6 25.7 1.0 2.1 0.1 2.4 47.0 9.6 0.4 2.0 2.1 24.9 0.4 3.1 2.0 2.1 0.0 10.3 0.0 0.1 12.6 0.2 14.9 12.4 16.6 6.2 0.7 0.3 0.2 22.8 0.6 0.0 0.0 0.8 0.1 2.6 0.8 8.4 0.1 0.4 0.1 3.4 13.2 7.0 0.0 1.1 0.2 2.5 0.1 7.8 30.6 8.9 1.8 9.9 0.3 1.0 0.0 6.3 0.0 11.9 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.7 18.4 22.6 14.3 8.4 12.7 7.2 7.4 11.3 2.0 0.0 0.0 0.0 0.2 1.5 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 17.9 1.1 0.0 0.0 3.2 0.0 2.5 2.0 0.0 0.0 0.1 1.6 0.0 1.3 0.0 11.5 1.1 0.8 1.7 0.0 0.0 13.2 8.3 0.0 1.1 1.2 1.1 12.9 4.7 2.1 3.1 0.9 0.0 0.0 0.0 0.0 GPR179 "CSNB1E, GPR158L1" ENSG00000277399 "G protein-coupled receptor 179" 17 38325530-38343847 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.0;retina: 7.5" "Cell type enriched" "Detected in some" 13 "Bipolar cells: 24.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;U-266/84: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA017885 Uncertain NA NA "HPA017885: AB_2279357" "unprognostic (1.65e-1)" "unprognostic (2.27e-1)" "unprognostic (1.24e-4)" "unprognostic (8.89e-3)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "unprognostic (3.04e-2)" "unprognostic (4.76e-2)" "unprognostic (2.34e-2)" "unprognostic (6.57e-3)" "unprognostic (5.31e-2)" "unprognostic (5.09e-10)" "unprognostic (6.18e-2)" "unprognostic (2.31e-1)" "unprognostic (1.62e-2)" "unprognostic (3.41e-4)" 0.2 0.6 1.6 0.0 3.0 0.0 0.2 0.8 1.9 0.1 0.1 0.2 0.0 0.3 0.2 1.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.4 0.3 0.0 7.5 0.6 0.3 1.5 0.0 0.3 0.1 0.6 0.0 0.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 1.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR18 ENSG00000125245 "G protein-coupled receptor 18" Q14330 13 99254714-99261744 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 25.4;lymphoid tissue: 25.1;testis: 15.0" "Group enriched" "Detected in some" 6 "Early spermatids: 170.3;Late spermatids: 143.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 25.4;NK-cells: 19.6;T-cells: 17.6" "Group enriched" "Detected in some" 4 "Daudi: 8.6;THP-1: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013873 Enhanced NA NA "HPA013873: AB_1849285" "unprognostic (3.87e-6)" "unprognostic (1.31e-3)" "unprognostic (3.22e-2)" "unprognostic (1.31e-6)" "unprognostic (2.89e-1)" "unprognostic (7.55e-4)" "unprognostic (4.27e-5)" "unprognostic (3.45e-3)" "unprognostic (2.31e-3)" "unprognostic (5.43e-2)" "unprognostic (9.70e-2)" "unprognostic (4.03e-1)" "unprognostic (3.20e-6)" "unprognostic (9.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-1)" "unprognostic (6.92e-3)" 0.7 0.3 0.3 13.2 0.3 6.0 0.4 0.3 0.2 0.5 1.2 0.0 0.0 0.4 0.4 0.4 0.8 0.3 0.7 0.6 0.3 0.3 0.6 0.9 1.9 25.1 0.3 0.0 0.4 0.4 0.0 0.5 0.5 0.4 1.0 0.5 0.2 2.8 0.0 0.3 0.5 5.3 0.0 0.5 24.0 0.8 15.0 0.0 14.4 0.7 0.3 20.6 4.0 0.7 25.4 4.8 0.9 2.0 19.6 17.6 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 3.4 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.9 0.0 0.0 20.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 3.3 0.0 0.1 0.7 0.2 10.0 2.0 16.9 25.4 9.0 13.8 4.7 21.4 17.6 15.6 0.9 19.6 1.9 4.8 2.3 5.0 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.0 0.4 0.0 0.0 2.2 25.1 0.0 0.2 0.8 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 170.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 143.8 0.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.0 1.2 0.4 0.3 0.0 21.0 0.0 0.0 GPR180 ITR ENSG00000152749 "G protein-coupled receptor 180" Q86V85 13 94601903-94634645 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047250 Approved Approved Vesicles NA NA Vesicles "HPA047250: AB_2679998" "unprognostic (3.91e-3)" "unprognostic (3.28e-1)" "unprognostic (4.16e-3)" "unprognostic (2.95e-1)" "unprognostic (1.17e-2)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (6.71e-2)" "unprognostic (1.47e-1)" "unprognostic (2.86e-2)" "prognostic unfavorable (3.18e-5)" "unprognostic (2.49e-2)" "unprognostic (1.10e-1)" "unprognostic (8.47e-2)" "unprognostic (2.80e-2)" 14.6 6.8 7.6 6.6 11.4 2.7 15.9 14.7 13.1 8.3 6.1 7.6 5.2 5.7 7.1 5.8 5.3 7.3 5.3 7.6 7.9 8.8 7.5 18.7 6.8 6.3 8.8 7.8 7.3 10.6 7.5 18.8 9.9 10.8 7.6 7.4 12.3 7.5 7.2 5.6 5.7 5.1 8.1 12.1 6.0 7.7 3.5 8.8 8.6 10.2 3.9 7.3 6.4 6.9 1.5 2.5 0.3 1.5 1.5 4.3 1.3 13.2 3.4 4.8 5.1 10.3 11.2 2.0 9.1 7.2 8.9 11.9 4.1 9.2 4.4 4.0 7.8 6.2 8.5 6.8 6.4 12.3 11.5 4.3 8.6 4.6 0.0 8.1 12.3 7.0 6.4 5.5 5.4 7.4 8.0 9.0 6.4 2.4 2.2 8.8 2.0 6.1 2.7 3.2 9.5 3.8 7.1 6.5 1.8 10.0 4.0 7.1 5.1 4.2 9.4 11.1 6.4 6.6 5.1 8.1 5.5 4.4 6.5 7.5 3.6 3.7 2.1 9.1 10.1 7.4 0.3 1.5 0.3 2.4 1.0 4.3 1.5 2.9 1.7 2.5 1.5 3.5 2.9 0.0 1.5 1.1 1.8 3.4 1.3 7.6 11.4 14.7 13.1 7.9 8.8 8.8 7.8 10.8 8.8 3.0 2.6 9.3 5.8 5.4 12.8 4.1 5.1 10.7 2.3 12.2 29.5 8.1 5.0 7.7 0.6 6.7 3.1 0.0 8.9 23.3 9.7 9.6 4.7 27.1 9.6 17.5 9.9 8.6 4.4 0.0 8.9 4.6 6.8 3.6 8.7 14.0 10.3 3.5 5.3 6.3 22.2 6.5 8.2 1.2 10.8 4.1 3.4 5.7 5.2 4.2 GPR182 "ADMR, AM-R, G10D, hrhAMR" ENSG00000166856 "G protein-coupled receptor 182" O15218 12 56994446-56998441 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "liver: 9.5;lymphoid tissue: 29.1;testis: 12.9" "Group enriched" "Detected in some" 32 "Early spermatids: 67.2;Ito cells: 90.2;Late spermatids: 117.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.2;RH-30: 6.2;SuSa: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027037 Enhanced NA NA "HPA027037: AB_1844622" "unprognostic (6.13e-2)" "unprognostic (6.23e-2)" "unprognostic (3.56e-2)" "unprognostic (5.88e-2)" "unprognostic (2.60e-2)" "unprognostic (3.30e-1)" "unprognostic (2.10e-4)" "unprognostic (2.04e-1)" "unprognostic (1.85e-1)" "unprognostic (4.94e-1)" "unprognostic (1.67e-2)" "unprognostic (8.13e-2)" "unprognostic (5.62e-3)" "unprognostic (9.31e-2)" "unprognostic (2.88e-2)" "unprognostic (1.42e-1)" "unprognostic (4.34e-3)" 0.4 3.2 0.0 0.8 0.0 0.0 0.6 0.1 0.3 0.7 0.4 0.0 0.6 0.0 1.2 0.7 1.3 0.7 0.1 0.3 0.0 0.0 1.3 9.5 1.9 7.5 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.6 0.1 0.1 0.3 0.3 0.7 0.0 29.1 0.2 12.9 0.0 0.2 1.4 0.3 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.5 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.8 0.8 0.0 1.4 1.1 0.7 0.0 0.1 0.0 0.3 6.2 0.0 0.0 0.6 0.1 0.5 0.0 0.2 0.0 1.8 0.4 0.0 0.0 0.1 0.5 0.3 0.0 0.5 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 90.2 2.8 117.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 GPR183 EBI2 ENSG00000169508 "G protein-coupled receptor 183" P32249 13 99294530-99307405 "G-protein coupled receptors, Predicted membrane proteins" "Adaptive immunity, Immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 101.7" "Cell type enhanced" "Detected in many" 15 "B-cells: 189.0;Macrophages: 550.4;monocytes: 424.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 22 "HDLM-2: 53.8;HL-60: 36.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028847, CAB033690, HPA075590" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "CAB033690: AB_2114269, HPA028847: AB_10603672, HPA075590: " "unprognostic (3.28e-3)" "prognostic favorable (9.77e-4)" "unprognostic (6.03e-2)" "unprognostic (4.61e-3)" "unprognostic (3.45e-1)" "unprognostic (7.11e-2)" "unprognostic (1.71e-1)" "unprognostic (6.29e-2)" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (2.33e-1)" "unprognostic (4.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.97e-3)" "unprognostic (9.31e-3)" "unprognostic (9.86e-3)" 27.0 5.5 3.1 33.8 5.0 40.8 7.6 1.1 2.9 5.9 11.2 7.5 4.5 3.2 3.8 9.2 9.3 6.4 17.3 11.7 4.8 6.1 5.4 7.2 26.5 53.7 7.5 2.6 4.4 2.1 2.1 4.8 11.1 9.3 7.4 9.2 4.8 6.6 2.0 4.1 5.3 19.2 9.0 31.3 46.5 6.0 3.7 7.4 13.2 6.5 8.3 38.9 34.9 5.2 46.8 30.6 101.7 1.2 55.0 60.2 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 53.8 0.0 0.4 0.1 0.0 0.0 36.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.2 0.0 101.7 1.2 46.1 5.7 0.4 34.0 46.8 60.2 30.9 9.3 19.1 38.1 5.2 1.2 55.0 0.4 30.6 47.3 27.8 3.1 5.0 1.1 2.9 4.8 6.1 7.5 2.6 9.3 7.4 14.9 41.9 189.0 0.4 54.7 0.2 1.8 0.0 6.7 10.3 0.0 5.9 0.9 1.7 0.1 0.6 2.3 0.0 0.0 2.5 1.3 21.6 0.4 60.0 0.5 114.3 0.0 0.0 0.6 92.9 1.3 0.3 550.4 138.3 424.8 0.0 0.1 0.7 0.0 0.0 0.3 0.8 6.5 3.6 0.5 0.2 46.7 1.5 126.8 0.0 0.3 GPR19 ENSG00000183150 "G protein-coupled receptor 19" Q15760 12 12660891-12696207 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 9.2;brain: 13.3;pituitary gland: 9.8;testis: 9.8" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 1.5;Early spermatids: 3.2;Muller glia cells: 1.5;Spermatocytes: 4.2" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 9.2" "Group enriched" "Detected in many" 16 "granulocytes: 4.2;T-cells: 9.2" "Cell line enhanced" "Detected in many" "HDLM-2: 22.7;NTERA-2: 23.6;SuSa: 17.8;WM-115: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013955 Uncertain NA NA "HPA013955: AB_1849287" "unprognostic (1.92e-1)" "unprognostic (3.38e-2)" "unprognostic (1.72e-1)" "unprognostic (8.62e-5)" "unprognostic (1.60e-1)" "unprognostic (3.21e-1)" "unprognostic (8.25e-4)" "unprognostic (1.37e-1)" "unprognostic (1.73e-1)" "unprognostic (6.90e-2)" "unprognostic (1.45e-1)" "unprognostic (1.70e-2)" "unprognostic (2.67e-12)" "unprognostic (5.19e-2)" "unprognostic (1.38e-1)" "unprognostic (7.60e-2)" "unprognostic (1.60e-1)" 1.0 2.4 7.5 4.8 13.3 2.3 1.2 11.5 13.0 0.8 1.5 2.8 0.0 1.1 0.7 0.7 1.5 1.0 1.1 0.7 8.5 8.4 0.7 0.8 0.8 4.3 5.6 6.3 0.5 1.1 1.0 9.8 1.1 3.7 0.5 1.9 0.4 0.6 0.6 0.4 2.2 1.1 1.1 6.7 1.7 1.3 9.8 3.6 0.3 0.7 0.0 5.8 1.3 0.2 0.3 0.0 4.2 0.0 0.4 9.2 0.5 0.9 0.3 9.8 0.2 0.0 0.0 4.2 0.9 1.0 1.7 1.5 3.8 5.9 3.9 1.5 0.7 1.3 0.7 1.6 0.2 2.9 22.7 0.2 0.9 0.4 0.6 0.0 1.0 0.4 0.0 0.0 1.9 1.1 0.7 0.3 0.4 0.1 8.2 0.3 1.4 0.3 0.5 23.6 1.0 1.8 2.5 1.5 0.1 0.1 0.8 3.2 3.0 0.4 0.8 7.5 17.8 0.5 0.9 0.0 0.5 4.4 0.8 2.2 4.5 3.9 7.6 1.8 2.7 12.0 0.0 0.0 0.0 1.8 0.0 1.4 0.3 3.8 2.1 0.0 0.1 0.7 1.4 4.2 0.4 0.0 0.0 9.2 0.5 7.5 13.3 11.5 10.6 8.5 8.4 5.6 6.3 3.7 3.6 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.1 0.3 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.4 0.0 0.0 4.2 0.2 0.0 0.1 0.8 0.0 0.0 GPR20 ENSG00000204882 "G protein-coupled receptor 20" Q99678 8 141356500-141367267 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 71.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "intermediate monocyte: 3.7;non-classical monocyte: 5.4" "Lineage enriched" "Detected in single" 14 "monocytes: 5.4" "Cell line enriched" "Detected in some" 4 "EFO-21: 7.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.3" HPA071337 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA071337: " "unprognostic (4.47e-2)" "unprognostic (2.64e-3)" "unprognostic (5.18e-2)" "unprognostic (2.00e-2)" "unprognostic (7.47e-2)" "unprognostic (2.28e-1)" "unprognostic (4.43e-2)" "unprognostic (5.01e-2)" "unprognostic (3.54e-1)" "unprognostic (2.13e-2)" "unprognostic (1.57e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (7.41e-2)" "unprognostic (5.50e-2)" "unprognostic (6.23e-2)" "unprognostic (4.07e-1)" 2.8 0.5 0.7 2.7 1.4 0.1 2.5 0.2 2.0 10.6 9.1 1.0 4.3 2.2 6.7 1.9 3.4 3.9 6.1 2.1 0.8 0.4 1.1 0.4 3.5 0.3 1.4 0.9 3.7 0.5 0.5 0.5 3.2 2.1 2.2 1.0 1.1 0.5 3.0 2.1 1.0 10.5 4.5 0.5 0.8 4.3 1.6 0.7 0.0 1.4 1.5 0.5 1.7 3.4 0.0 0.3 0.3 5.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 7.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.2 0.5 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 5.4 0.0 0.0 0.1 0.7 1.4 0.2 2.0 0.8 0.4 1.4 0.9 2.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 71.1 16.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GPR21 ENSG00000188394 "G protein-coupled receptor 21" Q99679 9 123034527-123035696 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HBEC3-KT: 8.4" "Low region specificity" "Detected in many" HPA041651 Uncertain NA NA "HPA041651: AB_10794673" "unprognostic (9.22e-3)" "unprognostic (1.46e-1)" 3.6 0.0 1.1 1.7 2.2 0.2 1.1 0.1 4.6 2.1 0.4 0.0 2.7 1.0 1.9 0.9 0.8 0.5 0.7 0.4 0.3 0.0 0.5 1.9 0.3 1.4 0.0 0.2 0.0 1.5 0.1 0.6 0.1 0.7 0.4 0.6 0.3 1.7 0.4 0.9 0.5 0.0 1.0 0.9 1.3 2.0 0.9 0.0 0.1 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 8.4 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR22 ENSG00000172209 "G protein-coupled receptor 22" Q99680 7 107470018-107475659 "G-protein coupled receptors, Predicted membrane proteins" "Cilium biogenesis/degradation" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 31.5;heart muscle: 18.7" "Group enriched" "Detected in some" 8 "Bipolar cells: 15.6;Cardiomyocytes: 57.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 33 "SH-SY5Y: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.23e-2)" "unprognostic (1.25e-2)" "unprognostic (1.19e-1)" "unprognostic (5.52e-2)" "unprognostic (7.73e-2)" "unprognostic (1.00e-1)" "unprognostic (4.27e-3)" "unprognostic (1.62e-1)" "unprognostic (8.76e-3)" "unprognostic (5.48e-2)" "unprognostic (1.25e-1)" "unprognostic (5.85e-4)" "unprognostic (1.55e-1)" "unprognostic (7.53e-3)" "unprognostic (2.27e-3)" "unprognostic (2.04e-1)" 0.6 2.7 10.9 0.6 4.4 0.7 0.6 15.5 31.5 6.3 0.6 0.0 0.0 0.6 4.1 0.6 0.6 0.6 0.6 18.7 19.4 2.0 1.0 0.6 0.6 0.6 1.8 13.0 0.6 0.6 0.6 0.3 0.6 6.0 0.6 0.6 0.0 0.6 0.8 0.6 0.6 0.6 1.0 0.7 0.6 0.6 0.6 1.1 0.0 0.6 0.0 0.6 0.6 1.7 1.0 0.2 0.3 0.3 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.2 0.3 0.9 0.4 0.5 0.0 1.0 0.4 1.0 0.3 0.2 0.2 0.2 0.4 0.0 10.9 4.4 15.5 31.5 19.4 2.0 1.8 13.0 6.0 1.1 0.0 0.0 0.0 0.0 0.2 15.6 57.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPR25 ENSG00000170128 "G protein-coupled receptor 25" O00155 1 200872955-200874178 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 22.9;lymphoid tissue: 11.6;stomach 1: 7.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 15.1;T-reg: 22.9" "Group enriched" "Detected in many" 63 "B-cells: 8.1;T-cells: 22.9" "Cell line enriched" "Detected in single" 6 "U-266/70: 5.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (2.80e-3)" "unprognostic (1.73e-2)" "unprognostic (1.06e-1)" "unprognostic (1.25e-4)" "unprognostic (2.21e-3)" "unprognostic (4.49e-5)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-2)" "unprognostic (1.04e-1)" "unprognostic (9.03e-2)" "unprognostic (1.29e-6)" "unprognostic (1.48e-2)" "unprognostic (3.71e-2)" "unprognostic (2.42e-2)" "unprognostic (3.22e-6)" 0.2 0.2 0.1 3.4 0.9 0.2 0.1 0.1 0.7 0.2 0.6 0.4 0.0 0.5 0.7 0.1 2.6 0.8 0.2 1.6 0.1 0.4 0.2 0.1 1.7 1.7 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.3 0.1 0.0 5.2 0.1 0.3 0.1 1.9 0.1 0.1 2.9 7.3 1.5 0.0 1.0 0.3 1.5 11.6 0.9 0.5 8.1 0.0 0.1 0.0 0.2 22.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 6.1 8.1 15.1 4.8 0.0 0.7 0.4 1.3 0.1 0.2 0.0 0.0 22.9 3.1 0.1 0.9 0.1 0.7 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR26 ENSG00000154478 "G protein-coupled receptor 26" Q8NDV2 10 123666355-123694607 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "brain: 8.6" "Cell type enhanced" "Detected in single" 28 "Horizontal cells: 1.6" "Cancer enriched" "Detected in single" 13 "breast cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "SCLC-21H: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062736 Enhanced NA NA "HPA062736: AB_2684855" "unprognostic (4.15e-2)" "unprognostic (5.75e-2)" "unprognostic (3.42e-1)" "unprognostic (2.12e-1)" "unprognostic (9.09e-2)" "unprognostic (9.98e-2)" "unprognostic (2.12e-2)" "unprognostic (1.16e-2)" "unprognostic (1.12e-1)" 0.0 0.0 1.0 0.1 0.2 0.1 0.0 0.0 8.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.6 2.4 0.0 0.3 0.0 0.1 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 GPR27 SREB1 ENSG00000170837 "G protein-coupled receptor 27" Q9NS67 3 71754050-71756496 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2;parathyroid gland: 29.6" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 11.0;Collecting duct cells: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "eosinophil: 3.7;neutrophil: 10.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.5" "Cell line enhanced" "Detected in some" "EFO-21: 13.0;HL-60: 12.5;MCF7: 10.8;NTERA-2: 21.5;RPTEC TERT1: 10.4;SH-SY5Y: 8.2;T-47d: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029395 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA029395: AB_10602907" "prognostic favorable (5.63e-4)" "unprognostic (2.99e-1)" "unprognostic (3.23e-2)" "unprognostic (3.22e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-2)" "unprognostic (2.17e-2)" "unprognostic (1.18e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.21e-6)" "unprognostic (2.97e-3)" "unprognostic (4.97e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.71e-2)" "unprognostic (1.45e-2)" "unprognostic (6.79e-2)" 1.7 4.5 14.9 1.7 23.2 14.5 4.3 4.4 15.4 3.4 1.0 5.8 1.7 0.6 5.5 3.3 2.7 7.7 1.2 3.5 12.8 12.4 3.2 0.9 2.4 5.5 10.6 8.8 5.0 2.6 29.6 5.1 2.0 5.9 5.7 0.7 3.3 1.7 5.1 1.8 1.9 0.7 3.3 16.8 3.7 2.4 4.2 3.6 0.0 6.8 1.2 0.5 2.1 2.8 0.0 0.2 10.5 0.8 0.0 0.4 0.1 0.0 0.8 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 13.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 12.5 0.7 0.0 2.2 0.0 0.9 0.0 0.0 2.7 0.0 0.0 0.0 10.8 0.9 0.2 21.5 0.0 0.0 0.0 0.0 0.0 10.4 5.8 2.3 8.2 2.8 0.0 0.0 2.9 7.5 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.8 3.7 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 10.5 0.0 0.1 0.0 0.0 0.1 14.9 23.2 4.4 9.9 12.8 12.4 10.6 8.8 5.9 3.6 0.0 1.4 0.0 4.0 1.6 11.0 2.8 5.1 2.7 2.3 12.2 3.9 1.1 1.7 0.4 0.1 0.0 0.0 0.0 0.0 1.1 0.9 4.5 0.0 0.0 1.0 0.0 1.2 0.0 5.1 0.0 0.9 0.5 0.0 0.0 0.0 0.5 0.4 0.0 1.1 0.0 0.3 0.0 0.4 0.2 0.9 1.5 0.2 0.0 0.0 1.8 GPR3 ACCA ENSG00000181773 "G protein-coupled receptor 3" P46089 1 27392644-27395814 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 1.8;Cardiomyocytes: 3.2;Horizontal cells: 4.8;Intestinal endocrine cells: 4.6;Smooth muscle cells: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB006254 Uncertain NA NA "CAB006254: AB_425462" "unprognostic (4.42e-2)" "unprognostic (2.22e-1)" "unprognostic (4.05e-2)" "unprognostic (1.55e-2)" "unprognostic (1.38e-2)" "unprognostic (1.27e-1)" "unprognostic (7.30e-3)" "unprognostic (6.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.09e-1)" "unprognostic (5.94e-2)" "unprognostic (1.97e-1)" "unprognostic (1.46e-1)" "unprognostic (8.17e-2)" "unprognostic (2.07e-2)" "unprognostic (6.54e-2)" "unprognostic (1.03e-2)" 3.5 1.5 4.0 2.8 7.5 3.2 1.5 5.5 12.3 1.2 1.1 2.1 0.2 1.0 2.3 0.5 2.0 1.1 2.9 7.1 5.0 6.3 1.9 2.0 2.7 1.0 4.4 1.7 1.2 2.6 2.8 6.1 1.8 13.9 1.8 1.1 1.1 0.7 1.0 0.6 0.6 0.9 2.5 6.5 0.7 1.3 0.8 0.5 0.0 3.0 0.8 0.7 1.6 0.5 0.7 0.4 0.0 0.1 0.0 0.1 0.0 1.6 0.9 4.8 5.4 0.2 0.6 0.6 3.1 3.6 4.8 3.5 1.4 1.0 0.3 0.7 1.4 4.9 1.2 1.3 3.8 3.7 0.1 0.2 1.3 0.3 3.0 0.6 3.0 4.1 0.7 0.0 6.7 1.5 0.5 1.5 2.1 3.7 5.3 5.8 2.4 0.6 4.2 7.1 2.4 7.6 8.1 3.8 2.2 2.0 0.4 0.9 2.3 1.5 0.6 5.7 2.2 0.1 0.6 0.9 3.6 6.5 21.0 3.7 0.7 3.6 0.4 5.4 1.0 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.0 7.5 5.5 12.3 5.0 6.3 4.4 1.7 13.9 0.5 0.0 0.0 0.0 1.8 0.1 1.4 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.6 0.0 0.0 0.2 4.8 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.3 0.1 GPR31 "12-HETER, HETER1" ENSG00000120436 "G protein-coupled receptor 31" O00270 6 167156271-167158329 "G-protein coupled receptors, Predicted membrane proteins" "Lipid metabolism" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.7;epididymis: 2.5;lymphoid tissue: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "myeloid DC: 2.7" "Lineage enriched" "Detected in single" 28 "dendritic cells: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014014, HPA027108" Uncertain NA NA "HPA014014: AB_1849292, HPA027108: AB_10601474" "unprognostic (9.92e-2)" "unprognostic (1.52e-1)" "unprognostic (1.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" "unprognostic (1.42e-3)" "unprognostic (2.20e-3)" "unprognostic (5.95e-3)" "unprognostic (4.03e-2)" "unprognostic (3.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.54e-2)" "unprognostic (2.86e-1)" "unprognostic (8.10e-4)" "unprognostic (2.45e-1)" "unprognostic (6.01e-2)" 0.0 0.0 0.1 0.9 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.5 0.0 2.5 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 4.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.2 2.1 0.3 1.1 0.1 1.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR32 RVDR1 ENSG00000142511 "G protein-coupled receptor 32" O75388 19 50770464-50771732 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 52 "parathyroid gland: 63.4" "Group enriched" "Detected in some" 10 "Extravillous trophoblasts: 4.2;Syncytiotrophoblasts: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "BEWO: 29.5" "Low region specificity" "Detected in some" NA NA "unprognostic (4.77e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 63.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 GPR33 ENSG00000214943 "G protein-coupled receptor 33 (gene/pseudogene)" Q49SQ1 14 31482875-31488142 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 5.7" "Lineage enhanced" "Detected in many" "dendritic cells: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.20e-1)" "unprognostic (8.10e-3)" "unprognostic (6.53e-4)" "unprognostic (9.13e-2)" "unprognostic (2.55e-1)" "unprognostic (2.10e-1)" 0.1 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 2.0 0.0 1.1 0.0 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 1.3 0.1 0.0 0.1 0.3 0.0 0.0 0.0 1.9 0.1 0.5 0.0 1.5 0.1 0.0 0.6 1.3 0.0 0.0 5.7 1.8 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR34 ENSG00000171659 "G protein-coupled receptor 34" Q9UPC5 X 41688973-41697277 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 60.8" "Cell type enhanced" "Detected in some" 23 "granulocytes: 35.9;Hofbauer cells: 198.9;Kupffer cells: 113.1;Macrophages: 46.2" "Cancer enhanced" "Detected in all" "glioma: 26.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "basophil: 60.8;eosinophil: 25.3" "Lineage enriched" "Detected in many" 20 "granulocytes: 60.8" "Cell line enhanced" "Detected in some" "HMC-1: 5.0;JURKAT: 2.6;U-937: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010668, CAB025490" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB025490: , HPA010668: AB_1849294" "unprognostic (1.26e-2)" "unprognostic (1.08e-1)" "unprognostic (1.43e-2)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.59e-2)" "unprognostic (9.81e-3)" "unprognostic (7.19e-2)" "unprognostic (1.74e-1)" "unprognostic (3.96e-1)" "unprognostic (2.72e-3)" "unprognostic (1.14e-1)" "unprognostic (1.88e-3)" "unprognostic (3.18e-2)" 25.1 12.4 15.1 9.7 16.6 0.4 15.0 2.1 11.7 10.5 9.1 13.5 1.0 4.4 4.9 6.6 5.8 5.5 12.2 5.9 16.0 9.5 11.7 5.3 11.4 26.8 22.4 7.5 5.4 4.4 2.8 3.3 29.3 15.4 5.7 9.3 4.9 7.1 6.4 2.1 2.4 11.4 11.5 34.0 22.3 5.1 5.0 21.4 1.9 3.4 1.5 11.1 12.5 3.7 0.3 0.4 60.8 2.8 3.0 0.1 0.5 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 1.0 0.4 0.0 0.2 0.0 0.1 5.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.0 0.2 0.7 0.3 0.0 0.4 0.1 1.1 0.0 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.1 0.8 0.1 0.0 0.0 0.1 0.6 1.3 0.0 60.8 2.2 25.3 0.0 2.8 0.0 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.2 3.0 1.5 0.0 0.1 0.5 15.1 16.6 2.1 11.7 16.0 9.5 22.4 7.5 15.4 21.4 0.0 3.2 2.7 0.2 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.3 1.7 0.1 35.9 0.0 198.9 0.0 1.2 3.1 113.1 0.6 0.9 46.2 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 19.4 0.0 0.0 0.1 0.9 2.1 1.7 0.0 0.0 GPR35 ENSG00000178623 "G protein-coupled receptor 35" Q9HC97 2 240605431-240631259 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 109.6" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 80.6;granulocytes: 38.0;Mucus-secreting cells: 25.1;Paneth cells: 24.6;Undifferentiated cells: 21.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 20.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "classical monocyte: 16.4;eosinophil: 16.8;intermediate monocyte: 22.7;myeloid DC: 14.5;non-classical monocyte: 6.1" "Group enriched" "Detected in many" 14 "dendritic cells: 14.5;granulocytes: 16.8;monocytes: 22.7" "Cell line enhanced" "Detected in some" "CACO-2: 10.8;CAPAN-2: 27.2;HDLM-2: 9.0;Hep G2: 17.3;HMC-1: 17.1;OE19: 20.1;U-937: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.05e-1)" "unprognostic (2.89e-2)" "unprognostic (4.35e-2)" "unprognostic (1.53e-1)" "unprognostic (5.99e-2)" "unprognostic (3.94e-3)" "unprognostic (2.71e-2)" "prognostic unfavorable (5.86e-4)" "unprognostic (2.01e-1)" "unprognostic (2.07e-1)" "unprognostic (7.98e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (2.59e-5)" "unprognostic (7.03e-3)" "unprognostic (1.30e-1)" "unprognostic (1.23e-2)" "unprognostic (1.10e-3)" 0.8 0.2 1.5 7.0 1.8 2.4 1.4 2.4 2.2 1.6 50.4 1.0 0.5 27.2 1.7 1.8 1.1 3.4 24.1 0.8 1.5 1.5 2.2 0.7 3.1 6.6 1.6 0.8 2.5 0.5 0.3 3.2 0.7 1.8 1.8 11.2 0.6 0.8 0.7 3.9 1.2 109.6 1.3 1.4 8.9 10.8 2.0 1.6 1.9 1.2 0.9 2.4 1.0 1.0 0.0 14.5 16.8 22.7 0.3 1.3 5.5 0.0 0.2 0.1 0.5 0.5 0.0 0.2 0.0 0.1 0.0 0.1 10.8 27.2 0.1 0.1 0.1 0.4 0.2 0.0 0.0 0.0 9.0 0.3 4.5 0.2 17.3 0.2 0.2 17.1 0.1 0.0 0.3 0.1 0.2 0.0 0.7 0.2 1.5 0.0 0.3 0.2 8.4 0.4 20.1 0.1 1.0 0.0 0.2 0.1 0.1 1.0 0.4 0.0 0.1 0.2 0.3 0.1 3.0 0.4 0.1 0.1 0.7 0.0 1.9 0.8 0.1 0.0 9.5 0.2 0.0 16.4 16.8 0.7 22.7 1.3 0.0 0.4 0.4 14.5 0.0 0.2 0.5 0.2 0.3 6.1 0.3 0.1 5.5 1.5 1.8 2.4 2.2 1.5 1.5 1.6 0.8 1.8 1.6 0.0 7.9 0.0 0.0 1.8 1.3 0.8 2.5 0.0 0.0 1.8 0.0 0.1 0.0 1.2 0.0 0.2 80.6 0.0 2.9 0.0 0.4 0.1 38.0 0.0 11.0 1.6 6.4 0.0 5.1 0.0 0.3 8.8 0.0 2.8 25.1 0.2 8.3 24.6 1.1 2.1 2.4 0.0 0.5 1.1 0.7 1.0 0.2 2.5 21.8 0.1 GPR37 "EDNRBL, hET(B)R-LP, PAELR" ENSG00000170775 "G protein-coupled receptor 37" O15354 7 124745997-124765627 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 62.4" "Cell type enriched" "Detected in many" 36 "Muller glia cells: 779.4" "Cancer enhanced" "Detected in many" "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.4;fHDF/TERT166: 22.0;hTCEpi: 9.8;SK-BR-3: 8.5;SuSa: 10.6;TIME: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042903, HPA068009" Approved Approved "Nuclear membrane,Cytosol" No No 48000 "Nuclear membrane, Cytosol" "HPA042903: AB_2678219, HPA068009: AB_2685940" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-2)" "unprognostic (7.29e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (6.00e-5)" "unprognostic (6.19e-2)" "prognostic favorable (7.26e-4)" "unprognostic (6.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.16e-2)" "unprognostic (6.12e-3)" "unprognostic (2.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.71e-4)" 1.6 1.0 14.5 1.1 19.6 0.9 1.7 2.3 52.6 1.5 1.4 62.4 0.0 1.0 2.1 1.4 7.8 2.1 1.4 0.9 23.9 11.3 1.2 8.8 1.3 1.1 33.5 12.3 1.0 3.0 0.8 0.3 10.0 23.3 1.8 1.5 3.5 1.6 1.8 1.1 4.1 1.3 3.0 49.4 4.3 1.2 15.5 26.5 0.0 0.9 0.0 0.9 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 9.4 0.0 0.0 0.0 2.7 0.5 2.5 2.4 0.6 0.4 0.8 0.0 0.0 22.0 0.3 0.2 2.8 0.0 0.5 0.4 1.2 0.1 5.9 0.0 2.8 0.0 0.4 0.0 9.8 0.0 0.1 0.0 4.5 0.0 0.0 4.3 0.0 0.5 0.0 0.0 1.4 0.0 4.5 0.0 0.0 0.0 0.0 0.1 2.2 3.3 0.0 8.5 3.2 10.6 2.2 0.0 15.3 2.0 0.7 0.0 0.0 1.3 0.0 0.0 1.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 19.6 2.3 19.6 23.9 11.3 33.5 12.3 23.3 26.5 0.0 0.0 0.0 0.3 4.0 21.7 0.4 2.5 0.0 0.0 1.8 5.9 7.1 0.0 4.3 0.2 0.5 0.0 0.0 0.5 15.1 2.7 2.1 0.0 21.5 1.0 17.5 0.0 0.0 0.3 0.9 2.6 0.0 3.3 1.0 0.4 779.4 0.4 0.0 0.7 0.0 12.5 0.0 0.9 0.6 0.7 8.9 2.5 0.0 0.0 0.1 GPR37L1 ETBR-LP-2 ENSG00000170075 "G protein-coupled receptor 37 like 1" O60883 1 202122858-202133592 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 44.0" "Cell type enriched" "Detected in some" 11 "Muller glia cells: 51.7" "Cancer enriched" "Detected in some" 57 "glioma: 36.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HaCaT: 2.9;MCF7: 3.3;T-47d: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064454 Enhanced NA NA "HPA064454: AB_2685268" "unprognostic (2.12e-2)" "unprognostic (1.83e-1)" "unprognostic (2.96e-1)" "unprognostic (1.61e-3)" "unprognostic (4.52e-1)" "unprognostic (8.20e-2)" "unprognostic (2.26e-4)" "unprognostic (5.83e-2)" "unprognostic (3.46e-3)" "unprognostic (2.07e-1)" "unprognostic (1.83e-1)" "unprognostic (3.28e-2)" "unprognostic (4.86e-3)" "unprognostic (1.14e-1)" "unprognostic (4.58e-2)" "unprognostic (1.18e-3)" "unprognostic (3.49e-1)" 1.6 2.0 20.5 1.6 25.2 1.9 1.6 13.2 44.0 2.0 2.4 33.4 0.0 1.9 1.8 1.8 1.7 1.8 1.7 1.6 22.3 12.6 1.5 1.6 1.6 1.5 17.7 22.1 1.7 1.5 1.5 0.4 1.6 23.8 1.7 1.9 0.9 1.9 2.3 1.7 1.8 2.1 1.7 11.1 1.6 1.6 1.9 15.7 0.0 1.8 0.0 1.5 1.6 0.2 0.9 0.9 1.8 0.9 0.6 1.4 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.1 2.9 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.1 1.2 0.0 0.1 9.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.0 0.8 0.7 0.5 0.9 0.7 0.6 0.3 0.2 0.6 0.9 0.7 0.5 1.8 0.6 0.4 0.9 1.4 0.2 20.5 25.2 13.2 39.3 22.3 12.6 17.7 22.1 23.8 15.7 0.0 0.0 0.0 0.5 0.3 1.1 0.8 0.0 0.0 2.3 0.0 3.9 0.0 0.0 2.5 3.5 0.0 1.0 0.0 1.1 0.8 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.5 51.7 1.5 2.9 1.8 0.0 4.7 0.0 0.2 0.0 0.1 0.1 0.6 0.0 0.4 0.8 GPR39 ENSG00000183840 "G protein-coupled receptor 39" O43194 2 132416574-132646559 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 22.0" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 14.9;Club cells: 10.3;Early spermatids: 16.6;Late spermatids: 12.5;Spermatocytes: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 4.3" "Lineage enriched" "Detected in single" 44 "dendritic cells: 4.3" "Cell line enhanced" "Detected in many" "A-431: 17.5;CAPAN-2: 15.0;hTEC/SVTERT24-B: 18.0;RT4: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA022111 Approved NA NA "HPA022111: AB_1849298" "unprognostic (4.06e-2)" "unprognostic (2.49e-1)" "unprognostic (2.23e-1)" "unprognostic (1.50e-2)" "unprognostic (5.19e-2)" "unprognostic (1.85e-1)" "unprognostic (8.54e-3)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (2.28e-1)" "unprognostic (1.64e-1)" "unprognostic (3.72e-1)" "unprognostic (4.69e-2)" "unprognostic (1.25e-1)" "unprognostic (6.58e-3)" 0.5 0.1 0.6 4.9 1.1 0.0 2.2 0.4 0.3 4.8 14.4 0.1 3.5 4.7 3.2 1.8 1.5 3.4 10.0 0.7 0.5 0.5 8.7 8.6 9.3 0.0 0.6 0.0 1.4 22.0 14.1 0.4 1.3 0.6 3.0 6.0 1.6 1.3 8.7 0.1 1.0 14.4 0.8 0.3 0.1 6.5 0.8 0.0 0.6 4.1 0.0 1.0 6.5 1.9 0.0 4.3 0.0 0.0 0.0 0.0 0.0 17.5 8.4 0.1 0.0 0.3 2.3 0.0 1.2 6.3 3.4 1.9 9.6 15.0 0.0 3.3 1.0 6.8 8.3 0.0 7.3 3.3 0.0 0.0 0.0 0.9 0.3 0.4 0.0 0.0 0.6 5.6 18.0 1.8 3.6 0.0 0.0 0.0 0.0 2.3 1.4 0.0 0.0 0.1 4.0 5.4 0.0 0.2 0.0 11.5 15.8 0.0 0.1 1.0 5.9 0.0 0.3 3.4 0.0 3.0 7.2 5.4 1.5 5.3 0.0 0.0 0.0 8.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.6 1.1 0.4 0.3 0.5 0.5 0.6 0.0 0.6 0.0 14.9 5.4 0.0 0.7 0.1 0.0 0.2 2.5 8.1 10.3 0.0 0.0 0.0 0.0 4.5 16.6 0.0 4.9 0.0 2.7 0.0 0.2 0.2 0.0 2.6 0.0 0.0 2.4 0.0 0.6 12.5 0.3 0.0 0.0 1.0 1.2 1.5 3.8 2.9 0.4 0.6 0.0 0.0 0.0 11.2 0.6 0.0 0.0 0.0 3.8 0.5 GPR4 ENSG00000177464 "G protein-coupled receptor 4" P46093 19 45589764-45602208 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 32.0" "Group enriched" "Detected in some" 7 "Endothelial cells: 19.4;Ito cells: 25.2;Sertoli cells: 6.5;Smooth muscle cells: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "HUVEC TERT2: 15.0;TIME: 24.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014278 Uncertain NA NA "HPA014278: AB_1849300" "unprognostic (2.49e-2)" "unprognostic (6.62e-3)" "unprognostic (1.33e-2)" "unprognostic (2.93e-2)" "unprognostic (2.70e-1)" "unprognostic (1.31e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (9.19e-4)" "unprognostic (1.29e-1)" "unprognostic (6.23e-2)" "unprognostic (1.70e-1)" "unprognostic (4.66e-2)" "prognostic unfavorable (2.07e-5)" "unprognostic (6.46e-3)" "unprognostic (1.93e-1)" "unprognostic (9.18e-2)" "unprognostic (2.49e-3)" 22.6 5.4 6.7 8.4 14.8 1.9 19.7 6.1 12.0 3.3 3.3 3.0 0.3 3.0 5.4 2.7 2.9 4.0 8.6 23.1 8.1 4.5 7.5 4.9 18.6 4.1 8.4 1.3 3.8 6.6 4.5 4.4 10.3 18.6 4.1 2.5 4.5 2.1 3.2 7.7 2.2 3.1 6.8 13.0 4.5 4.4 1.8 8.9 0.0 12.7 2.4 2.2 5.4 32.0 1.1 0.7 1.4 0.3 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.6 0.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.7 0.0 0.0 0.2 0.2 0.0 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 24.8 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.5 0.3 0.4 0.5 0.4 0.4 0.1 1.1 0.4 0.8 1.4 0.7 0.2 0.7 0.3 0.0 6.7 14.8 6.1 12.0 8.1 4.5 8.4 1.3 18.6 8.9 0.0 0.3 0.0 0.2 2.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 19.4 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 25.2 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.5 10.2 0.0 0.2 1.1 0.0 0.0 0.0 0.3 GPR42 "FFAR3L, GPR41L, GPR42P" ENSG00000126251 "G protein-coupled receptor 42 (gene/pseudogene)" O15529 19 35370929-35372962 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 2.3;blood: 2.1;intestine: 2.1" "Cell type enriched" "Detected in single" 4 "Alveolar cells type 2: 3.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 1.9;neutrophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "HHSteC: 1.0;RPMI-8226: 1.1" HPA044681 Uncertain NA NA "HPA044681: AB_2679043" "unprognostic (1.73e-3)" "unprognostic (1.31e-4)" 2.3 0.0 0.0 1.5 0.1 0.1 1.2 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.1 1.3 0.1 0.4 0.1 0.3 0.0 0.0 0.0 0.0 2.1 0.2 0.4 0.8 1.3 0.0 0.5 0.0 0.3 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.3 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GPR45 "PSP24, PSP24A" ENSG00000135973 "G protein-coupled receptor 45" Q9Y5Y3 2 105241743-105243049 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 5.7" "Group enriched" "Detected in some" 42 "Early spermatids: 3.5;Late spermatids: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "BEWO: 3.1;U-2 OS: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055940 Uncertain NA NA "HPA055940: AB_2682977" "unprognostic (3.80e-3)" "unprognostic (5.92e-2)" "unprognostic (2.19e-3)" "unprognostic (4.71e-1)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (6.87e-2)" "unprognostic (2.21e-1)" "unprognostic (1.13e-1)" "unprognostic (3.96e-1)" "unprognostic (1.61e-3)" "unprognostic (1.11e-2)" "unprognostic (3.13e-4)" "unprognostic (2.25e-1)" "unprognostic (2.76e-1)" "unprognostic (1.39e-1)" "unprognostic (3.99e-2)" 0.1 0.1 1.4 0.1 2.3 0.0 0.1 0.0 5.7 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 1.4 3.1 0.1 0.0 0.0 0.3 1.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.1 0.2 0.4 0.4 0.0 0.4 0.2 0.2 1.2 0.3 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.1 9.9 0.0 0.1 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR50 "H9, Mel1c" ENSG00000102195 "G protein-coupled receptor 50" Q13585 X 151176653-151181465 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "pituitary gland: 64.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEK 293: 9.6;SuSa: 8.1" "Region enriched" "Detected in some" 6 "hypothalamus: 16.8" "Region enriched" "Detected in some" 9 "hypothalamus: 6.4" "HPA049862, HPA054678" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA049862: AB_2680920, HPA054678: AB_2682570" "unprognostic (8.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.15e-1)" 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 64.9 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR52 ENSG00000203737 "G protein-coupled receptor 52" Q9Y2T5 1 174448111-174449198 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "brain: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "basal ganglia: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.0;Daudi: 1.5;Karpas-707: 2.5" "Low region specificity" "Detected in all" NA NA "unprognostic (1.93e-1)" "unprognostic (1.15e-1)" "unprognostic (8.60e-2)" "unprognostic (2.61e-2)" "unprognostic (3.65e-1)" "unprognostic (2.27e-1)" "unprognostic (4.49e-1)" 0.3 0.3 0.8 0.2 28.0 2.2 0.1 0.2 7.4 0.1 0.2 0.1 0.0 0.1 0.4 0.4 0.2 0.2 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.1 0.9 0.4 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.6 0.2 0.6 0.0 0.2 0.3 0.4 5.0 0.0 0.1 0.0 0.8 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.4 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 28.0 0.2 3.2 0.2 0.7 0.2 0.1 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR55 ENSG00000135898 "G protein-coupled receptor 55" Q9Y2T6 2 230907318-230961066 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.8;intestine: 8.2;lymphoid tissue: 13.2;testis: 7.7" "Cell type enhanced" "Detected in some" 17 "granulocytes: 1.1;Intestinal endocrine cells: 1.7;T-cells: 4.4" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 6 "basal ganglia: 7.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "Karpas-707: 27.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.88e-4)" "unprognostic (2.60e-2)" "unprognostic (2.27e-1)" "unprognostic (4.24e-3)" "unprognostic (5.93e-2)" "unprognostic (1.12e-4)" "unprognostic (3.79e-1)" "unprognostic (2.98e-2)" "unprognostic (1.08e-1)" "unprognostic (2.34e-1)" "unprognostic (4.37e-2)" "unprognostic (3.18e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.42e-2)" "unprognostic (4.26e-1)" 0.4 0.1 0.4 6.9 7.8 0.2 0.7 0.1 1.2 0.6 4.8 0.7 0.1 2.1 0.9 0.5 0.8 0.2 1.6 0.1 0.5 0.7 0.9 0.1 0.8 8.8 0.2 0.1 0.1 0.1 0.1 0.5 0.1 0.3 1.2 1.5 0.1 1.9 2.1 0.1 0.6 8.2 0.1 0.3 6.6 0.9 7.7 0.1 7.0 0.4 1.2 13.2 2.2 0.4 3.0 1.9 0.5 0.2 2.2 3.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.5 0.0 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 27.0 0.0 0.0 0.2 0.7 0.5 0.0 0.8 0.0 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 4.9 0.0 0.0 1.9 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.1 0.0 0.0 0.1 0.3 1.2 1.2 0.9 0.4 3.0 0.5 2.3 0.5 2.2 0.2 1.9 3.1 4.6 0.4 7.8 0.1 1.2 0.5 0.7 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 1.7 0.6 0.8 0.4 0.0 0.5 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.4 0.0 0.0 GPR6 ENSG00000146360 "G protein-coupled receptor 6" P46095 6 109978256-109980718 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "brain: 42.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "basal ganglia: 42.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 22 "SCLC-21H: 4.6" "Region enriched" "Detected in some" 11 "basal ganglia: 81.5" NA NA "unprognostic (1.14e-2)" "unprognostic (1.59e-2)" "unprognostic (7.10e-3)" 0.4 0.5 3.5 0.4 42.5 0.5 0.4 0.0 6.5 0.4 0.4 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.3 1.8 0.4 0.4 0.4 0.4 0.1 0.8 0.4 0.4 0.4 2.2 0.4 0.0 0.4 0.4 0.0 0.5 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.8 0.5 4.6 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 42.5 0.0 4.0 1.3 1.8 0.1 0.8 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR61 BALGR ENSG00000156097 "G protein-coupled receptor 61" Q9BZJ8 1 109539872-109548406 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;pituitary gland: 6.3;retina: 6.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 13.7;Cone photoreceptor cells: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.1;naive CD8 T-cell: 1.0" "Group enriched" "Detected in many" 11 "granulocytes: 1.1;T-cells: 1.0" "Cell line enhanced" "Detected in some" "JURKAT: 1.6;Karpas-707: 1.0;U-266/70: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007326, HPA026088" Supported NA NA "HPA007326: AB_1849308, HPA026088: AB_10602323" "unprognostic (1.70e-1)" "unprognostic (1.61e-1)" "unprognostic (1.91e-1)" "unprognostic (2.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.70e-2)" "unprognostic (7.51e-2)" "unprognostic (3.63e-3)" "unprognostic (2.94e-2)" "unprognostic (4.50e-2)" "unprognostic (1.46e-4)" "unprognostic (3.27e-1)" "unprognostic (4.08e-4)" "unprognostic (1.33e-1)" "unprognostic (1.07e-1)" "unprognostic (6.72e-2)" "unprognostic (3.85e-2)" 0.5 4.0 4.9 0.7 8.2 0.7 0.5 6.4 10.6 0.5 0.6 0.2 0.0 0.8 0.8 0.6 0.7 0.5 0.7 0.9 5.4 3.9 0.6 0.6 0.5 0.8 1.7 8.3 0.6 0.5 0.5 6.3 0.6 4.9 0.6 0.5 6.3 0.7 0.5 2.3 0.8 1.0 0.5 1.2 0.6 0.6 1.7 1.2 0.0 3.6 0.0 0.5 0.7 0.3 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.1 1.0 0.0 0.4 0.1 0.2 0.2 0.0 0.2 0.3 0.3 0.0 0.0 0.1 0.5 0.1 0.2 0.0 0.0 0.5 0.1 0.0 0.2 0.2 0.3 0.5 0.0 2.3 0.4 0.2 0.0 0.3 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.0 0.1 0.0 4.9 8.2 6.4 10.6 5.4 3.9 1.7 8.3 4.9 1.2 0.0 0.0 0.0 0.0 0.0 13.7 0.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GPR62 ENSG00000180929 "G protein-coupled receptor 62" Q9BZJ7 3 51955314-51957504 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 24.2" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 1.7;Cone photoreceptor cells: 3.9;Distal tubular cells: 1.7;Horizontal cells: 4.8;Rod photoreceptor cells: 1.4" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 6.5" "Low region specificity" "Detected in all" NA NA "unprognostic (9.56e-3)" "unprognostic (3.32e-3)" "unprognostic (2.21e-1)" "unprognostic (6.38e-2)" "unprognostic (7.98e-2)" "unprognostic (1.66e-2)" "unprognostic (9.02e-2)" "unprognostic (6.49e-2)" "unprognostic (2.03e-2)" "unprognostic (6.17e-2)" "unprognostic (3.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.82e-5)" "unprognostic (3.64e-2)" "unprognostic (2.45e-1)" "unprognostic (1.16e-2)" "unprognostic (1.77e-2)" 1.0 1.3 5.6 0.6 12.5 0.6 0.8 1.4 16.2 0.8 0.7 24.2 0.0 0.7 1.1 1.4 0.8 1.1 1.0 1.3 9.7 5.3 1.2 1.0 0.7 0.7 17.8 5.4 2.1 0.8 1.3 0.4 0.7 10.6 0.9 0.7 0.0 1.1 1.0 1.3 0.8 0.7 0.8 18.6 0.8 1.0 0.8 14.5 0.0 0.9 0.0 0.7 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.2 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.2 0.2 0.2 0.0 0.0 0.1 6.5 1.3 1.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 1.0 0.2 0.1 0.6 0.2 0.0 0.4 0.9 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 12.5 1.4 8.5 9.7 5.3 17.8 5.4 10.6 14.5 0.0 0.0 0.0 0.1 0.0 1.7 0.4 0.0 0.0 0.0 0.0 3.9 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GPR63 "PSP24(beta), PSP24B" ENSG00000112218 "G protein-coupled receptor 63" Q9BZJ6 6 96794126-96837463 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Early spermatids: 21.8;Late spermatids: 26.5;Spermatocytes: 22.8;Spermatogonia: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 7.8;HHSteC: 12.8;Karpas-707: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039103 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039103: AB_10672841" "unprognostic (8.22e-2)" "unprognostic (2.77e-1)" "unprognostic (1.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (1.33e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (3.39e-1)" "unprognostic (2.53e-2)" "unprognostic (7.29e-3)" "unprognostic (3.00e-1)" "unprognostic (2.03e-3)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-2)" 1.8 3.4 3.8 3.1 11.0 0.8 1.6 7.5 10.7 3.3 3.9 1.6 1.0 5.1 1.9 1.5 2.0 2.8 2.7 1.9 3.2 2.2 1.4 0.5 1.4 0.9 2.2 6.4 4.0 5.0 3.9 4.3 2.5 10.1 3.3 6.2 2.5 1.7 2.2 1.0 1.7 3.6 3.6 1.4 1.3 4.1 8.0 5.2 2.5 2.3 0.0 0.9 2.2 4.8 0.8 0.9 2.6 0.6 1.4 1.1 0.1 0.0 0.1 1.5 0.3 2.2 0.8 0.4 0.9 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.1 1.2 1.1 4.9 2.3 0.0 7.8 3.8 4.7 0.4 0.0 12.8 2.9 0.5 2.4 0.4 0.0 3.5 0.3 0.0 7.0 3.4 19.2 0.4 0.4 2.2 0.0 5.0 0.0 0.7 0.0 1.8 3.8 0.3 0.2 2.3 1.4 0.3 3.1 0.5 1.7 1.2 0.6 0.0 1.3 2.0 0.2 1.8 1.5 0.8 0.1 0.8 1.8 1.0 0.8 0.6 0.2 0.6 0.2 0.3 0.7 1.1 0.6 0.1 0.8 1.0 0.9 2.6 1.4 0.2 0.9 0.3 0.1 3.8 11.0 7.5 10.7 3.2 2.2 2.2 6.4 10.1 5.2 0.0 0.0 0.0 0.8 1.6 1.1 0.5 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.4 21.8 0.1 0.0 0.0 0.8 0.6 0.9 1.0 0.0 0.0 0.2 0.0 2.9 1.8 0.0 26.5 3.1 0.0 1.7 0.0 0.4 0.3 0.5 0.0 4.6 0.0 0.2 0.0 1.1 22.8 9.3 0.3 0.1 0.0 0.5 0.3 GPR65 "hTDAG8, TDAG8" ENSG00000140030 "G protein-coupled receptor 65" Q8IYL9 14 88005124-88014811 "G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.4;lymphoid tissue: 40.8" "Cell type enhanced" "Detected in many" 19 "granulocytes: 306.4;Kupffer cells: 79.3;monocytes: 79.4;T-cells: 135.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 6.3;HEL: 6.8;HL-60: 8.1;HMC-1: 10.4;RH-30: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA072624, HPA077397" Enhanced Approved Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA072624: , HPA077397: " "unprognostic (8.56e-2)" "unprognostic (8.65e-3)" "unprognostic (1.98e-3)" "unprognostic (3.59e-3)" "unprognostic (3.10e-1)" "unprognostic (3.55e-3)" "unprognostic (1.15e-1)" "unprognostic (3.01e-2)" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (3.79e-1)" "unprognostic (4.46e-3)" "unprognostic (9.03e-2)" "unprognostic (3.80e-1)" 9.8 3.1 1.8 12.1 6.4 15.2 2.3 0.7 3.0 1.9 2.4 0.9 0.9 2.3 2.2 2.2 2.3 2.2 4.1 2.3 6.0 2.1 4.0 6.9 10.6 13.1 8.2 0.0 1.7 1.8 0.8 6.2 3.6 6.3 2.9 2.3 1.2 2.6 0.9 0.9 1.2 7.7 3.3 15.7 40.8 2.5 1.5 6.2 12.5 1.8 2.3 8.9 4.8 2.3 4.3 5.9 19.1 13.7 21.3 30.4 9.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.8 0.0 0.0 0.3 8.1 10.4 0.4 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.2 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 14.6 9.1 19.1 16.5 12.8 30.4 4.3 8.4 12.6 5.9 4.0 4.4 9.7 6.9 21.3 13.7 2.7 4.0 9.4 1.8 6.4 0.7 3.0 6.0 2.1 8.2 0.0 6.3 6.2 3.0 35.3 38.9 0.4 3.8 0.0 0.3 5.1 1.4 2.3 0.0 0.0 0.2 0.0 0.0 5.5 0.1 0.0 0.0 0.0 0.1 1.5 0.2 306.4 1.0 60.2 0.0 0.0 4.3 79.3 1.0 0.6 64.5 3.3 79.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.3 0.0 0.1 4.5 0.3 135.4 0.0 0.1 GPR68 OGR1 ENSG00000119714 "G protein-coupled receptor 68" Q15743 14 91232532-91253925 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Amelogenesis imperfecta, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.0" "Cell type enhanced" "Detected in some" 12 "Hofbauer cells: 12.9;T-cells: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 16.4" "Group enriched" "Detected in many" 10 "NK-cells: 12.8;T-cells: 16.4" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 7.2;U-87 MG: 26.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.44e-1)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "prognostic favorable (3.06e-5)" "unprognostic (3.20e-2)" "unprognostic (1.43e-1)" "unprognostic (9.10e-2)" "unprognostic (1.58e-1)" "unprognostic (6.84e-2)" "unprognostic (9.63e-2)" "unprognostic (9.42e-2)" "unprognostic (3.73e-1)" "unprognostic (8.31e-9)" "unprognostic (1.70e-2)" "unprognostic (3.19e-2)" "unprognostic (9.44e-2)" "unprognostic (2.78e-3)" 5.1 1.6 2.1 7.9 2.0 1.6 4.4 6.1 6.1 3.9 2.6 0.4 0.0 2.6 1.0 0.7 8.6 0.9 6.3 3.0 1.1 5.2 1.1 0.8 5.4 7.8 0.9 3.9 0.8 1.8 1.5 17.0 4.8 2.3 3.1 2.2 0.9 4.0 0.8 0.5 9.2 3.2 5.3 1.4 4.3 6.5 1.5 0.0 0.8 2.2 3.7 9.6 7.3 3.2 0.4 0.1 1.5 0.1 12.8 16.4 2.5 0.1 0.1 0.4 0.0 0.1 1.0 0.4 0.8 0.5 0.0 0.0 0.2 0.8 0.7 0.4 7.2 0.0 0.8 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.4 3.4 0.3 0.1 4.4 0.0 3.6 0.3 2.4 4.4 0.7 3.2 1.0 0.6 5.0 0.1 0.0 0.1 0.3 0.2 0.2 0.1 0.3 2.6 3.7 0.1 0.1 0.0 0.2 1.2 0.3 2.2 5.4 0.1 0.9 0.3 0.8 1.0 0.1 26.5 0.9 0.1 0.0 0.1 0.0 16.4 0.0 10.1 0.4 3.6 9.4 0.1 0.2 0.5 3.4 1.5 12.8 0.0 0.0 5.8 2.5 2.1 2.0 6.1 6.1 1.1 5.2 0.9 3.9 2.3 0.0 0.0 4.5 0.0 0.2 3.2 0.5 1.7 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 4.0 0.5 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.0 12.9 0.0 0.0 0.6 0.0 1.0 0.3 1.7 3.3 1.0 0.0 0.0 1.7 0.0 4.2 0.1 0.1 0.0 0.9 0.2 0.4 2.6 0.6 15.2 0.0 0.2 GPR75 WI-31133 ENSG00000119737 "G protein-coupled receptor 75" O95800 2 53852913-53859989 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0" "Cell type enhanced" "Detected in single" 19 "Cone photoreceptor cells: 2.0" "Cancer enhanced" "Detected in many" "glioma: 4.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.88e-1)" "unprognostic (2.39e-2)" "unprognostic (2.77e-1)" "unprognostic (4.44e-2)" "unprognostic (5.96e-2)" "unprognostic (5.27e-3)" "unprognostic (8.31e-3)" "unprognostic (2.59e-3)" "unprognostic (4.71e-2)" "unprognostic (2.20e-1)" "unprognostic (3.07e-4)" "unprognostic (1.10e-1)" "unprognostic (3.97e-3)" "unprognostic (8.23e-2)" "unprognostic (1.94e-1)" "unprognostic (3.38e-1)" "unprognostic (5.75e-2)" 2.9 3.6 19.6 2.6 20.7 2.9 4.8 16.6 23.0 2.7 1.6 18.9 0.1 1.3 3.5 2.2 2.3 3.3 3.2 1.5 20.1 5.7 1.4 6.0 2.1 2.5 9.0 15.2 4.7 2.7 9.0 7.3 1.5 17.3 3.8 1.9 5.3 3.4 3.4 2.1 2.2 1.8 3.8 10.7 3.3 2.5 2.0 15.6 0.0 4.6 0.0 2.0 2.1 1.5 1.4 1.0 1.4 0.2 0.1 0.8 0.0 2.6 2.9 4.2 3.8 1.5 0.9 5.5 2.2 1.4 2.6 2.5 7.4 1.1 5.6 1.9 3.0 2.2 4.1 4.9 4.0 4.1 4.8 3.2 6.5 4.0 4.0 1.0 3.7 4.6 1.9 1.3 6.5 1.2 1.4 2.1 2.0 3.8 1.6 2.2 2.0 1.7 2.8 5.5 0.8 3.3 2.8 3.8 1.1 1.4 4.1 2.4 3.6 1.9 1.5 1.0 4.6 1.4 1.2 5.4 4.5 4.4 3.6 6.1 1.3 0.8 1.8 4.2 3.8 3.1 0.0 0.2 0.0 0.5 0.0 0.4 0.7 0.0 0.8 0.2 1.4 0.6 0.1 1.4 0.1 0.0 1.0 0.0 0.0 19.6 20.7 16.6 19.3 20.1 5.7 9.0 15.2 17.3 15.6 0.0 0.0 0.0 0.2 0.6 0.1 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 GPR78 ENSG00000155269 "G protein-coupled receptor 78" Q96P69 4 8558725-8619761 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "placenta: 53.3" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 4.8" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 202 "BEWO: 21.7" HPA013209 Uncertain NA NA "HPA013209: AB_10601657" "unprognostic (6.41e-2)" "unprognostic (1.77e-2)" "unprognostic (1.17e-2)" "unprognostic (2.51e-1)" "unprognostic (1.81e-2)" "unprognostic (3.70e-2)" "unprognostic (3.82e-4)" "unprognostic (6.46e-3)" "unprognostic (1.20e-1)" "unprognostic (3.80e-2)" "unprognostic (2.29e-1)" "unprognostic (4.88e-15)" "unprognostic (5.55e-3)" "unprognostic (3.93e-2)" "unprognostic (9.90e-3)" "unprognostic (8.15e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 GPR82 ENSG00000171657 "G protein-coupled receptor 82" Q96P67 X 41724155-41730135 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 23.2;lymphoid tissue: 12.0" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 19.6;Kupffer cells: 18.0;Macrophages: 18.7;T-cells: 20.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "eosinophil: 23.2;NK-cell: 6.6" "Group enriched" "Detected in many" 9 "granulocytes: 23.2;NK-cells: 6.6" "Cell line enriched" "Detected in single" 16 "HMC-1: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA035914 Approved NA NA "HPA035914: AB_10670671" "unprognostic (5.62e-3)" "unprognostic (1.81e-2)" "unprognostic (4.65e-2)" "unprognostic (3.88e-3)" "unprognostic (1.15e-2)" "unprognostic (3.28e-2)" "unprognostic (4.62e-4)" "unprognostic (1.41e-3)" "unprognostic (2.12e-2)" "unprognostic (5.00e-2)" "unprognostic (1.39e-1)" "unprognostic (3.01e-1)" "unprognostic (7.45e-2)" "unprognostic (2.37e-2)" "unprognostic (2.26e-1)" "unprognostic (8.00e-3)" "unprognostic (1.18e-1)" 1.2 2.2 1.6 3.9 5.9 0.2 1.1 0.6 1.5 0.9 2.7 0.3 0.0 3.0 0.8 1.1 1.1 1.1 1.1 0.7 2.5 1.1 4.7 5.0 10.0 9.0 2.5 0.1 0.7 1.5 0.1 1.1 0.3 3.2 1.1 2.1 0.8 0.8 0.7 0.4 0.7 5.2 0.6 7.3 3.6 1.6 0.4 2.3 1.6 0.8 0.6 12.0 2.4 0.9 0.1 0.2 23.2 1.6 6.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.3 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.2 23.2 0.0 1.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 6.6 1.4 0.0 0.0 0.1 1.6 5.9 0.6 1.5 2.5 1.1 2.5 0.1 3.2 2.3 0.0 11.1 5.2 4.1 4.1 14.7 0.3 0.0 1.4 9.1 1.8 19.6 0.7 0.0 1.8 0.2 2.2 3.9 0.0 1.0 0.2 5.1 2.7 0.0 0.8 1.3 12.7 1.2 4.3 18.0 0.0 3.7 18.7 3.3 1.8 1.3 0.9 1.7 4.2 2.8 0.0 16.7 0.0 3.8 1.0 1.1 2.4 0.6 20.2 3.2 3.1 GPR83 GPR72 ENSG00000123901 "G protein-coupled receptor 83" Q9NYM4 11 94377311-94401419 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 20.0;thyroid gland: 9.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 5.7" "Region enhanced" "Detected in many" "basal ganglia: 61.1" "Low region specificity" "Detected in all" NA NA "unprognostic (6.74e-2)" "unprognostic (7.78e-3)" "unprognostic (8.58e-2)" "unprognostic (2.60e-1)" "unprognostic (1.82e-1)" "unprognostic (2.88e-1)" "unprognostic (6.36e-3)" "unprognostic (6.89e-2)" "unprognostic (6.03e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (6.17e-2)" "unprognostic (1.47e-12)" "unprognostic (3.16e-1)" "unprognostic (1.64e-1)" "unprognostic (1.33e-2)" "unprognostic (8.28e-3)" 0.6 2.6 3.3 0.8 6.1 2.0 0.6 20.0 11.7 0.8 0.7 0.9 0.0 0.7 0.8 1.2 0.5 0.8 0.8 1.2 19.8 6.7 1.2 1.2 0.7 1.1 1.0 3.7 0.7 0.7 0.5 0.6 0.5 1.7 0.5 0.6 0.3 0.6 0.6 1.3 1.4 0.8 0.6 1.8 1.1 0.8 1.1 1.0 0.0 9.3 0.0 0.7 0.5 0.3 0.7 0.5 2.6 0.6 1.6 0.6 0.2 0.3 0.5 0.9 1.2 0.0 0.2 0.9 0.7 0.1 0.1 0.2 5.7 1.1 1.1 0.5 0.1 0.4 1.3 0.4 0.2 0.1 0.8 0.5 1.2 1.2 0.7 0.0 1.6 3.0 0.2 0.5 0.4 0.2 0.6 0.0 1.0 1.2 1.3 0.1 0.8 0.4 2.5 1.1 0.6 0.7 1.1 0.2 0.8 0.1 0.9 0.7 0.7 0.5 0.8 0.2 1.3 0.9 0.1 0.4 0.8 1.3 0.8 0.9 1.2 1.5 0.5 0.5 1.0 1.2 2.6 0.6 0.5 0.5 0.3 0.4 0.4 0.5 0.6 0.2 0.7 0.4 0.4 1.4 1.6 0.6 0.5 0.3 0.2 3.3 6.1 20.0 11.7 19.8 6.7 1.0 3.7 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 GPR84 EX33 ENSG00000139572 "G protein-coupled receptor 84" Q9NQS5 12 54362445-54364487 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.2" "Group enriched" "Detected in some" 5 "Hofbauer cells: 20.5;Macrophages: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "basophil: 6.0;classical monocyte: 8.7;myeloid DC: 12.9;neutrophil: 5.3" "Group enriched" "Detected in many" 53 "dendritic cells: 12.9;granulocytes: 6.0;monocytes: 8.7" "Group enriched" "Detected in some" 5 "HL-60: 9.4;NB-4: 29.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027603 Enhanced NA NA "HPA027603: AB_10612115" "unprognostic (5.40e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (3.92e-2)" "unprognostic (2.36e-2)" "unprognostic (4.54e-2)" "unprognostic (6.16e-3)" "unprognostic (7.43e-2)" "unprognostic (9.29e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-2)" "unprognostic (2.92e-1)" "unprognostic (1.36e-9)" "unprognostic (1.27e-1)" "unprognostic (4.42e-2)" "unprognostic (1.40e-1)" "unprognostic (9.44e-2)" 7.2 2.3 2.7 11.2 6.8 27.2 0.7 0.4 3.3 1.0 0.9 5.0 0.0 0.8 0.6 0.9 1.1 1.7 1.8 3.2 1.6 2.1 2.4 0.8 5.3 2.7 4.4 0.0 2.7 1.0 0.7 2.3 6.7 5.0 1.2 1.3 0.7 1.2 0.7 1.1 1.4 0.8 2.8 6.7 8.0 1.2 2.1 7.5 0.9 2.1 0.0 2.8 3.0 2.1 0.0 12.9 6.0 8.7 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.4 1.6 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 3.7 0.0 6.0 8.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 12.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.8 2.7 6.8 0.4 3.3 1.6 2.1 4.4 0.0 5.0 7.5 0.0 0.3 0.0 0.1 0.8 2.9 0.1 0.0 0.0 1.2 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 20.5 0.0 0.0 0.0 2.7 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.4 0.7 0.0 0.0 0.0 GPR85 SREB2 ENSG00000164604 "G protein-coupled receptor 85" P60893 7 113078331-113087778 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 15.0;skeletal muscle: 30.4" "Group enriched" "Detected in many" 5 "Bipolar cells: 34.4;Early spermatids: 106.1;Horizontal cells: 79.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "HEL: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.80e-2)" "unprognostic (1.93e-2)" "unprognostic (6.98e-3)" "unprognostic (3.92e-2)" "unprognostic (2.68e-2)" "unprognostic (2.41e-2)" "unprognostic (9.90e-2)" "unprognostic (1.94e-1)" "unprognostic (6.09e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" "unprognostic (1.68e-1)" "unprognostic (1.34e-5)" "unprognostic (5.89e-3)" "unprognostic (9.99e-2)" "unprognostic (1.69e-1)" "unprognostic (1.23e-2)" 2.1 1.1 8.9 1.2 15.0 1.9 0.9 12.2 11.2 0.7 0.9 2.4 0.0 0.9 1.2 1.1 1.1 1.9 4.4 2.4 11.8 9.2 0.7 4.5 2.5 1.6 10.8 7.7 0.5 1.6 2.0 4.0 5.3 6.2 1.2 0.8 0.9 2.8 0.8 30.4 0.9 1.0 1.2 8.1 3.1 1.0 3.4 4.3 0.0 0.9 0.0 1.0 1.4 0.3 1.3 1.0 3.0 2.1 1.5 1.1 0.5 0.1 0.1 0.3 0.3 1.0 1.5 0.3 1.3 2.0 2.8 3.8 0.1 0.5 0.1 0.3 1.1 0.9 0.2 0.2 1.2 5.9 0.2 0.1 49.4 0.5 0.1 0.5 9.2 0.5 2.0 0.2 4.7 0.1 0.1 0.1 0.4 0.2 0.5 3.1 0.2 1.0 5.9 0.6 0.0 0.3 0.2 0.7 0.2 0.0 0.8 1.4 1.1 0.1 0.6 0.4 0.3 0.3 2.1 0.3 3.4 0.5 0.9 1.2 1.1 0.1 0.6 4.0 3.6 1.3 3.0 1.2 1.0 1.0 1.4 1.0 0.9 0.8 0.6 0.6 1.3 1.1 1.0 2.1 1.5 2.1 1.0 0.9 0.5 8.9 15.0 12.2 10.8 11.8 9.2 10.8 7.7 6.2 4.3 0.0 1.0 0.0 11.9 7.8 34.4 2.6 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 106.1 2.9 0.0 0.0 0.2 0.7 1.9 13.8 1.1 0.0 10.0 79.4 0.0 0.6 5.1 8.6 1.1 3.2 10.1 0.0 0.0 1.7 0.1 0.0 0.4 0.4 4.5 0.0 4.2 0.7 0.4 9.3 0.3 0.0 0.0 9.0 GPR87 GPR95 ENSG00000138271 "G protein-coupled receptor 87" Q9BY21 3 151294086-151316952 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 24.8;skin 1: 19.7;tongue: 21.9" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 127.1;Suprabasal keratinocytes: 59.6;Syncytiotrophoblasts: 171.4;Urothelial cells: 178.7" "Group enriched" "Detected in many" 6 "cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3" "Region enriched" "Detected in single" 12 "pons and medulla: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 31.5;HaCaT: 25.2;HBEC3-KT: 33.5;hTCEpi: 44.8;hTERT-HME1: 18.8;RT4: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066313 Approved "Nucleoplasm,Lipid droplets,Mitochondria" No No "Lipid droplets, Mitochondria" Nucleoplasm "HPA066313: AB_2685656" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (4.07e-3)" "unprognostic (8.60e-2)" "unprognostic (1.28e-2)" "unprognostic (4.61e-3)" "unprognostic (3.28e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (4.62e-6)" "unprognostic (8.64e-2)" "unprognostic (1.50e-3)" "unprognostic (3.66e-4)" "unprognostic (8.73e-2)" "unprognostic (3.80e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.4 6.5 0.0 0.0 2.8 0.0 0.4 2.1 24.8 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 11.1 5.1 4.5 0.0 0.0 9.5 4.0 0.0 19.7 0.0 0.4 0.0 0.0 0.2 0.7 0.0 2.0 0.0 21.9 13.5 6.2 13.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.2 0.0 0.0 11.5 0.0 0.0 0.0 0.1 25.2 0.0 33.5 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 44.8 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 1.1 13.2 0.0 0.0 5.6 0.1 0.0 0.9 0.1 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.6 0.0 127.1 52.7 0.0 0.0 0.0 4.0 20.5 3.5 0.0 46.3 0.0 1.3 0.1 0.2 0.0 0.0 0.6 10.3 2.1 36.4 1.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 59.6 171.4 0.0 0.0 178.7 GPR88 ENSG00000181656 "G protein-coupled receptor 88" Q9GZN0 1 100538137-100542018 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Mental retardation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 62.7" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 9 "liver cancer: 12.0" "Group enriched" "Detected in many" 7 "basal ganglia: 62.7;thalamus: 32.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HSkMC: 4.9;SCLC-21H: 6.1" "Region enriched" "Detected in many" 11 "basal ganglia: 643.5" "Region enriched" "Detected in some" 34 "basal ganglia: 223.4" HPA007488 Approved NA NA "HPA007488: AB_2667844" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (8.30e-2)" "unprognostic (8.37e-3)" "unprognostic (5.41e-1)" "unprognostic (5.63e-2)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "unprognostic (1.03e-2)" "unprognostic (7.76e-2)" "unprognostic (8.23e-3)" "unprognostic (2.45e-1)" "unprognostic (3.93e-4)" "unprognostic (1.85e-2)" "unprognostic (5.56e-2)" "unprognostic (4.41e-1)" "unprognostic (1.35e-2)" 0.7 0.6 1.2 0.5 62.7 0.2 10.9 0.0 6.8 0.1 0.3 0.8 0.0 0.6 0.2 0.2 0.2 0.1 0.2 0.4 0.9 0.8 0.3 13.1 0.2 0.3 0.7 1.1 3.8 0.1 4.6 0.5 0.2 7.0 0.6 0.5 0.3 0.7 0.1 0.3 0.1 0.5 0.3 0.5 13.7 0.4 0.2 32.8 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 4.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 62.7 0.0 6.8 0.9 0.8 0.7 1.1 7.0 32.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR89A UNQ192 ENSG00000117262 "G protein-coupled receptor 89A" B7ZAQ6 1 145607990-145670648 "Predicted membrane proteins" "Ion transport, Protein transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 40.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA076096 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA076096: AB_2686777" "unprognostic (1.19e-1)" "unprognostic (6.71e-2)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.51e-3)" "unprognostic (4.51e-2)" "unprognostic (1.99e-3)" "unprognostic (8.14e-2)" "unprognostic (4.61e-3)" "unprognostic (5.41e-2)" "unprognostic (1.96e-1)" "unprognostic (3.00e-2)" "unprognostic (1.02e-5)" "unprognostic (1.42e-1)" "unprognostic (3.70e-2)" "unprognostic (5.47e-2)" "unprognostic (1.21e-1)" 4.0 9.3 4.3 3.8 5.4 2.2 9.2 4.6 6.9 6.2 4.7 7.0 7.5 5.4 9.0 4.5 4.1 4.7 5.9 5.9 5.2 5.1 17.5 15.3 4.8 9.6 4.9 4.0 4.2 13.6 5.9 4.2 3.5 3.9 5.5 7.5 4.9 9.0 9.9 7.6 3.3 7.0 6.1 4.7 2.9 8.7 6.7 4.0 3.3 6.6 6.5 7.0 5.2 8.8 6.2 5.5 6.3 5.1 7.6 8.3 2.8 10.4 6.9 8.4 3.7 19.6 17.7 8.2 9.8 10.8 13.9 17.7 14.5 9.0 3.1 5.4 13.4 5.7 9.1 9.0 9.9 12.8 7.6 6.2 3.9 7.8 7.9 11.1 12.1 3.1 18.7 13.8 11.7 13.1 7.0 8.5 7.4 11.2 14.9 22.2 13.4 5.0 6.3 11.0 12.4 11.1 5.5 10.0 18.4 9.4 6.0 2.6 7.8 9.1 20.6 7.4 13.7 15.4 9.4 5.0 13.2 3.4 7.9 10.5 6.0 12.8 8.7 9.5 7.5 9.9 6.3 4.2 4.0 7.1 4.7 8.3 6.2 5.2 7.2 5.5 3.0 5.2 6.1 0.3 7.6 5.1 5.4 6.1 2.8 4.3 5.4 4.6 6.9 5.2 5.1 4.9 4.0 3.9 4.0 20.8 5.1 11.8 7.8 6.8 6.5 11.1 12.7 5.3 6.8 14.0 11.8 17.5 0.0 12.8 5.5 4.7 9.2 0.0 17.6 17.8 8.8 7.2 5.7 9.0 8.2 3.2 13.1 7.4 4.0 6.8 8.9 4.5 10.1 8.2 9.4 6.9 13.3 6.6 6.7 10.2 6.2 12.9 7.6 40.7 17.9 7.4 13.5 14.1 8.9 4.7 GPR89B "GPR89, GPR89C, SH120" ENSG00000188092 "G protein-coupled receptor 89B" P0CG08 1 147928393-147993521 "Predicted membrane proteins" "Ion transport, Protein transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 23.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA076096 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA076096: AB_2686777" "unprognostic (7.78e-2)" "unprognostic (1.13e-1)" "unprognostic (2.58e-2)" "unprognostic (1.37e-1)" "unprognostic (2.39e-2)" "unprognostic (1.15e-1)" "unprognostic (4.19e-3)" "unprognostic (1.05e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-4)" "unprognostic (1.23e-2)" "unprognostic (2.38e-2)" "unprognostic (1.61e-1)" "unprognostic (2.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.69e-1)" "unprognostic (7.15e-4)" 4.0 5.1 4.0 4.0 4.0 2.0 5.4 5.1 5.4 6.0 4.1 4.0 4.0 6.0 4.9 4.0 4.0 3.6 4.0 4.0 4.0 4.8 20.3 9.4 4.0 4.0 4.0 4.0 4.7 5.1 4.4 4.0 4.0 4.0 4.8 3.9 4.0 4.7 4.3 5.2 5.4 7.9 4.0 5.3 4.0 4.8 7.6 4.0 4.0 4.0 4.0 4.0 4.0 4.0 8.2 9.5 9.3 8.1 10.8 12.6 7.1 7.1 1.0 7.1 7.4 8.3 9.0 10.7 8.8 7.9 10.5 11.2 10.2 11.2 13.8 8.4 7.3 8.2 10.2 10.2 7.2 8.5 12.7 11.0 8.4 7.4 4.6 14.6 10.0 5.4 8.5 10.4 6.7 13.9 3.4 9.5 9.8 6.6 11.8 6.6 16.3 11.5 5.9 13.6 17.8 10.8 10.6 11.8 21.1 13.7 6.8 4.7 5.8 19.2 6.1 8.7 13.3 11.8 10.8 3.0 7.6 3.5 11.5 10.7 19.2 16.0 8.5 9.8 7.6 5.4 6.7 7.7 9.3 11.3 6.1 12.6 7.6 12.4 12.0 9.5 8.2 11.3 10.7 4.3 10.8 8.1 7.9 9.7 7.1 4.0 4.0 5.1 4.1 4.0 4.8 4.0 4.0 4.0 4.0 6.0 4.0 6.9 5.2 0.1 3.2 5.7 0.0 6.7 6.8 5.2 2.0 12.1 0.0 6.1 3.4 3.8 7.7 0.0 6.2 11.1 5.1 3.6 6.9 6.6 3.7 0.0 4.6 3.1 1.0 3.6 5.2 2.9 0.0 3.6 6.8 2.9 5.5 7.8 3.2 20.0 3.6 0.0 5.1 23.7 9.1 0.0 13.2 11.8 5.1 3.1 GPRC5A "PEIG-1, RAI3, RAIG1, TIG1" ENSG00000013588 "G protein-coupled receptor class C group 5 member A" Q8NFJ5 12 12890782-12917937 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 155.0" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 872.5;Glandular cells: 325.5;Pancreatic endocrine cells: 368.5;Urothelial cells: 1048.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 3.1" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "Cell line enhanced" "Detected in many" "A-431: 42.7;CAPAN-2: 164.8;HaCaT: 43.2;SiHa: 60.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA007928, HPA046526" Enhanced Enhanced "Vesicles,Plasma membrane" NA Yes "Vesicles, Plasma membrane" "HPA007928: AB_1849318, HPA046526: AB_2679685" "unprognostic (4.79e-2)" "unprognostic (8.35e-2)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (4.65e-3)" "unprognostic (1.73e-1)" "unprognostic (2.38e-2)" "unprognostic (1.89e-2)" "unprognostic (3.48e-1)" "unprognostic (8.69e-3)" "prognostic unfavorable (4.63e-6)" "unprognostic (3.81e-1)" "prognostic unfavorable (9.02e-5)" "unprognostic (9.30e-2)" "unprognostic (4.34e-1)" "unprognostic (1.62e-2)" "unprognostic (2.49e-1)" 9.8 1.4 0.2 6.0 0.6 0.4 5.4 0.1 0.3 12.1 19.8 0.5 2.0 6.2 4.3 1.9 9.1 3.0 15.5 7.1 0.1 0.2 5.1 0.6 155.0 0.1 0.5 0.1 18.5 1.1 0.0 0.9 20.1 3.1 10.4 16.9 4.8 9.6 1.5 1.1 2.0 36.9 14.2 1.1 0.1 11.4 4.8 0.3 0.1 54.2 14.9 11.5 32.1 14.0 0.6 0.6 3.1 0.3 0.5 0.4 0.0 42.7 34.2 0.0 0.1 0.4 0.2 2.2 12.9 4.9 8.4 6.4 6.0 164.8 0.0 1.1 10.3 8.9 43.2 0.1 6.2 12.9 0.0 0.5 0.0 14.1 0.2 3.1 0.0 0.0 0.2 8.4 3.5 0.8 10.4 5.1 0.0 0.0 0.0 0.3 30.0 0.0 0.0 0.1 15.6 5.4 0.0 0.9 0.0 16.6 8.5 0.0 0.0 60.6 4.6 1.9 6.9 1.3 0.1 0.5 0.3 10.9 19.6 0.5 0.0 0.0 0.0 4.4 0.0 0.2 3.1 0.3 0.4 0.3 0.2 0.3 0.3 0.2 0.3 0.1 0.6 0.4 0.4 1.3 0.5 0.2 0.6 0.3 0.0 0.2 0.6 0.1 0.3 0.1 0.2 0.5 0.1 3.1 0.3 872.5 165.8 0.0 282.3 11.1 0.0 1.0 5.1 69.6 257.0 43.6 0.0 0.7 0.0 49.3 0.0 7.5 159.2 0.0 63.3 8.9 57.8 325.5 9.3 0.0 1.5 0.0 7.9 4.9 0.0 0.0 12.4 10.7 49.0 1.0 28.8 1.3 368.5 52.7 9.6 0.0 0.2 0.0 24.7 0.0 0.2 8.0 0.9 1.3 79.7 1048.5 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 108.0" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 172.9;Late spermatids: 145.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Cell line enhanced" "Detected in many" "EFO-21: 39.2;HHSteC: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 12.6 4.4 45.2 3.2 55.9 1.0 7.3 22.8 108.0 5.4 2.9 95.1 4.9 4.0 7.1 9.3 5.5 12.7 9.2 22.3 47.8 28.7 12.1 2.7 3.9 4.6 63.1 34.9 13.7 12.7 9.5 3.8 9.3 38.6 6.3 2.3 3.8 20.8 11.5 35.1 2.5 3.3 5.1 61.6 2.2 22.7 19.6 63.1 0.0 7.2 2.6 2.7 6.2 3.0 0.0 0.0 0.0 1.5 0.0 6.5 1.3 0.4 12.6 12.5 2.2 12.9 0.9 2.3 0.1 3.1 1.2 0.8 11.5 0.4 0.0 39.2 0.4 8.2 0.6 9.2 0.0 0.7 0.0 3.3 0.0 0.0 0.0 26.8 0.0 0.0 1.1 0.0 2.1 0.0 3.3 6.1 0.3 2.6 0.2 2.8 0.6 0.0 0.0 13.7 0.0 6.0 3.6 0.0 0.0 0.4 5.8 9.7 0.8 1.4 0.8 11.3 4.1 0.0 0.2 1.2 0.0 1.5 6.1 0.3 0.1 0.0 0.0 0.6 0.1 0.7 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 1.3 45.2 55.9 22.8 40.5 47.8 28.7 63.1 34.9 38.6 63.1 0.0 4.0 0.9 4.6 1.1 30.1 13.4 35.7 5.3 7.9 29.6 0.0 3.9 1.7 47.7 172.9 30.1 0.0 0.0 56.2 1.2 9.7 4.3 0.0 0.0 3.3 0.0 0.0 6.2 1.0 145.0 22.2 1.1 15.1 1.8 0.0 20.5 53.7 0.0 25.1 0.1 5.7 12.9 9.2 2.8 1.5 1.5 2.1 0.0 0.0 1.7 GPRC5C RAIG-3 ENSG00000170412 "G protein-coupled receptor class C group 5 member C" Q9NQ84 17 74424851-74451653 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 76.2" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 193.6;Hepatocytes: 148.3;Paneth cells: 149.7;Sertoli cells: 142.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 31.1" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 10.2" "Group enriched" "Detected in many" 9 "dendritic cells: 10.2;monocytes: 4.7" "Cell line enhanced" "Detected in many" "Hep G2: 24.0;HMC-1: 42.2;RPTEC TERT1: 56.9;RT4: 26.3;T-47d: 32.0" "Region enriched" "Detected in many" 9 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA029776 Enhanced Uncertain "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA029776: AB_10602324" "unprognostic (1.48e-1)" "unprognostic (3.35e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-3)" "unprognostic (1.80e-2)" "unprognostic (1.09e-2)" "unprognostic (4.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (9.61e-3)" "unprognostic (1.05e-1)" "prognostic favorable (1.58e-5)" "unprognostic (7.58e-2)" "unprognostic (3.70e-2)" "unprognostic (2.75e-2)" "unprognostic (1.54e-3)" 4.3 4.1 5.2 2.2 5.3 0.0 7.7 31.1 5.7 19.7 15.4 4.4 17.0 10.0 5.8 9.9 5.3 12.5 17.6 7.7 5.3 2.6 43.8 46.1 11.5 2.8 4.8 4.9 12.3 76.2 12.0 3.4 4.5 6.1 15.1 6.2 18.0 16.8 11.7 25.4 9.2 15.2 3.9 4.6 5.1 44.7 4.4 4.1 1.9 42.2 10.2 3.5 12.6 8.0 0.7 10.2 0.1 4.7 0.0 0.1 0.3 4.6 16.7 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 21.4 0.0 13.3 0.1 5.4 14.7 2.2 0.3 0.0 0.0 2.7 0.0 1.2 24.0 4.9 0.0 42.2 0.4 7.6 0.0 0.0 22.7 0.0 0.0 1.2 0.3 0.0 5.2 0.1 4.5 2.7 23.1 19.4 0.0 0.0 1.1 56.9 26.3 8.1 0.7 0.8 1.8 0.0 10.9 32.0 1.2 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 2.1 0.6 0.1 0.0 1.7 0.1 0.0 3.4 0.0 0.7 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 4.7 10.2 0.0 0.3 5.2 5.3 31.1 5.7 5.3 2.6 4.8 4.9 6.1 4.1 3.0 48.9 1.5 39.6 12.0 0.8 193.6 68.8 22.7 18.2 129.1 0.0 0.7 24.9 53.1 0.1 8.7 61.7 0.0 58.9 7.1 19.9 46.9 10.3 148.3 9.6 4.8 43.7 25.8 8.5 0.5 16.7 4.2 3.3 5.4 47.3 18.8 37.9 149.7 20.8 51.6 0.8 142.3 56.7 0.4 3.0 9.8 21.2 1.5 44.1 40.9 GPRC5D ENSG00000111291 "G protein-coupled receptor class C group 5 member D" Q9NZD1 12 12940775-12952147 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.4;skin 1: 33.9" "Group enriched" "Detected in some" 12 "B-cells: 3.9;Early spermatids: 5.3;Late spermatids: 4.5;Melanocytes: 5.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 2.1" "Cell type enriched" "Detected in some" 4 "memory B-cell: 18.4" "Lineage enriched" "Detected in many" 17 "B-cells: 18.4" "Group enriched" "Detected in some" 10 "Karpas-707: 37.5;RPMI-8226: 36.3;U-266/84: 10.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA071909 Approved NA NA "HPA071909: AB_2686470" "unprognostic (4.27e-2)" "unprognostic (8.58e-2)" "unprognostic (4.68e-2)" "unprognostic (2.02e-1)" "unprognostic (4.34e-2)" "prognostic favorable (5.09e-4)" "unprognostic (3.00e-5)" "unprognostic (4.06e-2)" "unprognostic (3.06e-2)" "unprognostic (5.53e-2)" "unprognostic (7.01e-2)" "unprognostic (2.27e-2)" "unprognostic (8.33e-3)" "unprognostic (9.54e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-2)" "unprognostic (6.63e-2)" 1.0 0.5 0.4 3.1 0.4 0.3 4.2 0.4 0.4 0.8 3.8 0.4 0.4 2.4 1.0 0.4 3.7 0.3 1.5 0.7 0.4 0.2 0.8 0.7 4.4 5.9 0.4 0.4 0.4 2.9 0.0 1.0 0.9 2.1 0.9 3.4 0.7 8.6 0.4 0.4 33.9 3.8 0.4 0.4 5.1 3.3 3.7 0.4 0.4 1.3 5.2 4.1 1.3 0.7 18.4 0.1 1.0 0.0 0.0 0.2 1.9 0.5 0.6 0.0 0.6 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.5 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 37.5 0.1 1.3 0.0 0.0 0.3 1.6 0.0 0.0 0.0 36.3 0.0 1.5 1.2 0.2 0.8 0.6 0.0 1.6 0.0 0.0 1.0 0.0 1.7 0.0 0.0 1.9 10.3 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 18.4 0.1 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.4 0.4 0.4 0.4 0.4 0.2 0.4 0.4 2.1 0.4 0.0 0.0 3.9 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPRC6A bA86F4.3 ENSG00000173612 "G protein-coupled receptor class C group 6 member A" Q5T6X5 6 116792085-116829037 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "adrenal gland: 1.1;kidney: 3.2;prostate: 1.4;salivary gland: 3.6" "Cell type enhanced" "Detected in single" 35 "Intestinal endocrine cells: 1.7" "Cancer enriched" "Detected in single" 11 "renal cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "U-266/70: 6.0;U-266/84: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (9.16e-2)" "unprognostic (2.48e-1)" "unprognostic (4.38e-3)" 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPX8 "EPLA847, UNQ847" ENSG00000164294 "Glutathione peroxidase 8 (putative)" Q8TED1 5 55160118-55167071 "Enzymes, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Extravillous trophoblasts: 185.8;Fibroblasts: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 52.6;fHDF/TERT166: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036720 Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA036720: AB_2675269" "unprognostic (4.85e-2)" "unprognostic (1.23e-2)" "unprognostic (6.53e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-2)" "unprognostic (9.74e-3)" "unprognostic (1.78e-2)" "unprognostic (1.63e-3)" "unprognostic (2.07e-2)" "unprognostic (4.34e-2)" "unprognostic (4.31e-2)" "unprognostic (8.68e-2)" "prognostic unfavorable (5.13e-9)" "prognostic unfavorable (7.96e-4)" "unprognostic (8.11e-2)" "unprognostic (1.16e-2)" "unprognostic (2.63e-2)" 12.6 7.1 0.8 5.8 1.0 0.0 12.2 0.5 0.7 31.4 6.8 1.7 17.3 1.3 23.6 34.5 13.3 13.2 11.2 12.1 1.0 0.9 13.7 2.6 7.3 5.6 1.1 0.9 31.5 5.0 4.5 3.2 40.9 4.0 24.2 4.7 17.8 7.3 16.7 5.0 5.1 4.4 14.1 3.3 7.5 4.9 10.2 0.5 0.7 28.4 11.0 5.4 15.8 19.7 1.0 0.7 2.4 0.5 0.6 0.9 0.2 7.1 5.9 13.0 12.6 34.3 39.0 7.1 36.2 52.6 20.4 40.7 0.6 16.2 0.0 38.6 49.2 17.4 6.1 7.7 10.5 28.0 0.0 3.2 0.3 10.6 1.3 10.8 0.0 0.0 27.6 10.5 12.4 6.5 19.2 23.6 0.0 0.2 0.0 23.1 2.2 0.0 0.0 5.9 0.2 8.4 0.0 7.4 0.0 12.5 0.2 0.0 0.3 12.1 0.9 12.8 15.5 11.6 0.7 21.2 10.9 12.0 16.1 19.4 0.0 0.0 0.0 17.3 0.0 23.6 1.4 0.5 0.3 0.5 0.3 0.5 0.6 0.5 0.5 0.2 1.0 0.9 0.9 2.4 0.6 0.3 0.7 0.2 0.2 0.8 1.0 0.5 0.7 1.0 0.9 1.1 0.9 4.0 0.5 0.0 0.6 0.0 4.8 6.4 0.0 2.6 0.0 14.7 13.6 24.4 0.0 48.1 5.0 12.0 0.4 13.5 0.0 0.0 34.7 185.8 64.1 2.1 4.6 0.0 9.1 0.0 0.0 19.0 0.0 0.2 47.5 1.3 23.6 1.8 3.6 6.6 18.2 0.0 37.4 0.2 0.2 12.9 11.2 0.1 0.1 5.4 11.1 0.7 0.8 1.8 GRAMD1A "FLJ90346, KIAA1533" ENSG00000089351 "GRAM domain containing 1A" Q96CP6 19 34994784-35026471 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "monocytes: 235.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008852, HPA012570" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA008852: AB_1079203, HPA012570: AB_2112577" "unprognostic (3.09e-2)" "unprognostic (4.62e-2)" "unprognostic (8.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.05e-1)" "unprognostic (2.87e-1)" "unprognostic (3.42e-3)" "unprognostic (5.96e-2)" "unprognostic (4.54e-1)" "unprognostic (5.70e-2)" "unprognostic (1.07e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (7.95e-12)" "unprognostic (2.04e-1)" "unprognostic (4.40e-1)" "unprognostic (2.90e-2)" "unprognostic (4.36e-2)" 15.6 19.1 14.6 21.4 14.0 17.1 19.4 13.8 18.1 16.8 13.2 10.4 17.4 13.0 16.9 12.9 7.8 17.2 13.8 17.2 15.9 12.0 13.3 11.0 27.5 42.0 13.7 12.2 21.8 44.1 11.5 14.9 14.1 16.6 15.6 7.5 11.5 45.3 17.2 35.7 6.8 10.9 21.3 12.8 21.1 16.1 11.7 12.1 17.9 12.7 11.5 12.1 17.3 21.4 1.1 4.1 13.1 14.9 3.8 5.5 2.5 5.5 42.9 8.4 16.6 9.8 11.2 7.0 6.7 11.1 9.0 8.9 16.2 4.8 3.1 13.4 10.0 7.9 3.6 8.7 13.2 3.4 13.3 15.2 9.2 10.6 14.9 19.8 6.5 14.7 19.8 8.2 6.4 10.9 14.2 29.2 20.5 10.0 2.2 6.2 5.3 14.8 8.0 13.2 11.0 4.8 14.0 2.6 3.9 9.6 1.0 12.7 25.6 6.8 5.1 11.0 7.7 7.8 7.2 15.9 14.4 7.4 2.9 9.5 2.4 7.9 7.6 9.5 7.2 10.7 13.1 4.5 3.6 2.9 7.3 5.5 0.5 3.9 2.1 4.1 1.1 2.9 4.2 9.8 3.8 14.9 1.4 3.1 2.5 14.6 14.0 13.8 18.1 15.9 12.0 13.7 12.2 16.6 12.1 20.8 34.1 13.4 49.1 18.4 13.5 8.1 0.0 16.0 14.8 15.7 15.7 10.8 3.3 29.5 0.8 46.6 1.8 0.0 49.7 25.1 19.4 49.8 9.2 6.7 44.3 7.9 37.8 51.0 37.3 1.8 23.9 26.0 32.1 235.4 12.5 28.8 44.0 10.5 23.7 11.5 14.9 12.9 32.0 0.0 2.7 13.4 27.7 41.5 18.6 48.2 GRAMD1B "KIAA1201, LINC01059" ENSG00000023171 "GRAM domain containing 1B" Q3KR37 11 123358428-123627774 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.7;brain: 55.2;intestine: 21.7" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 41.9;Cone photoreceptor cells: 108.0;Horizontal cells: 42.9;Rod photoreceptor cells: 85.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Group enriched" "Detected in many" 4 "A549: 22.2;HDLM-2: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008557, HPA075204" Approved Supported "Endoplasmic reticulum,Vesicles,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" Vesicles "HPA008557: AB_1079197, HPA075204: " "unprognostic (1.86e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.74e-3)" "unprognostic (8.15e-2)" "unprognostic (4.28e-2)" "unprognostic (2.69e-3)" "unprognostic (4.12e-3)" "unprognostic (1.40e-1)" "unprognostic (2.90e-2)" "unprognostic (9.60e-2)" "unprognostic (8.06e-2)" "prognostic unfavorable (4.30e-7)" "unprognostic (1.39e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" 1.4 67.7 15.5 3.1 16.0 11.8 1.1 55.2 25.0 1.2 3.1 5.1 5.9 21.7 1.2 6.6 0.9 2.9 8.1 4.3 13.6 7.5 10.4 1.3 1.9 3.6 6.8 15.1 7.6 2.0 0.6 6.7 5.0 14.4 1.1 1.2 11.9 1.3 2.5 1.8 0.8 15.6 1.3 4.1 2.7 7.8 10.6 5.1 3.4 3.7 0.0 2.7 1.5 0.8 0.1 11.5 0.6 2.0 2.6 2.7 0.7 0.0 22.2 1.2 0.0 0.1 0.2 3.6 7.4 5.3 1.6 0.6 0.9 0.1 1.3 3.9 3.7 2.5 0.0 2.3 0.0 1.7 58.9 2.0 0.0 10.0 0.2 0.0 7.6 0.0 0.4 0.0 2.8 0.0 1.9 0.7 0.6 0.0 0.0 1.4 0.1 1.3 2.6 2.8 9.9 8.4 4.0 3.6 2.4 0.1 0.0 7.4 6.0 1.7 0.1 0.0 3.4 0.2 4.3 4.4 8.9 1.4 1.5 0.3 0.0 0.0 0.0 1.8 8.0 0.4 0.0 2.0 0.6 0.7 1.0 0.4 0.0 2.7 2.1 3.0 0.1 0.3 0.3 0.2 2.6 1.0 11.5 1.1 0.7 15.5 16.0 55.2 25.0 13.6 7.5 6.8 15.1 14.4 5.1 0.0 0.3 0.0 0.0 0.0 41.9 5.5 25.5 0.0 0.0 5.2 108.0 4.5 3.3 0.5 5.2 0.7 0.3 0.0 0.4 3.0 1.1 0.1 0.0 0.0 2.3 42.9 0.0 0.6 3.5 2.3 0.6 2.8 0.0 1.0 0.8 21.5 2.3 0.2 0.7 5.5 85.7 0.0 0.8 1.0 1.5 0.4 2.1 1.0 0.4 0.0 GRAMD1C DKFZp434C0328 ENSG00000178075 "GRAM domain containing 1C" Q8IYS0 3 113828182-113947174 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 74.3;Late spermatids: 57.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 5.1;naive B-cell: 4.1;neutrophil: 4.0" "Group enriched" "Detected in many" 11 "B-cells: 5.1;granulocytes: 4.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.4;HUVEC TERT2: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012316 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA012316: AB_1849949" "unprognostic (2.73e-3)" "unprognostic (6.16e-3)" "unprognostic (3.27e-1)" "unprognostic (1.93e-1)" "unprognostic (5.50e-2)" "unprognostic (9.81e-3)" "unprognostic (1.43e-3)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (5.49e-2)" "prognostic favorable (4.22e-15)" "unprognostic (8.48e-2)" "unprognostic (9.96e-2)" "unprognostic (3.61e-2)" "unprognostic (2.09e-2)" 1.7 2.6 12.6 2.5 13.0 0.5 9.1 5.0 13.4 3.4 8.0 2.6 0.5 7.6 5.2 5.1 6.0 10.3 2.9 1.5 13.6 7.6 23.3 26.5 5.0 2.0 9.4 8.1 1.1 12.5 11.8 24.1 6.2 9.2 2.9 4.2 4.5 10.8 2.8 1.1 12.0 24.5 1.0 8.2 1.7 8.6 14.5 9.3 0.0 6.9 1.6 3.7 3.8 3.8 5.1 0.1 4.0 0.0 0.3 0.4 0.1 1.5 0.0 4.1 3.2 0.8 2.1 5.9 3.7 3.3 0.7 2.2 0.0 14.4 0.4 1.1 1.9 1.3 1.6 0.7 1.6 1.7 1.9 0.6 0.3 0.1 0.0 1.6 0.2 0.1 3.3 1.1 0.6 0.1 7.5 11.2 4.5 0.0 0.2 1.1 0.4 1.6 0.2 0.3 1.5 0.5 0.0 0.8 2.5 4.5 2.0 0.8 1.0 1.0 5.9 3.0 1.6 4.1 0.0 2.3 1.5 2.9 0.0 0.3 2.2 1.3 1.8 2.4 0.1 1.7 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.3 0.4 0.1 4.1 0.3 0.4 4.0 0.3 0.0 0.1 0.0 0.1 12.6 13.0 5.0 13.4 13.6 7.6 9.4 8.1 9.2 9.3 11.9 10.9 0.0 5.9 0.9 0.0 0.8 20.4 18.7 7.9 14.0 35.3 14.6 26.6 2.1 74.3 2.9 12.0 0.0 2.4 3.7 1.0 2.9 0.0 14.8 1.3 11.1 4.7 3.7 0.0 57.8 2.6 0.0 1.7 0.0 4.7 14.5 2.1 5.9 1.4 11.2 18.3 0.0 0.9 25.7 5.1 4.1 35.5 0.0 3.9 5.7 GRAMD2A GRAMD2 ENSG00000175318 "GRAM domain containing 2A" Q8IUY3 15 72159807-72197785 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 24.6;placenta: 49.2" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 65.5;Cytotrophoblasts: 93.9;Syncytiotrophoblasts: 123.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "myeloid DC: 2.3" "Lineage enriched" "Detected in single" 7 "dendritic cells: 2.3" "Group enriched" "Detected in some" 12 "BEWO: 59.5;SK-BR-3: 27.1" "Low region specificity" "Detected in many" HPA029435 Uncertain Approved "Nucleoli,Nuclear speckles,Cytosol" NA NA "Nucleoli, Nuclear speckles" Cytosol "HPA029435: AB_10601811" "unprognostic (5.70e-2)" "unprognostic (7.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.24e-1)" "unprognostic (9.51e-3)" "unprognostic (2.95e-1)" "unprognostic (9.96e-2)" "unprognostic (3.90e-3)" "unprognostic (2.80e-1)" "unprognostic (1.96e-1)" "unprognostic (2.62e-1)" "unprognostic (5.77e-2)" "unprognostic (4.45e-1)" "unprognostic (2.35e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (7.01e-4)" "unprognostic (7.29e-2)" 0.1 0.0 2.0 0.2 4.5 0.0 6.8 1.1 1.0 3.1 0.7 1.2 9.8 0.6 0.4 24.6 1.0 8.2 0.8 0.1 2.9 6.5 1.9 0.1 9.7 0.2 1.1 0.1 1.1 1.0 0.2 0.9 49.2 3.9 1.2 0.5 1.0 1.8 4.0 0.3 1.5 3.6 0.1 1.0 0.1 0.4 0.7 0.9 0.2 7.7 1.3 1.1 0.3 0.6 0.0 2.3 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 27.1 0.0 2.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.5 1.1 1.0 2.9 6.5 1.1 0.1 3.9 0.9 65.5 13.3 0.0 0.0 0.0 0.0 0.0 0.0 18.7 13.6 3.5 0.0 93.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 1.1 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 123.0 0.0 0.0 0.0 GRAMD2B "FLJ21313, GRAMD3, NS3TP2" ENSG00000155324 "GRAM domain containing 2B" Q96HH9 5 126360132-126496494 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 89.7;Club cells: 84.2;Collecting duct cells: 38.4;Extravillous trophoblasts: 38.4;Syncytiotrophoblasts: 49.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.6;MAIT T-cell: 4.8;memory CD4 T-cell: 2.6;memory CD8 T-cell: 3.9;myeloid DC: 2.5;naive CD4 T-cell: 5.1;naive CD8 T-cell: 3.1;NK-cell: 1.7;plasmacytoid DC: 6.5;T-reg: 3.8" "Group enriched" "Detected in many" 6 "dendritic cells: 6.5;NK-cells: 1.7;T-cells: 5.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 39.4;CAPAN-2: 26.5;fHDF/TERT166: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009678, HPA010095" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Cytosol "Nucleoplasm, Golgi apparatus" "HPA009678: AB_2112580, HPA010095: AB_1849952" "unprognostic (2.34e-1)" "unprognostic (4.01e-1)" "unprognostic (4.63e-2)" "unprognostic (3.42e-2)" "unprognostic (6.82e-2)" "unprognostic (1.95e-2)" "unprognostic (6.76e-2)" "unprognostic (3.84e-2)" "unprognostic (9.90e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-2)" "unprognostic (3.78e-1)" "unprognostic (2.20e-3)" "unprognostic (3.56e-3)" "unprognostic (2.39e-1)" "unprognostic (9.24e-2)" "unprognostic (1.12e-2)" 8.3 12.0 30.8 5.2 31.6 1.3 29.5 10.2 25.3 27.5 21.8 38.7 9.7 22.5 24.0 11.9 7.7 26.8 8.7 9.2 38.8 15.9 25.9 18.0 7.8 5.1 21.8 28.3 21.1 6.8 9.0 7.2 44.3 26.4 14.2 23.4 14.9 15.5 20.9 2.8 17.5 26.1 17.6 29.7 4.3 12.9 3.3 31.8 3.6 35.6 3.7 8.6 11.6 11.1 0.8 6.5 0.5 0.7 1.7 5.1 2.1 21.4 1.2 1.0 4.8 21.7 7.5 6.5 22.5 39.4 10.7 14.6 1.0 26.5 0.0 9.7 25.2 0.2 5.5 0.3 9.1 11.4 1.8 1.6 1.0 2.5 1.3 5.1 0.0 0.7 12.6 4.1 9.8 3.3 13.5 0.0 0.0 0.0 0.0 18.5 2.2 0.0 0.3 1.1 4.9 1.5 0.4 6.4 5.0 14.4 23.8 0.4 0.0 4.1 2.3 7.0 5.1 8.1 1.3 1.9 2.1 0.7 3.9 4.2 1.4 1.1 0.0 0.4 0.0 6.4 0.5 0.5 0.0 4.6 0.7 4.8 0.8 2.6 3.9 2.5 0.4 5.1 3.1 0.5 1.7 0.5 6.5 3.8 2.1 30.8 31.6 10.2 25.3 38.8 15.9 21.8 28.3 26.4 31.8 14.9 17.1 0.0 0.0 0.0 0.0 0.0 0.0 89.7 84.2 38.4 0.0 23.4 19.9 13.1 0.0 0.0 0.0 0.0 7.5 38.4 0.0 0.0 3.5 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.8 0.0 0.0 18.5 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 GRAMD4 "DIP, KIAA0767" ENSG00000075240 "GRAM domain containing 4" Q6IC98 22 46576012-46679790 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 83.9" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.67e-3)" "unprognostic (1.78e-3)" "unprognostic (2.19e-2)" "unprognostic (8.11e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.04e-4)" "unprognostic (1.08e-1)" "unprognostic (7.07e-2)" "unprognostic (5.72e-2)" "unprognostic (1.44e-3)" "unprognostic (1.54e-2)" "unprognostic (4.11e-1)" "unprognostic (1.61e-2)" "unprognostic (2.73e-2)" "unprognostic (2.08e-1)" "unprognostic (5.38e-2)" "unprognostic (8.69e-2)" 9.2 20.5 12.2 10.5 13.6 12.6 7.9 7.6 19.6 6.9 24.7 9.2 5.6 21.3 8.2 7.9 14.2 10.4 22.9 18.9 13.0 7.7 9.1 83.9 12.0 9.9 8.0 15.3 6.9 14.8 8.1 14.4 6.5 9.3 9.0 16.9 14.8 10.2 4.7 15.7 27.8 28.7 7.2 9.4 10.2 17.7 6.3 7.3 12.2 12.3 6.0 16.1 7.3 10.8 2.0 4.7 2.5 2.9 6.9 3.7 1.4 5.1 5.8 6.9 8.8 9.3 5.5 7.1 3.9 2.5 1.6 2.0 2.1 8.1 18.6 6.8 4.4 4.7 10.9 4.1 2.1 2.5 4.9 4.7 6.3 4.3 5.0 7.6 38.8 25.6 3.6 5.2 1.2 2.8 5.7 2.3 14.5 11.7 12.8 2.2 8.9 22.6 20.8 3.8 11.5 2.7 10.3 1.0 12.2 3.1 6.0 4.9 13.7 4.2 8.6 15.0 8.3 8.4 13.9 3.3 2.1 4.2 2.8 2.5 2.6 8.2 10.0 4.7 15.3 18.0 2.5 2.9 1.9 1.4 1.9 0.6 2.0 1.1 1.0 3.9 0.7 1.0 0.6 1.1 6.9 0.8 4.7 3.7 1.4 12.2 13.6 7.6 19.6 13.0 7.7 8.0 15.3 9.3 7.3 14.9 13.6 4.5 3.1 7.2 3.8 15.7 5.1 5.3 2.3 3.5 0.0 3.0 0.0 3.8 0.1 4.5 38.0 0.0 6.0 2.2 4.1 2.6 6.9 17.9 11.9 3.2 20.0 2.5 10.8 1.1 4.4 8.8 6.8 1.0 22.8 10.0 7.0 14.4 5.3 3.1 1.5 0.0 2.8 0.9 2.5 9.2 2.9 5.7 18.1 2.7 GREM1 "CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS" ENSG00000166923 "Gremlin 1, DAN family BMP antagonist" O60565 15 32717974-32745107 "Disease related genes, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 66.8;smooth muscle: 42.5" "Cell type enriched" "Detected in many" 7 "Collecting duct cells: 62.8" "Cancer enhanced" "Detected in many" "stomach cancer: 24.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 32.8;BJ hTERT+: 50.3;BJ hTERT+ SV40 Large T+ RasG12V: 31.6;fHDF/TERT166: 100.9;hTEC/SVTERT24-B: 31.6" "Group enriched" "Detected in some" 5 "hippocampal formation: 3.6;olfactory region: 13.4" "Low region specificity" "Detected in single" HPA007526 Uncertain "Secreted to blood" NA NA 242000000 "HPA007526: AB_1849971" "unprognostic (4.74e-2)" "unprognostic (2.78e-1)" "unprognostic (4.63e-2)" "unprognostic (6.80e-2)" "unprognostic (3.58e-1)" "unprognostic (1.72e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (5.33e-2)" "unprognostic (2.32e-1)" "unprognostic (7.20e-3)" "unprognostic (2.79e-1)" "unprognostic (2.13e-11)" "unprognostic (1.77e-2)" "unprognostic (6.60e-2)" "unprognostic (3.29e-2)" "unprognostic (1.16e-3)" 14.9 1.2 3.1 23.1 10.2 1.1 11.7 0.8 5.6 31.3 15.2 6.6 1.1 2.6 5.1 1.0 15.4 1.0 66.8 1.1 4.4 2.0 1.2 1.5 1.2 8.0 6.6 6.4 1.0 1.5 1.0 0.2 1.1 5.5 6.4 15.2 0.0 1.0 5.1 2.4 4.1 24.4 42.5 4.8 1.3 23.7 1.1 9.3 0.0 1.4 2.2 2.3 27.3 32.2 0.4 0.5 1.4 0.4 0.7 0.3 0.0 0.0 0.5 0.0 0.0 1.3 1.7 0.0 32.8 50.3 12.4 31.6 0.0 0.0 0.0 0.0 100.9 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 31.6 0.0 7.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.4 0.5 0.3 0.2 0.3 0.3 0.3 0.2 0.1 0.4 0.3 0.3 1.4 0.7 0.4 0.5 0.2 0.0 3.1 10.2 0.8 5.6 4.4 2.0 6.6 6.4 5.5 9.3 0.0 0.0 0.0 6.2 6.0 1.9 2.6 0.0 0.0 0.0 62.8 2.0 0.1 0.0 0.4 0.1 0.7 0.0 0.0 0.0 0.1 2.8 8.5 0.0 1.0 1.0 1.6 0.0 0.6 0.3 0.0 0.0 0.0 3.3 4.6 0.1 0.2 0.2 0.0 0.4 0.3 0.5 0.0 4.7 0.0 0.2 4.0 0.2 1.0 0.0 6.3 GRHL1 "LBP-32, MGR, TFCP2L2" ENSG00000134317 "Grainyhead like transcription factor 1" Q9NZI5 2 9951693-10002277 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.3;skin 1: 34.4" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 69.0;Suprabasal keratinocytes: 115.9;Syncytiotrophoblasts: 154.4;Urothelial cells: 97.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 4.8;neutrophil: 1.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.8" "Group enriched" "Detected in some" 4 "BEWO: 66.4;SK-BR-3: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA005798, HPA006420" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA005798: AB_1079026, HPA006420: AB_1079025" "unprognostic (2.26e-3)" "unprognostic (5.80e-2)" "unprognostic (8.35e-2)" "unprognostic (7.33e-3)" "unprognostic (2.70e-1)" "unprognostic (2.76e-2)" "unprognostic (4.43e-3)" "unprognostic (6.73e-2)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-4)" "unprognostic (3.66e-1)" "unprognostic (3.40e-1)" "unprognostic (4.04e-2)" "unprognostic (2.14e-1)" 1.7 0.6 1.5 0.2 2.4 2.8 15.9 2.0 1.6 10.2 0.9 0.2 10.8 0.3 0.9 3.8 40.3 0.7 1.0 1.6 1.9 1.2 2.5 4.9 2.3 0.2 0.7 1.4 0.5 1.5 12.9 2.6 31.0 0.8 6.1 0.2 1.8 17.5 9.7 0.9 34.4 0.7 5.1 0.6 0.6 1.3 1.6 0.4 0.4 2.8 22.3 25.3 6.7 16.9 0.1 0.2 4.8 0.2 0.5 0.6 4.5 3.2 0.0 0.4 0.9 0.1 0.1 66.4 0.3 0.4 0.2 0.3 0.2 2.3 0.4 0.1 0.0 0.4 2.0 4.0 0.4 0.9 0.9 1.8 0.1 0.6 1.2 0.0 0.2 0.3 0.1 1.7 1.9 0.0 0.0 0.3 0.7 0.6 1.2 0.0 4.2 0.6 0.5 0.2 1.0 0.7 0.2 0.3 0.5 0.4 12.6 0.7 0.5 0.6 34.9 0.8 5.7 4.2 0.1 0.3 0.2 0.8 1.0 0.4 0.8 0.5 0.4 0.2 0.5 0.5 0.0 0.2 4.8 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.6 4.5 1.5 2.4 2.0 1.6 1.9 1.2 0.7 1.4 0.8 0.4 3.0 7.2 0.0 18.6 35.5 20.9 1.2 0.0 6.7 29.6 19.2 58.9 48.9 0.0 2.8 6.0 3.1 0.5 0.0 8.0 69.0 6.1 30.1 10.3 5.7 6.7 11.1 3.4 3.1 1.3 2.1 0.0 2.7 20.3 1.0 0.6 1.7 4.8 0.0 0.4 1.7 11.8 0.0 6.1 5.1 5.3 115.9 154.4 1.3 0.4 97.4 GRIA1 "GluA1, GLUR1, GLURA" ENSG00000155511 "Glutamate ionotropic receptor AMPA type subunit 1" P42261 5 153489615-153813869 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 52.6" "Group enriched" "Detected in some" 7 "Bipolar cells: 34.6;Muller glia cells: 48.7" "Cancer enriched" "Detected in some" 15 "glioma: 9.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 13.7;ASC diff: 4.2;BJ: 6.5;BJ hTERT+: 3.4;LHCN-M2: 9.7;U-266/70: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035202 Enhanced NA NA "HPA035202: AB_2674516" "unprognostic (2.51e-1)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (4.20e-2)" "unprognostic (6.95e-2)" "unprognostic (2.43e-1)" "unprognostic (2.61e-1)" "unprognostic (1.18e-2)" "unprognostic (2.04e-1)" "unprognostic (2.35e-2)" "unprognostic (5.14e-4)" "unprognostic (7.97e-2)" "unprognostic (2.96e-2)" "unprognostic (1.01e-1)" "unprognostic (1.70e-1)" "unprognostic (2.80e-1)" "unprognostic (7.61e-2)" 1.8 1.6 44.9 1.2 23.1 1.0 1.5 23.6 52.6 1.4 1.2 3.7 0.0 1.3 1.2 2.0 1.2 1.2 1.1 2.0 50.4 13.4 1.1 1.1 9.5 1.0 4.8 20.0 1.3 1.4 1.2 0.5 1.1 4.6 1.1 1.2 0.7 1.1 1.7 1.1 1.1 1.3 2.3 2.3 1.1 1.2 2.1 5.2 0.0 1.1 0.0 1.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 4.2 2.9 0.0 6.5 3.4 0.4 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 23.1 23.6 24.3 50.4 13.4 4.8 20.0 4.6 5.2 0.0 0.0 0.0 0.0 0.0 34.6 0.8 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRIA2 "GluA2, GLUR2, GLURB" ENSG00000120251 "Glutamate ionotropic receptor AMPA type subunit 2" P42262 4 157204182-157366075 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 242.0;Horizontal cells: 130.3" "Group enriched" "Detected in some" 10 "breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008441 Enhanced NA NA "HPA008441: AB_1078983" "unprognostic (1.36e-1)" "unprognostic (9.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (3.87e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-3)" "unprognostic (7.40e-2)" "unprognostic (2.91e-5)" "unprognostic (2.42e-1)" "unprognostic (1.31e-1)" "unprognostic (1.82e-1)" "unprognostic (6.55e-2)" 1.2 6.5 36.9 1.3 39.1 1.1 2.0 22.1 95.9 8.2 1.3 5.6 0.0 1.2 13.5 9.8 1.2 9.6 1.2 1.2 30.1 15.7 1.5 1.1 1.4 1.2 10.0 30.6 1.7 2.2 1.2 10.5 1.2 7.1 1.8 1.2 0.1 2.1 3.0 1.2 1.1 1.2 6.1 6.9 1.3 1.5 2.1 8.8 0.0 1.2 0.0 1.2 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.9 2.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 0.2 0.0 0.0 0.6 0.0 0.0 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 39.1 22.1 41.2 30.1 15.7 10.0 30.6 7.1 8.8 0.0 0.0 0.0 0.0 0.0 242.0 2.2 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 130.3 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 3.1 0.0 0.0 0.4 0.0 14.0 0.0 0.7 3.9 1.5 0.0 0.0 0.0 0.0 0.0 GRIA3 "GluA3, GLUR3, GLURC, MRX94" ENSG00000125675 "Glutamate ionotropic receptor AMPA type subunit 3" P42263 X 123184153-123490915 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.8" "Cell type enriched" "Detected in some" 22 "Horizontal cells: 187.5" "Cancer enriched" "Detected in some" 11 "glioma: 10.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "BJ: 14.4;BJ hTERT+: 20.9;fHDF/TERT166: 27.5;U-2197: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058659, HPA073344" Enhanced "Intracellular and membrane" NA NA "HPA058659: AB_2683791, HPA073344: " "unprognostic (2.14e-2)" "unprognostic (6.00e-2)" "unprognostic (2.02e-2)" "unprognostic (2.94e-3)" "unprognostic (5.09e-2)" "unprognostic (4.29e-4)" "unprognostic (2.42e-1)" "unprognostic (6.74e-2)" "unprognostic (1.44e-1)" "unprognostic (2.36e-1)" "unprognostic (1.65e-3)" "unprognostic (1.31e-1)" "unprognostic (3.78e-3)" "unprognostic (8.05e-3)" "unprognostic (6.40e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" 1.5 10.7 31.4 1.0 27.4 0.7 2.3 3.5 40.8 9.1 1.3 3.7 0.1 0.9 3.0 4.9 1.1 2.0 1.9 2.7 26.1 8.1 3.4 9.3 1.0 1.1 10.2 21.2 5.6 2.6 0.6 0.6 1.1 4.9 2.1 1.5 0.7 0.9 3.0 0.9 1.2 1.0 2.9 8.4 0.7 3.0 1.4 7.8 0.0 0.8 0.0 1.5 1.3 1.8 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 14.4 20.9 0.2 0.5 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.1 0.0 9.2 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 27.4 3.5 27.5 26.1 8.1 10.2 21.2 4.9 7.8 0.0 0.0 0.0 0.0 0.2 4.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 3.1 0.5 0.0 4.7 0.1 187.5 0.0 0.6 0.0 0.0 8.6 0.0 1.7 0.0 0.0 1.5 0.5 0.0 3.9 6.0 3.1 0.0 0.5 0.0 0.0 0.9 0.1 0.0 0.0 0.0 GRIA4 "GluA4, GLUR4, GLURD" ENSG00000152578 "Glutamate ionotropic receptor AMPA type subunit 4" P48058 11 105609994-105982092 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 55.4" "Cell type enriched" "Detected in some" 22 "Horizontal cells: 444.9" "Group enriched" "Detected in some" 18 "glioma: 5.9;renal cancer: 1.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 15.8;NTERA-2: 5.2;RPMI-8226: 3.0;SCLC-21H: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "unprognostic (4.09e-4)" "unprognostic (4.45e-3)" "unprognostic (1.92e-3)" "unprognostic (4.14e-4)" "unprognostic (1.40e-2)" "unprognostic (3.73e-4)" "unprognostic (1.62e-1)" "unprognostic (3.89e-1)" "unprognostic (2.04e-1)" "unprognostic (1.53e-1)" "unprognostic (1.70e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (3.35e-2)" "unprognostic (1.28e-1)" 1.1 7.4 11.4 1.5 13.1 0.9 4.5 55.4 52.9 2.6 1.8 8.1 0.0 0.9 1.5 2.9 1.0 2.2 1.2 0.9 9.3 16.0 1.4 0.9 1.0 1.6 12.1 17.4 1.3 1.6 0.9 2.2 1.3 24.8 1.2 2.0 2.8 4.1 1.5 1.0 1.5 4.5 1.0 11.5 0.9 6.6 1.1 6.9 0.0 1.0 0.0 1.3 1.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.2 0.0 0.2 0.0 0.0 3.0 0.0 0.0 5.8 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.1 55.4 23.3 9.3 16.0 12.1 17.4 24.8 6.9 0.0 0.0 0.0 0.0 0.1 18.9 1.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 444.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.5 7.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 GRID1 "GluD1, KIAA1220" ENSG00000182771 "Glutamate ionotropic receptor delta type subunit 1" Q9ULK0 10 85599555-86366493 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.9" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 9.5;Melanocytes: 5.0;Peritubular cells: 4.2;Sertoli cells: 12.9" "Group enriched" "Detected in many" 5 "glioma: 3.6;thyroid cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "basophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "Daudi: 6.4;HEL: 6.2;SH-SY5Y: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.60e-2)" "unprognostic (2.75e-2)" "unprognostic (5.92e-2)" "unprognostic (4.31e-2)" "unprognostic (4.24e-1)" "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (4.21e-2)" "unprognostic (5.09e-2)" "unprognostic (1.49e-3)" "unprognostic (8.30e-2)" "unprognostic (8.26e-2)" "unprognostic (4.58e-9)" "unprognostic (3.15e-3)" "unprognostic (5.91e-2)" "unprognostic (2.21e-1)" "unprognostic (8.65e-3)" 2.5 4.2 8.8 1.0 13.0 0.8 1.6 3.1 15.7 4.5 1.4 20.9 0.0 1.7 2.6 3.4 1.3 4.8 1.6 1.3 8.8 6.9 1.0 1.3 2.1 1.7 19.6 8.7 1.4 1.2 1.1 0.9 3.1 9.9 2.1 1.3 1.0 1.1 4.4 1.4 2.1 1.7 2.4 6.4 0.9 1.2 2.8 14.2 0.0 7.0 0.0 1.5 1.2 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.8 6.4 0.2 0.0 0.1 0.0 0.9 0.0 0.0 0.3 1.4 6.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.8 13.0 3.1 14.3 8.8 6.9 19.6 8.7 9.9 14.2 3.0 0.3 0.0 0.1 0.5 9.5 1.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 2.0 0.0 5.0 0.0 0.0 0.7 0.0 0.0 4.2 0.0 0.5 12.9 1.9 0.1 0.9 0.0 0.1 0.0 0.0 0.0 GRID2 "GluD2, GluR-delta-2" ENSG00000152208 "Glutamate ionotropic receptor delta type subunit 2" O43424 4 92303622-93810157 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 45.1;testis: 38.2" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 94.0;Early spermatids: 359.2;Late spermatids: 508.8;Muller glia cells: 141.0" "Cancer enriched" "Detected in single" 7 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "U-2 OS: 12.9;U-266/70: 5.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 130.6" "HPA056253, HPA058538" Enhanced NA NA "HPA056253: AB_2683079, HPA058538: AB_2683747" "unprognostic (2.78e-1)" "unprognostic (1.29e-4)" "unprognostic (7.23e-3)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (3.50e-2)" "unprognostic (3.34e-1)" "unprognostic (6.92e-2)" "unprognostic (7.96e-3)" "unprognostic (4.36e-2)" "unprognostic (9.31e-2)" "unprognostic (7.38e-3)" 0.6 3.5 8.0 0.6 13.6 0.6 0.6 45.1 7.0 1.1 0.7 2.8 0.0 0.8 0.7 0.9 0.6 0.9 0.6 0.7 6.2 3.4 0.8 0.6 0.7 0.6 7.6 6.4 3.7 0.6 0.6 0.3 0.6 7.2 0.6 0.7 0.6 0.6 0.9 0.6 0.6 0.8 0.6 9.0 0.7 0.6 38.2 7.9 0.0 0.7 0.0 0.6 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 12.9 0.0 0.0 5.8 0.0 0.6 0.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 13.6 45.1 7.0 6.2 3.4 7.6 6.4 7.2 7.9 0.0 0.0 0.0 0.0 0.0 94.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 359.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 27.0 0.0 0.0 0.0 508.8 4.6 0.0 0.0 0.0 0.0 141.0 0.0 0.0 1.1 0.0 3.9 6.5 0.7 3.4 2.0 0.0 0.0 0.0 0.0 0.0 GRIK1 "GluK1, GLUR5" ENSG00000171189 "Glutamate ionotropic receptor kainate type subunit 1" P39086 21 29536933-29940033 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 23.7;brain: 44.2;retina: 12.0" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 6.8;Early spermatids: 4.6;Late spermatids: 7.9;Melanocytes: 3.3;Rod photoreceptor cells: 4.8" "Group enriched" "Detected in some" 7 "glioma: 4.5;prostate cancer: 0.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014623 Uncertain NA NA "HPA014623: AB_1850305" "unprognostic (1.39e-1)" "unprognostic (6.54e-2)" "unprognostic (1.32e-1)" "unprognostic (1.04e-2)" "unprognostic (1.03e-3)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (2.12e-3)" "unprognostic (1.25e-1)" "unprognostic (8.77e-2)" "unprognostic (4.89e-3)" "unprognostic (1.20e-3)" "unprognostic (1.47e-8)" "unprognostic (2.09e-1)" "unprognostic (2.68e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-3)" 0.8 23.7 9.8 0.9 10.2 0.7 4.1 6.6 18.3 1.2 1.2 2.9 0.0 0.7 0.7 4.3 1.2 0.7 0.8 0.6 10.0 13.4 0.6 0.8 0.8 0.9 7.1 7.6 1.1 0.6 0.6 0.3 1.3 44.2 5.3 1.5 12.0 0.7 0.8 0.8 2.1 1.3 0.8 2.6 0.8 0.7 1.4 2.7 0.0 0.7 0.0 0.6 1.0 0.6 0.4 0.3 1.6 1.1 0.2 0.4 0.0 0.2 0.5 0.8 0.3 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.7 4.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.4 1.3 1.0 0.2 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.9 1.8 0.0 0.0 0.4 1.0 1.1 0.1 0.3 0.2 1.2 0.3 0.0 0.4 0.1 0.3 0.1 1.0 0.1 0.6 0.5 1.0 0.4 0.6 1.0 0.2 0.2 0.5 0.9 0.2 0.8 0.8 1.8 0.0 1.1 0.6 0.1 0.8 0.0 0.2 0.1 0.0 0.3 0.4 0.3 0.1 1.6 0.2 0.5 0.1 0.4 0.0 9.8 10.2 6.6 18.3 10.0 13.4 7.1 7.6 44.2 2.7 0.0 0.0 0.0 0.0 0.2 6.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 1.6 0.0 0.0 0.0 7.9 0.3 0.0 3.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GRIK2 "GluK2, GLUR6, MRT6" ENSG00000164418 "Glutamate ionotropic receptor kainate type subunit 2" Q13002 6 101398788-102070083 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 4.6;Cardiomyocytes: 2.8;Ciliated cells: 2.7;Early spermatids: 3.3;Late spermatids: 5.6" "Cancer enhanced" "Detected in some" "glioma: 3.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 11.7;BJ hTERT+: 19.4;fHDF/TERT166: 14.5;HAP1: 7.5;SiHa: 7.8;WM-115: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014395, HPA014623, CAB022463" Approved "Intracellular and membrane" NA NA "CAB022463: , HPA014395: AB_1850303, HPA014623: AB_1850305" "unprognostic (1.43e-3)" "unprognostic (1.26e-2)" "unprognostic (3.99e-2)" "unprognostic (3.20e-1)" "unprognostic (1.92e-1)" "unprognostic (3.48e-2)" "unprognostic (2.57e-1)" "unprognostic (4.32e-2)" "unprognostic (8.46e-2)" "unprognostic (9.19e-2)" "unprognostic (4.01e-2)" "unprognostic (1.36e-1)" "unprognostic (1.34e-5)" "unprognostic (1.94e-3)" "unprognostic (7.78e-2)" "unprognostic (1.09e-2)" "unprognostic (8.68e-4)" 0.8 3.9 16.1 1.1 22.5 1.0 0.8 40.6 22.8 3.1 1.2 1.6 0.0 1.4 1.2 2.5 1.2 0.9 1.5 7.6 9.1 11.4 1.9 0.6 0.7 0.6 4.1 17.0 1.1 5.2 0.5 13.0 4.3 8.5 2.1 1.2 0.4 2.0 2.6 1.8 3.8 1.5 0.9 2.7 1.1 0.8 1.8 5.3 0.0 6.3 0.0 0.4 1.1 0.9 1.4 1.2 2.7 0.7 1.2 0.9 0.4 0.0 0.1 2.5 0.2 2.6 0.1 0.0 11.7 19.4 0.7 0.4 0.0 0.2 0.1 0.0 14.5 0.0 3.9 7.5 0.0 0.2 0.0 0.0 1.3 6.7 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.7 1.8 0.0 0.0 0.0 0.3 4.3 0.0 0.0 0.1 2.1 0.0 0.1 0.0 0.3 0.0 0.5 0.0 2.6 5.1 7.8 0.0 0.4 0.4 0.0 0.7 0.0 1.6 0.3 0.1 0.9 0.0 0.0 0.0 1.1 0.0 17.7 2.5 0.7 0.7 0.6 0.7 0.4 0.7 0.6 0.4 0.2 1.4 0.8 0.9 2.7 1.2 0.7 1.2 0.3 0.4 16.1 22.5 40.6 21.9 9.1 11.4 4.1 17.0 8.5 5.3 0.0 0.3 0.0 0.9 0.6 4.6 2.8 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.5 0.0 0.6 0.7 0.0 0.0 0.1 0.0 1.7 0.0 0.0 5.6 0.3 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.9 0.0 0.5 0.0 0.3 0.5 0.0 0.0 0.0 0.9 GRIK3 "GluK3, GLUR7" ENSG00000163873 "Glutamate ionotropic receptor kainate type subunit 3" Q13003 1 36795527-37034129 "Plasma proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;pituitary gland: 13.1" "Group enriched" "Detected in some" 5 "Late spermatids: 5.1;Muller glia cells: 14.3" "Cancer enhanced" "Detected in some" "glioma: 13.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "T-47d: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.20e-2)" "unprognostic (1.90e-1)" "unprognostic (7.66e-2)" "unprognostic (9.26e-3)" "unprognostic (2.87e-1)" "unprognostic (1.60e-1)" "unprognostic (1.45e-1)" "unprognostic (2.60e-3)" "unprognostic (9.06e-2)" "unprognostic (1.04e-1)" "unprognostic (3.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.28e-2)" "unprognostic (3.53e-3)" "unprognostic (2.06e-1)" "unprognostic (9.37e-2)" "unprognostic (2.08e-2)" 1.7 4.6 5.4 1.8 9.4 0.6 5.4 5.7 24.7 2.1 8.4 3.3 1.5 2.1 0.8 4.5 3.1 1.2 2.2 1.9 3.8 9.6 0.8 0.7 0.9 0.9 9.1 10.4 1.3 1.6 1.5 13.1 0.6 13.1 1.9 3.3 9.0 2.2 5.8 0.7 1.1 2.9 1.8 3.6 1.0 2.1 2.0 2.7 0.0 1.0 0.2 1.4 1.1 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.3 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 9.4 5.7 14.2 3.8 9.6 9.1 10.4 13.1 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.3 0.0 1.7 0.0 0.0 14.3 0.0 0.0 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRIK4 "GluK4, GRIK, KA1" ENSG00000149403 "Glutamate ionotropic receptor kainate type subunit 4" Q16099 11 120511700-120988904 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.3;ovary: 8.5" "Cell type enriched" "Detected in some" 8 "Cone photoreceptor cells: 33.4" "Cancer enriched" "Detected in some" 5 "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 6.4;HEL: 19.7;T-47d: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074453 Enhanced NA NA "HPA074453: AB_2732255" "unprognostic (9.63e-2)" "unprognostic (4.96e-2)" "unprognostic (1.58e-1)" "unprognostic (2.49e-1)" "unprognostic (2.37e-1)" "unprognostic (6.64e-4)" "unprognostic (1.48e-2)" "unprognostic (7.26e-2)" "unprognostic (3.16e-1)" "unprognostic (2.38e-1)" "unprognostic (4.53e-2)" "unprognostic (2.50e-1)" "unprognostic (4.84e-11)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (4.47e-3)" "unprognostic (2.58e-2)" 1.0 5.4 11.3 1.0 9.0 0.8 1.3 3.9 19.3 1.2 1.1 9.4 0.0 1.2 1.1 0.9 1.2 1.7 1.1 1.6 13.9 7.2 1.0 0.8 3.1 1.0 8.7 11.0 8.5 0.8 0.8 2.6 1.5 12.3 1.5 1.1 0.0 1.1 1.0 1.0 1.3 1.2 1.0 6.3 1.4 0.9 2.0 8.2 0.0 6.3 0.0 1.0 1.2 0.4 0.0 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 6.4 0.6 19.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.6 5.1 0.0 0.2 0.0 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 11.3 9.0 3.9 14.0 13.9 7.2 8.7 11.0 12.3 8.2 0.0 1.1 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.3 4.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.1 0.0 0.0 0.4 GRIK5 "GluK5, GRIK2, KA2" ENSG00000105737 "Glutamate ionotropic receptor kainate type subunit 5" Q16478 19 41998321-42069498 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 21.4;Horizontal cells: 17.5;Muller glia cells: 8.3;Rod photoreceptor cells: 20.6" "Cancer enhanced" "Detected in many" "glioma: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "eosinophil: 1.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "HEL: 9.0;hTERT-RPE1: 14.5;NTERA-2: 8.9;REH: 24.4;SCLC-21H: 7.0;SH-SY5Y: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074001 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA074001: AB_2732248" "unprognostic (4.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.30e-3)" "unprognostic (6.68e-3)" "unprognostic (4.28e-2)" "unprognostic (3.86e-1)" "unprognostic (5.82e-1)" "unprognostic (2.23e-1)" "unprognostic (3.89e-2)" "unprognostic (1.73e-2)" "prognostic favorable (7.23e-4)" "unprognostic (8.43e-2)" "prognostic unfavorable (9.32e-4)" "unprognostic (6.47e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-2)" "unprognostic (6.12e-2)" 1.7 5.4 9.6 2.3 12.2 3.4 2.4 17.2 23.9 2.7 6.9 4.9 1.3 1.2 3.8 2.7 2.4 4.5 2.6 5.6 21.7 8.9 3.8 0.3 0.6 2.6 5.0 5.3 5.3 3.5 17.8 9.1 0.3 5.5 4.5 1.6 5.8 0.7 8.9 1.0 1.1 1.4 6.7 7.6 1.8 2.7 13.6 3.5 1.0 10.3 0.3 1.0 2.2 2.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 9.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 14.5 0.0 0.4 0.0 0.4 0.0 0.1 0.1 0.0 8.9 0.1 0.0 24.4 0.0 0.1 4.0 0.0 7.0 15.5 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 12.2 17.2 12.7 21.7 8.9 5.0 5.3 5.5 3.5 0.0 0.0 0.0 0.1 0.3 21.4 2.3 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 4.6 0.0 0.0 17.5 0.0 0.0 0.0 2.2 0.9 0.0 0.0 0.0 0.0 8.3 0.1 0.0 0.4 0.0 20.6 0.0 0.9 3.8 1.5 0.4 0.0 0.0 0.0 0.0 GRIN1 "GluN1, NMDAR1" ENSG00000176884 "Glutamate ionotropic receptor NMDA type subunit 1" Q05586 9 137138390-137168762 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 38 "brain: 97.5" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 5.6;Cardiomyocytes: 2.4;monocytes: 3.6;Rod photoreceptor cells: 5.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 2.6;REH: 3.1;RPMI-8226: 4.3;SCLC-21H: 10.0;SH-SY5Y: 6.9;T-47d: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067773 Enhanced NA NA "HPA067773: " "unprognostic (3.58e-2)" "unprognostic (4.51e-1)" "unprognostic (2.68e-2)" "unprognostic (5.48e-4)" "unprognostic (5.20e-2)" "unprognostic (1.25e-1)" "unprognostic (2.34e-2)" "unprognostic (2.81e-2)" "unprognostic (6.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.21e-3)" "unprognostic (4.47e-2)" "unprognostic (1.44e-1)" "unprognostic (3.56e-3)" "unprognostic (4.72e-2)" 1.7 2.0 23.6 2.0 47.5 1.7 1.8 28.1 97.5 1.8 2.0 3.2 0.0 2.2 1.7 1.8 1.7 1.7 1.7 1.7 29.1 26.4 1.8 1.7 1.8 1.8 15.4 37.9 1.7 1.8 1.8 0.0 1.7 22.0 2.2 1.8 0.7 2.5 1.8 1.7 1.8 2.2 1.8 4.7 1.8 1.8 1.9 6.3 0.0 1.7 0.0 1.8 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.4 1.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 1.5 0.1 0.0 0.2 0.2 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.9 0.0 0.0 0.1 2.6 0.0 3.1 0.0 4.3 0.0 0.0 10.0 6.9 0.1 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 23.6 47.5 28.1 87.9 29.1 26.4 15.4 37.9 22.0 6.3 0.0 0.0 0.0 0.4 0.0 5.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.1 1.6 1.7 0.0 0.0 0.4 0.0 0.0 0.0 3.6 1.7 1.6 0.3 0.0 0.0 0.0 5.7 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.3 GRIN2A "GluN2A, NMDAR2A" ENSG00000183454 "Glutamate ionotropic receptor NMDA type subunit 2A" Q12879 16 9753404-10182754 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 25.2" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 14.9;Early spermatids: 13.4;Late spermatids: 13.0;Muller glia cells: 17.7;Rod photoreceptor cells: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 7.8;hTERT-RPE1: 3.4;RPMI-8226: 2.9;U-138 MG: 8.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB022725 Enhanced NA NA "CAB022725: " "unprognostic (6.43e-2)" "unprognostic (2.47e-1)" "unprognostic (5.97e-2)" "unprognostic (3.21e-2)" "unprognostic (3.13e-2)" "unprognostic (1.59e-2)" "unprognostic (1.62e-1)" "unprognostic (2.10e-1)" "unprognostic (2.08e-1)" "unprognostic (5.39e-2)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "unprognostic (3.75e-3)" "unprognostic (4.79e-3)" "unprognostic (2.05e-1)" "unprognostic (3.92e-3)" "unprognostic (3.33e-2)" 0.9 1.0 5.4 0.5 5.9 0.4 0.6 8.5 25.2 0.6 0.7 1.5 0.0 0.9 0.8 4.5 2.1 4.1 0.5 4.0 8.0 1.9 0.9 0.4 1.0 0.5 1.7 10.3 0.5 0.6 0.4 0.3 0.4 1.4 0.5 0.7 1.4 0.7 1.0 0.5 1.2 0.7 0.9 1.2 0.4 1.1 5.2 0.8 0.0 0.8 0.0 0.7 0.6 0.5 0.6 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 1.9 0.6 1.4 0.0 0.1 0.0 0.0 7.8 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 8.5 0.8 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 5.4 5.9 8.5 17.9 8.0 1.9 1.7 10.3 1.4 0.8 0.0 0.0 0.0 1.9 1.6 3.6 14.9 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.6 13.4 0.1 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.1 1.6 0.0 0.0 0.0 13.0 0.9 0.0 0.0 0.0 0.0 17.7 1.2 0.0 0.0 0.0 12.1 0.0 4.2 3.2 3.8 0.4 0.0 0.0 0.0 0.3 GRIN2B "GluN2B, NMDAR2B" ENSG00000273079 "Glutamate ionotropic receptor NMDA type subunit 2B" Q13224 12 13437942-13981957 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "brain: 36.5" "Group enriched" "Detected in some" 10 "Early spermatids: 36.4;Late spermatids: 25.3" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 19.5;basal ganglia: 26.0;cerebral cortex: 36.5;hippocampal formation: 19.6;olfactory region: 15.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.4;AF22: 3.4;CACO-2: 3.9;Daudi: 1.6;NTERA-2: 4.9;RPTEC TERT1: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069762 Approved NA NA "HPA069762: AB_2686192" "unprognostic (2.01e-2)" "unprognostic (4.07e-2)" "unprognostic (7.89e-2)" "unprognostic (3.77e-3)" "unprognostic (3.39e-3)" "unprognostic (9.36e-2)" "unprognostic (5.92e-2)" "unprognostic (1.77e-2)" "unprognostic (6.85e-2)" "unprognostic (2.24e-1)" "unprognostic (4.68e-2)" "unprognostic (4.12e-2)" "unprognostic (4.48e-5)" "unprognostic (2.43e-1)" "unprognostic (8.76e-2)" "unprognostic (1.63e-1)" "unprognostic (2.37e-1)" 1.9 0.9 19.5 0.8 26.0 0.8 0.9 0.9 36.5 0.8 1.9 1.9 0.0 0.8 0.8 0.8 0.9 0.8 0.8 0.8 19.6 3.5 1.0 1.6 0.8 1.4 1.8 15.0 0.9 0.8 0.8 0.4 0.9 2.6 0.8 1.2 0.0 0.8 0.8 0.8 0.8 1.8 0.8 0.8 0.9 1.0 1.5 3.6 0.0 0.8 0.0 1.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 26.0 0.9 36.5 19.6 3.5 1.8 15.0 2.6 3.6 0.0 0.0 0.0 0.0 0.0 0.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 36.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.4 0.0 GRIN2C "GluN2C, NMDAR2C" ENSG00000161509 "Glutamate ionotropic receptor NMDA type subunit 2C" Q14957 17 74842023-74861504 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 43.6;heart muscle: 13.2;salivary gland: 14.2;thyroid gland: 12.4" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 15.9;Hofbauer cells: 9.4;Muller glia cells: 18.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.3" "Region enriched" "Detected in many" 5 "cerebellum: 43.6" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 11.3;RPMI-8226: 4.0;SCLC-21H: 5.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 13 "cerebellum: 65.6" NA NA "unprognostic (7.21e-3)" "unprognostic (4.68e-2)" "unprognostic (9.38e-3)" "unprognostic (2.24e-5)" "unprognostic (3.42e-1)" "unprognostic (1.53e-2)" "unprognostic (1.84e-1)" "unprognostic (1.82e-2)" "unprognostic (1.78e-1)" "unprognostic (2.95e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-3)" "unprognostic (4.20e-2)" "unprognostic (1.49e-1)" "unprognostic (1.51e-2)" "unprognostic (1.14e-1)" 1.0 1.4 7.8 0.5 9.1 1.0 0.5 43.6 8.9 0.5 0.5 2.4 0.0 0.5 0.5 0.5 0.4 0.6 0.6 13.2 4.5 1.4 0.3 0.2 0.3 0.3 3.2 4.5 0.4 0.2 0.5 0.0 2.7 4.2 0.3 0.4 0.3 14.2 0.5 0.6 0.4 0.6 0.5 1.0 0.4 0.3 2.7 0.9 0.0 12.4 0.0 0.3 0.4 0.0 0.2 1.3 0.3 0.1 0.2 0.7 0.0 0.0 0.4 0.4 0.1 0.1 0.0 11.3 0.0 0.0 0.0 0.0 1.4 0.2 0.5 0.1 0.0 0.1 0.4 0.1 0.0 0.0 1.0 0.3 0.2 0.3 0.3 0.0 0.8 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.4 0.3 0.0 1.7 0.1 0.1 0.1 0.1 0.1 0.3 0.9 4.0 0.0 0.3 5.2 0.4 2.2 0.2 0.8 0.8 0.7 0.1 0.2 0.4 2.0 0.5 0.2 1.1 0.1 0.2 0.5 0.7 0.2 0.1 0.1 0.3 0.7 0.1 0.1 0.0 0.1 0.3 0.1 0.2 0.3 0.2 0.3 0.2 0.0 1.3 0.2 0.0 7.8 9.1 43.6 6.3 4.5 1.4 3.2 4.5 4.2 0.9 0.0 0.0 0.0 0.0 0.1 2.5 15.9 2.5 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.8 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 9.4 1.6 0.0 1.3 0.3 4.3 0.0 0.0 1.7 0.0 0.0 18.3 0.0 0.0 0.4 0.0 2.4 0.0 1.0 3.0 2.5 0.0 0.6 0.0 0.0 0.0 GRIN2D "EB11, GluN2D, NMDAR2D, NR2D" ENSG00000105464 "Glutamate ionotropic receptor NMDA type subunit 2D" O15399 19 48394875-48444931 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.9" "Cell type enhanced" "Detected in some" 8 "Cardiomyocytes: 2.8;Extravillous trophoblasts: 3.1;Ito cells: 3.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "classical monocyte: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 12.9;EFO-21: 8.9;HMC-1: 22.0;NB-4: 12.9;SK-BR-3: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009006 Approved NA NA "CAB009006: AB_2279191" "unprognostic (9.96e-2)" "unprognostic (6.98e-2)" "unprognostic (1.17e-1)" "unprognostic (5.08e-3)" "unprognostic (1.46e-1)" "unprognostic (4.17e-1)" "unprognostic (1.43e-4)" "unprognostic (7.84e-2)" "unprognostic (2.72e-1)" "unprognostic (2.23e-3)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (6.66e-13)" "unprognostic (2.15e-2)" "unprognostic (1.92e-2)" "unprognostic (1.26e-3)" "unprognostic (1.14e-1)" 0.5 0.1 4.1 1.1 1.7 0.1 0.1 2.0 5.0 0.1 0.6 1.8 0.0 0.1 0.0 0.2 1.1 0.3 2.4 6.9 0.0 0.0 0.4 0.3 3.1 0.0 0.0 1.4 0.0 3.2 0.8 0.0 0.5 0.1 0.1 1.0 2.8 0.4 1.1 0.4 0.7 1.6 1.0 0.1 0.5 0.1 0.0 0.8 0.0 1.2 0.0 0.0 0.0 1.0 12.9 0.3 0.0 1.0 2.8 7.6 1.6 0.0 0.4 0.1 0.9 7.6 0.3 8.9 0.8 0.0 0.1 0.1 0.1 0.2 1.3 0.3 3.9 0.2 1.6 1.5 0.3 22.0 1.0 0.0 0.8 0.0 0.1 0.3 0.1 7.2 0.4 0.1 2.3 0.0 12.9 0.4 6.4 0.2 0.0 0.0 0.1 0.2 0.0 1.3 1.2 0.5 11.5 0.1 0.2 0.0 4.9 4.3 0.0 0.1 0.0 0.0 2.0 2.4 0.0 0.0 1.5 0.1 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.1 0.0 0.0 0.2 3.1 1.3 0.2 0.0 0.0 1.2 0.0 0.0 3.1 0.3 1.3 0.6 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 1.1 0.0 0.0 0.3 0.2 0.0 1.5 0.0 0.0 0.0 GRIN3A GluN3A ENSG00000198785 "Glutamate ionotropic receptor NMDA type subunit 3A" Q8TCU5 9 101569353-101738580 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 17.3" "Cell type enhanced" "Detected in some" 21 "Cone photoreceptor cells: 3.9;Early spermatids: 1.4;Sertoli cells: 6.5" "Cancer enriched" "Detected in single" 7 "prostate cancer: 3.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "intermediate monocyte: 3.3;non-classical monocyte: 2.5" "Lineage enriched" "Detected in single" 7 "monocytes: 3.3" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.29e-1)" "unprognostic (7.10e-3)" "unprognostic (3.01e-5)" "unprognostic (3.39e-2)" "unprognostic (6.32e-2)" "unprognostic (7.06e-4)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (7.56e-2)" "unprognostic (7.34e-3)" "unprognostic (1.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (1.42e-1)" "unprognostic (4.87e-1)" "unprognostic (9.41e-2)" 0.6 0.6 7.4 0.8 4.2 0.5 0.7 0.4 17.3 4.1 1.0 2.6 0.0 0.6 1.0 1.0 0.5 0.6 0.5 1.2 6.8 6.4 0.6 0.6 0.7 1.1 3.8 12.4 2.4 0.5 0.4 0.4 0.4 4.6 1.8 0.8 2.7 0.6 2.6 0.7 1.0 0.7 0.7 3.0 1.8 0.6 1.0 2.3 0.0 0.5 0.0 0.8 0.5 0.6 0.0 0.4 0.1 3.3 0.0 0.4 0.2 0.0 0.2 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.2 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.1 0.0 0.1 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.3 0.7 0.1 0.5 0.3 0.4 0.1 0.0 0.3 6.4 0.7 0.2 0.2 0.2 0.6 0.2 0.3 0.3 0.4 0.1 0.7 0.3 0.6 1.0 0.3 0.7 0.3 1.2 0.0 0.6 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 2.5 0.0 0.4 0.2 7.4 4.2 0.4 13.4 6.8 6.4 3.8 12.4 4.6 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 GRIN3B GluN3B ENSG00000116032 "Glutamate ionotropic receptor NMDA type subunit 3B" O60391 19 1000419-1009732 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 8.7" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 2.7;Early spermatids: 2.6;Spermatogonia: 9.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 8.4" "Region enhanced" "Detected in single" "pons and medulla: 1.6" "Low region specificity" "Detected in some" NA NA "unprognostic (7.86e-2)" "unprognostic (1.09e-1)" "unprognostic (2.61e-2)" "unprognostic (3.43e-3)" "unprognostic (1.35e-1)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (9.20e-2)" "unprognostic (1.49e-1)" "unprognostic (3.78e-3)" "unprognostic (9.35e-3)" "unprognostic (3.62e-2)" "unprognostic (3.34e-5)" "unprognostic (1.94e-1)" "unprognostic (1.63e-1)" "unprognostic (1.72e-1)" "unprognostic (1.33e-1)" 0.3 0.5 0.1 0.4 0.4 0.2 0.1 0.6 0.1 2.0 0.0 0.7 0.3 0.0 0.1 8.7 0.0 0.0 0.3 0.4 1.0 0.0 2.2 1.1 0.0 0.2 0.6 0.0 0.7 0.2 0.2 0.0 0.5 0.0 0.4 1.6 0.4 0.0 0.2 3.0 0.4 0.7 0.6 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 1.0 0.7 0.3 0.3 1.5 2.6 1.3 0.2 0.0 0.0 0.1 0.2 1.2 1.7 0.0 0.7 0.8 0.0 0.2 0.0 0.5 2.6 0.5 0.6 0.3 0.1 0.2 1.9 0.1 0.1 0.0 0.0 0.1 0.1 0.5 0.5 1.2 0.0 0.8 0.4 0.3 0.4 0.1 0.1 2.7 0.3 1.0 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.2 0.4 1.0 1.1 0.3 0.7 0.8 0.1 8.4 2.0 0.2 0.1 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 1.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 9.0 0.0 0.0 0.0 0.0 0.0 GRINA "HNRGW, LFG1, NMDARA1, TMBIM3" ENSG00000178719 "Glutamate ionotropic receptor NMDA type subunit associated protein 1" Q7Z429 8 143990058-143993415 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 331.5;monocytes: 538.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036980, HPA036981" Approved Approved "Nucleoli fibrillar center,Cytosol" NA Yes "Nucleoli fibrillar center" Cytosol "HPA036980: AB_10696791, HPA036981: AB_10962980" "unprognostic (2.73e-3)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (1.12e-1)" "unprognostic (7.01e-3)" "unprognostic (3.72e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-1)" "unprognostic (6.70e-2)" "unprognostic (8.19e-2)" "unprognostic (3.13e-3)" "unprognostic (1.01e-3)" "unprognostic (1.55e-1)" "unprognostic (9.43e-2)" "unprognostic (6.75e-2)" "unprognostic (5.72e-2)" 76.4 48.8 46.6 52.3 61.0 89.0 70.2 73.8 85.8 37.1 28.4 34.5 37.1 35.6 33.1 42.1 30.5 41.4 37.5 35.2 54.2 45.1 61.7 143.7 49.7 67.4 47.4 51.5 46.1 32.0 66.8 29.3 42.4 46.5 42.6 17.7 49.3 44.4 99.4 32.8 37.4 33.5 38.0 43.3 82.0 23.2 52.2 24.3 24.3 54.7 19.2 26.8 43.2 31.3 4.5 12.4 10.2 19.3 1.6 2.6 6.4 12.8 25.2 12.9 21.9 68.8 34.7 19.1 18.4 43.6 31.4 29.1 15.3 10.8 9.2 20.3 41.5 21.9 11.6 23.0 27.2 12.9 13.1 15.8 9.6 14.6 18.1 72.9 2.0 15.5 44.7 75.4 22.7 33.2 33.0 15.2 4.0 8.9 13.0 27.0 77.6 5.3 5.2 9.0 12.4 38.2 7.3 6.5 17.8 16.1 36.5 8.8 14.3 26.8 30.2 35.8 18.3 58.1 12.7 15.2 19.9 21.9 26.5 13.4 21.1 12.1 6.9 25.2 12.7 11.3 0.9 16.6 4.6 1.4 19.3 2.0 4.5 1.4 1.6 7.1 4.3 2.6 2.3 10.2 1.6 18.0 12.4 1.2 6.4 46.6 61.0 73.8 85.8 54.2 45.1 47.4 51.5 46.5 24.3 17.9 65.6 14.3 28.0 33.1 86.7 19.7 40.8 17.4 18.2 50.6 74.6 108.2 19.9 63.5 214.4 42.1 42.7 46.7 60.2 47.1 58.4 38.3 15.1 167.7 158.2 31.8 40.5 54.0 188.9 331.5 57.0 128.7 35.4 538.4 24.1 77.3 64.0 46.0 63.6 61.9 71.2 45.3 40.6 89.2 11.3 32.2 220.9 15.9 22.4 21.6 GRM1 "GPRC1A, mGlu1, MGLUR1, PPP1R85" ENSG00000152822 "Glutamate metabotropic receptor 1" Q13255 6 146027646-146437598 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 39.9" "Cell type enriched" "Detected in some" 7 "Rod photoreceptor cells: 113.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 39.9" "Cell type enriched" "Detected in single" 4 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 1.4;GAMG: 2.5;HeLa: 1.2;hTERT-RPE1: 1.5;Karpas-707: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015701 Approved Supported Approved Vesicles NA NA Vesicles "HPA015701: AB_1853917" "unprognostic (1.04e-2)" "unprognostic (7.33e-2)" "unprognostic (3.73e-3)" "unprognostic (9.77e-3)" "unprognostic (6.75e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-2)" "unprognostic (4.31e-2)" "unprognostic (2.93e-2)" "unprognostic (9.48e-3)" "unprognostic (7.92e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (3.50e-2)" "unprognostic (8.33e-3)" "unprognostic (9.76e-2)" 0.5 0.5 6.6 0.4 6.0 0.4 0.5 39.9 13.0 0.5 0.5 0.9 0.0 0.4 0.5 0.7 0.5 0.7 0.5 7.7 6.0 2.7 2.7 0.5 0.6 0.5 2.6 4.1 0.5 0.5 0.4 0.2 0.5 3.6 0.5 0.4 2.6 0.5 0.8 0.4 0.5 0.5 0.5 1.0 0.6 0.5 1.3 0.9 0.0 0.8 0.0 0.4 0.5 0.1 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.1 1.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.1 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.3 1.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.6 0.0 0.0 1.2 0.1 0.0 0.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.9 0.5 0.1 0.1 0.4 0.1 0.0 0.4 0.1 0.0 0.1 0.6 0.2 0.2 0.0 0.1 0.4 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 6.6 6.0 39.9 10.5 6.0 2.7 2.6 4.1 3.6 0.9 0.0 0.0 0.0 0.0 0.0 13.4 3.9 0.0 0.0 0.0 1.8 15.7 0.0 1.7 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 113.7 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 GRM2 "GPRC1B, mGlu2, MGLUR2" ENSG00000164082 "Glutamate metabotropic receptor 2" Q14416 3 51707070-51718613 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 13.2" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 5.9;Rod photoreceptor cells: 1.6;Spermatocytes: 3.7" "Cancer enhanced" "Detected in single" "testis cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027868, HPA065166" Approved Supported NA NA "HPA027868: , HPA065166: AB_2685425" "unprognostic (1.01e-1)" "unprognostic (8.61e-4)" "unprognostic (7.66e-2)" "unprognostic (7.29e-3)" "unprognostic (1.98e-1)" "unprognostic (3.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.27e-1)" "unprognostic (1.39e-2)" "unprognostic (2.05e-1)" "unprognostic (4.45e-1)" "unprognostic (1.74e-1)" "unprognostic (1.37e-2)" "unprognostic (1.35e-1)" "unprognostic (1.82e-1)" "unprognostic (2.93e-2)" "unprognostic (1.19e-2)" 0.8 0.6 4.6 0.8 6.3 1.6 0.7 3.8 13.2 0.6 0.6 0.4 0.0 0.6 0.8 0.4 0.5 0.5 0.4 0.9 3.0 3.1 0.5 0.5 0.6 0.7 1.2 7.0 0.5 0.4 0.4 0.4 0.6 8.3 0.7 0.5 0.6 0.8 0.6 1.8 1.3 0.5 0.6 0.5 1.1 0.5 1.3 0.2 0.0 0.5 0.0 0.5 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 6.3 3.8 13.2 3.0 3.1 1.2 7.0 8.3 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 1.6 0.0 0.0 3.7 0.9 0.3 0.0 0.0 0.0 0.0 GRM3 "GPRC1C, mGlu3, MGLUR3" ENSG00000198822 "Glutamate metabotropic receptor 3" Q14832 7 86643914-86864884 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 24 "brain: 53.3" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 5.4;Cone photoreceptor cells: 3.9;Early spermatids: 16.8;Horizontal cells: 12.7" "Cancer enriched" "Detected in single" 7 "glioma: 2.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (2.05e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-1)" "unprognostic (2.70e-3)" "unprognostic (3.16e-1)" "unprognostic (1.07e-3)" "unprognostic (6.99e-3)" "unprognostic (2.98e-1)" "unprognostic (2.71e-1)" "unprognostic (9.13e-3)" "unprognostic (1.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.91e-3)" "unprognostic (4.00e-2)" "unprognostic (9.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.12e-2)" 1.2 2.2 10.6 1.2 22.5 1.2 1.2 4.6 53.3 1.3 1.3 23.9 0.0 1.3 1.3 1.2 1.2 1.2 1.3 1.3 12.6 5.6 1.4 1.2 1.3 1.2 18.9 13.0 1.2 1.2 1.2 0.2 1.2 11.5 1.7 1.2 0.0 1.3 1.3 2.1 1.2 1.2 1.2 12.0 1.8 1.3 2.2 22.1 0.0 1.2 0.0 1.2 1.4 0.1 0.5 0.1 0.5 0.0 0.1 0.3 0.1 0.0 0.0 28.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 10.6 22.5 4.6 20.2 12.6 5.6 18.9 13.0 11.5 22.1 0.0 0.0 0.0 0.7 0.1 5.4 1.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 16.8 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.5 0.3 0.0 1.7 0.0 0.0 0.3 0.1 0.0 0.4 0.0 1.8 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.2 GRM4 "GPRC1D, mGlu4, MGLUR4" ENSG00000124493 "Glutamate metabotropic receptor 4" Q14833 6 34018645-34155622 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "brain: 101.6" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 1.8;Early spermatids: 3.4;Intestinal endocrine cells: 2.9;Late spermatids: 1.5;Spermatogonia: 4.0" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Region enriched" "Detected in many" 21 "cerebellum: 101.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 6.5;SCLC-21H: 26.0" "Region enhanced" "Detected in all" "cerebellum: 83.5" "Region enriched" "Detected in all" 4 "cerebellum: 252.6" CAB022096 Enhanced NA NA "CAB022096: " "unprognostic (1.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (7.00e-2)" "unprognostic (4.03e-2)" "unprognostic (8.36e-2)" "unprognostic (9.05e-3)" "unprognostic (3.56e-1)" "unprognostic (9.45e-2)" "unprognostic (2.08e-2)" "unprognostic (6.21e-3)" "unprognostic (2.44e-1)" "unprognostic (2.15e-11)" "unprognostic (5.32e-2)" "unprognostic (9.16e-2)" "unprognostic (6.57e-2)" "unprognostic (3.07e-1)" 0.2 0.1 0.4 0.3 4.9 0.2 0.2 101.6 7.2 0.6 0.1 0.3 0.1 0.5 0.5 0.1 0.1 0.3 0.1 0.1 0.5 0.9 0.2 0.3 0.3 0.2 0.3 0.4 0.2 3.5 0.1 0.0 0.3 4.3 0.3 0.2 0.1 0.1 0.2 0.3 0.6 0.8 0.7 1.1 0.1 0.2 1.6 0.5 0.0 0.3 0.0 0.7 0.4 0.0 0.2 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.9 101.6 1.0 0.5 0.9 0.3 0.4 4.3 0.5 0.0 0.0 0.0 0.3 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 2.9 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 4.0 0.0 0.1 0.0 0.0 0.1 GRM5 "GPRC1E, mGlu5, MGLUR5, PPP1R86" ENSG00000168959 "Glutamate metabotropic receptor 5" P41594 11 88504576-89065945 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 27.7" "Group enriched" "Detected in some" 9 "Bipolar cells: 27.0;Early spermatids: 14.2;Late spermatids: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "Hep G2: 2.2;U-266/70: 1.5;U-937: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.94e-1)" "unprognostic (9.62e-2)" "unprognostic (9.57e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (2.62e-1)" "unprognostic (1.26e-1)" "unprognostic (7.16e-2)" "unprognostic (8.15e-4)" "unprognostic (3.43e-2)" 0.5 0.5 11.4 0.5 11.0 0.6 0.5 2.6 27.7 0.6 0.5 1.0 0.0 0.5 0.5 0.5 0.5 0.7 0.7 0.5 6.0 3.2 0.7 0.5 0.7 0.5 2.1 10.0 0.5 0.5 0.5 0.8 0.6 1.5 0.5 0.5 0.0 0.5 0.5 0.6 1.1 0.5 0.5 1.2 0.6 0.5 3.1 1.5 0.0 0.5 0.0 0.5 0.5 0.2 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.7 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.6 0.2 0.0 0.0 1.5 0.0 0.2 0.1 1.1 0.8 1.6 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.4 11.0 2.6 13.2 6.0 3.2 2.1 10.0 1.5 1.5 0.0 0.0 0.0 0.0 0.0 27.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 15.3 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 GRM6 "CSNB1B, GPRC1F, mGlu6, MGLUR6" ENSG00000113262 "Glutamate metabotropic receptor 6" O15303 5 178978327-178996206 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Receptor, Transducer" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 22.0" "Cell type enriched" "Detected in some" 31 "Bipolar cells: 422.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA014511 Enhanced NA NA "HPA014511: AB_2669025" "unprognostic (1.85e-1)" "unprognostic (1.54e-1)" "unprognostic (8.41e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-1)" "unprognostic (2.25e-3)" "unprognostic (7.72e-2)" "unprognostic (2.32e-2)" "unprognostic (2.12e-3)" "unprognostic (6.27e-2)" "unprognostic (3.34e-4)" "unprognostic (2.58e-1)" "unprognostic (3.36e-4)" "unprognostic (1.23e-1)" "unprognostic (6.45e-2)" "unprognostic (7.59e-3)" "unprognostic (1.97e-1)" 0.3 0.5 0.6 0.4 0.6 1.6 0.3 1.9 1.6 0.4 0.4 0.3 0.3 0.3 0.6 0.5 0.3 0.5 0.7 0.4 0.5 1.2 0.4 0.4 0.4 0.5 0.8 0.3 0.7 0.9 0.1 2.9 0.3 1.2 1.1 0.1 22.0 0.6 0.3 1.3 1.8 0.3 0.3 0.3 0.5 0.3 2.2 0.3 0.3 0.9 0.3 0.3 0.3 0.3 0.9 1.1 2.4 0.4 0.6 0.6 0.1 0.5 0.3 0.7 1.3 0.3 0.1 0.7 0.2 0.0 0.1 0.0 0.5 0.9 0.9 0.6 0.0 0.6 0.7 0.0 0.1 0.0 0.2 0.7 0.5 0.7 1.0 0.2 0.8 1.0 0.1 0.3 0.1 0.5 0.3 0.0 0.9 0.9 1.7 0.0 1.0 0.2 0.8 0.6 0.5 0.6 0.6 0.3 0.8 0.1 0.6 0.9 1.2 0.5 0.7 0.5 1.1 0.9 1.1 0.9 0.5 0.5 0.4 0.5 0.7 0.6 0.4 0.4 0.7 0.3 1.9 0.4 0.5 0.6 0.3 0.4 0.4 0.4 0.3 0.2 0.9 0.4 0.4 2.4 0.6 0.2 1.1 0.2 0.1 0.6 0.6 1.9 0.5 0.5 1.2 0.8 0.3 1.2 0.3 0.0 0.3 0.0 0.1 0.3 422.6 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.9 0.0 0.2 0.0 1.0 0.0 3.7 0.1 0.0 0.0 0.0 13.7 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 GRM7 "GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87" ENSG00000196277 "Glutamate metabotropic receptor 7" Q14831 3 6770001-7741533 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.8;parathyroid gland: 11.3" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 22.5;Early spermatids: 24.2;Late spermatids: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015964 Uncertain Cytosol NA NA Cytosol "HPA015964: " "unprognostic (2.04e-2)" "unprognostic (7.03e-3)" "unprognostic (1.43e-1)" "unprognostic (9.37e-2)" "unprognostic (8.48e-3)" "unprognostic (2.58e-1)" "unprognostic (7.30e-2)" "unprognostic (3.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.46e-2)" "unprognostic (2.54e-1)" "unprognostic (6.84e-6)" "unprognostic (1.45e-1)" "unprognostic (2.82e-2)" "unprognostic (5.43e-2)" "unprognostic (2.59e-2)" 0.9 5.3 8.1 0.6 10.5 0.6 0.9 1.6 15.8 2.9 0.8 2.1 0.0 0.9 3.1 0.5 0.6 1.0 0.7 0.6 11.1 9.3 0.5 0.7 0.8 0.5 2.3 10.1 0.8 0.7 11.3 0.6 0.9 4.3 1.2 0.8 0.8 2.1 1.4 0.5 0.6 0.6 5.9 2.8 0.8 0.6 2.8 4.1 0.0 0.7 0.0 0.7 1.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 10.5 1.6 15.8 11.1 9.3 2.3 10.1 4.3 4.1 0.0 0.0 0.0 0.9 0.1 22.5 1.1 7.6 6.7 1.2 0.0 7.9 0.0 1.7 0.0 24.2 0.1 0.0 0.0 0.0 0.1 0.7 1.1 1.1 0.0 0.1 1.6 0.0 0.0 0.0 29.9 0.3 0.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.2 6.5 0.0 1.7 0.7 0.0 0.0 0.0 0.0 0.6 GRM8 "GLUR8, GPRC1H, mGlu8, MGLUR8" ENSG00000179603 "Glutamate metabotropic receptor 8" O00222 7 126438598-127253294 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.5;liver: 8.0" "Group enriched" "Detected in some" 22 "Early spermatids: 53.0;Late spermatids: 55.2" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 5.6;HEK 293: 2.9;NTERA-2: 7.2;RH-30: 4.3;SCLC-21H: 6.5;SH-SY5Y: 3.5;U-2 OS: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051481 Uncertain NA NA "HPA051481: AB_2681499" "unprognostic (4.57e-3)" "unprognostic (5.10e-4)" "unprognostic (1.21e-1)" "unprognostic (2.09e-2)" "unprognostic (1.83e-1)" "unprognostic (5.54e-2)" "unprognostic (2.06e-4)" "unprognostic (1.79e-1)" "unprognostic (8.90e-2)" "unprognostic (1.31e-2)" "unprognostic (1.68e-1)" "unprognostic (1.69e-1)" "unprognostic (3.12e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (1.32e-2)" "unprognostic (1.12e-2)" 0.2 1.5 2.0 2.0 4.6 0.1 0.2 1.1 6.4 0.3 4.5 4.0 0.0 0.3 0.3 0.3 0.2 0.5 3.5 5.5 2.6 4.0 1.9 8.0 0.7 0.2 2.9 2.6 2.3 1.4 0.2 0.7 0.2 14.5 0.4 5.0 3.5 0.2 0.2 0.1 0.3 0.2 0.5 1.2 0.2 0.8 3.8 1.5 0.0 2.4 0.0 0.3 1.4 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 7.2 0.0 0.1 0.0 4.3 0.1 0.2 0.0 6.5 3.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 2.3 0.2 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.6 1.1 5.4 2.6 4.0 2.9 2.6 14.5 1.5 0.0 0.0 0.0 0.0 0.0 0.2 1.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.2 0.6 0.0 55.2 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.2 1.0 0.0 0.0 0.0 0.6 0.0 GRPR "BB2, BB2R" ENSG00000126010 "Gastrin releasing peptide receptor" P30550 X 16123556-16153021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 24.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 6.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.9;non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "PC-3: 18.0;T-47d: 22.5;U-138 MG: 30.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA069604 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA069604: AB_2686158" "unprognostic (3.32e-2)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (9.24e-2)" "unprognostic (2.87e-1)" "unprognostic (9.17e-2)" "unprognostic (5.06e-2)" "unprognostic (2.82e-1)" "unprognostic (1.01e-1)" "unprognostic (3.68e-3)" "unprognostic (2.62e-1)" "unprognostic (1.57e-1)" "unprognostic (5.59e-2)" "unprognostic (2.15e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-1)" "unprognostic (2.86e-2)" 0.5 0.4 3.4 4.7 2.3 0.2 3.5 0.3 3.5 3.7 1.4 0.0 2.5 0.2 1.0 2.8 7.5 0.3 0.2 0.5 3.5 0.4 0.3 0.3 0.4 0.2 0.3 1.9 0.3 24.5 0.4 0.3 0.2 1.1 0.7 0.6 2.0 0.4 0.4 0.4 0.3 0.5 1.2 0.4 0.3 2.1 0.4 0.0 0.0 0.4 0.0 0.2 0.4 0.4 0.6 0.2 0.4 1.9 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.5 0.0 2.3 1.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.3 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 22.5 0.0 0.1 30.8 0.3 0.0 0.9 0.1 0.1 0.1 0.0 0.0 0.4 0.0 1.1 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.4 0.0 1.6 0.1 0.0 0.4 3.4 2.3 0.3 3.5 3.5 0.4 0.3 1.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSG1 MGC3146 ENSG00000111305 "Germ cell associated 1" Q2KHT4 12 13083560-13103683 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "testis: 156.4" "Cell type enriched" "Detected in many" 5 "Late spermatids: 9027.4" "Cancer enhanced" "Detected in single" "testis cancer: 1.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 9.6;LHCN-M2: 11.0;RPTEC TERT1: 13.7;U-2 OS: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.50e-1)" "unprognostic (2.21e-2)" "unprognostic (6.33e-2)" "unprognostic (2.36e-2)" "unprognostic (1.34e-1)" "unprognostic (8.01e-2)" "unprognostic (1.04e-1)" "unprognostic (4.52e-1)" "unprognostic (6.85e-2)" "unprognostic (8.23e-2)" "unprognostic (5.91e-2)" "unprognostic (3.20e-3)" "unprognostic (1.48e-1)" "unprognostic (3.65e-2)" "unprognostic (1.79e-1)" "unprognostic (6.32e-3)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.2 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 156.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 2.6 0.7 0.5 1.2 0.1 0.1 0.5 0.3 0.1 2.3 1.4 0.5 0.2 0.4 0.4 0.5 0.2 0.1 0.2 0.2 9.6 0.8 0.1 0.2 0.0 0.9 0.2 0.0 0.2 0.6 0.3 0.0 0.2 0.1 0.9 0.0 1.8 0.1 0.1 0.0 0.1 0.1 1.8 11.0 0.3 0.1 1.1 2.3 0.1 0.2 0.1 4.0 0.2 13.7 0.2 0.6 0.3 0.2 0.0 0.1 0.3 0.1 1.6 0.1 0.6 6.9 0.3 0.3 0.6 0.4 0.1 3.0 0.3 0.2 1.3 0.5 0.9 1.2 0.4 0.6 0.8 0.6 1.0 0.4 1.3 0.8 0.9 2.6 0.5 0.7 0.7 0.5 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.2 0.0 3.0 1.4 0.0 0.1 0.1 9.4 0.4 0.0 0.0 0.0 0.0 5.9 0.1 1.7 0.4 1969.0 0.0 0.0 23.3 0.0 0.1 0.0 0.1 0.0 0.0 0.7 1.6 26.4 2.5 0.0 9027.4 49.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 37.4 0.0 14.7 6.5 0.0 51.2 19.7 0.0 0.0 0.0 0.0 0.0 GSG1L "KTSR5831, MGC18079, PRO19651" ENSG00000169181 "GSG1 like" Q6UXU4 16 27787535-28063509 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 14.6;heart muscle: 19.3" "Group enriched" "Detected in some" 8 "Bipolar cells: 1.4;Cardiomyocytes: 4.1;Club cells: 1.2;Early spermatids: 2.5;Horizontal cells: 1.6;Late spermatids: 1.8;Rod photoreceptor cells: 1.4;Spermatogonia: 1.2" "Cancer enriched" "Detected in some" 7 "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.7" "Group enriched" "Detected in some" 7 "HMC-1: 13.6;THP-1: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014479 Enhanced NA NA "HPA014479: AB_2247974" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (2.38e-1)" "unprognostic (7.06e-4)" "unprognostic (2.30e-1)" "unprognostic (1.10e-1)" "unprognostic (2.05e-2)" "unprognostic (6.68e-2)" "unprognostic (5.02e-2)" "unprognostic (1.25e-1)" "unprognostic (2.50e-1)" "unprognostic (6.66e-2)" "unprognostic (1.55e-1)" "unprognostic (3.13e-1)" "unprognostic (6.35e-2)" "unprognostic (9.77e-2)" 0.7 0.8 8.7 0.6 14.6 0.7 0.6 1.8 13.3 0.8 1.1 2.7 0.0 1.1 1.1 1.0 0.6 3.4 0.5 19.3 6.0 6.8 1.1 1.1 0.9 0.6 10.0 3.3 0.4 0.7 0.4 0.2 2.0 6.5 0.8 0.7 1.2 0.8 0.6 1.0 1.8 1.2 0.5 3.5 0.9 2.5 2.2 3.3 0.0 1.0 0.0 0.5 0.5 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.3 0.0 0.3 0.2 0.2 0.2 0.3 0.3 0.1 0.0 0.0 13.6 0.0 0.0 0.0 0.2 0.4 0.4 0.1 0.2 0.2 0.5 0.9 0.1 0.3 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.1 0.7 0.4 0.1 5.0 1.3 0.0 0.9 0.0 0.2 1.0 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 8.7 14.6 1.8 10.7 6.0 6.8 10.0 3.3 6.5 3.3 0.0 0.0 0.0 0.0 0.1 1.4 4.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 GSG1L2 ENSG00000214978 "GSG1 like 2" A8MUP6 17 9802386-9822071 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 36 "brain: 4.8;retina: 3.3;testis: 2.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 95 "renal cancer: 4.7" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.7;olfactory region: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 2.8" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 4.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 1.7 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GTF3C3 "TFIIIC102, TFiiiC2-102" ENSG00000119041 "General transcription factor IIIC subunit 3" Q9Y5Q9 2 196763032-196799725 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069179 Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA069179: AB_2686099" "unprognostic (1.44e-1)" "unprognostic (2.63e-2)" "unprognostic (1.89e-1)" "unprognostic (4.52e-2)" "unprognostic (5.88e-2)" "unprognostic (3.64e-2)" "prognostic unfavorable (1.26e-6)" "unprognostic (1.92e-1)" "unprognostic (9.28e-2)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (5.62e-2)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.72e-1)" "unprognostic (1.70e-1)" "unprognostic (3.08e-2)" 19.3 20.3 14.9 14.3 20.0 34.6 23.4 17.3 21.2 17.3 15.3 16.3 14.1 13.1 19.7 18.7 18.1 17.5 21.5 16.1 12.6 11.7 16.2 16.6 15.1 20.0 20.9 16.4 20.3 23.5 21.5 30.8 20.4 23.4 17.2 18.3 11.8 17.7 15.0 22.6 23.9 20.1 18.3 22.3 19.4 18.0 17.5 20.3 29.8 18.6 19.1 18.7 19.5 25.4 14.3 11.8 16.3 15.0 12.6 14.3 7.4 11.0 11.9 21.4 16.2 10.4 14.3 23.7 18.4 12.4 18.4 17.5 26.1 17.4 22.8 14.4 11.7 22.8 16.1 21.4 17.9 23.7 25.8 20.3 28.7 33.3 23.8 17.9 24.8 21.9 19.9 18.7 15.4 21.0 19.6 17.4 22.8 32.5 33.3 10.0 20.3 24.5 20.3 13.9 13.1 22.0 19.9 17.7 15.6 13.8 26.5 15.8 16.9 14.3 11.8 15.3 33.4 11.1 18.9 15.1 15.8 13.1 12.6 16.4 20.3 24.7 16.8 17.7 18.4 14.5 16.3 11.0 10.8 11.2 10.5 13.4 12.6 11.5 12.2 11.8 14.3 14.3 12.9 7.1 12.6 15.0 10.4 12.4 7.4 14.9 20.0 17.3 21.2 12.6 11.7 20.9 16.4 23.4 20.3 20.8 13.6 6.8 10.9 3.5 18.1 30.2 2.5 41.5 21.6 14.0 17.7 12.7 11.6 11.2 3.0 12.8 8.4 0.0 10.8 10.4 8.9 7.4 13.9 6.8 11.6 0.0 12.0 14.1 10.5 3.8 12.4 10.3 6.8 23.4 9.0 12.6 13.5 7.0 10.3 8.1 14.9 6.5 7.8 43.3 19.0 4.8 13.2 10.2 10.3 6.8 GUCA2A "GUCA2, STARA" ENSG00000197273 "Guanylate cyclase activator 2A" Q02747 1 42162691-42164718 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "intestine: 265.7" "Group enriched" "Detected in some" 16 "Enterocytes: 4125.7;Paneth cells: 4082.4" "Group enriched" "Detected in many" 7 "colorectal cancer: 31.6;urothelial cancer: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 34.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA018215 Enhanced "Secreted to blood" NA NA 26000000 "HPA018215: AB_1850443" "unprognostic (7.98e-3)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (9.07e-2)" "unprognostic (1.14e-1)" "unprognostic (8.06e-2)" "unprognostic (2.89e-1)" "unprognostic (3.10e-1)" "unprognostic (9.15e-2)" 0.2 0.1 0.2 8.0 0.2 0.0 0.2 0.2 0.2 0.2 87.3 0.2 0.2 6.6 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.7 0.0 0.2 3.5 0.2 0.2 91.9 0.2 0.2 0.2 0.2 0.1 265.7 2.1 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.1 0.0 4125.7 0.0 1.0 2.7 0.0 0.0 23.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 263.8 0.0 0.1 4082.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 76.4 0.1 GUCA2B ENSG00000044012 "Guanylate cyclase activator 2B" Q16661 1 42153421-42155824 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "intestine: 92.4" "Group enriched" "Detected in some" 27 "Enterocytes: 716.3;Paneth cells: 2864.6" "Cancer enhanced" "Detected in many" "liver cancer: 5.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "intermediate monocyte: 1.9" "Lineage enriched" "Detected in single" 19 "monocytes: 1.9" "Group enriched" "Detected in some" 6 "A549: 3.3;CACO-2: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 740000 "unprognostic (2.59e-2)" "unprognostic (1.44e-2)" "unprognostic (1.34e-1)" "unprognostic (6.22e-2)" "unprognostic (1.86e-1)" 0.1 0.0 0.1 1.2 0.1 0.0 0.1 0.1 0.1 0.1 55.2 0.1 0.1 13.5 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.0 0.1 2.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 8.7 0.1 0.1 0.1 0.1 0.0 92.4 0.1 0.1 0.2 5.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 9.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 716.3 0.0 43.1 0.1 0.0 0.0 23.0 2.6 0.1 0.0 21.9 0.6 0.0 1.1 0.0 0.0 0.0 0.0 67.1 0.0 3.8 2864.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 33.2 0.0 GUCY2C "GUC2C, STAR" ENSG00000070019 "Guanylate cyclase 2C" P25092 12 14612632-14696585 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters" "cGMP biosynthesis" "Lyase, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "intestine: 85.1" "Cell type enhanced" "Detected in some" 21 "Enterocytes: 37.2;Intestinal endocrine cells: 169.6;Mucus-secreting cells: 61.9;Paneth cells: 99.3;Undifferentiated cells: 41.2" "Group enriched" "Detected in many" 5 "colorectal cancer: 23.9;stomach cancer: 9.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 3.7;BEWO: 2.2;CACO-2: 3.2;CAPAN-2: 4.6;SiHa: 4.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037655, HPA073759" Uncertain Uncertain Vesicles NA NA Vesicles "HPA037655: AB_10672388, HPA073759: " "unprognostic (1.08e-1)" "unprognostic (2.12e-1)" "unprognostic (3.58e-2)" "unprognostic (2.11e-2)" "unprognostic (1.60e-2)" "unprognostic (5.67e-3)" "prognostic unfavorable (1.37e-5)" "unprognostic (9.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (1.58e-1)" "unprognostic (5.40e-2)" "unprognostic (2.35e-4)" "unprognostic (8.02e-2)" "unprognostic (1.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.98e-1)" 0.2 0.1 0.2 3.4 0.2 0.0 0.2 0.2 0.2 0.2 38.8 0.2 0.2 28.0 0.3 0.2 0.4 0.2 0.3 0.4 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.2 17.5 0.2 0.5 0.2 0.2 1.0 85.1 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 4.3 0.7 2.7 1.7 0.0 0.0 0.6 1.1 0.1 0.0 3.7 0.0 0.0 2.2 0.2 0.0 0.0 0.0 3.2 4.6 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.6 4.2 0.3 0.0 1.1 0.4 0.1 0.0 0.0 0.0 0.9 0.1 1.3 0.8 1.3 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.5 0.0 4.3 0.0 0.0 0.7 2.3 0.0 0.0 2.7 0.0 0.0 0.7 0.0 0.6 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 1.5 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.3 99.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 41.2 0.0 GUCY2D "CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, retGC, RETGC-1, ROS-GC1" ENSG00000132518 "Guanylate cyclase 2D, retinal" Q02846 17 8002594-8020339 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "cGMP biosynthesis, Sensory transduction, Vision" Lyase "Cone-rod dystrophy, Congenital stationary night blindness, Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 10.6;retina: 33.3" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 55.6" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 31 "plasmacytoid DC: 10.6" "Lineage enriched" "Detected in single" 53 "dendritic cells: 10.6" "Cell line enriched" "Detected in some" 4 "JURKAT: 11.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (3.57e-4)" "unprognostic (5.05e-1)" "unprognostic (1.49e-1)" "unprognostic (9.75e-5)" "unprognostic (5.94e-2)" "unprognostic (1.86e-1)" "unprognostic (4.44e-2)" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (2.26e-1)" "unprognostic (7.54e-2)" "unprognostic (4.44e-1)" "unprognostic (7.59e-5)" "unprognostic (1.05e-1)" "unprognostic (3.46e-1)" "unprognostic (3.08e-1)" "unprognostic (1.07e-1)" 0.1 0.0 0.1 0.3 0.1 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.5 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 1.3 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.4 0.0 33.3 0.4 0.1 0.1 0.4 0.1 0.1 0.1 0.6 0.1 5.0 0.1 0.2 0.1 0.1 0.9 0.1 0.2 0.0 10.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.1 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.3 0.1 0.1 0.1 0.0 0.0 0.0 1.2 0.3 2.4 1.6 0.0 0.0 0.0 0.0 58.9 1.2 1.7 0.1 6.8 0.0 0.0 0.0 0.0 0.5 0.0 1.5 0.0 0.8 1.1 0.0 0.0 0.0 0.3 11.0 0.0 0.0 0.0 1.0 0.0 2.5 0.2 0.0 0.4 0.5 55.6 0.0 0.0 0.2 0.0 0.3 1.8 0.0 0.0 0.4 GUCY2F "CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2" ENSG00000101890 "Guanylate cyclase 2F, retinal" P51841 X 109372906-109482072 "Enzymes, Plasma proteins, Predicted membrane proteins" "cGMP biosynthesis, Sensory transduction, Vision" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "retina: 23.1" "Cell type enriched" "Detected in some" 33 "Rod photoreceptor cells: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "THP-1: 4.5;U-266/70: 1.6;U-937: 1.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 0.4" NA NA "unprognostic (1.91e-1)" "unprognostic (4.45e-2)" "unprognostic (2.96e-1)" "unprognostic (2.23e-1)" 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.1 0.0 1.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GULP1 "CED-6, CED6, GULP" ENSG00000144366 "GULP, engulfment adaptor PTB domain containing 1" Q9UBP9 2 188291669-188595931 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid transport, Phagocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 86.0" "Cell type enhanced" "Detected in many" 7 "Intestinal endocrine cells: 131.2;Muller glia cells: 100.6;Syncytiotrophoblasts: 170.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 32.7;WM-115: 71.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020587 Enhanced Approved Vesicles NA NA Vesicles "HPA020587: AB_1850452" "unprognostic (1.95e-1)" "unprognostic (3.32e-1)" "unprognostic (3.80e-2)" "unprognostic (5.19e-2)" "unprognostic (2.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.06e-1)" "unprognostic (9.28e-2)" "unprognostic (8.25e-3)" "unprognostic (2.23e-1)" "prognostic favorable (4.25e-6)" "prognostic unfavorable (6.17e-4)" "unprognostic (1.29e-1)" "unprognostic (7.33e-2)" "unprognostic (3.04e-4)" 8.0 15.0 3.1 7.6 9.8 0.0 9.7 0.7 8.0 22.6 11.8 2.2 14.4 6.5 23.3 40.6 11.5 10.4 8.9 5.1 2.5 4.8 11.4 1.0 9.0 1.2 2.4 4.5 17.9 32.3 23.9 3.7 86.0 14.3 14.3 3.8 19.4 10.7 16.1 5.9 5.0 10.5 15.1 2.8 3.2 11.9 17.0 2.2 0.3 8.0 6.1 3.1 11.3 20.2 0.6 0.4 1.5 1.9 0.6 0.2 0.3 3.8 9.4 32.7 7.3 5.1 5.0 6.1 5.3 9.0 8.7 7.0 5.9 18.9 0.0 4.0 4.2 8.4 2.5 6.5 0.4 6.3 0.0 4.3 8.0 7.1 0.0 4.7 0.0 0.0 3.0 1.2 4.1 4.4 13.3 4.0 0.0 6.7 0.1 5.9 0.5 0.0 0.1 8.3 5.5 14.6 0.0 7.7 3.8 17.3 1.6 0.1 24.6 0.0 4.4 11.3 14.7 1.5 0.0 1.9 2.6 1.2 8.8 2.9 0.0 0.0 0.0 1.4 0.0 71.2 1.3 1.9 0.4 0.2 1.1 0.1 0.3 0.1 0.1 0.4 0.6 0.2 0.2 1.5 0.6 0.7 0.2 0.1 0.3 3.1 9.8 0.7 8.0 2.5 4.8 2.4 4.5 14.3 2.2 14.9 12.0 0.8 22.6 14.0 1.2 1.2 50.9 49.5 37.5 22.7 0.0 32.9 38.1 25.9 3.4 21.5 13.4 0.0 33.1 5.1 35.1 61.3 0.0 0.2 2.8 1.6 131.2 5.5 0.6 4.7 19.0 3.6 33.7 1.8 2.0 100.6 43.4 5.8 57.7 30.0 1.5 6.5 40.6 35.4 22.8 24.1 170.9 0.0 0.8 15.0 GUSB ENSG00000169919 "Glucuronidase beta" P08236 7 65960684-65982314 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Cancer-related genes, Disease mutation, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 56.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036322, HPA036323" Approved Supported Vesicles "Intracellular and membrane" NA NA 48000 Vesicles "HPA036322: AB_10670796, HPA036323: AB_2675059" "unprognostic (1.54e-2)" "unprognostic (6.49e-2)" "unprognostic (1.18e-2)" "unprognostic (3.50e-1)" "unprognostic (2.58e-2)" "unprognostic (4.46e-2)" "unprognostic (2.89e-1)" "unprognostic (1.56e-3)" "unprognostic (1.32e-1)" "unprognostic (2.32e-1)" "unprognostic (7.00e-3)" "unprognostic (1.91e-1)" "unprognostic (3.34e-2)" "unprognostic (8.83e-3)" "unprognostic (1.98e-1)" "unprognostic (5.06e-1)" "unprognostic (1.45e-1)" 23.5 12.0 3.7 7.9 5.5 20.7 25.4 5.7 4.4 10.4 14.6 7.7 22.0 10.0 10.4 12.2 9.3 7.6 11.1 8.0 3.7 2.9 11.8 50.4 15.3 12.3 6.3 3.1 8.6 17.1 9.0 7.3 30.0 4.5 12.1 11.4 9.9 17.2 11.8 5.9 10.0 16.1 8.3 3.9 17.5 11.0 7.9 5.8 14.7 17.7 5.9 13.0 9.2 7.4 9.7 27.7 22.1 36.0 15.2 11.5 15.8 17.0 6.6 6.5 14.5 22.1 13.2 9.4 5.4 15.1 11.9 11.0 9.5 17.6 7.8 8.5 6.9 6.2 6.9 4.2 6.5 7.1 7.3 8.5 10.6 10.0 6.4 10.8 22.7 17.7 9.1 7.0 6.9 9.0 14.2 10.4 4.5 16.1 56.5 7.7 12.4 8.3 24.4 4.3 26.0 5.5 8.6 15.0 44.2 7.5 10.3 9.5 8.4 14.5 33.9 18.9 7.6 18.9 22.6 7.3 14.6 13.2 5.5 13.5 32.1 38.5 13.1 10.9 30.2 17.7 7.4 28.1 22.1 11.5 36.0 10.3 9.7 9.0 10.2 27.7 7.8 6.2 7.3 4.5 15.2 30.0 11.3 11.3 15.8 3.7 5.5 5.7 4.4 3.7 2.9 6.3 3.1 4.5 5.8 47.6 56.2 18.6 26.4 16.0 13.7 8.3 25.5 48.2 37.5 27.9 7.9 72.3 5.0 32.4 47.6 31.3 41.1 23.3 26.7 48.8 48.3 25.5 35.8 64.7 114.3 15.9 41.2 39.9 74.2 36.8 40.0 72.1 37.1 43.3 42.3 27.3 25.9 48.9 26.9 19.2 17.7 25.8 22.6 41.3 28.8 12.9 56.0 34.6 40.6 25.3 GXYLT1 "FLJ43151, GLT8D3" ENSG00000151233 "Glucoside xylosyltransferase 1" Q4G148 12 42081845-42144879 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 3000000 "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (1.53e-1)" "unprognostic (5.07e-1)" "unprognostic (1.22e-1)" "unprognostic (9.89e-2)" "unprognostic (5.22e-3)" "unprognostic (1.77e-2)" "unprognostic (4.42e-3)" "unprognostic (1.46e-2)" "unprognostic (1.64e-2)" "unprognostic (3.20e-1)" "unprognostic (1.92e-2)" "unprognostic (8.16e-2)" "unprognostic (2.93e-1)" "unprognostic (3.96e-2)" "prognostic favorable (3.91e-4)" 9.1 7.6 9.7 8.3 10.9 9.4 8.6 12.5 8.9 8.7 5.9 9.7 5.2 5.9 8.6 5.8 7.7 7.9 6.1 6.4 8.1 6.2 9.7 18.4 8.8 7.0 8.7 4.4 10.4 7.9 11.2 25.6 16.0 11.5 7.5 7.4 9.0 8.6 8.2 5.5 6.3 8.1 5.5 7.4 9.2 6.7 13.4 7.8 6.0 13.2 2.8 9.0 7.6 7.8 1.4 2.7 4.9 4.0 2.4 2.0 0.9 6.6 5.7 6.5 6.4 4.7 12.3 24.6 15.0 10.1 11.2 11.4 13.1 13.7 5.8 11.8 8.2 8.0 3.1 10.9 4.8 20.8 9.6 12.4 9.6 4.7 10.6 7.4 10.3 9.1 9.4 4.2 17.0 7.6 6.7 14.7 6.7 6.0 10.3 14.2 4.6 6.6 6.3 7.9 2.5 5.4 3.1 13.2 5.1 6.8 10.0 3.4 5.7 10.7 6.1 8.8 12.8 12.5 8.1 12.6 8.0 27.3 4.6 9.4 13.6 15.3 7.4 10.8 28.1 4.9 0.3 1.8 4.9 1.2 3.6 0.8 1.1 1.9 1.6 2.7 1.4 1.7 1.5 1.4 2.4 4.0 0.9 2.0 0.9 9.7 10.9 12.5 8.9 8.1 6.2 8.7 4.4 11.5 7.8 14.9 12.9 15.7 9.7 2.9 8.7 6.7 2.5 10.7 9.1 33.2 7.9 33.2 1.7 8.5 1.0 15.5 9.2 0.0 9.1 33.4 15.5 12.9 19.5 27.6 12.2 14.3 2.9 21.5 15.8 2.8 10.9 9.8 5.0 15.4 8.4 10.8 7.5 10.5 7.1 3.6 14.6 12.9 6.4 25.6 29.1 3.9 38.1 20.3 8.6 10.3 GXYLT2 GLT8D4 ENSG00000172986 "Glucoside xylosyltransferase 2" A0PJZ3 3 72888073-72998138 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 37.7;Fibroblasts: 14.2;Late spermatids: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 14.6;JURKAT: 14.1;MOLT-4: 22.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA068429 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Midbody ring" Yes No Nucleoplasm "Cytokinetic bridge, Midbody ring" "HPA068429: AB_2685988" "unprognostic (9.43e-2)" "unprognostic (8.87e-3)" "unprognostic (1.90e-1)" "unprognostic (4.77e-2)" "unprognostic (3.33e-2)" "unprognostic (7.04e-2)" "unprognostic (4.79e-3)" "unprognostic (5.29e-2)" "unprognostic (5.25e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (1.46e-7)" "unprognostic (3.22e-3)" "unprognostic (4.70e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (2.42e-5)" 8.7 7.2 3.1 6.2 4.0 2.1 5.2 1.1 4.0 10.2 4.5 8.1 3.4 0.9 8.4 9.3 4.2 6.7 12.4 20.6 3.4 2.4 2.2 1.0 5.2 2.4 5.6 4.7 24.8 11.9 2.8 3.8 4.9 4.2 11.3 2.7 10.7 8.0 5.2 2.2 2.6 2.5 12.0 5.4 1.0 2.6 8.4 4.7 14.9 12.1 3.7 2.3 12.2 6.9 0.4 3.0 1.7 0.1 0.8 1.4 0.1 0.1 1.1 0.0 7.2 6.6 13.0 1.1 1.1 2.7 2.6 6.4 0.3 0.8 0.0 2.0 3.0 14.6 0.1 0.7 1.4 2.5 0.0 0.8 0.0 4.8 7.7 8.4 3.0 0.0 12.5 0.7 6.3 1.0 3.9 0.0 14.1 3.5 0.1 1.5 1.6 22.3 0.1 4.3 0.1 1.4 0.1 6.1 0.0 0.8 1.1 0.7 3.3 6.2 0.3 0.8 1.4 2.4 0.9 0.0 2.8 9.0 8.7 4.1 0.6 0.1 0.1 7.3 1.4 4.9 0.4 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.4 0.2 0.2 1.7 0.8 0.1 3.0 1.4 0.1 3.1 4.0 1.1 4.0 3.4 2.4 5.6 4.7 4.2 4.7 3.0 1.6 0.0 1.5 1.6 0.6 9.8 2.5 1.4 1.2 0.0 0.0 0.1 0.0 0.0 37.7 0.0 0.9 0.0 1.0 0.2 14.2 1.3 0.0 0.0 0.3 0.0 3.4 1.3 0.0 17.8 7.5 0.3 0.0 0.0 2.3 2.5 1.2 0.0 6.7 0.4 0.4 0.0 1.0 2.9 3.2 0.4 0.7 0.0 1.5 0.4 GYPA "CD235a, GPA, MN, MNS" ENSG00000170180 "Glycophorin A (MNS blood group)" P02724 4 144109303-144140786 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Host-virus interaction" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 56.9" "Cell type enriched" "Detected in some" 311 "Erythroid cells: 1331.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "HEL: 57.0" "CAB002658, HPA014811" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB002658: , HPA014811: AB_1849827" "unprognostic (1.60e-1)" "unprognostic (2.47e-2)" 0.1 0.0 0.2 0.1 0.4 56.9 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 1.7 1.3 3.2 0.1 0.3 0.1 0.1 0.1 0.0 0.3 4.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.5 0.3 0.4 0.2 0.2 0.6 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.2 0.9 0.1 0.2 0.2 1.5 0.2 0.6 0.2 0.2 0.2 0.3 0.0 0.8 0.2 0.4 0.1 0.5 0.2 0.3 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.3 0.0 0.0 1331.6 0.0 1.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GYPB "CD235b, GPB, MNS, SS" ENSG00000250361 "Glycophorin B (MNS blood group)" P06028 4 143996104-144019345 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 37.1" "Cell type enriched" "Detected in some" 591 "Erythroid cells: 981.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HEL: 61.4" "Intracellular and membrane" NA NA 0.2 0.0 0.2 0.1 0.1 37.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.8 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.2 3.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.2 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 981.2 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GYPC "CD236, CD236R, Ge, GPC, GYPD" ENSG00000136732 "Glycophorin C (Gerbich blood group)" P04921 2 126655933-126696670 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 18 "Erythroid cells: 1448.3;Hofbauer cells: 391.9" "Cancer enhanced" "Detected in all" "melanoma: 66.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 62.6;K-562: 46.5;SK-MEL-30: 91.9;U-266/70: 51.9" "Low region specificity" "Detected in all" "HPA008965, CAB009445" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB009445: AB_2116251, HPA008965: AB_1078455" "unprognostic (1.63e-2)" "unprognostic (7.14e-3)" "unprognostic (8.39e-2)" "unprognostic (3.31e-3)" "unprognostic (4.19e-2)" "unprognostic (1.69e-2)" "unprognostic (8.82e-2)" "unprognostic (3.52e-1)" "unprognostic (1.19e-1)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (1.11e-1)" "unprognostic (2.05e-2)" "unprognostic (2.73e-2)" "unprognostic (1.51e-1)" "unprognostic (2.29e-1)" "unprognostic (8.00e-3)" 44.5 21.7 3.9 34.5 5.3 95.0 99.8 1.3 4.3 20.7 24.8 5.9 9.8 5.0 20.3 26.0 22.9 18.5 21.4 61.2 4.4 3.4 15.2 6.3 29.5 75.8 8.0 3.7 37.4 18.7 1.7 5.5 17.5 5.6 24.5 5.5 13.8 13.0 15.5 48.9 11.3 15.2 34.8 8.3 41.1 13.5 13.4 4.6 28.5 11.6 29.9 22.5 37.1 38.8 21.2 9.9 4.2 7.7 14.7 41.4 21.8 0.1 0.0 22.5 0.0 16.7 14.6 0.0 3.3 26.0 4.0 12.1 0.0 0.0 0.0 0.0 9.4 15.6 0.0 12.2 0.0 1.3 10.7 0.0 37.8 0.0 0.0 62.6 13.2 0.1 32.9 0.0 3.2 0.0 0.3 0.1 26.2 46.5 31.3 9.8 0.0 0.0 20.9 6.7 0.0 0.0 2.4 1.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 91.9 3.0 0.0 35.9 9.0 15.4 0.1 1.0 0.1 51.9 33.6 0.0 7.5 19.1 13.9 0.1 5.9 0.4 32.3 7.7 36.4 18.9 29.3 39.1 9.9 21.2 41.4 40.4 4.2 14.7 4.7 5.5 35.1 21.8 3.9 5.3 1.3 4.3 4.4 3.4 8.0 3.7 5.6 4.6 6.0 11.4 163.5 2.9 33.8 0.7 31.5 68.8 2.7 5.7 14.0 2.0 4.8 114.4 182.3 1.2 74.4 0.0 1448.3 4.2 6.4 148.3 3.8 23.0 3.4 391.9 0.0 0.0 252.3 99.7 1.5 80.8 80.7 290.1 117.2 0.0 4.9 8.0 0.0 65.0 3.9 2.3 58.2 117.4 0.3 0.8 23.2 7.6 235.7 0.0 0.9 GYPE "GPE, MNS" ENSG00000197465 "Glycophorin E (MNS blood group)" P15421 4 143870867-143905563 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 14.5;lymphoid tissue: 6.9" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 70.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.5" "Group enriched" "Detected in many" 12 "B-cells: 3.5;NK-cells: 2.1;T-cells: 1.3" "Group enriched" "Detected in some" 11 "HEL: 50.9;K-562: 16.4" NA NA "unprognostic (2.17e-1)" "unprognostic (6.03e-2)" "unprognostic (2.66e-1)" "unprognostic (1.00e-2)" "unprognostic (4.71e-2)" "unprognostic (1.09e-4)" "unprognostic (2.05e-2)" "unprognostic (1.29e-1)" "unprognostic (6.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.53e-2)" "unprognostic (2.81e-3)" "unprognostic (1.10e-4)" "unprognostic (7.81e-3)" "unprognostic (1.76e-1)" "unprognostic (2.97e-1)" "unprognostic (3.49e-2)" 2.7 0.2 1.2 1.5 0.5 14.5 1.2 0.5 1.2 0.9 0.5 0.5 0.5 0.0 0.5 0.8 0.5 0.1 0.7 2.6 1.1 0.3 0.7 0.5 3.7 1.0 0.5 0.5 1.5 0.5 0.0 0.5 5.7 1.1 0.5 0.4 0.5 0.5 0.6 0.5 0.5 1.7 0.5 0.7 6.9 0.4 0.8 0.5 1.5 1.4 0.5 3.1 0.9 0.5 3.5 0.1 0.0 0.0 2.1 1.3 0.0 0.0 0.0 0.0 0.0 3.0 3.0 0.0 1.2 2.7 0.6 0.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 50.9 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.5 0.0 0.0 0.0 1.1 0.8 0.6 0.0 2.1 0.0 0.1 0.0 0.0 1.2 0.5 0.5 1.2 1.1 0.3 0.5 0.5 1.1 0.5 14.9 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 70.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.1 0.0 0.0 0.0 GZMK "PRSS, TRYP2" ENSG00000113088 "Granzyme K" P49863 5 55024253-55034570 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 95.8;lymphoid tissue: 37.3" "Cell type enriched" "Detected in some" 11 "T-cells: 137.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "MAIT T-cell: 95.8;memory CD8 T-cell: 59.0" "Group enriched" "Detected in many" 191 "NK-cells: 56.9;T-cells: 95.8" "Cell line enriched" "Detected in single" 10 "JURKAT: 5.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA063181, HPA065895" Enhanced "Secreted to blood" NA NA "HPA063181: AB_2684955, HPA065895: " "prognostic favorable (8.68e-4)" "unprognostic (3.26e-3)" "unprognostic (2.23e-2)" "unprognostic (1.83e-3)" "unprognostic (2.61e-2)" "unprognostic (1.12e-3)" "unprognostic (1.03e-3)" "unprognostic (8.13e-3)" "unprognostic (3.50e-2)" "unprognostic (4.53e-2)" "unprognostic (9.74e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (2.04e-1)" "unprognostic (2.42e-1)" "unprognostic (1.21e-2)" "unprognostic (1.00e-1)" 3.5 1.6 0.6 10.5 0.6 3.6 3.1 0.5 0.5 4.1 3.7 0.2 1.7 0.4 3.2 2.6 2.8 1.8 7.4 1.6 0.6 0.7 4.3 4.1 10.2 37.3 0.7 0.2 2.1 1.5 0.0 1.0 0.9 0.5 6.6 1.9 2.9 5.7 2.1 0.8 0.8 7.4 0.8 1.6 36.4 2.4 2.1 0.3 3.3 3.1 2.7 28.2 4.9 2.6 0.0 0.1 0.4 0.1 56.9 95.8 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 21.1 0.1 95.8 0.0 13.2 59.0 0.0 0.0 0.6 10.5 0.4 56.9 0.1 0.1 0.8 9.9 0.6 0.6 0.5 0.5 0.6 0.7 0.7 0.2 0.5 0.3 3.0 12.4 0.0 0.0 1.3 0.0 0.0 5.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.3 1.0 0.2 0.0 0.0 8.0 8.7 0.2 0.0 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.5 0.2 137.0 0.0 0.0 GZMM "LMET1, MET1" ENSG00000197540 "Granzyme M" P51124 19 544034-549924 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cytolysis, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 79.2;lymphoid tissue: 28.6" "Cell type enriched" "Detected in some" 8 "T-cells: 184.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "gdT-cell: 79.2" "Group enriched" "Detected in many" 31 "NK-cells: 22.7;T-cells: 79.2" "Cell line enhanced" "Detected in some" "EFO-21: 4.6;HDLM-2: 3.7;HMC-1: 4.6;JURKAT: 7.5;MOLT-4: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA015624 Enhanced "Secreted to blood" NA NA "HPA015624: AB_2669245" "unprognostic (2.97e-3)" "unprognostic (2.29e-3)" "unprognostic (7.53e-2)" "prognostic favorable (1.89e-4)" "unprognostic (1.07e-1)" "prognostic favorable (1.87e-7)" "unprognostic (2.35e-1)" "unprognostic (7.46e-2)" "unprognostic (1.67e-1)" "unprognostic (4.98e-2)" "unprognostic (4.53e-2)" "unprognostic (7.94e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.32e-1)" "unprognostic (9.51e-2)" "unprognostic (2.69e-3)" "unprognostic (9.94e-2)" 1.8 1.0 0.7 13.6 0.9 15.6 1.0 4.3 1.4 1.0 3.5 0.2 0.1 1.8 1.0 2.9 2.0 1.1 4.7 1.6 0.7 0.6 1.1 2.6 4.8 15.1 0.7 0.4 0.8 0.4 0.0 0.9 1.6 0.5 1.7 0.1 1.5 12.0 0.3 0.8 0.7 5.1 0.5 1.1 21.1 3.0 1.5 0.4 28.6 1.4 1.1 10.9 1.1 1.2 0.4 0.4 1.6 0.2 22.7 79.2 27.0 0.1 0.6 0.1 0.3 0.2 0.0 0.6 0.0 0.1 0.1 0.0 0.5 0.2 0.1 4.6 0.0 0.1 0.1 0.0 0.0 0.0 3.7 0.4 0.0 0.6 0.2 0.5 0.4 4.6 0.2 0.0 0.1 0.0 0.0 0.1 7.5 1.4 0.3 0.0 1.0 3.0 1.3 0.8 0.2 0.7 0.3 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.7 0.8 0.0 0.9 0.3 1.0 0.3 0.7 0.3 0.8 0.1 0.1 79.2 0.2 49.8 0.1 26.4 63.6 0.1 0.4 25.8 53.1 1.6 22.7 0.2 0.4 12.2 27.0 0.7 0.9 4.3 1.4 0.7 0.6 0.7 0.4 0.5 0.4 0.0 0.0 0.8 0.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.4 0.0 23.3 0.3 0.3 1.9 0.0 0.0 0.8 0.2 0.0 0.0 2.5 2.8 0.8 0.0 1.6 1.7 0.0 0.1 1.5 0.2 0.0 0.0 0.7 1.4 0.0 0.2 0.1 0.7 1.3 0.5 184.9 0.0 0.1 HACD1 "CAP, PTPLA" ENSG00000165996 "3-hydroxyacyl-CoA dehydratase 1" B0YJ81 10 17589032-17617377 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Developmental protein, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 80.1" "Cell type enhanced" "Detected in many" 16 "Cardiomyocytes: 116.4;Collecting duct cells: 29.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "T-reg: 27.6" "Lineage enriched" "Detected in many" 16 "T-cells: 27.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.73e-2)" "unprognostic (3.26e-2)" "unprognostic (3.54e-1)" "unprognostic (2.62e-2)" "unprognostic (4.10e-1)" "unprognostic (5.67e-3)" "unprognostic (4.21e-2)" "unprognostic (3.04e-2)" "unprognostic (2.38e-1)" "unprognostic (1.70e-2)" "unprognostic (2.61e-2)" "unprognostic (3.43e-1)" "unprognostic (2.46e-2)" "unprognostic (2.93e-2)" "unprognostic (3.40e-2)" "unprognostic (1.10e-1)" "unprognostic (6.49e-2)" 6.6 4.7 2.1 3.8 3.9 5.4 12.6 3.4 3.1 5.1 17.6 3.9 7.4 2.3 13.1 6.0 12.6 6.5 4.8 80.1 2.4 3.7 3.6 1.1 7.9 1.1 5.1 1.8 3.9 2.5 0.6 2.4 1.5 3.8 8.8 3.3 9.4 2.1 13.2 22.8 2.5 4.2 21.5 4.8 1.5 9.4 3.0 3.4 2.6 5.9 6.2 1.2 12.6 9.8 0.6 1.6 1.7 0.5 1.6 27.6 0.7 10.8 9.3 2.6 12.8 11.9 2.3 0.2 15.4 9.3 20.2 19.1 6.2 13.2 0.1 2.3 25.0 29.1 2.7 6.6 4.7 11.2 7.1 3.9 25.0 6.7 16.9 15.5 0.1 1.9 5.5 6.6 11.6 4.5 15.6 3.9 13.4 0.2 0.5 26.5 7.8 18.4 2.5 5.6 0.8 2.5 16.6 2.7 0.3 7.9 2.1 2.9 7.5 13.1 0.2 21.6 8.6 9.3 6.2 3.7 11.9 6.9 7.2 7.0 0.4 0.3 0.1 8.7 2.8 1.6 1.7 0.5 0.4 0.6 0.1 0.1 0.2 2.8 0.5 1.6 0.6 0.5 0.4 1.6 1.6 0.1 0.8 27.6 0.7 2.1 3.9 3.4 2.8 2.4 3.7 5.1 1.8 3.8 3.4 26.8 12.9 0.0 16.5 0.0 0.6 116.4 2.5 1.4 4.5 29.6 0.0 0.5 3.3 13.0 8.3 4.8 0.0 0.0 6.9 1.6 2.3 12.0 5.8 0.8 5.0 0.0 3.5 11.6 3.5 1.6 1.7 2.4 0.0 1.0 2.3 0.2 18.1 0.0 0.7 2.0 0.5 0.0 25.7 5.5 5.1 0.0 2.5 0.0 3.8 5.5 HACD2 PTPLB ENSG00000206527 "3-hydroxyacyl-CoA dehydratase 2" Q6Y1H2 3 123490820-123585185 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SiHa: 65.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB019282 Approved NA NA "CAB019282: " "unprognostic (3.04e-2)" "unprognostic (2.51e-1)" "unprognostic (6.11e-2)" "unprognostic (2.65e-3)" "unprognostic (5.36e-2)" "unprognostic (6.04e-2)" "unprognostic (1.32e-2)" "unprognostic (1.95e-2)" "unprognostic (1.96e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.59e-5)" "unprognostic (6.90e-2)" "unprognostic (7.03e-3)" "unprognostic (1.48e-1)" "unprognostic (3.85e-2)" "unprognostic (1.94e-2)" "unprognostic (2.59e-2)" 43.2 9.7 18.0 11.2 30.0 5.7 16.6 20.5 18.7 14.1 20.4 28.6 7.4 21.2 12.4 13.5 18.8 9.9 12.2 9.9 20.7 13.4 20.7 34.3 13.8 14.1 29.4 12.0 13.8 13.4 15.6 12.5 11.1 18.5 22.1 20.4 7.3 15.5 10.2 5.6 23.2 30.8 12.3 24.9 9.6 15.3 13.3 25.7 9.1 16.0 10.5 19.7 10.9 16.6 4.9 6.4 2.4 3.5 2.9 5.3 2.4 19.6 11.2 7.7 5.6 24.2 5.4 28.7 14.1 5.9 14.7 10.7 22.8 17.5 11.4 10.2 13.5 17.1 43.2 13.8 17.7 15.6 7.2 4.6 7.9 10.5 17.7 7.9 10.5 7.9 7.5 45.7 7.1 20.0 23.1 7.6 7.9 1.6 11.4 8.8 15.3 4.9 3.1 9.9 24.0 9.9 7.6 8.5 12.1 17.8 12.7 13.6 4.2 65.7 14.1 9.0 11.7 14.6 5.4 5.9 15.4 11.6 15.4 13.7 6.8 8.6 9.4 6.9 7.4 8.2 1.5 3.5 2.4 3.6 2.8 5.3 3.4 4.8 4.6 6.4 4.9 4.4 4.3 1.1 2.9 2.2 3.7 5.3 2.4 18.0 30.0 20.5 18.7 20.7 13.4 29.4 12.0 18.5 25.7 6.0 35.5 13.7 26.4 0.0 8.3 12.6 15.3 5.3 28.4 43.6 5.9 20.9 6.6 13.4 12.7 13.7 18.6 0.0 16.5 13.3 10.4 36.8 3.5 42.9 20.1 1.6 15.2 14.7 20.2 7.3 10.6 17.1 0.0 16.2 21.7 13.5 16.4 21.0 16.6 13.9 12.9 6.5 8.8 8.1 20.5 0.0 5.6 11.7 24.7 26.3 HACD3 "B-ind1, HSPC121, PTPLAD1" ENSG00000074696 "3-hydroxyacyl-CoA dehydratase 3" Q9P035 15 65530418-65578352 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014837, HPA060347" Enhanced Enhanced "Endoplasmic reticulum" NA NA 27000 "Endoplasmic reticulum" "HPA014837: AB_1855914, HPA060347: AB_2684260" "unprognostic (1.51e-2)" "unprognostic (2.89e-1)" "unprognostic (2.29e-1)" "unprognostic (2.18e-1)" "unprognostic (3.52e-1)" "unprognostic (1.92e-2)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" "unprognostic (3.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.57e-1)" "prognostic favorable (3.09e-5)" "unprognostic (3.44e-2)" "unprognostic (5.33e-2)" "unprognostic (1.10e-2)" "unprognostic (2.04e-2)" 9.6 37.4 31.0 7.4 36.0 6.2 33.3 28.6 37.6 18.5 12.5 24.2 10.1 12.2 13.1 19.4 8.4 14.3 14.7 5.9 29.2 44.8 35.0 50.0 12.7 7.2 36.5 26.0 21.7 12.6 22.5 33.9 15.9 45.9 18.5 15.1 17.9 11.6 15.8 3.3 11.7 12.0 12.2 41.5 8.5 29.0 13.9 19.7 8.9 30.7 5.6 8.3 18.8 10.4 13.0 9.0 2.7 6.1 11.7 19.9 11.2 19.4 43.6 48.5 24.2 30.6 18.5 23.0 21.6 18.7 24.6 27.8 33.4 29.2 24.5 18.9 23.4 30.7 53.9 78.2 18.0 22.1 13.6 43.6 19.5 21.9 36.4 15.5 24.1 15.0 18.9 13.5 16.8 12.2 23.8 23.9 14.7 25.5 9.3 39.6 23.2 17.8 18.8 41.3 52.2 14.8 20.2 41.1 27.6 35.1 33.9 29.3 25.9 23.3 26.3 24.4 47.7 26.7 12.8 18.9 31.3 27.6 15.3 29.9 18.2 54.0 34.6 20.9 23.6 18.7 2.7 3.9 1.2 17.6 5.8 19.9 13.0 16.1 16.6 6.8 13.0 18.9 18.5 0.4 11.7 6.1 9.0 12.4 11.2 31.0 36.0 28.6 34.1 29.2 44.8 36.5 26.0 45.9 19.7 59.6 49.7 22.9 50.2 0.0 116.3 6.4 61.1 66.9 51.2 167.5 94.2 155.3 21.6 61.1 83.6 35.9 7.7 46.7 39.9 101.8 47.3 63.7 15.1 153.2 44.7 131.9 42.1 42.4 18.0 21.8 80.8 16.2 0.0 3.6 25.8 78.8 35.8 14.0 83.1 44.0 65.7 77.6 27.2 123.2 116.2 0.0 94.6 13.1 52.6 77.6 HACD4 "Em:AL662879.1, PTPLAD2" ENSG00000188921 "3-hydroxyacyl-CoA dehydratase 4" Q5VWC8 9 20999515-21031636 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 44.7;Ciliated cells: 89.7;Hofbauer cells: 50.9;Kupffer cells: 90.6;Macrophages: 52.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 15.8;HDLM-2: 9.6;TIME: 7.9;U-937: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058666 Uncertain NA NA "HPA058666: AB_2683793" "unprognostic (1.71e-1)" "unprognostic (2.58e-2)" "unprognostic (5.47e-2)" "unprognostic (1.70e-2)" "unprognostic (7.66e-2)" "unprognostic (1.87e-2)" "unprognostic (2.21e-1)" "unprognostic (1.28e-2)" "unprognostic (1.11e-4)" "prognostic favorable (3.14e-4)" "unprognostic (8.72e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (6.77e-4)" "unprognostic (3.89e-3)" "unprognostic (7.33e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-3)" 4.3 7.9 4.9 9.2 7.1 16.3 10.3 3.3 3.1 8.9 10.1 2.6 1.2 3.2 6.9 5.6 10.7 6.5 7.6 7.5 4.1 3.2 3.3 1.8 24.1 18.2 5.2 1.8 6.5 1.9 4.0 2.3 9.9 3.7 5.9 5.0 6.3 3.6 3.8 1.5 4.7 7.5 11.5 9.6 10.1 5.4 1.8 5.5 19.9 4.1 6.2 7.9 5.1 5.6 1.2 8.4 13.6 8.8 3.0 3.0 3.9 3.7 1.1 0.4 0.1 0.0 0.1 0.1 3.4 15.8 2.8 3.2 0.0 0.0 3.4 1.9 6.7 0.0 1.0 0.2 1.4 3.5 9.6 0.1 0.0 1.2 0.0 2.2 2.8 3.0 6.4 6.2 2.5 0.0 0.0 0.9 3.9 0.0 2.0 0.5 0.1 0.0 3.9 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.6 0.0 0.8 0.3 0.0 2.3 2.8 5.3 7.9 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 12.1 0.1 13.6 7.1 11.4 2.2 8.8 2.0 1.2 2.4 2.5 8.4 1.2 1.7 2.4 10.2 3.0 8.5 0.9 3.0 3.9 4.9 7.1 3.3 3.1 4.1 3.2 5.2 1.8 3.7 5.5 44.7 6.7 16.7 9.5 0.0 1.4 1.6 0.0 89.7 20.5 12.2 0.0 10.0 5.0 0.5 0.4 3.3 0.0 0.0 0.4 30.5 7.8 3.2 3.5 1.3 50.9 0.0 0.0 9.8 90.6 0.0 3.4 52.2 0.0 14.4 0.0 6.7 0.1 0.0 1.1 5.1 1.5 12.9 7.3 0.3 1.3 0.0 4.2 28.8 0.1 3.8 HAMP "HEPC, HFE2B, LEAP-1, LEAP1" ENSG00000105697 "Hepcidin antimicrobial peptide" P81172 19 35280716-35285143 "Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Fungicide, Hormone" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 716.5" "Cell type enriched" "Detected in many" 8 "Hepatocytes: 1549.8" "Group enriched" "Detected in many" 12 "glioma: 6.5;liver cancer: 16.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "myeloid DC: 2.5;plasmacytoid DC: 7.6" "Lineage enriched" "Detected in single" 13 "dendritic cells: 7.6" "Cell line enriched" "Detected in single" 229 "Hep G2: 69.9" "Not detected" "Not detected" "Secreted to blood" NA NA 1900000 3900000 "unprognostic (5.53e-2)" "unprognostic (5.02e-4)" "unprognostic (2.10e-3)" "unprognostic (4.69e-3)" "unprognostic (5.35e-2)" "unprognostic (2.24e-1)" "unprognostic (3.92e-2)" "unprognostic (9.36e-2)" "unprognostic (2.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.61e-1)" "unprognostic (1.86e-1)" "unprognostic (3.68e-7)" "unprognostic (4.11e-2)" "unprognostic (3.93e-2)" "unprognostic (4.08e-2)" "unprognostic (7.77e-2)" 0.4 0.5 1.8 0.6 10.8 1.2 0.7 0.2 4.4 0.6 0.3 0.2 0.0 0.5 0.4 0.4 0.4 0.9 0.4 45.1 10.0 1.8 0.3 716.5 0.4 1.0 4.2 0.0 1.1 8.7 0.4 0.5 0.7 6.7 0.6 0.3 0.0 0.4 0.6 0.5 0.4 0.3 0.4 13.9 0.3 0.4 0.5 4.0 0.0 0.3 0.0 1.0 0.4 0.0 0.5 7.6 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 69.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 2.5 0.5 0.0 0.0 0.0 0.5 0.0 7.6 0.0 0.0 1.8 10.8 0.2 4.4 10.0 1.8 4.2 0.0 6.7 4.0 0.0 0.0 9.3 0.9 0.5 0.0 1.1 30.6 0.0 1.2 0.0 0.0 0.6 0.0 0.4 0.0 0.6 0.0 23.3 82.0 0.9 0.5 5.2 69.8 1549.8 198.8 0.0 0.0 28.3 41.3 0.0 0.0 3.4 0.0 0.0 1.0 0.5 36.6 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 16.3 0.6 1.5 0.2 1.7 HAPLN4 "BRAL2, KIAA1926" ENSG00000187664 "Hyaluronan and proteoglycan link protein 4" Q86UW8 19 19255641-19262796 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 38.5;intestine: 24.3" "Cell type enriched" "Detected in single" 6 "Hepatocytes: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 5.7;NTERA-2: 14.9;SCLC-21H: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055856 Enhanced "Secreted in brain" NA NA "HPA055856: AB_2682946" "unprognostic (3.36e-4)" 0.5 1.9 3.0 0.4 7.5 0.4 0.7 8.9 38.5 2.4 0.6 1.6 0.0 19.6 1.6 0.5 0.4 0.7 0.6 0.5 8.9 9.4 0.5 7.5 0.6 0.4 7.8 2.7 1.4 1.3 0.4 0.2 0.7 26.4 1.1 0.6 0.4 0.5 0.8 0.4 0.4 24.3 0.6 3.8 0.4 0.8 0.5 0.0 0.0 0.4 0.0 0.4 0.5 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 5.7 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.5 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 7.5 8.9 38.5 8.9 9.4 7.8 2.7 26.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 HAS1 HAS ENSG00000105509 "Hyaluronan synthase 1" Q92839 19 51713112-51723994 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 23.7;Fibroblasts: 9.0;Melanocytes: 8.5;Smooth muscle cells: 24.7;Suprabasal keratinocytes: 15.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "eosinophil: 5.9;neutrophil: 1.6" "Lineage enriched" "Detected in single" 15 "granulocytes: 5.9" "Cell line enriched" "Detected in some" 4 "U-87 MG: 51.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067602 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA067602: AB_2685871" "unprognostic (3.56e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "unprognostic (5.26e-4)" "unprognostic (7.17e-3)" "unprognostic (7.05e-2)" "unprognostic (1.02e-1)" "unprognostic (5.49e-4)" "unprognostic (4.80e-2)" "unprognostic (1.99e-2)" "unprognostic (8.43e-2)" "unprognostic (1.72e-1)" "unprognostic (2.30e-11)" "unprognostic (9.12e-4)" "unprognostic (8.99e-2)" "unprognostic (3.73e-4)" "unprognostic (2.43e-2)" 23.7 0.5 0.6 13.7 1.3 2.8 1.0 1.5 1.9 0.6 1.2 0.4 1.1 0.1 0.8 2.5 1.3 5.8 5.5 5.9 1.4 2.0 0.3 0.6 4.5 0.3 0.6 0.3 23.6 2.2 0.0 0.3 0.3 0.6 0.4 0.5 1.0 0.3 1.2 2.1 2.7 4.0 3.6 0.9 0.7 0.7 0.9 0.3 0.3 0.3 0.8 0.3 1.8 0.3 0.1 0.1 5.9 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 51.0 0.0 0.1 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 1.3 1.5 1.7 1.4 2.0 0.6 0.3 0.6 0.3 0.0 2.6 0.0 0.1 23.7 4.2 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.1 2.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.3 8.5 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.6 0.0 24.7 0.0 0.1 15.6 0.1 0.0 0.0 0.1 HAS2 ENSG00000170961 "Hyaluronan synthase 2" Q92819 8 121612116-121641390 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 22.8" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 44.7;Fibroblasts: 34.9;Melanocytes: 28.7;Urothelial cells: 95.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HBF TERT88: 34.7;hTEC/SVTERT24-B: 33.4;LHCN-M2: 44.3;U-138 MG: 87.1;U-251 MG: 25.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052060 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA052060: AB_2681712" "unprognostic (7.01e-2)" "unprognostic (1.34e-2)" "unprognostic (4.07e-2)" "unprognostic (4.65e-2)" "unprognostic (1.17e-1)" "unprognostic (2.91e-2)" "unprognostic (5.33e-2)" "unprognostic (2.57e-3)" "unprognostic (3.44e-2)" "unprognostic (1.34e-1)" "unprognostic (8.19e-3)" "unprognostic (1.24e-1)" "unprognostic (1.66e-7)" "unprognostic (1.47e-3)" "unprognostic (3.67e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-3)" 22.8 0.9 1.6 9.1 2.4 0.0 5.5 0.8 1.7 4.0 8.5 2.0 0.0 2.6 1.5 2.5 4.8 3.9 7.7 8.3 1.7 1.7 1.2 2.7 6.5 4.5 1.8 0.6 1.2 1.8 0.3 0.7 2.1 5.7 4.3 5.6 2.7 1.9 0.1 2.7 3.8 9.5 3.7 4.2 0.3 2.3 3.2 2.6 0.4 1.7 5.5 2.1 5.7 1.4 0.0 0.2 0.7 0.2 0.3 0.1 0.0 0.0 0.6 0.0 0.0 1.0 2.6 0.0 4.9 3.7 6.5 11.2 0.0 0.0 0.0 0.0 4.4 0.0 0.8 0.0 0.0 34.7 0.0 0.1 0.0 0.1 0.0 4.4 0.0 0.0 6.8 0.0 33.4 3.0 0.1 0.0 0.0 0.0 0.0 44.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.7 0.0 0.0 0.4 0.0 0.1 2.1 0.0 1.1 2.0 0.0 0.0 0.0 87.1 0.3 8.1 25.8 0.0 0.0 0.0 1.8 0.0 1.7 0.5 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.7 0.3 0.2 0.2 0.1 0.0 1.6 2.4 0.8 1.7 1.7 1.7 1.8 0.6 5.7 2.6 0.0 0.0 0.0 44.7 14.4 0.0 1.2 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.7 12.7 2.2 0.0 0.0 0.0 0.0 34.9 5.5 13.8 0.0 0.2 0.0 1.2 0.0 0.0 1.6 1.7 1.6 28.7 0.0 1.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 10.8 0.2 0.0 10.5 0.1 0.0 3.3 95.7 HAS3 ENSG00000103044 "Hyaluronan synthase 3" O00219 16 69105564-69118719 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.6;urinary bladder: 22.9" "Cell type enhanced" "Detected in many" 14 "Basal keratinocytes: 144.1;Suprabasal keratinocytes: 138.5;Urothelial cells: 89.2" "Group enriched" "Detected in many" 8 "cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 14.4;PC-3: 76.9;RT4: 30.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031554, CAB033850" Supported Approved Microtubules NA NA Microtubules "CAB033850: AB_2116418, HPA031554: AB_10670703" "unprognostic (3.26e-2)" "unprognostic (1.22e-1)" "unprognostic (5.12e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (7.59e-3)" "unprognostic (2.86e-3)" "unprognostic (1.84e-1)" "unprognostic (3.70e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (2.46e-1)" "unprognostic (3.27e-3)" "unprognostic (3.25e-2)" "unprognostic (1.32e-1)" "unprognostic (2.21e-2)" "unprognostic (3.40e-3)" 0.4 0.2 0.4 0.4 1.0 0.3 5.5 1.1 1.3 3.3 3.7 0.4 0.4 1.9 0.8 1.1 22.6 0.7 3.5 2.4 0.6 0.6 1.2 0.7 18.0 0.4 0.4 0.4 0.9 2.2 0.1 1.0 3.3 1.1 3.5 2.3 0.6 7.6 2.1 0.6 5.7 2.1 1.4 0.4 0.4 9.0 2.0 0.4 0.5 4.0 11.7 11.1 22.9 13.6 1.5 1.2 2.2 1.4 0.4 2.0 1.1 0.9 4.8 0.3 0.2 0.1 0.1 1.8 0.3 0.1 0.2 0.1 1.0 2.5 0.2 0.6 0.1 1.1 14.4 0.8 8.6 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.1 2.4 0.3 0.8 1.1 0.1 0.1 0.0 0.1 0.0 0.5 0.3 0.1 4.3 5.0 76.9 0.5 0.0 0.0 7.9 30.4 5.4 0.2 0.5 0.0 0.1 0.9 0.2 0.2 0.1 0.2 0.2 8.4 0.5 0.3 0.2 0.0 0.3 0.0 0.1 0.8 1.4 2.2 1.4 0.7 1.3 0.7 1.1 0.5 1.2 1.5 2.0 0.7 0.5 0.4 1.1 1.0 1.5 1.1 0.4 1.0 1.1 1.3 0.6 0.6 0.4 0.4 1.1 0.4 0.0 25.0 0.0 35.3 144.1 1.4 1.4 0.0 0.0 4.5 0.0 2.0 0.9 0.0 3.2 10.2 2.0 2.0 0.0 3.1 0.7 0.8 9.4 0.0 0.0 0.3 0.0 0.0 1.3 0.0 17.0 1.1 0.6 3.3 0.0 0.3 0.1 2.3 0.0 0.4 0.6 0.9 0.0 2.5 0.6 0.4 138.5 0.2 0.5 1.5 89.2 HAVCR1 "CD365, HAVCR, HAVCR-1, KIM1, TIM-1, TIM1, TIMD1" ENSG00000113249 "Hepatitis A virus cellular receptor 1" Q96D42 5 157029413-157059119 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 37.6" "Not detected" "Not detected" "Cancer enriched" "Detected in many" 12 "renal cancer: 26.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "A549: 36.6;CACO-2: 44.0;RPTEC TERT1: 17.5" "HPA007173, CAB075697" Uncertain Approved Vesicles NA NA 155000 Vesicles "CAB075697: , HPA007173: AB_1080282" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (6.99e-2)" "unprognostic (2.46e-3)" "unprognostic (4.75e-3)" "unprognostic (3.20e-2)" "unprognostic (3.21e-1)" "unprognostic (8.70e-4)" "unprognostic (3.81e-3)" "unprognostic (7.10e-3)" "prognostic unfavorable (7.81e-4)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "prognostic favorable (1.32e-4)" 0.4 0.1 0.2 1.0 0.2 0.9 0.2 0.2 0.2 0.2 6.7 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.5 0.2 0.3 0.2 37.6 0.5 0.6 0.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 5.3 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.5 0.5 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.3 0.2 1.3 1.2 2.0 1.8 2.1 3.4 2.3 0.0 36.6 0.1 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 44.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 1.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.0 1.8 0.5 0.7 1.1 1.0 0.8 1.8 0.9 1.2 1.3 3.4 2.5 1.3 2.1 0.8 0.8 2.8 2.3 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 HAVCR2 "CD366, FLJ14428, Tim-3, TIM3, TIMD3" ENSG00000135077 "Hepatitis A virus cellular receptor 2" Q8TDQ0 5 157085832-157142869 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 34.6" "Cell type enhanced" "Detected in many" 12 "granulocytes: 80.6;Hofbauer cells: 135.6;Kupffer cells: 75.1;Macrophages: 74.2;monocytes: 60.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 13.2;intermediate monocyte: 14.5;myeloid DC: 34.6;NK-cell: 24.1;non-classical monocyte: 8.6" "Group enriched" "Detected in many" 6 "dendritic cells: 34.6;monocytes: 14.5;NK-cells: 24.1" "Cell line enhanced" "Detected in some" "ASC diff: 5.9;Daudi: 3.9;HDLM-2: 17.4;HMC-1: 4.3;RPMI-8226: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB026003 Enhanced NA NA 2900000 "CAB026003: " "unprognostic (2.50e-2)" "unprognostic (1.11e-2)" "unprognostic (5.18e-2)" "unprognostic (2.04e-3)" "unprognostic (3.79e-2)" "unprognostic (1.14e-1)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" "unprognostic (8.48e-2)" "unprognostic (5.13e-2)" "unprognostic (7.83e-2)" "unprognostic (1.89e-1)" "unprognostic (1.83e-2)" "unprognostic (2.13e-1)" "unprognostic (1.34e-1)" 16.8 8.6 9.3 16.0 12.3 10.3 6.5 8.4 10.7 5.1 5.3 15.5 1.8 4.1 3.9 5.9 4.2 5.3 11.4 4.8 9.8 9.3 23.3 8.9 19.8 21.7 15.5 7.5 4.4 3.8 2.4 5.5 14.3 11.3 4.2 6.5 4.1 6.2 3.1 3.3 3.1 6.0 7.2 24.8 23.1 4.2 5.8 12.1 4.7 3.8 2.9 11.1 10.3 2.9 0.3 34.6 3.1 14.5 24.1 3.8 9.7 0.0 0.1 0.1 0.1 5.9 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.1 3.9 0.3 0.0 0.1 0.1 0.0 0.0 0.0 17.4 0.0 0.8 0.0 0.0 0.0 0.0 4.3 0.2 0.3 0.0 0.1 0.0 0.0 0.4 0.1 2.1 0.0 0.0 0.1 2.8 0.2 0.0 0.0 0.1 2.2 14.2 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.5 0.1 0.2 0.0 0.7 0.3 0.2 0.0 0.3 1.2 0.2 0.1 0.4 0.1 3.1 13.2 0.0 3.8 14.5 0.8 0.3 1.6 2.0 34.6 0.1 2.0 2.9 0.7 24.1 8.6 4.1 3.1 9.7 9.3 12.3 8.4 10.7 9.8 9.3 15.5 7.5 11.3 12.1 6.0 9.2 10.3 0.1 0.9 1.0 0.8 0.0 0.0 3.4 0.0 0.0 0.6 6.6 0.0 10.7 0.9 0.0 0.0 0.0 0.7 1.3 0.5 80.6 0.0 135.6 0.0 0.0 1.3 75.1 6.0 0.3 74.2 3.3 60.5 0.0 0.1 0.1 0.0 0.0 38.9 0.0 6.5 0.7 0.2 0.5 1.1 0.9 28.7 0.1 0.4 HBD ENSG00000223609 "Hemoglobin subunit delta" P02042 11 5232678-5243657 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 233.7" "Cell type enriched" "Detected in some" 231 "Erythroid cells: 15231.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 31.3;U-266/70: 42.6" "CAB037087, HPA043234" Supported NA NA 11000000000 "CAB037087: AB_260051, HPA043234: AB_2678378" "unprognostic (1.32e-2)" "unprognostic (4.87e-2)" "unprognostic (4.14e-2)" "unprognostic (2.26e-3)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "unprognostic (1.04e-1)" "unprognostic (8.67e-2)" "unprognostic (2.83e-2)" "unprognostic (3.17e-1)" "unprognostic (6.24e-2)" "unprognostic (3.17e-1)" 1.6 0.2 0.4 0.3 0.6 233.7 0.8 0.1 0.5 0.2 0.2 1.5 0.0 0.2 0.4 0.2 0.9 0.5 0.2 4.3 1.3 0.4 1.4 3.9 22.5 0.2 1.0 0.0 1.1 0.2 0.2 1.3 12.0 0.8 0.5 0.2 1.0 0.9 0.2 1.0 0.2 0.2 0.2 0.4 29.6 0.2 0.2 0.0 1.2 4.4 0.0 0.4 1.7 11.9 0.0 0.5 0.8 0.0 0.0 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 31.3 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.6 7.5 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 31.6 0.4 0.6 0.1 0.5 1.3 0.4 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15231.4 0.0 0.0 0.5 0.0 0.0 1.6 0.1 0.0 0.0 0.6 9.3 0.0 0.0 0.0 65.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 HBEGF "DTR, DTS, HEGFL" ENSG00000113070 "Heparin binding EGF like growth factor" Q99075 5 140332843-140346631 "Predicted membrane proteins, Predicted secreted proteins" "Growth factor, Heparin-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 536.0;Urothelial cells: 590.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.9;myeloid DC: 3.5;non-classical monocyte: 3.4" "Group enriched" "Detected in many" 5 "dendritic cells: 3.5;monocytes: 4.9" "Cell line enhanced" "Detected in many" "HBF TERT88: 23.2;JURKAT: 30.2;TIME: 25.2;U-698: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053243 Uncertain "Secreted to blood" NA NA 118000 "HPA053243: AB_2682086" "unprognostic (3.64e-1)" "unprognostic (3.05e-1)" "unprognostic (4.31e-2)" "unprognostic (5.09e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (2.41e-4)" "unprognostic (8.44e-3)" "unprognostic (3.51e-2)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (7.09e-4)" "prognostic favorable (6.00e-4)" "unprognostic (2.20e-2)" "unprognostic (6.77e-2)" "unprognostic (1.15e-1)" "unprognostic (1.54e-1)" "unprognostic (2.87e-2)" 31.1 7.0 5.5 18.0 7.5 17.0 22.4 6.8 5.8 8.1 11.1 13.0 5.7 2.6 12.1 13.8 25.3 6.3 32.8 24.3 7.7 6.2 6.9 5.6 36.0 2.7 10.5 4.2 6.5 4.1 4.6 7.3 8.9 8.1 7.8 9.1 6.7 7.0 6.4 14.3 9.8 8.2 20.6 14.1 3.4 13.7 6.4 8.4 1.2 8.5 27.6 13.4 18.2 10.3 0.7 3.5 0.1 4.9 0.0 0.3 0.4 8.2 0.6 1.2 3.0 0.6 0.2 1.0 8.0 3.1 15.2 12.6 4.7 9.0 0.1 6.4 1.9 5.3 2.6 1.5 13.6 23.2 0.4 1.4 0.1 1.7 0.6 0.4 0.5 0.4 0.3 17.2 16.7 6.7 4.5 7.6 30.2 0.0 1.3 3.2 0.5 0.7 3.8 1.1 3.3 2.2 1.4 4.9 0.2 9.4 1.1 0.4 0.4 2.3 0.3 2.7 9.0 0.5 2.1 25.2 8.7 7.3 2.7 17.9 0.1 0.6 33.9 11.0 4.0 11.2 0.0 0.8 0.0 0.0 4.9 0.0 0.7 0.1 0.0 3.5 0.0 0.3 0.1 0.1 0.0 3.4 0.6 0.0 0.4 5.5 7.5 6.8 5.8 7.7 6.2 10.5 4.2 8.1 8.4 205.4 73.7 0.9 536.0 190.6 1.8 73.4 12.7 17.4 61.4 10.4 0.0 2.2 0.0 42.2 0.5 52.6 189.4 0.0 9.6 1.6 18.8 102.7 20.8 1.9 65.1 4.8 84.7 16.0 33.7 0.0 0.3 85.3 30.4 1.8 54.7 6.0 53.3 73.7 0.7 0.4 0.3 0.0 21.2 1.6 5.3 109.4 2.2 0.7 56.1 590.9 HBS1L "DKFZp434g247, EF-1a, eRF3c, ERFS, HBS1, HSPC276, KIAA1038" ENSG00000112339 "HBS1 like translational GTPase" Q9Y450 6 134960378-135103056 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029728, HPA029729" Approved Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA029728: AB_10611112, HPA029729: AB_10601228" "unprognostic (3.68e-3)" "unprognostic (6.39e-2)" "prognostic favorable (6.77e-4)" "unprognostic (1.26e-1)" "unprognostic (2.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.89e-2)" "unprognostic (8.66e-2)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (1.23e-1)" "unprognostic (7.73e-2)" "unprognostic (3.84e-1)" "unprognostic (4.98e-2)" "unprognostic (1.47e-1)" "unprognostic (4.20e-2)" 16.9 18.6 17.5 13.0 27.3 31.8 18.0 23.2 34.7 16.7 14.9 18.2 9.2 10.1 15.6 10.8 20.0 13.8 12.0 22.3 18.4 18.8 17.4 28.4 11.7 16.3 21.1 16.0 15.6 20.4 19.5 25.4 18.7 33.6 14.2 13.5 11.0 17.1 14.1 66.4 14.7 15.3 18.6 25.0 14.4 14.2 14.0 17.1 42.5 17.5 19.9 18.5 16.3 13.6 25.2 28.4 38.4 24.6 32.9 38.4 28.3 15.1 10.2 21.3 30.9 19.6 17.5 16.3 30.7 26.5 29.3 36.3 17.1 11.5 26.3 13.9 27.1 21.2 11.4 29.8 22.6 45.8 26.7 20.4 80.4 28.9 22.9 23.5 49.6 22.0 17.2 17.2 27.7 34.1 22.0 24.2 31.5 42.9 22.2 30.9 14.4 30.5 12.6 13.7 18.2 11.2 28.7 23.8 17.9 18.1 14.5 21.1 14.4 21.0 22.0 21.8 17.6 18.3 30.0 22.8 20.8 21.7 25.7 32.4 50.7 36.5 44.7 31.7 25.8 25.8 38.4 24.6 25.4 23.4 22.1 26.3 25.2 28.1 23.8 28.4 22.6 38.4 31.6 11.2 32.9 21.1 22.6 32.9 28.3 17.5 27.3 23.2 34.7 18.4 18.8 21.1 16.0 33.6 17.1 23.8 21.7 26.8 23.0 24.3 42.7 51.6 22.9 28.1 36.4 10.4 13.7 27.2 21.6 20.9 27.5 18.0 9.8 93.5 17.8 26.9 19.6 19.2 56.8 33.1 12.0 20.6 15.6 17.2 22.1 11.0 17.3 14.9 28.7 27.1 11.4 26.1 16.4 13.9 20.8 19.2 26.4 38.8 24.0 25.9 25.7 16.3 33.9 20.3 14.5 22.5 HCAR1 "FKSG80, GPR104, GPR81, HCA1, LACR1, TA-GPCR" ENSG00000196917 "Hydroxycarboxylic acid receptor 1" Q9BXC0 12 122726076-122730843 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 13.9;parathyroid gland: 41.4" "Group enriched" "Detected in some" 4 "Club cells: 5.7;Early spermatids: 8.6;Extravillous trophoblasts: 2.5;Late spermatids: 4.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.6;MCF7: 6.2;RT4: 27.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "prognostic unfavorable (3.61e-5)" "unprognostic (8.90e-2)" "unprognostic (1.62e-1)" "unprognostic (1.31e-2)" "unprognostic (1.93e-2)" "unprognostic (3.80e-4)" "unprognostic (5.43e-4)" "unprognostic (1.41e-1)" "unprognostic (7.74e-2)" "unprognostic (2.22e-1)" "unprognostic (6.85e-3)" "unprognostic (1.26e-1)" "unprognostic (2.66e-3)" "unprognostic (2.14e-2)" "unprognostic (2.51e-1)" "unprognostic (2.38e-1)" "unprognostic (1.87e-2)" 7.1 0.4 0.4 0.0 0.4 0.4 13.9 0.4 0.4 0.5 0.5 0.2 12.2 0.1 0.4 2.8 0.9 0.9 0.7 2.1 0.4 0.4 1.2 0.4 0.6 0.6 0.4 0.2 0.5 0.4 41.4 0.5 1.0 0.5 1.8 0.0 2.4 8.0 3.2 0.4 0.9 0.5 0.6 2.2 5.2 0.7 1.4 0.0 0.0 2.0 0.0 0.5 1.0 1.8 1.5 1.2 4.4 0.9 1.4 0.9 0.3 0.1 0.2 0.2 0.3 0.0 0.1 1.6 0.1 0.0 0.0 0.1 1.9 9.6 0.2 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.1 0.5 1.4 0.2 0.2 0.2 0.6 0.0 0.5 0.0 0.1 0.1 0.2 0.2 0.5 0.1 6.2 0.2 0.3 0.3 2.3 0.6 0.2 0.2 0.2 0.1 27.4 2.1 0.2 0.1 3.3 0.0 0.3 2.8 0.1 0.3 0.3 0.2 0.2 0.1 0.4 0.1 0.3 0.2 0.2 0.3 4.4 0.9 0.8 0.9 0.5 0.7 0.8 0.8 0.6 0.3 1.5 0.8 0.8 4.0 1.4 0.5 1.2 0.5 0.3 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.2 0.5 0.0 0.0 0.3 0.0 1.2 0.1 0.4 0.3 0.0 0.0 5.7 0.0 0.0 0.2 0.0 0.0 8.6 0.0 0.0 0.0 0.0 2.5 0.2 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.7 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.9 HCAR2 "GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG" ENSG00000182782 "Hydroxycarboxylic acid receptor 2" Q8TDS4 12 122701293-122703343 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.9" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 69.6;Basal keratinocytes: 83.9;Suprabasal keratinocytes: 92.8" "Group enriched" "Detected in many" 8 "cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "neutrophil: 50.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 50.9" "Cell line enriched" "Detected in some" 6 "HaCaT: 52.0" HPA028660 Approved Supported "Cell Junctions" NA NA "Cell Junctions" "HPA028660: AB_10602139" "unprognostic (5.43e-2)" "unprognostic (1.27e-1)" "unprognostic (1.77e-1)" "unprognostic (2.05e-1)" "unprognostic (6.65e-2)" "unprognostic (1.33e-1)" "unprognostic (3.33e-3)" "unprognostic (7.26e-2)" "unprognostic (2.17e-1)" "unprognostic (1.77e-2)" "unprognostic (7.10e-2)" "unprognostic (7.33e-2)" "unprognostic (4.83e-4)" "unprognostic (5.76e-2)" "unprognostic (5.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.63e-2)" 16.1 0.2 0.4 6.4 0.5 13.2 8.3 0.2 0.7 5.8 3.6 0.3 6.2 0.4 0.8 1.6 26.0 0.4 1.1 1.2 0.8 0.2 1.9 1.8 11.3 0.7 3.3 0.2 1.2 0.2 4.4 0.9 8.2 1.0 8.6 0.0 0.3 9.7 10.7 0.7 17.8 0.7 0.4 0.9 16.5 0.8 2.8 1.1 1.1 0.4 13.5 21.5 3.5 8.3 0.0 0.5 50.9 6.6 0.0 0.0 0.3 1.9 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 52.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 9.0 0.6 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 50.9 0.0 6.6 0.0 0.0 0.3 0.4 0.5 0.2 0.7 0.8 0.2 3.3 0.2 1.0 1.1 0.0 7.0 0.0 69.6 83.9 0.4 0.0 0.0 6.7 33.0 0.0 0.0 0.4 0.0 0.0 21.5 0.4 0.0 0.0 0.0 22.6 2.3 8.9 2.3 0.0 3.8 0.0 0.0 0.0 4.1 2.3 0.0 30.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.8 2.2 0.0 0.0 18.6 HCAR3 "GPR109B, HCA3, HM74" ENSG00000255398 "Hydroxycarboxylic acid receptor 3" P49019 12 122714756-122716892 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.7" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 75.5;Basal keratinocytes: 83.9;Suprabasal keratinocytes: 93.0;Urothelial cells: 41.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "midbrain: 3.5" "Group enriched" "Detected in some" 6 "basophil: 12.1;neutrophil: 47.7;non-classical monocyte: 21.3" "Group enriched" "Detected in many" 49 "granulocytes: 47.7;monocytes: 21.3" "Group enriched" "Detected in some" 5 "HaCaT: 7.2;RT4: 27.9" HPA028660 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA028660: AB_10602139" "unprognostic (2.32e-1)" "unprognostic (5.82e-2)" "unprognostic (8.23e-2)" "unprognostic (2.27e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" "unprognostic (1.64e-3)" "unprognostic (1.60e-1)" "unprognostic (6.29e-2)" "unprognostic (9.87e-2)" "unprognostic (1.50e-2)" "unprognostic (2.80e-1)" "unprognostic (1.23e-1)" "unprognostic (2.30e-2)" "unprognostic (2.83e-1)" "unprognostic (1.16e-1)" "unprognostic (9.28e-2)" 4.8 0.2 0.6 7.9 0.3 20.8 4.0 0.4 0.5 2.3 0.9 0.2 2.2 0.1 0.4 0.4 18.2 0.5 0.5 1.0 0.3 0.3 0.9 2.5 10.2 3.5 3.5 0.0 1.6 0.2 6.6 1.1 3.0 0.7 4.2 0.0 0.3 2.9 4.3 0.6 13.9 0.3 0.4 1.2 21.6 0.5 1.6 0.4 0.3 0.5 12.0 14.9 5.7 7.2 0.0 0.7 47.7 21.3 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 7.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 12.1 0.5 0.2 0.0 4.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 47.7 0.0 21.3 0.0 0.0 0.6 0.6 0.3 0.4 0.5 0.3 0.3 3.5 0.0 0.7 0.4 3.0 10.7 0.0 75.5 83.9 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 19.1 2.0 5.3 3.5 0.0 6.1 0.0 0.0 0.0 7.3 0.0 0.0 22.1 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 93.0 11.6 0.0 0.0 41.6 HCN1 "BCNG-1, BCNG1, HAC-2" ENSG00000164588 "Hyperpolarization activated cyclic nucleotide gated potassium channel 1" O60741 5 45254950-45696498 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.4;retina: 16.1" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 125.7;Rod photoreceptor cells: 184.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.7;WM-115: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019195 Enhanced NA NA "HPA019195: AB_2670094" "unprognostic (1.30e-1)" "unprognostic (3.62e-1)" "unprognostic (1.64e-1)" "unprognostic (9.24e-3)" "unprognostic (6.82e-2)" "unprognostic (1.10e-1)" "unprognostic (9.63e-3)" "unprognostic (4.11e-3)" "unprognostic (6.78e-2)" "unprognostic (1.16e-2)" "unprognostic (7.42e-2)" "unprognostic (3.68e-3)" 1.0 2.8 6.0 1.0 13.0 1.3 1.2 9.8 26.4 0.9 1.0 0.5 0.0 0.9 1.1 0.9 1.1 1.0 1.0 4.6 8.1 4.5 0.9 1.0 1.0 1.0 2.6 11.1 1.1 1.7 0.9 4.0 0.9 9.2 1.0 1.0 16.1 1.0 0.9 3.6 1.6 1.1 0.9 1.2 1.1 1.1 1.2 0.0 0.0 1.1 0.0 0.9 0.9 0.3 0.6 0.2 0.6 0.2 0.3 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.3 0.1 0.4 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.2 0.3 4.7 0.5 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.6 0.2 0.3 0.6 0.3 0.1 0.2 0.0 0.0 6.0 13.0 9.8 26.4 8.1 4.5 2.6 11.1 9.2 0.0 0.0 0.0 0.0 0.0 0.1 25.3 3.6 0.0 0.0 0.0 0.0 125.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.1 0.0 0.0 0.0 184.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 HCN2 "BCNG-2, BCNG2, HAC-1" ENSG00000099822 "Hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2" Q9UL51 19 589893-617159 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 38.1;heart muscle: 16.8" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 58.4;Horizontal cells: 38.1;Rod photoreceptor cells: 14.2" "Group enriched" "Detected in many" 6 "glioma: 8.7;melanoma: 5.7;renal cancer: 2.8;testis cancer: 4.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 18.0;HeLa: 9.6;MCF7: 16.7;U-138 MG: 12.6;U-87 MG: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.69e-2)" "unprognostic (3.97e-3)" "unprognostic (3.31e-4)" "unprognostic (1.44e-1)" "unprognostic (2.44e-1)" "unprognostic (3.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" "unprognostic (5.32e-2)" "unprognostic (1.19e-3)" "unprognostic (8.00e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.07e-1)" "unprognostic (1.41e-1)" "unprognostic (5.53e-4)" "unprognostic (9.72e-3)" 1.1 4.8 12.0 1.4 29.1 1.5 1.0 8.5 38.1 1.1 1.2 8.2 0.0 1.2 1.0 1.3 2.2 1.0 1.1 16.8 18.3 11.7 1.5 1.1 1.1 1.5 22.0 6.6 1.0 1.5 1.2 3.0 1.1 11.4 1.2 1.1 0.6 1.4 1.2 1.1 1.7 1.2 1.2 24.5 1.3 1.3 3.7 7.3 0.0 1.1 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 18.0 0.2 0.6 1.9 1.3 0.6 1.2 1.5 0.5 0.1 2.5 0.1 0.0 4.0 1.7 1.3 0.1 0.4 0.1 0.0 3.0 7.6 0.0 9.6 0.2 1.4 0.2 3.4 3.5 0.3 0.1 0.0 0.5 0.1 0.4 1.0 0.1 1.3 16.7 0.0 0.0 0.9 0.4 0.5 0.1 0.1 0.4 0.3 0.5 7.0 3.6 4.4 0.0 1.3 0.3 3.6 0.6 1.7 12.6 1.9 0.2 4.9 0.3 0.2 0.1 25.9 0.8 3.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 12.0 29.1 8.5 19.6 18.3 11.7 22.0 6.6 11.4 7.3 0.0 0.0 0.0 0.0 0.6 58.4 3.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 38.1 1.2 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.7 0.0 14.2 0.0 0.8 0.1 0.9 0.5 0.2 0.0 0.0 0.0 HCN3 KIAA1535 ENSG00000143630 "Hyperpolarization activated cyclic nucleotide gated potassium channel 3" Q9P1Z3 1 155277583-155289848 "Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026584 Approved NA NA "HPA026584: AB_1850534" "unprognostic (1.04e-1)" "unprognostic (6.22e-2)" "unprognostic (7.17e-2)" "unprognostic (1.34e-1)" "unprognostic (3.17e-1)" "unprognostic (1.48e-3)" "unprognostic (1.63e-1)" "unprognostic (5.97e-2)" "unprognostic (4.44e-2)" "unprognostic (1.84e-2)" "unprognostic (4.36e-3)" "unprognostic (1.33e-1)" "prognostic unfavorable (7.49e-4)" "unprognostic (2.55e-2)" "unprognostic (1.85e-1)" "unprognostic (5.90e-2)" "prognostic favorable (6.93e-4)" 1.6 3.5 4.5 2.0 7.5 1.5 2.1 20.3 9.5 3.6 4.4 3.3 3.6 7.7 4.5 2.1 3.9 2.2 3.0 1.6 4.0 8.2 4.4 10.2 1.9 2.3 4.1 8.5 4.7 4.7 6.4 12.6 2.4 9.5 2.7 5.0 4.0 4.4 3.6 1.1 9.2 6.6 2.8 3.0 1.9 3.2 1.7 2.1 1.6 2.6 1.3 3.0 2.3 3.6 0.3 0.0 0.0 0.1 0.0 0.6 0.0 1.6 1.8 7.9 3.2 1.3 1.5 1.9 1.3 1.2 1.6 1.9 2.8 5.5 1.5 1.1 1.0 3.4 6.9 2.2 1.0 0.9 2.1 2.8 0.6 5.1 1.8 0.5 0.6 1.6 0.9 1.0 1.1 0.2 1.8 0.3 2.5 3.7 4.4 1.9 2.2 1.1 0.6 2.7 4.2 2.1 3.9 1.9 2.9 2.2 1.7 6.5 4.6 1.2 1.6 0.5 1.5 2.8 1.3 0.1 1.9 1.7 4.0 1.2 1.4 0.6 1.3 1.5 1.1 1.7 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 7.5 20.3 9.5 4.0 8.2 4.1 8.5 9.5 2.1 0.0 1.1 0.0 0.6 1.1 2.4 0.8 2.5 0.0 1.2 1.8 3.9 0.3 0.0 0.9 0.1 0.0 4.6 0.0 0.3 0.3 1.3 0.8 1.1 1.5 0.7 0.0 4.1 3.1 0.0 0.4 0.9 1.3 0.0 1.0 2.3 1.4 0.9 2.9 1.1 0.8 1.8 0.0 0.3 1.5 2.1 2.4 0.0 0.5 3.8 0.9 HCN4 ENSG00000138622 "Hyperpolarization activated cyclic nucleotide gated potassium channel 4" Q9Y3Q4 15 73319859-73369264 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Brugada syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 4.3;heart muscle: 12.5;testis: 9.6" "Group enriched" "Detected in some" 7 "Early spermatids: 28.7;Late spermatids: 33.9" "Group enriched" "Detected in some" 8 "testis cancer: 3.1;thyroid cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.6;CACO-2: 3.2;HDLM-2: 2.1;NTERA-2: 9.5;SuSa: 2.5;U-2 OS: 4.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073174 Approved NA NA "HPA073174: " "unprognostic (2.21e-1)" "unprognostic (1.39e-1)" "unprognostic (2.18e-2)" "unprognostic (3.14e-2)" "unprognostic (5.30e-3)" "unprognostic (1.92e-2)" "unprognostic (2.19e-1)" "unprognostic (3.50e-2)" "unprognostic (2.37e-1)" "unprognostic (6.56e-2)" "unprognostic (1.13e-3)" "unprognostic (1.13e-1)" "unprognostic (6.05e-5)" "unprognostic (5.56e-2)" "unprognostic (4.60e-2)" "unprognostic (1.51e-2)" "unprognostic (7.95e-2)" 0.2 1.3 4.3 0.2 1.1 0.1 0.1 0.9 3.4 0.2 0.4 2.1 0.0 1.2 0.1 0.2 0.1 0.3 0.2 12.5 0.6 2.0 0.4 0.1 0.3 0.1 1.8 0.9 0.1 0.2 0.1 2.1 0.1 3.9 0.6 0.3 0.2 0.1 1.0 0.1 0.2 0.4 0.2 0.7 0.1 0.6 9.6 1.9 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 1.5 0.0 0.6 0.2 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.1 0.9 3.4 0.6 2.0 1.8 0.9 3.9 1.9 0.0 0.0 0.0 0.0 0.0 0.5 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 28.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 33.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 1.2 0.0 0.1 0.6 1.3 0.0 0.0 0.0 0.0 0.0 HCRT "OX, PPOX" ENSG00000161610 "Hypocretin neuropeptide precursor" O43612 17 42184060-42185452 "Disease related genes, Predicted secreted proteins" Neuropeptide "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "brain: 84.3" "Cell type enhanced" "Detected in some" 12 "Collecting duct cells: 1.8;Intestinal endocrine cells: 2.9;Kupffer cells: 1.8" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.7;granulocytes: 2.3;T-cells: 2.2" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;Karpas-707: 1.0;RPMI-8226: 3.7" "Region enriched" "Detected in some" 5 "hypothalamus: 110.5" "Region enriched" "Detected in some" 57 "hypothalamus: 152.0" "HPA064801, CAB079778" Enhanced Supported "Secreted to blood" NA NA "CAB079778: , HPA064801: " "unprognostic (3.34e-2)" "unprognostic (7.76e-5)" "unprognostic (3.21e-2)" "unprognostic (3.01e-2)" "unprognostic (2.20e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" 0.9 0.0 0.0 1.1 0.2 0.9 0.0 0.0 0.7 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 84.3 0.4 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 2.7 0.4 2.3 0.5 0.4 2.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.0 0.0 0.0 0.8 0.8 0.4 0.9 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 0.7 0.8 0.2 0.0 0.1 0.0 2.3 0.5 0.0 1.2 0.4 2.2 1.5 0.9 1.6 0.4 2.7 1.4 1.3 0.1 0.4 0.2 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.9 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.7 0.1 HCRTR1 OX1R ENSG00000121764 "Hypocretin receptor 1" O43613 1 31617686-31632518 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.0" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 1.1;Late spermatids: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 1.7;HUVEC TERT2: 3.0;TIME: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014018 Approved NA NA "HPA014018: AB_1854810" "unprognostic (2.96e-2)" "unprognostic (2.34e-2)" "unprognostic (7.86e-3)" "unprognostic (3.72e-3)" "unprognostic (2.42e-1)" "unprognostic (3.45e-3)" "unprognostic (2.54e-5)" "unprognostic (3.58e-2)" "unprognostic (4.17e-2)" "unprognostic (1.19e-1)" "unprognostic (2.28e-1)" "unprognostic (2.93e-1)" "unprognostic (3.77e-3)" "unprognostic (2.16e-2)" "unprognostic (1.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" 3.3 4.3 0.9 0.3 1.4 1.6 2.7 0.7 4.5 0.1 0.3 0.0 0.0 0.2 0.6 0.3 0.7 0.5 0.8 1.8 0.8 4.6 0.5 0.1 0.2 0.6 1.1 0.0 0.5 0.3 0.0 1.7 2.3 8.0 0.5 0.2 0.7 0.5 0.0 2.4 1.1 0.5 0.0 0.5 0.6 0.4 0.4 0.0 0.0 2.9 0.8 0.2 0.6 0.1 1.1 0.2 0.0 0.2 0.2 0.5 0.1 0.4 0.0 0.4 0.1 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.6 0.6 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.7 0.0 0.0 1.0 0.4 0.0 0.0 0.5 0.0 0.5 3.0 0.5 0.4 0.2 0.0 0.5 0.1 0.1 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.7 0.1 0.4 0.3 0.2 0.0 0.8 0.2 0.0 1.7 0.1 0.2 0.3 0.4 0.5 0.1 0.2 0.0 0.6 1.0 0.0 0.2 0.0 0.5 0.2 0.0 0.1 0.2 0.0 0.1 1.1 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.1 0.9 1.4 0.7 4.5 0.8 4.6 1.1 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 HCRTR2 OX2R ENSG00000137252 "Hypocretin receptor 2" O43614 6 55106460-55282620 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 17.4" "Cell type enhanced" "Detected in some" 24 "Distal tubular cells: 1.7;Peritubular cells: 3.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "pons and medulla: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "AF22: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054516 Enhanced NA NA "HPA054516: AB_2682513" "unprognostic (4.86e-1)" "unprognostic (2.69e-2)" "unprognostic (1.86e-2)" "unprognostic (2.32e-1)" "unprognostic (7.45e-2)" "unprognostic (7.39e-2)" 0.1 0.2 1.7 0.0 1.3 0.0 0.1 0.6 2.2 0.1 0.1 0.3 0.0 0.0 0.1 0.5 0.0 0.1 0.1 1.1 0.9 4.2 3.7 0.1 0.4 0.1 2.6 1.7 1.7 0.0 0.0 0.3 2.2 17.4 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 1.3 0.6 2.2 0.9 4.2 2.6 1.7 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 HCST "DAP10, DKFZP586C1522, KAP10, PIK3AP" ENSG00000126264 "Hematopoietic cell signal transducer" Q9UBK5 19 35902480-35904377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 134.0;bone marrow: 84.0;lymphoid tissue: 79.1" "Group enriched" "Detected in many" 5 "granulocytes: 237.5;Hofbauer cells: 491.9;Kupffer cells: 329.9;Macrophages: 424.4;T-cells: 835.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 52.9;HL-60: 30.5;HMC-1: 35.3;THP-1: 40.0;U-937: 60.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB034435, HPA063026" Enhanced Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Vesicles "CAB034435: AB_2117803, HPA063026: " "unprognostic (1.40e-3)" "unprognostic (3.07e-2)" "unprognostic (3.04e-2)" "unprognostic (7.27e-3)" "unprognostic (1.23e-1)" "unprognostic (8.23e-3)" "unprognostic (1.85e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.70e-4)" "unprognostic (5.97e-2)" "unprognostic (1.94e-3)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.59e-10)" "unprognostic (3.78e-1)" "unprognostic (3.25e-2)" "unprognostic (1.65e-1)" "unprognostic (1.56e-1)" 29.4 4.0 6.5 19.9 5.2 84.0 5.9 1.4 3.1 3.9 4.9 4.8 0.5 4.5 5.4 6.0 3.0 4.5 6.3 7.3 5.7 5.9 5.6 6.9 38.4 79.1 7.7 2.2 3.4 2.9 0.7 4.3 10.6 4.9 5.5 3.6 7.1 6.2 3.7 2.4 2.8 10.9 4.5 12.7 49.5 5.6 1.7 4.4 56.8 3.4 3.3 26.7 5.2 3.6 6.1 66.6 15.9 57.0 96.4 134.0 89.5 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.2 0.0 0.1 0.2 0.2 5.7 0.3 0.4 0.1 0.2 0.0 0.0 0.0 0.1 0.0 52.9 0.1 0.1 0.1 30.5 35.3 0.3 0.0 0.0 0.0 0.1 0.0 3.2 0.4 7.6 0.1 0.0 3.5 11.9 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 40.0 0.1 0.3 0.4 0.0 0.0 0.3 0.2 8.7 0.3 60.0 0.0 7.3 57.0 7.9 134.0 42.0 99.3 6.1 57.4 108.5 32.6 3.7 48.3 96.4 15.9 96.4 23.0 66.6 48.5 89.5 6.5 5.2 1.4 3.1 5.7 5.9 7.7 2.2 4.9 4.4 6.0 65.6 87.2 1.1 25.3 0.2 0.8 5.1 8.1 11.4 8.7 0.0 3.2 0.0 2.1 0.3 9.0 1.4 0.0 1.0 3.2 13.1 0.6 237.5 11.3 491.9 1.6 0.0 19.6 329.9 1.8 2.0 424.4 42.2 31.5 0.7 0.2 1.1 0.9 0.0 4.4 1.9 19.4 1.9 1.7 2.8 18.3 5.0 835.8 1.7 0.8 HDAC2 "RPD3, YAF1" ENSG00000196591 "Histone deacetylase 2" Q92769 6 113933028-114011308 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005054, HPA011727" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB005054: AB_562295, HPA011727: AB_1850540" "prognostic unfavorable (7.07e-4)" "unprognostic (1.44e-1)" "unprognostic (2.67e-1)" "unprognostic (2.56e-2)" "unprognostic (2.61e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (5.39e-10)" "unprognostic (2.03e-1)" "unprognostic (2.63e-2)" "unprognostic (9.00e-2)" "unprognostic (2.01e-1)" "unprognostic (3.92e-1)" "unprognostic (1.84e-2)" "unprognostic (1.96e-1)" "unprognostic (2.42e-1)" "unprognostic (9.80e-2)" "unprognostic (3.51e-1)" 25.8 33.8 25.8 30.1 31.3 34.9 58.7 32.8 36.5 32.1 30.7 25.6 32.2 22.0 38.7 36.7 36.3 32.7 23.3 27.6 26.5 26.9 31.6 22.2 29.9 41.5 29.6 26.5 39.2 31.5 31.7 45.1 38.1 27.9 32.1 36.1 17.5 29.3 39.0 33.9 30.8 26.1 36.1 31.1 30.7 29.9 47.4 27.4 64.0 35.1 31.3 32.5 33.1 47.3 27.0 35.7 28.2 32.6 26.3 32.6 24.3 24.6 17.0 79.6 45.7 20.5 23.5 33.3 29.5 24.1 34.8 41.7 45.1 18.2 20.4 24.6 26.5 35.8 19.4 54.0 29.8 58.7 29.0 37.3 49.1 22.1 26.0 27.4 49.8 22.2 18.9 20.1 37.0 34.8 34.1 40.5 36.1 63.1 20.7 57.6 20.7 44.6 45.1 45.0 26.4 23.5 30.3 39.7 18.7 35.9 29.8 53.3 45.2 23.3 22.0 24.5 50.0 16.0 58.1 32.7 22.2 25.5 23.2 48.8 16.5 21.7 48.8 18.8 48.0 37.6 23.1 27.6 28.2 21.1 26.6 28.1 27.0 25.9 22.7 35.7 22.3 32.6 29.7 16.3 26.3 32.6 30.9 24.5 24.3 25.8 31.3 32.8 36.5 26.5 26.9 29.6 26.5 27.9 27.4 53.6 49.8 31.2 71.8 170.6 26.7 56.1 33.1 81.7 79.6 50.6 3.9 139.9 36.5 140.8 72.3 70.5 33.4 140.2 91.3 114.1 97.6 61.7 53.2 30.8 91.5 14.3 96.4 47.9 63.7 84.2 76.8 67.2 79.2 128.0 68.7 30.1 115.2 49.1 63.3 52.8 23.5 38.8 84.5 123.0 166.8 168.8 173.7 50.7 90.3 79.6 HEG1 "HEG, KIAA1237" ENSG00000173706 "Heart development protein with EGF like domains 1" Q9ULI3 3 124965710-125055958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 80.4;Cardiomyocytes: 80.5;Cone photoreceptor cells: 249.4;Ito cells: 95.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 42.0;HHSteC: 51.1;hTERT-RPE1: 77.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010952, HPA011559" Approved Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 360000000 Vesicles "Plasma membrane" "HPA010952: AB_2668389, HPA011559: AB_1850580" "unprognostic (1.10e-1)" "unprognostic (2.21e-1)" "unprognostic (6.52e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.48e-2)" "unprognostic (2.89e-2)" "unprognostic (2.36e-1)" "unprognostic (9.80e-2)" "unprognostic (1.69e-1)" "unprognostic (8.33e-2)" "prognostic unfavorable (1.93e-5)" "unprognostic (1.11e-2)" "unprognostic (4.99e-2)" "unprognostic (6.20e-3)" "prognostic unfavorable (1.16e-4)" 23.6 8.2 5.8 12.1 8.4 0.7 16.4 2.6 8.9 12.2 9.6 14.7 8.0 3.9 12.0 7.3 9.0 11.4 29.6 36.3 6.9 5.5 8.9 5.5 42.4 7.7 9.7 4.7 8.1 16.6 14.2 4.0 17.4 11.6 7.2 6.5 26.2 7.1 7.4 6.2 4.3 7.9 14.4 11.9 11.5 7.5 11.3 6.5 3.0 29.1 10.8 8.7 13.0 15.6 1.0 0.9 1.2 3.9 7.3 4.0 1.1 1.8 1.9 13.4 1.1 16.6 14.7 5.0 15.7 20.6 17.5 19.3 13.7 0.2 0.5 10.7 42.0 12.8 3.3 2.0 7.7 21.1 1.4 1.0 0.3 10.2 1.6 51.1 0.3 20.4 18.0 2.2 22.8 5.4 77.1 17.0 1.2 0.0 0.2 5.3 0.2 0.8 0.0 2.3 0.0 1.2 1.2 10.2 0.0 3.0 0.3 0.2 1.2 34.9 2.4 1.3 12.4 5.7 0.8 26.4 9.9 11.0 35.4 6.7 1.4 4.3 0.0 18.6 1.5 19.2 1.2 0.3 0.0 4.0 3.6 2.7 0.9 1.6 3.6 0.7 1.0 2.4 1.5 0.0 7.3 3.9 0.9 0.5 1.1 5.8 8.4 2.6 8.9 6.9 5.5 9.7 4.7 11.6 6.5 80.4 7.2 4.9 7.1 4.4 3.0 80.5 5.1 0.0 4.5 26.2 249.4 0.8 0.0 31.8 5.1 76.0 0.0 0.0 5.8 53.1 23.5 2.8 26.5 2.5 5.7 1.6 0.0 95.2 15.8 7.6 4.6 4.8 6.8 2.8 0.6 4.1 6.9 0.0 13.1 1.2 62.4 0.0 21.2 0.2 0.2 3.9 2.7 14.6 0.1 0.9 HELZ "DHRC, HUMORF5, KIAA0054" ENSG00000198265 "Helicase with zinc finger" P42694 17 67070438-67245989 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028276 Approved Approved "Nucleoli,Nucleoli rim,Plasma membrane,Actin filaments" NA NA "Nucleoli, Nucleoli rim" "Plasma membrane, Actin filaments" "HPA028276: AB_10601814" "unprognostic (3.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.56e-3)" "unprognostic (1.29e-1)" "unprognostic (4.83e-2)" "unprognostic (4.71e-2)" "unprognostic (5.85e-2)" "unprognostic (5.31e-2)" "unprognostic (3.60e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-3)" "unprognostic (1.42e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" 17.9 12.9 11.2 14.3 14.3 17.7 12.6 24.3 17.7 14.4 14.0 11.6 12.9 7.9 17.0 13.0 9.1 11.1 11.5 11.1 12.0 9.7 11.8 17.3 14.8 14.6 10.7 6.2 20.5 13.9 34.1 33.5 19.2 16.5 11.9 10.9 12.2 12.4 10.9 18.9 9.0 15.6 12.2 13.5 17.3 11.7 16.4 12.7 34.1 15.3 8.8 13.9 15.3 11.9 4.8 4.4 4.3 4.9 4.0 11.0 3.2 7.6 7.6 9.3 9.6 11.8 6.6 14.3 6.8 6.7 8.9 9.7 11.1 6.0 15.7 5.6 9.0 5.7 8.0 17.8 8.6 14.3 6.0 5.5 20.1 8.4 9.1 5.7 16.6 12.3 7.8 8.2 8.8 11.1 6.9 13.7 11.7 13.9 10.0 7.4 9.7 21.3 5.7 5.7 6.9 7.3 14.4 16.9 6.9 7.2 10.8 9.4 8.6 10.7 8.9 11.7 13.5 10.6 10.3 12.3 11.5 13.2 6.2 6.0 8.3 9.6 11.9 5.7 10.3 11.9 3.6 4.9 4.3 8.8 4.5 11.0 2.9 5.4 5.3 4.4 4.8 3.3 4.5 3.7 4.0 2.9 3.6 4.8 3.2 11.2 14.3 24.3 17.7 12.0 9.7 10.7 6.2 16.5 12.7 17.9 29.6 17.6 21.6 28.5 49.3 24.4 22.9 21.4 29.6 26.2 88.4 26.8 6.6 15.0 3.7 24.5 22.3 0.0 12.2 34.0 24.9 25.4 33.4 40.0 27.1 63.5 36.8 63.8 75.2 7.2 35.9 25.6 13.5 10.8 29.0 24.5 16.1 21.0 40.3 12.1 51.1 12.9 22.6 36.7 24.8 17.7 15.3 76.1 22.6 32.3 HEPACAM "FLJ25530, GLIALCAM, hepaCAM" ENSG00000165478 "Hepatic and glial cell adhesion molecule" Q14CZ8 11 124919193-124936412 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Cell cycle, Growth arrest, Growth regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "adipose tissue: 17.3;brain: 64.7;liver: 19.6" "Group enriched" "Detected in some" 7 "Hepatocytes: 9.3;Muller glia cells: 13.0" "Cancer enriched" "Detected in some" 12 "glioma: 29.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in single" 31 "Hep G2: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017613, CAB025486" Enhanced Approved Vesicles NA NA Vesicles "CAB025486: , HPA017613: AB_1850595" "unprognostic (3.22e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-1)" "unprognostic (6.41e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (2.25e-1)" "unprognostic (7.58e-2)" "unprognostic (1.33e-2)" "unprognostic (1.06e-6)" "unprognostic (2.62e-1)" "unprognostic (3.21e-1)" 17.3 1.8 25.6 1.7 25.7 1.5 2.6 8.5 64.7 1.6 1.8 55.4 0.0 1.6 1.6 1.7 1.6 1.6 1.6 1.7 31.0 10.8 1.6 19.6 1.6 1.7 30.3 22.4 1.5 1.6 1.5 0.6 1.5 27.9 1.6 1.8 0.0 1.7 2.1 1.6 1.6 1.6 1.6 21.5 1.5 1.6 1.7 35.5 0.0 1.6 0.0 2.3 1.5 0.3 1.5 1.2 3.0 1.4 2.0 1.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 1.1 1.2 1.1 1.2 1.5 1.5 1.4 1.0 1.2 1.3 1.7 1.5 1.3 2.0 1.4 1.0 1.1 1.5 25.6 25.7 8.5 29.7 31.0 10.8 30.3 22.4 27.9 35.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 HEPACAM2 FLJ38683 ENSG00000188175 "HEPACAM family member 2" A8MVW5 7 93188586-93226524 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 43.4;kidney: 24.5;pituitary gland: 16.1" "Group enriched" "Detected in some" 23 "Intestinal endocrine cells: 209.3;Mucus-secreting cells: 364.1;Paneth cells: 298.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 37 "SCLC-21H: 63.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012381 Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes NA 89000 "Vesicles, Mitotic spindle" Nucleoplasm "HPA012381: AB_1853037" "unprognostic (2.01e-3)" "unprognostic (6.05e-2)" "prognostic favorable (9.73e-5)" "unprognostic (1.33e-2)" "unprognostic (7.27e-2)" "unprognostic (2.24e-2)" "unprognostic (4.48e-2)" "unprognostic (8.40e-3)" "unprognostic (7.61e-2)" "unprognostic (8.68e-2)" "unprognostic (5.37e-3)" "unprognostic (4.93e-2)" "unprognostic (3.64e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (3.82e-1)" "unprognostic (6.34e-2)" 0.1 0.2 0.2 8.5 0.2 0.6 3.4 0.1 0.1 0.1 29.4 0.1 5.3 11.8 0.1 0.4 0.2 0.1 0.8 0.3 0.2 0.2 24.5 0.2 0.4 0.1 0.2 0.1 0.1 5.5 0.0 16.1 0.4 0.2 0.7 38.9 0.1 4.1 1.2 0.1 0.1 43.4 0.4 0.2 0.2 4.0 1.4 0.1 0.3 0.1 0.1 2.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 8.3 0.0 2.1 0.0 6.7 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 209.3 0.0 0.0 1.9 0.0 0.0 6.8 0.0 364.1 0.0 0.0 298.7 0.0 0.0 0.0 0.0 0.0 4.5 0.7 0.1 0.1 0.0 12.4 0.0 HEPH "CPL, KIAA0698" ENSG00000089472 Hephaestin Q9BQS7 X 66162549-66268867 "Predicted intracellular proteins, Predicted membrane proteins" "Copper transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 68.7" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 139.7;Mucus-secreting cells: 80.7;Paneth cells: 106.6;Undifferentiated cells: 56.0" "Cancer enhanced" "Detected in all" "colorectal cancer: 37.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.9;HEL: 11.0;HSkMC: 16.6;K-562: 30.8;LHCN-M2: 12.7;SuSa: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA005824 Approved NA NA 1200000 "HPA005824: AB_1850603" "unprognostic (3.10e-1)" "unprognostic (1.85e-1)" "unprognostic (1.25e-2)" "unprognostic (4.25e-2)" "unprognostic (1.29e-3)" "unprognostic (2.25e-1)" "unprognostic (4.94e-2)" "unprognostic (6.17e-2)" "unprognostic (1.40e-2)" "unprognostic (3.35e-1)" "unprognostic (2.40e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (7.00e-6)" "unprognostic (3.08e-2)" "unprognostic (4.46e-2)" "unprognostic (1.04e-1)" "unprognostic (1.17e-2)" 4.0 12.2 8.3 10.9 9.3 0.0 3.9 3.7 10.1 11.6 38.4 9.7 8.9 32.9 18.3 9.0 7.5 8.7 21.4 14.8 8.1 5.0 3.7 1.4 7.1 1.3 9.2 10.2 10.2 1.0 0.9 2.5 0.9 8.5 11.0 33.5 11.4 3.0 14.5 0.5 2.8 68.7 34.8 6.7 4.4 8.6 3.2 8.8 0.0 3.2 2.7 1.1 11.2 6.4 0.0 0.2 0.0 0.0 0.0 0.6 0.5 0.0 0.0 12.9 1.0 0.0 0.0 0.3 3.2 0.1 0.0 0.0 7.6 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 3.6 0.0 11.0 0.0 0.0 0.1 0.0 0.0 16.6 0.0 0.0 0.0 4.5 0.0 0.0 30.8 0.3 12.7 0.0 0.0 0.2 6.3 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 32.6 0.0 0.0 0.3 7.4 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 8.3 9.3 3.7 10.1 8.1 5.0 9.2 10.2 8.5 8.8 0.0 0.0 0.5 0.0 0.8 0.7 23.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.5 2.3 139.7 0.0 1.0 0.0 6.2 0.3 0.0 0.0 0.2 0.0 39.2 6.2 0.0 1.1 10.6 0.0 0.0 0.0 80.7 24.9 3.0 106.6 28.0 0.0 0.8 6.5 12.5 0.0 0.2 0.5 0.0 0.0 56.0 0.1 HEPHL1 DKFZp686F22190 ENSG00000181333 "Hephaestin like 1" Q6MZM0 11 94021361-94113751 "Predicted membrane proteins" "Copper transport, Ion transport, Transport" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 68.0" "Cell type enriched" "Detected in some" 5 "Basal keratinocytes: 9.3" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 20.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 1.4;HaCaT: 4.2;HBEC3-KT: 7.5" "Region enriched" "Detected in single" 21 "olfactory region: 1.4" "Not detected" "Not detected" HPA031517 Uncertain NA NA 51000000 "HPA031517: AB_10603769" "unprognostic (9.16e-2)" "prognostic unfavorable (4.94e-4)" "unprognostic (2.40e-1)" "unprognostic (3.26e-6)" "unprognostic (3.17e-1)" "unprognostic (3.45e-1)" "unprognostic (1.72e-2)" "unprognostic (6.71e-2)" "unprognostic (5.34e-1)" "unprognostic (1.09e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (1.00e-1)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.25e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 6.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 68.0 16.2 0.0 4.8 1.1 0.3 0.1 0.0 0.9 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.1 4.2 0.0 7.5 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.3 1.1 0.0 0.1 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 HERC4 "DKFZP564G092, KIAA1593" ENSG00000148634 "HECT and RLD domain containing E3 ubiquitin protein ligase 4" Q5GLZ8 10 67921899-68075348 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 55.9;fHDF/TERT166: 62.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045453, HPA070301" Uncertain Supported "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA045453: AB_10961917, HPA070301: AB_2686247" "unprognostic (3.66e-2)" "unprognostic (6.31e-2)" "unprognostic (1.58e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-1)" "unprognostic (4.23e-2)" "unprognostic (3.51e-2)" "unprognostic (1.01e-3)" "unprognostic (3.54e-1)" "unprognostic (8.57e-2)" "unprognostic (4.94e-3)" "unprognostic (2.25e-2)" "prognostic unfavorable (3.86e-5)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "unprognostic (3.98e-1)" "unprognostic (2.31e-2)" 25.3 29.4 21.9 28.0 28.4 14.6 22.7 30.5 24.9 24.2 20.5 22.2 26.7 20.0 28.1 24.3 22.2 19.2 20.2 20.5 21.9 22.7 20.6 24.5 20.6 30.2 30.9 14.8 24.5 17.1 25.2 35.6 23.8 26.8 19.4 23.9 17.8 17.7 24.1 19.6 20.9 25.8 23.0 28.7 27.0 17.3 22.2 33.6 23.6 19.5 13.8 28.3 24.7 47.9 7.7 10.4 13.5 9.3 9.9 11.5 6.5 22.8 8.2 5.1 8.6 13.4 18.4 4.6 55.9 34.6 21.0 13.6 4.6 10.8 8.0 4.4 62.8 13.1 12.1 5.7 8.3 28.4 5.2 2.8 3.7 13.5 3.5 7.1 4.5 6.6 9.0 9.7 11.2 10.0 26.4 13.0 4.5 3.9 4.1 32.3 9.8 3.2 5.3 3.0 5.3 14.3 4.3 2.1 2.8 9.5 6.5 2.5 2.8 18.2 7.8 7.9 11.1 4.8 5.7 17.7 11.1 6.2 27.2 9.6 2.8 3.3 5.1 20.3 8.7 3.8 13.5 9.3 11.1 8.2 7.9 11.5 7.7 9.1 9.8 10.4 7.5 8.8 9.0 11.7 9.9 7.6 2.7 10.6 6.5 21.9 28.4 30.5 24.9 21.9 22.7 30.9 14.8 26.8 33.6 44.7 27.7 32.0 24.8 44.8 51.3 21.2 12.7 17.4 15.9 17.4 41.2 23.4 6.6 17.2 55.0 28.7 37.8 0.0 10.6 35.6 22.1 32.9 30.0 21.3 20.3 50.9 21.2 31.3 32.9 34.9 24.7 27.8 16.9 16.2 25.6 23.2 28.7 31.6 18.0 18.2 45.2 6.5 25.8 22.4 10.2 53.2 13.0 27.3 17.7 45.1 HERPUD1 "HERP, KIAA0025, Mif1, SUP" ENSG00000051108 "Homocysteine inducible ER protein with ubiquitin like domain 1" Q15011 16 56932048-56944863 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Melanocytes: 899.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 78.5;U-266/70: 89.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037041, CAB037104, HPA040754, HPA041219" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268" "unprognostic (1.92e-1)" "unprognostic (3.47e-1)" "unprognostic (8.64e-2)" "unprognostic (3.93e-3)" "unprognostic (3.39e-1)" "unprognostic (5.00e-3)" "unprognostic (1.17e-1)" "unprognostic (9.69e-3)" "unprognostic (3.33e-1)" "unprognostic (2.56e-1)" "unprognostic (2.84e-1)" "unprognostic (3.50e-1)" "prognostic favorable (1.41e-9)" "unprognostic (1.06e-1)" "unprognostic (3.93e-2)" "unprognostic (2.19e-2)" "unprognostic (2.27e-3)" 22.7 38.8 16.2 35.6 20.7 21.6 39.4 17.7 20.0 30.1 32.1 20.0 48.8 21.4 21.6 51.6 15.0 20.2 32.5 28.8 15.8 15.5 42.9 57.7 30.4 40.0 25.6 12.5 44.8 148.6 37.6 26.7 26.2 25.6 49.5 32.3 35.3 108.6 76.1 34.6 18.3 24.7 17.6 24.2 38.3 37.2 10.6 20.8 9.6 64.2 20.4 53.8 24.4 25.9 50.8 121.9 29.0 39.5 22.4 33.4 46.5 4.5 5.0 4.9 10.2 11.4 15.0 17.6 10.8 17.2 14.0 11.0 6.9 10.4 18.5 13.9 10.5 14.3 7.9 8.3 3.8 13.9 10.7 5.0 1.6 8.3 25.0 62.5 3.3 8.3 18.1 36.5 6.3 20.2 16.9 10.6 20.7 2.5 26.5 39.0 3.8 6.2 6.8 3.1 26.5 11.4 4.3 12.5 78.5 30.0 5.1 5.4 6.3 9.4 46.4 47.9 7.3 5.2 12.5 6.5 5.8 5.8 5.1 4.3 89.5 29.1 28.9 8.3 4.6 7.6 23.9 39.5 18.0 16.1 31.0 17.4 50.8 17.5 21.1 30.6 37.8 11.4 17.4 29.0 22.4 21.5 121.9 33.4 46.5 16.2 20.7 17.7 20.0 15.8 15.5 25.6 12.5 25.6 20.8 65.5 113.2 400.7 628.3 323.4 125.0 136.3 71.4 44.2 47.8 68.0 265.1 118.1 144.2 165.3 52.0 119.9 168.3 70.0 173.1 150.4 186.1 478.3 152.0 140.9 178.2 44.5 416.3 118.4 182.3 185.2 96.4 276.3 899.3 227.2 208.8 76.2 141.3 182.4 89.8 157.6 103.7 97.0 210.0 43.1 8.9 223.2 580.2 183.3 123.2 295.1 HERPUD2 FLJ22313 ENSG00000122557 "HERPUD family member 2" Q9BSE4 7 35632659-35695571 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 290.9;Late spermatids: 471.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015630, HPA076087" Approved Approved "Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" "HPA015630: AB_1850609, HPA076087: AB_2686774" "unprognostic (1.85e-2)" "unprognostic (5.31e-3)" "unprognostic (2.76e-1)" "unprognostic (3.79e-1)" "unprognostic (3.46e-1)" "unprognostic (2.73e-2)" "unprognostic (2.48e-1)" "unprognostic (1.26e-1)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (2.30e-2)" "unprognostic (7.95e-2)" "unprognostic (5.13e-2)" "unprognostic (1.95e-1)" "unprognostic (5.42e-2)" "unprognostic (6.54e-2)" 22.7 13.7 19.2 25.6 21.7 34.3 21.9 25.0 21.7 24.2 20.3 18.6 18.8 16.1 24.3 17.1 21.2 19.9 26.4 16.6 17.5 14.0 17.6 25.3 22.7 33.7 16.7 18.3 37.0 31.4 18.0 22.5 21.6 15.4 21.6 19.3 19.5 19.6 23.8 17.9 20.9 20.5 23.9 18.5 24.1 18.0 39.5 18.3 34.3 22.5 15.4 23.2 25.0 22.0 5.7 5.9 19.2 9.2 12.1 12.2 4.8 18.0 6.9 13.0 12.7 19.5 14.9 10.5 12.9 18.1 8.4 9.5 8.2 21.6 13.0 20.5 16.3 28.8 22.8 7.2 9.3 13.1 8.6 9.3 9.0 8.4 5.5 16.8 9.1 11.5 18.6 16.8 10.6 17.2 17.3 13.9 16.1 14.1 17.4 14.5 7.6 10.3 14.9 10.9 11.2 9.5 12.5 15.7 10.4 10.9 8.1 10.8 17.9 16.3 15.5 11.1 20.7 15.6 11.0 16.2 13.2 15.2 12.8 10.2 24.3 27.6 13.7 12.7 14.1 24.1 5.8 6.8 19.2 10.6 7.6 12.2 4.4 9.5 11.3 5.9 5.7 5.9 8.0 11.7 12.1 9.2 3.6 8.6 4.8 19.2 21.7 25.0 21.7 17.5 14.0 16.7 18.3 15.4 18.3 23.8 17.9 41.2 14.4 14.9 13.6 11.8 15.3 10.7 11.4 5.2 7.9 14.5 14.9 21.2 290.9 17.4 20.8 0.0 25.4 21.7 16.6 16.1 35.8 17.9 15.8 11.1 13.7 20.9 26.3 471.7 25.3 19.2 21.9 22.6 12.2 22.4 26.9 14.0 23.7 11.2 13.0 12.9 15.0 27.7 18.3 13.8 26.0 62.3 13.4 18.2 HEXB ENSG00000049860 "Hexosaminidase subunit beta" P07686 5 74640023-74722647 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 174.3" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 395.6;Hofbauer cells: 319.1;Syncytiotrophoblasts: 412.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 108.4;GAMG: 90.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055409, HPA056010" Enhanced "Intracellular and membrane" NA NA 43000000 "HPA055409: AB_2682808, HPA056010: AB_2683008" "unprognostic (3.45e-1)" "unprognostic (5.84e-2)" "unprognostic (1.85e-2)" "unprognostic (8.72e-2)" "unprognostic (1.12e-2)" "unprognostic (6.44e-3)" "prognostic unfavorable (3.36e-8)" "unprognostic (2.21e-1)" "unprognostic (5.01e-2)" "unprognostic (1.58e-3)" "unprognostic (6.45e-2)" "unprognostic (2.27e-1)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (1.31e-2)" "unprognostic (9.67e-2)" "unprognostic (1.64e-2)" 48.0 21.9 7.7 13.6 11.6 11.1 26.1 7.4 11.2 25.8 34.2 9.5 18.0 21.6 22.1 77.3 20.6 17.3 28.1 46.3 7.1 9.1 30.4 44.5 40.9 19.3 8.5 6.7 22.7 30.4 21.8 14.3 174.3 9.3 22.6 26.3 21.0 34.6 13.3 21.0 15.3 33.6 21.0 8.7 20.5 20.7 16.2 6.1 10.8 33.7 15.2 15.4 24.0 19.7 8.9 59.8 23.8 65.9 7.6 16.4 42.9 20.3 16.0 5.6 18.5 108.4 33.5 18.2 25.0 81.1 24.4 53.0 18.8 26.6 0.0 19.8 20.5 90.2 16.4 6.0 25.4 32.3 11.4 10.8 2.6 15.5 14.1 31.8 2.2 22.0 29.5 15.0 25.6 17.2 38.5 27.9 6.4 7.5 33.3 26.7 20.6 2.6 5.1 5.2 19.3 7.2 6.2 8.1 26.5 16.8 18.6 3.6 4.5 19.4 13.2 24.1 10.1 13.9 15.1 16.6 16.1 4.0 29.6 23.0 15.4 26.5 0.1 36.7 20.0 29.2 14.5 65.9 18.6 14.2 24.5 16.4 8.9 11.7 13.1 59.8 5.5 11.2 10.9 23.8 7.6 14.6 18.0 13.7 42.9 7.7 11.6 7.4 11.2 7.1 9.1 8.5 6.7 9.3 6.1 38.7 35.5 39.5 70.4 39.0 9.5 18.9 63.7 20.1 18.2 27.9 7.9 395.6 16.6 123.0 1.1 60.6 71.9 0.0 111.0 143.1 100.1 65.8 69.2 62.8 319.1 9.5 21.9 83.4 134.6 1.7 78.9 151.2 69.2 83.8 50.0 34.8 68.2 51.8 67.8 65.5 10.6 45.3 54.5 0.2 1.1 28.4 412.8 37.3 76.2 54.8 HFE HLA-H ENSG00000010704 Hemochromatosis Q30201 6 26087281-26098343 "Disease related genes, Predicted membrane proteins" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017276, HPA053470" Approved Supported "Nucleoplasm,Plasma membrane" No No "Plasma membrane" Nucleoplasm "HPA017276: AB_1850677, HPA053470: AB_2682163" "unprognostic (6.96e-2)" "unprognostic (7.87e-2)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (6.07e-3)" "unprognostic (7.58e-2)" "unprognostic (4.23e-1)" "unprognostic (1.77e-1)" "unprognostic (8.21e-3)" "unprognostic (1.78e-1)" "unprognostic (3.31e-3)" "unprognostic (1.82e-1)" "unprognostic (1.33e-2)" "unprognostic (2.12e-2)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.17e-1)" 7.2 13.7 2.2 4.4 2.7 0.0 6.2 1.2 2.5 6.7 7.1 3.5 10.3 4.2 6.8 13.9 7.6 5.2 13.3 8.9 2.0 1.4 5.4 12.8 9.0 16.1 2.3 2.0 8.1 16.2 14.6 2.2 7.6 4.3 12.6 5.3 13.7 7.0 8.1 3.1 3.2 5.8 10.4 3.2 14.4 6.1 4.9 1.2 2.0 7.7 3.9 5.0 8.6 5.2 3.5 4.6 1.9 10.5 0.2 2.2 3.4 8.2 18.9 0.3 9.2 14.0 10.8 0.0 5.9 14.1 7.6 12.0 1.6 16.8 0.8 16.1 9.7 11.5 5.3 0.0 6.9 9.7 2.1 0.1 0.2 4.5 1.2 2.7 0.0 0.3 11.1 2.0 8.4 0.7 6.7 5.1 0.0 0.3 0.2 6.5 3.4 0.0 0.1 0.4 3.9 0.0 1.1 0.0 0.1 6.3 5.5 0.0 0.0 3.5 0.0 5.1 0.1 26.9 0.9 3.9 5.4 0.5 5.3 5.1 0.1 0.1 0.1 8.0 0.1 11.6 1.2 10.5 0.0 1.7 10.2 1.3 3.5 1.7 2.2 4.6 1.5 0.4 1.2 1.9 0.2 8.2 0.3 0.3 3.4 2.2 2.7 1.2 2.5 2.0 1.4 2.3 2.0 4.3 1.2 3.0 3.2 1.9 2.3 1.4 0.7 2.8 5.1 6.7 7.9 5.2 2.0 1.2 0.0 2.5 0.1 3.0 3.4 0.0 3.0 0.6 3.0 3.8 2.3 8.1 8.8 0.0 1.7 8.6 21.1 0.0 3.4 5.7 0.0 0.0 3.7 3.7 2.5 0.0 5.6 2.2 2.0 0.0 1.4 0.2 1.0 3.0 1.5 0.7 3.7 1.3 HFE2 "haemojuvelin, hemojuvelin, HFE2A, HJV, JH, RGMC" ENSG00000168509 "Hemochromatosis type 2 (juvenile)" Q6ZVN8 1 146017468-146036746 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 49.4;skeletal muscle: 128.9;tongue: 28.2" "Cell type enriched" "Detected in some" 21 "Hepatocytes: 163.4" "Cancer enriched" "Detected in some" 96 "liver cancer: 87.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.1;HSkMC: 5.0;K-562: 4.8;RH-30: 1.7" "Low region specificity" "Detected in many" NA NA 42000 "unprognostic (2.30e-1)" "unprognostic (6.98e-4)" "unprognostic (7.06e-2)" "unprognostic (1.11e-2)" "unprognostic (2.77e-3)" "unprognostic (2.55e-1)" "unprognostic (8.50e-2)" "unprognostic (2.36e-1)" "unprognostic (7.14e-2)" "unprognostic (1.18e-1)" "unprognostic (8.96e-8)" "unprognostic (6.61e-2)" "unprognostic (2.72e-1)" "unprognostic (1.76e-2)" 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 2.5 0.0 0.0 14.0 0.0 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 128.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 28.2 2.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.1 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 163.4 0.0 0.0 0.0 2.5 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HGF "DFNB39, F-TCF, HGFB, HPTA, SF" ENSG00000019991 "Hepatocyte growth factor" P14210 7 81699008-81770438 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Serine protease homolog" "Cancer-related genes, Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 116.9" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 19.8;Ito cells: 40.5;Muller glia cells: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "basophil: 33.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 33.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 45.8;HHSteC: 35.8;HL-60: 20.1;hTEC/SVTERT24-B: 22.5;Karpas-707: 62.0;U-87 MG: 16.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010333, HPA040360, HPA044088" Approved "Secreted to blood" NA NA 4110000 "CAB010333: AB_647965, HPA040360: AB_2676939, HPA044088: AB_2678804" "unprognostic (5.24e-2)" "unprognostic (6.77e-2)" "unprognostic (1.72e-2)" "unprognostic (5.12e-2)" "unprognostic (1.85e-2)" "unprognostic (7.45e-5)" "unprognostic (1.66e-1)" "unprognostic (9.28e-3)" "unprognostic (3.28e-2)" "unprognostic (2.97e-2)" "unprognostic (2.74e-1)" "unprognostic (5.29e-2)" "prognostic unfavorable (5.59e-4)" "unprognostic (7.90e-3)" "unprognostic (2.92e-2)" "unprognostic (1.14e-2)" "unprognostic (2.06e-2)" 6.2 10.6 1.4 2.9 1.2 4.6 4.8 0.5 4.5 5.1 4.0 0.4 2.9 1.5 5.2 3.1 2.9 4.0 7.1 9.3 3.6 1.3 7.3 27.5 15.8 2.0 1.3 1.4 3.2 1.4 1.6 4.3 116.9 1.9 10.8 1.9 2.0 2.2 3.2 1.4 0.9 1.8 15.1 6.0 6.6 2.3 2.0 0.9 0.5 5.3 1.4 1.4 10.5 21.5 0.0 2.0 33.5 7.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.7 45.8 0.0 0.1 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 35.8 20.1 0.1 10.8 0.0 22.5 0.0 0.0 0.5 0.0 0.0 62.0 0.1 0.0 0.0 13.9 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 16.4 4.2 0.0 33.5 6.6 1.6 0.0 7.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.3 0.0 6.7 0.4 0.0 1.5 1.4 1.2 0.5 4.5 3.6 1.3 1.3 1.4 1.9 0.9 0.0 5.5 0.0 0.3 0.9 0.1 0.8 2.5 0.0 1.2 0.0 0.0 4.6 0.0 0.0 11.8 6.3 0.0 0.0 0.0 3.2 19.8 0.2 1.1 0.5 17.6 0.0 0.0 40.5 14.3 1.7 17.0 5.5 1.7 3.6 0.0 30.6 0.0 0.0 10.3 0.0 0.3 12.9 13.8 0.0 0.1 0.1 10.1 0.0 0.0 0.1 HGFAC "HGFA, HGFAP" ENSG00000109758 "HGF activator" Q04756 4 3441887-3449495 "Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 141 "liver: 128.0" "Group enriched" "Detected in some" 14 "Early spermatids: 70.8;Hepatocytes: 52.3;Late spermatids: 115.2" "Cancer enriched" "Detected in some" 22 "liver cancer: 26.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Hep G2: 10.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA058279, HPA059076" Enhanced "Secreted to blood" NA NA 7590000 11000000000 "HPA058279: AB_2683665, HPA059076: AB_2683898" "unprognostic (2.70e-2)" "unprognostic (8.20e-2)" "unprognostic (1.57e-1)" "unprognostic (1.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.39e-2)" "unprognostic (2.85e-3)" "unprognostic (5.37e-3)" "unprognostic (5.90e-2)" "unprognostic (1.81e-1)" "unprognostic (8.54e-3)" "unprognostic (5.52e-2)" "prognostic unfavorable (9.31e-4)" "unprognostic (2.87e-1)" "unprognostic (2.24e-1)" "unprognostic (9.49e-2)" "unprognostic (3.74e-4)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 128.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.2 0.0 1.3 0.7 0.4 0.1 0.0 0.0 0.6 1.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.5 0.8 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 52.3 0.0 3.2 0.0 2.5 3.5 115.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 0.3 0.0 0.0 0.0 5.7 1.3 0.0 0.0 0.0 0.0 0.0 HGSNAT "FLJ32731, HGNAT, TMEM76" ENSG00000165102 "Heparan-alpha-glucosaminide N-acetyltransferase" Q68CP4 8 43140455-43202855 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Disease mutation, Mucopolysaccharidosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029578 Approved NA NA "HPA029578: AB_10602423" "unprognostic (5.35e-2)" "unprognostic (4.61e-2)" "unprognostic (4.31e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (5.46e-4)" "unprognostic (3.94e-3)" "unprognostic (1.10e-1)" "unprognostic (6.54e-3)" "unprognostic (5.02e-2)" "prognostic favorable (6.33e-5)" "unprognostic (2.55e-2)" "unprognostic (5.48e-3)" "unprognostic (2.03e-1)" "unprognostic (1.27e-2)" "unprognostic (1.55e-1)" "unprognostic (1.72e-1)" "unprognostic (3.45e-2)" 24.8 16.9 21.4 16.0 18.8 16.0 29.6 18.5 20.6 28.5 17.8 20.3 24.5 15.4 27.5 29.7 20.4 24.0 22.1 18.7 18.0 16.5 16.9 19.9 21.8 14.9 12.9 19.8 31.1 28.8 26.5 24.8 25.6 15.7 21.6 14.7 20.9 20.7 20.7 11.9 29.5 18.1 25.3 18.2 14.9 18.6 8.5 11.7 9.1 21.9 18.4 18.2 21.1 23.2 2.3 14.5 8.3 8.0 8.2 3.1 4.0 11.7 15.9 4.0 8.0 32.8 24.8 6.0 13.4 16.0 9.8 8.7 2.2 17.3 7.1 9.3 18.6 7.0 6.8 1.7 8.1 5.7 2.8 3.2 7.0 10.1 3.9 10.5 1.5 1.1 16.6 11.7 5.4 11.2 15.7 17.3 3.1 3.2 10.0 17.8 5.3 6.3 3.1 3.8 7.0 2.4 0.7 7.3 3.5 16.1 9.9 2.1 6.3 17.5 5.6 7.7 8.9 19.4 9.0 20.2 15.1 2.5 9.3 5.5 8.1 7.6 2.6 12.1 2.8 9.2 0.2 8.0 8.3 2.8 5.0 3.1 1.8 2.3 2.8 14.5 2.3 1.7 1.9 3.0 8.2 7.2 1.9 1.5 4.0 21.4 18.8 18.5 20.6 18.0 16.5 12.9 19.8 15.7 11.7 14.9 32.2 9.1 18.6 16.0 43.5 9.6 22.9 14.7 6.8 48.8 47.1 30.0 3.3 25.0 0.4 30.9 25.7 0.0 24.4 35.2 27.7 19.3 8.1 19.2 26.1 23.8 23.2 42.4 29.7 1.4 32.5 31.5 18.6 19.0 24.3 19.7 25.8 17.5 29.7 9.7 37.8 25.8 22.6 1.2 1.9 18.4 25.2 15.2 18.7 14.3 HHAT "FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn" ENSG00000054392 "Hedgehog acyltransferase" Q5VTY9 1 210328252-210676296 "Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 17.4;Muller glia cells: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.1" "Group enriched" "Detected in many" 5 "B-cells: 3.0;dendritic cells: 7.1;T-cells: 2.6" "Cell line enhanced" "Detected in many" "HMC-1: 13.4;LHCN-M2: 11.2;RH-30: 12.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA016462 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA016462: AB_2669360" "unprognostic (1.26e-1)" "unprognostic (1.45e-1)" "unprognostic (1.86e-1)" "unprognostic (5.02e-3)" "unprognostic (8.89e-3)" "unprognostic (4.81e-2)" "unprognostic (3.32e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (1.67e-3)" "unprognostic (1.43e-1)" "unprognostic (4.13e-3)" "prognostic favorable (8.47e-7)" "unprognostic (2.55e-1)" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (5.67e-2)" 3.8 11.7 5.1 5.4 5.3 1.3 7.5 0.9 5.0 10.4 4.9 3.9 9.7 3.3 12.8 10.6 4.7 8.1 8.5 4.1 3.1 2.6 6.3 4.3 4.1 2.3 2.7 3.8 4.9 5.2 4.2 15.1 3.8 3.3 11.6 4.0 11.5 10.4 6.6 2.8 5.3 4.2 5.1 2.3 3.8 3.9 6.2 2.5 7.1 12.8 3.1 5.7 6.7 4.9 3.0 7.1 0.0 0.7 0.2 2.6 0.7 0.7 0.9 2.3 1.4 1.0 1.3 4.7 1.1 1.0 1.8 3.1 0.2 0.9 0.0 1.2 0.9 3.0 0.6 0.5 0.5 2.2 1.6 1.1 0.0 0.1 1.0 0.2 0.3 13.4 1.2 2.7 1.6 1.2 3.1 0.3 1.1 0.0 0.0 11.2 1.1 0.6 0.0 0.6 0.6 0.1 1.2 12.2 0.0 7.3 2.5 1.9 7.7 2.0 0.0 5.6 6.1 3.9 0.7 1.7 2.8 8.5 1.6 4.3 3.8 0.1 0.0 1.2 0.8 2.3 0.0 0.6 0.0 1.5 0.7 2.6 3.0 1.8 1.7 0.7 2.7 0.1 0.6 0.0 0.2 0.2 7.1 0.4 0.7 5.1 5.3 0.9 5.0 3.1 2.6 2.7 3.8 3.3 2.5 0.0 3.7 1.4 4.9 1.9 0.4 2.2 2.5 17.4 0.0 8.7 0.0 4.0 3.3 2.6 0.7 2.1 1.3 0.0 0.6 2.6 1.1 5.2 0.0 2.1 1.8 0.0 0.0 2.5 2.4 0.0 1.1 0.9 0.0 0.0 3.1 21.1 1.2 2.5 0.4 0.8 0.5 0.0 1.0 0.3 0.9 2.3 1.8 0.8 1.9 4.6 HHATL "C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3" ENSG00000010282 "Hedgehog acyltransferase like" Q9HCP6 3 42692663-42702827 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "brain: 57.1;heart muscle: 184.7;skeletal muscle: 93.6" "Group enriched" "Detected in some" 7 "Bipolar cells: 96.4;Cardiomyocytes: 54.3;Muller glia cells: 48.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 25.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.2;HSkMC: 1.3;Karpas-707: 1.2;NTERA-2: 1.4;RPMI-8226: 4.2;THP-1: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA018174 Enhanced NA NA "HPA018174: AB_2116671" "unprognostic (1.72e-2)" "unprognostic (1.56e-1)" "unprognostic (5.20e-2)" "unprognostic (9.71e-2)" "unprognostic (7.94e-3)" "unprognostic (3.79e-2)" "unprognostic (8.80e-2)" "unprognostic (2.47e-1)" "unprognostic (5.98e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (9.68e-2)" "unprognostic (1.01e-1)" "unprognostic (2.89e-1)" "unprognostic (3.14e-1)" 1.5 1.6 12.9 1.3 29.0 1.3 1.9 2.3 15.2 1.5 1.4 36.5 0.0 1.3 1.7 1.5 2.7 2.0 1.5 184.7 14.5 8.9 1.4 1.3 1.5 1.4 51.6 10.5 1.4 1.8 1.4 0.9 1.4 25.9 1.9 1.4 5.4 4.7 1.4 93.6 1.6 1.4 1.4 57.1 1.4 1.3 1.7 39.9 0.0 9.3 7.2 1.4 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.5 0.0 4.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.3 0.5 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 29.0 2.3 15.2 14.5 8.9 51.6 10.5 25.9 39.9 0.0 0.0 0.0 0.0 0.3 96.4 54.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 48.8 0.3 0.0 0.0 0.0 9.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 HHIP "FLJ20992, HIP" ENSG00000164161 "Hedgehog interacting protein" Q96QV1 4 144646021-144745271 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.5;lung: 29.7" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 2: 177.0;Leydig cells: 126.0;Peritubular cells: 41.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.6" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 69.8;TIME: 80.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012616 Uncertain Approved Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "HPA012616: AB_1850687" "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (7.12e-3)" "unprognostic (8.18e-2)" "unprognostic (2.43e-2)" "unprognostic (1.02e-1)" "unprognostic (3.60e-1)" "unprognostic (1.95e-2)" "unprognostic (4.20e-1)" "unprognostic (1.90e-2)" "unprognostic (1.89e-1)" "unprognostic (9.66e-3)" "unprognostic (7.13e-3)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (2.38e-1)" 4.0 5.2 9.9 1.7 22.2 2.3 1.1 2.3 16.0 3.4 6.5 31.5 0.0 5.5 4.1 8.1 1.0 1.2 3.0 1.1 16.0 6.3 2.4 12.7 29.7 1.0 21.6 9.9 2.2 4.8 1.0 1.1 1.0 17.5 9.8 6.8 4.4 1.3 6.2 1.3 1.1 8.2 1.3 12.3 1.0 11.2 3.7 26.5 2.3 1.6 0.0 1.0 7.1 1.0 0.1 2.6 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.7 3.8 69.8 6.2 0.0 0.0 1.0 0.0 9.8 0.0 0.9 0.0 0.6 0.1 14.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.5 0.0 0.8 0.0 0.5 0.4 0.0 2.1 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 2.6 0.0 0.0 9.9 22.2 2.3 16.0 16.0 6.3 21.6 9.9 17.5 26.5 11.9 177.0 0.0 0.0 0.0 1.4 1.1 0.0 8.1 6.8 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.4 0.0 16.1 0.0 0.1 0.0 0.0 16.0 0.0 1.8 126.0 1.0 1.7 0.0 0.0 0.2 0.1 0.0 41.4 0.0 3.5 0.0 0.4 0.2 0.2 0.5 0.0 0.0 0.0 0.0 HHIPL2 "FLJ13840, KIAA1822L" ENSG00000143512 "HHIP like 2" Q6UWX4 1 222522258-222548103 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 9.4;testis: 10.4;thyroid gland: 4.6" "Group enriched" "Detected in some" 9 "Early spermatids: 14.1;Late spermatids: 21.2;Spermatocytes: 8.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 16.2;Hep G2: 4.9;RH-30: 18.4;SuSa: 7.1;U-87 MG: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA059673 Enhanced Uncertain Mitochondria,Cytosol "Secreted in other tissues" No NA Mitochondria Cytosol "HPA059673: AB_2684100" "unprognostic (1.35e-2)" "unprognostic (4.62e-3)" "unprognostic (2.91e-1)" "unprognostic (9.21e-2)" "unprognostic (3.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.74e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.07e-2)" "unprognostic (3.64e-1)" "unprognostic (2.29e-2)" "unprognostic (2.14e-2)" "unprognostic (0.00e+0)" "unprognostic (6.52e-2)" "unprognostic (4.21e-4)" "unprognostic (2.30e-3)" "unprognostic (8.38e-2)" 0.3 0.7 0.0 0.1 0.6 0.1 0.2 0.1 1.4 0.7 0.0 0.6 0.0 0.0 0.1 0.5 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.9 9.4 0.2 0.3 1.9 3.9 0.0 0.1 0.1 0.0 0.0 0.1 0.1 10.4 0.0 0.0 4.6 0.0 0.3 0.2 0.7 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.1 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 16.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 4.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.3 0.0 18.4 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 7.1 0.0 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.1 0.0 9.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.1 1.4 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 1.7 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.5 0.0 0.0 0.0 0.0 0.0 HHLA2 "B7-H5, B7H7, B7y" ENSG00000114455 "HERV-H LTR-associating 2" Q9UM44 3 108296490-108378285 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "intestine: 125.2" "Cell type enriched" "Detected in many" 5 "Enterocytes: 168.4" "Group enriched" "Detected in many" 12 "colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.1;Karpas-707: 5.9" "Low region specificity" "Detected in all" HPA055478 Enhanced NA NA "HPA055478: AB_2682830" "unprognostic (1.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.03e-1)" "unprognostic (3.11e-1)" "unprognostic (2.30e-1)" "unprognostic (1.59e-2)" "unprognostic (8.14e-5)" "unprognostic (1.76e-1)" "unprognostic (2.28e-1)" "unprognostic (1.08e-1)" "unprognostic (6.42e-3)" "unprognostic (1.24e-1)" "unprognostic (1.62e-3)" "unprognostic (1.47e-1)" "unprognostic (2.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.66e-2)" 0.2 0.2 0.3 4.3 0.3 0.0 0.2 0.2 0.3 0.3 39.6 0.2 0.2 25.5 0.2 0.5 0.2 0.9 8.5 0.2 0.3 0.3 7.8 0.4 2.2 0.2 0.3 0.2 0.6 1.2 0.0 0.3 0.2 0.2 0.2 25.2 0.2 0.2 0.2 0.2 0.1 125.2 0.3 0.5 0.3 2.5 1.9 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.3 5.1 1.2 1.5 0.3 0.5 0.7 0.4 0.6 0.4 0.5 0.0 0.0 1.6 0.1 0.0 0.0 0.5 3.5 0.5 0.3 0.4 0.1 0.2 0.4 1.2 0.0 0.0 8.1 0.3 0.2 2.7 0.5 0.0 1.7 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.7 5.9 0.0 0.5 0.8 3.0 1.2 0.4 0.6 0.7 0.3 1.7 0.1 0.4 1.5 1.4 1.4 0.1 0.4 1.1 0.3 0.4 0.3 0.3 1.5 0.5 0.4 3.1 1.4 0.8 0.1 1.0 0.2 1.2 0.3 1.1 0.1 0.4 0.1 0.3 0.2 0.5 5.1 0.3 0.2 0.1 0.5 0.3 1.5 0.1 0.0 0.7 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.0 1.3 0.0 0.1 0.0 0.0 0.1 20.4 24.1 2.3 0.0 0.0 0.0 0.0 5.2 2.6 0.0 168.4 0.0 32.0 0.1 0.0 0.1 2.3 0.0 0.1 0.0 1.7 0.0 0.0 3.1 0.3 0.2 0.0 1.8 9.4 0.0 36.5 9.5 0.0 19.5 0.0 0.0 0.0 0.7 0.2 0.0 0.1 0.0 13.6 0.0 HIGD1A "DKFZP564K247, HIG1, RCF1A" ENSG00000181061 "HIG1 hypoxia inducible domain family member 1A" Q9Y241 3 42784298-42804531 "Predicted membrane proteins" "Electron transport, Respiratory chain, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 535.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 89.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043336 Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA043336: AB_10795039" "unprognostic (6.46e-2)" "unprognostic (3.72e-3)" "prognostic favorable (2.12e-4)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (3.53e-1)" "unprognostic (3.70e-1)" "unprognostic (8.45e-2)" "unprognostic (6.14e-2)" "unprognostic (2.94e-1)" "unprognostic (1.24e-1)" "unprognostic (8.94e-2)" "prognostic favorable (3.99e-8)" "unprognostic (7.37e-2)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" 27.7 30.4 50.1 15.5 43.4 9.6 20.4 20.3 56.4 18.3 63.8 25.2 10.8 35.2 15.7 24.8 36.7 13.5 18.8 68.6 43.2 43.3 45.9 78.4 15.3 16.0 54.4 35.9 12.8 12.8 14.7 29.2 17.2 50.9 24.4 67.3 21.8 16.6 26.8 34.9 15.0 28.4 22.8 58.8 13.0 31.6 14.7 20.7 8.9 28.1 30.6 16.9 20.1 25.0 11.9 89.9 25.9 26.6 12.3 18.8 30.1 27.4 15.4 34.3 28.1 87.8 52.5 33.4 37.1 30.5 36.4 33.4 27.2 28.0 16.8 22.3 32.4 22.6 16.6 27.5 40.9 45.5 24.1 30.4 51.9 27.7 50.3 40.1 29.8 24.5 54.4 45.0 27.8 38.8 18.1 31.9 25.6 51.2 18.0 50.7 11.2 16.4 10.9 28.8 23.3 37.6 13.4 24.3 11.9 89.7 68.2 14.5 18.9 32.5 24.7 35.0 35.7 24.7 22.5 27.9 21.5 19.5 60.1 38.3 16.8 34.7 34.7 28.3 31.7 16.6 16.9 14.7 25.9 15.4 22.7 13.7 11.9 15.1 15.1 16.3 8.5 12.9 15.3 14.9 12.3 26.6 89.9 18.8 30.1 50.1 43.4 20.3 56.4 43.2 43.3 54.4 35.9 50.9 20.7 50.6 73.8 43.3 134.0 116.5 33.4 319.5 79.0 48.2 60.3 130.9 9.8 99.0 535.5 105.9 6.7 57.3 183.7 93.5 127.6 162.8 82.5 160.2 92.2 169.5 69.4 27.0 78.7 55.3 46.3 9.1 28.4 70.1 167.0 114.6 120.5 121.0 198.7 300.1 49.1 213.1 25.1 77.6 125.8 135.9 72.8 178.8 250.8 45.7 135.9 173.3 HIGD1B "CLST11240, CLST11240-15" ENSG00000131097 "HIG1 hypoxia inducible domain family member 1B" Q9P298 17 44846353-44850480 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 61.8" "Group enriched" "Detected in some" 32 "Sertoli cells: 750.3;Smooth muscle cells: 198.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079501 Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA079501: " "unprognostic (6.85e-2)" "unprognostic (9.41e-2)" "unprognostic (3.80e-3)" "unprognostic (2.07e-1)" "unprognostic (8.46e-2)" "unprognostic (2.37e-2)" "unprognostic (4.98e-3)" "unprognostic (3.61e-1)" "unprognostic (1.18e-2)" "unprognostic (3.98e-1)" "unprognostic (6.19e-2)" "unprognostic (3.56e-1)" "unprognostic (1.61e-3)" "unprognostic (5.23e-3)" "unprognostic (8.72e-2)" "unprognostic (1.79e-2)" "unprognostic (1.52e-2)" 6.4 0.7 12.4 0.7 18.2 0.6 3.2 4.5 9.7 5.7 1.9 3.6 0.4 1.5 6.4 7.6 2.5 3.1 7.1 11.0 12.4 10.1 2.6 0.6 21.6 1.7 15.8 6.8 2.0 2.0 2.5 0.3 61.8 8.7 3.6 1.0 0.7 1.3 4.4 7.9 1.3 1.3 7.3 6.2 0.4 1.5 1.2 8.9 0.1 3.4 1.8 1.1 3.0 1.6 1.1 3.3 4.6 2.9 1.9 3.5 1.1 0.5 1.8 0.0 2.0 0.0 0.0 1.8 1.7 0.0 0.0 0.0 1.0 0.6 1.7 0.5 0.0 0.1 0.7 0.0 0.0 0.0 1.4 2.0 0.4 2.1 1.3 0.0 2.6 3.7 0.0 0.0 0.0 0.0 0.6 0.0 2.6 2.1 1.5 0.0 0.7 1.9 2.0 1.3 0.7 1.0 2.2 1.2 2.5 0.0 1.3 2.2 1.0 0.6 0.0 0.3 0.1 0.9 1.1 0.0 1.8 0.6 1.2 1.4 1.3 3.9 2.0 1.6 3.1 2.2 4.6 1.9 0.7 3.5 2.9 1.3 0.7 2.3 2.6 3.3 1.1 2.5 2.3 0.0 1.9 0.3 0.9 2.0 1.1 12.4 18.2 4.5 9.7 12.4 10.1 15.8 6.8 8.7 8.9 0.0 0.3 0.0 0.5 3.1 0.4 3.9 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.1 14.7 0.0 0.0 0.0 0.2 2.0 0.3 0.0 0.0 0.6 1.6 0.0 1.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.5 750.3 198.1 0.0 0.2 2.0 0.2 0.0 0.0 0.7 HIGD1C Gm921 ENSG00000214511 "HIG1 hypoxia inducible domain family member 1C" A8MV81 12 50953922-50970506 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 19 "Early spermatids: 7.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 3.9;CACO-2: 2.2;Karpas-707: 4.9;TIME: 2.3" "Low region specificity" "Detected in all" NA NA "unprognostic (2.81e-1)" "unprognostic (3.10e-1)" "unprognostic (1.01e-1)" "unprognostic (4.21e-1)" "unprognostic (2.70e-1)" "unprognostic (5.49e-1)" "unprognostic (2.99e-1)" 0.8 0.4 0.2 0.0 0.4 0.0 0.6 0.9 0.3 1.4 0.6 0.0 0.8 0.0 0.1 1.1 0.9 0.3 0.5 0.3 0.1 2.7 1.3 1.3 0.3 0.8 2.3 3.3 0.8 0.0 0.4 0.5 0.9 0.2 0.4 1.1 0.6 0.6 0.3 0.5 1.1 3.6 2.4 0.3 1.2 0.5 2.0 1.2 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.4 1.6 0.0 1.6 3.9 0.0 0.0 0.0 0.0 2.2 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 4.9 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.3 1.4 0.0 0.6 0.0 0.3 0.0 0.0 2.3 0.0 0.1 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.5 0.0 2.0 0.1 0.0 1.2 0.4 0.0 0.5 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIGD2A "MGC2198, RCF1B" ENSG00000146066 "HIG1 hypoxia inducible domain family member 2A" Q9BW72 5 176388747-176389771 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA042715 Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA042715: AB_2678127" "unprognostic (9.24e-2)" "unprognostic (6.31e-3)" "unprognostic (7.96e-2)" "unprognostic (3.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.94e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (2.39e-1)" "unprognostic (3.19e-1)" "unprognostic (1.98e-2)" "unprognostic (3.11e-3)" "unprognostic (9.56e-2)" "unprognostic (2.39e-2)" "unprognostic (1.45e-1)" "unprognostic (8.09e-2)" "unprognostic (1.78e-1)" "unprognostic (9.65e-2)" 37.2 38.5 31.4 33.5 36.0 34.9 37.5 21.4 33.2 26.8 43.8 22.5 29.7 36.7 25.7 31.1 47.0 31.5 39.4 80.0 28.5 26.6 46.3 56.1 30.1 54.1 30.3 20.0 33.2 42.6 36.6 28.8 26.4 21.0 41.2 30.9 31.2 64.0 32.6 115.9 27.8 38.1 43.3 25.9 37.3 31.6 28.8 15.0 63.1 42.3 53.8 34.3 42.1 28.7 70.4 104.6 25.5 107.7 31.1 67.6 88.9 17.9 31.7 19.0 32.1 19.9 38.1 49.8 11.3 21.6 33.0 41.6 33.1 38.0 32.7 27.6 20.6 40.3 23.2 28.7 50.7 13.2 76.6 45.1 16.1 32.7 45.3 28.0 25.1 43.9 48.3 42.2 18.6 22.6 24.3 27.7 27.5 17.8 65.9 24.2 59.3 28.5 31.9 22.4 34.6 34.9 27.7 14.1 59.1 51.6 29.9 20.0 26.7 12.9 54.6 55.5 20.3 32.6 42.3 17.3 22.5 23.3 20.6 23.5 30.7 36.6 26.6 29.1 45.1 14.1 25.5 84.5 23.8 46.3 106.5 45.8 70.4 64.9 53.5 104.6 52.2 59.6 55.6 14.4 31.1 107.7 68.6 67.6 88.9 31.4 36.0 21.4 33.2 28.5 26.6 30.3 20.0 21.0 15.0 68.5 61.2 245.0 289.8 206.3 55.1 130.4 180.9 116.4 104.6 172.7 11.8 187.5 452.6 160.5 55.4 114.7 272.4 23.3 206.0 150.2 154.5 216.1 128.0 198.8 329.3 62.0 256.0 111.7 344.3 44.7 129.8 304.5 244.6 408.4 365.8 77.7 132.6 412.7 79.9 405.0 38.4 116.4 130.6 108.0 81.6 196.7 234.3 221.4 328.6 443.0 HIGD2B HIGD2BP ENSG00000175202 "HIG1 hypoxia inducible domain family member 2B" Q4VC39 15 72675783-72686149 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 11.6" "Group enriched" "Detected in some" 13 "Early spermatids: 11.0;Late spermatids: 7.1;Spermatocytes: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;ASC TERT1: 1.1;Karpas-707: 1.0" "HPA019016, HPA042715" Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA019016: AB_1850711, HPA042715: AB_2678127" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.24e-3)" "unprognostic (5.09e-2)" "unprognostic (3.34e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (6.98e-2)" "unprognostic (3.90e-1)" "unprognostic (8.80e-2)" "unprognostic (6.11e-4)" "unprognostic (6.95e-2)" "unprognostic (2.97e-1)" "unprognostic (1.11e-2)" "unprognostic (3.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.6 0.2 0.0 0.7 0.0 1.3 0.7 1.1 0.0 0.0 0.4 0.0 0.6 0.6 0.8 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.2 0.0 0.6 0.0 1.0 0.0 0.5 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.9 0.9 0.7 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 15.1 0.9 0.1 0.1 0.0 0.0 0.1 HILPDA "C7orf68, FLJ21076, HIG-2, HIG2" ENSG00000135245 "Hypoxia inducible lipid droplet associated" Q9Y5L2 7 128455849-128458418 "Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4;esophagus: 71.4" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 142.7;Syncytiotrophoblasts: 201.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010515 Approved Supported "Nucleoplasm,Lipid droplets" "Intracellular and membrane" NA NA "Lipid droplets" Nucleoplasm "HPA010515: AB_1850710" "unprognostic (1.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (2.27e-1)" "unprognostic (2.10e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.30e-11)" "unprognostic (9.20e-3)" "unprognostic (4.07e-3)" "unprognostic (2.49e-1)" "unprognostic (4.06e-3)" "unprognostic (2.15e-2)" "prognostic unfavorable (2.05e-7)" "unprognostic (2.23e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-2)" "unprognostic (1.27e-1)" 24.5 5.2 25.3 5.5 34.2 14.1 16.2 8.6 53.9 15.7 14.4 6.4 2.8 4.7 9.1 6.3 71.4 7.9 7.2 16.7 25.1 8.5 10.4 10.3 13.2 4.9 22.4 3.1 22.9 5.0 3.0 4.2 25.7 46.5 7.0 6.2 2.8 7.7 6.1 5.2 14.4 4.4 6.9 66.4 3.0 6.4 10.1 21.1 1.7 5.6 6.9 6.0 60.5 18.6 9.2 5.9 31.7 3.6 6.9 3.3 2.0 11.2 23.8 13.0 14.2 17.8 6.6 24.4 4.1 5.2 8.7 9.7 5.9 10.3 7.7 3.3 6.2 8.9 7.2 7.3 8.8 11.1 4.2 6.7 4.7 5.0 5.3 4.0 7.4 6.5 10.9 7.6 6.8 4.6 8.9 7.1 12.2 6.8 3.2 8.6 13.9 22.2 13.5 16.1 8.3 10.5 16.8 6.1 11.9 4.8 16.8 12.5 11.5 6.4 45.2 8.0 12.2 36.8 7.2 5.2 11.2 5.5 8.4 5.1 3.1 2.3 9.8 21.1 11.5 9.6 9.2 3.5 31.7 2.3 3.6 3.3 7.8 2.9 2.8 3.4 9.2 3.0 2.9 1.4 6.9 2.7 5.9 1.9 2.0 25.3 34.2 8.6 53.9 25.1 8.5 22.4 3.1 46.5 21.1 8.9 5.6 5.8 11.4 57.1 6.2 3.1 5.1 33.5 47.8 1.8 17.7 95.4 0.0 16.4 0.3 26.9 2.9 0.0 7.6 142.7 49.5 20.7 17.4 3.2 23.2 25.4 12.6 7.4 4.3 1.7 28.1 20.8 35.4 20.8 7.7 14.1 55.4 5.5 23.0 8.4 22.5 6.5 49.5 5.9 16.3 45.5 201.6 5.1 15.3 8.0 HLA-A ENSG00000206503 "Major histocompatibility complex, class I, A" "P04439, P13746, P16188" 6 29941260-29945884 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "monocytes: 4504.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 158.0;fHDF/TERT166: 42.3;HBEC3-KT: 43.4;RPMI-8226: 41.2;U-266/70: 42.1" CAB078470 Supported "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "CAB078470: AB_10985125" "unprognostic (1.56e-2)" "unprognostic (9.14e-2)" "unprognostic (1.34e-2)" "prognostic favorable (9.59e-4)" "unprognostic (3.49e-1)" "unprognostic (1.21e-1)" "unprognostic (1.12e-1)" "unprognostic (7.28e-2)" "unprognostic (3.42e-2)" "prognostic favorable (6.47e-4)" "unprognostic (2.96e-1)" "unprognostic (3.24e-1)" "unprognostic (1.84e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.54e-2)" 69.4 57.5 16.0 69.1 18.2 41.2 40.8 9.1 20.7 54.4 92.6 20.4 28.6 105.7 38.4 76.2 48.4 27.8 92.3 59.1 14.6 16.6 80.5 47.6 112.0 90.5 19.5 8.9 57.2 30.0 22.5 33.3 38.7 22.7 64.1 38.5 52.4 28.3 19.2 44.0 110.4 129.4 30.3 22.8 150.0 115.9 26.6 12.3 71.1 62.3 38.5 97.7 86.4 41.0 23.0 10.9 65.8 25.2 25.9 46.7 45.4 158.0 4.0 0.0 0.0 25.5 24.1 0.1 0.1 0.3 0.2 0.3 0.0 0.0 0.4 0.0 42.3 21.5 3.9 0.0 43.4 0.0 0.3 1.6 27.6 1.2 0.8 1.4 0.0 1.8 0.2 0.0 0.3 0.1 0.0 0.0 21.2 0.0 0.1 0.0 0.0 0.1 2.5 0.3 0.0 0.4 3.3 0.3 41.2 29.6 32.5 0.0 1.4 3.5 0.0 1.4 10.4 0.2 3.7 0.6 2.4 0.1 0.7 0.5 42.1 10.7 8.9 0.0 23.3 0.0 65.8 25.2 35.4 38.3 17.9 28.8 23.0 29.6 34.4 4.1 14.9 21.7 29.7 47.9 25.9 19.8 10.9 46.7 45.4 16.0 18.2 9.1 20.7 14.6 16.6 19.5 8.9 22.7 12.3 345.4 508.3 1064.2 718.5 760.7 31.3 128.4 937.6 317.2 366.3 478.1 5.9 16.7 74.6 2692.4 38.8 1227.5 2851.3 186.9 1168.0 15.8 685.4 823.3 585.8 217.5 1814.8 35.0 917.5 1170.5 1323.9 66.9 652.4 1239.0 602.3 4504.1 1496.2 150.9 1505.1 2283.0 455.0 258.2 20.0 549.7 859.0 132.4 24.5 828.4 26.5 2218.3 1070.6 1059.3 HLA-B AS ENSG00000234745 "Major histocompatibility complex, class I, B" "P01889, P30480, P30486, Q29836, Q31610, Q31612" 6 31269491-31357188 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "monocytes: 6264.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 71.3;EFO-21: 65.1;U-266/70: 165.1;U-698: 45.2" CAB015418 Enhanced NA NA "CAB015418: AB_831547" "unprognostic (2.87e-2)" "unprognostic (1.49e-1)" "unprognostic (4.90e-2)" "unprognostic (2.65e-2)" "unprognostic (1.86e-1)" "unprognostic (1.81e-1)" "unprognostic (5.16e-3)" "unprognostic (8.51e-2)" "prognostic favorable (2.90e-4)" "unprognostic (2.69e-3)" "unprognostic (3.05e-2)" "unprognostic (1.59e-1)" "unprognostic (9.28e-3)" "unprognostic (3.27e-1)" "unprognostic (7.83e-2)" "unprognostic (8.24e-3)" "unprognostic (3.67e-2)" 83.5 40.1 11.7 91.4 14.2 11.0 52.6 6.7 13.1 41.4 96.5 18.2 15.6 2.0 52.8 51.5 46.1 30.8 100.3 76.8 11.9 13.4 63.3 57.1 194.5 214.9 17.3 10.5 40.2 21.8 16.2 20.2 39.5 19.1 70.4 56.1 45.4 108.9 23.4 37.4 56.4 164.1 20.6 23.8 200.6 43.2 32.1 11.9 54.1 44.5 19.1 136.3 117.6 48.6 45.6 41.4 118.7 56.5 46.5 64.3 81.8 71.3 0.0 0.0 0.0 1.7 12.2 0.4 0.0 0.3 0.1 0.2 0.0 0.5 2.6 65.1 12.7 26.9 30.0 14.8 13.0 0.0 0.2 3.5 0.9 0.0 0.0 9.6 0.0 0.6 24.0 0.0 0.0 1.6 22.4 0.0 5.2 0.1 3.5 0.0 0.0 0.3 18.5 0.3 0.0 0.0 2.2 0.4 0.4 19.7 0.0 0.1 0.5 0.6 0.1 0.1 0.0 11.3 0.7 15.3 3.8 0.6 0.6 0.2 165.1 36.7 45.2 0.2 0.7 0.1 20.6 56.5 59.1 64.3 42.7 62.2 45.6 54.9 58.5 41.4 35.1 42.1 55.2 118.7 46.5 37.4 33.9 56.2 81.8 11.7 14.2 6.7 13.1 11.9 13.4 17.3 10.5 19.1 11.9 848.6 1033.3 1739.6 668.1 1035.7 22.9 112.5 1307.0 539.4 564.1 368.2 5.9 26.5 58.0 3170.1 45.1 1951.2 1835.2 93.5 1580.0 116.6 879.8 887.8 599.9 510.9 2564.6 57.2 803.7 1588.0 2761.1 31.5 597.1 2461.9 845.2 6264.3 1963.1 186.6 1772.9 2170.7 288.5 177.4 25.0 1293.5 783.2 642.1 29.1 877.9 42.6 2497.5 1111.5 867.3 HLA-C "D6S204, HLA-JY3, PSORS1" ENSG00000204525 "Major histocompatibility complex, class I, C" P10321 6 31268749-31272130 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "monocytes: 2958.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 95.2;EFO-21: 105.3;RPTEC TERT1: 60.2;U-266/70: 63.6;U-266/84: 49.5" "Intracellular and membrane" NA NA "unprognostic (2.17e-1)" "unprognostic (3.38e-1)" "unprognostic (3.05e-2)" "unprognostic (4.42e-2)" "unprognostic (1.56e-1)" "unprognostic (2.08e-1)" "unprognostic (1.51e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-3)" "unprognostic (3.23e-3)" "unprognostic (1.17e-1)" "unprognostic (2.39e-1)" "unprognostic (2.34e-1)" "unprognostic (2.00e-1)" "unprognostic (8.12e-2)" "unprognostic (1.87e-2)" "unprognostic (7.16e-2)" 48.6 34.7 14.8 87.9 17.9 38.3 32.9 7.8 14.3 33.1 51.3 11.7 8.7 1.8 36.4 92.7 25.1 49.7 37.6 62.2 13.9 9.9 41.4 92.2 165.9 100.3 21.5 2.8 47.5 16.6 1.4 21.1 34.5 19.5 35.8 11.2 29.2 25.9 20.5 25.0 42.3 117.4 18.2 18.0 142.8 40.1 20.3 17.0 36.5 33.5 12.7 58.9 64.2 42.8 0.2 0.2 2.0 1.2 0.5 0.6 22.3 95.2 0.1 0.0 0.0 16.1 12.7 0.2 0.4 0.1 0.1 0.3 0.1 0.0 0.0 105.3 24.4 27.6 0.0 0.0 24.2 0.0 0.1 22.1 0.1 1.1 0.0 0.1 0.0 0.1 10.8 0.0 0.0 0.0 36.1 0.0 12.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.1 0.2 0.0 0.2 60.2 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 26.1 8.8 0.3 0.3 63.6 49.5 36.1 0.0 1.0 0.0 1.0 1.2 1.5 0.5 0.5 0.4 0.2 0.3 0.4 0.2 0.2 0.3 0.3 2.0 0.5 0.2 0.1 0.6 22.3 14.8 17.9 7.8 14.3 13.9 9.9 21.5 2.8 19.5 17.0 211.4 409.9 1149.9 655.0 647.6 33.3 51.2 807.7 139.2 119.4 458.9 9.8 31.0 71.3 1526.8 20.1 1077.8 1941.0 116.8 1346.9 819.1 662.9 867.9 336.0 402.2 1566.8 93.8 463.1 1295.2 1614.9 19.9 469.7 1295.6 793.0 2958.6 1103.0 189.8 1039.6 2357.8 313.6 218.5 23.3 1183.5 495.5 145.4 25.7 569.6 101.7 2445.0 861.9 788.0 HLA-DMA "D6S222E, RING6" ENSG00000204257 "Major histocompatibility complex, class II, DM alpha" P28067 6 32948613-32969094 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "B-cells: 394.3;Hofbauer cells: 370.5;Kupffer cells: 264.8;Macrophages: 648.8;monocytes: 269.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 4.1;intermediate monocyte: 4.0;memory B-cell: 6.8;myeloid DC: 7.9;naive B-cell: 7.0;plasmacytoid DC: 5.7" "Group enriched" "Detected in many" 12 "B-cells: 7.0;dendritic cells: 7.9;monocytes: 4.1" "Group enriched" "Detected in some" 4 "U-266/70: 15.7;U-698: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012750, HPA017295" Enhanced Approved Vesicles NA NA Vesicles "HPA012750: AB_1853926, HPA017295: AB_2669575" "unprognostic (1.69e-3)" "unprognostic (3.52e-2)" "unprognostic (8.03e-2)" "prognostic favorable (4.64e-5)" "unprognostic (3.99e-1)" "unprognostic (3.90e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.59e-4)" "unprognostic (7.01e-2)" "unprognostic (9.69e-2)" "unprognostic (6.66e-2)" "unprognostic (1.89e-1)" "unprognostic (2.12e-3)" "unprognostic (1.41e-1)" "unprognostic (4.95e-2)" "unprognostic (3.80e-1)" "unprognostic (2.14e-2)" 22.9 20.5 5.1 27.2 7.9 18.9 17.4 1.0 5.0 11.3 18.4 9.8 5.7 3.2 8.0 25.3 6.7 32.1 11.1 13.1 4.6 5.2 19.3 12.4 50.7 24.5 10.1 2.0 14.9 20.2 2.1 5.0 3.2 9.7 7.6 14.3 8.4 17.3 10.1 4.3 7.3 28.4 4.3 15.2 38.5 23.1 3.5 7.9 17.3 10.0 11.9 42.1 5.9 6.0 7.0 7.9 0.5 4.1 0.3 0.4 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.2 0.1 0.0 1.3 0.2 0.0 0.0 0.2 1.9 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.7 6.9 40.0 0.3 0.0 0.0 0.0 4.1 0.4 0.2 4.0 0.0 6.8 0.1 0.3 7.9 7.0 0.1 0.2 0.5 0.3 1.1 5.7 0.4 3.1 5.1 7.9 1.0 5.0 4.6 5.2 10.1 2.0 9.7 7.9 68.5 147.1 394.3 13.3 42.8 1.6 3.6 50.9 37.5 51.2 50.6 2.0 3.8 14.9 38.3 2.8 85.6 22.0 23.3 46.1 3.5 19.8 18.9 40.4 2.9 370.5 0.0 2.9 32.5 264.8 4.3 15.0 648.8 75.9 269.7 18.9 4.1 34.9 15.3 17.7 36.3 0.8 19.4 18.6 3.6 4.4 36.6 3.3 44.0 22.6 27.6 HLA-DMB "D6S221E, RING7" ENSG00000242574 "Major histocompatibility complex, class II, DM beta" P28068 6 32934629-32941070 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "B-cells: 222.5;Hofbauer cells: 281.2;Kupffer cells: 131.2;Macrophages: 353.4;monocytes: 112.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 19.9;dendritic cells: 11.5;monocytes: 11.9" "Group enriched" "Detected in some" 13 "CAPAN-2: 7.3;Daudi: 10.3;EFO-21: 4.9;U-266/70: 3.9;U-698: 12.6" "HPA012298, HPA077524" Supported Supported Vesicles NA NA Vesicles "HPA012298: AB_1853927, HPA077524: " "unprognostic (5.34e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-2)" "prognostic favorable (3.89e-5)" "unprognostic (3.07e-1)" "unprognostic (7.64e-3)" "unprognostic (4.00e-1)" "unprognostic (3.46e-3)" "unprognostic (6.99e-2)" "unprognostic (8.76e-2)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (6.82e-3)" "unprognostic (2.03e-1)" "unprognostic (4.14e-2)" "unprognostic (8.35e-2)" "unprognostic (5.60e-2)" 12.0 13.0 5.9 20.2 7.5 4.3 7.9 0.4 4.9 8.1 9.7 8.8 2.1 1.2 6.2 10.2 3.3 12.6 6.0 8.0 5.7 4.2 13.1 5.4 20.8 24.0 10.2 2.3 7.4 5.0 1.2 3.2 6.2 8.1 6.3 10.5 6.3 7.8 3.2 2.9 4.5 31.8 1.9 14.5 35.6 6.1 2.1 7.3 10.5 33.7 3.8 34.5 10.6 3.2 19.9 11.5 2.2 11.9 2.2 1.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 10.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.3 12.6 0.0 0.0 0.0 0.0 11.9 2.2 0.3 10.1 0.4 15.1 0.2 0.5 11.1 19.9 0.1 0.5 0.5 2.2 3.5 11.5 1.0 10.3 5.9 7.5 0.4 4.9 5.7 4.2 10.2 2.3 8.1 7.3 8.9 53.6 222.5 0.9 10.6 0.1 2.2 7.6 10.7 6.8 15.7 0.0 1.4 10.0 10.4 0.5 31.8 3.1 0.0 4.0 1.2 4.7 1.4 14.0 0.6 281.2 0.0 4.1 3.7 131.2 0.7 3.1 353.4 15.1 112.8 1.5 0.5 3.9 0.9 1.8 6.0 1.2 6.5 4.1 0.4 0.5 9.5 2.3 15.0 1.7 2.4 HLA-DOA "HLA-D0-alpha, HLA-DNA, HLA-DZA" ENSG00000204252 "Major histocompatibility complex, class II, DO alpha" P06340 6 33004178-33009612 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 30.6" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 31.2;B-cells: 33.8;Macrophages: 41.0;monocytes: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 9.1;naive B-cell: 11.2" "Group enriched" "Detected in many" 9 "B-cells: 11.2;dendritic cells: 9.1;monocytes: 4.4" "Cell line enhanced" "Detected in some" "Daudi: 6.5;HDLM-2: 4.6;REH: 20.7;U-698: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045038 Enhanced NA NA "HPA045038: AB_10959457" "unprognostic (8.02e-2)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" "unprognostic (1.19e-1)" "unprognostic (3.01e-1)" "unprognostic (3.83e-2)" "unprognostic (2.60e-1)" "unprognostic (9.86e-3)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (3.68e-1)" "unprognostic (4.39e-2)" "unprognostic (1.91e-1)" "unprognostic (9.95e-2)" "unprognostic (3.65e-2)" "unprognostic (8.70e-2)" "unprognostic (5.94e-2)" 5.7 5.7 2.2 18.4 3.9 2.0 5.1 1.5 2.1 4.5 4.0 8.3 2.2 5.1 4.6 6.0 2.7 4.6 4.8 9.3 2.8 3.1 10.0 3.4 18.1 24.7 5.5 2.0 5.7 2.9 3.3 3.3 1.0 5.4 5.4 4.7 4.0 4.5 3.2 1.2 2.5 12.3 2.4 9.6 25.5 4.5 1.2 3.9 14.7 3.8 3.2 30.6 3.4 3.1 11.2 9.1 0.3 4.4 0.1 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.4 0.0 7.4 0.0 0.3 9.1 11.2 0.1 0.9 0.3 0.1 2.0 2.8 0.7 1.4 2.2 3.9 1.5 2.1 2.8 3.1 5.5 2.0 5.4 3.9 3.0 31.2 33.8 0.5 1.6 0.0 1.1 0.0 0.0 3.4 3.5 0.0 0.1 0.0 1.6 0.0 4.6 0.0 0.0 0.2 0.0 0.9 0.5 4.7 0.0 14.2 0.0 0.0 0.6 16.4 0.0 0.3 41.0 0.0 64.1 0.0 0.9 0.5 0.0 0.0 2.6 0.2 0.0 0.2 0.0 0.2 1.0 0.1 1.3 0.0 0.1 HLA-DOB ENSG00000241106 "Major histocompatibility complex, class II, DO beta" P13765 6 32812763-32817048 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.1;lymphoid tissue: 33.0" "Group enriched" "Detected in some" 6 "B-cells: 90.0;monocytes: 75.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "memory B-cell: 42.0;naive B-cell: 51.1" "Lineage enriched" "Detected in many" 19 "B-cells: 51.1" "Group enriched" "Detected in some" 5 "Daudi: 33.5;U-698: 11.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA013846 Enhanced NA NA "HPA013846: AB_1853928" "prognostic favorable (4.29e-4)" "unprognostic (3.84e-2)" "unprognostic (7.12e-3)" "unprognostic (6.02e-2)" "unprognostic (1.74e-1)" "unprognostic (1.00e-2)" "unprognostic (4.48e-2)" "unprognostic (4.26e-3)" "unprognostic (6.95e-2)" "prognostic favorable (4.17e-5)" "unprognostic (2.37e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (3.15e-5)" "unprognostic (1.37e-1)" "unprognostic (1.64e-1)" "unprognostic (7.18e-2)" "unprognostic (2.46e-1)" 0.7 0.4 0.3 28.8 0.3 2.7 1.4 0.7 0.3 1.2 2.7 0.4 0.0 1.7 0.7 0.5 1.3 0.5 1.4 2.2 0.2 0.4 1.8 0.7 3.3 33.0 0.4 0.2 0.5 0.2 0.0 1.8 0.5 0.8 0.7 2.4 0.7 3.8 0.9 0.4 1.0 12.2 0.2 0.7 28.5 1.4 1.7 0.1 5.8 1.1 0.9 29.8 5.5 0.8 51.1 2.6 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 1.7 33.5 0.1 0.1 0.0 0.2 1.0 1.8 0.0 1.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.6 0.3 11.8 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.0 0.0 0.0 2.6 51.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.5 0.3 0.3 0.7 0.3 0.2 0.4 0.4 0.2 0.8 0.1 0.0 4.5 90.0 0.1 0.9 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 1.0 0.5 0.0 0.0 0.2 0.3 0.4 0.1 1.1 0.0 0.7 0.0 0.0 0.0 0.3 0.2 0.0 3.9 13.5 75.7 0.0 0.6 0.2 0.0 0.0 0.0 0.7 6.5 0.3 0.0 0.2 1.4 0.0 1.0 0.0 0.3 HLA-DPA1 HLA-DP1A ENSG00000231389 "Major histocompatibility complex, class II, DP alpha 1" P20036 6 33064569-33080775 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 59.5" "Cell type enhanced" "Detected in many" 18 "B-cells: 1100.8;Hofbauer cells: 1218.6;Kupffer cells: 965.1;Macrophages: 2476.0;monocytes: 4193.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 16.3;intermediate monocyte: 37.8;memory B-cell: 30.0;myeloid DC: 59.5;naive B-cell: 26.7;non-classical monocyte: 23.2;plasmacytoid DC: 17.1" "Group enriched" "Detected in all" 8 "B-cells: 30.0;dendritic cells: 59.5;monocytes: 37.8" "Cell line enhanced" "Detected in some" "Daudi: 15.8;HDLM-2: 48.6;REH: 12.4;U-698: 11.4" HPA017967 Enhanced Supported Vesicles NA NA 92000 Vesicles "HPA017967: AB_1853929" "unprognostic (8.93e-3)" "unprognostic (3.15e-2)" "unprognostic (3.64e-2)" "unprognostic (9.40e-3)" "unprognostic (9.07e-2)" "unprognostic (2.80e-2)" "unprognostic (5.69e-2)" "unprognostic (1.82e-2)" "unprognostic (7.28e-2)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (8.38e-2)" "unprognostic (1.17e-1)" "unprognostic (4.69e-2)" "unprognostic (8.11e-2)" "unprognostic (1.06e-1)" 25.2 12.8 3.3 13.3 3.6 4.7 16.3 3.5 3.3 11.8 6.8 3.1 4.3 8.6 8.5 15.9 8.5 5.7 14.7 11.1 4.2 6.2 12.4 9.7 35.9 20.2 6.2 3.8 3.8 5.4 3.8 5.2 6.5 4.8 7.4 7.3 7.5 7.4 15.7 4.1 5.8 14.7 6.4 20.4 37.6 5.6 8.6 4.1 10.9 14.2 9.5 21.5 8.5 17.8 30.0 59.5 1.3 37.8 4.0 5.6 20.3 0.0 0.0 0.0 0.0 0.3 0.6 0.5 0.2 0.1 0.2 0.0 0.0 2.1 15.8 2.2 0.3 3.1 0.0 0.0 0.0 0.0 48.6 1.0 2.6 0.0 0.0 0.0 0.0 5.1 0.7 0.0 1.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 12.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 1.1 3.5 0.0 0.0 0.0 2.4 0.3 11.4 5.5 0.1 1.9 0.3 16.3 1.3 4.6 37.8 1.2 30.0 2.1 5.0 59.5 26.7 0.7 3.4 0.6 4.0 23.2 17.1 5.6 20.3 3.3 3.6 3.5 3.3 4.2 6.2 6.2 3.8 4.8 4.1 77.4 317.2 1100.8 5.1 183.6 2.5 10.5 76.5 80.3 113.7 22.7 0.0 4.2 8.3 15.4 2.1 188.1 6.1 0.0 15.8 5.3 55.4 10.4 62.4 4.5 1218.6 4.8 9.8 60.2 965.1 4.3 16.7 2476.0 286.8 4193.1 9.2 4.8 4.8 4.5 25.8 32.7 3.1 51.8 21.8 0.9 2.9 153.2 5.7 100.5 4.1 8.9 HLA-DPB1 HLA-DP1B ENSG00000223865 "Major histocompatibility complex, class II, DP beta 1" P04440 6 33075926-33087201 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 99.4" "Cell type enhanced" "Detected in many" 19 "B-cells: 1312.2;Hofbauer cells: 1159.7;Kupffer cells: 1265.6;Macrophages: 2334.4;monocytes: 5192.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 90.1" "Group enriched" "Detected in all" 8 "B-cells: 57.8;dendritic cells: 90.1;monocytes: 40.6" "Group enriched" "Detected in some" 6 "HDLM-2: 47.2;REH: 22.5" "HPA011078, HPA058509" Enhanced Approved "Nucleoplasm,Cell Junctions" NA NA 730000 "Cell Junctions" Nucleoplasm "HPA011078: AB_1079378, HPA058509: AB_2683737" "unprognostic (5.44e-3)" "unprognostic (7.03e-3)" "unprognostic (9.84e-2)" "prognostic favorable (3.38e-4)" "unprognostic (9.43e-2)" "unprognostic (1.80e-2)" "unprognostic (1.52e-1)" "unprognostic (1.51e-3)" "unprognostic (1.77e-2)" "unprognostic (5.64e-2)" "unprognostic (1.57e-1)" "unprognostic (4.34e-1)" "unprognostic (4.35e-2)" "unprognostic (1.80e-1)" "unprognostic (4.17e-2)" "unprognostic (3.58e-2)" "unprognostic (1.85e-1)" 29.6 31.9 9.8 52.8 15.1 6.9 22.0 6.1 7.7 15.5 11.8 14.9 6.9 14.4 15.3 23.4 9.8 11.0 26.6 29.6 9.7 10.4 25.5 12.4 79.9 99.4 23.5 6.0 10.8 10.5 4.3 11.5 6.2 19.6 19.4 6.6 22.2 25.0 15.4 6.1 14.8 33.7 8.9 35.3 88.8 15.8 4.3 16.2 51.9 14.2 20.7 69.3 35.5 11.9 57.8 90.1 1.1 40.6 2.8 7.6 23.5 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.2 0.1 0.0 0.0 0.0 0.0 47.2 2.2 1.3 0.0 0.0 0.0 0.0 0.1 1.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 22.5 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.7 0.0 0.2 0.0 0.0 6.0 0.1 3.9 0.0 0.0 0.0 0.2 18.7 1.1 5.3 40.6 0.7 57.8 1.9 7.6 90.1 56.9 0.7 4.2 0.4 2.8 17.0 25.7 7.2 23.5 9.8 15.1 6.1 7.7 9.7 10.4 23.5 6.0 19.6 16.2 62.5 286.9 1312.2 21.4 267.0 12.2 9.3 73.9 46.8 77.3 27.9 15.7 5.1 3.3 33.6 3.2 238.9 10.6 0.0 13.0 4.7 50.0 41.9 61.1 5.5 1159.7 7.9 9.2 88.4 1265.6 4.0 25.3 2334.4 307.1 5192.2 12.2 24.1 8.0 4.0 19.8 36.3 19.2 45.3 33.2 1.2 5.9 203.9 7.6 173.0 6.5 13.9 HLA-DQA1 "CELIAC1, HLA-DQA" ENSG00000196735 "Major histocompatibility complex, class II, DQ alpha 1" P01909 6 32628179-32647062 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 91.5;lymphoid tissue: 113.3" "Cell type enhanced" "Detected in many" 18 "B-cells: 621.2;Hofbauer cells: 402.6;Macrophages: 675.1;monocytes: 1355.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 91.5" "Group enriched" "Detected in many" 19 "B-cells: 43.3;dendritic cells: 91.5;monocytes: 32.1" "Cell line enriched" "Detected in some" 7 "HDLM-2: 176.7" HPA012315 Enhanced NA NA "HPA012315: AB_1853930" "unprognostic (4.24e-3)" "unprognostic (1.47e-2)" "unprognostic (1.43e-2)" "unprognostic (7.94e-3)" "unprognostic (1.72e-1)" "unprognostic (6.07e-2)" "unprognostic (3.26e-1)" "unprognostic (5.81e-3)" "unprognostic (2.84e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-2)" "unprognostic (1.15e-1)" "unprognostic (5.36e-2)" "unprognostic (6.74e-2)" "unprognostic (2.27e-1)" "unprognostic (7.43e-2)" "unprognostic (1.57e-1)" 44.6 8.9 3.9 63.5 6.9 0.7 14.8 1.2 3.1 11.4 13.6 7.4 6.1 0.0 10.6 45.5 8.1 6.1 23.7 4.4 3.8 4.9 23.8 17.2 69.0 48.2 8.7 2.6 16.4 5.1 0.0 6.5 3.7 8.9 5.8 22.1 14.8 11.4 1.2 7.6 11.3 26.1 4.2 19.5 97.0 17.3 2.1 6.7 113.3 8.5 0.5 63.6 42.3 6.6 43.3 91.5 0.4 32.1 1.0 2.9 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 176.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.2 0.1 19.5 3.2 0.0 0.0 0.1 14.8 0.0 0.3 32.1 0.1 42.8 0.4 2.3 91.5 43.3 0.0 0.6 0.4 1.0 8.1 22.7 2.9 15.8 3.9 6.9 1.2 3.1 3.8 4.9 8.7 2.6 8.9 6.7 11.9 132.6 621.2 0.4 44.6 0.0 2.0 12.7 10.7 21.6 0.0 2.0 0.7 1.7 1.4 0.4 35.0 0.3 0.0 3.8 1.1 13.6 1.2 46.5 0.4 402.6 0.0 0.0 9.8 236.5 0.2 2.8 675.1 67.4 1355.3 0.3 0.5 2.1 0.0 0.0 5.1 1.8 6.5 2.0 0.0 0.8 36.4 1.7 27.7 0.4 0.4 HLA-DQA2 HLA-DXA ENSG00000237541 "Major histocompatibility complex, class II, DQ alpha 2" P01906 6 32741342-32747215 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.7;lymphoid tissue: 51.1" "Cell type enhanced" "Detected in many" 22 "B-cells: 96.0;Hofbauer cells: 116.5;Kupffer cells: 86.7;Macrophages: 348.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.06e-3)" "unprognostic (2.46e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-2)" "unprognostic (2.69e-1)" "unprognostic (5.44e-2)" "unprognostic (2.64e-1)" "unprognostic (2.57e-2)" "unprognostic (8.85e-2)" "unprognostic (4.40e-1)" "unprognostic (1.04e-1)" "unprognostic (7.67e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-2)" "unprognostic (3.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.48e-2)" 6.1 2.7 0.5 1.5 0.5 1.5 3.6 0.0 1.5 6.3 1.8 2.1 0.0 1.5 3.8 1.5 2.5 1.9 27.2 16.5 1.0 0.9 12.5 3.5 37.7 43.6 1.3 0.6 1.5 1.5 1.5 1.5 1.9 3.0 7.9 1.5 6.5 19.9 2.5 1.5 4.7 11.7 1.5 5.9 35.5 2.3 1.5 0.0 40.5 3.5 6.7 51.1 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.2 1.0 0.9 1.3 0.6 3.0 0.0 3.0 2.2 96.0 0.2 20.8 0.0 0.4 0.0 5.3 5.7 3.5 0.0 0.2 0.0 0.0 0.5 8.7 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 116.5 0.0 2.4 3.1 86.7 0.5 1.1 348.8 23.6 35.1 0.0 0.0 0.3 0.0 0.0 1.5 0.0 6.5 0.2 0.0 0.0 20.5 0.3 21.5 0.0 0.7 HLA-DQB1 "CELIAC1, HLA-DQB, IDDM1" ENSG00000179344 "Major histocompatibility complex, class II, DQ beta 1" 6 32659467-32668383 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 74.6" "Group enriched" "Detected in many" 4 "B-cells: 690.1;Hofbauer cells: 446.2;Macrophages: 1016.1;monocytes: 1484.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 27.8;intermediate monocyte: 24.1;memory B-cell: 30.9;myeloid DC: 68.2;naive B-cell: 35.6;plasmacytoid DC: 21.4" "Group enriched" "Detected in all" 6 "B-cells: 35.6;dendritic cells: 68.2;monocytes: 27.8" "Cell line enriched" "Detected in some" 6 "HDLM-2: 114.5" HPA013667 Enhanced Supported "Golgi apparatus,Rods & Rings" NA NA "Rods & Rings" "Golgi apparatus" "HPA013667: AB_1853932" "unprognostic (8.60e-3)" "unprognostic (1.91e-2)" "unprognostic (5.91e-2)" "unprognostic (9.85e-3)" "unprognostic (4.48e-1)" "unprognostic (5.30e-2)" "unprognostic (4.75e-2)" "unprognostic (1.06e-2)" "unprognostic (2.51e-2)" "unprognostic (1.48e-1)" "unprognostic (3.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.34e-2)" "unprognostic (3.13e-1)" "unprognostic (4.16e-1)" "unprognostic (2.43e-1)" "unprognostic (1.40e-1)" 23.9 10.0 3.5 40.4 3.0 9.0 17.0 1.0 4.9 11.0 18.8 8.8 4.5 0.0 9.9 42.6 9.6 8.0 21.7 12.7 4.1 5.3 35.4 9.9 61.2 61.1 6.1 4.2 6.3 4.0 0.0 9.2 4.0 7.9 11.3 10.7 13.5 11.8 5.6 7.8 12.4 27.6 4.6 15.5 74.5 32.7 4.6 2.9 63.5 13.3 7.9 74.6 37.9 7.4 35.6 68.2 4.6 27.8 1.5 7.1 31.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.4 0.0 0.0 3.7 0.0 3.7 0.0 114.5 2.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.6 2.1 0.0 0.0 0.1 0.1 0.0 13.7 0.3 12.6 9.5 0.0 0.0 0.0 27.8 4.6 2.4 24.1 1.1 30.9 1.2 3.7 68.2 35.6 0.0 1.1 1.9 1.5 6.6 21.4 7.1 31.9 3.5 3.0 1.0 4.9 4.1 5.3 6.1 4.2 7.9 2.9 38.7 182.5 690.1 8.0 79.8 4.8 2.5 22.9 21.4 40.9 17.4 9.8 1.7 6.6 16.1 13.8 55.5 8.1 0.0 17.6 1.9 15.3 7.5 36.0 0.9 446.2 0.0 21.9 12.3 206.1 4.7 6.1 1016.1 92.8 1484.2 9.0 1.0 19.0 5.8 9.2 15.4 1.7 6.5 4.2 2.1 2.1 58.1 2.5 41.5 4.1 32.4 HLA-DQB2 HLA-DXB ENSG00000232629 "Major histocompatibility complex, class II, DQ beta 2" P05538 6 32756098-32763534 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.6;skin 1: 25.8" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 25.2;Macrophages: 78.8;Melanocytes: 25.3;Suprabasal keratinocytes: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "myeloid DC: 3.1" "Group enriched" "Detected in many" 7 "B-cells: 3.0;dendritic cells: 3.1;monocytes: 1.2" "Group enriched" "Detected in some" 4 "Daudi: 1.0;HDLM-2: 3.6;U-266/70: 1.0" HPA073187 Enhanced NA NA "HPA073187: " "prognostic favorable (5.55e-4)" "unprognostic (3.75e-3)" "unprognostic (2.16e-1)" "unprognostic (2.50e-2)" "unprognostic (2.10e-1)" "unprognostic (6.60e-2)" "unprognostic (8.15e-2)" "unprognostic (3.73e-3)" "unprognostic (6.48e-2)" "unprognostic (1.25e-1)" "unprognostic (3.74e-1)" "unprognostic (1.94e-1)" "unprognostic (6.66e-2)" "unprognostic (1.23e-1)" "unprognostic (4.10e-2)" "unprognostic (1.16e-1)" "unprognostic (6.92e-2)" 2.1 0.9 0.4 3.5 0.4 0.3 2.0 0.4 0.3 2.1 0.5 0.6 0.2 0.4 0.3 1.8 5.5 0.6 0.8 0.3 0.3 0.2 1.2 0.4 9.7 3.0 1.3 0.2 0.9 0.2 0.0 0.8 0.2 0.8 0.6 1.1 0.8 2.7 0.8 0.5 25.8 3.1 0.2 1.4 7.2 2.2 0.5 0.3 25.6 1.0 11.3 17.8 1.1 2.3 3.0 3.1 0.3 1.2 0.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.2 0.4 0.2 0.1 0.2 0.8 0.1 0.1 1.2 0.0 2.8 0.0 0.1 3.1 3.0 0.1 0.1 0.3 0.3 0.4 0.5 0.2 1.2 0.4 0.4 0.4 0.3 0.3 0.2 1.3 0.2 0.8 0.3 3.0 8.8 6.7 0.0 25.2 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 2.5 0.0 0.0 0.0 8.2 0.0 0.9 78.8 25.3 8.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.1 0.1 0.0 0.0 0.1 HLA-DRA HLA-DRA1 ENSG00000204287 "Major histocompatibility complex, class II, DR alpha" P01903 6 32439842-32445046 "Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 211.6" "Group enriched" "Detected in many" 5 "B-cells: 2551.2;Hofbauer cells: 2965.8;Kupffer cells: 2919.1;Macrophages: 6482.8;monocytes: 9158.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 29.8;intermediate monocyte: 46.8;memory B-cell: 59.4;naive B-cell: 61.7;non-classical monocyte: 28.0;plasmacytoid DC: 29.6" "Group enriched" "Detected in all" 5 "B-cells: 61.7;dendritic cells: 29.6;monocytes: 46.8" "Cell line enhanced" "Detected in some" "Daudi: 56.6;HDLM-2: 101.0;REH: 41.1;U-266/70: 24.9;U-698: 58.2;U-87 MG: 40.5" "Low region specificity" "Detected in all" "CAB002798, CAB015402, HPA050162, HPA053176" Enhanced NA NA 1600000 "CAB002798: , CAB015402: AB_629980, HPA050162: AB_2681037, HPA053176: AB_2682070" "unprognostic (1.20e-3)" "unprognostic (4.70e-3)" "prognostic favorable (5.30e-4)" "unprognostic (3.13e-3)" "unprognostic (1.30e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-2)" "unprognostic (2.77e-2)" "unprognostic (3.05e-2)" "unprognostic (3.92e-2)" "unprognostic (1.89e-1)" "unprognostic (1.35e-1)" "unprognostic (1.98e-1)" "unprognostic (4.42e-2)" "unprognostic (5.67e-2)" "unprognostic (2.52e-2)" 51.8 33.5 14.1 79.1 20.2 1.8 37.3 2.3 10.1 21.1 38.9 21.5 10.9 30.8 16.5 76.8 15.9 33.9 21.8 34.7 13.1 16.2 60.9 17.8 147.2 211.6 27.3 7.4 14.7 10.0 1.7 14.7 9.7 23.5 21.9 33.8 23.5 21.6 12.6 12.9 27.6 86.2 9.0 52.8 127.3 68.7 7.2 21.6 53.7 18.6 25.9 151.6 53.5 15.1 61.7 29.6 9.3 46.8 1.8 2.7 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 56.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 101.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 24.9 0.0 58.2 40.5 0.0 0.0 0.6 29.8 9.3 0.3 46.8 0.1 59.4 0.3 1.7 0.5 61.7 0.2 0.3 2.2 1.8 28.0 29.6 2.7 29.9 14.1 20.2 2.3 10.1 13.1 16.2 27.3 7.4 23.5 21.6 271.0 1055.7 2551.2 15.4 664.8 2.8 17.1 140.1 283.7 312.8 143.1 0.0 12.6 24.9 102.1 5.1 500.2 61.2 70.0 51.5 11.7 106.8 41.9 162.6 8.5 2965.8 1.6 62.4 159.6 2919.1 12.4 27.9 6482.8 733.9 9158.9 74.1 8.3 54.7 48.9 4.2 202.9 18.7 71.1 73.3 3.5 5.0 503.6 21.6 91.4 51.9 59.2 HLA-DRB1 HLA-DR1B ENSG00000196126 "Major histocompatibility complex, class II, DR beta 1" "P01911, P04229, Q29974, Q9GIY3" 6 32578769-32589848 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 95.6;lung: 95.9" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 1496.4;Macrophages: 3257.5;monocytes: 4435.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 95.6" "Group enriched" "Detected in all" 10 "B-cells: 41.3;dendritic cells: 95.6;monocytes: 52.5" "Cell line enhanced" "Detected in some" "HDLM-2: 157.6;HMC-1: 22.4;THP-1: 18.9;U-266/70: 21.0;U-698: 27.1;U-87 MG: 43.5" "CAB015400, CAB034021, HPA043151" Enhanced NA NA "CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342" "unprognostic (3.69e-3)" "unprognostic (3.66e-3)" "unprognostic (1.80e-2)" "unprognostic (2.40e-3)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (5.28e-2)" "unprognostic (1.22e-3)" "unprognostic (8.56e-2)" "unprognostic (3.00e-2)" "unprognostic (1.23e-1)" "unprognostic (2.08e-1)" "unprognostic (2.28e-3)" "unprognostic (6.16e-2)" "unprognostic (1.19e-1)" "unprognostic (5.10e-2)" "unprognostic (1.53e-1)" 36.8 18.7 9.7 32.2 15.9 8.7 24.9 3.6 10.0 14.2 18.2 11.5 11.2 0.2 10.5 27.2 12.1 13.3 12.0 11.9 8.5 6.9 50.0 15.6 95.9 80.8 18.9 5.4 6.9 8.0 0.0 9.4 5.7 14.8 9.5 23.7 16.1 11.3 2.4 8.2 13.3 42.1 3.8 19.7 62.1 38.1 5.6 13.2 33.6 14.1 3.8 44.7 29.7 17.0 41.3 95.6 6.3 52.5 2.7 4.7 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.2 0.0 0.6 0.0 157.6 1.7 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.7 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.5 0.2 0.6 18.9 0.0 0.0 0.1 0.3 0.0 21.0 0.5 27.1 43.5 0.7 0.0 0.2 34.6 6.3 1.8 52.5 0.3 32.7 1.2 3.7 95.6 41.3 0.1 1.6 1.2 2.7 26.9 20.4 4.7 37.7 9.7 15.9 3.6 10.0 8.5 6.9 18.9 5.4 14.8 13.2 137.0 520.2 984.8 8.4 154.2 1.7 28.0 109.5 140.5 174.0 134.3 0.0 2.5 21.6 104.5 3.5 441.7 148.8 0.0 65.2 4.6 54.7 18.7 119.2 3.4 1496.4 0.0 34.5 186.6 1186.4 7.6 13.8 3257.5 205.8 4435.6 52.0 8.3 76.3 364.7 25.1 169.2 9.4 25.8 72.3 1.8 3.4 129.4 5.7 137.1 73.6 61.3 HLA-DRB5 ENSG00000198502 "Major histocompatibility complex, class II, DR beta 5" Q30154 6 32517343-32530287 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 71.8;lymphoid tissue: 64.8" "Cell type enhanced" "Detected in many" 11 "B-cells: 354.6;Hofbauer cells: 502.6;Kupffer cells: 564.1;Macrophages: 808.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 26.4" "Group enriched" "Detected in many" 10 "B-cells: 13.3;dendritic cells: 26.4;monocytes: 16.0" "Group enriched" "Detected in some" 5 "HDLM-2: 112.0;HMC-1: 28.3;U-698: 33.5;U-87 MG: 44.2" HPA043151 Supported NA NA "HPA043151: AB_2678342" "unprognostic (1.97e-3)" "unprognostic (4.74e-2)" "unprognostic (3.30e-2)" "prognostic favorable (7.89e-4)" "unprognostic (2.28e-2)" "unprognostic (4.68e-3)" "unprognostic (9.09e-3)" "unprognostic (2.08e-3)" "unprognostic (1.06e-2)" "unprognostic (5.40e-2)" "unprognostic (4.31e-2)" "unprognostic (2.87e-1)" "unprognostic (2.89e-2)" "unprognostic (1.45e-1)" "unprognostic (7.60e-3)" "unprognostic (9.72e-2)" "unprognostic (5.48e-2)" 21.8 14.2 2.9 22.1 3.9 3.7 16.2 2.0 3.2 16.7 21.7 7.0 6.4 2.3 8.7 22.1 9.5 12.6 6.6 9.1 4.3 4.0 32.2 9.3 71.8 60.4 7.3 0.8 4.9 4.9 0.0 6.0 4.9 5.4 9.5 10.2 11.2 9.0 2.7 7.4 8.8 34.7 4.7 12.2 64.8 40.3 4.6 4.5 15.3 9.5 11.2 27.6 21.8 6.5 13.3 26.4 1.5 16.0 0.9 1.8 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 112.0 1.1 0.0 0.0 0.0 0.0 0.1 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 9.9 0.0 0.6 0.1 0.3 0.0 7.6 0.1 33.5 44.2 0.3 0.0 0.0 10.1 1.5 0.4 16.0 0.0 10.5 0.4 1.1 26.4 13.3 0.0 0.5 0.3 0.9 8.1 5.9 1.8 15.4 2.9 3.9 2.0 3.2 4.3 4.0 7.3 0.8 5.4 4.5 14.9 139.1 354.6 2.3 92.6 0.6 6.9 137.6 5.3 7.9 14.0 3.9 1.1 1.7 1.1 2.3 236.0 13.4 0.0 6.9 2.7 11.4 6.5 57.8 3.4 502.6 0.0 1.7 114.2 564.1 3.7 14.7 808.2 114.7 129.0 14.9 0.0 18.4 51.8 32.2 19.6 1.4 19.4 37.4 0.7 0.2 79.3 2.6 71.0 3.5 18.2 HLA-E ENSG00000204592 "Major histocompatibility complex, class I, E" 6 30489467-30494205 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Endothelial cells: 1478.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 25.2;U-266/70: 35.8" "CAB024589, HPA031454" Enhanced Approved Vesicles NA NA Vesicles "CAB024589: AB_324025, HPA031454: AB_2673891" "unprognostic (1.14e-2)" "unprognostic (1.38e-2)" "unprognostic (9.20e-2)" "unprognostic (2.47e-3)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.14e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-2)" "unprognostic (1.35e-2)" "unprognostic (5.57e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (2.90e-1)" "unprognostic (4.14e-2)" "unprognostic (1.75e-3)" "unprognostic (1.42e-3)" 81.4 19.4 12.6 42.9 16.9 81.7 49.9 6.5 14.9 37.6 32.7 23.2 15.5 2.1 41.2 30.6 40.1 28.2 44.0 36.7 15.1 13.3 34.8 56.5 129.7 76.7 19.9 10.5 29.1 14.6 33.9 11.6 33.1 24.9 32.2 28.6 33.9 23.1 27.5 34.8 97.2 36.8 22.9 21.7 97.1 50.5 18.1 14.6 35.0 45.7 36.4 72.4 45.9 33.3 23.0 7.8 90.2 28.9 23.2 37.1 56.3 11.3 1.8 0.7 6.7 25.2 20.0 0.0 0.0 0.0 0.0 0.0 4.7 23.1 7.4 11.5 10.1 19.8 14.0 1.5 5.8 0.0 7.5 4.8 8.8 2.2 0.0 0.0 0.0 3.2 15.7 10.9 8.0 0.0 0.0 0.0 4.8 1.1 0.1 6.0 0.0 0.0 0.0 0.0 3.8 0.0 1.6 0.0 9.7 10.2 6.4 0.0 0.5 7.8 6.2 0.0 0.1 0.0 15.1 11.2 7.1 0.0 0.0 1.4 35.8 20.4 2.9 0.0 6.7 18.6 56.6 14.0 52.5 37.0 24.6 31.5 23.0 28.1 37.1 7.8 22.5 28.5 28.4 90.2 23.2 28.9 6.6 29.4 56.3 12.6 16.9 6.5 14.9 15.1 13.3 19.9 10.5 24.9 14.6 288.8 451.7 691.8 327.5 430.6 2.0 80.3 247.1 216.8 225.2 116.9 5.9 69.1 14.9 371.5 3.5 1478.5 407.9 46.7 585.9 231.5 281.0 321.3 504.0 75.0 648.8 4.8 207.4 1236.3 939.1 5.9 122.3 661.4 442.1 534.8 437.5 90.5 562.6 382.2 71.8 70.5 5.3 174.6 453.2 9.2 3.3 372.8 300.2 1180.5 194.8 500.2 HLA-F ENSG00000204642 "Major histocompatibility complex, class I, F" P30511 6 29722775-29738528 "Plasma proteins, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 189.5;monocytes: 255.1;T-cells: 236.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "A-431: 25.3;GAMG: 9.9;HEK 293: 9.0;HEL: 6.2;HHSteC: 7.7;JURKAT: 5.4;U-266/70: 6.3;U-937: 9.6" NA NA 27000000 "unprognostic (3.07e-3)" "unprognostic (5.16e-2)" "unprognostic (3.05e-1)" "unprognostic (9.32e-2)" "unprognostic (1.48e-1)" "unprognostic (1.82e-1)" "unprognostic (4.99e-2)" "unprognostic (2.68e-1)" "unprognostic (4.21e-3)" "unprognostic (2.43e-3)" "unprognostic (3.21e-2)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (1.26e-1)" "unprognostic (2.95e-2)" "unprognostic (4.13e-2)" "unprognostic (1.30e-2)" 12.2 8.0 3.9 33.3 6.5 3.1 10.8 2.6 3.6 8.2 15.7 2.3 5.2 33.2 9.4 10.7 7.5 7.5 24.8 10.7 2.9 2.8 8.2 7.7 24.0 39.4 4.2 2.6 3.9 4.4 1.5 5.3 2.8 3.9 6.2 4.1 8.9 16.2 5.3 6.7 28.0 21.7 6.4 4.1 43.9 36.5 4.9 3.7 9.7 8.9 11.0 18.7 11.4 8.7 11.6 3.2 28.5 13.8 15.3 20.4 14.8 25.3 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 9.9 1.0 0.0 0.7 0.0 0.5 9.0 6.2 0.2 0.0 7.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 1.6 0.0 0.0 0.1 0.0 0.3 1.3 0.0 0.0 0.4 0.1 0.1 0.9 0.1 6.3 1.3 0.0 0.0 9.6 0.1 28.5 9.4 20.6 20.4 9.8 13.5 11.6 13.4 16.8 0.6 9.6 13.4 13.3 14.5 15.3 13.8 3.2 13.2 14.8 3.9 6.5 2.6 3.6 2.9 2.8 4.2 2.6 3.9 3.7 35.7 77.4 91.0 27.5 36.4 1.1 8.4 63.7 17.4 22.7 7.0 2.0 0.4 1.7 53.0 1.5 103.7 189.5 0.0 78.8 0.6 20.0 29.0 48.5 24.5 58.1 0.0 21.9 65.1 69.2 0.4 26.2 76.5 27.0 255.1 111.6 5.2 61.8 84.2 19.8 4.9 0.9 45.3 38.4 9.6 1.4 32.9 0.2 236.8 51.5 36.9 HLA-G ENSG00000204632 "Major histocompatibility complex, class I, G" P17693 6 29826967-29831125 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" Immunity "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 66.0" "Cell type enriched" "Detected in many" 15 "Extravillous trophoblasts: 586.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CAPAN-2: 1.2;SuSa: 3.9" CAB016158 Enhanced "Secreted to blood" NA NA 32800000 "CAB016158: AB_627938" "unprognostic (1.13e-2)" "unprognostic (9.95e-2)" "unprognostic (1.30e-1)" "unprognostic (3.40e-2)" "unprognostic (8.35e-2)" "unprognostic (1.35e-1)" "unprognostic (1.18e-3)" "unprognostic (2.51e-1)" "prognostic favorable (3.91e-5)" "unprognostic (6.34e-2)" "unprognostic (8.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.03e-2)" "unprognostic (6.56e-3)" "unprognostic (1.40e-1)" "unprognostic (1.52e-2)" "unprognostic (3.19e-3)" 0.2 0.1 0.0 0.5 0.1 0.2 0.3 0.1 0.1 0.2 0.5 0.1 0.0 1.2 0.2 0.6 0.1 0.1 0.2 0.3 0.2 0.0 0.5 0.2 2.8 0.7 0.1 0.1 0.3 1.9 0.1 15.2 66.0 0.1 0.2 0.2 0.3 0.4 0.6 0.2 0.2 0.8 0.1 0.2 1.2 0.9 2.2 0.2 1.3 0.4 0.2 0.2 0.2 0.3 0.3 0.3 2.2 0.9 0.2 1.2 5.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.6 0.9 1.2 0.7 0.5 1.2 0.3 0.1 0.5 0.3 0.3 0.6 1.2 2.2 0.2 0.6 0.1 0.5 5.7 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.0 1.1 1.4 6.4 20.3 0.0 0.8 5.1 0.0 0.0 0.0 0.0 7.8 0.0 2.8 16.1 5.2 2.6 0.0 4.7 586.1 11.7 5.5 0.0 1.1 21.9 0.0 16.8 8.0 11.0 5.3 2.3 3.3 11.8 0.0 39.2 0.0 15.5 20.1 2.5 0.2 0.0 0.0 3.3 4.7 3.0 30.7 33.9 6.9 9.7 6.7 HM13 "dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1" ENSG00000101294 "Histocompatibility minor 13" Q8TCT9 20 31514428-31577923 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hofbauer cells: 292.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045089, HPA056062" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA045089: AB_10962054, HPA056062: AB_2683022" "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (5.03e-2)" "unprognostic (1.59e-1)" "unprognostic (2.82e-1)" "unprognostic (5.87e-3)" "prognostic unfavorable (1.95e-5)" "unprognostic (2.66e-2)" "unprognostic (2.14e-2)" "unprognostic (2.55e-1)" "unprognostic (2.30e-1)" "unprognostic (8.10e-2)" "prognostic unfavorable (4.64e-12)" "unprognostic (3.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.85e-1)" "unprognostic (8.17e-2)" 25.2 34.3 9.2 20.1 11.1 19.8 36.4 10.2 17.5 37.9 17.0 13.2 64.7 18.1 23.3 40.7 39.2 21.4 24.1 17.9 9.3 13.0 30.2 121.3 25.5 38.7 10.8 9.8 20.8 132.3 24.4 28.6 45.9 14.5 22.4 16.3 15.4 149.6 84.3 13.1 15.0 17.8 17.9 11.0 22.0 25.3 11.7 9.0 15.5 33.5 21.5 30.5 18.1 21.4 16.7 48.2 50.1 65.3 19.4 29.8 52.6 24.8 26.3 10.6 15.6 48.3 31.1 36.5 42.6 39.9 29.1 30.0 52.1 29.9 16.1 57.4 46.4 38.5 45.5 14.9 28.6 19.1 8.1 20.1 35.5 19.1 31.2 53.8 20.2 14.3 28.4 18.7 24.6 33.7 29.4 22.5 10.6 15.6 63.9 27.0 29.4 17.3 14.6 12.2 40.8 45.0 11.0 49.9 74.9 28.1 13.3 13.9 16.9 43.5 42.0 34.4 11.0 32.6 19.3 27.3 44.3 23.6 44.6 23.9 41.3 24.5 12.7 60.4 72.9 39.1 18.4 65.3 31.8 21.7 64.0 29.8 16.7 20.5 20.9 46.0 12.6 13.8 16.2 50.1 19.4 58.6 48.2 18.1 52.6 9.2 11.1 10.2 17.5 9.3 13.0 10.8 9.8 14.5 9.0 47.6 55.6 31.3 46.0 29.8 39.1 11.5 58.6 38.8 43.3 50.6 115.8 131.4 11.6 140.0 12.3 43.8 63.3 23.3 146.7 111.1 86.5 75.1 40.5 74.0 292.9 41.3 59.0 58.3 73.4 10.6 56.1 83.9 62.4 38.7 63.2 49.7 138.8 42.7 41.1 44.1 38.7 32.3 39.1 21.7 29.0 30.9 178.6 56.7 51.9 55.3 HMGCR ENSG00000113161 "3-hydroxy-3-methylglutaryl-CoA reductase" P04035 5 75336329-75362104 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008338, CAB016797" Approved NA NA "CAB016797: , HPA008338: AB_10960401" "unprognostic (5.07e-2)" "unprognostic (1.65e-2)" "unprognostic (3.65e-3)" "unprognostic (1.02e-2)" "unprognostic (1.65e-3)" "unprognostic (1.02e-1)" "unprognostic (1.45e-1)" "unprognostic (4.41e-2)" "unprognostic (5.45e-2)" "unprognostic (1.90e-2)" "unprognostic (1.41e-1)" "unprognostic (3.99e-2)" "prognostic favorable (9.42e-6)" "unprognostic (2.44e-1)" "unprognostic (2.55e-2)" "unprognostic (3.64e-3)" "unprognostic (4.37e-2)" 5.6 28.9 12.4 8.7 31.1 12.1 16.4 14.4 36.3 13.9 23.0 10.9 7.1 18.9 9.0 14.4 35.0 6.5 8.2 4.0 21.8 16.5 12.1 53.5 12.1 7.0 9.8 19.4 15.2 8.4 16.2 11.4 9.2 29.6 12.4 19.7 7.8 12.4 4.5 3.4 36.1 19.0 6.8 17.0 7.9 14.6 14.0 8.8 13.9 12.5 23.2 12.4 6.2 18.1 4.3 12.5 23.2 11.0 9.5 6.5 5.1 15.3 6.0 61.4 21.1 13.0 25.2 15.4 4.4 12.4 9.0 20.1 22.6 37.8 13.7 16.1 7.1 58.9 19.4 31.9 51.8 9.6 4.6 11.7 10.5 9.1 17.5 19.2 8.7 7.7 16.3 30.5 31.5 15.6 4.5 7.2 19.7 11.2 21.0 14.2 10.0 16.0 8.8 26.2 3.9 4.5 11.3 18.4 19.6 37.1 35.8 21.3 9.7 9.7 10.1 8.8 22.1 10.0 22.9 8.4 4.9 7.3 5.2 7.5 6.7 8.5 18.9 7.1 17.1 10.1 6.7 11.0 6.3 6.1 6.9 5.1 4.3 4.6 6.4 12.5 4.2 4.5 6.2 23.2 9.5 7.4 3.9 6.5 5.1 12.4 31.1 14.4 36.3 21.8 16.5 9.8 19.4 29.6 8.8 17.9 33.4 7.5 8.5 36.9 20.9 5.7 12.7 32.1 22.7 26.2 17.7 16.3 3.3 12.1 38.1 7.6 33.8 0.0 18.8 21.6 10.5 13.9 24.2 22.5 11.5 38.1 41.2 9.8 19.3 19.5 8.6 12.3 15.1 2.8 50.6 10.3 11.9 20.1 5.6 6.3 13.1 12.9 8.2 21.0 14.0 80.0 39.0 8.7 20.2 17.3 HMOX1 "bK286B10, HO-1" ENSG00000100292 "Heme oxygenase 1" P09601 22 35380361-35394214 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 209.8" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 439.8;Kupffer cells: 915.4;monocytes: 247.9;Syncytiotrophoblasts: 419.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 17.7;intermediate monocyte: 40.5;non-classical monocyte: 53.4" "Lineage enriched" "Detected in many" 6 "monocytes: 53.4" "Cell line enhanced" "Detected in many" "BEWO: 108.8;GAMG: 71.3;U-138 MG: 63.5;U-87 MG: 61.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA000635, CAB017444" Enhanced Uncertain "Golgi apparatus,Plasma membrane" NA NA 17000 "Golgi apparatus, Plasma membrane" "CAB017444: AB_10617276, HPA000635: AB_1079089" "unprognostic (3.12e-1)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (6.94e-2)" "unprognostic (5.57e-2)" "unprognostic (2.47e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.56e-2)" "unprognostic (1.71e-1)" "unprognostic (4.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.95e-3)" "unprognostic (1.91e-1)" "unprognostic (4.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.54e-2)" 28.4 10.3 4.1 12.5 8.7 16.3 13.8 0.8 20.6 5.7 12.0 6.1 0.6 22.0 2.5 8.5 8.8 9.8 9.8 10.2 4.1 3.1 23.0 63.7 54.0 76.3 12.5 1.3 28.6 8.8 0.5 2.7 21.1 7.5 3.6 4.9 3.3 3.5 0.8 21.9 13.8 22.8 6.9 11.2 209.8 4.6 5.9 7.6 3.6 4.2 7.3 8.3 6.7 10.2 4.8 7.9 8.4 53.4 1.1 0.3 10.1 1.4 22.1 0.2 4.5 18.1 5.3 108.8 10.2 6.0 4.8 5.2 9.8 1.3 0.0 2.3 8.3 71.3 1.2 1.3 0.2 1.5 36.6 1.1 0.5 6.7 20.0 25.2 1.3 6.9 16.6 0.4 31.7 2.1 7.7 14.4 0.0 0.0 10.6 15.3 1.1 0.0 0.5 2.2 13.6 2.5 0.1 1.9 3.4 3.4 11.9 0.3 0.3 26.4 2.3 1.7 9.6 1.0 0.3 5.4 63.5 2.8 10.3 9.9 6.6 8.5 1.0 61.6 0.6 1.0 2.0 17.7 1.2 0.2 40.5 0.0 4.8 0.1 0.3 7.9 0.5 0.0 0.0 8.4 1.1 53.4 0.2 0.2 10.1 4.1 8.7 0.8 4.8 4.1 3.1 12.5 1.3 7.5 7.6 3.0 21.3 13.8 5.9 14.5 0.0 3.1 10.2 1.4 0.0 5.2 0.0 39.4 18.3 10.3 1.6 20.2 43.4 0.0 1.3 204.4 21.6 85.9 11.5 19.5 439.8 0.0 15.3 30.7 915.4 1.3 28.7 175.5 33.7 247.9 5.3 0.2 8.7 10.5 4.9 128.1 0.4 0.0 16.5 0.9 2.7 13.7 419.8 10.0 4.1 91.1 HMOX2 HO-2 ENSG00000103415 "Heme oxygenase 2" P30519 16 4474690-4510347 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 438.7;Late spermatids: 1517.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025464, HPA040611" Supported Approved Vesicles,Cytosol NA NA 1200000 "Vesicles, Cytosol" "CAB025464: , HPA040611: AB_10961034" "unprognostic (3.33e-1)" "unprognostic (3.58e-2)" "unprognostic (1.11e-1)" "prognostic favorable (7.91e-4)" "unprognostic (2.74e-1)" "unprognostic (4.27e-2)" "unprognostic (6.23e-2)" "unprognostic (5.77e-2)" "unprognostic (1.43e-2)" "unprognostic (3.60e-1)" "unprognostic (7.74e-3)" "unprognostic (9.87e-2)" "prognostic favorable (8.98e-6)" "unprognostic (3.51e-2)" "unprognostic (4.14e-2)" "unprognostic (1.65e-2)" "unprognostic (2.64e-1)" 19.4 19.2 32.1 15.7 50.7 13.6 16.6 19.7 38.6 13.3 17.9 22.9 12.2 23.5 11.9 18.7 36.6 15.6 19.7 57.2 29.3 22.0 32.2 39.7 15.8 20.8 27.3 35.1 12.5 22.4 20.6 14.7 12.5 36.5 12.1 19.9 8.6 16.0 10.0 20.1 16.6 19.3 16.6 27.2 23.3 29.7 48.1 28.2 8.7 13.8 16.7 25.3 16.5 15.0 14.5 14.5 48.7 8.9 18.7 35.8 25.8 24.9 10.7 6.3 13.8 19.1 9.8 10.6 17.3 8.5 14.7 12.8 13.5 17.0 11.6 19.4 15.8 10.3 15.2 20.0 37.0 16.7 14.8 13.6 8.4 10.3 18.3 12.9 18.2 14.4 15.3 12.4 17.0 12.5 12.3 26.9 14.0 13.6 5.9 13.5 31.0 15.0 14.3 9.7 24.1 10.1 16.0 11.2 24.3 20.4 16.5 10.8 6.3 13.8 29.3 18.6 12.6 18.2 10.2 26.3 8.3 12.3 35.6 8.8 7.3 9.0 25.6 5.3 15.1 10.5 13.7 7.4 48.7 35.2 8.9 29.9 14.5 32.7 35.8 14.5 13.0 31.7 32.7 26.1 18.7 6.5 8.2 30.0 25.8 32.1 50.7 19.7 38.6 29.3 22.0 27.3 35.1 36.5 28.2 32.8 46.9 52.0 27.0 48.7 27.1 59.3 33.1 30.8 38.7 34.9 19.6 64.6 109.5 72.8 438.7 41.7 76.2 0.0 78.6 57.9 43.8 31.4 19.6 78.8 59.5 27.0 30.5 66.3 24.7 1517.1 42.0 39.8 59.1 33.3 27.6 51.0 91.4 52.6 52.6 178.2 20.2 71.1 77.6 151.1 90.1 45.0 32.2 90.0 41.2 25.1 HOGA1 "C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2" ENSG00000241935 "4-hydroxy-2-oxoglutarate aldolase 1" Q86XE5 10 97584323-97612802 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 39.8;liver: 31.0" "Cell type enhanced" "Detected in some" 16 "Cholangiocytes: 35.7;Distal tubular cells: 24.9;Hepatocytes: 41.0;Proximal tubular cells: 71.6" "Group enriched" "Detected in many" 5 "liver cancer: 4.5;renal cancer: 9.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "AN3-CA: 6.1;EFO-21: 7.3;Hep G2: 19.0;RPTEC TERT1: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA039466 Approved NA NA 15000 "HPA039466: AB_2676522" "unprognostic (6.44e-2)" "unprognostic (3.64e-2)" "unprognostic (7.50e-2)" "unprognostic (2.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.29e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-3)" "unprognostic (4.72e-1)" "unprognostic (2.37e-1)" "unprognostic (1.28e-1)" "unprognostic (6.80e-2)" "prognostic favorable (9.08e-4)" "unprognostic (2.20e-1)" "unprognostic (1.80e-1)" "unprognostic (2.94e-3)" "unprognostic (7.20e-4)" 3.3 5.4 3.3 0.6 3.8 0.8 2.1 7.0 4.3 0.8 0.6 8.2 1.5 0.7 0.9 4.0 1.3 2.0 3.8 10.1 4.2 2.8 39.8 31.0 0.9 0.7 9.3 5.2 0.6 12.0 2.0 2.4 0.6 7.2 1.3 0.6 3.6 1.8 2.2 2.0 1.2 0.6 0.8 8.2 0.7 0.6 0.7 6.9 0.0 1.8 4.1 0.6 0.8 0.6 2.1 1.7 4.4 1.2 1.2 1.3 0.5 0.3 2.8 0.1 6.1 1.2 0.3 0.1 0.1 0.2 0.1 0.0 2.3 0.3 0.2 7.3 0.1 0.3 2.0 0.1 0.2 0.1 0.2 3.2 0.1 1.1 19.0 0.8 0.2 0.2 0.3 0.6 0.2 0.1 1.5 0.3 0.1 0.1 0.4 0.5 1.2 0.1 0.2 0.2 0.2 0.0 0.2 0.5 0.4 23.3 0.4 0.5 0.9 0.1 1.1 0.7 0.2 2.1 0.1 0.3 0.7 0.2 0.4 0.2 0.4 0.7 0.1 1.5 0.3 0.1 2.4 1.1 1.2 1.2 0.9 1.0 1.1 1.3 0.9 0.5 2.1 1.1 1.2 4.4 1.2 1.2 1.7 0.9 0.5 3.3 3.8 7.0 3.9 4.2 2.8 9.3 5.2 7.2 6.9 0.0 0.0 0.0 0.6 0.1 0.1 5.3 35.7 5.3 0.0 8.7 0.0 0.0 24.9 4.4 2.9 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 41.0 0.1 1.6 0.0 0.0 1.8 12.3 0.0 0.0 1.7 0.0 0.0 2.0 0.5 0.0 0.0 71.6 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 HPN TMPRSS1 ENSG00000105707 Hepsin P05981 19 35040506-35066571 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "kidney: 55.4;liver: 146.5;pancreas: 80.1" "Group enriched" "Detected in many" 7 "Hepatocytes: 406.8;Proximal tubular cells: 178.8" "Cancer enhanced" "Detected in many" "liver cancer: 127.5" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.2;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Group enriched" "Detected in some" 9 "EFO-21: 19.8;Hep G2: 28.1;T-47d: 13.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA006804 Approved NA NA 1000000 "HPA006804: AB_1079046" "unprognostic (6.74e-3)" "unprognostic (6.00e-2)" "unprognostic (4.10e-2)" "unprognostic (1.16e-1)" "unprognostic (2.72e-1)" "unprognostic (9.96e-2)" "unprognostic (4.22e-3)" "unprognostic (1.27e-1)" "unprognostic (4.13e-3)" "unprognostic (9.54e-2)" "unprognostic (3.54e-1)" "unprognostic (1.16e-1)" "prognostic favorable (5.45e-5)" "unprognostic (1.22e-1)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (7.96e-2)" 0.2 0.0 0.3 0.1 0.5 0.0 3.2 0.4 1.1 0.3 0.3 0.2 8.4 0.2 1.1 10.7 0.1 1.9 3.2 0.7 0.6 0.3 55.4 146.5 4.9 0.1 0.9 0.2 0.4 80.1 2.6 3.2 0.2 0.4 5.3 0.0 0.4 4.1 8.5 8.5 0.0 0.2 0.1 0.9 0.3 6.9 0.8 0.3 0.1 4.3 0.4 0.2 0.3 0.1 0.2 0.2 0.0 0.1 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.1 0.0 0.1 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 2.0 0.1 0.1 0.0 0.1 0.3 13.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 1.0 0.0 0.6 0.2 0.5 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.5 0.4 1.1 0.6 0.3 0.9 0.2 0.4 0.3 8.9 26.7 17.7 4.9 0.1 4.5 2.4 35.7 0.0 2.3 31.4 0.0 0.0 44.7 3.3 7.0 0.3 0.0 0.0 23.6 0.3 0.2 7.9 2.3 406.8 0.8 0.0 2.4 8.0 10.0 20.0 0.0 0.5 0.0 1.0 1.7 1.3 23.4 0.0 0.4 178.8 0.5 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.0 0.5 HRASLS2 FLJ20556 ENSG00000133328 "HRAS like suppressor 2" Q9NWW9 11 63552770-63563383 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 16.1;intestine: 42.5" "Group enriched" "Detected in many" 6 "Basal glandular cells: 19.5;Ciliated cells: 45.5;Enterocytes: 59.0;Proximal tubular cells: 75.2;Urothelial cells: 43.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "memory B-cell: 16.1;naive B-cell: 5.3" "Lineage enriched" "Detected in many" 12 "B-cells: 16.1" "Cell line enriched" "Detected in some" 8 "U-266/70: 54.4" HPA058997 Approved Approved Mitochondria NA NA Mitochondria "HPA058997: AB_2683874" "unprognostic (4.76e-2)" "prognostic favorable (6.87e-4)" "unprognostic (1.20e-1)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (9.69e-2)" "unprognostic (3.91e-3)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.56e-1)" "unprognostic (2.29e-1)" "unprognostic (1.38e-2)" "unprognostic (2.51e-1)" "unprognostic (2.43e-1)" "unprognostic (1.57e-2)" 0.4 0.0 0.4 1.5 0.4 0.0 4.7 0.4 0.4 0.6 20.6 0.5 0.4 33.4 0.6 1.1 0.5 2.1 0.4 1.0 0.4 0.2 5.5 1.9 3.3 1.1 0.4 0.4 0.4 0.4 0.0 0.4 1.4 0.4 0.4 6.5 0.4 0.7 0.4 0.4 0.2 42.5 0.4 0.4 0.7 8.8 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.4 16.1 0.8 0.1 0.1 1.2 0.9 3.6 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.4 0.0 0.4 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.1 0.0 3.5 0.8 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 54.4 6.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.9 16.1 0.2 0.9 0.0 5.3 0.2 0.6 0.1 1.2 0.0 0.8 0.0 3.6 0.4 0.4 0.4 0.4 0.4 0.2 0.4 0.4 0.4 0.4 3.0 0.6 3.0 19.5 0.1 0.0 0.3 5.1 45.5 5.7 0.0 0.0 0.1 8.3 0.4 0.3 0.0 59.0 0.0 0.4 0.3 0.0 6.2 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.7 7.0 0.0 75.2 0.0 0.0 0.0 0.7 0.1 0.0 0.7 1.0 0.9 43.6 HRCT1 "LGLL338, PRO537, UNQ338" ENSG00000196196 "Histidine rich carboxyl terminus 1" Q6UXD1 9 35906192-35907141 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 25.3" "Cell type enhanced" "Detected in many" 22 "Enterocytes: 63.2;Mucus-secreting cells: 49.5;Paneth cells: 238.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 13.8;HBEC3-KT: 7.6;HeLa: 11.3;Hep G2: 8.5;U-2197: 20.4;U-251 MG: 9.5" "Low region specificity" "Detected in all" HPA067038 Approved Nucleoplasm NA NA Nucleoplasm "HPA067038: AB_2685767" "unprognostic (2.48e-2)" "unprognostic (4.88e-2)" "unprognostic (2.43e-2)" "unprognostic (2.49e-1)" "unprognostic (5.69e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (6.63e-2)" "unprognostic (2.53e-2)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.80e-1)" "unprognostic (1.18e-1)" "unprognostic (2.00e-1)" "unprognostic (9.41e-2)" "unprognostic (2.80e-1)" "unprognostic (9.43e-2)" 25.3 1.9 1.9 3.6 2.8 0.4 21.4 0.9 3.4 5.3 16.8 1.8 1.4 11.2 4.2 3.9 6.6 3.5 2.1 7.6 2.6 1.6 17.6 1.8 5.2 5.0 2.4 2.3 2.2 1.6 0.3 0.7 4.7 3.6 3.6 14.8 5.8 4.6 4.0 6.1 4.2 14.3 6.5 1.5 0.8 2.5 5.3 1.4 0.0 3.5 1.2 1.5 4.6 3.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.6 4.6 0.0 0.2 0.4 0.1 0.0 0.1 1.2 0.0 13.8 0.3 2.6 0.0 0.0 7.6 0.0 0.0 0.0 0.0 11.3 8.5 1.8 0.0 0.0 4.5 3.9 1.5 0.9 0.6 4.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 3.5 1.8 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 3.9 0.2 4.1 20.4 9.5 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.8 0.9 3.4 2.6 1.6 2.4 2.3 3.6 1.4 6.0 1.0 0.0 0.4 1.9 1.5 0.6 2.5 1.4 3.4 0.0 0.0 20.6 1.7 0.8 0.0 21.2 63.2 0.0 0.2 6.6 4.2 0.6 0.0 0.4 1.6 0.0 1.2 35.0 0.8 0.0 10.0 0.9 1.7 0.0 49.5 7.5 2.7 238.4 8.9 9.3 2.6 12.9 4.6 0.0 0.2 1.6 2.2 0.0 18.6 0.1 HRH1 ENSG00000196639 "Histamine receptor H1" P35367 3 11137093-11263557 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 41.0;Club cells: 30.7;Enterocytes: 29.3;Suprabasal keratinocytes: 36.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 3.5" "Group enriched" "Detected in many" 7 "granulocytes: 1.2;T-cells: 3.5" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.5;hTEC/SVTERT24-B: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029740 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA029740: AB_10601578" "unprognostic (4.60e-3)" "unprognostic (3.41e-2)" "unprognostic (6.37e-3)" "unprognostic (9.55e-2)" "unprognostic (3.32e-2)" "unprognostic (1.07e-2)" "unprognostic (9.60e-3)" "unprognostic (4.00e-3)" "unprognostic (7.54e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (1.27e-5)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-2)" "unprognostic (7.19e-2)" "unprognostic (1.20e-1)" 9.1 4.4 7.3 4.6 4.4 0.2 9.6 0.5 10.6 8.0 13.5 1.3 2.4 3.8 6.2 7.2 5.7 10.6 9.9 7.0 5.1 4.0 3.3 1.1 8.2 1.8 2.2 2.1 8.7 2.1 1.7 1.2 5.5 3.2 7.2 7.2 2.0 3.4 6.1 3.0 8.0 10.5 9.2 8.6 1.4 3.3 2.4 2.0 0.1 2.5 7.2 3.1 11.2 16.2 0.1 0.3 1.2 0.2 0.1 3.5 0.1 1.5 3.5 0.0 0.0 1.6 17.5 2.4 2.6 8.8 7.8 5.3 0.6 12.6 0.0 7.8 6.1 8.0 9.9 0.0 3.6 10.7 5.5 0.0 0.8 5.7 0.0 5.3 2.4 1.4 6.1 2.2 17.7 6.2 10.9 10.9 0.1 0.0 0.0 3.5 0.0 0.0 1.1 0.0 1.5 3.2 0.2 0.9 0.3 14.0 2.0 0.1 0.0 3.7 2.7 0.0 0.1 0.0 2.0 16.2 8.8 5.5 9.0 13.1 0.0 0.9 0.0 13.5 2.2 7.6 0.4 0.2 0.0 0.1 0.2 0.0 0.0 1.3 0.5 0.3 0.1 0.1 0.1 1.2 0.1 0.0 0.1 3.5 0.1 7.3 4.4 0.5 8.4 5.1 4.0 2.2 2.1 3.2 2.0 6.0 1.4 0.0 7.7 41.0 0.0 0.4 0.0 2.7 30.7 1.8 0.0 0.2 0.0 0.4 0.3 9.3 29.3 0.0 0.6 1.0 6.7 3.9 2.3 0.0 21.0 0.0 3.4 0.6 6.9 0.0 3.4 5.7 0.0 0.0 8.0 0.0 8.3 11.4 0.0 0.3 0.1 0.0 2.3 2.3 2.8 36.3 0.5 0.0 8.8 18.2 HRH2 ENSG00000113749 "Histamine receptor H2" P25021 5 175658030-175710756 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 45.7;bone marrow: 30.1" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 21.0;Kupffer cells: 24.0;Macrophages: 14.4;Smooth muscle cells: 45.1" "Cancer enhanced" "Detected in many" "renal cancer: 4.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 45.7" "Group enriched" "Detected in many" 5 "granulocytes: 45.7;monocytes: 13.1" "Group enriched" "Detected in some" 4 "RPMI-8226: 36.2;SK-MEL-30: 10.8;THP-1: 10.0;U-937: 12.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013770 Approved NA NA "HPA013770: AB_1851086" "unprognostic (8.56e-3)" "unprognostic (1.62e-1)" "unprognostic (6.66e-2)" "unprognostic (5.96e-2)" "unprognostic (3.49e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (9.93e-2)" "unprognostic (5.76e-2)" "unprognostic (1.52e-1)" "unprognostic (2.35e-1)" "unprognostic (3.71e-3)" "unprognostic (2.01e-2)" "unprognostic (1.97e-2)" "unprognostic (1.97e-3)" "unprognostic (1.77e-2)" 7.9 1.5 5.9 11.1 11.6 30.1 2.8 1.0 12.1 3.9 2.8 0.9 0.5 5.9 2.3 1.3 1.6 2.7 2.6 18.6 3.4 1.7 2.4 1.2 5.4 12.3 2.3 4.9 1.6 1.6 0.3 1.3 9.5 2.4 3.0 1.3 0.6 1.7 4.8 1.2 2.1 7.2 3.5 4.4 9.9 10.3 1.2 5.6 9.9 1.8 0.2 3.0 2.8 2.0 0.0 6.4 45.7 13.1 0.6 2.3 3.7 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.8 1.7 0.0 0.0 3.9 0.0 36.2 0.0 0.2 0.2 0.0 0.0 0.0 10.8 1.0 0.0 10.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.1 2.4 28.9 12.9 13.6 0.0 12.0 0.1 0.0 1.1 0.2 6.4 0.0 2.3 1.4 45.7 0.6 13.1 5.0 0.8 3.7 5.9 11.6 1.0 12.1 3.4 1.7 2.3 4.9 2.4 5.6 0.0 4.5 0.5 0.1 0.7 4.5 21.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 2.2 0.1 5.2 0.1 2.3 0.0 10.1 1.6 0.0 0.0 24.0 0.7 0.0 14.4 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 45.1 0.2 1.1 0.3 0.0 2.5 0.0 0.0 HRH3 GPCR97 ENSG00000101180 "Histamine receptor H3" Q9Y5N1 20 62214970-62220267 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "brain: 50.1" "Group enriched" "Detected in some" 5 "Bipolar cells: 4.2;Horizontal cells: 3.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.56e-1)" "unprognostic (3.22e-1)" "unprognostic (4.15e-2)" "unprognostic (1.79e-1)" "unprognostic (2.77e-2)" "unprognostic (1.62e-2)" "unprognostic (7.30e-2)" "unprognostic (3.17e-4)" "unprognostic (2.40e-1)" "unprognostic (3.66e-3)" "unprognostic (3.30e-1)" "unprognostic (3.59e-2)" 1.0 2.3 5.7 0.8 50.1 0.9 0.9 16.7 20.6 0.8 0.9 2.8 0.0 1.0 0.8 0.8 0.9 0.8 0.8 0.8 5.1 16.5 0.9 0.9 0.9 0.9 2.7 8.7 0.8 0.8 0.8 0.7 0.8 2.6 1.4 0.9 0.0 1.1 0.8 0.8 1.6 0.9 0.9 1.0 0.8 0.9 1.6 10.5 0.0 0.8 0.0 0.9 2.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 19.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.7 50.1 16.7 15.1 5.1 16.5 2.7 8.7 2.6 10.5 0.0 0.0 0.0 0.0 0.0 4.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 HRH4 "AXOR35, GPCR105, GPRv53, H4R, HH4R" ENSG00000134489 "Histamine receptor H4" Q9H3N8 18 24460629-24479957 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "blood: 48.5" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 1.1;Club cells: 2.3;granulocytes: 1.1;Late spermatids: 1.1;Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 96 "basophil: 48.5;eosinophil: 16.7" "Lineage enriched" "Detected in single" 142 "granulocytes: 48.5" "Cell line enhanced" "Detected in some" "HEL: 2.9;HL-60: 5.0;HMC-1: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA035009 Uncertain NA NA "HPA035009: AB_10671507" "unprognostic (1.88e-1)" "unprognostic (2.62e-1)" "unprognostic (4.68e-2)" "unprognostic (9.83e-6)" "unprognostic (1.31e-2)" "unprognostic (3.61e-2)" "unprognostic (1.22e-1)" "unprognostic (8.96e-2)" "unprognostic (2.20e-1)" "unprognostic (3.30e-1)" "unprognostic (7.25e-2)" "unprognostic (2.91e-1)" "unprognostic (6.65e-7)" "unprognostic (1.89e-2)" "unprognostic (2.41e-1)" "unprognostic (2.03e-4)" "unprognostic (7.70e-2)" 1.7 0.6 0.4 1.5 0.4 2.8 0.6 0.3 0.3 0.4 0.6 0.3 0.3 2.1 1.4 1.9 1.3 0.3 0.8 0.5 0.4 0.4 0.4 1.7 1.9 0.7 0.4 0.3 0.8 0.4 0.0 2.5 0.3 0.8 1.0 0.4 1.0 1.1 0.3 0.8 2.3 1.9 2.8 2.6 1.4 0.9 1.4 0.3 0.3 0.5 0.3 5.1 1.9 0.6 0.0 0.0 48.5 0.0 0.0 0.3 0.1 0.4 0.3 0.2 0.9 0.1 0.0 0.6 0.2 0.0 0.0 0.1 0.8 0.7 0.1 0.5 0.2 0.3 0.8 0.2 0.3 0.2 0.2 0.2 2.9 0.9 0.7 0.2 5.0 3.0 0.2 1.0 0.1 0.0 0.5 0.3 0.4 0.2 0.5 0.1 0.4 0.4 0.8 0.3 0.2 0.3 0.3 0.3 0.3 0.5 0.6 0.5 0.2 0.2 0.1 0.2 0.1 0.3 1.1 0.3 1.2 0.2 0.8 0.1 0.5 0.2 0.2 0.9 0.8 0.5 48.5 0.0 16.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.4 0.3 0.3 0.4 0.4 0.4 0.3 0.8 0.3 0.0 1.1 0.0 0.5 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.9 0.2 0.5 0.0 0.0 0.0 0.3 HRK DP5 ENSG00000135116 "Harakiri, BCL2 interacting protein" O00198 12 116856144-116881441 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.3;lymphoid tissue: 12.9;thyroid gland: 8.1" "Cell type enhanced" "Detected in some" 10 "Ciliated cells: 6.7;Cone photoreceptor cells: 13.7;Early spermatids: 9.4;Intestinal endocrine cells: 10.9;Paneth cells: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "eosinophil: 2.2;memory B-cell: 6.7;naive B-cell: 5.5" "Group enriched" "Detected in many" 45 "B-cells: 6.7;granulocytes: 2.2" "Cell line enhanced" "Detected in some" "Daudi: 7.8;SCLC-21H: 6.7;SH-SY5Y: 5.7;SK-MEL-30: 15.2;U-698: 26.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB025973 Uncertain NA NA "CAB025973: " "unprognostic (9.38e-2)" "unprognostic (6.19e-2)" "unprognostic (1.14e-1)" "unprognostic (1.93e-3)" "unprognostic (2.54e-1)" "unprognostic (7.30e-2)" "unprognostic (1.82e-1)" "unprognostic (1.67e-2)" "unprognostic (1.10e-1)" "unprognostic (8.44e-3)" "unprognostic (1.28e-1)" "unprognostic (1.46e-1)" "unprognostic (7.24e-3)" "unprognostic (5.21e-2)" "unprognostic (2.49e-1)" "unprognostic (1.66e-1)" "unprognostic (9.42e-2)" 0.5 1.9 10.1 1.2 3.2 1.7 2.9 0.5 17.3 0.4 0.6 1.3 0.0 0.4 0.5 0.4 0.5 1.4 0.4 0.6 12.1 3.6 0.4 0.3 0.6 1.9 1.8 4.1 0.4 0.6 0.3 5.0 0.4 2.6 0.4 0.7 0.0 1.0 0.3 1.3 0.6 0.5 0.4 1.1 0.8 0.4 1.4 0.6 12.9 8.1 0.0 1.8 0.4 0.2 6.7 0.0 2.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.3 0.0 0.1 3.2 1.7 0.0 0.0 0.0 3.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.0 1.5 0.0 0.0 0.0 0.1 0.3 0.0 0.7 0.0 0.1 0.7 0.0 1.0 0.1 0.0 6.7 5.7 0.4 0.0 15.2 0.3 0.4 0.1 0.0 0.0 1.3 0.2 0.0 0.7 0.3 26.4 0.0 0.3 0.0 0.1 0.0 2.2 0.0 0.0 0.0 6.7 0.0 0.0 0.0 5.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 10.1 3.2 0.5 8.5 12.1 3.6 1.8 4.1 2.6 0.6 0.0 0.0 0.9 0.1 0.1 4.1 1.7 0.0 6.7 1.2 0.0 13.7 0.0 0.0 0.0 9.4 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 10.9 0.0 0.0 2.3 0.0 0.0 3.3 1.0 0.0 0.1 0.0 11.5 0.0 0.0 0.5 0.0 0.0 0.5 2.6 0.0 0.1 0.0 0.6 0.1 HS3ST2 3OST2 ENSG00000122254 "Heparan sulfate-glucosamine 3-sulfotransferase 2" Q9Y278 16 22814177-22916338 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 12.7;brain: 38.2;lung: 13.4" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 3.2;Bipolar cells: 3.5;Hofbauer cells: 13.5;Peritubular cells: 5.3;Smooth muscle cells: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 10.5;SH-SY5Y: 18.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017736 Approved NA NA "HPA017736: AB_1851095" "unprognostic (4.09e-2)" "unprognostic (2.90e-3)" "unprognostic (5.97e-3)" "unprognostic (3.46e-3)" "prognostic unfavorable (1.57e-4)" "unprognostic (2.00e-1)" "unprognostic (1.05e-1)" "unprognostic (2.17e-3)" "unprognostic (1.83e-1)" "unprognostic (2.75e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "prognostic favorable (1.35e-4)" "unprognostic (4.89e-2)" "unprognostic (1.16e-1)" "unprognostic (1.35e-1)" "unprognostic (3.00e-2)" 12.7 1.7 3.8 1.1 6.5 1.1 2.4 0.5 38.2 2.0 1.4 0.3 0.3 1.0 1.0 1.0 1.2 1.0 1.1 3.8 7.8 4.3 1.0 2.2 13.4 2.1 2.2 8.4 4.5 1.0 1.0 0.4 1.2 1.5 2.0 1.4 5.0 2.9 1.1 1.0 2.0 1.0 1.2 1.0 1.1 1.1 1.1 0.0 0.0 1.8 0.4 1.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 6.5 0.5 19.1 7.8 4.3 2.2 8.4 1.5 0.0 0.0 0.0 0.0 0.1 3.2 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.2 0.2 0.9 0.0 0.0 13.5 0.0 0.0 0.6 0.6 0.7 1.1 0.4 0.0 0.0 0.0 0.0 0.6 0.0 5.3 0.0 0.6 0.0 4.1 0.0 0.0 1.8 0.2 0.0 0.0 0.7 HS3ST3B1 "30ST3B1, 3OST3B1" ENSG00000125430 "Heparan sulfate-glucosamine 3-sulfotransferase 3B1" Q9Y662 17 14301083-14349404 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;liver: 29.1;lymphoid tissue: 26.6;placenta: 33.5;salivary gland: 12.6" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 37.3;Hepatocytes: 32.1;Ito cells: 34.4;Syncytiotrophoblasts: 30.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 2.7;pons and medulla: 6.0" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 20.6" "Group enriched" "Detected in many" 5 "dendritic cells: 20.6;T-cells: 14.7" "Cell line enhanced" "Detected in many" "AF22: 15.5;BEWO: 11.1;Hep G2: 13.5;HSkMC: 15.4;U-251 MG: 14.2" HPA064126 Approved Vesicles NA NA Vesicles "HPA064126: AB_2685194" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (2.85e-3)" "unprognostic (5.22e-2)" "unprognostic (5.03e-3)" "unprognostic (1.79e-1)" "unprognostic (2.93e-1)" "unprognostic (8.13e-3)" "unprognostic (8.80e-2)" "unprognostic (1.13e-1)" "unprognostic (1.02e-3)" "unprognostic (7.77e-3)" "unprognostic (9.46e-2)" "unprognostic (1.91e-1)" "unprognostic (1.54e-3)" 1.4 1.4 0.6 8.7 0.8 1.3 3.0 0.9 2.7 3.8 1.8 0.0 0.8 1.4 1.0 0.3 2.8 1.7 2.6 2.0 0.6 0.7 3.6 29.1 3.7 26.6 0.6 0.0 4.7 1.3 0.4 1.4 33.5 6.0 2.4 1.9 5.3 12.6 2.5 1.8 2.2 2.5 0.6 2.9 4.9 1.4 0.7 0.0 13.2 1.5 2.5 5.9 1.5 5.3 0.4 20.6 0.5 0.4 3.8 14.7 2.7 0.0 0.3 15.5 0.0 4.7 5.3 11.1 4.4 6.4 4.0 4.2 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.4 2.4 2.0 1.3 3.2 0.3 2.0 13.5 6.2 0.5 2.3 15.4 0.8 1.4 3.7 0.9 0.0 0.8 4.6 0.0 3.2 0.8 0.7 0.6 0.5 0.1 0.4 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.3 0.4 0.0 3.9 0.0 0.0 14.2 0.0 0.0 0.0 3.0 0.0 0.9 0.1 0.2 0.0 6.3 0.4 5.0 0.4 7.6 4.9 0.4 0.4 7.7 7.5 0.5 3.8 0.4 20.6 14.7 2.7 0.6 0.8 0.9 2.7 0.6 0.7 0.6 0.0 6.0 0.0 0.0 0.6 1.4 0.2 10.2 2.0 2.2 2.5 4.0 1.2 7.0 37.3 5.1 0.0 0.6 11.1 2.5 0.0 0.0 0.2 10.4 9.0 0.7 0.0 32.1 1.4 7.9 0.0 34.4 3.7 1.4 2.6 4.3 1.7 1.8 0.0 6.0 0.1 0.0 1.1 0.0 15.2 12.9 2.7 0.6 0.4 12.9 30.3 11.7 0.0 0.1 HS3ST5 3-OST-5 ENSG00000249853 "Heparan sulfate-glucosamine 3-sulfotransferase 5" Q8IZT8 6 114055586-114343045 "Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.1;seminal vesicle: 9.4;skeletal muscle: 10.1" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 5.0;Collecting duct cells: 10.4;Cone photoreceptor cells: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 5.0;RT4: 9.2;SCLC-21H: 17.8;U-266/70: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA021823, HPA064677" Approved NA NA "HPA021823: AB_1851100, HPA064677: AB_2685318" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" "unprognostic (2.81e-2)" "unprognostic (1.04e-2)" "unprognostic (1.72e-2)" "unprognostic (3.00e-2)" "unprognostic (7.98e-4)" "unprognostic (5.39e-2)" "unprognostic (6.29e-2)" "unprognostic (1.61e-1)" "unprognostic (1.91e-1)" "unprognostic (5.72e-2)" "unprognostic (3.28e-2)" "unprognostic (3.01e-1)" "unprognostic (3.48e-1)" "unprognostic (1.53e-2)" 0.5 1.9 3.3 0.9 13.1 1.3 0.5 0.6 11.9 0.8 1.0 9.1 3.5 0.7 0.8 0.5 0.6 0.6 0.7 0.5 4.2 3.5 0.9 0.5 1.1 0.5 6.1 2.7 0.6 1.3 0.5 0.3 0.6 7.8 0.7 0.9 0.6 0.7 9.4 10.1 1.3 1.2 0.9 7.5 0.5 1.2 0.9 8.0 0.0 0.6 0.0 0.5 2.5 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 2.5 5.0 0.0 1.0 0.0 0.0 9.2 17.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.1 4.5 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.3 13.1 0.6 5.7 4.2 3.5 6.1 2.7 7.8 8.0 0.0 0.0 0.0 0.0 1.1 5.0 0.7 0.0 0.0 0.0 10.4 17.7 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.7 0.4 0.0 0.1 0.0 0.0 0.2 HS6ST1 HS6ST ENSG00000136720 "Heparan sulfate 6-O-sulfotransferase 1" O60243 2 128236716-128318577 "Disease related genes, Predicted intracellular proteins" Transferase "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 71.5;granulocytes: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 39.5;HMC-1: 62.8;SCLC-21H: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044586 Approved Nucleoplasm "Intracellular and membrane" NA NA 27000 Nucleoplasm "HPA044586: AB_10963057" "unprognostic (9.94e-2)" "unprognostic (8.93e-3)" "unprognostic (4.94e-3)" "unprognostic (6.69e-3)" "unprognostic (1.99e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (4.28e-2)" "unprognostic (1.21e-2)" "unprognostic (2.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" 13.2 32.0 22.4 8.0 16.2 4.1 9.2 17.2 33.2 16.2 9.6 13.5 23.8 8.3 8.8 6.4 19.3 17.1 20.1 8.1 17.3 13.9 22.8 29.5 9.1 7.1 17.8 18.8 16.2 24.2 8.9 7.5 11.5 16.5 13.1 6.9 10.5 12.2 23.9 20.1 14.2 11.3 6.4 14.9 18.2 6.3 14.7 15.6 10.9 7.0 6.7 8.0 19.1 11.1 2.0 5.5 5.8 3.0 0.5 2.6 1.2 3.5 5.2 14.0 8.0 5.4 10.2 7.5 4.4 5.7 4.5 2.5 2.6 2.4 3.5 39.5 5.7 2.1 9.6 5.3 8.7 1.7 5.7 5.4 3.0 1.9 25.6 6.6 5.3 62.8 13.7 10.3 3.6 1.1 1.5 2.4 9.5 1.9 3.6 1.6 7.5 14.1 23.5 16.7 1.4 3.2 4.6 3.8 18.0 4.1 10.8 34.4 8.6 3.6 9.1 2.0 9.8 3.7 2.0 2.8 4.0 8.9 14.8 3.5 2.1 2.1 0.7 2.4 3.8 2.9 5.8 1.6 1.4 2.6 1.0 0.4 1.9 1.0 1.6 1.1 2.0 1.0 1.0 0.5 0.5 3.0 5.5 0.5 1.2 22.4 16.2 17.2 33.2 17.3 13.9 17.8 18.8 16.5 15.6 23.8 12.8 5.2 10.5 14.3 8.1 6.1 7.6 10.7 9.1 71.5 29.5 7.4 5.0 10.2 0.8 7.7 7.1 0.0 5.1 34.4 11.6 6.8 54.4 15.1 8.6 20.6 2.9 30.7 11.7 2.0 10.9 6.2 6.8 6.4 5.2 7.8 7.9 8.2 15.9 2.8 33.7 6.5 5.1 1.1 3.1 14.9 19.5 2.5 4.1 7.8 HS6ST2 ENSG00000171004 "Heparan sulfate 6-O-sulfotransferase 2" Q96MM7 X 132626016-132961395 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5;kidney: 17.3;ovary: 18.2" "Cell type enhanced" "Detected in some" 16 "Cytotrophoblasts: 31.0;Leydig cells: 58.1;Peritubular cells: 33.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 29.5" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Lineage enhanced" "Detected in single" "NK-cells: 1.8" "Cell line enhanced" "Detected in some" "HEK 293: 19.6;HeLa: 13.3;RH-30: 28.4;RT4: 14.1;SH-SY5Y: 35.5" "Low region specificity" "Detected in all" "HPA034625, HPA034626" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA034625: AB_10612119, HPA034626: AB_2674252" "unprognostic (7.62e-3)" "unprognostic (4.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.41e-1)" "unprognostic (3.24e-1)" "unprognostic (5.54e-2)" "unprognostic (1.44e-1)" "unprognostic (1.71e-2)" "unprognostic (1.14e-2)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-1)" "unprognostic (8.39e-5)" "unprognostic (1.36e-3)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.03e-4)" 0.4 3.2 6.5 0.9 29.5 0.1 2.6 3.0 6.7 1.0 0.8 0.8 0.6 0.3 4.5 3.2 5.0 2.5 0.5 0.4 4.1 9.1 17.3 0.2 1.0 0.3 3.5 0.9 18.2 6.5 0.1 1.3 9.9 3.3 5.4 1.2 0.0 1.1 1.6 6.7 0.3 0.2 2.0 3.3 0.2 1.1 7.9 0.7 0.7 0.6 1.7 2.7 2.3 0.6 0.0 0.0 0.0 0.0 1.8 0.6 0.0 4.3 0.0 6.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.1 0.0 0.0 6.5 0.0 0.0 0.2 9.2 0.0 0.0 0.0 19.6 0.0 13.3 0.0 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.2 0.1 0.0 5.0 3.0 0.2 0.0 28.4 0.0 5.7 14.1 0.7 35.5 6.2 0.0 0.0 10.7 0.0 0.0 0.0 0.0 1.1 4.1 9.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.5 29.5 3.0 5.8 4.1 9.1 3.5 0.9 3.3 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.0 13.4 7.9 3.5 0.0 31.0 5.0 0.0 0.4 0.4 0.0 0.0 1.6 1.3 2.2 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 58.1 0.0 0.0 0.0 0.0 5.3 1.2 0.0 33.2 0.0 0.0 0.0 0.3 0.2 1.2 0.3 14.5 0.0 0.0 0.2 HS6ST3 ENSG00000185352 "Heparan sulfate 6-O-sulfotransferase 3" Q8IZP7 13 96090839-96839562 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.7" "Cell type enhanced" "Detected in some" 13 "Horizontal cells: 3.2;Pancreatic endocrine cells: 1.0;Rod photoreceptor cells: 1.8;Spermatogonia: 1.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RT4: 19.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA078257 Approved "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA 9800 "Nucleoplasm, Nuclear membrane" "Plasma membrane, Actin filaments" "HPA078257: AB_2732374" "unprognostic (2.34e-2)" "unprognostic (1.90e-2)" "unprognostic (2.82e-2)" "unprognostic (1.72e-2)" "unprognostic (4.88e-2)" "unprognostic (2.78e-2)" "unprognostic (1.55e-1)" "unprognostic (3.67e-3)" "unprognostic (8.11e-3)" "unprognostic (1.19e-1)" "prognostic favorable (6.12e-5)" "unprognostic (1.54e-4)" "unprognostic (2.24e-1)" "unprognostic (1.57e-3)" "unprognostic (9.89e-2)" 0.9 4.5 1.5 0.0 1.9 0.0 0.0 0.4 18.7 1.9 0.0 0.2 2.1 2.2 0.2 0.1 0.0 0.2 3.2 2.7 0.7 0.0 0.0 0.0 0.9 0.0 2.1 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.0 1.6 0.4 0.0 0.7 0.1 2.4 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 19.6 1.0 0.8 0.1 0.1 0.0 0.3 0.6 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 HSD11B1 "HSD11, HSD11B, SDR26C1" ENSG00000117594 "Hydroxysteroid 11-beta dehydrogenase 1" P28845 1 209686178-209734950 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 183.4" "Cell type enriched" "Detected in many" 13 "Hepatocytes: 560.1" "Cancer enriched" "Detected in all" 28 "liver cancer: 197.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 9.2" "Lineage enriched" "Detected in single" 20 "T-cells: 9.2" "Cell line enriched" "Detected in some" 5 "ASC diff: 151.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047729 Enhanced NA NA 77000 "HPA047729: AB_2680135" "unprognostic (1.08e-3)" "unprognostic (2.13e-1)" "unprognostic (2.32e-1)" "unprognostic (1.40e-1)" "unprognostic (1.57e-1)" "unprognostic (3.68e-1)" "unprognostic (2.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.30e-1)" "unprognostic (3.63e-2)" "unprognostic (8.35e-3)" "unprognostic (8.69e-2)" "prognostic unfavorable (1.97e-10)" "unprognostic (3.41e-2)" "unprognostic (3.91e-2)" "unprognostic (6.45e-2)" "unprognostic (1.59e-2)" 4.6 1.6 1.1 3.0 3.1 0.3 2.4 9.9 3.9 0.6 1.0 1.6 2.7 0.5 0.8 8.7 1.5 0.9 1.9 3.0 1.8 0.9 2.6 183.4 7.2 1.3 8.2 2.0 12.6 0.9 0.3 1.5 26.5 3.3 7.1 0.9 1.5 0.6 3.0 1.5 6.3 0.9 2.7 1.3 3.5 1.4 2.3 2.5 0.0 1.0 0.6 0.6 3.9 1.4 0.2 0.0 0.2 0.1 0.4 9.2 0.8 0.0 0.0 0.0 0.0 151.9 15.8 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.8 0.0 1.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 1.2 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.6 0.2 9.2 2.0 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.0 2.4 0.8 1.1 3.1 9.9 3.9 1.8 0.9 8.2 2.0 3.3 2.5 3.0 0.0 2.4 0.5 0.1 0.0 0.8 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 10.8 0.5 0.0 560.1 8.7 0.0 0.0 8.6 8.9 2.2 27.0 2.2 0.0 1.0 0.0 15.4 0.2 0.0 7.4 0.0 0.3 0.0 2.1 0.0 0.2 0.1 0.2 0.5 0.0 1.6 HSD17B12 "KAR, SDR12C1" ENSG00000149084 "Hydroxysteroid 17-beta dehydrogenase 12" Q53GQ0 11 43680558-43856617 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016427 Approved NA NA 200000 "HPA016427: AB_1844347" "unprognostic (1.93e-1)" "unprognostic (1.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.14e-3)" "prognostic unfavorable (2.76e-4)" "unprognostic (2.99e-1)" "unprognostic (3.31e-2)" "unprognostic (9.16e-3)" "unprognostic (5.16e-2)" "unprognostic (7.54e-2)" "prognostic favorable (2.10e-8)" "unprognostic (6.87e-2)" "unprognostic (1.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.28e-2)" 27.2 32.6 33.5 16.6 31.9 10.5 30.4 12.8 33.1 26.3 30.7 31.4 29.3 32.0 22.3 25.3 24.3 20.1 28.0 36.9 30.9 31.1 42.9 59.8 25.8 19.9 38.5 21.4 22.4 26.4 66.6 29.4 19.4 45.7 26.4 29.4 26.6 25.3 22.9 16.1 18.2 30.8 23.3 44.9 23.5 25.6 17.6 24.4 15.2 32.4 32.5 17.5 19.4 18.6 12.8 18.7 9.8 12.7 13.5 15.0 9.6 9.0 14.8 16.5 16.7 55.3 52.6 10.8 23.4 23.1 16.3 17.8 17.9 19.1 22.7 16.6 21.0 27.0 35.7 11.5 29.5 20.2 4.2 21.3 10.5 8.3 15.6 28.1 32.5 30.1 32.3 22.7 16.4 46.8 20.8 22.5 14.3 9.9 37.9 14.0 5.2 8.6 14.5 30.2 11.4 10.8 14.6 24.5 25.6 31.1 22.4 6.0 13.6 31.3 26.4 22.8 16.2 18.9 26.2 21.5 17.6 6.9 45.7 27.3 19.5 24.5 13.6 19.1 5.8 13.2 6.1 12.2 5.5 11.0 12.7 11.7 11.0 8.8 9.2 18.7 12.8 15.0 12.9 9.8 13.5 6.5 15.1 5.0 9.6 33.5 31.9 12.8 30.8 30.9 31.1 38.5 21.4 45.7 24.4 59.6 94.5 60.7 41.7 28.2 71.5 81.5 76.5 89.7 64.8 48.8 72.6 50.4 23.2 87.7 47.4 65.0 71.5 23.3 72.4 37.6 41.7 54.4 152.4 109.0 55.3 114.4 132.6 70.0 43.0 14.4 31.7 49.6 37.1 32.5 68.5 118.3 65.6 45.6 53.4 39.7 63.0 77.6 48.4 11.4 11.5 40.0 62.6 27.4 93.1 38.3 HSD17B13 "SCDR9, SDR16C3" ENSG00000170509 "Hydroxysteroid 17-beta dehydrogenase 13" Q7Z5P4 4 87303789-87322906 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 158.8" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 61.6;Club cells: 78.5;Hepatocytes: 112.8;Urothelial cells: 30.7" "Cancer enriched" "Detected in some" 26 "liver cancer: 52.9" "Region enriched" "Detected in single" 6 "cerebellum: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 4.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA029125 Uncertain Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA Vesicles "Golgi apparatus" "HPA029125: AB_10601580" "unprognostic (2.49e-1)" "unprognostic (7.46e-2)" "unprognostic (7.02e-2)" "unprognostic (1.86e-4)" "unprognostic (4.74e-2)" "unprognostic (8.44e-2)" "prognostic favorable (2.94e-4)" "prognostic favorable (7.80e-4)" "unprognostic (4.97e-1)" "unprognostic (2.22e-2)" "unprognostic (1.00e-1)" "unprognostic (2.46e-1)" "unprognostic (7.18e-4)" "unprognostic (3.62e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-3)" 8.0 0.1 0.1 0.2 0.1 0.3 1.8 1.0 0.1 1.3 0.3 0.1 0.1 0.1 1.2 0.2 0.1 0.1 0.1 0.9 0.1 0.0 0.1 158.8 0.8 0.1 0.1 0.1 0.1 2.4 0.0 0.1 0.3 0.1 2.4 0.1 0.1 0.2 0.1 0.1 1.4 0.1 1.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.4 0.1 0.3 2.7 1.8 0.6 3.7 0.7 0.8 0.8 0.1 0.2 0.3 0.8 0.9 1.1 0.8 0.6 0.1 0.3 0.0 0.1 0.0 1.8 0.6 0.6 0.3 0.1 0.4 0.2 0.2 0.2 0.6 0.3 1.0 1.1 1.8 0.8 2.6 1.1 0.4 0.0 0.0 0.1 0.9 0.3 0.9 0.8 0.9 0.3 0.3 0.4 4.9 0.4 1.4 0.5 0.8 1.0 0.3 0.3 0.5 0.5 2.1 0.6 0.4 0.2 0.5 0.2 1.6 1.0 0.5 2.7 0.7 0.4 0.5 0.3 0.5 0.3 2.0 1.0 3.7 0.7 1.5 0.4 0.2 0.4 1.8 0.4 0.4 0.1 1.1 0.8 0.7 2.8 0.8 0.3 0.6 0.4 0.1 0.1 0.1 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 3.0 5.4 0.0 19.6 2.3 0.0 0.3 2.5 61.6 78.5 1.8 0.0 0.1 0.0 0.0 2.1 0.4 0.0 0.0 0.4 0.2 1.0 1.1 0.0 112.8 0.2 0.0 1.7 1.3 1.6 1.8 0.0 0.5 0.0 0.0 0.7 0.3 0.2 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.6 30.7 HSD17B2 "HSD17, SDR9C2" ENSG00000086696 "Hydroxysteroid 17-beta dehydrogenase 2" P37059 16 82035004-82098534 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.1;liver: 52.9;placenta: 110.8" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 137.6;Enterocytes: 250.1;Hepatocytes: 98.5;Paneth cells: 199.9" "Cancer enhanced" "Detected in many" "liver cancer: 10.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 22.4;Hep G2: 17.8;hTERT-HME1: 10.7;OE19: 32.8;RT4: 36.8;TIME: 20.6" "Group enriched" "Detected in some" 5 "midbrain: 2.6;pons and medulla: 3.5" "Not detected" "Not detected" "HPA021826, HPA050235" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA021826: AB_10961148, HPA050235: AB_2681059" "unprognostic (1.50e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.48e-2)" "unprognostic (2.58e-1)" "unprognostic (1.77e-1)" "unprognostic (4.29e-2)" "unprognostic (2.60e-1)" "unprognostic (7.35e-2)" "unprognostic (6.05e-3)" "unprognostic (4.98e-2)" "unprognostic (7.35e-2)" "unprognostic (6.31e-4)" "unprognostic (5.39e-2)" "unprognostic (1.14e-1)" "unprognostic (4.30e-2)" "prognostic favorable (3.83e-4)" 0.7 0.1 0.2 4.1 0.2 0.0 3.9 0.2 0.3 0.7 41.3 0.3 0.2 71.3 0.6 0.2 1.7 0.2 13.3 0.2 0.2 0.2 2.8 52.9 1.0 0.2 0.2 0.2 0.2 16.0 0.0 0.6 110.8 0.4 3.1 9.4 21.3 9.4 0.2 0.3 1.8 83.1 1.5 0.2 0.2 3.2 0.2 0.2 0.2 0.2 1.1 1.3 21.4 6.6 1.3 1.4 3.6 1.1 1.0 0.7 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.0 22.4 0.0 0.0 4.1 0.6 0.0 4.5 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.1 17.8 0.1 0.1 0.1 0.0 1.2 0.0 10.7 0.2 0.3 0.0 0.0 0.1 3.3 0.0 0.0 0.3 0.1 32.8 8.1 0.0 0.0 0.4 0.4 36.8 0.2 0.6 0.0 1.0 0.1 0.0 0.0 0.0 20.6 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 1.6 1.1 0.6 0.7 0.5 0.4 0.6 0.4 0.4 0.3 1.3 0.4 0.6 3.6 1.0 0.6 1.4 0.3 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 3.0 3.8 0.0 2.7 0.3 0.1 0.4 137.6 6.7 2.3 0.0 0.0 2.1 0.0 47.5 0.1 0.2 250.1 0.0 5.5 1.5 3.1 1.8 0.0 98.5 3.0 0.0 2.9 3.1 2.4 0.8 0.0 0.0 1.7 0.0 19.3 42.0 13.6 199.9 0.0 1.0 0.6 0.0 0.3 0.0 0.0 1.0 5.4 0.0 33.8 10.0 HSD17B3 SDR12C2 ENSG00000130948 "Hydroxysteroid 17-beta dehydrogenase 3" P37058 9 96235306-96302152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 41.9" "Cell type enriched" "Detected in some" 8 "Leydig cells: 100.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HBEC3-KT: 5.0;HEL: 4.4;U-2 OS: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA056833 Enhanced Approved Vesicles NA NA Vesicles "HPA056833: AB_2683252" "unprognostic (2.78e-1)" "unprognostic (6.61e-3)" "unprognostic (1.03e-1)" "unprognostic (5.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (3.08e-2)" "unprognostic (6.15e-2)" "unprognostic (1.74e-1)" "unprognostic (5.13e-2)" "unprognostic (3.26e-4)" "unprognostic (3.45e-1)" "unprognostic (5.48e-8)" "unprognostic (8.47e-3)" "unprognostic (1.15e-1)" "unprognostic (7.24e-2)" "unprognostic (3.11e-2)" 0.5 0.4 1.0 0.5 1.0 0.4 0.5 0.5 0.9 0.8 0.5 0.5 0.5 0.4 0.5 0.5 0.5 1.3 0.5 0.5 1.7 0.5 1.0 6.3 0.5 0.5 1.6 0.5 0.5 1.3 0.4 0.5 0.5 0.5 0.8 0.4 0.5 0.5 0.5 0.5 0.5 1.1 0.5 1.9 0.5 0.4 41.9 0.5 0.5 4.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.0 1.0 0.5 0.9 1.7 0.5 1.6 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.4 0.3 0.0 0.4 0.0 0.2 0.1 0.0 1.6 0.0 0.0 1.7 0.0 0.0 7.8 100.1 0.0 0.0 0.0 0.2 0.5 0.1 0.0 12.0 0.0 0.2 0.0 0.5 0.3 1.9 0.3 0.1 0.0 0.2 0.0 HSD3B1 "HSD3B, HSDB3, SDR11E1" ENSG00000203857 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1" P14060 1 119507198-119515054 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Isomerase, Multifunctional enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 231.4" "Group enriched" "Detected in some" 23 "Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 36.4;SuSa: 16.3" "HPA043261, HPA043264, HPA044028" Supported Approved "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" NA NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "prognostic favorable (4.59e-5)" 0.1 0.6 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 231.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.5 11.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 4.0 0.4 0.5 16.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 115.9 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 419.8 0.0 0.0 0.0 HSD3B2 SDR11E2 ENSG00000203859 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2" P26439 1 119414931-119423035 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis "Isomerase, Multifunctional enzyme, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adrenal gland: 223.2" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 1.6;Exocrine glandular cells: 1.1;Peritubular cells: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Region enriched" "Detected in single" 198 "basal ganglia: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;SuSa: 1.9;TIME: 1.2;WM-115: 3.2" "HPA043261, HPA043264, HPA044028" Supported Uncertain "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" NA NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (3.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.80e-1)" "unprognostic (2.72e-2)" "unprognostic (8.87e-2)" "unprognostic (3.91e-2)" "unprognostic (3.43e-2)" "unprognostic (1.94e-1)" "unprognostic (6.51e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" 0.0 223.2 0.0 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.5 43.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 1.4 0.0 0.0 5.1 1.9 0.0 0.0 1.2 0.2 0.1 0.1 0.7 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 HSD3B7 "C(27)-3BETA-HSD, SDR11E3" ENSG00000099377 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7" Q9H2F3 16 30985207-30989152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis Oxidoreductase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.1" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 52.9;Hofbauer cells: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "basophil: 24.5;eosinophil: 13.5" "Lineage enriched" "Detected in single" 29 "granulocytes: 24.5" "Cell line enhanced" "Detected in many" "HDLM-2: 31.6;Hep G2: 23.1;HMC-1: 35.9;U-2197: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015965, HPA050521, HPA060847" Uncertain Enhanced "Lipid droplets" NA NA "Lipid droplets" "HPA015965: , HPA050521: AB_2681155, HPA060847: AB_2684379" "unprognostic (5.41e-3)" "unprognostic (4.14e-3)" "prognostic unfavorable (5.95e-4)" "unprognostic (2.62e-2)" "unprognostic (5.06e-3)" "unprognostic (1.47e-2)" "unprognostic (3.52e-2)" "unprognostic (1.85e-1)" "unprognostic (2.04e-2)" "unprognostic (1.76e-1)" "unprognostic (3.20e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (1.60e-6)" "unprognostic (2.45e-1)" "unprognostic (1.12e-1)" "unprognostic (1.58e-1)" "unprognostic (1.79e-1)" 21.6 11.2 2.5 7.5 4.7 1.8 7.3 2.7 4.0 4.9 8.3 4.6 2.8 11.2 5.3 6.4 9.4 4.4 7.4 5.2 3.1 1.6 25.6 74.1 6.4 5.6 3.5 1.4 9.3 17.7 5.6 2.6 6.1 3.7 5.9 3.2 2.9 4.5 2.6 5.1 7.8 13.3 6.7 4.8 8.3 4.8 3.6 3.7 1.0 2.9 4.5 4.6 8.0 3.9 0.1 0.8 24.5 0.8 0.2 0.0 0.3 7.0 8.1 0.8 4.1 2.9 10.7 0.5 8.8 14.0 1.7 3.6 0.6 12.3 0.4 2.9 10.8 0.3 2.1 0.8 1.3 0.9 31.6 1.9 0.5 6.4 23.1 2.7 0.1 35.9 5.1 2.2 8.4 1.7 4.1 0.8 0.4 1.6 0.3 6.6 15.1 0.2 5.0 0.6 3.0 1.1 0.8 2.8 7.8 5.4 0.4 3.0 1.5 1.1 5.8 0.8 0.4 11.2 0.5 4.1 3.7 1.0 34.9 0.9 0.6 5.1 0.4 14.3 0.9 0.3 24.5 0.8 13.5 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.6 0.2 0.0 0.3 0.0 0.3 2.5 4.7 2.7 4.0 3.1 1.6 3.5 1.4 3.7 3.7 3.0 6.2 2.7 2.2 7.0 0.7 1.6 25.5 1.4 0.0 14.0 0.0 1.7 13.3 34.6 37.8 6.5 20.6 0.0 26.8 2.6 9.0 2.5 9.2 52.9 55.1 1.6 7.5 6.7 7.9 1.1 6.1 14.8 13.5 21.6 7.2 1.9 19.4 11.2 4.9 33.2 0.4 12.9 9.0 0.6 1.1 11.0 1.1 1.0 15.7 2.4 HSPA13 STCH ENSG00000155304 "Heat shock protein family A (Hsp70) member 13" P48723 21 14371115-14383484 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 67.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014797 Approved "Intracellular and membrane" NA NA 2200000 "HPA014797: AB_1857567" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (5.77e-3)" "unprognostic (1.06e-1)" "unprognostic (1.72e-1)" "unprognostic (2.85e-3)" "unprognostic (1.41e-2)" "unprognostic (7.86e-2)" "unprognostic (1.64e-1)" "unprognostic (2.46e-1)" "unprognostic (5.62e-2)" "unprognostic (1.52e-2)" "unprognostic (1.65e-1)" "unprognostic (2.29e-1)" "unprognostic (2.61e-1)" "unprognostic (1.16e-2)" 10.2 19.1 18.2 12.8 35.8 15.2 12.0 17.5 27.5 16.1 9.2 8.5 10.9 7.4 17.3 21.3 7.0 8.9 9.6 10.9 18.1 28.2 13.0 23.2 10.2 10.7 17.5 15.8 13.2 11.6 14.8 31.5 18.3 21.8 12.4 9.9 8.1 12.4 14.0 4.7 4.1 7.3 14.9 18.8 10.8 9.3 16.3 13.8 13.4 21.4 5.6 12.7 12.1 7.4 6.7 7.4 18.4 4.8 10.8 10.8 5.3 5.9 4.8 19.2 11.0 13.9 11.2 12.2 16.8 19.8 14.0 16.1 4.5 6.5 10.3 11.8 12.0 20.9 2.6 8.8 5.7 23.5 10.7 6.9 10.0 5.2 8.5 35.8 16.3 12.9 10.0 18.9 20.0 34.6 17.8 11.7 9.4 8.4 67.3 15.2 5.9 10.8 5.0 14.2 2.8 6.7 10.2 16.9 22.4 7.3 2.3 4.4 10.8 12.4 6.5 23.7 10.2 9.0 10.9 11.6 18.4 15.4 14.4 12.2 25.6 19.1 8.3 20.6 10.5 22.9 18.4 4.2 4.2 6.3 4.8 10.8 6.7 6.8 6.7 4.9 3.8 7.6 7.2 1.8 10.8 4.1 7.4 5.3 5.3 18.2 35.8 17.5 26.3 18.1 28.2 17.5 15.8 21.8 13.8 8.9 13.1 15.7 12.6 11.3 37.7 13.3 5.1 6.7 5.7 3.5 13.7 19.8 0.0 7.2 5.2 12.1 3.5 0.0 8.8 20.9 19.5 18.0 18.5 10.5 12.4 57.2 14.3 14.1 13.7 1.8 9.2 12.6 21.9 6.4 6.8 37.1 8.7 2.9 18.0 6.3 17.4 12.9 16.9 30.9 5.3 8.9 53.7 12.8 3.8 11.5 HTATIP2 "CC3, FLJ26963, SDR44U1, TIP30" ENSG00000109854 "HIV-1 Tat interactive protein 2" Q9BUP3 11 20363685-20383783 "Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Differentiation, Host-virus interaction" "Developmental protein, Oxidoreductase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 185.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006417, HPA024321" Approved Supported Cytosol NA NA Cytosol "HPA006417: AB_1079091, HPA024321: AB_1851288" "unprognostic (8.05e-3)" "unprognostic (2.13e-1)" "unprognostic (9.31e-2)" "unprognostic (3.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.79e-3)" "prognostic unfavorable (2.86e-4)" "unprognostic (1.20e-3)" "unprognostic (1.05e-1)" "unprognostic (4.93e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (1.75e-1)" "prognostic unfavorable (8.01e-4)" "unprognostic (1.20e-1)" "unprognostic (9.42e-2)" "unprognostic (1.71e-1)" "unprognostic (2.03e-1)" 16.3 28.1 8.5 11.9 16.3 6.3 26.3 3.2 10.6 9.4 50.4 16.2 10.8 52.2 6.8 13.0 23.1 5.7 17.6 9.5 10.8 9.9 21.5 41.8 19.5 16.2 24.3 8.0 6.8 11.9 17.9 27.4 22.9 12.4 13.9 32.2 3.3 16.5 9.2 19.4 14.8 74.6 12.1 15.0 19.6 29.4 10.6 14.6 6.6 23.9 17.2 12.1 17.8 26.7 16.4 17.4 69.4 30.6 13.5 30.6 23.8 23.1 38.5 0.8 0.0 11.8 9.0 8.6 10.1 10.0 7.8 9.4 22.2 20.4 5.3 20.8 12.6 30.4 32.6 0.0 6.1 7.6 60.3 4.7 6.5 38.0 0.0 28.5 2.4 31.1 12.9 43.5 6.3 9.9 0.0 22.3 0.0 16.0 7.0 14.5 21.7 0.0 1.5 12.5 40.7 19.2 4.9 0.0 19.0 10.6 12.9 10.5 0.1 32.8 13.0 15.4 4.2 27.2 12.2 27.1 5.6 12.3 11.3 0.2 7.5 9.2 0.1 0.0 16.5 24.1 43.7 30.6 37.3 15.5 27.5 17.5 14.9 18.0 16.5 17.4 16.4 15.8 15.5 69.4 13.5 28.3 5.1 30.6 23.8 8.5 16.3 3.2 10.6 10.8 9.9 24.3 8.0 12.4 14.6 23.8 8.1 24.1 49.8 32.3 0.3 9.7 117.2 8.1 10.3 45.4 0.0 50.0 26.6 84.2 36.1 22.9 185.2 0.0 63.6 102.1 14.2 53.7 23.0 69.2 75.1 3.2 23.2 28.8 55.0 45.4 18.4 40.5 42.2 143.3 93.7 9.4 88.6 161.4 8.9 60.3 1.7 12.9 29.5 27.3 17.2 36.8 51.5 35.8 83.1 52.5 HTR1A "5-HT1A, ADRB2RL1, ADRBRL1" ENSG00000178394 "5-hydroxytryptamine receptor 1A" P08908 5 63960356-63962507 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 21.5;ovary: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 14.7;cerebral cortex: 10.7;hippocampal formation: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "NTERA-2: 5.4;SCLC-21H: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA018073 Uncertain NA NA "HPA018073: AB_1856704" "unprognostic (1.81e-1)" 0.2 0.4 14.7 0.2 1.0 0.2 0.2 0.1 10.7 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.5 21.5 2.4 0.2 0.2 0.3 0.2 0.7 2.7 10.4 0.2 0.2 0.1 0.2 0.9 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.6 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 1.0 0.1 10.7 21.5 2.4 0.7 2.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR1B "5-HT1B, 5-HT1DB, HTR1D2, S12" ENSG00000135312 "5-hydroxytryptamine receptor 1B" P28222 6 77461753-77463773 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;placenta: 14.2;stomach 1: 10.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "basal ganglia: 11.8" "Cell type enriched" "Detected in single" 17 "basophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" "Group enriched" "Detected in some" 15 "HUVEC TERT2: 41.8;TIME: 18.4" "Region enriched" "Detected in many" 4 "basal ganglia: 34.5" HPA028808 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA028808: AB_2672782" "unprognostic (3.86e-2)" "unprognostic (3.56e-1)" "unprognostic (7.68e-2)" "unprognostic (2.58e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.11e-1)" "unprognostic (8.96e-2)" "unprognostic (4.03e-1)" "unprognostic (1.77e-2)" "unprognostic (1.24e-1)" "unprognostic (1.10e-3)" "unprognostic (3.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" 2.2 1.5 1.3 1.1 11.8 0.3 2.4 0.4 3.7 2.9 0.6 0.1 0.0 0.6 1.1 1.0 1.4 0.8 2.8 0.4 1.0 2.1 0.9 0.3 1.1 0.3 1.2 0.9 1.1 0.5 0.3 0.5 14.2 3.0 1.6 0.4 0.3 1.3 1.2 0.9 0.5 0.4 4.1 0.6 0.4 10.2 1.5 0.6 0.0 0.5 0.0 0.3 2.6 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.4 1.1 0.8 41.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 11.8 0.4 3.7 1.0 2.1 1.2 0.9 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR1D "5-HT1D, HT1DA, HTRL, RDC4" ENSG00000179546 "5-hydroxytryptamine receptor 1D" P28221 1 23191895-23194729 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;intestine: 12.2" "Cell type enriched" "Detected in single" 12 "Cholangiocytes: 7.6" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 8.5;hTERT-RPE1: 8.2;OE19: 11.4;TIME: 21.3;U-2 OS: 7.2" "Region enhanced" "Detected in some" "basal ganglia: 7.6" "Low region specificity" "Detected in many" NA NA "unprognostic (1.73e-2)" "unprognostic (8.69e-3)" "unprognostic (8.86e-3)" "unprognostic (2.03e-1)" "unprognostic (2.65e-2)" "unprognostic (5.97e-4)" "prognostic unfavorable (1.86e-4)" "unprognostic (3.87e-3)" "unprognostic (8.88e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (5.30e-4)" "unprognostic (3.17e-2)" "unprognostic (3.28e-6)" "unprognostic (9.14e-2)" "unprognostic (2.27e-1)" "unprognostic (2.45e-1)" "unprognostic (8.02e-3)" 0.0 0.0 0.3 0.0 3.9 0.1 0.0 0.0 0.2 0.0 0.1 12.2 0.0 0.0 0.0 0.5 1.9 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 10.4 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.5 0.0 1.0 0.7 2.2 1.2 1.2 0.9 0.2 2.5 8.5 0.0 0.0 0.0 0.2 0.7 0.0 0.6 0.3 0.3 0.5 6.1 0.0 2.5 0.3 4.3 1.8 1.7 0.0 0.4 0.0 0.7 0.0 5.0 0.1 0.3 0.0 0.0 0.1 0.1 1.0 0.3 8.2 5.0 0.1 0.0 0.0 0.2 1.0 0.0 0.0 2.0 11.4 0.1 0.0 0.0 0.0 0.2 0.0 2.1 0.0 5.7 0.3 0.1 0.7 0.1 0.0 21.3 0.0 7.2 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 1.2 0.5 0.6 0.8 0.4 1.0 0.9 0.6 0.4 1.0 0.6 0.6 2.2 1.2 1.0 0.7 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.3 7.6 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 HTR1E 5-HT1E ENSG00000168830 "5-hydroxytryptamine receptor 1E" P28566 6 86937306-87016683 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.4;ovary: 13.3" "Cell type enriched" "Detected in some" 4 "Early spermatids: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "PC-3: 2.9;SH-SY5Y: 11.6" "Low region specificity" "Detected in many" HPA004931 Approved NA NA "HPA004931: AB_1856706" "unprognostic (2.25e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (4.52e-2)" "unprognostic (1.25e-1)" 0.5 0.6 8.9 0.6 13.3 0.5 0.5 5.4 16.4 1.6 0.5 0.0 0.0 0.5 5.1 1.1 0.6 0.5 0.8 0.5 4.1 2.8 0.5 0.5 0.5 0.5 1.8 11.4 13.3 0.8 0.5 0.3 0.5 2.2 1.1 0.5 0.0 0.5 1.2 0.5 0.5 0.5 2.9 0.6 0.5 3.6 1.4 1.5 0.0 2.7 0.0 0.5 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.3 11.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 13.3 5.4 16.4 4.1 2.8 1.8 11.4 2.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 HTR1F "5-HT1F, HTR1EL" ENSG00000179097 "5-hydroxytryptamine receptor 1F" P30939 3 87990696-87993835 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 5.7" "Group enriched" "Detected in some" 10 "Muller glia cells: 19.5;Sertoli cells: 19.4;Smooth muscle cells: 11.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "basophil: 3.2" "Lineage enriched" "Detected in single" 16 "granulocytes: 3.2" "Group enriched" "Detected in some" 6 "A549: 1.2;K-562: 4.5;LHCN-M2: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005555 Uncertain NA NA "HPA005555: AB_1856708" "unprognostic (1.66e-1)" "unprognostic (2.62e-1)" "unprognostic (2.58e-1)" "unprognostic (9.03e-2)" "unprognostic (1.09e-1)" "unprognostic (1.01e-2)" "unprognostic (4.78e-1)" "unprognostic (1.58e-1)" "unprognostic (2.77e-2)" "unprognostic (2.24e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (2.67e-6)" "unprognostic (1.25e-4)" "unprognostic (1.55e-2)" "unprognostic (3.33e-2)" "unprognostic (3.31e-2)" 2.8 0.5 0.7 0.0 0.6 1.5 1.6 0.0 1.8 1.4 0.0 0.0 1.2 0.3 0.1 0.4 0.1 0.3 0.6 0.4 0.6 0.0 0.9 0.1 0.8 0.4 0.7 0.3 1.4 5.7 0.4 0.0 0.1 1.0 0.6 0.4 0.0 1.3 0.3 1.7 0.0 0.3 1.5 0.5 0.6 0.7 0.1 0.2 3.2 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.5 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.7 0.0 0.0 19.5 0.1 0.0 0.0 0.0 1.0 19.4 11.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 HTR2A "5-HT2A, HTR2" ENSG00000102468 "5-hydroxytryptamine receptor 2A" P28223 13 46831550-46897076 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "Behavior, Host-virus interaction" "G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 30.4" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 1.3;Late spermatids: 1.4;Muller glia cells: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "neutrophil: 1.2;plasmacytoid DC: 1.2" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;granulocytes: 1.2" "Cell line enhanced" "Detected in some" "ASC diff: 3.8;ASC TERT1: 9.3;BEWO: 2.9;HEL: 2.8;U-138 MG: 4.7;U-2 OS: 3.0;U-87 MG: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014011 Enhanced NA NA "HPA014011: AB_1856709" "unprognostic (8.01e-2)" "unprognostic (2.71e-2)" "unprognostic (9.49e-2)" "unprognostic (7.40e-2)" "unprognostic (2.78e-1)" "unprognostic (1.99e-1)" "unprognostic (2.70e-2)" "unprognostic (4.31e-2)" "unprognostic (5.27e-2)" "unprognostic (3.97e-2)" "unprognostic (2.61e-1)" "unprognostic (2.90e-1)" "unprognostic (9.94e-5)" "unprognostic (4.78e-3)" "unprognostic (2.54e-1)" "unprognostic (2.91e-2)" "unprognostic (8.28e-2)" 1.9 1.0 9.5 1.7 13.5 0.6 1.3 0.6 30.4 1.6 1.2 1.2 0.0 1.1 1.6 0.6 1.4 1.1 2.9 1.5 3.8 5.1 0.7 0.6 1.0 0.6 3.3 13.3 1.0 0.6 0.6 0.5 0.6 1.8 0.9 1.6 2.0 0.6 1.5 0.9 0.7 1.1 4.4 1.2 0.6 1.0 1.5 0.7 0.0 0.7 0.0 0.8 1.9 1.5 0.1 1.2 1.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 3.8 9.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.1 4.7 3.0 0.0 0.2 0.1 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 1.2 0.0 1.5 9.5 13.5 0.6 26.4 3.8 5.1 3.3 13.3 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.4 0.9 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.4 0.0 0.2 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 HTR2B "5-HT(2B), 5-HT2B" ENSG00000135914 "5-hydroxytryptamine receptor 2B" P41595 2 231108230-231125118 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 26.0" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 3.9;Ito cells: 5.5;monocytes: 10.8;Peritubular cells: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 3.8;T-reg: 2.9" "Group enriched" "Detected in many" 29 "granulocytes: 3.8;T-cells: 2.9" "Group enriched" "Detected in some" 4 "HHSteC: 7.0;HSkMC: 13.3;SK-MEL-30: 24.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012867, HPA063658" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA012867: AB_1856710, HPA063658: AB_2685079" "unprognostic (1.86e-1)" "unprognostic (3.55e-2)" "unprognostic (1.20e-3)" "unprognostic (1.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.53e-2)" "unprognostic (1.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.15e-4)" "unprognostic (3.59e-1)" "unprognostic (2.17e-2)" "unprognostic (1.42e-3)" "unprognostic (7.44e-4)" "unprognostic (1.81e-1)" "unprognostic (1.17e-1)" "unprognostic (1.14e-2)" 2.3 17.9 0.2 5.8 0.3 0.7 4.1 0.3 0.6 17.8 7.3 0.2 1.7 1.0 14.9 9.5 5.7 1.9 0.8 4.6 0.3 0.3 5.6 2.5 1.8 0.5 0.3 0.4 4.3 0.3 0.3 0.4 26.0 0.9 2.6 1.5 1.8 0.5 1.0 0.2 0.2 6.3 12.8 0.3 0.4 5.2 3.3 0.3 2.4 6.8 1.0 0.4 4.9 0.8 0.0 0.1 3.8 0.0 0.0 2.9 0.0 0.1 0.2 0.0 0.1 0.4 3.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.0 0.1 0.3 13.3 0.0 0.0 0.0 0.0 2.5 1.1 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 24.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 2.9 0.0 0.2 0.3 0.3 0.6 0.3 0.3 0.3 0.4 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 2.7 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.9 2.6 1.6 0.0 5.5 1.2 0.0 0.6 0.0 0.0 10.8 0.0 0.0 0.1 0.0 4.9 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 HTR2C "5-HT2C, 5HTR2C, HTR1C" ENSG00000147246 "5-hydroxytryptamine receptor 2C" P28335 X 114584078-114910061 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "brain: 45.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Region enhanced" "Detected in many" "basal ganglia: 45.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 5.0;RPMI-8226: 2.4;U-266/70: 8.9;U-266/84: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.14e-1)" "unprognostic (6.09e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (2.89e-2)" "unprognostic (3.42e-2)" "unprognostic (9.22e-4)" "unprognostic (1.37e-1)" "unprognostic (6.84e-2)" 0.5 0.5 2.4 0.4 45.3 0.5 0.5 0.0 9.4 2.3 0.4 8.5 0.0 0.4 0.5 0.6 0.4 0.4 0.5 0.4 2.4 9.8 0.5 0.5 0.5 0.4 2.0 1.2 0.4 0.4 0.4 0.3 1.0 29.7 0.9 0.4 0.8 0.4 1.1 0.4 0.4 0.4 0.4 1.7 0.4 0.4 0.6 2.4 0.0 0.4 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.3 1.2 0.0 0.0 0.0 2.4 0.0 1.4 0.0 0.0 0.1 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.9 0.0 0.0 8.9 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.4 45.3 0.0 4.6 2.4 9.8 2.0 1.2 29.7 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR3A "5-HT3A, 5-HT3R, HTR3" ENSG00000166736 "5-hydroxytryptamine receptor 3A" P46098 11 113974881-113990313 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.1;lymphoid tissue: 12.0;salivary gland: 8.6" "Group enriched" "Detected in some" 11 "Ductal cells: 14.6;Exocrine glandular cells: 44.3;Pancreatic endocrine cells: 54.7" "Cancer enriched" "Detected in many" 7 "ovarian cancer: 15.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 13 "memory B-cell: 4.1;naive B-cell: 9.7;plasmacytoid DC: 11.1" "Group enriched" "Detected in many" 104 "B-cells: 9.7;dendritic cells: 11.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.3;Daudi: 6.0;NTERA-2: 3.8;SCLC-21H: 20.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 15 "amygdala: 3.3;cerebral cortex: 4.0;hippocampal formation: 4.2" HPA069442 Supported NA NA "HPA069442: AB_2732132" "unprognostic (6.46e-3)" "prognostic favorable (6.26e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (3.36e-3)" "unprognostic (8.36e-3)" "unprognostic (1.65e-5)" "unprognostic (1.46e-2)" "unprognostic (8.87e-2)" "unprognostic (6.21e-2)" "unprognostic (6.80e-3)" "unprognostic (3.00e-2)" "unprognostic (1.65e-2)" "unprognostic (8.72e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-1)" "unprognostic (3.40e-2)" 0.3 0.5 2.2 4.4 3.9 0.0 0.3 0.3 0.9 0.3 2.5 0.3 0.3 1.0 0.3 0.3 0.8 0.0 0.3 0.3 2.1 0.0 0.3 0.3 0.3 9.7 0.3 0.3 0.3 3.7 0.0 0.3 0.3 0.3 0.3 0.6 0.3 8.6 0.3 0.3 0.6 2.0 1.0 0.3 3.0 0.9 0.3 0.3 0.7 0.3 0.3 12.0 0.3 0.3 9.7 11.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 6.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.6 9.7 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.2 2.2 3.9 0.3 0.9 2.1 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 44.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 54.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR3B 5-HT3B ENSG00000149305 "5-hydroxytryptamine receptor 3B" O95264 11 113904677-113946565 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "cerebral cortex: 8.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "hypothalamus: 0.4" "Not detected" "Not detected" HPA039559 Approved NA NA "HPA039559: AB_10672779" "unprognostic (1.60e-2)" "unprognostic (8.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.28e-1)" "unprognostic (1.71e-1)" "unprognostic (2.46e-1)" 0.2 0.2 1.0 0.8 2.1 2.4 0.2 0.4 8.7 0.3 0.4 0.2 0.0 0.3 0.5 1.6 2.6 0.2 0.2 0.2 1.2 0.7 1.0 0.2 0.2 0.5 0.8 1.4 0.3 0.3 0.1 0.2 0.2 0.0 0.2 0.5 0.0 0.5 0.1 0.5 1.2 0.5 0.1 0.7 0.5 0.3 1.5 0.0 0.0 0.5 0.0 0.5 0.3 0.6 1.6 1.3 2.9 0.9 1.9 0.9 0.1 0.5 1.4 0.8 0.8 1.6 0.9 1.2 0.1 0.2 0.2 0.2 1.0 0.9 1.9 0.5 0.5 0.7 0.5 0.6 0.6 0.8 0.5 0.8 0.6 1.9 1.8 0.3 1.6 1.4 1.1 0.5 0.2 0.0 0.6 0.2 1.0 0.8 1.5 0.3 0.2 0.9 1.6 0.4 0.7 0.2 0.8 1.4 0.9 0.9 0.7 0.7 2.8 0.5 1.6 1.1 1.3 0.6 0.4 1.8 1.5 1.1 1.5 1.1 1.1 0.7 1.4 0.9 0.6 0.8 1.6 0.9 0.3 0.9 0.5 0.7 1.3 0.8 0.6 0.5 1.6 0.9 0.9 2.9 1.9 0.3 1.3 0.7 0.1 1.0 2.1 0.4 8.7 1.2 0.7 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR3C ENSG00000178084 "5-hydroxytryptamine receptor 3C" Q8WXA8 3 184053047-184060671 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lung: 6.8" "Cell type enriched" "Detected in single" 7 "Intestinal endocrine cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "GAMG: 3.8" "Not detected" "Not detected" NA NA "unprognostic (4.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.39e-1)" "unprognostic (1.61e-1)" "unprognostic (2.88e-2)" "unprognostic (1.68e-2)" "unprognostic (8.72e-2)" "unprognostic (1.75e-1)" "unprognostic (3.88e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.3 0.0 0.1 0.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 HTR3D ENSG00000186090 "5-hydroxytryptamine receptor 3D" Q70Z44 3 184031544-184039369 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPTEC TERT1: 1.8" "Low region specificity" "Detected in many" NA NA "unprognostic (3.08e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR3E ENSG00000186038 "5-hydroxytryptamine receptor 3E" A5X5Y0 3 184097064-184106995 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 7.0" "Cell type enriched" "Detected in single" 24 "Intestinal endocrine cells: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "RH-30: 5.5" HPA049764 Enhanced NA NA "HPA049764: AB_2680869" "unprognostic (4.12e-2)" "unprognostic (5.86e-2)" "unprognostic (2.15e-1)" "unprognostic (4.57e-4)" "unprognostic (3.61e-3)" "unprognostic (1.15e-1)" "unprognostic (3.16e-1)" "unprognostic (4.47e-1)" "unprognostic (3.32e-1)" "unprognostic (2.67e-1)" "unprognostic (4.16e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 HTR4 5-HT4 ENSG00000164270 "5-hydroxytryptamine receptor 4" Q13639 5 148451032-148677235 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 18.1;heart muscle: 7.2;intestine: 14.6;pituitary gland: 5.9" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 4.3;Enterocytes: 2.8;Undifferentiated cells: 3.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 18.1" "Cell type enriched" "Detected in single" 8 "T-reg: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Cell line enriched" "Detected in single" 5 "Karpas-707: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040591 Enhanced NA NA "HPA040591: AB_2677028" "unprognostic (1.12e-1)" "unprognostic (4.60e-2)" "unprognostic (7.74e-2)" "unprognostic (2.37e-1)" "unprognostic (5.02e-2)" "unprognostic (3.77e-2)" "unprognostic (4.68e-2)" "unprognostic (1.10e-2)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (3.40e-2)" "unprognostic (2.25e-1)" "unprognostic (4.49e-2)" "unprognostic (8.83e-5)" 0.4 1.4 1.9 1.1 18.1 0.1 0.2 0.1 3.2 0.6 4.3 0.0 0.0 8.0 0.3 0.1 0.3 0.4 1.5 7.2 5.2 0.6 0.1 0.2 0.3 0.2 0.5 1.3 0.2 0.1 0.1 5.9 0.1 0.1 0.1 4.9 0.0 0.2 0.2 0.2 0.2 14.6 1.1 0.3 0.2 0.2 0.2 2.4 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 1.9 18.1 0.1 3.2 5.2 0.6 0.5 1.3 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 HTR5A 5-HT5A ENSG00000157219 "5-hydroxytryptamine receptor 5A" P47898 7 155070324-155085749 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 15.4" "Group enriched" "Detected in some" 14 "Early spermatids: 6.5;Late spermatids: 7.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB017467 Approved NA NA "CAB017467: AB_2122566" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.4 0.4 2.6 0.4 3.9 0.4 0.4 15.4 15.0 0.4 0.4 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 2.6 5.9 0.4 0.4 0.4 0.4 2.3 2.5 0.4 0.4 0.4 0.1 0.4 2.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.8 0.4 0.4 1.4 0.3 3.3 0.4 0.0 0.4 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 3.9 15.4 9.8 2.6 5.9 2.3 2.5 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 HTR6 "5-HT6, 5-HT6R" ENSG00000158748 "5-hydroxytryptamine receptor 6" P50406 1 19665287-19679562 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 24.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Group enriched" "Detected in many" 5 "basal ganglia: 24.6;cerebral cortex: 6.6" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in some" "MCF7: 1.2;NTERA-2: 2.4;SH-SY5Y: 6.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 9.5" HPA068165 Uncertain NA NA "HPA068165: " "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (7.19e-3)" "unprognostic (3.84e-5)" "unprognostic (1.38e-4)" "unprognostic (2.69e-2)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (5.33e-3)" "unprognostic (8.63e-2)" "unprognostic (5.47e-4)" "unprognostic (1.28e-1)" "unprognostic (2.49e-1)" "unprognostic (6.13e-3)" "unprognostic (2.02e-1)" 0.4 0.5 1.2 1.4 24.6 0.4 0.4 0.2 6.6 0.6 0.4 0.0 0.0 0.6 0.6 0.5 0.5 0.6 0.5 0.4 1.4 1.0 0.3 0.3 0.3 1.4 0.5 2.2 0.3 0.3 0.3 0.4 0.3 0.4 0.4 0.3 0.0 0.5 0.3 0.3 0.8 0.5 0.5 0.2 0.4 0.5 0.8 3.2 0.0 0.3 0.0 2.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 2.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 1.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.2 24.6 0.2 6.6 1.4 1.0 0.5 2.2 0.4 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR7 5-HT7 ENSG00000148680 "5-hydroxytryptamine receptor 7" P34969 10 90740823-90857698 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 30.8;testis: 14.3" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 4.8;Hofbauer cells: 1.3;Kupffer cells: 1.5;Late spermatids: 2.0;Spermatocytes: 1.4" "Group enriched" "Detected in some" 5 "cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "myeloid DC: 4.6" "Lineage enriched" "Detected in single" 12 "dendritic cells: 4.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 8.2;hTCEpi: 7.5;hTERT-HME1: 25.0;LHCN-M2: 10.0;U-87 MG: 7.7;WM-115: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022708, HPA073617" Approved Supported Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nuclear speckles, Cytosol" "CAB022708: , HPA073617: AB_2732228" "unprognostic (1.17e-1)" "unprognostic (1.24e-2)" "unprognostic (4.72e-2)" "unprognostic (1.33e-1)" "unprognostic (5.51e-3)" "unprognostic (1.71e-2)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (1.15e-1)" "unprognostic (4.58e-3)" "unprognostic (3.32e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-1)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (1.84e-2)" "unprognostic (6.49e-2)" 1.0 0.5 2.4 1.1 2.5 0.5 0.7 0.3 4.3 0.6 0.8 1.7 1.2 0.8 0.4 0.3 1.0 0.4 1.3 0.6 9.9 5.1 0.3 0.6 0.5 0.7 1.7 1.8 0.4 1.4 30.8 0.2 0.5 3.1 1.0 1.2 0.4 0.6 0.3 1.7 0.9 2.2 3.6 1.5 1.3 1.5 14.3 1.0 0.0 0.3 0.1 0.6 3.5 2.1 0.0 4.6 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.2 0.5 0.8 0.0 0.9 0.0 0.0 0.1 1.5 3.4 0.9 8.2 2.1 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.4 5.9 7.5 2.5 25.0 4.7 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.1 0.9 0.0 1.2 0.7 0.1 0.0 0.0 0.9 0.3 0.0 0.3 0.0 3.9 0.4 0.0 0.2 0.2 4.6 0.0 0.0 6.9 0.0 0.0 0.0 7.7 0.0 9.5 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 4.6 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.1 0.1 2.4 2.5 0.3 4.3 9.9 5.1 1.7 1.8 3.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.6 1.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.0 0.1 0.1 0.0 0.0 0.2 HTRA2 "OMI, PARK13, PRSS25" ENSG00000115317 "HtrA serine peptidase 2" O43464 2 74529377-74533348 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" Apoptosis "Hydrolase, Protease, Serine protease" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004004, HPA006602, HPA027366" Uncertain Supported Mitochondria NA NA Mitochondria "CAB004004: AB_326421, HPA006602: AB_2667622, HPA027366: AB_1851301" "unprognostic (3.09e-1)" "unprognostic (4.06e-2)" "unprognostic (2.82e-1)" "unprognostic (2.58e-2)" "unprognostic (1.56e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (7.77e-8)" "unprognostic (2.12e-3)" "unprognostic (4.18e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-2)" "unprognostic (8.15e-2)" "unprognostic (7.23e-3)" "unprognostic (4.03e-1)" "unprognostic (1.73e-1)" "unprognostic (1.72e-1)" "unprognostic (2.06e-2)" 16.4 12.7 10.6 14.9 11.3 18.9 12.9 10.7 17.7 12.3 12.8 12.6 9.7 12.6 12.9 6.9 10.7 10.6 9.0 12.9 11.6 8.7 13.1 11.4 11.3 13.2 10.8 11.9 18.7 12.9 10.5 9.0 10.4 13.5 11.6 5.5 10.2 13.1 9.2 17.6 9.0 12.6 11.8 9.1 17.3 11.8 13.9 12.6 12.2 16.8 12.6 9.3 10.4 15.2 12.9 9.4 5.9 8.1 5.5 7.8 7.0 8.0 5.0 5.7 5.0 7.9 3.2 15.4 7.0 3.7 4.2 2.5 9.2 3.6 7.3 5.5 4.0 11.8 9.1 6.8 8.0 1.1 16.4 13.6 14.6 4.8 8.1 7.4 6.8 10.7 3.8 5.4 8.0 6.8 6.8 5.3 12.3 19.1 10.8 3.2 5.3 12.6 14.4 4.8 9.6 14.3 8.6 16.3 8.0 3.5 3.3 6.7 8.0 3.8 8.6 13.3 3.4 3.9 6.6 3.7 7.4 9.1 14.9 15.6 13.3 4.4 4.7 6.4 10.8 5.9 5.9 8.1 4.8 7.3 6.2 7.8 12.9 7.3 6.2 9.4 11.6 6.3 6.4 3.2 5.5 4.7 6.6 7.4 7.0 10.6 11.3 10.7 17.7 11.6 8.7 10.8 11.9 13.5 12.6 0.0 3.7 23.9 16.6 18.3 12.1 0.8 17.8 9.4 9.1 10.4 0.0 20.6 29.9 26.3 24.4 29.4 13.6 116.8 15.4 31.8 26.6 15.0 26.5 10.6 27.5 9.5 8.6 16.5 9.5 32.5 23.0 17.8 28.7 36.1 10.3 19.0 22.8 14.2 19.4 29.1 11.9 25.8 26.4 55.8 34.3 19.3 16.9 25.4 19.8 12.9 HTRA4 FLJ90724 ENSG00000169495 "HtrA serine peptidase 4" P83105 8 38974164-38988662 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "placenta: 55.2" "Cell type enriched" "Detected in some" 9 "Extravillous trophoblasts: 319.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 23 "BEWO: 72.8" "Region enhanced" "Detected in some" "hippocampal formation: 2.3" "Low region specificity" "Detected in some" HPA045402 Enhanced "Secreted in female reproductive system" NA NA "HPA045402: AB_2679316" "unprognostic (1.20e-1)" "unprognostic (5.83e-4)" "unprognostic (8.02e-2)" "unprognostic (2.13e-2)" "unprognostic (8.20e-2)" "unprognostic (2.42e-2)" "unprognostic (1.80e-1)" "unprognostic (7.40e-3)" "unprognostic (1.40e-1)" "unprognostic (5.14e-4)" "unprognostic (1.01e-1)" "unprognostic (8.68e-2)" "unprognostic (1.42e-1)" "unprognostic (4.58e-1)" "unprognostic (5.19e-3)" "unprognostic (2.39e-3)" "unprognostic (1.19e-3)" 2.6 1.1 0.2 0.3 0.2 3.4 0.9 0.2 0.4 1.2 0.5 0.2 1.9 0.0 2.3 0.5 0.5 0.1 0.2 0.2 0.2 0.0 0.2 0.2 4.3 1.0 0.2 0.2 0.4 0.3 0.4 0.5 55.2 0.4 0.5 0.3 1.8 0.8 0.5 0.6 0.4 0.6 0.3 1.8 2.5 0.1 0.4 0.2 0.2 0.6 0.2 0.8 0.5 0.9 3.1 2.2 2.5 1.0 1.0 1.7 0.0 0.1 0.1 0.1 0.2 0.3 0.2 72.8 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 3.1 0.1 0.2 0.0 0.3 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 1.5 0.8 2.3 1.4 0.7 1.7 1.5 1.3 1.2 0.6 3.1 1.3 1.4 2.5 1.0 1.0 2.2 1.4 0.0 0.2 0.2 0.2 0.4 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 1.1 0.1 0.5 0.4 0.0 0.0 0.0 0.0 2.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 319.8 0.2 1.2 0.0 0.0 10.7 1.6 0.0 2.5 0.3 0.0 0.0 1.5 1.7 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 33.8 0.0 0.2 0.7 HVCN1 "Hv1, MGC15619, VSOP" ENSG00000122986 "Hydrogen voltage gated channel 1" Q96D96 12 110627841-110704950 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 99.8;lymphoid tissue: 40.6" "Cell type enhanced" "Detected in many" 7 "B-cells: 65.1;Early spermatids: 69.1;Hofbauer cells: 51.3;Late spermatids: 55.1;Macrophages: 42.5;Spermatocytes: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 99.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "NB-4: 78.2;U-698: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039329 Enhanced NA NA "HPA039329: AB_10674284" "unprognostic (3.43e-2)" "unprognostic (6.32e-3)" "unprognostic (7.05e-2)" "unprognostic (1.54e-2)" "unprognostic (4.62e-3)" "unprognostic (3.89e-2)" "unprognostic (1.96e-1)" "unprognostic (5.85e-3)" "unprognostic (2.40e-1)" "unprognostic (3.09e-2)" "unprognostic (1.54e-2)" "unprognostic (5.67e-2)" "unprognostic (3.35e-3)" "unprognostic (4.82e-2)" "unprognostic (1.33e-1)" "unprognostic (1.79e-1)" "unprognostic (1.68e-1)" 4.8 3.3 7.6 17.6 12.2 3.8 3.3 4.7 7.4 5.6 3.9 20.4 3.2 3.0 6.4 7.0 2.9 5.8 5.0 13.8 9.7 11.3 2.6 2.6 8.0 34.6 26.9 5.0 8.6 1.5 1.5 2.0 4.8 36.7 5.9 4.1 14.2 2.6 5.5 4.6 1.9 10.8 6.1 9.4 25.6 4.3 24.5 8.2 5.0 2.5 2.8 40.6 7.5 5.3 99.8 15.4 75.6 24.2 19.8 3.3 18.8 0.0 0.2 0.8 0.0 1.3 1.3 0.4 0.2 0.3 0.7 0.4 0.1 0.0 0.7 0.7 1.4 0.0 0.1 0.9 0.0 1.0 0.0 0.2 0.0 0.0 0.2 1.1 11.9 0.8 1.8 0.1 0.6 0.0 0.1 1.8 3.8 0.5 0.7 1.3 0.0 1.7 78.2 0.9 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 11.9 0.5 0.0 0.0 0.1 0.0 7.7 0.9 24.4 0.0 0.6 0.0 39.8 24.2 75.6 1.7 23.0 0.9 63.0 1.6 2.8 10.4 99.8 3.2 2.1 38.4 19.8 19.9 15.4 3.3 18.8 7.6 12.2 4.7 7.4 9.7 11.3 26.9 5.0 36.7 8.2 3.0 7.7 65.1 2.0 0.7 0.4 6.3 0.0 2.7 3.4 1.8 0.0 0.3 0.0 0.4 69.1 10.6 0.0 0.0 0.2 1.2 3.5 0.5 8.1 0.2 51.3 0.0 0.0 9.8 31.3 55.1 12.4 42.5 11.8 1.8 0.1 16.0 0.2 0.0 13.1 0.4 1.5 12.9 9.8 72.9 2.5 0.4 1.0 4.9 0.0 1.0 HYAL4 ENSG00000106302 "Hyaluronoglucosaminidase 4" Q2M3T9 7 123828983-123877478 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 7.1;skeletal muscle: 8.3" "Group enriched" "Detected in some" 7 "Cytotrophoblasts: 4.0;Extravillous trophoblasts: 5.9;Spermatogonia: 2.8;Syncytiotrophoblasts: 1.8" "Cancer enriched" "Detected in single" 48 "testis cancer: 8.4" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 4.5;CAPAN-2: 7.2;RT4: 17.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA029453 Uncertain NA NA "HPA029453: AB_10601432" "unprognostic (5.19e-5)" "unprognostic (4.18e-2)" "unprognostic (4.82e-2)" "unprognostic (2.20e-1)" "unprognostic (4.14e-2)" "unprognostic (2.60e-1)" "unprognostic (8.24e-2)" "unprognostic (5.26e-2)" "unprognostic (8.15e-3)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.19e-1)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (5.55e-3)" 0.1 0.3 0.0 0.0 0.0 0.7 0.2 0.0 0.5 0.0 0.1 0.0 0.1 0.4 0.4 0.2 0.0 0.4 0.0 0.0 0.6 0.1 0.4 0.0 0.0 0.1 0.6 0.0 0.1 7.1 0.2 0.0 1.2 0.0 8.3 1.4 0.2 0.0 0.1 1.0 0.2 3.4 0.4 1.5 1.0 0.1 1.3 0.6 3.3 0.6 1.0 0.9 0.1 0.3 0.6 0.1 0.4 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 7.2 0.3 0.4 0.0 0.7 1.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.0 17.0 0.2 0.1 0.0 1.0 0.0 1.4 0.4 0.2 2.4 0.1 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.5 0.4 0.6 0.5 0.5 0.4 0.5 0.5 0.2 1.3 0.7 0.9 3.3 1.0 0.6 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 5.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 1.8 0.0 0.0 0.1 HYOU1 "Grp170, HSP12A, ORP150" ENSG00000149428 "Hypoxia up-regulated 1" Q9Y4L1 11 119044189-119057202 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 97.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 24.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 95.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049296 Approved "Intracellular and membrane" NA NA 140000000 "HPA049296: AB_2680702" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "unprognostic (8.46e-2)" "prognostic favorable (2.58e-4)" "unprognostic (2.19e-1)" "unprognostic (1.35e-2)" "unprognostic (1.61e-3)" "unprognostic (1.81e-1)" "unprognostic (8.98e-2)" "unprognostic (7.93e-2)" "unprognostic (2.01e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (5.10e-5)" "unprognostic (3.86e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.38e-2)" 10.8 13.1 10.7 18.1 18.1 11.0 13.4 11.9 20.2 16.7 15.0 10.5 22.9 12.3 14.1 36.7 12.6 13.2 11.2 16.4 11.2 18.1 21.6 97.5 14.4 10.9 12.0 14.3 11.2 75.1 15.3 22.8 17.4 16.6 15.0 15.5 8.8 43.5 16.1 5.8 6.5 13.5 13.5 9.7 13.5 15.2 24.3 11.3 14.7 49.9 5.1 14.1 12.2 15.7 4.0 24.1 2.8 4.3 4.9 9.4 2.7 8.6 7.6 17.0 49.8 9.6 4.5 23.9 13.0 8.3 14.3 10.7 22.8 22.6 18.4 95.1 8.9 28.2 13.1 15.9 15.6 12.1 19.8 6.0 33.2 7.7 16.3 43.5 19.2 16.8 5.6 20.3 12.5 42.3 13.0 22.2 12.8 11.5 30.3 7.5 20.9 12.4 10.2 12.3 18.3 7.7 13.6 12.8 30.5 10.7 15.3 10.3 15.5 17.9 23.3 11.5 15.4 17.4 17.8 17.0 13.6 10.8 6.1 17.0 19.5 13.9 13.4 12.1 16.6 29.9 2.8 3.1 1.4 8.5 4.3 9.4 4.0 4.7 6.1 3.6 2.7 3.0 4.4 0.9 4.9 2.9 24.1 3.5 2.7 10.7 18.1 11.9 20.2 11.2 18.1 12.0 14.3 16.6 11.3 8.9 16.0 6.0 15.2 15.9 11.3 12.7 15.3 10.7 14.8 24.4 41.2 10.0 8.3 17.9 71.6 15.8 23.0 23.3 16.3 18.7 14.7 39.6 15.1 38.9 20.2 23.8 34.3 16.0 6.7 29.8 12.0 14.5 21.9 14.4 21.4 8.2 31.0 21.0 12.7 14.8 12.3 12.9 15.5 21.4 33.7 17.3 16.1 13.1 16.6 14.9 ICA1 "ICA69, ICAp69" ENSG00000003147 "Islet cell autoantigen 1" Q05084 7 8113184-8262687 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 58.6" "Group enriched" "Detected in many" 8 "Early spermatids: 546.5;Late spermatids: 690.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "T-reg: 20.8" "Lineage enriched" "Detected in many" 8 "T-cells: 20.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.3;MCF7: 15.3;OE19: 17.5;RT4: 17.9;SCLC-21H: 25.1;SH-SY5Y: 41.4;SK-BR-3: 19.6;T-47d: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017646, HPA061452" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA017646: AB_1851382, HPA061452: AB_2684525" "unprognostic (1.39e-1)" "unprognostic (1.37e-1)" "unprognostic (3.74e-1)" "unprognostic (6.83e-3)" "unprognostic (9.49e-2)" "unprognostic (8.57e-3)" "unprognostic (1.37e-2)" "unprognostic (3.54e-1)" "unprognostic (7.61e-2)" "unprognostic (3.42e-1)" "unprognostic (5.84e-2)" "unprognostic (2.62e-1)" "prognostic favorable (4.23e-8)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (4.08e-2)" 8.9 6.1 12.6 4.2 15.3 11.7 13.0 19.4 24.2 10.7 13.2 2.5 8.7 7.7 5.5 8.5 5.8 8.1 10.4 25.7 7.7 7.8 9.1 5.3 9.2 6.9 4.8 12.4 1.6 58.6 13.2 13.5 4.6 10.5 13.7 14.3 2.5 21.2 8.3 2.8 7.0 10.4 3.7 2.8 7.6 17.9 16.0 3.2 0.8 8.1 4.1 5.5 9.6 4.1 0.3 1.7 2.4 1.6 0.7 20.8 1.1 0.0 0.3 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.3 16.3 0.1 1.6 0.0 0.3 0.0 0.3 0.7 0.0 0.0 2.5 3.4 0.3 0.0 0.1 2.8 0.5 0.0 1.1 0.0 0.0 0.1 11.9 3.2 9.6 0.0 0.0 15.3 0.1 0.0 3.7 17.5 0.1 0.0 0.0 7.1 7.0 17.9 25.1 41.4 0.0 19.6 0.2 4.4 15.9 5.2 7.0 0.0 0.3 0.0 0.3 5.2 2.4 0.0 0.0 2.2 3.4 0.5 1.6 0.1 0.2 0.5 0.4 0.2 3.9 0.3 1.7 0.3 0.2 0.1 2.4 0.7 0.2 0.4 20.8 1.1 12.6 15.3 19.4 24.2 7.7 7.8 4.8 12.4 10.5 3.2 26.8 16.6 0.8 11.9 18.2 10.0 32.3 20.4 14.7 17.0 21.0 5.9 2.2 36.5 31.7 546.5 36.1 22.9 0.0 65.8 0.7 3.3 58.9 8.1 0.8 19.0 0.0 74.0 36.2 8.3 690.2 6.9 5.8 13.5 9.0 64.9 0.8 53.9 47.2 2.8 7.3 1.6 6.5 4.7 7.5 6.4 7.9 1.8 8.9 33.8 34.2 ICAM1 "BB2, CD54" ENSG00000090339 "Intercellular adhesion molecule 1" P05362 19 10270835-10286615 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 68.3;lung: 91.3" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 568.7;Alveolar cells type 2: 522.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 31.6;Karpas-707: 90.1;RPMI-8226: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002126, CAB002142, HPA004877" Enhanced Approved "Plasma membrane,Cytosol" NA NA 87900000 3100000000 "Plasma membrane, Cytosol" "CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317" "prognostic favorable (7.09e-4)" "unprognostic (1.88e-1)" "unprognostic (1.94e-1)" "unprognostic (2.63e-2)" "unprognostic (3.25e-3)" "unprognostic (3.05e-1)" "unprognostic (1.45e-2)" "unprognostic (3.48e-1)" "unprognostic (3.18e-2)" "unprognostic (1.09e-2)" "unprognostic (1.49e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.32e-6)" "unprognostic (2.77e-1)" "unprognostic (2.16e-2)" "unprognostic (2.25e-1)" "unprognostic (3.70e-3)" 26.1 8.6 4.0 41.0 4.1 36.5 15.0 1.0 4.5 5.6 10.0 2.7 1.6 6.1 8.5 7.7 7.9 10.7 19.8 16.3 2.6 2.1 10.9 68.3 91.3 32.8 5.4 1.7 12.4 7.2 2.5 4.0 9.3 6.8 10.4 6.6 10.6 7.2 3.6 13.9 6.9 7.9 8.0 7.8 42.2 7.3 6.5 3.6 8.3 11.6 13.7 13.4 14.8 17.1 2.2 13.3 22.2 14.2 7.9 5.6 8.9 8.4 0.1 1.5 0.0 0.4 0.9 2.1 1.7 18.8 4.2 12.7 2.8 9.5 7.7 26.2 0.7 19.3 1.7 0.3 0.0 8.9 23.1 0.0 0.7 0.2 11.5 31.6 0.2 4.5 11.1 0.7 2.6 4.1 0.4 2.1 0.9 2.9 90.1 0.3 0.6 0.1 6.5 0.5 0.1 4.8 0.2 0.0 28.6 7.2 0.0 0.0 0.2 11.6 0.6 18.4 0.7 1.4 0.5 6.5 4.3 0.4 2.4 0.1 27.5 28.3 4.8 7.0 4.9 6.3 2.2 13.9 2.6 3.0 14.2 5.6 2.2 2.4 3.6 13.3 0.9 1.0 2.2 22.2 7.9 7.9 7.5 3.4 8.9 4.0 4.1 1.0 4.5 2.6 2.1 5.4 1.7 6.8 3.6 568.7 522.3 12.0 22.9 75.8 0.0 0.8 20.4 80.3 159.3 3.5 0.0 1.0 0.0 152.6 1.9 139.3 0.5 0.0 84.4 2.5 171.6 19.1 133.1 12.9 75.0 0.0 2.4 56.4 41.3 1.1 4.4 160.6 72.6 168.7 0.3 2.3 107.4 0.0 1.4 9.4 0.3 6.5 95.4 0.5 1.7 60.6 1.0 12.7 0.5 10.0 ICAM2 CD102 ENSG00000108622 "Intercellular adhesion molecule 2" P13598 17 64002594-64020634 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 74.5;lymphoid tissue: 63.9" "Cell type enhanced" "Detected in many" 13 "B-cells: 46.1;Endothelial cells: 80.1;Ito cells: 147.3;Kupffer cells: 54.5;T-cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 167.1;TIME: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071155 Approved "Plasma membrane,Cytosol" NA NA 1200000000 "Plasma membrane" Cytosol "HPA071155: " "unprognostic (9.43e-3)" "unprognostic (3.31e-2)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (1.64e-3)" "unprognostic (1.34e-1)" "unprognostic (3.74e-1)" "unprognostic (8.28e-2)" "unprognostic (2.15e-1)" "unprognostic (4.18e-2)" "unprognostic (1.55e-2)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (3.93e-2)" "unprognostic (6.04e-2)" "unprognostic (2.29e-1)" 36.0 3.6 8.4 13.0 11.5 8.3 34.1 3.5 7.7 9.4 9.7 5.6 2.8 6.4 9.8 5.2 9.5 7.4 8.8 22.8 9.5 8.9 10.5 8.7 27.9 24.0 12.3 3.1 6.3 7.4 3.1 4.5 36.8 9.1 7.9 8.5 8.1 8.8 4.3 17.1 5.5 10.8 13.9 10.5 63.9 8.0 4.0 7.4 14.3 11.6 9.0 18.0 12.8 23.6 49.0 30.9 56.5 74.5 26.0 65.3 67.5 0.0 0.0 0.0 0.0 1.4 1.5 0.4 0.1 0.1 0.0 0.1 0.3 6.9 11.7 2.1 0.0 0.0 0.0 0.1 0.0 0.2 2.6 0.0 10.5 0.6 1.2 0.2 1.7 0.0 0.0 0.0 0.1 0.0 0.0 167.1 9.9 8.6 6.9 0.0 0.0 13.1 1.5 0.0 0.0 0.0 7.9 0.0 16.3 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 42.2 0.0 0.1 0.8 0.0 6.6 2.2 10.5 0.0 2.2 0.0 56.5 30.0 8.9 45.8 66.5 52.8 36.5 60.1 42.8 30.9 49.0 65.3 40.7 3.6 26.0 74.5 10.0 64.5 67.5 8.4 11.5 3.5 7.7 9.5 8.9 12.3 3.1 9.1 7.4 0.0 12.5 46.1 3.4 6.5 0.0 0.3 0.0 6.7 6.8 7.0 0.0 0.4 0.0 0.8 0.5 80.1 0.3 0.0 1.2 0.3 6.9 1.6 11.5 1.0 18.7 0.0 1.2 147.3 54.5 0.0 0.3 23.4 27.0 6.4 1.4 0.4 5.1 5.8 1.8 0.5 0.3 6.5 4.4 0.2 0.2 4.6 0.8 52.4 1.7 2.6 ICAM3 "CD50, CDW50, ICAM-R" ENSG00000076662 "Intercellular adhesion molecule 3" P32942 19 10333776-10339823 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5" "Cell type enhanced" "Detected in many" 7 "B-cells: 138.5;Hepatocytes: 150.6;Kupffer cells: 110.3;T-cells: 189.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 172.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 172.3" "Cell line enhanced" "Detected in many" "Karpas-707: 65.6;NB-4: 42.3;RPMI-8226: 49.2;U-266/84: 34.9;U-937: 34.5" "CAB002498, HPA049820" Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA 370000000 Mitochondria "Nucleoplasm, Nuclear membrane" "CAB002498: AB_563593, HPA049820: AB_2680897" "unprognostic (6.85e-4)" "unprognostic (5.28e-3)" "unprognostic (3.09e-3)" "unprognostic (1.57e-2)" "unprognostic (5.34e-3)" "unprognostic (5.79e-6)" "unprognostic (5.05e-3)" "unprognostic (3.73e-2)" "unprognostic (1.73e-3)" "unprognostic (7.93e-2)" "unprognostic (3.45e-2)" "unprognostic (2.54e-1)" "unprognostic (5.62e-4)" "unprognostic (1.13e-1)" "unprognostic (1.06e-2)" "unprognostic (3.43e-1)" "unprognostic (1.84e-1)" 6.8 2.8 1.7 23.5 1.9 51.5 5.5 0.6 1.5 3.0 6.8 1.1 1.2 4.3 1.7 3.0 4.0 2.9 7.2 6.4 1.1 0.9 5.1 28.7 13.2 68.5 1.8 1.4 1.7 6.8 0.2 0.4 4.8 1.5 2.8 3.3 2.4 10.3 1.3 5.0 1.6 11.9 1.8 1.0 39.4 5.4 1.4 1.0 47.6 3.0 5.7 38.4 4.5 4.9 25.5 28.4 172.3 33.5 31.0 41.0 43.1 2.7 1.3 1.0 3.0 1.6 1.3 1.7 1.7 1.1 1.4 1.2 1.1 1.8 0.0 5.8 1.5 0.0 1.1 0.0 1.2 0.4 20.3 0.8 5.2 1.2 5.1 0.8 18.7 21.1 1.1 1.0 1.6 0.6 1.5 0.6 10.9 2.8 65.6 1.6 5.5 2.4 42.3 0.7 6.9 9.2 1.5 0.6 49.2 1.4 2.4 0.3 1.3 1.4 4.6 3.7 0.5 4.0 5.3 1.1 6.5 0.5 7.1 1.6 3.2 34.9 7.8 4.6 34.5 5.0 15.3 33.1 72.0 33.8 24.4 41.0 25.5 32.7 31.2 28.4 23.9 29.3 27.4 172.3 31.0 33.5 4.8 36.9 43.1 1.7 1.9 0.6 1.5 1.1 0.9 1.8 1.4 1.5 1.0 3.0 43.3 138.5 7.1 7.2 0.1 0.0 25.5 9.4 4.5 5.2 0.0 10.4 53.0 13.7 4.2 18.0 53.5 0.0 30.7 20.6 13.1 14.3 30.0 150.6 21.1 1.6 5.2 26.4 110.3 7.2 5.8 19.9 52.3 12.6 29.1 1.5 17.7 45.3 3.9 54.2 1.2 0.0 13.3 0.5 0.9 7.3 3.9 189.2 31.2 8.4 ICAM4 "CD242, LW" ENSG00000105371 "Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)" Q14773 19 10286967-10288522 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 53.1;bone marrow: 13.7;lung: 13.5" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 62.5;Alveolar cells type 2: 75.3;Club cells: 34.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 2.0;pons and medulla: 2.4" "Cell type enriched" "Detected in many" 5 "non-classical monocyte: 53.1" "Lineage enriched" "Detected in many" 6 "monocytes: 53.1" "Cell line enhanced" "Detected in some" "HEL: 36.1;HMC-1: 9.1;K-562: 18.6;NB-4: 15.5;U-937: 8.7" "Intracellular and membrane" NA NA 1.9 0.4 0.4 1.6 0.4 13.7 0.6 0.2 2.0 1.0 2.9 0.2 0.0 1.1 1.1 2.9 2.3 1.1 1.1 1.1 0.5 0.3 1.6 1.7 13.5 3.3 0.4 0.0 1.2 0.4 0.1 0.4 1.9 2.4 2.4 0.5 0.9 2.5 2.7 1.7 0.8 1.4 0.2 0.9 2.8 1.6 0.6 0.3 1.5 0.9 0.0 4.5 3.3 0.7 0.5 8.4 4.5 53.1 0.1 0.6 2.4 0.1 0.1 0.1 0.2 0.0 0.0 3.1 0.3 0.1 0.0 0.0 4.0 0.2 0.4 0.4 0.0 0.2 0.3 0.1 0.0 0.0 0.3 0.2 36.1 0.2 5.4 1.0 0.6 9.1 0.2 0.0 0.1 0.1 0.0 0.0 5.8 18.6 1.6 0.0 0.1 1.0 15.5 0.1 0.0 0.1 2.6 1.5 6.8 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.4 0.1 1.0 0.3 0.1 0.0 0.3 0.0 0.5 1.0 0.1 0.3 8.7 0.2 4.5 2.6 2.6 0.2 9.7 0.5 0.5 0.3 0.2 8.4 0.4 0.3 0.1 0.7 0.1 53.1 2.7 0.6 2.4 0.4 0.4 0.2 2.0 0.5 0.3 0.4 0.0 2.4 0.3 62.5 75.3 0.8 0.9 0.9 0.0 0.0 0.0 4.0 34.2 0.0 0.0 0.3 0.0 0.5 0.0 6.7 0.0 0.0 1.8 0.7 11.2 1.4 20.9 0.0 5.2 0.0 0.0 1.8 3.5 0.0 0.0 8.1 5.0 19.8 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.1 1.1 0.7 0.0 0.0 1.6 ICAM5 "TLCN, TLN" ENSG00000105376 "Intercellular adhesion molecule 5" Q9UMF0 19 10289981-10296778 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 32.6" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 33.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.8" "Group enriched" "Detected in many" 15 "amygdala: 22.5;basal ganglia: 24.3;cerebral cortex: 32.6;hippocampal formation: 23.0;olfactory region: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 13.5;K-562: 10.8;RPMI-8226: 12.3;U-266/70: 14.8;U-87 MG: 8.8" "Group enriched" "Detected in many" 9 "amygdala: 111.1;basal ganglia: 75.7;cerebral cortex: 76.7;hippocampal formation: 105.7;olfactory region: 63.4" "Group enriched" "Detected in many" 13 "amygdala: 58.8;basal ganglia: 55.2;cerebral cortex: 67.5;hippocampal formation: 103.7;olfactory region: 57.5" "HPA008943, HPA009083, CAB025178" Enhanced NA NA 2400000 "CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094" "unprognostic (7.76e-2)" "unprognostic (1.91e-1)" "unprognostic (1.66e-2)" "unprognostic (4.24e-2)" "unprognostic (8.23e-3)" "unprognostic (2.58e-1)" "unprognostic (8.12e-2)" "unprognostic (9.99e-3)" "unprognostic (2.58e-1)" "unprognostic (2.44e-2)" "unprognostic (3.90e-3)" "unprognostic (9.89e-3)" "unprognostic (5.29e-5)" "unprognostic (6.47e-2)" "unprognostic (4.86e-2)" "unprognostic (5.44e-3)" "unprognostic (6.28e-3)" 0.8 0.9 22.5 0.8 24.3 2.0 0.9 0.0 32.6 0.8 0.8 1.0 0.0 0.8 0.8 0.8 0.8 0.9 0.8 1.0 23.0 1.4 1.1 0.8 3.6 1.2 0.9 15.9 1.4 0.8 0.8 0.1 1.1 0.0 0.9 0.8 0.0 0.8 0.9 0.8 0.8 1.0 0.8 0.1 1.0 1.0 1.9 1.6 0.0 0.8 0.0 0.9 0.8 0.3 0.0 0.0 0.4 0.0 0.0 0.4 0.0 2.9 0.0 0.0 6.2 0.0 0.0 0.1 4.4 0.7 0.1 0.4 0.0 0.1 4.7 2.0 0.0 0.0 5.4 0.2 0.0 0.0 0.1 0.9 13.5 4.3 0.4 0.1 0.0 2.7 0.0 0.5 0.1 0.0 0.0 0.0 1.7 10.8 0.1 0.0 0.6 0.0 1.9 0.0 0.2 4.4 0.1 0.0 12.3 0.2 0.0 0.8 0.1 2.0 0.1 0.3 0.0 2.2 0.0 0.0 1.3 0.0 0.6 0.0 14.8 2.4 2.7 8.8 0.0 1.3 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 24.3 0.0 32.6 23.0 1.4 0.9 15.9 0.0 1.6 6.0 3.2 0.0 0.2 0.2 0.0 33.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.4 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.1 1.6 0.1 0.1 0.0 0.0 0.1 ICMT "HSTE14, PCCMT, PPMT" ENSG00000116237 "Isoprenylcysteine carboxyl methyltransferase" O60725 1 6221193-6235972 "Enzymes, Plasma proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 126.5" "Low region specificity" "Detected in all" "HPA032024, HPA032025" Uncertain NA NA "HPA032024: AB_2674115, HPA032025: AB_10601819" "unprognostic (1.95e-3)" "unprognostic (3.83e-2)" "unprognostic (7.34e-2)" "unprognostic (4.40e-2)" "unprognostic (5.53e-2)" "unprognostic (9.30e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (2.30e-2)" "unprognostic (7.05e-2)" "unprognostic (2.15e-1)" "unprognostic (1.87e-1)" "unprognostic (6.58e-2)" "unprognostic (2.11e-2)" "unprognostic (4.11e-1)" "unprognostic (5.27e-1)" "unprognostic (8.97e-2)" "unprognostic (1.99e-3)" 19.0 20.9 11.2 11.4 22.6 3.2 37.4 20.1 19.8 19.8 16.6 12.9 13.3 17.3 18.0 19.7 19.0 15.1 17.7 28.5 11.5 10.3 23.5 14.5 17.2 13.9 13.9 8.4 8.7 20.2 26.2 24.0 20.3 12.7 16.2 16.0 21.5 15.4 18.2 41.3 16.9 22.8 19.8 11.1 11.3 13.5 9.1 7.8 13.0 18.1 30.3 17.2 15.4 13.6 4.1 6.2 4.1 5.1 4.6 7.4 3.9 12.7 11.9 16.4 16.0 50.4 20.1 7.0 30.8 20.8 18.4 14.0 12.7 10.4 14.0 11.9 24.4 15.8 17.4 18.7 13.1 19.6 27.9 18.1 9.6 17.5 9.7 9.8 15.1 13.7 12.8 8.8 19.2 7.3 12.3 14.2 11.7 9.3 11.1 20.7 8.0 15.1 10.5 11.0 23.2 16.6 12.7 23.1 8.1 22.1 9.4 22.3 10.9 15.1 36.0 13.2 19.1 9.4 12.8 17.6 21.0 8.2 24.5 22.1 10.3 20.1 11.3 10.3 35.0 10.8 4.1 4.2 3.6 7.4 5.1 6.5 2.7 6.0 7.3 3.9 4.1 5.4 4.5 1.8 4.6 4.0 6.2 3.4 3.9 11.2 22.6 20.1 19.8 11.5 10.3 13.9 8.4 12.7 7.8 20.8 8.9 6.0 9.0 5.6 15.7 32.2 20.4 24.1 19.4 27.9 29.5 48.9 11.6 19.2 3.3 13.5 31.1 0.0 19.1 66.8 18.8 11.7 4.7 21.7 25.0 46.1 21.9 21.5 8.6 2.9 19.2 7.9 6.8 10.8 18.3 15.1 21.2 7.0 24.8 31.9 55.6 12.9 15.5 13.4 29.6 9.2 26.8 10.0 19.9 12.3 ICOS "AILIM, CD278" ENSG00000163600 "Inducible T cell costimulator" Q9Y6W8 2 203936748-203961577 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 18.4;bone marrow: 13.8;lymphoid tissue: 51.8" "Cell type enriched" "Detected in some" 4 "T-cells: 23.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 18.4" "Lineage enriched" "Detected in single" 58 "T-cells: 18.4" "Group enriched" "Detected in some" 7 "HEL: 6.0;MOLT-4: 15.7" "Low region specificity" "Detected in single" "CAB032575, HPA034865" Approved Approved "Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA "Plasma membrane" "Actin filaments" "CAB032575: AB_2122593, HPA034865: " "unprognostic (2.66e-2)" "unprognostic (2.13e-3)" "unprognostic (4.19e-4)" "unprognostic (2.35e-5)" "unprognostic (1.07e-1)" "prognostic favorable (1.80e-4)" "unprognostic (9.38e-2)" "unprognostic (2.89e-2)" "unprognostic (1.49e-2)" "unprognostic (3.51e-4)" "unprognostic (7.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.86e-5)" "unprognostic (7.05e-2)" "unprognostic (2.48e-2)" "unprognostic (1.93e-1)" "unprognostic (8.82e-3)" 1.5 0.3 0.2 15.6 0.2 13.8 0.7 0.2 0.2 0.8 1.2 0.0 0.2 0.5 1.2 0.5 1.1 1.2 1.6 0.5 0.2 0.2 1.0 0.8 4.0 19.4 0.3 0.0 0.6 0.3 0.0 0.4 0.1 0.1 0.7 1.1 0.7 2.9 0.0 0.2 0.6 6.2 0.3 0.4 6.1 1.0 0.6 0.0 51.8 1.4 2.4 28.9 3.0 0.9 0.0 0.0 0.0 0.0 0.3 18.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 2.9 0.0 10.5 4.6 0.0 0.0 11.0 5.0 0.0 0.3 0.0 0.0 18.4 3.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.0 0.1 0.0 0.0 2.2 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 5.8 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.6 0.1 23.5 0.0 0.0 ICOSLG "B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653" ENSG00000160223 "Inducible T cell costimulator ligand" O75144 21 44217014-44240966 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, B-cell activation, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.1" "Cell type enhanced" "Detected in many" 9 "B-cells: 17.5;monocytes: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 14.1" "CAB026037, HPA029179" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" NA NA 150000000 "Plasma membrane, Cytoplasmic bodies" "CAB026037: , HPA029179: AB_2732445" "unprognostic (3.03e-2)" "unprognostic (1.40e-4)" "unprognostic (3.52e-2)" "unprognostic (1.94e-2)" "unprognostic (6.74e-2)" "unprognostic (9.40e-2)" "unprognostic (6.94e-2)" "unprognostic (3.71e-1)" "unprognostic (1.40e-1)" "unprognostic (3.76e-2)" "unprognostic (1.40e-1)" "unprognostic (2.42e-1)" "unprognostic (3.00e-2)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.84e-1)" 2.3 3.0 5.3 3.9 7.1 14.1 2.3 2.3 5.9 2.9 2.3 2.3 2.3 1.8 2.3 2.3 4.0 2.7 3.5 3.7 8.8 3.7 5.3 2.7 2.3 6.5 6.5 2.3 2.3 2.3 0.0 2.3 2.3 2.3 2.3 1.2 2.3 2.3 2.3 2.3 5.5 2.9 2.3 8.4 3.2 4.2 2.3 2.3 2.3 2.3 2.3 4.5 2.4 2.6 6.5 1.6 1.0 0.8 0.5 1.1 0.4 0.3 3.3 0.1 2.8 0.8 1.1 7.7 0.7 0.7 0.4 0.2 5.6 0.4 14.1 2.1 0.3 1.3 4.3 2.0 1.3 0.2 1.4 1.4 0.4 2.7 1.6 0.7 6.1 10.4 1.1 1.9 0.9 0.9 0.2 0.8 0.5 2.3 1.3 0.2 3.7 0.3 8.0 2.0 9.5 3.5 12.0 0.9 8.2 0.6 7.5 1.4 0.0 9.4 13.3 0.3 1.1 3.9 8.7 0.8 0.4 3.3 0.3 0.2 12.1 8.3 11.8 4.4 5.7 1.9 0.6 0.8 0.4 0.3 0.8 0.3 3.7 0.8 0.5 0.5 6.5 0.8 1.1 1.0 0.5 0.5 1.6 0.4 0.4 5.3 7.1 2.3 2.3 8.8 3.7 6.5 2.3 2.3 2.3 0.0 1.0 17.5 5.3 6.6 0.4 0.3 0.0 0.0 1.2 8.7 0.0 0.3 0.0 1.3 0.7 3.1 4.2 0.0 0.6 0.9 4.8 11.7 0.0 1.9 3.4 0.0 5.1 1.3 6.7 2.7 2.8 10.5 8.5 34.3 4.4 1.3 0.7 1.4 10.3 3.6 0.8 0.0 8.1 0.0 0.2 5.6 0.5 0.0 3.9 5.9 IER3IP1 ENSG00000134049 "Immediate early response 3 interacting protein 1" Q9Y5U9 18 47152834-47176374 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Diabetes mellitus, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 322.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA010027 Supported Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA010027: AB_1079098" "unprognostic (6.13e-2)" "unprognostic (2.96e-2)" "unprognostic (3.82e-2)" "unprognostic (1.45e-2)" "unprognostic (1.11e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (6.47e-6)" "unprognostic (9.86e-2)" "unprognostic (5.13e-2)" "prognostic favorable (8.59e-4)" "unprognostic (6.44e-2)" "unprognostic (6.24e-3)" "unprognostic (1.53e-3)" "unprognostic (8.55e-2)" "unprognostic (2.71e-2)" "unprognostic (8.75e-2)" "unprognostic (1.27e-3)" 16.9 21.7 13.1 13.7 12.9 15.0 33.1 22.4 21.4 15.7 17.7 7.3 18.4 20.3 15.6 19.6 19.2 12.8 17.9 40.2 12.3 15.3 38.1 45.7 28.3 25.7 12.5 9.1 15.7 30.6 16.3 30.5 29.7 13.9 17.7 16.4 13.3 29.8 17.9 33.8 16.7 27.7 17.7 11.3 22.7 19.0 17.0 7.6 16.4 19.7 24.8 17.6 17.9 15.9 14.2 24.5 10.7 12.4 11.5 18.6 11.8 12.8 7.4 11.3 10.0 15.4 17.3 7.9 30.5 14.9 15.2 16.1 6.0 11.0 12.6 9.6 13.5 12.4 15.7 10.6 10.7 16.7 20.6 9.5 11.0 11.6 18.1 16.5 33.1 16.5 13.6 13.7 13.7 10.3 14.4 13.0 11.5 9.0 19.5 16.1 7.1 11.7 15.9 5.7 5.5 9.0 11.7 17.8 17.9 15.3 12.5 13.1 14.6 10.4 8.9 17.9 8.5 8.8 19.1 18.7 22.7 11.6 10.9 16.6 28.4 30.9 13.4 17.6 21.2 18.1 8.3 12.4 10.7 18.6 11.2 16.6 13.2 16.0 16.0 11.7 14.2 15.3 15.9 1.3 11.5 11.6 24.5 15.8 11.8 13.1 12.9 22.4 21.4 12.3 15.3 12.5 9.1 13.9 7.6 80.4 47.5 40.4 52.1 0.0 44.4 56.7 71.4 48.2 35.2 48.8 7.9 93.8 119.3 98.9 15.0 64.4 58.4 46.7 121.4 103.0 48.3 96.8 12.8 120.7 96.4 38.1 36.3 71.2 54.7 10.5 78.6 44.2 0.0 84.8 96.6 50.4 129.9 66.6 45.6 322.7 34.3 51.8 36.5 70.2 134.6 0.0 148.2 59.8 85.7 73.1 IFI27 "FAM14D, ISG12, P27" ENSG00000165949 "Interferon alpha inducible protein 27" 14 94104836-94116698 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" 8 "Endothelial cells: 1184.0;Enterocytes: 2302.2;Exocrine glandular cells: 1468.8;Mucus-secreting cells: 1260.0;Paneth cells: 1956.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 9.4" "Group enriched" "Detected in many" 5 "monocytes: 9.4;T-cells: 4.1" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 184.7;BJ hTERT+ SV40 Large T+ RasG12V: 163.5;EFO-21: 49.9;Karpas-707: 45.4;SK-MEL-30: 51.1" HPA028875 Uncertain NA NA "HPA028875: AB_10601434" "unprognostic (1.15e-1)" "unprognostic (1.19e-1)" "unprognostic (2.43e-2)" "unprognostic (6.68e-2)" "unprognostic (4.74e-2)" "unprognostic (1.59e-2)" "unprognostic (6.78e-3)" "unprognostic (5.26e-2)" "unprognostic (2.10e-1)" "prognostic favorable (8.80e-4)" "unprognostic (1.13e-3)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (1.65e-1)" 37.0 13.5 9.7 21.1 12.7 14.8 22.8 5.7 8.4 14.0 38.1 6.6 10.2 12.7 18.9 24.7 31.9 17.1 53.5 25.9 11.2 8.9 12.8 12.1 61.3 4.6 12.5 9.7 8.1 4.8 0.3 5.5 39.7 12.7 9.0 23.2 9.7 15.5 7.1 15.0 12.6 14.2 12.0 12.0 64.0 72.0 20.9 7.3 7.9 8.9 28.4 18.5 9.2 11.4 0.1 1.2 0.6 9.4 0.4 4.1 2.5 15.6 0.0 0.1 0.0 0.0 2.0 0.1 0.2 0.7 184.7 163.5 0.3 13.1 0.1 49.9 10.1 3.0 0.5 0.0 0.0 7.3 0.1 0.3 0.0 0.1 0.0 1.2 0.0 0.0 0.1 0.1 32.1 0.0 0.1 25.4 0.1 0.0 45.4 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 51.1 0.1 0.0 0.2 0.0 0.0 0.2 29.5 0.0 0.8 1.2 0.3 0.0 0.0 0.1 0.0 1.9 0.6 0.5 9.4 0.5 0.0 4.1 1.1 1.2 0.1 0.0 0.7 0.1 0.4 2.8 0.2 3.4 2.5 9.7 12.7 5.7 8.4 11.2 8.9 12.5 9.7 12.7 7.3 363.3 101.8 51.4 3.9 152.0 4.1 23.8 259.9 317.2 80.8 12.2 7.9 2.6 1.7 62.4 12.0 1184.0 2302.2 23.3 1468.8 175.5 190.4 8.2 44.9 3.0 127.4 4.8 257.4 658.0 97.1 17.7 159.3 46.5 332.3 44.1 1260.0 5.6 981.1 1956.9 392.4 11.8 17.1 271.7 155.5 14.6 10.5 122.7 4.3 20.3 464.4 79.9 IFI27L1 FAM14B ENSG00000165948 "Interferon alpha inducible protein 27 like 1" Q96BM0 14 94081282-94103846 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.1" "Cell type enhanced" "Detected in all" 9 "Early spermatids: 249.4;Late spermatids: 110.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 52.2" NA NA "unprognostic (7.89e-3)" "unprognostic (1.47e-1)" "unprognostic (6.31e-2)" "unprognostic (8.54e-3)" "unprognostic (2.53e-1)" "unprognostic (4.81e-2)" "unprognostic (1.84e-2)" "unprognostic (2.63e-1)" "unprognostic (3.68e-1)" "unprognostic (7.63e-3)" "unprognostic (2.50e-1)" "unprognostic (2.00e-1)" "unprognostic (3.90e-2)" "unprognostic (3.50e-2)" "unprognostic (1.71e-1)" "unprognostic (5.93e-3)" "unprognostic (2.92e-1)" 7.9 22.3 12.5 7.7 11.3 9.4 5.7 10.9 11.5 5.3 8.1 6.0 8.8 6.7 5.9 12.6 5.2 8.7 6.2 7.8 12.6 11.1 7.4 4.9 6.5 4.3 14.3 10.5 20.8 6.2 4.1 6.7 3.4 12.0 3.9 9.9 7.4 6.3 7.4 9.3 9.3 7.1 6.8 9.9 5.1 9.6 39.1 11.9 5.9 3.7 7.3 6.5 3.0 4.4 6.7 10.9 7.0 2.5 5.6 7.0 3.6 4.5 5.2 8.7 7.3 7.7 10.1 3.5 6.8 5.3 6.1 13.8 1.9 10.5 4.7 8.5 5.2 6.8 5.1 2.1 2.9 4.6 10.9 7.5 3.6 10.4 3.0 3.9 4.5 4.0 7.7 3.9 8.1 4.5 8.8 5.2 20.2 7.4 52.2 9.3 4.1 4.8 5.1 2.5 8.6 4.5 9.4 5.5 6.9 6.0 1.3 7.0 4.3 8.4 4.6 8.9 6.6 6.7 6.2 4.6 2.9 3.0 7.1 3.8 12.4 11.4 6.7 9.3 5.9 3.2 7.0 2.0 4.8 4.9 2.5 3.3 6.7 6.1 7.0 4.0 5.6 5.1 4.1 1.2 5.6 2.4 10.9 6.1 3.6 12.5 11.3 10.9 11.5 12.6 11.1 14.3 10.5 12.0 11.9 26.8 10.7 11.5 17.0 15.1 16.7 15.1 15.3 12.0 9.1 19.2 9.8 16.1 23.2 21.5 249.4 20.2 64.6 23.3 23.3 11.7 19.9 15.5 5.7 13.2 29.7 12.7 14.9 24.5 7.3 110.8 39.4 12.5 25.3 5.4 44.1 28.4 21.0 31.6 53.7 27.4 22.9 12.9 12.3 18.1 35.3 12.4 5.9 20.1 24.9 14.8 IFI27L2 "FAM14A, TLH29" ENSG00000119632 "Interferon alpha inducible protein 27 like 2" Q9H2X8 14 94127779-94130253 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 57.7" "Low region specificity" "Detected in all" HPA049588 Approved Nucleoli,Cytosol "Intracellular and membrane" No No Cytosol Nucleoli "HPA049588: " "unprognostic (9.70e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-1)" "unprognostic (1.76e-1)" "unprognostic (2.45e-1)" "unprognostic (2.80e-2)" "unprognostic (7.46e-3)" "unprognostic (4.76e-2)" "unprognostic (4.69e-2)" "unprognostic (1.58e-2)" "unprognostic (4.79e-3)" "unprognostic (3.96e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (3.88e-1)" "unprognostic (5.09e-2)" "unprognostic (3.52e-2)" 11.4 39.9 38.6 18.3 23.8 17.0 18.8 15.2 24.7 19.9 16.0 23.5 8.7 11.6 15.8 9.6 24.5 21.9 20.8 38.9 29.7 32.4 13.2 3.7 16.5 21.5 37.1 22.8 25.9 13.2 11.7 20.6 5.4 27.4 10.6 9.7 20.4 7.2 12.5 4.0 16.0 13.5 15.5 35.7 17.0 15.7 9.1 22.9 13.8 8.5 16.0 22.5 12.0 17.2 31.5 29.6 19.8 38.7 6.0 30.5 31.9 8.4 5.9 1.7 12.1 8.7 22.4 1.1 15.9 16.4 12.0 14.1 1.6 3.9 3.7 17.4 17.1 10.6 10.5 1.3 21.1 4.9 25.3 0.9 5.8 5.9 0.5 14.8 6.8 16.0 20.3 7.8 7.1 4.4 20.5 7.9 14.6 0.5 57.7 12.4 15.9 3.9 4.1 2.1 5.6 6.8 0.1 5.6 4.9 18.2 3.3 3.1 4.7 0.4 0.1 10.2 3.3 19.6 11.4 7.7 8.0 4.9 10.7 4.4 23.6 19.5 1.3 25.6 15.2 5.2 19.8 38.7 7.1 25.6 25.9 16.4 31.5 24.4 28.1 29.6 27.4 17.6 23.0 5.7 6.0 18.8 24.6 30.5 31.9 38.6 23.8 15.2 22.8 29.7 32.4 37.1 22.8 27.4 22.9 35.7 60.1 82.7 48.1 82.4 19.9 126.7 48.4 18.7 11.4 169.3 19.6 1.8 150.9 127.6 5.8 62.7 86.6 0.0 26.4 2.5 85.0 7.4 88.9 2.6 167.2 22.3 95.7 122.2 166.9 22.7 169.5 141.7 224.4 80.2 146.1 108.3 55.0 123.8 108.5 51.2 76.6 122.9 100.0 4.5 24.8 58.5 2.4 89.6 75.5 44.4 IFI6 "6-16, FAM14C, G1P3, IFI-6-16, IFI616" ENSG00000126709 "Interferon alpha inducible protein 6" P09912 1 27666061-27672218 "Predicted membrane proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 225.6" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 3308.6;Extravillous trophoblasts: 1015.8;Syncytiotrophoblasts: 3573.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 134.5;BJ hTERT+ SV40 Large T+ RasG12V: 157.3;EFO-21: 54.1;SK-MEL-30: 95.5" "Low region specificity" "Detected in all" HPA005543 Approved Approved Mitochondria NA NA Mitochondria "HPA005543: AB_1849342" "unprognostic (4.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "unprognostic (6.96e-2)" "unprognostic (9.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.06e-1)" "unprognostic (6.77e-3)" "unprognostic (5.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.92e-3)" "unprognostic (1.81e-1)" "unprognostic (8.40e-2)" "unprognostic (3.42e-2)" "unprognostic (1.72e-2)" 32.3 27.5 24.9 13.5 28.2 37.3 10.9 14.2 36.1 11.4 13.8 22.9 6.5 16.5 26.8 68.0 8.6 11.9 113.9 19.3 23.0 42.3 44.8 23.5 31.6 5.8 20.0 17.0 14.1 21.3 5.9 60.1 225.6 34.3 13.9 10.1 31.6 111.4 10.1 7.4 5.4 12.5 17.0 26.0 27.3 35.4 15.4 6.8 24.8 35.2 7.9 9.7 7.8 7.6 9.7 19.4 84.9 58.6 15.8 27.5 16.8 1.4 0.4 2.2 1.4 7.3 4.0 9.0 4.7 21.7 134.5 157.3 0.7 5.7 0.5 54.1 2.1 35.6 0.5 0.5 1.0 4.4 11.1 1.8 3.4 1.1 0.4 1.9 1.1 4.5 4.3 0.1 8.1 0.1 2.1 1.2 3.1 0.2 9.5 1.5 0.4 4.1 14.5 0.4 2.7 4.5 2.8 1.2 1.3 1.1 0.0 3.2 2.9 5.8 1.3 95.5 0.7 0.6 4.4 2.1 1.2 1.9 0.9 0.8 11.3 6.4 0.3 2.4 10.1 3.5 29.3 44.4 39.4 22.7 58.6 22.4 9.7 23.0 20.7 19.4 8.0 24.3 23.6 84.9 15.8 38.8 2.0 27.5 16.8 24.9 28.2 14.2 36.1 23.0 42.3 20.0 17.0 34.3 6.8 131.0 105.4 20.9 17.6 20.8 10.1 13.4 73.9 88.3 37.5 61.1 9.8 3308.6 16.6 186.8 2.9 139.0 7.0 0.0 304.1 1015.8 142.9 71.5 60.2 43.3 628.8 3.2 56.0 68.2 47.6 8.5 102.4 129.6 67.4 56.9 22.2 79.9 144.2 8.7 192.3 28.3 5.5 109.9 38.2 1.7 0.9 19.6 3573.6 51.2 8.0 13.6 IFITM1 "9-27, CD225, IFI17" ENSG00000185885 "Interferon induced transmembrane protein 1" P13164 11 313506-315272 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity, Osteogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Club cells: 187.7;Leydig cells: 278.5;Sertoli cells: 271.7;T-cells: 358.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "eosinophil: 56.6;gdT-cell: 120.0;MAIT T-cell: 80.7;memory CD4 T-cell: 128.1;memory CD8 T-cell: 121.4;naive CD4 T-cell: 123.5;naive CD8 T-cell: 123.4;neutrophil: 106.8;NK-cell: 164.4;T-reg: 70.4" "Group enriched" "Detected in all" 7 "granulocytes: 106.8;NK-cells: 164.4;T-cells: 128.1" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 122.7;BJ hTERT+ SV40 Large T+ RasG12V: 219.9;HMC-1: 67.9" "HPA004810, CAB017615" Enhanced Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "CAB017615: AB_2264496, HPA004810: AB_1851419" "unprognostic (1.03e-3)" "unprognostic (6.79e-2)" "unprognostic (1.03e-1)" "unprognostic (2.98e-1)" "unprognostic (2.57e-1)" "unprognostic (9.06e-2)" "unprognostic (7.58e-2)" "unprognostic (3.03e-1)" "unprognostic (6.21e-2)" "unprognostic (5.53e-2)" "unprognostic (6.64e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (5.77e-9)" "unprognostic (7.29e-2)" "unprognostic (6.29e-2)" "unprognostic (3.15e-2)" "unprognostic (3.82e-2)" 81.1 14.2 17.4 36.7 24.5 41.2 57.0 11.9 23.1 71.0 28.2 12.9 20.6 17.2 48.3 152.4 44.4 67.2 31.2 62.6 19.8 13.9 59.8 34.5 44.1 159.7 34.8 14.7 100.2 16.3 22.3 23.3 36.3 27.3 38.7 22.1 49.5 27.4 41.6 38.7 23.6 33.0 46.0 37.9 112.9 20.5 29.4 20.1 42.7 48.3 28.0 50.3 39.3 52.8 13.0 4.3 106.8 18.6 164.4 128.1 147.7 6.4 0.1 53.3 4.3 3.9 13.7 0.3 11.3 53.0 122.7 219.9 0.1 44.5 0.1 8.5 11.9 1.2 15.1 1.7 1.1 2.4 13.5 2.8 6.5 4.1 0.4 35.3 9.5 67.9 25.6 0.0 1.3 0.1 1.3 0.2 2.1 23.2 53.9 0.0 0.9 4.7 18.3 15.2 0.0 1.6 1.2 0.1 1.2 32.8 0.0 0.0 0.0 5.9 0.6 10.9 7.6 2.2 0.8 0.3 0.1 0.1 0.0 0.0 3.8 2.0 0.3 0.1 14.3 0.1 15.6 2.3 56.6 120.0 10.9 80.7 13.0 128.1 121.4 4.3 11.3 123.5 123.4 106.8 164.4 18.6 1.2 70.4 147.7 17.4 24.5 11.9 23.1 19.8 13.9 34.8 14.7 27.3 20.1 32.8 96.7 12.5 9.5 24.7 0.0 4.8 0.0 36.1 187.7 31.4 0.0 1.2 5.0 0.9 1.2 146.9 12.4 0.0 1.2 25.0 131.5 1.8 17.4 17.9 9.3 0.0 1.2 130.1 11.0 0.0 278.5 21.9 74.2 0.0 14.4 0.0 0.9 10.1 117.0 0.3 0.0 271.7 95.7 0.3 1.0 12.5 3.3 358.0 24.3 4.4 IFITM10 ENSG00000244242 "Interferon induced transmembrane protein 10" A6NMD0 11 1732410-1750591 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 31.4" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 17.2;granulocytes: 27.7;Hofbauer cells: 21.3;Ito cells: 54.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.9;hTERT-RPE1: 6.6;MCF7: 5.5;SH-SY5Y: 13.1;U-87 MG: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.89e-3)" "unprognostic (2.10e-2)" "unprognostic (1.22e-6)" "unprognostic (6.49e-3)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" "unprognostic (3.66e-1)" "unprognostic (4.09e-1)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.68e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-1)" "unprognostic (2.44e-2)" "unprognostic (3.76e-2)" 1.9 13.3 0.7 1.0 2.2 4.3 0.9 1.4 2.0 0.7 0.8 4.3 2.2 1.2 0.7 1.0 0.8 0.7 3.0 0.6 1.0 0.7 1.8 6.6 2.1 0.7 7.4 0.2 0.8 0.6 0.5 0.4 1.0 4.1 2.7 0.6 31.4 6.7 4.8 1.2 2.0 1.0 1.0 8.2 2.2 0.6 1.6 2.7 0.0 0.5 10.8 1.6 2.6 3.4 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.1 6.6 0.1 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 13.1 0.0 0.0 2.0 0.0 1.4 0.0 0.0 0.5 0.0 0.0 0.2 0.3 0.8 0.0 7.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.2 1.4 2.0 1.0 0.7 7.4 0.2 4.1 2.7 3.0 1.1 2.2 10.8 1.9 17.2 1.7 2.5 4.0 5.7 0.0 0.0 1.2 1.7 2.1 0.1 0.5 3.3 0.0 2.1 0.5 2.1 0.8 27.7 0.6 21.3 1.6 0.0 54.6 6.5 0.0 0.9 3.0 0.0 3.6 0.7 2.0 2.1 3.5 1.4 0.0 1.3 0.0 1.7 0.5 1.1 0.6 2.2 2.5 1.5 10.5 IFITM2 1-8D ENSG00000185201 "Interferon induced transmembrane protein 2" Q01629 11 307631-315272 "Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 875.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 875.3" "Lineage enriched" "Detected in all" 12 "granulocytes: 875.3" "Cell line enhanced" "Detected in many" "HHSteC: 99.8;HMC-1: 113.9;HSkMC: 123.4;U-937: 88.6" HPA004337 Uncertain NA NA "HPA004337: AB_1851427" "unprognostic (2.39e-2)" "unprognostic (2.69e-2)" "unprognostic (4.54e-1)" "unprognostic (1.65e-2)" "unprognostic (3.41e-2)" "unprognostic (1.86e-1)" "unprognostic (3.56e-2)" "unprognostic (3.87e-2)" "unprognostic (3.87e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-3)" "unprognostic (1.64e-2)" "prognostic unfavorable (2.37e-9)" "unprognostic (2.79e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-1)" "unprognostic (1.16e-2)" 101.0 25.2 14.3 95.5 20.9 56.3 143.6 8.2 16.6 70.8 40.2 10.9 14.3 9.5 63.6 46.1 56.0 70.8 28.5 91.1 13.3 10.8 83.0 326.2 141.9 255.5 29.3 3.3 106.5 31.1 68.6 18.9 48.0 21.1 54.3 17.7 39.1 20.1 37.7 72.7 20.1 24.0 63.2 21.7 233.4 28.4 38.5 15.6 12.5 83.4 26.2 35.4 98.0 119.7 27.5 21.6 875.3 74.9 52.8 33.3 47.1 4.2 13.0 36.0 0.2 23.4 68.0 0.1 13.2 25.6 7.6 17.5 0.4 38.8 0.0 32.2 67.4 0.0 8.7 0.1 2.3 3.2 0.0 5.4 13.0 14.8 14.4 99.8 20.8 113.9 123.4 0.4 2.1 1.1 16.9 24.7 4.1 0.5 42.8 5.4 29.0 0.1 76.2 4.4 0.7 30.4 14.3 3.7 0.2 69.8 0.0 0.1 0.8 9.8 11.3 3.9 1.1 16.4 7.4 64.8 1.2 4.1 5.9 0.2 0.1 0.6 0.6 2.1 88.6 4.0 77.9 19.8 138.8 33.3 53.2 24.6 27.5 30.0 29.4 21.6 24.5 26.0 28.1 875.3 52.8 74.9 9.1 15.8 47.1 14.3 20.9 8.2 16.6 13.3 10.8 29.3 3.3 21.1 15.6 285.9 694.3 247.8 177.4 92.7 0.2 31.1 163.1 124.5 320.8 235.5 0.0 7.0 412.8 337.7 5.7 710.3 6.8 46.7 224.8 10.2 373.5 99.0 503.9 361.8 178.2 0.0 9.2 617.5 355.0 16.0 470.0 230.3 199.1 21.6 27.9 38.6 121.6 101.8 210.4 27.2 0.9 310.4 755.0 7.7 7.8 72.5 19.6 655.6 24.8 92.5 IFITM3 1-8U ENSG00000142089 "Interferon induced transmembrane protein 3" Q01628 11 319669-327537 "Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 148.9;non-classical monocyte: 150.9" "Group enriched" "Detected in all" 6 "granulocytes: 148.9;monocytes: 150.9;NK-cells: 44.7" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 144.3;BJ hTERT+ SV40 Large T+ RasG12V: 184.0;HHSteC: 168.6;HSkMC: 160.3" HPA004337 Uncertain NA NA "HPA004337: AB_1851427" "unprognostic (4.17e-2)" "unprognostic (4.19e-1)" "unprognostic (1.67e-1)" "unprognostic (2.25e-1)" "unprognostic (1.55e-3)" "unprognostic (6.00e-2)" "unprognostic (3.36e-2)" "unprognostic (6.44e-2)" "unprognostic (8.90e-2)" "unprognostic (9.42e-2)" "unprognostic (7.45e-2)" "unprognostic (1.95e-2)" "prognostic unfavorable (5.78e-7)" "unprognostic (7.81e-2)" "unprognostic (3.34e-2)" "unprognostic (8.28e-2)" "unprognostic (1.19e-1)" 109.8 46.1 34.2 64.5 39.8 21.2 197.5 15.1 36.3 135.2 70.4 28.3 45.8 25.3 98.7 143.6 50.9 118.2 68.7 162.1 31.6 24.8 94.3 157.0 161.7 135.3 36.2 15.3 148.4 47.5 99.8 33.7 92.5 39.6 78.2 25.4 81.0 52.8 70.8 62.0 31.1 50.0 111.5 43.8 153.4 51.3 54.3 30.4 6.8 115.9 60.7 27.8 89.2 75.9 3.0 20.1 148.9 150.9 44.7 4.9 34.0 24.8 2.2 94.9 24.7 43.5 70.6 2.0 38.6 72.1 144.3 184.0 3.0 83.9 0.0 41.4 56.1 39.6 40.6 0.0 27.3 9.0 0.9 2.7 0.3 33.9 30.9 168.6 0.2 0.3 160.3 6.1 11.6 26.6 20.6 26.4 0.2 0.1 0.3 13.2 52.4 0.1 1.1 11.3 0.1 19.2 3.3 8.7 0.4 83.5 2.8 0.0 0.1 46.3 7.8 39.3 14.8 1.9 2.1 51.6 9.5 6.4 8.4 1.5 0.1 0.1 0.3 4.3 0.4 14.5 21.0 33.1 21.2 4.9 132.0 2.8 3.0 2.9 4.5 20.1 2.4 3.0 4.3 148.9 44.7 150.9 1.5 1.6 34.0 34.2 39.8 15.1 36.3 31.6 24.8 36.2 15.3 39.6 30.4 494.3 647.7 89.1 597.6 281.8 1.2 92.7 535.0 289.1 593.8 500.7 2.0 85.1 474.2 1655.3 22.9 1810.3 50.2 0.0 1623.3 537.2 1132.6 295.6 229.5 1626.8 441.7 0.0 52.0 1856.2 459.6 48.4 1723.9 440.5 342.5 95.6 185.7 87.0 1285.6 219.8 997.1 331.8 3.9 944.3 1633.2 7.5 11.0 182.8 105.2 139.6 190.0 209.0 IFITM5 "BRIL, fragilis4, Hrmp1" ENSG00000206013 "Interferon induced transmembrane protein 5" A6NNB3 11 298200-299526 "Disease related genes, Predicted membrane proteins" "Mineral balance" "Developmental protein" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 11.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;HMC-1: 1.3;JURKAT: 1.5;Karpas-707: 5.0;NB-4: 1.0;PC-3: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (9.84e-2)" "unprognostic (2.15e-1)" "unprognostic (1.38e-1)" "unprognostic (5.80e-2)" "unprognostic (7.46e-2)" "unprognostic (4.20e-2)" "unprognostic (4.42e-2)" "unprognostic (8.31e-2)" "unprognostic (7.99e-3)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (4.90e-2)" 0.1 0.0 0.1 0.3 0.1 2.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.3 2.2 0.3 0.1 0.1 0.1 11.7 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.0 0.4 0.1 0.1 0.5 0.0 0.2 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.0 0.0 0.0 0.2 1.0 0.0 0.0 1.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNAR1 "IFNAR, IFRC" ENSG00000142166 "Interferon alpha and beta receptor subunit 1" P17181 21 33324477-33359862 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 50.8" "Low region specificity" "Detected in all" HPA029226 Approved NA NA 100000 "HPA029226: AB_2672954" "unprognostic (2.42e-3)" "unprognostic (2.95e-1)" "unprognostic (3.01e-1)" "unprognostic (1.15e-1)" "unprognostic (4.93e-2)" "unprognostic (2.22e-1)" "unprognostic (1.01e-1)" "unprognostic (3.02e-1)" "unprognostic (4.69e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (2.38e-1)" "unprognostic (9.38e-3)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (8.45e-2)" "unprognostic (3.06e-2)" 27.2 16.4 18.5 16.8 18.7 14.8 15.9 18.1 22.9 14.2 16.8 15.1 10.0 12.3 15.7 10.9 15.8 13.5 16.2 14.5 16.9 15.8 17.5 56.4 16.6 15.0 19.7 13.8 16.6 18.3 30.6 17.9 23.2 18.3 14.7 12.2 12.1 17.6 12.6 17.3 10.6 15.8 13.7 22.2 29.8 18.8 10.3 16.7 26.9 21.4 9.1 13.1 18.7 18.1 20.5 17.8 64.5 23.1 7.3 12.1 10.7 13.3 12.2 5.2 5.9 17.2 17.5 6.0 14.4 15.5 6.7 6.8 13.1 15.3 10.3 11.7 9.9 8.4 8.0 4.9 8.5 7.1 11.7 9.8 15.4 11.8 7.7 7.3 11.3 11.0 14.5 7.5 11.0 6.6 8.8 12.7 11.8 17.6 50.8 10.9 11.1 8.4 4.6 5.6 8.9 7.8 8.3 18.3 17.6 7.3 17.6 6.2 5.6 14.5 10.3 9.2 3.6 15.9 8.3 20.2 13.4 7.3 17.6 8.0 33.9 46.6 11.9 18.0 16.0 14.3 18.9 16.8 9.7 8.0 19.7 7.5 18.5 10.6 9.0 11.3 20.5 12.1 9.4 64.5 7.3 23.1 17.8 12.0 10.7 18.5 18.7 18.1 22.9 16.9 15.8 19.7 13.8 18.3 16.7 101.3 37.9 45.4 49.1 40.6 49.3 32.2 25.5 61.6 71.7 41.8 27.5 23.5 18.3 64.6 10.8 66.9 25.8 23.3 78.0 78.5 32.8 57.7 37.1 71.7 60.0 55.6 25.8 50.3 69.5 7.7 30.2 70.9 35.4 83.0 28.9 32.2 57.6 24.6 29.0 21.4 25.6 19.4 33.4 26.3 12.1 39.3 16.8 29.3 26.0 69.1 IFNAR2 IFNABR ENSG00000159110 "Interferon alpha and beta receptor subunit 2" P48551 21 33229901-33265675 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 52.3;U-266/70: 66.4;U-266/84: 34.4" "Secreted to blood" NA NA 610000 "unprognostic (2.00e-2)" "unprognostic (7.83e-3)" "unprognostic (4.98e-2)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (1.04e-1)" "unprognostic (4.50e-3)" "unprognostic (8.05e-2)" "unprognostic (4.17e-2)" "unprognostic (2.11e-2)" "unprognostic (7.65e-2)" "unprognostic (4.42e-1)" "prognostic unfavorable (7.54e-7)" "unprognostic (9.70e-3)" "unprognostic (2.39e-1)" "unprognostic (5.12e-3)" "unprognostic (1.85e-2)" 16.9 8.7 9.9 28.1 11.3 19.1 18.3 10.7 13.0 10.2 12.2 10.6 9.6 12.8 12.0 10.1 8.1 11.1 15.5 13.6 10.3 9.7 13.4 20.5 21.6 41.7 13.3 8.3 11.9 10.2 11.2 10.9 15.7 10.2 9.9 13.2 7.9 14.4 11.6 6.6 6.6 14.1 13.0 13.2 40.9 9.9 4.6 12.1 34.7 11.3 6.6 25.3 24.2 10.7 9.9 37.6 37.1 25.3 12.2 23.7 14.2 4.1 4.7 2.5 5.7 3.0 7.1 4.1 4.2 11.2 3.6 3.8 6.3 4.7 6.5 3.1 6.5 5.5 2.6 3.5 2.3 3.5 4.1 5.3 23.8 5.2 5.8 4.4 4.0 8.9 5.0 2.2 4.0 4.9 6.4 11.4 10.2 7.5 52.3 3.5 2.4 10.3 4.9 4.5 5.5 3.1 3.5 12.9 12.8 7.6 8.3 6.5 3.7 7.2 6.4 6.1 2.7 1.1 7.6 7.5 3.7 2.2 2.9 2.3 66.4 34.4 16.1 5.3 14.4 8.6 13.7 14.5 22.7 12.2 23.7 12.8 9.9 15.2 11.5 13.6 6.7 11.2 12.3 37.1 12.2 25.3 37.6 23.7 14.2 9.9 11.3 10.7 13.0 10.3 9.7 13.3 8.3 10.2 12.1 56.6 17.3 28.9 40.1 6.1 5.2 2.5 25.5 28.1 20.5 10.4 5.9 24.6 3.3 61.4 2.4 32.2 8.1 0.0 54.3 61.5 11.8 37.0 31.1 17.4 40.5 19.1 2.9 38.6 68.7 2.4 6.9 46.3 18.6 33.3 3.7 5.7 58.2 3.6 8.5 8.4 5.4 0.0 13.3 2.9 22.4 5.0 19.7 40.3 3.8 62.9 IFNB1 "IFB, IFF, IFNB" ENSG00000171855 "Interferon beta 1" P01574 9 21077105-21077963 "Cancer-related genes, Predicted secreted proteins" "Antiviral defense" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 1.8;bone marrow: 3.7;breast: 5.9" "Cell type enriched" "Detected in single" 21 "Hofbauer cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 8 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 4.8;GAMG: 1.2;NB-4: 1.2" "Low region specificity" "Detected in many" HPA073843 Supported "Secreted to blood" NA NA 3750 "HPA073843: " "unprognostic (2.38e-1)" "unprognostic (2.60e-4)" 0.1 0.3 0.0 0.0 0.0 3.7 5.9 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 4.8 0.0 0.0 0.1 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IFNE IFNE1 ENSG00000184995 "Interferon epsilon" Q86WN2 9 21480839-21482313 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 3.9;urinary bladder: 4.1" "Cell type enhanced" "Detected in some" 21 "Basal glandular cells: 3.6;Glandular cells: 1.1;Urothelial cells: 3.1" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 10 "intermediate monocyte: 1.0" "Lineage enriched" "Detected in single" 10 "monocytes: 1.0" "Cell line enhanced" "Detected in some" "BJ: 4.1;HeLa: 10.6;hTERT-RPE1: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA "unprognostic (1.52e-3)" "unprognostic (8.36e-2)" "unprognostic (5.44e-2)" "unprognostic (1.56e-5)" "unprognostic (2.70e-1)" "unprognostic (2.25e-1)" "unprognostic (5.14e-3)" "unprognostic (6.32e-1)" "unprognostic (2.68e-2)" "unprognostic (1.14e-2)" "unprognostic (1.43e-2)" "unprognostic (9.63e-3)" "unprognostic (1.04e-1)" "unprognostic (3.27e-2)" "unprognostic (6.58e-3)" "unprognostic (3.34e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.6 2.6 0.2 1.3 0.0 1.4 0.3 3.9 3.3 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.4 0.0 0.1 0.8 0.0 0.0 2.4 0.0 0.0 0.1 1.5 0.0 0.6 0.7 4.1 1.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.3 2.5 0.0 0.0 1.2 1.2 0.2 4.1 0.2 0.2 0.3 0.1 2.7 0.0 0.8 0.8 0.4 1.4 0.0 2.6 0.4 0.0 0.0 0.0 10.6 0.0 0.7 0.0 0.0 1.1 0.5 1.6 2.3 13.1 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.1 2.1 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 IFNGR1 "CD119, IFNGR" ENSG00000027697 "Interferon gamma receptor 1" P15260 6 137197484-137219449 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 258.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 57.1" "Low region specificity" "Detected in all" "CAB025889, HPA029213, HPA063871" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB025889: , HPA029213: AB_10601023, HPA063871: AB_2685138" "unprognostic (1.73e-1)" "unprognostic (8.86e-2)" "unprognostic (9.85e-3)" "unprognostic (1.71e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (4.05e-1)" "unprognostic (6.97e-2)" "unprognostic (9.86e-2)" "unprognostic (1.57e-2)" "unprognostic (4.09e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (5.48e-4)" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (1.81e-2)" "unprognostic (5.38e-3)" 69.5 22.2 17.4 36.9 23.5 37.7 65.3 8.4 18.5 23.6 27.1 27.8 13.8 28.0 19.2 21.2 23.0 20.3 25.9 53.7 20.6 17.4 19.3 66.4 58.7 86.9 33.8 13.2 19.2 17.5 9.2 12.8 47.0 29.9 20.1 22.8 11.6 24.5 18.0 25.3 24.0 46.7 22.5 45.7 69.1 20.3 14.1 26.3 14.5 22.8 19.7 38.2 25.0 22.3 12.2 39.4 92.3 65.4 5.4 29.7 52.3 4.8 4.7 6.2 8.0 40.8 21.5 5.2 13.9 20.7 9.1 12.3 30.5 9.5 4.8 22.3 8.0 13.2 30.3 5.4 14.1 12.7 10.4 7.5 7.6 5.8 45.1 23.1 23.7 11.4 47.5 57.1 7.6 12.3 8.4 11.4 7.0 6.4 8.3 6.8 5.5 3.8 10.9 5.1 44.4 3.8 11.7 6.5 7.3 15.8 23.0 6.2 9.6 17.2 10.1 12.6 12.3 3.6 15.7 15.8 8.9 6.5 11.5 7.3 6.1 5.7 5.4 4.6 15.8 8.6 16.5 65.4 43.3 14.1 63.0 29.7 10.9 8.0 11.8 39.4 12.2 5.2 5.8 92.3 5.4 44.1 10.1 5.6 52.3 17.4 23.5 8.4 18.5 20.6 17.4 33.8 13.2 29.9 26.3 74.5 64.2 57.6 146.1 113.3 14.2 38.0 33.1 83.0 77.3 26.2 11.8 63.2 6.6 61.6 3.2 106.4 70.3 0.0 88.3 59.0 70.9 89.3 61.2 50.3 132.8 9.5 12.6 63.8 258.9 4.3 40.9 249.4 47.2 88.4 19.2 19.7 74.0 28.1 46.3 15.1 20.6 12.9 65.2 8.4 20.4 99.0 175.5 67.8 27.9 144.7 IFNGR2 "AF-1, IFNGT1" ENSG00000159128 "Interferon gamma receptor 2" P38484 21 33402896-33479348 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" Receptor "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Glandular cells: 309.5;Urothelial cells: 502.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 55.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001535 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA001535: AB_1078432" "unprognostic (9.58e-2)" "unprognostic (5.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (3.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.53e-2)" "unprognostic (3.25e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (1.13e-10)" "unprognostic (6.74e-3)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (2.15e-3)" 27.2 13.4 11.9 20.8 12.6 45.1 64.4 4.6 18.0 12.5 21.6 5.7 13.0 18.5 10.6 14.1 21.9 11.5 15.2 17.7 11.1 10.1 14.6 20.2 26.3 46.3 8.7 9.4 13.0 21.7 7.1 12.6 20.5 12.2 14.9 11.7 12.1 21.9 11.7 13.1 16.7 20.0 15.3 18.1 27.4 30.3 14.1 7.2 7.9 18.1 19.4 18.9 14.8 26.8 13.2 7.7 55.1 22.8 0.3 3.3 13.8 3.0 2.6 1.3 2.7 3.8 6.5 4.3 8.8 6.4 2.0 3.3 3.1 1.7 5.3 4.9 5.3 5.9 2.3 2.8 6.1 1.1 20.4 17.2 1.5 1.1 2.7 2.6 7.6 4.8 4.9 4.0 3.5 3.5 3.8 5.2 2.6 8.0 2.6 2.8 0.9 1.8 5.2 4.9 3.6 16.7 4.5 4.2 4.4 2.2 4.1 1.9 4.7 4.4 0.5 8.4 0.7 1.6 4.9 8.8 2.5 5.5 2.1 2.1 5.6 7.6 6.8 2.2 6.8 12.0 12.9 22.2 14.8 0.1 22.0 0.1 11.5 1.3 0.1 7.7 13.2 3.3 1.4 55.1 0.3 22.8 2.4 1.4 13.8 11.9 12.6 4.6 18.0 11.1 10.1 8.7 9.4 12.2 7.2 38.7 25.1 76.3 178.2 64.0 8.7 16.6 43.3 13.4 19.4 26.2 7.9 28.1 23.2 100.9 35.4 41.3 130.0 0.0 48.9 66.1 81.2 309.5 59.9 24.9 150.7 14.3 49.5 36.8 129.5 44.6 38.9 162.5 54.0 211.0 45.2 7.8 102.1 105.2 30.8 39.8 7.2 12.9 30.1 3.9 1.7 61.2 14.5 13.8 35.8 502.7 IFNK ENSG00000147896 "Interferon kappa" Q9P0W0 9 27524314-27526498 "Predicted intracellular proteins, Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.9;skin 1: 1.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cervical cancer: 0.5;head and neck cancer: 0.6;urothelial cancer: 0.5" "Region enhanced" "Detected in single" "pons and medulla: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.8" "Low region specificity" "Detected in all" "Secreted to blood" NA NA "unprognostic (5.58e-3)" "unprognostic (4.64e-3)" "unprognostic (1.06e-1)" 0.1 0.0 0.1 0.1 0.5 0.7 0.1 0.5 0.1 1.0 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.8 0.1 0.0 0.1 0.1 1.9 0.1 0.0 0.1 0.3 0.1 0.1 1.7 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.1 0.1 0.0 0.1 0.1 1.9 0.1 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNL1 "IL-29, IL29" ENSG00000182393 "Interferon lambda 1" Q8IU54 19 39296325-39298673 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.1" "Cell type enriched" "Detected in single" 24 "T-cells: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "gdT-cell: 4.4;MAIT T-cell: 4.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 4.1;myeloid DC: 3.3;naive CD8 T-cell: 2.3;NK-cell: 6.1" "Group enriched" "Detected in many" 46 "dendritic cells: 3.3;NK-cells: 6.1;T-cells: 4.4" "Cell line enhanced" "Detected in some" "AN3-CA: 1.1;GAMG: 2.5;SK-MEL-30: 1.0;U-266/84: 1.9" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 97000 "unprognostic (3.08e-2)" "unprognostic (8.74e-2)" "unprognostic (2.46e-4)" "unprognostic (5.76e-2)" "unprognostic (6.91e-3)" "unprognostic (5.73e-3)" "unprognostic (3.94e-2)" "unprognostic (4.80e-2)" "unprognostic (2.96e-5)" "unprognostic (7.95e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" 0.1 0.0 0.1 0.9 0.1 0.6 0.1 0.1 0.1 0.3 0.3 0.1 0.1 1.1 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.0 0.2 0.3 0.9 0.4 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.5 0.3 0.1 0.1 1.6 0.1 0.6 0.1 1.8 1.6 0.1 0.1 0.1 0.1 0.0 3.3 0.0 0.0 6.1 4.4 0.9 0.0 0.9 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.9 0.3 0.0 0.0 2.5 0.0 0.0 0.0 0.8 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 4.4 0.0 2.1 4.1 3.3 0.0 0.2 2.3 0.0 6.1 0.0 0.0 0.3 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.9 0.0 0.0 IFNL2 "IL-28A, IL28A" ENSG00000183709 "Interferon lambda 2" Q8IZJ0 19 39268514-39270092 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 4.1;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "HDLM-2: 16.7" CAB025489 Uncertain "Secreted to blood" NA NA "CAB025489: " "unprognostic (1.37e-1)" "unprognostic (2.84e-1)" "unprognostic (1.05e-1)" "unprognostic (2.11e-2)" "unprognostic (1.08e-1)" "unprognostic (6.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNL3 "IL-28B, IL28B, IL28C" ENSG00000197110 "Interferon lambda 3" Q8IZI9 19 39243553-39245129 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.1;salivary gland: 1.0;skin 1: 1.4;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AN3-CA: 1.1;CACO-2: 3.3;GAMG: 2.2;HDLM-2: 1.8" "Secreted to blood" NA NA 1700 "unprognostic (2.67e-1)" "unprognostic (9.19e-2)" "unprognostic (4.17e-1)" "unprognostic (6.86e-2)" "unprognostic (1.89e-2)" "unprognostic (1.66e-1)" 0.1 0.0 0.5 0.0 0.3 0.2 0.0 1.1 0.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.3 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNLR1 "CRF2/12, IFNLR, IL-28R1, IL28RA" ENSG00000185436 "Interferon lambda receptor 1" Q8IU57 1 24154157-24187959 "Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 13.9;Urothelial cells: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.9" "Group enriched" "Detected in many" 5 "B-cells: 6.8;dendritic cells: 11.9" "Cell line enhanced" "Detected in many" "U-266/70: 30.2;U-266/84: 10.5;U-698: 22.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA017319 Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA017319: AB_1851708" "prognostic favorable (5.12e-4)" "unprognostic (7.16e-2)" "unprognostic (8.61e-3)" "unprognostic (8.48e-2)" "unprognostic (8.09e-2)" "unprognostic (1.22e-2)" "unprognostic (7.28e-3)" "unprognostic (2.33e-1)" "unprognostic (5.10e-2)" "unprognostic (1.93e-1)" "unprognostic (5.51e-2)" "unprognostic (4.50e-1)" "unprognostic (3.66e-3)" "unprognostic (5.15e-2)" "unprognostic (1.69e-1)" "unprognostic (2.69e-1)" "unprognostic (1.10e-1)" 3.0 3.0 1.1 9.5 1.9 0.4 2.9 10.2 2.1 2.1 9.9 3.8 3.6 6.5 0.8 6.7 4.7 2.0 2.9 6.4 0.9 2.1 4.3 10.1 9.2 8.2 2.0 1.9 1.5 7.8 5.7 8.2 2.5 2.9 4.1 4.6 1.6 9.3 5.7 3.5 8.3 19.2 0.2 5.3 4.4 3.1 1.2 1.1 1.2 5.3 3.1 10.7 2.0 2.7 6.8 11.9 0.0 0.0 0.0 2.0 0.5 3.7 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.7 0.5 6.3 1.1 8.1 8.8 0.0 3.1 2.8 3.8 6.6 0.5 1.6 2.0 0.0 1.3 1.9 0.0 0.0 0.0 0.0 2.2 0.2 2.0 1.4 0.0 1.6 0.1 0.0 0.0 0.8 0.1 0.2 8.1 0.3 2.4 0.0 0.0 0.6 1.5 1.6 1.2 0.7 2.0 1.1 0.8 1.4 1.5 0.0 0.0 0.0 1.6 0.0 0.0 30.2 10.5 22.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 5.1 0.3 1.5 0.0 6.8 0.6 1.6 0.0 0.0 0.0 11.9 0.3 0.5 1.1 1.9 10.2 2.1 0.9 2.1 2.0 1.9 2.9 1.1 0.0 4.5 2.2 6.8 9.8 2.1 2.9 2.5 5.3 1.2 1.8 0.0 0.3 3.3 2.2 2.0 0.2 13.9 0.0 2.1 1.0 0.4 4.3 0.0 7.8 2.4 0.0 0.0 0.0 0.3 3.4 0.3 2.7 0.0 9.0 3.0 3.3 1.7 4.8 0.0 1.8 2.6 0.0 0.5 0.0 0.6 11.0 0.2 1.3 2.9 12.7 IGDCC3 "HsT18880, PUNC" ENSG00000174498 "Immunoglobulin superfamily DCC subclass member 3" Q8IVU1 15 65327127-65378040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;parathyroid gland: 16.6;placenta: 12.2" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 31.4;Cytotrophoblasts: 90.9;Late spermatids: 38.7;Syncytiotrophoblasts: 34.6" "Cancer enhanced" "Detected in many" "testis cancer: 5.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 42.7;CACO-2: 10.7;Hep G2: 33.7;SuSa: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015713 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA015713: " "unprognostic (7.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.24e-2)" "unprognostic (7.25e-3)" "unprognostic (6.67e-2)" "unprognostic (7.35e-3)" "unprognostic (3.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-2)" "unprognostic (4.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.77e-5)" "unprognostic (4.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-2)" 0.2 0.6 3.5 0.4 2.1 0.2 1.7 10.8 4.6 1.0 0.5 3.3 0.0 0.3 1.6 0.4 0.2 1.4 0.4 0.4 3.2 2.6 0.6 0.2 0.3 0.2 2.5 1.7 1.7 0.3 16.6 2.9 12.2 2.6 0.5 0.3 0.6 0.2 0.5 0.5 0.4 0.3 0.6 2.2 0.3 0.4 4.7 2.7 3.7 1.7 0.0 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.6 0.0 0.0 0.0 17.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 2.1 10.8 4.6 3.2 2.6 2.5 1.7 2.6 2.7 0.0 0.0 0.0 0.2 0.0 4.0 0.5 0.0 0.0 0.0 1.8 31.4 90.9 0.0 0.0 18.8 0.0 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 38.7 0.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.9 12.6 0.0 34.6 0.0 0.0 0.0 IGDCC4 "LOC57722, NOPE" ENSG00000103742 "Immunoglobulin superfamily DCC subclass member 4" Q8TDY8 15 65381464-65423072 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 14.1" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 29.5;Fibroblasts: 17.9;Leydig cells: 32.2;Rod photoreceptor cells: 12.0" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.1;AF22: 10.2;CAPAN-2: 8.9;EFO-21: 5.1;HSkMC: 5.7;NTERA-2: 7.7;SuSa: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008510, HPA008576" Approved Approved Approved Nucleoplasm,Cytosol NA NA 34000000 "Nucleoplasm, Cytosol" "HPA008510: , HPA008576: AB_1079496" "unprognostic (1.16e-1)" "unprognostic (9.38e-2)" "unprognostic (1.92e-2)" "unprognostic (1.20e-2)" "unprognostic (1.58e-1)" "unprognostic (1.77e-2)" "unprognostic (2.75e-3)" "unprognostic (9.94e-2)" "unprognostic (4.18e-2)" "unprognostic (3.65e-2)" "unprognostic (3.29e-2)" "unprognostic (6.36e-2)" "unprognostic (1.83e-8)" "unprognostic (3.30e-2)" "unprognostic (4.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.32e-3)" 1.7 6.2 8.3 3.7 5.0 0.2 1.3 2.0 4.9 6.1 1.4 8.0 0.0 1.0 2.3 7.2 2.6 2.9 6.7 2.2 6.2 4.1 0.6 0.3 0.7 1.1 5.6 3.1 13.3 0.7 0.2 2.4 8.2 6.1 0.9 1.2 1.6 1.5 1.3 14.1 1.5 1.7 3.1 5.0 0.5 1.9 2.5 6.5 0.0 4.6 4.0 1.5 4.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 10.2 0.0 0.0 1.1 0.1 0.4 0.0 0.0 0.4 0.6 8.9 0.0 5.1 0.4 0.0 0.0 2.5 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.4 0.0 0.0 5.7 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.8 7.7 0.0 0.0 0.0 2.5 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.5 6.1 0.0 0.0 0.0 4.1 2.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 5.0 2.0 3.9 6.2 4.1 5.6 3.1 6.1 6.5 0.0 0.0 0.0 0.0 2.1 5.8 2.0 0.0 0.0 0.0 3.5 29.5 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.5 17.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 32.2 0.4 5.0 0.0 0.0 0.5 0.3 0.0 3.9 0.7 12.0 6.5 0.5 0.4 0.9 1.0 0.7 0.0 0.0 0.0 IGF1R "CD221, IGFIR, IGFR, JTK13, MGC18216" ENSG00000140443 "Insulin like growth factor 1 receptor" P08069 15 98648971-98964530 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 7.7" "Group enriched" "Detected in many" 5 "granulocytes: 7.7;T-cells: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010268, HPA045563" Approved NA NA 36000 "CAB010268: AB_671792, HPA045563: AB_2679368" "unprognostic (1.30e-3)" "unprognostic (5.81e-3)" "unprognostic (1.53e-1)" "unprognostic (3.34e-2)" "unprognostic (2.65e-1)" "unprognostic (2.05e-2)" "unprognostic (1.29e-2)" "unprognostic (6.87e-2)" "unprognostic (2.64e-2)" "unprognostic (2.87e-2)" "unprognostic (8.56e-2)" "unprognostic (1.62e-1)" "prognostic favorable (3.75e-7)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" 8.4 12.7 11.5 5.9 13.5 16.3 18.5 23.0 15.7 15.3 13.4 10.4 22.7 4.2 15.3 16.3 9.2 18.9 7.7 11.6 11.7 7.3 17.0 2.0 11.0 4.9 8.0 11.8 23.2 22.5 4.7 13.8 17.5 9.5 21.7 7.2 16.7 12.5 23.2 9.1 13.0 7.5 18.1 8.0 7.3 10.7 12.0 11.5 10.7 16.1 7.0 5.6 12.8 21.6 1.0 0.4 7.7 0.6 1.0 2.9 0.7 3.2 16.3 11.4 0.2 5.7 4.2 7.6 3.6 7.3 1.2 1.0 7.0 8.6 0.8 10.6 7.1 8.0 15.5 5.1 14.8 1.0 0.0 5.1 12.3 18.2 14.0 5.0 6.5 1.3 6.5 7.0 2.1 10.0 4.3 4.0 1.3 0.6 2.9 5.6 23.0 2.5 4.4 10.6 5.4 0.9 4.0 8.9 2.9 3.4 20.0 3.8 17.1 26.2 1.5 14.1 25.7 8.0 3.0 11.1 1.1 14.7 2.9 5.7 1.0 4.4 2.7 2.2 4.8 2.7 4.0 0.6 1.8 0.9 0.6 0.6 0.4 0.8 0.3 0.4 1.0 2.9 1.0 7.7 1.0 0.5 0.3 0.0 0.7 11.5 13.5 23.0 15.7 11.7 7.3 8.0 11.8 9.5 11.5 26.8 11.2 0.0 25.0 29.1 51.6 25.7 10.2 38.8 31.8 21.0 86.4 26.8 1.7 13.8 23.0 23.2 5.1 0.0 9.4 16.8 24.2 51.2 0.0 0.4 5.8 71.5 33.7 38.1 7.0 38.8 16.7 5.0 20.3 2.8 21.9 47.2 25.3 10.5 12.7 18.6 32.3 0.0 17.6 3.3 13.6 28.0 23.0 3.2 20.4 39.1 IGF2R "CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI" ENSG00000197081 "Insulin like growth factor 2 receptor" P11717 6 159969099-160113507 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009661, HPA011332" Supported Enhanced "Golgi apparatus,Vesicles" NA NA 150000000 "Golgi apparatus, Vesicles" "CAB009661: AB_2122795, HPA011332: AB_1846276" "prognostic unfavorable (3.01e-4)" "prognostic unfavorable (2.92e-5)" "unprognostic (5.83e-2)" "unprognostic (1.72e-1)" "unprognostic (4.15e-1)" "unprognostic (3.25e-1)" "unprognostic (7.32e-3)" "unprognostic (2.32e-1)" "unprognostic (1.62e-1)" "unprognostic (1.07e-2)" "unprognostic (2.37e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (6.08e-4)" 28.0 22.2 6.8 13.5 8.1 16.7 39.4 6.4 8.2 14.9 17.3 9.5 13.0 9.4 19.6 16.0 16.7 13.1 17.9 27.9 6.7 6.2 20.6 26.6 32.6 44.7 12.3 3.6 18.0 19.6 23.5 13.6 15.5 10.0 14.1 13.3 13.9 18.2 13.5 62.0 15.9 15.4 16.5 7.6 30.2 14.4 13.8 9.0 37.9 18.5 17.3 14.1 16.3 26.9 0.4 2.9 13.3 2.0 1.0 3.6 0.9 7.7 7.0 12.4 17.4 45.2 25.0 16.8 12.2 26.3 10.1 17.4 10.6 12.2 3.2 13.7 13.4 40.7 10.4 9.3 59.5 17.0 16.8 6.6 1.4 12.2 19.1 26.7 7.4 12.1 19.8 19.1 21.0 60.6 24.4 6.5 13.9 13.8 17.4 15.8 5.7 3.4 7.4 5.5 7.1 7.5 8.0 8.5 16.3 14.2 7.8 4.1 9.1 16.5 14.8 16.5 17.8 6.2 21.0 9.8 9.8 10.3 21.0 22.3 10.3 14.4 3.3 18.9 10.1 15.1 0.1 2.0 1.1 3.6 0.8 1.4 0.3 1.2 1.7 0.3 0.4 1.0 2.4 13.3 1.0 1.4 2.9 0.7 0.9 6.8 8.1 6.4 8.2 6.7 6.2 12.3 3.6 10.0 9.0 44.7 38.9 12.8 8.9 19.7 14.1 33.2 33.1 6.7 19.4 15.7 19.6 6.2 0.0 29.2 5.3 22.4 21.3 0.0 16.6 11.0 16.7 15.0 3.5 54.4 22.3 14.3 21.5 30.7 48.2 3.6 44.0 26.4 11.8 8.2 20.6 13.6 37.4 14.4 36.0 21.7 13.9 64.7 17.0 6.5 9.6 17.2 7.8 21.8 20.1 15.6 IGFL1 UNQ644 ENSG00000188293 "IGF like family member 1" Q6UW32 19 46229752-46231243 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 51.5;tongue: 29.7" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 1.4;Suprabasal keratinocytes: 3.0" "Group enriched" "Detected in many" 7 "cervical cancer: 47.6;head and neck cancer: 60.7;melanoma: 23.3;urothelial cancer: 84.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 6.3;RT4: 23.4;SK-BR-3: 8.0" HPA014001 Uncertain "Secreted in other tissues" NA NA "HPA014001: AB_2668919" "unprognostic (1.35e-1)" "unprognostic (9.70e-2)" "unprognostic (2.89e-1)" "unprognostic (1.01e-1)" "unprognostic (1.64e-2)" "unprognostic (2.67e-2)" "unprognostic (3.06e-1)" "unprognostic (4.50e-3)" "unprognostic (6.70e-3)" "unprognostic (1.67e-1)" "unprognostic (1.80e-1)" "unprognostic (1.64e-1)" "unprognostic (3.23e-1)" 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.1 14.7 0.1 0.0 0.0 0.1 0.3 0.1 51.5 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.7 0.1 0.0 11.0 0.1 0.1 1.8 0.1 0.1 0.0 0.2 0.1 0.3 0.0 1.9 0.1 29.7 14.4 0.4 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 6.3 0.0 1.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.2 8.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.0 0.0 0.0 0.0 0.0 IGFLR1 "FLJ22573, TMEM149, U2AF1L4" ENSG00000126246 "IGF like family receptor 1" Q9H665 19 35738801-35742453 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 121.2;liver: 46.2;lymphoid tissue: 40.7" "Cell type enriched" "Detected in many" 5 "monocytes: 187.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 121.2" "Lineage enriched" "Detected in all" 4 "dendritic cells: 121.2" "Cell line enhanced" "Detected in many" "HMC-1: 22.3;Karpas-707: 17.1;U-266/70: 22.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA012369 Uncertain Approved "Focal adhesion sites" "Intracellular and membrane" NA NA "Focal adhesion sites" "HPA012369: AB_1858095" "unprognostic (5.97e-3)" "prognostic favorable (6.55e-4)" "unprognostic (1.94e-1)" "unprognostic (5.42e-2)" "unprognostic (8.31e-3)" "unprognostic (2.34e-4)" "unprognostic (6.71e-2)" "unprognostic (1.74e-2)" "unprognostic (1.87e-2)" "prognostic favorable (1.59e-5)" "unprognostic (1.44e-3)" "unprognostic (3.52e-1)" "unprognostic (8.72e-12)" "unprognostic (2.74e-1)" "unprognostic (1.22e-1)" "unprognostic (2.29e-1)" "unprognostic (3.32e-3)" 5.3 7.3 4.5 17.8 7.6 10.1 4.1 2.0 5.3 3.1 5.0 3.8 0.0 5.6 2.6 4.7 3.4 4.5 5.9 5.8 4.5 3.1 17.0 46.2 8.5 40.7 7.7 1.6 4.5 6.9 1.1 3.4 3.8 5.6 4.0 5.4 2.2 7.4 1.8 3.9 4.6 8.4 3.5 5.4 20.2 6.3 3.5 4.5 14.6 10.0 3.2 19.3 8.0 4.9 22.3 121.2 28.6 26.5 18.1 17.4 16.3 1.3 6.5 2.3 5.4 0.8 1.2 1.3 1.5 0.7 1.2 3.1 1.9 1.6 2.8 2.1 0.4 0.4 1.0 1.3 1.3 0.6 2.1 3.3 10.0 2.7 6.8 1.9 1.3 22.3 1.8 0.8 2.3 0.5 0.9 1.2 5.0 3.0 17.1 0.3 5.5 3.1 10.5 1.6 5.9 1.7 3.8 2.2 5.2 1.1 2.4 1.6 3.1 2.1 1.5 1.1 1.1 2.4 5.4 0.3 2.8 1.3 1.7 2.5 22.5 4.7 1.7 3.3 3.8 2.1 16.2 26.5 23.6 13.3 22.2 15.2 22.3 15.4 12.6 33.9 21.8 13.9 11.1 28.6 18.1 15.5 121.2 17.4 16.3 4.5 7.6 2.0 5.3 4.5 3.1 7.7 1.6 5.6 4.5 0.0 15.7 9.9 0.3 0.6 0.2 0.6 2.5 6.7 9.1 0.0 0.0 0.4 1.7 1.6 0.0 0.5 0.8 0.0 3.6 1.5 0.7 0.3 38.1 16.4 13.3 0.0 2.9 2.5 14.3 0.2 0.0 28.0 5.0 187.6 1.7 1.2 1.5 0.0 0.0 4.4 0.1 0.0 0.9 0.5 0.5 0.6 0.2 8.5 1.2 0.0 IGSF1 "IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2" ENSG00000147255 "Immunoglobulin superfamily member 1" Q8N6C5 X 131273506-131578899 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pituitary gland: 138.7" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 3.0;Bipolar cells: 11.5;Horizontal cells: 3.2;Melanocytes: 3.3" "Cancer enriched" "Detected in many" 8 "thyroid cancer: 65.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Hep G2: 23.5;SH-SY5Y: 21.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012732, HPA035582" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 430000 Cytosol "HPA012732: AB_2732404, HPA035582: AB_2674687" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (4.11e-1)" "prognostic unfavorable (4.25e-8)" "unprognostic (1.01e-1)" "unprognostic (2.40e-2)" "unprognostic (1.90e-3)" "unprognostic (2.52e-3)" "unprognostic (8.03e-3)" "unprognostic (9.36e-2)" "unprognostic (5.65e-2)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (5.96e-2)" "unprognostic (1.66e-1)" "unprognostic (2.35e-1)" "unprognostic (5.13e-2)" 0.8 11.9 1.4 0.4 5.3 0.0 2.7 0.6 6.2 2.7 0.5 3.3 1.2 0.2 1.1 1.5 1.3 1.6 0.8 5.6 3.3 15.4 0.5 1.5 0.2 0.0 3.8 1.9 1.0 1.7 0.0 138.7 0.6 4.7 3.9 0.2 2.2 2.0 6.4 0.3 0.6 0.4 3.2 2.7 0.2 0.5 11.8 1.9 0.2 5.3 0.8 0.5 0.6 0.5 0.6 0.4 1.5 0.3 0.3 0.3 0.2 0.3 0.5 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.2 0.0 0.0 0.0 1.3 0.0 0.0 4.1 0.3 0.0 1.7 23.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 2.7 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 21.2 0.0 0.2 0.0 3.2 0.4 0.0 0.0 0.3 0.6 0.0 2.4 0.7 0.3 0.0 0.0 0.0 0.0 1.5 0.3 0.2 0.2 0.1 0.2 0.3 0.3 0.3 0.1 0.6 0.3 0.2 1.2 0.3 0.1 0.4 0.3 0.2 1.4 5.3 0.6 2.3 3.3 15.4 3.8 1.9 4.7 1.9 3.0 1.1 0.0 0.2 0.0 11.5 2.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.8 0.2 0.0 0.4 0.0 3.2 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.5 0.0 0.4 0.6 0.5 0.0 0.3 0.0 0.4 0.4 0.2 0.0 0.0 0.1 IGSF10 "CMF608, FLJ25972" ENSG00000152580 "Immunoglobulin superfamily member 10" Q6WRI0 3 151425384-151458709 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Osteogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 17.8" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 118.2;Horizontal cells: 57.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.5" "Group enriched" "Detected in some" 5 "HeLa: 25.6;HL-60: 12.4;REH: 9.2;RPMI-8226: 29.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA012655, HPA012921" Uncertain Approved Vesicles "Secreted - unknown location" NA NA 280000 Vesicles "HPA012655: , HPA012921: AB_1851526" "unprognostic (1.78e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.47e-7)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (9.82e-2)" "unprognostic (8.84e-4)" "unprognostic (9.38e-3)" "unprognostic (1.96e-1)" "unprognostic (5.70e-2)" "unprognostic (2.04e-1)" "unprognostic (7.52e-4)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (4.59e-3)" "unprognostic (7.57e-4)" 2.5 2.9 0.6 0.1 0.4 0.0 4.5 0.0 0.2 0.3 0.5 0.0 0.7 0.8 2.0 3.4 7.3 4.1 0.7 0.8 0.0 0.0 6.7 0.5 0.3 17.8 0.1 0.7 1.5 0.0 0.0 0.6 3.7 0.0 0.0 1.2 0.7 0.7 0.3 0.2 0.4 0.3 1.3 1.6 1.5 0.1 0.2 1.5 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.2 0.2 4.0 25.6 0.0 0.9 12.4 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 29.6 0.0 0.0 0.5 0.0 3.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.1 3.7 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.5 1.2 2.2 14.0 1.1 2.5 13.4 10.3 1.8 3.9 18.9 0.0 0.2 118.2 0.7 0.0 0.0 1.2 2.6 5.4 0.9 0.0 0.0 1.2 57.2 5.8 0.0 0.3 22.0 6.4 1.6 3.3 1.0 0.4 23.5 0.3 0.0 1.1 0.3 2.2 0.0 0.9 6.7 2.4 2.0 25.9 0.0 0.0 0.0 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;ovary: 21.1;testis: 39.9" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 70.7;Early spermatids: 226.0;Late spermatids: 237.3" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;HEL: 4.4;SK-MEL-30: 26.2;U-266/70: 9.1;U-266/84: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 1.1 10.5 12.5 1.4 14.6 0.9 1.2 3.4 23.9 1.3 2.6 27.8 0.0 1.1 1.6 2.3 2.0 1.6 1.9 2.2 12.3 6.0 10.6 0.9 1.0 1.0 25.2 8.9 21.1 5.1 3.8 1.4 1.1 15.3 1.3 1.8 7.0 1.4 2.0 2.9 2.6 1.6 1.5 20.5 1.0 1.4 39.9 20.7 0.0 5.0 0.0 1.1 1.1 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 6.0 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.7 2.0 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 26.2 1.7 0.5 0.1 0.0 0.0 1.0 0.0 0.0 9.1 10.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.5 14.6 3.4 13.6 12.3 6.0 25.2 8.9 15.3 20.7 0.0 0.0 0.0 0.1 0.3 5.1 1.1 0.0 0.0 0.0 0.0 70.7 0.1 0.0 0.3 226.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 237.3 3.4 0.2 3.3 0.0 0.0 24.3 0.2 0.0 1.8 5.1 24.8 0.0 0.0 11.7 5.9 0.0 0.1 0.0 0.0 0.2 IGSF23 ENSG00000216588 "Immunoglobulin superfamily member 23" A1L1A6 19 44613630-44636781 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 6.0;intestine: 19.9;liver: 20.6" "Group enriched" "Detected in some" 8 "Cholangiocytes: 7.6;Early spermatids: 7.7;Hepatocytes: 9.2;Late spermatids: 8.1" "Cancer enriched" "Detected in some" 10 "liver cancer: 12.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.0" "Cell line enhanced" "Detected in some" "CACO-2: 14.0;Hep G2: 8.3;SiHa: 6.4" "HPA051811, HPA054591" Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA051811: AB_2681621, HPA054591: AB_2682535" "unprognostic (1.54e-1)" "unprognostic (1.84e-3)" "unprognostic (5.74e-2)" "unprognostic (1.53e-3)" "unprognostic (4.58e-2)" "unprognostic (1.11e-1)" "prognostic favorable (7.20e-6)" "unprognostic (7.35e-3)" "unprognostic (2.71e-1)" "unprognostic (3.27e-2)" "unprognostic (2.93e-3)" "unprognostic (1.52e-1)" "unprognostic (1.19e-8)" "unprognostic (1.26e-1)" "unprognostic (6.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.85e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 10.8 0.1 0.1 12.2 0.1 0.5 0.1 0.1 0.1 0.6 0.1 0.1 0.4 20.6 0.1 0.1 0.1 0.1 0.1 3.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.1 0.1 0.0 19.9 0.1 0.6 0.1 0.0 1.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 6.0 1.2 0.0 0.0 0.2 0.4 0.8 0.0 0.5 0.0 0.0 0.7 0.5 0.7 0.0 0.6 14.0 0.5 0.0 1.0 0.4 0.3 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.3 8.3 0.0 0.0 0.1 0.4 0.0 0.8 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 6.4 2.3 0.0 0.0 0.3 0.0 2.6 0.5 0.5 0.6 0.0 1.2 0.0 0.0 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 7.7 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.6 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 IGSF3 "EWI-3, MGC117164, V8" ENSG00000143061 "Immunoglobulin superfamily member 3" O75054 1 116574399-116667755 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 62.5;WM-115: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036305, HPA036306" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036305: AB_2675050, HPA036306: AB_10671245" "unprognostic (9.87e-2)" "unprognostic (3.64e-1)" "unprognostic (9.51e-2)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (4.03e-6)" "unprognostic (9.40e-2)" "unprognostic (4.41e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (4.18e-1)" "prognostic favorable (2.87e-6)" "unprognostic (5.29e-2)" "unprognostic (4.23e-2)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" 1.4 1.5 1.9 1.2 5.1 0.1 7.7 2.5 8.3 5.8 5.7 1.5 3.0 6.7 2.5 6.5 22.0 1.7 3.5 7.9 1.8 2.8 10.7 0.8 7.4 0.3 1.8 2.8 0.7 4.5 1.4 2.7 42.9 4.1 5.1 5.1 7.8 9.3 5.5 1.1 16.1 12.9 2.4 1.7 0.5 7.3 3.6 0.9 6.2 8.1 9.0 9.3 8.2 9.8 0.0 0.2 0.3 0.6 0.0 0.7 0.2 5.4 9.3 7.2 1.8 1.6 3.5 19.3 0.0 0.2 0.7 0.2 5.3 3.1 0.0 2.9 0.0 4.0 15.2 3.2 7.5 0.3 62.5 2.3 2.9 3.6 0.1 0.0 0.2 5.7 0.4 5.9 0.0 1.3 1.3 0.0 1.0 0.9 0.0 0.1 19.1 0.2 0.1 4.5 3.3 0.2 2.2 8.8 0.0 5.5 6.8 4.2 12.8 2.2 21.5 13.7 14.4 7.2 0.3 0.0 1.2 4.3 0.0 5.6 0.0 0.3 0.0 0.5 0.1 60.3 0.0 0.6 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 1.9 5.1 2.5 8.3 1.8 2.8 1.8 2.8 4.1 0.9 14.9 25.2 0.0 7.0 17.4 1.9 14.4 12.7 8.1 5.7 14.0 0.0 10.1 3.3 13.2 1.8 2.1 14.7 0.0 1.7 24.6 6.6 7.2 1.1 0.0 1.9 6.4 2.9 1.8 1.6 2.1 1.1 0.9 8.5 5.4 5.5 12.8 11.2 8.6 0.0 11.3 0.5 0.0 2.1 0.5 4.3 24.2 11.1 0.0 7.1 9.6 IGSF6 DORA ENSG00000140749 "Immunoglobulin superfamily member 6" O95976 16 21639537-21652660 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 96.8;lymphoid tissue: 49.7" "Group enriched" "Detected in many" 7 "Hofbauer cells: 183.3;Kupffer cells: 173.4;Macrophages: 302.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 96.8" "Lineage enhanced" "Detected in many" "granulocytes: 96.8" "Cell line enhanced" "Detected in some" "THP-1: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041023, HPA041072" Uncertain NA NA "HPA041023: AB_10794434, HPA041072: AB_10794262" "unprognostic (7.94e-2)" "prognostic favorable (4.92e-4)" "unprognostic (1.18e-2)" "prognostic favorable (1.54e-5)" "unprognostic (3.27e-1)" "unprognostic (4.03e-2)" "unprognostic (2.31e-1)" "unprognostic (1.74e-2)" "unprognostic (1.35e-2)" "unprognostic (6.76e-2)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (8.12e-2)" "unprognostic (1.81e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-1)" "unprognostic (2.02e-1)" 17.8 3.9 5.0 16.7 7.7 2.0 2.0 0.9 5.1 2.3 5.8 3.8 0.0 4.1 1.1 2.7 1.2 2.1 1.3 3.6 4.7 2.7 1.7 8.5 16.2 30.2 6.5 0.2 3.5 1.4 0.8 1.1 6.5 5.9 2.1 1.6 0.8 3.6 2.1 0.7 0.9 3.5 1.3 10.6 49.7 2.4 0.6 6.2 3.4 1.2 0.9 2.1 1.5 1.0 0.2 18.7 96.8 28.5 0.2 0.1 12.7 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.6 1.7 0.1 0.1 1.0 0.4 0.1 0.1 0.1 1.0 0.0 0.4 0.0 0.7 0.0 1.6 1.2 0.1 0.0 0.1 0.0 0.2 0.2 0.3 0.5 0.4 0.1 0.5 0.7 0.9 0.6 0.0 0.0 1.7 0.0 0.6 0.3 0.8 0.5 0.3 0.3 0.1 0.2 0.2 0.3 2.0 0.4 1.7 0.1 0.1 0.9 0.8 0.4 1.3 0.6 0.8 0.3 0.0 23.7 3.4 0.0 28.5 0.0 0.2 0.0 0.0 18.7 0.0 0.0 0.1 96.8 0.2 18.6 4.0 0.0 12.7 5.0 7.7 0.9 5.1 4.7 2.7 6.5 0.2 5.9 6.2 3.0 13.5 13.7 0.7 2.9 1.2 1.1 5.1 8.1 9.1 1.8 9.8 0.5 0.0 0.0 0.3 1.5 0.0 0.0 0.0 1.0 2.6 0.4 9.3 0.9 183.3 0.0 0.0 2.5 173.4 0.0 0.9 302.4 8.5 29.7 0.0 0.9 0.0 0.0 0.0 0.3 1.8 0.0 1.2 0.1 0.0 1.8 1.1 2.5 0.0 0.3 IGSF8 "CD316, CD81P3, EWI2, PGRL" ENSG00000162729 "Immunoglobulin superfamily member 8" Q969P0 1 160091340-160098943 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.2" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 187.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011917, HPA075970" Approved Supported Vesicles NA NA 190000 Vesicles "HPA011917: AB_1851536, HPA075970: " "unprognostic (4.08e-1)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.30e-2)" "unprognostic (9.31e-2)" "unprognostic (1.46e-1)" "unprognostic (1.20e-1)" "unprognostic (1.71e-1)" "unprognostic (1.01e-3)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.31e-1)" "unprognostic (2.60e-2)" "unprognostic (2.35e-1)" "unprognostic (3.74e-3)" "unprognostic (1.75e-3)" 9.9 10.4 25.2 9.0 30.3 2.4 11.1 40.9 54.2 9.6 11.8 53.5 6.4 18.2 8.6 16.6 7.0 13.9 8.5 11.6 32.4 24.1 10.4 19.3 10.1 10.3 32.2 29.9 15.1 19.1 9.0 8.7 7.8 25.9 13.8 7.4 11.2 21.0 14.0 6.0 34.0 14.4 5.1 42.6 10.6 9.8 11.5 25.3 6.2 10.0 5.9 6.2 6.0 6.9 14.3 5.6 1.2 4.0 4.7 15.6 6.4 8.9 5.4 7.0 17.9 4.1 2.6 14.8 4.4 5.8 9.5 8.9 6.1 6.2 13.2 16.6 6.4 8.2 17.3 2.8 6.5 1.3 15.7 5.1 1.7 6.0 10.4 6.9 4.5 14.7 3.2 13.2 6.1 2.0 6.7 1.9 14.6 2.3 7.6 2.2 8.5 11.2 10.5 14.8 18.8 8.6 6.4 3.6 9.5 8.6 9.3 2.9 12.8 5.0 16.5 58.9 6.4 11.7 5.8 1.9 4.2 9.1 7.5 3.5 21.0 23.2 5.9 14.8 1.8 10.9 0.0 2.9 1.2 13.3 4.0 11.7 12.2 11.0 15.4 3.3 14.3 14.8 15.6 0.8 4.7 2.4 5.6 14.9 6.4 25.2 30.3 40.9 54.2 32.4 24.1 32.2 29.9 25.9 25.3 8.9 3.5 22.5 26.4 38.8 54.6 3.2 12.7 0.0 1.2 36.6 9.8 28.1 5.0 30.1 3.1 7.9 34.9 0.0 10.8 187.6 24.7 18.9 10.3 26.8 13.7 62.0 19.1 9.8 3.2 0.5 15.5 8.0 40.5 85.6 23.2 90.2 17.8 37.4 14.9 13.3 11.7 6.5 16.3 1.7 5.8 54.5 58.0 14.4 27.4 24.0 IGSF9 "IGSF9A, KIAA1355, Nrt1" ENSG00000085552 "Immunoglobulin superfamily member 9" Q9P2J2 1 159927039-159945604 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 65.3" "Cell type enhanced" "Detected in many" 17 "Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 150.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 15.2;HaCaT: 22.2;hTCEpi: 9.8;NTERA-2: 11.3;SCLC-21H: 19.9;SH-SY5Y: 10.2;T-47d: 11.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA037753 Uncertain "Intracellular and membrane" NA NA "HPA037753: AB_10672915" "unprognostic (5.73e-2)" "unprognostic (2.86e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.16e-4)" "unprognostic (3.30e-2)" "unprognostic (6.06e-3)" "unprognostic (8.93e-3)" "unprognostic (1.37e-1)" "unprognostic (5.73e-2)" "unprognostic (2.05e-1)" "unprognostic (2.04e-2)" "unprognostic (2.15e-2)" "unprognostic (6.03e-3)" "unprognostic (2.87e-1)" "unprognostic (8.60e-2)" "unprognostic (1.42e-1)" "unprognostic (2.17e-2)" 2.7 0.0 0.3 4.5 0.5 0.0 2.2 0.4 0.3 2.3 6.7 0.4 3.4 6.6 1.3 5.9 6.8 4.2 1.4 0.7 0.4 0.1 0.4 65.3 0.7 0.3 0.3 0.3 2.4 1.0 0.9 0.3 1.5 0.6 4.0 3.8 21.2 4.0 6.2 0.3 20.2 13.7 0.9 0.5 0.3 11.8 3.0 0.4 1.1 1.1 7.0 2.7 2.1 3.9 0.9 1.4 1.6 0.1 0.0 0.2 0.0 5.0 0.0 2.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 7.1 2.6 0.0 0.2 0.0 0.0 22.2 1.1 3.1 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.3 0.0 0.0 0.8 0.2 0.0 0.0 9.4 0.2 0.0 11.3 8.5 2.3 0.0 0.0 0.9 0.0 6.8 19.9 10.2 0.6 8.7 0.0 2.0 11.3 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.2 0.0 0.2 0.2 0.1 0.2 1.4 0.9 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.0 0.3 0.5 0.4 0.3 0.4 0.1 0.3 0.3 0.6 0.4 0.0 0.0 0.0 3.4 11.8 11.2 1.2 15.3 2.7 2.3 0.0 88.4 1.0 0.0 3.9 16.7 0.3 29.4 0.0 30.5 2.6 1.5 1.7 0.0 11.4 0.2 1.6 7.9 0.6 0.3 2.4 0.3 0.0 0.0 0.0 7.6 3.7 19.4 12.2 0.0 0.0 150.3 0.0 0.4 0.5 1.0 10.9 0.6 0.0 3.2 1.3 IGSF9B KIAA1030 ENSG00000080854 "Immunoglobulin superfamily member 9B" Q9UPX0 11 133908564-133956985 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.7" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 3.1;Bipolar cells: 2.2;Cardiomyocytes: 2.6;Distal tubular cells: 1.7;Muller glia cells: 2.0;Suprabasal keratinocytes: 4.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 39.7" "Cell type enriched" "Detected in single" 9 "T-reg: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "OE19: 8.2;SCLC-21H: 17.7;SH-SY5Y: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010744, HPA010802" Uncertain Approved Cytosol NA NA Cytosol "HPA010744: AB_2668357, HPA010802: AB_1079194" "unprognostic (9.04e-4)" "unprognostic (1.74e-2)" "unprognostic (7.52e-3)" "unprognostic (4.38e-4)" "unprognostic (8.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" "unprognostic (1.38e-1)" "unprognostic (8.10e-2)" "unprognostic (2.81e-1)" "unprognostic (2.99e-4)" "unprognostic (3.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-1)" "unprognostic (9.14e-4)" "unprognostic (3.12e-3)" 2.2 2.1 4.9 3.7 6.8 0.7 1.2 39.7 12.4 7.4 6.8 2.4 4.6 1.1 7.7 4.3 5.9 7.6 4.9 13.4 2.9 3.1 1.1 0.5 1.8 1.6 2.1 4.0 2.4 2.1 1.5 6.2 1.3 3.8 4.2 2.4 6.1 2.1 6.4 5.0 2.4 2.4 12.8 1.6 1.8 3.7 5.0 2.3 0.0 4.9 2.6 1.2 5.2 3.1 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.3 1.2 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.0 0.0 2.6 1.6 0.8 0.5 0.4 3.1 2.6 0.0 0.1 2.8 2.4 0.0 0.0 0.0 0.2 0.7 3.8 0.0 0.0 0.0 0.5 0.2 0.0 3.3 0.0 0.0 0.0 1.8 0.3 0.3 1.9 8.2 0.1 0.0 0.0 0.0 0.3 0.0 17.7 9.0 0.1 0.2 0.0 2.9 1.8 0.0 0.0 1.3 1.4 1.1 0.8 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.2 4.9 6.8 39.7 9.7 2.9 3.1 2.1 4.0 3.8 2.3 0.0 0.0 0.0 0.1 3.1 2.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.4 0.0 0.7 0.0 1.0 0.0 0.1 4.3 0.0 0.0 0.1 0.0 IHH "BDA1, HHG2" ENSG00000163501 "Indian hedgehog" Q14623 2 219054420-219060467 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Developmental protein, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 19.1;intestine: 42.8;lymphoid tissue: 20.2" "Cell type enhanced" "Detected in some" 16 "Enterocytes: 15.4;Intestinal endocrine cells: 47.3;Mucus-secreting cells: 35.7;Undifferentiated cells: 20.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 45.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 20.4;OE19: 9.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA 13000000 "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.63e-2)" "prognostic favorable (3.67e-6)" "unprognostic (4.01e-1)" "unprognostic (1.92e-1)" "unprognostic (3.28e-1)" "unprognostic (1.06e-1)" "unprognostic (5.86e-2)" "unprognostic (2.74e-1)" "unprognostic (6.31e-2)" "unprognostic (3.33e-3)" "unprognostic (1.81e-3)" "unprognostic (2.05e-1)" "unprognostic (5.31e-1)" "unprognostic (1.51e-2)" "unprognostic (2.91e-2)" 0.1 0.1 0.1 20.2 0.1 0.0 0.1 0.3 0.2 4.5 33.1 0.1 0.7 10.7 14.3 10.3 0.7 0.7 19.1 0.1 0.1 0.2 3.7 3.4 3.3 0.1 0.1 0.1 0.7 0.1 0.0 0.6 0.2 0.1 2.3 11.4 8.2 0.1 1.1 0.1 0.1 42.8 0.5 0.1 0.1 11.6 0.3 0.1 0.1 1.1 0.1 0.1 0.9 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 2.5 1.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 3.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.0 0.4 11.5 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.3 0.3 IL10RA "CD210, CD210a, CDW210A, HIL-10R, IL10R" ENSG00000110324 "Interleukin 10 receptor subunit alpha" Q13651 11 117986348-118003037 "CD markers, Disease related genes, Predicted membrane proteins" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 56.2" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 88.9;Kupffer cells: 162.4;Macrophages: 88.5;monocytes: 146.1;T-cells: 102.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 14.9;HDLM-2: 37.1;Karpas-707: 13.9;RPMI-8226: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065647, HPA069086" Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA065647: , HPA069086: " "unprognostic (1.01e-2)" "unprognostic (2.07e-3)" "unprognostic (1.58e-2)" "unprognostic (7.08e-2)" "unprognostic (8.27e-2)" "prognostic favorable (4.47e-4)" "unprognostic (5.27e-2)" "unprognostic (4.84e-2)" "unprognostic (7.70e-3)" "unprognostic (5.94e-2)" "unprognostic (2.14e-2)" "unprognostic (3.83e-1)" "prognostic unfavorable (1.45e-5)" "unprognostic (1.82e-1)" "unprognostic (8.43e-3)" "unprognostic (2.19e-1)" "unprognostic (1.27e-1)" 11.3 6.5 2.9 29.6 3.5 27.2 7.2 1.1 3.0 3.4 7.9 4.7 0.5 3.8 5.5 11.0 4.3 4.9 9.7 7.6 3.0 3.6 5.0 6.4 13.6 49.8 4.7 1.4 3.4 3.6 1.3 3.4 6.9 4.5 5.8 7.5 6.4 7.9 1.9 2.6 3.0 17.6 5.0 8.0 56.2 4.9 3.1 3.5 9.6 3.6 3.9 32.2 9.5 3.4 4.6 15.4 1.2 23.9 23.7 30.7 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.1 0.0 0.3 0.0 0.2 0.0 0.0 37.1 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.7 13.9 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 3.9 0.0 5.6 0.0 1.1 15.8 0.8 19.7 23.9 14.2 4.6 19.0 22.7 15.4 2.3 6.9 12.3 1.2 23.7 18.8 6.0 30.7 22.8 2.9 3.5 1.1 3.0 3.0 3.6 4.7 1.4 4.5 3.5 6.0 26.0 27.4 0.5 5.0 0.0 2.0 0.0 2.7 2.3 0.0 0.0 1.2 0.0 0.1 0.0 1.2 0.0 0.0 0.7 88.9 2.8 0.0 11.6 0.5 54.1 0.0 0.0 4.3 162.4 0.0 0.3 88.5 16.9 146.1 0.0 0.5 0.1 0.0 0.0 0.6 0.0 0.0 1.0 0.1 0.2 3.6 2.7 102.0 0.0 0.4 IL10RB "CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2" ENSG00000243646 "Interleukin 10 receptor subunit beta" Q08334 21 33266358-33310187 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 170.3;Syncytiotrophoblasts: 264.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB020670, HPA047550" Approved Approved Cytosol NA NA 1300000 Cytosol "CAB020670: , HPA047550: AB_2680086" "unprognostic (8.43e-2)" "unprognostic (6.50e-2)" "unprognostic (5.88e-2)" "unprognostic (1.77e-1)" "unprognostic (1.48e-2)" "unprognostic (7.78e-2)" "unprognostic (1.97e-3)" "unprognostic (1.26e-1)" "unprognostic (5.69e-3)" "unprognostic (1.31e-1)" "unprognostic (1.19e-1)" "unprognostic (6.93e-2)" "prognostic unfavorable (5.62e-9)" "unprognostic (3.09e-1)" "unprognostic (2.76e-1)" "unprognostic (1.29e-2)" "unprognostic (1.05e-1)" 17.6 11.0 5.4 19.6 7.3 8.9 21.5 3.6 4.4 15.2 29.2 10.3 10.6 19.6 17.5 9.6 22.7 13.2 14.8 12.3 5.6 5.4 11.6 27.5 19.3 36.1 6.6 3.1 18.2 23.2 5.5 9.7 47.4 9.3 17.7 20.8 11.7 26.0 9.7 12.4 13.8 53.6 12.2 8.0 31.7 17.6 8.4 7.3 34.0 14.3 15.3 26.2 15.1 22.6 13.8 19.4 57.9 34.7 14.0 19.5 20.4 10.3 8.0 1.5 6.4 32.4 23.8 11.4 7.9 22.5 8.8 12.6 7.5 12.8 2.9 9.1 13.8 17.9 12.9 4.3 5.4 5.8 9.6 5.9 8.0 6.0 5.7 22.6 10.2 19.5 23.9 10.2 15.3 9.0 13.8 11.6 8.6 7.2 24.2 12.1 10.7 6.8 9.9 1.1 21.0 4.3 6.4 3.6 12.2 7.9 6.1 2.1 2.9 16.3 12.1 13.8 3.6 8.0 38.7 10.5 8.8 8.6 14.9 4.3 12.8 14.3 1.7 15.5 14.7 5.6 22.3 30.1 24.8 8.8 34.4 9.6 13.6 11.1 10.6 17.8 13.8 10.5 10.4 57.9 14.0 34.7 19.4 19.5 20.4 5.4 7.3 3.6 4.4 5.6 5.4 6.6 3.1 9.3 7.3 32.8 21.5 27.9 30.6 12.9 6.2 10.4 22.9 5.3 6.8 3.5 13.7 170.3 0.0 16.0 0.7 24.6 75.7 46.7 26.6 126.8 31.9 37.4 35.7 19.5 105.9 7.9 9.8 35.6 102.1 0.7 29.4 27.9 13.5 55.1 53.6 5.6 21.9 73.7 22.3 0.8 5.5 19.4 14.2 2.2 4.7 12.8 264.0 21.8 41.1 53.1 IL11RA ENSG00000137070 "Interleukin 11 receptor subunit alpha" Q14626 9 34650702-34661892 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Craniosynostosis, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 55.3;Late spermatids: 74.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 21.7;HSkMC: 23.5" "Low region specificity" "Detected in all" "HPA013162, CAB032830, HPA036652" Supported NA NA "CAB032830: AB_2123745, HPA013162: AB_2668790, HPA036652: AB_2675229" "unprognostic (7.76e-2)" "unprognostic (7.63e-2)" "unprognostic (1.05e-1)" "unprognostic (6.76e-3)" "unprognostic (1.67e-1)" "unprognostic (1.39e-2)" "unprognostic (9.91e-2)" "unprognostic (1.52e-2)" "unprognostic (1.89e-2)" "unprognostic (4.02e-1)" "unprognostic (1.28e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (6.56e-4)" "unprognostic (2.14e-1)" "unprognostic (1.51e-1)" "unprognostic (2.93e-2)" "unprognostic (8.71e-2)" 9.6 4.4 6.8 8.5 10.1 5.2 9.4 13.0 8.7 24.4 15.6 23.2 3.4 9.8 14.2 9.2 8.8 12.6 17.7 38.2 7.1 5.9 6.1 14.1 8.6 13.4 9.7 12.7 11.5 3.7 18.6 6.3 8.2 9.8 12.4 5.1 30.9 11.9 7.8 12.6 28.5 9.9 23.6 6.6 9.9 7.9 9.2 11.9 3.4 14.5 18.1 9.5 13.6 10.7 2.5 2.7 3.4 2.7 1.9 6.0 3.3 1.4 3.3 7.2 7.2 10.2 18.3 3.3 8.1 11.2 5.3 7.5 1.1 2.7 1.4 2.2 21.7 2.0 2.9 2.0 2.9 2.4 13.3 5.4 4.5 11.6 0.6 5.1 1.5 2.5 23.5 3.6 2.9 1.0 7.1 3.3 9.5 1.8 3.3 6.7 0.9 2.0 10.6 1.5 1.3 2.0 3.1 1.6 1.5 1.7 1.3 2.1 7.3 1.0 2.2 3.0 4.0 5.7 5.9 3.1 2.5 5.7 1.9 0.0 2.2 1.4 0.6 6.6 1.7 11.9 3.4 2.2 0.0 3.2 2.7 4.4 1.9 6.0 4.7 2.7 2.5 5.9 3.8 0.6 1.9 0.6 1.1 3.2 3.3 6.8 10.1 13.0 8.7 7.1 5.9 9.7 12.7 9.8 11.9 3.0 14.7 0.0 6.7 15.5 18.5 32.2 2.5 1.4 4.5 3.5 13.7 9.5 0.0 1.9 16.6 11.1 4.2 0.0 0.6 3.1 55.3 3.0 0.0 24.5 4.0 22.3 8.7 11.6 2.8 74.5 10.3 5.5 30.4 0.0 3.1 15.3 0.2 3.5 5.3 2.4 9.1 0.0 4.6 4.1 17.8 12.3 10.4 4.9 4.8 0.9 IL12B "CLMF, CLMF2, IL-12B, NKSF, NKSF2" ENSG00000113302 "Interleukin 12B" P29460 5 159314783-159330887 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" Cytokine "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 10.8" "Cell type enriched" "Detected in single" 60 "monocytes: 11.8" "Cancer enriched" "Detected in single" 20 "testis cancer: 3.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 3.0;NB-4: 2.7;SCLC-21H: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA040970 Supported "Secreted to blood" NA NA 140000 "HPA040970: AB_10796234" "unprognostic (5.96e-5)" "unprognostic (4.59e-5)" "unprognostic (1.05e-1)" "unprognostic (3.40e-1)" "unprognostic (9.13e-4)" "unprognostic (6.89e-2)" "unprognostic (2.58e-4)" "unprognostic (6.69e-3)" "unprognostic (3.83e-2)" "unprognostic (4.50e-2)" "unprognostic (2.53e-1)" "unprognostic (7.15e-3)" "unprognostic (9.25e-2)" "unprognostic (1.87e-1)" "unprognostic (1.07e-1)" "unprognostic (1.02e-2)" 0.2 0.2 0.2 0.7 0.2 1.4 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.2 1.2 0.4 0.2 0.7 0.2 0.2 0.2 0.6 0.3 0.9 1.8 0.2 0.2 0.2 0.2 0.0 2.4 0.2 0.2 0.2 0.6 0.2 0.7 0.2 0.2 1.3 0.5 0.2 0.2 1.8 0.9 0.5 0.2 10.8 0.4 0.2 0.9 0.3 0.2 1.1 0.3 2.9 0.5 1.0 0.2 0.0 0.3 0.4 0.6 0.7 0.1 0.0 0.2 0.5 0.0 0.0 0.5 0.6 0.9 0.5 0.1 0.1 0.2 0.4 0.1 0.1 0.0 0.5 0.9 0.1 1.5 0.2 0.1 0.4 1.1 0.3 0.3 0.1 0.0 0.7 0.1 0.4 0.2 3.0 0.0 0.2 0.5 2.7 0.6 0.1 0.4 0.6 0.8 1.8 0.0 0.2 3.7 0.2 0.3 0.3 0.0 0.8 0.4 0.4 0.4 0.5 0.2 0.2 0.2 0.2 0.1 0.3 0.7 0.5 0.2 1.7 0.5 0.2 0.2 0.1 0.1 1.1 0.2 0.1 0.1 0.3 0.2 0.2 2.9 1.0 0.1 0.3 0.1 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL12RB1 "CD212, IL12RB" ENSG00000096996 "Interleukin 12 receptor subunit beta 1" P42701 19 18058995-18098944 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.6;lymphoid tissue: 21.4" "Cell type enhanced" "Detected in some" 20 "B-cells: 9.0;Kupffer cells: 10.0;T-cells: 35.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 10.7;HDLM-2: 18.0;Karpas-707: 30.8;U-698: 9.0" "Low region specificity" "Detected in all" HPA074414 Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA074414: AB_2686687" "unprognostic (7.70e-3)" "prognostic favorable (3.41e-4)" "unprognostic (9.08e-3)" "unprognostic (1.18e-4)" "unprognostic (2.91e-1)" "unprognostic (1.33e-3)" "unprognostic (2.27e-1)" "unprognostic (8.99e-2)" "unprognostic (1.65e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (2.94e-1)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.49e-1)" "unprognostic (2.21e-2)" "unprognostic (4.34e-2)" "unprognostic (2.93e-2)" 1.9 1.5 1.3 17.5 2.1 5.6 1.2 0.5 1.0 0.9 3.4 2.4 1.1 2.9 1.0 2.4 1.3 1.5 2.5 1.4 1.3 1.2 1.8 1.8 5.0 16.0 2.0 0.2 1.1 1.3 1.2 1.1 2.4 1.4 1.7 2.0 1.1 6.6 0.2 0.9 1.0 8.0 1.0 2.4 21.4 2.3 0.7 2.2 10.1 1.3 0.7 16.9 3.8 1.0 4.9 5.9 6.2 14.0 16.2 28.6 9.0 0.2 0.1 0.1 0.2 0.0 0.1 0.5 0.1 0.1 0.2 0.6 0.2 1.0 10.7 0.1 0.1 0.3 0.2 0.1 0.0 0.0 18.0 0.2 1.2 0.3 0.2 0.4 0.7 1.7 0.0 0.0 0.3 0.1 0.1 0.0 2.4 0.2 30.8 0.0 0.1 5.1 0.2 0.1 0.0 0.1 3.6 0.1 0.5 0.0 0.0 0.3 0.1 0.2 0.2 0.2 0.1 0.2 5.8 0.2 0.3 0.3 0.1 0.1 3.7 5.5 9.0 0.4 6.2 0.7 3.3 5.1 3.6 22.8 14.0 28.6 4.9 15.5 18.3 5.9 3.7 8.7 15.2 6.2 16.2 13.2 3.5 20.5 9.0 1.3 2.1 0.5 1.0 1.3 1.2 2.0 0.2 1.4 2.2 0.0 4.8 9.0 0.6 0.2 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.4 0.4 0.4 4.6 0.0 5.9 0.0 0.0 0.6 10.0 0.0 0.0 5.8 0.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.6 0.1 35.2 0.0 1.0 IL12RB2 ENSG00000081985 "Interleukin 12 receptor subunit beta 2" Q99665 1 67307364-67396900 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.2;pancreas: 15.0" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 2.9;Hofbauer cells: 2.9;Melanocytes: 1.7;T-cells: 6.4" "Cancer enhanced" "Detected in many" "melanoma: 5.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 18.2" "Group enriched" "Detected in many" 42 "NK-cells: 18.2;T-cells: 6.1" "Cell line enhanced" "Detected in some" "HMC-1: 4.5;SCLC-21H: 8.9;SK-MEL-30: 22.4;THP-1: 13.0" "Region enhanced" "Detected in single" "olfactory region: 1.8" "Low region specificity" "Detected in all" HPA024168 Uncertain Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA024168: AB_1851629" "unprognostic (1.32e-1)" "unprognostic (1.54e-3)" "unprognostic (2.09e-1)" "unprognostic (2.68e-2)" "unprognostic (2.82e-2)" "unprognostic (1.09e-3)" "unprognostic (2.37e-2)" "unprognostic (3.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.38e-2)" "unprognostic (1.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.08e-3)" "unprognostic (1.82e-1)" "unprognostic (4.69e-2)" "unprognostic (7.11e-3)" "unprognostic (1.90e-1)" 3.8 1.0 1.8 3.1 3.6 1.5 3.7 0.6 7.7 2.4 1.0 0.0 0.0 0.7 0.8 1.1 3.2 0.9 1.1 5.2 9.6 1.1 1.5 1.4 1.8 4.3 1.0 6.0 0.8 15.0 0.9 0.8 14.1 1.6 1.2 0.9 1.3 7.2 1.7 11.4 2.1 1.4 1.0 1.0 2.5 1.0 2.3 0.0 1.1 1.1 3.2 1.6 1.4 1.2 0.0 0.0 0.2 0.0 18.2 6.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 2.1 1.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.4 0.0 0.0 22.4 0.0 0.0 13.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 2.7 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.2 18.2 0.0 0.0 3.9 1.0 1.8 3.6 0.6 7.7 9.6 1.1 1.0 6.0 1.6 0.0 0.0 2.9 0.0 0.2 0.5 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.6 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.4 0.0 0.1 IL13 "ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600" ENSG00000169194 "Interleukin 13" P35225 5 132656263-132661110 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 20.7" "Group enriched" "Detected in some" 7 "Early spermatids: 74.4;Late spermatids: 141.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 177 "HDLM-2: 30.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA042421 Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 40000 "Plasma membrane, Cytosol" "HPA042421: AB_10795504" "unprognostic (2.17e-1)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (2.18e-2)" "unprognostic (1.92e-1)" "unprognostic (5.21e-3)" "unprognostic (1.79e-1)" "unprognostic (2.69e-1)" "unprognostic (5.20e-1)" "unprognostic (7.10e-2)" "unprognostic (3.61e-3)" "unprognostic (3.34e-1)" "unprognostic (5.97e-4)" "unprognostic (4.70e-2)" "unprognostic (2.05e-1)" "unprognostic (7.39e-2)" "unprognostic (1.38e-1)" 0.3 0.0 0.1 0.8 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.1 3.0 0.0 0.0 0.1 0.0 0.0 1.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.2 0.2 0.6 0.0 0.0 0.0 0.0 20.7 0.0 2.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 141.6 2.6 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.2 1.2 0.5 0.0 0.0 0.0 0.0 IL13RA1 "CD213a1, IL-13Ra, NR4" ENSG00000131724 "Interleukin 13 receptor subunit alpha 1" P78552 X 118727572-118794539 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 235.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 6.9;eosinophil: 7.1;myeloid DC: 10.9;neutrophil: 19.0" "Group enriched" "Detected in many" 6 "dendritic cells: 10.9;granulocytes: 19.0;monocytes: 6.9" "Cell line enhanced" "Detected in many" "HDLM-2: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001587 Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 4500000 Vesicles Nucleoplasm "HPA001587: AB_1079133" "unprognostic (5.14e-3)" "unprognostic (4.72e-2)" "unprognostic (7.12e-2)" "unprognostic (7.75e-2)" "unprognostic (8.81e-3)" "unprognostic (3.82e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.44e-1)" "unprognostic (1.90e-1)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.19e-8)" "unprognostic (1.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.82e-2)" "unprognostic (5.08e-2)" 31.5 17.5 9.3 15.3 13.3 2.1 19.8 3.6 10.2 16.6 23.8 12.6 7.2 18.9 16.6 18.0 33.0 15.4 17.7 17.5 11.4 9.4 22.7 73.3 27.7 33.9 15.2 6.0 25.2 12.9 9.5 16.1 15.2 13.4 15.3 25.2 14.5 21.8 13.0 22.3 10.2 37.7 16.3 24.5 17.4 18.5 9.9 11.9 4.8 24.0 20.1 20.0 16.5 15.4 1.9 10.9 19.0 6.9 0.0 0.1 1.7 8.2 10.3 4.9 13.5 11.2 33.2 8.9 17.4 24.2 8.3 10.8 6.0 15.4 0.0 30.6 23.9 24.1 7.9 5.3 7.4 9.2 45.2 4.1 1.4 9.3 15.1 6.8 0.1 3.6 30.1 6.7 11.3 14.0 25.1 17.3 0.0 4.4 0.9 11.7 12.1 0.0 2.2 4.5 15.8 9.9 0.0 12.1 0.0 12.4 9.1 1.8 1.7 27.3 10.0 6.8 6.7 6.4 7.9 22.0 16.2 7.7 27.3 13.6 0.2 4.1 0.0 35.8 4.3 6.8 0.0 6.9 7.1 0.0 1.7 0.0 1.9 0.0 0.0 10.9 1.8 0.0 0.0 19.0 0.0 0.6 1.9 0.1 1.7 9.3 13.3 3.6 10.2 11.4 9.4 15.2 6.0 13.4 11.9 65.5 43.2 10.0 29.8 15.2 2.0 9.2 53.5 40.2 51.2 27.9 15.7 7.4 8.3 30.4 30.3 46.6 51.4 0.0 85.9 27.9 14.8 39.1 0.0 133.7 39.4 0.0 89.3 79.8 108.2 5.6 22.5 97.3 20.3 235.4 131.1 39.2 63.8 20.1 17.7 20.5 10.7 32.3 30.6 3.6 26.6 10.7 7.9 3.8 25.1 29.4 IL13RA2 "CD213a2, CT19, IL-13R, IL13BP" ENSG00000123496 "Interleukin 13 receptor subunit alpha 2" Q14627 X 115003975-115019977 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 16.1;testis: 31.5" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 253.7;Ito cells: 63.3;Late spermatids: 36.6;Spermatocytes: 64.6" "Cancer enhanced" "Detected in many" "glioma: 17.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "PC-3: 27.0;U-2197: 86.8;U-251 MG: 58.3;U-87 MG: 34.6" "Region enhanced" "Detected in some" "olfactory region: 8.7" "Low region specificity" "Detected in many" "HPA045831, HPA067363" Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Vesicles" "HPA045831: , HPA067363: " "unprognostic (1.97e-1)" "unprognostic (2.83e-1)" "unprognostic (6.62e-4)" "unprognostic (7.39e-2)" "unprognostic (8.45e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.55e-4)" "unprognostic (3.54e-1)" "unprognostic (2.85e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-3)" "unprognostic (2.19e-2)" "unprognostic (1.53e-5)" "unprognostic (1.58e-1)" "unprognostic (1.63e-1)" "unprognostic (9.70e-3)" "unprognostic (1.20e-1)" 0.5 4.8 3.7 3.9 11.3 0.0 0.8 0.3 3.1 1.2 0.4 2.1 5.7 0.3 0.9 4.4 0.5 0.1 0.8 0.6 5.1 11.2 3.5 9.6 1.0 0.1 1.2 2.6 0.1 0.1 0.5 16.1 2.1 3.9 4.3 0.7 1.6 0.8 3.7 0.0 0.1 0.3 0.4 0.6 0.2 0.1 31.5 1.4 0.0 1.3 0.2 0.2 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.7 0.0 5.9 5.7 0.0 0.0 0.0 0.0 0.0 0.1 2.9 9.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 86.8 58.3 0.0 0.0 0.0 34.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 11.3 0.3 3.1 5.1 11.2 1.2 2.6 3.9 1.4 0.0 0.0 0.0 2.6 0.1 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 253.7 1.0 0.0 0.0 0.0 0.0 0.4 2.3 0.0 0.4 0.0 0.0 4.1 63.3 4.8 36.6 2.6 0.0 0.0 1.0 0.0 0.0 5.5 0.0 4.6 0.0 0.0 0.0 0.2 64.6 2.1 0.0 0.0 0.0 0.0 2.5 IL15RA "CD215, IL-15RA" ENSG00000134470 "Interleukin 15 receptor subunit alpha" Q13261 10 5943639-5978187 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Exocrine glandular cells: 48.0;monocytes: 89.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 30.0;EFO-21: 18.2;HDLM-2: 32.7;HHSteC: 18.7" CAB026215 Approved "Secreted to blood" NA NA "CAB026215: " "unprognostic (2.86e-2)" "unprognostic (8.41e-2)" "unprognostic (6.13e-2)" "unprognostic (4.45e-2)" "unprognostic (7.87e-2)" "unprognostic (5.49e-2)" "prognostic unfavorable (2.67e-6)" "unprognostic (5.09e-3)" "unprognostic (1.82e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (5.35e-4)" "unprognostic (6.18e-3)" "prognostic unfavorable (1.27e-12)" "unprognostic (4.43e-2)" "unprognostic (4.69e-2)" "unprognostic (4.08e-2)" "unprognostic (5.75e-2)" 20.5 5.6 2.2 13.0 4.1 6.4 33.9 1.4 2.6 12.7 15.6 1.6 7.7 10.1 10.9 9.4 14.3 10.6 18.7 19.2 2.6 1.9 7.8 17.5 35.7 15.2 4.0 2.0 8.7 9.6 0.9 3.9 15.5 3.6 13.2 7.4 6.4 8.9 9.4 9.2 7.6 18.8 10.8 2.7 18.8 10.3 5.0 2.7 3.5 13.9 7.5 9.8 12.9 17.3 7.0 4.2 6.3 19.5 6.8 18.7 6.7 7.0 1.0 0.0 0.3 9.3 2.2 1.9 3.6 7.8 4.8 5.0 0.1 30.0 0.8 18.2 6.8 2.6 6.7 0.8 5.3 1.0 32.7 1.4 0.8 1.8 0.5 18.7 0.4 0.2 1.9 1.8 2.5 0.1 1.8 11.7 0.6 8.7 10.0 0.1 3.7 1.4 3.4 0.2 2.5 3.3 4.2 0.0 5.7 1.1 0.5 0.0 0.0 5.5 0.5 0.2 0.0 2.6 3.2 4.5 0.1 0.5 13.0 4.8 9.0 2.4 0.1 2.2 5.3 0.3 6.3 16.0 3.9 12.3 19.5 18.7 7.0 9.5 12.5 4.2 3.3 4.1 7.1 4.7 6.8 11.7 0.0 10.2 6.7 2.2 4.1 1.4 2.6 2.6 1.9 4.0 2.0 3.6 2.7 6.0 5.3 7.5 4.2 5.0 0.0 5.3 25.5 2.7 0.0 0.0 0.0 0.6 0.0 30.4 1.5 20.4 6.9 23.3 48.0 1.6 12.7 6.8 3.5 6.4 6.3 0.0 5.2 34.4 12.7 1.5 4.6 6.2 3.3 89.2 7.1 0.0 29.3 13.5 0.7 0.0 0.0 0.0 5.1 0.2 0.2 5.6 0.1 5.7 7.5 6.5 IL17D "FLJ30846, IL-17D, IL-22, IL-27, IL27" ENSG00000172458 "Interleukin 17D" Q8TAD2 13 20702127-20723098 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 36.1;skeletal muscle: 65.7" "Cell type enhanced" "Detected in some" 12 "Early spermatids: 15.7;Late spermatids: 24.2;Leydig cells: 10.6;Melanocytes: 8.5;Muller glia cells: 18.6" "Group enriched" "Detected in many" 9 "glioma: 10.8;melanoma: 3.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD8 T-cell: 1.0;NK-cell: 1.9" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 1.0" "Cell line enhanced" "Detected in many" "TIME: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 25000 "unprognostic (1.76e-2)" "unprognostic (2.05e-1)" "unprognostic (1.38e-2)" "unprognostic (2.23e-1)" "unprognostic (4.26e-2)" "unprognostic (3.86e-2)" "unprognostic (5.96e-2)" "unprognostic (1.37e-2)" "unprognostic (4.00e-2)" "unprognostic (3.28e-2)" "unprognostic (1.35e-3)" "unprognostic (1.43e-1)" "unprognostic (1.33e-3)" "unprognostic (1.68e-1)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (5.97e-2)" 2.5 3.2 22.4 1.3 24.6 0.6 2.1 9.5 36.1 3.6 1.9 16.1 0.2 5.6 2.9 1.1 5.5 1.4 3.2 3.9 16.5 13.9 0.8 0.5 3.5 1.0 16.7 9.4 5.3 3.7 0.7 0.6 1.4 11.0 3.1 0.7 2.2 1.8 1.4 65.7 2.0 3.5 1.2 14.6 0.7 1.4 1.9 10.9 0.0 2.5 1.1 0.6 2.6 1.6 0.3 0.0 0.1 0.1 1.9 1.0 0.1 10.7 1.5 2.4 5.2 5.7 3.2 12.5 3.0 0.8 0.3 0.6 5.0 5.9 7.3 0.6 0.3 3.7 5.7 1.0 0.1 0.1 2.6 8.3 0.5 0.5 6.0 0.7 7.9 1.6 4.4 0.1 0.4 0.0 4.7 3.4 10.3 2.9 0.0 2.0 10.4 8.7 6.5 7.3 12.7 1.8 11.6 5.9 0.8 0.1 9.4 14.2 4.6 1.7 2.6 11.8 4.4 6.5 6.8 18.2 1.2 2.1 0.9 3.7 1.3 1.1 1.9 2.8 3.8 5.3 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.2 1.0 0.0 0.2 0.1 0.0 0.1 1.9 0.0 0.0 0.0 0.1 22.4 24.6 9.5 15.2 16.5 13.9 16.7 9.4 11.0 10.9 0.0 0.0 0.0 0.2 2.2 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 15.7 0.4 0.2 0.0 0.2 6.2 2.0 0.1 0.0 0.0 0.3 0.0 0.0 1.8 0.0 24.2 10.6 0.0 8.5 0.0 0.0 18.6 0.3 0.0 1.1 0.0 4.3 0.0 1.4 0.5 0.7 1.8 0.9 0.0 0.2 0.1 IL17RA "CD217, CDw217, hIL-17R, IL-17RA, IL17R" ENSG00000177663 "Interleukin 17 receptor A" Q96F46 22 17084954-17115694 "CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.0" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 84.8;Macrophages: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 27.6;NB-4: 24.3;THP-1: 35.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB024996 Enhanced Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA 20000 "Nucleoplasm, Cytosol" "CAB024996: " "unprognostic (1.92e-1)" "unprognostic (3.15e-1)" "unprognostic (1.65e-2)" "unprognostic (9.83e-2)" "unprognostic (7.66e-2)" "unprognostic (5.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.22e-2)" "unprognostic (1.41e-2)" "unprognostic (8.52e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.96e-2)" "prognostic favorable (8.35e-4)" "unprognostic (2.16e-2)" "unprognostic (1.27e-1)" "unprognostic (6.51e-3)" 17.7 7.6 6.5 13.6 13.8 40.5 24.7 4.0 6.7 8.6 8.1 7.7 4.6 6.2 7.4 9.4 6.8 7.8 7.4 8.8 6.1 4.9 8.3 11.6 16.8 39.2 10.3 2.0 7.7 7.7 6.9 5.4 6.2 8.3 6.9 5.7 5.3 7.0 5.3 5.3 8.6 9.1 8.3 11.2 23.4 7.3 5.3 9.7 50.0 7.9 3.2 11.0 6.3 12.8 0.5 3.6 15.6 6.9 1.4 2.4 2.0 3.6 2.1 1.9 2.5 3.9 2.3 2.5 5.5 3.6 2.6 3.3 2.0 2.4 3.3 2.3 5.5 3.4 6.0 2.7 2.6 1.8 5.4 3.2 0.0 1.2 1.3 4.5 27.6 8.6 3.4 3.8 2.3 1.8 2.5 2.7 2.7 1.4 3.5 2.6 3.1 3.3 24.3 1.1 4.7 2.1 0.7 0.4 0.6 2.4 2.7 1.3 0.0 3.8 3.3 2.7 2.3 2.5 35.0 7.5 2.0 2.9 3.0 2.0 2.8 1.5 1.6 2.9 13.4 2.1 6.7 6.9 6.1 1.1 3.2 0.9 0.4 1.5 1.1 3.6 0.5 2.4 1.8 15.6 1.4 2.9 1.7 0.9 2.0 6.5 13.8 4.0 6.7 6.1 4.9 10.3 2.0 8.3 9.7 11.9 13.1 6.7 5.5 7.8 2.0 4.5 15.3 5.3 3.4 5.2 7.9 5.4 0.0 8.0 2.5 9.3 15.1 0.0 10.8 10.6 8.2 8.5 7.0 9.6 29.2 3.2 12.7 20.9 84.8 1.4 8.3 43.1 8.5 3.6 13.1 3.8 10.5 11.8 4.2 3.1 3.2 12.9 9.0 1.4 14.7 5.9 5.4 20.0 10.6 9.3 IL17RB "CRL4, EVI27, IL17BR, IL17RH1" ENSG00000056736 "Interleukin 17 receptor B" Q9NRM6 3 53846580-53865800 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 63.0;liver: 26.6" "Group enriched" "Detected in many" 4 "Intestinal endocrine cells: 28.0;Proximal tubular cells: 57.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 11.1;Hep G2: 32.2;OE19: 25.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002837, HPA005482" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitotic spindle,Centriolar satellite" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane" "Mitotic spindle, Centriolar satellite" "HPA002837: , HPA005482: AB_1234567" "unprognostic (1.85e-3)" "unprognostic (4.22e-3)" "unprognostic (1.60e-3)" "unprognostic (2.86e-2)" "unprognostic (1.42e-2)" "unprognostic (6.20e-3)" "unprognostic (1.62e-2)" "unprognostic (6.09e-3)" "unprognostic (1.30e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" "unprognostic (4.27e-2)" "prognostic favorable (6.61e-4)" "unprognostic (8.10e-2)" "unprognostic (6.97e-2)" "unprognostic (5.29e-1)" "unprognostic (7.15e-3)" 1.1 2.1 13.4 2.2 12.2 0.9 9.2 15.1 14.7 17.1 5.8 6.8 0.0 5.1 5.0 1.3 1.9 3.2 2.4 2.5 17.1 7.4 63.0 26.6 3.5 2.3 11.9 6.4 1.8 5.3 1.4 3.9 1.2 11.2 2.5 6.1 1.9 4.1 1.0 1.4 2.3 5.1 1.2 11.3 1.4 3.4 2.5 15.2 0.0 2.9 0.0 1.0 1.7 1.0 0.9 1.1 4.1 0.6 0.5 3.1 0.5 0.8 1.7 2.5 1.9 0.0 0.0 4.0 1.7 0.0 0.0 0.0 11.1 0.8 2.5 0.6 0.5 0.9 0.4 6.8 0.0 0.0 0.9 1.9 3.3 3.4 32.2 0.0 3.0 1.8 0.0 0.0 0.0 0.0 2.2 0.0 0.9 2.6 1.2 0.0 2.2 0.5 1.2 6.8 25.2 1.4 0.9 1.0 2.9 0.7 2.9 3.6 2.1 5.6 1.3 1.0 1.9 5.2 1.1 1.3 1.7 1.9 1.5 2.1 2.6 2.9 1.6 1.5 1.8 0.9 4.1 0.6 0.2 1.0 0.6 0.6 0.5 2.1 0.6 0.2 0.9 0.8 0.9 0.3 0.5 0.2 1.1 3.1 0.5 13.4 12.2 15.1 14.7 17.1 7.4 11.9 6.4 11.2 15.2 0.0 2.6 0.0 2.0 0.2 0.0 3.4 10.2 0.0 2.3 0.0 0.0 0.3 8.3 3.7 0.8 0.0 1.3 0.0 1.3 0.9 0.2 6.7 2.3 8.9 0.1 0.0 28.0 0.6 0.0 0.0 1.1 0.8 0.0 0.0 4.3 4.5 2.7 2.0 0.4 57.9 0.0 0.0 0.6 0.4 1.3 0.1 0.3 0.0 6.6 0.5 IL17RC IL17-RL ENSG00000163702 "Interleukin 17 receptor C" Q8NAC3 3 9917074-9933630 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.6;myeloid DC: 4.8" "Group enriched" "Detected in many" 18 "dendritic cells: 4.8;monocytes: 3.6" "Cell line enhanced" "Detected in many" "ASC diff: 28.1;ASC TERT1: 19.9;HSkMC: 18.1;T-47d: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019885, CAB026255" Approved "Intracellular and membrane" NA NA "CAB026255: , HPA019885: AB_1851664" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.38e-4)" "unprognostic (2.58e-2)" "unprognostic (1.45e-3)" "unprognostic (8.60e-2)" "unprognostic (7.11e-2)" "unprognostic (1.38e-2)" "unprognostic (5.27e-2)" "unprognostic (4.30e-2)" "unprognostic (5.98e-2)" "unprognostic (9.35e-3)" "unprognostic (2.40e-1)" "unprognostic (2.63e-1)" "unprognostic (1.48e-1)" "unprognostic (2.83e-1)" 11.8 19.9 7.9 6.4 8.7 3.9 11.3 8.0 8.7 16.0 15.0 5.7 14.2 15.7 10.1 12.2 17.1 10.5 16.1 12.3 8.2 3.6 10.5 32.1 6.3 3.8 5.6 7.0 9.9 11.3 9.5 21.0 6.3 7.8 18.6 5.2 11.2 25.0 13.3 8.8 17.3 19.8 13.1 4.2 4.0 10.5 3.8 5.9 1.5 13.1 13.7 8.3 12.7 11.3 0.2 4.8 0.0 3.6 0.0 0.0 0.6 3.5 2.1 0.5 2.0 28.1 19.9 5.6 4.3 10.3 5.1 8.6 0.8 9.7 0.0 6.0 6.0 3.1 2.5 0.6 4.3 1.6 2.4 3.1 1.0 5.4 3.2 10.3 0.0 0.0 18.1 3.3 5.8 1.0 2.3 4.5 0.0 0.3 3.0 4.0 5.5 0.0 0.2 0.4 0.8 15.7 2.2 2.7 1.3 3.4 1.6 1.9 3.1 2.8 6.1 4.8 0.1 19.0 0.4 2.9 6.4 3.2 3.1 2.6 0.0 0.1 0.0 10.1 0.3 4.8 0.0 3.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 4.8 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.6 7.9 8.7 8.0 8.7 8.2 3.6 5.6 7.0 7.8 5.9 0.0 0.3 3.0 16.2 9.6 1.9 2.4 5.1 2.7 2.3 1.8 0.0 5.2 3.3 11.6 0.4 7.5 29.6 0.0 18.5 3.8 12.9 34.4 0.0 39.0 9.8 1.6 13.8 10.4 7.8 1.1 17.5 5.5 13.5 2.8 16.4 22.0 10.8 28.1 15.9 14.6 0.9 19.4 10.0 0.2 0.4 17.3 2.4 3.2 18.0 14.5 IL17RE FLJ23658 ENSG00000163701 "Interleukin 17 receptor E" Q8NFR9 3 9902612-9916402 "Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 55.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 71.8;Mucus-secreting cells: 43.2;Paneth cells: 38.6;Undifferentiated cells: 36.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 4 "cerebellum: 19.0" "Group enriched" "Detected in some" 8 "basophil: 3.1;MAIT T-cell: 1.9;memory CD8 T-cell: 2.0" "Group enriched" "Detected in many" 19 "granulocytes: 3.1;T-cells: 2.0" "Cell line enhanced" "Detected in many" "ASC diff: 11.0;ASC TERT1: 27.1;BEWO: 10.1;hTCEpi: 11.1;T-47d: 12.9" "Region enhanced" "Detected in single" "cerebellum: 1.7" HPA019011 Uncertain "Intracellular and membrane" NA NA "HPA019011: AB_1851667" "unprognostic (1.08e-2)" "unprognostic (7.58e-2)" "unprognostic (2.06e-1)" "unprognostic (1.43e-3)" "unprognostic (1.09e-1)" "unprognostic (9.81e-2)" "unprognostic (1.50e-1)" "unprognostic (8.43e-2)" "unprognostic (6.69e-2)" "unprognostic (6.31e-2)" "unprognostic (3.55e-3)" "unprognostic (4.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-1)" "unprognostic (5.96e-2)" "unprognostic (2.85e-2)" 7.6 0.9 0.6 6.9 4.3 0.0 7.8 19.0 0.7 4.5 39.3 0.0 1.9 15.5 2.4 4.0 10.4 1.9 18.3 1.4 0.7 0.8 3.4 1.0 13.5 0.5 0.7 0.1 0.9 12.7 3.6 1.7 4.6 2.5 4.7 10.5 2.6 17.7 3.9 1.0 16.8 55.7 1.2 0.7 1.3 12.4 0.6 0.4 5.1 4.8 6.8 5.3 2.1 4.4 0.0 0.0 3.1 0.0 0.1 2.0 0.0 1.9 0.2 0.0 0.0 11.0 27.1 10.1 1.5 0.9 0.2 0.6 2.0 1.5 0.0 0.5 1.9 0.0 4.5 0.0 4.1 0.0 0.0 0.1 0.5 0.3 4.6 0.3 0.0 2.0 1.9 11.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.5 2.2 0.3 8.1 0.4 5.3 0.4 0.0 0.0 0.0 2.0 2.3 0.5 0.1 0.0 4.3 0.0 0.2 12.9 0.5 0.7 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.3 4.9 0.1 3.1 0.0 0.0 0.0 0.0 1.9 0.0 0.3 2.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 4.3 19.0 0.7 0.7 0.8 0.7 0.1 2.5 0.4 6.0 0.6 3.0 10.3 12.9 3.0 0.8 15.3 0.0 1.2 15.7 0.0 3.9 6.6 2.7 0.1 1.0 71.8 0.0 4.1 1.1 3.8 9.2 0.0 13.6 2.2 1.6 32.2 1.8 0.0 0.0 2.0 1.4 5.0 0.0 43.2 2.7 2.3 38.6 3.2 5.6 1.0 19.4 6.4 1.0 1.9 12.9 0.7 1.3 36.3 2.7 IL18R1 "CD218a, IL-1Rrp, IL1RRP" ENSG00000115604 "Interleukin 18 receptor 1" Q13478 2 102311529-102398775 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 39.3" "Cell type enriched" "Detected in many" 5 "granulocytes: 104.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 26.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 13.8;HHSteC: 29.8;HMC-1: 20.0;U-937: 32.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA007615 Approved Approved Mitochondria "Intracellular and membrane" Yes No Mitochondria "HPA007615: AB_1851675" "unprognostic (3.60e-3)" "unprognostic (9.75e-3)" "unprognostic (1.12e-3)" "unprognostic (3.01e-2)" "unprognostic (2.34e-3)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.74e-2)" "unprognostic (3.59e-1)" "unprognostic (7.86e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.62e-1)" "unprognostic (1.62e-2)" "unprognostic (5.71e-2)" "unprognostic (2.48e-2)" 17.8 2.6 1.4 8.3 1.7 12.5 11.2 0.8 1.3 8.2 8.1 0.7 6.6 5.1 4.2 5.7 4.5 4.5 14.1 10.5 1.7 1.9 7.4 8.8 39.3 29.6 2.0 0.1 3.3 2.6 0.8 4.6 10.7 1.6 6.3 3.4 5.0 3.0 28.4 2.8 3.2 10.7 7.9 1.9 19.5 4.6 2.4 0.4 2.5 3.2 3.2 6.6 8.2 12.9 0.1 6.8 5.5 0.1 26.8 10.6 1.1 0.9 0.3 0.0 0.0 0.7 0.7 1.6 0.0 0.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.8 0.5 0.0 1.9 0.0 13.8 0.8 2.5 0.6 0.1 29.8 5.2 20.0 6.8 1.1 2.2 3.6 0.0 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.7 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.4 0.6 0.4 2.4 0.4 0.0 0.0 0.0 0.1 32.0 2.3 5.5 0.0 2.4 4.2 0.1 10.6 0.1 2.4 3.0 2.0 0.1 0.4 0.8 4.1 26.8 0.0 6.8 2.4 1.1 1.4 1.7 0.8 1.3 1.7 1.9 2.0 0.1 1.6 0.4 0.0 13.3 0.0 1.0 0.7 0.0 1.5 0.0 5.3 3.4 1.8 0.0 0.0 1.7 0.8 0.0 7.1 0.0 0.0 0.5 0.7 2.2 0.8 104.4 6.2 0.1 0.0 0.0 13.5 3.1 0.0 0.3 19.4 3.3 0.0 0.0 0.3 0.7 0.0 0.0 0.8 0.0 6.5 0.9 0.2 0.4 0.9 0.0 22.4 0.0 0.7 IL18RAP "AcPL, CD218b" ENSG00000115607 "Interleukin 18 receptor accessory protein" O95256 2 102418689-102452565 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.6;bone marrow: 50.2;lymphoid tissue: 29.8" "Cell type enriched" "Detected in some" 8 "T-cells: 24.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 34.6" "Group enriched" "Detected in many" 108 "granulocytes: 22.5;NK-cells: 34.6;T-cells: 22.1" "Cell line enriched" "Detected in some" 10 "U-937: 34.8" "Not detected" "Not detected" "Not detected" "Not detected" CAB025270 Enhanced NA NA "CAB025270: " "unprognostic (1.73e-3)" "unprognostic (6.27e-3)" "unprognostic (5.07e-3)" "unprognostic (4.64e-6)" "unprognostic (2.90e-1)" "unprognostic (1.18e-2)" "unprognostic (5.86e-5)" "unprognostic (5.09e-3)" "unprognostic (4.02e-2)" "unprognostic (1.57e-3)" "unprognostic (4.78e-2)" "unprognostic (5.31e-2)" "unprognostic (1.51e-2)" "unprognostic (2.71e-1)" "unprognostic (6.35e-2)" "unprognostic (8.56e-2)" "unprognostic (2.73e-2)" 3.6 0.3 0.2 6.1 0.5 50.2 0.9 0.3 0.4 1.2 4.8 0.5 0.0 1.2 1.2 2.1 0.8 3.8 3.0 2.1 0.2 0.2 0.9 2.6 9.6 16.4 0.9 0.0 1.1 0.4 0.0 0.9 0.8 0.2 0.6 0.9 1.5 0.8 0.3 0.6 0.2 8.1 1.0 1.0 29.8 1.5 1.3 0.0 1.3 0.8 0.9 3.5 2.5 1.3 0.0 0.2 22.5 0.0 34.6 22.1 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 1.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.8 0.2 0.0 0.0 6.1 15.7 0.0 22.1 0.0 2.0 4.2 0.1 0.0 0.0 0.5 22.5 34.6 0.0 0.2 0.1 2.0 0.2 0.5 0.3 0.4 0.2 0.2 0.9 0.0 0.2 0.0 3.0 0.6 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 IL1R1 "CD121A, D2S1473, IL1R, IL1RA" ENSG00000115594 "Interleukin 1 receptor type 1" P14778 2 102064544-102179874 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Hydrolase, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Club cells: 93.3;Ito cells: 139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 95.6;ASC TERT1: 42.7;HHSteC: 30.0;HSkMC: 117.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001237, HPA005823, CAB007779, HPA029560" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Secreted to blood" NA NA 1000000 "Nucleoplasm, Vesicles" "Plasma membrane, Cytosol" "CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094" "unprognostic (6.16e-3)" "unprognostic (3.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (7.10e-2)" "unprognostic (2.01e-1)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (3.16e-1)" "unprognostic (4.26e-2)" "unprognostic (7.77e-2)" "prognostic unfavorable (6.92e-6)" "unprognostic (2.48e-2)" "unprognostic (6.95e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" 48.6 25.2 2.6 18.2 5.2 4.0 92.4 2.4 3.9 47.8 21.0 2.5 34.3 5.2 15.2 30.2 18.2 17.1 25.8 27.0 4.2 2.5 23.7 74.8 40.5 28.0 5.6 1.1 25.1 17.1 16.9 7.3 66.2 10.9 26.0 8.4 8.6 12.7 36.4 15.5 13.5 13.0 15.1 10.0 19.2 15.6 13.4 2.8 3.5 33.6 9.0 9.6 32.0 36.4 0.1 0.1 4.0 0.5 0.8 1.8 0.2 0.2 1.8 0.0 1.5 95.6 42.7 0.6 4.0 18.2 2.8 4.3 0.8 0.5 0.0 2.9 8.0 5.0 0.8 0.0 0.3 2.4 7.9 0.0 0.1 0.4 4.4 30.0 0.0 0.0 117.7 0.3 3.2 0.7 1.2 1.2 0.0 0.5 0.1 4.1 0.8 0.0 0.1 0.1 0.8 0.1 0.0 0.3 0.0 2.7 1.9 0.0 0.0 1.8 1.1 0.0 0.5 1.6 0.1 0.0 8.2 0.5 13.7 0.3 0.0 0.0 0.0 3.2 0.0 0.5 0.6 0.5 0.1 0.0 0.0 0.7 0.1 1.1 0.0 0.1 0.1 0.0 0.1 4.0 0.8 0.0 0.1 1.8 0.2 2.6 5.2 2.4 3.9 4.2 2.5 5.6 1.1 10.9 2.8 23.8 55.6 3.7 27.6 27.6 0.0 3.9 28.1 40.2 93.3 5.2 0.0 5.3 3.3 21.6 6.4 58.3 0.0 0.0 18.7 76.6 77.2 84.5 1.1 43.2 5.1 0.0 1.2 139.3 12.4 9.4 25.9 21.6 18.6 9.0 0.7 7.3 15.4 0.0 1.4 6.2 1.0 6.5 23.1 0.7 0.9 33.8 20.0 2.6 0.9 19.6 IL1R2 "CD121b, IL1RB" ENSG00000115590 "Interleukin 1 receptor type 2" P27930 2 101991844-102028544 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 73.2;lymphoid tissue: 74.1" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 131.3;Kupffer cells: 197.6;Macrophages: 236.7;Mucus-secreting cells: 105.1;Pancreatic endocrine cells: 123.7;Suprabasal keratinocytes: 73.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "midbrain: 9.2" "Cell type enriched" "Detected in some" 25 "neutrophil: 73.2" "Lineage enriched" "Detected in many" 25 "granulocytes: 73.2" "Cell line enriched" "Detected in some" 8 "HDLM-2: 102.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA027597, HPA027598" Uncertain "Secreted to blood" NA NA 7130000 21000000 "HPA027597: AB_10600768, HPA027598: AB_10601229" "unprognostic (3.54e-2)" "unprognostic (1.87e-1)" "unprognostic (1.21e-1)" "unprognostic (3.83e-2)" "unprognostic (6.59e-2)" "unprognostic (1.42e-1)" "unprognostic (6.36e-2)" "unprognostic (4.82e-3)" "unprognostic (1.62e-2)" "unprognostic (7.15e-2)" "unprognostic (8.20e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.58e-12)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "unprognostic (1.77e-1)" "unprognostic (6.62e-2)" 9.1 3.2 1.2 16.4 1.9 22.3 1.6 1.2 1.9 6.4 13.4 0.4 0.1 0.1 1.3 1.3 20.4 9.7 3.4 15.1 1.2 0.5 5.8 8.2 25.5 74.1 9.2 0.2 2.5 1.4 0.0 2.4 24.9 2.2 1.1 20.0 1.8 4.3 0.8 2.8 14.1 2.2 1.3 4.4 47.5 14.6 1.6 1.1 1.6 1.8 8.5 25.1 3.2 9.1 0.0 2.8 73.2 0.8 0.0 1.1 0.2 1.5 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.3 0.0 0.0 0.6 0.0 0.1 0.0 102.2 0.1 0.0 0.0 0.8 0.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 5.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 73.2 0.0 0.0 0.0 1.1 0.2 1.2 1.9 1.2 1.9 1.2 0.5 9.2 0.2 2.2 1.1 6.0 0.6 5.4 8.6 131.3 0.0 0.4 17.8 4.0 0.0 1.8 0.0 0.4 5.0 8.0 2.6 1.9 8.6 0.0 7.3 28.9 9.3 2.5 2.3 14.4 5.9 0.0 6.4 4.3 197.6 1.5 0.3 236.7 30.4 1.0 105.1 0.0 123.7 31.7 0.0 0.4 0.0 6.5 8.9 0.0 1.4 73.4 23.2 1.0 20.4 7.1 IL1RAP "C3orf13, IL-1RAcP, IL1R3" ENSG00000196083 "Interleukin 1 receptor accessory protein" Q9NPH3 3 190514051-190659750 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.5;liver: 91.8;placenta: 35.9" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 100.2;Hepatocytes: 172.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "neutrophil: 36.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 36.5" "Cell line enhanced" "Detected in many" "SK-MEL-30: 72.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035293 Uncertain Approved Vesicles,Cytosol "Secreted to blood" NA NA 260000000 "Vesicles, Cytosol" "HPA035293: AB_10671511" "unprognostic (6.48e-2)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (8.84e-3)" "unprognostic (2.35e-2)" "unprognostic (6.60e-2)" "unprognostic (2.62e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.16e-7)" "unprognostic (4.02e-3)" "unprognostic (9.06e-2)" "unprognostic (5.72e-2)" "prognostic unfavorable (6.29e-4)" 3.4 1.7 3.7 5.2 4.5 7.8 2.8 0.8 6.0 2.9 1.8 3.4 0.7 1.1 2.6 1.7 9.1 3.2 5.7 3.3 7.4 2.9 1.9 91.8 6.3 12.6 3.5 2.5 2.2 2.0 1.0 1.4 35.9 5.5 2.1 1.4 1.6 4.7 2.0 1.2 5.8 1.5 3.1 6.3 7.1 2.3 1.0 2.9 2.3 2.2 3.8 3.4 3.3 4.4 0.9 1.4 36.5 2.2 0.1 1.3 0.5 3.9 1.0 1.6 0.2 2.9 2.4 3.1 1.7 3.5 4.1 4.0 1.7 8.8 0.7 18.3 4.8 9.5 10.2 0.9 17.1 5.7 0.7 1.0 0.8 1.7 4.2 6.1 5.8 2.8 3.2 7.0 5.9 18.9 8.6 1.8 1.8 0.1 0.0 1.9 1.8 0.5 2.6 2.6 1.7 1.8 2.8 2.5 1.4 1.5 4.2 0.3 0.0 8.0 4.4 72.7 1.6 2.9 4.2 2.4 3.2 3.2 9.7 7.9 1.5 0.0 0.1 5.4 5.3 18.6 3.5 1.5 8.5 0.7 1.7 1.3 0.9 0.8 0.9 1.4 0.9 0.8 0.5 36.5 0.1 2.2 0.2 0.8 0.5 3.7 4.5 0.8 6.0 7.4 2.9 3.5 2.5 5.5 2.9 0.0 14.3 1.4 14.3 39.8 5.4 4.0 43.3 2.7 20.5 3.5 7.9 3.1 0.0 6.5 2.3 7.1 1.3 0.0 6.4 100.2 7.0 5.6 7.0 172.7 6.9 0.0 5.2 8.0 33.0 0.0 4.0 18.3 8.5 1.0 1.3 0.9 14.8 0.0 2.5 0.8 0.6 0.0 3.1 0.0 0.6 32.5 20.3 2.5 1.2 12.8 IL1RAPL1 "IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2" ENSG00000169306 "Interleukin 1 receptor accessory protein like 1" Q9NZN1 X 28587399-29956723 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Receptor" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 26.7" "Cell type enriched" "Detected in some" 15 "granulocytes: 26.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 14.0;WM-115: 4.1" "Low region specificity" "Detected in all" NA NA "unprognostic (2.51e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (3.75e-3)" "unprognostic (1.17e-1)" "unprognostic (3.98e-1)" "unprognostic (2.25e-2)" "unprognostic (4.45e-2)" "unprognostic (1.29e-1)" "unprognostic (5.85e-2)" "unprognostic (3.95e-2)" "unprognostic (8.02e-2)" "unprognostic (1.08e-2)" "unprognostic (5.74e-4)" "unprognostic (2.29e-1)" "unprognostic (5.22e-2)" "unprognostic (3.58e-3)" 1.5 1.0 12.9 1.0 21.8 0.9 1.5 6.9 17.2 1.2 1.5 15.0 0.0 1.1 1.2 1.5 1.7 1.0 1.5 2.7 10.9 3.3 1.1 1.8 1.1 1.1 21.7 10.1 2.3 1.2 1.0 1.5 1.6 12.3 2.1 1.5 0.0 1.2 2.1 2.2 0.9 1.7 1.2 9.9 0.9 1.4 1.6 26.7 0.0 1.7 0.0 1.0 2.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 14.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 2.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 21.8 6.9 17.2 10.9 3.3 21.7 10.1 12.3 26.7 0.0 0.3 0.0 0.1 0.1 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 26.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.1 0.1 0.0 0.0 0.0 IL1RAPL2 "IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1" ENSG00000189108 "Interleukin 1 receptor accessory protein like 2" Q9NP60 X 104566315-105767829 "Predicted membrane proteins" "Hydrolase, Receptor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 8.0;parathyroid gland: 8.9" "Cell type enhanced" "Detected in some" 23 "Cytotrophoblasts: 1.2;Early spermatids: 1.5;Leydig cells: 5.5;Syncytiotrophoblasts: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.8;hTERT-HME1: 11.0;NTERA-2: 2.0;RT4: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.62e-1)" "unprognostic (1.50e-1)" "unprognostic (1.66e-2)" "unprognostic (3.09e-1)" "unprognostic (1.48e-4)" "unprognostic (9.32e-3)" "unprognostic (1.67e-1)" "unprognostic (6.80e-5)" "unprognostic (1.78e-2)" "unprognostic (2.79e-3)" "unprognostic (5.91e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.84e-2)" 0.2 4.2 1.5 0.0 5.0 0.0 1.2 1.1 8.0 0.4 0.6 0.0 0.8 0.4 0.1 0.2 0.2 0.4 1.9 0.5 0.4 0.8 0.4 2.8 0.1 0.0 1.1 2.2 0.9 0.2 8.9 0.1 1.1 2.2 0.4 0.1 0.0 0.8 1.1 0.1 0.3 0.2 0.4 0.3 0.1 0.4 1.9 0.5 0.0 0.2 0.0 0.1 2.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.7 0.2 0.1 0.4 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.0 1.1 8.0 0.4 0.8 1.1 2.2 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.4 IL1RL1 "DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1" ENSG00000115602 "Interleukin 1 receptor like 1" Q01638 2 102311502-102352037 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 49.7;lung: 77.2;placenta: 95.0" "Cell type enriched" "Detected in many" 11 "granulocytes: 477.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.9" "Group enriched" "Detected in many" 5 "basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6" "Group enriched" "Detected in some" 59 "basophil: 17.1;eosinophil: 17.0" "Lineage enriched" "Detected in single" 59 "granulocytes: 17.1" "Group enriched" "Detected in some" 6 "HHSteC: 55.4;HMC-1: 82.4;HUVEC TERT2: 40.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007406, HPA007917" Uncertain Supported "Plasma membrane,Focal adhesion sites,Cytosol" "Secreted to blood" NA NA 19100000 1700000 "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA007406: AB_1079128, HPA007917: AB_1079129" "unprognostic (7.25e-2)" "unprognostic (9.72e-2)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" "unprognostic (5.28e-2)" "unprognostic (1.98e-2)" "unprognostic (3.25e-3)" "unprognostic (2.07e-1)" "unprognostic (2.77e-1)" "unprognostic (4.50e-2)" "unprognostic (8.58e-2)" "unprognostic (9.74e-2)" "unprognostic (1.44e-1)" "unprognostic (1.32e-2)" "unprognostic (1.60e-2)" "unprognostic (1.17e-1)" "unprognostic (4.60e-3)" 10.7 7.5 1.4 2.0 11.4 0.9 6.9 0.5 6.6 2.6 3.1 0.1 0.1 1.3 1.7 0.9 2.7 0.8 7.8 16.6 5.6 1.8 49.7 6.2 77.2 1.4 3.8 0.0 0.7 2.8 0.8 1.8 95.0 14.6 1.9 2.3 1.0 0.7 5.7 2.8 1.1 2.0 3.3 5.0 1.0 6.7 0.8 0.3 0.0 5.6 0.7 0.9 6.0 2.6 0.0 0.0 17.1 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 3.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 1.3 0.1 0.0 0.0 9.7 0.1 0.1 55.4 0.4 82.4 1.1 0.3 1.3 8.9 0.1 40.2 0.0 0.2 0.1 0.1 0.0 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.1 17.1 0.0 17.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 11.4 0.5 6.6 5.6 1.8 3.8 0.0 14.6 0.3 8.9 22.8 0.0 15.1 7.6 0.0 1.8 0.0 12.0 13.6 1.8 0.0 0.0 0.0 0.0 0.2 29.2 0.0 0.0 0.4 0.1 4.2 8.9 477.2 0.0 0.0 0.0 0.0 44.2 0.3 0.9 0.9 11.2 3.3 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.2 38.8 5.2 0.0 0.0 4.4 0.0 4.3 0.0 11.1 IL1RL2 "IL1R-rp2, IL1RRP2" ENSG00000115598 "Interleukin 1 receptor like 2" Q9HB29 2 102186973-102240002 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 14.4" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 4.9;Distal tubular cells: 3.3;Suprabasal keratinocytes: 4.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 11.3;ASC TERT1: 7.6;HaCaT: 5.4;HSkMC: 6.3;hTCEpi: 3.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (6.70e-2)" "unprognostic (1.17e-1)" "unprognostic (6.57e-2)" "unprognostic (2.76e-4)" "unprognostic (3.42e-3)" "unprognostic (2.60e-1)" "unprognostic (3.13e-3)" "unprognostic (6.79e-2)" "unprognostic (9.10e-3)" "unprognostic (9.17e-2)" "unprognostic (4.61e-2)" "unprognostic (2.38e-1)" "unprognostic (1.05e-2)" "unprognostic (8.33e-3)" "unprognostic (3.80e-1)" "unprognostic (1.47e-1)" "unprognostic (7.65e-2)" 1.0 1.8 1.1 0.5 1.1 0.0 2.8 0.5 1.4 1.8 0.7 0.5 6.0 0.0 1.0 2.0 7.4 2.4 2.4 0.7 0.6 0.7 2.3 3.3 0.8 0.5 0.5 0.5 0.5 0.5 6.0 0.5 0.5 1.1 1.3 1.0 0.5 2.9 10.3 0.9 14.4 0.5 0.5 0.5 0.5 1.6 0.5 0.5 0.5 3.7 8.8 4.0 0.9 3.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 2.3 7.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 5.4 0.0 1.2 0.6 0.6 0.0 0.0 1.5 0.0 2.2 0.0 0.0 6.3 3.5 1.7 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.5 1.4 0.6 0.7 0.5 0.5 1.1 0.5 0.0 1.4 0.0 2.4 4.9 0.0 0.3 2.5 0.0 0.0 1.8 0.0 0.1 3.3 0.2 0.1 0.1 0.0 0.0 0.2 0.1 1.2 1.4 0.0 1.5 0.7 0.0 1.2 0.0 1.0 0.0 1.4 2.1 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 4.8 0.1 0.0 0.4 1.6 IL20RA "IL-20R1, ZCYTOR7" ENSG00000016402 "Interleukin 20 receptor subunit alpha" Q9UHF4 6 136999971-137045180 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 28.9" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 33.5;Muller glia cells: 36.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.4;HaCaT: 6.8;OE19: 9.7;RT4: 11.3;SH-SY5Y: 10.9;T-47d: 10.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB024990, HPA042281" Approved Approved Cytosol NA NA Cytosol "CAB024990: , HPA042281: AB_10806235" "unprognostic (3.75e-2)" "unprognostic (8.23e-2)" "unprognostic (1.96e-2)" "prognostic favorable (1.43e-6)" "unprognostic (1.57e-2)" "prognostic favorable (2.29e-5)" "unprognostic (9.87e-3)" "unprognostic (1.64e-1)" "unprognostic (2.43e-1)" "unprognostic (3.78e-1)" "unprognostic (8.03e-3)" "unprognostic (2.18e-1)" "unprognostic (1.85e-6)" "unprognostic (9.38e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-3)" "unprognostic (1.64e-3)" 0.6 7.0 2.0 1.6 5.9 0.1 21.2 4.4 2.8 13.9 3.5 4.3 0.6 2.4 5.5 3.7 6.4 13.6 7.9 5.9 3.6 3.0 0.4 0.8 4.7 0.1 3.7 2.3 5.4 16.3 0.2 1.8 0.4 4.6 7.3 3.7 3.5 11.8 7.8 0.5 28.9 1.3 2.9 5.5 0.0 4.9 2.9 3.3 1.0 2.2 3.7 5.6 5.6 9.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 9.4 0.0 0.1 1.4 0.1 6.8 1.2 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.3 9.7 1.4 0.0 0.4 0.0 0.0 11.3 0.7 10.9 0.5 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.9 4.4 2.8 3.6 3.0 3.7 2.3 4.6 3.3 3.0 18.4 0.0 11.2 19.5 1.7 3.9 25.5 33.5 14.8 3.5 0.0 2.4 0.0 11.1 0.2 0.6 5.2 0.0 0.6 6.6 2.4 18.3 2.3 0.0 0.4 0.0 7.0 0.6 0.0 0.5 8.1 1.7 13.5 0.0 18.4 36.8 8.0 2.9 14.2 0.6 0.7 0.0 1.2 0.2 3.4 15.7 6.9 0.0 13.3 17.1 IL20RB "DIRS1, FNDC6, IL-20R2, MGC34923" ENSG00000174564 "Interleukin 20 receptor subunit beta" Q6UXL0 3 136946230-137011085 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 64.5;skin 1: 61.2" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 32.6;Early spermatids: 38.8;Late spermatids: 24.0;Suprabasal keratinocytes: 33.2" "Group enriched" "Detected in many" 5 "cervical cancer: 54.5;head and neck cancer: 50.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "hTCEpi: 106.6" "Region enriched" "Detected in single" 9 "cerebellum: 0.6" "Not detected" "Not detected" HPA063914 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA063914: AB_2732709" "unprognostic (1.35e-2)" "unprognostic (1.05e-1)" "unprognostic (7.43e-4)" "unprognostic (2.48e-4)" "unprognostic (2.74e-1)" "unprognostic (3.31e-1)" "unprognostic (7.43e-4)" "unprognostic (4.08e-3)" "unprognostic (7.64e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (3.57e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.55e-1)" "unprognostic (3.55e-2)" "unprognostic (1.33e-2)" "unprognostic (5.57e-2)" 1.6 0.0 0.0 0.1 0.0 0.1 4.6 0.0 0.1 13.2 0.2 0.0 0.0 0.0 1.3 0.3 64.5 0.1 0.1 0.3 0.0 0.0 0.1 2.1 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.2 2.8 0.0 1.6 0.3 0.4 4.1 0.2 0.4 61.2 0.1 0.1 0.3 0.0 0.1 0.9 0.0 0.5 0.2 22.6 17.1 0.9 19.2 0.1 0.4 0.0 0.3 0.0 0.6 0.0 4.9 0.0 0.0 0.0 3.0 12.9 0.5 0.1 0.3 0.0 0.2 0.4 0.6 0.0 2.8 1.8 0.1 16.0 0.0 26.4 0.1 0.0 0.0 0.0 3.3 0.0 17.8 0.0 0.0 2.2 106.6 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.5 0.8 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 32.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 38.8 1.0 0.6 0.0 0.2 1.1 0.8 1.1 0.0 0.8 0.3 0.0 0.0 0.0 0.0 24.0 0.3 0.8 3.3 2.8 0.7 0.0 0.8 0.0 0.7 0.1 0.0 0.0 2.3 0.6 1.5 33.2 1.4 0.0 0.5 4.8 IL21R CD360 ENSG00000103522 "Interleukin 21 receptor" Q9HBE5 16 27402162-27452042 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 17.9;lymphoid tissue: 47.8" "Cell type enhanced" "Detected in some" 10 "B-cells: 11.8;Early spermatids: 5.2;Hofbauer cells: 7.0;T-cells: 8.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 10.3;HDLM-2: 43.9;Karpas-707: 20.4;RH-30: 15.4;RPMI-8226: 24.5;U-266/70: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042296 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042296: AB_10806236" "unprognostic (2.91e-2)" "unprognostic (2.65e-3)" "unprognostic (6.64e-4)" "unprognostic (1.58e-3)" "unprognostic (2.14e-1)" "prognostic favorable (7.29e-4)" "unprognostic (8.33e-2)" "unprognostic (2.06e-1)" "unprognostic (8.50e-6)" "unprognostic (2.26e-2)" "unprognostic (1.13e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-10)" "unprognostic (8.79e-2)" "unprognostic (4.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.58e-2)" 0.8 0.6 0.6 33.6 3.7 5.7 0.6 0.5 1.6 0.5 0.9 0.3 0.0 0.5 0.5 1.3 1.0 0.8 1.1 1.8 0.6 2.3 1.6 1.3 5.6 20.9 1.3 0.0 0.5 0.5 0.0 0.9 0.9 1.9 0.9 0.9 1.8 3.7 0.3 0.7 0.7 4.0 0.6 1.7 11.2 1.3 1.0 1.4 47.8 1.3 0.8 31.7 2.7 0.8 11.5 1.6 0.7 17.9 6.3 10.3 4.2 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.3 0.0 0.0 0.9 0.0 0.0 10.3 0.1 0.8 0.5 0.0 0.0 0.0 0.0 43.9 0.0 2.1 0.0 0.3 1.4 0.0 0.6 1.6 0.0 2.8 0.0 0.3 0.0 0.2 0.1 20.4 1.5 0.0 0.0 0.2 0.3 0.0 0.0 0.1 15.4 24.5 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.0 0.5 1.1 0.8 0.3 0.2 0.0 10.3 3.6 2.3 2.1 0.5 0.0 0.2 0.3 0.0 9.8 5.8 3.6 1.0 6.3 10.3 1.6 11.5 6.9 6.7 0.7 6.3 17.9 0.7 7.6 4.2 0.6 3.7 0.5 1.6 0.6 2.3 1.3 0.0 1.9 1.4 0.0 2.2 11.8 0.1 0.3 1.5 2.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 5.2 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 7.0 0.0 0.0 1.3 4.5 4.0 0.0 2.2 1.7 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.1 0.0 0.6 0.1 8.2 0.0 0.0 IL22 "IL-21, IL-22, IL-D110, IL-TIF, ILTIF, MGC79382, MGC79384, TIFa, TIFIL-23, zcyto18" ENSG00000127318 "Interleukin 22" Q9GZX6 12 68248242-68253607 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.8;urinary bladder: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTERT-HME1: 1.6" "Not detected" "Not detected" "Secreted to blood" NA NA 86900 "unprognostic (2.57e-1)" "unprognostic (4.24e-2)" 0.2 0.0 0.0 2.8 0.0 0.1 0.0 1.0 0.0 0.0 0.2 0.5 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.5 0.8 0.0 0.1 0.0 0.7 0.0 0.6 3.6 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 IL22RA1 "CRF2-9, IL22R" ENSG00000142677 "Interleukin 22 receptor subunit alpha 1" Q8N6P7 1 24119771-24143121 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "pancreas: 123.4" "Cell type enhanced" "Detected in some" 20 "Enterocytes: 31.9;Exocrine glandular cells: 10.6;Mucus-secreting cells: 7.9;Pancreatic endocrine cells: 7.7;Paneth cells: 7.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 10.9;Hep G2: 7.8;OE19: 18.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.68e-3)" "unprognostic (2.53e-1)" "unprognostic (1.09e-1)" "unprognostic (2.00e-3)" "unprognostic (1.48e-1)" "unprognostic (3.28e-1)" "unprognostic (1.74e-1)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (7.63e-2)" "unprognostic (1.72e-3)" "unprognostic (2.28e-1)" "unprognostic (4.78e-3)" "unprognostic (1.05e-2)" "unprognostic (2.57e-1)" "unprognostic (2.63e-1)" "unprognostic (1.64e-2)" 0.2 0.1 0.2 1.1 0.3 0.0 0.8 0.6 0.3 1.2 10.9 0.2 0.5 7.8 0.4 0.6 5.2 0.4 3.2 0.2 0.2 0.0 2.8 2.0 0.4 0.1 0.2 0.1 0.4 123.4 0.0 1.0 0.4 0.4 0.4 3.9 0.2 0.9 0.3 0.2 12.9 22.3 0.1 0.2 0.2 1.2 0.3 0.3 0.1 0.7 4.6 3.6 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.1 2.8 2.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 1.3 1.5 10.9 4.7 0.0 0.9 0.3 4.8 5.0 0.6 2.9 0.5 3.6 0.0 0.0 1.4 7.8 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.1 0.1 18.1 1.0 0.0 0.0 0.1 0.0 0.6 0.1 0.1 1.4 0.0 1.5 0.0 0.7 0.0 0.0 0.0 1.7 0.0 0.0 4.2 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.6 0.3 0.2 0.0 0.2 0.1 0.4 0.3 0.0 0.0 0.0 0.6 0.8 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 31.9 0.0 10.6 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.0 7.7 7.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 3.7 0.1 IL23R IL-23R ENSG00000162594 "Interleukin 23 receptor" Q5VWK5 1 67138907-67259979 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 18.1;lymphoid tissue: 11.0" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 8.3;Intestinal endocrine cells: 2.9;Late spermatids: 5.1;monocytes: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "MAIT T-cell: 18.1" "Lineage enriched" "Detected in single" 35 "T-cells: 18.1" "Cell line enhanced" "Detected in some" "HL-60: 2.7;HMC-1: 10.7;K-562: 4.0;U-2197: 16.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA056427 Uncertain NA NA "HPA056427: AB_2683129" "unprognostic (4.01e-3)" "unprognostic (8.04e-2)" "unprognostic (3.49e-2)" "unprognostic (6.41e-2)" "unprognostic (1.96e-1)" "unprognostic (3.16e-3)" "unprognostic (1.57e-1)" "unprognostic (2.22e-3)" "unprognostic (1.71e-1)" "unprognostic (1.88e-1)" "unprognostic (1.66e-2)" "unprognostic (1.40e-1)" "unprognostic (8.64e-5)" "unprognostic (1.43e-1)" "unprognostic (3.02e-1)" "unprognostic (2.73e-2)" "unprognostic (6.41e-3)" 0.2 4.8 0.2 11.0 0.3 0.0 0.2 0.2 0.2 0.2 2.4 0.2 0.0 0.9 0.3 1.0 0.3 0.2 0.6 0.2 0.2 0.2 0.3 0.5 0.5 4.8 0.2 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.2 2.6 0.6 2.3 0.0 0.2 0.2 2.7 0.0 0.2 3.3 1.3 4.1 0.0 1.2 0.2 1.4 7.6 0.9 0.3 0.0 0.0 0.0 0.0 0.5 18.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 2.7 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 16.2 0.0 0.3 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 18.1 0.0 0.5 2.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.9 0.0 0.0 5.1 0.0 0.0 0.0 2.8 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.0 0.0 0.2 0.1 IL25 "IL-17E, IL-25, IL17E" ENSG00000166090 "Interleukin 25" Q9H293 14 23372809-23376403 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 2.2;testis: 2.3" "Cell type enriched" "Detected in single" 40 "Cardiomyocytes: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB024864 Uncertain "Secreted to blood" NA NA 4230000 "CAB024864: " "unprognostic (1.49e-1)" "unprognostic (6.82e-2)" 0.5 0.2 0.4 0.3 0.6 0.0 0.6 0.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.5 0.3 0.0 0.0 0.0 1.4 0.3 0.1 0.0 0.5 0.0 0.0 0.8 0.0 0.3 0.5 0.8 1.0 0.2 0.7 0.5 0.5 0.0 2.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 IL27 "IL-27, IL-27A, IL27A, IL27p28, IL30, MGC71873, p28" ENSG00000197272 "Interleukin 27" Q8NEV9 16 28499362-28512051 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Antiviral protein, Cytokine" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.3;brain: 6.5;liver: 21.2" "Group enriched" "Detected in some" 5 "Hepatocytes: 17.1;Syncytiotrophoblasts: 19.3" "Cancer enriched" "Detected in some" 8 "liver cancer: 4.3" "Region enhanced" "Detected in many" "hippocampal formation: 6.5" "Cell type enhanced" "Detected in many" "classical monocyte: 6.2;intermediate monocyte: 6.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "BEWO: 20.4" "Not detected" "Not detected" "Not detected" "Not detected" CAB024722 Approved "Secreted to blood" NA NA 521000 "CAB024722: " "unprognostic (4.79e-3)" "unprognostic (2.66e-3)" "unprognostic (4.72e-2)" "unprognostic (1.52e-1)" "unprognostic (2.09e-1)" "unprognostic (6.55e-3)" "prognostic favorable (1.30e-4)" "unprognostic (3.76e-2)" "unprognostic (8.23e-3)" "unprognostic (1.29e-2)" "unprognostic (6.07e-3)" "unprognostic (4.57e-2)" "unprognostic (2.41e-7)" "unprognostic (6.44e-2)" "unprognostic (1.04e-3)" "unprognostic (2.13e-1)" "unprognostic (2.83e-2)" 0.8 0.2 0.1 1.4 0.9 0.9 0.1 0.1 1.0 0.2 0.2 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.0 0.1 6.5 0.1 0.1 21.2 0.6 0.4 0.2 0.0 0.0 0.1 0.0 0.1 0.8 2.2 0.2 0.0 0.4 0.1 0.0 0.6 0.1 0.1 0.2 1.4 2.9 0.1 0.5 1.2 1.9 0.4 0.0 0.0 0.2 0.0 0.3 1.1 3.5 6.3 2.7 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 6.2 1.3 0.1 6.3 0.2 0.3 0.0 0.1 1.1 0.0 0.0 0.0 3.5 2.7 0.2 0.0 0.4 1.5 0.1 0.9 0.1 1.0 6.5 0.1 0.2 0.0 2.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 17.1 0.8 0.0 0.0 0.0 3.7 0.0 0.0 1.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 IL27RA "CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1" ENSG00000104998 "Interleukin 27 receptor subunit alpha" Q6UWB1 19 14031748-14053216 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 25.2;lymphoid tissue: 32.3" "Cell type enhanced" "Detected in many" 9 "B-cells: 31.8;Kupffer cells: 33.3;T-cells: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA073441 Approved Vesicles NA NA 4100000 Vesicles "HPA073441: " "prognostic favorable (1.74e-6)" "unprognostic (1.99e-1)" "unprognostic (1.55e-1)" "unprognostic (6.09e-2)" "unprognostic (2.03e-3)" "unprognostic (2.28e-1)" "unprognostic (2.05e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.40e-3)" "unprognostic (9.92e-2)" "unprognostic (3.35e-2)" "prognostic unfavorable (2.58e-10)" "unprognostic (5.45e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.87e-3)" 8.4 2.1 2.8 26.0 2.7 3.5 20.6 3.0 3.5 3.5 3.9 1.1 2.7 3.6 3.6 2.0 3.4 4.2 4.1 5.8 3.8 3.6 4.8 2.1 11.8 25.3 2.6 2.3 2.3 3.5 8.1 1.1 2.0 2.5 5.0 3.4 1.2 7.4 2.1 2.8 2.6 9.0 3.0 2.5 18.0 4.1 2.4 1.6 32.3 4.9 2.2 28.3 6.0 6.8 14.6 18.2 5.3 19.7 19.1 25.2 16.9 8.3 3.6 3.7 4.9 0.3 1.9 1.5 3.9 8.2 7.2 10.4 1.7 6.8 0.1 4.2 3.5 3.3 1.6 5.7 2.3 5.6 16.0 3.9 20.3 0.8 3.0 0.6 9.7 0.3 1.9 0.9 3.4 0.7 5.8 2.8 5.1 14.0 15.2 0.3 11.7 7.2 21.1 4.8 5.0 2.5 6.4 2.1 7.7 4.4 2.0 3.2 1.7 5.0 0.3 5.7 2.0 6.4 6.0 4.5 0.7 9.0 7.3 4.2 15.8 7.6 7.4 0.7 19.8 4.7 5.3 19.7 0.5 22.9 16.3 20.2 14.6 22.7 18.9 18.2 12.8 25.2 19.4 1.5 19.1 7.5 6.8 19.9 16.9 2.8 2.7 3.0 3.5 3.8 3.6 2.6 2.3 2.5 1.6 0.0 10.6 31.8 10.6 1.6 0.0 1.2 5.1 0.0 7.9 3.5 0.0 0.5 0.0 9.0 0.3 16.3 0.0 0.0 2.3 1.6 3.0 6.3 17.3 0.8 20.7 1.6 2.4 20.9 33.3 0.0 3.1 26.0 5.0 4.6 0.9 0.2 4.1 0.0 3.2 0.7 0.0 0.0 1.7 0.1 13.4 1.1 0.1 61.2 1.1 3.1 IL2RA "CD25, IDDM10, IL2R" ENSG00000134460 "Interleukin 2 receptor subunit alpha" P01589 10 6010689-6062370 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 16.5;blood: 55.4;lymphoid tissue: 56.7" "Cell type enriched" "Detected in some" 4 "monocytes: 309.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 2.4" "Group enriched" "Detected in many" 6 "basophil: 30.3;T-reg: 55.4" "Group enriched" "Detected in many" 12 "granulocytes: 30.3;T-cells: 55.4" "Cell line enriched" "Detected in some" 59 "HDLM-2: 157.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002419, HPA054622" Enhanced NA NA 110000 "CAB002419: AB_563538, HPA054622: AB_2682546" "unprognostic (2.82e-1)" "unprognostic (8.10e-3)" "unprognostic (1.75e-2)" "unprognostic (5.86e-2)" "unprognostic (1.50e-1)" "unprognostic (1.45e-3)" "unprognostic (2.78e-2)" "unprognostic (2.73e-1)" "unprognostic (5.03e-2)" "unprognostic (6.32e-2)" "unprognostic (7.21e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.08e-9)" "unprognostic (2.10e-2)" "unprognostic (4.66e-2)" "unprognostic (2.22e-1)" "unprognostic (5.10e-2)" 16.5 2.5 0.3 10.9 0.6 0.1 1.4 0.3 0.3 0.6 3.1 0.1 0.0 1.3 0.8 4.9 1.9 0.8 2.2 1.9 0.4 0.5 2.6 1.3 4.0 50.4 0.5 0.0 0.6 1.0 0.0 1.8 1.8 2.4 1.1 1.6 3.4 2.2 0.5 0.8 0.6 10.3 3.5 2.2 56.7 1.4 0.4 0.0 4.5 4.2 2.0 16.8 5.0 0.6 3.6 0.0 30.3 0.0 2.9 55.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 30.3 0.0 4.5 0.1 0.0 0.5 3.6 6.8 0.7 0.0 1.5 0.5 0.0 0.2 2.9 0.0 0.0 55.4 0.7 0.3 0.6 0.3 0.3 0.4 0.5 0.5 0.0 2.4 0.0 0.0 2.6 7.5 0.1 0.8 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.2 74.4 0.0 0.3 0.0 0.0 0.6 5.6 0.0 0.0 3.7 3.3 309.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.0 7.7 0.0 0.1 IL2RB "CD122, IL15RB" ENSG00000100385 "Interleukin 2 receptor subunit beta" P14784 22 37125838-37175054 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.6;lymphoid tissue: 35.0;placenta: 58.5" "Group enriched" "Detected in many" 8 "Extravillous trophoblasts: 80.1;T-cells: 97.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 14.7;NK-cell: 51.6" "Group enriched" "Detected in many" 32 "NK-cells: 51.6;T-cells: 14.7" "Cell line enriched" "Detected in some" 8 "HDLM-2: 106.6" "Region enriched" "Detected in single" 7 "basal ganglia: 1.6" "Low region specificity" "Detected in single" HPA062657 Enhanced NA NA "HPA062657: AB_2684822" "unprognostic (3.38e-3)" "unprognostic (1.21e-2)" "prognostic favorable (6.76e-4)" "prognostic favorable (3.18e-5)" "unprognostic (2.44e-2)" "unprognostic (9.69e-3)" "unprognostic (2.60e-1)" "unprognostic (5.22e-2)" "unprognostic (1.03e-3)" "unprognostic (5.37e-2)" "unprognostic (1.09e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (3.50e-7)" "unprognostic (4.63e-2)" "unprognostic (7.96e-2)" "unprognostic (3.94e-3)" "unprognostic (2.46e-2)" 2.2 1.0 0.8 20.5 0.8 12.3 1.6 0.6 0.7 1.3 5.5 0.6 1.4 1.8 4.3 2.8 2.6 1.8 5.8 3.7 0.7 0.8 1.9 6.0 7.4 20.8 0.8 0.2 1.5 1.0 0.0 1.1 58.5 0.7 3.5 1.8 2.9 3.7 2.1 0.9 4.0 7.3 0.6 1.1 35.0 2.3 1.1 0.2 21.0 2.1 1.8 28.7 4.0 1.5 0.3 0.0 1.0 0.1 51.6 14.7 7.9 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 106.6 0.1 0.2 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.0 2.8 0.0 0.1 7.7 13.2 0.0 0.1 0.0 0.1 1.0 0.0 0.1 14.7 0.1 8.1 0.1 3.3 8.2 0.0 0.3 1.1 4.3 0.3 51.6 0.1 0.0 6.8 7.9 0.8 0.8 0.6 0.7 0.7 0.8 0.8 0.2 0.7 0.2 3.0 11.6 1.5 0.8 2.9 0.0 1.1 0.0 1.4 1.2 1.8 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.2 80.1 1.1 0.1 9.3 1.0 2.1 0.0 0.0 8.6 1.6 0.9 0.3 0.5 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 1.0 97.0 0.0 0.0 IL2RG "CD132, CIDX, IMD4, SCIDX1" ENSG00000147168 "Interleukin 2 receptor subunit gamma" P31785 X 71107404-71112108 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 115.3;lymphoid tissue: 169.3" "Cell type enhanced" "Detected in many" 12 "B-cells: 121.6;Enterocytes: 82.5;monocytes: 130.8;T-cells: 235.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 6 "Karpas-707: 225.6" "HPA046641, HPA049691" Enhanced Approved Vesicles NA NA Vesicles "HPA046641: AB_2679733, HPA049691: AB_2680851" "unprognostic (2.97e-3)" "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.73e-4)" "unprognostic (8.25e-2)" "unprognostic (1.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" "unprognostic (1.91e-3)" "unprognostic (1.23e-2)" "unprognostic (4.36e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.28e-7)" "unprognostic (1.73e-1)" "unprognostic (4.69e-2)" "unprognostic (4.89e-2)" "unprognostic (9.54e-2)" 5.8 1.3 1.4 39.5 1.4 12.8 3.6 0.8 0.9 2.9 16.6 0.9 0.9 8.2 3.0 2.1 5.3 3.1 5.3 2.6 1.4 1.5 3.7 4.7 13.6 70.4 1.8 0.6 2.9 1.5 0.0 1.2 5.3 1.5 3.2 20.8 2.9 10.4 1.8 1.6 2.7 28.6 1.5 2.9 58.7 6.0 2.0 0.9 169.3 3.3 4.2 61.4 7.6 3.1 51.9 30.6 65.6 19.7 94.6 115.3 99.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 17.6 1.3 0.0 0.0 0.1 0.0 0.0 0.0 14.8 0.0 2.3 0.0 0.0 0.0 9.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 21.0 3.9 225.6 0.0 0.0 32.6 17.8 0.0 0.0 0.0 7.5 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 12.9 22.7 11.3 0.2 37.8 0.0 35.2 8.5 13.4 107.2 19.7 105.6 51.9 97.7 110.4 20.3 51.6 68.0 84.9 65.6 94.6 13.5 30.6 115.3 99.0 1.4 1.4 0.8 0.9 1.4 1.5 1.8 0.6 1.5 0.9 3.0 15.7 121.6 6.6 7.2 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 1.0 0.0 4.5 82.5 0.0 2.0 0.2 3.3 3.6 38.1 1.5 32.3 0.0 74.7 6.7 21.7 0.0 0.0 41.4 40.5 130.8 19.5 0.0 16.5 58.8 0.4 1.1 0.2 0.0 4.1 0.0 0.0 5.9 0.2 235.1 18.0 6.8 IL31 IL-31 ENSG00000204671 "Interleukin 31" Q6EBC2 12 122172030-122174199 "Predicted secreted proteins" Immunity Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "HDLM-2: 1.3;Karpas-707: 2.5" CAB025657 Uncertain "Secreted to blood" NA NA 37800 "CAB025657: " "unprognostic (1.70e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 IL31RA "CRL, CRL3, GLM-R, Glmr, IL-31RA" ENSG00000164509 "Interleukin 31 receptor A" Q8NI17 5 55851379-55922853 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;tongue: 6.4" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 1.8;Spermatocytes: 2.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 6 "amygdala: 10.3" "Group enriched" "Detected in some" 5 "classical monocyte: 2.2;myeloid DC: 1.2" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;monocytes: 2.2" "Cell line enhanced" "Detected in some" "GAMG: 25.6;HBEC3-KT: 7.8;hTERT-HME1: 9.4;U-2 OS: 13.9;U-87 MG: 16.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.5;hippocampal formation: 1.1" "HPA051532, HPA068114" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA051532: , HPA068114: AB_2732779" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.13e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-3)" "unprognostic (7.34e-2)" "unprognostic (3.54e-1)" "unprognostic (5.38e-2)" "unprognostic (2.95e-3)" "unprognostic (7.75e-5)" "unprognostic (5.55e-2)" "unprognostic (2.65e-6)" "unprognostic (7.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.02e-1)" "unprognostic (1.76e-2)" 0.3 0.1 10.3 1.0 0.1 5.3 0.2 0.1 0.4 0.2 1.5 0.0 0.0 0.4 1.2 1.8 1.7 0.1 0.2 0.4 1.6 0.2 0.3 0.3 0.5 0.1 0.1 0.0 0.5 0.7 0.0 0.7 0.7 0.0 1.0 0.4 0.4 1.3 0.2 2.6 2.5 0.8 1.8 0.1 0.3 0.5 5.9 0.0 1.4 0.5 6.4 0.5 0.5 2.2 0.0 1.2 0.2 2.2 0.0 0.1 0.4 0.0 1.0 0.0 0.0 0.0 0.4 0.4 0.1 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.2 25.6 0.0 0.0 7.8 1.6 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 5.2 2.6 3.7 9.4 0.4 2.9 0.0 0.0 0.3 1.2 0.0 0.0 1.2 0.0 0.0 5.2 0.0 1.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.5 1.3 0.4 13.9 0.0 0.8 0.0 0.0 0.0 16.1 0.0 2.2 0.1 2.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 10.3 0.1 0.1 0.4 1.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.1 0.9 0.0 0.0 0.0 IL3RA CD123 ENSG00000185291 "Interleukin 3 receptor subunit alpha" P26951 X 1336616-1382689 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 163.1;breast: 50.7;vagina: 65.4" "Group enriched" "Detected in many" 5 "Endothelial cells: 40.7;Macrophages: 35.6;monocytes: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 16 "basophil: 163.1;plasmacytoid DC: 49.1" "Group enriched" "Detected in many" 33 "dendritic cells: 49.1;granulocytes: 163.1" "Cell line enhanced" "Detected in some" "HDLM-2: 49.0;NB-4: 9.4;RPMI-8226: 20.0" "HPA003539, CAB018374" Uncertain NA NA "CAB018374: AB_2233620, HPA003539: AB_1078438" "prognostic favorable (9.78e-4)" "prognostic favorable (4.27e-4)" "unprognostic (8.13e-2)" "unprognostic (9.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.29e-3)" "unprognostic (1.32e-1)" "unprognostic (1.67e-1)" "unprognostic (1.38e-1)" "unprognostic (3.73e-2)" "unprognostic (5.77e-3)" "unprognostic (1.43e-1)" "unprognostic (1.50e-3)" "unprognostic (9.41e-2)" "unprognostic (2.85e-3)" "unprognostic (2.49e-1)" "unprognostic (1.46e-1)" 14.9 1.2 7.8 7.7 7.8 12.1 50.7 5.0 10.1 9.7 4.6 1.5 1.5 2.4 13.8 1.5 2.8 4.2 5.6 9.2 11.1 2.4 5.4 1.5 15.9 12.3 8.5 3.9 7.6 2.6 0.6 3.7 9.3 10.9 4.4 3.1 1.5 5.6 1.5 5.7 6.8 5.4 6.1 7.6 5.3 4.2 1.5 7.9 1.5 7.0 1.5 6.4 6.8 65.4 0.7 49.1 163.1 3.2 1.1 0.0 0.7 0.1 4.0 1.5 0.5 0.0 0.0 0.5 0.5 0.1 0.0 0.0 0.4 0.6 0.5 2.8 0.0 0.2 3.9 0.0 0.0 0.0 49.0 1.6 0.2 0.7 0.1 0.0 0.3 6.7 0.0 0.0 0.0 0.0 1.7 3.2 0.4 0.1 2.5 0.0 0.6 0.2 9.4 1.2 0.3 0.2 0.6 1.8 20.0 0.0 0.5 0.2 0.2 0.2 0.1 1.1 0.7 0.5 7.5 0.1 0.2 0.6 0.2 0.1 5.3 1.5 0.4 4.4 1.1 0.0 163.1 0.4 6.7 0.0 2.4 0.0 0.2 0.0 0.0 1.1 0.7 0.0 0.0 0.3 1.1 3.2 49.1 0.0 0.7 7.8 7.8 5.0 10.1 11.1 2.4 8.5 3.9 10.9 7.9 3.0 2.6 7.7 0.5 5.3 2.7 2.4 2.5 0.0 1.2 0.0 9.8 0.0 0.0 0.3 0.0 40.7 0.4 0.0 0.2 0.1 2.8 0.4 11.5 0.0 4.4 0.0 0.0 14.1 3.5 0.0 0.3 35.6 8.5 120.0 1.3 0.8 0.1 3.4 0.7 0.0 2.2 0.0 4.1 0.0 0.2 4.8 0.2 0.0 0.2 1.8 IL4I1 FIG1 ENSG00000104951 "Interleukin 4 induced 1" Q96RQ9 19 49889654-49929539 "Enzymes, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.6;testis: 48.8" "Cell type enriched" "Detected in many" 12 "monocytes: 1188.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 38.6" "Group enriched" "Detected in many" 6 "monocytes: 13.0;T-cells: 38.6" "Cell line enhanced" "Detected in some" "EFO-21: 18.0;HDLM-2: 31.2;Karpas-707: 25.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA045598 Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA "Nucleoplasm, Cytosol" "HPA045598: AB_10969138" "unprognostic (6.23e-2)" "unprognostic (1.32e-2)" "unprognostic (8.39e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (5.61e-2)" "unprognostic (3.74e-3)" "unprognostic (7.03e-2)" "unprognostic (2.52e-2)" "unprognostic (3.84e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.23e-10)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (6.44e-2)" "unprognostic (2.11e-3)" 5.4 3.3 4.0 30.9 4.6 7.1 4.1 5.8 5.6 4.6 4.1 5.5 2.9 8.2 5.9 3.4 4.5 8.2 5.4 4.2 3.9 3.5 11.0 3.5 6.7 15.5 4.0 3.2 6.2 3.7 1.5 5.1 6.8 4.3 5.3 3.8 3.9 4.1 5.0 6.2 3.4 7.4 3.8 7.2 7.6 6.2 48.8 4.4 14.6 4.1 4.4 12.3 6.5 4.9 0.2 4.1 0.1 13.0 0.4 38.6 3.0 0.5 0.6 0.4 0.4 0.0 0.4 0.1 0.3 1.0 0.8 1.1 0.3 1.0 1.8 18.0 0.2 1.5 0.3 0.2 0.0 0.1 31.2 0.1 0.8 0.0 0.2 0.1 0.6 6.4 0.5 0.2 0.3 0.0 0.2 1.4 0.2 0.1 25.3 0.0 0.2 0.4 1.0 0.2 0.4 0.1 0.5 0.5 1.7 1.2 1.6 0.4 0.4 0.2 0.5 0.3 0.1 0.2 1.4 1.5 3.8 0.5 0.0 0.5 2.2 4.7 1.0 0.5 0.2 0.4 0.1 8.0 0.1 2.3 13.0 38.6 0.2 5.0 4.3 4.1 0.1 0.1 0.0 0.1 0.4 1.6 0.4 0.2 3.0 4.0 4.6 5.8 5.6 3.9 3.5 4.0 3.2 4.3 4.4 0.0 0.0 0.0 0.5 8.7 0.0 0.6 0.0 0.0 1.2 3.5 0.0 0.3 0.0 1.9 52.0 3.1 0.0 0.0 3.4 0.6 1.4 1.0 1.1 0.0 102.3 0.0 0.0 1.8 1.8 11.1 0.3 40.3 3.3 1188.5 0.0 0.1 0.5 0.0 0.4 1.6 0.2 0.0 2.1 11.9 2.5 7.2 0.7 5.0 0.1 1.4 IL4R CD124 ENSG00000077238 "Interleukin 4 receptor" P24394 16 27313668-27364778 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 107.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 34.4" "Group enriched" "Detected in all" 6 "B-cells: 34.4;granulocytes: 11.9" "Cell line enhanced" "Detected in many" "Daudi: 36.5;HBEC3-KT: 35.1;U-698: 34.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004451, HPA050124, HPA070380" Enhanced Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" "Secreted to blood" NA NA 49000 "Nucleoplasm, Plasma membrane" "Centriolar satellite" "CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: " "unprognostic (6.80e-2)" "unprognostic (6.35e-2)" "unprognostic (2.84e-1)" "prognostic favorable (6.43e-4)" "unprognostic (1.12e-1)" "unprognostic (1.14e-1)" "unprognostic (2.33e-2)" "unprognostic (1.95e-3)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.49e-2)" "unprognostic (1.73e-1)" "unprognostic (1.36e-1)" "unprognostic (9.58e-2)" 20.7 14.8 8.7 31.6 10.6 36.9 12.0 4.4 7.7 20.8 30.3 5.9 11.5 10.9 18.0 12.8 24.7 13.6 25.1 12.3 6.7 4.4 13.3 39.1 40.9 44.8 10.8 1.7 14.7 11.3 3.8 5.5 16.1 10.1 18.8 15.1 12.3 7.7 11.5 7.2 9.9 18.6 39.6 13.6 31.8 21.1 10.4 9.8 9.1 8.6 13.7 38.4 31.6 15.4 34.4 1.6 11.9 2.6 3.3 4.0 1.8 11.5 3.0 2.0 3.9 1.0 4.6 4.2 7.3 8.5 2.9 2.4 6.2 32.0 36.5 9.1 11.5 5.7 12.3 2.1 35.1 2.5 31.6 1.0 6.8 1.8 9.5 13.2 1.8 19.4 7.0 14.2 13.5 8.0 15.5 15.7 2.1 2.9 3.1 4.7 5.1 0.1 5.5 2.4 10.4 2.7 0.1 15.2 2.9 13.6 13.2 0.6 0.3 1.0 7.0 1.6 5.3 2.7 7.0 23.5 6.7 3.0 5.9 5.1 1.8 0.5 34.0 0.7 6.1 0.0 0.5 2.6 4.7 1.7 1.1 1.3 7.7 2.6 1.7 1.6 34.4 4.0 1.9 11.9 3.3 0.6 1.6 1.8 1.8 8.7 10.6 4.4 7.7 6.7 4.4 10.8 1.7 10.1 9.8 26.8 51.7 49.6 35.5 11.7 0.0 2.2 20.4 17.4 30.7 1.8 0.0 15.0 0.0 31.7 0.1 31.5 27.6 0.0 28.2 3.5 13.9 27.2 107.5 47.4 22.9 0.0 22.4 54.6 31.1 0.2 0.3 21.3 13.5 40.5 32.8 0.0 35.6 22.1 0.0 1.1 0.0 38.8 27.4 0.5 1.9 13.0 20.8 20.3 15.0 38.2 IL5RA "CD125, CDw125, IL5R" ENSG00000091181 "Interleukin 5 receptor subunit alpha" Q01344 3 3066326-3126613 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 70.1;fallopian tube: 18.6" "Cell type enhanced" "Detected in some" 18 "Ciliated cells: 21.4;granulocytes: 18.5;Melanocytes: 5.0" "Cancer enhanced" "Detected in some" "prostate cancer: 1.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 196 "basophil: 31.4;eosinophil: 70.1" "Lineage enriched" "Detected in single" 308 "granulocytes: 70.1" "Cell line enriched" "Detected in some" 30 "HMC-1: 42.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA 92000 "unprognostic (1.38e-3)" "unprognostic (2.26e-2)" "unprognostic (2.66e-1)" "unprognostic (6.13e-3)" "unprognostic (2.66e-1)" "unprognostic (1.54e-3)" "unprognostic (7.79e-3)" "unprognostic (8.42e-2)" "unprognostic (2.83e-1)" "unprognostic (1.67e-1)" "unprognostic (9.84e-4)" "unprognostic (4.32e-3)" "unprognostic (3.08e-2)" "unprognostic (6.95e-2)" "unprognostic (2.20e-1)" "unprognostic (7.49e-2)" "unprognostic (4.93e-2)" 0.5 0.2 6.7 0.6 6.2 0.7 1.3 0.2 0.3 1.8 0.9 1.8 0.0 2.2 0.6 8.2 0.6 18.6 2.0 2.4 2.3 2.1 0.6 1.3 7.9 1.2 0.1 0.0 3.8 0.5 0.1 7.5 0.1 11.8 2.6 1.4 0.5 2.2 0.1 0.3 0.4 2.1 0.6 0.6 4.6 1.3 1.6 0.7 1.1 0.4 1.1 1.9 4.2 0.4 0.1 0.0 70.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 31.4 0.0 70.1 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 6.7 6.2 0.2 0.3 2.3 2.1 0.1 0.0 11.8 0.7 0.0 4.5 0.0 0.0 0.1 0.0 2.4 0.0 21.4 2.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 18.5 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.0 0.0 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 IL6R CD126 ENSG00000160712 "Interleukin 6 receptor" P08887 1 154405193-154469450 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 59.6" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 107.2;Hepatocytes: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 35.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "THP-1: 55.9;U-266/84: 65.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 24800000 22000000 "unprognostic (1.19e-1)" "unprognostic (3.97e-1)" "unprognostic (1.19e-1)" "unprognostic (1.08e-1)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (1.01e-1)" "unprognostic (1.05e-2)" "unprognostic (3.27e-1)" "unprognostic (6.42e-2)" "prognostic favorable (1.65e-4)" "unprognostic (7.94e-2)" "unprognostic (1.05e-1)" "unprognostic (7.75e-2)" "unprognostic (1.51e-1)" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" 8.4 4.0 4.7 14.8 5.1 9.0 6.5 1.4 6.3 6.1 16.9 4.8 1.2 9.6 6.3 4.7 5.2 7.9 6.9 5.0 5.2 2.9 8.9 38.1 20.8 15.4 7.2 2.2 5.7 5.3 0.0 7.7 3.7 7.8 4.5 6.0 3.6 5.4 1.7 59.6 4.7 12.6 5.3 5.0 11.3 6.6 3.7 5.0 4.2 2.5 6.1 13.3 6.3 4.8 0.6 14.3 35.0 11.7 0.5 8.0 5.5 0.8 1.5 0.1 0.1 0.9 1.3 0.1 0.8 0.6 0.5 0.2 0.1 1.0 0.0 1.9 1.0 3.1 0.4 0.3 4.5 0.4 15.1 0.5 0.2 0.6 3.4 0.1 2.4 1.3 0.8 2.7 0.4 6.8 0.1 0.6 0.0 0.1 6.2 0.1 0.3 0.0 3.9 0.4 0.2 3.4 0.0 0.0 13.0 2.8 1.1 0.1 0.0 0.2 9.2 15.1 1.2 0.8 55.9 0.6 0.9 0.9 0.8 0.5 10.7 65.8 0.1 1.1 15.2 1.4 2.8 11.7 10.4 0.2 7.1 0.6 0.6 6.4 0.7 14.3 0.2 6.4 2.2 35.0 0.5 3.0 5.1 8.0 5.5 4.7 5.1 1.4 6.3 5.2 2.9 7.2 2.2 7.8 5.0 107.2 76.2 9.0 41.2 33.7 0.0 8.5 25.5 37.5 59.1 1.8 0.0 0.4 0.0 3.5 35.4 7.1 43.2 0.0 1.0 0.9 20.1 71.1 57.9 81.0 36.1 0.0 7.5 3.1 36.2 9.6 0.3 29.9 23.6 39.7 5.7 5.6 4.9 5.3 0.4 12.6 0.2 0.0 27.0 0.2 0.9 26.0 0.8 4.4 11.5 12.5 IL6ST "CD130, GP130" ENSG00000134352 "Interleukin 6 signal transducer" P40189 5 55935095-55994993 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Ito cells: 851.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 21.0" "Lineage enriched" "Detected in many" 5 "T-cells: 21.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 57.7;BJ hTERT+: 58.7;HHSteC: 65.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010558, CAB025784" Approved Supported "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 100000000 "Plasma membrane" "Golgi apparatus" "CAB025784: , HPA010558: AB_1078439" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (3.95e-2)" "unprognostic (8.93e-2)" "unprognostic (3.99e-2)" "unprognostic (5.18e-2)" "unprognostic (9.53e-3)" "unprognostic (1.89e-2)" "unprognostic (2.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (5.05e-4)" "unprognostic (3.69e-2)" "unprognostic (1.06e-1)" "unprognostic (1.80e-1)" "unprognostic (1.25e-1)" 44.8 34.2 24.7 25.5 23.4 8.8 76.9 15.9 22.9 38.1 23.9 15.0 29.0 8.7 26.1 24.9 22.7 23.1 31.1 31.9 21.9 19.7 37.2 71.2 36.3 70.0 25.8 14.7 42.1 16.4 35.8 36.2 97.0 22.5 31.9 17.1 20.0 26.3 33.0 27.1 12.5 20.6 36.6 33.8 35.5 19.7 13.7 20.3 19.4 37.6 12.5 18.7 33.7 51.1 0.7 2.1 0.9 3.8 0.8 21.0 4.0 9.5 11.9 3.9 9.2 27.6 57.7 15.9 28.5 58.7 15.4 22.9 16.7 9.2 0.3 21.4 17.6 35.0 4.1 3.0 8.5 31.6 0.8 3.1 2.2 9.8 13.7 65.6 0.2 4.6 50.5 4.6 33.4 16.3 22.9 35.1 0.8 1.6 40.2 17.7 1.6 0.4 0.4 0.6 1.2 3.9 0.5 10.8 5.5 8.4 5.6 2.1 3.4 11.5 3.8 11.7 10.7 19.2 1.5 56.4 5.9 6.7 24.1 15.0 9.9 4.2 0.3 15.9 0.4 15.5 0.2 3.8 0.1 0.8 3.5 0.4 0.7 4.9 0.8 2.1 0.6 21.0 5.9 0.9 0.8 0.6 1.8 3.4 4.0 24.7 23.4 15.9 22.9 21.9 19.7 25.8 14.7 22.5 20.3 125.0 112.6 23.8 82.7 92.3 54.8 67.9 140.1 99.0 149.0 64.6 33.4 63.8 6.6 64.2 9.5 210.0 31.1 23.3 53.6 60.1 240.2 110.2 31.3 186.2 46.3 15.9 19.0 851.3 103.7 11.5 98.1 51.0 75.9 21.6 29.0 179.7 66.2 30.6 122.7 46.2 33.9 97.0 142.0 37.1 34.3 73.0 85.1 35.0 13.3 89.2 IL7R CD127 ENSG00000168685 "Interleukin 7 receptor" P16871 5 35852695-35879603 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 70.3;intestine: 34.0;lung: 52.6;lymphoid tissue: 133.1" "Group enriched" "Detected in many" 5 "monocytes: 441.0;T-cells: 326.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 19.2;MAIT T-cell: 70.3;memory CD4 T-cell: 39.9;memory CD8 T-cell: 28.0;naive CD4 T-cell: 34.5;naive CD8 T-cell: 22.5;NK-cell: 19.1" "Group enriched" "Detected in many" 33 "NK-cells: 19.1;T-cells: 70.3" "Cell line enhanced" "Detected in many" "BJ: 22.2;BJ hTERT+ SV40 Large T+: 20.1;fHDF/TERT166: 41.6;HBF TERT88: 38.3;REH: 86.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB010215, HPA067550" Supported "Plasma membrane" "Intracellular and membrane" NA NA 180000 "Plasma membrane" "CAB010215: AB_673727, HPA067550: " "unprognostic (2.93e-3)" "unprognostic (3.38e-2)" "unprognostic (3.82e-3)" "unprognostic (5.58e-3)" "unprognostic (3.06e-2)" "unprognostic (1.74e-1)" "unprognostic (2.51e-3)" "unprognostic (5.53e-2)" "unprognostic (1.12e-1)" "unprognostic (9.29e-3)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (1.76e-2)" "unprognostic (5.64e-2)" "unprognostic (3.27e-3)" "unprognostic (2.22e-1)" "unprognostic (1.78e-1)" 6.7 3.6 0.7 34.0 0.7 3.1 4.8 0.5 0.6 4.8 20.6 0.3 0.9 3.5 1.8 2.9 6.6 3.7 8.5 1.9 0.7 0.7 7.0 2.7 52.6 133.1 0.8 0.1 2.5 1.7 0.0 1.5 1.2 0.8 3.3 5.4 1.7 13.2 1.8 0.9 1.8 34.0 1.2 1.5 32.3 7.8 3.0 0.4 130.9 5.1 5.3 42.9 12.6 4.6 0.4 0.3 1.3 0.2 19.1 70.3 12.7 0.1 0.0 0.1 0.1 0.1 0.1 0.2 22.2 11.2 20.1 11.9 0.1 0.1 2.1 0.0 41.6 3.7 3.5 0.0 1.3 38.3 1.8 0.2 0.6 2.4 0.0 0.3 0.2 1.6 0.3 0.0 4.3 0.9 0.5 0.5 0.1 0.1 0.3 15.7 0.0 0.5 0.2 0.1 0.0 1.0 86.5 1.2 0.1 0.0 1.2 0.0 0.0 3.7 0.3 0.0 0.1 0.1 0.0 1.5 7.9 13.4 3.4 2.9 0.2 0.0 2.5 4.0 2.1 6.1 0.5 0.2 0.1 19.2 0.2 70.3 0.2 39.9 28.0 0.1 0.4 34.5 22.5 1.3 19.1 0.2 0.3 6.7 12.7 0.7 0.7 0.5 0.6 0.7 0.7 0.8 0.1 0.8 0.4 14.9 19.4 10.9 1.9 10.3 0.0 3.2 0.0 10.7 4.5 0.0 0.0 0.1 0.0 0.9 0.1 3.6 0.0 23.3 1.6 0.1 7.1 1.1 18.5 4.5 10.4 0.0 0.0 17.8 12.7 0.0 0.0 79.7 20.3 441.0 0.0 0.0 0.2 0.9 0.0 0.6 0.0 0.0 9.0 0.0 0.0 9.2 0.2 326.6 0.0 3.8 IL9R CD129 ENSG00000124334 "Interleukin 9 receptor" Q01113 X 155997581-156010817 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.3;urinary bladder: 10.9" "Cell type enriched" "Detected in some" 4 "granulocytes: 4.6" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.4" "Group enriched" "Detected in some" 6 "basal ganglia: 1.7;pons and medulla: 4.7;thalamus: 1.5" "Cell type enhanced" "Detected in many" "eosinophil: 6.3" "Group enriched" "Detected in many" 25 "B-cells: 4.1;granulocytes: 6.3;T-cells: 2.4" "Cell line enriched" "Detected in some" 11 "HMC-1: 76.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA063240, HPA064557" Approved "Intracellular and membrane" NA NA "HPA063240: AB_2732700, HPA064557: AB_2732716" "unprognostic (1.07e-2)" "unprognostic (3.27e-3)" "unprognostic (9.52e-3)" "unprognostic (4.13e-2)" "unprognostic (7.35e-2)" "unprognostic (3.26e-4)" "unprognostic (8.94e-2)" "unprognostic (3.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.82e-1)" "unprognostic (2.90e-2)" "unprognostic (2.04e-1)" "unprognostic (3.98e-8)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (4.07e-1)" "prognostic favorable (1.90e-7)" 0.3 0.1 0.3 1.1 1.7 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.7 3.0 0.3 0.5 0.4 0.9 0.3 0.3 0.2 0.3 0.5 1.3 3.2 0.3 0.3 0.3 0.3 0.0 0.3 0.3 4.7 0.4 1.2 0.3 0.4 0.3 0.3 0.4 2.4 0.3 0.3 3.5 0.8 0.3 1.5 0.3 0.4 0.3 2.9 10.9 0.3 4.1 0.0 6.3 0.0 0.1 2.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 7.0 0.0 0.0 0.0 0.1 76.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.0 0.2 0.0 0.3 2.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 1.8 0.8 1.3 0.0 4.1 0.0 0.0 1.8 0.1 0.0 0.0 2.4 0.3 0.3 1.7 0.4 0.3 0.3 0.2 0.3 0.3 4.7 1.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 ILDR1 "DFNB42, MGC50831" ENSG00000145103 "Immunoglobulin like domain containing receptor 1" Q86SU0 3 121987323-122022258 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 28.9;seminal vesicle: 27.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 11.9;Ciliated cells: 13.4;Club cells: 11.4;Collecting duct cells: 19.2;Cytotrophoblasts: 12.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.7;HDLM-2: 9.8;MCF7: 6.1;RT4: 9.1;T-47d: 6.5;U-266/70: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA018207 Approved "Intracellular and membrane" NA NA "HPA018207: AB_1851742" "unprognostic (2.69e-1)" "unprognostic (1.28e-2)" "unprognostic (9.24e-2)" "unprognostic (4.46e-3)" "unprognostic (9.73e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-2)" "unprognostic (2.80e-2)" "unprognostic (2.00e-1)" "unprognostic (2.04e-1)" "unprognostic (7.78e-2)" "unprognostic (2.37e-1)" "prognostic favorable (5.79e-9)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "unprognostic (3.25e-3)" "unprognostic (2.21e-2)" 0.3 1.5 0.3 0.7 0.4 0.0 1.8 0.3 0.3 8.6 5.6 0.3 28.9 2.0 1.6 17.2 5.9 3.4 4.7 0.3 0.3 0.2 8.0 0.4 2.9 0.3 0.3 0.3 0.9 16.5 14.8 4.1 2.6 0.4 4.9 5.0 1.3 10.6 27.8 0.3 1.7 2.4 0.3 0.3 1.1 0.3 1.5 0.3 0.9 5.1 1.9 3.7 5.6 1.6 5.1 0.5 1.5 0.7 0.1 1.0 0.4 3.4 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 7.7 1.4 0.1 0.0 0.1 1.2 0.0 0.0 0.0 9.8 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 6.1 0.0 0.1 0.1 1.4 0.0 0.0 0.1 2.8 3.5 9.1 0.4 0.1 0.0 0.9 0.1 0.2 6.5 0.0 0.0 0.0 0.0 0.0 0.1 7.5 1.6 1.4 0.0 0.2 0.1 0.6 0.7 0.1 0.2 0.4 0.2 5.1 0.2 0.3 0.5 3.4 0.4 0.3 1.5 0.1 0.2 0.4 1.0 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.4 0.3 11.9 6.1 0.0 0.5 0.0 0.0 0.4 2.5 13.4 11.4 19.2 0.0 12.1 1.7 6.0 0.2 0.0 3.9 0.0 3.3 0.4 0.0 3.0 0.0 0.0 1.1 0.0 3.4 0.0 0.6 0.0 0.0 0.0 1.7 0.0 7.6 0.0 3.1 7.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.5 4.2 0.0 6.9 2.8 ILDR2 C1orf32 ENSG00000143195 "Immunoglobulin like domain containing receptor 2" Q71H61 1 166895711-166975482 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;testis: 18.0" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 116.0" "Cancer enhanced" "Detected in some" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.7;JURKAT: 7.4;MOLT-4: 5.1;U-2 OS: 12.5;U-251 MG: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012545, HPA012815" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA012545: AB_2126894, HPA012815: " "unprognostic (9.14e-2)" "unprognostic (5.05e-2)" "unprognostic (8.27e-2)" "unprognostic (2.16e-1)" "unprognostic (5.89e-2)" "unprognostic (5.33e-2)" "unprognostic (2.89e-5)" "unprognostic (2.09e-1)" "unprognostic (8.55e-2)" "unprognostic (4.51e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (9.17e-2)" "unprognostic (5.87e-3)" "unprognostic (4.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 0.8 1.1 9.8 0.9 6.4 1.4 0.5 2.1 14.6 0.7 2.9 3.6 0.1 0.7 0.9 1.4 0.9 0.8 1.3 3.1 7.2 7.7 6.3 1.3 1.4 1.0 2.7 8.0 0.8 0.7 0.5 3.3 0.8 3.1 2.3 1.2 2.8 0.8 2.8 0.8 0.7 0.8 2.0 2.3 0.7 0.7 18.0 3.1 1.9 0.9 0.0 1.1 0.9 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.5 0.0 0.0 9.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 1.0 1.8 0.3 0.0 0.4 0.0 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.2 0.0 3.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.1 0.2 0.0 5.1 0.0 3.3 0.1 0.0 0.0 0.3 0.7 0.7 0.2 1.3 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.0 0.0 12.5 0.0 6.6 2.3 0.0 0.5 1.4 1.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.5 9.8 6.4 2.1 11.4 7.2 7.7 2.7 8.0 3.1 3.1 0.0 0.0 0.0 0.0 0.0 3.9 3.2 0.0 0.0 1.2 0.0 5.9 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.1 1.6 1.2 0.0 0.0 13.8 0.6 0.0 0.0 1.0 0.0 116.0 0.1 0.0 0.0 4.6 6.5 0.0 0.1 3.3 1.3 0.0 0.2 0.0 0.2 0.0 ILVBL "209L8, AHAS, FLJ39061, HACL1L, ILV2H, MGC1269, MGC19535" ENSG00000105135 "IlvB acetolactate synthase like" A1L0T0 19 15114984-15125785 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Syncytiotrophoblasts: 211.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067682 Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA067682: AB_2685885" "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (8.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.04e-2)" "unprognostic (2.53e-1)" "unprognostic (3.83e-1)" "unprognostic (5.60e-2)" "unprognostic (1.77e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.91e-8)" "unprognostic (4.65e-2)" "unprognostic (1.68e-1)" "unprognostic (1.40e-1)" "unprognostic (2.40e-1)" 13.7 22.1 10.4 8.3 13.6 7.7 12.1 12.4 18.9 11.5 34.9 21.3 16.7 29.1 13.4 11.1 18.9 13.8 24.8 32.9 10.5 9.7 24.9 34.8 10.0 13.2 18.5 9.2 15.9 24.7 21.1 16.5 35.9 14.0 11.1 11.0 29.4 16.1 14.9 10.0 19.4 26.8 10.9 14.3 8.3 18.2 14.7 17.7 10.0 28.6 16.7 12.2 14.8 14.5 9.8 17.5 10.8 20.7 15.3 16.9 15.1 22.1 13.5 11.6 13.6 15.1 10.3 13.4 10.4 14.1 12.6 16.2 21.4 53.9 9.6 20.7 11.2 7.6 16.8 7.0 12.7 3.7 8.9 13.7 14.1 13.8 23.3 24.3 11.9 12.5 15.4 14.8 7.3 9.6 10.3 11.7 9.9 5.7 12.6 9.8 51.4 7.9 9.5 10.7 17.8 19.6 11.6 10.5 15.1 10.9 11.0 9.6 13.0 6.2 27.2 20.5 4.6 12.4 10.2 12.4 19.1 10.6 23.9 14.6 8.8 9.0 4.7 12.2 11.6 14.3 10.8 14.8 3.5 15.1 20.7 16.9 8.6 12.6 15.4 17.5 9.8 16.7 16.9 1.6 15.3 18.7 12.7 12.9 15.1 10.4 13.6 12.4 18.9 10.5 9.7 18.5 9.2 14.0 17.7 23.8 9.4 11.1 19.4 11.3 90.9 28.8 58.6 12.0 9.1 24.4 25.5 78.0 16.6 40.3 3.8 18.0 81.6 23.3 44.3 120.6 15.5 17.9 10.5 49.9 38.6 17.5 42.7 27.0 9.5 3.6 23.9 17.3 79.2 3.6 49.3 51.2 27.7 53.4 18.7 43.1 30.2 19.4 19.4 15.8 19.9 14.2 211.9 12.1 65.7 20.4 IMPAD1 "FLJ20421, gPAPP, IMPA3" ENSG00000104331 "Inositol monophosphatase domain containing 1" Q9NX62 8 56957933-56993844 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009411 Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 560000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA009411: AB_1079138" "unprognostic (1.62e-2)" "unprognostic (7.89e-3)" "unprognostic (6.58e-2)" "unprognostic (6.42e-2)" "unprognostic (2.00e-1)" "unprognostic (8.59e-2)" "unprognostic (1.88e-1)" "unprognostic (1.67e-2)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (4.24e-3)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (1.68e-3)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" 30.6 33.9 17.8 13.9 23.7 9.6 17.6 23.6 33.1 24.7 17.7 30.9 17.8 11.7 23.2 15.2 17.7 15.6 18.0 25.2 19.9 21.6 21.3 32.6 16.5 10.3 23.6 21.1 16.0 25.2 30.4 20.4 23.3 27.2 28.8 16.2 25.2 28.7 22.5 41.4 13.4 12.3 23.0 21.7 13.0 14.7 19.0 19.5 12.0 24.4 18.1 13.0 17.2 14.9 1.9 2.0 6.1 4.6 6.8 2.4 0.6 17.4 14.5 11.2 11.5 34.5 23.7 15.4 26.6 25.9 19.1 16.7 7.2 12.5 10.9 20.4 28.2 13.6 14.3 13.5 17.9 28.4 15.0 9.7 21.3 10.3 12.9 21.5 13.5 15.2 19.0 18.0 17.1 27.8 17.7 25.3 10.3 9.1 19.9 20.9 9.3 16.4 8.1 8.3 20.0 5.4 11.5 10.1 12.3 19.8 10.4 4.3 12.2 14.9 18.4 15.1 12.3 16.4 9.9 21.1 25.9 14.9 25.5 19.0 20.5 17.1 11.7 35.4 11.3 15.8 2.9 1.9 1.1 2.0 1.2 1.6 1.3 1.3 1.2 1.4 1.9 1.5 2.4 6.1 6.8 4.6 2.0 0.9 0.6 17.8 23.7 23.6 33.1 19.9 21.6 23.6 21.1 27.2 19.5 20.8 18.6 9.0 24.5 48.3 29.9 43.1 25.5 8.1 12.5 45.4 15.7 15.1 5.0 17.1 13.5 27.0 19.0 0.0 23.5 68.2 45.0 43.5 9.2 61.6 24.1 38.1 33.4 38.1 25.6 4.2 23.6 23.8 15.1 5.4 33.4 25.1 24.0 17.5 33.6 16.8 27.4 32.3 38.9 34.6 22.2 52.2 28.3 14.9 16.0 33.9 IMPG2 "IPM200, RP56" ENSG00000081148 "Interphotoreceptor matrix proteoglycan 2" Q9BZV3 3 101222546-101320560 "Disease related genes, Predicted membrane proteins" "Heparin-binding, Receptor" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 72.1" "Group enriched" "Detected in some" 29 "Cone photoreceptor cells: 486.9;Rod photoreceptor cells: 298.9" "Cancer enriched" "Detected in single" 12 "ovarian cancer: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008779, HPA015907" Enhanced NA NA "HPA008779: AB_2668138, HPA015907: AB_2669323" "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.40e-1)" "unprognostic (9.58e-3)" "unprognostic (1.28e-1)" "unprognostic (4.80e-5)" "unprognostic (6.66e-4)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (6.59e-2)" "unprognostic (7.51e-3)" "unprognostic (1.28e-1)" "unprognostic (4.50e-9)" "unprognostic (7.12e-2)" "unprognostic (2.70e-1)" "unprognostic (2.81e-2)" "unprognostic (6.08e-2)" 0.2 0.3 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.1 0.1 0.3 0.3 0.1 16.5 0.2 0.3 0.3 0.6 0.3 0.1 0.1 0.4 0.5 0.1 0.4 0.2 0.1 0.4 0.1 0.4 0.2 0.2 72.1 0.2 0.1 0.2 0.2 0.4 0.3 0.2 0.6 0.5 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.6 0.1 1.0 0.1 1.1 0.3 0.0 0.1 0.0 1.1 1.3 0.4 1.0 0.1 0.1 0.2 0.3 0.5 0.0 0.1 0.1 1.0 0.1 0.4 0.0 0.3 0.1 1.1 0.4 0.3 0.6 0.4 0.1 0.1 0.3 2.0 1.3 0.7 0.2 0.0 0.6 1.8 0.2 0.0 1.2 0.9 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.7 0.3 1.6 0.2 0.0 0.0 0.1 0.8 0.2 0.4 1.4 1.2 0.6 0.4 0.7 0.6 1.1 0.2 0.0 0.0 1.2 0.6 0.1 0.3 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.3 1.0 1.1 0.1 0.1 0.1 0.0 0.2 0.4 0.2 0.2 0.3 0.6 0.5 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 13.2 0.6 0.0 0.0 0.0 0.0 486.9 0.0 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.3 0.0 0.6 0.0 0.0 1.8 0.0 13.7 0.1 0.0 0.7 0.0 298.9 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 INAFM1 PRR24 ENSG00000257704 "InaF motif containing 1" C9JVW0 19 47274453-47275707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 71.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 24.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064015 Uncertain NA NA "HPA064015: AB_2685177" "unprognostic (3.88e-2)" "unprognostic (8.88e-3)" "prognostic unfavorable (3.20e-5)" "unprognostic (7.46e-2)" "unprognostic (1.48e-1)" "unprognostic (1.15e-2)" "unprognostic (3.60e-1)" "unprognostic (2.32e-1)" "unprognostic (3.57e-2)" "unprognostic (1.31e-1)" "unprognostic (2.22e-2)" "unprognostic (9.99e-2)" "prognostic unfavorable (3.04e-4)" "unprognostic (3.52e-2)" "unprognostic (2.02e-1)" "unprognostic (4.03e-1)" "unprognostic (4.36e-3)" 20.8 31.0 9.1 11.3 8.1 10.1 13.0 19.8 23.3 15.4 15.0 4.5 4.1 9.4 17.3 13.5 10.0 13.2 16.4 10.2 10.5 9.8 8.8 7.4 11.4 22.9 6.4 8.7 22.3 13.9 7.1 9.9 17.9 22.1 14.7 4.8 5.2 10.5 10.9 18.6 13.2 9.9 13.1 7.1 12.4 11.1 10.2 2.7 15.4 10.2 4.9 5.5 15.3 13.2 4.0 6.5 24.0 6.3 1.0 2.9 2.8 7.2 6.8 5.1 7.8 1.5 4.4 3.5 9.6 2.3 3.1 3.9 3.8 3.0 3.5 2.6 4.3 3.0 4.9 1.1 2.9 0.8 7.6 7.4 5.8 4.4 4.9 7.7 4.2 8.8 5.9 5.2 3.4 2.9 2.6 1.3 4.0 7.7 7.8 1.3 11.7 3.0 25.2 1.7 6.9 5.5 5.2 2.7 2.8 2.3 4.8 3.6 4.9 10.2 2.4 3.7 1.6 4.1 4.0 4.0 4.2 6.6 2.4 4.7 3.7 3.0 3.3 7.9 3.0 3.6 3.5 6.3 13.9 1.3 4.3 1.0 4.0 1.5 1.8 5.4 3.5 2.9 2.0 24.0 1.0 5.3 6.5 1.9 2.8 9.1 8.1 19.8 23.3 10.5 9.8 6.4 8.7 22.1 2.7 8.9 9.5 2.2 37.1 0.0 16.4 7.0 12.7 1.4 6.8 10.4 9.8 14.6 16.6 9.1 9.8 10.9 15.5 23.3 10.7 12.3 5.1 28.7 1.1 11.5 8.9 3.2 7.0 11.1 15.7 17.0 57.2 4.2 0.0 2.8 15.1 5.5 9.7 17.5 24.4 11.9 51.0 45.3 71.3 6.9 8.3 0.0 23.1 3.2 15.9 43.0 INAFM2 "LINC00984, OGU1" ENSG00000259330 "InaF motif containing 2" P0DMQ5 15 40323664-40326715 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 24.1" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 16.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 5.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.5;granulocytes: 5.8;monocytes: 2.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.03e-2)" "unprognostic (2.66e-1)" "unprognostic (1.68e-2)" "unprognostic (5.59e-2)" "unprognostic (9.05e-2)" "unprognostic (8.01e-3)" "unprognostic (2.43e-2)" "prognostic favorable (7.87e-4)" "unprognostic (1.23e-1)" "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (2.07e-2)" "prognostic unfavorable (1.88e-7)" "prognostic unfavorable (5.01e-4)" "unprognostic (2.35e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" 4.6 3.2 3.7 3.6 3.1 4.0 2.2 2.3 6.4 2.7 12.1 3.5 10.4 2.2 3.8 2.7 4.6 6.0 24.1 12.2 4.6 2.1 2.2 4.5 1.5 2.5 3.5 5.5 4.5 5.6 2.4 7.4 4.2 5.6 5.7 3.8 4.7 10.7 3.8 0.5 6.3 7.4 3.8 4.7 2.9 3.8 2.6 0.6 15.7 0.8 1.9 6.1 5.5 0.6 2.5 5.8 2.4 0.2 0.5 1.5 8.8 0.8 8.3 5.2 7.2 3.5 19.2 11.2 5.6 8.9 7.4 3.3 1.8 0.7 9.9 6.1 5.3 20.3 12.9 13.2 12.6 2.6 4.3 24.0 3.3 1.8 9.3 12.7 17.1 9.2 4.9 3.3 9.4 13.2 9.2 6.3 12.9 19.5 12.5 1.2 3.7 10.2 6.1 6.9 6.9 1.9 10.0 21.3 6.5 10.3 17.9 7.1 4.0 4.8 3.8 14.9 4.6 15.9 11.9 12.4 9.2 6.2 8.0 5.1 1.2 2.3 9.2 20.9 11.8 1.4 2.4 5.8 0.3 2.3 0.2 0.6 0.3 0.1 1.3 0.1 0.0 0.3 1.8 0.2 2.3 2.5 0.5 1.5 0.0 3.0 0.9 0.9 0.0 5.9 12.3 7.6 2.7 1.2 3.5 3.9 2.5 0.0 1.8 11.0 3.5 0.5 0.0 2.1 0.4 1.3 2.4 1.1 2.4 16.3 7.9 2.4 13.5 12.0 2.1 1.1 7.6 0.0 1.0 1.9 5.8 2.1 0.0 4.6 0.7 4.5 0.0 1.6 9.2 3.6 0.0 1.1 0.0 1.3 2.6 INPP4A INPP4 ENSG00000040933 "Inositol polyphosphate-4-phosphatase type I A" Q96PE3 2 98444854-98594390 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 46.8;Kupffer cells: 37.8;T-cells: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 34.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001628 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA001628: AB_10961254" "unprognostic (3.45e-1)" "unprognostic (2.39e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (3.70e-6)" "unprognostic (1.58e-1)" "unprognostic (3.10e-2)" "unprognostic (1.15e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-2)" "unprognostic (1.23e-1)" "unprognostic (9.65e-2)" "unprognostic (3.70e-2)" "unprognostic (2.90e-2)" "unprognostic (4.89e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (1.97e-2)" 9.0 15.0 11.4 13.5 23.1 12.3 7.0 24.0 28.4 7.5 8.5 8.3 3.8 7.7 8.2 5.7 8.4 6.7 11.0 10.8 12.9 7.8 8.1 7.2 13.5 17.0 6.1 19.8 8.3 8.2 12.7 7.0 8.6 17.9 6.8 8.6 16.1 9.3 7.2 13.6 7.3 12.1 10.5 10.4 24.0 8.4 6.4 6.8 17.6 8.4 2.7 13.4 16.8 6.9 0.8 5.9 3.8 5.1 5.8 6.4 1.8 6.4 5.4 10.0 8.0 5.7 6.5 10.0 5.6 5.0 6.0 6.2 6.9 5.7 4.1 6.4 8.2 7.3 6.0 7.1 5.5 4.9 13.7 6.1 4.8 4.9 3.2 5.1 9.1 17.8 5.8 5.2 5.7 5.1 5.1 8.4 23.3 4.4 34.2 4.4 7.8 13.8 8.1 9.4 3.6 5.3 6.0 7.0 26.7 2.9 19.8 6.6 8.6 6.4 5.2 5.1 10.7 2.4 7.3 7.9 7.0 8.9 5.5 3.8 24.3 14.1 2.8 5.7 8.7 6.0 2.0 1.8 3.8 5.5 3.9 6.4 0.8 3.1 3.7 1.9 0.2 4.3 4.9 2.0 5.8 5.1 5.9 1.6 1.8 11.4 23.1 24.0 28.4 12.9 7.8 6.1 19.8 17.9 6.8 6.0 9.6 10.0 4.7 7.1 46.8 10.5 2.5 0.0 10.3 5.2 7.9 7.2 3.3 3.9 12.8 10.1 1.7 0.0 1.3 6.6 7.2 4.6 0.0 3.2 9.0 31.8 5.2 14.7 37.8 5.4 8.6 17.7 10.1 4.6 5.4 9.2 3.8 3.4 11.3 2.2 13.8 6.5 9.0 9.7 11.2 5.4 7.9 39.8 3.5 5.4 INPP4B ENSG00000109452 "Inositol polyphosphate-4-phosphatase type II B" O15327 4 142023160-142847432 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 163.6;Late spermatids: 196.7;Sertoli cells: 84.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 19.2" "Group enriched" "Detected in many" 6 "NK-cells: 9.1;T-cells: 19.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 52.6;SK-MEL-30: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037681, HPA037682" Approved Approved Centrosome NA NA Centrosome "HPA037681: AB_10670389, HPA037682: AB_10671377" "unprognostic (9.79e-2)" "unprognostic (1.11e-1)" "unprognostic (1.95e-1)" "unprognostic (9.25e-2)" "unprognostic (1.77e-1)" "unprognostic (8.24e-2)" "unprognostic (3.03e-3)" "unprognostic (5.76e-3)" "unprognostic (1.95e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (8.58e-2)" "unprognostic (1.26e-2)" "unprognostic (2.79e-2)" "unprognostic (1.30e-1)" "unprognostic (4.58e-1)" "unprognostic (1.39e-2)" 15.4 4.7 8.4 8.5 12.5 2.2 21.2 5.1 10.3 28.1 7.1 1.8 5.6 5.0 19.7 18.4 9.1 9.2 8.7 18.4 5.9 6.1 6.1 2.0 9.9 10.8 5.5 8.9 15.4 4.0 2.3 3.8 6.2 4.6 8.3 5.8 1.7 4.9 6.8 10.8 4.7 7.3 10.2 3.1 7.0 7.0 19.6 2.4 8.2 6.5 4.9 7.4 15.8 14.6 0.0 0.0 2.2 0.1 9.1 19.2 3.7 9.3 3.9 2.6 1.2 2.0 1.2 0.5 11.3 13.3 2.9 5.5 1.0 52.6 0.2 3.2 10.1 4.5 14.3 0.0 13.2 6.9 0.0 0.4 2.2 1.5 0.0 0.6 0.4 1.8 2.1 1.8 2.0 7.0 8.8 1.6 0.0 0.0 0.5 6.3 16.7 0.3 0.0 0.1 5.7 2.8 0.1 8.7 0.4 4.0 17.4 0.2 0.2 1.3 4.0 23.4 1.6 12.0 1.6 1.0 6.7 8.2 9.9 0.1 0.1 0.0 0.0 1.5 10.3 17.4 2.2 0.1 0.0 3.3 0.0 6.5 0.0 19.2 8.5 0.0 0.0 13.2 5.7 0.2 9.1 0.0 0.0 9.8 3.7 8.4 12.5 5.1 10.3 5.9 6.1 5.5 8.9 4.6 2.4 0.0 1.1 0.0 9.8 6.0 7.3 36.2 7.6 17.4 9.1 8.7 0.0 1.4 5.0 12.2 163.6 10.8 8.4 0.0 26.9 3.9 4.1 13.4 5.8 0.0 6.2 6.4 8.5 3.7 4.4 196.7 12.7 1.9 69.2 0.0 3.4 0.8 47.4 0.0 6.0 0.8 0.6 84.1 43.7 3.1 2.0 2.3 1.6 16.6 3.4 41.0 INSIG1 "CL-6, MGC1405" ENSG00000186480 "Insulin induced gene 1" O15503 7 155297776-155310235 "Plasma proteins, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.4;liver: 143.2" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 494.0" "Cancer enhanced" "Detected in all" "liver cancer: 142.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "intermediate monocyte: 45.7;non-classical monocyte: 81.4" "Lineage enriched" "Detected in all" 6 "monocytes: 81.4" "Cell line enhanced" "Detected in many" "Karpas-707: 155.1;RPMI-8226: 72.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071524 Uncertain Vesicles NA NA Vesicles "HPA071524: " "unprognostic (8.11e-2)" "unprognostic (3.22e-1)" "unprognostic (2.91e-1)" "unprognostic (1.47e-1)" "unprognostic (9.23e-2)" "unprognostic (3.83e-2)" "unprognostic (2.05e-2)" "unprognostic (3.06e-1)" "unprognostic (1.60e-2)" "unprognostic (1.52e-1)" "unprognostic (4.64e-2)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (9.62e-4)" "unprognostic (4.97e-2)" 18.4 9.2 8.5 8.3 8.8 9.7 14.1 10.1 14.3 6.0 7.4 21.8 7.5 12.5 5.2 8.3 15.6 4.6 8.0 5.6 10.8 11.6 6.4 143.2 18.5 6.9 8.6 8.3 16.4 27.2 4.6 5.2 17.5 23.9 15.9 6.7 11.9 31.4 3.1 2.4 10.5 14.2 5.1 19.2 4.5 13.4 8.2 8.3 10.7 3.3 6.1 6.9 11.2 5.6 10.0 13.6 10.7 81.4 4.0 12.7 12.5 19.2 3.6 9.6 6.0 25.4 34.0 5.2 1.5 22.0 4.6 30.7 2.2 28.0 12.6 4.5 11.9 35.9 10.4 6.5 11.4 5.5 3.8 19.2 3.4 6.6 0.0 12.5 5.8 57.0 21.1 6.3 35.5 3.3 3.4 6.1 25.1 6.3 155.1 5.9 10.0 28.5 15.4 10.0 3.6 2.2 5.3 0.0 72.7 36.3 9.6 7.2 5.6 5.1 3.7 8.1 3.7 3.6 19.6 6.9 5.1 1.5 9.6 4.0 37.8 6.6 11.2 22.6 22.8 4.7 3.1 4.9 2.1 8.7 45.7 4.4 7.7 6.0 7.4 13.6 10.0 5.9 6.7 10.7 4.0 81.4 7.7 12.7 12.5 8.5 8.8 10.1 14.3 10.8 11.6 8.6 8.3 23.9 8.3 38.7 98.0 59.2 52.4 124.6 12.6 22.7 28.1 48.2 35.2 38.4 9.8 43.4 14.9 38.4 16.5 50.6 41.6 0.0 120.7 153.6 37.0 96.2 61.0 494.0 42.6 36.5 121.5 36.2 57.7 5.6 14.7 90.2 234.5 28.9 44.4 73.4 47.8 10.5 17.3 8.4 17.2 19.4 86.4 38.0 53.2 135.8 109.0 47.3 19.0 105.7 INSIG2 ENSG00000125629 "Insulin induced gene 2" Q9Y5U4 2 118088452-118110997 "Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033861 Uncertain NA NA "CAB033861: AB_2249149" "unprognostic (3.84e-3)" "unprognostic (4.54e-3)" "unprognostic (1.84e-1)" "unprognostic (7.00e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (7.10e-4)" "unprognostic (1.80e-1)" "unprognostic (7.30e-2)" "unprognostic (7.41e-2)" "unprognostic (2.37e-1)" "prognostic unfavorable (2.19e-6)" "unprognostic (2.40e-1)" "prognostic unfavorable (4.11e-6)" "unprognostic (1.40e-1)" "unprognostic (2.65e-1)" "unprognostic (1.42e-1)" "unprognostic (3.75e-2)" 12.3 8.2 14.3 7.1 16.5 3.2 13.5 24.4 22.5 10.0 9.6 8.9 7.8 11.6 12.1 16.8 8.1 8.3 9.4 11.0 12.2 10.6 16.0 38.6 12.9 10.2 12.0 13.1 11.8 14.5 16.9 15.8 11.0 17.5 11.8 8.3 8.9 9.4 10.1 8.8 12.1 14.7 10.1 13.9 14.1 13.5 7.3 11.6 18.5 13.2 1.8 9.6 10.0 9.8 11.8 11.4 17.5 17.6 15.4 15.4 9.2 23.6 4.2 6.4 2.7 16.4 8.1 7.0 6.7 7.3 5.4 9.5 3.9 22.8 4.6 22.6 8.5 8.4 8.8 4.8 11.2 10.1 8.7 5.8 4.4 5.5 26.9 6.3 5.5 7.2 12.8 10.2 4.9 11.5 18.0 12.5 7.0 2.4 8.7 8.8 2.5 7.0 7.4 3.1 6.7 5.9 4.6 5.5 5.0 12.3 7.4 5.1 6.8 3.9 6.9 3.8 7.4 3.5 5.4 13.3 6.8 4.9 6.1 3.4 16.1 8.6 4.2 13.8 4.4 4.4 10.2 10.3 17.5 11.9 15.2 13.9 11.8 13.0 11.4 11.4 10.8 14.2 15.4 10.8 15.4 17.6 10.6 11.6 9.2 14.3 16.5 24.4 22.5 12.2 10.6 12.0 13.1 17.5 11.6 32.8 21.6 20.4 11.6 36.4 15.1 17.3 48.4 10.7 15.9 41.8 11.8 16.4 16.6 75.4 3.4 16.9 14.9 23.3 54.3 27.8 15.5 20.7 20.7 37.6 24.9 23.8 20.1 42.4 24.1 2.5 11.8 21.4 30.4 24.4 13.2 17.1 69.7 11.0 13.4 23.7 11.5 0.0 31.1 33.8 14.3 35.0 16.6 21.4 12.3 13.3 INSL3 "MGC119818, MGC119819, RLF, RLNL" ENSG00000248099 "Insulin like 3" P51460 19 17816512-17821574 "Disease related genes, Predicted secreted proteins" Hormone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 234.1" "Group enriched" "Detected in some" 68 "Leydig cells: 1148.3;Peritubular cells: 938.7" "Cancer enriched" "Detected in many" 21 "testis cancer: 39.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 8.9;PC-3: 4.1;SCLC-21H: 8.2;SH-SY5Y: 7.4" HPA028615 Enhanced "Secreted to blood" NA NA 566000 "HPA028615: AB_10600717" "unprognostic (3.25e-1)" "unprognostic (2.25e-4)" "unprognostic (3.50e-5)" "unprognostic (7.04e-2)" "unprognostic (1.74e-4)" "unprognostic (4.60e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.44e-1)" "unprognostic (1.73e-1)" "unprognostic (4.46e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-10)" "unprognostic (6.80e-3)" "unprognostic (1.41e-1)" "unprognostic (8.85e-2)" "unprognostic (1.09e-5)" 0.1 0.4 0.1 1.1 0.2 0.3 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.3 0.1 1.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.1 9.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 1.1 0.1 234.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 2.4 0.3 5.7 1.2 1.3 2.9 1.1 0.4 1.0 0.2 0.8 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.1 1.7 0.2 2.3 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.1 0.7 0.0 0.3 0.0 0.1 2.0 1.3 0.9 0.0 0.0 0.0 0.0 0.2 0.1 8.9 0.0 1.6 0.3 1.6 0.0 1.7 4.1 1.3 0.0 0.2 0.2 0.5 8.2 7.4 0.1 2.5 0.0 0.1 0.7 0.0 0.0 0.0 0.0 2.2 0.0 0.7 3.1 0.2 0.1 2.0 0.0 0.8 0.5 0.0 1.8 1.2 1.8 0.3 2.4 2.3 0.3 2.4 2.1 2.9 5.7 1.3 0.3 0.3 2.0 1.1 0.1 0.2 0.2 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 15.4 1148.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 938.7 0.0 0.0 0.0 0.0 2.6 4.7 0.0 0.5 0.0 0.0 0.0 INSR CD220 ENSG00000171105 "Insulin receptor" P06213 19 7112255-7294034 "CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Carbohydrate metabolism" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 64.5" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 230.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 8.8;granulocytes: 5.1;monocytes: 10.5" "Cell line enhanced" "Detected in many" "Karpas-707: 31.3;U-266/70: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036302, HPA036303" Uncertain Approved "Vesicles,Plasma membrane" NA NA 72000 Vesicles "Plasma membrane" "HPA036302: AB_2675048, HPA036303: " "unprognostic (4.64e-2)" "unprognostic (2.42e-1)" "unprognostic (9.65e-3)" "unprognostic (9.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.15e-2)" "unprognostic (2.58e-1)" "unprognostic (5.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.05e-1)" "unprognostic (9.29e-2)" "unprognostic (1.86e-1)" "unprognostic (6.33e-2)" "unprognostic (3.45e-3)" "unprognostic (2.43e-1)" "unprognostic (2.75e-1)" "unprognostic (8.82e-2)" 13.9 14.7 7.1 3.5 8.2 4.5 12.0 12.0 8.2 10.3 15.2 11.7 10.6 8.4 15.5 6.1 4.7 13.1 7.7 17.7 6.4 5.8 18.7 32.5 5.3 2.2 10.1 4.9 28.3 64.5 11.6 11.6 26.2 8.0 10.5 8.9 11.0 12.0 10.6 15.1 7.3 16.0 10.6 6.8 47.3 8.7 6.9 9.7 2.2 17.1 5.0 3.2 11.3 16.0 1.1 8.8 5.1 10.5 0.8 0.7 1.3 3.8 2.1 2.0 3.0 10.9 3.8 6.5 2.2 2.0 1.2 1.2 5.4 4.4 4.8 5.4 3.9 2.6 1.0 4.7 1.0 0.7 0.0 3.8 0.0 1.5 11.8 4.7 2.2 3.9 5.9 2.4 0.1 2.8 2.4 2.2 2.7 5.9 31.3 0.9 1.7 1.7 3.9 1.8 2.0 3.4 16.7 1.1 4.2 0.1 15.8 3.7 2.9 3.9 2.1 2.1 3.7 1.0 11.0 2.0 2.3 1.4 4.9 2.8 23.1 12.6 11.2 2.6 3.9 0.0 2.0 8.2 5.1 0.2 7.8 0.3 0.8 0.3 0.1 8.8 1.1 0.7 0.1 1.7 0.8 10.5 7.4 0.0 1.3 7.1 8.2 12.0 8.2 6.4 5.8 10.1 4.9 8.0 9.7 44.7 26.7 8.2 54.6 57.7 38.7 85.3 107.0 41.5 50.0 59.3 74.6 15.8 13.3 41.1 2.9 52.3 87.1 0.0 68.2 39.2 29.8 84.0 3.5 214.7 8.6 36.5 157.1 201.3 47.7 3.6 89.2 26.7 49.0 8.2 103.9 26.9 67.8 56.1 230.5 116.2 22.2 58.2 42.3 6.2 1.2 60.1 32.0 6.4 56.3 113.2 INSRR IRR ENSG00000027644 "Insulin receptor related receptor" P14616 1 156840063-156859018 "Enzymes, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.5;brain: 5.9;kidney: 8.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 1.3;Cardiomyocytes: 1.7;Early spermatids: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 5.5;SH-SY5Y: 19.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA025285 Uncertain NA NA "HPA025285: AB_1851814" "unprognostic (1.19e-1)" "unprognostic (7.69e-2)" "unprognostic (2.42e-2)" "unprognostic (6.76e-4)" "unprognostic (1.51e-1)" "unprognostic (9.07e-3)" "unprognostic (5.57e-2)" "unprognostic (1.75e-1)" "unprognostic (6.17e-2)" "unprognostic (5.57e-2)" "unprognostic (2.20e-2)" "unprognostic (7.00e-2)" "unprognostic (4.22e-5)" "unprognostic (2.82e-1)" "unprognostic (9.55e-2)" "unprognostic (2.75e-3)" "unprognostic (3.66e-2)" 0.9 5.5 0.0 0.3 5.9 0.1 0.8 1.9 1.4 1.9 0.1 0.0 0.0 0.1 2.7 0.1 0.1 0.6 0.3 1.9 0.5 1.3 8.3 0.1 0.1 0.4 0.8 0.6 0.3 0.9 0.1 1.7 0.4 5.6 2.7 0.1 2.1 0.6 0.5 0.4 0.1 0.2 0.3 0.0 0.2 3.0 4.2 0.4 0.3 0.3 0.0 0.8 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.5 19.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 1.9 1.4 0.5 1.3 0.8 0.6 5.6 0.4 0.0 0.0 0.0 0.0 0.0 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 INTS14 "C15orf44, DKFZP564O1664, VWA9" ENSG00000138614 "Integrator complex subunit 14" Q96SY0 15 65578753-65611289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 32.4;Extravillous trophoblasts: 24.9;Syncytiotrophoblasts: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040255, HPA040651" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria" No No "Nucleoplasm, Nuclear bodies, Mitochondria" "Nuclear membrane" "HPA040255: AB_10805710, HPA040651: AB_10796559" "unprognostic (2.92e-1)" "unprognostic (3.01e-1)" "unprognostic (2.78e-1)" "unprognostic (2.41e-1)" "unprognostic (4.06e-1)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (5.80e-2)" "unprognostic (5.60e-2)" "unprognostic (2.57e-2)" "unprognostic (2.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.92e-2)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (1.30e-1)" 16.6 20.2 12.1 14.1 14.9 13.1 20.2 12.0 19.1 20.1 20.0 20.8 17.3 12.3 25.5 25.3 19.6 22.3 18.4 12.4 11.3 12.9 22.7 23.2 14.4 17.5 14.1 10.4 20.2 22.0 16.1 23.5 23.5 13.9 18.9 21.6 19.9 27.5 21.7 11.8 17.5 19.9 17.0 11.9 23.5 17.5 19.7 9.9 32.4 26.1 16.1 24.0 17.7 16.2 13.4 13.6 12.9 8.6 14.8 20.3 10.4 12.0 21.9 22.1 17.6 12.3 15.5 14.2 13.3 17.3 22.3 20.6 19.5 28.6 19.8 18.8 16.6 18.5 24.5 47.0 22.4 19.6 17.3 28.5 17.2 16.3 21.1 24.6 17.6 22.2 15.0 22.4 16.9 26.0 16.5 24.1 30.8 23.6 11.6 15.6 19.2 19.9 17.0 16.1 30.6 12.2 17.2 18.6 22.6 17.3 22.6 15.9 12.6 16.1 16.4 22.3 19.7 15.3 20.5 11.8 15.4 16.2 13.7 21.0 11.5 21.3 26.7 15.5 32.2 17.9 12.9 7.5 3.9 14.3 8.6 16.2 13.4 14.8 16.3 13.6 10.5 15.7 14.3 0.8 14.8 6.2 12.0 20.3 10.4 12.1 14.9 12.0 19.1 11.3 12.9 14.1 10.4 13.9 9.9 20.8 7.5 0.0 0.0 0.0 0.0 0.0 0.0 20.1 10.3 12.2 0.0 32.4 18.3 15.6 0.0 0.0 0.0 0.0 13.7 24.9 0.0 0.0 7.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 16.2 0.0 0.0 12.8 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 41.6 0.0 0.0 0.0 ISLR2 KIAA1465 ENSG00000167178 "Immunoglobulin superfamily containing leucine rich repeat 2" Q6UXK2 15 74100311-74138540 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;testis: 11.6" "Group enriched" "Detected in some" 7 "Early spermatids: 48.2;Late spermatids: 45.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "SCLC-21H: 27.5;SH-SY5Y: 41.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012930, HPA067333" Uncertain NA NA 66000 "HPA012930: AB_2668772, HPA067333: AB_2685824" "unprognostic (1.31e-2)" "unprognostic (3.27e-3)" "unprognostic (1.44e-2)" "unprognostic (8.65e-3)" "unprognostic (1.53e-3)" "unprognostic (7.73e-2)" "unprognostic (6.64e-2)" "unprognostic (1.46e-2)" "unprognostic (9.19e-3)" "unprognostic (1.72e-1)" "unprognostic (2.94e-2)" "unprognostic (2.46e-1)" "unprognostic (2.44e-4)" "unprognostic (1.31e-2)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" 1.6 2.1 7.5 1.0 16.8 0.4 1.5 2.0 25.9 2.4 1.2 0.1 0.0 1.1 3.9 0.6 1.2 2.0 1.6 6.3 3.5 4.8 0.5 0.5 1.2 2.6 0.7 7.2 0.6 1.3 1.3 0.6 0.6 1.7 0.7 0.9 3.0 0.9 1.1 3.0 1.0 2.0 1.8 0.3 1.5 1.0 11.6 3.4 0.0 0.7 2.1 0.6 0.9 0.4 1.1 0.9 2.5 0.7 0.5 0.4 0.2 0.0 0.1 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 41.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 1.5 0.7 0.2 0.4 0.3 0.2 0.5 0.3 0.2 0.2 1.1 0.4 0.4 2.5 0.5 0.4 0.9 0.2 0.2 7.5 16.8 2.0 20.3 3.5 4.8 0.7 7.2 1.7 3.4 0.0 1.1 0.0 0.0 0.1 0.3 6.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 48.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 45.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.9 0.0 0.0 2.1 0.6 0.0 0.0 0.0 0.0 0.0 ISM2 "FLJ32147, TAIL1, THSD3" ENSG00000100593 "Isthmin 2" Q6H9L7 14 77474394-77498850 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "placenta: 193.8" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 240.2;Extravillous trophoblasts: 440.1;Syncytiotrophoblasts: 148.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "basal ganglia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "BEWO: 91.4" "Not detected" "Not detected" "HPA039314, HPA039742" Supported Supported Nucleoplasm "Secreted in female reproductive system" NA NA Nucleoplasm "HPA039314: AB_10673239, HPA039742: AB_10673427" "unprognostic (5.69e-2)" "unprognostic (9.17e-3)" "unprognostic (2.58e-2)" "unprognostic (1.41e-3)" "unprognostic (3.73e-2)" "unprognostic (2.34e-1)" "unprognostic (2.16e-2)" "unprognostic (3.09e-3)" "unprognostic (2.11e-1)" "unprognostic (4.13e-1)" "unprognostic (8.10e-2)" "unprognostic (1.42e-2)" "unprognostic (9.36e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (3.95e-1)" 0.7 0.0 0.2 0.2 4.2 0.0 0.1 0.1 0.3 1.1 0.2 0.1 0.3 0.1 2.7 0.9 0.2 0.5 0.1 0.1 0.1 0.8 0.6 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.5 193.8 0.2 3.2 0.0 0.2 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.2 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.1 0.3 0.1 0.8 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 240.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 440.1 0.3 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 148.4 0.0 0.0 0.0 ITFG1 "CDA08, LNKN-1, TIP" ENSG00000129636 "Integrin alpha FG-GAP repeat containing 1" Q8TB96 16 47154387-47464149 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015590, HPA019728" Approved Approved "Intermediate filaments,Aggresome" "Intracellular and membrane" NA NA 21000 "Intermediate filaments" Aggresome "HPA015590: AB_1846347, HPA019728: AB_1846348" "unprognostic (6.53e-3)" "unprognostic (9.26e-3)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.27e-1)" "unprognostic (1.39e-3)" "unprognostic (3.70e-2)" "unprognostic (9.32e-2)" "unprognostic (2.47e-1)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "prognostic favorable (1.95e-8)" "unprognostic (1.56e-2)" "unprognostic (1.61e-1)" "unprognostic (3.28e-2)" "unprognostic (4.62e-3)" 14.0 26.6 19.9 8.8 52.4 6.4 15.0 31.2 34.6 18.3 20.0 14.8 9.8 17.3 17.5 19.0 11.5 15.8 17.1 26.0 20.7 26.6 28.7 26.5 15.8 11.0 17.0 19.0 17.4 20.2 43.0 22.9 30.7 28.7 17.9 19.9 13.8 15.1 18.1 14.6 10.8 19.4 17.4 17.6 12.4 16.0 20.7 15.7 13.4 25.8 7.6 11.5 15.3 11.6 12.8 18.7 23.4 24.4 16.6 18.3 17.7 8.0 9.4 17.1 11.9 33.5 25.9 20.5 19.5 27.8 17.7 9.5 5.3 19.7 9.8 26.6 24.0 12.0 12.0 8.3 12.4 17.7 4.2 5.7 5.1 9.0 12.4 15.7 12.1 22.8 19.0 21.7 9.0 11.8 37.6 17.0 9.2 14.6 12.9 22.2 7.8 7.5 5.6 5.5 10.2 9.2 11.5 16.9 24.2 23.5 6.0 8.4 11.9 17.7 20.6 8.6 17.8 9.0 11.1 16.4 18.9 9.2 10.0 7.4 18.2 23.9 18.2 18.9 7.7 14.7 13.5 24.4 23.4 12.4 23.8 12.0 12.8 15.4 13.7 18.7 11.4 16.9 14.1 15.4 16.6 21.9 13.0 18.3 17.7 19.9 52.4 31.2 34.6 20.7 26.6 17.0 19.0 28.7 15.7 47.6 29.1 31.2 36.5 34.1 48.8 52.0 33.1 21.4 20.5 78.5 45.2 90.9 8.3 48.2 66.3 35.8 59.3 46.7 46.4 73.7 50.5 38.7 8.1 58.9 45.3 38.1 59.5 36.8 54.3 25.1 32.5 33.8 27.0 41.5 40.4 43.5 41.4 31.7 57.7 48.2 40.9 77.6 42.2 46.1 97.5 26.5 95.3 20.6 32.4 30.2 ITGA1 "CD49a, VLA1" ENSG00000213949 "Integrin subunit alpha 1" P56199 5 52787896-52959210 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 50.6;Alveolar cells type 2: 39.3;Endothelial cells: 75.2;Fibroblasts: 29.3;Hepatocytes: 101.1;Ito cells: 98.2;Sertoli cells: 97.0;Smooth muscle cells: 74.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.8" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;T-cells: 1.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 21.4;HHSteC: 26.3;WM-115: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042555 Uncertain NA NA 2300000 "HPA042555: AB_10794281" "unprognostic (1.48e-1)" "unprognostic (1.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.33e-1)" "unprognostic (1.38e-1)" "unprognostic (9.89e-3)" "unprognostic (2.74e-1)" "unprognostic (1.72e-1)" "unprognostic (1.79e-3)" "unprognostic (1.50e-2)" "unprognostic (2.62e-1)" "unprognostic (9.86e-2)" "prognostic unfavorable (2.24e-4)" "unprognostic (3.13e-3)" "unprognostic (2.06e-2)" "unprognostic (1.07e-2)" "unprognostic (1.62e-2)" 22.6 20.2 2.3 12.7 2.7 0.0 12.4 1.2 2.9 10.9 28.2 1.5 13.6 5.3 15.9 12.5 22.3 9.2 13.9 11.1 2.5 2.2 17.9 40.4 28.8 10.2 3.1 1.4 9.6 3.3 11.5 3.0 24.8 3.3 26.1 8.2 5.9 2.9 18.2 9.7 2.4 13.5 52.8 2.7 66.0 16.8 4.1 1.6 0.6 10.7 3.5 2.2 42.7 17.8 0.0 0.1 1.2 0.3 0.0 1.8 0.1 0.0 0.0 2.0 0.0 5.9 1.7 1.2 2.8 7.3 1.6 4.9 3.8 0.3 0.0 0.9 21.4 4.8 1.4 0.4 2.4 1.5 0.0 1.5 0.0 3.5 2.7 26.3 0.0 0.0 4.0 0.2 2.0 0.7 4.5 0.3 0.1 0.0 0.0 2.5 0.0 0.8 0.0 1.2 0.1 0.7 0.0 2.0 0.0 3.1 0.0 0.1 9.2 2.8 0.7 0.6 6.0 0.0 0.0 2.2 4.5 0.4 0.1 1.4 0.0 0.0 0.0 2.9 0.0 19.5 0.0 0.3 1.1 0.1 0.0 0.0 0.0 0.6 1.8 0.1 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.1 0.1 2.3 2.7 1.2 2.9 2.5 2.2 3.1 1.4 3.3 1.6 50.6 39.3 2.2 3.3 2.9 1.7 10.4 2.5 10.7 14.8 5.2 2.0 1.2 1.7 2.6 16.7 75.2 5.2 0.0 4.8 12.0 29.3 1.3 9.3 101.1 2.0 0.0 15.7 98.2 9.7 4.1 8.6 3.9 6.8 14.4 11.8 0.2 12.6 7.0 7.8 15.3 1.6 97.0 74.8 0.9 0.7 2.8 2.9 15.2 9.9 1.7 ITGA10 ENSG00000143127 "Integrin subunit alpha 10" O75578 1 145891208-145910189 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 36.3;Endothelial cells: 21.6;Horizontal cells: 19.1;Ito cells: 30.7;Late spermatids: 33.3" "Cancer enhanced" "Detected in many" "melanoma: 6.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 6 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 19.8;HSkMC: 18.0;hTERT-HME1: 15.8;LHCN-M2: 27.3;TIME: 46.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "prognostic favorable (7.18e-4)" "unprognostic (4.53e-1)" "unprognostic (4.44e-3)" "unprognostic (2.32e-2)" "unprognostic (3.60e-2)" "unprognostic (2.19e-1)" "unprognostic (4.38e-2)" "unprognostic (1.84e-1)" "unprognostic (4.37e-1)" "unprognostic (5.72e-3)" "unprognostic (6.48e-2)" "unprognostic (5.79e-2)" "unprognostic (2.58e-6)" "unprognostic (2.77e-3)" "unprognostic (1.54e-1)" "unprognostic (2.05e-5)" "unprognostic (2.57e-2)" 3.7 2.9 2.7 1.8 6.0 0.7 9.7 5.1 7.1 12.6 4.4 3.3 0.0 3.2 6.7 5.0 2.5 3.0 3.4 7.2 2.2 1.5 2.5 1.3 13.1 2.1 9.7 4.1 4.9 1.4 2.8 4.8 4.3 10.2 3.7 1.8 12.2 4.2 2.4 16.0 3.3 4.0 4.5 15.5 1.7 3.4 3.4 3.7 0.0 4.4 4.2 2.1 6.8 2.5 0.1 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.5 0.1 0.1 0.5 19.8 0.0 0.2 5.3 0.0 0.2 0.0 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.2 0.2 0.0 0.1 0.0 0.2 3.6 0.0 0.2 18.0 1.0 0.7 15.8 7.4 8.8 0.5 0.0 0.0 27.3 0.1 0.0 0.1 0.0 0.4 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 46.2 8.5 0.1 0.1 0.1 0.1 0.2 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.1 0.0 1.1 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.0 5.1 7.1 2.2 1.5 9.7 4.1 10.2 3.7 0.0 3.0 0.0 5.9 2.1 10.6 2.4 0.0 0.0 4.5 7.0 7.9 0.8 0.0 0.0 36.3 21.6 0.1 0.0 0.2 0.7 1.0 2.8 0.0 0.8 0.5 19.1 0.0 30.7 0.0 33.3 0.9 0.8 0.0 0.0 0.1 0.7 0.0 0.0 0.7 0.0 7.3 0.0 3.8 6.0 2.0 2.4 0.7 0.5 0.3 1.1 ITGA11 HsT18964 ENSG00000137809 "Integrin subunit alpha 11" Q9UKX5 15 68296533-68432162 "Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 41.9;endometrium 1: 59.6;smooth muscle: 30.2" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 10.3;Fibroblasts: 8.2;Leydig cells: 6.4;Peritubular cells: 12.7;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "fHDF/TERT166: 55.3;hTERT-RPE1: 83.9;U-138 MG: 38.5;WM-115: 21.3" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 4 "basal ganglia: 6.1" HPA051813 Uncertain NA NA 42000 "HPA051813: AB_2681622" "unprognostic (4.85e-2)" "unprognostic (3.51e-1)" "unprognostic (6.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.87e-2)" "unprognostic (3.07e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-2)" "unprognostic (9.29e-3)" "unprognostic (6.63e-2)" "unprognostic (5.68e-3)" "unprognostic (3.36e-1)" "prognostic unfavorable (3.22e-7)" "unprognostic (8.38e-3)" "unprognostic (2.28e-4)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" 4.5 2.9 0.4 3.5 0.9 0.0 2.9 0.5 3.6 41.9 1.5 0.9 3.5 0.6 59.6 11.4 2.6 8.0 3.4 9.0 0.5 0.5 4.9 0.7 1.3 0.5 0.8 0.5 15.7 0.8 0.2 1.5 2.2 1.3 4.5 1.4 1.5 0.9 8.9 1.9 2.1 1.6 30.2 0.9 4.0 1.3 3.4 0.7 0.2 1.8 5.8 0.7 5.6 7.4 1.7 1.3 1.8 1.0 0.8 1.5 0.1 0.0 0.0 0.1 0.2 1.8 0.0 0.0 3.7 7.1 0.8 0.2 0.0 0.0 0.0 0.2 55.3 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.0 0.0 4.8 0.0 3.1 0.6 0.0 1.5 0.1 83.9 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 8.7 0.0 0.1 2.3 38.5 0.2 0.8 0.0 0.0 0.0 0.0 5.7 0.0 21.3 1.6 1.0 0.9 1.2 0.9 1.5 0.8 1.1 1.0 0.7 1.7 1.3 1.2 1.8 0.8 0.8 1.3 1.0 0.1 0.4 0.9 0.5 3.6 0.5 0.5 0.8 0.5 1.3 0.7 0.0 0.0 0.0 0.6 0.7 1.3 10.3 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.3 0.3 1.0 0.0 0.0 0.0 0.1 8.2 0.4 0.0 0.8 0.3 0.0 0.0 2.5 0.6 0.0 6.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 12.7 0.0 1.9 19.4 2.1 0.0 0.0 0.4 0.1 0.0 0.0 0.4 ITGA2 CD49b ENSG00000164171 "Integrin subunit alpha 2" P17301 5 52989326-53094779 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 300.3;Glandular cells: 266.4;Pancreatic endocrine cells: 350.7;Urothelial cells: 321.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 29.9;HaCaT: 30.2;hTERT-RPE1: 28.1;HUVEC TERT2: 27.8;TIME: 23.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017690, HPA060991, HPA063556" Enhanced Approved Nucleoplasm,Cytosol Yes No 46000000 Nucleoplasm Cytosol "CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-3)" "unprognostic (1.07e-1)" "unprognostic (1.22e-1)" "unprognostic (3.70e-2)" "unprognostic (2.67e-3)" "unprognostic (2.38e-2)" "unprognostic (1.87e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (4.27e-1)" "unprognostic (3.88e-2)" "unprognostic (2.87e-2)" "unprognostic (1.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.11e-1)" 1.9 14.0 2.9 4.7 13.4 0.4 7.9 1.8 6.8 7.1 6.5 22.5 12.1 7.6 5.1 10.4 16.7 2.8 9.3 2.5 5.4 3.6 15.1 1.8 17.2 1.4 18.3 4.5 1.8 2.7 16.1 2.5 4.8 10.7 8.5 6.0 0.8 15.8 16.8 1.2 16.9 17.0 2.5 8.4 9.1 7.4 1.3 13.0 1.5 2.5 7.4 10.0 7.5 11.1 0.5 1.5 1.7 0.6 0.2 0.6 0.3 19.4 5.0 0.4 0.2 1.3 2.4 1.5 19.6 29.9 0.7 1.2 9.3 13.7 0.0 3.4 8.3 11.5 30.2 1.6 22.1 2.8 0.0 1.5 1.4 1.2 5.5 4.5 0.2 0.4 0.9 3.8 19.7 3.5 28.1 27.8 1.0 0.0 0.0 0.5 3.6 0.2 0.0 1.2 5.0 10.0 0.0 0.1 0.0 6.3 10.3 0.2 1.1 1.0 1.3 2.0 0.8 3.2 0.0 23.8 3.6 2.1 0.5 3.9 0.0 0.0 0.0 21.6 0.0 15.8 1.7 0.6 0.2 0.6 0.2 0.4 0.4 0.5 0.5 0.1 0.5 0.5 0.6 0.8 0.2 0.1 1.5 0.4 0.3 2.9 13.4 1.8 6.8 5.4 3.6 18.3 4.5 10.7 13.0 53.6 13.6 0.0 300.3 134.2 2.3 1.2 20.4 88.3 161.5 50.6 3.9 0.2 8.3 157.1 0.0 15.8 20.6 0.0 144.3 1.6 1.9 266.4 1.1 0.0 0.3 0.0 13.3 5.5 0.0 0.0 1.1 3.8 11.8 1.8 32.4 18.0 350.7 15.2 0.0 2.9 5.0 0.0 4.2 0.0 0.9 32.5 0.3 1.9 28.1 321.7 ITGA2B "CD41, CD41B, GP2B, PPP1R93" ENSG00000005961 "Integrin subunit alpha 2b" P08514 17 44372180-44389505 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.5;epididymis: 25.2;lymphoid tissue: 22.8" "Cell type enhanced" "Detected in some" 11 "Cone photoreceptor cells: 7.9;Early spermatids: 14.4;granulocytes: 18.4;Late spermatids: 20.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "basophil: 28.5" "Lineage enriched" "Detected in single" 54 "granulocytes: 28.5" "Group enriched" "Detected in some" 13 "HEL: 71.0;HMC-1: 121.4" "Low region specificity" "Detected in single" "CAB018611, HPA031168, HPA031169, HPA031170, HPA031171" Enhanced Approved "Plasma membrane" NA NA 1100000000 "Plasma membrane" "CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773" "unprognostic (6.11e-2)" "unprognostic (3.23e-2)" "unprognostic (1.23e-1)" "unprognostic (4.85e-2)" "unprognostic (1.59e-2)" "unprognostic (3.98e-3)" "unprognostic (4.23e-5)" "unprognostic (1.25e-1)" "unprognostic (1.33e-2)" "unprognostic (7.22e-2)" "unprognostic (2.97e-3)" "unprognostic (1.30e-1)" "unprognostic (8.83e-9)" "unprognostic (7.82e-2)" "unprognostic (1.85e-1)" "unprognostic (1.95e-1)" "unprognostic (2.25e-1)" 0.7 0.2 1.4 0.4 1.0 15.2 0.6 3.8 2.4 1.2 0.9 0.4 0.4 0.1 1.1 25.2 0.7 1.9 1.4 10.6 0.9 1.6 1.0 0.4 6.5 0.5 0.7 0.8 2.1 2.5 0.1 2.5 1.9 1.1 0.6 0.3 0.6 0.4 1.6 0.8 0.1 0.6 0.4 0.8 22.8 0.2 3.0 0.4 0.4 5.2 1.0 0.6 0.7 1.9 0.0 0.5 28.5 0.2 0.0 0.2 11.1 0.0 0.1 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 71.0 0.1 0.7 0.0 0.0 121.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 7.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 28.5 0.2 2.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.5 0.0 11.1 1.4 1.0 3.8 2.4 0.9 1.6 0.7 0.8 1.1 0.4 0.0 1.0 0.0 0.5 0.2 4.5 1.2 0.0 0.0 2.3 5.2 7.9 0.5 0.0 0.0 14.4 0.6 0.0 0.0 0.0 1.1 0.8 0.3 18.4 0.0 0.2 3.2 0.0 0.6 0.3 20.0 1.7 0.0 0.0 0.0 0.0 1.9 0.1 0.0 1.8 0.0 3.1 0.0 0.0 0.7 3.4 0.0 0.6 0.0 0.0 0.1 ITGA3 "CD49c, GAP-B3, MSK18, VCA-2, VLA3a" ENSG00000005884 "Integrin subunit alpha 3" P26006 17 50055968-50090481 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 96.5;Exocrine glandular cells: 90.7;Pancreatic endocrine cells: 158.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.1" "Lineage enriched" "Detected in single" 4 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 74.4;hTERT-RPE1: 68.2;RPTEC TERT1: 65.6;U-87 MG: 111.7;WM-115: 67.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008572, CAB018594" Enhanced Supported "Plasma membrane" NA NA 180000 "Plasma membrane" "CAB018594: AB_668044, HPA008572: AB_2668094" "unprognostic (3.24e-3)" "prognostic unfavorable (6.75e-4)" "unprognostic (9.51e-2)" "unprognostic (3.46e-3)" "unprognostic (3.45e-3)" "prognostic unfavorable (1.36e-4)" "unprognostic (8.28e-3)" "unprognostic (2.76e-3)" "unprognostic (1.26e-3)" "unprognostic (1.82e-2)" "prognostic unfavorable (5.95e-5)" "unprognostic (7.05e-2)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (2.35e-2)" 15.7 15.8 4.1 8.6 5.1 0.1 8.7 7.7 6.5 10.9 20.9 2.3 8.9 17.1 11.6 11.6 12.8 14.5 32.6 8.4 4.2 5.4 36.0 1.7 37.6 3.2 3.2 6.7 10.7 8.0 13.0 11.2 26.4 4.3 12.0 8.9 11.6 10.0 9.7 6.6 17.3 37.3 11.6 3.3 6.5 13.7 3.9 1.5 3.3 36.1 13.3 8.3 19.0 8.1 0.2 0.0 0.0 0.0 0.0 1.1 0.2 20.4 27.1 0.1 0.8 0.5 2.1 4.4 9.6 20.7 14.5 11.1 0.6 31.9 0.0 60.6 6.9 48.4 14.6 0.2 74.4 8.9 2.5 0.4 0.0 6.8 0.1 12.8 0.0 0.6 2.6 36.7 14.5 64.6 68.2 10.6 1.0 0.0 0.3 27.3 5.9 0.0 0.0 0.6 9.2 16.4 0.0 1.4 1.5 65.6 35.7 1.1 0.4 10.4 1.4 24.0 6.9 2.4 0.2 23.0 64.8 20.4 0.6 37.3 0.9 1.5 0.6 111.7 0.2 67.3 0.0 0.0 0.0 0.8 0.0 1.0 0.2 0.1 0.1 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 1.1 0.2 4.1 5.1 7.7 6.5 4.2 5.4 3.2 6.7 4.3 1.5 50.6 29.6 5.7 51.4 50.9 14.4 4.4 33.1 4.0 27.3 73.3 23.6 1.8 0.0 96.5 0.4 11.2 77.3 0.0 90.7 2.6 4.5 26.1 3.5 0.0 1.1 3.2 13.9 4.9 1.5 0.0 1.7 3.8 16.9 7.2 21.8 2.3 158.1 31.7 3.9 2.2 13.1 12.9 18.6 0.2 1.6 20.3 1.5 1.3 29.6 70.4 ITGA4 CD49d ENSG00000115232 "Integrin subunit alpha 4" P13612 2 181457202-181536187 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.4;lymphoid tissue: 101.6" "Cell type enhanced" "Detected in many" 11 "B-cells: 42.0;Erythroid cells: 70.0;monocytes: 36.1;T-cells: 59.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 39.1;HEL: 62.0;JURKAT: 32.6;MOLT-4: 72.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 26.0" HPA074961 Approved "Plasma membrane" "Intracellular and membrane" NA NA 100000 "Plasma membrane" "HPA074961: AB_2732273" "unprognostic (5.31e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-2)" "unprognostic (3.94e-2)" "unprognostic (3.76e-1)" "prognostic favorable (8.29e-4)" "unprognostic (1.27e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-2)" "unprognostic (1.85e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.08e-5)" "unprognostic (2.26e-2)" "unprognostic (8.64e-3)" "unprognostic (2.49e-1)" "unprognostic (2.57e-2)" 3.8 1.7 1.3 39.7 1.1 19.2 3.2 2.4 1.9 6.7 4.8 0.5 1.1 3.8 3.0 3.1 2.9 2.1 6.9 1.7 2.9 1.3 3.0 2.5 13.6 33.7 1.2 0.5 1.8 1.6 0.0 1.3 7.1 0.9 3.8 4.9 2.9 7.5 2.0 1.0 1.5 11.6 2.4 1.6 36.0 4.4 1.2 0.2 101.6 2.6 1.5 14.3 6.0 4.1 11.0 19.1 38.4 38.3 8.8 15.9 16.2 0.0 0.2 1.0 0.0 9.2 13.9 0.0 9.0 11.3 4.8 10.2 0.0 0.0 7.2 0.0 39.1 4.2 5.3 3.2 0.1 5.8 0.0 0.7 62.0 0.2 0.0 0.9 27.4 1.5 9.9 0.0 0.3 0.0 4.7 0.5 32.6 0.0 10.5 3.0 0.0 72.3 19.2 0.8 0.0 0.0 15.9 4.5 1.0 0.0 0.0 1.6 0.6 0.0 0.0 0.3 0.4 0.0 18.1 4.9 1.5 0.9 0.1 1.8 20.5 15.2 4.1 0.8 13.6 20.8 6.7 16.2 38.4 12.9 38.3 9.7 11.0 14.6 15.9 19.1 10.0 8.5 10.4 2.1 8.8 37.5 5.0 3.7 16.2 1.3 1.1 2.4 1.9 2.9 1.3 1.2 0.5 0.9 0.2 0.0 7.9 42.0 0.2 0.2 2.4 0.8 5.1 1.4 3.4 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.2 2.9 0.3 17.4 0.0 5.8 0.0 0.0 1.8 21.0 0.0 0.6 22.7 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 1.6 0.4 0.9 0.5 0.3 59.7 0.0 0.2 ITGA5 "CD49e, FNRA" ENSG00000161638 "Integrin subunit alpha 5" P08648 12 54395261-54419460 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 137.7" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 377.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 31.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 67.2;HUVEC TERT2: 141.7;TIME: 134.9;U-87 MG: 67.3" "Region enriched" "Detected in single" 7 "basal ganglia: 9.3" "Not detected" "Not detected" "HPA002642, CAB009008" Enhanced NA NA 23000000 "CAB009008: AB_647474, HPA002642: AB_1078469" "unprognostic (7.51e-3)" "prognostic unfavorable (4.07e-6)" "prognostic unfavorable (8.43e-4)" "unprognostic (1.58e-1)" "unprognostic (8.51e-3)" "prognostic unfavorable (2.91e-4)" "prognostic unfavorable (2.23e-5)" "prognostic unfavorable (2.44e-4)" "unprognostic (2.76e-2)" "unprognostic (6.19e-2)" "unprognostic (8.99e-2)" "unprognostic (8.28e-2)" "prognostic unfavorable (1.32e-8)" "unprognostic (2.11e-3)" "unprognostic (3.35e-2)" "prognostic unfavorable (8.89e-4)" "unprognostic (2.18e-3)" 23.3 7.9 2.1 32.2 2.8 9.2 30.5 1.2 2.2 16.0 66.9 2.2 19.0 3.4 19.3 13.8 18.2 12.0 12.4 20.3 2.9 0.8 4.6 15.2 20.4 9.2 3.2 1.2 13.6 5.3 3.7 1.8 57.7 3.3 26.6 10.2 4.9 4.4 28.9 10.0 8.8 14.9 137.7 3.5 3.1 19.7 6.6 2.5 3.0 7.3 5.8 4.5 82.1 20.6 0.1 22.2 31.5 22.9 9.1 5.6 12.4 6.6 2.4 4.6 0.0 14.4 30.6 12.1 30.2 31.4 31.1 23.0 1.7 1.5 0.0 22.0 31.5 15.7 1.0 1.2 8.4 21.6 0.0 1.2 2.9 3.4 0.1 19.9 9.0 4.6 22.1 4.2 36.5 28.0 67.2 141.7 1.5 2.4 0.0 17.6 0.6 1.4 10.1 1.9 0.4 2.0 1.4 3.1 0.6 4.9 0.1 0.0 0.0 6.0 0.4 0.2 10.6 0.7 8.2 134.9 37.9 6.7 9.2 12.5 0.0 0.3 0.0 67.3 8.6 12.3 5.6 22.9 0.1 5.6 10.0 4.4 0.0 4.2 4.2 22.2 0.1 3.1 2.6 31.5 9.1 7.6 1.2 1.7 12.4 2.1 2.8 1.2 2.2 2.9 0.8 3.2 1.2 3.3 2.5 3.0 4.1 1.4 2.7 12.7 0.8 13.2 5.1 1.4 4.5 0.0 0.0 2.7 0.0 32.2 0.1 93.4 0.0 0.0 3.0 377.0 54.1 3.6 19.6 20.7 27.5 0.0 0.0 77.3 18.7 0.4 6.1 35.5 10.1 9.0 0.0 0.0 7.2 0.0 4.2 0.0 1.3 12.9 33.1 0.0 0.7 9.4 28.9 8.2 0.0 1.7 ITGA6 CD49f ENSG00000091409 "Integrin subunit alpha 6" P23229 2 172427354-172506282 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 170.5;Basal keratinocytes: 217.4;Urothelial cells: 209.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 16.2" "Group enriched" "Detected in many" 34 "granulocytes: 16.2;NK-cells: 5.5;T-cells: 10.0" "Cell line enhanced" "Detected in many" "BJ: 51.0;HaCaT: 56.1;HBEC3-KT: 110.4;hTCEpi: 48.1;hTERT-HME1: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009009, HPA012696, HPA027582" Enhanced NA NA 45000000 "CAB009009: AB_2128038, HPA012696: AB_1851822, HPA027582: AB_10602606" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (2.59e-2)" "unprognostic (5.96e-2)" "unprognostic (4.93e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.19e-1)" "unprognostic (1.61e-3)" "unprognostic (9.34e-2)" "unprognostic (6.01e-2)" "unprognostic (1.85e-3)" "unprognostic (1.84e-1)" "prognostic favorable (2.35e-11)" "unprognostic (3.35e-2)" "unprognostic (3.32e-1)" "unprognostic (2.98e-2)" "unprognostic (1.21e-3)" 28.0 3.1 9.8 19.1 10.5 1.6 30.1 3.0 8.4 27.0 34.9 9.4 42.3 28.5 28.2 11.3 17.0 11.1 23.8 21.7 9.7 8.2 22.0 4.9 29.0 14.9 9.8 5.1 7.6 31.3 7.4 4.9 38.7 12.6 14.3 25.2 17.6 37.1 32.4 13.5 17.5 44.2 15.2 9.6 14.9 25.0 12.4 6.9 15.1 11.5 35.2 13.2 24.1 17.3 0.3 0.1 16.2 0.2 5.5 10.0 3.3 11.6 10.0 4.4 7.8 0.2 0.1 24.0 51.0 5.5 5.2 3.2 5.6 22.3 0.1 14.4 13.5 11.9 56.1 2.9 110.4 9.5 0.1 2.6 0.2 10.7 9.3 0.7 3.2 0.3 1.0 48.1 0.3 48.9 5.3 33.4 6.3 0.0 0.8 6.6 0.5 0.9 2.8 7.9 33.2 8.6 0.1 13.1 0.2 7.9 16.4 0.1 0.5 9.4 0.0 10.9 4.8 2.1 0.2 15.0 7.3 6.6 13.5 8.8 0.7 0.5 0.3 0.2 1.1 29.4 2.6 0.2 16.2 4.2 0.0 8.5 0.2 5.4 5.0 0.1 0.3 10.0 4.6 0.5 5.5 0.0 0.0 5.7 3.3 9.8 10.5 3.0 8.4 9.7 8.2 9.8 5.1 12.6 6.9 8.9 15.0 7.5 170.5 217.4 1.2 28.0 28.1 4.0 5.7 26.2 53.0 80.2 5.0 26.3 28.6 129.7 78.8 0.0 53.3 26.5 14.5 163.8 8.1 17.0 24.0 1.6 55.0 14.1 1.6 33.8 3.7 9.2 49.0 0.0 103.3 1.5 85.9 64.5 2.5 49.4 12.5 0.0 12.7 3.3 25.5 73.4 18.7 14.9 95.0 209.9 ITGA7 ENSG00000135424 "Integrin subunit alpha 7" Q13683 12 55684568-55716043 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Cell shape" "Integrin, Receptor" "Congenital muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 66.4;skeletal muscle: 81.3" "Group enriched" "Detected in many" 17 "Cardiomyocytes: 123.1;Sertoli cells: 161.7;Smooth muscle cells: 105.1" "Cancer enhanced" "Detected in all" "glioma: 35.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "hTERT-RPE1: 85.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008427 Uncertain Approved "Nuclear speckles,Vesicles,Plasma membrane" NA NA 770000 "Plasma membrane" "Nuclear speckles, Vesicles" "HPA008427: AB_1851823" "unprognostic (4.71e-2)" "unprognostic (1.55e-1)" "unprognostic (2.00e-3)" "unprognostic (3.02e-3)" "unprognostic (2.50e-1)" "unprognostic (2.36e-1)" "unprognostic (1.66e-2)" "unprognostic (2.20e-1)" "unprognostic (2.20e-2)" "unprognostic (3.57e-1)" "prognostic favorable (1.75e-4)" "unprognostic (2.85e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-1)" "unprognostic (5.10e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (9.59e-5)" 46.2 3.4 6.1 7.2 6.8 0.9 20.6 3.6 7.6 6.3 22.4 5.7 5.9 6.6 15.1 13.5 11.6 12.9 14.8 66.4 7.8 2.6 3.1 4.1 3.4 2.9 3.9 7.6 5.1 1.9 3.4 3.1 1.0 5.7 8.9 3.7 5.6 3.3 14.6 81.3 3.6 7.2 33.3 4.5 2.4 10.3 2.9 5.3 0.2 6.5 10.6 2.2 13.6 14.1 0.5 1.7 0.0 1.0 0.0 0.8 0.3 0.0 1.0 1.9 3.2 18.2 3.6 0.2 1.3 2.3 3.1 3.2 2.1 1.7 0.6 1.9 0.8 0.2 0.2 1.3 0.0 2.7 0.0 1.0 0.2 0.6 0.8 0.1 0.0 0.7 5.1 0.0 17.2 0.1 85.4 0.0 0.5 0.2 0.4 10.4 1.3 0.0 0.7 5.6 0.4 0.1 0.0 7.5 0.1 0.0 0.0 0.2 0.7 0.1 0.0 12.6 1.1 0.2 3.5 0.0 0.3 3.4 0.2 2.1 0.8 0.5 0.2 15.6 2.1 0.1 0.0 0.7 0.0 0.4 1.0 0.0 0.1 0.0 0.8 1.7 0.5 0.3 0.4 0.0 0.0 1.0 0.6 0.0 0.3 6.1 6.8 3.6 7.6 7.8 2.6 3.9 7.6 5.7 5.3 0.0 0.0 0.0 0.5 1.6 1.0 123.1 5.1 0.0 0.0 1.8 3.9 0.0 0.0 0.2 0.1 5.1 1.1 0.0 0.0 0.1 1.1 0.6 0.0 0.9 0.5 0.0 7.5 1.3 1.8 0.0 6.1 1.2 3.3 0.0 1.1 4.4 0.4 0.0 6.0 0.6 0.2 161.7 105.1 3.7 2.2 1.9 0.1 0.0 0.8 0.3 ITGA8 ENSG00000077943 "Integrin subunit alpha 8" P53708 10 15513949-15720125 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein, Integrin, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Muller glia cells: 17.3;Sertoli cells: 51.8;Smooth muscle cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 7.9;HMC-1: 19.0;HSkMC: 8.4;U-266/70: 3.6;U-266/84: 8.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003432 Approved Approved "Plasma membrane" NA NA 110000 "Plasma membrane" "HPA003432: AB_1851825" "unprognostic (2.15e-1)" "unprognostic (1.22e-3)" "unprognostic (1.05e-2)" "unprognostic (2.03e-1)" "unprognostic (1.25e-2)" "unprognostic (8.44e-4)" "unprognostic (2.23e-1)" "unprognostic (6.13e-3)" "unprognostic (6.82e-2)" "unprognostic (3.80e-1)" "unprognostic (2.54e-2)" "unprognostic (1.27e-1)" "unprognostic (4.10e-3)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" "unprognostic (2.26e-1)" "unprognostic (6.03e-2)" 7.1 7.8 2.3 2.4 1.9 0.1 3.1 1.4 3.7 36.1 5.5 1.5 4.1 4.8 17.9 22.8 12.4 7.1 10.7 10.3 3.0 1.6 7.4 0.8 22.1 3.7 1.7 2.6 17.0 0.8 0.7 3.3 0.2 2.9 28.3 4.6 18.8 3.0 22.9 3.3 3.1 4.9 21.2 1.5 17.0 19.4 12.1 1.2 0.0 5.3 5.5 4.3 21.3 10.8 0.2 0.2 0.6 0.4 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 7.9 2.3 0.0 0.0 0.0 0.0 19.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.6 0.0 0.0 0.1 1.6 0.6 0.0 0.2 0.2 0.4 0.2 0.2 0.3 0.3 0.0 0.2 0.5 0.5 0.5 0.2 0.4 0.2 0.8 0.0 2.3 1.9 1.4 3.7 3.0 1.6 1.7 2.6 2.9 1.2 0.0 2.2 0.0 1.9 0.9 2.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 2.4 1.2 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.9 1.0 1.7 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.2 51.8 54.5 0.0 0.2 1.0 0.0 0.0 0.0 1.4 ITGA9 "ALPHA-RLC, ITGA4L, RLC" ENSG00000144668 "Integrin subunit alpha 9" Q13797 3 37452115-37823514 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Ito cells: 62.0;Kupffer cells: 24.9;Leydig cells: 38.3;Peritubular cells: 70.4" "Cancer enhanced" "Detected in all" "thyroid cancer: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.1" "Lineage enhanced" "Detected in single" "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "CACO-2: 9.4;HEL: 7.5;SH-SY5Y: 11.2;SuSa: 17.0;WM-115: 5.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030609 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 250000 Vesicles "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA030609: AB_10600815" "unprognostic (2.35e-2)" "unprognostic (3.36e-2)" "unprognostic (5.58e-2)" "unprognostic (3.94e-2)" "unprognostic (4.48e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (8.87e-3)" "unprognostic (3.23e-1)" "unprognostic (2.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-2)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-2)" "unprognostic (3.16e-2)" 8.5 15.5 3.1 5.3 3.7 5.8 9.6 1.6 5.7 17.9 11.1 2.9 5.8 4.6 17.3 7.5 12.3 6.9 17.8 25.0 4.5 2.0 4.6 13.6 8.3 16.8 3.4 2.7 7.5 2.1 2.4 3.0 7.3 2.6 10.0 5.3 8.4 4.7 8.7 3.7 3.5 8.7 16.2 4.0 30.5 10.9 10.2 2.7 1.0 35.4 7.2 3.6 7.4 8.4 0.0 0.7 2.1 0.2 0.0 0.0 0.4 0.2 0.0 4.1 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 9.4 0.0 3.0 1.3 0.0 0.1 0.2 3.6 0.0 0.0 0.0 0.6 7.5 0.1 0.2 0.2 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.5 11.2 0.1 0.5 0.6 17.0 0.0 2.9 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.2 5.8 2.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 3.1 3.7 1.6 5.7 4.5 2.0 3.4 2.7 2.6 2.7 0.0 14.3 0.0 1.0 2.3 0.8 13.2 2.5 0.0 5.7 1.8 0.0 0.2 0.0 0.1 0.9 18.0 0.0 0.0 0.0 0.2 3.2 0.2 5.8 0.2 2.2 0.0 0.0 62.0 24.9 3.1 38.3 1.3 3.3 0.0 0.0 0.5 0.0 0.0 70.4 0.0 0.0 0.0 3.3 0.5 0.9 1.5 0.2 0.0 0.0 0.3 ITGAD "ADB2, CD11d" ENSG00000156886 "Integrin subunit alpha D" Q13349 16 31393312-31426505 "CD markers, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 25.4" "Cell type enhanced" "Detected in single" 21 "Kupffer cells: 2.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;NK-cell: 2.6" "Group enriched" "Detected in many" 19 "NK-cells: 2.6;T-cells: 1.1" "Cell line enhanced" "Detected in single" "NB-4: 1.7" "Low region specificity" "Detected in many" HPA026786 Uncertain NA NA "HPA026786: AB_10603773" "unprognostic (2.79e-2)" "unprognostic (2.39e-4)" "unprognostic (2.88e-2)" "unprognostic (3.24e-2)" "unprognostic (6.17e-2)" "unprognostic (1.79e-2)" "unprognostic (7.44e-4)" "unprognostic (6.99e-3)" "unprognostic (6.89e-3)" "unprognostic (5.02e-4)" "unprognostic (5.50e-2)" "unprognostic (1.67e-1)" "unprognostic (1.74e-1)" "unprognostic (3.80e-2)" "unprognostic (3.17e-1)" "unprognostic (8.10e-2)" "unprognostic (5.51e-2)" 0.3 0.1 0.1 1.0 0.1 2.5 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 1.2 0.0 0.4 0.2 0.2 0.2 0.1 0.1 0.1 1.2 0.7 4.0 0.1 0.0 1.6 0.1 0.0 0.1 1.2 0.0 0.1 0.0 0.2 1.5 0.0 1.3 0.1 0.3 0.0 0.2 25.4 0.1 0.2 0.0 0.4 0.1 0.0 1.4 0.2 0.1 0.0 0.0 0.0 0.0 2.6 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.6 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 ITGAE "CD103, HUMINAE" ENSG00000083457 "Integrin subunit alpha E" P38570 17 3714628-3801243 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.2;lung: 25.9;lymphoid tissue: 13.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MAIT T-cell: 3.1;memory CD8 T-cell: 7.4;T-reg: 1.9" "Lineage enriched" "Detected in many" 7 "T-cells: 7.4" "Cell line enriched" "Detected in single" 21 "MOLT-4: 16.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA036313, HPA052147" Enhanced NA NA 13000 "HPA036313: AB_10795355, HPA052147: " "unprognostic (9.81e-2)" "unprognostic (1.78e-3)" "unprognostic (7.86e-2)" "prognostic favorable (1.04e-4)" "unprognostic (2.17e-1)" "unprognostic (1.45e-2)" "unprognostic (2.91e-1)" "unprognostic (8.02e-2)" "unprognostic (2.92e-2)" "unprognostic (1.10e-1)" "prognostic favorable (5.78e-4)" "unprognostic (3.34e-2)" "prognostic unfavorable (1.13e-8)" "unprognostic (8.40e-3)" "unprognostic (1.15e-1)" "unprognostic (1.82e-2)" "prognostic favorable (3.56e-4)" 3.6 0.2 0.3 13.0 0.6 8.0 0.9 0.2 0.2 0.6 9.6 0.2 0.0 4.9 0.4 0.4 2.0 1.5 2.7 0.2 0.5 0.4 0.3 0.3 25.9 8.1 0.3 0.0 0.9 1.2 0.5 0.4 0.1 0.2 1.2 2.0 0.2 1.8 3.9 0.3 0.6 20.2 2.0 0.7 1.4 3.6 1.6 0.1 3.1 1.0 1.5 5.3 1.9 2.5 0.2 0.1 0.0 1.0 0.0 7.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.7 16.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 1.0 3.1 0.2 1.0 7.4 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.9 0.9 0.3 0.6 0.2 0.2 0.5 0.4 0.3 0.0 0.2 0.1 6.0 25.5 50.2 35.5 26.7 15.9 58.6 43.3 28.1 21.6 14.0 7.9 24.2 77.9 33.2 38.9 29.2 23.6 0.0 57.0 49.7 37.3 38.0 67.9 39.4 49.2 6.4 27.1 40.5 43.7 30.3 24.7 54.5 55.6 41.5 24.9 35.9 42.9 21.0 28.0 67.5 13.0 25.8 38.1 61.9 29.7 36.1 11.0 55.3 34.6 29.8 ITGAL "CD11A, LFA-1" ENSG00000005844 "Integrin subunit alpha L" P20701 16 30472658-30523185 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction, Phagocytosis" "Integrin, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.7;lymphoid tissue: 74.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 14.6;Hofbauer cells: 17.3;Kupffer cells: 16.8;T-cells: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "HMC-1: 121.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" CAB025011 Enhanced "Intracellular and membrane" NA NA 1100000 "CAB025011: " "unprognostic (1.10e-2)" "unprognostic (4.26e-3)" "unprognostic (3.72e-3)" "prognostic favorable (5.63e-5)" "unprognostic (2.88e-1)" "prognostic favorable (3.34e-4)" "unprognostic (1.63e-1)" "unprognostic (5.69e-3)" "prognostic favorable (5.57e-4)" "unprognostic (3.37e-2)" "unprognostic (4.98e-2)" "unprognostic (1.84e-1)" "prognostic unfavorable (2.69e-5)" "unprognostic (2.89e-1)" "unprognostic (3.05e-2)" "unprognostic (1.39e-1)" "unprognostic (1.71e-2)" 2.8 1.1 1.8 29.8 2.0 15.1 1.8 0.6 1.5 1.3 3.0 2.7 0.5 2.4 1.7 1.4 2.2 2.6 4.9 1.4 1.3 1.3 2.6 6.7 16.2 29.0 3.1 1.4 1.4 1.2 0.0 1.4 1.7 1.7 2.0 3.4 1.9 6.6 0.7 0.8 1.0 12.7 1.4 4.7 44.1 3.5 0.8 2.7 74.6 2.8 2.0 41.8 4.4 1.9 2.1 7.5 7.2 36.7 9.5 22.5 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 121.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 27.3 0.0 0.0 8.1 0.7 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 4.3 0.0 0.0 0.0 0.0 0.0 7.7 2.6 0.0 0.1 0.8 0.0 3.1 8.4 6.5 22.5 16.9 11.2 2.1 8.8 16.2 7.5 1.3 4.9 11.4 7.2 9.5 36.7 3.0 6.3 11.5 1.8 2.0 0.6 1.5 1.3 1.3 3.1 1.4 1.7 2.7 6.0 14.6 8.2 0.2 0.7 0.0 1.1 0.0 12.0 3.4 1.8 0.0 0.2 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.4 0.8 0.1 4.7 3.2 17.3 0.0 0.0 4.3 16.8 0.4 0.0 5.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.4 0.1 0.2 0.3 0.6 66.0 0.0 0.1 ITGAM "CD11b, CR3A, MAC-1" ENSG00000169896 "Integrin subunit alpha M" P11215 16 31259990-31332892 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Innate immunity" "Integrin, Receptor" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 93.7" "Cell type enhanced" "Detected in many" 22 "granulocytes: 34.6;Hofbauer cells: 42.4;Kupffer cells: 152.2;Macrophages: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 29.4;classical monocyte: 19.1;eosinophil: 23.8;gdT-cell: 12.2;intermediate monocyte: 7.6;neutrophil: 21.0;NK-cell: 18.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HMC-1: 33.5;NB-4: 11.8;U-937: 14.3" "HPA002274, CAB025091, CAB072870" Enhanced NA NA 900000 "CAB025091: , CAB072870: AB_2665722, HPA002274: AB_1078435" "unprognostic (1.82e-2)" "unprognostic (1.70e-2)" "unprognostic (8.78e-2)" "unprognostic (2.54e-2)" "unprognostic (2.40e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (3.43e-4)" "unprognostic (1.86e-1)" "unprognostic (1.73e-1)" "unprognostic (3.29e-3)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (6.93e-5)" "unprognostic (9.89e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (3.99e-2)" "unprognostic (5.03e-2)" 19.7 5.0 6.0 14.0 7.2 93.7 6.0 2.0 4.5 2.9 3.2 9.4 0.5 1.8 2.5 3.5 2.2 4.8 4.0 6.5 4.3 3.9 3.0 3.3 14.6 22.8 10.5 1.6 2.5 2.9 1.6 1.8 4.9 5.3 3.6 2.7 3.3 3.2 2.0 1.6 1.5 4.4 6.9 8.6 29.9 2.8 1.5 7.4 2.3 2.1 1.7 6.6 4.9 4.5 1.9 3.4 29.4 19.1 18.8 12.2 8.0 0.5 1.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.3 0.5 0.9 0.6 0.0 0.2 0.1 0.0 0.2 0.0 4.8 0.0 0.6 0.0 0.0 0.0 1.2 33.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.2 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.3 0.2 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 14.3 0.0 29.4 19.1 23.8 12.2 7.6 0.7 1.9 1.3 3.6 3.4 0.3 0.3 3.0 21.0 18.8 1.1 0.2 0.5 8.0 6.0 7.2 2.0 4.5 4.3 3.9 10.5 1.6 5.3 7.4 3.0 15.6 5.1 0.1 1.0 0.0 1.5 2.5 0.0 2.3 0.0 0.0 0.3 0.0 1.1 0.3 0.6 0.0 0.0 0.0 0.4 1.0 0.5 34.6 0.8 42.4 0.0 3.5 1.8 152.2 1.5 0.3 53.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 12.9 0.0 0.4 0.7 0.9 0.7 5.4 0.0 0.1 ITGAV "CD51, MSK8, VNRA, VTNR" ENSG00000138448 "Integrin subunit alpha V" P06756 2 186590065-186680901 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.7" "Group enriched" "Detected in many" 4 "granulocytes: 7.7;monocytes: 2.3" "Cell line enhanced" "Detected in many" "RT4: 71.7;SuSa: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002499, HPA004856" Supported Approved "Focal adhesion sites,Cytosol" NA NA 750000 "Focal adhesion sites, Cytosol" "CAB002499: AB_563594, HPA004856: AB_1846316" "unprognostic (4.03e-2)" "unprognostic (5.17e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (1.48e-2)" "unprognostic (6.95e-2)" "unprognostic (2.89e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (5.84e-2)" "unprognostic (2.67e-2)" "prognostic unfavorable (1.05e-6)" "unprognostic (2.61e-1)" "unprognostic (9.11e-2)" "unprognostic (8.07e-2)" 23.2 22.1 17.9 18.3 21.8 3.1 25.8 16.7 23.1 22.9 13.6 23.4 11.6 8.4 26.0 11.4 14.2 14.5 25.2 40.7 16.8 12.3 51.5 9.5 20.6 7.6 24.2 11.6 35.4 18.7 65.0 11.0 29.6 22.1 16.5 11.9 83.4 17.9 15.9 13.1 21.5 10.1 29.6 33.0 12.1 17.3 11.2 17.0 7.8 33.1 10.9 11.1 17.6 17.9 0.3 0.9 7.7 2.3 0.4 1.1 0.5 9.3 11.1 7.4 23.7 27.3 18.5 28.3 18.3 14.8 6.5 6.5 9.7 32.2 0.0 36.1 20.6 22.7 11.7 3.8 17.2 9.4 1.8 3.4 2.2 14.6 13.3 10.8 1.5 1.4 13.4 8.2 14.4 12.3 39.0 15.4 1.1 2.1 4.7 17.2 3.7 0.9 1.3 5.6 5.6 5.6 0.0 15.2 1.2 16.8 71.7 1.5 4.6 21.1 6.5 7.7 62.1 5.1 4.3 46.8 40.2 12.6 8.2 15.4 1.1 1.9 1.0 16.2 0.6 19.8 7.7 1.1 1.6 1.0 2.3 0.7 0.3 0.5 0.8 0.9 0.1 0.5 0.5 0.5 0.4 1.2 0.4 1.1 0.5 17.9 21.8 16.7 17.3 16.8 12.3 24.2 11.6 22.1 17.0 26.8 18.5 2.4 54.8 114.0 118.2 124.7 73.9 12.0 20.5 73.3 72.6 46.9 1.7 78.4 0.5 50.4 13.2 0.0 89.0 21.8 61.3 83.9 49.5 15.8 26.1 14.3 7.0 34.4 33.9 1.6 17.8 18.2 43.9 20.8 18.9 82.5 120.4 18.2 24.4 16.5 54.8 32.3 47.2 0.7 1.4 90.7 33.2 6.9 11.4 48.6 ITGAX CD11c ENSG00000140678 "Integrin subunit alpha X" P20702 16 31355134-31382997 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.9;blood: 31.7;lung: 33.2;lymphoid tissue: 46.3" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 80.7;granulocytes: 70.6;Hofbauer cells: 46.3;Kupffer cells: 28.3;Macrophages: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 10.1;eosinophil: 9.2;intermediate monocyte: 18.1;myeloid DC: 12.4;neutrophil: 31.7;NK-cell: 14.9;non-classical monocyte: 20.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HMC-1: 49.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004458, HPA004723, CAB072871" Enhanced NA NA "CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231" "unprognostic (9.75e-3)" "unprognostic (2.49e-2)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (1.89e-1)" "unprognostic (2.29e-2)" "unprognostic (1.27e-1)" "unprognostic (9.59e-2)" "unprognostic (8.06e-3)" "unprognostic (3.20e-1)" "unprognostic (7.75e-2)" "unprognostic (3.34e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (3.92e-2)" "unprognostic (3.04e-2)" "unprognostic (2.82e-1)" "unprognostic (2.95e-2)" 47.9 1.9 4.4 28.1 5.7 28.6 2.9 1.4 4.4 1.8 2.1 17.1 0.6 1.7 2.1 2.5 1.9 4.3 7.7 2.5 5.3 4.6 2.3 4.6 33.2 24.4 13.6 3.8 3.0 2.1 0.8 2.4 3.3 8.1 2.5 3.2 2.5 4.3 1.3 1.1 1.6 3.8 3.3 15.6 46.3 3.3 0.9 7.5 3.8 2.2 0.9 9.7 5.1 1.9 0.8 12.4 31.7 20.3 14.9 1.8 3.2 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.1 0.0 0.0 0.1 0.0 8.3 0.0 0.0 0.1 0.1 0.0 0.5 49.2 0.0 0.0 0.8 0.1 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.5 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.3 0.8 0.1 3.9 10.1 9.2 1.8 18.1 0.1 0.8 0.0 0.3 12.4 0.4 0.0 0.2 31.7 14.9 20.3 0.2 0.0 3.2 4.4 5.7 1.4 4.4 5.3 4.6 13.6 3.8 8.1 7.5 11.9 80.7 2.9 0.2 2.5 0.0 1.4 0.0 2.7 19.4 0.0 0.0 0.3 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.2 2.1 0.2 70.6 0.0 46.3 0.0 0.0 0.0 28.3 0.0 0.0 71.4 1.7 2.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.1 1.0 0.3 5.0 0.0 0.0 ITGB1 "CD29, FNRB, GPIIA, MDF2, MSK12" ENSG00000150093 "Integrin subunit beta 1" P05556 10 32900319-33005792 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Ductal cells: 1163.1;Pancreatic endocrine cells: 917.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 196.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003434, HPA059297, HPA069003" Enhanced Supported "Endoplasmic reticulum,Plasma membrane,Focal adhesion sites" NA NA 540000000 "Plasma membrane, Focal adhesion sites" "Endoplasmic reticulum" "CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125" "unprognostic (3.07e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.67e-2)" "unprognostic (4.36e-1)" "unprognostic (1.20e-2)" "unprognostic (3.87e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (3.36e-6)" "unprognostic (3.22e-1)" "unprognostic (2.36e-3)" "unprognostic (3.68e-3)" "unprognostic (2.42e-1)" "unprognostic (1.02e-3)" "unprognostic (1.25e-2)" "unprognostic (2.23e-1)" "unprognostic (2.48e-1)" "unprognostic (3.08e-2)" 95.2 30.6 13.7 32.1 19.7 9.7 107.7 6.5 14.8 55.1 61.3 17.0 80.2 20.2 84.2 56.2 59.9 45.0 49.8 68.7 15.0 14.4 47.3 85.8 55.4 34.5 23.0 11.1 47.4 37.4 17.6 35.2 83.3 19.5 53.1 32.2 18.6 30.3 76.2 58.0 19.5 42.3 109.3 30.1 59.8 45.4 26.9 18.8 12.7 36.8 27.6 19.4 92.7 47.4 31.3 9.1 4.3 27.1 21.9 68.4 26.2 45.6 67.0 36.2 40.1 87.3 75.2 31.6 153.5 89.0 73.1 66.9 15.0 106.9 12.3 27.8 128.7 48.0 31.9 10.9 87.3 81.6 12.1 8.8 14.8 31.9 17.5 61.5 3.3 14.7 76.2 47.8 76.9 31.3 196.1 89.8 6.1 10.2 5.4 120.5 7.5 5.7 3.3 8.0 13.9 34.0 3.7 26.8 2.2 104.2 13.2 8.6 21.4 47.8 8.1 34.4 61.5 10.9 11.9 100.4 94.2 54.7 66.9 51.1 5.0 1.1 6.9 69.4 14.1 36.9 1.6 9.8 4.3 25.5 17.8 6.0 31.3 54.6 37.5 9.1 8.6 7.1 19.1 2.3 21.9 27.1 3.7 68.4 26.2 13.7 19.7 6.5 14.8 15.0 14.4 23.0 11.1 19.5 18.8 318.6 128.6 76.4 295.7 485.6 32.6 175.3 242.0 164.6 252.5 214.6 29.5 156.7 11.6 1163.1 4.3 314.7 83.6 70.0 355.7 460.3 265.1 177.2 86.6 221.3 161.3 36.5 185.6 387.9 152.7 9.7 235.6 174.3 325.6 83.0 81.4 76.8 917.0 113.2 565.7 64.3 45.2 627.3 497.4 10.0 63.7 149.1 183.8 106.6 98.8 257.2 ITGB2 "CD18, LFA-1, MAC-1, MFI7" ENSG00000160255 "Integrin subunit beta 2" P05107 21 44885953-44931989 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Integrin, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 159.7;bone marrow: 91.4;lymphoid tissue: 75.6" "Group enriched" "Detected in many" 4 "Hofbauer cells: 620.8;Kupffer cells: 458.1;Macrophages: 428.6;T-cells: 303.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "THP-1: 117.5;U-937: 87.3" "Low region specificity" "Detected in all" "HPA008877, HPA016894" Enhanced Supported "Plasma membrane,Rods & Rings" NA NA 2500000 "Plasma membrane" "Rods & Rings" "HPA008877: AB_1846256, HPA016894: AB_1846257" "unprognostic (1.94e-2)" "unprognostic (7.66e-3)" "unprognostic (1.23e-1)" "unprognostic (6.21e-3)" "unprognostic (2.95e-2)" "unprognostic (9.73e-3)" "unprognostic (2.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.18e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (1.87e-3)" "unprognostic (1.42e-1)" "unprognostic (4.42e-2)" "unprognostic (2.65e-2)" "unprognostic (4.83e-2)" 59.1 9.8 9.0 47.5 16.8 91.4 8.4 1.7 8.0 5.6 7.4 12.2 1.2 6.3 4.9 9.0 4.8 10.7 10.3 9.7 7.2 6.4 8.1 7.0 32.9 73.8 14.3 2.9 6.6 5.1 1.1 3.3 12.7 12.1 6.9 4.2 5.2 8.8 2.7 3.0 4.1 13.2 12.3 18.3 75.6 7.6 4.2 12.2 53.5 4.5 2.2 29.0 15.7 4.2 9.5 76.0 104.6 122.9 41.0 57.4 159.7 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 2.5 20.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 2.4 0.0 0.4 0.0 15.3 4.0 0.2 0.0 0.0 0.0 0.0 0.0 8.1 0.1 0.2 1.0 0.5 17.4 18.5 0.0 0.0 0.3 0.2 3.6 9.5 0.7 0.0 0.1 0.2 0.5 0.3 0.3 0.0 0.0 117.5 0.3 0.0 1.0 0.0 0.5 0.1 0.8 0.4 0.0 87.3 0.1 10.5 122.9 85.7 57.4 84.1 25.8 6.7 28.4 39.5 76.0 9.5 19.1 32.0 104.6 41.0 81.0 11.6 20.7 159.7 9.0 16.8 1.7 8.0 7.2 6.4 14.3 2.9 12.1 12.2 14.9 42.5 86.5 0.5 4.8 0.0 3.5 15.3 5.3 19.4 5.2 0.0 3.4 0.0 2.7 0.5 5.2 0.0 0.0 0.3 3.3 5.7 0.5 23.1 4.3 620.8 0.0 0.0 11.6 458.1 2.1 0.6 428.6 5.0 109.2 0.1 0.3 0.4 0.0 1.4 3.4 0.6 6.5 3.1 0.2 1.1 4.4 4.7 303.6 0.2 0.6 ITGB3 "CD61, GP3A, GPIIIa" ENSG00000259207 "Integrin subunit beta 3" P05106 17 47253846-47311816 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 36.6" "Cell type enhanced" "Detected in some" 10 "Late spermatids: 4.1;Proximal tubular cells: 3.5;Sertoli cells: 6.5" "Group enriched" "Detected in many" 6 "melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 19 "basophil: 2.8;neutrophil: 2.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "EFO-21: 46.6;HEL: 41.2;RPTEC TERT1: 26.8;U-87 MG: 21.1;WM-115: 67.2" HPA027852 Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 710000000 "Plasma membrane" Nucleoplasm "HPA027852: AB_10601760" "unprognostic (1.13e-2)" "unprognostic (1.97e-3)" "unprognostic (2.47e-1)" "unprognostic (3.00e-2)" "unprognostic (1.91e-2)" "unprognostic (6.04e-3)" "unprognostic (3.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-1)" "unprognostic (6.35e-2)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.03e-2)" "unprognostic (2.72e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-3)" 10.0 0.6 1.0 6.2 2.5 2.7 7.0 0.4 1.6 4.6 13.6 0.9 2.4 2.2 9.7 5.7 6.4 6.4 2.8 8.5 0.7 0.6 16.0 3.7 5.2 1.2 2.3 0.1 4.6 0.6 0.7 1.6 23.5 1.6 6.4 4.8 1.8 2.5 11.5 4.9 2.4 5.0 17.0 1.8 9.5 3.6 2.6 0.6 0.2 36.6 1.9 0.9 11.0 7.8 0.1 0.0 2.8 0.1 0.0 0.0 9.5 0.0 0.4 0.1 0.0 2.4 1.0 0.0 1.2 6.1 2.6 2.4 0.0 0.0 0.1 46.6 0.3 3.6 0.0 0.0 0.0 3.4 0.9 0.0 41.2 0.1 0.0 2.0 0.0 0.0 1.0 0.0 15.6 0.4 1.8 11.6 0.6 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.0 26.8 0.0 0.0 0.1 1.5 0.0 8.4 2.4 0.0 0.0 12.6 0.5 0.7 0.3 2.8 0.0 0.0 0.3 21.1 0.0 67.2 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 9.5 1.0 2.5 0.4 1.6 0.7 0.6 2.3 0.1 1.6 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 2.7 1.4 0.0 0.0 0.4 0.0 0.8 0.1 0.0 0.8 0.8 0.0 0.0 1.8 0.0 4.1 0.3 0.3 0.0 0.0 0.0 0.0 1.0 0.0 1.1 3.5 0.0 6.5 1.9 0.0 2.3 0.4 1.0 0.0 0.0 0.1 ITGB5 ENSG00000082781 "Integrin subunit beta 5" P18084 3 124761948-124901418 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 71.2;hTERT-RPE1: 81.6;WM-115: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001820, CAB022050" Approved Approved "Plasma membrane,Mitochondria" NA NA 95000 "Plasma membrane, Mitochondria" "CAB022050: , HPA001820: AB_1079142" "unprognostic (2.63e-1)" "unprognostic (1.04e-1)" "unprognostic (3.57e-1)" "unprognostic (4.44e-2)" "unprognostic (1.37e-2)" "unprognostic (6.07e-2)" "unprognostic (3.49e-3)" "unprognostic (3.16e-3)" "unprognostic (1.68e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.16e-1)" "unprognostic (2.16e-3)" "unprognostic (2.49e-3)" "unprognostic (1.12e-1)" "unprognostic (1.01e-1)" "unprognostic (4.38e-3)" 72.5 13.8 9.7 9.7 10.0 0.8 50.1 5.7 8.2 34.2 18.8 14.8 28.0 12.9 31.7 17.2 25.6 13.9 29.1 32.9 9.4 5.1 19.6 22.1 20.4 3.5 12.0 6.2 17.4 12.1 8.9 8.4 36.4 13.0 23.0 10.1 27.1 18.6 23.1 15.9 33.3 16.1 25.1 9.0 18.7 12.4 17.0 8.7 2.8 18.8 16.2 10.9 24.4 27.1 0.1 1.1 0.4 0.6 0.9 2.1 5.8 28.5 71.2 5.1 12.9 48.3 14.1 26.4 30.6 19.0 5.7 9.2 14.2 37.3 0.1 14.9 51.9 28.1 22.9 4.6 15.9 5.0 0.3 3.1 10.1 11.0 14.9 8.4 0.0 18.5 8.4 3.7 14.3 7.5 81.6 19.1 0.0 9.0 15.3 19.5 29.0 0.1 0.1 22.9 16.0 7.9 0.0 8.2 10.7 16.1 6.3 0.1 10.7 22.7 33.8 25.8 9.4 19.1 0.6 49.1 21.5 32.5 18.6 15.8 2.6 2.7 0.1 22.5 0.1 74.2 0.4 0.6 0.2 2.1 0.2 0.0 0.0 0.2 0.0 1.1 0.1 0.3 0.4 0.4 0.9 0.4 0.1 0.0 5.8 9.7 10.0 5.7 8.2 9.4 5.1 12.0 6.2 13.0 8.7 6.0 7.9 2.2 18.8 15.2 6.2 26.4 43.3 5.3 10.3 27.9 3.9 56.6 10.0 34.5 7.5 22.6 19.6 0.0 16.3 4.7 30.7 22.0 0.0 32.1 60.3 33.4 3.4 41.1 27.6 2.3 18.7 16.7 10.1 0.0 13.3 47.4 43.9 27.4 15.6 10.2 15.2 38.8 35.3 1.4 6.4 19.4 46.1 0.0 15.0 12.0 ITGB6 ENSG00000115221 "Integrin subunit beta 6" P18564 2 160099666-160200313 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Amelogenesis imperfecta, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 62.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 142.9;Alveolar cells type 2: 159.2;Pancreatic endocrine cells: 133.9;Spermatocytes: 219.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.5;RPTEC TERT1: 74.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023626, CAB073536" Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA "Nucleoplasm, Cell Junctions" Centrosome "CAB073536: , HPA023626: AB_2671267" "unprognostic (1.27e-1)" "unprognostic (1.57e-2)" "unprognostic (6.90e-2)" "unprognostic (8.22e-3)" "unprognostic (3.61e-3)" "unprognostic (1.50e-2)" "unprognostic (1.72e-3)" "unprognostic (2.04e-2)" "unprognostic (1.72e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (5.03e-6)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (1.00e-1)" 0.3 0.3 0.3 3.1 0.3 0.0 8.7 0.3 0.3 4.1 8.3 0.1 4.5 3.5 2.1 2.5 18.7 1.2 12.0 0.7 0.3 0.3 62.1 0.3 28.8 0.1 0.3 0.1 1.5 3.8 7.0 2.2 18.7 0.2 7.5 3.0 0.1 3.8 4.8 31.5 1.9 11.7 2.0 0.3 0.3 7.9 0.6 0.1 0.1 4.9 6.8 5.9 12.8 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 37.5 0.0 0.2 0.0 0.0 7.7 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 2.4 0.0 0.0 2.9 0.0 74.9 12.4 0.0 0.0 0.0 11.8 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 142.9 159.2 0.0 106.9 9.3 0.0 37.4 10.2 8.1 77.3 68.0 0.0 6.6 0.0 51.3 71.2 2.2 10.3 0.0 92.6 5.2 3.3 42.3 3.5 0.8 2.0 0.0 0.0 1.8 0.8 24.4 2.6 2.5 1.7 3.6 14.1 0.8 133.9 21.0 1.1 0.2 0.0 0.0 2.7 219.5 2.4 7.4 3.9 0.0 11.2 104.4 ITGB7 ENSG00000139626 "Integrin subunit beta 7" P26010 12 53191318-53207307 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.3;lymphoid tissue: 37.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 35.7;granulocytes: 29.9;T-cells: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 99 "Karpas-707: 295.2;RPMI-8226: 230.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA042277 Approved "Nucleoplasm,Nuclear membrane,Vesicles,Plasma membrane,Cytosol" NA NA 42000 "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA042277: AB_10793877" "unprognostic (5.34e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-3)" "unprognostic (1.40e-2)" "unprognostic (6.57e-4)" "unprognostic (3.51e-5)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.58e-1)" "unprognostic (2.18e-1)" "unprognostic (9.63e-3)" "unprognostic (3.36e-1)" "unprognostic (1.02e-2)" "unprognostic (2.16e-1)" "unprognostic (6.95e-2)" "unprognostic (9.34e-2)" "unprognostic (2.47e-4)" 1.8 1.4 1.4 29.1 1.8 7.5 1.5 0.6 1.2 1.8 8.7 2.9 0.8 6.7 2.3 2.8 6.6 2.0 5.6 1.4 1.5 1.0 5.4 5.1 4.9 26.4 1.9 1.0 1.1 1.3 0.7 1.7 1.8 2.4 2.7 5.6 2.1 10.7 2.2 1.0 6.4 15.1 1.5 2.0 26.7 4.3 0.9 2.0 7.8 3.6 4.4 37.6 4.6 3.0 10.1 15.4 31.3 1.9 7.5 23.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 295.2 0.0 0.0 0.0 0.4 0.0 2.4 0.0 0.1 0.0 230.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.2 0.2 0.1 0.1 22.6 1.9 31.3 19.3 0.5 14.3 10.1 19.4 23.0 15.4 8.3 16.3 17.1 0.5 7.5 0.1 4.2 22.7 5.2 1.4 1.8 0.6 1.2 1.5 1.0 1.9 1.0 2.4 2.0 3.0 8.5 35.7 0.3 1.9 0.0 0.4 2.5 0.0 0.0 7.0 3.9 0.1 6.6 0.2 0.0 0.1 0.0 0.0 0.5 0.1 1.0 0.1 29.9 1.6 13.8 0.0 0.0 0.6 3.0 0.0 0.0 7.0 6.8 7.2 0.3 6.6 0.6 0.0 0.0 4.4 0.7 0.0 0.4 0.2 1.1 3.1 0.1 27.7 0.9 1.3 ITGB8 ENSG00000105855 "Integrin subunit beta 8" P26012 7 20330702-20415754 "Cancer-related genes, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 99.3;Ciliated cells: 78.9;Glandular cells: 109.9;Urothelial cells: 146.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 105 "basophil: 13.8" "Lineage enriched" "Detected in single" 105 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "AF22: 16.6;EFO-21: 21.4;RPTEC TERT1: 33.2;WM-115: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027796, HPA027797" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA027796: AB_10600299, HPA027797: AB_10600879" "unprognostic (8.32e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (5.63e-2)" "unprognostic (3.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.46e-1)" "unprognostic (4.36e-2)" "unprognostic (1.75e-2)" "unprognostic (2.49e-3)" "unprognostic (8.47e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.63e-2)" "unprognostic (6.92e-3)" 4.7 4.1 18.0 5.8 20.0 1.2 12.7 7.8 24.3 22.1 4.6 19.4 9.0 4.6 10.5 19.0 8.8 10.4 11.7 3.9 19.4 12.5 28.1 1.7 3.7 1.3 29.3 14.5 7.1 17.5 8.1 7.7 10.7 22.8 9.6 4.4 37.5 16.6 13.1 0.9 8.5 6.0 7.0 23.1 0.8 6.2 8.7 24.0 0.0 3.4 1.3 9.0 6.8 9.9 0.0 0.0 13.8 0.1 0.0 0.1 0.0 10.2 0.4 16.6 2.1 1.4 5.9 0.0 0.0 0.1 0.1 0.6 0.1 2.6 0.0 21.4 0.7 0.6 11.4 0.7 1.6 0.2 0.0 0.2 0.0 8.0 0.0 0.7 0.0 0.0 0.7 4.7 0.2 0.9 10.2 0.8 0.0 0.0 3.1 0.3 0.0 0.0 0.0 1.2 0.1 1.8 0.0 1.4 0.0 33.2 0.9 0.2 0.7 3.2 0.0 8.3 0.3 0.2 0.0 1.1 4.3 2.8 1.2 2.1 3.9 0.0 0.0 1.0 0.0 47.5 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 18.0 20.0 7.8 14.2 19.4 12.5 29.3 14.5 22.8 24.0 11.9 3.7 0.8 99.3 29.5 5.2 3.1 43.3 78.9 30.7 36.6 0.0 12.5 6.6 22.1 2.3 1.9 4.6 0.0 15.3 0.9 3.2 109.9 1.1 0.0 3.1 1.6 32.6 1.3 1.5 3.5 40.9 12.4 3.3 55.1 6.8 26.0 24.5 6.2 42.1 44.6 1.2 0.0 1.4 0.5 0.7 10.8 4.1 0.5 7.3 146.8 ITIH1 "H1P, IATIH, ITIH" ENSG00000055957 "Inter-alpha-trypsin inhibitor heavy chain 1" P19827 3 52777592-52792068 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 95 "liver: 321.2" "Cell type enriched" "Detected in some" 23 "Hepatocytes: 864.9" "Cancer enriched" "Detected in some" 598 "liver cancer: 329.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 10.9;Hep G2: 3.3;HL-60: 2.5;RH-30: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041639, HPA042049" Approved Approved Vesicles "Secreted to blood" NA NA 4490000 31000000000 Vesicles "HPA041639: AB_10796349, HPA042049: AB_10797379" "unprognostic (1.87e-4)" "unprognostic (1.31e-3)" "unprognostic (2.38e-1)" "unprognostic (8.55e-2)" "unprognostic (1.03e-1)" "unprognostic (2.64e-3)" "prognostic favorable (1.89e-5)" "unprognostic (2.27e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (2.91e-2)" "unprognostic (8.45e-2)" "unprognostic (4.53e-4)" "unprognostic (4.02e-3)" "unprognostic (5.70e-3)" "unprognostic (2.08e-1)" "unprognostic (2.24e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 321.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.3 0.8 0.0 0.9 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.7 0.0 0.0 3.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 864.9 0.1 0.0 0.0 18.4 14.8 1.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.1 0.5 0.0 0.0 ITLN2 HL-2 ENSG00000158764 "Intelectin 2" Q8WWU7 1 160945025-160954799 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "intestine: 88.4" "Cell type enriched" "Detected in some" 9 "Alveolar cells type 1: 71.5" "Cancer enhanced" "Detected in many" "testis cancer: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 15.4;HHSteC: 2.6;HMC-1: 4.6;SK-MEL-30: 4.9;SuSa: 5.4" "HPA006683, HPA067326" Enhanced "Secreted to digestive system" NA NA "HPA006683: AB_2129681, HPA067326: AB_2732764" "unprognostic (1.42e-1)" "unprognostic (9.62e-3)" "unprognostic (4.61e-2)" "unprognostic (7.45e-2)" "unprognostic (2.25e-1)" "unprognostic (6.84e-4)" "unprognostic (2.47e-2)" "unprognostic (5.74e-2)" "unprognostic (1.31e-2)" "unprognostic (1.36e-1)" "unprognostic (5.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.49e-1)" "unprognostic (2.31e-1)" "unprognostic (4.91e-2)" 3.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 27.4 0.1 0.1 53.3 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 2.5 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 88.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 2.6 0.0 4.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.0 0.0 0.0 4.9 5.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 71.5 7.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 8.0 0.0 0.0 1.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 ITM2A "BRICD2A, E25A" ENSG00000078596 "Integral membrane protein 2A" O43736 X 79360384-79367667 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 100.7" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 252.4;granulocytes: 190.5;Leydig cells: 310.7;Muller glia cells: 153.0;T-cells: 187.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 26.5;eosinophil: 16.8;gdT-cell: 23.2;MAIT T-cell: 17.0;memory CD4 T-cell: 44.6;memory CD8 T-cell: 36.5;naive CD4 T-cell: 48.0;naive CD8 T-cell: 22.6;NK-cell: 25.2;T-reg: 32.4" "Group enriched" "Detected in many" 7 "granulocytes: 26.5;NK-cells: 25.2;T-cells: 48.0" "Cell line enriched" "Detected in some" 5 "MOLT-4: 191.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000296 Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA000296: " "unprognostic (1.05e-2)" "unprognostic (5.22e-3)" "unprognostic (2.77e-3)" "unprognostic (5.65e-2)" "unprognostic (1.73e-2)" "unprognostic (1.06e-3)" "prognostic favorable (3.66e-6)" "unprognostic (1.57e-1)" "unprognostic (4.94e-2)" "unprognostic (9.85e-2)" "unprognostic (1.33e-2)" "unprognostic (2.57e-1)" "unprognostic (1.04e-2)" "unprognostic (1.56e-1)" "unprognostic (3.31e-1)" "unprognostic (2.18e-1)" "unprognostic (4.30e-1)" 27.2 4.1 27.0 9.1 37.8 13.6 27.4 7.8 25.8 21.8 11.0 16.1 6.5 5.4 16.4 19.4 14.8 15.3 10.6 42.1 33.6 22.5 7.7 2.2 19.0 28.5 34.8 19.5 69.6 6.3 2.7 9.3 10.6 25.8 16.7 11.9 16.2 28.2 8.8 13.2 10.3 8.8 20.9 33.9 8.4 9.6 8.0 12.5 100.7 31.1 14.1 16.5 14.7 16.6 4.7 1.1 26.5 0.2 25.2 48.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.3 0.0 0.5 0.0 7.8 0.0 0.0 0.0 12.4 14.4 2.3 0.0 0.0 0.0 0.0 0.0 37.7 8.8 0.0 0.0 0.0 191.0 8.6 2.8 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 2.2 0.0 0.1 0.0 2.1 0.2 0.2 0.3 0.0 0.2 0.0 0.1 24.1 0.0 0.0 0.0 0.0 0.9 26.5 0.1 16.8 23.2 0.2 17.0 4.6 44.6 36.5 0.1 4.7 48.0 22.6 0.8 25.2 0.2 1.1 32.4 22.6 27.0 37.8 7.8 25.8 33.6 22.5 34.8 19.5 25.8 12.5 3.0 20.8 15.9 13.6 59.9 2.3 25.4 5.1 1.4 7.9 1.8 0.0 0.4 5.0 0.2 2.4 252.4 0.0 0.0 46.7 0.1 64.7 9.2 190.5 0.8 1.0 1.6 2.4 119.7 10.6 4.7 310.7 4.2 59.1 1.0 66.9 153.0 0.9 0.0 110.7 1.1 5.8 0.0 20.2 0.4 1.1 41.0 0.2 187.1 2.3 2.3 ITM2B "BRI, BRI2, BRICD2B, E25B, E3-16" ENSG00000136156 "Integral membrane protein 2B" Q9Y287 13 48233158-48270357 "Disease related genes, Predicted membrane proteins" "Amyloidosis, Deafness, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 346.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 236.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 236.4" "Cell line enhanced" "Detected in many" "HMC-1: 109.5;RPTEC TERT1: 155.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029292, HPA071992" Enhanced Enhanced "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 2600000 "Golgi apparatus, Vesicles" "HPA029292: AB_10601917, HPA071992: AB_2686480" "unprognostic (4.66e-2)" "unprognostic (2.02e-1)" "unprognostic (1.03e-2)" "unprognostic (1.00e-1)" "unprognostic (4.41e-2)" "unprognostic (6.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "unprognostic (9.88e-2)" "unprognostic (2.42e-1)" "unprognostic (5.89e-2)" "unprognostic (2.87e-2)" "prognostic favorable (3.73e-5)" "unprognostic (4.38e-2)" "unprognostic (4.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.22e-1)" 89.3 79.6 60.6 41.3 61.6 25.0 79.6 87.2 65.8 72.6 58.3 64.9 93.4 83.4 61.2 346.2 71.5 53.2 59.4 86.9 75.9 61.4 198.7 65.1 80.2 75.9 71.7 49.8 100.7 48.5 27.0 63.1 132.0 50.2 66.5 36.0 80.8 75.1 99.8 30.9 73.5 81.0 53.1 90.0 78.5 64.5 44.7 48.3 35.0 73.1 63.0 47.7 63.3 74.5 13.3 23.3 236.4 46.6 17.2 31.7 73.7 8.6 7.6 12.8 23.9 48.8 29.7 19.0 23.0 29.2 11.6 14.7 5.4 41.8 2.3 19.6 16.8 9.2 35.6 6.9 16.7 9.8 6.8 16.2 16.5 6.2 14.7 21.0 16.2 109.5 17.8 14.9 6.8 7.5 58.9 14.9 11.6 4.2 20.1 14.1 5.9 26.1 35.8 35.0 25.1 10.3 11.8 12.7 11.8 155.7 41.2 4.4 17.2 20.4 16.8 11.9 44.8 10.9 17.3 24.0 9.7 9.7 12.5 11.2 7.8 7.3 0.3 14.1 9.4 21.6 136.9 46.6 141.3 21.3 35.7 28.1 12.0 29.8 26.5 23.3 13.3 31.7 26.5 236.4 17.2 35.5 10.3 28.7 73.7 60.6 61.6 87.2 58.0 75.9 61.4 71.7 49.8 50.2 48.3 646.2 271.8 308.5 1451.5 766.1 652.6 328.8 715.9 234.2 337.8 1889.5 176.7 1011.0 462.6 652.8 18.2 997.4 807.3 186.9 609.1 1937.1 842.6 824.8 565.6 490.5 1723.2 333.7 272.1 1299.4 1392.0 32.7 1728.8 1023.4 646.2 1577.2 438.3 1662.7 462.4 719.8 1890.9 2151.3 195.5 1203.0 551.5 116.1 261.4 1004.9 1230.6 638.1 376.8 1464.7 ITM2C "BRI3, BRICD2C, E25, hRPC.1050_D_4, ITM3" ENSG00000135916 "Integral membrane protein 2C" Q9NQX7 2 230864639-230879248 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 187.0;brain: 138.3;intestine: 158.6" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 668.0;Mucus-secreting cells: 885.6;Paneth cells: 2044.1;Undifferentiated cells: 840.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "plasmacytoid DC: 187.0" "Lineage enriched" "Detected in many" 9 "dendritic cells: 187.0" "Cell line enhanced" "Detected in many" "EFO-21: 78.4;NB-4: 84.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.50e-3)" "unprognostic (1.46e-1)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (3.74e-1)" "unprognostic (6.03e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-2)" "unprognostic (4.44e-2)" "unprognostic (3.45e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (2.08e-1)" "unprognostic (4.92e-2)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (2.52e-2)" 9.7 21.5 113.6 23.9 138.3 21.7 6.6 15.9 122.4 18.2 158.6 41.9 3.9 18.4 19.4 9.9 20.2 12.7 12.7 11.5 81.8 96.8 29.5 7.7 8.2 15.9 97.3 63.4 19.7 18.5 23.1 39.6 24.8 51.4 24.7 124.0 26.1 17.1 27.4 5.1 4.3 41.7 22.5 68.1 18.1 18.3 4.4 44.3 29.6 12.7 1.9 16.4 27.5 10.8 14.9 187.0 21.1 0.2 3.6 4.5 3.6 4.8 9.7 32.4 25.5 4.1 2.3 10.4 25.5 28.6 14.0 21.9 13.0 6.9 0.0 78.4 18.3 14.5 2.5 19.5 3.7 8.8 48.1 16.0 6.4 5.2 16.6 14.8 11.5 27.5 20.1 3.7 12.6 1.2 5.2 0.5 11.4 6.1 16.4 5.2 7.6 8.4 84.6 39.4 27.0 8.8 12.5 5.4 68.8 18.5 28.9 1.8 50.0 12.5 1.6 29.4 35.8 2.5 66.8 0.4 6.0 17.4 10.5 7.2 0.1 1.2 0.6 18.9 10.1 49.9 4.6 0.2 21.1 1.0 0.1 2.7 14.9 3.2 2.6 5.2 6.9 3.2 2.5 0.5 3.6 0.0 187.0 4.5 3.6 113.6 138.3 15.9 93.6 81.8 96.8 97.3 63.4 51.4 44.3 6.0 6.7 71.1 42.3 21.4 377.7 20.6 58.6 24.1 22.7 130.9 237.6 89.5 23.2 90.7 0.8 14.6 668.0 0.0 34.5 56.3 95.7 68.8 181.1 12.9 61.5 95.3 392.4 20.9 5.3 2.4 50.3 12.1 192.3 116.4 885.6 180.3 43.5 2044.1 65.0 20.1 83.2 135.8 75.2 4.7 17.7 13.0 48.2 46.5 840.0 60.9 ITPR1 "ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29" ENSG00000150995 "Inositol 1,4,5-trisphosphate receptor type 1" Q14643 3 4493348-4847840 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Apoptosis, Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 46.6" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 49.5;Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 35.0;HeLa: 25.5;HMC-1: 16.9;U-87 MG: 20.8" "Region enhanced" "Detected in all" "cerebellum: 782.1" "Low region specificity" "Detected in all" "HPA014765, HPA016487" Approved Approved Vesicles NA NA 37000 Vesicles "HPA014765: AB_1851843, HPA016487: AB_1851842" "unprognostic (1.92e-1)" "unprognostic (5.04e-2)" "unprognostic (1.34e-1)" "unprognostic (1.75e-1)" "unprognostic (2.16e-2)" "unprognostic (3.61e-2)" "unprognostic (1.60e-1)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.17e-2)" "unprognostic (1.92e-2)" "unprognostic (2.08e-1)" "unprognostic (2.77e-2)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.43e-4)" "unprognostic (2.40e-1)" 4.8 8.2 6.1 7.4 18.6 3.2 11.9 39.5 30.2 10.2 7.4 1.7 21.5 2.4 18.4 13.2 7.8 10.1 11.8 5.3 8.7 5.1 8.7 2.5 6.4 7.1 4.8 10.4 14.2 2.7 46.6 7.3 4.6 3.8 15.0 3.7 12.5 9.6 27.4 3.2 3.2 5.0 17.4 3.7 6.0 5.5 3.0 4.3 7.0 19.3 0.6 8.6 14.1 10.6 8.9 3.6 5.4 1.6 1.2 2.2 1.2 0.0 1.3 0.2 0.6 10.0 0.4 3.2 0.2 0.2 0.3 0.3 0.3 0.3 4.4 0.4 0.4 1.8 0.0 0.9 1.1 0.5 35.0 1.4 12.7 25.5 1.6 13.8 5.4 16.9 2.6 0.7 1.7 0.5 3.6 1.4 3.4 1.4 5.1 1.3 0.5 2.4 1.8 0.9 0.2 3.9 1.4 0.2 0.3 1.1 1.1 0.1 8.5 2.3 1.4 2.3 0.3 0.9 7.7 1.7 0.8 1.4 1.1 1.0 7.8 3.7 2.9 20.8 5.8 1.8 5.4 1.6 1.9 1.5 1.0 1.9 6.6 1.7 1.5 2.1 8.9 2.2 1.9 0.8 1.2 0.7 3.6 1.3 1.2 6.1 18.6 39.5 30.2 8.7 5.1 4.8 10.4 3.8 4.3 0.0 31.8 25.3 4.8 3.4 1.6 4.8 5.1 21.4 14.8 8.7 0.0 0.5 3.3 1.5 4.4 22.4 0.0 0.0 4.5 0.4 13.0 6.1 24.4 1.8 4.7 1.6 3.4 22.1 13.3 5.7 27.9 15.3 6.8 6.4 0.8 3.9 1.5 0.3 49.5 3.5 1.0 38.8 26.4 1.4 2.6 2.8 0.8 19.5 0.6 3.1 ITPR2 "CFAP48, IP3R2" ENSG00000123104 "Inositol 1,4,5-trisphosphate receptor type 2" Q14571 12 26336515-26833198 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 137.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059144, HPA062260" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA059144: AB_2683925, HPA062260: AB_2684728" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.37e-2)" "unprognostic (3.59e-3)" "unprognostic (8.70e-2)" "unprognostic (1.66e-1)" "unprognostic (8.61e-2)" "unprognostic (2.06e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.82e-1)" "unprognostic (9.13e-2)" "unprognostic (3.99e-2)" "unprognostic (3.76e-1)" 8.8 20.6 12.8 14.5 13.8 6.1 18.5 9.3 15.0 7.9 9.9 7.8 3.7 6.0 7.2 7.8 12.0 7.3 8.0 7.1 14.2 6.0 14.4 47.1 6.5 8.1 12.8 4.6 8.0 9.2 17.4 9.9 11.9 13.0 6.6 7.8 4.8 17.6 3.8 4.7 13.3 8.9 5.4 20.3 12.5 5.9 3.4 15.3 35.3 5.3 6.6 10.7 5.5 8.1 4.3 9.0 17.3 5.2 3.6 3.1 0.7 2.7 1.2 1.6 2.6 5.0 5.1 1.8 2.5 3.5 1.8 1.9 0.1 1.4 9.4 1.6 3.4 1.9 3.0 8.7 5.3 2.4 2.2 2.9 7.5 2.5 15.1 4.6 6.7 3.4 4.8 0.7 3.7 7.0 3.5 16.6 3.7 3.3 3.0 2.2 2.3 4.7 9.0 7.2 2.4 0.9 1.5 3.9 5.9 4.1 4.3 0.5 2.6 11.4 2.1 6.3 7.0 4.3 3.3 36.3 3.6 1.4 3.4 3.2 2.8 2.1 17.6 3.3 3.1 2.3 17.3 5.2 7.1 2.4 2.2 2.0 4.2 2.1 1.9 1.0 4.3 2.5 2.2 13.5 3.6 3.0 9.0 3.1 0.7 12.8 13.8 9.3 15.0 14.2 6.0 12.8 4.6 13.0 15.3 44.7 38.7 25.7 17.2 18.5 3.1 19.1 35.7 8.1 13.6 22.7 137.4 16.2 6.6 19.4 2.6 26.3 10.3 23.3 20.5 7.7 11.6 22.1 43.8 96.9 31.6 0.0 75.3 16.5 35.2 4.7 16.7 48.3 32.1 6.4 36.5 12.6 14.9 35.3 16.6 14.6 67.9 0.0 11.7 2.8 4.9 23.3 23.3 16.0 8.4 14.6 ITPR3 IP3R3 ENSG00000096433 "Inositol 1,4,5-trisphosphate receptor type 3" Q14573 6 33620365-33696574 "Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 129.4;Late spermatids: 168.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "basophil: 1.8;gdT-cell: 2.8;MAIT T-cell: 2.1;memory B-cell: 1.5;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.0;naive B-cell: 2.0;naive CD4 T-cell: 1.4;naive CD8 T-cell: 1.7;T-reg: 2.4" "Group enriched" "Detected in many" 10 "B-cells: 2.0;granulocytes: 1.8;T-cells: 2.8" "Cell line enhanced" "Detected in many" "hTERT-HME1: 52.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA003915, HPA064704" Approved Uncertain Vesicles No No Vesicles "HPA003915: AB_1851845, HPA064704: " "unprognostic (2.57e-1)" "unprognostic (2.81e-2)" "unprognostic (1.52e-2)" "unprognostic (2.30e-1)" "unprognostic (5.40e-2)" "unprognostic (1.24e-1)" "unprognostic (2.08e-2)" "unprognostic (6.14e-2)" "unprognostic (3.35e-1)" "unprognostic (3.08e-2)" "unprognostic (4.14e-3)" "unprognostic (1.88e-1)" "unprognostic (6.44e-3)" "unprognostic (5.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.89e-2)" "unprognostic (2.43e-2)" 7.8 6.0 2.0 17.8 2.4 2.6 9.0 1.7 2.3 6.5 39.6 1.0 35.1 14.8 7.7 15.6 10.0 6.7 28.9 7.2 1.8 1.4 8.6 1.2 21.0 9.7 4.4 1.2 7.3 11.0 1.3 3.9 3.9 4.0 7.2 9.5 5.4 12.7 26.0 2.7 27.9 44.0 6.6 3.5 20.0 21.4 20.1 1.9 10.6 28.4 9.7 18.1 5.2 16.5 2.0 0.2 1.8 0.0 0.1 2.8 0.7 21.8 10.3 1.9 0.1 1.9 6.2 12.8 7.5 19.4 9.5 8.6 14.1 17.1 18.7 8.2 5.4 23.9 21.7 8.8 20.4 4.9 10.9 7.3 0.0 29.3 15.5 4.5 3.3 2.4 4.4 18.5 23.9 52.0 20.9 16.0 7.5 7.3 6.1 10.2 10.4 5.6 1.9 1.9 16.7 15.2 8.6 0.0 11.0 33.8 15.4 17.9 0.6 13.0 19.1 18.7 2.2 6.5 1.8 21.8 12.9 6.4 16.5 16.5 4.2 4.1 8.9 10.3 5.0 7.4 1.8 0.0 0.0 2.8 0.0 2.1 1.5 1.7 2.0 0.2 2.0 1.4 1.7 0.0 0.1 0.0 0.0 2.4 0.7 2.0 2.4 1.7 2.3 1.8 1.4 4.4 1.2 4.0 1.9 44.7 47.5 4.3 10.4 23.6 0.6 1.6 7.6 8.1 18.2 29.6 0.0 0.2 0.0 25.3 129.4 13.2 36.8 0.0 26.2 5.4 5.0 12.7 0.0 0.2 0.5 0.0 23.0 15.4 0.6 168.6 21.6 3.3 11.8 4.6 35.8 0.2 62.5 35.1 13.1 0.0 1.2 6.5 2.0 1.1 3.0 22.2 0.5 10.0 30.7 15.4 ITPRIPL1 KIAA1754L ENSG00000198885 "ITPRIP like 1" Q6GPH6 2 96325331-96330517 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 12.5;testis: 19.4" "Group enriched" "Detected in many" 11 "Early spermatids: 133.5;Late spermatids: 110.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 12.5" "Lineage enriched" "Detected in many" 5 "T-cells: 12.5" "Cell line enhanced" "Detected in many" "HEK 293: 16.9;HEL: 17.1;MOLT-4: 17.9;RPMI-8226: 17.7;U-698: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.26e-3)" "unprognostic (3.56e-3)" "unprognostic (4.78e-2)" "unprognostic (9.43e-2)" "unprognostic (2.22e-1)" "unprognostic (6.56e-4)" "unprognostic (3.04e-2)" "unprognostic (2.87e-1)" "unprognostic (6.50e-2)" "unprognostic (5.36e-2)" "unprognostic (8.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.41e-5)" "unprognostic (4.97e-2)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (6.39e-2)" 3.9 0.6 1.4 5.6 0.9 0.8 7.8 6.2 1.8 1.6 0.9 1.1 2.1 1.2 0.8 0.4 2.0 1.1 1.7 2.7 0.9 0.8 0.8 1.4 2.7 4.0 2.3 0.8 0.7 7.2 0.3 0.8 1.2 1.7 2.3 0.8 1.4 8.3 1.7 1.4 1.1 2.1 1.4 1.3 3.1 1.1 19.4 1.1 4.7 1.1 1.2 4.7 1.8 3.4 1.6 1.2 0.2 0.2 2.2 12.5 1.9 0.0 0.0 3.8 0.0 0.4 1.0 5.3 0.9 4.5 3.8 7.6 1.7 0.2 0.0 0.0 1.5 0.0 0.3 13.6 0.0 4.3 8.9 16.9 17.1 0.1 7.6 2.1 0.0 0.0 3.0 0.0 4.4 0.0 0.0 2.5 10.6 0.0 5.8 0.1 0.0 17.9 2.5 5.9 0.0 0.0 11.7 12.7 17.7 0.1 0.0 11.4 7.5 0.0 0.0 0.0 2.5 0.0 2.7 1.1 0.0 0.5 0.0 0.0 9.2 12.1 19.4 2.2 0.0 3.7 0.2 0.2 0.0 9.9 0.2 12.5 1.6 3.3 9.5 1.2 0.4 0.8 4.2 0.1 2.2 0.0 0.5 5.5 1.9 1.4 0.9 6.2 1.8 0.9 0.8 2.3 0.8 1.7 1.1 3.0 0.0 0.0 3.1 0.2 0.5 0.8 0.0 1.4 4.5 0.0 3.9 0.6 0.0 0.1 133.5 0.7 0.0 0.0 0.2 1.9 0.6 1.3 0.0 0.0 1.6 0.0 0.0 0.0 0.3 110.9 1.1 1.6 1.7 0.0 0.0 4.7 0.5 0.0 0.7 0.2 1.7 6.5 1.0 1.4 2.1 0.9 0.3 10.9 0.3 1.3 ITPRIPL2 "FLJ22994, LOC162073, MGC126798, MGC126800" ENSG00000205730 "ITPRIP like 2" Q3MIP1 16 19113932-19121629 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042011 Approved Centrosome NA NA Centrosome "HPA042011: AB_2677795" "unprognostic (1.07e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-2)" "unprognostic (9.64e-2)" "unprognostic (1.97e-1)" "unprognostic (2.20e-1)" "unprognostic (3.76e-2)" "unprognostic (6.72e-3)" "unprognostic (5.60e-2)" "unprognostic (1.90e-2)" "unprognostic (5.26e-3)" "unprognostic (4.24e-2)" "unprognostic (1.53e-1)" "unprognostic (7.23e-2)" "unprognostic (6.37e-2)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" 32.6 10.7 6.2 8.3 6.0 0.9 25.8 1.2 4.1 16.0 11.4 4.3 8.2 6.1 12.7 10.6 16.4 10.2 12.7 9.9 3.8 2.8 6.4 9.5 16.7 5.1 5.6 2.1 11.6 15.0 8.5 4.7 26.5 5.7 19.1 5.9 9.5 8.5 8.9 7.3 19.7 9.1 11.3 4.0 7.8 9.9 4.9 5.7 2.0 12.0 12.8 8.0 14.2 25.7 0.5 1.9 1.3 6.6 0.2 0.6 0.6 9.1 5.4 2.1 7.1 18.5 28.3 14.2 14.7 10.4 4.3 4.0 2.2 16.6 0.0 15.1 11.5 5.1 10.5 3.0 4.5 5.7 0.0 3.0 0.7 10.9 3.8 12.0 0.0 0.0 18.7 12.5 8.3 9.5 7.8 5.6 0.0 1.3 0.0 10.2 6.2 0.0 0.2 2.2 1.9 7.2 0.0 0.3 0.0 6.5 15.5 0.2 2.7 12.0 1.2 7.1 3.6 7.2 1.4 11.1 15.1 6.5 7.7 5.5 0.1 0.0 0.0 8.8 0.3 7.5 1.3 2.8 0.3 0.6 3.4 0.3 0.5 0.3 0.5 1.9 0.3 0.2 0.5 1.0 0.2 6.6 1.2 0.1 0.6 6.2 6.0 1.2 4.1 3.8 2.8 5.6 2.1 5.7 5.7 47.6 33.6 2.4 22.3 11.3 0.5 5.6 7.6 22.7 33.0 24.4 2.0 13.4 1.7 13.6 0.3 28.7 14.4 0.0 27.1 8.2 28.3 27.3 5.7 22.2 21.0 4.8 13.8 41.1 49.9 0.4 24.7 27.1 13.5 27.9 19.6 1.7 33.4 8.6 28.3 0.1 0.3 38.8 24.5 0.2 1.9 15.2 12.0 1.3 16.3 29.4 ITSN1 "ITSN, MGC134948, MGC134949, SH3D1A, SH3P17" ENSG00000205726 "Intersectin 1" Q15811 21 33642400-33899861 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Exocytosis, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 5.9;eosinophil: 7.2;intermediate monocyte: 4.1;myeloid DC: 1.8;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 7 "dendritic cells: 1.8;granulocytes: 7.2;monocytes: 6.3" "Cell line enhanced" "Detected in all" "BEWO: 43.0;NTERA-2: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018007 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA018007: AB_1851836" "unprognostic (2.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.62e-1)" "unprognostic (1.21e-1)" "unprognostic (3.91e-1)" "unprognostic (1.81e-1)" "unprognostic (1.10e-1)" "unprognostic (3.94e-2)" "unprognostic (7.33e-3)" "unprognostic (1.31e-2)" "unprognostic (3.23e-1)" "unprognostic (3.25e-2)" "unprognostic (1.16e-2)" "unprognostic (6.78e-3)" "unprognostic (2.37e-1)" "unprognostic (6.02e-2)" "unprognostic (5.64e-2)" 47.4 14.9 24.9 8.9 24.5 5.7 21.7 24.2 24.8 15.5 11.2 10.2 12.3 8.3 17.9 11.8 11.0 13.6 18.5 18.3 24.6 12.1 10.7 23.1 9.5 5.9 12.1 20.4 19.2 4.9 8.4 7.7 22.0 21.1 14.2 10.6 11.4 6.9 21.9 18.0 11.0 9.0 17.4 11.1 13.4 10.3 11.2 15.0 2.4 9.3 4.0 3.9 13.1 12.5 0.0 1.8 7.2 6.3 0.1 0.7 1.1 12.8 5.4 26.1 8.6 12.3 11.8 43.0 13.0 12.6 7.7 7.4 20.4 9.9 3.0 10.6 15.6 16.0 5.0 15.5 9.0 8.3 1.2 6.8 3.7 11.2 9.5 9.3 2.6 3.7 11.6 8.2 14.4 8.0 8.8 20.3 3.5 4.8 2.1 12.3 2.9 3.6 3.5 38.7 4.5 4.1 4.7 12.5 6.2 11.5 5.3 4.9 5.4 18.7 3.9 4.7 17.4 4.8 2.6 18.2 8.6 11.7 6.7 4.5 2.6 7.2 2.8 7.8 8.2 9.5 0.0 5.9 7.2 0.4 4.1 0.5 0.0 0.7 0.2 1.8 0.0 0.3 0.1 0.3 0.1 6.3 0.4 0.0 1.1 24.9 24.5 24.2 24.8 24.6 12.1 12.1 20.4 21.1 15.0 23.8 15.2 5.8 17.3 16.1 68.6 68.0 20.4 20.1 12.5 10.4 86.4 19.3 0.0 18.1 5.9 22.4 16.9 70.0 10.9 21.5 25.7 14.8 2.3 43.3 44.1 62.0 8.7 28.8 27.1 6.5 23.0 11.3 10.1 11.8 5.7 43.1 25.1 9.1 67.1 13.6 150.8 12.9 23.6 20.0 46.4 10.3 13.0 3.2 9.6 16.1 IYD "C6orf71, DEHAL1, dJ422F24.1" ENSG00000009765 "Iodotyrosine deiodinase" Q6PHW0 6 150368892-150405969 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "thyroid gland: 212.3" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 8.5;Cholangiocytes: 20.4;Club cells: 12.5;Enterocytes: 25.8;Hepatocytes: 18.3;Mucus-secreting cells: 15.4;Paneth cells: 17.3;Proximal tubular cells: 33.8;Undifferentiated cells: 10.3" "Cancer enriched" "Detected in many" 20 "thyroid cancer: 80.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "CACO-2: 3.0;OE19: 6.8;SK-BR-3: 7.4" "Group enriched" "Detected in some" 13 "hippocampal formation: 8.1;thalamus: 2.6" "Low region specificity" "Detected in many" HPA059627 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA059627: AB_2684086" "unprognostic (3.73e-4)" "unprognostic (2.93e-2)" "unprognostic (5.97e-2)" "unprognostic (1.95e-2)" "unprognostic (1.55e-1)" "unprognostic (2.98e-2)" "prognostic favorable (6.22e-4)" "unprognostic (1.11e-1)" "unprognostic (3.80e-2)" "unprognostic (1.17e-1)" "unprognostic (7.41e-2)" "unprognostic (1.02e-1)" "unprognostic (3.07e-9)" "unprognostic (9.79e-3)" "unprognostic (2.04e-1)" "unprognostic (2.03e-2)" "unprognostic (2.18e-2)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 8.2 0.1 0.1 3.6 0.1 0.3 0.1 0.1 6.7 0.1 0.1 0.1 5.4 6.8 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.5 0.1 1.2 0.0 0.3 0.0 0.1 0.2 13.5 0.0 0.1 0.1 0.3 0.1 0.0 0.0 212.3 0.0 0.1 0.1 0.1 1.4 1.0 5.9 1.3 2.3 0.7 2.3 0.1 0.0 0.2 0.3 0.1 0.8 0.4 0.0 0.0 0.0 0.0 3.0 0.5 0.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.2 0.4 0.8 0.3 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.6 0.0 0.4 0.0 0.3 0.3 6.8 0.2 0.3 0.2 0.2 0.0 0.7 0.3 0.2 0.0 7.4 0.0 0.1 0.7 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.0 0.1 0.4 0.2 0.1 3.3 1.3 0.7 0.7 1.1 0.5 0.6 0.6 0.5 0.1 1.4 0.6 0.7 5.9 2.3 0.5 1.0 0.5 2.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.0 3.0 8.5 0.0 0.5 0.1 0.0 0.5 20.4 1.4 12.5 0.0 0.0 0.0 1.7 0.1 0.0 0.0 25.8 0.0 0.2 0.0 0.0 1.0 1.1 18.3 0.1 0.0 3.5 1.3 0.0 0.0 0.0 0.5 0.0 0.0 15.4 0.0 0.2 17.3 0.0 33.8 1.1 0.0 0.0 0.0 0.2 0.4 0.2 0.0 10.3 0.7 IZUMO1 "IZUMO, MGC34799, OBF" ENSG00000182264 "Izumo sperm-egg fusion 1" Q8IYV9 19 48740852-48746909 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 17.2" "Group enriched" "Detected in some" 21 "Early spermatids: 134.8;Late spermatids: 82.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;CAPAN-2: 2.7;HaCaT: 1.8;hTCEpi: 4.4;K-562: 2.1;RT4: 2.8;U-266/84: 1.5" "Low region specificity" "Detected in many" HPA038104 Enhanced NA NA "HPA038104: AB_10670655" "unprognostic (2.03e-1)" "unprognostic (1.86e-3)" "unprognostic (3.73e-2)" "unprognostic (1.37e-2)" "unprognostic (1.17e-2)" "unprognostic (7.92e-2)" "unprognostic (3.49e-2)" "unprognostic (2.53e-4)" "unprognostic (3.61e-2)" "unprognostic (1.69e-2)" "unprognostic (1.45e-1)" "unprognostic (4.83e-2)" "unprognostic (1.32e-2)" "unprognostic (3.68e-1)" "unprognostic (2.92e-1)" "unprognostic (4.31e-3)" "unprognostic (6.92e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.6 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 17.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 2.7 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.3 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 134.8 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 3.1 0.0 82.3 1.1 0.0 1.7 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.1 IZUMO2 "C19orf41, MGC33947, SCRL" ENSG00000161652 "IZUMO family member 2" Q6UXV1 19 50152548-50163195 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "testis: 33.0" "Group enriched" "Detected in some" 30 "Early spermatids: 576.2;Late spermatids: 208.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 1.6;RH-30: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042143 Uncertain NA NA "HPA042143: AB_10794078" "unprognostic (1.21e-2)" "unprognostic (3.18e-2)" "unprognostic (4.31e-2)" "unprognostic (1.81e-1)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (8.75e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.0 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.1 0.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 576.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 1.1 0.0 0.1 0.0 3.5 0.6 0.0 208.4 4.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 3.2 0.0 0.1 12.9 0.4 4.1 4.5 0.4 0.0 0.0 0.0 1.6 IZUMO3 "bA20A20.1, C9orf134" ENSG00000205442 "IZUMO family member 3" Q5VZ72 9 24542952-24545946 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 169 "testis: 16.9" "Group enriched" "Detected in some" 89 "Early spermatids: 185.3;Late spermatids: 58.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 62 "SCLC-21H: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 JAG1 "AGS, AHD, AWS, CD339, HJ1, JAGL1" ENSG00000101384 "Jagged 1" P78504 20 10637684-10673999 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Smooth muscle cells: 154.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 56.7;hTERT-HME1: 35.0;U-251 MG: 47.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010343, HPA021555" Supported Approved "Golgi apparatus,Plasma membrane" NA NA 14000000 "Golgi apparatus, Plasma membrane" "CAB010343: AB_649685, HPA021555: AB_1851969" "unprognostic (2.23e-1)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (4.15e-2)" "unprognostic (1.21e-1)" "unprognostic (6.42e-2)" "unprognostic (4.21e-2)" "unprognostic (8.94e-3)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (4.10e-6)" "unprognostic (5.48e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-1)" "unprognostic (1.66e-1)" "unprognostic (3.10e-1)" "unprognostic (1.41e-3)" 27.7 5.6 6.8 14.5 5.4 9.7 56.5 2.9 6.7 34.2 20.1 4.3 17.4 7.2 26.1 22.8 33.9 16.7 23.1 18.8 5.4 5.1 12.9 3.8 22.0 12.4 5.4 4.0 14.7 22.2 21.7 6.0 36.3 6.0 19.2 12.7 21.4 11.2 23.4 16.8 34.8 11.7 21.4 13.0 14.2 13.4 9.1 3.8 1.5 14.5 24.6 16.1 18.7 31.4 0.0 0.9 2.4 2.0 0.4 0.1 0.4 1.0 5.3 16.6 20.4 3.2 3.1 0.6 0.6 3.1 0.9 0.4 4.7 2.9 0.1 15.7 0.6 4.7 22.2 2.4 56.7 0.7 0.0 1.1 1.7 0.5 22.2 1.5 7.1 0.1 1.2 16.8 2.8 35.0 3.3 5.5 0.0 0.0 2.3 1.5 0.0 0.0 5.1 4.8 17.5 5.3 1.3 1.0 3.3 8.0 6.5 0.7 0.5 1.6 1.1 6.7 13.8 0.1 0.8 20.7 3.8 2.6 3.1 47.7 0.9 0.1 0.2 2.4 2.6 2.9 0.0 2.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 1.6 0.4 0.3 0.9 0.0 0.4 6.8 5.4 2.9 6.7 5.4 5.1 5.4 4.0 6.0 3.8 38.7 12.5 0.0 46.4 93.0 10.0 12.5 35.7 20.1 22.7 15.7 41.2 12.0 1.7 26.8 3.9 70.8 26.0 0.0 27.0 0.9 33.7 18.4 6.9 1.5 3.7 20.6 5.1 38.1 3.7 6.3 19.8 7.7 13.5 1.8 10.2 9.3 60.7 22.4 31.8 2.1 72.6 84.1 154.6 0.7 2.8 93.3 1.8 0.0 22.9 32.5 JAG2 ENSG00000184916 "Jagged 2" Q9Y219 14 105140981-105168824 "Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 36.0" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 20.7;Cone photoreceptor cells: 23.6;Endothelial cells: 17.9;Horizontal cells: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 10.7;CAPAN-2: 10.7;HaCaT: 33.0;HBEC3-KT: 11.1;SCLC-21H: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025481, HPA030636, HPA050567" Approved Supported Vesicles,Cytosol NA NA 120000 Vesicles Cytosol "CAB025481: , HPA030636: AB_10602607, HPA050567: AB_2681178" "unprognostic (6.74e-2)" "unprognostic (4.49e-2)" "unprognostic (4.28e-2)" "unprognostic (6.97e-3)" "unprognostic (3.50e-1)" "unprognostic (2.13e-2)" "unprognostic (1.01e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-2)" "unprognostic (2.62e-1)" "unprognostic (1.67e-2)" "unprognostic (9.19e-2)" "unprognostic (8.47e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (2.39e-1)" "unprognostic (2.17e-1)" 11.5 2.5 5.4 3.5 6.3 1.3 11.4 6.4 8.4 4.2 3.0 3.5 5.2 3.2 7.5 8.4 8.1 5.0 4.4 9.5 5.6 6.4 3.0 1.5 6.6 2.4 4.5 5.3 2.7 5.8 4.3 15.9 6.8 8.7 7.1 1.7 5.9 12.2 6.9 16.8 36.0 4.3 3.2 2.9 3.7 3.8 4.2 3.0 2.7 4.2 11.0 4.1 5.2 5.6 0.0 0.0 0.0 0.0 0.5 0.3 0.0 8.5 3.5 0.2 0.9 0.0 0.0 10.7 0.1 0.1 0.0 0.0 2.9 10.7 0.0 7.4 0.0 0.0 33.0 2.1 11.1 0.0 1.1 5.1 0.0 9.5 0.0 0.1 0.0 2.1 0.1 5.4 0.0 1.2 0.1 2.7 0.4 2.1 0.0 0.0 3.9 0.0 0.0 1.1 1.0 1.2 2.7 2.1 3.7 0.1 2.3 16.9 0.5 2.9 0.7 0.1 0.2 8.4 1.3 9.1 0.0 0.9 0.0 0.1 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 5.4 6.3 6.4 8.4 5.6 6.4 4.5 5.3 8.7 3.0 6.0 2.7 0.0 7.9 20.7 1.1 5.9 0.0 5.3 7.9 0.0 23.6 1.9 0.0 3.4 0.1 17.9 4.9 0.0 2.2 0.9 1.0 2.7 0.0 0.6 0.6 25.4 0.0 5.5 0.0 0.4 1.4 1.2 6.8 1.8 2.8 0.6 3.6 2.8 0.7 0.1 4.8 0.0 2.1 0.5 13.7 5.9 1.1 2.6 2.9 1.4 JAGN1 "FLJ14602, GL009" ENSG00000171135 "Jagunal homolog 1" Q8N5M9 3 9890554-9894349 "Disease related genes, Predicted membrane proteins" "Immunity, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067610 Approved Vesicles NA NA Vesicles "HPA067610: " "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-3)" "unprognostic (1.97e-2)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (2.37e-2)" "unprognostic (6.36e-3)" "unprognostic (9.93e-3)" "unprognostic (2.70e-1)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.65e-2)" "unprognostic (2.49e-1)" 19.7 31.6 9.8 12.7 11.5 6.8 18.4 10.5 15.4 15.8 27.1 14.1 15.7 16.8 16.9 25.7 13.2 16.8 16.6 13.7 9.7 11.6 21.4 39.6 12.1 18.2 10.8 10.7 18.1 42.3 17.0 12.5 19.6 12.6 17.3 19.1 14.3 21.3 14.2 23.2 17.7 29.4 13.3 11.0 12.8 19.3 12.8 9.7 24.1 27.3 13.7 15.0 16.6 21.7 24.8 26.0 39.0 27.9 21.4 25.1 28.4 9.7 17.2 12.0 7.0 36.8 38.7 40.1 13.6 20.2 15.3 15.6 12.3 12.9 15.6 6.1 13.5 16.6 8.5 19.0 18.2 15.0 11.4 20.6 19.0 17.7 21.3 31.5 13.7 11.9 36.9 27.4 19.9 22.9 15.3 14.5 13.9 20.5 10.5 17.4 28.8 11.2 23.6 15.9 19.0 22.3 9.5 10.0 19.0 21.7 14.0 7.6 14.7 8.9 9.3 16.8 11.3 15.4 17.1 12.3 8.2 8.9 8.9 10.8 19.4 27.2 18.1 10.8 16.3 13.6 39.0 27.9 13.5 22.9 21.2 24.3 24.1 22.7 22.0 25.6 24.8 25.1 23.1 11.2 21.4 15.8 26.0 23.9 28.4 9.8 11.5 10.5 15.4 9.7 11.6 10.8 10.7 12.6 9.7 29.8 13.7 44.5 40.0 24.5 28.0 12.1 38.2 28.1 22.7 36.6 9.8 65.9 18.3 67.2 2.3 32.2 60.0 0.0 85.4 70.3 33.6 53.3 8.1 50.5 49.2 22.3 24.8 27.6 35.9 5.3 36.5 26.2 35.4 82.0 47.9 47.2 66.6 49.1 36.4 48.8 15.8 45.3 21.7 60.6 36.4 32.1 44.3 31.0 53.6 30.1 JAM2 "C21orf43, CD322, JAM-B, JAMB, VE-JAM" ENSG00000154721 "Junctional adhesion molecule 2" P57087 21 25639272-25717562 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.7" "Cell type enhanced" "Detected in many" 20 "Cardiomyocytes: 31.9;Endothelial cells: 151.0;Ito cells: 49.7" "Cancer enriched" "Detected in all" 9 "glioma: 27.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 18.2;BJ hTERT+: 11.6;HDLM-2: 11.3;hTERT-RPE1: 16.2;U-138 MG: 13.1;U-87 MG: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028789, HPA077346" Supported "Nucleoplasm,Plasma membrane" NA NA 17000 "Plasma membrane" Nucleoplasm "HPA028789: AB_2732443, HPA077346: AB_2732341" "unprognostic (1.42e-1)" "unprognostic (6.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.51e-4)" "unprognostic (2.61e-2)" "unprognostic (4.55e-1)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.81e-1)" "unprognostic (8.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.18e-1)" "unprognostic (2.20e-1)" "unprognostic (4.85e-3)" 16.6 17.2 13.8 8.4 18.9 1.5 14.6 9.9 23.4 18.1 14.7 14.5 8.0 7.5 20.5 13.5 13.3 12.0 14.4 21.9 13.5 12.5 6.5 3.5 17.1 4.6 17.6 13.5 18.9 3.9 5.8 7.7 66.7 18.5 12.0 9.7 11.1 5.5 18.0 8.4 6.9 9.2 21.8 23.0 2.8 9.7 25.8 12.2 0.6 9.5 10.1 6.3 13.5 15.1 3.1 1.9 1.9 0.7 2.8 1.1 0.4 0.0 0.0 18.2 0.1 0.7 0.2 0.4 0.5 11.6 1.5 5.5 0.0 0.0 0.1 0.0 0.2 7.0 0.0 1.6 0.0 3.4 11.3 0.5 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.0 1.3 0.0 16.2 0.0 0.4 0.0 0.2 5.6 0.1 0.3 0.1 5.7 0.1 0.0 2.1 3.7 0.0 0.0 0.0 0.3 2.7 0.1 0.2 0.0 0.2 0.6 0.1 0.0 13.1 1.2 0.1 1.8 1.5 0.0 0.0 9.6 0.1 0.5 1.4 0.7 0.3 0.4 0.5 0.6 0.3 0.4 0.9 0.4 3.1 0.7 1.1 1.9 2.8 0.6 1.9 0.2 0.4 13.8 18.9 9.9 20.5 13.5 12.5 17.6 13.5 18.5 12.2 0.0 2.9 1.4 1.4 6.6 1.5 31.9 0.0 1.4 0.0 3.5 13.7 0.3 0.0 0.3 12.9 151.0 0.0 0.0 0.2 2.2 18.5 1.2 0.0 0.0 1.0 0.0 0.0 49.7 2.2 13.2 9.2 1.4 15.1 0.0 0.0 0.9 0.1 0.0 23.0 0.0 3.6 0.0 7.6 4.8 3.9 5.8 0.7 0.0 0.0 0.7 JAM3 "JAM-C, JAMC" ENSG00000166086 "Junctional adhesion molecule 3" Q9BX67 11 134068925-134152001 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 77.0" "Cell type enhanced" "Detected in many" 7 "Peritubular cells: 60.5;Rod photoreceptor cells: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 8.2" "Group enriched" "Detected in many" 7 "B-cells: 8.2;T-cells: 4.0" "Cell line enhanced" "Detected in many" "RH-30: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003417, HPA050434" Approved Enhanced "Golgi apparatus" "Secreted to blood" NA NA 570000 "Golgi apparatus" "HPA003417: AB_1851981, HPA050434: AB_2681126" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (3.24e-1)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (3.23e-3)" "unprognostic (2.17e-1)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.68e-4)" 14.0 14.9 17.6 7.9 34.1 2.2 9.9 7.0 28.7 15.5 23.4 77.0 6.9 5.9 25.0 12.9 16.3 11.9 17.8 21.4 26.1 16.9 6.7 3.0 13.7 6.2 40.3 17.4 32.0 4.4 14.5 19.5 68.8 29.6 26.2 9.7 17.5 9.4 32.5 4.1 9.1 11.7 29.7 34.8 8.7 12.0 24.8 34.1 5.1 7.6 4.6 5.6 22.7 22.6 8.2 0.2 0.8 0.1 0.1 4.0 2.9 0.2 0.4 28.4 14.6 26.5 19.7 23.8 12.1 14.3 4.5 4.5 0.4 0.2 0.3 12.5 15.7 18.3 0.4 20.4 0.2 8.6 0.2 10.2 0.8 0.1 1.8 7.9 0.5 12.6 13.4 0.0 3.2 2.9 11.4 29.5 13.2 0.3 0.2 19.5 0.3 8.7 1.0 6.7 0.3 1.2 0.2 38.8 0.2 0.2 0.1 19.1 10.7 0.2 0.3 0.4 12.6 0.3 0.3 0.2 8.5 6.2 13.3 8.2 0.1 0.1 0.2 9.4 1.2 16.2 0.4 0.1 0.3 2.2 0.0 2.6 8.2 2.8 1.6 0.2 4.8 4.0 2.6 0.8 0.1 0.0 0.2 0.1 2.9 17.6 34.1 7.0 28.7 26.1 16.9 40.3 17.4 29.6 34.1 0.0 8.9 6.9 5.7 4.5 16.1 14.9 0.0 2.7 1.2 5.2 7.9 4.8 1.7 0.4 1.9 26.3 0.0 0.0 0.2 40.4 29.1 1.6 1.1 0.0 6.8 7.9 0.0 16.0 0.8 3.6 39.7 0.9 16.9 0.0 0.0 18.1 0.3 0.0 60.5 0.0 71.5 25.8 29.8 12.5 19.0 3.3 5.1 0.7 0.0 0.7 JAML "AMICA, AMICA1, Gm638" ENSG00000160593 "Junction adhesion molecule like" Q86YT9 11 118193740-118225094 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 202.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 48.3;Kupffer cells: 117.5;Macrophages: 185.0;T-cells: 45.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 202.6" "Group enriched" "Detected in many" 4 "dendritic cells: 60.5;granulocytes: 202.6;monocytes: 59.0" "Cell line enriched" "Detected in some" 5 "HMC-1: 24.9" "Region enriched" "Detected in single" 9 "cerebellum: 7.0" "Region enriched" "Detected in many" 12 "cerebellum: 113.6" "HPA005854, HPA047919" Approved Supported "Nucleoplasm,Plasma membrane" NA NA 1400000 "Plasma membrane" Nucleoplasm "HPA005854: , HPA047919: AB_2680209" "unprognostic (3.91e-3)" "unprognostic (1.55e-3)" "unprognostic (3.00e-2)" "unprognostic (1.28e-3)" "unprognostic (2.87e-3)" "prognostic favorable (3.11e-4)" "unprognostic (2.80e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (8.69e-2)" "unprognostic (5.08e-1)" "unprognostic (6.43e-3)" "unprognostic (8.96e-2)" "unprognostic (3.12e-2)" "unprognostic (4.10e-2)" "unprognostic (1.58e-2)" 6.7 2.1 0.9 23.1 1.1 6.6 2.1 5.3 0.8 4.1 8.4 0.7 1.3 6.1 3.8 9.6 4.0 3.1 8.9 3.1 0.9 0.9 3.4 4.3 34.4 43.2 3.7 0.5 2.1 1.8 0.0 2.7 4.2 2.3 3.4 8.3 6.7 6.7 1.1 1.0 2.2 14.0 4.7 1.8 43.4 3.9 1.9 0.6 14.3 2.6 5.9 25.0 9.8 3.0 0.3 60.5 202.6 59.0 1.4 25.2 40.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.1 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.7 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.3 2.3 0.3 2.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 5.8 59.0 202.6 3.9 36.6 25.2 0.3 7.0 7.4 60.5 0.1 8.3 6.7 126.6 1.4 17.1 46.6 11.1 40.1 0.9 1.1 5.3 0.8 0.9 0.9 3.7 0.5 2.3 0.6 6.0 48.3 15.4 0.1 0.0 0.0 0.0 0.0 4.0 10.3 1.8 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.2 0.4 0.1 14.0 2.1 29.9 0.0 0.0 8.0 117.5 0.9 0.0 185.0 0.0 11.8 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.1 1.4 0.0 0.3 45.3 0.0 0.1 JKAMP "C14orf100, CDA06, HSPC213, HSPC327, JAMP" ENSG00000050130 "JNK1/MAPK8 associated membrane protein" Q9P055 14 59484443-59505410 "Cancer-related genes, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031172, HPA071650" Supported Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA031172: AB_10670563, HPA071650: AB_2686429" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (4.95e-2)" "unprognostic (5.88e-2)" "unprognostic (2.54e-1)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.09e-6)" "unprognostic (2.68e-1)" "unprognostic (3.52e-1)" "unprognostic (1.16e-1)" "unprognostic (3.09e-1)" "unprognostic (3.14e-1)" "prognostic favorable (1.36e-4)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.73e-1)" 19.0 29.5 19.3 13.0 25.5 15.7 24.2 16.7 28.4 17.5 21.3 25.0 18.1 13.8 22.8 19.6 18.6 23.2 21.7 18.3 18.8 29.4 38.9 26.1 22.2 16.2 29.5 19.5 19.7 18.7 42.3 44.5 24.1 36.9 22.9 22.5 22.8 24.9 20.3 15.9 17.5 25.0 20.7 30.3 22.1 18.7 24.6 27.0 18.6 24.6 18.0 14.7 21.0 16.7 14.9 29.0 37.0 31.7 18.0 18.3 21.5 19.9 23.6 20.3 16.6 15.2 20.1 15.5 31.3 26.8 18.5 22.1 7.4 36.6 9.9 28.1 28.9 21.3 14.5 14.9 19.3 25.0 29.7 8.5 10.0 15.2 14.7 20.2 16.6 19.7 21.9 21.9 17.3 11.9 29.7 18.8 13.8 9.0 19.9 34.7 18.0 9.1 12.8 11.1 16.9 20.8 10.7 24.7 9.1 31.9 19.8 8.7 15.2 28.4 22.8 16.6 15.5 23.0 12.8 24.7 19.5 25.6 17.8 20.5 9.3 16.5 11.5 27.6 11.3 24.5 28.2 25.2 32.5 15.1 29.8 14.6 14.9 16.5 15.9 21.2 13.6 17.7 16.6 37.0 18.0 31.7 29.0 18.3 21.5 19.3 25.5 16.7 28.4 18.8 29.4 29.5 19.5 36.9 27.0 20.8 28.2 18.6 27.3 26.7 28.5 9.4 48.4 64.3 19.4 43.6 17.7 52.1 6.6 41.7 127.9 21.5 16.0 70.0 47.9 55.4 37.6 25.8 34.6 34.4 51.7 27.0 30.0 31.9 57.1 50.5 32.8 38.3 45.5 31.5 24.3 40.3 41.2 21.0 29.7 46.2 24.2 12.9 28.6 93.1 41.2 25.5 24.9 26.6 23.5 13.7 JPH1 JP-1 ENSG00000104369 "Junctophilin 1" Q9HDC5 8 74234700-74321328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 97.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 35.7;Basal glandular cells: 27.1;Cardiomyocytes: 31.6;Glandular cells: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 10.1;OE19: 12.1;SK-BR-3: 24.2;T-47d: 17.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008996, HPA009413, CAB013461" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163" "unprognostic (2.91e-3)" "unprognostic (3.01e-1)" "unprognostic (8.85e-2)" "unprognostic (8.73e-6)" "unprognostic (2.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.63e-2)" "prognostic favorable (5.77e-5)" "unprognostic (8.97e-2)" "unprognostic (1.30e-1)" "unprognostic (2.38e-1)" "unprognostic (5.99e-2)" "unprognostic (9.80e-2)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-2)" 1.7 0.6 1.8 0.7 5.7 0.5 0.8 13.7 3.1 0.8 1.9 0.8 0.4 0.8 1.5 1.7 1.8 0.6 0.6 3.3 2.1 0.7 0.8 0.5 2.2 0.5 1.0 4.2 0.5 3.5 1.1 0.4 1.1 2.4 1.8 2.8 0.0 1.3 0.8 97.2 0.7 0.9 1.4 2.4 0.5 0.9 0.9 2.3 2.4 1.2 21.5 1.4 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.4 0.1 3.1 0.0 1.0 0.0 0.7 4.5 3.9 3.1 1.0 0.0 5.9 0.0 3.6 0.0 0.5 2.0 0.2 0.6 2.6 0.0 2.9 0.0 0.0 7.8 0.5 0.0 0.2 2.8 10.1 0.0 6.8 12.1 2.0 5.1 3.9 0.0 0.1 9.0 5.2 0.7 0.0 24.2 1.2 1.2 17.2 0.1 0.0 1.2 1.7 0.4 1.0 0.0 0.0 0.0 2.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 5.7 13.7 3.1 2.1 0.7 1.0 4.2 2.4 2.3 35.7 8.0 0.0 27.1 2.5 0.0 31.6 0.0 8.1 15.9 1.8 5.9 0.0 0.0 0.2 2.1 0.4 1.3 0.0 1.2 0.0 2.1 24.9 0.0 0.0 0.1 0.0 12.1 0.0 0.0 0.4 0.9 0.2 1.7 0.0 10.1 0.2 3.4 8.0 0.0 0.7 0.0 0.0 2.3 0.1 3.6 1.8 0.0 0.0 5.6 16.6 JPH2 JP-2 ENSG00000149596 "Junctophilin 2" Q9BR39 20 44111695-44187578 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 72.6;smooth muscle: 55.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 53.2;Smooth muscle cells: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 12.9;EFO-21: 16.3;fHDF/TERT166: 16.3;HeLa: 10.7;SiHa: 10.9;T-47d: 10.6" "Low region specificity" "Detected in some" HPA052646 Approved NA NA "HPA052646: AB_2681899" "unprognostic (1.57e-1)" "unprognostic (1.82e-2)" "unprognostic (2.61e-4)" "unprognostic (4.71e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (1.06e-2)" "unprognostic (2.45e-3)" "unprognostic (6.87e-2)" "unprognostic (9.16e-2)" "unprognostic (2.57e-2)" "unprognostic (9.73e-2)" "unprognostic (4.76e-2)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.67e-1)" "unprognostic (1.10e-2)" 3.0 0.8 0.1 5.5 0.3 0.1 2.7 0.1 0.6 13.6 21.6 0.5 10.2 1.4 20.2 6.1 13.5 11.6 14.4 24.3 0.1 0.1 0.9 0.1 1.8 0.3 1.2 0.3 5.0 0.3 0.1 0.3 2.3 1.3 11.6 2.2 5.4 2.1 14.6 72.6 1.2 4.4 55.7 0.5 0.5 7.3 1.5 0.1 0.0 0.9 11.8 1.8 22.1 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.6 0.2 0.0 0.3 0.3 1.5 2.0 3.7 4.9 2.3 12.9 5.3 0.0 16.3 16.3 5.5 9.4 0.0 0.4 2.0 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 0.8 0.9 2.5 3.7 3.7 0.0 0.0 0.0 0.0 6.8 3.8 0.0 0.1 0.2 0.0 1.2 1.7 3.3 0.0 0.3 0.0 0.0 0.0 10.9 3.2 0.0 9.5 10.6 0.0 0.2 2.1 2.4 0.3 4.3 0.0 0.0 0.0 0.2 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.6 0.1 0.1 1.2 0.3 1.3 0.1 0.0 0.0 0.0 0.2 6.0 0.0 53.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 17.3 0.0 1.2 1.8 0.5 0.0 0.2 0.1 JPH3 "CAGL237, HDL2, JP-3, JP3, TNRC22" ENSG00000154118 "Junctophilin 3" Q8WXH2 16 87601835-87698156 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 44.2" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 25.0;Cone photoreceptor cells: 21.6;Early spermatids: 44.0;Horizontal cells: 47.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "MCF7: 6.5;NTERA-2: 5.8;SH-SY5Y: 7.5;SiHa: 4.9;U-2 OS: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076304 Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA076304: AB_2686793" "unprognostic (8.97e-3)" "unprognostic (3.17e-2)" "unprognostic (1.57e-3)" "unprognostic (4.82e-3)" "unprognostic (3.43e-1)" "unprognostic (9.12e-2)" "unprognostic (1.68e-2)" "unprognostic (8.10e-2)" "unprognostic (5.53e-2)" "unprognostic (1.48e-1)" "unprognostic (5.61e-3)" "unprognostic (2.80e-2)" "unprognostic (1.28e-4)" "unprognostic (3.01e-2)" "unprognostic (2.09e-1)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" 1.3 3.6 27.2 1.6 24.1 1.1 1.2 18.9 44.2 1.5 1.4 1.2 0.0 1.4 1.3 1.2 2.4 1.4 1.2 1.2 30.9 14.6 1.2 1.2 1.2 1.2 8.3 12.2 1.1 1.5 1.2 4.4 1.2 6.4 1.3 1.3 0.8 1.2 1.7 1.1 1.2 1.7 1.3 3.3 1.2 1.5 1.8 3.5 0.0 1.2 0.0 1.2 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 1.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 6.5 0.0 0.0 5.8 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 7.5 4.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 27.2 24.1 18.9 30.3 30.9 14.6 8.3 12.2 6.4 3.5 0.0 0.0 0.0 0.0 0.0 25.0 2.8 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 44.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.7 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.9 3.4 0.0 0.1 0.0 0.0 0.0 JTB "hJT, PAR" ENSG00000143543 "Jumping translocation breakpoint" O76095 1 153974269-153977688 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006514 Approved Approved Vesicles,Mitochondria NA NA Vesicles Mitochondria "HPA006514: AB_1079164" "unprognostic (1.33e-1)" "unprognostic (1.77e-1)" "unprognostic (8.01e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (3.40e-1)" "unprognostic (5.66e-3)" "unprognostic (8.62e-3)" "unprognostic (5.60e-2)" "prognostic favorable (7.87e-4)" "unprognostic (1.00e-3)" "unprognostic (8.16e-2)" "prognostic unfavorable (6.65e-9)" "unprognostic (1.36e-1)" "unprognostic (4.25e-1)" "unprognostic (5.48e-2)" "unprognostic (2.58e-3)" 23.9 30.2 28.5 23.0 32.7 43.2 32.6 30.7 32.3 31.8 36.0 23.6 51.3 35.9 25.1 41.0 30.4 26.1 37.1 36.2 25.4 23.9 34.2 81.1 27.7 34.7 27.7 19.8 26.9 106.8 24.8 49.8 30.0 24.4 33.4 36.0 24.9 100.6 45.9 42.1 23.4 45.6 21.6 20.5 35.9 42.4 15.3 25.2 30.5 58.5 32.0 34.0 25.2 33.0 47.4 54.1 60.7 43.0 30.4 46.4 30.2 38.4 26.6 11.5 21.0 37.7 23.5 32.4 28.1 27.4 18.8 18.9 25.6 32.0 36.8 39.9 32.5 11.6 35.2 29.0 21.6 15.4 34.7 58.0 21.4 31.7 25.9 39.7 41.0 32.9 22.2 40.9 19.8 23.5 26.0 22.2 42.9 31.6 27.1 13.2 67.0 29.6 52.8 24.6 75.6 47.0 31.3 15.6 73.9 23.8 21.1 31.5 31.9 22.2 64.8 37.6 22.0 40.6 59.7 17.3 9.3 16.1 28.1 35.8 40.4 45.0 39.9 22.9 39.5 20.0 32.6 43.0 60.7 29.4 30.3 35.5 47.4 41.1 46.4 33.4 45.2 42.4 33.7 39.9 30.4 33.4 54.1 33.6 30.2 28.5 32.7 30.7 32.3 25.4 23.9 27.7 19.8 24.4 25.2 74.5 93.5 143.8 144.8 139.2 56.2 87.0 188.5 84.3 73.9 94.2 21.6 271.1 218.8 215.2 5.3 130.2 265.0 46.7 360.4 333.7 188.8 298.2 81.8 277.1 261.0 54.0 203.5 111.1 203.5 13.6 140.4 174.8 161.9 144.3 351.4 98.5 241.9 276.3 116.0 209.1 47.9 103.5 125.2 54.7 68.8 166.2 242.1 188.1 283.1 216.6 KANSL1L "C2orf67, FLJ23861, FLJ32349, KIAA1267L, MSL1v2" ENSG00000144445 "KAT8 regulatory NSL complex subunit 1 like" A0AUZ9 2 210021423-210171383 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "parathyroid gland: 178.9" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 44.2;Spermatocytes: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043102, HPA046790" Uncertain Approved Cytosol NA NA Cytosol "HPA043102: AB_2678316, HPA046790: AB_2679808" "unprognostic (3.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.04e-1)" "unprognostic (7.55e-3)" "unprognostic (1.45e-2)" "unprognostic (2.55e-3)" "unprognostic (5.52e-2)" "unprognostic (1.46e-1)" "unprognostic (5.99e-3)" "unprognostic (4.65e-2)" "unprognostic (5.89e-3)" "unprognostic (5.75e-2)" "unprognostic (5.95e-3)" "unprognostic (7.44e-2)" "unprognostic (4.60e-2)" "unprognostic (3.21e-2)" "unprognostic (1.30e-3)" 8.4 5.6 8.3 6.0 12.9 3.8 8.8 12.7 10.9 10.4 6.9 7.5 11.1 4.4 11.3 9.9 5.9 8.9 8.9 7.9 8.8 5.7 12.3 5.8 9.8 4.3 12.1 5.5 16.2 10.0 178.9 14.4 5.3 9.5 14.3 4.7 6.2 7.6 9.9 8.8 7.7 4.9 9.8 13.0 4.5 7.2 12.4 13.6 21.6 14.2 4.4 3.8 11.1 33.0 2.1 2.1 2.7 2.2 3.1 1.7 0.5 2.4 1.3 12.7 5.4 10.3 7.8 3.7 3.6 4.6 2.3 6.5 2.5 9.5 6.7 4.9 2.3 5.7 3.5 2.9 1.2 3.7 2.9 2.4 5.5 4.9 4.3 6.4 6.4 4.0 4.9 5.6 2.3 1.7 10.2 5.2 6.2 4.1 6.2 3.5 2.3 7.1 16.5 7.7 4.2 1.8 5.2 3.6 5.2 14.0 3.7 8.0 7.6 3.3 2.2 2.6 13.3 2.2 13.7 4.5 5.1 4.1 1.7 2.7 4.4 1.9 6.6 6.2 3.2 6.1 1.1 1.4 2.7 1.2 2.2 1.1 0.9 1.0 1.4 2.1 2.1 1.7 1.7 2.4 3.1 0.9 1.4 0.8 0.5 8.3 12.9 12.7 10.9 8.8 5.7 12.1 5.5 9.5 13.6 26.8 15.3 2.0 7.6 6.5 9.3 7.6 7.6 44.2 7.9 29.6 13.7 1.3 3.3 8.2 20.3 7.8 1.8 0.0 4.8 0.8 9.3 6.6 10.4 5.5 2.3 4.8 5.8 5.5 2.6 17.2 13.6 6.0 6.8 1.8 2.8 9.7 7.7 2.5 28.3 10.2 8.9 12.9 9.2 38.9 6.4 9.7 1.6 3.2 2.4 3.0 KANTR "LINC01155, Spasm" ENSG00000232593 "KDM5C adjacent transcript" X 53094145-53170914 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.9" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 12.8;Club cells: 6.8;Collecting duct cells: 5.2;Cone photoreceptor cells: 9.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 5.0" "Low region specificity" "Detected in all" NA NA "unprognostic (2.89e-1)" "unprognostic (1.66e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (5.52e-2)" "unprognostic (2.18e-2)" "unprognostic (7.30e-2)" "unprognostic (4.79e-2)" "unprognostic (2.30e-3)" "unprognostic (2.54e-2)" "unprognostic (2.10e-2)" "unprognostic (1.46e-2)" "unprognostic (3.47e-6)" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "unprognostic (2.78e-3)" "unprognostic (1.81e-3)" 1.5 2.4 4.9 1.5 5.9 5.7 2.2 11.9 11.7 2.3 1.6 3.0 2.5 1.5 2.6 2.9 1.5 2.0 1.6 1.5 3.4 1.6 1.5 1.7 1.5 3.9 4.5 2.4 1.4 2.0 6.8 2.2 4.0 2.1 1.7 2.1 2.0 2.6 1.5 2.0 1.5 2.1 2.8 1.6 1.5 2.4 4.4 1.1 1.8 0.0 1.5 1.6 2.5 0.6 0.6 1.6 0.8 0.0 0.4 0.0 0.6 0.1 0.7 0.6 0.7 0.7 0.6 0.0 0.1 1.1 0.7 0.1 0.3 0.6 0.4 0.2 1.2 0.4 1.2 0.3 1.7 0.1 0.1 0.2 0.1 0.2 1.2 1.2 0.8 0.9 0.4 2.2 1.0 0.6 0.8 5.0 1.0 0.9 0.1 0.3 1.0 1.3 1.0 0.1 0.8 0.5 0.6 0.3 0.2 1.1 2.4 1.1 0.5 0.2 0.1 2.0 0.4 0.1 0.5 0.5 1.5 2.0 0.2 0.7 0.7 1.0 0.0 0.9 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.8 0.6 0.0 0.0 0.0 12.8 1.3 0.2 0.0 0.9 0.5 0.0 4.0 6.8 5.2 9.8 0.2 0.0 2.1 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.3 1.1 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.3 1.0 0.0 0.0 1.6 2.6 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 KCNA1 "AEMK, HUK1, Kv1.1, MBK1, RBK1" ENSG00000111262 "Potassium voltage-gated channel subfamily A member 1" Q09470 12 4909893-4918256 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 24.1" "Group enriched" "Detected in some" 6 "Bipolar cells: 10.8;Ciliated cells: 6.7" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "basal ganglia: 13.7;cerebellum: 23.8;cerebral cortex: 21.1;pons and medulla: 24.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "LHCN-M2: 2.4;NTERA-2: 2.1;SCLC-21H: 3.9;U-2 OS: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074471 Approved NA NA "HPA074471: " "unprognostic (6.39e-3)" "unprognostic (2.64e-1)" "unprognostic (1.09e-1)" "unprognostic (8.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.79e-2)" "unprognostic (4.69e-3)" "unprognostic (2.48e-1)" "unprognostic (8.77e-5)" "unprognostic (6.30e-2)" "unprognostic (1.08e-4)" 0.8 0.7 1.5 0.7 13.7 0.7 1.3 23.8 21.1 1.6 0.9 0.9 0.0 0.9 1.0 0.7 0.7 0.7 0.9 0.7 4.6 1.1 0.7 0.7 0.8 0.7 2.2 3.5 0.7 0.7 4.0 0.6 0.7 24.1 0.7 0.9 0.0 1.9 0.8 0.7 0.8 0.8 1.1 1.1 0.7 1.0 0.7 1.4 0.2 2.0 0.0 0.7 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 13.7 23.8 21.1 4.6 1.1 2.2 3.5 24.1 1.4 0.0 0.0 0.0 0.0 0.3 10.8 1.4 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNA10 Kv1.8 ENSG00000143105 "Potassium voltage-gated channel subfamily A member 10" Q16322 1 110517217-110519175 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.4;U-87 MG: 1.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.2" "HPA015061, CAB022564" Uncertain Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "CAB022564: , HPA015061: AB_1855573" "unprognostic (2.96e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNA2 "HK4, Kv1.2" ENSG00000177301 "Potassium voltage-gated channel subfamily A member 2" P16389 1 110519837-110631474 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 28.0" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 24.2" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.1" "Lineage enriched" "Detected in single" 8 "T-cells: 4.1" "Cell line enhanced" "Detected in some" "Karpas-707: 10.9;SCLC-21H: 2.8;U-2 OS: 2.4;U-266/70: 3.6;U-266/84: 5.4;WM-115: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB001976 Enhanced NA NA "CAB001976: " "unprognostic (1.84e-2)" "unprognostic (9.70e-3)" "unprognostic (1.97e-1)" "unprognostic (2.98e-1)" "unprognostic (7.17e-3)" "unprognostic (6.68e-3)" "unprognostic (5.05e-3)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (4.50e-3)" "unprognostic (3.08e-3)" "unprognostic (2.93e-4)" "unprognostic (2.15e-1)" "unprognostic (3.55e-1)" "unprognostic (6.41e-2)" "unprognostic (2.83e-1)" 3.2 1.4 7.1 2.2 13.1 0.8 1.2 17.2 28.0 1.2 1.6 3.1 0.0 1.4 1.0 1.3 1.7 1.1 1.6 1.6 7.2 6.1 0.9 0.9 1.0 1.9 7.2 14.5 1.1 1.9 0.8 1.4 0.7 21.1 1.8 2.0 1.4 1.8 2.4 2.1 1.6 1.6 1.6 2.8 1.3 1.3 2.5 3.8 0.3 5.3 0.0 3.5 1.4 0.5 0.5 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 2.8 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.1 2.4 0.0 0.0 3.6 5.4 0.2 0.1 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.3 0.5 1.8 1.3 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 4.1 0.1 7.1 13.1 17.2 26.3 7.2 6.1 7.2 14.5 21.1 3.8 0.0 0.0 0.0 0.0 0.0 3.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 4.9 0.0 2.9 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 KCNA3 "HLK3, HPCN3, Kv1.3, MK3" ENSG00000177272 "Potassium voltage-gated channel subfamily A member 3" P22001 1 110672465-110675033 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 59.4" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 3.4;Melanocytes: 3.3;Sertoli cells: 6.5;T-cells: 8.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 3.3;T-cells: 11.5" "Cell line enhanced" "Detected in some" "HDLM-2: 12.7;Karpas-707: 26.1;U-266/70: 18.9;U-266/84: 16.9" "Low region specificity" "Detected in all" HPA016625 Approved NA NA "HPA016625: AB_2669407" "unprognostic (2.17e-2)" "unprognostic (5.07e-3)" "unprognostic (3.92e-3)" "unprognostic (1.20e-2)" "unprognostic (2.35e-1)" "unprognostic (1.76e-5)" "unprognostic (1.70e-4)" "unprognostic (8.48e-2)" "unprognostic (1.49e-2)" "unprognostic (5.92e-4)" "unprognostic (1.81e-2)" "unprognostic (3.96e-2)" "unprognostic (1.39e-1)" "unprognostic (3.13e-2)" "unprognostic (2.99e-2)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" 1.9 1.3 4.0 7.8 5.7 5.6 1.3 5.0 5.6 1.7 3.1 0.5 0.0 3.2 1.1 0.4 1.1 1.3 2.3 1.4 3.5 4.3 1.5 1.3 7.8 14.5 1.5 3.1 1.3 0.9 0.4 1.8 0.9 3.1 1.1 2.6 0.5 3.7 0.3 0.5 0.8 5.9 0.7 1.9 7.7 5.3 1.4 1.5 59.4 2.1 0.3 10.9 5.8 1.3 3.3 1.0 0.0 0.7 0.9 11.5 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 26.1 0.0 0.0 5.4 0.0 0.5 0.0 0.0 0.0 0.0 5.2 0.0 0.0 3.6 0.3 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.4 0.0 0.0 18.9 16.9 6.5 0.0 1.5 0.0 0.0 0.7 0.0 7.2 0.0 8.2 2.3 10.8 11.5 1.0 3.3 8.5 6.4 0.0 0.9 0.1 0.5 9.5 2.9 4.0 5.7 5.0 5.6 3.5 4.3 1.5 3.1 3.1 1.5 0.0 3.4 2.2 0.0 0.3 1.3 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.6 0.0 0.0 1.6 3.3 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 6.5 0.0 0.9 0.2 0.5 0.0 8.7 0.0 0.0 KCNA4 "HK1, HPCN2, KCNA4L, Kv1.4" ENSG00000182255 "Potassium voltage-gated channel subfamily A member 4" P22459 11 30009741-30017023 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Cataract, Disease mutation, Dystonia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 16.5;brain: 39.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 9.6;Horizontal cells: 12.7;Muller glia cells: 6.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 39.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.6;WM-115: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001977, HPA016422" Approved NA NA "CAB001977: , HPA016422: AB_1855574" "unprognostic (1.12e-2)" "unprognostic (1.80e-2)" "unprognostic (1.31e-2)" "unprognostic (2.73e-2)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (2.24e-1)" "unprognostic (1.15e-2)" "unprognostic (6.71e-2)" "unprognostic (1.17e-1)" 2.2 16.5 9.8 0.6 39.0 0.6 0.6 0.2 12.2 0.6 0.6 0.8 1.8 0.7 1.1 0.9 0.6 0.8 0.6 5.9 6.1 2.7 1.2 0.6 2.4 0.6 1.6 6.2 0.6 0.6 0.6 2.8 1.2 10.5 0.6 0.6 0.0 0.6 1.7 0.6 0.8 0.6 0.8 0.6 0.6 1.0 0.7 5.9 0.0 0.6 0.0 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 0.6 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 39.0 0.2 12.2 6.1 2.7 1.6 6.2 10.5 5.9 0.0 0.0 0.0 0.0 0.0 9.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNA5 "HK2, HPCN1, Kv1.5" ENSG00000130037 "Potassium voltage-gated channel subfamily A member 5" P22460 12 5043989-5046788 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 33.0" "Cell type enriched" "Detected in some" 8 "Bipolar cells: 153.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 134 "plasmacytoid DC: 13.3" "Lineage enriched" "Detected in single" 134 "dendritic cells: 13.3" "Cell line enriched" "Detected in single" 12 "NTERA-2: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021516, CAB022562" Approved NA NA "CAB022562: , HPA021516: AB_2670732" "unprognostic (3.87e-1)" "unprognostic (9.91e-3)" "unprognostic (1.94e-1)" "unprognostic (3.23e-1)" "unprognostic (2.64e-1)" "unprognostic (7.06e-3)" "unprognostic (1.20e-1)" "unprognostic (4.61e-3)" "unprognostic (1.34e-1)" "unprognostic (2.14e-1)" "unprognostic (2.37e-2)" "unprognostic (5.08e-3)" "unprognostic (6.73e-4)" "unprognostic (1.92e-3)" "unprognostic (1.90e-1)" "unprognostic (2.86e-2)" "unprognostic (3.08e-2)" 3.4 1.4 1.9 0.9 8.6 0.7 1.2 0.4 2.3 1.6 3.3 7.2 0.0 1.1 1.7 2.6 7.6 2.1 2.3 33.0 3.5 5.8 1.9 0.8 2.3 0.9 2.3 2.2 3.2 2.4 0.6 7.5 3.4 8.8 3.7 1.3 7.2 0.9 2.0 5.3 0.6 1.1 3.0 3.9 1.2 3.3 0.8 4.9 0.0 1.1 3.4 1.2 4.5 3.4 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 1.9 8.6 0.4 2.3 3.5 5.8 2.3 2.2 8.8 4.9 0.0 0.0 0.0 0.0 0.8 153.4 8.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.4 0.0 3.4 12.9 19.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 KCNA6 "HBK2, Kv1.6, PPP1R96" ENSG00000151079 "Potassium voltage-gated channel subfamily A member 6" P17658 12 4809176-4813412 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.4;JURKAT: 4.5;TIME: 1.0;U-698: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 0.7 0.8 3.8 2.7 4.7 0.8 2.0 0.7 9.6 1.0 0.7 6.8 0.0 2.2 0.8 0.6 0.8 0.8 0.6 0.7 5.8 0.7 0.8 0.9 0.9 2.1 3.9 7.2 0.9 0.8 0.6 2.0 0.7 4.3 0.8 0.6 0.0 0.8 0.6 1.2 0.7 0.8 0.7 1.7 1.5 0.8 2.0 8.4 0.0 0.8 0.0 0.6 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 2.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 4.7 0.7 9.6 5.8 0.7 3.9 7.2 4.3 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNA7 "HAK6, Kv1.7" ENSG00000104848 "Potassium voltage-gated channel subfamily A member 7" Q96RP8 19 49067418-49072941 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 40.6" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 2: 25.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 4.0;U-251 MG: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.00e-1)" "unprognostic (2.10e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "unprognostic (1.68e-1)" "unprognostic (4.31e-2)" "unprognostic (3.17e-2)" "unprognostic (6.97e-2)" "unprognostic (2.94e-2)" "unprognostic (1.26e-1)" "unprognostic (2.21e-8)" "unprognostic (1.70e-1)" "unprognostic (2.62e-1)" "unprognostic (5.80e-2)" "unprognostic (5.29e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 40.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.6 0.3 0.0 0.0 1.1 0.9 3.3 0.8 0.9 0.8 0.2 0.7 0.3 0.4 2.0 0.0 0.2 0.7 0.4 0.0 0.1 0.0 0.5 0.9 0.4 0.2 0.2 0.7 1.3 0.1 0.2 0.0 0.4 0.6 0.2 1.5 0.4 0.2 0.6 4.0 0.1 0.3 0.1 0.1 0.4 0.0 0.4 0.5 1.1 0.1 0.5 0.3 0.7 0.5 0.3 0.3 0.4 0.2 0.5 0.2 0.5 0.4 0.4 1.5 0.3 0.1 0.6 0.5 1.1 0.7 1.4 0.5 0.9 4.0 0.7 0.3 0.3 0.6 0.4 0.5 3.3 0.8 0.7 0.8 0.4 0.5 0.5 0.7 0.7 0.2 1.1 0.7 0.8 2.6 0.9 0.7 0.9 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 25.9 0.0 1.2 0.3 0.4 3.1 0.0 1.4 5.7 0.0 5.9 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.1 0.4 0.5 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 1.6 0.0 0.1 0.1 0.7 0.3 0.9 0.0 0.0 0.3 KCNB1 Kv2.1 ENSG00000158445 "Potassium voltage-gated channel subfamily B member 1" Q14721 20 49293394-49484297 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Exocytosis, Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;retina: 22.4" "Group enriched" "Detected in some" 7 "Bipolar cells: 119.5;Cone photoreceptor cells: 200.3;Rod photoreceptor cells: 366.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 3.6;CACO-2: 5.1;hTCEpi: 3.2;U-2 OS: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB001979, HPA042434" Enhanced NA NA "CAB001979: , HPA042434: AB_2677996" "unprognostic (4.51e-1)" "unprognostic (1.72e-1)" "unprognostic (6.54e-3)" "unprognostic (4.87e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-1)" "unprognostic (8.09e-2)" "unprognostic (6.22e-2)" "unprognostic (5.31e-1)" "unprognostic (8.32e-2)" "unprognostic (1.87e-3)" "unprognostic (1.37e-1)" "unprognostic (1.31e-2)" "unprognostic (2.07e-3)" "unprognostic (8.17e-2)" "unprognostic (9.35e-2)" "unprognostic (5.25e-4)" 16.9 3.6 11.4 1.3 14.6 0.8 2.4 8.1 25.9 2.3 5.1 1.8 0.7 1.2 6.8 2.3 3.9 9.0 1.9 1.9 6.6 5.3 1.3 3.5 1.2 0.8 3.3 12.5 1.2 1.2 0.9 2.5 1.0 2.5 4.8 1.9 22.4 1.7 6.5 6.2 1.1 1.8 9.6 1.2 1.2 3.9 1.5 2.4 0.0 1.0 0.1 0.8 4.0 0.9 0.4 0.3 1.2 0.2 0.3 0.7 0.0 0.0 0.1 0.8 0.0 3.6 0.3 0.1 0.0 0.4 0.4 0.0 5.1 0.0 0.0 0.0 0.1 1.3 0.1 0.0 0.1 0.3 0.1 0.2 0.0 0.1 0.0 0.0 2.6 0.0 0.6 3.2 0.0 0.1 0.2 0.0 0.0 0.0 1.9 1.2 0.3 0.0 2.4 0.1 0.0 0.9 0.0 1.0 0.0 0.0 0.0 2.3 1.9 1.6 2.3 0.0 0.0 1.7 0.0 0.0 2.2 4.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.0 0.1 0.1 0.3 0.2 0.0 0.4 0.7 0.2 1.2 0.3 0.1 0.3 0.1 0.0 11.4 14.6 8.1 25.9 6.6 5.3 3.3 12.5 2.5 2.4 0.0 2.1 0.0 0.1 0.7 119.5 1.2 2.5 5.3 1.2 0.0 200.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.1 3.5 4.7 0.1 17.5 0.0 0.0 0.0 0.4 4.0 0.1 0.0 0.0 0.0 26.9 0.1 0.0 32.5 0.0 366.4 0.0 3.4 0.2 0.3 0.3 0.1 0.0 0.0 0.0 KCNB2 Kv2.2 ENSG00000182674 "Potassium voltage-gated channel subfamily B member 2" Q92953 8 72537391-72938349 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2" "Cell type enriched" "Detected in some" 15 "Cone photoreceptor cells: 249.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 3.2;HDLM-2: 3.1;HEK 293: 7.6;SCLC-21H: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065970 Approved "Nucleoli,Plasma membrane,Midbody" Yes NA "Plasma membrane" "Nucleoli, Midbody" "HPA065970: AB_2685591" "unprognostic (9.87e-3)" "unprognostic (1.71e-1)" "unprognostic (7.57e-2)" "unprognostic (1.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (2.72e-1)" "unprognostic (6.93e-5)" "unprognostic (5.53e-3)" "unprognostic (3.30e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-2)" "unprognostic (3.26e-1)" 0.8 1.9 3.8 0.6 5.3 0.4 0.7 0.3 9.7 0.5 0.7 0.0 0.0 1.2 0.4 0.4 1.1 2.1 0.5 0.4 7.1 3.1 0.5 0.4 0.6 0.5 0.9 7.8 0.4 2.4 0.4 9.2 0.5 3.2 0.7 0.7 4.2 0.5 0.5 0.4 0.4 1.6 0.5 1.6 8.6 2.4 1.7 0.4 0.9 0.4 0.0 0.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 5.3 0.3 9.7 7.1 3.1 0.9 7.8 3.2 0.4 0.0 0.0 0.0 0.0 0.0 12.9 0.2 0.0 0.0 0.0 1.8 249.4 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 17.1 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.4 0.0 2.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.5" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 36.6" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Region enhanced" "Detected in all" "cerebellum: 67.5" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RH-30: 7.5;SCLC-21H: 7.1;SH-SY5Y: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: AB_2680109, HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.7 2.3 8.2 1.0 10.0 2.9 0.9 67.5 33.3 3.0 1.0 1.0 0.0 1.4 1.5 0.6 1.1 0.9 1.3 0.6 5.6 4.9 0.9 1.1 1.0 1.2 3.3 12.6 1.1 0.9 0.6 1.4 0.7 19.5 1.2 0.8 0.7 1.2 0.7 1.7 1.8 1.2 0.8 1.9 1.0 1.3 2.9 2.0 0.0 1.5 0.0 0.8 2.4 0.5 1.7 0.8 5.8 0.8 0.7 1.1 0.3 0.4 0.1 3.1 1.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.2 0.0 0.9 1.1 1.8 0.0 0.3 0.3 2.1 0.6 3.0 0.2 0.4 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.5 1.4 0.0 0.5 0.5 1.2 1.5 0.0 0.0 0.8 7.5 0.9 0.0 0.4 7.1 4.4 0.4 0.5 0.0 0.4 0.6 0.5 0.1 0.2 2.3 0.3 0.3 0.5 0.6 1.0 0.5 0.3 1.0 5.8 0.7 1.1 1.1 0.7 0.7 0.7 0.9 0.5 0.2 1.7 0.7 0.8 3.8 0.7 0.8 0.8 0.4 0.3 8.2 10.0 67.5 33.3 5.6 4.9 3.3 12.6 19.5 2.0 0.0 0.0 0.0 0.0 0.0 36.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 7.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 7.5 0.0 0.0 8.4 0.3 0.0 0.0 1.0 0.0 1.5 0.2 0.0 0.0 0.1 7.4 0.0 0.4 5.4 4.5 0.0 0.0 0.0 0.0 0.0 KCNC2 Kv3.2 ENSG00000166006 "Potassium voltage-gated channel subfamily C member 2" Q96PR1 12 75040077-75209868 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 39.3" "Group enriched" "Detected in some" 12 "Basal glandular cells: 1.9;Bipolar cells: 5.0;Glandular cells: 1.6;Muller glia cells: 1.9;Rod photoreceptor cells: 5.9" "Group enriched" "Detected in some" 8 "breast cancer: 1.5;prostate cancer: 4.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019664, CAB022571" Uncertain NA NA "CAB022571: , HPA019664: AB_1855578" "unprognostic (2.01e-1)" "unprognostic (1.14e-1)" "unprognostic (2.68e-1)" "unprognostic (5.58e-3)" "unprognostic (4.46e-2)" "unprognostic (3.39e-2)" 0.7 0.7 8.7 0.7 12.9 0.7 3.3 0.4 39.3 0.7 0.8 1.9 0.0 0.7 0.9 0.9 0.7 0.7 0.7 0.7 7.4 10.4 0.7 0.9 0.7 0.7 4.7 13.5 0.7 0.7 0.7 6.0 0.7 19.1 4.4 0.8 1.3 1.1 0.7 0.7 0.7 0.8 0.7 1.0 0.7 0.7 1.0 0.6 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.7 12.9 0.4 27.3 7.4 10.4 4.7 13.5 19.1 0.6 0.0 0.0 0.0 1.9 0.0 5.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNC3 "Kv3.3, SCA13" ENSG00000131398 "Potassium voltage-gated channel subfamily C member 3" Q14003 19 50311937-50333515 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;parathyroid gland: 31.1;thyroid gland: 23.9" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 9.8;Collecting duct cells: 19.2;Cone photoreceptor cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 8.9;CAPAN-2: 7.8;HDLM-2: 8.0;HMC-1: 21.4;K-562: 7.9;SK-BR-3: 14.5;T-47d: 13.8;U-2 OS: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018041 Approved NA NA "HPA018041: AB_1855579" "unprognostic (8.05e-2)" "unprognostic (2.34e-2)" "unprognostic (3.01e-4)" "unprognostic (4.41e-2)" "unprognostic (3.84e-2)" "unprognostic (1.91e-2)" "unprognostic (2.79e-2)" "unprognostic (1.12e-2)" "unprognostic (1.46e-1)" "unprognostic (1.59e-1)" "unprognostic (3.94e-3)" "unprognostic (2.10e-5)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.68e-2)" "unprognostic (1.45e-1)" "unprognostic (2.85e-2)" "unprognostic (1.19e-1)" 1.4 2.2 7.2 5.4 9.4 1.4 2.3 32.1 31.2 3.1 1.1 3.4 3.0 1.8 4.5 5.8 1.1 12.8 1.4 1.7 6.9 4.2 10.6 2.5 4.5 4.7 4.0 6.6 0.6 3.7 31.1 9.7 2.4 15.6 2.4 1.4 3.0 2.3 15.1 1.2 2.1 1.8 1.7 3.8 6.5 2.1 2.4 2.9 1.1 23.9 0.0 3.4 1.8 1.0 0.4 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 4.2 0.0 0.0 0.0 0.0 8.9 7.8 0.7 1.0 0.0 0.5 1.2 0.2 0.0 0.0 8.0 1.8 0.0 0.0 1.7 0.0 0.0 21.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 7.9 0.0 0.0 2.8 0.1 0.0 1.1 0.9 3.3 0.0 0.1 0.0 0.5 0.2 0.0 1.4 1.7 14.5 0.0 0.2 13.8 2.2 0.2 0.0 9.5 0.0 0.0 0.1 0.1 0.5 0.3 1.8 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 7.2 9.4 32.1 31.2 6.9 4.2 4.0 6.6 15.6 2.9 0.0 0.3 0.0 0.8 0.7 9.8 2.6 0.0 1.4 1.2 19.2 7.9 1.9 0.0 1.2 0.3 0.0 0.0 0.0 1.2 0.7 0.2 1.1 0.0 1.5 2.8 1.6 4.1 0.6 5.3 0.0 0.6 2.3 0.0 2.8 0.0 0.7 0.2 0.0 0.0 2.3 6.3 0.0 1.0 0.9 1.1 0.5 1.9 0.0 0.0 0.9 KCNC4 "C1orf30, HKSHIIIC, Kv3.4" ENSG00000116396 "Potassium voltage-gated channel subfamily C member 4" Q03721 1 110211343-110283100 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 39.3;Ito cells: 63.3;Rod photoreceptor cells: 44.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 16.5;U-87 MG: 14.7;WM-115: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014740 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA014740: AB_1855580" "unprognostic (9.16e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-2)" "unprognostic (3.72e-1)" "unprognostic (4.12e-2)" "unprognostic (6.13e-2)" "unprognostic (2.33e-2)" "unprognostic (2.68e-1)" "unprognostic (7.48e-2)" "unprognostic (2.03e-1)" "unprognostic (4.26e-2)" "unprognostic (1.26e-1)" "unprognostic (3.04e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-1)" "unprognostic (1.83e-1)" "unprognostic (1.25e-2)" 2.3 4.7 12.1 1.6 3.2 0.7 3.3 9.2 12.7 1.9 1.4 1.9 1.1 0.8 4.5 3.1 2.1 3.7 4.8 4.5 9.1 14.2 5.1 1.1 3.0 1.9 6.8 2.0 3.4 4.3 11.2 3.8 2.8 14.3 2.4 1.3 4.7 7.1 3.7 4.5 4.0 2.0 2.6 3.6 3.3 2.8 2.2 1.1 7.2 2.3 7.8 2.3 1.2 1.5 0.8 0.7 0.9 0.4 0.3 1.5 0.1 1.9 1.5 0.4 2.9 1.1 0.3 3.5 8.5 1.5 0.6 0.8 4.8 0.9 3.3 3.4 3.1 2.6 3.2 1.4 0.7 0.4 16.5 1.6 0.1 3.3 0.7 0.5 2.7 0.8 0.3 0.3 1.9 0.2 0.5 4.4 1.8 0.6 1.4 0.0 0.4 1.8 0.6 1.7 0.7 3.9 2.7 0.1 0.5 4.1 0.1 0.6 0.8 0.4 8.3 0.8 2.7 1.1 1.4 1.6 1.1 4.0 0.7 0.3 2.1 1.9 0.6 14.7 2.3 9.5 0.8 0.4 0.2 0.5 0.2 1.5 0.6 0.9 0.4 0.0 0.8 1.3 0.5 0.9 0.3 0.3 0.7 0.4 0.1 12.1 3.2 9.2 12.7 9.1 14.2 6.8 2.0 14.3 1.1 0.0 1.4 0.0 12.5 2.9 1.4 6.7 7.6 4.0 2.3 3.5 39.3 0.3 0.0 5.0 0.3 9.8 2.2 0.0 14.8 0.3 2.4 7.4 1.1 0.5 1.2 3.2 12.7 63.3 3.1 0.4 1.4 0.5 1.7 1.8 5.7 3.7 8.7 6.6 3.9 0.5 44.8 25.8 5.1 0.0 5.7 2.6 0.9 1.3 8.3 10.3 KCND1 Kv4.1 ENSG00000102057 "Potassium voltage-gated channel subfamily D member 1" Q9NSA2 X 48961378-48971569 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in some" 8 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Intestinal endocrine cells: 3.4;Leydig cells: 1.7;Peritubular cells: 3.5;Rod photoreceptor cells: 2.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 13.2;NB-4: 10.5;SuSa: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000524, HPA001066" Supported Uncertain Nucleoplasm Yes No Nucleoplasm "HPA000524: AB_2666013, HPA001066: AB_1079662" "unprognostic (6.00e-2)" "unprognostic (2.58e-1)" "unprognostic (1.01e-4)" "unprognostic (2.19e-4)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" "unprognostic (2.79e-1)" "unprognostic (8.13e-3)" "unprognostic (1.13e-2)" "unprognostic (2.41e-3)" "prognostic favorable (2.66e-6)" "unprognostic (2.61e-1)" "unprognostic (4.30e-11)" "unprognostic (3.13e-2)" "unprognostic (3.49e-1)" "unprognostic (7.64e-2)" "unprognostic (2.22e-3)" 4.9 2.4 4.2 3.4 4.7 6.0 2.2 16.8 7.8 5.1 2.2 6.3 1.9 2.0 5.0 3.8 1.4 7.4 6.3 2.9 6.9 2.5 2.5 1.8 3.0 3.1 3.1 3.5 4.6 1.4 1.8 3.0 2.5 10.4 3.3 2.1 2.6 1.2 6.0 0.7 1.6 2.6 6.6 6.5 4.2 2.5 3.0 2.7 1.1 2.3 0.5 3.6 3.0 3.0 0.6 1.3 1.4 0.1 0.0 0.8 0.1 0.4 1.9 0.8 4.7 6.4 5.1 1.6 1.0 4.0 2.8 1.9 1.2 0.6 1.6 3.4 3.1 0.8 0.6 0.8 0.4 2.7 2.6 3.1 1.4 1.9 0.1 2.4 0.4 2.9 13.2 1.8 5.2 0.6 4.7 0.9 2.2 1.1 3.6 2.0 3.5 0.4 10.5 2.5 0.3 0.7 1.3 0.9 1.5 3.1 1.5 0.5 2.1 0.9 0.0 2.1 10.2 2.0 1.5 2.4 0.6 2.6 0.6 0.2 2.9 3.8 3.8 1.7 3.7 2.1 0.0 0.1 0.0 0.5 0.0 0.3 0.6 0.2 0.8 0.0 0.1 0.2 0.0 1.4 0.0 0.0 1.3 0.0 0.1 4.2 4.7 16.8 7.8 6.9 2.5 3.1 3.5 10.4 2.7 0.0 1.4 0.0 0.0 0.7 0.2 0.4 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 3.4 0.6 0.8 0.0 1.7 0.0 0.0 0.0 0.2 0.3 0.1 0.0 3.5 0.0 2.8 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.1 KCND2 "KIAA1044, Kv4.2, RK5" ENSG00000184408 "Potassium voltage-gated channel subfamily D member 2" Q9NZV8 7 120273668-120750331 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 41.1" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 2.9;Cholangiocytes: 5.1;Ductal cells: 2.5;Leydig cells: 3.4;Spermatocytes: 4.2;Spermatogonia: 3.3" "Cancer enhanced" "Detected in many" "glioma: 6.2" "Region enhanced" "Detected in all" "cerebellum: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.5;HSkMC: 4.1;NTERA-2: 3.2;RT4: 3.3;SCLC-21H: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029068 Enhanced NA NA "HPA029068: AB_10601436" "unprognostic (4.22e-1)" "unprognostic (2.79e-4)" "unprognostic (3.79e-2)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.91e-2)" "unprognostic (4.98e-3)" "unprognostic (9.07e-3)" "unprognostic (1.03e-1)" "unprognostic (1.14e-1)" "unprognostic (9.77e-3)" "unprognostic (1.51e-1)" "unprognostic (4.51e-4)" "unprognostic (4.07e-5)" "unprognostic (2.71e-2)" "unprognostic (2.92e-2)" "unprognostic (1.83e-3)" 2.9 1.0 3.9 1.0 6.7 0.3 1.9 41.1 20.6 2.4 0.7 1.5 0.0 0.7 5.6 0.5 0.5 1.7 7.0 0.5 3.7 5.4 0.3 0.4 0.6 0.5 4.2 3.6 5.9 0.6 2.5 6.6 0.8 12.1 0.5 0.6 0.0 0.7 1.7 0.5 0.3 0.5 3.7 3.7 0.3 0.5 2.9 4.5 0.0 0.8 1.1 0.3 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 6.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.7 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.0 3.3 16.6 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 6.7 41.1 5.3 3.7 5.4 4.2 3.6 12.1 4.5 0.0 0.0 0.0 0.0 0.0 2.9 1.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.3 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.5 0.0 0.4 4.2 3.3 0.1 0.0 0.0 0.0 0.1 KCND3 "KSHIVB, Kv4.3, SCA19, SCA22" ENSG00000171385 "Potassium voltage-gated channel subfamily D member 3" Q9UK17 1 111770662-111989155 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Brugada syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 38.5;Cardiomyocytes: 34.4;Early spermatids: 29.0;Horizontal cells: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "OE19: 6.6;SCLC-21H: 15.9;U-2 OS: 2.4;WM-115: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029452 Approved NA NA "HPA029452: AB_10602239" "unprognostic (1.11e-2)" "unprognostic (1.73e-3)" "unprognostic (1.71e-1)" "unprognostic (2.60e-2)" "unprognostic (1.37e-1)" "unprognostic (2.42e-1)" "unprognostic (1.41e-1)" "unprognostic (9.48e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-2)" "unprognostic (1.40e-1)" "unprognostic (7.44e-2)" "unprognostic (3.64e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-3)" "unprognostic (6.64e-3)" 3.3 0.8 6.8 3.1 6.9 0.0 2.1 25.9 11.9 1.3 2.5 1.3 1.3 0.3 4.1 9.6 3.2 3.4 4.2 5.5 5.6 5.6 1.3 11.6 1.3 1.3 8.9 5.7 1.3 2.2 4.1 1.5 1.3 1.6 9.2 1.6 1.9 1.3 10.0 2.8 5.1 1.3 7.7 1.3 2.0 1.7 1.3 1.3 1.3 1.3 2.3 1.3 3.7 1.3 0.5 0.4 1.2 0.3 0.9 0.3 0.7 0.0 0.0 0.3 0.0 0.5 0.1 0.1 0.4 0.0 0.0 0.0 0.8 0.1 0.0 1.6 0.6 0.0 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.2 0.3 6.6 0.0 0.0 0.1 0.0 0.0 0.3 15.9 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.5 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.3 0.4 0.5 0.3 0.2 1.2 0.9 0.3 0.3 0.1 0.7 6.8 6.9 25.9 9.3 5.6 5.6 8.9 5.7 1.6 1.3 0.0 9.4 0.0 10.7 6.6 38.5 34.4 0.0 0.0 1.2 0.0 3.9 0.1 0.0 0.7 29.0 1.8 0.0 0.0 21.1 0.1 1.4 14.3 0.0 23.7 0.2 28.6 0.0 1.8 0.6 20.3 16.7 0.0 3.3 0.0 0.2 6.1 4.4 0.3 1.8 0.2 4.2 0.0 3.1 1.1 0.7 5.8 0.0 0.0 0.0 12.3 KCNE1 "ISK, JLNS2, LQT5, minK" ENSG00000180509 "Potassium voltage-gated channel subfamily E regulatory subunit 1" P15382 21 34446688-34512275 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Deafness, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 17.6" "Group enriched" "Detected in many" 7 "Ciliated cells: 32.1;Cone photoreceptor cells: 23.6;Kupffer cells: 26.3;Macrophages: 15.3" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "pons and medulla: 10.6" "Cell type enhanced" "Detected in some" "eosinophil: 6.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.8" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 3.0;CACO-2: 9.2;HBF TERT88: 2.3" NA NA "unprognostic (8.24e-3)" "unprognostic (9.14e-3)" "unprognostic (1.26e-1)" "unprognostic (2.71e-3)" "unprognostic (1.01e-3)" "unprognostic (2.98e-2)" "unprognostic (2.45e-2)" "unprognostic (1.47e-2)" "unprognostic (2.58e-1)" "unprognostic (2.06e-1)" "unprognostic (9.30e-2)" "unprognostic (7.90e-3)" "unprognostic (1.41e-2)" "unprognostic (3.27e-2)" "unprognostic (2.34e-2)" "unprognostic (1.30e-1)" "unprognostic (4.40e-2)" 9.3 0.4 0.7 1.3 0.9 1.6 4.8 0.1 0.5 1.8 3.2 2.7 0.0 0.4 0.8 4.0 0.7 17.6 0.4 9.2 1.3 0.8 3.4 4.3 12.0 10.6 1.7 0.0 2.9 0.2 1.0 1.3 3.5 10.6 1.0 0.4 0.5 0.8 0.3 0.2 0.4 0.6 0.7 0.5 7.3 0.5 4.8 0.3 0.2 0.7 0.1 0.3 1.6 14.8 0.0 0.5 6.8 1.5 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.5 1.1 3.0 1.0 9.2 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.1 0.1 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.3 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.3 0.1 0.1 1.3 6.8 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.0 0.0 1.5 0.0 0.0 0.4 0.7 0.9 0.1 0.5 1.3 0.8 1.7 0.0 10.6 0.3 3.0 2.6 0.0 0.6 0.7 1.4 3.1 0.0 32.1 1.2 0.0 23.6 0.0 0.0 0.6 3.1 1.8 0.0 0.0 0.3 0.3 0.6 0.3 0.0 3.4 3.7 0.0 0.0 1.8 26.3 1.8 0.3 15.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.6 0.0 0.6 0.9 0.0 0.3 0.0 0.0 0.0 0.8 KCNE1B ENSG00000276289 "Potassium voltage-gated channel subfamily E regulatory subunit 1B" A0A087WTH5 21 7816675-7829926 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "blood: 4.0;fallopian tube: 8.2;heart muscle: 8.3;kidney: 3.8" "Cell type enriched" "Detected in single" 5 "Ciliated cells: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.0;eosinophil: 4.0" "Group enriched" "Detected in many" 17 "granulocytes: 4.0;monocytes: 1.6" "Cell line enhanced" "Detected in some" "CACO-2: 5.6;SK-MEL-30: 2.4;SuSa: 3.9" NA NA "unprognostic (5.41e-4)" "unprognostic (8.78e-2)" "unprognostic (7.14e-3)" "unprognostic (1.35e-1)" "unprognostic (3.34e-2)" "unprognostic (1.78e-2)" "unprognostic (3.08e-1)" "unprognostic (7.47e-2)" "unprognostic (3.24e-1)" "unprognostic (1.73e-3)" "unprognostic (6.59e-2)" "unprognostic (1.49e-1)" 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 8.3 3.8 0.4 1.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.0 1.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.7 0.5 5.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 3.0 1.6 4.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNE2 "LQT6, MiRP1" ENSG00000159197 "Potassium voltage-gated channel subfamily E regulatory subunit 2" Q9Y6J6 21 34364024-34371389 "Disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "stomach 1: 66.8" "Group enriched" "Detected in some" 51 "Early spermatids: 28.5;Late spermatids: 11.6" "Cancer enriched" "Detected in some" 6 "stomach cancer: 2.9" "Region enhanced" "Detected in single" "pons and medulla: 3.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 4.2;SCLC-21H: 5.0" "Region enhanced" "Detected in many" "pons and medulla: 30.5" "Not detected" "Not detected" "HPA029706, HPA051553" Enhanced NA NA "HPA029706: AB_2673159, HPA051553: AB_2681532" "unprognostic (5.29e-4)" "unprognostic (3.13e-1)" "unprognostic (6.69e-2)" "unprognostic (2.65e-5)" "unprognostic (7.45e-2)" "unprognostic (7.33e-3)" "unprognostic (5.77e-3)" "unprognostic (6.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.33e-2)" "unprognostic (9.30e-2)" "unprognostic (3.41e-2)" "unprognostic (2.19e-3)" "unprognostic (1.48e-1)" "unprognostic (3.97e-2)" "unprognostic (2.02e-1)" "unprognostic (8.81e-2)" 0.1 0.0 0.2 1.2 0.2 0.0 0.1 0.1 0.9 0.1 0.2 1.3 0.1 2.4 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.2 0.1 0.1 11.8 0.0 0.1 0.1 3.4 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 1.2 0.1 0.1 66.8 0.8 0.1 0.1 0.3 0.1 0.1 0.1 0.1 1.4 1.6 2.2 1.6 0.0 2.0 0.7 0.8 0.3 2.0 3.7 0.2 0.2 2.7 0.9 0.5 0.0 0.1 0.8 1.0 0.8 1.3 0.0 0.6 0.0 0.2 0.0 1.0 1.0 1.2 0.9 0.2 0.0 0.0 0.7 0.5 0.2 0.1 0.0 0.0 0.8 0.0 2.6 0.2 4.2 0.3 1.6 0.2 0.7 2.8 2.7 1.6 0.7 0.6 1.0 0.4 0.2 5.0 0.4 1.4 0.6 1.3 2.6 1.3 1.0 0.0 1.2 0.6 0.5 0.3 4.1 2.3 0.7 0.4 2.1 1.1 0.0 1.6 2.2 0.6 0.1 0.6 0.8 1.1 0.5 1.6 1.4 2.0 0.3 0.0 0.0 0.0 0.8 1.4 0.7 0.2 0.2 0.1 0.9 0.1 0.3 0.2 0.1 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 KCNE3 "HOKPP, MiRP2" ENSG00000175538 "Potassium voltage-gated channel subfamily E regulatory subunit 3" Q9Y6H6 11 74454841-74467729 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Brugada syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 63.7" "Cell type enhanced" "Detected in many" 14 "granulocytes: 33.4;Hofbauer cells: 34.3;Kupffer cells: 101.9;Undifferentiated cells: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 47 "basophil: 16.8;classical monocyte: 16.2;eosinophil: 9.3;intermediate monocyte: 17.4;myeloid DC: 7.6;neutrophil: 22.4;non-classical monocyte: 14.0" "Group enriched" "Detected in many" 122 "dendritic cells: 7.6;granulocytes: 22.4;monocytes: 17.4" "Cell line enhanced" "Detected in some" "HEL: 24.5;NB-4: 15.4;OE19: 55.0;THP-1: 11.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA014849 Approved NA NA "HPA014849: AB_1852112" "unprognostic (1.61e-2)" "unprognostic (2.94e-1)" "unprognostic (1.11e-1)" "unprognostic (8.69e-2)" "unprognostic (3.58e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (4.67e-3)" "unprognostic (4.89e-4)" "unprognostic (4.12e-3)" "unprognostic (2.56e-2)" "unprognostic (2.97e-2)" "unprognostic (1.45e-3)" "unprognostic (7.86e-2)" "unprognostic (1.33e-2)" "unprognostic (1.73e-1)" "unprognostic (2.00e-1)" 10.8 2.2 2.7 8.5 4.6 3.1 5.8 1.2 3.0 6.4 18.2 3.2 4.9 31.4 6.7 4.7 3.5 6.0 63.7 3.8 2.7 1.9 9.3 2.5 15.9 11.3 5.0 1.3 10.5 10.1 1.9 3.3 5.4 3.4 7.6 22.2 7.4 11.7 5.5 1.1 0.7 22.2 4.9 7.7 15.1 26.3 1.7 3.2 1.3 15.1 1.4 3.3 5.2 5.7 0.1 7.6 22.4 17.4 0.0 0.1 4.8 0.0 0.0 0.0 0.0 3.1 0.8 2.6 0.0 0.0 0.3 0.3 8.1 0.7 0.1 7.7 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 24.5 0.1 1.6 1.1 0.2 4.4 2.7 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.1 0.3 0.0 0.0 15.4 0.3 55.0 0.0 2.7 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 11.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 4.6 0.0 16.8 16.2 9.3 0.0 17.4 0.1 0.0 0.0 0.0 7.6 0.1 0.0 0.0 22.4 0.0 14.0 0.3 0.0 4.8 2.7 4.6 1.2 3.0 2.7 1.9 5.0 1.3 3.4 3.2 0.0 5.0 3.4 0.4 0.2 0.0 0.6 10.2 5.3 5.7 1.8 0.0 0.3 3.3 0.2 0.1 0.6 8.0 0.0 6.5 5.9 4.1 0.7 33.4 1.7 34.3 0.0 2.4 6.2 101.9 0.0 3.4 18.0 0.0 0.0 22.2 21.6 3.7 7.0 2.5 17.4 0.9 0.0 0.3 0.0 0.4 0.1 1.7 0.0 33.9 0.6 KCNE4 MiRP3 ENSG00000152049 "Potassium voltage-gated channel subfamily E regulatory subunit 4" Q8WWG9 2 223051814-223198399 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 27.0" "Group enriched" "Detected in many" 5 "Sertoli cells: 116.4;Smooth muscle cells: 171.0" "Cancer enhanced" "Detected in all" "breast cancer: 20.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "AN3-CA: 61.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011420 Approved Approved "Nuclear bodies,Microtubules" NA NA Microtubules "Nuclear bodies" "HPA011420: AB_1079170" "unprognostic (1.23e-1)" "unprognostic (2.02e-3)" "prognostic unfavorable (9.42e-5)" "unprognostic (2.17e-2)" "unprognostic (7.56e-2)" "unprognostic (2.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (7.89e-2)" "prognostic unfavorable (2.02e-7)" "unprognostic (4.70e-3)" "unprognostic (1.20e-1)" "unprognostic (6.24e-3)" "unprognostic (9.08e-3)" 9.0 2.4 5.5 7.5 5.7 0.2 6.6 2.6 11.9 4.5 3.3 1.2 1.4 0.8 21.9 4.4 3.7 3.4 14.8 3.5 6.5 2.5 2.4 3.6 2.1 3.3 9.4 0.7 9.2 6.4 0.7 5.3 4.6 8.7 3.7 1.4 11.6 2.3 4.2 2.1 2.1 2.3 27.0 21.5 4.7 4.9 2.2 8.4 0.0 5.2 1.7 0.6 7.7 12.5 0.7 0.3 2.3 0.3 0.4 0.3 0.0 0.0 0.3 0.0 61.0 14.0 1.4 0.0 1.4 1.4 0.3 0.7 0.0 0.0 0.0 0.0 0.9 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 2.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 2.4 0.0 4.5 0.2 0.0 0.0 0.0 1.4 0.0 1.1 2.3 0.3 0.2 0.3 0.1 0.3 0.2 0.3 0.2 0.0 0.7 0.3 0.3 0.9 0.4 0.2 0.3 0.1 0.0 5.5 5.7 2.6 11.9 6.5 2.5 9.4 0.7 8.7 8.4 0.0 2.1 0.0 0.2 3.4 0.0 1.2 0.0 6.7 2.3 0.0 0.0 0.3 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.2 12.9 0.6 3.5 0.0 0.1 3.2 4.6 6.2 0.0 0.0 19.5 2.2 30.4 0.0 0.0 4.8 0.6 0.0 15.9 0.0 0.2 116.4 171.0 0.0 0.2 2.8 0.2 0.0 0.0 1.1 KCNE5 KCNE1L ENSG00000176076 "Potassium voltage-gated channel subfamily E regulatory subunit 5" Q9UJ90 X 109623700-109625172 "Disease related genes, Predicted membrane proteins" "Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5" "Cell type enriched" "Detected in some" 5 "monocytes: 16.2" "Group enriched" "Detected in some" 8 "glioma: 7.9;testis cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 5.6" "Group enriched" "Detected in many" 4 "dendritic cells: 5.6;monocytes: 1.7" "Cell line enhanced" "Detected in some" "HMC-1: 4.2;hTEC/SVTERT24-B: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042316 Uncertain Cytosol NA NA Cytosol "HPA042316: AB_10795397" "unprognostic (5.33e-2)" "unprognostic (2.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (2.14e-3)" "unprognostic (3.27e-2)" "unprognostic (9.46e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-3)" "unprognostic (7.83e-2)" "unprognostic (5.64e-6)" "unprognostic (5.10e-2)" "unprognostic (9.06e-2)" "unprognostic (1.36e-1)" "unprognostic (5.37e-3)" 4.8 1.1 6.4 1.3 11.3 6.8 1.2 6.0 6.6 1.0 0.6 8.2 0.0 0.7 0.8 1.3 1.2 0.5 2.4 2.2 8.9 8.1 0.7 0.7 0.8 0.8 14.3 1.6 1.7 0.4 0.4 0.2 2.5 29.5 1.9 0.5 0.1 0.6 2.3 3.2 1.1 0.8 0.9 7.3 1.4 0.6 1.2 0.3 8.5 0.6 2.6 0.8 0.8 0.2 0.0 5.6 0.0 1.7 0.1 0.8 0.3 1.0 0.0 0.2 0.4 0.1 0.1 0.1 1.9 0.5 0.7 0.7 0.1 0.4 0.4 0.0 0.4 0.8 0.8 0.0 2.2 0.9 0.2 0.4 2.7 2.6 1.8 0.1 0.0 4.2 0.6 1.5 5.5 1.3 0.5 0.4 0.4 0.0 0.1 0.5 0.0 0.8 3.4 0.0 0.0 0.1 0.2 0.1 0.1 0.8 0.1 0.2 0.4 1.3 0.0 1.1 1.5 0.0 2.5 1.2 1.8 1.0 1.0 2.4 0.5 0.6 0.3 1.2 1.2 0.5 0.0 0.7 0.0 0.8 1.7 0.0 0.0 0.1 0.1 5.6 0.0 0.0 0.1 0.0 0.1 0.1 1.2 0.0 0.3 6.4 11.3 6.0 6.5 8.9 8.1 14.3 1.6 29.5 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 1.1 0.0 0.6 0.0 0.0 1.3 3.0 0.0 1.1 0.2 0.0 16.2 0.0 2.9 0.2 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 KCNF1 "IK8, KCNF, kH1, Kv5.1" ENSG00000162975 "Potassium voltage-gated channel modifier subfamily F member 1" Q9H3M0 2 10911937-10914225 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 36.9" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 10.2;Syncytiotrophoblasts: 6.4" "Cancer enriched" "Detected in many" 7 "glioma: 27.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 16.9;MCF7: 6.0;T-47d: 7.3" "Group enriched" "Detected in many" 4 "amygdala: 70.7;basal ganglia: 55.9;cerebral cortex: 78.2;hippocampal formation: 69.5;olfactory region: 141.1" "Low region specificity" "Detected in all" "HPA014738, HPA062278" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA014738: AB_1852114, HPA062278: AB_2732679" "unprognostic (2.54e-1)" "unprognostic (6.06e-3)" "unprognostic (1.37e-1)" "unprognostic (3.07e-2)" "unprognostic (4.39e-2)" "unprognostic (7.41e-4)" "unprognostic (1.54e-3)" "unprognostic (4.83e-5)" "unprognostic (1.57e-1)" "unprognostic (6.95e-2)" "unprognostic (1.60e-2)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (3.10e-4)" "unprognostic (2.37e-1)" "unprognostic (4.28e-2)" "unprognostic (4.08e-2)" 0.9 0.9 11.5 1.0 25.5 0.8 1.2 0.8 36.9 0.9 1.2 2.4 0.0 1.2 1.9 0.8 1.6 1.1 1.0 1.1 13.1 4.7 1.1 0.9 1.0 1.0 3.1 10.5 0.9 2.2 0.8 0.2 0.9 3.6 1.0 1.2 0.0 0.8 1.4 0.8 0.8 1.1 1.0 1.0 1.5 1.1 1.0 3.1 0.5 0.8 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 16.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.0 2.6 0.1 1.8 0.0 0.1 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.2 7.3 0.8 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 11.5 25.5 0.8 28.5 13.1 4.7 3.1 10.5 3.6 3.1 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 KCNG1 "K13, KCNG, kH2, Kv6.1" ENSG00000026559 "Potassium voltage-gated channel modifier subfamily G member 1" Q9UIX4 20 51003656-51023129 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 25.8;endometrium 1: 48.3" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 45.1;Syncytiotrophoblasts: 81.1" "Cancer enhanced" "Detected in many" "urothelial cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 27 "naive B-cell: 10.8" "Lineage enriched" "Detected in single" 87 "B-cells: 10.8" "Cell line enhanced" "Detected in many" "hTCEpi: 26.7;U-138 MG: 20.3;WM-115: 17.0" "Group enriched" "Detected in many" 5 "amygdala: 21.4;basal ganglia: 17.0;cerebral cortex: 15.2;hippocampal formation: 19.7" "Group enriched" "Detected in all" 4 "amygdala: 16.3;basal ganglia: 12.0;cerebral cortex: 22.5;hippocampal formation: 21.1" "HPA039530, HPA040024" Approved Approved Vesicles NA NA Vesicles "HPA039530: AB_10795144, HPA040024: AB_10796338" "unprognostic (1.19e-1)" "unprognostic (4.47e-2)" "unprognostic (8.70e-2)" "unprognostic (3.49e-2)" "unprognostic (4.07e-2)" "unprognostic (5.05e-4)" "unprognostic (2.53e-2)" "unprognostic (3.89e-3)" "unprognostic (3.64e-2)" "unprognostic (3.43e-2)" "unprognostic (8.74e-2)" "unprognostic (8.89e-2)" "unprognostic (1.83e-9)" "unprognostic (1.52e-1)" "unprognostic (7.42e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-2)" 0.5 4.5 13.3 2.9 7.0 0.3 0.7 2.3 11.9 9.6 2.4 1.6 25.8 0.6 48.3 2.8 3.7 11.9 1.9 1.0 7.9 2.9 0.5 0.4 0.5 3.0 2.0 9.5 0.9 3.7 1.3 0.8 9.3 6.7 5.6 1.3 0.7 1.4 18.3 0.3 0.5 7.2 5.8 1.0 3.5 0.8 5.4 2.6 0.0 0.5 0.0 1.4 2.8 3.4 10.8 0.0 0.0 0.1 0.0 0.0 0.1 0.4 1.7 1.3 6.5 0.7 1.7 0.1 5.7 0.0 3.4 2.6 0.1 0.1 0.0 3.5 1.7 9.4 1.6 0.8 1.7 3.4 0.2 2.2 0.0 6.3 0.0 11.9 0.0 0.2 3.4 26.7 12.8 13.1 0.6 0.9 0.0 0.1 0.0 0.3 6.3 0.0 0.1 6.8 0.0 11.8 0.0 0.0 0.0 0.0 2.0 2.0 7.4 12.4 14.5 9.3 2.2 1.0 0.9 0.3 20.3 12.0 0.1 1.6 0.0 0.0 0.0 6.0 0.4 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 13.3 7.0 2.3 11.9 7.9 2.9 2.0 9.5 6.7 2.6 3.0 1.4 1.5 9.3 1.0 0.3 0.8 0.0 1.4 1.2 0.0 0.0 45.1 0.0 2.9 14.5 0.3 3.5 0.0 0.0 2.4 1.0 5.6 0.0 0.0 2.9 1.6 0.0 0.0 0.0 14.4 1.4 0.0 0.0 0.0 0.2 0.2 0.3 3.5 3.9 0.0 0.1 0.0 1.0 1.2 0.9 0.3 81.1 0.0 0.3 7.9 KCNG2 "KCNF2, Kv6.2" ENSG00000178342 "Potassium voltage-gated channel modifier subfamily G member 2" Q9UJ96 18 79863668-79900184 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 5.3" "Cell type enriched" "Detected in some" 16 "Horizontal cells: 108.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 3.5;U-2 OS: 1.1;U-937: 1.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "hippocampal formation: 31.7" HPA048628 Enhanced NA NA "HPA048628: AB_2680466" "unprognostic (1.07e-2)" "unprognostic (1.34e-2)" "unprognostic (8.39e-2)" "unprognostic (4.41e-1)" "unprognostic (1.99e-1)" "unprognostic (9.69e-2)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (2.40e-1)" "unprognostic (3.78e-1)" "unprognostic (3.61e-3)" "unprognostic (1.09e-1)" "unprognostic (3.18e-5)" "unprognostic (1.05e-1)" "unprognostic (7.72e-2)" "unprognostic (4.08e-2)" "unprognostic (3.63e-2)" 0.2 0.1 1.5 0.8 2.2 0.6 0.0 0.1 2.4 0.0 0.3 1.1 0.3 0.0 0.1 0.0 0.0 0.0 5.3 1.0 0.9 0.1 0.2 0.4 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.2 0.3 0.3 1.2 0.0 0.0 0.5 0.0 0.6 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.0 0.7 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.7 0.1 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 1.2 108.1 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.3 2.1 0.0 5.3 0.0 0.0 0.0 KCNG3 Kv6.3 ENSG00000171126 "Potassium voltage-gated channel modifier subfamily G member 3" Q8TAE7 2 42442017-42494097 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.4" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 3.0;Intestinal endocrine cells: 1.7;Leydig cells: 1.7;Muller glia cells: 2.1;Peritubular cells: 2.5" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 6 "amygdala: 9.0;basal ganglia: 11.4;cerebral cortex: 7.1;hippocampal formation: 4.4;olfactory region: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HAP1: 5.1;HMC-1: 17.7;NTERA-2: 11.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "amygdala: 3.9;basal ganglia: 4.7;cerebral cortex: 5.3;hippocampal formation: 6.6;midbrain: 3.0" HPA041625 Approved "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "HPA041625: " "unprognostic (1.56e-1)" "unprognostic (4.22e-3)" "unprognostic (2.48e-1)" "unprognostic (7.67e-3)" "unprognostic (7.95e-2)" "unprognostic (9.14e-3)" "unprognostic (4.83e-3)" "unprognostic (6.59e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-1)" "unprognostic (2.56e-1)" "unprognostic (2.17e-1)" "unprognostic (1.67e-2)" "unprognostic (2.76e-1)" "unprognostic (6.47e-2)" "unprognostic (1.23e-1)" 0.4 5.2 9.0 2.5 11.4 0.3 0.5 0.2 7.1 0.8 2.3 0.1 1.6 0.4 1.6 0.7 0.4 0.5 0.7 0.3 4.4 0.9 1.2 0.3 1.2 0.4 1.2 3.6 0.9 2.9 0.3 1.8 0.3 0.5 1.2 1.3 0.6 0.3 1.7 0.3 0.6 0.5 0.6 0.3 0.4 0.3 3.3 1.1 4.9 0.3 0.0 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.2 0.0 5.1 0.0 0.0 0.0 2.7 0.0 0.5 0.9 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.1 0.9 0.0 11.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.6 0.7 1.1 1.7 0.5 1.8 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 11.4 0.2 7.1 4.4 0.9 1.2 3.6 0.5 1.1 3.0 0.6 0.0 0.2 1.1 1.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 2.1 0.2 0.0 2.5 0.0 0.0 0.0 0.4 0.2 1.0 1.0 0.1 0.0 0.0 0.1 KCNG4 Kv6.4 ENSG00000168418 "Potassium voltage-gated channel modifier subfamily G member 4" Q8TDN1 16 84218667-84239750 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 8.8" "Cell type enriched" "Detected in some" 18 "Bipolar cells: 29.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2" "Region enhanced" "Detected in many" "cerebellum: 101.5" "Low region specificity" "Detected in many" NA NA "unprognostic (3.54e-1)" "unprognostic (6.67e-2)" 0.7 2.8 2.6 0.2 1.8 1.8 0.1 0.7 3.5 0.0 0.1 1.6 0.0 0.1 0.3 0.8 0.4 0.2 0.3 0.1 2.8 2.0 0.2 0.1 0.1 0.5 2.8 0.0 0.6 0.3 0.0 1.1 0.2 2.3 0.4 0.2 8.8 0.4 0.1 1.0 2.1 0.4 0.1 1.3 0.4 0.4 0.7 1.0 0.0 0.4 0.0 0.1 0.4 0.0 0.9 0.8 2.4 0.6 1.3 0.6 0.2 0.3 0.3 0.9 3.2 0.3 0.3 0.9 0.6 0.0 0.0 0.0 0.6 0.7 0.5 0.4 0.2 0.1 0.4 0.0 0.0 0.2 0.2 0.7 0.5 1.1 1.0 0.2 0.1 0.3 0.1 0.0 0.1 0.3 0.6 0.1 0.5 0.6 1.4 0.0 0.8 0.3 1.0 0.8 0.0 0.8 0.4 0.9 0.1 0.0 0.8 0.8 0.7 0.7 0.4 1.8 0.3 0.6 0.3 0.5 0.5 0.4 0.9 0.4 0.6 0.3 0.4 0.7 0.5 0.6 2.4 0.6 0.6 0.4 0.3 0.3 0.4 0.4 0.3 0.2 0.9 0.4 0.6 2.1 1.3 0.3 0.8 0.4 0.2 2.6 1.8 0.7 3.5 2.8 2.0 2.8 0.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 29.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNH1 "eag, eag1, h-eag, Kv10.1" ENSG00000143473 "Potassium voltage-gated channel subfamily H member 1" O95259 1 210676823-211134180 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 20.2" "Group enriched" "Detected in some" 6 "Early spermatids: 9.0;Late spermatids: 13.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 4.3;RH-30: 7.2;RPTEC TERT1: 4.2;SH-SY5Y: 9.2;SK-MEL-30: 8.6;T-47d: 6.5" "Low region specificity" "Detected in all" "HPA014551, HPA019445, HPA076421" Enhanced Supported Vesicles NA NA Vesicles "HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: " "unprognostic (9.12e-2)" "unprognostic (4.82e-3)" "unprognostic (2.63e-1)" "unprognostic (6.70e-2)" "unprognostic (3.56e-1)" "unprognostic (3.63e-2)" "unprognostic (1.73e-1)" "unprognostic (9.36e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.77e-2)" "unprognostic (1.42e-3)" "unprognostic (1.17e-1)" "unprognostic (8.89e-2)" "unprognostic (1.36e-1)" "unprognostic (9.70e-2)" 0.9 2.3 6.3 1.3 13.3 0.7 0.6 19.1 20.2 1.0 1.3 3.3 0.2 1.2 1.5 1.0 0.9 1.2 1.0 0.7 3.8 1.7 1.0 0.7 0.7 0.7 1.1 7.5 0.8 0.9 0.9 0.8 1.1 1.7 1.3 1.3 0.0 0.8 0.9 0.7 0.9 1.0 1.0 2.1 0.6 1.5 2.4 1.5 0.0 0.8 0.0 0.7 0.9 0.7 0.1 0.7 0.7 0.1 0.1 0.3 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.1 0.7 0.1 1.5 1.7 0.0 0.0 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 4.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 7.2 0.0 4.2 0.0 0.3 9.2 1.6 0.1 8.6 1.2 6.5 0.0 0.0 1.1 0.1 1.4 0.8 0.0 0.0 0.0 0.2 0.0 0.6 0.7 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.7 0.1 0.0 6.3 13.3 19.1 20.2 3.8 1.7 1.1 7.5 1.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 KCNH2 "erg1, HERG, Kv11.1, LQT2" ENSG00000055118 "Potassium voltage-gated channel subfamily H member 2" Q12809 7 150944961-150978315 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Deafness, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.9" "Group enriched" "Detected in many" 5 "Bipolar cells: 199.1;Cardiomyocytes: 76.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.0" "Group enriched" "Detected in some" 7 "K-562: 59.8;NB-4: 29.8;SH-SY5Y: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (6.06e-5)" "unprognostic (9.79e-3)" "unprognostic (1.95e-2)" "unprognostic (3.40e-2)" "unprognostic (3.84e-2)" "unprognostic (3.53e-2)" "unprognostic (3.52e-1)" "prognostic favorable (5.61e-4)" "unprognostic (6.08e-2)" "unprognostic (2.26e-2)" "unprognostic (4.90e-2)" "unprognostic (2.83e-1)" "unprognostic (6.24e-2)" "unprognostic (3.02e-2)" 1.1 4.9 5.0 3.2 8.3 37.9 0.7 19.3 8.0 4.3 17.3 2.8 3.1 3.5 9.3 4.6 3.4 4.1 28.5 24.9 4.8 9.3 0.8 0.7 1.7 0.9 4.7 3.9 6.6 5.1 10.5 23.8 2.2 14.1 6.8 1.8 8.0 1.8 10.2 0.8 0.7 6.9 9.4 2.2 1.6 6.8 18.0 1.6 0.1 0.7 0.0 0.7 7.5 2.4 0.1 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.9 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.1 5.7 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 59.8 0.0 0.0 0.3 0.5 29.8 0.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 1.2 25.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.5 0.0 0.0 1.7 0.0 0.6 0.0 3.7 0.0 0.8 0.0 2.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 8.3 19.3 8.0 4.8 9.3 4.7 3.9 14.1 1.6 0.0 0.0 0.0 0.1 0.0 199.1 76.1 0.0 0.0 0.0 0.0 3.9 0.1 0.0 1.8 0.8 0.0 0.0 23.3 0.2 1.0 0.9 0.1 26.4 0.0 0.3 15.9 15.6 2.5 0.0 2.5 2.3 0.0 0.0 0.0 0.7 2.7 0.5 0.0 12.4 0.0 9.6 0.0 1.9 0.7 2.6 0.0 0.2 0.0 0.2 0.3 KCNH3 "BEC1, elk2, Kv12.2" ENSG00000135519 "Potassium voltage-gated channel subfamily H member 3" Q9ULD8 12 49539157-49558308 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 9.4;Early spermatids: 4.1;Late spermatids: 3.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.6" "Lineage enriched" "Detected in single" 5 "T-cells: 3.6" "Cell line enhanced" "Detected in some" "A549: 9.6;AN3-CA: 4.5;HMC-1: 4.6;RPTEC TERT1: 11.8;U-2 OS: 12.5" "Group enriched" "Detected in many" 11 "amygdala: 60.0;basal ganglia: 42.5;cerebral cortex: 73.6;hippocampal formation: 46.6;olfactory region: 50.0" "Low region specificity" "Detected in many" HPA051088 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA051088: AB_2681340" "unprognostic (5.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-4)" "unprognostic (8.24e-3)" "unprognostic (7.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.66e-1)" "unprognostic (9.91e-3)" "unprognostic (5.28e-2)" "unprognostic (6.39e-5)" "unprognostic (1.68e-1)" "unprognostic (1.07e-4)" "unprognostic (5.52e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" 0.9 3.8 24.3 1.5 18.5 1.4 1.0 5.8 30.7 0.9 0.8 0.5 0.0 0.9 1.3 0.9 0.7 8.7 1.7 1.2 22.0 3.0 1.6 0.7 1.2 1.9 1.9 13.0 0.8 1.4 6.3 9.3 0.8 0.0 1.2 0.7 0.0 1.1 1.6 0.8 1.1 1.0 1.0 0.6 1.4 1.4 2.6 2.1 0.0 1.7 0.0 1.4 0.9 0.0 0.0 0.1 0.6 0.8 0.4 3.6 0.5 1.0 9.6 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.6 0.0 0.3 2.3 0.7 0.2 0.0 0.1 0.4 0.0 0.5 0.1 0.1 0.0 4.6 0.0 0.0 0.1 0.0 1.8 0.0 0.2 0.0 0.3 0.0 1.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.6 11.8 0.0 1.8 0.3 0.3 0.0 0.3 0.0 1.1 0.2 0.1 0.0 12.5 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.7 0.0 3.6 0.0 0.3 1.1 0.1 0.0 1.1 2.6 0.6 0.4 0.1 0.0 0.4 0.5 24.3 18.5 5.8 30.7 22.0 3.0 1.9 13.0 0.0 2.1 0.0 0.3 0.0 0.2 0.1 0.0 0.6 2.5 9.4 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 1.6 2.4 1.3 0.8 3.6 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.1 0.0 0.2 0.0 0.0 0.9 2.5 0.3 0.0 1.0 0.0 0.0 KCNH4 "elk1, Kv12.3" ENSG00000089558 "Potassium voltage-gated channel subfamily H member 4" Q9UQ05 17 42156891-42181278 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.3;K-562: 6.0;RPMI-8226: 11.4;RT4: 4.3;U-266/70: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.07e-3)" "unprognostic (1.02e-2)" "unprognostic (4.02e-2)" "unprognostic (1.70e-1)" "unprognostic (9.30e-2)" "unprognostic (2.08e-3)" "unprognostic (4.59e-3)" "unprognostic (1.56e-1)" "unprognostic (2.41e-1)" "unprognostic (9.92e-2)" "unprognostic (4.77e-3)" "unprognostic (1.58e-1)" "unprognostic (1.36e-6)" "unprognostic (9.52e-2)" "unprognostic (2.66e-1)" "unprognostic (6.47e-2)" "unprognostic (1.72e-3)" 1.2 1.0 0.7 2.4 11.2 0.7 0.3 0.0 7.9 0.7 0.3 0.1 0.0 0.7 0.2 0.1 0.1 0.4 0.5 0.7 0.4 0.9 0.2 0.2 0.3 1.0 0.3 1.0 0.2 0.3 0.0 0.4 0.3 0.0 0.5 0.3 0.0 0.8 0.5 0.2 0.4 0.5 0.3 0.1 0.8 0.6 0.9 2.6 0.0 0.2 0.0 1.1 3.1 0.1 0.4 0.6 0.6 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 6.3 0.5 0.9 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.0 1.1 0.0 0.0 1.9 0.0 0.0 1.1 0.0 0.0 0.0 11.4 0.0 4.3 2.6 1.4 0.4 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.1 0.8 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.7 11.2 0.0 7.9 0.4 0.9 0.3 1.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 KCNH5 "eag2, H-EAG2, Kv10.2" ENSG00000140015 "Potassium voltage-gated channel subfamily H member 5" Q8NCM2 14 62699454-63102037 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.6;brain: 9.2;retina: 5.7" "Cell type enriched" "Detected in some" 15 "Bipolar cells: 64.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 10.1;RT4: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030487, HPA072351" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA030487: AB_10609995, HPA072351: " "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-2)" "unprognostic (8.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" 0.9 4.6 1.7 0.5 3.6 0.3 0.4 0.2 9.2 0.3 0.4 0.4 0.0 0.3 0.4 0.5 0.3 0.3 0.3 0.3 1.3 3.0 0.4 0.3 0.3 0.3 1.2 4.2 0.3 0.3 0.3 1.5 1.2 6.5 0.7 0.3 5.7 0.3 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 1.7 0.0 0.0 0.3 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 1.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.1 0.0 1.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.6 0.2 9.2 1.3 3.0 1.2 4.2 6.5 0.0 0.0 0.0 0.0 0.1 0.0 64.7 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.4 0.7 0.0 1.0 0.0 0.0 0.0 KCNH6 "erg2, HERG2, Kv11.2" ENSG00000173826 "Potassium voltage-gated channel subfamily H member 6" Q9H252 17 63523334-63548977 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 8.7;kidney: 15.4;pituitary gland: 7.6;retina: 7.6" "Group enriched" "Detected in some" 8 "Bipolar cells: 10.0;Cardiomyocytes: 19.6;Cone photoreceptor cells: 29.5;Intestinal endocrine cells: 33.3;Proximal tubular cells: 15.4" "Cancer enhanced" "Detected in some" "prostate cancer: 5.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "SCLC-21H: 8.7;SH-SY5Y: 3.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "olfactory region: 4.7;pons and medulla: 1.4" HPA061704 Approved NA NA "HPA061704: " "unprognostic (8.00e-2)" "unprognostic (1.80e-1)" "unprognostic (5.46e-2)" "unprognostic (5.68e-2)" "unprognostic (5.98e-5)" "unprognostic (3.39e-1)" "unprognostic (1.15e-1)" "unprognostic (3.03e-1)" "unprognostic (1.28e-2)" "unprognostic (3.25e-1)" "unprognostic (1.74e-3)" "unprognostic (3.95e-1)" "unprognostic (1.19e-1)" "unprognostic (9.80e-2)" "unprognostic (3.66e-1)" "unprognostic (8.05e-2)" "unprognostic (9.15e-2)" 0.0 0.2 0.3 0.7 1.1 0.3 0.0 0.1 1.2 0.0 4.2 0.0 0.0 3.9 0.0 0.5 0.0 0.3 0.1 0.6 0.3 2.8 15.4 0.0 0.9 0.1 1.1 0.5 0.1 2.4 0.1 7.6 0.6 1.0 6.2 0.4 7.6 0.1 0.0 0.2 0.3 8.7 0.0 0.7 0.1 1.7 1.4 0.3 0.3 0.1 0.0 0.0 0.1 0.0 0.8 0.4 1.7 0.5 0.7 0.5 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.2 0.7 0.0 0.2 0.1 0.1 0.0 0.0 0.3 8.7 3.3 0.0 0.2 0.1 0.2 0.3 0.2 0.0 0.3 1.0 0.2 0.1 0.2 0.1 0.2 0.1 0.1 0.2 1.2 0.5 0.4 0.4 0.3 0.1 0.6 0.2 0.2 0.2 0.8 0.5 0.4 1.7 0.7 0.3 0.4 0.2 0.4 0.3 1.1 0.1 1.2 0.3 2.8 1.1 0.5 1.0 0.3 0.0 0.0 0.0 0.2 0.2 10.0 19.6 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 33.3 0.0 0.0 2.0 0.0 0.0 1.7 0.0 1.6 0.5 0.1 0.0 0.0 15.4 2.7 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 KCNH7 "erg3, HERG3, Kv11.3" ENSG00000184611 "Potassium voltage-gated channel subfamily H member 7" Q9NS40 2 162371407-162838730 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.0;pituitary gland: 5.4" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 22.7;Horizontal cells: 20.6;Ito cells: 12.9;Late spermatids: 55.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 1.5;neutrophil: 3.0" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.0" "Group enriched" "Detected in some" 13 "SCLC-21H: 10.7;SK-BR-3: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018039 Uncertain NA NA "HPA018039: AB_1852125" "unprognostic (1.80e-1)" "unprognostic (2.68e-1)" "unprognostic (2.66e-1)" "unprognostic (5.55e-2)" "unprognostic (3.05e-2)" "unprognostic (5.51e-2)" "unprognostic (8.12e-3)" "unprognostic (7.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (3.52e-2)" "unprognostic (7.55e-3)" "unprognostic (2.76e-3)" "unprognostic (2.13e-1)" "unprognostic (4.71e-2)" "unprognostic (1.68e-2)" 0.4 1.0 4.4 0.9 6.8 0.8 0.4 6.0 11.0 0.4 0.4 0.0 0.7 0.7 0.4 0.6 0.4 0.5 0.4 1.0 2.6 1.8 0.6 2.7 0.5 0.5 0.7 4.6 0.4 1.0 0.3 5.4 0.6 3.1 0.4 0.3 0.4 0.4 1.5 0.3 0.4 0.5 0.4 0.7 1.1 2.5 1.6 0.3 0.0 0.4 0.0 0.3 0.4 0.4 0.1 0.1 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.7 0.7 0.0 9.6 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 4.4 6.8 6.0 11.0 2.6 1.8 0.7 4.6 3.1 0.3 0.0 0.0 0.0 0.0 0.0 8.6 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.6 0.0 12.9 1.6 55.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 KCNH8 "elk3, Kv12.1" ENSG00000183960 "Potassium voltage-gated channel subfamily H member 8" Q96L42 3 19148454-19535646 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.3;pituitary gland: 16.1" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 4.7;Early spermatids: 2.7;Intestinal endocrine cells: 3.5;Melanocytes: 3.3;Muller glia cells: 3.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 5 "B-cells: 4.5" "Cell line enhanced" "Detected in some" "HAP1: 2.1;OE19: 4.0;SH-SY5Y: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA016586, HPA077537, HPA077773" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA016586: AB_1852127, HPA077537: , HPA077773: " "unprognostic (6.68e-3)" "unprognostic (1.68e-1)" "unprognostic (2.99e-2)" "unprognostic (8.56e-6)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.88e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (1.69e-1)" "unprognostic (5.04e-3)" "unprognostic (2.90e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (3.89e-2)" "unprognostic (8.71e-5)" "unprognostic (1.72e-1)" 0.6 7.0 8.4 1.6 22.0 1.4 2.4 1.3 11.4 1.3 1.9 31.3 0.0 2.2 1.2 1.2 0.7 1.4 2.2 1.0 11.8 5.7 0.7 0.7 0.8 3.2 16.4 10.2 0.7 2.7 0.8 16.1 0.6 15.0 2.2 2.5 0.1 3.3 1.4 0.6 1.9 1.8 1.1 9.9 2.6 5.9 4.0 18.1 0.0 1.1 0.0 3.2 0.9 0.5 4.5 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.8 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.4 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 8.4 22.0 1.3 11.4 11.8 5.7 16.4 10.2 15.0 18.1 0.0 0.0 0.0 1.6 0.5 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.7 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.1 0.0 0.0 3.3 0.0 1.7 3.7 0.6 0.0 0.0 0.0 0.9 0.0 0.2 0.7 1.9 0.0 0.1 0.0 0.2 0.2 KCNIP3 "CSEN, DREAM, KCHIP3" ENSG00000115041 "Potassium voltage-gated channel interacting protein 3" Q9Y2W7 2 95297304-95386083 "Predicted intracellular proteins, Transporters" "Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport" "Ion channel, Potassium channel, Repressor, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.8;parathyroid gland: 32.5" "Group enriched" "Detected in some" 5 "Leydig cells: 23.6;Peritubular cells: 40.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.1;hTERT-RPE1: 15.9;RPTEC TERT1: 23.8;U-138 MG: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066717, HPA069797" Enhanced Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA066717: , HPA069797: AB_2686199" "unprognostic (1.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.33e-3)" "prognostic unfavorable (1.58e-5)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" "unprognostic (2.23e-1)" "unprognostic (2.96e-1)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (2.32e-1)" "unprognostic (4.09e-1)" "unprognostic (1.44e-3)" "unprognostic (8.90e-2)" "unprognostic (6.51e-2)" "unprognostic (7.33e-2)" "unprognostic (1.04e-1)" 4.2 1.8 19.8 1.5 20.1 0.7 2.8 3.7 39.8 6.0 4.6 12.9 0.6 2.1 5.8 4.9 3.5 5.3 2.4 3.4 16.7 7.8 4.6 1.2 1.5 1.1 9.1 19.5 8.8 2.5 32.5 5.6 6.5 8.2 5.7 1.8 1.4 6.9 18.6 2.2 3.9 1.9 6.4 6.3 2.2 2.9 9.2 15.9 5.4 19.5 0.0 1.3 4.5 5.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.9 0.0 0.5 4.1 3.6 2.9 0.0 4.2 12.1 6.9 6.4 0.0 0.0 0.0 0.4 5.5 3.7 0.1 2.7 0.7 2.9 0.0 0.9 0.0 1.1 0.0 1.5 0.0 0.0 2.0 2.4 1.5 6.8 15.9 0.0 0.7 0.0 0.0 0.5 5.2 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 23.8 0.0 0.4 0.1 0.2 0.2 4.6 0.0 0.2 0.0 0.2 11.2 2.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 20.1 3.7 39.8 16.7 7.8 9.1 19.5 8.2 15.9 0.0 0.6 0.0 0.7 0.3 0.6 0.9 0.0 0.0 0.0 1.8 0.0 0.0 6.6 0.3 0.3 0.6 0.2 0.0 0.0 0.0 3.3 0.4 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 23.6 0.0 6.8 1.0 0.0 0.7 0.3 0.0 40.3 0.6 0.0 0.0 2.3 0.0 0.9 0.6 0.0 0.0 0.1 0.0 KCNJ1 "Kir1.1, ROMK1" ENSG00000151704 "Potassium voltage-gated channel subfamily J member 1" P48048 11 128836315-128867373 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Bartter syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "kidney: 123.2" "Cell type enriched" "Detected in some" 5 "Distal tubular cells: 165.8" "Cancer enriched" "Detected in some" 7 "renal cancer: 3.4" "Region enriched" "Detected in single" 4 "basal ganglia: 2.3" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 40 "RPTEC TERT1: 51.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA026962 Enhanced NA NA "HPA026962: AB_10601934" "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (1.14e-1)" "unprognostic (3.19e-1)" "unprognostic (7.55e-2)" "unprognostic (1.29e-1)" "unprognostic (3.01e-2)" "unprognostic (2.69e-1)" "unprognostic (1.46e-1)" "unprognostic (2.44e-2)" "unprognostic (6.47e-2)" "unprognostic (2.78e-1)" "unprognostic (6.05e-2)" "unprognostic (4.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.28e-1)" "unprognostic (7.81e-3)" 0.1 0.0 0.5 0.2 2.3 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 123.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.3 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 51.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.9 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 2.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 36.6 0.0 0.0 165.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 KCNJ10 "Kir1.2, Kir4.1" ENSG00000177807 "Potassium voltage-gated channel subfamily J member 10" P78508 1 159998651-160070483 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Deafness, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 74.1;kidney: 28.1" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 83.5" "Cancer enriched" "Detected in some" 6 "glioma: 27.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.5" "Group enriched" "Detected in many" 6 "NK-cells: 1.7;T-cells: 2.5" "Cell line enhanced" "Detected in some" "Hep G2: 11.7;SK-MEL-30: 3.7;U-266/70: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078302 Enhanced NA NA "HPA078302: AB_2732378" "unprognostic (2.64e-2)" "unprognostic (3.54e-3)" "unprognostic (6.19e-2)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (6.98e-4)" "unprognostic (1.96e-1)" "unprognostic (7.13e-2)" "unprognostic (3.43e-1)" "unprognostic (1.28e-3)" "unprognostic (5.80e-4)" "unprognostic (9.52e-2)" "unprognostic (2.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (3.77e-1)" "unprognostic (6.70e-3)" 1.4 1.5 23.6 3.0 28.1 1.3 1.3 10.5 74.1 1.4 1.7 37.9 0.0 1.5 1.3 1.3 1.4 1.3 1.3 1.3 21.8 13.2 28.1 3.1 1.3 7.1 28.1 15.1 1.3 1.3 1.3 0.3 1.3 25.5 1.3 1.5 0.5 1.5 1.5 1.2 1.6 1.7 1.3 42.9 10.3 2.0 1.8 25.5 0.0 1.5 0.0 2.9 1.5 0.1 0.0 0.0 0.0 0.3 1.7 2.5 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.3 0.0 0.2 1.7 0.2 0.0 1.1 0.4 0.3 0.0 0.2 0.0 0.2 0.1 0.1 11.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.0 2.2 0.1 0.0 0.0 0.2 0.4 0.0 0.3 3.7 1.0 0.1 0.5 0.1 0.1 0.3 0.9 0.0 3.8 1.7 0.0 0.2 0.2 1.8 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.8 0.0 1.7 0.3 0.0 2.5 0.2 23.6 28.1 10.5 22.2 21.8 13.2 28.1 15.1 25.5 25.5 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 3.5 3.9 0.0 10.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.4 1.0 0.0 0.0 0.0 0.0 0.0 83.5 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 KCNJ11 "BIR, Kir6.2" ENSG00000187486 "Potassium voltage-gated channel subfamily J member 11" Q14654 11 17385859-17389331 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 63.1" "Cell type enhanced" "Detected in some" 17 "Cardiomyocytes: 11.3;Collecting duct cells: 5.2;Intestinal endocrine cells: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 7.1;HEK 293: 13.5;MCF7: 10.8;SCLC-21H: 9.2" "Low region specificity" "Detected in all" HPA048891 Approved NA NA "HPA048891: AB_2680547" "unprognostic (1.95e-2)" "unprognostic (6.18e-3)" "unprognostic (7.79e-2)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.25e-1)" "unprognostic (4.81e-5)" "unprognostic (1.83e-3)" "unprognostic (5.45e-2)" "unprognostic (8.09e-3)" "unprognostic (3.72e-3)" "unprognostic (9.23e-3)" "prognostic favorable (1.56e-4)" "unprognostic (4.05e-2)" "unprognostic (2.10e-2)" "unprognostic (1.67e-1)" "unprognostic (4.75e-2)" 2.5 1.1 2.9 1.0 7.8 0.8 2.7 13.6 7.8 1.0 1.1 0.7 4.9 1.4 1.1 2.1 1.7 1.1 1.1 6.2 3.5 2.4 1.3 0.9 1.3 1.2 2.7 5.2 0.8 8.7 2.7 3.3 0.7 3.5 2.5 1.0 0.1 1.2 7.6 63.1 1.0 1.1 0.8 1.7 1.0 4.6 0.8 1.9 0.0 4.1 4.5 1.0 0.9 1.1 0.8 0.4 1.4 0.3 0.8 0.4 0.4 1.5 2.4 0.3 4.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 2.5 0.2 7.1 0.2 0.0 0.3 0.3 4.8 0.1 0.3 1.7 13.5 3.7 0.9 0.8 0.1 0.4 0.3 0.1 0.3 0.0 0.1 0.1 0.0 6.1 3.8 3.8 0.0 10.8 0.7 0.1 1.0 4.2 0.3 1.4 1.7 2.1 0.4 0.9 9.2 0.8 0.0 3.6 0.0 0.0 4.7 0.2 0.0 0.0 1.2 0.0 0.1 0.2 6.0 0.9 0.0 1.0 0.0 1.4 0.3 0.2 0.4 0.3 0.3 0.7 0.4 0.4 0.1 0.8 0.4 0.4 1.3 0.8 0.1 0.4 0.3 0.4 2.9 7.8 13.6 7.8 3.5 2.4 2.7 5.2 3.5 1.9 0.0 2.4 0.0 0.1 0.0 2.4 11.3 0.0 0.0 1.2 5.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 1.0 0.1 0.0 4.1 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.1 KCNJ12 "hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v" ENSG00000184185 "Potassium voltage-gated channel subfamily J member 12" Q14500 17 21376197-21419872 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 39.4;skeletal muscle: 47.8" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 84.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 39.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.6;HeLa: 5.9;PC-3: 6.3;SCLC-21H: 7.3;SiHa: 3.7;SuSa: 8.0;U-2197: 6.3" "Low region specificity" "Detected in all" HPA027021 Approved Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (3.81e-3)" "unprognostic (2.69e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (7.84e-5)" "unprognostic (2.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (4.91e-2)" "unprognostic (8.12e-2)" "unprognostic (1.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-1)" "unprognostic (5.90e-2)" "unprognostic (9.70e-3)" 1.2 1.3 1.9 0.9 2.9 0.7 0.9 39.4 5.8 1.2 0.8 1.1 0.5 0.5 0.8 1.4 1.5 2.1 0.7 5.1 0.9 1.4 1.2 0.5 1.3 0.4 1.3 3.4 0.7 0.5 10.6 0.7 0.7 4.0 0.9 0.6 1.7 0.6 0.9 47.8 6.0 0.6 1.0 0.9 1.3 0.9 1.3 0.9 0.0 1.0 7.5 1.1 0.8 1.5 0.0 0.9 0.0 0.5 0.0 0.1 0.0 0.0 1.1 0.4 2.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 3.6 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 5.9 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.1 0.0 1.5 0.0 6.3 0.0 1.0 1.6 0.0 0.0 7.3 0.4 3.7 0.0 1.5 8.0 0.0 0.0 2.8 0.0 0.5 6.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 1.9 2.9 39.4 5.8 0.9 1.4 1.3 3.4 4.0 0.9 0.0 0.0 0.0 0.0 1.3 0.8 12.5 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.4 1.4 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.2 84.2 1.2 5.5 0.0 0.2 6.9 0.0 0.0 0.0 0.4 11.2 0.0 0.0 3.9 0.6 1.4 0.0 0.5 0.5 1.3 1.9 0.1 0.0 0.6 0.0 KCNJ13 "Kir1.4, Kir7.1, LCA16" ENSG00000115474 "Potassium voltage-gated channel subfamily J member 13" O60928 2 232766464-232776568 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Cataract, Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 22.9;intestine: 49.5;retina: 70.3" "Group enriched" "Detected in some" 14 "Melanocytes: 20.3;Muller glia cells: 44.0" "Cancer enriched" "Detected in some" 5 "melanoma: 5.9" "Region enriched" "Detected in some" 7 "pons and medulla: 22.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 1.7;CACO-2: 2.6;SuSa: 3.1;U-2197: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051609 Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA051609: " "unprognostic (4.29e-2)" "unprognostic (2.00e-1)" "unprognostic (2.69e-1)" "unprognostic (9.03e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-2)" "unprognostic (2.26e-1)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.41e-1)" "unprognostic (4.90e-2)" "unprognostic (1.86e-2)" "unprognostic (2.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.82e-2)" "unprognostic (1.11e-2)" 0.2 0.2 0.5 0.0 0.7 0.1 0.3 0.4 0.9 0.2 10.1 7.0 1.3 4.3 0.2 0.3 0.2 0.1 1.6 0.2 3.2 0.5 1.9 0.3 0.2 0.0 0.4 0.4 0.3 0.4 8.5 0.3 0.0 22.9 0.3 0.0 70.3 0.3 1.6 0.2 1.8 49.5 0.0 0.6 0.2 1.1 0.5 0.1 0.0 3.8 0.0 0.0 0.3 0.3 1.1 0.8 5.4 1.1 1.1 2.7 0.1 0.1 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.0 0.0 0.5 0.0 0.3 0.2 0.0 0.9 0.0 0.0 0.4 0.0 0.6 0.0 0.1 0.0 0.3 1.0 3.1 0.2 0.3 0.0 0.1 0.0 4.6 0.3 1.3 0.1 0.8 0.8 0.4 0.0 5.4 1.1 0.9 1.0 0.2 1.2 0.8 1.8 0.7 0.4 1.1 2.1 1.1 0.8 1.1 1.0 0.8 2.7 0.1 0.5 0.7 0.4 0.9 3.2 0.5 0.4 0.4 22.9 0.1 0.0 0.0 0.0 0.0 0.5 0.6 0.2 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 2.4 0.0 1.0 0.0 1.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 44.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KCNJ14 "IRK4, Kir2.4" ENSG00000182324 "Potassium voltage-gated channel subfamily J member 14" Q9UNX9 19 48455509-48466980 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 22.9" "Cell type enriched" "Detected in many" 8 "Rod photoreceptor cells: 311.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071765 Approved Nucleoli NA NA Nucleoli "HPA071765: AB_2686444" "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (1.33e-5)" "unprognostic (5.77e-2)" "unprognostic (9.41e-2)" "unprognostic (5.26e-2)" "unprognostic (7.05e-4)" "unprognostic (7.83e-4)" "unprognostic (1.26e-1)" "unprognostic (6.48e-2)" "unprognostic (4.43e-3)" "unprognostic (4.92e-2)" "unprognostic (5.02e-6)" "unprognostic (1.47e-1)" "unprognostic (4.98e-2)" "unprognostic (6.82e-3)" "unprognostic (4.41e-2)" 1.0 0.4 1.1 0.9 6.1 4.9 1.8 2.3 2.2 0.9 0.9 0.9 0.9 0.6 0.9 1.8 1.5 1.1 1.0 0.9 1.4 1.3 0.9 0.9 0.9 1.2 1.2 0.9 1.3 1.4 1.0 1.0 1.4 1.4 1.5 0.7 22.9 0.9 0.9 3.3 4.9 0.9 0.9 0.9 0.9 0.6 2.8 0.9 0.9 1.6 0.9 0.9 0.9 1.1 1.5 0.8 3.5 0.8 0.6 1.0 0.2 1.6 3.8 0.8 2.5 1.7 1.7 2.6 0.6 0.3 0.8 1.3 3.9 2.2 1.8 0.8 0.6 2.0 5.5 1.2 0.6 2.1 1.3 2.0 1.1 2.2 1.0 1.0 1.6 3.2 1.6 2.8 2.0 2.3 1.1 0.5 1.7 1.8 2.0 0.5 2.4 0.6 12.4 1.4 2.0 2.2 2.6 1.5 0.4 0.6 4.6 1.4 1.7 1.8 2.6 1.4 1.5 1.8 1.3 1.1 2.7 3.6 2.7 3.0 2.1 3.1 1.3 0.7 4.0 2.8 3.5 0.8 0.6 0.6 0.6 0.5 1.2 0.7 1.0 0.4 1.5 0.8 1.0 2.9 0.6 0.3 0.8 0.6 0.2 1.1 6.1 2.3 2.0 1.4 1.3 1.2 0.9 1.4 0.9 0.0 4.3 0.0 3.7 3.9 15.0 0.4 2.5 1.4 0.0 1.8 39.3 1.3 0.0 0.8 4.1 1.0 0.4 0.0 0.9 2.1 0.8 2.5 0.0 0.5 0.5 14.3 0.0 0.6 0.0 0.0 1.1 0.2 0.0 0.0 1.2 17.5 2.1 0.0 0.4 0.0 311.1 0.0 0.9 3.4 2.7 4.6 0.8 0.0 1.7 2.1 KCNJ15 "IRKK, Kir1.3, Kir4.2" ENSG00000157551 "Potassium voltage-gated channel subfamily J member 15" Q99712 21 38155549-38307357 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 74.8;kidney: 99.7" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 56.6;Alveolar cells type 2: 153.4;Cholangiocytes: 63.7;Proximal tubular cells: 211.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 29.6" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 21 "neutrophil: 74.8" "Lineage enriched" "Detected in many" 21 "granulocytes: 74.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 26.1;GAMG: 37.4;HBEC3-KT: 25.1;RPTEC TERT1: 25.0;RT4: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA016702 Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Vesicles, Cytosol" "HPA016702: AB_1855560" "unprognostic (6.34e-2)" "unprognostic (5.04e-2)" "unprognostic (7.92e-2)" "unprognostic (2.07e-3)" "unprognostic (1.21e-1)" "unprognostic (3.54e-3)" "unprognostic (2.72e-3)" "unprognostic (3.03e-2)" "unprognostic (6.79e-2)" "unprognostic (2.89e-3)" "unprognostic (3.77e-2)" "unprognostic (1.95e-2)" "prognostic favorable (4.09e-10)" "unprognostic (9.46e-3)" "unprognostic (1.82e-1)" "unprognostic (5.27e-2)" "prognostic favorable (1.95e-4)" 6.0 0.3 0.4 5.3 0.3 3.2 1.4 0.2 0.3 3.5 0.4 0.2 27.1 0.2 0.5 12.8 6.0 0.8 17.7 1.0 0.2 0.1 99.7 1.5 34.1 0.8 0.5 0.2 0.6 16.7 0.0 0.3 1.0 0.6 4.0 0.0 0.2 14.4 26.8 1.0 1.7 0.2 0.9 0.4 6.8 10.7 1.1 0.2 0.4 36.8 3.2 1.9 11.3 4.3 0.0 0.2 74.8 3.5 0.0 0.0 0.7 0.6 0.0 0.1 0.2 5.1 26.1 0.2 0.3 1.7 0.0 0.0 0.0 0.2 0.1 0.0 2.7 37.4 8.8 0.0 25.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 7.7 2.5 6.5 1.4 0.5 1.2 0.0 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 25.0 29.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 1.3 0.0 0.6 0.1 0.0 2.1 1.5 0.1 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 0.7 0.4 0.3 0.2 0.3 0.2 0.1 0.5 0.2 0.6 0.2 56.6 153.4 0.8 8.5 2.5 0.0 1.2 63.7 9.4 52.4 29.6 0.0 0.1 14.9 23.3 1.4 1.4 0.0 0.0 7.8 0.4 0.8 0.4 5.8 0.0 0.3 0.0 0.0 1.3 5.1 1.9 0.6 2.6 1.7 0.0 0.0 0.0 26.3 0.0 0.0 211.6 0.0 0.0 1.0 0.9 1.0 1.4 0.1 0.0 0.0 4.1 KCNJ16 "BIR9, Kir5.1" ENSG00000153822 "Potassium voltage-gated channel subfamily J member 16" Q9NPI9 17 70053429-70135608 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 96.5;parathyroid gland: 59.4;thyroid gland: 60.4" "Cell type enhanced" "Detected in some" 27 "Cholangiocytes: 43.3;Collecting duct cells: 232.1;Distal tubular cells: 34.9;Proximal tubular cells: 89.7" "Group enriched" "Detected in many" 10 "renal cancer: 37.2;thyroid cancer: 80.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 5.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.1" "Cell line enriched" "Detected in some" 23 "RPTEC TERT1: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059563 Approved Uncertain Vesicles NA NA Vesicles "HPA059563: AB_2684065" "unprognostic (2.81e-3)" "unprognostic (2.10e-1)" "unprognostic (6.06e-2)" "unprognostic (1.20e-3)" "unprognostic (1.16e-1)" "unprognostic (7.53e-2)" "unprognostic (4.38e-4)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-2)" "unprognostic (3.35e-1)" "unprognostic (1.34e-1)" "prognostic favorable (9.61e-7)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "prognostic favorable (6.58e-4)" "unprognostic (3.88e-1)" 0.4 0.3 4.1 0.3 4.4 0.4 1.5 22.6 6.1 0.3 0.4 1.7 12.6 0.4 0.4 6.4 0.3 2.0 6.5 0.4 6.0 7.2 96.5 0.9 0.5 0.4 8.3 3.4 0.4 15.8 59.4 0.8 0.5 25.5 1.0 0.3 0.0 4.1 14.3 0.4 0.5 1.2 0.2 7.5 1.1 7.4 0.8 5.3 0.0 60.4 0.0 0.2 0.3 0.3 1.1 0.5 5.1 0.2 0.9 1.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.5 0.0 0.0 80.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.6 0.9 0.1 1.2 1.0 1.0 0.5 0.1 1.1 0.7 0.6 5.1 0.9 0.1 0.5 1.1 0.3 4.1 4.4 22.6 6.1 6.0 7.2 8.3 3.4 25.5 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 43.3 17.4 4.5 232.1 0.0 0.0 34.9 6.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 89.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 KCNJ18 "KIR2.6, TTPP2" ENSG00000260458 "Potassium voltage-gated channel subfamily J member 18" B7U540 17 21692523-21704612 "Disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "lymphoid tissue: 3.5;skin 1: 8.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "cervical cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.0;HDLM-2: 2.1;HeLa: 1.7;RPMI-8226: 1.0;U-266/70: 3.3" "Region enhanced" "Detected in many" "cerebellum: 75.1" HPA027021 Uncertain Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (2.41e-1)" "unprognostic (3.90e-5)" "unprognostic (2.56e-1)" "unprognostic (1.95e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 KCNJ2 "IRK1, Kir2.1, LQT7" ENSG00000123700 "Potassium voltage-gated channel subfamily J member 2" P63252 17 70168673-70180048 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Atrial fibrillation, Disease mutation, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;parathyroid gland: 34.8" "Cell type enriched" "Detected in many" 8 "Horizontal cells: 227.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 20.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 20.8" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 7.5;HUVEC TERT2: 5.2;REH: 6.0;RH-30: 24.5;U-138 MG: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029109 Approved NA NA "HPA029109: AB_10602913" "unprognostic (1.32e-1)" "unprognostic (1.24e-1)" "unprognostic (1.18e-1)" "unprognostic (6.22e-2)" "unprognostic (3.50e-1)" "unprognostic (6.36e-3)" "unprognostic (1.22e-2)" "unprognostic (3.14e-1)" "unprognostic (1.09e-1)" "unprognostic (1.62e-1)" "unprognostic (3.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.74e-3)" "unprognostic (6.15e-3)" "unprognostic (9.60e-3)" "unprognostic (4.89e-2)" "unprognostic (5.49e-3)" 3.0 1.5 6.2 6.3 17.9 2.5 6.6 1.3 12.8 1.8 5.0 23.7 5.1 1.6 1.5 1.2 4.7 8.4 2.2 11.4 6.4 4.4 1.7 1.9 3.9 4.4 22.4 8.5 1.4 1.0 34.8 1.6 9.0 11.7 2.6 4.3 3.1 2.7 2.9 10.3 6.0 2.1 1.6 14.9 10.4 2.0 0.9 18.2 0.5 1.9 6.0 2.2 2.6 3.3 0.1 0.7 20.8 4.7 0.0 0.0 0.4 0.0 0.7 1.5 0.0 1.6 0.4 0.0 0.5 3.7 0.0 0.1 0.0 0.0 0.0 0.3 0.4 1.0 0.4 0.1 0.2 0.1 0.0 0.2 0.0 0.5 0.0 4.7 0.0 0.0 1.7 0.1 2.3 0.2 7.5 5.2 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.1 0.6 0.1 6.0 24.5 0.0 0.6 0.0 0.3 0.7 0.4 0.1 0.0 3.1 0.2 0.4 0.1 9.0 0.1 0.0 2.0 0.0 0.0 0.1 1.9 0.0 1.2 1.8 2.5 3.6 0.0 4.7 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 20.8 0.0 4.6 0.1 0.0 0.4 6.2 17.9 1.3 12.8 6.4 4.4 22.4 8.5 11.7 18.2 0.0 2.7 0.8 5.2 7.2 6.6 14.2 0.0 5.3 1.2 1.8 0.0 0.5 0.0 0.0 0.2 8.7 2.6 0.0 0.0 0.1 0.8 1.7 0.0 0.0 5.7 227.2 10.3 3.7 28.3 0.0 1.4 5.2 3.3 1.0 2.8 5.0 0.0 11.2 1.1 0.0 4.6 0.0 2.2 0.0 0.4 2.9 1.1 0.0 6.6 0.1 KCNJ3 "GIRK1, KGA, Kir3.1" ENSG00000162989 "Potassium voltage-gated channel subfamily J member 3" P48549 2 154698299-154858352 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;parathyroid gland: 22.1" "Cell type enhanced" "Detected in many" 21 "Cardiomyocytes: 43.7;Horizontal cells: 117.6;Intestinal endocrine cells: 29.9" "Group enriched" "Detected in many" 5 "breast cancer: 12.2;renal cancer: 4.4" "Region enhanced" "Detected in many" "cerebellum: 33.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 5.4;SCLC-21H: 1.7;SH-SY5Y: 3.3" "Low region specificity" "Detected in all" HPA024231 Uncertain NA NA "HPA024231: AB_1855558" "unprognostic (1.45e-1)" "unprognostic (9.42e-2)" "unprognostic (2.66e-2)" "unprognostic (4.49e-4)" "unprognostic (8.89e-2)" "unprognostic (6.81e-2)" "unprognostic (7.24e-3)" "unprognostic (1.15e-2)" "unprognostic (4.25e-3)" "unprognostic (3.72e-3)" "unprognostic (3.33e-1)" "unprognostic (8.90e-3)" "unprognostic (3.75e-2)" "unprognostic (5.59e-1)" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" 0.3 1.0 4.5 0.0 3.4 0.0 0.2 33.8 13.6 1.3 1.5 1.4 0.3 7.9 0.2 0.9 0.1 0.4 0.9 10.8 8.4 4.0 8.0 2.3 0.2 0.4 1.8 4.9 0.2 1.5 22.1 9.0 0.0 3.0 5.1 0.6 1.0 0.1 9.2 3.5 0.2 6.7 0.1 1.5 0.4 0.5 0.2 0.9 0.0 0.2 0.0 0.0 0.5 0.6 1.2 0.9 3.3 1.1 1.8 1.0 0.4 0.2 0.3 0.0 0.1 0.2 0.1 0.4 5.4 0.2 0.0 0.2 0.1 0.3 0.3 0.2 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.2 0.4 0.4 0.1 0.1 0.0 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.8 0.0 0.7 0.5 0.1 0.5 0.1 0.0 0.4 0.2 0.4 1.7 3.3 0.1 0.6 0.2 0.1 0.4 0.1 0.0 0.3 0.4 0.4 0.3 0.3 0.2 0.1 1.2 0.2 0.5 3.3 0.7 0.9 0.7 0.8 0.9 1.0 0.9 0.6 0.6 1.2 1.0 0.9 1.9 1.8 1.1 0.9 0.7 0.4 4.5 3.4 33.8 12.0 8.4 4.0 1.8 4.9 3.0 0.9 0.0 0.0 0.0 4.4 0.7 4.8 43.7 5.1 0.0 0.0 19.2 13.7 0.0 5.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.6 5.1 0.0 0.9 0.1 117.6 29.9 0.0 0.0 0.0 5.8 0.4 1.7 0.0 0.1 0.7 0.0 0.0 3.9 6.8 3.6 0.0 2.1 0.5 0.1 1.6 0.0 0.0 0.2 4.7 KCNJ4 "HIR, hIRK2, HRK1, IRK3, Kir2.3" ENSG00000168135 "Potassium voltage-gated channel subfamily J member 4" P48050 22 38426327-38455199 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 22 "brain: 25.9;heart muscle: 16.9" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 3.2;Horizontal cells: 9.5;Muller glia cells: 5.4" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 16.1" "Group enriched" "Detected in many" 10 "amygdala: 105.8;basal ganglia: 143.6;cerebral cortex: 111.8;hippocampal formation: 85.7;olfactory region: 150.7" "Group enriched" "Detected in many" 14 "amygdala: 32.2;basal ganglia: 63.2;cerebral cortex: 71.1;hippocampal formation: 59.7;olfactory region: 117.2" NA NA "unprognostic (4.76e-2)" "unprognostic (2.60e-3)" "unprognostic (2.21e-3)" "unprognostic (1.65e-1)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (9.68e-3)" "unprognostic (3.12e-1)" "unprognostic (8.96e-2)" "unprognostic (2.07e-1)" "unprognostic (3.15e-3)" "unprognostic (1.28e-3)" "unprognostic (1.05e-1)" "unprognostic (5.41e-2)" 0.1 0.2 9.9 0.1 17.9 0.1 0.1 0.0 25.9 0.1 0.1 0.3 0.1 0.1 0.1 0.7 0.8 16.9 9.4 1.7 0.2 0.4 0.1 0.1 0.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.6 1.1 0.0 0.5 0.1 0.1 2.3 0.0 0.2 0.0 0.0 16.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.5 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 KCNJ5 "CIR, GIRK4, KATP1, Kir3.4, LQT13" ENSG00000120457 "Potassium voltage-gated channel subfamily J member 5" P48544 11 128891356-128921035 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Cancer-related genes, Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 40.7;ductus deferens: 54.6;pituitary gland: 23.4" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 10.6;Hofbauer cells: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 13 "HBEC3-KT: 17.5" "Group enriched" "Detected in many" 6 "basal ganglia: 3.1;hypothalamus: 8.0;midbrain: 2.2;thalamus: 4.0" "Low region specificity" "Detected in all" "HPA014722, HPA017353, CAB022569" Approved NA NA "CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135" "unprognostic (2.01e-1)" "unprognostic (2.43e-3)" "unprognostic (2.56e-3)" "unprognostic (5.81e-2)" "unprognostic (4.24e-2)" "unprognostic (3.60e-2)" "unprognostic (2.90e-1)" "unprognostic (3.54e-2)" "unprognostic (6.83e-2)" "unprognostic (1.96e-1)" "unprognostic (3.17e-1)" "unprognostic (9.29e-2)" "unprognostic (1.81e-2)" "unprognostic (6.82e-2)" "unprognostic (9.49e-2)" "unprognostic (1.88e-2)" "unprognostic (2.23e-2)" 1.8 40.7 0.8 0.3 1.9 0.2 0.9 0.3 1.2 0.8 0.8 1.9 54.6 0.4 0.3 1.1 0.6 0.6 1.3 8.7 1.6 2.5 2.0 0.3 3.4 0.8 3.7 0.8 0.8 16.6 0.7 23.4 4.3 3.4 0.8 0.4 3.3 0.9 21.7 0.3 0.4 0.5 0.7 4.5 7.7 1.5 0.7 0.9 2.3 0.7 0.4 0.3 1.1 0.5 0.9 0.4 2.9 0.7 0.6 0.4 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.3 0.1 0.4 17.5 0.0 0.2 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.4 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.5 0.2 0.1 0.1 1.3 0.0 2.2 0.7 0.6 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.9 0.3 0.4 2.9 0.6 0.4 0.4 0.2 0.4 0.8 1.9 0.3 1.2 1.6 2.5 3.7 0.8 3.4 0.9 0.0 10.6 0.0 2.3 1.3 1.7 5.8 0.0 0.0 0.0 1.8 0.0 0.7 0.0 0.0 2.1 0.6 0.0 0.0 3.2 0.6 2.1 0.4 0.0 0.0 37.1 1.6 0.0 0.6 1.8 4.5 0.9 1.9 3.3 1.8 0.0 0.3 1.3 0.0 0.7 0.0 1.4 0.0 0.1 0.2 0.7 1.5 1.0 0.0 0.0 0.5 KCNJ6 "BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2" ENSG00000157542 "Potassium voltage-gated channel subfamily J member 6" P48051 21 37607376-38121345 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Congenital generalized lipodystrophy, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.0;pituitary gland: 12.2" "Cell type enriched" "Detected in some" 6 "Horizontal cells: 232.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basophil: 4.2;eosinophil: 3.6;neutrophil: 2.0" "Lineage enriched" "Detected in single" 12 "granulocytes: 4.2" "Cell line enriched" "Detected in some" 7 "LHCN-M2: 25.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.43e-1)" "unprognostic (1.96e-1)" "unprognostic (7.71e-2)" "unprognostic (1.26e-3)" "unprognostic (6.75e-2)" "unprognostic (3.59e-1)" "unprognostic (1.33e-1)" "unprognostic (1.25e-1)" "unprognostic (3.68e-1)" "unprognostic (8.76e-2)" "unprognostic (1.64e-2)" "unprognostic (3.49e-1)" "unprognostic (1.96e-10)" "unprognostic (2.42e-1)" "unprognostic (1.46e-1)" "unprognostic (9.87e-2)" "unprognostic (1.21e-1)" 2.0 1.2 7.7 0.9 8.4 1.0 1.1 24.0 15.6 0.9 1.4 0.8 0.0 1.1 1.4 0.6 0.7 0.7 0.8 1.2 14.6 1.1 1.2 0.9 1.0 1.4 1.3 10.8 0.8 2.7 0.7 12.2 7.4 13.5 1.5 0.9 0.0 0.8 0.6 2.2 1.1 1.1 0.5 1.5 1.6 2.7 2.0 0.4 0.0 0.8 0.0 0.6 0.8 0.8 0.3 0.3 4.2 0.3 0.3 0.2 0.0 0.0 0.0 0.6 0.3 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.8 1.4 0.0 0.0 0.0 2.9 0.1 25.6 0.1 0.0 0.0 0.3 0.0 2.5 0.0 0.1 0.8 3.6 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.3 0.0 0.1 0.2 3.8 1.0 0.0 0.0 0.0 0.0 4.2 0.3 3.6 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.2 2.0 0.3 0.2 0.3 0.1 0.0 7.7 8.4 24.0 15.6 14.6 1.1 1.3 10.8 13.5 0.4 0.0 0.6 0.0 0.4 0.1 31.8 21.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 232.0 39.7 0.0 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.9 1.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.1 0.1 0.2 0.0 0.1 0.3 KCNJ8 Kir6.1 ENSG00000121361 "Potassium voltage-gated channel subfamily J member 8" Q15842 12 21764955-21775581 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 60.1;pancreas: 47.6" "Group enriched" "Detected in many" 5 "Sertoli cells: 194.1;Smooth muscle cells: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "eosinophil: 4.5" "Lineage enriched" "Detected in single" 45 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "CACO-2: 42.5;HSkMC: 8.6;SH-SY5Y: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031066 Uncertain NA NA "HPA031066: AB_10602240" "unprognostic (8.12e-3)" "unprognostic (1.89e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (7.81e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-2)" "unprognostic (3.90e-2)" "unprognostic (3.66e-3)" "unprognostic (2.88e-2)" "prognostic unfavorable (1.62e-6)" "unprognostic (4.70e-3)" "unprognostic (9.61e-2)" "unprognostic (1.73e-2)" "unprognostic (3.54e-3)" 14.6 12.9 3.2 2.7 3.4 0.0 14.7 1.7 5.1 7.7 6.6 2.3 3.6 2.0 10.6 4.5 6.7 5.9 6.3 60.1 2.2 1.7 6.4 29.7 12.4 3.5 2.9 3.0 12.4 47.6 1.7 3.8 4.9 3.7 10.6 1.6 8.8 2.9 15.7 15.0 2.4 3.8 13.2 2.6 3.8 6.5 3.4 2.8 0.9 8.4 7.0 1.2 11.4 5.6 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 5.2 3.4 0.0 5.7 4.6 6.6 3.4 42.5 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.0 1.9 0.0 2.1 1.3 0.0 0.0 0.2 0.0 0.0 8.6 0.0 2.5 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 4.2 0.0 0.0 0.0 4.2 1.9 0.0 1.7 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.4 1.7 5.1 2.2 1.7 2.9 3.0 3.7 2.8 3.0 19.8 0.0 0.4 1.1 0.0 24.3 0.0 0.0 1.2 1.8 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 1.1 0.0 6.6 0.3 0.0 22.1 0.2 0.0 1.2 1.8 1.5 0.0 0.3 0.0 1.7 0.0 0.0 12.2 2.0 0.0 0.7 0.0 1.1 194.1 65.3 0.0 0.4 0.6 0.2 0.0 0.0 0.1 KCNJ9 "GIRK3, Kir3.3" ENSG00000162728 "Potassium voltage-gated channel subfamily J member 9" Q92806 1 160081570-160090563 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 27 "brain: 52.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 12.8;Horizontal cells: 7.9" "Cancer enriched" "Detected in single" 35 "glioma: 2.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "SCLC-21H: 2.3;SH-SY5Y: 2.7;U-266/70: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070478 Enhanced NA NA "HPA070478: AB_2686270" "unprognostic (2.35e-1)" "unprognostic (6.53e-2)" "unprognostic (2.17e-2)" "unprognostic (4.73e-1)" "unprognostic (1.05e-1)" "unprognostic (7.29e-3)" "unprognostic (1.66e-1)" "unprognostic (3.33e-2)" "unprognostic (2.64e-1)" "unprognostic (3.29e-1)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-2)" "unprognostic (2.66e-1)" "unprognostic (1.34e-1)" "unprognostic (2.44e-1)" "unprognostic (5.24e-2)" 1.4 1.9 15.6 1.4 15.3 1.4 1.4 32.1 52.0 1.4 1.4 11.9 0.0 1.4 1.4 1.4 1.4 1.4 1.4 1.4 18.4 11.1 1.5 1.4 1.4 1.4 18.3 20.6 1.4 1.4 1.4 0.7 1.4 7.4 1.4 1.4 0.0 1.4 1.4 1.4 1.4 1.5 1.4 11.4 1.4 1.5 1.7 11.6 0.0 1.4 0.0 1.4 1.4 0.0 0.8 0.0 0.0 0.3 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.2 2.3 2.7 0.0 0.1 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.0 2.9 0.2 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.5 0.3 1.1 0.4 0.2 1.1 0.0 0.8 0.6 0.1 0.0 0.5 0.0 0.0 0.0 0.0 15.6 15.3 32.1 27.2 18.4 11.1 18.3 20.6 7.4 11.6 0.0 0.0 0.0 0.0 0.0 12.8 0.6 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.6 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 KCNK1 "DPK, K2p1.1, TWIK-1" ENSG00000135750 "Potassium two pore domain channel subfamily K member 1" O00180 1 233614004-233672512 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 117.0;Glandular cells: 169.9;Horizontal cells: 189.1;Urothelial cells: 247.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 75.3" "Cell type enriched" "Detected in single" 98 "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in single" 98 "dendritic cells: 9.7" "Cell line enhanced" "Detected in many" "HeLa: 21.0;SCLC-21H: 19.8;U-266/70: 45.5;U-266/84: 41.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 236.2" "HPA016049, CAB022588" Approved Approved Vesicles NA NA Vesicles "CAB022588: , HPA016049: AB_1855571" "unprognostic (7.06e-3)" "unprognostic (1.76e-1)" "unprognostic (4.64e-2)" "unprognostic (7.46e-2)" "unprognostic (9.15e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.84e-4)" "unprognostic (4.32e-2)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (7.29e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (8.69e-8)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" 1.9 3.3 15.2 2.2 12.7 0.3 4.5 75.3 22.8 5.5 11.5 7.9 5.1 12.5 4.5 22.9 12.0 8.4 9.3 20.8 10.3 5.2 7.2 10.8 3.4 0.8 8.9 11.1 3.8 4.4 2.5 11.3 5.0 22.3 4.6 10.6 2.6 7.2 9.3 0.5 8.7 9.6 3.2 12.3 0.8 28.0 0.7 7.8 0.0 5.6 1.6 3.2 4.3 6.5 0.0 9.7 0.0 0.0 0.0 0.0 0.0 10.3 5.6 0.0 0.0 0.0 0.0 15.8 2.8 0.0 0.0 0.0 0.0 17.0 0.0 6.7 2.0 2.3 15.0 2.8 4.9 0.0 0.0 4.9 0.0 21.0 0.0 0.1 0.0 0.5 1.2 5.3 0.0 3.9 0.3 0.0 5.7 2.4 4.5 0.0 3.8 3.7 0.0 3.4 12.1 12.8 0.0 0.8 1.1 4.9 8.6 19.8 3.9 10.3 4.5 0.0 0.3 1.3 0.0 0.0 0.0 8.4 0.0 0.3 45.5 41.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 15.2 12.7 75.3 17.1 10.3 5.2 8.9 11.1 22.3 7.8 8.9 15.6 0.0 117.0 56.2 1.2 37.7 5.1 28.1 33.0 17.4 3.9 0.2 1.7 19.6 0.9 0.7 34.8 0.0 42.5 13.5 15.3 169.9 0.0 8.2 0.6 189.1 28.2 0.0 0.8 0.0 1.4 0.8 10.1 0.0 45.4 65.8 61.4 22.8 0.0 11.3 5.0 0.0 3.4 0.4 0.7 41.7 0.7 1.5 21.1 247.4 KCNK10 "K2p10.1, PPP1R97, TREK-2, TREK2" ENSG00000100433 "Potassium two pore domain channel subfamily K member 10" P57789 14 88180103-88326907 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 12.2;brain: 14.1;intestine: 11.6" "Cell type enhanced" "Detected in some" 15 "Enterocytes: 1.3;Intestinal endocrine cells: 1.7;Mucus-secreting cells: 1.6;Proximal tubular cells: 3.6;Undifferentiated cells: 1.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 67 "plasmacytoid DC: 12.2" "Lineage enriched" "Detected in single" 123 "dendritic cells: 12.2" "Cell line enhanced" "Detected in some" "AF22: 2.5;OE19: 3.7;REH: 4.2;SCLC-21H: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030462 Approved NA NA "HPA030462: AB_10601919" "unprognostic (9.52e-3)" "unprognostic (1.17e-1)" "unprognostic (1.94e-2)" "unprognostic (1.08e-1)" "unprognostic (8.20e-2)" "unprognostic (1.45e-1)" "unprognostic (1.18e-1)" "unprognostic (2.25e-1)" "unprognostic (4.58e-1)" "unprognostic (1.23e-2)" "unprognostic (2.70e-1)" "unprognostic (2.45e-1)" "unprognostic (6.97e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (1.29e-1)" "unprognostic (4.26e-3)" 0.4 1.1 7.4 1.2 6.9 0.9 0.5 14.1 11.2 0.4 3.2 5.6 0.0 11.6 0.3 0.3 2.2 0.4 0.5 0.4 7.2 4.5 5.7 0.4 0.6 0.7 5.0 5.7 0.4 3.5 0.4 0.9 0.3 6.4 0.5 2.1 0.0 0.5 0.3 0.4 0.4 5.7 0.5 5.0 0.6 6.7 1.3 2.3 0.0 0.4 0.5 1.3 0.5 0.4 0.0 12.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.7 3.7 0.2 4.2 0.1 0.0 0.1 0.1 7.7 0.3 0.1 0.1 0.0 0.3 0.0 1.0 0.1 0.1 1.4 0.2 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.1 7.4 6.9 14.1 11.2 7.2 4.5 5.0 5.7 6.4 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 KCNK12 "K2p12.1, THIK-2, THIK2" ENSG00000184261 "Potassium two pore domain channel subfamily K member 12" Q9HB15 2 47516581-47570939 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 22.7" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 8.7;Cone photoreceptor cells: 13.7;Early spermatids: 6.7;Extravillous trophoblasts: 30.7" "Cancer enriched" "Detected in single" 12 "testis cancer: 2.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "REH: 22.1;SCLC-21H: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (6.10e-2)" "unprognostic (1.24e-1)" "unprognostic (6.02e-3)" "unprognostic (3.29e-2)" "unprognostic (2.50e-1)" "unprognostic (3.77e-2)" "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (2.54e-2)" "unprognostic (2.14e-1)" "unprognostic (6.55e-3)" "unprognostic (2.12e-1)" "unprognostic (1.12e-6)" "unprognostic (1.36e-1)" "unprognostic (1.34e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-1)" 1.1 1.7 9.8 5.1 4.6 1.0 0.9 22.7 16.1 0.8 1.1 2.4 0.0 1.0 1.0 1.0 1.0 0.9 0.9 0.9 5.6 3.4 1.0 0.8 1.0 1.6 7.2 4.0 1.2 0.8 0.9 5.5 1.7 8.1 1.0 0.9 0.6 0.9 0.8 1.2 1.0 0.9 0.9 10.1 1.1 1.2 1.5 2.1 0.0 1.0 0.0 1.5 1.0 0.3 0.7 0.1 0.2 0.0 0.4 1.8 0.2 0.0 0.1 0.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.3 0.0 0.5 22.1 0.0 1.6 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.7 1.0 1.8 0.1 0.2 1.1 1.0 0.2 0.4 0.0 0.0 1.1 0.2 9.8 4.6 22.7 16.1 5.6 3.4 7.2 4.0 8.1 2.1 0.0 0.0 1.9 0.0 0.1 8.7 0.8 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.0 6.7 0.0 0.0 0.0 0.0 30.7 0.2 0.5 0.0 0.0 0.3 1.6 0.0 0.0 0.3 4.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 5.4 0.0 0.5 0.7 1.4 0.0 0.7 2.2 0.0 0.0 KCNK13 "K2p13.1, THIK-1, THIK1" ENSG00000152315 "Potassium two pore domain channel subfamily K member 13" Q9HB14 14 90061765-90185857 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.3;parathyroid gland: 14.3;testis: 13.2" "Cell type enhanced" "Detected in some" 24 "Hofbauer cells: 5.6;Kupffer cells: 2.5;Macrophages: 5.3;monocytes: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8" "Group enriched" "Detected in many" 7 "dendritic cells: 3.8;monocytes: 1.5" "Cell line enhanced" "Detected in some" "GAMG: 2.4;RT4: 4.2;SuSa: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003514 Approved Approved "Nuclear speckles,Cell Junctions" NA NA "Nuclear speckles, Cell Junctions" "HPA003514: AB_2666978" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (6.17e-2)" "unprognostic (6.31e-2)" "unprognostic (2.56e-1)" "unprognostic (5.55e-2)" "unprognostic (3.56e-2)" "unprognostic (3.98e-2)" "unprognostic (2.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-2)" "unprognostic (1.97e-1)" "unprognostic (2.04e-2)" "unprognostic (6.32e-2)" "unprognostic (1.46e-1)" "unprognostic (5.65e-2)" 0.8 1.1 2.9 2.2 3.5 0.1 0.4 0.2 4.2 0.4 0.6 4.0 0.0 0.6 0.3 1.5 0.3 0.4 0.5 2.7 2.9 2.4 4.8 0.7 0.7 1.6 6.3 1.4 0.4 2.7 14.3 0.6 1.2 3.6 0.4 0.7 0.1 1.1 0.7 0.1 0.1 0.7 0.4 8.3 1.1 0.5 13.2 5.4 0.7 2.7 0.0 0.6 0.8 0.1 0.0 3.8 0.0 1.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.9 0.0 0.0 0.8 1.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.4 4.2 1.8 0.5 0.0 1.8 1.2 7.1 0.0 1.6 0.0 0.0 2.1 0.0 0.6 0.6 1.8 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 2.9 3.5 0.2 4.2 2.9 2.4 6.3 1.4 3.6 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 2.5 0.6 0.0 5.3 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.1 0.0 0.0 0.1 KCNK15 "dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5" ENSG00000124249 "Potassium two pore domain channel subfamily K member 15" Q9H427 20 44745780-44752313 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 24.2" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 5.1;Collecting duct cells: 8.7;Exocrine glandular cells: 6.4;Leydig cells: 6.1;Urothelial cells: 7.0" "Cancer enriched" "Detected in many" 7 "ovarian cancer: 47.5" "Region enhanced" "Detected in some" "basal ganglia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "MCF7: 32.2" "Region enriched" "Detected in single" 18 "olfactory region: 8.4" "Region enriched" "Detected in many" 8 "olfactory region: 9.3" HPA064861 Uncertain NA NA "HPA064861: AB_2685373" "unprognostic (8.70e-2)" "prognostic unfavorable (3.68e-4)" "unprognostic (1.05e-2)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.50e-2)" "unprognostic (4.22e-2)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (6.27e-2)" "unprognostic (6.11e-2)" "unprognostic (7.38e-4)" "unprognostic (4.76e-2)" "unprognostic (4.79e-2)" "unprognostic (2.21e-3)" "unprognostic (2.11e-1)" 6.0 4.5 0.4 1.3 3.4 0.5 5.9 0.0 1.2 6.2 2.3 0.0 24.2 1.1 4.3 10.6 3.2 15.1 10.7 3.8 0.6 0.4 3.5 7.0 3.0 2.2 0.6 0.0 12.6 7.4 0.6 4.2 1.1 1.1 2.7 0.8 2.1 3.4 9.6 2.6 2.0 0.9 3.8 0.3 0.6 4.1 10.6 0.0 0.0 6.5 0.5 0.9 2.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.3 0.0 0.9 0.4 3.1 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.4 0.0 1.2 0.6 0.4 0.6 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.6 5.1 0.0 0.0 8.7 0.0 0.0 0.0 3.2 0.2 0.7 0.0 0.0 6.4 0.0 1.3 2.3 0.0 0.0 0.1 0.0 1.2 0.6 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.4 0.6 0.0 0.0 0.8 7.0 KCNK16 "K2p16.1, TALK-1, TALK1" ENSG00000095981 "Potassium two pore domain channel subfamily K member 16" Q96T55 6 39314698-39322968 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 22.4;stomach 1: 11.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 17 "pancreatic cancer: 13.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "basophil: 4.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.6" "Cell line enriched" "Detected in single" 406 "SCLC-21H: 55.9" "Low region specificity" "Detected in all" NA NA "unprognostic (3.29e-2)" "unprognostic (3.48e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.2 0.1 0.1 3.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 22.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.1 11.3 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.0 0.4 4.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK17 "K2p17.1, TALK-2, TALK2, TASK-4, TASK4" ENSG00000124780 "Potassium two pore domain channel subfamily K member 17" Q96T54 6 39299001-39314553 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.1;retina: 20.0" "Group enriched" "Detected in some" 4 "Exocrine glandular cells: 7.3;granulocytes: 5.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 34 "plasmacytoid DC: 29.1" "Lineage enriched" "Detected in single" 34 "dendritic cells: 29.1" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 42.5" "Not detected" "Not detected" HPA043892 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA043892: AB_10962838" "unprognostic (5.33e-3)" "unprognostic (6.42e-2)" "unprognostic (1.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "unprognostic (4.09e-2)" "unprognostic (4.95e-1)" "unprognostic (2.35e-1)" "unprognostic (1.71e-2)" "unprognostic (2.54e-1)" "unprognostic (3.77e-11)" "unprognostic (5.89e-2)" "unprognostic (5.36e-1)" "unprognostic (2.82e-1)" "unprognostic (3.86e-3)" 0.7 0.4 0.3 0.6 1.1 1.4 3.3 0.3 0.8 0.7 1.3 0.8 1.9 3.0 1.9 0.5 1.0 1.3 6.5 7.9 0.6 0.6 0.3 4.6 10.4 0.9 2.6 0.8 0.4 6.1 0.4 2.7 6.3 1.9 1.1 0.6 20.0 2.9 1.0 0.2 0.1 1.7 1.5 0.6 1.1 5.4 0.6 0.1 3.4 9.3 2.6 2.4 0.9 0.5 0.0 29.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 29.1 0.0 0.1 0.3 1.1 0.3 0.8 0.6 0.6 2.6 0.8 1.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK18 "K2p18.1, TRESK, TRESK-2, TRESK2, TRIK" ENSG00000186795 "Potassium two pore domain channel subfamily K member 18" Q7Z418 10 117197489-117210299 "Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 1.5;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA044739 Uncertain NA NA "HPA044739: AB_10795008" 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK2 "K2p2.1, TREK-1" ENSG00000082482 "Potassium two pore domain channel subfamily K member 2" O95069 1 215005775-215237093 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "adrenal gland: 49.1" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 1.1;Fibroblasts: 1.4;Melanocytes: 3.3;Suprabasal keratinocytes: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 31.4;fHDF/TERT166: 27.6;hTERT-RPE1: 18.9;T-47d: 42.0;U-2197: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.43e-2)" "unprognostic (1.02e-1)" "unprognostic (6.91e-2)" "unprognostic (3.81e-4)" "unprognostic (2.58e-1)" "unprognostic (3.58e-2)" "unprognostic (3.48e-3)" "unprognostic (1.26e-1)" "unprognostic (1.49e-2)" "unprognostic (1.82e-1)" "unprognostic (1.03e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-6)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "unprognostic (7.69e-3)" "unprognostic (7.46e-3)" 2.9 49.1 4.8 1.1 7.4 0.5 6.1 1.1 6.2 2.3 1.1 2.5 0.0 0.6 0.8 2.6 1.2 1.0 1.6 0.5 5.1 4.3 1.2 0.5 0.7 0.5 2.3 7.3 3.5 2.0 0.5 0.5 0.5 3.3 1.2 1.6 0.0 0.8 3.7 1.2 3.4 2.3 1.5 4.5 0.4 3.7 1.5 3.3 0.0 8.9 2.7 0.4 2.6 3.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 7.9 31.4 0.0 11.0 7.3 3.5 8.3 0.0 0.4 0.0 0.0 27.6 0.0 0.0 4.9 0.0 6.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 8.1 0.0 8.4 0.8 18.9 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.9 1.5 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.8 0.2 0.1 0.0 42.0 0.0 0.0 6.1 0.2 15.0 0.6 0.6 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.8 7.4 1.1 6.2 5.1 4.3 2.3 7.3 3.3 3.3 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.2 1.3 0.0 0.0 0.0 0.0 KCNK3 "K2p3.1, TASK, TASK-1" ENSG00000171303 "Potassium two pore domain channel subfamily K member 3" O14649 2 26692690-26733420 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 69.2" "Cell type enhanced" "Detected in many" 17 "Collecting duct cells: 97.7;Exocrine glandular cells: 82.2;Pancreatic endocrine cells: 31.4" "Cancer enhanced" "Detected in many" "renal cancer: 9.7" "Group enriched" "Detected in many" 4 "basal ganglia: 4.0;cerebellum: 4.7;cerebral cortex: 6.2;hypothalamus: 4.0;pons and medulla: 13.4" "Cell type enhanced" "Detected in some" "neutrophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 4.7;EFO-21: 10.0;HeLa: 3.4;SCLC-21H: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.16e-3)" "unprognostic (7.13e-2)" "unprognostic (1.04e-1)" "unprognostic (1.67e-4)" "unprognostic (2.08e-1)" "unprognostic (2.91e-1)" "unprognostic (5.01e-2)" "unprognostic (2.16e-1)" "unprognostic (3.31e-1)" "unprognostic (5.48e-2)" "unprognostic (3.77e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.37e-7)" "unprognostic (3.09e-2)" "unprognostic (7.45e-2)" "unprognostic (1.44e-2)" "unprognostic (9.24e-3)" 2.4 69.2 1.3 1.9 4.0 0.6 8.3 4.7 6.2 3.5 4.0 0.8 5.7 1.3 2.4 5.6 1.9 2.0 2.3 10.3 1.0 4.0 1.8 0.7 10.0 0.6 1.5 1.5 4.6 24.7 0.7 3.6 16.6 13.4 8.2 1.1 1.9 0.6 7.7 0.6 0.6 2.6 4.7 1.1 0.9 2.2 0.9 0.0 0.0 2.1 0.0 0.5 3.2 2.3 0.7 0.5 2.5 0.4 1.2 0.4 0.0 0.0 0.6 0.2 0.0 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 10.0 0.0 1.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 1.3 0.0 23.5 2.1 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.4 0.3 0.4 0.2 0.4 0.3 0.3 0.3 0.2 0.7 0.4 0.4 2.5 1.2 0.2 0.5 0.2 0.0 1.3 4.0 4.7 6.2 1.0 4.0 1.5 1.5 13.4 0.0 0.0 3.2 0.0 0.2 0.0 11.5 10.0 0.0 0.0 0.0 97.7 0.0 0.2 0.0 0.8 0.4 1.0 0.0 0.0 82.2 0.2 1.9 1.6 0.0 0.0 0.3 1.6 22.5 0.6 0.0 1.3 0.9 0.0 0.0 1.0 0.4 1.2 31.4 0.0 0.0 0.0 3.9 6.5 3.1 0.0 1.3 0.1 0.5 0.0 0.0 0.3 KCNK4 "K2p4.1, TRAAK" ENSG00000182450 "Potassium two pore domain channel subfamily K member 4" Q9NYG8 11 64291302-64300031 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 12.3" "Cell type enhanced" "Detected in some" 13 "Extravillous trophoblasts: 1.7;Fibroblasts: 1.1;Horizontal cells: 3.2;Muller glia cells: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.2;MCF7: 1.5;SH-SY5Y: 2.9;U-2197: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.85e-1)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (2.84e-1)" 0.7 0.5 12.2 0.5 11.6 0.5 0.5 1.0 12.3 1.6 0.6 0.3 0.0 0.6 1.2 0.5 0.5 0.6 0.6 0.6 10.2 3.1 0.7 0.5 0.6 0.6 1.5 4.0 0.5 0.5 0.5 0.0 2.0 2.7 0.9 0.5 1.1 0.5 0.8 0.5 0.5 0.7 0.5 0.3 0.6 0.6 0.9 0.1 0.0 0.6 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.1 0.2 0.2 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 1.2 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 11.6 1.0 12.3 10.2 3.1 1.5 4.0 2.7 0.1 0.0 0.0 0.0 0.0 0.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 KCNK5 "K2p5.1, TASK-2" ENSG00000164626 "Potassium two pore domain channel subfamily K member 5" O95279 6 39188973-39229450 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 48.4;intestine: 74.2;kidney: 46.3" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 43.3;Enterocytes: 50.9;Proximal tubular cells: 29.1;Syncytiotrophoblasts: 38.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 18.0;OE19: 14.7;T-47d: 14.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059148 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059148: AB_2683929" "unprognostic (1.46e-1)" "prognostic favorable (3.29e-4)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (8.09e-4)" "unprognostic (3.97e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-3)" "unprognostic (7.14e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (2.98e-1)" "prognostic favorable (4.98e-7)" "unprognostic (2.34e-1)" "unprognostic (7.13e-2)" "unprognostic (1.03e-2)" "prognostic favorable (4.45e-4)" 2.2 1.3 0.3 4.5 0.4 4.5 3.9 0.4 0.5 4.3 25.5 0.8 2.6 16.1 5.6 4.0 4.3 1.4 48.4 1.5 0.3 0.0 46.3 12.6 3.6 1.1 0.8 0.4 4.0 15.3 1.2 1.0 15.2 0.8 2.3 4.7 3.6 16.0 1.6 0.5 15.8 74.2 1.3 0.6 1.2 9.4 0.9 0.3 2.0 9.0 2.2 4.1 2.2 3.8 0.0 0.9 0.2 0.1 0.0 1.4 0.5 3.4 3.2 4.3 1.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 18.8 7.8 0.0 5.7 0.0 0.4 7.2 3.3 0.1 0.0 0.0 2.4 19.3 1.5 0.1 0.0 3.9 17.8 0.0 0.0 0.1 0.0 0.0 0.0 4.3 18.0 0.0 0.0 6.1 8.7 4.3 7.9 14.7 0.0 0.0 0.8 7.3 3.0 2.9 1.0 0.8 3.1 4.0 0.0 1.7 14.3 6.5 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.9 1.4 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.9 0.2 0.5 0.3 0.4 0.4 0.5 0.3 0.0 0.8 0.4 0.8 0.3 0.0 19.2 0.0 1.8 3.3 0.0 0.4 43.3 0.0 6.8 1.8 0.0 22.6 5.0 13.0 0.0 0.2 50.9 0.0 10.8 3.9 1.9 1.8 0.0 23.1 1.8 0.0 0.0 0.0 0.3 0.0 0.6 0.7 1.7 1.0 10.8 0.0 7.5 10.5 0.0 29.1 0.0 0.0 0.4 0.0 0.7 2.4 38.1 1.0 6.4 10.7 KCNK6 "K2p6.1, TWIK-2" ENSG00000099337 "Potassium two pore domain channel subfamily K member 6" Q9Y257 19 38319844-38332076 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Ito cells: 179.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 16.2" "Group enriched" "Detected in many" 5 "dendritic cells: 8.9;granulocytes: 16.2;monocytes: 5.4" "Cell line enhanced" "Detected in many" "HEL: 21.9;HMC-1: 24.6;T-47d: 13.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022637, HPA040184" Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "CAB022637: , HPA040184: AB_2676876" "unprognostic (7.98e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "prognostic favorable (1.45e-6)" "unprognostic (3.76e-1)" "unprognostic (6.88e-2)" "unprognostic (1.87e-1)" "unprognostic (3.08e-2)" "unprognostic (4.31e-1)" "unprognostic (4.91e-1)" "unprognostic (4.10e-3)" "unprognostic (3.15e-1)" "prognostic unfavorable (1.04e-5)" "unprognostic (1.07e-2)" "unprognostic (3.46e-1)" "unprognostic (5.88e-2)" "unprognostic (4.59e-3)" 3.0 2.0 2.1 7.4 2.5 2.8 4.9 0.8 2.0 25.3 9.2 1.7 10.6 3.8 20.1 5.2 21.7 8.6 13.1 4.3 2.1 1.0 2.8 2.7 7.1 8.9 2.0 1.3 8.0 21.3 0.2 1.7 11.6 2.3 7.3 8.3 2.3 29.0 13.5 0.9 15.1 10.1 13.4 3.7 12.7 7.0 2.0 2.2 4.2 1.7 17.5 18.8 14.3 12.5 1.2 8.9 16.2 5.4 0.6 1.9 1.5 5.3 2.0 0.3 0.3 3.2 2.1 0.4 4.6 2.3 1.2 1.6 1.5 5.9 0.4 2.2 6.6 1.3 7.0 2.5 10.5 0.8 0.2 0.2 21.9 1.0 0.2 2.9 1.6 24.6 0.5 9.5 1.5 2.9 6.4 3.2 3.6 0.3 1.7 3.4 11.7 1.5 1.4 0.3 11.3 1.3 2.3 0.4 1.6 4.3 0.5 0.3 0.5 0.5 0.5 0.2 1.1 13.8 6.2 3.5 0.4 2.8 2.5 0.2 0.6 0.1 0.6 0.4 7.9 0.2 16.2 5.4 11.7 1.3 4.8 1.1 1.2 1.7 1.6 8.9 1.1 1.5 1.1 4.2 0.6 5.1 2.5 1.9 1.5 2.1 2.5 0.8 2.0 2.1 1.0 2.0 1.3 2.3 2.2 0.0 14.6 13.7 23.5 38.2 2.8 10.2 22.9 6.7 9.1 7.0 5.9 1.3 0.0 19.0 1.1 17.5 33.5 70.0 41.6 3.3 11.7 39.3 21.9 1.0 34.5 0.0 12.1 179.2 66.5 0.5 23.9 52.6 5.0 14.4 56.7 0.9 47.3 39.3 19.1 0.3 5.0 25.8 6.9 9.3 2.7 58.7 2.1 10.1 24.1 88.8 KCNK7 K2p7.1 ENSG00000173338 "Potassium two pore domain channel subfamily K member 7" Q9Y2U2 11 65592855-65595996 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 35.0;tongue: 20.7" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 90.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 12 "basophil: 4.8;naive B-cell: 2.9;neutrophil: 3.6" "Group enriched" "Detected in many" 12 "B-cells: 2.9;granulocytes: 4.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA077577 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077577: AB_2686845" "unprognostic (1.12e-2)" "unprognostic (1.21e-1)" "unprognostic (6.08e-2)" "unprognostic (5.71e-2)" "unprognostic (8.59e-2)" "unprognostic (1.34e-1)" "unprognostic (1.68e-3)" "unprognostic (8.53e-2)" "unprognostic (1.69e-1)" "unprognostic (2.87e-1)" "unprognostic (6.90e-2)" "unprognostic (4.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.65e-1)" "unprognostic (3.57e-1)" "unprognostic (1.16e-1)" "unprognostic (8.11e-2)" 0.6 0.6 0.8 0.3 0.7 3.9 2.6 1.6 2.1 1.4 0.5 0.8 0.3 0.4 0.4 0.3 10.8 0.6 0.3 0.5 0.8 0.4 0.3 0.3 0.3 0.3 0.6 1.1 0.6 0.3 0.1 0.3 0.5 0.4 0.3 0.1 0.3 0.8 0.4 1.8 35.0 0.5 0.3 0.7 0.5 0.3 0.3 0.5 0.7 0.3 20.7 5.7 0.3 3.4 2.9 0.0 4.8 0.2 0.2 0.3 0.1 0.5 2.3 0.1 0.7 0.0 0.0 0.2 0.3 0.0 0.5 0.1 0.3 1.7 0.8 0.7 0.2 0.4 3.8 0.0 0.0 0.0 0.8 2.6 0.8 1.2 1.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.4 0.0 1.6 1.4 2.2 0.7 1.7 0.9 0.7 1.0 1.0 2.2 1.6 0.0 0.4 1.0 0.2 12.4 2.8 0.5 0.7 1.2 0.1 0.7 2.2 0.0 0.6 1.9 1.9 0.1 2.0 1.3 0.5 1.4 1.1 1.0 4.8 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 2.9 0.1 0.0 3.6 0.2 0.2 0.0 0.0 0.1 0.8 0.7 1.6 2.1 0.8 0.4 0.6 1.1 0.4 0.5 0.0 0.3 0.0 0.4 16.9 2.3 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.5 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.0 1.2 0.0 1.5 1.3 0.6 0.0 3.3 0.0 0.3 0.2 0.1 2.8 0.0 0.0 0.8 6.5 1.9 0.1 0.5 90.7 0.0 0.0 0.5 1.0 KCNK9 "K2p9.1, TASK-3, TASK3" ENSG00000169427 "Potassium two pore domain channel subfamily K member 9" Q9NPC2 8 139600838-139703056 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 9.4;brain: 15.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Exocrine glandular cells: 2.2;Late spermatids: 4.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 15.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "PC-3: 6.6;SCLC-21H: 2.9;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075842 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA075842: " "unprognostic (1.84e-2)" "unprognostic (2.57e-1)" "unprognostic (1.58e-1)" "unprognostic (8.96e-8)" "unprognostic (1.91e-1)" "unprognostic (8.17e-3)" "unprognostic (2.19e-3)" "unprognostic (1.65e-1)" "unprognostic (3.87e-1)" "unprognostic (1.69e-1)" "unprognostic (1.00e-2)" "unprognostic (3.21e-1)" "unprognostic (5.12e-6)" "unprognostic (2.94e-2)" "unprognostic (1.64e-1)" "unprognostic (9.99e-3)" "unprognostic (1.76e-1)" 0.2 9.4 0.5 0.5 1.0 0.1 0.1 15.4 7.7 1.3 0.5 0.0 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.2 1.6 1.4 0.1 0.1 0.1 0.1 0.7 1.7 0.1 0.1 0.1 1.1 0.2 6.6 0.1 0.2 0.2 0.1 0.1 1.4 0.1 0.1 0.6 0.6 0.1 0.3 0.5 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 2.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.0 15.4 3.7 1.6 1.4 0.7 1.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.2 1.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 KCNMA1 "KCa1.1, mSLO1, SLO" ENSG00000156113 "Potassium calcium-activated channel subfamily M alpha 1" Q12791 10 76869601-77638369 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 7 "Bipolar cells: 372.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 5.5;memory B-cell: 1.7;non-classical monocyte: 3.7" "Group enriched" "Detected in many" 5 "B-cells: 1.7;monocytes: 5.5" "Cell line enhanced" "Detected in many" "BJ: 27.4;hTERT-HME1: 32.2;PC-3: 43.8;U-138 MG: 31.6;U-87 MG: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054648 Approved NA NA "HPA054648: AB_2682556" "unprognostic (1.25e-1)" "unprognostic (2.23e-2)" "unprognostic (1.86e-2)" "unprognostic (5.29e-2)" "unprognostic (9.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.77e-1)" "unprognostic (2.81e-2)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (4.12e-3)" "unprognostic (1.20e-1)" "unprognostic (2.26e-2)" "unprognostic (1.42e-2)" "unprognostic (5.19e-2)" "unprognostic (1.42e-2)" "unprognostic (3.99e-3)" 6.0 8.1 12.5 8.8 13.6 1.1 7.1 8.2 18.5 36.3 39.0 5.7 27.9 4.8 54.0 19.7 20.7 18.3 15.6 2.7 10.8 8.2 2.0 6.6 4.0 6.2 7.4 16.5 7.0 4.1 0.7 10.1 3.3 10.1 30.1 13.2 6.6 24.0 47.6 37.1 1.8 8.6 55.1 6.8 10.4 14.8 2.6 4.9 0.4 1.4 2.7 2.5 21.7 12.6 1.7 0.6 0.3 5.5 0.0 0.0 0.3 0.0 8.2 0.0 0.1 1.3 7.1 0.1 27.4 24.5 6.6 3.3 1.8 0.1 0.0 0.2 20.4 15.8 0.0 0.0 16.0 4.1 16.2 0.1 0.0 0.0 0.0 12.8 0.0 0.1 4.9 2.9 10.6 32.2 23.5 2.6 0.1 0.0 0.0 11.6 0.3 0.5 0.0 0.5 0.0 43.8 0.0 1.0 0.0 4.2 0.0 2.5 0.3 0.0 0.7 0.0 3.4 3.3 0.0 17.7 31.6 3.5 5.6 24.2 0.0 0.0 0.0 30.8 0.0 12.3 0.0 0.2 0.0 0.0 5.5 0.0 1.7 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.0 3.7 0.0 0.0 0.3 12.5 13.6 8.2 18.5 10.8 8.2 7.4 16.5 10.1 4.9 0.0 7.0 2.7 41.2 1.8 372.4 2.5 2.5 0.0 6.8 1.8 56.9 0.3 24.9 2.9 55.5 0.9 1.5 0.0 9.7 0.1 4.1 44.9 0.0 23.7 11.3 6.4 4.7 2.5 53.8 46.9 3.4 19.8 45.5 4.6 52.9 48.0 11.6 0.8 1.1 0.8 15.2 6.5 17.9 1.4 1.6 0.3 0.2 0.7 1.1 1.4 KCNMB1 hslo-beta ENSG00000145936 "Potassium calcium-activated channel subfamily M regulatory beta subunit 1" Q16558 5 170374671-170389677 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 55.5" "Cell type enriched" "Detected in many" 6 "Peritubular cells: 333.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;monocytes: 7.1" "Cell line enhanced" "Detected in some" "REH: 13.0;SK-BR-3: 3.2;U-937: 5.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" NA NA "unprognostic (2.06e-2)" "unprognostic (2.70e-4)" "unprognostic (1.69e-2)" "unprognostic (1.27e-1)" "unprognostic (3.37e-2)" "unprognostic (8.88e-2)" "unprognostic (1.61e-2)" "unprognostic (3.46e-1)" "unprognostic (2.28e-1)" "unprognostic (4.68e-2)" "unprognostic (5.37e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.13e-6)" "unprognostic (1.08e-1)" "unprognostic (2.49e-1)" "unprognostic (4.31e-2)" "unprognostic (1.04e-2)" 3.2 1.0 0.6 7.7 0.5 0.7 4.2 0.4 0.6 26.8 34.7 0.8 12.6 2.2 31.3 10.6 29.8 10.9 32.4 2.6 0.6 0.7 1.9 0.4 2.2 1.3 1.1 0.9 8.7 0.5 0.1 0.5 0.9 2.2 29.4 5.0 5.6 5.3 29.3 0.9 1.6 11.4 55.5 1.5 1.1 13.4 8.0 0.6 0.3 1.0 1.5 1.6 43.4 6.4 0.5 7.0 1.4 7.1 0.6 0.3 1.0 0.1 0.2 2.3 0.6 0.2 0.0 0.4 0.3 0.1 0.1 0.1 0.5 0.4 0.2 1.6 0.1 0.6 0.2 0.1 0.1 0.1 0.5 0.1 1.5 0.8 0.3 0.0 0.6 0.4 0.4 0.0 0.2 0.4 0.2 0.2 0.7 0.5 1.1 0.1 1.0 0.0 1.4 0.4 0.1 0.2 13.0 0.1 0.3 0.1 0.4 0.5 0.3 0.1 3.2 0.0 1.1 0.2 1.4 0.8 0.3 0.5 0.5 0.1 0.8 0.3 0.2 0.2 5.4 0.2 1.3 4.3 0.4 0.2 7.1 0.1 0.2 0.3 0.2 7.0 0.5 0.2 0.2 1.4 0.6 6.0 2.6 0.2 1.0 0.6 0.5 0.4 0.5 0.6 0.7 1.1 0.9 2.2 0.6 0.0 7.5 1.3 1.0 1.8 1.5 2.6 2.5 8.1 7.9 1.8 5.9 0.5 0.0 0.1 0.5 2.7 0.0 0.0 0.4 0.6 14.4 1.0 19.6 0.0 7.7 1.6 0.0 1.8 9.1 1.6 35.6 21.4 3.3 29.7 0.0 1.1 0.0 0.0 333.0 0.0 1.8 45.3 59.8 0.7 0.9 1.5 0.5 0.0 0.0 0.5 KCNMB2 ENSG00000197584 "Potassium calcium-activated channel subfamily M regulatory beta subunit 2" Q9Y691 3 178272932-178844429 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 36.8" "Group enriched" "Detected in some" 4 "Ciliated cells: 14.7;Intestinal endocrine cells: 13.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.5;fHDF/TERT166: 2.6;RPMI-8226: 1.8;SCLC-21H: 8.5" CAB022649 Uncertain NA NA "CAB022649: " "unprognostic (9.52e-2)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (1.04e-2)" "unprognostic (2.43e-2)" "unprognostic (6.97e-2)" "unprognostic (6.74e-2)" "unprognostic (2.15e-1)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (1.71e-2)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-4)" "unprognostic (7.85e-2)" 0.7 6.3 7.8 0.5 6.2 0.4 1.3 1.8 11.2 2.5 1.9 2.2 4.4 1.0 7.2 36.8 0.9 14.3 0.9 7.4 13.2 4.5 4.1 0.6 1.6 0.4 4.7 4.9 16.3 4.5 0.4 10.2 0.5 6.2 1.1 0.9 0.5 0.6 1.9 0.6 0.7 0.9 3.0 3.2 1.9 3.6 0.6 3.2 0.0 1.1 0.0 0.4 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 6.5 0.0 0.0 0.4 0.0 0.0 1.4 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 1.8 0.0 1.0 8.5 0.0 0.0 0.5 0.0 0.6 1.4 0.0 0.3 0.0 0.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 6.2 1.8 11.2 13.2 4.5 4.7 4.9 6.2 3.2 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 14.7 1.2 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 13.3 2.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNMB3 "KCNMB2, KCNMBL" ENSG00000171121 "Potassium calcium-activated channel subfamily M regulatory beta subunit 3" Q9NPA1 3 179236691-179267002 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 13.7;Late spermatids: 10.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 11.2;NB-4: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015665, HPA019185" Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA015665: AB_1852142, HPA019185: AB_1852144" "unprognostic (2.50e-1)" "unprognostic (1.32e-1)" "unprognostic (6.76e-5)" "unprognostic (2.65e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.59e-3)" "unprognostic (1.14e-1)" "unprognostic (9.15e-3)" "unprognostic (5.09e-2)" "unprognostic (1.87e-2)" "unprognostic (1.95e-5)" "unprognostic (5.93e-10)" "unprognostic (7.22e-2)" "unprognostic (4.72e-1)" "unprognostic (8.69e-2)" "unprognostic (3.49e-2)" 3.0 2.0 0.7 2.9 0.7 1.2 3.3 0.2 0.6 1.8 2.0 1.9 2.0 2.3 0.7 1.0 2.4 1.8 1.0 0.9 2.2 4.0 1.2 2.9 1.1 1.6 5.3 3.7 2.1 6.6 2.9 2.2 2.7 1.4 0.5 0.6 2.2 1.9 1.5 5.9 2.6 4.5 2.4 2.6 1.9 1.5 3.5 0.3 2.3 0.4 3.6 1.0 0.0 3.0 0.7 1.2 0.0 1.4 1.1 1.9 0.8 0.5 1.3 0.6 6.5 2.6 0.1 3.0 0.6 2.7 1.1 0.0 0.2 1.5 3.8 0.4 11.2 2.9 2.5 1.2 0.2 3.7 1.9 0.6 0.9 0.0 1.0 1.1 0.1 0.4 0.1 1.5 1.8 0.1 7.6 0.0 1.2 2.3 3.3 0.0 0.1 1.0 2.1 1.5 0.4 1.0 1.2 0.7 1.1 3.1 6.1 0.7 0.6 1.1 0.3 0.9 1.0 0.4 3.6 0.6 4.3 0.8 2.3 0.4 0.5 1.0 0.3 0.6 3.5 0.6 0.8 0.1 2.1 0.4 0.7 1.9 3.6 0.1 0.3 0.9 0.0 0.0 2.2 0.8 1.8 0.2 2.3 0.6 2.5 1.4 2.3 0.0 13.7 1.0 0.0 4.3 8.0 2.7 1.5 0.0 3.1 1.0 1.2 1.6 2.3 1.5 1.0 0.0 4.7 1.8 1.6 10.9 2.6 0.8 0.0 1.0 1.3 1.9 2.7 0.0 2.8 0.0 5.3 6.5 1.4 1.6 1.4 0.1 1.0 0.0 1.1 0.7 KCNMB4 ENSG00000135643 "Potassium calcium-activated channel subfamily M regulatory beta subunit 4" Q86W47 12 70366276-70434292 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 24.4;brain: 37.7" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 16.9;Collecting duct cells: 22.7;Ito cells: 24.5;Peritubular cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 8.9;RH-30: 9.5;RT4: 10.4;SuSa: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072287 Enhanced Approved Approved Cytosol NA NA Cytosol "HPA072287: AB_2686507" "unprognostic (3.90e-1)" "unprognostic (1.72e-2)" "unprognostic (2.69e-2)" "unprognostic (2.62e-2)" "unprognostic (6.98e-2)" "unprognostic (1.13e-3)" "unprognostic (1.85e-1)" "unprognostic (2.48e-2)" "unprognostic (3.50e-1)" "unprognostic (2.95e-2)" "unprognostic (3.75e-1)" "unprognostic (2.47e-2)" "unprognostic (2.19e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (1.05e-2)" 4.4 24.4 19.8 2.6 24.6 1.3 2.6 13.8 37.7 3.5 5.0 28.4 1.0 2.5 3.2 2.8 2.6 3.3 3.2 5.9 25.9 10.4 5.8 1.8 4.6 2.8 28.6 19.3 5.4 1.5 1.3 1.4 4.9 11.6 2.9 2.9 2.0 3.8 4.5 4.2 4.9 3.0 2.8 15.2 2.8 1.8 3.8 26.0 0.8 3.3 0.0 2.6 2.4 2.1 1.7 0.6 0.3 0.3 0.2 2.8 0.5 0.0 0.3 5.6 3.1 0.3 0.3 0.6 0.6 1.0 0.3 0.9 0.2 2.1 2.7 0.3 0.0 1.2 0.1 6.0 0.9 0.2 1.3 3.5 1.4 1.3 3.2 0.0 0.1 0.1 1.6 0.1 0.0 0.0 0.6 0.2 4.0 0.0 0.0 1.1 0.7 1.9 0.4 8.9 0.1 6.4 2.8 9.5 0.2 0.2 10.4 2.7 3.4 0.8 1.1 0.1 8.9 3.1 0.1 0.1 0.4 1.5 0.1 0.3 2.0 0.0 2.8 0.5 0.0 0.9 0.3 0.3 0.0 0.3 0.3 0.3 0.6 0.6 0.6 0.6 1.7 2.2 2.8 0.3 0.2 0.1 0.2 0.6 0.5 19.8 24.6 13.8 19.1 25.9 10.4 28.6 19.3 11.6 26.0 0.0 1.1 0.0 0.1 2.9 16.9 3.1 0.0 0.0 0.0 22.7 0.0 0.2 0.0 0.0 0.9 6.0 0.0 0.0 0.0 0.2 2.2 0.4 0.0 0.2 1.1 0.0 0.0 24.5 9.5 1.8 6.1 2.0 1.7 0.0 0.0 0.4 0.0 0.0 17.0 7.8 2.7 0.0 1.7 1.5 4.9 4.8 0.2 0.5 0.0 0.0 KCNN1 "hSK1, KCa2.1" ENSG00000105642 "Potassium calcium-activated channel subfamily N member 1" Q92952 19 17951293-18000080 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 12 "brain: 32.5" "Cell type enhanced" "Detected in some" 6 "Melanocytes: 5.0;monocytes: 3.6;Spermatogonia: 4.3" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.3" "Cell line enriched" "Detected in some" 12 "REH: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065938 Approved "Actin filaments,Cytosol" Yes No "Actin filaments, Cytosol" "HPA065938: AB_2685582" "unprognostic (7.55e-2)" "unprognostic (4.03e-2)" "unprognostic (1.82e-1)" "unprognostic (7.80e-2)" "unprognostic (1.90e-1)" "unprognostic (8.94e-5)" "unprognostic (3.92e-3)" "unprognostic (1.01e-1)" "unprognostic (8.42e-2)" "unprognostic (3.59e-1)" "unprognostic (2.71e-3)" "unprognostic (3.38e-1)" "unprognostic (5.21e-3)" "unprognostic (2.70e-2)" "unprognostic (1.14e-1)" "unprognostic (7.24e-3)" "unprognostic (3.24e-1)" 0.8 0.9 25.8 1.5 11.3 0.9 0.8 3.3 27.0 1.6 1.0 0.5 0.1 1.0 1.7 1.0 1.0 0.9 1.0 1.3 32.5 3.3 0.9 0.8 0.8 1.0 5.0 8.7 2.6 0.9 0.7 0.2 0.8 4.1 1.2 0.8 0.0 1.5 1.3 1.0 0.9 1.2 0.9 1.2 0.9 0.9 2.8 1.6 0.0 0.9 0.0 1.0 0.9 0.0 0.2 0.2 2.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 2.1 0.0 0.1 0.1 0.9 1.9 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 58.8 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.1 0.0 0.2 0.0 0.0 25.8 11.3 3.3 22.4 32.5 3.3 5.0 8.7 4.1 1.6 0.0 0.0 0.0 2.5 2.3 2.2 0.8 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 1.0 2.3 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.9 0.9 5.0 3.6 0.0 1.3 0.2 0.0 1.8 0.0 0.9 0.0 1.9 0.4 4.3 3.3 0.1 0.7 0.0 1.4 KCNN2 "hSK2, KCa2.2" ENSG00000080709 "Potassium calcium-activated channel subfamily N member 2" Q9H2S1 5 114360945-114496500 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 25.3;brain: 23.1;liver: 33.2" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 10.8;Hepatocytes: 14.7;Melanocytes: 20.3;Rod photoreceptor cells: 7.2" "Group enriched" "Detected in some" 7 "glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 15.0;NTERA-2: 5.7;SK-MEL-30: 10.6;THP-1: 18.7;U-937: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038221 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA038221: AB_10673044" "unprognostic (9.22e-3)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (4.61e-1)" "unprognostic (3.16e-1)" "unprognostic (4.25e-1)" 0.8 25.3 12.6 0.8 7.3 0.6 1.1 21.7 15.0 1.7 1.2 9.5 0.0 0.9 3.9 0.9 0.8 1.0 1.0 7.7 23.1 3.6 4.8 33.2 2.5 0.9 4.5 16.9 1.4 3.8 1.0 16.0 0.6 9.1 11.7 1.3 4.2 1.1 5.4 9.9 2.1 0.9 2.8 8.4 1.1 1.1 3.8 6.5 0.0 0.9 0.0 0.8 2.4 1.1 0.3 0.3 0.8 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 15.0 2.3 0.3 0.1 0.0 0.2 0.0 0.5 0.0 2.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.1 0.0 0.2 0.0 1.2 5.7 0.0 0.0 0.1 0.0 0.7 0.3 0.1 1.8 0.0 0.0 0.2 10.6 0.3 0.2 18.7 0.2 0.0 0.4 1.7 0.0 0.1 0.0 0.1 1.8 6.7 0.5 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.3 0.1 0.3 0.8 0.1 0.3 0.3 0.1 0.0 12.6 7.3 21.7 15.0 23.1 3.6 4.5 16.9 9.1 6.5 0.0 0.6 0.0 0.1 0.2 6.8 10.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.7 5.2 0.0 0.0 0.8 0.0 0.9 4.5 0.0 14.7 0.0 0.0 0.0 6.2 1.0 0.0 0.0 0.0 20.3 0.0 0.5 0.3 1.4 0.0 0.0 0.5 7.2 0.0 0.5 0.5 3.2 0.3 0.0 0.0 0.4 0.1 KCNN3 "hSK3, KCa2.3, SKCA3" ENSG00000143603 "Potassium calcium-activated channel subfamily N member 3" Q9UGI6 1 154697455-154870280 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.7" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 11.9;Ciliated cells: 32.1;Endothelial cells: 16.9" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.8;memory B-cell: 4.8" "Group enriched" "Detected in many" 9 "B-cells: 4.8;granulocytes: 5.8;monocytes: 2.7" "Cell line enhanced" "Detected in some" "Daudi: 18.1;HMC-1: 12.5;Karpas-707: 31.0;RPMI-8226: 8.4;U-266/70: 29.9;U-698: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057127 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA057127: AB_2683345" "unprognostic (2.09e-1)" "unprognostic (2.91e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (7.22e-2)" "unprognostic (4.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (9.51e-2)" "unprognostic (4.07e-3)" "unprognostic (4.89e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (1.71e-2)" "unprognostic (1.54e-1)" "unprognostic (6.93e-2)" "unprognostic (1.80e-2)" 1.7 2.5 20.6 6.5 21.7 1.0 1.8 5.7 26.7 9.3 9.1 12.4 1.1 5.4 12.6 1.7 3.5 10.3 3.1 4.0 21.6 8.0 3.5 1.0 3.1 5.8 12.0 10.9 2.1 1.0 1.5 2.6 0.7 13.3 3.4 4.6 0.1 2.7 2.7 8.5 1.1 3.9 10.6 8.1 5.0 4.4 1.3 15.5 0.2 3.7 3.5 9.2 8.3 4.9 4.8 0.4 5.8 2.7 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 31.0 0.3 0.0 0.1 0.0 0.4 0.0 1.2 0.0 7.7 8.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 29.9 3.9 10.0 0.3 0.0 2.9 5.8 0.0 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.4 20.6 21.7 5.7 10.3 21.6 8.0 12.0 10.9 13.3 15.5 11.9 2.4 0.0 0.5 1.1 0.2 2.2 0.0 32.1 3.4 0.0 2.0 0.0 3.3 0.2 2.6 16.9 0.0 0.0 0.2 0.0 2.3 0.4 0.0 0.0 0.4 0.0 4.1 5.5 0.0 6.2 0.3 0.8 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.5 0.1 1.5 0.0 0.0 0.0 0.1 KCNN4 "hIKCa1, hKCa4, hSK4, IK, KCa3.1" ENSG00000104783 "Potassium calcium-activated channel subfamily N member 4" O15554 19 43766533-43781257 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Immunity, Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 45.7;salivary gland: 82.3" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 196.8;Syncytiotrophoblasts: 638.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.8;hTERT-RPE1: 24.5;SK-BR-3: 27.5;WM-115: 70.6" "Region enhanced" "Detected in single" "olfactory region: 2.3" "Not detected" "Not detected" "HPA053841, HPA059622" Approved NA NA "HPA053841: AB_2682278, HPA059622: AB_2684085" "unprognostic (1.23e-2)" "unprognostic (3.22e-2)" "unprognostic (4.29e-1)" "unprognostic (3.74e-3)" "prognostic unfavorable (2.68e-4)" "unprognostic (1.98e-2)" "unprognostic (7.33e-2)" "unprognostic (1.42e-2)" "unprognostic (2.48e-3)" "unprognostic (4.12e-2)" "prognostic unfavorable (4.56e-4)" "unprognostic (9.96e-3)" "prognostic unfavorable (1.05e-14)" "unprognostic (3.70e-2)" "unprognostic (2.17e-2)" "unprognostic (7.50e-2)" "prognostic favorable (1.75e-4)" 3.0 0.1 0.5 12.2 2.5 6.5 5.6 0.4 0.5 8.0 5.7 0.7 6.4 2.0 0.9 2.9 2.6 2.6 8.8 0.6 1.4 0.5 0.8 0.3 2.6 5.7 1.7 0.6 1.3 0.3 0.0 0.3 45.7 1.5 11.0 3.8 0.8 82.3 6.8 0.7 10.8 10.0 2.0 1.1 8.4 13.6 0.9 1.0 9.1 0.7 3.6 17.3 10.3 2.4 18.7 14.4 1.9 15.8 0.0 6.9 5.2 5.1 9.6 0.0 0.0 0.0 0.8 13.5 0.2 0.7 0.5 0.1 0.1 27.8 1.5 2.2 0.2 3.2 4.1 0.0 9.8 1.4 9.3 0.0 6.8 12.5 0.2 0.0 0.0 0.1 0.0 1.2 0.6 4.4 24.5 0.0 0.0 1.5 0.8 0.1 5.0 1.5 5.2 0.0 21.9 10.3 4.6 0.1 5.1 8.5 14.4 0.0 0.0 13.8 27.5 8.1 0.6 0.0 5.5 0.3 3.8 19.7 0.1 11.1 0.0 0.3 0.6 13.1 1.2 70.6 1.9 10.2 0.0 0.3 15.8 0.4 18.7 5.1 2.6 14.4 9.4 3.4 3.2 0.5 0.0 8.6 0.4 6.9 5.2 0.5 2.5 0.4 0.5 1.4 0.5 1.7 0.6 1.5 1.0 0.0 3.4 27.2 43.3 2.5 0.1 0.4 7.6 0.0 6.8 1.8 3.9 196.8 0.0 3.0 0.7 2.8 4.2 23.3 3.5 6.8 2.8 66.7 0.0 0.0 43.0 0.0 0.0 0.0 7.5 0.0 0.0 28.3 20.3 0.0 5.9 0.0 37.2 16.9 0.0 0.0 0.3 0.0 1.0 0.0 1.3 1.9 638.3 6.5 43.7 53.5 KCNQ1 "JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1" ENSG00000053918 "Potassium voltage-gated channel subfamily Q member 1" P51787 11 2444684-2849110 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, Deafness, Diabetes mellitus, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 78.2;ductus deferens: 88.1;seminal vesicle: 83.6" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 32.7;Undifferentiated cells: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 19.9;OE19: 24.0;RPMI-8226: 13.4;U-266/70: 7.9;U-937: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB018656, HPA048553" Enhanced NA NA "CAB018656: AB_2131551, HPA048553: AB_2680438" "unprognostic (6.02e-2)" "unprognostic (2.48e-1)" "unprognostic (6.39e-3)" "unprognostic (4.38e-1)" "unprognostic (1.86e-1)" "unprognostic (1.83e-1)" "unprognostic (3.46e-2)" "unprognostic (7.36e-2)" "unprognostic (8.07e-2)" "unprognostic (8.81e-2)" "unprognostic (1.58e-1)" "unprognostic (5.39e-2)" "unprognostic (2.46e-3)" "prognostic favorable (9.85e-4)" "unprognostic (3.99e-2)" "unprognostic (4.19e-2)" "unprognostic (5.27e-2)" 3.0 78.2 1.0 5.1 1.0 3.4 3.1 0.6 1.2 5.0 13.7 4.1 88.1 14.2 1.9 15.9 1.5 2.1 12.2 10.7 1.5 1.0 13.8 1.0 11.4 5.8 1.2 0.8 1.6 25.6 5.6 2.7 1.8 1.8 7.5 4.6 2.5 9.5 83.6 0.8 1.0 18.4 1.5 1.4 5.5 31.2 3.6 1.5 1.6 36.2 0.9 4.8 5.5 3.6 1.2 5.6 5.3 4.7 0.0 1.7 1.4 0.0 0.1 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 1.4 0.9 3.3 0.0 0.2 0.1 0.4 0.0 0.0 0.2 0.9 0.0 2.4 0.2 0.2 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.7 24.0 0.1 0.1 0.0 13.4 5.0 1.6 0.4 3.7 0.4 0.0 0.0 0.3 0.1 5.1 0.0 0.0 0.1 0.1 0.0 7.9 0.0 0.0 0.0 7.8 0.0 1.6 4.7 4.7 0.0 2.6 0.1 1.2 0.6 0.1 5.6 0.6 1.7 1.7 5.3 0.0 3.7 1.9 0.5 1.4 1.0 1.0 0.6 1.2 1.5 1.0 1.2 0.8 1.8 1.5 3.0 11.7 6.7 6.7 0.6 0.0 15.9 17.8 2.7 5.7 27.9 0.0 1.0 13.3 16.6 1.1 2.9 32.7 0.0 18.8 1.1 1.0 6.2 19.6 0.2 13.9 0.0 6.3 9.2 24.1 0.6 0.3 10.1 1.7 1.8 21.3 0.6 17.8 17.5 0.0 1.6 0.2 6.5 1.0 0.2 0.1 0.9 1.7 1.3 44.9 14.7 KCNQ2 "BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2" ENSG00000075043 "Potassium voltage-gated channel subfamily Q member 2" O43526 20 63400210-63472677 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.8" "Group enriched" "Detected in some" 5 "Early spermatids: 10.8;Horizontal cells: 12.7;Late spermatids: 5.7;Spermatocytes: 6.6;Spermatogonia: 17.0" "Cancer enriched" "Detected in some" 9 "glioma: 8.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.2;T-reg: 1.5" "Lineage enriched" "Detected in single" 22 "T-cells: 2.2" "Cell line enhanced" "Detected in some" "AF22: 8.5;AN3-CA: 14.0;NTERA-2: 7.8;SCLC-21H: 27.5;SH-SY5Y: 48.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016642, HPA057112" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA016642: AB_1855555, HPA057112: AB_2683339" "unprognostic (2.35e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-4)" "unprognostic (8.21e-6)" "unprognostic (6.18e-2)" "unprognostic (7.58e-2)" "unprognostic (6.06e-2)" "unprognostic (3.16e-1)" "unprognostic (1.73e-1)" "unprognostic (1.92e-1)" "unprognostic (9.96e-2)" "unprognostic (9.39e-2)" "unprognostic (1.43e-5)" "unprognostic (4.36e-2)" "unprognostic (1.02e-1)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" 1.2 10.0 18.7 1.3 21.4 1.2 1.2 24.1 50.8 1.2 1.3 2.4 0.0 1.3 1.2 1.3 1.2 1.7 1.7 1.2 15.4 10.0 1.2 1.2 1.2 1.2 8.4 14.1 1.2 1.9 1.2 9.2 1.2 8.9 2.8 1.2 0.0 1.2 1.2 1.2 1.2 1.3 1.2 2.6 1.2 1.3 6.9 4.2 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 8.5 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 27.5 48.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 1.5 0.0 18.7 21.4 24.1 31.2 15.4 10.0 8.4 14.1 8.9 4.2 0.0 0.0 0.0 0.0 0.1 1.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 12.7 0.0 0.0 0.0 5.7 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 2.1 0.0 0.0 6.6 17.0 0.0 0.0 0.0 0.0 0.0 KCNQ3 "EBN2, Kv7.3" ENSG00000184156 "Potassium voltage-gated channel subfamily Q member 3" O43525 8 132120858-132481019 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 29.5" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 9.4;Bipolar cells: 5.7;Cardiomyocytes: 4.5;Exocrine glandular cells: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 10.1;JURKAT: 5.6;RPMI-8226: 4.1;U-2 OS: 6.6;U-87 MG: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.90e-1)" "unprognostic (1.26e-3)" "unprognostic (1.45e-2)" "unprognostic (3.65e-5)" "unprognostic (2.32e-1)" "unprognostic (4.60e-2)" "unprognostic (5.57e-6)" "unprognostic (5.82e-2)" "unprognostic (7.32e-2)" "unprognostic (6.09e-2)" "unprognostic (7.09e-2)" "unprognostic (3.22e-1)" "unprognostic (2.71e-4)" "unprognostic (1.14e-3)" "unprognostic (3.52e-1)" "unprognostic (7.92e-2)" "unprognostic (2.50e-2)" 1.8 3.3 10.6 1.5 13.1 0.7 1.4 0.9 29.5 1.4 1.0 1.7 0.0 1.0 1.0 0.9 0.8 1.2 1.3 1.8 8.0 7.3 1.8 0.7 2.0 0.9 7.4 11.5 0.8 1.2 1.2 1.4 1.0 6.5 1.4 1.0 0.0 1.0 1.8 0.7 1.3 1.7 1.6 2.1 1.3 0.9 1.0 4.7 0.0 1.2 0.0 1.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.5 1.6 0.0 0.5 1.6 0.0 0.0 0.0 1.5 0.0 1.8 2.3 3.8 0.0 0.0 3.7 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 2.6 10.1 0.1 0.0 5.6 0.0 0.2 1.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 4.1 2.4 0.0 1.9 1.7 0.7 0.0 0.0 0.3 0.0 1.4 0.0 0.0 6.6 0.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 13.1 0.9 13.3 8.0 7.3 7.4 11.5 6.5 4.7 0.0 9.4 0.0 0.0 0.2 5.7 4.5 0.0 1.4 2.3 0.0 0.0 0.0 0.0 2.9 1.5 0.6 0.0 0.0 5.1 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.3 0.0 1.2 0.0 1.0 0.0 0.2 2.8 0.0 0.0 0.4 0.4 0.0 1.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 KCNQ4 "DFNA2, Kv7.4" ENSG00000117013 "Potassium voltage-gated channel subfamily Q member 4" P56696 1 40783814-40840452 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Hearing, Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 40.1;retina: 23.0" "Cell type enhanced" "Detected in some" 12 "Muller glia cells: 4.1;Sertoli cells: 6.5;Smooth muscle cells: 2.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.0;HEK 293: 5.9;K-562: 5.9;MCF7: 3.5;REH: 3.1;THP-1: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA018305 Uncertain NA NA "HPA018305: AB_1855556" "unprognostic (1.42e-2)" "unprognostic (1.56e-1)" "unprognostic (8.43e-3)" "unprognostic (4.59e-3)" "unprognostic (8.51e-2)" "unprognostic (1.64e-1)" "unprognostic (1.29e-2)" "unprognostic (5.86e-2)" "unprognostic (4.34e-2)" "unprognostic (6.64e-2)" "unprognostic (1.20e-1)" "unprognostic (7.40e-2)" "unprognostic (5.18e-4)" "unprognostic (2.68e-1)" "unprognostic (1.22e-1)" "unprognostic (3.17e-2)" "unprognostic (3.44e-2)" 2.5 0.9 1.1 1.5 2.9 0.4 1.3 3.8 3.6 2.5 9.1 0.9 1.5 1.5 5.8 0.9 3.5 4.6 2.8 2.1 1.6 0.7 0.4 0.4 1.4 0.4 1.4 2.1 1.6 40.1 0.5 0.6 2.1 1.3 3.3 1.7 23.0 5.4 5.3 5.9 1.1 2.3 7.5 2.0 0.4 2.9 1.2 1.4 0.5 0.6 0.9 0.4 5.3 2.5 0.0 0.5 0.0 0.0 0.0 0.4 0.4 0.1 0.2 0.3 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.3 1.6 0.4 0.6 0.0 0.0 0.0 4.0 0.0 0.0 0.1 5.9 2.0 0.3 0.0 0.4 0.4 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.9 5.9 0.1 0.0 3.5 0.7 0.0 0.4 0.0 0.1 3.1 0.0 0.0 0.7 0.0 2.6 0.5 0.0 1.5 0.6 0.4 0.3 3.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.4 1.1 2.9 3.8 3.6 1.6 0.7 1.4 2.1 1.3 1.4 0.0 0.0 0.0 0.0 0.1 0.3 1.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 1.2 0.2 0.1 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 1.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.1 0.3 0.0 0.7 0.0 0.3 6.5 2.7 0.2 0.5 0.4 0.0 0.0 0.4 0.1 KCNQ5 Kv7.5 ENSG00000185760 "Potassium voltage-gated channel subfamily Q member 5" Q9NR82 6 72621792-73198851 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 6.6;brain: 23.0;skeletal muscle: 26.1;thyroid gland: 6.9" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 3.2;Cardiomyocytes: 2.0;Horizontal cells: 1.6;Melanocytes: 1.7;Smooth muscle cells: 1.4;T-cells: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 20.4;HEL: 13.3;HL-60: 17.9;U-251 MG: 13.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016655 Enhanced Approved Vesicles NA NA Vesicles "HPA016655: AB_1855557" "unprognostic (4.91e-2)" "unprognostic (1.42e-1)" "unprognostic (4.96e-2)" "unprognostic (3.78e-2)" "unprognostic (2.69e-1)" "unprognostic (2.18e-2)" "unprognostic (3.57e-2)" "unprognostic (1.43e-1)" "unprognostic (6.09e-2)" "unprognostic (8.55e-2)" "unprognostic (7.96e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (1.08e-2)" "unprognostic (2.62e-1)" "unprognostic (8.16e-2)" "unprognostic (1.39e-3)" 0.7 2.8 4.2 3.0 14.9 6.6 1.1 0.6 19.6 0.6 0.9 0.0 0.0 0.8 0.7 0.6 1.7 1.0 0.9 0.6 6.9 2.7 0.6 0.8 0.8 3.4 3.0 7.5 0.7 0.6 0.6 0.5 1.0 23.0 2.4 0.9 2.2 2.1 1.9 26.1 0.6 0.9 1.7 0.9 2.0 0.8 2.0 0.7 1.6 6.9 0.4 3.1 1.2 0.7 2.7 0.5 1.2 0.0 2.2 1.7 0.2 2.5 0.6 0.0 0.1 0.0 0.9 0.0 20.4 3.0 3.0 2.6 0.0 0.0 12.2 0.0 6.9 0.3 0.4 0.1 1.2 3.6 0.1 4.3 13.3 0.0 0.0 0.5 17.9 0.0 0.2 0.5 8.7 9.1 2.0 0.0 0.0 0.7 8.4 6.0 0.1 0.0 7.7 0.8 0.0 4.3 0.0 0.7 8.4 1.2 0.0 3.4 1.6 0.0 0.0 8.3 0.1 2.5 1.3 0.0 12.7 5.6 0.1 13.5 8.8 0.2 5.6 0.1 8.6 0.7 1.2 0.0 0.0 0.2 0.0 1.1 2.7 0.5 1.5 0.5 1.4 1.7 1.2 0.0 2.2 0.0 0.0 0.0 0.2 4.2 14.9 0.6 19.6 6.9 2.7 3.0 7.5 23.0 0.7 0.0 0.0 0.8 3.2 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.2 0.3 0.2 2.2 0.0 0.3 KCNS1 Kv9.1 ENSG00000124134 "Potassium voltage-gated channel modifier subfamily S member 1" Q96KK3 20 45092310-45101112 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 27.0" "Cell type enriched" "Detected in some" 6 "Cholangiocytes: 10.2" "Cancer enhanced" "Detected in many" "cervical cancer: 6.1" "Region enhanced" "Detected in many" "cerebral cortex: 27.0" "Cell type enhanced" "Detected in single" "neutrophil: 2.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HBF TERT88: 3.2;HHSteC: 4.9;hTEC/SVTERT24-B: 2.7;THP-1: 4.1;U-87 MG: 7.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.46e-2)" "unprognostic (2.95e-3)" "unprognostic (2.03e-1)" "unprognostic (3.11e-4)" "unprognostic (8.91e-3)" "unprognostic (6.01e-3)" "unprognostic (7.47e-2)" "unprognostic (8.94e-2)" "unprognostic (4.37e-2)" "prognostic unfavorable (6.45e-4)" "unprognostic (6.74e-2)" "unprognostic (4.65e-2)" "unprognostic (6.35e-2)" "unprognostic (5.62e-2)" "unprognostic (3.06e-2)" "unprognostic (1.15e-1)" "unprognostic (1.39e-1)" 0.3 0.8 1.4 0.2 4.6 0.4 0.7 0.4 27.0 0.6 0.3 0.0 5.9 0.2 0.2 0.2 0.4 0.3 5.2 0.4 2.1 1.1 0.5 0.3 0.7 0.3 1.0 7.2 0.2 0.3 0.1 0.4 0.3 0.0 0.9 0.2 0.0 3.4 7.0 0.2 2.6 0.3 0.2 0.4 0.3 0.3 2.0 0.0 0.0 0.3 0.0 0.5 0.4 0.6 0.6 0.2 2.5 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.1 0.5 0.0 0.3 0.3 1.0 0.9 0.1 0.4 1.4 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.2 0.9 0.0 2.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.3 1.8 0.0 2.1 0.5 0.0 4.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 7.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.5 0.2 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 1.4 4.6 0.4 27.0 2.1 1.1 1.0 7.2 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.9 10.2 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.1 KCNS2 Kv9.2 ENSG00000156486 "Potassium voltage-gated channel modifier subfamily S member 2" Q9ULS6 8 98427022-98432848 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.9" "Cell type enhanced" "Detected in single" 20 "Leydig cells: 1.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HSkMC: 4.0;SCLC-21H: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051417 Uncertain NA NA "HPA051417: AB_2681478" "unprognostic (7.83e-2)" "unprognostic (9.39e-3)" "unprognostic (5.25e-2)" "unprognostic (2.87e-1)" "unprognostic (1.38e-2)" "unprognostic (2.59e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-2)" "unprognostic (4.27e-2)" "unprognostic (4.58e-2)" "unprognostic (1.47e-1)" "unprognostic (5.30e-5)" "unprognostic (2.43e-2)" "unprognostic (1.42e-2)" "unprognostic (2.31e-1)" "unprognostic (1.30e-1)" "unprognostic (1.27e-3)" 1.6 1.4 2.9 0.6 6.6 0.3 0.7 0.7 20.9 2.0 1.0 0.1 0.5 0.4 1.3 1.7 0.9 1.0 1.5 0.4 1.9 2.8 0.7 0.3 0.7 0.4 0.8 6.4 1.9 0.8 0.8 1.2 4.4 3.4 0.9 0.9 0.1 0.3 3.3 0.2 0.3 0.7 0.6 0.9 0.3 1.5 1.0 0.4 0.0 0.5 0.0 0.3 2.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 1.3 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 6.6 0.7 20.9 1.9 2.8 0.8 6.4 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 KCNS3 Kv9.3 ENSG00000170745 "Potassium voltage-gated channel modifier subfamily S member 3" Q9BQ31 2 17877847-18361616 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 54.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 26.8;Intestinal endocrine cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "memory B-cell: 1.6" "Lineage enriched" "Detected in single" 17 "B-cells: 1.6" "Cell line enhanced" "Detected in many" "RH-30: 33.8;RPMI-8226: 13.6;RT4: 23.0;U-266/84: 15.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014864 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "HPA014864: AB_1852155" "unprognostic (5.62e-2)" "unprognostic (4.27e-3)" "unprognostic (6.87e-2)" "unprognostic (1.68e-1)" "unprognostic (3.19e-1)" "unprognostic (1.64e-2)" "unprognostic (3.30e-1)" "unprognostic (9.47e-3)" "unprognostic (9.06e-2)" "unprognostic (8.45e-2)" "unprognostic (5.82e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" 2.2 1.1 2.7 5.6 3.2 0.4 14.8 0.5 5.1 6.8 7.9 4.8 1.3 3.1 4.5 2.4 7.2 3.3 5.3 4.6 3.9 3.4 4.2 2.6 17.6 1.2 6.8 1.4 1.1 7.7 1.9 0.8 8.3 15.2 4.4 4.1 9.9 7.6 2.8 54.4 3.7 4.3 9.7 4.7 1.1 7.0 3.9 1.4 0.2 2.4 19.0 3.6 5.0 4.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.7 0.3 0.0 0.8 0.4 1.8 1.3 4.1 0.8 1.0 0.0 8.3 0.0 0.4 1.4 0.9 1.2 10.0 0.0 0.9 0.0 2.6 0.0 0.1 0.0 4.0 0.1 0.3 0.3 6.3 0.0 0.6 7.7 0.2 1.8 0.2 0.0 0.5 1.0 0.0 0.0 5.0 5.4 0.1 1.1 33.8 13.6 0.8 23.0 10.0 0.3 0.0 2.6 2.7 2.4 1.3 0.0 0.1 1.3 0.0 0.1 10.1 0.0 15.7 0.0 7.5 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.2 0.5 5.1 3.9 3.4 6.8 1.4 15.2 1.4 26.8 5.1 0.0 10.1 12.4 0.0 0.4 20.4 0.0 4.5 10.4 0.0 0.5 0.0 16.1 0.2 6.0 3.2 0.0 0.3 2.9 16.6 8.1 1.1 3.2 0.4 0.0 31.2 3.1 0.0 0.2 1.4 0.6 20.3 1.0 3.0 0.1 3.7 3.5 3.5 2.6 0.1 6.5 9.5 0.2 3.1 5.1 0.7 0.0 9.9 5.4 KCNT1 "KCa4.1, KIAA1422, SLACK, Slo2.2" ENSG00000107147 "Potassium sodium-activated channel subfamily T member 1" Q5JUK3 9 135702185-135795508 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.7;skeletal muscle: 19.5" "Cell type enriched" "Detected in single" 5 "Cardiomyocytes: 4.5" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 5.6;RH-30: 1.9;RPMI-8226: 4.2;SCLC-21H: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059880 Uncertain NA NA "HPA059880: AB_2684149" "unprognostic (1.50e-3)" "unprognostic (1.72e-2)" "unprognostic (2.07e-3)" "unprognostic (2.98e-13)" "unprognostic (9.26e-2)" "unprognostic (7.73e-2)" "unprognostic (9.60e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (1.30e-3)" "unprognostic (9.89e-2)" "unprognostic (6.20e-2)" "unprognostic (4.89e-7)" "unprognostic (9.15e-2)" "unprognostic (2.70e-1)" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" 1.4 0.8 7.3 1.0 12.4 1.0 0.7 29.7 29.3 0.7 0.9 0.2 0.0 1.0 0.8 0.9 1.2 0.9 1.1 1.8 5.3 4.2 0.7 0.7 0.9 0.8 1.8 12.0 7.3 0.8 0.7 4.7 1.2 6.1 0.8 0.8 0.0 0.7 0.8 19.5 0.8 0.8 0.8 2.1 9.6 1.4 1.9 3.1 0.0 0.8 0.0 0.7 1.1 0.1 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 5.6 0.0 0.0 1.9 4.2 0.0 0.0 6.3 1.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 7.3 12.4 29.7 29.3 5.3 4.2 1.8 12.0 6.1 3.1 0.0 0.0 0.0 0.0 0.0 0.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.7 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 KCNT2 "KCa4.2, SLICK, SLO2.1" ENSG00000162687 "Potassium sodium-activated channel subfamily T member 2" Q6UVM3 1 196225779-196609225 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 38.7;Early spermatids: 12.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 4.3;hTERT-RPE1: 12.4;SCLC-21H: 9.3;SH-SY5Y: 8.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051218 Uncertain Approved Vesicles NA NA Vesicles "HPA051218: AB_2681392" "unprognostic (5.06e-2)" "unprognostic (2.94e-2)" "unprognostic (8.01e-2)" "unprognostic (5.10e-6)" "unprognostic (1.22e-3)" "unprognostic (1.30e-2)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (5.90e-2)" "unprognostic (2.18e-1)" "unprognostic (9.56e-3)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.67e-5)" "unprognostic (3.30e-4)" "unprognostic (2.95e-2)" "unprognostic (4.75e-1)" "unprognostic (1.72e-3)" 3.9 2.8 4.8 1.3 5.5 0.6 2.2 1.4 8.3 1.8 2.3 0.6 0.0 2.1 2.2 1.7 4.0 2.7 5.9 6.8 9.4 3.1 1.8 10.5 5.5 1.3 1.8 5.2 14.9 1.1 0.9 14.1 1.8 3.7 4.2 2.5 2.9 2.6 2.5 1.2 1.9 2.1 2.6 5.2 1.4 2.6 3.3 1.0 0.0 4.5 3.4 1.2 3.3 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.1 0.3 0.0 0.0 1.3 0.3 2.7 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.3 0.0 1.6 0.0 4.3 0.0 0.0 1.0 0.0 0.4 0.1 12.4 0.5 0.0 0.0 0.0 0.3 0.0 0.2 0.0 3.3 0.0 0.2 0.0 0.3 0.0 0.0 0.7 9.3 8.4 0.0 0.0 0.2 3.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 5.5 1.4 8.3 9.4 3.1 1.8 5.2 3.7 1.0 38.7 0.6 0.0 0.3 0.3 0.0 1.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 5.9 0.0 0.0 0.0 2.5 0.0 2.3 6.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 KCNU1 "KCa5.1, Kcnma3, KCNMC1, Slo3" ENSG00000215262 "Potassium calcium-activated channel subfamily U member 1" A8MYU2 8 36784324-36936128 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 15.8" "Group enriched" "Detected in some" 54 "Early spermatids: 49.4;Late spermatids: 18.0" "Cancer enhanced" "Detected in single" "liver cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HDLM-2: 13.1" "Not detected" "Not detected" HPA063317 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA063317: " "unprognostic (2.42e-3)" "unprognostic (4.26e-2)" "unprognostic (2.07e-1)" "unprognostic (4.76e-3)" "unprognostic (7.57e-2)" "unprognostic (1.12e-1)" "unprognostic (1.11e-1)" "unprognostic (2.71e-1)" "unprognostic (1.98e-1)" "unprognostic (7.73e-2)" "unprognostic (1.24e-2)" 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 13.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 KCNV1 Kv8.1 ENSG00000164794 "Potassium voltage-gated channel modifier subfamily V member 1" Q6PIU1 8 109963645-109975847 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 22.4" "Cell type enriched" "Detected in single" 7 "Intestinal endocrine cells: 6.8" "Cancer enhanced" "Detected in single" "renal cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.41e-1)" "unprognostic (1.81e-2)" "unprognostic (5.01e-4)" "unprognostic (2.30e-1)" "unprognostic (3.76e-2)" "unprognostic (1.13e-2)" "unprognostic (3.89e-2)" "unprognostic (2.27e-1)" "unprognostic (4.17e-2)" 0.5 0.5 10.6 0.6 10.2 1.1 0.6 0.2 22.4 0.4 1.1 0.0 0.0 0.5 0.6 1.2 0.5 0.4 0.5 0.5 3.9 1.6 0.6 0.5 0.5 0.7 0.9 8.2 0.8 1.0 0.4 0.7 0.6 0.9 0.7 0.9 0.0 0.6 0.5 0.5 1.1 0.8 0.4 0.4 0.6 0.5 0.7 0.0 0.0 0.9 0.0 0.5 0.4 0.2 0.8 0.6 2.5 0.9 0.6 0.5 0.1 2.1 2.7 1.9 0.8 0.3 0.3 0.7 0.6 0.0 0.4 0.4 0.5 0.8 0.8 0.6 0.1 1.7 2.1 0.7 0.3 0.5 1.0 0.3 1.3 2.0 0.5 0.1 1.1 1.5 0.3 0.4 0.6 0.5 0.8 0.4 1.1 1.0 2.6 0.3 0.6 0.8 1.3 0.9 0.5 1.2 0.2 1.0 0.3 3.4 1.1 1.5 0.7 0.5 0.4 0.6 2.1 1.0 0.5 1.3 2.3 2.0 1.5 0.6 0.9 0.5 0.4 1.0 0.9 0.9 2.5 0.8 0.3 0.5 0.9 0.4 0.6 0.5 0.5 0.5 0.8 0.5 0.5 1.1 0.6 0.8 0.6 0.3 0.1 10.6 10.2 0.2 19.5 3.9 1.6 0.9 8.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 KCNV2 Kv8.2 ENSG00000168263 "Potassium voltage-gated channel modifier subfamily V member 2" Q8TDN2 9 2717502-2730037 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 82.3" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 485.0;Rod photoreceptor cells: 393.2" "Cancer enriched" "Detected in single" 78 "testis cancer: 6.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HDLM-2: 2.9;HEK 293: 1.4;HeLa: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA031131 Enhanced NA NA "HPA031131: AB_10609996" "unprognostic (5.06e-2)" "unprognostic (1.47e-3)" "unprognostic (3.45e-3)" "unprognostic (6.41e-2)" "unprognostic (1.31e-1)" "unprognostic (2.28e-2)" "unprognostic (1.12e-3)" "unprognostic (5.38e-2)" "unprognostic (1.39e-2)" "unprognostic (1.69e-1)" "unprognostic (5.21e-2)" "unprognostic (2.35e-1)" "unprognostic (7.96e-8)" "unprognostic (3.01e-1)" "unprognostic (4.90e-2)" "unprognostic (9.90e-2)" "unprognostic (1.06e-2)" 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 82.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.6 0.0 0.2 0.7 0.2 0.4 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.9 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 1.4 0.8 2.3 0.3 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.5 0.7 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.1 0.1 0.6 0.0 0.0 0.7 0.4 0.6 0.3 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.1 0.2 0.0 0.0 0.0 0.0 485.0 0.0 0.0 0.0 85.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 19.8 0.6 0.0 0.0 0.0 0.0 36.6 0.0 0.0 1.1 0.0 393.2 12.9 0.0 5.9 11.4 0.0 0.0 0.0 0.0 0.0 KCTD8 ENSG00000183783 "Potassium channel tetramerization domain containing 8" Q6ZWB6 4 44173909-44448807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.5" "Cell type enhanced" "Detected in some" 20 "Cholangiocytes: 7.6;Collecting duct cells: 3.5;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 16.2" "Cancer enhanced" "Detected in some" "glioma: 0.9;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.1;NTERA-2: 2.9;PC-3: 1.8;SCLC-21H: 10.9;U-2 OS: 3.3" "Low region specificity" "Detected in all" HPA031562 Enhanced Approved Vesicles NA NA Vesicles "HPA031562: AB_10602609" "unprognostic (1.49e-2)" "unprognostic (7.70e-3)" "unprognostic (1.53e-1)" "unprognostic (4.15e-1)" "unprognostic (1.77e-2)" "unprognostic (1.48e-1)" "unprognostic (7.85e-2)" "unprognostic (2.62e-3)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (2.57e-3)" "unprognostic (8.72e-2)" "unprognostic (3.55e-2)" "unprognostic (2.44e-1)" 2.0 1.4 5.4 0.9 12.2 0.7 0.9 19.5 18.9 2.2 1.0 8.5 3.5 0.8 4.2 1.3 0.8 1.1 1.5 1.1 4.8 5.2 2.8 0.7 1.0 0.7 8.9 4.0 4.3 2.4 0.7 0.2 0.7 6.8 1.5 1.1 2.3 1.7 3.1 2.6 0.8 0.9 2.3 8.0 0.7 2.6 3.8 8.3 0.0 8.6 0.4 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 12.2 19.5 8.5 4.8 5.2 8.9 4.0 6.8 8.3 0.0 0.0 0.0 0.6 0.0 2.7 0.2 7.6 0.0 0.0 3.5 3.9 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 1.0 16.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 KDELR1 "ERD2, ERD2.1, HDEL" ENSG00000105438 "KDEL endoplasmic reticulum protein retention receptor 1" P24390 19 48382570-48391553 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 488.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017455 Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus" "Vesicles, Cytosol" "CAB017455: AB_10615208" "unprognostic (3.10e-2)" "unprognostic (4.17e-2)" "unprognostic (1.64e-1)" "unprognostic (1.87e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.49e-4)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.35e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-1)" "unprognostic (1.51e-1)" "unprognostic (7.55e-2)" "unprognostic (4.97e-2)" "unprognostic (3.81e-1)" "unprognostic (2.74e-1)" "unprognostic (3.06e-1)" "unprognostic (1.68e-2)" 46.9 49.3 22.6 23.4 21.5 14.5 60.6 16.1 28.8 51.8 43.3 24.4 64.8 47.7 44.0 45.2 41.3 40.3 56.5 42.8 20.9 20.4 57.3 81.3 38.0 44.6 18.6 20.4 68.9 61.0 63.5 45.7 81.4 20.9 44.8 47.7 39.7 65.8 69.9 31.8 37.4 59.9 39.6 26.0 33.7 42.5 33.2 18.6 26.2 75.5 32.9 42.3 53.2 54.4 10.6 26.5 6.8 23.3 11.6 12.8 9.3 30.2 43.8 25.4 26.9 57.2 67.0 18.6 29.9 52.9 36.5 41.9 28.8 34.6 12.6 19.6 65.3 22.8 27.2 30.6 32.0 34.9 10.2 32.6 10.5 15.6 53.7 49.8 11.7 19.7 63.2 39.5 24.7 26.5 57.6 33.9 10.9 18.2 23.5 48.4 24.4 11.0 120.4 18.4 60.6 17.8 15.8 15.2 19.7 46.3 25.2 25.5 19.9 26.2 23.5 15.6 30.4 18.5 14.5 26.2 25.8 21.4 21.3 25.4 66.6 52.1 8.5 16.4 15.9 26.3 5.9 23.3 6.8 11.2 19.8 12.8 10.6 11.0 12.1 17.7 9.6 9.2 9.9 5.9 11.6 16.5 26.5 11.7 9.3 22.6 21.5 16.1 28.8 20.9 20.4 18.6 20.4 20.9 18.6 32.8 44.6 55.9 109.7 66.9 36.0 25.0 94.3 48.2 69.4 89.0 5.9 200.0 48.0 191.8 3.8 91.1 175.8 46.7 148.2 488.3 138.8 143.5 61.2 66.0 162.8 38.1 139.2 77.3 97.8 10.5 151.3 75.4 87.7 106.4 269.4 89.6 162.2 178.9 124.1 122.0 21.4 84.1 77.3 41.2 38.1 61.4 324.3 45.4 168.0 114.5 KDELR2 "ELP-1, ERD2.2" ENSG00000136240 "KDEL endoplasmic reticulum protein retention receptor 2" P33947 7 6445953-6484242 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 814.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016459 Approved NA NA "HPA016459: AB_1852180" "unprognostic (2.16e-3)" "unprognostic (1.34e-3)" "unprognostic (1.77e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (5.40e-5)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.85e-2)" "unprognostic (7.05e-2)" "unprognostic (1.42e-1)" "unprognostic (1.95e-1)" "unprognostic (2.33e-2)" "unprognostic (5.42e-1)" "prognostic unfavorable (6.79e-8)" "unprognostic (7.72e-2)" "unprognostic (1.80e-1)" "unprognostic (4.29e-2)" "unprognostic (2.71e-2)" 35.9 28.7 11.5 18.7 11.9 6.0 53.7 11.6 13.4 41.2 37.3 17.5 35.6 32.8 30.7 35.6 29.2 25.4 47.7 35.0 12.0 13.8 43.6 158.4 30.3 44.9 14.1 9.3 40.8 85.1 20.0 34.0 76.5 12.3 31.6 41.7 25.5 62.2 40.3 18.3 20.0 56.3 30.2 13.5 26.2 43.7 48.3 13.1 11.6 40.4 26.9 28.8 28.3 36.3 18.6 50.9 29.6 29.8 16.9 26.1 20.6 39.3 17.0 16.9 31.7 82.0 75.9 17.3 59.4 53.1 34.1 51.5 27.3 25.4 6.3 17.0 82.6 51.2 35.3 24.0 24.3 53.1 3.4 14.3 7.6 18.6 37.3 49.9 11.8 10.7 48.1 24.7 33.1 39.5 38.2 30.7 6.1 16.9 18.7 46.1 32.2 3.6 11.0 16.1 50.8 26.6 8.7 26.0 16.1 27.2 16.2 15.6 18.8 24.4 43.4 18.1 26.9 35.9 20.2 26.6 26.1 39.3 63.0 31.4 14.0 11.6 10.8 43.5 22.7 74.6 25.8 28.9 29.6 20.4 29.8 26.1 18.6 21.5 22.3 28.9 16.6 17.6 19.1 19.2 16.9 29.2 50.9 19.4 20.6 11.5 11.9 11.6 13.4 12.0 13.8 14.1 9.3 12.3 13.1 23.8 60.1 62.1 144.5 170.7 27.1 51.3 129.9 29.4 35.2 59.3 11.8 369.6 29.9 196.3 618.8 92.2 203.3 46.7 285.3 814.0 314.5 260.1 69.0 330.7 277.3 30.2 109.8 138.7 77.5 68.7 140.1 111.9 168.7 101.8 375.9 27.8 206.3 206.7 114.5 91.3 29.7 71.1 143.2 369.8 134.3 173.9 635.5 74.6 235.6 207.9 KDELR3 ENSG00000100196 "KDEL endoplasmic reticulum protein retention receptor 3" O43731 22 38468062-38483447 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 48.5;salivary gland: 57.2" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 62.1;Fibroblasts: 54.4;Mucus-secreting cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 58.3;BJ: 36.7;BJ hTERT+: 37.8;fHDF/TERT166: 59.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043477, HPA076405" Uncertain Supported "Endoplasmic reticulum" No No "Endoplasmic reticulum" "HPA043477: AB_10962952, HPA076405: AB_2686797" "unprognostic (1.76e-1)" "unprognostic (3.77e-2)" "unprognostic (1.81e-1)" "unprognostic (1.20e-2)" "unprognostic (2.90e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (1.19e-4)" "unprognostic (2.26e-1)" "unprognostic (1.91e-1)" "unprognostic (1.23e-1)" "unprognostic (9.25e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (6.05e-10)" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (8.24e-2)" "unprognostic (2.07e-2)" 10.5 4.0 1.3 3.4 1.4 0.2 11.6 0.9 1.3 15.7 7.7 1.8 5.3 6.6 6.2 14.8 5.5 5.7 20.9 14.2 1.5 1.1 10.9 44.5 8.6 5.8 1.0 1.2 7.2 48.5 9.3 12.4 11.6 1.8 9.2 10.3 5.5 57.2 7.1 2.1 3.6 15.1 6.6 2.2 3.0 15.5 4.1 0.9 1.1 6.7 6.5 16.9 6.8 6.5 1.2 4.3 0.9 0.1 0.3 2.4 0.3 7.0 2.2 1.8 7.8 30.9 58.3 1.3 36.7 37.8 9.0 22.5 4.0 9.3 0.0 7.8 59.5 3.2 1.0 1.8 2.2 10.9 0.0 4.1 0.5 1.9 11.1 13.6 0.0 4.9 21.4 1.7 11.3 1.2 12.8 10.8 0.0 1.7 0.0 14.8 11.5 0.0 0.2 0.4 30.6 6.4 0.0 0.5 2.3 10.9 0.9 0.1 0.9 9.4 0.5 4.6 0.8 2.7 0.4 8.2 9.7 6.1 33.3 3.6 0.3 0.1 0.0 15.6 0.0 13.4 0.0 0.1 0.0 0.8 0.1 2.4 1.2 0.8 0.2 0.2 0.4 0.8 0.8 0.9 0.3 0.1 4.3 0.7 0.3 1.3 1.4 0.9 1.3 1.5 1.1 1.0 1.2 1.8 0.9 0.0 3.7 1.5 4.6 6.8 1.0 2.4 7.6 8.1 7.9 14.0 2.0 4.0 6.6 16.9 0.1 8.7 9.7 0.0 28.0 62.1 54.4 28.3 1.1 5.0 4.1 0.0 4.7 22.1 1.9 0.2 30.2 1.7 15.1 1.8 58.9 5.7 29.2 3.5 15.2 0.5 1.0 0.0 7.6 0.2 1.9 6.1 6.9 0.0 9.9 4.8 KDR "CD309, FLK1, VEGFR, VEGFR2" ENSG00000128052 "Kinase insert domain receptor" P35968 4 55078259-55125595 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Endothelial cells: 100.3;Ito cells: 200.7;Muller glia cells: 229.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 32.5;TIME: 36.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB004028 Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA 7400000 "Plasma membrane" "CAB004028: AB_2212507" "unprognostic (1.61e-1)" "unprognostic (2.03e-1)" "unprognostic (9.65e-2)" "unprognostic (1.97e-1)" "unprognostic (9.63e-2)" "unprognostic (1.22e-2)" "unprognostic (1.78e-3)" "unprognostic (2.59e-2)" "unprognostic (1.19e-2)" "unprognostic (1.10e-1)" "unprognostic (8.79e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (7.26e-4)" "unprognostic (4.00e-2)" "unprognostic (2.30e-1)" "unprognostic (3.22e-1)" "unprognostic (1.86e-1)" 19.7 6.2 1.8 4.4 3.1 0.4 20.5 1.1 2.2 11.4 6.0 1.8 11.5 2.3 28.8 10.2 5.2 9.5 6.2 12.1 2.3 1.7 7.8 10.4 13.2 14.1 3.1 2.9 6.0 8.1 8.0 6.8 34.5 3.9 9.5 1.4 27.6 7.1 10.3 5.3 3.0 3.8 7.7 2.6 4.4 4.2 5.3 1.2 0.5 20.0 5.3 3.0 4.4 12.0 0.1 0.1 0.7 0.0 0.2 0.2 0.1 0.0 0.0 1.7 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.2 0.2 32.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 1.8 3.1 1.1 2.2 2.3 1.7 3.1 2.9 3.9 1.2 0.0 8.2 7.5 0.4 2.3 7.4 4.8 0.0 6.7 30.7 0.0 0.0 0.1 0.0 0.5 0.8 100.3 0.0 0.0 0.0 0.1 1.9 0.4 2.3 1.3 0.4 0.0 0.0 200.7 14.5 0.6 0.0 1.0 6.8 0.0 0.0 229.2 0.3 0.0 0.4 0.0 6.0 0.0 1.4 0.2 0.2 2.4 0.1 0.0 0.0 0.4 KDSR "DHSR, FVT1, SDR35C1" ENSG00000119537 "3-ketodihydrosphingosine reductase" Q06136 18 63327726-63367510 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Oxidoreductase "Cancer-related genes, Disease mutation, Palmoplantar keratoderma, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-266/70: 38.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003673, HPA044884" Approved NA NA "CAB003673: AB_425440, HPA044884: AB_2679131" "unprognostic (4.44e-2)" "unprognostic (8.57e-2)" "unprognostic (2.52e-2)" "unprognostic (4.56e-2)" "unprognostic (5.88e-3)" "unprognostic (7.50e-3)" "unprognostic (1.80e-2)" "unprognostic (2.66e-1)" "unprognostic (2.97e-1)" "unprognostic (1.97e-1)" "unprognostic (2.70e-2)" "unprognostic (6.81e-2)" "prognostic favorable (9.53e-6)" "unprognostic (3.32e-2)" "unprognostic (5.77e-2)" "unprognostic (2.22e-1)" "unprognostic (2.16e-3)" 21.1 19.4 19.0 11.1 22.4 6.4 29.7 12.5 17.2 18.2 17.3 23.9 14.2 10.0 19.4 30.0 17.8 14.3 17.7 15.8 19.7 16.9 21.3 52.6 15.3 11.5 32.1 14.6 29.1 14.3 19.6 10.5 24.9 19.5 18.0 11.0 15.9 16.1 17.4 12.4 28.8 13.1 18.9 39.0 9.1 11.8 10.4 23.3 8.8 21.2 12.3 9.9 19.9 22.8 4.0 5.6 0.9 5.6 9.8 19.5 3.7 5.9 2.7 2.8 3.1 22.4 16.8 5.5 19.8 12.2 4.4 5.9 1.1 4.1 6.1 8.5 7.7 7.3 26.5 3.5 11.1 5.4 11.4 5.9 4.7 3.6 1.3 17.1 8.5 3.3 16.0 21.2 7.0 20.1 8.1 4.3 4.1 3.7 8.7 11.6 2.4 9.4 3.9 3.3 1.5 10.0 6.4 8.3 8.6 12.1 3.9 3.6 6.9 9.6 4.7 8.5 3.8 2.5 4.9 10.1 18.6 4.5 6.2 8.6 38.2 17.4 3.5 14.0 5.3 5.5 0.0 3.7 0.3 4.8 5.6 19.5 4.0 10.2 7.6 5.6 3.6 7.3 4.6 0.9 9.8 2.6 2.8 12.9 3.7 19.0 22.4 12.5 15.9 19.7 16.9 32.1 14.6 19.5 23.3 32.8 41.4 40.4 112.3 140.9 36.2 21.8 68.8 46.8 48.9 36.6 25.5 53.1 13.3 45.0 0.7 35.9 29.0 0.0 32.1 57.8 53.6 62.1 25.4 77.0 31.7 38.1 19.7 44.8 25.0 3.6 65.9 36.3 54.0 30.7 30.6 57.7 41.5 46.0 66.4 36.6 40.8 32.3 42.2 0.9 5.3 125.1 76.4 20.3 40.8 94.6 KEL "CD238, ECE3" ENSG00000197993 "Kell blood group, metallo-endopeptidase" P23276 7 142941114-142962681 "Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 21.1;testis: 36.4" "Cell type enriched" "Detected in some" 14 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Group enriched" "Detected in some" 12 "HEL: 15.3;K-562: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA064442 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA064442: " "unprognostic (5.78e-3)" "unprognostic (1.08e-5)" "unprognostic (5.29e-3)" "unprognostic (4.85e-3)" "unprognostic (9.68e-2)" "unprognostic (1.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "unprognostic (5.18e-2)" "unprognostic (1.08e-2)" "unprognostic (3.71e-2)" "unprognostic (3.57e-2)" "unprognostic (2.29e-3)" "unprognostic (9.24e-2)" "unprognostic (7.05e-2)" "unprognostic (3.32e-2)" "unprognostic (3.25e-3)" 0.2 0.0 0.9 2.5 1.1 21.1 0.2 0.2 0.4 0.4 0.2 0.3 0.2 0.0 0.2 0.2 0.6 0.1 0.2 0.2 1.4 0.7 0.4 0.2 1.4 5.0 2.0 0.2 0.2 0.2 0.0 0.2 1.1 0.3 0.2 0.0 0.3 2.5 0.2 0.2 0.0 0.5 0.2 4.4 3.8 0.0 36.4 0.3 0.4 0.2 0.2 3.7 0.2 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.4 0.1 0.0 0.0 0.5 0.3 0.3 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.1 0.2 0.0 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 1.1 0.2 0.4 1.4 0.7 2.0 0.2 0.3 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 2.3 3.5 0.0 0.0 1.7 0.2 1.9 0.0 0.0 46.7 0.0 0.2 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 1.0 KHDC1 "bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1" ENSG00000135314 "KH domain containing 1" Q4VXA5 6 73241314-73310365 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Sertoli cells: 19.4;Spermatocytes: 29.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA029032 Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA029032: AB_10602914" "unprognostic (3.46e-1)" "unprognostic (2.20e-2)" "unprognostic (1.74e-1)" "unprognostic (2.73e-4)" "unprognostic (1.95e-1)" "unprognostic (2.18e-1)" "unprognostic (1.20e-1)" "unprognostic (7.54e-2)" "unprognostic (5.76e-2)" "unprognostic (6.27e-2)" "unprognostic (1.16e-1)" "unprognostic (4.97e-3)" "unprognostic (1.83e-4)" "unprognostic (8.18e-2)" "unprognostic (2.97e-1)" "unprognostic (2.14e-1)" "unprognostic (5.17e-3)" 2.9 2.9 10.3 2.0 12.9 0.9 2.2 8.8 14.6 4.7 1.3 2.6 1.2 0.6 3.9 3.3 2.7 6.2 2.6 3.4 8.5 8.4 1.3 0.4 1.8 3.1 8.6 5.7 7.4 4.4 5.0 9.6 1.5 4.7 4.4 1.4 2.9 1.3 3.6 2.7 1.0 1.1 2.4 6.2 0.9 2.9 8.2 4.1 5.4 5.9 1.7 3.4 2.2 2.1 2.7 2.6 3.8 0.2 2.5 5.2 2.0 2.9 4.2 0.8 2.3 4.0 4.6 2.0 5.7 5.5 8.8 13.1 4.0 2.3 6.2 2.2 2.5 4.5 2.8 5.9 1.2 6.7 5.9 4.2 4.1 3.4 0.0 5.2 2.0 0.1 5.9 2.5 8.7 2.4 3.7 1.9 6.5 3.0 7.5 3.5 6.9 0.4 1.9 3.9 0.5 8.4 0.9 0.0 5.0 1.4 0.1 10.5 2.2 3.2 0.1 0.2 2.9 0.1 6.2 0.1 1.9 4.0 1.1 6.0 12.7 7.6 4.5 0.1 1.7 0.7 3.8 0.2 0.0 4.4 0.0 2.6 2.7 2.8 4.9 0.7 1.9 2.2 3.4 0.0 2.5 0.0 2.6 5.2 2.0 10.3 12.9 8.8 12.4 8.5 8.4 8.6 5.7 4.7 4.1 0.0 1.0 3.0 3.2 0.7 7.8 1.8 0.0 0.0 2.3 3.5 2.0 1.5 1.7 0.8 9.3 0.3 0.0 0.0 3.3 0.3 3.1 1.7 0.0 0.0 0.4 12.7 0.0 0.0 0.0 12.1 2.0 0.0 3.3 1.0 0.5 11.5 2.3 0.0 3.2 0.0 6.8 19.4 1.9 29.8 12.9 0.5 0.1 4.3 0.9 0.4 KIAA0040 ENSG00000235750 KIAA0040 Q15053 1 175156987-175192999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Syncytiotrophoblasts: 315.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 32.8;RPMI-8226: 23.3;U-698: 42.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA016895, HPA068812" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA016895: AB_2669476, HPA068812: AB_2686041" "unprognostic (5.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "unprognostic (2.99e-2)" "unprognostic (1.01e-2)" "unprognostic (8.54e-3)" "unprognostic (2.91e-1)" "unprognostic (2.87e-2)" "unprognostic (3.83e-1)" "unprognostic (1.21e-1)" "unprognostic (2.66e-2)" "unprognostic (1.63e-1)" "unprognostic (2.53e-2)" "unprognostic (1.49e-1)" "unprognostic (2.57e-1)" "unprognostic (2.28e-2)" "unprognostic (3.05e-1)" 25.7 4.0 2.7 18.4 7.4 5.1 16.0 2.0 3.9 8.0 7.7 1.8 3.5 5.2 8.6 7.9 7.0 9.2 11.0 16.3 3.2 2.9 17.8 12.1 25.3 16.1 6.9 1.0 5.0 17.9 4.6 13.6 45.6 7.6 7.9 5.6 12.2 15.2 4.1 11.1 5.1 10.2 6.0 5.4 27.6 9.8 3.4 3.5 14.8 9.6 7.2 18.6 6.6 10.7 16.5 5.4 26.4 6.1 3.3 9.6 5.4 3.1 0.1 0.1 0.0 0.0 0.0 0.0 1.4 3.8 0.0 0.0 1.6 4.6 32.8 7.8 0.0 0.1 13.2 2.3 15.4 0.0 11.1 1.9 3.5 7.2 0.2 0.4 0.2 0.4 0.0 4.2 0.0 5.9 0.0 5.1 4.8 2.8 5.5 0.0 0.7 4.1 0.0 1.0 2.7 2.8 3.5 1.7 23.3 5.0 7.9 0.2 1.2 2.4 12.9 0.3 8.4 8.2 0.7 2.0 0.0 1.5 0.0 0.3 13.6 16.5 42.2 0.6 0.0 3.5 12.8 6.1 1.0 5.9 3.3 5.3 16.2 6.5 4.9 5.4 16.5 6.9 5.9 26.4 3.3 1.2 1.2 9.6 5.4 2.7 7.4 2.0 3.9 3.2 2.9 6.9 1.0 7.6 3.5 35.7 5.6 53.8 61.7 23.7 0.0 3.1 12.7 20.1 15.9 12.2 0.0 57.4 11.6 11.3 0.5 20.2 11.2 0.0 20.8 5.6 39.4 46.5 10.5 6.0 10.4 0.0 4.1 13.5 10.6 1.2 15.5 16.9 6.8 10.0 5.5 4.3 17.8 14.2 9.9 4.7 0.0 25.8 65.9 0.3 3.3 9.7 315.3 25.4 10.3 30.7 KIAA0100 "BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488" ENSG00000007202 KIAA0100 Q14667 17 28614440-28645454 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042781 Uncertain Approved "Nuclear speckles,Cytosol" "Secreted - unknown location" No No "Nuclear speckles, Cytosol" "HPA042781: AB_10797020" "unprognostic (1.91e-1)" "unprognostic (1.03e-2)" "unprognostic (3.47e-2)" "unprognostic (5.26e-3)" "unprognostic (2.43e-1)" "unprognostic (6.89e-2)" "prognostic unfavorable (3.47e-5)" "unprognostic (4.99e-2)" "unprognostic (3.04e-1)" "unprognostic (3.03e-3)" "unprognostic (2.40e-2)" "unprognostic (2.53e-1)" "unprognostic (4.24e-3)" "unprognostic (7.58e-2)" "unprognostic (5.84e-2)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 27.7 31.2 22.3 21.3 34.7 21.9 26.3 28.1 40.1 20.0 24.0 28.2 20.9 15.5 24.7 21.6 25.4 24.0 20.1 21.4 22.0 22.4 38.1 30.7 24.1 26.3 23.1 19.6 25.6 24.6 48.0 27.0 32.7 35.6 22.7 28.5 22.1 27.0 23.3 40.7 25.0 27.9 28.4 21.4 26.4 22.8 24.8 18.6 26.3 28.6 20.2 26.6 22.7 18.8 2.9 7.2 3.5 3.0 2.0 3.3 1.3 19.6 37.6 19.1 18.1 34.8 20.8 13.9 18.4 24.6 22.6 21.3 25.8 9.0 27.4 22.2 33.6 23.6 26.3 28.0 27.3 27.4 30.3 26.2 21.8 29.8 14.1 15.0 38.0 37.9 21.2 21.2 30.5 23.3 17.6 32.2 19.6 20.5 8.9 20.5 28.2 27.7 18.1 8.3 35.7 13.9 21.3 21.4 17.9 13.6 35.4 18.8 14.5 23.2 63.6 15.5 24.8 38.0 26.6 29.7 17.3 19.1 23.1 34.7 8.4 9.7 17.7 19.7 24.7 20.1 0.8 3.0 3.5 3.0 2.5 3.3 2.9 1.5 2.7 3.3 1.7 1.8 1.8 1.8 2.0 2.7 7.2 1.7 1.3 22.3 34.7 28.1 40.1 22.0 22.4 23.1 19.6 35.6 18.6 14.9 19.1 3.9 6.3 9.2 31.3 27.1 15.3 12.0 12.5 12.2 27.5 10.4 5.0 8.4 12.4 10.5 22.7 23.3 9.4 8.0 8.9 11.1 8.1 28.0 9.4 27.0 11.6 21.5 29.7 18.3 8.6 15.0 10.1 14.4 15.6 12.6 9.2 8.6 6.0 13.8 22.8 0.0 7.8 16.9 20.9 9.7 38.1 8.6 16.1 11.2 KIAA0319 NMIG ENSG00000137261 KIAA0319 Q5VV43 6 24544104-24646155 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 23.5" "Group enriched" "Detected in some" 5 "Early spermatids: 57.8;Late spermatids: 47.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 1.4;neutrophil: 5.0" "Group enriched" "Detected in many" 32 "B-cells: 1.4;granulocytes: 5.0" "Cell line enhanced" "Detected in some" "A549: 4.1;GAMG: 4.3;HDLM-2: 4.8;SCLC-21H: 7.8;U-266/84: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015607, HPA076313" Enhanced Supported Approved Vesicles "Secreted in brain" NA NA Vesicles "HPA015607: AB_1852299, HPA076313: AB_2732308" "unprognostic (1.64e-1)" "unprognostic (2.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (1.77e-1)" "unprognostic (1.72e-2)" "unprognostic (4.65e-2)" "unprognostic (9.70e-2)" "unprognostic (2.21e-5)" "unprognostic (7.88e-4)" "unprognostic (9.53e-4)" "unprognostic (1.44e-6)" "unprognostic (1.20e-1)" "unprognostic (6.97e-2)" "unprognostic (3.13e-1)" "unprognostic (3.41e-2)" 0.9 1.9 9.9 1.3 10.2 0.9 1.1 10.7 23.5 0.9 1.6 4.0 0.0 0.9 0.9 0.9 0.8 4.8 1.4 0.8 9.7 7.7 0.9 0.8 2.2 0.9 5.8 12.1 0.8 3.0 0.8 3.8 1.1 10.2 1.7 1.7 0.0 0.8 0.9 0.8 2.4 1.1 1.1 1.4 1.1 3.2 3.5 2.3 0.0 0.8 0.0 1.1 0.9 0.1 1.4 0.0 5.0 0.0 0.0 0.0 0.0 3.6 4.1 0.2 2.6 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 1.5 1.1 2.0 0.0 4.3 1.7 0.7 0.0 0.0 4.8 1.8 0.0 3.5 0.2 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.3 0.0 1.9 0.0 0.2 0.0 1.2 0.1 0.0 0.5 0.2 0.3 0.2 0.0 0.8 0.1 0.2 7.8 0.5 0.1 2.2 0.0 0.1 0.8 0.0 0.0 0.0 0.6 0.4 0.8 0.6 6.3 0.3 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 9.9 10.2 10.7 14.9 9.7 7.7 5.8 12.1 10.2 2.3 3.0 0.3 0.0 0.0 0.0 1.8 1.2 0.0 10.7 2.3 0.0 0.0 0.0 0.0 0.2 57.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.8 0.0 0.0 47.2 0.6 0.0 0.0 1.0 0.7 0.2 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.9 1.4 0.0 0.6 0.0 0.3 0.2 KIAA0319L "AAVR, KIAA1837" ENSG00000142687 "KIAA0319 like" Q8IZA0 1 35433490-35557950 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 27.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072692 Supported Supported "Nucleoli,Golgi apparatus" NA NA 870000 "Golgi apparatus" Nucleoli "HPA072692: AB_2686549" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (4.23e-3)" "unprognostic (1.75e-1)" "unprognostic (1.30e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.92e-5)" "unprognostic (3.41e-3)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (2.05e-2)" "unprognostic (3.79e-1)" "prognostic favorable (1.27e-4)" "unprognostic (1.47e-1)" "unprognostic (1.26e-1)" "unprognostic (5.44e-2)" "unprognostic (1.84e-1)" 10.6 23.5 20.3 10.6 29.0 9.9 20.1 21.9 37.2 19.2 17.7 24.1 17.0 18.1 19.7 19.2 14.4 25.1 15.7 30.7 19.4 20.0 27.5 32.1 21.3 11.0 19.4 20.1 13.0 32.8 38.5 28.1 21.1 23.0 25.3 21.3 24.5 33.9 20.5 27.4 13.8 19.8 12.7 16.6 17.1 23.3 14.0 17.5 11.9 29.3 11.9 17.4 12.9 12.0 2.3 3.2 27.1 11.0 5.5 3.5 4.5 5.4 8.1 16.9 13.3 23.0 16.2 16.1 7.4 15.9 10.9 16.2 8.7 22.2 6.1 20.6 8.1 16.3 10.9 12.5 12.0 12.5 9.7 9.1 8.3 9.9 9.6 18.0 6.8 11.4 22.8 15.5 12.5 16.4 36.2 17.7 7.6 10.8 8.9 14.7 5.5 4.0 5.8 19.2 15.3 4.9 4.6 14.4 7.6 18.0 13.4 3.7 10.5 10.8 13.0 22.2 38.9 13.6 9.7 18.1 7.5 8.1 6.3 11.5 13.3 10.6 4.0 19.1 9.0 7.4 4.5 11.0 5.0 3.0 3.6 2.9 2.0 2.5 2.8 3.2 2.3 3.5 2.5 27.1 5.5 2.2 2.1 2.3 4.5 20.3 29.0 21.9 37.2 19.4 20.0 19.4 20.1 23.0 17.5 68.5 67.8 11.2 13.5 7.0 71.9 47.3 48.4 52.2 52.4 33.2 102.1 26.5 3.3 15.2 7.8 22.2 31.6 0.0 28.2 18.9 16.7 25.7 20.8 40.4 16.3 60.4 20.7 21.5 29.5 4.9 16.1 17.1 13.5 11.8 53.3 28.9 26.4 24.6 16.3 17.3 62.2 6.5 8.2 21.2 17.7 8.2 26.1 17.3 28.1 10.8 KIAA1024 ENSG00000169330 KIAA1024 Q9UPX6 15 79432516-79472290 "Predicted membrane proteins" Angiogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 16.8;brain: 10.8" "Group enriched" "Detected in some" 12 "Horizontal cells: 15.9;Muller glia cells: 22.6" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in many" 5 "cerebellum: 10.8;pons and medulla: 8.5" "Group enriched" "Detected in some" 12 "eosinophil: 2.5;non-classical monocyte: 1.9" "Group enriched" "Detected in many" 12 "granulocytes: 2.5;monocytes: 1.9" "Cell line enhanced" "Detected in many" "U-138 MG: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011545 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA011545: AB_1852361" "unprognostic (5.45e-5)" "unprognostic (3.26e-1)" "unprognostic (4.56e-3)" "unprognostic (2.12e-2)" "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (4.49e-2)" "unprognostic (5.66e-2)" "unprognostic (2.90e-1)" "unprognostic (3.16e-1)" "unprognostic (1.96e-1)" "unprognostic (4.45e-2)" "unprognostic (6.66e-13)" "unprognostic (7.08e-2)" "unprognostic (2.73e-2)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" 0.1 16.8 0.8 0.2 0.6 0.7 0.5 10.8 2.0 0.6 0.2 0.4 0.1 0.0 0.4 0.5 0.5 0.1 0.6 0.1 0.5 1.4 0.2 0.1 0.1 0.6 1.2 1.5 0.2 3.5 0.0 0.7 0.5 8.5 1.2 0.3 0.7 4.2 0.2 0.6 0.2 0.2 0.2 1.7 0.3 0.2 1.1 1.0 0.1 0.2 0.1 0.4 0.2 0.1 0.1 0.1 2.5 1.9 0.0 0.1 0.0 0.4 0.3 0.6 0.8 1.8 1.7 0.7 0.9 1.5 0.7 0.8 0.0 0.4 1.1 0.2 1.3 1.0 0.3 1.5 0.1 0.5 1.3 1.7 3.0 0.7 0.0 1.0 4.1 1.5 0.7 0.3 1.2 0.2 1.5 0.8 1.4 0.2 0.0 0.3 0.0 0.6 1.5 0.7 0.7 0.7 0.6 0.2 0.6 0.2 0.0 3.1 1.6 0.3 2.7 1.6 1.3 0.4 2.0 0.5 14.5 0.5 0.0 3.0 1.8 2.1 0.5 1.4 2.3 1.7 0.0 0.0 2.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.8 0.6 10.8 2.0 0.5 1.4 1.2 1.5 8.5 1.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.3 1.5 0.0 0.0 0.0 0.4 0.1 0.3 0.3 0.0 0.0 0.1 15.9 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 22.6 0.3 0.6 0.0 0.0 0.5 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.1 KIAA1024L ENSG00000186367 "KIAA1024 like" P59773 5 129748079-129766732 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 26.0" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 1.5;Melanocytes: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SH-SY5Y: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA013760 Uncertain NA NA "HPA013760: AB_1852363" "unprognostic (1.77e-1)" "unprognostic (5.13e-1)" 0.0 0.0 0.1 0.0 0.9 0.1 0.1 0.0 2.8 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.1 2.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.0 26.0 0.0 0.0 0.0 0.3 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 2.8 4.1 1.1 0.8 0.8 0.1 0.6 0.1 0.1 1.9 0.2 0.1 0.5 0.3 0.2 0.3 0.4 0.1 3.1 1.0 1.3 0.2 0.1 1.7 0.0 0.3 0.2 1.6 1.3 0.5 0.7 0.9 0.0 0.2 1.4 0.6 0.4 0.1 0.4 0.1 0.2 0.8 0.4 2.1 0.5 0.4 1.5 1.7 1.2 0.2 1.6 0.3 0.5 0.6 0.5 0.9 0.8 4.7 0.2 3.1 0.5 0.3 1.3 0.4 0.2 1.6 1.2 0.9 0.3 0.2 0.8 0.5 1.3 0.1 2.5 4.1 1.1 0.6 0.8 0.6 0.8 0.6 0.6 0.5 0.3 1.6 0.6 0.8 2.6 0.8 1.0 2.8 0.3 0.1 0.1 0.9 0.0 2.8 0.1 2.0 0.3 0.0 1.9 0.0 0.0 0.3 0.0 1.5 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.4 KIAA1109 "FLJ21404, FSA, KIAA1371, Tweek" ENSG00000138688 KIAA1109 Q2LD37 4 122152333-122362758 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Rod photoreceptor cells: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038076 Approved Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA038076: AB_10670652" "unprognostic (2.53e-1)" "unprognostic (2.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.63e-3)" "unprognostic (1.04e-1)" "unprognostic (6.62e-2)" "unprognostic (7.61e-2)" "unprognostic (3.65e-2)" "unprognostic (2.38e-1)" "unprognostic (7.97e-2)" "prognostic favorable (4.33e-8)" "unprognostic (2.04e-1)" "unprognostic (3.55e-1)" "unprognostic (2.28e-2)" "unprognostic (2.29e-2)" 18.4 17.1 25.6 18.0 34.1 42.9 26.1 33.4 34.2 22.9 18.7 24.1 17.9 15.6 20.9 25.4 12.3 16.8 16.4 15.3 25.5 22.0 24.0 17.4 19.5 14.8 26.4 26.2 34.3 16.6 68.2 33.1 14.3 33.6 19.1 18.8 22.6 16.6 21.5 40.1 23.1 20.8 18.6 29.3 20.0 15.2 20.4 24.2 15.3 25.4 12.6 13.6 18.0 18.5 3.1 2.3 7.7 3.6 1.7 3.5 0.7 16.4 5.4 12.5 8.3 21.0 27.3 6.5 7.5 14.1 7.7 8.5 4.0 8.7 8.7 4.4 17.6 10.4 6.2 7.7 9.2 12.6 6.5 4.9 9.5 9.8 7.4 10.9 8.9 5.3 15.7 11.1 9.2 12.8 21.1 16.4 9.4 6.2 10.5 15.8 5.5 7.7 7.0 4.2 7.9 5.9 4.4 17.5 2.2 13.6 12.4 7.4 6.6 4.7 5.4 10.5 21.2 5.9 7.3 21.9 9.6 9.6 7.9 7.6 10.2 6.5 6.3 10.2 7.9 7.0 3.3 1.4 7.7 3.3 3.6 3.5 2.5 2.3 2.3 1.4 3.1 2.0 2.3 6.6 1.7 1.7 2.3 2.9 0.7 25.6 34.1 33.4 34.2 25.5 22.0 26.4 26.2 33.6 24.2 80.4 33.9 13.7 17.7 18.5 114.9 62.7 7.6 37.5 44.3 40.1 117.8 8.9 1.7 11.4 26.6 33.8 40.9 23.3 15.1 5.7 21.1 21.2 20.8 21.5 11.1 87.4 20.7 36.2 31.0 20.3 47.5 20.1 15.1 17.2 25.2 59.6 17.8 25.9 47.7 10.5 143.8 32.3 29.9 49.5 31.9 21.3 10.9 32.4 23.9 23.0 KIAA1324 "EIG121, maba1" ENSG00000116299 KIAA1324 Q6UXG2 1 109113679-109206781 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 79.8;salivary gland: 169.4" "Cell type enhanced" "Detected in many" 9 "Glandular cells: 98.1;Intestinal endocrine cells: 156.4;Mucus-secreting cells: 151.0;Undifferentiated cells: 73.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 7 "neutrophil: 33.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 33.8" "Cell line enhanced" "Detected in some" "MCF7: 14.5;SCLC-21H: 9.3;SK-BR-3: 11.3;T-47d: 38.6;U-87 MG: 7.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA029869, HPA070749" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA029869: AB_10794320, HPA070749: AB_2686304" "unprognostic (2.10e-1)" "unprognostic (1.42e-2)" "unprognostic (1.99e-2)" "prognostic favorable (2.14e-7)" "unprognostic (4.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-3)" "prognostic favorable (5.69e-5)" "unprognostic (2.79e-2)" "prognostic favorable (2.16e-4)" "unprognostic (3.50e-3)" "unprognostic (1.01e-1)" "unprognostic (2.22e-16)" "unprognostic (2.46e-1)" "unprognostic (1.75e-1)" "unprognostic (5.64e-2)" "unprognostic (8.02e-2)" 0.7 0.9 3.7 3.6 7.9 0.0 16.4 0.7 5.6 23.9 11.8 0.4 0.0 14.6 5.5 5.7 1.3 7.8 19.1 0.6 3.3 2.3 0.6 0.6 2.2 0.7 1.0 2.7 1.2 79.8 6.1 46.6 0.0 1.1 15.8 10.0 0.0 169.4 0.0 0.6 2.5 16.5 0.2 0.9 0.9 27.3 9.4 1.1 0.0 3.9 5.2 11.5 0.9 0.6 0.2 0.0 33.8 0.0 0.2 4.6 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.8 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.3 14.5 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.5 0.2 0.0 9.3 0.2 0.0 11.3 0.0 0.0 38.6 0.0 0.2 0.0 1.4 0.0 0.1 0.8 2.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 2.2 0.0 3.9 0.2 3.9 1.7 0.0 0.0 1.8 0.7 33.8 0.2 0.0 0.0 4.6 1.0 3.7 7.9 0.7 5.6 3.3 2.3 1.0 2.7 1.1 1.1 14.9 43.1 0.0 6.2 0.5 5.1 1.5 0.0 34.8 62.6 0.0 3.9 0.5 0.0 0.9 32.7 0.5 13.1 0.0 33.1 0.6 1.6 98.1 22.1 0.0 0.9 1.6 156.4 1.3 1.6 12.3 4.0 2.3 3.3 0.0 151.0 1.4 16.5 24.6 2.1 0.0 2.6 0.0 1.4 13.7 1.7 1.4 0.5 4.4 73.4 8.3 KIAA1324L "EIG121L, FLJ31340" ENSG00000164659 "KIAA1324 like" A8MWY0 7 86876906-87059699 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.9" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 73.9;Early spermatids: 53.7;Horizontal cells: 31.8;Late spermatids: 70.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.8" "Group enriched" "Detected in many" 5 "B-cells: 2.7;NK-cells: 4.8;T-cells: 5.8" "Cell line enhanced" "Detected in many" "AF22: 15.4;hTERT-HME1: 17.9;HUVEC TERT2: 15.0;K-562: 23.0;SCLC-21H: 19.1;SuSa: 17.5;TIME: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044527, HPA076093" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044527: AB_10963793, HPA076093: AB_2686776" "unprognostic (2.78e-2)" "unprognostic (9.37e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-4)" "unprognostic (3.79e-1)" "unprognostic (4.00e-2)" "unprognostic (1.33e-3)" "unprognostic (1.89e-1)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (6.82e-2)" "unprognostic (8.82e-3)" "unprognostic (3.86e-3)" "unprognostic (1.25e-1)" "unprognostic (4.32e-1)" "unprognostic (1.37e-1)" 11.1 4.5 7.7 2.3 17.3 1.0 6.5 15.6 15.8 4.0 5.0 28.9 1.2 1.8 4.3 1.0 4.5 3.9 5.0 5.5 10.8 8.7 2.9 1.5 24.4 3.8 22.4 10.4 2.7 5.5 11.7 13.5 9.0 22.7 7.6 6.5 2.4 3.6 6.3 3.5 3.4 2.7 6.4 23.5 6.4 4.1 3.6 21.7 0.0 6.1 1.0 4.0 5.9 2.8 2.7 0.9 0.4 0.0 4.8 5.8 0.7 0.9 0.0 15.4 0.0 0.2 0.0 4.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 3.8 0.3 0.1 0.0 1.6 0.0 0.0 3.7 0.3 11.8 4.1 1.3 0.1 0.1 1.5 1.2 0.0 0.0 17.9 0.1 15.0 5.8 23.0 0.4 1.7 4.7 0.3 0.0 8.4 0.0 3.8 0.0 1.0 2.4 1.6 6.8 19.1 14.3 4.1 5.4 1.7 17.5 1.6 0.3 17.6 0.2 6.0 0.1 0.0 8.5 5.0 0.1 4.5 0.0 0.2 0.0 0.0 0.4 0.7 0.0 5.8 0.9 2.1 1.3 0.4 2.7 2.2 1.2 0.0 4.8 0.0 0.9 0.7 0.7 7.7 17.3 15.6 15.8 10.8 8.7 22.4 10.4 22.7 21.7 11.9 73.9 0.0 1.4 1.0 11.6 2.0 0.0 6.7 3.4 3.5 9.8 0.4 3.3 1.3 53.7 10.0 1.7 0.0 1.0 0.4 3.1 3.6 2.3 0.0 0.3 31.8 8.1 0.6 0.8 70.4 2.3 1.6 0.0 0.0 2.7 1.1 1.0 1.9 2.1 0.7 3.2 6.5 6.2 0.7 2.1 1.4 0.1 0.7 2.6 1.4 KIAA1549 ENSG00000122778 KIAA1549 Q9HCM3 7 138831381-138981318 "Disease related genes, Predicted membrane proteins" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 27.5;seminal vesicle: 39.0" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.2;neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "PC-3: 20.4;SH-SY5Y: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019560 Uncertain Approved "Nuclear membrane,Intermediate filaments" NA NA "Nuclear membrane" "Intermediate filaments" "HPA019560: AB_1852418" "unprognostic (7.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.63e-1)" "unprognostic (6.85e-2)" "unprognostic (2.29e-1)" "unprognostic (8.86e-2)" "unprognostic (2.55e-2)" "unprognostic (6.40e-2)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (2.33e-2)" "unprognostic (8.30e-2)" "prognostic favorable (3.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "unprognostic (2.38e-1)" "unprognostic (1.28e-2)" 2.1 3.2 3.3 0.6 4.4 0.6 2.9 1.2 8.3 2.7 1.8 1.6 27.5 1.5 3.7 4.1 1.4 4.9 2.5 1.9 3.1 2.0 8.0 1.5 4.7 0.3 1.6 3.8 2.6 12.9 6.5 3.6 4.6 3.7 3.1 1.5 2.0 4.4 39.0 1.4 2.6 1.8 2.9 3.3 1.2 3.0 2.9 1.2 3.1 2.2 0.1 0.4 3.8 4.4 0.3 0.1 1.5 0.1 0.3 0.2 0.0 5.1 9.7 8.6 15.0 0.1 0.0 5.0 5.2 4.7 3.0 3.9 9.0 3.1 0.0 3.2 7.9 9.3 1.0 5.3 1.5 3.7 2.4 3.3 2.4 10.4 2.3 1.3 3.7 3.5 1.3 2.4 1.1 1.6 2.9 5.0 3.4 1.9 0.1 3.4 4.8 2.6 3.6 8.1 3.7 20.4 7.2 4.4 0.0 1.5 3.1 11.4 19.5 2.8 5.2 2.3 5.2 4.3 2.3 3.2 3.1 3.2 0.0 4.9 0.7 0.0 0.2 4.1 1.5 7.2 1.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.5 0.3 0.1 0.1 0.0 0.0 3.3 4.4 1.2 8.3 3.1 2.0 1.6 3.8 3.7 1.2 0.0 2.1 0.0 2.1 0.5 13.5 2.2 0.0 9.4 3.4 7.0 53.0 2.1 0.0 2.3 0.3 4.5 0.1 0.0 2.8 1.9 2.1 3.0 16.1 0.5 0.4 3.2 10.4 1.8 1.0 0.0 1.4 0.2 1.7 0.0 2.0 7.7 4.7 0.6 2.5 6.9 26.7 6.5 1.6 0.0 7.7 0.6 1.3 1.0 1.5 1.4 KIAA1549L "C11orf41, C11orf69, G2, MGC34830" ENSG00000110427 "KIAA1549 like" Q6ZVL6 11 33376466-33674102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 30.4;parathyroid gland: 64.4" "Cell type enriched" "Detected in some" 4 "Melanocytes: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 23.0;U-138 MG: 30.4;WM-115: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010132, HPA051594" Approved Nucleoplasm,Vesicles NA NA 27000 Nucleoplasm Vesicles "HPA010132: AB_1078313, HPA051594: " "unprognostic (3.02e-1)" "unprognostic (1.18e-1)" "unprognostic (2.70e-2)" "unprognostic (1.34e-5)" "unprognostic (2.63e-1)" "unprognostic (7.92e-2)" "unprognostic (2.89e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-2)" "unprognostic (2.59e-4)" "unprognostic (8.88e-2)" "unprognostic (1.44e-1)" "unprognostic (3.62e-3)" "unprognostic (1.08e-3)" "unprognostic (8.46e-2)" "unprognostic (4.04e-1)" "unprognostic (1.09e-1)" 0.8 0.9 8.2 0.7 20.5 0.6 1.2 6.2 30.4 0.7 0.7 1.7 0.0 0.6 0.7 0.6 0.9 0.6 0.8 0.6 5.3 2.4 0.9 0.6 0.6 0.7 1.6 17.1 0.7 0.8 64.4 1.0 1.4 2.3 0.7 0.7 0.0 0.7 0.6 0.6 1.9 0.6 0.7 1.1 0.6 0.7 1.3 1.6 0.0 0.6 0.0 1.1 0.9 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 3.3 0.1 0.5 3.7 0.0 13.3 7.8 2.1 1.2 0.0 0.3 10.2 0.1 11.7 10.2 0.7 0.4 3.8 3.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.3 5.8 7.6 9.5 0.2 0.0 9.7 8.3 0.0 0.1 0.0 0.7 0.0 4.9 0.0 0.8 0.0 0.0 5.1 1.1 1.2 0.1 0.0 3.2 0.1 0.0 0.0 23.0 30.4 6.4 0.7 10.6 0.0 0.0 0.0 8.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.2 20.5 6.2 30.4 5.3 2.4 1.6 17.1 2.3 1.6 0.0 0.0 0.0 0.3 1.8 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.6 0.4 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.3 3.2 0.0 1.8 0.0 0.4 0.0 0.2 16.9 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.3 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.5 KIAA2013 "MGC33867, RP5-1077B9.1" ENSG00000116685 KIAA2013 Q8IYS2 1 11919591-11926428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Enterocytes: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052677, HPA060536" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA052677: AB_2681911, HPA060536: AB_2684313" "unprognostic (3.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.63e-2)" "unprognostic (1.48e-1)" "unprognostic (2.02e-2)" "unprognostic (1.87e-2)" "unprognostic (5.51e-3)" "unprognostic (8.60e-2)" "unprognostic (5.26e-2)" "unprognostic (2.92e-1)" "unprognostic (1.10e-2)" "unprognostic (5.04e-2)" "unprognostic (6.05e-2)" "unprognostic (2.04e-2)" "unprognostic (2.94e-2)" "unprognostic (8.24e-3)" "unprognostic (3.74e-3)" 13.8 13.9 12.0 10.6 16.7 10.9 12.9 11.9 18.7 13.7 32.0 25.2 16.7 42.6 19.1 24.9 15.4 14.7 19.7 18.9 12.5 10.8 17.1 34.4 12.4 12.6 22.8 10.6 12.2 34.0 9.6 17.7 24.6 16.1 15.1 13.5 14.8 26.2 18.6 24.4 18.6 55.1 14.4 16.0 19.2 16.0 21.7 19.0 15.0 19.8 11.2 14.1 17.4 13.1 7.0 10.8 13.8 6.3 4.6 6.3 3.0 23.7 17.7 8.3 16.4 14.2 9.8 13.8 15.2 16.1 18.5 19.2 21.8 24.8 15.7 23.4 14.4 14.4 27.8 11.2 15.0 9.9 18.0 28.8 10.7 16.4 37.2 16.1 22.2 22.2 12.4 16.8 18.0 8.0 20.1 17.6 12.6 16.4 20.9 11.0 18.0 14.1 31.3 10.9 10.6 24.5 18.1 15.3 37.8 11.7 6.5 31.2 17.6 12.3 13.8 29.0 8.7 11.6 20.8 16.8 15.6 20.5 22.9 20.6 25.3 17.8 17.8 18.6 36.2 16.5 4.2 6.3 6.1 6.2 5.3 4.9 6.1 3.4 4.7 4.3 7.0 3.4 4.5 13.8 4.6 4.2 10.8 6.3 3.0 12.0 16.7 11.9 18.7 12.5 10.8 22.8 10.6 16.1 19.0 20.8 11.2 32.1 8.7 19.7 20.2 16.9 25.5 13.4 9.1 24.4 11.8 15.2 3.3 14.9 19.3 18.7 101.7 23.3 16.5 23.6 14.4 15.6 12.7 63.7 23.1 30.2 39.3 30.1 29.1 27.2 21.0 21.6 18.6 9.0 52.1 20.8 20.2 63.3 21.5 21.4 21.4 19.4 12.0 21.8 10.0 24.6 11.1 17.8 48.7 16.6 KIDINS220 ARMS ENSG00000134313 "Kinase D interacting substrate 220" Q9ULH0 2 8721081-8837630 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014790 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA014790: AB_1852460" "unprognostic (3.58e-1)" "unprognostic (1.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.78e-3)" "unprognostic (2.05e-1)" "unprognostic (2.01e-1)" "unprognostic (1.33e-2)" "prognostic favorable (9.64e-4)" "unprognostic (1.68e-1)" "unprognostic (9.21e-2)" "unprognostic (9.74e-2)" "unprognostic (7.39e-2)" "prognostic favorable (9.29e-6)" "unprognostic (4.12e-2)" "unprognostic (1.47e-1)" "unprognostic (9.27e-2)" "unprognostic (1.15e-1)" 16.5 16.4 21.6 9.4 26.9 14.7 14.7 35.3 30.3 16.9 17.2 21.9 7.2 7.8 23.2 11.2 13.0 15.7 12.3 14.7 16.6 8.1 16.0 10.7 16.1 8.2 25.6 15.9 27.5 12.8 45.8 20.2 14.5 25.5 14.5 11.7 11.1 14.8 13.3 17.4 12.7 11.6 17.5 30.3 11.1 14.0 7.1 24.3 11.2 14.9 6.3 8.3 19.6 16.7 3.6 5.1 10.0 8.1 5.7 7.2 3.7 7.1 11.6 23.2 14.8 29.3 19.4 12.2 14.3 11.8 9.1 8.5 11.5 7.4 13.5 14.6 21.3 17.6 12.3 20.8 8.8 13.5 19.3 14.1 12.0 9.0 12.1 20.7 12.4 16.7 20.1 13.9 14.5 19.0 14.1 14.2 11.8 23.4 16.9 16.1 7.9 12.6 6.7 12.6 11.9 10.3 12.1 17.1 6.7 12.1 13.8 19.7 33.2 11.3 11.4 12.8 12.7 7.3 14.3 18.7 20.3 10.7 20.2 15.3 12.5 10.9 18.3 11.8 16.8 15.4 7.4 6.2 7.5 7.2 7.4 5.4 3.6 5.3 6.0 5.1 3.6 5.5 6.1 10.0 5.7 8.1 3.4 4.3 3.7 21.6 26.9 35.3 30.3 16.6 8.1 25.6 15.9 25.5 24.3 92.3 90.8 17.1 22.8 29.1 86.9 34.8 17.8 34.8 60.3 27.9 131.6 14.0 0.0 28.3 1.0 42.5 22.2 46.7 20.3 8.6 44.1 27.7 33.6 26.8 24.5 146.2 41.6 47.9 43.5 3.9 64.5 42.8 23.6 19.0 21.7 76.6 23.5 27.7 61.5 10.9 56.2 6.5 32.3 23.7 25.5 25.7 9.2 27.4 21.8 32.3 KIR2DL1 "47.11, CD158A, cl-42, nkat1, p58.1" ENSG00000125498 "Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1" P43626 19 54769811-54784322 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.8;lung: 4.0;lymphoid tissue: 4.5" "Cell type enhanced" "Detected in some" 30 "Alveolar cells type 2: 4.5;granulocytes: 2.3;T-cells: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Cell line enriched" "Detected in single" 26 "U-266/84: 2.5" NA NA "unprognostic (2.14e-1)" "unprognostic (9.82e-2)" "unprognostic (8.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.93e-1)" "unprognostic (1.55e-2)" "unprognostic (3.19e-4)" "unprognostic (4.11e-2)" "unprognostic (6.87e-2)" "unprognostic (1.14e-2)" "unprognostic (1.13e-1)" "unprognostic (6.84e-2)" "unprognostic (3.61e-2)" 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.6 0.1 0.1 0.0 0.0 0.1 2.8 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 2.2 4.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.8 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.8 4.5 0.4 1.4 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 KIR2DL3 "CD158B2, cl-6, nkat2, nkat2a, nkat2b, p58" ENSG00000243772 "Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3" P43628 19 54738515-54753052 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 3.0;lymphoid tissue: 5.6" "Group enriched" "Detected in some" 42 "Alveolar cells type 2: 2.2;T-cells: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.37e-2)" "unprognostic (2.35e-2)" "unprognostic (2.23e-1)" "unprognostic (6.88e-2)" "unprognostic (2.92e-1)" "unprognostic (7.76e-3)" "unprognostic (1.55e-2)" "unprognostic (1.99e-1)" "unprognostic (1.41e-2)" "unprognostic (2.41e-4)" "unprognostic (1.19e-1)" "unprognostic (1.91e-1)" "unprognostic (1.62e-2)" "unprognostic (1.59e-2)" 0.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.1 2.1 0.1 0.1 0.2 0.1 2.2 0.0 0.0 0.1 0.4 3.0 2.4 0.0 0.0 1.0 0.1 0.1 0.0 0.8 0.1 1.3 0.1 1.1 1.9 0.1 0.1 0.1 0.1 0.1 0.0 5.6 0.1 0.1 0.8 0.6 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 0.0 0.0 KIR2DL4 "103AS, 15.212, CD158D" ENSG00000189013 "Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4" Q99706 19 54803535-54814517 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 5.6;intestine: 7.3;lymphoid tissue: 13.9" "Cell type enhanced" "Detected in some" 26 "Alveolar cells type 2: 3.4;Collecting duct cells: 1.8;granulocytes: 2.3;T-cells: 10.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 56 "NK-cell: 5.6" "Lineage enriched" "Detected in single" 56 "NK-cells: 5.6" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.98e-2)" "unprognostic (4.16e-2)" "unprognostic (1.84e-2)" "unprognostic (3.70e-4)" "unprognostic (2.23e-1)" "unprognostic (5.95e-4)" "unprognostic (1.34e-1)" "unprognostic (1.49e-1)" "unprognostic (2.92e-5)" "unprognostic (5.15e-2)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.53e-8)" "unprognostic (6.47e-2)" "unprognostic (2.66e-1)" "unprognostic (6.10e-4)" "unprognostic (3.59e-3)" 0.2 0.3 0.0 2.8 0.0 0.3 0.1 0.0 0.2 0.1 3.8 0.0 0.0 0.1 1.4 0.2 0.2 0.2 0.3 0.9 0.1 0.0 0.2 0.3 1.2 0.3 0.0 0.0 1.1 0.1 0.1 0.1 1.7 0.0 0.2 0.3 0.0 0.1 0.8 0.1 0.1 7.3 0.1 0.0 13.9 0.3 0.3 0.0 0.4 0.5 0.0 1.5 0.8 0.1 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 KIR3DL1 "AMB11, CD158E1, CD158e1/2, CD158e2, cl-11, cl-2, KIR, nkat3, NKB1, NKB1B" ENSG00000167633 "Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1" P43629 19 54816468-54830778 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.4;bone marrow: 2.0;lymphoid tissue: 3.0" "Group enriched" "Detected in some" 9 "Alveolar cells type 2: 3.4;granulocytes: 1.1;T-cells: 4.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "gdT-cell: 5.4" "Lineage enriched" "Detected in many" 4 "T-cells: 5.4" "Not detected" "Not detected" NA NA "unprognostic (3.18e-1)" "unprognostic (8.01e-2)" "unprognostic (3.53e-2)" "unprognostic (4.85e-1)" "unprognostic (5.18e-3)" "unprognostic (6.19e-2)" "unprognostic (4.37e-2)" "unprognostic (9.97e-2)" "unprognostic (1.89e-2)" "unprognostic (3.28e-1)" "unprognostic (7.34e-2)" "unprognostic (2.07e-3)" "unprognostic (3.22e-2)" "unprognostic (2.07e-1)" "unprognostic (1.73e-1)" "unprognostic (2.19e-2)" 0.1 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 5.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.5 0.0 3.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 KIR3DL2 "CD158K, cl-5, nkat4, nkat4a, nkat4b" ENSG00000240403 "Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2" P43630 19 54850443-54867207 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 2.0;lymphoid tissue: 5.3;salivary gland: 2.0" "Cell type enriched" "Detected in some" 4 "T-cells: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Not detected" "Not detected" NA NA "unprognostic (6.99e-2)" "unprognostic (1.83e-1)" "unprognostic (3.64e-1)" "unprognostic (4.56e-4)" "unprognostic (1.40e-1)" "unprognostic (2.99e-2)" "unprognostic (8.39e-3)" "unprognostic (5.96e-2)" "unprognostic (2.73e-1)" "unprognostic (2.12e-1)" "unprognostic (4.04e-3)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.65e-3)" "unprognostic (3.62e-2)" 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.8 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 KIR3DL3 "CD158z, KIR3DL7, KIR44, KIRC1" ENSG00000242019 "Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3" 19 54724479-54736536 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.14e-2)" "unprognostic (2.79e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KIRREL1 "KIRREL, NEPH1" ENSG00000183853 "Kirre like nephrin family adhesion molecule 1" Q96J84 1 157993273-158100262 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 17.9;Ductal cells: 4.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "WM-115: 75.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030458 Approved NA NA 590000 "HPA030458: AB_10601438" "unprognostic (8.92e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (3.76e-1)" "unprognostic (1.07e-3)" "unprognostic (7.96e-3)" "unprognostic (3.62e-2)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (4.48e-2)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.12e-8)" "unprognostic (2.11e-3)" "unprognostic (5.24e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (2.85e-4)" 27.8 11.6 1.9 9.4 2.5 0.0 27.0 1.4 2.2 21.8 12.1 2.1 9.5 2.8 28.8 10.4 12.2 14.3 18.0 9.5 1.5 2.5 12.4 4.1 13.2 9.2 2.2 2.2 32.6 3.7 2.7 4.5 20.4 4.6 14.0 5.5 23.5 6.8 12.8 7.2 6.0 6.6 20.9 2.2 11.9 6.8 10.9 1.3 5.1 11.4 8.5 6.1 17.3 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 9.7 17.3 15.6 24.8 21.7 0.0 17.4 23.0 14.2 11.5 17.3 13.8 0.0 29.7 19.3 10.1 12.8 9.7 15.8 11.2 0.0 2.1 0.0 9.9 0.0 18.4 0.0 0.2 27.9 6.4 24.0 18.7 18.1 8.9 4.3 0.1 0.0 13.0 0.0 2.4 0.0 13.6 0.0 7.6 2.7 8.1 0.1 40.1 0.2 2.7 0.1 15.0 0.0 32.2 18.7 1.3 0.3 16.4 19.0 12.1 18.6 23.2 0.0 0.0 0.0 16.3 0.0 75.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.5 1.4 2.2 1.5 2.5 2.2 2.2 4.6 1.3 17.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 4.9 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 KIRREL2 "DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1" ENSG00000126259 "Kirre like nephrin family adhesion molecule 2" Q6UWL6 19 35855861-35867109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "pancreas: 38.5" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 27.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 5 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "HDLM-2: 15.1;HMC-1: 24.4;JURKAT: 14.1;U-937: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA071587, HPA074326" Enhanced Supported "Centriolar satellite" "Intracellular and membrane" NA NA "Centriolar satellite" "HPA071587: AB_2732182, HPA074326: AB_2732251" "unprognostic (1.28e-2)" "unprognostic (1.80e-1)" "unprognostic (3.29e-2)" "unprognostic (3.16e-3)" "unprognostic (2.05e-3)" "unprognostic (2.29e-1)" "unprognostic (2.00e-1)" "unprognostic (1.72e-3)" "unprognostic (3.30e-2)" "unprognostic (5.56e-2)" "unprognostic (4.85e-2)" "unprognostic (2.62e-2)" "unprognostic (2.43e-6)" "unprognostic (1.72e-1)" "unprognostic (4.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.62e-2)" 0.2 0.0 0.4 0.3 0.8 0.0 0.0 0.2 1.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.5 0.2 0.4 0.0 38.5 0.0 0.9 0.1 0.5 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.2 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.4 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.7 0.5 0.0 0.1 0.0 2.6 0.1 2.1 0.0 0.0 15.1 0.0 0.0 0.0 0.2 0.0 0.0 24.4 0.1 0.0 0.0 0.0 0.0 0.0 14.1 0.1 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 3.0 0.9 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.6 1.0 0.2 0.0 0.0 0.0 0.2 0.0 5.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.2 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.8 0.2 1.2 0.7 0.0 0.2 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 27.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 5.3 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 6.8 0.0 0.0 0.0 2.9 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 KIRREL3 "KIAA1867, KIRRE, NEPH2" ENSG00000149571 "Kirre like nephrin family adhesion molecule 3" Q8IZU9 11 126423359-127003460 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 10.9;brain: 28.2" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 7.4;Early spermatids: 2.6;Late spermatids: 10.7" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 10.9" "Lineage enriched" "Detected in single" 12 "dendritic cells: 10.9" "Cell line enhanced" "Detected in some" "BJ: 19.0;BJ hTERT+: 11.2;BJ hTERT+ SV40 Large T+: 7.2;BJ hTERT+ SV40 Large T+ RasG12V: 7.5;fHDF/TERT166: 13.7;U-138 MG: 8.8;U-251 MG: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053324 Enhanced "Intracellular and membrane" NA NA "HPA053324: " "unprognostic (1.92e-1)" "unprognostic (5.29e-2)" "unprognostic (1.06e-1)" "unprognostic (4.72e-2)" "unprognostic (2.50e-2)" "unprognostic (1.09e-1)" "unprognostic (4.49e-3)" "unprognostic (6.23e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (7.05e-3)" "unprognostic (3.81e-2)" "unprognostic (4.06e-6)" "unprognostic (9.91e-3)" "unprognostic (1.15e-1)" "unprognostic (2.76e-2)" "unprognostic (2.92e-1)" 1.2 4.0 12.3 1.9 20.0 1.4 1.0 13.2 28.2 1.5 2.2 23.6 0.0 1.7 1.1 1.0 1.7 1.1 1.4 2.3 9.1 7.2 1.1 1.0 1.0 2.1 7.2 11.7 1.3 1.4 0.9 0.1 1.6 9.9 1.0 1.8 0.6 3.5 3.4 1.0 1.1 1.7 1.9 8.9 2.6 1.5 1.2 12.1 0.0 1.0 0.0 1.9 1.1 0.2 0.0 10.9 0.9 0.0 0.0 0.0 0.0 0.3 2.2 0.1 0.0 0.0 0.1 0.1 19.0 11.2 7.2 7.5 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.5 0.0 0.0 1.4 0.0 3.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 4.5 0.1 0.3 0.3 0.0 0.0 0.9 0.0 0.1 2.1 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 8.8 6.1 3.4 10.4 0.0 0.0 0.0 0.0 0.0 4.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 12.3 20.0 13.2 17.4 9.1 7.2 7.2 11.7 9.9 12.1 0.0 0.0 0.0 0.0 0.0 7.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.0 10.7 0.0 0.0 1.7 0.0 0.1 0.3 0.1 0.3 0.0 0.0 1.5 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.1 KISS1R "AXOR12, GPR54, HOT7T175" ENSG00000116014 "KISS1 receptor" Q969F8 19 917287-921015 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;lymphoid tissue: 12.4" "Cell type enriched" "Detected in some" 18 "Extravillous trophoblasts: 31.2" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;neutrophil: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 10.8;RPMI-8226: 26.3;SCLC-21H: 5.5;SH-SY5Y: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007156, HPA071913" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA007156: , HPA071913: AB_2686471" "unprognostic (1.54e-1)" "unprognostic (3.01e-2)" "unprognostic (9.42e-2)" "unprognostic (2.15e-1)" "unprognostic (8.46e-3)" "unprognostic (9.23e-2)" "unprognostic (1.65e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (7.17e-2)" "prognostic unfavorable (3.33e-6)" "unprognostic (1.87e-1)" "unprognostic (8.09e-3)" "unprognostic (1.05e-1)" "unprognostic (2.05e-2)" 0.2 0.2 2.1 2.1 4.1 0.2 0.3 0.1 4.7 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.1 0.2 0.1 0.1 1.0 6.8 1.4 0.1 0.3 12.4 1.1 0.1 0.4 3.6 0.1 2.0 1.0 0.8 0.2 0.2 0.3 0.3 0.1 0.1 0.1 0.7 0.5 1.0 2.4 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.5 0.1 0.6 0.0 1.8 0.0 0.0 2.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 2.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.8 0.0 0.0 0.2 0.1 0.0 0.4 0.8 0.3 0.7 0.0 26.3 0.0 0.0 5.5 14.7 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.7 0.0 0.0 0.1 2.0 0.6 1.8 0.0 0.0 0.0 0.1 0.0 2.1 4.1 0.1 1.5 1.0 6.8 1.1 0.1 0.8 0.1 0.0 0.0 1.4 0.1 0.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.2 31.2 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.3 1.4 0.0 0.0 0.0 KIT "C-Kit, CD117, PBT, SCFR" ENSG00000157404 "KIT proto-oncogene receptor tyrosine kinase" P10721 4 54657918-54740715 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 65.5" "Group enriched" "Detected in many" 10 "granulocytes: 496.5;Melanocytes: 200.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 12.7;eosinophil: 10.0;NK-cell: 9.7" "Group enriched" "Detected in many" 6 "granulocytes: 12.7;NK-cells: 9.7" "Group enriched" "Detected in some" 13 "HEL: 48.8;HMC-1: 102.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003288, HPA004471, CAB068253, CAB072867, HPA073252" Enhanced Supported Supported "Plasma membrane" NA NA 48000000 "Plasma membrane" "CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589" "unprognostic (1.55e-2)" "unprognostic (1.91e-1)" "unprognostic (4.04e-2)" "unprognostic (8.19e-2)" "unprognostic (3.96e-2)" "unprognostic (2.18e-2)" "unprognostic (2.33e-2)" "unprognostic (1.97e-2)" "unprognostic (3.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.20e-1)" "unprognostic (1.92e-2)" "prognostic favorable (5.63e-4)" "unprognostic (1.34e-3)" "unprognostic (1.87e-1)" "unprognostic (1.29e-2)" "unprognostic (2.30e-1)" 8.1 1.6 9.5 6.6 11.8 3.7 65.5 18.3 12.0 12.1 10.3 6.5 10.2 5.8 8.9 4.2 9.9 2.5 15.5 2.4 36.0 4.4 9.4 1.1 13.8 3.8 3.6 6.0 28.5 2.1 1.3 2.3 6.2 5.7 9.6 10.4 20.7 12.9 6.9 1.3 14.6 8.9 10.2 3.9 3.2 12.8 4.0 4.5 0.4 28.9 4.3 4.9 9.8 12.5 0.0 1.8 12.7 0.9 9.7 1.9 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.6 0.9 2.6 3.2 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.5 0.0 2.2 0.0 1.2 48.8 0.0 0.0 0.0 0.0 102.6 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.6 0.1 0.0 0.0 0.2 0.4 1.4 0.0 0.0 0.1 0.0 0.0 0.0 4.8 1.2 0.4 0.0 0.0 0.0 3.0 0.0 0.5 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 12.7 0.0 10.0 0.1 0.0 1.9 0.0 0.3 0.7 1.8 0.0 0.0 0.0 0.8 9.7 0.9 0.0 0.0 0.1 9.5 11.8 18.3 12.0 36.0 4.4 3.6 6.0 5.7 4.5 6.0 34.8 1.4 1.1 12.7 0.0 0.4 5.1 0.0 5.7 3.5 0.0 0.0 3.3 0.8 0.0 2.4 0.0 0.0 0.0 0.1 1.3 0.5 496.5 0.0 0.3 0.0 5.2 1.8 0.3 0.0 1.1 3.1 200.8 0.0 0.3 2.4 0.0 0.0 0.0 0.6 0.3 0.0 0.5 0.0 8.2 3.3 0.2 2.2 0.3 0.3 KITLG "DFNA69, FPH2, Kitl, KL-1, MGF, SCF, SF, SLF" ENSG00000049130 "KIT ligand" P21583 12 88492793-88580851 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Cell adhesion" "Growth factor" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 66.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 83.5;SK-BR-3: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070395 Approved Approved Vesicles "Intracellular and membrane" NA NA 150000 Vesicles "HPA070395: AB_2686264" "unprognostic (7.13e-2)" "unprognostic (1.90e-1)" "unprognostic (5.00e-2)" "unprognostic (2.05e-1)" "unprognostic (2.70e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (4.01e-4)" "unprognostic (2.22e-3)" "unprognostic (5.61e-3)" "unprognostic (7.89e-2)" "unprognostic (5.47e-3)" "unprognostic (5.03e-2)" "prognostic favorable (5.81e-7)" "unprognostic (7.15e-2)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.54e-2)" 10.1 3.8 7.8 8.0 6.4 0.0 11.2 4.8 11.5 9.6 16.1 2.9 8.5 6.2 11.7 8.7 16.7 4.7 13.9 5.6 8.4 3.9 21.9 2.8 22.9 6.1 3.3 7.7 4.4 5.0 1.9 3.2 10.1 4.0 17.9 15.9 7.8 11.8 14.8 4.8 5.3 9.5 21.0 3.7 2.6 13.0 5.8 2.9 0.7 6.5 5.8 6.6 17.5 17.8 0.0 0.2 0.0 0.5 0.0 0.0 0.0 3.5 1.9 1.8 0.2 7.3 15.6 0.0 21.4 15.4 3.7 1.7 83.5 3.3 0.0 0.6 18.0 4.4 12.9 2.7 4.8 3.5 0.0 2.4 0.0 2.9 0.6 1.1 0.4 0.0 13.5 5.1 11.6 7.0 1.5 4.4 0.0 0.0 0.0 1.6 0.6 0.0 0.0 1.3 4.2 4.8 0.0 3.4 0.0 6.2 1.7 0.5 1.2 5.2 29.2 0.5 1.7 15.0 1.0 2.9 16.9 2.4 19.7 1.7 0.0 0.0 0.0 2.1 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 6.4 4.8 11.5 8.4 3.9 3.3 7.7 4.0 2.9 17.9 28.1 0.0 11.7 11.9 2.2 3.2 2.5 12.0 25.0 66.3 0.0 0.0 1.7 2.6 0.5 19.6 4.5 0.0 15.9 0.1 14.1 7.5 0.0 0.2 0.9 20.6 9.1 3.1 2.9 0.0 13.0 1.8 11.8 0.0 7.5 0.2 9.2 0.0 3.5 1.4 1.1 12.9 20.5 0.0 0.2 4.5 0.0 0.0 9.3 2.6 KL ENSG00000133116 Klotho Q9UEF7 13 33016433-33066145 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Glycosidase, Hormone, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 99.7" "Group enriched" "Detected in many" 6 "prostate cancer: 5.9;renal cancer: 17.8" "Region enhanced" "Detected in some" "pons and medulla: 11.6" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HMC-1: 5.1;SK-BR-3: 9.6" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 510000 "unprognostic (1.32e-1)" "unprognostic (3.10e-1)" "unprognostic (2.35e-1)" "unprognostic (2.73e-3)" "unprognostic (3.37e-1)" "unprognostic (1.15e-4)" "unprognostic (3.06e-2)" "unprognostic (6.50e-2)" "unprognostic (2.22e-2)" "unprognostic (2.60e-1)" "prognostic favorable (4.44e-4)" "unprognostic (9.46e-2)" "prognostic favorable (1.29e-9)" "unprognostic (4.76e-3)" "unprognostic (1.91e-1)" "unprognostic (2.86e-2)" "unprognostic (1.07e-1)" 4.8 0.6 0.8 0.9 4.3 0.1 7.4 0.0 0.8 0.7 2.1 3.3 0.2 1.0 1.0 3.2 0.8 0.7 0.9 0.9 2.4 0.8 64.3 0.2 10.4 0.9 0.5 0.3 0.4 1.6 76.9 0.3 25.5 11.6 3.3 0.4 0.3 0.7 1.0 0.9 0.4 3.2 0.7 0.4 3.1 1.9 0.6 0.3 0.0 1.4 1.3 0.3 1.5 1.1 0.0 0.0 0.0 1.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 9.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.8 4.3 0.0 0.8 2.4 0.8 0.5 0.3 11.6 0.3 0.0 0.3 0.0 0.1 0.1 0.0 0.8 0.0 1.4 1.2 12.2 0.0 0.1 5.0 0.0 1.7 1.8 0.9 0.0 0.0 0.1 0.7 4.4 0.0 0.0 2.1 0.0 15.6 0.0 0.8 0.0 0.3 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.4 99.7 0.0 0.0 0.3 0.5 0.2 0.1 0.1 0.0 0.6 0.1 KLB ENSG00000134962 "Klotho beta" Q86Z14 4 39406853-39451536 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adipose tissue: 17.3;liver: 49.2;pancreas: 21.4" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 12.1;Hepatocytes: 28.7;Intestinal endocrine cells: 16.7;Spermatocytes: 11.1" "Cancer enriched" "Detected in some" 16 "liver cancer: 11.6" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 23 "ASC diff: 6.5;Hep G2: 23.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021136 Uncertain NA NA 290000 "HPA021136: AB_1852616" "unprognostic (1.03e-2)" "unprognostic (1.61e-2)" "unprognostic (4.67e-2)" "unprognostic (2.69e-1)" "unprognostic (4.30e-2)" "unprognostic (7.02e-3)" "unprognostic (2.46e-1)" "unprognostic (9.92e-2)" "unprognostic (6.99e-3)" "unprognostic (4.51e-3)" "unprognostic (3.02e-3)" "unprognostic (8.90e-3)" "unprognostic (1.73e-1)" "unprognostic (5.03e-2)" "unprognostic (4.53e-2)" "unprognostic (3.87e-2)" "unprognostic (3.09e-2)" 17.3 0.0 0.2 1.9 1.0 0.2 3.9 0.4 0.2 0.0 1.6 0.0 0.0 0.2 0.1 0.5 0.3 0.1 1.3 0.5 1.0 0.2 0.1 49.2 1.4 0.5 0.1 0.0 0.2 21.4 0.2 0.2 0.0 0.4 0.0 0.4 0.0 0.3 0.0 0.4 0.5 0.6 0.3 0.0 0.0 1.5 2.5 0.2 0.0 0.1 0.4 0.0 0.3 0.2 0.5 2.5 2.3 0.7 0.4 0.4 0.2 0.0 0.2 0.0 0.0 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 23.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.7 0.2 0.3 0.4 0.2 0.4 0.2 0.2 0.1 0.5 0.2 0.4 2.3 0.4 0.5 2.5 0.1 0.2 0.2 1.0 0.4 0.2 1.0 0.2 0.1 0.0 0.4 0.2 3.0 12.1 0.0 0.9 0.5 2.1 0.9 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.9 5.9 0.3 1.4 0.0 3.7 1.1 0.4 1.0 0.0 28.7 0.2 1.6 16.7 0.0 0.3 1.1 1.4 0.2 1.7 0.0 6.7 0.3 1.4 3.5 0.7 0.8 1.6 0.0 0.0 11.1 0.7 0.6 1.1 0.0 0.6 0.7 KLHDC10 "KIAA0265, slim" ENSG00000128607 "Kelch domain containing 10" Q6PID8 7 130070510-130135720 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020119 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020119: AB_2249467" "unprognostic (2.83e-1)" "unprognostic (6.26e-2)" "unprognostic (1.13e-1)" "unprognostic (8.16e-3)" "unprognostic (3.22e-1)" "unprognostic (1.80e-2)" "unprognostic (5.55e-2)" "unprognostic (8.70e-2)" "unprognostic (7.97e-2)" "unprognostic (1.42e-2)" "unprognostic (8.69e-2)" "unprognostic (2.43e-1)" "unprognostic (1.24e-2)" "unprognostic (8.22e-2)" "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (1.64e-2)" 11.7 18.6 15.5 9.1 21.1 7.2 14.8 27.1 24.1 13.4 12.6 16.9 13.6 11.0 13.4 14.4 13.0 15.5 9.7 14.9 14.2 24.8 21.3 22.8 11.8 7.9 17.0 18.6 15.2 15.3 37.4 25.1 13.6 23.4 13.4 13.0 15.0 10.7 17.1 23.2 13.1 11.7 11.9 14.1 11.0 11.9 35.3 10.2 9.8 18.3 8.9 11.6 9.6 12.3 3.3 1.9 1.8 2.5 0.6 3.4 0.6 11.3 10.6 7.3 40.0 9.7 10.8 3.4 10.8 8.3 8.2 8.6 5.7 8.6 9.6 7.7 9.9 13.8 8.9 11.7 6.9 10.4 7.8 7.0 5.6 11.9 6.7 7.7 10.3 6.9 6.7 11.9 12.7 8.0 10.3 11.5 6.7 27.2 6.1 9.2 9.5 8.9 10.0 1.2 8.3 6.9 7.3 13.8 6.9 11.3 7.8 11.9 9.5 17.4 31.1 8.8 9.4 7.6 7.7 13.0 10.6 4.6 14.1 12.9 8.0 10.4 8.9 22.2 10.0 14.3 0.0 1.8 1.8 2.4 2.5 2.0 1.7 1.7 2.8 1.9 3.3 1.5 2.8 1.6 0.6 1.9 1.6 3.4 0.6 15.5 21.1 27.1 24.1 14.2 24.8 17.0 18.6 23.4 10.2 17.9 13.2 6.0 6.4 20.6 19.5 19.4 33.1 16.0 20.5 33.2 37.3 10.1 3.3 15.5 51.3 15.6 11.8 23.3 20.5 7.9 20.1 11.2 5.8 37.5 10.8 33.4 19.1 32.5 22.9 12.4 14.1 11.7 16.9 13.6 15.5 18.1 18.9 3.5 23.0 23.2 21.6 0.0 10.3 29.7 4.5 25.5 9.4 7.5 18.2 11.5 KLHDC7A FLJ38753 ENSG00000179023 "Kelch domain containing 7A" Q5VTJ3 1 18480982-18486126 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 36.4" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 7.6;Ciliated cells: 6.7;Collecting duct cells: 8.7;Hepatocytes: 5.7;Proximal tubular cells: 8.4" "Cancer enhanced" "Detected in many" "renal cancer: 10.9" "Region enriched" "Detected in single" 4 "pons and medulla: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.3;CAPAN-2: 10.4;EFO-21: 5.4;NTERA-2: 5.8;RPTEC TERT1: 11.9;RT4: 9.4;T-47d: 10.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA056616 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA056616: AB_2683193" "unprognostic (4.63e-1)" "unprognostic (3.74e-2)" "unprognostic (2.18e-1)" "unprognostic (5.25e-2)" "unprognostic (1.68e-3)" "unprognostic (2.02e-1)" "unprognostic (1.31e-2)" "unprognostic (1.80e-3)" "unprognostic (2.94e-2)" "unprognostic (1.91e-1)" "unprognostic (9.01e-2)" "unprognostic (2.79e-1)" "prognostic favorable (7.81e-9)" "unprognostic (4.64e-3)" "unprognostic (1.37e-1)" "unprognostic (3.44e-1)" "prognostic favorable (1.88e-4)" 0.6 0.0 0.0 0.3 0.2 0.0 5.0 0.5 0.5 2.5 0.6 0.7 2.6 0.3 0.0 2.6 1.8 0.8 7.4 0.3 0.0 0.0 36.4 6.9 1.4 0.0 0.1 0.6 0.2 5.7 0.0 0.3 0.3 2.9 0.5 0.7 2.8 2.2 1.2 0.0 0.1 0.4 1.0 0.1 0.0 4.8 0.2 0.0 0.0 1.6 0.3 0.8 5.5 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 5.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.1 10.4 0.0 5.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 1.1 0.0 0.2 0.0 0.0 11.9 9.4 2.9 0.0 0.0 0.8 0.0 1.1 10.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.5 0.5 0.0 0.0 0.1 0.6 2.9 0.0 0.0 2.7 0.0 0.1 0.1 0.0 1.2 7.6 6.7 1.2 8.7 0.0 0.0 1.7 2.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.9 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 KLHL2 MAV ENSG00000109466 "Kelch like family member 2" O95198 4 165207618-165323156 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 10.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051637 Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA051637: " "unprognostic (1.14e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (8.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.56e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (4.42e-2)" "unprognostic (2.06e-1)" "unprognostic (4.67e-1)" "unprognostic (4.88e-2)" "prognostic favorable (3.77e-4)" "unprognostic (4.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-2)" "unprognostic (1.81e-1)" 10.5 11.2 25.1 10.4 36.0 16.4 12.1 9.7 41.6 6.1 5.8 19.6 4.0 5.0 7.0 13.4 15.8 8.9 9.5 5.0 37.2 17.7 13.3 23.8 10.6 9.4 25.7 14.7 3.8 6.6 5.3 18.4 6.9 15.1 7.8 6.5 4.0 16.3 9.7 3.2 4.7 5.6 9.6 25.7 11.1 7.4 5.4 25.0 1.6 11.3 3.4 8.4 10.9 7.2 1.3 1.2 10.8 1.9 0.3 1.6 0.6 8.7 8.1 5.6 5.8 8.7 7.8 6.0 11.9 9.4 6.2 6.7 4.8 6.6 9.1 3.0 6.0 11.0 6.1 9.1 6.3 8.0 14.8 3.5 7.6 7.2 7.5 7.6 7.8 11.1 6.5 18.0 5.6 21.2 10.9 14.8 3.4 3.4 19.2 9.5 3.3 0.2 2.5 3.4 5.0 3.6 3.1 4.2 2.8 11.3 8.5 28.8 4.8 7.5 2.7 7.2 10.9 1.8 8.9 20.4 4.9 10.1 5.6 8.0 12.5 8.7 7.3 6.0 5.6 9.6 1.9 1.4 1.9 0.8 1.4 0.5 0.4 0.6 0.5 1.2 1.3 1.4 1.6 10.8 0.3 1.9 0.7 0.7 0.6 25.1 36.0 9.7 24.7 37.2 17.7 25.7 14.7 15.1 25.0 6.0 14.1 5.6 11.1 5.4 8.3 4.0 7.6 5.3 7.9 21.0 13.7 3.5 23.2 6.7 1.1 13.4 4.1 0.0 11.3 8.3 5.4 10.1 9.2 30.8 7.4 30.2 14.9 17.2 40.5 1.3 3.7 20.7 5.0 4.6 4.7 3.2 8.8 4.8 4.2 14.7 6.4 0.0 6.8 2.1 7.1 6.6 3.1 7.0 3.1 16.1 KLHL31 "bA345L23.2, BKLHD6, KBTBD1" ENSG00000124743 "Kelch like family member 31" Q9H511 6 53647901-53665708 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "heart muscle: 77.7;skeletal muscle: 57.7;tongue: 40.9" "Cell type enriched" "Detected in single" 284 "Cardiomyocytes: 217.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 2.8;SCLC-21H: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.27e-2)" "unprognostic (6.18e-2)" "unprognostic (2.31e-1)" "unprognostic (1.10e-1)" "unprognostic (1.67e-1)" "unprognostic (7.67e-4)" "unprognostic (2.23e-2)" "unprognostic (1.25e-1)" "unprognostic (2.55e-1)" "unprognostic (3.98e-2)" "unprognostic (5.50e-2)" "unprognostic (4.24e-1)" "unprognostic (1.09e-4)" "unprognostic (8.73e-2)" "unprognostic (2.88e-1)" "unprognostic (1.23e-1)" "unprognostic (1.40e-1)" 13.1 0.5 0.1 0.3 0.3 0.0 2.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.2 1.2 1.3 0.6 0.1 77.7 0.2 0.1 0.1 0.2 0.1 0.4 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.6 0.1 0.0 1.6 0.0 57.7 0.6 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.5 40.9 2.2 0.3 0.2 0.7 0.0 0.0 0.1 0.9 0.6 0.0 1.0 0.7 0.2 0.2 0.0 0.0 0.5 0.0 0.2 0.2 0.1 1.2 2.5 0.0 0.2 0.0 0.7 1.9 0.8 0.4 0.1 0.1 1.3 0.4 1.7 1.6 0.1 0.6 0.0 2.1 2.6 0.0 0.5 0.5 0.0 1.4 0.0 0.2 0.0 0.8 0.9 0.0 0.3 1.3 0.8 0.1 2.8 0.1 0.8 0.9 3.7 0.4 0.2 0.6 0.0 0.3 1.2 0.0 0.0 0.1 0.5 0.0 0.2 0.5 0.1 0.0 0.3 2.1 0.1 0.0 0.0 0.0 0.4 0.0 0.6 0.7 0.0 0.2 0.0 0.3 0.2 0.2 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.6 0.3 217.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.2 0.2 0.5 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.7 0.0 0.0 0.4 KLHL5 ENSG00000109790 "Kelch like family member 5" Q96PQ7 4 39045039-39126857 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013958 Approved NA NA "HPA013958: AB_1852590" "unprognostic (6.02e-2)" "unprognostic (3.94e-1)" "unprognostic (3.92e-1)" "unprognostic (7.54e-3)" "unprognostic (5.35e-2)" "unprognostic (3.43e-1)" "unprognostic (2.48e-2)" "unprognostic (3.98e-2)" "unprognostic (2.70e-1)" "unprognostic (1.10e-1)" "unprognostic (6.04e-2)" "unprognostic (2.87e-2)" "unprognostic (1.42e-2)" "unprognostic (1.05e-2)" "unprognostic (2.28e-1)" "unprognostic (1.36e-1)" "unprognostic (3.24e-3)" 24.6 15.0 31.9 21.2 27.6 5.1 33.1 10.4 20.9 11.9 29.5 20.7 15.6 8.1 12.7 9.2 21.3 6.7 15.1 10.1 31.5 25.2 16.4 35.2 14.0 19.6 33.4 11.9 12.5 7.3 7.3 6.4 33.1 18.1 24.4 10.9 6.5 8.1 44.5 6.1 4.6 9.8 32.3 34.2 14.3 10.9 6.9 20.7 6.9 14.0 4.6 23.9 25.7 14.3 7.4 4.1 5.6 5.2 1.8 2.6 1.3 12.5 17.8 9.5 6.9 5.4 14.0 13.8 10.1 74.2 8.5 8.3 14.6 9.2 19.4 12.3 10.3 45.2 0.7 11.6 25.6 10.9 1.9 2.3 8.2 16.8 10.4 46.8 2.4 2.8 17.7 14.4 12.9 32.4 31.5 16.9 3.1 6.2 3.9 20.0 5.3 2.5 4.3 2.9 3.2 17.4 4.6 12.5 0.4 7.3 5.2 0.6 6.9 5.7 1.8 4.9 12.0 4.4 5.1 21.4 22.8 15.6 5.9 12.0 4.5 4.0 17.9 18.5 6.4 5.2 5.6 3.9 0.8 1.4 5.2 2.1 7.4 2.6 1.5 4.1 5.9 2.1 1.0 4.3 1.8 2.3 1.5 0.5 1.3 31.9 27.6 10.4 15.8 31.5 25.2 33.4 11.9 18.1 20.7 14.9 1.4 25.3 7.3 3.3 6.5 3.9 15.3 24.1 29.6 10.4 3.9 0.5 14.9 33.8 2.4 26.3 0.0 0.0 18.5 50.9 10.0 14.8 2.3 27.6 12.6 66.7 1.2 20.3 18.6 5.4 7.5 19.4 16.9 22.6 0.0 9.2 18.6 0.0 13.1 17.9 3.2 0.0 16.5 8.4 4.4 3.0 4.8 7.5 0.0 6.7 KLK4 "EMSP, EMSP1, KLK-L1, PRSS17, PSTS" ENSG00000167749 "Kallikrein related peptidase 4" Q9Y5K2 19 50906352-50910738 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Hydrolase, Protease, Serine protease" "Amelogenesis imperfecta, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "prostate: 79.3" "Cell type enriched" "Detected in some" 23 "Glandular cells: 120.1" "Cancer enriched" "Detected in many" 55 "prostate cancer: 463.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.0;HaCaT: 9.8;OE19: 8.8;SK-BR-3: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA051839 Enhanced "Secreted in male reproductive system" NA NA "HPA051839: AB_2681632" "unprognostic (3.58e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-3)" "unprognostic (1.66e-3)" "unprognostic (3.11e-2)" "unprognostic (4.35e-1)" "unprognostic (3.18e-1)" "unprognostic (6.66e-2)" "unprognostic (9.69e-2)" "unprognostic (8.23e-3)" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (4.20e-3)" "unprognostic (3.27e-3)" "unprognostic (2.21e-2)" "unprognostic (1.64e-2)" "unprognostic (1.34e-1)" 0.2 0.8 0.1 0.3 0.1 0.1 0.7 0.2 0.5 2.0 1.2 0.0 3.8 1.8 1.5 7.7 0.4 0.2 0.1 0.1 0.3 0.2 0.2 0.1 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.5 79.3 0.8 0.2 3.2 2.1 0.7 2.4 1.2 0.6 0.1 0.1 0.3 0.6 0.1 0.0 8.7 0.0 0.0 0.2 0.2 0.1 0.4 0.6 0.1 0.0 0.3 0.0 4.9 2.0 0.2 0.3 0.0 0.0 4.4 0.1 0.0 0.0 0.0 4.5 8.0 0.5 0.4 0.1 0.2 9.8 0.0 5.3 0.0 1.3 1.3 1.5 3.6 1.7 0.0 1.6 2.2 0.0 2.5 0.0 0.0 0.3 0.0 0.4 0.9 4.1 0.0 1.2 0.1 2.4 0.1 8.8 0.4 0.3 0.5 1.1 0.0 3.2 0.0 0.6 0.3 6.3 0.0 0.2 5.1 0.4 1.1 0.3 0.3 1.3 0.3 2.6 1.0 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.5 0.3 0.2 0.2 0.0 0.5 0.1 0.0 0.0 0.0 2.9 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 120.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 1.7 KLK5 "KLK-L2, SCTE" ENSG00000167754 "Kallikrein related peptidase 5" Q9Y337 19 50943303-50953093 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skin 1: 69.2;tongue: 67.3" "Group enriched" "Detected in some" 5 "Early spermatids: 88.7;Late spermatids: 144.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 112.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 40 "A-431: 87.4;HaCaT: 85.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014343, CAB025503, CAB026341" Enhanced "Secreted in other tissues" NA NA "CAB025503: , CAB026341: , HPA014343: AB_1852603" "unprognostic (3.19e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (4.30e-4)" "unprognostic (3.01e-1)" "prognostic unfavorable (9.79e-4)" "unprognostic (3.04e-1)" "unprognostic (3.05e-1)" "unprognostic (1.70e-3)" "unprognostic (2.21e-1)" "unprognostic (2.76e-1)" "unprognostic (2.53e-1)" "unprognostic (9.16e-3)" "prognostic unfavorable (3.85e-6)" 1.1 0.0 0.7 0.4 0.2 0.0 12.1 0.2 0.5 3.8 0.3 0.2 0.2 0.1 1.4 0.9 6.5 0.2 0.3 0.2 0.2 0.1 0.6 0.2 2.5 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.3 7.0 0.2 0.4 69.2 0.2 0.2 0.2 0.2 0.0 3.3 0.2 0.4 0.3 67.3 4.4 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 85.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.5 0.2 0.1 0.2 0.2 0.4 0.2 14.9 0.0 0.0 1.9 23.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 144.1 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.5 9.5 0.0 0.0 0.0 0.0 KLK8 "HNP, neuropsin, ovasin, PRSS19, TADG14" ENSG00000129455 "Kallikrein related peptidase 8" O60259 19 50996007-51002711 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.6;skin 1: 40.4;tongue: 46.9" "Group enriched" "Detected in some" 13 "Basal keratinocytes: 58.6;Suprabasal keratinocytes: 157.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 29.9;ovarian cancer: 30.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 32.2;CAPAN-2: 42.3;HaCaT: 31.2" "Region enriched" "Detected in many" 5 "hippocampal formation: 39.6" "CAB019393, HPA035761" Enhanced Approved Vesicles "Secreted in other tissues" NA NA 950000 Vesicles "CAB019393: , HPA035761: AB_2674769" "unprognostic (4.27e-3)" "unprognostic (2.59e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (5.46e-2)" "prognostic unfavorable (5.72e-4)" "unprognostic (2.95e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.10e-4)" "unprognostic (4.29e-2)" "unprognostic (4.66e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (6.17e-4)" 1.6 0.0 0.1 0.4 0.1 0.0 4.5 1.0 0.3 8.1 0.7 0.1 0.1 0.0 1.1 0.7 43.6 6.7 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.0 0.1 0.4 0.6 0.3 0.0 0.3 6.0 0.1 0.3 40.4 0.1 0.1 0.6 0.3 0.0 0.7 0.1 0.5 0.3 46.9 11.1 0.3 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 0.2 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.6 42.3 0.0 0.8 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.3 0.1 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 58.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 1.7 0.0 8.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.4 157.5 0.0 0.0 0.0 0.1 KLRB1 "CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A" ENSG00000111796 "Killer cell lectin like receptor B1" Q12918 12 9594551-9607886 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 178.9" "Cell type enriched" "Detected in many" 21 "T-cells: 765.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "MAIT T-cell: 178.9" "Group enriched" "Detected in many" 133 "NK-cells: 53.0;T-cells: 178.9" "Cell line enhanced" "Detected in some" "HEL: 3.0;Karpas-707: 2.2" "Low region specificity" "Detected in all" HPA039113 Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039113: AB_10674979" "prognostic favorable (3.51e-5)" "unprognostic (1.23e-3)" "unprognostic (7.03e-3)" "prognostic favorable (1.42e-5)" "unprognostic (1.69e-1)" "prognostic favorable (6.99e-5)" "unprognostic (1.54e-3)" "unprognostic (7.15e-3)" "unprognostic (4.12e-1)" "unprognostic (8.23e-3)" "unprognostic (3.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.61e-4)" "unprognostic (1.17e-2)" 3.8 0.8 0.8 22.8 0.8 18.6 2.1 0.5 0.6 2.9 9.1 0.0 1.3 5.0 1.8 3.7 2.6 1.8 7.3 1.3 0.7 0.8 3.8 4.9 11.8 23.7 1.1 0.2 2.0 1.0 0.0 0.9 2.1 0.8 1.8 3.9 0.9 4.8 1.4 0.9 0.8 20.4 0.6 1.8 25.2 4.4 1.3 0.2 6.2 1.9 2.9 17.7 5.5 2.0 0.1 0.3 0.8 0.2 53.0 178.9 18.5 0.1 0.0 1.5 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.1 0.0 0.9 0.2 1.9 0.0 0.0 0.2 0.0 3.0 0.0 0.4 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.2 2.2 0.0 0.8 0.8 0.6 0.5 0.5 0.0 1.1 0.3 0.9 0.0 0.5 0.4 0.6 0.6 0.7 0.1 1.7 0.3 0.2 0.0 1.6 0.0 0.4 0.7 0.6 0.4 1.5 0.0 1.8 1.0 0.5 0.1 0.0 43.1 0.1 178.9 0.1 25.6 28.1 0.1 0.1 1.5 8.7 0.8 53.0 0.2 0.3 5.7 18.5 0.8 0.8 0.5 0.6 0.7 0.8 1.1 0.2 0.8 0.2 0.0 12.8 14.5 0.6 8.7 0.0 0.8 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 5.1 1.3 0.0 5.5 0.9 0.0 0.0 35.6 22.5 0.0 0.0 3.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.5 0.0 0.0 7.8 0.8 765.3 0.3 1.3 KLRC1 "CD159a, NKG2, NKG2-A, NKG2-B" ENSG00000134545 "Killer cell lectin like receptor C1" P26715 12 10442264-10454685 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 64.3;lymphoid tissue: 22.1" "Cell type enriched" "Detected in some" 22 "T-cells: 112.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 45.7;NK-cell: 64.3" "Group enriched" "Detected in many" 42 "NK-cells: 64.3;T-cells: 45.7" "Cell line enhanced" "Detected in some" "HeLa: 9.3;Karpas-707: 3.8;SuSa: 3.7" HPA058052 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058052: AB_2683589" "unprognostic (8.17e-3)" "unprognostic (2.13e-2)" "unprognostic (1.48e-2)" "unprognostic (4.58e-7)" "unprognostic (3.57e-1)" "unprognostic (1.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-2)" "unprognostic (3.73e-4)" "unprognostic (4.13e-2)" "unprognostic (6.49e-2)" "unprognostic (2.54e-1)" "unprognostic (1.18e-4)" "unprognostic (1.88e-1)" "unprognostic (3.23e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-3)" 2.4 0.5 1.2 5.8 1.4 5.6 2.3 1.0 2.7 1.7 3.3 0.7 1.2 1.5 5.5 3.9 1.7 2.5 2.4 2.6 1.6 1.3 1.9 2.0 5.9 10.3 2.3 0.6 1.2 1.4 0.3 1.3 3.6 1.5 1.9 2.5 2.0 3.1 0.3 0.5 1.0 5.0 2.1 2.6 22.1 5.2 1.4 0.5 3.5 1.9 3.0 2.9 2.9 1.8 0.1 0.0 1.2 0.1 64.3 45.7 5.1 0.4 1.6 0.1 0.1 0.5 0.4 0.8 0.0 0.0 0.8 1.7 0.0 1.3 0.2 0.1 0.4 3.3 0.3 0.6 2.8 1.1 0.9 0.4 2.1 9.3 0.0 0.1 0.6 0.4 1.0 0.0 0.3 0.0 0.0 0.8 0.7 1.3 3.8 0.8 0.0 0.2 2.8 0.0 0.1 0.0 0.9 0.2 0.3 0.2 0.0 0.5 0.1 0.8 0.0 0.3 3.7 0.3 0.0 2.6 0.4 0.0 0.0 0.3 0.0 0.0 0.7 2.1 0.8 0.0 0.2 0.0 0.0 45.7 0.0 5.8 0.1 0.0 7.9 0.0 0.0 0.0 6.9 1.2 64.3 0.1 0.0 0.0 5.1 1.2 1.4 1.0 0.9 1.6 1.3 2.3 0.6 1.5 0.5 0.0 1.1 0.0 0.2 0.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.8 0.1 1.6 1.7 1.3 3.2 0.0 0.6 0.0 5.0 0.0 1.9 0.0 0.0 0.3 1.1 0.6 1.5 0.0 0.3 0.5 0.2 0.1 0.1 112.3 0.0 0.4 KLRC2 "CD159c, NKG2-C" ENSG00000205809 "Killer cell lectin like receptor C2" P26717 12 10426854-10442300 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.8;brain: 16.2" "Group enriched" "Detected in some" 20 "Intestinal endocrine cells: 9.2;T-cells: 36.2" "Cancer enriched" "Detected in single" 8 "glioma: 3.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 10.7;NK-cell: 32.8" "Group enriched" "Detected in many" 92 "NK-cells: 32.8;T-cells: 10.7" "Cell line enhanced" "Detected in some" "GAMG: 17.9;HEL: 5.3;HeLa: 16.4;HSkMC: 4.0" HPA058052 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058052: AB_2683589" "unprognostic (9.05e-4)" "unprognostic (2.54e-2)" "unprognostic (3.77e-2)" "unprognostic (2.51e-3)" "unprognostic (2.83e-1)" "unprognostic (9.49e-4)" "unprognostic (1.27e-1)" "unprognostic (8.74e-2)" "unprognostic (2.88e-1)" "unprognostic (4.00e-3)" "unprognostic (2.88e-2)" "unprognostic (9.16e-3)" "unprognostic (1.55e-9)" "unprognostic (8.10e-2)" "unprognostic (2.34e-1)" "unprognostic (8.93e-2)" "unprognostic (5.31e-3)" 0.5 0.2 8.2 0.6 4.6 2.8 1.1 1.2 16.2 0.4 1.9 2.3 0.1 1.0 1.4 1.0 0.8 0.6 1.7 0.2 6.1 5.4 0.1 1.1 1.4 1.5 6.2 2.6 1.5 0.1 0.0 0.1 0.6 3.7 0.3 1.3 0.1 0.5 0.3 0.1 0.2 1.8 0.1 4.1 8.1 3.2 0.5 1.7 2.2 0.2 0.1 2.0 1.2 0.1 0.0 0.0 0.2 0.0 32.8 10.7 1.7 0.0 0.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 17.9 0.0 0.0 2.0 0.0 0.0 0.0 5.3 16.4 0.3 0.0 0.5 0.0 4.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.1 1.1 0.1 0.4 0.0 0.0 0.0 0.0 0.5 2.7 0.1 0.1 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 4.7 0.0 0.0 0.0 3.7 0.2 32.8 0.0 0.0 0.0 1.7 8.2 4.6 1.2 3.6 6.1 5.4 6.2 2.6 3.7 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0 KLRC3 NKG2-E ENSG00000205810 "Killer cell lectin like receptor C3" Q07444 12 10412312-10420595 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 28.5;brain: 9.7;lymphoid tissue: 6.9" "Cell type enhanced" "Detected in some" 19 "Club cells: 1.2;Intestinal endocrine cells: 1.7;T-cells: 1.3" "Cancer enriched" "Detected in single" 9 "glioma: 0.6" "Cell type enriched" "Detected in some" 5 "NK-cell: 28.5" "Lineage enriched" "Detected in many" 5 "NK-cells: 28.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.5;GAMG: 5.1;HEL: 2.2;HeLa: 11.6;HSkMC: 2.2;SuSa: 2.8;U-698: 3.2" "HPA039910, HPA062570" Approved Uncertain Vesicles NA NA Vesicles "HPA039910: , HPA062570: AB_2684795" "unprognostic (8.92e-4)" "unprognostic (4.47e-2)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.07e-3)" "unprognostic (2.48e-1)" "unprognostic (3.22e-1)" "unprognostic (9.12e-2)" "unprognostic (3.52e-3)" "unprognostic (3.09e-1)" "unprognostic (1.08e-1)" "unprognostic (3.15e-1)" 0.1 0.0 4.6 0.2 2.4 2.5 0.0 0.2 9.7 0.0 0.6 1.2 0.7 0.0 0.1 0.3 0.9 0.0 3.7 2.9 0.0 0.6 0.8 2.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.0 2.1 6.9 0.7 0.1 0.1 1.0 0.1 0.0 0.0 0.0 0.3 0.0 28.5 5.6 1.5 0.0 0.0 0.1 0.7 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.1 0.0 1.0 0.0 0.0 0.0 2.2 11.6 0.1 0.0 0.2 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.5 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 4.4 0.3 28.5 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 KLRC4 NKG2-F ENSG00000183542 "Killer cell lectin like receptor C4" O43908 12 10407382-10409757 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 9.3;lymphoid tissue: 11.8" "Cell type enriched" "Detected in some" 4 "T-cells: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 20 "gdT-cell: 9.3;memory CD8 T-cell: 6.5;naive CD8 T-cell: 7.5;NK-cell: 5.4" "Group enriched" "Detected in many" 67 "NK-cells: 5.4;T-cells: 9.3" "Cell line enhanced" "Detected in some" "HeLa: 9.7;HSkMC: 1.9;SuSa: 3.9;U-698: 3.5" NA NA "unprognostic (3.96e-2)" "unprognostic (1.35e-2)" "unprognostic (4.60e-1)" "unprognostic (7.00e-2)" "unprognostic (1.55e-4)" "unprognostic (1.89e-2)" "unprognostic (1.52e-1)" "unprognostic (3.32e-1)" "unprognostic (2.92e-1)" "unprognostic (4.36e-1)" "unprognostic (3.44e-7)" "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" "unprognostic (2.68e-1)" "unprognostic (5.51e-3)" 1.6 0.8 2.3 2.5 1.6 1.6 1.7 1.3 3.9 5.0 2.6 0.6 0.6 1.4 0.9 0.6 0.8 1.0 2.8 0.6 2.6 1.5 3.7 1.9 3.5 5.6 1.9 0.6 0.6 0.6 0.0 0.6 1.3 1.5 1.1 1.6 2.1 1.2 3.8 0.6 0.3 4.2 0.6 2.0 11.8 2.6 0.6 0.6 1.2 1.5 0.6 6.9 2.1 1.1 0.0 0.0 0.1 0.0 5.4 9.3 1.5 0.0 0.2 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.5 9.7 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.3 0.0 0.0 6.5 0.0 0.0 0.0 7.5 0.1 5.4 0.0 0.0 0.0 1.5 2.3 1.6 1.3 1.4 2.6 1.5 1.9 0.6 1.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.9 0.0 0.0 KLRD1 CD94 ENSG00000134539 "Killer cell lectin like receptor D1" Q13241 12 10226058-10329600 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 85.5;lymphoid tissue: 31.0;pituitary gland: 44.6" "Cell type enriched" "Detected in many" 26 "T-cells: 450.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 67.2;memory CD8 T-cell: 28.0;naive CD8 T-cell: 30.3;NK-cell: 85.5" "Group enriched" "Detected in many" 63 "NK-cells: 85.5;T-cells: 67.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA069688 Uncertain NA NA "HPA069688: AB_2686170" "unprognostic (3.75e-2)" "unprognostic (2.15e-3)" "unprognostic (4.95e-2)" "unprognostic (2.48e-3)" "unprognostic (2.13e-2)" "unprognostic (2.60e-3)" "unprognostic (2.26e-2)" "unprognostic (1.13e-1)" "unprognostic (8.94e-3)" "unprognostic (4.53e-3)" "unprognostic (8.78e-2)" "unprognostic (2.97e-2)" "unprognostic (1.47e-3)" "unprognostic (1.78e-1)" "unprognostic (3.07e-1)" "unprognostic (3.06e-1)" "unprognostic (1.37e-2)" 5.2 1.3 0.9 6.4 1.1 6.9 1.7 0.8 0.9 1.4 2.7 0.6 0.2 1.5 3.3 1.9 2.0 1.1 1.5 1.7 1.0 1.0 1.5 3.7 12.3 10.2 3.8 0.7 0.9 1.9 0.0 44.6 2.3 0.8 2.0 0.9 2.1 1.2 0.5 1.1 0.8 10.6 0.5 2.6 31.0 1.8 1.4 0.4 2.2 1.3 0.3 3.6 6.3 1.3 0.1 0.2 1.2 0.2 85.5 67.2 16.2 0.9 0.7 1.1 1.5 1.5 0.6 0.9 2.3 0.1 0.2 0.7 1.4 1.0 1.3 1.1 1.9 0.8 1.1 0.5 1.3 0.2 2.2 2.8 1.7 2.6 0.6 2.7 1.1 2.2 0.7 1.7 0.4 1.2 1.3 0.3 1.2 1.0 4.9 0.3 1.9 1.0 1.3 1.8 0.8 1.4 0.6 1.6 1.2 0.7 2.1 2.4 1.2 1.1 2.2 0.5 3.1 0.8 2.1 1.7 1.8 3.1 1.5 0.7 2.0 1.8 1.1 2.6 1.6 1.6 0.1 0.1 0.1 67.2 0.2 7.6 0.1 0.4 28.0 0.2 0.1 0.1 30.3 1.2 85.5 0.1 0.2 0.1 16.2 0.9 1.1 0.8 0.9 1.0 1.0 3.8 0.7 0.8 0.4 0.0 14.6 0.8 1.0 0.5 0.7 2.0 5.1 2.7 3.4 0.0 5.9 1.2 0.0 0.2 5.9 3.4 0.0 0.0 0.0 0.8 1.9 1.2 2.3 2.1 0.7 1.6 0.0 13.5 17.1 9.8 0.3 1.7 5.0 0.0 0.0 0.6 0.0 0.0 0.7 1.0 0.9 0.0 0.9 1.2 3.4 0.5 0.7 450.1 0.0 1.0 KLRF1 "CLEC5C, NKp80" ENSG00000150045 "Killer cell lectin like receptor F1" Q9NZS2 12 9827481-9845007 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 95.2;lymphoid tissue: 24.7" "Cell type enriched" "Detected in many" 10 "T-cells: 119.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "NK-cell: 95.2" "Lineage enriched" "Detected in many" 6 "NK-cells: 95.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;CAPAN-2: 1.9;HAP1: 3.0;U-937: 9.5" "Low region specificity" "Detected in some" HPA054038 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA054038: " "unprognostic (2.96e-1)" "unprognostic (8.59e-2)" "unprognostic (3.18e-2)" "unprognostic (2.95e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-4)" "unprognostic (6.06e-2)" "unprognostic (3.68e-2)" "unprognostic (9.95e-3)" "unprognostic (3.00e-1)" "unprognostic (2.90e-1)" "unprognostic (4.43e-2)" "unprognostic (6.53e-2)" "unprognostic (4.64e-2)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (8.89e-3)" 3.3 0.7 0.9 3.0 1.2 8.8 1.4 0.6 0.8 1.0 0.6 0.3 0.1 0.0 0.7 3.3 0.8 1.1 0.9 1.0 1.0 0.8 0.8 5.8 10.0 4.0 0.9 0.7 0.7 1.1 0.0 0.9 1.7 0.4 1.5 0.5 0.9 1.5 0.8 1.3 0.8 1.0 0.5 1.0 24.7 0.7 1.0 0.4 2.0 0.8 0.5 2.8 1.0 0.7 0.4 0.3 0.9 0.2 95.2 14.9 11.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 3.3 0.0 0.2 0.0 1.9 0.0 0.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.1 0.1 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 9.5 1.4 0.0 0.1 0.1 11.6 0.2 14.9 0.4 0.6 5.5 0.2 0.1 0.2 5.8 0.9 95.2 0.1 0.3 0.1 11.1 0.9 1.2 0.6 0.8 1.0 0.8 0.9 0.7 0.4 0.4 0.0 2.1 0.0 1.1 1.3 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.8 8.3 0.2 0.4 1.2 0.0 0.0 0.2 0.5 0.7 0.6 1.1 0.9 1.2 0.0 0.0 8.0 10.1 0.9 0.0 1.4 11.8 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.1 1.5 1.0 0.5 119.3 0.2 2.1 KLRF2 NKp65 ENSG00000256797 "Killer cell lectin like receptor F2" D3W0D1 12 9881489-9895833 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.0;skin 1: 16.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 56 "NK-cell: 5.2;plasmacytoid DC: 6.0" "Group enriched" "Detected in many" 56 "dendritic cells: 6.0;NK-cells: 5.2" "Cell line enriched" "Detected in single" 47 "U-937: 26.5" NA NA "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (6.24e-2)" "unprognostic (1.63e-1)" "unprognostic (5.57e-2)" "unprognostic (3.40e-5)" "unprognostic (9.03e-2)" "unprognostic (3.16e-1)" 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.9 0.3 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.6 3.9 0.0 0.0 0.1 0.0 0.0 0.1 2.2 0.0 0.6 0.2 0.5 2.9 0.0 0.0 16.7 2.4 0.0 0.1 0.7 0.1 0.4 0.0 0.0 0.5 0.0 1.2 0.1 0.1 0.0 6.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLRG1 "2F1, CLEC15A, MAFA, MAFA-L" ENSG00000139187 "Killer cell lectin like receptor G1" Q96E93 12 8950044-9010760 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 83.1" "Cell type enhanced" "Detected in many" 20 "Erythroid cells: 23.3;granulocytes: 113.5;T-cells: 58.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 71.3;MAIT T-cell: 83.1" "Lineage enriched" "Detected in many" 28 "T-cells: 83.1" "Group enriched" "Detected in many" 5 "HEL: 23.6;HUVEC TERT2: 8.3;NTERA-2: 16.2;U-937: 14.8" "Low region specificity" "Detected in some" "HPA051403, HPA076494" Approved Enhanced Vesicles NA NA Vesicles "HPA051403: , HPA076494: AB_2686800" "unprognostic (1.54e-2)" "unprognostic (8.42e-4)" "unprognostic (1.06e-1)" "unprognostic (1.28e-1)" "unprognostic (2.94e-1)" "unprognostic (1.53e-4)" "unprognostic (3.05e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-2)" "unprognostic (3.45e-3)" "unprognostic (6.88e-2)" "unprognostic (1.71e-2)" "unprognostic (2.05e-2)" "unprognostic (4.17e-2)" "unprognostic (4.96e-2)" "unprognostic (7.86e-2)" 15.4 3.9 4.4 7.3 5.8 5.6 5.7 12.3 5.0 3.2 3.5 7.1 0.8 1.7 5.6 4.2 2.2 2.6 7.7 5.1 4.4 5.8 3.2 6.4 5.5 17.3 8.3 3.4 2.7 1.9 1.5 5.6 1.5 5.5 4.8 4.7 5.6 3.5 1.8 3.1 2.2 5.0 3.9 5.5 19.0 3.6 2.2 6.8 6.8 2.9 2.3 11.1 8.3 2.6 0.5 1.3 2.4 0.6 2.9 83.1 14.0 0.1 2.2 1.2 1.7 2.0 0.4 1.1 0.3 0.3 0.2 0.7 0.8 0.7 3.1 0.1 0.3 1.6 0.2 2.9 0.3 0.3 2.3 1.5 23.6 0.3 1.2 0.6 0.8 1.2 1.4 0.3 0.4 0.0 0.4 8.3 1.8 1.0 0.3 0.2 0.5 0.5 1.6 16.2 0.8 1.5 0.9 0.7 0.0 0.3 0.3 0.4 3.2 0.7 0.4 0.9 3.1 0.2 1.1 0.6 0.5 0.7 0.4 1.0 1.0 2.8 1.8 1.4 14.8 0.2 2.4 0.3 0.2 71.3 0.4 83.1 0.5 15.8 43.4 1.3 0.5 4.3 29.9 0.9 2.9 0.6 0.5 1.2 14.0 4.4 5.8 12.3 5.0 4.4 5.8 8.3 3.4 5.5 6.8 0.0 7.0 4.7 0.4 0.3 4.1 2.5 0.0 0.0 0.0 0.0 7.9 0.8 1.7 0.5 1.7 1.6 0.0 23.3 0.2 0.3 0.4 0.2 113.5 1.8 3.0 4.8 1.2 16.0 5.9 2.0 0.6 1.7 1.7 1.0 0.0 1.5 0.2 0.0 0.0 2.2 3.5 0.0 0.5 1.6 4.3 0.0 0.2 58.9 0.6 0.0 KLRG2 "CLEC15B, FLJ44186" ENSG00000188883 "Killer cell lectin like receptor G2" A4D1S0 7 139452690-139483712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 9.7;thyroid gland: 22.1" "Group enriched" "Detected in some" 6 "Collecting duct cells: 7.0;Extravillous trophoblasts: 1.8;Syncytiotrophoblasts: 6.4" "Cancer enriched" "Detected in many" 11 "testis cancer: 42.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 11.2;HAP1: 11.8;NTERA-2: 6.2;SCLC-21H: 5.6;SK-BR-3: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018199 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA018199: AB_2133260" "unprognostic (2.50e-2)" "unprognostic (3.05e-2)" "unprognostic (9.82e-2)" "unprognostic (5.38e-8)" "unprognostic (2.41e-1)" "unprognostic (1.97e-2)" "unprognostic (3.13e-2)" "prognostic favorable (8.61e-4)" "unprognostic (2.14e-2)" "unprognostic (2.92e-1)" "unprognostic (5.19e-2)" "unprognostic (8.83e-2)" "unprognostic (1.10e-3)" "unprognostic (5.66e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-2)" "unprognostic (2.34e-2)" 0.2 0.1 0.0 0.0 0.3 0.0 2.4 0.0 0.8 1.0 0.0 0.2 0.0 0.0 0.2 0.7 7.3 0.2 0.0 0.0 0.0 0.0 4.5 0.0 6.2 0.0 0.1 0.0 0.0 0.2 6.5 0.9 0.7 0.3 0.2 0.1 0.3 9.7 0.3 0.1 4.7 0.0 1.5 1.4 0.0 0.2 2.3 0.0 0.9 22.1 2.6 2.3 0.8 2.4 0.4 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.3 0.0 0.0 1.7 11.8 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.1 0.0 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.0 1.8 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.4 0.1 5.6 0.3 1.7 23.9 0.0 4.8 5.3 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.3 0.0 0.0 0.0 7.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 6.4 0.0 0.0 0.3 KLRK1 "CD314, D12S2489E, KLR, NKG2-D, NKG2D" ENSG00000213809 "Killer cell lectin like receptor K1" P26718 12 10372353-10391874 "Cancer-related genes, CD markers, Predicted membrane proteins, Transporters" "Adaptive immunity, Differentiation, Immunity, Innate immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.8;lymphoid tissue: 30.7" "Cell type enriched" "Detected in some" 9 "T-cells: 20.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 39 "gdT-cell: 49.4;MAIT T-cell: 18.5;memory CD8 T-cell: 44.0;naive CD8 T-cell: 44.3;NK-cell: 50.8" "Group enriched" "Detected in many" 47 "NK-cells: 50.8;T-cells: 49.4" "Cell line enriched" "Detected in some" 8 "U-698: 36.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB021896, HPA068877" Enhanced Supported "Plasma membrane" NA NA 33000 "Plasma membrane" "CAB021896: , HPA068877: AB_2686052" "unprognostic (3.34e-4)" "unprognostic (2.65e-4)" "unprognostic (3.25e-1)" "unprognostic (2.59e-2)" "unprognostic (1.53e-1)" "unprognostic (1.01e-5)" "unprognostic (5.61e-4)" "unprognostic (1.00e-3)" "unprognostic (1.33e-1)" "unprognostic (9.22e-2)" "unprognostic (1.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-10)" "unprognostic (1.24e-2)" "unprognostic (6.32e-2)" "unprognostic (7.59e-2)" "unprognostic (7.08e-10)" 4.1 0.9 1.3 18.3 1.1 10.6 2.1 0.4 0.8 2.8 4.5 1.2 0.6 2.0 2.4 2.7 3.1 2.0 7.7 1.3 1.3 1.1 2.4 3.6 13.6 22.2 2.1 0.1 1.5 3.3 0.0 1.2 1.6 1.2 2.2 2.1 2.4 7.0 0.6 0.5 1.1 13.1 1.3 2.1 30.7 3.3 1.9 0.6 6.0 2.9 2.8 11.4 11.3 2.5 1.0 0.2 0.8 0.1 50.8 49.4 16.7 0.2 0.0 0.4 1.9 0.1 4.7 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.1 0.1 0.0 0.4 0.7 0.0 0.2 0.0 0.2 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 36.9 0.1 0.0 0.2 0.0 0.0 0.0 49.4 0.1 18.5 0.8 0.3 44.0 0.1 1.0 0.4 44.3 0.8 50.8 0.1 0.2 0.1 16.7 1.3 1.1 0.4 0.8 1.3 1.1 2.1 0.1 1.2 0.6 0.0 2.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 20.3 0.0 0.0 KMO ENSG00000117009 "Kynurenine 3-monooxygenase" O15229 1 241532134-241595642 "Enzymes, Predicted membrane proteins" "Pyridine nucleotide biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 20.3;liver: 58.6;placenta: 26.0" "Cell type enhanced" "Detected in many" 23 "Hepatocytes: 43.2;Proximal tubular cells: 45.1;Syncytiotrophoblasts: 150.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 79 "classical monocyte: 5.2;intermediate monocyte: 14.7;memory B-cell: 16.1;myeloid DC: 5.3;naive B-cell: 20.3;non-classical monocyte: 14.7;plasmacytoid DC: 11.1" "Group enriched" "Detected in many" 97 "B-cells: 20.3;dendritic cells: 11.1;monocytes: 14.7" "Cell line enhanced" "Detected in some" "Daudi: 5.4;RPMI-8226: 7.8;RPTEC TERT1: 20.0;SK-BR-3: 10.4;U-698: 8.3" "Region enriched" "Detected in single" 4 "thalamus: 1.3" "Not detected" "Not detected" "HPA031115, HPA056942" Enhanced NA NA "HPA031115: AB_10601924, HPA056942: AB_2683281" "unprognostic (4.27e-2)" "unprognostic (3.35e-2)" "unprognostic (3.95e-2)" "unprognostic (7.48e-3)" "unprognostic (8.37e-3)" "unprognostic (2.63e-1)" "unprognostic (9.79e-2)" "unprognostic (3.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.75e-3)" "unprognostic (8.07e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (6.49e-8)" "unprognostic (1.60e-2)" "unprognostic (3.65e-2)" "unprognostic (3.36e-2)" "unprognostic (6.81e-2)" 3.7 0.6 0.5 3.3 0.6 0.3 2.4 0.2 0.9 0.3 0.4 0.2 0.0 0.0 2.7 0.1 0.3 0.4 0.5 0.4 0.8 0.4 14.2 58.6 6.5 3.2 0.3 0.3 0.4 0.3 0.0 0.4 26.0 0.3 0.4 0.3 0.3 0.5 0.0 0.2 0.3 1.0 0.1 0.5 8.0 0.4 0.6 0.1 0.7 0.4 0.1 4.5 1.4 0.3 20.3 11.1 0.1 14.7 0.0 0.0 2.8 0.1 1.6 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.2 0.4 0.0 0.2 5.4 0.4 0.0 0.1 2.2 0.0 0.2 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.5 0.2 0.2 0.7 0.1 0.1 0.5 0.0 0.4 0.1 0.8 0.0 0.2 0.0 2.3 0.9 0.8 0.4 1.4 0.1 7.8 20.0 4.1 0.3 0.1 0.0 10.4 0.0 2.1 4.0 1.7 0.0 0.0 0.1 0.1 1.4 0.3 0.5 8.3 0.2 2.0 1.6 0.0 5.2 0.1 0.0 14.7 0.0 16.1 0.0 0.0 5.3 20.3 0.0 0.0 0.1 0.0 14.7 11.1 0.0 2.8 0.5 0.6 0.2 0.9 0.8 0.4 0.3 0.3 0.3 0.1 0.0 0.3 22.3 0.0 0.9 0.0 0.4 2.5 0.0 0.0 0.0 0.0 3.0 5.0 2.2 3.5 0.0 0.0 0.0 0.2 1.6 0.5 0.3 0.0 43.2 7.1 0.0 0.0 1.3 17.4 0.4 0.0 18.4 0.0 3.6 0.0 0.0 2.5 0.0 0.0 45.1 0.0 0.0 0.0 0.5 0.1 1.3 150.6 0.0 0.0 0.0 KMT2E "HDCMC04P, MLL5" ENSG00000005483 "Lysine methyltransferase 2E" Q8IZD2 7 105014179-105114361 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042866, HPA056125" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA042866: , HPA056125: AB_2683044" "unprognostic (1.05e-1)" "unprognostic (6.33e-2)" "unprognostic (6.49e-2)" "unprognostic (4.34e-1)" "unprognostic (1.94e-1)" "unprognostic (4.77e-2)" "unprognostic (2.20e-1)" "unprognostic (3.98e-3)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (3.53e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (3.80e-5)" "unprognostic (1.68e-1)" "unprognostic (1.53e-1)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" 22.7 11.8 18.6 24.5 23.5 44.8 20.9 41.6 22.4 26.4 20.9 18.6 21.7 14.7 25.3 15.8 16.5 18.6 18.2 16.8 20.6 15.1 14.2 11.6 22.8 20.1 22.7 17.4 33.5 15.6 20.5 20.1 18.7 18.6 21.2 20.5 17.6 19.6 19.2 21.3 25.7 18.5 26.2 23.1 21.6 17.9 12.9 27.2 24.6 21.7 15.1 22.7 26.6 21.4 38.2 24.7 72.9 20.8 20.3 30.6 14.7 15.1 10.7 22.7 19.5 14.1 16.9 5.8 11.6 17.4 9.8 12.1 8.7 13.9 12.6 11.6 13.6 13.2 11.8 12.5 11.5 16.3 20.3 7.2 12.7 14.0 7.4 13.3 17.0 16.0 11.8 10.8 13.6 14.6 17.9 17.7 14.1 17.3 36.1 13.8 11.9 27.1 14.6 7.9 8.3 8.6 23.4 14.0 14.6 9.7 15.4 13.0 15.7 16.1 13.9 8.8 15.9 6.0 10.2 21.8 23.2 16.2 26.5 11.5 27.6 21.8 29.1 15.2 13.0 15.9 48.5 18.0 39.4 30.6 13.6 30.3 35.6 28.4 26.1 12.8 38.2 28.0 26.0 72.9 20.3 20.8 24.7 23.6 14.7 18.6 23.5 41.6 22.4 20.6 15.1 22.7 17.4 18.6 27.2 131.0 136.3 133.9 100.8 130.3 219.2 86.5 76.5 84.3 142.1 109.9 237.6 33.5 29.9 70.0 19.2 197.7 91.8 93.5 59.6 38.6 151.9 115.7 236.2 33.7 53.7 174.8 96.0 86.5 76.0 18.6 130.6 138.7 133.3 110.0 88.5 114.4 63.9 84.2 123.8 28.6 269.1 122.9 222.6 98.9 71.7 117.7 54.6 186.4 107.4 119.5 KNCN "FLJ32011, KINO, L5" ENSG00000162456 Kinocilin A6PVL3 1 46545644-46551527 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.9;pituitary gland: 1.0;testis: 2.5" "Group enriched" "Detected in some" 41 "Early spermatids: 10.4;Late spermatids: 26.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (6.99e-3)" "unprognostic (2.28e-2)" "unprognostic (2.80e-2)" 0.0 0.5 0.4 0.0 0.1 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 KREMEN1 "KREMEN, KRM1" ENSG00000183762 "Kringle containing transmembrane protein 1" Q96MU8 22 29073078-29168333 "Disease related genes, Predicted membrane proteins" "Wnt signaling pathway" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "RH-30: 18.3;U-2197: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058513 Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No 400000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA058513: AB_2683739" 5.2 11.8 7.1 6.8 17.8 2.7 5.8 5.0 6.9 9.6 9.6 7.6 25.7 4.9 6.0 13.2 27.8 8.6 5.0 16.8 8.3 3.6 10.5 3.2 8.3 9.1 5.2 4.3 17.4 3.4 16.3 8.0 7.2 4.2 7.1 8.5 21.2 35.4 20.6 18.9 26.5 8.1 4.7 3.0 13.9 6.4 14.5 6.8 19.0 17.1 33.4 20.0 5.9 10.0 0.7 1.2 9.0 0.6 0.8 0.4 0.2 2.6 1.8 6.2 3.2 2.1 6.4 5.3 0.7 6.2 2.0 3.0 8.4 1.2 0.1 2.4 2.9 5.1 12.8 12.8 5.1 2.2 3.1 8.1 0.7 0.9 7.9 2.2 0.1 0.7 6.2 10.4 2.2 1.2 0.9 0.3 5.2 2.7 0.2 2.5 2.2 0.0 0.8 0.3 17.3 1.4 0.4 18.3 0.2 2.2 4.9 12.5 7.0 7.3 2.6 9.6 2.1 9.7 0.4 0.2 8.4 2.6 31.2 0.9 0.6 0.2 0.2 5.3 1.1 9.7 2.1 0.6 0.3 0.3 0.5 0.3 0.3 0.3 0.2 0.1 0.7 0.4 0.4 9.0 0.8 0.4 1.2 0.2 0.2 7.1 17.8 5.0 6.9 8.3 3.6 5.2 4.3 4.2 6.8 14.9 20.2 0.0 11.3 13.6 3.3 19.9 7.6 16.0 26.1 7.0 0.0 11.2 1.7 4.8 2.5 4.1 2.6 0.0 3.6 1.2 9.9 8.7 18.5 2.4 2.3 0.0 0.0 6.7 17.9 7.7 16.4 3.9 0.0 2.8 16.3 29.9 3.3 5.5 9.9 4.4 2.7 12.9 4.2 7.7 6.4 16.9 4.5 2.2 7.3 8.9 KREMEN2 "KRM2, MGC10791" ENSG00000131650 "Kringle containing transmembrane protein 2" Q8NCW0 16 2963944-2968383 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1;skin 1: 12.5" "Cell type enhanced" "Detected in some" 9 "Basal keratinocytes: 12.6;Cone photoreceptor cells: 5.9;Mucus-secreting cells: 9.5;Rod photoreceptor cells: 10.0;Spermatogonia: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory B-cell: 3.2;naive B-cell: 3.0;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 6 "B-cells: 3.2;monocytes: 1.4" "Cell line enhanced" "Detected in many" "HMC-1: 20.3;MCF7: 10.2;RPMI-8226: 19.1;T-47d: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA003223 Uncertain Approved Nucleoli "Intracellular and membrane" NA NA Nucleoli "HPA003223: AB_1079217" "unprognostic (8.36e-2)" "unprognostic (4.65e-1)" "unprognostic (6.24e-3)" "unprognostic (4.61e-2)" "unprognostic (1.69e-1)" "unprognostic (1.73e-1)" "unprognostic (4.02e-3)" "prognostic unfavorable (8.98e-4)" "unprognostic (3.34e-2)" "unprognostic (1.57e-2)" "unprognostic (8.03e-2)" "unprognostic (8.57e-2)" "unprognostic (7.79e-12)" "unprognostic (6.69e-2)" "unprognostic (1.14e-1)" "unprognostic (1.46e-2)" "unprognostic (6.58e-3)" 0.2 0.1 1.6 2.0 0.7 1.7 0.2 0.2 3.0 1.8 0.4 0.2 4.5 0.3 0.3 0.8 3.8 0.6 0.3 0.2 1.9 0.3 0.2 0.2 0.2 0.8 0.7 0.2 0.2 0.4 0.0 0.2 0.2 0.3 1.6 0.0 1.9 1.6 0.2 0.6 12.5 0.6 0.2 1.7 0.9 0.5 2.1 0.2 13.1 0.2 1.8 6.8 0.2 0.6 3.2 0.3 0.0 1.4 0.0 0.0 0.0 1.2 0.8 0.3 7.3 0.0 0.0 1.1 0.4 0.0 0.0 0.0 2.9 1.1 5.3 1.5 0.0 0.8 6.0 0.9 0.5 0.0 0.8 0.8 0.3 1.7 1.7 0.0 0.4 20.3 0.2 0.0 0.0 0.1 0.6 0.0 0.6 2.1 2.1 0.0 10.2 1.2 2.4 2.0 2.1 1.5 3.2 8.3 19.1 0.0 0.2 2.1 1.2 1.4 3.3 3.3 0.2 10.3 1.9 0.1 0.6 8.9 0.7 0.5 3.8 0.8 3.2 0.3 0.9 0.5 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.6 0.7 0.2 2.3 1.9 0.3 0.7 0.2 0.3 0.2 0.0 0.0 0.0 0.6 12.6 0.4 0.8 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.4 0.0 0.5 0.0 2.4 1.6 0.0 2.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 3.3 0.0 9.5 0.2 0.2 0.2 0.0 0.0 10.0 0.0 0.0 0.5 5.9 4.8 0.1 0.0 0.2 0.3 KRT5 "EBS2, KRT5A" ENSG00000186081 "Keratin 5" P13647 12 52514575-52520687 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 463.1;skin 1: 338.1;tongue: 522.3" "Cell type enhanced" "Detected in some" 30 "Basal glandular cells: 909.3;Basal keratinocytes: 5214.3;Suprabasal keratinocytes: 1765.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 3340.4" "Region enriched" "Detected in single" 7 "pons and medulla: 1.7" "Cell type enriched" "Detected in single" 197 "plasmacytoid DC: 19.6" "Lineage enriched" "Detected in single" 197 "dendritic cells: 19.6" "Cell line enhanced" "Detected in some" "HaCaT: 120.8;HBEC3-KT: 216.3;hTCEpi: 494.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000027, CAB000129, HPA059479" Enhanced Approved "Intermediate filaments" NA NA 6500000000 "Intermediate filaments" "CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034" "prognostic favorable (1.27e-4)" "unprognostic (9.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (1.84e-1)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" "unprognostic (7.20e-2)" "unprognostic (2.82e-1)" "unprognostic (1.90e-1)" "unprognostic (1.41e-2)" "unprognostic (1.73e-1)" "unprognostic (6.01e-7)" "unprognostic (3.46e-2)" "unprognostic (5.56e-2)" "unprognostic (7.96e-2)" "unprognostic (2.81e-3)" 0.3 0.0 0.1 0.3 0.2 0.2 15.9 0.1 0.2 74.2 0.2 0.3 6.2 0.0 4.9 6.4 463.1 0.7 0.1 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 4.4 1.7 5.8 0.0 0.4 46.9 7.8 0.5 338.1 0.1 0.3 0.1 0.1 0.1 0.7 0.1 31.7 0.1 522.3 128.9 4.0 96.8 0.0 19.6 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 120.8 0.0 216.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 494.5 0.0 43.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.2 1.7 0.1 0.0 0.6 0.0 909.3 5214.3 0.0 0.6 0.0 30.8 153.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 28.8 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 271.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 66.8 0.0 0.0 1765.9 0.0 0.0 0.0 372.4 KRTAP19-1 KAP19.1 ENSG00000184351 "Keratin associated protein 19-1" Q8IUB9 21 30479699-30480344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "skin 1: 17.6" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 19 "melanoma: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "HEK 293: 22.3" NA NA "unprognostic (2.36e-2)" "unprognostic (8.67e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 KRTAP19-3 KAP19.3 ENSG00000244025 "Keratin associated protein 19-3" Q7Z4W3 21 30491464-30491985 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 279 "skeletal muscle: 39.3;skin 1: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.3 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-4 KAP19.4 ENSG00000186967 "Keratin associated protein 19-4" Q3LI73 21 30496824-30497133 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 15 "skin 1: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-6 KAP19.6 ENSG00000186925 "Keratin associated protein 19-6" Q3LI70 21 30541535-30541864 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "skin 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.4;HMC-1: 1.5" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-7 KAP19.7 ENSG00000244362 "Keratin associated protein 19-7" Q3SYF9 21 30560875-30561314 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "skin 1: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-8 ENSG00000206102 "Keratin associated protein 19-8" Q3LI54 21 31038159-31038476 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 1.4;skin 1: 1.4;testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "JURKAT: 3.3;NTERA-2: 1.4;U-937: 2.3" NA NA "unprognostic (1.94e-1)" 0.0 0.0 0.1 0.0 0.0 1.4 0.4 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP20-1 KAP20.1 ENSG00000244624 "Keratin associated protein 20-1" Q3LI63 21 30616425-30616699 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 21 "skin 1: 2.7;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP20-2 KAP20.2 ENSG00000184032 "Keratin associated protein 20-2" Q3LI61 21 30635236-30635619 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 12 "skin 1: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "ASC diff: 3.3;U-2 OS: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 KRTAP20-4 KAP20.4 ENSG00000206105 "Keratin associated protein 20-4" Q3LI62 21 30620627-30620850 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 41 "testis: 6.8" "Cell type enriched" "Detected in single" 6 "Spermatogonia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "U-2 OS: 11.1" NA NA "unprognostic (1.31e-1)" "unprognostic (2.73e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 KRTAP6-1 "C21orf103, KAP6.1" ENSG00000184724 "Keratin associated protein 6-1" Q3LI64 21 30613431-30613930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTCAP2 KCP2 ENSG00000163463 "Keratinocyte associated protein 2" Q8N6L1 1 155169408-155173475 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.57e-2)" "unprognostic (5.93e-2)" "unprognostic (2.63e-2)" "unprognostic (2.67e-1)" "unprognostic (1.53e-1)" "unprognostic (4.76e-2)" "unprognostic (2.44e-3)" "unprognostic (3.64e-1)" "unprognostic (3.38e-1)" "unprognostic (2.13e-2)" "unprognostic (7.81e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (9.70e-11)" "unprognostic (3.17e-1)" "unprognostic (8.95e-2)" "unprognostic (6.30e-2)" "unprognostic (4.94e-3)" 43.7 39.6 25.5 30.1 28.8 27.7 71.1 14.4 27.4 49.9 39.6 26.9 64.5 30.1 47.3 69.0 39.2 35.4 53.1 54.5 25.3 26.9 52.5 71.9 40.2 72.8 28.4 23.0 46.3 144.2 27.2 42.0 49.1 29.8 40.5 35.8 35.8 87.6 91.5 38.2 27.4 44.8 40.3 34.5 38.4 42.1 46.4 21.5 42.6 74.8 36.0 41.8 37.5 37.3 69.6 121.1 74.4 51.5 43.7 77.3 62.3 22.9 42.1 20.1 22.5 60.8 42.9 21.0 27.5 32.5 32.5 26.5 52.2 45.8 17.8 44.3 50.7 19.2 31.2 22.1 31.4 20.5 24.7 47.1 19.5 47.1 25.9 56.5 38.5 21.1 40.5 71.8 37.5 49.1 25.2 29.0 35.2 28.2 83.0 33.0 77.7 17.9 36.3 20.1 80.9 56.6 22.7 13.0 95.5 48.1 34.6 31.8 20.3 27.8 48.4 29.7 30.8 36.1 25.5 19.1 20.5 19.5 17.8 26.2 46.5 35.9 28.6 35.0 27.9 22.9 74.4 51.5 50.7 68.1 40.9 76.8 69.6 77.3 71.9 53.6 60.2 58.9 63.3 22.4 43.7 33.6 121.1 70.3 62.3 25.5 28.8 14.4 27.4 25.3 26.9 28.4 23.0 29.8 21.5 65.5 91.4 132.0 46.6 56.1 13.2 1.0 170.7 168.6 108.1 197.1 3.9 69.0 38.1 180.8 194.5 164.1 160.7 70.0 259.6 175.7 160.0 45.7 83.1 218.4 144.7 7.9 126.6 183.0 173.2 53.9 211.5 152.7 239.6 85.6 209.2 30.2 227.0 198.6 154.5 134.1 9.9 116.4 109.9 280.1 70.9 79.2 78.7 132.0 157.9 49.3 KRTCAP3 KCP3 ENSG00000157992 "Keratinocyte associated protein 3" Q53RY4 2 27442366-27446481 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.8" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 157.5;Undifferentiated cells: 162.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "MAIT T-cell: 6.9;memory B-cell: 5.4;memory CD4 T-cell: 6.2;memory CD8 T-cell: 3.2;naive B-cell: 4.6;naive CD4 T-cell: 7.0;naive CD8 T-cell: 3.3;T-reg: 4.8" "Group enriched" "Detected in many" 19 "B-cells: 5.4;T-cells: 7.0" "Cell line enhanced" "Detected in some" "A-431: 28.1;CAPAN-2: 32.2;HaCaT: 10.3;OE19: 14.3;SCLC-21H: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047136, HPA060203" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA047136: AB_2679949, HPA060203: AB_2684221" "prognostic favorable (2.67e-5)" "unprognostic (5.93e-2)" "unprognostic (5.03e-2)" "unprognostic (3.41e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (1.44e-2)" "unprognostic (4.63e-2)" "unprognostic (1.04e-1)" "unprognostic (3.73e-3)" "unprognostic (3.79e-2)" "unprognostic (8.21e-2)" "unprognostic (9.42e-3)" 0.9 1.0 0.5 10.0 0.8 0.5 6.3 1.3 1.7 4.6 24.4 0.7 13.3 16.2 1.5 3.2 8.5 9.8 16.5 1.7 0.7 0.3 4.8 6.5 11.8 1.9 0.7 1.4 2.7 28.8 3.3 6.9 1.5 1.5 9.7 6.2 1.9 17.4 22.6 1.0 4.9 34.8 0.9 0.9 1.0 16.7 1.8 0.8 2.3 12.3 6.9 5.4 7.6 4.5 5.4 0.0 0.1 0.0 0.3 7.0 1.8 28.1 0.2 0.7 0.5 0.0 0.0 5.9 0.0 0.0 0.0 0.1 9.0 32.2 0.2 0.2 0.0 0.0 10.3 0.2 7.3 0.0 0.2 0.2 0.0 0.2 0.6 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.1 0.0 0.7 0.3 0.1 0.0 7.5 0.3 1.9 6.1 14.3 0.1 0.1 0.2 0.7 0.0 0.0 15.1 0.5 0.4 9.4 0.6 0.5 0.2 0.2 0.0 0.3 0.7 0.3 0.2 1.6 1.1 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.6 0.0 6.9 5.4 6.2 3.2 0.0 4.6 7.0 3.3 0.0 0.3 0.0 0.0 4.8 1.8 0.5 0.8 1.3 1.7 0.7 0.3 0.7 1.4 1.5 0.8 20.8 18.0 3.7 106.9 20.7 2.6 0.2 86.6 56.2 43.3 40.1 7.9 15.0 5.0 85.6 4.7 0.8 81.3 0.0 157.5 26.3 1.5 101.7 4.6 12.1 1.8 1.6 59.7 1.3 0.6 3.6 0.3 1.8 6.8 4.6 108.5 1.5 121.7 98.2 0.0 4.9 5.9 0.0 1.0 2.7 33.8 13.6 6.6 1.0 162.2 123.8 KTN1 "CG1, KIAA0004, KNT" ENSG00000126777 "Kinectin 1" Q86UP2 14 55559072-55701526 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003178, CAB015331, HPA017876" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652" "unprognostic (7.00e-3)" "unprognostic (2.99e-2)" "unprognostic (8.60e-2)" "unprognostic (5.50e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.83e-5)" "prognostic unfavorable (3.76e-4)" "unprognostic (1.75e-1)" "unprognostic (1.21e-2)" "unprognostic (1.01e-1)" "unprognostic (9.08e-2)" "unprognostic (8.72e-2)" "prognostic favorable (1.01e-6)" "unprognostic (1.27e-1)" "unprognostic (2.75e-1)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" 26.5 27.5 30.8 18.9 37.3 9.5 44.2 30.8 35.2 22.7 28.8 15.8 23.4 13.0 18.8 30.8 26.1 16.8 18.1 36.1 32.2 25.3 33.1 31.8 21.2 16.9 39.3 24.5 23.1 22.8 48.3 54.7 21.3 49.5 26.9 28.7 13.1 21.4 24.0 101.9 41.4 20.1 40.5 51.9 22.1 18.9 40.9 42.0 14.5 33.3 37.9 17.9 32.7 39.7 35.6 58.3 27.0 15.5 19.6 24.0 4.8 40.7 28.2 21.1 23.0 29.2 28.0 30.6 33.3 26.8 20.9 18.6 18.8 50.7 31.4 47.7 34.2 22.3 76.3 25.8 29.0 35.4 52.8 14.1 22.2 46.7 35.6 27.6 32.5 18.0 26.0 26.6 25.8 44.8 45.0 34.3 25.1 21.6 18.4 40.1 31.8 27.9 19.3 16.2 18.9 42.1 22.3 55.5 14.9 52.5 64.1 26.0 21.7 52.7 24.2 29.2 45.0 25.1 20.9 48.3 42.8 54.8 21.9 31.2 8.3 11.2 23.4 50.1 19.1 23.7 27.0 14.8 14.6 19.6 13.1 18.7 28.3 23.2 22.1 14.2 35.6 24.0 20.6 9.4 19.6 15.5 58.3 14.8 4.8 30.8 37.3 30.8 35.2 32.2 25.3 39.3 24.5 49.5 42.0 285.9 218.9 134.1 191.3 581.3 188.0 751.3 254.8 254.3 215.0 406.5 339.7 116.7 26.6 214.2 480.1 300.8 208.9 46.7 262.9 169.7 168.2 247.6 130.6 360.3 102.3 308.3 215.0 264.6 155.1 281.2 230.1 161.1 163.6 161.5 208.3 454.2 307.7 252.8 415.1 100.9 370.8 329.8 235.9 615.9 350.9 632.0 137.8 123.1 224.4 298.6 L1CAM "CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1" ENSG00000198910 "L1 cell adhesion molecule" P32004 X 153861514-153886174 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 29.6;brain: 54.5" "Group enriched" "Detected in some" 6 "Collecting duct cells: 80.3;Horizontal cells: 31.8;Melanocytes: 42.2" "Cancer enhanced" "Detected in many" "melanoma: 34.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 1.0;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 7 "B-cells: 2.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 73.5;BJ hTERT+ SV40 Large T+ RasG12V: 40.4;HeLa: 53.0;RH-30: 32.2;RPTEC TERT1: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010896 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 59000000 "Nucleoplasm, Plasma membrane" "CAB010896: AB_609903" "unprognostic (1.33e-3)" "unprognostic (3.43e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (8.51e-10)" "unprognostic (2.04e-2)" "prognostic unfavorable (3.81e-4)" "unprognostic (9.44e-2)" "prognostic unfavorable (2.36e-6)" "unprognostic (1.13e-1)" "unprognostic (9.12e-2)" "unprognostic (8.52e-3)" "unprognostic (8.02e-2)" "prognostic unfavorable (1.17e-4)" "unprognostic (3.07e-1)" "unprognostic (6.31e-2)" "unprognostic (1.69e-1)" "unprognostic (7.47e-3)" 4.4 29.6 19.9 8.0 21.9 1.2 1.7 54.5 43.6 2.8 16.3 1.5 2.0 4.9 1.7 3.0 5.3 2.6 3.2 5.2 11.2 20.6 12.3 1.3 1.3 3.7 7.3 22.4 1.4 3.0 1.0 6.1 1.4 19.3 3.5 5.7 6.2 5.9 10.8 1.6 9.9 7.6 6.1 3.5 1.7 4.8 1.5 3.4 0.0 1.2 1.3 2.6 2.3 3.9 2.2 0.0 0.0 0.0 0.0 0.3 0.2 17.9 1.4 5.4 0.0 0.0 0.0 2.3 25.5 73.5 24.6 40.4 7.3 0.1 0.0 24.3 0.1 20.6 0.7 0.6 0.4 12.9 0.0 0.1 0.0 53.0 1.1 0.0 0.0 4.0 0.1 0.3 3.7 2.5 0.0 0.0 0.0 0.0 0.0 0.1 24.4 0.0 0.5 1.2 0.0 0.9 0.0 32.2 0.1 43.2 0.3 16.2 10.6 14.3 12.7 10.3 12.7 1.3 0.3 0.0 0.0 10.8 1.1 12.1 0.2 0.3 0.1 0.1 0.2 20.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.9 21.9 54.5 30.2 11.2 20.6 7.3 22.4 19.3 3.4 0.0 0.0 0.8 0.0 1.0 8.5 0.8 0.0 0.0 0.0 80.3 3.9 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 31.8 0.0 1.8 0.0 0.0 0.9 0.0 42.2 0.0 0.0 0.8 0.0 0.0 0.0 0.2 8.6 0.0 0.4 0.0 0.1 1.1 0.1 0.0 0.0 0.1 L3MBTL2 "dJ756G23.3, DKFZP761I141, H-l(3)mbt-l" ENSG00000100395 "L3MBTL2, polycomb repressive complex 1 subunit" Q969R5 22 41205205-41231271 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000815 Approved Nucleoplasm NA NA Nucleoplasm "HPA000815: AB_1079220" "unprognostic (2.42e-1)" "prognostic favorable (6.39e-5)" "unprognostic (3.98e-2)" "prognostic favorable (4.37e-4)" "unprognostic (3.48e-1)" "unprognostic (1.19e-2)" "unprognostic (4.16e-3)" "unprognostic (1.03e-2)" "unprognostic (2.19e-1)" "unprognostic (2.26e-1)" "unprognostic (7.95e-3)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (2.07e-3)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" "unprognostic (2.19e-1)" 10.8 15.8 15.2 13.5 26.4 11.1 12.9 20.6 32.7 15.5 12.8 16.8 17.9 10.1 15.0 15.2 12.6 24.0 11.4 14.3 15.6 16.6 12.4 16.9 13.9 18.5 14.5 19.2 18.7 15.9 23.6 22.6 12.4 15.4 15.1 12.5 15.2 15.8 17.9 11.6 15.6 11.8 16.9 12.6 16.9 13.2 14.5 16.0 16.7 14.7 9.3 20.4 13.8 10.9 13.1 13.2 7.2 13.3 14.5 17.7 15.2 9.8 9.9 8.3 17.2 10.6 7.9 9.9 9.5 11.2 18.7 15.5 6.2 7.2 16.1 7.6 13.0 11.3 9.7 20.2 12.7 12.0 20.0 25.7 6.3 17.9 15.0 11.2 30.7 15.0 10.8 4.9 14.9 14.0 8.0 13.3 12.7 11.4 13.3 8.8 17.3 15.3 10.3 11.7 36.2 11.6 15.8 6.7 19.0 9.3 10.1 7.0 4.9 16.7 12.4 9.9 8.8 8.2 17.2 10.6 9.9 9.3 7.9 10.5 10.8 19.8 13.5 11.6 14.1 12.7 6.5 10.4 7.2 17.7 12.9 16.3 13.1 14.1 13.9 13.2 9.3 16.9 15.9 1.1 14.5 13.3 9.8 13.5 15.2 15.2 26.4 20.6 32.7 15.6 16.6 14.5 19.2 15.4 16.0 14.9 18.7 6.0 5.1 2.4 23.9 9.2 17.8 26.8 22.7 10.4 15.7 14.9 10.0 8.4 10.3 6.8 7.1 23.3 6.7 16.3 5.7 5.8 10.5 12.3 11.1 15.9 14.5 8.0 9.1 23.9 6.6 9.9 3.3 10.8 7.5 14.1 7.2 5.8 8.9 6.7 14.2 6.5 8.2 18.4 12.4 3.3 14.3 12.5 8.0 5.3 LAG3 CD223 ENSG00000089692 "Lymphocyte activating 3" P18627 12 6772512-6778455 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.1;ovary: 28.4" "Cell type enhanced" "Detected in many" 13 "Intestinal endocrine cells: 20.8;Leydig cells: 36.2;Peritubular cells: 65.0;T-cells: 29.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "pons and medulla: 2.7" "Cell type enhanced" "Detected in many" "gdT-cell: 11.3;MAIT T-cell: 9.2;memory CD8 T-cell: 10.0" "Lineage enriched" "Detected in single" 56 "T-cells: 11.3" "Cell line enriched" "Detected in single" 144 "HDLM-2: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002301, HPA013967" Enhanced "Secreted - unknown location" NA NA "CAB002301: AB_564101, HPA013967: AB_1846277" "unprognostic (9.39e-2)" "prognostic favorable (3.89e-4)" "unprognostic (8.88e-2)" "unprognostic (7.00e-3)" "unprognostic (1.08e-1)" "unprognostic (6.74e-3)" "unprognostic (8.85e-2)" "unprognostic (4.63e-3)" "unprognostic (1.94e-2)" "unprognostic (1.97e-3)" "unprognostic (8.71e-2)" "unprognostic (9.93e-2)" "prognostic unfavorable (4.62e-11)" "unprognostic (3.07e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" "unprognostic (8.19e-3)" 1.7 0.4 0.3 33.2 0.3 1.0 1.0 0.8 0.7 7.7 4.4 0.5 2.7 2.9 6.4 3.3 2.4 3.8 3.0 2.2 0.3 0.4 1.2 5.9 3.8 12.4 0.4 0.0 28.4 0.4 0.1 1.0 1.3 2.7 2.8 1.8 1.1 2.0 6.8 0.8 0.6 9.6 1.7 0.9 58.1 2.0 6.1 0.1 4.1 1.0 1.3 23.5 2.6 3.6 0.0 0.2 0.0 0.0 0.0 11.3 0.8 0.0 0.2 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 57.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 9.2 0.0 2.2 10.0 0.0 0.0 0.6 4.0 0.0 0.0 0.0 0.2 1.7 0.8 0.3 0.3 0.8 0.7 0.3 0.4 0.4 0.0 2.7 0.1 0.0 3.5 0.9 0.8 4.5 4.0 1.2 0.0 0.0 5.7 0.0 9.8 0.2 0.0 0.1 0.3 1.9 1.1 0.0 0.0 0.2 2.1 1.9 0.0 2.5 8.7 0.0 20.8 5.5 3.5 1.1 36.2 0.3 1.7 4.6 4.5 1.3 0.3 0.0 65.0 0.2 6.2 6.5 2.5 0.3 2.0 2.6 0.1 29.6 2.5 0.3 LAIR1 CD305 ENSG00000167613 "Leukocyte associated immunoglobulin like receptor 1" Q6GTX8 19 54351384-54370558 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.0" "Cell type enhanced" "Detected in many" 12 "granulocytes: 103.2;Hofbauer cells: 178.5;Kupffer cells: 84.4;Macrophages: 142.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 6.6;Karpas-707: 17.1;THP-1: 19.4" HPA011155 Enhanced Supported "Plasma membrane" NA NA 130000 "Plasma membrane" "HPA011155: AB_1852685" "unprognostic (1.91e-1)" "unprognostic (1.12e-2)" "unprognostic (2.81e-2)" "unprognostic (1.25e-2)" "unprognostic (2.03e-2)" "unprognostic (4.38e-2)" "unprognostic (2.16e-2)" "unprognostic (1.74e-1)" "unprognostic (5.00e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "prognostic unfavorable (5.01e-5)" "unprognostic (1.72e-1)" "unprognostic (2.72e-3)" "unprognostic (3.52e-2)" "unprognostic (5.22e-2)" 12.7 7.0 4.5 10.9 9.9 13.5 6.9 0.5 4.5 2.7 5.1 6.7 0.2 2.7 2.2 6.8 2.5 3.6 4.4 3.9 5.2 4.2 3.8 2.9 16.5 33.1 10.2 1.9 2.0 2.4 1.4 2.8 7.0 7.0 3.0 2.0 3.1 3.9 2.2 2.3 2.3 7.6 7.8 11.9 28.6 2.9 3.1 7.4 39.0 2.0 0.5 6.1 3.7 1.7 6.0 10.3 12.4 8.8 5.8 8.0 5.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 2.8 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 17.1 0.0 0.0 2.2 1.5 0.0 0.0 0.0 2.2 0.1 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 19.4 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 2.7 0.2 12.4 4.2 10.0 8.0 8.3 4.6 2.3 2.4 4.3 0.1 6.0 3.8 4.9 0.6 5.8 8.8 10.3 1.6 5.7 4.5 9.9 0.5 4.5 5.2 4.2 10.2 1.9 7.0 7.4 14.9 34.1 29.8 0.5 0.6 5.5 1.3 0.0 20.1 20.5 0.0 35.3 4.4 0.0 0.0 15.9 0.7 0.0 0.0 0.0 4.1 1.9 0.5 103.2 0.8 178.5 1.6 0.0 4.3 84.4 20.4 0.3 142.0 0.0 1.0 0.0 1.1 0.1 0.0 0.0 0.1 14.8 0.0 0.9 1.4 1.0 1.0 8.4 33.0 0.0 0.8 LAMP1 CD107a ENSG00000185896 "Lysosomal associated membrane protein 1" P11279 13 113297241-113323672 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 526.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004260, HPA014750" Supported NA NA 460000000 "CAB004260: AB_626851, HPA014750: AB_1846219" "unprognostic (3.98e-1)" "unprognostic (1.18e-1)" "unprognostic (7.55e-2)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "unprognostic (7.04e-3)" "unprognostic (9.26e-2)" "unprognostic (1.07e-1)" "unprognostic (5.80e-2)" "unprognostic (1.44e-2)" "unprognostic (2.91e-3)" "unprognostic (2.04e-1)" "prognostic favorable (4.15e-5)" "unprognostic (2.06e-2)" "unprognostic (2.22e-1)" "unprognostic (2.59e-1)" "unprognostic (1.54e-1)" 61.3 41.9 34.6 36.7 44.7 28.5 70.7 17.6 50.6 50.4 39.0 77.9 46.7 49.9 55.7 73.4 50.6 38.1 60.8 45.0 38.0 30.7 61.2 83.3 74.6 78.1 64.3 42.3 44.4 79.5 38.2 43.7 68.6 42.1 47.0 31.3 30.1 60.6 47.8 26.6 72.0 46.7 43.3 67.6 46.2 43.6 41.6 57.3 34.9 59.5 43.1 37.0 47.6 48.1 3.1 7.6 12.2 7.0 5.4 6.5 2.7 43.5 15.1 15.8 43.1 88.8 33.5 29.8 51.5 54.3 32.1 43.0 29.6 81.5 10.3 23.6 52.2 55.1 56.0 15.4 32.7 22.0 21.5 25.5 17.0 30.1 27.8 46.0 51.9 39.9 40.8 44.7 29.7 19.5 52.4 38.7 10.1 14.1 15.2 39.4 17.5 10.4 25.4 11.9 42.0 16.6 15.5 13.7 15.5 29.1 32.9 14.5 15.2 30.2 45.0 29.7 15.9 43.4 37.0 58.4 33.0 35.8 43.5 22.9 28.6 28.2 11.0 55.1 51.9 38.1 3.8 7.0 12.2 5.9 5.3 5.0 3.1 4.6 6.5 3.5 3.0 5.2 4.3 9.2 5.4 5.8 7.6 4.6 2.7 34.6 44.7 17.6 50.6 38.0 30.7 64.3 42.3 42.1 57.3 80.4 59.2 63.9 130.8 125.1 41.6 48.2 104.4 22.7 31.8 174.5 72.6 154.6 34.9 98.2 251.4 94.3 194.6 46.7 53.5 180.7 117.2 107.4 70.3 264.0 253.3 28.6 114.5 160.2 161.9 526.2 151.6 139.9 94.5 36.1 89.0 55.4 78.3 154.3 160.1 159.6 73.1 116.4 98.8 100.7 113.1 172.6 261.2 98.0 112.3 103.9 LAMP2 CD107b ENSG00000005893 "Lysosomal associated membrane protein 2" P13473 X 120427827-120469365 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Autophagy "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 336.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 112.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 112.9" "Cell line enhanced" "Detected in all" "ASC diff: 112.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005272, HPA029100, HPA029101" Supported Supported "Vesicles,Plasma membrane" NA NA 820000000 "Vesicles, Plasma membrane" "CAB005272: AB_647855, HPA029100: AB_10795022, HPA029101: " "unprognostic (2.99e-3)" "unprognostic (5.26e-2)" "unprognostic (2.66e-3)" "unprognostic (1.74e-1)" "unprognostic (3.10e-1)" "unprognostic (2.50e-2)" "unprognostic (4.84e-1)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (9.73e-2)" "unprognostic (1.11e-2)" "unprognostic (2.50e-2)" "unprognostic (2.85e-1)" "unprognostic (6.78e-2)" "unprognostic (2.66e-1)" "unprognostic (5.53e-3)" 21.8 33.6 39.9 16.1 87.9 22.6 27.1 16.2 55.5 33.0 18.3 88.7 27.9 25.1 20.8 37.5 34.6 22.4 43.3 20.9 52.5 30.3 55.0 83.7 25.3 14.3 131.0 36.9 22.7 27.4 28.8 20.2 35.4 58.6 37.3 19.7 17.2 47.8 32.9 32.4 26.9 20.5 21.1 84.3 17.9 23.6 11.9 116.9 21.2 33.7 14.3 15.4 21.1 27.0 3.7 11.6 112.9 21.7 5.4 5.8 10.5 11.7 11.6 8.6 10.9 112.3 38.3 23.6 20.3 35.4 19.7 37.0 9.6 21.0 8.3 17.9 35.2 63.0 19.7 12.4 15.3 32.2 9.3 8.8 6.5 12.9 12.9 37.4 28.7 18.2 41.5 30.9 26.3 17.4 52.1 26.9 5.9 7.5 29.7 31.9 21.6 8.0 14.7 6.6 16.8 10.2 6.2 14.5 14.8 28.9 8.7 2.9 4.5 21.7 22.1 43.3 15.8 13.1 32.1 27.8 28.4 13.8 36.5 54.7 14.9 14.2 5.4 27.1 34.7 67.9 4.9 21.7 41.3 5.0 18.7 4.0 3.1 4.8 4.7 11.6 3.7 4.3 4.1 112.9 5.4 17.3 6.3 5.8 10.5 39.9 87.9 16.2 55.5 52.5 30.3 131.0 36.9 58.6 116.9 68.5 48.0 23.8 73.6 89.6 15.0 29.0 186.0 44.2 52.4 62.8 13.7 140.2 33.2 170.8 2.3 65.2 53.1 0.0 62.0 111.7 86.5 124.2 16.3 167.8 191.1 17.5 35.2 100.7 120.2 4.2 105.3 97.6 124.9 124.4 31.2 128.8 66.8 43.5 103.3 128.2 9.3 38.8 61.8 5.6 13.2 119.1 336.5 30.5 31.0 76.1 LAMP3 "CD208, DC-LAMP, DCLAMP, LAMP, TSC403" ENSG00000078081 "Lysosomal associated membrane protein 3" Q9UQV4 3 183122213-183163839 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lung: 123.9" "Group enriched" "Detected in many" 7 "Alveolar cells type 2: 374.8;monocytes: 592.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 7.6" "Group enriched" "Detected in many" 8 "granulocytes: 7.6;T-cells: 6.6" "Cell line enhanced" "Detected in some" "EFO-21: 57.7;HDLM-2: 14.6;HHSteC: 21.4;hTCEpi: 19.5;JURKAT: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB025133, HPA051467" Enhanced Enhanced Vesicles NA NA 47000 Vesicles "CAB025133: , HPA051467: AB_2681495" "unprognostic (1.43e-3)" "unprognostic (2.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.99e-3)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (7.67e-2)" "unprognostic (8.64e-2)" "unprognostic (4.95e-2)" "prognostic favorable (9.90e-4)" "unprognostic (1.80e-3)" "unprognostic (5.80e-2)" "prognostic unfavorable (1.89e-7)" "unprognostic (3.12e-1)" "unprognostic (4.13e-2)" "unprognostic (8.35e-2)" "unprognostic (1.29e-1)" 0.5 0.7 0.4 14.1 0.4 0.0 0.5 0.3 0.4 1.0 0.6 0.1 0.6 0.4 0.4 1.0 2.5 0.5 0.8 0.4 0.4 0.4 0.8 0.6 123.9 11.2 0.4 0.1 0.4 8.3 0.0 0.6 1.0 0.6 1.0 1.7 0.2 6.8 1.9 0.4 1.9 1.4 0.8 0.5 2.0 0.8 8.4 0.0 21.3 8.3 3.1 11.3 3.3 0.9 0.4 0.0 7.6 0.1 0.8 6.6 1.1 3.5 0.1 0.0 0.5 0.0 0.0 2.8 0.0 0.9 0.6 0.1 0.8 1.8 0.0 57.7 0.3 6.5 0.5 1.2 2.2 0.1 14.6 1.7 0.0 0.1 0.1 21.4 0.0 0.5 0.3 19.5 0.0 2.6 0.0 2.6 17.7 0.1 3.4 0.1 0.0 0.8 0.1 0.1 0.3 0.8 0.0 0.0 0.2 0.0 1.1 0.2 0.1 0.2 0.1 1.5 0.7 1.1 0.1 2.7 0.0 1.0 0.1 0.0 1.2 4.3 0.1 0.0 0.0 0.0 0.4 0.1 7.6 0.4 0.0 3.2 0.1 2.7 1.7 0.0 0.4 3.5 2.0 1.9 0.8 0.1 0.0 6.6 1.1 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.1 0.6 0.0 59.6 374.8 0.5 3.2 5.4 0.0 1.2 2.5 9.4 15.9 1.8 0.0 1.9 0.0 0.6 26.0 0.5 0.0 0.0 5.3 0.2 0.2 1.2 17.4 0.0 1.3 0.0 0.0 0.0 0.0 69.6 0.6 3.1 1.7 592.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.5 5.0 1.0 0.5 0.3 2.0 LAMP5 "BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46" ENSG00000125869 "Lysosomal associated membrane protein family member 5" Q9UJQ1 20 9514358-9530524 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.1;brain: 105.2" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 57.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "basal ganglia: 105.2" "Cell type enriched" "Detected in some" 15 "plasmacytoid DC: 42.1" "Lineage enriched" "Detected in many" 30 "dendritic cells: 42.1" "Cell line enhanced" "Detected in some" "Karpas-707: 95.0;SH-SY5Y: 17.4;THP-1: 33.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004802, HPA070765" Enhanced Uncertain "Mitotic spindle,Centriolar satellite,Cytosol" NA NA Cytosol "Mitotic spindle, Centriolar satellite" "HPA004802: AB_10603682, HPA070765: AB_2686309" "unprognostic (2.78e-2)" "unprognostic (3.90e-3)" "unprognostic (5.73e-4)" "unprognostic (5.47e-2)" "unprognostic (7.89e-2)" "unprognostic (2.67e-1)" "unprognostic (3.80e-3)" "unprognostic (1.45e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (6.46e-6)" "unprognostic (5.12e-3)" "unprognostic (3.74e-2)" "unprognostic (1.08e-2)" "unprognostic (4.49e-3)" 0.5 4.1 21.6 1.5 105.2 2.0 1.0 2.3 28.6 9.1 1.3 0.6 1.8 1.3 4.6 6.0 0.6 9.7 2.9 0.6 18.7 4.1 0.9 0.5 1.1 4.8 4.5 7.7 21.2 1.3 0.3 2.0 0.4 23.2 2.3 1.4 2.6 1.4 3.6 0.3 0.5 1.4 3.8 6.7 1.4 1.6 1.1 4.8 0.0 1.1 0.0 4.7 1.2 0.6 1.4 42.1 0.9 0.5 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.1 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.9 0.5 0.0 0.0 0.1 0.0 1.4 0.0 0.0 2.8 0.1 0.0 0.0 0.1 0.0 0.0 42.1 0.0 0.7 21.6 105.2 2.3 19.1 18.7 4.1 4.5 7.7 23.2 4.8 0.0 1.4 2.2 0.0 0.1 7.5 0.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.6 5.8 0.1 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 1.1 57.2 0.0 0.0 1.2 5.6 0.6 0.2 3.3 8.2 0.0 4.0 0.2 0.0 0.0 0.0 4.9 0.0 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 LAPTM4A "HUMORF13, KIAA0108, LAPTM4, MBNT, Mtrp" ENSG00000068697 "Lysosomal protein transmembrane 4 alpha" Q15012 2 20032650-20052028 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 133.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031402, HPA031404, HPA068554" Approved Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles" "Plasma membrane" "HPA031402: AB_10669882, HPA031404: AB_10670293, HPA068554: AB_2686003" "unprognostic (2.01e-1)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (5.73e-1)" "unprognostic (6.04e-2)" "unprognostic (3.00e-2)" "unprognostic (1.53e-3)" "unprognostic (5.37e-2)" "unprognostic (1.27e-1)" "unprognostic (3.65e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (8.70e-2)" "unprognostic (1.05e-2)" "unprognostic (7.78e-3)" "unprognostic (2.18e-2)" "unprognostic (7.98e-3)" "unprognostic (2.36e-1)" 59.2 63.8 23.4 20.1 22.8 19.8 53.6 15.9 23.4 85.7 44.0 25.9 181.0 26.0 80.3 57.4 50.4 53.0 49.9 50.1 22.3 19.0 95.9 83.0 48.7 24.3 22.0 17.3 72.7 63.6 28.9 46.5 137.6 24.9 64.9 28.4 56.8 49.9 175.6 33.6 41.2 44.9 56.4 21.6 34.8 40.7 83.3 18.6 13.7 75.3 37.9 37.7 65.3 57.8 27.2 37.4 82.4 53.4 16.5 19.4 48.0 37.5 20.8 12.8 26.5 133.1 99.0 47.9 47.7 59.9 32.7 37.2 16.3 37.0 6.6 11.0 57.9 34.0 37.4 10.6 22.9 29.9 16.2 16.9 10.1 24.6 46.3 51.4 7.8 28.1 66.1 46.6 31.7 36.5 45.7 33.7 5.7 7.6 12.7 48.4 21.6 4.6 10.2 28.2 32.2 19.1 8.1 37.5 12.5 80.0 31.5 20.3 19.6 44.3 36.7 30.0 48.7 15.8 6.4 42.9 55.0 19.7 47.2 30.6 21.2 30.4 10.7 43.5 15.6 21.8 82.4 53.4 38.5 14.2 44.2 17.1 27.2 17.0 15.7 37.4 26.2 19.4 17.3 28.1 16.5 50.3 31.3 15.9 48.0 23.4 22.8 15.9 23.4 22.3 19.0 22.0 17.3 24.9 18.6 181.7 179.3 127.9 498.3 585.3 19.7 191.2 331.2 204.8 200.2 525.1 11.8 156.0 137.6 412.4 1117.0 311.4 159.7 46.7 306.5 887.8 890.1 264.1 506.1 427.2 285.9 19.1 132.5 307.6 307.4 952.2 773.5 352.6 558.5 334.6 176.2 293.0 282.2 210.1 564.6 774.3 23.0 523.9 560.6 321.9 146.0 620.4 253.3 94.8 178.7 415.2 LAPTM4B LC27 ENSG00000104341 "Lysosomal protein transmembrane 4 beta" Q86VI4 8 97775057-97853013 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 397.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.0" "Group enriched" "Detected in many" 4 "granulocytes: 5.0;T-cells: 3.5" "Cell line enhanced" "Detected in many" "HEL: 86.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020782, HPA068830" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB020782: , HPA068830: AB_2686044" "prognostic unfavorable (5.63e-4)" "unprognostic (1.91e-2)" "unprognostic (7.04e-2)" "unprognostic (6.83e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.70e-4)" "prognostic unfavorable (2.70e-6)" "unprognostic (9.25e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-1)" "unprognostic (7.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.71e-1)" "unprognostic (1.65e-1)" "unprognostic (3.14e-1)" "unprognostic (9.16e-2)" "unprognostic (1.49e-1)" 12.3 19.7 12.2 6.1 14.2 1.6 14.9 5.9 27.3 19.7 14.4 21.0 4.0 26.8 24.8 11.5 13.2 24.2 25.8 75.1 10.3 13.7 33.9 12.5 14.8 9.4 15.3 8.4 25.8 28.1 16.1 9.8 9.6 21.9 14.7 11.4 56.1 29.8 16.1 50.6 14.8 41.9 17.0 16.2 20.4 14.4 32.2 9.0 2.6 18.1 27.1 8.9 17.9 13.4 1.0 0.5 5.0 0.2 0.9 3.5 0.6 34.7 30.2 24.0 48.1 12.3 8.6 17.3 16.3 7.4 31.5 27.0 15.5 23.3 0.1 70.3 12.0 11.3 37.9 35.2 15.8 36.2 0.2 52.9 86.2 25.2 21.8 9.7 0.0 16.8 12.9 10.0 22.5 11.5 10.6 4.7 10.9 62.8 0.1 12.5 22.3 8.1 4.4 46.0 15.2 19.0 0.0 12.2 0.0 74.0 17.0 25.8 43.7 18.7 8.6 21.0 28.0 22.1 10.9 1.3 8.3 16.3 14.7 10.7 3.9 11.9 0.2 9.3 0.0 20.5 5.0 0.2 0.0 1.4 0.0 3.5 1.0 1.3 1.1 0.5 0.3 2.3 2.5 0.4 0.9 0.1 0.3 0.7 0.6 12.2 14.2 5.9 27.3 10.3 13.7 15.3 8.4 21.9 9.0 95.3 44.3 3.6 46.8 49.0 192.0 174.6 91.7 6.7 19.4 101.2 210.1 23.4 33.2 202.9 6.3 36.0 24.5 0.0 110.3 32.0 43.2 49.2 12.7 30.4 6.9 127.1 34.0 98.8 3.2 7.0 22.2 7.7 40.5 4.6 24.5 101.1 68.4 34.3 29.0 46.1 397.0 58.2 31.9 7.6 39.3 38.8 11.8 7.5 49.0 77.9 LAPTM5 ENSG00000162511 "Lysosomal protein transmembrane 5" Q13571 1 30732469-30757820 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 166.6;bone marrow: 157.5;lymphoid tissue: 144.5" "Group enriched" "Detected in many" 5 "B-cells: 749.7;granulocytes: 621.6;Hofbauer cells: 1099.3;Kupffer cells: 831.6;Macrophages: 787.9;T-cells: 409.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 47.1;HEL: 89.3;HL-60: 56.6;HMC-1: 211.5;REH: 66.3;U-698: 76.8;U-937: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051293 Approved Approved Cytosol NA NA Cytosol "HPA051293: AB_2681424" "unprognostic (3.12e-2)" "prognostic favorable (3.40e-4)" "unprognostic (6.86e-2)" "unprognostic (4.05e-3)" "unprognostic (1.63e-1)" "unprognostic (8.45e-2)" "unprognostic (1.43e-1)" "unprognostic (3.76e-1)" "unprognostic (1.22e-3)" "unprognostic (2.30e-1)" "unprognostic (6.75e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (9.47e-2)" "unprognostic (8.18e-3)" "unprognostic (5.98e-2)" "unprognostic (3.94e-2)" 56.0 15.5 11.5 59.1 17.8 157.5 15.0 2.2 10.4 8.2 11.2 20.7 1.8 9.5 7.5 6.8 8.3 13.7 19.9 9.2 11.2 12.7 14.0 18.2 60.8 144.5 19.0 3.3 7.7 6.3 2.0 6.8 20.1 14.6 8.2 13.2 7.4 11.7 4.7 4.0 5.5 37.1 12.9 33.8 130.9 9.5 6.7 15.8 75.2 10.1 5.2 91.2 21.4 6.4 98.2 69.1 145.1 109.3 26.0 55.4 166.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.1 4.9 0.1 0.1 0.1 0.0 0.0 0.0 5.2 0.0 89.3 0.0 0.1 0.0 56.6 211.5 0.0 0.1 0.0 0.3 0.0 10.8 6.1 1.1 2.9 0.7 0.0 9.7 11.9 0.0 0.0 0.0 66.3 8.7 32.9 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 36.0 12.5 0.0 0.2 0.0 0.2 0.2 0.0 76.8 0.2 46.2 0.1 73.5 109.3 115.3 47.7 87.9 55.4 70.2 43.7 44.6 69.1 98.2 44.2 43.1 145.1 26.0 83.9 33.2 53.7 166.6 11.5 17.8 2.2 10.1 11.2 12.7 19.0 3.3 14.6 15.8 23.8 148.6 749.7 1.1 21.2 0.0 5.6 10.2 18.7 25.0 3.5 0.0 5.6 0.0 0.4 1.5 31.3 0.7 0.0 0.6 5.1 16.6 0.8 621.6 4.2 1099.3 0.0 1.2 36.2 831.6 1.7 1.4 787.9 47.2 70.3 0.6 0.2 0.9 0.0 0.4 2.2 1.3 0.0 6.8 0.3 0.3 17.6 7.4 409.7 0.3 1.6 LARGE1 "KIAA0609, LARGE" ENSG00000133424 "LARGE xylosyl- and glucuronyltransferase 1" O95461 22 33162226-33922841 "Disease related genes, Predicted intracellular proteins" "Glycosyltransferase, Multifunctional enzyme, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 43.1" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 5.1;Club cells: 4.5;Ductal cells: 6.3;Exocrine glandular cells: 6.9;Hofbauer cells: 4.6;Pancreatic endocrine cells: 5.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 5.8" "Group enriched" "Detected in many" 4 "B-cells: 5.8;granulocytes: 1.9" "Cell line enhanced" "Detected in many" "U-266/84: 19.2" "Low region specificity" "Detected in all" NA NA "unprognostic (1.16e-1)" "unprognostic (7.77e-3)" "unprognostic (3.79e-1)" "unprognostic (1.74e-3)" "unprognostic (1.63e-1)" "unprognostic (1.48e-2)" "unprognostic (4.90e-2)" "unprognostic (1.39e-2)" "unprognostic (5.21e-3)" "unprognostic (6.00e-2)" "unprognostic (2.12e-2)" "unprognostic (1.35e-2)" "unprognostic (7.12e-3)" "unprognostic (1.19e-1)" "unprognostic (3.68e-2)" "unprognostic (2.93e-1)" "unprognostic (3.96e-3)" 3.2 2.8 4.4 3.2 6.9 0.0 3.2 4.7 10.6 5.1 7.7 3.2 3.2 2.9 7.2 3.2 3.2 3.5 3.3 16.6 6.8 2.0 3.2 3.2 3.2 3.2 3.2 3.2 9.2 3.9 2.0 3.2 3.2 3.2 7.0 4.5 3.2 3.2 10.7 18.0 2.0 3.2 7.6 3.2 3.2 4.8 43.1 3.2 3.2 3.2 3.2 3.2 6.8 3.3 5.8 0.3 1.9 0.2 0.4 0.8 0.1 3.0 8.1 11.9 5.1 2.8 0.9 5.6 9.6 4.4 1.4 0.0 2.2 0.4 11.8 1.9 10.9 3.3 1.5 7.6 0.0 0.3 0.2 6.0 0.0 0.1 7.3 3.8 0.0 1.3 1.4 0.7 0.2 0.0 0.1 0.0 0.2 0.2 2.0 3.1 9.1 0.1 6.0 5.0 8.9 0.6 7.5 11.6 2.1 3.2 12.1 4.9 2.0 4.9 6.5 7.7 10.6 9.5 0.7 0.2 5.8 9.3 4.2 2.1 15.1 19.2 0.4 10.3 0.0 0.1 0.3 0.2 0.1 0.4 0.1 0.8 2.0 0.3 0.3 0.0 5.8 0.1 0.3 1.9 0.4 0.1 0.3 0.1 0.1 4.4 6.9 4.7 8.0 6.8 2.0 3.2 3.2 3.2 3.2 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.5 1.8 0.0 0.1 0.0 6.3 0.0 0.0 0.0 0.0 6.9 0.6 0.0 0.0 1.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 LARGE2 "FLJ35207, GYLTL1B, PP5656" ENSG00000165905 "LARGE xylosyl- and glucuronyltransferase 2" Q8N3Y3 11 45921621-45929096 "Predicted intracellular proteins" "Glycosyltransferase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 38.9;placenta: 29.6" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 128.7;Syncytiotrophoblasts: 97.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "pons and medulla: 2.1" "Cell type enhanced" "Detected in some" "memory B-cell: 3.5;naive B-cell: 5.8" "Lineage enriched" "Detected in many" 5 "B-cells: 5.8" "Cell line enhanced" "Detected in some" "BEWO: 17.8;NTERA-2: 16.7;SK-BR-3: 12.0;T-47d: 36.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA056621 Approved "Intracellular and membrane" NA NA "HPA056621: AB_2683194" "unprognostic (9.82e-2)" "unprognostic (3.63e-2)" "unprognostic (3.65e-2)" "unprognostic (2.43e-2)" "unprognostic (6.20e-2)" "unprognostic (4.46e-3)" "unprognostic (1.36e-1)" "unprognostic (3.93e-2)" "unprognostic (1.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.30e-2)" "unprognostic (6.94e-2)" "prognostic favorable (3.04e-12)" "unprognostic (2.31e-1)" "unprognostic (9.77e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-2)" 0.2 1.4 0.2 2.8 0.2 0.1 2.8 0.2 0.4 3.5 0.8 0.8 16.0 0.6 1.6 8.3 10.5 2.5 0.4 0.4 0.4 0.1 12.2 1.7 2.5 2.8 0.2 0.2 1.8 38.9 9.5 6.6 29.6 2.1 5.8 0.2 14.8 20.7 12.7 0.2 11.1 2.3 0.7 0.2 1.6 5.2 1.2 0.2 2.0 8.1 3.9 8.1 1.3 3.7 5.8 0.0 0.1 0.0 0.8 1.1 0.2 0.6 0.8 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 4.2 0.3 0.0 0.4 0.0 0.4 4.0 0.0 7.6 0.0 0.0 2.4 0.0 0.5 4.6 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.0 4.8 0.0 0.0 1.3 0.1 0.0 16.7 6.0 0.5 0.4 0.0 1.5 0.2 0.3 4.9 0.5 0.1 12.0 0.0 1.0 36.4 0.0 0.0 0.1 5.5 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 3.5 0.3 0.9 0.0 5.8 0.2 0.4 0.1 0.8 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.4 0.4 0.1 0.2 0.2 2.1 0.2 3.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 7.0 0.0 128.7 3.3 3.5 0.0 0.0 0.0 0.0 5.5 5.5 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 97.1 0.0 0.0 0.0 LAT LAT1 ENSG00000213658 "Linker for activation of T cells" O43561 16 28984826-28990783 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Adaptive immunity, Immunity, Mast cell degranulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 10 "blood: 58.1;lymphoid tissue: 193.6" "Group enriched" "Detected in many" 5 "granulocytes: 73.2;T-cells: 103.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 18 "basophil: 38.2;gdT-cell: 47.9;MAIT T-cell: 33.5;memory CD4 T-cell: 46.9;memory CD8 T-cell: 47.9;naive CD4 T-cell: 44.6;naive CD8 T-cell: 42.6;NK-cell: 15.7;T-reg: 58.1" "Group enriched" "Detected in many" 134 "granulocytes: 38.2;NK-cells: 15.7;T-cells: 58.1" "Cell line enhanced" "Detected in some" "HEL: 31.0;HMC-1: 131.1;MOLT-4: 44.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002223, HPA011157, CAB012978" Enhanced Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 75000 "Plasma membrane" "Golgi apparatus" "CAB002223: AB_563852, CAB012978: , HPA011157: AB_1079237" "unprognostic (4.35e-3)" "unprognostic (5.17e-3)" "unprognostic (1.25e-2)" "unprognostic (1.21e-1)" "unprognostic (1.62e-1)" "unprognostic (7.15e-5)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.25e-2)" "unprognostic (1.52e-3)" "unprognostic (5.33e-2)" "unprognostic (1.02e-8)" "unprognostic (1.04e-2)" "unprognostic (5.58e-2)" "unprognostic (3.25e-1)" "unprognostic (1.51e-4)" 4.8 1.8 1.6 27.6 3.0 8.5 2.5 6.6 2.3 3.9 10.8 2.0 2.0 4.9 7.7 3.1 4.3 4.2 5.8 3.1 1.9 1.9 6.0 3.3 7.8 33.2 1.7 1.7 3.0 2.7 1.4 6.0 2.8 1.8 8.5 2.8 3.1 12.2 5.4 2.0 5.8 9.0 3.1 1.9 13.9 5.1 2.3 1.7 193.6 7.3 4.6 50.3 6.4 5.4 0.2 0.2 38.2 0.2 15.7 58.1 26.8 0.1 0.3 0.2 0.4 0.6 0.3 0.8 0.8 0.2 0.2 0.3 0.3 0.5 0.1 1.1 0.3 0.1 0.4 0.4 0.2 0.1 0.2 0.5 31.0 0.7 0.5 0.1 0.9 131.1 0.3 0.6 0.2 0.1 0.4 0.1 10.5 0.4 3.7 0.1 0.8 44.6 6.1 0.5 0.0 0.4 0.5 0.1 3.9 0.3 0.2 0.8 0.1 0.1 0.3 0.3 0.2 0.4 5.1 0.6 0.6 3.0 0.6 0.2 1.2 1.0 0.4 7.9 0.4 0.5 38.2 0.2 0.1 47.9 0.2 33.5 0.2 46.9 47.9 0.1 0.2 44.6 42.6 2.3 15.7 0.1 0.2 58.1 26.8 1.6 3.0 6.6 2.3 1.9 1.9 1.7 1.7 1.8 1.7 0.0 19.1 1.9 1.7 6.4 10.4 0.4 7.6 0.0 4.5 8.7 5.9 1.9 1.7 1.3 0.1 2.4 0.7 0.0 0.5 0.8 2.7 1.8 73.2 2.6 14.9 6.4 0.0 8.6 6.5 0.0 1.4 9.0 10.1 1.8 1.5 5.7 0.7 0.0 0.7 0.4 10.7 0.0 3.4 1.4 2.4 4.5 2.3 103.8 1.3 0.7 LAT2 "HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5" ENSG00000086730 "Linker for activation of T cells family member 2" Q9GZY6 7 74199652-74229834 "Disease related genes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Mast cell degranulation" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 98.4;lymphoid tissue: 36.7" "Cell type enhanced" "Detected in many" 12 "B-cells: 89.1;granulocytes: 165.4;Hofbauer cells: 75.1;Kupffer cells: 75.9;Macrophages: 83.0;monocytes: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 98.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "NB-4: 46.6;REH: 53.0;RPMI-8226: 19.0;THP-1: 48.0;U-937: 46.8" "Low region specificity" "Detected in all" HPA003462 Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA003462: AB_1079238" "unprognostic (1.24e-2)" "unprognostic (1.14e-2)" "unprognostic (1.32e-2)" "unprognostic (3.55e-3)" "unprognostic (1.09e-1)" "unprognostic (3.30e-3)" "unprognostic (2.79e-2)" "unprognostic (1.33e-1)" "unprognostic (9.27e-2)" "unprognostic (1.19e-1)" "unprognostic (6.34e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (1.80e-1)" "prognostic unfavorable (6.10e-4)" "unprognostic (7.44e-2)" "unprognostic (2.03e-1)" 4.6 3.7 10.3 21.4 19.3 32.8 2.5 2.7 9.6 2.8 3.9 11.6 0.5 3.3 2.5 2.4 2.5 3.8 5.9 2.4 8.8 6.5 3.0 3.8 11.6 29.3 21.9 2.5 1.4 2.8 1.0 2.8 4.4 15.7 4.5 4.7 2.3 3.6 2.2 2.7 1.8 9.9 5.0 19.3 36.7 3.6 1.6 17.6 3.2 2.4 1.0 32.7 5.8 4.6 26.8 32.5 98.4 39.5 10.0 1.3 24.7 0.4 0.2 0.2 0.8 0.0 0.0 0.3 0.3 0.3 0.2 0.2 0.5 8.1 5.3 0.1 0.1 1.6 0.2 0.0 0.3 0.1 8.5 0.3 2.1 0.3 0.3 0.0 15.5 15.6 0.1 0.2 0.5 0.1 0.3 0.0 0.2 0.3 2.4 0.2 0.3 0.3 46.6 0.2 1.3 0.5 53.0 0.2 19.0 0.0 0.4 0.2 0.2 0.1 0.3 0.2 0.2 0.2 48.0 0.6 0.6 5.6 0.2 0.4 0.2 1.5 8.3 2.7 46.8 0.3 98.4 39.5 5.9 1.3 22.3 0.1 24.4 0.3 0.1 32.5 26.8 0.1 0.4 69.1 10.0 12.4 1.2 0.6 24.7 10.3 19.3 2.7 9.6 8.8 6.5 21.9 2.5 15.7 17.6 3.0 23.9 89.1 0.6 3.1 0.0 0.8 7.6 10.7 5.7 3.5 0.0 0.5 0.0 0.0 2.3 1.0 0.0 0.0 0.2 0.9 1.4 1.0 165.4 3.2 75.1 0.0 7.5 4.9 75.9 1.9 0.0 83.0 1.7 54.1 0.2 0.3 0.6 0.0 0.7 0.0 1.3 0.0 0.7 0.4 1.1 2.3 1.0 51.6 0.4 0.5 LAX1 "FLJ20340, LAX" ENSG00000122188 "Lymphocyte transmembrane adaptor 1" Q8IWV1 1 203765176-203776233 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.7" "Group enriched" "Detected in some" 5 "granulocytes: 78.7;T-cells: 27.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 9.9;MAIT T-cell: 7.4;memory B-cell: 6.5;memory CD4 T-cell: 5.7;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.5;naive CD8 T-cell: 5.9;NK-cell: 4.6;T-reg: 6.0" "Group enriched" "Detected in many" 19 "B-cells: 6.5;NK-cells: 4.6;T-cells: 9.9" "Group enriched" "Detected in some" 4 "Karpas-707: 11.7;U-266/70: 14.4;U-266/84: 32.4;U-698: 12.3" "Low region specificity" "Detected in all" "HPA002461, HPA003887, CAB025358" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus" "CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240" "unprognostic (2.85e-3)" "unprognostic (3.83e-3)" "unprognostic (3.90e-4)" "unprognostic (3.65e-2)" "unprognostic (5.22e-2)" "unprognostic (1.03e-5)" "unprognostic (2.99e-2)" "unprognostic (4.91e-2)" "unprognostic (4.36e-2)" "unprognostic (3.31e-3)" "unprognostic (4.77e-1)" "unprognostic (4.36e-1)" "unprognostic (4.23e-4)" "unprognostic (3.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (1.51e-1)" 1.6 0.6 0.4 19.9 0.4 1.3 1.3 0.4 0.4 1.8 3.4 0.0 0.2 2.1 1.2 1.1 4.5 1.1 3.8 0.6 0.4 0.4 1.0 0.8 6.3 17.4 0.4 0.0 0.7 0.6 0.0 0.5 0.1 0.0 2.2 2.6 1.1 5.7 1.5 0.5 1.0 5.5 1.1 0.5 11.7 3.4 1.0 0.0 22.7 1.1 0.7 26.7 6.3 2.8 6.5 0.0 0.3 0.0 4.6 9.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 11.7 0.0 0.0 3.8 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 32.4 12.3 0.0 0.9 0.0 0.0 0.0 0.3 9.9 0.0 7.4 6.5 5.7 7.3 0.0 1.5 4.5 5.9 0.0 4.6 0.0 0.0 6.0 2.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 3.4 11.5 0.3 1.0 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 78.7 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.9 10.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 27.9 0.0 0.4 LAYN "FLJ30977, FLJ31092" ENSG00000204381 Layilin Q6UX15 11 111540280-111561745 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 43.8;Endothelial cells: 33.1;Peritubular cells: 51.9;Sertoli cells: 32.3;Urothelial cells: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "myeloid DC: 10.3;T-reg: 11.8" "Group enriched" "Detected in many" 111 "dendritic cells: 10.3;T-cells: 11.8" "Cell line enhanced" "Detected in many" "BJ: 39.7;BJ hTERT+: 43.3;BJ hTERT+ SV40 Large T+ RasG12V: 27.6;fHDF/TERT166: 25.7;HSkMC: 25.5;hTERT-RPE1: 25.7;U-138 MG: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040087 Approved Approved Cytosol NA NA Cytosol "HPA040087: AB_10793927" "unprognostic (2.27e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-3)" "unprognostic (1.96e-1)" "unprognostic (3.90e-2)" "unprognostic (1.83e-2)" "unprognostic (5.62e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-1)" "unprognostic (7.75e-3)" "unprognostic (4.47e-2)" "unprognostic (1.18e-1)" "unprognostic (1.61e-2)" "unprognostic (5.01e-2)" "unprognostic (1.65e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-2)" 7.7 2.3 9.3 5.9 12.8 1.3 8.0 1.7 12.5 11.3 21.2 28.9 3.0 4.0 15.1 10.5 5.3 12.8 17.0 5.6 12.6 7.5 4.1 1.4 9.6 12.4 20.6 5.9 39.5 2.3 1.6 5.4 13.1 12.3 13.2 3.8 10.9 4.4 17.9 4.8 2.1 8.2 21.7 10.1 7.5 12.1 4.6 13.1 4.6 26.9 4.8 5.0 11.3 10.1 0.0 10.3 0.0 0.0 0.0 11.8 0.4 0.1 1.0 0.2 0.0 7.1 13.7 1.9 39.7 43.3 20.1 27.6 0.0 0.0 0.0 0.3 25.7 5.0 0.8 2.5 0.2 20.8 0.0 0.1 0.2 0.0 0.0 12.1 0.0 0.0 25.5 0.0 8.3 0.0 25.7 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 3.1 0.0 0.1 0.0 1.3 4.8 0.1 0.0 0.1 9.9 0.0 0.1 0.1 29.8 22.0 0.2 19.3 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 10.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 11.8 0.4 9.3 12.8 1.7 12.5 12.6 7.5 20.6 5.9 12.3 13.1 17.9 3.2 0.0 43.8 1.9 0.2 1.4 5.1 18.7 13.6 0.0 0.0 1.1 0.0 5.9 2.2 33.1 0.0 0.0 0.2 1.2 6.5 13.4 1.1 0.0 0.7 0.0 0.0 4.3 1.2 1.3 21.0 1.3 0.0 0.0 0.0 0.2 0.7 0.0 51.9 0.0 0.1 32.3 10.8 0.0 0.7 1.9 0.5 2.2 0.0 40.4 LBR "DHCR14B, TDRD18" ENSG00000143815 "Lamin B receptor" Q14739 1 225401502-225428925 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "DNA-binding, Oxidoreductase, Receptor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 88.7" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049840, HPA062236" Enhanced Enhanced "Nuclear membrane" NA Yes "Nuclear membrane" "HPA049840: AB_2680908, HPA062236: AB_2684721" "unprognostic (2.57e-1)" "unprognostic (1.57e-1)" "unprognostic (2.14e-3)" "unprognostic (1.32e-2)" "unprognostic (7.96e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (7.30e-4)" "unprognostic (3.60e-2)" "unprognostic (1.11e-2)" "unprognostic (3.43e-2)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (6.42e-2)" "unprognostic (2.08e-1)" "unprognostic (5.45e-1)" "unprognostic (8.32e-2)" "unprognostic (2.78e-1)" 16.7 4.2 5.6 22.9 7.8 37.0 14.6 5.5 7.2 23.4 37.7 14.5 10.8 16.8 31.4 19.5 17.2 21.8 11.1 7.2 6.5 6.1 15.4 18.9 12.3 31.0 9.9 4.2 14.3 11.8 2.4 5.0 11.2 9.4 19.6 19.7 6.2 8.2 16.6 6.8 7.3 20.4 32.8 9.9 25.4 21.5 8.0 8.9 88.7 8.7 6.9 28.1 28.8 16.2 14.1 13.1 70.9 15.0 12.2 19.9 20.2 25.1 9.9 33.5 14.9 14.1 8.8 16.9 6.6 8.4 13.9 14.9 19.8 43.4 51.9 14.8 6.9 8.3 19.2 23.9 7.0 21.0 30.2 24.8 12.9 9.6 16.9 8.7 56.1 22.9 7.6 4.5 12.6 11.2 7.2 17.6 25.7 39.1 35.3 9.3 3.5 51.4 31.7 30.2 24.7 3.4 34.7 30.5 48.3 15.9 11.8 9.0 11.9 11.3 8.4 5.5 15.2 11.5 37.0 11.5 3.8 20.0 10.7 23.8 12.7 17.3 58.0 5.2 25.4 13.0 22.2 15.0 21.1 15.3 10.1 17.1 13.8 14.6 16.2 13.1 14.1 14.7 17.4 70.9 12.2 7.8 6.6 19.9 20.2 5.6 7.8 5.5 7.2 6.5 6.1 9.9 4.2 9.4 8.9 26.8 31.3 74.4 22.1 24.0 4.2 5.1 50.9 28.1 45.5 29.6 5.9 27.8 5.0 20.9 0.7 42.7 17.2 163.5 17.2 18.7 25.9 27.1 9.3 64.4 38.4 11.1 25.9 44.2 84.0 2.3 31.4 51.1 25.3 15.4 30.9 12.0 18.1 21.0 30.4 22.5 9.8 38.8 33.0 14.0 27.7 31.0 9.3 46.3 62.8 28.9 LCAT ENSG00000213398 "Lecithin-cholesterol acyltransferase" P04180 16 67939750-67944131 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Hydrolase, Transferase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "brain: 64.4;liver: 154.2" "Cell type enriched" "Detected in many" 16 "Hepatocytes: 204.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 64.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 35.6;Hep G2: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044767 Approved Nucleoplasm "Secreted to blood" NA NA 6470000000 9500000000 Nucleoplasm "HPA044767: AB_2756312" "unprognostic (3.34e-2)" "unprognostic (3.56e-2)" "prognostic unfavorable (8.50e-4)" "unprognostic (5.43e-3)" "unprognostic (1.25e-2)" "unprognostic (2.16e-1)" "prognostic favorable (4.21e-8)" "unprognostic (6.42e-2)" "unprognostic (4.26e-1)" "unprognostic (4.12e-1)" "unprognostic (1.50e-2)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (9.93e-2)" "unprognostic (1.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.90e-3)" 4.4 3.6 6.3 2.2 3.7 0.9 4.3 64.4 9.6 4.5 4.4 7.3 1.4 1.3 5.3 3.0 1.8 3.5 3.5 4.5 8.4 1.8 3.9 154.2 5.6 1.9 5.5 6.3 4.7 2.5 5.9 2.7 5.5 9.2 6.4 1.3 1.8 2.4 6.2 3.4 9.9 2.4 3.8 7.5 3.9 2.3 2.2 6.1 1.4 7.6 1.6 1.4 2.6 4.5 1.8 0.8 5.0 1.1 1.3 1.4 0.1 2.5 4.0 6.0 6.8 5.2 7.4 35.6 9.9 4.3 6.7 4.7 13.3 3.1 1.3 1.9 14.3 2.4 8.8 1.4 13.6 4.2 0.6 3.6 1.7 8.9 27.7 7.2 0.3 4.7 12.8 12.9 13.9 4.8 9.1 4.9 4.0 3.8 0.6 4.7 4.1 1.6 4.2 3.9 0.4 2.2 1.7 6.5 1.4 1.9 4.3 0.2 3.1 15.0 0.7 1.7 12.9 8.5 2.7 9.3 8.7 13.6 9.5 3.5 8.2 2.2 3.7 4.1 1.1 7.5 2.4 1.1 5.0 0.9 0.1 1.3 1.2 0.7 0.8 0.2 1.8 1.4 0.4 2.8 1.3 0.5 0.8 0.0 0.1 6.3 3.7 64.4 9.6 8.4 1.8 5.5 6.3 9.2 6.1 8.9 4.5 0.0 4.1 8.4 0.2 4.2 7.6 2.7 3.4 3.5 2.0 6.0 0.0 1.6 0.0 4.3 0.0 0.0 0.9 2.7 7.1 2.9 1.1 204.0 2.1 0.0 1.2 12.3 3.2 0.5 8.1 1.6 6.8 2.8 0.0 7.5 1.4 0.0 8.1 0.0 0.5 12.9 7.1 1.0 1.5 2.3 10.2 0.0 0.0 1.4 LCLAT1 "AGPAT8, ALCAT1, FLJ37965, LYCAT" ENSG00000172954 "Lysocardiolipin acyltransferase 1" Q6UWP7 2 30447226-30644225 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031880, HPA049217" Uncertain Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum" Cytosol "HPA031880: AB_10610002, HPA049217: AB_2680678" "unprognostic (6.60e-2)" "unprognostic (2.47e-1)" "unprognostic (1.12e-1)" "unprognostic (9.52e-3)" "unprognostic (4.10e-1)" "prognostic unfavorable (9.67e-4)" "prognostic unfavorable (8.72e-4)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (3.88e-2)" "unprognostic (7.11e-3)" "unprognostic (2.85e-2)" "unprognostic (4.14e-2)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (3.93e-3)" "unprognostic (1.10e-1)" 7.7 9.7 7.0 13.7 8.7 12.3 7.1 10.2 10.1 11.6 10.7 5.2 12.6 15.7 18.7 15.0 13.0 9.9 12.6 21.7 7.5 9.2 15.2 13.8 10.0 12.5 6.1 6.0 15.4 16.7 10.8 21.8 5.7 7.0 10.7 10.6 9.7 9.5 16.3 10.9 9.4 25.0 11.3 5.5 8.0 8.4 12.1 4.2 20.7 17.9 11.9 11.7 9.1 10.4 9.6 2.8 10.5 3.9 4.1 12.6 2.8 11.0 14.6 7.9 13.3 1.8 4.2 11.3 8.0 8.0 8.5 7.2 14.7 13.0 7.1 7.4 12.4 10.6 12.5 26.1 10.8 8.5 9.0 8.9 13.1 9.2 14.1 8.4 18.5 10.0 3.2 8.5 9.0 12.6 5.6 5.9 4.1 12.0 6.8 6.5 8.6 10.5 10.9 8.6 9.0 8.4 10.3 15.8 14.5 6.8 16.2 9.2 14.2 17.9 11.9 10.3 5.7 8.6 6.4 6.7 15.5 12.9 8.3 12.5 4.9 10.3 16.0 15.8 13.6 11.8 10.5 2.5 4.8 5.6 3.9 6.6 7.5 8.7 7.1 2.8 9.6 12.6 12.1 7.4 4.1 3.5 2.2 4.0 2.8 7.0 8.7 10.2 10.1 7.5 9.2 6.1 6.0 7.0 4.2 8.9 5.8 4.5 4.6 6.4 12.5 15.1 22.9 13.4 7.9 14.0 25.5 4.3 0.0 7.2 3.1 6.7 11.5 0.0 14.3 4.3 5.5 7.7 3.5 19.0 4.9 14.3 12.6 11.1 5.4 1.2 5.2 2.7 5.0 0.0 15.3 7.3 10.3 7.0 8.5 12.2 16.7 6.5 16.2 8.9 20.5 5.8 1.6 8.7 14.3 4.4 LCN10 ENSG00000187922 "Lipocalin 10" Q6JVE6 9 136738167-136743356 "Predicted secreted proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 21.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 8 "thyroid cancer: 1.2" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 21 "memory B-cell: 5.5;naive B-cell: 6.2" "Lineage enriched" "Detected in single" 22 "B-cells: 6.2" "Cell line enhanced" "Detected in some" "HeLa: 3.8;Hep G2: 1.3;REH: 2.1;RPMI-8226: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA055919 Approved "Secreted in male reproductive system" NA NA "HPA055919: AB_2682969" "unprognostic (2.02e-1)" "unprognostic (1.35e-2)" "unprognostic (2.62e-1)" "unprognostic (1.89e-1)" "unprognostic (5.85e-2)" "unprognostic (6.54e-3)" "unprognostic (2.22e-4)" "unprognostic (4.54e-2)" "unprognostic (3.97e-1)" "unprognostic (1.31e-1)" "unprognostic (4.14e-3)" "unprognostic (2.96e-1)" "unprognostic (2.77e-2)" "unprognostic (3.11e-2)" "unprognostic (2.52e-1)" "unprognostic (8.32e-2)" "unprognostic (3.86e-1)" 2.8 0.0 0.5 1.4 0.5 0.2 2.2 0.5 1.0 6.2 0.9 0.7 3.2 0.2 7.2 21.8 0.8 7.8 1.2 4.5 0.5 0.0 0.5 0.5 0.5 0.8 0.5 0.5 1.8 1.5 0.0 0.5 0.5 0.5 2.1 0.6 0.5 1.2 0.8 0.6 0.2 2.0 2.5 0.5 1.4 1.5 2.1 0.5 0.5 4.3 0.5 0.9 2.1 2.6 6.2 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.5 0.7 0.6 0.0 0.0 2.1 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 6.2 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.5 0.5 0.5 1.0 0.5 0.0 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCT ENSG00000115850 Lactase P09848 2 135787840-135837180 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 133 "intestine: 255.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 19 "dendritic cells: 1.9" "Group enriched" "Detected in some" 4 "JURKAT: 3.6;MOLT-4: 6.9;RPMI-8226: 13.7" "Region enriched" "Detected in single" 16 "hippocampal formation: 17.3" NA NA "unprognostic (2.21e-2)" "unprognostic (1.65e-4)" "unprognostic (2.54e-1)" "unprognostic (2.06e-1)" "unprognostic (3.39e-2)" "unprognostic (8.03e-4)" "unprognostic (3.55e-3)" "unprognostic (6.71e-3)" "unprognostic (1.89e-1)" "unprognostic (3.57e-1)" "unprognostic (1.69e-1)" "unprognostic (9.32e-2)" "unprognostic (1.64e-4)" "unprognostic (4.90e-2)" "unprognostic (8.92e-2)" "unprognostic (8.97e-2)" "unprognostic (1.02e-1)" 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.1 0.1 209.8 0.0 0.0 67.7 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 255.5 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.7 0.0 0.0 6.9 1.1 0.0 0.0 0.0 1.6 0.0 13.7 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.1 0.2 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCTL "FLJ33279, KLG, KLPH" ENSG00000188501 "Lactase like" Q6UWM7 15 66547179-66565979 "Cancer-related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.4" "Group enriched" "Detected in some" 4 "Early spermatids: 5.0;Late spermatids: 7.5;Spermatogonia: 2.7" "Group enriched" "Detected in some" 5 "glioma: 1.5;melanoma: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 6.3;hTERT-RPE1: 7.5;NTERA-2: 5.8;SuSa: 7.0;U-2 OS: 16.2;U-251 MG: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA071640 Approved "Endoplasmic reticulum,Plasma membrane" NA NA "Plasma membrane" "Endoplasmic reticulum" "HPA071640: AB_2686428" "unprognostic (4.60e-2)" "unprognostic (5.46e-2)" "unprognostic (8.70e-2)" "unprognostic (1.56e-2)" "unprognostic (3.22e-3)" "unprognostic (3.53e-2)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (4.51e-3)" "unprognostic (4.44e-16)" "unprognostic (6.06e-2)" "unprognostic (3.39e-1)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" 0.4 0.7 6.0 0.9 4.3 3.1 0.4 0.7 3.1 0.4 0.5 3.1 0.0 1.4 0.8 0.9 0.7 0.3 1.0 0.4 3.3 1.2 0.4 0.4 0.4 1.0 5.3 3.1 0.6 0.7 0.2 0.4 0.3 4.9 0.4 0.3 1.1 0.6 0.3 3.0 2.6 0.7 0.4 10.4 0.8 0.7 1.5 2.3 0.0 0.5 0.0 0.2 0.3 0.3 0.9 0.6 3.9 0.7 1.0 0.5 0.2 0.3 0.3 3.2 0.3 0.1 0.1 0.8 0.8 0.0 0.0 0.3 0.4 0.4 0.4 6.3 0.2 0.6 0.6 0.0 0.0 0.2 0.2 0.2 0.7 1.0 1.5 0.0 0.2 0.4 0.4 0.0 0.3 0.0 7.5 0.0 0.2 0.4 0.4 0.2 0.1 0.2 0.4 5.8 0.4 0.1 0.2 3.4 0.3 0.0 0.4 0.4 0.3 0.1 0.3 1.8 7.0 0.4 0.5 0.4 1.6 16.2 0.6 6.9 0.2 0.2 0.2 2.1 0.7 2.9 1.6 0.7 0.5 0.5 0.4 0.3 0.4 0.5 0.3 0.2 0.9 0.5 0.4 3.9 1.0 0.4 0.6 0.5 0.2 6.0 4.3 0.7 2.7 3.3 1.2 5.3 3.1 4.9 2.3 0.0 0.0 0.0 0.5 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.0 0.1 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 7.5 0.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 1.1 0.0 0.4 1.2 2.7 0.3 0.2 0.0 0.0 0.3 LDHA ENSG00000134333 "Lactate dehydrogenase A" P00338 11 18394388-18408425 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 249.1" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 1952.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015336, CAB069404" Uncertain Supported Vesicles,Cytosol NA NA 300000000 Cytosol Vesicles "CAB015336: AB_2134947, CAB069404: " "unprognostic (8.83e-2)" "prognostic unfavorable (2.78e-5)" "unprognostic (3.81e-2)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (4.66e-3)" "prognostic unfavorable (3.26e-8)" "prognostic unfavorable (2.27e-6)" "unprognostic (1.08e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.09e-6)" "unprognostic (1.76e-2)" "prognostic unfavorable (9.69e-9)" "unprognostic (4.15e-2)" "unprognostic (1.89e-1)" "unprognostic (3.07e-1)" "unprognostic (1.05e-2)" 84.2 56.4 24.5 52.6 32.5 64.0 56.0 22.3 40.2 38.1 53.5 13.5 9.1 60.5 24.9 36.2 77.7 29.0 31.6 59.4 24.4 33.0 100.1 249.1 37.1 59.4 29.7 25.7 49.7 34.1 10.5 16.4 49.7 44.3 33.3 51.2 45.9 46.3 37.0 199.6 70.2 128.3 50.7 35.5 45.0 31.2 25.9 23.9 45.0 56.4 90.6 60.1 81.9 44.8 27.6 76.5 29.1 61.2 32.8 52.2 72.1 131.7 82.0 3.1 46.2 72.2 49.3 44.0 127.5 135.5 112.0 166.7 36.6 21.7 99.7 41.9 128.8 80.8 106.6 82.0 195.4 242.9 34.0 48.5 34.5 74.9 62.8 17.8 85.1 25.9 49.2 90.1 44.0 44.1 189.0 66.1 31.6 48.6 48.0 131.1 34.9 70.0 53.9 19.8 43.8 102.6 45.4 32.7 83.5 178.0 30.6 24.6 30.4 69.1 57.0 23.6 50.2 26.8 20.3 59.5 140.3 50.9 122.1 1.5 38.2 55.9 95.9 200.8 44.1 47.2 28.9 53.1 29.1 38.1 61.2 42.6 27.6 50.2 40.1 76.5 19.2 32.8 33.3 18.1 32.8 59.5 25.8 52.2 72.1 24.5 32.5 22.3 40.2 24.4 33.0 29.7 25.7 44.3 23.9 68.5 191.6 171.4 331.5 1952.6 415.5 222.7 142.7 85.6 187.7 293.1 137.4 475.1 368.1 1059.9 147.3 475.2 671.1 0.0 1350.8 1780.5 725.6 281.3 256.4 438.3 607.6 486.3 43.8 182.3 215.4 106.3 266.3 427.9 1116.8 1462.6 176.8 316.6 1380.9 487.5 192.7 408.8 354.8 187.5 1239.9 102.9 38.5 1506.3 419.6 213.6 251.8 384.9 LDLR LDLCQ2 ENSG00000130164 "Low density lipoprotein receptor" P01130 19 11089362-11133816 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Endocytosis, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 369.2;Alveolar cells type 2: 436.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 23.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 23.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009647, HPA013159" Approved NA NA 12000000 "HPA009647: AB_1079243, HPA013159: AB_1852775" "unprognostic (4.39e-1)" "unprognostic (1.93e-3)" "unprognostic (2.52e-1)" "unprognostic (2.76e-1)" "unprognostic (4.03e-2)" "unprognostic (1.17e-1)" "unprognostic (6.71e-2)" "unprognostic (4.26e-2)" "unprognostic (3.73e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (6.60e-5)" "unprognostic (1.19e-1)" "prognostic unfavorable (5.92e-4)" "unprognostic (1.62e-1)" "unprognostic (2.78e-2)" "unprognostic (9.83e-2)" "prognostic unfavorable (3.43e-4)" 24.6 50.7 6.1 13.7 5.6 11.9 20.0 4.7 9.1 15.4 10.3 17.2 4.8 12.3 14.0 6.5 33.6 12.2 27.2 11.3 7.4 5.0 5.3 33.4 28.7 5.2 4.2 4.9 42.4 26.7 9.6 4.3 9.7 18.9 11.3 6.6 7.1 11.4 4.6 3.2 12.5 15.1 15.1 14.6 8.7 19.5 6.3 9.1 2.1 4.8 17.5 13.2 13.2 13.8 0.4 1.0 23.6 1.7 1.6 3.7 1.8 27.3 12.7 15.8 7.5 21.5 41.1 5.3 5.9 22.9 10.7 23.4 13.2 26.2 9.3 23.5 11.4 35.2 21.8 8.0 47.4 5.1 6.5 1.5 4.5 8.8 11.8 31.8 4.6 25.6 50.9 17.8 36.1 7.8 7.4 11.6 7.5 9.2 53.7 8.0 10.3 5.9 5.9 16.9 13.8 17.2 4.1 11.5 11.7 26.4 22.0 3.7 3.9 5.0 11.5 0.9 11.9 4.8 10.9 12.5 9.3 6.7 5.8 10.7 6.6 5.5 5.6 10.9 11.0 21.1 23.6 1.7 0.1 3.7 1.6 0.9 0.4 1.5 1.1 1.0 0.4 1.6 1.5 0.6 1.6 0.5 0.4 1.0 1.8 6.1 5.6 4.7 9.1 7.4 5.0 4.2 4.9 18.9 9.1 369.2 436.1 9.6 159.5 127.4 3.8 21.8 101.9 97.7 208.1 14.0 5.9 17.8 1.7 47.9 1.0 47.6 71.0 0.0 77.9 25.8 39.9 168.7 71.8 120.7 12.0 1.6 59.3 25.2 10.4 0.4 18.1 19.4 54.0 1.8 66.6 2.7 63.1 19.8 6.7 0.2 6.7 6.5 32.5 3.9 1.3 172.4 40.3 20.3 29.9 183.1 LDLRAD1 ENSG00000203985 "Low density lipoprotein receptor class A domain containing 1" Q5T700 1 54007299-54018186 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 64.2;lung: 16.1;ovary: 20.5" "Cell type enriched" "Detected in some" 15 "Ciliated cells: 499.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 3.7;Hep G2: 15.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA052489 Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA052489: AB_2681850" "unprognostic (6.53e-3)" "unprognostic (2.05e-2)" "unprognostic (2.51e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.59e-2)" "unprognostic (1.67e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-1)" "unprognostic (8.07e-3)" "unprognostic (2.43e-1)" "unprognostic (2.86e-1)" "unprognostic (5.23e-1)" "unprognostic (4.27e-2)" 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.1 0.1 0.0 0.0 0.6 2.1 0.4 64.2 1.1 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 20.5 0.1 0.0 1.5 0.1 0.2 0.5 0.0 0.0 2.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.8 4.8 0.0 0.0 0.7 0.5 2.1 0.4 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 3.7 0.0 1.9 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 0.3 0.8 15.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.6 0.3 0.0 0.1 1.0 0.0 0.1 0.8 0.1 0.0 0.3 0.2 0.1 0.1 0.4 0.0 0.1 0.3 0.0 0.2 2.1 0.4 0.3 0.4 0.2 0.3 0.5 0.3 0.4 0.1 0.7 0.4 0.5 2.1 0.4 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.0 7.4 0.0 0.2 0.0 0.0 0.0 0.0 499.2 34.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.6 4.7 0.0 0.1 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 LDLRAD3 LRAD3 ENSG00000179241 "Low density lipoprotein receptor class A domain containing 3" Q86YD5 11 35943981-36232136 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.5" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 19.0;Peritubular cells: 23.3;Suprabasal keratinocytes: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.1;non-classical monocyte: 7.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 28.5;RH-30: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038251 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA038251: AB_10675790" "unprognostic (1.59e-3)" "prognostic unfavorable (2.24e-4)" "unprognostic (3.25e-2)" "unprognostic (4.08e-3)" "unprognostic (1.81e-1)" "unprognostic (1.93e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (9.34e-6)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (1.68e-2)" "unprognostic (6.93e-2)" "prognostic unfavorable (5.05e-8)" "unprognostic (3.32e-2)" "unprognostic (9.21e-3)" "unprognostic (9.33e-2)" "prognostic unfavorable (2.14e-5)" 12.0 5.0 9.5 6.0 13.7 2.0 23.4 32.5 17.9 9.3 2.8 20.7 1.7 2.9 8.2 4.7 8.8 5.0 6.5 3.6 10.8 7.2 3.0 2.6 3.3 4.4 18.0 4.0 15.0 5.1 1.5 9.2 3.4 18.1 14.8 3.2 5.3 23.9 6.0 5.5 17.0 3.3 7.2 24.4 2.9 3.4 4.8 13.5 0.1 3.0 2.6 4.8 5.3 6.5 0.0 4.1 1.9 7.7 0.0 0.0 2.0 4.8 4.6 14.4 8.7 11.5 12.6 11.0 2.8 2.5 6.4 5.7 3.4 3.0 0.0 2.1 3.0 9.6 2.5 4.4 6.3 9.0 0.4 9.3 15.7 3.0 1.0 15.2 3.4 1.9 15.1 28.5 2.9 25.2 2.6 10.7 0.0 4.0 0.6 11.7 2.7 0.0 0.8 5.9 0.5 8.1 0.0 26.9 1.5 1.1 0.7 4.9 11.1 4.9 5.4 15.8 5.8 7.5 4.6 10.7 7.7 6.9 0.6 9.3 0.3 0.0 0.0 3.8 4.2 13.7 1.9 6.1 0.6 0.0 6.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 0.0 7.7 0.3 0.0 2.0 9.5 13.7 32.5 9.1 10.8 7.2 18.0 4.0 18.1 13.5 0.0 5.6 0.5 6.7 13.7 0.2 0.4 0.0 0.0 1.2 0.0 0.0 2.1 0.0 3.6 12.5 5.5 0.0 0.0 0.9 11.4 4.4 19.0 0.0 0.6 3.8 0.0 0.0 9.8 13.5 11.9 8.9 5.1 6.8 1.0 0.0 0.5 1.2 0.0 23.3 1.6 0.0 12.9 8.2 0.5 3.0 22.7 1.1 0.0 0.4 2.2 LDLRAD4 C18orf1 ENSG00000168675 "Low density lipoprotein receptor class A domain containing 4" O15165 18 13217498-13652755 "Predicted intracellular proteins, Predicted membrane proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.4;lymphoid tissue: 49.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 112.3;Late spermatids: 181.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 15.6;JURKAT: 15.5;MOLT-4: 47.7;REH: 14.4;U-698: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047633, HPA065246" Approved Supported Vesicles NA NA Vesicles "HPA047633: , HPA065246: AB_2685444" "unprognostic (2.52e-1)" "unprognostic (4.31e-3)" "unprognostic (5.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.64e-1)" "unprognostic (3.94e-3)" "unprognostic (9.73e-2)" "unprognostic (2.26e-2)" "unprognostic (2.21e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (4.58e-4)" "unprognostic (2.51e-2)" "unprognostic (4.38e-2)" "unprognostic (6.58e-2)" "unprognostic (8.18e-2)" 8.3 6.6 9.6 11.5 22.0 11.9 7.5 10.3 22.9 8.6 6.1 45.4 4.3 9.8 12.9 5.2 5.6 11.0 7.8 17.8 14.6 10.7 3.9 10.4 5.9 11.6 19.9 12.5 3.6 6.2 4.6 8.3 8.0 23.5 10.4 3.3 3.7 4.8 8.3 19.0 4.8 10.9 7.5 30.7 8.9 7.6 8.9 21.2 49.2 5.2 2.5 8.5 7.9 6.7 8.2 8.2 17.2 11.0 12.5 14.5 6.2 0.1 0.2 0.9 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.5 0.4 0.2 0.0 0.0 0.0 7.8 0.8 15.6 3.2 0.2 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 15.5 0.2 0.6 0.0 1.2 47.7 0.6 1.2 0.2 5.5 14.4 0.1 0.6 0.0 0.8 1.1 1.6 0.2 1.1 0.0 0.7 2.1 4.8 1.4 0.8 5.6 0.1 1.0 2.2 0.2 12.0 0.0 3.5 3.2 12.7 10.3 3.4 10.2 10.3 8.9 7.2 9.7 8.8 5.1 8.2 14.5 12.6 17.2 12.5 11.0 8.2 5.2 6.2 9.6 22.0 10.3 20.6 14.6 10.7 19.9 12.5 23.5 21.2 3.0 6.6 34.6 2.1 9.3 4.2 15.4 0.0 6.7 7.9 1.8 66.8 0.6 1.7 5.0 112.3 18.0 7.1 0.0 3.3 0.4 27.0 21.2 23.1 21.7 18.5 0.0 56.4 18.4 18.9 181.4 10.3 35.0 13.5 6.4 7.9 4.3 0.5 3.5 23.0 2.1 17.0 6.5 9.2 2.3 5.3 6.8 1.4 16.6 6.7 3.0 LEMD1 "CT50, LEMP-1" ENSG00000186007 "LEM domain containing 1" Q68G75 1 205381378-205457091 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 13.1;testis: 34.8" "Group enriched" "Detected in some" 129 "Early spermatids: 869.0;Late spermatids: 3077.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.6" "Group enriched" "Detected in some" 13 "cerebellum: 2.6;pons and medulla: 5.3" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 29.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045425 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA045425: AB_10960538" "unprognostic (1.78e-1)" "unprognostic (2.00e-1)" "unprognostic (1.88e-2)" "unprognostic (4.20e-3)" "unprognostic (7.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.72e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.26e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.31e-1)" "unprognostic (5.66e-6)" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-2)" 0.2 0.2 0.2 0.0 0.3 0.0 0.3 2.6 0.2 0.4 1.4 0.0 3.8 0.6 1.0 13.1 1.0 1.5 0.7 0.2 0.2 0.3 0.9 0.2 0.4 0.0 0.3 0.0 0.6 0.6 0.0 0.6 4.7 5.3 0.3 0.0 0.3 3.2 0.4 0.2 0.3 1.4 0.1 0.2 0.2 0.3 34.8 0.0 0.0 4.8 2.2 2.6 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.7 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 29.9 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.9 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.2 0.3 2.6 0.2 0.2 0.3 0.3 0.0 5.3 0.0 0.0 1.6 0.0 1.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.4 869.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3077.5 11.8 0.0 0.0 0.0 0.0 0.9 4.0 0.0 13.1 1.5 0.7 6.5 0.0 15.3 7.2 0.0 0.3 0.0 0.0 2.2 LEMD2 "dJ482C21.1, NET25" ENSG00000161904 "LEM domain containing 2" Q8NC56 6 33771202-33789136 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017340 Supported Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA017340: AB_2296925" "unprognostic (9.01e-2)" "unprognostic (7.99e-2)" "unprognostic (1.18e-1)" "unprognostic (4.12e-2)" "unprognostic (2.98e-1)" "unprognostic (8.29e-3)" "unprognostic (6.53e-2)" "unprognostic (5.98e-2)" "unprognostic (4.42e-2)" "unprognostic (7.03e-2)" "unprognostic (1.67e-3)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.43e-1)" "unprognostic (7.54e-2)" "unprognostic (3.82e-2)" "unprognostic (7.12e-2)" 18.7 24.1 23.9 22.9 30.4 37.8 23.5 49.0 26.0 25.2 22.0 31.1 17.9 21.8 24.3 28.7 23.6 22.3 20.7 19.6 24.0 18.3 22.5 22.8 23.9 28.3 32.2 17.3 28.1 26.9 31.6 28.5 29.2 25.5 24.9 21.2 28.9 23.5 24.1 17.1 34.9 25.8 25.9 21.8 34.4 21.0 20.0 27.7 18.7 28.0 15.6 27.8 18.3 27.2 5.4 6.9 6.8 4.5 3.0 7.2 2.5 12.7 14.7 25.0 24.2 14.3 15.5 18.8 14.0 21.9 18.1 19.2 11.1 13.8 12.0 19.8 20.1 51.0 22.4 14.5 18.9 12.8 12.5 13.4 4.5 14.8 14.4 30.0 9.0 15.8 16.7 36.1 19.2 33.1 30.0 19.3 16.0 12.6 14.1 15.7 10.9 16.9 22.7 14.3 19.2 8.5 11.1 10.3 10.0 19.3 18.3 17.8 14.2 8.4 26.9 18.2 26.5 18.2 25.2 8.9 25.4 9.9 13.5 16.4 18.3 14.5 8.5 10.0 14.5 30.3 3.8 4.1 6.8 5.9 3.7 7.2 5.2 6.3 5.6 3.9 5.4 5.0 6.0 3.3 3.0 4.5 6.9 6.3 2.5 23.9 30.4 49.0 26.0 24.0 18.3 32.2 17.3 25.5 27.7 3.0 7.0 8.2 11.4 9.6 17.6 9.0 5.1 2.7 2.3 8.7 17.7 22.1 1.7 7.6 19.6 15.7 15.2 23.3 5.8 29.7 12.2 11.1 12.7 6.8 15.3 41.3 5.2 12.3 13.2 30.2 9.8 11.5 11.8 5.4 16.0 14.5 11.1 17.5 15.2 6.0 12.3 19.4 15.9 17.6 7.2 8.9 24.9 11.7 14.3 11.0 LEMD3 MAN1 ENSG00000174106 "LEM domain containing 3" Q9Y2U8 12 65169571-65248327 "Disease related genes, Plasma proteins, Predicted membrane proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025078, HPA076986" Uncertain Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA025078: AB_10601908, HPA076986: AB_2686821" "unprognostic (2.10e-2)" "unprognostic (6.83e-3)" "unprognostic (1.63e-3)" "unprognostic (1.76e-3)" "unprognostic (2.79e-1)" "unprognostic (1.04e-1)" "unprognostic (1.68e-3)" "unprognostic (7.22e-2)" "unprognostic (3.06e-2)" "unprognostic (4.16e-2)" "unprognostic (8.89e-2)" "unprognostic (2.43e-1)" "prognostic favorable (2.30e-4)" "unprognostic (4.37e-2)" "unprognostic (3.93e-1)" "unprognostic (1.35e-1)" "unprognostic (1.72e-1)" 13.7 11.9 21.9 15.3 27.3 24.8 15.3 36.0 26.3 13.3 14.4 10.9 11.4 13.4 18.0 13.1 14.5 14.3 10.0 11.1 19.4 12.5 14.2 13.3 13.9 17.2 15.8 16.9 17.8 16.4 25.7 15.2 10.4 16.9 14.0 14.6 12.1 14.8 11.9 14.9 13.3 14.8 12.1 15.8 16.2 13.5 28.6 19.6 23.2 15.3 8.4 16.7 13.1 15.8 4.8 5.0 3.1 2.1 3.8 5.3 1.6 11.6 6.6 10.7 10.6 7.5 8.8 7.3 13.7 7.4 6.9 6.0 8.2 7.6 32.0 8.8 8.4 5.3 15.9 11.4 9.8 10.0 7.6 13.2 13.0 6.3 6.3 5.8 19.7 9.5 6.3 10.6 8.2 11.1 9.8 8.1 9.0 17.0 15.3 9.6 6.9 10.3 10.3 14.6 5.3 6.8 24.3 10.5 15.9 8.7 13.0 11.1 6.9 13.7 14.0 8.2 10.7 14.0 15.7 11.0 8.4 9.1 7.9 9.4 10.9 10.3 19.7 7.1 9.7 10.3 2.3 1.8 3.1 3.9 1.6 5.0 4.5 5.2 5.2 2.4 4.8 5.0 5.3 2.1 3.8 2.1 5.0 4.1 1.6 21.9 27.3 36.0 26.3 19.4 12.5 15.8 16.9 16.9 19.6 35.7 15.2 15.9 16.0 28.5 19.5 14.6 5.1 21.4 13.6 10.4 17.7 6.6 0.0 9.2 1.5 14.3 13.1 23.3 11.2 3.6 13.1 17.1 21.9 11.9 5.6 15.9 14.3 8.6 17.7 2.4 14.7 10.8 16.9 10.0 11.9 19.1 11.6 14.2 11.7 4.5 19.5 6.5 17.9 47.2 39.4 34.3 12.0 15.4 11.2 19.0 LEPR "CD295, OBR" ENSG00000116678 "Leptin receptor" P48357 1 65420652-65641559 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 82.8" "Cell type enhanced" "Detected in many" 18 "Endothelial cells: 59.1;Hepatocytes: 196.4" "Cancer enriched" "Detected in many" 7 "liver cancer: 13.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 15.7;K-562: 46.5;RPTEC TERT1: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030899 Approved Supported "Secreted to blood" NA NA 8240000 8300000 "HPA030899: AB_10610003" "unprognostic (1.59e-2)" "unprognostic (1.09e-3)" "unprognostic (3.09e-1)" "unprognostic (8.95e-2)" "unprognostic (2.32e-1)" "unprognostic (2.64e-1)" "unprognostic (2.58e-1)" "unprognostic (2.30e-1)" "unprognostic (1.78e-1)" "unprognostic (6.59e-3)" "unprognostic (1.79e-1)" "unprognostic (2.41e-1)" "unprognostic (7.53e-2)" "unprognostic (1.11e-1)" "unprognostic (2.27e-1)" "unprognostic (3.49e-2)" "unprognostic (1.73e-1)" 15.9 5.5 3.8 3.7 4.3 3.3 23.5 2.5 3.9 15.0 9.2 5.6 5.4 3.2 20.6 7.3 10.9 11.7 10.1 9.2 4.3 4.9 14.6 82.8 20.3 9.0 4.9 3.3 18.4 16.7 3.9 13.1 12.8 8.2 10.8 4.1 18.1 12.0 5.7 5.6 10.2 7.3 12.9 7.0 6.4 11.9 6.6 3.1 1.9 13.1 11.2 6.9 13.6 8.6 0.6 1.8 6.9 1.9 1.1 2.3 1.8 1.3 0.8 1.1 1.2 5.0 4.7 3.9 5.9 3.4 2.0 1.9 0.6 3.2 0.5 4.4 7.5 0.5 1.1 0.9 5.2 5.5 7.0 1.5 7.7 3.6 0.1 3.0 0.5 0.6 13.2 3.0 1.2 4.7 15.7 5.9 0.6 46.5 0.9 9.5 0.3 0.6 0.1 1.8 0.8 0.1 0.1 0.9 0.3 22.5 0.6 0.7 11.4 1.4 0.6 1.6 6.7 2.1 2.1 2.2 2.1 4.4 0.4 3.2 1.3 0.9 0.2 4.5 2.2 2.0 6.9 1.9 2.8 1.3 1.5 1.3 0.6 1.1 1.1 1.8 0.3 0.9 1.5 1.1 1.1 1.7 1.2 2.3 1.8 3.8 4.3 2.5 3.9 4.3 4.9 4.9 3.3 8.2 3.1 0.0 16.5 3.0 1.9 31.4 4.9 3.5 10.2 2.7 4.5 8.7 0.0 1.2 3.3 1.5 1.0 59.1 0.4 0.0 0.9 2.3 20.2 3.3 1.1 196.4 1.9 1.6 0.0 27.6 6.5 1.5 31.9 5.8 33.7 2.8 0.9 0.0 1.6 1.7 7.1 6.8 0.9 0.0 17.7 1.1 0.6 25.7 2.2 0.5 0.8 1.4 LEPROT "FLJ90360, OB-RGRP, OBRGRP, VPS55" ENSG00000213625 "Leptin receptor overlapping transcript" O15243 1 65420587-65436007 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 60.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069444 Approved Centrosome NA NA Centrosome "HPA069444: AB_2686137" "unprognostic (3.64e-2)" "unprognostic (2.24e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.22e-1)" "unprognostic (6.13e-3)" "unprognostic (1.52e-1)" "unprognostic (2.21e-1)" "unprognostic (4.88e-2)" "unprognostic (6.85e-2)" "unprognostic (6.43e-3)" "unprognostic (2.25e-2)" "unprognostic (4.56e-3)" "unprognostic (2.25e-3)" "unprognostic (8.22e-2)" "unprognostic (1.67e-2)" "unprognostic (1.45e-2)" 37.3 30.0 13.9 12.6 14.0 17.1 37.8 9.2 13.3 25.4 20.5 18.0 16.1 12.5 42.6 18.4 25.5 20.7 20.8 22.1 11.4 11.0 50.7 31.1 26.3 24.5 16.5 10.1 28.7 30.8 22.5 21.7 44.3 18.9 25.4 16.9 30.4 21.4 20.5 13.6 16.2 23.5 26.2 20.0 24.3 18.1 17.4 11.7 6.5 34.2 14.0 14.7 28.5 19.5 2.2 8.1 15.3 18.0 4.1 4.9 8.4 10.7 4.5 4.7 2.0 41.7 28.2 15.0 16.6 23.3 13.5 13.7 3.8 6.8 2.5 9.6 16.6 16.0 6.7 2.5 6.9 17.3 11.5 2.6 12.3 5.8 6.9 11.5 2.4 6.6 38.6 17.6 10.8 8.5 17.9 15.4 1.7 7.3 6.1 24.2 2.7 0.9 2.8 7.5 3.7 4.9 0.5 10.4 3.8 60.6 8.0 4.8 6.4 10.1 9.0 9.6 18.9 6.9 4.6 18.0 13.7 10.1 10.5 6.2 7.5 6.6 1.1 11.0 6.3 8.7 15.3 12.7 10.7 4.1 12.7 4.9 2.2 3.9 3.7 8.1 1.5 3.9 3.8 11.8 4.1 18.0 6.7 3.0 8.4 13.9 14.0 9.2 13.3 11.4 11.0 16.5 10.1 18.9 11.7 154.9 49.4 25.7 74.0 51.2 17.8 51.3 89.2 85.6 66.0 169.3 21.6 193.8 69.6 117.2 5.0 175.0 47.0 46.7 125.5 93.2 138.0 69.9 60.2 71.7 95.6 36.5 53.6 190.3 110.3 5.1 184.1 107.1 69.2 63.1 58.2 82.8 129.1 63.0 140.0 131.1 26.2 187.5 142.2 17.1 17.5 58.5 307.6 40.3 43.3 74.9 LEPROTL1 "my047, Vps55" ENSG00000104660 "Leptin receptor overlapping transcript like 1" O95214 8 30095398-30177208 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047911 Uncertain NA NA "HPA047911: AB_2680206" "unprognostic (4.42e-2)" "unprognostic (1.33e-2)" "prognostic favorable (9.04e-4)" "unprognostic (1.92e-2)" "unprognostic (3.77e-2)" "unprognostic (4.56e-2)" "unprognostic (1.25e-3)" "unprognostic (5.24e-2)" "unprognostic (2.44e-1)" "unprognostic (4.73e-3)" "unprognostic (2.30e-1)" "unprognostic (9.44e-3)" "prognostic unfavorable (1.94e-5)" "unprognostic (3.03e-1)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (2.53e-1)" 26.2 41.7 16.1 23.4 19.9 33.4 34.3 18.8 27.5 15.6 19.8 16.3 12.0 15.8 18.8 19.6 15.4 15.8 18.2 27.3 21.5 18.0 21.6 32.3 23.5 60.0 16.3 18.5 17.8 26.7 14.4 14.3 56.0 18.9 14.3 19.2 19.3 17.0 16.9 10.2 17.0 20.6 17.3 21.2 27.2 17.6 24.5 15.0 49.8 14.2 10.0 25.0 17.1 14.4 7.2 21.4 43.7 27.6 19.4 74.4 46.5 16.6 19.5 29.7 22.4 15.1 11.5 12.7 23.5 18.0 15.5 25.1 16.0 17.5 10.0 21.0 20.2 20.0 15.8 21.4 16.0 24.6 14.0 12.6 30.9 15.5 29.3 23.1 10.8 25.1 13.3 17.0 17.1 11.0 19.0 19.3 24.4 30.5 17.6 18.0 20.2 25.0 12.9 22.8 29.0 12.2 18.0 11.8 11.1 19.2 19.5 7.7 24.3 13.2 13.2 22.1 19.7 12.2 10.9 16.1 10.6 51.1 8.7 17.5 7.6 9.7 20.2 14.9 21.2 23.6 41.9 22.8 30.9 29.0 22.1 37.7 7.2 51.0 35.6 15.8 6.8 74.4 54.8 43.7 19.4 27.6 21.4 62.6 46.5 16.1 19.9 18.8 27.5 21.5 18.0 16.3 18.5 18.9 15.0 32.8 49.7 49.1 14.1 26.0 21.8 35.6 45.9 34.8 22.7 40.1 11.8 48.7 16.6 95.2 88.6 58.5 31.4 46.7 88.4 89.6 40.4 14.0 138.5 78.3 89.1 19.1 31.7 71.2 86.4 65.5 32.8 90.7 59.1 44.1 29.5 25.6 88.3 34.5 24.8 66.5 23.8 51.8 30.1 87.4 61.2 30.4 43.4 156.9 28.3 14.8 LETM1 SLC55A1 ENSG00000168924 "Leucine zipper and EF-hand containing transmembrane protein 1" O95202 4 1811479-1856247 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011029, HPA011100" Supported Supported Mitochondria NA NA Mitochondria "HPA011029: AB_1852804, HPA011100: AB_1852802" "unprognostic (1.16e-1)" "unprognostic (1.80e-1)" "unprognostic (3.85e-2)" "unprognostic (5.04e-2)" "unprognostic (5.48e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.37e-3)" "unprognostic (1.87e-1)" "unprognostic (3.29e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.77e-4)" "prognostic favorable (8.90e-4)" "unprognostic (8.06e-3)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (2.42e-1)" 16.9 15.3 11.9 11.2 13.1 9.9 16.8 17.3 19.9 6.7 23.7 10.0 7.5 20.3 8.5 6.9 22.0 8.1 15.0 18.9 10.2 10.2 16.2 20.4 9.4 10.7 10.6 10.5 9.5 19.7 13.0 8.7 7.6 10.7 8.2 16.3 9.2 9.7 7.2 17.2 18.5 19.4 8.0 7.7 10.6 15.6 12.6 9.0 50.7 10.9 19.9 16.6 8.0 9.7 5.0 14.7 3.8 5.6 6.7 7.1 2.1 12.0 20.6 6.4 19.8 9.9 6.9 11.5 12.0 5.9 12.1 9.5 19.0 13.5 20.0 8.6 12.5 18.9 12.3 16.3 16.9 7.4 13.2 17.0 20.4 16.7 13.6 12.8 20.7 16.8 11.3 12.2 13.8 12.2 5.6 10.4 12.3 26.8 12.6 8.3 13.3 29.9 23.7 16.8 13.2 23.7 17.2 9.0 11.7 9.4 16.9 16.4 14.4 13.7 17.3 7.1 5.8 16.3 10.8 15.6 13.9 8.3 11.7 19.9 11.0 16.8 15.9 12.3 18.1 11.1 3.8 4.5 2.1 7.1 5.6 7.0 5.0 6.0 6.1 4.7 4.6 4.0 5.9 0.7 6.7 5.3 14.7 4.6 2.1 11.9 13.1 17.3 19.9 10.2 10.2 10.6 10.5 10.7 9.0 14.9 7.8 27.6 25.3 35.5 17.1 18.2 7.6 1.4 9.1 26.2 31.4 14.6 26.6 22.9 25.3 14.3 78.7 23.3 27.0 18.4 16.4 20.8 10.3 24.1 19.6 14.3 15.0 16.5 15.3 31.9 18.7 15.0 18.6 10.0 27.0 11.6 31.9 43.2 15.6 38.2 26.2 12.9 19.8 34.8 40.1 44.7 12.7 20.2 29.9 41.9 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.8;testis: 28.6" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 41.6;Late spermatids: 34.7;Pancreatic endocrine cells: 29.9;Spermatocytes: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 16.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.8;hTERT-HME1: 15.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 50.6" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 2.3 1.3 3.3 1.7 7.9 6.8 1.5 9.9 6.6 2.6 1.3 2.9 0.5 1.5 2.1 2.1 2.1 2.1 2.0 1.4 4.3 4.1 3.5 1.4 3.2 1.7 3.1 4.2 2.6 1.4 3.6 5.5 6.7 3.3 1.9 1.5 3.0 1.4 1.4 0.8 1.8 1.1 1.2 3.2 2.3 4.1 28.6 1.6 3.8 1.6 1.0 2.2 3.1 1.7 1.4 1.3 16.8 3.8 1.2 4.0 1.2 13.8 2.5 1.9 1.8 1.5 4.3 1.4 4.7 5.6 6.7 4.1 1.0 5.5 1.7 11.1 1.0 2.0 1.5 3.8 16.8 7.0 0.8 1.6 2.0 1.9 2.5 1.9 0.3 1.9 1.2 4.7 7.1 15.3 3.6 7.0 2.2 1.7 2.7 5.9 2.9 5.0 1.2 0.4 1.0 11.8 1.7 3.1 1.0 11.0 0.6 1.6 1.6 1.6 0.3 0.5 1.3 1.6 0.8 12.1 2.1 14.8 3.8 1.1 1.8 1.0 1.3 3.3 2.2 1.6 0.9 3.4 0.5 0.9 1.3 1.5 1.4 0.8 1.3 1.3 1.4 1.6 1.5 16.8 1.2 3.8 0.6 4.0 1.2 3.3 7.9 9.9 6.6 4.3 4.1 3.1 4.2 3.3 1.6 3.0 5.4 0.5 11.6 0.5 7.0 1.6 5.1 4.0 2.3 5.2 5.9 1.4 1.7 3.5 41.6 2.6 0.2 0.0 17.9 4.8 2.2 2.1 9.2 0.0 1.3 6.4 0.0 1.3 1.5 34.7 2.0 2.5 1.7 1.0 1.4 3.5 29.9 0.0 1.4 2.2 8.2 0.0 2.8 24.4 1.5 0.6 6.8 3.8 1.0 4.4 LETMD1 "HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3" ENSG00000050426 "LETM1 domain containing 1" Q6P1Q0 12 51047962-51060424 "Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074361 Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Mitochondria "Nucleoplasm, Nucleoli" "HPA074361: AB_2686682" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.11e-1)" "unprognostic (2.20e-2)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "unprognostic (5.05e-2)" "unprognostic (7.86e-2)" "unprognostic (6.57e-2)" "prognostic favorable (3.26e-4)" "unprognostic (4.07e-1)" "unprognostic (7.79e-2)" "unprognostic (2.58e-1)" "prognostic favorable (3.16e-4)" 25.7 27.5 23.0 18.1 31.2 17.1 27.1 23.1 37.5 18.6 26.8 18.8 21.5 31.9 22.9 22.4 16.2 30.0 23.5 16.4 21.2 19.0 29.3 35.1 16.6 18.5 20.6 21.3 34.3 38.6 28.5 20.2 12.3 21.6 19.1 26.1 22.6 28.2 24.0 23.8 18.5 28.5 18.7 21.4 17.5 22.6 15.5 14.3 19.9 34.1 10.7 20.1 20.3 14.8 11.3 7.2 2.9 11.6 8.6 17.1 9.3 7.4 6.7 5.0 13.5 22.8 37.4 5.1 7.7 12.8 8.1 9.2 16.2 15.4 19.7 9.6 8.3 5.9 13.9 10.3 10.4 9.4 7.1 12.9 14.1 9.3 12.7 15.1 12.7 10.3 31.5 33.7 9.6 22.8 24.8 8.2 19.1 14.6 14.3 11.1 11.6 8.9 12.3 3.4 9.3 18.3 7.6 6.1 10.7 10.2 11.4 15.0 6.9 5.8 13.1 17.6 5.3 20.7 11.6 6.2 5.1 5.5 8.4 4.4 13.0 20.2 8.4 9.5 8.3 3.6 2.5 7.3 2.9 8.6 7.8 12.5 11.3 14.2 10.6 7.2 8.1 17.1 15.5 2.4 8.6 11.6 6.4 12.6 9.3 23.0 31.2 23.1 37.5 21.2 19.0 20.6 21.3 21.6 14.3 20.8 22.7 30.4 41.1 44.1 20.2 12.5 22.9 25.4 11.4 22.7 9.8 40.0 77.9 12.6 6.3 19.6 22.0 23.3 28.4 18.9 32.4 29.0 25.3 16.3 26.2 17.5 26.7 20.3 41.0 11.9 30.2 21.2 37.1 17.2 34.4 24.4 16.0 28.1 28.7 31.5 16.5 25.8 38.1 20.6 19.4 38.8 23.3 42.4 49.8 24.8 LFNG SCDO3 ENSG00000106003 "LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" Q8NES3 7 2512529-2529177 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 55.0" "Cell type enhanced" "Detected in many" 12 "Intestinal endocrine cells: 84.0;Kupffer cells: 31.7;Mucus-secreting cells: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.5;OE19: 22.3;RH-30: 23.0;U-2 OS: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069130 Approved "Intracellular and membrane" NA NA 620000 "HPA069130: AB_2686091" "unprognostic (4.58e-2)" "unprognostic (1.17e-2)" "unprognostic (2.52e-2)" "prognostic favorable (6.36e-4)" "unprognostic (1.85e-2)" "unprognostic (8.34e-2)" "unprognostic (4.15e-1)" "unprognostic (7.86e-2)" "unprognostic (1.91e-1)" "unprognostic (2.25e-1)" "unprognostic (8.55e-3)" "unprognostic (1.89e-1)" "unprognostic (5.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.09e-1)" "unprognostic (1.97e-2)" "unprognostic (2.28e-2)" 10.4 4.9 8.3 12.6 13.5 6.5 15.7 8.3 12.0 10.9 17.3 11.2 0.8 11.9 15.0 5.9 7.9 4.1 16.9 10.1 7.1 11.8 6.6 1.9 15.6 18.1 15.0 6.6 3.0 55.0 1.7 2.6 6.2 19.4 13.0 9.6 8.4 16.5 7.3 3.7 43.0 11.6 6.0 10.2 13.2 28.4 3.4 5.2 5.8 4.4 10.4 19.8 9.0 8.3 2.6 2.5 12.8 7.7 1.3 4.5 1.5 0.7 6.9 9.1 1.2 1.0 0.9 0.6 2.6 1.4 2.4 3.0 2.9 18.5 0.5 8.4 7.2 4.1 13.3 1.4 2.5 1.2 4.1 0.3 2.1 3.6 1.5 0.0 2.9 3.8 1.7 6.3 3.8 0.4 1.6 0.9 0.1 0.3 0.1 1.8 16.4 0.0 4.1 11.1 22.3 5.1 0.8 23.0 1.4 0.9 2.1 8.4 2.1 3.0 0.7 0.1 2.5 5.0 3.5 2.2 5.3 25.4 0.2 7.2 0.1 0.0 0.7 5.8 7.9 1.0 5.3 5.9 12.8 2.0 7.7 2.4 1.3 2.0 1.0 2.5 2.6 2.2 2.0 3.2 1.3 7.0 0.6 4.5 1.5 8.3 13.5 8.3 12.0 7.1 11.8 15.0 6.6 19.4 5.2 6.0 8.9 9.3 2.7 6.1 1.0 2.8 7.6 1.4 4.5 0.0 0.0 0.1 0.0 1.1 0.1 12.7 6.6 0.0 5.5 0.2 2.6 2.0 17.3 0.0 6.9 0.0 84.0 12.9 31.7 0.0 1.7 12.3 3.3 9.0 36.6 26.9 14.2 0.0 0.0 0.3 0.7 0.0 2.1 0.2 3.3 3.4 0.0 10.9 11.5 0.3 LGI2 "FLJ10675, KIAA1916" ENSG00000153012 "Leucine rich repeat LGI family member 2" Q8N0V4 4 24998847-25030879 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "parathyroid gland: 113.9" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 2.6;Collecting duct cells: 5.2;Hofbauer cells: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.3" "Lineage enriched" "Detected in single" 10 "monocytes: 1.3" "Cell line enhanced" "Detected in some" "AF22: 22.7;HAP1: 4.1;RPMI-8226: 10.4;SCLC-21H: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017140 Approved Uncertain Centrosome "Secreted to blood" NA NA Centrosome "HPA017140: AB_1852833" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-5)" "unprognostic (3.99e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (3.47e-2)" "unprognostic (1.62e-1)" "unprognostic (9.38e-5)" "unprognostic (5.78e-2)" "unprognostic (1.61e-1)" "unprognostic (2.06e-4)" "unprognostic (5.03e-3)" 2.5 1.6 2.8 6.7 3.3 0.8 2.3 7.9 7.8 3.7 4.0 0.0 1.0 1.1 8.9 4.9 4.1 11.4 4.2 3.7 2.4 3.9 3.0 0.9 1.4 2.0 7.2 0.4 9.1 2.6 113.9 0.5 2.6 18.7 1.0 1.6 6.0 0.9 1.4 0.9 0.9 2.6 7.1 2.9 1.2 2.4 2.0 0.9 0.6 1.8 0.6 4.6 1.8 1.1 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.6 0.0 0.2 0.0 4.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.7 0.0 0.8 0.0 0.9 10.4 0.4 0.0 14.7 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.2 1.6 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 3.3 7.9 7.8 2.4 3.9 7.2 0.4 18.7 0.9 0.0 0.0 0.0 0.1 0.1 0.4 2.6 0.0 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.8 1.6 0.0 1.3 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 LGR4 GPR48 ENSG00000205213 "Leucine rich repeat containing G protein-coupled receptor 4" Q9BXB1 11 27365961-27472775 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Differentiation, Immunity, Innate immunity, Spermatogenesis, Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 134.9;Syncytiotrophoblasts: 107.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.4;intermediate monocyte: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 29.2;RPTEC TERT1: 35.8;U-2197: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030267, HPA054350" Uncertain Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA030267: AB_10610004, HPA054350: " "unprognostic (5.27e-3)" "unprognostic (5.18e-2)" "unprognostic (4.64e-3)" "unprognostic (1.59e-1)" "unprognostic (4.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.98e-1)" "unprognostic (2.02e-2)" "unprognostic (2.00e-2)" "unprognostic (4.63e-2)" "unprognostic (5.84e-3)" "unprognostic (2.10e-1)" "prognostic favorable (2.00e-7)" "unprognostic (5.01e-1)" "unprognostic (3.59e-1)" "unprognostic (3.54e-2)" "unprognostic (1.76e-1)" 7.6 10.4 9.4 4.0 11.2 0.9 8.2 15.6 7.6 6.0 18.7 7.8 8.5 11.4 6.5 7.3 9.5 5.7 9.5 14.7 7.1 3.7 30.6 30.5 2.3 0.5 9.1 6.9 12.5 37.0 5.0 5.6 24.9 12.1 8.3 19.3 15.7 8.7 13.3 7.5 11.7 17.5 6.8 8.2 6.5 15.8 7.5 6.8 2.1 7.9 7.2 3.3 7.0 8.4 0.5 0.2 1.4 1.3 0.1 0.5 0.0 9.6 17.6 17.6 2.0 1.6 1.1 19.9 5.5 5.2 4.9 4.2 2.6 0.2 0.0 3.6 7.3 8.3 16.1 29.2 10.8 8.4 0.0 13.0 5.2 10.2 12.3 0.5 0.5 0.0 1.5 6.9 3.3 7.5 20.4 2.4 0.0 1.5 0.0 2.0 3.0 0.0 0.9 16.9 26.1 7.2 0.0 12.0 1.1 35.8 4.2 0.2 2.1 2.7 16.2 1.6 14.0 5.3 8.0 7.8 3.6 3.0 29.3 5.0 6.7 5.1 0.0 6.2 0.0 2.2 1.4 0.3 0.0 0.2 1.3 0.2 0.3 0.0 0.5 0.2 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 9.4 11.2 15.6 7.6 7.1 3.7 9.1 6.9 12.1 6.8 3.0 0.3 0.9 10.7 27.0 12.4 22.9 12.7 5.3 4.5 41.8 23.6 44.8 3.3 18.8 3.8 2.9 55.1 0.0 43.6 26.7 12.5 10.0 0.0 58.0 7.1 23.8 16.1 2.5 5.0 1.3 4.6 1.6 6.8 2.8 51.6 134.9 32.9 51.6 15.9 18.9 13.2 6.5 6.6 0.5 1.8 19.2 107.6 2.5 47.3 17.2 LGR5 "FEX, GPR49, GPR67, HG38" ENSG00000139292 "Leucine rich repeat containing G protein-coupled receptor 5" O75473 12 71439770-71586310 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.3;fallopian tube: 19.9;placenta: 21.6;skeletal muscle: 26.6" "Cell type enhanced" "Detected in some" 23 "Cytotrophoblasts: 46.3;Syncytiotrophoblasts: 22.1;Undifferentiated cells: 11.5" "Group enriched" "Detected in many" 7 "colorectal cancer: 16.8;endometrial cancer: 26.8;ovarian cancer: 9.8;stomach cancer: 6.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 10 "B-cells: 1.1" "Group enriched" "Detected in some" 5 "Hep G2: 16.2;SH-SY5Y: 47.7" "Region enriched" "Detected in some" 8 "olfactory region: 41.8" "Low region specificity" "Detected in many" HPA012530 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA012530: AB_1849329" "unprognostic (5.19e-2)" "unprognostic (3.79e-1)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.49e-3)" "unprognostic (1.52e-1)" "prognostic favorable (5.09e-4)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (3.71e-1)" "unprognostic (8.10e-2)" "unprognostic (2.01e-5)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (2.28e-2)" "unprognostic (6.25e-3)" 2.3 2.2 3.5 0.8 18.1 0.4 2.1 0.9 9.5 2.2 4.2 24.5 0.0 6.1 4.9 1.7 0.6 19.9 0.8 0.8 5.0 3.4 0.9 1.4 1.4 0.4 32.3 5.1 1.5 0.6 1.0 2.0 21.6 10.8 1.8 4.6 0.9 3.1 9.0 26.6 4.0 6.5 0.7 15.0 0.6 2.9 0.7 25.7 0.0 0.9 0.9 2.1 0.7 1.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.4 16.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 5.3 0.7 1.0 0.0 0.0 0.0 6.5 0.1 47.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 18.1 0.9 9.5 5.0 3.4 32.3 5.1 10.8 25.7 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 46.3 0.0 0.0 0.3 0.1 0.4 0.0 0.0 1.7 1.7 0.0 0.0 0.4 5.5 0.0 4.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 22.1 0.0 11.5 0.0 LGR6 FLJ14471 ENSG00000133067 "Leucine rich repeat containing G protein-coupled receptor 6" Q9HBX8 1 202193901-202319781 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 49.6" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 2.8;Cardiomyocytes: 8.3;Late spermatids: 3.2;Spermatocytes: 6.0;Spermatogonia: 3.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "gdT-cell: 14.3;memory CD8 T-cell: 8.3;naive CD8 T-cell: 4.7" "Lineage enriched" "Detected in single" 41 "T-cells: 14.3" "Cell line enhanced" "Detected in some" "A549: 16.6;CAPAN-2: 14.8;HaCaT: 8.0;HeLa: 4.0" "Region enriched" "Detected in some" 9 "olfactory region: 30.0" HPA008556 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA008556: " "unprognostic (4.72e-3)" "unprognostic (5.29e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (1.08e-1)" "unprognostic (5.13e-2)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (4.01e-2)" "unprognostic (7.89e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-3)" "unprognostic (2.08e-1)" "unprognostic (1.70e-1)" "unprognostic (7.83e-2)" 1.1 0.1 0.9 0.8 3.2 1.8 7.9 6.0 2.4 2.6 2.2 1.5 0.5 0.2 1.6 7.3 4.4 13.8 49.6 12.3 0.7 3.3 0.9 1.4 6.9 1.1 6.8 0.2 2.2 0.5 0.1 15.9 0.9 9.3 6.7 1.1 0.8 8.5 2.5 0.3 3.2 1.6 2.6 1.6 5.3 0.7 4.9 3.9 0.2 4.1 2.6 3.4 3.2 2.9 0.0 0.0 0.0 0.0 0.3 14.3 2.5 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 1.7 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.9 0.0 1.7 8.3 0.0 0.0 0.7 4.7 0.0 0.3 0.0 0.0 0.4 2.5 0.9 3.2 6.0 2.4 0.7 3.3 6.8 0.2 9.3 3.9 0.0 0.0 0.0 2.8 1.1 0.0 8.3 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 3.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 6.0 3.3 0.1 0.7 0.5 1.7 0.3 LHCGR "HHG, LCGR, LGR2, LHR, ULG5" ENSG00000138039 "Luteinizing hormone/choriogonadotropin receptor" P22888 2 48686775-48755730 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;testis: 18.8" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 1.1;Leydig cells: 1.1;Suprabasal keratinocytes: 1.3" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.8;HSkMC: 1.0;NTERA-2: 1.6;SuSa: 1.0" CAB009814 Uncertain NA NA "CAB009814: AB_2135467" "unprognostic (8.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (3.14e-2)" "unprognostic (2.97e-2)" "unprognostic (2.24e-2)" "unprognostic (5.22e-2)" 3.6 2.9 0.3 1.4 6.1 0.0 1.6 0.3 0.4 0.2 0.5 0.2 0.0 0.2 0.4 0.3 2.1 0.2 1.8 0.6 0.7 0.4 0.9 0.1 0.4 0.1 2.6 0.0 5.0 0.1 0.0 2.7 0.1 1.4 0.4 0.2 0.3 1.0 0.1 0.2 0.6 0.3 1.0 10.3 0.1 0.6 18.8 0.0 0.4 2.2 0.1 0.1 0.4 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 6.1 0.3 0.4 0.7 0.4 2.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 LHFPL1 ENSG00000182508 "LHFPL tetraspan subfamily member 1" Q86WI0 X 112630648-112680054 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 13.7;pituitary gland: 15.9;salivary gland: 8.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.9;SK-MEL-30: 5.4;SuSa: 8.6" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "olfactory region: 6.1" HPA003029 Uncertain NA NA "HPA003029: AB_1079248" "unprognostic (2.23e-2)" "unprognostic (2.78e-3)" "unprognostic (2.49e-1)" "unprognostic (1.36e-1)" "unprognostic (2.65e-1)" "unprognostic (1.54e-1)" "unprognostic (5.31e-3)" "unprognostic (1.29e-1)" "unprognostic (4.41e-3)" "unprognostic (5.19e-5)" "unprognostic (1.33e-1)" "unprognostic (7.63e-3)" "unprognostic (4.83e-2)" "unprognostic (1.21e-1)" "unprognostic (6.98e-2)" "unprognostic (1.92e-1)" 0.2 0.6 3.1 0.4 13.7 0.1 2.0 0.1 3.8 1.5 0.3 0.6 0.9 0.3 0.6 0.9 0.5 1.3 0.2 2.2 2.8 2.5 0.6 0.2 0.2 0.4 4.5 1.5 1.1 0.1 0.3 15.9 0.5 3.8 1.2 0.4 0.0 8.2 3.3 0.5 0.3 0.5 0.3 0.5 0.4 0.2 0.4 1.6 0.3 6.1 0.1 0.5 0.5 0.2 0.7 0.0 0.0 0.0 0.8 2.6 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 1.9 0.0 0.0 1.2 0.2 0.7 0.1 0.3 0.1 0.2 0.0 0.0 5.4 8.6 0.0 0.0 0.0 0.2 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.2 0.7 1.0 2.6 0.0 0.6 0.2 0.8 0.0 0.8 0.0 0.0 0.1 0.4 3.1 13.7 0.1 2.7 2.8 2.5 4.5 1.5 3.8 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 LHFPL2 KIAA0206 ENSG00000145685 "LHFPL tetraspan subfamily member 2" Q6ZUX7 5 78485215-78770021 "Predicted membrane proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.0;plasmacytoid DC: 7.9" "Group enriched" "Detected in many" 7 "dendritic cells: 7.9;granulocytes: 8.0;monocytes: 4.7" "Cell line enhanced" "Detected in many" "GAMG: 41.5;hTERT-HME1: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042402, HPA076743" Uncertain Approved "Nuclear bodies,Vesicles,Plasma membrane" NA NA 110000 "Plasma membrane" "Nuclear bodies, Vesicles" "HPA042402: AB_10794276, HPA076743: " "unprognostic (2.19e-2)" "unprognostic (3.86e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-1)" "unprognostic (2.40e-1)" "unprognostic (4.45e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (3.44e-3)" "unprognostic (2.32e-1)" "unprognostic (8.43e-2)" "unprognostic (3.62e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.45e-7)" "unprognostic (3.40e-2)" "unprognostic (3.88e-2)" "unprognostic (1.34e-2)" "unprognostic (7.85e-2)" 17.1 18.2 10.3 16.1 11.7 11.5 34.7 3.5 9.1 15.8 15.4 12.0 14.1 17.6 14.6 15.0 7.6 10.7 17.6 14.1 11.7 7.6 3.8 4.7 17.2 10.3 15.2 7.2 18.7 18.0 9.2 7.3 11.3 12.9 13.3 13.5 18.2 21.4 20.5 4.6 6.7 27.1 16.6 18.0 4.7 10.8 10.9 13.1 5.7 10.3 4.9 10.4 15.4 18.2 0.9 7.9 8.0 4.7 0.0 0.1 1.5 3.2 12.3 3.7 4.9 22.8 6.6 11.6 3.8 9.7 6.6 11.6 4.3 9.9 8.3 1.7 7.4 41.5 5.8 3.5 4.1 11.0 0.0 3.2 8.2 2.5 7.3 16.9 0.0 0.0 7.5 16.5 20.3 31.7 10.5 15.6 0.3 0.0 6.2 15.0 1.7 0.0 0.4 4.1 2.7 3.6 1.6 5.3 2.3 2.5 14.7 0.7 5.1 6.2 2.3 21.1 8.2 1.3 1.0 10.2 7.7 4.2 21.2 11.3 0.2 0.0 11.9 20.6 0.0 13.8 8.0 4.7 4.8 0.0 1.8 0.1 0.9 0.0 0.0 1.1 0.9 0.0 0.0 1.0 0.0 0.6 7.9 0.1 1.5 10.3 11.7 3.5 9.1 11.7 7.6 15.2 7.2 12.9 13.1 3.0 4.3 4.2 6.0 7.7 6.1 3.4 2.5 2.7 7.9 7.0 0.0 3.2 0.0 6.9 1.1 22.2 23.7 23.3 11.2 2.0 20.9 10.4 0.0 0.5 56.6 3.2 2.4 33.7 28.3 0.5 17.8 20.5 10.1 1.0 10.7 5.0 15.0 8.6 31.5 0.3 2.1 6.5 8.2 0.5 0.9 4.3 6.1 0.0 8.6 11.1 LHFPL3 LHFPL4 ENSG00000187416 "LHFPL tetraspan subfamily member 3" Q86UP9 7 104328656-104907232 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "brain: 36.5" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 7.0" "Cancer enriched" "Detected in some" 12 "glioma: 27.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;K-562: 2.2;SCLC-21H: 4.1;SH-SY5Y: 5.5;SK-BR-3: 4.6;SK-MEL-30: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069691 Approved Vesicles No NA Vesicles "HPA069691: AB_2686171" "unprognostic (1.20e-2)" "unprognostic (6.91e-2)" "unprognostic (4.59e-3)" "unprognostic (5.03e-2)" "unprognostic (2.27e-2)" "unprognostic (2.22e-1)" "unprognostic (1.07e-1)" "unprognostic (6.96e-2)" "unprognostic (5.81e-2)" "unprognostic (5.99e-3)" "unprognostic (8.50e-3)" "unprognostic (3.07e-1)" "unprognostic (1.33e-1)" 0.5 0.6 6.4 0.6 7.7 0.5 0.5 2.3 36.5 4.3 0.8 6.1 0.0 2.0 0.7 0.5 0.5 0.9 0.5 0.5 4.9 5.6 1.4 0.5 2.2 0.5 4.8 4.2 0.7 1.5 0.5 0.1 0.5 5.6 0.7 0.6 3.8 0.5 0.5 0.5 0.7 1.4 0.5 6.0 0.9 0.8 0.7 6.7 0.0 0.5 0.0 0.6 0.5 0.2 0.5 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.2 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 4.1 5.5 0.0 4.6 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 7.7 2.3 7.1 4.9 5.6 4.8 4.2 5.6 6.7 0.0 0.3 0.0 0.0 0.0 0.7 0.2 0.0 1.4 0.0 0.0 7.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 LHFPL4 ENSG00000156959 "LHFPL tetraspan subfamily member 4" Q7Z7J7 3 9498361-9553802 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 29.1;pituitary gland: 9.0" "Group enriched" "Detected in some" 4 "Bipolar cells: 39.8;Cone photoreceptor cells: 17.7;Horizontal cells: 14.3;Rod photoreceptor cells: 16.4" "Group enriched" "Detected in some" 13 "glioma: 6.8;pancreatic cancer: 1.3;testis cancer: 5.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 13.5;NTERA-2: 4.3;SCLC-21H: 10.1;SH-SY5Y: 12.5;U-266/84: 10.5;WM-115: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041421 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA041421: AB_10796673" "unprognostic (6.81e-2)" "unprognostic (3.65e-2)" "unprognostic (4.50e-1)" "unprognostic (6.62e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.65e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (3.77e-1)" "unprognostic (1.90e-2)" "unprognostic (6.78e-2)" "unprognostic (2.99e-1)" "unprognostic (3.03e-3)" "unprognostic (8.21e-2)" 0.9 4.9 8.0 1.0 11.4 0.9 0.9 16.0 29.1 0.9 1.4 1.5 0.0 1.2 0.9 0.8 0.9 0.9 0.9 0.8 8.4 8.5 0.9 0.8 1.0 0.8 4.2 8.6 0.8 1.8 1.2 9.0 0.8 9.2 0.9 1.4 1.7 0.9 0.9 0.8 0.9 1.3 0.9 4.2 0.8 1.3 1.6 1.8 0.0 0.9 0.0 0.8 0.8 0.1 0.0 1.2 0.6 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 10.1 12.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 2.8 0.0 10.5 0.0 0.5 0.0 3.8 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.0 0.0 8.0 11.4 16.0 15.6 8.4 8.5 4.2 8.6 9.2 1.8 0.0 0.0 0.0 2.6 0.0 39.8 0.6 0.0 0.0 0.0 0.0 17.7 0.5 0.0 0.3 0.4 0.0 0.5 0.0 0.2 0.8 0.3 1.5 1.1 0.0 0.2 14.3 1.2 4.9 0.3 0.4 0.0 0.0 0.0 0.0 0.6 1.3 0.3 1.4 0.0 0.1 16.4 0.0 0.1 1.7 1.0 0.0 1.1 0.0 1.0 2.5 LHFPL5 "DFNB67, dJ510O8.8, MGC33835, Tmhs" ENSG00000197753 "LHFPL tetraspan subfamily member 5" Q8TAF8 6 35805293-35833874 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 7.4;brain: 6.7;epididymis: 12.0;pancreas: 12.3" "Cell type enriched" "Detected in single" 16 "Cardiomyocytes: 13.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055110 Uncertain NA NA "HPA055110: AB_2682697" "unprognostic (2.35e-1)" "unprognostic (6.45e-2)" "unprognostic (2.41e-2)" "unprognostic (1.22e-3)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (4.89e-3)" "unprognostic (2.96e-3)" "unprognostic (2.46e-2)" "unprognostic (1.47e-8)" "unprognostic (5.53e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" "unprognostic (1.41e-1)" 0.5 0.5 3.9 1.2 4.1 7.4 0.5 0.4 5.8 0.4 0.4 0.2 0.0 0.9 0.9 12.0 0.3 0.3 0.7 0.3 3.5 2.8 0.4 0.4 0.3 1.5 1.2 6.7 0.6 12.3 0.0 2.2 0.6 2.0 0.6 0.3 0.2 1.1 0.1 0.6 2.3 0.8 0.1 0.6 1.0 0.5 0.8 0.0 0.0 0.8 0.0 0.4 0.3 0.4 1.0 0.3 1.0 0.8 0.5 0.9 0.0 1.5 1.9 3.6 2.2 0.6 1.7 3.2 2.5 0.9 0.4 1.1 2.1 2.2 3.6 1.9 1.3 2.3 2.0 0.6 1.4 0.9 1.8 2.9 3.8 5.6 1.9 0.1 1.7 2.6 1.4 0.7 0.7 1.0 3.1 0.5 3.4 2.0 7.2 2.0 1.2 2.3 1.8 2.4 0.9 1.5 2.0 1.6 1.0 1.2 3.3 3.3 2.2 1.6 1.9 1.1 2.5 3.0 1.3 3.6 2.4 2.1 3.3 1.0 4.1 3.4 2.8 1.1 2.4 1.5 1.0 0.3 0.2 0.9 0.6 0.5 0.5 0.5 0.3 0.0 1.0 0.6 0.8 0.9 0.5 0.8 0.3 0.4 0.0 3.9 4.1 0.4 5.8 3.5 2.8 1.2 6.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 LHFPL6 "LHFP, MGC22429" ENSG00000183722 "LHFPL tetraspan subfamily member 6" Q9Y693 13 39342892-39603528 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "Extravillous trophoblasts: 146.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "myeloid DC: 9.4;plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 14 "dendritic cells: 9.4" "Cell line enhanced" "Detected in many" "ASC diff: 66.1;HSkMC: 48.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058975 Approved Approved Nucleoli NA NA Nucleoli "HPA058975: AB_2683866" "unprognostic (6.98e-2)" "unprognostic (2.71e-1)" "unprognostic (2.00e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (4.10e-2)" "unprognostic (5.84e-2)" "unprognostic (1.08e-1)" "unprognostic (2.76e-1)" "unprognostic (5.45e-2)" "unprognostic (8.68e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (1.20e-7)" "unprognostic (4.41e-3)" "unprognostic (5.25e-2)" "unprognostic (7.75e-2)" "prognostic unfavorable (2.30e-4)" 57.2 26.8 12.5 14.8 17.7 0.9 45.7 40.8 19.0 20.3 16.4 12.3 8.5 5.3 28.6 23.7 17.9 27.0 34.9 49.4 12.7 12.9 12.8 6.9 27.0 27.4 19.3 12.6 25.7 8.3 7.1 14.3 62.0 16.8 21.4 8.4 19.8 11.4 18.8 13.6 13.1 9.6 33.1 18.5 18.5 10.2 16.2 11.9 1.3 22.7 22.1 8.3 20.1 25.8 0.2 9.4 0.1 0.6 0.0 0.0 0.4 2.7 1.0 30.0 1.3 66.1 30.0 13.1 15.3 22.1 7.8 5.9 0.1 2.9 4.2 0.3 21.3 10.2 4.3 3.7 8.9 6.5 4.1 4.4 11.5 0.9 0.0 6.9 0.2 0.3 48.3 1.2 7.0 11.7 7.0 7.2 0.2 0.0 0.0 15.0 2.4 0.0 3.5 2.2 0.0 4.0 1.8 13.0 0.0 5.2 3.7 0.1 0.9 1.4 1.8 4.1 17.9 1.7 0.0 13.5 19.9 2.9 6.1 8.3 0.2 0.0 12.0 8.3 0.0 14.3 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.4 0.2 0.0 0.0 0.1 0.0 0.1 3.2 0.0 0.4 12.5 17.7 40.8 19.0 12.7 12.9 19.3 12.6 16.8 11.9 3.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 4.0 18.2 0.0 0.0 3.1 1.7 0.6 0.0 0.0 0.0 0.0 0.6 146.6 0.0 0.0 2.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 LIFR CD118 ENSG00000113594 "LIF receptor alpha" P42702 5 38474963-38608354 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "Ito cells: 765.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 40.6;HHSteC: 17.3;SCLC-21H: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 74000 "unprognostic (6.00e-3)" "unprognostic (2.53e-1)" "unprognostic (1.05e-1)" "unprognostic (2.81e-3)" "unprognostic (8.80e-2)" "unprognostic (7.13e-2)" "unprognostic (1.11e-1)" "prognostic favorable (1.92e-4)" "unprognostic (1.78e-1)" "unprognostic (9.80e-2)" "unprognostic (2.73e-3)" "unprognostic (1.06e-1)" "prognostic favorable (1.40e-7)" "unprognostic (3.69e-2)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" "unprognostic (1.65e-1)" 35.3 14.7 15.8 8.2 19.2 0.5 33.9 10.1 21.3 27.7 10.4 25.3 22.8 4.9 34.8 14.8 10.4 26.0 10.2 16.3 19.1 11.0 20.3 23.9 21.7 20.2 24.3 11.8 17.9 17.8 13.5 12.5 41.5 23.4 23.6 7.5 17.1 24.9 24.7 24.0 10.5 11.7 26.9 21.4 22.5 18.8 9.3 25.3 4.7 31.4 7.3 8.1 13.6 15.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 2.3 40.6 3.0 11.4 12.7 0.3 3.4 1.9 2.7 1.7 0.4 2.2 0.0 0.5 4.8 6.9 0.3 2.6 0.9 4.7 0.0 3.7 0.0 4.3 1.6 17.3 0.0 0.2 10.6 0.7 6.6 0.7 2.6 3.8 0.4 1.1 6.5 3.4 0.5 0.0 0.1 1.0 0.0 7.2 0.0 8.6 0.0 2.6 1.0 26.6 3.3 14.0 0.7 0.0 5.3 0.9 0.0 0.8 4.4 8.7 10.3 2.0 0.0 0.0 0.0 7.2 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 19.2 10.1 21.3 19.1 11.0 24.3 11.8 23.4 25.3 11.9 34.9 9.3 5.9 20.6 5.8 24.6 10.2 10.7 10.3 14.0 7.9 7.7 5.0 1.9 12.6 122.5 0.0 0.0 7.8 22.5 46.1 21.1 1.1 6.8 3.2 1.6 0.0 765.5 62.0 21.6 105.3 2.6 16.9 0.0 0.0 5.1 6.9 0.0 18.7 13.5 35.3 38.8 42.2 8.9 6.1 15.8 23.9 7.5 0.0 4.7 LILRB1 "CD85, CD85j, ILT2, LIR-1, LIR1, MIR-7, PIR-B, PIRB" ENSG00000104972 "Leukocyte immunoglobulin like receptor B1" 19 54617158-54637528 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "blood: 26.7;lymphoid tissue: 52.5" "Group enriched" "Detected in some" 7 "B-cells: 16.2;Hofbauer cells: 16.3;Kupffer cells: 58.9;Macrophages: 35.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "intermediate monocyte: 19.1;non-classical monocyte: 26.7" "Lineage enriched" "Detected in many" 10 "monocytes: 26.7" "Group enriched" "Detected in some" 19 "Daudi: 10.6;THP-1: 5.5" "Intracellular and membrane" NA NA "unprognostic (9.23e-2)" "unprognostic (4.20e-2)" "unprognostic (4.95e-2)" "unprognostic (3.29e-2)" "unprognostic (1.11e-1)" "unprognostic (1.43e-2)" "unprognostic (1.24e-1)" "unprognostic (3.89e-2)" "unprognostic (3.58e-1)" "unprognostic (9.64e-2)" "unprognostic (1.24e-1)" "unprognostic (5.92e-2)" "prognostic unfavorable (3.08e-6)" "unprognostic (6.57e-2)" "unprognostic (1.62e-2)" "unprognostic (7.06e-2)" "unprognostic (8.03e-2)" 2.6 1.5 2.5 11.9 4.5 2.5 0.9 0.4 2.5 1.1 1.8 3.1 0.5 0.6 0.5 1.8 0.8 1.4 0.7 2.5 2.2 1.6 1.5 3.2 5.6 18.7 4.7 0.9 1.7 0.7 0.3 1.1 2.7 3.7 1.4 1.1 0.8 1.2 0.8 0.3 0.3 4.8 5.4 5.8 52.5 1.0 0.5 4.6 0.8 0.8 0.1 3.0 4.9 0.6 1.2 2.5 0.1 26.7 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 3.1 0.0 0.6 19.1 0.0 1.2 0.0 0.5 2.5 1.1 0.0 0.4 0.1 0.0 26.7 1.0 0.0 1.7 2.5 4.5 0.4 2.5 2.2 1.6 4.7 0.9 3.7 4.6 0.0 2.1 16.2 0.3 0.2 0.0 0.6 2.5 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.2 2.3 0.4 16.3 0.0 0.0 3.7 58.9 0.0 0.0 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 0.0 1.4 LILRB2 "CD85d, ILT4, LIR-2, LIR2, MIR-10, MIR10" ENSG00000131042 "Leukocyte immunoglobulin like receptor B2" Q8N423 19 54273821-54281184 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.9;bone marrow: 30.3;lymphoid tissue: 31.9" "Cell type enhanced" "Detected in some" 24 "Hofbauer cells: 26.7;Kupffer cells: 133.7;Macrophages: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 15.9;intermediate monocyte: 33.8;neutrophil: 16.7;non-classical monocyte: 37.9" "Group enriched" "Detected in many" 5 "granulocytes: 16.7;monocytes: 37.9" "Cell line enhanced" "Detected in single" "THP-1: 1.2" NA NA 52000000 "unprognostic (1.23e-1)" "unprognostic (1.12e-2)" "unprognostic (3.21e-2)" "unprognostic (3.51e-2)" "unprognostic (6.21e-3)" "unprognostic (1.70e-2)" "unprognostic (1.44e-2)" "unprognostic (2.94e-1)" "unprognostic (1.08e-2)" "unprognostic (2.98e-2)" "unprognostic (2.64e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.45e-7)" "unprognostic (1.90e-2)" "unprognostic (4.68e-3)" "unprognostic (3.72e-1)" "unprognostic (9.73e-2)" 3.2 1.4 0.4 6.8 0.6 30.3 1.0 0.3 1.9 0.5 1.1 0.6 0.4 3.3 0.6 0.9 0.5 2.3 6.6 1.5 1.6 0.4 1.5 3.6 18.4 4.9 2.6 0.0 0.4 0.7 0.2 0.7 0.7 1.8 0.9 1.0 1.1 7.4 2.6 0.5 0.4 1.5 0.6 3.4 31.9 1.0 0.3 0.8 0.8 0.6 5.0 0.7 0.6 1.9 0.0 5.3 16.7 37.9 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 15.9 4.2 0.0 33.8 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.0 16.7 0.0 37.9 2.2 0.1 8.1 0.4 0.6 0.3 1.9 1.6 0.4 2.6 0.0 1.8 0.8 3.0 17.0 3.4 0.0 1.3 0.0 0.6 2.5 4.0 5.7 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.8 0.0 4.7 0.8 26.7 0.0 0.0 3.1 133.7 0.0 0.0 59.3 3.3 5.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.5 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 LILRB3 "CD85a, HL9, ILT5, LIR-3, LIR3, PIR-B, PIRB" ENSG00000204577 "Leukocyte immunoglobulin like receptor B3" O75022 19 54216278-54223506 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.4;bone marrow: 15.3;lymphoid tissue: 23.4" "Cell type enhanced" "Detected in many" 14 "Hofbauer cells: 57.4;Kupffer cells: 90.9;Macrophages: 66.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 24.4" "Group enriched" "Detected in many" 4 "granulocytes: 24.4;monocytes: 9.4" "Cell line enhanced" "Detected in some" "BJ: 1.7;HaCaT: 1.9;HEK 293: 2.6" NA NA "unprognostic (7.51e-2)" "unprognostic (3.52e-2)" "unprognostic (9.59e-2)" "unprognostic (4.53e-1)" "unprognostic (1.83e-3)" "unprognostic (5.28e-3)" "unprognostic (2.91e-2)" "unprognostic (2.55e-1)" "unprognostic (5.58e-2)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.92e-8)" "unprognostic (2.18e-1)" "unprognostic (2.19e-3)" "unprognostic (1.84e-1)" "unprognostic (1.75e-1)" 5.1 0.8 0.4 8.9 1.0 15.3 0.8 0.4 0.5 0.7 1.6 0.0 0.2 0.2 0.6 2.5 0.7 1.3 1.1 7.8 1.5 0.6 0.7 1.5 10.9 19.7 0.5 0.0 3.0 1.7 0.0 0.5 2.0 0.6 0.9 0.0 1.0 0.8 0.0 1.7 0.6 0.9 0.9 2.2 23.4 0.8 0.7 0.0 0.3 1.5 0.0 0.1 6.4 1.1 0.1 4.0 24.4 9.4 0.0 0.1 4.5 1.5 0.6 0.4 0.8 0.0 0.0 0.5 1.7 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.4 1.9 0.0 0.0 0.0 0.4 2.6 1.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.4 0.0 1.1 0.2 0.5 0.6 0.2 0.0 0.0 1.0 1.7 0.0 0.0 0.6 0.1 0.0 1.6 0.0 0.0 0.7 0.8 0.0 0.0 0.5 0.3 0.0 0.3 1.0 0.0 0.4 9.4 0.3 0.0 7.5 0.1 0.1 0.1 0.0 4.0 0.1 0.0 0.0 24.4 0.0 3.3 0.4 0.0 4.5 0.4 1.0 0.4 0.5 1.5 0.6 0.5 0.0 0.6 0.0 8.9 18.3 3.0 1.2 2.2 0.7 0.4 5.1 8.1 11.4 1.8 0.0 1.4 0.0 0.3 0.9 0.6 0.0 0.0 0.5 2.6 1.3 0.8 7.0 2.1 57.4 0.0 0.0 2.5 90.9 2.6 0.3 66.5 1.7 2.8 0.7 0.9 0.2 0.6 0.7 0.3 3.0 6.5 1.2 0.5 1.6 2.6 1.0 1.8 1.2 0.3 LILRB4 "CD85k, HM18, ILT3, LIR-5, LIR5" ENSG00000186818 "Leukocyte immunoglobulin like receptor B4" Q8NHJ6 19 54643889-54670359 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 22.8;lymphoid tissue: 33.1" "Group enriched" "Detected in some" 6 "Hofbauer cells: 134.1;Kupffer cells: 95.5;Macrophages: 56.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 22.8" "Group enriched" "Detected in many" 69 "dendritic cells: 22.8;monocytes: 6.2" "Cell line enriched" "Detected in some" 35 "Karpas-707: 97.2" HPA052807 Approved NA NA 9900 "HPA052807: AB_2681958" "unprognostic (4.09e-2)" "unprognostic (5.75e-3)" "unprognostic (6.06e-2)" "unprognostic (1.91e-2)" "unprognostic (1.82e-1)" "unprognostic (1.55e-1)" "unprognostic (5.03e-2)" "unprognostic (3.53e-1)" "unprognostic (4.13e-2)" "unprognostic (1.52e-1)" "unprognostic (5.43e-1)" "unprognostic (2.79e-1)" "unprognostic (1.91e-2)" "unprognostic (1.08e-1)" "unprognostic (4.42e-2)" "unprognostic (4.51e-2)" "unprognostic (4.52e-2)" 15.4 4.3 5.1 20.1 7.4 4.5 3.1 0.8 5.9 1.6 3.6 12.8 0.0 4.0 1.0 4.7 2.1 4.2 4.4 3.9 5.3 5.3 3.1 3.9 12.3 33.1 10.8 1.9 1.7 1.6 1.5 2.4 4.2 6.6 1.7 5.5 2.9 3.8 1.4 0.8 0.9 5.4 2.1 15.1 18.0 2.8 1.3 6.9 3.1 2.3 0.7 6.1 13.8 0.8 0.2 22.8 0.1 6.2 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 6.2 0.0 0.1 0.0 0.0 7.0 0.2 0.0 0.0 0.1 0.1 4.8 22.8 0.0 1.8 5.1 7.4 0.8 4.5 5.3 5.3 10.8 1.9 6.6 6.9 0.0 5.5 16.7 0.0 0.3 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.5 0.0 1.1 0.2 134.1 0.0 0.0 2.5 95.5 0.0 0.0 56.7 1.7 12.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 6.5 0.3 0.0 0.4 0.1 0.7 0.0 0.0 0.0 LILRB5 "CD85c, LIR-8, LIR8" ENSG00000105609 "Leukocyte immunoglobulin like receptor B5" O75023 19 54249431-54257301 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 31.0;lymphoid tissue: 35.1" "Group enriched" "Detected in some" 5 "Hofbauer cells: 46.1;Kupffer cells: 83.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SiHa: 2.3" HPA012069 Approved NA NA 36000000 "HPA012069: AB_1852873" "unprognostic (3.55e-3)" "unprognostic (5.38e-2)" "unprognostic (2.20e-2)" "unprognostic (7.03e-2)" "unprognostic (8.86e-2)" "unprognostic (5.44e-2)" "unprognostic (3.02e-5)" "unprognostic (6.80e-2)" "unprognostic (2.23e-1)" "unprognostic (2.33e-1)" "unprognostic (9.95e-2)" "unprognostic (8.68e-2)" "unprognostic (3.31e-1)" "unprognostic (2.07e-1)" "unprognostic (4.14e-2)" "unprognostic (1.42e-2)" "unprognostic (1.73e-1)" 23.6 8.3 0.7 5.4 0.8 0.8 31.0 0.6 0.6 2.1 11.9 0.5 1.6 5.2 1.2 16.2 5.8 4.9 6.2 10.0 0.7 0.8 2.1 22.8 8.6 13.3 0.8 0.0 4.1 2.7 0.7 1.0 5.6 0.7 4.0 5.5 3.6 2.9 1.1 6.1 2.0 9.0 5.9 0.9 35.1 2.4 3.9 0.0 1.2 2.6 4.9 1.3 10.6 1.8 0.9 0.7 3.1 0.9 0.9 0.5 0.3 0.4 0.0 0.8 0.5 0.2 0.1 1.0 1.1 0.3 0.4 0.0 0.3 0.6 0.2 0.4 0.1 0.5 1.4 0.3 0.6 0.0 0.5 0.9 1.1 1.8 0.4 0.5 0.6 0.7 0.5 0.3 0.1 0.3 0.1 0.5 0.7 0.6 1.0 0.2 0.0 0.3 0.3 0.7 0.2 0.0 0.6 0.7 0.6 0.2 0.8 0.5 0.9 2.3 0.8 0.7 0.8 0.8 0.1 0.3 0.8 0.7 0.5 0.6 0.4 1.1 0.1 0.4 0.3 0.2 3.1 0.9 0.4 0.4 0.6 0.3 0.4 0.5 0.3 0.3 0.9 0.4 0.4 2.3 0.9 0.8 0.7 0.3 0.3 0.7 0.8 0.6 0.6 0.7 0.8 0.8 0.0 0.7 0.0 0.0 0.6 0.8 0.0 0.9 0.0 1.2 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 1.0 46.1 0.0 0.0 12.9 83.3 1.6 0.0 7.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.0 0.0 0.0 LIM2 "MP17, MP19" ENSG00000105370 "Lens intrinsic membrane protein 2" P55344 19 51379909-51387960 "Disease related genes, Predicted membrane proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "blood: 12.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 40 "testis cancer: 18.3" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "gdT-cell: 12.9" "Lineage enriched" "Detected in many" 8 "T-cells: 12.9" "Cell line enhanced" "Detected in single" "SuSa: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.25e-2)" "unprognostic (1.09e-3)" "unprognostic (1.21e-1)" 0.1 0.1 0.1 0.1 0.1 2.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.3 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.2 1.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.4 0.0 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 1.5 12.9 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.2 1.6 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 1.5 0.0 0.0 0.0 1.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 LIME1 "dJ583P15.4, FLJ20406, LIME" ENSG00000203896 "Lck interacting transmembrane adaptor 1" Q9H400 20 63736283-63739103 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 87.5;liver: 43.7;lymphoid tissue: 80.4" "Cell type enriched" "Detected in single" 11 "Hepatocytes: 2.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 39.4;MAIT T-cell: 35.4;memory CD4 T-cell: 54.9;memory CD8 T-cell: 51.2;naive CD4 T-cell: 37.5;naive CD8 T-cell: 40.6;plasmacytoid DC: 87.5;T-reg: 77.8" "Group enriched" "Detected in many" 9 "dendritic cells: 87.5;T-cells: 77.8" "Cell line enhanced" "Detected in some" "Karpas-707: 13.4;MOLT-4: 14.0;RPMI-8226: 51.4;U-266/70: 27.8" CAB015363 Approved "Intracellular and membrane" NA NA "CAB015363: AB_629890" "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (5.95e-3)" "unprognostic (3.01e-1)" "unprognostic (1.34e-1)" "unprognostic (3.85e-3)" "unprognostic (3.06e-2)" "unprognostic (1.46e-1)" "unprognostic (1.36e-1)" "unprognostic (1.94e-1)" "unprognostic (1.05e-3)" "unprognostic (1.51e-3)" "prognostic unfavorable (5.04e-5)" "unprognostic (2.39e-2)" "unprognostic (4.25e-2)" "unprognostic (1.67e-1)" "prognostic favorable (6.92e-6)" 1.9 0.6 2.1 17.9 4.9 4.0 0.7 4.4 2.1 2.0 5.2 0.4 0.5 2.2 0.9 0.3 4.2 0.7 8.4 0.8 2.0 1.8 13.6 43.7 5.0 20.3 1.4 1.1 1.2 0.5 0.4 1.8 0.6 0.4 2.3 0.6 1.1 9.9 0.7 0.9 4.9 3.7 0.7 1.7 10.0 16.9 0.7 0.5 80.4 1.6 2.4 22.8 2.5 1.1 9.6 87.5 1.3 0.1 9.2 77.8 22.3 0.7 0.2 0.0 0.1 0.0 0.0 1.8 0.9 0.0 0.1 0.0 0.4 0.8 2.2 1.4 0.0 0.0 1.9 0.0 0.1 0.1 0.9 1.7 0.4 0.7 8.6 0.0 0.6 0.8 0.1 0.2 0.0 0.0 0.0 0.0 6.4 0.8 13.4 0.0 0.4 14.0 3.8 0.7 0.6 2.4 9.7 0.3 51.4 0.2 0.1 0.7 1.1 0.5 0.5 1.0 0.0 0.4 0.3 0.2 0.7 1.0 0.7 0.5 27.8 1.0 4.4 0.6 0.4 0.2 0.1 0.1 0.2 39.4 0.1 35.4 9.6 54.9 51.2 0.2 3.7 37.5 40.6 1.3 9.2 0.1 87.5 77.8 22.3 2.1 4.9 4.4 2.1 2.0 1.8 1.4 1.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 LINC00672 ENSG00000263874 "Long intergenic non-protein coding RNA 672" 17 38925168-38929384 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 16.8" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 29.3;granulocytes: 35.6;Horizontal cells: 28.6" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 11.7" NA NA "unprognostic (3.28e-1)" "unprognostic (9.28e-2)" "unprognostic (6.62e-2)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (2.06e-1)" "unprognostic (4.15e-2)" "unprognostic (8.81e-2)" "unprognostic (7.08e-2)" "unprognostic (2.02e-2)" "unprognostic (4.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.68e-6)" "unprognostic (7.29e-2)" "unprognostic (6.58e-2)" "unprognostic (3.44e-2)" "unprognostic (2.59e-4)" 0.7 2.5 4.6 1.0 9.6 3.5 0.9 5.1 16.8 0.4 1.1 4.0 0.0 1.0 2.5 3.1 0.7 1.5 1.8 1.1 5.0 0.3 0.2 1.4 1.4 2.8 7.5 2.7 0.3 0.4 0.4 1.0 7.1 1.5 1.7 2.1 0.6 3.1 0.6 2.3 1.8 2.3 3.5 1.9 1.6 0.3 3.7 0.0 0.2 0.0 0.9 0.8 0.0 1.3 1.0 4.0 1.2 1.4 2.8 0.5 0.7 1.0 2.1 1.4 1.2 1.5 0.3 0.9 0.7 0.2 0.6 0.4 3.8 0.7 0.8 1.3 0.2 2.0 0.0 0.5 0.7 0.4 0.6 1.1 1.1 0.1 0.8 1.4 2.7 1.6 0.8 0.7 0.3 1.6 0.3 1.0 0.2 0.8 0.5 0.8 0.7 1.5 11.7 0.7 0.0 3.3 0.2 1.0 1.2 1.0 0.2 4.5 1.2 1.3 0.7 1.0 1.5 1.3 2.2 0.6 0.9 0.8 0.4 1.1 1.6 0.8 1.1 1.5 0.4 1.6 1.2 1.9 1.1 0.5 0.5 0.7 0.8 0.8 0.5 1.3 0.9 2.8 4.0 1.4 0.7 1.0 0.7 0.5 11.9 4.3 0.0 1.4 1.0 29.3 2.6 0.0 5.3 2.3 0.0 2.0 0.1 0.0 1.5 0.5 2.1 2.1 0.0 1.2 0.6 2.5 2.1 35.6 0.8 1.4 28.6 1.7 6.2 3.7 0.2 3.4 2.6 3.3 2.8 2.9 6.6 2.8 3.4 3.9 0.0 8.1 0.0 2.1 0.0 0.4 0.5 0.2 6.9 3.9 0.9 LINC02203 ENSG00000280709 "Long intergenic non-protein coding RNA 2203" 15 21552795-21653276 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 11.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "U-2 OS: 11.9" HPA057442 Uncertain Approved Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LINC02210-CRHR1 ENSG00000263715 "LINC02210-CRHR1 readthrough" 17 45620344-45835826 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "U-2 OS: 1.8" NA NA 0.9 0.9 0.8 0.9 2.6 0.9 0.9 2.1 7.3 1.4 0.9 1.8 1.0 0.9 4.0 0.9 0.9 1.6 0.9 0.9 7.5 0.9 0.9 0.9 0.9 0.0 2.7 0.9 2.2 0.9 2.1 1.0 4.2 1.2 0.9 0.9 3.3 0.9 1.2 0.9 0.9 1.4 0.0 0.9 0.9 2.6 0.4 1.1 0.9 0.9 1.3 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 1.7 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LINGO1 "FLJ14594, LERN1, LRRN6A" ENSG00000169783 "Leucine rich repeat and Ig domain containing 1" Q96FE5 15 77613027-77820900 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 67.2" "Cell type enhanced" "Detected in some" 22 "Horizontal cells: 125.5;Muller glia cells: 49.3;Sertoli cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 13.2;AN3-CA: 11.0;HAP1: 16.7;HEK 293: 11.7;NTERA-2: 31.4;SuSa: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074653 Enhanced Supported "Plasma membrane" NA NA 8400 "Plasma membrane" "HPA074653: AB_2686706" "unprognostic (1.06e-1)" "unprognostic (7.07e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-2)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.84e-2)" "unprognostic (3.77e-2)" "unprognostic (3.40e-1)" "unprognostic (1.10e-1)" "unprognostic (7.36e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (3.23e-7)" "unprognostic (2.07e-1)" "unprognostic (7.06e-2)" "unprognostic (2.85e-1)" "unprognostic (2.59e-2)" 3.0 1.6 27.4 1.7 21.8 0.8 1.3 9.1 67.2 3.8 2.0 5.9 0.0 2.0 3.3 2.7 1.4 3.1 2.5 9.7 29.8 12.2 2.2 1.1 1.1 1.3 10.3 21.8 1.7 2.7 1.1 0.5 6.1 6.8 1.7 1.5 1.8 3.4 2.5 1.0 3.0 1.5 4.5 6.8 3.3 2.0 3.7 3.9 0.0 1.7 0.0 1.1 3.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 13.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.2 0.0 16.7 0.0 0.0 0.0 11.7 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 7.2 0.0 0.0 31.4 0.7 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.7 0.0 1.3 2.8 13.1 0.2 0.2 1.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 21.8 9.1 47.5 29.8 12.2 10.3 21.8 6.8 3.9 0.0 0.0 0.0 0.1 0.2 14.5 6.1 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.5 8.3 0.9 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.2 125.5 0.0 3.7 0.0 13.7 0.3 0.0 3.3 0.0 0.0 49.3 0.3 8.6 0.4 0.0 15.9 25.8 5.7 0.1 2.5 0.1 0.2 0.0 0.0 0.0 LINGO2 "LERN3, LRRN6C" ENSG00000174482 "Leucine rich repeat and Ig domain containing 2" Q7L985 9 27948078-28670286 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 10.5;smooth muscle: 11.4" "Group enriched" "Detected in some" 6 "Bipolar cells: 7.3;Early spermatids: 12.0;Late spermatids: 11.5" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 8 "NK-cells: 3.4" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;hTERT-HME1: 2.3;SH-SY5Y: 13.7;U-87 MG: 2.4;WM-115: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA016633, CAB025361" Approved NA NA "CAB025361: , HPA016633: AB_1853362" "unprognostic (1.27e-1)" "unprognostic (3.58e-1)" "unprognostic (1.20e-2)" "unprognostic (1.98e-4)" "unprognostic (9.86e-4)" "unprognostic (7.55e-3)" "unprognostic (2.67e-6)" "unprognostic (1.08e-1)" "unprognostic (2.38e-1)" "unprognostic (2.34e-2)" "unprognostic (3.74e-2)" "unprognostic (8.13e-2)" "unprognostic (1.07e-1)" "unprognostic (4.08e-2)" "unprognostic (2.30e-2)" "unprognostic (1.95e-4)" 0.0 0.3 1.8 0.0 1.7 0.0 0.0 1.0 3.4 0.3 0.0 0.0 10.5 1.0 0.0 0.4 1.0 0.0 1.4 4.1 0.6 0.0 0.0 0.0 0.6 0.0 0.0 2.7 0.6 1.8 0.6 0.0 0.0 1.9 0.0 0.0 0.0 11.4 0.3 0.0 0.4 1.8 3.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.4 0.4 1.7 0.0 0.5 0.3 3.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 1.1 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 13.7 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.4 0.0 6.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.2 0.0 1.7 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.2 0.6 0.0 0.0 1.2 0.9 0.0 0.2 0.0 0.0 0.0 LINGO3 "LERN2, LRRN6B" ENSG00000220008 "Leucine rich repeat and Ig domain containing 3" P0C6S8 19 2289784-2292024 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.9;brain: 15.7;lymphoid tissue: 7.1" "Cell type enriched" "Detected in some" 7 "Bipolar cells: 32.9" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Cell type enhanced" "Detected in some" "eosinophil: 6.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 6.9" "Cell line enriched" "Detected in some" 4 "HMC-1: 19.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 7 "basal ganglia: 34.0;cerebellum: 34.4;hippocampal formation: 11.5" "HPA043781, HPA059558" Enhanced Approved Mitochondria NA NA Mitochondria "HPA043781: AB_2678668, HPA059558: AB_2684062" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (7.16e-3)" "unprognostic (3.10e-1)" "unprognostic (1.59e-1)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (7.45e-3)" "unprognostic (1.11e-2)" "unprognostic (3.19e-2)" "unprognostic (4.03e-4)" "unprognostic (2.35e-2)" "unprognostic (1.36e-2)" "unprognostic (1.79e-1)" "unprognostic (5.74e-2)" "unprognostic (1.05e-1)" "unprognostic (4.14e-2)" 0.1 0.2 2.2 3.1 15.7 2.8 0.0 4.6 2.9 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.2 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 1.2 0.0 0.4 7.1 1.2 0.1 0.0 0.0 0.0 0.0 1.0 0.1 6.9 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 2.1 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 2.6 0.2 0.0 0.1 1.9 0.0 4.8 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 1.9 0.1 6.9 0.4 0.0 0.4 0.5 0.0 0.2 0.1 1.0 0.1 0.0 2.9 0.3 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 32.9 0.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 0.2 3.2 0.0 0.0 2.1 0.0 0.0 0.2 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 LINGO4 LRRN6D ENSG00000213171 "Leucine rich repeat and Ig domain containing 4" Q6UY18 1 151800264-151806154 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 5.4;skeletal muscle: 17.7" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 1.4;Ciliated cells: 1.4;Club cells: 1.2;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 4.0;JURKAT: 1.5;Karpas-707: 1.1;SH-SY5Y: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA060781 Uncertain NA NA "HPA060781: AB_2684361" "unprognostic (2.71e-2)" "unprognostic (1.98e-1)" "unprognostic (1.33e-3)" "unprognostic (1.96e-1)" "unprognostic (8.65e-2)" "unprognostic (3.16e-2)" "unprognostic (1.49e-5)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (2.39e-1)" "unprognostic (1.94e-4)" "unprognostic (6.92e-2)" "unprognostic (3.94e-4)" "unprognostic (3.84e-1)" "unprognostic (1.65e-1)" "unprognostic (7.06e-2)" "unprognostic (5.60e-2)" 0.0 2.5 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.8 0.0 0.3 0.0 0.1 0.3 0.7 0.1 0.1 0.0 0.0 0.3 0.4 1.2 0.0 0.8 0.0 0.4 0.1 17.7 0.3 0.0 0.0 0.3 0.0 0.3 0.4 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 LIPF "HGL, HLAL" ENSG00000182333 "Lipase F, gastric type" P07098 10 88664441-88678814 "Enzymes, FDA approved drug targets, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "stomach 1: 762.9" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 75 "stomach cancer: 278.5" "Region enhanced" "Detected in single" "cerebral cortex: 1.9" "Cell type enriched" "Detected in single" 16 "eosinophil: 1.5" "Lineage enriched" "Detected in single" 16 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "HMC-1: 6.4;MOLT-4: 5.0;NTERA-2: 5.3;REH: 3.1;THP-1: 10.0;U-2 OS: 3.6;U-266/70: 4.9" "Region enriched" "Detected in single" 51 "olfactory region: 9.9" HPA045930 Enhanced "Secreted to digestive system" NA NA "HPA045930: AB_10959518" "unprognostic (1.53e-1)" "unprognostic (1.83e-1)" 0.1 0.0 0.1 0.1 0.5 0.0 0.1 0.1 1.9 0.1 0.2 28.2 0.1 8.2 0.1 0.1 31.6 0.1 0.6 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 9.9 0.1 0.1 0.0 0.1 0.1 0.1 0.1 762.9 0.1 0.1 0.2 0.1 1.1 0.1 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 5.3 0.0 0.0 3.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 3.6 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 1.9 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 LITAF "FLJ38636, PIG7, SIMPLE, TP53I7" ENSG00000189067 "Lipopolysaccharide induced TNF factor" Q99732 16 11547722-11636381 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 202.5" "Cell type enhanced" "Detected in many" 5 "monocytes: 551.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 202.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 202.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006960 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA006960: AB_1079254" "unprognostic (2.26e-1)" "unprognostic (4.96e-2)" "unprognostic (2.32e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (4.07e-2)" "unprognostic (8.75e-3)" "unprognostic (3.60e-1)" "unprognostic (6.15e-3)" "unprognostic (1.04e-1)" "unprognostic (4.61e-2)" "unprognostic (5.01e-1)" "unprognostic (1.85e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (3.57e-2)" "unprognostic (1.60e-1)" 55.0 14.1 18.0 49.2 42.4 53.3 65.7 5.0 18.5 50.4 36.4 45.2 20.2 13.9 42.7 28.8 19.6 34.0 35.3 31.5 20.7 15.7 48.9 66.3 73.0 80.6 28.6 13.2 43.1 26.3 15.9 17.1 46.2 42.8 36.2 36.7 26.0 57.3 32.2 18.6 28.5 24.1 41.6 52.1 57.9 26.3 11.0 19.0 18.7 53.3 18.8 36.4 47.4 41.6 14.1 16.9 202.5 10.3 20.2 37.6 35.6 13.9 26.1 16.5 7.9 2.5 1.9 16.7 18.2 56.1 17.4 25.9 10.8 37.7 7.0 23.3 15.3 20.2 17.3 6.9 30.5 16.6 53.6 7.2 0.5 22.7 54.7 38.7 2.1 2.4 5.8 59.3 14.2 38.9 15.6 0.0 0.4 4.3 27.3 0.2 13.3 0.3 32.3 26.8 18.6 0.1 2.1 3.6 40.3 14.5 19.8 4.1 12.4 31.5 40.3 32.4 26.6 22.5 11.9 0.1 7.2 12.2 4.2 4.2 10.7 23.5 18.0 8.3 17.1 41.3 32.2 10.3 20.8 37.6 9.8 22.8 14.1 23.5 33.5 13.6 13.9 26.8 31.7 202.5 20.2 5.7 16.9 26.2 35.6 18.0 42.4 5.0 18.5 20.7 15.7 28.6 13.2 42.8 19.0 41.7 81.4 104.3 281.2 139.8 1.8 51.2 129.9 133.8 114.9 155.3 0.0 57.9 411.1 191.6 1.7 48.8 46.4 0.0 64.4 335.4 125.8 223.3 202.9 35.5 219.5 0.0 16.8 61.4 140.8 7.9 52.0 294.8 148.5 551.0 130.0 207.3 91.3 203.2 64.3 66.5 3.5 51.8 174.1 0.0 4.7 115.6 31.0 220.6 89.7 303.0 LMAN1 "ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60" ENSG00000074695 "Lectin, mannose binding 1" P49257 18 59327823-59359962 "Disease related genes, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 369.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002320, CAB037163" Supported Uncertain Cytosol NA NA 13000000 Cytosol "CAB037163: AB_532237, HPA002320: AB_1079256" "unprognostic (5.64e-2)" "unprognostic (8.96e-3)" "unprognostic (4.20e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-2)" "unprognostic (2.61e-1)" "unprognostic (1.65e-1)" "unprognostic (5.40e-3)" "unprognostic (1.16e-1)" "unprognostic (2.03e-1)" "unprognostic (2.40e-2)" "unprognostic (1.06e-1)" "unprognostic (5.79e-2)" "unprognostic (4.28e-2)" "unprognostic (5.37e-3)" "unprognostic (7.05e-2)" "unprognostic (3.71e-3)" 6.2 7.7 2.6 4.5 3.0 1.6 5.7 4.6 1.8 9.8 3.9 5.7 6.7 7.4 6.6 6.5 3.8 8.0 2.7 3.0 9.1 26.2 7.0 2.7 2.8 8.1 15.3 12.7 9.7 7.1 8.2 5.0 8.4 6.1 6.9 3.4 6.1 4.6 3.5 4.8 7.5 2.1 12.3 3.9 4.7 5.6 6.9 8.2 4.0 3.4 9.0 9.8 3.8 18.7 11.1 11.9 9.9 27.9 48.3 24.1 34.0 48.8 23.0 30.9 11.0 18.2 3.3 24.2 40.3 16.5 23.1 16.9 19.2 42.0 12.7 10.8 10.9 14.9 22.8 33.2 37.8 16.8 32.1 23.2 22.2 45.7 43.4 23.1 11.6 18.3 37.4 22.3 5.0 10.9 7.8 8.2 9.5 13.8 12.4 21.7 36.3 12.8 14.2 8.2 8.9 17.1 16.8 19.2 17.5 12.4 14.8 19.0 37.5 13.1 11.9 19.7 28.6 14.2 16.2 39.3 20.2 30.5 4.0 2.3 0.6 7.2 3.4 9.8 6.9 7.9 7.5 3.1 4.7 7.6 7.5 0.3 9.0 1.9 8.2 8.7 3.8 95.3 75.6 40.2 99.5 62.0 36.5 107.3 68.8 120.5 94.4 76.8 100.1 135.4 18.3 109.7 19.1 71.9 34.5 0.0 73.5 233.6 149.7 186.9 32.4 369.6 72.2 55.6 49.5 84.1 33.9 6.3 102.4 44.4 64.1 62.3 110.0 95.5 79.1 59.6 80.2 62.0 60.8 64.7 72.9 37.1 59.8 49.8 193.4 52.2 80.9 90.2 LMAN2 "C5orf8, GP36B, VIP36" ENSG00000169223 "Lectin, mannose binding 2" Q12907 5 177331562-177351852 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003927 Approved NA NA 110000000 "HPA003927: AB_1079257" "unprognostic (5.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.87e-2)" "unprognostic (1.85e-3)" "unprognostic (6.25e-2)" "unprognostic (3.90e-3)" "unprognostic (2.88e-3)" "unprognostic (2.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.51e-3)" "unprognostic (4.56e-2)" "unprognostic (6.67e-2)" "prognostic unfavorable (8.53e-4)" "unprognostic (4.43e-2)" "unprognostic (6.13e-2)" "unprognostic (1.45e-2)" "unprognostic (2.32e-1)" 18.3 25.2 15.0 18.9 17.4 21.7 19.0 9.5 16.4 23.4 24.5 15.4 31.4 29.4 22.8 47.6 41.6 20.7 19.3 23.3 13.9 10.2 33.3 91.7 23.1 29.1 16.4 12.7 22.2 123.4 7.3 19.1 37.5 14.8 21.4 13.0 20.1 37.2 17.8 13.6 17.4 32.9 22.2 11.9 26.7 23.6 28.4 14.1 22.2 45.7 16.4 39.0 18.8 21.0 43.6 85.3 95.2 71.2 56.9 73.7 115.8 17.5 31.9 9.1 53.2 35.5 11.9 50.6 20.2 18.4 16.1 20.3 53.6 42.8 19.0 49.3 27.2 32.4 27.3 11.4 40.4 6.5 90.5 26.7 11.9 23.7 31.8 34.2 25.3 36.1 24.4 14.7 18.0 16.1 18.9 22.5 16.2 14.6 77.5 11.7 51.5 18.6 41.8 13.6 25.9 29.4 21.6 16.5 65.7 15.1 20.4 16.0 17.7 19.0 32.8 32.5 8.4 25.4 58.0 24.2 29.1 18.8 14.9 29.6 43.1 31.9 18.8 40.5 35.4 31.4 79.2 71.2 78.1 73.7 62.9 62.9 43.6 54.6 61.6 61.4 42.6 45.5 52.9 95.2 56.9 54.4 85.3 57.3 115.8 15.0 17.4 9.5 16.4 13.9 10.2 16.4 12.7 14.8 14.1 53.6 74.8 75.9 123.0 50.6 29.0 41.1 132.5 81.7 70.5 102.9 15.7 270.2 44.7 202.2 69.2 77.2 152.5 70.0 207.8 336.5 120.4 135.0 77.2 199.1 216.0 52.4 56.6 72.4 94.5 17.3 81.4 90.1 114.7 127.2 115.4 86.9 201.9 122.2 60.1 91.5 34.1 64.7 82.4 261.5 199.7 61.1 443.5 121.5 129.7 136.6 LMAN2L "DKFZp564L2423, VIPL" ENSG00000114988 "Lectin, mannose binding 2 like" Q9H0V9 2 96705929-96740064 "Disease related genes, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026600 Approved NA NA "HPA026600: AB_1852939" "unprognostic (3.02e-1)" "unprognostic (2.34e-1)" "unprognostic (2.17e-3)" "unprognostic (1.83e-2)" "unprognostic (2.19e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-2)" "unprognostic (4.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.80e-1)" "unprognostic (6.91e-3)" "unprognostic (1.16e-1)" "unprognostic (5.30e-2)" "unprognostic (8.14e-2)" "unprognostic (2.17e-1)" "unprognostic (1.52e-1)" "unprognostic (3.29e-1)" 10.1 11.1 10.4 11.8 15.5 1.6 17.0 22.9 11.5 15.5 12.4 13.3 9.9 6.4 15.9 20.3 9.9 19.9 10.2 14.3 11.3 13.6 20.2 18.1 10.8 6.0 11.6 9.9 24.9 15.8 12.6 19.8 12.9 11.4 16.9 12.2 14.6 12.4 16.4 14.5 9.8 9.4 17.7 8.4 8.1 9.9 13.7 11.2 8.6 26.4 8.0 8.2 10.5 24.0 15.0 15.7 20.1 13.7 10.4 25.7 13.4 8.5 13.9 10.9 11.3 13.9 6.6 10.0 8.1 10.1 17.1 18.8 23.7 6.6 4.2 30.7 19.8 42.6 10.6 15.5 12.6 21.7 11.0 8.5 3.6 9.4 20.0 8.8 6.2 6.1 7.6 12.1 13.0 4.1 14.9 9.9 7.2 8.1 8.7 10.7 5.9 4.4 5.8 5.8 6.1 15.2 9.4 9.0 4.7 13.9 4.5 6.9 3.6 9.1 7.0 8.0 21.0 8.4 11.0 7.2 13.7 9.8 10.7 10.6 5.6 18.4 3.5 8.0 7.4 11.0 20.1 13.7 16.5 11.3 7.5 25.7 15.0 13.3 15.1 11.0 12.6 16.4 13.7 7.4 10.4 10.8 15.7 10.7 13.4 10.4 15.5 22.9 11.5 11.3 13.6 11.6 9.9 11.4 11.2 11.9 5.0 2.2 5.2 3.1 2.6 10.6 5.1 1.4 3.4 12.2 5.9 16.1 8.3 11.3 13.9 5.4 4.2 0.0 6.9 10.4 12.2 4.3 4.7 9.3 8.6 1.6 9.1 6.7 3.2 14.3 6.4 2.5 3.3 16.2 4.9 13.0 7.4 3.5 8.1 9.1 4.9 12.9 10.3 10.9 15.9 2.4 11.2 4.4 6.9 1.6 LMBR1 "ACHP, C7orf2, FLJ11665, ZRS" ENSG00000105983 "Limb development membrane protein 1" Q8WVP7 7 156668946-156893230 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016592 Approved Approved Cytosol NA NA Cytosol "HPA016592: AB_1852943" "unprognostic (8.81e-3)" "unprognostic (1.73e-2)" "unprognostic (9.49e-2)" "unprognostic (2.02e-1)" "unprognostic (3.77e-3)" "unprognostic (6.90e-2)" "unprognostic (1.30e-2)" "unprognostic (3.28e-1)" "unprognostic (1.21e-2)" "unprognostic (1.12e-2)" "unprognostic (1.69e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.44e-6)" "unprognostic (3.35e-1)" "unprognostic (3.93e-2)" "unprognostic (1.48e-1)" "unprognostic (7.10e-2)" 15.8 30.5 15.2 12.4 23.7 7.1 12.9 20.4 25.5 16.3 10.1 13.4 12.8 9.1 19.0 19.4 12.1 16.9 12.8 12.9 15.9 17.4 17.5 15.9 11.5 11.3 17.8 11.5 18.9 12.0 38.2 22.7 11.6 24.4 14.1 12.2 11.3 10.6 13.1 14.8 11.2 10.9 15.1 14.4 9.4 12.7 20.3 13.2 14.7 20.9 8.7 12.8 13.9 12.3 2.3 3.6 4.2 2.0 0.9 4.1 1.5 12.5 11.0 12.5 15.4 10.1 12.2 8.5 7.3 9.2 6.6 7.3 7.9 20.5 12.3 14.0 9.4 12.4 10.1 13.1 13.6 14.0 8.8 13.3 9.1 6.1 9.5 7.0 11.2 6.3 9.2 12.3 9.6 12.6 10.5 14.2 10.5 17.4 11.3 13.4 11.8 11.2 9.0 14.5 13.3 9.9 6.1 8.9 15.0 10.4 12.5 13.3 24.8 9.6 13.1 7.0 8.4 9.2 6.2 19.9 11.9 4.6 40.9 9.2 13.7 10.7 12.2 20.2 14.3 7.3 4.2 2.0 2.7 1.7 1.0 4.1 1.3 3.6 2.6 3.6 2.3 4.0 2.5 1.5 0.9 1.7 2.2 2.2 1.5 15.2 23.7 20.4 25.5 15.9 17.4 17.8 11.5 24.4 13.2 3.0 7.2 6.4 11.5 9.3 11.2 15.4 12.7 5.3 4.5 12.2 2.0 12.6 5.0 9.4 6.0 20.0 8.4 0.0 8.9 4.8 11.6 16.2 5.7 18.1 8.5 7.9 7.9 8.6 8.6 8.0 9.8 6.1 6.8 4.6 9.7 6.5 10.3 7.0 8.1 9.4 10.6 0.0 6.0 9.6 27.4 11.2 19.3 5.7 11.0 13.3 LMBR1L "FLJ10494, KIAA1174" ENSG00000139636 "Limb development membrane protein 1 like" Q6UX01 12 49096551-49110900 "Predicted membrane proteins" "Endocytosis, Wnt signaling pathway" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 90.1;Late spermatids: 124.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.25e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.05e-1)" "unprognostic (1.89e-1)" "unprognostic (2.62e-1)" "unprognostic (6.56e-3)" "unprognostic (1.17e-1)" "unprognostic (1.77e-3)" "unprognostic (1.59e-1)" "prognostic favorable (3.50e-4)" "unprognostic (2.72e-2)" "prognostic unfavorable (4.45e-7)" "unprognostic (2.48e-2)" "unprognostic (1.16e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-3)" 12.5 10.7 7.7 9.8 9.4 9.9 11.5 19.7 10.4 11.3 12.7 7.4 14.8 9.3 13.8 15.3 11.0 9.0 9.0 7.8 7.9 7.6 8.1 9.2 8.7 11.2 10.7 6.9 11.7 11.0 5.6 14.4 13.7 8.1 9.3 8.6 10.9 6.7 16.2 10.1 6.3 15.0 13.8 6.9 12.8 7.5 33.5 9.3 12.5 6.7 6.0 12.0 12.2 15.1 9.6 7.3 27.5 11.7 3.1 11.5 8.0 4.5 6.8 8.8 8.2 6.5 8.2 8.3 4.0 6.8 6.0 5.4 6.0 2.6 1.4 3.5 9.4 3.9 1.5 6.9 2.0 3.8 7.5 10.7 4.7 3.9 4.9 7.6 3.0 8.2 8.1 3.2 8.0 5.5 17.9 19.4 7.9 12.5 2.0 5.3 1.5 6.6 6.2 4.1 12.3 5.1 4.3 2.6 2.2 2.3 10.0 4.4 5.1 3.6 3.3 6.8 10.2 2.1 4.0 16.8 2.9 2.0 1.8 1.9 5.7 3.7 3.2 5.8 2.5 2.2 10.8 10.0 27.5 7.3 8.6 6.1 9.6 7.9 8.4 7.3 9.5 11.5 9.6 5.5 3.1 11.7 5.2 11.1 8.0 7.7 9.4 19.7 10.4 7.9 7.6 10.7 6.9 8.1 9.3 6.0 21.9 11.5 12.1 13.7 33.7 5.5 5.1 4.0 5.7 8.7 19.6 13.1 3.3 13.2 90.1 22.9 18.4 0.0 9.0 33.4 20.1 13.4 17.3 7.5 14.5 30.2 45.2 16.5 11.9 124.2 12.7 20.7 20.3 32.5 11.0 8.4 14.6 12.7 6.3 2.8 35.1 12.9 17.6 10.2 12.6 12.9 18.7 27.7 10.9 13.7 LMBRD1 "bA810I22.1, C6orf209, cblF, FLJ11240" ENSG00000168216 "LMBR1 domain containing 1" Q9NUN5 6 69675802-69797111 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016491, HPA019547" Uncertain Supported Vesicles NA NA Vesicles "HPA016491: , HPA019547: AB_2281256" "unprognostic (1.44e-1)" "unprognostic (3.84e-2)" "unprognostic (7.67e-2)" "unprognostic (7.64e-2)" "unprognostic (2.41e-1)" "unprognostic (5.37e-2)" "unprognostic (2.26e-1)" "unprognostic (4.39e-2)" "unprognostic (2.19e-1)" "unprognostic (1.97e-1)" "unprognostic (2.22e-1)" "unprognostic (1.47e-1)" "prognostic favorable (1.07e-7)" "unprognostic (7.99e-2)" "unprognostic (1.67e-1)" "unprognostic (2.60e-2)" "unprognostic (2.68e-2)" 21.3 44.1 34.1 14.2 32.5 5.4 29.1 32.9 34.1 23.7 20.9 38.1 20.0 23.1 18.4 32.1 20.6 25.5 23.9 19.8 35.8 32.7 53.1 38.9 24.7 21.9 37.9 22.8 29.0 36.8 58.9 23.6 25.0 32.5 19.0 21.8 26.5 22.4 24.6 17.9 18.6 30.2 17.2 57.8 19.9 19.9 11.9 30.6 17.8 41.8 13.2 18.7 22.7 19.4 24.4 9.9 37.8 18.5 7.8 14.4 11.5 6.7 3.2 7.6 10.3 22.9 24.5 11.4 5.4 19.8 4.5 9.5 5.3 14.0 9.0 15.4 14.2 7.0 10.8 8.4 8.0 8.1 17.6 10.8 8.7 6.3 7.7 14.0 5.3 11.8 17.3 17.0 5.2 7.3 21.7 8.0 7.3 15.9 13.5 14.4 4.6 3.6 5.6 3.9 12.7 3.4 4.1 18.7 25.3 31.0 11.2 4.9 8.1 6.8 9.3 9.9 6.1 9.9 19.0 12.2 6.3 4.0 5.9 5.4 8.1 7.0 3.4 7.8 8.6 11.9 25.2 10.6 19.0 8.4 13.2 8.6 24.4 11.2 9.5 9.9 21.7 12.8 9.0 37.8 7.8 18.5 9.6 14.4 11.5 34.1 32.5 32.9 34.1 35.8 32.7 37.9 22.8 32.5 30.6 59.6 34.7 34.6 36.9 25.8 68.6 35.2 45.9 52.2 50.0 55.8 104.1 65.0 16.6 37.2 15.4 36.2 60.6 23.3 43.3 52.5 48.2 25.5 39.3 51.4 37.9 52.4 18.0 36.8 63.3 3.2 32.8 46.1 30.4 39.7 38.1 48.7 36.8 42.1 31.8 49.4 81.3 25.8 22.8 17.0 15.9 33.2 64.8 31.0 27.5 33.1 LMBRD2 DKFZp434H2226 ENSG00000164187 "LMBR1 domain containing 2" Q68DH5 5 36098412-36151961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "basophil: 11.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 11.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012165 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA012165: AB_2136131" "unprognostic (9.43e-3)" "unprognostic (3.03e-1)" "unprognostic (1.80e-2)" "unprognostic (7.09e-2)" "unprognostic (1.79e-1)" "unprognostic (9.53e-3)" "unprognostic (6.58e-2)" "unprognostic (8.46e-3)" "unprognostic (6.45e-3)" "unprognostic (2.80e-1)" "unprognostic (8.61e-2)" "unprognostic (6.94e-2)" "unprognostic (2.30e-3)" "unprognostic (7.53e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-2)" "unprognostic (5.35e-2)" 6.2 9.7 12.1 6.6 21.4 2.2 8.8 12.8 25.5 7.3 8.7 9.5 7.6 9.6 5.3 7.2 6.8 4.8 5.8 8.2 14.2 11.4 10.5 14.2 5.7 7.6 9.9 15.6 5.0 7.7 16.9 16.9 8.4 14.1 9.7 9.1 4.8 7.6 6.8 11.1 7.7 9.6 5.5 10.5 6.7 10.1 5.2 8.6 8.4 12.8 2.9 7.4 7.6 6.1 1.5 1.2 11.0 1.2 1.0 2.3 0.8 4.9 3.7 4.5 7.4 9.4 8.3 15.9 10.3 5.4 7.6 7.6 4.6 10.8 8.9 5.2 5.4 7.8 6.8 5.9 3.6 12.5 12.7 3.6 6.9 12.6 0.8 6.0 8.3 9.2 4.9 6.4 6.5 6.5 5.7 4.1 6.9 8.1 9.4 9.1 3.3 7.1 5.5 2.5 7.7 4.7 5.4 10.5 5.4 6.5 4.4 8.5 6.6 14.8 8.8 3.6 4.6 10.0 10.1 5.4 9.1 2.4 11.5 5.4 7.7 11.3 7.8 8.6 9.5 6.2 11.0 1.2 2.0 1.6 1.2 1.1 1.5 1.4 1.4 1.0 1.3 1.9 1.9 0.8 1.0 1.2 1.2 2.3 0.8 12.1 21.4 12.8 25.5 14.2 11.4 9.9 15.6 14.1 8.6 8.9 9.8 5.6 4.2 6.2 10.8 22.2 10.2 9.4 2.3 12.2 7.9 8.0 3.3 4.4 1.3 5.8 11.8 0.0 6.6 5.6 6.6 8.8 6.9 25.2 9.7 14.3 6.4 9.8 13.2 1.4 4.4 7.7 6.8 6.4 14.8 11.6 5.6 3.5 6.7 10.2 10.7 12.9 7.9 21.2 8.1 8.8 16.2 6.7 10.4 2.5 LMF1 "C16orf26, FLJ12681, FLJ22302, JFP11, TMEM112, TMEM112A" ENSG00000103227 "Lipase maturation factor 1" Q96S06 16 853634-981318 "Disease related genes, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.42e-2)" "unprognostic (7.56e-2)" "unprognostic (1.02e-2)" "unprognostic (1.16e-3)" "unprognostic (5.58e-3)" "unprognostic (1.20e-2)" "unprognostic (5.24e-3)" "unprognostic (1.41e-2)" "unprognostic (6.22e-2)" "unprognostic (3.02e-2)" "unprognostic (1.36e-1)" "unprognostic (4.01e-3)" "prognostic favorable (7.95e-8)" "unprognostic (2.00e-1)" "unprognostic (1.26e-1)" "unprognostic (1.45e-1)" "unprognostic (2.03e-3)" 8.5 12.5 40.0 6.4 66.1 6.6 8.8 7.3 37.2 7.2 6.4 30.0 5.3 7.2 8.1 22.9 7.3 9.3 7.6 6.8 27.4 10.5 8.6 12.4 7.3 6.7 23.6 23.9 9.5 33.2 23.5 8.0 5.8 23.5 11.1 5.7 8.6 22.5 9.5 6.5 10.6 7.5 8.2 31.4 9.5 10.1 5.8 42.1 3.0 13.6 3.2 6.2 8.7 7.8 3.6 10.1 2.5 7.2 8.2 9.0 4.8 0.7 9.0 6.4 11.5 8.1 8.3 2.8 4.4 14.4 1.6 2.9 1.8 12.0 1.9 6.8 11.4 4.3 3.4 2.4 0.0 0.9 5.9 3.2 0.6 0.5 2.2 4.2 1.6 2.3 4.8 0.0 0.3 3.8 7.2 3.4 3.3 1.4 7.8 5.3 10.3 3.4 0.9 3.3 7.2 5.0 3.5 6.4 12.5 5.8 2.1 0.0 3.5 2.2 2.4 8.1 3.6 5.5 5.4 3.6 0.9 1.5 3.6 0.6 9.6 1.3 2.7 2.4 1.7 7.3 2.5 6.4 1.4 9.0 7.2 5.2 3.6 5.1 6.2 10.1 3.2 5.2 4.1 0.3 8.2 4.3 9.5 4.8 4.8 40.0 66.1 7.3 37.2 27.4 10.5 23.6 23.9 23.5 42.1 11.9 11.3 3.0 5.5 3.7 10.5 3.6 2.5 13.4 6.8 5.2 13.7 1.1 3.3 11.8 0.5 6.3 8.0 0.0 15.1 1.2 7.4 6.1 2.3 7.9 6.1 12.7 8.1 7.4 6.0 2.9 13.6 4.5 15.1 1.8 5.3 19.7 15.0 5.1 9.2 7.7 8.7 6.5 5.1 1.5 3.8 1.8 0.9 4.4 5.4 4.6 LMF2 "TMEM112B, TMEM153" ENSG00000100258 "Lipase maturation factor 2" Q9BU23 22 50502949-50507691 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 122.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062626 Approved Approved Centrosome NA NA Centrosome "HPA062626: AB_2684812" "unprognostic (2.69e-1)" "prognostic favorable (3.47e-4)" "unprognostic (8.67e-2)" "unprognostic (2.25e-2)" "unprognostic (1.68e-2)" "unprognostic (5.13e-2)" "unprognostic (1.21e-2)" "unprognostic (2.70e-2)" "unprognostic (5.11e-2)" "unprognostic (2.90e-1)" "unprognostic (2.97e-2)" "unprognostic (3.12e-3)" "unprognostic (8.49e-2)" "unprognostic (1.47e-1)" "unprognostic (2.08e-1)" "unprognostic (2.54e-2)" "unprognostic (8.75e-2)" 18.2 13.7 7.7 14.3 10.1 20.9 16.9 14.6 16.6 16.9 20.0 16.1 11.0 18.7 14.7 19.3 17.5 13.0 19.0 11.2 8.1 8.7 18.5 34.7 14.2 15.3 10.7 10.1 18.0 122.0 8.7 20.8 14.2 11.3 15.8 5.3 16.9 27.3 16.4 10.8 17.8 21.3 11.3 7.8 19.0 12.9 12.0 7.8 12.8 20.4 13.9 19.9 13.3 14.1 10.8 25.3 16.1 17.7 12.1 21.0 12.6 18.0 13.6 7.8 14.8 11.3 9.7 18.2 32.4 17.2 20.9 23.5 13.4 9.4 8.0 8.8 17.0 9.3 21.8 2.6 10.2 2.9 6.3 28.5 4.4 25.0 14.1 14.2 8.2 17.6 14.3 9.5 14.2 3.5 9.0 11.6 6.3 5.2 27.1 9.0 13.0 5.8 9.7 4.6 4.6 17.0 13.3 12.5 21.8 8.4 9.8 7.0 10.3 22.1 19.2 14.9 3.9 11.0 5.8 16.8 29.6 16.8 21.1 1.6 10.5 3.4 4.8 21.5 5.1 24.1 10.3 13.2 16.1 21.0 17.7 15.9 10.8 17.5 19.4 14.0 7.3 10.4 10.9 12.4 12.1 14.5 25.3 15.9 12.6 7.7 10.1 14.6 16.6 8.1 8.7 10.7 10.1 11.3 7.8 11.9 9.6 31.3 14.9 16.6 13.7 8.1 35.7 5.3 12.5 14.0 21.6 50.7 3.3 33.0 7.3 17.9 48.5 0.0 65.4 89.5 42.9 11.0 15.1 31.6 38.4 11.1 14.5 23.4 17.3 14.8 27.0 23.9 23.6 19.0 25.4 24.6 31.0 59.6 24.1 19.5 14.1 19.4 19.4 11.2 20.1 15.2 23.8 34.6 24.4 13.1 LMLN "Gp63, LMNL1, Msp" ENSG00000185621 "Leishmanolysin like peptidase" Q96KR4 3 197960200-198043720 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 32.1;Early spermatids: 29.2;Spermatocytes: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016481, HPA028844" Uncertain Supported "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA016481: AB_1852955, HPA028844: AB_10602347" "unprognostic (2.54e-1)" "unprognostic (3.15e-1)" "unprognostic (7.63e-2)" "prognostic favorable (6.77e-4)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (4.07e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-1)" "unprognostic (6.36e-2)" "unprognostic (2.98e-1)" "unprognostic (4.82e-3)" "unprognostic (8.78e-2)" "unprognostic (7.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.63e-1)" 3.9 4.9 5.2 2.5 11.0 2.3 4.5 6.1 9.1 6.2 3.5 5.8 14.3 2.2 4.8 20.3 3.5 9.3 5.1 5.9 5.7 7.4 6.6 3.7 8.1 3.5 5.6 8.9 6.5 6.1 8.8 15.0 3.9 11.6 4.6 4.1 5.4 4.2 11.7 3.7 6.5 2.3 4.0 5.5 3.0 3.9 27.0 4.4 1.2 7.6 3.0 2.6 3.5 3.7 1.9 1.9 0.8 2.4 1.8 2.4 1.2 6.5 2.5 2.9 3.5 5.8 8.2 2.5 3.4 3.1 6.1 5.1 2.4 2.4 2.1 15.8 2.4 13.3 2.5 2.7 2.7 9.0 0.3 2.0 1.2 2.1 1.8 3.6 3.6 1.8 3.9 6.1 7.6 5.0 3.6 2.6 5.3 6.3 4.0 5.9 4.8 2.2 3.2 3.3 4.7 5.9 2.5 0.7 2.2 6.3 1.7 4.8 1.4 4.7 4.2 3.4 3.5 11.0 2.8 5.7 7.6 1.1 9.1 5.7 7.1 13.7 0.6 10.8 6.4 6.8 0.2 0.6 0.5 1.2 2.4 1.7 1.9 0.8 1.6 1.9 1.1 2.2 2.4 0.8 1.8 0.9 0.5 0.0 1.2 5.2 11.0 6.1 9.1 5.7 7.4 5.6 8.9 11.6 4.4 14.9 11.3 1.9 1.5 1.8 7.7 9.2 2.5 32.1 13.6 8.7 15.7 2.5 0.0 2.5 29.2 2.5 1.0 0.0 2.3 2.1 3.3 1.9 2.3 2.4 4.2 7.9 4.6 4.3 2.8 18.6 4.4 2.0 3.3 0.0 3.1 7.7 1.8 0.0 5.3 3.7 16.3 0.0 3.2 29.2 24.7 1.5 2.4 1.3 2.3 1.3 LMLN2 ENSG00000283654 "Leishmanolysin like peptidase 2" 14 23099065-23104992 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 12 "HSkMC: 7.7" "Not detected" "Not detected" NA NA 0.3 0.5 0.0 0.4 2.5 1.2 0.3 1.1 2.0 0.2 0.7 3.7 0.0 0.4 0.4 1.4 0.2 0.2 1.4 0.1 0.0 0.0 0.0 0.1 1.0 0.9 1.1 0.7 0.0 0.7 0.0 0.0 3.9 0.3 0.7 0.9 0.4 0.0 0.1 1.3 0.6 1.7 0.9 0.6 0.1 1.1 0.7 0.0 1.4 0.0 1.0 0.1 0.0 0.7 0.3 1.0 0.5 0.4 0.7 0.2 0.2 0.2 0.6 0.5 0.1 0.2 0.3 0.2 0.2 0.0 0.2 0.5 0.2 0.4 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.2 0.6 0.3 0.3 0.1 0.3 7.7 0.1 0.1 0.0 0.4 0.3 0.4 0.1 0.4 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.2 0.2 0.6 0.2 0.0 0.2 0.6 0.1 0.2 0.2 0.2 0.1 0.0 0.1 0.2 0.0 0.8 0.5 0.2 0.7 0.1 0.3 0.0 0.1 0.3 0.2 0.7 0.5 0.3 1.0 0.4 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LMO7 "FBX20, FBXO20, KIAA0858" ENSG00000136153 "LIM domain 7" Q8WWI1 13 75620434-75859870 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 65.6" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 1563.3;Club cells: 396.9;Urothelial cells: 377.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.1" "Lineage enriched" "Detected in many" 5 "T-cells: 14.1" "Cell line enhanced" "Detected in many" "BJ: 55.4;fHDF/TERT166: 91.4;LHCN-M2: 86.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 32.9;basal ganglia: 46.3;cerebral cortex: 39.4;hippocampal formation: 54.2" "HPA020923, HPA050184" Enhanced Supported "Actin filaments,Cytosol" NA NA "Actin filaments" Cytosol "HPA020923: AB_1852963, HPA050184: AB_2681045" "unprognostic (2.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.75e-2)" "unprognostic (1.44e-1)" "unprognostic (1.57e-2)" "unprognostic (1.97e-1)" "unprognostic (1.52e-2)" "unprognostic (3.42e-2)" "prognostic unfavorable (3.51e-4)" "unprognostic (2.14e-1)" "prognostic favorable (7.75e-12)" "unprognostic (2.49e-1)" "unprognostic (2.82e-1)" "unprognostic (1.08e-1)" "unprognostic (8.33e-2)" 2.2 2.2 10.1 6.3 32.6 0.9 2.5 2.7 13.2 6.7 24.3 0.5 2.4 17.5 2.3 7.8 42.5 4.0 16.3 65.6 9.8 2.5 21.7 19.9 57.0 2.6 2.3 8.8 5.5 6.8 6.2 3.1 10.9 1.1 7.6 8.9 2.7 14.3 7.0 44.4 8.6 55.0 2.1 2.0 1.5 16.7 4.7 4.1 16.2 25.7 36.3 23.7 4.6 15.4 2.4 1.1 3.0 0.5 0.5 14.1 2.6 12.2 7.0 0.2 0.2 14.6 10.4 2.4 55.4 27.4 14.1 15.3 17.1 15.9 1.0 4.2 91.4 3.5 11.9 3.0 2.6 16.3 16.5 0.7 7.5 37.2 16.0 4.2 2.4 3.9 7.1 5.2 6.1 7.0 34.6 5.9 2.4 0.2 0.1 86.0 4.8 1.8 1.0 0.3 19.0 10.6 1.1 25.9 0.2 6.0 2.8 0.9 1.9 10.1 1.7 2.2 1.5 2.3 1.8 9.0 34.9 6.5 4.1 13.5 3.7 2.7 4.4 10.2 2.7 15.8 3.0 0.2 2.4 0.7 0.5 0.9 1.1 3.2 1.0 0.4 2.4 14.1 8.5 0.1 0.5 0.3 1.1 1.2 2.6 10.1 32.6 2.7 13.2 9.8 2.5 2.3 8.8 1.1 4.1 1563.3 242.1 2.7 51.2 21.3 5.2 309.1 48.4 234.2 396.9 59.3 2.0 38.6 13.3 56.6 4.7 11.3 219.0 0.0 32.9 6.2 66.8 251.0 19.7 61.7 5.1 6.4 68.3 6.7 3.7 5.6 38.9 4.9 15.1 1.8 69.4 1.7 146.0 64.9 40.0 13.6 10.9 12.9 19.1 8.1 3.2 39.5 14.2 7.0 44.1 377.1 LMTK2 "AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100" ENSG00000164715 "Lemur tyrosine kinase 2" Q8IWU2 7 98106885-98209633 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010657, HPA041836" Uncertain Approved "Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Nuclear speckles, Centriolar satellite" "Plasma membrane, Cytosol" "HPA010657: AB_1079259, HPA041836: AB_2677698" "unprognostic (7.36e-2)" "unprognostic (3.16e-1)" "unprognostic (1.59e-1)" "unprognostic (2.60e-3)" "unprognostic (2.47e-2)" "unprognostic (2.45e-1)" "unprognostic (2.35e-2)" "unprognostic (1.23e-1)" "unprognostic (4.96e-1)" "prognostic unfavorable (8.03e-4)" "unprognostic (1.23e-1)" "unprognostic (4.65e-1)" "prognostic favorable (1.12e-7)" "unprognostic (1.88e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (6.38e-3)" 5.1 10.3 13.7 5.6 21.3 17.3 5.6 16.6 34.3 7.3 13.8 6.1 5.6 12.6 6.1 6.3 12.7 6.4 7.9 16.9 11.0 10.1 10.1 8.5 10.0 5.1 7.5 18.9 8.0 21.0 22.2 10.0 4.8 13.2 7.9 11.8 5.4 10.5 6.5 17.5 11.5 13.8 5.7 5.5 6.8 9.4 8.0 6.9 7.2 8.7 5.7 7.4 8.3 8.1 0.6 0.7 4.8 0.9 0.3 1.6 0.5 9.8 11.6 9.0 9.2 4.8 3.9 8.4 4.1 4.5 4.0 4.9 9.1 9.0 5.2 11.8 5.2 15.3 10.8 10.4 6.3 6.3 7.4 7.3 3.5 10.4 9.1 5.9 6.2 6.3 2.6 8.7 8.3 11.3 4.1 6.0 6.0 9.1 10.9 3.6 13.3 6.6 3.7 11.0 13.5 5.7 7.2 6.1 10.2 6.7 17.3 6.5 12.9 8.2 15.0 6.0 9.5 4.1 2.5 7.3 8.4 13.8 16.8 9.3 4.9 8.5 10.3 5.7 4.9 10.0 1.2 0.6 0.5 0.8 0.3 0.5 0.6 0.9 0.9 0.3 0.6 1.1 1.6 4.8 0.3 0.9 0.7 0.8 0.5 13.7 21.3 16.6 34.3 11.0 10.1 7.5 18.9 13.2 6.9 26.8 10.5 0.0 4.2 8.7 14.0 18.7 17.8 10.7 9.1 1.8 13.7 2.3 1.7 5.0 0.8 3.1 26.2 0.0 7.9 1.6 3.5 6.2 2.3 6.8 1.8 6.4 11.5 3.1 2.6 2.1 1.7 2.3 1.7 0.0 13.5 5.8 8.6 13.1 4.2 2.4 9.9 0.0 3.8 6.3 4.7 9.5 2.5 2.9 12.6 13.2 LMTK3 "KIAA1883, LMR3, PPP1R101, TYKLM3" ENSG00000142235 "Lemur tyrosine kinase 3" Q96Q04 19 48485271-48513189 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.1" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 21.6;Ductal cells: 19.4;Horizontal cells: 17.5;Urothelial cells: 44.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 8.6;SK-BR-3: 10.2;U-266/70: 9.5;U-266/84: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040203, HPA077070" Enhanced Supported Uncertain "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA040203: AB_10671690, HPA077070: AB_2732330" "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (5.37e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-1)" "unprognostic (1.71e-2)" "unprognostic (5.67e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-3)" "unprognostic (5.71e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.18e-8)" "unprognostic (1.38e-1)" "unprognostic (3.22e-2)" "unprognostic (3.24e-1)" "unprognostic (6.11e-2)" 1.3 4.4 19.8 2.3 28.6 2.0 2.0 20.0 38.1 2.0 1.5 6.0 0.2 6.2 1.4 1.5 2.3 1.6 1.9 1.7 17.2 11.1 2.5 1.3 3.2 2.2 6.5 23.8 1.3 2.1 8.5 6.1 2.1 12.5 3.5 1.2 1.6 5.2 3.1 1.2 2.4 4.0 1.2 6.6 1.8 2.9 1.5 10.3 0.0 2.3 0.0 2.2 1.6 1.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 4.6 3.1 0.4 0.0 0.0 0.0 4.5 0.0 0.3 0.0 0.1 2.2 3.7 1.7 1.3 0.0 1.2 2.2 0.3 1.6 0.0 0.0 1.2 0.2 0.3 0.7 0.0 0.0 8.6 0.2 0.9 0.0 0.0 2.0 0.1 2.8 1.4 2.9 0.0 3.1 0.6 0.8 1.1 2.4 0.9 3.9 0.0 1.3 1.1 0.8 0.7 2.9 0.1 10.2 0.0 0.6 3.9 0.2 0.1 0.0 0.8 0.1 0.0 9.5 7.7 0.4 0.2 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 19.8 28.6 20.0 38.1 17.2 11.1 6.5 23.8 12.5 10.3 3.0 1.7 0.8 9.2 0.5 16.4 2.2 2.5 4.0 4.5 7.0 0.0 4.3 21.6 19.4 0.1 0.0 0.7 0.0 0.4 2.5 0.9 15.7 0.0 0.0 1.0 17.5 0.0 1.3 0.3 0.0 0.6 0.3 3.3 0.0 1.0 7.3 10.7 0.0 0.0 0.6 1.9 0.0 0.7 2.4 1.3 1.6 5.7 0.0 0.6 44.3 LNPEP "CAP, IRAP, P-LAP, PLAP" ENSG00000113441 "Leucyl and cystinyl aminopeptidase" Q9UIQ6 5 96935394-97037515 "Enzymes, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 104.4" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 117.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043642 Approved "Intracellular and membrane" NA NA 390000 "HPA043642: AB_10964137" "unprognostic (1.52e-1)" "unprognostic (5.39e-2)" "unprognostic (7.78e-2)" "unprognostic (1.53e-2)" "unprognostic (6.38e-2)" "unprognostic (6.59e-3)" "unprognostic (6.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.11e-1)" "unprognostic (3.54e-3)" "unprognostic (6.24e-2)" "unprognostic (2.08e-1)" "unprognostic (3.28e-1)" "unprognostic (4.13e-3)" "unprognostic (1.46e-1)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" 9.8 4.7 5.6 12.0 7.3 13.2 7.7 23.3 12.9 6.3 7.6 6.9 7.8 4.2 8.2 4.4 10.2 6.6 4.3 10.1 5.2 5.6 7.6 4.3 6.9 15.9 7.7 8.8 8.2 5.9 13.8 9.7 104.4 9.1 7.9 6.8 3.9 7.8 7.7 13.2 14.0 9.0 6.6 7.5 10.0 8.5 3.3 7.7 23.6 7.2 2.9 15.8 8.9 7.7 4.1 3.5 5.0 12.8 11.2 7.9 4.3 5.3 6.2 2.8 2.9 17.1 8.2 3.3 5.5 7.3 6.5 9.9 5.2 8.7 26.5 10.4 7.4 18.3 7.1 3.6 10.4 6.8 9.4 2.0 6.6 4.5 3.6 4.4 7.6 9.1 6.3 6.4 9.4 6.9 7.0 6.8 5.9 2.8 17.6 7.4 4.7 9.0 5.3 0.6 1.7 3.3 6.5 10.6 4.0 23.2 11.1 5.5 1.4 6.7 5.9 3.3 2.8 18.1 10.0 13.5 9.5 5.3 7.5 8.3 3.8 8.8 24.2 8.4 7.2 4.3 5.0 3.3 4.4 7.9 5.5 6.8 3.1 5.9 6.1 3.5 4.1 5.9 6.4 4.1 11.2 12.8 3.3 5.1 4.3 5.6 7.3 23.3 12.9 5.2 5.6 7.7 8.8 9.1 7.7 32.8 42.4 53.7 16.7 52.8 57.3 58.2 17.8 22.7 20.5 34.9 117.8 9.5 5.0 14.0 2.4 31.5 15.8 0.0 12.3 21.8 30.1 24.6 24.4 14.1 14.7 22.3 24.6 33.7 46.5 3.8 30.5 38.3 20.3 12.6 27.8 43.8 15.9 14.0 43.9 9.1 35.8 25.8 24.7 21.4 23.1 41.3 22.9 70.5 21.5 19.9 LNPK "KIAA1715, LNP, LNP1, Ul" ENSG00000144320 "Lunapark, ER junction formation factor" Q9C0E8 2 175923892-176002839 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9;Ciliated cells: 16.0;Collecting duct cells: 15.7;Extravillous trophoblasts: 15.2;Hofbauer cells: 20.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 60.1" "Low region specificity" "Detected in all" HPA014205 Approved Supported "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA014205: AB_2234186" "unprognostic (4.93e-2)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.85e-2)" "unprognostic (1.08e-2)" "unprognostic (8.73e-2)" "unprognostic (1.27e-1)" "unprognostic (3.15e-1)" "unprognostic (2.72e-2)" "unprognostic (3.13e-1)" "unprognostic (4.17e-3)" "unprognostic (1.63e-1)" "unprognostic (9.27e-2)" "unprognostic (2.35e-3)" "unprognostic (3.43e-2)" 14.2 10.8 13.4 8.4 16.0 29.4 11.3 12.9 26.5 15.0 13.3 13.4 7.1 8.6 11.9 7.7 15.1 8.2 9.1 13.6 13.8 16.1 9.8 16.3 8.1 7.6 19.9 14.2 12.8 6.4 16.8 22.8 9.4 21.1 12.0 11.9 10.1 8.6 10.1 33.5 13.5 8.4 11.3 26.2 6.6 8.9 25.4 14.6 16.4 10.3 14.8 8.7 12.2 15.1 7.1 6.7 11.6 7.3 9.7 11.6 5.2 8.7 4.4 10.6 14.9 22.3 13.9 5.3 25.9 12.5 12.1 17.1 6.1 10.4 8.8 14.8 11.4 15.9 9.7 9.9 6.9 16.9 13.3 10.1 9.9 5.7 5.4 5.3 16.7 12.3 11.4 6.6 11.7 5.8 9.9 2.2 7.0 10.1 11.7 16.5 5.7 11.0 6.7 3.4 9.0 8.6 11.2 10.7 6.4 5.1 8.0 12.2 12.4 11.4 6.5 8.6 10.4 9.7 5.5 3.3 60.1 8.9 20.0 12.1 6.9 12.6 7.3 18.6 5.5 11.2 5.7 6.6 11.6 8.1 7.3 9.5 7.1 7.2 8.9 6.0 5.0 7.2 11.2 5.6 9.7 6.7 6.7 11.6 5.2 13.4 16.0 12.9 23.3 13.8 16.1 19.9 14.2 21.1 14.6 17.9 9.9 0.0 0.0 0.0 0.0 0.0 0.0 16.0 11.4 15.7 0.0 4.3 5.0 14.3 0.0 0.0 0.0 0.0 8.3 15.2 0.0 0.0 10.5 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 3.6 0.0 0.0 11.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 LPAR1 "edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1" ENSG00000198121 "Lysophosphatidic acid receptor 1" Q92633 9 110873263-111038458 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4" "Cell type enhanced" "Detected in many" 12 "Fibroblasts: 45.6;Leydig cells: 35.9;Peritubular cells: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.5;eosinophil: 15.6" "Group enriched" "Detected in many" 6 "granulocytes: 15.6;monocytes: 7.5" "Cell line enhanced" "Detected in many" "ASC diff: 98.3;ASC TERT1: 57.4;BJ hTERT+: 69.5;HSkMC: 41.7" "Low region specificity" "Detected in all" HPA050667 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA050667: " "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (4.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.17e-2)" "unprognostic (2.10e-1)" "unprognostic (1.40e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (4.29e-3)" "unprognostic (2.12e-2)" "unprognostic (5.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.97e-3)" "unprognostic (1.65e-1)" 16.3 9.5 55.8 12.0 56.2 0.3 14.8 4.7 30.9 43.7 12.3 71.4 3.4 9.4 12.1 12.3 10.6 10.1 9.8 8.5 55.6 30.6 5.7 1.9 7.3 10.5 59.4 17.0 8.9 4.6 1.1 2.3 25.7 29.1 9.4 12.8 3.5 5.6 17.2 3.3 6.9 10.2 14.0 69.8 9.5 6.5 4.8 49.4 0.1 6.2 3.2 11.3 15.4 17.8 0.0 1.9 15.6 7.5 1.8 0.0 1.6 1.8 3.5 5.0 0.0 98.3 57.4 0.0 24.5 69.5 17.2 7.8 0.4 0.3 0.0 0.0 25.3 3.1 7.3 0.0 19.1 14.2 0.0 0.6 0.0 0.2 0.0 26.6 0.0 0.0 41.7 1.1 8.5 16.2 10.3 0.3 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.9 0.0 19.8 0.0 3.7 0.0 3.9 3.3 0.1 1.2 0.5 0.0 0.0 1.0 1.7 0.0 0.0 8.1 0.2 5.8 0.0 0.2 0.0 0.0 1.2 0.0 8.9 0.9 7.5 15.6 0.0 2.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.6 1.8 1.1 0.1 0.0 1.6 55.8 56.2 4.7 29.5 55.6 30.6 59.4 17.0 29.1 49.4 0.0 0.6 0.0 10.4 11.6 0.0 0.8 0.0 2.7 10.3 0.0 0.0 0.5 1.7 1.3 1.0 1.7 5.1 0.0 2.5 0.3 45.6 9.6 0.0 0.0 3.3 0.0 0.0 3.1 3.3 1.5 35.9 2.5 13.5 12.6 3.7 1.1 1.7 0.0 66.4 0.0 0.0 0.0 7.2 0.0 2.4 8.2 0.7 0.0 4.0 5.5 LPAR2 "EDG-4, EDG4, LPA2" ENSG00000064547 "Lysophosphatidic acid receptor 2" Q9HBW0 19 19623668-19628930 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 43.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 32.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA019616 Approved NA NA "HPA019616: AB_1847988" "unprognostic (1.60e-2)" "unprognostic (1.83e-3)" "unprognostic (6.39e-2)" "unprognostic (1.19e-2)" "unprognostic (1.05e-1)" "unprognostic (2.29e-3)" "unprognostic (1.12e-2)" "unprognostic (1.82e-1)" "unprognostic (2.32e-1)" "unprognostic (1.05e-3)" "unprognostic (8.07e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (1.61e-7)" "prognostic favorable (1.43e-4)" "unprognostic (2.40e-1)" "unprognostic (5.87e-2)" "unprognostic (2.29e-2)" 3.4 1.2 2.2 12.6 1.9 26.1 4.6 1.3 2.4 6.5 7.9 1.4 13.8 5.1 2.4 3.9 10.5 4.4 17.9 1.9 2.2 4.0 7.0 2.4 11.0 17.7 2.4 1.1 6.1 27.3 7.4 4.0 4.2 2.7 8.2 4.3 7.4 12.3 12.3 1.6 7.2 16.4 1.1 2.8 31.4 19.2 43.7 1.1 18.5 23.2 10.0 21.1 4.9 4.1 3.8 1.1 6.7 1.0 1.7 15.9 4.1 12.8 1.4 15.3 3.4 4.0 2.0 13.2 0.8 1.2 0.6 1.1 9.2 12.4 8.3 8.6 1.2 0.8 13.6 2.3 4.6 0.6 3.5 3.9 1.9 2.6 0.7 0.5 3.1 32.0 2.1 11.6 0.6 0.9 2.1 0.3 4.1 1.8 3.3 0.5 21.0 1.8 5.1 15.2 17.4 5.9 8.2 1.2 3.7 9.4 19.0 5.4 10.2 3.4 2.8 2.0 8.8 7.2 19.6 3.8 3.0 2.5 5.3 1.2 1.5 4.3 2.8 0.6 22.4 1.4 0.1 0.6 2.2 6.1 0.7 11.2 3.8 14.0 8.0 0.4 2.0 12.8 9.2 6.7 1.7 1.0 1.1 15.9 4.1 2.2 1.9 1.3 2.4 2.2 4.0 2.4 1.1 2.7 1.1 3.0 11.1 4.2 8.9 5.6 0.4 1.2 7.6 4.0 5.7 7.0 2.0 0.7 3.3 12.1 0.3 0.7 9.3 0.0 17.2 5.0 1.3 10.5 3.5 0.4 2.3 1.6 2.4 1.8 5.4 1.3 0.6 4.7 0.0 6.4 10.0 5.8 13.8 6.8 0.4 0.6 1.3 0.0 0.9 1.1 3.7 4.4 0.1 13.8 7.8 9.5 LPAR3 "Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3" ENSG00000171517 "Lysophosphatidic acid receptor 3" Q9UBY5 1 84811602-84893213 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 32.0" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 13.1;Cardiomyocytes: 24.9;Ciliated cells: 25.4;Glandular cells: 15.0;Urothelial cells: 10.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 24.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 13.3;HBEC3-KT: 16.3;hTCEpi: 17.6;NTERA-2: 14.8;PC-3: 16.6;SK-MEL-30: 15.6" "Region enhanced" "Detected in some" "olfactory region: 3.5" "Low region specificity" "Detected in some" HPA013421 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA013421: AB_1847990" "unprognostic (2.85e-2)" "unprognostic (1.67e-1)" "unprognostic (2.66e-1)" "unprognostic (4.42e-1)" "unprognostic (2.72e-2)" "unprognostic (6.46e-3)" "unprognostic (1.15e-1)" "unprognostic (1.29e-2)" "unprognostic (1.20e-1)" "prognostic favorable (4.31e-5)" "unprognostic (1.11e-2)" "unprognostic (7.52e-2)" "unprognostic (1.13e-4)" "unprognostic (4.11e-2)" "unprognostic (1.19e-1)" "unprognostic (4.27e-2)" "unprognostic (5.43e-2)" 0.0 1.2 2.4 0.5 1.9 0.3 0.7 0.2 3.5 8.8 0.4 2.2 2.9 0.1 2.4 11.8 7.2 32.0 0.5 12.4 3.7 0.9 0.0 0.1 4.2 0.1 0.1 2.6 5.1 8.6 0.3 0.4 1.1 6.8 11.5 0.5 0.7 5.0 4.7 0.3 4.0 0.5 0.5 0.3 0.1 0.2 14.7 0.2 0.7 0.2 3.3 4.3 4.8 6.9 0.6 0.4 1.1 0.1 1.8 0.5 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.5 0.2 1.2 1.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.2 13.3 16.3 1.0 0.1 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.1 17.6 4.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 16.6 0.0 0.0 0.0 0.0 3.8 0.9 0.7 0.0 0.3 15.6 1.0 0.0 1.3 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.2 0.3 0.0 0.2 0.4 0.5 0.5 0.3 0.6 0.4 0.3 1.1 1.8 0.1 0.4 0.1 0.1 2.4 1.9 0.2 3.5 3.7 0.9 0.1 2.6 6.8 0.2 0.0 0.3 0.0 13.1 3.1 0.0 24.9 0.0 25.4 7.9 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 1.1 0.0 0.2 15.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.6 0.6 1.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.2 4.4 8.0 0.1 0.0 0.0 10.8 LPAR4 "GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9" ENSG00000147145 "Lysophosphatidic acid receptor 4" Q99677 X 78747709-78757094 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8;ovary: 10.0" "Cell type enriched" "Detected in some" 7 "Leydig cells: 18.7" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "basophil: 7.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.4" "Cell line enhanced" "Detected in some" "AF22: 10.3;NTERA-2: 16.7;RH-30: 7.0;SuSa: 4.0;U-937: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046563, HPA054951, HPA055571" Uncertain Supported "Nuclear bodies,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nuclear bodies, Vesicles" "HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853" "unprognostic (1.62e-1)" "unprognostic (3.53e-1)" "unprognostic (1.58e-1)" "unprognostic (5.81e-4)" "unprognostic (3.12e-2)" "unprognostic (4.85e-3)" "unprognostic (2.81e-1)" "unprognostic (2.57e-1)" "unprognostic (6.75e-2)" "unprognostic (6.73e-2)" "unprognostic (8.91e-2)" "unprognostic (4.86e-4)" "unprognostic (2.99e-5)" "unprognostic (9.27e-3)" "unprognostic (1.00e-1)" "unprognostic (3.58e-2)" "unprognostic (6.03e-3)" 1.5 0.2 6.0 1.0 2.1 0.6 2.0 4.9 3.7 1.8 0.9 7.4 0.7 0.2 2.9 0.8 1.8 1.1 2.1 1.9 15.8 1.4 0.3 0.3 0.3 0.2 2.4 4.0 10.0 0.7 0.1 0.7 0.2 3.6 0.6 1.2 0.5 1.0 1.6 0.2 1.6 0.9 1.3 3.8 0.4 1.5 0.8 5.6 0.0 0.6 0.8 1.2 1.4 0.9 0.0 0.5 7.4 0.0 0.0 0.0 0.1 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.6 1.1 1.4 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.7 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.1 2.3 0.0 0.5 1.8 16.7 0.0 0.2 0.9 7.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 2.7 0.0 0.0 0.2 0.0 0.7 1.4 0.0 0.7 0.7 4.0 1.6 7.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 6.0 2.1 4.9 3.5 15.8 1.4 2.4 4.0 3.6 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.7 0.0 1.7 1.0 0.0 0.5 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 LPAR5 "GPR92, GPR93, KPG_010, LPA5" ENSG00000184574 "Lysophosphatidic acid receptor 5" Q9H1C0 12 6618835-6636447 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 28.4;brain: 20.3;esophagus: 21.1" "Cell type enhanced" "Detected in many" 9 "B-cells: 17.5;Enterocytes: 15.1;granulocytes: 16.1;Hofbauer cells: 29.9;Paneth cells: 15.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 28.4;T-cells: 23.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.6;HEL: 13.9;HMC-1: 20.2;K-562: 10.3;U-698: 10.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013170 Approved NA NA "HPA013170: AB_1849314" "unprognostic (1.94e-1)" "unprognostic (6.43e-2)" "unprognostic (1.78e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (1.37e-1)" "unprognostic (5.95e-2)" "unprognostic (3.45e-1)" "unprognostic (1.41e-2)" "unprognostic (3.62e-3)" "unprognostic (2.07e-1)" "unprognostic (6.27e-2)" "unprognostic (7.99e-3)" "unprognostic (5.43e-1)" "prognostic favorable (6.56e-5)" "unprognostic (7.43e-2)" 2.1 3.2 11.2 5.6 12.4 1.1 1.6 1.3 8.9 5.8 10.2 20.3 0.5 11.2 0.7 3.2 21.1 2.0 1.9 3.6 10.9 4.0 1.3 1.5 2.1 9.2 9.3 4.0 0.9 0.8 0.9 1.4 7.2 9.2 1.7 9.7 1.7 6.3 1.6 0.3 6.8 9.3 1.3 11.7 10.6 8.3 1.7 13.6 2.2 2.0 1.1 13.5 3.4 9.0 28.4 5.5 2.5 1.8 1.3 23.9 6.5 4.1 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 7.6 3.2 1.0 0.0 0.1 5.3 0.0 2.2 0.0 0.0 0.0 13.9 0.4 0.3 0.0 0.0 20.2 0.0 2.6 0.1 1.1 0.0 0.0 3.0 10.3 0.0 0.0 0.3 0.4 4.3 0.0 6.7 0.7 3.6 0.0 0.0 0.0 2.4 0.1 0.1 2.1 0.0 0.0 0.8 0.0 1.6 0.1 0.0 3.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 2.5 0.1 0.0 23.9 1.0 18.0 28.4 4.0 14.1 5.5 27.8 4.0 8.9 0.2 1.3 1.8 0.3 5.4 6.5 11.2 12.4 1.3 8.9 10.9 4.0 9.3 4.0 9.2 13.6 0.0 0.0 17.5 0.5 1.3 0.0 1.6 0.0 0.0 2.3 1.8 0.0 0.2 0.0 0.4 2.2 0.0 15.1 0.0 0.8 0.2 0.6 0.6 16.1 0.0 29.9 0.0 1.2 0.6 10.7 13.0 0.0 3.7 0.0 6.4 10.6 0.0 5.5 15.8 0.0 0.0 0.0 0.0 0.0 0.6 0.7 1.1 0.5 6.9 9.1 1.7 LPAR6 "P2RY5, P2Y5" ENSG00000139679 "Lysophosphatidic acid receptor 6" P43657 13 48389567-48444704 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 54.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 329.7;Late spermatids: 239.9;Macrophages: 212.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 13.4;HUVEC TERT2: 21.7;MOLT-4: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028934 Approved NA NA "HPA028934: AB_2672833" "unprognostic (1.19e-1)" "unprognostic (4.10e-1)" "unprognostic (8.82e-2)" "unprognostic (9.30e-3)" "unprognostic (2.31e-1)" "unprognostic (5.57e-2)" "unprognostic (7.40e-2)" "prognostic favorable (6.22e-4)" "unprognostic (1.07e-2)" "unprognostic (8.00e-2)" "unprognostic (2.63e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (3.60e-4)" "unprognostic (6.54e-2)" "unprognostic (3.81e-2)" "unprognostic (2.09e-2)" "unprognostic (1.94e-2)" 10.9 6.0 7.6 5.3 10.0 0.3 11.0 5.4 10.6 8.7 4.5 11.1 2.9 2.7 6.5 9.7 25.6 4.9 8.0 5.6 8.4 4.1 7.6 4.7 9.6 9.4 7.9 10.9 3.7 2.9 2.0 4.8 18.7 14.1 17.7 6.3 5.9 18.3 7.8 3.4 7.5 5.5 6.0 17.4 9.4 4.4 54.2 12.6 2.9 7.3 2.9 9.1 9.6 21.3 0.3 7.3 1.6 31.0 1.8 23.0 16.3 0.0 1.2 13.4 0.0 4.4 5.5 0.1 2.7 7.8 0.5 1.6 0.0 4.0 0.0 0.0 2.9 0.0 7.8 0.4 4.3 0.2 0.0 2.6 0.1 0.1 9.6 3.0 0.0 0.1 7.3 7.8 0.4 4.4 0.0 21.7 4.2 0.0 0.2 2.6 0.0 11.8 3.7 5.3 0.2 3.6 10.2 0.0 0.1 3.7 8.0 0.0 0.0 0.0 0.0 2.6 8.6 1.4 0.1 5.6 1.5 0.0 0.1 0.7 0.0 0.0 0.0 0.4 0.6 4.8 0.3 20.8 0.0 7.6 31.0 4.1 0.3 21.5 9.0 7.3 0.1 15.5 4.8 1.6 1.8 26.6 0.3 23.0 16.3 7.6 10.0 5.4 10.6 8.4 4.1 7.9 10.9 14.1 12.6 3.0 11.9 12.6 163.9 107.2 1.5 3.6 17.8 32.1 33.0 5.2 0.0 0.9 0.0 7.7 329.7 100.6 4.1 0.0 3.6 0.9 17.8 82.2 7.0 2.4 67.9 0.0 20.5 130.8 61.7 239.9 21.0 212.7 47.2 78.5 4.5 8.8 4.9 0.0 14.9 21.8 1.1 12.9 15.6 2.7 1.7 125.0 0.7 58.9 7.3 144.8 LPCAT1 "AGPAT10, AGPAT9, AYTL2, FLJ12443" ENSG00000153395 "Lysophosphatidylcholine acyltransferase 1" Q8NF37 5 1456480-1523977 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 35.6" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 286.5;Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 34.9;EFO-21: 33.5;PC-3: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012501, HPA022268" Enhanced Supported "Endoplasmic reticulum,Lipid droplets" NA NA "Endoplasmic reticulum" "Lipid droplets" "HPA012501: AB_1845224, HPA022268: AB_1845225" "unprognostic (5.33e-3)" "prognostic unfavorable (7.11e-5)" "unprognostic (3.11e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (3.13e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.88e-8)" "unprognostic (5.90e-2)" "unprognostic (6.37e-2)" "unprognostic (2.08e-2)" "prognostic favorable (4.90e-5)" "unprognostic (4.89e-2)" "prognostic unfavorable (2.64e-7)" "unprognostic (2.60e-1)" "unprognostic (3.13e-1)" "unprognostic (1.52e-1)" "unprognostic (4.03e-1)" 9.8 5.6 5.2 9.0 5.7 5.1 7.4 9.2 9.5 5.4 7.5 2.9 4.5 3.9 7.0 3.2 3.2 5.9 5.8 4.3 5.3 5.2 4.9 3.1 35.6 8.5 3.2 3.7 5.0 5.4 3.1 5.6 10.0 4.6 5.2 2.3 13.6 4.5 4.4 3.5 3.2 5.9 5.5 3.3 28.8 9.4 3.0 2.9 5.8 4.7 1.4 8.1 6.6 10.6 0.9 0.7 2.4 1.7 1.7 3.6 0.6 2.0 3.0 0.5 3.3 0.3 0.5 34.9 7.8 0.4 0.4 0.3 1.1 0.9 6.8 33.5 0.2 1.4 5.8 0.6 0.2 0.2 16.5 14.2 1.6 4.9 2.0 0.6 1.7 4.6 0.6 0.1 0.3 0.1 0.5 0.4 2.3 3.7 1.3 0.0 4.3 6.4 2.6 12.3 0.1 23.3 12.3 0.6 4.9 1.4 2.8 4.4 4.3 6.2 5.7 1.8 0.3 2.6 2.7 3.9 0.6 7.7 2.3 2.8 4.4 4.2 1.6 1.4 2.8 2.1 0.0 0.6 0.8 3.6 1.7 3.6 0.9 0.8 1.8 0.7 0.7 0.1 1.0 2.4 1.7 1.2 0.2 0.8 0.6 5.2 5.7 9.2 8.0 5.3 5.2 3.2 3.7 4.6 2.9 80.4 286.5 25.1 1.9 5.6 52.2 3.2 7.6 5.3 21.6 14.0 137.4 5.1 0.0 16.9 1.5 10.3 2.6 0.0 11.7 67.8 9.3 5.6 8.1 4.0 21.8 22.3 14.3 18.4 26.3 1.5 10.0 16.2 6.8 10.8 9.0 28.2 22.2 0.0 14.5 4.4 124.0 0.0 12.3 1.7 9.8 3.4 26.5 26.7 2.5 1.6 LPCAT2 "AGPAT11, AYTL1, FLJ20481, LysoPAFAT" ENSG00000087253 "Lysophosphatidylcholine acyltransferase 2" Q7L5N7 16 55508998-55586670 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 64.6;granulocytes: 165.5;Kupffer cells: 68.0;Macrophages: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 28.8;eosinophil: 49.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 49.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 32.0;HaCaT: 24.5;HL-60: 27.3;HMC-1: 45.6;hTERT-RPE1: 45.8;WM-115: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007891, HPA008433" Enhanced Supported Supported "Endoplasmic reticulum,Lipid droplets" NA NA "Endoplasmic reticulum" "Lipid droplets" "HPA007891: AB_1845223, HPA008433: " "unprognostic (1.43e-1)" "unprognostic (2.44e-2)" "prognostic favorable (3.43e-4)" "prognostic favorable (8.03e-6)" "unprognostic (2.91e-1)" "unprognostic (9.65e-3)" "unprognostic (8.12e-3)" "unprognostic (3.26e-3)" "unprognostic (1.67e-1)" "unprognostic (7.97e-2)" "unprognostic (3.18e-3)" "unprognostic (9.16e-2)" "unprognostic (1.93e-1)" "unprognostic (2.33e-1)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (3.53e-2)" 10.5 7.5 10.5 8.0 16.2 43.5 9.9 1.7 7.5 11.0 5.2 18.2 36.5 4.3 17.0 21.5 7.2 8.5 6.2 5.7 9.6 6.3 6.7 2.4 7.4 10.3 18.6 3.1 11.0 3.8 12.7 1.9 9.0 16.1 8.2 5.5 5.1 7.7 33.2 3.0 10.2 5.4 8.9 30.7 8.9 5.3 4.6 14.9 0.9 49.0 5.2 2.6 8.5 8.5 0.0 5.4 49.4 9.3 0.0 0.0 1.4 8.9 1.1 0.9 0.0 3.1 1.2 1.6 3.8 3.7 1.9 1.9 2.0 32.0 0.0 13.2 5.4 1.5 24.5 0.6 5.3 3.1 2.4 2.6 9.2 2.9 4.6 1.1 27.3 45.6 0.6 5.3 2.1 1.7 45.8 14.7 0.5 0.4 0.1 3.2 0.5 0.0 11.0 1.4 2.5 0.1 2.8 1.0 1.3 1.8 3.5 0.6 7.1 7.4 3.0 5.3 4.6 1.3 6.9 16.5 0.3 0.0 1.9 2.6 0.1 0.0 0.0 0.7 13.3 32.5 28.8 4.5 49.4 0.0 6.9 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 12.1 0.0 9.3 0.1 0.0 1.4 10.5 16.2 1.7 7.5 9.6 6.3 18.6 3.1 16.1 14.9 6.0 31.3 1.7 29.9 13.7 1.6 1.6 5.1 2.7 23.9 64.6 9.8 0.7 1.7 7.2 1.3 22.7 4.1 0.0 8.5 6.9 13.8 6.0 165.5 1.7 33.6 0.0 1.2 4.3 68.0 1.7 15.3 64.1 16.9 7.2 11.9 26.1 20.5 31.6 12.0 4.4 5.2 0.0 2.4 11.6 3.8 13.4 1.6 1.3 9.8 15.9 LPCAT3 "C3F, MBOAT5, nessy, OACT5" ENSG00000111684 "Lysophosphatidylcholine acyltransferase 3" Q6P1A2 12 6976186-7018510 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 85.5;liver: 78.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.74e-1)" "unprognostic (3.33e-2)" "unprognostic (1.70e-1)" "unprognostic (1.57e-1)" "unprognostic (6.72e-2)" "unprognostic (3.86e-1)" "unprognostic (2.40e-2)" "unprognostic (6.90e-2)" "unprognostic (1.88e-1)" "unprognostic (5.00e-3)" "unprognostic (2.06e-1)" "unprognostic (2.58e-2)" "prognostic favorable (4.89e-5)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (6.49e-3)" "unprognostic (1.23e-1)" 16.4 24.4 4.2 8.8 5.0 8.1 15.1 15.7 5.4 7.9 37.5 6.1 8.1 43.4 8.2 7.8 13.6 9.1 11.3 20.2 4.1 2.7 37.3 78.2 20.3 17.9 5.2 5.3 13.9 38.7 4.6 9.4 29.0 4.8 13.7 17.2 8.3 22.2 8.2 19.4 13.3 85.5 12.4 4.9 11.3 22.8 7.6 4.0 14.1 14.6 10.3 13.7 15.7 8.5 5.3 13.9 32.3 33.7 11.5 10.8 12.4 6.2 11.6 5.0 14.1 35.4 16.7 10.8 3.6 15.5 10.0 17.1 24.7 32.7 6.8 2.1 5.8 21.4 15.8 6.0 13.4 7.8 16.7 7.3 13.7 10.3 22.1 7.6 7.0 14.7 26.3 7.8 9.6 4.8 6.4 9.3 10.5 7.3 4.9 6.5 9.5 8.6 8.7 16.8 22.4 6.8 9.1 7.1 7.0 12.3 48.9 4.4 4.2 21.9 33.9 2.4 16.5 3.4 9.9 3.8 6.2 9.3 10.9 2.6 6.2 4.4 10.0 7.7 7.4 5.4 13.9 20.8 32.3 8.6 30.0 10.0 5.0 9.0 9.7 13.9 5.3 8.5 8.7 20.0 11.5 33.7 7.9 10.8 12.4 4.2 5.0 15.7 5.4 4.1 2.7 5.2 5.3 4.8 4.0 65.5 29.7 4.5 32.1 20.9 5.2 0.4 15.3 13.4 23.9 19.2 0.0 71.1 10.0 25.0 1.5 9.8 66.7 0.0 29.4 45.9 18.4 22.1 13.9 52.5 36.0 11.1 41.5 14.1 18.0 1.2 17.0 13.7 6.8 16.2 22.8 12.3 18.9 24.6 6.0 34.4 3.9 19.4 9.4 14.6 30.6 19.4 55.5 13.8 32.4 25.1 LPCAT4 "AGPAT7, AYTL3, FLJ10257, LPAAT-eta, LPEAT2" ENSG00000176454 "Lysophosphatidylcholine acyltransferase 4" Q643R3 15 34358618-34367278 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 63.9;Paneth cells: 83.4;Undifferentiated cells: 62.1;Urothelial cells: 107.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 41.5;OE19: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057321 Supported NA NA "HPA057321: " "unprognostic (2.79e-2)" "unprognostic (8.34e-2)" "unprognostic (1.08e-2)" "unprognostic (4.64e-3)" "unprognostic (1.29e-2)" "unprognostic (2.15e-2)" "prognostic unfavorable (9.99e-4)" "unprognostic (7.47e-2)" "unprognostic (1.13e-1)" "unprognostic (2.90e-1)" "unprognostic (1.23e-3)" "unprognostic (1.33e-1)" "unprognostic (9.95e-3)" "unprognostic (1.52e-2)" "unprognostic (1.37e-1)" "unprognostic (1.69e-2)" "unprognostic (3.44e-3)" 9.7 5.3 20.1 9.6 35.1 5.0 11.0 38.6 32.2 11.9 30.5 4.3 3.5 25.3 8.0 8.6 17.7 16.4 19.0 17.1 14.2 21.0 4.9 1.8 7.8 7.2 13.2 18.2 9.6 6.8 6.4 6.1 4.6 28.9 5.7 30.0 2.9 6.4 8.3 6.1 15.2 23.8 14.4 7.1 8.5 33.1 2.6 13.1 4.5 4.4 4.5 9.3 15.4 14.2 2.6 6.2 4.7 1.8 2.1 9.4 1.0 5.1 12.2 6.1 4.8 16.6 16.9 2.9 7.2 12.2 6.9 9.4 4.4 13.8 4.6 15.0 10.0 16.2 41.5 5.3 13.6 3.0 9.4 3.0 4.6 5.1 4.2 3.4 4.9 4.8 12.5 6.2 6.5 8.5 16.0 11.2 8.5 3.0 9.0 12.8 4.9 4.3 9.7 6.1 42.9 9.7 5.4 6.9 9.3 15.0 12.3 4.8 3.7 4.3 5.8 2.7 7.4 4.5 6.7 13.8 12.8 7.8 20.1 6.8 11.1 8.7 1.6 9.5 13.8 2.9 0.1 1.1 4.5 3.9 1.4 9.4 2.3 4.6 6.0 1.8 2.6 2.8 2.5 4.7 2.1 1.8 6.2 7.3 1.0 20.1 35.1 38.6 32.2 14.2 21.0 13.2 18.2 28.9 13.1 23.8 5.1 11.9 7.6 4.2 10.4 10.4 30.6 13.4 7.9 8.7 3.9 3.4 1.7 9.9 0.0 22.7 63.9 0.0 8.6 14.1 6.6 8.4 11.5 0.8 6.9 9.5 24.3 13.5 6.5 0.6 14.4 6.1 8.5 4.6 52.9 0.8 28.2 83.4 6.3 3.3 6.1 12.9 8.5 0.7 4.9 5.4 2.1 15.2 62.1 107.8 LPGAT1 "FAM34A, FAM34A1, KIAA0205, NET8" ENSG00000123684 "Lysophosphatidylglycerol acyltransferase 1" Q92604 1 211743457-211830772 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 75.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 288.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 13.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.60e-2)" "unprognostic (1.04e-1)" "unprognostic (3.90e-1)" "unprognostic (1.28e-1)" "unprognostic (1.36e-1)" "unprognostic (1.66e-1)" "unprognostic (9.47e-3)" "unprognostic (1.12e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.54e-1)" "unprognostic (1.31e-1)" "unprognostic (1.64e-2)" "unprognostic (1.18e-1)" "unprognostic (2.02e-1)" "unprognostic (1.50e-2)" "unprognostic (3.70e-2)" 15.9 17.4 11.8 10.7 20.3 14.9 16.5 12.3 22.7 10.5 13.3 25.9 9.9 19.5 7.9 9.4 6.7 7.5 10.4 9.7 15.1 13.6 8.6 75.6 9.6 13.8 19.0 11.9 6.1 13.1 15.1 9.0 7.7 15.5 9.5 9.0 21.8 9.0 15.6 8.3 5.2 39.8 10.3 16.0 13.3 6.4 17.5 18.9 5.1 22.1 3.9 8.0 9.2 6.9 1.6 2.7 13.4 2.3 4.5 1.2 0.7 14.7 16.3 5.4 12.8 9.7 13.7 7.7 10.6 16.9 9.9 9.2 4.8 12.4 6.0 6.2 16.4 11.1 8.1 18.0 9.5 12.6 11.8 6.1 6.3 13.7 11.0 11.7 15.6 10.9 8.0 11.7 9.1 12.0 18.3 11.9 8.8 7.2 0.1 13.1 4.6 5.9 5.8 5.9 6.4 2.7 14.3 21.3 1.8 11.0 12.3 31.2 16.2 17.4 18.5 18.1 8.7 9.4 10.2 11.4 18.1 8.0 16.6 17.2 8.9 10.9 16.3 9.0 13.3 12.4 9.5 2.3 13.4 1.2 1.9 1.0 1.6 0.8 0.9 2.7 1.0 0.2 0.7 10.4 4.5 1.3 2.1 0.2 0.7 11.8 20.3 12.3 22.7 15.1 13.6 19.0 11.9 15.5 18.9 26.8 18.9 11.0 47.5 10.9 140.9 25.4 73.9 37.5 18.2 12.2 58.9 1.6 1.7 53.5 288.3 27.4 28.8 0.0 50.8 3.5 14.7 35.8 12.7 49.1 18.6 33.4 13.2 21.5 35.6 39.3 43.7 26.7 28.7 19.8 12.2 31.9 50.2 16.9 52.3 18.6 121.2 19.4 20.6 61.8 32.6 6.6 0.9 16.6 19.1 57.7 LRAT LCA14 ENSG00000121207 "Lecithin retinol acyltransferase" O95237 4 154626945-154753118 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "Acyltransferase, Transferase" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 82.4" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 7.6;Early spermatids: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 4.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "NTERA-2: 16.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA070726 Uncertain "Endoplasmic reticulum,Golgi apparatus" NA NA "Golgi apparatus" "Endoplasmic reticulum" "HPA070726: " "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (4.75e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.65e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-4)" "unprognostic (4.49e-6)" "unprognostic (6.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.98e-1)" 0.9 0.8 2.2 0.8 3.2 1.8 1.4 0.7 1.1 0.9 4.2 3.0 0.8 3.7 0.5 1.2 0.5 0.9 2.3 0.6 3.1 4.2 0.6 3.3 1.0 0.5 2.9 2.4 1.0 2.9 0.3 1.0 0.3 8.9 1.6 0.4 82.4 0.5 1.6 2.3 1.4 11.1 0.3 7.0 0.7 0.9 2.9 3.1 0.0 4.9 0.2 0.6 0.5 0.7 0.9 3.7 2.0 4.5 0.6 0.3 3.9 0.7 0.5 0.4 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.2 0.0 0.0 0.1 0.8 0.6 0.1 0.1 0.2 0.5 0.4 0.3 0.1 0.1 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.3 16.5 0.0 0.0 0.1 0.0 0.1 2.0 0.5 0.1 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.0 0.4 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.2 0.5 1.0 4.5 0.4 0.3 1.6 0.3 0.5 0.3 0.3 3.7 0.9 0.3 0.3 2.0 0.6 0.5 0.5 0.2 3.9 2.2 3.2 0.7 1.1 3.1 4.2 2.9 2.4 8.9 3.1 0.0 4.1 0.0 4.2 1.0 0.8 0.2 7.6 0.0 1.2 0.0 0.0 0.1 3.3 0.8 7.2 0.2 2.0 0.0 0.7 0.1 0.3 2.4 0.0 2.0 0.1 0.0 0.0 1.8 0.0 1.6 0.0 0.0 5.0 0.0 0.7 3.7 1.4 0.0 0.0 0.3 0.9 0.0 0.1 4.8 4.5 1.0 0.2 0.7 0.3 0.6 LRCH1 "CHDC1, KIAA1016" ENSG00000136141 "Leucine rich repeats and calponin homology domain containing 1" Q9Y2L9 13 46553168-46753040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 46.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021536 Approved Approved "Nucleoli,Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" Nucleoli "HPA021536: AB_1853258" "unprognostic (7.13e-3)" "prognostic unfavorable (6.24e-4)" "unprognostic (3.59e-2)" "unprognostic (8.93e-2)" "unprognostic (7.50e-2)" "unprognostic (1.37e-1)" "unprognostic (5.16e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (2.16e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.04e-4)" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-1)" "unprognostic (1.98e-2)" 17.9 5.0 6.5 20.3 5.9 7.2 15.2 46.4 7.2 17.5 14.6 4.6 11.5 7.0 24.6 9.8 10.6 11.9 14.1 8.0 6.3 5.9 13.8 10.9 14.3 13.5 6.6 4.9 9.5 5.1 5.2 13.1 24.1 8.0 12.8 9.3 8.4 11.3 14.5 5.3 18.1 12.0 20.9 8.5 13.7 14.6 5.0 6.0 31.7 7.8 6.4 13.7 16.6 18.3 6.2 2.3 1.8 2.0 5.1 3.6 1.8 4.3 6.3 5.7 5.9 4.2 8.0 14.7 7.5 9.9 9.4 8.9 14.2 7.5 14.0 2.1 7.1 6.1 6.3 4.3 7.6 13.6 14.4 4.1 12.6 2.5 6.6 5.2 8.1 21.6 5.1 6.0 8.6 10.5 7.7 8.0 9.5 2.4 4.3 6.9 8.5 8.7 10.2 3.2 27.7 3.3 4.8 6.2 3.7 17.5 4.6 9.1 9.1 4.2 4.2 11.2 10.6 3.2 11.0 7.6 5.5 3.7 6.8 7.1 0.8 2.1 6.3 6.4 7.2 6.6 1.5 2.0 1.8 3.6 1.6 2.1 5.3 2.7 2.6 1.9 6.2 2.1 2.1 0.7 5.1 1.2 2.3 1.9 1.8 6.5 5.9 46.4 7.2 6.3 5.9 6.6 4.9 8.0 6.0 6.0 6.7 15.1 9.1 33.3 8.2 6.7 25.5 1.4 6.8 21.0 21.6 11.1 8.3 7.2 1.2 25.9 6.9 0.0 3.5 10.0 10.5 7.9 27.6 7.9 11.4 3.2 1.7 16.5 16.7 1.1 12.0 9.9 28.7 5.4 9.7 6.4 9.5 5.8 15.9 7.3 8.9 12.9 21.7 0.7 3.2 29.1 8.1 10.2 6.5 7.8 LRCH3 MGC4126 ENSG00000186001 "Leucine rich repeats and calponin homology domain containing 3" Q96II8 3 197791226-197888436 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012380, HPA017299" Uncertain Enhanced Cytosol "Secreted - unknown location" NA NA Cytosol "HPA012380: AB_1853260, HPA017299: AB_2669576" "unprognostic (1.25e-1)" "unprognostic (4.92e-1)" "unprognostic (1.43e-1)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (8.26e-2)" "prognostic unfavorable (2.95e-4)" "unprognostic (3.29e-1)" "unprognostic (4.13e-1)" "unprognostic (9.85e-2)" "unprognostic (1.64e-1)" "unprognostic (2.06e-2)" "unprognostic (1.79e-3)" "unprognostic (3.29e-2)" "unprognostic (2.67e-1)" "unprognostic (5.59e-2)" "unprognostic (1.32e-1)" 16.4 14.0 19.3 23.4 19.1 11.0 18.0 37.5 19.1 21.9 19.0 28.2 15.6 11.0 24.7 14.8 15.6 18.3 16.7 18.2 15.9 14.5 12.6 14.2 14.8 23.4 19.7 13.1 27.5 12.9 23.7 26.0 15.2 15.4 20.4 16.7 23.6 15.6 22.4 23.0 15.7 15.9 28.3 15.9 18.7 15.0 20.2 20.4 27.0 13.5 9.5 26.0 20.3 18.0 6.9 2.8 22.6 4.8 4.9 6.0 3.3 18.1 6.5 17.5 10.8 21.2 24.1 6.8 13.2 16.0 16.1 18.9 15.3 9.6 9.9 20.7 16.2 22.9 11.9 14.6 12.8 21.7 7.9 9.1 16.5 9.7 13.0 14.5 12.6 13.0 16.5 7.8 15.3 19.6 15.6 19.0 8.8 10.4 16.5 15.2 15.4 9.5 5.5 12.0 9.3 13.6 10.0 10.9 7.1 8.5 10.7 8.7 9.4 16.0 12.1 12.7 16.8 21.2 11.1 18.5 13.4 7.7 16.2 13.2 15.3 13.7 9.0 12.7 18.0 12.6 22.6 3.4 7.0 5.9 4.8 4.5 6.9 4.6 5.0 2.8 5.7 4.3 6.0 2.3 4.9 4.6 2.6 4.4 3.3 19.3 19.1 37.5 19.1 15.9 14.5 19.7 13.1 15.4 20.4 29.8 24.8 15.9 14.0 9.4 55.4 14.2 17.8 16.0 19.4 8.7 53.0 7.0 1.7 10.1 9.5 20.2 6.8 0.0 8.4 5.5 19.9 12.7 10.5 13.0 7.6 36.5 5.8 41.7 13.0 7.1 23.3 15.3 16.9 28.9 8.2 26.6 11.3 7.0 26.9 4.2 44.4 19.4 17.0 16.3 16.6 9.3 5.0 14.0 9.2 13.1 LRCH4 "LRN, LRRN1" ENSG00000077454 "Leucine rich repeats and calponin homology domain containing 4" O75427 7 100574011-100586153 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 153.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 45.7;NB-4: 70.7" "Low region specificity" "Detected in all" "HPA037667, HPA037668" Enhanced Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA037667: AB_10671882, HPA037668: AB_10672910" "unprognostic (2.41e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (1.61e-7)" "unprognostic (8.32e-3)" "unprognostic (2.76e-2)" "unprognostic (3.96e-3)" "unprognostic (8.98e-3)" "unprognostic (3.72e-2)" "unprognostic (2.52e-1)" "unprognostic (5.51e-2)" "unprognostic (2.63e-3)" "unprognostic (7.81e-2)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (7.96e-2)" "unprognostic (1.26e-2)" 11.4 15.2 14.5 32.0 25.7 52.7 13.8 19.7 22.2 12.0 14.0 16.4 11.8 22.0 12.3 9.6 14.4 14.0 15.9 10.2 16.2 9.1 16.1 12.2 20.8 39.1 25.8 13.1 23.7 17.3 8.9 22.8 26.4 19.2 14.6 7.2 18.3 23.5 13.0 15.8 15.0 27.8 8.1 25.7 54.5 14.9 43.3 23.1 31.1 20.0 6.8 25.2 9.9 12.0 5.9 6.2 24.2 8.4 1.4 7.3 2.9 7.9 4.5 4.5 4.0 2.7 2.1 8.6 7.7 3.5 4.5 3.7 7.5 11.7 5.8 8.7 2.3 4.8 6.9 2.2 3.2 1.3 5.7 6.0 6.6 5.3 3.5 8.6 11.4 45.7 3.5 3.5 3.8 2.1 2.9 4.6 15.2 8.2 11.9 3.2 15.0 13.1 70.7 4.7 7.4 5.3 14.6 3.7 7.1 3.5 2.8 5.9 8.8 3.7 11.8 9.0 6.1 7.9 24.9 7.2 6.2 11.3 8.6 4.6 12.1 5.7 5.2 4.8 28.3 10.6 12.6 8.4 11.9 5.2 6.8 4.7 4.7 5.1 5.9 6.2 5.9 7.3 5.9 24.2 1.4 4.7 5.9 5.2 2.9 14.5 25.7 19.7 22.2 16.2 9.1 25.8 13.1 19.2 23.1 8.9 16.7 24.7 13.8 10.6 13.6 0.7 25.5 6.7 6.8 21.0 39.3 33.4 13.3 27.1 153.1 9.5 22.2 0.0 21.3 11.2 9.5 12.1 18.5 11.3 30.3 12.7 5.8 15.4 53.4 19.7 23.0 33.3 13.5 52.3 12.9 15.5 23.1 14.0 9.6 6.2 29.9 19.4 12.2 42.6 28.7 10.0 86.4 42.9 11.0 14.2 LRCOL1 ENSG00000204583 "Leucine rich colipase like 1" A6NCL2 12 132603150-132610543 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "epididymis: 54.8" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 39.8" "Cancer enhanced" "Detected in some" "liver cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;BJ hTERT+ SV40 Large T+: 1.2;RPMI-8226: 1.0" "Secreted in male reproductive system" NA NA "unprognostic (5.09e-3)" "unprognostic (7.83e-3)" "unprognostic (3.26e-1)" "unprognostic (6.94e-2)" "unprognostic (3.15e-2)" "unprognostic (2.38e-2)" "prognostic favorable (7.04e-4)" "unprognostic (4.54e-2)" "unprognostic (6.08e-2)" "unprognostic (5.29e-2)" "unprognostic (4.66e-3)" "unprognostic (1.52e-1)" "unprognostic (6.50e-6)" "unprognostic (1.46e-3)" "unprognostic (9.63e-2)" "unprognostic (3.31e-1)" "unprognostic (4.00e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.4 0.1 0.0 54.8 0.0 0.2 0.4 0.0 0.2 0.1 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.5 1.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.8 0.0 0.0 0.0 3.1 1.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.0 0.0 LRFN1 "KIAA1484, SALM2" ENSG00000128011 "Leucine rich repeat and fibronectin type III domain containing 1" Q9P244 19 39306568-39315336 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.5" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 22.8;Cone photoreceptor cells: 7.9;Muller glia cells: 7.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 14.9;HEK 293: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.92e-3)" "unprognostic (2.00e-1)" "unprognostic (6.36e-4)" "prognostic unfavorable (3.31e-5)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (1.87e-2)" "unprognostic (6.75e-2)" "unprognostic (4.25e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.45e-3)" "unprognostic (1.08e-1)" "unprognostic (0.00e+0)" "unprognostic (1.89e-3)" "unprognostic (2.10e-2)" "unprognostic (1.31e-3)" "unprognostic (1.78e-1)" 1.6 0.3 5.5 1.3 3.4 1.1 0.6 9.5 9.0 0.4 0.6 1.0 1.2 1.4 0.2 0.6 0.3 0.2 5.2 6.6 0.3 0.5 0.9 1.0 2.9 0.3 2.0 0.2 0.1 0.5 1.1 0.4 2.0 0.3 0.2 1.4 1.5 0.7 1.0 3.8 0.7 0.6 0.3 0.6 0.2 0.0 0.3 0.4 3.2 0.8 1.8 1.0 0.0 1.1 4.7 0.1 4.1 0.0 0.0 5.1 0.1 0.0 0.3 0.1 14.9 0.6 0.4 2.0 0.0 1.2 0.2 1.9 0.1 0.1 0.4 18.2 0.8 0.7 0.6 0.1 0.3 3.9 0.3 0.2 0.1 0.0 0.4 0.1 5.5 7.5 0.4 0.0 2.4 1.9 2.3 2.0 1.5 5.0 6.4 0.0 1.6 0.0 0.2 1.4 7.3 1.6 3.1 1.2 0.4 1.5 1.5 0.3 1.7 5.9 1.4 0.1 0.7 0.2 1.8 0.1 0.9 0.5 1.7 0.3 3.2 1.0 0.2 0.9 0.1 0.4 1.0 0.0 0.3 0.5 0.7 2.6 1.8 0.8 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.7 22.8 0.8 2.5 0.0 0.0 0.0 7.9 0.4 0.0 0.2 0.0 1.0 0.0 0.0 0.6 0.4 1.0 0.4 0.0 0.8 0.8 3.2 0.0 2.5 4.0 0.0 0.0 0.7 0.0 1.0 0.0 7.5 0.2 0.0 2.5 0.0 2.3 0.0 0.1 0.9 0.7 0.4 0.7 3.1 0.0 0.1 LRFN2 "FIGLER2, KIAA1246, SALM1" ENSG00000156564 "Leucine rich repeat and fibronectin type III domain containing 2" Q9ULH4 6 40391586-40587465 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 21.7" "Cell type enriched" "Detected in some" 5 "Cone photoreceptor cells: 58.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 1.8;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;T-cells: 1.8" "Group enriched" "Detected in some" 5 "REH: 3.5;SH-SY5Y: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA076660 Enhanced Supported Vesicles NA NA Vesicles "HPA076660: AB_2686812" "unprognostic (1.93e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (4.58e-4)" "unprognostic (3.10e-1)" "unprognostic (1.21e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-3)" "unprognostic (4.94e-2)" "unprognostic (1.80e-1)" "unprognostic (9.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (1.64e-1)" "unprognostic (2.98e-1)" "unprognostic (1.16e-1)" "unprognostic (2.66e-4)" 0.5 1.4 5.9 0.5 7.6 1.3 0.6 4.5 21.7 0.5 0.8 0.0 0.0 0.5 0.6 0.4 1.8 0.6 0.6 0.4 5.0 5.2 0.5 0.4 0.4 0.5 2.3 7.4 2.1 0.7 0.4 0.6 0.5 0.9 0.5 0.7 2.7 0.4 0.4 0.4 0.5 0.5 0.5 0.8 3.1 0.7 2.5 0.5 0.0 0.7 0.0 0.6 0.5 0.2 0.0 1.3 0.0 0.0 0.3 1.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.0 3.5 0.0 0.0 0.0 0.3 1.4 10.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.4 0.0 0.3 0.0 1.3 0.0 0.2 5.9 7.6 4.5 21.7 5.0 5.2 2.3 7.4 0.9 0.5 0.0 0.0 0.0 0.0 0.0 11.6 0.6 0.0 0.0 0.0 0.0 58.9 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 LRFN3 "FIGLER1, MGC2656, SALM4" ENSG00000126243 "Leucine rich repeat and fibronectin type III domain containing 3" Q9BTN0 19 35935358-35945767 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Ito cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in single" 5 "T-cells: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048923 Approved NA NA "HPA048923: AB_2680558" "unprognostic (1.88e-1)" "unprognostic (7.22e-3)" "unprognostic (1.82e-1)" "unprognostic (4.90e-2)" "unprognostic (1.17e-1)" "unprognostic (7.37e-2)" "unprognostic (8.14e-2)" "unprognostic (2.34e-3)" "unprognostic (1.23e-2)" "unprognostic (1.48e-1)" "unprognostic (3.49e-3)" "unprognostic (1.74e-1)" "prognostic favorable (8.46e-7)" "unprognostic (6.84e-3)" "unprognostic (2.62e-1)" "unprognostic (4.07e-2)" "unprognostic (1.03e-1)" 7.2 4.8 6.5 3.6 10.6 0.2 3.8 13.8 17.1 5.9 4.6 3.2 2.9 7.5 7.4 2.6 4.3 5.1 5.4 3.8 6.3 5.1 4.5 6.9 8.9 2.1 3.8 9.4 9.3 7.1 8.1 9.3 3.2 5.0 5.7 3.2 4.4 7.7 7.6 6.5 5.3 7.2 5.8 2.2 5.0 6.3 7.7 2.9 3.2 3.9 2.2 2.1 4.9 5.0 0.5 0.1 0.0 0.0 0.0 2.9 0.5 10.3 11.8 5.4 8.4 11.3 6.0 2.5 4.4 5.6 4.2 4.3 2.1 4.9 5.9 9.1 5.2 5.3 3.9 2.3 4.9 2.5 11.8 4.6 0.7 2.6 2.3 4.4 0.3 9.2 6.7 6.8 2.6 2.7 5.3 5.1 7.5 1.7 8.8 3.8 7.5 4.7 0.3 4.2 7.1 5.2 6.2 3.2 0.2 3.1 3.9 7.0 9.3 6.0 4.6 3.5 2.9 3.6 2.9 6.4 9.8 8.7 8.8 6.7 3.4 3.5 0.2 8.8 3.2 6.7 0.0 0.0 0.0 2.7 0.0 2.9 0.3 2.2 2.6 0.0 0.5 1.4 0.5 0.0 0.0 0.0 0.1 1.1 0.5 6.5 10.6 13.8 17.1 6.3 5.1 3.8 9.4 5.0 2.9 0.0 0.0 0.8 2.8 1.0 7.7 8.7 0.0 0.0 0.0 3.5 2.0 0.3 0.0 3.2 0.4 2.1 5.4 0.0 3.7 1.7 2.3 3.1 0.0 3.4 1.6 7.9 2.9 10.4 0.3 0.4 4.0 0.4 0.0 0.0 2.2 2.8 3.5 4.8 7.1 2.2 4.6 6.5 2.1 0.2 1.1 1.0 0.1 0.0 2.9 1.4 LRFN4 "FIGLER6, MGC3103, SALM3." ENSG00000173621 "Leucine rich repeat and fibronectin type III domain containing 4" Q6PJG9 11 66856647-66860475 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 17.3;Late spermatids: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 3.6" "Lineage enriched" "Detected in single" 4 "dendritic cells: 3.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077570 Enhanced NA NA "HPA077570: " "unprognostic (2.25e-2)" "unprognostic (5.90e-3)" "unprognostic (7.51e-2)" "unprognostic (2.01e-2)" "unprognostic (4.35e-2)" "unprognostic (6.73e-2)" "unprognostic (1.80e-2)" "unprognostic (1.03e-3)" "unprognostic (6.56e-2)" "unprognostic (6.93e-2)" "unprognostic (5.69e-2)" "unprognostic (9.45e-2)" "unprognostic (1.93e-1)" "unprognostic (6.80e-3)" "unprognostic (1.81e-1)" "unprognostic (2.85e-1)" "unprognostic (3.53e-1)" 16.6 5.9 10.4 5.9 12.2 8.9 5.9 22.0 23.4 5.4 10.9 7.6 2.2 4.4 6.7 2.7 3.6 6.3 2.5 6.3 9.7 7.4 4.4 1.3 5.2 4.8 7.9 11.1 4.7 2.9 2.5 4.0 3.2 5.5 4.6 4.4 3.3 10.2 7.5 14.7 8.2 4.0 3.5 3.9 5.9 13.8 12.4 6.3 3.5 2.6 7.3 3.6 3.4 5.1 0.2 3.6 0.0 0.7 0.0 0.8 0.3 11.2 9.6 1.6 4.7 1.2 2.5 0.1 8.0 2.4 4.6 2.5 6.1 5.6 5.6 9.4 2.8 5.0 7.1 2.7 2.6 0.5 2.7 9.1 4.2 23.3 2.4 8.0 8.6 10.6 3.7 4.2 2.1 2.2 2.8 3.4 7.5 11.0 0.1 0.7 23.9 15.9 27.9 13.4 5.2 17.2 11.6 6.4 18.1 2.0 0.0 8.8 8.6 10.9 9.5 25.1 0.3 12.1 6.4 7.2 6.5 12.5 18.7 7.4 5.6 5.2 1.1 4.2 9.2 4.9 0.0 0.7 0.0 0.4 0.4 0.8 0.0 0.3 0.3 0.6 0.2 0.0 0.1 0.0 0.0 0.7 3.6 0.8 0.3 10.4 12.2 22.0 23.4 9.7 7.4 7.9 11.1 5.5 6.3 0.0 0.6 0.0 1.8 1.9 17.3 0.6 0.0 1.4 2.3 3.5 3.9 0.2 0.0 1.1 15.0 1.3 3.8 0.0 0.7 1.1 3.0 3.6 1.1 0.0 5.2 12.7 1.7 2.5 4.8 21.0 3.4 3.9 5.0 11.8 11.8 1.7 2.9 11.5 1.4 0.6 7.9 0.0 2.3 4.4 2.4 1.5 0.2 0.0 13.7 1.6 LRFN5 "C14orf146, FIGLER8, SALM5" ENSG00000165379 "Leucine rich repeat and fibronectin type III domain containing 5" Q96NI6 14 41607570-41904549 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;parathyroid gland: 38.4" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 4.1;Fibroblasts: 3.3;Leydig cells: 7.8;Peritubular cells: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 17.7;HSkMC: 3.6;RPTEC TERT1: 6.0;SCLC-21H: 9.3;U-138 MG: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001177 Uncertain "Intracellular and membrane" NA NA "HPA001177: AB_1079274" "unprognostic (5.23e-3)" "unprognostic (1.37e-1)" "unprognostic (5.10e-1)" "unprognostic (6.24e-2)" "unprognostic (2.39e-1)" "unprognostic (3.54e-1)" "unprognostic (1.31e-1)" "unprognostic (6.38e-3)" "unprognostic (2.61e-2)" "unprognostic (5.78e-2)" "unprognostic (2.70e-2)" "unprognostic (9.27e-2)" "unprognostic (6.02e-3)" "unprognostic (3.79e-3)" "unprognostic (1.98e-1)" "unprognostic (6.07e-3)" "unprognostic (2.92e-3)" 1.5 3.3 7.9 1.7 9.3 0.5 2.4 3.1 19.1 13.7 2.2 0.8 1.3 0.8 3.8 1.5 1.2 5.0 1.9 0.9 12.2 9.5 0.9 0.6 1.2 0.6 4.3 11.9 2.7 0.9 38.4 1.0 1.8 8.7 3.7 1.9 0.9 0.8 9.3 0.8 1.0 0.9 9.3 1.6 1.2 1.0 1.7 1.2 0.0 1.0 0.0 0.8 7.8 6.3 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.8 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 9.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.5 0.1 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.9 9.3 3.1 19.1 12.2 9.5 4.3 11.9 8.7 1.2 0.0 0.0 0.0 0.0 0.2 4.1 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.3 0.5 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.8 7.8 0.0 1.7 0.0 0.0 0.2 0.2 0.0 3.9 0.0 1.0 0.0 1.0 0.0 1.5 0.3 0.1 0.0 0.0 0.0 LRIG1 "DKFZP586O1624, LIG-1, LIG1" ENSG00000144749 "Leucine rich repeats and immunoglobulin like domains 1" Q96JA1 3 66378797-66501263 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 64.0" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 48.2;Muller glia cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.7" "Lineage enhanced" "Detected in single" "T-cells: 2.7" "Cell line enhanced" "Detected in many" "Daudi: 23.8;hTEC/SVTERT24-B: 18.7;U-698: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011846 Approved Approved Cytosol NA NA 21000 Cytosol "HPA011846: AB_2668545" "unprognostic (6.41e-2)" "unprognostic (4.18e-2)" "unprognostic (4.35e-3)" "unprognostic (4.58e-2)" "unprognostic (2.12e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "prognostic favorable (3.01e-5)" "unprognostic (5.12e-1)" "unprognostic (7.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.18e-1)" "unprognostic (2.12e-1)" "unprognostic (8.79e-2)" "unprognostic (1.30e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (1.50e-4)" 12.6 1.7 22.3 8.1 21.1 2.4 13.4 9.6 31.8 15.5 24.6 20.3 0.7 8.2 12.7 2.6 6.9 13.3 13.8 16.8 24.6 7.1 2.5 15.8 8.6 4.1 19.8 12.4 8.8 64.0 4.2 6.7 2.8 18.9 12.2 7.6 4.8 9.4 4.3 16.6 6.6 7.5 14.5 10.9 2.4 21.2 6.4 19.8 0.2 8.1 5.0 5.0 5.1 5.4 0.3 0.0 0.7 0.0 0.0 2.7 0.4 0.4 0.4 9.5 0.1 2.6 1.7 0.8 1.5 8.9 1.5 4.8 7.4 0.0 23.8 4.1 0.7 2.1 0.0 1.8 3.2 3.4 0.0 4.9 0.0 1.4 0.6 0.6 0.2 5.4 2.1 1.8 18.7 3.1 6.5 8.2 0.1 0.0 0.0 0.3 1.1 0.0 0.0 7.1 0.7 0.0 4.3 2.8 1.2 1.8 0.0 1.2 0.3 1.4 1.4 0.0 1.7 8.5 2.1 2.5 4.7 2.0 9.2 3.9 1.9 0.9 18.2 8.3 0.0 1.6 0.0 0.0 0.7 0.4 0.0 1.4 0.3 1.1 1.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 2.7 0.4 22.3 21.1 9.6 20.2 24.6 7.1 19.8 12.4 18.9 19.8 35.7 42.0 2.7 7.5 10.1 1.7 28.8 7.6 48.2 30.7 0.0 7.9 0.2 1.7 5.5 1.5 9.8 7.1 0.0 14.9 0.1 9.4 18.3 1.1 17.4 1.5 7.9 25.4 4.3 1.0 1.3 10.6 3.1 10.1 1.8 24.4 47.3 6.2 7.0 16.3 1.0 6.5 0.0 9.2 1.5 18.1 10.0 0.1 9.6 19.5 3.7 LRIG2 KIAA0806 ENSG00000198799 "Leucine rich repeats and immunoglobulin like domains 2" O94898 1 113073209-113132260 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015538 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA 510000 "Golgi apparatus" Nucleoplasm "HPA015538: AB_2250170" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (9.08e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (4.72e-2)" "unprognostic (1.27e-3)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (3.27e-2)" "unprognostic (5.95e-2)" "unprognostic (1.03e-2)" "unprognostic (1.03e-2)" "unprognostic (1.27e-2)" "unprognostic (2.34e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" 8.3 7.7 10.1 11.4 10.6 4.7 10.7 15.6 10.0 11.6 9.2 16.1 6.0 10.8 15.1 14.9 7.8 9.2 8.2 7.3 9.3 9.1 9.2 6.3 8.0 9.7 13.0 6.7 15.0 8.5 13.4 11.6 10.1 9.2 9.3 8.6 14.6 9.0 11.2 13.1 16.6 9.5 8.9 11.6 10.1 8.1 9.4 13.4 10.4 12.6 5.0 10.7 8.6 10.7 4.4 2.6 4.9 2.5 4.8 3.9 1.7 4.3 2.4 6.7 5.0 6.4 6.6 3.8 2.8 4.2 3.4 5.8 3.5 2.8 4.5 5.0 3.5 1.9 5.0 4.6 3.0 5.7 3.1 2.7 4.8 4.5 1.7 6.5 5.7 2.3 6.5 5.5 5.4 7.1 5.3 4.4 6.3 5.7 4.3 4.2 3.2 5.7 6.1 6.2 1.8 4.0 5.3 8.4 2.2 3.3 2.9 4.8 3.8 5.0 3.3 6.4 5.7 2.5 6.4 6.6 6.4 3.4 8.7 4.5 4.7 2.2 4.6 6.8 3.6 5.9 4.9 2.5 1.5 3.1 2.0 3.5 3.1 3.4 3.2 1.9 4.4 3.9 3.6 1.7 4.8 2.1 2.6 2.6 1.7 10.1 10.6 15.6 10.0 9.3 9.1 13.0 6.7 9.2 13.4 0.0 13.3 5.9 2.5 7.4 19.1 8.1 12.7 12.0 6.8 14.0 35.3 5.8 0.0 3.2 0.9 6.3 9.9 0.0 2.3 3.7 5.7 4.7 5.7 4.3 4.1 17.5 5.2 6.2 8.5 0.0 17.0 5.9 6.8 1.8 7.1 27.0 2.7 7.0 15.2 4.1 21.3 0.0 4.2 8.6 14.9 5.8 4.5 7.0 8.3 3.4 LRIG3 "FLJ90440, KIAA3016" ENSG00000139263 "Leucine rich repeats and immunoglobulin like domains 3" Q6UXM1 12 58872149-58920522 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Cholangiocytes: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 27.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010773 Approved Approved Cytosol NA NA Cytosol "HPA010773: AB_1853275" "unprognostic (1.79e-1)" "unprognostic (2.71e-1)" "unprognostic (1.01e-2)" "unprognostic (3.88e-2)" "unprognostic (2.53e-1)" "unprognostic (3.46e-2)" "unprognostic (1.83e-2)" "unprognostic (1.34e-3)" "unprognostic (1.21e-1)" "unprognostic (1.92e-1)" "unprognostic (3.04e-2)" "unprognostic (4.25e-2)" "unprognostic (2.74e-3)" "unprognostic (2.47e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (1.46e-2)" 15.8 1.7 3.6 11.8 4.1 0.0 16.4 1.0 3.7 18.7 14.8 7.8 12.1 8.4 14.2 13.8 17.1 9.9 17.8 4.7 4.6 1.8 6.5 6.1 9.6 5.0 3.6 2.6 14.7 15.3 4.8 10.3 6.8 5.8 15.5 16.0 13.5 24.9 11.6 5.0 25.9 10.0 21.6 3.0 7.2 13.5 6.4 6.6 5.4 37.6 15.0 12.8 15.7 20.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 2.0 1.9 7.4 0.5 13.6 15.9 1.7 4.9 14.3 4.8 5.1 5.8 2.7 1.9 10.0 5.4 5.8 9.6 2.7 12.6 3.5 14.6 9.6 0.5 3.3 2.8 2.6 0.8 0.2 15.7 27.4 5.1 11.0 9.4 13.1 2.2 0.1 2.4 3.2 0.9 2.3 0.0 7.9 2.4 2.9 0.0 6.3 4.8 3.7 10.6 7.5 0.0 4.3 2.7 4.5 11.0 5.0 0.1 5.6 6.5 4.5 3.9 6.4 1.0 0.0 0.0 1.3 0.0 3.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 4.1 1.0 3.7 4.6 1.8 3.6 2.6 5.8 6.6 14.9 17.4 0.0 7.5 19.9 2.6 4.1 33.1 13.4 23.9 1.8 0.0 0.7 0.0 9.0 0.3 11.4 10.7 0.0 15.8 0.4 8.2 2.6 0.0 6.8 1.9 3.2 11.1 4.3 0.3 0.0 25.0 0.2 3.3 0.0 11.8 2.8 7.5 14.0 27.3 4.2 0.1 6.5 11.3 0.4 1.5 19.6 0.2 0.0 25.9 2.7 LRIT1 "DKFZP434K091, FIGLER9, LRRC21, PAL" ENSG00000148602 "Leucine rich repeat, Ig-like and transmembrane domains 1" Q9P2V4 10 84231593-84241461 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 67 "retina: 20.7;testis: 10.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 13.8;Early spermatids: 21.9;Late spermatids: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.13e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 LRIT2 "AC022389.4, LRRC22" ENSG00000204033 "Leucine rich repeat, Ig-like and transmembrane domains 2" A6NDA9 10 84220495-84225589 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 25.4;skin 1: 8.5" "Group enriched" "Detected in some" 6 "Bipolar cells: 5.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 16.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "basal ganglia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA037788 Enhanced NA NA "HPA037788: AB_10672393" "unprognostic (3.12e-1)" "unprognostic (1.09e-3)" "unprognostic (3.99e-1)" "unprognostic (9.44e-2)" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (2.41e-1)" 0.1 0.2 0.2 0.1 3.4 0.0 0.1 0.1 2.2 0.1 1.6 0.1 0.1 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 25.4 0.1 0.1 0.1 8.5 0.7 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.4 0.1 0.5 0.3 0.3 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRIT3 "CSNB1F, FIGLER4, FLJ44691" ENSG00000183423 "Leucine rich repeat, Ig-like and transmembrane domains 3" Q3SXY7 4 109848202-109872315 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 17.1" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 31.4;Muller glia cells: 15.4;Rod photoreceptor cells: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013454 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA013454: AB_1853277" "unprognostic (5.41e-2)" "unprognostic (6.82e-2)" "unprognostic (4.20e-2)" "unprognostic (6.50e-2)" "unprognostic (3.42e-1)" "unprognostic (7.67e-3)" "unprognostic (1.54e-1)" "unprognostic (5.25e-2)" "unprognostic (3.16e-2)" "unprognostic (4.49e-2)" "unprognostic (6.92e-3)" "unprognostic (3.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.14e-2)" 0.6 0.6 0.7 0.6 1.2 0.4 1.7 2.0 1.3 1.2 0.6 0.6 0.6 0.3 0.7 1.8 0.6 1.0 0.6 0.6 0.8 0.7 4.4 0.7 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.6 0.6 0.6 0.9 0.5 17.1 0.8 0.6 1.6 3.2 0.6 0.6 0.6 0.8 0.2 1.3 0.6 0.6 0.8 0.6 0.6 0.6 0.6 0.1 0.3 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.0 0.6 0.6 0.0 0.0 0.1 1.3 0.1 0.2 0.3 1.6 0.3 0.4 0.2 0.1 1.3 0.0 0.0 2.0 0.1 0.3 0.2 0.1 1.3 0.3 0.6 0.0 0.0 0.9 1.0 0.2 0.8 0.2 0.6 0.0 0.2 1.0 0.3 0.5 0.0 0.0 0.4 0.0 0.3 0.1 1.2 0.0 0.3 0.3 0.6 0.3 0.6 1.0 0.0 0.3 0.9 0.3 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 1.2 2.0 1.3 0.8 0.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 31.4 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.1 0.0 0.0 0.0 9.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 LRMP JAW1 ENSG00000118308 "Lymphoid restricted membrane protein" Q12912 12 25004342-25108334 "Predicted intracellular proteins, Predicted membrane proteins" "Fertilization, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;lymphoid tissue: 69.5" "Cell type enhanced" "Detected in many" 9 "B-cells: 52.5;granulocytes: 24.4;Kupffer cells: 29.4;T-cells: 40.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 51.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Daudi: 96.3;REH: 33.5;U-698: 110.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA002967, HPA018505" Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA002967: AB_1079161, HPA018505: AB_1851988" "unprognostic (3.78e-2)" "unprognostic (2.59e-3)" "unprognostic (7.54e-2)" "unprognostic (7.08e-3)" "unprognostic (2.36e-1)" "unprognostic (1.48e-3)" "unprognostic (7.98e-2)" "unprognostic (4.08e-2)" "unprognostic (7.32e-2)" "unprognostic (1.15e-1)" "unprognostic (3.59e-2)" "unprognostic (7.97e-2)" "unprognostic (7.25e-3)" "unprognostic (7.72e-2)" "unprognostic (9.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.59e-2)" 5.5 1.4 15.1 51.7 2.9 19.2 4.6 0.4 5.6 1.9 3.6 2.1 0.9 3.2 1.4 1.8 3.9 2.3 3.0 1.7 8.1 1.8 5.5 2.3 5.6 57.8 3.5 4.7 2.3 15.1 0.4 2.1 1.7 7.4 2.8 3.5 1.3 4.1 2.1 0.8 2.7 13.2 1.8 5.3 27.6 3.6 0.7 2.8 67.0 3.6 1.7 69.5 10.4 5.7 17.4 5.7 51.8 12.2 12.0 7.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 5.7 0.0 0.0 0.0 7.4 8.5 0.0 0.0 0.1 0.0 0.0 0.0 4.9 1.1 6.4 0.0 0.0 8.1 13.7 0.0 0.0 0.0 33.5 0.0 9.5 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.2 0.0 0.0 6.3 1.1 110.1 0.0 3.3 0.0 17.0 5.4 51.8 6.5 10.5 5.4 17.4 4.1 6.6 5.7 13.3 7.1 6.9 39.3 12.0 12.2 5.4 0.7 4.7 15.1 2.9 0.4 5.6 8.1 1.8 3.5 4.7 7.4 2.8 0.0 7.4 52.5 2.5 0.8 0.2 0.4 0.0 9.4 15.9 0.0 0.0 0.1 0.0 0.2 1.5 2.1 0.0 0.0 7.5 0.1 0.5 0.2 24.4 1.0 11.5 0.0 8.5 4.9 29.4 0.4 0.9 20.0 5.0 1.8 0.0 0.0 1.6 3.5 4.6 13.0 0.2 0.0 0.2 0.2 0.0 4.8 0.1 40.3 0.2 14.4 LRP1 "A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A" ENSG00000123384 "LDL receptor related protein 1" Q07954 12 57128493-57213351 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 153.3;Leydig cells: 216.0;Peritubular cells: 173.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "classical monocyte: 7.6;intermediate monocyte: 4.0;myeloid DC: 2.8;non-classical monocyte: 3.7" "Group enriched" "Detected in many" 20 "dendritic cells: 2.8;monocytes: 7.6" "Cell line enhanced" "Detected in many" "ASC diff: 83.1;ASC TERT1: 84.4;fHDF/TERT166: 36.2;HSkMC: 54.7;hTERT-RPE1: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004182, CAB018621, HPA022903" Supported Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 88000000 Vesicles Nucleoplasm "CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426" "unprognostic (1.65e-1)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (2.71e-1)" "unprognostic (5.00e-2)" "unprognostic (4.33e-2)" "unprognostic (3.98e-1)" "unprognostic (8.68e-2)" "unprognostic (1.70e-1)" "unprognostic (3.37e-3)" "unprognostic (1.48e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.52e-5)" "unprognostic (2.81e-3)" "unprognostic (6.13e-2)" "unprognostic (2.80e-2)" "prognostic unfavorable (1.29e-5)" 77.8 12.0 19.8 21.5 21.3 6.1 27.7 28.1 25.3 31.4 19.7 11.9 9.0 17.8 26.9 18.2 19.2 21.0 24.1 26.0 18.6 10.4 6.3 31.4 24.7 5.5 13.9 15.6 56.9 8.8 8.5 8.0 29.4 17.1 21.4 9.5 20.0 14.8 17.0 11.3 15.7 14.2 22.4 14.3 11.3 11.8 11.1 15.4 0.3 13.2 9.3 3.1 22.9 39.4 0.0 2.8 0.1 7.6 0.0 0.2 1.9 1.2 2.3 5.1 4.0 83.1 84.4 15.3 14.0 18.1 4.6 4.5 4.3 2.0 0.0 1.7 36.2 1.0 5.5 0.8 1.4 1.6 0.1 0.2 0.0 2.7 9.0 11.4 0.0 2.4 54.7 0.5 10.3 1.2 42.1 0.2 0.1 0.0 0.2 14.4 0.2 0.0 0.0 5.8 1.7 1.4 0.5 28.8 0.2 0.3 0.3 0.2 2.8 3.1 0.1 2.2 7.4 0.4 0.2 0.2 16.2 6.0 9.0 0.8 0.1 0.0 0.0 28.4 0.0 3.1 0.0 7.6 0.0 0.0 4.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.2 0.1 0.0 3.7 0.0 0.0 1.9 19.8 21.3 28.1 19.7 18.6 10.4 13.9 15.6 17.1 15.4 11.9 9.6 3.7 11.4 21.3 25.5 12.1 20.4 5.3 11.4 1.8 0.0 65.3 0.0 7.8 1.6 5.8 72.1 0.0 1.6 42.2 117.6 4.4 5.8 153.3 72.0 7.9 4.1 16.0 118.9 3.6 216.0 50.7 27.0 3.6 14.3 130.1 9.9 18.6 173.2 2.2 3.8 38.8 44.2 1.4 2.2 14.1 105.3 0.9 20.9 10.2 LRP10 "DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087" ENSG00000197324 "LDL receptor related protein 10" Q7Z4F1 14 22871613-22881580 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 29.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 29.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000932 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA000932: AB_2281523" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (3.72e-2)" "unprognostic (4.59e-2)" "unprognostic (1.72e-1)" "unprognostic (5.01e-2)" "prognostic unfavorable (3.54e-7)" "prognostic unfavorable (9.17e-4)" "unprognostic (8.32e-2)" "unprognostic (1.48e-2)" "unprognostic (1.97e-2)" "unprognostic (4.55e-2)" "prognostic favorable (6.31e-5)" "unprognostic (3.06e-2)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (4.14e-2)" 33.1 20.1 12.7 26.0 13.1 23.7 37.2 5.8 10.3 32.0 52.4 16.2 41.0 31.7 39.0 46.8 66.1 27.1 65.1 27.7 13.6 6.0 46.5 63.3 34.1 30.0 14.2 8.1 30.7 36.6 31.4 11.7 32.0 14.4 36.9 19.0 22.6 36.1 41.1 21.2 32.9 65.9 32.0 11.2 26.1 37.9 19.1 12.9 20.7 46.9 34.1 36.2 43.3 42.8 3.8 2.3 29.7 2.6 2.4 6.3 3.4 15.4 18.9 4.1 10.8 56.7 32.9 14.1 24.5 46.6 15.5 21.5 5.8 55.1 8.1 12.3 55.1 17.7 22.2 2.7 28.0 6.1 13.2 2.9 2.8 10.4 4.0 25.3 6.4 25.9 35.9 32.8 23.1 12.0 43.0 28.2 3.7 3.4 31.4 20.8 17.8 1.8 1.9 0.9 15.0 25.5 4.1 4.2 8.1 16.6 27.6 0.3 4.5 13.5 26.0 10.6 3.2 13.6 4.6 29.3 23.9 6.8 12.3 10.0 14.7 8.7 3.7 12.3 2.6 10.2 5.9 2.2 15.8 5.1 2.3 5.0 3.8 6.3 6.0 2.3 2.7 5.5 3.1 29.7 2.4 2.6 1.9 6.0 3.4 12.7 13.1 5.8 10.3 13.6 6.0 14.2 8.1 14.4 12.9 98.3 51.7 60.9 74.0 34.2 2.2 27.2 107.0 37.5 59.1 78.5 0.0 55.7 8.3 146.7 9.9 50.6 243.0 46.7 208.6 82.1 65.3 100.3 34.6 35.4 52.6 0.0 63.9 69.3 49.2 11.4 52.6 36.1 52.3 101.0 99.6 89.2 227.5 199.9 68.6 40.8 8.3 64.7 65.9 2.6 6.7 41.5 110.6 62.3 73.3 132.4 LRP11 "bA350J20.3, MANSC3" ENSG00000120256 "LDL receptor related protein 11" Q86VZ4 6 149818798-149864026 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017267 Approved "Vesicles,Plasma membrane" NA NA 640000 "Plasma membrane" Vesicles "HPA017267: " "prognostic unfavorable (2.31e-8)" "unprognostic (3.85e-3)" "unprognostic (1.68e-1)" "unprognostic (1.30e-2)" "unprognostic (5.17e-2)" "unprognostic (4.25e-3)" "prognostic unfavorable (2.01e-5)" "unprognostic (5.05e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (3.29e-1)" "unprognostic (2.63e-1)" "unprognostic (4.76e-2)" "unprognostic (2.47e-1)" "unprognostic (6.75e-2)" "unprognostic (1.34e-2)" "unprognostic (4.23e-2)" 12.0 16.5 17.8 4.4 26.9 1.6 11.2 17.9 25.6 14.0 11.5 15.1 9.4 10.5 10.6 14.8 20.2 20.2 10.5 8.0 19.7 19.3 18.2 9.0 12.1 2.2 15.0 16.9 15.3 17.2 46.2 15.2 14.7 20.6 23.3 11.4 10.8 14.2 12.3 8.1 20.2 8.7 10.9 13.3 3.6 14.4 7.2 15.6 0.8 20.8 13.8 6.4 17.3 14.2 3.5 1.0 0.0 1.7 0.0 0.7 0.1 9.5 8.4 6.4 5.6 14.3 26.2 1.2 10.0 19.6 7.0 8.5 2.5 20.0 0.1 13.7 15.7 30.9 25.6 7.2 18.2 5.0 15.4 7.2 4.5 30.9 11.0 8.8 4.6 0.1 16.3 35.5 9.0 17.8 19.9 10.8 4.4 9.3 4.3 8.3 16.5 0.1 0.1 3.8 19.0 8.4 5.0 9.6 2.2 12.6 19.6 8.5 5.7 31.6 17.7 6.0 3.3 14.5 9.6 8.4 8.8 2.0 18.3 7.6 0.0 3.0 2.2 15.9 4.7 5.1 0.0 0.1 0.0 0.2 0.4 0.0 3.5 0.7 0.6 1.0 0.6 0.2 0.3 0.0 0.0 1.7 0.0 0.0 0.1 17.8 26.9 17.9 25.6 19.7 19.3 15.0 16.9 20.6 15.6 6.0 3.2 0.8 10.9 10.1 10.5 7.6 20.4 24.1 5.7 19.2 2.0 1.4 5.0 5.6 26.8 6.8 3.9 0.0 19.4 2.2 12.9 21.0 0.0 8.3 2.9 7.9 28.3 11.1 1.8 24.2 15.3 1.1 13.5 0.0 3.7 6.3 16.2 2.9 13.8 5.4 5.4 0.0 5.6 6.1 5.9 12.5 4.7 0.0 11.3 20.6 LRP12 "FLJ12929, ST7" ENSG00000147650 "LDL receptor related protein 12" Q9Y561 8 104489231-104589024 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 22.6" "Lineage enriched" "Detected in many" 22 "granulocytes: 22.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017245 Uncertain Approved "Nucleoli fibrillar center,Plasma membrane,Mitochondria" NA NA "Nucleoli fibrillar center, Plasma membrane, Mitochondria" "HPA017245: AB_1857532" "unprognostic (2.17e-1)" "unprognostic (6.80e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.07e-1)" "unprognostic (2.15e-3)" "unprognostic (4.87e-4)" "unprognostic (2.96e-2)" "unprognostic (3.96e-1)" "unprognostic (4.59e-2)" "unprognostic (1.32e-1)" "unprognostic (3.39e-2)" "unprognostic (9.89e-2)" "unprognostic (7.56e-3)" "unprognostic (4.88e-2)" "unprognostic (1.45e-1)" "unprognostic (4.05e-3)" 6.1 5.3 10.7 4.0 23.4 2.1 4.7 11.3 16.3 7.4 5.1 4.3 5.1 3.3 18.2 4.5 4.6 6.9 8.1 14.2 8.7 6.5 7.2 1.6 4.8 1.6 4.6 9.5 6.9 5.4 13.0 11.0 5.6 7.1 7.4 5.3 3.3 5.0 6.8 11.8 5.1 3.1 20.2 4.1 3.8 3.8 5.0 5.2 18.0 7.4 3.4 2.4 6.2 5.4 0.0 0.3 22.6 0.4 0.4 1.0 0.2 7.3 4.3 8.8 15.4 10.0 8.0 1.9 21.1 21.2 7.4 10.4 0.9 7.3 0.0 8.5 19.9 8.9 3.3 3.6 9.0 15.9 13.7 3.4 11.5 2.0 0.3 6.2 0.1 9.3 10.6 6.4 12.3 10.1 26.8 3.8 9.0 2.4 0.0 26.4 1.2 10.5 0.2 2.2 0.6 7.5 0.8 8.6 1.6 5.9 0.3 11.3 6.9 6.7 0.3 18.0 6.9 2.0 2.2 10.5 20.4 13.2 6.5 13.6 10.0 7.8 0.0 11.0 0.0 22.3 22.6 0.2 3.5 0.1 0.4 1.0 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.3 0.3 0.0 0.2 10.7 23.4 11.3 16.3 8.7 6.5 4.6 9.5 7.1 5.2 14.9 2.1 0.0 5.3 10.2 16.6 9.8 7.6 4.0 3.4 14.0 5.9 0.2 0.0 3.9 3.3 6.7 0.8 0.0 3.9 0.3 9.4 5.6 8.1 0.5 5.1 27.0 13.8 3.7 7.3 1.6 8.1 4.8 6.8 8.2 2.3 4.8 4.4 0.0 8.5 2.9 7.4 6.5 9.0 7.2 11.0 9.5 0.2 4.9 1.7 4.3 LRP1B "LRP-DIT, LRPDIT" ENSG00000168702 "LDL receptor related protein 1B" Q9NZR2 2 140231423-142131701 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7;thyroid gland: 14.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 15.8;Early spermatids: 4.6;Late spermatids: 4.3" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "myeloid DC: 1.4;plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.4" "Cell line enhanced" "Detected in some" "ASC diff: 4.2;HEK 293: 4.5;HeLa: 2.3;HSkMC: 2.2;U-138 MG: 4.9;U-87 MG: 2.6" "Low region specificity" "Detected in all" "HPA069094, HPA074788" Approved Approved Vesicles NA NA 63000 Vesicles "HPA069094: AB_2686082, HPA074788: AB_2797273" "unprognostic (5.31e-4)" "unprognostic (3.68e-2)" "unprognostic (2.61e-1)" "unprognostic (7.36e-4)" "unprognostic (5.19e-2)" "unprognostic (1.26e-1)" "unprognostic (2.00e-2)" "unprognostic (3.49e-1)" "unprognostic (3.75e-1)" "unprognostic (7.02e-3)" "unprognostic (1.64e-3)" "unprognostic (1.05e-1)" "unprognostic (2.94e-3)" "unprognostic (4.85e-3)" "unprognostic (1.52e-1)" "unprognostic (1.66e-2)" "unprognostic (1.36e-1)" 4.8 4.5 17.6 1.3 14.1 1.2 2.6 23.2 25.7 1.4 1.3 6.5 0.0 1.2 1.3 6.8 1.3 1.9 1.4 1.6 18.3 9.3 2.2 1.6 1.4 1.2 10.8 16.7 3.0 1.2 1.1 12.7 1.2 12.8 3.5 1.3 0.1 2.5 3.8 10.5 1.7 1.3 1.3 8.2 1.2 1.5 1.9 10.6 0.0 14.9 0.0 1.3 1.2 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 4.2 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 1.0 0.2 0.2 0.6 4.5 0.0 2.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.4 1.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.2 0.0 0.0 0.4 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 17.6 14.1 23.2 21.3 18.3 9.3 10.8 16.7 12.8 10.6 0.0 0.0 0.0 0.3 0.2 15.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.7 0.0 0.8 0.0 0.3 0.1 0.1 0.3 0.0 0.0 0.0 0.6 LRP2 "DBS, gp330" ENSG00000081479 "LDL receptor related protein 2" P98164 2 169127109-169362685 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endocytosis, Hearing, Neurogenesis, Transport" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 61.7;parathyroid gland: 61.4" "Cell type enhanced" "Detected in many" 23 "Cone photoreceptor cells: 82.5;Cytotrophoblasts: 52.4;Proximal tubular cells: 250.3" "Group enriched" "Detected in many" 6 "breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "AF22: 21.9;CACO-2: 36.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA005980, HPA064792" Enhanced Approved Vesicles,Mitochondria No NA "Vesicles, Mitochondria" "HPA005980: AB_1079278, HPA064792: AB_2685353" "unprognostic (1.87e-1)" "unprognostic (1.04e-3)" "unprognostic (1.32e-3)" "unprognostic (3.65e-3)" "unprognostic (3.18e-2)" "unprognostic (1.60e-2)" "unprognostic (1.64e-3)" "unprognostic (2.99e-1)" "unprognostic (1.94e-1)" "unprognostic (1.39e-1)" "unprognostic (4.09e-2)" "unprognostic (4.38e-1)" "prognostic favorable (3.43e-5)" "unprognostic (1.37e-1)" "unprognostic (4.21e-1)" "unprognostic (2.44e-2)" "unprognostic (1.62e-2)" 1.7 0.4 2.7 0.4 12.9 0.5 7.4 0.7 5.7 0.6 0.4 18.5 0.0 0.4 0.5 4.8 0.4 0.4 0.6 0.5 6.2 3.4 61.7 0.6 1.8 0.4 20.7 1.9 0.4 0.4 61.4 0.4 10.5 8.5 0.5 0.4 7.9 1.1 0.5 0.5 0.5 0.4 0.4 17.2 0.4 0.5 0.6 17.0 0.0 18.2 0.0 0.4 0.4 0.2 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.7 12.9 0.7 5.7 6.2 3.4 20.7 1.9 8.5 17.0 6.0 39.5 0.0 0.1 0.2 1.9 1.7 2.5 4.0 4.5 3.5 82.5 52.4 14.9 0.0 1.4 0.0 0.0 0.0 0.0 1.9 0.8 0.0 2.3 0.0 4.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.0 250.3 18.0 0.0 0.0 0.0 0.5 0.0 19.3 0.0 0.0 0.1 LRP3 "hLRp105, LRP-3" ENSG00000130881 "LDL receptor related protein 3" O75074 19 33177603-33208867 "Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 50.0" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 28.5;Hepatocytes: 25.9;Leydig cells: 24.2;Peritubular cells: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.8;non-classical monocyte: 2.6" "Lineage enriched" "Detected in single" 4 "monocytes: 2.8" "Cell line enhanced" "Detected in many" "THP-1: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041658 Approved "Lipid droplets" NA NA "Lipid droplets" "HPA041658: " "unprognostic (3.10e-1)" "unprognostic (2.55e-2)" "unprognostic (3.25e-2)" "unprognostic (1.45e-2)" "unprognostic (2.38e-2)" "unprognostic (1.80e-1)" "unprognostic (1.39e-1)" "unprognostic (3.14e-2)" "unprognostic (3.07e-2)" "unprognostic (4.67e-2)" "prognostic favorable (6.12e-7)" "unprognostic (1.34e-1)" "unprognostic (2.71e-3)" "unprognostic (4.36e-1)" "unprognostic (2.85e-2)" "unprognostic (2.40e-1)" "unprognostic (1.32e-1)" 23.5 16.6 28.3 5.1 33.1 15.3 15.6 14.2 41.2 12.1 7.8 6.6 4.4 7.1 11.2 8.8 7.4 12.4 8.2 10.9 27.6 13.0 4.2 15.5 5.3 3.2 15.4 19.4 50.0 16.8 9.8 10.3 3.8 11.0 15.5 3.4 10.0 14.4 12.7 21.9 5.0 6.6 10.6 6.3 4.8 7.0 5.6 7.7 0.0 9.5 4.7 3.1 9.0 9.1 0.0 0.0 0.6 2.8 0.5 0.1 0.7 0.0 20.7 5.7 20.6 14.4 5.4 4.3 5.3 5.2 4.9 1.9 5.9 0.2 0.0 13.9 6.5 6.9 0.0 5.5 0.5 0.4 0.0 11.2 0.0 4.6 20.7 5.5 7.4 0.7 8.2 4.9 1.3 0.7 0.8 4.0 0.0 0.0 0.0 6.2 19.1 0.0 8.4 11.7 4.1 1.0 0.0 2.6 0.0 0.0 8.3 12.6 19.0 8.6 0.0 1.5 0.6 8.7 26.2 0.0 10.2 9.1 15.1 3.0 0.0 0.0 0.1 0.0 12.5 3.0 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.5 2.6 0.0 0.0 0.7 28.3 33.1 14.2 41.2 27.6 13.0 15.4 19.4 11.0 7.7 0.0 2.2 0.9 2.1 3.0 28.5 0.4 10.2 0.0 3.4 5.2 3.9 0.1 0.0 5.8 2.2 1.8 0.9 0.0 6.5 0.6 7.0 8.2 0.0 25.9 8.2 22.3 1.7 6.2 10.0 5.2 24.2 2.3 3.3 1.8 6.6 23.0 8.9 0.0 30.8 0.5 3.6 6.5 5.2 0.2 0.4 2.3 0.0 0.0 4.9 1.4 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856868-46918642 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;skin 1: 33.0" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 17.0;SuSa: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 1.2 1.9 16.0 1.3 20.3 0.5 2.1 7.3 23.7 3.0 5.4 11.6 0.6 3.9 2.1 1.3 2.4 2.0 2.5 7.2 20.4 5.8 1.2 0.7 3.4 0.5 9.6 12.6 5.4 2.7 9.3 3.3 3.1 14.5 2.7 4.1 1.3 2.1 3.0 4.4 33.0 5.3 2.0 9.7 4.2 9.6 1.6 19.0 0.0 2.9 1.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 17.0 5.2 10.6 2.9 3.9 0.7 1.5 2.3 2.5 2.2 0.0 0.0 1.1 8.7 2.4 3.0 9.5 5.8 1.8 0.0 7.9 0.8 3.0 5.2 2.2 0.1 1.5 3.6 3.4 3.5 0.9 2.0 1.9 2.1 0.7 0.0 1.3 0.6 0.1 0.2 9.2 0.0 0.7 1.2 5.8 0.0 0.2 2.2 0.0 11.2 0.9 0.0 2.8 13.6 0.2 0.4 0.1 4.6 2.9 5.2 1.6 0.0 0.0 0.3 3.4 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 20.3 7.3 17.3 20.4 5.8 9.6 12.6 14.5 19.0 0.0 3.4 0.0 2.5 7.2 0.4 4.8 0.0 0.0 2.3 1.8 39.3 1.8 1.7 0.0 0.4 0.7 6.3 0.0 0.3 0.4 4.3 0.3 4.7 0.0 0.2 0.0 0.0 1.3 0.0 0.0 1.7 0.0 1.7 1.0 2.2 8.7 0.5 2.3 1.1 0.2 2.6 0.0 1.2 0.1 0.7 9.5 1.1 0.0 1.8 0.7 LRP5 "BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPS, OPTA1, VBCH2" ENSG00000162337 "LDL receptor related protein 5" O75197 11 68312609-68449275 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Disease mutation, Osteogenesis imperfecta, Osteopetrosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 40.4;Hepatocytes: 38.9;Mucus-secreting cells: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.8" "Lineage enhanced" "Detected in single" "dendritic cells: 2.8" "Cell line enhanced" "Detected in many" "OE19: 48.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013001, HPA030505" Approved NA NA "CAB013001: AB_2533267, HPA030505: AB_2673505" "unprognostic (3.67e-1)" "unprognostic (2.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.13e-2)" "unprognostic (3.33e-1)" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (2.94e-2)" "unprognostic (9.63e-2)" "unprognostic (2.54e-1)" "unprognostic (2.78e-1)" "unprognostic (6.82e-2)" "prognostic favorable (3.55e-10)" "unprognostic (2.28e-2)" "unprognostic (1.62e-2)" "unprognostic (1.58e-1)" "unprognostic (7.42e-2)" 15.9 14.7 3.1 6.8 4.0 1.1 25.6 1.6 3.7 13.5 14.9 5.3 16.8 20.4 12.4 11.8 8.7 10.1 29.8 14.3 2.9 2.1 12.5 49.4 12.9 4.8 2.9 2.6 11.8 30.8 8.1 6.9 12.7 5.2 13.3 5.3 11.6 35.3 22.0 7.4 8.9 23.5 15.4 3.1 3.6 12.7 3.6 3.4 9.2 17.2 10.4 8.3 11.2 17.5 0.1 2.8 0.0 0.0 0.7 0.1 0.0 9.2 31.8 3.4 7.9 6.6 3.7 14.8 4.3 3.8 2.6 2.4 17.8 32.2 0.0 27.6 5.5 11.0 12.0 3.1 11.5 0.4 1.5 7.0 6.5 16.3 23.1 6.7 4.7 0.6 5.3 3.9 0.1 4.3 7.1 7.3 5.8 11.4 0.5 1.8 21.0 7.0 18.7 6.1 48.8 13.0 8.9 9.4 15.0 4.4 25.1 3.3 6.8 11.4 15.4 12.5 1.7 10.8 10.9 9.6 0.0 2.9 3.6 4.7 1.9 0.2 1.9 0.0 2.9 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 2.8 0.0 0.0 3.1 4.0 1.6 3.7 2.9 2.1 2.9 2.6 5.2 3.4 6.0 4.8 0.0 7.1 8.1 0.0 4.0 28.1 0.0 3.4 7.0 0.0 36.6 0.0 10.1 1.1 10.5 40.4 0.0 8.4 5.2 7.4 9.4 1.1 38.9 7.4 0.0 16.8 25.8 3.1 0.9 2.8 1.0 1.7 1.8 39.1 10.6 11.8 26.8 9.2 9.1 0.0 6.5 4.6 0.3 6.1 4.5 20.7 0.0 21.7 9.6 LRP6 ADCAD2 ENSG00000070018 "LDL receptor related protein 6" O75581 12 12116025-12267012 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.7" "Lineage enhanced" "Detected in single" "T-cells: 1.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004490, HPA029925" Enhanced NA NA 270000 "CAB004490: AB_627894, HPA029925: AB_10601768" "unprognostic (1.80e-1)" "unprognostic (3.72e-1)" "unprognostic (2.76e-1)" "unprognostic (1.91e-1)" "unprognostic (6.11e-2)" "unprognostic (1.07e-1)" "unprognostic (4.56e-2)" "unprognostic (1.37e-2)" "unprognostic (3.35e-2)" "unprognostic (6.98e-2)" "unprognostic (1.82e-1)" "unprognostic (5.00e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-2)" "unprognostic (3.16e-1)" "unprognostic (1.23e-2)" "unprognostic (2.47e-1)" 7.6 5.3 7.3 5.6 10.1 1.2 9.9 11.6 8.2 16.7 8.7 7.4 5.8 6.8 14.2 8.2 5.0 8.7 9.3 7.3 8.1 4.7 11.7 17.9 10.9 2.4 5.5 8.7 13.1 10.1 21.5 11.2 18.4 7.8 8.8 6.9 9.9 13.3 11.9 10.8 6.9 5.9 9.6 5.5 2.7 8.5 7.9 8.2 4.2 10.3 7.3 3.6 7.5 14.1 0.4 0.0 0.0 0.0 0.0 1.7 0.0 4.2 12.0 9.4 4.7 5.9 3.9 8.4 7.5 4.9 4.1 4.9 5.8 3.4 0.0 3.7 4.8 3.5 3.7 13.1 3.3 7.9 0.0 4.9 4.2 4.7 3.1 2.1 5.7 3.1 3.1 2.1 6.2 4.9 4.8 4.3 4.0 5.6 0.0 2.7 2.7 4.0 1.0 15.7 1.9 2.2 5.2 9.2 1.0 6.4 6.6 2.0 6.3 7.1 2.4 6.1 10.9 1.8 3.3 7.7 3.3 14.1 2.6 5.3 0.0 0.0 2.0 3.2 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 7.3 10.1 11.6 8.2 8.1 4.7 5.5 8.7 7.8 8.2 38.7 37.2 0.8 7.7 13.7 26.7 14.2 5.1 1.4 17.0 14.0 21.6 2.9 1.7 7.9 0.9 16.6 17.0 0.0 11.9 2.7 19.6 11.8 0.0 38.4 1.8 6.4 10.4 18.4 2.2 2.8 28.1 2.1 13.5 1.0 12.6 23.9 11.3 15.8 36.4 4.3 26.0 0.0 12.2 23.1 22.2 12.0 2.9 1.3 12.7 6.4 LRP8 "APOER2, HSZ75190, LRP-8, MCI1" ENSG00000157193 "LDL receptor related protein 8" Q14114 1 53242364-53328070 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.5;thyroid gland: 48.7" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 39.8;Ciliated cells: 14.7;Horizontal cells: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.2" "Group enriched" "Detected in many" 6 "dendritic cells: 3.2;T-cells: 1.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073031 Enhanced "Secreted in other tissues" NA NA 240000 "HPA073031: AB_2732217" "unprognostic (3.83e-2)" "unprognostic (6.06e-2)" "unprognostic (6.36e-2)" "prognostic unfavorable (3.46e-6)" "unprognostic (3.46e-1)" "unprognostic (6.13e-2)" "unprognostic (1.03e-3)" "prognostic unfavorable (7.02e-4)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (1.66e-1)" "unprognostic (9.11e-2)" "unprognostic (8.88e-16)" "unprognostic (7.73e-3)" "unprognostic (5.47e-2)" "unprognostic (6.98e-2)" "unprognostic (3.00e-2)" 2.6 1.9 7.0 5.5 7.1 5.8 1.9 13.0 15.1 1.8 1.8 2.7 0.3 1.4 2.0 2.8 6.1 3.6 2.3 1.9 7.6 8.0 1.4 0.8 3.2 5.6 5.8 7.9 1.3 0.9 0.8 4.2 5.0 6.6 1.5 2.4 11.9 1.4 1.6 0.8 1.5 1.5 2.9 3.8 2.3 1.3 22.5 3.4 1.7 48.7 2.4 4.9 1.7 2.0 0.3 3.2 0.0 0.4 0.0 1.6 0.2 10.0 21.4 8.4 12.1 5.8 5.6 10.8 12.4 10.3 18.8 13.1 5.8 12.0 16.4 14.4 8.3 27.9 17.1 6.6 14.2 8.9 12.0 6.5 9.2 24.4 10.2 6.0 16.6 16.6 1.6 1.6 20.5 11.2 2.9 14.7 12.7 3.6 7.2 2.7 12.5 10.2 7.8 15.6 9.8 15.6 18.2 12.3 14.2 7.3 8.5 19.2 7.3 5.9 33.5 7.9 5.3 4.0 11.3 11.8 4.9 7.9 10.7 24.7 11.5 17.8 6.8 24.5 23.1 28.1 0.0 0.4 0.0 1.0 0.0 1.6 0.3 0.6 0.4 0.5 0.2 0.2 0.2 0.0 0.0 0.0 3.2 1.4 0.2 7.0 7.1 13.0 12.7 7.6 8.0 5.8 7.9 6.6 3.4 0.0 6.7 3.0 1.7 1.3 39.8 2.3 0.0 14.7 6.8 0.0 0.0 2.0 0.0 2.3 2.1 1.9 0.0 0.0 2.1 1.6 0.9 5.1 1.1 0.0 1.7 25.4 2.4 0.0 6.2 3.8 0.6 2.0 0.0 10.0 1.2 1.4 2.9 0.0 2.5 0.0 1.8 0.0 2.7 3.2 0.9 1.3 8.1 2.5 0.5 4.6 LRPAP1 "A2MRAP, HBP44, RAP" ENSG00000163956 "LDL receptor related protein associated protein 1" P30533 4 3506376-3532559 "Disease related genes, Predicted intracellular proteins" Heparin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 500.6;Syncytiotrophoblasts: 580.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008001, CAB025518" Enhanced Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "CAB025518: , HPA008001: AB_1853292" "unprognostic (3.20e-3)" "unprognostic (7.01e-2)" "unprognostic (2.30e-1)" "unprognostic (2.22e-2)" "unprognostic (1.37e-2)" "unprognostic (9.61e-2)" "unprognostic (1.01e-2)" "unprognostic (3.89e-3)" "unprognostic (8.58e-2)" "unprognostic (6.12e-2)" "unprognostic (2.14e-3)" "unprognostic (2.19e-1)" "prognostic favorable (4.67e-11)" "unprognostic (6.25e-2)" "unprognostic (1.56e-1)" "unprognostic (2.58e-1)" "unprognostic (5.61e-2)" 9.4 11.3 13.7 8.7 34.4 17.4 8.5 11.4 22.1 10.1 9.3 9.1 15.5 10.6 11.1 16.7 7.2 10.5 11.2 28.1 11.6 13.1 17.7 16.5 10.8 9.9 10.6 14.5 13.2 28.8 20.0 18.1 35.2 9.9 11.2 7.6 11.5 23.0 18.9 12.5 10.9 10.3 8.4 7.2 10.9 10.7 10.9 12.0 4.8 11.6 6.9 6.5 8.6 8.0 6.2 8.8 37.7 15.9 7.3 7.1 15.1 4.3 9.1 6.6 9.6 9.3 4.9 14.2 7.1 8.1 6.4 5.2 17.9 8.7 2.3 7.5 6.8 8.8 7.0 4.2 7.6 3.8 1.8 9.9 3.2 9.1 11.8 5.8 5.3 15.3 6.2 5.9 5.1 2.8 6.1 7.9 4.5 5.8 8.9 5.6 7.0 3.4 20.3 5.5 6.5 9.5 4.6 5.1 8.5 7.0 9.9 6.0 5.3 8.7 3.6 9.2 4.4 7.8 9.8 6.4 6.2 5.8 4.8 9.2 5.0 3.3 3.2 7.4 15.7 8.4 11.2 15.9 37.7 6.5 12.5 5.6 6.2 6.0 6.1 8.8 5.9 6.7 6.1 13.3 7.3 11.4 6.6 7.1 15.1 13.7 34.4 11.4 22.1 11.6 13.1 10.6 14.5 9.9 12.0 101.3 71.8 70.1 148.3 60.2 64.5 138.2 94.3 111.1 83.0 184.9 43.2 500.6 43.1 137.9 29.8 84.7 141.2 0.0 93.8 144.8 164.2 115.9 79.6 88.4 225.9 36.5 79.3 47.9 91.5 43.0 116.8 129.5 140.0 128.0 72.2 127.1 91.5 101.7 142.5 235.8 70.5 77.6 128.1 198.2 166.9 53.6 580.0 69.2 81.2 127.8 LRRC15 LIB ENSG00000172061 "Leucine rich repeat containing 15" Q8TF66 3 194355247-194369743 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 48.1" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 1.6;Suprabasal keratinocytes: 1.3" "Cancer enhanced" "Detected in many" "breast cancer: 25.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 48.9;U-138 MG: 9.5;U-87 MG: 26.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA035503 Uncertain Approved "Vesicles,Plasma membrane" NA NA 1800000 Vesicles "Plasma membrane" "HPA035503: AB_10961253" "unprognostic (3.20e-2)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (3.53e-2)" "unprognostic (3.97e-2)" "unprognostic (1.88e-3)" "unprognostic (1.22e-8)" "unprognostic (5.81e-2)" "unprognostic (1.11e-1)" "unprognostic (5.62e-3)" "unprognostic (7.54e-3)" 3.3 0.5 0.5 3.1 0.6 0.0 5.3 0.5 0.5 4.6 2.1 0.2 0.0 0.4 3.5 0.3 1.0 1.3 2.0 1.8 0.5 0.5 0.5 0.5 2.5 0.8 0.5 0.0 3.1 0.8 0.0 0.5 48.1 0.3 0.6 4.2 0.7 1.6 0.0 1.0 9.1 0.8 0.7 0.5 1.3 1.9 0.9 0.0 1.1 1.8 7.7 7.7 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.4 48.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.5 1.6 1.2 0.0 0.0 0.0 0.0 26.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 LRRC19 FLJ21302 ENSG00000184434 "Leucine rich repeat containing 19" Q9H756 9 26993136-27005693 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "intestine: 61.3;kidney: 50.0" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 22.7;Enterocytes: 78.3;Paneth cells: 39.5;Proximal tubular cells: 50.0;Undifferentiated cells: 24.0" "Group enriched" "Detected in some" 5 "colorectal cancer: 6.0;renal cancer: 5.8;stomach cancer: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 2.4;RPTEC TERT1: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 96000 "unprognostic (2.27e-2)" "unprognostic (1.19e-1)" "unprognostic (5.23e-2)" "unprognostic (6.30e-2)" "unprognostic (5.20e-2)" "unprognostic (2.30e-1)" "unprognostic (4.05e-2)" "unprognostic (1.85e-2)" "unprognostic (4.16e-2)" "unprognostic (9.21e-5)" "unprognostic (1.87e-2)" "unprognostic (4.48e-2)" "prognostic favorable (7.08e-8)" "unprognostic (2.46e-2)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (3.32e-2)" 0.2 0.2 0.2 5.9 0.2 0.0 0.2 0.2 0.2 0.2 23.4 0.1 0.1 11.9 0.2 1.3 0.2 0.2 2.9 0.1 0.2 0.2 50.0 0.8 0.2 0.1 0.2 0.1 0.2 0.6 0.0 0.2 0.1 0.1 0.2 17.0 0.1 0.2 0.1 0.1 0.2 61.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.2 2.0 0.9 1.1 0.7 0.4 0.8 0.0 2.4 0.6 0.3 0.4 0.0 0.4 0.9 0.7 0.0 0.0 0.0 0.6 0.3 0.3 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.3 0.6 1.0 0.5 0.0 0.6 0.8 0.1 0.5 0.0 0.3 1.0 0.0 0.2 0.3 1.0 0.0 0.3 0.5 1.5 1.7 0.3 1.1 0.5 0.5 0.6 4.2 0.4 0.6 0.3 1.7 0.3 0.1 0.6 0.3 0.5 1.2 0.8 0.4 1.6 0.5 0.3 0.3 0.1 0.2 0.6 0.2 1.0 0.7 0.6 0.5 0.6 0.4 0.6 0.8 0.4 0.5 2.0 0.8 0.7 1.1 0.4 0.6 0.9 0.6 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.4 0.4 20.4 0.0 0.0 22.7 0.0 0.0 8.3 0.1 0.0 0.0 78.3 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.1 0.1 39.5 0.4 50.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 LRRC24 LRRC14OS ENSG00000254402 "Leucine rich repeat containing 24" Q50LG9 8 144522377-144527032 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.9" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 100.1;Cone photoreceptor cells: 68.7;Late spermatids: 50.7;Rod photoreceptor cells: 63.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 4.2;SCLC-21H: 4.5;SH-SY5Y: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028171, HPA052250" Enhanced Approved Vesicles NA NA Vesicles "HPA028171: AB_2672504, HPA052250: AB_2681774" "unprognostic (1.75e-1)" "unprognostic (5.76e-2)" "unprognostic (2.33e-3)" "unprognostic (3.63e-2)" 2.5 4.0 5.1 1.4 9.3 1.7 1.5 12.3 16.9 2.3 2.1 1.6 0.6 2.0 2.5 1.7 1.7 2.8 1.3 1.5 4.5 7.9 2.2 1.6 2.0 1.4 4.5 8.4 4.5 3.2 9.3 8.4 1.5 5.9 11.4 1.1 10.3 2.8 3.2 2.3 1.7 2.0 1.6 2.1 2.2 1.9 1.5 1.3 0.6 1.6 1.0 1.1 1.4 1.6 0.0 0.5 0.0 0.1 0.1 0.5 0.0 0.4 0.8 0.6 1.6 0.8 0.5 1.8 0.5 0.6 0.7 0.6 0.2 1.6 0.8 3.5 0.2 0.3 0.1 0.0 0.0 0.1 1.2 2.3 0.5 1.0 0.3 0.6 0.0 1.0 0.7 0.4 0.5 0.1 0.4 0.3 0.9 0.9 0.1 0.1 4.2 1.2 1.7 0.2 0.2 0.8 1.8 0.1 0.6 0.1 0.5 4.5 12.4 0.4 0.1 0.4 0.0 3.8 1.3 0.0 0.1 1.2 0.5 0.2 1.0 0.1 0.1 0.6 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 9.3 12.3 16.9 4.5 7.9 4.5 8.4 5.9 1.3 0.0 2.9 0.0 0.5 0.8 100.1 0.0 2.5 0.0 1.2 1.8 68.7 0.4 3.3 0.2 19.3 0.0 1.8 0.0 0.2 0.4 0.8 1.5 0.0 2.4 0.4 28.6 10.3 0.0 1.5 50.7 2.6 0.8 5.0 0.0 1.7 12.1 0.4 1.9 2.8 3.0 63.8 0.0 1.4 4.8 2.9 0.4 0.3 0.0 1.6 0.5 LRRC25 "FLJ38116, MAPA" ENSG00000175489 "Leucine rich repeat containing 25" Q8N386 19 18391144-18397617 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 79.9;lymphoid tissue: 50.7" "Group enriched" "Detected in some" 6 "Hofbauer cells: 45.4;Kupffer cells: 107.3;Macrophages: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "classical monocyte: 37.6;eosinophil: 41.2;intermediate monocyte: 61.8;myeloid DC: 27.9;neutrophil: 70.3;non-classical monocyte: 79.9" "Group enriched" "Detected in many" 50 "dendritic cells: 27.9;granulocytes: 70.3;monocytes: 79.9" "Cell line enhanced" "Detected in some" "HMC-1: 5.2;THP-1: 4.8;U-937: 3.9" "Low region specificity" "Detected in all" HPA029459 Approved NA NA 250000 "HPA029459: AB_10610005" "unprognostic (2.72e-2)" "unprognostic (6.08e-2)" "unprognostic (1.76e-2)" "unprognostic (2.07e-1)" "unprognostic (3.77e-2)" "unprognostic (9.15e-2)" "unprognostic (5.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.20e-2)" "unprognostic (4.63e-2)" "unprognostic (2.02e-1)" "unprognostic (1.73e-1)" "unprognostic (1.19e-3)" "unprognostic (5.77e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (1.74e-1)" "unprognostic (1.14e-1)" 12.7 7.0 2.1 14.6 3.0 19.5 5.2 0.6 1.2 1.6 3.4 2.7 0.4 2.3 1.6 5.4 1.5 3.4 3.5 6.4 1.6 1.3 4.1 10.0 10.5 30.7 2.6 0.4 3.2 1.7 0.1 1.3 5.5 2.5 3.5 1.7 2.7 2.5 0.6 2.0 1.1 3.9 4.3 2.7 50.7 2.1 2.2 1.7 2.5 1.4 0.6 3.0 4.5 2.8 1.1 27.9 70.3 79.9 0.6 0.2 21.2 0.2 0.0 0.3 0.4 0.1 0.2 0.7 0.3 0.3 0.1 0.3 0.4 0.5 0.5 0.2 0.1 0.1 0.3 0.3 0.1 0.2 0.1 0.2 2.0 0.8 2.6 2.6 1.1 5.2 1.5 0.1 0.0 0.1 0.7 0.0 0.2 0.2 1.4 0.0 0.5 0.1 1.2 0.7 0.2 0.1 0.2 0.1 1.3 0.3 0.1 0.2 0.2 0.0 0.1 0.3 0.2 0.5 4.8 1.1 0.6 0.4 0.4 0.3 0.3 0.2 0.2 0.6 3.9 0.2 5.8 37.6 41.2 0.1 61.8 0.2 0.9 0.0 0.1 27.9 1.1 0.0 0.0 70.3 0.6 79.9 3.9 0.1 21.2 2.1 3.0 0.6 1.2 1.6 1.3 2.6 0.4 2.5 1.7 0.0 2.2 9.7 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.1 5.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.4 0.0 10.3 0.4 45.4 0.0 0.0 2.5 107.3 0.0 0.0 46.0 1.7 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.1 LRRC26 bA350O14.10 ENSG00000184709 "Leucine rich repeat containing 26" Q2I0M4 9 137168758-137170051 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "salivary gland: 173.1" "Cell type enriched" "Detected in some" 9 "Mucus-secreting cells: 513.0" "Cancer enriched" "Detected in many" 5 "prostate cancer: 47.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 408 "plasmacytoid DC: 40.8" "Lineage enriched" "Detected in single" 408 "dendritic cells: 40.8" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 52.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA056312 Approved Supported "Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoli fibrillar center" "HPA056312: AB_2683098" "unprognostic (1.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.04e-2)" "prognostic favorable (4.82e-6)" "unprognostic (3.39e-1)" "unprognostic (1.67e-2)" "unprognostic (1.82e-1)" "unprognostic (2.13e-2)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "prognostic favorable (3.48e-4)" "unprognostic (3.27e-1)" "unprognostic (2.29e-1)" 0.1 0.0 0.0 1.3 0.0 0.0 2.1 0.7 0.1 0.3 6.8 0.0 11.2 1.2 0.3 0.1 0.7 0.3 0.4 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 15.4 0.4 0.0 173.1 20.0 0.0 1.3 4.0 0.0 0.0 0.1 1.0 0.0 0.0 0.7 0.0 10.3 4.6 0.0 0.1 0.0 40.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.3 8.7 0.0 52.8 0.0 0.0 0.4 0.1 0.2 2.6 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 13.9 0.0 0.4 0.0 0.1 45.8 0.0 0.0 0.1 0.0 8.6 0.0 0.0 0.6 0.0 0.0 54.0 1.0 513.0 0.0 0.2 12.5 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.3 0.0 0.0 16.2 3.3 LRRC3 C21orf102 ENSG00000160233 "Leucine rich repeat containing 3" Q9BY71 21 44455486-44462196 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 35.3;liver: 19.1" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 26.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 11.2;U-2 OS: 8.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017975 Uncertain NA NA "HPA017975: AB_1853307" "unprognostic (1.36e-2)" "unprognostic (5.48e-3)" "unprognostic (1.49e-2)" "unprognostic (2.10e-4)" "unprognostic (1.55e-1)" "unprognostic (1.74e-2)" "unprognostic (7.20e-3)" "unprognostic (2.59e-1)" "unprognostic (4.61e-1)" "unprognostic (7.43e-2)" "unprognostic (1.37e-1)" "unprognostic (1.38e-2)" "unprognostic (1.74e-5)" "unprognostic (6.44e-2)" "unprognostic (2.01e-1)" "unprognostic (7.51e-2)" "unprognostic (6.66e-3)" 3.7 2.7 1.1 2.5 1.6 1.0 3.9 0.3 1.0 4.5 7.6 1.1 2.5 3.1 2.1 3.3 3.7 1.9 35.3 2.8 1.2 1.4 1.1 19.1 3.8 3.7 0.5 0.2 5.7 2.3 0.1 2.0 1.8 0.9 4.1 1.6 2.1 2.6 1.3 1.0 3.3 3.0 5.2 0.8 1.9 5.4 5.4 0.0 2.2 1.0 2.2 1.6 4.5 5.8 0.9 0.5 2.1 0.8 0.5 1.1 0.1 0.7 0.5 4.5 3.7 0.0 0.0 11.2 1.9 0.0 0.2 0.0 1.7 1.5 0.0 3.4 0.9 2.5 0.2 2.1 0.0 0.1 0.3 4.9 0.0 0.5 5.0 0.8 0.0 2.9 1.4 1.8 0.0 0.0 0.0 1.8 0.7 0.4 5.7 0.0 1.6 0.7 0.2 1.2 5.5 1.8 2.4 0.0 1.8 0.1 0.2 3.7 4.1 1.7 0.3 0.7 2.6 1.1 2.3 3.5 0.0 8.4 0.0 0.0 3.2 6.2 0.0 0.0 2.0 0.6 1.8 0.8 0.2 0.3 0.7 1.1 0.6 0.5 0.2 0.3 0.9 0.4 0.4 2.1 0.5 0.6 0.5 0.2 0.1 1.1 1.6 0.3 1.0 1.2 1.4 0.5 0.2 0.9 0.0 0.0 1.0 1.4 0.5 0.6 0.7 1.5 2.5 0.0 0.0 1.8 0.0 0.2 0.0 0.4 0.2 0.2 1.3 0.0 0.3 4.7 1.3 1.1 1.1 26.8 2.2 0.0 4.1 0.0 2.1 1.4 0.6 1.1 0.0 5.4 2.2 1.5 1.2 0.0 0.7 0.0 0.0 0.0 1.0 0.5 1.3 0.5 0.2 0.0 1.5 0.7 LRRC32 "D11S833E, GARP" ENSG00000137507 "Leucine rich repeat containing 32" Q14392 11 76657524-76670747 "Predicted intracellular proteins, Predicted membrane proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 91.0;Extravillous trophoblasts: 149.6;Fibroblasts: 48.9;Ito cells: 70.6;Sertoli cells: 38.8;Smooth muscle cells: 74.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "neutrophil: 1.0;T-reg: 3.1" "Group enriched" "Detected in many" 7 "granulocytes: 1.0;T-cells: 3.1" "Group enriched" "Detected in some" 6 "ASC diff: 42.0;ASC TERT1: 25.9;HSkMC: 16.1;HUVEC TERT2: 18.2;U-2197: 38.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA055775, HPA058434" Enhanced Nucleoplasm "Intracellular and membrane" NA NA 19000 Nucleoplasm "HPA055775: AB_2732600, HPA058434: AB_2732622" "unprognostic (3.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (4.19e-3)" "unprognostic (1.16e-1)" "unprognostic (8.84e-2)" "unprognostic (1.39e-2)" "unprognostic (2.24e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.58e-1)" "unprognostic (9.86e-2)" "prognostic unfavorable (3.93e-5)" "unprognostic (7.99e-3)" "unprognostic (1.15e-2)" "unprognostic (5.22e-3)" "prognostic unfavorable (2.64e-4)" 50.5 16.5 5.4 8.0 11.3 1.9 35.1 4.6 9.1 19.8 12.4 4.4 3.5 7.0 15.2 10.4 11.1 10.8 22.6 18.0 7.6 3.5 19.5 8.5 51.8 4.7 10.2 4.3 19.9 8.7 7.9 7.0 40.5 10.1 12.6 5.1 16.6 5.2 9.4 29.0 9.9 7.7 13.0 5.7 21.2 8.1 8.6 8.7 0.6 16.6 9.7 2.1 19.8 25.1 0.2 0.0 1.0 0.0 0.0 3.1 9.6 0.0 0.0 0.4 0.0 42.0 25.9 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.2 0.0 0.8 0.0 0.0 16.1 0.0 1.4 0.0 0.3 18.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 4.8 2.7 0.3 38.6 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 3.1 9.6 5.4 11.3 4.6 9.1 7.6 3.5 10.2 4.3 10.1 8.7 0.0 7.0 3.4 0.2 12.9 0.0 3.4 0.0 1.4 2.3 0.0 0.0 1.3 0.0 0.1 1.3 91.0 0.0 0.0 0.0 149.6 48.9 1.2 2.3 0.8 3.3 0.0 0.0 70.6 4.4 1.1 8.3 5.2 16.9 0.0 0.2 0.4 0.0 2.9 8.5 0.1 0.0 38.8 74.8 0.5 2.7 10.9 7.0 1.3 0.0 1.1 LRRC37A KIAA0563 ENSG00000176681 "Leucine rich repeat containing 37A" A6NMS7 17 46292733-46337794 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 9.4;testis: 15.2" "Cell type enriched" "Detected in some" 5 "Early spermatids: 18.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 8.0" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.22e-2)" "unprognostic (3.75e-2)" "unprognostic (6.02e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-2)" "unprognostic (5.23e-2)" "unprognostic (5.20e-2)" "unprognostic (8.22e-2)" "unprognostic (2.05e-1)" "unprognostic (2.65e-3)" "unprognostic (3.37e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-2)" "unprognostic (4.30e-2)" 0.9 0.4 1.4 2.0 1.8 1.4 1.7 2.6 1.7 0.7 0.9 0.5 1.1 0.4 1.1 1.0 0.5 1.1 1.5 1.2 0.9 0.6 0.9 1.5 0.6 1.2 0.9 0.5 2.1 0.7 1.3 1.0 1.0 0.9 9.4 1.8 1.3 0.6 0.8 1.2 0.8 15.2 1.2 0.9 1.1 1.1 1.4 1.7 2.1 1.4 2.1 1.5 0.2 0.2 0.2 1.6 0.2 0.3 0.0 0.5 0.1 0.4 0.1 0.2 3.6 0.3 8.0 0.3 0.3 2.5 0.3 0.0 0.0 0.0 0.5 1.2 0.4 4.0 2.7 0.6 0.0 0.2 0.0 1.0 0.0 0.0 0.2 0.5 0.3 0.2 0.6 0.9 0.0 0.3 0.7 1.2 0.0 0.0 2.7 2.9 1.8 0.0 1.9 0.5 1.1 0.2 0.6 0.1 0.0 0.5 3.6 1.2 1.4 2.4 0.4 0.2 3.6 2.5 0.5 1.3 2.4 2.3 2.1 1.1 1.0 1.0 1.0 0.9 0.8 0.8 1.5 1.1 1.4 1.3 1.1 1.9 2.1 1.4 1.7 1.0 0.2 3.0 0.3 0.0 0.3 0.1 0.6 3.6 0.0 1.4 0.0 0.0 0.0 0.1 1.7 0.2 18.2 0.0 1.3 0.0 0.4 0.0 0.2 0.1 1.1 0.0 0.3 0.0 1.2 0.0 2.7 1.0 0.0 0.4 0.0 0.0 1.1 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.7 0.2 0.1 0.1 0.5 1.0 0.0 LRRC37A2 FLJ45049 ENSG00000238083 "Leucine rich repeat containing 37 member A2" A6NM11 17 46511511-46555650 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.5" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 20.8;Early spermatids: 32.7" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "eosinophil: 2.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.9" "Cell line enhanced" "Detected in some" "Daudi: 4.0;THP-1: 4.3;U-138 MG: 2.5" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624" "unprognostic (1.59e-2)" "unprognostic (3.75e-2)" "unprognostic (8.96e-2)" "unprognostic (6.35e-2)" "unprognostic (2.53e-1)" "unprognostic (2.97e-3)" "unprognostic (4.61e-3)" "unprognostic (1.63e-1)" "unprognostic (6.47e-2)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (8.00e-2)" "unprognostic (3.02e-7)" "unprognostic (8.40e-2)" "unprognostic (2.82e-1)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" 0.5 0.0 0.3 0.4 0.7 0.9 0.8 0.9 0.4 0.1 0.4 0.0 0.2 0.1 0.5 0.3 0.0 0.1 0.4 0.4 0.5 0.4 0.7 0.5 0.1 0.3 0.1 0.1 1.2 0.1 0.4 0.9 0.4 0.7 0.6 0.9 0.4 0.5 0.2 0.0 0.5 13.5 0.4 0.5 0.6 0.3 0.2 0.3 2.9 0.1 0.1 0.4 0.0 0.5 0.7 0.4 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.9 0.0 4.0 0.1 0.3 0.8 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.9 0.5 0.7 0.0 0.0 0.0 0.8 0.0 0.3 0.0 2.0 0.1 0.0 0.8 2.0 0.0 0.3 0.1 0.2 0.0 0.1 1.8 0.8 0.4 0.0 1.4 0.2 0.4 0.3 0.0 0.3 0.0 1.4 4.3 0.8 2.5 1.9 0.0 0.8 1.4 1.1 0.5 0.2 1.0 1.6 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 20.8 10.5 0.8 3.8 1.3 7.1 2.0 2.5 14.7 7.9 0.0 11.8 1.0 0.0 1.9 32.7 1.9 1.0 0.0 0.8 0.8 1.9 1.9 10.5 0.4 1.2 12.7 1.7 1.3 1.5 7.5 3.1 3.2 0.0 0.0 1.7 2.8 0.9 1.4 1.8 0.3 8.4 12.9 2.0 6.8 2.5 1.9 0.6 4.4 1.0 2.7 LRRC37A3 "FLJ34306, KIAA0563" ENSG00000176809 "Leucine rich repeat containing 37 member A3" O60309 17 64854312-64919480 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 23.2;Horizontal cells: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA042121, HPA043056, HPA045090" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211" "unprognostic (2.28e-1)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (4.73e-2)" "unprognostic (2.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.84e-2)" "unprognostic (2.27e-1)" "unprognostic (3.29e-1)" "unprognostic (1.80e-2)" "unprognostic (5.31e-6)" "unprognostic (1.83e-1)" "prognostic unfavorable (3.25e-6)" "unprognostic (2.26e-1)" "unprognostic (4.89e-2)" "unprognostic (5.18e-2)" "unprognostic (7.43e-3)" 4.4 6.6 14.8 5.5 14.0 6.2 8.8 27.9 16.0 4.3 3.6 7.4 5.4 3.2 6.9 16.0 3.9 7.8 6.8 3.8 15.1 15.0 15.7 3.4 4.8 4.3 12.8 7.2 8.4 5.2 5.7 18.8 4.6 12.1 6.7 4.0 8.3 4.3 6.2 6.4 7.1 4.0 4.2 6.6 4.6 4.2 25.8 12.6 7.3 14.3 0.3 3.1 4.6 10.0 2.3 2.3 5.3 1.0 3.1 1.2 0.3 2.3 4.5 4.4 9.8 4.9 3.1 3.1 3.2 2.6 2.4 2.5 2.0 3.4 2.3 1.5 1.6 3.9 1.9 1.2 0.9 1.0 3.0 4.4 7.1 2.7 1.4 2.0 2.7 1.8 2.1 1.7 1.6 0.7 9.9 1.6 3.0 1.4 1.3 1.6 6.1 1.3 4.6 3.4 0.5 1.3 1.5 2.3 1.0 5.0 2.1 2.9 11.0 1.2 5.6 1.3 13.1 2.5 4.9 5.3 4.0 1.3 1.6 1.7 1.9 1.8 1.8 2.8 11.3 6.8 5.3 0.4 0.7 0.7 0.7 0.8 0.6 1.0 0.4 0.6 2.3 1.2 1.1 2.0 3.1 1.0 2.3 0.9 0.3 14.8 14.0 27.9 16.0 15.1 15.0 12.8 7.2 12.1 12.6 0.0 2.1 1.4 1.8 1.5 10.2 2.1 0.0 9.4 2.3 1.8 3.9 1.1 1.7 1.8 23.2 2.6 1.2 0.0 1.2 0.1 1.6 1.7 2.3 0.8 1.4 23.8 1.2 3.7 1.9 5.6 2.0 0.8 1.7 1.8 0.8 4.3 0.7 1.4 2.8 5.1 3.6 6.5 1.2 6.0 1.7 0.9 0.8 1.3 0.6 1.4 LRRC37B ENSG00000185158 "Leucine rich repeat containing 37B" Q96QE4 17 32007872-32053504 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.5" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 71.2;Spermatocytes: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 2.8;NK-cells: 6.4;T-cells: 4.9" "Low cell line specificity" "Detected in all" HPA015135 Approved Approved Cytosol NA NA Cytosol "HPA015135: AB_1853309" "unprognostic (5.46e-3)" "unprognostic (2.56e-2)" "unprognostic (5.08e-2)" "unprognostic (5.30e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-1)" "unprognostic (3.60e-2)" "unprognostic (9.65e-3)" "unprognostic (5.06e-2)" "unprognostic (3.19e-2)" "unprognostic (1.72e-4)" "unprognostic (6.99e-2)" "unprognostic (5.72e-3)" "unprognostic (6.94e-2)" "unprognostic (3.35e-2)" "unprognostic (4.97e-2)" "unprognostic (1.36e-3)" 4.7 5.0 13.7 4.8 15.0 28.5 6.4 35.5 14.4 5.9 5.2 7.2 5.0 4.5 8.3 6.5 4.6 8.2 4.8 2.7 10.7 8.5 3.7 3.0 6.7 5.5 8.6 10.2 12.1 4.3 7.4 13.8 4.6 8.9 5.3 6.4 6.1 6.5 4.2 3.5 11.7 6.3 7.2 8.5 7.6 6.6 24.5 10.3 8.3 4.4 1.8 5.8 5.3 10.2 0.8 1.1 2.8 0.5 6.4 4.9 0.5 2.1 3.9 12.5 7.1 3.2 4.0 3.9 1.9 7.1 5.5 7.1 5.4 2.1 5.6 4.0 4.3 6.9 2.8 7.4 1.5 4.4 1.6 6.3 2.6 5.8 2.0 4.7 10.1 4.8 4.2 4.7 5.0 12.8 5.3 4.6 9.6 6.1 5.4 2.1 1.9 17.6 15.6 3.8 1.9 2.7 12.4 2.9 4.5 3.1 5.2 2.4 4.0 4.8 3.1 6.5 4.3 8.2 16.3 3.9 3.9 2.7 8.6 4.6 5.4 7.7 5.6 2.8 10.2 2.8 0.0 0.4 2.8 1.1 0.5 2.1 0.2 2.2 3.0 0.8 0.8 3.0 0.8 1.1 6.4 0.2 1.1 4.9 0.5 13.7 15.0 35.5 14.4 10.7 8.5 8.6 10.2 8.9 10.3 6.0 7.8 2.7 6.4 3.7 7.8 4.4 10.2 8.1 10.3 1.8 0.0 1.8 8.3 8.5 71.2 5.0 2.9 23.3 9.0 1.9 5.0 8.3 3.5 2.9 8.3 3.2 1.7 7.4 7.9 11.8 6.4 8.3 8.5 7.2 5.5 9.2 8.3 0.0 6.7 6.9 8.7 0.0 9.6 37.1 10.6 4.4 1.8 10.1 5.4 6.5 LRRC38 ENSG00000162494 "Leucine rich repeat containing 38" Q5VT99 1 13474977-13514048 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 16.0;skeletal muscle: 60.8" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 1.4;Cardiomyocytes: 1.9;Rod photoreceptor cells: 2.2" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 7 "cerebellum: 4.1;cerebral cortex: 3.0;pons and medulla: 1.1" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 1.8" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.8" "Cell line enhanced" "Detected in some" "EFO-21: 3.9;MOLT-4: 14.6;PC-3: 10.5;U-138 MG: 17.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038778 Approved NA NA "HPA038778: AB_10673294" "unprognostic (5.13e-2)" "unprognostic (3.98e-1)" "unprognostic (3.12e-1)" "unprognostic (3.88e-1)" "unprognostic (5.49e-2)" "unprognostic (1.45e-3)" "unprognostic (1.72e-1)" "unprognostic (2.70e-1)" "unprognostic (9.70e-2)" "unprognostic (4.23e-1)" "unprognostic (7.81e-2)" "unprognostic (4.47e-2)" "unprognostic (1.05e-1)" 0.4 16.0 0.1 0.1 0.3 0.2 0.7 4.1 3.0 0.2 0.2 0.2 0.0 0.2 0.2 1.4 0.4 0.2 0.2 1.0 0.2 0.1 0.2 0.1 0.2 0.2 0.4 0.3 0.2 0.1 0.2 0.1 0.7 1.1 0.4 0.2 0.8 0.5 0.2 60.8 0.8 0.2 0.2 6.8 0.2 0.2 0.5 0.0 5.7 0.2 10.0 0.3 0.2 0.5 0.1 1.8 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 10.5 0.0 0.1 1.6 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 17.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.1 0.3 4.1 3.0 0.2 0.1 0.4 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 LRRC3B LRP15 ENSG00000179796 "Leucine rich repeat containing 3B" Q96PB8 3 26622806-26710776 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 21.3;skeletal muscle: 17.4;testis: 12.0" "Cell type enriched" "Detected in some" 28 "Early spermatids: 56.9" "Group enriched" "Detected in some" 9 "endometrial cancer: 0.7;glioma: 2.6;ovarian cancer: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 3.8;REH: 1.8;SuSa: 9.0;THP-1: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015568 Approved NA NA "HPA015568: AB_1853282" "unprognostic (1.22e-2)" "unprognostic (2.94e-1)" "unprognostic (1.87e-1)" "unprognostic (7.42e-2)" "unprognostic (8.82e-4)" "unprognostic (2.84e-2)" "unprognostic (1.55e-1)" "unprognostic (2.77e-1)" "unprognostic (1.91e-4)" "unprognostic (3.31e-2)" "unprognostic (2.63e-1)" "unprognostic (1.60e-1)" "unprognostic (2.82e-1)" 0.8 0.9 15.5 0.7 13.6 0.6 1.6 18.5 21.3 0.8 1.2 2.2 0.0 0.8 2.3 0.7 1.5 1.6 0.7 1.4 9.5 7.3 0.8 0.8 0.8 0.6 8.7 5.6 2.9 0.6 0.7 0.8 0.7 5.7 0.8 1.9 3.0 1.9 1.1 17.4 0.7 1.2 2.0 4.9 0.8 1.5 12.0 1.7 0.0 0.7 0.1 0.7 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 3.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.5 13.6 18.5 10.1 9.5 7.3 8.7 5.6 5.7 1.7 0.0 0.0 0.0 0.0 0.1 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.7 0.5 0.1 0.0 0.0 0.0 0.0 LRRC3C ENSG00000204913 "Leucine rich repeat containing 3C" A6NJW4 17 39941474-39944747 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "parathyroid gland: 1.9;testis: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HDLM-2: 2.2;Karpas-707: 3.9;U-266/70: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA071271 Uncertain NA NA "HPA071271: AB_2686378" "unprognostic (1.59e-1)" "unprognostic (6.57e-2)" "unprognostic (6.17e-2)" "unprognostic (2.81e-1)" "unprognostic (3.16e-4)" "unprognostic (9.20e-2)" "unprognostic (4.27e-1)" "unprognostic (6.00e-2)" "unprognostic (1.24e-1)" "unprognostic (2.14e-1)" "unprognostic (1.90e-2)" 0.2 0.0 0.3 0.3 0.2 0.1 0.2 0.0 0.2 0.6 0.1 0.0 0.4 0.3 0.0 0.8 0.0 0.6 0.2 0.0 0.2 0.5 0.2 0.0 0.1 0.3 0.1 1.9 0.0 0.0 0.4 0.0 0.3 0.2 0.1 0.4 0.1 0.1 0.2 0.0 0.2 3.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.4 0.1 0.0 0.2 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC4 NAG14 ENSG00000128594 "Leucine rich repeat containing 4" Q9HBW1 7 128027071-128032107 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 57.6;Club cells: 43.3;Horizontal cells: 52.4;Rod photoreceptor cells: 40.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 14.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 14.3" "Group enriched" "Detected in some" 6 "AF22: 10.7;NTERA-2: 23.8;REH: 21.9;SCLC-21H: 12.2;SH-SY5Y: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051100 Approved "Golgi apparatus" NA NA 1100000 "Golgi apparatus" "HPA051100: AB_2797241" "unprognostic (7.98e-2)" "unprognostic (6.15e-3)" "unprognostic (2.85e-2)" "prognostic favorable (8.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.34e-3)" "unprognostic (3.43e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (7.63e-2)" "unprognostic (3.23e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.98e-4)" "unprognostic (4.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-1)" "unprognostic (5.84e-3)" 2.6 7.7 11.6 2.9 13.1 10.0 0.8 22.3 33.2 2.3 1.1 3.2 0.7 0.9 3.4 0.5 4.0 7.3 3.4 2.0 10.1 6.6 4.6 2.2 6.3 1.9 5.1 15.5 5.5 0.6 8.6 1.5 4.7 3.1 0.9 0.8 1.7 1.5 3.5 1.0 0.5 1.0 1.9 3.4 4.7 1.5 6.3 2.9 0.8 0.8 3.6 2.4 1.5 2.0 0.0 0.0 14.3 0.6 0.0 0.1 0.1 0.0 0.1 10.7 0.0 0.4 0.0 0.0 0.6 0.0 0.9 0.3 0.0 0.0 0.0 0.8 0.9 0.0 1.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.1 0.0 23.8 0.0 0.0 21.9 0.0 0.2 0.1 0.0 12.2 7.6 0.0 0.0 0.9 1.8 0.0 2.4 0.3 0.7 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.0 1.5 0.5 0.3 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.3 0.0 0.6 0.0 0.0 0.1 11.6 13.1 22.3 28.4 10.1 6.6 5.1 15.5 3.1 2.9 14.9 14.7 0.0 1.1 0.1 12.7 1.1 0.0 57.6 43.3 1.8 25.5 0.1 0.0 0.0 4.3 1.6 0.0 0.0 0.0 0.2 0.4 2.5 1.1 0.0 14.9 52.4 0.0 15.4 7.6 0.0 0.0 0.6 1.7 0.0 0.0 1.2 0.0 0.0 0.7 0.3 40.6 0.0 0.4 4.7 4.8 0.0 0.3 0.0 0.1 16.9 LRRC4B "DKFZp761A179, HSM, LRIG4" ENSG00000131409 "Leucine rich repeat containing 4B" Q9NT99 19 50516892-50568045 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.9" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 18.8;Horizontal cells: 9.5;Peritubular cells: 4.2;Spermatogonia: 5.3" "Group enriched" "Detected in many" 9 "glioma: 36.5;testis cancer: 9.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 6.0;HMC-1: 22.2;REH: 6.1;SH-SY5Y: 19.4;U-2 OS: 18.2;WM-115: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058986 Uncertain NA NA 2300000 "HPA058986: AB_2683871" "unprognostic (1.52e-2)" "unprognostic (1.14e-1)" "unprognostic (4.46e-2)" "unprognostic (4.48e-2)" "unprognostic (3.56e-1)" "unprognostic (5.39e-4)" "unprognostic (2.70e-2)" "unprognostic (1.11e-1)" "unprognostic (5.28e-2)" "unprognostic (4.61e-3)" "unprognostic (1.11e-3)" "unprognostic (3.41e-1)" "unprognostic (3.15e-5)" "unprognostic (4.29e-2)" "unprognostic (2.61e-1)" "unprognostic (3.64e-1)" "unprognostic (2.17e-1)" 3.0 8.8 28.7 2.3 24.6 1.2 1.3 21.7 52.9 13.4 2.3 4.0 0.0 2.3 9.4 1.4 3.3 3.6 2.8 2.5 23.4 22.9 1.7 1.7 3.6 2.7 17.8 20.6 2.8 1.7 1.3 8.8 6.9 12.8 2.2 1.4 2.2 2.3 2.8 1.7 1.7 3.2 3.1 15.0 1.9 2.4 2.3 8.5 0.0 1.8 0.0 1.9 3.2 3.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.5 0.1 0.1 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.3 0.0 0.6 0.1 0.0 5.7 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.0 19.4 0.0 0.0 3.8 0.1 0.0 0.2 0.0 0.0 18.2 0.0 0.0 0.4 0.0 0.0 0.1 0.2 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 28.7 24.6 21.7 31.9 23.4 22.9 17.8 20.6 12.8 8.5 0.0 0.0 0.0 0.0 0.0 18.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 9.5 0.0 1.3 0.0 1.6 2.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.2 0.0 1.0 0.0 2.1 3.9 5.3 0.0 0.1 0.0 0.0 0.0 LRRC4C "KIAA1580, NGL-1" ENSG00000148948 "Leucine rich repeat containing 4C" Q9HCJ2 11 40114203-41459773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 31.5" "Group enriched" "Detected in some" 12 "Muller glia cells: 106.3;Rod photoreceptor cells: 97.7" "Cancer enhanced" "Detected in some" "glioma: 3.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "naive B-cell: 1.7" "Lineage enriched" "Detected in single" 18 "B-cells: 1.7" "Group enriched" "Detected in some" 6 "AF22: 17.3;U-2 OS: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054800, HPA075816" Supported Approved Cytosol NA NA Cytosol "HPA054800: AB_2682603, HPA075816: " "unprognostic (4.86e-3)" "unprognostic (3.43e-2)" "unprognostic (7.62e-3)" "unprognostic (4.87e-3)" "unprognostic (6.48e-2)" "unprognostic (1.42e-1)" "unprognostic (2.84e-1)" "unprognostic (4.64e-2)" "unprognostic (1.93e-1)" "unprognostic (2.22e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-1)" "unprognostic (4.90e-13)" "unprognostic (5.05e-4)" "unprognostic (5.21e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-3)" 1.6 5.7 20.2 1.6 23.7 0.5 2.6 3.6 31.5 5.3 1.9 3.3 0.0 1.1 2.3 1.0 1.2 1.3 1.8 2.6 16.7 8.7 0.9 2.1 1.6 1.4 7.5 10.3 1.6 1.0 4.3 3.2 0.5 8.7 1.5 1.6 1.3 1.4 3.0 0.7 0.7 1.3 2.4 6.0 1.3 0.9 0.9 7.9 0.0 4.0 0.0 1.6 1.1 1.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 19.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 23.7 3.6 16.4 16.7 8.7 7.5 10.3 8.7 7.9 0.0 2.2 0.0 0.0 0.1 8.7 1.0 0.0 0.0 1.2 0.0 5.9 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.1 7.9 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 0.0 106.3 0.2 0.0 1.4 0.6 97.7 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 LRRC52 FLJ25811 ENSG00000162763 "Leucine rich repeat containing 52" Q8N7C0 1 165544007-165563961 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "testis: 31.9" "Cell type enriched" "Detected in some" 5 "Early spermatids: 118.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "U-937: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.09e-2)" "unprognostic (1.76e-2)" "unprognostic (6.48e-2)" "unprognostic (3.79e-2)" "unprognostic (8.45e-2)" "unprognostic (6.70e-4)" "unprognostic (6.05e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 LRRC55 FLJ45686 ENSG00000183908 "Leucine rich repeat containing 55" Q6ZSA7 11 57181747-57191717 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 9.2;lymphoid tissue: 24.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "glioma: 9.0;ovarian cancer: 2.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" "Cell line enriched" "Detected in some" 4 "AF22: 21.0" "Low region specificity" "Detected in many" HPA014053 Uncertain NA NA "HPA014053: AB_2137630" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (3.68e-2)" "unprognostic (3.03e-2)" "unprognostic (2.78e-3)" "unprognostic (2.29e-3)" "unprognostic (2.30e-1)" "unprognostic (1.43e-1)" "unprognostic (2.26e-2)" "unprognostic (3.39e-1)" "unprognostic (9.43e-2)" "unprognostic (2.11e-2)" "unprognostic (3.32e-2)" "unprognostic (7.17e-4)" "unprognostic (6.66e-2)" "unprognostic (3.59e-1)" "unprognostic (3.79e-2)" 0.8 1.0 2.2 3.4 2.3 0.0 0.1 0.8 9.2 0.1 0.9 0.4 0.1 0.6 3.1 0.1 1.2 0.7 0.6 0.5 2.7 7.3 0.6 2.5 1.5 24.4 6.9 0.5 0.6 0.4 0.0 0.1 2.9 1.7 0.1 1.0 0.1 3.4 0.1 0.6 0.1 0.9 2.2 7.3 2.6 0.1 0.2 0.1 2.2 0.2 2.1 1.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.2 2.3 0.8 3.7 2.7 7.3 6.9 0.5 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC59 "FLJ21675, PRO1855" ENSG00000108829 "Leucine rich repeat containing 59" Q96AG4 17 50375059-50397553 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030827, HPA030829" Enhanced Enhanced "Endoplasmic reticulum" NA NA 5400000 "Endoplasmic reticulum" "HPA030827: AB_10602704, HPA030829: AB_10670045" "unprognostic (4.73e-2)" "unprognostic (2.15e-2)" "prognostic favorable (2.60e-4)" "unprognostic (5.63e-3)" "unprognostic (2.80e-1)" "prognostic unfavorable (1.00e-5)" "prognostic unfavorable (3.12e-6)" "unprognostic (1.88e-3)" "unprognostic (9.95e-2)" "unprognostic (5.62e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.68e-2)" "prognostic unfavorable (1.19e-6)" "unprognostic (2.77e-1)" "unprognostic (1.44e-1)" "unprognostic (3.39e-3)" "prognostic unfavorable (1.90e-5)" 20.7 40.5 10.6 21.8 14.5 28.4 16.3 11.5 21.6 28.2 30.0 11.4 28.8 19.6 17.2 24.9 23.5 15.8 22.8 17.4 10.2 8.8 22.1 74.7 23.0 15.9 12.7 11.5 15.8 87.9 15.4 11.6 35.3 10.8 17.7 31.5 10.0 48.6 26.2 16.0 11.2 27.3 22.0 8.9 19.0 30.7 18.2 10.4 18.0 22.8 22.4 20.8 13.7 17.0 8.6 14.9 14.4 19.6 5.9 9.1 9.0 62.1 47.4 13.6 20.5 23.2 27.4 24.5 51.0 28.5 47.8 42.3 108.3 18.0 27.2 35.0 58.0 29.4 22.7 33.9 43.5 57.1 14.4 49.4 47.6 26.9 57.9 48.7 46.7 22.6 24.1 35.4 51.1 59.6 13.9 35.2 15.8 44.0 25.9 31.3 42.3 32.9 22.2 15.4 58.8 69.5 28.2 43.9 52.0 26.0 31.7 33.5 27.8 17.6 19.8 25.9 21.2 33.4 25.4 37.5 55.5 23.0 51.1 66.3 39.0 31.9 35.2 37.6 31.8 34.8 14.4 15.7 13.4 7.4 19.6 9.1 8.6 7.5 8.9 14.9 6.4 5.0 6.3 8.0 5.9 18.6 12.1 7.5 9.0 10.6 14.5 11.5 21.6 10.2 8.8 12.7 11.5 10.8 10.4 20.8 21.3 38.0 75.9 123.9 20.8 4.0 38.2 14.7 35.2 19.2 2.0 78.1 24.9 166.2 37.0 22.6 79.6 23.3 164.5 210.3 84.3 117.1 30.0 58.2 94.9 20.6 36.8 25.8 26.9 12.2 32.8 46.2 62.4 46.9 93.0 24.6 158.0 71.6 27.3 38.3 11.1 12.9 67.0 41.7 28.5 115.9 197.4 27.7 82.6 133.9 LRRC66 ENSG00000188993 "Leucine rich repeat containing 66" Q68CR7 4 51993702-52017620 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 50.2" "Cell type enhanced" "Detected in some" 23 "Enterocytes: 11.9;Mucus-secreting cells: 4.0;Paneth cells: 2.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.0;CAPAN-2: 5.1;OE19: 6.5" "Low region specificity" "Detected in all" "HPA014549, HPA027839" Uncertain NA NA "HPA014549: AB_1853062, HPA027839: AB_10602705" "unprognostic (1.10e-1)" "unprognostic (4.87e-2)" "unprognostic (8.62e-2)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.87e-1)" "unprognostic (2.57e-2)" "unprognostic (4.83e-3)" "unprognostic (2.93e-1)" "unprognostic (4.09e-3)" "unprognostic (1.61e-2)" "unprognostic (1.89e-1)" "unprognostic (6.31e-3)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (3.05e-1)" "unprognostic (4.06e-1)" 0.5 0.1 0.8 2.6 1.0 0.0 0.5 1.4 0.9 0.5 11.3 0.5 0.5 19.6 0.5 0.5 0.5 0.5 1.6 0.6 0.8 0.8 0.9 0.5 0.5 0.5 0.8 0.5 0.5 0.5 0.5 3.1 0.5 0.5 0.5 5.2 0.5 0.5 0.5 6.7 0.0 50.2 0.5 0.6 0.5 4.6 0.7 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.2 0.4 0.6 1.7 4.0 0.1 0.6 1.0 0.3 0.7 0.2 5.1 0.0 0.1 0.9 0.1 0.0 0.3 0.2 0.3 1.6 0.6 0.0 0.2 0.0 0.2 0.1 0.1 1.6 0.8 0.8 0.2 1.3 0.4 0.3 0.0 0.0 2.0 0.0 0.1 0.0 0.0 6.5 0.9 0.0 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.4 1.1 0.0 0.7 0.5 0.6 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 1.4 0.9 0.8 0.8 0.8 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 11.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.0 4.0 0.0 0.3 2.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 LRRC70 "LOC100130733, SLRN" ENSG00000186105 "Leucine rich repeat containing 70" Q7Z2Q7 5 62578735-62581448 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 25 "Endothelial cells: 1.1;granulocytes: 3.5;Ito cells: 1.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.0" "Group enriched" "Detected in many" 20 "granulocytes: 1.5;NK-cells: 3.0;T-cells: 1.3" "Group enriched" "Detected in some" 18 "HUVEC TERT2: 18.4;TIME: 9.9" "Low region specificity" "Detected in all" HPA013409 Uncertain NA NA "HPA013409: AB_10601911" "unprognostic (1.60e-1)" "unprognostic (1.27e-2)" "unprognostic (4.04e-1)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.17e-4)" "unprognostic (3.03e-1)" "unprognostic (3.77e-2)" "unprognostic (1.60e-1)" "unprognostic (2.19e-1)" "unprognostic (4.15e-1)" "unprognostic (7.40e-4)" "unprognostic (5.67e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" 18.4 1.6 1.3 3.2 2.1 5.9 18.0 0.9 2.2 9.5 4.2 0.0 3.4 1.5 5.3 2.4 5.4 4.2 6.7 4.6 2.0 1.6 10.0 5.9 3.9 5.9 1.7 0.2 5.7 2.2 2.6 4.8 9.6 2.7 6.8 2.7 2.8 2.4 1.1 2.8 4.9 3.5 6.5 3.4 25.2 2.3 4.9 1.8 3.5 10.4 4.1 1.5 6.1 17.6 0.0 0.0 1.5 0.0 3.0 1.3 0.2 0.2 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 18.4 0.3 0.2 0.8 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 9.9 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.3 0.2 1.5 3.0 0.0 0.0 0.0 0.2 1.3 2.1 0.9 2.2 2.0 1.6 1.7 0.2 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 LRRC8A "FLJ10337, KIAA1437, LRRC8, SWELL1" ENSG00000136802 "Leucine rich repeat containing 8 VRAC subunit A" Q8IWT6 9 128882112-128918039 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 147.0;Glandular cells: 170.8;Urothelial cells: 292.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 50.6" "Low region specificity" "Detected in all" NA NA "unprognostic (6.33e-2)" "unprognostic (3.88e-2)" "unprognostic (1.88e-3)" "unprognostic (2.61e-2)" "unprognostic (1.72e-1)" "unprognostic (4.38e-3)" "unprognostic (4.29e-2)" "unprognostic (1.19e-3)" "unprognostic (2.44e-1)" "unprognostic (4.80e-2)" "prognostic unfavorable (3.83e-4)" "unprognostic (3.53e-1)" "prognostic favorable (5.27e-5)" "unprognostic (3.69e-1)" "unprognostic (8.77e-2)" "unprognostic (3.93e-3)" "unprognostic (1.02e-2)" 25.8 10.6 24.3 14.2 26.8 13.4 17.8 28.5 50.4 13.8 14.0 18.5 10.9 9.0 18.8 7.4 37.9 12.4 21.1 14.5 22.6 21.0 11.6 16.4 20.3 7.7 27.2 19.5 11.4 19.0 21.3 7.4 21.8 21.1 18.4 8.2 12.1 16.2 24.8 8.0 16.0 9.5 25.8 13.0 10.5 16.7 9.2 22.6 8.4 13.5 12.0 14.3 20.9 18.7 2.5 2.8 3.2 1.9 6.1 7.4 1.7 10.5 16.6 10.1 8.6 23.7 9.2 12.7 12.2 8.1 7.6 5.4 7.3 22.7 3.8 13.8 13.2 9.5 50.6 6.2 27.0 3.6 3.9 5.0 3.4 10.7 8.8 16.1 4.1 6.4 7.1 19.2 13.4 16.1 15.4 26.2 5.4 7.6 3.9 9.9 9.1 4.6 3.9 30.0 17.7 18.1 6.4 11.6 6.2 11.9 5.3 6.0 12.6 13.6 8.5 4.8 7.9 6.2 3.1 45.8 22.3 9.6 9.4 17.7 4.5 10.6 4.7 12.3 3.1 12.8 1.2 1.4 3.2 7.4 1.9 3.4 2.5 3.7 4.7 1.8 2.0 3.7 3.6 2.6 6.1 0.5 2.8 6.1 1.7 24.3 26.8 28.5 32.6 22.6 21.0 27.2 19.5 21.1 22.6 14.9 14.1 6.0 147.0 93.9 11.9 28.4 15.3 9.4 34.2 7.0 5.9 10.4 0.0 22.5 5.2 46.3 20.4 46.7 18.3 15.3 18.4 170.8 5.8 12.4 5.3 23.8 15.4 51.0 7.6 2.2 21.3 7.4 25.3 2.8 15.4 42.9 51.7 13.9 41.8 7.3 9.7 64.7 30.8 3.3 5.1 126.8 17.4 10.9 8.8 292.5 LRRC8B "KIAA0231, TA-LRRP" ENSG00000197147 "Leucine rich repeat containing 8 VRAC subunit B" Q6P9F7 1 89524836-89597864 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 81.5;Late spermatids: 55.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017950 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA017950: AB_1853346" "unprognostic (2.50e-2)" "unprognostic (3.93e-2)" "prognostic favorable (7.15e-4)" "prognostic unfavorable (9.99e-4)" "unprognostic (1.22e-1)" "unprognostic (5.24e-2)" "unprognostic (3.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-2)" "unprognostic (1.72e-1)" "unprognostic (8.80e-3)" "unprognostic (2.30e-2)" "unprognostic (1.85e-1)" "unprognostic (4.17e-2)" "unprognostic (2.06e-1)" 8.1 18.0 13.0 4.4 19.3 3.0 6.6 2.5 27.8 3.8 5.6 15.4 0.5 7.4 2.6 6.9 5.0 4.3 6.2 3.3 15.3 6.5 4.9 4.8 5.8 4.9 8.8 17.1 2.6 8.5 12.4 5.1 2.4 8.3 5.6 6.8 4.4 5.0 1.6 5.9 6.9 4.9 3.6 16.2 4.3 6.4 17.4 8.2 3.1 6.1 2.7 5.9 3.3 3.3 3.0 2.4 1.5 2.2 0.9 3.7 1.6 8.5 3.3 2.4 8.4 12.2 7.3 9.7 0.2 2.5 1.1 1.6 5.2 5.2 0.7 3.5 1.2 3.3 4.5 22.3 1.9 1.4 4.1 4.5 16.6 2.2 4.5 1.2 7.9 11.8 4.0 7.1 0.9 3.7 0.4 11.9 6.7 18.5 5.7 1.3 4.6 3.9 3.8 13.8 3.5 4.8 8.8 1.1 3.0 2.7 10.7 7.0 11.2 4.7 11.4 8.1 3.0 6.9 3.8 3.9 1.0 5.7 2.6 2.7 4.2 3.4 4.2 1.4 2.0 2.0 1.4 2.2 1.5 1.1 1.1 1.7 3.0 2.1 1.7 2.4 2.3 3.7 2.9 0.7 0.9 1.2 2.1 3.4 1.6 13.0 19.3 2.5 27.5 15.3 6.5 8.8 17.1 8.3 8.2 14.9 11.5 5.6 11.4 29.3 34.9 3.4 12.7 20.1 14.8 7.0 45.2 2.6 1.7 12.0 81.5 8.4 5.1 0.0 16.2 9.6 1.5 17.3 2.3 6.7 6.1 0.0 25.8 19.6 13.2 55.3 2.3 7.7 1.7 3.6 13.0 5.5 12.8 3.5 2.5 4.5 21.5 6.5 14.7 6.9 4.1 24.1 2.1 2.5 11.0 8.9 LRRC8C AD158 ENSG00000171488 "Leucine rich repeat containing 8 VRAC subunit C" Q8TDW0 1 89633072-89769903 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 40.3;Endothelial cells: 39.4;Suprabasal keratinocytes: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 9.1;monocytes: 6.1;T-cells: 11.3" "Cell line enhanced" "Detected in many" "THP-1: 22.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029347 Uncertain Approved "Golgi apparatus" No No "Golgi apparatus" "HPA029347: AB_10601544" "unprognostic (2.61e-2)" "unprognostic (3.09e-2)" "unprognostic (3.83e-2)" "unprognostic (1.76e-2)" "unprognostic (3.32e-2)" "unprognostic (1.65e-2)" "unprognostic (5.02e-2)" "unprognostic (3.76e-3)" "unprognostic (4.28e-2)" "unprognostic (4.90e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (3.75e-4)" "unprognostic (2.78e-2)" "unprognostic (4.42e-2)" "unprognostic (1.94e-2)" "unprognostic (3.38e-2)" 19.8 12.6 8.3 11.7 11.4 9.2 27.8 2.0 11.0 6.6 4.8 12.9 1.4 4.5 11.9 7.3 4.4 6.0 9.2 8.2 7.8 7.4 4.5 4.8 10.4 14.8 13.0 7.6 7.8 3.0 5.8 6.9 9.0 9.0 4.5 5.5 6.4 5.0 3.2 5.9 8.3 7.7 21.3 10.8 12.1 4.5 6.4 10.2 3.4 7.6 6.1 10.3 7.5 7.5 0.8 9.1 0.9 6.1 1.9 11.3 3.3 0.1 2.0 1.7 1.5 5.1 5.8 0.8 10.6 11.9 4.8 4.5 0.0 0.7 3.2 3.0 4.6 8.3 7.2 5.5 15.8 11.8 7.9 3.3 3.1 1.7 0.1 4.2 14.1 1.0 2.5 3.2 10.5 5.6 3.2 19.5 5.1 2.0 4.4 4.1 0.3 2.0 13.9 1.8 0.0 4.3 14.1 0.8 1.1 1.0 1.7 1.3 6.0 3.9 0.3 8.8 2.7 0.1 22.2 16.3 8.6 4.1 2.9 8.0 1.6 1.3 1.7 2.7 10.6 1.4 0.4 6.1 0.0 4.2 5.5 3.7 0.8 6.7 5.5 9.1 0.5 5.4 5.0 0.9 1.9 6.1 0.7 11.3 3.3 8.3 11.4 2.0 11.0 7.8 7.4 13.0 7.6 9.0 10.2 3.0 5.1 4.7 3.0 40.3 2.5 5.2 5.1 4.0 3.4 0.0 0.0 0.1 0.0 1.5 29.1 39.4 0.0 0.0 2.2 0.4 4.0 0.9 0.0 0.0 12.1 1.6 1.2 31.3 28.6 17.3 0.0 24.5 25.3 16.2 0.2 0.4 7.7 1.9 0.7 0.6 1.3 0.0 16.5 1.4 1.7 39.3 0.2 17.5 0.2 1.7 LRRC8D "FLJ10470, LRRC5" ENSG00000171492 "Leucine rich repeat containing 8 VRAC subunit D" Q7L1W4 1 89821014-89936611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA No "unprognostic (2.92e-3)" "unprognostic (9.50e-2)" "unprognostic (1.06e-3)" "prognostic unfavorable (3.21e-5)" "unprognostic (4.98e-2)" "unprognostic (7.03e-2)" "unprognostic (7.71e-3)" "unprognostic (7.74e-2)" "unprognostic (9.67e-2)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" "unprognostic (2.77e-1)" "unprognostic (4.91e-2)" "unprognostic (9.52e-3)" "unprognostic (1.23e-1)" "unprognostic (2.65e-2)" "unprognostic (9.61e-2)" 4.4 26.3 15.7 11.0 24.0 9.6 9.7 8.8 21.3 9.7 13.1 46.2 4.3 14.1 7.7 8.1 6.7 5.9 6.0 5.5 24.5 16.9 19.8 17.6 7.1 17.0 34.7 20.3 4.6 9.6 6.8 16.2 7.5 24.5 4.3 14.0 7.5 17.8 4.6 7.8 5.0 13.6 8.6 38.5 16.8 8.3 7.5 31.6 11.8 12.1 4.3 14.8 8.9 3.4 5.8 7.8 3.0 8.8 10.5 14.3 8.4 24.7 16.2 6.6 15.6 11.9 10.1 22.5 17.0 25.7 9.7 12.2 6.9 6.3 19.6 19.4 28.2 11.0 32.7 15.2 20.4 12.3 15.3 8.4 23.0 14.7 14.6 23.3 26.2 7.3 6.3 17.0 8.2 18.0 13.4 16.4 11.4 12.5 6.2 10.5 7.4 10.8 17.0 11.5 5.6 14.9 14.7 9.6 14.0 24.4 8.8 12.4 8.7 21.1 21.9 47.0 12.0 5.2 26.1 7.2 10.4 3.5 21.1 12.8 7.6 12.9 11.8 4.0 33.1 9.1 0.0 7.1 1.2 6.2 8.8 10.3 5.8 14.3 7.4 6.8 5.3 13.8 10.2 3.0 10.5 6.6 7.8 13.8 8.4 15.7 24.0 8.8 21.3 24.5 16.9 34.7 20.3 24.5 31.6 3.0 1.7 6.5 1.5 5.4 6.1 2.1 10.2 6.7 4.5 12.2 2.0 3.5 6.6 5.0 0.6 5.8 17.1 23.3 7.4 7.9 1.8 2.0 5.7 26.3 10.8 3.2 7.5 9.2 20.6 0.0 1.1 16.3 10.1 20.8 11.2 6.5 5.7 10.5 3.5 9.7 7.1 6.5 1.4 0.1 0.6 1.0 1.5 8.7 9.8 1.4 LRRC8E FLJ23420 ENSG00000171017 "Leucine rich repeat containing 8 VRAC subunit E" Q6NSJ5 19 7888505-7902021 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 8.5;Ciliated cells: 8.1;Club cells: 6.8;Suprabasal keratinocytes: 9.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 22.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA020466 Uncertain NA NA "HPA020466: AB_1853352" "unprognostic (3.79e-2)" "unprognostic (2.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.33e-1)" "unprognostic (1.10e-3)" "unprognostic (8.28e-3)" "unprognostic (7.64e-2)" "unprognostic (1.71e-2)" "unprognostic (3.36e-1)" "unprognostic (8.38e-2)" "unprognostic (3.98e-6)" "unprognostic (1.11e-1)" "unprognostic (2.30e-2)" "unprognostic (3.29e-2)" "unprognostic (3.21e-1)" "unprognostic (2.84e-1)" "unprognostic (4.07e-1)" 2.2 7.6 0.6 0.9 0.6 1.5 4.4 0.3 0.5 4.3 1.1 0.3 15.3 0.4 2.2 6.3 8.3 1.7 3.8 0.9 0.3 0.3 3.1 10.4 5.1 0.3 0.6 0.3 1.0 7.7 2.4 1.3 14.2 0.5 4.1 0.7 1.7 19.6 7.4 2.9 13.4 1.0 0.9 0.6 0.3 3.3 1.3 0.3 0.3 4.2 7.4 7.8 3.3 5.6 3.0 1.6 5.0 1.4 3.2 2.1 0.4 13.9 3.6 0.1 0.4 0.7 3.6 2.2 6.1 5.3 9.9 7.7 4.9 3.2 0.5 4.7 5.9 14.1 11.1 4.7 6.0 9.4 0.2 5.5 0.2 1.7 4.8 2.6 0.3 0.4 5.8 8.6 6.5 4.9 13.3 1.2 2.5 3.9 0.5 1.1 7.1 0.1 0.4 1.1 2.6 13.3 0.8 0.1 0.4 7.5 12.9 0.4 0.2 4.7 6.5 0.2 1.1 7.9 0.3 1.9 3.1 5.6 8.3 3.6 0.9 1.8 0.3 22.8 0.4 1.0 3.9 1.4 1.4 1.6 1.2 2.0 1.9 1.3 1.2 0.5 3.0 1.6 2.1 5.0 3.2 1.3 1.6 1.2 0.4 0.6 0.6 0.3 0.5 0.3 0.3 0.6 0.3 0.5 0.3 3.0 5.6 0.0 4.4 8.5 0.0 0.1 0.0 8.1 6.8 1.8 0.0 0.6 0.0 5.9 0.0 0.1 0.0 0.0 5.2 0.8 0.7 5.0 1.1 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 5.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 9.8 1.6 0.0 1.1 5.2 LRRN1 FIGLER3 ENSG00000175928 "Leucine rich repeat neuronal 1" Q6UXK5 3 3799437-3847703 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.5" "Cell type enhanced" "Detected in some" 10 "Cholangiocytes: 10.2;Muller glia cells: 4.3;Pancreatic endocrine cells: 6.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 2.1;memory B-cell: 1.0;neutrophil: 2.6" "Group enriched" "Detected in many" 8 "B-cells: 1.0;granulocytes: 2.6" "Cell line enhanced" "Detected in some" "AF22: 48.6;CAPAN-2: 17.2;HAP1: 14.5;NTERA-2: 28.8;SuSa: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011071 Enhanced NA NA 1400000 "HPA011071: AB_1853355" "unprognostic (1.27e-2)" "unprognostic (4.87e-1)" "unprognostic (1.32e-2)" "unprognostic (3.30e-3)" "unprognostic (2.01e-2)" "unprognostic (3.02e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-2)" "unprognostic (3.34e-1)" "unprognostic (2.96e-1)" "unprognostic (2.85e-2)" "unprognostic (2.70e-1)" "unprognostic (1.39e-3)" "unprognostic (1.86e-3)" "unprognostic (1.67e-1)" "unprognostic (1.75e-1)" "unprognostic (7.25e-2)" 1.4 0.8 12.5 1.1 19.0 2.4 7.6 13.8 32.5 7.1 0.9 5.0 0.3 1.9 4.7 2.5 1.9 2.9 4.6 0.7 11.1 9.4 1.3 0.7 2.1 0.9 8.5 6.1 10.0 3.8 14.2 2.7 0.9 22.2 7.7 1.0 11.5 8.9 8.2 9.2 2.2 2.6 3.2 8.3 1.8 1.8 10.3 10.7 8.7 4.8 0.7 1.7 10.6 1.5 1.0 0.0 2.6 0.0 0.1 0.2 0.0 0.0 0.0 48.6 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 14.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.2 0.0 2.1 0.0 3.6 0.0 0.0 0.4 0.0 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.2 0.0 0.0 0.0 50.0 1.8 0.0 0.0 0.0 5.9 0.0 0.5 5.0 10.1 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 1.0 0.0 0.2 0.0 0.3 0.0 0.1 2.6 0.1 0.0 0.0 0.0 0.0 12.5 19.0 13.8 10.3 11.1 9.4 8.5 6.1 22.2 10.7 3.0 0.0 0.8 1.2 1.9 2.7 0.3 10.2 0.0 1.2 0.0 0.0 0.2 0.0 0.7 2.1 0.2 0.0 0.0 2.0 0.1 0.8 2.2 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.8 2.3 0.0 1.7 0.0 0.3 4.3 6.7 0.0 0.7 0.3 0.5 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.7 LRRN2 "FIGLER7, GAC1, LRANK1, LRRN5" ENSG00000170382 "Leucine rich repeat neuronal 2" O75325 1 204617170-204685733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 49.3" "Group enriched" "Detected in many" 6 "breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 7.1;NTERA-2: 14.3;RPMI-8226: 22.2;SuSa: 8.2;T-47d: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029124 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029124: AB_10601545" "unprognostic (2.16e-2)" "unprognostic (1.93e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.59e-7)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (2.89e-2)" "unprognostic (1.21e-1)" "unprognostic (4.63e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (1.68e-2)" "unprognostic (1.43e-2)" "unprognostic (7.33e-2)" "unprognostic (1.88e-1)" "unprognostic (1.59e-3)" 4.9 6.6 11.8 3.7 16.5 2.4 3.3 9.7 20.3 1.9 7.9 5.3 1.0 1.9 3.9 0.8 2.4 10.2 6.1 6.0 11.7 12.8 7.3 0.7 2.5 2.9 6.3 13.8 3.3 1.4 19.1 9.7 1.3 8.1 1.6 7.5 12.2 2.8 3.7 2.2 0.7 3.3 9.9 3.1 6.3 1.4 3.8 6.1 3.2 2.8 0.0 1.3 2.1 1.5 0.4 0.1 1.7 0.3 0.7 0.8 0.2 0.0 3.3 2.7 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 7.1 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.7 1.1 0.0 14.3 0.0 0.1 0.2 0.0 22.2 0.0 0.1 1.9 0.3 4.4 0.1 0.0 8.2 7.9 0.0 0.0 0.0 3.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.2 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.4 0.1 0.2 0.7 0.7 0.0 0.1 0.8 0.2 11.8 16.5 9.7 15.7 11.7 12.8 6.3 13.8 8.1 6.1 0.0 0.0 0.0 0.5 0.3 4.6 1.0 0.0 0.0 0.0 1.8 2.0 0.1 0.0 2.7 0.0 0.7 1.7 0.0 0.8 0.1 1.1 0.3 0.0 0.0 5.3 49.3 10.9 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.9 3.3 0.3 0.0 2.7 0.9 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.7 0.3 LRRN3 "FIGLER5, FLJ11129, NLRR3" ENSG00000173114 "Leucine rich repeat neuronal 3" Q9H3W5 7 111091006-111125454 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.5;brain: 23.8" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 33.5;Leydig cells: 52.0;Peritubular cells: 15.2" "Group enriched" "Detected in many" 7 "glioma: 17.5;thyroid cancer: 4.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4" "Lineage enriched" "Detected in single" 98 "T-cells: 20.3" "Cell line enhanced" "Detected in some" "AF22: 14.7;BJ: 8.3;BJ hTERT+: 18.2;GAMG: 9.3;SH-SY5Y: 26.4;SuSa: 8.5;T-47d: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043820, HPA046792" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043820: AB_2678687, HPA046792: AB_2679810" "unprognostic (4.93e-2)" "unprognostic (4.55e-2)" "unprognostic (5.92e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-2)" "unprognostic (4.78e-3)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.84e-2)" "unprognostic (4.85e-3)" "unprognostic (1.08e-2)" "unprognostic (3.29e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (7.23e-2)" 7.8 26.5 12.7 1.6 21.2 1.1 2.1 20.0 23.8 3.6 1.4 1.9 0.8 1.0 1.0 3.1 1.9 1.3 1.6 9.0 10.4 10.7 0.9 2.7 8.7 3.6 7.7 13.0 7.9 1.5 0.7 4.9 6.7 9.0 4.7 1.6 0.8 1.9 6.4 4.0 0.8 2.1 1.0 2.9 2.0 0.9 16.4 6.3 8.8 22.3 0.0 4.4 1.6 1.3 0.2 0.0 0.1 0.0 0.0 20.3 4.0 0.0 0.0 14.7 1.8 6.8 2.9 0.0 8.3 18.2 0.8 0.7 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.9 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 26.4 0.0 0.0 0.0 8.5 14.4 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 1.2 0.0 0.0 20.3 18.4 0.1 0.0 0.0 0.0 0.2 4.0 12.7 21.2 20.0 23.8 10.4 10.7 7.7 13.0 9.0 6.3 0.0 7.0 0.0 0.0 0.0 33.5 12.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.3 9.6 0.0 1.1 0.0 0.7 3.2 1.7 1.3 0.0 3.4 52.0 0.0 1.7 0.0 0.0 10.8 0.0 0.0 15.2 0.0 3.9 0.0 1.2 0.9 0.5 0.1 0.3 3.2 0.0 0.1 LRRN4 "C20orf75, dJ1056H1.1, NLRR4" ENSG00000125872 "Leucine rich repeat neuronal 4" Q8WUT4 20 6040778-6054049 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 9.5;kidney: 13.0;lung: 36.4" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 3.8;Ductal cells: 3.6;Proximal tubular cells: 2.2" "Group enriched" "Detected in many" 7 "lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7" "Region enriched" "Detected in single" 5 "basal ganglia: 1.1" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 11 "RPTEC TERT1: 40.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA075974 Uncertain "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 32000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA075974: AB_2686770" "unprognostic (6.16e-2)" "unprognostic (1.69e-3)" "unprognostic (2.40e-3)" "unprognostic (9.04e-3)" "unprognostic (5.95e-2)" "unprognostic (1.32e-2)" "unprognostic (2.59e-1)" "unprognostic (8.94e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-2)" "unprognostic (2.79e-2)" "unprognostic (4.83e-3)" "unprognostic (1.15e-3)" "unprognostic (2.33e-2)" "unprognostic (6.88e-2)" "unprognostic (2.31e-1)" "unprognostic (9.84e-3)" 9.5 0.1 0.0 2.4 1.1 0.1 0.1 0.0 0.2 0.7 2.2 0.0 0.0 0.1 0.1 2.8 0.1 1.5 0.1 1.1 0.0 0.2 13.0 0.4 36.4 0.1 0.0 0.0 1.6 2.6 0.1 0.0 3.4 0.0 0.1 0.1 0.0 0.1 0.5 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 40.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.8 0.4 0.2 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.9 3.8 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 1.8 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LRRN4CL ENSG00000177363 "LRRN4 C-terminal like" Q8ND94 11 62686402-62689899 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 17.2;Leydig cells: 25.0;Melanocytes: 32.1;Peritubular cells: 16.3" "Cancer enriched" "Detected in many" 5 "melanoma: 26.5" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 5.7;ASC TERT1: 19.1;HHSteC: 14.9;HSkMC: 8.0;LHCN-M2: 9.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA050317 Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA050317: AB_2681084" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (2.84e-1)" "unprognostic (9.95e-3)" "unprognostic (2.61e-2)" "unprognostic (4.03e-3)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (3.04e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-7)" "unprognostic (2.73e-2)" "unprognostic (6.12e-2)" "unprognostic (4.53e-3)" "unprognostic (1.86e-2)" 15.7 4.8 0.2 5.0 0.6 0.6 11.6 0.6 0.9 27.2 12.1 0.1 3.5 2.1 27.0 14.0 19.1 11.4 6.7 9.3 0.3 0.2 0.8 0.2 3.1 1.8 0.3 0.6 24.9 2.1 0.4 1.2 4.4 2.2 10.8 2.5 17.8 3.2 6.7 17.0 6.8 4.3 15.1 1.9 0.3 5.7 8.5 0.0 0.0 3.5 10.4 2.4 18.2 11.2 0.9 0.6 3.3 0.8 0.8 0.6 0.1 0.0 0.1 0.2 0.2 5.7 19.1 0.2 2.0 2.9 0.2 1.0 0.2 0.1 0.1 0.2 3.2 0.0 0.3 0.1 0.0 0.3 0.1 0.2 0.3 0.1 0.1 14.9 0.2 0.1 8.0 0.2 0.4 0.0 0.1 0.0 0.3 0.2 0.1 9.7 0.1 0.2 0.4 0.4 0.1 0.1 0.1 1.3 0.3 0.0 0.1 0.6 0.2 0.3 0.2 0.6 0.1 0.1 0.2 0.2 1.8 0.1 2.0 0.1 0.2 0.2 0.2 1.1 0.2 0.0 0.9 0.8 0.3 0.4 0.3 0.3 0.4 0.4 0.3 0.1 0.9 0.5 0.6 3.3 0.8 0.4 0.6 0.2 0.1 0.2 0.6 0.6 0.9 0.3 0.2 0.3 0.6 2.2 0.0 0.0 2.6 0.0 1.9 6.0 1.9 1.1 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.1 17.2 0.8 1.1 0.0 0.3 1.6 1.2 1.3 1.2 0.0 25.0 1.5 32.1 0.0 0.1 0.3 0.0 0.0 16.3 0.1 0.7 0.0 1.7 0.4 0.2 6.0 0.1 0.0 0.0 1.0 LRRTM1 FLJ32082 ENSG00000162951 "Leucine rich repeat transmembrane neuronal 1" Q86UE6 2 80288351-80304749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.8;salivary gland: 19.8" "Group enriched" "Detected in some" 4 "Distal tubular cells: 1.7;Sertoli cells: 6.5" "Group enriched" "Detected in many" 11 "endometrial cancer: 8.8;ovarian cancer: 16.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.2;CAPAN-2: 3.2;NTERA-2: 2.1;SH-SY5Y: 4.7;U-266/70: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062660 Approved NA NA "HPA062660: AB_2684824" "unprognostic (2.47e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (5.63e-2)" "unprognostic (6.67e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-1)" "unprognostic (8.16e-2)" "unprognostic (6.03e-3)" "unprognostic (7.10e-4)" "unprognostic (3.16e-2)" "unprognostic (1.90e-1)" "unprognostic (4.96e-4)" 0.7 2.2 8.1 1.0 17.8 0.5 0.6 0.5 17.6 1.5 2.2 2.7 0.1 1.7 1.7 1.2 1.1 2.8 0.9 1.3 10.7 6.3 0.9 0.7 0.7 0.5 2.5 7.8 0.9 0.5 0.5 1.3 0.5 1.8 0.9 1.1 1.7 19.8 2.8 0.5 0.7 1.9 1.1 2.1 0.5 0.9 0.7 2.4 0.0 2.9 0.0 0.6 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.9 4.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 17.8 0.5 17.6 10.7 6.3 2.5 7.8 1.8 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.4 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRTM2 KIAA0416 ENSG00000146006 "Leucine rich repeat transmembrane neuronal 2" O43300 5 138868923-138875368 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 33.1" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 6.0;Bipolar cells: 9.8;Cone photoreceptor cells: 3.9;Horizontal cells: 6.4;Ito cells: 3.7" "Cancer enriched" "Detected in single" 11 "glioma: 4.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "HDLM-2: 18.3;SCLC-21H: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.77e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-1)" "unprognostic (2.85e-1)" "unprognostic (3.58e-1)" "unprognostic (8.72e-2)" "unprognostic (4.31e-2)" "unprognostic (4.48e-1)" "unprognostic (4.47e-2)" "unprognostic (8.54e-2)" "unprognostic (1.13e-2)" "unprognostic (3.13e-2)" "unprognostic (2.86e-2)" "unprognostic (8.11e-2)" "unprognostic (1.08e-1)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" 2.3 4.1 11.0 1.1 15.7 1.1 1.5 15.6 33.1 1.3 1.4 5.1 0.0 1.3 1.1 1.0 1.0 1.1 1.4 1.1 9.7 9.1 1.2 1.3 1.1 1.2 5.4 17.7 1.2 1.4 0.9 0.7 4.5 8.4 1.0 1.4 1.0 1.0 0.9 1.1 1.2 1.5 1.4 5.8 1.9 1.0 0.9 9.9 0.0 1.1 0.0 1.0 1.2 0.3 0.5 0.0 1.0 0.8 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.1 0.4 1.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.5 18.3 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 1.5 0.0 0.8 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 11.0 15.7 15.6 20.8 9.7 9.1 5.4 17.7 8.4 9.9 6.0 1.0 0.8 0.2 0.0 9.8 0.6 0.0 0.0 1.2 0.0 3.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.1 6.4 0.0 3.7 0.3 0.0 0.0 0.0 1.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 LRRTM3 ENSG00000198739 "Leucine rich repeat transmembrane neuronal 3" Q86VH5 10 66926006-67099830 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 7.3;brain: 29.1;ovary: 8.0;pituitary gland: 26.6" "Group enriched" "Detected in some" 11 "Early spermatids: 137.5;Late spermatids: 100.5" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.8;Daudi: 2.3;HAP1: 10.8;NTERA-2: 2.3;RPMI-8226: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA070444, HPA078598" Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA070444: , HPA078598: " "unprognostic (1.21e-2)" "unprognostic (4.85e-2)" "unprognostic (1.12e-1)" "unprognostic (4.02e-2)" "unprognostic (1.15e-4)" "unprognostic (8.11e-2)" "unprognostic (4.77e-1)" 0.9 7.3 12.9 1.0 18.7 0.9 0.9 19.7 29.1 1.7 0.9 3.2 0.0 1.0 1.2 0.9 1.4 0.9 0.9 0.9 7.0 6.5 1.0 0.9 1.4 0.9 3.7 16.0 8.0 3.7 0.9 26.6 0.9 4.5 1.2 0.9 0.0 1.0 1.2 1.0 0.9 1.1 1.0 2.8 0.9 0.9 1.9 5.9 0.0 0.9 0.0 0.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.3 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 18.7 19.7 21.3 7.0 6.5 3.7 16.0 4.5 5.9 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 100.5 8.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 11.3 0.0 0.3 0.0 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 LRRTM4 FLJ12568 ENSG00000176204 "Leucine rich repeat transmembrane neuronal 4" Q86VH4 2 76747719-77593319 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 12.7;Cone photoreceptor cells: 3.9;Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "Karpas-707: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.00e-1)" "unprognostic (4.40e-2)" "unprognostic (3.13e-1)" "unprognostic (4.72e-4)" "unprognostic (7.20e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-2)" "unprognostic (9.15e-2)" "unprognostic (3.93e-1)" "unprognostic (5.84e-2)" "unprognostic (4.22e-2)" "unprognostic (1.40e-1)" "unprognostic (2.64e-1)" "unprognostic (5.77e-3)" "unprognostic (3.54e-2)" "unprognostic (7.99e-2)" 1.2 1.5 13.7 1.2 15.7 4.5 0.8 1.8 25.4 1.0 1.5 1.6 0.8 2.1 1.3 3.7 2.4 1.2 2.3 1.3 8.9 8.0 0.9 3.4 1.9 1.9 4.1 16.4 2.4 1.2 0.2 7.9 2.3 5.5 1.7 1.2 1.0 1.9 3.1 2.8 2.1 1.2 0.8 3.1 1.5 1.8 1.2 5.1 0.0 2.2 0.0 0.8 1.6 1.6 0.0 0.4 3.3 0.6 0.9 1.2 0.2 0.8 1.3 0.5 0.5 0.1 0.0 0.8 0.1 0.0 0.0 0.0 1.1 0.3 0.5 1.3 0.5 0.4 0.4 0.0 0.0 0.1 0.3 1.1 0.2 1.9 1.7 0.2 0.6 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 54.3 0.1 1.1 0.2 0.5 5.5 0.1 0.5 0.7 0.0 1.2 0.0 2.3 2.0 0.6 0.3 0.4 0.5 0.9 0.8 0.4 0.0 1.6 2.0 0.2 0.2 0.3 1.2 0.1 1.2 0.1 1.5 0.0 0.6 0.9 0.3 0.4 0.1 0.0 1.0 0.9 0.0 0.0 1.2 0.7 3.3 0.9 0.3 0.4 0.4 0.2 13.7 15.7 1.8 25.4 8.9 8.0 4.1 16.4 5.5 5.1 0.0 0.3 0.0 0.0 0.0 12.7 0.3 0.0 1.4 0.0 0.0 3.9 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.4 0.0 2.4 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRTM1 HT017 ENSG00000144771 "Leucine rich repeats and transmembrane domains 1" Q9HBL6 3 54918237-54967088 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 12.2;retina: 18.8;skeletal muscle: 22.5;tongue: 15.3" "Cell type enriched" "Detected in many" 14 "Bipolar cells: 403.4" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.5" "Region enriched" "Detected in single" 7 "pons and medulla: 2.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.28e-1)" "unprognostic (1.58e-2)" "unprognostic (9.56e-2)" "unprognostic (2.16e-1)" "unprognostic (1.87e-3)" 0.3 0.1 0.3 0.0 0.3 0.0 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.3 3.6 0.1 0.4 0.1 0.3 0.2 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.1 0.3 0.1 0.4 2.9 1.2 0.0 18.8 2.1 0.4 22.5 0.1 0.3 0.0 1.0 12.2 0.1 0.3 0.0 0.0 0.1 15.3 0.5 0.1 0.1 0.7 1.0 2.3 1.9 0.7 0.9 0.5 0.5 0.3 1.7 0.2 0.2 0.0 1.8 0.0 0.5 0.9 1.6 0.3 1.3 0.0 0.8 0.8 0.0 1.0 0.4 1.5 0.6 1.0 0.2 4.3 1.1 0.9 0.2 0.5 1.1 1.8 0.4 0.7 0.2 0.1 0.1 0.3 0.1 1.6 0.3 0.2 0.4 2.3 1.5 0.0 0.5 0.1 0.3 1.3 0.2 0.7 0.5 0.7 0.5 2.3 0.3 0.7 1.2 0.3 0.0 0.7 0.9 0.7 0.1 0.0 1.0 0.1 0.4 0.6 0.9 2.3 0.5 0.6 0.7 0.6 0.9 0.7 0.6 0.3 1.0 0.3 0.8 0.6 1.5 0.7 1.9 0.6 0.7 0.5 0.3 0.3 0.1 0.2 0.3 0.2 0.3 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.3 403.4 0.4 0.0 0.0 0.0 1.8 15.7 7.8 0.0 0.0 2.0 0.2 0.0 0.0 0.3 1.1 0.8 0.4 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 16.2 1.4 0.0 4.2 0.0 28.5 0.0 1.0 3.0 2.2 0.4 18.5 0.0 0.0 0.4 LRTM2 ENSG00000166159 "Leucine rich repeats and transmembrane domains 2" Q8N967 12 1820267-1836752 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "brain: 18.7" "Cell type enhanced" "Detected in some" 29 "Bipolar cells: 3.7;Cone photoreceptor cells: 2.0;Horizontal cells: 11.1;Rod photoreceptor cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 9.2;SCLC-21H: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055094, HPA062745" Uncertain Approved Cytosol NA NA Cytosol "HPA055094: AB_2682693, HPA062745: " "unprognostic (1.84e-3)" "unprognostic (4.83e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (5.49e-2)" "unprognostic (1.60e-1)" "unprognostic (1.34e-3)" "unprognostic (2.25e-1)" "unprognostic (1.24e-1)" "unprognostic (6.20e-4)" "unprognostic (2.21e-1)" "unprognostic (8.02e-2)" 0.7 0.7 5.1 0.7 12.3 0.7 0.7 0.8 18.7 0.7 0.7 1.7 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 3.3 5.0 0.7 0.7 0.7 0.7 1.7 10.5 0.7 0.7 0.7 0.1 0.7 4.7 0.7 0.7 0.1 0.7 0.8 0.7 0.7 0.7 0.7 1.7 0.7 0.8 0.9 4.3 0.0 0.7 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.3 0.8 18.7 3.3 5.0 1.7 10.5 4.7 4.3 0.0 0.0 0.0 0.0 0.0 3.7 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRTOMT "CFAP111, COMT2, DFNB63, LRRC51" ENSG00000184154 "Leucine rich transmembrane and O-methyltransferase domain containing" "Q8WZ04, Q96E66" 11 72080331-72110782 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Hearing, Neurotransmitter degradation" "Methyltransferase, Transferase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 49.8;testis: 47.8" "Group enriched" "Detected in many" 10 "Early spermatids: 522.5;Late spermatids: 1781.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 27.7" HPA039949 Approved Uncertain Microtubules NA NA Microtubules "HPA039949: AB_10960708" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (1.85e-2)" "prognostic favorable (7.70e-4)" "unprognostic (8.09e-2)" "unprognostic (9.07e-2)" "unprognostic (1.42e-1)" "unprognostic (1.90e-1)" "unprognostic (4.22e-2)" "prognostic favorable (5.36e-4)" "unprognostic (6.12e-2)" "unprognostic (8.43e-2)" "unprognostic (2.64e-2)" "unprognostic (1.58e-1)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" 3.5 3.7 10.6 2.0 11.1 2.1 7.1 3.7 8.9 7.1 4.2 14.0 6.1 3.2 6.0 13.6 3.5 49.8 5.3 2.6 8.8 7.6 9.0 6.2 6.2 2.6 7.7 8.5 8.5 7.0 7.1 8.9 4.4 10.6 7.5 6.2 7.3 4.3 4.7 5.2 4.5 2.5 4.8 7.7 3.2 3.6 47.8 8.9 3.1 9.3 2.4 3.5 3.5 2.6 4.3 4.2 9.2 2.9 10.1 6.2 2.0 2.6 9.8 6.2 5.0 5.4 4.8 1.5 3.1 2.5 2.8 2.5 4.7 14.3 3.4 4.7 5.3 6.9 5.3 4.4 7.4 3.2 6.4 4.3 2.5 4.5 3.3 0.9 2.0 2.7 2.1 3.8 4.3 3.3 4.6 1.0 7.2 2.7 5.3 4.1 9.3 6.0 4.0 3.1 15.4 2.6 7.3 6.3 5.2 11.0 3.2 5.8 4.5 6.1 14.0 7.5 4.5 27.7 2.4 4.6 3.0 4.2 8.0 2.1 5.7 6.2 3.9 2.9 1.7 3.3 2.3 2.9 5.0 3.1 2.8 3.2 4.2 3.3 2.6 1.7 4.3 3.0 3.0 9.2 10.1 1.8 4.2 6.2 2.0 10.6 11.1 3.7 8.9 8.8 7.6 7.7 8.5 10.6 8.9 0.0 1.0 6.1 6.6 2.1 3.7 1.7 5.1 115.1 9.1 3.5 11.8 11.0 10.0 6.1 522.5 4.5 3.1 0.0 2.1 6.7 4.1 11.4 0.0 5.6 2.7 6.4 1.2 3.1 1.0 1781.2 13.8 2.2 1.7 1.8 8.8 12.6 1.8 2.9 9.6 14.6 12.6 6.5 7.1 69.5 22.8 2.0 11.0 2.6 4.3 4.7 LSAMP "IGLON3, LAMP" ENSG00000185565 "Limbic system-associated membrane protein" Q13449 3 115802363-117139389 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.4" "Cell type enhanced" "Detected in many" 13 "Horizontal cells: 208.2;Leydig cells: 116.8;Muller glia cells: 166.8;Peritubular cells: 86.3" "Cancer enhanced" "Detected in many" "glioma: 13.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 7.0;SH-SY5Y: 14.2;WM-115: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054051, HPA076122" Enhanced Cytosol NA NA 200000000 Cytosol "HPA054051: AB_2682358, HPA076122: AB_2686779" "unprognostic (4.18e-2)" "unprognostic (2.54e-1)" "unprognostic (9.97e-3)" "unprognostic (6.03e-2)" "unprognostic (9.63e-2)" "unprognostic (4.15e-3)" "unprognostic (6.81e-2)" "unprognostic (2.70e-2)" "unprognostic (5.71e-2)" "unprognostic (6.82e-3)" "unprognostic (1.26e-1)" "unprognostic (6.03e-2)" "unprognostic (1.92e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (5.23e-5)" "unprognostic (1.31e-2)" 2.3 12.7 21.9 4.3 23.7 1.1 1.6 43.4 48.4 17.8 5.5 16.6 0.0 1.9 4.4 2.8 3.4 2.9 11.3 2.1 23.7 18.8 2.5 1.0 8.5 4.0 17.6 21.5 4.8 11.1 0.6 3.1 1.2 18.3 21.1 3.5 1.2 1.7 6.2 0.7 4.6 1.9 3.3 13.1 1.7 3.2 3.9 21.3 0.0 4.2 0.0 5.2 7.3 3.4 1.6 0.4 3.0 0.8 0.3 1.0 0.3 0.2 2.2 7.0 0.2 0.7 2.2 0.7 0.6 0.3 0.2 0.7 0.2 0.4 0.5 0.2 3.6 0.2 0.1 0.1 0.1 0.3 0.5 0.1 0.2 0.8 0.3 0.1 0.5 0.4 1.7 0.0 0.8 0.1 0.2 0.0 0.9 0.3 2.3 0.0 0.2 0.8 0.6 2.7 0.3 0.8 0.2 0.1 0.1 1.7 1.6 1.6 14.2 0.0 0.1 2.2 3.2 0.2 0.8 0.1 1.5 1.3 1.7 0.4 1.5 1.9 0.2 0.5 0.2 34.6 3.0 0.8 1.4 0.9 0.5 1.0 0.7 0.6 0.5 0.2 1.6 1.0 0.7 2.8 0.3 0.6 0.4 0.5 0.3 21.9 23.7 43.4 23.7 23.7 18.8 17.6 21.5 18.3 21.3 0.0 0.6 0.5 0.2 6.8 47.9 18.9 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 15.9 2.5 0.0 0.0 3.0 0.0 16.0 17.5 0.0 0.0 0.3 208.2 0.0 1.8 0.0 18.1 116.8 1.8 54.0 0.0 0.0 166.8 0.6 0.0 86.3 0.0 9.7 0.0 1.3 0.9 0.2 4.4 0.0 0.0 0.0 0.5 LSMEM1 "C7orf53, FLJ39575" ENSG00000181016 "Leucine rich single-pass membrane protein 1" Q8N8F7 7 112480853-112491062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "skeletal muscle: 51.3;tongue: 19.2" "Group enriched" "Detected in many" 6 "Early spermatids: 43.6;Late spermatids: 47.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "cerebellum: 3.6" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "HeLa: 12.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA013753, HPA047988" Uncertain Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA013753: AB_1848926, HPA047988: AB_2680229" "unprognostic (6.87e-2)" "unprognostic (5.94e-2)" "unprognostic (2.79e-2)" "unprognostic (2.77e-2)" "unprognostic (1.38e-1)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (6.68e-2)" "unprognostic (3.54e-2)" "unprognostic (2.80e-3)" "unprognostic (1.47e-6)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (4.25e-2)" "unprognostic (3.42e-2)" 1.1 0.7 0.6 0.6 0.6 0.8 0.9 3.6 0.7 0.6 0.6 0.6 0.6 1.3 0.6 1.7 0.7 0.4 0.6 2.1 0.7 0.8 1.4 3.5 1.8 0.6 0.7 0.6 0.6 2.8 0.3 0.9 0.6 0.6 0.9 0.8 0.6 1.9 0.6 51.3 0.8 0.8 0.6 0.6 1.9 0.8 1.1 0.6 0.6 0.9 19.2 1.5 0.6 0.6 0.0 0.1 2.7 0.1 0.0 0.2 2.2 0.8 1.3 0.7 2.8 2.9 3.2 0.1 1.3 0.9 0.6 0.5 2.2 1.9 1.2 1.9 0.3 1.9 0.7 0.8 1.0 1.2 0.6 0.8 0.8 12.5 2.3 1.3 1.2 0.7 2.2 3.8 0.8 0.8 2.7 0.8 1.1 0.9 2.8 0.4 1.1 1.0 3.7 0.6 1.1 0.9 0.4 0.2 0.6 2.4 1.5 2.7 1.4 2.3 1.1 1.5 3.4 0.4 0.5 0.5 2.8 1.0 0.8 1.1 0.9 1.7 1.1 0.8 0.8 0.9 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 2.2 0.6 0.6 3.6 0.7 0.7 0.8 0.7 0.6 0.6 0.6 0.0 3.2 0.8 2.4 4.8 2.2 7.7 5.1 1.4 2.3 1.8 2.0 1.2 0.0 0.6 43.6 2.9 7.1 0.0 0.8 0.7 2.8 7.4 0.0 1.0 3.2 0.0 2.9 1.8 2.7 47.7 0.9 1.3 1.7 2.8 4.0 0.3 1.0 4.3 0.4 0.1 3.4 0.0 6.6 0.5 0.6 4.1 1.6 0.7 3.2 2.2 LSMEM2 "C3orf45, FLJ38608" ENSG00000179564 "Leucine rich single-pass membrane protein 2" Q8N112 3 50279027-50288114 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2" "Cell type enriched" "Detected in some" 5 "Late spermatids: 197.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HeLa: 3.7;WM-115: 3.5" "Low region specificity" "Detected in many" HPA079523 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA079523: " "unprognostic (2.84e-3)" "unprognostic (6.54e-2)" "unprognostic (2.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.46e-2)" "unprognostic (2.48e-1)" "unprognostic (6.49e-3)" "unprognostic (1.71e-1)" 0.6 0.3 1.2 0.2 2.1 0.4 0.2 0.7 1.9 1.1 0.3 2.1 0.1 0.4 1.4 0.4 0.7 0.8 0.4 26.6 1.4 0.7 0.3 0.1 0.3 0.1 1.3 0.6 0.9 0.3 0.1 0.1 0.2 1.3 0.4 0.3 1.6 1.4 0.5 16.3 0.1 0.5 0.5 1.6 0.2 0.2 3.0 0.9 0.1 0.2 7.2 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 0.2 0.3 0.0 0.0 0.4 0.4 0.4 0.4 0.2 0.3 0.5 0.1 0.1 0.0 0.5 0.1 0.1 1.1 0.1 0.0 0.5 0.2 3.7 0.2 0.0 0.3 0.2 0.2 0.0 0.1 0.2 0.5 0.0 1.1 0.0 1.0 0.0 0.2 0.1 0.7 0.5 0.4 0.0 0.0 0.3 0.0 0.3 0.3 0.1 0.5 0.0 0.8 1.0 0.4 0.0 0.0 0.0 0.2 1.3 0.4 0.4 0.9 0.6 0.6 0.1 0.9 3.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.1 0.7 1.9 1.4 0.7 1.3 0.6 1.3 0.9 0.0 1.1 0.0 0.1 0.9 0.1 3.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.1 41.7 0.0 0.9 0.0 0.2 0.1 0.3 0.3 4.7 0.0 0.1 0.0 0.0 0.0 0.0 197.4 1.1 0.0 1.7 0.0 0.4 0.5 0.1 0.0 0.7 0.0 0.2 0.0 0.7 1.6 1.0 1.1 0.1 0.0 0.6 0.1 LSR "ILDR3, LISCH7" ENSG00000105699 "Lipolysis stimulated lipoprotein receptor" Q86X29 19 35248330-35267964 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 106.3;pancreas: 98.6" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 229.3;Exocrine glandular cells: 243.9;Pancreatic endocrine cells: 273.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 88.1;CACO-2: 38.6;CAPAN-2: 41.0;HaCaT: 37.0;OE19: 53.1;RT4: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007270, HPA075309" Approved Supported "Plasma membrane" NA NA 2100000 "Plasma membrane" "HPA007270: AB_1079253, HPA075309: " "unprognostic (3.90e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (2.67e-3)" "unprognostic (2.28e-2)" "unprognostic (6.07e-3)" "unprognostic (1.55e-1)" "unprognostic (9.84e-2)" "unprognostic (2.17e-1)" "unprognostic (2.70e-2)" "unprognostic (2.23e-2)" "unprognostic (3.42e-2)" "prognostic favorable (8.09e-4)" "unprognostic (1.64e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-2)" "unprognostic (1.54e-2)" 5.0 11.2 2.9 20.9 4.0 0.9 12.4 2.0 4.5 8.7 32.8 4.0 24.4 29.5 6.5 21.4 20.3 10.6 58.2 2.6 3.4 3.1 15.7 106.3 21.1 17.0 4.1 2.6 4.8 98.6 6.2 13.4 36.6 7.1 11.2 15.4 40.9 26.2 33.8 1.9 16.8 39.5 1.8 3.8 9.1 46.7 21.0 1.9 3.4 24.0 20.1 20.9 9.9 9.5 5.3 0.3 5.9 0.2 6.1 7.1 3.2 88.1 1.4 0.1 0.1 0.2 0.1 16.0 0.2 0.3 0.4 0.3 38.6 41.0 3.5 13.6 0.2 1.3 37.0 8.2 13.5 0.0 5.3 14.9 0.0 1.2 17.0 0.3 0.0 0.1 0.2 15.1 0.3 4.5 0.1 0.1 0.1 13.9 3.1 0.2 31.3 0.1 0.1 12.7 53.1 0.5 0.7 0.1 9.5 8.5 35.7 7.0 0.2 7.4 24.1 6.6 4.2 20.6 0.4 0.0 0.7 8.4 0.5 0.4 5.0 8.9 8.0 0.6 0.1 2.2 5.9 0.2 0.2 3.3 0.0 3.3 5.3 7.1 6.7 0.1 4.1 5.5 6.0 0.1 6.1 0.0 0.3 4.8 3.2 2.9 4.0 2.0 4.5 3.4 3.1 4.1 2.6 7.1 1.9 14.9 17.1 13.9 106.8 45.9 1.4 3.2 79.0 12.0 27.3 34.9 15.7 183.2 10.0 229.3 8.5 29.2 159.2 0.0 243.9 80.3 15.6 94.1 31.1 77.6 19.8 0.0 54.2 17.2 1.5 2.1 6.1 3.7 13.5 11.8 103.4 9.1 273.3 171.7 3.2 20.3 11.0 0.0 24.6 5.4 13.4 45.2 207.4 8.6 101.9 201.4 LST1 "B144, D6S49E, LST-1" ENSG00000204482 "Leukocyte specific transcript 1" O00453 6 31586124-31588909 "Predicted intracellular proteins, Predicted membrane proteins" "Cell shape, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 115.3;bone marrow: 60.9;lymphoid tissue: 72.4" "Group enriched" "Detected in many" 6 "Hofbauer cells: 354.0;Kupffer cells: 1112.1;Macrophages: 1026.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 38.4;eosinophil: 60.8;intermediate monocyte: 95.8;myeloid DC: 34.1;neutrophil: 99.1;non-classical monocyte: 115.3" "Group enriched" "Detected in all" 12 "dendritic cells: 34.1;granulocytes: 99.1;monocytes: 115.3" "Cell line enhanced" "Detected in some" "HEL: 11.9;HMC-1: 23.3;MOLT-4: 11.7;NB-4: 24.2;THP-1: 58.1;U-937: 30.9" NA NA "unprognostic (1.08e-2)" "prognostic favorable (7.89e-4)" "unprognostic (6.99e-2)" "unprognostic (4.16e-3)" "unprognostic (3.13e-1)" "unprognostic (3.92e-2)" "unprognostic (3.65e-1)" "unprognostic (7.06e-3)" "unprognostic (2.81e-3)" "unprognostic (2.12e-1)" "unprognostic (1.70e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (5.97e-5)" "unprognostic (1.47e-1)" "prognostic unfavorable (7.62e-4)" "unprognostic (1.03e-1)" "unprognostic (1.95e-1)" 4.6 3.1 5.2 14.9 7.3 60.9 2.4 1.0 4.0 1.5 3.3 7.7 0.2 4.2 1.3 3.9 1.9 2.2 2.8 3.2 4.9 5.4 2.8 11.9 16.2 25.7 9.7 1.9 2.3 1.6 0.7 2.2 7.0 6.2 2.7 2.6 2.6 3.0 1.7 1.0 2.3 4.1 4.2 13.6 72.4 2.8 0.9 6.6 12.6 1.5 1.2 5.8 4.1 1.7 1.9 34.1 99.1 115.3 1.6 7.0 35.7 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.1 0.1 0.1 3.8 0.0 11.9 0.0 0.0 0.2 8.7 23.3 0.0 0.1 0.0 0.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 11.7 24.2 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 30.9 0.0 8.6 38.4 60.8 0.8 95.8 7.0 1.9 1.3 1.7 34.1 1.8 0.9 0.8 99.1 1.6 115.3 6.0 0.9 35.7 5.2 7.3 1.0 4.0 4.9 5.4 9.7 1.9 6.2 6.6 32.8 129.2 43.8 0.3 31.3 0.0 1.7 7.6 20.1 23.9 10.4 0.0 2.5 0.0 0.6 0.9 11.7 0.0 0.0 0.2 2.3 12.2 0.3 68.2 2.6 354.0 0.0 0.0 27.0 1112.1 3.2 3.4 1026.6 42.2 27.9 0.0 0.5 0.1 0.0 1.1 2.2 0.2 25.8 3.6 0.6 2.2 24.7 4.5 39.9 0.0 0.3 LTA "LT, TNFB, TNFSF1" ENSG00000226979 "Lymphotoxin alpha" P01374 6 31572054-31574324 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 25.3" "Group enriched" "Detected in some" 4 "B-cells: 13.7;T-cells: 7.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.2;MOLT-4: 3.6;U-266/84: 1.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA007729 Uncertain "Secreted to blood" NA NA 8150 "HPA007729: AB_1852906" "unprognostic (3.76e-2)" "unprognostic (1.48e-2)" "unprognostic (1.36e-3)" "unprognostic (8.99e-5)" "unprognostic (3.22e-1)" "unprognostic (5.13e-3)" "unprognostic (2.07e-1)" "unprognostic (4.71e-2)" "unprognostic (3.10e-2)" "unprognostic (3.39e-4)" "unprognostic (2.68e-2)" "unprognostic (6.77e-2)" "unprognostic (8.72e-12)" "unprognostic (2.59e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-2)" "unprognostic (3.03e-1)" 0.4 0.1 0.2 25.3 0.6 1.1 0.1 1.3 0.2 0.2 0.5 0.1 0.0 0.1 0.1 0.1 0.9 0.2 0.1 0.1 0.2 0.1 0.3 0.4 2.0 7.2 0.1 0.0 0.3 0.1 0.1 0.1 0.3 0.0 0.6 0.4 0.2 2.4 0.5 0.3 0.2 2.8 0.2 0.3 10.0 0.4 6.0 0.0 11.2 0.2 0.5 17.5 0.7 0.1 0.2 0.0 0.5 0.6 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.0 0.0 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.6 0.5 0.1 0.6 0.0 0.1 0.0 0.2 0.6 1.3 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.6 13.7 0.0 0.1 0.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 2.1 0.5 0.4 0.0 7.5 0.0 0.0 LTB "p33, TNFC, TNFSF3" ENSG00000227507 "Lymphotoxin beta" Q06643 6 31580525-31582522 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.1;lymphoid tissue: 81.5" "Cell type enriched" "Detected in many" 4 "B-cells: 1026.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.1;Daudi: 19.8;HDLM-2: 11.2;HMC-1: 5.8;NB-4: 12.8;REH: 12.2;U-698: 14.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048884 Approved Approved Centrosome NA NA Centrosome "HPA048884: AB_2680543" "unprognostic (1.43e-2)" "unprognostic (3.89e-2)" "unprognostic (7.29e-2)" "prognostic favorable (2.36e-6)" "unprognostic (2.91e-3)" "prognostic favorable (1.74e-4)" "unprognostic (1.45e-1)" "unprognostic (9.49e-3)" "unprognostic (1.42e-3)" "unprognostic (4.26e-2)" "unprognostic (4.52e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.31e-7)" "unprognostic (8.91e-2)" "unprognostic (4.92e-2)" "unprognostic (6.56e-3)" "unprognostic (1.99e-1)" 1.0 0.2 0.2 35.9 0.2 3.4 0.5 0.1 0.1 0.2 1.5 0.0 0.0 1.3 0.2 0.3 2.7 0.4 0.7 1.9 0.2 0.1 4.2 1.3 4.2 27.8 0.2 0.0 0.5 0.8 0.0 0.2 0.3 0.1 0.7 0.6 0.5 6.1 0.3 0.1 0.6 18.0 0.3 0.3 69.7 2.0 0.2 0.0 81.5 1.1 0.8 41.6 1.6 0.5 44.1 15.6 17.8 3.6 5.2 39.3 10.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 19.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.3 12.8 0.0 0.0 0.0 12.2 0.0 2.7 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 2.5 0.4 17.8 3.7 2.0 26.8 42.5 39.3 17.3 0.6 44.1 33.5 14.2 14.5 5.2 3.6 15.6 22.2 10.7 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 13.6 1026.5 0.2 14.4 0.2 0.4 0.0 0.0 4.5 85.5 0.0 0.3 1.7 211.4 1.9 3.8 0.0 0.0 97.9 0.2 5.6 1.2 13.9 2.8 8.9 0.0 0.0 6.7 27.5 0.0 0.6 21.2 40.5 10.0 0.3 1.0 243.4 1.5 0.0 8.6 0.1 6.5 10.8 0.1 1.1 10.8 0.2 247.3 0.4 0.3 LTB4R "BLTR, CMKRL1, GPR16, LTB4R1, P2RY7, P2Y7" ENSG00000213903 "Leukotriene B4 receptor" Q15722 14 24311450-24318036 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.8;skin 1: 47.0" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 21.3;Kupffer cells: 41.4;Macrophages: 20.5;Suprabasal keratinocytes: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 13.8;eosinophil: 13.9;neutrophil: 36.8" "Group enriched" "Detected in many" 6 "granulocytes: 36.8;monocytes: 13.8" "Cell line enhanced" "Detected in many" "HaCaT: 17.6;Karpas-707: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA003873 Approved NA NA "HPA003873: AB_1078288" "unprognostic (4.07e-2)" "unprognostic (7.67e-2)" "unprognostic (3.67e-3)" "unprognostic (2.40e-3)" "unprognostic (4.90e-2)" "unprognostic (9.00e-3)" "unprognostic (1.15e-2)" "unprognostic (8.63e-2)" "unprognostic (3.68e-1)" "unprognostic (2.06e-1)" "prognostic favorable (1.85e-4)" "unprognostic (7.25e-2)" "prognostic unfavorable (3.44e-15)" "unprognostic (2.88e-1)" "unprognostic (2.97e-1)" "unprognostic (6.59e-2)" "unprognostic (7.45e-2)" 7.8 2.7 0.4 3.5 1.7 9.8 2.9 1.7 2.2 8.4 2.8 0.9 0.4 3.0 2.4 4.0 27.0 2.5 2.6 6.5 1.0 0.2 3.1 10.8 9.2 27.7 1.4 0.4 3.6 3.5 0.6 2.5 2.3 1.2 3.9 1.3 2.9 5.9 2.0 2.6 47.0 2.6 1.3 2.1 23.9 1.6 1.7 1.0 2.4 2.3 14.3 7.2 2.5 11.6 0.1 4.0 36.8 13.8 0.7 1.2 4.3 2.1 4.9 1.7 1.4 1.1 1.1 7.4 1.0 0.7 1.1 1.3 3.6 2.6 3.6 1.6 0.9 1.9 17.6 1.5 2.8 1.5 9.4 5.5 3.8 5.9 2.3 0.6 5.1 5.0 0.6 5.0 2.2 2.6 1.5 2.0 6.0 3.0 14.9 0.5 4.8 2.1 8.7 1.3 0.2 3.8 7.7 1.6 6.1 0.6 3.5 3.9 1.4 5.2 2.5 2.3 3.2 4.1 5.2 1.1 3.6 3.6 3.7 1.3 8.4 1.9 5.8 0.7 13.6 2.4 4.9 13.8 13.9 1.2 1.7 0.9 0.0 0.9 1.0 4.0 0.1 0.4 0.3 36.8 0.7 0.3 0.4 0.2 4.3 0.4 1.7 1.7 2.2 1.0 0.2 1.4 0.4 1.2 1.0 0.0 1.1 0.9 8.4 21.3 3.0 1.2 5.1 2.7 3.4 0.0 5.9 0.7 0.0 2.1 0.2 3.6 2.6 0.0 5.5 0.6 2.6 2.1 1.1 3.6 12.9 0.0 0.0 8.0 41.4 0.4 3.1 20.5 3.3 0.0 2.3 0.6 3.6 2.9 1.4 0.5 11.0 6.5 1.7 1.2 1.3 41.0 0.7 10.1 2.6 2.4 LTB4R2 "BLT2, BLTR2, JULF2, NOP9" ENSG00000213906 "Leukotriene B4 receptor 2" Q9NPC1 14 24305734-24312053 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6" "Cell type enhanced" "Detected in some" 7 "Basal glandular cells: 3.0;Horizontal cells: 3.2;Kupffer cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 15.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB022689, HPA029680, HPA072921" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (9.53e-2)" "unprognostic (8.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (1.48e-3)" "unprognostic (7.18e-2)" "unprognostic (7.05e-11)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "unprognostic (4.23e-2)" "unprognostic (1.19e-1)" 1.5 1.2 0.4 1.8 0.5 4.8 1.1 0.4 0.6 7.9 0.4 0.6 0.8 2.4 1.0 4.7 38.9 0.8 0.7 0.4 0.5 0.1 6.1 0.5 1.1 1.8 0.4 0.7 0.7 0.5 0.3 0.7 0.8 0.5 1.8 0.3 0.5 4.7 1.1 0.9 21.4 1.8 0.4 0.4 3.5 1.0 1.4 0.4 3.1 0.9 43.6 26.8 0.6 9.0 0.3 2.2 1.4 2.0 0.9 2.7 1.1 2.5 4.4 1.9 1.8 0.4 0.6 7.7 0.9 0.4 1.3 0.9 3.4 1.5 3.2 1.6 0.6 1.9 15.9 1.3 2.7 1.0 4.0 4.9 2.2 3.5 1.6 0.5 3.6 4.2 0.5 3.6 2.0 2.3 1.2 0.6 5.8 2.8 3.6 0.6 4.8 1.9 3.8 1.0 0.1 5.4 7.9 1.7 1.8 0.4 3.1 3.4 1.6 1.6 2.0 1.3 2.1 3.7 2.7 1.6 2.6 3.2 4.0 1.3 7.9 2.3 5.2 0.5 6.1 2.0 0.0 2.0 1.4 2.7 1.6 1.6 0.1 2.2 2.0 2.2 0.3 1.7 0.9 1.3 0.9 0.8 0.6 0.4 1.1 0.4 0.5 0.4 0.6 0.5 0.1 0.4 0.7 0.5 0.4 0.0 0.0 0.0 3.0 0.2 0.2 0.0 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.9 0.3 0.0 1.2 0.1 0.0 0.2 0.0 0.8 0.6 3.2 1.7 1.3 2.2 0.0 0.3 0.2 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.7 0.2 0.1 0.2 0.0 0.6 0.9 LTBP3 LTBP2 ENSG00000168056 "Latent transforming growth factor beta binding protein 3" Q9NS15 11 65538805-65558930 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding" "Amelogenesis imperfecta, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 28.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 74.2;U-87 MG: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 760000 "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (8.50e-3)" "unprognostic (4.01e-2)" "unprognostic (1.04e-1)" "unprognostic (1.59e-1)" "unprognostic (2.24e-2)" "unprognostic (9.22e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-2)" "unprognostic (1.04e-2)" "unprognostic (4.52e-2)" "unprognostic (1.45e-1)" "unprognostic (2.67e-2)" "unprognostic (1.51e-1)" "unprognostic (4.25e-2)" "unprognostic (2.24e-2)" 35.3 31.6 25.2 14.9 21.5 7.3 33.4 24.3 27.2 41.8 29.4 28.7 37.5 12.2 43.5 42.7 17.1 36.0 45.0 38.7 24.6 12.7 22.9 25.7 36.7 16.1 22.1 22.7 55.1 35.7 48.1 37.1 18.2 23.4 40.2 6.8 36.1 34.4 43.5 33.9 13.9 16.9 30.3 34.4 24.4 19.8 16.8 23.7 12.5 40.6 17.2 11.8 30.7 29.6 28.6 8.0 1.3 5.4 4.6 6.7 3.6 3.9 16.1 2.1 10.7 15.5 25.1 2.1 15.8 10.8 2.0 1.3 6.1 21.0 0.4 13.6 15.6 5.1 17.7 2.9 2.9 0.9 2.2 6.5 3.8 5.8 6.2 10.3 0.5 3.3 28.2 1.2 3.0 0.3 74.2 7.9 1.2 1.1 3.1 1.4 9.3 2.5 1.4 1.9 3.5 20.1 7.1 0.2 7.6 1.7 1.3 0.7 10.5 4.2 6.2 8.1 0.9 11.4 1.4 26.1 6.3 8.4 10.6 4.2 3.4 6.2 0.3 39.9 0.6 12.9 0.0 3.3 1.2 4.3 4.9 6.7 28.6 6.1 5.0 4.0 22.7 5.2 5.4 1.3 4.6 5.4 8.0 6.2 3.6 25.2 21.5 24.3 22.9 24.6 12.7 22.1 22.7 23.4 23.7 11.9 13.2 21.5 23.8 65.6 52.7 11.0 38.2 4.0 13.6 38.4 2.0 17.2 18.3 24.9 0.9 26.0 20.9 0.0 10.2 7.9 35.2 30.8 24.2 45.0 19.0 27.0 29.4 38.1 8.3 2.2 80.3 18.2 28.7 10.8 9.3 76.6 17.0 14.4 116.3 14.6 13.3 38.8 37.1 4.6 40.3 69.4 13.6 20.2 14.5 24.3 LTBR "D12S370, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3" ENSG00000111321 "Lymphotoxin beta receptor" P36941 12 6375045-6391571 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Host-virus interaction" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 24.6;intermediate monocyte: 22.9;myeloid DC: 17.6;neutrophil: 15.8;non-classical monocyte: 16.4" "Group enriched" "Detected in many" 32 "dendritic cells: 17.6;granulocytes: 15.8;monocytes: 24.6" "Cell line enhanced" "Detected in many" "HHSteC: 76.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026202, HPA061617" Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "CAB026202: , HPA061617: AB_2732666" "unprognostic (2.60e-2)" "unprognostic (1.24e-2)" "unprognostic (7.75e-3)" "unprognostic (2.23e-2)" "unprognostic (3.01e-2)" "unprognostic (3.24e-3)" "prognostic unfavorable (5.13e-4)" "unprognostic (2.08e-2)" "unprognostic (2.24e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-3)" "unprognostic (1.91e-1)" "prognostic unfavorable (5.92e-4)" "unprognostic (3.66e-2)" "unprognostic (9.84e-3)" "unprognostic (6.91e-2)" "unprognostic (2.86e-1)" 32.7 24.8 6.0 13.6 8.1 3.6 77.6 2.7 4.8 25.0 25.1 4.9 31.3 18.9 26.7 19.5 34.9 18.1 29.8 15.2 9.5 3.3 39.4 85.2 38.7 21.7 8.1 2.6 28.3 79.8 18.1 10.6 27.0 8.4 31.3 13.7 16.9 31.3 27.0 19.1 25.2 43.6 28.2 12.5 23.3 24.5 14.3 5.7 4.2 45.8 33.6 19.1 27.0 23.0 0.0 17.6 15.8 24.6 0.6 0.1 8.0 17.6 23.8 0.0 7.6 47.4 35.7 16.5 12.2 28.5 18.7 19.3 11.0 27.5 0.0 7.5 26.7 0.1 20.4 0.0 25.9 7.4 0.0 0.0 10.4 9.8 6.2 76.0 0.7 17.6 52.2 48.0 13.3 37.5 19.5 16.9 0.0 9.9 0.1 21.3 16.4 0.0 4.9 0.2 28.2 13.1 0.0 1.2 0.0 27.8 20.4 0.1 0.1 11.5 23.0 25.7 0.9 3.8 19.1 10.5 6.5 7.4 24.1 13.1 0.0 0.0 0.0 2.7 6.4 24.0 1.4 24.6 0.1 0.0 22.9 0.0 0.0 0.0 0.0 17.6 0.0 0.1 0.1 15.8 0.6 16.4 4.2 0.0 8.0 6.0 8.1 2.7 4.8 9.5 3.3 8.1 2.6 8.4 5.7 56.6 71.3 7.8 71.3 34.7 4.0 15.0 38.2 48.2 64.8 29.6 0.0 27.2 8.3 44.1 0.4 45.0 92.5 0.0 85.4 36.2 45.6 92.6 27.8 53.3 42.3 0.0 50.0 46.6 71.4 1.6 48.9 39.6 21.9 34.3 54.3 11.7 62.6 77.2 37.4 22.5 1.5 25.8 42.3 1.4 0.5 54.0 31.4 3.9 51.1 75.1 LTC4S MGC33147 ENSG00000213316 "Leukotriene C4 synthase" Q16873 5 179793980-179796647 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism" "Lyase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.3" "Cell type enriched" "Detected in many" 6 "granulocytes: 332.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 8.5;eosinophil: 31.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 31.3" "Cell line enriched" "Detected in some" 10 "HMC-1: 52.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044688 Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA Nucleoplasm "Endoplasmic reticulum, Cytosol" "HPA044688: " "unprognostic (8.94e-2)" "unprognostic (2.40e-2)" "unprognostic (9.35e-3)" "unprognostic (3.57e-2)" "unprognostic (1.24e-2)" "unprognostic (9.40e-2)" "unprognostic (4.53e-5)" "unprognostic (2.27e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (2.65e-1)" "unprognostic (1.98e-2)" "unprognostic (4.62e-1)" 9.0 6.7 3.5 2.8 3.5 8.6 4.6 1.7 5.0 6.9 5.0 9.4 5.4 3.6 8.7 10.4 4.2 13.0 15.7 11.3 3.9 3.1 6.2 2.3 28.3 8.0 6.8 4.2 5.8 2.4 2.0 3.2 2.9 4.3 5.6 1.9 3.3 7.4 11.6 2.7 3.5 5.7 4.5 6.3 6.7 5.0 3.3 3.9 0.8 5.3 5.6 3.2 3.6 3.9 0.1 4.5 31.3 0.3 2.2 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 5.3 0.0 0.2 0.2 0.3 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 8.5 0.2 31.3 0.5 0.3 1.7 0.1 1.2 0.8 4.5 0.1 0.2 0.5 0.1 2.2 0.0 0.2 0.1 0.3 3.5 3.5 1.7 5.0 3.9 3.1 6.8 4.2 4.3 3.9 0.0 5.6 2.2 7.5 8.9 0.2 0.0 12.7 4.0 3.4 14.0 0.0 6.9 1.7 4.1 0.3 11.3 0.4 0.0 2.1 1.5 4.7 3.1 332.3 0.8 33.8 0.0 2.9 53.4 8.9 0.0 15.3 23.5 1.7 1.0 1.6 0.0 2.1 0.0 44.6 40.2 0.3 0.0 0.9 0.0 0.7 6.0 2.5 5.0 2.6 5.0 LTF HLF2 ENSG00000012223 Lactotransferrin P02788 3 46435645-46485234 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Ion transport, Iron transport, Osteogenesis, Transcription, Transcription regulation, Transport" "Antibiotic, Antimicrobial, DNA-binding, Heparin-binding, Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 277.8;salivary gland: 181.9;seminal vesicle: 177.1" "Group enriched" "Detected in many" 4 "Club cells: 55.7;Collecting duct cells: 68.0;Glandular cells: 88.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 27 "neutrophil: 4.0;non-classical monocyte: 13.5" "Group enriched" "Detected in many" 27 "granulocytes: 4.0;monocytes: 13.5" "Group enriched" "Detected in some" 10 "RPMI-8226: 29.8;TIME: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB008646, CAB016201, HPA057177, HPA059976" Enhanced "Secreted in other tissues" NA NA 600000000 "CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185" "unprognostic (7.24e-3)" "unprognostic (2.43e-1)" "unprognostic (5.94e-2)" "unprognostic (3.41e-2)" "unprognostic (7.14e-3)" "unprognostic (3.45e-2)" "unprognostic (6.43e-3)" "unprognostic (2.52e-1)" "unprognostic (1.92e-1)" "unprognostic (4.21e-2)" "unprognostic (3.43e-1)" "unprognostic (1.04e-1)" "prognostic favorable (6.30e-5)" "unprognostic (1.66e-2)" "unprognostic (3.53e-1)" "unprognostic (2.05e-1)" "unprognostic (9.09e-3)" 1.0 0.3 0.4 8.8 0.5 277.8 23.0 0.3 0.3 53.1 0.3 3.2 108.0 0.0 0.7 39.3 3.8 0.9 2.2 2.5 0.6 0.6 20.8 0.6 10.8 1.3 0.6 0.0 0.3 2.7 0.0 1.2 0.8 1.5 13.0 0.0 0.2 181.9 177.1 0.4 1.2 0.9 0.1 0.7 9.1 22.6 2.8 0.1 4.0 1.6 13.4 30.7 2.3 1.0 0.0 0.3 4.0 13.5 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.5 29.8 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.2 0.9 0.1 0.5 0.0 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 13.5 0.3 0.0 14.7 0.4 0.5 0.3 0.3 0.6 0.6 0.6 0.0 1.5 0.1 0.0 3.2 0.0 7.7 1.0 0.0 1.2 5.1 12.0 55.7 68.0 0.0 0.0 0.0 0.3 0.7 2.3 0.0 0.0 0.8 0.1 0.5 88.7 1.1 0.0 0.0 0.0 0.0 2.5 0.0 0.7 4.6 0.9 0.0 0.0 0.0 0.0 5.0 0.0 0.0 10.8 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 16.6 LTK TYK1 ENSG00000062524 "Leukocyte receptor tyrosine kinase" P29376 15 41503638-41513887 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 13.4;Ito cells: 14.7;Mucus-secreting cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "MAIT T-cell: 8.3;plasmacytoid DC: 7.0" "Group enriched" "Detected in many" 10 "dendritic cells: 7.0;T-cells: 8.3" "Cell line enhanced" "Detected in some" "HEL: 5.4;NB-4: 10.5;RH-30: 5.1;THP-1: 16.1" "Low region specificity" "Detected in many" HPA059545 Approved Vesicles NA NA Vesicles "HPA059545: AB_2684057" "unprognostic (9.47e-4)" "unprognostic (5.52e-4)" "unprognostic (1.51e-1)" "unprognostic (2.49e-1)" "unprognostic (4.12e-1)" "unprognostic (5.65e-3)" "unprognostic (1.74e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "unprognostic (2.81e-3)" "unprognostic (9.36e-3)" "unprognostic (5.36e-2)" "unprognostic (4.68e-2)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" 1.0 0.5 0.5 5.1 1.6 3.1 0.5 2.0 3.2 0.6 8.2 0.5 1.9 10.6 1.3 1.1 1.2 0.3 2.0 2.2 0.5 0.1 3.5 4.3 15.1 0.6 0.5 0.5 1.0 0.5 1.0 0.7 8.9 0.5 0.7 4.8 4.3 11.7 0.5 2.0 0.9 10.7 0.5 0.5 5.5 8.3 2.4 0.8 0.5 0.7 0.5 2.2 0.6 0.7 0.7 7.0 0.0 0.0 0.0 8.3 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.1 0.6 1.0 1.3 2.4 0.0 0.0 0.1 0.7 0.0 0.0 2.9 0.0 0.4 0.2 1.4 5.4 0.0 0.0 2.4 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 2.0 0.0 2.1 0.0 0.0 10.5 0.4 2.0 0.2 0.2 5.1 0.2 0.0 0.0 0.5 3.4 0.1 0.2 0.0 3.0 0.2 16.1 0.0 0.0 0.2 0.2 0.1 0.4 0.2 0.2 0.0 0.5 0.9 0.0 0.0 0.0 0.6 0.0 8.3 0.7 0.5 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 7.0 0.0 0.2 0.5 1.6 2.0 3.2 0.5 0.1 0.5 0.5 0.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 5.1 4.0 1.2 0.0 0.0 0.2 0.0 0.0 2.1 0.1 13.4 0.0 0.2 1.1 0.2 0.0 0.0 0.2 0.1 0.0 1.7 14.7 3.2 1.7 0.0 0.0 3.3 0.0 7.8 0.0 0.5 3.5 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.1 0.3 1.3 2.8 0.0 LVRN "APQ, AQPEP, FLJ90650, TAQPEP" ENSG00000172901 Laeverin Q6Q4G3 5 115962454-116027619 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 75.1" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 25.5;Extravillous trophoblasts: 21.0;Late spermatids: 42.0;Syncytiotrophoblasts: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.4;ASC TERT1: 3.9;CAPAN-2: 1.8;SiHa: 1.5;U-266/70: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA053254 Enhanced "Intracellular and membrane" NA NA "HPA053254: AB_2682092" "unprognostic (1.47e-1)" "unprognostic (3.38e-3)" "unprognostic (5.81e-2)" "unprognostic (2.97e-3)" "unprognostic (5.38e-2)" "unprognostic (1.32e-1)" "unprognostic (2.59e-3)" "unprognostic (1.88e-2)" "unprognostic (2.23e-1)" "unprognostic (2.23e-2)" "unprognostic (3.83e-3)" "unprognostic (1.22e-1)" "unprognostic (1.67e-7)" "unprognostic (1.05e-2)" "unprognostic (5.94e-2)" "unprognostic (6.53e-2)" "unprognostic (3.31e-2)" 10.6 0.1 0.0 0.5 0.0 0.1 3.9 0.0 0.0 0.3 1.4 0.0 0.4 0.1 0.0 0.0 1.8 0.2 0.4 1.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.1 75.1 0.0 0.7 0.4 0.0 0.6 1.2 1.3 1.0 1.7 0.5 0.0 0.0 0.4 0.3 0.0 0.0 0.3 1.7 0.1 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.1 2.4 3.9 0.9 0.2 0.3 0.1 0.3 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.1 0.0 0.9 0.0 0.0 0.2 0.3 1.3 0.4 0.0 0.0 0.3 0.1 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.3 0.0 0.6 1.6 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 25.5 0.0 0.0 0.0 0.0 21.0 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 42.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.2 0.0 8.9 0.0 0.0 0.0 LY6D E48 ENSG00000167656 "Lymphocyte antigen 6 family member D" Q14210 8 142784880-142786592 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 236.9;skin 1: 111.6;tongue: 316.2" "Group enriched" "Detected in some" 14 "Basal keratinocytes: 1040.7;Suprabasal keratinocytes: 3379.4" "Group enriched" "Detected in many" 7 "cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "A-431: 57.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA024755, HPA064317" Enhanced NA NA 92000 "HPA024755: AB_1853410, HPA064317: AB_2685244" "unprognostic (2.13e-2)" "unprognostic (7.48e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-2)" "unprognostic (8.97e-2)" "unprognostic (1.51e-2)" "unprognostic (3.84e-1)" "unprognostic (5.11e-2)" "prognostic unfavorable (1.94e-6)" "unprognostic (8.68e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (2.50e-1)" "unprognostic (3.97e-1)" "unprognostic (5.40e-4)" "unprognostic (1.06e-1)" 0.2 3.7 0.2 0.2 0.2 0.1 3.7 0.2 0.2 23.0 0.2 0.2 0.2 0.1 2.1 0.2 236.9 0.1 0.5 0.2 0.2 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 1.3 0.2 1.2 0.1 0.2 18.1 0.2 0.4 111.6 0.2 0.9 0.2 0.2 2.0 0.2 0.2 0.9 0.2 316.2 61.8 6.3 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 1.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 0.0 0.0 6.9 1040.7 0.0 0.0 0.0 1.4 39.8 1.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 4.6 0.5 2.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 155.3 0.0 0.0 0.0 4.1 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 3379.4 6.9 0.0 0.0 148.4 LY6G5C "C6orf20, G5c, NG33" ENSG00000204428 "Lymphocyte antigen 6 family member G5C" Q5SRR4 6 31676684-31684040 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 17.4;Spermatocytes: 12.9;Spermatogonia: 13.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 3.1;HDLM-2: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038690 Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA038690: AB_10673286" "unprognostic (1.51e-2)" "unprognostic (7.26e-2)" "unprognostic (7.19e-2)" "prognostic favorable (1.07e-4)" "unprognostic (4.83e-1)" "unprognostic (6.91e-2)" "unprognostic (1.33e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-2)" "unprognostic (5.63e-2)" "unprognostic (3.74e-5)" "unprognostic (5.84e-2)" "unprognostic (3.78e-4)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.88e-2)" "unprognostic (1.39e-2)" 0.4 0.0 0.5 2.1 2.5 1.1 0.3 4.6 3.8 0.0 0.0 0.2 0.3 0.4 0.0 0.5 2.0 0.8 0.4 0.7 0.0 0.9 0.5 1.2 0.3 0.4 2.5 0.0 1.0 0.4 0.1 0.0 0.2 0.0 1.3 0.3 0.3 0.0 0.4 0.8 1.2 2.1 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.4 2.1 3.1 0.1 0.1 0.1 0.3 0.3 0.8 0.0 2.4 1.5 0.1 0.1 0.0 0.6 0.0 0.0 0.9 2.7 1.4 1.1 0.0 0.5 0.0 0.3 1.2 0.0 0.0 0.7 1.7 0.1 0.0 0.9 0.0 1.5 0.1 0.0 2.3 0.4 0.1 0.1 0.0 1.0 0.4 0.8 0.1 0.5 0.3 0.2 0.9 0.0 0.5 0.0 0.1 1.8 0.0 0.2 1.1 1.8 0.1 0.4 0.5 0.5 2.3 1.5 0.6 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 3.0 1.0 0.0 1.7 1.4 3.1 0.8 2.5 17.4 1.2 1.8 2.0 0.4 3.3 1.5 9.4 4.3 2.9 0.0 4.3 0.1 1.2 2.4 4.7 1.7 5.2 0.0 3.4 7.4 6.5 4.4 1.1 2.2 1.7 1.8 1.7 5.7 3.7 2.5 1.4 3.8 0.9 0.0 1.9 12.9 13.4 0.6 0.2 4.4 2.5 0.9 LY6G6C "C6orf24, G6c, NG24" ENSG00000204421 "Lymphocyte antigen 6 family member G6C" O95867 6 31718648-31721845 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "lymphoid tissue: 24.8;placenta: 26.5;skin 1: 89.7;tongue: 56.1" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 10.2;Late spermatids: 8.8;Suprabasal keratinocytes: 56.1;Syncytiotrophoblasts: 17.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.3;HaCaT: 1.9;MCF7: 2.4;OE19: 1.2;SuSa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.21e-1)" "unprognostic (3.05e-2)" "unprognostic (1.68e-1)" "unprognostic (4.85e-3)" "unprognostic (2.59e-3)" "unprognostic (1.35e-1)" "unprognostic (9.03e-2)" "unprognostic (1.79e-1)" "unprognostic (4.13e-1)" "unprognostic (1.76e-3)" "unprognostic (2.85e-1)" "unprognostic (8.80e-7)" "unprognostic (1.33e-2)" "unprognostic (2.56e-1)" "unprognostic (6.09e-2)" "unprognostic (9.38e-2)" 0.1 0.1 0.0 0.1 0.1 0.1 1.9 0.0 0.1 2.5 0.1 0.0 0.0 0.1 0.4 0.1 5.4 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 26.5 0.0 0.1 0.1 0.0 2.4 0.1 0.2 89.7 0.0 0.1 0.0 0.1 0.1 0.2 0.0 1.8 0.1 56.1 24.8 0.1 4.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.7 0.4 0.1 0.0 0.1 0.0 1.9 0.0 0.2 0.1 0.0 0.2 0.8 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.0 0.2 0.0 0.4 0.1 0.0 0.0 2.4 0.1 0.9 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 1.5 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.1 0.0 0.1 0.0 1.4 0.0 0.0 0.0 1.6 0.0 0.0 10.2 0.1 0.7 0.0 0.0 1.0 0.6 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 2.1 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 56.1 17.0 0.0 1.7 2.3 LY6G6E "C6orf22, G6e" ENSG00000255552 "Lymphocyte antigen 6 family member G6E" 6 31711771-31714065 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 111 "HEL: 23.1" HPA056234 Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA056234: AB_2732601" "unprognostic (1.77e-1)" "unprognostic (1.58e-2)" "unprognostic (2.25e-1)" "unprognostic (6.88e-2)" 0.3 0.0 2.9 0.0 0.5 4.3 0.0 0.0 5.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.3 0.2 1.7 0.1 0.0 0.3 3.9 0.0 0.0 0.0 0.6 0.0 0.2 0.2 0.6 0.7 0.2 0.0 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.6 2.2 0.0 0.1 0.2 0.4 0.4 0.8 1.1 0.4 0.1 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.4 0.4 0.4 0.7 0.4 0.0 0.2 0.3 0.4 1.1 0.1 0.3 0.8 0.7 1.0 2.9 0.5 0.0 5.2 1.7 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY6G6F "C6orf21, G6f, LY6G6D, NG32" ENSG00000204424 "Lymphocyte antigen 6 family member G6F" Q5SQ64 6 31706885-31710595 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.0;bone marrow: 4.0;lung: 3.3;lymphoid tissue: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Cell line enriched" "Detected in single" 141 "HEL: 14.0" HPA008053 Uncertain NA NA 12000000 "HPA008053: AB_1840160" "unprognostic (3.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.66e-3)" 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 1.1 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 4.3 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY6G6F-LY6G6D ENSG00000250641 "LY6G6F-LY6G6D readthrough" 6 31706904-31717918 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 9.3;testis: 4.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 23 "colorectal cancer: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.7" HPA008053 Uncertain NA NA "HPA008053: AB_1840160" "unprognostic (5.02e-2)" "unprognostic (1.31e-1)" "unprognostic (3.47e-1)" "unprognostic (5.90e-2)" "unprognostic (1.07e-2)" "unprognostic (2.66e-1)" "unprognostic (2.42e-1)" 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 1.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.7 0.1 0.0 0.0 0.4 0.0 9.3 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY6K "CT97, FLJ35226, HSJ001348" ENSG00000160886 "Lymphocyte antigen 6 family member K" Q17RY6 8 142700111-142705127 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 39.3" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 132.9;Glandular cells: 88.0;Spermatocytes: 359.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "neutrophil: 5.3" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.3" "Cell line enhanced" "Detected in many" "A-431: 28.8;BJ: 31.3;HeLa: 34.1;SiHa: 49.0;U-2197: 66.2" "HPA017770, CAB075742, CAB075743" Enhanced Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" Nucleoplasm "CAB075742: AB_2665748, CAB075743: AB_2665749, HPA017770: AB_1853414" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (1.48e-1)" "unprognostic (7.23e-3)" "unprognostic (3.47e-2)" "unprognostic (2.39e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.17e-5)" "unprognostic (4.18e-2)" "unprognostic (6.89e-2)" "unprognostic (9.75e-2)" "unprognostic (1.40e-1)" "unprognostic (5.27e-5)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.61e-2)" 6.6 0.4 1.4 0.3 1.8 0.4 7.6 0.9 3.8 1.8 1.6 0.1 9.8 0.5 0.7 0.8 10.9 0.8 1.2 1.2 1.5 1.9 2.0 0.2 0.6 1.9 1.7 0.0 0.7 0.4 0.0 0.3 6.3 1.0 1.1 0.1 0.1 1.4 7.0 6.3 4.3 0.2 0.6 1.1 0.3 0.4 39.3 0.2 0.2 1.1 4.5 6.8 1.0 3.2 0.1 0.1 5.3 0.2 0.4 0.2 0.0 28.8 0.5 0.0 1.5 0.6 1.9 0.3 31.3 3.7 9.7 5.9 0.0 0.2 0.0 2.6 3.5 3.4 2.6 0.0 1.7 8.2 0.3 0.0 0.0 34.1 0.0 0.4 0.0 0.0 2.9 5.1 7.2 9.3 0.0 0.8 0.0 0.0 0.1 18.2 0.2 0.0 0.0 1.0 0.9 0.5 0.0 0.1 0.0 1.6 0.4 0.9 0.1 49.0 0.6 9.5 1.7 0.1 0.0 1.2 0.4 2.8 66.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.5 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 5.3 0.4 0.1 0.1 0.0 0.0 1.4 1.8 0.9 1.7 1.5 1.9 1.7 0.0 1.0 0.2 3.0 0.3 0.0 65.7 34.6 0.3 0.1 10.2 1.4 7.9 24.4 0.0 11.3 0.0 0.5 5.0 3.3 0.0 0.0 0.0 132.9 2.9 88.0 0.0 0.0 5.3 0.0 0.0 1.3 0.0 10.1 3.7 2.8 11.8 0.0 0.0 0.5 3.9 0.0 2.8 0.0 0.7 0.0 13.3 359.5 76.0 39.3 21.2 0.0 0.0 76.5 LY75 "CD205, CLEC13B, DEC-205" ENSG00000054219 "Lymphocyte antigen 75" O60449 2 159803355-159904749 "CD markers, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 28.8;lymphoid tissue: 61.9" "Cell type enriched" "Detected in many" 7 "monocytes: 150.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.5;HDLM-2: 9.9;Karpas-707: 42.2;RT4: 14.3;THP-1: 10.6" "CAB001450, HPA049108, HPA054073" Enhanced Approved "Golgi apparatus" NA NA 960000 "Golgi apparatus" "CAB001450: AB_563525, HPA049108: AB_2680635, HPA054073: AB_2682370" "unprognostic (7.29e-3)" "unprognostic (1.92e-3)" "unprognostic (3.15e-1)" "unprognostic (1.52e-2)" "unprognostic (4.60e-3)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (6.24e-2)" "unprognostic (2.80e-1)" "unprognostic (2.36e-1)" "unprognostic (8.74e-3)" "unprognostic (3.92e-1)" "prognostic unfavorable (2.39e-5)" "unprognostic (2.66e-1)" "unprognostic (4.89e-2)" "unprognostic (1.94e-2)" "prognostic favorable (3.86e-4)" 3.5 1.8 1.9 21.4 2.6 4.9 6.1 1.2 1.8 4.5 9.3 2.0 1.0 10.8 2.1 1.9 4.5 5.0 10.7 2.8 1.8 1.7 2.8 1.2 10.3 33.9 2.5 1.1 1.6 2.3 0.2 1.9 0.8 2.4 2.0 7.2 1.3 7.2 1.3 0.8 6.5 28.8 1.3 3.4 17.2 3.8 1.1 3.0 61.9 10.7 3.6 17.1 6.9 3.8 5.8 4.3 5.9 2.6 7.5 8.0 2.3 1.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 10.5 7.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 9.9 0.0 2.1 0.0 0.0 0.2 1.6 0.0 0.2 0.0 0.2 0.1 0.0 5.4 0.0 0.0 42.2 0.0 0.0 0.0 2.7 0.2 0.2 0.0 2.7 0.0 1.8 3.2 14.3 0.0 0.0 3.4 2.4 0.0 0.1 0.0 10.6 8.1 0.0 0.0 0.0 0.0 6.5 1.1 1.4 0.0 3.6 0.0 3.4 2.0 3.5 6.5 2.6 7.1 5.8 5.9 7.5 4.3 4.5 6.7 8.0 5.9 7.5 1.0 1.5 4.3 2.3 1.9 2.6 1.2 1.8 1.8 1.7 2.5 1.1 2.4 3.0 0.0 4.3 8.8 1.9 6.6 0.0 0.4 5.1 6.7 4.5 22.7 2.0 0.1 0.0 0.9 0.3 2.2 20.2 0.0 4.9 0.1 1.5 1.1 11.5 0.0 4.2 0.0 1.7 3.1 7.9 0.0 2.3 11.0 5.0 150.5 11.0 0.5 3.2 10.5 0.4 1.2 0.2 0.0 0.7 0.0 0.7 5.8 0.2 8.7 12.4 4.3 LY75-CD302 ENSG00000248672 "LY75-CD302 readthrough" 2 159771851-159904710 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 17.0;lymphoid tissue: 37.5" "Cell type enhanced" "Detected in some" 20 "Ciliated cells: 2.7;Club cells: 2.3;granulocytes: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 5.7;HDLM-2: 6.0;Karpas-707: 22.7;RT4: 9.6;TIME: 5.5" HPA049108 Uncertain NA NA "HPA049108: AB_2680635" "unprognostic (2.53e-1)" "unprognostic (1.55e-1)" "unprognostic (2.33e-1)" "unprognostic (1.86e-1)" "unprognostic (9.04e-2)" "unprognostic (1.68e-4)" "unprognostic (1.14e-1)" "unprognostic (2.24e-1)" "unprognostic (3.32e-1)" "unprognostic (4.47e-2)" "unprognostic (1.88e-1)" 1.1 1.2 0.9 12.5 1.0 5.9 2.1 1.0 1.0 1.1 5.0 0.5 0.0 4.5 0.9 0.4 1.3 1.1 5.8 1.1 1.0 1.1 1.0 1.0 5.6 20.2 0.9 0.0 1.0 1.1 0.0 1.0 0.4 0.7 1.0 3.6 0.0 2.7 0.0 1.0 1.3 17.0 0.2 1.2 9.9 1.1 1.0 1.1 37.5 4.6 1.5 9.8 1.5 1.2 1.7 10.0 6.9 4.2 0.9 2.7 3.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 5.7 2.7 0.7 0.2 0.1 0.0 0.0 0.0 0.1 0.0 6.0 0.0 3.3 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.4 0.0 0.0 2.7 0.0 0.0 22.7 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 9.6 0.0 0.0 2.4 0.5 0.0 0.1 0.0 0.7 5.5 0.0 0.0 0.0 0.0 1.9 0.4 0.7 0.0 1.3 0.0 3.0 3.7 4.4 1.7 4.2 2.7 1.5 1.6 2.0 10.0 1.7 1.9 1.4 6.9 0.9 1.8 2.0 1.8 3.1 0.9 1.0 1.0 1.0 1.0 1.1 0.9 0.0 0.7 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY9 "CD229, hly9, mLY9, SLAMF3" ENSG00000122224 "Lymphocyte antigen 9" Q9HBG7 1 160796074-160828261 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 30.8;intestine: 11.3;lymphoid tissue: 43.7;urinary bladder: 28.6" "Group enriched" "Detected in some" 19 "B-cells: 55.0;Erythroid cells: 23.3;Melanocytes: 67.4;T-cells: 45.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 30.6;MAIT T-cell: 30.7;memory B-cell: 15.2;memory CD4 T-cell: 26.8;memory CD8 T-cell: 29.6;naive B-cell: 13.9;naive CD4 T-cell: 30.5;naive CD8 T-cell: 30.8;plasmacytoid DC: 18.6;T-reg: 19.7" "Group enriched" "Detected in many" 4 "B-cells: 15.2;dendritic cells: 18.6;T-cells: 30.8" "Cell line enhanced" "Detected in some" "Daudi: 7.3;JURKAT: 7.4;Karpas-707: 14.9;U-266/70: 37.8;U-266/84: 14.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA050917 Approved NA NA 23000 "HPA050917: AB_2681272" "unprognostic (8.04e-4)" "unprognostic (2.31e-5)" "unprognostic (8.08e-3)" "unprognostic (1.20e-3)" "unprognostic (9.83e-3)" "unprognostic (1.87e-5)" "unprognostic (1.16e-2)" "unprognostic (3.84e-3)" "unprognostic (1.23e-2)" "unprognostic (2.89e-3)" "unprognostic (1.64e-1)" "unprognostic (2.30e-1)" "unprognostic (2.70e-3)" "unprognostic (8.69e-2)" "unprognostic (9.47e-2)" "unprognostic (3.49e-2)" "unprognostic (6.88e-2)" 2.8 0.5 0.4 20.9 0.4 6.9 2.7 0.4 0.4 1.4 3.7 0.2 0.4 2.4 0.9 0.8 3.5 1.0 2.0 0.9 0.4 0.4 1.7 1.3 6.1 35.3 0.4 0.0 1.1 0.5 0.0 0.5 0.2 0.1 1.0 2.3 1.0 6.5 0.4 0.4 0.8 11.3 0.1 0.7 25.3 3.4 1.1 0.0 35.7 1.6 1.8 43.7 28.6 1.2 15.2 18.6 0.6 0.2 5.2 30.8 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 14.9 0.0 0.0 1.1 0.2 0.0 0.4 0.0 0.8 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 37.8 14.6 0.1 0.0 2.1 0.0 0.2 0.2 0.1 30.6 0.2 30.7 15.2 26.8 29.6 1.3 13.9 30.5 30.8 0.6 5.2 0.2 18.6 19.7 12.9 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.1 0.0 0.0 2.6 55.0 0.5 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 23.3 0.2 0.0 0.5 0.2 0.0 0.4 2.0 0.0 1.2 2.5 2.4 0.0 0.0 2.2 67.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.9 0.1 45.3 0.0 0.4 LYPD1 "LYPDC1, MGC29643" ENSG00000150551 "LY6/PLAUR domain containing 1" Q8N2G4 2 132644853-132671579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;fallopian tube: 74.6" "Group enriched" "Detected in many" 5 "Ductal cells: 49.4;Exocrine glandular cells: 65.7;monocytes: 108.2;Pancreatic endocrine cells: 67.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 57.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 10.9" "Lineage enriched" "Detected in single" 36 "granulocytes: 10.9" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 17.4;HUVEC TERT2: 14.8;SK-MEL-30: 15.2;SuSa: 13.7;U-251 MG: 31.7;WM-115: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068333 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA068333: " "unprognostic (9.25e-2)" "unprognostic (7.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.07e-2)" "unprognostic (6.40e-3)" "unprognostic (5.60e-2)" "unprognostic (8.36e-3)" "unprognostic (1.05e-2)" "unprognostic (6.70e-2)" "unprognostic (2.86e-2)" "unprognostic (1.51e-2)" "unprognostic (1.43e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" 1.5 2.5 16.4 1.7 27.8 1.2 1.4 3.8 16.8 1.3 2.5 4.6 0.0 1.4 2.5 1.8 1.4 74.6 3.6 1.8 18.9 19.0 3.2 1.6 1.4 3.5 16.9 5.4 8.4 3.5 2.0 12.4 1.2 11.8 1.4 1.4 5.4 21.7 1.4 1.2 1.5 1.4 1.8 7.0 1.3 1.4 1.5 3.4 1.2 1.3 1.1 2.5 1.4 0.0 0.3 0.0 10.9 0.0 0.0 0.0 0.0 0.2 4.8 5.4 0.0 0.0 0.0 0.0 1.1 0.6 2.4 0.5 0.4 0.6 0.0 10.1 2.0 1.6 5.2 0.0 0.0 1.2 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 1.0 14.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.3 0.1 2.1 0.0 0.0 0.0 7.1 0.1 0.7 1.3 0.6 0.0 15.2 13.7 0.0 0.1 0.7 0.3 7.6 3.2 31.7 0.0 0.0 0.0 6.2 0.0 63.9 1.3 0.0 10.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 27.8 3.8 11.0 18.9 19.0 16.9 5.4 11.8 3.4 0.0 0.0 0.0 0.0 0.1 0.8 0.2 5.1 0.0 0.0 5.2 0.0 0.0 1.7 49.4 4.4 0.0 0.0 0.0 65.7 0.0 0.1 0.1 0.0 0.0 0.1 14.3 1.7 0.6 0.3 6.3 3.7 0.0 0.0 108.2 0.0 1.5 67.6 0.0 0.0 2.2 0.8 0.0 5.3 1.1 1.8 0.0 0.0 0.0 0.0 0.0 LYPD6B "CT116, LYPD7" ENSG00000150556 "LY6/PLAUR domain containing 6B" Q8NI32 2 149038107-149215262 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 38.9" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 202.8;Late spermatids: 80.2;Suprabasal keratinocytes: 60.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "basophil: 14.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.0" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 26.0;LHCN-M2: 41.7;NB-4: 13.6;RT4: 22.0;SK-BR-3: 13.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049239 Uncertain "Intracellular and membrane" NA NA "HPA049239: AB_2680688" "unprognostic (2.42e-2)" "unprognostic (1.65e-1)" "unprognostic (8.42e-2)" "unprognostic (3.12e-3)" "unprognostic (1.64e-1)" "unprognostic (3.37e-1)" "unprognostic (2.01e-2)" "unprognostic (6.27e-2)" "unprognostic (3.64e-2)" "unprognostic (7.95e-3)" "unprognostic (2.59e-2)" "unprognostic (4.40e-2)" "unprognostic (1.77e-2)" "unprognostic (1.45e-1)" "unprognostic (2.85e-1)" "unprognostic (2.68e-1)" "unprognostic (1.32e-3)" 0.2 0.2 1.4 0.1 1.5 0.0 8.9 0.7 2.4 1.4 2.3 0.6 21.8 1.1 1.1 0.5 2.1 12.2 27.3 0.1 5.0 2.4 4.0 0.4 2.7 2.4 0.7 0.6 1.7 13.2 9.8 0.6 0.6 0.9 5.0 1.5 2.5 11.9 26.6 0.1 38.9 2.9 1.8 0.6 1.3 20.3 16.9 0.7 0.2 0.2 0.6 2.3 9.1 3.7 2.8 0.0 14.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.6 2.7 1.0 0.3 0.0 0.0 0.0 26.0 0.0 5.6 0.6 0.6 8.6 0.0 3.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 9.4 0.0 13.6 0.8 5.8 0.1 0.0 0.1 1.7 1.3 22.0 1.5 0.0 0.1 13.2 0.0 2.7 1.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 14.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 1.5 0.7 2.4 5.0 2.4 0.7 0.6 0.9 0.7 0.0 1.3 2.0 20.2 26.6 0.0 1.1 50.9 22.7 6.8 43.6 0.0 0.0 6.6 10.6 202.8 0.8 3.6 0.0 16.3 0.5 0.8 26.4 0.0 0.0 0.1 0.0 2.4 0.0 0.0 80.2 2.0 1.1 5.0 1.0 3.1 0.0 23.2 6.5 0.0 0.0 0.0 0.0 0.9 1.5 1.5 60.3 0.2 0.0 2.5 35.1 LYPLA1 LPL1 ENSG00000120992 "Lysophospholipase I" O75608 8 54046367-54102017 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 729.6;Late spermatids: 528.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050941, HPA063151" Enhanced Approved Nucleoplasm,Cytosol NA NA 1700000 "Nucleoplasm, Cytosol" "HPA050941: AB_2681284, HPA063151: " "unprognostic (2.62e-2)" "unprognostic (1.28e-2)" "unprognostic (3.25e-3)" "unprognostic (9.42e-2)" "unprognostic (9.48e-2)" "unprognostic (3.56e-1)" "unprognostic (9.58e-2)" "unprognostic (2.05e-2)" "unprognostic (6.52e-3)" "unprognostic (3.76e-2)" "prognostic unfavorable (2.34e-4)" "unprognostic (2.58e-1)" "unprognostic (2.15e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (2.56e-3)" 14.1 17.7 7.2 12.2 8.9 13.4 16.4 10.8 15.2 10.7 14.6 6.9 4.7 15.4 8.0 11.1 30.4 8.0 11.9 27.1 6.8 6.8 31.1 37.3 13.6 23.4 7.3 4.9 12.3 24.3 9.0 7.4 51.1 12.0 15.3 15.2 17.0 23.3 7.1 26.4 22.1 17.6 10.4 6.3 14.0 14.9 64.8 4.1 21.3 13.3 19.3 19.7 24.6 17.3 29.1 37.1 42.7 40.4 27.1 29.2 35.1 30.2 17.1 22.3 20.0 8.1 13.2 28.1 18.1 10.4 16.8 15.8 12.3 29.4 53.0 21.2 11.7 18.5 20.3 31.3 30.1 23.4 19.2 17.1 36.9 10.9 19.8 13.3 22.5 50.1 11.6 26.6 13.0 29.4 14.4 43.3 23.1 37.4 16.1 23.2 8.0 34.3 17.2 33.1 50.7 7.9 20.8 11.8 24.2 25.8 41.0 11.7 20.0 12.7 23.8 27.8 22.1 34.7 20.2 20.8 10.1 14.8 17.5 16.7 22.5 33.8 47.8 13.7 24.0 19.8 31.4 33.1 42.7 19.1 31.1 19.0 29.1 18.2 18.4 37.1 23.9 18.4 17.8 19.5 27.1 40.4 23.8 29.2 35.1 7.2 8.9 10.8 15.2 6.8 6.8 7.3 4.9 12.0 4.1 26.8 44.0 77.0 68.7 54.8 33.9 58.1 45.9 38.8 33.0 59.3 49.1 180.5 257.0 74.6 729.6 72.2 62.9 0.0 77.4 255.5 43.3 142.6 49.5 102.9 105.0 17.5 55.2 78.0 108.6 528.5 26.2 78.4 70.9 59.5 73.4 26.2 94.9 67.1 21.5 145.1 62.5 45.3 42.2 70.4 176.9 70.9 279.5 61.2 78.8 160.0 LYSMD3 FLJ13542 ENSG00000176018 "LysM domain containing 3" Q7Z3D4 5 90515611-90529584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018024 Approved Approved Cytosol NA NA Cytosol "HPA018024: AB_2138525" "unprognostic (4.50e-2)" "unprognostic (1.85e-2)" "prognostic favorable (3.83e-4)" "unprognostic (5.59e-2)" "unprognostic (5.61e-2)" "unprognostic (9.80e-3)" "unprognostic (3.99e-2)" "unprognostic (4.66e-2)" "unprognostic (6.23e-2)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (2.02e-1)" "prognostic favorable (9.25e-4)" "unprognostic (1.81e-1)" "unprognostic (8.48e-2)" "unprognostic (4.97e-3)" "unprognostic (9.46e-2)" 12.7 14.0 8.9 11.1 10.5 9.3 11.1 16.0 11.2 15.8 14.1 4.7 16.2 11.8 13.1 9.3 12.0 11.2 12.8 15.7 10.2 8.9 21.1 33.6 15.6 12.9 11.9 6.1 19.1 13.1 24.5 31.1 19.0 12.2 12.9 10.8 7.3 13.3 21.2 16.6 6.4 17.4 10.5 12.1 14.6 9.5 6.6 12.7 18.5 18.8 9.0 11.4 15.4 12.5 6.4 7.3 27.7 9.4 11.9 10.4 7.4 10.3 6.9 8.9 9.4 14.0 14.3 8.8 16.6 18.1 11.6 19.1 5.9 10.7 12.8 7.2 14.5 18.1 5.3 13.7 16.2 22.7 9.4 8.6 9.7 8.6 9.6 14.5 8.1 16.5 10.5 11.4 10.6 17.8 12.4 16.5 8.4 9.3 19.6 12.9 9.1 9.3 4.7 4.4 2.6 11.8 8.8 15.1 18.4 12.7 7.1 2.7 5.5 9.8 7.5 13.5 7.4 8.5 7.7 20.5 7.0 9.9 15.3 11.9 22.4 14.2 10.9 11.9 13.9 10.9 27.7 7.7 11.6 6.5 9.4 10.4 6.4 7.5 7.9 7.3 5.4 10.3 8.8 11.5 11.9 9.3 3.5 8.1 7.4 8.9 10.5 16.0 11.2 10.2 8.9 11.9 6.1 12.2 12.7 32.8 21.9 13.7 9.3 12.7 10.2 22.1 7.6 14.7 21.6 12.2 3.9 8.4 1.7 6.4 0.8 15.5 13.7 23.3 7.0 8.2 18.2 18.7 25.4 28.8 7.7 19.1 20.7 16.0 14.0 1.3 15.5 14.4 6.8 6.4 11.1 18.9 5.9 8.6 12.4 10.1 12.8 19.4 17.8 7.0 4.1 14.4 11.7 15.4 9.0 8.0 LYSMD4 FLJ33008 ENSG00000183060 "LysM domain containing 4" Q5XG99 15 99715697-99733561 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029152, HPA059824" Approved Approved "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA029152: AB_10602033, HPA059824: AB_2684135" "unprognostic (2.43e-3)" "unprognostic (1.30e-2)" "unprognostic (1.53e-1)" "unprognostic (2.81e-1)" "unprognostic (4.07e-3)" "unprognostic (3.80e-2)" "unprognostic (1.53e-3)" "unprognostic (3.75e-1)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (6.35e-3)" "unprognostic (9.77e-2)" "unprognostic (1.02e-2)" "unprognostic (2.06e-1)" "unprognostic (9.23e-2)" "unprognostic (3.29e-2)" "unprognostic (3.30e-1)" 8.8 4.7 5.8 11.6 8.7 4.7 11.1 8.6 14.1 9.5 6.4 7.8 3.6 8.1 9.3 11.4 11.4 5.5 8.3 9.2 7.1 5.6 4.7 6.6 7.0 3.9 4.7 5.7 7.8 6.5 14.9 5.4 5.0 6.7 6.3 5.9 8.3 15.9 7.7 12.3 25.2 6.5 6.9 7.9 4.5 5.6 6.8 6.3 5.4 4.1 11.1 6.3 4.6 8.4 3.1 4.8 8.0 4.0 1.0 6.2 3.4 3.7 3.5 7.2 4.2 8.1 7.4 4.3 4.3 3.0 3.7 5.4 8.8 3.3 4.1 2.5 3.9 6.4 11.0 5.6 6.9 4.3 0.8 10.1 2.7 7.2 6.0 4.6 1.9 5.1 4.2 10.2 3.4 4.0 2.3 4.9 12.0 6.5 5.3 2.4 4.4 5.1 5.4 4.8 10.4 4.1 3.6 5.1 2.0 6.6 9.8 4.2 3.7 7.8 2.4 4.1 9.7 1.7 3.7 6.3 3.0 8.3 4.1 1.8 7.0 9.3 3.3 3.9 4.8 3.2 0.0 2.0 8.0 3.8 3.3 2.9 1.8 5.2 4.5 1.1 3.1 6.2 2.8 0.7 1.0 4.0 4.8 5.0 3.4 5.8 8.7 8.6 14.1 7.1 5.6 4.7 5.7 6.7 6.3 6.0 3.5 0.8 7.0 7.7 8.9 9.7 7.6 2.7 3.4 3.5 9.8 2.0 1.7 3.4 5.6 4.6 4.0 23.3 8.4 2.1 4.5 1.5 0.0 3.6 3.6 9.5 2.9 5.5 2.2 4.3 4.9 4.7 1.7 11.8 4.0 10.8 5.7 2.9 6.3 3.8 10.0 12.9 6.1 10.8 5.5 8.0 1.1 2.5 2.2 3.9 LYVE1 "LYVE-1, XLKD1" ENSG00000133800 "Lymphatic vessel endothelial hyaluronan receptor 1" Q9Y5Y7 11 10556966-10611689 "Plasma proteins, Predicted membrane proteins" Transport Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 87.6" "Group enriched" "Detected in many" 26 "Hofbauer cells: 604.0;Ito cells: 335.7;Kupffer cells: 258.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.0;neutrophil: 1.7" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 12 "HUVEC TERT2: 43.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB025860, HPA042953" Supported NA NA 3000000000 "CAB025860: , HPA042953: AB_2678238" "unprognostic (9.83e-2)" "unprognostic (1.52e-1)" "unprognostic (1.87e-1)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "unprognostic (1.94e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.07e-4)" "unprognostic (7.53e-2)" "unprognostic (4.09e-2)" "prognostic unfavorable (6.98e-5)" "unprognostic (1.67e-2)" "unprognostic (2.51e-1)" "unprognostic (1.07e-1)" "unprognostic (2.43e-3)" 51.8 28.6 3.3 7.4 4.2 0.4 23.0 2.8 2.8 7.9 26.4 2.4 2.9 5.3 5.3 20.8 17.7 17.2 8.0 19.8 3.8 2.0 18.0 31.1 15.7 47.7 3.2 1.6 11.0 5.4 1.6 3.6 56.6 6.2 15.2 8.0 6.0 4.8 4.7 15.4 5.1 17.8 25.5 2.9 87.6 8.4 11.9 2.5 0.0 21.4 9.1 2.7 25.9 10.9 0.7 0.0 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 43.2 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.3 4.2 2.8 1.8 3.8 2.0 3.2 1.6 6.2 2.5 0.0 3.2 7.0 0.0 3.3 0.0 3.1 15.3 2.7 0.0 0.0 0.0 4.6 0.0 0.0 0.7 11.4 0.0 0.0 0.0 4.4 4.4 0.1 1.1 1.5 604.0 0.0 0.0 335.7 258.9 0.8 3.4 8.5 6.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 12.9 5.1 0.0 0.0 2.9 9.3 0.0 0.0 0.1 M6PR "CD-M6PR, CD-MPR" ENSG00000003056 "Mannose-6-phosphate receptor, cation dependent" P20645 12 8940363-8949955 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Hofbauer cells: 214.9;monocytes: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 127.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034464, HPA040445" Approved NA NA 280000 "CAB034464: AB_2139108, HPA040445: AB_2676989" "unprognostic (2.43e-1)" "unprognostic (1.22e-1)" "unprognostic (1.74e-2)" "unprognostic (1.54e-1)" "unprognostic (3.00e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (3.89e-4)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "unprognostic (5.82e-3)" "unprognostic (1.44e-2)" "unprognostic (6.82e-2)" "unprognostic (4.53e-3)" "unprognostic (3.79e-2)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (3.98e-1)" 37.9 40.5 24.7 40.7 27.6 34.8 32.3 21.8 39.6 25.6 28.3 26.3 27.9 20.8 37.4 26.2 30.0 29.2 28.0 36.5 23.3 22.8 37.2 50.6 42.8 46.8 27.4 23.0 30.1 40.0 31.3 24.8 34.0 24.2 27.8 35.2 26.1 37.0 29.4 32.3 27.7 36.9 31.7 26.5 56.1 31.6 33.9 25.2 43.1 46.9 24.4 44.8 34.3 27.2 17.6 47.4 75.4 74.6 22.1 30.4 57.5 14.7 23.0 15.4 17.3 27.2 13.1 46.4 19.4 22.6 26.7 29.4 24.5 36.0 25.8 7.1 20.4 58.1 22.3 21.8 19.4 30.9 127.9 12.0 45.0 19.3 18.3 32.3 48.9 85.5 19.7 23.0 28.6 36.3 26.5 14.5 18.9 12.7 17.1 23.1 14.4 17.5 16.3 53.7 26.7 9.8 16.9 33.9 14.2 20.6 37.4 3.5 15.8 21.4 20.4 25.6 57.2 5.1 31.3 14.6 22.1 26.4 26.6 28.5 21.6 37.7 29.4 25.6 29.8 16.2 75.4 40.3 42.9 26.9 64.5 29.7 17.6 30.4 28.0 47.4 14.5 22.5 25.4 5.9 22.1 74.6 28.2 23.9 57.5 24.7 27.6 21.8 39.6 23.3 22.8 27.4 23.0 24.2 25.2 53.6 53.6 73.6 61.1 39.2 43.5 8.7 17.8 60.2 69.4 29.6 21.6 56.3 16.6 78.0 6.0 32.2 18.8 23.3 58.0 58.9 32.0 49.1 127.2 22.7 214.9 52.4 36.8 31.9 110.8 5.2 32.5 120.2 64.1 227.2 29.6 31.8 48.3 24.6 30.1 33.8 31.4 25.8 44.8 102.2 45.3 35.4 44.4 78.7 41.7 55.7 MACF1 "ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF" ENSG00000127603 "Microtubule-actin crosslinking factor 1" Q9UPN3 1 39081316-39487177 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" Actin-binding "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 734.3;Rod photoreceptor cells: 425.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013713, HPA068064, HPA068103" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" NA NA "Plasma membrane, Cell Junctions, Actin filaments" "HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953" "unprognostic (2.71e-1)" "unprognostic (3.14e-2)" "unprognostic (5.18e-2)" "unprognostic (1.02e-2)" "unprognostic (9.00e-2)" "unprognostic (6.19e-3)" "unprognostic (1.32e-1)" "unprognostic (7.40e-3)" "unprognostic (5.45e-2)" "unprognostic (1.23e-1)" "unprognostic (1.34e-1)" "unprognostic (3.98e-1)" "prognostic favorable (2.77e-5)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (8.57e-2)" "unprognostic (4.22e-2)" 24.1 22.6 41.4 21.4 44.0 21.2 25.2 62.6 54.0 37.1 42.2 35.3 22.7 11.9 66.5 33.6 20.3 28.0 31.5 39.0 35.9 32.7 27.2 24.4 53.5 21.2 41.1 28.6 41.5 25.0 46.2 37.1 22.8 40.5 26.3 18.2 23.3 26.0 32.0 40.8 59.2 18.4 56.7 37.0 29.7 22.9 17.7 39.0 13.3 34.5 17.9 16.0 28.0 34.8 4.8 2.6 4.9 2.8 6.4 13.7 2.0 12.6 15.4 19.0 8.6 16.8 17.4 8.2 17.4 23.6 10.8 10.8 9.2 15.3 6.6 18.4 24.7 18.1 8.4 3.4 12.5 15.1 12.7 9.4 11.7 11.5 14.9 19.2 10.8 5.0 11.8 12.9 29.9 16.1 24.8 38.2 23.1 17.2 9.0 42.4 4.2 6.1 14.1 26.2 5.3 9.1 11.5 29.1 1.2 56.4 13.7 10.5 10.7 6.9 4.7 16.6 23.9 2.0 10.7 43.0 17.7 14.2 8.4 30.4 5.4 5.2 7.9 29.0 10.3 16.2 4.9 1.5 3.8 13.7 2.7 6.7 2.3 6.8 8.6 1.9 4.8 5.4 6.8 1.3 6.4 2.8 2.6 2.9 2.0 41.4 44.0 62.6 54.0 35.9 32.7 41.1 28.6 40.5 39.0 140.0 115.4 34.3 51.5 137.1 376.9 222.7 76.5 60.2 85.3 76.8 734.3 41.1 0.0 105.2 8.2 146.8 21.9 0.0 98.3 49.9 58.2 60.0 73.1 41.2 44.1 111.2 34.7 127.1 56.4 6.8 40.6 41.9 67.4 45.1 23.8 104.0 136.1 16.9 105.7 7.9 425.5 103.5 69.7 34.4 25.0 167.4 58.5 78.3 17.8 61.3 MACO1 "FLJ10747, TMEM57" ENSG00000204178 "Macoilin 1" Q8N5G2 1 25430858-25500209 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 25.4;Ductal cells: 30.7;Exocrine glandular cells: 53.7;Pancreatic endocrine cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019680 Approved Cytosol NA NA Cytosol "HPA019680: AB_1858125" "unprognostic (2.42e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.83e-2)" "unprognostic (2.16e-1)" "unprognostic (1.10e-2)" "unprognostic (5.39e-2)" "unprognostic (1.69e-2)" "unprognostic (6.40e-2)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (7.02e-2)" "prognostic favorable (7.13e-4)" "unprognostic (2.54e-2)" "unprognostic (4.22e-2)" "unprognostic (5.22e-2)" "unprognostic (5.35e-3)" 9.8 16.5 12.1 6.9 11.3 26.5 8.9 27.8 13.2 9.2 8.9 11.3 12.7 9.5 9.7 11.9 17.2 7.9 8.8 8.8 8.7 9.4 11.9 33.0 9.4 7.8 12.9 11.5 17.2 28.1 11.4 12.8 8.1 11.3 12.9 9.2 10.4 20.7 13.5 31.2 10.7 9.7 8.5 10.1 9.6 11.5 15.6 13.8 17.9 13.2 12.5 11.1 10.5 10.2 2.6 4.0 6.8 2.5 1.5 3.0 0.7 10.2 3.4 10.5 18.9 12.7 9.7 5.6 11.0 11.5 9.9 10.9 3.1 13.7 20.7 12.8 12.1 6.3 10.6 8.9 10.4 10.4 10.7 8.7 25.7 5.8 8.5 9.0 9.1 18.9 9.6 12.8 14.5 9.7 8.9 11.2 12.7 16.9 7.5 9.7 6.2 22.0 11.8 12.4 9.4 5.6 13.5 11.1 16.3 10.9 5.2 17.8 19.3 8.3 21.1 13.2 9.3 7.7 11.2 13.1 11.8 7.6 14.7 7.1 13.4 8.7 12.0 12.9 12.6 9.2 6.8 1.1 6.2 2.1 0.9 3.0 1.6 2.4 2.7 1.4 2.6 2.5 3.0 0.5 1.5 2.5 4.0 1.4 0.7 12.1 11.3 27.8 13.2 8.7 9.4 12.9 11.5 11.3 13.8 17.9 20.5 0.0 0.0 0.0 0.0 0.0 0.0 25.4 20.5 7.0 0.0 11.1 5.0 30.7 0.0 0.0 0.0 0.0 53.7 16.7 0.0 0.0 9.3 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 12.6 0.0 0.0 38.1 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 MADCAM1 MACAM1 ENSG00000099866 "Mucosal vascular addressin cell adhesion molecule 1" Q13477 19 489176-505342 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 19.9;lymphoid tissue: 27.2" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 6.6;Collecting duct cells: 3.5;Muller glia cells: 6.5;Rod photoreceptor cells: 5.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "neutrophil: 10.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 10.3" "Cell line enhanced" "Detected in some" "HEK 293: 3.7;Hep G2: 4.4;U-266/70: 4.9" "CAB075699, HPA077998" Enhanced NA NA 41000000 "CAB075699: , HPA077998: " "unprognostic (2.30e-1)" "unprognostic (7.81e-2)" "unprognostic (5.52e-2)" "unprognostic (1.56e-1)" "unprognostic (7.56e-2)" "unprognostic (6.26e-4)" "unprognostic (1.68e-2)" "unprognostic (2.17e-4)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" "unprognostic (2.44e-2)" "unprognostic (1.09e-1)" "unprognostic (2.54e-4)" "unprognostic (2.42e-1)" "unprognostic (4.95e-3)" "unprognostic (9.80e-2)" "unprognostic (2.07e-2)" 1.4 0.9 4.6 27.2 5.2 0.9 1.1 6.8 6.3 0.7 5.6 0.9 1.2 5.1 0.9 3.3 1.6 0.6 19.9 0.7 3.6 2.9 0.7 0.9 0.8 3.2 2.4 3.1 0.7 3.3 2.9 2.9 0.9 2.7 0.9 5.0 0.5 1.3 0.7 1.5 0.9 12.1 0.8 2.4 13.7 5.0 1.6 3.2 1.0 2.3 0.0 0.8 0.7 1.5 1.0 0.4 10.3 0.4 0.4 1.2 0.1 0.8 0.1 0.3 1.2 1.1 0.1 1.5 0.3 0.2 0.4 0.1 0.8 0.5 0.5 2.5 0.2 0.5 1.3 0.2 0.0 0.1 2.8 3.7 0.0 2.3 4.4 0.1 0.1 2.8 1.2 0.2 0.3 0.0 0.4 0.0 0.8 0.8 2.0 0.4 2.7 0.2 1.4 0.4 0.1 2.1 0.7 0.0 0.2 0.0 0.6 1.8 0.4 0.2 0.3 0.2 0.2 0.1 0.0 0.0 1.5 0.3 1.0 0.2 4.9 1.7 0.9 0.2 1.2 0.1 0.0 0.4 1.0 0.5 0.4 0.6 0.6 0.4 0.3 0.1 1.0 1.2 1.2 10.3 0.4 0.3 0.4 0.0 0.1 4.6 5.2 6.8 6.3 3.6 2.9 2.4 3.1 2.7 3.2 0.0 0.0 0.0 0.4 0.5 6.6 0.8 0.0 1.4 0.0 3.5 0.0 0.5 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.2 0.7 0.6 0.0 0.0 0.4 1.6 0.0 2.5 0.0 0.0 0.9 0.0 0.0 0.0 0.6 6.5 0.1 0.0 0.7 0.7 5.1 0.0 0.9 2.2 2.5 0.4 0.2 0.0 0.0 0.4 MAG "GMA, S-MAG, SIGLEC-4A, SIGLEC4A" ENSG00000105695 "Myelin associated glycoprotein" P20916 19 35292125-35313804 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 113.6" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 2.8;Distal tubular cells: 1.7;Extravillous trophoblasts: 2.5;granulocytes: 4.6;Ito cells: 1.8;Leydig cells: 1.7;Spermatogonia: 1.9" "Cancer enriched" "Detected in some" 7 "glioma: 20.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 15 "dendritic cells: 6.4" "Cell line enriched" "Detected in some" 22 "WM-115: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009345, HPA012499" Enhanced NA NA "CAB009345: AB_670104, HPA012499: AB_1854238" "unprognostic (2.70e-3)" "unprognostic (2.70e-2)" "unprognostic (8.06e-3)" "unprognostic (1.23e-1)" "unprognostic (6.93e-2)" "unprognostic (3.74e-1)" "unprognostic (1.50e-1)" "unprognostic (2.39e-1)" "unprognostic (1.06e-1)" "unprognostic (2.00e-1)" "unprognostic (5.62e-2)" "unprognostic (5.18e-4)" "unprognostic (6.29e-2)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.66e-1)" 1.5 2.3 19.5 1.4 29.9 1.4 1.5 3.6 90.8 1.5 1.4 97.0 0.0 1.4 1.6 1.4 1.5 5.1 1.4 1.4 36.7 19.1 1.5 1.6 1.7 1.5 48.9 18.0 21.8 1.4 1.4 0.1 1.7 38.0 1.5 1.4 0.0 1.4 1.7 1.4 1.4 1.5 1.4 113.6 1.6 1.4 1.7 38.1 0.0 1.8 0.0 1.5 1.4 0.1 0.4 6.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 28.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 6.4 0.0 0.1 19.5 29.9 3.6 38.5 36.7 19.1 48.9 18.0 38.0 38.1 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.3 0.0 4.6 0.0 1.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 MAGEH1 APR1 ENSG00000187601 "MAGE family member H1" Q9H213 X 55452105-55453566 "Predicted membrane proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "epididymis: 207.1" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011324, HPA011971" Uncertain Supported "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA011324: AB_1853499, HPA011971: " "unprognostic (2.50e-1)" "unprognostic (3.01e-1)" "unprognostic (4.07e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (3.95e-2)" "unprognostic (8.50e-2)" "unprognostic (1.13e-2)" "unprognostic (9.93e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "prognostic favorable (2.60e-4)" "unprognostic (6.37e-2)" "unprognostic (1.81e-2)" "unprognostic (1.29e-3)" "unprognostic (1.90e-1)" "unprognostic (3.95e-2)" "unprognostic (2.52e-1)" 8.3 13.2 21.5 7.6 21.6 3.0 8.1 19.9 29.7 13.5 7.5 14.4 13.8 5.2 13.3 207.1 5.2 19.2 8.3 10.2 22.8 32.1 11.4 8.7 10.2 9.0 19.8 20.6 16.1 11.9 9.0 22.5 9.2 17.9 20.8 5.9 11.4 8.9 19.6 5.7 5.6 6.3 11.8 17.2 8.1 9.3 18.2 15.3 10.8 12.4 5.2 7.5 8.5 10.0 9.4 14.0 9.5 8.5 8.3 26.0 9.4 0.0 2.6 15.0 0.0 24.3 14.7 0.2 16.2 15.0 4.5 12.1 0.0 3.4 0.0 22.3 16.3 8.5 2.2 5.6 6.1 7.1 18.7 0.9 5.0 0.0 2.0 8.0 0.2 6.5 12.2 0.5 2.6 1.9 4.2 6.8 5.4 2.8 20.1 4.9 9.6 13.3 4.3 4.2 0.0 3.1 8.4 1.9 10.5 8.2 0.0 0.1 11.4 0.0 4.4 6.7 11.8 2.1 3.8 7.9 6.2 7.2 3.7 0.8 12.0 15.1 2.1 11.5 7.0 7.8 5.0 4.4 9.5 11.3 6.8 10.1 9.4 18.7 12.9 6.7 8.8 26.0 16.1 0.6 8.3 8.5 14.0 24.7 9.4 21.5 21.6 19.9 28.4 22.8 32.1 19.8 20.6 17.9 15.3 6.0 11.8 20.4 7.1 7.1 37.4 7.9 22.9 9.4 18.2 12.2 9.8 2.2 11.6 27.6 0.8 20.5 1.0 0.0 9.3 1.3 39.5 9.9 12.7 13.6 12.7 35.0 15.2 30.7 2.5 2.1 43.7 7.1 20.3 10.8 6.4 51.7 5.9 7.0 60.1 14.4 15.4 25.8 37.6 1.2 1.7 5.5 1.4 10.7 4.5 3.0 MAGT1 "DKFZp564K142, IAP, MRX95, OST3B" ENSG00000102158 "Magnesium transporter 1" Q9H0U3 X 77826364-77895593 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049851 Approved "Intracellular and membrane" NA NA 14000 "HPA049851: AB_2680913" "prognostic unfavorable (1.30e-4)" "unprognostic (3.32e-1)" "unprognostic (6.47e-2)" "unprognostic (1.16e-1)" "unprognostic (2.39e-1)" "unprognostic (3.81e-3)" "unprognostic (1.07e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (8.98e-4)" "unprognostic (2.03e-2)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.03e-1)" "unprognostic (1.60e-2)" "unprognostic (5.56e-3)" "unprognostic (1.14e-1)" "unprognostic (6.25e-3)" "unprognostic (1.66e-1)" 17.3 17.1 11.3 11.7 15.4 9.2 18.3 4.7 10.1 21.4 15.5 25.9 17.5 12.7 17.5 28.1 18.4 14.2 13.1 22.3 11.5 9.5 29.0 69.5 20.4 20.3 19.3 8.2 19.8 49.8 20.0 21.3 28.6 14.0 17.3 13.8 13.6 28.9 17.6 13.7 14.1 22.4 13.4 22.6 21.0 14.5 11.1 18.2 19.8 45.3 11.0 17.6 18.2 15.4 14.3 23.6 13.2 21.3 18.5 20.8 17.3 23.1 13.6 16.4 18.4 28.1 19.5 25.2 25.1 25.0 19.7 21.6 17.0 38.5 16.6 34.5 27.1 20.7 21.7 34.3 18.4 31.2 12.3 20.8 11.2 20.3 15.1 25.0 23.2 12.5 17.0 15.9 26.1 21.8 20.3 27.9 11.8 13.4 48.7 23.4 14.8 13.6 8.3 21.1 22.8 15.3 16.7 27.3 31.1 22.7 17.1 5.4 9.9 34.5 23.6 20.7 16.9 16.9 12.5 28.4 18.0 20.5 27.8 12.5 17.1 38.0 21.7 19.8 21.7 23.3 12.8 14.2 13.2 20.6 21.1 20.8 14.3 17.9 18.9 12.4 12.3 17.8 20.7 11.9 18.5 21.3 23.6 13.0 17.3 11.3 15.4 4.7 10.1 11.5 9.5 19.3 8.2 14.0 18.2 38.7 53.0 20.1 43.3 29.3 5.4 40.3 58.6 13.4 38.7 38.4 3.9 29.0 3.3 29.8 1.6 35.9 32.9 46.7 30.6 45.3 37.3 74.8 29.0 127.0 37.8 1.6 21.8 43.6 35.8 1.1 28.4 35.6 32.1 21.6 34.3 15.8 34.2 30.0 25.5 25.2 4.6 19.4 26.7 3.2 16.9 39.9 68.0 29.9 24.1 56.7 MAL ENSG00000172005 "Mal, T cell differentiation protein" P21145 2 95025677-95053996 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "esophagus: 447.4" "Cell type enhanced" "Detected in many" 24 "Collecting duct cells: 354.2;Distal tubular cells: 200.6;Muller glia cells: 85.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 42.0;naive CD4 T-cell: 57.9;naive CD8 T-cell: 26.4;T-reg: 40.1" "Lineage enriched" "Detected in many" 44 "T-cells: 57.9" "Cell line enhanced" "Detected in some" "HDLM-2: 45.9;MOLT-4: 64.2;RPMI-8226: 22.7;RPTEC TERT1: 232.7" "Low region specificity" "Detected in all" HPA065691 Approved "Golgi apparatus,Centrosome" NA NA "Golgi apparatus" Centrosome "HPA065691: AB_2685533" "unprognostic (1.57e-3)" "unprognostic (2.64e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (5.18e-6)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (5.13e-2)" "unprognostic (2.35e-2)" "unprognostic (1.06e-1)" "unprognostic (3.59e-1)" "unprognostic (4.61e-2)" "unprognostic (3.89e-2)" "prognostic favorable (3.96e-9)" "unprognostic (1.91e-1)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.57e-1)" 2.3 2.0 14.3 3.5 21.8 3.7 2.0 1.8 20.6 35.8 3.7 43.2 0.4 2.0 1.8 3.4 447.4 3.4 2.2 3.3 18.2 8.3 53.1 1.7 4.3 5.9 27.4 13.2 2.0 1.9 1.6 0.2 2.2 11.8 2.5 2.9 2.8 42.5 3.9 2.0 3.7 2.4 2.1 27.6 3.2 9.3 1.7 27.2 35.0 5.8 56.1 90.1 2.6 64.8 0.6 0.2 0.4 0.1 1.3 57.9 13.7 4.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 64.2 0.0 0.0 0.0 0.0 0.0 0.0 22.7 232.7 5.8 0.0 0.0 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.4 0.6 42.0 7.5 0.0 0.5 57.9 26.4 0.4 1.3 0.0 0.2 40.1 13.7 14.3 21.8 1.8 20.6 18.2 8.3 27.4 13.2 11.8 27.2 0.0 0.0 0.0 0.1 1.0 1.1 8.1 0.0 0.0 0.0 354.2 3.9 0.1 200.6 0.1 5.3 0.1 0.0 0.0 0.0 0.0 1.9 0.2 1.1 0.0 0.1 4.8 0.0 4.3 0.0 16.2 0.9 0.5 16.9 0.0 0.0 85.5 0.1 0.0 0.0 2.8 2.5 6.5 1.5 0.0 0.4 0.9 0.2 17.0 0.0 0.7 MAL2 ENSG00000147676 "Mal, T cell differentiation protein 2 (gene/pseudogene)" Q969L2 8 119165034-119245673 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 70.4" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 369.9;Suprabasal keratinocytes: 398.5;Urothelial cells: 421.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 104.3;HaCaT: 46.6;OE19: 114.7;RPTEC TERT1: 40.4;SK-BR-3: 150.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043831 Uncertain NA NA "HPA043831: " "prognostic unfavorable (4.57e-6)" "unprognostic (3.12e-1)" "unprognostic (4.04e-1)" "prognostic unfavorable (8.44e-5)" "unprognostic (2.10e-2)" "unprognostic (1.83e-2)" "unprognostic (1.03e-2)" "unprognostic (7.20e-2)" "unprognostic (5.86e-2)" "unprognostic (2.00e-3)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.09e-1)" "prognostic favorable (2.39e-5)" "unprognostic (5.48e-2)" "unprognostic (1.34e-1)" "unprognostic (3.33e-1)" "unprognostic (9.27e-3)" 3.3 1.3 7.8 5.5 21.1 0.0 17.4 17.4 26.4 13.1 25.5 1.6 19.2 16.0 1.5 5.4 70.4 13.9 16.2 1.9 8.6 4.0 22.8 11.5 20.4 0.0 2.2 11.8 1.3 19.0 9.3 22.7 6.6 1.2 6.8 24.3 0.6 21.1 16.9 1.1 31.0 18.3 0.5 1.8 1.2 33.8 3.3 1.6 0.5 43.8 30.4 31.5 13.3 28.5 0.0 0.0 0.0 0.0 0.0 0.6 0.1 104.3 0.0 0.1 0.0 0.0 0.0 9.7 0.0 0.2 0.1 0.1 8.9 34.0 0.0 5.9 0.0 0.0 46.6 0.0 3.3 0.0 0.0 0.2 0.0 1.5 8.6 0.0 0.0 0.0 0.0 23.7 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.8 114.7 32.1 0.0 0.0 0.0 40.4 26.2 5.9 0.0 1.8 150.4 0.3 0.7 19.9 0.3 0.0 0.0 0.3 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.8 21.1 17.4 26.4 8.6 4.0 2.2 11.8 1.2 1.6 104.2 103.7 5.7 58.8 102.0 1.8 1.4 79.0 52.2 76.2 369.9 0.0 18.2 92.9 208.4 0.4 0.6 183.7 0.0 156.8 18.1 7.3 197.7 14.9 43.1 2.4 4.8 40.2 0.6 0.3 1.1 0.6 4.4 15.1 6.4 101.9 0.3 231.3 126.8 0.0 14.7 1.0 0.0 2.8 1.1 5.5 398.5 7.8 2.5 89.8 421.4 MALL BENE ENSG00000144063 "Mal, T cell differentiation protein like" Q13021 2 110083870-110116566 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 107.7;intestine: 142.1;lung: 72.9" "Cell type enhanced" "Detected in many" 14 "Ductal cells: 224.3;Enterocytes: 724.1;Pancreatic endocrine cells: 223.5;Urothelial cells: 444.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 9.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 9.3" "Cell line enhanced" "Detected in some" "A-431: 40.7;A549: 39.9;CAPAN-2: 55.2;fHDF/TERT166: 60.6;HaCaT: 43.0;PC-3: 24.4" "Low region specificity" "Detected in single" HPA051410 Uncertain NA NA "HPA051410: AB_2681474" "unprognostic (5.17e-1)" "unprognostic (4.15e-2)" "unprognostic (2.92e-1)" "unprognostic (3.53e-1)" "unprognostic (1.92e-2)" "unprognostic (1.66e-1)" "unprognostic (2.22e-1)" "unprognostic (4.46e-2)" "unprognostic (6.50e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (2.37e-1)" "unprognostic (7.27e-2)" "unprognostic (2.23e-1)" "unprognostic (2.84e-1)" "unprognostic (2.80e-1)" "unprognostic (6.50e-3)" 5.5 1.0 0.9 11.1 2.1 0.1 7.7 0.4 1.1 22.5 46.4 0.2 1.3 41.2 6.0 2.7 107.7 2.8 6.7 10.8 1.7 1.0 1.9 1.1 72.9 3.7 1.1 0.2 1.6 2.9 49.8 1.0 3.7 3.6 5.5 19.0 1.6 11.2 1.5 2.1 11.1 142.1 5.1 4.2 2.0 1.8 2.2 0.4 0.6 5.6 45.8 63.8 7.8 35.4 0.9 0.7 9.3 0.7 2.1 1.0 0.5 40.7 39.9 0.0 0.1 0.0 0.0 0.1 7.9 0.4 0.0 0.0 6.6 55.2 0.1 20.1 60.6 0.0 43.0 0.0 2.3 0.0 0.1 0.0 0.3 1.1 0.0 0.3 0.0 0.1 0.9 2.2 0.1 0.0 0.0 19.8 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 19.1 24.4 0.0 0.0 0.1 5.2 2.3 0.1 0.0 0.0 1.4 0.1 0.0 0.0 0.2 20.3 0.0 0.1 0.1 0.1 0.0 0.0 4.7 0.0 0.0 0.0 9.3 0.7 1.0 0.4 0.4 0.4 0.7 0.8 0.7 0.3 0.9 0.5 1.0 4.4 2.1 0.2 0.7 0.6 0.5 0.9 2.1 0.4 1.1 1.7 1.0 1.1 0.2 3.6 0.4 38.7 157.7 0.0 55.9 14.5 0.0 2.8 5.1 10.7 42.1 1.8 0.0 0.1 0.0 224.3 19.6 50.2 724.1 0.0 57.6 0.1 7.4 142.5 6.9 0.6 6.2 0.0 16.8 27.6 1.2 5.6 2.3 1.8 13.5 1.8 39.1 0.0 223.5 112.2 1.1 11.3 0.0 0.0 5.0 7.7 0.9 11.5 0.5 1.3 52.5 444.9 MALRD1 "bA265G8.2, C10orf112, Diet1" ENSG00000204740 "MAM and LDL receptor class A domain containing 1" Q5VYJ5 10 19048771-19790401 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "intestine: 60.5" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 2.6;Early spermatids: 6.8;Spermatocytes: 6.3" "Cancer enhanced" "Detected in some" "stomach cancer: 1.1" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 3.6" "Cell line enriched" "Detected in some" 10 "Karpas-707: 31.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035732, HPA038106, HPA046848" Uncertain Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837" "unprognostic (9.03e-3)" "unprognostic (1.38e-1)" "unprognostic (2.40e-2)" "unprognostic (4.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (2.74e-2)" "unprognostic (5.57e-2)" "unprognostic (5.01e-1)" "unprognostic (1.00e-1)" "unprognostic (3.55e-1)" "unprognostic (7.69e-2)" "unprognostic (3.16e-2)" "unprognostic (9.80e-2)" "unprognostic (8.90e-2)" "unprognostic (3.13e-2)" "unprognostic (3.78e-4)" 0.5 0.8 2.0 0.3 2.0 0.4 0.6 0.3 0.9 0.8 19.4 0.6 0.1 25.2 1.3 2.3 0.3 0.3 0.4 1.3 1.6 0.8 1.3 0.3 0.9 0.2 0.8 0.0 1.1 0.3 0.1 4.7 0.4 0.8 0.9 0.2 1.4 0.5 0.4 0.5 0.4 60.5 1.3 0.7 0.3 0.5 1.7 0.7 2.6 0.6 0.3 0.1 0.5 0.5 0.0 3.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 31.9 0.0 3.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.0 3.6 0.0 0.0 2.0 2.0 0.3 0.9 1.6 0.8 0.8 0.0 0.8 0.7 0.0 2.6 0.0 0.2 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 6.8 0.0 0.0 0.0 0.0 0.4 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.7 0.0 0.0 0.0 0.4 6.3 2.1 0.1 0.2 0.0 0.0 0.0 MAMDC4 "AEGP, DKFZp434M1411" ENSG00000177943 "MAM domain containing 4" Q6UXC1 9 136850943-136860799 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;liver: 48.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 19.8;Hepatocytes: 16.6;Horizontal cells: 15.9;Mucus-secreting cells: 19.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 10 "cerebellum: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 18.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB026377, HPA059977" Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB026377: , HPA059977: AB_2684186" "unprognostic (2.79e-1)" "unprognostic (7.90e-2)" "unprognostic (4.09e-3)" "unprognostic (6.86e-2)" "unprognostic (8.33e-2)" "unprognostic (2.66e-4)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "unprognostic (1.31e-1)" "unprognostic (7.37e-2)" "prognostic favorable (1.88e-6)" "unprognostic (8.22e-3)" "unprognostic (1.58e-2)" "unprognostic (1.22e-3)" "unprognostic (9.22e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" 2.0 1.6 1.2 1.9 1.5 1.4 1.2 14.9 1.2 1.2 2.3 1.2 1.2 5.0 1.2 1.2 1.2 1.7 1.2 1.6 1.2 0.4 2.6 48.9 1.2 2.5 1.2 1.2 1.2 3.4 0.5 7.2 1.2 1.2 3.2 0.9 1.2 3.5 1.4 1.7 1.5 6.1 1.2 1.2 5.1 2.3 6.5 1.2 1.2 5.1 1.2 1.2 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 1.6 2.6 1.5 2.9 0.6 0.1 18.9 2.7 0.3 0.3 0.6 2.0 1.6 1.4 0.6 0.7 0.8 2.2 0.3 1.3 0.0 2.1 0.9 0.8 5.3 2.3 1.2 0.2 4.9 0.8 1.7 1.4 0.6 1.4 0.6 2.5 2.7 1.2 0.2 4.2 1.0 3.7 1.4 1.1 0.7 1.6 0.4 2.5 0.9 1.4 1.7 2.1 0.6 1.3 1.1 1.0 4.4 0.9 0.8 7.6 4.8 1.5 0.4 3.1 1.6 0.4 1.7 2.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 14.9 1.2 1.2 0.4 1.2 1.2 1.2 1.2 0.0 4.3 0.0 0.8 0.7 5.4 6.2 12.7 2.7 0.0 1.8 0.0 2.2 1.7 0.8 1.7 1.4 19.8 0.0 4.4 2.8 2.6 1.3 0.0 16.6 2.4 15.9 0.0 2.5 2.4 1.9 1.7 2.2 0.0 1.0 19.5 2.6 0.9 12.5 1.4 2.1 7.4 0.0 1.4 1.2 2.2 0.4 1.9 1.3 10.3 0.7 MAN1A1 ENSG00000111885 "Mannosidase alpha class 1A member 1" P33908 6 119177209-119349761 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 149.9;Hepatocytes: 232.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 60.3;Hep G2: 42.3;Karpas-707: 47.2;U-266/70: 63.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037058, HPA053198, HPA063561" Uncertain Supported "Golgi apparatus" NA NA 390000000 "Golgi apparatus" "CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042" "unprognostic (1.50e-1)" "unprognostic (7.36e-3)" "unprognostic (4.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.95e-2)" "unprognostic (2.19e-1)" "unprognostic (3.33e-3)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" "unprognostic (5.11e-2)" "unprognostic (1.68e-3)" "unprognostic (4.62e-1)" "unprognostic (2.37e-2)" "unprognostic (3.49e-2)" "unprognostic (2.25e-1)" "unprognostic (6.89e-2)" "unprognostic (3.40e-1)" 41.8 19.8 5.8 10.5 17.4 8.1 32.2 1.5 7.9 12.3 23.3 3.2 3.6 17.4 11.3 12.0 10.6 9.5 22.0 10.4 5.0 3.3 23.4 74.2 16.4 16.8 2.8 5.7 10.3 22.0 3.4 6.4 26.1 3.7 14.7 9.9 10.5 41.0 5.3 7.1 9.6 36.3 19.7 3.5 20.9 10.0 8.7 3.7 8.8 15.2 10.3 9.1 21.2 36.4 1.4 5.5 6.0 1.1 1.9 4.7 0.6 0.0 0.0 0.7 0.0 60.3 26.7 1.4 1.4 8.8 1.1 2.7 4.1 0.5 9.0 0.0 5.5 14.2 0.1 1.6 0.0 1.4 13.3 4.1 7.5 0.8 42.3 6.0 0.0 3.8 18.2 1.1 9.0 5.5 4.8 0.7 2.6 26.0 47.2 8.5 1.2 0.3 0.0 0.5 4.1 2.1 2.5 0.9 13.6 2.9 7.4 3.0 4.5 0.0 0.1 0.0 1.9 2.2 1.0 5.2 3.7 3.4 6.9 3.3 63.8 9.0 17.8 10.9 0.1 2.2 6.0 0.6 2.0 2.4 1.1 4.7 1.4 1.3 1.3 0.6 0.9 0.8 1.9 3.8 1.9 0.9 5.5 1.4 0.6 5.8 17.4 1.5 7.9 5.0 3.3 2.8 5.7 3.7 3.7 8.9 36.6 18.6 5.7 28.2 18.6 3.9 45.9 8.1 11.4 101.2 0.0 4.7 5.0 5.1 149.9 42.5 42.8 23.3 32.8 8.0 90.1 5.0 3.5 232.5 81.6 0.0 46.1 103.7 76.4 24.4 24.5 57.9 27.0 6.4 55.5 1.3 20.9 14.4 3.9 32.2 4.7 6.5 18.1 2.1 3.9 24.3 5.1 26.1 11.5 7.6 MAN1A2 MAN1B ENSG00000198162 "Mannosidase alpha class 1A member 2" O60476 1 117367449-117528872 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 122.4" "Cell type enhanced" "Detected in all" 7 "Extravillous trophoblasts: 201.3;Syncytiotrophoblasts: 318.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034559, HPA057364" Enhanced Enhanced "Golgi apparatus" NA NA 1100000 "Golgi apparatus" "HPA034559: AB_10671229, HPA057364: AB_2683419" "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" "unprognostic (2.92e-3)" "unprognostic (2.15e-1)" "unprognostic (3.11e-2)" "unprognostic (9.70e-2)" "unprognostic (1.95e-2)" "unprognostic (8.01e-2)" "unprognostic (8.19e-3)" "prognostic favorable (4.08e-4)" "unprognostic (1.41e-1)" "unprognostic (4.38e-2)" "unprognostic (6.84e-2)" "unprognostic (1.45e-1)" "unprognostic (7.39e-2)" "unprognostic (1.17e-1)" "unprognostic (5.08e-2)" 11.1 9.7 13.9 9.1 15.8 3.8 9.7 11.9 15.2 14.4 10.7 8.5 9.4 8.1 15.8 10.7 11.5 12.2 9.2 11.0 11.2 9.2 11.8 16.4 8.1 9.9 12.0 13.9 11.2 27.4 21.7 9.6 122.4 11.3 11.2 9.5 8.3 11.1 10.5 10.5 7.5 9.0 13.7 10.4 10.4 10.3 10.1 14.4 16.1 19.4 6.9 9.8 13.6 9.8 3.7 4.4 4.0 2.7 6.0 9.8 2.4 14.4 6.3 10.8 9.3 14.2 17.1 34.6 12.0 18.8 5.4 5.1 4.8 8.3 10.8 22.3 15.4 5.1 8.6 5.0 10.2 12.2 13.5 7.6 6.4 8.9 5.3 8.6 10.0 14.8 11.5 11.0 8.3 7.3 10.0 16.1 7.6 10.3 16.7 11.3 28.1 6.1 3.2 5.5 7.3 6.6 5.5 23.5 7.4 7.5 19.7 5.9 8.6 11.9 12.8 9.4 14.7 6.3 6.4 15.3 12.2 10.1 8.6 12.2 11.4 7.7 7.3 16.2 8.0 29.0 1.3 2.7 4.0 5.2 2.1 6.2 3.3 4.3 4.3 2.3 3.7 3.6 5.2 2.1 6.0 1.7 4.4 9.8 2.4 13.9 15.8 11.9 15.2 11.2 9.2 12.0 13.9 11.3 14.4 35.7 30.2 42.7 29.6 27.5 59.3 85.6 35.7 42.8 40.9 41.8 21.6 40.9 14.9 26.4 27.9 33.3 25.6 23.3 52.0 201.3 31.7 37.6 15.1 78.0 25.6 41.3 20.8 34.4 30.7 15.9 49.8 22.8 38.8 12.6 32.4 40.2 36.9 21.0 61.5 21.5 39.0 38.8 29.1 63.9 52.5 30.2 318.2 30.5 26.4 37.2 MAN1B1 "ERManI, MANA-ER, MRT15" ENSG00000177239 "Mannosidase alpha class 1B member 1" Q9UKM7 9 137086927-137109187 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051516 Approved Uncertain Vesicles NA NA 540000 Vesicles "HPA051516: AB_2681518" "unprognostic (1.21e-2)" "unprognostic (4.66e-1)" "unprognostic (1.25e-3)" "unprognostic (4.67e-3)" "unprognostic (2.27e-1)" "unprognostic (3.70e-3)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.59e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-2)" "unprognostic (5.93e-3)" "unprognostic (1.75e-1)" "unprognostic (3.55e-2)" "unprognostic (2.28e-1)" "unprognostic (5.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.44e-3)" 20.4 25.4 19.7 13.5 23.7 9.8 18.6 21.6 36.1 24.3 21.6 24.5 20.6 19.8 22.7 28.1 23.1 28.9 25.9 19.5 20.5 21.5 24.3 32.7 20.4 19.9 18.6 25.2 24.2 32.6 23.6 25.1 30.8 18.0 21.2 12.0 22.0 32.7 23.1 12.2 25.4 17.8 18.5 16.4 22.2 21.8 30.3 18.2 19.9 25.1 12.7 19.3 21.0 16.0 13.0 23.0 16.3 24.4 18.0 21.9 18.5 7.2 17.1 6.0 16.9 22.5 19.4 19.8 12.4 26.2 16.5 14.7 8.4 22.9 6.6 41.5 20.6 23.3 25.1 3.6 12.0 3.0 9.1 6.0 2.9 15.4 9.6 21.3 5.1 11.4 22.9 22.7 9.6 8.1 22.1 10.9 8.9 8.0 10.9 11.7 14.7 5.4 12.1 8.0 21.4 17.3 3.1 10.0 20.9 13.2 3.6 6.9 6.2 18.3 19.4 12.6 3.2 21.6 10.9 15.3 24.5 9.1 18.0 14.4 4.4 3.6 4.4 29.4 6.5 21.0 7.9 20.1 16.3 21.9 21.8 20.5 13.0 17.3 20.6 23.0 11.0 17.0 17.0 5.9 18.0 24.4 16.1 21.5 18.5 19.7 23.7 21.6 36.1 20.5 21.5 18.6 25.2 18.0 18.2 17.9 33.0 15.9 12.9 10.3 17.8 9.3 15.3 16.0 7.9 24.4 15.7 44.1 6.6 27.3 4.5 16.8 31.6 0.0 27.7 61.8 26.8 11.6 20.7 17.9 29.2 28.6 29.2 17.8 16.4 4.3 19.5 16.3 21.9 33.3 26.3 17.7 26.2 24.6 20.5 13.0 18.2 12.9 16.0 15.6 26.2 14.2 38.0 24.5 21.3 6.8 MAN1C1 HMIC ENSG00000117643 "Mannosidase alpha class 1C member 1" Q9NR34 1 25617468-25786207 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 51.1;Ito cells: 82.9" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.3" "Lineage enriched" "Detected in many" 5 "T-cells: 8.3" "Cell line enhanced" "Detected in many" "AF22: 12.7;HSkMC: 47.0;U-266/70: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048352 Uncertain Uncertain Nucleoplasm,Vesicles NA NA 1200000 "Nucleoplasm, Vesicles" "HPA048352: AB_2680368" "unprognostic (2.75e-1)" "unprognostic (5.45e-3)" "unprognostic (5.71e-3)" "unprognostic (2.05e-2)" "unprognostic (1.95e-1)" "unprognostic (8.90e-3)" "unprognostic (4.78e-2)" "prognostic favorable (7.55e-4)" "unprognostic (1.80e-1)" "unprognostic (5.70e-2)" "prognostic favorable (4.79e-4)" "unprognostic (2.51e-1)" "unprognostic (9.09e-3)" "unprognostic (3.18e-2)" "unprognostic (7.23e-2)" "unprognostic (7.44e-2)" "unprognostic (5.18e-2)" 4.6 4.5 4.2 3.0 3.8 0.0 2.2 9.9 8.8 8.6 3.6 1.2 6.6 2.5 2.4 3.9 7.3 3.4 5.2 3.2 10.3 12.1 3.2 4.0 4.2 7.1 0.7 4.4 7.8 8.3 7.2 1.2 1.8 7.5 0.9 2.7 1.9 8.0 6.0 7.0 3.1 1.0 10.7 3.2 4.3 4.0 1.0 0.6 1.1 1.6 0.8 8.3 1.1 0.0 0.1 12.7 2.7 9.5 7.4 3.7 0.1 2.4 0.6 0.2 0.2 0.0 0.1 0.1 0.9 1.7 0.1 1.2 0.1 0.2 4.0 0.5 0.2 0.2 0.0 1.1 2.1 5.3 47.0 0.2 0.2 0.0 0.2 0.0 0.5 0.0 0.5 0.0 0.6 0.0 2.3 3.3 0.0 0.1 0.2 7.8 0.2 0.1 0.2 7.5 0.2 0.3 2.0 0.6 2.4 1.0 1.5 0.0 0.0 0.7 8.6 0.3 14.0 0.0 0.0 1.9 4.5 0.6 0.4 1.6 0.7 0.6 1.0 0.8 0.4 3.6 1.6 0.6 1.0 8.3 4.8 1.1 0.8 1.3 0.4 0.8 1.1 3.0 2.7 1.9 2.9 6.0 19.1 6.4 5.1 2.7 7.9 21.0 51.1 8.3 8.3 0.5 0.3 11.1 0.0 0.0 3.4 1.0 9.9 2.6 2.3 37.6 19.1 20.6 2.9 82.9 16.5 0.9 25.0 3.6 1.7 0.0 0.0 20.6 2.2 0.0 20.8 12.8 4.5 6.5 3.1 0.2 2.0 4.5 35.7 5.3 0.0 1.3 MAN2A1 "GOLIM7, MANA2" ENSG00000112893 "Mannosidase alpha class 2A member 1" Q16706 5 109689366-109869625 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.8" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 88.9;Hepatocytes: 113.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022377, HPA026896" Enhanced Supported "Golgi apparatus" NA NA 70000000 "Golgi apparatus" "CAB022377: , HPA026896: AB_1853512" "unprognostic (1.62e-2)" "unprognostic (4.06e-2)" "unprognostic (1.25e-2)" "unprognostic (6.96e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-1)" "unprognostic (5.80e-2)" "unprognostic (4.20e-2)" "unprognostic (3.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.73e-2)" "unprognostic (1.23e-1)" "unprognostic (6.77e-3)" "unprognostic (2.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.11e-3)" "unprognostic (5.31e-3)" 7.6 17.5 10.9 7.7 21.8 5.7 7.4 1.9 13.2 8.4 11.2 46.8 2.4 17.2 9.2 1.8 7.7 6.2 10.6 4.2 11.7 4.8 9.5 20.7 8.5 7.8 29.9 10.4 7.5 16.7 20.1 3.4 8.7 19.8 4.7 11.9 5.6 9.0 6.0 8.7 7.0 14.4 11.2 23.1 6.9 8.9 7.5 30.6 15.0 9.0 1.8 7.8 10.9 6.2 3.3 2.7 5.8 6.7 0.9 5.5 1.6 7.3 6.8 8.5 3.6 16.4 14.5 32.0 16.4 27.1 9.3 16.9 8.0 11.9 5.3 10.6 21.3 6.5 8.7 4.5 17.0 20.5 5.7 3.5 10.8 5.1 7.3 9.2 4.9 5.9 12.3 7.0 14.9 19.9 11.5 18.4 5.4 2.9 31.1 22.0 3.6 9.1 1.3 6.1 4.9 2.5 3.6 13.3 23.5 7.5 11.7 1.2 1.1 7.7 6.9 4.6 9.6 6.8 4.3 19.6 18.5 8.2 10.0 10.6 16.6 21.5 4.5 14.2 6.3 10.2 5.8 2.9 0.9 3.0 3.8 1.9 3.3 4.5 4.9 2.7 2.9 5.5 4.8 2.1 0.9 6.7 2.5 4.1 1.6 10.9 21.8 1.9 13.2 11.7 4.8 29.9 10.4 19.8 30.6 6.0 6.7 28.2 9.3 15.9 0.2 5.9 40.8 9.4 7.9 29.6 0.0 16.0 1.7 21.5 7.3 22.4 45.5 23.3 30.1 88.9 21.8 26.3 14.0 113.4 16.8 0.0 23.7 41.7 62.5 4.9 9.2 22.8 25.3 25.2 37.1 7.5 30.3 28.1 6.3 21.4 0.3 19.4 16.0 5.5 19.1 20.7 19.8 15.8 41.2 17.8 MAN2A2 "HsT19662, MANA2X" ENSG00000196547 "Mannosidase alpha class 2A member 2" P49641 15 90902218-90922584 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.4;neutrophil: 10.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077930 Approved "Cytoplasmic bodies" NA NA 30000000 "Cytoplasmic bodies" "HPA077930: AB_2732363" "unprognostic (5.17e-2)" "unprognostic (9.80e-2)" "unprognostic (2.43e-2)" "unprognostic (2.41e-1)" "unprognostic (2.58e-1)" "unprognostic (1.86e-2)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" "unprognostic (3.41e-1)" "unprognostic (2.27e-1)" "unprognostic (5.06e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (8.95e-4)" "unprognostic (7.55e-3)" "unprognostic (1.13e-1)" "unprognostic (8.36e-2)" "unprognostic (2.33e-2)" 17.8 12.1 15.9 11.5 24.3 58.1 17.3 33.7 31.2 7.2 9.9 52.4 6.3 12.0 8.9 9.8 7.6 8.0 9.4 22.7 17.8 14.0 8.1 16.7 13.3 12.4 31.6 19.7 9.7 24.0 13.0 15.2 12.4 31.0 9.2 9.0 17.2 20.6 12.6 41.8 14.8 13.0 7.6 33.1 19.1 12.4 12.7 28.3 3.8 13.8 2.7 9.1 7.5 10.7 1.5 2.1 10.0 3.2 0.1 1.4 1.5 5.8 6.1 4.3 10.2 13.0 3.5 8.4 4.3 3.9 4.5 3.5 4.9 4.4 0.8 10.6 5.0 4.1 6.7 4.5 2.5 2.8 14.5 10.6 40.0 9.2 3.3 4.3 5.8 21.7 2.5 4.7 5.4 4.4 9.0 5.9 10.7 15.0 5.3 2.0 7.9 3.8 11.6 1.4 9.7 1.9 5.2 4.1 6.1 5.6 14.1 10.4 6.0 5.9 11.1 8.4 4.5 5.2 19.1 5.0 3.7 4.0 4.5 5.6 8.1 24.9 2.1 4.3 8.5 6.2 8.4 1.6 0.6 1.4 1.1 0.9 1.0 0.6 0.8 0.3 1.5 0.4 0.4 10.0 0.1 3.2 2.1 1.3 1.5 15.9 24.3 33.7 31.2 17.8 14.0 31.6 19.7 31.0 28.3 11.9 23.5 5.6 2.9 5.4 24.8 12.6 7.6 5.3 10.3 8.7 25.5 7.3 0.0 3.9 5.9 7.9 8.1 23.3 5.6 1.8 6.4 5.8 15.1 19.2 5.4 23.8 4.1 7.4 12.2 5.2 6.4 13.5 28.7 10.0 7.2 18.0 4.1 5.7 4.6 3.0 69.2 12.9 8.5 8.8 6.1 4.1 6.3 8.7 7.9 3.0 MANBAL dJ1141E15.2 ENSG00000101363 "Mannosidase beta like" Q9NQG1 20 37289638-37317260 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052348 Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA052348: AB_2681795" "unprognostic (1.86e-2)" "unprognostic (9.15e-2)" "unprognostic (1.85e-1)" "unprognostic (2.45e-2)" "unprognostic (3.12e-1)" "unprognostic (2.21e-3)" "prognostic unfavorable (7.07e-4)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (9.61e-2)" "unprognostic (2.83e-1)" "unprognostic (3.43e-1)" "prognostic favorable (3.62e-4)" "unprognostic (1.06e-1)" "unprognostic (1.86e-1)" "unprognostic (8.03e-2)" "unprognostic (2.70e-2)" 17.3 25.2 19.6 10.7 27.6 2.9 29.8 11.4 32.7 22.5 22.1 15.9 21.9 17.0 26.7 29.7 22.1 28.9 23.3 13.9 20.8 20.1 19.0 14.5 15.1 19.3 18.9 23.2 28.5 21.4 15.1 16.9 16.1 22.1 24.0 20.3 27.5 16.6 32.9 7.1 19.8 15.6 33.5 13.4 11.1 18.7 17.6 11.2 9.8 23.2 13.7 13.7 20.5 28.3 18.0 21.7 25.4 19.3 14.5 17.3 11.1 17.2 33.9 17.3 17.4 28.4 20.7 15.0 24.1 25.2 23.4 18.5 39.9 23.6 4.4 29.0 29.3 23.9 23.8 16.3 37.7 16.1 3.3 16.9 4.7 14.2 35.4 30.7 4.9 3.0 22.5 26.8 21.7 36.1 23.6 16.3 5.9 7.5 4.9 23.3 20.3 6.2 6.5 13.7 29.0 31.8 3.7 22.7 5.2 22.2 24.1 16.6 19.0 24.5 36.9 19.8 15.5 24.8 8.0 17.8 43.2 16.2 24.2 18.5 6.6 8.9 3.7 31.0 2.7 22.2 9.2 17.0 23.7 11.8 19.3 13.6 18.0 14.2 14.0 15.5 17.8 17.3 16.6 25.4 14.5 15.1 21.7 9.3 11.1 19.6 27.6 11.4 32.7 20.8 20.1 18.9 23.2 22.1 11.2 23.8 31.4 8.3 66.3 26.8 21.0 16.9 33.1 13.4 25.0 41.8 3.9 82.3 33.2 65.8 4.1 25.8 22.5 0.0 96.6 107.8 49.0 70.0 7.0 18.7 26.4 19.1 29.3 30.7 12.6 5.7 43.4 19.2 43.9 21.6 32.4 50.8 77.2 44.8 64.3 47.6 11.3 19.4 44.2 23.2 48.1 26.6 64.3 10.7 32.7 98.7 MANEA "FLJ12838, mandaselin" ENSG00000172469 "Mannosidase endo-alpha" Q5SRI9 6 95577543-95609457 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.9" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 53.1;Ito cells: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011046, HPA011069" Enhanced Supported "Golgi apparatus" NA NA 87000 "Golgi apparatus" "HPA011046: AB_1079303, HPA011069: AB_1079304" "unprognostic (6.00e-2)" "unprognostic (7.81e-2)" "prognostic favorable (3.04e-4)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (5.03e-2)" "unprognostic (2.98e-3)" "unprognostic (2.74e-1)" "unprognostic (5.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.44e-1)" "unprognostic (9.07e-2)" "unprognostic (2.86e-3)" "unprognostic (5.18e-2)" "unprognostic (3.08e-1)" "unprognostic (9.68e-2)" "unprognostic (7.47e-2)" 18.0 8.1 6.0 6.7 6.9 2.4 14.4 8.3 6.0 9.6 9.5 5.0 5.8 7.7 7.5 8.2 11.5 7.2 7.1 9.3 6.5 6.2 14.6 44.9 9.8 12.3 8.9 6.7 10.4 8.0 10.9 13.5 7.4 7.8 9.2 8.0 4.5 8.1 7.6 3.8 5.9 9.5 6.0 11.6 13.2 10.7 7.1 6.9 17.9 11.7 5.9 9.7 11.2 7.5 6.6 3.4 8.5 5.7 3.8 10.4 3.3 3.8 3.3 12.5 10.1 20.8 24.5 4.8 10.8 9.9 6.3 9.5 3.7 9.7 7.4 13.5 7.0 9.5 6.4 8.6 7.2 14.5 12.7 7.7 10.0 3.1 6.0 7.2 13.1 8.9 24.2 8.4 7.5 5.3 9.1 14.7 7.7 15.4 17.2 13.4 2.7 7.6 5.6 1.8 10.2 3.3 9.2 12.5 11.0 9.6 6.7 10.1 5.4 6.1 4.4 3.8 9.3 7.0 12.3 13.3 6.3 4.5 11.3 10.6 12.9 7.5 9.2 11.3 11.5 14.3 8.5 3.3 1.9 4.8 5.7 6.8 6.6 5.9 5.5 3.4 3.3 6.9 4.6 0.7 3.8 4.9 1.3 10.4 3.3 6.0 6.9 8.3 6.0 6.5 6.2 8.9 6.7 7.8 6.9 11.9 6.7 4.5 4.6 6.5 8.3 3.2 7.6 10.7 7.9 12.2 3.9 4.5 5.0 3.3 12.0 6.3 2.5 0.0 6.2 4.6 5.2 3.2 2.3 53.1 9.2 11.1 1.7 36.8 9.1 10.0 5.5 6.9 8.5 2.8 4.7 9.1 3.3 3.5 14.9 8.6 4.8 12.9 5.3 6.8 12.5 6.0 1.1 6.4 5.2 3.0 MANEAL FLJ31434 ENSG00000185090 "Mannosidase endo-alpha like" Q5VSG8 1 37793802-37801137 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 15.6;Horizontal cells: 25.4;Intestinal endocrine cells: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.6" "Lineage enriched" "Detected in single" 6 "T-cells: 3.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063423 Approved "Golgi apparatus" "Intracellular and membrane" NA NA 24000 "Golgi apparatus" "HPA063423: AB_2685011" "unprognostic (8.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (7.92e-2)" "prognostic favorable (5.28e-4)" "prognostic unfavorable (3.32e-4)" "unprognostic (3.02e-1)" "unprognostic (1.03e-2)" "unprognostic (7.67e-2)" "unprognostic (6.27e-3)" "unprognostic (1.08e-1)" "unprognostic (1.17e-3)" "unprognostic (8.29e-3)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (2.26e-1)" 1.6 9.5 12.3 2.6 15.2 0.4 6.4 11.2 21.7 4.1 7.6 6.6 2.4 4.5 2.6 8.8 4.8 3.8 2.4 1.5 12.0 20.3 3.8 11.4 3.9 1.5 10.4 9.6 1.8 12.8 6.2 16.2 1.3 15.4 5.6 8.2 4.1 4.4 3.8 4.6 5.2 4.4 3.1 6.2 1.9 6.3 3.5 3.8 0.8 7.3 1.8 2.4 2.7 2.1 0.6 0.3 0.1 0.4 0.0 3.6 0.6 8.1 10.4 1.9 20.1 2.6 0.9 18.2 1.5 9.0 7.8 3.4 17.2 19.3 13.5 6.7 1.0 9.3 1.8 3.8 2.0 2.8 16.0 8.2 10.0 9.4 13.7 0.2 14.2 8.3 0.3 10.8 0.4 0.3 11.0 0.2 2.4 5.8 10.8 1.2 16.0 3.9 0.0 6.3 19.4 11.0 6.2 13.8 15.8 4.6 21.6 50.0 15.1 21.9 0.7 8.1 0.4 9.6 1.5 1.2 11.1 6.8 10.7 13.9 15.6 14.7 4.5 1.8 4.7 8.2 0.0 0.0 0.0 1.5 0.1 3.6 0.6 0.7 0.8 0.0 0.6 0.0 1.2 0.1 0.0 0.4 0.3 0.6 0.6 12.3 15.2 11.2 21.7 12.0 20.3 10.4 9.6 15.4 3.8 3.0 2.4 0.8 0.9 0.5 15.6 0.7 2.5 0.0 0.0 3.5 3.9 0.1 0.0 1.5 0.2 0.4 1.1 0.0 5.0 1.3 0.3 1.2 0.0 2.9 0.8 25.4 29.2 0.0 0.3 0.0 0.3 0.2 3.3 0.0 4.5 4.1 3.2 0.0 0.0 0.2 8.4 0.0 0.4 0.0 1.4 0.0 0.1 0.0 3.0 1.1 MANSC1 "FLJ10298, LOH12CR3" ENSG00000111261 "MANSC domain containing 1" Q9H8J5 12 12326056-12350541 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 24 "neutrophil: 37.5" "Lineage enriched" "Detected in many" 36 "granulocytes: 37.5" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 27.2;OE19: 28.5;RPTEC TERT1: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007955, HPA007956" Approved Approved "Golgi apparatus,Vesicles" NA NA 28000000 "Golgi apparatus, Vesicles" "HPA007955: AB_1079306, HPA007956: AB_1079305" "unprognostic (5.41e-3)" "unprognostic (3.10e-2)" "unprognostic (1.24e-1)" "unprognostic (5.46e-3)" "unprognostic (9.64e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-2)" "unprognostic (8.47e-2)" "unprognostic (9.18e-2)" "unprognostic (5.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.03e-1)" "prognostic favorable (3.30e-5)" "unprognostic (1.15e-2)" "unprognostic (4.46e-2)" "unprognostic (3.65e-1)" "unprognostic (1.03e-2)" 13.1 8.8 9.7 5.1 13.7 4.2 14.7 10.1 18.4 13.5 17.8 7.5 12.9 13.4 15.1 14.1 27.3 11.2 19.3 7.9 9.2 7.6 9.5 7.6 8.4 6.6 6.9 9.0 11.3 26.4 18.5 19.5 11.0 9.0 15.0 18.5 12.8 42.6 15.2 3.6 13.3 13.3 14.4 5.8 8.4 21.3 9.1 6.2 0.0 9.5 16.7 18.2 12.6 12.9 0.2 0.2 37.5 0.5 0.2 1.0 0.1 0.1 3.0 0.9 0.0 3.1 3.0 3.3 2.1 2.5 1.1 1.4 2.5 9.7 0.0 2.3 2.0 1.1 0.4 3.8 1.7 0.8 0.0 3.4 4.3 3.8 2.0 0.5 0.6 1.2 1.9 2.9 0.7 0.5 7.6 27.2 0.1 2.7 0.0 0.3 5.7 0.0 0.3 3.4 28.5 1.6 0.1 0.0 0.0 14.1 9.9 1.3 5.4 1.1 9.1 3.1 1.6 8.2 2.7 10.6 1.5 1.3 0.4 2.8 0.2 0.1 1.4 1.1 0.0 1.1 1.5 0.5 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.2 1.0 0.1 37.5 0.2 0.1 0.0 0.0 0.1 9.7 13.7 10.1 18.4 9.2 7.6 6.9 9.0 9.0 6.2 8.9 20.5 6.9 7.0 3.5 6.8 2.1 28.1 18.7 6.8 22.7 7.9 28.7 1.7 15.0 0.8 20.4 18.1 0.0 33.2 5.4 6.9 10.2 2.3 7.5 6.5 9.5 20.8 30.1 5.9 1.8 12.7 1.4 0.0 1.0 32.2 11.7 15.8 28.1 15.6 1.6 12.6 0.0 4.7 1.7 1.5 4.1 14.2 4.4 25.5 7.2 MANSC4 ENSG00000205693 "MANSC domain containing 4" A6NHS7 12 27762738-27771276 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 3.3;testis: 5.9" "Cell type enhanced" "Detected in single" 26 "Cytotrophoblasts: 2.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 13 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "HaCaT: 2.2;HUVEC TERT2: 5.2;PC-3: 2.6;U-2 OS: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039454, HPA039682" Uncertain NA NA "HPA039454: AB_2676515, HPA039682: AB_10805483" "unprognostic (1.13e-1)" "unprognostic (4.74e-2)" "unprognostic (2.34e-2)" "unprognostic (2.75e-2)" "unprognostic (6.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (2.25e-4)" "unprognostic (1.96e-1)" "unprognostic (2.49e-2)" "unprognostic (2.87e-3)" "unprognostic (2.50e-3)" "unprognostic (7.15e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-2)" "unprognostic (1.21e-1)" "unprognostic (2.10e-2)" 0.1 0.0 0.2 0.6 0.5 0.1 0.5 3.3 0.2 0.2 0.0 0.2 0.5 0.0 0.0 0.2 0.0 0.0 0.2 1.2 0.7 0.0 0.8 1.9 0.1 0.7 0.6 0.0 2.0 2.0 0.2 0.0 0.0 0.4 0.0 0.3 0.2 0.0 0.2 0.1 0.1 5.9 0.2 1.4 0.1 0.2 0.1 0.0 0.0 0.0 0.1 1.7 0.2 0.1 0.8 0.0 0.1 0.7 0.2 0.8 0.4 0.0 0.0 0.3 1.7 0.3 0.1 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.1 0.2 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.1 5.2 0.4 0.3 0.1 0.0 0.0 0.1 0.0 0.5 0.0 2.6 0.2 0.1 0.0 0.0 1.1 0.1 0.0 0.2 0.7 0.0 0.5 0.4 1.0 1.2 0.2 1.9 0.4 0.2 0.5 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 MAOB ENSG00000069535 "Monoamine oxidase B" P27338 X 43766611-43882447 "Enzymes, FDA approved drug targets, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 104.9" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 111.3;granulocytes: 138.1;Hepatocytes: 197.3;Peritubular cells: 89.5;Proximal tubular cells: 130.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 6 "T-cells: 1.0" "Group enriched" "Detected in some" 7 "Hep G2: 20.6;SiHa: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002328, CAB037200" Enhanced NA NA 3600000 "CAB037200: AB_1841012, HPA002328: AB_1854062" "unprognostic (1.19e-2)" "unprognostic (1.36e-1)" "unprognostic (5.16e-2)" "unprognostic (1.85e-2)" "unprognostic (4.39e-2)" "unprognostic (2.69e-2)" "unprognostic (5.61e-2)" "unprognostic (4.37e-2)" "unprognostic (1.56e-1)" "unprognostic (1.04e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-2)" "unprognostic (9.74e-2)" "unprognostic (5.35e-3)" "unprognostic (1.48e-2)" "unprognostic (3.53e-1)" "unprognostic (1.90e-3)" 25.0 18.2 24.8 3.9 34.8 0.5 16.5 5.5 24.5 12.0 18.9 20.3 15.6 24.9 38.0 20.0 11.4 34.9 15.4 32.4 21.2 46.9 41.8 104.9 10.9 2.3 24.4 19.9 56.0 4.1 15.6 8.9 9.4 26.8 30.1 6.3 3.0 38.0 55.9 34.8 3.0 30.5 35.9 39.1 1.3 8.4 5.2 21.3 0.2 1.8 8.2 2.8 12.1 8.5 0.0 0.0 0.0 0.1 0.0 1.0 1.2 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 2.7 2.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.5 20.6 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.6 39.9 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.2 24.8 34.8 5.5 24.5 21.2 46.9 24.4 19.9 26.8 21.3 0.0 5.5 0.0 0.4 4.8 1.0 111.3 38.2 21.4 3.4 5.2 3.9 0.3 53.0 15.6 0.1 11.3 8.0 0.0 2.5 0.7 11.2 0.6 138.1 197.3 1.4 14.3 0.0 4.9 4.7 0.4 42.6 1.3 6.8 0.0 2.9 25.5 4.7 8.0 89.5 130.3 0.7 12.9 15.6 0.0 0.1 3.4 0.3 4.3 3.9 0.3 MARC1 "FLJ22390, MOSC1" ENSG00000186205 "Mitochondrial amidoxime reducing component 1" Q5VT66 1 220786759-220819657 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 71.3;breast: 81.3" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 94.8;Extravillous trophoblasts: 36.6;Syncytiotrophoblasts: 62.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 12.0;classical monocyte: 20.6;eosinophil: 8.1;neutrophil: 28.5" "Group enriched" "Detected in many" 32 "granulocytes: 28.5;monocytes: 20.6" "Cell line enhanced" "Detected in many" "BEWO: 51.6;HeLa: 22.0;Hep G2: 25.3;NTERA-2: 21.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA028702 Approved Supported Mitochondria NA NA Mitochondria "HPA028702: AB_10601135" "unprognostic (3.15e-2)" "unprognostic (1.27e-1)" "unprognostic (2.16e-2)" "unprognostic (5.04e-2)" "unprognostic (2.90e-1)" "unprognostic (2.31e-1)" "unprognostic (3.71e-3)" "unprognostic (1.39e-1)" "unprognostic (7.51e-2)" "unprognostic (7.71e-3)" "unprognostic (3.71e-1)" "unprognostic (4.30e-1)" "prognostic unfavorable (4.51e-4)" "unprognostic (3.85e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (1.50e-1)" 71.3 3.0 4.6 7.5 6.1 7.3 81.3 3.1 4.0 3.4 7.8 2.1 18.7 3.3 1.4 5.5 3.4 2.8 6.4 6.7 3.7 4.6 3.4 33.6 4.3 4.3 4.0 3.3 2.5 4.0 4.0 3.3 9.7 4.3 14.9 6.8 4.4 27.8 10.5 4.2 1.4 3.8 2.6 2.6 4.3 3.2 0.6 1.4 0.1 22.0 2.7 1.4 3.9 7.5 0.2 0.7 28.5 20.6 0.0 0.1 4.9 5.7 3.1 2.0 0.0 0.4 0.1 51.6 0.5 0.4 0.3 0.5 17.0 0.3 0.0 2.1 0.5 0.0 0.0 10.7 1.0 0.7 0.0 10.9 0.0 22.0 25.3 1.3 0.1 0.1 2.0 0.6 0.0 0.0 0.0 0.3 0.0 1.6 0.1 0.3 5.6 0.0 10.9 21.8 16.8 9.5 0.0 0.0 0.1 2.4 6.4 6.1 14.2 3.1 3.8 0.0 6.0 14.4 13.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.0 20.6 8.1 0.1 1.5 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 28.5 0.0 0.4 0.2 0.0 4.9 4.6 6.1 3.1 4.0 3.7 4.6 4.0 3.3 4.3 1.4 0.0 12.8 0.9 0.0 0.8 5.7 5.1 0.0 2.7 0.0 8.7 0.0 94.8 1.7 0.0 4.4 2.9 6.3 0.0 0.0 36.6 1.0 0.0 2.3 22.1 10.4 0.0 4.1 3.1 22.0 2.6 0.6 0.2 0.0 0.0 22.2 12.4 0.0 9.5 5.6 2.5 1.4 0.0 3.1 0.0 0.7 0.5 62.8 0.0 9.5 0.0 MARC2 "FLJ20605, MOSC2" ENSG00000117791 "Mitochondrial amidoxime reducing component 2" Q969Z3 1 220748225-220784815 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.3;parathyroid gland: 63.3" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 81.6;Proximal tubular cells: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 14.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 14.1" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.4;T-47d: 21.9;TIME: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015085, HPA017572" Enhanced NA NA "HPA015085: AB_1848780, HPA017572: AB_1848778" "unprognostic (8.17e-2)" "unprognostic (1.92e-2)" "unprognostic (1.80e-1)" "unprognostic (1.66e-2)" "unprognostic (1.16e-1)" "unprognostic (8.20e-2)" "prognostic favorable (1.40e-10)" "unprognostic (4.78e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-1)" "unprognostic (1.90e-1)" "unprognostic (2.05e-2)" "prognostic favorable (3.09e-4)" "unprognostic (1.45e-1)" "unprognostic (1.81e-1)" "unprognostic (2.39e-2)" "unprognostic (6.23e-2)" 8.1 8.2 5.5 4.6 5.9 0.1 9.5 2.7 5.6 4.4 19.4 3.7 5.0 16.7 4.8 6.6 6.7 3.8 10.3 10.2 5.0 3.7 38.2 73.3 12.5 2.2 4.0 5.7 9.2 12.7 63.3 4.3 3.5 8.0 6.4 5.9 6.9 24.3 3.9 8.8 2.0 36.4 8.1 1.9 4.5 9.1 7.4 2.7 0.4 19.6 6.2 2.9 5.5 9.0 2.2 0.0 14.1 0.1 0.0 0.0 0.1 5.6 4.7 2.5 3.3 6.3 2.9 1.9 4.1 7.1 4.9 5.0 3.1 7.2 0.0 2.8 3.8 2.7 0.7 0.0 5.6 4.6 0.0 9.7 0.0 9.2 6.5 5.9 2.6 0.0 5.0 8.7 1.9 0.0 7.5 13.5 0.0 3.6 0.0 3.1 1.4 0.0 9.2 4.0 1.9 4.7 0.0 8.0 0.1 17.4 6.1 1.4 3.7 6.4 0.0 8.7 2.9 21.9 3.4 20.3 0.0 3.0 6.5 7.1 1.2 0.0 0.0 1.1 0.0 0.1 14.1 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.5 5.9 2.7 5.6 5.0 3.7 4.0 5.7 8.0 2.7 35.7 26.1 3.9 0.0 0.8 0.6 22.0 20.4 5.3 6.8 17.4 0.0 0.7 10.0 0.0 0.4 8.2 18.8 0.0 0.0 0.4 5.2 0.0 5.7 81.6 0.7 0.0 0.0 9.2 3.2 1.3 19.2 1.0 13.5 0.0 13.0 10.2 0.0 11.6 23.0 51.6 0.5 12.9 8.2 0.5 0.5 1.1 4.7 0.0 14.4 0.0 MARCH1 "FLJ20668, MARCH-I, RNF171" ENSG00000145416 "Membrane associated ring-CH-type finger 1" Q8TCQ1 4 163524298-164384050 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.4;lymphoid tissue: 32.4" "Cell type enhanced" "Detected in many" 11 "B-cells: 128.6;Cone photoreceptor cells: 184.6;Kupffer cells: 192.5;Macrophages: 105.3;Rod photoreceptor cells: 172.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 95 "classical monocyte: 16.8;eosinophil: 9.9;intermediate monocyte: 17.0;memory B-cell: 18.5;myeloid DC: 18.1;naive B-cell: 15.7;non-classical monocyte: 17.2;plasmacytoid DC: 6.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 9.6;U-266/70: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014600 Uncertain NA NA "HPA014600: AB_1853573" "unprognostic (7.29e-2)" "unprognostic (5.82e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" "unprognostic (8.25e-2)" "unprognostic (2.98e-2)" "unprognostic (4.79e-3)" "unprognostic (9.00e-2)" "unprognostic (3.00e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-1)" "unprognostic (2.20e-1)" "unprognostic (1.24e-1)" "unprognostic (7.00e-2)" "unprognostic (2.48e-2)" "unprognostic (2.70e-1)" "unprognostic (2.91e-2)" 7.7 4.2 11.6 20.5 19.7 3.9 4.0 3.1 14.5 3.7 3.9 8.5 0.1 4.4 3.9 4.6 3.6 4.2 5.9 2.6 12.6 10.1 3.0 4.5 8.3 28.5 17.3 6.3 4.2 4.1 1.5 4.1 10.2 13.5 3.5 5.1 2.4 4.6 1.8 1.6 4.9 9.0 6.5 24.4 32.4 4.1 2.3 17.9 2.6 3.2 1.4 24.6 9.0 4.2 18.5 18.1 9.9 17.2 0.1 0.0 6.6 0.8 0.7 2.9 1.7 0.0 0.0 1.9 1.2 0.1 0.0 0.0 1.6 3.3 9.6 3.6 0.0 0.4 1.4 0.0 0.0 0.0 1.0 1.0 6.8 3.7 0.6 0.0 4.1 2.2 0.0 0.0 0.0 0.2 4.0 0.0 1.9 2.5 5.0 3.3 1.0 2.3 2.6 3.6 0.3 1.3 2.7 0.5 0.7 0.1 1.6 1.5 1.3 0.9 1.5 0.5 2.2 4.0 0.7 3.1 1.1 2.0 0.7 2.3 9.8 3.3 2.7 1.4 2.1 1.5 0.0 16.8 9.9 0.0 17.0 0.0 18.5 0.0 0.0 18.1 15.7 0.0 0.0 0.1 0.1 17.2 6.8 0.0 6.6 11.6 19.7 3.1 12.5 12.6 10.1 17.3 6.3 13.5 17.9 0.0 2.7 128.6 0.0 1.5 24.7 2.4 0.0 1.4 4.5 3.5 184.6 0.3 0.0 0.0 4.6 1.1 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.9 43.0 11.1 0.0 3.1 192.5 1.7 0.0 105.3 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.1 172.3 12.9 0.0 0.6 1.5 0.9 0.7 0.8 0.0 0.0 MARCH11 "MARCH-XI, RNF226" ENSG00000183654 "Membrane associated ring-CH-type finger 11" A6NNE9 5 16067139-16180762 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 42.1" "Group enriched" "Detected in some" 7 "Early spermatids: 83.9;Spermatocytes: 30.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 44.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (9.91e-3)" "unprognostic (1.08e-1)" "unprognostic (2.98e-1)" "unprognostic (1.50e-1)" "unprognostic (1.54e-1)" "unprognostic (1.52e-1)" "unprognostic (3.55e-2)" 0.4 1.1 1.8 0.3 3.4 0.3 0.4 3.7 3.7 0.3 0.4 0.0 0.0 0.3 0.4 0.3 0.3 0.3 0.3 2.2 2.0 3.2 0.5 0.5 0.4 0.3 1.5 2.0 0.5 1.0 0.3 6.8 0.4 2.1 0.6 0.4 0.6 1.4 0.3 0.3 0.3 0.4 0.3 0.5 0.3 0.4 42.1 0.0 0.0 0.3 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 44.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.4 3.7 3.7 2.0 3.2 1.5 2.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 5.9 2.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 2.4 6.5 0.0 30.3 1.4 0.0 0.0 0.0 0.0 0.0 MARCH2 "HSPC240, MARCH-II, RNF172" ENSG00000099785 "Membrane associated ring-CH-type finger 2" Q9P0N8 19 8413270-8439017 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014063 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum" Cytosol "HPA014063: AB_1853576" "unprognostic (1.15e-2)" "unprognostic (4.01e-3)" "prognostic unfavorable (6.48e-4)" "prognostic favorable (1.05e-5)" "unprognostic (3.00e-1)" "prognostic favorable (8.29e-4)" "unprognostic (3.43e-2)" "unprognostic (6.95e-2)" "unprognostic (3.06e-3)" "unprognostic (2.32e-1)" "prognostic favorable (6.21e-4)" "unprognostic (2.01e-1)" "unprognostic (3.52e-1)" "unprognostic (1.01e-1)" "unprognostic (3.16e-1)" "unprognostic (9.91e-2)" "unprognostic (1.80e-2)" 37.7 12.4 30.7 13.5 28.3 17.5 23.9 8.6 39.1 9.8 29.8 20.7 9.7 11.2 12.5 39.0 19.3 10.0 11.4 38.9 23.5 21.9 11.0 17.9 18.2 15.0 30.8 19.8 8.2 10.0 10.5 11.3 13.9 20.2 16.0 10.3 12.7 13.4 21.8 46.9 12.7 11.7 28.5 27.8 18.9 13.3 8.6 13.3 8.4 21.3 14.1 10.0 20.4 9.7 3.6 26.5 20.4 14.6 3.7 7.3 10.1 5.6 7.2 3.2 15.1 19.9 6.5 5.5 6.1 7.5 4.9 5.1 3.5 2.6 2.2 18.0 13.1 6.5 4.0 4.2 8.6 3.8 11.1 9.9 17.0 3.3 7.8 10.8 2.5 25.7 7.8 9.9 4.7 4.2 7.1 19.2 9.0 2.4 12.5 3.8 10.7 3.4 8.1 6.8 6.8 17.4 5.4 1.0 5.6 11.3 6.7 1.6 9.1 0.4 6.6 11.5 11.6 5.0 5.4 19.3 6.9 4.2 22.8 5.1 11.2 13.3 2.5 11.2 5.1 5.2 20.4 10.0 15.4 5.7 14.6 5.9 3.6 5.9 4.6 6.7 3.5 4.0 5.4 12.5 3.7 12.8 26.5 7.3 10.1 30.7 28.3 8.6 39.1 23.5 21.9 30.8 19.8 20.2 13.3 3.0 10.9 4.5 0.0 6.6 10.7 38.1 7.6 2.7 3.4 19.2 2.0 6.6 33.2 0.0 8.1 27.0 13.6 23.3 0.0 9.3 10.5 0.0 12.7 24.6 57.4 22.3 11.6 47.9 48.6 36.4 8.6 19.4 23.6 0.0 5.5 17.5 0.0 7.4 11.0 43.4 7.7 12.9 20.6 5.4 8.5 11.3 4.8 18.1 4.6 0.0 MARCH3 "MARCH-III, MGC48332, RNF173" ENSG00000173926 "Membrane associated ring-CH-type finger 3" Q86UD3 5 126867714-127030808 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 52.5;Spermatocytes: 61.1;Syncytiotrophoblasts: 82.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 8.8;naive B-cell: 13.1" "Lineage enriched" "Detected in many" 5 "B-cells: 13.1" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 25.1;HUVEC TERT2: 16.7;TIME: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043406 Uncertain Supported Vesicles NA NA Vesicles "HPA043406: AB_10793947" "unprognostic (5.96e-3)" "unprognostic (1.46e-2)" "unprognostic (1.91e-2)" "unprognostic (4.21e-2)" "unprognostic (9.00e-3)" "unprognostic (1.17e-2)" "unprognostic (7.75e-3)" "unprognostic (9.41e-2)" "unprognostic (8.93e-2)" "unprognostic (2.05e-3)" "unprognostic (3.15e-2)" "unprognostic (1.82e-1)" "unprognostic (5.60e-6)" "unprognostic (7.74e-2)" "unprognostic (7.64e-2)" "unprognostic (1.05e-1)" "unprognostic (3.64e-1)" 11.3 6.0 5.6 11.0 9.4 6.6 6.2 5.3 4.8 2.0 10.8 8.2 0.5 2.4 3.7 3.6 3.4 3.2 10.4 15.2 7.8 6.8 2.0 1.9 5.2 5.2 9.5 2.3 4.0 5.0 1.7 10.8 4.0 12.3 2.9 11.8 9.7 11.2 1.1 11.9 11.5 5.2 6.5 16.0 3.7 5.5 14.2 7.6 2.1 3.6 3.4 5.8 6.5 6.7 13.1 0.7 2.5 0.4 1.9 2.6 0.7 0.3 1.2 2.4 1.3 2.1 2.1 0.8 8.5 3.6 6.9 10.2 1.1 0.5 2.3 0.8 1.3 1.5 0.7 3.0 1.5 9.8 0.5 2.7 7.2 2.0 1.1 3.5 2.9 1.8 1.5 0.5 25.1 3.0 1.6 16.7 0.3 3.0 0.4 5.7 0.8 0.3 1.3 2.0 1.8 2.8 0.9 9.6 0.6 0.5 1.2 0.7 0.5 2.0 0.3 1.0 1.2 1.7 3.0 20.3 1.3 1.1 7.9 0.9 1.1 1.3 1.3 5.1 2.3 1.2 0.0 0.2 2.5 0.5 0.4 0.1 8.8 0.6 0.3 0.1 13.1 2.4 0.5 0.8 1.9 0.3 0.7 2.6 0.7 5.6 9.4 5.3 4.8 7.8 6.8 9.5 2.3 12.3 7.6 3.0 3.4 18.2 0.0 5.4 18.3 12.9 17.8 1.4 3.4 0.0 2.0 33.6 0.0 0.0 33.1 6.0 15.5 23.3 0.0 3.1 6.7 0.0 24.3 0.8 7.7 35.0 14.3 11.6 3.5 9.8 0.3 2.0 3.3 0.0 23.4 52.5 0.0 44.4 1.8 0.2 25.6 0.0 0.9 61.1 12.7 7.8 82.5 5.1 21.9 0.0 MARCH4 "KIAA1399, MARCH-IV, RNF174" ENSG00000144583 "Membrane associated ring-CH-type finger 4" Q9P2E8 2 216257865-216372027 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 16.6;pituitary gland: 13.1" "Cell type enriched" "Detected in some" 6 "Intestinal endocrine cells: 15.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 33.8;fHDF/TERT166: 21.5;TIME: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014348 Approved NA NA "HPA014348: AB_1853578" "unprognostic (4.84e-2)" "unprognostic (1.02e-4)" "unprognostic (1.63e-1)" "unprognostic (5.42e-2)" "unprognostic (3.31e-2)" "unprognostic (1.88e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-2)" "unprognostic (1.24e-2)" "unprognostic (6.49e-2)" "unprognostic (5.55e-3)" "unprognostic (1.07e-1)" "unprognostic (6.81e-5)" "unprognostic (4.82e-2)" "unprognostic (2.06e-1)" "unprognostic (1.23e-1)" "unprognostic (1.09e-3)" 0.7 2.9 7.0 0.7 11.9 0.7 0.6 1.0 16.6 0.6 1.1 0.3 0.0 1.5 0.7 0.7 0.6 2.5 0.6 0.6 5.8 5.6 0.6 0.6 0.8 0.6 2.0 4.8 0.6 1.5 0.6 13.1 3.1 3.4 0.7 1.2 0.1 0.6 0.6 0.6 0.7 1.4 0.6 1.6 0.6 5.1 0.7 1.1 0.0 0.6 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.0 5.6 1.2 0.0 0.0 0.1 0.8 0.0 33.8 11.6 7.3 2.6 0.0 0.5 0.0 5.2 21.5 12.2 0.0 0.0 13.3 7.2 0.0 0.0 2.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 6.6 10.0 4.7 9.5 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.9 0.0 0.0 0.0 1.1 0.0 0.0 15.9 11.3 11.8 0.0 9.0 0.0 0.0 0.0 2.6 0.0 8.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.0 11.9 1.0 16.6 5.8 5.6 2.0 4.8 3.4 1.1 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MARCH5 "FLJ20445, MARCH-V, MITOL, RNF153" ENSG00000198060 "Membrane associated ring-CH-type finger 5" Q9NX47 10 92291163-92353964 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056596 Supported Mitochondria NA NA Mitochondria "HPA056596: AB_2683181" "unprognostic (4.00e-2)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (4.10e-2)" "unprognostic (5.47e-3)" "unprognostic (2.33e-3)" "unprognostic (4.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.24e-2)" "unprognostic (9.77e-2)" "unprognostic (5.50e-3)" "unprognostic (4.02e-3)" "unprognostic (6.14e-2)" "unprognostic (2.87e-1)" "unprognostic (1.62e-1)" "unprognostic (4.53e-1)" "unprognostic (2.85e-2)" 18.2 21.7 17.5 17.7 18.3 20.7 27.1 16.8 25.7 15.5 15.4 12.7 20.7 15.8 19.3 18.8 28.0 14.8 15.4 18.4 15.8 15.1 21.7 27.6 16.5 16.6 16.3 17.9 20.9 16.7 16.3 12.3 16.3 14.8 22.2 14.8 14.5 19.4 19.3 42.6 13.7 16.0 18.1 14.0 12.1 14.4 20.1 13.5 25.0 24.5 21.5 17.3 14.7 21.0 7.3 9.4 16.8 10.2 6.5 8.7 6.6 16.2 8.8 17.5 20.0 11.9 12.4 9.0 14.6 16.1 18.2 18.7 5.9 11.7 9.5 10.1 14.2 8.0 13.4 12.1 12.2 26.2 7.1 14.3 7.6 8.3 13.8 14.5 12.1 7.6 12.7 16.5 12.0 25.2 24.3 16.0 10.2 8.3 11.9 14.5 10.3 10.7 14.0 4.1 10.6 13.3 11.6 17.9 5.6 18.6 10.5 8.1 15.0 12.6 9.4 15.4 8.7 16.4 9.5 15.5 8.6 9.4 9.3 19.9 12.1 9.2 8.4 7.8 16.9 5.7 5.2 8.3 9.0 7.6 10.2 7.6 7.3 8.4 8.0 9.4 6.7 8.7 8.3 16.8 6.5 8.5 6.2 7.8 6.6 17.5 18.3 16.8 25.7 15.8 15.1 16.3 17.9 14.8 13.5 20.8 22.1 26.1 0.0 78.5 12.2 22.9 20.4 9.4 9.1 19.2 7.9 35.2 72.9 0.0 116.8 22.5 30.7 0.0 0.0 36.8 29.4 0.0 28.8 32.6 30.8 9.5 28.6 20.3 24.8 37.2 27.3 19.9 37.1 0.0 22.9 18.6 0.0 23.0 17.3 56.2 10.9 19.4 24.5 37.4 28.3 68.3 54.6 25.5 24.7 0.0 MARCH6 "MARCH-VI, RNF176, TEB4" ENSG00000145495 "Membrane associated ring-CH-type finger 6" O60337 5 10353703-10440388 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040841, HPA063246" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA040841: AB_2677162, HPA063246: AB_2684970" "unprognostic (3.31e-2)" "unprognostic (2.04e-1)" "unprognostic (2.85e-2)" "unprognostic (3.80e-3)" "unprognostic (4.00e-1)" "unprognostic (2.26e-1)" "unprognostic (3.06e-2)" "unprognostic (9.52e-3)" "unprognostic (1.53e-1)" "unprognostic (1.05e-3)" "unprognostic (3.94e-2)" "unprognostic (5.58e-2)" "unprognostic (5.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.88e-1)" "unprognostic (3.57e-1)" "unprognostic (8.50e-3)" 22.5 25.6 28.6 21.2 25.5 57.0 62.4 42.0 53.8 21.4 23.0 24.0 18.3 28.6 24.7 24.2 22.8 25.1 22.0 35.5 27.6 23.7 31.9 28.9 35.0 33.2 29.8 39.1 34.0 41.5 56.0 27.4 20.3 33.4 21.4 18.4 20.3 28.0 23.4 49.8 23.9 32.1 27.4 38.6 31.2 26.0 25.6 26.9 18.0 26.8 17.1 20.3 24.6 36.4 13.4 7.3 15.6 12.1 9.9 15.7 9.4 12.6 19.0 31.9 24.7 18.3 14.7 26.1 20.1 18.7 17.3 22.2 18.1 33.9 13.3 30.6 18.7 24.0 17.6 16.9 13.0 23.5 28.2 15.4 17.3 63.2 12.3 12.9 20.5 19.5 17.1 14.4 17.3 19.0 17.9 16.0 14.4 20.7 30.1 15.7 14.4 11.1 15.9 11.6 10.2 13.4 17.3 13.3 19.2 13.5 24.6 13.7 19.9 37.3 20.4 13.1 15.4 17.0 11.1 15.4 21.0 20.5 10.3 14.9 21.1 30.3 19.0 15.5 14.3 14.9 15.6 8.5 13.6 13.5 9.6 15.4 13.4 13.4 13.4 7.3 11.5 15.7 14.6 13.7 9.9 12.1 5.6 11.7 9.4 28.6 25.5 42.0 53.8 27.6 23.7 29.8 39.1 33.4 26.9 50.6 44.3 66.5 0.0 124.9 104.6 89.0 53.5 62.9 56.9 68.0 62.8 47.1 18.3 0.0 9.4 58.6 66.9 93.5 0.0 24.4 54.5 0.0 48.5 71.6 32.5 128.7 95.5 58.9 54.8 10.0 64.5 39.1 89.4 0.0 73.5 52.7 0.0 56.1 72.2 52.5 79.3 77.6 80.4 84.4 67.3 119.4 68.0 58.0 58.3 0.0 MARCH8 "c-MIR, CMIR, MARCH-VIII, MIR, RNF178" ENSG00000165406 "Membrane associated ring-CH-type finger 8" Q5T0T0 10 45454585-45594906 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 20 "Cone photoreceptor cells: 106.0;Early spermatids: 508.4;Late spermatids: 175.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014597 Approved NA NA "HPA014597: AB_1853580" "unprognostic (1.38e-1)" "unprognostic (3.69e-2)" "unprognostic (1.74e-1)" "unprognostic (1.68e-3)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (3.51e-1)" "unprognostic (2.58e-1)" "unprognostic (1.56e-2)" "unprognostic (2.04e-1)" "prognostic favorable (2.71e-4)" "unprognostic (1.28e-1)" "prognostic favorable (6.64e-4)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (1.85e-1)" "unprognostic (3.12e-2)" 10.0 17.6 13.5 11.4 16.0 28.8 12.1 37.5 12.2 10.3 14.6 24.5 8.5 9.7 14.3 8.2 7.5 11.1 9.9 14.1 12.7 11.8 11.0 16.7 10.3 13.5 19.0 9.3 14.2 18.2 15.1 18.1 13.2 14.5 8.8 12.9 12.9 11.5 11.4 9.0 8.9 18.8 12.4 18.2 14.3 9.7 43.2 14.9 10.5 11.5 8.5 13.6 11.0 8.0 5.3 1.7 13.6 1.8 7.3 4.7 2.4 9.3 9.4 8.0 7.1 11.7 14.6 6.0 4.3 20.1 7.9 8.7 2.4 9.7 13.4 7.4 12.4 7.2 1.7 8.7 7.3 7.4 20.3 9.6 5.2 4.3 5.6 8.1 6.2 23.0 11.9 9.5 4.0 10.7 7.9 12.9 12.9 14.5 13.2 6.1 3.3 6.3 4.0 2.6 1.3 3.0 7.1 8.0 3.9 6.0 5.4 7.1 9.9 8.4 2.0 8.0 8.2 12.4 2.9 8.8 6.3 8.1 9.1 6.7 23.3 18.6 5.9 12.3 8.7 1.6 9.7 1.1 10.0 3.1 1.8 4.7 3.5 3.4 3.3 1.6 5.3 2.7 3.3 13.6 7.3 0.9 1.7 3.1 2.4 13.5 16.0 37.5 12.2 12.7 11.8 19.0 9.3 14.5 14.9 8.9 7.5 13.4 0.0 3.1 6.6 21.0 10.2 6.7 12.5 10.4 106.0 1.7 5.0 0.0 508.4 8.7 20.2 70.0 0.0 1.1 5.6 0.0 17.3 22.5 5.4 11.1 39.0 12.9 15.9 175.4 7.8 7.0 5.0 0.0 11.9 6.3 0.0 10.4 8.5 9.9 23.0 6.5 2.8 21.5 13.4 3.3 1.4 8.3 11.2 0.0 MARCH9 "FLJ36578, RNF179" ENSG00000139266 "Membrane associated ring-CH-type finger 9" Q86YJ5 12 57755098-57760407 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Bipolar cells: 72.9;Cone photoreceptor cells: 119.8;Horizontal cells: 54.0;Muller glia cells: 63.3;Rod photoreceptor cells: 188.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 12 "RH-30: 110.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.96e-2)" "unprognostic (6.78e-2)" "unprognostic (1.90e-3)" "prognostic favorable (3.07e-4)" "unprognostic (2.16e-1)" "unprognostic (6.85e-2)" "unprognostic (8.15e-3)" "prognostic favorable (1.54e-5)" "unprognostic (7.76e-2)" "prognostic favorable (1.59e-4)" "unprognostic (1.08e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.98e-5)" "unprognostic (2.44e-1)" "unprognostic (2.86e-1)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" 5.9 11.8 11.0 10.7 14.1 6.1 8.8 25.0 16.6 9.5 9.3 7.8 17.5 10.1 6.8 11.9 8.3 9.6 14.3 12.2 10.8 9.9 16.9 5.6 16.5 16.6 7.7 11.0 6.4 14.4 26.3 24.6 10.3 7.4 11.0 9.0 16.8 12.3 17.6 10.5 13.4 12.7 7.0 6.1 19.4 11.6 5.2 6.8 37.6 20.2 6.2 17.8 9.2 7.7 6.8 11.0 2.2 0.7 3.0 6.1 1.3 3.1 1.5 2.4 2.6 0.2 0.0 3.2 0.4 3.3 1.9 1.8 2.0 2.5 7.6 2.6 0.0 3.2 2.8 4.0 3.4 1.2 4.5 4.4 1.0 1.1 1.0 2.3 0.9 1.6 0.4 3.5 0.5 1.9 5.6 0.8 7.7 1.4 7.9 0.5 2.9 4.8 1.1 1.6 2.2 3.4 4.0 110.2 8.2 3.7 2.7 5.6 3.6 0.2 0.2 2.0 1.2 5.6 1.8 0.0 2.4 2.0 1.3 1.5 8.9 4.0 4.7 2.7 0.2 2.4 2.2 0.5 0.1 4.0 0.7 5.9 5.3 6.0 5.2 1.5 6.8 6.1 4.6 0.2 3.0 0.2 11.0 3.6 1.3 11.0 14.1 25.0 16.6 10.8 9.9 7.7 11.0 7.4 6.8 20.8 12.3 17.1 0.0 9.2 72.9 9.4 12.7 1.4 5.7 8.7 119.8 1.6 5.0 0.0 0.3 7.3 5.3 0.0 0.0 0.7 3.1 0.0 2.3 3.9 6.6 54.0 14.6 12.3 1.2 0.8 9.2 3.3 6.8 0.0 8.0 63.3 0.0 2.9 10.6 7.0 188.1 6.5 4.7 2.3 3.4 8.3 0.9 10.1 11.0 0.0 MARCO "SCARA2, SR-A6" ENSG00000019169 "Macrophage receptor with collagenous structure" Q9UEW3 2 118942166-118994660 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 66.3;lung: 65.6;lymphoid tissue: 58.7" "Cell type enriched" "Detected in some" 6 "Kupffer cells: 829.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 15.8;intermediate monocyte: 26.7" "Lineage enriched" "Detected in many" 5 "monocytes: 26.7" "Cell line enhanced" "Detected in some" "HaCaT: 4.0;THP-1: 5.7;U-2 OS: 6.2;U-266/70: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063793 Enhanced Approved "Golgi apparatus,Vesicles" NA NA 24000000 "Golgi apparatus" Vesicles "HPA063793: AB_2685123" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" "unprognostic (5.96e-3)" "unprognostic (3.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.58e-2)" "unprognostic (3.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (6.27e-3)" "unprognostic (5.13e-2)" "unprognostic (2.24e-3)" "unprognostic (1.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (6.55e-2)" 22.8 11.7 0.8 29.6 1.1 0.9 3.3 2.3 1.3 0.3 2.8 0.9 0.0 0.6 0.3 12.9 5.2 13.8 0.8 10.8 0.6 0.4 1.6 66.3 65.6 29.3 1.3 3.1 4.7 0.4 0.2 0.8 2.3 2.7 4.5 0.7 1.0 2.9 0.8 6.8 1.1 1.3 9.6 1.7 58.7 2.2 2.8 0.6 0.0 3.0 0.5 0.4 8.8 1.1 0.0 5.0 0.3 26.7 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.9 4.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 5.7 0.0 0.0 6.2 0.9 0.0 3.6 0.0 0.2 0.0 1.3 0.0 0.0 15.8 0.0 0.0 26.7 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.3 0.0 3.2 0.4 0.0 3.4 0.8 1.1 2.3 1.3 0.6 0.4 1.3 3.1 2.7 0.6 23.8 42.6 0.0 0.0 1.0 0.0 0.4 0.0 24.1 30.7 3.5 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.7 1.5 0.1 11.6 0.8 145.4 0.0 0.0 13.5 829.9 0.0 0.0 63.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.6 1.3 0.0 0.0 MARS "CMT2U, MetRS, SPG70" ENSG00000166986 "Methionyl-tRNA synthetase" P56192 12 57475445-57517569 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 118.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004125, CAB017097" Supported Approved Enhanced Cytosol NA NA 21000 Cytosol "CAB017097: , HPA004125: AB_1079312" "prognostic unfavorable (1.73e-4)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.57e-2)" "unprognostic (4.90e-3)" "prognostic unfavorable (4.55e-7)" "unprognostic (8.47e-2)" "unprognostic (1.73e-1)" "unprognostic (4.03e-2)" "unprognostic (2.85e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (1.13e-2)" "unprognostic (1.96e-1)" "unprognostic (1.13e-1)" "unprognostic (2.06e-2)" 23.8 26.7 35.1 27.3 29.1 23.0 19.8 25.1 36.0 17.4 23.9 23.1 23.9 17.3 23.3 36.3 29.5 17.9 16.1 25.0 28.0 29.5 20.5 45.9 24.3 25.1 40.1 25.5 25.8 48.3 35.7 34.0 22.2 30.9 25.6 24.7 19.8 26.0 30.0 24.5 18.4 20.1 33.7 30.7 30.7 31.3 29.6 30.9 21.4 26.9 22.3 34.3 24.3 27.9 12.9 29.3 19.0 27.0 14.1 18.9 15.5 16.8 23.4 15.7 27.1 17.6 10.7 28.9 24.1 28.2 25.5 27.3 25.1 18.7 29.6 16.0 29.2 15.9 19.2 35.7 31.1 26.8 25.6 15.5 20.9 8.7 14.1 39.2 31.4 24.0 15.5 48.4 29.2 75.7 12.2 18.2 37.8 32.3 63.4 17.7 23.3 28.1 23.7 29.6 27.0 25.8 24.4 118.3 30.6 19.2 13.2 20.9 21.3 12.5 19.3 33.4 18.4 25.4 41.2 13.5 9.2 27.3 13.3 14.3 58.2 58.8 35.7 22.7 23.9 31.5 12.1 14.6 19.0 18.9 27.0 17.2 12.9 12.9 17.1 29.3 7.7 11.1 15.2 7.2 14.1 21.8 28.4 13.1 15.5 35.1 29.1 25.1 36.0 28.0 29.5 40.1 25.5 30.9 30.9 35.7 22.7 29.8 15.6 16.6 14.8 10.1 12.7 28.1 29.6 17.4 31.4 24.6 5.0 32.2 19.0 13.7 11.1 0.0 39.9 18.6 15.5 18.1 26.7 11.3 17.0 6.4 14.5 8.0 12.0 6.6 12.0 22.6 3.3 32.5 10.3 11.5 33.5 14.0 14.2 9.8 28.8 12.9 17.9 33.4 34.1 14.1 31.8 20.3 9.7 23.1 MARVELD1 "bA548K23.8, FLJ22343, FLJ23440, GB14, MGC4415, MRVLDC1" ENSG00000155254 "MARVEL domain containing 1" Q9BSK0 10 97713173-97718152 "Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 5.6;intermediate monocyte: 4.6;myeloid DC: 5.3" "Group enriched" "Detected in many" 17 "dendritic cells: 5.3;monocytes: 5.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.28e-2)" "unprognostic (2.11e-2)" "unprognostic (1.26e-3)" "unprognostic (3.05e-2)" "unprognostic (1.36e-3)" "unprognostic (8.82e-2)" "unprognostic (7.40e-3)" "prognostic unfavorable (5.85e-5)" "unprognostic (1.54e-2)" "unprognostic (7.44e-3)" "unprognostic (3.40e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (8.89e-7)" "unprognostic (3.92e-3)" "unprognostic (7.02e-2)" "unprognostic (1.50e-1)" "unprognostic (3.86e-3)" 14.5 4.0 4.5 5.9 4.4 1.8 18.2 3.8 3.9 30.5 21.5 4.5 9.9 3.5 26.5 13.2 15.6 20.0 16.9 10.2 5.2 2.7 6.2 2.5 21.9 10.0 3.9 3.5 22.5 2.9 9.6 8.6 19.4 5.1 21.6 12.3 21.7 7.8 25.1 5.1 12.5 9.0 40.7 4.3 6.8 11.0 8.0 2.5 3.1 6.9 5.3 6.3 21.1 19.3 0.0 5.3 0.0 5.6 0.0 0.3 1.5 11.7 8.8 7.6 29.0 29.3 28.4 7.9 16.2 40.9 15.1 10.2 3.8 20.3 0.0 13.1 29.9 2.1 14.4 6.5 15.3 7.7 0.8 8.1 5.7 6.7 0.0 12.3 7.9 0.0 24.8 40.2 9.7 11.3 28.1 18.8 5.0 1.6 0.0 16.7 6.7 1.0 2.7 5.7 1.2 8.9 7.3 6.5 1.9 8.0 2.5 5.0 5.2 9.7 0.0 16.6 4.9 3.9 9.5 18.8 15.4 6.3 14.8 6.0 0.0 0.8 0.0 7.8 0.0 11.6 0.0 5.6 0.0 0.1 4.6 0.2 0.0 0.0 0.2 5.3 0.0 0.0 0.3 0.0 0.0 1.2 1.4 0.0 1.5 4.5 4.4 3.8 3.9 5.2 2.7 3.9 3.5 5.1 2.5 8.9 4.6 0.8 29.2 6.8 1.6 4.1 5.1 0.0 9.1 12.2 5.9 9.2 0.0 8.0 0.5 8.7 2.8 0.0 0.8 17.2 31.0 3.0 2.3 0.8 11.8 0.0 2.9 13.5 27.8 1.5 21.3 14.2 11.8 4.6 29.6 15.0 1.8 2.9 36.4 0.0 3.0 0.0 21.5 0.2 0.9 4.6 2.9 0.0 6.6 4.7 MARVELD2 "DFNB49, FLJ30532, MRVLDC2, TRIC" ENSG00000152939 "MARVEL domain containing 2" Q8N4S9 5 69415065-69444330 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 18.4;CAPAN-2: 15.9;HaCaT: 12.3;hTCEpi: 10.3;RT4: 14.2;SCLC-21H: 16.7;T-47d: 12.4" "Region enriched" "Detected in single" 8 "cerebellum: 8.8" "Low region specificity" "Detected in all" "HPA018119, HPA061726" Uncertain Supported "Cell Junctions" NA NA "Cell Junctions" "HPA018119: AB_2669771, HPA061726: AB_2684595" "unprognostic (4.11e-2)" "unprognostic (3.05e-1)" "unprognostic (1.22e-2)" "unprognostic (2.44e-3)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.49e-1)" "unprognostic (8.84e-2)" "unprognostic (2.43e-1)" "unprognostic (3.47e-2)" "unprognostic (2.60e-2)" "unprognostic (1.75e-1)" "prognostic favorable (2.84e-13)" "unprognostic (1.78e-1)" "unprognostic (1.19e-1)" "unprognostic (3.67e-2)" "unprognostic (1.82e-1)" 0.6 0.7 1.1 2.3 1.4 0.2 4.5 0.7 1.3 2.6 13.2 1.6 9.5 9.4 1.6 6.4 9.1 4.4 9.2 0.9 1.4 1.2 12.2 24.2 11.2 0.4 1.7 0.8 1.0 18.9 3.9 8.0 9.9 2.1 5.0 7.3 5.2 10.9 7.4 0.4 5.4 21.8 1.4 1.3 0.6 8.9 2.7 0.7 1.1 25.7 6.4 7.3 4.7 4.1 1.4 0.4 1.5 0.8 1.1 2.3 1.0 6.6 2.5 0.0 0.0 0.0 0.0 18.4 0.1 0.0 0.1 0.4 8.6 15.9 0.0 1.8 1.1 0.0 12.3 0.0 9.2 0.3 0.1 3.5 0.0 0.8 4.6 1.1 0.0 0.0 0.3 10.3 0.1 1.4 0.4 0.7 0.1 0.0 0.1 0.0 6.6 0.0 0.0 1.3 3.9 0.2 0.0 0.0 0.4 6.9 14.2 16.7 0.0 1.7 1.7 0.2 3.2 12.4 0.0 1.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.1 0.0 1.5 0.8 0.2 0.4 0.2 1.1 1.2 2.3 0.2 0.3 1.4 0.7 0.5 0.9 1.1 0.1 0.4 0.1 1.0 1.1 1.4 0.7 1.3 1.4 1.2 1.7 0.8 2.1 0.7 20.8 21.6 0.8 16.8 4.4 0.1 2.5 25.5 30.8 20.5 15.7 2.0 19.2 14.9 19.8 4.6 3.1 25.7 0.0 22.9 7.1 0.8 23.1 1.1 33.9 1.6 0.0 16.1 3.7 0.6 1.6 0.0 0.8 1.7 13.6 23.4 0.8 23.3 31.9 0.0 5.3 0.2 0.0 1.0 3.8 1.9 5.6 10.1 0.0 24.5 33.8 MARVELD3 MRVLDC3 ENSG00000140832 "MARVEL domain containing 3" Q96A59 16 71626161-71642114 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.9;pancreas: 34.5" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 154.2;Paneth cells: 84.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 11.7;BEWO: 17.6;CACO-2: 13.0;CAPAN-2: 12.6;HaCaT: 11.9;MCF7: 22.2;RT4: 10.4;SK-BR-3: 10.5;T-47d: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043514, HPA045471" Approved "Vesicles,Intermediate filaments" No NA Vesicles "Intermediate filaments" "HPA043514: AB_10959475, HPA045471: " "unprognostic (1.18e-1)" "unprognostic (3.92e-1)" "unprognostic (9.92e-2)" "unprognostic (5.56e-2)" "unprognostic (1.03e-1)" "unprognostic (6.16e-3)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (2.54e-1)" "unprognostic (8.75e-3)" "unprognostic (3.29e-1)" "unprognostic (5.16e-2)" "prognostic favorable (6.80e-10)" "unprognostic (2.63e-3)" "unprognostic (4.76e-1)" "unprognostic (3.59e-2)" "unprognostic (2.43e-1)" 0.4 0.3 0.4 12.5 0.3 0.0 5.0 0.7 1.2 2.0 35.7 0.3 5.2 17.3 1.3 8.6 4.1 2.1 15.4 0.5 0.5 0.4 14.2 4.3 3.3 0.5 0.3 0.1 1.0 34.5 5.4 1.2 5.3 2.4 6.5 10.5 2.4 10.4 4.3 0.3 3.0 52.9 0.7 0.4 0.4 2.1 1.2 0.1 1.3 8.3 2.3 4.6 3.0 3.4 1.5 1.4 4.1 0.8 1.5 0.8 0.2 11.7 0.4 0.2 0.5 0.0 0.1 17.6 0.0 0.0 0.0 0.0 13.0 12.6 0.1 1.3 0.0 0.0 11.9 1.1 5.7 0.0 0.0 6.8 0.0 0.1 3.4 0.0 0.1 0.1 0.5 7.1 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 22.2 0.1 0.2 2.0 7.4 0.1 0.0 0.0 4.7 0.2 10.4 2.1 0.1 0.2 10.5 0.0 1.5 14.9 0.2 0.0 0.0 0.2 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 4.1 0.8 0.8 0.7 0.5 0.4 0.8 0.8 0.6 0.3 1.5 0.7 0.7 4.0 1.5 0.5 1.4 0.7 0.2 0.4 0.3 0.7 0.5 0.5 0.4 0.3 0.1 2.4 0.1 8.9 5.9 0.0 25.0 7.0 5.9 0.4 38.2 20.1 12.5 8.7 0.0 31.8 1.7 23.0 4.2 0.0 154.2 0.0 29.6 0.7 1.0 32.3 0.0 5.0 2.5 0.0 59.0 0.6 1.2 2.2 0.3 1.0 0.0 1.0 62.0 0.8 24.0 84.2 0.7 20.2 19.7 0.0 1.0 7.7 4.3 3.1 4.0 1.3 44.3 38.8 MAS1 ENSG00000130368 "MAS1 proto-oncogene, G protein-coupled receptor" P04201 6 159906690-159916530 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.5;cervix, uterine: 1.9" "Cell type enhanced" "Detected in some" 7 "Alveolar cells type 1: 3.0;Cone photoreceptor cells: 2.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "HMC-1: 13.3" "Group enriched" "Detected in many" 25 "amygdala: 40.1;basal ganglia: 26.8;cerebral cortex: 31.9;hippocampal formation: 71.0" "Group enriched" "Detected in many" 7 "amygdala: 8.6;cerebral cortex: 13.2;hippocampal formation: 26.9" HPA079325 Approved NA NA "HPA079325: " "unprognostic (3.31e-1)" "unprognostic (2.25e-3)" "unprognostic (2.91e-1)" "unprognostic (2.22e-3)" "unprognostic (8.15e-3)" "unprognostic (7.05e-2)" "unprognostic (1.88e-1)" "unprognostic (5.53e-2)" "unprognostic (6.52e-2)" "unprognostic (1.48e-5)" "unprognostic (1.69e-1)" "unprognostic (7.67e-2)" "unprognostic (6.28e-1)" 0.1 0.0 0.9 0.0 0.0 0.8 0.0 0.0 4.5 1.9 0.0 0.0 0.3 0.7 0.0 0.3 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.2 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.0 0.5 0.3 1.5 0.2 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 1.6 0.1 1.5 0.2 0.3 0.2 0.1 0.2 0.3 0.2 0.2 0.1 0.5 0.3 0.3 1.5 0.3 0.1 0.3 0.1 0.1 3.0 1.1 0.5 1.1 0.0 1.2 0.7 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.5 0.2 0.0 0.0 1.3 1.5 0.0 0.9 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.7 0.0 1.6 0.0 0.1 0.4 0.7 0.0 0.2 0.0 0.0 1.4 MAS1L "dJ994E9.2, MAS-L, MRG" ENSG00000204687 "MAS1 proto-oncogene like, G protein-coupled receptor" P35410 6 29486697-29487956 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 7.5;epididymis: 4.0" "Cell type enriched" "Detected in single" 58 "granulocytes: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 40 "HEL: 3.9" HPA017983 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA017983: AB_1849332" "unprognostic (3.66e-2)" "unprognostic (2.51e-1)" "unprognostic (2.30e-2)" "unprognostic (5.22e-2)" "unprognostic (1.65e-1)" 2.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 7.5 1.3 0.4 1.2 4.0 2.1 0.2 1.2 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 1.5 0.3 0.2 1.7 1.5 1.1 0.0 0.0 0.5 0.3 0.0 0.5 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAVS "Cardif, IPS-1, KIAA1271, VISA" ENSG00000088888 "Mitochondrial antiviral signaling protein" Q7Z434 20 3846799-3876123 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009187, HPA049850, HPA053524" Enhanced Enhanced Mitochondria NA NA 230000 Mitochondria "CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177" "unprognostic (1.30e-2)" "unprognostic (4.51e-2)" "unprognostic (2.17e-1)" "unprognostic (6.67e-2)" "unprognostic (1.42e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-3)" "unprognostic (2.23e-2)" "unprognostic (2.30e-2)" "unprognostic (5.95e-2)" "prognostic favorable (3.81e-4)" "unprognostic (1.92e-1)" "prognostic favorable (4.13e-5)" "unprognostic (4.97e-2)" "unprognostic (3.03e-1)" "unprognostic (3.12e-2)" "unprognostic (7.39e-2)" 15.9 13.9 13.0 15.5 17.7 10.8 25.5 17.7 15.7 12.3 18.5 17.2 15.1 17.2 14.9 10.6 17.3 13.8 12.2 15.4 12.3 8.0 13.3 13.9 18.1 17.4 19.9 9.0 18.9 22.5 23.4 13.7 12.0 13.8 13.1 18.6 13.6 15.3 22.4 39.4 22.1 17.0 17.1 13.7 12.7 15.8 5.9 17.1 15.1 14.6 14.0 14.3 18.2 21.6 5.1 5.6 6.4 6.9 5.9 4.8 4.6 16.6 19.4 7.9 9.8 21.8 14.9 6.2 10.1 13.0 10.8 7.9 15.1 10.8 7.2 6.2 14.1 30.8 21.0 9.4 15.1 11.1 4.4 4.6 13.9 7.2 24.0 12.1 8.7 5.9 15.0 12.9 18.3 10.9 10.8 10.9 9.5 15.6 5.6 10.5 15.0 13.1 7.4 5.0 8.3 10.7 9.9 11.0 7.2 11.4 16.7 5.9 6.2 11.5 22.5 9.7 11.7 12.0 8.1 16.4 14.8 5.5 17.4 11.7 11.4 13.7 5.1 5.8 10.7 7.5 4.4 6.9 6.1 4.8 5.1 3.6 3.8 3.8 3.7 4.4 5.1 4.4 4.4 6.4 5.9 5.5 5.6 3.0 4.6 13.0 17.7 17.7 15.7 12.3 8.0 19.9 9.0 13.8 17.1 53.6 40.3 27.3 12.5 1.9 31.8 52.6 66.2 25.4 35.2 27.9 15.7 28.8 11.6 21.9 0.9 25.1 79.6 23.3 26.2 23.2 18.1 15.7 8.1 39.0 21.3 42.9 33.4 41.1 29.1 1.5 28.4 13.1 1.7 17.2 28.4 23.6 28.0 21.0 26.5 18.3 34.3 32.3 8.1 4.2 3.8 1.8 15.1 19.2 45.8 14.3 MBOAT1 "dJ434O11.1, LPEAT1, MGC44669, OACT1" ENSG00000172197 "Membrane bound O-acyltransferase domain containing 1" Q6ZNC8 6 20102145-20212399 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 9.7;Melanocytes: 8.5;Paneth cells: 8.6;Suprabasal keratinocytes: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 30.3;HEL: 24.9;T-47d: 22.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (1.26e-2)" "unprognostic (4.18e-2)" "unprognostic (2.06e-2)" "unprognostic (5.85e-3)" "unprognostic (3.88e-2)" "unprognostic (5.31e-2)" "unprognostic (2.55e-2)" "unprognostic (6.57e-3)" "unprognostic (1.87e-1)" "unprognostic (1.62e-3)" "prognostic unfavorable (9.15e-4)" "unprognostic (2.90e-2)" "unprognostic (5.59e-2)" "unprognostic (5.17e-2)" "unprognostic (2.56e-1)" "unprognostic (1.70e-1)" "unprognostic (4.24e-2)" 9.9 3.3 1.4 16.5 2.1 6.2 16.5 1.5 1.8 22.5 17.3 6.4 7.1 9.7 18.8 9.9 9.6 18.1 18.8 8.4 1.7 1.7 4.4 4.0 14.0 7.6 6.5 0.7 10.5 4.4 4.7 2.7 3.2 6.2 9.3 15.4 7.2 6.5 9.4 2.2 4.3 21.1 17.2 10.0 4.6 10.6 2.6 3.2 3.9 6.6 6.5 11.1 10.4 12.8 0.3 2.8 6.4 6.8 0.5 4.1 0.9 3.3 3.5 6.6 4.5 0.7 2.2 0.3 5.3 1.5 3.7 4.1 1.9 12.9 0.0 11.1 5.1 2.7 30.3 6.4 2.7 5.2 8.3 3.1 24.9 5.7 0.0 4.1 7.9 8.7 0.9 2.4 1.6 6.7 1.8 2.0 5.2 4.0 4.7 0.8 3.0 4.4 4.7 1.4 2.8 1.8 1.6 7.6 17.5 3.7 6.6 0.2 4.1 1.1 5.3 5.7 12.2 22.9 2.7 1.9 4.4 3.0 2.5 2.2 6.9 15.4 0.0 0.3 5.5 5.3 6.4 4.4 6.0 0.7 4.7 4.1 0.2 1.2 1.7 2.6 0.3 0.3 0.3 5.7 0.5 6.8 2.8 1.3 0.9 1.4 2.1 1.5 1.8 1.7 1.7 6.5 0.7 6.2 3.2 3.0 0.3 0.0 0.6 9.7 0.0 0.3 0.0 4.0 0.0 0.0 0.0 0.1 1.7 1.9 0.0 0.2 3.6 0.0 1.0 0.1 0.8 0.6 0.0 0.0 1.2 0.0 0.0 0.0 1.5 0.0 0.3 2.1 8.5 0.0 0.9 2.0 1.3 8.6 0.0 0.0 0.0 0.0 0.8 0.0 0.1 13.6 0.2 0.0 2.0 1.3 MBOAT2 "FLJ14415, FLJ90298, OACT2" ENSG00000143797 "Membrane bound O-acyltransferase domain containing 2" Q6ZWT7 2 8852690-9003813 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 34.7" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 133.5;Muller glia cells: 95.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 6.3;eosinophil: 2.8;neutrophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014836 Uncertain Approved Vesicles NA NA Vesicles "HPA014836: AB_1854745" "unprognostic (2.49e-1)" "unprognostic (2.17e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.13e-9)" "unprognostic (1.30e-1)" "unprognostic (2.32e-2)" "unprognostic (2.38e-1)" "unprognostic (3.97e-3)" "unprognostic (3.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.03e-3)" "unprognostic (1.70e-1)" "unprognostic (5.90e-2)" "unprognostic (2.23e-1)" "unprognostic (3.04e-2)" "unprognostic (6.66e-2)" "prognostic unfavorable (5.32e-4)" 2.3 2.9 12.8 2.9 18.0 24.2 10.1 10.1 20.2 6.0 8.2 16.6 1.2 3.1 5.3 3.5 14.2 3.7 4.3 5.1 14.7 12.4 8.0 1.3 10.9 2.9 23.3 10.3 6.8 2.1 34.7 5.5 3.8 16.2 16.1 9.3 6.4 5.6 4.1 1.2 12.3 4.3 4.6 18.5 2.5 6.9 2.7 17.8 1.9 5.3 16.1 10.3 4.4 7.5 0.0 0.8 6.7 0.7 0.0 0.2 0.3 8.4 2.6 7.9 3.4 3.6 8.0 4.6 4.1 1.5 5.3 3.5 0.7 13.5 2.4 4.9 9.7 4.2 6.5 7.0 8.2 8.0 7.5 12.1 10.1 3.7 0.0 4.4 0.0 3.2 5.8 4.9 5.0 3.5 11.7 2.8 3.5 8.6 1.9 4.6 2.2 3.0 0.2 3.1 3.8 10.0 4.5 12.5 0.1 7.8 1.2 4.7 14.5 4.2 25.5 4.0 4.1 4.8 2.9 1.5 9.4 5.0 7.2 11.6 0.7 0.2 2.7 14.7 1.4 3.1 6.3 0.7 2.8 0.0 0.2 0.0 0.0 0.2 0.1 0.8 0.0 0.2 0.1 6.7 0.0 0.2 0.1 0.0 0.3 12.8 18.0 10.1 15.8 14.7 12.4 23.3 10.3 16.2 17.8 17.9 10.1 4.5 2.9 3.0 18.3 10.6 5.1 16.0 19.4 38.4 7.9 2.5 5.0 4.5 7.3 8.8 10.3 46.7 1.4 1.3 9.8 21.0 8.1 0.0 1.7 133.5 36.0 4.3 2.1 7.8 4.9 4.3 13.5 44.1 49.8 95.3 52.2 20.4 7.1 8.4 7.2 6.5 12.0 10.7 23.7 4.4 1.6 2.1 11.9 29.8 MBOAT4 "FKSG89, GOAT, OACT4" ENSG00000177669 "Membrane bound O-acyltransferase domain containing 4" Q96T53 8 30131824-30144686 "Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 23.9;stomach 1: 7.7" "Cell type enhanced" "Detected in some" 22 "Cholangiocytes: 5.1;Ductal cells: 1.6;Early spermatids: 1.0;Intestinal endocrine cells: 3.4" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 1.9;Hep G2: 6.9;OE19: 7.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044509 Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA044509: AB_2678966" "unprognostic (4.35e-3)" "unprognostic (2.08e-1)" "unprognostic (2.55e-1)" "unprognostic (3.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.76e-2)" "unprognostic (1.85e-3)" "unprognostic (4.48e-2)" "unprognostic (2.56e-1)" "unprognostic (1.07e-1)" "unprognostic (6.30e-2)" "unprognostic (7.02e-2)" "unprognostic (4.24e-6)" "unprognostic (9.87e-3)" "unprognostic (1.58e-1)" "unprognostic (2.18e-1)" "unprognostic (3.66e-2)" 0.4 1.8 0.3 0.5 0.6 1.0 0.3 0.3 0.3 0.3 0.5 0.3 0.3 0.8 0.9 0.3 0.3 3.9 2.1 0.4 0.3 0.1 0.4 1.5 0.9 0.8 0.3 0.3 0.5 23.9 0.0 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.1 1.3 0.3 0.3 1.4 7.7 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.8 0.7 2.6 1.5 2.8 4.1 0.6 0.4 1.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 1.9 0.0 0.3 0.4 0.0 0.1 0.0 0.5 0.3 0.3 0.1 6.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.6 0.0 0.1 0.5 0.3 0.0 7.7 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.7 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.2 1.3 0.0 0.2 0.1 0.0 0.0 1.1 0.8 0.4 0.6 0.6 2.1 0.5 1.5 2.4 0.0 1.6 2.0 0.7 1.8 2.4 4.1 2.6 2.8 0.2 0.4 0.5 0.6 0.3 0.6 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBOAT7 "BB1, hMBOA-7, LENG4, LPIAT" ENSG00000125505 "Membrane bound O-acyltransferase domain containing 7" Q96N66 19 54173412-54189882 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "basophil: 15.7;eosinophil: 30.6;neutrophil: 30.0" "Lineage enriched" "Detected in many" 10 "granulocytes: 30.6" "Cell line enhanced" "Detected in many" "HMC-1: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055967 Approved Approved Cytosol NA NA Cytosol "HPA055967: AB_2682990" "unprognostic (1.89e-2)" "unprognostic (2.60e-2)" "unprognostic (2.60e-1)" "unprognostic (3.31e-1)" "unprognostic (3.54e-2)" "unprognostic (5.95e-2)" "prognostic unfavorable (5.55e-6)" "prognostic unfavorable (5.13e-4)" "unprognostic (5.36e-2)" "unprognostic (2.31e-2)" "unprognostic (1.08e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (6.62e-5)" "unprognostic (1.31e-1)" "unprognostic (4.75e-2)" "unprognostic (3.95e-1)" "prognostic favorable (4.31e-4)" 10.7 63.1 16.8 14.8 24.2 15.9 7.9 11.3 37.8 10.3 17.7 9.2 15.6 30.3 10.5 8.0 10.5 11.5 14.3 6.9 18.5 23.4 10.5 11.6 11.5 14.7 10.0 18.8 15.1 24.4 23.8 12.4 11.9 21.6 11.4 6.1 8.1 10.8 28.8 7.9 10.0 28.5 6.5 9.2 14.4 16.4 30.8 6.8 7.6 12.7 5.0 6.3 22.6 17.5 0.3 2.9 30.6 2.1 0.9 0.5 0.8 14.2 8.5 1.3 14.0 4.6 3.6 12.3 25.0 8.9 5.8 11.5 4.8 16.2 3.7 11.2 5.4 2.5 29.2 0.0 5.1 1.1 5.1 16.6 3.9 9.2 3.1 4.5 9.0 57.3 6.7 3.4 2.8 2.0 4.6 10.4 2.7 14.7 11.8 2.0 8.6 2.6 3.2 5.9 2.5 18.2 8.4 2.4 7.5 5.8 17.3 0.5 3.7 16.7 10.2 5.1 0.1 10.3 0.8 20.7 12.3 4.4 3.6 9.9 5.4 9.3 1.5 17.7 6.4 8.1 15.7 2.1 30.6 0.2 1.5 0.5 0.2 0.2 0.2 2.9 0.3 0.1 0.2 30.0 0.9 0.8 0.8 0.2 0.8 16.8 24.2 11.3 37.8 18.5 23.4 10.0 18.8 21.6 6.8 11.9 26.6 12.2 44.1 12.4 15.8 6.5 30.6 13.4 14.8 41.8 5.9 38.6 5.0 45.1 1.1 16.6 88.9 0.0 28.7 43.8 12.7 39.8 76.1 13.9 28.4 28.6 40.8 14.7 36.9 1.9 17.8 32.1 8.5 19.8 45.8 22.4 34.4 40.3 14.5 12.2 6.8 38.8 23.4 3.9 14.5 18.9 43.1 11.4 38.5 48.0 MBTPS1 "KIAA0091, PCSK8, S1P, SKI-1" ENSG00000140943 "Membrane bound transcription factor peptidase, site 1" Q14703 16 84053761-84116906 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Protease, Serine protease" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 157.1;Rod photoreceptor cells: 283.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056109 Supported NA NA "HPA056109: AB_2683040" "unprognostic (1.50e-1)" "unprognostic (9.73e-2)" "unprognostic (1.58e-1)" "unprognostic (3.10e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (2.50e-1)" "unprognostic (2.02e-1)" "unprognostic (1.47e-1)" "unprognostic (1.59e-1)" "unprognostic (1.00e-2)" "unprognostic (2.19e-1)" "prognostic favorable (2.21e-5)" "unprognostic (2.62e-1)" "unprognostic (2.92e-1)" "unprognostic (6.63e-2)" "unprognostic (6.88e-2)" 26.6 25.3 15.2 17.9 32.0 13.2 27.2 29.9 30.2 27.5 23.6 20.5 21.5 15.8 33.5 22.2 18.8 29.2 20.4 31.5 15.7 18.2 23.4 28.9 22.1 17.1 14.8 15.9 34.3 32.6 47.5 38.7 28.5 15.9 24.0 21.2 33.1 29.7 26.8 16.2 18.7 19.0 25.9 11.4 21.8 23.5 17.7 16.1 24.0 36.7 16.7 23.2 26.1 19.6 10.9 11.5 12.8 14.3 14.4 16.7 15.4 15.4 19.6 17.6 24.4 41.6 33.8 13.8 26.0 40.3 23.0 17.4 13.9 22.9 14.8 27.1 37.2 18.3 17.0 16.1 18.0 25.6 13.3 18.1 10.8 18.9 19.3 20.1 26.1 23.9 34.7 26.2 21.1 18.2 33.1 29.8 20.1 14.1 13.1 13.9 26.7 14.3 14.7 16.4 8.7 14.0 18.7 9.4 10.6 18.6 12.8 13.5 16.8 50.2 13.9 19.3 19.9 43.6 24.1 31.7 23.9 17.5 14.2 12.2 16.6 30.8 28.5 17.4 16.0 14.5 6.6 14.3 12.8 15.8 12.1 16.2 10.9 13.6 14.7 11.5 9.9 16.7 14.8 4.1 14.4 9.8 6.4 8.7 15.4 15.2 32.0 29.9 30.2 15.7 18.2 14.8 15.9 15.9 16.1 44.7 42.4 21.6 19.9 12.2 63.0 46.9 38.2 60.2 50.0 24.4 157.1 18.8 10.0 21.2 0.6 34.9 15.3 0.0 23.6 18.0 31.0 27.3 27.8 28.8 14.6 79.4 33.6 33.7 14.8 3.7 49.5 16.1 18.6 1.8 28.7 40.6 25.3 21.0 47.4 15.9 283.9 25.8 21.3 13.7 19.9 13.8 18.1 16.2 29.3 24.0 MBTPS2 "KFSD, S2P" ENSG00000012174 "Membrane bound transcription factor peptidase, site 2" O43462 X 21839636-21885424 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005494, CAB009486" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "CAB009486: AB_2140370, HPA005494: AB_1079329" "unprognostic (7.97e-3)" "unprognostic (9.12e-2)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (7.22e-2)" "unprognostic (3.32e-1)" "unprognostic (9.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (8.38e-2)" "unprognostic (7.76e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" "unprognostic (3.05e-2)" 12.0 17.4 9.3 7.2 13.9 2.5 12.7 20.8 18.5 11.8 9.3 13.4 6.9 7.6 14.7 9.1 9.3 10.9 10.1 11.6 9.9 10.7 13.9 26.0 8.6 6.6 10.6 13.0 18.7 12.2 17.9 15.6 22.3 17.4 15.7 9.1 12.4 14.1 13.1 14.5 8.2 8.1 14.6 14.6 7.5 9.1 6.9 7.0 7.1 13.1 7.4 6.7 11.4 9.1 3.9 6.9 1.5 4.8 4.6 5.9 3.3 8.9 18.6 8.9 9.1 11.3 14.0 4.3 13.3 13.6 12.7 11.1 7.4 12.3 7.8 6.9 14.2 24.8 8.4 12.3 7.6 15.7 5.8 9.8 3.8 11.8 6.1 15.5 8.2 3.8 13.2 8.3 19.1 14.1 12.9 9.7 4.6 10.6 8.7 14.4 5.6 3.3 4.3 8.3 4.7 13.8 4.2 16.6 8.7 8.8 4.6 2.2 18.3 18.7 11.9 16.4 12.4 15.9 7.1 11.5 16.0 3.7 23.2 9.9 10.7 13.5 3.8 17.8 3.4 15.3 0.1 4.3 1.5 4.5 4.8 4.2 3.9 3.5 4.1 6.9 3.8 4.7 5.6 0.5 4.6 4.8 4.8 5.9 3.3 9.3 13.9 20.8 18.5 9.9 10.7 10.6 13.0 17.4 7.0 8.9 7.8 3.0 3.4 4.8 11.7 12.0 7.6 10.7 6.8 7.0 17.7 5.6 0.0 5.1 0.3 4.6 3.3 0.0 7.7 5.4 8.9 6.6 10.4 16.1 8.0 28.6 2.4 10.4 9.5 0.9 9.8 4.4 10.1 3.6 3.3 7.7 5.3 3.1 12.4 7.5 14.0 0.0 6.9 2.8 1.7 2.4 4.0 4.3 4.2 4.1 MC1R MSH-R ENSG00000258839 "Melanocortin 1 receptor" Q01726 16 89912119-89920977 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "granulocytes: 17.3;Melanocytes: 16.9" "Cancer enhanced" "Detected in many" "melanoma: 6.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 13.2;SK-MEL-30: 25.1;T-47d: 13.7" NA NA "unprognostic (3.90e-2)" "unprognostic (9.05e-2)" "unprognostic (5.39e-7)" "unprognostic (5.00e-2)" "unprognostic (1.39e-1)" "unprognostic (1.30e-1)" "unprognostic (1.00e-2)" "unprognostic (1.73e-1)" "unprognostic (1.55e-2)" "unprognostic (8.26e-2)" "prognostic favorable (7.88e-4)" "unprognostic (1.02e-2)" "unprognostic (5.20e-3)" "unprognostic (4.25e-2)" "unprognostic (5.17e-2)" "unprognostic (2.58e-2)" "unprognostic (1.16e-2)" 1.7 2.7 4.0 2.6 9.3 1.0 1.1 13.9 9.2 4.4 2.2 1.6 3.2 2.5 2.4 4.2 2.0 3.9 3.9 3.7 0.9 2.0 3.2 0.8 1.8 2.2 1.7 1.8 3.8 1.9 1.3 13.8 5.0 4.5 3.8 1.0 2.0 2.2 2.4 1.4 9.0 2.5 2.7 2.2 1.6 2.5 13.1 2.6 1.3 7.0 0.8 1.1 2.6 1.8 0.3 1.5 0.0 0.2 0.0 0.9 0.2 2.2 8.5 1.7 2.2 1.5 2.7 2.1 2.5 2.1 1.8 1.2 2.1 2.2 1.6 3.5 2.6 1.0 5.0 0.9 0.6 0.7 0.9 2.5 0.3 3.1 5.7 0.3 0.5 2.1 3.8 1.2 2.7 0.9 1.6 1.5 0.5 1.8 2.3 1.2 13.2 0.0 11.4 1.7 2.1 1.5 1.1 2.1 1.6 1.7 1.1 3.1 1.6 3.2 1.1 25.1 1.0 13.7 1.9 1.0 3.0 6.8 1.6 1.0 10.0 5.6 0.8 3.9 6.3 8.1 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.3 0.9 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.2 4.0 9.3 13.9 9.2 0.9 2.0 1.7 1.8 4.5 2.6 3.0 1.7 0.0 0.5 2.1 5.3 0.8 2.5 0.0 1.2 1.8 7.9 1.1 0.0 0.7 0.6 1.0 1.3 0.0 1.5 1.6 1.9 1.7 17.3 1.5 0.7 6.4 4.1 3.1 0.3 0.9 0.6 1.6 16.9 0.0 2.3 2.3 1.0 1.1 0.4 0.1 2.6 0.0 1.6 6.5 3.0 2.0 3.8 0.0 1.0 0.6 MC2R ACTHR ENSG00000185231 "Melanocortin 2 receptor" Q01718 18 13882044-13915707 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 31.7;pituitary gland: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "HeLa: 1.7;MCF7: 3.6;SuSa: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA079148 Enhanced NA NA "HPA079148: " "unprognostic (2.09e-1)" "unprognostic (3.63e-2)" "unprognostic (1.85e-2)" 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 14.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.1 1.3 0.3 0.1 0.1 0.0 0.2 0.0 0.1 0.3 0.1 0.3 1.1 0.2 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.4 0.1 0.3 0.1 0.9 0.1 0.0 0.5 0.0 1.7 0.2 0.0 0.2 0.0 0.0 0.9 0.0 0.6 0.2 0.0 0.2 0.1 0.4 0.0 3.6 0.0 0.0 0.6 0.0 0.1 0.2 0.5 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 1.8 0.1 0.3 0.0 0.2 0.3 0.5 0.0 0.2 0.2 0.0 0.1 0.4 0.0 1.3 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MC3R MC3 ENSG00000124089 "Melanocortin 3 receptor" P41968 20 56248732-56249815 "G-protein coupled receptors, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "hTERT-HME1: 2.4" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "basal ganglia: 4.8;hypothalamus: 3.3;thalamus: 2.6" HPA074739 Uncertain NA NA "HPA074739: " 0.0 0.4 0.1 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MC4R ENSG00000166603 "Melanocortin 4 receptor" P32245 18 60371110-60372775 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.8;fallopian tube: 10.3" "Group enriched" "Detected in some" 11 "Bipolar cells: 1.1;Rod photoreceptor cells: 1.1" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 69 "fHDF/TERT166: 47.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA016719 Uncertain NA NA "HPA016719: AB_1853617" "unprognostic (2.29e-1)" "unprognostic (5.31e-3)" "unprognostic (5.78e-2)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (3.33e-1)" "unprognostic (2.54e-1)" "unprognostic (1.48e-1)" "unprognostic (2.49e-2)" "unprognostic (2.30e-1)" "unprognostic (2.59e-1)" 0.4 1.1 4.0 0.3 9.8 0.2 0.9 0.7 6.4 0.5 0.5 0.3 0.0 0.6 0.4 1.3 0.4 10.3 0.4 0.4 3.0 7.8 0.4 0.2 0.3 0.4 1.1 7.6 0.6 0.2 0.2 0.3 0.2 3.3 0.4 0.5 0.1 2.5 0.5 0.2 0.3 0.4 0.2 0.8 0.8 0.6 0.6 5.1 0.0 0.2 0.0 1.4 0.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 9.8 0.7 6.4 3.0 7.8 1.1 7.6 3.3 5.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MC5R ENSG00000176136 "Melanocortin 5 receptor" P33032 18 13824149-13827323 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 7.9;esophagus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;OE19: 1.6;SiHa: 1.7;U-138 MG: 6.2;U-2 OS: 1.4;U-2197: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA042365, HPA058088" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA042365: AB_2677961, HPA058088: " "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" "unprognostic (8.77e-2)" "unprognostic (7.10e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-2)" "unprognostic (9.04e-3)" "unprognostic (1.54e-1)" 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 7.9 2.7 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.2 0.0 0.4 0.1 1.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.0 0.0 6.2 1.4 1.2 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCAM "CD146, MUC18" ENSG00000076706 "Melanoma cell adhesion molecule" P43121 11 119308529-119321521 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Endothelial cells: 83.4;Muller glia cells: 87.4;Sertoli cells: 316.9;Smooth muscle cells: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "HUVEC TERT2: 128.2;TIME: 125.2;WM-115: 99.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002147, HPA008848" Enhanced Approved "Plasma membrane" NA NA 2600000000 "Plasma membrane" "CAB002147: AB_563499, HPA008848: AB_1078445" "unprognostic (6.45e-2)" "prognostic unfavorable (7.61e-4)" "unprognostic (7.03e-2)" "unprognostic (1.22e-2)" "unprognostic (6.67e-2)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (8.42e-2)" "unprognostic (2.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.58e-1)" "unprognostic (9.39e-2)" "prognostic unfavorable (5.14e-4)" "unprognostic (8.75e-3)" "unprognostic (7.84e-2)" "unprognostic (2.31e-1)" "unprognostic (2.79e-3)" 88.2 8.9 6.4 18.5 10.3 0.4 86.1 17.7 13.4 22.3 33.2 13.3 11.7 8.3 40.1 32.5 27.6 29.3 50.9 32.0 7.1 8.2 7.5 3.8 23.8 13.0 7.4 8.1 23.6 6.2 54.5 3.9 47.4 11.1 22.9 9.7 25.0 9.4 44.9 21.1 10.5 15.6 67.1 6.5 9.6 25.0 18.4 5.4 2.2 13.1 15.7 4.8 55.0 24.3 0.8 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.5 0.5 0.0 2.5 0.0 2.6 0.3 0.0 3.4 1.5 1.9 0.1 0.1 10.9 1.2 5.2 0.3 4.4 0.9 1.7 6.2 1.5 0.1 12.3 2.2 6.0 0.0 0.0 1.8 0.0 4.7 2.2 0.1 128.2 0.8 4.1 0.1 0.7 0.0 0.1 1.0 2.2 0.0 0.5 0.1 17.1 3.6 3.1 0.0 1.4 0.4 9.8 0.2 28.2 5.6 0.5 0.1 125.2 0.3 18.4 0.0 9.9 0.2 0.2 0.0 5.0 0.0 99.5 0.0 0.0 0.0 0.0 0.0 2.2 0.8 0.6 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 6.4 10.3 17.7 13.4 7.1 8.2 7.4 8.1 11.1 5.4 0.0 2.9 0.8 0.5 4.1 1.3 57.3 12.7 1.4 1.2 0.0 21.6 0.3 0.0 14.3 1.6 83.4 0.0 0.0 0.3 34.2 4.4 1.1 0.0 0.0 0.7 0.0 0.0 74.9 1.6 0.6 0.9 2.7 20.3 1.0 0.0 87.4 2.5 0.0 23.7 0.0 2.1 316.9 214.2 2.2 1.2 2.9 0.3 0.7 0.0 0.7 MCEMP1 "C19orf59, MGC132456" ENSG00000183019 "Mast cell expressed membrane protein 1" Q8IX19 19 7676628-7679826 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 36.5;bone marrow: 30.9;lung: 66.4;lymphoid tissue: 24.2" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 34.6;Club cells: 20.5;Hofbauer cells: 30.0;Kupffer cells: 41.3;Macrophages: 51.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 2.9" "Group enriched" "Detected in some" 5 "classical monocyte: 36.5;neutrophil: 16.6" "Group enriched" "Detected in many" 5 "granulocytes: 16.6;monocytes: 36.5" "Group enriched" "Detected in some" 6 "THP-1: 19.2;U-937: 59.8" HPA014731 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014731: AB_1845619" "unprognostic (4.84e-2)" "unprognostic (9.81e-4)" "unprognostic (2.41e-1)" "unprognostic (4.36e-2)" "unprognostic (8.85e-3)" "unprognostic (2.62e-3)" "unprognostic (5.57e-3)" "unprognostic (1.42e-1)" "unprognostic (2.19e-1)" "unprognostic (4.36e-2)" "unprognostic (1.77e-2)" "unprognostic (3.50e-1)" "unprognostic (2.69e-5)" "unprognostic (1.15e-2)" "unprognostic (7.37e-2)" "unprognostic (1.93e-2)" "unprognostic (7.95e-2)" 2.2 0.3 0.3 10.0 0.5 30.9 0.5 0.4 0.9 0.1 0.3 0.0 0.0 0.1 0.1 0.2 0.3 1.2 0.2 4.8 0.2 0.2 0.6 1.3 66.4 11.8 2.9 0.0 0.4 0.4 0.0 0.1 0.8 0.6 0.4 0.0 0.1 0.6 0.0 0.2 0.1 0.3 2.4 0.9 24.2 0.6 0.7 0.3 0.3 0.7 0.0 0.1 0.5 2.9 0.0 5.3 16.6 36.5 0.2 0.1 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.8 0.0 0.0 36.5 0.9 0.1 2.1 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.1 16.6 0.2 0.1 0.3 0.1 11.6 0.3 0.5 0.4 0.9 0.2 0.2 2.9 0.0 0.6 0.3 17.9 34.6 1.4 0.0 0.0 0.0 0.3 0.0 9.4 20.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 7.0 0.0 30.0 0.0 0.0 0.0 41.3 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 MCHR1 "GPR24, MCH1R, SLC1" ENSG00000128285 "Melanin concentrating hormone receptor 1" Q99705 22 40678750-40682814 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Group enriched" "Detected in some" 5 "Leydig cells: 2.6;Melanocytes: 8.5" "Group enriched" "Detected in some" 7 "glioma: 4.9;liver cancer: 1.5;melanoma: 3.1;renal cancer: 2.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 2.5;RH-30: 3.4;SuSa: 10.1;T-47d: 2.8;U-87 MG: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.37e-2)" "unprognostic (1.37e-2)" "unprognostic (2.45e-3)" "unprognostic (2.68e-1)" "unprognostic (2.84e-3)" "unprognostic (4.92e-3)" "unprognostic (4.51e-3)" "unprognostic (1.19e-2)" "unprognostic (1.58e-2)" "unprognostic (9.35e-4)" "unprognostic (3.05e-1)" "unprognostic (2.26e-1)" "prognostic unfavorable (1.49e-6)" "unprognostic (3.07e-2)" "unprognostic (5.40e-2)" "unprognostic (2.42e-1)" "unprognostic (3.91e-2)" 0.7 0.8 3.4 1.1 4.7 0.4 0.4 1.0 14.4 1.2 0.5 0.2 0.0 0.7 4.8 1.5 0.4 1.2 0.4 3.1 4.6 7.3 0.4 2.6 0.5 0.8 3.4 4.9 5.1 0.5 0.3 2.8 0.6 2.5 0.4 0.5 0.8 0.4 0.5 0.5 1.7 0.5 2.4 1.2 0.4 0.5 0.6 0.1 0.0 0.3 0.0 0.7 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 2.5 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.1 2.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.7 1.0 11.6 4.6 7.3 3.4 4.9 2.5 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.6 0.0 0.0 2.6 0.0 8.5 0.0 0.0 1.2 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MCHR2 "GPR145, MCH2, MCH2R, SLT" ENSG00000152034 "Melanin concentrating hormone receptor 2" Q969V1 6 99919910-99994247 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "brain: 14.9;testis: 5.5" "Cell type enriched" "Detected in single" 5 "Early spermatids: 1.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 6.3;cerebral cortex: 14.9;olfactory region: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;HMC-1: 1.9;U-266/70: 1.8" "Region enhanced" "Detected in single" "cerebral cortex: 0.9" NA NA "unprognostic (5.76e-2)" 0.2 0.2 1.9 0.3 6.3 0.3 0.2 0.2 14.9 0.2 0.5 0.0 0.0 0.3 0.2 0.2 0.4 0.2 0.2 0.2 0.7 0.6 0.2 0.2 0.2 0.3 0.5 4.4 0.3 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.0 0.2 0.2 0.2 0.3 0.5 0.2 0.2 0.2 0.3 5.5 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.3 0.2 0.6 0.2 0.5 0.3 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.4 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 2.1 0.2 0.1 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.5 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.2 0.0 0.4 0.1 0.1 0.2 0.2 1.8 0.9 0.3 0.0 0.1 0.0 0.6 0.2 0.2 0.2 0.0 0.1 0.1 0.2 0.3 0.0 0.3 0.1 0.1 0.3 0.5 0.0 0.2 0.2 0.1 1.9 6.3 0.2 14.9 0.7 0.6 0.5 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 MCL1 "BCL2L3, Mcl-1" ENSG00000143384 "MCL1, BCL2 family apoptosis regulator" Q07820 1 150574551-150579738 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 42.1" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "U-698: 335.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002781, HPA008455, HPA031125, CAB068195" Approved Enhanced Mitochondria Yes No Mitochondria "CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026" "unprognostic (3.82e-2)" "unprognostic (8.79e-2)" "unprognostic (9.15e-2)" "unprognostic (2.05e-2)" "unprognostic (1.34e-1)" "unprognostic (3.91e-2)" "unprognostic (3.16e-2)" "unprognostic (2.43e-2)" "unprognostic (1.29e-1)" "unprognostic (8.60e-2)" "unprognostic (1.57e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (7.16e-4)" "unprognostic (3.22e-2)" "unprognostic (1.94e-1)" "unprognostic (4.87e-2)" "unprognostic (4.46e-2)" 67.7 37.1 19.0 59.3 21.6 134.5 46.3 15.3 18.9 35.9 38.5 19.0 23.9 21.2 36.1 27.6 56.5 57.2 73.3 32.5 20.4 14.9 30.5 76.7 61.8 52.4 28.2 11.4 32.1 41.9 20.3 27.7 59.4 26.7 34.0 30.7 31.0 36.0 24.5 39.8 45.7 50.2 38.9 26.4 51.1 44.3 19.8 23.0 32.3 45.4 53.3 57.4 40.6 59.4 5.0 6.2 42.1 8.0 3.8 11.1 3.9 10.0 5.2 9.7 5.8 19.6 20.6 13.2 12.3 12.7 13.0 10.5 6.4 8.3 12.8 7.3 8.8 7.0 13.5 7.3 14.8 13.1 10.5 5.0 5.2 8.3 7.4 15.4 8.8 11.9 11.3 17.0 12.7 24.8 12.1 14.3 3.9 11.7 18.6 17.0 11.1 4.3 6.7 17.8 8.6 9.1 6.6 7.8 6.7 14.3 7.3 7.5 10.1 8.8 12.0 15.9 15.3 7.6 13.6 17.5 8.3 8.7 5.2 15.5 23.8 27.9 335.8 14.2 7.0 10.8 7.6 8.0 18.8 6.1 6.5 7.2 5.0 8.0 6.7 6.2 4.6 9.6 7.2 42.1 3.8 5.8 3.7 11.1 3.9 19.0 21.6 15.3 18.9 20.4 14.9 28.2 11.4 26.7 23.0 184.6 337.7 161.5 413.1 434.6 37.7 75.0 170.7 65.6 141.0 31.4 56.9 80.9 34.9 139.8 191.3 189.6 281.5 23.3 149.6 178.6 195.3 286.6 340.1 210.0 235.2 11.1 249.0 192.8 356.1 271.6 67.3 381.9 259.8 113.6 185.2 58.8 165.7 122.2 57.3 57.2 70.9 77.6 218.3 33.9 33.0 500.0 226.1 179.7 132.6 219.4 MCOLN1 "ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1" ENSG00000090674 "Mucolipin 1" Q9GZU1 19 7522626-7534009 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Ion channel" "Disease mutation, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hofbauer cells: 91.8;Kupffer cells: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 30.9;monocytes: 28.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031763, CAB032637, HPA069495" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: " "unprognostic (5.51e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-2)" "unprognostic (3.30e-2)" "unprognostic (2.66e-1)" "unprognostic (4.07e-2)" "unprognostic (8.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.79e-2)" "unprognostic (1.47e-1)" "prognostic favorable (5.60e-5)" "unprognostic (1.36e-1)" "prognostic favorable (5.67e-4)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (1.83e-1)" 18.9 27.5 10.1 10.3 11.9 10.0 10.3 8.2 19.7 7.7 9.6 11.2 7.2 9.6 8.8 9.5 11.2 8.4 11.7 11.7 9.0 9.2 11.5 20.6 17.9 20.6 10.6 10.0 7.8 10.5 9.8 26.0 17.9 13.6 8.8 6.9 9.7 9.2 8.0 14.2 13.9 8.0 9.5 10.4 38.3 8.9 6.5 9.4 7.0 6.2 7.6 5.1 12.5 8.7 1.3 6.2 30.9 28.9 2.8 2.7 4.4 6.4 6.6 3.2 11.0 18.9 6.1 9.3 12.0 9.7 14.6 12.6 5.0 5.7 3.6 14.8 8.1 12.9 3.0 5.4 4.1 4.3 7.0 12.0 3.2 6.5 4.0 16.6 3.6 14.2 8.6 9.7 13.9 2.4 4.6 6.1 8.1 5.9 16.1 8.4 2.1 4.9 3.6 7.2 3.4 14.2 6.9 5.4 7.7 5.5 5.6 8.4 10.3 5.1 9.1 15.2 3.7 5.5 6.4 7.6 7.0 4.0 28.1 8.9 12.4 19.0 2.5 11.2 5.1 10.4 30.9 13.7 29.7 2.3 27.5 2.0 1.1 2.0 1.9 5.6 1.3 1.9 2.0 12.2 2.8 28.9 6.2 2.7 4.4 10.1 11.9 8.2 19.7 9.0 9.2 10.6 10.0 13.6 9.4 3.0 1.6 10.4 6.1 11.8 26.9 2.0 17.8 4.0 1.2 29.6 21.6 10.4 1.7 20.9 4.9 11.9 19.5 46.7 19.9 15.2 17.9 4.5 1.1 12.4 91.8 55.6 16.1 11.1 81.2 10.8 15.3 42.0 20.3 5.4 8.6 23.6 17.7 20.1 14.9 9.2 37.0 6.5 9.2 10.2 11.9 15.2 24.7 10.2 8.6 4.1 MCOLN2 "FLJ36691, TRP-ML2, TRPML2" ENSG00000153898 "Mucolipin 2" Q8IZK6 1 84925583-84997113 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.9;epididymis: 18.4;lymphoid tissue: 31.9" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 34.6;Macrophages: 15.1;monocytes: 53.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 18.9" "Group enriched" "Detected in many" 12 "B-cells: 6.6;dendritic cells: 18.9;T-cells: 5.9" "Cell line enhanced" "Detected in many" "Daudi: 14.1;HAP1: 10.1;HDLM-2: 16.8;THP-1: 20.1;U-698: 12.5" "Region enriched" "Detected in single" 5 "amygdala: 0.4" "Low region specificity" "Detected in all" HPA019114 Uncertain NA NA "HPA019114: AB_1853645" "unprognostic (3.02e-2)" "unprognostic (5.67e-2)" "unprognostic (3.07e-1)" "unprognostic (1.44e-1)" "unprognostic (2.47e-1)" "unprognostic (5.66e-3)" "unprognostic (2.38e-1)" "prognostic favorable (2.56e-4)" "unprognostic (8.92e-2)" "unprognostic (1.48e-2)" "unprognostic (6.84e-2)" "unprognostic (2.21e-2)" "unprognostic (3.12e-4)" "unprognostic (3.68e-2)" "unprognostic (4.69e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-2)" 1.3 12.5 0.4 31.9 0.4 2.2 1.1 0.2 0.4 1.7 8.5 0.5 1.6 1.2 1.4 18.4 1.3 2.9 3.8 2.0 0.6 0.4 1.4 0.6 7.5 18.4 0.6 0.0 1.0 1.8 0.0 1.2 2.1 1.5 1.5 14.0 1.6 3.2 0.9 0.6 1.8 7.5 0.5 1.7 9.7 1.7 2.7 0.4 4.1 1.0 2.8 27.5 2.3 1.3 6.6 18.9 0.2 0.8 0.4 5.9 1.4 1.0 1.1 0.1 3.0 0.6 0.2 0.4 0.7 3.8 0.9 1.2 0.0 0.1 14.1 0.4 0.0 1.8 0.1 10.1 1.2 1.1 16.8 7.5 1.4 0.4 0.0 0.8 0.3 1.3 0.2 0.0 0.9 0.8 0.1 0.1 3.7 0.0 0.3 0.2 0.4 0.2 0.1 1.1 0.0 1.9 0.1 2.3 0.0 0.1 0.3 0.7 0.0 0.1 0.2 6.2 0.2 1.8 20.1 0.1 1.0 1.6 0.1 2.6 0.1 0.0 12.5 0.9 0.1 2.4 0.1 0.2 0.0 4.1 0.8 1.3 6.6 3.3 5.9 4.5 1.9 0.5 3.4 0.2 0.4 0.1 18.9 0.2 1.4 0.4 0.4 0.2 0.4 0.6 0.4 0.6 0.0 1.5 0.4 0.0 1.1 9.8 0.5 3.9 0.0 0.5 0.0 2.7 2.3 1.8 0.0 0.1 0.0 0.0 34.6 0.1 6.0 0.0 1.2 0.1 2.1 0.7 0.0 0.0 0.7 0.0 2.4 1.3 0.6 14.2 0.0 15.1 8.5 53.3 4.1 0.0 0.4 5.8 0.0 0.3 0.0 0.0 0.1 0.2 3.7 2.9 0.2 8.2 2.3 0.1 MCOLN3 "FLJ11006, TRP-ML3, TRPML3" ENSG00000055732 "Mucolipin 3" Q8TDD5 1 85018082-85048499 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.2;pituitary gland: 38.3" "Group enriched" "Detected in many" 8 "Intestinal endocrine cells: 109.0;Melanocytes: 143.4" "Cancer enriched" "Detected in many" 6 "melanoma: 8.0" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 10.1;HAP1: 10.0;RH-30: 12.2;SK-MEL-30: 21.6" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 1.7" "HPA018106, HPA062137" Enhanced Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA018106: AB_1853647, HPA062137: AB_2684695" "unprognostic (5.91e-2)" "unprognostic (1.24e-1)" "unprognostic (1.49e-2)" "unprognostic (3.21e-5)" "unprognostic (2.25e-1)" "unprognostic (8.80e-3)" "unprognostic (3.97e-3)" "unprognostic (1.13e-1)" "unprognostic (2.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.45e-3)" "unprognostic (3.09e-2)" "unprognostic (7.32e-5)" "unprognostic (6.36e-3)" "unprognostic (2.61e-1)" "unprognostic (6.11e-2)" "unprognostic (6.43e-2)" 4.7 29.2 1.5 0.8 0.8 0.0 3.0 0.2 0.4 6.1 2.8 0.9 2.1 3.2 5.4 15.6 0.8 1.1 0.6 5.1 3.4 0.3 4.5 0.2 4.1 0.0 0.5 0.0 2.2 6.5 17.9 38.3 1.8 2.7 0.5 0.5 4.5 8.1 0.4 1.9 2.5 1.9 1.1 0.3 0.9 1.6 0.4 0.3 2.6 1.5 0.9 0.4 0.7 2.8 0.0 0.0 0.0 0.0 0.0 2.9 0.7 6.5 1.5 0.0 0.0 5.3 4.8 1.7 0.1 10.1 2.5 7.0 0.5 1.2 0.0 0.7 0.1 2.3 0.0 10.0 3.2 1.6 2.6 5.9 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.2 2.1 1.2 2.6 0.0 0.0 0.0 0.0 4.9 0.6 0.0 0.0 0.7 0.0 0.6 0.0 12.2 0.0 0.3 0.0 0.4 0.0 0.3 0.0 21.6 0.8 4.1 5.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.8 0.2 0.4 3.4 0.3 0.5 0.0 2.7 0.3 14.9 1.7 0.0 3.6 7.7 0.0 6.9 10.2 0.0 1.2 3.5 0.0 6.4 0.0 1.9 0.3 0.5 1.3 0.0 8.4 0.1 5.1 1.1 0.0 0.0 3.4 0.0 109.0 0.0 0.0 0.0 1.7 0.8 143.4 2.8 0.6 0.0 4.9 7.8 0.0 2.2 0.0 6.5 1.2 0.9 1.6 3.0 2.2 0.0 0.6 0.3 MCTP1 FLJ22344 ENSG00000175471 "Multiple C2 and transmembrane domain containing 1" Q6DN14 5 94703741-95284575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 49.2;brain: 42.4" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 29.9;granulocytes: 61.2;Kupffer cells: 33.5;Macrophages: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 41 "basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 52 "dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2" "Cell line enhanced" "Detected in many" "Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019018 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA019018: AB_1853665" "unprognostic (1.20e-2)" "unprognostic (6.70e-4)" "unprognostic (1.77e-2)" "unprognostic (1.03e-2)" "unprognostic (1.16e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (2.47e-2)" "unprognostic (1.86e-1)" "unprognostic (6.99e-2)" "unprognostic (5.31e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-6)" "unprognostic (5.38e-2)" "unprognostic (3.65e-2)" "unprognostic (2.89e-3)" "unprognostic (4.43e-2)" 49.2 2.7 6.5 11.4 42.4 36.9 18.3 18.3 16.5 6.9 7.2 0.3 4.4 5.0 11.1 9.2 6.5 4.1 16.7 4.6 8.5 7.4 3.0 3.8 11.3 5.5 4.1 3.8 3.3 3.4 3.1 5.2 7.1 3.9 5.9 7.3 1.0 4.3 2.7 5.1 4.5 4.8 10.9 5.7 8.2 5.3 4.0 8.1 5.5 5.0 21.2 4.3 17.3 12.6 0.3 10.1 18.7 19.2 0.2 0.2 3.3 0.1 2.0 1.3 0.0 20.0 8.0 0.0 0.1 9.8 0.9 3.2 0.0 5.2 7.2 7.7 0.0 20.5 0.0 0.1 0.1 1.1 0.0 1.4 4.3 4.9 0.0 2.6 8.9 5.8 2.9 0.0 3.6 13.1 8.5 20.7 3.0 0.1 28.3 7.4 0.2 0.5 6.8 1.6 0.1 8.2 0.3 0.0 28.0 21.3 11.3 4.0 0.2 0.6 0.0 14.6 0.6 0.0 8.4 0.1 3.6 5.6 0.1 1.6 2.0 0.0 0.0 16.9 14.9 3.6 11.5 12.9 5.8 0.0 19.2 0.0 0.3 0.0 0.1 10.1 0.1 0.2 0.0 18.7 0.2 17.6 5.3 0.0 3.3 6.5 42.4 18.3 12.2 8.5 7.4 4.1 3.8 3.9 8.1 3.0 9.6 0.0 0.1 16.1 2.0 2.5 0.0 4.0 6.8 3.5 0.0 0.3 0.0 0.0 20.6 29.9 0.0 0.0 0.2 0.1 3.0 0.6 61.2 0.5 10.7 3.2 0.0 1.8 33.5 12.2 0.6 35.3 11.8 0.0 0.0 3.6 0.8 0.0 0.0 0.0 3.7 0.0 2.2 1.4 1.4 11.7 0.2 2.2 0.0 0.4 MCTP2 "FLJ11175, FLJ33303" ENSG00000140563 "Multiple C2 and transmembrane domain containing 2" Q6DN12 15 94231538-94483952 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.6" "Cell type enhanced" "Detected in many" 5 "granulocytes: 35.7;Mucus-secreting cells: 42.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 14.5;HMC-1: 12.0;U-698: 15.9;U-87 MG: 18.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA051176, HPA070541" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051176: AB_2681373, HPA070541: AB_2686277" "unprognostic (1.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.63e-2)" "unprognostic (7.15e-4)" "unprognostic (3.57e-2)" "unprognostic (2.66e-3)" "unprognostic (3.45e-2)" "unprognostic (3.68e-3)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (2.97e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (2.18e-5)" "unprognostic (5.87e-2)" "unprognostic (4.36e-1)" "unprognostic (1.76e-3)" "unprognostic (9.41e-2)" 5.3 4.1 0.8 19.7 1.7 12.6 2.7 0.7 1.5 5.4 12.3 0.0 6.9 5.6 4.0 9.5 5.7 4.5 10.3 4.6 1.0 2.2 3.6 2.3 12.4 18.4 2.5 0.8 3.8 10.0 5.3 24.4 17.1 0.6 6.8 10.2 2.5 16.8 9.6 0.8 4.0 10.9 4.0 0.9 41.6 3.7 1.7 0.4 3.0 8.7 4.1 12.9 6.2 14.8 2.7 0.1 21.2 0.5 6.8 4.4 1.1 2.5 0.0 0.0 0.0 0.0 0.0 1.8 1.3 0.8 0.2 0.1 1.7 3.1 7.3 0.3 0.0 0.0 5.7 0.1 4.7 0.0 1.4 0.5 14.5 2.0 0.8 1.0 3.0 12.0 0.8 5.8 0.1 6.0 0.0 0.0 2.5 0.5 4.1 0.0 0.0 1.4 8.0 0.6 2.4 2.6 3.3 0.1 2.7 0.3 7.6 1.4 0.3 0.1 2.4 0.9 0.5 0.0 0.2 0.0 0.0 1.2 0.0 0.0 8.7 0.1 15.9 18.0 7.9 0.9 3.2 0.5 7.7 4.4 0.1 2.1 2.2 1.2 1.9 0.0 2.7 0.5 1.9 21.2 6.8 0.5 0.1 0.0 1.1 0.8 1.7 0.7 1.5 1.0 2.2 2.5 0.8 0.6 0.4 3.0 24.7 20.4 10.8 3.8 0.8 0.8 5.1 5.3 15.9 3.5 0.0 13.2 0.0 2.7 3.2 2.1 18.6 0.0 4.1 5.9 7.2 13.7 35.7 1.3 7.5 0.0 15.0 1.3 12.7 3.9 0.3 2.1 1.7 0.0 42.4 0.2 4.0 21.0 0.0 1.7 0.5 0.0 0.8 0.1 2.0 1.9 20.5 19.7 18.7 14.9 MCU "C10orf42, CCDC109A, FLJ46135" ENSG00000156026 "Mitochondrial calcium uniporter" Q8NE86 10 72692131-72887694 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 41.0" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016480 Approved Supported Mitochondria No No 1400000 Mitochondria "HPA016480: AB_2071893" "unprognostic (2.42e-2)" "unprognostic (1.58e-2)" "unprognostic (3.01e-2)" "unprognostic (5.37e-2)" "unprognostic (7.84e-2)" "unprognostic (3.05e-1)" "prognostic unfavorable (6.06e-5)" "unprognostic (1.23e-1)" "unprognostic (2.28e-1)" "unprognostic (2.33e-1)" "unprognostic (5.12e-3)" "unprognostic (1.73e-1)" "prognostic favorable (5.07e-4)" "unprognostic (4.51e-2)" "unprognostic (3.79e-1)" "unprognostic (2.74e-2)" "unprognostic (2.48e-2)" 8.2 6.5 6.3 9.4 6.1 12.3 9.8 41.0 6.8 7.0 19.8 4.1 8.5 19.1 10.9 7.4 13.4 7.8 11.5 6.9 4.8 4.3 11.1 7.2 10.1 7.4 3.4 4.1 5.8 12.1 8.2 5.5 8.8 5.5 4.6 21.9 5.1 9.5 5.8 41.4 9.0 23.0 11.0 3.8 4.9 29.4 4.7 3.5 4.9 5.4 14.9 7.3 10.1 15.0 3.4 5.4 16.6 7.6 1.9 4.6 3.6 19.7 32.0 8.3 6.0 12.7 14.3 8.5 12.2 17.4 12.2 13.1 19.0 18.9 8.4 9.8 14.9 6.6 18.1 10.9 14.5 16.4 9.2 10.2 10.5 12.0 10.5 9.9 26.3 8.9 14.5 12.4 10.9 23.4 19.2 14.6 9.0 6.5 6.3 11.3 11.5 7.1 5.7 9.2 21.6 6.7 7.4 17.8 2.2 16.5 10.8 8.9 3.9 15.0 16.8 3.6 10.5 3.3 6.9 11.8 5.9 10.2 12.7 8.1 4.7 5.9 5.9 7.9 13.2 4.5 1.7 6.1 16.6 2.9 6.7 3.1 3.4 3.0 3.5 5.4 1.7 2.3 2.6 8.2 1.9 7.6 1.9 4.6 3.6 6.3 6.1 41.0 6.8 4.8 4.3 3.4 4.1 5.5 3.5 32.8 13.4 2.7 10.4 10.4 3.0 5.9 10.2 18.7 26.1 17.4 2.0 6.4 1.7 7.2 10.7 7.4 22.6 0.0 22.1 8.3 6.7 8.1 8.1 5.0 6.3 0.0 8.1 8.6 6.3 4.7 4.9 3.7 8.5 2.8 24.0 4.8 27.5 8.6 3.9 6.1 3.3 12.9 8.9 3.9 4.9 10.8 7.8 2.5 20.4 20.7 MCUB "CCDC109B, FLJ20647" ENSG00000005059 "Mitochondrial calcium uniporter dominant negative beta subunit" Q9NWR8 4 109560205-109688726 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 39.3;lymphoid tissue: 45.3" "Cell type enhanced" "Detected in some" 9 "Cytotrophoblasts: 107.3;Exocrine glandular cells: 99.3;Extravillous trophoblasts: 82.0;Hofbauer cells: 95.7;Pancreatic endocrine cells: 50.6;Syncytiotrophoblasts: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048776 Enhanced Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Vesicles, Mitochondria" "HPA048776: AB_2680518" "unprognostic (6.12e-3)" "unprognostic (1.70e-2)" "unprognostic (3.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.42e-1)" "unprognostic (1.70e-1)" "unprognostic (1.70e-2)" "unprognostic (3.06e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-3)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.35e-6)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" 11.6 2.2 4.1 21.0 3.2 8.3 16.6 0.4 3.7 8.2 4.9 4.6 1.4 3.5 12.3 5.5 9.2 6.3 7.3 14.9 4.5 4.7 3.9 2.1 7.8 44.2 3.5 2.6 7.5 2.1 2.3 5.1 9.9 6.5 5.4 6.1 4.1 6.5 2.2 4.3 7.6 8.8 8.4 8.5 13.8 4.2 3.6 1.9 45.3 4.7 9.5 24.8 7.3 9.0 14.0 15.7 1.1 16.0 20.0 39.3 25.7 10.4 4.5 2.5 12.8 2.8 7.4 9.7 9.0 5.5 9.9 8.9 0.2 8.5 36.7 1.9 7.7 5.5 3.0 9.4 5.5 8.8 23.3 7.4 4.4 5.0 0.6 4.9 8.9 0.1 4.7 1.5 6.0 5.1 7.0 13.2 13.6 1.3 23.4 7.5 12.8 20.4 0.1 11.6 1.8 6.5 7.8 19.4 4.1 11.6 4.6 10.3 4.5 9.7 28.9 3.0 2.1 3.6 0.4 9.4 3.9 5.1 20.6 15.6 9.1 6.3 8.9 12.0 1.9 2.7 0.0 16.0 0.2 6.3 9.7 9.0 13.5 26.7 19.0 15.7 14.0 39.3 22.2 1.1 20.0 7.2 11.0 22.4 25.7 4.1 3.2 0.4 3.7 4.5 4.7 3.5 2.6 6.5 1.9 8.9 6.9 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 5.2 0.0 107.3 0.0 22.4 0.0 0.0 0.0 0.0 99.3 82.0 0.0 0.0 1.1 0.0 95.7 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 25.2 0.0 0.0 50.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 61.4 0.0 0.0 0.0 MCUR1 "C6orf79, CCDC90A, FLJ20958" ENSG00000050393 "Mitochondrial calcium uniporter regulator 1" Q96AQ8 6 13786557-13814568 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Proximal tubular cells: 205.7;Rod photoreceptor cells: 250.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078654 Approved NA NA "HPA078654: " "unprognostic (1.82e-3)" "unprognostic (1.58e-2)" "unprognostic (1.20e-1)" "unprognostic (1.19e-3)" "unprognostic (8.62e-2)" "unprognostic (2.25e-3)" "unprognostic (2.01e-3)" "unprognostic (2.16e-1)" "unprognostic (4.83e-2)" "prognostic favorable (5.51e-4)" "unprognostic (3.40e-1)" "unprognostic (5.77e-2)" "prognostic favorable (3.32e-4)" "unprognostic (5.86e-2)" "unprognostic (2.68e-1)" "unprognostic (4.05e-2)" "unprognostic (2.39e-1)" 11.2 7.3 19.9 8.6 16.2 7.6 18.8 11.3 19.4 10.4 15.3 10.3 19.1 22.7 9.1 17.1 12.2 6.3 7.1 12.0 17.2 20.9 27.8 21.4 10.7 8.2 22.1 14.5 5.6 21.9 4.5 9.5 11.7 14.1 8.5 12.4 15.2 13.4 15.6 20.7 22.3 29.5 6.6 16.5 10.6 7.9 6.1 10.1 9.1 20.2 14.3 11.1 6.6 9.0 4.4 7.0 6.0 3.4 4.0 5.2 6.3 10.4 3.2 15.6 16.1 9.4 8.2 9.9 9.4 9.2 10.4 11.0 10.9 5.1 14.1 19.4 6.8 16.4 4.6 9.8 7.8 11.8 9.5 6.0 14.4 5.7 10.7 9.1 14.4 5.7 5.6 7.8 13.3 9.7 7.7 3.6 17.5 10.7 7.7 7.2 4.4 17.4 21.8 10.3 26.9 4.2 12.9 14.0 20.3 12.5 6.4 10.2 11.6 6.3 16.3 24.4 26.1 6.0 6.6 5.0 15.7 8.8 11.2 13.1 9.4 31.3 20.6 7.2 8.5 21.2 6.0 2.9 0.8 3.5 2.5 4.2 4.4 5.0 5.2 7.0 3.9 3.8 3.6 2.1 4.0 3.4 4.6 2.8 6.3 19.9 16.2 11.3 19.4 17.2 20.9 22.1 14.5 14.1 10.1 14.9 23.5 19.3 19.0 39.8 34.3 40.3 25.5 5.3 10.3 54.1 113.9 37.7 117.7 23.3 39.1 29.3 86.7 70.0 27.5 51.7 37.7 49.1 6.9 60.4 75.5 25.4 15.0 25.2 24.4 3.6 20.4 39.2 49.0 45.9 44.1 30.8 28.8 77.7 25.5 205.7 250.4 19.4 35.8 3.5 39.8 50.2 72.1 13.8 33.6 27.1 MDGA2 MAMDC1 ENSG00000139915 "MAM domain containing glycosylphosphatidylinositol anchor 2" Q7Z553 14 46840092-47674954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 8.6;testis: 7.9" "Group enriched" "Detected in some" 7 "Bipolar cells: 39.5;Early spermatids: 31.0" "Cancer enhanced" "Detected in single" "melanoma: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.0;T-47d: 4.0;U-138 MG: 8.8;U-2 OS: 6.3;U-87 MG: 3.4;WM-115: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003084 Uncertain NA NA "HPA003084: AB_1079302" "unprognostic (3.27e-1)" "unprognostic (5.38e-2)" "unprognostic (9.13e-2)" "unprognostic (8.92e-3)" "unprognostic (6.36e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.49e-3)" "unprognostic (3.62e-3)" "unprognostic (3.06e-2)" "unprognostic (5.89e-1)" 0.2 0.3 1.4 0.0 1.5 0.0 0.2 0.4 8.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.3 2.2 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 3.3 0.0 0.5 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.7 4.0 0.0 0.0 8.8 6.3 0.0 0.0 0.0 0.0 0.0 3.4 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 39.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 0.0 5.0 0.0 0.0 0.5 0.1 0.0 0.7 0.0 1.8 0.0 0.2 3.9 3.6 0.0 0.0 0.0 0.0 0.0 MDK "FLJ27379, MK, NEGF2" ENSG00000110492 Midkine P21741 11 46380756-46383837 "Cancer-related genes, Predicted secreted proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 115.9" "Cell type enhanced" "Detected in many" 11 "Intestinal endocrine cells: 971.2;Paneth cells: 1226.4;Urothelial cells: 439.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.6;neutrophil: 4.9" "Group enriched" "Detected in many" 5 "B-cells: 3.6;granulocytes: 4.9;T-cells: 2.0" "Cell line enhanced" "Detected in many" "NTERA-2: 89.4;REH: 130.0;SH-SY5Y: 111.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010055, HPA057126" Uncertain Approved Vesicles "Secreted to blood" NA NA 158000 1200000 Vesicles "CAB010055: AB_627949, HPA057126: AB_2683344" "unprognostic (8.87e-3)" "unprognostic (6.65e-2)" "unprognostic (4.02e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (5.48e-4)" "unprognostic (1.90e-1)" "unprognostic (5.67e-3)" "unprognostic (1.02e-1)" "unprognostic (3.66e-2)" "unprognostic (1.11e-2)" "unprognostic (4.01e-2)" "unprognostic (4.15e-1)" "prognostic unfavorable (3.06e-6)" "unprognostic (8.78e-2)" "unprognostic (1.31e-1)" "unprognostic (3.48e-1)" "unprognostic (1.12e-2)" 8.0 16.2 4.7 11.9 5.6 1.7 13.5 5.3 5.9 62.5 36.3 5.3 13.9 50.6 41.0 33.9 6.5 34.6 35.0 6.4 4.0 5.9 6.1 2.0 8.0 3.6 4.9 4.4 115.9 13.1 8.9 64.8 11.5 5.5 47.7 7.4 59.0 22.2 24.5 4.7 4.1 58.4 16.6 4.0 13.9 21.0 9.3 2.1 22.5 5.2 5.5 12.4 15.3 23.0 3.6 0.2 4.9 0.6 0.2 2.0 1.5 4.9 6.5 76.3 0.2 0.5 6.4 1.8 3.8 7.7 14.7 13.1 49.5 21.8 0.3 53.8 5.6 0.6 42.5 43.0 0.0 1.3 15.1 9.0 2.1 0.6 67.8 34.8 0.1 0.3 10.3 1.3 8.9 0.0 3.1 21.4 2.9 36.6 0.3 8.2 33.8 1.8 0.9 89.4 26.7 38.8 130.0 2.9 0.4 0.1 0.1 42.4 111.0 12.7 1.1 1.0 70.5 34.8 34.3 5.8 22.6 54.3 0.3 2.6 0.2 1.0 0.4 0.6 1.3 19.6 0.0 0.1 0.0 0.3 0.5 0.0 3.6 0.2 0.5 0.1 1.1 0.2 0.0 4.9 0.2 0.6 0.2 2.0 1.5 4.7 5.6 5.3 5.9 4.0 5.9 4.9 4.4 5.5 2.1 0.0 4.8 2.4 142.7 9.8 0.1 5.8 40.8 41.5 46.6 45.4 0.0 140.1 1.7 217.8 16.4 56.2 413.9 0.0 92.4 97.9 99.4 135.8 4.6 5.9 43.2 0.0 971.2 77.3 4.0 90.5 101.5 7.1 35.4 16.2 245.7 23.8 203.6 1226.4 17.7 13.5 0.7 84.1 56.5 14.9 29.0 7.0 128.0 3.2 126.6 439.7 MDM1 ENSG00000111554 "Mdm1 nuclear protein" Q8TC05 12 68272443-68332381 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 49.5;Spermatocytes: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA040411, HPA041594" Uncertain Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA040411: AB_10805711, HPA041594: AB_10793968" "unprognostic (7.41e-2)" "prognostic favorable (6.01e-4)" "unprognostic (8.58e-2)" "unprognostic (2.62e-3)" "unprognostic (1.21e-1)" "unprognostic (3.50e-3)" "unprognostic (4.24e-3)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" "unprognostic (2.92e-1)" "unprognostic (2.56e-3)" "unprognostic (3.13e-2)" "unprognostic (4.29e-3)" "unprognostic (1.29e-1)" "unprognostic (2.84e-1)" "unprognostic (4.63e-2)" "unprognostic (5.23e-3)" 7.0 6.7 11.5 11.9 11.4 15.4 10.0 8.2 12.7 11.9 28.7 9.6 12.4 5.1 15.2 12.7 5.4 20.3 6.5 6.7 12.3 10.0 8.8 4.9 6.8 12.8 11.4 10.5 10.9 11.3 8.8 22.8 6.0 14.9 12.3 11.1 9.0 6.8 15.9 3.8 4.2 9.0 18.8 11.4 9.5 9.8 20.7 12.4 14.6 11.0 5.3 13.4 17.0 8.9 7.1 4.0 13.3 17.2 6.0 8.1 5.4 5.0 4.2 8.1 7.8 4.0 5.5 6.2 6.7 3.7 10.7 9.9 5.0 2.3 11.6 4.4 3.0 5.3 5.2 5.5 3.6 12.2 15.1 5.3 25.4 5.4 3.4 6.2 14.0 10.1 2.5 4.7 7.2 7.0 5.8 6.0 13.4 4.8 13.0 6.2 3.6 19.8 9.9 4.3 5.0 5.1 19.5 7.2 3.4 5.1 4.4 7.4 3.9 6.5 3.9 6.6 6.7 9.3 10.1 3.2 8.6 3.8 5.4 6.1 6.8 19.8 7.8 4.5 9.2 5.5 6.0 4.7 13.3 5.0 11.1 8.1 6.8 6.4 5.2 4.0 7.1 7.7 6.2 3.1 6.0 17.2 2.3 5.9 5.4 11.5 11.4 8.2 12.7 12.3 10.0 11.4 10.5 14.9 12.4 3.0 5.8 13.3 3.9 4.2 12.7 8.1 0.0 49.5 7.9 7.0 0.0 3.7 8.3 4.3 22.5 6.3 1.6 23.3 3.1 3.8 5.8 2.3 6.9 4.2 5.4 7.9 2.4 3.7 2.4 9.0 8.3 7.6 15.1 3.6 2.6 24.9 2.7 3.6 12.7 8.4 32.9 6.5 7.2 38.1 17.8 3.6 0.2 13.6 4.1 1.3 MEGF10 KIAA1780 ENSG00000145794 "Multiple EGF like domains 10" Q96KG7 5 127290831-127465737 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Myogenesis, Phagocytosis" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 48.7" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 21.6;RH-30: 26.5" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 27000000 "unprognostic (7.02e-2)" "unprognostic (4.50e-2)" "unprognostic (1.02e-1)" "unprognostic (2.26e-3)" "unprognostic (8.91e-3)" "unprognostic (1.59e-2)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (1.52e-1)" "unprognostic (1.41e-1)" "unprognostic (1.76e-4)" "unprognostic (5.28e-3)" "unprognostic (2.59e-1)" "unprognostic (9.36e-4)" "unprognostic (1.17e-1)" 1.3 5.1 9.8 1.2 12.9 0.9 2.8 3.3 24.6 1.8 1.4 25.8 0.0 1.2 2.8 2.0 1.2 1.2 1.1 1.5 11.6 5.6 1.1 1.8 1.0 1.0 21.7 10.4 1.2 0.9 0.9 2.4 1.2 12.2 2.8 1.5 2.4 5.0 3.7 7.3 1.1 1.3 1.6 14.8 1.2 1.0 1.9 23.1 0.0 1.1 2.0 1.5 1.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.7 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 9.8 12.9 3.3 10.8 11.6 5.6 21.7 10.4 12.2 23.1 0.0 0.0 0.0 0.0 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 7.9 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.0 MEGF11 "DKFZp434L121, KIAA1781" ENSG00000157890 "Multiple EGF like domains 11" A6BM72 15 65895079-66253747 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 34.7;fallopian tube: 16.3" "Group enriched" "Detected in many" 6 "Early spermatids: 136.6;Horizontal cells: 119.2;Late spermatids: 159.9" "Cancer enhanced" "Detected in some" "glioma: 2.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 4.6;HEK 293: 3.6;RPTEC TERT1: 12.7;SCLC-21H: 9.9" "Region enriched" "Detected in many" 4 "cerebellum: 39.2" "Region enriched" "Detected in all" 7 "cerebellum: 62.2" NA NA "unprognostic (2.97e-2)" "unprognostic (1.23e-1)" "unprognostic (7.95e-2)" "unprognostic (1.84e-2)" "unprognostic (9.02e-3)" "unprognostic (6.45e-3)" "unprognostic (1.51e-1)" "unprognostic (4.08e-2)" "unprognostic (2.92e-1)" "unprognostic (1.23e-1)" "unprognostic (6.79e-3)" "unprognostic (6.81e-3)" "unprognostic (5.71e-5)" "unprognostic (7.94e-2)" "unprognostic (9.78e-3)" "unprognostic (2.03e-1)" "unprognostic (4.89e-2)" 0.6 0.8 8.7 0.9 5.4 1.3 0.6 34.7 17.1 0.6 0.7 5.3 0.0 0.6 0.8 2.3 0.7 16.3 0.7 0.6 11.6 5.7 4.6 0.6 1.6 0.9 6.5 2.5 0.7 1.0 0.5 1.5 0.6 9.2 0.7 0.6 3.4 0.6 0.8 0.6 3.2 0.7 0.6 9.2 0.9 1.0 2.6 5.5 0.0 0.7 0.0 0.7 0.6 0.2 0.3 0.1 0.5 0.2 0.0 1.5 0.0 0.0 0.1 0.5 4.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.8 0.0 0.3 0.1 0.3 0.0 0.1 0.2 3.6 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 1.5 0.0 0.1 12.7 0.3 9.9 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.3 0.3 0.0 0.0 0.1 0.4 1.5 0.5 0.0 0.0 0.1 0.1 0.0 8.7 5.4 34.7 4.7 11.6 5.7 6.5 2.5 9.2 5.5 0.0 3.0 0.0 0.5 1.9 4.9 0.6 0.0 1.4 0.0 3.5 7.9 0.2 0.0 0.0 136.6 0.7 0.0 0.0 0.2 0.1 1.1 0.3 0.0 0.0 0.1 119.2 0.0 1.3 0.3 159.9 2.3 0.9 0.0 0.0 0.0 3.5 0.1 0.0 1.4 0.8 25.0 0.0 0.5 2.1 2.0 3.3 0.5 0.0 0.0 0.4 MEGF6 EGFL3 ENSG00000162591 "Multiple EGF like domains 6" O75095 1 3489920-3611495 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 37.8" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 19.4;Basal keratinocytes: 16.4;Ito cells: 16.5;Melanocytes: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 4.8" "Group enriched" "Detected in many" 4 "granulocytes: 4.8;T-cells: 1.9" "Cell line enhanced" "Detected in many" "BJ: 22.5;HeLa: 20.3;hTERT-RPE1: 26.6;U-2197: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052129 Uncertain Approved "Microtubules,Cytokinetic bridge" "Secreted - unknown location" Yes No 580000 Microtubules "Cytokinetic bridge" "HPA052129: AB_2681739" "unprognostic (1.95e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "prognostic favorable (6.57e-4)" "unprognostic (1.19e-1)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "unprognostic (2.03e-1)" "unprognostic (3.09e-3)" "unprognostic (1.60e-1)" "unprognostic (1.64e-1)" "unprognostic (9.51e-2)" "unprognostic (3.43e-2)" 15.0 2.3 0.5 8.5 1.0 9.2 13.4 0.8 2.0 8.1 5.9 1.8 7.5 2.3 5.1 13.1 6.6 14.6 21.0 6.1 1.4 0.5 2.7 1.9 12.6 12.6 0.7 1.9 8.8 4.8 0.8 1.5 2.8 2.3 12.0 0.9 11.0 8.7 5.5 6.1 37.8 4.2 3.0 0.8 5.7 4.2 4.6 1.4 5.0 5.2 12.0 12.0 6.7 10.1 0.8 0.3 4.8 0.1 0.0 1.9 0.2 4.5 7.2 1.6 3.1 0.1 0.1 0.5 22.5 6.3 1.9 0.6 1.5 5.3 0.0 7.2 7.7 1.3 2.8 0.0 0.2 0.2 0.0 0.1 0.0 20.3 1.3 0.0 0.1 0.4 0.0 0.2 0.1 0.2 26.6 2.4 0.0 0.0 0.0 0.0 2.5 0.0 4.1 1.0 1.0 0.4 0.9 0.9 2.7 0.4 1.4 1.6 1.5 8.1 0.5 2.8 2.3 2.2 0.4 1.0 8.2 0.8 20.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 4.8 0.1 0.0 0.4 0.0 0.4 0.4 0.3 0.8 0.8 0.1 2.2 0.0 0.0 0.0 1.9 0.2 0.5 1.0 0.8 2.0 1.4 0.5 0.7 1.9 2.3 1.4 20.8 19.4 0.0 7.5 16.4 0.8 3.0 5.1 0.0 6.8 1.8 0.0 0.1 0.0 3.0 0.2 8.7 0.3 0.0 1.2 1.0 6.4 3.4 1.1 0.9 1.0 0.0 0.0 16.5 0.8 0.0 10.6 2.8 18.6 0.0 1.3 9.5 3.6 0.0 3.2 1.7 1.0 0.0 2.1 0.5 0.6 9.9 0.3 0.0 0.7 3.0 MEGF8 "C19orf49, EGFL4, FLJ22365, SBP1" ENSG00000105429 "Multiple EGF like domains 8" Q7Z7M0 19 42325609-42378769 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 34.1;Cone photoreceptor cells: 72.6;Horizontal cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049248 Approved NA NA 370000000 "HPA049248: AB_2680691" "unprognostic (5.52e-3)" "unprognostic (1.52e-1)" "unprognostic (5.35e-2)" "unprognostic (1.66e-2)" "unprognostic (1.20e-1)" "unprognostic (4.63e-2)" "unprognostic (3.25e-2)" "unprognostic (8.58e-2)" "unprognostic (9.25e-2)" "unprognostic (3.64e-2)" "prognostic favorable (6.03e-4)" "unprognostic (4.33e-2)" "prognostic favorable (2.17e-7)" "unprognostic (1.18e-1)" "unprognostic (7.34e-2)" "unprognostic (1.06e-2)" "unprognostic (1.08e-1)" 15.7 10.6 17.0 5.6 22.5 3.0 8.1 22.9 31.3 8.3 7.7 13.6 8.6 6.5 9.2 9.9 6.3 8.5 6.9 13.1 15.8 16.3 11.6 5.2 6.1 5.0 12.8 15.2 12.1 6.9 28.8 8.4 8.2 11.7 10.9 6.2 9.1 9.9 11.7 12.0 8.1 6.7 9.1 8.4 8.3 5.9 6.0 12.2 3.2 8.5 6.1 4.6 7.0 9.2 2.0 1.5 1.7 2.1 2.2 1.1 0.6 6.6 11.8 12.3 3.0 27.9 13.2 4.5 5.8 8.1 3.4 5.3 2.3 6.3 5.7 12.5 8.0 4.4 3.6 8.9 7.5 3.3 6.8 8.0 4.1 5.7 3.7 10.7 5.8 5.2 15.9 7.7 4.0 6.2 22.4 11.4 1.7 6.1 2.6 6.2 4.3 1.3 3.6 6.3 6.2 1.9 5.5 11.1 1.3 9.1 8.7 6.5 16.1 7.1 3.9 7.6 14.1 3.9 13.1 16.9 7.0 7.0 2.2 7.8 6.1 3.3 3.2 7.7 3.5 16.6 1.7 1.7 1.4 1.1 2.1 1.1 1.0 0.8 0.5 1.5 2.0 0.8 0.8 1.1 2.2 2.0 1.3 0.9 0.6 17.0 22.5 22.9 30.3 15.8 16.3 12.8 15.2 11.7 12.2 6.0 9.6 0.0 2.2 1.9 34.1 15.8 5.1 4.0 11.4 7.0 72.6 2.9 0.0 6.7 2.8 4.6 5.4 0.0 3.0 1.3 6.2 2.4 3.5 7.3 5.1 38.1 12.7 5.5 4.9 1.3 11.8 3.0 8.5 3.6 4.8 14.6 3.9 3.5 13.4 4.3 15.9 0.0 5.1 5.6 3.6 0.9 1.9 1.3 10.4 1.3 MEGF9 EGFL5 ENSG00000106780 "Multiple EGF like domains 9" Q9H1U4 9 120600813-120714470 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 80.4;Cone photoreceptor cells: 200.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.1" "Group enriched" "Detected in many" 5 "granulocytes: 19.1;monocytes: 5.7" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014319, HPA050238" Approved Approved Nucleoplasm,Cytosol NA NA 32000000 Nucleoplasm Cytosol "HPA014319: AB_1848035, HPA050238: AB_2681060" "unprognostic (1.18e-1)" "unprognostic (5.33e-2)" "unprognostic (1.84e-1)" "unprognostic (1.75e-2)" "unprognostic (3.30e-1)" "unprognostic (3.68e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-2)" "unprognostic (3.63e-2)" "unprognostic (1.13e-2)" "unprognostic (5.92e-2)" "unprognostic (4.97e-2)" "prognostic favorable (5.48e-11)" "unprognostic (1.90e-2)" "unprognostic (1.50e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" 15.0 9.6 22.4 9.9 21.7 15.4 12.8 27.9 26.2 11.7 6.7 29.3 2.1 6.4 6.1 5.5 12.8 12.8 7.9 6.1 24.6 16.4 12.5 33.8 17.9 7.0 28.6 16.0 9.3 5.4 15.6 6.8 4.8 22.6 8.4 5.8 21.4 7.8 6.6 6.0 19.0 6.5 8.1 21.1 12.9 7.2 3.1 25.8 3.2 25.5 4.6 5.6 11.3 9.6 0.3 2.2 19.1 5.7 0.3 0.6 1.3 2.7 10.7 9.4 2.9 13.1 8.1 3.0 2.8 2.4 0.7 1.0 0.6 1.6 10.1 4.2 2.6 3.4 11.8 13.5 4.8 2.0 8.2 3.9 1.4 20.1 4.4 5.6 4.0 8.7 3.8 14.8 4.6 3.7 26.3 6.6 5.5 3.2 4.8 7.8 7.8 7.9 1.4 0.4 6.0 2.9 6.0 10.5 4.3 19.3 8.9 9.3 7.9 3.3 2.7 7.9 1.6 8.1 4.1 7.7 2.8 1.6 10.4 4.2 8.8 10.3 3.3 4.0 4.8 16.1 0.4 5.7 3.6 0.6 1.9 0.2 0.3 0.6 0.5 2.2 0.3 0.5 0.4 19.1 0.3 3.0 0.2 0.5 1.3 22.4 21.7 27.9 21.5 24.6 16.4 28.6 16.0 22.6 25.8 80.4 47.6 4.9 4.8 24.4 27.8 23.0 15.3 6.7 21.6 22.7 200.3 0.3 0.0 3.9 0.6 7.3 6.5 23.3 4.7 1.1 6.1 8.8 6.9 41.0 5.9 12.7 6.3 10.4 54.2 0.9 10.6 18.5 25.3 2.8 3.3 28.2 11.0 6.8 11.0 5.0 70.5 12.9 9.9 8.4 6.1 38.3 1.0 9.6 6.0 5.7 MEMO1 "C2orf4, CGI-27, MEMO" ENSG00000162959 "Mediator of cell motility 1" Q9Y316 2 31865060-32011230 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042603, HPA057952" Approved Approved Vesicles NA NA Vesicles "HPA042603: AB_10806243, HPA057952: AB_2683562" "unprognostic (1.33e-1)" "unprognostic (1.28e-3)" "unprognostic (1.81e-1)" "unprognostic (2.94e-5)" "unprognostic (1.02e-2)" "unprognostic (3.96e-2)" "unprognostic (2.24e-4)" "unprognostic (1.70e-2)" "unprognostic (6.73e-2)" "unprognostic (8.37e-3)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (5.95e-9)" "unprognostic (6.57e-2)" "unprognostic (2.26e-1)" "unprognostic (3.77e-2)" "unprognostic (4.23e-2)" 9.3 14.9 11.5 12.1 24.2 22.4 8.3 23.5 21.5 9.1 9.5 9.4 12.5 9.4 8.9 9.8 19.6 7.8 7.6 19.8 12.9 10.1 9.2 20.0 8.2 16.2 10.2 13.8 6.7 10.2 9.3 13.0 11.4 12.1 11.4 12.0 11.6 9.9 10.5 31.3 11.0 8.9 11.0 9.8 12.4 9.8 33.0 9.1 32.4 8.2 3.9 18.4 14.2 10.6 6.9 17.0 11.4 18.2 8.7 12.0 6.8 32.0 14.0 15.5 14.4 13.8 19.6 27.8 27.5 17.4 15.9 12.4 18.9 18.3 34.2 8.9 19.0 20.8 16.3 18.3 24.2 21.2 22.6 10.0 24.6 9.2 23.0 19.2 24.7 20.6 14.6 15.9 15.6 16.0 18.1 24.9 8.2 17.7 15.8 27.5 14.1 29.4 50.6 22.9 27.7 17.6 20.0 17.7 26.4 31.4 31.6 13.1 24.3 14.2 34.7 21.8 13.7 14.5 29.7 22.7 22.2 24.4 17.6 30.2 16.6 24.9 29.2 20.2 35.5 17.3 1.2 11.8 11.4 5.6 16.3 4.3 6.9 7.0 6.8 17.0 5.3 5.0 5.1 9.7 8.7 18.2 6.5 12.0 6.8 11.5 24.2 23.5 21.5 12.9 10.1 10.2 13.8 12.1 9.1 6.0 14.1 7.7 13.6 24.6 14.2 3.9 7.6 8.1 7.9 10.4 15.7 10.5 1.7 4.2 2.7 11.3 5.4 0.0 2.1 8.7 11.3 12.0 9.3 11.1 8.7 11.1 12.6 15.4 21.6 1.7 12.0 16.6 11.8 12.6 5.0 6.7 6.3 9.3 8.1 1.3 9.7 6.5 8.2 8.1 6.1 14.4 13.8 9.2 8.9 16.5 MEP1A PPHA ENSG00000112818 "Meprin A subunit alpha" Q16819 6 46793390-46839782 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 52 "intestine: 243.0" "Group enriched" "Detected in some" 4 "Enterocytes: 391.5;Paneth cells: 129.6" "Cancer enriched" "Detected in many" 5 "colorectal cancer: 38.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.6" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.6" "Cell line enhanced" "Detected in some" "BEWO: 3.1;CACO-2: 7.1;Hep G2: 1.9;NB-4: 3.1;RPMI-8226: 3.5;SH-SY5Y: 2.2;U-2197: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025163, HPA029416" Enhanced NA NA 990000 "CAB025163: , HPA029416: AB_10600823" "unprognostic (1.83e-1)" "unprognostic (2.81e-4)" "unprognostic (2.03e-1)" "unprognostic (8.53e-2)" "unprognostic (8.73e-2)" "unprognostic (1.13e-1)" "unprognostic (2.43e-2)" "unprognostic (5.27e-4)" "unprognostic (2.05e-1)" "unprognostic (2.35e-2)" "unprognostic (1.42e-1)" "unprognostic (2.11e-1)" "unprognostic (1.11e-3)" "unprognostic (1.45e-1)" "unprognostic (1.91e-2)" "unprognostic (4.70e-3)" "unprognostic (1.68e-1)" 0.1 0.1 0.1 4.7 0.1 0.0 0.1 0.1 0.1 0.1 100.5 0.1 0.1 51.7 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 19.8 0.1 0.2 0.1 0.1 0.1 243.0 0.2 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.2 0.0 0.0 0.0 3.5 0.0 0.0 0.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 391.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.9 0.0 0.0 4.7 0.0 0.0 0.0 0.0 61.3 0.0 0.0 129.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 28.3 0.0 MEP1B ENSG00000141434 "Meprin A subunit beta" Q16820 18 32185069-32220404 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 167 "intestine: 241.5" "Group enriched" "Detected in some" 6 "Early spermatids: 2.1;Enterocytes: 6.3" "Group enriched" "Detected in some" 5 "pancreatic cancer: 3.0;stomach cancer: 0.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA029119 Enhanced "Secreted to digestive system" NA NA 120000 "HPA029119: AB_2672913" "unprognostic (1.33e-1)" "unprognostic (6.72e-2)" "unprognostic (2.79e-2)" "unprognostic (1.00e-1)" "unprognostic (3.50e-4)" "unprognostic (1.27e-1)" "unprognostic (1.74e-2)" "unprognostic (4.30e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.55e-1)" "unprognostic (8.31e-4)" "unprognostic (4.74e-2)" "unprognostic (3.39e-1)" "unprognostic (2.71e-1)" "unprognostic (3.39e-2)" "unprognostic (3.75e-2)" 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.3 0.1 0.1 78.8 0.0 0.0 54.5 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 241.5 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.1 0.4 0.3 0.3 0.0 1.4 0.5 0.2 0.0 0.0 0.5 0.6 0.0 2.1 1.0 0.3 0.3 0.1 0.6 1.4 1.7 0.5 0.0 0.8 0.2 0.0 0.0 0.0 0.8 1.0 1.1 0.7 0.6 0.4 1.3 0.3 0.0 0.7 0.0 0.1 0.7 0.5 1.6 1.1 0.2 0.0 1.9 1.3 4.1 1.3 0.5 0.0 1.8 1.8 2.9 0.0 0.7 10.6 2.4 0.8 0.2 0.3 0.3 0.4 3.1 0.9 1.4 0.8 3.4 0.0 0.6 2.3 0.5 2.6 0.0 0.5 0.0 0.3 0.3 1.0 0.1 1.3 1.1 0.7 1.4 0.4 0.1 1.2 0.3 0.2 0.0 0.1 0.2 0.5 0.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 MERTK "c-Eyk, mer, RP38, Tyro12" ENSG00000153208 "MER proto-oncogene, tyrosine kinase" Q12866 2 111898479-112029561 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation, Proto-oncogene, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Ito cells: 36.8;Kupffer cells: 92.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "intermediate monocyte: 10.3;non-classical monocyte: 6.4" "Lineage enriched" "Detected in single" 48 "monocytes: 10.3" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;Hep G2: 22.1;HUVEC TERT2: 22.0;RT4: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036196, HPA075622" Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol" NA NA 29000000 "Plasma membrane" "Endoplasmic reticulum, Midbody, Cytosol" "HPA036196: AB_10670676, HPA075622: AB_2686759" "unprognostic (2.17e-2)" "unprognostic (8.10e-2)" "unprognostic (4.85e-2)" "unprognostic (2.68e-1)" "unprognostic (2.44e-1)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.74e-4)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (6.22e-2)" "unprognostic (3.72e-1)" "prognostic favorable (4.43e-5)" "unprognostic (5.13e-2)" "unprognostic (2.11e-1)" "unprognostic (5.86e-2)" "unprognostic (2.05e-2)" 20.1 55.1 13.1 12.5 17.8 1.9 31.8 6.2 13.8 10.8 13.8 6.8 27.7 11.5 11.3 25.4 8.4 12.8 11.7 7.1 16.5 6.3 14.2 18.9 12.7 30.3 8.1 10.1 12.9 9.0 23.9 14.3 18.4 18.6 14.1 7.9 20.4 6.8 24.9 6.4 6.4 12.8 13.6 12.2 38.4 12.3 17.3 9.8 1.7 9.9 2.0 8.4 14.1 26.6 0.0 0.2 0.1 10.3 0.0 0.0 0.3 0.5 0.9 4.4 10.0 0.2 0.1 7.1 0.0 0.1 0.5 1.0 21.3 1.3 0.1 4.7 0.0 4.6 0.1 5.8 0.0 0.8 0.8 3.1 3.8 0.0 22.1 0.1 0.1 0.9 0.2 0.0 5.1 0.3 2.3 22.0 0.8 1.2 2.0 1.7 1.0 0.0 5.0 2.7 0.6 3.4 1.4 1.2 1.7 11.2 13.1 0.1 4.2 0.1 0.3 1.7 1.6 0.0 0.2 3.3 0.6 2.0 0.0 0.0 1.7 2.5 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 6.4 0.1 0.0 0.3 13.1 17.8 6.2 13.8 16.5 6.3 8.1 10.1 18.6 9.8 3.0 20.1 0.8 2.9 1.4 0.6 2.1 5.1 1.4 11.4 0.0 2.0 2.6 1.7 0.8 1.6 7.1 1.6 0.0 0.8 1.0 4.1 2.0 0.0 8.9 23.6 0.0 0.0 36.8 92.6 1.5 4.6 11.0 0.0 0.0 2.3 8.6 1.7 1.9 6.3 1.9 9.2 6.5 11.3 0.5 1.5 1.1 15.8 0.8 1.8 1.4 MEST PEG1 ENSG00000106484 "Mesoderm specific transcript" Q5EB52 7 130486171-130506465 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 63.8;placenta: 193.5" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 680.5;Syncytiotrophoblasts: 836.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 18.8" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "AN3-CA: 525.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005623 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Cytosol" "HPA005623: AB_1079364" "unprognostic (6.14e-2)" "unprognostic (5.06e-3)" "unprognostic (9.82e-2)" "unprognostic (1.64e-3)" "unprognostic (3.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.36e-3)" "unprognostic (1.12e-1)" "unprognostic (7.81e-2)" "unprognostic (6.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (6.20e-5)" "unprognostic (7.09e-2)" "unprognostic (1.05e-1)" "unprognostic (2.30e-1)" "unprognostic (1.67e-2)" 44.9 26.0 7.8 4.7 12.9 3.4 63.8 2.6 22.7 2.4 7.5 3.4 1.1 7.9 7.3 4.6 2.6 5.2 6.6 3.7 7.9 8.0 6.7 13.7 18.8 4.1 3.3 9.0 7.8 13.0 2.5 15.4 193.5 15.5 4.1 6.1 8.4 7.0 2.5 2.2 2.1 7.2 5.3 3.2 22.4 3.0 10.1 3.3 2.0 4.3 2.5 1.9 4.5 3.7 3.1 6.7 8.6 2.0 2.7 18.8 5.3 3.2 1.7 8.5 525.5 0.1 0.0 0.0 3.5 1.6 3.7 1.7 10.1 4.9 1.6 1.2 0.1 3.2 0.4 0.1 0.0 1.4 0.0 0.0 2.8 2.7 1.6 14.5 0.1 0.0 0.2 0.1 2.7 0.0 18.9 1.4 0.0 3.1 0.0 7.1 4.5 0.3 3.5 5.3 4.8 0.8 0.0 94.6 1.0 4.0 3.0 30.0 0.0 3.1 10.2 0.0 9.0 0.3 2.4 1.4 1.2 0.0 11.7 0.2 0.1 0.3 0.0 4.5 0.0 0.4 8.6 1.9 6.2 0.7 2.0 1.7 3.1 2.0 1.4 6.7 2.8 7.6 18.8 1.1 2.7 1.2 0.3 0.1 5.3 7.8 12.9 2.6 22.7 7.9 8.0 3.3 9.0 15.5 3.3 6.0 3.8 2.4 36.0 3.9 9.1 0.6 17.8 4.0 5.7 15.7 3.9 680.5 10.0 19.8 53.5 3.4 10.9 0.0 35.4 99.2 31.1 18.0 0.0 15.8 79.5 1.6 28.4 35.6 7.7 27.3 78.6 1.9 1.7 1.0 19.5 40.4 28.9 28.1 12.7 9.2 19.9 19.4 5.2 33.9 38.5 0.5 836.0 0.0 33.2 16.5 MET "DFNB97, HGFR, RCCP2" ENSG00000105976 "MET proto-oncogene, receptor tyrosine kinase" P08581 7 116672390-116798386 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 78.1;Club cells: 116.0;Urothelial cells: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 45.3;CAPAN-2: 49.5" "Group enriched" "Detected in many" 5 "amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1" "Low region specificity" "Detected in many" "CAB005282, CAB018577, HPA055607" Approved Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 179000000 70000000 "Plasma membrane, Cytosol" "CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860" "unprognostic (1.60e-2)" "unprognostic (7.71e-2)" "unprognostic (2.53e-2)" "unprognostic (1.58e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (6.75e-4)" "unprognostic (1.68e-1)" "unprognostic (3.22e-2)" "unprognostic (3.81e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.21e-7)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (5.53e-2)" "unprognostic (8.88e-2)" "unprognostic (2.01e-2)" "unprognostic (2.20e-1)" 16.2 1.1 1.8 4.5 2.3 4.3 11.2 0.9 15.2 9.9 6.5 2.4 2.4 4.4 7.5 5.2 5.1 4.6 12.3 5.4 5.7 1.8 20.1 30.2 15.6 1.4 3.6 2.1 2.0 9.3 0.7 8.1 24.4 2.6 8.0 6.6 34.1 12.2 8.4 12.8 7.2 8.6 4.0 2.3 5.7 10.6 2.7 2.4 0.5 21.4 7.0 2.1 10.1 15.0 0.2 0.3 1.2 0.2 0.3 0.4 0.0 45.3 26.1 0.0 0.1 2.0 2.0 1.8 25.9 10.5 14.0 11.8 5.4 49.5 2.0 43.2 16.2 37.7 12.0 4.4 24.7 28.6 0.1 5.6 0.0 27.1 4.7 0.3 0.0 0.0 2.6 9.8 9.1 30.0 25.3 9.6 0.0 0.9 0.2 25.9 1.0 0.0 0.0 3.9 7.2 26.6 0.0 22.0 0.0 24.5 5.2 3.8 0.0 10.6 3.4 10.1 4.7 0.0 0.2 17.6 20.9 7.4 11.0 20.0 0.5 4.0 0.2 22.9 0.0 2.9 1.1 0.2 0.4 0.4 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 1.2 0.3 0.1 0.3 0.1 0.0 1.8 2.3 0.9 15.2 5.7 1.8 3.6 2.1 2.6 2.4 26.8 78.1 2.4 56.1 34.7 0.9 10.0 15.3 22.7 116.0 29.6 0.0 57.9 0.0 28.0 0.0 11.7 11.2 0.0 39.8 5.0 4.0 55.8 0.0 26.0 6.1 0.0 6.9 1.3 1.0 0.0 0.6 2.0 3.3 1.8 19.7 7.4 69.4 7.0 0.0 13.5 0.3 0.0 2.3 0.0 0.6 15.6 18.2 0.0 12.7 88.5 METTL21A "FAM119A, HCA557b, HSPA-KMT, LOC151194" ENSG00000144401 "Methyltransferase like 21A" Q8WXB1 2 207580631-207625928 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034712 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034712: AB_10670160" "unprognostic (1.41e-1)" "unprognostic (1.50e-1)" "unprognostic (4.56e-2)" "unprognostic (2.09e-3)" "unprognostic (2.00e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (1.87e-5)" "unprognostic (4.80e-2)" "unprognostic (2.30e-2)" "unprognostic (2.47e-3)" "unprognostic (6.65e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (5.43e-4)" "unprognostic (5.01e-2)" "unprognostic (3.05e-1)" "unprognostic (1.52e-2)" "unprognostic (2.05e-1)" 10.4 9.1 16.5 13.8 18.2 20.2 14.6 14.0 16.9 9.0 9.3 8.7 3.8 8.1 10.0 8.4 6.7 8.3 7.1 13.2 16.3 15.4 11.1 20.9 8.9 15.4 25.8 10.6 12.0 10.6 11.6 10.1 12.7 20.2 8.8 9.2 8.8 8.4 7.1 19.5 9.0 8.3 8.3 19.2 15.4 12.3 7.1 18.8 18.5 15.2 6.2 14.8 10.1 24.3 25.2 14.8 25.9 20.6 7.5 14.4 8.3 8.0 7.6 12.6 9.5 5.6 5.9 24.5 4.5 5.6 7.3 7.4 14.4 13.0 11.7 10.0 3.5 12.9 4.7 18.0 5.9 6.1 6.8 12.4 13.6 12.2 23.7 9.9 17.8 13.8 5.2 7.9 3.6 6.1 9.1 8.2 19.6 19.6 6.9 4.8 13.1 17.9 30.5 20.9 11.0 5.4 13.2 5.3 16.9 10.5 6.8 14.9 12.3 9.7 3.4 9.4 18.3 4.7 26.4 4.2 6.4 14.0 5.9 7.9 10.2 12.8 24.1 10.5 14.0 9.5 13.8 14.4 25.9 5.0 13.9 8.3 25.2 7.6 7.1 11.8 21.6 14.4 9.2 5.0 7.5 20.6 14.8 5.9 8.3 16.5 18.2 14.0 16.9 16.3 15.4 25.8 10.6 20.2 18.8 14.9 22.3 43.0 29.8 14.2 19.9 23.8 15.3 25.4 21.6 10.4 7.9 32.6 24.9 21.2 24.4 14.8 9.7 0.0 22.0 25.1 20.5 35.0 46.1 10.9 26.1 17.5 5.2 12.3 20.6 28.4 9.2 39.1 42.2 19.0 14.2 15.6 18.5 61.9 7.1 19.3 19.9 12.9 12.5 9.8 17.2 11.0 8.8 18.3 16.6 16.6 METTL2B "FLJ11350, METL, METTL2" ENSG00000165055 "Methyltransferase like 2B" Q6P1Q9 7 128476729-128506602 "Predicted intracellular proteins, Predicted membrane proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (2.56e-2)" "unprognostic (1.72e-1)" "unprognostic (1.88e-1)" "unprognostic (4.00e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-1)" "unprognostic (1.81e-3)" "unprognostic (9.91e-2)" "unprognostic (1.21e-1)" "unprognostic (4.36e-2)" "unprognostic (3.40e-2)" "unprognostic (4.57e-2)" "unprognostic (1.37e-1)" "unprognostic (1.35e-3)" "unprognostic (3.46e-2)" "unprognostic (8.38e-2)" "unprognostic (5.67e-2)" 10.2 7.2 7.5 7.4 12.7 4.1 8.3 8.6 16.3 4.6 6.9 5.4 4.8 4.8 6.9 7.7 7.7 5.8 4.9 8.0 17.3 7.8 6.8 9.8 5.1 6.6 7.3 8.7 6.2 7.9 5.6 13.0 7.0 9.6 5.8 7.9 4.8 7.5 8.0 11.0 11.6 5.2 6.9 6.9 7.6 6.1 5.3 9.8 6.5 7.8 10.0 8.1 7.0 5.3 7.7 5.3 5.5 8.5 7.2 8.8 5.0 10.6 12.0 8.7 16.3 7.4 9.4 6.5 8.4 5.9 9.0 7.5 10.1 13.0 10.1 4.1 10.1 14.1 10.7 16.0 9.9 11.5 11.0 14.6 11.3 13.0 8.9 12.3 15.3 8.2 6.3 9.4 11.5 11.6 6.8 9.9 12.4 21.5 7.7 13.0 8.5 17.5 12.9 15.0 11.9 13.1 7.0 12.0 9.5 10.5 9.2 9.2 15.2 7.0 35.6 10.6 12.5 10.1 9.2 9.6 10.6 5.0 11.5 17.9 12.1 11.8 18.1 20.1 15.5 14.8 5.1 6.2 3.3 8.8 5.6 7.9 4.5 6.6 6.5 5.1 7.7 7.5 8.8 5.5 7.2 8.5 5.3 5.3 5.0 7.5 12.7 8.6 16.3 17.3 7.8 7.3 8.7 9.6 9.8 11.9 19.7 3.7 15.2 14.5 28.9 9.6 10.2 40.2 25.0 12.2 37.3 18.8 5.0 17.0 1.1 13.5 8.0 0.0 15.5 10.3 11.4 14.2 17.4 9.7 9.3 35.0 8.1 9.2 6.9 1.1 13.6 9.9 8.5 17.2 13.5 21.5 15.6 7.0 14.9 10.3 33.6 6.5 14.2 14.0 16.6 16.4 20.4 8.7 15.1 21.3 METTL7A DKFZP586A0522 ENSG00000185432 "Methyltransferase like 7A" Q9H8H3 12 50923472-50932517 "Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 126.5;thyroid gland: 120.3" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 780.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 29.7;classical monocyte: 12.7;eosinophil: 25.8;intermediate monocyte: 14.2;memory B-cell: 13.6;myeloid DC: 11.5;naive B-cell: 14.7;non-classical monocyte: 20.2;plasmacytoid DC: 10.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 77.1;Karpas-707: 77.0;RPMI-8226: 42.5" HPA017434 Supported "Lipid droplets" NA NA 140000 "Lipid droplets" "HPA017434: AB_1853835" "unprognostic (2.31e-2)" "unprognostic (2.82e-2)" "unprognostic (9.85e-3)" "unprognostic (9.43e-2)" "unprognostic (1.52e-1)" "unprognostic (3.38e-2)" "unprognostic (1.09e-3)" "unprognostic (2.68e-3)" "unprognostic (5.48e-2)" "unprognostic (9.94e-2)" "unprognostic (2.57e-2)" "unprognostic (4.49e-2)" "prognostic favorable (0.00e+0)" "unprognostic (8.64e-2)" "unprognostic (5.94e-2)" "unprognostic (1.39e-1)" "unprognostic (1.22e-2)" 38.3 35.2 25.3 10.3 32.1 4.4 44.8 22.7 21.5 21.4 36.6 17.8 15.6 18.3 16.1 13.0 19.9 29.1 25.2 12.8 27.1 12.6 43.0 126.5 26.4 24.5 29.3 22.2 29.0 35.6 11.9 10.5 7.9 26.5 13.6 20.0 13.0 19.0 14.2 16.1 10.9 22.3 19.4 32.2 16.0 28.1 17.3 25.9 3.6 120.3 9.4 16.0 29.1 15.8 14.7 11.5 29.7 20.2 3.8 3.7 5.4 0.2 0.0 1.9 11.2 77.1 22.2 24.3 0.2 1.9 0.1 0.3 0.9 1.0 13.1 1.0 0.8 0.2 1.5 1.2 1.3 0.0 1.4 2.9 3.2 2.3 7.4 16.8 0.8 6.7 23.0 0.1 0.1 0.0 0.4 5.1 0.5 1.8 77.0 0.7 0.0 0.6 3.4 9.1 0.3 0.0 0.7 0.1 42.5 3.6 13.8 4.3 7.1 0.2 7.6 0.2 2.5 22.0 0.7 2.9 0.1 0.2 0.9 0.0 3.9 0.7 5.9 1.5 1.5 0.0 29.7 12.7 25.8 1.0 14.2 0.6 13.6 0.4 0.8 11.5 14.7 0.1 0.7 0.8 3.8 20.2 10.1 3.7 5.4 25.3 32.1 22.7 20.0 27.1 12.6 29.3 22.2 26.5 25.9 187.6 116.7 62.3 43.3 7.7 1.4 8.5 221.7 247.6 86.4 68.0 0.0 69.2 36.5 5.5 1.6 39.3 112.5 70.0 33.4 24.6 39.1 44.0 31.3 780.7 32.3 7.9 65.3 120.3 246.1 3.2 200.5 33.3 11.8 8.2 68.5 143.2 5.5 67.6 140.0 124.1 4.6 51.8 27.8 1.6 1.0 8.2 32.0 25.4 61.7 44.6 METTL7B "ALDI, MGC17301" ENSG00000170439 "Methyltransferase like 7B" Q6UX53 12 55681546-55684611 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 35.7;heart muscle: 46.1;intestine: 44.7;liver: 82.4" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 50.8;Hepatocytes: 89.3;Hofbauer cells: 55.0;Proximal tubular cells: 31.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 5.4;myeloid DC: 8.6;naive B-cell: 2.5;non-classical monocyte: 4.0" "Group enriched" "Detected in many" 56 "B-cells: 2.5;dendritic cells: 8.6;monocytes: 5.4" "Cell line enhanced" "Detected in many" "CACO-2: 11.9;CAPAN-2: 24.1;EFO-21: 18.1;LHCN-M2: 19.9;OE19: 13.5;THP-1: 17.6;U-87 MG: 18.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038644 Enhanced Approved Vesicles,Microtubules NA NA Microtubules Vesicles "HPA038644: AB_2676130" "unprognostic (7.54e-2)" "unprognostic (7.15e-2)" "unprognostic (5.55e-2)" "unprognostic (3.07e-3)" "unprognostic (6.30e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (2.00e-1)" "unprognostic (2.22e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-2)" "unprognostic (5.33e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-2)" "unprognostic (7.10e-2)" "prognostic favorable (2.37e-4)" "unprognostic (2.43e-1)" 1.3 0.9 1.2 2.1 0.9 0.1 0.5 0.5 2.2 0.4 15.2 3.0 0.0 15.2 0.4 35.7 0.3 0.7 8.1 46.1 4.6 0.6 12.6 82.4 0.8 0.8 1.8 1.5 0.3 1.2 0.0 1.3 4.3 3.2 0.3 6.0 1.4 0.4 0.1 2.7 0.5 44.7 0.4 1.0 3.1 1.0 0.4 0.6 0.0 1.0 0.1 0.0 0.3 0.3 2.5 8.6 0.0 5.4 0.0 0.0 0.4 0.2 9.2 0.0 0.2 1.9 6.8 0.1 0.3 1.4 0.1 0.6 11.9 24.1 4.8 18.1 0.5 0.5 0.0 1.7 0.1 0.3 0.0 2.3 0.4 1.5 11.7 0.0 0.2 0.0 1.7 0.0 0.4 0.0 1.8 0.0 0.0 0.1 0.0 19.9 8.3 0.0 0.1 2.4 13.5 1.1 0.0 0.6 1.1 0.2 0.0 0.0 0.1 0.9 0.0 1.6 0.1 1.6 17.6 0.0 1.3 1.6 0.2 1.2 0.0 0.2 1.4 18.3 4.1 0.1 0.0 1.0 0.0 0.0 5.4 0.0 0.7 0.0 0.0 8.6 2.5 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.4 1.2 0.9 0.5 2.2 4.6 0.6 1.8 1.5 3.2 0.6 0.0 1.0 0.0 0.1 0.0 0.0 14.9 25.5 0.0 1.2 0.0 0.0 0.4 3.3 3.3 0.0 0.0 50.8 0.0 4.6 0.4 0.4 0.0 0.0 89.3 55.0 0.0 1.2 1.8 14.6 0.0 0.0 0.0 0.0 0.0 8.5 0.5 3.8 17.3 1.1 31.2 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 17.2 0.1 MFAP3 ENSG00000037749 "Microfibril associated protein 3" P55082 5 154038906-154220478 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015883, HPA049198" Approved Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" Nucleoplasm "HPA015883: AB_1853840, HPA049198: AB_2680672" "unprognostic (6.02e-2)" "prognostic unfavorable (4.28e-4)" "unprognostic (1.58e-3)" "unprognostic (2.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (6.58e-3)" "unprognostic (1.21e-1)" "unprognostic (3.07e-2)" "unprognostic (1.53e-2)" "unprognostic (7.00e-2)" "unprognostic (1.30e-1)" "unprognostic (1.33e-2)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (9.35e-3)" 21.3 7.6 5.8 8.0 12.2 7.9 11.3 12.6 11.4 11.1 8.3 6.3 7.8 7.2 14.1 7.3 11.6 7.5 8.9 9.2 7.2 6.8 9.5 9.4 10.9 6.8 6.4 7.1 9.4 6.3 27.2 9.6 15.0 8.8 7.8 8.4 9.5 8.8 6.4 13.2 6.4 9.5 11.7 8.9 7.9 7.4 8.3 7.0 9.1 11.3 6.3 9.2 12.2 10.1 3.0 10.6 14.6 10.3 7.7 9.6 5.4 9.7 12.7 21.6 22.7 19.5 18.3 21.2 17.6 18.9 18.4 23.8 19.1 22.2 14.0 20.5 16.6 18.3 22.0 20.3 22.0 29.5 6.3 13.3 9.2 19.5 6.9 18.6 16.4 10.8 19.7 21.9 22.0 18.7 15.2 25.7 12.7 10.4 15.2 16.0 6.4 9.1 3.7 11.2 10.4 7.5 8.7 25.6 12.8 11.9 13.8 22.3 24.9 19.3 21.8 17.4 20.0 22.9 8.1 23.3 24.0 16.8 13.2 17.9 15.3 19.6 13.2 12.2 11.3 18.8 8.1 10.3 14.6 6.5 9.8 9.6 3.0 5.6 4.9 10.6 3.0 7.4 5.4 8.4 7.7 7.0 3.8 4.9 5.4 5.8 12.2 12.6 11.4 7.2 6.8 6.4 7.1 8.8 7.0 0.0 0.3 0.0 0.9 5.4 3.3 2.0 0.0 0.0 0.0 5.2 5.9 3.5 1.7 0.9 4.5 4.8 2.0 0.0 1.0 2.4 2.7 1.1 4.6 1.6 1.6 3.2 0.0 0.0 1.2 3.3 1.7 2.5 8.5 1.0 0.6 7.8 0.9 0.0 0.0 1.1 4.3 0.0 3.0 2.1 2.1 4.8 5.0 1.3 0.6 1.4 MFAP3L "KIAA0626, NYD-sp9" ENSG00000198948 "Microfibril associated protein 3 like" O75121 4 169986597-170033031 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 32.9" "Group enriched" "Detected in many" 20 "Early spermatids: 409.5;Late spermatids: 1347.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 7.9;eosinophil: 2.1;neutrophil: 4.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 7.9" "Cell line enhanced" "Detected in many" "HMC-1: 14.4;RT4: 23.5;SK-BR-3: 21.6;SuSa: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017986, HPA062306, HPA077490" Enhanced Supported "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA Nucleoplasm "Cell Junctions" "HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842" "unprognostic (8.04e-3)" "unprognostic (8.67e-3)" "unprognostic (3.74e-1)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (7.92e-2)" "unprognostic (3.50e-2)" "unprognostic (3.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.33e-1)" "unprognostic (3.96e-1)" "unprognostic (7.58e-2)" "prognostic favorable (1.42e-8)" "unprognostic (6.59e-3)" "unprognostic (2.12e-1)" "unprognostic (1.62e-4)" "unprognostic (2.40e-3)" 2.1 3.4 15.0 1.3 19.6 2.7 10.2 4.9 19.4 11.4 2.1 21.1 4.2 1.0 4.9 32.9 1.2 4.0 2.6 1.9 15.4 11.1 25.6 29.5 2.7 1.2 21.8 10.0 1.1 1.6 5.7 3.3 5.5 21.1 2.9 2.2 17.5 2.0 11.7 4.2 19.7 1.1 3.9 16.4 1.7 1.3 30.6 20.8 0.0 2.8 0.2 1.0 11.9 1.5 0.0 0.7 7.9 0.8 0.0 0.8 6.9 0.2 3.5 1.9 2.0 1.6 0.8 0.7 3.8 0.5 1.8 1.6 1.2 0.2 0.0 0.1 5.9 3.4 1.8 6.9 0.8 0.8 0.0 2.6 0.0 3.7 1.4 0.9 0.0 14.4 1.2 2.1 0.2 0.6 1.0 0.2 2.2 0.5 0.7 3.6 2.0 0.6 0.5 2.0 0.4 3.0 0.0 1.1 0.0 5.2 23.5 1.6 3.5 3.2 21.6 6.9 12.8 1.2 0.0 0.1 1.9 7.1 3.5 7.3 0.3 0.0 0.0 4.8 0.7 7.1 7.9 0.2 2.1 0.8 0.8 0.4 0.0 0.7 0.2 0.3 0.0 0.3 0.1 4.9 0.0 0.0 0.7 0.1 6.9 15.0 19.6 4.9 15.4 15.4 11.1 21.8 10.0 21.1 20.8 0.0 6.4 0.0 0.2 2.3 9.2 2.5 0.0 0.0 0.0 34.9 19.6 2.9 5.0 0.4 409.5 2.3 0.4 23.3 1.0 0.9 0.5 0.5 4.6 43.3 0.9 3.2 2.4 4.9 1.0 1347.3 4.9 0.6 6.8 0.0 0.1 2.3 1.3 0.0 8.5 17.3 14.7 19.4 3.4 18.0 13.6 7.3 7.9 0.0 0.4 2.1 MFF "C2orf33, GL004" ENSG00000168958 "Mitochondrial fission factor" Q9GZY8 2 227325151-227357836 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 827.2;Late spermatids: 1262.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010968, HPA074625" Enhanced Supported Mitochondria No No Mitochondria "HPA010968: AB_1845714, HPA074625: AB_2686704" "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "unprognostic (2.16e-1)" "unprognostic (1.15e-2)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.20e-4)" "unprognostic (3.07e-2)" "unprognostic (1.32e-1)" "unprognostic (6.07e-2)" "unprognostic (3.00e-2)" "unprognostic (6.24e-3)" "unprognostic (5.50e-2)" "unprognostic (1.00e-1)" "unprognostic (2.70e-2)" "unprognostic (1.51e-1)" "unprognostic (3.22e-1)" 20.2 23.9 31.6 18.0 27.6 22.3 21.3 25.7 38.4 19.6 22.5 26.5 14.7 22.1 21.9 20.9 21.5 18.0 17.1 40.5 27.8 28.4 33.7 24.4 16.6 27.1 30.2 20.2 25.7 27.6 25.0 19.3 17.7 28.0 20.6 22.5 25.6 20.6 27.6 37.4 16.7 18.6 22.9 33.4 16.9 18.8 97.0 20.6 25.9 19.8 22.2 23.3 20.7 17.8 40.2 34.9 59.9 33.8 29.3 44.1 33.1 23.2 20.0 24.6 33.8 31.9 30.7 32.7 23.2 31.4 28.3 30.3 21.7 16.6 13.3 27.8 25.3 29.8 19.3 40.4 29.5 38.5 28.1 32.5 28.1 51.6 54.4 42.1 27.1 25.2 27.5 38.9 26.8 28.7 37.1 24.4 30.7 24.4 40.0 25.0 23.4 28.6 41.8 33.3 25.0 21.2 26.0 31.1 25.7 41.3 22.0 26.1 24.5 50.9 23.7 33.8 21.2 15.2 26.9 16.4 27.6 23.3 40.8 25.7 32.6 22.1 26.7 36.5 24.2 37.5 42.4 32.9 59.9 32.8 33.8 35.3 40.2 34.5 32.0 34.5 38.2 36.6 31.0 31.0 29.3 30.6 34.9 44.1 33.1 31.6 27.6 25.7 38.4 27.8 28.4 30.2 20.2 28.0 20.6 29.8 37.7 68.1 54.7 42.8 34.0 71.6 35.7 26.8 52.4 57.6 29.5 82.2 107.8 83.0 827.2 38.3 47.7 93.5 82.7 82.5 63.5 55.3 20.9 54.0 67.9 38.1 31.0 41.1 54.0 1262.3 81.4 51.9 77.6 56.9 59.6 185.4 78.7 66.6 80.6 97.9 56.3 58.2 52.6 274.7 48.3 41.4 76.9 53.7 69.3 60.3 MFN2 "CMT2A2, CPRP1, KIAA0214, MARF" ENSG00000116688 "Mitofusin 2" O95140 1 11980181-12013514 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy, Unfolded protein response" Hydrolase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 100.9;skeletal muscle: 111.1" "Cell type enriched" "Detected in all" 8 "Cardiomyocytes: 308.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030554, CAB079902" Uncertain Supported Mitochondria NA NA Mitochondria "CAB079902: AB_2724683, HPA030554: AB_10603018" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.42e-1)" "unprognostic (4.38e-2)" "unprognostic (8.36e-2)" "unprognostic (9.71e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (3.45e-1)" "unprognostic (2.19e-2)" "unprognostic (1.43e-1)" "unprognostic (3.55e-1)" "prognostic favorable (2.36e-8)" "unprognostic (4.69e-2)" "unprognostic (2.76e-1)" "unprognostic (8.84e-3)" "unprognostic (2.12e-1)" 12.8 10.1 16.4 8.9 20.3 17.2 10.1 15.9 32.1 8.7 17.0 17.0 11.2 16.5 12.1 8.7 20.1 9.0 9.0 100.9 17.9 16.0 14.8 20.4 10.6 8.0 18.8 19.3 10.2 9.0 22.0 9.3 12.9 20.8 14.1 13.2 16.5 10.7 23.7 111.1 18.8 25.7 22.9 15.7 10.2 14.0 11.3 10.9 7.3 18.7 28.5 12.1 16.3 10.6 7.3 8.9 18.5 16.9 5.8 10.2 13.4 26.0 15.9 18.1 23.8 18.3 13.8 21.0 20.6 19.1 28.3 22.1 26.3 17.4 19.1 22.4 24.9 18.6 27.9 29.9 47.8 25.4 69.2 22.7 27.3 25.6 20.4 19.0 27.7 17.2 17.4 36.9 39.8 36.9 12.2 19.9 10.3 28.2 16.8 20.9 13.1 16.8 12.7 12.5 17.5 23.5 19.7 26.4 17.8 17.0 17.4 21.1 13.8 24.2 25.8 23.9 14.2 13.9 16.7 19.9 19.0 19.0 28.8 21.5 20.1 21.1 31.3 22.5 31.2 20.5 8.5 10.3 7.1 9.6 13.5 10.2 7.3 7.2 8.6 8.9 6.6 6.3 8.0 18.5 5.8 16.9 4.6 8.0 13.4 16.4 20.3 15.9 32.1 17.9 16.0 18.8 19.3 20.8 10.9 20.8 18.6 11.5 8.2 20.3 24.8 308.6 12.7 12.0 14.8 14.0 11.8 12.2 18.3 12.7 3.6 12.0 31.1 23.3 17.3 13.2 9.3 12.5 10.4 39.2 14.2 28.6 17.3 13.5 18.1 4.4 6.6 11.8 16.9 10.0 20.9 11.6 13.9 14.0 14.2 13.3 18.6 12.9 14.4 27.7 16.8 26.3 21.1 9.6 22.1 12.9 MFRP "C1QTNF5, FLJ30570, NNO2, rd6" ENSG00000235718 "Membrane frizzled-related protein" Q9BY79 11 119338942-119346673 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Microphthalmia, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 40 "brain: 54.9;retina: 112.9" "Cell type enriched" "Detected in single" 27 "Ciliated cells: 2.7" "Not detected" "Not detected" "Region enriched" "Detected in some" 10 "pons and medulla: 54.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.5;JURKAT: 1.0;NB-4: 1.8" "Group enriched" "Detected in many" 4 "basal ganglia: 3.5;hippocampal formation: 13.2;pons and medulla: 10.8;thalamus: 8.9" "Low region specificity" "Detected in some" NA NA 0.9 0.3 0.6 0.0 0.4 0.1 0.1 0.2 2.8 0.2 0.1 14.6 0.0 0.2 0.3 0.0 0.1 0.2 0.1 0.2 5.5 0.5 0.2 0.1 0.3 0.2 0.8 0.0 0.1 0.1 2.0 0.5 0.6 54.9 0.1 0.0 112.9 0.1 0.1 0.5 0.1 0.2 0.4 0.4 0.3 0.2 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 1.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.4 0.2 2.8 5.5 0.5 0.8 0.0 54.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MFSD1 "FLJ14153, UG0581B09" ENSG00000118855 "Major facilitator superfamily domain containing 1" Q9H3U5 3 158732198-158829719 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Hofbauer cells: 192.2;Kupffer cells: 259.8;Macrophages: 135.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 45.3;granulocytes: 42.6;monocytes: 49.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065858 Approved Approved "Plasma membrane,Cytosol" NA NA 14000 "Plasma membrane" Cytosol "HPA065858: AB_2685569" "unprognostic (9.94e-2)" "unprognostic (3.12e-3)" "unprognostic (3.54e-2)" "unprognostic (1.00e-1)" "unprognostic (2.16e-2)" "unprognostic (7.37e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (2.52e-1)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (2.92e-1)" "prognostic favorable (5.60e-5)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (4.66e-2)" "unprognostic (2.57e-1)" 26.2 29.5 11.4 22.0 11.8 17.2 24.2 9.1 14.0 18.7 15.7 13.4 18.9 13.2 18.3 20.6 37.0 18.4 17.5 17.7 10.8 10.3 20.7 24.8 24.9 39.8 15.7 11.7 15.3 16.8 16.5 16.8 18.3 13.6 14.7 11.5 14.5 34.5 17.9 9.2 18.6 16.8 15.0 14.5 29.1 19.9 15.0 14.3 11.3 18.7 16.3 16.7 23.8 24.1 10.5 45.3 42.6 49.6 5.4 7.3 35.3 14.9 6.4 1.6 5.0 8.7 8.2 10.3 23.4 10.5 8.3 8.2 2.6 14.8 4.2 17.2 14.9 5.0 7.8 4.0 5.1 7.8 16.6 10.9 11.2 4.9 1.1 9.4 41.3 28.1 12.2 6.7 7.5 2.1 3.3 6.5 2.8 8.7 8.6 14.7 3.4 2.5 12.2 1.6 6.3 16.4 5.6 2.4 36.6 3.0 3.9 4.8 7.2 17.2 13.3 4.1 2.0 10.5 16.2 21.3 11.9 4.6 17.6 11.5 27.4 19.2 2.3 15.0 30.0 8.3 14.0 49.6 42.6 7.3 38.5 6.6 10.5 5.8 6.5 45.3 8.5 6.4 7.0 17.6 5.4 31.6 14.7 6.8 35.3 11.4 11.8 9.1 14.0 10.8 10.3 15.7 11.7 13.6 14.3 17.9 31.3 39.5 33.3 19.1 11.9 17.1 12.7 40.2 29.6 21.0 5.9 23.7 16.6 28.2 3.5 25.1 25.5 23.3 24.8 27.2 23.6 39.9 47.4 30.1 192.2 17.5 21.9 39.3 259.8 5.3 11.2 135.3 30.4 15.4 26.6 23.4 26.7 20.1 10.6 25.9 10.0 12.9 15.5 8.8 7.0 22.7 46.8 15.4 24.0 47.5 MFSD10 "IT10C3, TETRAN" ENSG00000109736 "Major facilitator superfamily domain containing 10" Q14728 4 2930561-2934859 "Predicted membrane proteins" "Apoptosis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 71.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043209 Uncertain Approved "Nucleoplasm,Nuclear membrane" No No "Nuclear membrane" Nucleoplasm "HPA043209: AB_2678364" "unprognostic (1.44e-1)" "unprognostic (2.26e-2)" "unprognostic (7.06e-2)" "unprognostic (2.11e-3)" "unprognostic (7.76e-2)" "unprognostic (9.43e-2)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.82e-3)" "unprognostic (4.70e-3)" "unprognostic (3.21e-1)" "unprognostic (1.91e-2)" "unprognostic (5.42e-3)" "prognostic unfavorable (5.68e-5)" "unprognostic (8.32e-2)" "unprognostic (2.30e-1)" "unprognostic (8.03e-2)" "unprognostic (1.00e-2)" 21.6 9.1 10.3 15.2 10.7 62.9 34.4 20.2 13.0 17.1 18.1 8.9 17.5 13.8 16.0 17.1 18.0 16.3 23.5 13.5 9.6 10.1 15.7 6.0 16.8 17.6 9.1 10.1 20.6 20.9 4.2 13.3 13.5 8.4 22.0 5.2 7.1 27.1 14.5 10.3 10.0 19.0 10.9 7.7 16.3 18.7 11.1 7.4 8.3 29.9 15.0 14.9 15.2 16.7 18.4 22.2 42.5 33.1 16.1 33.2 15.0 12.9 12.3 3.5 9.0 6.0 4.3 9.8 12.0 5.9 5.9 6.8 6.5 31.4 2.3 6.4 7.5 10.9 12.2 3.2 17.3 1.6 14.6 11.1 4.9 10.5 6.7 10.1 15.5 7.2 6.5 10.2 6.6 4.2 9.1 6.7 5.2 6.8 4.8 4.4 14.0 4.4 71.8 11.7 10.2 14.8 5.4 1.7 10.8 8.7 8.0 9.3 11.1 2.8 8.4 12.5 3.8 22.1 29.5 9.8 4.7 8.3 5.9 9.5 3.2 1.4 3.5 13.7 39.7 7.5 21.0 21.4 42.5 29.9 26.4 25.3 18.4 19.3 33.2 22.2 14.8 9.9 17.3 16.8 16.1 33.1 17.4 12.6 15.0 10.3 10.7 20.2 13.0 9.6 10.1 9.1 10.1 8.4 7.4 35.7 29.0 29.6 60.0 27.8 6.7 4.6 28.1 29.4 21.6 43.6 7.9 55.4 3.3 85.0 10.1 33.1 37.5 0.0 39.9 70.0 33.4 67.6 32.3 2.9 65.2 14.3 27.1 38.6 37.6 12.2 33.6 46.5 40.5 72.1 34.1 9.8 74.5 42.1 21.2 17.3 9.4 90.5 37.6 14.3 16.0 23.5 70.0 69.2 41.7 89.7 MFSD11 "FLJ20226, FLJ22196" ENSG00000092931 "Major facilitator superfamily domain containing 11" O43934 17 76735865-76781449 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 231.7;Early spermatids: 185.4;Late spermatids: 141.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022001 Uncertain Approved "Nuclear speckles" Yes No "Nuclear speckles" "HPA022001: AB_2297599" "unprognostic (2.84e-2)" "unprognostic (1.22e-1)" "unprognostic (2.43e-2)" "prognostic unfavorable (7.69e-4)" "unprognostic (4.87e-2)" "unprognostic (1.17e-1)" "unprognostic (1.78e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-3)" "unprognostic (1.68e-2)" "unprognostic (2.06e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-1)" "unprognostic (1.18e-2)" "unprognostic (6.98e-2)" "prognostic unfavorable (7.90e-4)" 17.2 20.7 13.9 14.3 21.3 15.6 18.7 20.4 25.0 18.0 20.9 19.6 16.9 17.4 18.8 18.8 24.1 13.4 14.3 23.5 13.3 14.8 13.3 19.2 17.4 22.0 20.1 16.1 14.4 17.4 24.6 27.9 27.4 18.1 14.8 22.8 32.8 21.3 17.3 26.8 20.8 17.7 16.8 17.9 19.0 21.7 28.6 19.7 15.6 18.0 16.8 18.6 16.8 21.6 8.0 14.9 16.7 16.1 6.3 18.3 8.2 13.8 7.9 9.3 8.8 20.0 12.2 10.9 12.3 11.5 11.9 10.6 15.8 25.4 11.2 10.5 12.5 13.1 13.6 6.5 6.4 12.4 5.1 13.1 11.3 14.9 10.9 9.6 6.0 11.2 14.4 10.5 15.2 6.9 17.3 22.6 15.1 13.5 16.8 15.1 10.6 13.5 9.8 3.9 15.8 4.6 10.7 12.1 23.3 9.2 10.3 9.0 15.2 11.8 16.8 10.5 14.3 29.5 9.2 15.9 21.7 10.7 13.6 10.2 18.7 7.4 17.0 16.8 5.3 14.3 11.2 14.1 11.3 15.2 16.1 6.4 7.5 13.6 15.3 14.9 8.0 8.5 10.6 16.7 6.3 12.5 10.7 18.3 8.2 13.9 21.3 20.4 25.0 13.3 14.8 20.1 16.1 18.1 19.7 11.9 12.3 7.5 17.8 14.9 36.0 15.1 10.2 4.0 14.8 14.0 231.7 33.6 5.0 13.3 185.4 14.8 23.9 0.0 15.9 60.6 17.0 13.3 26.5 15.6 29.3 38.1 16.1 17.2 21.9 141.7 17.0 18.6 18.6 21.6 14.2 18.8 16.6 10.5 13.1 8.7 96.6 6.5 12.8 33.4 10.4 15.1 34.6 17.5 14.3 12.5 MFSD12 "C19orf28, MGC20700, PP3501" ENSG00000161091 "Major facilitator superfamily domain containing 12" Q6NUT3 19 3538261-3574290 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 101.3;Extravillous trophoblasts: 117.0;Melanocytes: 185.5" "Cancer enriched" "Detected in all" 7 "melanoma: 124.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-MEL-30: 59.6;WM-115: 113.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042149, HPA043088" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA042149: AB_2677875, HPA043088: AB_2678308" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "prognostic favorable (5.66e-6)" "unprognostic (1.56e-2)" "unprognostic (6.51e-2)" "prognostic unfavorable (6.61e-4)" "prognostic unfavorable (2.34e-4)" "unprognostic (3.19e-2)" "unprognostic (9.12e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.13e-1)" "prognostic favorable (7.70e-4)" "unprognostic (1.95e-1)" "unprognostic (3.90e-2)" "unprognostic (1.73e-1)" 25.9 13.0 15.4 19.0 14.4 23.5 9.3 10.4 22.9 8.1 8.9 24.3 11.2 12.5 10.2 12.7 11.1 14.3 10.0 7.6 23.9 12.8 38.0 21.5 13.8 15.2 20.7 10.0 9.7 19.8 15.7 11.9 46.6 15.6 10.2 5.7 13.5 23.7 10.5 8.1 43.6 13.8 9.9 18.6 19.7 14.1 7.5 16.1 37.0 9.1 6.1 11.8 7.9 7.8 2.4 12.9 2.6 7.9 0.5 3.1 1.6 17.0 13.8 3.4 8.9 7.1 5.5 12.3 10.5 5.7 12.3 13.5 5.9 5.8 4.8 8.0 5.5 19.6 10.7 4.4 5.4 4.4 10.5 12.5 2.8 44.2 6.0 8.9 6.0 9.5 4.9 8.2 12.6 2.9 4.7 3.3 7.2 13.4 7.0 3.1 10.2 5.9 10.8 6.4 7.5 11.2 4.3 4.9 20.3 5.1 7.3 12.9 6.5 20.7 9.7 59.6 4.4 3.3 12.6 13.5 5.6 8.2 22.7 11.8 8.0 4.5 4.4 24.6 15.6 113.8 0.1 4.0 2.6 2.1 7.9 2.1 2.4 3.1 1.6 2.8 1.7 2.7 2.1 1.3 0.5 7.6 12.9 0.5 1.6 15.4 14.4 10.4 22.9 23.9 12.8 20.7 10.0 15.6 16.1 6.0 3.2 15.2 3.8 23.6 15.8 1.6 12.7 4.0 4.5 19.2 5.9 10.7 0.0 19.3 101.3 10.8 13.8 0.0 26.4 117.0 8.0 13.6 0.0 19.2 73.9 35.0 26.9 8.6 19.6 20.9 2.3 32.4 185.5 19.8 9.3 8.3 29.4 17.3 3.2 33.8 11.5 12.9 5.0 4.2 9.1 22.2 77.5 7.5 8.6 13.2 MFSD13A "bA18I14.8, C10orf77, FLJ22529, TMEM180" ENSG00000138111 "Major facilitator superfamily domain containing 13A" Q14CX5 10 102461395-102477045 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9;Horizontal cells: 20.6;Syncytiotrophoblasts: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018031 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA018031: AB_2204891" "unprognostic (2.24e-2)" "prognostic favorable (8.29e-4)" "unprognostic (7.73e-2)" "unprognostic (1.13e-1)" "unprognostic (2.79e-1)" "unprognostic (2.11e-1)" "unprognostic (9.16e-3)" "unprognostic (4.70e-2)" "unprognostic (4.03e-2)" "unprognostic (8.10e-2)" "unprognostic (2.04e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.66e-3)" "unprognostic (2.44e-1)" "unprognostic (2.74e-1)" "unprognostic (4.02e-2)" 3.8 3.3 8.8 5.9 15.7 9.0 2.6 18.0 18.7 2.4 7.0 8.5 0.4 10.2 4.3 1.8 3.0 2.4 4.7 5.2 9.0 6.5 3.3 5.7 14.1 5.6 7.9 8.7 2.3 5.1 2.8 4.4 7.2 8.2 3.1 6.4 3.9 3.0 2.3 3.9 17.4 7.5 4.9 5.2 6.9 7.1 5.8 8.6 2.3 5.7 1.8 6.7 3.1 2.5 5.0 7.5 5.5 7.2 2.2 5.8 3.4 9.3 4.3 3.3 7.9 0.3 0.3 5.1 1.9 4.9 3.7 8.7 8.5 12.9 8.4 9.8 0.7 3.6 11.7 6.2 5.0 1.4 10.6 5.5 10.3 6.1 4.4 8.5 5.2 10.1 4.3 2.1 2.1 3.8 3.1 4.3 11.4 2.3 4.6 0.3 1.9 8.7 3.4 5.6 8.2 4.2 10.6 0.5 1.4 1.7 2.5 8.2 7.8 1.8 1.0 4.2 1.2 4.8 3.5 1.3 1.7 2.1 2.1 2.6 1.6 4.1 10.9 9.6 8.6 2.4 0.7 7.2 5.5 5.2 5.3 5.2 5.0 5.0 4.1 7.5 2.8 5.2 5.8 4.4 2.2 3.0 0.8 1.4 3.4 8.8 15.7 18.0 18.7 9.0 6.5 7.9 8.7 8.2 8.6 17.9 9.6 0.0 1.2 0.0 6.8 0.0 2.5 1.4 1.2 1.8 3.9 1.5 0.0 2.4 1.1 2.3 2.9 0.0 3.2 2.5 0.7 1.4 1.1 4.9 15.8 20.6 2.4 4.9 3.5 0.4 0.9 7.8 0.0 4.6 3.9 3.0 2.8 5.7 2.1 1.2 13.5 0.0 0.0 3.4 2.9 0.0 23.8 1.5 6.0 0.9 MFSD14A "DKFZP564L0864, HIAT1" ENSG00000156875 "Major facilitator superfamily domain containing 14A" Q96MC6 1 100038097-100083377 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 248.4;Late spermatids: 274.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA073127, HPA073681" Approved Approved Vesicles NA NA Vesicles "HPA073127: , HPA073681: AB_2686625" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.18e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (2.16e-1)" "unprognostic (7.75e-2)" "unprognostic (2.39e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-1)" "unprognostic (1.18e-1)" "unprognostic (2.41e-1)" "unprognostic (3.84e-1)" "unprognostic (1.05e-1)" "unprognostic (5.15e-2)" 24.3 23.7 21.8 23.9 23.5 55.7 34.7 16.3 28.3 22.0 23.5 30.2 21.2 14.7 29.4 20.6 24.5 22.9 19.3 17.0 19.9 20.8 22.7 21.7 27.1 24.1 24.5 16.8 27.0 29.2 92.6 19.4 25.0 23.6 26.0 17.1 20.5 23.0 32.0 18.8 22.4 18.5 29.3 33.9 20.6 21.7 28.3 22.3 24.4 21.3 15.9 21.0 23.0 22.9 24.1 27.0 47.1 28.1 26.9 29.8 30.8 23.5 9.8 22.2 11.4 26.0 24.7 18.7 17.3 29.6 23.5 27.5 8.3 16.5 17.7 28.3 22.4 15.5 22.7 19.7 19.0 22.6 15.4 15.6 17.4 15.0 12.4 23.0 28.0 22.9 20.1 29.2 20.7 26.6 20.8 18.0 20.1 21.3 34.8 21.6 6.9 21.0 16.5 25.5 11.5 14.5 14.8 27.1 17.3 25.1 20.7 23.1 20.6 19.5 28.5 28.5 14.7 11.0 28.6 19.7 19.4 13.7 20.3 17.8 33.2 34.9 24.7 21.1 20.5 8.3 32.8 28.1 26.1 25.9 25.2 29.2 24.1 26.5 28.3 27.0 19.4 29.8 27.6 47.1 26.9 20.7 12.6 28.6 30.8 21.8 23.5 16.3 28.3 19.9 20.8 24.5 16.8 23.6 22.3 6.0 8.6 16.2 37.8 0.0 16.3 0.0 25.5 10.7 6.8 3.5 9.8 31.3 1.7 8.7 248.4 19.6 4.3 46.7 6.2 26.8 8.2 35.5 2.3 14.3 20.0 12.7 12.9 17.2 28.9 274.7 21.0 4.2 0.0 7.2 13.2 20.5 5.7 19.3 28.7 0.6 10.5 12.9 0.0 16.3 20.7 0.0 48.7 13.8 13.6 47.7 MFSD14B "FLJ14753, HIATL1" ENSG00000148110 "Major facilitator superfamily domain containing 14B" Q5SR56 9 94374551-94461042 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.0" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017978 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017978: AB_2116836" "unprognostic (3.03e-2)" "unprognostic (2.28e-1)" "unprognostic (3.96e-3)" "unprognostic (5.95e-3)" "unprognostic (1.39e-1)" "unprognostic (3.29e-2)" "unprognostic (4.13e-3)" "unprognostic (3.27e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-2)" "unprognostic (1.16e-2)" "unprognostic (3.11e-3)" "unprognostic (1.15e-1)" "unprognostic (9.12e-2)" "unprognostic (6.63e-2)" "unprognostic (1.93e-1)" "unprognostic (9.01e-2)" 15.1 18.9 13.3 14.3 14.7 9.0 20.2 11.6 12.8 14.9 14.2 19.7 15.5 9.9 18.6 16.1 28.1 14.4 12.5 13.4 13.3 12.4 14.7 9.0 25.7 21.5 14.6 7.8 15.9 21.5 86.0 9.2 24.2 28.3 14.5 15.4 21.6 15.9 14.2 7.3 21.8 16.0 12.8 19.1 19.3 13.0 9.2 13.2 24.0 16.7 14.2 23.9 14.1 18.8 4.6 7.8 10.4 11.4 3.6 7.1 3.6 25.9 16.7 13.1 10.2 28.8 20.7 20.9 25.3 22.0 22.5 22.1 8.4 31.1 31.3 15.1 21.7 26.1 57.4 15.6 16.1 22.0 22.3 8.4 10.7 16.1 12.6 20.5 33.8 20.0 18.9 24.4 23.8 18.3 12.6 19.2 17.2 20.3 18.6 29.9 19.7 24.7 19.4 19.2 38.0 13.5 12.4 30.1 10.1 24.0 20.0 12.6 16.6 21.5 25.5 26.7 16.4 11.6 20.0 20.6 23.6 16.7 36.2 23.3 20.6 25.5 8.6 21.0 16.6 21.1 0.6 7.9 5.9 5.6 11.4 5.1 4.6 5.1 5.6 7.8 2.9 5.1 7.1 10.4 3.6 7.7 7.7 5.1 3.6 13.3 14.7 11.6 12.8 13.3 12.4 14.6 7.8 28.3 13.2 6.0 21.9 13.7 20.2 0.0 11.2 0.0 17.8 13.4 12.5 41.8 3.9 12.4 6.6 15.2 2.6 11.3 7.1 0.0 16.4 22.4 13.2 30.5 3.5 10.4 25.8 4.8 7.0 27.0 63.5 2.1 15.5 18.5 0.0 10.8 26.6 18.1 22.0 15.8 15.2 5.7 9.1 12.9 0.0 10.4 17.5 0.0 16.0 13.8 14.9 41.4 MFSD14C "HIATL2, MGC12945" ENSG00000196312 "Major facilitator superfamily domain containing 14C" Q5VZR4 9 96887373-97013708 "Predicted membrane proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 25.4;Club cells: 38.7;Collecting duct cells: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 21.3" NA NA "unprognostic (3.81e-2)" "unprognostic (8.73e-2)" "unprognostic (1.27e-1)" "unprognostic (3.74e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (5.34e-2)" "unprognostic (4.26e-2)" "unprognostic (1.38e-2)" "unprognostic (8.78e-2)" "unprognostic (3.94e-1)" "unprognostic (3.29e-1)" "unprognostic (5.42e-2)" "unprognostic (3.12e-1)" 6.6 6.0 9.1 8.2 14.1 10.9 10.7 8.1 11.2 9.4 5.0 6.3 4.9 4.8 7.6 10.5 9.3 5.5 7.7 7.3 7.8 5.0 5.2 7.4 8.3 7.3 9.5 6.6 13.0 8.8 4.6 6.0 5.3 6.0 9.9 4.0 7.1 7.9 8.4 8.3 13.2 4.8 10.8 5.9 6.5 8.0 11.3 6.7 4.5 8.1 2.8 6.4 7.3 11.7 2.5 2.9 9.3 2.4 0.7 1.6 0.4 5.3 1.2 2.3 1.3 1.5 8.3 3.3 2.8 0.9 3.4 3.2 3.5 1.9 1.4 0.8 3.7 9.1 4.9 21.3 2.4 4.2 10.8 10.5 9.0 2.5 2.8 0.1 2.0 4.6 3.0 2.9 2.2 1.0 3.2 2.8 4.2 3.2 2.2 7.0 1.0 6.8 1.8 2.2 1.9 6.5 2.2 2.1 0.6 6.6 3.2 11.0 1.1 0.6 1.2 1.8 2.3 1.3 1.9 2.3 5.0 1.6 1.3 1.8 1.2 0.5 4.9 8.4 0.8 2.1 9.3 2.4 2.0 1.5 2.2 0.5 2.5 0.7 0.5 0.8 2.1 1.6 1.4 4.9 0.7 1.4 2.9 0.5 0.4 9.1 14.1 8.1 10.6 7.8 5.0 9.5 6.6 6.0 6.7 20.8 20.5 0.0 4.9 0.0 4.9 0.0 5.1 25.4 38.7 26.2 5.9 1.1 8.3 11.9 5.2 2.0 0.0 0.0 10.8 1.0 0.0 3.6 11.6 0.4 1.5 4.8 0.0 0.0 2.8 1.3 1.4 5.3 0.0 12.6 0.4 2.8 9.6 0.0 1.8 4.5 7.6 0.0 0.0 3.9 5.8 0.0 0.5 0.0 0.4 6.8 MFSD2A "FLJ14490, MFSD2" ENSG00000168389 "Major facilitator superfamily domain containing 2A" Q8NA29 1 39955112-39969968 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Symport, Transport" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 112.2;Enterocytes: 112.9;Hepatocytes: 268.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7" "Group enriched" "Detected in many" 11 "dendritic cells: 16.7;monocytes: 9.3" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.9;THP-1: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043107 Uncertain Approved "Plasma membrane,Cytosol,Cytoplasmic bodies" NA NA Cytosol "Plasma membrane, Cytoplasmic bodies" "HPA043107: AB_10794387" "unprognostic (2.20e-1)" "unprognostic (1.15e-1)" "unprognostic (5.23e-3)" "unprognostic (1.06e-1)" "unprognostic (1.30e-1)" "unprognostic (6.92e-2)" "unprognostic (2.61e-2)" "unprognostic (2.45e-2)" "unprognostic (1.60e-1)" "unprognostic (4.33e-1)" "unprognostic (2.85e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.22e-6)" "unprognostic (9.26e-2)" "unprognostic (4.11e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.33e-4)" 2.0 0.9 6.0 1.6 7.2 3.3 6.2 2.4 6.5 1.6 5.6 4.3 96.9 6.4 4.3 45.0 5.0 1.5 1.2 0.7 7.6 6.1 7.2 87.9 15.8 1.1 7.5 2.6 0.8 0.5 0.3 3.0 111.3 7.8 1.0 2.5 2.0 1.7 121.2 0.3 27.0 20.4 1.8 7.3 0.8 1.0 17.7 2.3 0.2 2.9 4.7 1.7 2.6 4.6 1.1 16.7 0.9 9.3 0.1 0.1 2.3 2.1 0.9 4.5 6.8 3.2 0.6 0.0 2.0 4.0 4.6 5.5 0.2 1.2 13.3 1.2 1.0 3.2 5.3 4.4 7.7 3.6 1.7 2.1 1.6 0.0 0.0 10.7 2.3 7.9 3.6 4.8 18.9 7.8 0.8 1.1 4.1 0.0 3.4 2.0 0.2 3.6 3.6 3.6 7.4 1.6 2.5 6.6 3.0 0.7 6.3 1.6 2.4 1.6 11.4 1.1 0.4 0.5 59.5 0.7 1.0 2.0 3.4 8.7 0.6 1.2 2.9 10.6 9.0 3.3 0.0 9.3 0.9 0.1 4.6 0.1 1.1 0.0 0.1 10.3 0.2 0.0 0.0 0.5 0.1 0.8 16.7 0.0 2.3 6.0 7.2 2.4 6.5 7.6 6.1 7.5 2.6 7.8 2.3 17.9 112.2 11.5 13.4 46.9 1.9 0.6 12.7 12.0 31.8 15.7 0.0 0.3 0.0 3.2 0.6 6.7 112.9 0.0 22.5 6.5 9.7 5.7 17.3 268.3 6.4 0.0 1.2 10.4 12.4 0.9 0.6 11.4 0.0 2.8 16.4 41.8 16.3 3.5 0.4 3.7 1.8 0.0 3.4 1.1 1.0 47.9 43.9 2.2 10.0 23.0 MFSD2B ENSG00000205639 "Major facilitator superfamily domain containing 2B" A6NFX1 2 24010081-24063321 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 17.4;brain: 7.5;placenta: 7.5" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 46.7;Glandular cells: 24.5;Urothelial cells: 32.0" "Not detected" "Not detected" "Region enriched" "Detected in single" 16 "basal ganglia: 7.5" "Cell type enriched" "Detected in some" 4 "basophil: 5.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 5.5" "Group enriched" "Detected in some" 14 "HEL: 13.1;K-562: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044145 Enhanced NA NA "HPA044145: AB_2678833" "unprognostic (5.67e-2)" "unprognostic (1.25e-3)" "unprognostic (1.84e-1)" "unprognostic (5.35e-5)" "unprognostic (2.82e-1)" "unprognostic (1.74e-1)" "unprognostic (4.26e-2)" "unprognostic (7.47e-2)" "unprognostic (2.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.21e-3)" "unprognostic (1.90e-2)" "unprognostic (6.87e-6)" "unprognostic (7.76e-2)" "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.72e-1)" 0.2 0.1 0.1 0.6 7.5 17.4 0.2 0.1 0.3 0.3 0.4 0.0 1.1 0.3 0.5 0.3 0.1 0.2 0.2 0.5 0.1 0.4 0.1 0.4 3.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 7.5 0.3 1.2 0.2 0.2 1.0 0.1 0.5 0.2 0.2 0.1 0.3 2.3 0.2 2.0 0.0 0.1 0.1 0.0 0.4 0.8 1.8 0.0 0.2 5.5 0.0 0.2 0.0 3.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 5.6 0.0 0.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.0 3.4 0.1 7.5 0.1 0.3 0.1 0.4 0.3 0.0 0.3 0.0 0.0 2.2 1.5 12.3 9.0 0.6 3.9 2.5 0.0 0.0 0.0 3.9 5.7 3.3 1.2 0.5 1.4 0.9 46.7 1.6 3.6 1.8 24.5 4.7 0.0 2.8 0.0 1.2 0.0 0.8 0.2 0.0 1.1 0.0 0.0 3.3 0.2 6.3 2.9 0.0 0.0 1.3 0.0 0.9 0.6 2.5 9.8 6.3 1.5 4.7 32.0 MFSD3 ENSG00000167700 "Major facilitator superfamily domain containing 3" Q96ES6 8 144509074-144511213 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056013 Uncertain Approved Vesicles NA NA Vesicles "HPA056013: AB_2683009" "unprognostic (7.92e-2)" "prognostic unfavorable (5.08e-4)" "unprognostic (2.00e-1)" "unprognostic (5.18e-2)" "unprognostic (6.50e-2)" "unprognostic (3.74e-2)" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (9.41e-2)" "unprognostic (1.06e-1)" "unprognostic (5.49e-2)" "unprognostic (5.29e-2)" "prognostic favorable (5.44e-7)" "unprognostic (4.08e-3)" "unprognostic (2.37e-1)" "unprognostic (1.50e-1)" "unprognostic (9.81e-2)" 7.7 12.3 12.5 7.4 12.5 3.0 7.2 12.0 17.3 5.6 12.7 5.6 19.6 19.8 4.3 12.5 8.0 6.3 10.3 10.2 8.8 9.2 17.7 21.2 8.0 6.4 10.0 15.3 3.5 19.2 14.3 9.7 4.8 10.4 10.5 5.5 5.0 24.0 9.4 23.5 11.3 13.1 3.0 4.6 6.4 12.7 4.1 9.1 4.2 12.8 8.7 5.5 5.8 4.9 4.7 17.2 3.4 6.6 3.2 4.0 3.2 7.8 10.9 2.7 2.3 3.0 2.3 9.0 2.5 2.7 1.4 2.1 3.6 5.6 11.5 8.9 2.4 2.9 7.7 1.3 6.0 0.2 5.4 22.2 3.6 9.7 8.9 5.8 1.7 5.1 3.4 11.4 0.9 4.0 6.3 3.7 8.1 6.8 3.1 3.4 26.3 4.3 9.2 7.3 11.3 18.7 4.9 1.5 20.1 6.7 4.7 20.1 10.1 6.5 16.1 5.4 1.8 16.8 2.5 3.9 1.9 5.1 2.1 3.5 3.1 1.2 3.9 4.1 5.6 3.3 1.6 6.6 3.4 3.7 5.6 3.5 4.7 3.6 3.8 9.9 2.4 3.5 3.5 0.4 3.2 3.1 17.2 4.0 3.2 12.5 12.5 12.0 17.3 8.8 9.2 10.0 15.3 10.4 9.1 3.0 3.0 13.7 9.1 5.4 8.0 8.5 25.5 0.0 3.4 26.2 9.8 13.2 31.5 15.6 0.4 3.7 33.3 23.3 18.4 11.6 4.1 11.3 0.0 16.3 13.7 15.9 19.0 2.5 2.8 0.2 4.0 6.8 8.5 4.6 15.9 14.3 14.0 17.8 4.6 53.6 9.1 0.0 2.3 3.2 12.6 6.1 7.8 2.9 24.5 6.7 MFSD4A "DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064" ENSG00000174514 "Major facilitator superfamily domain containing 4A" Q8N468 1 205568885-205602918 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9;kidney: 37.6;stomach 1: 60.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 6.0;Ciliated cells: 5.3;Club cells: 11.4;Collecting duct cells: 8.7;Distal tubular cells: 11.6;Exocrine glandular cells: 5.6;Proximal tubular cells: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 2.1;HAP1: 2.7;HMC-1: 4.6;SCLC-21H: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 17.1;cerebellum: 24.8;cerebral cortex: 56.2;hippocampal formation: 32.0" NA NA "unprognostic (7.15e-4)" "prognostic favorable (7.54e-4)" "unprognostic (5.60e-2)" "unprognostic (1.38e-1)" "unprognostic (2.09e-1)" "unprognostic (1.56e-2)" "unprognostic (1.25e-1)" "prognostic favorable (4.59e-4)" "unprognostic (2.73e-2)" "unprognostic (1.65e-2)" "unprognostic (3.20e-2)" "unprognostic (6.97e-3)" "prognostic favorable (2.27e-13)" "unprognostic (1.58e-1)" "unprognostic (4.44e-2)" "unprognostic (5.75e-3)" "unprognostic (8.78e-2)" 1.7 0.6 17.3 0.8 10.6 0.3 2.1 18.8 24.9 4.9 7.3 1.3 0.0 1.2 0.8 5.2 1.0 1.6 11.1 0.8 11.9 4.3 37.6 0.5 3.8 0.5 3.6 13.3 0.6 1.0 0.4 3.2 3.5 8.4 1.1 9.5 2.4 8.6 0.6 0.6 3.3 1.1 0.7 2.8 0.6 60.0 0.5 0.2 0.0 0.7 0.8 2.8 0.9 0.8 1.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.2 0.8 0.1 0.8 0.0 0.1 2.1 2.7 0.0 0.0 0.0 1.1 0.0 0.0 0.9 0.0 0.0 4.6 0.2 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.2 0.5 5.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.6 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.3 0.1 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 17.3 10.6 18.8 24.9 11.9 4.3 3.6 13.3 8.4 0.2 6.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.3 11.4 8.7 0.0 0.5 11.6 1.2 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MFSD4B "KIAA1919, MGC33953" ENSG00000173214 "Major facilitator superfamily domain containing 4B" Q5TF39 6 111259348-111271167 "Predicted membrane proteins" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 40.3;Ciliated cells: 18.7;Club cells: 25.0;Cytotrophoblasts: 18.5;granulocytes: 18.6;Syncytiotrophoblasts: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 15.7" "Low region specificity" "Detected in all" HPA031784 Approved NA NA "HPA031784: AB_10603775" "unprognostic (2.98e-2)" "unprognostic (1.64e-2)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (1.94e-1)" "unprognostic (3.07e-2)" "unprognostic (7.50e-5)" "unprognostic (3.51e-2)" "unprognostic (2.33e-1)" "unprognostic (6.84e-2)" "unprognostic (2.94e-2)" "unprognostic (3.41e-1)" "unprognostic (6.04e-3)" "unprognostic (9.27e-2)" "unprognostic (3.68e-1)" "unprognostic (6.32e-2)" "unprognostic (1.98e-4)" 4.7 5.8 5.3 7.2 8.7 4.6 6.4 5.5 6.6 6.4 8.3 4.1 7.8 9.1 6.8 10.1 5.4 5.9 3.9 5.5 3.4 3.5 13.3 8.4 5.4 5.0 3.2 2.6 5.7 6.2 6.0 12.3 26.1 3.3 5.2 5.3 6.9 7.8 8.0 6.1 8.3 14.6 4.0 3.6 5.9 5.3 9.1 3.0 8.1 6.5 2.7 7.6 5.0 5.3 6.0 4.0 3.6 3.3 2.4 3.7 1.8 1.5 2.6 3.0 6.9 2.3 1.4 5.3 2.0 2.4 2.7 3.5 5.5 2.9 3.9 3.1 1.7 2.6 3.8 5.1 1.9 3.6 3.0 2.2 5.4 4.3 4.4 3.3 4.9 8.7 1.3 4.0 3.3 2.1 3.9 2.1 5.8 6.0 4.9 2.9 2.5 3.4 3.1 2.1 2.4 1.0 3.7 2.1 1.8 4.5 3.2 2.5 2.4 2.3 2.6 1.4 2.9 2.0 4.4 3.1 3.3 2.1 15.7 3.2 3.5 2.7 3.9 4.0 3.1 3.3 3.0 3.3 3.6 3.7 3.1 3.6 6.0 2.1 2.9 2.5 3.9 3.1 3.5 3.5 2.4 2.3 4.0 1.5 1.8 5.3 8.7 5.5 6.6 3.4 3.5 3.2 2.6 3.3 3.0 8.9 40.3 0.0 0.0 0.0 0.0 0.0 0.0 18.7 25.0 5.2 0.0 18.5 1.7 4.8 0.0 0.0 0.0 0.0 3.1 10.5 0.0 0.0 18.6 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 4.6 0.0 0.0 3.9 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 0.0 0.0 MFSD5 "HsMOT2, MGC11308" ENSG00000182544 "Major facilitator superfamily domain containing 5" Q6N075 12 53251251-53254405 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039773 Uncertain NA NA "HPA039773: AB_10793920" "unprognostic (9.42e-3)" "unprognostic (9.03e-3)" "unprognostic (4.25e-2)" "unprognostic (1.10e-1)" "unprognostic (1.37e-2)" "unprognostic (5.04e-2)" "prognostic unfavorable (1.43e-6)" "unprognostic (2.20e-2)" "unprognostic (1.69e-1)" "unprognostic (4.25e-1)" "unprognostic (9.79e-2)" "unprognostic (4.52e-2)" "unprognostic (5.63e-2)" "unprognostic (1.65e-2)" "unprognostic (2.12e-1)" "unprognostic (6.51e-3)" "unprognostic (1.19e-2)" 13.8 20.2 9.8 12.1 11.1 16.1 25.2 7.9 17.4 14.0 14.3 12.1 9.6 11.4 11.8 11.5 38.6 11.9 12.9 14.7 9.9 10.7 17.7 13.6 13.1 18.6 11.3 8.8 14.5 20.2 17.0 8.5 26.4 10.0 12.4 12.8 9.9 19.9 13.4 17.2 37.2 17.8 11.5 10.0 14.5 12.3 12.3 7.9 13.8 16.6 17.5 20.9 13.2 18.7 18.9 16.3 41.9 13.7 11.1 15.0 8.8 10.7 23.8 7.2 13.1 28.0 16.1 8.4 16.2 20.4 17.4 16.5 12.5 20.5 8.9 14.2 23.2 16.5 20.2 11.7 13.4 11.6 11.4 16.4 6.8 9.3 16.4 19.6 12.9 17.1 19.9 18.8 16.4 8.2 18.9 15.8 8.8 12.5 16.3 16.6 40.8 6.3 16.0 12.5 12.5 21.0 7.8 7.3 12.0 12.6 19.0 6.0 9.0 11.6 16.2 12.6 8.9 28.2 12.1 15.0 14.9 9.7 15.2 10.4 9.9 12.0 7.0 19.7 12.6 14.2 21.4 13.7 41.9 12.1 10.6 15.0 18.9 14.3 13.7 16.3 16.8 10.6 10.3 7.6 11.1 7.1 13.7 11.2 8.8 9.8 11.1 7.9 17.4 9.9 10.7 11.3 8.8 10.0 7.9 8.9 11.7 7.1 5.0 11.6 4.7 7.3 7.6 5.3 15.9 12.2 29.5 33.6 5.0 17.3 0.4 9.0 11.2 0.0 23.0 20.0 13.8 6.8 5.7 10.2 24.7 3.2 2.4 13.5 14.3 1.1 5.8 11.9 15.1 13.6 11.8 7.5 18.9 13.6 4.6 8.6 13.7 6.5 4.2 4.6 14.0 14.9 27.8 9.6 6.8 7.8 MFSD6 FLJ20160 ENSG00000151690 "Major facilitator superfamily domain containing 6" Q6ZSS7 2 190408355-190509205 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022274 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA022274: AB_2142776" "unprognostic (9.47e-2)" "unprognostic (7.01e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-2)" "unprognostic (2.49e-1)" "unprognostic (4.13e-3)" "unprognostic (1.78e-2)" "unprognostic (3.08e-2)" "unprognostic (3.92e-1)" "unprognostic (3.77e-1)" "unprognostic (9.54e-2)" "unprognostic (2.08e-1)" "prognostic favorable (1.05e-4)" "unprognostic (3.46e-2)" "unprognostic (3.27e-1)" "unprognostic (9.14e-2)" "unprognostic (9.18e-2)" 12.3 26.9 20.8 9.3 23.3 4.2 13.8 19.4 33.1 15.3 20.0 29.0 29.0 12.6 7.1 22.3 26.6 13.0 10.3 11.1 25.4 26.5 7.4 2.0 16.9 8.7 36.2 22.9 3.5 10.9 28.2 35.7 5.6 43.1 15.7 19.0 12.2 19.2 29.6 3.8 18.9 15.4 9.5 36.7 12.7 20.2 4.9 18.3 13.0 25.5 10.8 12.7 13.3 13.6 2.4 2.6 8.1 2.0 3.3 5.6 1.2 10.6 6.6 0.2 2.3 4.8 6.2 9.1 5.5 11.1 3.7 4.7 2.4 13.6 16.7 2.6 11.4 7.0 18.2 3.2 9.6 4.2 33.9 5.0 8.9 6.5 1.2 1.9 3.5 2.8 0.9 17.5 5.5 3.6 12.2 1.3 13.3 2.2 18.6 0.9 4.1 16.3 0.7 1.5 11.6 7.1 3.6 0.5 14.3 7.1 19.5 21.2 5.4 7.8 18.4 10.6 0.7 6.0 4.1 5.5 0.6 1.3 7.3 8.4 8.6 3.5 6.0 6.1 7.3 3.0 8.1 2.0 0.6 2.6 0.6 2.7 2.4 3.5 3.6 2.6 1.3 1.6 3.6 0.1 3.3 0.9 1.3 5.6 1.2 20.8 23.3 19.4 33.1 25.4 26.5 36.2 22.9 43.1 18.3 29.8 21.2 3.9 9.9 5.7 8.3 17.9 5.1 108.4 37.5 22.7 7.9 0.1 0.0 12.6 37.9 12.8 13.4 0.0 17.7 0.1 2.3 15.4 22.1 0.6 4.2 27.0 34.0 11.1 2.1 9.9 5.2 9.2 8.5 4.6 38.6 7.1 20.1 17.5 4.9 1.3 7.7 0.0 3.1 0.9 1.1 15.9 0.0 10.2 14.4 19.0 MFSD6L FLJ35773 ENSG00000185156 "Major facilitator superfamily domain containing 6 like" Q8IWD5 17 8797162-8799349 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 8.5;testis: 20.1" "Group enriched" "Detected in some" 6 "Early spermatids: 104.1;Late spermatids: 27.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.4" "Cell line enriched" "Detected in some" 6 "HMC-1: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA023164 Uncertain NA NA "HPA023164: AB_2142777" "prognostic favorable (1.84e-4)" "unprognostic (1.70e-1)" "unprognostic (1.04e-1)" "unprognostic (3.64e-2)" "unprognostic (1.07e-4)" "unprognostic (3.31e-1)" "unprognostic (1.33e-1)" "unprognostic (2.32e-1)" "unprognostic (2.77e-1)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" "unprognostic (7.26e-2)" "unprognostic (3.98e-3)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (7.68e-3)" "unprognostic (1.25e-1)" 0.5 0.0 0.5 3.2 0.5 0.0 0.5 0.5 0.5 1.4 2.1 0.5 0.5 1.8 0.5 0.9 0.5 1.6 0.5 0.5 0.5 0.0 1.1 0.5 2.2 0.5 0.5 0.5 0.5 8.5 4.8 4.3 0.5 0.5 0.5 2.6 0.5 5.5 1.8 0.5 0.2 1.0 0.5 0.5 0.5 3.4 20.1 0.5 0.5 3.1 0.5 0.5 0.7 0.5 0.0 0.3 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.1 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.5 0.5 0.0 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 2.3 0.0 6.0 104.1 0.0 0.0 0.0 6.7 0.1 0.0 0.6 0.0 0.0 0.6 0.0 1.2 0.0 0.8 27.4 0.9 0.0 0.0 0.0 5.8 0.0 3.0 0.0 1.1 0.0 0.0 0.0 0.1 10.7 0.2 0.0 1.3 0.0 3.7 0.6 MFSD8 "CLN7, MGC33302" ENSG00000164073 "Major facilitator superfamily domain containing 8" Q8NHS3 4 127917732-127966034 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044802 Approved Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA044802: AB_10963221" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (8.10e-2)" "unprognostic (1.57e-1)" "unprognostic (4.12e-2)" "unprognostic (1.18e-1)" "unprognostic (8.99e-2)" "unprognostic (2.19e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (3.44e-2)" "unprognostic (3.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.61e-3)" "unprognostic (3.14e-1)" "prognostic favorable (2.21e-4)" 8.9 9.6 9.1 11.7 15.4 5.3 13.0 19.6 15.4 12.2 12.1 14.6 9.4 17.1 19.0 11.9 10.3 9.8 9.2 7.5 8.9 10.1 12.6 19.1 9.1 9.7 9.3 11.8 13.2 14.5 16.7 21.5 18.0 15.8 10.2 15.6 14.8 10.9 9.7 7.2 11.0 15.0 12.4 11.8 13.5 12.0 9.4 10.2 12.9 13.6 7.1 15.0 9.9 10.5 7.0 5.8 7.1 8.2 5.4 8.3 4.1 8.3 6.9 7.2 4.0 6.4 5.7 6.2 6.2 8.1 8.2 8.2 4.3 11.9 3.9 12.2 11.2 13.2 6.9 8.4 6.3 11.8 9.1 6.7 4.8 7.8 6.6 7.2 5.0 5.9 6.2 2.1 7.7 5.8 4.1 8.7 6.1 8.1 5.3 11.6 7.7 4.3 1.7 1.4 8.6 4.6 4.6 0.5 4.5 5.8 11.9 7.3 2.6 7.8 8.0 3.3 5.7 4.7 3.4 4.5 2.7 2.8 10.1 5.9 11.5 18.9 8.8 8.7 4.3 7.3 4.6 5.6 7.1 7.1 6.2 6.2 7.0 7.9 6.6 4.5 3.6 8.3 8.3 6.3 5.4 8.2 5.8 8.0 4.1 9.1 15.4 19.6 15.4 8.9 10.1 9.3 11.8 15.8 10.2 11.9 13.1 8.1 4.7 2.9 16.3 2.8 2.5 10.7 13.6 15.7 19.6 9.8 1.7 7.4 9.5 5.6 7.0 0.0 6.1 6.5 5.6 4.3 12.7 9.4 6.6 11.1 4.1 8.0 7.5 10.7 8.6 6.0 3.3 6.4 6.8 11.0 6.3 9.7 8.9 5.7 21.2 6.5 3.8 11.4 4.3 5.0 18.4 14.4 6.8 3.5 MFSD9 MGC11332 ENSG00000135953 "Major facilitator superfamily domain containing 9" Q8NBP5 2 102715840-102736888 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055293, HPA061859" Approved Approved "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA055293: AB_2682775, HPA061859: AB_2684627" "unprognostic (1.27e-2)" "unprognostic (5.07e-2)" "unprognostic (5.00e-2)" "unprognostic (1.93e-2)" "prognostic unfavorable (8.38e-4)" "unprognostic (2.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.32e-1)" "unprognostic (2.60e-2)" "unprognostic (2.98e-1)" "unprognostic (1.06e-1)" "unprognostic (8.42e-2)" "unprognostic (6.88e-3)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (3.33e-1)" "unprognostic (2.28e-2)" 4.3 4.1 3.0 3.5 3.1 6.2 6.2 12.9 5.2 4.6 8.4 2.4 11.0 11.6 2.8 3.8 7.2 2.7 4.1 3.8 2.3 2.8 7.2 16.2 3.0 4.5 2.3 1.5 3.3 16.8 6.3 10.7 3.4 4.8 3.4 7.9 5.1 9.0 6.8 2.2 4.4 16.0 4.0 2.7 4.8 6.7 2.7 1.7 10.0 5.0 3.9 6.3 5.5 3.5 3.0 4.4 6.4 3.2 4.1 4.3 3.0 3.9 3.3 3.6 6.3 4.2 1.8 8.7 2.6 2.4 3.9 3.9 10.0 6.0 3.2 4.2 1.8 6.4 6.2 4.9 2.6 2.7 13.0 5.0 5.8 3.6 13.1 3.6 4.5 7.7 2.1 6.5 2.7 1.4 3.4 2.6 9.2 3.5 2.0 1.8 3.8 4.3 7.0 3.4 7.8 3.7 3.5 5.6 3.3 6.7 13.5 6.9 5.1 2.6 7.8 7.7 3.9 3.3 6.5 1.9 3.1 5.7 4.2 3.4 4.7 3.7 2.4 2.8 9.7 3.6 3.7 1.2 6.4 4.3 3.2 3.3 3.0 3.4 3.1 2.6 2.7 3.7 3.8 5.0 4.1 1.9 4.4 2.2 3.0 3.0 3.1 12.9 5.2 2.3 2.8 2.3 1.5 4.8 1.7 0.0 1.0 4.4 2.9 3.0 1.5 2.2 2.5 2.7 4.5 7.0 3.9 7.3 0.0 5.3 13.0 1.2 8.4 0.0 7.4 7.2 2.1 3.9 3.5 7.8 4.1 0.0 2.9 0.6 1.2 3.0 0.9 2.1 0.0 4.6 7.9 1.7 8.5 8.6 1.1 2.9 2.6 6.5 1.2 0.9 4.9 3.9 9.6 5.2 6.3 8.0 MGAM MGA ENSG00000257335 Maltase-glucoamylase O43451 7 141907813-142106747 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 155.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 50.7;Late spermatids: 90.5;Proximal tubular cells: 18.9" "Cancer enriched" "Detected in some" 7 "renal cancer: 4.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "neutrophil: 14.1" "Lineage enriched" "Detected in single" 104 "granulocytes: 14.1" "Cell line enhanced" "Detected in some" "A549: 3.7;BJ hTERT+: 3.3;HL-60: 5.5;U-937: 8.7;WM-115: 2.1" "Region enriched" "Detected in single" 12 "olfactory region: 3.1" HPA002270 Enhanced NA NA 68000 "HPA002270: AB_1079366" "unprognostic (1.02e-2)" "unprognostic (1.45e-1)" "unprognostic (1.13e-1)" "unprognostic (6.95e-3)" "unprognostic (2.80e-1)" "unprognostic (7.81e-2)" "unprognostic (7.32e-3)" "unprognostic (3.83e-2)" "unprognostic (4.97e-1)" "unprognostic (2.17e-2)" "unprognostic (6.86e-2)" "unprognostic (1.99e-1)" "prognostic favorable (6.16e-5)" "unprognostic (1.82e-1)" "unprognostic (2.82e-1)" "unprognostic (1.34e-3)" "unprognostic (3.03e-1)" 0.9 0.2 0.3 0.8 0.2 6.9 0.3 0.2 0.2 0.2 59.4 0.1 7.6 25.2 0.2 36.0 0.2 1.0 0.1 0.3 0.2 0.2 8.7 0.4 2.1 0.1 0.3 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.6 0.0 0.1 0.2 3.2 0.2 0.1 155.5 0.1 0.3 8.3 0.7 4.3 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 14.1 0.1 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.0 0.0 0.5 0.1 3.3 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.3 1.0 0.4 0.1 0.3 0.0 0.1 0.0 8.7 2.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.0 4.5 0.0 0.0 0.0 0.0 1.1 0.0 2.7 2.3 12.2 0.0 0.0 1.7 0.0 50.7 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 90.5 0.6 1.8 0.0 0.0 0.4 0.5 0.2 0.0 0.4 18.9 0.0 0.0 0.0 1.6 1.2 0.0 0.0 0.0 0.2 0.2 MGAM2 ENSG00000257743 "Maltase-glucoamylase 2 (putative)" Q2M2H8 7 142111749-142222324 "Enzymes, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 61.2;pancreas: 15.6;salivary gland: 35.4" "Group enriched" "Detected in some" 10 "Early spermatids: 21.0;Late spermatids: 12.0" "Group enriched" "Detected in some" 11 "colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Group enriched" "Detected in some" 8 "OE19: 5.5;RH-30: 4.0" "Low region specificity" "Detected in many" HPA055697 Enhanced Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA055697: AB_2682890" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-3)" "unprognostic (5.65e-2)" "unprognostic (2.19e-2)" "unprognostic (1.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-2)" "unprognostic (5.93e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-1)" "unprognostic (5.50e-4)" "unprognostic (7.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.71e-2)" "unprognostic (9.33e-2)" 0.2 0.1 0.1 2.5 0.1 0.2 1.3 0.1 0.1 0.1 28.8 0.0 0.0 15.0 0.1 0.4 0.1 0.3 7.0 0.1 0.1 0.1 0.1 0.2 0.4 0.0 0.4 0.0 0.1 15.6 0.0 0.1 0.0 0.1 0.1 1.4 0.7 35.4 0.0 0.1 0.2 61.2 0.0 0.5 1.5 0.7 1.0 0.0 0.0 0.1 1.7 0.8 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 4.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MGARP "C4orf49, CESP-1, HUMMR, OSAP" ENSG00000137463 "Mitochondria localized glutamic acid rich protein" Q8TDB4 4 139266163-139280338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 88.9;retina: 30.7" "Group enriched" "Detected in some" 9 "Bipolar cells: 140.5;Horizontal cells: 197.0;Muller glia cells: 424.1" "Cancer enhanced" "Detected in some" "renal cancer: 4.1" "Group enriched" "Detected in many" 4 "basal ganglia: 4.5;cerebellum: 8.0" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 10.7;fHDF/TERT166: 15.9;HHSteC: 12.9;HUVEC TERT2: 32.4" "Low region specificity" "Detected in some" "HPA015994, HPA070835" Enhanced Supported Mitochondria NA NA Mitochondria "HPA015994: AB_2630370, HPA070835: " "unprognostic (2.68e-1)" "unprognostic (1.73e-1)" "unprognostic (8.18e-2)" "unprognostic (4.25e-2)" "unprognostic (3.54e-2)" "unprognostic (3.11e-2)" "unprognostic (3.42e-2)" "unprognostic (1.02e-3)" "unprognostic (2.90e-2)" "unprognostic (4.96e-2)" "unprognostic (1.50e-2)" "unprognostic (1.31e-1)" "unprognostic (4.08e-2)" "unprognostic (1.47e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-2)" "unprognostic (2.36e-1)" 3.2 88.9 1.0 0.5 4.5 0.4 1.2 8.0 1.2 3.6 1.0 2.1 1.1 0.4 2.6 3.0 0.5 0.8 1.3 6.1 0.8 1.4 1.0 0.4 0.5 0.6 1.0 0.0 20.1 0.5 0.4 15.3 0.5 1.5 2.0 0.5 30.7 0.4 2.0 0.6 0.5 0.4 2.3 0.7 0.6 0.4 5.9 0.5 0.0 0.5 0.0 0.5 2.1 1.0 0.5 0.0 0.0 0.3 0.5 1.7 0.3 0.0 0.5 0.3 0.2 0.8 0.4 0.0 10.7 0.0 1.6 0.0 0.0 0.1 0.0 0.1 15.9 4.6 0.2 2.3 0.0 0.9 0.0 1.0 0.0 0.0 0.1 12.9 0.1 0.1 3.9 0.3 1.7 0.1 3.8 32.4 0.1 0.2 0.2 2.6 0.0 0.4 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.6 0.0 0.0 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.3 4.5 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.7 0.4 0.0 0.3 1.6 0.7 0.0 0.5 0.2 0.0 0.3 0.3 1.0 4.5 8.0 1.2 0.8 1.4 1.0 0.0 1.5 0.5 0.0 0.0 0.0 0.7 1.4 140.5 2.5 0.0 0.0 0.0 0.0 7.9 0.2 1.7 0.0 0.2 0.2 0.0 0.0 0.0 0.1 2.4 0.3 0.0 0.0 0.5 197.0 0.0 0.6 0.0 0.0 15.8 0.0 0.0 0.0 0.0 424.1 0.1 0.0 23.3 7.6 28.7 0.0 0.4 0.7 0.3 0.6 0.2 0.0 0.0 0.3 MGAT1 "GLCNAC-TI, GLYT1, GNT-1, GnTI, MGAT" ENSG00000131446 "Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase" P26572 5 180784782-180815652 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 254.2;Syncytiotrophoblasts: 321.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017432 Approved NA NA 7200000 "HPA017432: AB_1853851" "unprognostic (1.12e-1)" "unprognostic (1.34e-2)" "unprognostic (3.38e-2)" "unprognostic (2.11e-1)" "unprognostic (3.91e-2)" "unprognostic (6.70e-2)" "unprognostic (4.39e-2)" "unprognostic (9.34e-2)" "unprognostic (2.00e-1)" "unprognostic (2.98e-1)" "unprognostic (3.70e-3)" "unprognostic (6.44e-2)" "prognostic unfavorable (8.65e-4)" "unprognostic (4.15e-2)" "unprognostic (3.52e-2)" "unprognostic (5.68e-2)" "unprognostic (5.00e-2)" 67.7 20.9 14.9 30.8 20.1 25.5 53.3 15.6 19.3 22.3 29.0 14.6 22.4 24.8 26.1 26.8 31.2 26.4 19.8 26.4 16.1 10.6 20.8 55.6 42.7 50.5 25.6 10.3 27.2 37.1 8.5 20.8 84.9 17.7 26.6 15.3 24.1 28.4 21.8 18.5 22.9 35.1 20.7 31.1 45.7 24.5 19.2 21.9 27.0 32.1 16.9 29.8 38.2 39.1 13.2 40.8 37.7 54.9 16.5 24.9 47.2 14.3 14.4 7.9 17.0 42.0 19.2 27.8 34.2 42.1 21.5 26.9 20.6 11.8 12.3 19.3 33.0 20.8 17.2 4.2 51.0 12.7 66.0 11.9 10.8 8.3 15.9 20.4 9.8 35.4 22.2 24.5 17.3 17.3 14.1 18.6 8.5 6.2 22.1 19.2 20.3 9.2 14.1 7.7 9.4 18.6 11.3 11.7 16.1 8.2 17.1 6.8 8.2 14.3 14.8 28.2 7.3 11.4 17.6 19.9 26.2 11.7 11.2 15.4 41.8 34.5 10.8 21.3 20.0 13.2 19.5 54.9 25.3 22.4 45.9 24.9 13.2 16.4 18.7 40.8 12.1 14.4 16.0 37.7 16.5 35.1 38.9 18.8 47.2 14.9 20.1 15.6 19.3 16.1 10.6 25.6 10.3 17.7 21.9 44.7 30.3 44.7 32.3 54.4 15.3 16.2 33.1 10.7 10.3 27.9 53.0 78.1 31.5 43.2 24.8 80.8 40.7 46.7 68.5 254.2 87.6 52.3 30.0 71.9 181.6 60.4 47.8 132.0 151.5 31.6 58.1 136.4 77.6 84.8 43.1 15.3 50.1 31.6 71.5 17.0 77.1 32.3 55.2 18.4 19.0 55.8 321.9 60.9 34.7 55.2 MGAT2 GNT-II ENSG00000168282 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase" Q10469 14 49620795-49623481 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043721, HPA056824" Approved Supported "Golgi apparatus" NA NA 5000000 "Golgi apparatus" "HPA043721: AB_2678636, HPA056824: AB_2683248" "unprognostic (1.20e-2)" "prognostic unfavorable (3.22e-4)" "unprognostic (2.84e-1)" "unprognostic (5.49e-2)" "unprognostic (1.37e-1)" "unprognostic (1.70e-1)" "unprognostic (3.77e-1)" "unprognostic (1.92e-2)" "unprognostic (1.14e-1)" "unprognostic (7.44e-2)" "unprognostic (7.12e-2)" "unprognostic (5.63e-2)" "unprognostic (2.59e-3)" "unprognostic (9.14e-2)" "unprognostic (3.74e-2)" "unprognostic (4.72e-2)" "unprognostic (2.12e-2)" 14.0 17.0 7.4 14.0 7.1 5.0 12.3 7.3 8.4 11.7 16.5 7.8 16.5 13.9 12.9 14.1 11.7 11.4 16.8 10.1 6.2 6.6 13.2 34.4 10.3 20.5 6.1 7.2 15.3 27.9 4.8 8.2 14.1 5.8 9.4 13.7 10.7 34.9 19.1 5.1 6.3 29.1 9.7 7.1 20.9 12.3 27.7 5.8 18.2 9.0 7.2 14.8 11.6 9.1 15.5 28.2 22.1 22.8 12.0 24.7 23.2 18.9 9.4 7.2 12.2 17.2 16.8 4.7 21.1 21.0 19.6 17.7 11.4 14.5 19.3 18.0 19.2 11.3 15.2 10.2 12.2 21.2 19.6 9.0 12.3 7.0 11.2 13.6 28.1 28.8 12.8 9.8 11.6 16.5 14.4 23.4 9.7 9.4 53.3 20.6 7.2 9.7 18.0 7.4 6.7 15.2 11.0 21.1 16.6 15.3 11.1 7.5 8.1 15.1 4.0 11.9 7.3 12.2 19.3 24.2 17.8 19.3 12.9 15.0 57.7 27.6 17.2 8.6 14.1 11.9 21.7 22.8 22.1 23.0 20.0 24.7 15.5 21.3 20.7 23.6 10.4 12.6 17.3 6.8 12.0 21.6 28.2 18.2 23.2 7.4 7.1 7.3 8.4 6.2 6.6 6.1 7.2 5.8 5.8 11.9 10.4 19.4 21.6 14.0 13.0 0.0 30.6 6.7 5.7 10.4 3.9 22.7 8.3 27.1 6.0 17.8 21.0 0.0 30.2 35.1 27.8 21.6 16.2 45.1 33.0 17.5 11.6 23.9 33.8 4.6 16.1 22.6 20.3 37.9 18.9 14.9 29.0 23.0 20.8 12.2 14.8 6.5 16.7 40.5 12.8 12.3 4.5 33.7 19.6 25.3 MGAT3 GNT-III ENSG00000128268 "Mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase" Q09327 22 39457344-39492194 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0;intestine: 27.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 41.7;Bipolar cells: 30.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.5;eosinophil: 3.3;memory B-cell: 1.7;naive B-cell: 1.2" "Group enriched" "Detected in many" 9 "B-cells: 1.7;granulocytes: 3.5" "Cell line enhanced" "Detected in some" "BEWO: 28.1;HMC-1: 24.3;OE19: 24.3;U-266/70: 31.6;U-266/84: 12.8;U-698: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017598 Approved "Intracellular and membrane" NA NA 78000 "HPA017598: AB_1853853" "unprognostic (1.41e-3)" "unprognostic (5.98e-3)" "unprognostic (4.79e-2)" "unprognostic (2.96e-1)" "unprognostic (2.76e-1)" "unprognostic (5.71e-3)" "unprognostic (8.92e-2)" "unprognostic (2.17e-1)" "unprognostic (4.35e-3)" "unprognostic (6.77e-2)" "unprognostic (8.12e-3)" "unprognostic (8.74e-2)" "prognostic unfavorable (5.04e-8)" "unprognostic (6.73e-2)" "unprognostic (1.46e-1)" "unprognostic (5.89e-2)" "unprognostic (4.92e-2)" 5.3 1.2 17.1 3.9 18.7 9.2 3.6 29.0 24.6 7.1 11.9 8.9 0.0 21.1 3.4 1.2 1.4 4.0 7.9 3.0 18.1 14.9 3.3 0.4 14.9 7.2 13.1 13.4 1.0 3.1 0.9 1.4 10.5 10.7 1.0 4.9 1.7 2.1 1.4 1.6 2.5 27.1 3.2 10.4 3.3 7.8 4.9 9.0 0.2 1.1 0.0 8.9 3.0 2.7 1.7 0.1 3.5 0.2 0.0 0.2 0.1 0.1 0.1 4.6 0.4 0.0 0.0 28.1 0.2 0.3 0.2 0.0 6.2 1.5 9.7 3.4 0.0 0.0 0.5 2.3 0.0 0.0 0.0 0.2 7.8 0.0 0.0 0.1 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 6.4 1.2 0.0 0.1 0.2 0.6 1.3 24.3 0.0 0.4 0.0 1.6 0.2 0.2 2.6 1.9 0.0 0.0 0.0 8.4 0.3 0.4 0.0 0.0 3.7 0.0 0.0 31.6 12.8 13.7 0.0 0.0 0.7 3.5 0.1 3.3 0.1 0.2 0.1 1.7 0.0 0.0 0.1 1.2 0.2 0.2 0.4 0.0 0.0 0.0 0.1 0.1 17.1 18.7 29.0 24.6 18.1 14.9 13.1 13.4 10.7 9.0 41.7 4.0 3.7 0.1 0.3 30.0 1.2 2.5 2.7 1.2 0.0 5.9 4.6 0.0 0.0 11.0 2.3 5.2 0.0 0.2 10.1 0.6 0.0 2.3 0.0 1.3 12.7 7.5 0.0 0.0 16.2 4.0 0.7 0.0 0.0 3.2 1.5 1.3 3.4 3.5 1.3 2.3 6.5 1.4 0.7 1.0 0.5 3.1 0.9 3.4 1.3 MGAT4A "GnT-4a, GnT-Iva" ENSG00000071073 "Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A" Q9UM21 2 98619106-98731126 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 49.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 46.0;HUVEC TERT2: 17.2;JURKAT: 30.7;TIME: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007608 Enhanced Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Golgi apparatus" "HPA007608: AB_10602008" "prognostic unfavorable (4.30e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.48e-8)" "unprognostic (1.35e-1)" "unprognostic (2.28e-2)" "unprognostic (3.82e-3)" "unprognostic (1.89e-1)" "unprognostic (3.76e-1)" "unprognostic (3.58e-1)" "unprognostic (2.80e-2)" "unprognostic (2.32e-2)" "unprognostic (4.17e-2)" "unprognostic (1.50e-1)" "unprognostic (4.62e-2)" "unprognostic (4.04e-2)" "unprognostic (2.04e-1)" 8.1 5.1 11.3 11.9 15.6 49.2 8.2 28.5 14.3 6.1 14.6 8.3 6.8 17.6 5.2 4.1 4.1 6.2 8.0 5.1 11.3 10.4 17.1 6.0 13.7 16.7 9.9 8.3 2.9 26.7 33.3 14.1 11.9 10.4 6.6 15.8 5.6 14.5 4.4 3.3 3.4 38.5 7.2 16.1 7.0 8.4 3.9 14.3 20.3 6.4 3.1 11.6 8.3 5.0 2.0 9.3 7.6 2.9 7.7 19.7 7.4 3.0 0.6 1.2 2.6 0.0 0.0 46.0 0.0 0.0 0.3 0.0 7.3 3.7 0.0 6.9 0.0 0.9 0.1 2.5 0.3 0.0 3.6 2.8 0.1 0.0 12.7 0.0 6.1 2.3 0.0 1.7 0.0 0.2 0.1 17.2 30.7 0.5 3.3 0.0 5.9 13.3 10.7 0.4 2.6 0.5 3.3 0.0 3.6 8.9 6.2 3.7 1.2 0.8 11.5 1.6 3.4 2.7 8.3 27.8 0.0 1.4 0.0 0.9 1.1 2.5 0.7 0.0 9.2 0.2 3.3 2.9 6.6 12.3 0.5 15.9 2.0 14.9 13.7 2.0 1.1 19.7 16.1 7.6 7.7 1.1 9.3 8.4 7.4 11.3 15.6 28.5 14.3 11.3 10.4 9.9 8.3 10.4 14.3 50.6 31.3 18.2 18.4 8.9 20.9 11.7 10.2 5.3 13.6 21.0 3.9 3.9 18.3 15.5 10.0 32.8 84.5 0.0 25.8 66.5 5.4 17.8 12.7 8.5 53.2 46.1 50.8 20.3 30.7 13.9 2.3 33.8 10.1 10.0 34.5 13.6 22.1 48.9 2.1 25.6 4.8 6.5 5.1 2.8 3.4 9.3 12.5 74.0 30.1 20.1 MGAT4B GnT-Ivb ENSG00000161013 "Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B" Q9UQ53 5 179797597-179806952 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 125.6;liver: 100.0" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 212.8;Paneth cells: 114.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "eosinophil: 8.5" "Lineage enriched" "Detected in single" 9 "granulocytes: 8.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012804, HPA052134" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA Nucleoplasm "Golgi apparatus, Vesicles, Cytosol" "HPA012804: , HPA052134: AB_2681741" "unprognostic (2.01e-2)" "unprognostic (8.68e-3)" "unprognostic (1.40e-1)" "unprognostic (3.83e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (3.61e-3)" "unprognostic (7.57e-3)" "unprognostic (1.22e-2)" "unprognostic (2.02e-1)" "unprognostic (5.13e-2)" "unprognostic (2.26e-2)" "unprognostic (2.27e-2)" "prognostic favorable (5.78e-4)" "unprognostic (1.52e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-2)" "unprognostic (1.42e-1)" 13.2 22.8 9.1 19.5 8.2 9.5 18.7 15.3 13.5 8.7 77.3 5.9 10.1 61.7 9.2 10.4 16.8 10.7 26.0 20.6 9.5 5.4 31.9 100.0 17.1 15.6 6.3 5.2 9.1 13.4 10.3 8.3 14.4 6.3 8.8 30.9 10.1 19.2 8.2 8.4 12.1 125.6 7.5 4.9 12.5 22.3 11.2 5.6 7.0 16.6 14.6 10.0 9.5 13.7 0.9 0.6 8.5 0.7 0.0 0.6 0.2 20.8 21.1 10.4 24.1 32.0 17.2 18.1 12.4 24.9 11.3 8.9 23.1 58.2 3.5 31.9 28.6 50.4 15.8 15.2 27.9 8.6 29.2 8.1 10.7 19.2 20.1 22.6 13.5 3.3 18.6 19.6 11.5 14.3 44.4 23.2 4.2 6.9 9.6 19.0 23.3 2.0 11.2 6.4 31.9 8.5 5.2 8.3 9.9 33.9 40.6 17.2 10.1 18.6 19.3 33.4 9.2 13.2 13.7 28.3 28.6 12.7 16.0 19.8 8.2 9.4 8.8 34.3 17.0 20.6 0.0 0.7 8.5 0.3 0.1 0.1 0.0 0.5 0.2 0.6 0.9 0.4 0.6 0.3 0.0 0.5 0.5 0.0 0.2 9.1 8.2 15.3 13.5 9.5 5.4 6.3 5.2 6.3 5.6 11.9 8.6 8.5 16.0 11.1 15.5 21.6 25.5 0.0 5.7 26.2 3.9 6.8 3.3 60.0 0.5 14.3 212.8 0.0 46.0 9.9 10.4 29.2 4.7 75.0 15.1 28.6 22.0 31.9 17.0 1.6 14.1 11.7 10.1 18.0 64.6 23.5 79.0 114.3 15.9 20.7 10.4 12.9 8.6 1.6 4.8 10.5 11.7 5.0 102.6 39.7 MGAT4C HGNT-IV-H ENSG00000182050 "MGAT4 family member C" Q9UBM8 12 85955666-86838904 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0" "Group enriched" "Detected in some" 6 "Early spermatids: 99.1;Late spermatids: 74.0" "Cancer enriched" "Detected in single" 19 "thyroid cancer: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "NTERA-2: 11.0;SCLC-21H: 4.8;SuSa: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016418 Approved Approved "Vesicles,Plasma membrane,Centriolar satellite" NA NA "Vesicles, Plasma membrane" "Centriolar satellite" "HPA016418: AB_2732416" "unprognostic (5.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.32e-4)" "unprognostic (1.07e-1)" "unprognostic (9.64e-2)" "unprognostic (5.94e-3)" "unprognostic (1.88e-1)" "unprognostic (8.05e-2)" "unprognostic (1.89e-1)" "unprognostic (6.32e-3)" "unprognostic (3.51e-2)" "unprognostic (6.85e-10)" "unprognostic (3.15e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" "unprognostic (4.74e-3)" 1.0 3.0 5.5 1.0 12.3 1.1 0.9 4.9 12.8 1.3 1.2 2.5 0.4 0.9 1.0 10.9 1.1 1.1 1.2 3.6 9.4 3.9 1.0 0.9 1.0 0.9 3.0 9.3 0.9 0.9 0.9 25.9 0.8 10.6 1.1 1.2 0.0 0.9 2.4 0.8 1.0 1.0 1.0 4.3 0.9 1.0 7.8 5.1 0.0 18.0 0.0 0.8 0.9 0.6 0.5 0.3 0.8 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.0 11.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.1 0.8 0.2 0.1 0.3 0.2 0.0 5.5 12.3 4.9 12.8 9.4 3.9 3.0 9.3 10.6 5.1 6.0 0.6 0.0 0.1 0.1 9.7 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 74.0 15.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 3.9 0.0 1.6 0.0 0.0 1.7 0.6 0.1 0.0 0.0 0.0 0.3 MGAT4D GnT1IP ENSG00000205301 "MGAT4 family member D" A6NG13 4 140442262-140498377 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 56 "testis: 33.8" "Cell type enhanced" "Detected in some" 33 "Early spermatids: 12.4;Late spermatids: 20.4;Spermatocytes: 70.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036523 Enhanced NA NA "HPA036523: AB_10670110" "unprognostic (2.70e-1)" "unprognostic (3.16e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 70.7 1.0 0.0 0.0 0.0 0.0 0.0 MGAT5 GNT-V ENSG00000152127 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase" Q09328 2 134119983-134454621 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010919 Approved NA NA 96000 "HPA010919: AB_10601864" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.21e-2)" "unprognostic (3.65e-1)" "unprognostic (3.76e-1)" "unprognostic (4.45e-3)" "unprognostic (3.41e-3)" "unprognostic (5.68e-2)" "unprognostic (8.63e-3)" "unprognostic (1.59e-1)" "unprognostic (2.64e-1)" "unprognostic (5.97e-2)" "unprognostic (1.81e-2)" "unprognostic (9.27e-2)" "unprognostic (2.17e-2)" "unprognostic (1.91e-1)" 8.4 9.8 13.0 21.7 15.7 12.0 8.0 21.3 17.6 9.0 13.2 17.2 4.6 14.2 8.5 6.3 8.2 17.5 15.1 33.9 13.9 17.5 14.3 4.9 9.3 20.1 23.6 11.6 11.3 11.1 18.8 7.9 22.0 28.0 7.9 13.8 8.3 11.9 9.1 3.2 6.6 19.2 10.1 28.7 23.1 15.0 6.6 13.2 16.5 10.3 5.1 28.9 11.0 9.2 7.5 1.8 2.3 0.8 2.4 3.1 1.1 10.2 4.1 10.5 7.5 9.4 18.0 7.3 13.7 20.9 5.5 4.7 1.7 5.1 16.5 10.5 10.9 6.3 3.6 8.2 6.4 10.7 16.1 4.8 9.2 5.3 21.4 6.1 8.9 32.9 4.9 6.7 11.6 7.2 7.5 41.3 8.3 4.7 11.3 10.0 6.6 4.8 4.2 4.8 10.7 10.2 6.0 12.4 10.3 4.3 12.6 17.4 21.4 4.4 3.8 26.1 7.4 2.9 6.2 18.6 17.5 9.3 12.7 7.1 3.2 1.5 6.2 14.7 12.8 27.8 1.2 0.7 1.8 1.6 0.7 2.7 5.6 3.1 2.1 0.6 7.5 1.3 1.6 2.3 2.4 0.8 1.8 1.9 1.1 13.0 15.7 21.3 17.2 13.9 17.5 23.6 11.6 28.0 13.2 3.0 3.7 22.6 5.1 7.1 27.7 52.8 5.1 13.4 3.4 1.8 2.0 3.0 0.0 8.0 14.2 11.6 18.6 0.0 7.8 24.2 4.1 7.5 0.0 2.9 12.9 15.9 6.9 11.1 12.7 10.6 4.0 7.3 13.5 1.8 17.2 8.8 10.4 14.2 8.9 2.1 4.7 0.0 11.8 0.3 7.0 6.4 4.5 10.2 9.4 13.2 MGAT5B "FLJ25132, GnT-IX, GnT-VB" ENSG00000167889 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B" Q3V5L5 17 76868456-76950393 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 28.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 5.1;Early spermatids: 6.3;Extravillous trophoblasts: 2.8;Late spermatids: 6.8" "Group enriched" "Detected in many" 5 "glioma: 2.6;melanoma: 7.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 21.8;SCLC-21H: 11.2;U-138 MG: 13.2;U-2 OS: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011082 Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes No "Nucleoplasm, Mitotic spindle" "Cytokinetic bridge" "HPA011082: AB_2668423" "unprognostic (6.37e-2)" "unprognostic (9.16e-3)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (5.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.28e-3)" "unprognostic (1.52e-3)" "unprognostic (5.30e-2)" "unprognostic (3.89e-2)" "unprognostic (1.68e-1)" "unprognostic (5.67e-2)" "unprognostic (1.46e-7)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.04e-1)" "unprognostic (3.01e-1)" 1.1 1.2 9.3 1.1 13.4 1.0 0.9 4.4 28.1 1.0 0.9 1.1 0.0 0.8 1.1 0.7 0.9 1.0 0.9 0.8 5.5 2.8 0.9 0.7 1.0 0.9 2.3 8.1 1.2 0.8 1.0 0.6 1.1 2.6 0.8 0.8 1.1 0.8 0.8 0.7 0.9 0.9 0.8 0.7 1.4 1.0 2.3 1.7 0.0 0.8 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 21.8 4.4 2.2 0.0 0.0 2.3 0.3 0.9 8.0 4.7 0.0 0.5 0.0 1.7 1.0 9.4 0.1 1.0 0.2 2.1 0.0 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.3 3.6 1.4 0.4 0.1 0.0 0.0 1.0 0.0 0.0 1.2 0.5 2.3 3.0 3.9 4.5 6.2 0.0 11.2 4.3 3.8 1.7 3.4 0.2 0.1 0.1 4.0 13.2 14.3 0.2 4.1 0.0 0.0 0.5 0.4 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 13.4 4.4 27.4 5.5 2.8 2.3 8.1 2.6 1.7 0.0 0.0 0.0 0.1 0.1 5.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 6.8 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 2.1 0.0 0.2 0.9 2.2 0.0 0.1 0.0 0.0 0.0 MGP ENSG00000111341 "Matrix Gla protein" P08493 12 14881181-14885926 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Developmental protein" Deafness "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Fibroblasts: 1780.1;Ito cells: 1289.1;Leydig cells: 1866.9;Peritubular cells: 1223.8;Sertoli cells: 827.9" "Cancer enhanced" "Detected in all" "breast cancer: 845.3" "Group enriched" "Detected in many" 4 "olfactory region: 7.9;pons and medulla: 22.5" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 4.8" "Lineage enriched" "Detected in single" 8 "dendritic cells: 4.8" "Cell line enriched" "Detected in some" 5 "AN3-CA: 471.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013949 Approved "Secreted to blood" NA NA 15000000 "HPA013949: AB_1853599" "unprognostic (5.71e-3)" "unprognostic (5.85e-3)" "unprognostic (1.20e-3)" "unprognostic (2.83e-2)" "unprognostic (1.27e-1)" "unprognostic (1.21e-1)" "unprognostic (1.55e-2)" "unprognostic (4.17e-3)" "unprognostic (1.01e-2)" "unprognostic (6.93e-2)" "unprognostic (1.90e-1)" "unprognostic (4.26e-2)" "prognostic unfavorable (4.15e-6)" "unprognostic (1.55e-2)" "unprognostic (4.69e-2)" "unprognostic (7.50e-2)" "unprognostic (8.97e-3)" 97.0 82.5 0.7 53.2 2.2 0.0 303.5 1.6 3.2 190.5 93.5 5.7 145.0 5.1 149.5 404.0 94.1 118.3 82.0 156.2 1.9 1.1 120.8 6.8 109.2 24.7 3.5 7.9 86.5 22.9 4.8 54.4 18.8 22.5 189.7 21.3 195.1 245.8 96.5 33.3 20.1 45.2 160.5 13.0 11.0 55.8 143.0 0.8 2.1 203.9 58.8 16.0 183.7 135.7 0.0 4.8 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 471.2 79.7 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 1.6 0.0 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.2 1.4 0.0 0.4 0.0 0.1 86.3 0.0 1.0 0.5 0.0 0.1 1.3 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.7 2.2 1.6 3.2 1.9 1.1 3.5 7.9 22.5 0.8 17.9 88.3 12.5 172.0 132.6 0.6 41.2 0.0 45.5 342.4 109.9 3.9 17.9 1.7 1.6 12.8 555.1 0.0 0.0 72.4 10.5 1780.1 99.4 12.8 2.6 28.3 0.0 0.0 1289.1 5.4 23.5 1866.9 34.3 214.2 4.6 0.0 27.6 1.3 0.0 1223.8 0.6 5.5 827.9 564.2 6.8 5.6 103.5 33.1 3.2 0.0 53.8 MGST1 "GST12, MGST-I" ENSG00000008394 "Microsomal glutathione S-transferase 1" P10620 12 16347142-16609259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 382.8" "Cell type enhanced" "Detected in many" 16 "Hepatocytes: 3471.1;Proximal tubular cells: 978.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 46.1;myeloid DC: 34.1" "Group enriched" "Detected in many" 15 "dendritic cells: 34.1;monocytes: 46.1" "Cell line enhanced" "Detected in many" "ASC diff: 342.0;ASC TERT1: 132.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044840 Enhanced Approved "Endoplasmic reticulum,Mitochondria" NA NA Mitochondria "Endoplasmic reticulum" "HPA044840: AB_10965550" "unprognostic (4.57e-2)" "unprognostic (4.80e-3)" "unprognostic (5.82e-2)" "unprognostic (2.92e-3)" "unprognostic (3.97e-3)" "unprognostic (1.03e-1)" "unprognostic (8.19e-2)" "unprognostic (1.03e-1)" "unprognostic (4.82e-2)" "unprognostic (3.42e-1)" "unprognostic (1.37e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (7.45e-4)" "unprognostic (9.90e-2)" "unprognostic (4.61e-1)" "prognostic favorable (1.97e-4)" "unprognostic (4.19e-1)" 127.9 106.0 18.5 10.8 32.6 9.5 116.8 10.3 14.0 9.3 39.7 9.6 2.6 17.0 4.1 6.4 19.5 6.9 26.6 12.1 19.6 13.9 56.9 382.8 42.0 2.7 18.9 8.9 3.1 12.4 0.8 5.3 8.7 18.4 23.5 28.3 3.0 14.7 8.2 8.9 7.0 15.5 11.5 20.1 0.9 10.3 6.8 12.0 0.0 69.9 13.9 3.6 32.6 37.2 0.2 34.1 2.7 46.1 0.0 0.2 13.0 0.0 30.6 7.3 8.5 342.0 132.0 0.0 25.1 25.7 13.7 21.3 11.6 51.3 0.0 3.0 32.1 43.1 0.1 19.0 40.2 12.4 0.0 2.5 10.4 17.0 40.7 79.9 20.2 0.0 85.6 44.8 41.8 44.1 34.0 24.0 0.0 7.3 0.0 29.4 6.2 0.0 8.1 60.9 0.0 24.3 0.0 4.3 13.8 30.8 60.5 1.3 1.1 39.2 25.2 1.0 41.3 27.1 11.4 15.1 14.1 1.9 27.7 32.3 0.0 0.0 0.0 46.4 32.3 0.4 2.7 46.1 0.4 0.0 7.0 0.1 0.2 0.0 0.0 34.1 0.0 0.0 0.0 1.5 0.0 1.5 9.6 0.2 13.0 18.5 32.6 10.3 14.0 19.6 13.9 18.9 8.9 18.4 12.0 247.1 493.0 46.4 120.5 22.8 0.0 5.3 738.8 293.1 502.7 68.0 0.0 2.3 154.2 22.7 20.8 14.2 262.1 46.7 371.4 189.8 162.1 379.2 32.4 3471.1 168.6 0.0 43.8 78.5 223.7 10.9 30.8 51.0 37.1 187.6 224.9 0.0 374.3 135.3 106.4 978.0 1.0 0.0 12.2 0.5 2.2 15.4 6.6 37.4 362.2 564.6 MGST2 MGST-II ENSG00000085871 "Microsomal glutathione S-transferase 2" Q99735 4 139665768-139740745 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Leukotriene biosynthesis, Lipid metabolism" "Lyase, Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 46.9" "Group enriched" "Detected in many" 4 "dendritic cells: 46.9;monocytes: 25.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.4;OE19: 91.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA010707 Approved NA NA "HPA010707: AB_1853922" "unprognostic (9.35e-2)" "unprognostic (6.13e-2)" "unprognostic (4.33e-2)" "prognostic favorable (5.26e-5)" "unprognostic (1.58e-1)" "unprognostic (8.26e-2)" "unprognostic (1.02e-2)" "unprognostic (1.18e-1)" "unprognostic (4.38e-2)" "unprognostic (2.77e-2)" "unprognostic (8.78e-2)" "unprognostic (6.41e-2)" "prognostic favorable (3.22e-9)" "unprognostic (4.10e-1)" "unprognostic (9.91e-2)" "unprognostic (1.77e-2)" "unprognostic (1.01e-2)" 26.9 30.2 6.9 9.7 10.8 7.4 29.0 12.6 9.3 16.4 27.3 7.3 31.3 27.3 12.2 19.4 54.9 14.7 42.0 26.9 7.4 9.0 25.3 79.1 20.6 21.6 10.1 5.9 10.6 27.8 16.4 18.2 19.2 10.2 23.3 25.4 14.7 30.4 36.7 20.4 24.2 60.3 13.3 10.7 19.6 15.2 29.0 8.8 8.3 23.7 40.9 26.8 19.1 22.6 0.5 46.9 8.1 25.9 5.8 8.8 8.8 6.6 9.7 5.0 0.0 0.8 2.7 3.0 1.2 11.0 0.5 1.8 10.1 47.4 0.0 27.7 2.9 2.4 12.6 8.9 13.7 0.8 3.7 8.0 29.3 10.7 40.0 2.3 25.2 22.6 9.2 33.7 0.3 2.1 11.1 27.7 0.0 12.1 4.4 4.0 5.5 0.0 4.1 1.1 91.7 9.9 2.1 5.9 8.9 25.8 14.3 12.7 3.8 9.0 14.1 10.7 0.3 9.0 33.5 17.6 0.9 4.8 1.3 1.0 5.2 3.6 1.6 0.6 42.7 2.2 8.1 25.9 7.0 1.1 15.4 0.7 0.3 1.9 0.9 35.7 0.5 0.6 0.6 4.4 5.8 4.8 46.9 8.8 8.8 6.9 10.8 12.6 9.3 7.4 9.0 10.1 5.9 10.2 8.8 23.8 29.3 18.2 223.2 54.3 8.1 90.8 229.3 57.6 47.8 90.7 23.6 70.4 76.3 102.7 5.6 212.7 268.6 23.3 122.5 52.4 30.4 143.0 43.7 322.9 310.1 6.4 117.0 164.5 94.6 9.0 41.1 102.8 37.1 19.0 165.9 13.7 108.9 204.6 31.5 203.6 2.7 12.9 48.4 3.7 15.1 109.2 56.2 27.1 227.8 357.7 MGST3 GST-III ENSG00000143198 "Microsomal glutathione S-transferase 3" O14880 1 165630861-165661796 "Enzymes, Predicted membrane proteins" "Lyase, Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cytotrophoblasts: 1846.4;Syncytiotrophoblasts: 1983.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 88.9;HDLM-2: 94.3;OE19: 97.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053311, HPA077929" Enhanced Approved Nucleoplasm NA NA 40000 Nucleoplasm "HPA053311: AB_2682108, HPA077929: " "unprognostic (1.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.65e-2)" "unprognostic (1.22e-2)" "unprognostic (2.67e-1)" "unprognostic (7.78e-2)" "unprognostic (3.09e-1)" "unprognostic (2.06e-2)" "unprognostic (2.16e-1)" "unprognostic (1.90e-1)" "unprognostic (3.96e-1)" "unprognostic (3.34e-2)" "unprognostic (1.12e-2)" "unprognostic (7.60e-2)" "unprognostic (8.88e-2)" "unprognostic (1.89e-1)" "unprognostic (1.90e-1)" 42.8 30.8 52.5 9.7 30.5 19.0 51.2 17.9 56.0 18.4 39.7 18.4 19.1 65.2 19.5 101.8 19.7 20.6 26.5 133.6 38.1 33.9 45.2 29.5 20.8 11.0 44.2 37.6 22.7 17.7 11.1 18.3 30.9 39.6 21.2 40.4 20.3 29.8 20.6 87.2 15.6 53.4 24.7 38.7 12.4 29.8 19.4 23.3 2.7 25.7 41.8 8.2 19.9 17.3 21.3 35.1 20.7 47.0 15.7 38.0 40.7 22.2 16.3 17.7 13.9 62.1 37.3 88.9 18.6 30.0 14.5 25.3 17.0 29.0 1.4 14.7 22.7 14.3 27.2 4.3 18.2 14.7 94.3 11.1 3.4 12.8 7.7 17.5 5.3 7.5 31.8 14.7 20.0 7.7 28.6 23.6 6.1 8.3 8.5 27.1 4.9 5.9 12.3 38.7 97.4 21.0 5.6 7.6 2.8 76.5 20.9 13.7 16.8 18.7 24.3 37.0 37.1 18.5 26.2 21.4 18.0 10.7 12.4 13.4 6.3 4.3 0.7 33.4 14.1 11.6 10.4 45.7 20.7 30.1 37.0 30.3 21.3 38.0 33.5 35.1 19.9 24.4 26.7 9.8 15.7 47.0 15.1 32.3 40.7 52.5 30.5 17.9 56.0 38.1 33.9 44.2 37.6 39.6 23.3 95.3 125.6 83.1 202.5 202.9 129.1 591.8 331.2 242.2 134.2 528.7 251.3 1846.4 848.8 339.3 13.2 253.1 716.8 630.8 371.6 1154.8 298.4 174.8 89.0 248.3 760.5 123.9 146.8 184.8 114.8 21.3 359.3 238.2 492.6 405.8 197.9 162.7 335.4 599.7 375.8 841.2 122.6 498.0 374.9 15.6 33.3 203.4 1983.2 87.4 339.8 197.4 MIA CD-RAP ENSG00000261857 "Melanoma inhibitory activity" Q16674 19 40771648-40777490 "Cancer-related genes, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 16.1;breast: 28.7;pituitary gland: 33.5;salivary gland: 22.7;stomach 1: 28.9" "Group enriched" "Detected in some" 10 "Melanocytes: 97.8;monocytes: 52.3;Pancreatic endocrine cells: 38.8" "Cancer enriched" "Detected in many" 5 "melanoma: 58.6" "Region enriched" "Detected in some" 8 "midbrain: 16.1" "Cell type enhanced" "Detected in some" "basophil: 1.6;neutrophil: 3.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.0" "Group enriched" "Detected in some" 31 "AN3-CA: 21.8;CAPAN-2: 18.3;SK-MEL-30: 63.5;WM-115: 60.2" HPA042369 Approved "Secreted to blood" NA NA 8270000 "HPA042369: AB_10794420" "prognostic favorable (2.08e-4)" "unprognostic (1.30e-1)" "unprognostic (3.15e-1)" "unprognostic (9.02e-3)" "unprognostic (2.27e-1)" "unprognostic (1.11e-1)" "unprognostic (6.37e-3)" "unprognostic (3.67e-2)" "unprognostic (1.61e-1)" "unprognostic (9.37e-2)" "unprognostic (1.17e-1)" "unprognostic (3.19e-1)" "unprognostic (3.29e-8)" "unprognostic (5.88e-2)" "unprognostic (2.44e-1)" "unprognostic (2.20e-1)" "unprognostic (2.56e-1)" 0.7 1.5 0.6 3.5 0.6 1.4 28.7 0.9 0.4 3.7 6.1 0.5 2.2 0.8 2.8 3.2 4.0 1.0 3.2 4.1 0.4 0.4 0.9 0.8 1.4 0.7 16.1 0.4 2.6 0.4 0.0 33.5 0.9 2.1 2.2 1.9 6.0 22.7 1.7 0.8 4.5 2.2 3.4 3.1 2.4 28.9 1.0 0.4 0.5 1.1 5.9 4.4 2.0 1.5 0.7 0.0 3.0 0.1 0.0 0.3 0.1 0.0 0.1 0.2 21.8 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.1 18.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 63.5 0.8 0.1 0.2 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.2 0.0 0.1 60.2 1.6 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.1 0.0 0.0 0.1 0.6 0.6 0.9 0.4 0.4 0.4 16.1 0.4 2.1 0.4 0.0 0.3 0.0 0.1 4.6 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.7 0.0 0.4 0.0 0.6 0.7 0.0 2.7 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.6 0.0 97.8 52.3 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.6 0.0 0.5 0.4 MIA3 "FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077" ENSG00000154305 "MIA family member 3, ER export factor" Q5JRA6 1 222618086-222668012 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055922, HPA056816" Supported Enhanced Vesicles "Intracellular and membrane" NA NA 750000 Vesicles "HPA055922: AB_2682971, HPA056816: AB_2683243" "unprognostic (1.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.43e-1)" "unprognostic (6.60e-2)" "unprognostic (1.86e-2)" "unprognostic (8.57e-2)" "unprognostic (1.28e-3)" "unprognostic (5.41e-2)" "unprognostic (2.56e-1)" "unprognostic (5.65e-2)" "unprognostic (6.73e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (3.57e-2)" "unprognostic (1.83e-1)" "unprognostic (8.62e-3)" "unprognostic (3.26e-1)" 20.5 24.1 21.4 17.4 23.7 25.8 25.0 32.8 25.0 23.3 19.3 10.0 26.2 18.7 23.5 24.4 15.7 18.1 18.5 19.5 18.4 17.4 19.5 63.7 18.4 19.0 17.0 18.8 23.4 34.1 30.2 34.7 22.7 25.6 30.1 23.1 9.9 32.8 31.7 25.5 16.5 23.2 21.3 22.9 23.0 36.6 29.3 19.6 19.5 25.6 19.5 19.3 26.8 19.8 18.6 14.9 29.4 20.1 22.0 18.3 11.1 11.7 8.9 13.9 21.1 44.1 22.2 23.3 16.9 25.3 18.7 22.3 9.2 12.2 9.7 16.1 19.1 11.3 20.1 14.8 15.6 19.2 16.6 9.2 13.3 9.2 14.4 40.5 22.8 16.1 20.3 15.0 17.9 31.7 21.9 19.6 14.6 17.0 23.7 14.1 7.1 17.8 14.7 15.3 36.8 12.8 12.1 37.7 23.3 9.6 11.7 15.0 15.8 17.4 15.8 14.0 20.4 16.9 15.0 14.2 12.7 9.8 21.4 17.9 27.1 17.2 12.1 15.9 11.0 16.6 23.6 14.6 29.4 17.4 19.5 18.3 18.3 15.0 17.0 10.4 18.6 17.8 17.4 24.8 22.0 20.1 14.9 16.0 11.1 21.4 23.7 32.8 25.0 18.4 17.4 17.0 18.8 25.6 19.6 65.5 44.7 27.0 22.7 16.7 55.5 55.8 28.1 60.2 58.0 5.2 29.5 23.4 0.0 21.4 25.4 21.9 30.2 23.3 30.0 14.2 25.4 40.1 16.3 52.3 18.5 42.9 58.0 17.8 17.4 18.1 34.2 23.7 18.6 13.6 83.2 42.1 26.6 22.0 46.0 21.6 37.6 19.4 25.6 49.2 40.6 14.1 30.0 34.1 22.9 26.0 MICA PERB11.1 ENSG00000204520 "MHC class I polypeptide-related sequence A" 6 31399784-31415315 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 15.8;ASC TERT1: 16.1;GAMG: 37.0;HBEC3-KT: 14.4;HSkMC: 25.0;hTERT-RPE1: 16.5;RPTEC TERT1: 16.4" NA NA "unprognostic (1.94e-1)" "prognostic unfavorable (5.88e-4)" "unprognostic (1.01e-1)" "unprognostic (6.55e-2)" "unprognostic (2.66e-2)" "unprognostic (6.10e-2)" "unprognostic (5.19e-2)" "unprognostic (4.09e-2)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (1.13e-1)" "unprognostic (1.77e-1)" "unprognostic (1.23e-1)" "unprognostic (4.92e-2)" "unprognostic (2.18e-1)" "unprognostic (1.12e-2)" 10.4 9.7 3.0 7.0 4.3 0.7 8.3 3.0 6.8 11.0 9.5 4.4 16.9 0.7 9.0 14.7 6.9 7.9 13.1 10.8 3.9 1.0 19.1 7.5 15.3 6.5 4.3 3.2 15.1 10.9 13.4 2.8 4.3 12.6 12.6 5.6 13.8 6.5 2.1 6.2 5.4 7.6 3.7 7.9 7.7 6.2 24.6 3.4 1.2 8.7 10.2 3.4 6.3 11.9 1.7 1.8 4.5 1.9 0.3 2.5 1.7 15.8 0.0 0.0 0.0 12.5 16.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 9.2 13.3 37.0 6.5 11.4 14.4 0.3 0.0 5.3 0.0 10.4 0.2 4.5 0.0 0.6 25.0 0.0 0.0 0.2 16.5 0.0 1.1 1.3 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 16.4 0.0 0.0 0.0 0.9 0.0 0.2 0.1 0.0 0.3 10.5 0.0 0.2 0.4 0.1 1.7 8.4 0.6 0.1 0.0 0.7 0.0 1.3 4.5 1.7 1.9 2.0 1.4 1.3 2.0 1.8 1.7 2.5 1.4 3.7 0.3 1.0 0.2 1.5 1.7 3.0 4.3 3.0 6.8 3.9 1.0 4.3 3.2 12.6 3.4 29.8 9.8 5.2 25.1 35.5 0.4 6.5 10.2 10.7 9.1 17.4 0.0 0.2 0.0 31.3 1.7 18.5 23.1 0.0 39.1 0.5 19.0 25.8 9.2 8.3 13.3 0.0 2.4 25.8 16.1 1.1 13.8 20.7 32.1 19.0 17.9 8.7 34.5 14.0 14.9 5.6 0.6 19.4 34.9 14.0 3.8 30.1 0.7 13.8 11.4 17.9 MICU3 "DKFZp313A0139, EFHA2" ENSG00000155970 "Mitochondrial calcium uptake family member 3" Q86XE3 8 17027238-17122644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 76.0;Horizontal cells: 69.9;Rod photoreceptor cells: 78.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.0;HBF TERT88: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024048, HPA024771, HPA024779" Uncertain NA NA "HPA024048: AB_1848021, HPA024771: AB_1848022, HPA024779: AB_1848023" "unprognostic (2.99e-2)" "unprognostic (7.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.80e-2)" "unprognostic (1.19e-1)" "unprognostic (7.49e-2)" "unprognostic (2.25e-2)" "unprognostic (9.01e-5)" "unprognostic (9.82e-2)" "unprognostic (2.80e-1)" "unprognostic (1.11e-3)" "unprognostic (8.45e-2)" "unprognostic (2.32e-2)" "unprognostic (3.03e-3)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (4.65e-2)" 9.1 11.7 13.7 3.3 18.7 1.4 7.0 34.1 32.3 8.6 4.1 7.7 1.9 2.0 10.4 7.0 5.1 5.4 6.0 6.6 15.4 12.0 7.3 14.8 5.5 4.1 10.5 15.1 12.9 4.6 13.9 13.3 22.1 19.8 9.5 3.5 5.8 5.2 7.5 5.4 2.4 2.7 9.1 10.2 6.9 3.5 7.9 6.3 1.8 7.9 1.3 3.2 6.1 7.5 1.4 0.0 0.1 0.0 0.8 0.9 0.0 0.0 1.1 5.7 2.2 4.4 6.6 1.5 8.4 12.0 6.5 5.3 0.0 0.2 0.1 1.7 4.4 4.6 0.0 2.5 1.7 12.3 0.0 1.5 0.0 0.0 2.1 7.6 0.0 0.3 4.9 0.0 5.5 5.5 6.0 2.5 4.3 0.3 1.6 6.0 0.0 0.7 1.0 4.0 0.0 1.4 0.0 2.6 0.0 4.5 0.0 9.4 4.4 0.0 0.0 3.3 2.6 0.0 0.0 3.1 2.8 1.1 0.4 1.5 1.6 1.2 2.9 5.3 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.8 0.2 0.4 0.0 0.0 1.4 0.9 0.7 0.0 0.8 0.0 0.0 0.0 0.0 13.7 18.7 34.1 24.3 15.4 12.0 10.5 15.1 19.8 6.3 6.0 5.9 3.9 6.9 0.8 76.0 14.4 5.1 2.7 3.4 5.2 39.3 1.6 6.6 4.2 4.0 4.5 0.0 0.0 2.6 1.1 11.2 5.0 8.1 13.2 0.5 69.9 0.0 4.3 2.1 5.8 25.3 1.0 1.7 2.8 0.0 25.8 3.2 0.0 22.6 3.3 78.8 38.8 26.4 23.6 12.0 1.4 6.1 1.0 0.0 2.0 MID1 "FXY, OS, RNF59, TRIM18" ENSG00000101871 "Midline 1" O15344 X 10445310-10833654 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 65.2;Ito cells: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 57.2;AF22: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002878, HPA003715" Approved Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA002878: , HPA003715: AB_1079384" "unprognostic (1.99e-1)" "unprognostic (2.81e-1)" "unprognostic (4.66e-2)" "unprognostic (2.79e-1)" "unprognostic (2.78e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (3.06e-4)" "unprognostic (1.19e-1)" "unprognostic (3.61e-1)" "unprognostic (2.09e-1)" "unprognostic (2.87e-1)" "unprognostic (9.43e-2)" "unprognostic (1.25e-3)" "unprognostic (9.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.12e-3)" "unprognostic (5.88e-2)" 13.4 3.6 6.5 10.4 8.4 0.3 8.6 16.3 7.1 17.5 21.5 3.8 11.7 7.7 17.9 11.3 12.2 7.7 13.1 13.2 6.2 4.2 7.9 4.9 10.4 4.2 4.5 3.7 12.0 4.8 2.7 6.6 7.8 4.9 14.6 12.8 15.9 7.1 19.1 2.8 3.9 8.7 30.6 2.6 1.3 5.3 6.5 4.1 0.8 6.2 7.1 5.8 17.1 20.5 1.0 0.7 3.3 0.0 0.0 0.1 0.1 12.3 57.2 43.3 6.6 2.5 3.6 5.3 7.7 6.5 8.0 8.2 10.5 3.7 4.2 2.5 7.0 22.4 8.5 3.5 5.4 6.0 0.2 5.2 0.9 8.1 0.2 1.1 0.0 0.2 4.1 2.8 5.2 5.5 7.5 7.6 1.9 0.6 0.7 3.1 2.0 1.6 0.1 13.8 1.6 4.2 1.2 11.0 0.0 5.9 11.4 3.0 1.1 3.3 9.8 3.6 14.6 6.8 0.0 4.8 2.6 0.3 13.4 6.8 0.6 0.3 0.1 5.7 0.0 12.9 0.1 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.1 6.5 8.4 16.3 5.2 6.2 4.2 4.5 3.7 4.9 4.1 32.8 16.5 0.0 25.6 19.1 7.7 4.1 7.6 14.7 21.6 22.7 17.7 7.1 1.7 12.3 1.5 24.5 14.4 0.0 7.5 22.8 11.8 5.9 1.1 5.4 1.4 65.2 11.6 85.3 4.4 4.5 27.9 1.1 3.3 0.0 8.1 44.8 5.7 14.4 38.9 1.4 2.5 6.5 2.3 0.2 1.9 8.8 16.7 0.0 18.0 51.2 MIEF1 "FLJ20232, MiD51, SMCR7L" ENSG00000100335 "Mitochondrial elongation factor 1" Q9NQG6 22 39499432-39518132 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 232.6;Late spermatids: 280.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061059 Approved "Intermediate filaments,Mitochondria" NA NA "Intermediate filaments, Mitochondria" "HPA061059: " "unprognostic (5.35e-2)" "unprognostic (2.66e-2)" "unprognostic (2.86e-3)" "unprognostic (1.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (1.95e-3)" "unprognostic (1.85e-2)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (6.65e-2)" "prognostic favorable (3.96e-5)" "unprognostic (1.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.30e-1)" 14.9 12.6 14.5 15.1 14.9 16.2 12.3 17.3 21.3 10.0 15.1 12.3 12.9 17.5 12.1 12.9 13.9 10.9 14.2 11.6 13.0 12.9 19.6 26.2 10.8 15.5 13.6 15.9 12.1 14.3 16.6 8.3 12.6 12.1 10.6 14.2 12.5 15.6 14.1 16.7 11.5 16.6 10.3 10.8 18.0 11.7 43.1 10.7 15.9 12.6 11.1 16.6 11.5 13.8 7.1 8.1 5.9 8.3 8.7 9.2 7.6 8.0 8.1 9.0 14.2 8.5 9.3 10.3 7.7 9.2 8.9 8.2 13.3 4.2 22.4 6.5 8.3 5.9 10.3 20.2 10.7 11.1 9.5 18.7 9.2 11.4 13.4 16.4 32.5 12.3 12.2 13.1 7.9 16.9 8.6 9.4 7.6 16.2 12.4 8.8 5.4 10.2 9.0 8.3 16.7 8.9 14.1 12.7 22.8 10.2 9.8 8.2 6.8 8.6 14.9 22.0 9.8 6.6 11.8 9.2 8.4 11.9 7.4 9.4 22.7 23.6 22.8 9.7 14.2 12.9 0.6 7.4 5.9 7.6 8.3 9.2 7.0 7.3 7.2 8.1 7.1 8.1 7.5 0.7 8.7 7.8 4.5 6.3 7.6 14.5 14.9 17.3 21.3 13.0 12.9 13.6 15.9 12.1 10.7 11.9 16.0 5.2 10.4 17.3 18.5 15.7 12.7 8.1 5.7 15.7 23.6 16.0 21.6 10.9 232.6 9.8 16.0 0.0 11.7 16.5 10.1 14.5 9.2 34.2 14.0 6.4 9.4 20.3 15.4 280.8 14.4 13.6 15.1 8.2 10.7 19.8 14.0 3.5 13.1 20.3 13.5 0.0 8.5 17.2 27.1 20.1 10.9 7.7 18.9 14.7 MIEF2 "MGC23130, MiD49, SMCR7" ENSG00000177427 "Mitochondrial elongation factor 2" Q96C03 17 18260534-18266552 "Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042334 Uncertain NA NA "HPA042334: AB_10794418" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (7.56e-3)" "unprognostic (1.30e-1)" "unprognostic (8.28e-2)" "unprognostic (2.34e-1)" "unprognostic (1.73e-1)" "unprognostic (1.28e-2)" "unprognostic (3.62e-2)" "prognostic favorable (1.75e-7)" "unprognostic (4.68e-2)" "unprognostic (1.39e-1)" "unprognostic (2.40e-2)" "unprognostic (3.06e-2)" 4.9 8.7 5.4 4.2 6.7 3.3 5.3 12.0 13.5 9.7 6.0 7.6 13.3 7.0 6.7 11.0 9.0 9.0 9.0 13.2 5.3 6.6 9.7 5.1 6.2 4.7 4.7 10.3 11.7 7.0 7.9 9.2 7.5 7.2 7.5 3.7 7.2 10.4 7.7 34.9 8.0 6.3 6.6 4.0 5.6 6.3 3.7 5.4 5.3 11.9 11.8 5.7 7.5 6.6 4.7 4.1 8.7 5.7 10.9 5.3 2.9 18.3 5.4 2.1 4.4 1.5 1.8 3.5 6.2 3.7 5.5 2.7 7.8 5.7 2.6 6.7 3.3 2.4 13.9 1.5 4.9 2.7 2.5 7.9 0.9 8.8 3.6 2.7 0.4 2.2 1.8 5.1 2.7 2.0 4.4 2.2 3.5 2.1 0.7 2.0 5.1 2.3 1.8 1.7 4.4 2.8 3.2 5.7 3.1 7.5 3.3 1.4 3.3 4.9 6.1 2.7 13.9 14.3 1.7 2.6 3.8 6.1 5.7 2.9 2.9 1.7 0.7 5.3 0.9 2.0 2.4 2.4 8.7 5.3 2.5 4.7 3.1 4.1 4.4 2.8 4.7 5.0 4.7 4.0 10.9 5.7 4.1 4.8 2.9 5.4 6.7 12.0 13.5 5.3 6.6 4.7 10.3 7.2 5.4 14.9 5.9 5.7 4.4 1.6 16.0 8.5 2.5 8.1 2.3 10.4 15.7 9.7 8.3 14.4 15.0 3.6 5.4 0.0 5.2 4.6 3.5 3.8 2.3 3.6 3.5 36.5 4.1 1.3 3.8 1.4 7.5 1.7 0.0 1.8 4.7 9.1 15.1 5.8 9.6 4.4 19.1 6.5 4.1 1.8 3.6 1.5 6.4 4.3 4.8 2.2 MIGA1 "FAM73A, FLJ35093" ENSG00000180488 "Mitoguardin 1" Q8NAN2 1 77779624-77879539 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 27.0;Collecting duct cells: 22.7;Proximal tubular cells: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017589 Approved Supported Mitochondria NA NA Mitochondria "HPA017589: AB_1848409" "unprognostic (3.27e-1)" "unprognostic (1.19e-2)" "unprognostic (7.31e-3)" "unprognostic (4.62e-3)" "unprognostic (2.40e-1)" "unprognostic (3.48e-2)" "unprognostic (2.70e-2)" "unprognostic (7.27e-2)" "unprognostic (1.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (6.82e-2)" "unprognostic (3.13e-3)" "unprognostic (1.89e-1)" "unprognostic (1.68e-1)" "unprognostic (4.71e-2)" "unprognostic (4.75e-2)" 11.7 11.0 12.2 6.9 23.7 8.1 19.2 18.1 25.4 10.5 8.2 20.3 7.2 9.7 12.0 7.5 8.7 9.1 10.3 8.6 15.7 16.1 20.2 11.2 8.3 6.6 19.2 19.7 12.7 8.9 28.0 13.9 10.1 26.4 13.3 8.0 7.6 12.1 9.6 15.7 7.6 10.6 10.1 29.9 7.5 9.8 7.6 18.8 5.9 21.8 5.1 5.9 10.5 8.1 6.2 3.7 7.3 6.8 5.8 6.7 3.2 8.6 5.6 3.5 4.5 8.7 11.4 9.3 12.5 5.9 7.4 7.6 6.2 6.0 3.8 13.9 8.6 8.9 6.0 4.7 7.4 14.1 5.5 4.8 4.4 6.9 2.9 8.9 4.1 3.4 8.1 8.1 15.1 11.0 10.6 7.4 3.4 2.4 5.2 11.2 1.4 3.9 2.3 3.0 4.3 7.0 2.1 8.6 1.9 9.0 9.4 7.1 5.8 5.8 8.8 16.0 6.1 3.3 2.7 11.8 10.6 4.9 16.0 13.1 3.1 4.3 2.4 9.4 3.6 4.6 7.3 5.5 6.6 5.9 6.8 6.2 4.6 4.7 4.7 3.7 6.2 6.7 5.9 3.5 5.8 4.3 3.0 4.3 3.2 12.2 23.7 18.1 25.4 15.7 16.1 19.2 19.7 26.4 18.8 32.8 27.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 19.4 22.7 0.0 13.4 5.0 13.8 0.0 0.0 0.0 0.0 12.6 10.5 0.0 0.0 11.6 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 4.6 0.0 0.0 15.3 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 MIGA2 "C9orf54, FAM73B, FLJ00199, FLJ14596" ENSG00000148343 "Mitoguardin 2" Q7L4E1 9 129036621-129072082 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 9.0;Club cells: 5.7;Collecting duct cells: 7.0;monocytes: 6.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041363 Approved Approved "Cell Junctions,Cytosol" NA NA Cytosol "Cell Junctions" "HPA041363: AB_10794664" "unprognostic (2.10e-1)" "unprognostic (4.82e-3)" "unprognostic (1.07e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-2)" "unprognostic (1.01e-1)" "unprognostic (3.93e-2)" "unprognostic (3.07e-3)" "unprognostic (2.90e-2)" "prognostic favorable (3.04e-6)" "unprognostic (1.12e-2)" "unprognostic (1.44e-3)" "unprognostic (8.57e-3)" "unprognostic (1.25e-1)" "unprognostic (4.63e-2)" "unprognostic (4.15e-3)" 10.1 14.3 7.7 11.5 10.2 17.3 6.8 17.6 16.0 5.6 17.2 8.9 14.6 23.7 7.6 8.7 11.5 7.1 13.3 24.4 7.9 11.6 7.6 7.4 5.2 7.5 9.0 10.9 8.4 6.8 7.5 8.5 3.1 9.4 9.3 5.5 8.7 11.1 12.3 13.0 9.8 21.6 9.0 7.6 7.1 9.9 7.0 7.2 8.0 9.6 5.3 10.8 10.0 9.8 2.8 3.9 8.5 3.1 1.2 6.5 2.2 4.0 8.3 2.6 13.0 7.1 3.7 5.8 7.3 5.5 8.4 5.3 7.2 8.5 6.1 3.3 5.6 7.3 19.3 3.5 5.4 1.3 5.6 5.1 4.4 16.2 5.3 7.9 5.0 10.1 5.2 4.3 7.6 3.9 2.7 5.8 5.8 6.4 2.6 4.5 10.6 5.0 10.3 6.0 9.7 12.1 10.3 7.6 10.1 4.4 7.8 8.2 5.8 8.1 12.9 4.5 1.6 9.3 5.4 5.7 5.5 6.3 9.1 5.5 3.5 5.1 5.7 7.8 4.0 6.4 8.5 2.6 2.4 3.0 3.1 6.5 2.3 2.2 3.9 2.9 2.8 2.2 1.3 4.8 1.2 1.7 3.9 1.9 2.2 7.7 10.2 17.6 16.0 7.9 11.6 9.0 10.9 9.4 7.2 3.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.7 7.0 0.0 2.5 1.7 4.7 0.0 0.0 0.0 0.0 4.0 1.9 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 6.4 0.0 0.0 4.5 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 MILR1 "Allergin-1, C17orf60, MCA-32" ENSG00000271605 "Mast cell immunoglobulin like receptor 1" Q7Z6M3 17 64449037-64468643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.0" "Group enriched" "Detected in many" 8 "granulocytes: 33.5;Hofbauer cells: 64.4;Kupffer cells: 28.0;Macrophages: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.9;CAPAN-2: 46.9;Daudi: 23.0;REH: 18.3;U-698: 24.6" "Low region specificity" "Detected in all" HPA014347 Enhanced NA NA 130000 "HPA014347: AB_2732408" "unprognostic (8.40e-2)" "unprognostic (9.77e-2)" "unprognostic (9.28e-3)" "unprognostic (3.27e-1)" "unprognostic (1.17e-1)" "unprognostic (1.21e-2)" "unprognostic (1.27e-2)" "unprognostic (1.22e-1)" "unprognostic (3.25e-1)" "unprognostic (3.31e-2)" "unprognostic (5.99e-3)" "unprognostic (4.78e-2)" "prognostic unfavorable (5.07e-6)" "unprognostic (2.51e-2)" "unprognostic (7.12e-3)" "unprognostic (1.09e-1)" "unprognostic (5.99e-2)" 8.4 6.7 6.6 22.3 12.6 13.1 5.0 1.5 6.7 6.8 3.9 11.8 0.6 3.7 3.0 6.9 3.4 4.2 7.3 6.2 7.4 5.4 4.3 3.2 11.4 24.6 13.9 2.3 3.9 2.9 2.5 3.1 13.6 9.8 4.4 7.7 5.6 5.0 2.0 1.6 1.9 7.1 6.7 18.6 24.2 3.1 2.2 11.2 2.2 3.8 3.1 17.7 7.1 3.4 9.4 21.5 28.0 18.7 0.6 0.4 5.2 2.8 0.6 0.0 0.1 1.7 17.9 0.3 0.0 1.9 0.3 3.9 0.1 46.9 23.0 1.0 0.2 9.1 0.5 0.0 0.8 1.1 0.1 0.0 0.5 0.3 0.0 0.3 1.5 15.3 1.7 0.1 5.7 0.7 2.2 1.7 0.2 1.6 2.8 11.1 0.0 0.2 3.0 0.1 0.2 3.2 18.3 3.1 9.5 0.6 0.3 0.1 0.0 1.5 0.2 3.0 0.0 0.1 12.8 6.0 0.2 0.6 0.1 1.1 0.2 0.0 24.6 12.4 2.6 0.0 28.0 18.7 1.0 0.4 15.4 0.3 9.4 0.2 0.3 11.9 6.5 0.3 0.4 5.7 0.6 9.6 21.5 0.2 5.2 6.6 12.6 1.5 6.7 7.4 5.4 13.9 2.3 9.8 11.2 0.0 0.3 4.2 2.3 0.5 0.1 0.4 2.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 1.6 0.0 0.0 0.0 2.1 1.9 2.0 33.5 0.0 64.4 0.0 4.7 1.8 28.0 0.0 3.7 28.9 0.0 1.0 0.2 0.5 0.0 0.3 1.4 0.0 0.6 0.0 2.0 0.2 0.2 1.5 1.0 0.5 1.5 2.2 MINOS1 "C1orf151, FLJ36999, Mic10, MIO10, RP5-1056L3.2" ENSG00000173436 "Mitochondrial inner membrane organizing system 1" Q5TGZ0 1 19596977-19629821 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059930 Enhanced Supported Mitochondria NA NA Mitochondria "HPA059930: AB_2684167" "unprognostic (3.84e-2)" "unprognostic (8.74e-3)" "unprognostic (2.66e-2)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.98e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.88e-1)" "unprognostic (8.74e-2)" "unprognostic (3.96e-1)" "unprognostic (1.37e-1)" "unprognostic (2.43e-2)" "unprognostic (1.24e-3)" "unprognostic (7.13e-2)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "prognostic favorable (8.11e-4)" 10.1 9.7 22.0 8.1 21.3 5.4 12.6 20.4 22.2 17.7 16.3 7.2 7.5 10.6 14.5 13.7 15.1 15.2 13.7 25.4 18.3 21.4 19.8 12.5 9.7 8.3 20.6 15.5 14.0 13.3 14.5 16.6 8.3 17.0 17.2 18.3 9.3 13.8 17.8 25.2 10.1 17.4 18.2 12.1 8.9 11.4 5.0 11.8 7.7 13.7 20.3 11.8 13.9 10.9 7.0 8.4 9.0 10.5 3.7 11.3 8.9 7.6 10.6 6.0 6.6 11.6 11.1 3.7 6.7 7.6 7.9 8.0 7.4 7.1 6.5 5.6 8.8 6.4 5.6 10.5 8.8 12.8 9.8 7.3 5.7 17.0 10.2 5.1 8.8 4.3 9.0 14.5 7.9 9.7 6.0 11.5 4.9 12.1 4.9 11.8 13.6 4.5 11.5 5.1 10.0 13.5 4.5 7.3 8.6 19.3 4.7 12.5 5.6 7.4 6.0 5.8 5.0 5.9 4.9 7.6 6.2 4.8 7.8 6.6 3.1 5.2 6.7 4.8 16.9 5.8 5.6 8.1 9.0 6.4 10.5 5.8 7.0 8.7 7.0 8.2 6.7 11.3 8.1 5.5 3.7 10.5 8.4 7.8 8.9 22.0 21.3 20.4 22.2 18.3 21.4 20.6 15.5 17.0 11.8 157.8 125.9 175.7 110.6 149.9 78.1 411.9 318.5 207.5 112.6 347.2 43.2 260.0 704.6 351.8 112.1 128.1 424.9 46.7 394.4 215.9 199.3 157.4 195.4 297.4 460.5 85.8 231.3 133.8 238.8 184.5 222.6 223.0 214.2 236.3 403.3 76.4 343.8 474.2 207.9 655.8 74.3 64.7 206.0 163.1 143.3 192.6 153.4 121.5 528.4 124.4 MIP "AQP0, LIM1, MP26" ENSG00000135517 "Major intrinsic protein of lens fiber" P30301 12 56449502-56469166 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Transport, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 2.9;retina: 2.1;testis: 3.3" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 1.9;Horizontal cells: 1.6;Late spermatids: 2.4;Spermatocytes: 6.0;Spermatogonia: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 2.8;SK-BR-3: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA014940 Supported NA NA "HPA014940: AB_2669122" "unprognostic (6.48e-2)" "unprognostic (6.12e-2)" "unprognostic (2.23e-1)" "unprognostic (1.62e-1)" "unprognostic (7.14e-2)" "unprognostic (3.96e-2)" "unprognostic (2.90e-3)" "unprognostic (1.72e-1)" "unprognostic (3.47e-1)" "unprognostic (1.51e-5)" "unprognostic (4.56e-3)" "unprognostic (6.75e-2)" "unprognostic (1.16e-2)" "unprognostic (2.83e-2)" "unprognostic (3.27e-1)" "unprognostic (2.62e-1)" "unprognostic (8.82e-2)" 0.2 0.4 0.4 0.2 0.5 0.1 0.2 0.3 0.7 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.4 0.5 0.8 0.2 2.9 0.2 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.3 2.1 0.2 0.2 0.2 0.1 0.2 0.2 0.6 0.2 0.0 3.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.1 1.3 1.0 1.4 0.3 0.6 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.6 0.1 0.0 0.3 0.8 0.0 0.2 0.9 0.1 0.1 0.2 0.2 0.2 0.0 0.0 0.6 0.4 2.8 0.2 0.0 0.1 0.9 1.8 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.4 1.7 0.4 0.4 0.0 0.9 0.6 0.0 0.6 0.0 0.1 0.7 0.4 0.4 1.5 0.5 0.9 2.6 0.8 0.2 0.5 1.8 0.2 0.4 0.3 0.0 0.0 0.1 0.2 0.9 0.0 0.8 0.3 1.0 1.4 0.1 0.6 0.8 0.3 0.7 0.6 0.2 0.0 1.1 0.2 0.4 0.6 0.3 0.3 1.3 0.5 0.0 0.4 0.5 0.3 0.5 0.5 0.8 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 6.0 1.3 0.0 0.2 0.0 0.0 0.0 MLANA MART1 ENSG00000120215 Melan-A Q16655 9 5890802-5910606 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 191.5" "Cell type enriched" "Detected in some" 25 "Melanocytes: 1629.7" "Cancer enriched" "Detected in single" 556 "melanoma: 277.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in single" 385 "SK-MEL-30: 123.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000057, HPA048662" Enhanced NA NA "CAB000057: AB_442107, HPA048662: AB_2680485" "unprognostic (2.52e-2)" "unprognostic (6.87e-2)" "unprognostic (5.20e-2)" "unprognostic (5.61e-2)" "unprognostic (2.58e-2)" "unprognostic (1.46e-1)" "unprognostic (4.53e-1)" "unprognostic (3.32e-1)" "unprognostic (2.82e-2)" "unprognostic (1.71e-3)" "unprognostic (3.60e-3)" "unprognostic (1.20e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (8.01e-2)" "unprognostic (5.78e-2)" "unprognostic (9.43e-2)" 0.1 0.1 0.1 0.2 0.1 0.6 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 191.5 1.2 0.1 0.2 31.5 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.3 2.1 1.6 3.5 1.2 1.8 1.5 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.5 1.2 0.8 1.4 0.8 1.1 1.4 1.3 1.2 0.4 2.1 1.4 1.5 2.9 1.8 1.1 1.6 0.6 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 65.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1629.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 12.7 0.0 0.0 0.0 0.0 MLC1 "KIAA0027, LVM, MLC, VL" ENSG00000100427 "Megalencephalic leukoencephalopathy with subcortical cysts 1" Q15049 22 50059391-50085902 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.0;brain: 95.3" "Cell type enhanced" "Detected in some" 23 "Hofbauer cells: 2.6;Muller glia cells: 12.6;T-cells: 4.5" "Cancer enriched" "Detected in some" 69 "glioma: 122.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 15.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 46.8;NB-4: 43.3;THP-1: 82.0;U-266/70: 28.7;U-266/84: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003040 Enhanced Supported Cytosol NA NA Cytosol "HPA003040: AB_1079387" "unprognostic (2.68e-2)" "unprognostic (5.46e-6)" "unprognostic (5.41e-3)" "unprognostic (1.51e-1)" "unprognostic (1.47e-1)" "unprognostic (2.42e-3)" "unprognostic (9.54e-3)" "unprognostic (7.21e-2)" "unprognostic (2.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.31e-1)" "unprognostic (1.51e-3)" "unprognostic (8.39e-4)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (3.66e-2)" "unprognostic (2.92e-1)" 1.6 1.4 42.3 1.9 45.4 27.0 1.4 17.6 95.3 2.5 1.5 25.9 0.0 1.8 1.5 2.3 1.4 2.8 2.1 1.6 30.9 19.6 1.4 1.6 2.3 1.6 22.5 28.9 1.4 1.4 1.4 0.1 3.2 18.4 2.9 1.4 0.0 1.5 2.6 1.4 2.2 1.5 1.6 18.9 2.8 1.5 2.8 17.3 0.0 1.4 0.0 1.8 1.8 2.6 0.1 0.7 0.1 7.1 15.8 3.3 2.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 46.8 15.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 43.3 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 82.0 0.0 0.0 0.0 0.0 0.0 28.7 24.5 0.0 0.0 7.2 0.4 0.0 0.7 0.0 3.3 5.7 0.1 0.1 0.2 1.4 0.7 0.0 0.1 1.6 0.1 15.8 7.1 0.1 0.1 2.7 42.3 45.4 17.6 29.8 30.9 19.6 22.5 28.9 18.4 17.3 0.0 0.3 0.0 0.0 0.2 0.2 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 2.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.2 4.5 0.0 0.0 MLEC KIAA0152 ENSG00000110917 Malectin Q14165 12 120686869-120701864 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 1300000 "unprognostic (1.50e-1)" "unprognostic (1.74e-1)" "unprognostic (2.01e-2)" "prognostic favorable (9.60e-6)" "unprognostic (4.99e-2)" "unprognostic (1.59e-1)" "unprognostic (5.41e-2)" "unprognostic (3.94e-1)" "unprognostic (3.39e-1)" "unprognostic (9.77e-2)" "unprognostic (5.90e-2)" "unprognostic (1.76e-1)" "unprognostic (1.15e-2)" "prognostic favorable (8.77e-4)" "unprognostic (1.98e-1)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" 22.1 57.6 15.2 23.0 18.2 10.7 18.6 10.1 16.8 19.9 43.9 17.3 48.1 27.4 20.9 50.8 12.0 17.6 34.1 33.7 14.8 15.8 35.2 81.2 13.9 13.2 14.6 11.6 23.5 52.9 37.4 22.8 24.1 15.1 22.9 42.2 15.9 32.5 41.0 24.5 9.6 40.8 17.7 15.1 20.2 20.4 35.9 15.6 18.0 57.9 15.8 15.0 15.6 20.5 5.2 17.3 6.6 7.1 3.5 3.9 1.7 34.5 50.7 32.9 43.2 56.8 31.5 37.5 42.3 35.4 31.5 23.5 35.5 21.9 28.3 38.3 39.3 25.1 29.5 39.7 24.6 40.0 24.3 21.9 40.6 22.5 27.7 20.9 56.3 36.9 23.8 23.5 34.2 26.6 49.9 27.4 26.6 23.7 33.4 32.7 35.4 29.5 33.2 45.5 43.0 26.0 32.7 24.1 30.7 37.6 58.6 17.0 20.2 48.8 24.5 24.1 42.8 36.8 39.8 22.7 34.1 33.1 33.0 28.5 24.8 44.9 21.8 42.7 41.2 34.9 0.3 5.5 6.6 3.6 7.1 3.9 3.7 2.2 3.3 4.6 5.2 3.8 3.2 1.5 3.5 5.3 17.3 2.1 1.7 15.2 18.2 10.1 16.8 14.8 15.8 14.6 11.6 15.1 15.6 23.8 57.6 35.0 52.2 64.7 39.0 136.7 94.3 29.4 31.8 82.0 43.2 78.6 31.5 110.1 196.0 69.4 147.4 93.5 159.1 142.5 71.3 147.8 49.5 167.7 112.5 79.4 77.2 32.5 54.9 186.3 76.5 65.4 183.9 43.3 171.4 73.5 119.5 42.1 101.5 100.9 39.6 84.1 56.0 129.9 183.1 51.3 96.7 39.9 273.6 75.8 MLF2 NTN4 ENSG00000089693 "Myeloid leukemia factor 2" Q15773 12 6747996-6767475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010811, HPA010859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA010811: AB_1079389, HPA010859: AB_1079388" "unprognostic (1.65e-1)" "unprognostic (6.55e-2)" "unprognostic (4.42e-1)" "unprognostic (9.88e-3)" "unprognostic (1.76e-1)" "unprognostic (4.19e-2)" "unprognostic (1.52e-1)" "unprognostic (4.15e-2)" "unprognostic (1.31e-1)" "unprognostic (9.11e-2)" "unprognostic (3.37e-1)" "unprognostic (6.23e-2)" "unprognostic (1.38e-1)" "unprognostic (5.83e-2)" "unprognostic (4.72e-1)" "unprognostic (8.44e-2)" "unprognostic (3.63e-1)" 31.4 45.6 55.8 23.3 65.4 36.9 24.9 50.5 100.5 28.6 30.9 44.0 23.9 36.5 32.1 30.5 39.3 31.7 28.6 44.1 54.4 47.2 37.9 77.4 24.8 21.5 40.2 42.5 28.3 33.4 43.3 31.1 32.5 44.8 38.4 27.6 28.2 43.1 36.7 45.3 33.6 35.1 35.9 33.7 21.8 27.7 21.0 30.7 26.0 36.3 28.9 29.4 29.3 23.6 17.0 38.9 86.7 20.1 11.8 14.8 16.9 39.1 64.9 33.4 58.7 31.3 31.9 51.3 38.6 46.4 66.4 58.3 62.7 38.9 28.3 10.2 50.2 43.4 32.9 41.0 55.8 41.3 44.5 38.0 20.0 34.4 35.9 34.6 21.2 27.6 29.8 45.6 51.3 39.3 48.8 27.0 27.0 25.1 11.8 46.2 55.6 29.1 32.8 107.8 42.5 22.4 18.6 30.7 25.1 55.4 49.5 21.3 42.2 34.8 61.6 37.3 73.7 17.9 35.1 26.6 39.6 52.8 41.8 56.3 14.4 16.3 37.6 52.9 18.5 46.6 35.4 20.1 73.9 14.8 18.0 14.3 15.3 11.5 13.9 22.6 17.0 12.2 13.5 86.7 11.8 19.5 38.9 11.2 16.9 55.8 65.4 50.5 100.5 54.4 47.2 40.2 42.5 44.8 30.7 35.7 25.7 57.9 127.1 121.2 102.4 55.8 104.4 45.5 36.4 104.7 39.3 229.6 237.1 156.1 7.9 68.0 134.5 0.0 110.6 175.2 95.0 155.3 83.1 146.5 129.4 76.3 96.6 62.0 41.9 7.0 105.6 62.0 97.8 201.0 116.3 120.9 125.1 111.0 100.8 262.4 48.7 51.8 117.9 51.9 90.7 109.8 357.4 59.8 120.9 152.3 MLLT10 AF10 ENSG00000078403 "MLLT10, histone lysine methyltransferase DOT1L cofactor" P55197 10 21524675-21743630 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 158.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005747 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA005747: AB_1079393" "unprognostic (6.58e-2)" "unprognostic (1.57e-1)" "unprognostic (7.32e-2)" "unprognostic (1.47e-2)" "unprognostic (1.31e-2)" "prognostic favorable (8.75e-4)" "unprognostic (1.03e-3)" "unprognostic (9.56e-3)" "unprognostic (9.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.69e-2)" "unprognostic (7.85e-2)" "unprognostic (6.57e-2)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" 16.3 12.1 11.7 18.4 14.3 21.9 12.8 25.4 13.6 19.0 17.0 12.0 13.6 8.5 26.3 12.8 14.7 14.5 13.7 15.8 10.2 8.5 12.3 13.5 12.3 11.6 10.5 9.9 21.4 12.3 16.6 23.2 20.3 11.8 12.6 11.3 14.6 13.2 16.3 13.4 18.7 12.1 18.7 11.2 10.6 11.4 71.2 14.3 14.6 18.1 9.7 15.2 18.5 19.6 5.5 6.9 12.0 6.8 5.3 7.2 2.8 14.5 12.4 19.1 13.2 12.1 15.3 21.0 9.2 5.8 11.6 11.3 13.1 15.5 17.4 5.1 10.2 10.0 13.7 21.0 12.4 11.6 12.0 12.2 27.0 10.8 18.9 15.0 0.6 17.4 11.4 14.8 9.6 11.1 11.8 15.3 18.3 28.8 13.6 9.1 11.3 20.9 12.6 7.8 8.1 3.9 18.3 10.2 14.6 11.1 6.9 6.7 18.6 12.2 14.7 20.7 17.7 6.9 18.7 13.8 7.3 12.7 14.5 9.1 11.8 13.6 19.5 8.4 10.4 5.6 10.6 6.8 12.0 5.3 4.6 5.2 5.0 6.2 5.7 5.6 5.5 7.2 6.7 5.8 5.3 5.2 6.9 4.6 2.8 11.7 14.3 25.4 13.6 10.2 8.5 10.5 9.9 11.8 14.3 26.8 36.0 13.7 13.7 33.5 31.4 23.5 20.4 17.4 20.5 17.4 41.2 28.7 11.6 12.4 52.7 20.3 15.5 0.0 11.2 48.3 23.9 18.2 23.3 17.8 25.1 28.6 3.4 27.0 30.5 78.0 36.5 23.5 45.5 20.8 15.6 19.7 11.6 14.0 45.3 17.5 50.9 38.8 19.4 158.1 57.1 38.3 42.0 23.5 18.3 10.1 MLN ENSG00000096395 Motilin P12872 6 33794673-33804011 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 175 "intestine: 76.0" "Cell type enriched" "Detected in single" 34 "Intestinal endocrine cells: 3.4" "Cancer enriched" "Detected in some" 6 "testis cancer: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;BEWO: 1.8;CACO-2: 7.3;RPMI-8226: 1.7;SuSa: 3.1;TIME: 3.4" "Not detected" "Not detected" HPA069392 Enhanced "Secreted to blood" NA NA 450000 "HPA069392: AB_2686136" "unprognostic (7.70e-2)" "unprognostic (6.70e-2)" "unprognostic (4.44e-2)" "unprognostic (3.14e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 58.4 0.0 0.0 76.0 0.1 0.0 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 30.6 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.8 0.0 0.0 0.0 3.1 0.0 0.0 3.4 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MLNR GPR38 ENSG00000102539 "Motilin receptor" O43193 13 49220338-49222377 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "bone marrow: 3.9;stomach 1: 2.8;thyroid gland: 5.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "testis cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;NTERA-2: 3.0;THP-1: 9.2" "Low region specificity" "Detected in many" NA NA "unprognostic (9.75e-2)" "unprognostic (2.13e-2)" "unprognostic (2.90e-1)" "unprognostic (1.13e-1)" "unprognostic (6.03e-2)" "unprognostic (7.80e-2)" "unprognostic (1.54e-2)" "unprognostic (7.79e-2)" "unprognostic (1.88e-2)" "unprognostic (3.74e-1)" "unprognostic (2.61e-4)" "unprognostic (3.53e-2)" "unprognostic (1.04e-1)" "unprognostic (1.38e-1)" 0.1 0.1 0.2 0.0 0.2 3.9 0.0 0.0 0.1 0.3 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.1 2.8 0.4 5.6 0.0 0.0 0.1 0.0 0.0 0.7 0.6 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.1 0.1 0.0 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.3 0.0 0.8 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MMD "MMA, PAQR11" ENSG00000108960 "Monocyte to macrophage differentiation associated" Q15546 17 55392613-55421992 "Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 61.1;brain: 40.5;breast: 46.0" "Cell type enhanced" "Detected in many" 6 "monocytes: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 32.8;HSkMC: 59.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026978 Approved Vesicles NA NA Vesicles "HPA026978: AB_2672068" "unprognostic (1.33e-1)" "unprognostic (2.92e-2)" "prognostic favorable (3.52e-5)" "prognostic unfavorable (3.88e-4)" "unprognostic (2.48e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (6.39e-5)" "unprognostic (8.07e-3)" "unprognostic (6.67e-2)" "unprognostic (2.15e-1)" "unprognostic (1.30e-1)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (3.71e-3)" "unprognostic (7.93e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.12e-2)" 61.1 6.6 33.4 7.1 40.5 5.3 46.0 2.0 23.7 2.6 5.6 4.1 1.7 5.0 3.2 4.9 3.6 1.8 4.7 5.0 26.9 7.5 3.2 6.0 4.7 9.0 11.2 5.1 1.5 1.6 0.9 2.1 13.4 4.6 3.2 6.5 3.2 2.2 4.1 2.5 2.5 4.7 5.4 6.5 8.7 2.4 7.8 5.0 1.4 3.3 1.2 5.6 5.7 4.1 4.1 3.6 9.6 1.6 2.2 4.2 15.9 5.1 13.2 19.5 3.8 32.8 25.9 9.6 3.2 1.5 2.0 3.0 2.0 15.3 7.4 9.4 1.1 5.8 0.3 5.4 4.1 4.3 9.7 1.9 2.7 0.7 23.9 8.8 2.6 0.8 59.3 1.3 2.9 3.3 4.6 2.6 7.2 0.9 5.9 4.3 0.7 7.3 1.9 5.3 0.9 3.4 2.9 12.6 2.7 5.7 1.4 1.8 18.6 1.1 2.0 2.9 12.7 4.3 4.7 2.4 5.4 6.5 4.3 3.6 2.6 1.3 10.4 7.8 2.2 4.3 9.6 1.3 1.5 1.4 1.6 4.2 3.6 1.6 2.9 3.6 4.1 2.7 2.9 3.8 2.2 1.5 1.1 1.7 15.9 33.4 40.5 2.0 16.9 26.9 7.5 11.2 5.1 4.6 5.0 3.0 1.1 10.5 17.0 4.7 24.9 4.3 7.6 0.0 1.2 7.0 3.9 8.1 13.3 22.9 2.1 11.3 2.6 46.7 1.2 13.7 8.0 18.3 0.0 17.0 32.6 15.9 7.5 10.4 35.9 2.5 1.7 28.4 6.8 74.9 5.8 11.5 12.0 0.0 3.2 7.1 9.3 19.4 5.2 15.6 16.0 15.3 16.7 12.5 7.9 4.0 MMD2 PAQR10 ENSG00000136297 "Monocyte to macrophage differentiation associated 2" Q8IY49 7 4905989-4959213 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 38.5;testis: 10.1" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 2.0;Muller glia cells: 2.4;Rod photoreceptor cells: 2.3" "Cancer enriched" "Detected in single" 59 "glioma: 3.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.9;SH-SY5Y: 2.0;U-87 MG: 1.0" "Low region specificity" "Detected in all" NA NA "unprognostic (2.32e-1)" "unprognostic (1.53e-2)" "unprognostic (5.03e-2)" "unprognostic (2.03e-1)" 0.9 1.2 10.6 0.9 16.2 0.8 0.8 2.4 38.5 0.9 0.9 4.0 0.0 0.9 0.8 0.9 0.9 0.8 0.9 0.8 7.4 6.5 0.9 0.8 0.8 0.9 7.4 6.8 1.0 0.8 0.8 1.9 0.8 7.9 0.9 0.9 1.4 1.0 1.0 0.8 0.8 1.0 0.9 16.7 0.8 0.9 10.1 3.7 0.0 0.9 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.6 16.2 2.4 9.8 7.4 6.5 7.4 6.8 7.9 3.7 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 MME "CALLA, CD10, NEP" ENSG00000196549 "Membrane metalloendopeptidase" P08473 3 155024124-155183729 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.1;intestine: 136.0;kidney: 64.9" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 62.4;Cytotrophoblasts: 71.6;Proximal tubular cells: 101.6;Syncytiotrophoblasts: 105.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 129 "neutrophil: 61.1" "Lineage enriched" "Detected in single" 129 "granulocytes: 61.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 97.1;BJ hTERT+: 146.1;HSkMC: 94.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 26.8" "CAB000013, HPA052583, HPA056072" Enhanced NA NA 99000 "CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027" "unprognostic (1.36e-1)" "unprognostic (1.02e-3)" "unprognostic (8.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.78e-2)" "unprognostic (6.52e-3)" "unprognostic (1.20e-1)" "unprognostic (1.67e-2)" "unprognostic (8.67e-2)" "unprognostic (1.96e-1)" "unprognostic (7.30e-3)" "unprognostic (1.31e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-1)" "unprognostic (7.29e-2)" "unprognostic (1.06e-2)" "unprognostic (1.37e-2)" 26.5 0.4 0.4 3.4 7.4 1.9 14.7 0.4 0.7 4.8 65.6 0.1 18.4 74.0 2.8 8.1 0.7 0.9 8.5 1.8 0.3 0.4 64.9 11.5 13.7 3.0 2.1 0.2 0.9 0.6 0.0 0.6 35.0 8.6 18.3 0.4 1.3 3.7 11.3 11.7 1.4 136.0 0.6 0.9 2.7 0.7 1.0 1.2 13.2 1.0 5.3 2.3 3.4 4.9 0.1 0.4 61.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 39.4 97.1 0.2 21.7 146.1 11.1 28.7 0.0 0.0 23.9 0.0 19.2 15.1 0.0 0.7 0.8 26.7 0.0 0.1 0.0 0.0 0.0 31.6 0.0 0.0 94.2 0.1 5.9 42.5 12.3 8.4 0.0 0.0 0.0 17.7 0.1 0.0 0.1 0.9 0.0 0.1 39.7 18.7 0.1 0.6 0.2 0.0 0.2 0.0 0.0 4.2 8.9 0.0 0.0 23.8 47.7 0.1 16.3 3.7 0.0 0.0 31.5 5.7 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 61.1 0.0 0.0 0.4 0.0 0.0 0.4 7.4 0.4 0.7 0.3 0.4 2.1 0.2 8.6 1.2 8.9 18.3 0.9 62.4 0.7 0.0 1.1 17.8 2.7 19.4 21.0 0.0 71.6 8.3 0.1 0.3 0.6 0.0 0.0 0.0 48.9 19.2 29.2 2.3 48.9 8.1 0.0 0.0 3.1 1.8 0.2 3.7 2.7 0.0 0.0 0.2 0.0 0.3 0.0 1.1 101.6 0.0 0.0 3.1 0.2 0.4 0.3 105.4 0.0 0.0 29.2 MMEL1 "MMEL2, NEPII, NL1, NL2, SEP" ENSG00000142606 "Membrane metalloendopeptidase like 1" Q495T6 1 2590639-2632990 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 30.2" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 28.1;Early spermatids: 82.5;Late spermatids: 27.3;Paneth cells: 37.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 8.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007876, HPA008205, CAB020786" Uncertain "Intracellular and membrane" NA NA "CAB020786: , HPA007876: AB_1854012, HPA008205: AB_1854011" "unprognostic (5.80e-2)" "unprognostic (4.61e-2)" "unprognostic (1.87e-1)" "unprognostic (4.27e-2)" "unprognostic (1.33e-1)" "unprognostic (2.71e-2)" "unprognostic (1.45e-1)" "unprognostic (7.96e-2)" "unprognostic (1.36e-2)" "unprognostic (2.37e-1)" "unprognostic (4.54e-3)" "unprognostic (2.44e-2)" "unprognostic (4.79e-2)" "unprognostic (3.18e-1)" "unprognostic (2.82e-1)" "unprognostic (2.18e-3)" "unprognostic (7.01e-4)" 1.5 0.5 0.8 1.8 8.5 0.6 1.8 0.4 0.6 4.3 4.2 0.4 1.9 3.2 0.8 10.3 3.0 3.0 9.6 1.3 1.0 2.6 1.4 0.4 1.4 1.4 1.7 0.4 1.1 7.3 0.3 0.4 0.7 0.5 4.2 1.4 0.4 2.0 2.0 0.4 0.3 2.6 0.9 0.7 1.4 7.9 30.2 0.9 0.8 1.1 0.8 0.8 3.7 1.6 0.6 1.1 6.6 5.1 2.3 6.1 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.5 0.0 17.8 0.0 0.1 1.7 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 1.5 6.6 0.5 3.9 0.3 0.6 1.7 0.7 1.1 0.0 4.5 2.2 1.0 2.3 5.1 0.2 6.1 2.2 0.8 8.5 0.4 0.6 1.0 2.6 1.7 0.4 0.5 0.9 0.0 0.0 0.0 4.6 0.0 0.0 0.8 28.1 10.7 2.3 17.4 0.0 0.0 0.0 7.1 82.5 0.6 15.7 0.0 3.1 0.0 0.3 12.4 0.0 0.0 1.3 0.0 1.2 0.6 1.5 27.3 1.7 0.5 0.0 0.0 14.9 0.5 2.7 37.7 1.1 0.0 0.0 0.0 0.4 0.5 0.9 0.0 0.0 0.0 9.7 10.9 MMGT1 "EMC5, TMEM32" ENSG00000169446 "Membrane magnesium transporter 1" Q8N4V1 X 135962070-135974063 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032037 Approved NA NA "HPA032037: AB_10670705" "prognostic unfavorable (8.54e-4)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (1.90e-2)" "unprognostic (2.23e-3)" "unprognostic (8.94e-3)" "unprognostic (2.61e-2)" "unprognostic (1.34e-1)" "unprognostic (2.73e-1)" "unprognostic (3.87e-1)" "unprognostic (2.35e-1)" "unprognostic (2.38e-1)" "prognostic favorable (1.94e-5)" "unprognostic (6.08e-2)" "unprognostic (2.94e-2)" "unprognostic (1.05e-1)" "unprognostic (1.29e-2)" 25.6 13.4 12.2 11.4 21.3 25.6 16.7 13.7 22.7 19.5 18.7 17.0 10.0 12.5 24.8 17.9 18.5 17.0 15.4 18.0 12.1 18.0 19.4 10.7 18.8 19.2 14.4 12.3 18.6 14.8 18.4 20.8 13.5 15.8 17.5 17.1 17.2 16.5 15.6 28.0 14.2 13.9 21.0 18.8 14.5 16.5 7.2 9.8 23.3 23.6 12.9 14.2 24.6 15.3 8.6 11.7 9.7 14.3 10.7 15.3 9.7 13.9 8.4 8.6 13.5 17.9 17.3 11.1 15.7 15.2 13.3 26.5 9.8 21.7 9.2 31.2 17.0 15.6 12.7 21.6 11.7 20.8 10.3 12.4 5.7 10.8 6.2 13.2 12.8 10.1 14.0 21.3 22.3 16.3 13.9 9.9 10.8 7.8 19.3 15.0 14.5 9.5 8.7 6.0 17.3 13.2 8.8 13.7 17.2 12.2 7.6 12.5 11.5 8.4 10.1 21.6 13.2 8.5 7.8 10.1 16.4 9.7 23.7 21.1 11.8 16.6 10.0 14.0 19.2 18.7 9.7 12.3 7.2 9.5 12.5 12.5 8.6 13.1 11.5 11.7 6.2 12.8 12.2 6.2 10.7 14.3 8.0 15.3 9.7 12.2 21.3 13.7 22.7 12.1 18.0 14.4 12.3 15.8 9.8 11.9 10.7 10.0 15.3 19.7 15.1 23.7 15.3 8.1 12.5 14.0 7.9 6.4 6.6 11.2 0.0 11.7 14.8 0.0 10.6 10.3 10.8 19.3 13.9 9.6 13.4 19.1 24.8 14.1 31.7 0.2 12.7 20.8 25.3 7.2 16.7 16.7 11.4 3.5 18.0 12.9 9.9 6.5 21.7 1.4 7.9 21.7 9.6 13.8 14.5 14.8 MMP14 MT1-MMP ENSG00000157227 "Matrix metallopeptidase 14" P50281 14 22836557-22849027 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 216.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 96.4;HHSteC: 91.2;HSkMC: 92.7;hTERT-RPE1: 91.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009918, HPA051432" Approved Approved "Intermediate filaments,Cytosol" No No 570000 Cytosol "Intermediate filaments" "CAB009918: AB_2250767, HPA051432: AB_2681484" "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (4.28e-2)" "unprognostic (1.12e-2)" "unprognostic (3.05e-3)" "unprognostic (5.91e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (3.82e-3)" "unprognostic (7.31e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (5.02e-2)" "unprognostic (6.69e-2)" "unprognostic (1.00e-2)" "unprognostic (3.41e-3)" 60.9 10.5 2.4 16.6 4.7 0.2 64.2 2.2 3.2 56.3 35.0 8.2 12.7 12.0 53.1 24.1 47.0 21.9 39.6 17.5 3.4 1.8 16.8 9.0 29.8 16.9 5.8 2.9 39.3 11.2 34.4 4.7 73.5 16.4 39.1 11.3 27.1 24.4 16.7 20.4 37.0 22.9 28.5 20.7 22.5 18.2 26.3 4.6 5.4 22.3 14.6 16.7 52.5 53.9 0.1 0.7 0.0 0.7 0.0 0.0 0.1 7.8 0.1 2.4 0.1 96.4 61.3 44.3 24.7 49.8 7.5 13.4 2.3 29.4 0.1 13.8 26.0 2.3 20.0 0.0 25.7 9.6 0.1 0.1 3.6 0.1 0.5 91.2 0.0 0.1 92.7 15.5 31.2 26.8 91.6 45.3 0.1 0.0 0.2 17.6 0.1 0.0 8.8 1.4 1.7 4.3 0.3 8.5 0.0 6.8 13.5 0.0 0.0 16.1 0.0 53.5 10.8 0.1 7.9 40.0 60.9 5.2 17.7 28.1 0.1 0.1 0.1 37.1 0.0 35.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 4.7 2.2 3.2 3.4 1.8 5.8 2.9 16.4 4.6 11.9 4.8 3.7 19.4 30.2 0.0 3.6 53.5 2.7 3.4 7.0 0.0 83.6 10.0 61.2 0.4 13.5 16.8 0.0 24.9 216.8 65.7 13.9 3.5 2.9 79.3 0.0 7.5 41.1 18.3 0.7 66.7 26.5 35.4 34.3 32.5 17.1 102.2 28.5 51.6 13.0 0.8 38.8 34.8 0.9 0.7 29.9 102.6 1.0 17.1 28.7 MMP15 "MT2-MMP, MTMMP2, SMCP-2" ENSG00000102996 "Matrix metallopeptidase 15" P51511 16 58025566-58046901 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.2" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 56.0;Enterocytes: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 2.9" "Lineage enriched" "Detected in single" 30 "dendritic cells: 2.9" "Cell line enhanced" "Detected in many" "BEWO: 37.1;Hep G2: 19.3;SK-BR-3: 18.6;WM-115: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002611, HPA040390" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB002611: , HPA040390: AB_2676956" "unprognostic (1.76e-2)" "unprognostic (7.32e-2)" "unprognostic (2.69e-1)" "unprognostic (6.85e-2)" "unprognostic (3.09e-1)" "unprognostic (1.68e-1)" "unprognostic (6.88e-3)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (1.24e-2)" "unprognostic (4.81e-2)" "unprognostic (1.81e-1)" "prognostic favorable (8.54e-8)" "unprognostic (3.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "prognostic favorable (3.08e-4)" 5.9 2.3 2.0 5.5 3.0 0.1 7.7 3.7 7.2 3.3 19.5 4.2 16.3 22.6 2.9 1.7 2.5 3.6 15.9 17.6 2.3 3.7 8.4 26.4 6.1 2.0 2.5 2.2 2.1 10.3 7.3 5.2 28.5 10.4 3.6 8.2 9.5 4.7 14.7 3.4 2.3 43.2 3.4 3.4 5.2 14.7 28.0 2.1 1.1 26.8 2.5 2.2 3.3 4.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 5.7 4.4 2.3 11.9 2.4 0.1 37.1 0.5 0.3 2.1 0.5 3.5 14.9 0.0 7.0 0.6 1.6 8.1 2.0 1.7 0.6 0.0 3.9 0.0 1.9 19.3 3.1 0.1 7.7 1.2 3.1 0.3 0.9 3.3 1.4 3.3 4.8 0.0 0.7 2.9 0.2 0.9 6.8 17.0 1.2 2.9 0.3 3.1 6.5 2.1 0.6 4.1 7.7 18.6 3.5 5.5 2.0 3.1 1.3 0.1 3.7 1.4 0.5 0.0 0.0 0.1 0.7 0.9 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.0 3.0 3.7 7.2 2.3 3.7 2.5 2.2 10.4 2.1 17.9 11.8 0.9 1.0 2.3 1.9 19.3 56.0 5.3 9.1 17.4 15.7 33.4 1.7 33.5 2.2 6.0 81.1 0.0 10.5 19.6 2.8 1.6 0.0 29.0 10.2 1.6 10.9 19.6 3.5 4.8 0.9 0.1 1.7 0.0 31.8 1.7 13.5 40.7 3.2 5.4 1.4 0.0 0.8 0.9 4.9 1.9 40.5 1.5 28.3 1.4 MMP16 "C8orf57, DKFZp761D112, MT3-MMP" ENSG00000156103 "Matrix metallopeptidase 16" P51512 8 88032009-88328025 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.9" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 3.9;Early spermatids: 4.9;Fibroblasts: 9.9;Late spermatids: 4.7" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 20.4;HUVEC TERT2: 8.8;SH-SY5Y: 11.4;U-138 MG: 9.7;WM-115: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023693 Uncertain Approved Vesicles,Cytosol "Secreted to extracellular matrix" NA NA Cytosol Vesicles "HPA023693: AB_1854025" "unprognostic (2.58e-1)" "unprognostic (2.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.31e-2)" "unprognostic (2.39e-3)" "unprognostic (1.45e-3)" "unprognostic (2.46e-1)" "unprognostic (2.61e-1)" "unprognostic (9.42e-2)" "unprognostic (2.92e-1)" "unprognostic (2.09e-8)" "unprognostic (6.90e-3)" "unprognostic (1.16e-1)" "unprognostic (3.62e-1)" "unprognostic (2.19e-3)" 2.4 1.3 11.0 1.4 6.8 0.5 4.9 8.3 15.9 5.3 2.2 2.9 0.7 0.8 4.9 2.1 1.7 2.1 7.3 2.7 8.7 6.9 0.8 0.9 1.0 1.0 5.5 9.1 3.3 2.1 1.5 1.7 3.0 6.3 3.2 1.7 0.6 1.2 2.4 0.7 1.1 1.3 4.0 4.6 1.5 1.4 1.5 5.5 0.0 3.2 0.7 1.0 2.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.5 20.4 0.7 1.4 0.0 7.5 1.1 2.1 1.3 0.0 0.0 0.0 0.0 3.3 1.2 0.0 4.0 0.0 2.6 0.0 2.4 0.0 0.0 0.0 1.7 0.0 0.3 1.0 0.0 3.1 0.9 3.8 8.8 0.0 0.0 0.7 1.1 0.0 0.0 0.0 1.2 0.0 2.0 0.2 0.4 0.0 0.4 0.0 0.1 11.4 0.0 0.0 0.1 1.6 0.8 0.0 4.9 9.7 5.5 0.1 2.8 0.0 0.0 0.0 3.9 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 6.8 8.3 14.1 8.7 6.9 5.5 9.1 6.3 5.5 0.0 0.0 0.0 0.0 1.0 3.9 0.6 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 4.9 2.9 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.3 1.6 0.0 0.6 0.0 4.7 0.9 0.6 1.7 0.0 0.0 3.2 0.2 0.0 1.1 0.0 0.3 0.0 1.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 MMP20 ENSG00000137674 "Matrix metallopeptidase 20" O60882 11 102576835-102625332 "Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Amelogenesis imperfecta, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.0;testis: 3.5" "Cell type enriched" "Detected in some" 10 "Early spermatids: 66.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (4.62e-3)" "unprognostic (2.61e-2)" "unprognostic (1.68e-3)" "unprognostic (1.75e-1)" "unprognostic (2.13e-1)" "unprognostic (3.06e-1)" "unprognostic (2.97e-2)" "unprognostic (6.75e-2)" "unprognostic (9.58e-5)" "unprognostic (6.10e-2)" "unprognostic (2.35e-1)" 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.5 MMP23B "MIFR, MIFR-1, MMP22" ENSG00000189409 "Matrix metallopeptidase 23B" O75900 1 1632095-1635263 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 51.8" "Group enriched" "Detected in many" 6 "Fibroblasts: 124.0;Leydig cells: 90.9;Peritubular cells: 167.3" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.8" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 12.3" "Lineage enriched" "Detected in many" 5 "dendritic cells: 12.3" "Cell line enhanced" "Detected in some" "AN3-CA: 3.4;HHSteC: 8.3;NTERA-2: 3.6;PC-3: 3.6;U-266/70: 6.5" "Region enriched" "Detected in some" 5 "cerebellum: 8.7" "Not detected" "Not detected" NA NA "unprognostic (2.19e-2)" "unprognostic (6.31e-2)" "unprognostic (6.70e-3)" "unprognostic (1.29e-1)" "unprognostic (3.99e-2)" "unprognostic (9.31e-2)" "unprognostic (6.94e-2)" "unprognostic (1.20e-1)" "unprognostic (8.06e-2)" "unprognostic (8.37e-2)" "unprognostic (2.22e-1)" "unprognostic (2.33e-1)" "unprognostic (2.26e-11)" "unprognostic (1.60e-3)" "unprognostic (1.36e-1)" "unprognostic (2.44e-2)" "unprognostic (6.66e-2)" 4.7 2.4 0.3 3.9 0.3 2.1 2.3 0.5 0.4 19.6 3.2 0.1 4.2 3.9 17.3 20.1 4.7 6.4 28.5 14.4 0.2 0.3 3.6 2.3 11.0 3.3 0.1 0.0 51.8 0.7 0.0 3.1 10.5 0.1 32.1 0.2 1.2 1.4 6.3 0.9 2.5 2.7 11.7 0.2 4.1 4.3 13.5 0.0 0.4 1.2 0.9 2.8 13.9 7.0 0.2 12.3 0.1 0.2 2.2 1.8 1.3 1.0 0.0 0.3 3.4 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.7 1.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.7 2.6 1.0 0.3 2.2 8.3 0.4 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.3 0.0 0.9 0.0 0.6 3.6 0.0 3.6 1.3 0.1 1.6 0.0 0.1 0.6 0.2 0.5 0.0 0.2 0.1 1.0 0.0 0.7 0.5 0.3 0.7 0.0 6.5 0.3 1.1 0.1 0.4 0.3 0.0 0.2 0.0 1.8 0.0 1.1 0.0 0.4 1.1 0.0 0.2 0.1 0.9 0.1 2.2 0.1 12.3 0.2 1.3 0.3 0.3 0.5 0.4 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.9 11.8 1.1 9.0 2.5 0.0 0.0 1.8 0.0 2.7 0.0 0.8 0.8 1.5 1.7 0.0 0.5 1.6 124.0 0.4 0.0 1.0 5.1 3.2 2.9 20.9 1.5 3.2 90.9 1.0 18.6 1.0 1.7 0.8 3.4 0.0 167.3 0.6 5.7 0.0 8.2 1.6 10.7 13.8 8.6 9.2 1.2 0.7 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226654-35277000 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.5" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 38.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 91.3" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" Yes No "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favorable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 1.6 1.3 4.0 0.4 7.8 0.6 0.4 38.5 8.9 0.7 0.3 1.3 0.2 2.8 1.6 0.9 0.2 2.8 0.6 1.0 2.7 3.2 8.6 0.9 6.1 0.3 1.8 1.5 0.9 8.0 0.0 3.8 0.6 1.7 2.2 0.1 0.5 0.4 6.0 0.2 1.5 1.7 2.5 0.9 0.6 0.7 0.4 1.4 0.2 0.8 0.2 0.2 0.5 0.2 0.8 0.4 2.2 0.8 0.6 1.2 0.3 0.3 20.1 0.0 0.1 0.1 0.0 0.6 1.1 1.3 2.1 1.1 30.6 5.4 0.0 9.0 1.4 0.7 0.3 4.7 0.0 0.9 0.1 0.2 1.1 0.6 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.1 7.7 0.0 1.4 0.0 0.1 0.0 13.8 0.1 8.0 5.5 1.4 0.5 0.2 1.8 0.3 0.1 0.3 4.3 10.4 1.0 0.4 0.1 0.1 0.0 0.9 0.1 0.6 1.0 0.6 0.1 1.0 0.7 1.2 0.6 0.7 0.8 0.4 0.8 0.6 0.6 2.2 0.6 0.8 0.2 0.0 0.3 4.0 7.8 38.5 5.3 2.7 3.2 1.8 1.5 1.7 1.4 14.9 1.0 0.0 0.1 0.1 3.6 0.6 12.7 0.0 2.3 1.8 0.0 0.0 5.0 7.5 0.6 0.7 0.3 0.0 0.8 0.1 0.2 0.4 0.0 0.2 0.0 14.3 0.0 0.0 0.3 0.0 0.3 0.0 1.7 0.0 0.0 0.2 2.1 0.0 0.0 7.3 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MOG "BTN6, BTNL11" ENSG00000204655 "Myelin oligodendrocyte glycoprotein" Q16653 6 29656981-29672372 "Disease related genes, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 47 "brain: 106.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 45 "glioma: 15.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 3.4;HEK 293: 2.1;SuSa: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021873 Enhanced NA NA "HPA021873: AB_1854055" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (7.87e-2)" "unprognostic (3.00e-4)" "unprognostic (4.89e-2)" "unprognostic (4.90e-2)" 1.9 1.7 22.1 1.7 35.1 1.7 1.7 3.1 30.0 1.7 1.9 79.5 0.0 1.7 1.7 1.7 1.7 1.7 1.7 1.7 40.2 19.6 2.0 1.7 1.8 1.7 49.2 17.1 2.0 1.7 1.7 0.0 1.8 39.8 1.8 2.1 0.0 1.7 2.2 1.7 1.7 2.0 1.7 106.4 1.7 1.7 2.0 46.4 0.0 1.7 0.0 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 22.1 35.1 3.1 30.0 40.2 19.6 49.2 17.1 39.8 46.4 0.0 0.6 0.0 0.3 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 MOGAT1 "DGAT2L, DGAT2L1, MGAT1" ENSG00000124003 "Monoacylglycerol O-acyltransferase 1" Q96PD6 2 222671786-222709930 "Enzymes, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "gallbladder: 40.9" "Cell type enhanced" "Detected in some" 13 "Cholangiocytes: 5.1;Exocrine glandular cells: 4.5;Hepatocytes: 2.1;Muller glia cells: 2.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 0.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 3.4" "Lineage enriched" "Detected in single" 7 "dendritic cells: 3.4" "Cell line enhanced" "Detected in single" "Hep G2: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA049944 Uncertain NA NA "HPA049944: AB_2680964" "unprognostic (6.32e-2)" "unprognostic (2.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.41e-1)" "unprognostic (4.28e-3)" "unprognostic (4.39e-2)" "unprognostic (4.32e-2)" "unprognostic (9.44e-2)" "unprognostic (1.91e-1)" "unprognostic (8.59e-2)" "unprognostic (3.07e-3)" "unprognostic (4.99e-2)" "unprognostic (3.89e-1)" "unprognostic (9.03e-3)" 2.3 0.1 0.6 0.1 0.5 0.1 1.3 0.2 0.9 0.3 0.6 0.5 0.2 0.0 1.0 1.1 0.5 0.1 40.9 0.8 0.5 0.2 5.7 7.6 1.1 0.3 0.2 0.9 0.1 1.5 2.3 0.4 0.0 0.9 0.2 0.1 0.0 1.4 2.6 0.5 1.6 0.2 0.1 0.3 0.1 1.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 3.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 1.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.5 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.6 0.5 0.2 0.9 0.5 0.2 0.2 0.9 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 2.2 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 MOGAT2 "DGAT2L5, FLJ22644, MGAT2" ENSG00000166391 "Monoacylglycerol O-acyltransferase 2" Q3SYC2 11 75717819-75732958 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "intestine: 90.2;liver: 40.5" "Cell type enhanced" "Detected in some" 19 "Enterocytes: 91.9;Hepatocytes: 64.7;Mucus-secreting cells: 33.4;Undifferentiated cells: 25.8" "Cancer enhanced" "Detected in many" "liver cancer: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Hep G2: 8.6;RPMI-8226: 5.8" "Not detected" "Not detected" HPA028834 Uncertain NA NA "HPA028834: AB_10601865" "unprognostic (5.63e-2)" "unprognostic (2.71e-2)" "unprognostic (6.37e-2)" "unprognostic (6.88e-3)" "unprognostic (1.15e-4)" "unprognostic (2.66e-3)" "unprognostic (1.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.42e-2)" "unprognostic (1.12e-1)" "unprognostic (4.21e-2)" "unprognostic (3.02e-1)" "unprognostic (1.24e-5)" "unprognostic (2.13e-3)" "unprognostic (1.84e-2)" "unprognostic (2.13e-1)" "unprognostic (2.83e-3)" 0.1 0.0 0.1 4.8 0.1 0.0 2.1 0.1 0.1 0.2 34.0 0.1 1.4 22.3 0.1 0.1 0.2 0.0 2.6 0.1 0.1 0.0 0.2 40.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 7.0 0.1 0.4 2.2 0.4 0.9 90.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 1.0 0.0 0.0 0.1 5.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.9 0.0 0.5 0.0 0.0 0.8 0.0 64.7 0.0 0.0 2.4 0.6 0.6 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 18.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.1 MOGAT3 "DC7, DGAT2L2, MGAT3" ENSG00000106384 "Monoacylglycerol O-acyltransferase 3" Q86VF5 7 101195007-101201021 "Enzymes, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 61.6;liver: 16.0" "Cell type enhanced" "Detected in some" 22 "Enterocytes: 76.6;Paneth cells: 56.1;Undifferentiated cells: 21.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.0;liver cancer: 11.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CACO-2: 4.8;Hep G2: 16.2" HPA011940 Approved Approved Centrosome NA NA Centrosome "HPA011940: AB_1854057" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (7.14e-2)" "unprognostic (6.11e-2)" "unprognostic (3.20e-1)" "unprognostic (9.54e-3)" "unprognostic (9.36e-2)" "unprognostic (3.08e-1)" "unprognostic (1.05e-3)" "unprognostic (1.87e-1)" "unprognostic (1.23e-1)" "unprognostic (9.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.59e-2)" 0.2 0.1 0.2 2.6 0.2 0.4 0.2 0.2 0.2 0.2 17.3 0.2 0.2 19.7 0.2 0.5 0.2 0.1 0.2 0.2 0.2 0.1 0.9 16.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 7.1 0.2 0.2 0.2 0.2 0.1 61.6 0.4 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.7 1.2 5.3 0.9 1.9 1.2 0.3 0.6 0.2 0.2 0.5 0.0 0.2 0.4 0.6 0.0 0.0 0.0 4.8 1.1 0.4 0.6 0.1 0.6 0.4 0.2 0.1 0.1 0.1 0.2 0.6 0.6 16.2 0.2 0.5 0.6 0.1 0.1 0.0 0.1 0.4 0.1 0.3 0.2 0.7 0.1 0.3 0.3 0.5 0.2 0.5 0.6 0.3 0.1 0.4 0.7 0.6 0.3 0.3 0.3 0.6 0.1 0.8 0.3 0.3 0.8 0.9 0.2 1.0 0.5 0.4 0.2 0.1 1.7 0.6 1.4 2.2 0.9 1.1 1.0 0.7 0.7 1.0 0.8 0.7 0.5 1.7 0.9 1.2 5.3 1.9 0.6 1.2 0.5 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 76.6 0.0 0.0 0.0 0.2 0.2 0.0 5.5 0.0 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.1 56.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 21.5 0.4 MOGS "CWH41, DER7, GCS1" ENSG00000115275 "Mannosyl-oligosaccharide glucosidase" Q13724 2 74461057-74465410 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Late spermatids: 186.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011322, HPA011969" Approved Supported "Endoplasmic reticulum" NA NA 88000000 "Endoplasmic reticulum" "HPA011322: AB_2668483, HPA011969: AB_1849579" "unprognostic (5.66e-2)" "unprognostic (1.98e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (4.67e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (2.34e-6)" "unprognostic (1.48e-2)" "unprognostic (2.66e-2)" "unprognostic (3.32e-2)" "unprognostic (6.21e-2)" "unprognostic (4.36e-1)" "prognostic unfavorable (2.79e-8)" "unprognostic (1.40e-2)" "unprognostic (3.06e-2)" "unprognostic (2.66e-1)" "unprognostic (7.59e-3)" 15.8 12.8 8.7 15.2 10.6 8.5 13.1 11.3 12.1 13.9 19.4 10.8 24.9 36.5 14.2 15.8 15.5 13.4 16.4 11.2 7.7 6.1 14.8 40.5 17.2 15.6 9.2 7.9 14.2 30.6 20.4 15.7 35.8 8.3 15.9 11.2 11.7 24.5 25.3 14.1 17.4 35.8 9.8 7.1 22.4 22.3 11.9 8.1 17.6 18.9 11.4 19.5 14.1 12.9 3.9 3.4 2.3 4.4 12.7 5.1 2.5 22.2 19.8 13.1 12.6 27.1 19.2 40.3 18.2 26.5 27.7 26.7 36.2 23.8 24.1 16.3 18.4 20.8 22.4 19.8 20.6 17.2 20.8 19.2 11.3 12.8 27.7 22.4 26.4 22.7 11.2 33.0 19.6 19.2 30.9 31.0 14.3 19.6 23.4 12.2 27.7 14.3 20.3 17.3 28.2 11.0 16.4 29.3 31.2 15.1 13.8 10.8 14.2 8.7 36.3 23.7 13.0 17.5 14.2 22.1 12.8 22.3 18.5 24.1 36.2 14.9 10.7 20.1 21.6 17.3 2.3 4.0 1.1 5.0 2.5 5.1 2.5 4.2 4.5 3.4 3.9 3.7 2.4 0.7 12.7 4.4 3.2 3.8 2.5 8.7 10.6 11.3 12.1 7.7 6.1 9.2 7.9 8.3 8.1 6.0 15.7 9.0 17.4 14.1 14.2 5.8 15.3 9.4 12.5 22.7 17.7 32.9 5.0 19.7 52.1 10.9 21.0 23.3 22.8 34.8 8.7 19.5 4.6 22.1 17.5 6.4 13.4 17.8 7.9 186.6 14.1 16.0 10.1 27.1 24.4 8.3 19.0 20.3 6.7 8.4 12.7 12.9 7.6 8.6 3.2 15.2 43.5 14.0 17.9 17.3 MOSMO "ATTHOG, BC030336, C16orf52" ENSG00000185716 "Modulator of smoothened" Q8NHV5 16 22007638-22087534 "Predicted membrane proteins" Differentiation "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 7 "Alveolar cells type 2: 6.7;Club cells: 9.1;Collecting duct cells: 5.2;Pancreatic endocrine cells: 6.5;Proximal tubular cells: 6.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "WM-115: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "unprognostic (4.18e-2)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (4.10e-2)" "unprognostic (1.78e-1)" "unprognostic (1.23e-1)" "unprognostic (2.78e-2)" "unprognostic (8.84e-2)" "unprognostic (5.50e-2)" "unprognostic (1.54e-1)" "unprognostic (1.27e-2)" "unprognostic (2.22e-3)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (2.75e-1)" 10.7 23.3 9.7 9.2 14.3 2.5 11.9 19.0 25.6 11.8 8.3 9.3 13.9 8.4 13.8 8.6 10.5 9.4 11.3 11.1 11.3 11.6 9.5 13.9 11.2 10.1 10.8 10.0 14.2 8.1 26.6 18.3 13.3 12.8 11.9 8.9 9.2 9.3 13.6 10.9 10.3 7.4 10.6 9.3 9.5 10.4 10.3 9.5 8.2 10.4 5.8 9.8 9.0 15.1 2.4 0.7 1.2 0.9 1.0 1.9 0.2 5.8 2.2 4.1 3.2 7.4 15.2 2.9 6.2 7.4 3.3 5.0 1.9 3.8 3.0 2.5 6.4 5.2 3.3 2.6 6.4 6.1 7.1 2.9 2.5 4.3 7.0 6.8 2.1 3.9 8.7 4.4 4.9 12.1 5.6 7.8 2.5 1.7 7.9 14.2 3.6 2.0 1.8 3.0 2.8 5.5 4.4 4.2 3.0 3.0 2.9 2.8 4.9 3.2 1.6 10.9 4.3 3.4 2.2 4.4 6.3 4.7 4.5 2.7 4.0 3.6 2.0 4.5 2.6 29.8 0.9 0.7 1.2 1.2 0.9 1.0 0.9 0.5 0.6 0.1 2.4 1.0 1.1 0.4 1.0 0.8 0.7 1.9 0.2 9.7 14.3 19.0 25.6 11.3 11.6 10.8 10.0 12.8 9.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 9.1 5.2 0.0 4.6 1.7 3.6 0.0 0.0 0.0 0.0 4.9 3.6 0.0 0.0 2.3 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 6.5 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 MOSPD1 dJ473B4 ENSG00000101928 "Motile sperm domain containing 1" Q9UJG1 X 134887626-134915267 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 80.8;Late spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031158 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA031158: AB_10603874" "unprognostic (2.23e-3)" "unprognostic (3.37e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-1)" "unprognostic (1.77e-1)" "unprognostic (3.36e-1)" "unprognostic (6.78e-3)" "unprognostic (5.15e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (6.20e-3)" "unprognostic (4.27e-2)" "unprognostic (6.45e-3)" "unprognostic (2.92e-2)" "unprognostic (2.01e-1)" "unprognostic (5.71e-2)" "unprognostic (1.15e-1)" 11.0 19.7 6.2 6.5 8.0 12.3 7.9 7.8 10.4 11.1 6.9 8.8 5.5 5.4 19.3 12.5 20.5 25.1 6.6 17.4 7.3 6.2 11.8 10.3 8.0 5.5 9.9 7.4 12.9 8.9 10.3 8.1 23.2 21.2 8.1 7.0 10.3 14.6 7.6 17.6 14.5 6.9 10.7 9.0 8.3 7.5 16.4 7.5 10.2 9.1 13.5 10.1 9.5 12.0 6.2 8.3 12.3 6.8 6.0 14.3 5.1 7.7 6.1 5.2 3.6 8.2 4.8 11.3 13.1 23.8 12.6 12.3 15.0 3.1 2.6 18.3 8.3 22.9 2.8 8.0 6.8 16.7 8.7 4.7 2.2 16.2 6.0 34.9 6.1 3.8 8.7 8.3 14.2 6.1 14.4 9.2 5.4 2.7 10.7 15.2 10.8 4.3 2.8 5.3 4.1 13.9 3.3 9.2 4.8 5.4 22.3 3.1 3.8 6.6 6.7 22.5 26.3 2.7 3.8 4.6 6.2 3.8 23.2 11.6 8.3 11.1 4.2 8.5 10.6 8.1 6.0 6.8 12.3 7.6 5.0 10.0 6.2 9.0 8.3 7.5 5.1 10.2 9.8 4.0 6.0 5.5 8.3 14.3 5.1 6.2 8.0 7.8 10.4 7.3 6.2 9.9 7.4 21.2 7.5 6.0 4.3 6.7 9.8 18.9 9.0 42.3 5.1 16.0 6.8 10.4 2.0 6.1 18.3 21.3 80.8 12.7 5.7 46.7 10.7 12.5 9.1 9.7 5.7 4.9 13.2 4.8 4.1 13.5 11.4 57.7 6.4 7.2 28.7 5.4 7.2 8.3 17.9 11.5 10.3 20.2 9.0 6.5 15.3 3.0 5.3 17.9 21.9 10.1 6.6 8.1 MOSPD2 MGC26706 ENSG00000130150 "Motile sperm domain containing 2" Q8NHP6 X 14873441-14922327 "Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 30.2" "Group enriched" "Detected in all" 4 "granulocytes: 30.2;monocytes: 8.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003334 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA003334: AB_2146004" "unprognostic (2.74e-1)" "unprognostic (4.39e-2)" "unprognostic (6.52e-2)" "unprognostic (2.29e-1)" "unprognostic (7.57e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (8.91e-4)" "unprognostic (1.51e-1)" "unprognostic (7.24e-2)" "unprognostic (4.21e-3)" "unprognostic (1.00e-1)" "unprognostic (8.64e-2)" "unprognostic (1.04e-1)" "unprognostic (4.56e-1)" "unprognostic (1.37e-1)" "unprognostic (2.69e-1)" "unprognostic (1.96e-2)" 11.2 7.1 11.9 10.4 20.8 12.4 8.5 8.0 18.0 11.3 6.2 24.6 8.5 7.4 9.1 9.9 11.9 6.5 10.9 5.9 16.7 11.1 8.6 8.3 12.2 11.1 33.0 13.8 10.4 7.8 6.6 11.5 14.1 33.9 7.1 8.1 4.9 18.5 6.4 3.7 21.4 7.3 8.0 40.4 12.0 7.3 5.6 27.0 7.8 13.1 6.2 9.2 7.8 10.6 2.3 2.7 30.2 8.4 4.3 2.3 2.7 5.5 7.4 5.6 3.0 18.9 11.9 6.0 12.6 11.9 9.0 10.9 3.7 6.8 7.0 3.5 21.1 14.3 8.9 6.9 5.3 12.0 5.3 6.3 2.4 7.1 3.4 11.7 4.6 7.0 10.8 7.6 8.0 10.8 9.0 8.0 7.7 3.2 10.1 8.6 2.4 4.6 3.8 3.8 4.9 6.7 4.4 7.4 5.9 7.4 3.7 1.8 4.2 9.7 4.5 20.5 22.7 3.9 6.8 8.0 8.6 3.6 29.0 4.9 6.0 5.6 4.7 11.2 3.8 11.7 7.8 8.3 3.9 2.0 7.9 2.1 1.2 1.8 1.2 2.7 2.3 2.0 2.3 30.2 4.3 8.4 1.1 1.9 2.7 11.9 20.8 8.0 18.0 16.7 11.1 33.0 13.8 33.9 27.0 20.8 15.6 11.3 5.6 7.6 6.2 5.7 5.1 17.4 13.6 21.0 5.9 8.8 8.3 5.5 4.4 12.3 5.9 0.0 5.4 7.5 12.6 7.4 7.0 6.8 19.6 6.4 12.1 22.1 28.4 12.1 9.8 26.2 10.1 23.4 7.7 6.8 5.9 5.8 14.2 9.1 4.3 12.9 7.4 3.4 8.3 11.2 19.7 6.9 5.9 5.8 MOSPD3 "CDS3, NET30" ENSG00000106330 "Motile sperm domain containing 3" O75425 7 100612102-100615384 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1149.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041137, HPA048240" Uncertain Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA041137: AB_10803996, HPA048240: AB_2680325" "unprognostic (1.24e-1)" "unprognostic (8.98e-2)" "unprognostic (1.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.25e-2)" "unprognostic (1.80e-2)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (9.88e-2)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (8.65e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" 13.8 22.3 13.0 7.7 12.8 17.4 9.8 9.0 16.9 14.7 9.1 14.5 13.9 9.9 12.0 12.9 22.5 12.0 14.9 10.2 11.2 10.8 19.3 29.8 11.1 18.5 10.6 11.6 13.1 17.1 6.7 9.8 7.8 12.0 12.9 4.8 14.9 19.1 11.3 11.3 24.4 10.6 10.3 9.5 11.8 14.7 37.0 9.9 16.6 12.2 13.6 16.8 12.4 13.4 11.6 17.9 22.2 16.7 20.9 29.7 8.0 6.0 8.2 6.6 11.4 3.5 2.6 4.7 4.6 5.5 4.8 4.9 7.6 8.1 3.8 10.2 4.2 6.8 4.7 3.8 6.6 0.9 9.8 5.1 3.9 6.1 11.4 4.5 3.0 15.1 7.4 5.7 4.1 2.4 4.2 8.2 6.4 9.1 7.8 4.9 17.9 8.4 23.0 6.0 7.9 12.4 7.9 6.9 9.1 7.6 9.1 3.6 21.7 8.6 13.4 4.6 2.8 8.1 8.9 9.2 9.3 14.7 19.3 4.4 6.2 5.8 2.6 9.3 33.7 11.4 18.5 16.7 22.2 18.8 12.4 22.2 11.6 21.8 21.8 17.9 11.3 13.0 13.5 12.3 20.9 8.5 12.0 29.7 8.0 13.0 12.8 9.0 16.9 11.2 10.8 10.6 11.6 12.0 9.9 8.9 6.5 11.9 14.9 10.8 6.6 3.2 17.8 9.4 4.5 19.2 5.9 6.0 36.5 33.9 271.2 15.7 8.7 0.0 37.6 23.2 22.0 20.1 3.5 26.2 25.2 6.4 20.7 19.0 23.0 1149.7 25.6 15.1 25.3 14.4 14.9 11.4 39.0 17.5 20.5 35.7 3.4 12.9 20.0 17.7 21.5 17.1 5.1 29.3 16.9 17.8 MPC1 "BRP44L, CGI-129, dJ68L15.3, SLC54A1" ENSG00000060762 "Mitochondrial pyruvate carrier 1" Q9Y5U8 6 166364919-166383013 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.8;liver: 129.7" "Cell type enhanced" "Detected in all" 12 "Cardiomyocytes: 875.4;Distal tubular cells: 1458.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045119, HPA055790" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA045119: AB_10960421, HPA055790: AB_2682923" "unprognostic (3.30e-2)" "prognostic favorable (1.45e-4)" "unprognostic (5.24e-3)" "unprognostic (1.68e-1)" "unprognostic (3.17e-2)" "unprognostic (2.85e-2)" "unprognostic (7.61e-2)" "prognostic favorable (1.29e-4)" "unprognostic (3.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.11e-3)" "unprognostic (5.64e-2)" "prognostic favorable (4.79e-11)" "unprognostic (4.13e-2)" "unprognostic (1.03e-1)" "unprognostic (7.48e-2)" "unprognostic (8.45e-2)" 13.1 9.4 27.1 7.2 28.5 10.9 12.2 12.3 21.6 12.4 21.1 26.1 8.3 18.8 8.4 10.5 16.0 8.3 9.5 149.8 27.6 21.5 56.1 129.7 10.0 8.7 39.2 18.3 10.5 14.9 12.4 9.4 5.4 23.8 10.3 19.9 11.5 23.0 10.5 63.3 9.2 16.9 11.0 43.3 9.2 19.7 5.0 25.8 9.0 18.6 43.9 9.9 10.6 8.1 12.2 26.5 32.2 43.7 13.9 24.5 17.1 6.5 1.9 8.1 27.9 23.6 13.6 12.0 7.5 12.2 11.8 11.5 9.9 4.6 13.7 13.6 11.6 9.5 6.2 12.1 9.5 8.3 9.3 20.8 6.8 10.1 32.9 9.8 26.2 8.9 10.9 13.4 9.6 6.9 3.6 9.5 21.3 23.6 21.9 7.3 10.4 18.2 48.6 4.1 37.3 9.2 10.0 13.5 34.2 22.0 5.2 25.5 22.6 8.7 38.0 8.6 7.0 9.0 39.4 6.6 6.9 7.1 24.2 7.7 15.0 10.3 11.4 6.3 32.4 10.9 18.6 23.0 32.2 16.4 35.3 15.4 12.2 19.4 17.6 26.5 9.2 18.2 17.4 20.4 13.9 43.7 15.7 24.5 17.1 27.1 28.5 12.3 21.6 27.6 21.5 39.2 18.3 23.8 25.8 110.2 37.1 53.6 36.9 40.5 51.2 875.4 183.4 44.2 47.8 101.2 9.8 19.1 1458.9 78.7 46.1 45.8 147.2 23.3 122.5 67.4 59.4 34.7 70.3 365.8 104.2 46.1 35.7 38.6 74.2 5.6 61.5 76.9 123.2 111.8 87.8 137.3 56.8 120.7 84.5 301.3 55.1 90.5 90.6 126.5 39.4 48.8 20.4 54.3 110.8 45.7 MPC1L SLC54A3 ENSG00000238205 "Mitochondrial pyruvate carrier 1 like" P0DKB6 X 40623566-40624136 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 26.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 9 "testis cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.1;BJ hTERT+: 1.1;PC-3: 1.9;U-2197: 1.4" "Not detected" "Not detected" NA NA "unprognostic (8.47e-4)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.3 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MPDU1 "CDGIf, Lec35, PQLC5, SL15" ENSG00000129255 "Mannose-P-dolichol utilization defect 1" O75352 17 7583529-7592789 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transport "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014845 Uncertain Supported "Endoplasmic reticulum,Mitochondria" NA NA "Endoplasmic reticulum" Mitochondria "HPA014845: AB_1854072" "unprognostic (1.96e-1)" "unprognostic (8.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.36e-2)" "unprognostic (5.00e-2)" "unprognostic (5.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" "unprognostic (4.70e-2)" "unprognostic (3.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.95e-1)" "unprognostic (2.34e-3)" "unprognostic (9.00e-2)" "unprognostic (2.60e-1)" "unprognostic (2.48e-3)" "unprognostic (2.93e-1)" 15.4 24.6 12.6 10.3 16.5 16.6 16.7 9.1 26.2 16.0 27.3 22.8 4.6 18.5 8.2 15.3 20.5 14.2 16.4 9.1 11.6 10.3 36.0 80.1 15.4 12.3 12.9 8.4 10.8 24.3 21.0 9.3 27.4 15.7 15.1 30.0 17.3 17.2 9.6 11.0 14.7 39.0 11.8 13.3 23.8 20.3 9.1 10.9 17.6 21.4 12.5 17.5 15.5 11.3 7.5 19.7 5.5 26.8 6.4 10.0 8.7 12.5 26.3 19.2 12.6 24.3 22.4 11.6 20.8 30.6 39.5 29.0 13.7 21.2 7.5 15.1 36.0 17.0 24.4 29.1 35.7 33.7 15.6 26.6 13.6 17.4 23.4 30.4 11.3 21.2 22.8 29.5 36.8 21.8 18.3 29.8 21.0 22.2 9.7 42.7 18.0 7.4 7.0 20.7 29.3 12.5 17.2 14.8 12.7 39.6 12.3 12.1 22.0 27.1 18.9 7.2 17.9 22.1 9.2 20.0 16.3 8.4 9.5 25.9 4.9 9.0 6.2 23.3 14.7 23.2 5.5 16.2 4.8 6.7 26.8 5.5 7.5 6.5 9.0 19.7 7.5 6.7 7.6 2.6 6.4 24.2 18.5 10.0 8.7 12.6 16.5 9.1 26.2 11.6 10.3 12.9 8.4 15.7 10.9 8.9 26.0 42.4 30.9 9.5 15.5 4.3 40.8 17.4 12.5 22.7 11.8 99.2 29.9 56.7 2.3 16.3 81.1 0.0 66.5 77.5 25.4 35.1 13.9 42.4 70.3 15.9 35.7 27.0 31.6 3.6 15.8 35.1 23.6 39.7 56.4 28.4 60.1 66.6 6.0 39.4 20.1 25.8 11.3 19.7 30.4 11.0 131.8 21.8 53.6 36.1 MPEG1 MPG1 ENSG00000197629 "Macrophage expressed 1" Q2M385 11 59208510-59212951 "Predicted membrane proteins, Transporters" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.3;lymphoid tissue: 108.6" "Cell type enriched" "Detected in many" 5 "Kupffer cells: 355.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 47.3;intermediate monocyte: 38.9;myeloid DC: 26.6;non-classical monocyte: 41.6;plasmacytoid DC: 38.3" "Group enriched" "Detected in many" 6 "dendritic cells: 38.3;monocytes: 47.3" "Cell line enhanced" "Detected in some" "Daudi: 2.8;HMC-1: 1.3;THP-1: 3.8" HPA046801 Approved NA NA "HPA046801: AB_2679814" "unprognostic (1.24e-1)" "unprognostic (2.17e-3)" "unprognostic (1.05e-2)" "unprognostic (2.00e-2)" "unprognostic (3.38e-2)" "unprognostic (2.79e-3)" "unprognostic (7.82e-2)" "unprognostic (1.41e-2)" "unprognostic (6.23e-2)" "unprognostic (2.76e-1)" "unprognostic (5.48e-2)" "unprognostic (3.51e-1)" "unprognostic (1.48e-1)" "unprognostic (9.38e-2)" "unprognostic (2.48e-2)" "unprognostic (1.76e-1)" "unprognostic (5.86e-2)" 17.6 6.4 2.2 27.7 2.1 3.6 5.9 1.3 1.8 3.3 9.5 4.9 0.9 9.0 3.2 13.2 3.7 4.9 8.2 7.7 2.2 2.3 7.0 17.3 13.1 51.3 2.6 1.0 4.2 2.7 0.8 2.3 13.4 2.5 5.6 10.0 8.9 7.5 2.4 2.9 2.6 20.6 6.0 3.9 108.6 4.0 3.2 1.7 18.5 3.7 5.5 23.0 11.0 2.7 2.9 38.3 7.0 47.3 0.2 0.1 29.1 0.0 0.0 0.2 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.3 0.5 0.5 0.1 0.0 0.5 0.4 0.7 0.0 0.5 0.3 0.5 0.2 0.0 0.0 0.0 0.0 3.8 0.5 0.0 0.2 0.4 0.0 0.9 0.1 0.5 0.0 0.2 0.1 0.0 47.3 1.4 0.1 38.9 0.1 2.4 0.0 0.0 26.6 2.9 0.0 0.0 7.0 0.2 41.6 38.3 0.1 29.1 2.2 2.1 1.3 1.8 2.2 2.3 2.6 1.0 2.5 1.7 0.0 12.2 29.3 0.0 1.0 0.0 1.2 2.5 1.4 1.2 0.0 0.0 0.3 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.4 0.9 0.0 2.3 1.7 41.8 0.0 0.0 6.2 355.6 0.0 0.0 71.1 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 6.5 0.3 0.0 0.0 1.4 0.2 0.0 0.0 0.0 MPG MDG ENSG00000103152 "N-methylpurine DNA glycosylase" P29372 16 77007-85853 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006531 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006531: AB_1854075" "unprognostic (1.78e-2)" "unprognostic (8.48e-2)" "unprognostic (9.99e-2)" "prognostic favorable (2.82e-5)" "unprognostic (8.54e-2)" "unprognostic (3.27e-1)" "unprognostic (2.75e-2)" "unprognostic (1.63e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-2)" "unprognostic (1.83e-2)" "unprognostic (1.39e-2)" "unprognostic (1.86e-3)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 20.8 32.1 18.4 21.1 18.4 25.3 33.2 18.3 32.1 19.5 20.4 12.6 24.6 21.0 22.6 30.5 21.5 18.5 28.5 37.4 16.7 15.1 16.1 32.0 20.1 39.7 15.8 18.2 23.8 36.5 8.0 21.7 19.0 16.5 23.2 7.2 15.2 47.1 24.2 33.6 19.0 19.4 19.2 13.6 25.6 27.3 10.9 11.2 18.3 29.2 22.4 22.8 27.2 25.2 33.5 38.8 27.2 27.4 41.2 31.1 22.4 14.0 20.5 5.6 17.1 10.3 23.5 14.0 20.1 27.8 13.1 14.4 12.9 18.9 10.0 17.6 11.4 6.5 18.0 3.9 8.8 2.0 17.1 14.9 6.5 10.4 19.2 29.8 6.7 40.2 22.6 12.2 14.7 6.1 17.5 22.8 11.3 14.2 18.0 17.0 48.4 11.7 31.1 10.1 8.1 22.4 22.3 6.7 38.0 10.9 5.1 4.6 11.7 10.6 11.5 25.3 2.7 16.4 34.9 19.9 10.7 13.6 14.5 9.9 17.6 5.9 12.7 19.8 19.5 38.1 14.2 27.4 27.2 22.7 19.2 20.6 33.5 21.8 22.6 28.5 30.6 16.8 17.2 14.0 41.2 15.7 38.8 31.1 22.4 18.4 18.4 18.3 32.1 16.7 15.1 15.8 18.2 16.5 11.2 3.0 24.6 65.6 62.0 31.8 13.4 1.1 30.6 20.1 22.7 38.4 3.9 68.9 28.2 68.7 6.3 43.1 60.4 0.0 99.2 74.2 79.8 90.4 54.4 44.9 80.7 9.5 47.8 47.3 65.5 3.6 60.9 47.4 54.0 72.1 66.3 38.4 109.6 66.2 54.5 52.3 9.1 84.1 64.9 18.8 43.7 35.9 51.7 62.9 63.6 97.9 MPIG6B "C6orf25, G6b, G6b-B, NG31" ENSG00000204420 "Megakaryocyte and platelet inhibitory receptor G6b" O95866 6 31718594-31726714 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heparin-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.2" "Cell type enriched" "Detected in single" 30 "granulocytes: 9.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "NK-cell: 3.0;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 4 "dendritic cells: 1.8;NK-cells: 3.0" "Cell line enriched" "Detected in single" 17 "HEL: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA054404, HPA073017" Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 7400000 "Golgi apparatus" "Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA054404: , HPA073017: AB_2686566" "unprognostic (1.45e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (6.53e-2)" "unprognostic (3.53e-2)" "unprognostic (2.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (1.82e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-2)" "unprognostic (1.71e-2)" 0.8 0.2 0.0 1.2 0.5 5.3 0.7 0.1 0.4 1.0 0.9 0.0 0.0 0.9 1.0 0.8 2.0 0.7 1.5 7.4 0.2 0.0 0.4 0.5 7.6 2.8 1.0 0.0 2.7 0.2 0.2 0.2 1.4 0.7 0.9 0.2 1.1 1.8 0.3 1.2 10.5 0.8 1.9 0.6 33.2 0.4 2.7 0.1 1.2 1.0 1.4 0.8 1.6 1.6 0.2 1.8 0.5 0.1 3.0 0.1 5.7 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.5 3.0 0.1 1.8 0.0 5.7 0.0 0.5 0.1 0.4 0.2 0.0 1.0 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MPL "CD110, TPOR" ENSG00000117400 "MPL proto-oncogene, thrombopoietin receptor" P40238 1 43337849-43352772 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enriched" "Detected in single" 78 "HEL: 41.7" "Region enhanced" "Detected in single" "cerebral cortex: 1.4" "Low region specificity" "Detected in all" HPA007619 Supported "Nuclear membrane,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane" "HPA007619: AB_1854080" "unprognostic (2.74e-1)" "unprognostic (6.56e-2)" "unprognostic (2.95e-1)" "unprognostic (8.71e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-3)" "unprognostic (1.19e-1)" "unprognostic (1.22e-2)" "unprognostic (5.83e-2)" "unprognostic (1.03e-1)" "unprognostic (5.94e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-4)" "unprognostic (2.39e-1)" "unprognostic (3.26e-1)" "unprognostic (1.03e-4)" "unprognostic (1.42e-1)" 1.1 0.3 0.9 0.5 0.8 2.0 0.9 0.5 2.2 0.6 0.6 0.5 0.5 0.3 0.9 1.7 0.9 2.1 0.5 3.9 0.8 0.6 0.5 0.5 2.0 0.5 0.9 0.5 6.6 1.1 0.6 0.6 2.2 0.5 1.5 0.7 0.5 0.5 0.7 0.6 0.4 1.2 2.1 2.5 8.6 0.5 2.1 0.5 0.5 2.2 2.4 0.5 0.9 0.5 0.0 0.0 1.6 0.3 0.0 0.0 4.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 41.7 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.0 0.9 0.8 0.5 2.2 0.8 0.6 0.9 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MPPE1 PGAP5 ENSG00000154889 "Metallophosphoesterase 1" Q53F39 18 11882622-11909223 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, GPI-anchor biosynthesis, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 22.1;neutrophil: 66.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 66.2" "Cell line enhanced" "Detected in all" "OE19: 34.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 10 "basal ganglia: 104.4" HPA012639 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA012639: AB_1854088" "unprognostic (9.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-1)" "unprognostic (7.92e-3)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.00e-2)" "unprognostic (4.46e-1)" "unprognostic (1.61e-1)" "prognostic favorable (6.45e-7)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (7.79e-2)" "unprognostic (6.15e-2)" 15.0 13.7 11.8 16.5 16.0 19.9 15.2 11.4 20.9 14.1 16.4 20.1 18.2 13.5 18.7 22.1 13.4 15.8 23.6 17.2 11.5 14.4 23.7 20.8 24.7 29.0 19.8 12.2 11.7 24.6 22.2 16.5 15.2 14.1 13.1 17.2 14.8 16.8 26.6 19.3 22.4 19.7 14.0 15.1 17.5 17.7 6.7 14.8 22.7 37.1 14.6 17.6 14.9 13.9 4.5 8.5 66.2 9.5 6.3 6.0 6.7 3.9 5.7 4.3 10.5 12.5 14.8 4.1 9.4 13.7 5.6 8.9 10.6 11.3 7.8 20.8 9.1 5.6 4.3 3.0 5.3 5.3 8.6 5.2 2.2 11.5 2.4 17.6 10.1 16.3 21.9 7.0 4.9 3.6 8.4 3.3 7.1 2.8 7.6 9.3 9.3 7.4 6.8 3.0 34.0 1.5 3.0 2.7 9.5 9.2 6.0 6.2 3.5 8.8 6.9 8.2 5.0 5.1 13.2 6.8 11.4 4.4 10.9 5.2 11.9 10.5 9.9 8.5 5.3 11.2 4.1 9.5 22.1 6.0 7.7 4.3 4.0 3.7 5.6 8.5 4.5 4.5 5.7 66.2 6.3 5.2 6.7 5.8 6.7 11.8 16.0 11.4 20.9 11.5 14.4 19.8 12.2 14.1 14.8 53.6 33.6 15.2 11.9 16.0 17.3 1.6 20.4 28.1 18.2 21.0 11.8 22.8 18.3 24.9 15.7 14.7 31.5 23.3 36.6 26.4 17.4 11.4 26.6 23.6 22.2 7.9 9.2 9.8 29.2 25.1 11.8 25.8 18.6 10.0 18.0 19.8 30.1 15.9 14.2 23.0 17.9 12.9 13.7 3.4 7.2 17.6 14.0 30.5 13.7 16.6 MPV17 SYM1 ENSG00000115204 "MPV17, mitochondrial inner membrane protein" P39210 2 27309492-27325680 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.34e-3)" "unprognostic (2.70e-1)" "unprognostic (9.50e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (6.99e-6)" "unprognostic (1.05e-1)" "unprognostic (1.37e-1)" "unprognostic (1.56e-1)" "unprognostic (2.22e-1)" "unprognostic (1.48e-1)" "unprognostic (1.44e-3)" "unprognostic (2.59e-3)" "unprognostic (2.52e-1)" "unprognostic (5.10e-3)" "unprognostic (4.62e-2)" 25.2 49.2 25.5 18.3 26.6 13.8 20.9 15.2 41.5 20.0 15.1 29.5 8.4 12.8 20.7 25.3 17.0 20.4 18.7 39.5 24.0 23.6 25.0 16.0 20.2 19.8 24.9 22.9 23.6 17.7 26.3 21.2 17.5 27.7 17.7 18.1 28.8 18.4 19.2 8.8 15.0 13.4 30.1 25.8 20.5 15.1 10.3 22.8 15.2 26.8 12.6 23.8 21.0 14.7 30.7 45.6 18.7 35.8 26.4 30.1 30.7 17.9 17.0 12.6 10.8 53.2 61.5 12.0 17.9 36.0 17.3 15.5 13.6 13.2 10.2 18.7 24.2 31.9 15.4 16.1 33.5 18.0 14.0 13.0 19.0 15.0 25.4 31.8 11.4 12.6 60.2 28.8 30.3 43.6 23.9 25.2 12.2 18.4 19.6 28.1 26.2 11.0 16.1 14.1 26.3 13.6 15.9 17.3 20.8 36.9 14.6 8.4 27.2 9.5 11.1 19.0 13.1 12.4 14.9 22.4 17.4 17.5 21.3 18.8 26.4 25.3 31.0 28.2 24.3 19.2 18.7 35.8 15.7 24.0 29.8 26.1 30.7 25.0 27.0 45.6 26.5 24.2 27.9 3.2 26.4 28.3 33.0 30.1 30.7 25.5 26.6 15.2 41.5 24.0 23.6 24.9 22.9 27.7 22.8 23.8 24.0 31.8 29.7 15.2 21.7 41.5 25.5 25.4 21.6 31.4 7.9 45.3 54.7 33.2 22.9 32.4 9.6 0.0 21.2 50.9 29.8 26.7 41.5 11.9 96.0 7.9 16.1 22.7 26.2 23.7 32.8 30.1 38.8 39.7 14.6 25.8 21.1 11.5 32.9 59.3 12.2 0.0 28.6 14.0 19.5 16.4 49.7 20.8 19.1 25.5 MPZ "CMT1, CMT1B, CMT2I, CMT2J, HMSNIB" ENSG00000158887 "Myelin protein zero" P25189 1 161304735-161309972 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 118.7;retina: 60.6" "Cell type enhanced" "Detected in many" 5 "monocytes: 5.4;Sertoli cells: 6.5" "Cancer enriched" "Detected in many" 11 "melanoma: 83.9" "Region enriched" "Detected in many" 4 "midbrain: 118.7" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.9" "Cell line enriched" "Detected in some" 5 "WM-115: 68.2" "Group enriched" "Detected in some" 5 "olfactory region: 3.6;pons and medulla: 1.4" "Region enriched" "Detected in single" 58 "midbrain: 262.7" HPA068925 Enhanced NA NA "HPA068925: AB_2732123" "unprognostic (6.77e-2)" "unprognostic (2.98e-1)" "unprognostic (9.27e-2)" "unprognostic (1.46e-1)" "unprognostic (3.35e-2)" "unprognostic (1.78e-1)" "unprognostic (1.49e-2)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (1.33e-1)" "unprognostic (7.88e-3)" "unprognostic (1.51e-1)" "unprognostic (6.62e-8)" "unprognostic (6.75e-2)" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (8.32e-2)" 14.3 12.6 2.2 3.4 2.9 1.3 4.7 6.0 2.2 4.5 6.1 2.6 9.9 2.6 1.7 7.5 8.7 1.5 4.3 7.2 2.4 4.3 3.2 7.9 3.1 1.3 118.7 0.7 1.9 2.2 0.5 7.4 0.8 28.4 7.3 5.0 60.6 6.4 15.6 4.2 2.3 6.3 5.6 40.9 6.8 2.1 2.7 0.8 0.2 2.8 26.3 3.0 9.3 3.3 0.1 0.0 1.9 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.9 0.4 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.7 0.5 0.1 0.1 0.0 0.6 0.2 0.0 0.3 0.0 0.3 0.1 12.6 0.4 1.5 1.2 1.4 0.0 2.1 0.1 0.0 0.9 0.6 3.2 0.0 1.4 0.0 0.2 2.5 0.5 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 0.0 0.0 6.5 0.3 0.0 3.1 0.9 0.1 0.1 0.9 0.0 0.3 0.3 0.4 1.6 5.7 68.2 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.2 0.1 2.2 2.9 6.0 2.2 2.4 4.3 118.7 0.7 28.4 0.8 3.0 1.1 0.0 2.3 0.5 2.8 0.2 0.0 0.0 0.0 3.5 2.0 0.4 0.0 0.1 4.2 0.8 0.0 0.0 1.0 0.5 0.2 1.3 0.0 0.8 1.6 1.6 1.7 3.1 2.7 1.1 1.4 1.2 3.3 5.4 0.4 0.7 0.1 0.0 0.4 0.3 1.1 6.5 0.8 0.5 0.7 0.4 0.2 0.5 0.4 1.4 MPZL1 "FLJ21047, PZR" ENSG00000197965 "Myelin protein zero like 1" O95297 1 167721192-167791919 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 51.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 51.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026966, HPA063538" Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA026966: AB_10600931, HPA063538: AB_2685034" "unprognostic (6.54e-2)" "unprognostic (9.26e-3)" "unprognostic (4.59e-2)" "unprognostic (4.88e-1)" "unprognostic (2.18e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (4.27e-6)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.22e-1)" "unprognostic (3.41e-2)" "unprognostic (2.59e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (3.99e-7)" "unprognostic (3.55e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.08e-4)" "unprognostic (4.21e-2)" 34.4 19.1 13.6 21.4 13.9 3.2 42.0 14.3 13.7 32.2 27.3 15.4 15.9 18.5 34.8 25.2 32.1 30.1 34.3 29.2 12.0 14.0 22.2 20.9 22.2 20.7 14.4 10.0 38.3 25.4 13.7 24.3 34.0 14.3 28.3 28.2 28.0 51.7 19.4 11.0 17.7 26.6 30.5 13.0 19.6 21.3 27.7 10.9 9.7 29.0 25.8 28.0 33.6 35.0 4.2 12.5 51.4 8.9 2.9 2.4 3.0 18.1 26.5 20.8 16.1 67.3 30.5 65.9 28.4 36.8 18.6 23.2 48.9 25.4 6.4 33.3 35.9 16.4 30.7 20.7 31.4 15.8 14.5 11.2 5.3 14.2 11.7 41.9 6.2 3.4 28.0 39.7 29.7 33.4 26.3 24.7 19.7 19.7 13.5 22.0 6.0 20.9 7.4 13.2 36.6 11.4 12.8 17.9 28.3 28.5 17.6 12.1 19.9 25.3 26.4 14.6 50.2 14.2 3.3 28.0 21.4 9.6 27.4 15.3 20.3 31.3 29.8 30.6 7.3 3.3 1.9 8.1 5.4 0.8 6.8 0.4 4.2 0.8 1.2 10.9 2.5 2.4 0.8 51.4 2.9 8.9 12.5 0.1 3.0 13.6 13.9 14.3 13.7 12.0 14.0 14.4 10.0 14.3 10.9 26.8 25.9 20.1 58.0 67.9 7.6 5.3 20.4 21.4 37.5 19.2 5.9 107.3 5.0 59.9 1.4 40.7 44.8 0.0 66.1 111.2 70.6 98.3 3.5 16.9 33.1 9.5 45.9 22.7 24.2 2.4 64.7 22.2 15.1 124.4 41.1 10.6 61.2 28.8 78.8 10.2 13.2 19.4 47.4 9.7 24.9 48.6 64.3 5.2 51.7 53.8 MPZL2 "EVA, EVA1" ENSG00000149573 "Myelin protein zero like 2" O60487 11 118253403-118264536 "Predicted membrane proteins" "Cell adhesion" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.8" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 405.2;Basal keratinocytes: 295.4;Suprabasal keratinocytes: 408.6;Urothelial cells: 416.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 9.3;intermediate monocyte: 7.2;myeloid DC: 13.4;neutrophil: 10.9" "Group enriched" "Detected in many" 10 "dendritic cells: 13.4;granulocytes: 10.9;monocytes: 9.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 25.3;EFO-21: 27.9;HaCaT: 34.9;RT4: 66.3;TIME: 72.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA060740 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA060740: AB_2684352" "unprognostic (1.74e-1)" "unprognostic (6.02e-2)" "unprognostic (8.23e-2)" "unprognostic (3.28e-3)" "unprognostic (9.95e-3)" "unprognostic (1.56e-1)" "unprognostic (2.11e-3)" "unprognostic (3.58e-1)" "unprognostic (7.39e-2)" "unprognostic (5.45e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.07e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.62e-4)" "unprognostic (2.08e-2)" 11.7 1.7 1.5 2.8 1.5 0.0 17.1 1.5 1.6 31.0 8.5 1.0 26.3 4.4 6.8 17.8 103.8 13.4 12.3 4.7 2.4 1.5 11.7 7.9 21.7 1.8 2.4 0.6 7.4 4.6 10.2 9.2 1.5 4.0 17.8 8.7 6.2 21.6 32.8 7.8 11.4 4.4 5.6 4.3 1.3 10.0 3.7 1.3 5.7 21.7 52.3 41.1 29.4 37.4 0.0 13.4 10.9 9.3 0.3 1.0 2.8 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 25.3 0.0 27.9 0.0 0.1 34.9 0.0 8.0 0.0 0.0 2.0 0.0 0.3 7.3 0.0 0.0 0.0 0.0 19.2 0.0 0.6 0.0 18.2 0.1 0.0 0.0 0.0 10.5 0.0 0.0 0.3 7.0 0.0 0.0 0.0 1.3 3.1 66.3 0.0 0.0 1.2 12.9 0.0 0.1 5.5 0.1 72.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 9.3 2.3 0.1 7.2 1.0 0.0 0.5 0.4 13.4 0.0 0.6 0.7 10.9 0.3 1.0 0.2 0.2 2.8 1.5 1.5 1.5 1.6 2.4 1.5 2.4 0.6 4.0 1.3 77.4 91.1 0.0 405.2 295.4 0.0 3.4 28.1 46.8 146.7 122.1 0.0 1.0 0.0 32.1 0.0 28.8 29.1 0.0 45.6 0.1 7.2 133.5 6.9 13.6 0.8 0.0 5.1 23.4 4.0 0.0 0.0 11.0 20.3 0.0 3.3 0.0 45.3 14.8 0.0 5.6 0.0 0.0 7.1 0.0 0.6 408.6 14.9 2.6 32.4 416.5 MPZL3 ENSG00000160588 "Myelin protein zero like 3" Q6UWV2 11 118226690-118252350 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Suprabasal keratinocytes: 55.8;Urothelial cells: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 11.4;eosinophil: 33.0;MAIT T-cell: 10.6;neutrophil: 30.6" "Group enriched" "Detected in many" 8 "granulocytes: 33.0;T-cells: 10.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.7;HMC-1: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029116 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA029116: AB_10610142" "unprognostic (2.54e-2)" "unprognostic (1.24e-1)" "unprognostic (5.87e-2)" "unprognostic (1.25e-1)" "unprognostic (3.13e-3)" "unprognostic (1.52e-1)" "unprognostic (8.74e-3)" "unprognostic (2.86e-2)" "unprognostic (9.82e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (4.86e-2)" "unprognostic (1.58e-2)" "unprognostic (1.89e-1)" "unprognostic (3.90e-1)" "prognostic favorable (3.64e-4)" "unprognostic (1.20e-1)" 3.5 0.7 0.8 3.6 3.0 5.2 7.1 6.9 1.4 9.2 5.5 0.5 8.4 4.3 5.2 6.8 28.5 4.4 8.7 1.4 0.8 1.0 4.7 9.4 10.6 4.4 0.8 0.4 1.5 9.0 7.4 12.4 2.6 2.4 5.3 5.1 1.4 19.6 11.1 1.0 23.1 8.3 1.5 1.2 5.4 5.6 2.6 0.4 5.8 7.3 27.1 32.6 6.5 12.8 0.6 2.8 33.0 2.1 2.8 10.6 1.7 3.2 0.4 0.0 0.5 0.0 0.0 0.5 0.4 0.0 0.0 0.1 11.1 17.7 3.2 8.6 0.0 1.3 4.6 0.8 3.7 0.1 0.2 1.3 2.0 0.9 5.3 0.1 2.6 20.0 0.2 9.4 0.0 3.7 0.0 6.0 2.2 2.5 1.8 0.0 11.2 1.2 1.4 1.6 10.9 0.8 0.0 0.0 4.8 6.8 4.2 2.3 0.2 4.4 5.8 0.3 0.9 10.5 1.4 2.8 0.1 0.9 0.0 0.1 0.3 3.2 2.0 0.1 0.1 0.2 11.4 2.1 33.0 2.6 1.2 10.6 0.6 4.2 3.5 2.8 0.6 3.2 2.5 30.6 2.8 0.8 0.3 2.8 1.7 0.8 3.0 6.9 1.4 0.8 1.0 0.8 0.4 2.4 0.4 14.9 24.0 0.8 20.0 31.6 0.3 1.4 5.1 22.7 9.1 8.7 2.0 0.6 0.0 9.4 6.5 3.8 10.6 0.0 7.5 0.5 1.7 30.2 1.1 6.6 1.1 0.0 11.5 0.6 6.8 4.9 0.0 6.9 10.1 0.0 4.0 0.3 12.7 7.0 0.4 0.6 1.6 0.0 2.0 0.5 1.1 55.8 1.4 26.1 6.7 36.6 MR1 HLALS ENSG00000153029 "Major histocompatibility complex, class I-related" Q95460 1 181033425-181061938 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048304 Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA048304: AB_2680347" "unprognostic (6.89e-2)" "unprognostic (1.54e-1)" "unprognostic (1.31e-2)" "unprognostic (1.96e-1)" "unprognostic (8.66e-3)" "unprognostic (4.37e-2)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.18e-1)" "unprognostic (3.49e-2)" "unprognostic (6.41e-2)" "unprognostic (1.05e-2)" "unprognostic (7.40e-3)" "unprognostic (4.69e-2)" "unprognostic (2.39e-1)" "unprognostic (1.07e-2)" 10.5 13.8 5.3 10.2 7.1 7.7 8.3 1.7 5.5 8.6 8.2 5.3 6.8 5.3 10.4 10.9 12.6 8.6 13.2 8.9 5.2 3.1 10.5 10.7 16.6 16.2 5.9 5.0 13.9 5.1 12.4 17.6 11.5 5.1 13.2 6.3 12.3 8.1 8.6 3.8 10.1 7.8 9.6 6.1 14.9 6.7 5.5 6.2 23.2 13.6 7.1 18.4 16.4 9.6 12.9 15.6 24.0 22.2 14.9 14.3 11.1 3.7 2.6 0.1 2.2 16.0 19.5 6.8 7.4 20.4 6.2 10.6 1.0 15.2 4.5 15.5 13.3 4.9 9.9 0.3 8.7 5.4 13.7 2.4 6.6 3.0 4.5 5.4 5.3 19.9 12.7 24.3 9.2 10.0 11.6 0.6 8.5 12.2 12.4 12.0 4.1 5.6 3.8 0.0 0.0 0.4 6.4 0.1 12.6 6.7 11.0 0.1 0.2 3.9 7.2 5.2 3.1 7.6 11.5 3.8 6.1 0.8 10.6 3.6 20.6 6.9 8.5 5.7 7.2 0.6 24.0 17.9 18.1 14.3 22.2 12.7 12.1 13.0 12.7 15.6 12.9 9.7 14.3 13.4 14.9 18.7 8.4 13.6 11.1 5.3 7.1 1.7 5.5 5.2 3.1 5.9 5.0 5.1 6.2 17.9 25.9 17.9 7.5 4.4 0.8 3.9 10.2 10.7 11.4 14.0 0.0 13.9 5.0 7.7 0.2 4.4 1.4 23.3 5.6 7.4 9.3 6.2 16.2 9.0 24.5 0.0 2.4 1.8 22.5 0.0 10.0 17.1 6.8 25.2 3.2 4.5 6.1 5.5 11.3 2.1 0.4 0.0 6.6 0.3 1.1 4.6 20.5 15.2 4.0 12.7 MRAP "B27, C21orf61, FALP" ENSG00000170262 "Melanocortin 2 receptor accessory protein" Q8TCY5 21 32291813-32314784 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adipose tissue: 28.3;adrenal gland: 52.7;breast: 68.6" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 41.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "basal ganglia: 2.6" "Cell type enhanced" "Detected in many" "NK-cell: 5.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Hep G2: 4.7;HSkMC: 5.4" "HPA011024, HPA011093" Uncertain Supported "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA011024: AB_10599292, HPA011093: AB_10600889" "unprognostic (1.38e-1)" "unprognostic (1.55e-3)" "unprognostic (1.53e-1)" "unprognostic (1.11e-1)" "unprognostic (9.53e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (1.80e-2)" "unprognostic (4.12e-1)" "unprognostic (6.30e-6)" "unprognostic (3.32e-2)" "unprognostic (2.37e-1)" "unprognostic (1.18e-1)" "unprognostic (5.76e-2)" 28.3 52.7 0.0 1.6 2.6 0.0 68.6 0.3 0.1 0.0 3.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.4 1.6 0.0 0.0 0.1 0.6 0.2 1.8 0.2 0.1 0.8 0.1 0.0 0.0 1.1 0.3 0.1 0.1 0.2 1.7 0.0 0.9 0.2 1.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.8 0.1 0.6 4.3 1.8 1.5 0.0 0.5 5.5 1.8 0.1 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.9 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.9 0.5 0.7 1.8 0.7 1.2 0.5 1.4 0.8 1.6 0.0 5.5 0.3 1.5 1.8 0.1 0.0 2.6 0.3 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.3 0.1 41.3 0.0 0.0 0.0 4.6 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 MRAP2 "bA51G5.2, C6orf117" ENSG00000135324 "Melanocortin 2 receptor accessory protein 2" Q96G30 6 84033756-84090881 "Disease related genes, Predicted membrane proteins" Obesity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 12.2;Mucus-secreting cells: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Lineage enhanced" "Detected in single" "B-cells: 2.3" "Group enriched" "Detected in some" 6 "K-562: 43.5;SCLC-21H: 15.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.82e-4)" "unprognostic (7.11e-2)" "unprognostic (2.35e-1)" "prognostic favorable (1.66e-4)" "unprognostic (8.80e-3)" "unprognostic (3.15e-1)" "unprognostic (9.85e-2)" "unprognostic (7.43e-2)" "unprognostic (2.76e-1)" "unprognostic (2.05e-3)" "unprognostic (1.41e-2)" "unprognostic (4.47e-1)" "unprognostic (6.02e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (4.50e-3)" "unprognostic (9.12e-2)" 1.4 9.6 7.8 1.5 11.6 0.2 2.1 14.5 19.0 3.6 6.8 3.5 4.2 4.7 3.5 1.5 2.0 10.8 3.5 1.2 5.2 16.3 4.6 0.4 1.2 0.6 5.8 14.5 6.4 5.4 0.2 3.7 0.3 8.4 8.2 6.6 4.7 7.4 10.3 1.5 2.5 5.0 1.5 3.0 8.0 10.0 3.2 1.9 0.1 0.8 2.0 2.1 1.2 2.1 2.3 0.1 0.6 0.0 0.0 0.1 0.1 0.0 1.2 0.4 0.0 0.1 0.7 0.0 0.4 0.0 0.7 0.1 0.5 0.0 0.1 0.0 4.7 1.6 0.0 0.8 0.1 0.0 0.4 0.4 1.5 0.1 0.1 0.0 0.3 0.1 0.2 0.6 0.0 0.0 0.0 2.8 0.0 43.5 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.2 0.0 2.5 0.0 2.6 0.7 15.2 5.1 0.1 0.0 0.7 0.6 0.1 1.3 0.2 0.2 0.2 2.5 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 2.3 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.1 7.8 11.6 14.5 19.0 5.2 16.3 5.8 14.5 8.4 1.9 0.0 0.3 0.0 6.7 1.5 0.6 0.3 0.0 2.7 2.3 12.2 0.0 0.0 1.7 2.7 2.2 0.7 2.8 0.0 4.8 0.0 0.6 2.9 0.0 0.0 0.0 0.0 0.0 2.5 0.0 4.2 3.7 0.0 0.0 0.0 12.4 0.0 0.6 7.0 4.9 0.0 0.2 0.0 1.4 0.2 2.7 0.9 0.0 0.0 3.7 2.4 MRC1 "bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1" ENSG00000260314 "Mannose receptor C-type 1" P22897 10 17809344-17911170 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 44.8;lymphoid tissue: 37.8" "Group enriched" "Detected in many" 6 "Hofbauer cells: 135.5;Ito cells: 511.3;Kupffer cells: 324.4;Macrophages: 182.8" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "myeloid DC: 8.2" "Lineage enriched" "Detected in single" 15 "dendritic cells: 8.2" "Group enriched" "Detected in some" 19 "MOLT-4: 17.7;TIME: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA004114, HPA045134, CAB068203" Enhanced NA NA 130000000 "CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228" "unprognostic (2.20e-1)" "unprognostic (2.07e-1)" "unprognostic (1.03e-2)" "unprognostic (2.58e-1)" "unprognostic (5.62e-2)" "unprognostic (4.30e-1)" "unprognostic (6.36e-3)" "unprognostic (1.35e-1)" "unprognostic (1.05e-2)" "unprognostic (6.05e-2)" "unprognostic (5.61e-2)" "unprognostic (4.12e-1)" "unprognostic (2.94e-2)" "unprognostic (4.97e-2)" "unprognostic (3.05e-2)" "unprognostic (1.74e-2)" "unprognostic (7.02e-2)" 34.8 8.3 0.3 6.2 1.2 0.0 19.8 0.7 0.6 5.2 11.2 0.6 0.9 2.2 4.5 10.4 4.2 1.3 7.9 13.4 0.9 12.4 16.4 44.8 37.8 1.0 0.0 3.6 5.1 1.8 2.4 15.4 3.1 5.5 5.1 7.0 0.7 1.9 5.1 0.0 6.5 8.2 1.4 30.6 2.2 7.1 0.8 0.8 6.5 3.5 0.7 7.5 5.1 0.0 8.2 0.1 0.5 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.7 0.0 0.2 0.0 0.0 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.2 29.8 47.4 11.5 0.0 0.3 0.0 3.6 5.1 10.7 13.6 0.0 0.0 0.8 0.0 0.0 26.7 4.8 1.3 0.0 0.3 1.1 1.0 0.0 12.8 2.5 135.5 0.0 0.0 511.3 324.4 7.9 1.4 182.8 0.0 0.0 0.4 0.0 0.1 1.1 0.0 0.0 0.0 32.3 0.0 0.3 1.2 0.4 1.7 4.9 0.8 0.0 MRC2 "CD280, CLEC13E, ENDO180, KIAA0709" ENSG00000011028 "Mannose receptor C type 2" Q9UBG0 17 62627401-62693597 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Alveolar cells type 2: 33.9;Early spermatids: 89.0;Fibroblasts: 61.1;Late spermatids: 54.5;Leydig cells: 66.4;Peritubular cells: 96.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 46.5;fHDF/TERT166: 31.6;U-138 MG: 47.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041991 Enhanced NA NA 28000000 "HPA041991: AB_10794166" "unprognostic (3.22e-1)" "unprognostic (2.19e-1)" "unprognostic (4.45e-2)" "unprognostic (2.59e-2)" "unprognostic (4.29e-2)" "unprognostic (2.67e-2)" "unprognostic (6.21e-2)" "unprognostic (1.80e-1)" "unprognostic (7.39e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (7.70e-2)" "unprognostic (7.75e-2)" "prognostic unfavorable (4.94e-7)" "unprognostic (5.25e-2)" "unprognostic (6.13e-2)" "unprognostic (3.00e-2)" "unprognostic (1.93e-2)" 14.7 5.7 2.4 14.7 5.2 3.2 27.3 1.4 3.4 30.4 7.0 6.5 18.7 4.4 31.7 46.3 15.7 15.7 37.2 44.1 2.5 2.6 8.7 2.2 46.8 2.5 3.4 4.0 33.6 4.7 0.9 11.3 5.4 6.8 25.7 1.9 35.1 10.9 17.1 7.3 19.0 7.1 28.7 8.2 9.7 5.8 13.3 2.5 4.8 4.6 21.2 5.3 18.1 18.1 0.0 0.6 0.2 0.0 0.0 1.0 0.0 0.0 8.5 4.6 6.1 12.8 23.1 0.7 46.5 27.2 6.8 8.2 0.5 0.1 0.0 3.3 31.6 3.0 3.9 0.8 3.9 1.9 5.8 1.3 3.9 6.2 0.0 19.1 4.8 0.0 30.0 2.0 6.0 0.6 29.4 3.1 2.3 2.2 0.0 9.4 1.4 1.2 16.6 1.1 0.0 0.5 4.7 3.3 0.0 0.7 0.1 0.7 12.2 3.1 0.1 0.0 3.1 0.1 19.4 15.5 47.9 19.6 8.3 8.2 0.0 0.0 0.0 15.0 4.9 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 1.0 0.9 0.2 0.0 0.0 0.0 0.9 0.0 2.4 5.2 1.4 3.4 2.5 2.6 3.4 4.0 6.8 2.5 3.0 33.9 0.0 6.4 10.1 1.6 3.2 0.0 1.4 2.3 1.8 0.0 0.7 0.0 0.3 89.0 2.2 0.0 0.0 0.2 2.1 61.1 1.1 2.3 0.0 6.8 0.0 0.0 5.5 6.7 54.5 66.4 6.4 5.0 1.0 0.0 0.8 0.4 0.0 96.2 0.0 0.5 0.0 6.6 5.2 3.2 6.8 1.6 0.5 0.0 0.9 MRGPRD mrgD ENSG00000172938 "MAS related GPR family member D" Q8TDS7 11 68980021-68980986 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "JURKAT: 4.7" "Not detected" "Not detected" HPA031346 Uncertain NA NA "HPA031346: AB_10602710" "unprognostic (1.92e-1)" "unprognostic (7.14e-2)" "unprognostic (1.72e-1)" 0.4 0.4 0.0 0.3 0.0 0.5 0.1 2.0 0.0 0.9 2.5 0.0 1.8 0.0 0.9 0.9 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 2.2 0.0 0.1 0.8 1.1 0.0 0.0 0.5 0.3 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRE "GPR167, mrgE" ENSG00000184350 "MAS related GPR family member E" Q86SM8 11 3227698-3232386 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 34.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Region enriched" "Detected in many" 14 "pons and medulla: 34.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NB-4: 2.6;RPMI-8226: 5.0;SCLC-21H: 8.2" "Low region specificity" "Detected in many" HPA046556 Uncertain NA NA "HPA046556: AB_10961404" "unprognostic (1.18e-1)" "unprognostic (7.52e-4)" "unprognostic (1.04e-1)" "unprognostic (9.09e-2)" "unprognostic (6.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.27e-1)" "unprognostic (1.83e-1)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" 0.1 0.8 0.1 0.1 0.3 2.1 0.8 1.5 2.0 3.5 0.8 0.0 0.0 0.0 2.0 0.7 0.6 1.7 0.5 1.1 0.6 2.3 0.1 0.0 0.3 0.0 2.5 0.0 0.1 0.3 0.0 0.5 1.8 34.9 1.1 0.0 3.9 1.6 1.3 0.1 0.3 0.3 0.5 1.5 1.9 0.1 0.2 0.1 0.0 0.9 0.2 0.0 0.6 1.6 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 8.2 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.1 0.3 1.5 2.0 0.6 2.3 2.5 0.0 34.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRF "GPR140, GPR168, MGC21621, mrgF" ENSG00000172935 "MAS related GPR family member F" Q96AM1 11 69004395-69013409 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Fibroblasts: 34.7;Leydig cells: 61.2;Peritubular cells: 94.7;Sertoli cells: 51.8;Smooth muscle cells: 90.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 26.8;ASC TERT1: 12.0;BJ: 15.1;BJ hTERT+: 38.1;BJ hTERT+ SV40 Large T+: 14.3;fHDF/TERT166: 11.6;U-2197: 18.2" "Region enriched" "Detected in some" 5 "cerebellum: 16.6" "Low region specificity" "Detected in all" HPA028811 Approved Supported "Nuclear membrane,Plasma membrane" NA NA "Nuclear membrane, Plasma membrane" "HPA028811: AB_10603875" "unprognostic (2.49e-2)" "unprognostic (3.89e-2)" "unprognostic (1.20e-1)" "unprognostic (9.03e-2)" "unprognostic (5.16e-2)" "unprognostic (6.52e-3)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" "unprognostic (8.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.55e-7)" "unprognostic (2.75e-2)" "unprognostic (2.27e-1)" "unprognostic (2.86e-2)" "unprognostic (3.62e-3)" 10.8 1.7 0.8 7.6 1.2 0.0 26.6 7.8 1.5 61.9 39.5 1.2 13.9 4.8 49.2 22.3 28.2 28.0 30.6 6.2 0.7 0.4 4.2 2.1 4.8 5.6 1.1 1.3 25.6 0.9 0.4 1.1 5.9 1.8 29.6 4.8 5.8 2.9 25.5 3.1 4.0 10.1 41.1 1.0 8.2 14.2 13.1 0.6 0.1 3.8 6.4 2.7 42.2 19.6 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 26.8 12.0 0.5 15.1 38.1 14.3 9.5 0.0 0.6 0.0 0.3 11.6 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.1 0.0 3.3 0.0 0.0 8.8 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.8 0.0 18.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 7.8 1.5 0.7 0.4 1.1 1.3 1.8 0.6 0.0 0.0 0.0 0.2 4.4 0.0 0.6 2.5 0.0 0.0 10.4 0.0 0.6 0.0 0.0 3.6 0.6 0.0 0.0 0.0 0.6 34.7 0.3 0.0 3.4 0.9 0.0 0.0 5.5 0.0 5.2 61.2 0.0 6.8 0.0 0.0 2.8 0.1 0.0 94.7 0.6 0.2 51.8 90.4 1.0 0.5 3.3 0.9 0.0 0.0 0.2 MRGPRG "GPR169, mrgG" ENSG00000182170 "MAS related GPR family member G" Q86SM5 11 3217944-3218813 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "testis: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NB-4: 1.1;REH: 2.6;SCLC-21H: 4.0" "Not detected" "Not detected" HPA058909 Uncertain NA NA "HPA058909: AB_2683852" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRX1 MRGX1 ENSG00000170255 "MAS related GPR family member X1" Q96LB2 11 18933813-18939507 "G-protein coupled receptors, Predicted membrane proteins" "Acute phase" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "SuSa: 6.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MRGPRX2 MRGX2 ENSG00000183695 "MAS related GPR family member X2" Q96LB1 11 19054455-19060681 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 9.2" "Cell type enriched" "Detected in single" 9 "Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 2.0" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Cell line enriched" "Detected in single" 4 "U-266/84: 1.9" HPA055220 Approved NA NA "HPA055220: AB_2682743" "unprognostic (1.56e-2)" "unprognostic (1.79e-1)" 5.2 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.0 2.8 0.5 0.0 0.0 0.0 2.0 1.0 0.7 0.1 2.9 0.1 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.7 1.1 0.0 1.3 0.0 0.3 4.3 0.5 9.2 0.0 0.3 0.4 0.8 0.0 0.0 0.0 1.6 0.4 2.8 2.2 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRX3 MRGX3 ENSG00000179826 "MAS related GPR family member X3" Q96LB0 11 18120955-18138480 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 10.3;salivary gland: 7.9;tongue: 4.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 2.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 7 "HBEC3-KT: 18.2" NA NA "unprognostic (1.54e-3)" "unprognostic (5.07e-2)" "unprognostic (1.61e-1)" "unprognostic (1.50e-1)" "unprognostic (7.65e-2)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (2.09e-1)" 0.1 0.0 0.1 0.8 0.1 0.4 10.3 0.1 0.3 0.3 0.1 0.1 0.1 0.3 0.1 0.1 3.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 7.9 0.1 0.4 0.4 0.2 0.1 0.1 0.6 0.1 0.9 0.1 0.1 0.1 4.4 1.4 0.1 0.5 0.1 0.2 1.6 0.1 0.0 0.1 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 2.6 0.4 0.0 18.2 0.0 0.1 0.3 0.0 0.1 0.6 0.0 0.1 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.7 0.4 0.2 0.3 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.7 0.1 0.0 0.8 0.2 0.2 0.5 0.4 0.2 0.1 1.9 1.2 0.4 0.2 0.7 0.2 0.1 0.2 0.3 0.5 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 MRGPRX4 MRGX4 ENSG00000179817 "MAS related GPR family member X4" Q96LA9 11 18172837-18174280 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 10 "melanoma: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SK-MEL-30: 4.4;WM-115: 5.7" NA NA "unprognostic (2.10e-2)" 0.1 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.5 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRLN "Linc-RAM, LINC00948, M1, MLN, MUSER1" ENSG00000227877 Myoregulin P0DMT0 10 59736692-59756041 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.1;skeletal muscle: 59.2;tongue: 22.0" "Group enriched" "Detected in some" 5 "Ciliated cells: 65.6;Rod photoreceptor cells: 27.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 10 "RH-30: 22.7" "Region enriched" "Detected in single" 11 "cerebellum: 24.2" "Low region specificity" "Detected in some" NA NA "unprognostic (2.32e-2)" "unprognostic (1.52e-1)" "unprognostic (2.27e-1)" "unprognostic (4.54e-1)" "unprognostic (3.17e-3)" "unprognostic (9.77e-2)" "unprognostic (1.09e-2)" "unprognostic (8.49e-2)" "unprognostic (1.23e-1)" "unprognostic (2.79e-2)" "unprognostic (1.12e-2)" "unprognostic (6.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.46e-1)" 0.8 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 2.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 4.4 0.0 0.9 0.4 0.0 1.2 0.1 0.0 59.2 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.9 22.0 0.7 0.0 0.0 2.5 1.7 4.2 1.4 1.7 2.4 0.4 0.0 0.8 0.4 0.9 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.8 0.6 1.1 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.7 0.2 1.9 0.3 0.1 0.0 1.1 1.9 0.0 0.6 0.0 0.1 0.0 0.1 0.1 1.3 0.0 2.1 0.0 0.9 0.2 0.2 1.6 0.5 22.7 0.0 0.0 0.1 0.6 0.2 0.3 0.1 0.1 0.1 0.4 0.7 0.0 0.3 0.8 0.9 0.6 1.1 0.1 0.1 0.4 0.3 0.0 4.2 1.4 1.6 2.4 1.0 1.7 2.0 1.7 1.5 1.2 2.5 1.2 2.1 4.2 1.7 1.0 1.7 1.5 0.4 0.0 0.3 0.0 0.0 0.0 2.2 0.9 0.0 65.6 3.4 0.0 2.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.2 4.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.3 0.4 0.0 0.4 10.2 27.6 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 MRS2 MRS2L ENSG00000124532 "MRS2, magnesium transporter" Q9HD23 6 24402908-24426194 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017642 Uncertain NA NA "HPA017642: AB_2669628" "unprognostic (2.12e-3)" "unprognostic (1.22e-1)" "unprognostic (5.64e-3)" "prognostic unfavorable (5.32e-4)" "unprognostic (7.23e-2)" "unprognostic (8.57e-2)" "unprognostic (1.82e-1)" "unprognostic (1.20e-1)" "unprognostic (3.89e-3)" "prognostic favorable (5.14e-11)" "unprognostic (8.75e-2)" "unprognostic (2.94e-2)" "unprognostic (8.32e-2)" "unprognostic (2.53e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (8.03e-4)" "unprognostic (1.55e-3)" 14.3 18.6 13.0 16.3 16.1 6.2 18.4 27.4 17.8 11.8 14.5 10.9 15.2 15.7 11.5 15.9 14.5 10.3 12.8 34.1 15.6 13.7 24.4 17.7 11.4 14.0 14.9 15.1 13.8 24.1 16.3 18.9 19.1 14.4 14.1 16.6 16.3 16.9 22.3 47.7 14.0 15.0 12.2 12.1 15.4 15.4 7.9 11.4 11.1 17.4 20.9 14.9 13.9 11.6 11.5 19.4 5.4 15.2 11.2 12.4 9.6 13.2 7.6 9.7 17.2 6.2 5.8 20.8 6.2 7.5 8.0 7.2 30.1 6.2 7.9 25.3 5.4 12.1 8.3 9.6 11.9 8.6 9.6 16.9 12.8 6.6 34.4 9.1 14.1 11.3 9.0 9.6 7.9 6.4 9.2 8.3 10.2 17.7 0.0 8.8 10.3 13.3 13.6 25.3 7.6 7.1 0.1 1.7 17.5 35.0 13.7 14.9 9.1 10.3 32.1 16.9 29.4 16.2 10.1 3.7 3.4 5.3 7.1 11.7 14.4 23.7 10.8 4.3 17.2 14.2 2.3 13.1 5.4 9.5 15.2 12.4 11.5 10.2 10.4 19.4 8.2 11.5 10.6 1.5 11.2 13.5 11.4 8.7 9.6 13.0 16.1 27.4 17.8 15.6 13.7 14.9 15.1 14.4 11.4 32.8 18.3 12.7 11.4 6.4 31.0 50.4 17.8 10.7 11.4 19.2 37.3 38.2 44.7 19.2 0.2 9.5 10.6 0.0 16.5 18.6 12.4 12.6 11.5 12.5 19.8 47.7 9.2 16.5 15.1 0.0 11.2 13.9 6.8 15.4 15.0 21.1 14.0 17.5 15.6 32.6 41.5 19.4 8.9 5.6 10.4 9.8 21.2 12.9 23.3 12.3 MRVI1 "IRAG, JAW1L" ENSG00000072952 "Murine retrovirus integration site 1 homolog" Q9Y6F6 11 10573091-10693988 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Peritubular cells: 82.0;Sertoli cells: 51.8;Smooth muscle cells: 82.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 18.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 18.5" "Cell line enhanced" "Detected in some" "ASC diff: 18.0;BJ: 12.7;BJ hTERT+: 14.7;fHDF/TERT166: 5.7;REH: 5.5" "Region enriched" "Detected in many" 5 "thalamus: 8.3" "Low region specificity" "Detected in many" HPA008704 Uncertain Approved "Nuclear bodies,Cytosol" NA NA 280000 Cytosol "Nuclear bodies" "HPA008704: AB_1079413" "unprognostic (2.18e-1)" "unprognostic (3.40e-2)" "unprognostic (2.86e-3)" "prognostic favorable (5.78e-4)" "unprognostic (5.30e-1)" "unprognostic (3.37e-3)" "unprognostic (1.04e-2)" "unprognostic (1.87e-1)" "unprognostic (5.63e-3)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (6.98e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (3.72e-2)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (9.97e-3)" 15.7 6.3 19.4 12.4 22.0 1.5 6.6 4.4 13.7 31.6 26.7 15.5 10.7 6.3 42.1 17.1 27.1 19.6 23.2 6.3 13.8 12.0 5.3 1.7 5.5 2.9 21.3 10.6 16.4 1.9 2.8 1.8 8.7 18.2 24.8 12.9 37.6 3.3 29.0 4.1 4.0 9.4 47.3 12.1 3.5 16.4 8.3 10.3 0.0 4.5 2.3 1.8 27.3 10.4 0.7 0.4 18.5 4.1 0.0 0.0 0.5 0.1 0.0 3.6 0.0 18.0 3.5 0.1 12.7 14.7 0.0 0.0 0.3 1.4 0.0 0.1 5.7 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.6 0.0 0.1 0.2 0.0 0.2 4.1 0.3 0.0 0.1 0.0 1.0 0.0 0.5 0.1 0.2 0.0 0.1 0.3 0.4 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 2.6 0.0 2.2 0.0 3.9 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 4.9 0.0 0.6 1.7 1.2 0.0 2.9 0.0 0.5 0.0 0.0 0.4 0.7 0.0 0.0 18.5 0.0 4.1 0.1 0.0 0.5 19.4 22.0 4.4 13.2 13.8 12.0 21.3 10.6 18.2 10.3 0.0 4.5 0.5 0.3 1.8 6.8 6.1 0.0 0.0 2.3 0.0 3.9 0.3 1.7 0.0 25.8 1.6 0.0 0.0 0.0 0.1 3.1 0.3 1.1 0.0 8.4 7.9 0.0 3.1 12.0 23.3 19.8 2.1 1.7 0.0 0.0 2.1 0.0 0.0 82.0 0.0 1.0 51.8 82.4 1.7 2.2 1.6 1.4 0.0 0.0 0.6 MS4A1 "B1, Bp35, CD20, MS4A2" ENSG00000156738 "Membrane spanning 4-domains A1" P11836 11 60455752-60470760 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "B-cell activation" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 77.7;intestine: 46.1;lymphoid tissue: 134.1" "Cell type enriched" "Detected in some" 61 "B-cells: 527.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 105 "memory B-cell: 77.7;naive B-cell: 77.7" "Lineage enriched" "Detected in single" 105 "B-cells: 77.7" "Group enriched" "Detected in some" 25 "Daudi: 122.9;U-698: 61.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000015, HPA014341, HPA014391" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264" "prognostic favorable (4.34e-5)" "unprognostic (4.45e-4)" "unprognostic (1.19e-4)" "unprognostic (2.04e-3)" "unprognostic (1.06e-1)" "unprognostic (5.53e-7)" "unprognostic (2.46e-3)" "unprognostic (1.85e-3)" "unprognostic (3.06e-2)" "unprognostic (2.89e-4)" "unprognostic (6.96e-2)" "unprognostic (2.84e-2)" "unprognostic (3.96e-5)" "unprognostic (2.23e-1)" "unprognostic (8.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-1)" 1.6 0.3 0.3 79.0 0.3 3.6 0.6 0.3 0.3 0.5 2.0 0.0 0.0 0.2 0.4 0.5 7.0 0.4 1.3 0.7 0.3 0.3 2.0 0.9 2.7 81.2 0.3 0.1 0.3 0.4 0.0 0.4 0.4 0.1 1.1 1.7 0.6 14.5 0.2 0.3 0.3 46.1 0.1 0.4 90.7 2.6 0.6 0.0 15.7 2.5 2.7 134.1 6.4 0.8 77.7 0.0 0.2 0.0 0.7 0.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 122.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 77.7 0.3 0.6 0.0 77.7 0.0 0.2 0.2 0.7 0.0 0.0 0.0 3.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.1 0.0 0.0 6.7 527.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.6 1.8 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.7 0.0 0.0 MS4A10 "CD20L7, MS4A9" ENSG00000172689 "Membrane spanning 4-domains A10" Q96PG2 11 60785348-60801305 "Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "intestine: 115.7" "Cell type enhanced" "Detected in single" 26 "Enterocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.3;NB-4: 2.4" "Low region specificity" "Detected in all" HPA014778 Uncertain NA NA "HPA014778: AB_2669089" "unprognostic (7.67e-3)" "unprognostic (1.28e-1)" "unprognostic (8.73e-3)" "unprognostic (1.27e-1)" "unprognostic (5.21e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 28.3 0.0 0.0 33.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 115.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 3.5 0.5 0.9 0.5 0.1 0.3 0.9 0.4 0.2 0.2 0.0 2.3 0.2 0.1 0.1 0.0 0.8 0.2 0.4 0.3 0.1 0.0 0.7 0.2 0.3 0.2 0.0 0.3 2.1 0.7 0.3 0.1 0.6 1.9 0.0 0.0 0.6 0.3 0.2 0.0 0.3 0.5 1.4 0.7 0.3 0.5 2.4 0.0 0.4 0.3 0.2 0.0 1.7 0.1 0.4 1.0 1.0 0.4 0.6 0.0 0.8 0.4 0.2 1.5 0.7 0.2 1.5 0.3 0.2 0.2 0.4 0.4 0.7 0.2 3.5 0.4 0.7 0.5 0.3 0.4 0.5 0.3 0.3 0.2 0.8 0.5 0.5 1.4 0.9 0.5 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 MS4A12 "FLJ20217, Ms4a10" ENSG00000071203 "Membrane spanning 4-domains A12" Q9NXJ0 11 60492778-60507430 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "intestine: 64.7;lymphoid tissue: 28.6" "Group enriched" "Detected in some" 6 "Enterocytes: 108.9;Paneth cells: 59.6" "Cancer enriched" "Detected in some" 8 "colorectal cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.6;LHCN-M2: 2.2;NTERA-2: 3.1;RH-30: 4.3;U-2 OS: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048616, HPA057657" Enhanced Approved "Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli, Endoplasmic reticulum, Golgi apparatus" "HPA048616: , HPA057657: AB_2683491" "unprognostic (2.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.49e-1)" "unprognostic (3.26e-1)" "unprognostic (2.83e-1)" "unprognostic (9.20e-3)" 0.1 0.0 0.1 28.6 0.1 0.0 0.1 0.1 0.1 0.1 57.7 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 64.7 0.1 0.1 0.1 0.1 0.0 0.2 1.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.1 0.0 0.0 0.2 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 1.8 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 108.9 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 59.6 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 13.2 0.0 MS4A13 ENSG00000204979 "Membrane spanning 4-domains A13" Q5J8X5 11 60515413-60542721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 85 "testis: 8.4" "Group enriched" "Detected in some" 6 "Early spermatids: 20.4;Late spermatids: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "U-2 OS: 2.1;U-266/70: 6.4;U-266/84: 2.0" "HPA045017, HPA063626" Uncertain NA NA "HPA045017: AB_10962976, HPA063626: AB_2685065" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.1 0.7 0.0 6.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.8 2.1 0.0 0.0 0.0 0.0 0.0 MS4A14 "DKFZp434H092, FLJ32856, MS4A16, NYD-SP21" ENSG00000166928 "Membrane spanning 4-domains A14" Q96JA4 11 60378530-60417756 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 79.3;testis: 53.6" "Group enriched" "Detected in some" 41 "Early spermatids: 207.0;Late spermatids: 514.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 6.8;non-classical monocyte: 9.2" "Lineage enriched" "Detected in many" 5 "monocytes: 9.2" "Cell line enriched" "Detected in single" 24 "THP-1: 14.6" HPA058973 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA058973: " "unprognostic (1.78e-1)" "unprognostic (1.76e-1)" "unprognostic (5.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.27e-1)" "unprognostic (1.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.45e-2)" "unprognostic (4.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.77e-1)" "unprognostic (2.14e-1)" "unprognostic (4.50e-6)" "unprognostic (3.73e-2)" "unprognostic (7.16e-3)" "unprognostic (8.40e-2)" "unprognostic (7.11e-2)" 14.5 4.4 2.0 4.6 2.3 1.5 5.4 0.8 1.5 2.4 3.9 1.9 1.1 1.5 1.9 6.4 1.8 1.3 2.3 6.4 2.5 2.3 3.5 13.3 18.0 11.3 2.4 0.1 1.3 1.5 1.2 3.2 6.0 2.4 3.0 2.2 4.5 2.1 1.6 1.3 1.3 4.0 2.4 5.5 79.3 1.5 53.6 1.5 3.7 1.7 0.7 3.0 2.4 1.7 0.5 1.8 0.1 9.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 4.3 0.0 0.0 6.8 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.9 2.0 2.3 0.8 1.5 2.5 2.3 2.4 0.1 2.4 1.5 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 207.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 7.5 514.6 3.7 8.8 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 6.5 0.0 5.7 2.4 0.3 0.1 0.0 0.0 0.0 MS4A15 ENSG00000166961 "Membrane spanning 4-domains A15" Q8N5U1 11 60756953-60776732 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 9.9;lung: 32.4" "Cell type enriched" "Detected in some" 8 "Alveolar cells type 1: 89.3" "Cancer enhanced" "Detected in many" "lung cancer: 6.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 9.9" "Lineage enriched" "Detected in single" 15 "T-cells: 9.9" "Cell line enhanced" "Detected in some" "HEL: 9.2;JURKAT: 3.4;Karpas-707: 3.8;MOLT-4: 4.1;U-266/70: 13.5;U-266/84: 5.7" "Region enriched" "Detected in single" 28 "olfactory region: 205.0" "Region enriched" "Detected in single" 30 "olfactory region: 39.1" HPA054563 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA054563: " "unprognostic (1.85e-1)" "unprognostic (4.31e-3)" "unprognostic (8.59e-2)" "unprognostic (5.89e-4)" "unprognostic (4.49e-1)" "unprognostic (1.09e-3)" "unprognostic (3.92e-3)" "unprognostic (5.43e-3)" "unprognostic (1.20e-1)" "unprognostic (7.30e-2)" "unprognostic (3.14e-1)" "unprognostic (1.04e-9)" "unprognostic (7.02e-2)" "unprognostic (8.63e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-1)" 0.3 0.2 0.3 0.3 0.3 0.0 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 1.8 0.3 0.4 1.0 0.3 0.3 0.3 0.2 0.3 0.3 32.4 0.3 0.3 0.3 2.4 0.3 0.0 0.3 1.1 0.3 0.3 0.5 0.3 0.3 1.9 0.3 0.2 1.4 1.7 0.3 0.3 0.2 0.6 0.3 0.3 0.3 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.0 0.6 9.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 9.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.4 1.6 3.8 0.0 0.0 4.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.5 0.0 0.0 13.5 5.7 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.9 0.5 0.0 0.0 1.8 0.7 0.0 0.6 0.0 0.0 9.9 0.7 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 89.3 4.8 0.0 0.0 0.0 0.0 0.2 0.0 2.7 11.4 0.0 0.0 0.7 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.0 0.0 0.0 MS4A18 ENSG00000214782 "Membrane spanning 4-domains A18" Q3C1V0 11 60729304-60744212 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 7.8;intestine: 21.9;testis: 4.3" "Group enriched" "Detected in some" 41 "Early spermatids: 3.9;Late spermatids: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.4" HPA045121 Approved NA NA "HPA045121: AB_10969456" "unprognostic (1.02e-1)" "unprognostic (8.87e-2)" "unprognostic (2.51e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 3.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A2 "APY, FCER1B, IGER, MS4A1" ENSG00000149534 "Membrane spanning 4-domains A2" Q01362 11 60088261-60098466 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 72.0" "Cell type enriched" "Detected in some" 18 "granulocytes: 912.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 720 "basophil: 72.0" "Lineage enriched" "Detected in single" 720 "granulocytes: 72.0" "Cell line enhanced" "Detected in some" "HEL: 7.1;NB-4: 2.6;THP-1: 4.2;U-937: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059967 Enhanced NA NA "HPA059967: AB_2684183" "unprognostic (7.28e-2)" "unprognostic (9.21e-2)" "unprognostic (2.50e-4)" "unprognostic (4.97e-2)" "unprognostic (4.47e-1)" "unprognostic (2.40e-6)" "unprognostic (1.88e-2)" "unprognostic (6.21e-3)" "unprognostic (3.96e-1)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (6.63e-3)" "unprognostic (6.49e-3)" "unprognostic (9.95e-2)" "unprognostic (4.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.74e-1)" 4.9 0.5 0.4 5.1 0.4 0.2 2.1 0.4 0.4 11.9 4.6 0.1 4.5 4.7 14.3 11.2 5.9 1.1 14.6 2.1 0.4 0.4 1.5 0.9 12.9 0.5 0.4 0.1 1.1 1.2 0.2 0.6 0.6 0.1 17.5 5.6 4.5 3.2 5.4 1.5 4.3 7.4 15.9 0.4 0.6 4.5 2.7 0.2 1.2 0.6 6.7 3.4 5.1 4.1 0.0 0.0 72.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.2 0.4 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.0 7.1 0.5 0.2 0.3 0.9 0.4 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.9 0.3 0.0 0.1 0.0 2.6 0.1 0.0 0.1 0.1 0.0 0.2 0.0 1.0 0.2 0.1 0.1 0.2 0.0 0.0 0.3 4.2 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.2 1.9 0.2 72.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.1 0.1 0.2 0.0 51.4 0.0 0.6 0.0 0.4 0.4 0.0 1.4 12.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 912.4 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MS4A3 "CD20L, HTM4" ENSG00000149516 "Membrane spanning 4-domains A3" Q96HJ5 11 60056587-60071128 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 196.2;bone marrow: 105.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebral cortex: 1.6" "Cell type enriched" "Detected in single" 1061 "basophil: 196.2" "Lineage enriched" "Detected in single" 1963 "granulocytes: 196.2" "Group enriched" "Detected in some" 4 "HEL: 37.1;K-562: 31.7;NB-4: 25.7;THP-1: 75.0;U-937: 29.6" "Not detected" "Not detected" HPA019210 Supported Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus" "Vesicles, Cytosol" "HPA019210: AB_1854134" "unprognostic (6.37e-3)" "unprognostic (1.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.77e-1)" 0.2 0.0 0.1 0.1 0.3 105.4 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 14.7 0.1 0.1 0.1 0.5 6.8 0.0 0.1 0.0 0.1 0.0 0.0 0.4 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.1 8.6 0.0 1.0 0.0 7.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 196.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 9.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.6 0.0 196.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A4A "CD20L1, MS4A4, MS4A7" ENSG00000110079 "Membrane spanning 4-domains A4A" Q96JQ5 11 60280541-60308972 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "adipose tissue: 47.2" "Cell type enhanced" "Detected in many" 19 "Hofbauer cells: 321.0;Kupffer cells: 359.4;Macrophages: 124.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 26.4;myeloid DC: 11.9;non-classical monocyte: 31.6;plasmacytoid DC: 11.7" "Group enriched" "Detected in many" 27 "dendritic cells: 11.9;monocytes: 31.6" "Cell line enriched" "Detected in some" 18 "K-562: 54.8" HPA029323 Approved NA NA "HPA029323: AB_10601866" "unprognostic (7.93e-2)" "unprognostic (2.05e-2)" "unprognostic (1.37e-3)" "unprognostic (1.98e-1)" "unprognostic (4.46e-2)" "unprognostic (2.31e-1)" "unprognostic (9.66e-2)" "unprognostic (1.59e-1)" "unprognostic (4.56e-1)" "unprognostic (6.65e-2)" "unprognostic (8.10e-2)" "unprognostic (2.11e-1)" "unprognostic (5.02e-3)" "unprognostic (3.32e-2)" "unprognostic (4.66e-2)" "unprognostic (4.89e-2)" "unprognostic (4.21e-2)" 47.2 13.9 3.8 10.2 5.3 1.3 18.8 1.4 3.1 8.5 9.8 2.8 2.5 2.6 4.4 18.9 6.2 10.6 14.8 13.7 4.1 3.0 12.6 9.9 20.4 28.2 4.9 1.5 4.4 3.1 1.6 5.0 32.7 6.7 8.3 9.5 8.7 7.7 2.7 3.9 2.6 9.9 12.1 7.4 30.7 5.7 5.6 3.6 2.8 5.0 3.4 4.0 13.1 3.1 0.2 11.9 0.3 31.6 0.8 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.2 0.0 0.0 26.4 0.0 0.2 0.0 0.0 11.9 0.0 0.0 0.0 0.3 0.8 31.6 11.7 0.0 2.3 3.8 5.3 1.4 3.1 4.1 3.0 4.9 1.5 6.7 3.6 0.0 9.3 9.5 0.1 1.5 0.0 3.6 5.1 0.0 4.5 0.0 0.0 1.5 0.0 0.0 0.6 2.1 0.0 0.0 0.0 1.3 2.6 0.0 7.0 2.6 321.0 0.0 0.0 74.9 359.4 0.8 0.9 124.2 3.3 3.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.9 0.9 0.0 0.1 1.6 3.0 4.1 0.0 0.0 MS4A4E ENSG00000214787 "Membrane spanning 4-domains A4E" Q96PG1 11 60201253-60243088 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 17.1" "Cell type enhanced" "Detected in some" 21 "Club cells: 1.2;Kupffer cells: 2.1" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in some" 7 "basophil: 17.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 17.1" "Cell line enhanced" "Detected in some" "K-562: 5.2;NB-4: 1.7;THP-1: 7.5;U-937: 1.0" HPA040075 Uncertain NA NA "HPA040075: AB_10793915" "unprognostic (1.90e-1)" "unprognostic (2.64e-2)" "unprognostic (7.05e-2)" "unprognostic (9.42e-2)" "unprognostic (5.99e-2)" "unprognostic (1.45e-2)" "unprognostic (8.97e-2)" "unprognostic (1.23e-3)" "unprognostic (3.33e-2)" "unprognostic (1.74e-1)" "unprognostic (1.28e-3)" "unprognostic (4.16e-2)" "unprognostic (9.88e-3)" "unprognostic (4.97e-2)" "unprognostic (4.38e-2)" "unprognostic (1.07e-2)" "unprognostic (4.05e-2)" 4.7 2.2 0.2 1.2 0.2 7.1 3.4 0.1 0.2 0.5 1.6 1.0 0.8 1.1 1.2 0.9 2.9 1.2 0.3 0.3 1.0 0.8 1.9 1.6 0.2 0.8 0.8 0.8 0.7 1.0 0.9 1.2 1.9 0.1 0.6 1.0 2.8 3.3 0.5 3.1 1.6 0.5 0.7 0.4 2.1 0.9 0.0 2.4 17.1 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.6 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 17.1 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 1.3 1.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A5 CD20L2 ENSG00000166930 "Membrane spanning 4-domains A5" Q9H3V2 11 60429589-60455214 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 54 "testis: 46.6" "Group enriched" "Detected in some" 89 "Early spermatids: 541.0;Late spermatids: 817.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 2.1;U-2 OS: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA043732 Uncertain NA NA "HPA043732: AB_10959759" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 541.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 817.7 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 6.5 0.0 7.6 2.0 0.0 0.0 0.0 0.0 0.0 MS4A6A "CD20L3, MS4A6" ENSG00000110077 "Membrane spanning 4-domains A6A" Q9H2W1 11 60172014-60184666 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 112.4;lymphoid tissue: 89.5" "Group enriched" "Detected in many" 14 "Hofbauer cells: 335.3;Ito cells: 767.3;Kupffer cells: 1329.9;Macrophages: 569.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 32.4;classical monocyte: 112.4;intermediate monocyte: 35.6;myeloid DC: 65.3;plasmacytoid DC: 46.3" "Group enriched" "Detected in many" 96 "dendritic cells: 65.3;granulocytes: 32.4;monocytes: 112.4" "Cell line enriched" "Detected in some" 9 "THP-1: 32.6" "HPA011391, HPA076623" Approved Approved Vesicles NA NA Vesicles "HPA011391: AB_10603876, HPA076623: AB_2686809" "unprognostic (1.17e-1)" "prognostic favorable (6.33e-4)" "unprognostic (2.35e-2)" "unprognostic (1.21e-2)" "unprognostic (1.00e-1)" "unprognostic (8.51e-2)" "unprognostic (2.33e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (3.20e-1)" "unprognostic (4.75e-3)" "unprognostic (1.06e-1)" "unprognostic (4.66e-2)" "unprognostic (3.94e-2)" "unprognostic (2.97e-2)" 29.3 17.8 12.3 18.3 26.7 9.1 18.1 2.8 14.6 10.2 14.9 4.7 4.0 9.0 7.0 28.3 8.7 11.3 21.0 23.1 10.7 6.9 18.0 35.6 23.0 89.5 22.2 2.4 7.7 6.0 2.4 8.8 21.5 20.5 9.6 19.0 10.2 11.8 6.3 6.0 5.1 20.4 17.2 32.0 78.1 8.5 8.3 19.4 8.5 7.0 6.7 15.4 21.5 6.3 0.7 65.3 32.4 112.4 0.2 0.3 61.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.8 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 32.4 112.4 0.7 0.1 35.6 0.3 0.7 0.2 0.1 65.3 0.1 0.1 0.1 7.4 0.2 2.3 46.3 0.1 61.3 12.3 26.7 2.8 14.6 10.7 6.9 22.2 2.4 20.5 19.4 6.0 31.7 53.0 0.4 8.2 0.0 2.4 30.6 2.7 4.5 3.5 0.0 1.6 0.0 0.0 2.0 8.5 0.0 0.0 0.0 1.7 7.3 0.2 12.8 6.0 335.3 0.0 0.0 767.3 1329.9 1.1 1.4 569.3 13.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.4 45.3 7.2 0.3 1.0 6.9 1.7 27.7 0.0 0.1 MS4A6E ENSG00000166926 "Membrane spanning 4-domains A6E" Q96DS6 11 60334831-60396596 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 28.2" "Cell type enriched" "Detected in some" 21 "Early spermatids: 1123.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 1.2" "Lineage enriched" "Detected in single" 6 "monocytes: 1.2" "Group enriched" "Detected in some" 7 "K-562: 2.1;SuSa: 4.2" HPA076623 Approved Vesicles NA NA Vesicles "HPA076623: AB_2686809" "unprognostic (2.58e-1)" "unprognostic (3.35e-1)" "unprognostic (3.47e-1)" "unprognostic (6.81e-3)" "unprognostic (4.55e-4)" "unprognostic (1.08e-1)" "unprognostic (1.71e-1)" "unprognostic (1.76e-1)" 2.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 28.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1123.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 53.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 5.1 2.5 0.0 0.0 0.0 0.0 0.0 MS4A7 "CD20L4, CFFM4, MS4A8" ENSG00000166927 "Membrane spanning 4-domains A7" Q9GZW8 11 60378482-60395951 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in all" 4 "blood: 132.8;lymphoid tissue: 126.7" "Group enriched" "Detected in many" 12 "Hofbauer cells: 291.6;Kupffer cells: 748.0;Macrophages: 338.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 71.2;non-classical monocyte: 132.8" "Lineage enriched" "Detected in many" 11 "monocytes: 132.8" "Cell line enriched" "Detected in some" 24 "THP-1: 51.2" "Low region specificity" "Detected in all" "HPA017418, CAB026387" Approved NA NA "CAB026387: , HPA017418: AB_1854137" "unprognostic (1.43e-1)" "unprognostic (2.60e-3)" "unprognostic (3.24e-2)" "unprognostic (9.67e-2)" "unprognostic (2.04e-1)" "unprognostic (1.81e-1)" "unprognostic (1.04e-1)" "unprognostic (9.51e-2)" "unprognostic (3.02e-2)" "unprognostic (4.85e-2)" "unprognostic (5.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.43e-2)" "unprognostic (4.59e-2)" "unprognostic (3.90e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" 24.2 11.9 4.4 15.1 4.9 2.0 9.7 1.3 3.5 5.9 7.4 4.2 2.9 5.2 4.2 11.0 4.0 4.8 15.2 11.3 5.1 3.9 6.8 22.3 29.7 19.1 4.6 1.3 3.2 3.4 2.3 6.2 13.3 5.0 5.9 7.5 8.4 5.3 3.4 2.2 2.3 8.1 4.8 9.9 126.7 4.3 6.0 3.5 7.0 3.3 2.3 5.6 9.7 3.9 2.0 11.9 0.9 132.8 0.1 0.1 10.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.3 0.2 0.0 0.0 51.2 0.0 0.0 0.0 0.1 0.1 0.1 0.1 1.2 0.0 1.6 0.0 0.5 18.8 0.2 0.1 71.2 0.1 2.0 0.0 0.0 11.9 1.8 0.0 0.0 0.9 0.1 132.8 0.3 0.0 10.9 4.4 4.9 1.3 3.5 5.1 3.9 4.6 1.3 5.0 3.5 11.9 38.5 23.0 0.6 2.4 0.8 1.9 0.0 13.4 6.8 8.7 0.0 1.0 0.0 0.0 2.0 2.1 0.0 0.0 0.2 1.2 3.1 1.2 12.8 0.9 291.6 0.0 0.0 16.0 748.0 0.5 1.1 338.5 1.7 15.4 0.0 0.3 0.1 0.0 0.0 0.6 0.5 19.4 1.2 0.0 0.3 1.6 1.6 4.1 0.0 0.8 MS4A8 "CD20L5, MS4A4, MS4A8B" ENSG00000166959 "Membrane spanning 4-domains A8" Q9BY19 11 60699574-60715811 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "fallopian tube: 36.8;intestine: 123.9" "Group enriched" "Detected in many" 6 "Ciliated cells: 681.3;Intestinal endocrine cells: 454.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 14.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;CAPAN-2: 1.5;HDLM-2: 1.4;NB-4: 2.2;OE19: 5.3;RPMI-8226: 3.9;SCLC-21H: 2.8;SH-SY5Y: 1.5" "Not detected" "Not detected" HPA007319 Enhanced NA NA "HPA007319: AB_1854138" "unprognostic (7.28e-3)" "unprognostic (2.11e-1)" "unprognostic (9.03e-2)" "unprognostic (1.91e-2)" "unprognostic (2.52e-2)" "unprognostic (9.41e-2)" "unprognostic (4.89e-3)" "unprognostic (9.33e-2)" "unprognostic (7.97e-3)" "unprognostic (2.40e-1)" "unprognostic (2.40e-9)" "unprognostic (2.46e-1)" "unprognostic (3.02e-2)" "unprognostic (1.59e-3)" 0.1 0.2 1.4 2.0 0.2 0.0 0.1 0.2 0.6 7.1 43.9 0.4 0.6 46.6 2.5 5.9 0.3 36.8 8.9 0.3 0.6 0.3 0.2 0.1 8.6 0.1 0.1 0.5 4.2 1.2 0.0 4.7 0.1 1.0 2.3 4.0 0.2 0.4 10.9 0.8 0.1 123.9 0.1 0.1 0.1 12.7 0.7 0.1 0.2 0.1 0.1 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 5.3 0.0 0.0 0.0 3.9 0.0 0.0 2.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.2 0.6 0.6 0.3 0.1 0.5 1.0 0.1 6.0 5.4 0.0 0.1 0.0 0.0 0.3 20.4 681.3 94.4 1.8 0.0 0.0 0.0 0.2 1.1 0.0 24.2 0.0 2.3 0.0 0.0 1.9 1.1 0.0 0.0 0.0 454.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 10.5 0.0 0.1 24.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 MSANTD3-TMEFF1 C9orf30-TMEFF1 ENSG00000251349 "MSANTD3-TMEFF1 readthrough" 9 100442271-100577636 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 21.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 40.5;NTERA-2: 20.5;SCLC-21H: 21.8;SuSa: 30.2" "Low region specificity" "Detected in all" NA NA "unprognostic (8.53e-3)" "unprognostic (1.95e-3)" "unprognostic (5.92e-2)" "unprognostic (5.32e-2)" "unprognostic (8.87e-2)" "unprognostic (3.00e-1)" "unprognostic (3.39e-4)" "unprognostic (6.34e-2)" "unprognostic (2.19e-1)" "unprognostic (8.88e-3)" "unprognostic (1.46e-1)" "unprognostic (9.55e-3)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.02e-3)" 0.6 0.6 7.7 1.1 4.9 0.0 0.5 7.1 21.4 2.3 0.8 0.0 3.5 1.0 0.6 0.6 1.1 0.7 5.5 3.9 0.4 0.0 0.5 0.0 2.9 1.2 0.0 0.1 0.0 1.1 1.1 0.6 0.0 2.0 0.3 0.0 0.3 2.8 3.5 0.0 0.2 3.3 3.7 0.2 0.9 0.1 0.2 1.0 1.0 0.0 0.0 1.0 0.7 1.1 1.8 40.5 3.3 5.0 2.8 6.7 4.4 3.1 3.3 3.5 0.2 1.2 0.8 2.2 3.9 9.3 0.7 12.7 1.3 7.6 3.1 2.4 0.2 1.3 0.6 2.5 0.8 0.7 1.2 1.1 3.2 3.8 7.4 8.2 7.7 0.8 0.5 6.5 0.7 5.0 0.7 20.5 3.4 1.7 6.0 17.2 0.1 3.2 0.4 21.8 10.2 1.4 0.9 2.1 30.2 0.4 2.5 2.9 3.5 3.6 4.0 3.9 1.9 4.3 3.7 5.3 0.5 3.3 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.4 0.3 1.0 0.2 0.3 0.5 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MSI1 ENSG00000135097 "Musashi RNA binding protein 1" O43347 12 120341330-120369180 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 27.3;skeletal muscle: 23.2" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 51.1;Early spermatids: 46.0;Late spermatids: 40.7;Muller glia cells: 68.3;Rod photoreceptor cells: 92.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 43.8;HAP1: 20.0;NTERA-2: 22.8;SCLC-21H: 32.5;SH-SY5Y: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074923, HPA075573" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA074923: , HPA075573: " "unprognostic (1.21e-1)" "unprognostic (3.46e-3)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (3.89e-1)" "unprognostic (3.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (1.90e-2)" "unprognostic (2.75e-2)" "prognostic favorable (5.99e-4)" "unprognostic (3.66e-1)" "unprognostic (1.46e-3)" "unprognostic (7.61e-2)" "unprognostic (7.35e-2)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" 0.8 6.8 8.7 0.6 7.4 0.4 1.2 3.9 14.2 1.9 1.5 8.6 2.2 7.8 4.3 2.7 1.5 3.1 1.4 4.0 11.3 5.9 0.7 1.0 1.0 0.6 4.7 6.1 2.9 7.3 1.3 12.8 1.4 4.6 4.5 1.5 27.3 1.3 2.5 23.2 0.5 5.2 2.2 4.7 0.7 3.1 12.5 5.4 0.0 1.3 0.0 0.4 0.9 0.9 0.1 0.4 0.6 0.2 0.2 0.3 0.0 0.0 0.5 43.8 11.1 0.0 0.0 5.6 0.0 0.0 0.3 0.5 7.7 0.2 0.0 0.6 0.0 0.2 0.1 20.0 0.0 0.1 0.2 4.5 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.1 22.8 0.2 0.2 0.1 0.0 0.1 0.0 0.0 32.5 15.8 0.0 0.3 0.3 4.4 6.7 0.0 0.0 0.1 6.0 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.4 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.6 0.2 0.2 0.4 0.1 0.0 8.7 7.4 3.9 7.2 11.3 5.9 4.7 6.1 4.6 5.4 0.0 0.0 0.0 1.0 0.9 20.9 2.6 0.0 0.0 0.0 0.0 51.1 0.0 1.7 1.0 46.0 0.3 0.5 0.0 4.5 0.5 0.5 5.5 0.0 0.0 0.1 3.2 9.7 0.0 0.0 40.7 0.3 0.0 0.0 1.0 0.7 68.3 2.0 5.5 0.4 0.0 92.6 12.9 2.1 7.0 1.3 0.0 0.3 0.0 2.5 0.3 MSLN "CAK1, MPF" ENSG00000102854 Mesothelin Q13421 16 760762-768865 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 85.5;lung: 88.5" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 175.7;Alveolar cells type 2: 67.0;Club cells: 66.0;Paneth cells: 190.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 343.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 9.0" "Group enriched" "Detected in many" 59 "dendritic cells: 9.0;monocytes: 2.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 104.2;EFO-21: 16.1;HeLa: 31.8;hTCEpi: 23.1;OE19: 19.3" "Low region specificity" "Detected in many" "CAB002216, HPA017172" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 14000000 Vesicles Nucleoplasm "CAB002216: AB_563874, HPA017172: AB_1853819" "unprognostic (1.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.06e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (3.95e-2)" "unprognostic (2.46e-1)" "unprognostic (9.47e-2)" "unprognostic (8.57e-2)" "unprognostic (4.69e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (2.63e-1)" "prognostic favorable (5.91e-4)" "unprognostic (2.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.14e-2)" "unprognostic (3.35e-2)" 36.5 0.0 0.4 6.7 0.5 0.7 0.3 0.1 0.4 5.4 5.4 0.8 26.8 2.1 4.8 18.9 3.1 85.5 9.6 4.3 0.4 0.3 2.6 0.2 88.5 0.4 0.6 0.0 22.3 0.4 0.0 0.6 13.7 0.9 1.9 1.2 0.2 14.4 33.1 0.0 0.5 0.7 1.0 0.8 0.1 3.7 2.1 0.0 0.1 0.1 0.6 7.8 1.4 1.3 0.0 9.0 0.0 2.6 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.5 1.8 0.4 1.5 104.2 0.0 16.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 31.8 1.2 0.9 0.0 0.0 0.0 23.1 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 19.3 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.4 0.4 0.5 0.1 0.4 0.4 0.3 0.6 0.0 0.9 0.0 175.7 67.0 0.0 1.3 0.2 1.3 1.2 50.9 25.4 66.0 24.4 0.0 0.1 0.0 1.6 1.1 0.0 1.9 0.0 0.7 0.0 0.6 1.2 0.0 0.0 2.9 0.0 2.9 0.0 0.6 4.5 4.4 2.6 1.7 7.2 1.3 0.0 19.2 190.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.1 0.1 0.0 2.5 37.2 MSMB "IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94" ENSG00000263639 "Microseminoprotein beta" P08118 10 46033307-46046269 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "prostate: 437.8" "Cell type enriched" "Detected in some" 25 "Glandular cells: 8376.6" "Cancer enriched" "Detected in many" 42 "prostate cancer: 3435.3" "Cell type enriched" "Detected in single" 5 "eosinophil: 1.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "BEWO: 20.5;NB-4: 16.5;RPMI-8226: 8.6;SH-SY5Y: 4.7;SK-BR-3: 4.8;U-2197: 9.7" "CAB026357, HPA051257" Enhanced "Secreted in male reproductive system" NA NA 3700000 "CAB026357: , HPA051257: AB_2681410" "unprognostic (6.47e-2)" "unprognostic (7.21e-3)" "unprognostic (1.37e-2)" "unprognostic (8.18e-3)" "unprognostic (4.28e-3)" "unprognostic (9.24e-3)" "unprognostic (1.66e-1)" "unprognostic (8.66e-2)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" "unprognostic (2.01e-1)" "unprognostic (7.04e-2)" "unprognostic (1.39e-1)" "prognostic favorable (7.19e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 1.0 0.8 0.0 0.1 0.1 0.0 1.8 0.1 0.0 7.2 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 437.8 0.0 0.0 14.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 26.8 0.6 0.0 0.0 0.0 0.1 0.7 0.7 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.2 0.3 16.5 0.2 0.1 0.0 0.0 0.0 8.6 0.0 1.2 0.9 4.7 0.0 4.8 0.0 0.2 0.4 0.0 0.0 0.0 0.0 9.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 273.5 0.0 0.0 0.0 7.6 333.3 236.6 0.0 0.0 1.9 0.0 0.0 43.1 0.0 0.0 0.0 0.2 0.2 0.0 8376.6 1.1 1.0 0.2 0.0 0.0 0.0 0.0 49.8 0.3 0.0 3.3 0.0 0.0 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 1.3 0.0 0.0 190.4 MSMO1 "DESP4, ERG25, SC4MOL" ENSG00000052802 "Methylsterol monooxygenase 1" Q15800 4 165327623-165343160 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 171.6" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 234.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 69.5;Karpas-707: 68.2;RPTEC TERT1: 65.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056127 Enhanced NA NA "HPA056127: AB_2683045" "unprognostic (5.76e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (3.35e-2)" "unprognostic (7.85e-2)" "unprognostic (1.74e-1)" "unprognostic (1.20e-2)" "unprognostic (7.14e-2)" "unprognostic (1.75e-2)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" "unprognostic (3.22e-3)" "unprognostic (2.28e-1)" "prognostic favorable (9.21e-4)" "unprognostic (2.39e-1)" "unprognostic (1.56e-2)" "unprognostic (3.54e-1)" "unprognostic (1.40e-1)" 5.0 26.5 17.1 6.7 23.7 3.5 21.5 7.7 29.6 15.6 12.6 22.8 4.0 22.6 6.1 31.5 44.9 7.1 7.4 5.8 18.8 20.8 16.3 171.6 30.0 6.4 13.1 18.6 18.0 7.5 10.9 7.0 7.4 41.1 19.1 10.8 12.1 10.6 4.7 2.2 22.5 20.7 5.7 33.5 4.3 10.3 15.8 12.5 4.3 7.5 17.6 12.9 8.6 17.7 21.2 10.1 6.2 9.8 12.1 20.8 15.8 14.0 3.4 33.1 6.0 16.4 52.8 6.2 5.7 25.9 7.4 20.5 6.6 60.4 7.0 3.4 6.9 69.5 11.6 16.6 59.9 8.2 5.9 10.2 3.1 3.6 20.3 33.1 5.6 4.4 32.6 39.4 27.1 16.8 10.1 9.5 9.1 5.5 68.2 12.1 7.2 5.0 9.2 19.0 7.4 3.4 2.6 3.6 21.0 65.8 16.5 6.6 4.9 8.9 12.7 5.3 21.2 5.9 7.1 10.9 3.4 6.1 3.0 3.9 12.6 13.2 9.2 7.3 5.7 4.6 6.2 4.6 4.5 19.0 5.9 14.2 21.2 18.3 17.6 7.8 18.9 20.0 20.8 3.4 12.1 9.8 10.1 15.8 15.8 17.1 23.7 7.7 29.6 18.8 20.8 13.1 18.6 41.1 12.5 47.6 144.4 35.8 51.9 32.1 27.2 5.8 45.9 68.3 60.3 66.3 25.5 47.4 29.9 52.5 2.8 17.5 70.9 0.0 62.6 72.4 27.9 84.9 48.3 234.0 24.0 33.4 58.1 29.4 29.7 4.5 23.0 15.0 30.4 36.1 42.1 22.3 58.7 24.6 17.7 36.0 46.7 19.4 20.2 7.4 14.4 100.6 102.9 22.4 21.1 123.4 MSMP "PC-3, PSMP" ENSG00000215183 "Microseminoprotein, prostate associated" Q1L6U9 9 35752990-35756613 "Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;pituitary gland: 6.0;placenta: 5.7" "Group enriched" "Detected in some" 67 "Early spermatids: 95.5;Late spermatids: 142.6" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.9" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 35.1;PC-3: 44.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA055174 Uncertain Supported Vesicles,Cytosol "Secreted in male reproductive system" No No Vesicles Cytosol "HPA055174: AB_2682726" 0.5 0.0 1.2 1.1 0.6 0.0 0.8 0.0 0.7 0.2 0.8 0.6 0.0 0.0 0.1 0.0 0.0 0.5 1.9 0.0 0.1 0.1 0.4 0.0 0.4 0.9 3.9 0.0 0.0 0.0 0.0 6.0 5.7 0.8 0.7 0.5 0.0 0.0 0.3 1.3 0.5 1.5 0.3 2.2 0.0 0.1 0.6 0.0 0.0 1.3 0.0 0.2 0.1 0.1 0.0 0.1 3.2 0.3 1.2 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.2 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.7 1.1 0.0 1.2 0.3 0.1 0.3 0.4 1.2 0.6 0.0 0.6 0.1 0.1 3.9 0.0 0.8 0.0 0.0 0.6 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 95.5 0.3 0.0 0.0 1.8 0.1 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 142.6 0.3 0.0 1.7 0.0 0.0 0.8 1.3 0.0 0.7 0.2 0.6 0.0 0.0 0.7 0.4 0.1 0.2 0.0 0.0 1.1 MSR1 "CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII" ENSG00000038945 "Macrophage scavenger receptor 1" P21757 8 16107878-16567490 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "adipose tissue: 88.1;lung: 70.4" "Group enriched" "Detected in many" 4 "Hofbauer cells: 144.7;Kupffer cells: 246.5;Macrophages: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 16.0" "Lineage enriched" "Detected in many" 5 "monocytes: 16.0" "Group enriched" "Detected in many" 7 "BJ hTERT+: 48.2;REH: 18.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA000272, CAB032491" Enhanced NA NA 25000 "CAB032491: AB_672722, HPA000272: AB_1846269" "unprognostic (8.19e-3)" "unprognostic (4.87e-2)" "unprognostic (1.93e-2)" "unprognostic (2.10e-1)" "unprognostic (9.24e-2)" "unprognostic (1.32e-2)" "unprognostic (5.85e-3)" "unprognostic (2.89e-1)" "unprognostic (9.70e-2)" "unprognostic (1.62e-2)" "unprognostic (7.19e-2)" "unprognostic (8.82e-2)" "unprognostic (2.76e-2)" "unprognostic (9.16e-2)" "unprognostic (7.39e-2)" "unprognostic (6.85e-2)" "unprognostic (4.69e-2)" 88.1 9.0 2.2 6.1 4.5 3.7 6.9 10.4 3.3 4.5 3.1 1.8 1.0 2.1 3.1 6.2 2.4 4.5 11.4 8.0 3.8 3.1 9.5 13.6 70.4 6.9 4.3 0.8 6.7 3.8 1.2 2.6 10.4 7.7 3.2 3.9 4.5 6.2 2.3 3.2 1.6 4.0 6.5 11.9 10.9 2.5 4.9 3.1 1.5 2.2 1.7 0.7 10.8 1.8 1.5 1.0 3.0 16.0 0.3 1.3 0.5 0.6 0.9 1.3 0.6 0.6 0.6 0.6 0.3 48.2 0.1 0.2 1.6 0.1 1.5 2.4 0.4 0.3 0.3 0.3 0.4 0.9 0.2 2.0 2.0 1.8 1.9 0.4 1.0 1.1 0.3 0.4 0.4 0.7 0.8 0.0 0.8 0.7 1.4 0.9 1.9 0.6 0.6 0.2 0.7 0.6 18.3 1.0 0.4 0.9 2.8 1.0 0.5 0.4 1.3 0.1 2.4 0.2 0.5 1.1 1.3 0.5 5.0 1.3 4.9 3.8 3.3 0.5 0.7 1.0 1.1 3.1 0.5 0.9 16.0 0.4 0.9 0.7 0.7 1.0 1.5 1.3 0.9 3.0 0.3 7.8 0.5 0.6 0.5 2.2 4.5 10.4 2.7 3.8 3.1 4.3 0.8 7.7 3.1 20.8 40.5 8.2 0.0 2.4 0.0 1.7 5.1 12.0 14.8 3.5 23.6 0.5 1.7 0.0 2.2 1.3 0.0 0.0 0.0 0.4 0.9 0.0 16.3 0.9 144.7 0.0 0.0 7.4 246.5 2.1 1.7 103.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 19.4 0.9 3.3 1.4 1.8 0.7 1.3 0.0 0.1 MST1R "CD136, CDw136, PTK8, RON" ENSG00000164078 "Macrophage stimulating 1 receptor" Q04912 3 49887002-49903873 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.7;intestine: 34.3;skin 1: 28.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 23.8;Enterocytes: 29.1;Mucus-secreting cells: 21.5;Pancreatic endocrine cells: 19.7;Paneth cells: 20.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Lineage enhanced" "Detected in single" "T-cells: 2.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 35.9;HaCaT: 19.8;HBEC3-KT: 21.6;hTCEpi: 30.3;RT4: 23.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007657, HPA008180, CAB008972" Enhanced Approved Cytosol NA NA Cytosol "CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291" "unprognostic (3.84e-3)" "unprognostic (3.86e-1)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.82e-2)" "unprognostic (2.32e-1)" "unprognostic (8.07e-3)" "unprognostic (1.54e-2)" "unprognostic (4.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.24e-3)" "unprognostic (2.28e-1)" "unprognostic (8.08e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-1)" "unprognostic (8.00e-3)" "prognostic favorable (2.33e-5)" 1.7 0.1 0.4 7.5 0.6 0.0 2.4 0.5 0.7 1.8 20.5 0.7 2.0 11.2 1.2 1.3 6.1 0.6 27.7 0.9 0.5 0.1 1.4 0.4 5.0 1.1 0.4 0.6 0.5 4.1 0.0 1.3 0.8 0.9 1.7 9.7 2.5 2.1 0.4 0.5 28.7 34.3 0.7 0.4 0.6 19.1 1.9 0.4 7.7 1.3 6.0 4.5 4.3 3.5 0.2 0.0 0.0 0.0 0.6 2.1 0.0 12.9 5.0 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.2 35.9 0.5 3.1 0.2 0.0 19.8 0.0 21.6 0.0 0.3 0.3 0.0 8.5 0.3 0.3 0.0 0.4 0.1 30.3 0.1 4.3 0.1 0.0 0.0 0.2 0.1 0.0 1.8 0.0 0.0 0.1 11.6 10.5 0.9 0.0 0.3 13.3 23.1 0.3 0.0 3.6 8.4 0.0 0.0 6.6 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.4 0.6 0.5 0.7 0.5 0.1 0.4 0.6 0.9 0.4 23.8 10.1 0.0 2.2 7.8 0.0 1.2 0.0 2.7 9.1 0.0 0.0 0.1 0.0 5.2 13.7 0.0 29.1 0.0 8.7 0.4 0.4 1.7 0.0 0.0 0.1 0.0 4.1 0.0 0.0 7.9 0.3 0.0 0.0 1.0 21.5 0.0 19.7 20.4 0.0 0.0 0.0 0.0 0.4 1.6 0.8 4.1 0.0 0.0 12.4 4.6 MT-ATP6 "ATP6, ATPase-6, MTATP6, RP, Su6m" ENSG00000198899 "Mitochondrially encoded ATP synthase membrane subunit 6" P00846 MT 8527-9207 "Disease related genes, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Cardiomyopathy, Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, Neuropathy, Primary mitochondrial disease, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 419.0;skeletal muscle: 475.3" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 108059.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 419.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 1186.6" "Low region specificity" "Detected in all" NA NA "unprognostic (2.97e-1)" "unprognostic (4.16e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" "unprognostic (8.45e-3)" "unprognostic (1.66e-1)" "prognostic favorable (3.79e-4)" "unprognostic (6.47e-2)" "unprognostic (2.39e-1)" "unprognostic (1.44e-2)" "prognostic favorable (7.64e-4)" "unprognostic (6.01e-2)" "unprognostic (4.64e-2)" "unprognostic (1.46e-1)" "unprognostic (1.37e-1)" "unprognostic (3.56e-1)" "unprognostic (2.52e-3)" 85.2 89.2 126.0 25.1 159.3 20.1 29.6 45.2 81.2 20.1 60.3 75.6 23.5 30.9 42.8 19.8 24.6 309.5 122.3 90.2 154.4 166.8 18.0 19.3 102.8 26.5 54.7 36.2 22.0 34.1 37.6 59.4 66.8 35.6 475.3 62.5 52.6 27.9 61.3 20.7 58.4 27.7 22.4 18.6 23.0 15.7 110.2 58.9 419.0 88.2 72.3 90.5 35.3 100.8 166.4 116.2 182.2 221.8 50.9 75.9 148.7 27.1 20.1 34.0 195.6 110.9 179.7 63.2 80.2 31.2 219.8 12.1 116.0 37.3 128.3 105.3 157.3 1186.6 338.6 37.7 93.1 203.9 83.0 102.9 36.1 34.9 141.5 35.7 100.8 103.4 131.1 78.3 284.0 57.3 247.9 30.5 77.4 68.9 72.2 49.5 110.7 208.9 256.0 66.4 85.2 53.3 113.7 107.5 199.3 121.6 319.6 188.2 82.0 121.2 135.4 106.1 58.0 76.5 124.6 71.6 198.7 45.8 419.0 88.2 156.1 56.6 66.3 71.6 106.0 64.7 71.1 47.5 110.2 76.5 90.5 100.1 72.3 67.8 58.9 47.6 35.3 1381.7 1526.0 11633.9 5315.5 2578.7 0.0 108059.0 10741.3 2731.6 2651.3 6092.6 0.0 0.0 1593.2 1756.2 808.5 1505.8 13591.3 14997.7 2949.2 0.0 1371.6 3985.7 1952.8 21340.2 0.0 0.0 3847.9 7623.7 10387.2 3622.6 7103.8 2816.3 2404.1 3082.2 11928.5 0.0 2519.5 9780.9 4668.2 10316.3 0.0 6202.4 2943.8 6022.8 4841.7 2653.0 0.0 6498.2 11027.9 6485.3 MT-ATP8 "A6L, ATP8, MTATP8" ENSG00000228253 "Mitochondrially encoded ATP synthase membrane subunit 8" P03928 MT 8366-8572 "Disease related genes, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 959.7" "Cell type enriched" "Detected in many" 31 "Cardiomyocytes: 20663.1" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 352.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 352.9" "Cell line enhanced" "Detected in all" "HeLa: 805.0" NA NA "unprognostic (1.54e-1)" "unprognostic (4.12e-2)" "unprognostic (3.95e-2)" "unprognostic (2.56e-1)" "unprognostic (3.07e-2)" "unprognostic (1.17e-1)" "prognostic favorable (7.56e-5)" "unprognostic (5.17e-2)" "unprognostic (6.61e-2)" "unprognostic (2.52e-3)" "unprognostic (8.26e-2)" "unprognostic (1.30e-2)" "unprognostic (1.10e-1)" "unprognostic (1.31e-1)" "unprognostic (2.76e-1)" "unprognostic (2.62e-1)" "unprognostic (1.63e-2)" 257.8 128.5 111.1 33.5 124.1 20.5 31.2 42.1 82.1 14.9 78.9 115.5 23.9 11.6 31.6 14.4 19.9 203.6 108.7 78.8 151.5 165.2 16.9 18.5 88.8 24.3 56.4 22.8 21.1 27.7 44.2 38.7 65.2 25.7 959.7 33.1 91.5 14.2 52.0 19.3 67.4 26.1 23.2 11.8 19.6 15.4 87.7 58.0 352.9 78.1 75.9 79.1 24.2 189.4 69.9 228.3 43.4 248.7 39.8 112.1 398.9 23.6 18.1 31.7 81.2 127.3 485.5 99.6 85.8 69.2 326.0 14.0 131.5 28.5 214.5 91.1 367.2 805.0 183.1 45.4 213.8 314.4 85.5 69.8 40.2 34.6 254.6 25.8 193.9 194.4 154.0 55.5 101.3 125.2 315.4 50.2 106.8 50.5 103.4 111.0 102.1 133.6 189.5 71.8 129.8 151.3 140.3 147.4 378.1 136.9 449.1 377.2 88.4 195.8 194.6 182.8 104.4 174.8 277.5 87.1 380.3 53.6 352.9 78.1 97.9 49.4 68.6 73.5 87.7 55.9 58.5 47.2 87.3 68.9 79.1 49.0 75.9 68.0 58.0 44.0 24.2 175.7 127.6 194.5 6.6 10.3 0.0 20663.1 265.0 662.5 619.9 12.2 0.0 0.0 3.3 11.5 6.0 7.1 98.6 420.4 26.4 0.0 6.7 3.9 274.2 625.8 0.0 0.0 28.0 241.2 345.1 31.7 37.7 12.6 11.8 11.8 48.6 0.0 16.1 47.0 23.7 20.3 0.0 38.8 11.3 24.7 22.2 8.0 0.0 192.9 46.4 6.2 MT-CO1 "COI, COX1, MTCO1" ENSG00000198804 "Mitochondrially encoded cytochrome c oxidase I" P00395 MT 5904-7445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" Translocase "Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 81405.0;Enterocytes: 59874.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 872.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016241, HPA069328" Enhanced Supported Mitochondria NA NA Mitochondria "CAB016241: AB_2229888, HPA069328: AB_2686122" "unprognostic (4.39e-1)" "unprognostic (2.45e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (1.59e-1)" "unprognostic (3.31e-1)" "prognostic favorable (2.29e-4)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (1.20e-2)" "unprognostic (6.60e-2)" "unprognostic (2.83e-2)" "unprognostic (5.06e-3)" "unprognostic (4.50e-2)" "unprognostic (2.15e-2)" "unprognostic (2.44e-2)" 57.6 82.5 184.1 22.2 164.2 26.4 37.4 40.6 117.1 31.5 80.8 78.1 25.7 42.7 43.5 24.8 32.4 345.0 161.8 111.7 151.0 150.5 20.9 22.6 126.3 23.7 42.5 62.3 10.1 29.0 35.8 84.4 65.6 54.2 380.7 68.9 60.0 38.2 61.2 28.1 65.5 27.8 23.8 21.9 31.6 15.3 292.2 232.9 177.4 396.5 182.8 192.4 130.5 114.5 173.2 235.7 256.3 540.3 247.5 249.9 261.4 87.1 66.0 110.6 208.4 373.6 302.7 125.7 198.6 65.0 435.2 26.9 231.6 94.6 143.0 165.0 181.7 872.7 389.9 74.8 104.9 230.2 288.6 241.1 65.3 145.0 306.7 79.4 172.7 115.3 217.3 195.5 277.4 85.7 469.5 59.9 156.0 141.8 112.3 70.4 181.6 334.7 303.0 112.7 150.2 90.6 351.3 163.0 296.6 201.5 352.9 316.5 264.7 180.2 259.8 131.1 103.0 98.6 68.6 130.7 276.7 128.6 177.4 396.5 169.3 156.6 236.0 176.4 255.6 154.9 171.8 163.0 292.2 159.7 192.4 93.5 182.8 260.1 232.9 138.6 130.5 2694.8 3022.9 23660.6 9171.4 8678.3 0.0 81405.0 28094.1 4463.5 5243.5 18590.0 0.0 0.0 3606.0 6482.3 1224.4 4243.1 59874.1 34807.7 4485.9 0.0 3116.3 8181.6 3594.1 45857.2 0.0 0.0 7240.0 18002.1 27410.8 6497.0 10830.0 8032.7 6539.1 13021.9 32338.6 0.0 5722.6 29051.7 7980.9 24852.9 0.0 13394.3 6634.5 9840.4 12887.5 10030.7 0.0 18830.6 25753.2 17251.8 MT-CO2 "CO2, COX2, MTCO2" ENSG00000198712 "Mitochondrially encoded cytochrome c oxidase II" P00403 MT 7586-8269 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 489.9;skeletal muscle: 343.4" "Cell type enriched" "Detected in many" 10 "Cardiomyocytes: 412590.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 1073.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016243, HPA051505, HPA054758" Enhanced NA NA 1300000 "CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595" "unprognostic (2.67e-1)" "unprognostic (5.72e-2)" "unprognostic (4.57e-2)" "unprognostic (5.31e-2)" "unprognostic (2.77e-2)" "unprognostic (1.96e-2)" "prognostic favorable (2.89e-4)" "unprognostic (1.06e-1)" "unprognostic (3.39e-1)" "unprognostic (2.72e-3)" "prognostic favorable (7.10e-4)" "unprognostic (1.25e-1)" "unprognostic (9.30e-2)" "unprognostic (3.05e-1)" "unprognostic (1.70e-1)" "unprognostic (9.50e-2)" "unprognostic (3.72e-3)" 54.6 64.8 149.7 21.7 194.8 30.2 45.5 48.9 99.5 27.0 106.9 73.6 23.8 46.3 35.8 25.1 23.7 252.1 151.9 112.4 158.4 173.8 22.7 22.8 154.6 21.2 46.4 50.4 22.5 41.4 38.2 106.4 61.7 56.0 343.4 56.4 51.1 40.0 77.8 25.9 68.5 28.2 23.3 29.5 29.9 16.2 379.8 278.1 489.9 409.1 220.4 273.9 181.4 111.2 179.1 238.3 230.3 487.6 188.0 175.6 145.1 117.7 82.5 124.6 192.6 251.5 232.6 121.5 213.4 84.9 422.7 31.5 298.5 111.8 180.1 161.5 166.8 1073.7 370.2 106.1 140.2 187.4 275.7 441.7 42.5 152.4 270.3 91.3 232.4 155.7 226.9 226.0 240.8 102.5 404.1 62.3 220.6 114.0 107.2 72.6 194.8 336.5 310.9 89.2 147.6 119.5 294.8 209.6 367.9 205.2 568.6 225.1 200.0 173.5 188.5 102.0 115.3 114.6 131.1 106.4 283.3 131.3 489.9 409.1 476.0 194.9 292.9 236.6 379.8 217.1 218.8 205.5 378.1 227.9 273.9 180.3 220.4 308.7 278.1 170.3 181.4 1343.0 1746.9 18282.0 6995.6 5999.6 0.0 412590.4 19500.5 2813.3 2462.5 17642.7 0.0 0.0 3143.4 3272.8 866.0 2789.7 27604.7 22029.3 4281.1 0.0 1817.5 4991.0 2029.2 43011.4 0.0 0.0 6162.7 12438.4 17929.8 4401.0 7095.7 4687.5 4875.7 4595.3 21499.4 0.0 3881.8 14501.3 4815.7 15512.8 0.0 6946.2 3920.2 6682.3 8100.4 5859.1 0.0 11198.1 21247.6 11593.6 MT-CO3 "CO3, COIII, COX3, MTCO3" ENSG00000198938 "Mitochondrially encoded cytochrome c oxidase III" P00414 MT 9207-9990 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Translocase "Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 319.5" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 76804.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 810.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042788 Approved NA NA "HPA042788: AB_10793985" "unprognostic (2.38e-1)" "unprognostic (5.24e-2)" "unprognostic (1.71e-1)" "unprognostic (1.88e-1)" "unprognostic (3.04e-1)" "unprognostic (2.93e-1)" "prognostic favorable (2.01e-4)" "unprognostic (1.18e-1)" "unprognostic (1.45e-2)" "unprognostic (1.05e-2)" "prognostic favorable (1.04e-4)" "unprognostic (1.05e-1)" "unprognostic (8.80e-3)" "unprognostic (2.75e-2)" "unprognostic (1.20e-1)" "unprognostic (9.29e-2)" "unprognostic (1.33e-2)" 56.5 83.7 174.1 20.5 149.4 34.8 55.5 47.4 106.2 30.5 90.9 76.1 27.5 46.0 40.4 26.3 28.7 290.4 159.6 111.4 190.3 143.1 21.0 22.8 120.2 27.9 38.9 60.5 26.7 32.5 37.3 95.5 79.0 64.3 319.5 70.0 55.3 39.0 61.9 21.7 60.5 36.5 31.0 31.0 26.9 18.7 247.1 126.7 244.3 245.3 141.7 181.1 106.8 130.8 155.4 238.8 339.1 475.8 196.3 130.7 170.6 101.1 67.4 104.1 208.0 195.6 292.9 73.9 141.6 73.7 359.5 37.6 204.9 119.5 99.3 164.3 155.7 810.6 345.5 96.2 92.6 205.1 188.5 291.4 74.1 110.5 238.7 124.6 168.0 123.3 296.8 222.5 267.4 94.0 540.0 53.0 208.4 112.2 100.6 75.3 211.0 420.2 231.5 107.0 148.6 79.5 87.1 164.8 347.1 182.0 408.6 199.6 113.0 193.8 211.0 111.3 122.2 78.6 163.5 112.8 302.0 74.2 132.0 245.3 121.5 110.0 128.3 137.4 198.7 119.5 127.0 126.7 247.1 153.2 181.1 244.3 141.7 122.3 107.8 79.5 106.8 1774.7 2343.8 18268.7 8249.8 7411.8 0.0 76804.5 19304.4 3075.6 3885.5 15697.2 0.0 0.0 3702.1 4549.9 1673.9 3293.3 31596.9 21118.2 5876.9 0.0 3002.6 5473.3 1979.3 30765.6 0.0 0.0 6556.1 11050.6 17592.2 7669.6 10722.1 5677.4 5267.0 6541.2 23740.6 0.0 4985.0 16907.1 7340.6 25199.2 0.0 11945.6 6322.1 9983.2 10814.8 7412.6 0.0 11568.9 24590.7 11079.5 MT-CYB "COB, CYTB, MTCYB, UQCR3" ENSG00000198727 "Mitochondrially encoded cytochrome b" P00156 MT 14747-15887 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Cataract, Deafness, Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 324.2;skeletal muscle: 302.1" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 61379.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 490.3;HeLa: 493.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032215, HPA068400, HPA074796" Approved Supported Mitochondria NA NA Mitochondria "CAB032215: AB_2261378, HPA068400: AB_2685982, HPA074796: " "unprognostic (4.50e-1)" "unprognostic (2.56e-1)" "unprognostic (9.12e-2)" "unprognostic (3.88e-2)" "unprognostic (9.22e-2)" "unprognostic (3.50e-1)" "prognostic favorable (5.96e-4)" "unprognostic (1.63e-2)" "unprognostic (8.53e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-3)" "unprognostic (6.09e-2)" "unprognostic (1.40e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (4.09e-2)" "unprognostic (1.54e-2)" 78.0 52.4 98.5 14.7 143.5 14.4 32.3 38.4 59.6 30.9 54.0 55.6 25.0 43.6 28.0 25.0 21.2 222.5 93.9 68.0 128.7 144.7 19.6 13.7 83.6 25.3 51.4 33.6 23.7 32.6 32.9 57.7 59.2 49.5 302.1 63.5 37.2 37.4 44.3 15.7 55.2 20.2 20.9 20.6 23.6 14.7 183.7 78.7 324.2 155.7 90.0 146.7 57.6 73.4 99.2 123.0 131.3 490.3 78.9 99.1 84.7 35.1 22.2 38.5 97.6 162.5 188.2 41.5 100.3 26.6 231.5 18.2 104.1 54.5 91.9 81.5 105.1 493.3 174.0 92.4 59.0 128.5 170.3 155.3 42.0 90.5 150.2 56.2 76.8 53.7 118.5 113.1 202.8 54.8 121.7 27.3 71.8 67.4 64.8 48.4 117.8 176.2 171.6 43.9 77.6 59.0 111.5 83.4 192.8 162.6 203.7 176.1 77.9 101.9 141.8 65.0 32.5 43.6 80.6 46.8 92.0 48.9 324.2 155.7 235.1 102.8 94.4 135.3 150.5 118.7 132.0 78.0 183.7 128.3 146.7 148.0 90.0 96.8 78.7 79.8 57.6 1101.8 1182.9 10535.1 6605.8 2949.0 0.0 61379.6 10280.2 2941.7 2205.5 7087.1 0.0 0.0 1833.6 2297.4 679.0 1928.7 15168.1 14904.3 3076.0 0.0 1463.9 4337.7 1777.7 14746.0 0.0 0.0 2756.0 7288.5 8580.4 3048.7 7355.0 2431.1 2478.3 3811.6 11241.0 0.0 2672.3 10113.2 5078.0 11513.5 0.0 5704.4 3210.7 4468.4 3767.8 2992.1 0.0 6827.7 9828.0 8723.5 MT-ND1 "MTND1, NAD1, ND1" ENSG00000198888 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1" P03886 MT 3307-4262 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease mutation, Epilepsy, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 314.4;skeletal muscle: 398.2" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 72531.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 314.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 314.4" "Cell line enhanced" "Detected in all" "HeLa: 673.1" "Low region specificity" "Detected in all" "CAB033779, HPA066847" Approved NA NA "CAB033779: AB_2149736, HPA066847: " "prognostic favorable (3.63e-4)" "unprognostic (3.55e-1)" "unprognostic (3.77e-2)" "unprognostic (3.65e-1)" "unprognostic (3.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.95e-3)" "unprognostic (5.84e-2)" "unprognostic (1.06e-1)" "unprognostic (5.05e-2)" "prognostic favorable (3.26e-4)" "unprognostic (8.67e-2)" "unprognostic (8.66e-2)" "unprognostic (3.24e-2)" "unprognostic (1.42e-2)" "unprognostic (3.99e-2)" "unprognostic (2.85e-2)" 83.5 48.0 118.0 15.2 136.1 17.7 31.8 45.0 85.9 19.6 58.3 40.2 16.3 43.4 30.7 16.7 17.6 223.1 106.1 74.3 96.0 104.7 20.5 12.1 101.8 14.2 48.2 35.1 14.3 32.2 26.6 58.6 71.2 48.4 398.2 75.4 33.3 24.6 55.2 16.7 45.0 29.8 13.8 17.1 19.9 9.4 60.8 32.2 314.4 54.4 35.8 46.4 19.5 101.9 104.3 85.6 77.9 325.0 59.2 110.1 88.0 26.0 24.4 25.8 181.3 111.3 125.2 56.0 66.3 24.8 68.2 9.4 53.0 49.0 89.2 73.5 139.3 673.1 257.0 69.8 65.9 137.7 140.2 144.8 37.8 54.6 99.7 26.2 36.7 64.0 78.3 72.4 140.2 53.0 273.1 22.9 64.3 78.6 55.9 38.9 67.2 135.5 165.5 35.6 56.7 48.8 78.1 85.3 108.9 69.7 228.7 137.9 81.8 73.9 104.2 73.1 86.9 53.5 58.0 55.0 116.9 22.3 314.4 54.4 103.0 25.7 31.4 37.3 54.3 30.8 34.0 20.6 60.8 41.1 46.4 157.8 35.8 32.0 32.2 22.0 19.5 1256.6 1138.7 6703.3 2831.5 2012.7 0.0 72531.4 10000.0 1801.4 2082.6 4374.0 0.0 0.0 875.4 1190.4 925.4 1519.1 10706.5 9881.7 3135.3 0.0 1058.8 2565.3 1330.0 13675.3 0.0 0.0 3018.7 7368.9 9328.1 4287.1 6527.3 2029.2 1420.6 1887.4 12938.3 0.0 1718.0 6638.7 3334.2 5210.0 0.0 6305.8 2437.5 5090.3 4626.8 1812.2 0.0 3284.5 11055.0 4223.0 MT-ND2 "MTND2, NAD2, ND2" ENSG00000198763 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2" P03891 MT 4470-5511 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Alzheimer disease, Amyloidosis, Disease mutation, Leber hereditary optic neuropathy, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 432.3" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 49093.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "basophil: 432.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 432.3" "Cell line enhanced" "Detected in all" "HeLa: 612.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.82e-3)" "unprognostic (1.58e-2)" "unprognostic (1.53e-2)" "unprognostic (1.36e-1)" "unprognostic (4.77e-1)" "unprognostic (4.79e-2)" "unprognostic (9.56e-3)" "unprognostic (3.74e-2)" "unprognostic (2.18e-1)" "unprognostic (3.38e-3)" "unprognostic (4.55e-3)" "unprognostic (3.79e-2)" "unprognostic (4.35e-2)" "unprognostic (3.94e-2)" "unprognostic (2.11e-1)" "unprognostic (5.92e-2)" "unprognostic (4.35e-2)" 93.0 57.2 116.0 16.9 169.9 15.6 33.9 40.1 73.5 22.6 53.7 50.1 21.5 59.8 29.0 22.1 19.3 262.4 112.2 85.2 125.9 128.9 20.9 14.7 113.0 25.1 62.0 24.3 20.3 37.0 28.1 59.0 85.3 41.0 263.4 72.7 39.2 24.6 72.4 15.2 49.2 27.3 18.2 17.7 23.8 13.1 66.1 43.5 432.3 54.8 43.0 57.9 21.8 94.6 104.2 93.3 157.4 337.2 60.2 88.3 88.4 22.1 23.6 29.9 131.2 128.0 135.9 84.1 63.4 38.9 170.0 14.6 110.5 51.2 118.3 75.9 156.8 612.6 211.5 69.1 152.0 182.5 99.4 202.0 58.1 57.6 84.5 34.7 75.0 114.3 133.2 56.7 111.9 86.3 246.1 46.8 99.5 68.3 75.8 52.3 113.9 175.1 146.5 58.4 70.0 38.2 117.4 140.8 155.7 180.7 175.9 109.6 88.9 110.1 125.0 111.9 87.1 74.6 114.4 57.7 131.3 39.7 432.3 54.8 93.1 34.1 39.7 54.7 58.6 39.5 42.5 23.0 66.1 48.5 57.9 88.6 43.0 45.7 43.5 25.9 21.8 854.6 571.9 9056.6 6978.7 2368.7 0.0 49093.4 9352.8 2568.3 1610.6 5912.8 0.0 0.0 1531.9 1483.8 1182.4 1676.0 12590.8 16329.3 3187.2 0.0 1222.0 4063.7 1766.1 15003.8 0.0 0.0 3057.2 8326.4 10199.3 4945.8 8393.1 2380.5 1572.4 3231.9 13237.7 0.0 2288.2 10285.9 4266.6 9047.2 0.0 7166.1 2550.6 5515.5 4332.8 2146.6 0.0 6221.6 10985.9 6668.6 MT-ND3 "MTND3, NAD3, ND3" ENSG00000198840 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3" P03897 MT 10059-10404 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 357.8" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 33020.6;Erythroid cells: 20674.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 644.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063296 Enhanced Uncertain Cytosol NA NA Cytosol "HPA063296: AB_2684978" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (8.10e-2)" "unprognostic (3.07e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "prognostic favorable (4.63e-5)" "unprognostic (2.45e-2)" "unprognostic (7.13e-2)" "unprognostic (8.85e-2)" "unprognostic (1.76e-3)" "unprognostic (1.74e-1)" "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-1)" "unprognostic (5.65e-3)" 102.1 73.9 117.3 17.6 137.2 17.9 59.3 33.7 70.5 31.2 76.3 64.0 25.9 49.2 21.7 24.7 19.7 256.8 110.3 81.7 138.1 145.8 19.7 17.4 92.0 27.5 77.8 14.6 22.2 34.6 39.1 59.1 67.6 50.7 357.8 42.2 48.9 28.4 66.8 19.1 60.6 21.0 25.0 20.3 24.2 15.9 84.8 32.6 159.6 48.5 48.6 75.3 24.4 85.5 139.7 93.3 91.5 644.7 129.2 77.7 72.1 42.4 39.1 44.3 210.2 133.3 89.1 111.9 92.5 70.8 178.3 40.1 157.5 67.3 127.7 192.1 87.6 465.1 346.0 100.6 129.0 132.7 223.4 292.0 65.5 73.9 233.9 60.8 102.4 69.0 104.2 73.7 279.5 67.7 172.2 47.9 245.4 129.3 58.7 91.7 82.0 237.9 236.2 38.5 83.7 34.8 69.8 142.5 254.3 161.5 208.4 103.2 60.5 91.9 105.1 77.0 40.5 53.1 192.1 49.1 78.4 34.2 159.6 48.5 36.6 36.7 36.4 49.8 73.1 42.6 44.8 32.6 84.8 63.1 75.3 100.7 48.6 32.7 32.3 27.6 24.4 652.1 738.1 6543.7 1904.3 1765.5 0.0 33020.6 8848.3 2785.1 1856.3 4782.3 0.0 0.0 986.5 1173.3 880.9 872.1 11850.5 20674.5 2500.6 0.0 790.1 1401.0 1375.6 14769.6 0.0 0.0 2746.0 8921.3 11655.5 4356.4 8457.2 1642.1 1763.0 2463.5 12873.7 0.0 1918.1 9893.1 4573.5 7467.5 0.0 6887.9 1962.1 6063.0 3539.9 1651.0 0.0 4305.8 10869.3 1952.0 MT-ND4 "LHON, MTND4, NAD4, ND4" ENSG00000198886 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4" P03905 MT 10760-12137 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 392.9" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 130137.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 821.0" "Low region specificity" "Detected in all" HPA053928 Approved Supported Mitochondria NA NA Mitochondria "HPA053928: AB_2682313" "unprognostic (8.39e-2)" "unprognostic (1.83e-1)" "unprognostic (7.29e-2)" "unprognostic (9.54e-2)" "unprognostic (5.41e-2)" "unprognostic (3.78e-2)" "unprognostic (2.50e-3)" "unprognostic (8.16e-2)" "unprognostic (1.45e-1)" "prognostic favorable (1.76e-4)" "unprognostic (1.01e-2)" "unprognostic (7.23e-2)" "unprognostic (2.79e-2)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (3.14e-2)" "unprognostic (4.24e-2)" 82.5 72.4 124.2 19.8 138.2 14.9 34.5 43.8 78.5 34.1 68.7 56.5 27.8 37.1 32.9 25.2 23.7 292.7 122.4 90.3 129.8 178.5 20.8 17.4 101.6 25.5 58.3 37.8 19.7 39.1 37.3 82.1 61.7 65.6 288.4 61.1 41.0 37.8 63.6 21.7 67.7 29.6 24.3 23.4 26.0 15.3 164.7 87.6 392.9 119.5 87.1 129.7 53.0 102.6 106.9 138.9 205.1 326.5 82.3 97.3 104.6 40.0 24.3 47.5 162.1 117.7 182.9 92.3 89.1 35.8 192.5 12.4 169.4 43.6 105.5 67.2 112.6 821.0 271.8 49.3 113.1 134.0 139.2 179.5 35.8 128.4 229.8 58.7 92.3 93.8 226.5 87.5 231.7 44.5 257.0 39.3 89.7 72.7 60.6 43.6 110.2 177.8 222.1 51.2 69.3 60.8 202.4 104.6 257.3 141.7 267.4 162.8 99.5 96.8 133.1 81.0 135.9 55.1 81.4 64.9 196.6 52.9 392.9 119.5 268.8 82.9 91.3 115.5 148.0 93.0 98.9 65.9 164.7 109.6 129.7 105.7 87.1 89.0 87.6 67.6 53.0 1179.2 1324.7 15760.8 7514.4 3912.5 0.0 130137.0 15452.1 2295.3 2103.1 12148.5 0.0 0.0 2064.1 2636.7 917.0 2449.9 17720.8 23127.3 3538.6 0.0 2017.3 5309.0 2067.8 31565.1 0.0 0.0 4902.7 11944.3 15339.0 4282.8 8180.5 3605.2 3603.6 4879.3 17860.7 0.0 3353.9 12846.0 5441.2 13683.6 0.0 6208.8 3859.5 7259.5 5529.7 4316.1 0.0 9799.9 18174.2 10097.1 MT-ND4L "MTND4L, NAD4L, ND4L" ENSG00000212907 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L" P03901 MT 10470-10766 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 434.4;skeletal muscle: 294.4" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 16050.3;Hepatocytes: 4100.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 885.9" "Low region specificity" "Detected in all" HPA075648 Approved Centrosome,Mitochondria NA NA Mitochondria Centrosome "HPA075648: AB_2686760" "unprognostic (5.81e-2)" "unprognostic (3.46e-2)" "unprognostic (2.76e-2)" "unprognostic (7.91e-2)" "unprognostic (5.64e-2)" "unprognostic (1.05e-1)" "prognostic favorable (4.47e-4)" "unprognostic (1.97e-1)" "unprognostic (4.04e-2)" "unprognostic (4.63e-3)" "unprognostic (6.61e-2)" "unprognostic (7.38e-3)" "unprognostic (1.39e-1)" "unprognostic (3.09e-1)" "unprognostic (3.73e-1)" "unprognostic (2.97e-2)" "unprognostic (5.68e-2)" 101.1 71.9 102.4 20.3 114.5 13.2 39.4 41.5 73.3 39.4 83.8 48.0 26.1 34.1 30.7 23.9 23.4 187.5 102.7 79.1 123.5 185.7 20.2 13.1 88.6 26.2 43.4 29.7 18.5 30.9 34.2 80.0 43.2 75.4 294.4 31.8 38.4 38.6 59.2 16.1 62.5 27.5 24.6 24.4 25.8 14.3 200.8 111.2 434.4 139.9 112.1 153.0 66.8 97.1 90.4 163.1 166.1 571.6 120.3 71.9 208.6 52.3 32.7 59.8 150.2 89.8 241.1 85.5 140.9 53.6 185.3 25.3 223.3 65.2 94.9 104.4 173.3 885.9 279.0 83.9 178.2 155.8 210.6 228.8 62.4 218.5 246.4 65.5 125.0 95.5 172.9 119.9 173.6 67.7 228.6 41.1 103.4 109.2 39.3 70.3 107.2 174.1 205.2 49.5 67.0 102.3 162.1 69.9 366.4 115.3 224.3 209.4 86.0 107.1 125.8 79.8 156.5 73.2 128.4 61.7 242.4 40.1 434.4 139.9 290.0 102.4 110.6 140.6 166.9 110.0 117.5 86.1 200.8 132.4 153.0 78.4 112.1 99.4 111.2 79.0 66.8 208.4 153.9 1221.6 193.7 203.1 0.0 16050.3 1630.6 940.9 684.7 307.1 0.0 0.0 76.3 127.4 46.0 141.8 949.6 2499.6 297.1 0.0 116.0 126.2 448.0 4100.6 0.0 0.0 246.6 1665.3 1966.8 217.5 386.3 249.3 243.0 242.5 657.8 0.0 237.0 573.3 217.1 415.7 0.0 342.8 211.1 226.8 167.2 211.8 0.0 631.2 458.3 137.0 MT-ND5 "MTND5, NAD5, ND5" ENSG00000198786 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5" P03915 MT 12337-14148 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 193.9;heart muscle: 190.3;skeletal muscle: 223.2" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 21708.1;Hepatocytes: 6052.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 367.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.87e-1)" "unprognostic (3.18e-2)" "unprognostic (3.00e-1)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (1.30e-1)" "unprognostic (1.07e-3)" "unprognostic (5.09e-3)" "unprognostic (1.06e-2)" "unprognostic (3.01e-1)" "unprognostic (3.29e-3)" "unprognostic (4.78e-2)" "prognostic favorable (7.31e-5)" "unprognostic (9.93e-3)" "unprognostic (8.75e-2)" "unprognostic (1.26e-2)" "unprognostic (3.68e-2)" 47.2 30.4 71.2 14.8 94.5 11.3 16.5 23.2 45.8 13.6 30.3 38.9 16.6 24.9 26.2 21.4 19.1 190.3 65.0 52.8 56.3 66.6 19.3 9.4 56.1 18.6 22.9 23.1 7.9 15.1 27.5 28.0 25.7 21.5 223.2 63.9 29.5 25.3 37.9 12.6 41.4 14.6 12.8 13.2 24.9 8.0 124.1 89.3 193.9 123.4 79.6 99.3 33.7 70.0 74.7 91.4 88.3 276.3 72.4 49.3 144.0 22.1 16.2 27.1 109.7 92.4 170.5 73.1 67.2 18.2 150.6 8.5 75.6 27.0 95.4 58.2 124.9 367.2 185.3 31.9 87.3 130.0 108.0 60.5 18.3 44.0 89.3 32.6 55.4 45.4 81.7 55.2 132.9 32.7 107.8 18.0 40.1 41.0 62.8 42.9 73.1 98.0 139.7 27.3 41.8 67.1 120.3 40.1 144.3 87.4 131.2 227.9 93.3 65.1 109.9 55.7 31.2 53.9 47.5 49.9 79.8 40.5 193.9 123.4 79.9 81.3 100.2 99.3 99.4 79.3 87.3 73.4 124.1 78.5 86.6 45.3 79.6 95.9 89.3 62.1 33.7 583.6 431.9 2723.9 906.1 795.2 0.0 21708.1 2619.1 1640.9 1064.6 1097.4 0.0 0.0 240.4 680.7 99.3 666.5 2590.2 4134.9 811.9 0.0 364.3 748.8 814.8 6052.2 0.0 0.0 752.3 2617.9 3186.6 403.9 979.2 872.2 577.0 1484.2 1582.7 0.0 1038.2 1813.1 797.6 2081.7 0.0 685.6 570.5 650.3 492.1 851.0 0.0 1584.2 1461.9 1233.6 MT-ND6 "MTND6, NAD6, ND6" ENSG00000198695 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6" P03923 MT 14149-14673 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Dystonia, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 395.3;skeletal muscle: 593.2" "Cell type enriched" "Detected in many" 16 "Cardiomyocytes: 10763.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 524.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.96e-1)" "unprognostic (3.27e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.03e-3)" "unprognostic (6.02e-3)" "unprognostic (1.68e-2)" "unprognostic (1.48e-1)" "unprognostic (6.06e-3)" "unprognostic (2.91e-1)" "prognostic favorable (8.91e-6)" "unprognostic (3.64e-2)" "unprognostic (1.42e-2)" "unprognostic (1.15e-2)" "unprognostic (2.92e-2)" 79.2 43.1 55.5 34.4 78.5 30.7 9.6 14.7 76.1 5.9 30.2 90.3 19.2 0.0 69.5 23.2 40.2 395.3 50.7 41.2 65.5 42.8 28.5 25.9 41.9 23.2 48.0 0.0 3.5 10.3 28.0 0.3 48.1 0.0 593.2 176.3 63.8 0.0 24.8 19.9 53.2 22.7 17.5 0.0 32.3 5.7 127.3 91.2 164.8 108.2 88.8 104.3 29.7 99.5 80.8 71.5 90.8 12.0 1.1 51.3 134.7 0.2 0.4 0.4 109.8 101.1 214.8 91.6 3.6 13.5 149.0 0.7 2.4 0.7 126.9 62.0 128.7 524.8 313.8 0.9 81.4 121.6 2.0 3.3 3.3 2.7 68.1 0.7 45.0 55.3 84.4 2.9 212.8 25.0 112.4 15.5 57.2 39.8 60.9 45.7 92.3 1.9 293.8 29.5 47.4 70.1 123.5 55.6 118.8 95.7 158.8 273.9 79.6 67.2 112.6 53.9 28.9 77.1 51.5 54.0 83.1 46.2 164.8 108.2 68.3 89.1 103.5 104.3 118.4 94.5 96.1 66.2 127.3 94.7 102.4 53.7 88.8 103.7 91.2 71.8 29.7 77.4 48.1 340.3 38.0 14.9 0.0 10763.4 298.1 156.6 138.8 122.1 0.0 0.0 14.9 22.5 5.1 82.2 98.6 584.0 30.5 0.0 11.3 44.8 92.7 656.7 0.0 0.0 29.0 406.4 492.6 24.4 57.8 31.8 32.1 42.3 60.4 0.0 23.3 63.7 42.5 111.6 0.0 58.2 27.7 25.6 53.0 17.9 0.0 156.7 77.0 76.6 MTCH1 "CGI-64, PSAP, SLC25A49" ENSG00000137409 "Mitochondrial carrier 1" Q9NZJ7 6 36968141-36986298 "Predicted membrane proteins, Transporters" "Apoptosis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 146.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015971 Approved NA NA "HPA015971: AB_1854171" "unprognostic (3.17e-2)" "unprognostic (1.37e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (2.06e-4)" "unprognostic (1.40e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (1.29e-1)" "unprognostic (2.88e-2)" "unprognostic (1.54e-1)" "unprognostic (7.49e-2)" "unprognostic (1.35e-3)" "prognostic favorable (1.16e-7)" "unprognostic (1.32e-2)" "unprognostic (3.11e-1)" "unprognostic (6.68e-2)" "unprognostic (4.70e-2)" 32.3 50.8 46.3 25.6 57.2 45.2 31.3 28.4 86.3 34.1 26.1 43.1 32.0 25.8 26.7 91.7 25.8 44.0 34.3 47.6 46.9 56.9 31.0 29.6 33.7 23.4 47.1 47.0 38.0 34.7 33.0 52.8 28.9 49.3 34.4 27.5 31.5 34.2 58.8 21.6 37.2 23.2 32.1 45.8 27.7 28.9 21.5 32.4 21.3 98.9 18.3 23.7 23.3 56.3 14.8 17.7 23.9 23.7 10.6 17.6 8.4 28.6 19.4 26.2 32.6 39.7 27.1 15.1 33.7 31.5 47.7 49.8 31.8 17.8 14.4 30.1 56.4 45.9 25.1 28.5 27.1 55.6 15.1 27.6 14.9 33.2 24.2 28.8 9.6 14.0 30.4 21.3 44.0 21.8 41.7 40.7 19.9 26.8 14.8 30.0 32.1 19.2 21.6 25.7 25.8 22.3 17.9 20.4 15.0 26.0 24.0 42.5 18.3 24.5 21.5 29.7 27.5 27.6 26.6 44.9 47.6 38.0 37.2 36.3 13.0 13.1 146.1 17.4 26.5 37.6 6.3 19.0 23.9 8.9 18.9 8.3 10.1 16.7 17.6 17.7 14.8 15.5 9.3 21.7 10.6 23.7 9.8 11.7 8.4 46.3 57.2 28.4 86.3 46.9 56.9 47.1 47.0 49.3 32.4 44.7 85.6 50.2 157.0 101.0 0.0 139.3 96.8 32.1 70.5 66.3 0.0 156.3 142.6 190.2 6.0 114.2 120.7 70.0 149.2 190.3 178.9 169.5 28.8 45.5 161.7 0.0 143.2 73.1 86.8 10.9 128.0 80.4 129.9 242.5 104.4 0.0 154.2 143.8 124.5 103.2 0.0 51.8 128.2 16.3 60.8 107.9 207.7 55.4 120.0 163.4 MTDH "3D3, AEG-1, LYRIC" ENSG00000147649 Metadherin Q86UE4 8 97644179-97728770 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010932, HPA015104, CAB068204, CAB068205" Supported Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB068204: AB_2665655, CAB068205: AB_2665654, HPA010932: AB_1079422, HPA015104: AB_1854173" "unprognostic (1.01e-3)" "unprognostic (1.41e-2)" "unprognostic (2.05e-2)" "unprognostic (6.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.24e-2)" "unprognostic (4.08e-2)" "prognostic unfavorable (7.76e-4)" "unprognostic (1.25e-1)" "unprognostic (2.08e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.82e-4)" "unprognostic (3.84e-3)" "unprognostic (3.88e-2)" "unprognostic (2.77e-1)" "unprognostic (1.40e-1)" 26.5 28.5 17.2 28.3 21.9 44.5 29.0 21.8 20.2 27.5 24.9 20.7 24.7 23.2 31.6 28.6 27.6 23.6 23.5 23.6 18.7 16.6 24.3 97.8 21.9 31.4 26.5 19.6 26.7 22.7 27.1 18.0 13.4 23.0 24.0 22.8 16.4 22.3 21.2 49.8 19.5 32.7 29.5 34.6 35.8 21.8 19.0 24.8 40.0 30.5 22.7 27.5 27.5 35.7 26.2 42.4 17.4 26.6 19.2 20.9 10.1 38.8 20.2 13.2 18.1 22.0 23.3 6.5 35.0 29.8 22.4 17.4 11.9 29.1 36.0 39.5 34.3 24.8 25.9 32.0 24.3 31.4 38.3 16.8 66.1 21.9 14.1 26.7 34.6 30.8 17.8 24.5 27.1 61.8 21.2 25.7 26.6 43.1 64.0 23.7 16.1 58.3 9.6 8.1 34.0 24.6 38.2 15.7 52.3 14.6 22.4 20.0 15.0 24.8 21.9 27.4 13.3 33.4 22.2 26.7 31.8 11.4 29.2 25.8 35.7 38.9 36.5 29.2 40.7 27.7 17.4 26.6 13.4 14.2 17.8 20.1 26.2 20.4 20.9 32.6 18.6 20.8 18.4 3.8 19.2 19.5 42.4 11.7 10.1 17.2 21.9 21.8 20.2 18.7 16.6 26.5 19.6 23.0 24.8 119.1 103.5 196.6 171.8 232.4 0.0 87.6 201.2 52.2 100.1 134.3 0.0 9.1 21.6 197.1 211.2 149.0 122.0 46.7 201.2 89.0 152.1 236.8 136.0 389.3 243.9 0.0 116.8 148.0 225.6 132.2 180.9 250.7 175.5 149.7 148.0 0.0 214.1 126.3 203.3 76.1 0.0 219.9 203.9 116.5 108.0 275.1 11.4 146.0 177.0 291.2 MTFP1 "HSPC242, MTP18" ENSG00000242114 "Mitochondrial fission process 1" Q9UDX5 22 30425530-30429053 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 56.3;Exocrine glandular cells: 45.3;monocytes: 60.5;Pancreatic endocrine cells: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077396 Approved Mitochondria NA NA Mitochondria "HPA077396: AB_2686837" "unprognostic (2.19e-2)" "unprognostic (1.18e-1)" "unprognostic (3.12e-1)" "unprognostic (6.20e-2)" "unprognostic (4.86e-2)" "unprognostic (1.72e-3)" "unprognostic (1.52e-3)" "unprognostic (8.98e-2)" "unprognostic (2.07e-1)" "unprognostic (1.65e-1)" "unprognostic (6.37e-3)" "unprognostic (1.54e-1)" "unprognostic (1.49e-1)" "unprognostic (6.40e-2)" "unprognostic (3.06e-2)" "unprognostic (3.84e-1)" "unprognostic (1.66e-2)" 8.9 9.6 6.4 13.0 6.6 9.8 13.5 3.7 6.5 7.6 13.3 2.8 14.5 11.7 2.9 16.2 12.3 2.8 10.2 18.3 5.0 6.0 27.4 20.8 8.3 17.3 7.2 2.2 9.3 12.9 10.3 5.7 9.2 9.8 8.5 12.9 9.8 9.0 4.4 14.6 4.6 10.2 4.1 3.8 17.4 11.3 3.2 5.9 5.3 11.2 8.9 13.0 7.7 5.6 13.0 7.6 0.7 6.4 4.8 25.7 9.9 26.2 19.5 6.8 11.0 1.4 0.7 8.2 2.5 1.7 15.0 23.4 9.2 16.0 27.9 7.1 1.4 11.9 12.2 23.8 18.3 13.1 15.1 27.1 8.1 11.6 19.3 4.1 20.4 15.7 2.1 7.2 8.1 13.9 3.8 10.3 13.1 12.8 11.0 5.0 31.5 18.4 23.0 12.3 24.7 20.0 23.7 6.8 26.7 19.0 6.9 12.3 12.8 5.3 28.4 10.3 6.8 8.7 10.1 5.2 16.0 21.5 8.2 6.6 5.7 3.9 25.0 6.3 23.0 6.7 0.0 5.5 0.0 19.3 6.4 25.7 13.0 16.2 16.5 7.6 9.3 16.8 19.6 0.7 4.8 3.8 3.7 13.3 9.9 6.4 6.6 3.7 6.5 5.0 6.0 7.2 2.2 9.8 5.9 6.0 4.0 28.4 1.4 4.9 0.0 4.0 7.6 0.0 3.4 3.5 0.0 10.1 13.3 56.3 0.0 3.1 25.2 0.0 45.3 27.0 4.3 3.0 9.2 12.5 15.5 0.0 8.1 4.3 8.7 0.0 0.6 3.7 3.3 60.5 17.7 0.0 42.1 11.5 0.4 9.2 0.0 0.0 1.9 0.4 1.4 4.8 14.1 14.6 36.7 1.6 MTHFD1 "MTHFC, MTHFD" ENSG00000100714 "Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1" P11586 14 64388031-64463457 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis" "Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 121.6" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000704, HPA001290, HPA015006, HPA050052" Approved Enhanced Cytosol NA Yes 250000 Cytosol "HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998" "unprognostic (3.58e-2)" "unprognostic (5.50e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.37e-1)" "unprognostic (7.01e-2)" "unprognostic (8.85e-3)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.84e-1)" "prognostic favorable (5.93e-5)" "unprognostic (2.45e-2)" "unprognostic (1.75e-1)" "unprognostic (7.30e-2)" "unprognostic (2.29e-2)" 18.9 9.0 8.1 8.4 18.1 9.7 12.2 5.7 15.9 7.1 9.3 9.0 4.0 7.5 8.5 6.9 12.0 6.7 6.4 10.6 8.4 6.5 20.5 121.6 6.8 9.2 8.0 10.4 10.1 13.4 13.1 5.6 5.6 10.0 5.5 11.4 9.3 11.6 5.6 26.5 7.6 7.3 8.8 6.9 8.3 7.9 2.3 7.4 15.6 8.6 14.0 12.5 8.7 7.3 21.1 12.8 0.5 13.2 12.8 14.9 8.4 72.5 41.3 15.7 34.2 16.9 13.8 25.5 28.5 19.6 37.0 36.7 40.1 33.4 30.5 13.5 16.9 18.6 35.7 48.4 28.3 43.3 30.3 31.9 37.8 41.4 30.4 12.5 29.0 20.6 10.7 9.2 33.0 17.9 15.3 23.0 30.9 28.1 25.1 28.0 60.2 46.7 17.0 28.7 46.2 43.8 37.3 54.6 27.6 27.8 42.5 34.0 13.2 47.6 25.9 14.3 15.3 40.3 14.7 14.1 27.9 48.4 25.7 34.1 16.8 20.6 53.8 25.6 33.5 31.6 0.2 8.2 0.1 8.1 13.2 10.9 21.1 9.0 9.9 12.8 11.6 7.6 10.1 0.5 12.8 10.3 3.2 14.9 8.4 8.1 18.1 5.7 15.9 8.4 6.5 8.0 10.4 10.0 7.4 17.9 26.3 11.5 9.9 12.2 0.0 38.1 17.8 12.0 20.5 15.7 0.0 20.0 34.9 15.4 0.9 9.9 5.2 0.0 9.0 24.2 10.6 8.3 49.7 125.3 21.6 0.0 2.9 7.4 11.3 0.9 12.0 10.9 13.5 14.4 11.9 0.0 10.8 2.9 12.4 49.9 0.0 19.4 18.6 0.9 7.5 9.4 8.2 20.0 21.3 9.9 MTNR1A MEL-1A-R ENSG00000168412 "Melatonin receptor 1A" P48039 4 186533655-186555567 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.8;intestine: 3.1;kidney: 5.7;testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.8;EFO-21: 2.0;HEK 293: 2.1;NTERA-2: 1.8;SCLC-21H: 1.6;SH-SY5Y: 3.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (7.99e-2)" "unprognostic (2.27e-1)" "unprognostic (2.16e-1)" "unprognostic (3.67e-1)" "unprognostic (2.14e-1)" "unprognostic (9.88e-2)" "unprognostic (9.20e-2)" "unprognostic (8.81e-2)" 0.0 0.0 0.1 1.2 0.1 0.0 0.0 3.8 0.2 0.0 3.1 0.3 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.1 5.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTNR1B ENSG00000134640 "Melatonin receptor 1B" P49286 11 92969720-92985066 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.0;lymphoid tissue: 1.9;placenta: 4.5;testis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "GAMG: 10.6;SuSa: 2.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "midbrain: 0.8;pons and medulla: 1.2" HPA074024 Supported NA NA "HPA074024: " "unprognostic (3.61e-1)" "unprognostic (1.43e-1)" 0.1 0.0 0.3 0.0 3.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MTUS1 "ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1" ENSG00000129422 "Microtubule associated scaffold protein 1" Q9ULD2 8 17643795-17800917 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 229.1;Endothelial cells: 164.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 2.2;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6" "Lineage enriched" "Detected in single" 21 "T-cells: 4.8" "Cell line enhanced" "Detected in many" "A549: 29.7;AN3-CA: 26.1;HUVEC TERT2: 77.2;SK-MEL-30: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067903, HPA069795" Enhanced Nucleoli,Microtubules No No "Nucleoli, Microtubules" "HPA067903: AB_2685921, HPA069795: AB_2686198" "unprognostic (3.20e-1)" "unprognostic (3.29e-1)" "prognostic favorable (1.05e-4)" "unprognostic (2.50e-2)" "unprognostic (2.27e-1)" "unprognostic (7.72e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-3)" "unprognostic (2.44e-1)" "unprognostic (9.73e-2)" "unprognostic (7.93e-3)" "unprognostic (3.33e-1)" "prognostic favorable (2.76e-4)" "unprognostic (2.04e-1)" "unprognostic (2.38e-2)" "unprognostic (2.53e-3)" "unprognostic (2.43e-1)" 45.0 20.8 20.9 6.8 38.2 0.4 21.8 51.0 27.7 19.8 19.0 56.5 9.9 16.9 16.9 12.6 20.3 12.8 20.0 44.3 27.4 17.3 14.4 29.3 20.9 4.4 34.7 18.0 28.2 47.1 43.8 15.0 36.1 33.7 17.5 21.1 10.3 24.3 14.0 49.7 12.2 17.4 20.5 48.3 8.2 21.4 6.5 49.3 0.7 15.7 10.9 7.5 21.4 26.7 0.2 0.0 0.0 0.0 0.0 4.8 1.0 5.5 29.7 4.8 26.1 0.0 0.1 8.8 0.2 2.0 0.1 0.6 2.2 2.0 0.7 2.2 0.0 1.2 5.7 8.0 2.8 0.2 3.9 3.4 0.0 5.1 14.1 1.7 0.0 0.1 2.4 4.3 0.6 8.8 0.0 77.2 2.0 0.0 11.3 0.0 1.4 1.0 1.4 6.9 11.2 0.7 0.0 4.4 2.9 1.5 11.4 2.4 0.6 3.8 6.9 21.9 3.0 5.0 0.0 15.7 0.0 6.5 0.0 0.0 1.5 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 2.2 0.6 0.0 0.2 4.8 3.6 0.0 0.0 0.0 0.0 0.0 1.0 20.9 38.2 51.0 27.7 27.4 17.3 34.7 18.0 33.7 49.3 65.5 229.1 0.8 50.7 18.7 0.0 122.8 56.0 50.9 106.9 19.2 0.0 16.2 10.0 33.7 16.9 164.1 52.5 0.0 150.0 30.8 30.4 68.9 9.2 60.6 44.7 0.0 14.5 20.9 3.7 19.2 70.8 10.5 27.0 4.6 40.5 0.0 66.3 14.0 53.7 8.9 0.0 19.4 41.9 1.7 5.1 17.8 45.2 4.4 32.2 49.8 MTX1 "MTX, MTXN" ENSG00000173171 "Metaxin 1" Q13505 1 155208699-155213824 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 517.8;Late spermatids: 1060.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011543 Uncertain Approved Mitochondria NA NA Mitochondria "HPA011543: AB_1853824" "unprognostic (2.57e-1)" "unprognostic (9.51e-3)" "unprognostic (3.27e-1)" "unprognostic (5.98e-3)" "unprognostic (1.60e-1)" "unprognostic (2.62e-2)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (8.38e-2)" "unprognostic (1.28e-2)" "unprognostic (1.71e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (1.30e-2)" "unprognostic (1.70e-1)" "unprognostic (1.37e-1)" "unprognostic (1.96e-2)" 15.4 19.8 11.6 9.9 12.6 22.9 15.8 5.7 18.1 15.8 15.9 12.2 14.8 12.4 14.9 13.9 18.0 21.4 13.5 11.8 10.8 10.0 24.4 36.4 12.8 18.7 11.8 12.9 14.0 26.3 23.4 12.0 28.4 11.7 12.3 12.7 14.6 20.7 19.2 10.4 13.8 13.7 12.7 10.2 17.1 14.7 60.0 9.0 14.5 19.3 14.3 18.0 11.6 11.5 14.4 23.1 43.8 26.8 12.2 14.0 14.4 17.4 28.7 9.2 13.1 17.2 15.5 29.1 9.0 18.3 26.9 18.8 35.7 29.2 14.4 29.9 20.7 8.5 17.5 13.5 25.5 9.8 10.5 31.7 9.1 23.0 34.4 27.2 16.8 12.9 19.8 23.9 27.7 18.7 10.3 23.7 21.3 18.4 7.2 15.9 42.3 18.8 21.2 18.3 24.8 33.4 15.5 5.8 34.1 24.2 15.1 15.0 18.7 11.2 35.6 10.3 14.7 28.8 27.3 9.8 12.9 14.5 8.5 15.1 13.9 11.5 14.6 17.0 8.6 13.7 10.2 26.8 6.3 9.8 13.7 9.2 14.4 12.1 10.3 23.1 12.4 12.1 10.9 43.8 12.2 7.9 12.4 14.0 14.4 11.6 12.6 5.7 18.1 10.8 10.0 11.8 12.9 11.7 9.0 8.9 17.1 31.2 37.1 18.0 0.0 1.1 30.6 36.1 9.1 33.2 0.0 91.6 82.9 61.0 517.8 26.4 34.8 0.0 73.6 112.1 34.7 39.6 26.5 48.6 89.5 0.0 19.0 20.9 42.2 1060.3 40.0 30.1 47.2 74.9 33.2 0.0 60.6 41.8 37.1 103.2 0.0 45.3 25.4 80.9 35.8 18.3 74.1 22.4 48.1 34.2 MUC1 "ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM" ENSG00000185499 "Mucin 1, cell surface associated" P15941 1 155185824-155192916 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 168.1;kidney: 158.5;lung: 143.5" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 1308.2;Collecting duct cells: 465.9;Exocrine glandular cells: 994.6;Pancreatic endocrine cells: 807.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.0" "Group enriched" "Detected in many" 10 "granulocytes: 1.3;T-cells: 4.0" "Group enriched" "Detected in many" 6 "CAPAN-2: 139.4;OE19: 65.3;RPTEC TERT1: 107.0;T-47d: 47.0" "CAB000036, CAB001986, HPA004179, HPA007235, HPA008855" Enhanced Supported "Plasma membrane" "Secreted in other tissues" NA NA 4900000 "Plasma membrane" "CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283" "unprognostic (4.74e-2)" "unprognostic (2.84e-2)" "unprognostic (2.19e-1)" "unprognostic (8.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.70e-1)" "unprognostic (2.61e-3)" "unprognostic (6.34e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (4.60e-4)" "unprognostic (4.75e-1)" "unprognostic (2.05e-2)" "unprognostic (1.13e-1)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (1.21e-1)" 1.5 0.7 0.8 12.6 1.2 0.9 12.6 0.4 0.7 31.6 15.9 1.2 2.4 2.9 10.5 9.8 51.8 18.7 168.1 0.8 0.5 0.3 158.5 2.0 143.5 0.3 0.5 0.3 14.9 74.2 0.0 4.7 15.5 2.1 6.1 16.1 0.8 17.0 5.9 0.8 1.8 3.6 2.8 0.7 0.6 105.0 4.3 0.5 0.7 15.7 10.5 47.8 12.3 5.2 0.0 0.2 1.3 0.1 0.0 4.0 0.2 1.8 0.9 0.6 0.5 0.4 0.5 0.2 0.6 1.4 0.7 1.9 0.0 139.4 0.0 10.1 1.1 0.3 2.8 0.1 0.0 0.2 1.2 0.1 0.2 11.8 0.0 0.3 0.0 4.4 1.2 0.2 0.3 0.2 1.5 0.2 0.2 1.0 1.9 0.5 14.2 0.1 0.1 0.4 65.3 0.2 0.2 0.0 3.4 107.0 0.1 0.6 0.2 3.3 5.9 0.1 0.5 47.0 0.6 0.2 0.4 0.8 1.3 0.1 2.1 1.1 0.0 0.7 0.1 0.1 1.3 0.1 0.0 0.0 0.0 0.8 0.0 2.3 0.4 0.2 0.0 0.3 0.7 0.0 0.0 0.0 0.0 4.0 0.2 0.8 1.2 0.4 0.7 0.5 0.3 0.5 0.3 2.1 0.5 402.0 1308.2 0.9 16.1 0.6 1.0 0.4 384.7 92.3 252.5 465.9 3.9 0.1 29.9 144.7 27.3 3.5 49.2 0.0 994.6 1.2 3.1 11.6 45.2 0.5 0.2 1.6 29.4 1.3 3.4 68.9 2.3 2.6 5.0 42.3 249.7 1.1 807.2 66.2 1.4 0.9 0.2 0.0 1.9 6.2 0.8 1.0 0.2 0.0 132.5 164.3 MUC12 MUC11 ENSG00000205277 "Mucin 12, cell surface associated" Q9UKN1 7 100969623-101018949 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 35.6" "Group enriched" "Detected in many" 5 "Enterocytes: 444.8;Mucus-secreting cells: 128.0;Paneth cells: 173.4;Undifferentiated cells: 234.4" "Cancer enriched" "Detected in some" 7 "colorectal cancer: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.8" HPA023835 Enhanced NA NA "HPA023835: AB_1854199" "unprognostic (1.38e-1)" "unprognostic (2.09e-1)" "unprognostic (2.80e-2)" "unprognostic (1.60e-1)" "unprognostic (3.84e-4)" "unprognostic (4.40e-2)" "unprognostic (1.30e-3)" "unprognostic (1.84e-2)" "unprognostic (1.40e-1)" "unprognostic (6.52e-2)" "unprognostic (3.72e-1)" "unprognostic (1.92e-1)" "unprognostic (3.33e-7)" "unprognostic (8.42e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-1)" "unprognostic (7.54e-2)" 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 35.6 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 10.9 3.4 0.0 2.0 0.0 6.7 2.3 1.8 0.0 0.2 0.0 4.6 2.9 1.3 444.8 0.0 2.3 1.2 14.1 7.1 9.2 0.0 2.0 0.0 45.6 1.3 0.6 4.0 0.9 4.8 3.3 0.0 128.0 0.0 7.9 173.4 3.2 0.0 0.0 0.0 5.9 2.4 1.3 2.6 0.5 1.0 234.4 4.3 MUC13 DRCC1 ENSG00000173702 "Mucin 13, cell surface associated" Q9H3R2 3 124905442-124953819 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "intestine: 334.4" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 474.6;Intestinal endocrine cells: 147.6;Mucus-secreting cells: 321.7;Paneth cells: 299.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 198.4;stomach cancer: 152.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "OE19: 70.4" HPA045163 Enhanced "Secreted to digestive system" NA NA "HPA045163: AB_10960396" "unprognostic (8.42e-2)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (1.55e-3)" "unprognostic (2.93e-1)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (3.48e-2)" "unprognostic (2.94e-1)" "unprognostic (5.10e-2)" "unprognostic (2.02e-1)" "unprognostic (9.64e-2)" "prognostic unfavorable (9.73e-5)" "unprognostic (2.05e-3)" "unprognostic (1.10e-1)" "unprognostic (2.29e-1)" "unprognostic (1.42e-1)" 0.5 0.6 0.5 16.4 0.5 0.0 0.5 0.5 0.5 0.5 83.1 0.0 0.0 79.9 0.5 0.3 0.5 0.5 16.7 0.5 0.5 0.5 3.3 8.7 0.5 0.0 0.5 0.0 0.5 1.8 0.0 0.5 0.1 0.1 0.5 40.6 0.1 0.5 0.0 0.5 0.5 334.4 1.0 0.5 0.5 4.1 0.5 0.0 0.1 0.5 0.0 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 2.0 4.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.0 70.4 0.3 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.0 0.1 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.3 15.3 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.6 0.1 474.6 0.0 28.4 0.0 0.0 2.1 9.2 0.0 0.0 0.0 147.6 0.0 0.3 2.7 0.0 0.0 0.0 0.0 321.7 0.0 14.3 299.5 0.7 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 111.9 0.1 MUC15 ENSG00000169550 "Mucin 15, cell surface associated" Q8N387 11 26559033-26572233 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 265.1;placenta: 56.8;thyroid gland: 77.8" "Cell type enhanced" "Detected in many" 25 "Alveolar cells type 1: 101.3;Ciliated cells: 164.6;Syncytiotrophoblasts: 556.9" "Cancer enriched" "Detected in many" 11 "thyroid cancer: 56.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.8;K-562: 9.7;SK-BR-3: 16.6;SuSa: 11.3;U-266/70: 6.5;U-266/84: 17.4" "Group enriched" "Detected in some" 4 "cerebellum: 1.3;thalamus: 1.5" "Low region specificity" "Detected in many" "HPA026110, HPA073304" Enhanced "Intracellular and membrane" NA NA "HPA026110: AB_1854200, HPA073304: " "unprognostic (1.49e-1)" "unprognostic (2.08e-3)" "unprognostic (7.71e-5)" "unprognostic (5.09e-3)" "unprognostic (2.77e-2)" "unprognostic (3.04e-2)" "unprognostic (6.58e-2)" "unprognostic (1.12e-1)" "unprognostic (9.44e-3)" "unprognostic (1.98e-1)" "unprognostic (7.27e-3)" "unprognostic (4.96e-3)" "unprognostic (1.09e-1)" "unprognostic (5.70e-2)" "unprognostic (4.54e-3)" 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 3.9 0.0 0.0 9.3 0.0 0.1 265.1 11.0 1.0 0.1 0.1 0.0 0.0 5.2 0.1 4.8 0.1 0.0 0.0 0.1 1.8 0.0 2.1 56.8 0.0 0.8 0.0 0.0 14.4 1.0 0.0 12.0 0.0 0.0 0.0 0.0 0.2 4.1 0.0 1.1 77.8 8.1 1.7 3.0 6.5 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.6 0.0 16.6 0.0 11.3 0.1 0.0 0.0 0.0 2.5 0.0 0.0 6.5 17.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.3 20.9 0.0 12.3 3.1 0.0 0.0 0.0 164.6 64.8 47.1 0.0 52.1 26.6 3.0 0.4 0.0 0.0 0.0 0.0 15.5 0.5 0.6 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 26.0 556.9 0.0 0.0 10.5 MUC16 "CA125, FLJ14303" ENSG00000181143 "Mucin 16, cell surface associated" Q8WXI7 19 8848844-8981342 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adipose tissue: 6.6;cervix, uterine: 19.3;fallopian tube: 6.7;salivary gland: 6.3" "Cell type enhanced" "Detected in some" 27 "Ciliated cells: 49.5;Club cells: 10.3;Early spermatids: 11.7;Late spermatids: 12.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 21.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 15.9;CAPAN-2: 5.6;HaCaT: 5.4;HeLa: 27.6;SK-BR-3: 3.5" "CAB055172, HPA065600" Enhanced "Secreted in other tissues" NA NA "CAB055172: AB_2148831, HPA065600: AB_2732736" "unprognostic (8.66e-2)" "unprognostic (3.89e-2)" "unprognostic (5.37e-2)" "unprognostic (3.07e-1)" "unprognostic (1.76e-2)" "unprognostic (3.01e-3)" "unprognostic (3.83e-3)" "unprognostic (1.31e-2)" "unprognostic (1.00e-2)" "unprognostic (1.86e-1)" "unprognostic (1.89e-3)" "unprognostic (1.81e-1)" "unprognostic (2.60e-8)" "unprognostic (3.50e-2)" "unprognostic (2.86e-1)" "unprognostic (1.43e-1)" "unprognostic (3.68e-3)" 6.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.3 0.0 0.0 2.4 0.0 0.2 6.7 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.4 2.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 2.2 0.0 49.5 10.3 0.0 0.0 1.4 0.0 0.2 11.7 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 2.7 0.0 0.0 0.6 MUC17 ENSG00000169876 "Mucin 17, cell surface associated" Q685J3 7 101020072-101058745 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 299 "intestine: 125.2" "Cell type enriched" "Detected in some" 5 "Enterocytes: 59.0" "Group enriched" "Detected in some" 29 "colorectal cancer: 6.1;pancreatic cancer: 4.9;stomach cancer: 22.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.2;OE19: 1.0" HPA031634 Enhanced "Intracellular and membrane" NA NA "HPA031634: AB_10603021" "unprognostic (2.37e-2)" "unprognostic (2.41e-1)" "unprognostic (8.17e-3)" "unprognostic (5.57e-3)" "unprognostic (6.07e-2)" "unprognostic (8.79e-8)" "unprognostic (1.28e-1)" "unprognostic (2.47e-2)" 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 64.7 0.0 0.0 15.8 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 2.5 0.0 0.1 0.0 0.1 0.1 125.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 3.5 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 MUC21 "bCX31G15.2, C6orf205" ENSG00000204544 "Mucin 21, cell surface associated" Q5SSG8 6 30983718-30989903 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 251.5;lymphoid tissue: 126.1" "Group enriched" "Detected in some" 17 "Alveolar cells type 2: 4.8;Club cells: 9.1;Urothelial cells: 11.2" "Group enriched" "Detected in many" 9 "cervical cancer: 6.8;head and neck cancer: 6.6;lung cancer: 13.9;stomach cancer: 7.0;thyroid cancer: 5.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.0" "Cell line enriched" "Detected in single" 14 "Karpas-707: 4.3" HPA052028 Enhanced NA NA "HPA052028: AB_2681700" "unprognostic (2.27e-2)" "unprognostic (4.85e-3)" "unprognostic (5.24e-3)" "unprognostic (1.68e-2)" "unprognostic (2.68e-2)" "unprognostic (2.98e-3)" "unprognostic (1.32e-4)" "unprognostic (1.05e-1)" "unprognostic (1.53e-1)" "unprognostic (3.24e-2)" "unprognostic (7.81e-2)" 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 34.7 0.2 0.0 0.0 0.2 1.3 0.2 251.5 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.7 0.2 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 16.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.0 0.2 33.7 126.1 0.2 33.2 0.0 0.0 1.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.5 0.0 0.0 0.2 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 MUC22 PBMUCL1 ENSG00000261272 "Mucin 22" E2RYF6 6 31010474-31035402 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "esophagus: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.38e-1)" "unprognostic (1.57e-1)" "unprognostic (1.46e-1)" "unprognostic (1.91e-1)" "unprognostic (4.03e-1)" "unprognostic (1.46e-2)" "unprognostic (9.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.65e-1)" "unprognostic (1.35e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 MUC3A MUC3 ENSG00000169894 "Mucin 3A, cell surface associated" Q02505 7 100949555-100968346 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 84.4;intestine: 138.0" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 181.0;Mucus-secreting cells: 104.0;Paneth cells: 136.8;Undifferentiated cells: 104.3" "Cancer enhanced" "Detected in many" "stomach cancer: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 11.8;CAPAN-2: 3.9;MCF7: 2.6;OE19: 5.9" HPA010871 Uncertain "Intracellular and membrane" NA NA "HPA010871: AB_1854201" "unprognostic (1.12e-2)" "unprognostic (3.78e-2)" "unprognostic (1.75e-1)" "unprognostic (4.22e-3)" "unprognostic (2.91e-1)" "unprognostic (5.16e-2)" "unprognostic (2.06e-1)" "unprognostic (5.29e-3)" "unprognostic (2.87e-1)" "unprognostic (1.33e-1)" "unprognostic (7.01e-2)" "unprognostic (2.99e-1)" "unprognostic (6.50e-3)" "unprognostic (8.73e-2)" "unprognostic (1.01e-1)" "unprognostic (2.39e-1)" "unprognostic (4.51e-2)" 0.1 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 31.4 0.0 0.0 23.3 0.0 0.0 0.0 0.0 84.4 0.8 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.5 6.7 0.0 0.0 0.0 2.4 0.0 138.0 0.1 0.0 0.0 1.4 0.0 0.0 19.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 11.8 3.9 0.0 0.1 0.0 0.1 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 2.6 0.0 0.0 1.7 5.9 0.0 0.0 0.0 0.3 0.6 0.0 0.9 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 1.2 33.1 0.0 0.0 1.8 0.0 0.3 0.0 12.0 0.4 0.0 181.0 0.0 25.0 0.6 0.0 42.1 0.0 5.1 0.2 0.0 9.9 0.6 1.5 0.0 0.3 0.0 0.0 1.8 104.0 0.0 34.7 136.8 0.0 0.1 0.0 0.0 1.3 0.5 3.4 0.1 0.2 0.0 104.3 12.8 MUC4 ENSG00000145113 "Mucin 4, cell surface associated" Q99102 3 195746765-195812277 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.5;lymphoid tissue: 57.2" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 85.6;Club cells: 86.4;Mucus-secreting cells: 154.7;Undifferentiated cells: 114.6;Urothelial cells: 276.8" "Cancer enhanced" "Detected in many" "cervical cancer: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.6" "HPA005895, CAB013536" Approved "Secreted in other tissues" NA NA "CAB013536: , HPA005895: AB_1079427" "unprognostic (4.16e-3)" "unprognostic (1.00e-2)" "unprognostic (6.79e-2)" "unprognostic (1.11e-2)" "unprognostic (3.03e-2)" "unprognostic (5.16e-2)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (3.19e-1)" "unprognostic (4.22e-3)" "unprognostic (6.68e-3)" "unprognostic (5.30e-2)" "unprognostic (2.43e-3)" "unprognostic (3.19e-1)" "unprognostic (6.78e-2)" "unprognostic (3.46e-3)" "unprognostic (9.97e-3)" 0.4 0.4 0.0 28.7 0.0 0.4 0.4 0.0 0.4 13.4 21.5 0.0 0.0 0.4 1.4 0.4 13.0 1.7 0.4 0.4 0.0 0.0 0.4 0.4 10.3 0.4 0.0 0.0 0.5 0.4 0.4 0.0 6.2 0.2 10.0 1.9 0.0 5.5 0.4 0.4 0.4 1.7 0.4 0.0 0.4 2.4 0.5 0.0 0.5 0.4 6.1 57.2 6.5 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.0 14.1 0.0 11.3 0.0 0.0 2.0 0.0 85.6 86.4 0.0 0.0 0.1 0.0 0.2 2.4 0.0 53.1 0.0 4.7 4.0 0.0 10.6 2.3 0.0 0.1 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 154.7 0.0 22.6 40.3 0.4 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.1 0.0 114.6 276.8 MUL1 "C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218" ENSG00000090432 "Mitochondrial E3 ubiquitin protein ligase 1" Q969V5 1 20499448-20508161 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026827 Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA026827: AB_10601137" "unprognostic (1.39e-1)" "unprognostic (2.73e-2)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (6.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.31e-2)" "unprognostic (5.86e-3)" "unprognostic (4.05e-1)" "unprognostic (9.10e-2)" "prognostic favorable (6.15e-14)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" 13.3 15.9 10.3 12.9 12.3 20.6 20.4 9.2 22.2 13.1 15.8 19.0 8.0 11.6 18.2 10.7 17.2 17.0 18.5 26.2 11.7 12.5 20.5 20.1 16.3 12.1 16.8 9.5 17.5 26.8 21.9 13.0 21.6 17.6 13.9 13.3 14.3 15.3 18.1 26.7 17.4 19.5 17.0 11.7 13.6 15.2 14.1 11.6 18.5 15.1 14.6 14.0 16.3 13.6 23.2 26.0 31.9 30.4 25.2 32.1 27.5 17.1 16.6 9.6 19.8 20.8 11.7 10.4 17.0 20.4 21.2 20.5 10.2 28.5 12.9 19.1 24.0 16.1 26.1 17.2 24.6 15.5 12.8 13.6 9.9 11.2 14.8 24.5 13.5 17.0 19.1 32.5 21.7 22.6 12.5 13.8 11.7 12.9 15.8 23.0 8.7 8.1 9.1 9.8 14.3 15.9 8.0 12.1 16.7 25.0 9.6 9.8 14.5 15.3 16.4 20.9 8.1 11.5 13.0 15.6 20.7 11.9 18.0 15.2 18.5 16.1 13.9 16.2 18.4 19.1 26.3 26.5 31.9 30.9 30.4 32.1 23.2 23.6 31.4 26.0 21.5 27.1 26.3 24.0 25.2 25.4 20.1 32.1 27.5 10.3 12.3 9.2 22.2 11.7 12.5 16.8 9.5 17.6 11.6 20.8 9.3 11.7 7.8 4.6 12.5 14.6 12.7 9.4 6.8 17.4 5.9 33.7 10.0 21.4 1.6 9.7 12.0 0.0 20.3 20.8 12.1 8.1 3.5 11.9 19.7 12.7 8.2 10.4 11.4 2.8 12.0 7.7 18.6 21.6 11.8 15.6 19.7 11.5 14.5 8.7 10.5 19.4 8.5 10.6 13.4 6.1 31.5 10.8 10.1 9.0 MUSK ENSG00000030304 "Muscle associated receptor tyrosine kinase" O15146 9 110668771-110801620 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein, Kinase, Muscle protein, Receptor, Transferase, Tyrosine-protein kinase" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 50.0" "Cell type enhanced" "Detected in some" 31 "Early spermatids: 2.7;Late spermatids: 3.3;Leydig cells: 4.9;Peritubular cells: 18.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "LHCN-M2: 19.8;RH-30: 20.1" "Region enhanced" "Detected in some" "basal ganglia: 4.5" "Not detected" "Not detected" NA NA "unprognostic (6.12e-2)" "unprognostic (9.01e-2)" "unprognostic (5.39e-2)" "unprognostic (3.66e-1)" "unprognostic (3.14e-1)" "unprognostic (1.20e-2)" "unprognostic (1.50e-2)" "unprognostic (2.46e-1)" "unprognostic (3.13e-1)" "unprognostic (7.58e-2)" "unprognostic (6.03e-5)" "unprognostic (4.58e-2)" "unprognostic (1.62e-1)" "unprognostic (9.67e-2)" "unprognostic (5.11e-2)" 7.5 0.3 0.6 5.8 0.7 0.0 0.2 0.1 0.2 0.3 6.8 0.0 0.0 2.3 0.2 4.0 3.8 0.1 2.1 3.2 0.9 0.7 0.2 0.5 4.2 0.9 0.2 0.1 0.3 0.3 0.0 0.2 0.6 0.3 1.9 5.3 0.0 0.4 0.0 50.0 0.3 5.0 3.0 0.3 0.2 2.6 5.9 0.0 0.0 0.3 1.4 3.9 3.6 2.9 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.4 0.0 0.2 0.0 20.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.1 0.2 0.9 0.7 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 MXRA7 "FLJ46603, PS1TP1, TMAP1" ENSG00000182534 "Matrix remodeling associated 7" P84157 17 76672551-76711016 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 140.1;Muller glia cells: 291.2;Peritubular cells: 134.7;Rod photoreceptor cells: 125.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 93.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044819, HPA075316" Uncertain Enhanced "Endoplasmic reticulum" "Secreted - unknown location" NA NA "Endoplasmic reticulum" "HPA044819: AB_10964134, HPA075316: " "unprognostic (1.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.32e-1)" "unprognostic (2.92e-1)" "unprognostic (1.19e-1)" "unprognostic (3.16e-2)" "prognostic unfavorable (4.70e-4)" "unprognostic (3.38e-2)" "unprognostic (1.21e-1)" "unprognostic (1.51e-3)" "unprognostic (2.07e-2)" "unprognostic (8.33e-2)" "unprognostic (5.39e-3)" "unprognostic (4.67e-3)" "unprognostic (6.21e-2)" "unprognostic (4.63e-3)" "prognostic unfavorable (1.80e-5)" 28.4 46.7 14.7 18.2 43.2 1.8 32.4 15.6 30.5 31.0 44.0 14.6 16.9 6.6 44.5 40.4 33.2 28.0 28.1 93.3 15.1 13.1 14.1 5.1 24.7 13.3 16.2 16.3 36.1 16.4 40.1 7.8 21.1 20.6 32.8 14.5 41.9 15.0 61.7 13.9 10.8 13.3 59.9 15.8 31.4 21.9 20.7 10.0 6.4 51.0 9.3 6.6 44.7 31.4 2.9 3.6 1.9 3.9 7.8 7.0 4.0 2.5 7.6 11.4 21.5 60.5 55.4 5.7 36.1 29.3 26.4 25.8 10.2 0.4 0.0 16.4 49.9 27.6 10.3 12.7 20.0 43.2 0.1 12.6 6.5 5.7 16.9 37.0 3.0 0.8 34.4 23.9 30.6 25.2 59.4 38.8 1.6 4.6 0.1 60.8 0.7 0.3 2.1 3.6 4.0 21.6 5.7 44.9 2.1 21.2 0.6 4.0 29.1 10.7 0.1 20.6 34.0 7.1 3.9 47.5 59.7 12.7 24.3 37.9 3.4 0.6 0.1 93.7 1.3 8.6 1.5 3.9 0.8 6.3 1.2 4.8 2.9 3.5 7.0 3.1 0.7 2.3 4.9 1.9 7.8 0.4 3.6 0.8 4.0 14.7 43.2 15.6 30.5 15.1 13.1 16.2 16.3 20.6 10.0 14.9 10.5 2.9 23.3 9.2 140.1 103.5 2.5 9.4 11.4 29.6 90.3 1.0 1.7 20.9 3.3 36.2 0.9 0.0 3.6 4.2 41.8 16.2 2.3 3.2 2.8 104.9 6.4 54.0 5.6 6.6 93.7 2.2 13.5 1.8 5.6 291.2 7.9 0.0 134.7 5.8 125.1 12.9 36.0 1.2 12.1 7.8 0.7 9.6 1.2 18.1 MXRA8 DKFZp586E2023 ENSG00000162576 "Matrix remodeling associated 8" Q9BRK3 1 1352689-1361777 "Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Extravillous trophoblasts: 236.0;Fibroblasts: 92.6;Leydig cells: 163.1;Peritubular cells: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "naive CD8 T-cell: 9.8" "Lineage enriched" "Detected in single" 98 "T-cells: 9.8" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.7;BJ: 50.0;BJ hTERT+: 23.5;fHDF/TERT166: 24.8;HHSteC: 15.7;HSkMC: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053958, HPA055780" Uncertain Approved Nucleoli NA NA 450000 Nucleoli "HPA053958: AB_2682322, HPA055780: AB_2682918" "unprognostic (1.39e-1)" "unprognostic (2.85e-1)" "unprognostic (7.31e-3)" "unprognostic (1.26e-2)" "unprognostic (1.94e-3)" "unprognostic (2.61e-1)" "unprognostic (6.75e-2)" "unprognostic (2.03e-1)" "unprognostic (4.22e-2)" "unprognostic (5.38e-2)" "unprognostic (2.97e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.43e-6)" "prognostic unfavorable (9.93e-4)" "unprognostic (1.55e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (9.87e-4)" 45.6 5.3 2.3 11.4 4.6 1.1 25.2 3.9 3.8 34.8 14.3 4.8 6.2 6.5 34.0 16.3 13.7 14.4 20.5 12.7 3.6 1.1 7.6 3.5 13.4 5.6 2.6 2.6 30.4 3.7 1.6 6.0 25.0 5.4 23.4 2.3 36.6 8.4 12.3 15.5 10.9 8.6 22.0 4.5 9.5 8.7 16.4 2.9 0.3 13.9 11.8 4.5 22.3 17.8 0.0 0.0 0.0 0.0 0.0 9.8 0.3 1.3 0.3 0.4 0.3 6.0 16.7 15.1 50.0 23.5 5.9 7.0 2.7 1.1 0.5 0.2 24.8 0.0 1.0 0.3 0.0 1.1 1.0 0.4 0.4 0.9 4.2 15.7 0.0 0.5 19.9 0.0 2.2 0.0 11.1 0.0 0.3 5.8 0.5 7.4 0.1 0.1 0.1 4.9 0.1 1.6 0.2 0.1 0.1 0.0 0.2 1.1 3.1 0.1 0.5 0.0 3.6 3.9 0.2 0.4 0.2 8.3 7.7 0.2 1.1 0.1 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 9.8 0.0 0.0 0.0 0.0 0.0 0.3 2.3 4.6 3.9 2.7 3.6 1.1 2.6 2.6 5.4 2.9 3.0 0.0 0.0 0.8 9.5 0.7 3.2 0.0 0.0 0.0 8.7 0.0 5.9 0.0 4.6 1.4 1.6 0.0 0.0 0.0 236.0 92.6 0.5 0.0 0.0 8.3 0.0 0.0 9.8 0.0 6.1 163.1 1.6 10.1 1.0 0.0 44.6 0.8 0.0 172.5 1.5 1.0 12.9 36.9 0.7 5.2 9.3 24.6 0.0 0.0 0.3 MYADM ENSG00000179820 "Myeloid associated differentiation marker" Q96S97 19 53866223-53876437 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 336.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 52.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056301 Approved "Nuclear speckles" NA NA 34000 "Nuclear speckles" "HPA056301: " "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-1)" "unprognostic (2.94e-1)" "unprognostic (6.41e-2)" "unprognostic (1.01e-2)" "unprognostic (8.21e-3)" "prognostic unfavorable (8.15e-4)" "unprognostic (3.97e-2)" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (4.11e-1)" "prognostic unfavorable (7.71e-7)" "unprognostic (2.28e-3)" "unprognostic (1.29e-1)" "unprognostic (2.37e-2)" "unprognostic (6.14e-3)" 58.2 9.5 9.2 26.4 13.9 53.5 39.2 7.4 17.1 67.9 58.9 18.8 25.1 15.8 105.6 33.0 44.6 66.1 40.8 39.9 9.3 11.7 13.0 15.6 42.4 22.3 8.2 11.4 51.7 31.8 8.7 8.9 46.5 13.3 41.9 13.4 22.2 21.1 45.4 13.2 19.5 26.8 76.8 9.6 22.6 37.6 28.7 9.4 20.3 20.5 32.6 15.3 81.6 30.5 2.0 14.3 52.2 11.6 4.1 5.4 3.9 6.5 55.1 7.0 5.7 24.1 16.6 11.3 35.1 25.2 13.9 14.2 22.6 20.4 0.6 12.5 44.6 15.1 13.5 3.5 13.3 12.1 8.2 8.3 9.0 9.1 17.2 55.1 18.4 32.5 18.1 3.1 17.8 2.5 23.0 12.5 3.5 9.4 16.9 8.8 7.9 4.9 14.4 6.7 24.7 15.7 19.4 7.6 3.3 15.6 0.7 0.1 10.9 0.3 11.0 3.4 15.0 10.7 15.8 25.5 31.3 11.2 4.1 15.7 11.0 6.9 0.1 19.2 9.0 0.5 14.1 11.6 38.3 5.4 6.7 5.1 1.4 3.5 3.9 14.3 2.0 3.4 2.8 52.2 4.1 5.4 5.5 1.3 3.9 9.2 13.9 7.4 17.1 9.3 11.7 8.2 11.4 13.3 9.4 151.8 58.6 29.9 149.5 91.5 3.9 57.6 43.3 57.6 119.4 19.2 3.9 32.7 0.0 107.8 2.1 93.1 5.4 0.0 45.1 208.7 179.0 42.1 336.4 16.3 69.9 9.5 194.1 115.4 66.4 2.0 83.4 144.1 57.3 15.4 91.5 1.7 54.2 52.6 109.6 0.3 0.9 148.8 157.7 22.0 7.7 52.2 41.4 54.3 65.7 78.1 MYADML2 LOC255275 ENSG00000185105 "Myeloid associated differentiation marker like 2" A6NDP7 17 81939645-81947233 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 20 "skeletal muscle: 44.5" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 4.8;Early spermatids: 1.4;Horizontal cells: 1.6" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 8.4" "Low region specificity" "Detected in all" "HPA041856, HPA048476" Uncertain NA NA "HPA041856: AB_2677709, HPA048476: AB_2680410" "unprognostic (1.83e-1)" "unprognostic (1.71e-2)" "unprognostic (7.07e-2)" "unprognostic (2.90e-4)" "unprognostic (2.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (1.44e-2)" "unprognostic (3.37e-2)" "unprognostic (4.16e-7)" "unprognostic (1.86e-1)" "unprognostic (1.91e-1)" "unprognostic (8.68e-2)" 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.4 2.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 1.5 0.6 1.5 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 44.5 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.3 1.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.7 0.0 0.6 0.0 0.1 0.6 0.1 0.5 0.0 0.4 0.1 0.0 0.2 8.4 0.7 0.2 0.2 0.6 0.0 0.2 0.0 0.0 0.3 0.7 0.2 0.0 1.5 1.1 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 MYC "bHLHe39, c-Myc, MYCC" ENSG00000136997 "MYC proto-oncogene, bHLH transcription factor" P01106 8 127735434-127741434 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 812.6;Basal keratinocytes: 900.0;Smooth muscle cells: 529.5;Suprabasal keratinocytes: 935.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 132.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000084, CAB010307, HPA055893, HPA066556" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000084: , CAB010307: AB_631274, HPA055893: AB_2682960, HPA066556: AB_2685691" "unprognostic (1.45e-2)" "unprognostic (4.00e-3)" "unprognostic (3.94e-3)" "unprognostic (2.41e-3)" "unprognostic (8.14e-2)" "unprognostic (3.36e-3)" "unprognostic (5.80e-2)" "unprognostic (4.94e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.19e-3)" "unprognostic (9.86e-3)" "prognostic unfavorable (5.49e-8)" "unprognostic (7.85e-2)" "unprognostic (4.66e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (4.96e-5)" 67.4 20.8 3.2 46.6 7.1 16.3 36.0 1.2 5.0 23.9 23.3 3.8 11.8 11.1 23.8 14.4 47.6 59.5 32.4 23.7 5.8 2.2 11.2 36.6 16.0 40.5 5.8 1.2 38.7 64.6 2.1 7.4 14.9 9.8 20.6 11.3 6.1 14.4 21.8 69.6 78.5 17.2 21.3 12.0 38.3 24.7 16.3 3.8 40.2 9.0 48.4 27.1 28.9 37.3 25.5 8.8 1.0 10.3 20.9 55.2 22.0 7.2 14.0 1.2 12.5 20.4 24.1 3.7 8.7 3.8 10.9 9.1 19.2 19.1 74.3 12.3 5.2 10.7 15.8 65.1 28.3 7.2 17.5 22.7 44.7 23.8 25.0 18.8 31.2 7.2 16.8 62.6 7.3 58.0 8.8 12.5 26.2 66.0 39.3 5.4 20.8 51.0 68.1 3.5 31.3 28.1 28.4 5.3 132.1 9.1 7.5 86.4 8.2 4.0 34.1 22.6 2.1 13.9 20.5 15.2 8.2 9.8 6.3 10.9 0.7 1.2 35.9 7.2 35.0 4.1 0.7 10.3 0.1 8.6 9.1 43.4 25.5 31.1 18.6 8.8 20.6 55.2 34.8 1.0 20.9 6.1 0.3 24.8 22.0 3.2 7.1 1.2 3.6 5.8 2.2 5.8 1.2 9.8 3.8 53.6 68.5 50.1 812.6 900.0 0.0 10.2 28.1 18.7 83.0 12.2 0.0 20.0 1.7 71.3 0.9 89.5 6.3 0.0 37.0 51.5 149.4 176.0 54.4 27.1 25.9 0.0 12.0 96.3 42.9 1.1 91.5 19.1 160.3 3.6 66.1 1.0 60.5 11.5 63.3 5.3 0.2 45.3 529.5 0.5 0.7 935.3 4.9 39.5 82.4 301.8 MYCT1 "FLJ21269, MTLC" ENSG00000120279 "MYC target 1" Q8N699 6 152697895-152724567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 121.1;Ito cells: 178.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 39 "eosinophil: 20.4" "Lineage enriched" "Detected in single" 190 "granulocytes: 20.4" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 46.9;TIME: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047992 Approved Nucleoplasm,Vesicles NA NA 69000 Nucleoplasm Vesicles "HPA047992: " "unprognostic (2.92e-1)" "unprognostic (1.82e-1)" "unprognostic (5.95e-2)" "unprognostic (2.06e-1)" "unprognostic (6.73e-2)" "unprognostic (6.80e-2)" "unprognostic (4.64e-3)" "unprognostic (6.78e-2)" "unprognostic (9.90e-2)" "unprognostic (2.10e-1)" "unprognostic (2.66e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.26e-3)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (3.36e-2)" 37.3 3.1 4.1 4.4 6.3 1.1 27.5 3.0 7.7 16.2 8.4 1.5 5.2 3.1 14.5 9.4 14.4 6.8 9.1 17.2 5.1 4.2 6.9 11.1 24.1 4.9 5.8 1.9 8.2 2.5 3.4 2.7 17.4 6.6 8.8 5.3 8.3 4.0 3.7 14.2 4.8 5.5 10.8 5.4 39.4 4.6 7.7 5.2 0.6 12.5 11.0 2.8 17.0 12.3 0.1 0.0 20.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.8 0.1 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 38.8 0.2 0.3 0.5 0.0 0.4 0.0 5.8 0.0 0.0 0.0 0.4 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 4.1 6.3 3.0 7.7 5.1 4.2 5.8 1.9 6.6 5.2 0.0 6.9 0.0 0.1 6.4 0.0 2.8 5.1 29.4 1.2 0.0 0.0 0.0 0.0 0.1 6.0 121.1 0.0 0.0 0.2 0.0 2.4 0.4 1.1 1.0 0.1 0.0 0.0 178.6 9.1 2.9 0.3 0.8 13.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.1 4.8 0.0 0.0 0.0 0.2 MYLK4 SgK085 ENSG00000145949 "Myosin light chain kinase family member 4" Q86YV6 6 2663629-2750966 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 23.6;tongue: 63.6" "Cell type enhanced" "Detected in some" 6 "Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Proximal tubular cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "HEL: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA015860 Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoli, Vesicles" "HPA015860: AB_2147922" "unprognostic (1.75e-1)" "unprognostic (2.04e-1)" "unprognostic (1.87e-1)" "unprognostic (5.22e-3)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (7.48e-2)" "unprognostic (2.80e-1)" "unprognostic (5.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.91e-1)" "unprognostic (2.74e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-1)" "unprognostic (1.19e-2)" "unprognostic (4.63e-2)" 0.5 0.3 0.3 0.3 0.4 0.4 0.8 1.4 0.7 0.3 0.3 0.3 0.3 0.1 0.3 0.5 1.0 0.2 0.3 1.0 0.5 0.5 2.6 0.3 0.5 0.3 0.4 0.3 0.3 1.1 0.7 0.7 0.4 0.4 0.4 0.1 0.4 2.4 0.4 23.6 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.0 63.6 1.5 0.5 0.3 0.1 0.8 0.3 0.3 0.9 1.4 0.1 0.3 0.2 0.6 1.2 1.0 1.2 0.6 0.7 1.6 0.5 0.4 0.5 1.1 1.1 1.6 0.8 0.2 1.9 0.2 0.5 0.7 0.2 0.6 12.7 0.6 0.1 0.3 0.3 0.6 1.5 0.5 0.1 1.2 0.6 0.5 0.2 0.1 0.1 0.3 0.5 0.1 1.4 0.2 0.4 0.0 0.9 0.0 0.0 0.9 0.3 1.0 0.6 0.3 0.2 0.5 1.1 0.4 0.8 0.7 0.5 0.1 0.2 0.4 0.4 0.2 0.1 0.2 0.3 1.3 0.1 0.1 0.1 0.5 0.0 0.3 0.1 0.2 1.4 0.2 0.1 0.6 0.1 0.3 0.9 0.3 0.8 0.1 0.1 0.3 0.4 1.4 0.7 0.5 0.5 0.4 0.3 0.4 0.3 3.0 0.6 0.0 0.1 0.1 0.8 1.2 2.5 0.0 1.2 0.0 0.0 0.3 0.0 0.1 0.4 0.5 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.2 1.6 1.2 0.0 0.3 0.0 0.3 1.0 0.0 1.8 0.0 0.2 0.0 0.0 1.4 2.9 0.2 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.1 MYMK "TMEM226, TMEM8C" ENSG00000187616 "Myomaker, myoblast fusion factor" A6NI61 9 133514586-133528612 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Myogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.3;epididymis: 3.1;skeletal muscle: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 34 "HSkMC: 18.4;RH-30: 8.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA051846, HPA055785" Uncertain NA NA "HPA051846: AB_2681636, HPA055785: AB_2682920" "unprognostic (9.17e-3)" "unprognostic (8.63e-2)" "unprognostic (3.76e-1)" "unprognostic (1.13e-1)" "unprognostic (1.03e-1)" "unprognostic (5.37e-1)" "unprognostic (9.32e-2)" "unprognostic (1.91e-1)" 0.6 0.2 0.5 0.0 3.3 0.2 0.0 0.7 2.6 0.0 0.0 0.8 0.0 0.0 0.0 3.1 0.6 0.1 0.0 0.3 1.0 0.4 1.7 0.2 0.3 0.0 0.9 2.1 0.0 0.0 0.0 0.1 2.0 1.6 0.6 0.0 0.0 0.2 0.0 8.0 0.2 0.0 0.0 0.4 0.1 0.0 1.5 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.3 0.7 2.6 1.0 0.4 0.9 2.1 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYOF "FER1L3, KIAA1207" ENSG00000138119 Myoferlin Q9NZM1 10 93306429-93482317 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Pancreatic endocrine cells: 95.7;Urothelial cells: 93.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 15.9;non-classical monocyte: 18.0" "Group enriched" "Detected in many" 65 "dendritic cells: 6.2;monocytes: 18.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 76.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014245 Enhanced Supported "Vesicles,Plasma membrane" NA NA 14000 Vesicles "Plasma membrane" "HPA014245: AB_1848495" "unprognostic (3.41e-2)" "unprognostic (3.85e-1)" "unprognostic (2.88e-2)" "unprognostic (7.44e-2)" "unprognostic (3.50e-2)" "unprognostic (8.57e-3)" "unprognostic (3.48e-2)" "unprognostic (7.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.55e-1)" "unprognostic (5.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.94e-2)" "unprognostic (9.17e-2)" "unprognostic (9.18e-2)" 27.5 7.3 2.1 8.9 4.1 0.2 21.7 1.3 2.7 27.0 12.3 5.1 16.0 2.0 27.2 17.7 27.2 16.2 11.4 7.2 3.5 2.1 12.2 1.7 18.7 7.5 5.8 2.5 12.7 3.3 16.1 4.2 31.9 15.0 20.7 12.8 10.1 14.9 17.4 5.7 22.4 6.8 49.0 9.4 10.0 8.8 5.7 4.4 1.5 15.7 14.2 9.4 35.0 20.0 0.0 6.2 0.1 18.0 0.0 0.1 1.1 36.1 34.2 3.7 2.3 25.6 57.0 10.4 31.8 76.2 19.4 19.2 8.2 28.4 0.0 12.7 58.2 19.9 55.3 0.3 32.6 14.3 0.2 0.1 0.0 13.4 0.3 8.9 0.0 0.0 29.9 11.3 13.1 53.6 48.5 50.3 0.0 0.0 0.0 45.7 5.7 0.0 0.1 0.2 10.9 30.5 0.0 2.6 0.0 50.3 45.2 0.0 0.0 21.8 4.6 8.0 14.3 22.6 0.7 62.8 28.6 1.9 18.9 18.5 0.0 0.0 0.0 21.2 0.4 33.7 0.0 4.3 0.0 0.0 15.9 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.1 0.0 18.0 2.1 0.1 1.1 2.1 4.1 1.3 2.7 3.5 2.1 5.8 2.5 15.0 4.4 56.6 42.0 2.7 42.9 21.1 0.0 7.6 10.2 32.1 66.0 21.0 0.0 48.8 1.7 48.5 0.5 20.4 36.0 0.0 28.8 20.4 33.3 62.3 1.1 0.0 21.2 0.0 1.7 27.0 31.3 0.6 5.5 20.9 8.5 3.6 24.4 0.0 95.7 18.2 8.5 0.5 0.9 6.5 31.9 0.1 0.1 26.8 42.8 0.0 13.3 93.6 MYORG "KIAA1161, NET37" ENSG00000164976 "Myogenesis regulating glycosidase (putative)" Q6NSJ0 9 34366670-34376853 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 56.1" "Cell type enhanced" "Detected in some" 18 "Cytotrophoblasts: 41.5;Exocrine glandular cells: 10.3;Syncytiotrophoblasts: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 17.6;SK-BR-3: 29.4;T-47d: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060533, HPA067487" Enhanced Approved Mitochondria NA NA Mitochondria "HPA060533: AB_2684311, HPA067487: AB_2685848" "unprognostic (6.56e-2)" "unprognostic (1.51e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (2.44e-1)" "unprognostic (1.20e-1)" "unprognostic (2.44e-1)" "unprognostic (2.03e-2)" "unprognostic (1.55e-1)" "unprognostic (4.68e-3)" "unprognostic (1.91e-3)" "unprognostic (3.20e-1)" "prognostic favorable (1.20e-13)" "unprognostic (4.08e-3)" "unprognostic (3.68e-1)" "unprognostic (3.09e-1)" "unprognostic (1.00e-3)" 6.3 5.6 16.7 4.7 20.5 2.1 3.5 6.9 16.0 2.0 19.9 9.8 1.3 20.9 2.2 2.8 4.8 3.6 11.6 2.9 11.1 8.7 11.7 31.8 3.1 1.7 11.2 12.6 1.6 16.6 2.0 4.0 15.4 10.7 3.2 13.1 0.5 4.7 4.9 56.1 3.6 26.7 4.8 7.0 1.7 9.9 1.7 6.9 0.0 2.2 6.4 2.1 3.5 1.9 1.1 0.8 1.9 0.8 1.9 3.3 0.6 4.1 2.9 4.9 2.9 2.0 0.7 10.4 0.8 0.6 0.4 0.7 7.1 4.3 2.3 8.4 0.7 2.1 8.4 3.4 7.8 0.6 0.7 1.9 0.4 13.0 17.6 0.3 0.4 1.4 1.0 3.8 1.3 1.6 2.3 1.9 1.7 0.5 2.4 1.1 6.8 1.3 0.7 2.9 13.7 2.3 2.1 2.5 0.7 2.6 1.5 0.7 6.8 5.8 29.4 0.5 4.3 27.3 0.7 1.7 1.1 6.0 0.9 1.8 1.5 3.2 0.9 0.9 1.6 0.9 1.9 0.6 1.2 3.3 0.6 2.6 0.8 2.0 1.9 0.3 1.1 1.3 1.6 1.6 1.9 0.8 0.8 2.6 0.6 16.7 20.5 6.9 16.0 11.1 8.7 11.2 12.6 10.7 6.9 8.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 3.5 0.0 41.5 1.7 5.6 0.0 0.0 0.0 0.0 10.3 1.9 0.0 0.0 1.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 9.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 MYRF "C11orf9, MRF, Ndt80, pqn-47" ENSG00000124920 "Myelin regulatory factor" Q9Y2G1 11 61752642-61788518 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.7;stomach 1: 57.2" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 44.7;Cholangiocytes: 58.6;Ductal cells: 29.2;Exocrine glandular cells: 31.5;Pancreatic endocrine cells: 47.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 17.5;CACO-2: 29.3;CAPAN-2: 16.9;EFO-21: 22.9;Hep G2: 12.4;HHSteC: 13.1;OE19: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018310 Approved Nucleoplasm,Cytosol NA NA 550000 Nucleoplasm Cytosol "HPA018310: AB_1845534" "unprognostic (3.51e-2)" "unprognostic (3.34e-1)" "unprognostic (1.56e-1)" "unprognostic (5.39e-2)" "unprognostic (1.54e-1)" "unprognostic (3.65e-2)" "unprognostic (1.34e-1)" "unprognostic (9.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (8.91e-3)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" 4.6 1.3 16.4 2.1 42.9 1.4 1.5 3.3 38.5 3.7 4.3 96.7 0.0 12.8 6.9 1.6 2.0 8.0 22.4 1.5 29.2 13.9 4.5 5.8 15.8 1.2 54.3 19.9 5.8 19.7 1.2 0.2 2.6 35.7 1.2 4.0 11.6 1.7 1.6 1.0 1.4 11.4 5.4 53.8 1.3 57.2 3.0 51.4 0.0 1.2 0.0 1.2 1.3 0.3 0.0 0.0 0.2 0.3 0.5 2.1 0.5 1.3 17.5 3.1 1.0 0.0 0.0 0.1 0.1 0.0 0.6 0.7 29.3 16.9 0.6 22.9 0.0 0.8 0.7 1.0 0.1 1.2 0.0 0.3 0.1 0.3 12.4 13.1 0.0 0.3 0.3 0.1 0.4 0.0 7.7 0.1 0.9 5.4 0.2 0.1 0.3 0.0 0.6 0.8 25.8 2.3 0.0 0.1 1.1 7.8 0.1 0.1 0.6 0.1 1.2 0.3 10.9 0.3 0.1 0.6 0.2 10.2 0.2 0.3 0.3 0.1 0.1 0.1 1.2 0.2 0.0 0.0 0.2 2.1 0.3 1.2 0.0 0.7 1.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.5 16.4 42.9 3.3 29.3 29.2 13.9 54.3 19.9 35.7 51.4 44.7 6.1 0.0 0.0 0.1 0.1 0.8 58.6 0.0 2.3 3.5 0.0 0.2 0.0 29.2 0.3 0.0 8.4 0.0 31.5 0.2 4.9 0.2 0.0 5.3 0.8 0.0 1.2 0.6 0.0 0.2 5.5 0.6 3.3 1.8 3.2 3.7 47.6 11.5 3.5 1.0 0.0 0.0 0.3 1.0 3.2 0.0 0.7 0.0 5.2 0.7 MYRFL "bcm1377, C12orf15, C12orf28, FLJ25056" ENSG00000166268 "Myelin regulatory factor-like" Q96LU7 12 69825304-69959097 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "intestine: 56.1" "Cell type enhanced" "Detected in some" 21 "Collecting duct cells: 5.2;Early spermatids: 12.4;Late spermatids: 22.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 7.0;SK-BR-3: 3.5;T-47d: 15.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049340 Approved Approved Nucleoli "Intracellular and membrane" NA NA Nucleoli "HPA049340: AB_2680719" "unprognostic (2.95e-2)" "unprognostic (6.25e-2)" "unprognostic (2.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.18e-2)" "unprognostic (2.34e-1)" "unprognostic (5.45e-2)" "unprognostic (6.50e-2)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (3.08e-1)" "unprognostic (8.99e-2)" "unprognostic (1.91e-2)" "unprognostic (3.89e-2)" "unprognostic (2.07e-2)" "unprognostic (1.17e-1)" "unprognostic (9.96e-2)" 0.3 0.3 0.5 0.0 0.6 0.0 0.5 3.6 0.6 0.1 20.7 0.0 0.4 21.4 0.1 0.9 0.1 0.1 0.7 0.2 0.4 0.2 2.0 0.3 0.2 0.2 0.5 0.2 0.0 0.8 0.0 1.0 0.3 0.7 0.6 0.1 0.3 1.3 0.4 0.0 1.6 56.1 0.1 1.0 0.1 0.1 2.4 0.5 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.1 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 7.0 0.1 0.0 0.1 0.0 1.1 1.0 0.0 0.3 0.1 0.0 3.5 0.0 1.2 15.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.5 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 3.6 0.6 0.4 0.2 0.5 0.2 0.7 0.5 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.0 0.0 5.2 0.0 0.2 3.3 0.8 12.4 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 22.2 0.9 0.0 0.0 0.0 0.0 0.2 0.3 2.9 0.4 0.5 0.0 0.0 0.0 0.7 0.4 1.0 0.0 0.0 0.0 0.0 N4BP2L2 "CG005, PFAAP5" ENSG00000244754 "NEDD4 binding protein 2 like 2" Q92802 13 32432417-32538885 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039338, HPA039434, HPA059327" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039338: AB_2676453, HPA039434: AB_10673143, HPA059327: AB_2683981" "unprognostic (1.13e-1)" "unprognostic (1.72e-1)" "unprognostic (3.15e-1)" "unprognostic (5.81e-2)" "unprognostic (6.83e-2)" "unprognostic (6.51e-2)" "unprognostic (8.95e-2)" "unprognostic (6.29e-3)" "unprognostic (6.04e-2)" "unprognostic (1.87e-1)" "unprognostic (2.71e-3)" "unprognostic (2.67e-2)" "unprognostic (4.73e-3)" "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (4.03e-3)" 24.4 22.6 22.8 27.3 28.0 17.4 29.7 43.4 34.0 34.1 25.2 18.0 31.6 13.9 38.3 25.8 19.5 26.3 22.1 30.3 23.7 18.8 23.7 25.4 26.2 20.1 30.2 23.3 38.5 19.5 19.1 75.7 20.6 24.6 28.1 23.3 15.5 22.4 27.3 49.3 23.0 21.4 28.7 39.8 24.3 23.1 14.7 29.6 31.4 27.8 21.1 20.4 29.4 27.1 12.7 10.2 23.0 12.5 14.2 17.7 7.7 7.7 5.4 17.6 12.4 14.8 18.5 14.4 15.0 14.7 12.5 11.7 10.0 20.4 9.8 8.5 15.1 21.3 13.4 17.1 14.0 15.9 20.8 7.6 19.6 12.1 10.9 22.6 21.0 9.5 19.4 18.7 10.9 14.0 21.8 18.7 16.0 14.1 9.8 18.2 9.1 17.7 18.4 17.2 34.6 7.2 13.4 16.4 9.6 15.4 9.7 6.8 14.8 10.9 12.0 21.4 18.9 12.7 24.7 14.8 7.9 8.1 7.2 7.5 7.5 7.8 8.0 9.1 14.7 11.8 23.0 8.6 19.7 12.4 9.6 17.0 12.7 14.4 12.4 7.7 11.4 17.7 15.2 15.4 14.2 12.5 10.2 13.3 7.7 22.8 28.0 43.4 34.0 23.7 18.8 30.2 23.3 24.6 29.6 160.8 148.3 169.0 254.9 122.5 229.6 159.8 99.3 147.2 134.2 205.9 233.7 140.7 77.9 107.5 102.8 157.2 207.2 93.5 65.1 67.9 132.2 215.5 205.8 114.9 103.8 235.2 168.7 154.7 146.4 89.3 342.6 171.5 118.1 247.1 126.1 127.5 94.1 273.5 283.5 60.3 318.6 310.4 155.5 171.9 86.9 120.3 160.2 246.8 107.6 246.1 NAAA ASAHL ENSG00000138744 "N-acylethanolamine acid amidase" Q02083 4 75913657-75941051 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 89.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 97.1;Kupffer cells: 106.0" "Cancer enhanced" "Detected in all" "prostate cancer: 31.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "intermediate monocyte: 89.9" "Lineage enriched" "Detected in all" 5 "monocytes: 89.9" "Cell line enhanced" "Detected in many" "U-2197: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB026135 Approved "Intracellular and membrane" NA NA "CAB026135: " "unprognostic (5.30e-3)" "unprognostic (1.23e-2)" "unprognostic (1.41e-2)" "prognostic favorable (1.93e-4)" "unprognostic (1.10e-1)" "unprognostic (2.17e-2)" "unprognostic (2.92e-2)" "unprognostic (2.34e-2)" "unprognostic (2.24e-1)" "unprognostic (2.87e-2)" "prognostic favorable (4.90e-4)" "unprognostic (1.63e-1)" "unprognostic (2.15e-2)" "unprognostic (2.54e-1)" "unprognostic (3.20e-2)" "unprognostic (3.42e-3)" "unprognostic (6.21e-2)" 11.2 6.7 5.8 12.3 10.3 6.5 16.9 10.2 10.5 10.8 26.4 6.0 6.0 13.1 9.8 7.1 12.5 8.4 6.8 9.5 7.0 8.2 18.2 29.6 10.0 52.2 11.8 5.3 6.1 6.9 5.5 9.0 8.2 9.1 32.4 31.2 16.6 19.8 5.1 6.2 11.2 34.0 10.2 11.2 44.9 9.8 3.4 6.9 10.2 11.2 8.0 19.5 10.3 12.6 8.1 19.7 14.3 89.9 4.5 15.1 25.9 4.4 10.1 0.4 0.3 24.6 25.0 0.4 6.6 4.4 4.6 1.5 3.4 15.7 0.4 3.5 16.3 0.1 8.8 13.2 5.1 2.8 6.3 0.5 3.1 7.5 8.3 5.7 11.5 11.5 6.3 3.9 4.0 1.4 7.1 7.3 7.1 3.4 13.8 4.0 16.2 7.3 7.5 5.1 19.8 4.0 5.0 0.1 20.5 4.8 2.5 6.1 0.9 6.8 21.6 1.9 0.7 24.3 20.1 10.8 0.2 0.6 30.4 0.3 3.4 1.3 2.2 5.8 16.6 2.8 5.5 37.2 14.3 9.0 89.9 9.7 8.1 11.5 8.9 19.7 5.3 9.7 8.1 12.5 4.5 74.4 7.3 15.1 25.9 5.8 10.3 10.2 10.5 7.0 8.2 11.8 5.3 9.1 6.9 0.0 8.2 28.2 16.1 10.1 9.6 3.9 28.1 24.1 6.8 5.2 17.7 21.0 11.6 4.6 0.4 11.7 97.1 0.0 7.4 16.3 27.2 69.0 14.0 30.2 35.4 11.1 46.1 17.8 106.0 0.0 9.8 77.1 16.9 16.2 28.2 6.5 3.9 28.5 7.1 9.2 78.9 0.0 18.4 0.7 0.9 16.6 11.1 36.2 21.4 12.1 NAALAD2 "GCPIII, NAALADASE2" ENSG00000077616 "N-acetylated alpha-linked acidic dipeptidase 2" Q9Y3Q0 11 90131515-90192894 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 44.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 15.8;Early spermatids: 37.5;Horizontal cells: 66.7" "Cancer enhanced" "Detected in some" "testis cancer: 1.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 2.4" "Lineage enriched" "Detected in single" 12 "monocytes: 2.4" "Cell line enhanced" "Detected in some" "CACO-2: 20.0;SH-SY5Y: 6.7;SuSa: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060820, HPA065419" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA060820: AB_2684373, HPA065419: AB_2685487" "unprognostic (1.68e-1)" "unprognostic (2.66e-3)" "unprognostic (1.49e-1)" "unprognostic (4.52e-3)" "unprognostic (4.73e-3)" "unprognostic (2.97e-1)" "unprognostic (3.82e-3)" "unprognostic (1.77e-2)" "unprognostic (2.44e-1)" "unprognostic (2.30e-1)" "unprognostic (3.30e-2)" "unprognostic (8.00e-2)" "unprognostic (9.97e-4)" "unprognostic (1.52e-2)" "unprognostic (2.54e-1)" "unprognostic (1.63e-2)" "unprognostic (2.93e-1)" 7.7 13.0 5.3 1.8 9.9 1.1 3.1 2.1 9.8 7.8 2.1 3.7 2.8 1.3 10.3 5.4 1.8 4.7 3.7 2.5 5.5 7.4 2.7 1.7 2.8 1.6 6.5 5.0 12.9 2.5 0.9 44.1 8.8 11.9 5.2 2.2 5.8 1.9 3.7 2.1 1.5 2.1 3.5 6.2 4.4 1.8 16.6 7.4 0.0 1.7 1.7 1.2 1.8 3.8 0.0 0.1 0.0 2.4 0.0 0.1 0.1 0.1 0.2 1.9 0.1 0.6 0.1 2.4 0.1 0.1 0.1 0.0 20.0 0.7 0.3 0.2 0.0 0.3 0.3 1.4 0.0 0.0 0.0 0.4 1.9 0.4 1.8 0.2 0.1 0.1 2.3 0.0 0.0 0.0 0.6 0.4 0.2 0.1 0.0 0.0 0.0 0.3 0.3 1.9 0.5 0.2 0.3 0.0 0.2 0.0 0.0 0.2 6.7 0.0 0.2 0.0 4.9 0.2 0.4 2.6 0.1 1.6 0.4 0.3 1.1 0.3 0.3 0.7 0.3 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.1 0.1 5.3 9.9 2.1 9.8 5.5 7.4 6.5 5.0 11.9 7.4 0.0 0.0 0.0 0.1 0.2 15.8 0.8 2.5 0.0 1.2 0.0 0.0 0.8 0.0 0.0 37.5 0.7 0.0 0.0 0.0 0.5 3.4 0.2 0.0 0.0 0.3 66.7 0.0 1.3 5.4 13.2 10.3 0.2 0.0 0.0 0.0 10.1 0.0 0.0 13.8 0.0 2.3 0.0 4.7 0.3 4.4 0.0 0.7 0.0 0.0 0.0 NAALADL1 ENSG00000168060 "N-acetylated alpha-linked acidic dipeptidase like 1" Q9UQQ1 11 65044818-65058549 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "blood: 49.5;intestine: 123.4" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 39.3;monocytes: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 49.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.4;fHDF/TERT166: 6.8;HHSteC: 19.0;HSkMC: 12.5;SCLC-21H: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047123 Enhanced Uncertain Cytosol NA NA Cytosol "HPA047123: AB_2679942" "unprognostic (2.98e-2)" "unprognostic (2.06e-1)" "unprognostic (1.58e-1)" "unprognostic (8.76e-2)" "unprognostic (1.70e-1)" "unprognostic (1.28e-3)" "unprognostic (1.36e-1)" "unprognostic (1.40e-1)" "unprognostic (1.89e-2)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.18e-1)" "unprognostic (1.75e-4)" "unprognostic (2.10e-3)" "unprognostic (3.22e-2)" "unprognostic (1.45e-1)" "unprognostic (4.80e-2)" 4.1 0.9 1.4 3.3 1.6 7.0 4.1 1.9 1.4 6.0 54.3 1.2 2.6 7.8 7.2 1.8 2.7 4.4 3.4 3.5 1.3 0.6 2.3 1.2 3.4 5.2 1.5 1.5 6.2 1.0 0.9 2.0 1.5 1.6 4.6 2.6 3.1 2.3 4.8 2.0 1.6 123.4 4.3 1.4 5.0 2.8 1.8 1.2 1.8 1.8 2.3 2.9 3.1 5.4 8.8 4.9 49.5 6.3 22.2 12.9 7.0 0.0 0.0 0.1 0.2 0.5 5.4 0.9 2.0 0.0 2.5 1.1 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.0 0.1 0.0 0.8 0.3 0.0 0.1 3.1 19.0 0.0 0.0 12.5 0.0 2.5 0.0 0.0 3.2 0.1 0.0 0.2 0.0 0.2 0.2 0.6 0.0 0.0 0.1 0.1 0.0 0.8 0.2 0.0 9.8 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.7 0.0 0.1 0.1 49.5 6.3 10.3 9.5 4.3 4.9 8.0 7.6 4.8 4.9 8.8 8.8 4.9 1.1 22.2 2.5 0.2 12.9 7.0 1.4 1.6 1.9 1.4 1.3 0.6 1.5 1.5 1.6 1.2 0.0 0.0 8.2 3.2 3.2 1.1 1.1 2.5 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.6 9.0 39.3 0.0 0.7 0.2 5.7 0.5 19.6 0.0 2.8 9.5 1.2 16.5 7.6 1.7 10.9 6.4 15.1 22.6 0.7 10.8 0.3 14.4 17.0 0.0 0.9 0.0 13.7 1.6 2.6 2.9 0.3 11.7 0.4 0.3 NAALADL2 ENSG00000177694 "N-acetylated alpha-linked acidic dipeptidase like 2" Q58DX5 3 174438573-175810552 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 29.3" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 60.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.7;BJ hTERT+: 4.2;fHDF/TERT166: 4.9;WM-115: 4.5" "Low region specificity" "Detected in many" "HPA012413, HPA017425, CAB025586" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275" "unprognostic (7.28e-3)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (1.60e-1)" "unprognostic (2.56e-1)" "unprognostic (2.56e-1)" "unprognostic (2.29e-4)" "unprognostic (3.44e-3)" "unprognostic (5.70e-2)" "unprognostic (7.42e-2)" "unprognostic (7.85e-3)" "unprognostic (9.49e-2)" "unprognostic (3.66e-6)" "unprognostic (7.11e-2)" "unprognostic (1.48e-1)" "unprognostic (9.05e-2)" "unprognostic (2.22e-2)" 4.9 2.3 2.2 4.6 3.7 0.8 7.0 1.9 2.7 8.3 8.3 5.4 23.8 2.4 9.7 10.5 2.3 5.0 8.9 5.4 2.5 1.8 7.0 3.7 3.3 1.3 2.3 2.0 5.4 3.9 20.6 3.0 6.4 4.0 9.6 3.3 4.4 17.0 29.3 1.8 3.2 6.6 6.0 3.6 2.6 4.5 1.9 2.9 4.9 3.5 2.6 1.7 8.7 5.0 0.1 1.7 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.2 0.0 3.5 11.7 0.1 2.3 4.2 0.6 0.7 0.2 1.3 0.0 0.5 4.9 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 3.2 0.6 0.1 0.0 3.0 0.4 0.0 0.0 0.1 2.3 0.4 0.2 0.0 0.0 1.6 0.0 0.0 0.2 0.1 1.7 0.2 0.0 0.0 0.2 0.2 0.9 0.3 3.1 0.1 0.5 2.3 0.1 0.1 0.5 0.0 0.0 0.0 1.5 0.0 4.5 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.1 0.0 1.7 0.0 0.0 2.2 3.7 1.9 2.7 2.5 1.8 2.3 2.0 4.0 2.9 0.0 11.5 0.0 7.2 2.1 7.6 2.8 10.2 18.7 6.8 12.2 11.8 16.3 6.6 6.8 60.1 2.1 11.1 0.0 2.3 1.5 7.8 18.3 4.6 2.4 1.6 0.0 8.6 3.1 0.3 28.0 14.1 0.7 3.3 0.0 1.1 7.7 2.5 3.5 11.3 1.7 6.6 0.0 2.3 3.2 1.9 1.6 10.3 0.0 14.9 13.7 NAGPA "APAA, UCE" ENSG00000103174 "N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase" Q9UK23 16 5024844-5034141 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064055 Approved NA NA 3600000 "HPA064055: AB_2685183" "unprognostic (9.93e-2)" "unprognostic (1.61e-2)" "unprognostic (2.08e-2)" "unprognostic (2.21e-2)" "unprognostic (7.12e-3)" "unprognostic (3.30e-3)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.05e-2)" "unprognostic (2.98e-2)" "unprognostic (1.35e-1)" "unprognostic (9.51e-3)" "unprognostic (9.41e-2)" "prognostic unfavorable (2.67e-5)" "unprognostic (1.26e-1)" "unprognostic (6.09e-2)" "unprognostic (7.47e-2)" "unprognostic (1.02e-1)" 8.3 6.3 9.9 9.0 20.1 8.7 4.7 4.7 25.0 6.8 8.5 4.6 5.8 11.4 6.2 4.7 6.1 4.8 5.6 5.0 15.3 5.3 7.2 7.6 7.6 9.1 5.0 9.5 4.2 7.3 7.6 4.9 6.8 6.6 4.9 5.1 4.0 6.0 6.2 6.7 8.5 9.2 5.5 4.4 10.9 12.4 2.7 5.5 4.3 5.1 2.6 5.6 6.0 4.4 9.5 26.5 5.1 20.9 5.1 9.9 9.7 1.5 6.0 1.0 6.5 2.6 3.4 6.8 4.5 8.0 5.9 7.4 5.0 12.5 0.6 5.7 6.1 10.2 4.6 2.7 5.0 1.8 7.3 8.4 2.2 3.9 32.2 8.3 5.3 9.5 5.1 5.2 3.9 1.7 7.4 9.1 5.6 6.9 8.9 3.6 6.8 2.4 14.4 3.2 3.8 6.4 6.5 2.4 11.8 3.8 2.4 2.6 3.5 3.6 8.9 9.1 1.0 6.1 6.6 6.7 6.5 4.7 15.1 3.3 4.9 3.8 1.4 3.0 8.2 5.4 1.2 20.9 5.1 9.9 18.2 7.9 9.5 9.8 8.8 26.5 8.3 8.1 7.4 0.6 5.1 11.7 6.8 8.7 9.7 9.9 20.1 4.7 25.0 15.3 5.3 5.0 9.5 6.6 5.5 0.0 2.4 13.7 4.8 2.6 13.3 1.5 7.6 4.0 3.4 5.2 29.5 11.3 1.7 10.2 0.2 6.7 17.1 0.0 7.5 12.5 3.2 3.7 1.1 7.3 25.0 15.9 1.2 8.6 17.2 0.9 7.5 19.1 3.3 25.2 9.9 5.4 8.5 14.4 6.0 7.4 12.5 0.0 3.1 4.4 8.1 2.0 7.9 13.8 10.6 2.1 NALCN "bA430M15.1, CanIon, VGCNL1" ENSG00000102452 "Sodium leak channel, non-selective" Q8IZF0 13 101053776-101416492 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 14.4;Cone photoreceptor cells: 5.9;Horizontal cells: 25.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 7.8;HaCaT: 11.8;HHSteC: 12.7;hTERT-RPE1: 9.4;TIME: 15.3;U-87 MG: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031889, HPA031890, HPA031958" Approved NA NA "HPA031889: AB_10669638, HPA031890: AB_10696056, HPA031958: AB_10601039" "unprognostic (4.66e-1)" "unprognostic (6.55e-3)" "unprognostic (1.86e-3)" "unprognostic (6.78e-3)" "unprognostic (1.16e-1)" "unprognostic (1.37e-3)" "unprognostic (8.11e-2)" "unprognostic (2.60e-1)" "unprognostic (7.72e-2)" "unprognostic (5.92e-2)" "unprognostic (1.25e-1)" "unprognostic (2.18e-1)" "unprognostic (1.58e-5)" "unprognostic (1.77e-3)" "unprognostic (5.44e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" 1.5 8.3 9.8 1.4 18.3 1.6 5.2 13.4 29.4 3.6 1.3 18.6 0.0 1.1 1.5 3.4 1.1 2.6 4.6 6.0 10.8 11.4 1.2 2.3 2.7 1.0 11.0 13.1 5.6 2.1 4.2 13.0 5.6 17.0 1.3 1.7 4.3 1.6 2.5 1.0 1.6 1.4 1.3 12.7 1.3 1.8 2.0 14.1 0.0 4.8 0.0 0.8 1.6 0.6 1.4 0.8 5.4 0.5 0.9 0.9 0.3 0.1 6.6 1.3 0.2 0.6 0.3 0.1 0.7 0.6 1.6 0.4 0.1 7.8 0.0 0.4 3.1 0.8 11.8 0.0 1.8 4.2 0.0 0.8 0.4 3.8 0.1 12.7 0.2 0.2 0.2 0.5 1.4 3.9 9.4 6.9 0.0 0.1 0.4 5.0 0.0 0.1 0.0 0.3 1.1 1.4 0.0 0.0 0.0 3.9 1.6 1.0 0.2 0.1 0.1 0.6 0.7 0.2 0.1 15.3 0.4 0.1 0.3 1.6 0.0 0.1 0.0 9.7 0.0 0.3 5.4 0.5 0.8 0.9 0.3 0.4 0.7 0.5 0.5 0.1 1.4 0.6 0.5 1.8 0.9 0.2 0.8 0.4 0.3 9.8 18.3 13.4 18.2 10.8 11.4 11.0 13.1 17.0 14.1 0.0 0.0 0.0 0.0 0.2 14.4 4.5 0.0 0.0 0.0 0.0 5.9 0.9 0.0 0.5 3.5 0.3 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.1 25.4 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.8 0.0 2.4 0.0 0.3 0.2 0.7 0.1 0.5 0.0 0.0 0.0 NAT10 "FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43" ENSG00000135372 "N-acetyltransferase 10" Q9H0A0 11 34105602-34147670 "Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035546, HPA057576, HPA071628" Approved Enhanced Nucleoli,Midbody Yes No Nucleoli Midbody "CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426" "unprognostic (3.04e-1)" "unprognostic (9.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (1.07e-4)" "prognostic unfavorable (9.61e-8)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.83e-5)" "unprognostic (1.24e-1)" "unprognostic (7.18e-2)" "unprognostic (9.55e-2)" "unprognostic (8.69e-2)" 18.5 22.8 20.5 21.9 27.5 23.6 20.8 21.9 29.9 18.1 17.6 24.3 16.4 13.7 30.6 19.8 25.2 21.7 14.7 16.4 17.2 18.6 15.9 21.8 15.1 28.7 16.9 19.8 26.4 24.9 31.5 23.1 20.1 23.4 19.5 21.7 23.0 22.5 17.8 23.4 31.0 16.6 21.5 15.1 23.6 18.0 30.9 16.9 31.2 18.3 19.4 35.3 17.8 19.7 10.4 12.8 2.2 11.1 11.8 13.7 6.9 12.4 17.6 9.4 20.0 11.4 10.1 10.9 12.4 9.1 15.8 12.6 19.7 7.2 40.0 9.2 10.4 13.6 18.9 35.4 18.9 20.2 11.1 22.7 18.1 14.4 18.4 10.3 45.3 13.2 10.3 13.0 10.3 29.0 7.4 12.0 19.3 39.5 14.0 13.1 23.6 36.9 20.6 13.5 21.6 21.2 27.8 31.9 16.7 9.1 21.8 14.0 10.6 16.7 17.7 7.4 9.5 17.7 12.5 9.6 14.1 11.2 20.6 22.9 15.3 18.3 38.1 14.2 18.8 13.9 0.5 6.6 2.2 10.3 11.1 13.7 10.4 11.1 11.7 12.8 9.6 11.5 11.2 0.8 11.8 9.7 9.7 9.6 6.9 20.5 27.5 21.9 29.9 17.2 18.6 16.9 19.8 23.4 16.9 6.0 16.5 12.0 9.6 10.9 11.2 9.8 10.2 14.7 22.7 14.0 11.8 15.4 5.0 6.8 3.8 7.8 3.5 23.3 8.3 9.9 7.4 6.4 4.7 7.2 10.5 11.1 6.9 6.7 4.0 2.1 8.6 6.0 1.7 11.8 8.5 7.7 6.9 2.9 12.4 5.0 10.1 12.9 8.1 17.9 25.4 12.0 12.0 10.2 12.4 6.3 NAT14 KLP1 ENSG00000090971 "N-acetyltransferase 14 (putative)" Q8WUY8 19 55485004-55487568 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 42.2" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 60.2;Horizontal cells: 139.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047187 Approved Mitochondria NA NA Mitochondria "HPA047187: AB_2679974" "unprognostic (5.96e-2)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "unprognostic (5.43e-2)" "unprognostic (1.32e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-2)" "unprognostic (7.01e-2)" "unprognostic (1.94e-1)" "unprognostic (2.97e-1)" "unprognostic (9.12e-2)" "unprognostic (6.41e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (7.00e-2)" "unprognostic (6.74e-2)" "unprognostic (9.85e-2)" "unprognostic (1.58e-1)" 3.6 10.1 15.8 5.7 19.6 4.5 5.5 25.8 25.8 8.2 7.0 8.9 3.1 3.5 12.6 10.1 2.9 24.1 6.5 5.9 15.4 16.7 9.2 2.5 7.8 4.6 10.8 15.5 14.1 5.6 11.2 19.2 8.5 10.6 6.8 3.1 7.8 5.0 10.5 2.9 4.1 3.4 11.1 6.5 3.7 5.6 4.9 9.5 42.2 9.8 1.3 3.8 6.0 4.3 1.8 1.8 2.3 0.3 0.3 1.0 0.6 2.4 8.9 9.8 18.1 4.1 5.1 6.2 9.2 10.7 10.1 14.4 3.1 7.9 1.0 3.2 5.9 5.0 3.3 6.4 5.6 6.2 9.9 55.3 8.0 11.9 6.7 7.4 5.9 8.1 7.3 2.1 7.4 1.9 19.9 7.3 14.5 9.9 2.8 5.8 3.0 9.9 9.0 14.0 4.7 4.9 9.8 6.3 3.6 23.0 4.6 30.3 20.6 3.7 5.4 8.1 3.8 4.4 5.7 8.8 3.7 10.2 0.5 7.3 5.7 2.3 4.2 8.2 1.0 9.2 0.0 0.3 0.2 0.5 0.3 1.0 0.6 0.4 0.3 0.0 1.8 0.7 0.7 2.3 0.3 0.3 1.8 0.0 0.6 15.8 19.6 25.8 25.8 15.4 16.7 10.8 15.5 10.6 9.5 6.0 2.7 7.3 6.1 2.6 60.2 4.5 2.5 14.7 2.3 27.9 33.4 10.6 13.3 14.0 1.4 4.3 0.7 0.0 1.0 6.9 8.2 4.4 0.0 2.9 2.6 139.8 12.2 4.9 0.8 1.7 10.9 0.7 5.0 3.6 1.8 34.9 4.7 0.0 9.9 3.5 34.0 0.0 9.2 4.1 2.9 0.5 5.0 1.3 0.9 1.4 NAT2 AAC2 ENSG00000156006 "N-acetyltransferase 2" P11245 8 18391245-18401218 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 22 "intestine: 28.4;liver: 75.5" "Cell type enhanced" "Detected in some" 25 "Enterocytes: 16.0;Hepatocytes: 52.3;Paneth cells: 10.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.0;liver cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.8;RT4: 4.2;SCLC-21H: 5.8;SK-BR-3: 3.6" HPA043704 Uncertain NA NA "HPA043704: AB_2678625" "unprognostic (2.74e-3)" "unprognostic (4.03e-1)" "prognostic favorable (4.61e-5)" "unprognostic (1.43e-2)" "unprognostic (1.07e-1)" "unprognostic (1.83e-1)" "unprognostic (2.52e-2)" "unprognostic (2.67e-2)" "unprognostic (1.27e-1)" "unprognostic (1.33e-2)" "unprognostic (4.07e-1)" "unprognostic (6.05e-3)" "unprognostic (1.02e-1)" "unprognostic (3.40e-1)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" 0.2 0.1 0.2 2.3 0.3 0.0 0.3 0.1 0.2 0.3 14.0 0.1 0.1 13.0 0.4 0.4 0.1 0.2 0.3 0.4 0.1 0.1 0.6 75.5 0.2 0.1 0.2 0.2 0.2 0.1 0.0 0.2 0.2 0.3 0.3 5.1 0.1 0.1 0.1 0.1 0.1 28.4 0.4 0.2 0.6 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.3 0.0 1.8 0.0 0.2 0.0 1.4 0.0 0.0 0.3 0.3 0.1 0.5 0.1 0.5 0.1 0.7 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 1.0 0.9 0.0 0.0 0.9 0.0 2.8 4.2 5.8 0.1 0.1 3.6 0.0 0.5 1.0 0.6 1.5 1.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.2 0.1 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 5.0 0.0 0.1 0.0 16.0 0.0 0.0 0.8 0.0 0.1 0.0 52.3 0.2 0.0 0.0 0.6 0.6 0.0 0.6 0.0 0.0 0.0 7.5 0.0 0.1 10.1 2.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 4.2 0.0 NAT8 "ATase2, GLA, Hcml1, TSC501" ENSG00000144035 "N-acetyltransferase 8 (putative)" Q9UHE5 2 73640832-73642393 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 140.4" "Cell type enriched" "Detected in some" 12 "Proximal tubular cells: 1951.9" "Cancer enriched" "Detected in some" 5 "renal cancer: 242.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "Hep G2: 16.9" "Low region specificity" "Detected in all" "HPA067855, HPA074519" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA067855: AB_2732774, HPA074519: AB_2686699" "unprognostic (4.51e-2)" "unprognostic (6.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (4.95e-3)" "unprognostic (2.46e-1)" "unprognostic (1.90e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-1)" "unprognostic (2.13e-2)" "unprognostic (8.60e-2)" "unprognostic (1.37e-3)" "unprognostic (2.07e-2)" "unprognostic (4.11e-3)" "unprognostic (2.13e-2)" "unprognostic (8.36e-5)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 140.4 15.8 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 1.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 16.9 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 159.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 40.4 0.0 0.0 0.0 22.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1951.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NAT8L "FLJ37478, Hcml3" ENSG00000185818 "N-acetyltransferase 8 like" Q8N9F0 4 2059512-2069089 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 45.9;brain: 45.9;testis: 11.8" "Group enriched" "Detected in some" 5 "Horizontal cells: 76.3;Muller glia cells: 25.6" "Group enriched" "Detected in many" 6 "endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 3.8" "Lineage enriched" "Detected in single" 28 "dendritic cells: 3.8" "Cell line enhanced" "Detected in many" "NB-4: 14.7;SCLC-21H: 19.0;SK-MEL-30: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040677 Approved Mitochondria NA NA Mitochondria "HPA040677: AB_2732486" "unprognostic (1.32e-2)" "unprognostic (8.62e-2)" "unprognostic (3.02e-3)" "prognostic unfavorable (1.01e-5)" "unprognostic (2.56e-1)" "unprognostic (2.63e-4)" "unprognostic (6.58e-2)" "unprognostic (1.79e-1)" "unprognostic (2.90e-2)" "unprognostic (4.54e-1)" "unprognostic (3.70e-2)" "unprognostic (7.06e-2)" "unprognostic (1.78e-3)" "unprognostic (7.24e-3)" "unprognostic (1.14e-2)" "unprognostic (2.10e-2)" "unprognostic (1.35e-2)" 45.9 2.0 23.5 1.3 28.3 1.2 7.9 16.4 45.9 1.2 1.5 7.4 0.3 1.3 1.6 2.8 1.3 2.4 1.3 2.1 20.8 12.9 8.2 1.2 1.2 1.4 16.4 12.6 1.4 3.9 1.2 5.6 1.3 12.8 2.4 1.3 1.2 3.8 3.2 7.3 2.4 1.5 1.4 6.5 1.5 1.6 11.8 8.2 0.0 1.6 0.0 1.2 1.2 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 6.6 3.6 7.3 0.7 0.0 4.2 0.1 0.0 0.2 0.0 2.9 0.2 0.0 1.3 0.0 1.1 0.1 8.2 0.0 0.1 0.0 9.6 0.1 1.4 4.7 1.2 10.1 5.0 0.0 0.1 0.0 0.0 1.4 0.0 2.5 7.8 0.0 0.3 4.4 0.1 14.7 10.3 0.0 3.0 0.5 1.7 0.2 0.1 0.3 19.0 6.3 4.8 0.0 15.1 0.6 0.5 5.9 0.0 0.0 2.5 0.1 3.9 0.0 0.0 0.1 0.0 4.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 23.5 28.3 16.4 32.7 20.8 12.9 16.4 12.6 12.8 8.2 0.0 0.0 0.0 0.0 0.2 7.1 2.0 0.0 0.0 0.0 1.8 5.9 0.0 0.0 4.2 0.8 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.7 76.3 1.7 0.0 0.0 3.1 0.0 0.1 10.1 0.0 0.0 25.6 0.5 0.0 0.0 0.0 4.7 0.0 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 NAXD "CARKD, FLJ10769, LP3298" ENSG00000213995 "NAD(P)HX dehydratase" Q8IW45 13 110615460-110639993 "Enzymes, Predicted intracellular proteins" Lyase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 28.5;Distal tubular cells: 33.2;Extravillous trophoblasts: 22.2;Syncytiotrophoblasts: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010551 Uncertain NA NA 230000 "HPA010551: AB_1848669" "unprognostic (1.24e-1)" "unprognostic (5.14e-2)" "unprognostic (1.79e-2)" "prognostic favorable (3.15e-4)" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (3.48e-2)" "unprognostic (2.89e-1)" "unprognostic (3.20e-1)" "unprognostic (9.01e-2)" "unprognostic (1.94e-2)" "unprognostic (4.36e-3)" "prognostic favorable (4.63e-5)" "unprognostic (2.19e-2)" "unprognostic (1.27e-1)" "unprognostic (2.30e-1)" "unprognostic (1.62e-2)" 9.1 22.8 17.3 10.9 20.5 4.6 12.5 20.4 25.0 11.5 17.2 19.0 18.0 11.6 13.9 15.3 16.3 14.0 13.6 14.7 20.9 12.0 14.3 30.4 12.1 11.7 15.0 19.4 28.8 24.8 12.7 15.2 14.7 14.8 16.5 12.4 12.7 12.7 21.2 15.1 20.8 12.6 13.7 13.8 13.2 16.7 17.9 17.0 9.2 15.5 10.5 9.9 12.7 11.8 7.3 7.6 0.7 6.9 6.2 8.5 6.1 10.9 5.0 8.3 6.4 10.8 6.6 14.3 8.5 8.0 9.3 9.6 17.1 11.3 2.0 9.3 6.6 8.0 9.1 4.7 8.9 4.5 8.3 10.5 7.1 15.7 9.5 10.5 9.4 6.7 9.3 16.5 5.9 6.6 10.6 9.8 9.1 6.0 0.1 7.3 11.9 6.9 17.9 7.5 19.6 6.1 2.3 3.2 2.5 9.9 9.4 14.5 8.6 4.9 26.3 5.9 5.7 12.0 15.7 5.7 6.3 5.2 0.1 6.7 7.7 5.2 0.1 10.1 2.1 8.2 0.0 5.9 0.5 8.5 6.9 5.4 7.3 7.7 7.6 7.4 6.5 8.3 8.2 0.7 6.2 4.5 7.6 8.4 6.1 17.3 20.5 20.4 25.0 20.9 12.0 15.0 19.4 14.8 17.0 17.9 10.1 0.0 0.0 0.0 0.0 0.0 0.0 16.0 18.2 21.0 0.0 28.5 33.2 12.7 0.0 0.0 0.0 0.0 10.3 22.2 0.0 0.0 1.1 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 18.0 0.0 0.0 10.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.0 NBAS NAG ENSG00000151779 "Neuroblastoma amplified sequence" A2RRP1 2 15166909-15561330 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036817 Approved Approved "Nuclear membrane,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nuclear membrane, Nucleoli" "HPA036817: AB_10670925" "unprognostic (1.72e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.33e-1)" "unprognostic (1.55e-1)" "unprognostic (1.53e-2)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-1)" "prognostic unfavorable (5.84e-5)" 16.8 18.1 23.2 16.3 30.9 21.9 22.5 21.5 28.3 21.9 17.1 20.6 17.4 13.3 27.1 23.4 14.1 18.7 13.5 21.6 20.9 21.5 19.1 16.9 15.4 16.3 19.3 20.8 24.1 28.6 34.1 35.5 16.2 24.9 16.9 17.7 16.8 22.9 19.0 26.5 23.4 20.5 21.0 18.1 18.1 19.0 31.4 16.7 23.8 20.1 14.6 20.0 14.4 15.2 5.3 6.0 3.2 8.7 9.4 9.9 3.6 5.5 7.3 8.1 5.6 21.3 23.4 8.4 10.3 11.3 8.0 8.1 7.3 8.0 7.1 2.3 15.6 8.3 6.7 8.8 12.9 9.6 7.0 5.6 27.1 6.5 20.4 21.9 7.0 13.8 15.4 10.3 10.6 17.8 16.6 16.5 10.1 21.0 8.2 12.2 6.8 5.8 15.8 7.0 9.0 7.0 6.2 14.3 8.4 16.6 7.5 4.8 7.8 8.7 7.2 12.9 10.6 5.1 6.4 14.3 10.2 6.3 7.2 7.4 12.2 10.3 10.1 18.1 8.2 9.1 1.4 5.7 3.2 7.6 3.9 9.5 5.3 5.9 9.9 5.2 5.1 5.9 6.1 1.0 9.4 8.7 6.0 6.9 3.6 23.2 30.9 21.5 28.3 20.9 21.5 19.3 20.8 24.9 16.7 17.9 14.4 12.9 8.3 6.5 15.6 26.3 22.9 25.4 13.6 17.4 27.5 9.8 0.0 9.6 29.5 10.5 11.9 0.0 12.1 11.2 8.0 7.9 37.0 7.8 7.7 12.7 7.0 7.4 9.5 46.9 10.6 8.2 5.0 19.0 13.5 15.2 8.1 9.3 15.6 7.7 22.9 0.0 11.7 30.4 16.6 9.8 8.7 11.8 11.0 5.8 NBPF10 AG1 ENSG00000271425 "NBPF member 10" 1 146064699-146144804 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 71.5;Basal keratinocytes: 50.6;Suprabasal keratinocytes: 92.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.05e-1)" "unprognostic (8.84e-2)" "unprognostic (5.84e-2)" "unprognostic (5.61e-3)" "unprognostic (1.06e-1)" "unprognostic (5.16e-3)" "unprognostic (3.26e-1)" "unprognostic (2.17e-1)" "unprognostic (9.49e-2)" "unprognostic (6.64e-5)" "unprognostic (1.60e-1)" "unprognostic (6.01e-2)" "unprognostic (1.11e-3)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (9.61e-2)" "unprognostic (6.68e-2)" 1.5 0.0 0.9 3.3 2.3 0.0 3.0 0.9 0.0 1.6 1.9 1.0 1.3 0.5 0.0 0.4 1.2 1.3 0.6 3.2 1.1 1.5 0.7 1.1 1.1 0.3 1.3 0.0 4.2 0.0 1.5 2.0 0.1 1.2 0.7 0.6 0.2 1.3 2.4 3.7 1.5 0.4 0.4 0.2 5.3 1.4 3.2 2.3 11.3 13.4 2.8 3.1 4.1 3.1 3.2 1.4 2.5 2.5 0.6 6.0 2.7 2.6 3.8 4.1 6.4 2.8 2.4 5.4 3.8 0.7 4.5 2.5 1.7 12.3 4.0 8.3 8.5 10.4 3.7 1.4 1.7 7.6 6.7 6.7 1.0 2.1 1.5 1.5 4.4 1.3 2.0 3.2 2.4 3.6 0.3 0.4 4.7 4.7 1.6 5.5 3.8 3.1 11.3 3.1 2.7 2.8 3.8 4.7 1.9 3.0 2.8 2.7 2.4 0.8 1.5 1.8 0.4 1.1 0.2 1.1 0.2 0.3 0.7 1.3 0.4 0.3 3.7 0.4 1.2 2.4 0.3 0.2 71.5 40.3 0.5 3.4 50.6 0.5 7.2 0.0 14.7 12.5 0.0 0.0 0.6 0.0 4.1 6.4 3.6 1.3 0.0 2.3 4.1 26.7 1.3 18.6 1.3 1.3 0.0 0.0 1.3 4.6 1.3 6.1 18.6 28.7 1.8 2.6 1.7 4.4 28.3 7.8 0.0 2.2 0.0 30.9 9.0 4.3 92.5 0.5 1.8 3.0 3.4 NCAM1 "CD56, NCAM" ENSG00000149294 "Neural cell adhesion molecule 1" P13591 11 112961247-113278436 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 110.6;heart muscle: 67.7" "Group enriched" "Detected in many" 4 "Bipolar cells: 108.7;Cardiomyocytes: 109.4;Horizontal cells: 165.3;Muller glia cells: 263.9;Rod photoreceptor cells: 95.4" "Cancer enriched" "Detected in many" 8 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 14 "NK-cell: 27.2" "Lineage enriched" "Detected in many" 14 "NK-cells: 27.2" "Cell line enhanced" "Detected in some" "HEL: 19.5;RH-30: 44.0;SCLC-21H: 35.8;SH-SY5Y: 17.6;U-138 MG: 24.5;WM-115: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000142, CAB018071, HPA039835" Enhanced Enhanced "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 1200000 2800000000 "Plasma membrane" Cytosol "CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705" "unprognostic (7.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.77e-2)" "unprognostic (2.18e-2)" "unprognostic (2.91e-1)" "unprognostic (1.74e-3)" "unprognostic (2.82e-1)" "unprognostic (4.42e-3)" "unprognostic (2.13e-1)" "unprognostic (1.63e-2)" "prognostic favorable (9.11e-6)" "unprognostic (8.13e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.97e-2)" "unprognostic (2.24e-1)" "unprognostic (3.75e-2)" "unprognostic (5.82e-5)" 3.5 36.4 22.7 3.0 35.7 1.8 2.1 20.2 110.6 13.3 9.0 55.8 0.3 3.4 24.7 3.0 4.8 8.3 3.6 67.7 22.5 19.2 2.3 2.6 2.0 1.7 45.0 27.1 21.9 2.3 1.1 9.1 1.4 38.8 8.4 4.6 5.5 2.5 10.9 14.6 1.8 5.3 25.6 27.6 3.4 6.7 2.9 39.2 0.0 16.9 0.7 1.7 7.0 6.5 0.0 0.0 0.4 0.1 27.2 2.0 0.9 0.0 0.0 6.9 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.4 0.1 0.1 1.0 6.1 6.5 0.2 0.1 0.0 0.0 0.0 0.1 3.9 19.5 0.0 0.0 0.7 0.0 3.1 4.2 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.3 6.8 0.0 0.0 1.6 0.6 0.0 0.1 0.0 44.0 3.1 0.0 0.0 35.8 17.6 0.0 0.1 0.0 0.7 0.0 0.2 0.0 24.5 11.4 0.1 10.2 0.0 0.1 0.0 2.7 9.2 25.9 0.0 0.1 0.0 2.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.4 27.2 0.0 0.0 0.1 0.9 22.7 35.7 20.2 41.6 22.5 19.2 45.0 27.1 38.8 39.2 0.0 0.0 0.0 0.4 1.4 108.7 109.4 0.0 1.4 0.0 0.0 35.3 0.5 1.7 14.4 4.5 0.3 0.0 0.0 0.0 0.2 7.6 0.3 1.1 0.5 0.4 165.3 5.2 6.7 5.1 3.9 14.1 1.7 0.0 0.0 0.0 263.9 1.7 0.0 9.6 0.0 95.4 0.0 3.8 0.5 2.3 1.5 0.1 11.4 0.0 0.1 NCAM2 "MGC51008, NCAM21" ENSG00000154654 "Neural cell adhesion molecule 2" O15394 21 20998315-21543329 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 15.9;brain: 52.7" "Group enriched" "Detected in some" 4 "Early spermatids: 44.1;Late spermatids: 20.9" "Cancer enhanced" "Detected in some" "glioma: 5.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "T-47d: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030900, HPA030901" Enhanced Supported Supported "Nuclear bodies,Plasma membrane" No No 100000000 "Nuclear bodies, Plasma membrane" "HPA030900: AB_10602037, HPA030901: AB_2673650" "unprognostic (9.70e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (2.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.81e-1)" "unprognostic (1.37e-2)" "unprognostic (3.01e-2)" "unprognostic (5.90e-2)" "unprognostic (1.62e-1)" "unprognostic (1.31e-1)" "unprognostic (5.61e-1)" "unprognostic (3.07e-4)" "unprognostic (2.47e-4)" "unprognostic (1.62e-1)" "unprognostic (8.05e-2)" "unprognostic (1.35e-3)" 2.0 15.9 25.8 2.0 22.3 1.1 3.1 7.0 52.7 3.3 2.1 14.7 0.0 1.3 2.3 1.8 1.7 1.8 2.6 3.1 18.7 13.9 1.3 9.1 4.4 1.2 21.6 19.4 1.4 1.3 1.1 1.0 1.7 17.9 2.2 2.4 0.5 1.8 2.3 1.5 2.0 1.9 2.7 17.3 2.0 1.3 8.3 26.6 0.0 1.5 0.0 1.3 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.6 0.0 1.1 0.0 0.0 5.7 0.0 1.7 0.0 0.2 0.0 0.0 5.3 1.2 0.1 7.2 0.1 0.0 0.2 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 2.6 0.0 0.4 0.3 0.0 45.2 3.4 0.0 0.6 0.4 0.0 0.0 0.3 0.0 0.0 1.2 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 22.3 7.0 22.4 18.7 13.9 21.6 19.4 17.9 26.6 3.0 2.2 0.0 0.2 0.5 0.2 1.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 44.1 0.0 0.0 0.0 0.0 0.4 2.4 0.8 0.0 0.0 0.3 0.0 0.0 3.7 0.0 20.9 0.9 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.1 3.3 8.0 0.1 0.2 0.0 0.0 0.1 NCEH1 "AADACL1, KIAA1363, NCEH" ENSG00000144959 "Neutral cholesterol ester hydrolase 1" Q6PIU2 3 172630249-172711218 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 15.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 70.8;LHCN-M2: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026888, HPA043873" Enhanced Approved "Endoplasmic reticulum" No No "Endoplasmic reticulum" "HPA026888: AB_10601557, HPA043873: " "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (5.74e-2)" "unprognostic (1.27e-1)" "unprognostic (6.88e-3)" "unprognostic (5.41e-2)" "unprognostic (3.29e-2)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (8.25e-5)" "unprognostic (5.29e-2)" "unprognostic (2.96e-2)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (2.81e-2)" "unprognostic (2.28e-1)" 17.0 14.8 6.5 7.1 23.8 6.0 5.1 14.3 30.1 4.1 9.8 2.3 1.4 3.5 3.9 2.9 4.4 3.5 6.0 14.6 13.2 9.6 18.8 4.2 17.0 11.2 6.6 11.4 2.5 4.0 6.3 4.2 5.7 17.7 6.0 10.7 4.3 8.2 4.2 6.6 2.7 4.1 2.9 5.0 9.1 10.9 2.0 4.0 1.9 3.9 3.1 9.3 5.1 3.4 3.0 10.6 4.8 15.1 2.8 2.3 4.8 23.3 13.6 0.4 0.7 0.8 0.9 1.9 17.6 11.7 11.7 6.8 3.4 70.8 1.9 26.5 10.6 11.2 4.7 0.5 8.6 27.2 6.5 1.1 1.3 2.2 2.6 1.0 3.5 4.9 0.4 0.8 8.0 12.0 11.0 7.8 1.0 0.3 1.7 33.1 1.9 0.5 1.2 0.6 6.6 11.2 0.5 1.3 2.4 20.9 3.1 0.4 0.2 10.6 11.2 2.3 0.8 3.8 1.6 21.1 18.0 2.7 8.4 31.8 2.0 3.8 1.6 13.4 3.4 13.6 4.8 15.1 0.5 2.3 9.6 1.5 3.0 1.5 1.6 10.6 1.9 1.5 1.8 0.5 2.8 6.2 0.6 1.3 4.8 6.5 23.8 14.3 30.1 13.2 9.6 6.6 11.4 17.7 4.0 44.7 19.9 6.4 16.9 6.1 12.9 27.7 25.5 30.8 28.4 15.7 21.6 6.2 3.3 54.9 4.5 8.7 13.1 46.7 26.6 3.8 6.1 23.2 4.7 1.6 48.4 4.8 7.5 5.5 34.7 2.6 0.9 14.5 5.0 1.8 9.7 4.9 50.0 10.5 2.5 25.4 19.2 6.5 5.8 0.0 0.9 3.0 8.8 3.8 6.0 22.8 NCLN "NET59, NICALIN" ENSG00000125912 Nicalin Q969V3 19 3185563-3209575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006625 Approved Approved "Nucleoplasm,Lipid droplets" NA NA 12000 "Lipid droplets" Nucleoplasm "HPA006625: AB_1079453" "unprognostic (4.32e-2)" "unprognostic (1.88e-1)" "unprognostic (1.89e-1)" "prognostic favorable (1.19e-4)" "unprognostic (8.55e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (9.38e-2)" "unprognostic (2.02e-2)" "unprognostic (1.26e-3)" "prognostic unfavorable (8.37e-5)" "prognostic favorable (8.82e-5)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" 15.8 27.4 10.2 18.2 15.3 31.1 10.2 21.2 23.6 9.3 20.4 14.7 14.9 32.9 12.7 7.2 14.1 11.0 15.5 10.5 12.2 8.5 13.3 48.3 15.5 19.8 9.7 9.0 12.1 41.3 9.5 11.5 11.3 10.8 13.3 9.7 13.0 18.7 9.9 16.3 14.9 27.8 9.5 8.0 20.6 18.9 17.2 12.1 11.8 11.8 11.8 13.2 9.4 11.8 5.3 17.8 8.8 12.2 4.3 7.7 7.1 27.0 31.6 7.9 24.4 7.8 6.4 20.5 29.8 12.5 22.5 18.3 42.8 15.7 16.3 26.0 19.5 14.4 32.1 9.3 22.7 5.0 21.4 21.4 11.4 19.5 29.1 15.5 20.3 21.3 11.2 14.4 18.1 9.9 5.7 12.4 16.2 29.2 18.3 10.2 24.0 17.6 21.7 22.2 16.1 22.4 28.6 8.4 26.0 13.3 18.6 17.0 16.8 12.0 22.5 18.9 4.0 16.3 23.4 16.7 19.5 17.0 31.8 35.9 23.0 20.8 12.6 20.6 26.1 29.9 1.1 11.9 8.8 6.9 12.2 6.1 5.3 4.2 7.7 8.7 4.4 4.6 6.1 7.3 4.3 4.9 17.8 3.8 7.1 10.2 15.3 21.2 23.6 12.2 8.5 9.7 9.0 10.8 12.1 14.9 17.1 21.6 7.6 7.3 14.5 8.7 17.8 5.3 9.1 10.4 9.8 17.5 3.3 30.0 12.3 11.3 71.0 0.0 31.8 38.3 11.6 13.6 16.1 39.4 37.7 22.3 12.1 14.7 22.2 39.2 8.6 12.5 13.5 14.4 38.1 5.0 30.8 40.3 8.5 10.3 12.2 12.9 10.3 12.5 18.3 10.9 14.2 12.8 53.7 13.3 NCMAP "C1orf130, FLJ42528, MP11" ENSG00000184454 "Non-compact myelin associated protein" Q5T1S8 1 24556111-24609328 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 28.8;placenta: 21.2" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 2: 15.3;Ductal cells: 15.9;Exocrine glandular cells: 41.1;Pancreatic endocrine cells: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.1;RPTEC TERT1: 3.4;T-47d: 8.1;U-266/70: 6.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013656 Uncertain NA NA "HPA013656: AB_2275006" "unprognostic (3.38e-2)" "unprognostic (3.52e-2)" "unprognostic (2.79e-1)" "prognostic favorable (2.83e-6)" "unprognostic (3.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" "unprognostic (4.14e-1)" "unprognostic (1.73e-1)" "unprognostic (2.41e-2)" "unprognostic (1.04e-1)" "unprognostic (3.28e-3)" "unprognostic (9.88e-2)" "unprognostic (9.53e-2)" "unprognostic (1.63e-2)" "unprognostic (7.27e-3)" 0.6 0.2 0.6 0.5 0.7 0.6 4.6 0.2 0.7 1.3 7.0 1.3 0.0 6.3 0.5 1.8 0.5 1.1 15.0 0.5 0.8 0.6 2.2 5.8 4.7 0.2 1.0 0.1 0.2 28.8 0.0 9.1 21.2 0.8 2.1 0.2 1.3 13.4 0.0 0.6 0.6 7.5 0.2 2.2 0.3 5.7 0.2 1.1 0.2 5.3 0.7 1.4 0.9 0.3 1.4 1.0 2.7 0.9 0.7 0.8 0.1 0.2 4.1 0.1 0.1 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.2 1.8 0.4 1.1 0.0 0.1 0.3 0.6 0.0 0.0 0.2 0.1 0.4 0.3 1.9 0.0 0.2 0.4 0.0 0.2 0.1 0.0 0.3 0.0 0.3 0.2 0.5 0.0 0.4 0.2 0.4 0.2 1.5 0.0 0.4 0.1 1.1 3.4 1.1 0.4 0.3 0.2 0.3 0.0 1.1 8.1 0.2 0.5 0.2 0.3 0.5 0.2 6.4 0.8 0.1 0.1 0.2 0.3 2.7 0.9 0.6 0.5 0.3 0.4 0.8 0.5 0.4 0.2 1.4 0.7 0.8 2.0 0.7 0.4 1.0 0.3 0.1 0.6 0.7 0.2 0.7 0.8 0.6 1.0 0.1 0.8 1.1 3.0 15.3 0.0 1.7 0.0 0.0 1.1 0.0 1.4 2.3 3.5 3.9 1.0 0.0 15.9 0.0 0.0 0.7 0.0 41.1 0.2 0.4 2.8 1.1 1.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.3 1.8 0.6 3.2 14.2 1.4 0.0 0.7 0.4 0.0 0.3 0.0 0.2 0.1 7.8 0.0 0.8 1.7 NCR1 "CD335, LY94, NK-p46, NKP46" ENSG00000189430 "Natural cytotoxicity triggering receptor 1" O76036 19 54906150-54916140 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 5.5;lymphoid tissue: 13.9" "Cell type enriched" "Detected in some" 9 "T-cells: 10.9" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049311 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA049311: AB_2680707" "unprognostic (3.92e-2)" "unprognostic (2.21e-3)" "unprognostic (1.67e-1)" "unprognostic (2.87e-4)" "unprognostic (2.89e-1)" "unprognostic (6.32e-4)" "unprognostic (2.22e-2)" "unprognostic (3.29e-1)" "unprognostic (1.07e-1)" "unprognostic (1.89e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-5)" "unprognostic (1.82e-2)" "unprognostic (5.92e-2)" "unprognostic (3.81e-3)" "unprognostic (6.05e-3)" 1.4 0.2 0.1 3.7 0.4 2.1 0.3 0.1 0.3 0.3 2.1 0.0 0.5 0.1 1.2 1.3 0.3 0.2 2.1 1.9 0.2 0.2 0.3 2.5 5.5 3.8 0.2 0.0 0.2 0.1 0.1 0.2 0.4 0.0 0.6 0.2 1.0 0.4 0.1 0.3 0.5 3.4 1.2 0.2 13.9 0.3 0.4 0.0 2.0 0.3 0.1 2.6 0.7 0.3 0.2 0.2 1.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.2 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.4 0.1 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.1 NCR2 "CD336, LY95, NK-p44" ENSG00000096264 "Natural cytotoxicity triggering receptor 2" O95944 6 41335655-41350887 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 8.5;intestine: 3.3;lymphoid tissue: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "NK-cell: 2.5;plasmacytoid DC: 8.5" "Group enriched" "Detected in many" 13 "dendritic cells: 8.5;NK-cells: 2.5" "Cell line enhanced" "Detected in some" "HMC-1: 1.6;JURKAT: 1.7;MOLT-4: 1.9" HPA067249 Uncertain NA NA "HPA067249: AB_2685811" "unprognostic (5.81e-2)" "unprognostic (3.39e-1)" "unprognostic (1.95e-1)" "unprognostic (2.12e-2)" "unprognostic (1.65e-1)" 0.1 0.1 0.1 1.9 0.1 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 2.8 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.1 0.2 0.0 0.1 2.5 0.1 0.0 0.6 0.1 0.3 0.0 1.2 0.1 1.7 3.7 0.0 0.1 0.0 8.5 0.0 0.0 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 8.5 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 NCR3 "1C7, CD337, LY117, NKp30" ENSG00000204475 "Natural cytotoxicity triggering receptor 3" O14931 6 31588895-31592985 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 28.5;lymphoid tissue: 18.5" "Group enriched" "Detected in some" 5 "B-cells: 22.0;T-cells: 69.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "MAIT T-cell: 28.5" "Lineage enriched" "Detected in many" 4 "T-cells: 28.5" "Cell line enriched" "Detected in some" 4 "NB-4: 9.5" NA NA "unprognostic (3.99e-3)" "unprognostic (9.23e-4)" "unprognostic (1.23e-3)" "unprognostic (2.49e-4)" "unprognostic (2.15e-1)" "unprognostic (2.57e-4)" "unprognostic (5.99e-2)" "unprognostic (1.15e-2)" "unprognostic (1.40e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-1)" "unprognostic (1.81e-1)" "unprognostic (2.21e-4)" "unprognostic (1.72e-1)" "unprognostic (1.83e-1)" "unprognostic (8.17e-2)" "unprognostic (1.43e-1)" 1.8 0.1 0.2 10.5 0.2 4.3 0.3 0.1 0.1 0.1 0.4 0.0 0.0 0.2 0.3 0.5 0.9 0.2 0.3 1.2 0.6 0.1 0.5 1.3 3.9 11.4 0.2 0.0 0.5 1.1 0.0 0.1 0.8 0.1 0.3 0.3 0.1 8.4 0.4 0.1 0.3 5.8 0.2 0.2 18.5 0.4 0.8 0.0 3.6 0.4 0.1 12.8 1.0 0.3 6.1 0.0 0.1 0.2 6.4 28.5 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 10.5 0.0 28.5 6.1 1.2 5.2 0.0 4.4 0.5 3.3 0.1 6.4 0.2 0.0 1.7 2.5 0.2 0.2 0.1 0.1 0.6 0.1 0.2 0.0 0.1 0.0 0.0 3.4 22.0 0.0 3.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 9.2 0.2 0.3 0.0 0.0 1.8 1.2 0.0 0.3 0.4 3.3 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.5 0.6 1.5 0.1 69.1 0.0 0.0 NCR3LG1 "B7-H6, DKFZp686O24166" ENSG00000188211 "Natural killer cell cytotoxicity receptor 3 ligand 1" Q68D85 11 17351726-17377341 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9;parathyroid gland: 15.4" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 8.1;Early spermatids: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.5" "Lineage enriched" "Detected in single" 4 "T-cells: 2.5" "Cell line enhanced" "Detected in many" "HL-60: 29.3;K-562: 16.6" HPA024137 Uncertain NA NA 7300 "HPA024137: AB_1859534" "unprognostic (1.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.52e-2)" "unprognostic (1.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.05e-1)" "unprognostic (7.03e-5)" "unprognostic (6.24e-2)" "unprognostic (1.09e-1)" "unprognostic (3.59e-1)" "unprognostic (2.62e-1)" "unprognostic (2.36e-1)" "prognostic favorable (4.21e-12)" "unprognostic (7.88e-3)" "unprognostic (1.72e-1)" "unprognostic (3.52e-3)" "unprognostic (1.36e-1)" 2.4 1.4 1.6 2.2 9.4 3.1 1.4 14.9 14.1 1.7 6.2 1.1 0.0 8.1 2.1 1.1 2.0 3.5 2.4 2.4 1.9 2.9 5.0 1.3 2.7 1.1 1.5 5.3 3.2 2.2 15.4 7.9 0.9 4.3 1.5 9.6 3.6 2.0 1.4 1.2 2.0 10.1 2.1 1.2 1.3 2.4 4.2 0.4 0.4 4.9 1.0 1.4 1.6 2.1 0.0 0.3 0.0 0.6 0.0 2.5 0.1 2.1 0.7 5.0 0.7 1.8 4.8 0.3 1.6 3.0 2.2 5.2 4.0 0.8 12.4 0.2 1.7 0.6 2.2 8.1 2.0 1.8 2.1 13.5 11.3 5.2 3.9 7.4 29.3 0.5 3.9 1.0 3.0 7.4 0.9 2.4 4.6 16.6 0.0 0.7 0.2 2.8 2.6 0.3 7.9 1.2 0.9 2.6 0.1 1.8 0.7 5.4 2.0 1.7 0.4 1.5 0.0 1.2 6.6 3.4 0.4 0.7 1.3 0.8 1.4 2.4 14.3 2.2 9.9 1.0 0.0 0.6 0.0 0.6 0.3 2.5 0.0 0.1 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.1 1.6 9.4 14.9 14.1 1.9 2.9 1.5 5.3 4.3 0.4 0.0 1.3 0.0 1.9 2.3 6.0 0.7 2.5 8.1 2.3 1.8 2.0 0.0 0.0 2.0 12.5 0.3 4.1 0.0 0.7 0.0 1.3 1.4 0.0 0.4 1.0 4.8 1.7 5.5 0.6 1.0 0.6 2.6 3.3 0.0 5.0 1.1 0.9 3.5 0.4 0.6 1.1 0.0 2.1 0.7 1.1 3.1 1.3 1.0 7.2 1.0 NCSTN "APH2, KIAA0253" ENSG00000162736 Nicastrin Q92542 1 160343272-160358952 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021982, HPA054846, HPA070642" Approved Approved Cytosol NA NA 120000 Cytosol "CAB021982: , HPA054846: AB_2682624, HPA070642: AB_2686289" "unprognostic (1.08e-1)" "unprognostic (5.22e-3)" "unprognostic (1.51e-1)" "unprognostic (2.89e-2)" "unprognostic (1.19e-2)" "unprognostic (2.22e-2)" "unprognostic (1.69e-3)" "unprognostic (2.89e-1)" "unprognostic (3.30e-2)" "unprognostic (3.62e-2)" "unprognostic (8.21e-2)" "unprognostic (2.06e-2)" "prognostic unfavorable (7.75e-9)" "unprognostic (1.36e-3)" "unprognostic (3.15e-1)" "unprognostic (3.14e-2)" "unprognostic (4.89e-2)" 25.6 23.8 12.7 15.3 20.9 12.8 23.3 15.8 24.3 21.8 24.1 39.0 16.5 31.7 24.1 23.3 23.3 19.9 19.5 23.7 13.8 13.9 25.3 37.8 24.7 19.8 28.2 14.2 29.5 41.3 38.9 21.8 63.3 21.5 18.5 24.6 25.1 49.2 19.6 24.2 20.2 38.5 20.7 25.4 25.8 21.4 22.4 22.8 20.3 25.9 13.6 20.6 26.1 20.1 12.5 28.8 27.0 30.5 13.1 11.1 16.8 10.4 12.9 22.2 18.1 68.0 34.4 24.5 21.5 39.4 20.9 24.6 10.0 30.8 7.7 44.8 44.0 14.5 17.8 10.0 20.5 17.7 12.3 8.8 7.3 16.0 15.0 27.0 15.8 33.7 35.0 20.4 19.9 20.8 45.9 30.6 11.9 13.6 22.2 29.8 7.3 5.6 8.3 18.1 27.3 7.2 7.7 13.7 21.7 29.2 14.6 7.4 16.7 23.2 26.5 15.7 37.0 23.7 39.5 24.6 15.7 10.3 10.9 16.3 28.8 40.7 7.7 24.5 10.0 28.6 17.8 29.9 25.0 11.1 30.5 10.4 12.5 9.5 9.5 28.8 11.2 9.9 9.4 27.0 13.1 27.9 16.9 10.0 16.8 12.7 20.9 15.8 24.3 13.8 13.9 28.2 14.2 21.5 22.8 6.0 9.4 20.1 21.7 9.3 17.2 15.2 35.7 12.0 12.5 50.6 49.1 93.6 6.6 34.8 2.1 17.5 49.8 0.0 23.7 84.3 24.4 16.5 12.7 26.8 52.0 17.5 19.4 28.3 43.7 3.1 25.0 26.3 16.9 14.4 31.1 35.8 29.7 28.1 19.8 21.9 19.7 25.8 15.0 43.2 41.7 9.9 123.2 16.0 27.7 17.4 NDC1 "FLJ10407, NET3, TMEM48" ENSG00000058804 "NDC1 transmembrane nucleoporin" Q9BTX1 1 53765460-53838860 "Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069751, HPA070882" Approved Supported "Nuclear membrane,Plasma membrane,Actin filaments" NA NA "Nuclear membrane" "Plasma membrane, Actin filaments" "HPA069751: AB_2686189, HPA070882: AB_2686320" "unprognostic (2.51e-1)" "unprognostic (1.93e-1)" "prognostic favorable (4.48e-5)" "unprognostic (6.96e-3)" "unprognostic (1.31e-1)" "unprognostic (1.36e-3)" "prognostic unfavorable (7.52e-7)" "unprognostic (3.46e-3)" "unprognostic (1.53e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.58e-4)" "unprognostic (9.27e-2)" "unprognostic (6.22e-3)" "unprognostic (3.00e-3)" "unprognostic (4.38e-2)" "unprognostic (9.24e-2)" "unprognostic (6.07e-2)" 8.8 6.7 3.3 8.6 5.7 4.9 12.9 10.9 7.7 4.8 8.4 5.1 1.9 6.2 6.0 5.4 11.0 5.3 2.9 5.5 4.3 2.8 4.9 11.7 4.4 10.6 8.0 1.5 4.6 6.0 7.6 5.5 5.5 6.6 4.0 10.7 5.5 6.4 3.7 7.1 6.8 6.5 5.0 7.5 7.1 5.8 17.4 7.5 9.1 5.8 6.7 13.0 6.4 5.8 5.5 3.8 2.0 7.2 4.0 8.2 3.4 20.0 10.6 14.4 14.7 5.3 5.4 17.0 13.8 10.3 21.6 17.5 15.6 13.5 39.6 9.0 6.1 17.5 24.2 24.3 14.3 30.6 9.8 17.5 19.3 15.5 13.2 5.0 30.9 11.0 3.2 5.7 21.3 12.7 6.3 13.0 14.8 22.0 5.7 11.8 7.2 15.1 12.3 34.3 17.0 16.9 17.1 23.3 21.6 10.1 13.8 8.7 11.1 12.3 24.0 11.8 16.0 18.6 16.4 7.6 11.3 11.3 15.5 24.7 6.3 15.6 28.2 9.4 23.5 14.1 0.0 3.2 2.0 4.5 7.2 6.9 5.5 4.3 4.0 3.8 4.1 8.2 6.3 0.2 4.0 4.5 3.3 4.7 3.4 3.3 5.7 10.9 7.7 4.3 2.8 8.0 1.5 6.6 7.5 6.0 4.6 3.7 6.1 9.0 4.1 7.6 2.5 2.7 2.3 5.2 2.0 8.2 0.0 5.9 1.7 4.8 3.3 0.0 7.7 16.4 5.9 5.0 7.0 5.9 10.3 3.2 0.0 4.3 9.1 1.7 2.6 6.7 6.8 2.8 8.4 4.1 6.1 2.9 3.2 4.5 3.2 6.5 4.7 9.3 13.1 7.4 5.7 4.1 15.1 5.4 NDFIP1 "MGC10924, N4WBP5" ENSG00000131507 "Nedd4 family interacting protein 1" Q9BT67 5 142108505-142154443 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009682 Approved "Intracellular and membrane" NA NA "HPA009682: AB_1079455" "unprognostic (2.78e-2)" "unprognostic (1.62e-1)" "unprognostic (9.26e-2)" "unprognostic (5.66e-3)" "unprognostic (4.74e-2)" "prognostic unfavorable (2.33e-7)" "unprognostic (6.95e-2)" "unprognostic (4.96e-2)" "unprognostic (5.97e-2)" "unprognostic (1.74e-2)" "unprognostic (3.28e-1)" "unprognostic (4.46e-2)" "prognostic favorable (2.39e-7)" "unprognostic (9.18e-2)" "unprognostic (2.06e-1)" "unprognostic (6.23e-2)" "unprognostic (8.76e-2)" 23.3 34.2 43.8 12.9 48.8 9.0 23.4 47.5 68.3 24.0 16.2 21.3 21.6 19.7 18.9 57.4 12.6 19.5 18.6 21.7 42.6 55.0 38.9 47.7 20.0 21.5 36.8 44.0 26.4 25.8 64.6 25.8 18.1 46.2 28.4 16.0 24.3 36.8 31.6 16.5 12.3 18.8 16.9 26.7 21.3 20.0 16.2 18.4 11.7 42.4 8.8 13.7 18.7 14.7 4.9 14.0 21.0 14.8 8.7 34.0 21.8 16.4 11.1 20.0 26.9 42.6 24.3 13.4 18.0 18.9 15.6 17.9 12.4 27.9 1.5 37.7 19.6 21.7 16.6 12.7 18.9 18.5 18.9 15.6 21.8 10.9 8.9 18.6 11.8 7.8 18.5 17.9 10.9 14.3 22.4 17.9 17.2 7.1 26.9 19.3 8.5 13.1 3.7 10.7 16.3 10.7 5.0 11.1 37.7 38.4 17.7 21.2 22.0 19.7 29.6 26.5 15.6 20.8 11.8 20.5 19.3 7.2 15.5 17.7 17.4 19.9 6.8 20.4 7.8 14.6 21.0 12.4 9.6 9.3 14.8 11.8 4.9 16.7 11.4 14.0 3.8 34.0 26.1 7.5 8.7 14.2 4.2 18.6 21.8 43.8 48.8 47.5 68.3 42.6 55.0 36.8 44.0 46.2 18.4 53.6 60.0 62.4 137.2 99.1 191.3 61.8 109.5 28.1 37.5 146.5 133.5 129.0 119.3 174.5 17.1 98.8 109.7 163.5 126.9 230.0 162.0 235.1 58.9 149.5 139.2 300.3 132.1 108.1 191.1 10.1 107.9 128.4 161.9 202.0 70.9 284.2 150.5 92.1 147.4 149.1 267.3 129.4 117.6 20.0 28.7 88.5 160.2 97.0 70.7 226.5 NDFIP2 "KIAA1165, N4wbp5a" ENSG00000102471 "Nedd4 family interacting protein 2" Q9NV92 13 79481124-79556075 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 304.4;Suprabasal keratinocytes: 321.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 17.3" "Group enriched" "Detected in many" 18 "granulocytes: 17.3;T-cells: 5.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009160 Uncertain Supported Vesicles NA NA Vesicles "HPA009160: AB_1079456" "unprognostic (2.56e-1)" "unprognostic (5.51e-3)" "unprognostic (1.95e-3)" "unprognostic (9.61e-2)" "unprognostic (2.60e-1)" "prognostic unfavorable (5.99e-4)" "unprognostic (1.50e-1)" "unprognostic (5.53e-2)" "unprognostic (2.30e-1)" "unprognostic (3.12e-1)" "unprognostic (1.52e-2)" "unprognostic (2.63e-2)" "prognostic favorable (4.18e-5)" "unprognostic (1.32e-1)" "unprognostic (1.31e-1)" "unprognostic (6.47e-2)" "unprognostic (1.02e-1)" 8.0 13.0 15.3 6.7 28.4 1.2 12.8 8.7 39.6 11.8 24.0 12.0 10.5 27.9 5.8 12.9 36.4 9.4 11.1 13.9 23.6 9.6 25.2 24.7 9.5 6.4 11.6 27.3 4.8 16.9 8.8 7.5 29.7 20.4 12.8 25.8 4.8 15.8 9.3 18.2 39.4 36.1 5.0 12.7 6.1 13.7 9.4 13.8 7.3 10.7 15.7 10.7 16.8 18.8 0.3 0.1 17.3 0.0 0.6 5.0 2.1 36.3 6.2 6.5 8.3 8.0 14.8 12.4 13.4 18.8 14.2 23.8 13.6 40.8 1.5 9.3 17.6 8.1 49.8 5.7 23.6 21.6 18.8 15.9 1.7 20.7 7.4 14.7 28.6 5.0 11.7 31.1 9.5 15.1 15.9 6.7 2.9 7.3 2.8 15.9 5.2 2.3 6.5 4.8 30.0 6.3 0.1 13.0 6.8 34.9 21.3 6.7 9.5 15.2 14.8 10.6 11.2 12.3 24.1 5.7 4.6 5.8 8.8 9.0 10.7 11.7 5.7 18.8 0.1 18.3 9.7 0.0 17.3 2.6 0.0 2.2 0.2 2.4 2.1 0.0 0.3 5.0 2.8 0.1 0.6 0.0 0.1 2.4 2.1 15.3 28.4 8.7 39.6 23.6 9.6 11.6 27.3 20.4 13.8 38.7 28.2 13.7 104.5 304.4 31.6 25.7 66.2 52.2 45.5 45.4 5.9 82.8 19.9 74.5 207.3 20.9 161.3 0.0 62.9 127.6 41.2 71.9 87.6 57.0 12.8 15.9 66.7 22.7 13.6 210.2 16.1 6.1 32.1 4.6 78.3 18.6 82.7 70.2 12.0 89.2 13.9 12.9 22.7 38.1 46.6 321.3 91.8 11.5 62.9 132.4 NDRG1 "CAP43, DRG1, NDR1, RTP, TDD5" ENSG00000104419 "N-myc downstream regulated 1" Q92597 8 133237171-133302022 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 508.1;Horizontal cells: 556.2;Suprabasal keratinocytes: 583.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 70.6;hTERT-HME1: 142.3;U-87 MG: 95.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006881 Approved Supported Microtubules,Cytosol NA NA Cytosol Microtubules "HPA006881: AB_1078392" "unprognostic (6.96e-3)" "unprognostic (3.31e-3)" "unprognostic (8.53e-2)" "unprognostic (1.41e-3)" "unprognostic (1.54e-3)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.47e-4)" "unprognostic (3.04e-3)" "unprognostic (5.33e-2)" "unprognostic (4.29e-2)" "unprognostic (9.09e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (4.13e-4)" "unprognostic (7.27e-2)" "unprognostic (1.91e-1)" "unprognostic (2.47e-3)" "unprognostic (4.28e-2)" 43.9 23.6 42.0 17.0 80.9 18.0 29.8 6.4 36.2 33.1 47.7 73.2 24.2 74.2 20.9 20.6 83.0 24.7 26.8 22.2 48.7 32.9 62.6 12.1 31.0 11.4 96.3 19.8 37.5 16.7 17.8 18.6 32.5 50.0 115.0 22.4 16.2 29.0 26.4 13.2 56.9 78.2 19.2 102.0 11.5 45.7 15.0 74.3 10.3 21.4 40.0 34.9 58.7 64.9 1.9 12.2 8.9 4.1 1.3 9.3 2.9 22.0 2.7 0.2 0.1 14.0 9.8 3.0 1.6 12.1 1.1 6.2 1.4 3.1 0.1 15.8 6.6 2.6 7.1 0.2 34.8 2.4 1.4 26.1 0.2 5.6 1.6 5.3 0.7 0.5 9.1 70.6 5.9 142.3 13.4 5.2 2.9 0.2 15.4 2.0 1.3 2.0 2.1 0.4 8.1 18.3 0.2 2.4 10.2 3.6 3.2 1.6 1.6 3.4 36.5 8.8 6.1 0.1 2.4 6.8 9.9 5.1 4.3 1.2 11.5 30.3 0.1 95.8 8.3 19.5 8.9 4.1 0.0 6.3 3.7 9.3 1.7 5.9 7.5 6.1 1.9 4.6 3.1 4.2 1.3 4.0 12.2 8.0 2.9 42.0 80.9 6.4 36.2 48.7 32.9 96.3 19.8 50.0 74.3 134.0 42.5 17.1 123.5 508.1 21.1 16.5 73.9 9.4 26.1 177.9 2.0 8.9 28.2 21.1 5.4 137.1 330.3 0.0 11.8 79.9 76.6 236.9 21.9 52.2 15.9 556.2 21.2 77.3 31.9 4.3 45.5 36.0 96.2 19.0 134.0 72.1 84.1 91.2 41.4 59.7 33.2 45.3 59.4 0.9 6.4 583.4 36.3 25.4 80.8 209.3 NDRG2 "KIAA1248, SYLD" ENSG00000165795 "NDRG family member 2" Q9UN36 14 21016763-21070872 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 310.5;skeletal muscle: 253.0" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 411.1;Leydig cells: 322.7;Muller glia cells: 402.9;Sertoli cells: 588.6" "Cancer enhanced" "Detected in all" "glioma: 78.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "myeloid DC: 54.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 54.5" "Cell line enhanced" "Detected in many" "Hep G2: 27.9;HMC-1: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002896, HPA003590, CAB017491" Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA 150000 "Centriolar satellite" "Nucleoplasm, Cytosol" "CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458" "unprognostic (9.27e-3)" "unprognostic (2.97e-3)" "unprognostic (1.26e-2)" "unprognostic (5.09e-3)" "unprognostic (2.00e-2)" "unprognostic (2.92e-2)" "prognostic favorable (6.71e-4)" "unprognostic (1.85e-3)" "unprognostic (5.57e-2)" "unprognostic (3.46e-2)" "unprognostic (1.69e-1)" "unprognostic (5.10e-2)" "prognostic favorable (1.43e-12)" "unprognostic (1.46e-1)" "unprognostic (5.56e-2)" "unprognostic (6.11e-2)" "unprognostic (4.19e-2)" 19.3 45.3 140.2 4.8 135.1 1.4 50.3 93.5 110.0 35.5 21.0 89.6 23.8 12.2 30.7 44.4 37.3 29.5 21.5 45.2 103.6 86.1 24.3 84.8 13.7 7.7 128.9 73.5 79.7 15.5 35.6 6.0 8.1 95.4 23.7 18.8 8.9 310.5 37.3 253.0 18.9 12.0 22.0 73.0 21.1 11.2 5.2 71.2 0.4 13.6 53.4 16.1 13.9 19.3 1.8 54.5 0.4 1.8 0.7 5.4 4.0 5.3 1.1 3.4 6.4 0.5 0.0 0.5 0.1 2.2 2.0 1.1 7.4 10.0 0.3 2.0 0.1 3.2 8.8 15.3 3.1 2.7 0.0 5.5 6.9 1.2 27.9 0.7 0.6 20.0 6.1 6.7 0.4 0.9 3.2 0.0 6.3 13.9 0.6 0.3 4.5 2.4 1.9 9.1 17.3 0.4 7.1 0.3 1.6 3.8 13.6 0.0 9.9 1.5 1.7 7.0 9.3 13.5 4.0 0.0 0.6 10.9 0.2 0.2 3.1 2.2 0.1 0.9 0.1 2.3 0.0 1.8 0.2 2.4 0.4 3.2 1.8 3.6 3.3 54.5 1.3 5.4 4.0 0.4 0.7 0.0 1.9 2.4 4.0 140.2 135.1 93.5 110.0 103.6 86.1 128.9 73.5 95.4 71.2 0.0 14.8 8.5 70.8 25.4 6.7 160.9 140.1 20.1 13.6 38.4 9.8 8.0 411.1 69.3 4.7 52.6 25.5 0.0 18.9 0.6 20.1 71.2 47.4 183.0 19.8 3.2 32.1 116.6 25.7 5.9 322.7 43.4 305.4 6.4 71.2 402.9 14.6 28.8 156.3 32.0 12.8 588.6 188.5 1.1 3.4 26.6 18.1 10.1 86.6 132.0 NDRG4 "KIAA1180, SMAP-8" ENSG00000103034 "NDRG family member 4" Q9ULP0 16 58462846-58513628 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 59.2;brain: 134.1;heart muscle: 112.6" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 389.7;Horizontal cells: 487.8" "Cancer enriched" "Detected in many" 6 "glioma: 23.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 18.4;GAMG: 16.2;hTERT-RPE1: 15.2;SCLC-21H: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015313, HPA017587" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015313: AB_1854343, HPA017587: AB_1854344" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" "unprognostic (9.03e-3)" "unprognostic (1.59e-2)" "unprognostic (3.97e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (6.07e-2)" "unprognostic (1.02e-1)" "unprognostic (4.84e-3)" "unprognostic (5.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.22e-2)" "unprognostic (8.51e-2)" "unprognostic (4.45e-2)" "unprognostic (7.17e-2)" 3.6 59.2 28.7 2.9 49.4 1.6 2.3 65.4 134.1 3.8 3.5 11.0 15.6 3.4 10.2 5.1 10.0 3.9 3.4 112.6 30.5 32.0 2.3 1.9 6.5 3.4 33.7 35.4 2.1 2.6 10.8 11.6 2.6 81.2 2.1 3.2 8.7 2.9 18.2 5.3 3.9 3.2 8.7 11.7 11.7 2.6 19.9 7.4 0.0 2.6 0.3 3.5 2.7 8.0 1.5 0.1 0.2 0.0 0.1 0.9 0.2 0.1 9.3 8.9 1.7 0.2 1.7 0.7 2.9 4.5 1.4 0.9 3.5 2.4 0.2 18.4 2.2 16.2 0.8 0.7 0.5 1.2 0.0 1.8 0.4 1.5 2.5 2.5 0.1 0.1 2.1 0.2 0.9 0.0 15.2 11.7 0.0 0.1 0.1 1.3 2.3 0.9 0.1 0.8 0.3 6.8 0.2 2.5 0.2 0.4 5.8 27.8 10.4 0.3 0.8 0.1 1.1 0.3 0.1 4.2 1.2 3.5 0.3 0.4 0.5 0.2 3.0 6.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.2 28.7 49.4 65.4 63.4 30.5 32.0 33.7 35.4 81.2 7.4 0.0 3.4 0.0 4.0 1.8 38.9 389.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 3.6 4.6 13.5 0.0 0.0 0.2 0.1 1.5 1.4 0.0 0.2 0.0 487.8 1.7 23.9 1.0 6.2 4.0 0.7 6.8 0.0 0.0 74.2 3.2 0.0 2.5 0.0 22.6 6.5 5.7 3.9 3.6 5.1 0.0 0.0 0.0 7.5 NDST1 "HSST, NST1" ENSG00000070614 "N-deacetylase and N-sulfotransferase 1" P52848 5 150485818-150558211 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Multifunctional enzyme, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 42.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "dendritic cells: 5.5;granulocytes: 7.2;monocytes: 6.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060532 Approved NA NA 1000000 "HPA060532: AB_2684310" "unprognostic (1.36e-1)" "unprognostic (5.54e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (6.99e-4)" "unprognostic (1.77e-1)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.47e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (5.13e-4)" "unprognostic (4.97e-3)" "unprognostic (6.92e-2)" "unprognostic (7.45e-2)" "unprognostic (2.46e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.08e-2)" 26.3 15.5 17.3 9.9 20.2 4.9 21.3 8.6 28.3 12.9 10.2 41.7 7.3 9.3 11.8 10.0 25.5 11.0 16.9 19.6 17.9 14.4 11.4 49.2 25.2 6.1 28.5 13.8 17.3 28.9 16.5 4.7 10.0 26.1 11.3 7.3 10.8 25.4 13.5 15.3 24.9 14.7 14.3 32.8 30.1 10.2 12.6 19.6 1.4 17.3 11.9 9.8 10.5 11.5 0.6 5.5 7.2 6.5 0.1 0.6 2.9 9.8 8.8 14.6 17.8 14.7 14.7 14.7 18.1 23.9 18.1 27.3 25.9 10.4 6.7 18.4 36.1 29.1 16.9 7.8 36.7 12.1 0.8 12.2 7.9 5.7 4.0 10.9 5.9 14.5 20.0 15.3 21.8 9.9 18.2 24.6 4.0 7.5 2.4 17.6 8.3 0.7 1.8 6.8 2.7 10.4 11.4 12.2 2.9 10.6 10.0 4.4 15.4 10.9 34.3 14.5 10.9 18.3 1.4 12.0 31.0 28.1 13.4 14.8 5.4 1.4 2.5 25.4 9.2 11.9 1.7 6.5 4.4 0.1 2.3 0.0 0.6 0.0 0.6 5.5 0.1 0.1 0.2 7.2 0.1 5.5 0.4 0.0 2.9 17.3 20.2 8.6 28.3 17.9 14.4 28.5 13.8 26.1 19.6 35.7 8.3 0.8 2.4 5.0 11.1 10.4 15.3 0.0 7.9 15.7 7.9 7.4 1.7 8.2 0.4 12.6 12.1 0.0 8.9 9.2 10.0 6.0 1.1 42.9 7.0 12.7 1.2 35.0 17.9 1.5 11.5 5.0 10.1 1.0 6.3 12.2 13.6 5.8 30.1 8.4 10.1 0.0 7.1 0.0 0.6 10.8 3.8 1.0 4.4 3.5 NDST2 "HSST2, NST2" ENSG00000166507 "N-deacetylase and N-sulfotransferase 2" P52849 10 73801911-73811798 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "granulocytes: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 50.8" HPA051515 Approved Approved Cytosol NA NA 72000 Cytosol "HPA051515: AB_2681517" "unprognostic (8.84e-2)" "unprognostic (7.57e-2)" "unprognostic (2.53e-2)" "unprognostic (9.43e-3)" "unprognostic (5.69e-1)" "unprognostic (1.07e-2)" "unprognostic (5.83e-3)" "unprognostic (2.16e-2)" "unprognostic (8.19e-2)" "unprognostic (1.61e-2)" "unprognostic (2.23e-5)" "unprognostic (1.49e-2)" "unprognostic (4.08e-7)" "unprognostic (3.71e-2)" "unprognostic (3.69e-2)" "unprognostic (5.93e-2)" "unprognostic (9.06e-2)" 12.6 14.6 7.9 19.2 11.3 37.5 11.8 30.2 12.2 16.6 10.7 13.8 13.4 8.9 18.4 14.8 14.4 12.8 15.5 9.3 9.6 8.4 11.0 9.4 14.7 21.9 7.3 8.8 15.1 12.3 17.3 26.5 14.1 9.2 13.6 10.5 14.7 20.1 17.2 16.4 15.1 14.4 13.4 7.5 31.8 11.8 13.5 9.2 35.3 12.2 8.2 19.3 12.3 13.3 3.1 6.8 5.8 5.3 2.2 7.1 3.2 4.3 3.6 7.5 11.5 9.3 10.8 3.9 5.1 10.9 5.9 6.1 1.9 5.3 3.9 3.1 9.7 6.0 5.0 3.7 5.4 4.8 10.4 3.6 3.9 2.7 3.0 16.4 5.0 50.8 10.2 6.6 10.2 10.5 18.4 7.7 7.9 3.7 15.1 7.4 3.3 5.8 5.5 2.1 2.7 15.3 3.6 3.7 2.4 5.0 3.0 2.5 4.2 4.5 10.7 3.5 5.2 8.2 7.7 12.3 3.0 3.5 3.9 3.6 7.5 3.3 5.2 3.5 7.7 2.3 1.4 5.3 2.1 5.5 3.7 6.5 2.5 4.7 4.8 4.0 3.1 5.6 7.1 5.8 2.2 3.5 6.8 3.1 3.2 7.9 11.3 30.2 12.2 9.6 8.4 7.3 8.8 9.2 9.2 0.0 4.8 3.7 0.3 1.1 0.6 1.4 0.0 4.0 2.3 0.0 0.0 1.2 0.0 4.4 5.7 0.5 3.5 0.0 8.4 1.4 1.0 1.5 13.9 3.8 4.5 1.6 2.4 0.0 6.7 6.8 0.0 3.5 1.7 4.6 2.3 0.7 5.5 2.6 0.0 5.6 0.7 0.0 1.0 2.4 1.4 1.4 5.1 3.2 1.7 2.1 NDST3 HSST3 ENSG00000164100 "N-deacetylase and N-sulfotransferase 3" O95803 4 118033618-118258648 "Enzymes, Predicted intracellular proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 22.2;lymphoid tissue: 6.8;pituitary gland: 7.6" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 20.2;Horizontal cells: 6.4;Kupffer cells: 27.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 17.0;cerebellum: 22.2;cerebral cortex: 5.7" "Cell type enhanced" "Detected in some" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 10 "MOLT-4: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056189 Uncertain NA NA "HPA056189: AB_2683061" "unprognostic (1.95e-2)" "unprognostic (7.58e-2)" "unprognostic (4.34e-3)" "unprognostic (2.55e-7)" "unprognostic (4.05e-2)" "unprognostic (2.18e-2)" "unprognostic (2.86e-3)" "unprognostic (2.32e-2)" "unprognostic (1.87e-1)" "unprognostic (1.46e-2)" "unprognostic (7.43e-2)" "unprognostic (1.99e-2)" "unprognostic (1.09e-3)" "unprognostic (1.37e-1)" "unprognostic (4.39e-3)" "unprognostic (6.83e-2)" "unprognostic (8.85e-2)" 0.3 2.0 3.2 0.3 17.0 0.6 0.3 22.2 6.9 2.1 0.4 0.0 0.0 0.3 0.4 0.2 0.3 1.3 0.4 0.3 2.3 2.0 0.9 4.6 0.4 0.6 0.9 1.7 0.6 0.2 0.2 7.6 0.4 1.7 0.5 0.4 1.3 0.2 1.2 0.3 0.4 0.4 0.4 0.6 6.8 1.0 0.5 2.4 6.8 0.6 0.0 0.4 0.3 0.3 0.3 0.4 1.3 0.2 0.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.9 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.9 1.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.3 0.4 0.1 0.4 0.0 0.0 3.2 17.0 22.2 5.7 2.3 2.0 0.9 1.7 1.7 2.4 0.0 0.0 0.0 0.0 0.0 20.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 6.4 0.0 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NDST4 ENSG00000138653 "N-deacetylase and N-sulfotransferase 4" Q9H3R1 4 114827763-115113876 "Enzymes, Predicted intracellular proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 17 "pons and medulla: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RH-30: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011129 Uncertain NA NA "HPA011129: AB_1079460" "unprognostic (5.58e-2)" "unprognostic (5.90e-2)" "unprognostic (4.82e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-1)" "unprognostic (1.11e-1)" "unprognostic (1.94e-1)" "unprognostic (6.55e-2)" 0.1 0.0 1.3 0.0 1.7 0.0 0.1 0.2 3.4 1.4 0.3 0.3 0.3 0.1 1.5 0.0 0.1 0.1 0.3 0.1 0.7 1.9 0.1 0.0 0.1 0.0 1.3 1.4 5.7 0.1 0.0 0.6 0.0 34.6 1.5 0.1 0.0 0.5 0.6 0.1 0.2 0.1 1.6 1.0 2.5 1.1 0.7 0.0 0.0 0.1 0.1 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 0.2 1.7 0.7 1.9 1.3 1.4 34.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NDUFA1 "CI-MWFE, MWFE" ENSG00000125356 "NADH:ubiquinone oxidoreductase subunit A1" O15239 X 119871487-119876662 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 144.8;skeletal muscle: 138.8" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 3052.5;Distal tubular cells: 1856.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029768, HPA054359" Enhanced Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA029768: AB_2673192, HPA054359: AB_2682461" "unprognostic (1.72e-1)" "unprognostic (3.00e-3)" "unprognostic (3.12e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (7.34e-3)" "unprognostic (1.56e-1)" "unprognostic (8.20e-3)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (8.11e-3)" "unprognostic (4.77e-2)" "prognostic favorable (3.48e-4)" "unprognostic (1.16e-1)" "unprognostic (3.62e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-3)" 24.5 30.1 37.9 20.1 42.5 25.2 23.8 27.9 37.8 19.7 38.4 8.7 27.3 41.0 13.5 25.8 21.6 15.9 24.8 144.8 30.1 28.5 46.0 40.2 21.1 22.2 34.6 32.8 14.6 40.4 22.7 21.7 15.4 29.5 17.9 31.1 15.5 38.4 29.6 138.8 12.1 34.6 19.3 31.5 17.1 28.1 7.7 21.1 9.2 16.2 67.4 16.7 14.0 14.9 66.3 90.5 96.3 85.7 49.8 75.5 73.8 33.6 36.4 26.0 27.7 31.4 19.9 32.6 26.6 24.3 18.7 23.4 20.3 28.2 27.5 41.1 27.8 40.0 32.5 36.5 25.6 21.5 37.9 50.4 28.5 66.4 45.5 24.4 43.5 31.7 32.4 34.8 19.9 15.5 30.6 23.2 28.1 15.5 42.7 25.7 59.6 30.9 41.2 38.4 87.9 65.0 31.3 24.8 82.5 56.4 48.0 19.0 25.1 54.7 67.9 36.5 36.6 17.2 51.3 29.9 16.0 16.2 33.2 51.9 39.4 48.8 35.9 29.0 51.7 19.7 96.3 79.0 91.6 60.2 80.4 57.1 66.3 67.1 62.8 84.0 52.7 56.1 65.7 94.6 49.8 85.7 90.5 75.5 73.8 37.9 42.5 27.9 37.8 30.1 28.5 34.6 32.8 29.5 21.1 148.9 173.3 221.0 195.7 189.9 139.0 3052.5 636.9 330.6 205.9 533.9 74.6 331.6 1856.9 408.0 28.1 249.5 1244.9 256.9 444.8 351.6 251.4 215.4 204.5 881.4 567.3 77.9 441.2 254.8 408.9 27.3 272.7 346.6 541.6 587.1 745.3 168.3 446.0 706.9 268.0 1089.7 161.0 213.4 269.6 46.1 78.8 217.9 318.3 243.7 663.1 282.7 NDUFA11 B14.7 ENSG00000174886 "NADH:ubiquinone oxidoreductase subunit A11" Q86Y39 19 5891276-5904006 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA072209 Uncertain Mitochondria NA NA Mitochondria "HPA072209: AB_2686495" "unprognostic (2.24e-1)" "prognostic favorable (4.54e-5)" "unprognostic (8.20e-3)" "prognostic favorable (3.38e-5)" "unprognostic (4.54e-2)" "unprognostic (7.73e-2)" "unprognostic (6.30e-2)" "unprognostic (7.26e-3)" "unprognostic (3.95e-1)" "unprognostic (4.20e-2)" "unprognostic (1.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.12e-2)" "unprognostic (2.91e-1)" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (6.16e-3)" 32.3 70.8 50.2 40.9 41.3 43.4 49.3 29.9 75.2 35.3 45.1 25.8 41.2 41.6 35.9 36.9 53.1 38.4 41.4 149.3 41.9 45.8 44.1 59.8 37.9 51.9 48.3 45.8 38.4 70.9 13.5 33.8 32.5 35.9 35.1 19.6 35.9 76.3 41.1 106.0 32.4 39.5 45.2 40.2 31.5 38.8 21.2 27.0 37.3 37.8 72.1 30.5 38.3 37.2 63.3 90.2 54.3 87.4 44.8 73.7 121.4 49.2 38.1 28.4 46.2 23.3 37.9 31.8 34.1 39.4 62.5 57.8 45.5 26.3 48.7 53.8 32.5 26.8 32.6 19.6 39.7 15.1 42.0 73.5 20.0 36.6 72.7 61.0 29.7 29.8 51.8 36.1 35.4 16.8 24.1 40.7 44.8 42.2 54.3 31.4 37.5 77.1 53.0 43.0 39.3 95.9 53.5 35.5 69.7 38.6 33.0 41.1 43.7 26.5 43.6 60.0 12.7 33.5 63.4 36.4 34.9 33.5 69.3 55.6 82.6 71.6 63.0 58.8 71.4 44.7 54.3 87.4 47.7 53.5 68.0 54.8 63.3 59.6 54.0 74.9 54.6 56.7 49.5 39.2 44.8 57.7 90.2 73.7 121.4 50.2 41.3 29.9 75.2 41.9 45.8 48.3 45.8 35.9 27.0 134.0 182.8 195.8 195.3 182.6 52.9 357.1 252.3 159.3 142.1 277.4 23.6 487.2 712.9 246.9 126.8 162.6 455.6 140.2 261.1 500.5 250.4 204.0 208.9 654.2 369.3 47.7 337.5 259.7 354.1 271.6 180.4 216.7 271.7 380.5 351.7 119.5 275.3 350.7 157.3 766.8 60.4 116.4 219.2 83.0 80.8 212.9 496.2 182.7 391.9 191.2 NDUFA13 "B16.6, CDA016, CGI-39, GRIM-19, GRIM19" ENSG00000186010 "NADH:ubiquinone oxidoreductase subunit A13" Q9P0J0 19 19515736-19529054 "Disease related genes, Predicted membrane proteins" "Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 116.3;testis: 140.2" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 2344.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041213 Supported Supported Mitochondria NA NA Mitochondria "HPA041213: AB_10794988" "unprognostic (2.87e-1)" "unprognostic (2.88e-3)" "unprognostic (9.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-2)" "unprognostic (5.78e-2)" "unprognostic (6.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.81e-1)" "unprognostic (1.83e-3)" "unprognostic (1.26e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-2)" "unprognostic (1.33e-1)" "unprognostic (2.37e-1)" "unprognostic (2.15e-2)" "unprognostic (2.15e-2)" 17.9 16.9 20.0 11.7 23.9 15.4 14.4 20.7 25.2 11.0 19.2 8.7 16.5 16.5 9.7 19.6 12.2 11.7 12.9 68.0 16.4 13.9 18.9 20.8 8.4 11.9 19.9 22.3 10.6 17.8 10.6 12.1 12.1 20.0 12.9 11.9 9.8 15.2 15.5 79.7 9.5 14.9 12.1 13.4 10.1 15.0 140.2 16.2 7.6 11.3 28.1 8.4 9.6 10.2 73.7 74.9 61.4 76.8 44.8 72.7 116.3 33.1 24.5 45.3 45.0 46.2 37.5 42.5 39.5 43.8 44.6 43.5 39.7 49.8 44.1 93.0 47.6 27.8 27.0 32.0 42.9 18.4 26.9 72.4 33.7 39.1 48.6 41.3 63.3 47.6 50.3 39.0 31.2 36.0 31.5 32.0 51.6 37.2 63.2 35.4 65.9 75.1 62.9 46.1 85.3 68.2 43.1 29.4 67.4 65.0 47.6 43.0 54.4 40.2 47.4 39.3 26.4 29.3 87.2 33.3 43.7 14.8 50.9 49.0 45.0 35.4 47.5 38.5 49.2 31.9 61.4 76.8 57.8 51.2 72.9 45.5 73.7 58.9 56.0 74.9 60.5 56.9 51.1 26.9 44.8 60.8 61.2 72.7 116.3 20.0 23.9 20.7 25.2 16.4 13.9 19.9 22.3 20.0 16.2 122.1 153.3 217.5 53.6 114.6 57.3 436.5 216.6 210.1 204.8 237.3 23.6 341.6 517.3 485.5 369.3 147.4 952.4 140.2 502.5 299.6 215.0 71.6 253.9 389.3 292.2 39.7 534.5 181.7 314.3 2344.2 142.1 234.7 249.7 531.2 516.2 105.2 438.1 641.8 121.3 667.2 59.7 90.5 183.3 59.7 92.9 111.0 416.8 195.8 508.5 65.7 NDUFA3 B9 ENSG00000170906 "NADH:ubiquinone oxidoreductase subunit A3" O95167 19 54102728-54109257 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 1041.5;Late spermatids: 1291.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 38.9" "Low region specificity" "Detected in all" HPA046976 Supported NA NA "HPA046976: AB_10960994" "unprognostic (3.04e-2)" "unprognostic (4.12e-3)" "unprognostic (9.53e-2)" "unprognostic (5.95e-2)" "unprognostic (6.73e-2)" "unprognostic (3.14e-2)" "unprognostic (3.91e-1)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.00e-2)" "prognostic favorable (9.65e-4)" "unprognostic (9.91e-2)" "unprognostic (3.24e-3)" "unprognostic (7.79e-2)" "unprognostic (1.33e-1)" "unprognostic (7.24e-2)" "prognostic favorable (4.80e-4)" 17.7 20.8 47.4 15.4 50.9 21.8 22.0 17.3 36.5 12.8 22.6 13.7 21.5 31.8 11.7 25.1 15.8 17.1 20.0 66.1 40.9 33.1 29.7 37.2 20.8 26.9 43.3 31.1 12.9 34.0 22.2 25.5 12.3 29.5 15.9 25.8 13.9 27.0 24.7 95.7 42.4 27.6 15.7 26.8 14.7 23.7 32.6 19.6 16.1 19.5 34.7 16.6 16.3 15.1 20.9 27.3 21.7 16.7 17.1 16.4 18.8 5.4 4.7 4.7 6.4 6.2 5.7 3.7 4.6 5.0 3.7 4.2 5.9 4.0 4.3 3.1 4.1 3.6 3.4 3.7 8.9 1.7 6.5 19.6 4.8 6.3 6.6 4.4 5.3 2.0 3.7 8.8 3.2 4.3 2.5 6.7 4.2 2.6 3.1 3.7 17.4 4.9 6.2 3.9 38.9 9.0 2.2 2.5 9.0 2.7 13.6 7.8 4.1 4.3 10.3 2.5 5.8 12.0 5.2 5.9 4.9 2.4 2.1 7.5 4.7 3.5 2.5 5.4 5.0 2.3 17.2 16.3 21.7 15.0 16.7 15.0 20.9 15.5 15.6 15.8 19.8 16.3 16.4 15.9 17.1 13.7 27.3 15.4 18.8 47.4 50.9 17.3 36.5 40.9 33.1 43.3 31.1 29.5 19.6 89.3 115.3 159.2 44.9 35.3 34.7 1041.5 244.5 190.1 113.7 373.4 9.8 147.2 691.4 171.8 409.1 107.4 555.4 163.5 167.0 149.5 119.0 58.2 112.2 459.8 264.7 22.3 288.8 206.2 255.7 1291.0 151.0 163.3 207.5 272.3 310.4 63.8 191.8 343.7 133.0 664.3 46.3 84.1 82.1 132.9 71.5 54.6 124.1 142.2 317.6 56.7 NDUFA4 "CI-9k, MLRQ" ENSG00000189043 "NDUFA4, mitochondrial complex associated" O00483 7 10931951-10940256 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.9;skeletal muscle: 151.6" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 3966.4;Distal tubular cells: 3355.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055323, HPA078265" Approved Approved Mitochondria NA NA 18000 Mitochondria "HPA055323: , HPA078265: " "unprognostic (1.83e-1)" "unprognostic (6.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (2.16e-1)" "unprognostic (4.97e-3)" "unprognostic (3.85e-1)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.90e-2)" "unprognostic (8.65e-3)" "unprognostic (1.74e-1)" "prognostic favorable (4.61e-8)" "unprognostic (1.24e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-3)" "unprognostic (2.08e-1)" 21.9 22.0 72.8 13.6 55.3 19.8 27.0 33.1 74.4 20.5 18.3 12.0 16.8 25.1 16.9 29.6 15.8 20.2 16.7 149.9 56.1 32.1 46.2 46.7 15.9 13.5 47.6 48.9 17.1 23.7 18.9 5.6 11.4 33.0 23.1 20.4 14.1 36.0 31.1 151.6 12.1 17.3 21.4 26.3 13.6 23.6 7.4 23.2 6.8 20.4 60.1 15.6 15.8 11.6 29.0 41.1 52.8 39.6 21.7 37.5 48.0 11.4 19.7 33.6 38.7 19.1 18.0 15.5 14.5 13.8 13.7 12.1 24.7 31.5 22.4 13.9 20.9 37.5 20.3 22.3 17.3 15.0 11.0 16.3 18.7 23.2 23.0 16.7 25.8 18.5 19.3 17.4 16.7 14.8 26.1 19.0 20.2 27.8 30.5 28.5 22.1 11.5 22.7 36.8 78.1 40.0 15.6 24.0 25.1 34.7 24.9 21.1 21.9 23.1 66.5 13.1 49.0 42.0 31.7 16.6 16.3 22.6 23.4 24.0 18.5 23.6 25.7 22.6 27.9 50.7 52.8 32.5 44.4 23.4 38.6 27.4 29.0 32.7 29.3 41.1 22.0 34.1 29.7 7.4 21.7 39.6 38.5 37.5 48.0 72.8 55.3 33.1 74.4 56.1 32.1 47.6 48.9 33.0 23.2 455.6 386.9 389.1 472.6 361.6 472.0 3966.4 996.2 704.0 533.5 903.7 251.3 756.7 3355.6 748.9 115.7 549.6 532.5 186.9 833.3 599.3 543.2 716.7 552.0 1498.2 844.7 149.4 201.3 748.3 552.8 81.7 457.0 587.9 868.9 625.8 610.1 384.0 636.5 584.4 737.2 2069.7 472.4 329.8 932.8 105.9 274.8 422.2 550.9 350.3 618.2 678.3 NDUFA4L2 "FLJ26118, NUOMS" ENSG00000185633 "NDUFA4, mitochondrial complex associated like 2" Q9NRX3 12 57234903-57240715 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 82.5;skin 1: 93.4" "Group enriched" "Detected in many" 4 "Muller glia cells: 315.5;Sertoli cells: 1112.4;Smooth muscle cells: 398.4" "Cancer enhanced" "Detected in all" "renal cancer: 356.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.4;T-reg: 2.8" "Group enriched" "Detected in many" 24 "B-cells: 2.4;T-cells: 2.8" "Cell line enriched" "Detected in many" 7 "AN3-CA: 55.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA055323, HPA078265" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA055323: , HPA078265: " "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (2.11e-3)" "unprognostic (3.23e-3)" "unprognostic (5.06e-2)" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (3.53e-1)" "unprognostic (6.67e-2)" "unprognostic (5.79e-2)" "unprognostic (2.13e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (1.37e-5)" "unprognostic (9.10e-3)" "unprognostic (1.31e-1)" "unprognostic (6.41e-2)" "unprognostic (2.74e-2)" 24.5 9.6 8.3 4.9 15.5 1.3 11.5 7.7 10.4 19.1 4.4 8.3 1.1 4.6 4.6 5.4 82.5 3.6 11.0 30.9 9.8 7.3 5.4 4.2 12.7 4.6 10.9 10.7 6.1 6.7 4.6 6.2 42.7 13.2 6.8 2.4 13.7 10.3 7.4 19.0 93.4 4.7 5.6 5.6 29.9 4.3 3.0 8.9 0.7 12.0 14.8 11.9 10.2 31.4 2.4 0.1 0.0 0.0 0.0 2.8 0.3 0.3 0.5 0.1 55.4 2.3 1.3 0.1 0.8 0.6 0.2 0.5 0.0 0.6 2.2 2.3 0.8 0.0 0.4 0.3 0.4 0.0 1.2 0.1 0.2 0.1 0.0 7.9 1.6 0.8 5.1 1.0 0.1 2.0 0.3 0.0 3.1 0.2 2.9 0.1 1.1 0.4 0.0 0.1 0.2 1.0 0.8 0.4 4.2 0.0 0.0 3.0 1.0 0.1 0.1 1.8 0.0 0.6 5.8 0.2 0.5 0.0 0.4 0.2 4.2 1.3 1.0 2.0 3.9 0.3 0.0 0.0 0.0 0.6 0.0 0.0 2.4 0.7 0.0 0.1 0.4 1.1 0.0 0.0 0.0 0.0 0.0 2.8 0.3 8.3 15.5 7.7 10.4 9.8 7.3 10.9 10.7 13.2 8.9 0.0 0.3 0.9 0.7 134.3 28.0 0.8 0.0 0.0 0.0 0.0 17.7 0.8 0.0 1.0 1.0 3.6 0.0 0.0 0.0 0.8 18.6 1.5 9.2 0.0 1.5 11.1 0.0 4.9 0.0 1.3 2.8 1.4 28.7 1.8 0.0 315.5 7.7 0.0 2.1 0.0 17.5 1112.4 398.4 8.1 0.9 141.0 0.9 0.0 0.0 0.9 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 161.6" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 2033.2;Hepatocytes: 1436.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "HPA063737: AB_2685109" "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favorable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 38.3 48.3 47.8 22.4 43.1 30.2 22.1 30.9 53.6 12.4 39.7 13.4 28.1 36.4 14.8 39.2 23.2 15.9 20.0 142.2 38.4 35.7 51.2 64.6 28.1 24.9 40.6 36.0 16.5 48.5 9.9 30.6 13.2 41.8 19.3 26.9 22.9 54.1 35.9 161.6 12.6 32.9 25.9 31.3 19.3 29.4 10.0 26.4 11.9 21.6 48.9 21.3 17.1 16.3 61.7 98.6 116.1 93.9 45.1 70.1 95.0 27.1 55.1 44.7 28.8 29.3 21.9 20.5 33.5 18.9 19.9 18.4 33.2 46.3 24.5 31.2 18.7 29.1 34.0 25.6 27.2 18.0 38.6 58.5 47.5 86.5 39.5 23.3 37.5 27.2 27.0 16.5 20.8 18.4 47.1 17.7 47.1 25.8 50.5 27.2 102.8 37.0 33.6 22.6 103.1 67.5 33.1 42.5 36.4 49.6 67.3 29.9 21.7 65.6 40.0 42.6 39.3 59.8 58.6 39.5 12.7 24.1 25.3 22.3 40.0 62.3 54.5 38.2 27.8 26.2 58.1 93.9 67.8 43.7 63.5 50.2 61.7 64.7 49.8 82.6 52.0 65.4 60.4 116.1 45.1 58.1 98.6 70.1 95.0 47.8 43.1 30.9 53.6 38.4 35.7 40.6 36.0 41.8 26.4 154.9 246.4 237.3 88.1 114.4 72.8 2033.2 565.6 282.4 178.6 369.9 37.3 225.4 988.2 197.4 98.7 145.0 655.0 280.4 371.9 86.0 164.5 117.3 207.1 1436.2 359.0 52.4 305.2 426.6 707.7 29.0 243.1 282.3 315.5 296.6 433.5 108.9 268.5 512.0 226.7 864.5 130.9 219.9 185.4 133.6 144.5 153.9 172.1 204.2 467.2 90.1 NDUFB11 "ESSS, Np15, NP17.3" ENSG00000147123 "NADH:ubiquinone oxidoreductase subunit B11" Q9NX14 X 47142216-47145504 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030367 Supported Approved Mitochondria NA NA Mitochondria "HPA030367: AB_10603882" "unprognostic (2.20e-1)" "unprognostic (6.77e-3)" "unprognostic (1.39e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (8.84e-2)" "unprognostic (3.31e-2)" "unprognostic (2.05e-1)" "unprognostic (5.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (2.19e-1)" "unprognostic (6.58e-2)" "unprognostic (3.27e-1)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (8.46e-3)" 16.9 33.4 26.1 21.2 24.8 25.2 29.2 18.9 29.7 17.6 23.3 10.5 24.7 24.2 14.3 25.1 23.3 18.8 24.0 64.4 22.4 20.6 24.4 48.8 18.1 36.5 22.5 22.0 14.9 50.9 15.6 24.5 14.2 24.4 18.1 21.2 13.0 37.0 30.2 164.0 17.3 22.8 16.0 18.3 19.2 22.8 9.7 12.3 30.4 38.5 53.6 21.2 14.3 20.5 58.9 69.0 22.2 44.7 27.7 54.6 59.5 19.9 29.7 23.5 27.1 20.3 17.5 25.0 14.5 16.9 23.8 23.1 31.6 24.5 24.6 12.6 15.8 25.1 25.6 26.4 15.4 16.0 23.7 70.6 14.1 40.6 26.1 20.4 23.6 21.7 19.1 14.1 20.6 13.7 15.3 17.7 32.1 16.8 32.4 13.3 45.1 27.8 65.3 36.7 23.8 54.6 30.3 23.2 55.8 24.1 21.3 43.3 32.0 27.6 31.8 22.0 31.3 45.6 30.9 13.5 16.7 22.8 31.0 17.0 32.0 27.9 27.5 18.2 14.8 22.2 22.2 44.7 19.8 34.0 32.0 42.2 58.9 48.4 39.0 52.8 52.8 54.6 43.6 9.5 27.7 23.7 69.0 51.0 59.5 26.1 24.8 18.9 29.7 22.4 20.6 22.5 22.0 24.4 12.3 98.3 106.3 255.4 204.6 230.6 88.2 209.9 272.6 84.3 121.7 275.7 35.3 385.7 494.0 274.0 3.3 148.1 318.7 303.7 319.8 368.1 203.9 216.1 191.4 557.4 340.7 52.4 317.3 186.6 292.7 7.4 168.2 251.5 251.4 301.2 382.3 151.0 288.4 321.1 165.9 606.1 75.5 161.7 184.4 17.2 37.7 253.9 377.1 200.3 398.2 277.3 NDUFB3 B12 ENSG00000119013 "NADH:ubiquinone oxidoreductase subunit B3" O43676 2 201071433-201085750 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.9" "Cell type enhanced" "Detected in all" 10 "Cardiomyocytes: 1805.8;Distal tubular cells: 901.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034596 Enhanced NA NA "HPA034596: AB_10602712" "unprognostic (5.38e-2)" "unprognostic (2.90e-1)" "unprognostic (4.46e-2)" "unprognostic (6.85e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (7.24e-4)" "unprognostic (1.41e-3)" "unprognostic (6.29e-2)" "unprognostic (8.81e-3)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-1)" "unprognostic (1.37e-2)" "unprognostic (9.40e-3)" "unprognostic (9.20e-2)" "unprognostic (1.94e-1)" "unprognostic (7.27e-2)" 16.9 19.9 23.4 13.9 23.6 10.1 14.7 13.5 33.3 10.4 27.1 8.2 16.8 23.8 8.4 18.9 21.1 8.6 13.0 57.5 24.2 19.9 35.2 25.8 10.4 12.6 25.6 29.7 6.8 13.0 15.3 13.2 10.9 20.8 11.7 23.8 8.8 21.8 11.7 113.9 8.6 21.2 10.8 19.2 13.4 17.5 17.2 17.8 10.8 11.6 39.1 16.9 9.4 12.0 40.5 55.8 66.2 52.9 36.4 47.3 27.2 25.1 20.6 31.1 17.6 26.6 22.9 26.7 29.4 18.6 21.7 23.8 46.1 31.2 18.1 36.5 24.1 34.8 23.9 25.4 35.8 33.2 37.3 59.5 42.1 49.9 54.3 17.2 60.6 24.7 22.3 27.1 25.4 15.1 25.9 27.9 33.3 38.3 35.8 34.3 29.3 43.4 67.3 20.7 48.1 68.3 31.8 25.9 55.9 46.2 38.4 31.1 22.7 22.5 23.7 36.8 47.5 22.1 54.0 27.9 20.8 27.8 22.0 31.6 27.3 54.2 61.4 37.7 35.5 24.1 43.5 37.7 40.0 32.7 51.7 36.3 40.5 38.5 37.8 45.8 31.4 33.8 41.2 66.2 36.4 52.9 55.8 47.3 27.2 23.4 23.6 13.5 33.3 24.2 19.9 25.6 29.7 20.8 17.8 74.5 43.1 110.7 86.1 69.4 45.6 1805.8 155.4 131.2 79.6 177.9 11.8 229.3 901.9 200.3 116.7 76.5 387.2 23.3 176.3 165.0 71.9 72.2 76.2 207.9 250.1 30.2 140.6 86.5 115.2 32.2 88.3 118.4 160.3 347.2 205.2 105.4 170.7 284.0 95.5 609.5 64.6 90.5 95.2 200.4 91.8 80.4 131.8 87.3 261.2 108.6 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596309-120602500 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.7" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 1416.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051739, HPA064441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Mitochondria" No No Mitochondria "Nucleoplasm, Nuclear membrane" "HPA051739: AB_2681585, HPA064441: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favorable (1.79e-4)" 25.5 68.2 37.6 20.1 37.7 22.4 59.4 40.7 51.6 25.6 37.2 19.1 25.6 33.6 23.2 32.2 30.2 24.3 27.8 130.2 32.5 30.8 53.3 46.9 25.4 42.0 37.3 29.4 25.8 36.5 34.1 32.8 18.5 36.7 26.8 34.8 24.6 33.9 29.5 195.7 27.3 30.6 37.6 32.4 22.6 28.7 26.6 25.6 31.1 25.9 64.8 25.4 32.3 29.1 64.5 73.4 52.1 60.5 39.1 79.7 49.0 51.3 37.5 44.9 44.9 28.3 33.8 36.5 28.9 38.4 37.6 41.6 36.4 39.5 26.1 58.7 32.3 47.2 49.8 34.6 36.8 28.4 40.0 39.8 40.3 39.4 36.6 17.2 35.4 47.8 30.5 49.1 18.3 24.1 45.6 46.9 49.7 23.8 40.2 40.3 40.3 70.0 51.3 35.7 84.6 102.8 40.6 25.6 57.4 60.9 32.1 50.6 51.8 33.9 38.0 61.5 31.3 64.0 56.5 36.0 33.3 43.9 14.1 40.2 49.6 44.7 78.9 52.6 49.9 45.1 46.2 46.2 52.1 45.5 60.5 47.4 64.5 63.5 51.3 58.4 47.2 54.8 53.4 28.1 39.1 60.5 73.4 79.7 49.0 37.6 37.7 40.7 51.6 32.5 30.8 37.3 29.4 36.7 25.6 151.8 116.9 147.4 227.4 197.5 114.3 1416.5 333.7 208.8 175.1 303.6 55.0 310.4 1039.5 474.7 797.6 248.2 436.8 93.5 541.7 349.0 180.0 247.2 169.9 411.5 288.6 79.4 286.7 153.4 221.7 73.1 254.9 235.4 411.7 399.5 378.0 175.1 503.3 436.8 260.6 758.9 123.5 252.2 270.2 329.1 90.3 219.8 294.7 162.0 391.3 307.0 NDUFB5 "CI-SGDH, MGC12314, SGDH" ENSG00000136521 "NADH:ubiquinone oxidoreductase subunit B5" O43674 3 179604690-179627647 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005640 Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA005640: AB_1079461" "unprognostic (6.76e-2)" "unprognostic (1.09e-2)" "unprognostic (6.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-1)" "unprognostic (7.35e-3)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "unprognostic (4.46e-2)" "unprognostic (5.96e-3)" "unprognostic (4.83e-2)" "unprognostic (7.11e-2)" "prognostic favorable (3.32e-5)" "unprognostic (3.05e-1)" "unprognostic (1.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" 32.2 39.6 41.3 16.0 44.6 12.1 27.2 20.0 45.7 23.7 32.3 22.0 21.2 43.7 16.2 15.4 26.4 20.0 20.5 86.9 34.1 31.7 48.1 42.3 17.8 21.7 39.4 33.6 22.1 23.2 31.1 18.7 21.3 37.6 19.6 29.9 24.8 35.8 21.3 96.3 17.5 38.5 21.3 30.9 20.4 24.9 21.8 18.4 22.7 27.7 47.3 18.5 26.5 17.3 27.7 41.4 19.5 44.9 14.6 25.0 26.7 23.4 6.6 16.4 19.9 21.7 29.2 22.2 14.9 18.8 21.3 21.6 19.7 17.1 20.5 45.2 12.6 36.6 26.0 17.7 19.7 21.5 42.4 14.8 22.0 12.0 16.4 19.9 26.3 17.5 26.9 25.5 12.0 20.0 22.1 24.4 20.0 18.6 29.9 22.8 16.7 15.1 20.4 23.7 45.5 26.7 16.8 19.0 63.6 38.6 18.1 11.7 19.6 9.0 50.9 35.1 15.4 77.6 42.9 15.7 14.1 13.4 19.2 35.4 39.8 41.2 30.3 22.8 28.2 20.0 19.5 29.9 14.4 13.9 37.6 22.1 27.7 20.0 17.0 41.4 19.5 20.8 21.0 6.7 14.6 44.9 24.0 25.0 26.7 41.3 44.6 20.0 45.7 34.1 31.7 39.4 33.6 37.6 18.4 44.7 44.0 87.9 92.8 75.7 45.3 340.1 112.1 52.2 53.4 83.7 31.4 192.8 431.0 110.3 85.8 85.1 125.2 0.0 92.5 115.9 83.1 75.7 92.3 108.0 222.8 38.1 112.9 97.6 229.9 13.7 75.1 156.2 128.2 124.4 173.7 74.4 86.7 189.4 65.7 379.0 54.1 71.1 81.4 233.1 125.2 77.5 192.3 81.2 242.9 137.2 NDUFB6 "B17, CI" ENSG00000165264 "NADH:ubiquinone oxidoreductase subunit B6" O95139 9 32552999-32573184 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 591.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044001, HPA053334" Supported Enhanced Mitochondria No No Mitochondria "HPA044001: AB_10959448, HPA053334: AB_2682116" "unprognostic (4.09e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.81e-2)" "unprognostic (1.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.10e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-3)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "prognostic favorable (7.47e-10)" "unprognostic (2.70e-1)" "unprognostic (1.82e-1)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" 21.9 26.8 33.9 17.7 31.8 16.0 18.7 22.6 28.3 13.7 21.9 15.5 17.3 26.5 16.8 17.4 18.6 15.4 15.9 58.6 27.6 27.9 32.8 36.6 13.9 15.4 28.4 27.2 14.1 19.5 15.4 17.8 15.5 22.9 15.1 18.2 14.6 22.7 16.1 87.2 14.6 25.5 16.4 25.9 13.5 20.0 28.9 17.1 19.2 22.2 34.4 14.5 14.1 13.5 26.0 38.8 77.4 27.3 22.2 27.5 26.5 30.2 18.6 20.7 23.7 14.1 13.2 13.3 20.3 16.6 18.8 20.8 18.2 13.7 22.6 21.2 13.9 19.5 17.2 19.5 22.4 14.1 31.0 31.3 53.7 28.6 18.8 13.8 26.7 13.9 13.6 10.9 16.9 12.9 14.2 16.9 34.7 17.1 25.5 20.9 17.5 36.0 63.1 21.9 26.0 41.4 24.8 17.4 20.9 21.0 11.4 20.9 23.6 23.5 27.0 13.6 16.2 25.5 20.8 15.0 20.5 31.1 22.6 29.7 11.4 21.2 36.6 34.3 18.9 9.6 25.0 25.8 33.3 21.0 23.1 20.2 26.0 22.4 21.6 27.6 21.8 23.0 24.3 77.4 22.2 27.3 38.8 27.5 26.5 33.9 31.8 22.6 28.3 27.6 27.9 28.4 27.2 22.9 17.1 116.1 94.0 77.4 80.5 83.7 39.2 514.3 107.0 155.2 108.1 102.9 5.9 175.9 452.6 143.9 591.4 96.3 138.7 93.5 145.0 113.2 93.0 79.2 86.8 170.4 141.7 17.5 62.0 71.8 59.8 88.6 84.8 89.6 151.8 111.8 116.6 72.0 133.2 118.5 84.5 440.9 40.8 103.5 124.6 143.8 114.3 84.6 87.1 65.4 146.3 88.4 NDUFB8 "ASHI, CI-ASHI" ENSG00000166136 "NADH:ubiquinone oxidoreductase subunit B8" O95169 10 100523740-100530000 "Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 742.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003886, HPA065549" Supported Enhanced Mitochondria NA NA Mitochondria "HPA003886: AB_1079463, HPA065549: " "unprognostic (4.07e-2)" "unprognostic (1.95e-3)" "unprognostic (2.28e-1)" "unprognostic (7.33e-2)" "unprognostic (4.88e-2)" "unprognostic (5.78e-2)" "unprognostic (3.02e-1)" "unprognostic (6.46e-2)" "unprognostic (8.33e-2)" "unprognostic (9.09e-2)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (5.10e-2)" 35.2 39.8 86.7 27.0 67.4 35.6 26.1 39.3 81.5 25.4 37.7 23.8 23.1 38.8 24.7 42.3 36.8 28.8 28.2 110.0 70.6 62.8 50.4 50.6 19.8 28.1 63.9 54.1 27.7 36.3 31.5 31.4 19.9 49.9 26.6 36.2 25.7 39.7 34.5 88.5 24.3 33.8 41.5 38.9 22.1 31.5 12.0 41.4 18.3 28.3 49.2 27.8 25.2 21.5 76.6 88.6 62.2 74.4 60.5 105.9 129.7 42.2 71.3 38.5 68.3 29.2 28.4 42.6 28.9 62.8 44.4 48.1 96.6 49.3 44.8 26.1 32.3 32.8 50.7 28.8 46.9 35.4 29.4 73.6 31.5 60.5 78.2 39.6 64.3 54.3 34.9 42.4 44.3 59.8 32.2 48.5 59.6 32.7 28.5 38.2 51.3 62.0 81.0 25.8 54.4 66.6 43.3 42.1 59.1 52.0 48.4 26.7 37.4 21.3 40.5 41.9 27.6 60.3 57.6 32.5 25.4 28.8 27.1 50.5 51.7 46.9 55.6 50.5 68.2 28.3 35.1 74.4 62.2 59.0 72.9 69.5 76.6 73.6 67.8 80.4 64.1 79.8 76.7 17.1 60.5 61.4 88.6 105.9 129.7 86.7 67.4 39.3 81.5 70.6 62.8 63.9 54.1 49.9 41.4 71.5 126.9 126.6 146.5 0.0 174.3 341.7 234.4 156.6 88.7 188.5 55.0 285.1 742.8 226.5 20.4 131.5 123.8 116.8 230.9 258.4 136.0 175.3 101.1 286.9 348.6 144.6 101.8 146.7 171.1 43.8 202.0 160.0 0.0 261.5 229.2 129.5 225.4 259.6 204.4 592.8 122.1 168.1 220.6 53.7 79.5 0.0 257.3 174.0 305.7 185.2 NDUFC2 "B14.5b, HLC-1" ENSG00000151366 "NADH:ubiquinone oxidoreductase subunit C2" O95298 11 78068304-78080219 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria NA NA Mitochondria "HPA038873: AB_10673480, HPA056195: AB_2683063" "unprognostic (7.32e-2)" "unprognostic (5.91e-3)" "unprognostic (4.00e-2)" "unprognostic (6.14e-2)" "unprognostic (1.94e-1)" "unprognostic (8.97e-2)" "unprognostic (1.60e-1)" "unprognostic (4.23e-3)" "unprognostic (4.75e-3)" "unprognostic (3.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "prognostic favorable (5.00e-5)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (4.18e-2)" "unprognostic (3.61e-3)" 55.0 70.8 40.8 23.3 44.4 32.3 46.2 51.4 58.4 22.5 41.1 31.2 68.0 63.4 31.8 32.8 41.8 35.6 31.9 60.4 41.0 44.5 37.5 89.6 30.1 36.4 43.2 47.0 27.3 48.4 25.3 34.7 31.8 40.8 27.3 20.3 29.7 79.5 59.0 122.8 29.0 55.3 23.7 41.1 24.5 36.6 28.6 23.2 26.9 63.5 43.7 23.3 31.9 24.1 50.3 78.2 70.3 73.2 44.5 46.3 81.2 36.0 45.0 24.5 15.4 23.3 14.7 30.2 44.1 26.5 35.1 25.0 120.6 40.5 21.6 80.9 20.8 28.7 38.1 18.4 25.9 13.4 40.9 52.1 23.2 46.7 94.9 39.8 50.7 23.1 20.4 24.1 26.9 10.2 21.6 23.8 23.2 45.7 36.5 19.6 62.1 33.1 91.4 27.6 88.8 56.9 29.0 46.6 73.1 26.5 54.3 34.6 30.7 31.4 64.8 22.7 22.3 51.3 42.1 31.1 34.2 42.2 81.4 37.8 33.6 65.8 49.7 19.5 30.5 32.7 65.8 73.2 70.3 39.4 58.2 36.2 50.3 45.6 41.5 77.2 45.5 39.6 41.3 21.0 44.5 48.0 78.2 46.3 81.2 40.8 44.4 51.4 58.4 41.0 44.5 43.2 47.0 40.8 23.2 154.9 160.2 100.4 139.2 84.8 134.1 213.8 247.1 202.1 144.5 371.6 62.8 347.5 258.6 334.7 231.4 158.7 177.9 70.0 374.9 317.5 154.4 190.2 148.0 738.1 305.1 85.8 161.2 184.1 179.8 53.3 199.6 133.3 232.8 193.8 274.2 214.0 379.3 301.9 189.5 354.7 91.8 232.8 163.6 380.6 170.3 100.0 323.7 113.3 343.3 186.0 NDUFC2-KCTD14 ENSG00000259112 "NDUFC2-KCTD14 readthrough" E9PQ53 11 78016971-78079865 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 9 "Alveolar cells type 2: 1.3;Ciliated cells: 2.7;Club cells: 2.3;Melanocytes: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 10.4;EFO-21: 8.5;RPMI-8226: 7.5;U-2 OS: 13.0" "HPA038873, HPA056195" Approved Supported Mitochondria NA NA Mitochondria "HPA038873: AB_10673480, HPA056195: AB_2683063" 7.1 11.3 6.3 5.8 7.9 9.7 8.9 13.8 11.7 9.6 7.4 5.5 13.8 27.3 8.8 5.9 9.5 9.7 5.6 11.3 7.7 7.1 6.9 18.7 6.6 6.7 6.4 9.1 6.6 8.8 5.4 5.6 5.6 7.7 8.4 6.3 5.1 18.0 11.8 10.1 5.7 10.6 5.9 5.9 5.9 15.9 4.9 3.7 4.5 12.7 8.3 4.8 4.6 6.1 30.7 37.7 30.7 33.7 16.5 33.2 39.7 0.0 2.1 0.6 0.6 0.6 0.0 1.4 1.5 0.9 1.3 2.9 10.4 1.2 0.2 8.5 0.0 1.8 0.3 1.7 0.0 0.7 5.9 0.0 1.2 0.0 0.0 0.7 0.8 2.1 0.0 0.3 0.3 1.8 1.8 0.9 6.4 0.3 0.1 0.2 0.0 3.0 1.1 5.2 1.0 0.3 1.0 0.1 7.5 0.0 0.0 1.5 2.3 0.0 1.1 3.3 0.0 0.6 1.1 0.9 0.5 13.0 4.2 0.0 1.2 1.4 3.0 0.8 0.3 1.4 22.5 33.7 30.7 24.5 24.1 19.3 30.7 22.8 23.0 37.7 23.7 20.5 21.5 10.0 16.5 25.7 37.5 33.2 39.7 6.3 7.9 13.8 11.7 7.7 7.1 6.4 9.1 7.7 3.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 NECTIN1 "CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12" ENSG00000110400 "Nectin cell adhesion molecule 1" Q15223 11 119623408-119729084 "CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 55.3;skin 1: 73.5" "Cell type enhanced" "Detected in some" 10 "Club cells: 7.9;Ductal cells: 6.5;Exocrine glandular cells: 10.7;Pancreatic endocrine cells: 12.5;Syncytiotrophoblasts: 7.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 59.2;hTCEpi: 36.9;RT4: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016135, HPA026846" Approved "Secreted in other tissues" NA NA 97000000 "CAB016135: AB_626865, HPA026846: AB_1846226" "unprognostic (1.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.11e-1)" "unprognostic (3.87e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-2)" "unprognostic (2.25e-3)" "unprognostic (2.03e-1)" "unprognostic (3.76e-2)" "unprognostic (3.42e-1)" "unprognostic (3.58e-2)" "unprognostic (3.28e-1)" "unprognostic (3.59e-3)" "unprognostic (2.13e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (9.62e-2)" 3.1 3.0 7.7 3.0 11.1 11.9 5.3 8.4 20.8 6.6 7.3 27.3 2.4 9.6 2.3 2.0 55.3 2.9 2.5 3.0 16.1 8.2 3.0 2.4 2.5 1.7 12.7 10.6 1.8 10.8 2.4 4.1 8.2 10.1 5.9 7.8 6.3 8.7 4.4 1.6 73.5 6.9 3.1 14.3 2.2 3.2 1.3 12.4 2.5 1.8 25.3 20.8 17.3 14.8 0.1 4.8 1.0 1.5 0.1 0.1 0.2 4.1 3.4 3.3 4.7 1.7 0.5 23.2 1.6 1.5 1.4 1.0 7.3 14.2 5.5 6.9 1.9 2.8 59.2 8.4 30.2 0.6 12.9 1.3 0.7 1.1 3.3 0.7 3.7 9.3 0.5 36.9 4.4 16.5 0.5 4.2 1.6 0.1 29.4 1.8 10.8 0.0 2.2 10.8 14.0 4.8 0.3 19.8 6.6 1.3 40.1 8.0 18.0 5.6 14.9 0.5 5.2 13.5 0.5 2.3 1.2 4.7 10.2 1.5 5.4 6.8 0.0 0.4 3.0 2.8 0.0 0.3 0.2 0.1 0.5 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 1.0 0.1 1.5 4.8 0.0 0.2 7.7 11.1 8.4 20.8 16.1 8.2 12.7 10.6 10.1 12.4 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 2.7 7.9 1.8 0.0 3.5 0.0 6.5 0.0 0.0 0.0 0.0 10.7 0.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 12.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 NECTIN2 "CD112, HVEB, PRR2, PVRL2, PVRR2" ENSG00000130202 "Nectin cell adhesion molecule 2" Q92692 19 44846175-44889228 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ductal cells: 182.4;Exocrine glandular cells: 136.8;monocytes: 139.7;Pancreatic endocrine cells: 178.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 11.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012759, CAB026138, HPA073459" Enhanced Approved "Nucleoli fibrillar center,Cell Junctions" NA NA 3400000 "Nucleoli fibrillar center, Cell Junctions" "CAB026138: , HPA012759: AB_1846227, HPA073459: " "unprognostic (3.30e-2)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "unprognostic (5.61e-3)" "unprognostic (7.45e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-2)" "unprognostic (6.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.97e-1)" "unprognostic (6.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (2.15e-1)" "unprognostic (1.61e-1)" "unprognostic (8.19e-2)" "unprognostic (2.05e-1)" 29.5 28.2 7.9 15.6 7.7 5.6 38.0 4.5 9.0 24.2 34.0 9.3 22.3 24.2 23.2 27.4 33.6 16.7 54.1 21.9 10.5 8.1 29.0 53.7 39.6 23.0 8.2 6.8 25.5 20.6 22.5 15.9 45.8 11.2 25.8 14.8 22.9 24.4 28.9 14.6 18.3 42.9 13.8 8.4 31.4 26.2 38.7 5.8 3.8 32.2 19.2 24.1 21.6 31.4 0.0 3.3 11.5 2.6 0.0 0.3 0.7 16.9 20.3 26.2 31.0 13.3 8.1 30.5 14.5 18.0 25.7 29.7 41.9 37.3 0.1 19.6 16.7 13.5 23.2 23.2 12.0 20.5 0.7 12.1 10.3 7.0 27.0 31.9 0.1 27.5 14.1 4.8 12.2 10.0 27.4 33.2 0.6 16.7 0.1 12.8 30.8 0.1 1.2 21.8 53.0 6.1 0.9 8.9 0.6 30.4 20.9 1.2 3.5 18.0 27.4 6.2 49.0 21.4 10.0 33.1 7.1 24.9 5.2 10.7 2.1 6.0 0.1 12.9 2.2 18.3 1.5 2.6 11.5 0.0 0.9 0.3 0.0 0.1 0.0 3.3 0.0 0.0 0.0 2.4 0.0 0.5 0.3 0.0 0.7 7.9 7.7 4.5 9.0 10.5 8.1 8.2 6.8 11.2 5.8 32.8 33.2 0.0 0.0 0.0 0.0 0.0 0.0 6.7 12.5 55.8 0.0 82.4 3.3 182.4 0.0 0.0 0.0 0.0 136.8 82.2 0.0 0.0 3.5 0.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 139.7 0.0 0.0 178.3 0.0 0.0 25.8 0.0 0.0 0.0 0.0 0.0 0.0 85.1 0.0 0.0 0.0 NECTIN3 "CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3" ENSG00000177707 "Nectin cell adhesion molecule 3" Q9NQS3 3 111070071-111275563 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 94.2" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 4 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "AF22: 33.5;TIME: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009869, HPA011038" Approved Approved "Cell Junctions,Cytosol" NA NA 20000000 Cytosol "Cell Junctions" "CAB009869: AB_2284699, HPA011038: AB_1079719" "unprognostic (3.76e-2)" "unprognostic (3.81e-3)" "unprognostic (1.74e-1)" "unprognostic (1.97e-2)" "unprognostic (1.02e-1)" "unprognostic (9.77e-2)" "unprognostic (3.26e-3)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (3.94e-2)" "unprognostic (5.33e-2)" "unprognostic (7.04e-2)" "prognostic favorable (9.82e-7)" "unprognostic (2.01e-1)" "unprognostic (1.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.05e-1)" 5.6 4.0 5.4 4.4 6.0 0.0 4.5 1.3 8.9 4.6 12.6 6.5 2.8 17.8 5.0 2.2 3.5 5.4 4.4 4.8 6.3 5.0 6.9 16.4 5.6 1.9 6.0 4.1 9.2 4.7 1.9 1.9 94.2 5.5 6.9 12.6 10.7 3.4 4.8 2.3 1.8 18.9 7.2 8.9 1.8 13.2 27.6 4.5 0.4 24.1 2.0 1.4 5.4 7.7 0.1 0.0 0.3 0.0 0.2 1.7 0.7 0.0 10.1 33.5 2.2 13.6 25.2 2.0 22.0 23.3 13.7 11.7 9.3 4.7 0.0 7.3 31.3 7.6 0.1 9.3 3.2 25.2 0.2 2.5 0.0 3.6 0.7 23.0 1.6 0.3 12.7 1.4 9.0 8.7 12.3 11.5 0.4 0.0 8.8 29.5 0.0 2.2 0.0 9.4 3.1 3.6 0.0 16.6 0.0 8.5 5.3 0.8 6.1 0.4 0.0 4.6 11.7 0.3 0.1 47.5 17.4 7.2 3.1 13.1 4.9 0.0 0.0 11.0 0.0 16.0 0.0 0.0 0.3 0.1 0.0 1.2 0.0 1.7 1.0 0.0 0.1 0.3 0.4 0.0 0.2 0.0 0.0 0.1 0.7 5.4 6.0 1.3 8.9 6.3 5.0 6.0 4.1 5.5 4.5 23.8 7.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.7 12.2 0.0 3.3 0.0 3.9 0.0 0.0 0.0 0.0 16.4 7.6 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 13.3 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 98.1 0.0 0.0 0.0 NECTIN4 "LNIR, nectin-4, PRR4, PVRL4" ENSG00000143217 "Nectin cell adhesion molecule 4" Q96NY8 1 161070995-161089599 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.1;placenta: 46.6;skin 1: 39.3" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 321.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "BEWO: 28.2;HaCaT: 18.2;MCF7: 11.4;OE19: 11.8;SK-BR-3: 23.7;T-47d: 15.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA010775 Enhanced Supported "Plasma membrane" "Secreted in other tissues" No No 11000 "Plasma membrane" "HPA010775: AB_1079720" "unprognostic (1.09e-3)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (1.11e-2)" "unprognostic (5.69e-3)" "unprognostic (2.09e-2)" "unprognostic (6.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-3)" "unprognostic (1.13e-1)" "unprognostic (2.24e-8)" "unprognostic (2.98e-2)" "unprognostic (2.43e-1)" "unprognostic (3.68e-2)" "unprognostic (4.97e-2)" 0.2 0.1 0.1 0.8 0.1 0.1 7.7 0.1 0.1 9.8 0.6 0.1 5.4 0.2 1.5 3.7 40.1 1.4 5.6 0.1 0.1 0.1 1.3 0.2 3.1 0.0 0.1 0.0 0.5 4.4 0.0 0.3 46.6 0.1 7.8 0.7 0.1 13.5 5.5 0.1 39.3 0.4 2.0 0.1 0.1 4.5 0.2 0.0 0.5 0.1 22.7 23.1 12.6 18.5 0.2 0.3 3.6 0.1 0.1 0.2 0.0 5.2 0.1 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.1 0.0 7.1 0.0 0.1 0.0 0.0 18.2 0.0 0.6 0.1 0.0 0.2 0.0 0.4 5.3 0.0 0.0 0.3 0.0 7.2 1.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.1 0.1 23.7 0.0 3.3 15.3 0.0 0.0 0.0 1.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.1 1.2 0.2 0.0 0.1 0.2 0.2 0.0 0.3 0.2 0.1 0.1 3.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 6.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 18.7 14.8 15.7 0.0 24.1 0.0 34.7 0.0 0.0 0.0 0.0 26.2 43.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.0 0.0 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 321.3 0.0 0.0 0.0 NELL2 NRP2 ENSG00000184613 "Neural EGFL like 2" Q99435 12 44508275-44921848 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.8;brain: 73.3;fallopian tube: 35.1" "Group enriched" "Detected in many" 6 "Bipolar cells: 38.4;Ciliated cells: 40.2;Club cells: 11.4;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 43.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 33.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 24.5;naive CD8 T-cell: 36.8" "Lineage enriched" "Detected in many" 11 "T-cells: 36.8" "Cell line enhanced" "Detected in some" "AF22: 41.8;HEK 293: 10.9;NTERA-2: 16.4;SCLC-21H: 30.4;U-266/70: 11.1;U-266/84: 11.1;U-698: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035714, HPA035715" Uncertain Approved Vesicles "Secreted to blood" NA NA 4700000 Vesicles "HPA035714: AB_2674746, HPA035715: AB_10669602" "unprognostic (4.25e-3)" "unprognostic (4.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (7.18e-2)" "unprognostic (5.85e-2)" "unprognostic (2.59e-2)" "unprognostic (4.85e-2)" "unprognostic (2.80e-1)" "prognostic favorable (5.56e-4)" "unprognostic (1.19e-1)" "unprognostic (1.71e-5)" "unprognostic (8.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.60e-3)" "unprognostic (3.75e-2)" 2.0 10.5 22.4 6.1 24.8 4.2 1.6 15.7 73.3 14.9 2.9 3.6 0.0 15.3 1.9 0.8 1.3 35.1 1.7 0.8 40.2 20.4 1.2 1.1 3.4 11.2 6.6 27.0 1.0 1.1 0.6 18.4 0.8 7.5 18.8 1.8 9.3 1.5 1.8 0.7 5.0 8.6 2.2 2.6 3.8 2.1 2.2 2.4 0.4 4.4 0.0 9.1 2.3 2.0 0.0 0.0 0.1 0.0 3.3 36.8 8.5 0.1 0.0 41.8 1.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 5.0 0.0 0.0 0.1 9.9 0.0 0.0 0.0 10.9 0.1 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.1 16.4 0.0 5.4 0.0 5.0 0.0 0.0 0.0 30.4 0.7 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.2 1.5 0.0 0.7 11.1 11.1 15.1 0.1 0.1 0.2 0.0 0.0 0.0 1.6 0.0 8.5 0.0 10.3 18.1 0.0 0.0 24.5 36.8 0.1 3.3 0.0 0.0 0.1 8.5 22.4 24.8 15.7 50.4 40.2 20.4 6.6 27.0 7.5 2.4 0.0 2.2 0.0 0.0 1.0 38.4 0.4 0.0 40.2 11.4 0.0 31.4 0.1 0.0 0.0 0.2 0.5 5.4 0.0 0.2 0.2 1.4 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 5.2 0.3 0.0 0.4 0.1 43.8 0.0 1.4 1.5 3.4 1.0 0.1 5.3 0.6 0.0 NEMP1 "KIAA0286, TMEM194, TMEM194A" ENSG00000166881 "Nuclear envelope integral membrane protein 1" O14524 12 57055643-57088063 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 20.8;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014394 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA014394: AB_2204899" "unprognostic (9.24e-2)" "unprognostic (1.78e-1)" "unprognostic (1.18e-1)" "unprognostic (4.97e-2)" "unprognostic (1.43e-1)" "unprognostic (4.57e-3)" "prognostic unfavorable (1.93e-4)" "unprognostic (8.36e-2)" "unprognostic (2.42e-3)" "unprognostic (2.11e-1)" "unprognostic (1.64e-1)" "unprognostic (6.61e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (2.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.63e-2)" "unprognostic (7.05e-2)" 9.5 7.3 7.6 16.7 7.8 7.8 8.6 10.6 8.5 8.1 12.2 8.1 3.6 4.9 14.8 7.6 8.8 9.4 5.8 4.8 6.6 3.8 6.0 8.1 9.7 15.1 7.7 5.8 12.3 6.4 5.9 12.7 20.6 6.2 9.6 9.4 8.2 7.2 7.5 3.6 14.3 11.0 12.8 8.3 11.4 8.5 15.4 6.9 26.6 8.7 4.1 15.1 9.3 8.9 4.6 2.2 5.5 3.5 5.4 4.7 2.0 8.1 6.9 15.9 17.1 5.3 5.3 9.1 12.6 7.2 17.6 14.3 8.2 15.6 19.3 16.3 4.3 15.0 12.0 21.1 5.4 20.3 10.2 9.6 11.4 8.0 4.3 2.3 14.1 13.1 1.8 5.2 14.4 9.0 7.3 4.8 17.6 23.1 38.6 14.7 4.4 15.4 12.0 8.9 7.7 7.7 15.7 22.6 8.8 3.8 5.0 9.5 6.4 10.7 9.0 10.1 11.8 16.2 14.2 3.4 16.8 9.8 15.4 11.7 17.4 33.1 17.0 9.9 13.6 17.2 5.5 1.1 1.9 2.8 3.5 3.7 4.6 3.1 3.6 1.2 3.6 4.7 3.9 0.5 5.4 2.0 2.2 2.8 2.0 7.6 7.8 10.6 8.5 6.6 3.8 7.7 5.8 6.2 6.9 20.8 1.6 0.0 2.9 0.0 2.3 1.2 0.0 5.3 3.4 5.2 3.9 3.2 0.0 1.7 1.0 2.9 0.4 0.0 0.7 3.1 2.1 3.6 0.0 3.9 4.8 1.6 0.0 5.5 5.3 0.2 5.8 5.9 0.0 3.6 1.7 2.9 2.1 0.0 4.9 0.6 3.9 12.9 1.9 10.1 6.9 0.0 2.5 3.2 1.8 2.0 NEMP2 TMEM194B ENSG00000189362 "Nuclear envelope integral membrane protein 2" A6NFY4 2 190504342-190534722 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 27.3" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" HPA057719 Approved Nucleoplasm NA NA Nucleoplasm "HPA057719: AB_2683510" "unprognostic (3.51e-1)" "unprognostic (9.99e-2)" "unprognostic (1.11e-3)" "unprognostic (1.05e-2)" "unprognostic (2.06e-2)" "unprognostic (1.03e-1)" "unprognostic (8.65e-3)" "unprognostic (5.70e-2)" "unprognostic (1.06e-1)" "unprognostic (5.61e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (5.82e-2)" "unprognostic (7.76e-3)" "unprognostic (4.75e-3)" "unprognostic (1.32e-1)" 7.8 4.9 2.9 14.5 2.9 4.5 4.3 7.5 3.6 6.0 3.6 4.3 2.2 2.5 8.5 6.8 4.4 3.3 3.0 4.3 3.5 2.9 5.7 5.7 9.3 11.3 3.8 3.2 5.6 3.2 2.6 4.0 3.7 3.4 3.9 2.6 6.6 9.3 4.8 1.7 5.1 4.5 3.4 3.4 12.3 5.1 8.1 2.4 27.3 5.4 3.5 15.8 4.4 4.3 3.6 3.4 0.2 0.8 2.4 5.6 2.2 5.2 2.8 1.9 2.4 1.1 3.0 5.1 3.8 3.3 3.8 4.7 4.2 7.3 7.6 2.5 1.9 2.7 9.3 3.0 8.1 7.6 5.6 2.6 5.5 2.8 2.9 2.9 5.9 1.9 3.1 3.4 17.3 4.5 3.5 1.7 8.5 4.7 9.0 7.3 2.4 6.4 2.8 2.1 2.9 3.1 2.7 4.2 3.5 3.4 3.9 3.5 3.0 5.9 0.6 5.7 3.4 1.5 6.4 3.1 8.5 6.6 1.6 4.1 4.9 5.3 4.1 6.5 6.2 6.1 0.1 0.8 0.1 3.0 0.7 3.9 2.7 3.3 2.7 0.9 3.6 5.4 4.6 0.2 2.4 0.6 3.4 5.6 2.2 2.9 2.9 7.5 3.6 3.5 2.9 3.8 3.2 3.4 2.4 0.0 1.1 2.4 1.3 0.0 4.5 1.6 0.0 0.0 0.0 1.8 0.0 2.1 0.0 1.5 2.5 3.8 0.0 0.0 1.7 2.8 1.3 1.5 1.1 2.5 2.6 3.2 0.0 3.1 5.4 4.2 2.6 2.3 0.0 1.8 1.2 3.3 0.6 1.5 1.1 2.1 2.1 0.0 2.5 16.7 5.9 0.0 1.0 5.7 1.8 1.3 NEO1 "HsT17534, IGDCC2, NGN, NTN1R2" ENSG00000067141 "Neogenin 1" Q92859 15 73051710-73305206 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 57.8;Peritubular cells: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009320, HPA027804, HPA027805, HPA027806" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 280000000 "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006" "unprognostic (1.90e-1)" "unprognostic (2.38e-2)" "unprognostic (7.60e-3)" "unprognostic (3.76e-2)" "unprognostic (5.44e-1)" "unprognostic (3.83e-2)" "unprognostic (8.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.22e-1)" "unprognostic (3.30e-2)" "unprognostic (5.51e-2)" "unprognostic (8.05e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-2)" "unprognostic (3.75e-1)" 7.3 5.8 19.2 6.2 22.4 1.2 11.4 12.7 23.9 13.4 30.0 44.5 14.8 17.9 14.2 7.2 8.0 15.4 13.4 6.8 20.1 14.1 16.2 5.9 10.7 2.7 27.1 15.7 17.5 11.5 44.4 6.9 1.5 19.3 23.1 36.9 16.0 11.5 25.5 17.9 24.6 19.0 16.0 22.3 3.6 15.1 9.0 22.5 2.1 12.5 3.8 4.7 10.1 9.5 0.0 0.3 1.4 0.3 0.8 3.1 0.3 3.7 18.3 21.9 14.4 13.3 3.9 5.5 1.4 1.8 3.6 0.7 2.7 18.5 1.0 2.2 4.0 13.6 0.8 15.3 8.4 1.5 6.6 11.3 12.3 0.2 2.5 3.8 0.3 0.4 9.6 15.6 0.7 7.2 4.2 0.0 9.6 0.0 23.5 0.8 11.2 4.3 0.2 20.9 2.8 1.5 10.0 11.7 2.4 7.0 10.1 10.0 14.1 17.2 7.7 9.1 18.4 8.1 2.2 0.0 16.9 9.0 5.4 3.9 10.1 18.6 2.6 3.6 3.5 4.7 0.0 0.3 0.4 1.8 0.0 3.1 0.0 1.1 1.4 0.0 0.0 0.6 0.5 1.4 0.8 0.0 0.3 0.0 0.3 19.2 22.4 12.7 23.9 20.1 14.1 27.1 15.7 19.3 22.5 8.9 7.2 1.7 6.9 12.6 14.6 4.2 22.9 4.0 6.8 21.0 13.7 0.5 1.7 8.7 3.0 2.9 34.1 0.0 5.5 0.6 7.9 14.5 0.0 5.9 0.7 9.5 57.8 8.0 0.3 4.1 29.4 0.5 10.1 0.0 37.7 10.4 9.4 38.6 59.1 14.3 21.5 6.5 8.6 5.7 18.1 22.2 0.2 4.5 47.7 6.1 NETO1 "BCTL1, BTCL1" ENSG00000166342 "Neuropilin and tolloid like 1" Q8TDF5 18 72742314-72868146 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 47.9" "Cell type enriched" "Detected in some" 38 "Bipolar cells: 163.9" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 27 "memory B-cell: 1.6;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 38 "B-cells: 3.7" "Cell line enhanced" "Detected in some" "MOLT-4: 15.1;NTERA-2: 6.9;REH: 14.9;RPMI-8226: 23.7;RT4: 15.7;SCLC-21H: 20.9;U-2 OS: 7.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064630 Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA064630: AB_2685305" "unprognostic (4.02e-2)" "unprognostic (4.08e-3)" "unprognostic (2.75e-1)" "unprognostic (1.55e-2)" "unprognostic (6.04e-2)" "unprognostic (1.35e-5)" "unprognostic (4.05e-1)" "unprognostic (4.73e-2)" "unprognostic (3.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.63e-2)" "unprognostic (1.20e-1)" "unprognostic (1.73e-2)" "unprognostic (3.70e-2)" "unprognostic (3.35e-2)" "unprognostic (1.59e-1)" "unprognostic (9.13e-3)" 2.0 0.8 9.1 1.3 18.3 1.0 1.7 0.4 47.9 0.9 0.9 0.7 0.0 0.8 0.9 0.9 1.0 0.8 0.9 1.4 15.9 3.9 1.0 0.8 0.9 3.8 3.0 15.1 0.8 0.8 1.0 0.3 0.8 5.0 0.9 1.1 3.9 1.1 0.8 0.8 1.2 0.8 0.8 1.1 4.0 0.9 2.0 2.8 0.8 2.3 0.0 2.7 1.2 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 6.9 0.0 0.0 14.9 0.0 23.7 3.7 15.7 20.9 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 18.3 0.4 22.8 15.9 3.9 3.0 15.1 5.0 2.8 0.0 0.0 0.0 0.0 0.0 163.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 NETO2 "FLJ10430, NEOT2" ENSG00000171208 "Neuropilin and tolloid like 2" Q8NC67 16 47077703-47143997 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.6;lymphoid tissue: 23.8" "Cell type enhanced" "Detected in many" 11 "Muller glia cells: 40.0;Spermatogonia: 22.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013180 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA013180: AB_1854383" "unprognostic (2.67e-2)" "unprognostic (3.46e-2)" "unprognostic (3.90e-1)" "unprognostic (1.51e-3)" "unprognostic (2.25e-1)" "unprognostic (5.26e-3)" "unprognostic (1.10e-2)" "unprognostic (5.73e-2)" "unprognostic (1.92e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (3.98e-1)" "prognostic unfavorable (5.53e-6)" "unprognostic (3.48e-2)" "unprognostic (1.66e-1)" "unprognostic (6.79e-2)" "unprognostic (1.32e-1)" 3.3 6.7 6.9 6.9 23.6 2.4 3.4 11.8 15.8 1.8 9.5 2.1 0.6 1.9 2.8 0.9 5.6 1.1 5.5 2.4 8.3 5.9 2.5 0.9 5.3 6.6 4.9 7.1 2.0 9.8 11.6 1.4 3.8 13.5 1.4 2.8 10.1 2.6 1.6 4.5 1.7 2.7 1.9 2.5 23.8 1.9 8.6 4.7 1.9 10.0 3.1 6.8 4.2 2.5 1.0 2.1 0.9 3.3 0.3 2.2 0.7 25.0 28.0 40.6 0.1 6.0 35.0 6.7 25.0 4.0 22.2 12.1 5.8 16.1 6.2 15.4 5.3 21.4 11.3 25.9 24.8 27.3 0.1 16.7 5.0 10.0 6.2 7.4 16.0 13.3 21.0 16.6 8.9 12.6 21.6 14.7 15.0 7.4 7.7 14.2 6.8 9.1 8.8 19.5 7.5 20.6 0.0 7.9 12.6 15.6 5.4 26.7 19.4 33.0 2.6 3.7 6.9 0.5 11.8 7.1 0.0 0.0 0.0 0.1 8.3 6.8 13.8 18.1 11.4 17.8 0.9 3.3 0.1 0.1 1.6 1.3 1.0 1.3 0.1 2.1 0.4 0.0 0.1 0.9 0.3 1.5 0.2 2.2 0.7 6.9 23.6 11.8 15.8 8.3 5.9 4.9 7.1 13.5 4.7 0.0 5.0 0.0 0.6 6.9 0.7 1.2 0.0 2.7 3.4 0.0 0.0 0.7 0.0 0.4 2.5 4.4 3.5 0.0 2.6 0.4 2.6 2.0 2.3 0.0 6.3 0.0 10.4 0.6 9.4 4.2 0.6 11.3 3.3 6.4 1.3 40.0 1.1 1.1 0.0 0.0 0.8 6.5 2.5 7.7 22.0 2.9 0.7 1.9 1.6 0.9 NEU1 NEU ENSG00000204386 "Neuraminidase 1" Q99519 6 31857659-31862906 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015634, HPA021506" Approved Supported "Vesicles,Cell Junctions" NA NA 86000 Vesicles "Cell Junctions" "HPA015634: AB_1854386, HPA021506: AB_1854385" "unprognostic (3.84e-2)" "unprognostic (7.47e-2)" "unprognostic (9.64e-2)" "unprognostic (4.65e-2)" "unprognostic (3.00e-1)" "unprognostic (4.42e-3)" "unprognostic (1.38e-3)" "unprognostic (8.58e-3)" "unprognostic (7.49e-2)" "unprognostic (5.21e-2)" "unprognostic (4.44e-3)" "unprognostic (1.27e-1)" "unprognostic (2.70e-2)" "unprognostic (6.22e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (2.13e-3)" 10.5 30.2 8.6 9.4 11.1 5.2 10.5 15.5 14.6 13.4 14.1 7.4 16.1 14.1 9.8 13.9 9.0 8.3 16.1 9.8 8.0 9.5 29.7 24.2 16.1 7.2 9.4 6.6 12.7 20.6 13.6 16.5 19.8 10.3 15.1 9.1 14.7 18.1 13.8 10.0 9.1 23.5 9.8 4.7 13.4 12.7 6.5 10.0 5.8 22.7 7.0 9.6 13.6 9.5 4.2 7.7 15.2 13.4 3.0 5.1 7.4 2.4 2.4 2.4 5.6 8.2 3.1 4.8 2.2 7.5 6.5 9.6 14.1 2.6 0.8 5.7 2.9 38.4 1.3 5.1 2.0 2.5 2.0 3.4 1.2 1.4 16.5 14.7 1.5 6.9 5.1 3.8 7.9 4.1 3.9 5.8 1.6 2.6 5.8 3.3 4.3 1.2 2.3 1.9 4.3 1.9 1.7 1.3 8.5 10.8 5.2 1.8 1.1 2.4 3.3 5.8 3.2 6.2 7.1 2.4 4.3 2.5 6.0 3.9 7.2 11.5 1.7 3.1 3.9 3.0 6.4 13.4 8.7 5.1 10.3 4.2 3.9 3.9 4.1 7.7 4.2 4.0 3.9 15.2 3.0 9.2 4.3 4.8 7.4 8.6 11.1 15.5 14.6 8.0 9.5 9.4 6.6 10.3 10.0 23.8 47.7 44.6 42.4 30.5 24.5 18.7 38.2 10.7 17.0 45.4 23.6 52.4 8.3 82.1 0.8 27.6 80.5 0.0 51.5 49.0 63.2 112.7 66.9 21.3 139.8 9.5 108.9 26.4 42.3 0.7 25.6 53.4 67.4 25.2 37.4 48.4 45.4 80.7 21.9 55.3 29.8 25.8 42.2 5.0 7.5 36.4 164.8 28.7 38.6 31.8 NF1 ENSG00000196712 "Neurofibromin 1" P21359 17 31094927-31382116 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "GTPase activation" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 149.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 2.3;granulocytes: 6.5;T-cells: 8.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045502 Uncertain Approved Mitochondria No No Mitochondria "HPA045502: AB_2679352" "unprognostic (6.69e-2)" "unprognostic (8.73e-2)" "unprognostic (8.26e-2)" "unprognostic (1.76e-2)" "unprognostic (2.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.11e-1)" "unprognostic (1.30e-2)" "unprognostic (3.14e-2)" "unprognostic (3.88e-2)" "unprognostic (1.00e-2)" "unprognostic (2.19e-1)" "unprognostic (1.53e-1)" "unprognostic (1.40e-1)" "unprognostic (3.70e-1)" 12.9 15.9 22.6 13.3 25.9 5.5 18.5 30.2 26.0 17.6 13.6 19.8 12.2 11.0 16.9 17.0 10.5 15.2 13.1 17.3 21.6 19.6 20.0 15.1 12.7 11.5 19.4 25.6 22.9 16.5 34.1 19.0 19.4 20.9 16.1 14.7 12.1 14.4 20.5 14.8 12.0 12.1 14.5 21.4 11.9 13.0 15.4 21.5 11.6 31.1 7.6 12.4 15.3 19.5 2.3 0.7 6.5 0.4 0.9 8.4 1.0 9.8 12.9 15.7 8.4 13.4 17.5 7.9 8.6 15.5 12.7 14.4 11.6 6.7 9.5 2.5 16.0 15.0 17.3 14.2 12.0 21.5 4.6 8.9 8.4 12.1 5.9 9.5 15.0 7.0 13.8 7.7 13.5 16.5 14.4 6.1 10.1 12.0 9.5 12.1 7.8 12.5 5.5 4.6 6.1 4.3 9.8 24.0 7.6 9.6 14.2 6.5 9.8 15.9 5.3 8.8 11.6 16.2 9.6 8.9 10.2 14.2 12.0 3.2 8.7 4.2 10.5 8.3 6.3 10.5 6.5 0.4 0.9 2.3 0.2 1.6 2.3 4.4 3.9 0.5 2.1 3.3 3.2 1.0 0.9 0.4 0.7 8.4 1.0 22.6 25.9 30.2 23.5 21.6 19.6 19.4 25.6 20.9 21.5 29.8 23.6 12.7 38.9 34.3 61.1 39.2 40.8 29.4 20.5 38.4 129.6 44.8 19.9 23.9 149.0 31.8 28.2 0.0 19.3 22.1 28.2 47.4 10.4 31.7 18.9 66.7 19.0 31.9 24.3 70.0 34.5 21.8 20.3 16.2 26.8 49.7 28.6 35.4 47.4 23.7 66.0 45.3 36.7 28.2 25.6 29.6 41.2 18.5 22.6 60.1 NFAM1 CNAIP ENSG00000235568 "NFAT activating protein with ITAM motif 1" Q8NET5 22 42380410-42432395 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.0;bone marrow: 28.0;lymphoid tissue: 35.2" "Cell type enhanced" "Detected in some" 20 "granulocytes: 11.5;Hofbauer cells: 15.6;Kupffer cells: 46.1;Macrophages: 14.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 34.0" "Group enriched" "Detected in many" 4 "granulocytes: 34.0;monocytes: 17.5" "Cell line enriched" "Detected in some" 4 "THP-1: 28.6" "Group enriched" "Detected in many" 4 "basal ganglia: 2.9;hypothalamus: 3.7;midbrain: 7.4;pons and medulla: 7.8;thalamus: 8.3" HPA031812 Uncertain NA NA "HPA031812: AB_10603121" "unprognostic (9.77e-3)" "unprognostic (2.77e-3)" "unprognostic (8.21e-2)" "prognostic favorable (6.16e-4)" "unprognostic (4.83e-2)" "unprognostic (8.76e-3)" "unprognostic (2.34e-1)" "unprognostic (1.08e-1)" "unprognostic (9.12e-3)" "unprognostic (9.97e-2)" "unprognostic (1.13e-1)" "unprognostic (1.00e-1)" "unprognostic (8.12e-3)" "unprognostic (1.75e-1)" "unprognostic (4.42e-2)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" 10.9 3.1 1.7 12.3 3.1 28.0 2.0 0.9 1.9 2.2 1.8 4.0 0.7 1.5 1.4 4.2 2.0 3.3 2.8 4.8 1.8 2.2 2.5 9.9 12.1 35.2 2.4 0.6 1.5 1.7 0.4 1.3 4.4 2.7 2.5 1.4 2.4 2.0 1.8 1.1 1.6 3.3 3.0 4.8 27.7 1.7 1.4 2.5 2.8 1.5 1.2 3.7 3.1 1.5 0.0 6.1 34.0 17.5 0.0 0.1 7.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.6 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.1 4.6 0.0 0.0 0.1 0.0 0.3 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 0.1 17.5 0.9 0.0 12.2 0.1 0.0 0.0 0.0 6.1 0.0 0.0 0.0 34.0 0.0 10.6 0.1 0.0 7.3 1.7 3.1 0.9 1.9 1.8 2.2 2.4 0.6 2.7 2.5 0.0 5.9 0.5 0.6 0.8 0.1 0.6 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.6 0.2 0.0 0.0 0.2 0.1 0.8 0.2 11.5 0.2 15.6 0.0 1.2 0.6 46.1 3.6 0.3 14.9 0.0 2.8 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.3 0.2 0.6 0.9 0.2 0.0 0.0 0.4 NFASC "FLJ46866, KIAA0756, NF, NRCAML" ENSG00000163531 Neurofascin O94856 1 204828651-205022822 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.6" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 165.2;Horizontal cells: 208.2;Rod photoreceptor cells: 212.3" "Cancer enhanced" "Detected in many" "glioma: 8.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "BJ: 13.3;fHDF/TERT166: 24.1;hTERT-RPE1: 11.8;SCLC-21H: 11.2;U-138 MG: 31.3;U-87 MG: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008832 Enhanced NA NA 2100000 "HPA008832: AB_1854411" "unprognostic (1.71e-1)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (3.39e-2)" "unprognostic (6.65e-2)" "unprognostic (1.18e-2)" "unprognostic (3.71e-3)" "unprognostic (3.37e-1)" "unprognostic (6.34e-3)" "unprognostic (2.79e-1)" "prognostic favorable (3.21e-5)" "unprognostic (3.76e-1)" "prognostic unfavorable (2.93e-5)" "unprognostic (1.56e-3)" "unprognostic (1.91e-1)" "unprognostic (6.90e-2)" "unprognostic (5.26e-3)" 4.9 8.7 21.1 3.9 25.9 0.6 3.8 22.3 37.3 4.6 7.8 49.6 1.1 5.1 9.1 10.4 11.3 12.0 6.6 17.4 19.5 10.8 10.7 2.4 5.7 2.6 27.9 25.2 11.9 6.4 1.6 11.7 11.2 28.7 8.7 6.8 8.1 2.6 18.4 3.3 4.2 5.6 15.3 17.5 6.8 5.3 2.0 34.0 0.0 3.0 0.2 3.4 8.9 7.9 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.5 0.0 0.2 0.4 0.0 13.3 0.0 9.7 2.9 0.0 0.0 0.0 0.0 24.1 9.1 6.3 0.2 0.3 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 6.1 0.3 11.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.4 0.1 0.0 1.1 0.0 0.0 0.0 11.2 0.6 0.0 0.7 0.0 1.0 0.1 0.0 0.0 31.3 6.7 0.0 0.0 0.0 0.0 0.0 15.5 0.0 7.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 25.9 22.3 35.0 19.5 10.8 27.9 25.2 28.7 34.0 0.0 1.1 0.0 1.5 1.9 165.2 19.5 0.0 0.0 1.2 0.0 11.8 0.3 0.0 0.2 5.3 4.9 0.0 0.0 0.0 0.2 10.1 1.0 0.0 2.0 0.4 208.2 36.4 2.5 0.6 9.7 6.1 0.0 1.7 0.0 4.8 12.0 0.8 0.0 5.3 1.4 212.3 51.8 51.4 1.9 3.2 4.1 0.6 0.0 0.9 0.7 NFE2L3 Nrf3 ENSG00000050344 "Nuclear factor, erythroid 2 like 3" Q9Y4A8 7 26152240-26187125 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 54.9" "Group enriched" "Detected in many" 14 "Cytotrophoblasts: 226.3;Syncytiotrophoblasts: 584.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 44.0;NTERA-2: 36.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055889 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA055889: AB_2682958" "unprognostic (4.99e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-3)" "unprognostic (5.37e-2)" "unprognostic (8.41e-2)" "unprognostic (4.00e-3)" "unprognostic (7.29e-3)" "unprognostic (1.87e-1)" "unprognostic (2.12e-1)" "unprognostic (9.88e-2)" "prognostic unfavorable (6.62e-5)" "unprognostic (2.32e-1)" "prognostic unfavorable (7.58e-12)" "prognostic favorable (2.14e-4)" "unprognostic (2.40e-1)" "unprognostic (8.25e-2)" "unprognostic (4.13e-3)" 3.5 2.5 0.8 7.8 1.2 1.6 4.1 6.2 1.6 1.8 6.7 4.0 2.4 6.2 1.9 1.7 3.1 2.4 7.1 3.6 1.3 1.1 4.2 2.3 5.8 6.9 2.5 0.8 1.7 7.5 0.0 2.1 54.9 2.1 3.7 4.0 2.1 7.7 0.4 3.4 8.2 7.1 0.8 3.7 10.4 5.6 2.5 1.5 11.2 1.6 1.5 8.9 3.1 2.1 1.4 2.8 0.8 1.1 1.1 2.6 0.4 12.7 1.1 0.5 1.3 0.0 0.0 44.0 2.5 5.0 4.9 9.1 8.4 22.3 0.9 16.8 0.2 18.6 2.7 1.9 4.3 11.3 8.7 2.7 1.7 1.8 6.1 3.4 1.5 17.0 0.4 0.5 2.0 0.7 7.3 11.4 3.6 2.6 22.6 1.0 1.7 1.0 2.7 36.9 3.5 4.5 1.5 0.1 6.3 6.7 12.6 4.0 4.7 0.0 1.0 0.4 12.8 0.6 0.9 23.9 0.4 0.7 0.2 10.2 13.8 21.9 1.0 0.0 5.5 17.0 0.0 1.1 0.0 0.5 1.1 1.6 1.0 2.1 1.0 2.8 1.4 1.2 0.7 0.8 1.1 0.3 0.9 2.6 0.4 0.8 1.2 6.2 1.6 1.3 1.1 2.5 0.8 2.1 1.5 6.0 3.2 0.8 2.8 1.5 1.2 1.4 17.8 1.4 5.7 10.4 0.0 226.3 0.0 9.8 0.7 3.8 3.3 0.0 4.7 28.3 2.3 3.6 27.6 0.0 21.3 0.0 1.2 3.1 12.9 0.0 0.0 11.1 1.7 5.4 6.5 0.9 11.2 4.3 0.0 0.3 1.3 0.0 1.0 0.3 5.7 1.4 584.2 4.9 8.3 5.4 NFXL1 HOZFP ENSG00000170448 "Nuclear transcription factor, X-box binding like 1" Q6ZNB6 4 47847233-47914667 "Predicted membrane proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 100.7;Spermatocytes: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059132 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059132: AB_2683917" "unprognostic (5.37e-2)" "unprognostic (2.89e-1)" "unprognostic (5.14e-3)" "unprognostic (6.13e-2)" "unprognostic (1.81e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (1.13e-2)" "unprognostic (6.26e-3)" "unprognostic (8.48e-3)" "unprognostic (8.34e-2)" "unprognostic (4.47e-2)" "unprognostic (4.72e-3)" "unprognostic (8.89e-2)" "unprognostic (3.15e-1)" "unprognostic (6.67e-2)" "unprognostic (8.01e-2)" 8.3 5.8 7.8 7.2 8.7 6.5 10.8 19.1 9.4 10.1 7.4 6.2 12.2 7.8 13.3 19.2 9.7 9.6 6.9 5.5 6.7 5.5 7.4 9.5 7.4 6.5 7.0 9.6 10.9 12.8 11.9 19.6 8.7 7.6 9.0 8.6 5.3 12.4 10.2 7.1 9.3 7.4 8.8 8.8 7.5 8.2 21.3 7.0 5.9 17.2 4.4 7.7 9.2 10.9 2.5 1.9 5.6 2.3 1.5 3.5 1.7 5.5 3.5 3.9 8.1 7.5 12.4 13.4 3.8 5.4 6.2 7.8 5.9 12.7 4.4 7.3 2.5 12.1 5.7 10.1 7.6 7.4 3.4 3.9 4.7 6.5 10.8 9.7 11.5 9.5 8.1 10.2 4.3 25.6 7.4 5.4 9.3 8.4 5.5 6.4 5.3 9.0 5.4 9.5 7.6 5.5 8.1 7.6 7.3 7.9 10.6 12.5 6.0 2.8 8.0 5.5 7.9 5.5 3.4 4.4 8.2 5.1 3.8 8.4 8.9 5.4 8.9 4.7 6.5 7.1 0.0 1.7 1.7 2.3 2.3 2.8 2.2 3.2 2.5 1.6 2.5 3.5 3.4 5.6 1.5 1.1 1.9 2.0 1.7 7.8 8.7 19.1 9.4 6.7 5.5 7.0 9.6 7.6 7.0 6.0 8.3 1.5 4.0 4.7 19.0 100.7 15.3 8.1 13.6 7.0 9.8 5.0 10.0 7.2 28.3 7.3 5.8 0.0 6.0 9.5 8.0 6.1 2.3 7.2 4.3 7.9 10.9 4.3 3.5 12.4 11.8 6.2 1.7 4.6 7.4 9.1 6.3 3.5 9.6 3.1 16.0 0.0 3.6 72.2 24.3 3.8 5.6 4.9 6.9 5.1 NGFR "CD271, p75NTR, TNFRSF16" ENSG00000064300 "Nerve growth factor receptor" P08138 17 49495293-49515017 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Apoptosis, Biological rhythms, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 33.8;Leydig cells: 88.9;Muller glia cells: 122.0;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 4.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 4.2" "Group enriched" "Detected in some" 7 "RH-30: 56.0;WM-115: 62.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 13.1;hypothalamus: 8.2;pons and medulla: 3.7" "CAB000143, CAB001995, HPA004765" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 100000 "Nucleoplasm, Plasma membrane" "CAB000143: , CAB001995: , HPA004765: AB_1079233" "unprognostic (6.25e-3)" "unprognostic (1.06e-3)" "unprognostic (3.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-2)" "unprognostic (2.26e-1)" "unprognostic (8.22e-2)" "unprognostic (4.94e-2)" "unprognostic (1.08e-2)" "unprognostic (4.10e-3)" "unprognostic (1.85e-2)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (4.01e-2)" "unprognostic (3.06e-2)" "unprognostic (2.77e-3)" "prognostic unfavorable (3.40e-4)" 30.9 24.0 1.2 9.2 7.4 1.0 11.7 6.1 4.5 7.6 9.4 10.4 7.9 3.2 6.8 15.0 11.3 12.6 10.8 22.2 2.4 2.9 4.8 29.1 1.4 11.6 13.8 1.3 7.6 6.2 2.8 6.7 16.7 15.9 17.7 3.4 20.2 17.2 9.7 4.8 8.4 5.0 10.7 22.4 18.9 4.9 12.2 4.4 0.4 25.8 7.4 7.0 13.1 6.8 0.0 4.2 0.0 0.4 0.0 0.5 0.2 0.0 0.0 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 1.3 0.4 1.2 0.0 0.1 0.2 0.1 0.0 1.0 0.1 0.0 0.1 6.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 8.1 0.1 0.0 0.0 1.0 0.0 0.0 1.0 56.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 3.7 2.2 0.1 0.0 0.0 0.0 1.0 0.1 2.7 0.0 0.0 0.0 0.0 0.5 62.2 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 4.2 0.0 0.2 1.2 7.4 6.1 4.0 2.4 2.9 13.8 1.3 15.9 4.4 0.0 0.0 0.5 33.8 3.2 6.1 0.5 0.0 1.4 2.3 0.0 3.9 0.2 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.4 3.3 2.4 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.9 88.9 1.8 15.1 0.0 0.0 122.0 0.0 0.0 26.2 0.0 5.7 32.3 9.5 0.5 0.9 1.5 0.1 1.0 0.0 2.0 NGLY1 "FLJ11005, PNG1" ENSG00000151092 "N-glycanase 1" Q96IV0 3 25718944-25790039 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 518.0;Late spermatids: 684.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036825 Approved "Intracellular and membrane" NA NA "HPA036825: AB_10672231" "unprognostic (3.65e-2)" "unprognostic (8.65e-2)" "prognostic favorable (1.17e-5)" "unprognostic (2.96e-2)" "unprognostic (1.72e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (1.96e-6)" "unprognostic (2.20e-1)" "unprognostic (2.34e-1)" "unprognostic (3.73e-3)" "unprognostic (2.55e-1)" "unprognostic (4.23e-2)" "unprognostic (4.92e-3)" "unprognostic (1.07e-2)" "unprognostic (2.47e-1)" "unprognostic (9.08e-2)" "unprognostic (1.89e-2)" 10.7 14.4 11.4 19.6 11.4 12.9 15.0 17.1 15.0 9.5 12.4 6.9 11.7 10.5 10.2 13.8 13.2 8.4 10.5 14.3 12.0 9.0 12.8 18.1 13.9 17.4 9.5 12.5 10.6 20.7 9.0 11.3 8.7 11.0 10.9 15.2 7.8 12.4 18.0 46.6 9.0 11.2 8.7 10.1 14.6 11.9 42.0 9.0 18.0 10.3 10.9 18.1 11.5 10.6 26.1 39.7 19.9 10.8 22.6 14.7 10.3 12.5 10.7 6.0 12.7 11.6 10.7 8.6 10.8 9.1 13.6 12.3 6.6 9.6 31.9 12.3 9.1 14.1 5.7 20.2 5.7 18.5 15.0 8.6 23.7 8.2 10.7 13.0 21.8 13.0 9.5 7.6 14.9 14.0 14.8 14.5 15.7 22.4 23.0 13.8 5.5 25.9 12.9 8.1 14.7 19.5 26.5 7.9 22.7 12.5 15.4 3.7 4.5 15.6 15.1 10.0 12.0 14.3 18.3 9.8 10.7 11.1 12.9 13.9 28.3 24.4 22.2 12.9 23.7 8.4 19.9 10.8 18.9 13.7 10.1 14.7 26.1 13.8 12.6 16.3 21.7 14.0 13.6 12.8 22.6 8.4 39.7 10.4 10.3 11.4 11.4 17.1 15.0 12.0 9.0 9.5 12.5 11.0 9.0 17.9 12.9 39.7 20.7 11.2 21.6 22.4 22.9 28.1 15.9 5.2 11.8 36.2 29.9 26.6 518.0 20.1 20.2 0.0 38.1 28.0 19.8 22.0 19.7 22.7 21.1 11.1 6.9 15.4 16.4 684.0 13.8 24.8 23.6 20.8 27.3 19.8 25.0 24.6 14.9 29.8 20.4 0.0 14.6 73.4 43.7 12.0 47.4 33.3 28.9 19.0 NHLRC3 ENSG00000188811 "NHL repeat containing 3" Q5JS37 13 39038306-39050109 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013738 Uncertain "Secreted - unknown location" NA NA 240000 "HPA013738: AB_1854455" "unprognostic (7.92e-2)" "unprognostic (3.51e-2)" "unprognostic (5.96e-2)" "unprognostic (3.90e-1)" "unprognostic (2.92e-2)" "unprognostic (1.22e-1)" "unprognostic (2.99e-1)" "unprognostic (1.54e-1)" "unprognostic (2.15e-1)" "unprognostic (8.88e-2)" "unprognostic (2.28e-2)" "unprognostic (4.83e-2)" "unprognostic (3.21e-1)" "unprognostic (1.58e-2)" "unprognostic (2.99e-2)" "unprognostic (1.66e-1)" "unprognostic (7.81e-2)" 21.3 14.5 12.3 18.8 14.7 7.3 17.6 13.8 19.1 13.9 14.2 18.2 16.4 12.7 17.8 37.1 9.8 13.8 18.0 13.0 12.4 12.2 20.1 28.2 17.6 17.7 15.5 15.9 21.9 17.2 7.8 16.5 24.4 15.2 13.0 19.0 18.4 15.7 22.9 10.8 13.5 14.8 13.6 17.3 20.1 18.3 14.0 13.1 13.0 21.2 8.9 13.1 14.6 12.6 5.7 7.9 2.0 9.2 5.6 7.3 4.6 3.4 2.2 9.6 4.5 11.1 11.5 14.6 5.4 6.7 5.8 7.6 6.8 15.5 9.4 10.3 3.5 7.3 7.3 3.7 3.1 5.0 13.5 4.2 7.6 4.5 7.5 7.1 7.4 11.1 9.3 4.1 3.9 3.9 8.8 3.6 7.8 2.6 11.7 5.2 2.6 5.8 11.8 2.5 7.9 2.2 6.2 25.5 5.2 8.8 6.9 2.2 4.0 3.4 4.8 12.2 5.6 6.3 12.0 4.2 7.9 3.9 10.3 5.6 9.4 8.0 3.8 10.5 8.1 5.7 2.0 9.0 1.0 6.6 9.2 7.3 5.7 4.8 5.3 7.9 4.6 4.9 7.0 0.8 5.6 8.2 7.3 5.4 4.6 12.3 14.7 13.8 19.1 12.4 12.2 15.5 15.9 15.2 13.1 11.9 19.8 23.0 12.8 7.4 71.9 10.8 17.8 25.4 29.6 33.2 53.0 56.2 8.3 16.4 5.1 23.3 21.0 0.0 14.5 13.2 18.0 9.5 15.1 29.4 37.9 74.7 13.3 43.6 40.6 2.8 56.7 39.9 16.9 16.2 25.9 44.6 14.0 34.0 39.3 13.3 83.5 58.2 11.1 32.5 31.9 7.9 20.3 35.5 26.2 6.8 NINJ1 NIN1 ENSG00000131669 "Ninjurin 1" Q92982 9 93121489-93134288 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 149.2" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 430.2;monocytes: 299.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 149.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 149.2" "Cell line enhanced" "Detected in many" "Hep G2: 48.1;HHSteC: 43.8;MCF7: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045063 Uncertain NA NA "HPA045063: AB_10964133" "unprognostic (1.23e-2)" "unprognostic (8.25e-3)" "unprognostic (3.64e-3)" "unprognostic (1.40e-2)" "unprognostic (8.18e-2)" "unprognostic (1.28e-2)" "unprognostic (4.29e-2)" "unprognostic (5.88e-2)" "unprognostic (6.82e-2)" "unprognostic (9.06e-2)" "unprognostic (1.93e-1)" "unprognostic (1.74e-2)" "unprognostic (9.45e-3)" "unprognostic (2.51e-1)" "unprognostic (2.69e-2)" "unprognostic (1.40e-3)" "unprognostic (7.46e-3)" 20.7 42.5 14.8 15.2 15.5 92.9 30.5 7.5 14.7 14.9 19.9 20.4 9.6 10.6 12.9 27.0 14.7 14.9 16.5 27.1 14.3 14.6 39.0 51.7 24.3 28.1 17.1 7.2 16.9 17.9 39.3 20.2 37.3 15.6 18.9 7.3 24.6 31.9 25.7 16.9 30.7 15.4 17.2 20.7 34.7 13.5 21.7 12.9 11.4 43.8 13.7 13.4 25.4 14.3 0.6 6.7 149.2 29.5 3.9 9.0 15.3 10.5 16.5 3.4 7.2 12.6 5.0 13.3 7.7 21.9 11.2 6.9 7.2 3.6 0.1 3.7 7.4 12.4 11.0 3.8 21.3 2.4 24.4 7.3 1.6 4.2 48.1 43.8 1.1 3.4 16.7 20.9 10.7 5.8 34.8 10.6 4.1 1.1 12.0 2.5 46.8 3.3 3.4 4.6 13.0 13.6 5.9 2.5 18.9 9.0 4.5 1.0 4.7 16.2 25.6 9.9 6.0 19.8 7.4 7.5 3.9 11.5 8.1 5.3 6.8 2.6 0.2 11.9 3.5 3.0 9.8 27.1 69.4 6.6 27.3 9.0 0.6 6.1 5.6 6.7 0.2 7.5 5.2 149.2 3.9 29.5 0.9 6.3 15.3 14.8 15.5 7.5 14.7 14.3 14.6 17.1 7.2 15.6 12.9 26.8 38.2 13.7 83.7 101.8 2.3 26.6 58.6 2.7 31.8 38.4 0.0 109.8 109.5 86.6 2.1 46.7 23.4 0.0 90.1 67.0 78.7 64.1 47.2 36.4 430.2 1.6 17.3 22.7 131.8 10.5 38.9 172.3 140.0 299.4 18.9 48.7 57.0 24.6 68.2 194.8 2.7 12.9 88.6 0.5 7.2 118.6 61.3 41.5 18.0 50.4 NINJ2 ENSG00000171840 "Ninjurin 2" Q9NZG7 12 564296-663779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.7;brain: 43.6" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 32.8;Hofbauer cells: 25.9;Kupffer cells: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 41.4;MOLT-4: 70.0;THP-1: 14.8;U-698: 13.3" "Low region specificity" "Detected in many" "HPA058980, HPA067226" Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoplasm, Plasma membrane, Centriolar satellite, Cytosol" "HPA058980: AB_2683869, HPA067226: " "unprognostic (1.16e-1)" "unprognostic (2.19e-1)" "unprognostic (9.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.37e-1)" "prognostic favorable (5.31e-4)" "unprognostic (5.72e-3)" "unprognostic (1.90e-3)" "unprognostic (4.60e-2)" "unprognostic (4.98e-3)" "unprognostic (5.88e-2)" "unprognostic (5.12e-2)" "unprognostic (2.68e-2)" "unprognostic (9.05e-2)" "unprognostic (1.03e-2)" "unprognostic (3.51e-3)" "unprognostic (1.23e-1)" 11.8 1.4 9.8 9.2 14.1 27.8 9.2 2.4 18.5 7.3 5.0 43.6 1.6 4.6 2.9 3.3 8.4 3.8 4.7 7.9 16.4 8.7 1.4 13.8 31.3 10.8 21.8 10.2 0.8 1.8 0.9 1.1 3.9 17.2 2.7 4.5 2.9 4.5 2.8 20.1 6.7 3.9 4.8 26.4 8.8 3.6 3.9 21.1 3.6 2.6 2.2 9.2 9.0 3.9 5.6 14.9 34.2 17.7 5.7 44.7 9.1 0.4 0.1 0.0 0.4 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.8 3.2 0.0 0.1 1.6 0.4 0.0 0.0 0.0 0.0 2.3 0.0 41.4 9.9 0.5 0.0 1.1 1.7 0.6 0.0 0.0 0.0 0.0 0.8 0.8 2.4 7.1 0.0 0.0 70.0 2.2 0.7 0.0 0.0 1.8 0.0 0.2 0.7 0.0 0.0 0.0 7.8 0.0 0.0 0.1 0.0 14.8 0.2 0.0 0.4 2.7 0.0 0.0 1.1 13.3 0.1 7.7 0.0 2.0 17.7 14.1 10.5 13.7 3.1 5.6 11.8 11.1 14.9 4.5 2.6 5.5 34.2 5.7 11.2 7.8 44.7 9.1 9.8 14.1 2.4 18.5 16.4 8.7 21.8 10.2 17.2 21.1 20.8 32.8 6.5 0.2 5.0 0.0 1.2 0.0 6.7 14.8 0.0 0.0 2.3 1.7 0.0 2.1 5.4 1.6 0.0 0.0 3.2 5.6 0.2 2.3 10.6 25.9 0.0 4.1 5.5 33.3 1.9 7.5 17.3 6.8 6.4 3.2 0.3 0.5 3.5 3.9 0.0 0.0 0.0 1.0 3.2 2.5 4.8 0.7 14.4 3.3 0.0 NIPA1 "MGC35570, SLC57A1, SPG6" ENSG00000170113 "Non imprinted in Prader-Willi/Angelman syndrome 1" Q7RTP0 15 22773063-22829791 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 9.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023269 Uncertain NA NA "HPA023269: AB_1854485" "unprognostic (1.64e-2)" "unprognostic (7.60e-2)" "unprognostic (2.61e-2)" "unprognostic (2.13e-1)" "unprognostic (2.83e-1)" "unprognostic (1.79e-1)" "unprognostic (3.31e-2)" "unprognostic (2.13e-2)" "unprognostic (2.77e-1)" "unprognostic (2.42e-2)" "unprognostic (6.25e-2)" "unprognostic (6.32e-2)" "unprognostic (6.95e-2)" "unprognostic (8.80e-2)" "unprognostic (1.62e-1)" "unprognostic (8.42e-3)" "unprognostic (8.66e-2)" 3.4 4.9 15.2 4.1 18.1 1.3 3.4 8.3 27.0 4.6 4.6 20.7 1.3 7.3 2.7 2.6 4.5 3.1 5.5 2.9 18.7 15.7 7.3 4.7 5.3 5.4 26.9 11.8 1.6 7.6 12.3 2.9 4.0 24.8 7.9 5.0 2.2 3.9 4.2 2.4 5.6 7.2 2.9 36.7 4.5 7.4 4.9 15.1 2.6 8.5 0.4 6.0 3.6 2.6 2.0 9.1 0.6 0.2 0.6 1.7 0.8 9.8 11.6 3.6 8.3 4.7 3.8 2.9 11.5 8.4 5.8 4.7 8.8 4.9 4.5 9.7 4.8 12.3 6.7 10.8 3.2 6.8 26.5 7.0 6.9 7.1 7.4 5.6 0.1 14.0 1.4 10.4 3.7 6.5 9.2 5.5 10.2 5.5 7.8 3.2 3.7 3.8 6.2 4.1 10.4 13.2 8.4 5.1 3.6 9.0 9.8 10.2 10.5 9.2 1.0 10.9 5.0 7.9 9.0 9.9 16.3 9.5 6.7 18.1 8.8 8.8 8.5 8.5 0.0 10.8 0.6 0.2 0.3 1.1 0.1 1.2 1.8 1.7 1.2 1.4 2.0 0.8 0.6 0.5 0.6 0.1 9.1 1.3 0.8 15.2 18.1 8.3 19.7 18.7 15.7 26.9 11.8 24.8 15.1 11.9 5.1 1.5 3.5 7.8 4.1 3.5 10.2 2.7 4.5 5.2 5.9 2.0 3.3 5.1 2.8 6.0 8.0 0.0 10.3 1.9 4.7 6.9 0.0 5.8 3.4 4.8 2.9 4.9 4.5 3.2 2.0 2.6 5.0 5.4 6.0 5.2 12.8 5.9 2.8 4.8 5.8 19.4 4.4 3.7 9.8 13.0 1.3 5.0 6.0 4.6 NIPA2 SLC57A2 ENSG00000140157 "Non imprinted in Prader-Willi/Angelman syndrome 2" Q8N8Q9 15 22838641-22868384 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067160, HPA071342" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA067160: AB_2685794, HPA071342: AB_2686391" "unprognostic (2.88e-3)" "unprognostic (1.82e-1)" "unprognostic (9.34e-3)" "unprognostic (1.17e-1)" "unprognostic (4.49e-1)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.22e-2)" "unprognostic (2.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.46e-3)" "unprognostic (2.94e-1)" "unprognostic (7.75e-3)" "unprognostic (3.53e-2)" "unprognostic (1.59e-1)" "unprognostic (3.22e-2)" "unprognostic (2.93e-2)" 19.3 26.9 18.6 26.1 22.2 22.1 19.9 17.7 28.2 16.8 30.0 16.6 23.9 28.4 21.7 18.3 26.5 16.1 21.3 17.4 16.7 21.3 26.3 27.8 22.5 35.0 17.9 13.8 19.0 30.8 21.1 24.7 31.3 18.5 20.6 30.1 20.0 26.9 14.0 18.8 16.4 37.1 18.2 13.5 43.9 21.4 19.5 13.1 27.9 21.1 19.2 31.5 22.2 17.2 38.1 40.3 27.2 26.5 22.1 24.6 21.5 30.1 30.8 15.8 18.6 15.2 17.3 17.9 33.9 30.0 23.3 27.3 22.8 19.2 29.8 21.6 19.5 24.0 24.2 29.1 17.1 23.7 31.6 18.8 26.7 20.6 18.4 22.6 37.8 25.3 16.9 19.3 19.2 20.1 15.1 27.2 24.6 40.0 35.8 29.8 12.0 12.0 17.7 18.5 32.4 28.5 26.2 26.8 22.6 22.3 37.1 21.3 22.5 25.9 25.7 28.5 15.3 23.3 35.6 28.2 30.9 20.1 22.3 68.6 28.4 41.1 32.3 23.6 38.3 26.5 27.2 21.4 18.0 21.4 26.5 24.4 38.1 19.3 23.5 26.2 32.7 18.4 18.7 15.8 22.1 24.9 40.3 24.6 21.5 18.6 22.2 17.7 28.2 16.7 21.3 17.9 13.8 18.5 13.1 14.9 20.2 64.8 29.3 40.1 8.8 2.0 15.3 16.0 14.8 12.2 11.8 35.4 18.3 36.8 4.8 28.5 29.6 0.0 38.2 54.4 23.4 34.7 9.3 19.4 43.1 20.6 23.4 24.5 25.4 2.2 12.4 28.7 21.9 27.9 26.1 23.6 43.8 31.3 19.8 18.6 11.6 12.9 29.9 21.5 32.4 50.6 70.6 34.6 32.2 91.1 NIPAL1 "DKFZp686A06115, NPAL1" ENSG00000163293 "NIPA like domain containing 1" Q6NVV3 4 47914142-48040173 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 30.8" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 40.1;Paneth cells: 31.6;Urothelial cells: 36.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 11.0;CAPAN-2: 9.9;HaCaT: 13.1;HBEC3-KT: 9.4;RT4: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA036765 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036765: AB_10672366" "unprognostic (3.03e-1)" "unprognostic (4.55e-2)" "unprognostic (2.34e-3)" "unprognostic (2.18e-2)" "unprognostic (1.12e-2)" "unprognostic (3.57e-1)" "unprognostic (9.55e-2)" "unprognostic (4.16e-3)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (3.71e-3)" "unprognostic (1.34e-1)" "unprognostic (9.03e-7)" "unprognostic (2.55e-1)" "unprognostic (3.73e-1)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" 0.5 0.4 0.4 5.4 1.4 0.0 2.2 0.8 0.7 3.6 9.1 0.1 0.0 3.3 0.4 6.3 18.5 1.1 1.8 0.6 0.7 0.7 4.6 10.7 0.5 0.0 0.4 0.2 0.8 6.6 2.9 5.5 30.8 0.7 3.0 8.9 1.2 5.3 0.6 0.7 17.1 12.6 1.0 0.6 0.4 4.3 0.8 0.3 0.2 2.0 9.8 11.2 4.2 5.3 1.0 1.4 1.4 0.8 0.6 0.9 0.0 11.0 0.2 0.0 0.0 0.0 0.0 1.8 2.1 2.0 1.6 2.8 6.6 9.9 0.0 1.5 0.0 2.9 13.1 1.9 9.4 4.1 0.1 2.4 0.0 0.1 0.4 0.0 0.1 0.1 0.1 3.5 0.1 2.3 2.7 0.5 0.7 0.1 0.0 2.3 4.2 0.1 0.1 1.7 7.6 2.9 0.0 0.0 0.0 5.6 15.1 1.0 0.3 1.0 3.7 1.6 0.9 2.4 0.0 4.2 0.1 3.9 0.0 0.2 0.1 0.1 0.0 0.2 0.0 4.2 0.9 0.8 0.5 0.8 0.4 0.6 0.4 0.5 0.3 0.1 1.0 0.7 0.9 1.4 0.6 0.5 1.4 0.3 0.0 0.4 1.4 0.8 0.7 0.7 0.7 0.4 0.2 0.7 0.3 8.9 6.7 0.0 22.7 12.8 0.1 2.6 0.0 2.7 14.8 40.1 0.0 1.6 0.0 8.8 0.5 0.3 27.6 0.0 5.8 1.0 1.3 24.9 0.0 10.4 0.3 0.0 11.1 0.6 0.0 0.0 0.0 0.2 1.7 1.0 27.4 0.5 10.3 31.6 0.0 1.0 3.8 0.0 2.1 1.0 1.5 28.9 3.0 0.7 29.9 36.3 NIPAL2 "FLJ13955, NPAL2" ENSG00000104361 "NIPA like domain containing 2" Q9H841 8 98189833-98294393 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 24.9;OE19: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071759 Uncertain NA NA "HPA071759: AB_2686443" "unprognostic (5.14e-3)" "unprognostic (6.43e-2)" "unprognostic (8.01e-2)" "unprognostic (2.02e-1)" "unprognostic (4.52e-2)" "unprognostic (5.18e-2)" "unprognostic (3.72e-1)" "unprognostic (9.45e-2)" "unprognostic (1.90e-2)" "unprognostic (3.67e-1)" "unprognostic (3.42e-1)" "unprognostic (2.41e-1)" "unprognostic (2.18e-3)" "unprognostic (1.28e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-1)" "unprognostic (4.76e-2)" 9.1 10.1 6.0 7.7 8.5 3.6 11.5 8.0 18.3 13.6 11.3 2.0 13.8 5.8 10.8 27.8 22.2 8.6 11.5 6.5 6.5 5.9 4.6 4.9 7.9 8.0 3.2 8.8 22.2 18.3 8.4 28.9 5.4 6.9 15.5 15.9 9.1 15.4 14.0 3.4 33.8 7.9 5.2 3.1 5.9 12.5 4.9 1.8 2.3 5.8 9.4 13.5 11.0 15.6 4.2 6.7 4.9 3.6 2.7 3.6 2.8 4.0 1.6 0.5 0.0 24.9 15.2 0.1 7.3 9.3 1.3 1.8 0.0 12.0 7.6 8.5 10.2 2.0 4.8 0.3 4.3 1.0 0.6 1.5 2.8 1.1 0.5 3.2 2.9 3.0 15.6 11.6 1.3 4.1 0.8 1.6 0.0 0.0 15.5 5.4 5.6 0.1 1.6 1.0 19.7 0.6 0.0 0.1 0.8 4.9 9.2 0.8 1.6 5.3 4.6 1.8 0.6 4.9 5.4 4.9 1.0 0.1 3.8 0.0 0.2 0.0 0.0 1.8 9.5 5.0 0.2 3.6 4.9 1.3 3.4 0.1 3.4 1.2 1.3 6.7 4.2 0.1 1.0 0.7 2.7 2.6 2.8 3.6 2.8 6.0 8.5 8.0 18.3 6.5 5.9 3.2 8.8 6.9 1.8 3.0 5.7 4.2 7.0 13.6 16.1 4.2 7.6 12.0 4.5 3.5 2.0 0.1 0.0 7.2 5.7 8.7 10.3 0.0 11.0 0.9 7.5 17.9 5.7 3.0 4.1 20.6 6.9 9.8 4.7 2.9 23.9 7.4 3.3 1.0 21.4 11.4 9.8 7.0 21.5 1.0 2.7 6.5 3.9 0.7 0.6 19.9 0.2 1.9 12.8 19.2 NIPAL3 "DJ462O23.2, NPAL3" ENSG00000001461 "NIPA like domain containing 3" Q6P499 1 24415794-24472976 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.4" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 104.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039978 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039978: AB_10697712" "unprognostic (9.36e-2)" "unprognostic (7.63e-2)" "unprognostic (2.88e-2)" "unprognostic (1.19e-2)" "unprognostic (5.96e-2)" "unprognostic (5.38e-2)" "unprognostic (3.72e-3)" "unprognostic (3.60e-2)" "unprognostic (2.43e-1)" "unprognostic (6.66e-2)" "unprognostic (2.79e-1)" "unprognostic (3.14e-1)" "prognostic favorable (3.03e-7)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic favorable (3.95e-4)" "unprognostic (2.85e-1)" 5.3 5.1 21.4 5.2 21.8 4.9 8.3 41.2 29.4 6.9 8.9 42.4 5.6 7.1 4.2 7.4 10.3 10.4 6.3 9.2 25.5 21.3 9.4 2.3 9.2 7.1 32.9 14.7 5.5 11.3 14.0 6.5 2.8 31.5 38.4 9.3 7.1 9.9 5.7 3.5 7.7 8.5 8.1 34.8 4.8 9.6 3.1 22.5 5.8 20.7 2.3 7.9 7.8 5.4 12.9 8.4 8.9 3.6 9.2 26.0 9.7 12.8 5.2 0.5 1.7 7.9 8.8 1.9 41.7 29.9 15.3 11.3 1.8 14.7 6.0 13.4 23.0 3.1 12.6 5.1 15.5 15.0 12.2 15.9 6.6 8.7 2.1 7.3 5.8 6.0 8.8 14.4 10.1 30.9 13.9 5.2 11.8 3.8 3.8 9.2 2.8 4.7 2.4 3.2 6.2 14.7 2.2 0.0 6.8 16.2 4.1 19.4 1.8 5.6 7.9 11.2 3.6 10.8 4.4 7.5 13.7 2.9 4.5 9.1 11.9 9.7 2.1 9.2 10.6 12.2 8.9 3.6 4.7 10.8 3.4 10.7 12.9 18.2 14.0 6.5 10.9 26.0 16.1 1.6 9.2 2.3 8.4 17.6 9.7 21.4 21.8 41.2 24.6 25.5 21.3 32.9 14.7 31.5 22.5 44.7 28.0 14.5 11.0 8.1 52.0 21.5 17.8 9.4 19.4 38.4 104.1 3.0 3.3 11.5 2.8 8.5 24.1 46.7 13.4 4.0 8.5 26.1 12.7 3.2 4.2 12.7 18.0 7.4 3.8 5.6 3.7 7.1 13.5 6.4 14.9 15.3 17.2 14.4 4.9 3.6 53.0 0.0 6.2 2.4 5.5 14.3 3.5 20.8 16.3 16.1 NIPAL4 ICHYN ENSG00000172548 "NIPA like domain containing 4" Q0D2K0 5 157460019-157474717 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" Receptor "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;skin 1: 38.1" "Group enriched" "Detected in some" 6 "Basal glandular cells: 9.4;Basal keratinocytes: 26.4;Suprabasal keratinocytes: 36.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 33 "memory B-cell: 2.6;naive B-cell: 8.7" "Lineage enriched" "Detected in single" 51 "B-cells: 8.7" "Group enriched" "Detected in some" 8 "hTCEpi: 14.1;RT4: 46.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038259 Approved NA NA "HPA038259: AB_10672510" "unprognostic (6.74e-4)" "unprognostic (9.54e-2)" "unprognostic (2.63e-2)" "unprognostic (1.49e-1)" "unprognostic (2.61e-1)" "unprognostic (6.56e-2)" "unprognostic (3.55e-2)" "unprognostic (5.20e-2)" "unprognostic (2.53e-1)" "unprognostic (2.99e-2)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (5.28e-9)" "unprognostic (3.12e-2)" "unprognostic (8.66e-3)" "unprognostic (1.18e-2)" "prognostic favorable (6.82e-4)" 0.6 0.5 1.5 2.5 7.1 3.3 3.0 0.4 7.7 3.6 2.1 25.9 0.0 0.8 1.7 0.6 10.6 0.5 1.0 1.0 3.1 1.7 0.5 0.5 0.5 0.9 8.0 2.5 0.5 0.5 0.5 0.4 1.1 10.9 2.6 1.1 0.0 1.2 1.9 0.6 38.1 0.7 5.8 11.9 0.7 1.9 0.6 6.9 0.0 0.8 15.8 6.0 10.7 7.7 8.7 0.0 0.1 0.0 0.0 0.1 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.2 0.0 2.7 0.1 1.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 14.1 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 46.8 0.0 0.1 0.0 0.0 0.0 4.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.1 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 7.1 0.4 7.7 3.1 1.7 8.0 2.5 10.9 6.9 0.0 0.3 0.8 9.4 26.4 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 36.8 0.0 0.0 0.0 3.9 NKAIN1 "FAM77C, FLJ12650" ENSG00000084628 "Sodium/potassium transporting ATPase interacting 1" Q4KMZ8 1 31179745-31239554 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 15.5;brain: 23.2;skeletal muscle: 26.2" "Cell type enhanced" "Detected in some" 12 "Distal tubular cells: 1.7;Suprabasal keratinocytes: 1.3" "Group enriched" "Detected in many" 5 "breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 10.4;AN3-CA: 17.2;NTERA-2: 44.3;SCLC-21H: 13.2;SH-SY5Y: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006873 Uncertain NA NA "HPA006873: AB_1848410" "unprognostic (1.58e-2)" "unprognostic (7.99e-2)" "unprognostic (8.54e-2)" "unprognostic (6.11e-5)" "unprognostic (6.59e-2)" "unprognostic (1.24e-1)" "unprognostic (4.30e-4)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (2.78e-2)" "unprognostic (2.01e-2)" "unprognostic (8.07e-2)" "unprognostic (6.31e-9)" "unprognostic (1.00e-2)" "unprognostic (8.83e-3)" "unprognostic (1.62e-4)" "unprognostic (5.50e-2)" 0.7 15.5 4.2 0.8 13.3 0.5 1.2 23.2 11.8 0.6 0.7 10.7 0.0 0.7 1.5 5.8 1.4 0.8 0.6 0.6 6.3 4.3 0.6 0.5 0.5 0.5 4.7 7.2 0.6 0.7 0.7 0.3 0.9 18.2 2.2 0.7 0.0 0.7 1.1 26.2 1.9 0.7 0.8 3.3 0.5 0.6 0.9 9.0 0.0 0.5 0.1 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.4 17.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 44.3 0.0 0.4 0.0 0.1 0.0 0.0 1.5 13.2 21.0 0.4 0.1 1.1 1.2 4.6 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.3 23.2 9.5 6.3 4.3 4.7 7.2 18.2 9.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.6 1.3 0.3 0.0 0.0 0.1 NKAIN2 "FAM77B, TCBA1" ENSG00000188580 "Sodium/potassium transporting ATPase interacting 2" Q5VXU1 6 123804141-124825657 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 43.2" "Group enriched" "Detected in some" 16 "Horizontal cells: 44.5;Muller glia cells: 20.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 4.3" "Lineage enriched" "Detected in single" 44 "granulocytes: 4.3" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.9;HEK 293: 6.5;HEL: 8.2;Karpas-707: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045860 Approved Cytosol NA NA Cytosol "HPA045860: AB_10983192" "unprognostic (3.09e-2)" "unprognostic (1.06e-2)" "unprognostic (2.33e-2)" "unprognostic (4.53e-3)" "unprognostic (5.67e-2)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.19e-1)" "unprognostic (5.41e-3)" "unprognostic (2.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.95e-3)" "unprognostic (3.63e-3)" "unprognostic (1.77e-1)" "unprognostic (1.66e-1)" "unprognostic (1.63e-1)" 2.2 1.6 12.9 1.1 12.1 1.9 1.3 17.3 43.2 1.4 1.7 24.9 0.0 1.1 1.2 1.6 1.4 1.4 1.3 2.6 17.5 8.8 1.3 1.2 1.3 1.3 18.1 10.9 1.2 1.0 1.0 1.1 1.2 18.0 1.4 1.3 0.5 1.1 1.3 4.8 1.1 1.5 1.5 42.9 1.1 1.0 1.6 16.1 0.0 1.2 0.5 1.3 1.5 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.2 0.1 0.0 0.6 0.0 0.0 1.6 0.2 0.0 0.5 0.1 0.0 0.0 0.0 13.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 12.1 17.3 15.3 17.5 8.8 18.1 10.9 18.0 16.1 0.0 0.0 0.0 0.0 0.1 2.0 0.6 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 44.5 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NKAIN3 "FAM77D, FLJ39630" ENSG00000185942 "Sodium/potassium transporting ATPase interacting 3" Q8N8D7 8 62248591-62999652 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.5" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 1.4;Early spermatids: 1.9;Late spermatids: 2.9;Melanocytes: 1.7;Proximal tubular cells: 1.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.5;HeLa: 2.0;OE19: 1.0;PC-3: 2.5;REH: 2.6;RT4: 1.6;SCLC-21H: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018833 Enhanced NA NA "HPA018833: AB_2669943" "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (1.12e-2)" "unprognostic (1.83e-1)" "unprognostic (3.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.81e-3)" "unprognostic (4.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.22e-2)" "unprognostic (3.15e-2)" "unprognostic (1.58e-1)" 0.8 3.4 13.7 1.2 15.5 0.8 1.0 0.6 9.7 1.3 1.4 6.9 0.0 0.7 1.7 0.7 0.8 1.1 0.8 1.1 15.1 1.6 0.8 0.9 0.7 0.8 2.3 7.5 0.9 0.7 0.7 0.8 1.0 7.3 1.0 0.8 0.3 5.9 1.4 2.2 0.7 2.3 0.7 7.3 0.9 0.9 1.9 7.1 0.0 0.8 0.0 0.7 2.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.5 2.6 0.0 0.0 0.0 1.6 5.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 15.5 0.6 9.7 15.1 1.6 2.3 7.5 7.3 7.1 0.0 0.0 0.0 0.1 0.3 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.1 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.3 0.0 1.7 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 NKAIN4 "bA261N11.2, C20orf58, FAM77A" ENSG00000101198 "Sodium/potassium transporting ATPase interacting 4" Q8IVV8 20 63240784-63272694 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 51.7" "Group enriched" "Detected in some" 11 "Muller glia cells: 68.6;Proximal tubular cells: 169.4" "Cancer enriched" "Detected in many" 6 "glioma: 45.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 15.6;MOLT-4: 25.4;SK-MEL-30: 5.6;SuSa: 20.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 3.2;cerebral cortex: 3.9;hippocampal formation: 2.5" HPA029876 Approved NA NA "HPA029876: AB_10602038" "unprognostic (1.26e-1)" "unprognostic (4.27e-1)" "unprognostic (6.07e-5)" "prognostic unfavorable (3.14e-4)" "unprognostic (6.65e-2)" "unprognostic (2.59e-1)" "unprognostic (7.07e-3)" "unprognostic (1.94e-1)" "unprognostic (3.62e-2)" "unprognostic (2.69e-2)" "unprognostic (1.83e-2)" "unprognostic (1.27e-1)" "unprognostic (2.12e-2)" "unprognostic (1.44e-4)" "unprognostic (5.66e-2)" "unprognostic (6.74e-2)" "unprognostic (4.01e-1)" 1.1 1.9 21.7 1.2 23.0 1.0 1.0 5.7 51.7 1.3 1.1 9.9 0.0 1.2 1.4 1.3 0.9 1.3 1.0 0.9 15.5 15.5 10.9 0.9 0.9 0.9 18.5 11.8 0.9 1.0 0.9 0.4 3.9 6.2 1.0 1.0 1.0 0.9 1.1 0.9 1.4 1.1 1.0 9.1 1.0 1.1 2.7 7.1 0.0 1.2 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.7 0.5 0.0 2.4 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 25.4 0.0 3.2 0.0 0.0 4.6 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.1 5.6 20.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 23.0 5.7 13.2 15.5 15.5 18.5 11.8 6.2 7.1 0.0 0.0 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.0 10.4 0.0 0.6 5.0 0.2 0.1 0.1 0.0 0.0 0.5 3.6 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 4.9 0.0 0.0 0.0 0.0 68.6 2.6 0.0 0.0 169.4 1.7 0.0 0.2 0.2 1.9 0.0 1.9 0.0 0.0 0.0 NKG7 "GIG1, GMP-17" ENSG00000105374 "Natural killer cell granule protein 7" Q16617 19 51371606-51372715 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 270.6;bone marrow: 108.2" "Cell type enriched" "Detected in many" 16 "T-cells: 1698.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 270.6;MAIT T-cell: 113.5;memory CD8 T-cell: 168.7;naive CD8 T-cell: 130.3;NK-cell: 166.7" "Group enriched" "Detected in all" 46 "NK-cells: 166.7;T-cells: 270.6" "Group enriched" "Detected in some" 5 "NB-4: 60.2;THP-1: 17.9;U-937: 15.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071454 Approved Vesicles NA NA Vesicles "HPA071454: AB_2686399" "unprognostic (1.56e-2)" "unprognostic (1.05e-2)" "unprognostic (6.54e-2)" "prognostic favorable (7.42e-6)" "unprognostic (1.27e-2)" "unprognostic (3.25e-3)" "unprognostic (2.96e-3)" "unprognostic (2.14e-1)" "unprognostic (3.22e-3)" "unprognostic (3.89e-3)" "unprognostic (3.39e-1)" "unprognostic (9.93e-2)" "prognostic unfavorable (3.32e-6)" "unprognostic (7.62e-3)" "unprognostic (2.61e-1)" "unprognostic (1.30e-2)" "unprognostic (6.44e-3)" 7.4 1.8 1.3 11.2 1.7 108.2 3.3 0.7 1.0 2.9 2.2 0.8 0.4 2.2 5.4 6.3 3.8 1.8 10.6 6.0 1.2 1.2 3.2 9.4 26.1 31.0 2.3 0.7 4.1 2.6 0.0 1.8 9.3 1.3 6.8 1.6 6.2 3.5 0.9 5.6 1.0 7.6 2.5 2.8 63.3 2.5 1.9 0.2 7.3 3.1 2.0 16.0 5.1 2.3 1.1 3.2 4.5 4.7 166.7 270.6 141.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.6 0.2 0.0 0.0 6.4 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.2 0.0 0.0 0.7 60.2 0.0 0.0 0.1 1.4 3.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 17.9 0.1 0.0 0.0 0.2 0.0 0.9 0.2 0.3 0.0 15.6 0.0 2.2 1.3 0.5 270.6 4.7 113.5 1.1 34.1 168.7 3.2 0.5 11.5 130.3 4.5 166.7 3.6 2.5 0.6 141.5 1.3 1.7 0.7 1.0 1.2 1.2 2.3 0.7 1.3 0.2 3.0 10.1 16.0 0.0 4.4 0.0 0.4 10.2 1.4 2.3 5.2 0.0 0.4 3.3 0.0 0.0 2.8 0.3 0.0 0.0 0.4 2.3 0.0 24.2 3.4 12.4 0.0 0.0 45.4 103.5 0.0 0.0 26.0 16.9 1.8 0.0 0.0 0.0 0.3 0.0 6.9 0.0 0.0 0.5 0.0 0.2 5.6 0.9 1698.3 0.0 0.1 NKPD1 FLJ33600 ENSG00000179846 "NTPase KAP family P-loop domain containing 1" Q17RQ9 19 45149750-45158737 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 17.5" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 4.8" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTCEpi: 4.0;SiHa: 3.5;U-266/70: 7.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA043339 Uncertain NA NA "HPA043339: AB_10962493" "unprognostic (3.98e-2)" "unprognostic (5.94e-2)" "unprognostic (2.14e-1)" "unprognostic (8.30e-4)" "unprognostic (2.23e-1)" "unprognostic (4.60e-2)" "unprognostic (2.41e-3)" "unprognostic (2.01e-2)" "unprognostic (2.60e-1)" "unprognostic (2.35e-2)" "unprognostic (7.73e-4)" "unprognostic (1.30e-1)" "unprognostic (2.77e-5)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (8.90e-2)" "unprognostic (2.13e-1)" 0.0 0.1 0.0 0.0 0.1 0.2 0.8 0.5 0.2 0.9 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.8 0.1 17.5 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 2.4 0.2 0.2 0.5 0.1 0.2 1.8 0.0 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.4 0.3 0.7 0.0 0.1 0.4 0.0 0.0 0.0 0.5 0.6 1.5 0.1 0.1 0.1 0.0 0.0 0.2 4.0 0.0 0.1 0.1 0.1 0.2 0.4 0.7 0.0 1.1 0.7 0.5 0.3 1.8 0.4 0.1 0.0 0.3 0.0 0.1 0.6 0.3 3.5 1.8 0.1 0.5 1.3 0.3 0.0 0.0 0.0 0.0 0.0 7.3 1.7 0.3 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.5 0.6 0.0 0.2 1.8 0.1 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 1.1 0.1 0.0 0.0 0.0 NLGN1 KIAA1070 ENSG00000169760 "Neuroligin 1" Q8N2Q7 3 173396284-174286644 "Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 50.9;Leydig cells: 23.9;Muller glia cells: 30.8" "Group enriched" "Detected in some" 9 "glioma: 3.8;melanoma: 2.2;renal cancer: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 16.2;HUVEC TERT2: 15.8;RH-30: 16.9;WM-115: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006572, HPA006680, CAB033261" Enhanced Uncertain "Nuclear bodies,Plasma membrane" NA NA 40000 "Plasma membrane" "Nuclear bodies" "CAB033261: AB_2151659, HPA006572: , HPA006680: AB_1854400" "unprognostic (2.81e-1)" "unprognostic (9.86e-2)" "unprognostic (3.08e-5)" "unprognostic (7.52e-5)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (6.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.78e-1)" "unprognostic (8.07e-2)" "unprognostic (3.21e-3)" "unprognostic (1.86e-2)" "unprognostic (1.97e-1)" "unprognostic (4.08e-2)" "unprognostic (8.81e-2)" "unprognostic (2.41e-3)" "unprognostic (5.37e-2)" 3.9 2.4 13.4 1.4 9.4 0.6 1.6 20.2 26.9 6.3 3.2 5.6 0.0 1.0 4.3 5.0 4.8 5.9 3.3 5.7 8.8 9.1 5.6 0.6 1.2 1.0 6.3 7.8 2.8 2.0 0.6 6.9 1.4 6.8 4.4 2.2 4.3 0.9 5.9 0.7 1.0 1.6 8.2 4.6 0.7 2.0 11.1 8.9 0.0 2.2 0.4 0.8 5.1 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 7.7 8.3 0.0 3.2 8.1 0.4 0.5 0.0 0.3 0.0 0.1 16.2 3.0 0.0 2.3 0.0 0.8 0.0 3.8 1.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 6.5 15.8 0.0 0.0 1.0 0.1 0.0 0.0 0.0 4.6 0.0 1.1 0.0 16.9 3.9 3.0 0.0 1.6 1.1 0.0 0.0 7.9 0.7 0.4 0.0 1.9 8.8 0.9 6.3 7.2 7.6 0.0 0.0 3.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 9.4 20.2 10.9 8.8 9.1 6.3 7.8 6.8 8.9 0.0 0.3 0.0 0.6 0.7 11.4 2.0 0.0 0.0 0.0 3.5 3.9 0.2 0.0 0.3 50.9 0.3 0.0 0.0 0.0 0.1 2.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 23.9 0.0 13.5 0.0 0.0 30.8 0.1 0.0 13.4 7.1 9.7 6.5 1.0 0.4 0.7 0.6 0.1 0.0 0.0 0.1 NLGN2 KIAA1366 ENSG00000169992 "Neuroligin 2" Q8NFZ4 17 7404874-7419860 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.0" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 31.6;Horizontal cells: 54.0;Muller glia cells: 23.0;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AF22: 26.1" "Low region specificity" "Detected in all" "HPA055321, HPA069278" Enhanced Approved Mitochondria NA NA Mitochondria "HPA055321: AB_2682783, HPA069278: AB_2686105" "unprognostic (1.31e-1)" "unprognostic (1.87e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-3)" "unprognostic (2.92e-1)" "unprognostic (1.56e-1)" "unprognostic (6.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.58e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (5.50e-3)" "unprognostic (1.81e-2)" 13.0 10.9 31.3 9.9 45.3 2.4 7.4 32.7 47.0 16.9 11.3 18.3 9.5 4.4 25.3 16.4 9.0 13.8 15.5 6.6 28.8 16.0 5.7 3.3 6.2 6.1 13.9 27.5 24.3 7.4 20.7 8.3 8.5 21.3 11.6 5.9 11.2 6.5 19.2 6.3 8.7 5.4 24.3 19.4 7.5 5.9 4.8 15.9 0.0 4.8 1.7 5.0 9.8 11.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 4.2 5.9 26.1 15.1 8.0 11.2 0.6 7.0 11.1 11.9 11.0 1.3 1.4 0.0 3.4 9.7 7.0 2.4 4.8 2.9 6.4 6.3 4.9 1.8 5.3 1.0 4.1 1.8 6.4 9.0 2.4 9.8 1.6 18.0 4.0 2.3 1.7 3.4 5.0 4.0 0.8 1.8 4.4 0.2 2.8 7.5 3.1 0.8 3.5 0.9 0.4 10.5 3.2 1.5 1.8 5.4 4.2 0.2 5.5 10.3 13.1 6.5 3.4 3.9 1.3 0.7 10.7 1.7 3.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 31.3 45.3 32.7 37.2 28.8 16.0 13.9 27.5 21.3 15.9 0.0 1.6 0.0 2.5 4.1 31.6 10.9 0.0 0.0 0.0 0.0 7.9 0.3 0.0 2.7 1.3 5.2 0.0 0.0 0.3 5.7 11.2 2.1 0.0 2.1 0.8 54.0 0.0 4.9 0.3 2.5 15.8 0.0 1.7 1.0 0.0 23.0 2.1 0.0 20.8 1.0 15.3 32.3 10.3 0.3 1.3 3.3 0.7 1.0 0.0 1.0 NLGN3 "ASPGX1, AUTSX1, HNL3, KIAA1480" ENSG00000196338 "Neuroligin 3" Q9NZ94 X 71144831-71171201 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Asperger syndrome, Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.9" "Cell type enriched" "Detected in some" 6 "Peritubular cells: 16.3" "Cancer enriched" "Detected in many" 19 "glioma: 37.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.3" "Cell line enhanced" "Detected in some" "AF22: 11.1;NTERA-2: 8.1;SH-SY5Y: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003183, HPA004066" Enhanced Supported "Golgi apparatus,Cell Junctions" "Intracellular and membrane" NA NA "Golgi apparatus, Cell Junctions" "HPA003183: AB_1079469, HPA004066: AB_2732397" "unprognostic (4.06e-2)" "unprognostic (1.77e-1)" "unprognostic (1.59e-2)" "unprognostic (2.38e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-1)" "unprognostic (6.52e-2)" "unprognostic (1.63e-1)" "unprognostic (7.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (6.18e-2)" "unprognostic (4.27e-9)" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (2.22e-5)" "unprognostic (9.01e-2)" 1.4 8.9 16.3 1.6 19.4 2.2 1.3 11.5 45.9 3.2 1.6 30.0 0.1 1.1 4.2 8.1 1.5 6.0 2.4 2.1 15.7 9.7 1.2 0.9 1.3 1.2 12.7 13.1 6.1 1.2 1.4 1.1 1.5 15.2 7.9 1.4 1.6 1.6 16.0 0.8 1.6 1.6 2.9 12.9 1.4 1.5 3.8 12.3 0.0 1.0 0.0 1.1 1.5 1.3 0.2 0.1 3.3 0.3 0.3 0.5 0.0 0.1 0.8 11.1 0.3 2.6 1.1 1.9 0.3 0.1 0.0 0.2 0.1 0.5 0.8 0.8 0.1 0.0 0.2 0.4 0.0 0.2 0.7 1.3 0.5 0.5 0.1 0.0 0.2 0.9 0.6 0.1 0.3 0.0 0.5 0.1 3.1 0.7 2.1 0.1 0.6 0.7 1.7 8.1 0.1 0.0 0.9 0.4 0.5 0.0 1.2 2.7 4.4 0.3 0.0 1.0 1.4 0.0 0.5 0.3 0.2 1.3 0.5 0.1 1.7 1.5 0.6 0.3 0.5 0.6 0.3 0.3 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.5 0.1 3.3 0.3 0.0 0.1 0.1 0.0 16.3 19.4 11.5 23.1 15.7 9.7 12.7 13.1 15.2 12.3 0.0 0.0 0.0 0.4 0.6 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 2.5 2.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 16.3 0.0 0.5 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.0 0.3 NLGN4X "HLNX, KIAA1260, NLGN, NLGN4" ENSG00000146938 "Neuroligin 4, X-linked" Q8N0W4 X 5840637-6228863 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Asperger syndrome, Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 56.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 19.4;Cone photoreceptor cells: 23.6;Leydig cells: 16.7;Melanocytes: 13.5;Peritubular cells: 28.0;Sertoli cells: 12.9" "Cancer enhanced" "Detected in many" "glioma: 8.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 6 "B-cells: 1.5" "Group enriched" "Detected in some" 4 "AF22: 29.3;NTERA-2: 23.2;SuSa: 23.7" HPA001651 Approved NA NA "HPA001651: AB_1079470" "unprognostic (2.21e-1)" "unprognostic (4.01e-2)" "unprognostic (1.11e-1)" "unprognostic (8.57e-2)" "unprognostic (1.28e-1)" "unprognostic (1.52e-1)" "unprognostic (1.36e-1)" "unprognostic (1.04e-1)" "unprognostic (1.67e-1)" "unprognostic (9.49e-2)" "unprognostic (1.48e-2)" "unprognostic (9.32e-2)" "unprognostic (5.10e-3)" "unprognostic (7.16e-4)" "unprognostic (6.70e-2)" "unprognostic (2.98e-2)" "unprognostic (1.10e-2)" 4.9 2.3 8.3 2.8 10.7 0.3 3.4 12.2 19.2 8.2 3.6 3.7 0.4 2.1 3.7 1.0 1.3 3.4 4.0 5.4 7.9 9.9 0.8 2.2 1.9 1.7 5.6 6.4 16.8 0.9 12.3 2.6 5.4 5.7 2.0 3.2 2.1 1.5 3.3 0.7 1.2 2.9 5.6 4.3 3.2 1.9 3.9 3.9 56.3 1.0 0.0 1.1 3.6 1.8 1.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 3.7 0.0 23.2 0.0 0.0 0.0 0.0 0.0 2.1 5.9 1.4 1.8 0.0 0.0 0.0 23.7 3.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 8.3 10.7 12.2 14.7 7.9 9.9 5.6 6.4 5.7 3.9 0.0 0.3 0.0 0.1 0.2 19.4 2.7 0.0 1.4 0.0 0.0 23.6 3.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.0 4.3 0.0 0.0 0.0 0.5 0.0 0.0 2.5 0.3 0.2 16.7 0.0 13.5 0.0 0.0 10.3 0.0 0.0 28.0 0.0 3.0 12.9 0.7 1.6 4.9 0.5 3.0 0.0 0.0 0.3 NLGN4Y KIAA0951 ENSG00000165246 "Neuroligin 4, Y-linked" Q8NFZ3 Y 14522573-14845650 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.8;seminal vesicle: 15.3" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 9.5;Bipolar cells: 8.5;Urothelial cells: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.0;memory CD4 T-cell: 1.7" "Group enriched" "Detected in many" 12 "B-cells: 3.0;T-cells: 1.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 19.6;fHDF/TERT166: 15.0;HDLM-2: 17.5;hTCEpi: 13.1;SuSa: 12.8;U-138 MG: 14.3" HPA001651 Approved "Intracellular and membrane" NA NA "HPA001651: AB_1079470" "unprognostic (2.31e-1)" "unprognostic (9.19e-2)" "unprognostic (2.84e-5)" "unprognostic (7.85e-2)" "unprognostic (6.46e-2)" "unprognostic (8.80e-3)" "unprognostic (7.71e-2)" "unprognostic (6.26e-2)" "unprognostic (5.89e-2)" "unprognostic (7.20e-3)" "unprognostic (1.88e-1)" "unprognostic (5.65e-2)" 1.4 1.9 4.7 1.4 18.7 0.4 1.3 11.2 23.8 0.4 2.5 11.2 2.4 1.2 0.4 4.0 4.3 0.4 4.8 0.8 4.9 5.7 2.0 4.4 1.3 2.7 3.7 0.0 0.5 3.3 0.4 2.9 0.9 12.6 12.6 3.1 7.2 2.2 15.3 0.6 1.3 2.0 3.7 3.5 1.1 1.5 1.3 0.0 2.5 2.6 4.0 2.5 6.0 0.0 3.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.3 19.6 1.2 1.6 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 3.1 17.5 0.0 0.0 0.0 2.8 2.1 0.0 0.0 6.8 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 1.2 0.0 3.9 0.0 0.0 0.0 1.2 0.0 4.7 7.5 2.6 0.0 0.0 0.0 0.0 12.8 0.0 0.4 5.6 14.3 0.0 0.0 3.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.0 1.7 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 4.7 18.7 11.2 23.8 4.9 5.7 3.7 0.0 12.6 0.0 0.0 2.2 0.0 9.5 3.1 8.5 0.7 2.5 2.7 6.8 7.0 0.0 0.3 0.0 1.6 0.0 0.7 0.0 0.0 0.0 0.1 7.1 4.5 0.0 0.0 0.2 6.4 0.0 0.0 0.0 0.0 2.6 0.0 1.7 4.6 0.0 4.0 0.0 0.0 7.8 0.6 0.7 0.0 1.0 0.1 0.4 2.8 0.2 0.0 0.0 10.1 NMB "MGC17211, MGC2277, MGC3936" ENSG00000197696 "Neuromedin B" P08949 15 84655129-84658563 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 37.2;brain: 28.5;breast: 59.9" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 91.4" "Cancer enhanced" "Detected in all" "glioma: 93.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 28.0" "Region enriched" "Detected in many" 16 "olfactory region: 206.6" "Group enriched" "Detected in many" 6 "olfactory region: 80.6;pons and medulla: 17.5" CAB019302 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted to blood" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "CAB019302: " "unprognostic (2.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-3)" "unprognostic (3.79e-1)" "prognostic favorable (3.43e-4)" "unprognostic (3.81e-1)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (2.17e-1)" "unprognostic (4.36e-1)" "unprognostic (7.24e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.25e-4)" "unprognostic (7.92e-3)" "unprognostic (1.45e-1)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" 37.2 8.0 4.6 2.8 7.5 3.3 59.9 2.4 28.5 4.0 6.5 13.7 1.0 2.3 3.1 3.2 2.5 5.0 4.5 7.0 7.0 12.2 4.4 1.9 3.8 3.6 6.6 3.5 3.4 3.3 2.7 4.2 1.4 5.6 1.9 2.1 2.6 4.6 1.8 2.0 1.8 1.4 2.9 9.9 2.0 2.5 6.4 4.8 2.2 8.9 4.9 1.9 4.7 8.5 7.0 10.4 5.9 0.8 1.3 6.4 2.6 28.0 10.7 2.0 0.4 5.5 2.5 0.2 1.7 3.3 3.8 5.2 3.7 7.7 1.2 4.5 4.4 0.0 5.0 10.7 2.2 2.2 10.5 13.5 4.3 4.2 17.4 1.4 2.9 4.7 2.5 0.9 5.9 2.3 2.5 5.5 7.7 0.0 0.4 2.1 16.4 2.7 9.5 7.9 5.9 3.1 8.4 0.0 12.4 3.6 2.2 1.1 12.2 2.8 1.6 12.7 2.1 1.9 11.2 1.4 0.7 3.7 3.5 2.7 0.2 3.0 2.6 8.7 16.2 4.5 0.0 0.8 5.9 6.3 0.6 2.3 4.9 5.0 6.4 3.5 7.0 4.8 3.6 1.2 1.3 0.3 10.4 5.6 2.6 4.6 7.5 2.4 8.5 7.0 12.2 6.6 3.5 5.6 4.8 3.0 2.4 14.3 22.9 13.9 1.6 2.2 7.6 10.7 7.9 29.6 0.0 1.7 11.6 91.4 24.0 11.3 1.7 0.0 50.2 7.5 17.3 30.7 5.7 2.9 30.9 4.8 17.9 4.9 4.8 7.5 4.0 28.4 32.1 29.7 4.9 7.0 39.2 7.0 3.5 22.5 2.3 12.9 29.9 11.1 21.2 11.2 2.6 11.4 8.0 39.6 NMBR "BB1, BB1R" ENSG00000135577 "Neuromedin B receptor" P28336 6 142058330-142088799 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.5;fallopian tube: 3.3;testis: 5.1" "Cell type enhanced" "Detected in some" 35 "Early spermatids: 5.9;Late spermatids: 1.6;Spermatocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.9;RPTEC TERT1: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026665 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA026665: AB_1854527" "unprognostic (6.24e-2)" "unprognostic (3.05e-1)" "unprognostic (2.77e-2)" "unprognostic (7.88e-2)" "unprognostic (3.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.63e-2)" "unprognostic (1.54e-1)" "unprognostic (3.95e-1)" "unprognostic (7.94e-3)" "unprognostic (3.44e-1)" "unprognostic (2.11e-1)" "unprognostic (8.45e-2)" 0.1 0.0 0.6 0.0 2.5 0.0 0.4 0.0 0.8 0.5 0.0 0.0 0.2 0.3 0.6 3.3 0.0 0.0 0.5 1.6 0.2 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.8 0.1 0.2 5.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.9 0.9 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.9 0.0 0.6 0.1 0.0 0.3 0.5 0.0 0.0 0.5 0.2 0.0 0.4 0.0 0.2 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 NMU ENSG00000109255 "Neuromedin U" P48645 4 55595229-55636698 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.9;skin 1: 28.3;tongue: 28.4" "Cell type enhanced" "Detected in some" 24 "Basal keratinocytes: 14.4;Erythroid cells: 23.3;Suprabasal keratinocytes: 64.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 3.4" "Group enriched" "Detected in some" 10 "MAIT T-cell: 7.2;memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 51 "T-cells: 7.2" "Cell line enhanced" "Detected in many" "HaCaT: 81.3;K-562: 63.9;Karpas-707: 29.3" "Region enhanced" "Detected in single" "pons and medulla: 4.7" "Low region specificity" "Detected in many" HPA025926 Uncertain "Secreted in other tissues" NA NA "HPA025926: AB_1854539" "unprognostic (4.42e-2)" "unprognostic (1.00e-1)" "unprognostic (5.83e-2)" "prognostic unfavorable (2.60e-5)" "unprognostic (1.08e-1)" "unprognostic (5.19e-2)" "unprognostic (7.12e-2)" "unprognostic (7.29e-3)" "unprognostic (9.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.03e-2)" "unprognostic (3.00e-1)" "prognostic unfavorable (4.07e-10)" "unprognostic (1.61e-1)" "unprognostic (5.66e-2)" "unprognostic (2.54e-2)" "unprognostic (5.55e-2)" 0.1 0.3 0.2 2.0 1.1 5.9 1.3 0.1 3.4 5.4 1.1 0.2 2.5 0.6 0.5 0.0 42.9 0.2 0.3 0.3 0.2 0.9 0.1 0.0 1.0 0.4 0.4 0.5 0.0 0.0 0.0 2.8 2.1 0.3 0.1 0.6 0.0 6.6 1.5 0.1 28.3 1.7 0.2 1.2 0.1 3.1 1.3 0.0 0.7 17.2 28.4 8.5 0.1 12.2 0.1 0.0 0.0 0.0 0.0 7.2 0.1 8.5 0.0 4.7 1.2 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.0 13.1 18.9 1.8 0.0 1.8 81.3 9.8 0.7 0.5 1.1 5.3 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 2.2 0.0 1.3 63.9 29.3 0.0 2.0 0.2 0.0 2.5 1.5 2.4 0.0 0.0 0.1 0.4 0.0 4.2 10.7 6.5 0.1 0.0 0.9 4.5 0.0 0.5 0.0 6.1 0.0 11.4 8.5 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.2 0.0 2.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.1 3.4 0.2 0.9 0.4 0.5 0.3 0.0 0.0 2.9 1.5 0.6 14.4 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.2 0.2 0.0 23.3 0.2 0.1 1.1 0.2 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.5 2.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 1.5 7.6 64.4 0.1 0.0 1.7 8.0 NMUR1 "FM-3, GPC-R, GPR66, NMU1R" ENSG00000171596 "Neuromedin U receptor 1" Q9HB89 2 231523160-231530495 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Ito cells: 8.0;Peritubular cells: 7.1;Rod photoreceptor cells: 15.5;T-cells: 10.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 6 "gdT-cell: 15.2;MAIT T-cell: 3.9;memory CD8 T-cell: 7.3;naive CD8 T-cell: 4.6;NK-cell: 8.1" "Group enriched" "Detected in many" 18 "NK-cells: 8.1;T-cells: 15.2" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA027895 Uncertain NA NA "HPA027895: AB_10602713" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (6.74e-3)" "unprognostic (9.44e-3)" "unprognostic (2.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.74e-1)" "unprognostic (3.13e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-1)" "unprognostic (1.22e-2)" "unprognostic (2.07e-1)" "unprognostic (4.08e-4)" "unprognostic (3.76e-3)" "unprognostic (2.26e-1)" "unprognostic (2.61e-1)" "unprognostic (5.25e-2)" 13.6 2.2 0.6 1.2 0.9 3.5 3.2 2.1 0.8 2.5 3.5 0.4 4.4 4.4 1.8 3.8 3.3 3.0 4.6 12.6 0.3 0.3 2.1 2.0 6.4 0.5 0.3 0.1 2.8 7.7 0.2 0.6 4.8 0.6 4.0 1.2 8.4 4.6 3.6 0.3 0.8 7.3 8.4 0.6 7.3 1.7 3.0 0.7 0.2 1.8 0.6 0.8 4.4 1.4 0.0 0.3 0.6 0.1 8.1 15.2 3.6 0.3 1.2 1.5 1.5 0.1 0.4 1.3 0.5 0.0 0.0 0.1 0.4 0.5 0.8 0.4 0.4 0.7 0.7 2.6 0.5 0.1 0.5 0.9 0.8 1.1 0.4 0.1 0.8 1.3 0.7 0.3 0.4 0.0 1.2 0.6 0.6 2.5 1.4 0.1 0.8 0.6 1.1 0.7 0.6 0.3 0.4 0.8 0.7 0.1 0.9 0.6 0.7 1.0 0.6 0.3 1.1 1.3 1.6 1.6 1.7 1.3 0.8 0.4 2.0 0.1 0.6 0.5 0.8 0.6 0.4 0.1 0.0 15.2 0.0 3.9 0.0 1.2 7.3 0.0 0.0 0.1 4.6 0.6 8.1 0.1 0.3 0.5 3.6 0.6 0.9 2.1 0.8 0.3 0.3 0.3 0.1 0.6 0.7 0.0 0.0 0.0 0.1 0.9 1.4 2.0 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.8 0.4 0.0 0.0 0.2 0.1 1.4 0.0 1.1 0.0 0.2 1.6 0.0 8.0 1.9 0.2 2.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 7.1 0.0 15.5 0.0 0.3 1.5 3.2 0.4 0.6 10.9 0.0 0.1 NMUR2 NMU2R ENSG00000132911 "Neuromedin U receptor 2" Q9GZQ4 5 152391532-152433368 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.9;stomach 1: 5.0;testis: 8.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "colorectal cancer: 0.5;endometrial cancer: 0.6;pancreatic cancer: 1.8;stomach cancer: 2.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "EFO-21: 14.8" "Region enhanced" "Detected in single" "hypothalamus: 2.0" "Low region specificity" "Detected in all" "HPA027800, HPA045836" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA027800: , HPA045836: AB_10968856" "unprognostic (1.82e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-1)" "unprognostic (9.29e-2)" "unprognostic (5.87e-2)" "unprognostic (6.44e-3)" "unprognostic (3.13e-1)" "unprognostic (6.47e-2)" "unprognostic (5.63e-2)" "unprognostic (8.20e-3)" "unprognostic (8.90e-5)" "unprognostic (1.48e-2)" "unprognostic (9.24e-2)" "unprognostic (9.56e-2)" "unprognostic (2.29e-1)" 0.1 0.5 0.6 0.7 1.0 0.0 0.1 0.2 1.2 0.4 0.2 0.7 1.1 0.6 0.9 0.2 0.4 0.1 0.6 1.4 0.9 2.8 2.0 0.1 2.9 0.1 4.3 0.4 0.1 0.0 0.0 0.7 0.5 1.6 0.2 0.4 0.0 0.0 0.2 0.8 0.0 0.3 0.2 8.9 0.0 5.0 8.0 1.4 0.9 2.5 0.0 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 14.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.2 1.2 0.9 2.8 4.3 0.4 1.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NNAT Peg5 ENSG00000053438 Neuronatin Q16517 20 37521215-37523693 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "brain: 117.2;pituitary gland: 165.1;placenta: 69.1" "Group enriched" "Detected in many" 9 "Early spermatids: 30.8;Late spermatids: 51.7;Muller glia cells: 77.7" "Group enriched" "Detected in many" 16 "glioma: 87.5;testis cancer: 55.0;urothelial cancer: 37.4" "Region enhanced" "Detected in all" "basal ganglia: 117.2" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 22 "SH-SY5Y: 127.5" "Low region specificity" "Detected in all" NA NA "unprognostic (1.18e-2)" "unprognostic (7.41e-3)" "unprognostic (1.85e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (9.66e-4)" "unprognostic (7.08e-2)" "unprognostic (1.42e-1)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (7.52e-2)" "unprognostic (4.94e-2)" "unprognostic (1.64e-2)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.96e-1)" "unprognostic (1.15e-3)" "unprognostic (5.90e-2)" 17.0 11.6 35.4 2.6 117.2 2.3 3.5 4.9 68.4 2.3 7.0 11.1 0.0 3.4 4.6 2.5 2.6 2.8 4.2 1.7 35.0 21.4 1.4 1.1 1.7 1.9 4.9 14.0 1.3 1.6 1.0 165.1 69.1 7.9 2.4 3.9 1.5 3.4 1.5 8.0 3.8 3.2 4.4 2.1 1.8 2.1 2.9 3.8 0.2 1.5 0.0 1.1 3.3 0.6 0.7 0.7 0.3 0.3 0.0 1.0 0.0 0.3 0.2 2.2 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.6 0.1 0.1 0.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.3 0.0 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.6 0.0 0.0 3.2 0.3 127.5 0.1 0.7 0.0 0.1 0.2 0.0 0.1 0.9 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 1.0 0.3 0.0 0.0 0.7 0.0 0.0 35.4 117.2 4.9 41.0 35.0 21.4 4.9 14.0 7.9 3.8 0.0 0.0 0.0 0.7 3.5 3.7 0.0 0.0 1.4 1.2 0.0 0.0 0.5 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.4 1.0 2.2 1.1 0.0 1.4 0.0 0.0 0.0 0.0 51.7 0.6 0.0 1.7 0.0 0.0 77.7 0.0 0.0 1.1 0.0 6.0 0.0 0.4 1.1 3.8 0.9 0.2 0.0 0.0 2.3 NNT ENSG00000112992 "Nicotinamide nucleotide transhydrogenase" Q13423 5 43602692-43707405 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Translocase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.0" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 303.5;Hepatocytes: 274.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004829, CAB004975" Enhanced Approved Mitochondria,Cytosol NA NA 1100000 Mitochondria Cytosol "CAB004975: AB_425908, HPA004829: AB_1079495" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" "unprognostic (3.33e-2)" "unprognostic (4.81e-2)" "unprognostic (5.02e-2)" "unprognostic (1.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.96e-3)" "unprognostic (2.20e-2)" "unprognostic (3.98e-2)" "unprognostic (1.65e-1)" "unprognostic (8.33e-2)" "prognostic favorable (1.22e-15)" "unprognostic (8.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (2.58e-1)" 10.8 10.5 11.7 8.3 14.0 7.3 9.1 8.3 19.0 7.6 11.2 7.3 8.8 9.2 7.1 8.8 7.9 5.4 7.1 62.1 10.8 8.2 26.0 48.5 7.2 9.6 9.2 10.3 5.8 12.2 15.6 6.2 5.8 10.0 8.5 12.1 6.7 14.4 7.8 100.0 6.0 8.9 14.7 6.1 6.5 13.6 4.2 6.1 14.0 14.0 32.6 8.7 10.9 6.2 11.4 25.5 13.1 18.5 18.2 19.1 13.5 8.3 6.2 14.3 26.6 16.7 18.6 4.5 8.4 14.4 10.4 9.4 7.1 13.9 8.6 10.5 16.0 11.0 8.0 56.7 2.0 11.0 13.6 15.3 12.4 33.3 8.7 9.6 20.7 18.5 16.0 6.3 5.9 8.5 18.2 20.5 12.5 8.9 34.4 24.7 5.7 22.3 11.2 2.8 0.0 5.6 25.1 33.8 30.8 19.7 7.4 21.1 17.6 30.9 0.4 19.1 3.1 21.6 20.9 11.2 15.2 14.8 6.3 4.1 18.5 19.0 13.2 3.1 27.7 9.8 9.3 14.2 13.1 14.4 18.4 14.8 11.4 15.6 14.5 25.5 10.3 14.6 13.3 2.4 18.2 18.5 9.2 19.1 13.5 11.7 14.0 8.3 19.0 10.8 8.2 9.2 10.3 10.0 6.1 50.6 27.8 20.7 7.7 10.2 17.5 303.5 28.1 24.1 31.8 26.2 33.4 7.2 23.2 10.7 12.2 12.6 17.2 23.3 9.3 2.1 17.9 10.5 23.3 274.2 21.7 6.4 19.1 20.3 31.4 3.4 13.8 18.2 13.5 10.8 24.6 13.2 9.5 11.5 18.0 21.1 11.9 0.0 15.1 2.1 1.2 7.0 1.7 27.7 25.8 7.6 NOTCH2 ENSG00000134250 "Notch 2" Q04721 1 119911553-120069626 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 129.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048743 Approved Supported "Nucleoplasm,Plasma membrane" NA NA 67000000 "Nucleoplasm, Plasma membrane" "HPA048743: AB_2680508" "unprognostic (1.33e-1)" "unprognostic (1.43e-2)" "unprognostic (2.66e-1)" "unprognostic (1.40e-3)" "unprognostic (7.98e-2)" "unprognostic (4.01e-2)" "unprognostic (1.22e-1)" "unprognostic (7.32e-2)" "unprognostic (1.18e-2)" "prognostic unfavorable (5.24e-4)" "prognostic unfavorable (9.48e-4)" "unprognostic (3.86e-2)" "unprognostic (6.12e-3)" "unprognostic (1.55e-2)" "unprognostic (2.65e-2)" "unprognostic (1.12e-2)" "unprognostic (7.35e-3)" 12.0 7.3 6.0 9.4 6.8 4.4 10.6 3.0 5.6 14.5 7.6 4.4 11.3 1.6 12.3 11.8 13.4 11.4 12.8 7.9 6.8 2.3 5.5 11.4 10.6 5.7 5.3 7.6 15.5 27.6 6.1 3.3 10.3 6.5 9.9 5.2 9.4 17.7 10.0 9.3 17.2 6.1 12.4 6.2 11.5 5.8 15.7 4.4 8.0 11.4 8.6 6.6 9.6 13.0 4.2 5.2 7.7 9.6 1.5 1.7 2.0 15.0 5.1 7.9 6.1 33.0 28.3 7.9 11.5 15.9 15.4 16.7 4.7 4.1 0.3 9.7 21.8 13.7 5.7 12.5 10.2 24.6 18.1 8.0 8.7 13.7 0.4 12.3 9.1 2.3 22.7 6.6 46.1 30.7 23.3 7.8 4.1 0.1 19.2 18.5 16.9 3.8 2.6 10.2 1.4 5.7 2.5 27.9 9.7 8.1 9.6 0.3 4.0 15.6 14.7 8.3 16.7 8.1 3.1 27.4 20.1 13.9 30.1 18.0 8.0 3.9 4.4 29.5 8.4 19.1 5.6 6.4 6.4 1.5 6.6 1.7 4.2 1.3 1.1 5.2 3.9 1.0 1.7 7.7 1.5 9.6 4.2 0.8 2.0 6.0 6.8 3.0 5.6 6.8 2.3 5.3 7.6 6.5 4.4 32.8 21.6 24.1 40.5 41.1 3.5 11.2 25.5 2.7 13.6 17.4 5.9 1.2 0.0 37.1 15.7 3.7 3.0 0.0 11.3 6.7 53.5 36.6 15.1 35.0 29.9 3.2 5.8 5.5 68.6 9.3 50.9 36.3 37.1 13.6 7.5 46.7 22.9 129.8 80.2 4.3 10.2 19.4 32.3 4.8 3.6 77.8 1.4 13.6 13.8 52.7 NOX1 "GP91-2, MOX1, NOH-1, NOH1" ENSG00000007952 "NADPH oxidase 1" Q9Y5S8 X 100843324-100874345 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 15.0;intestine: 36.3;seminal vesicle: 18.0" "Cell type enriched" "Detected in some" 5 "Undifferentiated cells: 70.7" "Cancer enriched" "Detected in many" 18 "colorectal cancer: 82.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 14 "CACO-2: 25.8;OE19: 9.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (8.31e-2)" "unprognostic (2.07e-3)" "prognostic favorable (9.71e-4)" "unprognostic (1.67e-2)" "unprognostic (3.37e-1)" "unprognostic (6.55e-3)" "unprognostic (5.48e-3)" "unprognostic (8.68e-3)" "unprognostic (1.32e-1)" "unprognostic (5.23e-2)" "unprognostic (1.18e-1)" "unprognostic (3.86e-3)" "unprognostic (2.56e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-2)" "unprognostic (5.28e-2)" "unprognostic (1.81e-3)" 0.1 0.1 0.2 8.8 0.2 0.0 0.1 0.2 0.2 0.2 28.3 0.0 15.0 0.1 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.3 36.3 0.0 0.1 18.0 0.1 0.8 1.7 0.7 0.1 0.1 0.1 0.4 0.0 0.4 0.1 0.0 0.1 0.6 0.1 0.2 0.7 0.9 0.6 0.8 1.5 0.2 0.3 0.9 0.4 0.3 0.2 0.0 0.3 0.3 0.0 0.0 0.0 25.8 0.3 0.3 0.6 0.0 0.2 0.6 0.0 0.0 0.0 0.3 1.2 0.4 0.6 0.7 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.3 0.2 0.0 0.2 1.1 1.0 0.7 9.7 0.9 0.6 0.6 0.4 0.0 0.9 0.4 0.5 0.6 0.3 0.6 0.2 0.2 0.8 0.2 0.3 0.2 0.5 0.6 0.3 0.6 0.3 0.7 1.1 0.2 0.9 0.3 0.3 0.5 0.3 0.3 0.2 1.1 0.2 0.1 0.1 1.5 0.6 0.1 0.8 0.6 0.7 1.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 70.7 0.5 NOX3 GP91-3 ENSG00000074771 "NADPH oxidase 3" Q9HBY0 6 155395370-155455903 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "adrenal gland: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "MCF7: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA073837 Uncertain Vesicles NA NA Vesicles "HPA073837: " "unprognostic (3.42e-1)" 0.0 1.8 0.4 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NOX4 "KOX, KOX-1" ENSG00000086991 "NADPH oxidase 4" Q9NPH5 11 89324356-89498187 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 65.2" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 119.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 8.5;HUVEC TERT2: 15.6;TIME: 34.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015475 Approved Nucleoplasm NA NA Nucleoplasm "HPA015475: AB_1854574" "unprognostic (2.91e-2)" "unprognostic (1.08e-1)" "unprognostic (1.74e-3)" "unprognostic (6.58e-3)" "unprognostic (1.92e-1)" "unprognostic (2.33e-1)" "unprognostic (8.83e-3)" "unprognostic (8.95e-3)" "unprognostic (3.80e-1)" "unprognostic (6.88e-2)" "unprognostic (1.56e-2)" "unprognostic (1.73e-1)" "prognostic favorable (6.14e-4)" "unprognostic (1.99e-4)" "unprognostic (9.71e-2)" "unprognostic (5.69e-2)" "unprognostic (3.03e-3)" 7.5 0.6 0.2 0.6 0.6 0.3 6.5 0.3 0.5 1.2 0.9 1.1 0.4 0.3 7.3 2.5 1.5 0.8 1.3 6.9 0.6 0.2 65.2 0.3 1.2 0.3 0.3 0.2 0.7 1.1 3.8 0.8 1.7 1.0 2.6 0.4 0.8 2.6 0.9 5.1 1.1 0.5 3.5 1.2 0.4 0.4 1.0 0.0 0.0 1.7 1.7 0.4 2.1 1.1 0.4 0.3 1.7 0.3 0.8 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 8.5 15.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.2 4.3 0.3 0.0 34.8 0.1 2.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.4 0.3 0.3 1.7 0.8 0.2 0.3 0.2 0.0 0.2 0.6 0.3 0.5 0.6 0.2 0.3 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 4.1 1.1 0.0 0.0 0.0 10.4 5.9 1.2 13.3 0.0 0.8 1.1 0.0 0.0 0.0 0.6 1.1 0.1 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.4 0.3 0.0 0.0 0.0 0.0 3.7 0.1 0.0 1.1 119.8 19.3 0.0 0.3 0.5 0.1 0.3 2.1 0.0 0.0 0.0 NOX5 "NOX5A, NOX5B" ENSG00000255346 "NADPH oxidase 5" Q96PH1 15 68930525-69062743 "Predicted membrane proteins, Transporters" "Angiogenesis, Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 19.1;placenta: 11.1;testis: 43.7" "Group enriched" "Detected in some" 4 "Early spermatids: 14.7;Late spermatids: 9.0;Spermatocytes: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.5;EFO-21: 3.2" "Low region specificity" "Detected in many" NA NA "unprognostic (2.33e-1)" "unprognostic (1.63e-2)" "unprognostic (6.11e-2)" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (4.91e-3)" "unprognostic (6.80e-2)" "unprognostic (5.50e-3)" "unprognostic (3.48e-2)" "unprognostic (2.08e-1)" "unprognostic (1.41e-1)" "unprognostic (8.21e-2)" "unprognostic (4.58e-3)" "unprognostic (2.71e-3)" "unprognostic (4.81e-2)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" 1.5 1.0 0.8 0.4 2.3 0.4 1.5 0.8 1.2 3.0 0.9 0.9 5.3 0.4 1.5 2.5 1.1 1.1 1.1 1.6 0.8 0.9 1.4 0.5 0.6 1.1 1.3 0.1 1.2 0.6 0.5 1.9 11.1 2.7 2.1 0.9 1.1 0.6 2.3 0.9 0.8 1.0 2.3 1.3 19.1 0.9 43.7 0.5 0.2 1.4 0.2 0.6 1.5 1.0 0.4 0.1 0.4 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 2.4 0.6 2.0 2.5 1.3 1.5 0.0 3.2 0.4 0.1 0.0 0.0 0.1 1.6 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.5 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.7 1.1 0.0 0.0 0.7 0.6 1.5 0.0 0.1 0.3 1.3 0.0 1.7 0.0 0.1 0.6 2.0 0.2 0.9 0.3 0.0 0.1 0.2 0.2 0.4 0.2 0.0 0.1 0.3 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 2.3 0.8 1.2 0.8 0.9 1.3 0.1 2.7 0.5 0.0 0.0 0.0 0.1 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 14.7 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 4.3 1.3 0.0 1.5 0.0 0.0 0.0 NPB "PPL7, PPNPB" ENSG00000183979 "Neuropeptide B" Q8NG41 17 81900745-81902905 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.2" "Group enriched" "Detected in many" 8 "Spermatogonia: 28.8;Syncytiotrophoblasts: 81.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 2.1;MAIT T-cell: 2.2" "Group enriched" "Detected in many" 14 "granulocytes: 2.1;T-cells: 2.2" "Cell line enhanced" "Detected in some" "HDLM-2: 4.2;PC-3: 5.6;RH-30: 4.3;SH-SY5Y: 4.7;U-2 OS: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (2.44e-2)" "unprognostic (6.21e-2)" "unprognostic (2.90e-1)" "unprognostic (3.47e-3)" "unprognostic (9.42e-2)" "unprognostic (1.46e-1)" "unprognostic (3.31e-1)" "unprognostic (1.92e-1)" "unprognostic (3.55e-2)" "unprognostic (5.40e-2)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (6.06e-2)" "unprognostic (3.71e-1)" "unprognostic (4.32e-1)" 1.5 0.6 4.7 5.2 5.1 1.1 2.2 3.4 6.9 2.3 1.3 3.8 0.1 0.4 2.8 2.4 0.6 2.1 0.8 1.0 2.7 10.3 1.3 1.2 1.1 4.4 6.1 2.7 2.4 0.9 1.1 0.7 8.0 4.5 1.4 1.2 1.9 0.8 1.8 1.6 2.5 1.3 1.9 13.2 2.8 1.0 2.0 1.4 1.9 0.7 0.0 3.7 0.8 2.5 0.1 0.0 2.1 0.0 0.0 2.2 0.0 0.7 2.1 1.5 0.4 0.3 0.4 1.3 0.6 0.4 0.4 0.0 1.0 0.2 0.4 0.2 0.3 1.3 0.0 0.9 0.3 0.6 4.2 0.2 0.9 0.1 0.0 0.3 0.1 0.6 0.0 1.7 0.6 0.5 1.2 0.1 1.0 1.3 0.2 0.2 0.4 0.1 1.1 0.5 0.6 5.6 0.4 4.3 0.0 0.3 1.1 0.9 4.7 0.4 0.6 0.9 3.0 0.1 0.1 0.5 0.8 5.3 0.2 0.6 0.6 0.5 0.0 0.1 1.3 0.4 0.2 0.0 2.1 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 4.7 5.1 3.4 6.9 2.7 10.3 6.1 2.7 4.5 1.4 0.0 0.0 0.0 0.4 2.3 0.9 0.0 2.5 0.0 0.0 0.0 0.0 1.8 1.7 0.8 1.3 0.0 0.6 0.0 0.2 2.2 3.3 0.9 0.0 0.0 1.1 0.0 0.0 1.8 1.9 2.8 4.6 0.0 5.0 0.0 0.2 0.3 1.3 3.2 2.5 1.8 1.3 0.0 1.5 6.9 28.8 1.0 81.1 0.0 0.3 0.4 NPBWR1 GPR7 ENSG00000183729 "Neuropeptides B and W receptor 1" P48145 8 52938431-52941117 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.1;brain: 2.8;liver: 2.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 9 "classical monocyte: 1.6;eosinophil: 3.1" "Group enriched" "Detected in many" 9 "granulocytes: 3.1;monocytes: 1.6" "Group enriched" "Detected in some" 5 "A549: 2.3;HaCaT: 2.9;SiHa: 4.6" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 10.5" NA NA "unprognostic (2.33e-1)" "unprognostic (1.01e-1)" "unprognostic (7.86e-2)" "unprognostic (2.67e-2)" "unprognostic (2.05e-1)" "unprognostic (1.02e-2)" "unprognostic (2.21e-1)" "unprognostic (3.89e-3)" "unprognostic (2.18e-1)" "unprognostic (8.55e-2)" "unprognostic (2.84e-1)" "unprognostic (6.76e-2)" "unprognostic (4.71e-2)" "unprognostic (2.26e-1)" "unprognostic (4.90e-2)" "unprognostic (2.68e-1)" "unprognostic (1.23e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.3 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.3 0.1 0.0 0.0 3.1 1.6 0.0 0.2 0.8 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.3 0.0 4.6 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPBWR2 GPR8 ENSG00000125522 "Neuropeptides B and W receptor 2" P48146 20 64105820-64107171 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "cerebral cortex: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 0.6;hypothalamus: 0.4;olfactory region: 1.5" NA NA "unprognostic (1.44e-1)" 0.2 2.4 0.3 0.3 1.8 0.3 0.2 0.4 14.8 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.2 2.3 0.2 0.2 0.2 1.6 0.2 0.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.4 14.8 0.2 0.5 0.2 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPC1 SLC65A1 ENSG00000141458 "NPC intracellular cholesterol transporter 1" O15118 18 23506184-23586898 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.6" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 32.7" "Group enriched" "Detected in all" 4 "dendritic cells: 32.7;T-cells: 14.5" "Cell line enhanced" "Detected in all" "hTERT-HME1: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026618, CAB070132, HPA077445" Approved Supported Nucleoplasm,Vesicles NA NA 27000 "Nucleoplasm, Vesicles" "CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: " "unprognostic (1.74e-1)" "unprognostic (1.53e-3)" "unprognostic (2.67e-1)" "unprognostic (1.25e-1)" "unprognostic (3.20e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (2.26e-6)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (7.36e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-3)" "unprognostic (2.78e-2)" "unprognostic (1.89e-1)" "unprognostic (2.73e-2)" "unprognostic (1.38e-1)" "unprognostic (2.08e-3)" 13.4 38.8 17.4 11.2 30.9 26.4 15.8 7.1 25.1 10.1 8.7 65.6 3.4 10.2 11.1 11.7 12.8 8.2 11.2 7.1 23.4 14.3 9.9 10.3 17.8 13.0 46.0 15.4 12.0 7.9 51.8 9.9 18.9 27.7 9.7 8.9 12.0 25.4 10.1 13.7 17.0 12.2 10.9 41.4 11.5 12.0 9.5 38.4 7.0 8.3 5.3 10.7 10.8 10.8 3.6 32.7 3.8 5.8 4.6 14.5 4.1 5.3 10.7 4.6 7.4 15.0 11.6 10.5 9.3 20.2 9.9 21.5 7.1 7.8 4.5 7.2 13.4 33.8 15.0 5.8 16.0 8.8 3.5 4.6 1.6 9.7 16.0 21.4 6.1 7.4 11.1 15.9 20.9 70.4 19.6 9.7 5.2 4.8 12.1 11.1 8.1 2.5 3.6 3.2 6.1 9.6 3.6 7.2 11.2 23.0 13.3 1.9 3.7 11.1 16.2 13.7 7.4 4.0 4.8 12.5 21.0 4.1 8.3 8.0 7.5 23.1 3.1 46.3 5.4 9.4 1.8 4.1 3.8 14.5 3.8 9.8 2.4 5.9 9.9 1.7 3.6 2.7 7.3 3.7 4.6 5.8 32.7 7.7 4.1 17.4 30.9 7.1 25.1 23.4 14.3 46.0 15.4 27.7 38.4 23.8 44.3 6.2 23.3 8.2 5.0 4.4 10.2 0.0 15.9 8.7 17.7 11.6 0.0 9.3 1.1 11.4 11.3 0.0 12.8 6.2 6.5 30.4 10.4 7.9 25.1 3.2 3.5 7.4 9.2 1.4 8.3 17.9 11.8 2.8 4.8 16.2 23.5 14.0 9.9 4.7 12.4 0.0 9.0 12.6 20.4 12.7 19.9 20.3 4.5 51.4 NPC1L1 SLC65A2 ENSG00000015520 "NPC1 like intracellular cholesterol transporter 1" Q9UHC9 7 44512535-44541315 "FDA approved drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 77.0;liver: 29.8" "Group enriched" "Detected in some" 9 "Cholangiocytes: 10.2;Early spermatids: 13.1;Hepatocytes: 27.0" "Group enriched" "Detected in many" 5 "liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 6.9;Hep G2: 17.2;SCLC-21H: 14.8" "Region enhanced" "Detected in single" "cerebral cortex: 0.7" "Low region specificity" "Detected in all" "CAB070127, CAB070128" Enhanced NA NA "CAB070127: AB_10002744, CAB070128: AB_10000815" "unprognostic (2.96e-2)" "unprognostic (2.23e-1)" "unprognostic (7.57e-3)" "unprognostic (8.43e-2)" "unprognostic (1.62e-1)" "unprognostic (2.07e-1)" "unprognostic (9.40e-2)" "unprognostic (6.75e-2)" "unprognostic (1.44e-1)" "unprognostic (1.96e-2)" "unprognostic (4.51e-2)" "unprognostic (7.59e-2)" "unprognostic (8.08e-10)" "unprognostic (1.64e-2)" "unprognostic (2.83e-1)" "unprognostic (3.62e-2)" "unprognostic (5.83e-2)" 0.5 0.1 0.1 0.0 0.2 0.0 0.4 0.5 0.2 0.3 42.0 0.0 0.0 30.5 0.4 0.3 0.3 0.3 11.4 0.1 0.1 0.1 0.7 29.8 0.2 0.0 0.1 0.0 0.5 1.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.2 77.0 0.0 0.1 0.1 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.2 0.0 0.6 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 14.8 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 10.2 0.0 0.0 1.8 0.0 0.0 0.0 0.2 13.1 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.0 27.0 0.0 0.0 1.7 1.8 1.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 NPDC1 "CAB-, CAB1, DKFZp586J0523" ENSG00000107281 "Neural proliferation, differentiation and control 1" Q9NQX5 9 137039470-137046203 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Glandular cells: 329.4;Intestinal endocrine cells: 270.4;Ito cells: 337.0;Mucus-secreting cells: 535.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 8.4;MAIT T-cell: 10.7;memory CD4 T-cell: 13.2;memory CD8 T-cell: 13.6;T-reg: 10.4" "Lineage enriched" "Detected in many" 7 "T-cells: 13.6" "Cell line enhanced" "Detected in many" "T-47d: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008189 Approved Approved Nucleoplasm,Cytosol NA NA 180000 Nucleoplasm Cytosol "HPA008189: AB_1854584" "unprognostic (6.94e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.01e-5)" "prognostic favorable (6.19e-5)" "unprognostic (2.06e-1)" "unprognostic (4.83e-3)" "unprognostic (1.24e-1)" "unprognostic (4.35e-2)" "unprognostic (8.65e-2)" "unprognostic (1.53e-1)" "prognostic favorable (3.18e-4)" "unprognostic (2.40e-1)" "unprognostic (2.65e-2)" "unprognostic (1.23e-2)" "unprognostic (2.35e-1)" "unprognostic (4.20e-2)" "unprognostic (8.84e-2)" 35.4 21.7 33.1 11.9 35.5 4.1 21.6 59.7 65.6 27.8 27.1 18.4 23.8 22.2 26.7 10.8 11.6 25.4 32.3 20.4 34.5 35.3 12.7 5.9 18.9 11.5 25.1 49.0 12.0 28.6 17.2 47.7 20.1 29.5 73.1 13.3 10.6 58.0 35.5 19.0 17.7 23.0 16.4 30.3 32.4 59.6 10.4 14.5 0.8 11.5 8.6 7.2 12.8 20.2 0.1 2.0 0.5 0.4 0.1 13.6 2.6 9.4 11.4 2.8 18.4 6.6 6.8 0.7 20.4 6.4 4.6 1.8 4.6 5.2 9.4 15.5 7.8 1.4 35.7 2.4 5.5 0.5 7.6 11.6 3.8 29.2 3.3 9.5 3.3 0.0 4.7 8.6 2.5 5.0 12.0 11.8 3.8 0.2 0.2 0.9 35.9 0.2 0.3 6.1 30.0 19.0 5.6 0.0 36.0 7.8 6.1 22.7 15.7 5.4 18.2 12.2 1.1 39.3 4.7 20.3 3.4 6.2 24.3 6.2 0.0 0.1 0.3 5.0 0.3 2.9 0.0 0.4 0.5 8.4 0.0 10.7 0.1 13.2 13.6 0.7 0.0 0.3 2.3 0.0 0.1 0.0 2.0 10.4 2.6 33.1 35.5 59.7 65.6 34.5 35.3 25.1 49.0 29.5 14.5 0.0 10.6 4.2 65.4 20.9 88.5 13.4 79.0 2.7 4.5 27.9 15.7 1.0 0.0 43.0 1.0 147.8 41.7 23.3 59.4 1.0 34.3 329.4 0.0 0.8 17.1 58.8 270.4 337.0 25.4 2.5 149.3 6.8 28.7 2.8 535.1 32.8 34.0 79.7 136.9 0.3 54.6 38.8 34.0 2.9 19.1 20.7 1.5 7.7 84.8 89.4 NPFFR1 "GPR147, NPFF1R1, OT7T022" ENSG00000148734 "Neuropeptide FF receptor 1" Q9GZQ6 10 70247329-70283676 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 34.9" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 15.1" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Group enriched" "Detected in all" 5 "basal ganglia: 10.2;cerebellum: 34.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 4.8" "Group enriched" "Detected in some" 6 "basal ganglia: 16.1;hypothalamus: 7.3" "Low region specificity" "Detected in many" HPA037521 Uncertain NA NA "HPA037521: AB_2675520" "unprognostic (1.73e-3)" "unprognostic (7.29e-4)" "unprognostic (2.12e-1)" "unprognostic (3.50e-2)" "unprognostic (2.07e-1)" "unprognostic (8.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.48e-1)" "unprognostic (4.14e-2)" "unprognostic (3.51e-1)" "unprognostic (9.62e-2)" "unprognostic (6.78e-2)" "unprognostic (5.84e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" 0.6 0.5 1.9 1.8 10.2 1.3 0.9 34.9 2.6 0.9 0.6 2.6 0.0 0.8 1.0 1.2 0.4 1.6 0.6 0.4 2.7 4.1 0.5 0.5 1.3 2.5 2.2 4.1 0.8 0.3 0.9 0.4 0.4 4.7 0.6 0.8 5.4 0.4 1.1 1.0 1.0 0.8 0.4 4.0 1.0 1.4 4.7 2.0 0.0 0.6 0.0 1.4 0.6 0.7 1.0 1.2 2.4 2.2 1.3 0.6 2.6 1.1 0.8 0.9 0.7 0.8 1.3 0.7 0.3 0.4 0.3 0.3 1.3 2.3 0.8 0.7 1.0 0.4 1.0 2.2 1.2 0.7 0.7 0.9 1.1 1.0 1.0 0.8 0.8 1.3 0.7 1.1 0.5 0.8 0.9 0.9 1.0 0.9 0.9 0.5 0.9 0.7 0.9 0.8 1.9 0.3 0.9 0.8 0.5 0.8 0.8 0.8 0.8 0.8 1.2 0.4 0.8 0.5 0.6 1.0 0.9 4.8 0.8 1.0 0.7 0.8 0.5 0.6 0.9 0.7 2.4 2.2 0.4 0.5 0.7 0.5 0.5 0.5 0.4 1.2 1.0 0.6 0.6 1.9 1.3 0.4 0.9 0.4 2.6 1.9 10.2 34.9 2.6 2.7 4.1 2.2 4.1 4.7 2.0 0.0 1.3 0.0 1.2 1.4 0.7 0.8 2.5 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.1 1.0 1.0 2.3 0.0 0.1 0.0 0.0 0.0 0.3 1.1 0.6 1.1 0.0 0.0 0.0 15.1 0.1 0.0 0.4 0.0 1.5 0.0 1.4 0.2 0.4 1.8 0.9 0.0 0.0 0.8 NPFFR2 "GPR74, NPFF2, NPGPR" ENSG00000056291 "Neuropeptide FF receptor 2" Q9Y5X5 4 72031804-72148067 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.4;seminal vesicle: 10.1" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 5.4;Extravillous trophoblasts: 7.3;Horizontal cells: 3.2;Muller glia cells: 4.8;Syncytiotrophoblasts: 8.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "GAMG: 22.5;NTERA-2: 7.3;RPTEC TERT1: 9.5;SH-SY5Y: 11.2;U-2 OS: 11.2" "Region enriched" "Detected in single" 4 "olfactory region: 5.3" "Low region specificity" "Detected in many" HPA026825 Approved "Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA "Plasma membrane" "Actin filaments" "HPA026825: AB_10603123" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (6.07e-2)" "unprognostic (4.68e-2)" "unprognostic (5.77e-2)" "unprognostic (1.43e-2)" "unprognostic (1.34e-1)" "unprognostic (1.51e-1)" "unprognostic (2.40e-5)" "unprognostic (5.75e-2)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (1.48e-1)" 0.9 0.2 5.5 0.7 2.6 0.2 1.4 0.2 3.5 0.5 0.5 0.0 0.0 0.5 0.1 2.8 0.3 0.8 0.4 0.4 0.9 2.9 0.6 0.2 0.2 0.6 0.5 4.0 0.3 1.2 0.1 1.0 4.6 1.5 3.2 0.9 1.4 0.3 10.1 0.3 0.7 0.5 0.2 0.6 0.5 0.4 1.6 0.0 15.4 1.2 0.0 0.6 2.5 0.7 0.6 0.3 2.3 0.3 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 11.2 0.0 0.0 0.0 1.6 0.0 0.0 1.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.4 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.6 0.2 0.2 1.1 0.8 0.3 0.3 0.2 0.1 5.5 2.6 0.2 3.5 0.9 2.9 0.5 4.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.2 0.4 0.1 0.0 0.0 0.2 7.3 1.0 0.0 0.0 0.0 0.9 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.8 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 8.1 0.0 0.0 0.0 NPHP4 "KIAA0673, POC10, SLSN4" ENSG00000131697 "Nephrocystin 4" O75161 1 5862811-5992473 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ciliopathy, Disease mutation, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063852, HPA065526" Approved Approved "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies, Vesicles" "HPA063852: , HPA065526: AB_2685505" "unprognostic (1.82e-1)" "unprognostic (1.57e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (5.83e-2)" "unprognostic (2.53e-2)" "unprognostic (1.08e-2)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (1.23e-2)" "unprognostic (7.49e-3)" "unprognostic (9.00e-2)" "unprognostic (1.75e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" 5.6 4.7 7.3 4.7 11.2 7.2 4.9 6.3 12.0 5.4 3.5 4.9 8.9 4.4 5.2 11.9 3.7 17.4 5.7 3.7 6.6 3.9 4.5 2.5 6.7 4.6 2.8 6.4 7.0 4.9 7.1 17.8 3.7 5.4 4.5 2.9 8.3 4.1 5.7 3.7 9.6 4.5 5.3 3.5 4.6 4.3 11.4 3.7 5.8 14.9 3.7 2.6 4.3 4.5 0.5 0.4 2.6 1.0 0.5 0.8 0.4 7.6 4.2 5.7 4.4 5.1 7.4 4.4 4.0 4.1 5.6 4.4 4.0 6.7 4.0 10.1 4.5 3.8 7.2 2.8 6.8 2.8 4.9 6.5 3.4 7.7 3.6 3.5 6.6 5.2 6.0 3.4 6.6 4.2 3.4 3.9 9.7 6.1 4.3 2.5 5.6 8.0 6.6 1.0 4.0 4.5 6.9 3.6 6.5 2.5 1.0 18.0 5.5 6.3 4.6 6.6 2.6 6.1 7.2 3.5 8.1 3.4 13.4 4.9 5.2 6.9 4.0 3.4 8.4 2.1 2.6 1.0 0.0 0.5 0.2 0.8 0.3 0.5 0.0 0.4 0.5 0.4 0.0 1.4 0.5 0.8 0.3 0.2 0.4 7.3 11.2 6.3 12.0 6.6 3.9 2.8 6.4 5.4 3.7 0.0 0.6 0.0 1.0 3.5 6.4 2.5 5.1 5.3 5.7 3.5 31.4 0.5 1.7 0.8 1.5 2.2 1.6 0.0 1.6 0.4 1.8 1.5 0.0 1.5 1.7 4.8 3.5 1.3 4.3 1.0 3.7 2.6 10.1 1.0 2.3 5.4 1.9 2.6 2.1 1.4 19.4 6.5 2.1 11.2 6.0 4.5 0.9 0.7 1.2 0.9 NPHS1 "CNF, NPHN" ENSG00000161270 "NPHS1, nephrin" O60500 19 35825964-35869287 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Myogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "kidney: 20.2;pancreas: 21.8" "Cell type enhanced" "Detected in some" 17 "Collecting duct cells: 3.5;Early spermatids: 9.6;Late spermatids: 4.7" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "neutrophil: 2.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "A549: 1.1;HMC-1: 4.8;JURKAT: 3.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB035555 Enhanced NA NA "CAB035555: " "unprognostic (3.42e-2)" "unprognostic (1.53e-1)" "unprognostic (1.96e-1)" "unprognostic (3.53e-2)" "unprognostic (1.65e-1)" "unprognostic (2.39e-2)" "unprognostic (6.47e-3)" "unprognostic (2.25e-2)" "unprognostic (1.58e-1)" "unprognostic (1.69e-1)" "unprognostic (3.32e-2)" "unprognostic (3.17e-1)" "unprognostic (3.83e-5)" "unprognostic (4.30e-2)" "unprognostic (4.38e-2)" "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 3.4 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.9 0.0 0.0 0.1 0.1 2.4 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.7 1.0 0.6 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 9.6 0.0 0.0 0.0 2.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.0 0.8 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.5 0.0 0.0 0.7 0.5 0.4 0.4 0.0 0.0 0.0 0.3 NPHS2 "PDCN, SRN1" ENSG00000116218 "NPHS2, podocin" Q9NP85 1 179550539-179575952 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 143 "kidney: 66.5" "Group enriched" "Detected in some" 12 "Collecting duct cells: 19.2;Early spermatids: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "NTERA-2: 5.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB037267, HPA049486" Enhanced NA NA "CAB037267: AB_261982, HPA049486: AB_2680788" "unprognostic (6.77e-2)" "unprognostic (9.71e-2)" "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 NPIPA1 "morpheus, NPIP" ENSG00000183426 "Nuclear pore complex interacting protein family member A1" Q9UND3 16 14922802-14952060 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.1" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 54.9;Early spermatids: 43.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 16 "B-cells: 2.3;granulocytes: 1.7;T-cells: 1.3" "Cell line enhanced" "Detected in many" "HHSteC: 34.1" HPA053611 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.77e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-2)" "unprognostic (2.29e-2)" "unprognostic (9.21e-2)" "unprognostic (1.65e-2)" "unprognostic (5.12e-2)" "unprognostic (1.08e-1)" "unprognostic (8.82e-3)" "unprognostic (3.65e-2)" "unprognostic (1.74e-7)" "unprognostic (2.28e-1)" "unprognostic (8.76e-2)" "unprognostic (1.73e-2)" "unprognostic (2.66e-5)" 5.1 6.0 5.9 3.8 4.9 4.2 4.8 33.1 8.3 5.0 5.8 1.8 15.6 0.0 3.0 16.3 2.7 4.6 7.0 6.2 6.6 3.0 4.3 5.4 3.7 25.2 4.7 1.1 13.6 3.0 7.8 3.3 2.5 11.7 7.9 16.3 3.0 12.4 3.8 5.0 3.2 6.5 6.1 4.1 5.0 4.0 2.3 0.0 1.7 0.1 0.1 1.3 0.7 0.1 5.3 24.6 9.5 0.0 0.4 4.2 9.3 6.5 8.6 7.7 3.7 5.8 1.5 13.4 12.9 10.3 4.3 11.3 1.3 8.9 4.8 4.3 0.0 8.3 19.6 34.1 11.7 2.8 18.9 18.5 7.2 13.1 5.1 4.1 8.1 1.3 6.5 9.7 11.3 0.0 6.3 0.2 0.0 0.2 4.6 0.1 2.1 13.8 11.3 1.0 9.3 5.0 0.6 10.6 3.1 1.9 10.3 0.8 11.5 0.5 0.2 2.9 3.9 2.8 3.1 0.4 0.7 5.8 1.7 0.0 0.0 0.8 0.0 1.3 2.3 0.3 1.2 0.0 1.3 0.6 0.4 0.0 0.1 0.1 0.0 0.7 0.7 6.0 18.3 0.0 1.1 8.2 7.4 2.0 0.0 54.9 29.6 8.7 5.9 1.8 0.0 5.2 43.7 3.6 2.6 0.0 1.7 1.2 6.2 1.3 20.9 2.9 2.0 6.4 4.7 6.7 5.2 17.6 19.8 4.0 0.0 6.4 4.5 3.0 4.9 3.5 18.0 1.0 4.8 19.4 3.9 12.2 10.4 3.4 1.0 5.0 7.5 0.9 NPIPB11 ENSG00000254206 "Nuclear pore complex interacting protein family member B11" E5RHQ5 16 29381354-29404029 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 8.9;Early spermatids: 12.3" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (6.82e-2)" "unprognostic (2.99e-1)" "unprognostic (1.93e-3)" "unprognostic (1.42e-1)" "unprognostic (1.14e-1)" "unprognostic (6.92e-3)" "unprognostic (3.06e-1)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (1.36e-1)" "unprognostic (5.57e-4)" "unprognostic (7.41e-2)" "unprognostic (2.94e-6)" "unprognostic (2.79e-1)" "unprognostic (1.98e-1)" "unprognostic (5.96e-3)" "unprognostic (4.79e-5)" 2.0 1.0 1.9 3.2 2.5 5.3 1.9 5.9 2.4 1.6 1.8 2.3 2.1 4.2 1.7 2.9 2.1 1.8 2.4 1.9 2.7 3.5 1.9 7.4 1.5 4.4 1.6 0.7 2.3 1.2 2.3 2.0 2.8 0.5 5.1 8.8 3.1 0.9 1.7 5.5 3.2 4.5 2.9 1.0 1.0 1.9 3.1 0.7 1.4 0.5 0.4 1.1 0.2 1.9 1.6 2.9 4.1 2.1 1.7 3.9 1.7 0.8 1.5 0.7 2.1 3.7 12.1 2.8 0.9 0.7 3.3 2.2 2.7 1.6 2.8 3.1 2.6 4.9 3.5 1.1 3.3 6.4 1.0 2.1 1.7 2.3 3.3 0.8 3.2 3.3 3.5 1.4 4.2 2.6 10.3 5.0 1.1 3.5 4.2 1.1 3.7 1.7 1.4 3.7 1.9 0.5 2.6 1.4 9.3 1.4 4.1 3.7 4.0 1.7 2.9 2.4 3.3 2.0 9.9 2.2 4.1 2.9 0.2 0.5 0.1 1.0 0.0 0.2 0.5 0.5 0.8 0.7 3.1 1.1 1.1 1.4 0.4 0.4 0.2 0.0 0.2 8.9 6.4 2.2 0.0 0.0 0.0 1.8 0.0 4.0 4.5 0.0 0.0 0.3 0.0 0.9 12.3 0.6 3.9 0.0 0.7 0.2 0.0 0.1 4.7 0.0 0.3 4.8 6.9 0.0 0.0 4.5 0.3 0.7 0.0 1.0 6.2 0.1 1.5 5.8 0.7 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.3 0.0 4.8 0.0 NPIPB12 ENSG00000169203 "Nuclear pore complex interacting protein family, member B12" 16 29483642-29505999 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 1: 3.0;Club cells: 1.2;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 59.4" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (3.83e-2)" "unprognostic (1.08e-1)" "unprognostic (2.09e-2)" "unprognostic (1.77e-1)" "unprognostic (7.92e-2)" "unprognostic (1.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.20e-2)" "unprognostic (2.42e-1)" "unprognostic (6.08e-2)" "unprognostic (1.28e-2)" "unprognostic (6.28e-7)" "unprognostic (3.32e-2)" "unprognostic (4.11e-2)" "unprognostic (2.33e-1)" "unprognostic (2.14e-4)" 4.4 2.8 3.2 7.5 4.2 11.3 3.7 10.1 6.3 4.1 5.0 4.4 4.3 7.9 2.9 3.3 4.7 4.3 3.9 3.4 4.7 8.2 5.3 10.8 2.9 5.6 3.8 4.7 5.8 3.5 4.6 4.9 7.8 3.7 8.1 23.7 6.2 3.5 4.0 9.0 4.2 5.3 6.7 5.3 3.1 4.0 9.0 2.2 14.5 3.0 12.6 3.7 0.9 9.3 9.5 7.6 19.8 9.3 5.5 14.4 5.7 1.6 2.9 2.5 8.1 19.5 15.7 10.4 4.6 5.7 12.3 13.0 9.1 3.9 10.1 9.7 11.7 10.9 16.0 8.6 12.6 23.0 8.7 7.2 6.3 6.8 7.4 3.2 8.8 11.7 13.6 4.6 15.5 9.0 59.4 11.8 6.3 6.9 22.0 3.3 15.2 7.0 6.8 8.4 5.8 3.2 14.1 8.2 3.4 6.9 15.9 8.2 19.1 7.2 13.1 10.7 7.5 7.2 15.5 7.8 22.9 8.7 14.5 3.0 1.1 3.7 1.0 0.9 3.4 2.1 2.4 2.0 9.0 2.9 1.9 8.1 12.6 2.3 2.2 1.5 0.9 3.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPB13 ENSG00000198064 "Nuclear pore complex interacting protein family, member B13" A6NJU9 16 30222937-30254510 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 8 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 8.8;Ciliated cells: 18.7;Club cells: 13.6;granulocytes: 11.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (7.11e-3)" "unprognostic (4.08e-2)" "unprognostic (1.83e-1)" "unprognostic (1.89e-3)" "unprognostic (4.87e-2)" "unprognostic (2.49e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (7.69e-2)" "unprognostic (3.67e-1)" "unprognostic (1.41e-1)" "unprognostic (3.09e-7)" "unprognostic (1.86e-2)" "unprognostic (2.98e-1)" "unprognostic (3.17e-1)" "unprognostic (2.58e-2)" 1.8 1.1 1.9 2.3 2.0 6.5 2.3 7.6 3.3 2.3 2.3 1.7 2.4 6.2 2.0 1.9 1.7 1.5 2.4 1.6 1.6 2.3 2.7 4.2 1.5 2.7 1.4 4.8 2.9 1.7 2.8 2.5 2.8 1.7 3.5 9.0 3.3 0.4 1.4 3.9 3.5 1.8 2.8 2.1 1.4 2.2 1.3 0.6 0.8 1.6 1.9 3.2 0.5 3.3 7.8 2.0 6.8 2.0 2.4 3.9 0.6 0.0 0.7 0.3 0.9 4.5 4.7 3.4 1.4 0.7 3.9 4.3 1.9 1.1 2.9 1.7 5.0 8.7 4.1 0.9 6.9 4.4 3.0 2.7 3.0 1.9 1.0 1.3 2.2 2.1 7.2 1.6 7.0 3.0 6.4 2.7 0.7 2.0 6.1 1.0 2.7 2.2 5.5 2.4 2.4 0.9 2.7 1.2 2.9 2.2 1.9 3.4 4.1 3.9 3.6 2.0 2.8 3.2 6.2 3.8 3.0 1.9 0.1 1.6 0.2 3.2 0.4 1.6 0.4 1.3 1.3 0.5 1.3 1.4 0.4 0.8 1.9 1.6 0.6 0.4 0.5 14.9 8.8 0.0 0.0 0.0 0.0 0.0 0.0 18.7 13.6 1.8 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 11.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 NPIPB3 "KIAA0220, NPIPL3" ENSG00000169246 "Nuclear pore complex interacting protein family member B3" Q92617 16 21402237-21448567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 10 "Basal keratinocytes: 2.5;Ciliated cells: 2.7;Club cells: 2.3;Melanocytes: 1.7;Suprabasal keratinocytes: 1.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 54.1" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.68e-2)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.38e-1)" "unprognostic (8.01e-2)" "unprognostic (9.97e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-2)" "unprognostic (3.14e-1)" "unprognostic (3.91e-1)" "unprognostic (1.65e-1)" "unprognostic (4.66e-5)" "unprognostic (1.50e-7)" "unprognostic (1.30e-1)" "unprognostic (3.02e-2)" "unprognostic (5.94e-2)" "unprognostic (9.00e-4)" 7.3 5.0 8.2 8.6 9.8 32.4 8.8 15.5 8.8 6.4 7.6 6.9 5.2 12.4 6.2 6.4 6.8 5.5 9.6 7.2 8.2 9.6 7.9 18.1 6.7 6.7 5.9 4.0 9.5 5.0 9.8 8.2 11.7 5.6 19.7 36.9 9.6 6.1 7.6 14.6 7.1 7.3 9.7 7.9 5.2 6.6 5.3 9.0 6.5 3.6 3.4 5.7 0.4 13.7 12.5 8.6 14.9 11.5 6.6 25.5 9.5 3.4 5.1 5.7 19.3 17.0 20.0 9.6 13.0 6.2 15.7 5.6 14.1 4.7 11.2 7.9 8.8 17.2 54.1 10.4 16.0 16.9 3.5 6.1 12.2 15.6 7.3 6.7 18.2 15.9 26.6 6.9 24.7 16.9 39.2 15.8 7.5 14.7 26.9 8.9 11.8 10.2 8.0 10.9 8.3 5.5 13.1 10.0 16.4 12.9 7.8 11.0 24.2 13.3 2.3 13.8 14.1 9.9 18.1 9.6 14.1 12.7 6.5 3.6 2.6 5.7 2.7 2.3 4.4 3.0 2.9 2.2 5.3 3.9 2.6 3.9 3.4 2.0 9.0 2.0 0.4 0.0 0.0 0.0 0.4 2.5 0.0 0.8 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.1 NPIPB4 ENSG00000185864 "Nuclear pore complex interacting protein family member B4" C9JG80 16 21834569-21880827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skin 1: 31.2" "Cell type enriched" "Detected in many" 7 "Early spermatids: 92.2" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (3.09e-3)" "unprognostic (3.51e-3)" "unprognostic (4.01e-2)" "unprognostic (1.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-3)" "unprognostic (2.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.82e-2)" "unprognostic (3.66e-1)" "unprognostic (1.76e-1)" "unprognostic (4.05e-3)" "unprognostic (6.04e-8)" "unprognostic (3.37e-1)" "unprognostic (7.78e-2)" "unprognostic (2.32e-1)" "unprognostic (5.46e-3)" 5.5 3.7 4.4 7.0 4.6 23.5 6.1 10.4 5.4 5.1 6.5 4.5 5.4 22.4 4.5 5.7 4.9 4.2 5.0 4.0 5.4 6.6 6.0 10.7 3.8 5.9 5.3 3.3 5.4 3.8 6.6 8.2 5.5 3.2 7.1 31.2 8.6 3.5 4.4 10.1 7.3 4.3 7.9 7.5 4.1 5.4 6.3 3.7 4.7 2.5 5.2 2.3 0.3 7.1 9.7 9.3 7.3 6.7 9.7 15.7 8.8 2.7 3.0 4.9 20.6 10.2 13.8 6.8 7.6 2.8 8.2 5.2 7.4 6.0 5.6 4.7 5.5 24.8 27.2 4.5 22.6 14.6 7.2 9.2 8.0 13.3 6.1 6.5 11.3 11.8 12.2 4.5 20.9 8.5 14.2 11.3 2.3 5.4 13.0 5.6 8.0 3.4 7.1 9.4 5.7 5.9 6.8 4.8 9.3 9.0 6.8 14.2 16.0 8.0 7.6 7.6 6.3 5.8 14.7 5.0 10.8 7.4 4.7 2.5 0.7 1.8 1.0 1.3 2.2 2.3 1.1 0.4 6.3 1.8 1.9 3.0 5.2 1.2 3.7 0.6 0.3 3.0 12.6 2.0 1.0 6.8 4.7 1.5 0.0 6.7 10.3 0.0 3.9 0.4 0.0 0.9 92.2 4.2 1.1 0.0 0.5 0.2 5.9 0.4 10.4 1.0 0.6 1.6 1.2 1.8 0.8 13.6 0.3 3.0 0.0 2.8 1.1 1.9 1.2 2.3 0.4 0.0 7.1 0.0 2.9 1.6 0.5 7.3 0.7 2.2 1.7 0.5 NPIPB5 ENSG00000243716 "Nuclear pore complex interacting protein family member B5" A8MRT5 16 22479121-22536521 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 44.9;Ciliated cells: 54.9;Club cells: 89.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (7.52e-4)" "unprognostic (2.08e-1)" "unprognostic (2.32e-2)" "unprognostic (9.43e-3)" "unprognostic (3.96e-1)" "unprognostic (2.64e-3)" "unprognostic (2.40e-3)" "unprognostic (4.20e-2)" "unprognostic (1.65e-1)" "unprognostic (4.19e-2)" "unprognostic (1.09e-1)" "unprognostic (3.87e-2)" "unprognostic (1.90e-10)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (3.86e-2)" "unprognostic (3.76e-5)" 10.8 7.0 13.4 34.7 12.0 30.6 10.4 18.3 13.4 9.6 10.8 9.6 12.5 7.7 8.6 33.3 7.2 8.4 6.6 8.4 24.1 6.1 8.7 6.1 13.6 19.3 17.5 16.7 9.9 10.1 6.4 8.7 7.2 13.7 10.5 12.1 14.6 12.2 22.9 17.8 54.2 17.1 6.8 9.7 16.3 8.9 10.6 11.8 7.0 14.4 6.8 14.2 8.0 10.0 11.7 7.0 8.3 3.5 4.4 5.9 1.3 10.9 9.6 6.1 7.8 10.4 9.8 14.5 6.7 2.4 4.2 5.3 13.5 18.5 15.1 12.5 8.9 4.0 9.8 14.2 9.6 7.5 18.6 5.2 5.8 25.2 26.0 10.1 31.6 9.8 11.9 7.3 10.3 19.0 7.7 7.4 17.5 16.1 24.6 5.1 18.6 14.0 42.3 17.0 2.0 4.1 15.3 4.4 18.0 7.6 6.4 6.8 5.7 8.3 11.7 5.6 15.1 6.9 10.9 25.2 13.5 6.1 11.2 11.3 13.6 6.4 19.7 5.6 23.0 6.0 6.7 3.5 2.7 5.5 1.7 2.3 8.6 5.2 3.7 2.0 11.7 5.9 4.9 8.3 4.4 3.2 7.0 2.4 1.3 13.4 12.0 18.3 13.4 24.1 6.1 17.5 16.7 13.7 11.8 26.8 44.9 3.7 11.4 12.8 13.0 28.7 2.5 54.9 89.9 5.2 9.8 3.6 0.0 3.1 4.7 11.9 2.6 0.0 1.2 2.3 8.9 9.1 9.3 1.6 3.7 6.4 1.2 6.7 4.6 1.8 9.5 11.0 5.0 9.0 3.0 5.0 4.0 4.9 6.0 0.7 24.7 0.0 17.6 3.0 2.6 10.0 4.9 11.4 3.9 9.2 NPPA "ANP, PND" ENSG00000175206 "Natriuretic peptide A" P01160 1 11845709-11848345 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hormone, Vasoactive, Vasodilator" "Atrial fibrillation, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 418 "heart muscle: 1267.7" "Cell type enriched" "Detected in some" 14450 "Cardiomyocytes: 19644.9" "Cancer enriched" "Detected in some" 9 "glioma: 7.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.5;SH-SY5Y: 12.0" "Region enriched" "Detected in some" 8 "olfactory region: 28.1" "Not detected" "Not detected" "HPA058269, HPA064007" Enhanced "Secreted to blood" NA NA 190000 "HPA058269: AB_2683660, HPA064007: " "unprognostic (1.27e-3)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.30e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "unprognostic (2.02e-1)" "unprognostic (2.01e-1)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (9.72e-3)" "unprognostic (2.21e-1)" "unprognostic (5.93e-4)" "unprognostic (2.31e-1)" "unprognostic (1.59e-1)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 1267.7 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 1.7 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.0 0.3 0.8 0.0 0.5 3.0 1.1 1.7 2.6 2.1 0.0 0.0 1.6 0.9 0.0 0.0 0.0 6.7 2.7 4.3 0.3 0.0 1.5 4.0 0.0 0.0 0.0 1.0 2.6 2.7 1.5 6.6 0.0 1.4 4.6 0.0 0.0 0.0 0.0 0.6 0.0 1.2 5.9 5.1 0.0 0.9 0.5 7.7 1.9 0.1 0.7 0.6 0.8 0.8 0.0 1.8 12.5 12.0 0.7 0.0 2.2 1.2 1.6 0.2 0.4 2.1 4.3 3.4 0.3 1.3 3.2 4.9 0.3 3.5 1.1 0.0 0.4 0.0 0.1 0.8 0.4 1.3 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.5 0.0 0.0 3.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 19644.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPR3 "ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC" ENSG00000113389 "Natriuretic peptide receptor 3" P17342 5 32689070-32791724 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.2" "Group enriched" "Detected in many" 4 "Distal tubular cells: 44.7;Proximal tubular cells: 133.6" "Cancer enhanced" "Detected in many" "renal cancer: 19.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.3;fHDF/TERT166: 10.5;HeLa: 37.5;HSkMC: 24.4;U-138 MG: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052702 Supported Approved Cytosol NA NA Cytosol "HPA052702: AB_2681922" "unprognostic (8.56e-3)" "unprognostic (1.54e-2)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (7.64e-3)" "unprognostic (2.66e-3)" "unprognostic (1.68e-2)" "unprognostic (9.28e-2)" "unprognostic (6.78e-3)" "unprognostic (1.76e-1)" "unprognostic (6.07e-2)" "unprognostic (3.46e-3)" "prognostic favorable (5.43e-6)" "unprognostic (6.00e-4)" "unprognostic (5.74e-2)" "unprognostic (2.80e-2)" "unprognostic (3.38e-2)" 26.9 3.5 0.4 0.4 1.5 1.9 2.7 0.2 0.8 4.5 5.3 0.3 1.4 0.3 4.2 3.3 6.8 2.5 3.9 16.4 0.4 0.5 54.2 7.6 24.2 0.5 0.2 0.8 1.9 0.7 0.3 0.7 5.3 3.1 8.8 0.5 7.3 1.2 18.1 9.5 3.7 1.4 1.8 0.3 4.5 1.0 1.5 0.0 1.1 11.0 13.4 1.4 5.5 4.5 1.4 0.9 7.3 0.6 1.1 1.1 0.2 0.1 1.9 0.1 0.2 1.1 17.3 0.0 4.6 0.9 0.2 0.2 0.0 0.1 0.0 0.1 10.5 0.3 0.0 2.3 0.0 0.5 0.0 0.0 0.2 37.5 0.0 3.4 0.0 0.1 24.4 0.3 1.2 3.3 1.1 0.1 0.0 0.0 0.3 1.5 0.3 0.0 0.2 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 6.3 0.0 0.1 0.1 0.0 0.1 10.3 0.1 0.8 0.1 0.1 0.0 0.0 1.7 0.0 0.1 0.3 0.6 0.4 0.8 0.3 0.5 0.9 0.7 0.5 0.0 1.4 0.9 1.1 7.3 1.1 0.1 0.9 0.4 0.2 0.4 1.5 0.2 0.8 0.4 0.5 0.2 0.8 3.1 0.0 14.9 8.2 0.9 0.0 4.7 3.3 20.6 0.0 6.7 2.3 8.7 0.0 0.0 44.7 0.0 1.1 3.3 0.0 0.0 0.0 0.1 1.5 2.5 3.5 1.5 0.1 3.2 0.0 4.9 0.0 2.2 10.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 12.0 133.6 1.2 6.5 2.7 0.1 0.9 1.1 0.1 0.0 0.0 0.1 NPSR1 "GPR154, GPRA, PGR14" ENSG00000187258 "Neuropeptide S receptor 1" Q6W5P4 7 34658239-34878332 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.5;retina: 9.1;stomach 1: 3.7" "Cell type enriched" "Detected in single" 6 "Early spermatids: 3.7" "Cancer enhanced" "Detected in some" "stomach cancer: 2.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 4.7;SCLC-21H: 2.6" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 9.6" NA NA "unprognostic (3.56e-1)" "unprognostic (9.34e-2)" "unprognostic (7.55e-2)" "unprognostic (1.80e-1)" "unprognostic (2.00e-2)" "unprognostic (9.35e-2)" "unprognostic (6.34e-3)" "unprognostic (2.85e-1)" "unprognostic (1.36e-2)" "unprognostic (2.08e-2)" 0.0 0.2 0.5 1.0 0.1 0.0 0.0 3.5 1.0 0.1 0.9 1.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 3.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.6 9.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 3.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 3.5 1.0 0.6 3.2 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 NPTN "GP55, GP65, np55, np65, SDFR1, SDR1" ENSG00000156642 Neuroplastin Q9Y639 15 73560014-73634134 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051497, HPA072453" Approved Approved "Plasma membrane" NA No 21000 "Plasma membrane" "HPA051497: AB_2681507, HPA072453: AB_2686523" "unprognostic (9.30e-3)" "unprognostic (1.70e-1)" "unprognostic (5.01e-2)" "unprognostic (4.14e-1)" "unprognostic (3.11e-2)" "unprognostic (7.42e-3)" "unprognostic (9.74e-2)" "unprognostic (9.67e-2)" "unprognostic (3.63e-2)" "unprognostic (1.68e-1)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "unprognostic (1.60e-3)" "unprognostic (5.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" 20.8 24.9 49.0 17.8 72.9 6.9 22.5 55.3 84.5 30.3 36.2 11.9 28.1 33.2 52.3 39.9 34.2 35.2 30.5 48.4 43.6 38.3 32.7 18.2 27.2 15.9 30.3 47.8 21.0 23.8 35.9 18.3 30.3 40.0 45.3 36.6 22.7 25.9 54.9 12.1 19.5 39.8 75.3 16.8 16.7 27.1 18.8 20.4 6.3 28.7 18.5 16.6 32.7 25.9 3.0 3.9 19.7 13.3 2.5 4.9 7.3 17.5 31.5 18.2 13.3 37.2 33.6 25.5 40.5 66.5 46.8 41.7 21.4 56.4 10.2 24.2 58.1 58.0 72.9 29.2 33.7 27.0 18.2 19.4 8.1 16.1 19.0 26.4 12.4 22.6 27.4 29.9 30.2 18.3 46.4 24.8 9.2 4.5 11.7 33.4 14.0 5.5 7.6 16.7 22.2 11.3 8.9 20.8 8.6 63.7 26.0 11.1 3.4 39.2 21.9 26.0 47.4 19.8 16.9 27.9 36.4 24.5 20.8 23.5 10.2 19.0 8.8 33.8 19.3 24.8 3.6 10.0 9.5 4.9 13.3 4.0 3.0 2.8 4.4 3.7 2.3 2.9 3.3 19.7 2.5 9.6 3.9 3.0 7.3 49.0 72.9 55.3 84.5 43.6 38.3 30.3 47.8 40.0 20.4 71.5 54.8 7.7 22.7 57.8 76.4 87.0 58.6 87.0 66.0 78.5 47.1 5.7 1.7 17.0 2.8 30.7 78.3 0.0 20.5 7.9 45.4 26.3 26.7 38.2 22.1 36.5 98.8 47.9 71.6 6.6 14.1 37.1 40.5 12.6 77.6 35.4 30.5 49.9 36.0 16.8 47.1 19.4 36.0 8.2 10.4 47.7 5.7 12.5 39.9 25.1 NPTXR ENSG00000221890 "Neuronal pentraxin receptor" O95502 22 38818452-38843982 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 73.6" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "GAMG: 11.4;SCLC-21H: 15.0;SiHa: 11.2;U-87 MG: 43.1" "Low region specificity" "Detected in all" HPA001079 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 280000 "Plasma membrane, Cytosol" Nucleoplasm "HPA001079: AB_1078414" "unprognostic (6.29e-2)" "prognostic favorable (3.93e-4)" "unprognostic (6.82e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.55e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (1.52e-3)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.49e-2)" "unprognostic (9.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.77e-2)" 2.3 3.8 39.1 1.8 17.5 0.8 1.9 16.2 73.6 5.8 2.6 4.3 0.5 1.5 5.6 3.3 2.7 6.1 2.0 10.5 57.4 15.2 1.3 0.8 1.7 1.6 5.6 20.7 6.2 3.6 5.9 2.0 0.9 4.5 6.2 1.7 1.0 3.2 5.6 0.9 1.2 1.4 5.7 3.3 2.1 2.0 1.6 4.0 0.0 2.5 0.0 1.6 2.5 1.9 0.3 0.2 0.6 0.2 0.6 2.3 0.4 0.4 2.9 0.1 0.8 6.0 0.6 0.0 1.9 0.4 3.8 1.3 2.9 0.6 0.0 3.5 0.5 11.4 0.4 0.8 0.1 1.3 0.2 1.0 0.0 0.1 4.5 0.6 0.0 0.1 1.9 0.1 3.5 0.0 5.6 0.1 0.0 3.6 0.1 0.1 4.5 0.0 0.2 3.5 1.4 1.0 0.7 0.0 7.0 1.0 8.1 15.0 0.9 11.2 0.0 0.3 0.8 4.8 1.1 0.2 6.9 4.2 0.0 0.3 1.0 0.0 0.0 43.1 8.7 3.5 0.5 0.2 0.1 1.8 0.0 1.3 0.1 1.0 2.3 0.0 0.3 1.5 1.2 0.6 0.6 0.1 0.2 0.0 0.4 39.1 17.5 16.2 49.0 57.4 15.2 5.6 20.7 4.5 4.0 0.0 0.0 0.0 1.9 1.0 5.4 14.2 5.1 2.7 3.4 3.5 2.0 0.0 0.0 5.7 1.6 4.2 0.0 0.0 3.3 0.0 0.8 4.6 0.0 0.2 0.2 0.0 1.7 5.5 0.3 0.4 1.7 0.3 1.7 0.0 0.0 6.5 3.1 0.0 2.1 0.5 3.1 0.0 2.6 0.0 0.8 0.9 0.0 0.0 0.0 3.3 NPY PYY4 ENSG00000122585 "Neuropeptide Y" P01303 7 24284163-24291865 "Plasma proteins, Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 50.5;brain: 63.6;prostate: 131.2" "Cell type enriched" "Detected in some" 5 "Glandular cells: 55.9" "Cancer enriched" "Detected in many" 187 "prostate cancer: 1214.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 36 "SH-SY5Y: 124.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016733, CAB034368, HPA036636, HPA044572, HPA056798" Supported Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 30700000 "Golgi apparatus" "CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371" "unprognostic (2.00e-1)" "prognostic unfavorable (5.78e-4)" "unprognostic (4.15e-1)" "unprognostic (3.76e-2)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "unprognostic (6.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.78e-1)" "unprognostic (2.52e-1)" 1.6 50.5 27.2 5.5 63.6 2.8 1.0 0.1 55.9 1.0 1.8 2.8 1.4 4.7 1.1 1.1 2.5 1.0 1.4 1.0 11.9 20.6 1.1 1.0 1.1 1.0 2.6 18.3 1.0 4.0 1.0 0.5 1.0 1.9 131.2 1.7 0.0 1.0 14.7 1.0 1.0 5.0 1.4 1.4 1.0 1.7 1.3 13.9 0.0 1.1 0.0 1.0 3.9 4.5 0.5 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.1 124.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 27.2 63.6 0.1 31.2 11.9 20.6 2.6 18.3 1.9 13.9 0.0 0.0 0.0 1.3 0.1 1.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.2 0.2 55.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 8.5 0.3 0.0 1.7 0.0 0.0 0.4 0.5 0.0 0.4 0.0 0.5 0.0 0.0 2.3 2.1 0.0 4.2 0.0 0.0 0.7 NPY1R NPYR ENSG00000164128 "Neuropeptide Y receptor Y1" P25929 4 163323961-163344832 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 55.2" "Cell type enhanced" "Detected in many" 25 "Intestinal endocrine cells: 31.4;Ito cells: 157.8;Sertoli cells: 45.3" "Cancer enriched" "Detected in many" 13 "breast cancer: 65.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 18 "HEL: 51.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "prognostic favorable (7.68e-5)" "unprognostic (9.14e-3)" "unprognostic (1.55e-1)" "unprognostic (5.09e-2)" "unprognostic (2.60e-1)" "unprognostic (9.29e-2)" "unprognostic (5.28e-3)" "unprognostic (2.26e-1)" "unprognostic (4.14e-2)" "unprognostic (2.50e-1)" "unprognostic (1.89e-2)" "unprognostic (5.92e-2)" "unprognostic (7.39e-2)" "unprognostic (1.92e-3)" "unprognostic (5.48e-2)" "unprognostic (1.74e-1)" "unprognostic (2.21e-1)" 18.0 15.9 5.2 1.5 17.1 0.2 17.5 0.9 11.4 6.2 3.1 0.7 3.9 0.7 5.0 5.4 2.3 4.3 2.4 2.6 7.1 4.2 16.6 8.3 1.2 7.2 1.5 5.8 1.8 14.5 1.1 3.9 2.7 3.5 1.9 2.4 2.0 11.0 4.5 1.5 5.0 0.9 3.1 3.7 55.2 1.2 2.7 6.0 0.0 4.4 1.4 0.6 3.4 3.3 0.5 0.3 1.2 0.4 0.3 1.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 51.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.6 0.0 2.0 0.7 0.4 1.2 0.5 0.1 0.6 0.4 0.7 0.9 0.0 0.5 0.7 1.2 1.1 0.3 0.2 0.3 0.3 0.0 5.2 17.1 0.9 11.4 7.1 4.2 1.5 5.8 3.5 6.0 0.0 0.3 0.0 0.7 2.5 4.4 0.8 0.0 0.0 0.0 0.0 2.0 0.0 11.6 7.6 3.7 2.4 2.0 0.0 0.0 0.0 1.2 0.4 0.0 0.8 0.1 0.0 31.4 157.8 11.8 2.0 10.6 0.0 5.0 0.0 0.9 0.5 0.2 10.4 0.4 0.0 1.8 45.3 5.1 0.5 0.2 1.5 0.0 0.0 1.3 0.3 NPY2R ENSG00000185149 "Neuropeptide Y receptor Y2" P49146 4 155208629-155217078 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.2;breast: 4.1" "Cell type enriched" "Detected in some" 11 "Leydig cells: 19.5" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.6;ASC diff: 3.6;HSkMC: 1.7;SH-SY5Y: 12.9" "Group enriched" "Detected in many" 5 "amygdala: 13.5;basal ganglia: 13.1;hippocampal formation: 51.2;hypothalamus: 27.7" "Region enriched" "Detected in all" 5 "hippocampal formation: 19.7" NA NA "unprognostic (7.14e-2)" "unprognostic (4.36e-3)" "unprognostic (7.08e-2)" "unprognostic (5.50e-2)" "unprognostic (9.35e-2)" 0.8 1.1 3.4 1.3 6.9 0.1 4.1 0.1 8.6 0.4 2.7 1.8 0.0 1.1 0.2 0.4 0.2 0.5 0.2 0.7 7.3 5.5 0.3 0.1 0.2 0.2 0.8 0.0 0.4 0.1 0.1 0.2 0.2 7.8 0.5 2.8 0.2 2.0 0.2 0.1 0.5 1.5 0.6 10.2 0.6 0.3 2.5 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 3.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 6.9 0.1 8.6 7.3 5.5 0.8 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 NPY4R "PP1, PPYR1, Y4" ENSG00000204174 "Neuropeptide Y receptor Y4" P50391 10 46461099-46465881 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 9.4;skin 1: 4.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "prostate cancer: 0.8" "Group enriched" "Detected in some" 5 "cerebellum: 1.6;cerebral cortex: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "A549: 25.5" HPA027863 Approved NA NA "HPA027863: AB_10602819" "unprognostic (2.26e-6)" "unprognostic (2.94e-1)" "unprognostic (8.17e-2)" "unprognostic (1.20e-1)" "unprognostic (1.30e-1)" "unprognostic (1.77e-3)" "unprognostic (1.98e-1)" "unprognostic (2.64e-3)" "unprognostic (6.58e-2)" "unprognostic (9.79e-2)" 0.2 0.0 0.2 0.7 0.2 0.0 0.2 1.6 1.2 0.3 7.4 0.2 0.2 2.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.9 9.4 0.2 0.2 0.2 0.2 4.3 2.6 1.4 0.2 0.2 2.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 25.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.1 0.0 0.7 0.0 0.0 5.2 0.0 0.4 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.6 1.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPY4R2 CH17-360D5.1 ENSG00000264717 "Neuropeptide Y receptor Y4-2" 10 47918739-47923524 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 4.2;intestine: 6.3;skin 1: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "A549: 21.2" HPA027863 Uncertain NA NA "HPA027863: AB_10602819" "unprognostic (1.74e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-1)" "unprognostic (7.78e-2)" "unprognostic (6.72e-3)" "unprognostic (1.23e-1)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" 0.2 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.4 0.0 6.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.7 0.0 0.0 0.0 0.0 3.3 3.4 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 21.2 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPY5R NPYR5 ENSG00000164129 "Neuropeptide Y receptor Y5" Q15761 4 163343939-163351934 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.2;lymphoid tissue: 13.6" "Cell type enhanced" "Detected in single" 21 "Spermatocytes: 1.6" "Cancer enhanced" "Detected in single" "breast cancer: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.5;RPTEC TERT1: 3.5;T-47d: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (4.63e-6)" "unprognostic (3.00e-1)" "unprognostic (2.79e-1)" "unprognostic (2.13e-1)" "unprognostic (1.24e-1)" "unprognostic (3.74e-2)" "unprognostic (3.94e-2)" "unprognostic (5.40e-2)" "unprognostic (4.30e-2)" "unprognostic (3.99e-2)" "unprognostic (1.76e-1)" "unprognostic (3.94e-1)" 10.6 5.7 3.6 1.6 12.2 0.1 3.2 0.3 6.2 1.5 0.7 0.1 0.3 0.2 2.2 1.9 0.6 1.4 1.0 1.3 4.5 3.1 7.8 1.8 0.7 6.6 1.3 4.6 0.5 1.8 0.8 0.6 4.9 2.3 0.5 0.6 1.1 6.1 1.7 0.4 1.4 0.3 1.5 4.2 13.6 0.5 9.1 2.2 0.0 1.3 0.4 0.3 0.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 12.2 0.3 6.2 4.5 3.1 1.3 4.6 2.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 NRCAM "Bravo, KIAA0343" ENSG00000091129 "Neuronal cell adhesion molecule" Q92823 7 108147623-108456717 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.0" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 66.8;Cone photoreceptor cells: 96.2;Muller glia cells: 46.7" "Cancer enriched" "Detected in all" 7 "glioma: 57.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD8 T-cell: 5.5" "Lineage enriched" "Detected in single" 15 "T-cells: 5.5" "Cell line enhanced" "Detected in some" "A549: 26.4;AF22: 25.7;EFO-21: 47.9;HMC-1: 51.2;SH-SY5Y: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012606 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 70000000 Nucleoplasm "Vesicles, Plasma membrane" "HPA012606: AB_1854636" "unprognostic (2.66e-1)" "unprognostic (2.65e-1)" "unprognostic (2.52e-3)" "unprognostic (2.18e-2)" "unprognostic (4.08e-3)" "unprognostic (1.01e-2)" "unprognostic (4.47e-3)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "unprognostic (4.81e-2)" "unprognostic (9.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.22e-2)" "unprognostic (9.70e-3)" "unprognostic (6.42e-2)" "unprognostic (6.51e-3)" "unprognostic (3.28e-2)" 2.5 28.7 24.5 2.3 23.7 1.2 1.6 16.6 82.0 5.0 1.6 10.5 9.5 1.5 2.6 26.6 1.5 3.7 6.3 1.1 19.1 15.9 5.8 1.3 2.7 1.6 11.8 21.2 2.1 21.5 1.2 14.6 6.4 21.7 1.6 1.6 0.7 2.4 12.1 1.0 1.6 1.5 1.6 10.8 4.2 2.3 2.2 9.9 0.0 4.0 0.0 2.9 1.5 0.8 0.1 0.0 0.3 0.0 0.0 5.5 0.6 0.0 26.4 25.7 0.0 3.1 0.6 0.5 0.1 0.1 0.2 0.4 10.6 0.0 0.0 47.9 0.2 0.4 0.1 0.6 0.4 0.2 0.0 3.4 0.0 0.2 0.2 0.0 0.2 51.2 4.3 0.0 0.0 0.1 0.0 16.5 0.0 0.0 0.2 0.4 9.9 0.1 0.0 3.5 15.7 0.0 0.0 7.5 8.6 5.9 0.0 5.0 31.5 0.3 0.0 0.5 0.9 0.0 0.0 17.5 1.1 0.2 0.0 4.3 0.0 0.1 0.2 0.2 0.0 14.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.0 0.6 24.5 23.7 16.6 34.7 19.1 15.9 11.8 21.2 21.7 9.9 0.0 0.0 0.0 0.0 0.3 66.8 0.5 2.5 0.0 0.0 5.2 96.2 2.1 3.3 1.3 25.4 0.9 0.0 0.0 10.2 0.2 0.9 0.7 22.0 0.0 0.7 12.7 0.0 2.5 1.5 4.7 0.9 0.0 3.3 1.0 0.0 46.7 5.7 0.0 0.4 2.1 7.9 0.0 0.9 1.0 1.1 0.1 3.7 0.0 0.0 0.0 NRG1 "GGF, HGL, HRG, NDF, NRG1-IT2" ENSG00000157168 "Neuregulin 1" Q02297 8 31639386-32767959 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.3" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 35.7;Basal glandular cells: 36.6;Early spermatids: 31.2;Horizontal cells: 27.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "classical monocyte: 22.8" "Lineage enriched" "Detected in many" 5 "monocytes: 22.8" "Cell line enhanced" "Detected in many" "A549: 38.0;BJ: 26.0;fHDF/TERT166: 29.1;GAMG: 40.0;HBF TERT88: 25.6;hTEC/SVTERT24-B: 27.3;hTERT-HME1: 28.6" "Low region specificity" "Detected in all" HPA010964 Uncertain Approved Nucleoplasm "Secreted to blood" NA NA Nucleoplasm "HPA010964: AB_1854641" "unprognostic (5.76e-3)" "unprognostic (8.60e-2)" "unprognostic (1.96e-4)" "unprognostic (2.67e-1)" "unprognostic (1.94e-4)" "unprognostic (4.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.72e-2)" "unprognostic (2.98e-1)" "unprognostic (5.65e-2)" "unprognostic (7.99e-2)" "unprognostic (8.49e-2)" "unprognostic (4.47e-2)" "unprognostic (1.31e-1)" "unprognostic (2.88e-1)" "unprognostic (5.40e-2)" "unprognostic (7.83e-2)" 0.7 2.1 4.6 5.0 3.3 1.2 8.8 14.8 8.1 10.6 4.2 0.3 2.1 3.5 2.5 1.1 3.7 2.0 4.8 2.2 4.7 15.4 11.5 23.6 5.7 0.6 6.2 3.5 2.9 0.9 0.8 23.9 0.2 28.3 3.2 5.4 3.6 2.5 1.6 0.2 4.3 5.7 1.1 2.5 1.7 3.1 6.4 0.8 0.2 13.8 7.2 2.2 7.2 3.5 0.0 4.9 0.8 22.8 0.0 0.0 4.6 0.1 38.0 0.6 0.0 0.3 0.7 0.0 26.0 18.4 21.6 16.6 0.0 0.8 0.0 4.8 29.1 40.0 20.5 0.1 10.4 25.6 0.0 0.2 0.5 0.5 0.5 0.1 0.0 0.0 0.3 1.1 27.3 28.6 1.9 12.4 0.0 0.0 0.1 7.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 16.0 1.1 1.1 1.3 1.9 0.0 0.0 2.1 0.0 0.0 9.0 15.0 4.6 23.9 14.5 0.0 0.0 0.2 7.7 0.0 1.8 0.0 22.8 0.2 0.0 2.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.6 4.6 3.3 14.8 8.1 4.7 15.4 6.2 3.5 28.3 0.8 35.7 2.4 0.5 36.6 23.1 11.2 1.7 10.2 4.0 13.6 3.5 7.9 0.0 8.3 1.8 31.2 1.4 0.0 0.0 0.2 0.0 0.7 14.3 1.1 6.6 0.5 27.0 0.0 6.7 16.0 14.6 0.3 1.8 1.7 0.0 0.0 4.8 0.8 0.0 0.4 14.6 3.0 0.0 0.9 1.4 1.0 5.4 0.0 0.0 0.0 5.6 NRG2 "Don-1, HRG2, NTAK" ENSG00000158458 "Neuregulin 2" O14511 5 139846779-140043299 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.3" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 9.0;Bipolar cells: 15.1;Leydig cells: 8.9;Muller glia cells: 9.7;Peritubular cells: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Lineage enriched" "Detected in single" 4 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "AN3-CA: 8.4;Karpas-707: 5.6;PC-3: 14.8;RPTEC TERT1: 7.5;SCLC-21H: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038935, HPA047973" Approved Supported Nucleoplasm,Nucleoli "Secreted to blood" No NA Nucleoplasm Nucleoli "HPA038935: AB_10672833, HPA047973: AB_2680226" "unprognostic (8.66e-4)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (6.04e-2)" "unprognostic (3.22e-1)" "unprognostic (2.96e-2)" "unprognostic (8.66e-3)" "unprognostic (1.11e-1)" "unprognostic (3.99e-1)" "unprognostic (1.88e-1)" "unprognostic (4.26e-3)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (3.64e-3)" "unprognostic (9.54e-2)" "unprognostic (2.23e-2)" "unprognostic (2.07e-2)" 4.5 4.5 4.0 1.4 7.0 0.6 4.4 27.3 5.1 13.1 2.3 3.8 2.6 1.0 3.0 2.9 3.7 7.6 7.6 1.5 4.2 3.5 1.3 0.6 1.2 2.1 5.2 3.4 15.9 3.2 15.8 7.7 1.1 4.1 4.5 0.9 2.9 13.6 4.7 6.0 5.0 1.0 5.1 3.6 3.3 1.1 2.7 4.9 0.0 0.8 1.0 1.5 4.8 3.7 0.4 0.1 0.0 0.1 0.0 2.1 0.1 0.0 2.0 0.2 8.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.0 0.4 0.0 4.0 2.4 0.4 0.2 0.1 4.8 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.5 0.9 0.2 0.2 0.0 5.6 0.0 0.4 0.0 0.0 0.1 0.0 14.8 0.1 0.0 0.0 7.5 1.8 5.6 3.4 0.0 3.2 3.3 0.0 0.0 0.0 0.2 2.6 0.4 0.0 1.6 1.1 0.0 0.0 3.7 0.0 0.7 0.0 0.0 0.0 2.1 0.1 0.5 0.1 0.2 0.4 0.0 0.4 0.4 1.2 0.0 0.0 0.0 0.1 0.0 0.1 4.0 7.0 27.3 5.1 4.2 3.5 5.2 3.4 4.1 4.9 0.0 0.0 0.0 9.0 2.5 15.1 1.4 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.3 0.5 0.9 0.0 0.0 1.9 0.0 1.8 1.3 0.0 0.0 0.1 6.4 0.0 0.0 0.0 0.6 8.9 0.0 3.3 0.0 0.0 9.7 0.8 0.0 9.6 1.5 0.7 6.5 1.1 3.0 4.3 0.3 0.0 0.8 0.0 5.9 NRG3 ENSG00000185737 "Neuregulin 3" P56975 10 81875314-82987179 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6" "Group enriched" "Detected in some" 5 "Bipolar cells: 13.7;Cholangiocytes: 5.1;Early spermatids: 17.6;Ito cells: 7.4;Late spermatids: 7.9;Muller glia cells: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.5;HEK 293: 3.4;HUVEC TERT2: 1.7;SK-MEL-30: 7.3;U-2 OS: 6.4" "Low region specificity" "Detected in all" HPA075789 Uncertain Vesicles "Secreted in brain" NA NA Vesicles "HPA075789: " "unprognostic (6.15e-3)" "unprognostic (2.43e-2)" "unprognostic (1.65e-5)" "unprognostic (1.89e-1)" "unprognostic (7.03e-4)" "unprognostic (1.85e-2)" "unprognostic (1.06e-1)" "unprognostic (7.05e-2)" "unprognostic (9.33e-2)" "unprognostic (1.82e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-2)" "unprognostic (3.31e-4)" "unprognostic (1.04e-1)" "unprognostic (7.68e-3)" "unprognostic (7.27e-4)" 0.9 1.5 15.6 1.2 8.2 0.6 2.8 1.9 30.6 0.8 0.9 4.8 0.0 0.8 0.7 0.7 0.9 8.0 5.3 0.9 14.5 6.2 1.2 1.5 1.6 0.8 4.9 8.0 0.7 0.9 0.7 1.6 1.2 6.5 0.9 0.9 3.1 5.0 1.1 0.7 0.8 0.9 0.9 5.6 0.8 0.8 3.3 6.0 0.0 0.9 0.0 0.8 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 7.3 0.5 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 8.2 1.9 12.8 14.5 6.2 4.9 8.0 6.5 6.0 0.0 0.0 0.0 0.0 0.0 13.7 0.8 5.1 0.0 0.0 0.0 2.0 0.0 0.0 0.9 17.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 7.9 0.6 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.7 0.0 1.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 NRG4 HRG4 ENSG00000169752 "Neuregulin 4" Q8WWG1 15 75935969-76059795 "Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 36.6" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 14.7;Cone photoreceptor cells: 13.7;Exocrine glandular cells: 20.5;Pancreatic endocrine cells: 14.0;Rod photoreceptor cells: 22.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 8.7;HL-60: 3.2;THP-1: 2.9;U-698: 2.9;U-937: 5.3" "Not detected" "Not detected" "Region enriched" "Detected in all" 4 "cerebellum: 282.0" HPA010957 Uncertain "Secreted to digestive system" NA NA "HPA010957: AB_1079504" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (3.94e-2)" "unprognostic (1.67e-2)" "unprognostic (5.66e-2)" "unprognostic (4.10e-2)" "unprognostic (1.12e-2)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (2.82e-5)" "unprognostic (1.91e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-5)" "unprognostic (8.28e-2)" "unprognostic (7.45e-2)" "unprognostic (1.08e-2)" "unprognostic (2.06e-1)" 0.4 0.5 3.5 0.2 1.3 0.8 0.3 6.9 2.7 0.3 0.4 0.5 0.0 0.2 0.3 2.1 0.8 2.2 0.2 0.4 1.4 1.0 0.5 1.1 0.7 0.2 0.5 1.8 0.3 36.6 0.2 2.5 0.8 2.1 1.2 0.3 0.0 1.5 0.3 4.8 0.6 0.3 0.2 0.5 0.4 3.0 6.3 0.3 0.0 0.4 0.5 0.2 0.5 0.3 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 1.8 0.8 0.0 0.0 1.3 0.4 0.1 0.0 0.1 1.5 0.1 8.7 0.4 0.0 3.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.1 2.9 0.3 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 5.3 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.3 6.9 2.7 1.4 1.0 0.5 1.8 2.1 0.3 0.0 0.0 2.2 0.9 6.6 2.2 0.2 0.0 14.7 3.4 1.8 13.7 2.0 1.7 0.2 12.2 0.3 0.3 0.0 20.5 1.9 0.4 1.7 2.3 2.9 0.3 6.4 1.2 1.3 0.0 7.0 0.6 0.3 1.7 0.0 0.0 1.5 14.0 2.9 0.0 0.0 22.2 0.0 0.1 6.1 0.7 1.1 0.7 0.0 0.3 3.8 NRK DKFZp686A17109 ENSG00000123572 "Nik related kinase" Q7Z2Y5 X 105822543-105958610 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 42.2;placenta: 64.8" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 56.0;Leydig cells: 105.0;Syncytiotrophoblasts: 56.8" "Cancer enriched" "Detected in some" 8 "testis cancer: 6.1" "Region enriched" "Detected in single" 10 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 30.7;HSkMC: 5.9;RH-30: 7.0;RPTEC TERT1: 18.9;SuSa: 23.1" "Region enriched" "Detected in single" 28 "cerebellum: 16.0" "Low region specificity" "Detected in many" HPA017238 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017238: AB_1854645" "unprognostic (2.64e-4)" "unprognostic (9.82e-2)" "unprognostic (5.98e-3)" "unprognostic (5.52e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (1.35e-2)" "unprognostic (6.08e-2)" "unprognostic (3.24e-2)" "unprognostic (5.28e-3)" "unprognostic (1.47e-3)" "unprognostic (1.14e-1)" "unprognostic (4.28e-2)" "unprognostic (6.80e-3)" 2.6 12.7 0.4 2.7 0.4 0.0 0.8 4.3 0.3 3.5 1.5 0.1 4.6 0.0 4.3 15.6 1.6 1.3 7.5 2.9 0.4 0.4 9.9 0.4 0.5 0.0 0.3 0.0 42.2 0.5 0.0 2.9 64.8 0.2 22.0 0.1 0.0 2.1 1.6 0.4 0.4 0.5 2.8 0.4 0.3 0.9 10.6 0.0 0.0 0.5 3.1 0.3 1.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.9 0.0 0.0 0.0 1.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.0 0.0 18.9 0.3 0.0 0.1 0.0 1.0 0.0 23.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 4.3 0.3 0.4 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 56.0 16.6 0.2 0.9 0.3 0.0 0.0 0.0 7.2 0.5 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 1.1 105.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.1 0.0 0.0 0.0 0.6 1.4 0.0 56.8 0.0 0.0 0.1 NRM NRM29 ENSG00000137404 Nurim Q8IXM6 6 30688047-30691420 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA072545, HPA073982" Enhanced "Nuclear membrane" NA NA "Nuclear membrane" "HPA072545: AB_2686532, HPA073982: AB_2686649" "unprognostic (2.09e-1)" "unprognostic (6.35e-2)" "unprognostic (1.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.71e-1)" "unprognostic (2.32e-2)" "unprognostic (3.13e-3)" "unprognostic (1.30e-1)" "unprognostic (8.44e-2)" "unprognostic (1.32e-2)" "unprognostic (2.87e-2)" "unprognostic (2.44e-1)" "prognostic unfavorable (3.52e-8)" "unprognostic (3.95e-2)" "unprognostic (1.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" 14.2 5.6 1.4 6.5 2.4 10.0 11.4 2.2 2.5 16.2 6.6 2.9 5.8 2.6 15.3 5.3 11.4 7.7 7.4 7.5 1.5 1.4 7.3 3.0 8.1 15.7 2.1 1.5 13.7 5.7 3.6 1.7 11.3 2.4 10.4 4.2 5.4 4.2 7.0 4.5 9.0 6.0 7.4 2.4 9.6 4.2 9.7 2.2 23.3 5.0 14.4 11.9 9.9 9.2 4.2 3.7 1.6 3.8 0.8 1.6 1.0 3.8 3.7 6.9 4.8 1.1 3.8 0.8 1.9 3.9 6.2 5.7 3.9 2.7 6.5 1.4 4.0 2.8 6.0 3.8 6.5 1.8 9.0 2.0 4.0 5.3 5.1 1.4 3.1 6.1 2.3 2.4 6.0 2.3 2.1 4.8 5.4 3.5 6.0 4.2 3.4 4.8 3.3 1.4 4.3 2.2 11.7 4.6 7.9 2.7 2.0 2.6 2.2 2.2 2.8 1.2 2.2 4.5 3.0 1.9 5.7 3.1 3.2 3.5 2.2 4.0 2.3 0.9 8.3 7.3 0.9 3.8 0.2 1.0 1.1 0.8 4.2 1.1 1.6 3.3 4.1 0.5 0.6 1.6 0.8 0.4 3.7 0.8 1.0 1.4 2.4 2.2 2.5 1.5 1.4 2.1 1.5 2.4 2.2 3.0 1.3 16.4 5.8 8.8 0.2 1.6 10.2 0.0 6.8 1.8 2.0 15.7 3.3 9.9 8.4 11.7 0.2 0.0 5.0 23.5 13.6 1.2 12.7 0.8 15.3 3.2 1.2 1.8 21.2 44.7 5.2 14.9 3.3 27.9 1.9 1.1 5.2 0.0 5.6 0.6 1.5 6.5 9.2 4.5 1.7 5.5 4.2 8.6 3.0 2.6 NRP1 "CD304, NRP, VEGF165R" ENSG00000099250 "Neuropilin 1" O14786 10 33177492-33336262 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Neurogenesis" "Developmental protein, Heparin-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Ito cells: 238.8;Sertoli cells: 278.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 14 "plasmacytoid DC: 24.0" "Lineage enriched" "Detected in many" 14 "dendritic cells: 24.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 69.4;hTERT-RPE1: 59.9;TIME: 57.7;U-87 MG: 69.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004511, HPA030278" Approved "Secreted in other tissues" NA NA 720000000 "CAB004511: AB_2282634, HPA030278: AB_10601976" "unprognostic (3.19e-1)" "prognostic unfavorable (7.10e-5)" "unprognostic (1.50e-2)" "unprognostic (3.80e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (6.17e-2)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (6.66e-2)" "unprognostic (2.52e-1)" "unprognostic (1.82e-1)" "unprognostic (4.78e-2)" "prognostic unfavorable (3.87e-4)" "prognostic unfavorable (1.22e-5)" "unprognostic (3.83e-2)" "unprognostic (5.48e-2)" "unprognostic (7.79e-2)" 69.9 15.0 4.9 13.6 4.9 0.7 53.8 1.3 5.6 25.1 17.6 2.4 16.4 6.7 29.8 21.9 14.7 17.0 23.3 50.5 17.2 5.9 47.1 27.4 47.1 30.1 3.5 3.2 27.1 14.1 11.7 6.4 44.3 3.6 25.2 7.8 24.3 11.8 31.6 22.3 9.1 14.6 19.1 5.5 38.7 9.8 15.6 2.8 5.9 30.4 24.6 7.9 22.3 23.8 0.4 24.0 0.3 1.7 0.6 0.4 0.4 8.6 33.8 1.7 0.1 33.0 37.0 0.2 35.0 34.1 17.6 19.0 4.2 20.8 0.1 4.2 69.4 18.7 2.4 2.1 10.2 14.4 0.1 1.7 0.0 3.9 7.2 11.7 3.1 0.2 44.2 1.7 41.9 19.0 59.9 47.9 0.2 0.1 0.2 34.4 14.6 0.2 0.5 0.8 1.8 32.1 1.4 3.8 0.1 16.6 0.1 0.7 0.4 3.5 2.7 0.1 1.5 0.1 0.4 57.7 25.2 5.9 30.3 23.5 0.1 0.1 0.1 69.1 4.0 22.7 0.2 1.7 0.3 0.3 0.3 0.4 0.4 0.3 0.3 1.4 0.3 0.4 0.3 0.3 0.6 0.1 24.0 0.3 0.4 4.9 4.9 1.3 5.6 17.2 5.9 3.5 3.2 3.6 2.8 0.0 22.7 8.1 9.5 14.0 8.7 57.4 35.7 8.1 13.6 17.4 3.9 48.5 1.7 46.0 0.7 84.2 1.0 0.0 16.8 10.8 38.6 3.8 7.0 11.4 109.4 0.0 4.1 238.8 53.2 2.6 39.1 27.1 11.8 9.0 0.3 3.5 10.9 0.0 19.8 29.4 0.6 278.1 64.5 0.2 0.7 9.3 56.2 2.5 0.1 2.8 NRP2 VEGF165R2 ENSG00000118257 "Neuropilin 2" O60462 2 205681990-205798133 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Heparin-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Ito cells: 162.7;monocytes: 389.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.8;naive B-cell: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.5;HUVEC TERT2: 30.2;TIME: 28.8;U-251 MG: 58.9;U-87 MG: 27.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039980, HPA054974" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted in other tissues" NA NA 15000000 "Vesicles, Plasma membrane" Nucleoplasm "HPA039980: AB_10795517, HPA054974: AB_2682657" "unprognostic (4.28e-2)" "unprognostic (1.17e-1)" "unprognostic (8.12e-3)" "unprognostic (3.38e-1)" "unprognostic (1.62e-1)" "unprognostic (1.57e-2)" "unprognostic (9.36e-2)" "unprognostic (3.70e-1)" "unprognostic (2.15e-3)" "unprognostic (2.90e-2)" "unprognostic (2.56e-3)" "unprognostic (4.17e-1)" "prognostic unfavorable (7.68e-7)" "unprognostic (2.22e-3)" "unprognostic (5.45e-2)" "unprognostic (6.41e-3)" "prognostic unfavorable (7.80e-5)" 24.3 14.5 8.7 11.4 7.4 2.6 7.8 1.2 7.0 34.4 35.4 3.9 8.4 3.5 33.7 4.6 24.8 13.1 25.8 4.4 11.5 8.3 3.4 6.2 15.8 4.9 8.9 3.9 33.0 1.4 2.5 6.6 29.9 9.0 18.6 7.0 27.7 2.6 21.0 2.5 3.3 8.2 44.7 8.6 4.7 17.1 3.4 5.2 2.6 7.3 6.0 3.0 39.3 24.6 1.4 0.5 0.0 1.8 0.0 0.0 0.5 0.7 14.2 9.1 0.0 8.2 2.6 2.7 2.2 4.3 2.8 2.7 13.4 34.5 0.0 3.4 7.1 5.6 5.5 0.4 4.4 4.7 0.0 1.9 0.1 0.6 0.1 22.4 0.0 0.5 19.7 3.4 3.9 3.5 17.4 30.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 11.4 0.0 2.5 0.0 0.5 3.1 5.7 0.0 8.2 0.3 0.3 0.0 20.3 24.3 0.0 0.1 28.8 12.5 0.1 3.2 58.9 0.0 0.0 0.8 27.8 0.0 26.1 0.0 1.8 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.7 7.4 1.2 3.8 11.5 8.3 8.9 3.9 9.0 5.2 83.4 48.1 3.9 13.9 17.2 25.2 4.8 7.6 64.3 72.8 1.8 0.0 68.2 0.0 2.1 5.6 84.5 0.0 0.0 3.3 4.0 46.3 4.7 3.5 0.9 113.5 0.0 1.2 162.7 27.7 10.2 2.6 22.5 18.6 389.5 0.1 4.3 31.6 0.0 4.6 0.6 2.4 0.0 10.3 1.7 0.7 11.0 21.5 0.7 0.0 44.5 NRROS "ELLP3030, GARPL1, LRRC33, MGC50789, UNQ3030" ENSG00000174004 "Negative regulator of reactive oxygen species" Q86YC3 3 196639686-196662004 "Predicted membrane proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 30.4" "Cell type enhanced" "Detected in some" 14 "Hofbauer cells: 61.8;Ito cells: 18.4;Kupffer cells: 33.8;Macrophages: 36.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 7.4;classical monocyte: 1.9;eosinophil: 3.3;intermediate monocyte: 2.0;myeloid DC: 2.5;non-classical monocyte: 1.9" "Group enriched" "Detected in many" 5 "dendritic cells: 2.5;granulocytes: 7.4;monocytes: 2.0" "Cell line enhanced" "Detected in some" "HEL: 16.4;HMC-1: 34.6;Karpas-707: 21.4;MOLT-4: 18.2;NB-4: 42.6;RPMI-8226: 21.2;THP-1: 18.8;U-937: 23.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031586 Uncertain NA NA "HPA031586: AB_10601543" "unprognostic (5.28e-2)" "unprognostic (8.92e-3)" "unprognostic (1.02e-1)" "unprognostic (3.05e-2)" "unprognostic (2.23e-1)" "unprognostic (1.41e-3)" "unprognostic (1.05e-1)" "unprognostic (9.67e-2)" "unprognostic (3.20e-2)" "prognostic unfavorable (9.63e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (6.73e-3)" "unprognostic (1.47e-1)" "unprognostic (7.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" 17.0 3.6 3.8 9.3 4.4 30.4 12.4 1.6 3.1 4.7 3.3 4.0 1.0 3.0 7.6 7.1 2.7 4.2 5.8 8.5 3.1 2.7 4.3 3.4 13.4 23.0 4.3 1.3 2.6 2.6 1.2 2.3 12.4 3.4 4.5 2.2 5.7 3.8 2.2 3.1 3.1 6.9 4.9 5.2 22.5 3.4 2.8 4.8 15.6 3.5 2.4 8.8 6.3 3.5 0.6 2.5 7.4 2.0 0.6 0.7 1.2 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.3 0.0 0.0 1.2 0.0 16.4 0.0 0.0 0.1 13.4 34.6 0.1 0.0 0.5 0.2 0.6 1.3 15.5 1.6 21.4 0.4 0.0 18.2 42.6 1.4 0.0 0.0 4.9 0.0 21.2 0.0 0.1 0.1 0.0 0.0 0.0 8.6 0.3 0.0 18.8 0.1 0.1 0.0 0.6 0.0 8.6 12.9 3.8 1.1 23.7 0.2 7.4 1.9 3.3 0.7 2.0 0.2 0.6 0.5 0.4 2.5 0.5 0.2 0.4 0.0 0.6 1.9 0.3 0.5 1.2 3.8 4.4 1.6 3.1 3.1 2.7 4.3 1.3 3.4 4.8 0.0 0.3 15.9 0.0 1.3 0.0 0.1 0.0 0.0 1.2 0.0 3.9 0.3 0.0 0.0 0.9 3.8 0.0 0.0 0.0 0.5 0.8 0.0 13.9 0.0 61.8 0.0 0.0 18.4 33.8 0.0 0.6 36.2 8.5 3.6 0.0 0.0 0.0 0.0 0.7 0.0 0.4 6.5 0.5 0.5 0.2 0.6 0.5 13.1 0.0 0.0 NRSN1 "p24, VMP" ENSG00000152954 "Neurensin 1" Q8IZ57 6 24126122-24154900 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 67.2" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 114.4" "Cancer enriched" "Detected in single" 17 "glioma: 3.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SCLC-21H: 14.6;SH-SY5Y: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019681, HPA061006" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019681: , HPA061006: AB_2684413" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (8.00e-3)" "unprognostic (8.01e-3)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (7.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.40e-3)" "unprognostic (1.45e-1)" "unprognostic (1.57e-1)" 1.3 6.9 21.5 1.7 27.7 1.7 1.3 5.3 67.2 1.3 1.7 2.1 0.0 1.7 1.5 1.4 1.4 1.3 1.5 1.4 15.3 25.0 1.5 1.4 1.4 1.5 12.4 25.4 1.3 2.6 1.4 12.9 1.3 27.4 1.4 1.7 0.3 1.5 1.3 3.3 1.5 1.6 1.6 6.7 1.5 1.9 1.6 5.0 0.0 1.4 0.0 1.3 1.3 0.1 0.5 0.2 1.8 0.2 0.1 0.3 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.7 0.1 1.7 0.0 0.0 0.3 0.1 0.0 0.1 1.7 0.6 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.3 2.0 1.3 0.1 0.2 0.3 0.9 0.7 0.2 2.5 0.5 0.2 0.5 0.0 0.0 14.6 11.7 0.0 0.1 0.9 0.2 1.7 3.5 0.2 0.5 0.6 0.1 0.4 0.8 2.3 0.9 0.7 0.0 1.3 1.8 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.3 1.0 0.1 0.2 0.2 0.0 0.0 21.5 27.7 5.3 34.1 15.3 25.0 12.4 25.4 27.4 5.0 0.0 0.0 0.0 0.0 0.0 24.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NRSN2 "C20orf98, dJ1103G7.6" ENSG00000125841 "Neurensin 2" Q9GZP1 20 346782-359660 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.9" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015967 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA015967: AB_1854647" "unprognostic (5.67e-2)" "unprognostic (3.47e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (4.05e-2)" "unprognostic (4.48e-2)" "unprognostic (1.48e-1)" "unprognostic (4.96e-2)" "unprognostic (5.92e-2)" "prognostic favorable (1.61e-4)" "unprognostic (6.96e-2)" "unprognostic (1.96e-3)" "unprognostic (2.94e-2)" "unprognostic (1.96e-1)" "unprognostic (7.85e-3)" "unprognostic (1.73e-3)" 8.4 18.6 34.3 6.0 39.3 0.9 7.2 22.7 70.9 12.8 6.6 11.0 4.9 3.5 12.5 16.0 6.1 13.4 9.3 13.5 31.1 24.9 10.1 1.8 8.7 4.1 17.1 28.5 18.3 10.5 26.5 16.3 10.1 27.8 12.2 6.1 12.8 13.3 16.5 1.4 5.0 3.8 16.3 8.7 5.7 5.3 12.8 6.8 1.3 14.9 2.5 4.2 9.4 4.8 9.4 4.8 1.5 1.1 3.4 3.9 1.5 18.9 23.0 13.9 13.1 18.4 20.6 5.4 12.6 24.3 22.9 23.0 12.6 0.4 0.0 4.4 23.3 16.8 8.3 11.2 1.9 14.6 0.1 11.3 6.8 11.0 24.0 18.6 0.2 1.1 23.3 1.5 16.3 2.7 18.7 15.7 0.1 13.5 12.3 20.0 3.3 0.3 5.8 10.7 0.2 11.9 10.8 7.8 0.9 22.8 0.1 28.4 20.4 15.0 4.4 21.5 9.5 18.4 7.1 10.4 24.5 13.0 0.9 15.3 2.3 0.4 5.1 3.2 0.2 12.9 0.0 1.1 1.5 3.8 0.3 1.1 7.2 1.1 3.9 2.1 9.4 1.6 2.7 0.0 3.4 0.4 4.8 0.9 1.5 34.3 39.3 22.7 70.9 31.1 24.9 17.1 28.5 27.8 6.8 0.0 1.9 0.0 3.1 2.9 24.5 4.0 0.0 2.7 7.9 12.2 2.0 6.1 1.7 11.0 5.5 4.5 1.3 0.0 1.4 5.3 10.8 2.5 4.7 0.4 2.7 15.9 28.3 4.3 1.2 10.0 12.0 1.2 3.3 3.6 2.7 12.3 3.8 1.9 9.9 5.7 12.7 19.4 9.2 21.3 6.6 1.9 3.7 1.0 2.0 2.7 NRXN1 "Hs.22998, KIAA0578" ENSG00000179915 "Neurexin 1" "P58400, Q9ULB1" 2 49918505-51225575 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Angiogenesis, Cell adhesion" "Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 81.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 70.6;Early spermatids: 130.0;Horizontal cells: 73.1;Late spermatids: 79.3" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.4" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071400 Supported "Plasma membrane" "Intracellular and membrane" NA NA 620000 "Plasma membrane" "HPA071400: AB_2732180" "unprognostic (7.01e-2)" "unprognostic (9.96e-2)" "unprognostic (7.68e-2)" "unprognostic (1.74e-4)" "unprognostic (2.46e-1)" "unprognostic (8.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.85e-1)" "unprognostic (8.19e-2)" "unprognostic (6.37e-4)" "unprognostic (2.85e-2)" "unprognostic (6.68e-7)" "unprognostic (3.40e-2)" "unprognostic (1.75e-1)" "unprognostic (5.57e-2)" "unprognostic (1.99e-3)" 2.1 3.2 22.4 2.1 20.3 1.4 1.7 56.5 81.9 2.8 5.1 3.0 0.5 2.1 2.1 3.7 3.0 1.4 2.2 3.8 16.9 13.8 1.5 1.6 1.5 1.4 8.3 25.9 2.1 2.3 1.3 4.8 1.1 12.6 2.5 3.8 2.0 3.5 9.3 1.3 2.0 3.1 2.1 6.5 1.3 2.3 6.5 4.7 0.0 1.4 0.0 1.4 2.0 1.6 0.0 0.0 4.4 0.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 29.0 1.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 2.4 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.3 0.0 0.0 0.0 0.0 22.4 20.3 56.5 33.2 16.9 13.8 8.3 25.9 12.6 4.7 0.0 0.0 0.0 0.4 0.0 70.6 15.4 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 130.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 73.1 1.7 5.5 0.0 79.3 2.3 0.2 1.7 0.0 0.0 20.9 0.3 0.0 0.7 0.0 8.0 0.0 0.3 9.9 3.8 0.1 0.2 0.0 0.0 0.0 NRXN2 ENSG00000110076 "Neurexin 2" "P58401, Q9P2S2" 11 64606174-64723188 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 101.5" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 43.6;Horizontal cells: 141.4;Muller glia cells: 51.8;Peritubular cells: 55.5" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 2.0;non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 6 "monocytes: 2.0" "Cell line enhanced" "Detected in some" "REH: 28.4;SCLC-21H: 14.3;SH-SY5Y: 6.5;U-2 OS: 16.6;U-87 MG: 11.7" "Low region specificity" "Detected in all" NA NA "unprognostic (3.87e-2)" "unprognostic (1.54e-4)" "unprognostic (2.60e-2)" "unprognostic (1.96e-1)" "unprognostic (8.07e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (5.08e-2)" "unprognostic (3.23e-1)" "unprognostic (5.93e-3)" "unprognostic (3.40e-1)" "unprognostic (9.97e-3)" "unprognostic (2.39e-2)" "unprognostic (6.99e-2)" "unprognostic (4.27e-4)" "unprognostic (5.46e-3)" 3.4 7.5 33.3 4.1 26.3 2.5 2.3 68.8 101.5 7.3 4.6 6.5 1.0 3.1 11.7 3.3 2.5 6.4 4.4 2.9 28.8 23.5 3.8 2.4 2.5 3.0 15.2 32.8 6.3 2.5 2.2 1.3 2.8 14.0 4.5 2.7 3.5 3.2 5.6 2.5 2.2 3.0 4.7 12.4 3.5 2.4 11.6 8.7 0.0 2.9 0.0 2.5 2.4 2.5 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.2 0.2 1.5 1.3 0.0 2.0 0.0 0.0 0.2 0.2 3.9 0.0 0.0 0.0 0.0 0.3 0.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 5.5 1.9 0.0 0.4 0.2 4.7 0.0 0.0 28.4 0.9 1.1 0.0 0.0 14.3 6.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 16.6 0.3 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 33.3 26.3 68.8 41.2 28.8 23.5 15.2 32.8 14.0 8.7 0.0 0.0 0.0 0.0 0.5 43.6 2.4 0.0 0.0 0.0 1.8 5.9 0.1 3.3 0.0 19.4 0.9 2.0 0.0 2.3 0.2 2.5 0.0 0.0 6.4 0.2 141.4 6.4 3.1 0.0 37.1 39.4 0.0 0.0 1.0 1.1 51.8 0.7 3.4 55.5 34.9 18.9 0.0 3.1 19.5 7.0 0.1 0.2 0.0 0.6 0.0 NRXN3 "C14orf60, KIAA0743" ENSG00000021645 "Neurexin 3" "Q9HDB5, Q9Y4C0" 14 78170373-79868290 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 134.6;Horizontal cells: 109.7;Muller glia cells: 64.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 8.4;RT4: 20.7;SK-BR-3: 8.0" "Low region specificity" "Detected in all" HPA002727 Approved NA NA 520000 "HPA002727: AB_1079468" "unprognostic (7.96e-2)" "unprognostic (5.70e-4)" "unprognostic (8.18e-3)" "unprognostic (2.19e-2)" "unprognostic (2.31e-4)" "unprognostic (9.56e-2)" "unprognostic (2.80e-1)" "unprognostic (2.99e-3)" "unprognostic (1.12e-2)" "unprognostic (7.91e-2)" "unprognostic (2.40e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.83e-7)" "unprognostic (4.81e-2)" "unprognostic (2.61e-1)" "unprognostic (3.61e-2)" "unprognostic (2.91e-1)" 1.8 7.5 15.1 4.1 24.7 1.1 2.8 75.3 36.9 6.3 12.3 2.6 7.3 3.6 4.7 2.8 6.7 3.9 3.9 2.3 12.7 9.4 2.3 1.3 4.0 1.3 11.9 20.2 1.4 4.5 1.7 9.2 2.3 14.7 9.5 6.0 7.8 4.1 15.7 1.1 2.9 5.6 25.5 8.6 7.4 6.9 7.5 4.3 0.0 1.2 0.0 1.2 8.1 2.1 0.5 0.3 2.2 0.4 0.4 0.2 0.1 0.0 0.0 6.4 0.0 0.1 0.3 0.0 2.5 1.9 8.4 6.3 2.2 0.0 0.1 0.0 0.2 0.0 2.4 0.0 0.2 5.8 2.4 5.2 0.0 0.2 0.0 0.7 0.0 0.0 1.5 0.2 3.6 1.2 4.0 2.1 0.0 0.0 0.1 0.1 0.0 0.2 0.2 1.4 0.0 0.0 0.2 0.0 0.0 4.5 20.7 1.1 0.0 0.0 8.0 0.4 2.8 0.0 0.0 0.0 0.1 5.5 0.0 2.7 0.0 0.0 0.0 1.5 0.3 4.6 2.2 0.4 0.5 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.5 0.2 0.2 1.6 0.4 0.2 0.3 0.1 0.1 15.1 24.7 75.3 36.9 12.7 9.4 11.9 20.2 14.7 4.3 11.9 5.6 0.0 7.9 4.0 134.6 3.9 2.5 10.7 4.5 3.5 11.8 5.3 0.0 2.2 11.3 1.4 0.0 0.0 2.8 0.3 1.0 6.1 0.0 0.0 0.6 109.7 5.8 2.5 0.0 14.4 6.9 0.0 16.9 0.0 0.2 64.1 1.0 0.0 6.0 0.0 9.9 0.0 0.7 0.7 0.7 0.6 31.7 0.0 0.2 1.4 NSDHL "H105e3, SDR31E1, XAP104" ENSG00000147383 "NAD(P) dependent steroid dehydrogenase-like" Q15738 X 152830967-152869729 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000248, HPA000571" Enhanced Enhanced "Endoplasmic reticulum,Lipid droplets" NA NA "Endoplasmic reticulum" "Lipid droplets" "HPA000248: AB_1079507, HPA000571: AB_1079506" "unprognostic (1.84e-1)" "prognostic favorable (5.65e-4)" "unprognostic (2.66e-1)" "unprognostic (1.81e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.04e-4)" "unprognostic (1.03e-1)" "unprognostic (5.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.62e-2)" "unprognostic (2.63e-1)" "prognostic favorable (6.09e-5)" "unprognostic (3.53e-2)" "unprognostic (1.36e-1)" "unprognostic (3.91e-2)" "unprognostic (4.79e-2)" 17.4 24.8 11.0 7.7 10.5 6.0 20.4 7.7 15.0 13.4 23.4 13.9 20.5 13.3 10.4 35.7 36.2 11.9 7.4 16.7 14.3 11.4 11.6 38.1 9.9 8.7 9.7 10.4 9.8 7.9 9.8 6.9 7.9 18.9 12.0 10.7 7.9 12.2 17.7 6.9 14.5 24.0 9.9 14.2 7.3 9.6 8.6 9.3 6.0 11.0 22.2 17.0 7.5 16.1 16.2 17.5 16.4 17.7 17.0 17.3 13.0 40.6 14.9 20.4 10.6 17.6 13.4 11.5 8.1 10.9 14.8 18.8 20.6 22.2 20.1 27.3 11.0 55.0 20.9 26.5 37.5 13.1 6.7 15.2 8.2 14.6 20.9 12.8 8.2 6.7 16.4 14.5 28.9 7.3 6.4 13.7 8.9 13.6 9.1 11.2 18.0 8.0 10.7 8.1 20.4 18.0 6.0 14.8 16.5 30.7 16.8 7.4 8.4 7.2 10.9 8.5 14.8 7.2 10.5 11.6 6.9 11.4 16.6 15.6 12.9 8.6 34.6 12.8 12.9 6.5 16.4 17.7 15.8 15.6 16.2 15.7 16.2 15.6 13.5 17.5 12.9 11.4 12.6 1.9 17.0 12.1 15.6 17.3 13.0 11.0 10.5 7.7 15.0 14.3 11.4 9.7 10.4 18.9 9.3 11.9 14.7 9.7 9.8 9.6 3.8 21.0 15.3 18.7 10.3 12.2 0.0 18.3 8.3 16.9 8.7 7.4 12.0 0.0 17.6 18.3 9.8 7.8 8.1 26.3 16.1 1.6 5.8 8.0 8.3 5.9 7.8 9.3 5.0 15.4 8.7 10.3 16.2 7.8 8.5 11.5 5.4 0.0 8.2 3.7 8.2 10.7 15.6 5.7 9.4 15.3 NSG1 "D4S234E, NEEP21, P21" ENSG00000168824 "Neuronal vesicle trafficking associated 1" P42857 4 4348140-4419058 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.8;pituitary gland: 49.1;skin 1: 70.0" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 151.1;Cytotrophoblasts: 92.7;Melanocytes: 276.7;Suprabasal keratinocytes: 155.8" "Cancer enhanced" "Detected in many" "melanoma: 61.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 25.5" "Lineage enriched" "Detected in single" 58 "T-cells: 25.5" "Cell line enhanced" "Detected in some" "HAP1: 23.4;SCLC-21H: 47.7;SH-SY5Y: 23.2;SK-MEL-30: 22.3;TIME: 56.4;U-698: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.21e-3)" "unprognostic (2.33e-1)" "unprognostic (5.29e-3)" "unprognostic (7.60e-2)" "unprognostic (8.06e-2)" "unprognostic (1.49e-1)" "unprognostic (1.32e-3)" "unprognostic (3.47e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-3)" "prognostic favorable (9.49e-4)" "unprognostic (2.50e-1)" "unprognostic (6.85e-2)" "unprognostic (4.21e-2)" "unprognostic (7.33e-2)" "unprognostic (2.85e-1)" "unprognostic (7.41e-2)" 1.4 16.1 8.9 2.8 44.8 1.0 4.2 32.2 32.0 4.7 5.1 3.1 0.4 4.4 5.3 2.6 17.2 12.7 1.3 3.8 6.0 31.9 1.3 0.7 1.4 2.3 15.8 19.2 29.5 1.6 0.5 49.1 20.9 38.8 14.4 4.8 7.6 4.5 12.5 1.0 70.0 3.8 4.7 6.2 1.8 5.3 9.8 4.4 3.7 0.8 4.3 2.6 10.2 8.3 0.0 0.0 0.4 0.0 0.3 25.5 6.9 0.0 0.0 0.2 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 2.9 0.1 0.9 0.6 23.4 1.5 0.1 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.3 0.0 0.6 0.0 4.0 6.2 0.0 0.0 0.3 0.0 1.8 0.1 2.8 0.0 0.1 0.0 0.0 0.1 0.0 1.3 47.7 23.2 0.1 0.0 22.3 2.0 0.2 0.0 56.4 0.0 3.7 0.0 0.0 0.0 0.1 20.3 0.0 0.0 0.1 0.0 0.0 0.0 19.2 0.0 25.5 0.0 18.0 15.6 0.0 0.0 4.7 12.0 0.4 0.3 0.0 0.0 1.7 6.9 8.9 44.8 32.2 32.0 6.0 31.9 15.8 19.2 38.8 4.4 8.9 0.0 0.0 71.8 77.0 151.1 0.0 0.0 1.4 5.7 0.0 3.9 92.7 0.0 0.0 30.8 0.5 0.0 0.0 0.0 13.3 7.6 12.1 1.1 0.0 7.4 7.9 2.4 1.8 0.0 35.3 2.8 1.7 276.7 0.0 0.0 6.4 0.2 0.0 5.3 3.7 17.4 0.0 2.1 2.3 12.8 155.8 64.2 11.5 0.0 80.5 NSG2 "CALY3, HMP19, Nsg2" ENSG00000170091 "Neuronal vesicle trafficking associated 2" Q9Y328 5 174045604-174243501 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 120.8" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 8 "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 58 "SCLC-21H: 21.9;SH-SY5Y: 35.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046531, HPA056191" Enhanced Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA046531: AB_2732528, HPA056191: AB_2683062" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (3.27e-1)" "unprognostic (3.36e-5)" "unprognostic (1.93e-1)" "unprognostic (2.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.07e-1)" "unprognostic (3.29e-1)" "unprognostic (1.76e-1)" "unprognostic (3.86e-3)" "unprognostic (8.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.02e-2)" "unprognostic (5.20e-2)" "unprognostic (9.31e-4)" "unprognostic (1.55e-1)" 1.7 23.1 31.6 3.0 92.4 1.4 1.4 19.7 120.8 1.4 3.6 5.0 0.0 2.8 1.4 1.7 1.5 1.4 1.6 1.6 27.3 40.2 1.6 1.4 1.6 1.4 20.2 27.6 1.4 2.0 1.4 0.9 1.4 22.5 1.4 4.1 0.8 1.4 1.5 1.4 1.4 3.8 2.5 4.6 1.4 3.3 5.0 11.7 0.0 1.8 0.0 1.4 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 92.4 19.7 49.8 27.3 40.2 20.2 27.6 22.5 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NT5C3A "cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1" ENSG00000122643 "5'-nucleotidase, cytosolic IIIA" Q9H0P0 7 33014113-33062797 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010630, HPA029058" Uncertain "Intracellular and membrane" NA NA "HPA010630: AB_2668319, HPA029058: AB_10601380" "unprognostic (7.50e-2)" "unprognostic (3.10e-1)" "unprognostic (1.14e-1)" "unprognostic (2.69e-2)" "unprognostic (1.22e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (3.25e-2)" "unprognostic (3.12e-2)" "unprognostic (2.82e-3)" "unprognostic (2.08e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (9.37e-2)" "unprognostic (2.05e-1)" "unprognostic (2.12e-3)" "unprognostic (3.43e-3)" 12.3 12.1 9.9 17.0 9.9 15.4 11.4 16.2 12.2 12.0 27.5 7.4 8.1 20.9 14.7 11.6 12.0 9.0 12.9 11.6 9.8 10.3 11.7 10.5 11.6 15.0 10.3 9.8 10.3 19.1 5.5 10.9 10.6 8.4 9.6 27.2 8.5 9.0 8.9 53.3 15.0 19.7 7.5 9.9 18.4 14.5 6.3 8.9 15.4 9.8 28.8 22.8 12.0 11.6 21.4 6.8 36.6 11.4 8.6 18.9 13.3 14.3 10.5 9.8 8.7 7.4 6.5 7.9 15.7 10.3 10.7 14.6 6.5 40.6 36.1 9.1 9.2 18.7 21.9 10.5 10.4 15.9 5.6 13.5 16.4 12.4 9.4 7.9 19.5 13.6 7.2 9.3 11.7 23.5 6.5 7.0 12.4 14.1 9.6 13.2 9.8 7.2 30.6 10.0 17.3 9.2 9.6 8.9 21.3 34.1 15.1 10.5 13.1 10.3 19.4 24.6 8.6 12.9 10.9 6.1 9.1 8.2 15.5 20.5 19.3 22.0 17.7 7.5 12.1 14.2 26.9 8.0 29.8 9.0 10.2 10.2 21.4 12.1 11.0 6.8 20.5 12.4 10.6 36.6 8.6 11.4 6.4 18.9 13.3 9.9 9.9 16.2 12.2 9.8 10.3 10.3 9.8 8.4 8.9 20.8 10.7 82.5 30.5 41.6 22.0 14.0 30.6 37.5 27.3 15.7 39.3 30.8 24.9 25.8 3.2 34.9 102.1 46.7 70.0 25.2 31.9 27.6 17.3 16.3 22.9 1.6 114.8 20.3 26.5 3.6 31.4 25.2 25.3 17.2 74.0 23.6 44.1 98.2 20.8 48.5 23.5 12.9 27.8 30.9 17.2 34.0 23.7 34.5 50.5 60.6 NT5E "CALJA, CD73, eN, eNT, NT5" ENSG00000135318 "5'-nucleotidase ecto" P21589 6 85449584-85495791 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ito cells: 45.4;Pancreatic endocrine cells: 72.9;Rod photoreceptor cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3" "Group enriched" "Detected in many" 47 "B-cells: 19.9;T-cells: 17.3" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 93.4;LHCN-M2: 105.7;TIME: 61.2;U-87 MG: 95.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA017357 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 1600000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017357: AB_1846330" "unprognostic (1.92e-2)" "unprognostic (4.44e-3)" "unprognostic (1.54e-1)" "unprognostic (1.57e-3)" "unprognostic (9.33e-2)" "unprognostic (1.82e-3)" "unprognostic (1.20e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.49e-2)" "unprognostic (2.26e-1)" "unprognostic (2.78e-1)" 12.2 3.2 9.3 7.7 11.6 0.5 16.6 1.1 6.9 58.8 13.9 3.6 8.1 18.6 33.3 14.8 7.6 12.2 15.4 6.1 5.7 5.5 8.8 26.0 3.4 6.8 6.3 6.6 25.4 1.4 1.6 9.3 42.2 5.3 16.4 15.6 15.3 4.6 17.8 5.7 4.5 14.9 35.3 6.3 7.0 6.0 12.4 4.2 1.6 26.5 7.3 7.1 16.6 20.2 19.9 0.0 0.2 0.0 0.4 17.3 3.9 5.3 2.8 4.9 0.1 11.2 35.7 0.0 34.5 37.8 17.0 32.0 0.0 53.0 0.0 12.4 30.1 43.8 2.7 0.0 34.7 40.6 0.0 0.0 0.0 0.8 0.6 5.6 0.0 0.0 9.1 0.4 34.7 22.1 93.4 14.1 0.0 0.0 0.1 105.7 0.9 0.0 0.0 0.1 0.9 3.8 0.1 1.1 0.1 36.8 2.4 0.0 0.6 0.4 2.1 11.7 0.2 0.0 0.9 61.2 13.9 0.1 17.5 56.1 2.6 1.6 0.0 95.4 0.0 43.5 0.0 0.0 0.2 2.0 0.0 3.5 13.4 2.3 6.6 0.0 19.9 2.4 17.3 0.2 0.4 0.0 0.0 0.8 3.9 9.3 11.6 1.1 6.9 5.7 5.5 6.3 6.6 5.3 4.2 0.0 4.3 15.6 1.0 4.6 4.6 0.8 20.4 6.7 6.8 1.8 9.8 0.4 3.3 3.7 0.5 13.5 10.3 0.0 3.7 1.5 16.9 0.9 0.0 29.0 1.3 0.0 0.0 45.4 5.3 0.9 12.0 2.5 6.8 0.0 33.2 5.6 72.9 31.7 24.1 20.6 77.4 0.0 8.0 0.0 0.2 4.3 12.7 2.2 13.8 5.9 NTF3 NGF2 ENSG00000185652 "Neurotrophin 3" P20783 12 5432112-5521536 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.2" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 26.7;Basal keratinocytes: 16.5;Sertoli cells: 32.3;Smooth muscle cells: 32.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 16 "cerebellum: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 16.2;HBF TERT88: 15.0;RT4: 6.8" "Group enriched" "Detected in many" 5 "amygdala: 4.1;basal ganglia: 7.4;cerebellum: 12.3;hippocampal formation: 12.3" "Low region specificity" "Detected in all" HPA032001 Uncertain Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA032001: AB_2674106" "unprognostic (3.04e-2)" "unprognostic (7.46e-2)" "unprognostic (7.33e-3)" "unprognostic (4.66e-3)" "unprognostic (8.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.36e-3)" "unprognostic (7.68e-2)" "unprognostic (1.35e-1)" "unprognostic (2.14e-1)" "unprognostic (1.86e-1)" "unprognostic (2.20e-1)" "unprognostic (7.77e-4)" "unprognostic (4.02e-3)" "unprognostic (1.92e-1)" "unprognostic (8.06e-3)" "unprognostic (4.51e-3)" 4.9 2.7 0.5 2.4 0.5 0.0 5.4 29.2 0.6 12.9 4.7 0.3 5.6 2.7 9.2 6.8 5.0 2.2 5.3 4.1 1.7 0.2 4.3 10.4 2.5 1.0 0.7 0.2 16.8 0.4 0.1 1.3 2.7 1.2 8.9 1.5 8.9 4.6 3.7 3.6 3.7 6.6 11.5 0.4 8.5 3.0 3.5 0.0 0.2 1.2 3.9 2.0 10.4 9.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.5 0.0 0.0 0.0 0.0 3.4 9.2 12.1 16.2 0.1 0.2 0.0 5.5 5.7 0.0 2.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.6 3.8 6.8 0.2 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 29.2 0.6 1.7 0.2 0.7 0.2 1.2 0.0 0.0 0.0 0.0 26.7 16.5 0.0 0.6 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.1 5.2 4.7 0.0 2.4 0.0 0.0 0.0 8.0 0.0 0.0 7.8 0.9 6.8 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 32.3 32.7 0.6 0.7 2.9 0.1 0.0 0.0 3.9 NTM "CEPU-1, HNT, IGLON2, NTRI" ENSG00000182667 Neurotrimin Q9P121 11 131370478-132336822 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.2" "Cell type enhanced" "Detected in many" 21 "Alveolar cells type 1: 565.8;Cone photoreceptor cells: 895.3;Rod photoreceptor cells: 1396.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 157 "plasmacytoid DC: 15.6" "Lineage enriched" "Detected in single" 157 "dendritic cells: 15.6" "Cell line enhanced" "Detected in many" "LHCN-M2: 38.4;U-138 MG: 15.3;U-2 OS: 26.6;WM-115: 52.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB024875 Enhanced "Intracellular and membrane" NA NA 58000000 "CAB024875: " "unprognostic (1.52e-2)" "unprognostic (4.38e-3)" "unprognostic (1.61e-2)" "unprognostic (1.89e-1)" "unprognostic (4.25e-1)" "unprognostic (1.07e-1)" "unprognostic (9.99e-3)" "unprognostic (9.61e-2)" "unprognostic (1.26e-2)" "unprognostic (2.52e-2)" "unprognostic (4.29e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.10e-8)" "unprognostic (4.60e-3)" "unprognostic (1.37e-1)" "unprognostic (2.94e-1)" "unprognostic (9.31e-3)" 14.0 5.0 22.5 2.7 22.5 0.9 3.5 39.0 63.0 2.4 4.7 31.2 0.0 3.0 2.0 1.4 9.0 1.7 9.1 15.9 23.4 13.7 1.6 1.1 22.6 1.2 29.3 20.8 0.9 1.7 7.5 0.6 1.4 29.6 1.6 4.2 8.7 3.3 3.4 1.5 5.9 4.1 4.6 66.2 1.3 1.8 1.4 29.1 0.0 1.5 0.3 1.2 3.8 1.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.3 7.3 0.0 11.4 6.1 3.7 2.2 0.0 0.0 0.0 0.0 6.2 0.0 0.1 0.0 13.6 4.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 12.0 14.4 9.2 2.3 0.0 0.0 0.1 38.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.2 6.6 0.0 0.7 1.2 0.0 0.0 0.0 0.4 0.0 0.0 2.5 15.3 26.6 0.7 9.6 0.0 0.0 0.0 0.0 0.0 52.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 22.5 22.5 39.0 25.8 23.4 13.7 29.3 20.8 29.6 29.1 565.8 25.9 0.0 0.0 1.5 253.4 5.5 0.0 2.7 54.6 19.2 895.3 0.0 0.0 0.1 8.4 0.6 0.0 0.0 0.0 0.0 5.1 0.2 48.8 0.0 0.1 38.1 0.0 0.6 0.0 1.1 0.3 0.7 3.3 0.0 0.0 31.8 0.2 0.0 0.4 0.0 1396.8 0.0 2.8 0.3 0.0 4.3 0.0 0.0 0.0 0.0 NTN1 NTN1L ENSG00000065320 "Netrin 1" O95631 17 9021542-9244000 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 20.9;Hepatocytes: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 20.2;T-47d: 12.0;U-2 OS: 10.7;U-251 MG: 15.6;WM-115: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA056419 Approved "Secreted to extracellular matrix" NA NA 150000 "HPA056419: AB_2683124" "unprognostic (2.72e-1)" "unprognostic (2.59e-2)" "unprognostic (7.12e-2)" "unprognostic (5.25e-2)" "unprognostic (2.51e-1)" "unprognostic (9.33e-3)" "unprognostic (9.42e-2)" "unprognostic (2.20e-1)" "unprognostic (1.63e-1)" "unprognostic (1.33e-2)" "unprognostic (1.89e-1)" "unprognostic (1.15e-1)" "unprognostic (2.49e-2)" "unprognostic (2.20e-2)" "unprognostic (2.60e-1)" "unprognostic (6.07e-3)" "unprognostic (8.31e-3)" 3.9 1.1 1.2 3.6 1.6 0.0 4.3 1.3 5.7 6.3 10.4 2.7 0.8 5.0 5.6 3.2 21.2 8.1 16.7 20.8 1.5 1.6 1.8 5.3 3.8 0.1 2.8 0.3 1.9 1.4 0.0 1.8 0.5 6.9 3.2 3.0 15.6 7.0 1.5 1.6 2.7 9.4 6.8 4.4 1.0 6.4 1.6 1.5 0.0 1.5 6.0 8.0 7.1 4.1 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 3.3 3.1 0.1 20.2 0.2 0.3 0.2 0.3 0.0 4.1 0.0 4.6 0.0 6.6 0.1 0.9 0.6 0.0 4.4 7.5 1.0 0.0 0.0 0.1 0.4 0.1 0.1 1.5 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 3.9 0.0 0.4 1.3 0.0 0.0 2.4 3.5 0.0 0.0 0.2 0.0 0.0 0.1 3.4 0.8 3.4 12.0 0.2 0.0 4.9 10.7 0.0 15.6 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 1.3 1.6 1.5 1.6 2.8 0.3 6.9 1.5 0.0 0.0 0.0 5.1 3.0 2.8 20.9 0.0 5.3 6.8 1.8 0.0 0.2 0.0 2.8 7.9 2.1 0.2 0.0 1.6 0.9 3.5 2.7 0.0 14.0 0.1 0.0 0.0 1.3 0.6 3.6 0.3 0.0 1.7 1.0 1.1 0.2 1.9 0.0 0.0 0.0 0.1 0.0 5.7 1.1 1.5 2.5 0.5 0.0 0.6 2.8 NTN4 ENSG00000074527 "Netrin 4" Q9HB63 12 95657807-95791152 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 76.9" "Cell type enhanced" "Detected in many" 15 "Collecting duct cells: 188.5;Ito cells: 457.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 49 "T-cells: 4.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 94.4;hTERT-HME1: 39.1;PC-3: 35.7;TIME: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049832 Approved "Secreted to extracellular matrix" NA NA "HPA049832: AB_2680905" "unprognostic (3.08e-1)" "unprognostic (2.17e-1)" "unprognostic (2.33e-1)" "unprognostic (4.15e-2)" "unprognostic (2.11e-2)" "unprognostic (1.42e-1)" "unprognostic (1.67e-1)" "unprognostic (3.03e-2)" "unprognostic (8.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (9.50e-4)" "unprognostic (2.85e-1)" "prognostic favorable (8.12e-9)" "unprognostic (3.52e-2)" "unprognostic (7.08e-2)" "unprognostic (1.93e-1)" "prognostic favorable (6.67e-5)" 11.1 8.5 4.0 4.4 6.3 0.0 22.8 1.2 9.0 9.9 8.9 2.5 7.3 3.4 8.2 11.9 10.7 10.7 13.0 27.2 3.9 2.4 35.8 13.6 21.7 0.7 4.1 6.1 28.5 18.2 6.6 4.5 7.7 2.8 24.1 5.4 8.4 14.7 19.6 7.2 3.8 8.7 7.2 2.2 76.9 14.5 6.5 2.2 1.5 6.7 9.7 4.2 14.1 11.9 0.0 0.0 0.0 0.0 0.0 4.9 0.0 4.8 13.3 0.3 0.0 5.4 8.7 0.5 9.2 94.4 12.6 15.1 10.4 9.2 0.0 0.6 19.5 17.2 7.7 0.1 2.7 6.4 0.0 0.8 0.4 2.4 2.0 0.3 0.0 0.0 0.2 8.1 14.5 39.1 13.9 24.7 0.0 0.0 0.0 4.7 3.6 0.0 0.0 0.2 1.4 35.7 0.0 0.1 0.0 12.2 24.8 0.0 0.1 11.2 14.4 0.2 0.4 4.2 0.0 53.7 4.9 1.8 19.1 0.9 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 6.3 1.2 9.0 3.9 2.4 4.1 6.1 2.8 2.2 38.7 99.7 15.7 94.2 4.1 1.9 36.7 40.8 14.7 17.0 188.5 0.0 3.8 5.0 34.9 7.2 20.0 1.7 0.0 24.2 2.0 15.0 61.0 1.1 6.8 0.3 0.0 0.0 457.9 41.5 3.1 2.0 2.5 6.8 1.0 41.2 0.2 37.2 2.9 3.2 38.3 0.0 25.8 33.3 1.9 0.5 1.9 1.4 4.9 5.3 78.5 NTRK1 "MTC, TRK, TRKA" ENSG00000198400 "Neurotrophic receptor tyrosine kinase 1" P04629 1 156815640-156881850 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 15.8;blood: 32.3;brain: 28.3" "Group enriched" "Detected in some" 8 "granulocytes: 56.4;Horizontal cells: 54.0" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Region enriched" "Detected in many" 5 "pons and medulla: 28.3" "Cell type enriched" "Detected in single" 127 "basophil: 32.3" "Lineage enriched" "Detected in single" 323 "granulocytes: 32.3" "Cell line enriched" "Detected in some" 4 "HMC-1: 42.1" "Region enhanced" "Detected in some" "basal ganglia: 8.2" "Low region specificity" "Detected in all" "CAB004606, HPA035799, HPA076570" Approved Approved Vesicles,Cytosol NA NA 140000 "Vesicles, Cytosol" "CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: " "unprognostic (5.89e-3)" "unprognostic (7.56e-2)" "unprognostic (2.74e-2)" "unprognostic (5.99e-3)" "unprognostic (7.26e-2)" "unprognostic (1.43e-3)" "unprognostic (1.56e-1)" "unprognostic (7.42e-3)" "unprognostic (7.63e-2)" "unprognostic (1.35e-1)" "unprognostic (6.73e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-11)" "unprognostic (2.18e-3)" "unprognostic (3.79e-2)" "unprognostic (1.07e-1)" "unprognostic (4.89e-1)" 1.0 15.8 0.5 0.8 6.0 0.9 0.4 0.0 0.7 0.9 1.1 0.1 0.0 0.8 1.6 2.0 0.7 0.6 2.1 1.5 0.0 1.2 2.9 0.2 1.9 0.3 2.1 0.6 0.3 0.3 0.3 1.1 0.5 28.3 2.2 0.2 3.1 1.2 0.5 0.7 0.2 0.4 1.1 1.2 0.2 1.0 2.4 1.5 0.4 0.3 0.0 0.4 0.7 0.8 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 6.8 0.0 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.6 1.2 0.0 0.1 0.0 0.0 0.8 9.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 32.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.0 0.0 0.6 0.0 1.2 2.1 0.6 28.3 1.5 0.0 2.2 0.0 0.0 0.0 6.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 56.4 0.0 0.1 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 2.5 0.1 0.0 0.0 0.0 0.0 NTRK2 TRKB ENSG00000148053 "Neurotrophic receptor tyrosine kinase 2" Q16620 9 84668551-85027070 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Epilepsy, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 133.8;thyroid gland: 63.4" "Cell type enhanced" "Detected in many" 12 "Horizontal cells: 228.8;Leydig cells: 96.4;Muller glia cells: 248.1;Sertoli cells: 122.9;Smooth muscle cells: 96.9" "Group enriched" "Detected in many" 5 "glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in some" "AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.7;SH-SY5Y: 13.4;SuSa: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007637, CAB010346, HPA074873" Enhanced Approved Cytosol NA NA 13000000 Cytosol "CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: " "unprognostic (2.75e-3)" "unprognostic (3.48e-2)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-2)" "unprognostic (1.29e-2)" "unprognostic (9.16e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (4.25e-2)" "unprognostic (2.18e-2)" "unprognostic (2.66e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-3)" 19.8 2.7 66.1 2.0 56.7 1.2 33.2 15.1 133.8 6.4 4.4 27.4 0.0 1.4 3.0 3.3 5.6 3.7 18.7 5.8 61.0 30.7 12.5 2.1 6.3 2.7 32.4 41.4 6.6 18.9 1.6 3.0 2.1 34.1 3.8 3.1 2.0 8.6 11.9 2.0 7.2 1.6 3.0 22.1 6.5 1.4 2.4 34.1 0.0 63.4 2.6 3.4 3.5 3.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 11.7 0.8 0.9 13.4 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 66.1 56.7 15.1 45.6 61.0 30.7 32.4 41.4 34.1 34.1 0.0 0.3 0.0 1.0 50.4 24.4 8.7 0.0 2.7 0.0 8.7 5.9 0.0 23.2 26.5 1.5 4.5 0.0 0.0 0.6 0.1 10.6 0.9 0.0 0.0 0.2 228.8 0.0 5.5 0.0 1.7 96.4 1.2 16.9 1.0 0.0 248.1 0.5 7.2 45.3 7.9 9.1 122.9 96.9 0.7 1.1 21.5 0.0 0.0 5.4 0.8 NTRK3 TRKC ENSG00000140538 "Neurotrophic receptor tyrosine kinase 3" Q16288 15 87859751-88256768 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 58.9;Early spermatids: 85.5;Late spermatids: 103.3;Sertoli cells: 51.8;Smooth muscle cells: 37.7" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "U-138 MG: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009233, HPA027484, HPA048065" Approved Supported "Nuclear membrane,Nucleoli,Nucleoli rim" NA NA 11000000 "Nucleoli, Nucleoli rim" "Nuclear membrane" "CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245" "unprognostic (1.27e-3)" "unprognostic (1.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.04e-2)" "unprognostic (1.65e-1)" "unprognostic (3.34e-1)" "unprognostic (3.18e-2)" "unprognostic (2.23e-2)" "unprognostic (2.34e-1)" "unprognostic (3.91e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-3)" "unprognostic (6.45e-3)" "unprognostic (1.06e-2)" "unprognostic (1.26e-2)" "unprognostic (2.49e-3)" 20.8 7.4 22.0 2.5 28.1 1.5 6.2 30.4 41.8 7.0 4.0 8.4 1.3 2.0 12.4 6.7 3.4 9.5 3.9 5.5 22.0 11.1 5.1 2.0 5.7 3.1 11.2 18.7 5.1 2.9 1.6 7.9 2.8 14.7 6.8 4.7 8.0 11.5 8.7 1.9 2.9 2.5 7.7 13.7 4.1 3.0 13.8 13.7 0.0 2.5 0.7 4.3 7.1 4.8 0.7 0.4 1.3 0.5 0.5 0.8 0.0 0.0 6.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 48.6 0.9 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.1 1.2 0.5 0.4 0.3 0.1 0.2 0.4 0.3 0.3 0.1 0.7 0.4 0.4 1.3 0.5 0.1 0.4 0.8 0.0 22.0 28.1 30.4 28.9 22.0 11.1 11.2 18.7 14.7 13.7 0.0 0.0 0.0 5.9 0.5 58.9 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 85.5 0.7 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.9 1.6 0.0 1.8 0.0 103.3 3.1 0.2 0.0 0.0 0.0 8.9 0.0 0.0 25.8 0.0 2.7 51.8 37.7 8.8 1.9 0.1 0.1 0.0 0.0 0.1 NTSR1 NTR ENSG00000101188 "Neurotensin receptor 1" P30989 20 62708837-62762771 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.0;intestine: 15.1" "Cell type enhanced" "Detected in single" 29 "Kupffer cells: 3.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "PC-3: 35.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050299 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA050299: " "unprognostic (4.14e-2)" "unprognostic (2.02e-2)" "unprognostic (2.75e-2)" "unprognostic (8.87e-4)" "unprognostic (9.27e-3)" "unprognostic (1.45e-1)" "unprognostic (4.17e-2)" "unprognostic (2.80e-3)" "unprognostic (7.16e-2)" "unprognostic (3.10e-3)" "unprognostic (3.55e-2)" "unprognostic (2.53e-1)" "unprognostic (1.27e-2)" "unprognostic (1.25e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (2.49e-1)" 0.3 0.1 3.7 2.5 3.6 3.8 0.1 0.1 7.0 0.1 15.1 0.0 0.0 0.4 0.2 0.1 0.1 0.1 1.4 0.1 2.0 1.1 0.6 0.2 0.3 0.3 3.3 1.0 0.4 0.1 0.2 0.3 0.2 1.4 0.2 0.5 1.2 0.3 0.1 0.2 0.2 1.5 0.8 0.8 0.6 0.5 0.5 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.3 0.0 0.3 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.2 6.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 1.7 0.1 1.6 0.2 0.7 35.8 1.1 0.0 5.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.7 3.6 0.1 7.0 2.0 1.1 3.3 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NTSR2 NTR2 ENSG00000169006 "Neurotensin receptor 2" O95665 2 11658178-11670164 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 33.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 15 "glioma: 6.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.0;NTERA-2: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.40e-2)" "unprognostic (2.30e-2)" "unprognostic (2.36e-2)" "unprognostic (5.32e-2)" "unprognostic (2.23e-1)" "unprognostic (1.80e-1)" "unprognostic (2.75e-1)" "unprognostic (4.98e-1)" "unprognostic (1.64e-1)" 1.3 1.8 22.3 1.1 30.7 1.1 1.1 2.1 33.4 1.1 1.1 11.9 0.0 1.1 1.1 1.2 1.1 1.1 1.1 1.1 13.4 15.6 1.1 1.1 1.1 1.1 26.8 13.8 2.8 1.7 1.1 0.0 1.1 10.6 1.1 1.1 0.0 1.1 1.1 1.2 1.1 1.1 1.1 4.3 1.1 1.1 1.5 8.7 0.0 1.1 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 30.7 2.1 14.5 13.4 15.6 26.8 13.8 10.6 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 NUCB1 "Calnuc, NUC" ENSG00000104805 "Nucleobindin 1" Q02818 19 48900050-48923372 "Plasma proteins, Predicted secreted proteins" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008176 Supported Supported "Golgi apparatus,Microtubules" "Secreted to blood" NA NA 15000000 "Golgi apparatus" Microtubules "HPA008176: AB_1845923" "unprognostic (2.13e-1)" "unprognostic (2.83e-1)" "unprognostic (4.36e-3)" "unprognostic (6.28e-2)" "unprognostic (1.06e-2)" "unprognostic (2.95e-1)" "unprognostic (6.86e-2)" "unprognostic (1.98e-1)" "unprognostic (9.51e-2)" "unprognostic (8.14e-3)" "unprognostic (2.34e-3)" "unprognostic (9.89e-2)" "unprognostic (5.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (8.90e-3)" "unprognostic (3.41e-1)" 49.5 32.2 18.1 30.5 20.2 19.3 50.1 17.9 36.0 31.0 42.5 24.8 32.5 51.6 36.7 46.8 33.1 30.7 47.2 58.8 16.8 20.3 56.7 144.7 42.6 48.4 20.5 25.2 40.0 37.4 42.7 21.3 46.9 29.1 36.6 15.3 31.0 37.8 29.7 46.7 26.0 51.8 36.7 20.7 32.4 33.4 19.0 15.9 17.1 48.0 29.0 23.2 36.4 58.2 19.1 42.3 39.2 47.7 24.4 40.2 40.1 10.1 33.1 15.9 34.2 57.8 44.7 18.3 39.5 34.9 19.3 27.1 16.6 37.1 9.9 30.1 48.1 18.9 24.3 9.1 19.3 8.1 35.9 16.5 25.7 23.6 21.4 27.9 15.5 34.2 52.5 8.6 18.3 12.2 52.5 29.4 11.1 31.2 52.6 18.8 12.1 7.4 9.6 7.8 23.3 17.2 14.0 23.9 20.7 14.2 24.3 11.3 23.6 46.2 28.6 15.7 15.5 14.6 20.4 44.4 32.6 22.2 20.1 18.6 39.7 91.3 6.8 25.0 9.7 38.2 31.6 39.6 37.6 40.2 47.7 30.4 19.1 27.3 30.5 29.9 15.5 22.9 22.7 39.2 24.4 40.7 42.3 27.0 40.1 18.1 20.2 17.9 36.0 16.8 20.3 20.5 25.2 29.1 15.9 38.7 74.0 44.2 50.6 42.8 21.0 48.1 61.1 21.4 35.2 66.3 13.7 88.7 34.9 114.5 6.4 86.3 281.0 0.0 103.8 125.2 120.9 70.5 94.5 109.2 190.7 19.1 71.4 106.8 122.6 6.8 102.1 89.3 96.2 150.5 83.5 49.5 91.7 154.3 116.7 115.0 14.5 90.5 94.8 11.2 46.6 43.5 85.4 88.5 101.9 56.4 NUCB2 NEFA ENSG00000070081 "Nucleobindin 2" 11 17208153-17349980 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 160.3" "Cell type enhanced" "Detected in all" 8 "Ciliated cells: 702.6;Early spermatids: 595.9;Syncytiotrophoblasts: 968.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 188.9" "Low region specificity" "Detected in many" "HPA008395, CAB015931, CAB079781" Enhanced Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1250000 "Golgi apparatus" "CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683" "unprognostic (2.49e-1)" "unprognostic (1.75e-2)" "unprognostic (1.39e-1)" "prognostic favorable (8.27e-6)" "unprognostic (5.24e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-3)" "unprognostic (3.66e-3)" "unprognostic (1.81e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.46e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.94e-5)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (4.78e-2)" "unprognostic (8.02e-3)" 10.2 13.9 9.5 7.5 13.1 66.4 17.9 13.5 7.5 18.3 7.8 3.8 79.5 6.6 11.4 59.6 29.7 13.7 7.3 25.0 7.5 10.9 10.8 51.1 12.5 13.5 8.5 7.6 15.4 92.8 58.9 69.7 35.8 10.3 13.4 8.3 5.8 160.3 104.9 7.2 4.2 6.8 11.3 9.4 9.8 11.4 18.7 6.1 86.1 22.7 17.7 10.4 12.1 11.0 3.7 71.7 28.8 7.6 45.2 49.5 20.1 12.2 5.1 5.7 17.2 12.9 17.8 6.9 27.4 40.0 12.3 21.8 5.0 2.8 18.9 6.9 26.0 11.5 5.3 3.6 6.9 19.3 13.0 8.0 13.9 6.4 8.7 37.3 188.9 25.6 7.7 9.2 8.8 21.6 30.7 15.0 71.0 12.0 38.3 12.1 10.8 66.5 68.3 1.3 20.0 5.4 24.6 13.9 1.5 5.5 3.9 6.8 3.8 12.0 12.1 6.1 8.7 9.9 51.4 13.4 13.1 12.1 39.5 11.5 7.5 4.1 10.4 15.1 66.8 11.1 28.8 7.6 27.6 17.1 5.0 22.3 3.7 16.3 31.5 6.9 2.4 46.0 49.5 7.0 45.2 4.0 71.7 7.0 20.1 9.5 13.1 13.5 7.5 7.5 10.9 8.5 7.6 10.3 6.1 41.7 59.0 14.1 53.1 24.5 64.5 145.2 50.9 702.6 152.4 40.1 51.1 105.9 23.2 65.4 595.9 97.2 5.4 23.3 116.0 281.9 179.4 156.8 63.8 119.0 65.3 33.4 40.7 105.0 27.2 377.7 138.7 39.7 65.8 11.8 82.2 101.2 103.6 8.6 107.5 16.5 80.2 45.3 51.5 125.6 53.1 26.3 968.6 104.6 35.5 54.9 NUDC NudC ENSG00000090273 "Nuclear distribution C, dynein complex regulator" Q9Y266 1 26900238-26946862 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027183, HPA028105" Enhanced Enhanced Cytosol NA NA 18000 Cytosol "HPA027183: AB_10600086, HPA028105: AB_10601988" "unprognostic (1.40e-1)" "unprognostic (1.74e-2)" "unprognostic (5.61e-2)" "unprognostic (6.52e-3)" "unprognostic (2.30e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (1.11e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (4.12e-2)" "unprognostic (3.82e-1)" "unprognostic (3.26e-2)" "unprognostic (2.90e-2)" "unprognostic (1.55e-1)" "unprognostic (2.53e-1)" "unprognostic (5.10e-2)" 30.7 57.9 49.9 25.8 44.9 31.8 30.9 40.1 59.0 30.5 35.7 32.0 31.7 25.8 30.0 53.0 26.6 69.2 28.2 41.8 39.3 41.0 28.2 46.8 26.4 27.3 39.6 49.7 34.5 44.7 36.7 32.3 29.2 38.6 34.2 23.7 25.0 35.0 43.9 65.6 30.8 22.9 39.0 32.9 29.2 36.6 41.4 35.9 30.0 36.8 24.8 29.5 37.6 84.4 73.7 69.0 63.1 62.8 57.9 71.8 64.8 42.6 44.7 23.5 32.6 18.8 16.9 26.7 34.3 21.2 46.3 34.2 41.0 29.9 35.9 30.4 23.4 34.1 33.6 49.9 45.2 35.8 27.8 51.7 44.6 45.5 70.1 33.2 47.0 33.0 18.1 29.6 55.6 36.0 20.2 33.9 42.2 63.5 20.2 31.1 37.1 47.2 60.9 61.7 56.1 58.1 49.5 29.8 36.6 39.4 16.9 39.2 29.4 37.3 23.8 30.2 23.1 23.2 29.0 33.4 33.1 39.5 41.3 43.9 40.7 63.9 43.3 35.7 66.5 37.1 63.1 60.3 57.5 69.1 62.8 69.7 72.0 70.4 65.3 59.8 73.7 70.0 71.8 41.0 57.9 60.0 69.0 66.5 64.8 49.9 44.9 40.1 59.0 39.3 41.0 39.6 49.7 38.6 35.9 125.0 96.1 101.3 254.2 136.9 88.8 139.6 127.4 592.9 157.0 104.7 49.1 182.7 222.2 232.6 46.2 119.1 64.9 0.0 274.8 170.3 125.0 214.5 143.3 551.3 129.0 104.9 125.9 76.1 61.3 97.3 125.7 95.2 143.4 146.1 65.8 130.4 273.1 71.9 143.9 157.8 81.0 109.9 158.4 185.6 247.7 129.7 136.0 118.6 82.6 183.4 NUP210 "FLJ22389, GP210, KIAA0906, POM210" ENSG00000132182 "Nucleoporin 210" Q8TEM1 3 13316235-13420309 "Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 31.0;lymphoid tissue: 44.2" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 33.4;T-cells: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 47.0;U-266/84: 52.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066888 Approved NA NA 28000 "HPA066888: AB_2685741" "unprognostic (3.17e-2)" "unprognostic (2.09e-1)" "unprognostic (2.53e-1)" "unprognostic (3.60e-2)" "unprognostic (2.33e-1)" "unprognostic (9.72e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (1.30e-1)" "unprognostic (3.15e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (5.87e-2)" "unprognostic (1.96e-3)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.59e-2)" "unprognostic (1.63e-2)" 1.6 4.1 4.0 25.6 5.2 31.0 3.7 12.6 6.7 1.7 4.2 8.0 3.3 4.9 1.8 7.0 5.6 2.9 4.0 2.0 4.1 5.3 6.8 13.8 5.3 25.6 4.9 3.5 1.4 11.4 7.2 10.9 4.3 4.5 4.2 3.9 6.3 6.8 4.4 7.2 3.8 16.4 1.6 3.6 25.3 5.6 6.6 6.1 44.2 6.5 3.1 23.1 5.6 1.8 6.7 6.8 1.0 3.9 6.2 9.3 3.6 8.4 14.9 7.4 19.1 0.0 0.0 29.4 0.1 0.0 1.8 0.0 7.6 13.8 34.4 11.9 0.0 0.8 4.9 16.3 0.0 0.7 27.6 12.1 13.3 16.9 8.0 0.0 42.5 4.8 0.0 0.0 0.0 0.0 1.3 0.0 26.0 20.5 37.0 0.0 21.1 22.5 16.9 8.5 2.6 3.1 0.0 0.0 47.0 3.6 7.9 8.5 8.5 10.7 14.3 4.5 3.4 13.6 35.4 0.1 0.0 2.5 0.0 6.5 37.6 52.0 30.0 0.0 23.8 0.0 0.0 2.9 1.0 9.3 3.9 7.4 6.7 6.7 9.0 6.4 4.5 5.6 7.3 0.1 6.2 2.4 6.8 5.6 3.6 4.0 5.2 12.6 6.7 4.1 5.3 4.9 3.5 4.5 6.1 14.9 4.8 32.0 1.2 1.4 16.7 9.6 10.2 2.7 6.8 5.2 13.7 13.4 3.3 5.0 18.8 0.7 1.1 23.3 3.8 3.8 0.5 3.1 4.7 11.6 14.7 33.4 7.9 4.3 12.8 16.6 0.6 8.0 1.7 2.8 4.6 3.2 3.5 0.0 0.4 3.4 20.9 0.0 0.3 3.8 10.0 2.0 4.1 37.3 3.8 1.6 NUP210L ENSG00000143552 "Nucleoporin 210 like" Q5VU65 1 153992685-154155116 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 42.7" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 15.2;Late spermatids: 6.7;Sertoli cells: 6.5;Spermatocytes: 26.5;Spermatogonia: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 43 "MCF7: 18.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047195, HPA064245, HPA066707" Enhanced Approved "Nuclear bodies" No No "Nuclear bodies" "HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706" "unprognostic (2.11e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.80e-2)" "unprognostic (1.63e-2)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.79e-3)" "unprognostic (3.45e-2)" "unprognostic (5.57e-2)" "unprognostic (4.51e-4)" "unprognostic (1.15e-1)" "unprognostic (9.35e-10)" "unprognostic (4.20e-2)" "unprognostic (3.78e-2)" "unprognostic (7.45e-2)" "unprognostic (4.09e-2)" 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.9 0.1 0.1 1.5 0.0 0.0 1.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.2 0.0 0.4 0.4 0.6 0.1 0.0 0.8 0.9 0.4 0.1 0.1 0.1 3.4 0.2 0.1 0.1 42.7 0.0 0.3 0.3 0.0 0.1 1.2 0.1 0.6 0.6 1.8 0.2 0.9 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.8 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.3 0.1 0.2 0.6 0.4 0.5 0.0 0.5 0.8 0.3 1.8 0.9 0.0 0.6 0.7 0.0 0.1 0.3 0.1 0.9 0.1 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.3 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 6.5 0.1 26.5 5.1 0.5 0.0 0.0 0.0 0.2 NUP50 NPAP60L ENSG00000093000 "Nucleoporin 50" Q9UKX7 22 45163841-45188015 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047162 Enhanced Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA047162: AB_2679963" "unprognostic (2.64e-1)" "unprognostic (1.21e-2)" "unprognostic (4.96e-2)" "unprognostic (1.22e-1)" "unprognostic (2.17e-1)" "unprognostic (1.57e-1)" "unprognostic (5.46e-3)" "unprognostic (5.83e-3)" "unprognostic (4.94e-2)" "unprognostic (4.94e-2)" "unprognostic (7.22e-2)" "unprognostic (5.31e-2)" "unprognostic (1.97e-2)" "prognostic favorable (4.06e-4)" "unprognostic (1.43e-1)" "unprognostic (3.17e-2)" "unprognostic (3.63e-2)" 9.0 12.0 8.0 12.3 9.3 26.4 12.8 11.3 11.4 8.7 13.2 6.6 15.8 9.0 9.1 11.0 18.1 10.4 8.0 5.3 7.4 8.6 10.8 13.6 10.4 17.6 7.1 8.4 9.9 11.7 8.2 16.1 12.9 16.8 11.9 9.6 8.2 11.3 15.0 6.5 10.8 18.1 6.2 6.3 19.3 13.4 20.0 7.5 41.3 12.2 5.5 19.5 10.7 15.3 8.2 10.3 37.6 16.2 11.8 12.5 12.3 24.3 11.7 22.4 14.5 10.5 11.0 23.9 20.4 13.6 15.8 16.1 25.3 10.9 26.7 9.6 13.4 11.8 17.2 27.5 16.6 22.9 14.2 29.2 23.4 18.3 15.4 11.0 61.7 24.9 13.3 11.5 20.2 15.4 7.6 17.4 23.6 24.2 28.2 16.2 16.3 27.9 16.0 16.8 16.2 12.1 29.7 13.6 18.7 12.3 23.7 14.0 13.6 20.3 12.6 24.0 17.9 7.8 16.4 15.8 33.6 30.2 17.3 17.1 19.7 15.9 39.3 12.6 16.0 23.3 19.7 15.7 31.0 8.8 16.2 12.0 8.2 10.6 10.0 10.3 7.4 12.5 8.5 37.6 11.8 9.2 5.7 10.1 12.3 8.0 9.3 11.3 11.4 7.4 8.6 7.1 8.4 16.8 7.5 8.9 24.7 25.2 40.1 76.0 14.5 9.0 22.9 33.5 18.2 31.4 11.8 20.7 11.6 16.5 34.0 19.0 21.4 70.0 18.1 32.1 18.9 47.3 32.5 32.4 24.1 12.7 16.7 35.0 41.1 58.5 13.6 24.9 23.6 23.4 22.0 9.7 22.7 31.6 13.1 17.4 16.3 25.8 14.7 31.2 39.5 78.2 47.4 37.1 22.2 77.6 NXPE1 "FAM55A, MGC34290" ENSG00000095110 "Neurexophilin and PC-esterase domain family member 1" Q8N323 11 114521645-114559895 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "intestine: 44.0;lymphoid tissue: 20.4" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 50.2;Late spermatids: 47.7;Mucus-secreting cells: 34.2;Undifferentiated cells: 40.5" "Cancer enriched" "Detected in single" 23 "colorectal cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.0;U-138 MG: 1.1;WM-115: 1.0" HPA049133 Enhanced "Intracellular and membrane" NA NA "HPA049133: AB_2680647" "unprognostic (2.81e-1)" "unprognostic (2.19e-3)" "unprognostic (3.40e-3)" "unprognostic (4.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (3.40e-2)" "unprognostic (1.76e-1)" 0.1 0.0 0.1 20.4 0.1 0.0 0.1 0.1 0.1 0.1 44.0 0.1 0.1 0.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 36.9 0.1 0.3 0.1 0.1 0.0 4.4 1.0 0.1 0.1 0.0 2.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 0.0 12.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.5 0.0 0.0 47.7 0.3 0.0 0.0 0.0 34.2 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 40.5 0.0 NXPE2 "FAM55B, FLJ25224" ENSG00000204361 "Neurexophilin and PC-esterase domain family member 2" Q96DL1 11 114678386-114706933 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 22.9;salivary gland: 44.1" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 1.1;Enterocytes: 1.3;Intestinal endocrine cells: 1.7;Mucus-secreting cells: 2.5;Undifferentiated cells: 1.4" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.0;U-87 MG: 2.7" "Low region specificity" "Detected in some" "HPA039744, HPA039876" Enhanced NA NA "HPA039744: AB_2676660, HPA039876: AB_2676721" "unprognostic (2.85e-1)" "prognostic favorable (9.29e-5)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (3.46e-2)" "unprognostic (9.35e-2)" "unprognostic (1.27e-1)" "unprognostic (6.40e-2)" "unprognostic (1.61e-1)" "unprognostic (3.96e-4)" "unprognostic (9.00e-2)" "unprognostic (9.22e-2)" 0.2 0.1 0.2 3.0 0.2 0.0 0.2 0.1 0.2 0.3 7.4 0.0 0.8 0.3 0.5 22.9 0.4 0.2 0.0 0.3 0.2 0.2 0.2 0.1 0.2 0.0 0.2 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.5 7.1 0.0 44.1 0.0 0.2 0.2 1.8 0.5 0.2 0.1 0.2 0.5 0.0 0.0 0.2 0.7 4.8 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 3.0 0.1 0.8 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.2 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 NXPE3 "FAM55C, MGC15606" ENSG00000144815 "Neurexophilin and PC-esterase domain family member 3" Q969Y0 3 101779202-101827392 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.6" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 37.8;Horizontal cells: 46.1;Ito cells: 40.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036259 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA 7600 Vesicles Nucleoplasm "HPA036259: AB_10671838" "unprognostic (3.30e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (4.42e-5)" "unprognostic (4.98e-2)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (7.42e-2)" "unprognostic (1.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.57e-3)" "unprognostic (3.43e-1)" "prognostic unfavorable (7.76e-6)" "unprognostic (2.89e-1)" "unprognostic (5.23e-2)" "unprognostic (1.77e-1)" "unprognostic (8.75e-3)" 6.1 4.7 7.2 7.6 16.6 7.8 5.3 6.1 16.2 6.3 5.2 29.5 6.0 2.4 7.9 2.6 4.5 8.2 4.8 12.6 9.8 5.9 3.0 2.5 6.9 10.7 24.0 8.6 5.5 2.6 15.8 6.9 4.7 22.0 6.2 3.4 3.4 4.2 7.5 44.6 2.5 4.9 7.6 9.4 8.7 4.6 5.1 17.2 6.6 5.3 4.1 9.8 7.3 5.0 8.9 11.6 15.9 13.6 6.7 19.5 11.1 7.8 12.0 10.4 3.7 11.2 11.7 2.3 8.7 11.1 10.5 15.3 2.8 0.8 11.5 25.8 9.8 12.7 1.7 11.5 9.4 13.0 14.3 3.6 8.9 7.6 7.4 14.8 7.5 8.3 6.7 1.6 8.7 3.2 13.7 11.3 11.2 1.8 37.8 17.3 4.1 10.0 1.8 5.9 0.4 7.4 4.6 12.6 4.9 7.7 2.0 8.2 9.8 3.7 0.9 6.5 6.5 1.7 10.8 9.8 11.7 13.9 1.3 9.0 18.0 17.8 13.6 10.0 33.3 2.2 6.3 13.6 15.9 12.7 10.4 8.8 8.9 14.2 13.2 11.6 5.8 19.5 15.5 6.9 6.7 9.9 7.4 16.3 11.1 7.2 16.6 6.1 16.2 9.8 5.9 24.0 8.6 22.0 17.2 23.8 6.1 9.7 1.9 3.3 23.7 37.8 5.1 2.7 3.4 0.0 7.9 0.7 0.0 2.6 1.0 11.7 0.0 0.0 2.2 1.2 7.8 0.8 12.7 1.6 6.3 46.1 6.9 40.5 18.4 1.3 8.6 9.5 6.8 10.8 0.5 22.7 2.0 0.0 7.1 0.5 15.7 19.4 7.6 9.3 15.2 2.6 0.6 10.9 0.4 1.0 NXPE4 "C11orf33, FAM55D, FLJ20127" ENSG00000137634 "Neurexophilin and PC-esterase domain family member 4" Q6UWF7 11 114570591-114595762 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "intestine: 44.3;lymphoid tissue: 21.7;salivary gland: 71.7" "Cell type enhanced" "Detected in some" 18 "Enterocytes: 29.3;Mucus-secreting cells: 101.9;Paneth cells: 37.4;Undifferentiated cells: 91.1" "Cancer enriched" "Detected in some" 15 "colorectal cancer: 13.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA042801 Approved "Secreted to digestive system" NA NA "HPA042801: AB_10793986" "unprognostic (1.35e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-3)" "unprognostic (1.27e-1)" "unprognostic (3.51e-3)" "unprognostic (1.06e-1)" "unprognostic (1.32e-1)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (7.47e-3)" "unprognostic (4.36e-2)" "unprognostic (2.05e-1)" 0.2 0.2 0.2 21.7 0.2 0.0 0.2 0.2 0.2 0.2 41.5 0.1 0.1 0.0 0.2 2.4 0.3 0.3 0.1 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.1 0.2 0.2 0.0 0.2 0.1 0.1 2.1 44.3 0.1 71.7 0.1 0.2 0.2 0.5 1.9 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.3 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 29.3 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.9 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.1 0.1 NYX "CLRP, CSNB1, CSNB1A, CSNB4" ENSG00000188937 Nyctalopin Q9GZU5 X 41447434-41475710 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 13.9" "Cell type enriched" "Detected in some" 8 "Bipolar cells: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HDLM-2: 7.4;NTERA-2: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Intracellular and membrane" NA NA "unprognostic (3.27e-2)" "unprognostic (6.72e-2)" "unprognostic (4.21e-2)" "unprognostic (4.10e-4)" "unprognostic (1.83e-1)" "unprognostic (3.96e-2)" "unprognostic (1.80e-1)" 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 13.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.7 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.4 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.5 1.1 0.0 0.2 0.0 0.0 0.0 OCA2 "BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P" ENSG00000104044 "OCA2 melanosomal transmembrane protein" Q04671 15 27754875-28099358 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Albinism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.9;skin 1: 12.3" "Cell type enhanced" "Detected in some" 24 "Leydig cells: 8.6;Melanocytes: 40.5;Peritubular cells: 13.8" "Cancer enriched" "Detected in many" 17 "melanoma: 19.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SH-SY5Y: 5.9;SK-MEL-30: 22.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA036402 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA036402: " "unprognostic (6.07e-3)" "unprognostic (1.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.82e-2)" "unprognostic (4.60e-4)" "unprognostic (7.11e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (3.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.96e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-6)" "unprognostic (2.61e-1)" "unprognostic (4.21e-1)" "unprognostic (3.28e-2)" "unprognostic (2.28e-2)" 0.4 0.1 0.9 1.3 4.8 0.0 0.3 0.2 2.9 2.4 0.3 3.6 0.2 0.0 0.4 1.7 2.9 1.6 0.5 0.2 1.3 3.6 0.4 0.4 1.2 3.1 0.3 0.4 0.4 0.2 0.0 1.0 2.9 9.5 0.9 0.2 37.9 1.9 2.7 0.4 12.3 0.2 0.2 0.2 2.0 0.1 2.6 0.2 0.3 7.0 0.5 1.5 0.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.1 5.9 0.0 0.0 22.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 4.8 0.2 2.9 1.3 3.6 0.3 0.4 9.5 0.2 0.0 0.0 0.0 0.1 1.8 0.0 0.3 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 8.6 0.0 40.5 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 1.7 2.9 3.9 0.6 0.1 0.0 0.0 0.1 OCEL1 FLJ22709 ENSG00000099330 "Occludin/ELL domain containing 1" Q9H607 19 17226204-17229219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 112.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 24.0" "HPA042070, HPA043223" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA042070: AB_2677830, HPA043223: " "unprognostic (6.34e-2)" "unprognostic (6.28e-2)" "unprognostic (3.13e-1)" "unprognostic (3.00e-3)" "unprognostic (6.40e-2)" "unprognostic (2.06e-2)" "unprognostic (4.33e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "unprognostic (1.67e-1)" "unprognostic (7.73e-2)" "unprognostic (4.64e-1)" "unprognostic (1.34e-1)" "unprognostic (2.52e-1)" "unprognostic (2.88e-1)" "unprognostic (9.19e-2)" "unprognostic (1.18e-3)" 12.1 14.3 9.2 7.3 7.4 5.9 10.6 7.3 16.5 9.6 18.6 6.2 14.0 20.4 9.7 21.3 8.8 14.7 11.0 9.1 8.3 8.2 23.3 48.1 11.1 7.6 9.9 9.5 12.3 15.9 12.3 6.5 13.0 7.8 13.4 13.7 9.9 11.5 21.7 8.6 5.6 32.2 8.2 8.1 11.8 15.1 4.9 8.1 9.4 20.5 6.8 10.0 9.7 13.6 12.2 18.2 17.2 23.7 11.2 14.4 9.5 5.8 4.4 2.5 2.0 24.0 9.8 6.2 3.6 9.5 2.9 4.9 3.2 6.7 5.0 13.9 5.2 2.5 2.7 3.1 3.7 2.7 4.2 3.7 4.8 4.8 15.4 8.1 1.0 7.4 8.1 3.8 3.6 5.3 9.7 4.0 6.7 3.9 4.8 5.2 4.7 2.4 2.7 3.8 8.3 7.8 2.2 2.1 12.1 12.1 7.7 0.8 3.9 2.2 7.3 6.2 5.1 11.1 4.2 2.5 1.7 2.1 3.7 1.9 13.6 10.2 3.8 6.1 4.4 1.2 17.2 23.7 11.2 8.1 15.7 7.9 12.0 12.2 9.2 18.2 12.2 14.0 8.7 7.5 11.2 12.4 8.0 14.4 9.5 9.2 7.4 7.3 16.5 8.3 8.2 9.9 9.5 7.8 8.1 11.9 5.1 15.2 23.6 5.7 11.6 5.9 30.6 62.9 7.9 19.2 2.0 35.5 51.4 17.4 3.9 15.0 74.1 0.0 24.2 36.0 17.5 26.5 16.1 76.1 23.5 23.8 16.7 21.5 20.4 12.0 26.2 17.1 15.1 10.8 30.2 29.0 21.0 49.1 21.9 112.8 8.2 32.3 13.4 7.7 13.8 5.8 86.3 19.7 25.9 18.2 OCIAD1 "Asrij, FLJ20455, OCIA, TPA018" ENSG00000109180 "OCIA domain containing 1" Q9NX40 4 48805212-48861817 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044803 Approved Approved Mitochondria NA NA Mitochondria "HPA044803: AB_10961287" "unprognostic (8.18e-2)" "unprognostic (1.60e-2)" "unprognostic (4.82e-2)" "unprognostic (7.39e-2)" "unprognostic (1.69e-1)" "unprognostic (4.17e-2)" "unprognostic (2.53e-1)" "unprognostic (1.60e-1)" "unprognostic (4.10e-1)" "unprognostic (2.83e-3)" "unprognostic (1.34e-1)" "unprognostic (5.42e-2)" "unprognostic (1.47e-3)" "unprognostic (9.23e-2)" "unprognostic (2.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.16e-2)" 28.8 43.6 59.9 24.7 73.5 21.8 35.9 55.3 82.2 37.4 37.6 36.1 35.4 33.5 34.1 49.3 28.1 41.6 29.9 47.9 62.7 61.9 57.8 79.0 27.7 32.0 51.4 60.7 40.4 34.6 52.4 53.5 29.0 53.6 34.8 39.6 29.1 34.8 36.4 53.5 23.9 30.1 33.4 51.0 23.7 31.0 23.7 35.1 29.1 55.1 37.2 31.0 31.6 24.0 33.2 35.9 30.7 33.6 41.9 43.2 30.0 25.3 18.6 38.3 26.2 38.0 45.9 29.6 41.5 64.9 42.7 50.1 18.1 72.1 29.4 41.5 36.4 50.3 22.2 36.3 38.4 51.9 24.4 24.3 45.8 18.9 14.7 56.3 47.1 49.6 48.9 56.2 33.5 41.4 50.5 43.7 28.7 50.9 16.5 49.6 17.3 40.4 47.1 31.5 31.6 17.5 28.2 37.2 31.1 82.7 25.6 22.5 41.4 20.4 16.2 45.9 31.9 32.7 41.3 33.0 28.3 32.7 19.4 51.7 42.8 59.3 46.3 34.5 37.8 34.5 17.6 26.0 30.7 30.5 28.5 41.6 33.2 34.7 36.2 32.5 29.3 43.2 37.2 21.2 41.9 33.6 35.9 29.0 30.0 59.9 73.5 55.3 82.2 62.7 61.9 51.4 60.7 53.6 35.1 148.9 102.8 64.1 94.0 70.7 125.5 130.0 91.7 135.1 126.3 115.1 62.8 145.3 116.0 119.6 27.3 96.7 127.3 23.3 111.9 141.2 103.1 99.3 136.5 146.0 135.1 84.2 124.9 116.0 90.1 28.7 122.6 103.2 82.7 75.7 122.7 180.6 107.9 109.4 130.8 136.7 91.1 122.9 84.8 156.2 74.3 66.4 137.8 88.7 125.2 76.6 OCLM ENSG00000262180 Oculomedin Q9Y5M6 1 186400572-186401455 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 8.5" NA NA "unprognostic (1.83e-1)" "unprognostic (3.14e-2)" "unprognostic (3.23e-2)" "unprognostic (2.99e-2)" "unprognostic (2.70e-1)" "unprognostic (3.84e-2)" "unprognostic (7.14e-2)" "unprognostic (2.98e-1)" "unprognostic (1.94e-2)" "unprognostic (5.55e-2)" "unprognostic (1.98e-1)" "unprognostic (1.58e-2)" "unprognostic (2.36e-5)" "unprognostic (2.65e-1)" "unprognostic (1.79e-1)" "unprognostic (1.11e-1)" "unprognostic (5.81e-2)" 1.8 0.9 0.1 1.1 0.2 6.2 1.8 1.5 0.9 1.3 0.9 0.5 1.7 4.2 1.2 1.4 0.7 1.9 0.2 0.2 0.7 1.2 2.1 1.8 0.1 2.8 4.9 2.2 1.5 1.7 1.3 1.6 2.2 0.1 1.1 3.5 1.4 1.0 0.5 1.2 1.6 1.4 2.0 1.2 1.4 2.0 1.1 1.3 0.6 1.0 0.9 1.8 0.0 0.6 2.1 1.6 3.8 1.2 1.0 3.7 0.9 0.3 0.4 0.8 1.9 2.6 2.4 1.0 1.4 0.1 2.7 1.5 0.6 0.4 0.3 0.8 0.5 5.6 1.0 0.2 1.7 1.6 1.2 2.4 1.1 4.0 1.8 0.8 1.0 2.0 4.2 1.1 1.8 0.8 0.9 3.1 0.4 0.0 1.6 1.1 1.3 0.1 2.5 1.6 2.3 1.6 2.4 0.0 2.9 1.5 0.9 2.6 3.5 1.8 3.1 1.3 8.5 1.7 1.0 1.0 1.1 1.2 0.0 1.0 0.4 0.8 0.2 0.5 0.3 1.0 0.6 0.6 1.1 1.2 1.8 0.6 0.9 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OCLN PPP1R115 ENSG00000197822 Occludin Q16625 5 69492292-69558104 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 58.1" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 101.3;Urothelial cells: 183.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;CAPAN-2: 28.4;HaCaT: 22.9;MCF7: 22.6;RPTEC TERT1: 17.7;RT4: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005933, CAB013075, CAB068212, CAB068213, CAB068214" Enhanced Supported "Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA "Plasma membrane, Cell Junctions" "CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: AB_2665713, HPA005933: AB_1079520" "unprognostic (2.28e-1)" "unprognostic (1.88e-1)" "unprognostic (2.50e-2)" "unprognostic (9.94e-2)" "unprognostic (3.65e-1)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.08e-2)" "unprognostic (8.25e-2)" "unprognostic (8.20e-2)" "unprognostic (2.58e-2)" "unprognostic (3.48e-1)" "prognostic favorable (6.59e-11)" "unprognostic (2.83e-1)" "unprognostic (4.01e-1)" "unprognostic (1.33e-1)" "unprognostic (3.35e-1)" 1.2 0.8 3.4 3.8 3.7 0.5 7.6 3.9 2.9 4.3 15.5 3.2 21.9 10.2 1.7 7.4 10.6 7.9 17.1 1.1 4.0 2.9 15.3 31.7 29.2 0.4 4.0 1.7 2.3 33.2 12.0 3.2 9.0 6.7 5.7 10.9 7.7 7.1 25.0 0.5 8.7 24.5 1.2 3.8 2.1 15.1 2.0 1.5 0.4 58.1 9.8 8.6 5.0 6.5 1.2 1.2 1.8 0.3 2.0 0.9 0.1 15.4 6.2 0.1 0.5 0.2 0.4 12.5 0.0 1.5 2.1 3.1 21.3 28.4 0.1 5.4 0.3 7.8 22.9 6.3 3.0 5.8 0.1 11.1 1.2 0.2 6.5 0.1 0.5 1.6 0.0 3.2 4.8 0.2 1.1 1.2 2.1 0.0 0.1 0.0 22.6 0.6 0.4 2.4 6.8 2.6 0.0 4.7 0.5 17.7 19.3 2.1 1.0 0.1 16.9 0.2 4.4 9.5 1.9 0.2 0.1 6.4 1.3 1.5 0.3 0.1 0.1 0.1 0.1 0.1 0.8 0.3 0.7 0.8 0.2 0.2 0.8 0.9 0.3 0.1 1.2 0.7 0.9 1.8 2.0 0.2 1.2 0.4 0.1 3.4 3.7 3.9 2.9 4.0 2.9 4.0 1.7 6.7 1.5 101.3 47.6 3.2 51.5 3.3 6.0 1.3 56.0 48.2 55.7 24.4 13.7 26.5 8.3 49.2 2.0 5.3 55.1 0.0 52.8 1.2 3.2 76.5 2.3 42.9 2.6 6.4 25.2 16.0 25.3 1.1 2.8 2.6 1.7 5.4 35.4 3.5 63.1 47.2 1.4 11.3 6.2 12.9 2.7 4.2 7.8 13.6 13.7 4.9 33.9 183.7 OCSTAMP "C20orf123, dJ257E24.3" ENSG00000149635 "Osteoclast stimulatory transmembrane protein" Q9BR26 20 46540946-46550574 "Predicted membrane proteins, Transporters" Differentiation "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 6.9;blood: 2.6" "Cell type enriched" "Detected in single" 5 "Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 26 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 26 "dendritic cells: 2.6" "Cell line enhanced" "Detected in some" "AF22: 2.7;HMC-1: 5.2;Karpas-707: 3.0;NB-4: 5.7;RPMI-8226: 2.4;U-266/70: 1.9;U-266/84: 5.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA031116 Uncertain NA NA "HPA031116: AB_10600758" "unprognostic (2.77e-1)" "unprognostic (3.04e-1)" "unprognostic (8.80e-2)" "unprognostic (5.02e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-1)" "unprognostic (2.65e-1)" "unprognostic (9.59e-2)" "unprognostic (2.08e-1)" 6.9 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.1 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.1 0.2 0.6 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 5.7 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.9 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.4 0.0 0.1 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ODAPH "AI2A4, C4orf26, FLJ23657" ENSG00000174792 "Odontogenesis associated phosphoprotein" Q17RF5 4 75556048-75565885 "Disease related genes, Predicted secreted proteins" "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 10.4;placenta: 34.3" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 6.2;Syncytiotrophoblasts: 22.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 20 "basophil: 10.4" "Lineage enriched" "Detected in single" 24 "granulocytes: 10.4" "Cell line enriched" "Detected in some" 5 "HDLM-2: 31.1" "Secreted in other tissues" NA NA "unprognostic (1.13e-1)" "unprognostic (4.45e-3)" "unprognostic (3.78e-1)" "unprognostic (1.66e-1)" "unprognostic (6.12e-2)" "unprognostic (2.12e-2)" "unprognostic (1.75e-2)" "unprognostic (2.44e-1)" "unprognostic (3.87e-2)" "unprognostic (5.30e-2)" "unprognostic (3.43e-1)" "unprognostic (1.17e-7)" "unprognostic (8.31e-2)" "unprognostic (2.70e-2)" "unprognostic (8.40e-4)" "unprognostic (6.53e-3)" 0.3 0.1 1.5 0.4 1.9 0.6 0.2 1.2 0.9 0.3 0.2 0.2 0.2 0.1 0.3 0.4 0.4 0.1 0.3 0.2 1.9 1.5 0.3 0.4 0.3 0.5 2.4 0.2 0.4 0.2 0.0 1.3 34.3 0.7 0.2 0.5 0.2 0.2 0.3 1.6 0.9 0.3 0.2 2.7 0.4 0.3 0.8 0.4 0.2 0.2 0.2 0.7 0.2 0.2 0.4 0.1 10.4 0.2 0.2 0.3 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 31.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 1.4 0.0 1.3 0.1 0.1 0.0 0.0 1.4 0.1 0.4 5.6 0.0 0.1 0.3 0.2 0.0 10.4 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.1 1.5 1.9 1.2 0.9 1.9 1.5 2.4 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 6.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 ODF4 "CT136, OPPO1" ENSG00000184650 "Outer dense fiber of sperm tails 4" Q2M2E3 17 8339864-8346048 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 15.6" "Group enriched" "Detected in some" 84 "Early spermatids: 23.8;Late spermatids: 23.4;Spermatocytes: 24.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA072129 Enhanced NA NA "HPA072129: " "unprognostic (5.16e-2)" "unprognostic (5.13e-1)" "unprognostic (3.54e-4)" "unprognostic (3.64e-1)" "unprognostic (5.40e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.1 0.0 0.0 0.0 0.0 0.0 ODR4 "C1orf27, FLJ20505, odr-4, TTG1" ENSG00000157181 "Odr-4 GPCR localization factor homolog" Q5SWX8 1 186375838-186421378 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 28.6;Ciliated cells: 28.1;Club cells: 54.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015988, HPA031352" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA015988: AB_1845644, HPA031352: AB_2673838" "unprognostic (1.19e-2)" "unprognostic (4.23e-2)" "unprognostic (1.12e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (2.11e-1)" "unprognostic (8.57e-2)" "unprognostic (8.11e-3)" "prognostic favorable (9.92e-4)" "unprognostic (1.15e-2)" "unprognostic (9.85e-2)" "unprognostic (2.18e-2)" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (4.20e-2)" 11.9 15.9 18.2 7.0 22.9 12.2 13.7 27.7 18.7 13.9 10.3 11.4 16.2 12.5 9.6 16.6 9.5 9.1 10.3 11.8 14.3 11.3 16.1 20.0 10.4 6.1 21.9 14.0 12.1 26.5 44.8 26.5 13.4 16.0 16.1 12.8 9.7 18.3 15.3 10.3 9.5 14.8 9.0 21.3 10.1 12.8 8.1 19.1 9.0 19.0 10.1 6.9 10.4 9.7 4.1 8.6 4.4 11.8 10.6 6.2 4.6 7.5 8.5 9.5 7.5 11.6 11.1 18.0 12.4 7.9 8.1 8.0 16.7 17.5 5.4 14.8 6.1 7.3 19.5 6.9 6.6 7.8 4.7 7.1 5.0 10.9 9.5 10.7 8.3 6.3 8.4 13.5 9.4 15.2 8.5 8.6 5.6 18.9 11.0 9.8 8.0 5.9 8.2 13.1 29.4 2.9 6.7 6.4 14.8 16.0 7.7 6.8 10.6 9.4 20.3 14.4 17.5 17.7 7.2 7.9 11.3 7.1 7.8 11.5 13.4 8.1 8.4 6.3 4.5 10.2 1.5 10.5 2.7 3.8 10.0 5.5 4.1 4.8 5.0 8.6 3.1 6.0 4.6 4.4 10.6 11.8 5.4 6.2 4.6 18.2 22.9 27.7 18.7 14.3 11.3 21.9 14.0 16.0 19.1 26.8 28.6 0.0 0.0 0.0 0.0 0.0 0.0 28.1 54.6 24.4 0.0 20.7 8.3 18.4 0.0 0.0 0.0 0.0 22.2 19.9 0.0 0.0 11.6 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 11.8 0.0 0.0 21.7 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 OGFOD3 "C17orf101, FLJ22222" ENSG00000181396 "2-oxoglutarate and iron dependent oxygenase domain containing 3" Q6PK18 17 82389223-82418637 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052099 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA052099: AB_2681725" "unprognostic (1.12e-2)" "unprognostic (5.85e-2)" "unprognostic (9.66e-2)" "unprognostic (9.69e-2)" "unprognostic (4.11e-3)" "unprognostic (2.09e-1)" "unprognostic (2.80e-2)" "unprognostic (1.99e-1)" "unprognostic (5.41e-2)" "unprognostic (7.15e-2)" "unprognostic (8.05e-3)" "unprognostic (2.95e-1)" "prognostic favorable (5.72e-4)" "unprognostic (7.43e-2)" "unprognostic (1.40e-1)" "unprognostic (7.08e-2)" "unprognostic (1.02e-1)" 12.9 18.0 7.6 11.3 10.4 10.2 12.1 15.4 13.7 12.0 11.1 14.3 21.8 11.5 14.7 24.9 10.7 15.0 19.0 20.9 7.2 8.5 13.7 16.8 14.4 12.3 9.1 11.9 15.1 30.0 15.3 20.4 12.8 9.0 13.8 6.6 13.9 21.8 22.9 24.4 11.3 11.6 13.4 10.7 10.5 13.0 9.8 8.6 6.9 18.8 17.0 12.8 11.6 12.0 10.1 18.5 3.1 10.3 5.2 10.9 5.2 12.6 15.9 5.3 17.8 10.4 13.2 9.3 13.0 12.1 13.4 13.9 17.0 17.3 8.6 10.4 10.0 13.7 9.5 4.6 10.8 5.6 6.8 14.2 13.3 12.2 21.5 9.3 15.2 15.6 10.5 8.1 6.2 5.4 9.8 14.0 9.7 16.6 6.8 3.9 11.9 10.3 15.8 5.0 13.3 19.4 7.0 10.4 13.2 7.6 11.8 11.6 23.1 22.3 20.4 10.4 4.7 12.1 20.0 10.8 25.4 16.0 9.9 16.4 12.1 1.0 8.2 15.8 8.9 13.1 0.1 10.3 3.1 5.4 9.4 6.1 10.1 7.8 10.9 18.5 8.8 9.4 7.8 1.3 5.2 6.3 9.6 2.9 5.2 7.6 10.4 15.4 13.7 7.2 8.5 9.1 11.9 9.0 8.6 23.8 13.9 24.6 17.8 10.1 21.1 15.3 17.8 8.1 12.5 21.0 9.8 33.4 8.3 22.5 21.6 17.6 23.8 0.0 27.3 50.7 23.5 29.8 9.2 23.5 34.2 28.6 27.6 5.5 19.2 32.5 19.2 14.7 13.5 28.9 21.9 11.9 20.3 31.6 17.7 21.4 14.4 6.5 15.6 10.7 9.1 11.2 26.5 11.7 28.7 25.3 OLFML2B DKFZP586L151 ENSG00000162745 "Olfactomedin like 2B" Q68BL8 1 161983192-162023854 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 56.2;Hofbauer cells: 31.7;Kupffer cells: 20.4;Leydig cells: 19.2;Peritubular cells: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 8.8;non-classical monocyte: 6.5" "Lineage enriched" "Detected in single" 10 "monocytes: 8.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 16.0;HSkMC: 45.3;RH-30: 34.6" "Region enriched" "Detected in many" 6 "hippocampal formation: 45.1" "Low region specificity" "Detected in many" "HPA054136, HPA062739" Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA054136: AB_2682397, HPA062739: AB_2684858" "unprognostic (2.97e-2)" "unprognostic (1.79e-1)" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (6.01e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (5.97e-3)" "unprognostic (7.32e-2)" "unprognostic (7.68e-3)" "unprognostic (1.16e-1)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.01e-12)" "unprognostic (1.64e-3)" "unprognostic (2.11e-2)" "unprognostic (4.53e-3)" "unprognostic (1.97e-2)" 19.6 6.6 1.7 12.8 3.0 0.3 12.3 0.6 4.1 13.0 14.5 2.9 6.5 1.5 14.2 21.8 3.2 9.8 33.7 25.4 2.9 1.6 3.9 1.2 12.8 24.1 2.9 1.2 7.0 2.3 3.2 2.6 27.6 2.2 6.6 2.2 14.5 9.0 6.1 6.1 8.9 5.0 15.1 3.6 22.4 3.4 12.5 2.1 1.9 18.3 13.7 8.5 12.4 7.3 0.0 0.8 0.3 8.8 0.0 0.1 0.2 0.0 0.1 2.6 0.8 8.4 16.0 0.0 0.8 4.1 1.7 4.6 0.0 0.0 0.0 0.1 9.7 1.7 0.0 0.2 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.3 45.3 0.0 2.0 0.0 0.8 0.2 0.0 0.0 0.4 7.4 0.0 0.0 0.1 0.8 0.0 0.4 0.0 34.6 3.3 0.6 0.0 0.3 0.1 3.4 0.0 0.2 8.0 0.0 0.0 0.0 1.0 0.2 1.5 1.3 0.0 0.0 0.0 9.9 1.0 0.5 0.0 0.6 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.3 0.0 6.5 0.0 0.0 0.2 1.7 3.0 0.6 4.1 2.9 1.6 2.9 1.2 2.2 2.1 0.0 1.1 0.0 0.0 3.0 0.0 2.5 0.0 0.0 1.2 1.8 0.0 0.2 0.0 0.0 56.2 0.0 0.0 0.0 0.0 0.3 9.3 0.1 1.1 0.0 31.7 0.0 0.0 1.8 20.4 4.5 19.2 9.9 1.7 1.0 0.0 0.9 0.0 0.0 27.6 0.0 0.0 6.5 12.6 1.5 0.9 1.9 0.2 0.0 0.0 0.0 OLR1 "CLEC8A, LOX-1, SCARE1" ENSG00000173391 "Oxidized low density lipoprotein receptor 1" P78380 12 10158301-10172138 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;lung: 46.8;placenta: 53.4" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 386.0;Hofbauer cells: 209.3;Macrophages: 102.1;Syncytiotrophoblasts: 387.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.9" "Group enriched" "Detected in many" 6 "dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5" "Cell line enhanced" "Detected in some" "CACO-2: 32.7;HaCaT: 17.2;HHSteC: 34.6;hTCEpi: 15.9;SiHa: 65.9;SK-BR-3: 26.2" "Low region specificity" "Detected in all" HPA050798 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1060000 "Nucleoplasm, Plasma membrane" Vesicles "HPA050798: AB_2756318" "unprognostic (2.30e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "prognostic unfavorable (8.24e-5)" "unprognostic (6.34e-2)" "unprognostic (6.07e-3)" "unprognostic (5.40e-2)" "unprognostic (2.64e-1)" "unprognostic (1.97e-2)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (4.94e-3)" "unprognostic (3.47e-2)" "unprognostic (1.48e-2)" "unprognostic (1.42e-1)" 2.0 1.9 6.0 14.1 10.3 10.6 2.0 1.3 10.2 1.9 0.5 21.3 0.0 0.8 1.0 0.9 0.5 1.2 3.9 1.1 8.5 6.7 6.9 1.8 46.8 0.5 16.4 4.4 0.4 1.6 2.8 1.9 53.4 12.3 1.4 0.7 0.2 2.0 0.7 0.4 0.5 0.8 1.2 28.5 0.6 1.4 2.8 10.5 0.0 1.5 0.0 0.6 4.3 0.4 0.5 5.9 3.3 1.5 0.3 0.3 1.1 1.8 0.1 0.0 0.1 0.0 0.0 4.5 3.1 0.5 2.0 0.7 32.7 0.0 0.4 0.0 4.2 0.1 17.2 0.0 0.1 1.3 0.0 0.0 0.0 1.6 0.0 34.6 0.0 0.0 0.2 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 65.9 26.2 0.0 4.9 7.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 1.5 2.7 0.2 0.2 0.3 0.3 0.3 0.2 5.9 0.5 0.3 0.3 3.3 0.3 0.4 0.8 0.2 1.1 6.0 10.3 1.3 7.4 8.5 6.7 16.4 4.4 12.3 10.5 26.8 30.9 0.0 0.2 1.3 0.4 0.0 2.5 12.0 7.9 0.0 0.0 386.0 0.0 0.0 9.4 1.2 0.0 0.0 0.0 8.5 1.3 0.0 14.0 0.8 209.3 0.0 0.0 0.0 21.9 7.6 0.3 102.1 0.0 36.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 387.3 0.0 0.0 0.0 OMA1 "FLJ33782, MPRP-1, YKR087C, ZMPOMA1" ENSG00000162600 "OMA1 zinc metallopeptidase" Q96E52 1 58415384-58546802 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 54.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055120 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA055120: AB_2682702" "prognostic favorable (1.63e-4)" "unprognostic (2.67e-2)" "prognostic favorable (7.70e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-1)" "unprognostic (9.57e-2)" "unprognostic (3.94e-3)" "prognostic favorable (8.52e-4)" "unprognostic (8.22e-3)" "unprognostic (6.91e-2)" "unprognostic (4.10e-2)" "unprognostic (1.40e-1)" "unprognostic (9.54e-3)" "unprognostic (2.52e-2)" "unprognostic (3.93e-2)" "unprognostic (1.74e-2)" "unprognostic (5.24e-3)" 10.2 22.4 13.8 21.5 18.1 9.2 15.8 10.6 14.6 14.5 16.4 14.1 20.1 12.1 15.4 15.1 17.1 15.9 12.1 15.8 12.6 10.0 23.0 23.8 19.1 17.9 16.7 9.6 15.0 18.2 15.7 20.9 8.9 13.0 17.8 16.1 11.3 20.6 22.7 20.9 10.2 16.1 24.2 18.2 17.2 13.9 6.9 19.4 18.4 18.3 14.5 16.4 17.0 20.6 22.5 9.5 18.6 19.5 18.6 22.8 10.2 13.5 5.7 3.8 3.5 19.2 18.0 10.9 5.6 6.1 4.9 6.2 1.6 8.2 30.6 11.9 5.8 17.2 13.9 13.4 13.6 5.8 23.4 7.5 9.5 4.4 6.6 9.5 23.3 6.7 16.9 15.3 4.8 10.0 11.1 4.3 15.3 18.0 9.2 13.4 8.3 7.9 8.3 5.6 20.5 12.4 9.9 12.5 12.8 10.7 9.1 4.0 1.9 11.4 18.8 15.8 18.3 8.5 9.0 2.5 2.5 5.1 12.6 5.8 7.5 9.8 20.1 7.8 18.3 6.2 10.8 9.2 18.6 12.8 14.5 16.5 22.5 15.7 15.0 9.5 21.4 22.8 20.8 10.6 18.6 19.5 5.0 13.9 10.2 13.8 18.1 10.6 14.6 12.6 10.0 16.7 9.6 13.0 19.4 17.9 11.5 14.7 15.7 5.4 7.2 25.0 10.2 54.9 11.4 24.4 11.8 19.1 21.6 7.7 5.0 4.9 6.9 0.0 4.8 7.8 8.6 15.0 5.8 15.5 13.6 1.6 5.8 8.6 10.7 9.7 9.2 10.4 6.8 7.2 15.0 10.0 5.2 10.4 8.1 20.7 19.6 6.5 4.4 11.7 12.1 5.9 15.3 13.8 13.0 17.5 OMG OMGP ENSG00000126861 "Oligodendrocyte myelin glycoprotein" P23515 17 31272013-31297539 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 40 "brain: 89.6" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 335.9" "Group enriched" "Detected in some" 7 "endometrial cancer: 3.5;glioma: 9.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "HAP1: 3.6;U-87 MG: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008206, HPA012693" Enhanced "Intracellular and membrane" NA NA "HPA008206: AB_1854240, HPA012693: AB_1854239" "unprognostic (8.05e-4)" "unprognostic (2.11e-2)" "unprognostic (1.27e-1)" "unprognostic (3.03e-3)" "unprognostic (1.85e-1)" "unprognostic (4.16e-2)" "unprognostic (1.63e-1)" "unprognostic (3.81e-2)" "unprognostic (9.54e-2)" "unprognostic (8.60e-2)" "unprognostic (7.03e-2)" "unprognostic (1.52e-1)" "unprognostic (3.96e-13)" "unprognostic (7.80e-3)" "unprognostic (6.00e-2)" "unprognostic (3.24e-1)" "unprognostic (2.42e-2)" 1.6 1.8 25.2 1.6 25.4 2.2 1.6 10.2 89.6 1.6 1.7 20.3 0.0 1.7 1.6 1.6 1.6 1.6 1.6 1.6 26.8 20.6 1.6 1.6 1.6 1.6 30.8 23.2 1.6 1.6 1.6 0.1 1.6 36.8 1.6 1.7 1.4 1.6 1.6 1.7 1.6 1.7 1.6 23.0 1.7 1.6 1.6 39.6 0.0 1.6 0.0 1.6 1.6 0.0 0.0 0.1 1.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.2 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.6 1.4 0.0 0.7 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 25.2 25.4 10.2 34.1 26.8 20.6 30.8 23.2 36.8 39.6 0.0 3.0 0.0 0.0 0.3 3.7 0.7 0.0 335.9 6.8 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.4 0.0 0.0 1.3 11.2 0.0 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 9.8 0.7 0.0 0.0 OPALIN "HTMP10, TMEM10, TMP10" ENSG00000197430 "Oligodendrocytic myelin paranodal and inner loop protein" Q96PE5 10 96343216-96359365 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 43 "brain: 69.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 36 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "JURKAT: 1.2;MOLT-4: 2.2;REH: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014372 Supported NA NA "HPA014372: AB_2158172" "unprognostic (1.18e-1)" 1.5 1.5 35.0 1.5 42.1 1.6 1.5 2.8 69.7 1.5 1.5 52.5 0.0 1.5 1.5 1.5 1.5 1.5 1.5 1.5 40.1 15.1 1.5 1.5 1.5 1.5 19.9 17.8 1.5 1.5 1.5 0.0 1.5 13.8 1.5 1.5 0.0 1.5 1.5 1.5 1.5 1.5 1.5 17.8 1.5 1.5 1.5 29.5 0.0 1.5 0.0 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 42.1 2.8 33.4 40.1 15.1 19.9 17.8 13.8 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPCML "IGLON1, OBCAM, OPCM" ENSG00000183715 "Opioid binding protein/cell adhesion molecule like" Q14982 11 132414977-133532519 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 49.9" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 32.6;Early spermatids: 6.7;Late spermatids: 9.8;Sertoli cells: 6.5" "Group enriched" "Detected in some" 10 "glioma: 3.7;renal cancer: 0.7;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BJ: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 6300000 "unprognostic (1.59e-1)" "unprognostic (2.26e-2)" "unprognostic (3.70e-2)" "unprognostic (3.31e-4)" "unprognostic (8.23e-2)" "unprognostic (3.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (8.46e-3)" "unprognostic (2.59e-2)" "unprognostic (2.80e-1)" "unprognostic (4.73e-2)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" "unprognostic (1.76e-1)" "unprognostic (9.71e-2)" "unprognostic (2.19e-1)" 1.2 1.5 10.5 1.1 22.3 0.9 1.0 31.4 49.9 1.6 1.1 3.9 0.0 1.1 1.7 1.1 1.5 1.6 1.3 1.4 14.7 8.9 2.9 1.0 1.0 1.0 4.2 21.2 1.3 1.0 7.0 1.1 0.9 4.0 1.1 1.2 4.8 1.2 1.8 1.0 1.1 1.1 1.7 2.6 1.8 1.2 1.5 6.6 0.0 1.2 0.0 1.0 1.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 14.4 0.1 2.2 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 2.1 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.9 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.5 22.3 31.4 35.6 14.7 8.9 4.2 21.2 4.0 6.6 0.0 0.0 0.0 0.0 0.1 32.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 6.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.1 0.3 3.4 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN1LW "CBBM, CBP, COD5, RCP" ENSG00000102076 "Opsin 1, long wave sensitive" P04000 X 154144224-154159032 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 14.0" "Cell type enriched" "Detected in some" 29 "Cone photoreceptor cells: 683.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.05e-2)" 0.3 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.1 0.0 1.2 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 683.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OPN1MW "CBBM, CBD, COD5, GCP, OPN1MW1" ENSG00000268221 "Opsin 1, medium wave sensitive" P04001 X 154182596-154196135 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.5" "Cell type enriched" "Detected in single" 97 "Cone photoreceptor cells: 31.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.9" NA NA 0.0 0.6 1.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN1MW2 ENSG00000166160 "Opsin 1, medium wave sensitive 2" P0DN77 X 154219756-154233286 "Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 4 "skin 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN1MW3 ENSG00000269433 "Opsin 1, medium wave sensitive 3" P0DN78 X 154257538-154271805 "Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 4 "blood: 2.2;skin 1: 1.8" "Cell type enriched" "Detected in some" 12 "Cone photoreceptor cells: 17.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 2.2" "Lineage enriched" "Detected in single" 23 "T-cells: 2.2" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN1SW "BCP, BOP, CBT" ENSG00000128617 "Opsin 1, short wave sensitive" P03999 7 128772491-128775790 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 11.4;retina: 23.9" "Cell type enriched" "Detected in some" 12 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 37.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013562, HPA014083" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytokinetic bridge, Cytosol" "HPA013562: AB_2668850, HPA014083: AB_2668938" "unprognostic (2.88e-1)" "unprognostic (5.17e-2)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (8.50e-5)" "unprognostic (1.13e-1)" "unprognostic (1.27e-1)" "unprognostic (6.33e-2)" "unprognostic (3.79e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.26e-8)" "prognostic unfavorable (5.98e-8)" "unprognostic (2.53e-1)" "unprognostic (8.99e-2)" "prognostic unfavorable (9.33e-4)" 0.9 1.8 0.7 3.7 0.9 1.7 0.7 1.0 2.3 0.7 2.2 0.7 0.7 0.5 2.6 0.7 2.4 0.8 4.2 11.4 0.7 0.8 0.7 0.7 0.9 1.0 0.7 1.3 0.7 0.7 0.0 0.7 0.7 0.7 1.4 0.0 23.9 1.1 0.7 1.9 0.9 0.9 0.7 0.7 1.1 1.4 1.1 0.7 0.7 2.3 0.7 0.7 4.3 0.7 0.5 1.2 0.6 1.4 0.0 1.4 0.3 1.7 2.2 5.2 1.7 0.0 0.0 1.5 9.8 0.0 0.0 0.0 5.0 2.1 2.6 1.5 0.0 1.6 1.4 0.0 0.0 0.0 0.3 3.6 1.6 3.0 2.5 0.0 2.0 1.6 0.0 0.0 0.0 0.0 7.0 0.0 1.7 2.2 0.6 1.1 0.7 2.0 3.6 4.7 1.7 3.0 1.0 5.4 3.0 0.0 0.6 0.7 6.9 2.3 5.2 4.4 7.3 0.5 2.0 4.0 10.0 1.0 7.7 8.7 2.1 2.2 1.6 37.6 4.6 9.3 0.0 0.3 0.6 1.4 1.4 0.9 0.2 0.8 1.0 1.2 0.5 0.3 0.9 0.0 0.0 1.0 0.7 0.4 0.3 0.7 0.9 1.0 0.9 0.7 0.8 0.7 1.3 0.7 0.7 0.0 0.6 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 39.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OPN3 "ECPN, encephalopsin, ERO, NMO-1, PPP1R116" ENSG00000054277 "Opsin 3" Q9H1Y3 1 241590102-241677376 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 211.3;Syncytiotrophoblasts: 143.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 12.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 12.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 35.8" "Low region specificity" "Detected in all" "CAB013682, HPA064443" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB013682: , HPA064443: AB_2685267" "unprognostic (2.41e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (1.75e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (7.12e-2)" "unprognostic (5.10e-3)" "unprognostic (1.24e-2)" "unprognostic (2.39e-1)" "unprognostic (4.96e-1)" "unprognostic (2.66e-2)" "unprognostic (3.44e-1)" "unprognostic (9.13e-2)" "unprognostic (9.15e-3)" "unprognostic (2.61e-2)" "unprognostic (7.12e-2)" "unprognostic (9.44e-3)" 5.3 4.2 5.1 4.5 8.8 1.7 6.4 1.9 22.1 4.4 9.0 2.4 1.0 2.6 6.2 6.7 7.9 6.7 4.6 3.5 5.2 4.9 6.2 18.1 11.8 8.4 5.0 11.1 6.8 4.2 1.8 6.9 26.4 3.4 2.3 8.0 1.4 4.1 2.3 2.6 4.1 4.4 2.9 3.2 7.8 5.6 4.7 1.7 12.5 9.3 1.7 7.1 6.2 5.1 2.5 12.1 0.9 1.4 0.5 0.5 0.6 2.1 7.0 5.1 0.4 18.8 35.8 3.9 3.7 2.8 2.7 2.7 0.5 5.8 0.3 0.2 4.5 3.0 12.2 1.6 2.6 2.7 7.6 0.4 0.0 1.6 4.3 9.5 1.7 4.0 18.1 7.4 1.6 4.1 18.2 5.4 6.3 3.5 1.0 4.3 1.1 0.6 2.2 13.9 8.9 3.8 2.9 0.3 6.7 18.3 3.1 1.4 5.2 2.4 7.4 2.0 10.8 0.4 6.8 6.5 0.6 0.5 1.0 3.9 2.5 3.9 0.3 2.0 5.7 7.8 0.0 1.1 0.9 0.1 1.4 0.1 2.2 0.2 0.2 2.7 2.5 0.3 0.5 0.3 0.5 1.2 12.1 0.2 0.6 5.1 8.8 1.9 22.1 5.2 4.9 5.0 11.1 3.4 1.7 6.0 4.8 15.9 11.0 13.1 2.3 0.6 15.3 1.4 3.4 12.2 0.0 62.4 11.6 13.0 80.4 5.8 7.3 0.0 8.9 211.3 7.6 6.9 2.3 20.3 25.1 0.0 4.1 6.7 25.6 64.2 10.3 41.2 27.0 30.7 9.0 2.1 20.4 8.2 15.6 15.4 2.1 0.0 9.0 7.7 9.1 10.8 143.5 2.6 8.2 11.6 OPN4 "melanopsin, MOP" ENSG00000122375 "Opsin 4" Q9UHM6 10 86654557-86666848 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Biological rhythms, Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.2;skeletal muscle: 14.6" "Cell type enriched" "Detected in single" 34 "Cardiomyocytes: 3.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 21.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA039147 Approved NA NA "HPA039147: AB_10673304" "unprognostic (3.67e-3)" "unprognostic (1.40e-2)" "unprognostic (3.02e-2)" "unprognostic (1.62e-1)" "unprognostic (7.03e-3)" "unprognostic (2.89e-2)" "unprognostic (3.26e-1)" "unprognostic (9.54e-2)" "unprognostic (5.68e-2)" "unprognostic (8.88e-3)" "unprognostic (1.93e-6)" "unprognostic (4.10e-2)" "unprognostic (5.58e-2)" "unprognostic (6.76e-2)" 3.5 0.3 5.4 0.4 21.2 0.2 1.1 0.0 5.1 0.6 0.9 0.0 0.0 0.5 0.4 0.4 0.6 0.4 0.5 3.1 3.0 0.1 0.3 0.2 0.3 0.2 0.2 3.3 0.3 0.4 3.6 0.6 0.5 0.0 0.2 0.7 1.2 1.6 0.2 14.6 1.2 1.1 0.5 0.0 0.3 0.5 0.5 2.0 0.0 1.4 2.7 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 21.2 0.0 3.5 3.0 0.1 0.2 3.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN5 "dJ402H5.1, neuropsin, TMEM13" ENSG00000124818 "Opsin 5" Q6U736 6 47781982-47832780 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 7.3" "Group enriched" "Detected in some" 42 "Early spermatids: 22.0;Late spermatids: 19.1;Spermatocytes: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.0;Karpas-707: 1.0;SK-BR-3: 1.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 4 "hypothalamus: 1.3" HPA026084 Supported NA NA "HPA026084: AB_2671807" "unprognostic (1.95e-1)" "unprognostic (6.18e-2)" "unprognostic (4.84e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.6 0.2 0.0 0.0 0.0 0.0 0.0 OPRD1 ENSG00000116329 "Opioid receptor delta 1" P41143 1 28812142-28871267 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.7" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 3.4;Urothelial cells: 1.1" "Cancer enhanced" "Detected in single" "melanoma: 1.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "RH-30: 14.9;SCLC-21H: 5.9;SH-SY5Y: 5.9;WM-115: 19.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070831 Approved NA NA "HPA070831: AB_2732167" "unprognostic (1.44e-1)" "unprognostic (4.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.89e-2)" "unprognostic (2.68e-1)" "unprognostic (5.84e-3)" "unprognostic (6.28e-3)" "unprognostic (5.92e-2)" "unprognostic (1.82e-2)" "unprognostic (5.95e-3)" "unprognostic (4.28e-3)" "unprognostic (2.98e-1)" "unprognostic (1.52e-7)" "unprognostic (1.44e-2)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (2.18e-3)" 0.4 2.4 5.5 0.6 3.9 1.9 0.4 0.4 8.7 0.4 0.6 0.0 0.0 0.5 0.4 0.4 0.4 0.4 0.6 0.4 3.0 1.3 0.4 0.4 0.5 0.7 0.6 5.9 0.5 1.3 0.2 0.5 0.5 4.7 0.4 0.5 0.1 1.0 0.2 3.2 1.0 0.6 0.4 0.4 0.7 0.8 0.8 0.2 0.0 0.6 0.0 0.2 0.4 0.4 1.2 1.1 3.1 0.5 1.1 0.7 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.9 0.0 0.0 0.0 14.9 0.1 0.0 0.0 5.9 5.9 0.0 0.1 1.0 0.3 0.1 0.1 0.0 0.1 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.3 19.8 3.1 0.5 0.6 0.6 0.3 0.4 0.6 0.6 0.5 0.1 1.2 0.6 0.7 2.5 1.1 0.3 1.1 0.3 0.1 5.5 3.9 0.4 8.7 3.0 1.3 0.6 5.9 4.7 0.2 0.0 0.0 0.0 0.8 0.0 3.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.1 OPRK1 "KOR, OPRK" ENSG00000082556 "Opioid receptor kappa 1" P41145 8 53225716-53251697 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.0;prostate: 6.7" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 7.3;Leydig cells: 4.4" "Cancer enhanced" "Detected in some" "prostate cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "U-937: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067549 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA067549: AB_2732770" "unprognostic (1.01e-1)" "unprognostic (1.17e-2)" "unprognostic (8.70e-3)" "unprognostic (3.73e-2)" "unprognostic (6.74e-2)" "unprognostic (2.22e-3)" "unprognostic (8.09e-2)" "unprognostic (9.71e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" "unprognostic (3.35e-2)" "unprognostic (9.54e-4)" "unprognostic (1.61e-1)" 0.7 0.7 15.9 0.3 18.0 0.4 0.3 2.2 8.8 0.4 0.4 0.3 0.0 0.4 0.4 0.6 0.5 0.7 0.4 0.8 4.5 6.2 0.3 0.5 0.8 0.4 1.7 5.8 0.4 0.3 0.4 0.8 2.8 3.1 6.7 0.4 0.0 0.3 0.4 3.8 0.4 0.5 0.5 0.5 0.6 0.3 2.8 1.6 0.2 0.9 0.0 0.3 0.3 0.1 0.2 0.8 1.2 0.2 0.1 0.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 22.1 0.1 1.2 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.8 0.0 0.0 15.9 18.0 2.2 8.8 4.5 6.2 1.7 5.8 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 OPRL1 "KOR-3, NOCIR, NOPr, OOR, ORL1" ENSG00000125510 "Opioid related nociceptin receptor 1" P41146 20 64080173-64100643 "G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.9;brain: 17.5" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 10.8;Kupffer cells: 5.7;Late spermatids: 23.7;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 3.7;eosinophil: 5.6;intermediate monocyte: 5.6;myeloid DC: 4.9;neutrophil: 4.9;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 8 "dendritic cells: 4.9;granulocytes: 5.6;monocytes: 11.9" "Cell line enhanced" "Detected in many" "REH: 6.1;SCLC-21H: 10.4;U-937: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.03e-3)" "unprognostic (4.78e-2)" "unprognostic (4.35e-3)" "unprognostic (3.74e-1)" "unprognostic (4.13e-2)" "unprognostic (9.63e-2)" "unprognostic (2.13e-4)" "unprognostic (1.53e-1)" "unprognostic (1.67e-1)" "unprognostic (2.91e-1)" "unprognostic (2.66e-4)" "unprognostic (1.47e-1)" "unprognostic (1.12e-4)" "unprognostic (1.99e-2)" "unprognostic (4.17e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-3)" 2.1 2.6 4.7 2.9 9.4 3.6 1.5 6.0 17.5 1.7 0.8 3.6 0.7 1.1 1.7 1.4 0.9 1.4 1.8 0.9 4.5 8.9 1.6 1.1 2.5 6.3 3.9 0.9 1.1 4.2 0.8 1.5 2.4 4.0 1.3 0.8 0.2 5.0 1.2 0.7 0.7 1.4 1.1 2.7 8.2 0.9 9.2 1.5 1.9 0.8 0.3 5.2 1.6 1.3 0.9 4.9 5.6 11.9 0.0 0.4 1.8 0.0 0.8 1.1 4.5 3.3 1.0 0.6 0.2 0.3 0.1 0.4 0.2 1.0 1.7 0.6 0.8 3.6 0.0 0.1 0.0 0.0 1.0 0.0 1.5 0.0 0.3 0.1 4.4 0.8 1.1 0.2 0.0 0.1 0.3 1.8 2.2 0.3 1.5 0.0 0.1 0.4 2.4 0.3 0.5 1.9 6.1 0.0 0.2 0.0 0.0 10.4 3.5 0.0 0.0 0.0 1.7 0.4 4.2 0.4 0.4 0.3 0.0 0.0 0.2 0.8 3.0 0.6 11.6 0.4 0.0 3.7 5.6 0.2 5.6 0.4 0.7 0.3 0.1 4.9 0.9 0.2 0.0 4.9 0.0 11.9 0.5 0.4 1.8 4.7 9.4 6.0 11.9 4.5 8.9 3.9 0.9 4.0 1.5 0.0 1.4 3.5 0.1 0.7 0.2 1.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 10.8 0.3 0.0 0.0 0.0 0.1 0.5 0.3 1.1 0.0 2.6 3.2 0.0 1.3 5.7 23.7 0.0 1.3 0.0 3.6 0.0 0.2 0.3 0.0 0.0 0.0 0.1 6.5 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 OPRM1 MOR1 ENSG00000112038 "Opioid receptor mu 1" P35372 6 154010496-154246867 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 37.9" "Group enriched" "Detected in some" 33 "Early spermatids: 24.0;Late spermatids: 23.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 37.9" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 24 "SH-SY5Y: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014509, HPA067435" Enhanced Supported NA NA "HPA014509: AB_1854801, HPA067435: " "unprognostic (7.34e-2)" "unprognostic (6.91e-2)" 0.5 3.4 7.0 0.6 17.5 1.8 0.9 37.9 7.6 0.5 0.6 0.8 0.0 0.6 0.7 1.4 3.7 0.5 1.0 0.5 2.6 2.3 0.5 0.5 0.5 0.9 0.6 9.3 0.8 0.7 0.4 0.6 0.5 5.2 0.7 0.4 0.0 0.6 0.2 0.9 1.8 0.5 0.3 1.9 0.6 1.0 8.0 0.5 0.0 1.0 0.0 0.3 0.5 0.5 0.5 0.2 2.1 0.1 0.1 0.7 0.0 0.1 0.0 0.2 0.4 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.2 0.4 0.4 0.1 0.0 0.5 0.3 0.3 0.2 0.1 0.3 0.1 0.1 0.4 0.1 0.0 0.3 0.5 0.1 0.5 0.0 0.1 0.0 0.1 0.2 0.1 0.3 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.3 13.1 0.0 0.1 0.3 0.4 0.3 0.1 0.3 0.4 0.1 0.3 0.1 0.4 0.2 0.1 0.3 0.1 0.0 0.2 0.1 0.6 0.6 0.0 0.7 0.2 0.3 0.5 0.1 0.5 0.4 0.1 2.1 0.1 0.0 0.2 0.3 0.0 7.0 17.5 37.9 7.6 2.6 2.3 0.6 9.3 5.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.5 0.0 0.1 OR10A2 "OR10A2P, OST363" ENSG00000170790 "Olfactory receptor family 10 subfamily A member 2" Q9H208 11 6863057-6874717 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.9" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.9" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (5.04e-2)" 0.0 0.3 0.2 0.4 0.6 1.0 0.0 0.0 0.3 0.2 0.0 0.5 0.2 0.0 0.0 0.2 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.8 0.0 0.0 0.2 0.4 0.0 0.6 0.1 0.1 0.3 0.0 0.6 0.8 2.9 0.4 0.5 0.3 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.3 0.1 0.8 0.1 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.6 0.3 0.5 0.3 0.0 0.8 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.8 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.2 0.2 0.1 0.1 0.8 0.3 0.0 0.4 0.6 0.0 0.4 0.5 0.0 0.3 0.1 0.4 0.2 0.0 0.4 0.2 0.2 0.4 0.1 0.3 1.2 0.4 0.3 0.3 0.2 0.2 0.4 0.2 0.1 0.0 0.6 0.3 0.3 2.9 0.5 0.3 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A3 "HSHTPCRX12, HTPCRX12" ENSG00000170683 "Olfactory receptor family 10 subfamily A member 3" P58181 11 7937171-7941708 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.2;bone marrow: 1.4;skin 1: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.2" "Cell line enhanced" "Detected in some" "A-431: 2.2;HMC-1: 2.8" NA NA "unprognostic (2.53e-2)" "unprognostic (3.24e-3)" 0.1 0.1 0.0 0.2 0.0 1.4 0.4 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 1.8 0.2 0.0 0.0 0.4 0.3 0.2 0.1 0.0 0.9 0.1 0.5 0.4 2.2 0.3 0.2 0.3 0.1 2.2 0.2 0.0 0.4 0.0 0.5 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.8 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.2 0.8 0.3 0.4 0.2 0.5 0.2 0.1 0.2 0.3 0.2 0.1 0.0 0.3 0.3 0.3 0.6 0.5 0.1 0.2 0.1 0.0 0.3 0.1 0.2 0.3 0.3 0.0 0.1 0.1 0.1 0.3 0.1 2.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.1 0.5 0.2 0.3 1.7 0.2 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A4 OR10A4P ENSG00000170782 "Olfactory receptor family 10 subfamily A member 4" Q9H209 11 6876625-6877619 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.4" "Cell line enriched" "Detected in single" 4 "NTERA-2: 1.6" "Not detected" "Not detected" NA NA "unprognostic (1.16e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A5 "JCG6, OR10A1, OR11-403" ENSG00000166363 "Olfactory receptor family 10 subfamily A member 5" Q9H207 11 6845652-6846705 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.14e-5)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A6 ENSG00000279000 "Olfactory receptor family 10 subfamily A member 6 (gene/pseudogene)" Q8NH74 11 7924592-7931268 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "skin 1: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.1;Karpas-707: 1.2;LHCN-M2: 2.4;RPMI-8226: 2.3" NA NA 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 1.2 2.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 2.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A7 ENSG00000179919 "Olfactory receptor family 10 subfamily A member 7" Q8NGE5 12 55221025-55221975 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055111 Uncertain NA NA "HPA055111: AB_2682698" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10AD1 OR10AD1P ENSG00000172640 "Olfactory receptor family 10 subfamily AD member 1" Q8NGE0 12 48202083-48203387 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;K-562: 1.2;U-937: 4.2" HPA049913 Uncertain NA NA "HPA049913: AB_2680950" "unprognostic (2.90e-1)" "unprognostic (2.79e-1)" "unprognostic (2.67e-2)" "unprognostic (1.70e-2)" "unprognostic (6.43e-2)" "unprognostic (1.36e-1)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "unprognostic (7.10e-2)" "unprognostic (1.17e-1)" "unprognostic (3.08e-2)" "unprognostic (1.74e-1)" 0.0 2.5 0.2 1.7 0.5 0.2 0.0 1.9 0.6 0.3 0.6 1.0 0.6 0.0 0.6 0.6 0.1 0.2 0.1 0.3 0.4 0.0 0.3 1.6 0.0 1.4 0.3 0.0 2.9 0.4 0.7 0.0 0.7 0.0 0.3 0.9 0.7 0.0 0.0 0.9 0.6 2.5 1.5 0.0 0.6 0.3 0.0 0.0 0.0 0.4 0.2 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.3 0.2 1.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.3 0.6 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.3 0.0 0.0 0.4 0.0 0.0 1.0 0.9 0.1 0.0 4.2 0.1 0.0 0.4 0.0 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.8 0.7 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10AG1 ENSG00000174970 "Olfactory receptor family 10 subfamily AG member 1" Q8NH19 11 55965755-55969945 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10C1 "hs6M1-17, OR10C1P, OR10C2" ENSG00000206474 "Olfactory receptor family 10 subfamily C member 1 (gene/pseudogene)" Q96KK4 6 29439306-29440977 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049336 Uncertain NA NA "HPA049336: AB_2680718" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10D3 "HTPCRX09, OR10D3P" ENSG00000197309 "Olfactory receptor family 10 subfamily D member 3 (putative)" Q8NH80 11 124183345-124188780 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "testis: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G2 ENSG00000255582 "Olfactory receptor family 10 subfamily G member 2" Q8NGC3 14 21633836-21634940 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "GAMG: 1.4" "Not detected" "Not detected" NA NA "unprognostic (7.80e-3)" 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 1.8 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G3 ENSG00000169208 "Olfactory receptor family 10 subfamily G member 3" Q8NGC4 14 21568520-21580076 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "blood: 3.4;bone marrow: 2.0;pituitary gland: 4.3;skin 1: 1.2" "Cell type enhanced" "Detected in some" 29 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 18.9;Club cells: 4.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.1" "Not detected" "Not detected" HPA019766 Uncertain NA NA "HPA019766: AB_1854780" 0.3 0.4 0.0 0.2 0.0 2.0 0.2 0.0 0.2 0.1 0.1 0.0 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 4.3 0.0 0.0 0.1 0.0 0.0 0.2 1.2 0.6 0.0 0.0 0.1 0.2 0.6 0.1 0.0 0.0 0.0 1.0 0.9 3.4 1.0 0.7 0.7 0.0 0.1 0.0 0.7 0.7 0.0 0.0 0.6 0.5 0.0 0.0 0.0 2.1 0.6 0.8 0.1 0.0 0.3 0.4 0.7 0.0 0.3 0.6 0.0 0.0 0.8 0.0 0.0 0.7 0.3 0.0 0.0 0.0 1.0 0.7 0.4 0.9 0.1 0.4 0.4 0.0 0.6 0.4 0.6 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 1.0 0.5 1.2 0.0 0.0 0.9 0.6 0.9 0.1 0.2 0.2 0.2 0.6 0.5 0.3 0.9 1.0 0.5 0.6 0.2 0.3 0.4 0.5 0.4 0.2 1.0 0.7 0.5 3.4 0.7 0.3 0.9 0.3 0.0 6.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G4 ENSG00000254737 "Olfactory receptor family 10 subfamily G member 4" Q8NGN3 11 124012997-124018732 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 2.7;pancreas: 3.7" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 1.4;Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 3.0" NA NA 0.1 0.2 0.1 0.1 0.1 2.7 0.1 0.1 0.1 0.1 0.3 0.3 0.1 0.5 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.2 3.7 0.1 0.1 0.1 0.1 0.5 0.1 0.0 0.5 0.7 0.4 0.0 0.1 0.4 0.1 0.6 0.2 0.0 0.2 0.1 1.2 0.5 1.6 0.6 0.5 0.5 0.1 0.3 0.1 0.4 0.3 0.5 0.1 0.5 0.4 0.0 0.1 0.0 0.4 0.3 0.0 0.4 0.2 0.4 0.2 0.1 0.0 0.1 0.6 1.0 1.5 1.6 0.9 0.1 0.6 3.0 0.0 0.5 0.0 0.1 0.3 0.3 0.1 0.3 1.4 0.0 1.1 0.2 1.6 1.2 0.4 1.0 0.1 0.4 0.4 0.0 1.2 0.5 0.2 0.2 0.3 0.2 0.5 0.2 0.5 0.5 0.6 0.3 0.8 0.1 0.7 0.5 0.2 0.2 1.4 0.2 0.7 0.5 0.8 0.5 0.2 0.3 0.5 0.5 0.5 0.3 1.2 0.5 0.5 1.6 0.5 0.6 0.5 0.3 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G6 "OR10G6P, OR10G6Q" ENSG00000198674 "Olfactory receptor family 10 subfamily G member 6" Q8NH81 11 123994163-123995161 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "pancreas: 1.7" "Cell type enriched" "Detected in single" 17 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G7 ENSG00000182634 "Olfactory receptor family 10 subfamily G member 7" Q8NGN6 11 124036013-124041325 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 4 "pancreas: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G8 ENSG00000234560 "Olfactory receptor family 10 subfamily G member 8" Q8NGN5 11 124026798-124030634 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "HUVEC TERT2: 1.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G9 OR10G10P ENSG00000236981 "Olfactory receptor family 10 subfamily G member 9" Q8NGN4 11 124023013-124023948 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10H1 ENSG00000186723 "Olfactory receptor family 10 subfamily H member 1" Q9Y4A9 19 15804549-15815664 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.7;urinary bladder: 6.1" "Group enriched" "Detected in some" 60 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 43.2;Ciliated cells: 37.5;Club cells: 54.6;granulocytes: 36.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 8.0" NA NA "unprognostic (3.29e-1)" "unprognostic (1.97e-3)" "unprognostic (4.18e-1)" "unprognostic (1.63e-2)" "unprognostic (2.38e-1)" "unprognostic (9.30e-2)" 0.4 0.3 0.3 0.4 0.3 2.3 0.5 0.3 0.8 0.3 0.3 1.1 0.3 1.3 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.6 0.3 0.2 0.4 0.0 0.9 0.2 0.4 0.0 2.1 1.8 0.6 0.2 0.3 0.3 0.3 1.8 0.3 0.1 6.1 0.4 1.1 1.0 3.7 0.7 1.2 0.7 0.1 1.1 0.5 1.2 0.9 0.1 0.5 1.2 1.6 0.0 0.2 0.2 0.5 2.0 1.2 1.3 0.4 1.9 1.0 0.4 0.6 0.3 0.9 0.6 1.7 1.5 0.6 0.2 1.0 2.1 0.4 0.2 0.4 0.4 1.6 0.0 1.1 0.7 2.7 0.3 0.3 0.7 1.1 1.2 1.0 0.6 0.9 0.9 0.7 0.6 8.0 0.7 0.7 3.0 0.9 0.9 1.4 0.5 0.5 1.6 2.4 2.1 1.1 1.6 1.4 0.9 1.1 1.0 0.7 0.7 3.7 0.7 0.6 0.5 0.4 0.6 0.6 0.5 0.4 0.2 1.1 0.6 0.7 3.7 1.2 0.4 1.0 0.4 0.1 53.6 43.2 0.0 0.0 0.0 0.0 0.0 0.0 37.5 54.6 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 OR10H2 ENSG00000171942 "Olfactory receptor family 10 subfamily H member 2" O60403 19 15728020-15729060 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.2 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10H3 ENSG00000171936 "Olfactory receptor family 10 subfamily H member 3" O60404 19 15737985-15742343 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10H4 ENSG00000176231 "Olfactory receptor family 10 subfamily H member 4" Q8NGA5 19 15944299-15950350 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10H5 ENSG00000172519 "Olfactory receptor family 10 subfamily H member 5" Q8NGA6 19 15787661-15801025 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.3" "Group enriched" "Detected in some" 19 "Alveolar cells type 2: 1.7;Ciliated cells: 2.7;Club cells: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA 0.2 0.3 0.4 0.4 0.3 2.5 0.2 0.4 0.8 0.3 0.2 0.5 0.2 0.5 0.3 0.3 0.3 0.2 0.4 0.6 0.2 0.2 0.2 0.5 0.4 0.4 0.3 0.0 0.5 0.1 0.2 0.4 0.2 0.0 2.2 1.7 0.4 0.0 0.3 0.4 0.3 1.1 0.4 0.1 1.0 0.2 1.5 1.2 4.3 0.9 1.2 0.7 0.1 0.9 0.8 1.0 1.3 0.9 0.4 1.7 0.7 0.1 0.3 0.4 0.7 1.5 1.3 0.5 0.4 0.7 0.9 1.1 0.8 0.2 0.7 1.4 1.2 2.8 0.9 0.2 1.6 1.3 0.5 0.3 0.5 0.4 0.5 0.3 1.2 0.8 1.9 0.1 1.6 0.7 1.8 0.7 0.3 0.5 1.0 0.3 0.7 0.4 1.4 1.0 0.8 1.0 1.0 0.6 1.0 1.0 0.9 0.9 1.3 1.2 1.3 0.9 1.3 0.5 1.0 1.1 1.6 1.0 4.3 0.9 0.7 0.6 0.5 0.4 0.6 0.5 0.4 0.2 1.5 0.6 0.7 3.3 1.2 0.5 1.2 0.4 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10J1 "HGMP07J, HSHGMP07J" ENSG00000196184 "Olfactory receptor family 10 subfamily J member 1" P30954 1 159437845-159443078 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 10.9" "Group enriched" "Detected in some" 47 "Early spermatids: 31.7;Late spermatids: 34.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 1.1;RT4: 1.1" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.8 0.4 2.4 0.5 0.5 0.5 0.2 0.2 0.5 0.3 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.6 0.7 0.3 0.0 0.4 0.2 0.1 0.0 0.0 0.4 0.0 0.1 0.3 0.8 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.2 1.1 0.0 0.5 0.3 0.2 0.2 0.0 0.0 0.2 0.2 1.0 0.1 1.1 0.1 0.0 0.1 0.3 0.0 0.1 0.4 0.3 0.0 0.6 0.6 0.2 0.4 0.3 0.2 0.3 0.4 0.2 0.3 2.4 0.5 0.4 0.3 0.2 0.2 0.3 0.3 0.3 0.1 0.8 0.3 0.5 2.1 0.5 0.5 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 OR10J3 OR10J3P ENSG00000196266 "Olfactory receptor family 10 subfamily J member 3" Q5JRS4 1 159313670-159314659 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "placenta: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "LHCN-M2: 5.6" HPA042963 Uncertain NA NA "HPA042963: AB_10961176" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10J5 ENSG00000184155 "Olfactory receptor family 10 subfamily J member 5" Q8NHC4 1 159535078-159536007 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "liver: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10K1 ENSG00000173285 "Olfactory receptor family 10 subfamily K member 1" Q8NGX5 1 158461574-158470857 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.4;esophagus: 2.9" "Group enriched" "Detected in some" 149 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 13.9;Ciliated cells: 22.7;Club cells: 9.1;granulocytes: 8.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA059125 Uncertain NA NA "HPA059125: AB_2683913" 0.2 0.4 0.2 0.8 0.3 2.0 0.2 0.2 0.4 0.7 0.3 0.2 0.3 0.8 2.9 0.2 0.2 0.3 0.2 0.2 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.3 0.0 0.2 0.0 0.2 0.0 1.6 0.4 0.3 0.0 0.3 0.5 0.3 0.9 0.2 1.0 0.8 0.3 1.4 0.5 2.4 0.6 0.9 1.2 0.1 1.2 1.0 1.0 1.0 0.7 0.6 1.3 0.7 0.5 0.1 0.4 0.6 0.9 1.2 1.8 0.3 2.8 1.0 0.4 0.4 1.5 1.6 0.4 1.3 1.1 0.8 0.3 0.9 1.6 0.1 0.1 0.9 0.4 0.7 0.1 0.6 0.9 3.8 0.1 0.4 1.2 1.6 2.1 0.2 0.2 1.0 0.5 0.8 0.0 0.9 0.8 1.2 0.8 0.4 2.0 0.9 0.9 1.1 0.4 1.2 2.2 2.1 0.9 2.1 1.6 1.0 0.7 1.0 1.9 1.6 0.6 0.2 1.2 0.5 1.2 0.7 0.9 1.0 0.3 1.4 0.9 1.0 2.4 0.9 0.4 0.5 0.8 0.1 20.8 13.9 0.0 0.0 0.0 0.0 0.0 0.0 22.7 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10K2 ENSG00000180708 "Olfactory receptor family 10 subfamily K member 2" Q6IF99 1 158418210-158426237 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "blood: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "MCF7: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA059125 Uncertain NA NA "HPA059125: AB_2683913" 0.1 0.1 0.1 0.3 0.0 0.4 0.1 0.1 0.3 0.1 0.1 0.4 0.1 0.7 0.1 0.4 0.2 0.1 0.1 0.1 0.5 0.1 0.1 0.2 0.0 0.6 0.7 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.5 0.3 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.7 0.2 1.2 0.2 0.4 0.4 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.5 0.5 2.2 0.2 0.2 0.2 0.5 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.1 0.2 0.1 0.4 0.8 0.1 0.3 0.0 0.0 0.9 0.1 0.1 0.2 0.1 0.2 0.6 0.1 0.2 0.0 0.7 0.3 0.4 1.2 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10P1 "OR10P1P, OR10P2P, OR10P3P, OST701" ENSG00000175398 "Olfactory receptor family 10 subfamily P member 1" Q8NGE3 12 55636860-55637854 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 2.0;heart muscle: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.0;T-reg: 1.7" "Lineage enriched" "Detected in single" 7 "T-cells: 2.0" "Cell line enhanced" "Detected in single" "THP-1: 2.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA074114 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA074114: " 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10Q1 ENSG00000180475 "Olfactory receptor family 10 subfamily Q member 1" Q8NGQ4 11 58227882-58228918 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 1.3;placenta: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HHSteC: 1.2" "Not detected" "Not detected" HPA046968 Uncertain NA NA "HPA046968: AB_2679881" "unprognostic (4.82e-1)" "unprognostic (6.34e-2)" "unprognostic (4.37e-1)" 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.0 1.4 0.0 0.3 0.6 0.0 0.7 0.2 0.5 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10R2 OR10R2Q ENSG00000198965 "Olfactory receptor family 10 subfamily R member 2" Q8NGX6 1 158472220-158480936 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "thyroid gland: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "MOLT-4: 26.4" "HPA059775, HPA060399" Uncertain NA NA "HPA059775: AB_2684124, HPA060399: AB_2684276" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10S1 ENSG00000196248 "Olfactory receptor family 10 subfamily S member 1" Q8NGN2 11 123976661-123977781 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "thyroid gland: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.4;hTCEpi: 3.1" "Not detected" "Not detected" HPA019038 Uncertain NA NA "HPA019038: AB_1854785" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10T2 ENSG00000186306 "Olfactory receptor family 10 subfamily T member 2" Q8NGX3 1 158398522-158399466 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "JURKAT: 1.6;MCF7: 1.2;MOLT-4: 4.0;SCLC-21H: 3.7" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.2 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10V1 ENSG00000172289 "Olfactory receptor family 10 subfamily V member 1" Q8NGI7 11 59712916-59713845 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "NTERA-2: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA060076 Uncertain NA NA "HPA060076: AB_2684198" 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10W1 OR10W1P ENSG00000172772 "Olfactory receptor family 10 subfamily W member 1" Q8NGF6 11 58266792-58268260 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.61e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10X1 OR10X1P ENSG00000279111 "Olfactory receptor family 10 subfamily X member 1 (gene/pseudogene)" Q8NGY0 1 158578919-158579899 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "bone marrow: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10Z1 ENSG00000198967 "Olfactory receptor family 10 subfamily Z member 1" Q8NGY1 1 158605268-158612514 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "bone marrow: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "K-562: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.9 0.1 0.2 0.0 0.1 1.0 0.3 0.1 0.0 0.3 0.0 0.0 0.6 0.0 0.1 0.1 0.2 0.3 4.8 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.8 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11A1 "hs6M1-18, OR11A2" ENSG00000204694 "Olfactory receptor family 11 subfamily A member 1" Q9GZK7 6 29425504-29457071 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.1" "Group enriched" "Detected in some" 73 "Early spermatids: 29.0;Late spermatids: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 1.3;U-2197: 1.7" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.3 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 1.1 0.1 0.4 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 1.3 0.1 0.2 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OR11G2 ENSG00000196832 "Olfactory receptor family 11 subfamily G member 2" Q8NGC1 14 20190894-20201075 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 5 "blood: 5.9" "Group enriched" "Detected in some" 57 "Alveolar cells type 2: 7.4;Ciliated cells: 4.0;Club cells: 5.7;granulocytes: 5.8" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "neutrophil: 5.9" "Lineage enriched" "Detected in single" 12 "granulocytes: 5.9" "Cell line enriched" "Detected in single" 14 "HEL: 7.2" NA NA 0.4 0.2 0.1 0.4 0.1 1.0 0.1 0.1 0.2 0.3 0.1 0.4 0.3 0.6 0.1 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.4 0.0 0.1 0.2 0.2 0.0 0.5 0.0 0.5 0.8 0.2 0.0 0.1 0.7 0.2 1.2 0.4 0.0 0.2 0.1 0.3 0.2 5.9 0.3 0.4 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.2 7.2 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.8 0.3 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.2 0.2 5.9 0.4 0.2 0.2 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11H1 OR22-1 ENSG00000130538 "Olfactory receptor family 11 subfamily H member 1" Q8NG94 22 15528159-15529139 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047370 Uncertain NA NA "HPA047370: AB_2680016" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11H12 ENSG00000257115 "Olfactory receptor family 11 subfamily H member 12" B2RN74 14 18601045-18602129 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "AN3-CA: 1.0;JURKAT: 1.2" HPA047370 Uncertain NA NA "HPA047370: AB_2680016" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11H2 "C14orf15, OR11H2P, OR11H8P" ENSG00000258453 "Olfactory receptor family 11 subfamily H member 2" Q8NH07 14 19712904-19714332 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A549: 1.6" HPA047370 Uncertain NA NA "HPA047370: AB_2680016" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11H4 ENSG00000176198 "Olfactory receptor family 11 subfamily H member 4" Q8NGC9 14 20239286-20244349 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skin 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 1.1;U-266/70: 1.5" "Not detected" "Not detected" HPA052790 Uncertain NA NA "HPA052790: AB_2681950" 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11H6 ENSG00000176219 "Olfactory receptor family 11 subfamily H member 6" Q8NGC7 14 20223710-20224702 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11L1 ENSG00000197591 "Olfactory receptor family 11 subfamily L member 1" Q8NGX0 1 247840928-247841896 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "thyroid gland: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR12D2 hs6M1-20 ENSG00000280236 "Olfactory receptor family 12 subfamily D member 2 (gene/pseudogene)" P58182 6 29395631-29398008 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR12D3 hs6M1-27 ENSG00000112462 "Olfactory receptor family 12 subfamily D member 3" Q9UGF7 6 29373423-29375291 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13A1 ENSG00000256574 "Olfactory receptor family 13 subfamily A member 1" Q8NGR1 10 45302298-45315608 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.3;urinary bladder: 4.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.8" "Cell type enhanced" "Detected in single" "memory B-cell: 2.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 34 "Daudi: 13.5;U-698: 12.5" "Not detected" "Not detected" HPA057237 Uncertain NA NA "HPA057237: AB_2683378" "unprognostic (7.88e-2)" "unprognostic (1.90e-1)" "unprognostic (5.52e-2)" "unprognostic (2.33e-5)" "unprognostic (6.43e-3)" "unprognostic (6.04e-2)" "unprognostic (8.65e-2)" "unprognostic (3.59e-1)" "unprognostic (2.45e-1)" "unprognostic (2.54e-2)" "unprognostic (1.31e-1)" "unprognostic (1.67e-15)" "unprognostic (6.54e-2)" "unprognostic (2.87e-1)" "unprognostic (8.55e-2)" "unprognostic (4.09e-3)" 0.0 0.0 0.1 0.4 0.2 0.5 0.1 1.9 0.1 0.0 0.2 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.4 2.2 0.2 0.1 0.2 0.0 0.0 0.0 0.9 0.3 0.5 0.0 0.3 0.0 1.6 0.0 0.4 2.3 0.2 0.3 0.0 2.0 4.2 0.3 2.0 0.0 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.2 0.0 0.0 0.1 0.3 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 OR13C2 ENSG00000276119 "Olfactory receptor family 13 subfamily C member 2" Q8NGS9 9 104604671-104605627 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "ASC diff: 1.5" NA NA 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.2 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13C3 ENSG00000204246 "Olfactory receptor family 13 subfamily C member 3" Q8NGS6 9 104535749-104536856 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "testis: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.4" "Not detected" "Not detected" HPA053978 Uncertain NA NA "HPA053978: AB_2682330" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13C4 ENSG00000148136 "Olfactory receptor family 13 subfamily C member 4" Q8NGS5 9 104526253-104527209 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13C5 ENSG00000277556 "Olfactory receptor family 13 subfamily C member 5" Q8NGS8 9 104598457-104599413 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "pancreas: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.1;CACO-2: 1.0;HEL: 1.6" NA NA "unprognostic (4.88e-2)" 0.0 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.4 0.0 0.3 0.6 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OR13C8 ENSG00000186943 "Olfactory receptor family 13 subfamily C member 8" Q8NGS7 9 104569168-104570130 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "blood: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "T-reg: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13C9 ENSG00000136839 "Olfactory receptor family 13 subfamily C member 9" Q8NGT0 9 104617248-104618204 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "pituitary gland: 1.2;skeletal muscle: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13D1 ENSG00000179055 "Olfactory receptor family 13 subfamily D member 1" Q8NGV5 9 104694379-104695485 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.0" "Not detected" "Not detected" HPA055921 Uncertain NA NA "HPA055921: AB_2682970" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13F1 ENSG00000186881 "Olfactory receptor family 13 subfamily F member 1" Q8NGS4 9 104504263-104505222 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13G1 ENSG00000197437 "Olfactory receptor family 13 subfamily G member 1" Q8NGZ3 1 247670812-247679739 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.9;NB-4: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "olfactory region: 0.1" NA NA 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13H1 ENSG00000171054 "Olfactory receptor family 13 subfamily H member 1" Q8NG92 X 131543976-131545056 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "NTERA-2: 1.3" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13J1 ENSG00000168828 "Olfactory receptor family 13 subfamily J member 1" Q8NGT2 9 35869263-35870601 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.2;skeletal muscle: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "AN3-CA: 2.4" "Not detected" "Not detected" NA NA "unprognostic (6.58e-2)" "unprognostic (2.89e-2)" "unprognostic (1.82e-1)" "unprognostic (2.49e-1)" "unprognostic (9.58e-2)" "unprognostic (7.73e-2)" "unprognostic (1.45e-1)" "unprognostic (2.09e-3)" "unprognostic (1.68e-1)" "unprognostic (4.07e-1)" 0.1 0.2 1.2 0.2 1.6 0.0 0.0 0.9 2.2 0.0 0.1 0.4 0.1 0.0 0.4 0.1 0.2 0.6 1.7 0.8 0.1 0.1 0.0 0.2 0.6 0.4 0.0 0.0 0.4 0.1 0.3 0.1 1.1 0.0 1.4 0.5 0.0 0.0 0.8 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14A16 OR5AT1 ENSG00000196772 "Olfactory receptor family 14 subfamily A member 16" Q8NHC5 1 247814660-247824119 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.9" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14A2 "OR5AX1, OR5AX1P" ENSG00000241128 "Olfactory receptor family 14 subfamily A member 2" Q96R54 1 247722957-247724043 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 12 "testis: 7.4" "Cell type enriched" "Detected in some" 7 "Early spermatids: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 109 "GAMG: 10.9" HPA052685 Uncertain NA NA "HPA052685: AB_2681914" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OR14C36 OR5BF1 ENSG00000177174 "Olfactory receptor family 14 subfamily C member 36" Q8NHC7 1 248348775-248349713 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "prostate: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "HeLa: 2.3" NA NA 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14I1 "OR5BU1, OR5BU1P" ENSG00000189181 "Olfactory receptor family 14 subfamily I member 1" A6ND48 1 248681369-248682304 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 7.4" "Cell type enriched" "Detected in single" 7 "Early spermatids: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.1" NA NA "unprognostic (3.68e-1)" "unprognostic (1.63e-1)" 0.0 0.0 1.2 0.0 1.9 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14J1 "hs6M1-28, OR5U1" ENSG00000204695 "Olfactory receptor family 14 subfamily J member 1" Q9UGF5 6 29301701-29313017 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.5;testis: 4.4" "Group enriched" "Detected in some" 9 "Ciliated cells: 1.4;Club cells: 2.3;granulocytes: 4.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA 0.4 0.4 0.4 1.0 0.4 3.0 0.4 0.4 0.7 0.4 0.4 0.8 0.4 1.5 0.4 0.4 0.5 0.4 0.4 0.5 0.4 1.4 0.4 0.8 0.4 0.6 0.4 0.0 0.4 0.4 0.4 0.1 0.7 0.0 0.9 2.0 0.7 0.0 0.4 0.9 0.6 4.4 0.4 0.0 0.4 0.4 1.7 1.0 3.5 0.8 1.0 1.2 0.0 2.3 0.9 1.9 2.1 0.7 0.6 1.3 1.6 0.2 0.2 0.1 1.4 1.8 1.9 2.3 0.4 1.0 1.0 0.3 0.3 0.2 2.2 0.5 1.8 3.6 1.8 0.1 1.9 1.8 0.2 0.2 0.4 0.5 0.8 0.1 1.3 1.5 5.4 0.5 1.1 1.1 1.9 2.4 0.7 0.7 1.1 1.3 1.5 0.4 2.3 1.6 2.2 1.9 1.2 0.7 1.9 1.7 1.5 3.9 2.2 2.0 3.7 1.8 3.4 2.0 1.4 1.7 1.6 1.8 3.5 0.8 0.7 1.2 0.5 0.8 0.9 0.7 0.8 0.3 1.7 0.8 0.8 3.2 1.0 0.8 1.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14K1 OR5AY1 ENSG00000153230 "Olfactory receptor family 14 subfamily K member 1" Q8NGZ2 1 247738615-247739559 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "GAMG: 11.0" "Not detected" "Not detected" HPA016643 Uncertain NA NA "HPA016643: AB_1854788" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" 0.1 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.2 0.2 0.0 0.3 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1A1 OR17-7 ENSG00000172146 "Olfactory receptor family 1 subfamily A member 1" Q9P1Q5 17 3207539-3218896 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.1;bone marrow: 3.2;salivary gland: 4.2" "Group enriched" "Detected in some" 169 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 15.6;Ciliated cells: 13.4;Club cells: 27.3;granulocytes: 10.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 7.9" NA NA 0.3 0.3 0.4 0.6 0.5 3.2 0.3 0.4 0.6 1.2 0.4 0.8 0.3 0.9 0.4 0.3 0.1 0.5 0.4 0.3 0.4 0.4 0.3 0.5 0.3 0.4 0.5 0.0 0.3 0.0 0.3 0.0 4.2 0.0 0.5 1.5 0.3 0.0 0.4 0.5 0.4 1.2 0.3 0.1 0.6 0.4 2.2 1.4 4.1 1.3 1.5 1.6 0.3 1.6 0.9 0.8 1.4 0.4 0.3 1.6 0.8 0.3 0.2 0.3 0.6 1.1 1.9 1.5 0.4 1.6 0.9 0.1 0.2 0.3 2.1 0.6 1.3 2.9 0.8 0.1 1.4 4.3 0.4 0.3 0.3 0.4 0.4 0.3 1.2 0.9 7.9 0.0 0.9 1.6 1.5 1.9 0.6 1.0 2.0 1.3 2.4 0.2 1.8 1.5 1.2 0.6 1.0 1.0 1.4 1.6 1.5 0.8 1.4 2.6 1.4 1.5 3.3 2.0 1.5 1.1 1.5 1.2 4.1 1.2 1.0 1.4 1.2 1.2 1.3 1.2 1.0 0.8 2.2 1.6 1.5 2.0 1.5 1.3 1.4 0.9 0.3 17.9 15.6 0.0 0.0 0.0 0.0 0.0 0.0 13.4 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1A2 OR17-6 ENSG00000172150 "Olfactory receptor family 1 subfamily A member 2" Q9Y585 17 3197519-3198448 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1B1 OR9-B ENSG00000280094 "Olfactory receptor family 1 subfamily B member 1 (gene/pseudogene)" Q8NGR6 9 122628579-122629573 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "bone marrow: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "RT4: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.2 0.0 0.0 1.2 0.7 0.6 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 4.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1C1 "HSTPCR27, TPCR27" ENSG00000221888 "Olfactory receptor family 1 subfamily C member 1" Q15619 1 247754846-247760556 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "blood: 1.4;testis: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" NA NA "unprognostic (3.40e-1)" "unprognostic (3.58e-1)" "unprognostic (3.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 5.7 0.1 0.0 0.1 0.0 0.7 0.5 1.4 0.6 0.4 0.6 0.3 0.7 1.4 0.6 0.7 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.6 0.8 0.4 0.1 1.0 0.6 0.2 0.0 0.0 0.1 0.1 0.5 0.3 0.4 0.0 0.8 0.7 0.0 0.4 0.5 0.0 0.3 0.0 0.1 0.4 0.7 0.0 0.8 0.2 0.2 0.3 0.6 0.7 0.1 0.4 0.0 0.1 0.3 0.4 0.1 0.1 0.2 0.1 1.4 0.5 0.5 0.9 1.0 1.1 0.4 0.7 0.0 0.1 0.3 0.6 0.3 1.5 1.3 0.2 0.4 0.3 0.6 0.3 0.4 0.5 0.2 0.4 0.7 0.4 0.6 1.4 0.4 0.6 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1D2 "OLFR1, OR17-4" ENSG00000184166 "Olfactory receptor family 1 subfamily D member 2" P34982 17 3088484-3104422 "G-protein coupled receptors, Predicted membrane proteins" "Chemotaxis, Fertilization, Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in single" 11 "granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA 0.5 0.5 0.7 0.7 0.8 2.4 0.7 0.8 1.5 0.7 0.5 0.9 0.5 2.4 0.5 0.6 0.7 0.5 0.7 0.8 1.2 0.9 0.5 1.2 0.6 0.8 0.5 0.4 0.7 0.1 0.6 0.4 0.9 0.1 0.7 2.1 0.7 0.0 0.6 1.1 0.5 3.1 2.2 0.8 0.5 0.5 1.5 1.0 3.5 0.8 0.7 0.9 0.2 1.3 1.0 1.3 1.9 0.7 0.7 3.3 0.9 0.4 0.5 0.9 3.5 2.0 2.1 1.9 0.7 2.4 2.3 0.5 0.4 0.9 2.2 1.7 5.5 2.6 0.8 0.5 1.7 3.6 0.5 1.2 0.6 0.4 1.3 0.5 1.9 2.5 6.1 0.4 1.8 1.0 2.9 2.1 0.8 0.5 1.2 0.8 1.5 1.4 2.7 3.5 1.9 1.2 0.6 1.0 3.8 2.7 2.3 1.2 1.5 3.9 1.3 0.9 2.8 1.2 1.9 1.2 1.6 2.0 1.1 0.8 0.8 0.8 0.6 0.8 1.3 0.7 0.5 0.4 1.5 0.8 0.9 3.5 0.7 0.8 1.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1D5 OR17-31 ENSG00000262628 "Olfactory receptor family 1 subfamily D member 5" P58170 17 3062669-3063607 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1E1 "HGM071, OR13-66, OR17-2, OR17-32, OR1E5, OR1E6, OR1E9P" ENSG00000180016 "Olfactory receptor family 1 subfamily E member 1" P30953 17 3397104-3398410 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.7;placenta: 1.5;testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.7" "Not detected" "Not detected" NA NA "unprognostic (1.12e-1)" "unprognostic (1.33e-1)" 0.4 0.1 0.2 0.0 0.4 0.0 0.6 0.0 0.1 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.9 0.0 1.4 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1E2 "OR17-135, OR17-93, OR1E4" ENSG00000127780 "Olfactory receptor family 1 subfamily E member 2" P47887 17 3432870-3433841 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "HL-60: 1.6" NA NA 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.3 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1F1 "Olfmf, OR16-36, OR16-37, OR16-88, OR16-89, OR16-90, OR1F10, OR1F13P, OR1F4, OR1F5, OR1F6, OR1F7, OR1F8, OR1F9, OR3-145" ENSG00000168124 "Olfactory receptor family 1 subfamily F member 1" O43749 16 3204247-3205188 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.2;brain: 7.4;testis: 2.8" "Group enriched" "Detected in some" 33 "Early spermatids: 2.7;Late spermatids: 4.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "eosinophil: 2.2;memory CD4 T-cell: 1.1;naive CD4 T-cell: 1.2" "Group enriched" "Detected in many" 18 "granulocytes: 2.2;T-cells: 1.2" "Cell line enhanced" "Detected in some" "THP-1: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.72e-1)" "unprognostic (2.99e-2)" "unprognostic (1.22e-1)" "unprognostic (4.94e-2)" "unprognostic (4.88e-1)" "unprognostic (4.16e-1)" "unprognostic (1.26e-1)" 0.0 0.0 0.5 0.2 1.8 0.4 0.0 7.4 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.7 2.2 1.4 0.2 0.0 0.0 0.3 1.2 0.2 1.1 0.8 2.3 0.0 0.0 0.0 0.6 0.3 0.7 0.0 1.8 0.7 1.0 0.0 1.3 1.2 0.6 0.3 0.3 0.0 1.5 0.0 0.0 0.7 1.7 0.8 1.0 0.0 0.3 0.0 0.5 0.4 0.0 0.0 1.5 0.6 0.0 0.0 1.1 0.7 2.4 0.0 0.0 1.6 0.0 0.0 1.2 0.3 0.0 3.5 2.1 0.0 1.1 0.3 0.3 0.4 0.0 0.0 1.4 1.4 0.3 0.0 0.0 2.2 0.3 0.0 0.0 0.0 1.1 0.2 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1G1 "OR17-209, OR1G2" ENSG00000183024 "Olfactory receptor family 1 subfamily G member 1" P47890 17 3126584-3127581 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 1.6;urinary bladder: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HBEC3-KT: 1.2" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.5 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1I1 "OR19-20, OR1I1P, OR1I1Q" ENSG00000094661 "Olfactory receptor family 1 subfamily I member 1" O60431 19 15082211-15092970 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.5;bone marrow: 3.1" "Group enriched" "Detected in some" 23 "Alveolar cells type 2: 3.4;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.3 0.6 0.4 0.7 0.4 3.1 0.3 0.4 0.4 0.3 0.3 0.4 0.4 0.9 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.7 0.4 0.4 0.8 0.0 0.3 0.8 0.4 0.1 0.3 0.0 0.7 2.2 0.3 0.0 0.3 0.5 0.4 0.7 0.7 0.0 0.3 0.4 2.0 1.7 4.5 1.3 3.2 1.5 0.9 0.9 1.3 1.0 1.1 0.6 0.7 1.5 0.7 0.4 0.3 0.3 0.9 1.5 1.7 0.6 0.9 0.5 1.9 0.6 0.2 0.5 1.5 0.9 1.6 3.7 1.3 0.4 0.9 3.2 0.6 0.8 0.3 0.4 1.0 0.3 1.2 1.4 2.2 0.6 1.3 1.0 1.7 1.4 0.7 1.3 0.7 0.8 0.9 0.3 2.2 1.2 1.1 0.7 0.8 0.4 2.0 1.2 0.7 0.7 1.7 1.1 1.6 0.7 1.4 0.7 1.2 0.7 0.9 0.9 3.1 1.2 1.0 1.2 0.9 1.4 1.3 1.0 1.2 0.5 2.0 1.3 1.5 4.5 3.2 1.3 1.7 1.1 0.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1J1 hg32 ENSG00000136834 "Olfactory receptor family 1 subfamily J member 1" Q8NGS3 9 122476958-122477926 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;JURKAT: 3.0;MCF7: 1.1;PC-3: 1.3;REH: 1.4;RT4: 1.3;U-266/70: 1.1" "Not detected" "Not detected" NA NA "unprognostic (5.33e-2)" "unprognostic (2.86e-2)" "unprognostic (3.08e-2)" "unprognostic (9.41e-2)" "unprognostic (3.03e-1)" "unprognostic (2.05e-1)" "unprognostic (1.10e-1)" 0.3 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.4 0.6 0.4 0.0 0.4 0.0 0.3 0.1 0.3 0.2 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.2 0.3 0.0 0.5 0.6 0.3 0.0 0.4 0.2 1.4 0.3 0.1 0.5 0.2 0.3 0.1 1.1 0.1 0.0 0.3 0.0 0.1 0.7 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.3 0.2 0.0 1.2 0.0 0.7 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 1.3 1.4 0.0 0.0 0.0 1.3 0.6 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1J2 "OR1J3, OR1J5, OST044" ENSG00000197233 "Olfactory receptor family 1 subfamily J member 2" Q8NGS2 9 122510802-122511743 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.3;testis: 1.2;urinary bladder: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;HSkMC: 1.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.4 1.3 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 1.2 0.0 0.0 1.7 0.0 0.5 0.6 0.6 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1J4 "HSHTPCRX01, HTPCRX01" ENSG00000239590 "Olfactory receptor family 1 subfamily J member 4" Q8NGS1 9 122519141-122520082 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.4;BJ hTERT+: 3.1;fHDF/TERT166: 2.6;HMC-1: 1.3;JURKAT: 1.6;U-266/70: 1.2" "Not detected" "Not detected" NA NA "unprognostic (7.83e-2)" "unprognostic (2.53e-1)" "unprognostic (4.13e-2)" "unprognostic (1.82e-1)" "unprognostic (4.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.0 0.3 2.0 0.2 0.5 0.2 0.1 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.4 0.3 0.0 0.0 0.6 0.2 0.8 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 1.4 3.1 0.0 0.0 0.0 0.4 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1K1 "hg99, MNAB" ENSG00000165204 "Olfactory receptor family 1 subfamily K member 1" Q8NGR3 9 122800123-122801073 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.1;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.77e-1)" 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.6 0.8 0.0 0.1 0.2 0.0 1.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1L1 "OR1L2, OR9-C" ENSG00000173679 "Olfactory receptor family 1 subfamily L member 1" Q8NH94 9 122661566-122662648 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "urinary bladder: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "RT4: 2.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1L3 OR9-D ENSG00000171481 "Olfactory receptor family 1 subfamily L member 3" Q8NH93 9 122675036-122676153 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.0" HPA058878 Uncertain NA NA "HPA058878: AB_2683843" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.1 1.3 0.7 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1L4 "OR1L5, OR9-E" ENSG00000136939 "Olfactory receptor family 1 subfamily L member 4" Q8NGR5 9 122723990-122724925 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "breast: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 1.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1L6 OR1L7 ENSG00000171459 "Olfactory receptor family 1 subfamily L member 6" Q8NGR2 9 122742303-122750783 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1L8 ENSG00000171496 "Olfactory receptor family 1 subfamily L member 8" Q8NGR8 9 122567117-122583384 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "RT4: 10.4" "Not detected" "Not detected" NA NA "unprognostic (9.76e-2)" "unprognostic (1.11e-1)" "unprognostic (4.32e-2)" "unprognostic (3.86e-2)" "unprognostic (1.68e-1)" "unprognostic (4.94e-3)" "unprognostic (1.36e-2)" "unprognostic (9.11e-3)" "unprognostic (8.51e-3)" "unprognostic (1.81e-4)" "unprognostic (9.82e-3)" "unprognostic (3.33e-1)" "unprognostic (7.99e-2)" "unprognostic (1.06e-1)" 0.9 0.1 0.3 0.0 0.6 0.1 1.0 0.3 0.7 0.8 0.4 0.1 1.4 0.7 0.2 0.9 0.8 0.9 0.7 0.9 0.7 0.6 0.8 0.5 0.5 0.4 0.1 0.0 0.6 0.5 0.6 0.2 0.8 0.4 0.7 0.6 0.3 0.4 0.9 3.7 0.3 2.0 0.7 0.2 1.1 0.5 0.6 0.2 1.6 0.2 1.1 1.2 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 10.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.4 0.2 0.0 0.1 0.1 0.2 0.2 0.0 0.6 1.2 0.8 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1M1 OR19-6 ENSG00000170929 "Olfactory receptor family 1 subfamily M member 1" Q8NGA1 19 9087061-9095669 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (3.29e-2)" 0.2 0.3 0.3 0.4 0.3 2.7 0.3 0.3 0.7 0.7 0.3 0.4 0.2 0.4 0.3 1.2 0.7 0.3 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.7 0.4 0.1 0.3 0.1 0.3 0.1 0.9 0.0 0.4 2.2 0.5 0.0 0.2 0.2 0.3 0.5 1.7 0.0 0.8 0.3 1.7 1.1 4.2 1.0 1.0 0.9 0.2 0.8 0.6 0.6 1.2 0.9 1.0 2.5 0.4 0.1 0.3 0.7 1.5 2.0 1.1 0.5 0.4 0.7 1.7 0.0 0.3 0.8 0.6 1.0 0.7 1.3 0.9 0.5 0.8 1.2 0.6 0.2 0.8 0.7 0.6 0.2 1.2 0.5 2.8 0.3 1.1 1.1 0.9 0.8 0.7 0.1 0.5 1.0 0.7 0.6 1.8 1.0 1.3 0.2 1.2 0.4 1.0 1.6 0.2 0.7 2.1 1.1 1.7 0.9 1.3 0.7 0.7 0.7 1.5 0.9 2.8 0.9 1.0 0.8 0.6 0.7 0.9 0.7 0.6 0.3 1.7 0.9 0.9 4.2 1.0 1.0 1.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1N1 "OR1-26, OR1N3" ENSG00000171505 "Olfactory receptor family 1 subfamily N member 1" Q8NGS0 9 122526358-122527296 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "cervix, uterine: 1.2;testis: 1.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "endometrial cancer: 0.8;ovarian cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 1.2;U-266/70: 1.3" NA NA "unprognostic (3.63e-2)" 0.2 0.0 0.2 0.0 0.5 0.0 0.2 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1N2 ENSG00000171501 "Olfactory receptor family 1 subfamily N member 2" Q8NGR9 9 122553112-122554214 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" 33 "Cardiomyocytes: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "RT4: 1.1" "Not detected" "Not detected" HPA060968 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoli, Plasma membrane" Nucleoplasm "HPA060968: " 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OR1Q1 "HSTPCR106, OR1Q2, OR1Q3, OR9-A, OST226, OST226OR9-A, TPCR106" ENSG00000165202 "Olfactory receptor family 1 subfamily Q member 1" Q15612 9 122614738-122615682 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "epididymis: 4.4;urinary bladder: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.2;CAPAN-2: 1.4;fHDF/TERT166: 2.3;HSkMC: 1.4;JURKAT: 1.7;Karpas-707: 1.6" "Not detected" "Not detected" HPA044828 Uncertain NA NA "HPA044828: AB_10960565" "unprognostic (5.41e-2)" "unprognostic (2.00e-1)" "unprognostic (1.98e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.1 0.2 0.0 0.7 4.4 0.2 0.5 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.3 0.1 0.0 0.4 0.3 0.0 0.0 0.1 0.4 0.3 0.0 0.1 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 1.2 0.2 1.0 3.2 0.0 0.0 0.0 1.4 0.0 0.2 2.3 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.3 0.0 0.0 0.0 0.0 1.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1S1 OST034 ENSG00000280204 "Olfactory receptor family 1 subfamily S member 1 (gene/pseudogene)" Q8NH92 11 58212720-58216084 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049304 Uncertain NA NA "HPA049304: AB_2680704" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1S2 ENSG00000197887 "Olfactory receptor family 1 subfamily S member 2" Q8NGQ3 11 58203202-58204181 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049304 Uncertain NA NA "HPA049304: AB_2680704" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A1 ENSG00000221970 "Olfactory receptor family 2 subfamily A member 1" Q8NGT9 7 144312464-144322668 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "thyroid gland: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 1.1;T-reg: 1.0" "Group enriched" "Detected in many" 4 "granulocytes: 1.1;T-cells: 1.0" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.4;SK-MEL-30: 2.4;WM-115: 1.9" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" "unprognostic (3.98e-1)" "unprognostic (6.53e-2)" "unprognostic (1.13e-2)" "unprognostic (9.14e-2)" "unprognostic (2.22e-1)" 1.1 1.1 0.0 0.8 0.0 1.8 1.4 0.0 0.3 1.0 0.6 0.4 0.8 0.7 0.2 0.8 1.0 0.8 0.0 0.0 0.8 0.5 1.4 0.8 0.0 2.4 0.4 0.0 0.5 0.2 0.7 0.0 0.5 0.3 0.5 1.0 1.0 0.5 0.0 1.4 0.4 0.2 5.2 0.4 0.7 1.0 0.2 0.0 1.1 0.1 0.0 1.0 0.1 0.3 0.0 0.0 0.2 0.1 0.2 0.9 0.1 0.1 0.2 0.0 0.1 0.1 0.5 0.2 0.2 0.3 0.3 0.1 0.0 0.4 0.3 0.0 0.4 0.3 0.0 0.3 0.2 0.0 0.5 0.0 0.2 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.6 0.0 0.7 0.2 0.0 0.2 0.5 0.3 0.0 0.1 0.5 0.2 2.4 0.2 0.1 0.2 0.0 0.1 0.3 0.1 0.9 0.3 0.1 0.3 0.0 0.1 1.9 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A12 OR2A12P ENSG00000221858 "Olfactory receptor family 2 subfamily A member 12" Q8NGT7 7 144086278-144098953 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "parathyroid gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.3 1.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.6 0.5 0.6 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A14 "OR2A14P, OR2A6, OST182" ENSG00000221938 "Olfactory receptor family 2 subfamily A member 14" Q96R47 7 144123176-144131188 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.6 0.7 0.1 0.2 0.3 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A2 "OR2A17P, OR2A2P, OST008" ENSG00000221989 "Olfactory receptor family 2 subfamily A member 2" Q6IF42 7 144109514-144110564 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.1 0.3 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A25 "OR2A25P, OR2A27" ENSG00000221933 "Olfactory receptor family 2 subfamily A member 25" A4D2G3 7 144069811-144075870 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.4" "Group enriched" "Detected in some" 55 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 6.9;Club cells: 3.4;granulocytes: 5.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.1;THP-1: 1.5" "Not detected" "Not detected" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" 0.1 0.7 0.0 1.1 0.0 0.5 0.3 0.0 0.1 0.3 0.1 0.5 0.3 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.5 0.4 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.2 1.0 0.3 0.0 0.0 0.2 0.1 0.4 1.0 0.1 0.1 0.2 1.4 0.8 3.4 0.5 0.7 0.5 0.5 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.3 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.2 0.3 0.4 0.6 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.2 1.5 0.0 0.0 0.3 0.4 0.1 0.4 0.0 0.0 0.2 0.2 0.2 3.4 0.5 0.2 0.3 0.3 0.3 0.6 0.5 0.4 0.2 1.4 0.4 0.5 1.8 0.7 0.2 0.8 0.4 0.5 6.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A4 OR2A10 ENSG00000180658 "Olfactory receptor family 2 subfamily A member 4" O95047 6 131699644-131701401 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 10.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 17 "renal cancer: 0.8" "Group enriched" "Detected in some" 48 "basophil: 10.6;NK-cell: 3.8" "Group enriched" "Detected in many" 48 "granulocytes: 10.6;NK-cells: 3.8" "Cell line enhanced" "Detected in some" "HEL: 1.3;HMC-1: 1.1;MCF7: 1.7" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" "unprognostic (1.22e-5)" "unprognostic (3.60e-2)" 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.2 1.4 2.1 0.0 0.0 0.4 0.4 0.8 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.0 0.0 1.0 0.3 0.5 0.0 0.6 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.9 0.2 0.0 0.0 10.6 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.5 0.5 0.0 0.6 0.1 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.3 1.3 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.9 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A42 ENSG00000212807 "Olfactory receptor family 2 subfamily A member 42" Q8NGT9 7 144228244-144239605 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "thyroid gland: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.3;THP-1: 1.1;WM-115: 3.8" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" "unprognostic (1.41e-1)" "unprognostic (3.14e-1)" 0.6 0.8 0.1 0.0 0.1 1.7 0.9 0.0 0.0 0.7 0.2 0.1 0.4 0.5 0.2 0.3 0.5 0.5 0.0 0.0 0.7 0.2 0.7 1.2 0.1 1.2 0.3 0.0 0.4 0.0 0.4 0.2 0.7 0.1 0.3 1.9 0.9 0.0 0.0 1.4 0.3 0.2 3.8 0.0 1.0 0.4 1.4 0.5 1.5 0.5 1.0 1.0 0.0 0.9 0.2 0.0 0.2 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.5 0.3 0.0 0.0 0.0 1.3 0.8 0.1 0.2 0.6 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.8 0.1 1.1 0.8 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 3.8 1.1 0.5 0.4 0.4 0.3 0.3 0.6 0.4 0.3 0.2 1.4 0.5 0.4 1.5 1.0 0.3 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A5 "OR2A26, OR2A8, OR7-138, OR7-141" ENSG00000221836 "Olfactory receptor family 2 subfamily A member 5" Q96R48 7 144048948-144058845 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 1.7" "Not detected" "Not detected" NA NA 0.3 0.2 0.0 0.6 0.1 1.0 0.7 0.0 0.1 0.0 0.2 0.1 0.4 0.5 0.1 0.3 0.1 0.3 0.0 0.0 0.5 0.1 0.2 0.3 0.1 0.3 0.4 0.2 0.2 0.3 0.3 0.2 0.6 0.1 0.1 0.8 0.1 0.0 0.0 0.3 0.2 0.6 0.9 0.1 0.6 0.2 0.4 0.3 1.8 0.2 0.5 0.2 0.0 0.1 0.2 0.4 0.2 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.4 0.4 0.2 0.1 0.0 0.1 0.2 0.2 0.0 0.5 0.2 0.2 0.2 0.1 0.1 0.0 0.3 0.2 0.5 0.1 0.5 0.4 1.7 0.2 0.1 0.9 0.4 0.2 0.0 0.0 1.1 1.2 0.2 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.5 0.0 0.0 0.7 0.4 0.4 0.5 0.3 0.6 0.8 0.3 0.2 0.2 0.1 0.6 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.4 0.1 0.2 1.8 0.5 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A7 HSDJ0798C17 ENSG00000243896 "Olfactory receptor family 2 subfamily A member 7" Q96R45 7 144257663-144264792 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Ciliated cells: 1.4;Club cells: 1.2" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 7.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 10.2;hTCEpi: 5.2;RT4: 4.1;SK-BR-3: 4.5" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" "unprognostic (6.48e-2)" "unprognostic (3.07e-1)" "unprognostic (3.44e-2)" "unprognostic (2.57e-1)" "unprognostic (1.40e-2)" "unprognostic (1.01e-1)" "unprognostic (4.05e-1)" "unprognostic (4.13e-2)" "unprognostic (5.75e-2)" "unprognostic (7.28e-2)" "unprognostic (3.33e-1)" "unprognostic (9.08e-2)" "unprognostic (3.58e-3)" "unprognostic (5.52e-2)" "unprognostic (5.13e-2)" "unprognostic (3.06e-1)" "unprognostic (3.22e-1)" 0.9 0.1 0.0 0.2 0.0 1.4 3.9 0.0 0.0 2.7 3.4 6.5 0.7 2.2 3.9 2.3 1.6 0.7 0.0 0.0 3.3 2.1 2.1 0.4 0.0 2.6 4.8 2.3 1.3 0.7 3.7 3.4 4.0 0.6 0.0 7.9 4.5 0.3 0.0 0.8 3.8 0.2 8.1 0.4 2.5 2.8 2.0 0.0 7.8 0.0 1.5 1.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 1.8 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 5.2 0.3 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.2 0.0 0.0 0.0 0.0 2.7 4.1 0.0 0.0 2.6 4.5 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.8 0.0 0.0 0.7 0.0 0.2 0.5 1.0 0.5 0.0 2.0 0.6 0.5 0.0 1.5 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AE1 OR2AE2 ENSG00000244623 "Olfactory receptor family 2 subfamily AE member 1" Q8NHA4 7 99875987-99877057 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enhanced" "Detected in single" "B-cells: 1.5" "Cell line enhanced" "Detected in some" "HBF TERT88: 1.0;hTEC/SVTERT24-B: 1.2;U-2197: 2.3;U-266/70: 1.0;U-266/84: 1.2" HPA042957 Uncertain NA NA "HPA042957: AB_10794539" "unprognostic (6.75e-2)" "unprognostic (6.22e-2)" "unprognostic (5.21e-2)" "unprognostic (1.58e-1)" "unprognostic (3.16e-2)" 0.4 0.4 0.0 0.0 0.2 0.1 1.2 0.3 0.2 0.4 0.1 1.1 0.7 1.4 0.3 0.4 0.0 0.3 0.0 0.1 0.3 0.1 0.4 0.6 0.0 0.2 0.3 1.2 0.8 0.2 0.5 0.5 1.3 0.2 1.2 0.8 0.2 0.4 0.1 0.3 0.1 0.1 0.3 0.4 0.3 0.1 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.6 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.8 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.3 0.1 1.0 1.2 0.1 0.2 0.5 0.5 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AG1 OR2AG3 ENSG00000279486 "Olfactory receptor family 2 subfamily AG member 1 (gene/pseudogene)" Q9H205 11 6783020-6791558 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "blood: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "TIME: 2.0" NA NA 0.0 0.0 0.2 0.9 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.6 0.5 1.5 0.2 0.3 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.3 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.3 2.0 0.1 0.1 0.5 0.2 0.0 0.2 0.1 0.0 0.3 0.2 1.2 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.6 0.1 0.2 1.5 0.3 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AG2 OR2AG2P ENSG00000188124 "Olfactory receptor family 2 subfamily AG member 2" A6NM03 11 6765626-6771976 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "K-562: 2.6;U-698: 2.5" NA NA "unprognostic (6.24e-3)" "unprognostic (7.69e-2)" "unprognostic (1.21e-2)" "unprognostic (1.56e-1)" "unprognostic (7.30e-2)" 0.0 0.1 0.3 0.4 1.1 1.7 0.0 0.1 0.8 0.4 0.3 0.6 0.1 0.3 0.1 0.4 0.0 0.1 0.2 0.5 0.1 0.2 0.1 0.5 0.2 0.5 0.3 0.0 0.1 0.0 0.3 0.5 0.1 0.0 0.3 0.2 0.3 0.2 0.0 0.1 0.0 1.0 0.2 0.3 0.5 0.1 0.6 0.4 1.0 0.4 0.5 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.8 1.0 1.3 0.4 1.5 0.1 0.0 0.6 0.2 1.0 0.9 0.3 0.3 1.1 1.3 0.0 0.8 0.0 0.2 0.0 0.6 1.9 0.0 0.4 0.2 0.0 1.6 0.1 1.5 0.1 2.6 0.9 0.4 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.0 0.2 0.0 1.8 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.3 1.0 0.9 0.2 0.0 0.3 0.0 2.5 1.2 0.2 0.7 0.9 0.4 0.1 0.2 0.2 0.1 0.6 0.5 0.2 0.0 0.6 0.6 0.3 1.0 0.5 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AJ1 "OR2AJ1P, OR2AJ1Q" ENSG00000177275 "Olfactory receptor family 2 subfamily AJ member 1" Q8NGZ0 1 247924889-247935339 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.5;thyroid gland: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.5" NA NA 0.0 0.0 0.3 0.0 0.3 0.6 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AK2 OR2AK1P ENSG00000187080 "Olfactory receptor family 2 subfamily AK member 2" Q8NG84 1 247965233-247966386 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "bone marrow: 2.5;testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.5" HPA052544 Uncertain NA NA "HPA052544: AB_2681865" 0.0 0.2 0.0 0.0 0.3 2.5 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.3 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AP1 OR2AP1P ENSG00000179615 "Olfactory receptor family 2 subfamily AP member 1" Q8NGE2 12 55572468-55575612 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "REH: 4.1;U-937: 4.1" NA NA 0.1 0.2 0.2 0.0 0.2 1.0 0.2 0.1 0.4 0.1 0.1 0.6 0.4 0.0 0.1 0.1 0.0 0.4 0.1 0.1 0.2 0.3 0.1 0.2 0.1 0.6 0.1 0.6 0.1 0.6 0.1 0.0 0.1 0.1 0.6 0.1 0.3 0.0 0.1 0.1 0.2 0.5 0.1 0.0 0.1 0.1 0.7 0.0 1.1 0.2 0.1 0.3 0.0 0.5 0.0 0.1 0.4 0.2 0.0 0.6 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.2 0.7 0.2 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.3 0.5 1.0 0.8 0.0 0.6 0.3 0.4 0.4 0.2 0.2 4.1 0.2 0.3 0.0 0.1 0.5 1.0 0.2 0.6 0.9 0.1 0.4 0.3 0.0 0.6 0.7 0.5 0.3 0.9 0.2 0.2 0.6 4.1 0.6 1.1 0.2 0.3 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.7 0.2 0.3 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AT4 ENSG00000171561 "Olfactory receptor family 2 subfamily AT member 4" A6NND4 11 75081753-75096876 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.6;bone marrow: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 6.8" "Not detected" "Not detected" NA NA 0.4 0.5 0.4 0.4 0.6 3.5 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.2 0.4 1.7 0.4 0.3 0.5 0.4 0.4 0.4 0.4 1.7 0.5 0.7 0.4 0.4 0.8 0.4 0.3 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.5 1.9 0.6 0.4 0.4 0.6 0.4 1.5 0.4 0.4 0.6 0.4 0.4 0.4 0.4 1.2 0.8 3.6 0.8 0.7 0.7 0.1 1.1 0.8 1.5 1.3 0.7 0.8 1.2 0.7 0.4 0.4 0.4 1.3 1.3 2.1 0.7 0.7 0.9 1.1 0.7 0.5 0.8 1.0 0.9 2.3 2.2 1.2 0.4 1.6 1.7 0.6 0.6 0.7 0.7 1.2 0.6 1.6 6.8 3.1 0.4 1.3 0.8 1.7 2.0 0.5 0.8 1.1 1.6 1.9 0.5 1.9 1.7 1.2 0.7 1.1 1.0 1.7 1.0 0.9 1.6 1.2 1.3 1.2 0.7 1.7 1.5 1.3 1.1 1.1 1.3 1.7 0.8 0.5 0.7 0.5 0.6 0.6 0.6 0.5 0.3 1.2 0.7 0.7 3.6 0.7 0.7 0.8 0.5 0.1 0.4 0.6 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2B11 ENSG00000177535 "Olfactory receptor family 2 subfamily B member 11" Q5JQS5 1 247449118-247458105 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.1" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 14.7;Club cells: 9.1;granulocytes: 3.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 5 "THP-1: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA047459 Uncertain NA NA "HPA047459: AB_10963692" "unprognostic (1.83e-1)" 1.5 0.1 0.1 1.2 0.1 3.1 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.1 0.7 1.0 0.2 0.1 0.1 0.0 0.1 0.4 0.3 0.1 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.7 0.1 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.5 1.5 0.0 0.3 0.0 0.1 0.2 0.6 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.3 0.1 0.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.0 5.2 0.6 0.1 0.4 0.1 0.1 0.1 0.1 0.4 0.9 0.6 0.1 0.5 0.8 0.0 0.3 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 14.7 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2B2 "hs6M1-10, OR2B2Q, OR2B9, OR6-1" ENSG00000168131 "Olfactory receptor family 2 subfamily B member 2" Q9GZK3 6 27911185-27912396 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "liver: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.1;U-266/84: 2.4" "Low region specificity" "Detected in some" NA NA "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2B3 "OR2B3P, OR6-4" ENSG00000204703 "Olfactory receptor family 2 subfamily B member 3" O76000 6 29086208-29087313 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2B6 "dJ408B20.2, OR2B1, OR2B1P, OR2B5, OR2B6P, OR5-40, OR5-41, OR6-31" ENSG00000124657 "Olfactory receptor family 2 subfamily B member 6" P58173 6 27957241-27958182 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.1;neutrophil: 1.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "HeLa: 3.0;K-562: 3.3;U-266/84: 8.5;U-937: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (7.98e-2)" "unprognostic (3.10e-3)" "unprognostic (7.02e-3)" "unprognostic (1.58e-4)" "unprognostic (3.07e-1)" "unprognostic (1.49e-1)" "unprognostic (1.10e-1)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "unprognostic (4.29e-2)" "unprognostic (6.54e-3)" "unprognostic (1.75e-2)" "unprognostic (1.89e-15)" "unprognostic (1.23e-2)" "unprognostic (5.26e-1)" "unprognostic (1.25e-1)" "unprognostic (3.47e-3)" 0.0 0.4 0.0 0.6 0.0 0.6 0.6 0.2 0.0 0.0 0.2 0.3 0.0 0.4 0.4 0.1 0.0 0.1 0.1 0.1 0.0 1.4 0.5 0.2 0.1 0.0 0.0 0.0 0.0 1.2 1.7 1.2 0.0 0.0 0.0 0.3 0.2 0.0 0.3 1.6 0.3 1.6 0.3 0.4 0.3 0.0 0.0 0.2 1.1 0.1 0.0 0.1 1.3 0.4 0.0 1.1 0.4 0.2 0.0 0.1 0.2 0.1 2.0 0.8 0.0 0.5 0.0 0.7 0.0 0.7 1.2 0.8 0.0 1.1 1.0 0.4 0.0 3.0 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.1 3.3 2.3 0.1 0.4 0.0 0.4 0.3 0.9 0.2 0.0 0.2 0.6 0.1 0.0 2.7 0.0 2.5 0.6 0.7 0.9 0.5 0.0 0.0 0.2 0.0 0.0 0.1 1.4 8.5 0.3 0.0 4.2 0.1 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 OR2C1 "OLFmf3, OR2C2P" ENSG00000168158 "Olfactory receptor family 2 subfamily C member 1" O95371 16 3355889-3357294 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Daudi: 3.9;RPMI-8226: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (1.40e-1)" "unprognostic (1.46e-1)" "unprognostic (7.58e-2)" "unprognostic (1.01e-2)" "unprognostic (2.76e-1)" "unprognostic (7.11e-3)" "unprognostic (5.26e-2)" "unprognostic (8.44e-2)" "unprognostic (2.83e-2)" "unprognostic (4.10e-3)" "unprognostic (2.41e-2)" "unprognostic (1.09e-1)" "unprognostic (6.42e-2)" "unprognostic (3.70e-2)" "unprognostic (1.08e-1)" 0.2 0.3 0.7 0.0 1.0 0.0 0.5 0.9 1.0 0.3 0.1 0.1 0.7 0.0 0.0 3.8 0.1 0.1 0.9 0.7 0.5 0.3 0.0 0.8 0.7 0.6 0.2 1.3 0.1 0.2 0.5 0.3 0.1 0.7 0.1 0.3 0.2 0.3 1.3 0.6 0.1 0.7 0.3 0.8 0.3 0.1 1.3 0.1 0.0 0.0 0.4 1.9 0.4 0.1 0.0 0.3 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.6 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.6 0.1 1.3 1.9 0.8 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2C3 "OR2C4, OR2C5P, OST742" ENSG00000196242 "Olfactory receptor family 2 subfamily C member 3" Q8N628 1 247524677-247536440 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.2;testis: 4.6" "Group enriched" "Detected in some" 6 "Early spermatids: 1.6;granulocytes: 1.1;Late spermatids: 2.1;Spermatocytes: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 4.2;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 18 "dendritic cells: 1.3;granulocytes: 4.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8" HPA058578 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058578: AB_2683761" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (3.45e-2)" "unprognostic (1.03e-1)" 0.2 0.4 0.1 0.0 0.1 0.1 0.2 0.4 0.1 0.9 0.1 0.0 0.2 0.9 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 1.3 0.1 0.4 0.7 0.0 0.1 0.0 0.5 0.1 0.1 0.4 0.1 0.1 0.1 4.6 0.1 0.0 0.2 0.1 0.0 1.3 4.2 0.0 0.1 0.1 0.0 0.5 0.3 0.6 0.2 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.3 1.8 0.6 0.2 0.0 1.1 0.3 0.0 0.1 0.0 0.7 0.5 0.1 0.2 0.1 0.1 0.2 0.5 0.5 0.0 0.1 0.0 0.4 0.1 0.5 1.2 0.7 0.1 0.0 0.4 0.2 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.8 0.3 0.0 0.3 0.5 0.6 0.6 0.3 0.7 0.4 1.2 0.1 0.1 0.0 0.2 0.3 0.5 0.1 0.5 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 OR2D2 "hg27, OR11-610, OR2D1" ENSG00000166368 "Olfactory receptor family 2 subfamily D member 2" Q9H210 11 6891490-6892599 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.3;HSkMC: 1.6;U-698: 1.3" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2D3 ENSG00000178358 "Olfactory receptor family 2 subfamily D member 3" Q8NGH3 11 6920974-6922043 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "K-562: 1.2" "Low region specificity" "Detected in single" HPA052551 Uncertain NA NA "HPA052551: AB_2681867" "unprognostic (4.52e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2F1 "OLF3, OR14-60, OR2F3, OR2F3P, OR2F4, OR2F5, OR7-139, OR7-140" ENSG00000213215 "Olfactory receptor family 2 subfamily F member 1 (gene/pseudogene)" Q13607 7 143954844-143997312 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.2" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2F2 OR7-1 ENSG00000221910 "Olfactory receptor family 2 subfamily F member 2" O95006 7 143935166-143936279 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2G2 ENSG00000177489 "Olfactory receptor family 2 subfamily G member 2" Q8NGZ5 1 247588360-247589313 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 46 "granulocytes: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.3" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2G3 ENSG00000177476 "Olfactory receptor family 2 subfamily G member 3" Q8NGZ4 1 247605586-247606515 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2G6 ENSG00000188558 "Olfactory receptor family 2 subfamily G member 6" Q5TZ20 1 248508073-248527337 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.2" "Group enriched" "Detected in some" 19 "Alveolar cells type 2: 2.6;Ciliated cells: 2.7;Club cells: 1.2;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 3.2" NA NA 0.2 0.2 0.2 0.2 0.2 3.2 0.2 0.2 0.2 0.3 0.2 0.6 0.2 1.1 0.2 0.2 0.1 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.2 1.1 0.0 0.2 0.1 0.8 0.0 0.6 0.0 0.3 0.9 0.3 0.0 0.2 0.5 1.1 1.9 0.2 0.3 0.4 0.2 1.4 0.7 1.8 0.8 0.6 0.6 0.1 0.7 0.5 0.6 0.7 0.1 0.4 1.0 1.0 0.1 0.1 0.2 0.7 0.9 0.8 1.1 0.0 0.6 0.8 0.3 0.1 0.4 0.9 0.7 0.8 1.3 0.4 0.0 1.0 0.9 0.1 0.4 0.1 0.4 0.5 0.3 0.9 0.7 3.2 0.1 0.6 0.7 0.8 1.2 0.3 0.7 0.9 0.6 0.4 0.2 1.4 0.6 0.8 0.8 0.7 0.7 0.6 2.0 0.9 2.4 0.9 1.2 1.2 0.8 1.3 0.9 1.0 0.5 0.9 0.7 1.7 0.5 0.5 0.5 0.3 0.4 0.4 0.4 0.4 0.2 1.4 0.5 0.6 1.8 0.6 0.8 0.7 0.3 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2H1 "OR2H6, OR2H8, OR6-2" ENSG00000204688 "Olfactory receptor family 2 subfamily H member 1" Q9GZK4 6 29457181-29464328 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 124 "testis: 12.3" "Cell type enriched" "Detected in some" 5 "Early spermatids: 52.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 OR2H2 hs6M1-12 ENSG00000204657 "Olfactory receptor family 2 subfamily H member 2" O95918 6 29585121-29590500 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 3.3;epididymis: 11.7;testis: 4.8" "Cell type enriched" "Detected in some" 7 "Early spermatids: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.3;NTERA-2: 3.5;TIME: 1.9" NA NA "unprognostic (2.95e-1)" "unprognostic (3.76e-1)" "unprognostic (2.33e-2)" "unprognostic (2.42e-1)" "unprognostic (2.34e-1)" "unprognostic (3.11e-1)" "unprognostic (2.76e-1)" "unprognostic (3.20e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" 0.2 0.1 1.5 0.3 3.3 1.5 0.1 2.2 0.9 0.1 0.1 0.0 0.2 11.7 0.1 0.1 0.1 0.3 1.2 0.9 0.1 0.1 0.2 0.4 0.6 0.2 0.0 0.0 0.7 0.1 0.2 0.1 0.1 0.9 0.1 0.4 0.1 0.1 0.2 0.4 0.2 4.8 0.2 0.2 0.1 0.1 0.4 0.2 0.8 0.1 0.1 0.3 0.0 0.4 0.0 2.3 0.3 0.0 0.0 0.5 0.2 0.1 0.0 0.2 0.0 0.2 0.5 0.1 0.4 0.2 0.3 0.2 0.0 0.0 0.2 0.7 0.9 0.7 0.6 0.1 0.6 1.0 0.1 0.1 0.0 0.2 0.3 0.3 0.7 0.4 0.7 0.2 0.1 0.0 0.2 3.5 0.1 0.2 0.4 0.3 0.0 0.0 0.2 0.7 0.2 0.3 0.2 0.0 1.1 0.2 0.2 1.9 0.4 0.9 0.3 0.2 1.0 0.2 0.5 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2I1P "HS6M1-14, OR2I1, OR2I2, OR2I3P, OR2I4P" ENSG00000237988 "Olfactory receptor family 2 subfamily I member 1 pseudogene" 6 29550407-29557721 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 3.0;granulocytes: 1.1;monocytes: 1.8;Pancreatic endocrine cells: 1.0" "Cancer enhanced" "Detected in all" "liver cancer: 71.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.45e-3)" "unprognostic (1.69e-2)" "unprognostic (6.00e-2)" "prognostic favorable (3.29e-4)" "unprognostic (1.60e-2)" "unprognostic (1.07e-3)" "unprognostic (3.29e-1)" "unprognostic (2.23e-1)" "unprognostic (5.34e-3)" "prognostic favorable (5.58e-4)" "unprognostic (1.32e-1)" "unprognostic (3.17e-1)" "prognostic unfavorable (4.00e-6)" "unprognostic (8.46e-2)" "unprognostic (1.50e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2J1 "dJ80I19.2, hs6M1-4, OR2J1P, OR6-5" ENSG00000204702 "Olfactory receptor family 2 subfamily J member 1 (gene/pseudogene)" Q9GZK6 6 29099657-29102701 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2J2 "dJ80I19.4, hs6M1-6, OR6-8" ENSG00000204700 "Olfactory receptor family 2 subfamily J member 2" O76002 6 29170907-29175811 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.6;bone marrow: 1.5;testis: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 1.0;Karpas-707: 2.2" NA NA 0.0 0.0 0.3 0.4 0.7 1.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.6 0.2 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.3 3.0 0.5 0.0 0.1 0.0 1.0 0.7 1.6 0.4 0.3 0.5 0.0 0.1 0.3 0.1 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.4 0.2 0.2 0.3 1.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.5 0.1 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.7 0.0 0.4 0.3 0.0 0.0 0.4 0.1 0.6 0.4 0.7 0.5 0.2 0.3 0.4 0.3 0.3 0.1 1.0 0.4 0.3 1.6 0.3 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 OR2J3 OR6-6 ENSG00000204701 "Olfactory receptor family 2 subfamily J member 3" O76001 6 29108059-29114770 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "CAPAN-2: 1.5" NA NA 0.2 0.0 0.1 0.1 0.0 0.6 0.3 0.0 0.2 0.4 0.1 0.4 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.3 0.5 0.4 0.1 0.3 0.2 0.0 0.1 0.0 0.5 0.3 0.1 0.0 0.1 0.1 0.2 2.5 0.2 0.0 0.1 0.2 0.2 0.3 1.2 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.2 0.0 0.3 0.0 0.1 0.2 0.2 0.4 1.5 0.3 0.2 0.0 0.5 0.5 0.4 0.2 0.7 0.2 0.4 0.6 0.7 0.1 0.8 0.0 0.8 0.2 0.0 0.4 0.6 0.7 0.0 0.0 0.3 0.1 0.4 0.5 0.2 0.0 0.5 0.4 0.5 0.0 0.8 0.0 0.1 0.2 0.7 0.0 0.3 0.4 0.1 0.0 0.5 0.0 0.4 0.5 0.5 0.9 0.6 0.0 0.3 0.2 0.1 0.2 0.7 0.6 0.3 0.2 0.1 0.3 0.2 0.0 0.0 0.2 0.1 0.2 0.0 0.1 1.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2K2 "HSHTPCRH06, HTPCRH06, OR2AR1P" ENSG00000171133 "Olfactory receptor family 2 subfamily K member 2" Q8NGT1 9 111327483-111330183 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.2;skeletal muscle: 1.6;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 1.7;Karpas-707: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA024261 Uncertain NA NA "HPA024261: AB_1854786" "unprognostic (1.03e-1)" 0.0 0.2 0.3 0.0 0.4 0.4 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.9 0.8 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.7 0.0 0.2 3.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2L13 OR2L14 ENSG00000196071 "Olfactory receptor family 2 subfamily L member 13" Q8N349 1 248095184-248101103 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.2;brain: 7.3" "Cell type enhanced" "Detected in single" 20 "Early spermatids: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 13 "B-cells: 1.0;granulocytes: 3.2;T-cells: 1.5" "Group enriched" "Detected in some" 9 "ASC diff: 1.1;GAMG: 2.5;WM-115: 2.9" NA NA "unprognostic (1.39e-2)" "unprognostic (1.53e-1)" "unprognostic (9.89e-2)" "unprognostic (3.66e-1)" "unprognostic (7.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.14e-1)" 0.0 2.0 2.1 0.0 2.4 0.2 0.6 0.7 7.3 0.1 0.1 0.0 0.0 1.2 0.0 1.0 0.0 0.0 2.5 3.2 0.0 0.0 0.0 0.2 3.5 0.2 0.0 0.0 0.2 0.1 1.8 0.1 0.0 0.6 0.0 0.0 0.0 0.1 4.5 1.1 0.0 1.2 0.9 0.1 0.1 0.0 1.0 0.1 3.2 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 3.2 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.6 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 OR2L2 "HSHTPCRH07, HTPCRH07, OR2L12, OR2L4P" ENSG00000203663 "Olfactory receptor family 2 subfamily L member 2" Q8NH16 1 248030070-248042305 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.1;testis: 3.3" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 10.8;Ciliated cells: 18.7;Club cells: 13.6;granulocytes: 10.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "unprognostic (3.37e-2)" "unprognostic (2.16e-2)" "unprognostic (3.88e-2)" "unprognostic (2.96e-2)" 0.3 0.4 1.1 0.4 1.1 2.7 0.0 0.4 0.9 0.1 0.1 0.9 0.2 0.1 0.3 0.1 0.4 0.0 1.6 1.2 0.2 1.7 0.2 0.3 1.7 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.0 2.2 0.6 1.0 0.0 4.1 0.7 0.9 3.3 0.2 0.0 0.0 0.0 1.7 0.8 2.7 0.8 1.2 1.0 0.2 1.0 0.7 0.9 1.0 0.2 0.1 2.3 0.6 0.0 0.0 0.0 0.6 1.2 1.2 1.2 0.1 0.9 0.8 0.0 0.0 0.3 1.2 0.3 1.0 1.8 0.7 0.0 0.7 1.2 0.0 0.1 0.1 0.0 1.0 0.1 1.0 0.5 2.9 0.1 0.6 0.4 1.4 1.2 1.0 1.4 1.2 1.4 0.8 0.2 1.6 1.3 2.2 1.3 0.7 0.5 1.4 0.9 0.7 1.4 0.9 1.9 1.9 1.4 2.2 1.3 1.1 1.3 1.0 1.3 2.5 0.8 0.6 1.0 0.4 0.8 0.7 0.6 0.5 0.2 1.7 0.8 0.9 2.7 1.2 0.6 0.8 0.4 0.2 17.9 10.8 0.0 0.0 0.0 0.0 0.0 0.0 18.7 13.6 0.0 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OR2L3 ENSG00000198128 "Olfactory receptor family 2 subfamily L member 3" Q8NG85 1 248046836-248063407 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.0;prostate: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.8;Karpas-707: 1.9" NA NA 0.3 0.2 0.4 1.0 0.4 3.0 0.6 1.3 0.5 0.4 0.0 0.1 0.2 0.1 0.0 0.4 0.3 0.0 0.6 0.8 0.0 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.9 0.2 4.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 1.5 0.8 0.0 0.2 0.4 0.0 0.3 0.0 0.1 0.0 0.5 0.2 0.1 0.3 0.0 0.5 0.4 0.8 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.4 0.1 0.5 0.1 0.0 0.9 0.3 0.0 0.0 0.1 0.3 0.3 0.0 1.8 0.1 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.2 1.9 0.0 0.8 0.4 0.5 0.5 0.2 0.7 0.1 0.8 0.2 0.1 0.5 0.2 0.1 0.4 0.0 0.0 0.5 0.1 1.0 0.0 0.8 0.5 0.3 0.4 1.0 0.5 0.7 1.1 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2L5 "OR2L11, OR2L5P" ENSG00000197454 "Olfactory receptor family 2 subfamily L member 5" Q8NG80 1 248013660-248024276 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "bone marrow: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.2" NA NA 0.1 0.1 0.3 0.2 0.6 1.7 0.0 0.7 0.6 0.5 0.1 0.0 0.1 0.5 0.0 0.2 0.2 0.0 0.5 0.5 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.2 0.6 0.5 0.0 0.1 0.5 0.6 0.0 0.5 0.3 0.5 0.2 0.0 0.6 0.2 0.7 0.3 0.1 0.4 0.0 0.1 0.4 0.0 0.1 0.4 0.3 0.6 0.5 0.1 0.0 0.1 0.4 0.5 0.1 0.1 0.6 0.4 0.4 0.0 0.6 0.0 0.0 0.0 0.3 0.9 0.6 0.0 0.2 0.5 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.0 0.5 0.0 0.3 0.1 0.1 0.1 0.0 1.2 0.4 0.2 0.2 0.0 0.2 0.1 0.0 0.3 0.2 0.0 0.7 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.4 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2L8 ENSG00000279263 "Olfactory receptor family 2 subfamily L member 8 (gene/pseudogene)" Q8NGY9 1 247948858-247949796 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2M2 "OR2M2Q, OST423" ENSG00000198601 "Olfactory receptor family 2 subfamily M member 2" Q96R28 1 248174821-248181067 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2M3 "OR2M3P, OR2M6, OST003" ENSG00000228198 "Olfactory receptor family 2 subfamily M member 3" Q8NG83 1 248197265-248212925 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 23 "Club cells: 2.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA 0.5 0.5 0.9 0.5 0.9 3.6 0.5 0.6 1.2 1.5 1.2 0.7 0.6 2.0 0.5 0.5 0.6 0.5 1.0 1.1 1.6 1.6 0.5 0.8 1.1 1.0 0.7 0.0 0.7 0.3 0.5 1.4 1.4 0.0 0.8 2.4 0.6 0.0 0.7 0.8 0.8 1.6 0.9 0.0 0.7 0.5 1.7 1.4 3.3 1.9 0.9 1.4 0.5 2.8 1.6 2.5 2.6 1.0 1.1 2.4 2.2 0.3 0.3 0.6 6.2 3.7 3.3 2.4 0.5 3.6 2.6 1.1 0.8 0.9 3.2 2.2 1.7 5.2 2.0 0.4 2.2 2.1 0.9 1.1 0.6 0.8 1.7 0.5 2.3 3.7 6.6 0.7 2.4 1.8 2.5 3.9 2.4 1.4 2.1 2.8 3.0 1.0 2.2 2.7 2.3 2.9 1.5 1.7 3.1 2.9 2.0 3.1 2.9 3.6 2.9 1.9 4.2 2.6 2.5 2.4 2.0 2.6 3.3 1.6 0.8 1.4 1.9 1.2 1.0 1.1 0.9 0.6 1.7 1.2 1.2 3.2 0.9 1.3 1.4 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2M4 "HSHTPCRX18, HTPCRX18, OST710, TPCR100" ENSG00000171180 "Olfactory receptor family 2 subfamily M member 4" Q96R27 1 248231417-248244679 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" HPA051308 Uncertain NA NA "HPA051308: AB_2681435" 0.4 0.1 0.5 0.0 0.6 2.6 0.5 0.4 1.3 0.3 0.2 0.2 0.3 1.1 0.1 0.5 0.5 0.1 0.7 1.3 0.1 1.5 0.1 0.2 1.1 0.8 1.4 0.6 0.3 0.0 0.2 0.0 0.7 0.0 0.1 1.0 0.2 0.0 1.0 0.2 0.2 0.4 0.4 0.0 0.2 0.2 1.0 0.6 2.1 0.6 1.3 0.7 0.3 0.7 0.2 0.5 0.7 1.2 2.3 0.4 0.4 0.2 0.1 0.0 0.8 0.4 0.7 0.3 0.3 0.9 0.4 0.5 0.7 0.1 0.1 0.3 1.0 1.6 0.7 0.1 1.2 0.7 1.6 0.1 0.3 0.2 0.4 0.8 0.5 0.9 1.8 0.2 0.9 0.3 1.0 0.9 0.2 0.8 1.9 0.4 0.8 0.2 1.4 1.3 1.0 0.4 0.5 0.8 0.5 0.6 0.1 1.7 0.8 0.8 0.9 0.3 1.3 0.7 0.4 0.6 1.0 1.0 1.9 0.6 0.4 0.6 0.5 0.4 0.5 0.5 0.4 0.1 1.0 0.5 0.7 2.1 1.3 0.6 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2M5 OR2M5P ENSG00000162727 "Olfactory receptor family 2 subfamily M member 5" A3KFT3 1 248145148-248146086 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2M7 ENSG00000177186 "Olfactory receptor family 2 subfamily M member 7" Q8NG81 1 248323630-248324568 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2S2 ENSG00000278889 "Olfactory receptor family 2 subfamily S member 2 (gene/pseudogene)" Q9NQN1 9 35957108-35958154 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.3;BJ: 1.3;BJ hTERT+: 1.9;fHDF/TERT166: 1.3;HeLa: 1.3;HHSteC: 1.6;U-138 MG: 2.2" "Region enriched" "Detected in single" 8 "cerebellum: 0.6" NA NA 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T1 OR1-25 ENSG00000175143 "Olfactory receptor family 2 subfamily T member 1" O43869 1 248403048-248408020 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA063064 Uncertain NA NA "HPA063064: AB_2684935" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T10 ENSG00000184022 "Olfactory receptor family 2 subfamily T member 10" Q8NGZ9 1 248590487-248597700 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "kidney: 11.2" "Cell type enriched" "Detected in single" 59 "Proximal tubular cells: 5.9" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 15 "B-cells: 1.4" "Group enriched" "Detected in some" 7 "BJ hTERT+: 3.1;Karpas-707: 2.4" HPA052019 Uncertain NA NA "HPA052019: AB_2681696" "unprognostic (8.58e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T11 OR2T11Q ENSG00000279301 "Olfactory receptor family 2 subfamily T member 11 (gene/pseudogene)" Q8NH01 1 248623557-248635091 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;bone marrow: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "HeLa: 1.2" NA NA 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 1.1 0.4 1.4 0.3 0.3 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.3 0.7 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.2 0.4 0.0 0.2 0.3 0.0 0.6 0.0 0.4 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.2 0.0 0.2 0.2 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.0 1.1 0.0 0.1 1.4 0.3 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T12 ENSG00000177201 "Olfactory receptor family 2 subfamily T member 12" Q8NG77 1 248290139-248303424 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 2.4;epididymis: 2.9;liver: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 4.7;U-2197: 3.6" NA NA 0.1 0.1 0.1 0.2 0.3 0.9 0.2 0.1 0.4 0.4 0.2 0.1 0.3 2.9 0.1 0.3 0.0 0.1 0.4 0.4 0.1 4.7 0.2 0.2 0.4 0.2 0.1 0.0 0.2 0.0 0.1 0.4 0.1 0.0 0.2 0.7 0.3 0.0 0.2 0.2 0.2 0.7 0.6 0.2 0.2 0.2 1.3 0.6 2.4 0.4 1.0 0.8 0.1 1.0 0.3 0.4 0.8 0.1 0.2 0.8 0.1 0.1 0.1 0.2 0.7 0.6 1.1 0.5 0.1 0.5 0.3 0.2 0.3 0.2 0.9 0.3 0.9 4.7 0.7 0.1 0.9 1.2 0.2 0.2 0.3 0.0 0.3 0.1 0.6 0.4 2.1 0.1 0.9 1.4 0.8 1.3 0.4 0.3 0.5 0.6 0.7 0.2 1.1 0.7 0.8 0.6 0.9 0.3 1.0 0.7 0.9 1.2 1.0 0.9 3.6 0.6 0.9 0.9 0.5 0.6 0.5 0.8 2.4 0.4 0.3 0.8 0.3 0.6 0.8 0.6 0.6 0.2 1.3 0.8 0.8 1.1 1.0 0.4 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T2 OR2T2P ENSG00000196240 "Olfactory receptor family 2 subfamily T member 2" Q6IF00 1 248445512-248455725 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "kidney: 14.1" "Cell type enriched" "Detected in single" 14 "Proximal tubular cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Lineage enriched" "Detected in single" 20 "B-cells: 1.9" "Cell line enriched" "Detected in single" 22 "Karpas-707: 3.2" NA NA 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 1.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T27 ENSG00000187701 "Olfactory receptor family 2 subfamily T member 27" Q8NH04 1 248649838-248655528 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T29 ENSG00000182783 "Olfactory receptor family 2 subfamily T member 29" Q8NH02 1 248556912-248562772 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.5;kidney: 2.7;prostate: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "memory B-cell: 1.3;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 15 "B-cells: 1.5" "Cell line enriched" "Detected in single" 33 "Karpas-707: 3.2" NA NA 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.1 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T3 ENSG00000196539 "Olfactory receptor family 2 subfamily T member 3" Q8NH03 1 248473351-248474307 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "salivary gland: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T33 ENSG00000177212 "Olfactory receptor family 2 subfamily T member 33" Q8NG76 1 248269917-248277976 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.2;thyroid gland: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 2.1" NA NA "unprognostic (5.79e-2)" "unprognostic (2.22e-1)" 0.1 0.2 0.4 0.2 1.0 2.2 0.1 0.0 0.8 0.5 0.1 0.5 0.0 0.5 0.1 0.2 0.3 0.0 0.2 1.1 0.1 0.2 0.0 0.2 0.8 0.5 0.0 0.0 0.1 0.1 0.5 0.0 1.5 0.0 0.7 0.3 0.6 0.0 0.1 0.3 0.7 1.7 2.4 0.1 0.6 0.0 0.6 0.9 1.3 0.3 0.4 0.7 0.0 0.6 0.0 0.3 0.4 0.2 0.0 0.3 0.5 0.0 0.0 0.0 0.2 0.4 2.1 0.5 0.0 1.2 0.6 0.0 0.0 0.0 0.6 0.1 1.6 0.7 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.4 0.3 0.9 0.0 0.6 0.5 0.7 0.4 0.5 1.8 0.3 0.5 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.3 0.8 0.1 0.4 0.6 0.7 0.9 1.8 0.1 0.8 0.3 0.8 0.2 1.2 0.5 1.3 0.2 0.3 0.5 0.3 0.3 0.6 0.4 0.4 0.2 0.6 0.7 0.7 0.7 0.4 0.3 0.9 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T34 ENSG00000183310 "Olfactory receptor family 2 subfamily T member 34" Q8NGX1 1 248573801-248574757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "blood: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 15 "T-cells: 1.4" "Cell line enriched" "Detected in single" 15 "Karpas-707: 1.5" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T35 ENSG00000177151 "Olfactory receptor family 2 subfamily T member 35" Q8NGX2 1 248636356-248645278 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "Daudi: 1.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T4 OR2T4Q ENSG00000196944 "Olfactory receptor family 2 subfamily T member 4" Q8NH00 1 248361581-248362627 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 1.0;cervix, uterine: 1.1;prostate: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BJ hTERT+: 1.4" NA NA 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T5 ENSG00000203661 "Olfactory receptor family 2 subfamily T member 5" Q6IEZ7 1 248488589-248491113 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "salivary gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T6 "OR2T6P, OR2T9, OST703" ENSG00000198104 "Olfactory receptor family 2 subfamily T member 6" Q8NHC8 1 248375746-248391811 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.6;HBF TERT88: 1.2" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.1 0.8 0.1 0.0 0.8 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.3 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.6 0.3 0.0 1.6 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 1.2 0.0 0.3 0.1 0.2 0.1 0.0 0.3 0.4 0.0 0.1 0.1 0.7 0.3 0.1 0.1 0.6 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 0.5 0.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.7 0.2 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T8 OR2T8P ENSG00000177462 "Olfactory receptor family 2 subfamily T member 8" A6NH00 1 247920252-247921956 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 2.4;thyroid gland: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.0;HaCaT: 1.1;HEL: 2.6;PC-3: 1.9;U-2 OS: 1.2;U-937: 2.4" NA NA "unprognostic (7.26e-2)" "unprognostic (4.16e-1)" "unprognostic (2.88e-1)" "unprognostic (1.06e-1)" "unprognostic (2.83e-2)" 0.1 0.0 0.3 0.1 1.1 2.4 0.2 0.0 0.7 0.2 0.1 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 1.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 1.1 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OR2V1 "OR2V1P, OST265" ENSG00000185372 "Olfactory receptor family 2 subfamily V member 1" Q8NHB1 5 181123122-181131169 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "fallopian tube: 3.5;liver: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA049953 Uncertain NA NA "HPA049953: AB_2680971" 0.2 0.1 0.1 0.2 0.1 0.6 1.2 0.1 0.2 0.4 0.1 0.0 0.3 0.7 0.2 3.5 0.0 0.1 0.5 0.1 0.2 5.0 0.1 0.5 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.3 0.2 0.2 1.3 0.2 0.1 0.1 1.7 0.7 1.0 0.5 0.2 0.7 0.2 1.3 0.9 2.1 1.9 0.6 0.5 0.6 0.6 0.2 0.9 0.2 1.1 1.0 1.0 0.8 0.1 1.8 1.3 0.2 0.8 0.7 0.4 0.1 0.8 0.8 0.9 0.6 0.7 1.3 0.8 0.2 0.9 1.0 0.8 0.3 0.8 0.6 1.4 1.1 1.1 1.3 0.8 1.4 0.5 0.3 0.7 0.5 0.4 0.2 2.4 1.8 1.4 0.8 0.1 0.4 0.6 0.9 0.7 1.1 0.8 1.0 0.3 1.2 1.1 0.9 1.2 0.4 0.5 0.2 0.7 0.5 1.0 0.7 0.2 0.6 1.7 0.7 0.3 0.1 1.0 0.4 0.4 0.7 0.2 0.3 0.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2V2 "OR2V3, OST713" ENSG00000182613 "Olfactory receptor family 2 subfamily V member 2" Q96R30 5 181147586-181159285 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 2.8;bone marrow: 2.5;fallopian tube: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" HPA049953 Uncertain NA NA "HPA049953: AB_2680971" 0.3 0.2 0.2 0.3 0.2 2.5 0.1 0.3 0.3 0.3 0.1 0.1 0.2 0.0 0.2 2.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.2 0.7 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.9 0.3 0.0 0.1 0.3 0.4 0.7 0.4 0.0 0.2 0.1 0.7 0.4 2.8 0.3 0.5 0.3 0.1 0.4 0.8 0.5 0.8 0.2 0.0 0.4 0.2 0.1 0.0 0.3 0.4 1.0 0.2 0.2 0.0 0.1 0.6 0.2 0.1 0.1 0.1 0.7 0.8 1.9 0.7 0.0 0.7 1.0 0.1 0.1 0.0 0.0 0.7 0.0 0.7 0.5 1.1 0.0 1.6 0.6 0.4 0.4 0.1 0.6 0.4 0.2 0.5 0.0 0.8 0.6 0.5 0.5 1.7 0.4 0.6 0.8 1.4 0.4 0.4 0.7 0.7 0.2 0.8 0.3 0.3 0.5 0.7 0.1 2.8 0.3 0.6 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.7 0.3 0.3 1.6 0.5 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2W1 hs6M1-15 ENSG00000204704 "Olfactory receptor family 2 subfamily W member 1" Q9Y3N9 6 29044213-29045240 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2W3 "OR2W3P, OR2W8P, OST718" ENSG00000238243 "Olfactory receptor family 2 subfamily W member 3" Q7Z3T1 1 247895587-247896531 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "bone marrow: 13.8;thyroid gland: 8.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Cell type enhanced" "Detected in some" "myeloid DC: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 13.1;PC-3: 13.2;U-2 OS: 8.6;U-937: 6.2;WM-115: 9.4" HPA045594 Uncertain NA NA "HPA045594: AB_10960280" "unprognostic (9.44e-2)" "unprognostic (3.03e-1)" "unprognostic (3.29e-2)" "unprognostic (1.57e-5)" "unprognostic (1.98e-1)" "unprognostic (5.11e-2)" "unprognostic (2.79e-6)" "unprognostic (2.71e-1)" "unprognostic (1.03e-1)" "unprognostic (6.73e-2)" "unprognostic (1.48e-2)" "unprognostic (2.71e-3)" "unprognostic (9.05e-3)" "unprognostic (9.34e-3)" "unprognostic (5.66e-2)" "unprognostic (1.48e-1)" 0.2 0.7 0.6 0.3 1.6 13.8 0.2 0.0 2.2 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.4 1.7 0.0 0.1 0.5 0.0 1.1 0.0 0.2 0.0 0.3 1.6 0.5 0.6 0.0 0.0 0.0 0.3 0.2 0.4 0.4 0.8 0.1 1.1 8.2 0.0 0.3 0.2 0.6 1.4 1.0 0.6 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 3.9 0.0 0.0 0.0 0.3 13.1 0.0 0.0 0.0 1.7 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.3 3.9 0.0 0.0 0.0 0.0 0.1 0.5 0.0 13.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 8.6 0.0 0.0 1.5 0.0 0.0 0.0 6.2 9.4 0.0 0.2 1.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.6 0.2 0.0 0.8 0.0 0.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2Y1 ENSG00000174339 "Olfactory receptor family 2 subfamily Y member 1" Q8NGV0 5 180739042-180740099 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "salivary gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2Z1 OR2Z2 ENSG00000181733 "Olfactory receptor family 2 subfamily Z member 1" Q8NG97 19 8721634-8732160 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.4" "Not detected" "Not detected" HPA048760 Uncertain NA NA "HPA048760: AB_2680513" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR3A1 "OLFRA03, OR17-40, OR40" ENSG00000180090 "Olfactory receptor family 3 subfamily A member 1" P47881 17 3291017-3298360 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.4;testis: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 19 "B-cells: 1.4;dendritic cells: 1.8;T-cells: 2.4" "Cell line enriched" "Detected in some" 20 "HDLM-2: 20.9" "Low region specificity" "Detected in many" NA NA "unprognostic (3.69e-3)" "unprognostic (4.73e-2)" 0.0 0.4 0.1 0.0 0.4 0.0 0.4 0.0 0.3 0.6 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.4 0.5 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.2 4.1 0.0 0.2 0.0 0.0 1.4 1.8 0.0 0.1 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 1.9 1.4 1.4 1.6 0.6 0.4 0.0 2.4 0.0 0.0 0.0 1.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR3A2 "OLFRA04, OR17-228, OR228" ENSG00000221882 "Olfactory receptor family 3 subfamily A member 2" P47893 17 3276942-3386317 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 3.6;brain: 8.6;lymphoid tissue: 6.5;pituitary gland: 5.5;testis: 10.9" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 2: 4.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HDLM-2: 13.1;JURKAT: 14.2" NA NA "unprognostic (7.58e-2)" "unprognostic (5.10e-2)" "unprognostic (6.89e-2)" "unprognostic (1.12e-1)" "unprognostic (1.32e-1)" 0.5 0.5 2.2 0.5 8.6 0.5 0.6 0.4 2.8 0.6 0.4 1.2 0.0 0.4 0.5 1.5 0.4 0.3 0.2 0.4 2.5 1.2 0.5 0.3 0.8 6.5 1.4 0.6 1.0 0.4 0.2 5.5 1.0 2.7 0.7 0.4 1.3 0.3 0.5 0.8 0.6 0.5 0.4 1.9 0.9 0.4 10.9 2.1 2.3 0.3 0.0 0.7 0.6 0.4 3.0 3.4 3.6 0.6 0.7 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.6 0.7 0.9 0.3 1.6 3.0 1.2 0.3 0.8 0.8 1.2 1.8 1.6 0.7 0.4 3.4 0.5 0.8 2.2 8.6 0.4 2.8 2.5 1.2 1.4 0.6 2.7 2.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR3A3 "OR17-137, OR17-16, OR17-201, OR3A6, OR3A7, OR3A8P" ENSG00000159961 "Olfactory receptor family 3 subfamily A member 3" P47888 17 3411370-3424070 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 10.6;bone marrow: 2.6" "Cell type enriched" "Detected in single" 11 "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 10.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 10.6" "Cell line enriched" "Detected in single" 5 "HDLM-2: 4.4" NA NA "unprognostic (2.01e-1)" 0.1 0.0 0.6 0.2 0.9 2.6 0.1 1.2 0.4 0.2 0.2 0.5 0.4 0.1 0.0 0.2 0.5 0.2 0.6 0.5 0.2 0.2 0.1 0.8 1.1 0.1 0.0 0.0 0.3 0.4 0.1 0.0 0.1 0.1 0.5 1.0 0.0 0.0 0.5 0.4 0.4 1.1 0.2 0.4 0.3 0.2 0.3 10.6 0.6 0.2 0.2 0.2 0.0 0.2 0.1 0.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.5 0.1 0.3 0.1 0.0 0.1 0.2 0.1 0.0 0.0 4.4 0.5 0.4 0.6 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.4 0.4 0.0 0.3 0.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.3 0.1 0.2 0.9 0.3 0.2 0.1 0.0 0.3 0.2 0.3 0.3 0.3 0.2 0.4 0.2 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.2 0.6 0.2 0.1 10.6 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A15 ENSG00000181958 "Olfactory receptor family 4 subfamily A member 15" Q8NGL6 11 55367884-55368918 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A16 OR4A16Q ENSG00000181961 "Olfactory receptor family 4 subfamily A member 16" Q8NH70 11 55343151-55344231 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.6" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A47 ENSG00000237388 "Olfactory receptor family 4 subfamily A member 47" Q6IF82 11 48488717-48489780 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "blood: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "memory CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA059763 Uncertain NA NA "HPA059763: AB_2684122" 0.0 0.0 0.2 0.6 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A5 ENSG00000221840 "Olfactory receptor family 4 subfamily A member 5" Q8NH83 11 54706832-54707902 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4B1 OST208 ENSG00000175619 "Olfactory receptor family 4 subfamily B member 1" Q8NGF8 11 48216810-48217739 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059443 Uncertain NA NA "HPA059443: AB_2684019" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C11 OR4C11P ENSG00000172188 "Olfactory receptor family 4 subfamily C member 11" Q6IEV9 11 55602360-55607645 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C12 ENSG00000221954 "Olfactory receptor family 4 subfamily C member 12" Q96R67 11 49981473-49982535 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C13 ENSG00000258817 "Olfactory receptor family 4 subfamily C member 13" Q8NGP0 11 49952391-49953419 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C15 ENSG00000181939 "Olfactory receptor family 4 subfamily C member 15" Q8NGM1 11 55554307-55555419 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA061939 Uncertain NA NA "HPA061939: AB_2684643" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C16 ENSG00000279514 "Olfactory receptor family 4 subfamily C member 16 (gene/pseudogene)" Q8NGL9 11 55572128-55573060 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C3 ENSG00000176547 "Olfactory receptor family 4 subfamily C member 3" Q8NH37 11 48324920-48328471 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049116 Uncertain NA NA "HPA049116: AB_2680638" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C46 ENSG00000185926 "Olfactory receptor family 4 subfamily C member 46" A6NHA9 11 54603069-54603998 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C5 "OR4C5P, OR4C5Q" ENSG00000176540 "Olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)" Q8NGB2 11 48365485-48366465 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "NTERA-2: 1.4" "Not detected" "Not detected" HPA049516 Uncertain NA NA "HPA049516: AB_2680800" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C6 ENSG00000181903 "Olfactory receptor family 4 subfamily C member 6" Q8NH72 11 55662201-55666195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 1.8;lymphoid tissue: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "memory B-cell: 1.8" "Lineage enriched" "Detected in single" 18 "B-cells: 1.8" "Group enriched" "Detected in some" 5 "CAPAN-2: 8.1;Karpas-707: 8.6" NA NA 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 1.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D1 "OR4D3, TPCR16" ENSG00000141194 "Olfactory receptor family 4 subfamily D member 1" Q15615 17 58148449-58159555 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 4.4;bone marrow: 2.2;lymphoid tissue: 1.8;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "granulocytes: 2.0;NK-cells: 4.4;T-cells: 3.7" "Cell line enhanced" "Detected in some" "BEWO: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.1 0.1 0.5 0.1 2.2 0.1 0.1 0.6 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 1.8 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.1 0.0 0.1 1.3 0.1 1.5 0.1 0.9 0.5 0.1 0.2 0.4 2.0 0.1 4.4 3.7 0.9 0.2 0.3 0.1 0.7 0.0 0.3 3.7 0.2 0.0 0.1 0.3 0.4 0.6 0.2 0.2 0.1 0.4 0.2 0.3 0.1 0.2 0.4 1.1 0.2 0.4 0.3 0.3 0.5 0.3 0.0 0.4 0.4 0.4 0.1 0.1 0.5 0.6 1.0 0.0 0.4 0.3 0.7 1.9 0.1 0.4 0.2 0.1 0.5 0.1 0.5 0.7 0.6 0.3 0.8 0.0 0.7 0.4 0.8 0.0 0.4 1.1 0.6 0.3 0.4 0.4 0.5 0.5 1.0 0.6 2.0 0.1 0.8 2.3 0.1 2.4 0.2 2.2 2.1 0.1 0.2 3.4 3.7 0.8 4.4 0.1 0.4 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D10 "OR4D10P, OST711" ENSG00000254466 "Olfactory receptor family 4 subfamily D member 10" Q8NGI6 11 59473315-59479361 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 11 "thyroid cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.59e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D11 OR4D11P ENSG00000176200 "Olfactory receptor family 4 subfamily D member 11" Q8NGI4 11 59503576-59504511 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "AN3-CA: 1.2" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D2 ENSG00000255713 "Olfactory receptor family 4 subfamily D member 2" P58180 17 58166982-58171411 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D5 ENSG00000171014 "Olfactory receptor family 4 subfamily D member 5" Q8NGN0 11 123939543-123940637 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "pancreas: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045005 Uncertain NA NA "HPA045005: AB_10959302" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D6 ENSG00000166884 "Olfactory receptor family 4 subfamily D member 6" Q8NGJ1 11 59456938-59457991 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.96e-3)" 0.2 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D9 ENSG00000172742 "Olfactory receptor family 4 subfamily D member 9" Q8NGE8 11 59511368-59520703 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 4.6;bone marrow: 3.4" "Group enriched" "Detected in some" 15 "Alveolar cells type 2: 1.7;Ciliated cells: 1.4;Collecting duct cells: 1.8;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA 0.2 0.2 0.2 0.5 0.2 3.4 0.2 0.2 0.3 0.5 0.3 1.4 0.4 0.3 0.2 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.3 0.0 0.2 0.1 0.2 0.4 0.5 0.0 0.3 1.4 0.7 0.0 0.2 0.5 0.3 0.5 0.2 0.0 0.7 0.3 1.6 1.0 4.6 1.1 1.6 0.8 0.5 0.8 0.8 0.5 1.2 0.0 0.6 1.1 0.7 0.1 0.3 0.5 1.2 1.4 1.0 0.5 0.4 0.6 1.4 0.5 0.5 0.4 0.7 0.7 1.2 3.2 0.9 0.1 0.8 1.2 0.2 0.3 0.5 0.4 0.5 0.3 1.3 1.3 2.9 0.2 1.2 0.7 1.9 1.1 0.3 1.0 1.2 0.6 0.3 0.2 1.3 1.3 0.7 0.7 1.0 1.9 1.0 1.0 0.9 1.0 1.6 1.0 1.5 0.9 1.2 0.7 1.2 0.9 1.2 1.0 3.4 1.1 0.9 0.7 0.6 0.5 0.9 0.6 0.6 0.5 1.6 0.7 0.8 4.6 1.6 0.5 1.0 0.4 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4E1 OR4E1P ENSG00000276240 "Olfactory receptor family 4 subfamily E member 1 (gene/pseudogene)" 14 21667940-21673818 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.9;bone marrow: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA 0.0 0.0 0.8 1.4 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.4 0.9 0.0 0.0 0.8 0.1 0.4 0.2 0.1 0.0 1.3 0.4 2.9 0.5 0.9 1.1 0.0 0.3 0.2 0.3 0.5 0.2 0.0 0.2 0.7 0.0 0.3 0.0 0.4 0.6 0.2 0.4 0.0 0.5 0.5 0.0 0.0 0.6 0.3 0.0 0.8 1.2 0.5 0.0 0.0 0.3 0.8 0.7 0.4 0.1 0.4 0.1 0.4 0.1 0.3 0.5 0.5 0.1 0.5 0.3 0.1 0.5 0.1 0.0 0.2 0.3 0.2 0.8 0.0 0.6 0.7 0.3 0.3 0.5 0.0 0.7 1.1 0.4 0.7 0.4 0.6 0.3 0.0 0.0 0.8 0.2 2.0 0.5 0.3 0.5 0.3 0.8 0.7 0.5 0.4 0.1 1.3 1.1 1.1 2.9 0.9 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4E2 ENSG00000221977 "Olfactory receptor family 4 subfamily E member 2" Q8NGC2 14 21653835-21667642 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "blood: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.5 0.5 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.1 0.8 0.1 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.6 0.0 0.5 0.2 1.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.8 0.0 0.0 0.2 0.1 0.3 0.0 0.8 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.6 0.1 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 1.0 0.4 0.1 0.2 0.0 0.2 0.1 0.1 0.3 0.0 0.5 0.3 0.5 0.8 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F15 ENSG00000182854 "Olfactory receptor family 4 subfamily F member 15" Q8NGB8 15 101812202-101820197 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 2.7;neutrophil: 1.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.7" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA 0.1 0.1 0.1 0.8 0.1 0.7 0.1 0.1 0.3 0.7 0.1 0.5 0.3 0.2 0.4 0.4 0.4 0.4 0.0 0.1 0.1 0.1 0.5 0.2 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 1.1 0.4 0.0 0.1 0.8 0.1 0.4 0.4 0.0 0.3 0.2 0.5 0.3 2.7 0.3 0.5 0.2 0.1 0.1 0.0 0.9 0.9 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.2 0.5 1.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.7 1.1 0.4 0.0 0.2 1.0 0.6 0.0 0.2 0.0 0.3 0.0 0.5 0.3 0.4 0.0 0.7 0.1 0.7 0.5 0.0 0.5 0.3 0.1 0.3 0.5 0.3 0.3 0.0 0.2 0.3 0.0 0.5 0.5 0.6 0.0 1.5 0.5 1.2 0.7 0.9 0.3 0.5 1.5 0.3 0.8 2.7 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.2 0.2 1.9 0.5 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F16 ENSG00000284662 "Olfactory receptor family 4 subfamily F member 16" Q6IEY1 1 685679-686673 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.4 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.0 0.3 0.0 0.0 0.3 0.7 0.2 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F17 "OR4F11P, OR4F18, OR4F19" ENSG00000176695 "Olfactory receptor family 4 subfamily F member 17" Q8NGA8 19 107104-117102 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "urinary bladder: 1.0" "Group enriched" "Detected in some" 462 "Alveolar cells type 1: 71.5;Alveolar cells type 2: 42.0;Ciliated cells: 44.2;Club cells: 47.8;granulocytes: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 71.5 42.0 0.0 0.0 0.0 0.0 0.0 0.0 44.2 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F21 OR4F21P ENSG00000176269 "Olfactory receptor family 4 subfamily F member 21" O95013 8 166049-167043 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 5.6" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.1 0.0 0.0 0.3 0.2 0.0 0.4 0.6 0.2 0.3 0.2 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.7 0.6 0.0 0.5 1.0 0.3 0.1 0.1 0.0 0.0 0.8 0.2 0.2 0.1 0.5 0.2 1.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F29 ENSG00000284733 "Olfactory receptor family 4 subfamily F member 29" Q6IEY1 1 450703-451697 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.4 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.0 0.3 0.0 0.0 0.3 0.7 0.2 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F3 ENSG00000230178 "Olfactory receptor family 4 subfamily F member 3" Q6IEY1 5 181367268-181368262 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.0 0.1 0.1 0.0 0.4 0.0 0.4 0.2 0.2 0.3 0.1 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.2 0.2 0.2 0.4 0.1 0.1 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.6 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.4 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.0 0.3 0.0 0.0 0.3 0.7 0.2 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F4 OR4F18 ENSG00000177693 "Olfactory receptor family 4 subfamily F member 4" Q96R69 15 101922042-101923095 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "cervix, uterine: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F5 ENSG00000186092 "Olfactory receptor family 4 subfamily F member 5" Q8NH21 1 65419-71585 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F6 OR4F12 ENSG00000184140 "Olfactory receptor family 4 subfamily F member 6" Q8NGB9 15 101803509-101806887 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K1 ENSG00000155249 "Olfactory receptor family 4 subfamily K member 1" Q8NGD4 14 19930917-19936757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "testis: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HEL: 3.2" "Not detected" "Not detected" HPA028877 Uncertain NA NA "HPA028877: AB_10600923" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K13 ENSG00000176253 "Olfactory receptor family 4 subfamily K member 13" Q8NH42 14 20029399-20036038 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.7;skin 1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" NA NA 0.1 0.6 0.1 0.4 0.1 1.2 0.1 0.1 0.3 0.4 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.3 1.6 0.1 0.0 0.1 0.4 0.1 0.5 0.4 0.0 0.2 0.3 0.8 0.6 1.7 0.6 0.8 0.3 0.2 0.2 0.1 0.4 0.7 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.4 0.4 0.4 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.5 1.1 0.6 0.3 0.3 0.6 0.0 0.2 0.1 0.0 0.3 0.0 0.3 0.3 1.2 0.0 0.5 0.6 0.4 0.4 0.1 0.0 0.4 0.1 0.2 0.0 0.4 0.4 0.3 0.1 0.2 0.1 0.3 0.9 0.0 0.2 0.8 0.4 0.7 0.2 0.6 0.3 0.4 0.6 0.3 0.1 1.7 0.6 0.3 0.2 0.3 0.2 0.3 0.2 0.3 0.1 0.8 0.3 0.3 1.3 0.8 0.3 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K14 ENSG00000169484 "Olfactory receptor family 4 subfamily K member 14" Q8NGD5 14 20014143-20019307 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K15 OR4K15Q ENSG00000169488 "Olfactory receptor family 4 subfamily K member 15" Q8NH41 14 19975444-19976659 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055732 Uncertain NA NA "HPA055732: AB_2682900" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K17 ENSG00000176230 "Olfactory receptor family 4 subfamily K member 17" Q8NGC6 14 20110739-20122199 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 3.5;liver: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA 0.2 0.2 0.2 0.4 0.2 3.5 0.2 0.2 0.3 1.0 0.3 0.7 0.4 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.4 7.7 0.2 0.5 0.3 0.2 0.3 0.0 0.2 0.0 0.3 0.0 0.4 0.0 1.3 0.9 0.2 0.0 0.2 0.3 0.3 0.4 0.3 0.0 0.4 0.3 1.3 1.2 3.0 1.3 1.4 1.3 0.5 1.3 1.3 1.6 1.5 0.3 0.2 1.9 0.4 0.0 0.1 0.2 1.3 1.9 2.2 1.2 0.2 1.1 1.2 0.2 0.6 0.2 2.0 1.1 2.5 2.0 0.8 0.3 2.6 2.0 0.4 0.4 0.5 0.4 1.0 0.3 2.0 2.4 2.3 0.1 1.9 1.2 2.8 2.0 1.5 1.0 1.0 1.5 1.5 0.2 2.1 1.3 1.5 2.0 1.4 0.6 1.4 1.4 1.2 1.1 1.4 0.8 1.2 1.0 2.5 1.2 2.4 1.4 1.4 0.6 3.0 1.0 1.4 0.8 1.0 0.9 1.0 1.0 0.9 0.6 1.3 1.3 1.2 2.7 1.4 1.3 1.2 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K2 ENSG00000165762 "Olfactory receptor family 4 subfamily K member 2" Q8NGD2 14 19875142-19883932 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K5 ENSG00000176281 "Olfactory receptor family 4 subfamily K member 5" Q8NGD3 14 19920582-19921659 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4L1 OR4L2P ENSG00000176246 "Olfactory receptor family 4 subfamily L member 1" Q8NH43 14 20060045-20060983 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "SK-BR-3: 1.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4M1 ENSG00000176299 "Olfactory receptor family 4 subfamily M member 1" Q8NGD0 14 19773504-19783696 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 32 "testis: 3.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 OR4M2 ENSG00000274102 "Olfactory receptor family 4 subfamily M member 2" Q8NGB6 15 22070241-22083221 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.1" "Cell type enriched" "Detected in single" 9 "Sertoli cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "U-2 OS: 1.0" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4N2 ENSG00000176294 "Olfactory receptor family 4 subfamily N member 2" Q8NGD1 14 19719015-19830253 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 9.0" "Group enriched" "Detected in some" 43 "Early spermatids: 23.4;Late spermatids: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hTERT-HME1: 2.7;U-2 OS: 6.7" NA NA "unprognostic (2.80e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 OR4N4 ENSG00000183706 "Olfactory receptor family 4 subfamily N member 4" Q8N0Y3 15 22094522-22095472 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 22 "testis: 13.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 20.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.7;THP-1: 2.9" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 OR4N5 ENSG00000184394 "Olfactory receptor family 4 subfamily N member 5" Q8IXE1 14 20138820-20145471 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 116 "HEL: 11.6" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4P4 OR4P3P ENSG00000181927 "Olfactory receptor family 4 subfamily P member 4" Q8NGL7 11 55635113-55640309 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.6;bone marrow: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.7;MOLT-4: 1.6" HPA059458 Uncertain NA NA "HPA059458: AB_2684027" 0.1 0.3 0.1 0.0 0.1 2.2 0.1 0.1 0.3 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.7 1.3 0.2 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.3 0.1 0.7 0.4 1.6 0.2 1.3 0.4 0.2 0.1 0.7 0.2 0.7 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.1 0.0 0.1 0.2 0.2 0.2 0.1 0.7 0.8 0.2 1.7 0.5 0.0 0.5 0.7 0.0 0.0 0.2 0.8 0.1 0.1 0.7 0.0 0.4 0.0 0.0 1.6 1.1 0.7 0.0 0.0 0.2 0.3 1.1 0.0 0.8 0.3 0.6 0.2 0.3 0.7 0.1 0.7 0.1 0.0 0.8 0.0 0.0 0.2 0.4 0.3 0.3 0.4 0.4 0.4 0.9 0.1 0.4 0.4 0.2 0.3 0.4 0.2 0.3 0.1 0.7 0.3 0.3 1.6 1.3 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4Q3 "C14orf13, OR4Q4" ENSG00000182652 "Olfactory receptor family 4 subfamily Q member 3" Q8NH05 14 19743571-19749469 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.0;testis: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "A549: 2.2;Karpas-707: 1.2" "Not detected" "Not detected" HPA049924 Uncertain NA NA "HPA049924: AB_2680955" 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.2 0.2 1.0 0.2 0.3 0.3 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.2 0.0 0.2 0.1 0.3 1.0 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4S1 ENSG00000176555 "Olfactory receptor family 4 subfamily S member 1" Q8NGB4 11 48306223-48307152 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "NTERA-2: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4S2 "OR4S2P, OST725" ENSG00000174982 "Olfactory receptor family 4 subfamily S member 2" Q8NH73 11 55648327-55652854 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 0.6;hippocampal formation: 0.6" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4X1 ENSG00000176567 "Olfactory receptor family 4 subfamily X member 1 (gene/pseudogene)" Q8NH49 11 48263861-48264778 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4X2 ENSG00000172208 "Olfactory receptor family 4 subfamily X member 2 (gene/pseudogene)" Q8NGF9 11 48245056-48246080 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "bone marrow: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51A2 ENSG00000205496 "Olfactory receptor family 51 subfamily A member 2" Q8NGJ7 11 4954772-4955713 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51A4 ENSG00000205497 "Olfactory receptor family 51 subfamily A member 4" Q8NGJ6 11 4942831-4947605 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51A7 ENSG00000176895 "Olfactory receptor family 51 subfamily A member 7" Q8NH64 11 4903783-4909462 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA061356 Uncertain NA NA "HPA061356: AB_2684488" "unprognostic (4.57e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51B2 OR51B1P ENSG00000279012 "Olfactory receptor family 51 subfamily B member 2 (gene/pseudogene)" Q9Y5P1 11 5323359-5324297 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 3.1;U-2197: 2.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51B4 ENSG00000183251 "Olfactory receptor family 51 subfamily B member 4" Q9Y5P0 11 5301014-5301946 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "ovary: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "K-562: 7.2;U-2197: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.16e-2)" "unprognostic (5.01e-1)" 0.3 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.7 0.1 0.0 0.6 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 1.6 0.2 0.0 0.3 0.7 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 1.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.8 9.2 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51B5 ENSG00000167355 "Olfactory receptor family 51 subfamily B member 5" Q9H339 11 5303444-5505652 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.0;epididymis: 1.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.1" "Cell type enriched" "Detected in single" 4 "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 4 "T-cells: 1.0" "Group enriched" "Detected in some" 6 "K-562: 9.3;U-2197: 2.8" "Region enhanced" "Detected in single" "olfactory region: 0.3" HPA063124 Uncertain NA NA "HPA063124: AB_2684943" "unprognostic (9.22e-3)" "unprognostic (1.80e-1)" "unprognostic (2.01e-1)" "unprognostic (3.76e-2)" "unprognostic (4.75e-1)" "unprognostic (1.36e-1)" "unprognostic (7.37e-5)" "unprognostic (2.94e-1)" "unprognostic (2.43e-1)" "unprognostic (4.20e-2)" "unprognostic (2.71e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.3 0.0 0.1 0.5 0.3 0.0 0.0 0.6 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51B6 ENSG00000176239 "Olfactory receptor family 51 subfamily B member 6" Q9H340 11 5351508-5352446 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HBF TERT88: 1.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51D1 OR51D1Q ENSG00000197428 "Olfactory receptor family 51 subfamily D member 1" Q8NGF3 11 4637477-4643060 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 1.0;SCLC-21H: 1.1" "Not detected" "Not detected" HPA061240 Uncertain NA NA "HPA061240: AB_2684457" "unprognostic (1.90e-1)" 1.1 0.1 0.0 0.2 0.0 0.8 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.1 0.4 0.0 0.0 0.7 0.1 0.4 0.0 0.1 0.4 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.5 0.0 1.0 0.6 1.3 0.7 0.1 0.6 0.0 0.3 0.3 0.0 0.1 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 1.1 0.2 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.1 0.3 0.0 0.1 1.3 0.7 0.4 0.6 0.3 0.5 0.4 0.5 0.3 0.1 1.0 0.5 0.6 1.3 0.1 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51E1 "GPR136, GPR164, OR51E1P, OR52A3P" ENSG00000180785 "Olfactory receptor family 51 subfamily E member 1" Q8TCB6 11 4643420-4655488 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 10.0;prostate: 12.1" "Group enriched" "Detected in some" 6 "Intestinal endocrine cells: 20.4;Sertoli cells: 25.8" "Cancer enriched" "Detected in many" 21 "prostate cancer: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 114 "SCLC-21H: 14.4" "Low region specificity" "Detected in many" "CAB019995, HPA051439" Approved NA NA "CAB019995: AB_10283600, HPA051439: AB_2681487" "unprognostic (6.67e-3)" "unprognostic (2.34e-3)" "unprognostic (9.71e-2)" "unprognostic (4.87e-5)" "unprognostic (3.55e-2)" "unprognostic (9.80e-3)" "unprognostic (1.76e-1)" "unprognostic (2.30e-3)" "unprognostic (2.00e-2)" "unprognostic (3.94e-3)" "unprognostic (7.36e-2)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.23e-6)" "unprognostic (2.72e-3)" "unprognostic (1.12e-1)" "unprognostic (1.61e-1)" "unprognostic (2.86e-1)" 7.6 0.0 0.6 1.9 0.8 0.0 5.1 0.1 0.6 0.9 2.6 0.1 0.1 0.4 2.5 0.3 0.8 0.8 0.7 4.8 0.1 0.2 1.6 0.1 0.1 1.9 0.6 0.1 1.0 0.1 0.2 1.0 10.0 0.6 12.1 1.1 0.8 4.4 0.8 2.4 0.3 2.1 1.3 1.8 0.1 0.9 0.3 0.1 0.1 0.9 0.9 0.4 1.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.1 0.6 0.1 0.2 0.6 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.1 0.0 20.4 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 25.8 3.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 OR51E2 PSGR ENSG00000167332 "Olfactory receptor family 51 subfamily E member 2" Q9H255 11 4680171-4697854 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "prostate: 42.1;retina: 14.6" "Cell type enriched" "Detected in some" 13 "Intestinal endocrine cells: 74.5" "Cancer enriched" "Detected in some" 274 "prostate cancer: 217.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.9;BJ hTERT+: 3.3;hTERT-RPE1: 4.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (1.98e-3)" "unprognostic (1.91e-1)" "unprognostic (6.09e-3)" "unprognostic (1.57e-2)" "unprognostic (8.00e-4)" "unprognostic (3.61e-2)" "unprognostic (6.27e-2)" "unprognostic (1.66e-1)" "unprognostic (3.05e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-1)" "unprognostic (3.61e-1)" "unprognostic (5.04e-5)" "unprognostic (3.34e-2)" "unprognostic (4.66e-2)" "unprognostic (5.76e-2)" "unprognostic (3.29e-1)" 0.7 0.2 0.2 5.0 0.2 0.1 1.7 0.1 0.5 0.6 8.2 0.0 0.5 0.2 1.6 1.3 0.6 0.6 0.3 1.1 0.2 0.2 0.4 0.1 0.1 0.0 0.2 0.0 1.1 0.2 0.1 0.2 5.1 0.4 42.1 2.2 14.6 0.2 2.4 0.5 0.3 0.9 2.0 0.2 0.1 0.5 0.7 0.0 0.0 0.2 0.4 0.0 1.6 0.3 1.6 0.9 2.2 0.6 0.8 1.2 0.4 0.0 0.0 0.1 0.1 0.7 5.9 0.2 0.0 3.3 0.0 0.2 0.2 0.3 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 1.1 1.1 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 4.3 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.3 0.0 0.3 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.5 0.4 0.7 0.3 0.0 0.4 0.0 0.1 0.4 0.0 0.0 1.5 0.6 0.5 1.2 0.5 0.8 0.8 0.8 0.6 0.3 1.6 0.8 1.1 2.2 0.8 0.5 0.9 0.4 0.4 0.2 0.2 0.1 0.5 0.2 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.6 0.0 0.0 0.1 0.0 74.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51F1 OR51F1P ENSG00000280021 "Olfactory receptor family 51 subfamily F member 1 (gene/pseudogene)" A6NGY5 11 4768979-4769938 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "CACO-2: 1.6" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51F2 ENSG00000176925 "Olfactory receptor family 51 subfamily F member 2" Q8NH61 11 4821321-4822456 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51G1 OR51G3P ENSG00000278870 "Olfactory receptor family 51 subfamily G member 1 (gene/pseudogene)" Q8NGK1 11 4923374-4924339 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "CAPAN-2: 1.0" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51G2 ENSG00000176893 "Olfactory receptor family 51 subfamily G member 2" Q8NGK0 11 4912588-4919350 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51I1 ENSG00000167359 "Olfactory receptor family 51 subfamily I member 1" Q9H343 11 5440570-5441514 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.8;testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 1.0;U-2197: 1.6" "Not detected" "Not detected" "Region enriched" "Detected in some" 9 "olfactory region: 6.3" NA NA "unprognostic (2.36e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.2 1.8 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51I2 ENSG00000187918 "Olfactory receptor family 51 subfamily I member 2" Q9H344 11 5449323-5456518 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "blood: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "basophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Cell line enhanced" "Detected in single" "U-2197: 1.0" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51L1 ENSG00000176798 "Olfactory receptor family 51 subfamily L member 1" Q8NGJ5 11 4994851-5005536 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "TIME: 1.0;U-2197: 1.4" "Low region specificity" "Detected in some" NA NA 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.3 0.1 0.1 0.6 0.2 0.3 0.5 0.7 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.2 0.1 0.1 0.5 0.0 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.1 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.5 0.0 1.4 0.1 0.2 0.0 0.0 0.1 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51M1 ENSG00000184698 "Olfactory receptor family 51 subfamily M member 1" Q9H341 11 5383812-5393263 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.4;Club cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "RT4: 4.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "olfactory region: 0.4" HPA056773 Uncertain NA NA "HPA056773: AB_2683233" 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51Q1 ENSG00000167360 "Olfactory receptor family 51 subfamily Q member 1 (gene/pseudogene)" Q8NH59 11 5422111-5423206 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;epididymis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "RT4: 8.0" "Region enriched" "Detected in single" 11 "olfactory region: 4.5" HPA044998 Uncertain NA NA "HPA044998: AB_10794780" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.2 0.0 0.0 0.0 2.0 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51S1 ENSG00000176922 "Olfactory receptor family 51 subfamily S member 1" Q8NGJ8 11 4847489-4849238 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (4.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51T1 ENSG00000176900 "Olfactory receptor family 51 subfamily T member 1" Q8NGJ9 11 4881819-4882883 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "prostate: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons and medulla: 0.5" "Low region specificity" "Detected in some" HPA046877 Uncertain NA NA "HPA046877: AB_2679853" "unprognostic (2.59e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51V1 OR51A12 ENSG00000176742 "Olfactory receptor family 51 subfamily V member 1" Q9H2C8 11 5199735-5200700 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "bone marrow: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "HMC-1: 1.0" "Region enriched" "Detected in single" 9 "olfactory region: 0.3" NA NA 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52A1 HPFH1OR ENSG00000182070 "Olfactory receptor family 52 subfamily A member 1" Q9UKL2 11 5143219-5154757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3;testis: 1.9" "Group enriched" "Detected in some" 33 "Ciliated cells: 22.7;Club cells: 18.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 3.0;U-266/70: 3.5" NA NA 0.2 0.3 0.2 0.5 0.2 0.6 0.4 1.1 0.3 0.2 0.2 0.4 0.3 0.4 0.2 0.6 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.0 0.3 0.0 0.4 0.0 1.2 0.9 0.4 0.0 0.2 0.2 0.5 1.9 0.2 0.0 0.2 0.2 1.3 0.6 2.3 0.5 0.8 0.5 0.1 0.4 0.6 0.1 0.5 0.0 0.1 1.2 0.4 0.0 0.2 0.0 0.6 1.1 0.5 0.5 0.0 0.3 0.5 0.0 0.0 0.0 2.5 0.4 0.6 1.6 0.5 0.0 0.7 1.6 0.0 0.2 0.2 0.0 0.2 0.1 0.7 0.9 2.6 0.0 0.7 0.3 1.5 1.7 0.3 0.3 0.6 0.3 0.7 0.1 0.5 0.8 0.9 0.4 1.7 0.3 0.6 0.7 1.3 0.4 0.6 3.0 0.6 0.4 3.5 0.8 1.0 0.4 0.6 0.3 1.7 0.5 1.4 0.4 0.3 0.4 1.2 0.4 0.4 0.2 1.3 0.5 0.4 2.3 0.8 0.3 0.6 0.3 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 22.7 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52A5 ENSG00000171944 "Olfactory receptor family 52 subfamily A member 5" Q9H2C5 11 5128776-5138356 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "bone marrow: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52B2 ENSG00000255307 "Olfactory receptor family 52 subfamily B member 2" Q96RD2 11 6169330-6170408 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.53e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.3 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52B4 ENSG00000221996 "Olfactory receptor family 52 subfamily B member 4 (gene/pseudogene)" Q8NGK2 11 4367263-4368386 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "ASC TERT1: 1.1" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.6 0.1 0.8 0.0 0.2 0.2 0.0 0.5 0.2 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52B6 ENSG00000187747 "Olfactory receptor family 52 subfamily B member 6" Q8NGF0 11 5580877-5581884 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "ovary: 1.4;pancreas: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.57e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.0 1.4 1.8 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52D1 ENSG00000181609 "Olfactory receptor family 52 subfamily D member 1" Q9H346 11 5488685-5489749 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046965 Uncertain NA NA "HPA046965: AB_2679878" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E2 ENSG00000176787 "Olfactory receptor family 52 subfamily E member 2" Q8NGJ4 11 5058650-5059627 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 10 "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045748 Uncertain NA NA "HPA045748: AB_10959665" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E4 ENSG00000180974 "Olfactory receptor family 52 subfamily E member 4" Q8NGH9 11 5880629-5887079 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA 0.3 0.5 0.3 0.4 0.3 0.9 0.3 0.3 0.6 0.3 0.3 0.2 0.6 1.8 0.3 0.4 0.7 0.3 0.3 0.3 0.3 1.2 0.3 0.7 0.3 0.4 0.5 0.6 0.3 0.0 0.3 0.0 0.3 0.0 0.8 2.0 0.3 0.0 0.3 0.4 0.3 1.7 1.2 0.0 0.3 0.3 0.4 0.6 1.5 0.2 0.1 1.1 0.3 2.9 0.4 0.6 1.9 0.4 0.5 1.3 1.2 0.2 0.2 0.3 2.4 1.2 1.9 0.6 0.3 0.6 0.7 0.2 2.3 0.1 1.7 0.8 1.6 2.6 1.9 0.2 1.3 1.1 0.3 2.0 0.1 0.7 0.8 0.7 1.6 0.9 1.6 0.2 1.2 1.4 1.9 1.3 1.0 1.5 0.9 0.7 1.0 0.6 1.6 2.3 1.4 0.9 1.4 0.6 1.2 1.2 0.6 1.0 0.9 1.0 0.8 0.7 1.4 0.8 0.7 0.8 0.8 0.7 1.5 0.1 0.4 0.9 0.2 0.3 0.4 0.4 1.0 0.1 0.4 0.4 1.1 0.9 0.1 0.2 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E5 ENSG00000277932 "Olfactory receptor family 52 subfamily E member 5" Q8NH55 11 5893208-5902730 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E6 ENSG00000205409 "Olfactory receptor family 52 subfamily E member 6" Q96RD3 11 5840928-5841952 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "T-47d: 2.1" NA NA "unprognostic (2.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E8 ENSG00000183269 "Olfactory receptor family 52 subfamily E member 8" Q6IFG1 11 5856674-5857734 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52H1 ENSG00000181616 "Olfactory receptor family 52 subfamily H member 1" Q8NGJ2 11 5544489-5548533 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "BJ hTERT+ SV40 Large T+ RasG12V: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (2.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.4 0.1 0.0 0.2 1.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.8 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OR52I1 ENSG00000232268 "Olfactory receptor family 52 subfamily I member 1" Q8NGK6 11 4593614-4596574 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 11 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 9.2;Ciliated cells: 9.4;Club cells: 15.9;granulocytes: 8.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "unprognostic (2.95e-1)" 0.2 0.3 0.2 0.6 0.3 2.1 0.7 1.9 0.6 0.2 0.3 0.8 0.4 0.6 0.2 1.0 0.5 0.3 0.3 0.2 0.3 0.3 0.3 0.6 0.3 0.6 0.4 1.0 0.4 0.0 0.8 0.5 0.5 0.0 0.5 2.4 0.6 0.1 0.2 0.9 0.6 1.0 0.5 0.5 0.6 0.4 1.1 0.7 1.6 0.6 0.7 0.7 0.1 0.8 0.2 0.5 1.5 0.4 0.7 0.5 0.5 0.3 0.3 0.2 0.2 1.0 1.3 0.6 0.0 0.3 0.9 0.5 0.0 0.4 0.7 0.5 0.4 0.9 0.5 0.0 1.2 1.7 0.2 0.0 0.4 1.0 0.6 0.4 0.5 1.3 1.9 0.8 0.3 0.8 2.0 0.8 0.5 1.0 2.2 1.6 1.8 0.1 0.7 1.2 1.1 1.5 0.6 0.2 0.4 1.2 2.2 0.0 1.8 1.3 1.8 0.7 1.1 1.4 1.1 1.0 1.8 2.1 0.4 0.5 1.6 0.7 0.4 0.4 0.6 0.5 0.3 0.2 1.1 0.4 0.4 1.4 0.7 0.6 0.7 0.3 0.1 8.9 9.2 0.0 0.0 0.0 0.0 0.0 0.0 9.4 15.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52I2 ENSG00000226288 "Olfactory receptor family 52 subfamily I member 2" Q8NH67 11 4581743-4593340 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049343 Uncertain NA NA "HPA049343: AB_2680721" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 2.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52J3 ENSG00000205495 "Olfactory receptor family 52 subfamily J member 3" Q8NH60 11 5046526-5047461 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-266/70: 2.0" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52K1 ENSG00000196778 "Olfactory receptor family 52 subfamily K member 1" Q8NGK4 11 4482646-4493497 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.1;bone marrow: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 5.1;RT4: 7.5" NA NA 0.3 0.3 0.3 0.8 0.3 3.9 0.2 0.2 0.3 0.3 0.3 0.5 0.3 0.5 0.3 0.3 0.2 0.2 0.3 0.2 0.9 0.8 0.5 0.9 0.4 1.2 0.3 0.0 0.2 1.4 0.3 0.1 0.3 0.0 0.4 1.2 1.8 0.0 0.5 0.9 0.2 1.1 0.3 0.6 0.4 0.4 0.6 0.6 3.1 1.4 0.3 0.5 0.3 0.9 1.9 1.4 1.5 0.3 0.2 0.9 1.3 0.3 0.8 0.8 1.8 1.5 1.1 1.2 0.7 0.9 1.8 1.4 0.8 1.0 0.6 0.8 1.4 5.1 1.9 0.2 0.7 2.0 0.4 0.3 0.9 0.7 0.5 0.6 1.4 0.9 2.7 2.1 1.0 0.5 1.6 0.8 0.3 1.1 1.8 1.0 0.8 0.5 7.5 1.6 0.7 0.4 0.6 0.3 1.3 1.1 0.5 0.3 2.6 0.7 0.8 2.7 1.5 0.7 0.7 0.6 2.5 1.6 0.7 1.4 0.4 0.4 1.2 0.2 0.3 0.3 0.5 0.6 0.6 0.4 0.5 3.1 0.3 1.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52K2 ENSG00000181963 "Olfactory receptor family 52 subfamily K member 2" Q8NGK3 11 4449295-4450361 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 6.9;bone marrow: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 1.9;neutrophil: 6.9" "Group enriched" "Detected in many" 25 "granulocytes: 6.9;monocytes: 1.9" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 6.9 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.9 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52L1 ENSG00000183313 "Olfactory receptor family 52 subfamily L member 1" Q8NGH7 11 5985892-5986985 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.5 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52M1 OR52M1P ENSG00000197790 "Olfactory receptor family 52 subfamily M member 1" Q8NGK5 11 4545191-4546144 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "blood: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52N1 ENSG00000181001 "Olfactory receptor family 52 subfamily N member 1" Q8NH53 11 5786471-5791265 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "adipose tissue: 1.8;bone marrow: 1.4" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 1.4;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "Karpas-707: 1.7" HPA054028 Uncertain NA NA "HPA054028: AB_2682348" 1.8 0.0 0.0 0.3 0.0 1.4 0.3 0.0 0.2 0.0 0.1 0.0 0.4 0.1 0.1 0.2 0.9 0.2 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.3 0.1 0.6 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.5 0.7 1.2 0.6 1.0 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.3 0.0 0.2 0.7 0.5 0.0 0.2 0.3 0.2 0.0 0.1 0.0 0.7 0.8 0.7 0.2 0.1 0.2 0.0 0.1 0.4 0.6 1.2 0.6 0.2 0.5 0.4 0.6 0.5 0.7 0.6 0.0 0.5 0.7 0.7 0.5 1.0 0.5 0.7 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52N2 ENSG00000180988 "Olfactory receptor family 52 subfamily N member 2" Q8NGI0 11 5820314-5821348 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 7.0;testis: 2.9" "Group enriched" "Detected in some" 26 "Early spermatids: 2.2;Late spermatids: 3.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 29 "basophil: 7.0" "Lineage enriched" "Detected in single" 29 "granulocytes: 7.0" "Cell line enhanced" "Detected in some" "HDLM-2: 1.7;SK-BR-3: 1.4" NA NA "unprognostic (3.45e-1)" "unprognostic (2.81e-1)" "unprognostic (3.44e-1)" "unprognostic (7.82e-2)" 0.7 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.1 0.0 0.2 0.3 0.1 0.7 0.9 0.3 0.1 0.0 0.3 0.0 0.3 0.3 0.0 0.3 0.1 0.0 0.3 0.0 0.2 0.0 0.2 0.5 0.2 0.7 0.8 0.0 0.1 1.1 0.0 2.9 0.0 0.5 0.1 0.1 0.0 0.2 7.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52N4 ENSG00000181074 "Olfactory receptor family 52 subfamily N member 4 (gene/pseudogene)" Q8NGI2 11 5754243-5755905 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3;T-reg: 3.1" "Group enriched" "Detected in many" 6 "B-cells: 2.3;T-cells: 3.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.5;BJ hTERT+ SV40 Large T+ RasG12V: 1.5;hTERT-RPE1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.44e-2)" "unprognostic (2.59e-3)" "unprognostic (4.06e-2)" "unprognostic (1.32e-1)" "unprognostic (2.86e-4)" "unprognostic (1.75e-1)" "unprognostic (1.95e-1)" "unprognostic (3.03e-1)" "unprognostic (5.08e-2)" "unprognostic (2.62e-1)" "unprognostic (5.62e-2)" "unprognostic (1.41e-3)" "unprognostic (1.41e-1)" "unprognostic (3.80e-2)" "unprognostic (3.18e-2)" "unprognostic (4.41e-2)" 1.3 0.4 0.1 1.1 0.1 0.8 1.4 0.0 0.4 0.8 0.6 0.0 1.4 3.4 0.7 1.6 0.5 0.7 0.2 0.1 1.1 0.3 1.3 2.9 0.2 3.5 0.0 0.0 0.9 0.0 1.2 0.6 0.6 1.8 0.2 0.6 3.6 0.1 0.5 5.7 0.4 0.6 0.6 2.9 0.5 1.4 2.3 0.4 0.0 0.1 0.0 3.1 0.3 0.0 0.0 0.3 0.0 0.0 1.5 0.3 0.0 0.2 0.2 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.5 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.7 0.0 0.0 2.3 0.4 0.6 0.0 0.0 0.1 0.4 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52N5 OR52N5Q ENSG00000181009 "Olfactory receptor family 52 subfamily N member 5" Q8NH56 11 5776165-5783355 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "adipose tissue: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "T-47d: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 1.8 0.2 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.8 0.3 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.4 2.1 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52R1 ENSG00000279270 "Olfactory receptor family 52 subfamily R member 1 (gene/pseudogene)" Q8NGF1 11 4803433-4804380 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52W1 OR52W1P ENSG00000175485 "Olfactory receptor family 52 subfamily W member 1" Q6IF63 11 6199146-6200259 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "bone marrow: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.33e-1)" "unprognostic (1.91e-1)" 0.0 0.0 0.1 0.2 0.7 1.9 0.0 0.8 0.4 0.0 0.3 0.5 0.3 0.0 0.2 0.2 0.1 0.0 0.2 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.7 0.3 0.0 0.0 0.3 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.4 0.4 0.0 0.3 0.8 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A1 ENSG00000180934 "Olfactory receptor family 56 subfamily A member 1" Q8NGH5 11 6019336-6034338 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.8;testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" NA NA 0.1 0.1 0.1 0.2 0.1 1.8 0.1 0.1 0.2 0.1 0.4 0.0 0.2 0.8 0.1 0.2 0.5 0.1 0.1 0.2 0.3 0.8 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.1 0.4 0.0 0.1 0.3 0.1 0.0 0.1 0.3 0.1 2.7 0.3 0.0 0.2 0.1 0.8 0.4 0.8 0.1 0.6 1.2 0.1 0.4 0.1 0.8 0.6 0.1 0.5 0.3 0.7 0.6 0.5 0.2 0.2 1.0 0.9 1.2 0.2 0.6 0.6 0.1 0.0 0.9 0.3 0.3 0.6 0.7 0.8 0.2 0.9 0.8 0.3 1.2 0.6 0.2 0.7 0.2 0.5 0.8 0.8 0.2 1.0 0.2 0.6 1.2 0.4 0.4 0.6 0.8 0.1 0.5 0.8 0.6 0.8 0.1 0.5 0.5 2.1 0.6 0.6 0.5 0.9 0.9 0.5 0.3 1.0 0.7 0.4 0.5 0.5 0.6 0.7 0.1 0.4 0.6 0.0 1.0 0.5 1.0 0.8 0.1 0.8 1.2 0.9 0.8 0.6 0.1 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A3 "OR56A3P, OR56A6" ENSG00000184478 "Olfactory receptor family 56 subfamily A member 3" Q8NH54 11 5938751-5951347 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;U-266/84: 2.7" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A4 ENSG00000183389 "Olfactory receptor family 56 subfamily A member 4" Q8NGH8 11 5999445-6006946 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.2;bone marrow: 1.5" "Cell type enriched" "Detected in single" 11 "granulocytes: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 2.1" NA NA 0.3 0.1 0.1 0.0 0.1 1.5 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.4 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 1.3 0.0 0.4 0.6 0.4 0.0 0.1 0.1 0.1 1.0 0.1 0.0 0.0 0.1 0.5 0.4 2.2 0.5 0.4 0.4 0.0 0.7 0.2 0.2 0.3 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.6 0.9 0.5 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.5 1.3 0.1 0.0 0.9 0.7 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.2 2.1 0.1 0.6 0.0 0.5 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.5 0.4 0.7 0.5 0.2 0.3 0.2 0.5 0.0 1.4 0.4 1.3 0.2 0.4 0.8 0.6 0.4 0.5 0.2 0.4 0.6 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.2 0.5 0.4 0.4 2.2 0.4 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A5 OR56A5P ENSG00000188691 "Olfactory receptor family 56 subfamily A member 5" P0C7T3 11 5967177-5968494 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.2;U-266/70: 1.6;U-266/84: 1.0" NA NA "unprognostic (9.82e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56B1 OR56B1P ENSG00000181023 "Olfactory receptor family 56 subfamily B member 1" Q8NGI3 11 5736448-5738522 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045043 Uncertain NA NA "HPA045043: AB_10794296" 0.2 0.0 0.0 1.2 0.0 0.3 0.3 0.0 0.2 0.9 0.1 0.0 0.3 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.0 0.5 1.3 0.0 0.8 0.0 0.7 0.1 0.0 0.3 0.1 0.2 0.5 0.0 0.0 0.7 0.0 0.0 1.4 0.0 0.2 0.1 0.9 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56B4 ENSG00000180919 "Olfactory receptor family 56 subfamily B member 4" Q8NH76 11 6107684-6108835 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.2;SuSa: 1.0;U-266/70: 4.6;U-266/84: 2.7" NA NA "unprognostic (2.04e-3)" "unprognostic (8.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (3.83e-1)" "unprognostic (3.01e-1)" "unprognostic (3.48e-2)" "unprognostic (9.71e-2)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.27e-1)" "unprognostic (2.46e-1)" 0.2 0.2 0.0 1.0 0.0 0.0 0.2 0.0 0.1 0.3 0.6 0.4 0.4 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.2 0.6 0.5 0.2 0.0 0.3 1.1 0.0 0.2 0.3 0.3 0.0 0.5 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.1 0.4 0.9 0.0 0.7 0.2 0.1 0.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.2 0.1 0.0 1.0 0.0 0.3 0.6 0.3 0.2 0.1 0.0 4.6 2.7 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5A1 "OR5A1P, OST181" ENSG00000172320 "Olfactory receptor family 5 subfamily A member 1" Q8NGJ0 11 59436469-59451380 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.4;bone marrow: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 3.5" "Not detected" "Not detected" NA NA "unprognostic (1.73e-2)" 0.2 0.4 0.2 0.4 0.2 2.4 0.2 0.2 0.3 0.7 0.3 0.1 0.3 1.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.5 0.2 0.5 0.3 0.0 0.2 0.1 0.2 0.0 0.4 0.0 0.5 2.0 0.4 0.0 0.2 0.5 0.3 1.6 0.4 0.0 0.3 0.2 0.8 0.4 2.4 0.3 0.3 0.5 0.0 0.7 0.3 0.8 1.2 0.5 0.3 0.8 0.6 0.1 0.1 0.1 0.8 0.7 1.3 0.6 0.1 0.7 0.7 0.3 0.0 0.1 0.7 1.0 0.9 2.6 0.6 0.1 0.7 1.7 0.0 0.3 0.1 0.1 0.7 0.1 0.9 1.0 3.5 0.3 0.7 0.8 1.0 1.3 0.3 0.8 0.7 0.7 1.4 0.2 1.5 1.0 0.9 0.7 0.4 0.4 1.1 1.2 0.7 0.6 0.9 1.1 0.9 0.7 1.3 1.0 0.8 1.1 1.0 0.8 0.9 0.3 0.2 0.5 0.2 0.3 0.4 0.3 0.3 0.1 0.8 0.4 0.4 2.4 0.3 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5A2 ENSG00000172324 "Olfactory receptor family 5 subfamily A member 2" Q8NGI9 11 59416969-59426412 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 4.9" "Not detected" "Not detected" "HPA047135, HPA049575" Uncertain NA NA "HPA047135: AB_2679948, HPA049575: AB_2680820" 0.4 0.4 0.4 0.5 0.4 2.1 0.4 0.4 0.9 0.9 0.4 0.6 0.9 1.1 0.4 1.0 0.2 0.4 0.4 0.4 0.5 0.6 0.4 0.8 0.4 0.4 0.4 0.0 0.4 0.0 0.4 0.2 0.6 0.1 0.8 1.5 1.0 0.0 0.5 1.2 0.4 1.2 0.6 0.1 0.4 0.4 1.2 0.7 2.7 1.3 1.0 1.1 0.2 0.7 0.9 1.6 1.3 0.5 0.6 1.0 0.6 0.4 0.5 0.8 0.8 0.9 1.4 0.4 0.3 0.7 1.2 1.6 0.2 0.8 4.9 0.7 1.2 2.0 1.2 0.1 0.7 2.5 0.4 0.5 0.3 0.4 0.9 0.3 2.0 1.2 2.7 0.3 0.9 0.8 1.3 1.9 0.6 0.3 1.8 1.1 0.8 0.6 1.1 1.3 0.5 0.9 0.4 1.7 1.7 0.7 0.8 1.1 0.6 1.3 1.7 0.4 2.4 1.7 1.0 0.8 2.3 0.6 1.5 0.7 1.0 1.1 0.8 0.9 0.8 1.0 0.9 0.4 1.2 1.1 0.8 2.7 1.0 1.3 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AC2 HSA1 ENSG00000196578 "Olfactory receptor family 5 subfamily AC member 2" Q9NZP5 3 98087173-98088102 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 2.3" "Cell type enriched" "Detected in single" 9 "Early spermatids: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AK2 ENSG00000181273 "Olfactory receptor family 5 subfamily AK member 2" Q8NH90 11 56988872-56989867 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "lymphoid tissue: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AF22: 1.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AN1 ENSG00000176495 "Olfactory receptor family 5 subfamily AN member 1" Q8NGI8 11 59358895-59371714 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.5;bone marrow: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.5" NA NA 0.1 0.0 0.0 0.0 0.1 2.2 0.1 0.1 0.1 0.8 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.4 0.1 0.1 1.5 0.7 0.4 0.0 0.1 0.0 0.4 0.1 0.2 0.5 0.0 0.5 0.2 0.7 0.5 0.1 0.1 0.2 0.1 1.0 0.2 1.4 0.6 0.2 0.2 0.8 0.4 0.4 0.3 0.6 0.7 0.7 0.0 0.3 0.4 0.0 0.0 0.5 2.5 0.5 0.1 0.2 0.7 1.2 0.7 1.1 0.1 0.4 0.3 0.1 1.5 0.6 0.4 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.2 0.2 0.2 0.2 1.4 0.4 1.4 0.8 0.3 0.4 0.6 0.7 0.7 0.2 0.3 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AP2 ENSG00000172464 "Olfactory receptor family 5 subfamily AP member 2" Q8NGF4 11 56641466-56642471 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AR1 ENSG00000172459 "Olfactory receptor family 5 subfamily AR member 1 (gene/pseudogene)" Q8NGP9 11 56663662-56664687 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AS1 ENSG00000181785 "Olfactory receptor family 5 subfamily AS member 1" Q8N127 11 56027654-56038191 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 4.6" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 8.3;Ciliated cells: 8.1;Club cells: 10.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA 0.5 0.6 0.5 0.5 0.5 3.2 0.7 0.6 1.3 1.5 0.6 0.2 0.6 1.4 0.5 0.7 0.3 0.9 0.6 0.5 0.5 1.6 0.5 0.7 0.6 1.1 0.6 0.0 0.5 1.0 0.8 0.2 0.9 0.5 0.7 2.8 0.5 0.0 0.5 0.7 0.5 1.6 0.5 0.0 0.7 0.6 2.7 1.3 4.6 1.6 1.6 1.6 0.2 2.1 1.0 3.0 2.3 0.9 1.4 2.3 1.5 0.3 0.4 0.8 1.9 2.1 3.7 2.0 1.0 2.1 2.3 0.7 0.9 1.2 3.0 1.2 2.2 4.4 1.5 0.4 2.6 2.8 1.1 1.3 1.9 1.0 1.5 1.0 2.1 2.8 5.7 0.6 1.4 3.1 2.3 3.6 1.2 1.2 2.0 2.7 1.2 0.9 2.6 2.0 2.2 1.5 1.4 1.1 2.8 2.7 1.4 3.9 3.3 2.7 2.6 1.8 3.8 2.9 1.2 2.0 2.4 4.1 4.6 1.6 1.0 1.6 1.1 1.4 1.1 1.3 1.2 0.9 2.7 1.4 1.4 3.8 1.6 1.5 1.3 0.7 0.2 6.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 8.1 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AU1 ENSG00000169327 "Olfactory receptor family 5 subfamily AU member 1" Q8NGC0 14 21148370-21159060 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3;bone marrow: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-2197: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.1 0.1 0.2 0.1 0.3 2.4 0.6 0.1 0.3 0.4 0.2 0.4 0.2 0.5 0.2 0.1 0.2 0.1 0.2 0.3 0.1 0.1 0.2 0.4 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.4 0.9 1.7 0.6 0.4 0.0 0.1 0.4 0.2 0.9 0.3 0.0 0.1 0.5 0.8 0.8 2.3 0.7 0.7 0.4 0.0 0.3 0.4 0.3 0.3 0.2 0.1 0.5 0.4 0.0 0.0 0.0 0.7 0.6 0.3 0.3 0.2 0.3 0.7 0.1 0.0 0.1 0.3 0.2 0.7 0.9 0.8 0.3 0.6 0.6 0.1 0.0 0.1 0.2 0.1 0.1 0.8 0.7 1.0 0.1 0.5 0.3 0.9 0.4 0.5 0.1 0.5 0.7 0.3 0.1 0.8 0.7 0.6 0.6 1.7 0.1 0.8 0.3 0.1 0.1 0.7 0.4 4.5 0.4 0.6 0.4 0.4 0.4 1.0 0.5 1.1 0.7 0.4 0.4 0.3 0.3 0.4 0.3 0.3 0.1 0.8 0.4 0.3 2.3 0.7 0.3 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B12 "OR5B12P, OR5B16, OST743" ENSG00000172362 "Olfactory receptor family 5 subfamily B member 12" Q96R08 11 58439077-58442758 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BJ hTERT+: 1.0" NA NA 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.5 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.2 0.4 0.0 0.3 1.2 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.1 0.2 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.3 0.6 0.7 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B17 OR5B20P ENSG00000197786 "Olfactory receptor family 5 subfamily B member 17" Q8NGF7 11 58358124-58359069 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B2 OST073 ENSG00000172365 "Olfactory receptor family 5 subfamily B member 2" Q96R09 11 58421264-58428121 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA 0.2 0.6 0.0 0.0 0.1 1.8 0.5 0.4 0.3 0.5 0.1 0.0 0.2 0.2 0.3 0.4 0.4 0.1 0.1 0.1 0.4 0.3 0.3 0.6 0.0 0.6 0.1 0.3 0.2 0.3 0.4 0.3 0.2 0.3 0.3 0.5 0.5 0.0 0.1 0.5 0.2 1.0 0.2 0.1 0.7 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.6 0.3 0.5 0.2 0.0 0.6 0.0 0.8 0.4 0.2 0.0 0.2 0.3 1.4 0.3 0.8 0.2 0.3 0.1 0.2 0.6 0.9 0.2 1.3 0.9 0.0 0.0 0.4 1.2 1.0 0.5 0.4 0.4 0.6 0.0 1.7 0.3 1.2 0.7 0.5 1.6 0.6 0.3 0.5 0.2 1.0 0.3 0.3 0.0 0.1 0.1 0.0 0.0 0.6 0.7 0.3 1.0 0.5 0.0 0.3 0.1 0.2 0.8 0.4 0.1 0.4 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B21 ENSG00000198283 "Olfactory receptor family 5 subfamily B member 21" A6NL26 11 58507175-58508105 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "testis: 1.9;urinary bladder: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 3.5;hTEC/SVTERT24-B: 1.6;U-2197: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.3 0.2 1.9 0.0 0.8 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B3 "OR5B13, OST129" ENSG00000172769 "Olfactory receptor family 5 subfamily B member 3" Q8NH48 11 58402464-58406874 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "HL-60: 1.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5BS1P OR5BS1 ENSG00000198678 "Olfactory receptor family 5 subfamily BS member 1 pseudogene" 12 48559882-48562956 "Predicted membrane proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5C1 "hRPK-465_F_21, OR5C2P, OR9-F" ENSG00000148215 "Olfactory receptor family 5 subfamily C member 1" Q8NGR4 9 122788933-122789895 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.0" "Not detected" "Not detected" NA NA "unprognostic (2.73e-1)" 1.0 0.2 0.3 0.2 1.3 0.2 2.8 0.4 0.8 0.5 0.2 0.3 0.0 0.2 0.2 0.4 0.2 0.5 0.6 6.1 1.2 0.2 0.8 0.5 0.3 0.5 0.1 0.4 0.4 0.3 0.2 0.4 1.0 0.1 1.0 0.2 0.0 1.5 0.2 2.4 0.8 0.3 0.2 0.9 0.6 0.2 1.0 0.1 0.0 1.2 0.7 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.4 0.7 1.2 0.2 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D13 ENSG00000279761 "Olfactory receptor family 5 subfamily D member 13 (gene/pseudogene)" Q8NGL4 11 55773438-55774382 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D14 ENSG00000186113 "Olfactory receptor family 5 subfamily D member 14" Q8NGL3 11 55795556-55796500 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D16 ENSG00000205029 "Olfactory receptor family 5 subfamily D member 16" Q8NGK9 11 55838752-55839738 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046711 Uncertain NA NA "HPA046711: AB_2679766" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D18 ENSG00000186119 "Olfactory receptor family 5 subfamily D member 18" Q8NGL1 11 55819607-55820597 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5F1 OR11-10 ENSG00000149133 "Olfactory receptor family 5 subfamily F member 1" O95221 11 55993681-55994625 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059360 Uncertain NA NA "HPA059360: AB_2683990" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H1 "HSHTPCRX14, HTPCRX14" ENSG00000231192 "Olfactory receptor family 5 subfamily H member 1" A6NKK0 3 98130721-98138548 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.1;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.1" "Cell line enriched" "Detected in single" 6 "BEWO: 5.2" NA NA 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.6 0.0 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.5 0.1 1.5 0.2 0.0 0.6 0.1 0.2 1.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.8 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H14 ENSG00000236032 "Olfactory receptor family 5 subfamily H member 14" A6NHG9 3 98147479-98156614 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.1;placenta: 2.1" "Group enriched" "Detected in some" 17 "Collecting duct cells: 1.8;Early spermatids: 1.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Low cell line specificity" "Detected in some" NA NA 0.1 0.1 0.1 0.0 0.1 1.5 0.1 0.1 0.2 0.4 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.7 0.1 0.2 0.1 0.2 0.1 0.0 0.1 2.1 0.1 0.0 0.3 0.0 0.1 0.9 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.2 0.1 0.4 0.4 2.1 0.4 0.4 0.4 0.0 0.6 0.6 0.6 0.6 0.3 0.1 0.5 0.8 0.5 0.1 0.0 0.9 0.5 0.3 0.4 0.0 0.6 0.9 0.1 0.3 0.0 0.5 0.6 0.6 1.0 0.7 0.2 0.4 0.5 0.1 0.7 0.2 0.0 0.5 0.0 1.1 0.3 1.4 0.0 1.0 0.3 0.7 0.7 0.3 1.1 0.7 0.2 0.4 0.1 1.0 0.3 0.5 0.4 0.4 0.5 1.1 0.6 0.3 0.1 0.6 1.1 0.9 0.4 0.8 0.8 0.7 0.5 0.3 0.5 2.1 0.4 0.4 0.4 0.2 0.3 0.2 0.3 0.2 0.1 0.4 0.3 0.3 1.4 0.4 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H15 ENSG00000233412 "Olfactory receptor family 5 subfamily H member 15" A6NDH6 3 98166696-98169774 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H2 ENSG00000197938 "Olfactory receptor family 5 subfamily H member 2" Q8NGV7 3 98282888-98283832 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H6 ENSG00000230301 "Olfactory receptor family 5 subfamily H member 6 (gene/pseudogene)" Q8NGV6 3 98263252-98265356 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.5" "Group enriched" "Detected in some" 12 "Early spermatids: 1.2;Late spermatids: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;NTERA-2: 1.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5I1 "HSOlf1, OLF1" ENSG00000167825 "Olfactory receptor family 5 subfamily I member 1" Q13606 11 55935456-55936400 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "NTERA-2: 1.0" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5J2 ENSG00000174957 "Olfactory receptor family 5 subfamily J member 2" Q8NH18 11 56176618-56177556 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "brain: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" "Not detected" "Not detected" HPA059466 Uncertain NA NA "HPA059466: AB_2684029" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5K1 "HSHTPCRX10, HTPCRX10" ENSG00000232382 "Olfactory receptor family 5 subfamily K member 1" Q8NHB7 3 98463201-98472924 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5K2 ENSG00000231861 "Olfactory receptor family 5 subfamily K member 2" Q8NHB8 3 98497604-98498663 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.4;THP-1: 3.0;U-266/70: 1.5" NA NA "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (8.45e-3)" "unprognostic (1.69e-3)" "unprognostic (6.47e-3)" "unprognostic (7.17e-2)" "unprognostic (1.45e-1)" "unprognostic (3.61e-2)" "unprognostic (1.19e-2)" "unprognostic (6.57e-2)" "unprognostic (3.77e-2)" "unprognostic (5.93e-2)" 0.4 0.4 0.0 0.6 1.3 0.0 0.4 2.3 0.8 0.9 1.4 0.2 1.2 0.0 0.6 0.1 0.4 0.9 0.0 0.0 0.4 0.0 1.4 1.2 0.0 1.4 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.0 4.3 1.5 1.3 0.0 0.0 1.4 0.4 0.6 0.4 0.0 1.1 0.6 0.5 0.3 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.5 0.3 0.9 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5K3 ENSG00000206536 "Olfactory receptor family 5 subfamily K member 3" A6NET4 3 98390666-98391631 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5K4 ENSG00000196098 "Olfactory receptor family 5 subfamily K member 4" A6NMS3 3 98353854-98354819 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5L1 OST262 ENSG00000279395 "Olfactory receptor family 5 subfamily L member 1 (gene/pseudogene)" Q8NGL2 11 55811367-55812476 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047524 Uncertain NA NA "HPA047524: AB_2680076" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5L2 "HSHTPCRX16, HTPCRX16" ENSG00000205030 "Olfactory receptor family 5 subfamily L member 2" Q8NGL0 11 55827219-55828154 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047524 Uncertain NA NA "HPA047524: AB_2680076" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M1 OST050 ENSG00000255012 "Olfactory receptor family 5 subfamily M member 1" Q8NGP8 11 56609236-56614874 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M10 ENSG00000254834 "Olfactory receptor family 5 subfamily M member 10" Q6IEU7 11 56576736-56577787 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "salivary gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M11 OR11-199 ENSG00000255223 "Olfactory receptor family 5 subfamily M member 11" Q96RB7 11 56542262-56543281 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 1.3;urinary bladder: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 2.6" NA NA "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M3 ENSG00000174937 "Olfactory receptor family 5 subfamily M member 3" Q8NGP4 11 56469274-56473352 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M8 ENSG00000181371 "Olfactory receptor family 5 subfamily M member 8" Q8NGP6 11 56490349-56491395 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "U-2 OS: 1.1" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M9 ENSG00000150269 "Olfactory receptor family 5 subfamily M member 9" Q8NGP3 11 56462469-56463401 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5P2 JCG3 ENSG00000183303 "Olfactory receptor family 5 subfamily P member 2" Q8WZ92 11 7795905-7796973 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "skin 1: 1.7;urinary bladder: 1.3" "Cell type enriched" "Detected in some" 5 "Rod photoreceptor cells: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5P3 JCG1 ENSG00000182334 "Olfactory receptor family 5 subfamily P member 3" Q8WZ94 11 7824818-7830840 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.7;skin 1: 2.1;urinary bladder: 1.0" "Group enriched" "Detected in some" 21 "Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060787 Uncertain NA NA "HPA060787: AB_2684364" "unprognostic (1.54e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 OR5R1 OR5R1P ENSG00000279961 "Olfactory receptor family 5 subfamily R member 1 (gene/pseudogene)" Q8NH85 11 56417258-56418232 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5T1 OR5T1P ENSG00000181698 "Olfactory receptor family 5 subfamily T member 1" Q8NG75 11 56274154-56276819 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050952 Uncertain NA NA "HPA050952: AB_2681287" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5T2 ENSG00000181718 "Olfactory receptor family 5 subfamily T member 2" Q8NGG2 11 56231282-56234255 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skin 1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA 0.3 0.1 0.1 0.2 0.1 0.4 0.3 0.1 0.2 0.3 0.1 0.1 0.2 0.0 0.4 0.3 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.2 0.1 0.5 0.0 0.1 0.1 0.1 0.0 0.7 0.2 0.3 1.6 0.3 0.0 0.4 0.1 0.1 0.9 0.1 0.0 0.3 0.1 0.5 0.3 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.7 2.2 0.2 0.6 0.2 0.3 0.6 0.2 0.5 1.4 0.0 0.8 0.1 0.1 1.0 1.2 0.5 0.6 0.1 1.3 1.8 0.6 0.7 1.4 0.0 0.4 0.5 0.2 0.0 0.3 0.2 0.7 0.9 1.0 0.6 0.5 0.0 0.4 0.6 1.1 0.9 0.1 0.4 0.4 0.8 0.2 0.0 1.0 0.7 0.5 0.1 0.3 0.3 0.5 0.5 0.4 0.4 1.0 0.2 0.5 0.4 1.1 2.4 0.7 0.3 1.0 0.8 0.0 0.0 0.0 0.3 0.0 0.2 0.5 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5T3 OR5T3Q ENSG00000172489 "Olfactory receptor family 5 subfamily T member 3" Q8NGG3 11 56252200-56253222 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044986 Uncertain NA NA "HPA044986: AB_10963548" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5V1 hs6M1-21 ENSG00000243729 "Olfactory receptor family 5 subfamily V member 1" Q9UGF6 6 29353749-29431967 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.1" "Group enriched" "Detected in some" 23 "Early spermatids: 13.0;Late spermatids: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046707 Uncertain NA NA "HPA046707: AB_2679763" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5W2 "OR5W2P, OR5W3P" ENSG00000187612 "Olfactory receptor family 5 subfamily W member 2" Q8NH69 11 55913650-55914582 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6A2 "OR11-55, OR6A1, OR6A2P" ENSG00000184933 "Olfactory receptor family 6 subfamily A member 2" O95222 11 6791736-6799689 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B1 OR7-3 ENSG00000221813 "Olfactory receptor family 6 subfamily B member 1" O95007 7 144000320-144008793 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 3.2;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 5.6;RPMI-8226: 2.1;U-266/84: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 20 "olfactory region: 0.1" HPA053164 Uncertain NA NA "HPA053164: AB_2682065" 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.5 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 5.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.1 0.5 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B2 OR6B2P ENSG00000182083 "Olfactory receptor family 6 subfamily B member 2" Q6IFH4 2 240028965-240030456 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.5" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B3 "OR6B3P, OR6B3Q" ENSG00000178586 "Olfactory receptor family 6 subfamily B member 3" Q8NGW1 2 240045077-240047027 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 6 "brain: 1.6;epididymis: 6.5;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.2" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.1 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C1 OST267 ENSG00000205330 "Olfactory receptor family 6 subfamily C member 1" Q96RD1 12 55314343-55322364 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C2 OR6C67 ENSG00000179695 "Olfactory receptor family 6 subfamily C member 2" Q9NZP2 12 55444069-55453347 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "epididymis: 1.5;testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "Karpas-707: 3.9" "Not detected" "Not detected" NA NA "unprognostic (2.37e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.1 1.5 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C3 OST709 ENSG00000205329 "Olfactory receptor family 6 subfamily C member 3" Q9NZP0 12 55330043-55332687 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C4 ENSG00000179626 "Olfactory receptor family 6 subfamily C member 4" Q8NGE1 12 55549602-55555832 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-266/84: 3.2" NA NA 0.3 0.2 0.1 0.9 0.2 1.3 0.2 0.2 0.8 0.4 0.3 0.5 0.3 0.1 0.2 0.7 0.3 0.8 0.1 0.1 0.3 0.2 0.2 1.0 0.2 0.6 0.8 0.0 0.2 0.1 0.2 0.0 0.3 0.0 0.5 1.6 0.4 0.0 0.1 0.4 0.3 0.4 0.6 0.0 0.5 0.2 0.9 1.6 2.9 0.6 1.2 1.1 0.2 0.8 0.0 1.1 1.3 0.1 0.0 0.9 0.8 0.1 0.0 0.0 0.6 0.7 1.5 0.2 0.2 0.6 0.6 0.0 0.0 0.0 1.5 0.6 0.6 1.2 0.6 0.1 1.6 1.0 0.0 0.1 0.0 0.0 0.5 0.2 0.9 0.6 2.1 0.1 0.4 0.7 1.0 0.8 0.1 0.6 0.4 0.9 1.6 0.1 0.9 1.4 1.1 0.4 0.8 1.7 0.7 0.1 1.3 1.1 1.8 0.8 0.7 0.5 1.1 3.2 1.2 0.9 1.2 1.5 2.9 0.6 0.7 0.7 0.4 0.7 0.6 0.7 0.6 0.2 0.9 1.1 0.9 1.5 1.2 0.4 1.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C6 ENSG00000188324 "Olfactory receptor family 6 subfamily C member 6" A6NF89 12 55293988-55296569 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 2.3;skin 1: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.1;MCF7: 1.6;THP-1: 1.0" HPA051090 Uncertain Approved "Lipid droplets,Plasma membrane" NA NA "Lipid droplets, Plasma membrane" "HPA051090: AB_2681341" 0.0 0.0 0.0 0.4 0.1 1.1 0.1 0.1 0.2 0.5 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.5 1.7 0.0 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 1.1 1.0 2.3 0.5 0.5 0.6 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.4 0.0 0.4 0.0 0.5 0.0 0.0 1.1 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.5 0.8 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.0 0.3 0.0 0.3 0.2 0.2 0.0 0.0 0.5 0.2 2.3 0.5 0.9 0.6 0.1 0.3 0.6 0.5 0.4 0.1 1.1 0.5 0.6 1.8 0.5 0.3 1.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C65 ENSG00000205328 "Olfactory receptor family 6 subfamily C member 65" A6NJZ3 12 55400430-55401505 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C68 ENSG00000205327 "Olfactory receptor family 6 subfamily C member 68" A6NDL8 12 55492378-55493316 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "heart muscle: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "U-266/70: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C70 ENSG00000184954 "Olfactory receptor family 6 subfamily C member 70" A6NIJ9 12 55469200-55470138 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "heart muscle: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "Karpas-707: 7.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C74 ENSG00000197706 "Olfactory receptor family 6 subfamily C member 74" A6NCV1 12 55247198-55248302 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C75 ENSG00000187857 "Olfactory receptor family 6 subfamily C member 75" A6NL08 12 55362975-55369279 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Group enriched" "Detected in some" 88 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 9.1;Ciliated cells: 9.4;Club cells: 11.4;granulocytes: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 9.4 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C76 ENSG00000185821 "Olfactory receptor family 6 subfamily C member 76" A6NM76 12 55426254-55427192 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "epididymis: 1.2;fallopian tube: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6F1 OST731 ENSG00000169214 "Olfactory receptor family 6 subfamily F member 1" Q8NGZ6 1 247711436-247716646 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "testis: 4.6" "Group enriched" "Detected in some" 63 "Early spermatids: 13.9;Late spermatids: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 57 "GAMG: 6.4" "Not detected" "Not detected" NA NA "unprognostic (5.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 OR6J1 "OR6J1P, OR6J2" ENSG00000255804 "Olfactory receptor family 6 subfamily J member 1 (gene/pseudogene)" Q8NGC5 14 22630929-22644352 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 3.3;bone marrow: 3.4" "Group enriched" "Detected in some" 18 "Ciliated cells: 1.4;granulocytes: 2.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" NA NA 0.3 0.2 0.7 0.7 0.6 3.4 0.3 0.3 1.0 0.3 0.2 0.3 0.5 0.9 0.3 0.2 0.3 0.2 0.5 0.3 0.3 0.3 0.4 0.4 0.7 0.4 0.5 0.0 0.3 0.0 0.3 0.1 0.7 0.0 1.0 1.5 0.6 0.0 0.4 0.6 0.6 0.6 0.4 0.0 0.1 0.4 0.9 0.8 3.3 0.8 1.1 0.9 0.4 1.1 0.6 1.3 1.4 0.3 0.4 2.1 0.3 0.0 0.2 0.1 1.5 1.1 1.0 0.6 0.0 0.6 1.1 0.2 0.2 0.2 1.9 0.8 0.7 2.9 1.6 0.0 1.2 1.8 0.1 0.6 0.3 0.3 0.4 0.1 1.1 0.6 2.5 0.6 1.3 1.2 1.0 1.2 0.7 0.8 1.0 0.7 0.7 0.2 1.8 1.7 1.4 1.4 1.1 0.7 1.4 1.2 0.5 1.7 1.1 1.1 1.2 0.4 1.1 0.7 1.4 0.7 1.2 0.6 3.1 0.8 1.1 0.7 0.6 0.7 0.5 0.7 0.5 0.2 0.9 0.7 0.9 3.3 1.1 0.6 0.8 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6K2 ENSG00000196171 "Olfactory receptor family 6 subfamily K member 2" Q8NGY2 1 158699678-158700652 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6K3 ENSG00000203757 "Olfactory receptor family 6 subfamily K member 3" Q8NGY3 1 158716327-158720720 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 10.4;bone marrow: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 6 "basophil: 10.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.4" "Cell line enhanced" "Detected in some" "Karpas-707: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA055949 Uncertain NA NA "HPA055949: AB_2682982" 0.1 0.1 0.0 0.0 0.1 4.8 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 2.2 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.5 0.1 0.4 0.1 0.0 0.2 0.1 1.3 1.0 10.4 0.9 0.9 1.5 0.3 0.2 0.3 0.1 0.9 0.6 0.2 0.5 0.2 0.4 0.4 0.2 0.6 0.7 1.1 0.3 0.2 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.5 0.2 0.8 0.4 0.9 0.6 0.3 1.8 0.4 0.3 0.7 0.5 2.8 0.2 0.7 0.3 1.0 0.2 0.5 0.0 0.4 0.2 0.4 0.2 0.6 0.4 0.0 0.0 0.3 0.1 0.7 0.2 0.0 1.6 0.6 0.5 0.4 0.1 0.6 0.6 0.6 0.0 0.6 0.7 10.4 0.9 0.9 1.3 0.8 1.4 1.1 1.3 1.0 0.4 1.3 1.4 1.5 1.7 0.9 0.7 1.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6K6 ENSG00000180433 "Olfactory receptor family 6 subfamily K member 6" Q8NGW6 1 158754720-158755891 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "blood: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 57 "basophil: 5.7" "Lineage enriched" "Detected in single" 57 "granulocytes: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6M1 ENSG00000196099 "Olfactory receptor family 6 subfamily M member 1" Q8NGM8 11 123805335-123806387 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "pancreas: 3.1;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;SCLC-21H: 2.1" "Not detected" "Not detected" HPA048674 Uncertain NA NA "HPA048674: AB_2680489" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6N1 ENSG00000197403 "Olfactory receptor family 6 subfamily N member 1" Q8NGY5 1 158747814-158772195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 7.5;bone marrow: 4.4" "Cell type enriched" "Detected in single" 33 "Distal tubular cells: 3.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "basophil: 7.5" "Lineage enriched" "Detected in single" 75 "granulocytes: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6N2 ENSG00000188340 "Olfactory receptor family 6 subfamily N member 2" Q8NGY6 1 158774222-158781204 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 9 "blood: 2.9;bone marrow: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "basophil: 2.9" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056637 Uncertain NA NA "HPA056637: AB_2683198" 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6P1 ENSG00000186440 "Olfactory receptor family 6 subfamily P member 1" Q8NGX9 1 158560606-158570580 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 10 "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047466 Uncertain NA NA "HPA047466: AB_10963091" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6Q1 ENSG00000279051 "Olfactory receptor family 6 subfamily Q member 1 (gene/pseudogene)" Q8NGQ2 11 58030930-58031931 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6S1 OR6S1Q ENSG00000181803 "Olfactory receptor family 6 subfamily S member 1" Q8NH40 14 20640696-20641691 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "HDLM-2: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.62e-2)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.1 0.5 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6T1 ENSG00000181499 "Olfactory receptor family 6 subfamily T member 1" Q8NGN1 11 123942785-123943873 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 16 "pancreas: 4.5;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "hTCEpi: 2.3" "Low region specificity" "Detected in some" HPA060893 Uncertain NA NA "HPA060893: AB_2684380" "unprognostic (9.30e-4)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6V1 GPR138 ENSG00000225781 "Olfactory receptor family 6 subfamily V member 1" Q8N148 7 143052320-143053347 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "blood: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (3.24e-2)" 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6X1 ENSG00000221931 "Olfactory receptor family 6 subfamily X member 1" Q8NH79 11 123753488-123754545 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6Y1 OR6Y2 ENSG00000197532 "Olfactory receptor family 6 subfamily Y member 1" Q8NGX8 1 158544550-158554405 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.4 0.4 0.3 0.2 0.4 2.5 0.4 0.4 0.4 0.9 0.4 0.6 0.3 1.2 0.4 0.3 0.5 0.4 0.3 0.3 0.3 0.6 0.3 0.5 0.4 0.5 0.4 2.6 0.3 0.0 0.3 0.2 0.8 0.0 0.6 2.6 0.4 0.0 0.4 0.4 0.8 0.9 0.4 0.2 0.7 0.4 1.1 0.5 2.5 0.8 0.6 0.6 0.0 1.4 0.7 1.1 1.6 0.6 0.6 1.2 0.9 0.1 0.0 0.1 0.8 1.1 0.9 1.1 0.5 1.8 1.4 0.6 0.8 0.7 1.4 0.4 1.5 2.9 1.0 0.5 1.1 1.7 0.4 0.7 2.0 0.8 0.8 0.1 1.2 1.2 2.9 0.5 1.4 1.4 1.6 1.9 0.8 0.8 0.9 5.3 0.8 1.0 1.5 1.0 1.1 0.7 0.7 1.2 1.4 1.1 0.9 1.4 1.2 2.1 1.6 0.6 1.8 1.2 1.0 1.1 1.3 0.9 2.5 0.4 0.6 0.6 0.3 0.4 0.6 0.5 0.5 0.3 1.1 0.6 0.4 1.3 0.6 0.8 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7A10 ENSG00000127515 "Olfactory receptor family 7 subfamily A member 10" O76100 19 14840466-14848922 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7A17 HTPCRX19 ENSG00000185385 "Olfactory receptor family 7 subfamily A member 17" O14581 19 14878203-14886132 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.1" "Group enriched" "Detected in some" 59 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 4.3;Club cells: 6.8;granulocytes: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" NA NA 0.2 0.3 0.2 0.9 0.2 1.5 0.2 0.2 0.6 1.0 0.2 0.0 0.2 1.1 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.5 0.2 0.0 0.2 0.0 0.2 0.3 0.2 0.0 0.4 1.6 0.2 0.0 0.2 0.4 0.2 0.2 0.9 0.0 0.4 0.2 1.4 1.0 3.1 0.7 1.0 0.7 0.2 1.4 0.6 0.7 1.6 0.5 0.4 0.5 0.6 0.8 0.6 0.7 0.5 2.4 0.1 0.5 0.5 0.2 1.0 1.2 0.2 0.7 0.4 1.0 0.5 1.9 0.5 0.0 1.0 0.5 0.5 0.6 0.7 0.2 1.0 0.3 0.3 1.1 1.9 1.4 0.3 0.7 1.1 0.6 0.0 0.3 0.3 0.6 0.4 0.3 1.1 0.7 0.7 0.2 0.1 0.4 0.5 0.7 0.1 0.9 1.8 0.4 1.1 0.3 0.5 0.4 0.4 0.6 0.6 0.1 2.3 0.7 0.7 0.7 0.5 0.4 0.8 0.5 0.3 0.2 1.4 0.5 0.7 3.1 1.0 0.5 1.0 0.4 0.2 8.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7A5 HTPCR2 ENSG00000188269 "Olfactory receptor family 7 subfamily A member 5" Q15622 19 14824251-14835285 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.4;pituitary gland: 33.6" "Cell type enhanced" "Detected in single" 25 "Spermatocytes: 1.2" "Cancer enriched" "Detected in single" 8 "melanoma: 2.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" HPA053823 Uncertain NA NA "HPA053823: AB_2682274" "unprognostic (3.26e-4)" "unprognostic (1.44e-1)" "unprognostic (7.46e-2)" "unprognostic (6.19e-3)" "unprognostic (4.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (6.78e-2)" "unprognostic (2.01e-7)" "unprognostic (6.45e-2)" "unprognostic (9.64e-2)" "unprognostic (6.44e-2)" "unprognostic (2.47e-3)" 0.3 0.7 1.7 0.4 7.3 1.0 2.0 0.4 3.8 0.7 0.5 4.7 3.2 0.5 0.4 10.1 0.5 0.5 0.5 0.3 4.4 2.1 0.6 0.8 0.6 0.5 16.4 1.3 0.4 0.8 6.9 33.6 0.4 10.9 1.5 0.6 7.0 0.9 2.6 0.5 2.2 0.7 0.3 6.1 0.5 6.4 5.0 16.4 0.0 0.5 0.0 0.3 0.4 0.9 1.0 0.7 1.3 0.3 0.4 0.5 0.0 0.5 0.6 0.4 0.6 0.1 0.1 0.7 0.2 0.2 0.0 0.1 0.6 0.7 0.6 0.3 0.0 0.3 0.5 0.2 0.1 0.0 0.3 0.3 0.5 1.8 0.6 0.1 1.2 0.3 1.8 0.7 0.4 0.2 0.4 0.2 0.5 0.4 1.0 0.0 0.6 0.3 0.5 1.1 0.1 0.2 0.6 0.1 0.6 0.0 1.5 0.4 0.4 0.6 0.2 1.8 0.8 0.1 0.1 0.7 0.4 0.5 0.5 0.3 1.0 0.3 0.5 0.5 0.6 0.7 1.1 0.3 0.3 0.5 0.2 0.3 0.4 0.3 0.2 0.1 1.0 0.4 0.5 1.3 0.4 0.2 0.7 0.1 0.0 1.7 7.3 0.4 3.8 4.4 2.1 16.4 1.3 10.9 16.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 OR7C1 "OR19-5, OR7C4" ENSG00000127530 "Olfactory receptor family 7 subfamily C member 1" O76099 19 14789260-14835376 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.6;pituitary gland: 34.0" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 2: 5.6;Ciliated cells: 2.7;Club cells: 4.5;Melanocytes: 1.7" "Cancer enriched" "Detected in single" 9 "melanoma: 1.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 4 "granulocytes: 4.8;monocytes: 1.5" "Low cell line specificity" "Detected in many" HPA047127 Uncertain NA NA "HPA047127: AB_2679944" "unprognostic (7.68e-4)" "unprognostic (1.31e-1)" "unprognostic (2.13e-1)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.39e-1)" "unprognostic (4.30e-2)" "unprognostic (6.11e-4)" "unprognostic (1.90e-1)" "unprognostic (6.80e-2)" "unprognostic (6.91e-2)" 0.5 3.3 1.4 0.7 7.4 1.9 1.5 0.5 3.9 0.7 0.5 4.7 3.2 0.7 0.5 5.9 0.5 0.5 0.6 0.5 3.2 0.9 0.6 0.6 0.5 0.8 16.6 1.4 0.5 0.5 7.3 34.0 0.5 11.0 3.0 0.4 7.1 1.1 2.9 3.6 3.1 0.7 0.3 3.8 0.7 0.6 6.3 16.6 0.0 1.0 0.0 0.4 0.5 1.0 0.7 0.5 4.8 1.5 0.5 0.4 0.2 0.8 1.1 0.8 2.2 0.7 0.5 1.1 0.5 0.3 0.6 0.8 1.2 1.8 1.4 1.5 0.6 0.8 1.0 0.3 0.6 0.8 0.7 0.6 1.0 2.2 0.7 0.6 0.9 1.4 0.8 0.3 0.5 0.5 1.0 0.3 1.1 0.7 3.1 0.3 0.5 0.7 1.5 1.1 0.5 1.0 0.8 0.4 0.6 0.7 1.3 1.7 1.0 0.6 0.7 1.0 1.0 0.6 1.6 0.9 1.0 2.2 1.1 0.7 1.3 0.8 1.0 1.0 0.8 0.7 2.9 0.9 1.7 0.3 0.8 0.3 0.4 0.3 0.2 0.4 0.7 0.3 0.4 4.8 0.5 1.5 0.5 0.2 0.2 1.4 7.4 0.5 3.9 3.2 0.9 16.6 1.4 11.0 16.6 0.0 5.6 0.0 0.6 0.0 0.0 0.0 0.0 2.7 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 OR7C2 "OR19-18, OR7C3" ENSG00000127529 "Olfactory receptor family 7 subfamily C member 2" O60412 19 14941489-14942448 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047295 Uncertain NA NA "HPA047295: AB_2680013" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7D2 "FLJ38149, HTPCRH03, OR19-4" ENSG00000188000 "Olfactory receptor family 7 subfamily D member 2" Q96RA2 19 9178979-9188817 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 4.4" "Cell type enriched" "Detected in single" 9 "Early spermatids: 4.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 6.0" NA NA "unprognostic (5.00e-4)" "unprognostic (2.03e-1)" "unprognostic (3.40e-2)" "unprognostic (1.66e-1)" "unprognostic (3.84e-1)" "unprognostic (2.86e-2)" "unprognostic (2.56e-2)" "unprognostic (3.40e-2)" "unprognostic (6.34e-2)" "unprognostic (1.54e-1)" "unprognostic (7.09e-2)" "unprognostic (3.07e-1)" "unprognostic (5.16e-2)" "unprognostic (1.35e-2)" "unprognostic (2.63e-1)" "unprognostic (4.08e-2)" "unprognostic (4.92e-4)" 0.6 0.8 0.6 0.9 0.8 2.3 0.5 0.7 1.5 0.6 0.5 0.1 0.7 0.8 0.4 0.5 0.2 0.4 0.6 0.8 0.6 0.5 0.3 1.9 0.4 0.3 0.6 0.1 0.8 0.1 0.6 0.4 0.5 1.2 0.9 1.9 0.8 0.6 0.6 1.5 1.2 4.4 0.6 0.9 0.9 0.3 1.0 1.2 3.1 0.7 1.3 1.0 0.1 0.6 0.5 0.8 2.8 0.9 0.8 0.6 0.6 0.1 0.3 0.2 0.5 0.7 1.2 1.4 0.2 0.8 1.3 0.5 0.4 0.5 0.9 0.7 6.0 1.2 1.0 0.2 0.8 1.4 0.2 0.8 0.2 0.3 0.7 0.2 1.4 1.8 2.9 0.1 0.3 1.4 1.6 0.8 0.3 0.8 1.3 1.3 0.0 0.1 1.8 1.1 0.8 0.6 1.1 0.4 1.2 1.0 0.3 0.0 1.0 1.1 0.6 0.7 1.6 0.9 1.0 0.8 0.7 0.5 2.8 0.7 0.5 0.9 0.4 0.7 0.6 0.6 0.5 0.3 1.0 0.7 1.0 3.1 1.3 0.6 1.2 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 OR7D4 "hg105, OR19-B, OR7D4P" ENSG00000174667 "Olfactory receptor family 7 subfamily D member 4" Q8NG98 19 9210276-9219589 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.8;testis: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "HDLM-2: 2.6" NA NA "unprognostic (1.30e-1)" 0.1 0.2 0.1 0.3 0.1 2.0 0.2 0.2 0.7 0.4 0.2 0.2 0.2 0.6 0.4 0.1 0.0 0.2 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.2 0.0 0.1 0.2 0.2 0.3 0.2 0.0 0.5 1.1 0.5 0.0 0.1 0.6 0.2 2.1 0.3 0.4 0.2 0.2 0.7 0.7 3.8 0.4 0.9 0.4 0.0 0.3 0.2 0.7 1.2 0.4 0.1 0.8 0.2 0.0 0.4 0.0 0.5 0.3 1.0 0.3 0.1 0.5 1.1 0.6 0.1 0.3 2.6 1.1 0.8 1.4 0.9 0.1 0.8 1.3 0.4 0.1 0.5 0.2 0.6 0.0 0.6 0.5 1.4 0.0 0.9 1.0 0.6 0.9 0.1 0.1 0.7 0.6 0.2 0.2 0.6 0.6 0.4 0.7 0.4 0.5 0.6 0.9 0.3 1.2 0.9 0.5 1.0 0.4 1.1 0.3 0.6 0.5 0.6 0.9 3.8 0.4 0.3 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.4 0.3 2.3 0.9 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7E24 "HSHT2, OR19-8, OR7E24P, OR7E24Q" ENSG00000237521 "Olfactory receptor family 7 subfamily E member 24" Q6IFN5 19 9247344-9252625 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 5.8" "Group enriched" "Detected in some" 32 "Early spermatids: 12.3;Late spermatids: 4.0" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 OR7G1 "OR19-15, OR7G1P" ENSG00000161807 "Olfactory receptor family 7 subfamily G member 1" Q8NGA0 19 9114828-9115763 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7G2 OST260 ENSG00000170923 "Olfactory receptor family 7 subfamily G member 2" Q8NG99 19 9100407-9107475 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" NA NA "unprognostic (2.04e-1)" 0.2 0.4 0.2 0.3 0.2 1.7 0.1 0.2 0.3 0.4 0.2 0.4 0.5 0.5 0.5 0.6 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.3 0.1 0.4 0.2 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.7 1.7 0.2 0.0 0.1 0.3 0.3 0.7 0.3 0.0 0.4 0.2 1.3 0.7 4.3 0.9 1.5 0.6 0.2 0.8 0.2 0.4 1.4 0.0 0.0 1.3 0.4 0.1 0.0 0.1 1.1 1.2 0.6 0.7 0.2 0.3 0.8 0.5 0.0 0.4 1.3 1.0 0.3 1.2 0.7 0.1 0.6 1.2 0.1 0.3 0.2 0.0 0.6 0.1 0.7 0.8 1.9 0.0 0.7 0.5 0.8 0.9 0.1 0.6 0.5 0.5 0.9 0.0 0.7 0.8 0.4 0.9 0.7 0.7 0.3 1.0 0.8 0.0 1.3 0.6 1.4 0.9 1.1 1.3 0.5 0.5 1.0 0.9 3.4 0.9 0.7 0.6 0.5 0.5 0.9 0.5 0.3 0.2 1.3 0.6 0.6 4.3 1.5 0.4 0.7 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7G3 OST085 ENSG00000170920 "Olfactory receptor family 7 subfamily G member 3" Q8NG95 19 9126012-9126950 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "fallopian tube: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8A1 OST025 ENSG00000196119 "Olfactory receptor family 8 subfamily A member 1" Q8NGG7 11 124566660-124582942 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 20 "Early spermatids: 1.3;granulocytes: 3.5;Late spermatids: 2.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA 0.2 0.2 0.2 0.2 0.3 2.5 1.0 0.2 0.2 0.4 0.2 0.0 0.2 0.4 0.2 0.2 0.6 0.2 0.2 0.4 0.2 2.6 0.2 0.3 0.2 0.3 0.5 1.7 0.2 0.2 0.3 0.0 0.4 0.0 0.2 1.8 0.5 0.0 0.2 0.3 0.3 2.4 0.3 0.0 0.2 0.2 0.9 0.6 1.8 0.3 0.4 0.6 0.0 0.4 0.3 0.8 1.2 0.8 0.6 2.7 0.6 0.3 0.0 0.3 0.2 0.9 0.5 0.4 0.1 1.0 0.7 0.3 0.2 0.4 0.7 0.2 0.7 1.2 0.4 0.3 0.8 0.6 1.1 0.3 0.3 0.6 0.8 0.2 1.3 1.3 2.8 0.5 1.6 0.6 1.1 0.9 0.5 0.3 0.7 0.4 0.5 0.4 0.9 1.6 0.5 0.7 1.0 0.1 1.0 1.0 0.1 1.2 0.8 0.9 0.9 0.5 2.1 0.9 0.8 0.7 0.7 0.4 1.8 0.3 0.4 0.4 0.2 0.3 0.5 0.5 0.4 0.1 0.9 0.4 0.6 1.7 0.4 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B12 ENSG00000170953 "Olfactory receptor family 8 subfamily B member 12" Q8NGG6 11 124539635-124545333 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 2.1" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B2 ENSG00000284680 "Olfactory receptor family 8 subfamily B member 2" Q96RD0 11 124382394-124384462 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 52 "testis: 5.2" "Group enriched" "Detected in some" 48 "Early spermatids: 32.9;Late spermatids: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OR8B3 ENSG00000284609 "Olfactory receptor family 8 subfamily B member 3" Q8NGG8 11 124395534-124399024 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 28 "testis: 2.7" "Group enriched" "Detected in some" 21 "Early spermatids: 9.7;Late spermatids: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BJ hTERT+ SV40 Large T+ RasG12V: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 OR8B4 OR8B4P ENSG00000280090 "Olfactory receptor family 8 subfamily B member 4 (gene/pseudogene)" Q96RC9 11 124423904-124424893 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B8 TPCR85 ENSG00000197125 "Olfactory receptor family 8 subfamily B member 8" Q15620 11 124437445-124445696 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 0.4" NA NA 0.2 0.3 0.2 0.7 0.2 1.3 0.2 0.4 0.7 0.4 0.2 1.2 0.4 0.0 0.3 0.4 0.4 0.9 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.7 0.7 0.0 0.2 0.3 0.2 0.0 0.7 0.0 0.2 2.0 0.6 0.0 0.2 0.8 1.1 0.4 0.6 0.0 0.5 0.2 1.2 1.1 2.6 1.6 0.8 0.9 0.5 0.7 0.5 0.7 1.7 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.1 1.4 0.4 0.8 0.0 0.8 1.3 0.0 0.0 0.0 0.5 0.6 0.9 0.7 0.3 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.9 2.2 1.8 0.0 1.3 0.7 0.8 0.4 0.8 0.6 0.9 0.5 1.1 0.0 0.4 0.9 1.6 0.8 1.5 0.7 0.9 2.9 0.9 1.9 1.3 0.9 0.8 0.5 3.0 0.7 1.2 0.9 1.7 1.4 2.6 1.6 1.2 0.8 1.0 0.6 1.0 0.8 0.7 1.1 1.2 0.9 0.8 2.2 0.8 0.6 0.8 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D1 "OR8D3, OST004" ENSG00000196341 "Olfactory receptor family 8 subfamily D member 1" Q8WZ84 11 124302831-124315099 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.2;testis: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-HME1: 1.3;K-562: 1.8;PC-3: 1.5" "Not detected" "Not detected" HPA059510 Uncertain NA NA "HPA059510: AB_2684045" 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.1 0.0 0.1 0.2 1.2 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.4 0.3 0.0 0.0 0.1 0.2 0.1 0.0 1.3 0.2 0.0 0.4 1.8 0.7 0.0 0.9 0.1 0.0 0.2 0.1 1.5 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.6 0.8 0.1 0.6 0.2 0.0 0.0 0.0 1.2 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D2 ENSG00000279116 "Olfactory receptor family 8 subfamily D member 2 (gene/pseudogene)" Q9GZM6 11 124319238-124320288 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "K-562: 1.3" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D4 ENSG00000181518 "Olfactory receptor family 8 subfamily D member 4" Q8NGM9 11 123902167-123909229 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.8;pancreas: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "U-138 MG: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.1 1.0 0.3 0.0 0.3 0.2 0.1 0.0 0.1 0.7 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.3 2.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.3 0.0 0.6 0.6 1.8 0.5 0.9 0.5 0.3 0.0 0.0 0.4 0.6 0.0 0.7 0.3 0.0 0.0 0.5 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.5 0.1 0.2 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.6 0.2 0.3 0.0 0.6 0.0 0.2 0.3 0.2 0.0 0.4 0.1 0.3 0.0 0.9 0.1 0.0 0.2 0.3 0.2 0.0 0.5 0.1 0.5 0.1 0.0 0.3 0.0 0.8 0.1 0.0 0.0 1.2 0.1 0.2 0.4 0.2 0.0 0.0 0.2 0.6 0.2 1.6 0.5 0.6 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.6 0.4 0.5 1.8 0.9 0.4 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8G1 "HSTPCR25, OR8G1P, TPCR25" ENSG00000197849 "Olfactory receptor family 8 subfamily G member 1 (gene/pseudogene)" Q15617 11 124241095-124254364 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 23 "testis: 18.2" "Group enriched" "Detected in some" 21 "Early spermatids: 2.7;Late spermatids: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.3 18.2 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.5 0.3 0.7 0.4 0.1 0.3 0.0 0.3 0.1 0.7 0.2 0.0 0.6 1.2 0.4 0.4 0.7 0.1 0.0 0.7 0.7 0.2 0.0 0.1 0.6 0.3 0.4 0.2 0.2 0.4 0.5 0.6 0.5 0.1 1.3 0.5 0.1 0.2 0.4 0.4 0.3 0.1 0.8 1.0 0.7 0.1 1.2 0.5 0.5 0.6 0.3 0.4 0.2 0.3 0.1 0.1 0.3 0.9 0.4 0.1 0.3 0.0 0.5 0.4 0.5 0.8 0.3 0.2 0.7 0.2 0.4 0.6 0.3 0.2 0.3 0.4 0.3 0.4 0.2 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.7 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OR8G5 "OR8G5P, OR8G6" ENSG00000255298 "Olfactory receptor family 8 subfamily G member 5" Q8NG78 11 124256376-124266218 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 5.2;lung: 4.0;testis: 7.8" "Group enriched" "Detected in some" 23 "Early spermatids: 12.8;Late spermatids: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "K-562: 5.1;PC-3: 3.2;T-47d: 5.4" NA NA "unprognostic (1.48e-1)" 5.2 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.6 0.1 0.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 17.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 OR8H1 ENSG00000181693 "Olfactory receptor family 8 subfamily H member 1" Q8NGG4 11 56288462-56292254 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 1.2;NTERA-2: 1.0" NA NA 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.7 0.7 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.6 0.1 0.9 0.8 2.6 0.7 1.2 1.5 0.2 1.2 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.7 0.4 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.5 0.0 0.5 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.4 0.0 0.0 0.2 0.0 0.6 1.0 0.2 0.0 0.1 0.3 0.0 0.0 0.5 0.3 0.6 0.0 0.0 0.2 0.8 0.2 0.2 0.0 0.1 0.3 0.0 0.2 0.7 0.4 0.0 0.4 0.1 0.0 1.7 0.7 0.6 1.5 0.4 0.7 0.6 1.1 0.7 0.4 0.9 1.0 1.0 2.6 1.2 0.7 0.8 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8H2 ENSG00000181767 "Olfactory receptor family 8 subfamily H member 2" Q8N162 11 56103687-56107658 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 3.1;bone marrow: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 3.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 3.1" "Not detected" "Not detected" NA NA 0.3 0.1 0.0 0.1 0.0 1.3 0.0 0.0 0.3 0.5 0.1 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.7 0.1 0.2 0.1 3.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.4 0.5 0.0 0.0 0.3 0.0 0.1 0.9 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.3 0.1 3.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8H3 ENSG00000181761 "Olfactory receptor family 8 subfamily H member 3" Q8N146 11 56122373-56123311 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8I2 ENSG00000172154 "Olfactory receptor family 8 subfamily I member 2" Q8N0Y5 11 56093277-56094286 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8J1 ENSG00000172487 "Olfactory receptor family 8 subfamily J member 1" Q8NGP2 11 56354291-56361511 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8J3 ENSG00000167822 "Olfactory receptor family 8 subfamily J member 3" Q8NGG0 11 56134721-56140201 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.8 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8K1 ENSG00000150261 "Olfactory receptor family 8 subfamily K member 1" Q8NGG5 11 56345945-56347031 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055233 Uncertain NA NA "HPA055233: AB_2682749" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8K3 ENSG00000280314 "Olfactory receptor family 8 subfamily K member 3 (gene/pseudogene)" Q8NH51 11 56315144-56320639 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8K5 ENSG00000181752 "Olfactory receptor family 8 subfamily K member 5" Q8NH50 11 56159394-56160317 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 10 "stomach cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8S1 ENSG00000284723 "Olfactory receptor family 8 subfamily S member 1" Q8NH09 12 48525632-48528103 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "intestine: 1.2;ovary: 1.0" "Cell type enriched" "Detected in single" 7 "Spermatocytes: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;CAPAN-2: 1.6" "Not detected" "Not detected" HPA045595 Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA045595: AB_10964447" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.0 0.0 0.0 0.0 OR8U1 ENSG00000172199 "Olfactory receptor family 8 subfamily U member 1" Q8NH10 11 56375624-56376553 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9A2 ENSG00000179468 "Olfactory receptor family 9 subfamily A member 2" Q8NGT5 7 143026158-143027195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9A4 ENSG00000258083 "Olfactory receptor family 9 subfamily A member 4" Q8NGU2 7 141916399-141920625 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.9;epididymis: 1.0;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-937: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.77e-1)" 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.0 0.1 0.2 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.4 0.1 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9G1 OR9G5 ENSG00000174914 "Olfactory receptor family 9 subfamily G member 1" Q8NH87 11 56699095-56703884 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.44e-1)" 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.2 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.5 0.4 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9G4 ENSG00000172457 "Olfactory receptor family 9 subfamily G member 4" Q8NGQ1 11 56741223-56748697 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9I1 ENSG00000172377 "Olfactory receptor family 9 subfamily I member 1" Q8NGQ6 11 58116742-58125530 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9K2 ENSG00000170605 "Olfactory receptor family 9 subfamily K member 2" Q8NGE7 12 55126406-55132750 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA015808 Uncertain NA NA "HPA015808: AB_2669306" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9Q1 ENSG00000186509 "Olfactory receptor family 9 subfamily Q member 1" Q8NGQ5 11 58023881-58181616 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "skeletal muscle: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.65e-3)" "unprognostic (2.27e-1)" 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.1 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.5 0.4 0.3 0.7 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.5 0.1 0.2 0.5 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.8 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9Q2 OR9Q2P ENSG00000186513 "Olfactory receptor family 9 subfamily Q member 2" Q8NGE9 11 58189070-58194053 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ORAI1 "CRACM1, FLJ14466, TMEM142A" ENSG00000276045 "ORAI calcium release-activated calcium modulator 1" Q96D31 12 121626550-121642677 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 26.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 35.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016583, HPA061823" Approved Enhanced Cytosol NA NA Cytosol "HPA016583: AB_1848720, HPA061823: AB_2684619" "unprognostic (2.22e-2)" "unprognostic (3.78e-3)" "unprognostic (7.82e-3)" "unprognostic (8.83e-2)" "unprognostic (3.20e-1)" "unprognostic (1.99e-3)" "unprognostic (4.25e-3)" "unprognostic (1.92e-1)" "unprognostic (2.00e-2)" "prognostic favorable (4.30e-4)" "unprognostic (1.41e-1)" "unprognostic (2.59e-1)" "unprognostic (6.84e-2)" "unprognostic (1.95e-1)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" 4.3 1.3 0.0 6.2 1.1 3.7 7.1 0.0 1.3 2.1 9.8 1.7 5.0 10.6 2.3 2.2 3.4 1.7 4.8 3.5 0.4 4.9 9.6 7.5 14.1 2.5 0.6 4.8 5.9 1.4 0.0 4.6 5.6 3.3 0.1 10.6 6.8 3.0 26.0 17.0 14.0 4.4 0.9 11.4 3.9 6.8 0.9 8.1 6.5 7.0 9.1 3.8 2.3 6.9 5.6 6.3 4.3 4.9 14.4 5.1 6.1 13.1 1.4 6.0 1.5 2.0 6.7 7.4 1.2 3.4 2.2 11.3 5.0 4.4 12.3 1.4 5.1 11.3 1.1 5.1 0.0 14.8 3.1 8.0 2.2 4.9 4.2 5.0 15.0 0.6 2.1 5.1 0.2 1.9 5.5 13.3 6.4 1.0 1.0 13.6 14.3 35.2 6.2 4.5 15.6 6.5 2.3 7.1 2.5 3.4 5.4 0.8 2.8 3.8 5.5 0.1 8.7 1.9 6.5 7.8 3.5 9.2 5.6 3.8 2.5 1.8 5.2 8.8 5.8 6.3 4.2 5.7 14.1 4.3 10.9 4.4 11.5 14.4 5.6 6.9 11.2 9.8 5.2 4.9 3.7 1.4 10.0 5.1 26.8 16.0 20.4 7.7 20.0 1.9 3.7 22.9 8.1 15.9 1.8 3.9 2.0 1.7 10.9 2.7 38.3 8.6 23.3 17.0 12.5 10.4 5.4 6.9 14.3 32.8 0.0 2.4 32.5 19.7 9.7 12.4 33.8 20.3 19.8 7.1 4.5 23.1 7.0 8.9 9.0 6.5 0.0 8.2 1.2 3.2 32.6 6.5 41.5 16.4 7.5 ORAI2 "C7orf19, CBCIP2, FLJ12474, FLJ14733, H_NH0514P08.8, TMEM142B" ENSG00000160991 "ORAI calcium release-activated calcium modulator 2" Q96SN7 7 102433106-102456821 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "B-cells: 169.1;Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 30.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 46.5;RPMI-8226: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055137, HPA065937" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055137: AB_2682712, HPA065937: AB_2685581" "unprognostic (5.09e-3)" "unprognostic (1.23e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (5.07e-3)" "unprognostic (8.56e-2)" "unprognostic (3.82e-2)" "unprognostic (7.07e-2)" "unprognostic (7.61e-2)" "unprognostic (1.47e-1)" "prognostic favorable (8.49e-5)" "unprognostic (7.16e-2)" "unprognostic (1.57e-3)" "unprognostic (7.97e-2)" "unprognostic (1.88e-1)" "prognostic favorable (6.65e-4)" "unprognostic (2.46e-1)" 6.3 7.2 13.8 28.1 15.8 24.3 8.0 18.6 15.9 4.7 5.7 5.0 5.6 5.6 7.7 6.2 2.7 7.7 6.6 4.1 11.9 17.1 6.9 1.5 6.2 25.9 9.3 4.8 5.0 4.8 13.9 24.8 4.1 10.3 4.3 2.8 4.3 5.1 7.6 1.8 1.6 10.3 4.6 7.0 21.9 7.7 1.8 5.1 9.9 10.9 1.3 20.3 10.0 4.4 14.4 2.5 30.9 2.7 7.4 2.3 2.5 6.4 14.7 5.7 10.9 5.2 5.9 0.4 6.3 7.0 7.0 6.1 8.4 6.8 46.5 17.6 10.7 14.0 2.5 2.2 1.6 2.4 5.0 4.1 6.6 6.9 2.5 7.9 15.8 8.9 5.5 1.1 11.4 1.9 7.3 12.5 6.3 8.2 37.3 5.4 13.5 23.4 7.3 7.1 2.2 6.9 9.6 5.1 45.7 4.1 4.8 9.7 24.2 6.2 2.6 3.4 3.1 3.8 6.2 11.9 16.5 18.4 11.3 8.3 36.4 25.5 34.0 12.3 9.6 8.4 4.9 2.7 30.9 2.0 2.4 2.3 13.3 1.8 1.6 1.6 14.4 1.2 1.4 25.6 7.4 1.4 2.5 0.8 2.5 13.8 15.8 18.6 11.2 11.9 17.1 9.3 4.8 10.3 5.1 3.0 11.1 169.1 8.0 3.5 25.3 2.6 12.7 20.1 15.9 15.7 62.8 1.0 5.0 18.0 2.6 20.1 0.3 0.0 10.3 1.5 12.6 8.4 25.4 0.8 14.7 41.3 16.6 23.4 19.4 4.9 7.5 17.5 10.1 29.7 2.0 11.8 9.9 0.0 9.6 7.9 21.1 0.0 5.9 3.2 9.4 2.8 2.5 25.5 1.3 5.8 ORAI3 "MGC13024, TMEM142C" ENSG00000175938 "ORAI calcium release-activated calcium modulator 3" Q9BRQ5 16 30949066-30956461 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015022 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015022: AB_1854807" "unprognostic (1.17e-1)" "unprognostic (3.88e-2)" "unprognostic (2.94e-3)" "unprognostic (1.15e-2)" "unprognostic (8.29e-2)" "unprognostic (1.46e-1)" "unprognostic (8.60e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-1)" "unprognostic (1.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (3.87e-5)" "unprognostic (2.30e-2)" "unprognostic (4.46e-2)" "unprognostic (6.43e-3)" "unprognostic (9.17e-3)" 13.4 22.9 5.5 13.0 5.6 12.4 14.8 6.0 8.1 17.0 12.8 9.1 13.3 7.5 12.4 16.9 19.9 13.6 16.5 10.8 4.9 5.1 16.5 39.6 15.4 20.7 5.9 3.6 16.9 14.5 13.5 12.1 14.8 5.8 26.2 7.3 13.3 10.3 15.3 9.4 10.2 9.9 16.4 5.1 20.0 10.4 19.7 5.2 14.2 25.6 6.3 13.7 29.1 15.2 5.1 6.8 17.9 8.5 8.1 2.8 2.2 1.0 5.8 3.0 4.0 26.1 23.5 0.2 3.3 23.0 2.5 6.5 0.5 9.6 1.4 7.8 6.5 10.3 4.7 0.5 6.4 1.7 4.4 1.9 3.7 1.8 5.7 36.5 4.0 11.5 25.2 17.2 4.9 9.7 24.2 4.3 0.8 4.1 7.7 8.2 3.8 0.2 15.0 2.4 3.2 1.6 3.1 2.3 10.8 9.7 2.5 0.7 5.0 3.1 0.9 5.2 7.7 7.3 16.5 3.1 1.9 1.3 4.2 0.7 18.9 1.3 1.1 9.6 9.4 2.9 14.1 6.5 17.9 2.5 6.3 2.8 5.1 1.4 2.0 6.1 4.8 1.7 2.3 10.9 8.1 8.5 6.8 1.9 2.2 5.5 5.6 6.0 8.1 4.9 5.1 5.9 3.6 5.8 5.2 6.0 9.6 31.2 20.7 7.0 1.7 5.6 5.1 8.1 3.4 15.7 2.0 19.6 11.6 14.8 48.3 11.6 5.1 0.0 10.1 2.1 16.0 14.7 6.9 65.7 77.4 33.4 14.5 17.2 29.5 24.4 49.2 21.5 20.3 28.9 12.9 22.3 8.7 16.9 40.7 47.0 3.4 25.8 6.6 24.5 1.5 4.0 3.7 15.0 6.2 19.2 ORMDL1 ENSG00000128699 "ORMDL sphingolipid biosynthesis regulator 1" Q9P0S3 2 189770323-189784371 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA065643 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA065643: AB_2685525" "unprognostic (1.45e-1)" "unprognostic (5.34e-3)" "unprognostic (1.05e-1)" "unprognostic (1.08e-1)" "unprognostic (2.56e-1)" "unprognostic (1.80e-1)" "unprognostic (4.85e-3)" "unprognostic (1.86e-2)" "unprognostic (6.70e-3)" "prognostic favorable (3.04e-5)" "unprognostic (5.90e-3)" "unprognostic (2.16e-2)" "prognostic unfavorable (5.84e-9)" "unprognostic (2.62e-1)" "unprognostic (1.14e-1)" "unprognostic (2.87e-2)" "prognostic favorable (1.49e-5)" 24.9 31.1 23.1 27.3 29.6 28.5 36.8 29.4 30.8 24.7 23.1 24.1 56.0 24.2 28.9 63.8 21.8 25.7 28.5 17.9 22.6 25.1 26.5 30.3 31.5 40.4 30.6 24.1 25.7 39.9 25.1 50.6 37.5 29.9 29.7 30.5 30.4 55.2 41.2 18.3 47.0 38.1 25.6 25.1 63.1 28.1 37.3 24.7 26.3 31.1 21.7 40.3 24.6 23.9 28.7 36.8 29.0 35.2 21.0 37.7 26.2 13.2 10.4 27.6 21.4 37.6 42.7 30.4 25.8 28.1 33.7 33.7 20.4 21.8 22.8 19.5 20.8 18.8 20.7 19.2 17.2 36.6 26.1 24.1 32.4 36.6 25.5 47.8 28.0 27.1 47.7 21.6 28.2 32.3 39.3 24.1 26.3 21.7 35.4 32.6 13.8 26.1 52.4 29.8 15.7 47.5 17.7 23.7 32.4 39.0 20.4 18.1 20.8 14.4 13.8 34.7 32.7 15.7 31.0 22.1 29.8 22.3 21.5 28.5 32.4 26.9 23.9 32.4 30.5 16.3 25.7 25.0 29.0 28.7 30.5 28.6 28.7 33.3 31.1 20.5 24.5 37.7 34.6 10.0 21.0 35.2 36.8 33.8 26.2 23.1 29.6 29.4 30.8 22.6 25.1 30.6 24.1 29.9 24.7 74.5 42.8 77.9 46.4 50.0 133.7 29.1 35.7 62.9 48.9 34.9 164.9 178.2 28.2 47.2 32.5 57.1 35.5 46.7 58.9 59.1 53.0 65.1 43.9 30.6 77.0 62.0 40.7 40.5 102.6 15.7 68.7 72.5 37.1 81.2 33.3 99.7 53.1 47.6 45.6 41.1 186.8 51.8 49.5 126.1 133.3 53.1 182.4 89.2 41.3 44.2 ORMDL2 "adoplin-2, HSPC160, MST095, MSTP095" ENSG00000123353 "ORMDL sphingolipid biosynthesis regulator 2" Q53FV1 12 55817919-55821879 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065643 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA065643: AB_2685525" "unprognostic (1.12e-1)" "unprognostic (2.59e-2)" "unprognostic (2.41e-1)" "prognostic favorable (3.30e-5)" "unprognostic (6.92e-2)" "unprognostic (1.52e-3)" "prognostic unfavorable (9.75e-4)" "unprognostic (1.45e-2)" "unprognostic (1.11e-1)" "unprognostic (2.88e-2)" "unprognostic (1.84e-3)" "unprognostic (1.49e-1)" "unprognostic (2.75e-3)" "unprognostic (1.25e-1)" "unprognostic (2.20e-1)" "unprognostic (3.04e-2)" "unprognostic (5.68e-2)" 19.5 20.3 6.7 14.1 8.5 9.5 26.9 6.5 10.0 14.6 23.9 11.7 25.7 14.6 15.4 29.9 37.6 13.7 23.3 17.2 7.3 8.2 32.0 44.4 20.1 22.5 10.1 7.7 18.6 34.7 15.9 15.6 31.9 11.4 15.8 27.8 9.1 24.0 20.9 14.5 16.9 24.8 14.5 13.0 24.0 16.2 31.9 8.7 28.4 22.2 23.0 22.0 14.6 17.5 38.8 53.3 45.2 44.6 29.8 45.8 29.0 15.4 29.5 12.5 6.4 24.1 12.1 13.9 19.0 18.9 16.6 14.7 32.9 38.3 9.6 20.3 22.8 17.1 28.7 9.9 39.5 16.6 10.0 14.8 13.0 28.5 18.3 25.6 15.6 13.8 15.1 36.4 29.1 30.4 21.5 23.2 10.9 6.8 26.3 21.1 24.8 9.5 7.0 6.0 24.6 23.5 6.3 10.0 24.7 43.1 45.1 10.9 6.9 24.2 28.9 10.5 19.8 34.6 11.3 16.8 9.0 12.6 10.5 12.0 12.7 10.4 7.9 14.3 6.3 12.4 21.1 32.8 45.2 40.5 39.9 36.2 38.8 39.3 42.9 32.6 34.2 32.9 39.2 41.1 29.8 44.6 53.3 45.8 29.0 6.7 8.5 6.5 10.0 7.3 8.2 10.1 7.7 11.4 8.7 68.5 31.8 52.9 52.0 20.7 9.4 3.4 58.6 69.6 43.3 50.6 11.8 65.8 24.9 118.7 136.0 35.0 96.4 0.0 146.5 97.7 20.3 85.8 49.8 82.3 112.2 7.9 44.3 33.2 42.9 45.2 23.6 61.7 54.0 155.1 48.2 22.3 157.8 91.2 21.9 66.7 14.0 19.4 14.1 69.9 49.6 29.2 126.8 41.5 43.3 74.9 ORMDL3 ENSG00000172057 "ORMDL sphingolipid biosynthesis regulator 3" Q8N138 17 39921041-39927601 "Disease related genes, Predicted membrane proteins" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 239.1;Late spermatids: 240.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 92.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065643 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA065643: AB_2685525" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "unprognostic (3.31e-2)" "unprognostic (6.49e-2)" "unprognostic (4.11e-2)" "unprognostic (1.55e-1)" "unprognostic (2.96e-1)" "prognostic favorable (9.29e-4)" "unprognostic (1.26e-1)" "unprognostic (3.67e-1)" "unprognostic (5.68e-2)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "unprognostic (2.37e-1)" "unprognostic (4.55e-1)" "unprognostic (1.09e-3)" "prognostic favorable (5.18e-4)" 48.9 12.4 16.1 19.9 20.6 11.7 36.1 14.9 18.2 14.9 17.4 12.6 29.9 17.2 15.3 23.8 10.9 10.4 17.3 21.6 16.1 12.5 14.1 83.0 16.9 17.3 14.6 16.3 15.7 68.4 14.9 21.0 28.6 12.6 17.0 13.7 14.4 24.4 24.1 13.5 15.4 16.2 14.1 13.5 15.5 16.9 18.1 16.1 29.7 20.9 11.0 24.9 17.8 10.4 11.9 8.8 24.9 4.3 7.4 24.8 15.9 7.2 8.9 9.4 7.8 24.6 9.4 8.6 10.6 12.4 11.4 11.1 10.1 8.1 5.4 10.2 13.1 7.8 12.4 6.6 8.5 10.7 92.6 11.9 5.2 5.0 24.4 9.6 6.1 9.2 10.2 9.0 7.9 4.5 13.0 5.1 15.3 6.6 43.9 6.2 6.5 18.2 6.9 5.3 9.6 4.5 15.4 8.5 16.9 6.3 17.7 8.3 8.4 7.0 44.4 7.0 11.0 15.9 6.7 4.1 6.2 7.8 5.3 8.0 23.7 20.0 7.5 6.4 6.0 4.6 3.5 2.0 24.9 17.5 3.1 12.5 11.9 17.8 19.3 1.7 10.8 20.9 24.8 3.3 7.4 4.3 8.8 11.3 15.9 16.1 20.6 14.9 18.2 16.1 12.5 14.6 16.3 12.6 16.1 47.6 27.5 22.9 12.1 14.5 16.0 23.6 17.8 2.7 15.9 40.1 0.0 21.4 3.3 16.6 239.1 10.5 23.4 70.0 25.7 14.9 13.9 17.1 18.4 78.8 7.0 12.7 24.9 3.7 5.7 240.9 17.3 5.8 15.1 32.5 22.8 38.4 28.9 17.5 26.9 10.2 9.8 25.8 13.7 6.4 5.7 12.5 7.8 34.8 16.6 11.3 OS9 "ERLEC2, OS-9" ENSG00000135506 "OS9, endoplasmic reticulum lectin" Q13438 12 57693955-57721557 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "RH-30: 291.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011518, HPA013694" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "CAB011518: AB_776918, HPA013694: AB_1854812" "unprognostic (1.67e-2)" "unprognostic (4.20e-1)" "unprognostic (3.93e-2)" "unprognostic (1.50e-1)" "unprognostic (9.79e-3)" "unprognostic (1.32e-3)" "unprognostic (4.78e-2)" "unprognostic (8.54e-2)" "unprognostic (2.67e-1)" "unprognostic (1.64e-1)" "unprognostic (5.67e-3)" "unprognostic (2.23e-1)" "unprognostic (1.83e-2)" "unprognostic (2.78e-1)" "unprognostic (1.67e-2)" "unprognostic (4.81e-2)" "unprognostic (2.21e-2)" 39.3 32.9 24.4 28.1 27.6 32.2 38.0 27.0 34.9 37.4 39.1 27.6 34.5 37.2 36.2 37.7 35.2 32.0 33.0 39.2 23.2 23.1 42.9 94.4 40.2 34.2 27.7 22.0 44.2 110.7 49.5 29.2 47.0 28.2 34.7 34.1 42.0 53.2 28.5 19.0 36.9 47.4 28.1 18.6 37.5 35.7 21.4 24.0 23.8 47.6 23.2 34.4 33.3 35.1 11.5 35.8 54.1 48.7 11.4 16.1 36.7 6.7 13.8 7.0 17.4 36.7 24.9 15.6 17.0 21.7 12.6 12.8 14.3 22.1 8.7 28.4 20.3 9.7 12.3 6.5 11.0 10.0 11.1 7.9 9.8 9.8 12.9 24.0 15.3 25.2 22.8 17.7 12.3 12.6 43.4 20.9 5.8 7.4 34.7 13.1 11.7 4.1 18.6 7.9 13.5 9.8 5.4 291.6 21.8 9.6 16.8 7.2 9.6 24.2 16.7 13.7 13.4 19.9 30.2 19.1 17.0 10.2 11.5 10.7 20.7 17.8 9.0 14.4 11.2 23.4 30.6 48.7 54.1 16.1 44.4 15.2 10.9 13.7 14.2 35.8 11.5 10.7 12.3 52.0 11.4 35.0 31.1 15.0 36.7 24.4 27.6 27.0 34.9 23.2 23.1 27.7 22.0 28.2 24.0 80.4 110.4 55.1 75.1 51.3 42.6 12.6 91.7 93.7 103.5 69.8 72.6 122.4 8.3 114.5 4.8 76.5 142.5 46.7 96.4 106.6 99.6 64.6 86.8 139.4 128.9 47.7 99.5 76.7 105.2 9.1 105.0 115.3 113.1 158.7 107.2 85.8 84.7 129.8 74.3 44.0 34.1 90.5 57.7 33.4 54.8 45.0 165.3 69.2 78.8 57.0 OSBPL8 "MST120, MSTP120, ORP8, OSBP10" ENSG00000091039 "Oxysterol binding protein like 8" Q9BZF1 12 76351797-76559809 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "granulocytes: 242.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001309 Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA001309: AB_1079530" "unprognostic (2.55e-1)" "unprognostic (2.68e-2)" "unprognostic (2.77e-1)" "unprognostic (1.70e-1)" "unprognostic (5.20e-2)" "unprognostic (1.23e-1)" "unprognostic (6.55e-3)" "unprognostic (2.84e-1)" "unprognostic (7.88e-2)" "unprognostic (1.61e-2)" "prognostic unfavorable (9.79e-4)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (5.63e-3)" "unprognostic (2.96e-1)" "unprognostic (1.16e-1)" "unprognostic (3.19e-3)" 29.3 11.4 13.9 18.4 41.9 23.1 17.2 13.7 20.2 20.0 11.5 6.8 8.4 7.5 18.5 10.7 20.1 10.4 15.0 19.3 13.4 12.9 30.2 15.2 20.5 22.7 12.1 13.2 14.9 11.2 12.4 16.5 14.4 13.9 16.2 9.7 9.2 15.8 11.1 21.5 22.9 12.6 15.5 14.8 24.9 12.4 12.8 14.7 41.0 11.7 10.6 24.8 18.0 24.5 11.7 15.8 57.2 15.0 9.9 10.9 8.1 12.4 8.0 17.8 12.6 24.8 35.1 11.3 19.2 27.0 12.4 11.3 11.5 5.2 17.5 11.0 22.8 7.7 5.2 13.2 11.1 18.7 14.9 11.7 46.9 7.9 6.8 15.3 29.7 19.1 18.5 21.2 18.4 23.0 22.3 10.6 10.2 32.1 8.1 20.3 8.6 19.8 14.1 8.7 4.5 7.9 10.4 24.3 10.0 9.5 10.6 9.7 10.2 16.4 6.0 11.9 14.6 4.6 18.1 24.8 20.0 10.0 20.6 10.3 8.1 12.7 19.3 7.6 16.7 11.6 27.5 15.0 20.1 9.0 10.8 8.5 11.7 9.6 7.3 13.2 11.6 8.7 7.1 57.2 9.9 11.7 15.8 10.9 8.1 13.9 41.9 13.7 19.9 13.4 12.9 12.1 13.2 13.9 14.7 53.6 69.1 48.0 37.5 103.3 37.1 37.6 20.4 40.2 34.2 48.8 84.4 28.5 51.4 49.5 35.1 65.2 13.0 23.3 47.9 23.5 68.6 48.2 242.1 32.5 69.5 39.7 9.1 50.3 88.2 15.3 60.9 125.5 33.7 85.6 23.5 51.8 73.4 24.6 77.8 126.3 27.5 45.3 89.0 45.6 131.8 108.8 40.3 78.4 14.9 59.7 OSMR OSMRB ENSG00000145623 "Oncostatin M receptor" Q99650 5 38845858-38945596 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 38.4;GAMG: 39.5;HSkMC: 47.5;U-2197: 38.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017278 Approved Approved Nucleoli "Intracellular and membrane" NA NA 21000000 Nucleoli "HPA017278: AB_1854818" "unprognostic (6.34e-3)" "prognostic unfavorable (4.87e-4)" "unprognostic (2.58e-1)" "unprognostic (2.11e-1)" "unprognostic (2.18e-3)" "unprognostic (1.13e-1)" "unprognostic (8.00e-3)" "unprognostic (5.70e-2)" "unprognostic (1.79e-3)" "unprognostic (1.72e-3)" "unprognostic (1.60e-3)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.96e-6)" "unprognostic (1.88e-2)" "unprognostic (1.49e-2)" "unprognostic (4.43e-1)" "unprognostic (1.75e-2)" 41.1 18.0 7.3 18.7 9.4 0.3 31.0 3.1 9.4 14.1 13.7 2.8 4.6 4.4 14.4 12.9 14.7 14.5 22.4 22.4 5.4 3.5 19.7 23.6 25.7 31.7 9.0 1.3 33.6 10.1 6.6 10.5 40.1 13.3 20.8 8.6 9.2 17.2 11.1 13.0 12.5 8.0 32.5 15.6 23.5 11.5 10.8 6.9 3.6 17.5 10.4 11.3 40.4 43.6 0.6 0.6 1.6 0.4 0.7 0.6 0.1 7.4 9.7 1.6 4.2 17.9 38.4 5.6 12.2 19.4 12.0 16.2 0.0 20.3 0.0 5.8 12.9 39.5 10.4 2.1 15.0 19.5 0.0 1.2 0.5 7.6 7.3 20.3 0.0 0.1 47.5 9.0 27.0 23.1 22.4 1.8 0.0 0.0 0.0 7.5 2.0 0.0 0.0 0.2 1.5 3.2 0.0 0.5 0.0 24.2 2.2 0.0 0.0 27.6 0.0 0.0 2.4 8.4 0.0 2.8 29.4 11.1 38.0 6.5 0.0 0.0 0.0 23.6 0.0 6.3 1.6 0.4 0.4 0.5 0.3 0.2 0.3 0.3 0.1 0.1 0.6 0.4 0.6 1.0 0.7 0.1 0.6 0.2 0.1 7.3 9.4 3.1 9.4 5.4 3.5 9.0 1.3 13.3 6.9 41.7 42.5 0.0 57.8 27.0 0.0 2.8 22.9 9.4 46.6 12.2 0.0 5.3 0.0 43.3 0.5 37.0 0.0 0.0 41.7 6.0 25.9 39.4 1.1 11.3 1.3 0.0 0.0 60.2 9.7 0.4 38.6 1.3 6.8 2.8 0.0 0.8 60.1 0.0 7.1 3.3 0.6 19.4 24.0 0.3 0.6 21.0 14.3 0.5 0.0 57.6 OST4 ENSG00000228474 "Oligosaccharyltransferase complex subunit 4, non-catalytic" P0C6T2 2 27070472-27071773 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.15e-2)" "unprognostic (4.42e-2)" "unprognostic (2.24e-1)" "unprognostic (3.63e-1)" "unprognostic (5.95e-2)" "unprognostic (1.95e-3)" "prognostic unfavorable (5.11e-4)" "unprognostic (2.66e-1)" "unprognostic (1.18e-1)" "unprognostic (2.88e-2)" "unprognostic (7.89e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (7.35e-5)" "unprognostic (1.33e-1)" "unprognostic (8.52e-2)" "unprognostic (1.38e-1)" "unprognostic (9.88e-2)" 59.5 78.3 55.7 51.8 50.0 70.8 97.3 19.3 46.1 69.3 73.0 35.8 71.8 51.2 55.9 83.8 82.8 46.9 61.8 129.2 41.7 42.5 78.6 144.6 58.3 114.2 53.5 31.8 71.8 137.6 29.2 44.1 62.9 43.4 77.0 59.9 56.3 107.8 79.4 83.5 47.8 83.6 73.7 58.6 97.4 58.3 47.0 33.0 93.9 87.9 72.5 82.1 81.7 68.6 105.2 156.8 146.4 84.3 57.9 112.9 236.3 48.1 37.6 45.2 30.8 120.3 99.0 30.6 58.9 62.2 32.9 47.8 37.2 39.5 21.7 40.8 88.4 53.2 22.5 27.4 59.7 25.4 44.7 42.5 47.1 27.4 87.7 68.7 34.4 43.9 109.0 48.7 44.4 41.0 87.1 74.6 44.2 28.4 46.9 71.9 52.6 41.8 63.1 27.2 90.8 59.5 24.7 50.7 53.4 76.1 48.0 26.5 62.6 30.9 50.2 41.5 59.3 27.0 41.3 62.7 50.4 44.2 38.1 41.0 80.3 56.2 73.8 51.7 36.5 42.5 146.4 84.3 122.3 85.1 71.3 98.2 105.2 112.9 92.8 80.3 87.3 105.3 100.8 70.0 57.9 67.9 156.8 105.5 236.3 55.7 50.0 19.3 46.1 41.7 42.5 53.5 31.8 43.4 33.0 163.8 250.1 493.4 343.8 365.3 56.2 326.8 356.7 191.4 263.9 629.8 19.6 452.2 1013.0 592.2 171.1 384.9 698.0 233.6 575.7 642.6 480.5 447.4 443.0 660.9 735.0 31.8 418.0 572.7 531.5 116.8 466.9 462.4 566.8 1200.2 851.9 130.3 621.9 666.5 403.4 914.5 56.8 291.1 279.1 220.3 371.3 514.9 482.6 442.8 601.0 460.9 OSTC DC2 ENSG00000198856 "Oligosaccharyltransferase complex non-catalytic subunit" Q9NRP0 4 108650584-108667820 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 444.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.26e-1)" "unprognostic (1.00e-1)" "unprognostic (2.10e-2)" "prognostic favorable (1.44e-4)" "unprognostic (6.05e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (2.77e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (6.46e-2)" "unprognostic (4.55e-2)" "unprognostic (3.13e-3)" "unprognostic (9.16e-3)" "prognostic unfavorable (2.31e-8)" "unprognostic (2.06e-1)" "unprognostic (1.68e-1)" "unprognostic (4.06e-2)" "unprognostic (1.55e-2)" 21.3 25.4 9.4 17.6 12.3 18.6 22.5 6.8 10.5 28.9 23.0 9.3 22.1 21.2 23.7 43.0 25.8 20.1 18.5 18.0 9.9 10.3 29.6 62.8 21.9 27.8 13.2 7.3 24.4 61.1 7.4 31.5 33.5 15.5 20.2 22.6 15.2 32.1 18.5 9.8 15.0 33.5 18.4 12.3 25.0 21.2 16.2 11.8 35.1 39.6 24.7 21.3 21.4 19.9 26.2 79.4 25.3 29.8 30.3 45.4 41.6 19.7 12.4 33.6 23.1 72.2 96.6 26.6 54.2 52.6 28.1 34.5 26.3 45.5 42.0 40.0 63.6 17.1 13.5 26.5 22.0 32.8 17.5 19.5 21.5 18.1 57.5 58.2 48.5 21.0 62.3 42.8 23.1 47.6 59.4 62.9 26.4 40.4 49.3 54.7 24.4 33.7 42.5 23.0 53.9 15.9 34.8 36.6 45.5 48.7 14.0 16.9 20.9 18.4 44.4 41.4 43.4 20.4 40.1 49.1 29.9 31.5 22.2 22.0 28.4 28.6 40.8 38.3 29.8 32.5 25.3 29.5 15.5 29.6 29.8 45.4 26.2 31.7 32.0 42.9 19.4 29.9 32.1 4.0 30.3 24.8 79.4 21.8 41.6 9.4 12.3 6.8 10.5 9.9 10.3 13.2 7.3 15.5 11.8 35.7 37.4 113.9 97.2 86.4 14.4 28.2 107.0 80.3 67.1 80.3 15.7 237.0 74.6 194.0 6.1 91.3 59.7 0.0 139.2 444.7 245.3 126.1 121.1 179.6 234.0 11.1 55.7 105.0 126.6 8.4 151.8 168.9 153.5 106.4 158.3 42.3 168.8 84.2 102.6 141.0 18.1 71.1 99.3 40.3 76.8 103.1 305.6 120.4 156.8 112.1 OSTM1 "GL, HSPC019" ENSG00000081087 "Osteopetrosis associated transmembrane protein 1" Q86WC4 6 108041409-108165854 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Osteopetrosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Melanocytes: 143.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010851 Uncertain Approved Nucleoplasm,Vesicles,Cytosol No No 130000 Cytosol "Nucleoplasm, Vesicles" "HPA010851: AB_1079533" "prognostic unfavorable (4.36e-4)" "unprognostic (4.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (1.72e-3)" "prognostic unfavorable (4.26e-4)" "unprognostic (9.40e-2)" "unprognostic (2.56e-1)" "unprognostic (2.25e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.34e-6)" "prognostic unfavorable (1.20e-4)" "unprognostic (2.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" 26.3 21.9 9.0 18.1 13.5 5.5 16.7 13.7 17.2 14.4 17.8 12.8 9.9 8.4 21.8 10.3 14.1 15.0 13.5 23.2 10.4 16.5 22.0 15.9 17.0 17.2 11.0 10.5 15.6 9.7 11.8 26.0 24.7 20.0 15.4 12.4 29.7 10.8 19.0 18.0 10.4 12.9 24.7 13.1 21.7 14.3 11.1 10.7 13.6 12.4 8.1 13.9 21.0 19.4 10.8 12.4 20.9 28.1 14.5 16.4 16.9 2.1 6.4 7.6 11.1 23.0 7.5 10.9 16.0 16.1 11.7 19.5 3.8 3.6 5.0 13.2 11.1 31.6 4.1 7.5 5.4 18.1 11.5 5.9 10.6 4.1 4.7 17.8 11.6 24.7 10.9 13.6 14.4 11.5 10.8 5.9 5.7 8.3 18.5 18.9 3.0 2.5 2.6 3.0 2.6 4.9 4.1 11.1 2.7 8.4 5.8 0.8 4.5 12.9 3.3 28.5 10.6 3.7 16.9 7.2 10.3 3.8 22.7 22.6 7.1 12.1 4.4 30.4 7.9 22.6 16.8 13.9 15.2 15.0 19.9 16.0 10.8 12.8 16.4 12.4 6.2 12.0 15.0 20.9 14.5 28.1 8.9 15.4 16.9 9.0 13.5 13.7 17.2 10.4 16.5 11.0 10.5 20.0 10.7 8.9 21.3 25.4 14.7 41.4 29.2 18.5 12.7 5.3 6.8 12.2 9.8 18.7 1.7 10.8 3.4 18.0 10.3 0.0 19.8 29.3 16.9 16.3 24.2 12.4 46.3 27.0 4.1 28.8 46.6 2.7 13.3 33.0 143.4 10.8 4.2 24.0 15.6 12.9 26.9 21.0 15.7 25.8 33.9 19.8 19.5 27.1 51.1 27.7 2.9 14.0 OTOF "DFNB6, DFNB9, FER1L2" ENSG00000115155 Otoferlin Q9HC10 2 26457203-26558698 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Hearing "Deafness, Disease mutation, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "bone marrow: 13.8;brain: 26.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "basal ganglia: 26.8" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;memory CD8 T-cell: 1.6" "Lineage enhanced" "Detected in single" "T-cells: 1.6" "Cell line enriched" "Detected in some" 17 "HDLM-2: 27.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012410 Approved NA NA "HPA012410: AB_1854836" "unprognostic (4.01e-3)" "unprognostic (7.85e-2)" "unprognostic (8.95e-2)" "unprognostic (7.20e-5)" "unprognostic (1.82e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (6.61e-2)" "unprognostic (1.78e-2)" "unprognostic (1.26e-1)" "unprognostic (2.97e-3)" "unprognostic (4.85e-14)" "unprognostic (1.33e-2)" "unprognostic (5.19e-1)" "unprognostic (9.65e-2)" "unprognostic (8.96e-5)" 0.5 0.7 5.5 0.8 26.8 13.8 0.2 0.4 2.2 0.3 0.4 0.3 0.0 1.1 0.2 0.1 0.4 0.3 0.9 0.2 1.6 2.0 0.1 0.2 0.6 0.5 0.6 0.7 0.2 0.1 0.1 0.0 0.2 1.1 0.3 0.3 0.0 0.3 0.2 0.7 0.2 0.7 0.4 0.7 1.2 0.5 1.4 2.6 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.6 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 5.5 26.8 0.4 2.2 1.6 2.0 0.6 0.7 1.1 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.0 0.1 0.0 0.0 0.0 OTOGL "C12orf64, FLJ90579" ENSG00000165899 "Otogelin like" Q3ZCN5 12 80099537-80380879 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0" "Cell type enhanced" "Detected in some" 24 "Cardiomyocytes: 6.1;Distal tubular cells: 1.7;Early spermatids: 1.1;Proximal tubular cells: 3.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in many" 4 "amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.9;U-2 OS: 2.5;U-87 MG: 7.2" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 5.2" "HPA040364, HPA053392" Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA040364: AB_10795365, HPA053392: AB_2682135" "unprognostic (2.43e-1)" "unprognostic (2.78e-2)" "unprognostic (2.55e-2)" "unprognostic (1.50e-1)" "unprognostic (5.99e-2)" "unprognostic (3.10e-1)" "unprognostic (3.34e-3)" "unprognostic (4.76e-2)" "unprognostic (2.72e-2)" "unprognostic (4.52e-2)" "unprognostic (2.79e-2)" "unprognostic (1.57e-1)" "unprognostic (1.95e-5)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.79e-2)" "unprognostic (2.04e-2)" 0.4 0.2 3.5 0.2 4.3 0.1 0.4 0.2 5.8 0.4 2.7 0.0 0.0 0.2 0.5 3.1 0.5 0.5 0.4 9.8 1.0 0.4 13.3 0.1 0.3 0.5 0.5 3.6 0.2 0.7 0.2 21.0 1.4 0.3 0.5 0.3 1.4 0.3 0.5 1.0 0.3 0.6 0.6 0.3 0.4 0.4 0.8 0.0 0.0 0.2 0.0 0.3 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.7 0.5 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.5 3.9 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.4 0.5 2.5 0.0 0.2 0.9 0.0 0.1 7.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 0.2 5.8 1.0 0.4 0.5 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OTOL1 "C1QTNF15, C1QTNF16" ENSG00000182447 "Otolin 1" A6NHN0 3 161496808-161503942 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 8 "brain: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041030 Uncertain "Secreted in other tissues" NA NA "HPA041030: AB_10795000" 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTOP1 ENSG00000163982 "Otopetrin 1" Q7RTM1 4 4188803-4226889 "Predicted membrane proteins, Transporters" "Biomineralization, Hydrogen ion transport, Ion transport, Transport" "Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 1.1;skin 1: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035599 Uncertain NA NA "HPA035599: AB_10600924" "unprognostic (1.83e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTOP2 ENSG00000183034 "Otopetrin 2" Q7RTS6 17 74924275-74933912 "Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 20.4;testis: 5.1" "Cell type enriched" "Detected in some" 48 "Paneth cells: 508.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "Cell line enriched" "Detected in single" 47 "HDLM-2: 15.2" "Region enriched" "Detected in single" 13 "olfactory region: 15.6" "Low region specificity" "Detected in all" "HPA024524, HPA053090" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA024524: AB_2671592, HPA053090: AB_2682041" "unprognostic (1.62e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (3.21e-2)" "unprognostic (3.62e-1)" "unprognostic (1.30e-1)" "unprognostic (2.85e-2)" "unprognostic (3.81e-1)" "unprognostic (9.04e-2)" "unprognostic (2.04e-2)" 0.1 0.0 0.1 2.9 0.1 0.0 0.1 0.1 0.1 0.1 20.4 0.1 0.1 0.2 0.5 0.1 1.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 10.9 0.1 0.1 0.1 0.1 0.2 11.3 0.2 0.1 0.1 0.0 5.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 10.6 0.0 0.0 0.0 0.0 2.7 0.0 0.0 508.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.5 0.0 OTOP3 ENSG00000182938 "Otopetrin 3" Q7RTS5 17 74935719-74949992 "Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "esophagus: 17.5;intestine: 42.9" "Cell type enriched" "Detected in some" 11 "Paneth cells: 71.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.3;HDLM-2: 2.4;RPMI-8226: 2.3;SH-SY5Y: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.28e-3)" "prognostic favorable (3.86e-4)" "unprognostic (2.77e-1)" "unprognostic (8.60e-2)" "unprognostic (3.42e-1)" "unprognostic (1.03e-1)" "unprognostic (8.36e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 34.1 0.0 0.0 42.9 0.0 0.0 17.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.0 0.0 2.5 29.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 1.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 71.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 OTOR "FDP, MIAL, MIAL1" ENSG00000125879 Otoraplin Q9NRC9 20 16748358-16770062 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;stomach 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 17.0" "Not detected" "Not detected" HPA024335 Uncertain "Secreted in other tissues" NA NA "HPA024335: AB_1854838" "unprognostic (8.50e-3)" "unprognostic (9.56e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-1)" "unprognostic (1.72e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 17.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OXA1L "MGC133129, OXA1" ENSG00000155463 "OXA1L, mitochondrial inner membrane protein" Q15070 14 22766522-22773041 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003531 Approved Supported Mitochondria NA NA Mitochondria "HPA003531: AB_1079539" "unprognostic (4.04e-3)" "unprognostic (2.41e-2)" "unprognostic (3.39e-1)" "unprognostic (2.24e-2)" "unprognostic (7.25e-2)" "unprognostic (1.42e-2)" "unprognostic (1.08e-2)" "unprognostic (1.06e-2)" "unprognostic (1.92e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (1.78e-1)" "prognostic favorable (4.82e-4)" "unprognostic (8.35e-2)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (1.15e-3)" 27.8 36.0 11.9 21.2 15.5 25.1 28.4 13.5 23.0 25.4 30.9 18.5 24.3 27.2 22.7 23.9 30.2 21.5 30.6 48.3 12.9 13.0 31.9 58.4 25.8 45.0 15.2 10.9 31.4 59.6 30.0 12.3 18.3 17.9 25.3 24.2 28.1 24.9 27.5 76.3 24.9 32.8 23.9 13.5 32.9 29.9 17.0 10.3 32.7 37.3 49.0 38.3 31.3 22.3 22.1 39.9 7.2 29.4 16.3 22.6 19.9 21.3 29.5 13.3 22.3 37.8 56.3 24.5 16.3 34.4 23.7 27.5 22.1 24.5 40.2 21.9 18.9 18.4 30.6 25.6 31.7 23.9 16.7 16.5 19.9 20.4 80.9 42.3 37.1 24.8 55.1 35.3 19.6 30.4 30.4 68.2 23.6 14.7 32.9 26.0 31.4 21.9 14.4 13.5 28.4 37.2 22.5 22.0 30.5 30.3 26.8 9.1 17.6 23.7 52.8 31.2 16.5 22.5 30.1 21.8 14.2 16.5 25.8 18.6 24.8 19.7 18.8 11.1 21.4 15.2 4.8 27.9 7.2 13.4 29.4 16.3 22.1 19.2 16.9 39.9 21.9 21.9 16.3 6.3 16.3 22.9 11.3 22.6 19.9 11.9 15.5 13.5 23.0 12.9 13.0 15.2 10.9 17.9 10.3 44.7 38.2 84.8 43.0 61.7 27.2 99.9 84.1 38.8 36.4 27.9 9.8 61.8 63.0 75.1 6.3 57.3 51.9 23.3 140.4 103.7 55.7 38.4 77.5 82.5 125.3 17.5 39.0 57.7 124.8 10.2 52.9 86.1 49.0 93.8 66.6 20.9 92.6 80.7 34.6 95.3 30.4 38.8 51.5 34.7 25.8 58.8 47.8 70.4 100.6 68.0 OXER1 "GPCR, GPR170, TG1019" ENSG00000162881 "Oxoeicosanoid receptor 1" Q8TDS5 2 42762481-42764261 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.9;liver: 26.9" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 5.1;Hepatocytes: 8.1" "Cancer enhanced" "Detected in all" "liver cancer: 12.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 17.4;eosinophil: 42.9" "Lineage enriched" "Detected in single" 76 "granulocytes: 42.9" "Cell line enhanced" "Detected in some" "CACO-2: 9.0;Hep G2: 10.0;HMC-1: 8.6;REH: 4.3;THP-1: 3.9" HPA051433 Uncertain NA NA "HPA051433: AB_2681485" "unprognostic (6.77e-2)" "unprognostic (4.20e-2)" "unprognostic (3.13e-2)" "unprognostic (1.07e-1)" "unprognostic (4.09e-3)" "unprognostic (4.45e-3)" "unprognostic (7.80e-2)" "unprognostic (4.40e-2)" "unprognostic (1.18e-1)" "unprognostic (1.55e-1)" "unprognostic (3.42e-3)" "unprognostic (5.39e-2)" "unprognostic (1.82e-3)" "unprognostic (5.83e-2)" "unprognostic (1.66e-1)" "unprognostic (4.89e-2)" "unprognostic (5.46e-2)" 8.2 0.7 0.7 1.2 0.7 2.0 0.9 0.7 1.5 1.9 2.1 0.7 0.7 4.9 1.7 2.9 1.1 1.4 1.1 2.0 1.5 0.3 4.1 26.9 9.1 4.1 0.7 0.7 5.4 3.8 0.4 2.0 2.7 1.3 3.4 1.6 3.3 3.4 1.7 2.1 2.9 8.3 0.7 0.7 6.4 1.6 1.1 2.7 3.8 1.6 2.2 1.6 2.5 4.8 0.0 0.4 42.9 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 9.0 0.0 0.2 0.1 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.5 3.0 0.0 10.0 0.1 0.2 8.6 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 1.9 0.1 0.0 4.3 1.5 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.9 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 17.4 0.5 42.9 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.7 0.7 0.7 1.5 1.5 0.3 0.7 0.7 1.3 2.7 0.0 0.3 0.0 0.6 0.5 0.7 0.4 5.1 0.0 0.0 1.8 0.0 0.1 1.7 0.4 0.0 0.0 2.1 0.0 1.7 0.1 1.5 0.4 2.3 8.1 0.8 0.0 1.2 0.6 1.5 0.0 3.1 1.4 3.3 1.8 2.7 0.8 0.6 4.5 1.8 3.7 0.0 0.0 1.9 0.0 0.0 0.1 0.2 0.0 3.3 0.1 OXGR1 "aKGR, GPR80, GPR99, P2RY15, P2Y15" ENSG00000165621 "Oxoglutarate receptor 1" Q96P68 13 96985719-96994730 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 7.0" "Cell type enriched" "Detected in some" 11 "Extravillous trophoblasts: 35.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "myeloid DC: 2.9;plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.2" "Cell line enhanced" "Detected in some" "RT4: 7.8;SK-BR-3: 3.6;T-47d: 1.7;U-2 OS: 4.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA067673 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA067673: AB_2685883" "unprognostic (1.83e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-1)" "unprognostic (6.97e-4)" "unprognostic (7.23e-2)" "unprognostic (1.52e-1)" "unprognostic (8.38e-2)" "unprognostic (2.16e-1)" "unprognostic (1.16e-1)" "unprognostic (2.22e-2)" "unprognostic (4.14e-2)" "unprognostic (3.88e-2)" "unprognostic (1.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.54e-1)" "unprognostic (9.68e-2)" 2.1 0.0 0.7 1.7 0.2 0.0 6.7 0.0 2.0 1.6 3.0 0.1 0.6 4.0 3.2 2.5 0.0 0.0 0.8 0.8 7.0 0.0 0.5 0.0 0.7 0.0 0.6 0.0 0.3 1.2 0.5 2.4 4.9 0.3 0.1 4.3 0.5 0.5 1.6 0.3 0.1 0.0 0.8 0.9 1.8 0.9 0.0 5.2 0.1 0.5 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.2 0.0 3.6 0.0 0.2 1.7 0.0 0.0 0.0 4.1 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.0 0.1 0.8 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.1 0.0 0.0 5.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 1.1 1.7 0.0 0.2 0.1 0.0 0.0 0.0 35.1 0.1 0.0 0.0 0.0 1.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.8 0.0 OXTR ENSG00000180914 "Oxytocin receptor" P30559 3 8750408-8769628 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "breast: 42.5" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 93.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "BJ: 81.2;BJ hTERT+: 24.9;BJ hTERT+ SV40 Large T+: 23.6;fHDF/TERT166: 81.3;HBF TERT88: 18.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.18e-1)" "unprognostic (7.94e-2)" "unprognostic (4.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.02e-2)" "unprognostic (2.02e-1)" "unprognostic (1.46e-2)" "unprognostic (2.56e-3)" "unprognostic (2.12e-1)" "unprognostic (3.42e-1)" "unprognostic (2.76e-1)" "unprognostic (3.80e-2)" "unprognostic (4.24e-4)" "unprognostic (8.25e-2)" "unprognostic (4.60e-2)" "unprognostic (2.71e-1)" "unprognostic (1.84e-1)" 0.5 0.4 1.8 0.3 6.5 0.6 42.5 0.9 2.2 0.5 0.3 0.1 0.0 0.3 2.8 0.5 1.1 2.7 1.0 0.6 1.8 4.0 0.6 0.4 1.0 0.4 8.6 0.8 2.8 0.3 0.3 0.3 1.3 3.7 0.9 0.3 1.6 0.4 0.9 0.3 0.4 0.4 0.6 2.5 0.5 0.3 0.5 1.2 0.1 0.4 0.0 0.4 0.4 0.0 0.0 0.2 1.6 0.1 0.1 0.3 1.0 0.2 0.8 0.4 0.1 0.1 0.2 0.1 81.2 24.9 23.6 12.6 0.1 2.1 0.0 0.1 81.3 0.3 0.1 0.3 0.1 18.4 0.7 0.4 0.2 0.3 0.1 0.4 0.1 0.2 0.1 0.1 0.3 0.1 7.1 0.0 0.2 0.0 0.1 13.1 0.0 0.1 0.6 0.5 0.2 3.6 0.1 0.3 4.8 0.9 0.0 0.1 0.1 0.1 0.1 0.0 1.6 0.0 0.1 0.1 1.1 0.3 0.2 0.2 0.1 0.2 0.0 0.1 0.2 0.2 0.5 0.0 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.3 1.6 0.1 0.0 0.1 0.1 1.0 1.8 6.5 0.9 2.2 1.8 4.0 8.6 0.8 3.7 1.2 8.9 1.4 0.0 0.4 0.3 0.2 1.2 0.0 93.7 11.4 0.0 0.0 0.0 0.0 2.6 0.9 0.0 0.0 0.0 0.0 0.1 0.5 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 5.8 1.0 0.0 0.4 0.0 0.0 0.0 0.5 0.7 1.3 0.1 0.0 0.0 0.0 0.1 P2RX1 P2X1 ENSG00000108405 "Purinergic receptor P2X 1" P51575 17 3896592-3916500 "Predicted membrane proteins" "Apoptosis, Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 98.3;urinary bladder: 60.0" "Cell type enriched" "Detected in some" 17 "granulocytes: 178.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "non-classical monocyte: 22.4" "Group enriched" "Detected in many" 22 "dendritic cells: 8.2;granulocytes: 12.8;monocytes: 22.4" "Cell line enhanced" "Detected in some" "HEL: 12.4;HMC-1: 8.0;Karpas-707: 15.5;THP-1: 12.8;U-937: 6.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA 1300000 "unprognostic (1.27e-3)" "unprognostic (1.61e-2)" "unprognostic (2.65e-1)" "unprognostic (3.54e-2)" "unprognostic (7.34e-3)" "unprognostic (9.89e-5)" "unprognostic (1.77e-2)" "unprognostic (6.15e-3)" "unprognostic (2.98e-1)" "unprognostic (2.52e-3)" "unprognostic (1.90e-1)" "unprognostic (2.20e-2)" "unprognostic (4.47e-3)" "unprognostic (2.60e-1)" "unprognostic (5.58e-2)" "unprognostic (4.29e-1)" "unprognostic (1.09e-2)" 5.2 0.7 0.3 2.9 0.5 17.0 1.1 0.3 0.6 5.9 6.3 0.5 10.7 4.0 4.2 5.2 11.0 2.0 3.0 1.1 0.4 0.3 0.9 0.6 3.8 2.0 0.4 0.5 2.4 29.7 0.0 0.4 1.8 0.5 15.3 4.1 0.7 1.8 16.9 1.0 3.0 4.6 98.3 0.7 6.7 1.4 1.6 0.5 1.5 0.5 1.2 2.7 60.0 5.8 0.6 8.2 12.8 22.4 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.1 0.1 1.0 1.6 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.2 3.0 0.0 0.3 0.0 2.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.1 6.7 0.0 0.0 5.8 6.1 0.0 10.6 0.0 0.2 0.0 0.0 3.2 0.6 0.0 0.0 12.8 0.0 22.4 8.2 0.0 4.5 0.3 0.5 0.3 0.6 0.4 0.3 0.4 0.5 0.5 0.5 3.0 6.2 10.4 0.0 0.3 0.0 0.4 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.7 0.1 0.5 0.0 178.1 0.0 3.2 0.0 0.0 0.0 4.6 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.2 0.0 P2RX2 "DFNA41, P2X2" ENSG00000187848 "Purinergic receptor P2X 2" Q9UBL9 12 132618776-132622386 "Disease related genes, Predicted membrane proteins" "Hearing, Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 23.1;prostate: 11.1;seminal vesicle: 16.1" "Cell type enriched" "Detected in single" 5 "Peritubular cells: 2.8" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 4 "amygdala: 6.1;hippocampal formation: 8.6" "Cell type enriched" "Detected in single" 13 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 13 "dendritic cells: 1.2" "Group enriched" "Detected in some" 4 "MCF7: 6.7;T-47d: 15.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.12e-1)" "unprognostic (1.49e-2)" "unprognostic (5.92e-2)" "unprognostic (5.94e-2)" "unprognostic (2.79e-1)" "unprognostic (1.07e-1)" "unprognostic (3.12e-1)" "unprognostic (5.79e-3)" "unprognostic (6.75e-2)" "unprognostic (2.92e-1)" "unprognostic (1.11e-2)" "unprognostic (3.66e-2)" "unprognostic (1.88e-2)" "unprognostic (6.21e-2)" "unprognostic (3.05e-1)" "unprognostic (9.12e-2)" 0.4 0.1 6.1 0.5 0.6 0.0 0.3 0.3 1.6 0.7 1.5 0.3 3.0 1.1 0.3 23.1 5.3 2.5 0.3 0.3 8.6 0.9 1.1 0.3 3.6 1.8 0.3 0.3 0.3 0.3 0.0 0.9 0.7 0.3 11.1 0.3 0.6 0.3 16.1 0.3 0.0 3.4 0.3 0.3 2.4 1.3 1.3 0.3 0.3 0.3 0.3 0.8 0.7 1.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 6.7 0.1 0.4 0.7 0.0 0.1 0.1 0.2 0.1 0.0 0.4 0.1 0.0 0.0 2.7 0.0 1.0 15.4 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.3 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 6.1 0.6 0.3 1.6 8.6 0.9 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 P2RX3 P2X3 ENSG00000109991 "Purinergic receptor P2X 3" P56373 11 57338374-57370600 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 7.9;testis: 16.3" "Group enriched" "Detected in some" 40 "Early spermatids: 34.4;Late spermatids: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.8;hTEC/SVTERT24-B: 1.4;NTERA-2: 1.2;U-87 MG: 1.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA057776 Uncertain NA NA "HPA057776: AB_2683526" "unprognostic (5.44e-2)" "unprognostic (9.43e-2)" "unprognostic (2.84e-1)" "unprognostic (1.33e-3)" "unprognostic (2.24e-2)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-1)" "unprognostic (3.49e-7)" "unprognostic (1.58e-1)" "unprognostic (2.88e-1)" "unprognostic (3.00e-2)" "unprognostic (1.29e-1)" 0.1 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.0 0.1 0.6 7.9 0.1 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.4 0.4 0.0 2.3 0.0 0.0 1.8 0.0 0.7 0.0 0.4 0.0 1.2 16.3 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.8 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.2 1.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 P2RX4 P2X4 ENSG00000135124 "Purinergic receptor P2X 4" Q99571 12 121209857-121234106 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 110.0;Hofbauer cells: 116.1;Syncytiotrophoblasts: 130.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039494 Enhanced NA NA "HPA039494: AB_10969132" "unprognostic (4.02e-3)" "unprognostic (1.06e-1)" "unprognostic (5.43e-2)" "prognostic favorable (6.30e-10)" "unprognostic (2.98e-2)" "unprognostic (2.52e-1)" "unprognostic (2.06e-3)" "unprognostic (1.68e-1)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (7.71e-2)" "unprognostic (2.18e-1)" "unprognostic (1.81e-2)" "unprognostic (1.13e-1)" "unprognostic (6.06e-2)" "unprognostic (1.42e-2)" "unprognostic (4.76e-3)" 14.1 7.8 4.9 6.5 4.7 4.8 13.8 24.0 8.1 11.3 16.3 8.8 5.5 13.4 6.3 5.5 5.6 8.4 8.6 6.1 3.9 3.4 10.2 13.2 11.6 16.1 6.0 3.5 9.9 22.7 15.7 8.4 25.9 5.8 7.7 13.9 7.0 15.7 9.5 2.3 4.1 17.6 8.4 6.8 11.5 11.2 4.2 5.0 4.2 7.1 2.8 7.1 7.8 5.8 2.7 6.1 17.1 14.2 5.6 6.1 7.2 2.2 6.2 0.1 7.7 4.0 3.7 19.3 2.3 12.4 3.2 5.6 3.6 9.1 1.6 7.0 7.5 20.0 0.9 2.1 1.2 1.5 7.7 4.5 1.0 0.1 3.2 9.7 2.8 16.7 4.6 2.5 3.2 4.2 7.8 11.1 2.5 2.8 5.8 2.4 11.6 1.5 1.9 2.0 11.3 5.0 1.6 11.2 11.9 1.1 3.8 1.9 3.7 5.4 3.2 20.9 2.2 15.6 5.2 0.6 4.5 3.7 0.4 1.3 8.3 9.4 1.5 9.0 3.4 4.3 17.1 13.0 2.1 4.2 14.2 4.2 2.7 6.1 3.4 6.1 1.5 4.5 2.2 0.1 5.6 12.2 1.4 3.9 7.2 4.9 4.7 24.0 8.1 3.9 3.4 6.0 3.5 5.8 5.0 6.0 19.2 9.8 7.8 3.4 11.5 2.7 17.8 9.4 14.8 19.2 2.0 110.0 0.0 52.0 12.4 8.8 73.4 0.0 31.1 62.5 11.8 13.0 12.8 8.5 116.1 14.3 20.6 27.0 43.8 19.4 8.1 37.9 10.1 84.8 75.8 6.3 36.8 55.1 9.2 18.9 7.4 19.4 9.2 5.1 4.9 3.4 130.2 15.2 22.5 8.0 P2RX5 "LRH-1, P2X5" ENSG00000083454 "Purinergic receptor P2X 5" Q93086 17 3672199-3696404 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 30.4;intestine: 12.0;lymphoid tissue: 39.1;skeletal muscle: 11.4" "Cell type enriched" "Detected in some" 7 "B-cells: 69.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 18 "memory B-cell: 28.1;naive B-cell: 30.4" "Lineage enriched" "Detected in many" 19 "B-cells: 30.4" "Cell line enhanced" "Detected in many" "Daudi: 24.5;Karpas-707: 15.9;RPMI-8226: 27.6;U-698: 22.8" "HPA021948, HPA067827" Supported Supported Cytosol NA NA Cytosol "HPA021948: AB_1854878, HPA067827: AB_2685908" "unprognostic (1.08e-3)" "unprognostic (9.16e-2)" "unprognostic (1.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.79e-1)" "unprognostic (1.06e-1)" "unprognostic (8.33e-2)" "unprognostic (4.34e-1)" "unprognostic (1.24e-1)" "unprognostic (1.14e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.99e-8)" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (3.50e-2)" "unprognostic (3.63e-2)" 0.6 0.3 2.2 32.0 4.9 4.8 0.5 4.1 5.1 0.3 1.4 0.0 0.4 0.9 0.2 0.2 2.4 0.2 0.8 4.9 1.8 3.0 0.8 0.4 1.0 39.1 1.5 2.1 0.2 0.8 0.1 1.2 0.2 1.7 0.5 1.2 0.0 5.4 0.1 11.4 0.2 12.0 0.4 0.6 29.6 1.8 0.6 0.2 9.3 0.5 1.9 27.6 2.2 0.3 30.4 0.1 0.7 0.0 0.0 1.6 1.6 3.9 3.2 0.0 0.0 0.1 0.6 0.0 4.1 1.9 0.4 1.3 2.4 4.8 24.5 2.5 1.9 1.3 2.1 8.8 0.0 0.8 0.4 1.5 1.2 8.7 2.9 0.6 1.6 2.1 1.0 0.9 0.1 5.7 3.2 0.0 5.8 0.2 15.9 8.9 0.0 11.0 3.7 2.4 1.9 9.9 0.5 0.0 27.6 0.1 3.0 2.0 0.0 3.4 1.1 1.8 0.0 1.0 1.5 0.0 0.0 2.3 0.1 0.7 5.6 11.9 22.8 0.0 2.4 0.2 0.0 0.0 0.7 1.1 0.0 1.6 28.1 1.0 0.8 0.1 30.4 0.1 0.1 0.0 0.0 0.0 0.0 0.5 1.6 2.2 4.9 4.1 5.1 1.8 3.0 1.5 2.1 1.7 0.2 0.0 1.1 69.3 0.1 0.3 0.4 2.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 4.6 0.4 0.2 0.0 0.0 0.6 1.2 2.2 1.4 0.6 3.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.3 0.5 0.7 0.0 0.0 9.6 0.0 0.0 P2RX6 "MGC129625, P2RXL1, P2X6, P2XM" ENSG00000099957 "Purinergic receptor P2X 6" O15547 22 21009808-21028830 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 12.4" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 7.4;Ciliated cells: 4.0;Intestinal endocrine cells: 3.4" "Cancer enhanced" "Detected in some" "melanoma: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 11.4;LHCN-M2: 7.7;RH-30: 4.8;U-87 MG: 13.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028776, HPA028777" Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA028776: AB_2672771, HPA028777: AB_2672772" "unprognostic (1.81e-2)" "unprognostic (5.15e-3)" "unprognostic (2.11e-2)" "unprognostic (1.12e-1)" "unprognostic (4.28e-2)" "unprognostic (1.79e-5)" "unprognostic (1.70e-2)" "unprognostic (6.20e-2)" "unprognostic (1.49e-1)" "unprognostic (2.59e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-2)" "unprognostic (2.88e-10)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (7.33e-2)" "unprognostic (2.39e-3)" 0.2 1.6 0.0 0.2 0.2 0.0 0.0 0.9 3.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 1.1 1.9 0.2 0.8 0.1 0.0 0.2 0.0 0.6 0.3 0.0 0.0 1.6 1.1 0.2 0.0 0.1 1.1 12.4 0.0 0.0 0.0 0.8 2.3 0.1 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.8 0.3 0.1 0.0 1.0 0.1 1.9 0.8 1.4 0.0 0.0 0.0 1.3 0.5 3.4 1.6 0.0 0.1 0.1 0.3 0.0 2.1 0.8 0.0 3.3 0.0 2.8 0.4 0.0 1.4 0.1 11.4 0.0 0.0 2.3 0.7 7.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.8 0.2 0.0 0.0 0.2 3.6 1.4 0.1 0.6 0.2 0.0 0.0 0.0 2.5 0.4 0.0 0.0 0.2 0.0 0.0 13.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.8 0.1 7.4 2.4 0.0 4.0 0.0 1.8 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 2.3 0.0 0.1 1.6 3.4 2.5 0.0 1.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.4 0.0 0.6 0.0 0.0 1.4 0.4 0.1 0.3 0.0 0.0 0.0 P2RX7 "MGC20089, P2X7" ENSG00000089041 "Purinergic receptor P2X 7" Q99572 12 121132819-121188032 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 22.5;Kupffer cells: 18.7;Macrophages: 34.0" "Cancer enhanced" "Detected in all" "melanoma: 19.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 4.2;monocytes: 7.5;T-cells: 2.3" "Cell line enhanced" "Detected in some" "Karpas-707: 23.5;RPMI-8226: 13.8;SK-MEL-30: 23.3;U-266/70: 12.9;U-266/84: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034968, HPA042013, HPA044141" Approved NA NA "HPA034968: AB_10673105, HPA042013: AB_2677797, HPA044141: AB_2678830" "unprognostic (1.05e-1)" "unprognostic (4.90e-2)" "unprognostic (8.87e-2)" "unprognostic (6.54e-3)" "unprognostic (4.49e-2)" "unprognostic (1.55e-2)" "unprognostic (8.82e-2)" "unprognostic (9.11e-2)" "unprognostic (1.05e-2)" "unprognostic (1.08e-1)" "unprognostic (2.42e-1)" "unprognostic (6.62e-2)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.91e-1)" "unprognostic (3.59e-2)" "unprognostic (5.55e-2)" "unprognostic (1.65e-1)" 2.4 3.1 13.7 5.7 25.2 2.9 2.4 7.8 23.3 4.6 3.0 26.5 0.1 1.7 4.8 1.8 1.7 2.9 4.1 1.5 14.8 5.9 1.2 5.3 7.4 6.0 30.5 9.4 10.2 1.2 2.4 2.0 3.4 14.5 2.3 2.8 3.1 2.8 2.2 0.8 15.1 1.7 5.1 16.3 6.5 1.8 1.6 26.1 0.4 1.4 0.5 4.0 3.1 3.3 0.6 4.2 0.5 7.5 1.0 2.3 1.3 0.0 0.0 0.0 0.6 0.7 0.3 0.5 0.0 1.1 0.4 1.0 0.0 0.0 0.0 0.0 0.4 2.5 0.1 0.0 0.0 0.3 1.0 0.1 0.4 0.0 0.0 0.5 0.9 6.9 0.6 0.0 1.1 0.0 0.0 1.1 0.2 0.0 23.5 0.0 0.0 0.1 2.5 0.0 0.0 0.2 2.1 5.2 13.8 0.0 0.0 0.3 1.4 0.1 0.0 23.3 0.0 0.3 4.5 0.0 0.4 0.1 0.0 0.1 12.9 11.2 0.1 1.4 6.7 3.6 0.4 4.8 0.0 2.3 7.5 0.8 0.6 1.1 1.0 4.2 0.4 1.0 1.0 0.5 1.0 5.1 0.8 2.3 1.3 13.7 25.2 7.8 23.3 14.8 5.9 30.5 9.4 14.5 26.1 3.0 4.5 2.0 3.1 6.2 2.0 2.2 7.6 6.7 6.8 0.0 2.0 2.5 0.0 0.8 0.6 3.4 0.0 0.0 0.0 0.8 2.3 0.9 5.8 2.9 22.5 1.6 0.0 5.5 18.7 0.4 10.3 34.0 15.1 3.6 0.0 1.4 0.3 0.0 9.9 0.0 0.7 6.5 2.3 1.1 0.7 3.1 3.3 4.6 0.0 0.7 P2RY1 "P2Y1, SARCC" ENSG00000169860 "Purinergic receptor P2Y1" P47900 3 152834693-152841439 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;placenta: 24.7" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 22.9;Kupffer cells: 17.8;Muller glia cells: 16.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 29.1" "Group enriched" "Detected in some" 5 "basophil: 7.0;non-classical monocyte: 4.1" "Group enriched" "Detected in many" 6 "granulocytes: 7.0;monocytes: 4.1" "Cell line enriched" "Detected in some" 5 "HEL: 30.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015577 Enhanced NA NA "HPA015577: AB_1854882" "unprognostic (3.30e-1)" "unprognostic (4.52e-2)" "unprognostic (2.68e-2)" "unprognostic (4.76e-2)" "unprognostic (9.70e-2)" "unprognostic (1.40e-3)" "unprognostic (3.32e-2)" "unprognostic (2.53e-1)" "unprognostic (5.14e-1)" "unprognostic (2.58e-1)" "unprognostic (4.68e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (2.04e-7)" "unprognostic (1.36e-1)" "unprognostic (8.98e-2)" "unprognostic (7.33e-2)" "unprognostic (3.20e-2)" 2.9 1.7 4.7 5.9 29.1 4.8 2.0 3.1 6.3 6.7 8.7 4.9 0.6 3.3 8.5 0.8 19.4 2.3 2.2 2.9 8.4 2.3 1.1 1.6 10.4 2.1 1.8 6.1 9.6 3.6 0.5 2.3 24.7 2.4 8.0 6.9 2.6 5.6 2.6 7.1 8.8 6.1 4.8 3.8 2.4 1.7 1.3 3.3 3.0 1.5 9.9 3.5 3.0 9.5 0.0 0.9 7.0 4.1 0.0 0.0 0.2 0.0 0.5 4.8 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.4 6.0 0.0 0.0 0.5 0.0 0.7 1.0 2.6 0.8 0.2 0.0 2.3 30.3 0.0 0.0 0.0 3.5 2.8 0.4 6.0 0.0 0.3 2.4 0.0 1.0 0.9 0.0 0.0 0.0 0.5 0.1 4.4 0.0 3.7 0.0 0.1 0.8 0.0 2.0 0.8 0.0 0.0 0.0 0.6 1.1 0.0 1.6 0.0 0.5 1.2 0.0 2.5 0.0 0.0 0.0 3.1 0.0 3.5 7.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.1 0.9 0.0 0.2 4.7 29.1 3.1 6.3 8.4 2.3 1.8 6.1 2.4 3.3 0.0 0.3 0.8 6.8 1.6 8.2 6.3 22.9 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.1 0.6 10.5 0.0 0.0 0.2 2.7 6.6 9.3 0.2 6.2 0.0 0.0 12.9 17.8 0.0 13.8 6.3 0.0 0.0 8.4 16.6 1.1 10.5 5.6 0.0 1.0 0.0 0.5 0.5 0.4 1.8 0.1 0.0 6.6 4.2 P2RY10 P2Y10 ENSG00000078589 "P2Y receptor family member 10" O00398 X 78945332-78961954 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 51.6;lymphoid tissue: 47.0" "Group enriched" "Detected in some" 5 "B-cells: 33.8;granulocytes: 29.9;monocytes: 54.1;T-cells: 38.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 51.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "Karpas-707: 53.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036757, HPA065766" Enhanced NA NA "HPA036757: AB_10696786, HPA065766: AB_2685556" "unprognostic (3.02e-3)" "unprognostic (1.47e-3)" "unprognostic (1.50e-6)" "unprognostic (6.62e-3)" "unprognostic (1.19e-1)" "unprognostic (1.13e-4)" "unprognostic (3.33e-2)" "unprognostic (8.30e-2)" "unprognostic (1.13e-2)" "unprognostic (4.13e-3)" "unprognostic (1.01e-1)" "unprognostic (8.66e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (2.23e-1)" "unprognostic (6.54e-2)" "unprognostic (3.85e-2)" "unprognostic (3.99e-2)" 1.9 0.5 0.4 19.1 0.5 5.7 1.0 0.4 0.4 1.4 3.8 0.0 0.1 1.7 1.0 0.5 2.6 0.8 2.2 0.8 0.5 0.5 1.4 1.0 6.2 47.0 0.5 0.0 1.1 0.5 0.0 0.6 0.1 0.1 0.9 2.5 0.8 3.9 0.3 0.5 0.8 11.0 0.4 0.7 31.2 2.3 0.5 0.0 23.3 1.5 1.8 30.0 9.9 1.3 19.3 0.9 51.6 2.3 4.0 9.7 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 53.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.6 0.0 0.1 0.0 51.6 0.0 36.8 3.2 0.2 2.9 17.8 7.3 6.4 0.9 19.3 6.8 5.0 6.8 4.0 2.3 0.7 9.7 3.2 0.4 0.5 0.4 0.4 0.5 0.5 0.5 0.0 0.1 0.0 0.0 1.7 33.8 0.0 1.5 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 29.9 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 8.5 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 38.8 0.0 0.1 P2RY11 P2Y11 ENSG00000244165 "Purinergic receptor P2Y11" Q96G91 19 10111538-10115372 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 23.3;Hofbauer cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 6.8;MAIT T-cell: 16.4;memory CD8 T-cell: 6.9;naive CD8 T-cell: 5.4;NK-cell: 10.7" "Group enriched" "Detected in all" 6 "NK-cells: 10.7;T-cells: 16.4" "Cell line enhanced" "Detected in many" "HEK 293: 20.5;NB-4: 21.3" HPA014232 Approved NA NA "HPA014232: AB_1854883" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (2.76e-3)" "unprognostic (2.61e-3)" "unprognostic (1.82e-1)" "unprognostic (2.79e-2)" "unprognostic (2.34e-1)" "unprognostic (5.56e-2)" "unprognostic (2.23e-1)" "unprognostic (1.93e-1)" "unprognostic (2.04e-3)" "unprognostic (2.22e-2)" "unprognostic (4.32e-3)" "unprognostic (1.76e-2)" "unprognostic (3.78e-2)" "unprognostic (1.58e-1)" "prognostic favorable (1.77e-4)" 9.0 3.6 4.8 21.7 6.7 8.5 4.9 5.5 6.5 3.1 9.4 6.0 3.4 7.8 3.2 3.2 4.4 5.3 3.5 3.8 5.1 4.6 2.9 4.9 13.6 11.1 3.2 2.3 4.3 6.3 1.5 4.2 3.4 4.0 5.0 1.8 5.0 7.6 2.5 6.6 9.0 9.2 2.8 4.9 13.4 5.1 4.9 2.5 7.5 5.2 2.6 22.8 2.9 3.1 1.5 1.2 2.1 2.1 10.7 16.4 4.3 3.6 3.4 1.2 3.9 1.6 1.3 6.7 1.5 0.6 0.7 1.2 4.0 1.8 6.4 2.3 0.3 0.6 5.3 1.0 3.0 0.1 3.1 20.5 5.7 5.1 2.4 2.3 3.0 9.6 2.2 2.5 1.2 1.7 1.4 0.4 4.1 2.8 8.5 0.7 5.3 4.5 21.3 7.6 3.1 4.2 6.8 2.4 3.7 1.2 4.6 4.7 7.8 1.0 2.7 8.4 0.5 2.1 8.5 1.4 4.3 2.1 7.7 2.8 17.3 12.4 2.3 3.1 12.7 3.8 2.1 1.9 0.3 6.8 2.1 16.4 1.5 1.5 6.9 1.2 1.0 1.2 5.4 0.4 10.7 1.4 0.7 1.8 4.3 4.8 6.7 5.5 5.2 5.1 4.6 3.2 2.3 4.0 2.5 6.0 3.0 0.0 2.5 4.2 7.7 1.4 5.1 2.7 2.3 1.8 2.0 1.4 1.7 1.3 0.2 2.1 1.3 23.3 1.0 1.0 1.2 1.6 3.5 3.0 39.3 6.4 3.5 2.5 1.3 0.0 3.1 6.7 1.7 0.0 4.6 1.6 1.1 1.5 1.1 1.0 5.3 0.0 1.7 1.7 3.6 3.4 1.1 12.7 3.4 1.1 P2RY12 "HORK3, P2Y12, SP1999" ENSG00000169313 "Purinergic receptor P2Y12" Q9H244 3 151337380-151384812 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.0" "Cell type enhanced" "Detected in some" 27 "granulocytes: 1.1;Kupffer cells: 2.9" "Cancer enriched" "Detected in many" 14 "glioma: 17.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 12.4" "Group enriched" "Detected in many" 13 "dendritic cells: 5.0;monocytes: 12.4" "Cell line enhanced" "Detected in some" "HSkMC: 1.7;JURKAT: 1.1;Karpas-707: 1.1;REH: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013796, HPA014518" Enhanced NA NA "HPA013796: AB_1854884, HPA014518: AB_2669027" "unprognostic (2.39e-2)" "unprognostic (1.60e-3)" "unprognostic (5.93e-2)" "unprognostic (1.77e-1)" "unprognostic (2.41e-2)" "unprognostic (2.52e-2)" "unprognostic (8.09e-2)" "unprognostic (1.72e-3)" "unprognostic (6.46e-2)" "unprognostic (8.64e-4)" "unprognostic (4.84e-2)" "unprognostic (5.96e-2)" "unprognostic (2.03e-1)" "unprognostic (8.92e-2)" "unprognostic (1.65e-1)" "unprognostic (3.52e-2)" "unprognostic (4.04e-1)" 7.4 4.3 15.3 2.2 14.2 0.8 4.3 2.3 46.0 2.0 2.0 13.4 0.0 1.6 1.1 1.1 1.7 3.2 2.7 1.8 14.3 11.6 1.1 2.7 2.9 9.2 21.1 10.0 2.2 0.9 2.0 0.9 2.7 16.8 1.4 1.8 0.2 3.1 2.9 0.6 0.8 3.1 2.1 24.9 5.3 1.5 0.6 18.8 0.0 0.9 0.0 8.6 1.9 0.9 0.6 5.0 0.3 12.4 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.3 0.3 0.0 2.9 0.0 0.0 12.4 0.0 0.6 0.0 0.0 5.0 0.6 0.0 0.0 0.3 0.0 3.3 0.5 0.0 2.0 15.3 14.2 2.3 14.6 14.3 11.6 21.1 10.0 16.8 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P2RY13 "FKSG77, GPR86, GPR94, P2Y13" ENSG00000181631 "Purinergic receptor P2Y13" Q9BPV8 3 151326312-151329548 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 88.4;lymphoid tissue: 44.1" "Group enriched" "Detected in some" 6 "Kupffer cells: 83.1;Macrophages: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 88.4" "Group enriched" "Detected in many" 6 "granulocytes: 88.4;monocytes: 26.1" "Cell line enhanced" "Detected in some" "HEK 293: 1.2;U-937: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049047 Enhanced NA NA "HPA049047: AB_2680611" "unprognostic (1.09e-3)" "unprognostic (7.51e-4)" "unprognostic (1.68e-2)" "unprognostic (2.37e-3)" "unprognostic (3.95e-2)" "unprognostic (8.66e-3)" "unprognostic (7.66e-2)" "unprognostic (5.48e-3)" "unprognostic (2.84e-3)" "unprognostic (1.83e-1)" "unprognostic (4.97e-2)" "unprognostic (1.17e-1)" "unprognostic (4.05e-1)" "unprognostic (4.46e-1)" "unprognostic (5.95e-2)" "unprognostic (2.21e-3)" "unprognostic (3.78e-1)" 4.0 2.6 5.1 13.4 6.1 15.1 2.7 1.7 8.2 1.7 2.8 13.8 0.1 3.0 1.5 2.2 2.1 2.1 2.5 1.7 4.9 4.7 1.8 5.1 5.0 35.1 7.1 3.4 1.3 2.1 1.0 1.7 3.2 8.1 2.1 4.2 2.0 1.9 2.1 1.3 1.6 7.4 3.5 8.2 44.1 1.8 1.2 5.1 2.0 1.5 1.1 5.5 3.8 1.5 0.2 10.1 88.4 26.1 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.2 0.2 0.2 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 1.1 0.1 0.1 23.6 20.3 0.0 23.5 0.0 0.2 0.0 0.0 10.1 0.0 0.0 0.0 88.4 0.0 26.1 0.1 0.0 10.2 5.1 6.1 1.7 8.2 4.9 4.7 7.1 3.4 8.1 5.1 0.0 9.6 3.2 0.1 0.0 0.8 0.4 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 6.6 1.6 0.0 0.6 83.1 0.0 0.0 40.1 0.0 6.4 0.0 2.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 P2RY14 "GPR105, KIAA0001" ENSG00000174944 "Purinergic receptor P2Y14" Q15391 3 151212117-151278467 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 54.9" "Group enriched" "Detected in some" 4 "granulocytes: 45.0;Macrophages: 18.5;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "eosinophil: 54.9;plasmacytoid DC: 24.4" "Group enriched" "Detected in many" 8 "dendritic cells: 24.4;granulocytes: 54.9" "Cell line enriched" "Detected in single" 73 "HMC-1: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022646 Uncertain NA NA "CAB022646: " "unprognostic (9.78e-2)" "unprognostic (7.47e-4)" "unprognostic (3.89e-2)" "unprognostic (4.52e-4)" "unprognostic (1.69e-2)" "unprognostic (2.57e-5)" "unprognostic (2.68e-2)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (1.64e-3)" "unprognostic (6.30e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.72e-5)" "unprognostic (3.79e-2)" "unprognostic (6.89e-2)" "unprognostic (1.58e-1)" "unprognostic (2.58e-2)" 14.3 0.9 3.9 9.0 6.9 0.5 6.1 1.9 3.8 5.2 17.6 1.3 1.3 5.7 7.2 9.4 17.6 1.2 4.4 4.4 4.3 3.0 2.1 0.7 8.5 7.1 5.0 2.8 1.8 0.9 2.2 4.7 25.9 3.7 10.4 8.3 11.2 2.1 1.1 4.2 2.8 16.3 15.8 2.3 4.4 17.2 2.1 4.2 4.7 3.6 8.9 5.3 21.4 1.7 4.9 24.4 54.9 0.1 2.8 5.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 0.1 54.9 0.2 0.0 5.0 0.8 0.1 0.5 3.3 4.9 0.0 0.0 2.2 2.8 0.0 24.4 0.2 0.5 3.9 6.9 1.9 3.8 4.3 3.0 5.0 2.8 3.7 4.2 3.0 0.3 6.7 0.0 2.1 1.7 1.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.3 2.8 0.0 45.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 18.5 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 25.8 2.7 0.0 0.1 1.5 0.2 2.9 0.0 0.1 P2RY2 P2U ENSG00000175591 "Purinergic receptor P2Y2" P41231 11 73218298-73236352 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.1;skeletal muscle: 29.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 14.0;Enterocytes: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 28.1" "Group enriched" "Detected in many" 12 "granulocytes: 28.1;monocytes: 10.4" "Cell line enhanced" "Detected in many" "HaCaT: 16.4;HL-60: 15.5;MCF7: 12.4;NB-4: 12.6;PC-3: 12.9;SK-BR-3: 14.3;THP-1: 36.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB022642 Uncertain Uncertain Cytosol NA NA Cytosol "CAB022642: " "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (6.50e-4)" "unprognostic (2.04e-2)" "unprognostic (4.66e-3)" "unprognostic (8.93e-2)" "unprognostic (2.87e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (9.69e-2)" "unprognostic (4.92e-4)" "unprognostic (1.34e-1)" "unprognostic (2.82e-1)" "unprognostic (1.05e-1)" "unprognostic (8.57e-3)" 0.4 2.3 0.9 1.4 1.2 10.8 1.3 0.3 1.1 5.5 3.1 1.1 0.3 2.2 1.3 2.3 20.0 1.2 2.8 11.7 0.6 0.3 0.9 2.6 2.9 1.5 1.2 0.6 1.7 1.7 6.1 1.1 10.3 1.0 1.7 2.4 3.3 4.0 1.6 29.5 3.4 10.8 0.4 0.4 6.6 0.6 0.7 0.6 0.6 20.2 20.6 12.8 2.1 10.9 0.0 1.6 28.1 10.4 0.0 0.0 1.2 3.6 3.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 8.4 2.8 0.0 5.6 0.2 0.0 16.4 0.4 7.7 0.0 0.0 0.3 1.2 0.2 1.5 0.0 15.5 0.0 0.0 3.6 1.2 0.2 0.0 0.7 0.0 0.7 0.0 0.0 12.4 0.0 12.6 0.2 3.3 12.9 0.0 0.0 0.5 1.2 8.8 0.0 0.0 0.2 14.3 0.0 0.1 6.6 36.3 5.3 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 2.8 0.0 0.2 3.4 28.1 0.0 10.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 1.2 0.9 1.2 0.3 1.1 0.6 0.3 1.2 0.6 1.0 0.6 3.0 0.3 0.0 6.8 3.3 0.5 5.3 7.6 0.0 4.5 0.0 0.0 14.0 1.7 5.0 5.3 0.5 12.9 0.0 5.6 0.5 0.4 1.1 0.0 4.5 2.3 0.0 0.0 0.0 2.7 6.7 0.0 0.9 0.0 0.0 2.9 5.2 11.6 10.5 0.0 0.3 0.2 0.0 0.2 0.0 0.0 6.4 9.2 0.0 2.3 11.1 P2RY4 "NRU, P2P, P2Y4, UNR" ENSG00000186912 "Pyrimidinergic receptor P2Y4" P51582 X 70258170-70259764 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" CAB022644 Uncertain NA NA "CAB022644: " "unprognostic (4.59e-2)" "unprognostic (4.23e-1)" "unprognostic (7.10e-2)" "unprognostic (1.69e-1)" "unprognostic (9.53e-4)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (6.77e-2)" "unprognostic (2.43e-1)" "unprognostic (2.09e-1)" "unprognostic (8.89e-3)" "unprognostic (2.90e-2)" "unprognostic (3.72e-2)" "unprognostic (3.61e-2)" "unprognostic (1.50e-2)" "unprognostic (3.89e-1)" 0.3 0.1 0.2 0.2 0.2 0.1 0.4 0.2 0.2 2.1 2.9 0.2 0.2 0.7 0.2 0.6 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 1.6 0.2 0.6 0.2 0.2 2.1 14.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.8 0.3 0.5 0.0 0.2 0.4 0.1 0.3 0.1 0.6 0.1 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.5 1.8 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.6 0.0 1.1 0.3 0.8 0.2 0.6 0.1 0.0 0.3 0.7 0.3 0.0 0.0 0.4 0.1 0.7 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.8 1.2 0.1 1.2 0.3 0.6 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P2RY6 P2Y6 ENSG00000171631 "Pyrimidinergic receptor P2Y6" Q15077 11 73264505-73298617 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 36.4;lymphoid tissue: 31.1;placenta: 38.0" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 107.7;Syncytiotrophoblasts: 227.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "myeloid DC: 10.9;plasmacytoid DC: 36.4" "Lineage enriched" "Detected in many" 20 "dendritic cells: 36.4" "Cell line enhanced" "Detected in some" "AN3-CA: 33.7;EFO-21: 10.6;MCF7: 15.7;SK-BR-3: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074751 Enhanced NA NA "HPA074751: " "unprognostic (2.55e-2)" "unprognostic (1.12e-1)" "unprognostic (2.04e-2)" "unprognostic (5.54e-3)" "unprognostic (4.18e-3)" "unprognostic (1.94e-2)" "unprognostic (3.93e-3)" "unprognostic (4.00e-3)" "unprognostic (1.86e-4)" "unprognostic (3.08e-1)" "unprognostic (1.25e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (2.50e-7)" "unprognostic (1.48e-2)" "unprognostic (1.38e-3)" "unprognostic (7.67e-2)" "unprognostic (1.05e-1)" 2.5 1.8 2.7 8.3 3.5 0.8 1.5 0.5 3.2 2.5 2.1 3.1 0.0 3.0 1.2 2.6 2.9 1.6 2.4 2.7 1.8 1.0 6.2 3.7 3.0 4.8 2.3 1.7 2.1 1.7 0.5 2.7 38.0 2.8 2.1 2.2 5.9 2.0 0.9 2.9 0.9 4.9 3.4 3.8 31.1 1.9 0.8 3.5 3.3 5.0 1.8 3.1 4.1 1.6 0.0 36.4 0.1 1.8 1.5 0.1 1.0 0.7 8.0 0.0 33.7 0.0 0.0 6.9 0.1 0.0 0.1 0.1 7.2 0.1 0.0 10.6 0.3 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.7 3.8 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.2 0.1 15.7 0.1 1.3 0.1 0.1 0.0 0.0 0.0 1.0 5.5 0.0 0.1 0.5 1.4 27.2 0.0 0.6 6.4 1.5 0.1 1.3 0.1 1.1 0.1 0.3 0.0 0.0 1.3 2.2 0.0 0.0 1.1 0.0 0.0 1.8 0.1 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.1 1.5 0.6 36.4 0.0 1.0 2.7 3.5 0.5 3.2 1.8 1.0 2.3 1.7 2.8 3.5 0.0 1.1 1.5 0.3 0.1 0.0 0.8 0.0 1.4 0.0 8.7 0.0 107.7 3.3 2.4 0.4 2.2 0.0 0.0 13.1 7.5 0.2 0.2 0.0 0.0 17.0 0.0 0.0 1.8 3.9 1.7 0.0 9.7 0.0 21.6 0.0 0.6 9.6 0.0 0.0 7.0 0.0 0.0 0.8 0.0 0.0 0.4 227.8 0.0 0.0 0.1 P2RY8 P2Y8 ENSG00000182162 "P2Y receptor family member 8" Q86VZ1 X 1462572-1537107 "Cancer-related genes, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.7;lymphoid tissue: 19.0" "Group enriched" "Detected in some" 5 "B-cells: 29.8;Kupffer cells: 10.2;monocytes: 20.8;T-cells: 20.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 33.9;MOLT-4: 16.7;NB-4: 16.7;RPMI-8226: 20.8;THP-1: 20.8;U-266/70: 28.5;U-698: 55.5;U-937: 17.2" "Not detected" "Not detected" HPA003631 Enhanced NA NA "HPA003631: AB_1079543" "unprognostic (4.32e-2)" "unprognostic (3.22e-5)" "unprognostic (6.31e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "prognostic favorable (7.80e-5)" "prognostic favorable (1.73e-4)" "unprognostic (5.27e-3)" "unprognostic (5.76e-3)" "unprognostic (5.52e-3)" "prognostic favorable (6.54e-4)" "unprognostic (4.29e-2)" "unprognostic (8.45e-3)" "unprognostic (2.90e-1)" "unprognostic (4.00e-2)" "unprognostic (3.55e-1)" "unprognostic (2.80e-1)" 2.9 4.8 0.5 8.9 2.2 13.9 8.2 0.9 1.8 4.7 1.6 0.5 0.5 1.3 7.1 0.5 0.8 0.8 1.6 11.8 0.9 0.2 13.5 0.8 2.1 19.0 3.6 1.7 5.8 1.1 1.0 6.9 3.4 2.7 1.6 1.3 0.5 1.6 0.5 1.1 0.4 7.8 0.5 3.9 16.6 2.0 0.5 2.0 0.5 8.1 0.5 16.7 2.7 2.8 18.5 5.8 17.8 7.3 15.6 26.7 18.3 0.1 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 33.9 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.1 0.3 0.3 1.7 0.0 14.8 3.6 0.0 0.0 0.0 0.0 0.3 0.0 10.1 0.3 14.3 0.0 0.0 16.7 16.7 0.2 0.0 0.3 15.1 0.1 20.8 0.0 0.2 0.0 0.2 0.1 0.3 0.1 0.3 0.1 20.8 0.0 0.3 0.3 0.1 0.0 28.5 5.3 55.5 0.0 17.2 0.0 17.8 7.3 12.4 26.7 5.5 24.6 15.4 20.2 25.1 5.8 18.5 16.1 16.5 4.7 15.6 2.2 1.5 15.9 18.3 0.5 2.2 0.9 1.8 0.9 0.2 3.6 1.7 2.7 2.0 0.0 2.6 29.8 0.0 0.3 0.0 0.8 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.4 0.1 1.1 0.0 1.9 0.0 0.0 4.3 10.2 0.0 0.0 1.6 1.7 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 20.1 0.0 0.0 P4HA2 C-P4Halpha(II) ENSG00000072682 "Prolyl 4-hydroxylase subunit alpha 2" O15460 5 132191838-132295315 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 62.2;U-87 MG: 60.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA016997, HPA027824, CAB062557" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" No No "Endoplasmic reticulum, Vesicles" "CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402" "unprognostic (1.30e-3)" "prognostic unfavorable (1.24e-5)" "unprognostic (2.56e-3)" "unprognostic (1.28e-3)" "unprognostic (2.08e-3)" "unprognostic (1.62e-3)" "unprognostic (1.16e-3)" "unprognostic (1.93e-3)" "unprognostic (2.83e-2)" "unprognostic (1.92e-1)" "unprognostic (8.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (2.77e-7)" "unprognostic (2.50e-2)" "unprognostic (1.61e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (3.12e-4)" 10.2 5.6 7.1 6.5 5.4 0.8 12.2 9.5 7.8 14.4 12.5 4.6 6.1 9.8 20.0 35.3 11.6 13.7 9.7 26.1 6.6 7.0 34.4 6.3 16.0 4.3 6.3 4.2 6.7 42.5 6.7 15.8 15.1 9.5 9.3 14.6 15.1 21.1 8.4 7.1 9.3 17.1 23.3 5.1 6.3 12.6 5.1 4.4 4.1 12.2 10.8 5.4 11.3 34.5 0.2 1.0 3.1 1.3 2.6 2.6 0.7 10.3 6.3 2.0 10.1 28.3 33.8 11.5 48.2 41.2 20.5 50.8 14.2 9.1 0.2 14.2 51.6 22.9 13.0 6.3 25.2 32.5 7.6 2.1 0.0 9.3 8.6 62.2 0.0 6.2 20.4 37.3 24.3 22.4 30.7 10.8 0.0 3.7 0.6 25.0 4.1 0.0 0.0 0.5 9.5 5.2 0.1 0.6 1.6 5.7 2.0 1.0 2.8 12.3 4.1 8.2 16.5 5.1 0.7 16.5 31.2 12.2 9.4 10.4 4.4 4.7 2.0 60.1 0.0 8.7 0.0 1.3 0.0 2.6 1.1 2.4 0.0 1.4 0.4 0.6 0.2 0.0 0.4 3.1 2.6 0.2 1.0 0.0 0.7 7.1 5.4 9.5 7.8 6.6 7.0 6.3 4.2 9.5 4.4 32.8 10.1 1.4 26.7 14.9 7.9 11.8 12.7 60.2 14.8 10.4 21.6 2.4 5.0 58.5 1.0 9.8 35.4 0.0 62.7 51.9 40.5 21.4 5.7 5.9 7.2 0.0 14.5 15.4 1.8 1.6 7.5 4.7 28.7 3.6 12.9 7.5 69.0 34.5 4.9 34.1 5.5 25.8 27.8 18.2 29.4 8.5 6.3 2.5 10.8 16.5 P4HTM "EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4" ENSG00000178467 "Prolyl 4-hydroxylase, transmembrane" Q9NXG6 3 48989886-49007154 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007199 Supported Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA007199: AB_1855272" "unprognostic (1.95e-2)" "unprognostic (3.12e-2)" "unprognostic (9.47e-2)" "prognostic favorable (8.18e-4)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (6.47e-2)" "unprognostic (2.02e-2)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-2)" "prognostic favorable (3.28e-5)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (2.60e-2)" "unprognostic (9.65e-3)" 7.4 25.5 22.1 6.4 28.5 4.7 8.9 17.6 32.9 13.5 10.8 15.9 13.8 10.4 9.7 18.9 5.4 34.7 13.0 18.6 23.0 26.5 14.1 5.4 10.6 5.6 18.7 20.3 11.4 29.9 20.8 35.7 9.6 15.7 15.5 6.7 14.1 16.0 16.5 10.0 4.3 7.8 7.0 14.3 6.3 15.7 11.7 16.4 3.4 21.5 3.3 6.7 7.5 6.1 9.8 7.8 6.7 7.6 4.9 14.4 4.8 3.7 10.3 1.9 0.0 5.8 6.9 0.1 6.7 8.9 5.1 5.5 2.3 20.2 3.2 7.1 8.2 4.1 2.0 4.4 2.2 1.5 12.1 7.6 0.0 15.3 0.0 15.3 3.1 0.1 4.0 2.2 5.1 0.4 19.2 5.7 0.0 0.0 14.0 2.4 16.1 0.4 0.4 2.8 18.8 12.1 0.0 0.0 18.8 9.0 5.8 8.0 0.1 7.6 8.1 0.0 0.5 7.1 5.2 4.0 3.0 2.6 7.6 5.3 19.9 11.0 0.0 22.5 0.3 3.1 6.7 7.6 4.8 6.4 2.7 8.7 7.0 11.6 10.3 7.8 9.8 12.0 8.3 0.8 4.9 3.6 1.4 14.4 4.8 22.1 28.5 17.6 32.9 23.0 26.5 18.7 20.3 15.7 16.4 20.8 12.9 13.4 30.2 8.1 71.6 10.6 22.9 76.3 21.6 43.6 82.5 24.6 16.6 32.6 102.4 11.9 34.1 0.0 34.1 8.5 27.3 29.0 23.0 7.6 14.9 111.2 77.7 12.3 8.1 112.9 28.1 11.2 11.8 12.6 33.5 60.4 23.6 40.3 24.4 25.5 55.3 19.4 27.4 37.5 7.9 9.2 21.9 22.4 42.1 30.2 PAAF1 "FLJ11848, Rpn14, WDR71" ENSG00000175575 "Proteasomal ATPase associated factor 1" Q9BRP4 11 73876699-73931124 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cone photoreceptor cells: 106.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039952, HPA040020" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039952: AB_10793925, HPA040020: AB_2676802" "unprognostic (3.13e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.05e-1)" "unprognostic (2.13e-2)" "unprognostic (4.51e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (1.74e-1)" "unprognostic (4.48e-1)" "unprognostic (2.30e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (2.73e-1)" "unprognostic (4.42e-1)" 9.5 12.8 32.4 6.9 30.6 5.2 12.3 18.0 23.2 11.7 8.7 34.4 7.6 7.8 11.5 17.2 10.0 13.9 8.0 9.9 30.5 27.4 16.0 13.8 7.9 7.6 37.4 19.6 17.8 19.8 16.8 10.1 7.7 25.4 14.5 11.5 12.9 9.9 14.5 11.9 12.8 7.8 12.1 38.9 7.1 6.8 18.8 27.0 8.2 13.0 2.1 11.1 7.9 6.3 22.6 19.3 22.1 15.1 16.5 22.6 15.1 5.6 13.1 11.9 9.3 13.0 13.4 6.8 9.7 11.3 15.6 11.1 25.6 4.5 17.1 15.2 9.9 14.5 13.0 14.5 11.7 23.2 12.7 9.0 17.4 12.9 21.0 15.6 16.2 6.7 13.7 18.4 17.0 20.9 12.6 11.7 13.8 21.0 14.7 14.4 11.0 14.3 16.9 5.5 30.0 10.3 13.3 31.9 27.9 11.5 9.8 12.7 14.9 11.5 7.7 30.0 11.7 23.1 9.2 8.4 11.0 7.0 15.5 9.4 18.2 20.4 34.8 7.7 10.6 11.5 22.1 15.1 17.4 16.0 9.5 17.5 22.6 17.5 16.2 19.3 18.8 22.6 19.4 1.3 16.5 3.4 14.0 19.6 15.1 32.4 30.6 18.0 22.3 30.5 27.4 37.4 19.6 25.4 27.0 3.0 12.2 13.7 9.7 4.1 48.0 18.3 12.7 10.7 9.1 15.7 106.0 29.8 11.6 14.3 27.2 7.1 7.7 23.3 12.1 3.2 10.4 7.7 18.5 11.9 16.3 44.5 3.5 11.1 7.3 17.7 15.5 10.4 13.5 16.2 8.0 35.5 8.4 7.0 17.0 42.1 46.1 6.5 13.7 49.6 25.8 7.0 15.3 11.5 10.3 6.5 PACRG "FLJ32724, Glup, HAK005771, PARK2CRG" ENSG00000112530 "Parkin coregulated" Q96M98 6 162727132-163315492 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 30.3;pituitary gland: 55.9;testis: 44.6" "Group enriched" "Detected in many" 4 "Ciliated cells: 96.4;Early spermatids: 253.8;Late spermatids: 263.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066293 Enhanced NA NA "HPA066293: AB_2685652" "unprognostic (3.06e-2)" "unprognostic (1.81e-2)" "unprognostic (1.59e-1)" "unprognostic (1.56e-2)" "unprognostic (2.48e-1)" "unprognostic (1.84e-1)" "unprognostic (6.26e-4)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "unprognostic (3.34e-1)" "unprognostic (8.31e-3)" "unprognostic (1.48e-1)" "prognostic favorable (2.55e-6)" "unprognostic (1.00e-1)" "unprognostic (3.68e-2)" "unprognostic (8.35e-2)" "unprognostic (2.93e-3)" 0.7 2.3 8.6 1.0 15.5 4.7 1.8 2.3 10.6 2.3 1.1 6.5 4.4 1.2 4.7 8.6 2.7 30.3 4.3 10.7 10.3 12.1 6.8 4.1 5.5 1.4 4.7 9.4 3.8 3.4 2.0 55.9 0.4 17.7 3.2 2.3 2.0 2.5 3.4 1.8 4.3 0.7 1.9 3.7 1.5 1.7 44.6 5.9 0.0 3.7 0.0 0.9 4.5 0.9 1.7 1.1 6.0 2.0 0.1 3.3 0.5 0.8 2.5 1.1 1.6 0.0 1.0 1.8 0.6 2.3 0.0 0.5 5.1 0.6 4.6 0.6 0.0 0.5 2.7 1.2 0.0 2.6 0.0 1.7 0.0 2.6 0.0 0.0 0.6 0.8 2.1 0.0 0.9 0.0 1.0 0.0 1.6 0.8 0.9 0.5 0.1 0.3 1.7 0.0 4.1 4.4 0.8 0.0 0.0 5.5 5.4 10.6 4.8 0.0 0.0 0.0 0.4 0.0 1.6 1.8 1.1 0.6 0.0 0.4 2.1 0.7 1.7 0.5 1.3 2.0 4.3 2.0 1.4 1.9 0.6 1.4 0.9 2.6 1.2 0.3 1.7 3.3 1.6 6.0 0.1 0.2 1.1 1.1 0.5 8.6 15.5 2.3 10.6 10.3 12.1 4.7 9.4 17.7 5.9 0.0 1.7 0.0 3.4 0.2 1.7 43.4 0.0 96.4 6.8 5.2 7.9 0.1 46.4 2.6 253.8 0.9 0.0 0.0 6.4 0.1 1.0 3.0 0.0 3.6 0.1 0.0 6.3 0.0 0.6 263.8 3.4 0.1 0.0 0.0 0.3 6.3 2.3 0.3 2.5 5.1 7.7 0.0 0.9 13.4 3.6 0.3 0.2 0.0 0.4 2.2 PAG1 "CBP, PAG" ENSG00000076641 "Phosphoprotein membrane anchor with glycosphingolipid microdomains 1" Q9NWQ8 8 80967810-81112068 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "granulocytes: 124.4;Melanocytes: 133.3;Sertoli cells: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 19.6;HMC-1: 26.2;SK-MEL-30: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001632, HPA066527" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001632: AB_1079557, HPA066527: AB_2685685" "unprognostic (8.30e-2)" "unprognostic (3.84e-2)" "unprognostic (5.89e-2)" "unprognostic (4.79e-2)" "unprognostic (1.55e-1)" "unprognostic (6.91e-2)" "unprognostic (3.71e-3)" "unprognostic (3.84e-2)" "unprognostic (3.73e-2)" "unprognostic (4.52e-2)" "unprognostic (2.93e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.24e-6)" "unprognostic (2.12e-1)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.80e-1)" "unprognostic (1.94e-3)" 5.5 3.8 5.3 20.2 6.1 12.2 4.1 22.3 7.6 2.7 12.3 5.4 2.3 8.6 3.5 2.8 2.9 3.2 12.1 5.5 6.4 4.3 3.2 6.4 20.3 21.2 7.5 4.2 2.6 16.6 0.8 4.2 17.7 7.7 3.9 10.1 10.6 5.0 4.4 3.8 6.2 14.9 3.5 9.9 12.1 5.1 1.4 7.4 15.2 3.4 0.4 15.3 6.2 4.4 2.2 4.1 10.9 13.3 1.6 6.8 2.4 0.0 0.0 2.7 0.1 5.2 5.0 0.1 1.1 8.8 0.5 1.1 0.1 0.0 19.6 0.1 0.3 4.4 0.8 0.0 1.0 0.5 0.5 2.5 11.4 0.2 0.0 5.3 1.8 26.2 2.4 0.7 5.1 4.8 0.5 0.0 3.5 0.1 0.1 8.4 0.1 6.8 0.1 0.2 4.4 0.8 5.2 1.4 0.1 0.9 4.2 0.5 1.0 0.0 0.2 20.3 0.5 0.6 1.9 0.1 0.6 0.3 0.0 0.6 3.2 0.8 7.0 5.6 6.5 4.8 10.9 1.4 1.9 2.6 6.3 6.5 2.2 6.6 4.6 1.8 1.4 5.4 4.0 2.3 1.6 13.3 4.1 6.8 2.4 5.3 6.1 22.3 7.6 6.4 4.3 7.5 4.2 7.7 7.4 0.0 11.3 16.6 3.6 27.9 36.6 12.1 12.7 0.0 18.2 3.5 0.0 0.5 0.0 2.2 3.2 10.5 93.4 0.0 5.7 19.0 22.5 7.3 124.4 8.1 23.3 60.4 3.5 17.2 58.9 1.5 2.3 68.1 133.3 38.7 19.5 45.0 2.3 48.0 7.4 0.3 3.0 122.9 31.9 0.2 0.7 19.7 1.9 59.0 19.2 3.4 PAM "PAL, PHM" ENSG00000145730 "Peptidylglycine alpha-amidating monooxygenase" P19021 5 102753981-103031105 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 304.2" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 852.6;Intestinal endocrine cells: 308.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 75.3;fHDF/TERT166: 96.5;hTERT-RPE1: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026119, HPA042260" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted in other tissues" NA NA 59000000 "Golgi apparatus, Cytosol" "CAB026119: , HPA042260: AB_2677919" "unprognostic (4.30e-3)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "prognostic favorable (1.63e-4)" "unprognostic (4.23e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (6.20e-4)" "unprognostic (7.58e-2)" "unprognostic (6.62e-2)" "unprognostic (2.71e-1)" "unprognostic (9.91e-2)" "unprognostic (3.18e-1)" "unprognostic (1.86e-2)" "unprognostic (1.08e-1)" "unprognostic (9.79e-2)" "unprognostic (5.51e-2)" "unprognostic (8.80e-3)" 16.5 24.5 8.2 6.5 16.4 0.8 17.3 6.6 16.5 74.9 14.0 5.4 9.5 5.8 21.3 83.8 11.7 10.6 11.5 304.2 8.8 23.5 13.7 2.1 13.2 5.8 10.0 7.6 17.0 16.4 49.5 18.3 26.3 15.5 13.4 9.5 8.7 53.8 29.4 22.0 8.5 8.5 18.5 4.8 8.9 17.2 7.2 4.6 1.8 21.7 13.2 7.3 15.8 15.3 0.5 2.0 10.1 5.3 16.2 14.1 6.3 14.7 2.2 27.1 12.0 75.3 45.1 10.8 41.8 62.6 12.4 37.8 7.1 19.5 0.0 9.0 96.5 17.5 5.0 1.5 18.4 34.3 1.8 6.1 3.0 8.8 2.3 11.4 0.9 3.3 24.6 7.9 9.1 6.9 78.8 25.5 1.2 0.1 2.0 35.1 3.0 0.0 0.4 4.8 2.6 8.1 1.1 15.1 8.1 47.8 1.7 12.8 8.9 17.8 1.1 10.9 16.6 4.6 0.9 19.6 39.4 10.2 18.4 12.4 4.6 1.1 0.0 45.2 4.1 33.9 1.9 5.3 0.1 14.1 0.9 10.0 0.5 8.5 10.4 2.0 0.3 2.9 4.8 10.1 16.2 1.9 1.1 12.1 6.3 8.2 16.4 6.6 16.5 8.8 23.5 10.0 7.6 15.5 4.6 50.6 28.7 3.7 10.4 25.0 10.9 852.6 0.0 10.7 27.3 57.6 2.0 0.7 6.6 11.6 5.0 54.1 6.8 0.0 18.6 37.1 102.7 20.4 9.2 2.4 5.5 7.9 308.8 70.0 12.0 4.7 55.8 6.7 35.4 5.4 12.6 13.0 34.7 2.9 55.2 41.6 2.8 19.4 47.4 1.6 2.1 20.7 5.6 15.3 6.6 13.1 PANK2 "C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN" ENSG00000125779 "Pantothenate kinase 2" Q9BZ23 20 3888839-3929882 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008440 Approved Supported Cytosol NA NA Cytosol "HPA008440: AB_1079559" "unprognostic (4.50e-2)" "unprognostic (7.96e-3)" "unprognostic (2.26e-1)" "unprognostic (1.39e-2)" "unprognostic (1.68e-1)" "unprognostic (6.00e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (2.75e-1)" "unprognostic (3.39e-1)" "unprognostic (2.52e-1)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" "unprognostic (6.01e-3)" "unprognostic (1.73e-2)" "unprognostic (2.18e-3)" "unprognostic (2.63e-1)" "unprognostic (1.81e-1)" 15.2 21.5 18.7 18.5 18.9 20.8 19.7 21.8 24.8 14.7 14.4 16.8 10.7 11.8 15.5 15.5 28.9 19.1 14.3 11.0 17.4 18.6 18.8 20.3 16.1 18.5 16.2 16.2 14.4 13.5 15.3 15.7 18.1 20.8 14.5 16.4 17.0 15.8 13.2 14.4 12.8 14.5 16.6 12.3 20.6 12.1 28.9 14.1 23.2 17.0 10.5 24.6 17.3 16.4 5.8 8.6 8.0 12.8 8.3 6.4 3.1 20.8 13.5 14.6 7.4 17.5 15.2 8.0 13.7 15.0 18.1 23.5 18.2 11.2 17.0 6.4 15.3 36.2 17.3 15.7 26.7 23.1 5.0 6.9 23.2 9.7 33.9 14.7 15.4 7.7 13.4 11.6 20.2 13.0 6.9 16.9 12.0 17.0 15.9 19.4 5.2 13.2 13.6 14.6 8.6 10.2 10.9 20.4 10.7 11.2 19.2 19.0 9.3 17.0 18.6 34.0 14.9 11.3 12.5 11.6 21.7 10.9 28.3 21.0 8.9 25.9 12.9 6.4 14.1 16.9 1.6 11.2 4.7 4.4 12.8 4.3 4.7 4.3 4.5 8.6 5.8 4.4 4.0 8.0 8.3 10.7 3.0 6.4 3.1 18.7 18.9 21.8 24.8 17.4 18.6 16.2 16.2 20.8 14.1 17.9 9.4 18.5 15.5 22.7 20.0 9.0 7.6 16.0 9.1 14.0 23.6 25.6 19.9 16.8 63.9 22.4 12.3 23.3 15.4 29.5 18.0 15.9 7.0 13.0 29.7 33.4 19.4 20.3 37.4 13.0 19.5 30.0 18.6 36.1 9.9 13.3 12.2 11.5 21.2 15.3 20.0 6.5 16.9 32.6 21.8 21.2 15.6 25.5 12.6 16.5 PANX1 "MRS1, PX1, UNQ2529" ENSG00000110218 "Pannexin 1" Q96RD7 11 94128928-94181972 "Predicted membrane proteins, Transporters" "Calcium transport, Differentiation, Ion transport, Oogenesis, Transport" "Calcium channel, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 90.6;Suprabasal keratinocytes: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016930 Uncertain Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA016930: AB_1854954" "unprognostic (1.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.16e-1)" "unprognostic (7.02e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (7.09e-5)" "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.00e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (1.15e-2)" "unprognostic (9.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-3)" 13.5 9.4 7.9 13.5 14.3 3.8 18.0 7.8 14.8 10.1 11.8 5.6 4.3 6.1 10.8 6.6 9.4 8.7 13.7 13.4 5.6 10.2 8.7 19.4 14.7 6.7 7.4 9.2 9.0 8.5 10.1 7.8 11.0 8.7 9.4 8.6 3.9 9.7 8.6 29.8 11.5 7.4 14.7 5.0 9.6 10.7 12.3 7.4 12.7 10.2 13.9 8.7 13.6 14.1 2.6 5.0 3.6 7.4 4.2 5.1 6.1 11.7 5.0 13.2 8.0 12.3 16.8 8.6 14.7 31.3 12.7 15.6 12.7 18.6 3.7 13.8 14.9 23.3 24.9 10.4 24.3 12.8 16.1 5.4 17.4 5.3 6.5 11.9 8.9 15.6 13.2 17.1 16.5 14.9 8.2 10.5 9.9 11.2 13.7 14.1 3.7 14.8 2.1 10.5 9.5 9.1 17.7 17.6 4.7 8.2 11.7 5.5 16.1 10.3 5.9 7.0 7.0 12.6 4.6 7.6 25.2 13.0 8.2 14.5 2.2 8.5 6.2 10.5 9.3 16.0 3.6 7.4 0.5 4.3 4.2 5.0 2.6 3.5 4.4 5.0 2.4 3.2 3.6 0.5 4.2 2.6 0.8 5.1 6.1 7.9 14.3 7.8 14.8 5.6 10.2 7.4 9.2 8.7 7.4 0.0 8.3 1.9 8.9 90.6 1.2 3.1 0.0 6.7 2.3 1.8 0.0 10.6 0.0 12.9 4.7 3.1 3.3 0.0 15.8 28.0 12.4 6.8 9.2 6.4 16.9 0.0 2.4 2.5 4.4 2.2 4.0 10.1 16.9 3.6 3.3 0.9 18.5 3.4 3.5 1.9 1.3 0.0 14.4 1.0 6.8 63.1 19.9 3.2 2.8 13.1 PANX2 "hPANX2, PX2" ENSG00000073150 "Pannexin 2" Q96RD6 22 50170731-50180294 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 10.2;Hepatocytes: 6.8;Muller glia cells: 21.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.2" "Group enriched" "Detected in many" 36 "dendritic cells: 1.8;granulocytes: 5.2" "Cell line enhanced" "Detected in many" "EFO-21: 9.1;HDLM-2: 13.9;Hep G2: 16.3;MCF7: 9.0;SCLC-21H: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004624, HPA039117" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA004624: , HPA039117: AB_10805354" "unprognostic (1.00e-1)" "unprognostic (7.25e-2)" "unprognostic (2.72e-2)" "unprognostic (1.05e-1)" "unprognostic (3.01e-3)" "unprognostic (2.11e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (1.56e-1)" "unprognostic (4.43e-2)" "unprognostic (3.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-9)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.00e-1)" "unprognostic (4.08e-1)" 1.6 2.6 10.3 2.6 9.2 5.3 1.4 22.4 31.4 1.8 1.1 1.2 10.5 1.1 2.4 2.7 3.8 4.9 2.3 1.1 14.2 8.8 3.4 7.8 2.4 1.2 15.9 7.9 3.5 3.0 1.0 4.1 1.6 23.9 3.8 1.0 1.5 5.5 6.2 1.5 2.6 1.2 1.2 4.5 2.7 1.4 2.6 2.4 0.0 3.8 0.2 1.5 1.8 0.9 0.0 1.8 5.2 0.0 0.0 0.0 0.0 0.8 1.8 0.3 2.0 0.0 0.2 4.3 2.2 2.2 0.5 0.4 0.4 6.9 0.0 9.1 0.2 1.3 0.4 1.1 0.9 0.1 13.9 1.2 0.3 2.9 16.3 0.7 0.1 1.1 0.2 0.9 0.6 0.0 1.0 0.5 0.0 1.1 0.0 0.2 9.0 0.0 0.8 3.4 0.0 3.7 0.8 0.0 3.3 0.0 1.4 8.6 0.8 1.4 0.1 5.2 0.4 0.6 0.6 3.8 0.4 3.7 5.9 4.1 1.6 0.1 0.5 0.2 0.0 6.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 1.8 0.0 0.0 10.3 9.2 22.4 31.4 14.2 8.8 15.9 7.9 23.9 2.4 0.0 1.4 0.0 2.3 0.5 10.2 0.6 2.5 4.0 4.5 0.0 0.0 0.0 5.0 1.7 0.2 0.0 0.0 0.0 2.4 0.1 0.5 4.0 0.0 6.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.8 0.0 21.1 2.2 0.0 1.1 1.2 3.6 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 2.8 PANX3 Px3 ENSG00000154143 "Pannexin 3" Q96QZ0 11 124611490-124620356 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.8;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.4;MCF7: 2.6;U-266/70: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.80e-2)" "unprognostic (3.10e-1)" 0.1 0.4 0.1 0.1 1.8 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.2 0.0 0.1 1.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 2.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 2.6 0.2 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 2.8 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.1 0.5 0.1 0.7 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PAQR3 ENSG00000163291 "Progestin and adipoQ receptor family member 3" Q6TCH7 4 78887127-78939438 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.9" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 70.2;Late spermatids: 101.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 3.5;HMC-1: 3.6;MOLT-4: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.41e-2)" "unprognostic (2.43e-1)" "unprognostic (2.27e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (2.33e-1)" "unprognostic (7.12e-3)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (2.74e-1)" "unprognostic (4.39e-2)" "unprognostic (7.65e-2)" "unprognostic (6.45e-2)" "unprognostic (5.93e-2)" "unprognostic (2.75e-1)" "unprognostic (1.34e-3)" "unprognostic (1.27e-1)" 2.7 2.1 4.6 3.4 7.7 2.8 2.2 5.2 6.7 2.1 2.9 4.3 0.0 5.1 2.2 1.7 2.1 1.9 2.9 2.4 3.6 1.9 2.7 2.3 2.1 4.0 3.7 4.2 2.2 2.1 1.4 2.1 2.2 5.6 2.3 1.7 1.6 2.4 1.3 2.4 3.5 4.4 1.6 7.6 2.6 2.4 12.9 3.3 1.5 2.6 1.7 1.9 2.3 2.2 0.6 0.3 0.1 0.1 0.9 0.3 0.0 0.5 0.0 0.6 1.0 0.1 0.1 0.9 1.4 0.1 0.2 0.1 0.0 0.3 1.8 1.5 0.2 0.0 0.4 0.6 0.2 0.2 0.7 3.5 1.1 0.9 0.4 0.2 1.8 3.6 0.1 0.0 0.2 0.1 0.3 0.1 0.7 1.9 0.6 0.2 0.0 3.9 0.7 0.4 0.8 0.8 1.5 0.6 0.3 0.0 0.5 1.3 1.0 2.1 0.2 1.3 0.6 0.3 0.7 1.6 0.8 2.0 0.6 1.7 1.4 0.9 1.1 1.2 0.8 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.6 0.1 0.2 0.0 0.9 0.1 0.3 0.1 0.0 4.6 7.7 5.2 6.7 3.6 1.9 3.7 4.2 5.6 3.3 3.0 8.8 2.7 4.7 15.7 19.7 8.6 2.5 2.7 5.7 10.4 3.9 7.8 0.0 2.4 70.2 5.8 8.5 0.0 3.2 10.7 10.6 4.8 23.1 9.0 3.8 4.8 8.1 2.5 6.0 101.4 6.9 6.9 6.8 1.8 6.7 11.1 2.4 7.0 9.9 2.4 11.0 12.9 5.9 9.1 13.6 20.5 10.9 6.9 5.0 2.8 PAQR4 FLJ30002 ENSG00000162073 "Progestin and adipoQ receptor family member 4" Q8N4S7 16 2969245-2973489 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.4;parathyroid gland: 32.8" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 145.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "non-classical monocyte: 6.7" "Lineage enriched" "Detected in single" 8 "monocytes: 6.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068394 Approved Vesicles NA Yes Vesicles "HPA068394: AB_2685980" "unprognostic (1.93e-1)" "unprognostic (2.75e-1)" "unprognostic (6.73e-2)" "unprognostic (1.30e-3)" "unprognostic (8.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavorable (6.86e-4)" "unprognostic (2.62e-2)" "unprognostic (7.59e-2)" "unprognostic (9.65e-3)" "unprognostic (5.21e-2)" "unprognostic (8.59e-2)" "prognostic unfavorable (3.01e-6)" "prognostic favorable (1.70e-4)" "unprognostic (1.36e-1)" "unprognostic (3.79e-2)" "unprognostic (6.06e-3)" 3.1 3.2 14.1 5.2 19.2 10.3 2.3 8.0 26.3 2.4 4.8 49.6 1.3 4.9 1.8 1.0 4.2 3.0 5.5 4.2 24.1 11.7 1.7 1.6 3.9 6.3 30.6 11.1 0.4 6.6 32.8 0.9 2.2 19.1 9.6 4.5 16.8 17.0 1.3 12.3 12.3 4.9 2.8 54.4 3.2 7.4 1.6 20.3 3.6 1.5 3.5 7.8 2.1 1.7 0.5 0.9 0.1 6.7 0.0 0.4 0.5 12.9 11.0 12.5 18.0 2.0 3.7 4.2 4.9 5.9 9.1 8.6 6.6 13.8 12.9 6.7 5.6 6.4 18.2 12.9 7.7 3.8 13.7 5.6 3.9 21.6 8.9 0.2 8.4 14.4 0.9 4.1 4.9 1.3 4.6 5.9 11.0 7.7 35.1 7.7 25.9 12.1 9.0 10.5 19.4 7.5 24.1 16.4 41.6 6.2 4.5 28.6 13.3 18.2 17.6 13.2 1.7 18.9 13.1 3.6 16.0 9.8 7.3 6.9 15.3 10.6 17.2 7.0 11.4 17.5 0.0 1.0 0.1 0.4 0.5 0.0 0.5 0.2 0.1 0.9 0.1 0.0 0.3 0.1 0.0 6.7 0.5 0.1 0.5 14.1 19.2 8.0 21.2 24.1 11.7 30.6 11.1 19.1 20.3 0.0 0.0 2.9 1.4 2.7 14.6 0.8 12.7 10.7 6.8 0.0 55.0 0.7 0.0 4.4 0.5 1.0 2.0 0.0 9.9 7.2 0.8 7.5 2.3 0.0 11.5 6.4 4.1 3.7 9.5 3.0 0.6 4.5 5.0 1.0 5.3 15.7 6.5 2.9 0.0 0.3 145.7 0.0 1.2 1.6 5.2 4.4 0.5 0.0 9.3 0.8 PAQR5 "FLJ20190, MPRG" ENSG00000137819 "Progestin and adipoQ receptor family member 5" Q9NXK6 15 69298947-69407780 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 41.4" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 39.7;Early spermatids: 33.3;granulocytes: 65.8;Late spermatids: 86.2;Proximal tubular cells: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.5" "Cell line enhanced" "Detected in many" "A549: 17.5;CAPAN-2: 21.1;fHDF/TERT166: 14.9;HMC-1: 37.0;U-87 MG: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA076729 Approved Vesicles NA NA Vesicles "HPA076729: AB_2686813" "unprognostic (4.47e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-1)" "unprognostic (4.05e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (3.58e-3)" "unprognostic (6.12e-3)" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (2.00e-1)" "prognostic favorable (1.47e-14)" "unprognostic (5.64e-2)" "unprognostic (1.73e-1)" "unprognostic (4.16e-4)" "unprognostic (4.94e-2)" 1.8 15.4 1.9 4.1 2.6 0.7 1.2 1.5 3.1 1.6 12.3 3.0 1.7 1.5 1.1 1.6 9.0 1.0 1.7 1.9 1.8 1.5 41.4 1.0 10.4 0.3 2.0 1.0 0.5 4.8 5.8 0.9 1.0 3.5 1.1 10.8 3.6 1.8 4.2 0.4 3.2 5.2 3.2 3.8 0.2 4.5 1.5 2.2 0.0 0.6 5.7 4.9 2.3 2.6 0.2 0.2 3.5 0.3 0.4 0.7 0.0 5.1 17.5 0.3 0.3 0.7 2.0 0.1 1.6 10.1 2.0 4.3 1.0 21.1 0.0 2.7 14.9 1.7 0.3 5.0 0.2 3.5 0.0 0.7 3.0 2.7 0.3 1.3 0.1 37.0 1.0 0.8 9.0 9.7 2.6 0.0 0.1 0.0 0.3 8.4 0.7 0.0 0.1 1.2 2.7 1.5 0.0 0.3 0.9 7.7 0.4 1.5 0.3 2.7 1.0 1.4 1.0 0.4 1.2 0.2 6.1 2.0 0.5 0.2 0.1 0.1 0.0 15.4 0.0 1.7 3.5 0.3 0.1 0.3 0.1 0.2 0.1 0.2 0.2 0.1 0.2 0.3 0.7 1.3 0.4 0.2 0.2 0.1 0.0 1.9 2.6 1.5 3.1 1.8 1.5 2.0 1.0 3.5 2.2 11.9 21.8 0.0 1.1 0.8 0.5 0.8 22.9 1.4 1.2 19.2 0.0 0.0 39.7 16.0 33.3 0.4 18.4 0.0 0.4 0.0 0.2 0.5 65.8 0.0 3.5 0.0 0.0 0.0 0.3 86.2 0.9 0.9 0.0 0.0 4.8 5.7 1.8 3.5 1.1 33.2 0.0 6.5 0.4 0.3 0.5 1.6 0.1 0.5 11.5 0.7 PAQR6 "FLJ22672, PRdelta" ENSG00000160781 "Progestin and adipoQ receptor family member 6" Q6TCH4 1 156243321-156248117 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 138.1" "Cell type enriched" "Detected in some" 7 "Muller glia cells: 71.8" "Cancer enriched" "Detected in all" 6 "glioma: 34.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "NK-cell: 10.5" "Lineage enriched" "Detected in many" 6 "NK-cells: 10.5" "Cell line enhanced" "Detected in many" "U-266/70: 20.9" NA No "unprognostic (1.64e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (7.42e-2)" "unprognostic (5.52e-2)" "unprognostic (4.50e-3)" "unprognostic (4.75e-1)" "unprognostic (2.25e-1)" "unprognostic (2.57e-1)" "unprognostic (3.13e-1)" "unprognostic (4.25e-3)" "prognostic unfavorable (1.99e-4)" "prognostic unfavorable (1.58e-8)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.86e-4)" 2.1 3.6 42.5 2.2 38.0 7.6 2.2 8.7 71.6 2.0 2.7 102.9 0.0 2.8 2.3 2.9 2.5 2.2 2.9 2.0 48.1 37.6 2.0 2.1 2.1 2.1 82.7 16.1 1.6 1.6 2.4 1.2 2.2 72.5 3.5 2.3 0.0 3.2 3.0 2.1 11.5 3.0 2.0 138.1 2.3 3.1 2.5 46.0 0.0 2.0 0.0 2.0 2.5 0.3 0.8 1.6 0.0 0.0 10.5 1.2 0.1 1.8 2.0 3.3 3.4 0.6 0.5 8.2 0.2 0.5 0.0 0.2 1.0 6.4 3.3 1.5 0.5 0.2 5.8 0.0 0.7 0.4 1.9 2.7 2.0 1.7 0.9 0.3 0.6 5.3 1.6 2.6 2.4 2.4 3.3 0.3 6.7 1.5 9.5 0.6 6.7 0.2 1.0 3.8 1.1 0.9 1.4 0.7 1.5 2.3 10.7 2.9 5.8 0.7 0.7 3.8 6.9 10.8 1.1 0.5 1.0 5.3 1.7 0.5 20.9 4.6 2.0 0.2 7.5 0.9 0.0 0.0 0.0 0.4 0.0 1.2 0.8 0.6 0.2 0.0 0.1 0.0 0.0 0.0 10.5 0.0 1.6 0.1 0.1 42.5 38.0 8.7 34.4 48.1 37.6 82.7 16.1 72.5 46.0 0.0 0.3 0.0 0.2 1.1 3.2 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.7 0.7 0.0 3.0 0.1 0.6 0.7 1.1 0.9 0.5 6.4 4.1 0.6 0.6 0.6 0.3 0.7 0.0 0.0 0.4 71.8 1.3 0.0 2.1 0.0 10.3 0.0 0.2 0.7 0.4 1.3 0.2 4.6 0.9 0.4 PAQR7 "MPRA, mSR" ENSG00000182749 "Progestin and adipoQ receptor family member 7" Q86WK9 1 25861210-25871253 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 12 "Early spermatids: 346.5;Late spermatids: 1377.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 30.3;HaCaT: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046936 Approved Approved Cytosol NA NA Cytosol "HPA046936: AB_2679869" "unprognostic (1.12e-1)" "unprognostic (2.08e-2)" "unprognostic (8.03e-2)" "unprognostic (4.54e-3)" "unprognostic (1.32e-1)" "unprognostic (3.41e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.47e-1)" "unprognostic (4.59e-3)" "unprognostic (7.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "prognostic favorable (1.05e-5)" "unprognostic (1.60e-2)" "unprognostic (2.98e-2)" "unprognostic (1.15e-2)" "unprognostic (1.54e-2)" 1.2 9.5 1.8 0.7 2.3 1.0 1.4 1.8 1.8 2.8 1.6 6.7 4.1 10.2 6.1 6.8 2.1 0.6 1.7 2.6 11.9 1.9 1.6 0.6 2.0 13.2 1.8 3.9 2.1 6.9 2.4 0.4 1.5 8.9 0.2 10.7 5.7 2.9 1.4 3.5 2.3 16.2 1.4 1.0 6.3 4.6 3.2 5.5 10.8 11.7 2.4 1.4 0.8 11.7 2.3 2.4 7.8 2.9 6.2 8.4 7.7 6.9 7.8 7.0 3.9 30.3 0.1 5.5 7.6 2.5 24.9 1.3 13.1 4.7 4.6 1.3 10.0 3.3 4.7 4.9 0.1 1.3 6.3 17.5 5.5 4.1 6.9 2.9 1.1 1.0 0.8 5.7 2.7 0.0 0.7 3.7 1.2 4.0 0.8 0.2 1.4 15.8 9.1 1.2 4.7 12.6 16.5 5.7 3.5 4.7 1.8 3.2 1.3 4.0 4.1 2.1 0.1 0.1 0.5 5.9 0.3 2.6 3.1 5.7 10.8 1.1 10.2 1.1 3.2 0.6 0.8 5.5 1.2 1.0 1.4 2.6 2.4 11.7 0.6 0.2 0.8 0.0 1.9 1.9 4.7 16.1 1.9 1.6 17.8 10.7 6.8 73.3 0.0 36.5 18.3 4.9 346.5 4.5 1.3 0.0 12.5 10.0 7.5 1.0 6.9 4.9 9.2 3.2 4.6 10.4 7.3 1377.7 18.4 5.3 20.3 5.4 1.5 2.0 7.0 3.5 14.2 49.2 0.6 12.9 4.0 11.1 9.1 11.4 29.9 0.9 2.9 2.2 PAQR8 "C6orf33, LMPB1, MPRB" ENSG00000170915 "Progestin and adipoQ receptor family member 8" Q8TEZ7 6 52361421-52407777 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.2" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 94.7;Mucus-secreting cells: 40.0;Paneth cells: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 19.4;OE19: 41.1;SuSa: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064625 Supported "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA064625: AB_2685304" "prognostic favorable (4.61e-4)" "unprognostic (7.39e-3)" "unprognostic (2.77e-3)" "unprognostic (8.23e-2)" "unprognostic (4.33e-1)" "unprognostic (4.08e-3)" "unprognostic (2.66e-2)" "unprognostic (5.67e-2)" "unprognostic (6.37e-2)" "unprognostic (4.30e-3)" "unprognostic (2.10e-1)" "unprognostic (5.55e-2)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (2.12e-1)" "unprognostic (3.14e-2)" "prognostic favorable (6.40e-4)" 2.4 3.5 25.6 6.6 32.4 1.3 2.2 14.9 31.0 4.2 28.9 35.5 14.2 14.5 4.4 6.7 13.7 5.4 4.9 2.9 27.3 17.5 5.3 1.5 5.8 7.2 48.5 15.8 19.5 2.5 3.7 1.8 5.5 28.2 3.8 28.1 1.9 1.9 28.5 1.1 2.7 25.1 5.2 69.2 4.8 24.1 3.1 36.5 3.1 2.6 0.4 6.0 7.3 3.3 1.0 6.0 2.0 2.6 7.0 16.3 3.2 0.4 0.4 5.2 2.2 3.1 5.1 3.5 1.5 5.8 1.0 2.1 1.9 1.8 0.5 0.5 1.0 2.3 0.2 0.6 2.5 1.6 6.9 0.8 3.1 0.4 19.4 0.8 0.8 0.4 1.4 0.3 0.6 3.7 3.6 5.5 6.1 0.7 3.1 4.0 0.7 2.0 2.8 2.6 41.1 0.2 5.3 0.8 1.2 6.0 1.4 1.9 4.2 0.4 0.1 5.8 17.5 0.1 6.9 2.3 2.0 0.8 0.5 0.9 0.9 1.2 0.7 1.8 8.0 10.3 2.0 2.6 1.3 2.5 0.5 3.8 0.9 7.6 5.2 6.0 1.0 16.3 7.6 0.5 7.0 0.5 3.0 4.7 3.2 25.6 32.4 14.9 22.8 27.3 17.5 48.5 15.8 28.2 36.5 3.0 8.8 0.0 3.2 1.8 1.6 4.6 15.3 0.0 1.2 3.5 7.9 1.4 0.0 3.2 0.4 3.8 94.7 0.0 1.0 2.6 4.7 6.0 4.6 0.0 7.9 0.0 22.1 3.7 16.7 1.0 5.2 3.9 13.5 5.4 40.0 4.5 3.0 55.1 9.6 0.0 3.0 0.0 1.9 11.4 2.9 0.9 0.7 5.9 24.1 7.8 PAQR9 FLJ41938 ENSG00000188582 "Progestin and adipoQ receptor family member 9" Q6ZVX9 3 142949164-142963682 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.1;heart muscle: 12.1;liver: 18.6;testis: 20.8" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 33.7;Erythroid cells: 23.3;Hepatocytes: 17.3;Late spermatids: 72.6;Syncytiotrophoblasts: 30.6" "Cancer enriched" "Detected in single" 15 "liver cancer: 5.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.4;AF22: 3.4;HEL: 3.7;NTERA-2: 4.1;U-266/70: 10.2;U-266/84: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052798 Uncertain NA NA "HPA052798: AB_2681955" "unprognostic (4.13e-2)" "unprognostic (2.54e-1)" "unprognostic (2.81e-1)" "unprognostic (3.09e-2)" "unprognostic (1.21e-2)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (3.56e-2)" "unprognostic (1.23e-2)" "unprognostic (1.09e-1)" "unprognostic (6.91e-2)" 0.4 0.6 2.5 0.3 7.0 7.0 0.3 0.5 10.1 0.3 0.3 0.6 0.0 0.3 0.3 0.3 0.3 0.3 0.4 12.1 3.3 1.7 0.3 18.6 0.3 0.3 0.7 3.1 0.3 0.5 0.3 1.4 0.8 6.0 0.4 0.3 2.7 0.3 0.3 5.9 0.3 0.3 0.3 1.0 0.3 0.3 20.8 0.3 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 1.0 0.0 0.1 0.0 0.3 3.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 4.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.0 0.7 0.4 10.2 5.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 7.0 0.5 10.1 3.3 1.7 0.7 3.1 6.0 0.3 0.0 0.0 0.0 0.0 0.2 4.5 5.3 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 33.7 0.0 0.0 23.3 0.0 0.1 0.0 0.0 0.0 17.3 0.1 0.0 0.0 0.0 0.0 72.6 1.1 0.0 0.0 0.0 0.0 1.9 0.1 0.0 1.8 0.0 6.4 0.0 0.0 1.1 4.9 0.1 30.6 0.0 0.0 0.0 PARL "PRO2207, PSARL, PSARL1, RHBDS1" ENSG00000175193 "Presenilin associated rhomboid like" Q9H300 3 183829271-183884933 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA019545 Approved Approved Mitochondria NA NA Mitochondria "HPA019545: AB_1855796" "unprognostic (2.10e-1)" "unprognostic (1.53e-3)" "unprognostic (5.88e-2)" "unprognostic (1.17e-2)" "unprognostic (5.76e-2)" "unprognostic (9.55e-2)" "unprognostic (3.17e-3)" "unprognostic (8.97e-2)" "unprognostic (1.81e-1)" "unprognostic (3.62e-3)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (4.28e-2)" "unprognostic (5.49e-2)" "unprognostic (2.58e-1)" "unprognostic (1.73e-1)" "prognostic favorable (9.11e-5)" 24.2 20.6 26.2 19.2 30.1 21.2 30.4 22.1 29.6 22.7 29.0 24.4 19.4 21.5 20.2 43.8 21.4 19.6 21.2 30.9 23.1 23.4 27.0 26.7 20.3 26.5 28.4 20.3 20.3 47.5 22.0 20.6 18.5 19.5 22.1 31.3 25.9 35.1 33.4 41.2 22.3 27.0 38.1 19.4 22.3 24.5 22.2 18.9 22.1 20.7 25.4 24.3 23.2 18.2 21.5 45.4 44.3 50.0 21.5 25.9 35.4 32.6 15.5 11.5 9.8 11.2 12.9 23.9 12.3 16.7 23.7 18.6 47.7 17.1 14.6 27.4 15.6 21.3 14.6 18.3 18.9 26.7 20.7 22.5 22.0 10.4 26.1 16.8 21.8 18.6 17.5 24.3 16.6 20.3 11.2 16.8 23.2 12.5 13.6 19.4 35.4 41.6 53.4 30.9 27.4 15.9 18.4 22.5 26.5 22.1 27.3 11.6 16.5 14.6 47.2 30.0 14.7 48.5 41.4 9.8 8.8 19.2 18.2 31.2 27.4 18.5 33.6 16.9 22.2 10.5 27.6 50.0 44.3 19.0 35.4 21.7 21.5 21.6 22.1 45.4 19.9 25.9 21.1 14.5 21.5 26.2 27.0 24.4 35.4 26.2 30.1 22.1 29.6 23.1 23.4 28.4 20.3 19.5 18.9 20.8 26.1 28.3 47.3 27.0 33.9 33.9 20.4 18.7 15.9 29.6 29.5 49.5 99.5 41.8 15.3 30.4 28.2 0.0 73.6 40.6 37.9 39.4 69.2 28.2 68.8 31.8 32.4 30.1 52.8 7.4 26.7 58.0 40.5 60.5 36.5 35.7 49.3 35.1 25.5 71.7 38.7 6.5 49.1 43.3 46.0 26.2 35.2 38.5 49.1 46.1 PARM1 "Cipar1, DKFZP564O0823, WSC4" ENSG00000169116 "Prostate androgen-regulated mucin-like protein 1" Q6UWI2 4 74933095-75050115 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 143.3;Mucus-secreting cells: 90.2;Paneth cells: 120.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 10.1;myeloid DC: 4.6;naive B-cell: 6.4" "Group enriched" "Detected in many" 15 "B-cells: 10.1;dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "ASC diff: 24.5;Karpas-707: 23.9;U-266/70: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038236 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles, Cytosol" "HPA038236: AB_10675789" "unprognostic (2.57e-2)" "unprognostic (5.20e-2)" "unprognostic (1.26e-3)" "unprognostic (8.61e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-3)" "unprognostic (3.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.73e-1)" "unprognostic (9.74e-2)" "unprognostic (9.44e-2)" "unprognostic (3.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.23e-1)" 23.1 21.5 5.7 25.0 15.2 0.3 16.4 1.3 29.4 18.7 36.0 1.2 28.5 2.8 20.3 18.0 5.8 12.2 11.5 39.8 6.9 13.0 27.5 1.1 15.1 10.2 3.3 10.3 11.9 29.2 23.2 32.1 16.1 4.8 35.0 45.8 70.2 25.6 27.6 7.4 6.2 8.3 29.3 2.4 9.7 5.5 11.2 1.2 6.3 79.8 3.7 8.0 24.9 19.7 10.1 4.6 0.1 0.5 0.0 0.0 0.7 0.5 1.0 0.9 0.0 24.5 0.1 0.1 0.0 0.1 0.0 0.0 2.0 0.2 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 4.1 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 23.9 0.4 0.2 2.6 0.1 2.3 0.0 1.4 0.0 2.2 6.0 0.1 4.9 1.5 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 1.4 1.6 0.1 2.1 26.8 2.5 6.8 2.5 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 10.1 0.0 0.0 4.6 6.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.7 5.7 15.2 1.3 29.4 6.9 13.0 3.3 10.3 4.8 1.2 14.9 63.1 13.4 17.1 2.9 7.9 143.3 30.6 1.4 11.4 0.0 0.0 0.3 3.3 0.1 6.8 3.8 80.6 23.3 43.2 0.6 15.4 43.3 1.1 0.0 1.4 0.0 19.1 3.1 0.0 20.6 33.9 7.2 8.5 1.0 90.2 0.0 26.9 120.2 70.0 27.6 1.0 45.3 52.3 1.7 3.3 1.6 0.7 1.5 46.2 8.4 PARP16 "C15orf30, FLJ20509, FLJ25281, pART15" ENSG00000138617 "Poly(ADP-ribose) polymerase family member 16" Q8N5Y8 15 65234460-65300618 "Enzymes, Predicted membrane proteins" "Unfolded protein response" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 31.3;Spermatogonia: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017081 Approved NA NA "HPA017081: AB_10963218" "unprognostic (1.17e-2)" "unprognostic (6.51e-3)" "unprognostic (2.82e-2)" "unprognostic (6.37e-2)" "unprognostic (7.38e-2)" "unprognostic (2.88e-2)" "unprognostic (3.05e-2)" "unprognostic (6.82e-2)" "unprognostic (2.18e-1)" "unprognostic (2.70e-1)" "unprognostic (1.00e-1)" "unprognostic (1.78e-1)" "unprognostic (3.41e-3)" "unprognostic (1.11e-1)" "unprognostic (2.71e-1)" "unprognostic (1.01e-1)" "unprognostic (9.61e-2)" 8.9 14.2 12.0 13.1 11.6 8.0 20.4 32.2 17.7 18.6 12.8 5.6 11.9 9.3 13.1 8.5 10.5 12.0 8.7 7.2 9.7 5.3 9.0 18.1 11.5 14.0 11.5 6.2 17.6 11.3 12.7 8.5 9.2 9.1 11.5 10.4 7.5 10.3 21.4 5.4 10.8 9.7 17.7 8.0 9.3 11.0 7.6 12.0 15.1 9.5 6.3 12.4 14.0 25.6 10.1 4.4 14.1 5.3 10.3 14.2 6.0 3.7 3.8 4.2 6.6 3.5 3.6 1.9 1.7 4.6 4.8 5.0 3.1 3.4 12.1 4.8 2.1 10.3 6.1 19.6 2.4 3.6 4.4 7.8 2.0 4.1 4.3 6.5 5.5 3.8 4.2 4.0 1.2 4.9 7.1 4.4 11.6 5.0 4.6 4.1 4.5 11.4 5.9 2.0 19.3 5.2 21.1 7.7 9.1 3.4 3.4 7.3 4.9 5.3 5.1 4.3 3.5 6.0 5.0 1.8 5.7 4.3 3.2 2.6 8.6 10.1 15.8 4.7 8.2 2.6 14.1 3.3 10.0 11.6 5.3 12.9 7.8 11.2 11.8 4.4 10.1 14.2 10.5 13.0 10.3 5.2 3.9 9.2 6.0 12.0 11.6 32.2 17.7 9.7 5.3 11.5 6.2 9.1 12.0 3.0 1.9 6.6 4.9 4.6 10.8 3.9 7.6 4.0 3.4 3.5 0.0 10.7 0.0 5.2 0.7 3.5 4.0 0.0 7.9 4.2 5.6 2.6 0.0 5.1 3.4 3.2 1.7 1.3 1.8 1.8 9.2 1.8 3.3 4.6 5.2 6.2 3.7 3.4 7.4 3.3 31.3 6.5 4.7 1.6 26.2 3.8 4.6 5.7 6.0 2.4 PATE3 "HEL-127, PATE-DJ" ENSG00000236027 "Prostate and testis expressed 3" B3GLJ2 11 125788111-125791600 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "epididymis: 86.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.8;RPMI-8226: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.3 0.2 0.1 0.1 0.0 8.7 0.0 0.1 86.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 3.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAX6 "AN, AN2, D11S812E, WAGR" ENSG00000007372 "Paired box 6" P26367 11 31784779-31818062 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.3;retina: 29.4" "Group enriched" "Detected in some" 5 "Horizontal cells: 249.5;Muller glia cells: 410.0" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Region enriched" "Detected in all" 5 "cerebellum: 78.3" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 9.4;AN3-CA: 12.1;HEK 293: 11.3;hTERT-RPE1: 32.3;U-251 MG: 9.9" "Group enriched" "Detected in many" 5 "cerebellum: 61.0;olfactory region: 41.2" "Low region specificity" "Detected in all" "HPA030775, CAB034143" Enhanced Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034143: AB_1127044, HPA030775: AB_10601243" "unprognostic (2.89e-1)" "unprognostic (2.98e-2)" "unprognostic (8.34e-2)" "unprognostic (3.85e-2)" "unprognostic (4.42e-2)" "unprognostic (7.82e-2)" "unprognostic (2.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.24e-3)" "unprognostic (1.68e-1)" "unprognostic (1.20e-2)" "unprognostic (3.91e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" 0.8 2.0 12.6 0.8 10.4 1.1 1.0 78.3 23.5 0.8 1.1 9.3 0.0 3.5 0.8 1.8 0.8 0.8 0.8 0.8 16.0 3.7 0.9 0.9 0.7 0.9 3.9 9.1 0.8 15.8 0.8 4.6 0.8 10.8 0.8 1.4 29.4 0.8 0.9 1.9 1.6 2.0 0.8 16.1 0.8 19.4 2.8 9.8 0.0 0.8 0.0 1.0 1.1 0.3 0.2 0.2 1.6 0.4 0.4 0.5 0.1 0.0 0.1 9.4 12.1 2.9 4.0 3.6 0.0 0.0 0.1 0.0 0.7 2.2 0.0 3.8 1.2 5.5 0.2 1.0 0.0 0.2 0.0 11.3 5.3 8.8 5.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 32.3 0.0 3.3 4.2 0.0 0.1 0.0 2.2 0.3 0.2 0.0 6.1 0.0 4.4 0.0 0.5 0.3 0.4 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 3.2 0.2 0.0 9.9 0.0 0.1 0.0 5.0 0.0 0.0 1.6 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.2 0.2 0.2 0.3 1.0 0.4 0.4 0.2 0.1 0.1 12.6 10.4 78.3 12.2 16.0 3.7 3.9 9.1 10.8 9.8 0.0 0.0 0.0 0.0 0.5 15.4 4.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 249.5 71.5 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.1 410.0 4.1 0.6 0.0 0.0 27.5 0.0 0.3 3.7 2.9 0.0 0.0 0.0 0.0 0.0 PCDH1 pc42 ENSG00000156453 "Protocadherin 1" Q08174 5 141853111-141879246 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 37.9;Exocrine glandular cells: 40.1;Pancreatic endocrine cells: 44.8;Urothelial cells: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.5;HaCaT: 36.8;HUVEC TERT2: 19.3;OE19: 26.1;RT4: 25.2;TIME: 25.1;WM-115: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047720, HPA050538" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" NA NA 270000 "Nucleoplasm, Cell Junctions" Nucleoli "HPA047720: AB_2680130, HPA050538: AB_2681162" "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (5.30e-2)" "unprognostic (4.61e-3)" "unprognostic (5.03e-2)" "unprognostic (4.16e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (1.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.43e-1)" "prognostic favorable (7.55e-5)" "unprognostic (2.05e-1)" "unprognostic (4.16e-2)" "unprognostic (3.13e-2)" "unprognostic (1.91e-1)" 22.4 4.5 14.8 7.4 17.6 1.4 19.0 16.1 25.6 8.3 22.2 7.3 11.4 20.6 7.0 7.0 26.9 9.7 6.8 8.9 11.6 7.4 14.9 13.0 18.9 3.4 8.8 16.9 2.5 11.0 1.3 5.2 32.5 9.2 11.1 14.4 6.0 23.7 12.3 7.4 17.3 15.8 7.5 7.5 1.6 22.8 1.5 9.8 0.0 9.1 3.9 8.8 8.6 11.7 0.0 0.0 0.3 0.0 0.0 2.2 0.5 6.2 0.3 2.6 2.9 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.5 29.5 0.0 15.2 0.2 0.3 36.8 3.4 2.7 0.0 0.0 0.1 0.0 0.1 0.0 2.4 0.0 0.1 0.0 6.2 0.0 0.4 6.3 19.3 0.0 0.0 3.1 0.0 5.0 0.1 0.0 11.2 26.1 5.0 0.1 0.0 4.2 2.1 25.2 0.3 0.6 0.1 8.1 6.5 7.9 6.5 0.1 25.1 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.2 0.0 17.8 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.5 14.8 17.6 16.1 25.6 11.6 7.4 8.8 16.9 9.2 9.8 0.0 4.0 0.0 10.2 0.9 9.1 2.2 22.9 4.0 2.3 12.2 0.0 0.6 3.3 13.6 0.3 21.8 37.9 0.0 40.1 0.2 1.6 22.4 0.0 26.0 0.2 25.4 7.5 6.2 1.9 0.8 0.6 0.5 0.0 0.0 17.6 4.0 44.8 19.3 0.4 5.1 0.4 12.9 15.1 0.2 0.2 2.3 16.8 0.0 14.7 43.0 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149315-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0;placenta: 31.1;seminal vesicle: 23.6" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 16.2;Muller glia cells: 8.7;Smooth muscle cells: 4.7" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 6.9;HUVEC TERT2: 16.1;MOLT-4: 13.4;TIME: 32.0;U-138 MG: 8.6;U-251 MG: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: AB_2686605" "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 1.9 7.6 17.9 1.5 35.5 1.2 1.3 1.7 48.0 3.3 1.5 23.2 4.5 1.3 3.1 1.9 1.6 2.6 1.9 1.8 17.5 12.6 3.7 1.3 2.0 1.2 13.2 16.3 4.1 1.4 1.2 1.7 31.1 13.6 14.7 1.5 1.3 1.8 23.6 1.2 1.3 1.7 2.0 6.8 1.2 1.3 2.9 19.2 0.9 1.5 0.0 1.2 3.6 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 5.2 0.0 0.1 0.0 0.0 5.0 2.7 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.9 16.1 0.0 0.2 0.0 2.4 0.0 13.4 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 32.0 8.6 0.0 0.0 7.3 0.0 0.0 0.0 0.6 0.0 4.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.9 35.5 1.7 27.7 17.5 12.6 13.2 16.3 13.6 19.2 0.0 1.1 0.0 0.2 0.1 16.2 2.0 0.0 0.0 1.2 0.0 0.0 0.7 1.7 0.0 3.3 1.0 0.0 0.0 0.0 0.7 1.6 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.4 0.0 2.3 0.0 4.7 1.8 0.7 0.3 2.4 0.0 0.0 0.4 PCDH11X "PCDH-X, PCDH11, PCDHX, PPP1R119" ENSG00000102290 "Protocadherin 11 X-linked" Q9BZA7 X 91779261-92623230 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 7.0;ovary: 12.6;parathyroid gland: 5.2" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 16.9;Horizontal cells: 31.8;Syncytiotrophoblasts: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.3;AN3-CA: 6.5;NTERA-2: 1.1;SuSa: 1.9;THP-1: 1.1" HPA077495 Approved NA NA "HPA077495: " "unprognostic (4.22e-3)" "unprognostic (1.16e-1)" "unprognostic (1.39e-4)" "unprognostic (1.18e-1)" "unprognostic (8.20e-3)" "unprognostic (6.32e-2)" "unprognostic (9.10e-2)" "unprognostic (6.19e-2)" "unprognostic (4.58e-1)" "unprognostic (1.58e-1)" "unprognostic (2.45e-2)" "unprognostic (3.86e-1)" 0.0 0.3 2.6 0.1 7.0 0.0 0.2 0.0 4.8 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 4.2 0.0 0.0 0.0 0.2 1.3 12.6 0.0 5.2 0.3 1.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 9.0 0.0 0.3 1.3 3.5 0.6 0.0 1.4 5.7 0.0 0.0 16.9 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 0.8 0.2 1.1 0.4 0.9 31.8 0.0 1.3 0.0 0.0 8.9 1.4 10.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 6.5 1.0 0.0 0.9 0.6 13.2 0.0 0.0 0.4 PCDH11Y "PCDH22, PCDHY" ENSG00000099715 "Protocadherin 11 Y-linked" Q9BZA8 Y 5000226-5742224 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.9;seminal vesicle: 9.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 42.2;Ciliated cells: 17.4;Club cells: 25.0;Collecting duct cells: 14.0;granulocytes: 17.4;Horizontal cells: 44.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 21.9" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;RPMI-8226: 2.3;SuSa: 2.1;U-266/70: 2.2" NA NA "unprognostic (9.26e-2)" "unprognostic (1.84e-1)" "unprognostic (7.64e-3)" "unprognostic (2.36e-2)" "unprognostic (3.55e-2)" 0.2 0.3 4.5 5.4 3.1 0.3 0.1 0.0 21.9 0.2 0.4 1.1 2.7 0.2 0.2 0.3 0.5 0.1 0.3 0.5 4.2 5.6 0.2 0.2 0.3 0.4 1.8 0.0 0.5 0.2 0.2 0.2 1.8 0.7 0.5 0.9 0.9 0.3 9.1 0.2 0.4 0.6 0.2 0.4 0.6 0.4 0.4 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.5 0.4 2.0 0.3 0.8 0.3 0.6 0.0 0.2 0.3 0.4 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.4 0.2 0.3 0.0 0.2 0.1 0.7 1.4 0.0 0.2 0.1 0.0 2.3 0.3 0.1 0.3 0.1 0.2 0.0 0.0 2.1 0.0 0.8 0.2 0.1 0.2 0.0 0.1 2.2 0.0 0.2 0.2 0.2 0.1 0.8 0.3 0.2 0.2 0.1 0.1 0.3 0.1 0.2 0.1 0.5 0.2 0.3 2.0 0.8 0.1 0.4 0.1 0.6 4.5 3.1 0.0 21.9 4.2 5.6 1.8 0.0 0.7 0.0 6.0 42.2 0.0 0.9 1.5 1.9 0.5 0.0 17.4 25.0 14.0 0.0 3.7 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 1.2 0.7 17.4 0.0 0.2 44.5 0.0 0.6 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 3.8 0.0 0.0 0.2 2.1 1.4 1.8 0.0 0.0 1.6 PCDH12 VE-cadherin-2 ENSG00000113555 "Protocadherin 12" Q9NPG4 5 141943585-141969741 "Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Disease mutation, Epilepsy, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.9" "Group enriched" "Detected in some" 5 "Endothelial cells: 24.8;Hofbauer cells: 25.9;Ito cells: 56.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.0" "Lineage enriched" "Detected in single" 35 "monocytes: 7.0" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 14.2;Karpas-707: 35.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051242 Uncertain "Secreted to blood" NA NA 720000 "HPA051242: AB_2681402" "unprognostic (6.62e-2)" "unprognostic (6.94e-2)" "unprognostic (4.74e-3)" "unprognostic (4.12e-2)" "unprognostic (3.99e-1)" "unprognostic (3.25e-1)" "unprognostic (4.35e-1)" "unprognostic (1.88e-2)" "unprognostic (4.29e-2)" "unprognostic (2.76e-1)" "unprognostic (9.99e-2)" "unprognostic (3.87e-1)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.11e-2)" "unprognostic (5.21e-2)" "unprognostic (9.37e-2)" "unprognostic (9.33e-2)" 7.9 2.9 0.5 0.7 0.6 0.0 3.1 2.2 0.6 1.3 0.8 0.7 1.3 0.0 0.7 1.2 1.8 4.6 0.5 0.4 3.7 2.1 9.0 0.7 0.4 0.9 0.6 1.4 2.5 17.9 1.1 0.4 0.6 1.0 1.6 0.5 1.0 2.6 0.3 11.3 1.0 0.1 4.8 0.1 2.1 1.1 0.1 0.2 0.0 7.0 0.0 0.1 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.2 14.2 0.1 0.0 35.1 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.3 0.1 1.5 0.0 0.1 0.2 0.3 0.0 0.0 0.2 0.1 0.0 0.9 0.9 0.2 0.0 0.5 0.0 0.2 0.1 0.0 0.2 5.7 1.2 0.0 0.4 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.6 1.0 4.4 0.0 0.0 0.0 0.0 2.0 0.2 3.3 0.0 1.4 24.8 0.0 0.0 0.0 0.2 0.2 0.0 1.1 0.0 25.9 0.0 0.0 56.4 7.5 0.8 0.0 0.1 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.1 PCDH15 "CDHR15, DFNB23, USH1F" ENSG00000150275 "Protocadherin related 15" Q96QU1 10 53802771-55627942 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Hearing" "Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 27.4;retina: 25.1" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 92.2" "Cancer enriched" "Detected in single" 9 "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;HUVEC TERT2: 1.7;SH-SY5Y: 1.6;U-138 MG: 1.6;U-2 OS: 2.8;U-266/70: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074437 Supported "Intracellular and membrane" NA NA "HPA074437: " "unprognostic (1.38e-1)" "unprognostic (3.39e-1)" "unprognostic (8.15e-5)" "unprognostic (3.07e-3)" "unprognostic (2.79e-1)" "unprognostic (9.15e-4)" "unprognostic (2.02e-1)" "unprognostic (3.89e-2)" "unprognostic (1.12e-3)" "unprognostic (1.31e-3)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (7.66e-3)" 0.7 27.4 9.7 0.9 7.4 0.6 0.5 4.3 10.9 0.7 0.7 5.6 0.0 0.8 0.6 1.1 0.6 0.6 0.6 0.9 10.5 5.8 11.0 0.5 3.7 1.8 6.0 3.2 0.5 0.5 0.4 6.9 0.7 8.7 0.7 0.5 25.1 0.6 0.5 0.4 0.5 0.8 0.5 5.7 1.3 0.9 4.4 7.9 0.0 0.6 0.0 1.2 1.5 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.6 2.8 0.0 0.0 8.3 0.8 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.7 7.4 4.3 7.1 10.5 5.8 6.0 3.2 8.7 7.9 0.0 0.0 0.0 0.0 0.2 4.2 3.2 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.7 92.2 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 PCDH17 "PCDH68, PCH68" ENSG00000118946 "Protocadherin 17" O14917 13 57631810-57729311 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 31.0;Endothelial cells: 49.1;Ito cells: 86.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "AF22: 16.2;HEK 293: 10.1;U-87 MG: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026817 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA 31000 Cytosol "Vesicles, Plasma membrane" "HPA026817: AB_1855044" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-1)" "unprognostic (6.52e-2)" "unprognostic (6.98e-3)" "unprognostic (1.95e-2)" "unprognostic (8.26e-4)" "unprognostic (3.56e-1)" "unprognostic (2.38e-2)" "unprognostic (2.82e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.40e-2)" 2.0 2.4 8.0 2.1 11.2 0.3 0.9 4.6 18.2 2.9 1.2 6.2 0.3 1.1 2.6 1.3 1.7 2.5 3.6 2.3 6.5 12.1 1.6 1.4 13.5 0.9 7.4 4.8 0.8 6.2 2.0 1.0 4.7 4.4 1.2 1.2 1.1 1.0 1.1 1.8 0.6 0.7 2.6 4.4 32.7 1.8 8.9 7.7 0.0 3.4 0.4 0.8 3.4 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.1 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 2.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 1.4 0.0 1.0 0.0 0.0 0.0 6.1 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 11.2 4.6 7.8 6.5 12.1 7.4 4.8 4.4 7.7 0.0 7.0 0.0 0.0 2.4 3.5 4.2 0.0 9.4 15.9 1.8 0.0 0.2 0.0 6.9 31.0 49.1 0.0 0.0 7.0 0.1 1.8 0.3 0.0 0.0 0.5 0.0 0.0 86.5 2.8 11.9 1.7 0.8 10.1 2.8 0.0 2.1 2.1 0.0 1.1 0.0 0.0 6.5 7.6 15.8 10.1 0.9 0.0 0.0 0.0 0.1 PCDH18 "KIAA1562, PCDH68L" ENSG00000189184 "Protocadherin 18" Q9HCL0 4 137518918-137532494 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Fibroblasts: 43.4;Leydig cells: 35.1;Peritubular cells: 55.2;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.3;memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 35.8;ASC diff: 43.2;ASC TERT1: 48.1;BJ hTERT+: 21.1;fHDF/TERT166: 34.1;HHSteC: 31.9;HSkMC: 48.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017976 Approved Approved "Golgi apparatus,Cytosol" No NA 1200000 Cytosol "Golgi apparatus" "HPA017976: AB_1855045" "unprognostic (2.77e-1)" "unprognostic (1.86e-2)" "unprognostic (3.73e-3)" "unprognostic (9.19e-2)" "unprognostic (1.59e-1)" "unprognostic (3.39e-2)" "unprognostic (2.36e-1)" "unprognostic (4.30e-2)" "unprognostic (1.97e-3)" "unprognostic (2.20e-2)" "unprognostic (8.76e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.79e-2)" "unprognostic (6.27e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (4.71e-4)" 28.4 3.5 4.2 7.2 4.0 0.0 16.2 2.0 2.7 30.4 13.3 2.1 9.8 6.0 34.0 8.7 11.2 8.6 14.9 8.9 2.7 3.6 5.4 3.0 5.9 2.6 5.2 1.4 14.9 2.4 1.8 3.5 29.0 5.4 23.3 9.5 21.8 6.3 9.5 10.3 5.1 9.0 25.4 5.4 4.0 5.5 9.7 4.0 1.0 8.2 7.7 1.9 17.5 16.3 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 35.8 0.0 43.2 48.1 0.0 6.4 21.1 1.2 1.9 0.0 0.0 0.0 0.0 34.1 0.1 0.0 8.3 0.1 0.6 0.0 0.2 0.0 0.0 0.0 31.9 0.0 0.0 48.9 0.0 2.3 0.9 1.2 0.2 0.1 0.0 0.1 0.6 0.0 0.9 0.0 0.0 0.0 0.6 2.7 1.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 9.8 0.2 0.0 0.0 16.7 1.0 3.3 0.1 0.0 0.0 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.2 4.0 2.0 2.7 2.7 3.6 5.2 1.4 5.4 4.0 0.0 0.3 0.0 0.2 3.7 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.2 43.4 0.0 0.0 0.0 2.6 0.0 0.0 4.3 0.0 0.2 35.1 0.0 1.7 0.0 0.0 6.5 0.0 0.0 55.2 0.0 0.1 19.4 8.6 0.7 0.1 2.3 0.7 0.0 0.0 0.0 PCDH19 "EFMR, EIEE9, KIAA1313" ENSG00000165194 "Protocadherin 19" Q8TAB3 X 100291644-100410273 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 27.1" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 7.1;Cholangiocytes: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027533 Approved Approved Cytosol NA NA Cytosol "HPA027533: AB_10602043" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (5.04e-2)" "unprognostic (2.13e-1)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (4.77e-2)" "unprognostic (3.64e-2)" "unprognostic (1.36e-2)" "unprognostic (2.53e-1)" "unprognostic (2.79e-1)" "unprognostic (9.77e-3)" "unprognostic (2.82e-3)" "unprognostic (1.53e-1)" "unprognostic (1.80e-4)" "unprognostic (1.37e-1)" 4.9 1.1 19.8 1.3 10.5 0.7 3.7 1.0 22.5 5.5 4.0 1.9 0.0 1.2 3.8 1.3 2.9 2.2 2.0 1.6 27.1 12.8 1.4 0.9 1.0 1.3 3.7 14.2 3.6 1.1 1.2 2.1 1.0 7.3 1.4 5.5 6.4 2.1 1.6 2.4 3.3 1.8 3.1 3.7 0.8 2.0 2.3 1.0 0.0 1.1 0.7 0.9 2.3 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.1 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 3.5 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 10.5 1.0 22.5 27.1 12.8 3.7 14.2 7.3 1.0 0.0 0.3 0.0 0.0 2.7 7.1 1.4 7.6 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.7 2.8 0.0 0.0 0.0 0.1 1.8 0.4 0.0 0.0 0.1 0.0 1.7 1.3 0.0 1.9 3.1 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.4 0.0 1.6 0.0 0.5 0.0 0.7 1.4 0.0 0.0 0.0 0.0 PCDH20 "FLJ22218, PCDH13" ENSG00000280165 "Protocadherin 20" Q8N6Y1 13 61409685-61415522 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;smooth muscle: 12.7" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 3.0;Ciliated cells: 1.4;Melanocytes: 1.7;Mucus-secreting cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "RPTEC TERT1: 34.6" HPA062669 Approved "Vesicles,Cytokinetic bridge" NA NA Vesicles "Cytokinetic bridge" "HPA062669: AB_2732687" "unprognostic (2.40e-1)" "unprognostic (1.80e-1)" "unprognostic (2.45e-1)" "unprognostic (7.83e-2)" "unprognostic (6.79e-4)" "unprognostic (2.32e-2)" "unprognostic (1.56e-1)" "unprognostic (5.34e-4)" "unprognostic (6.96e-2)" "unprognostic (1.67e-1)" "unprognostic (3.12e-1)" 0.3 1.6 6.7 0.4 5.8 0.0 1.3 0.0 13.1 3.5 4.5 0.0 0.2 1.2 4.3 4.3 1.8 0.2 0.9 4.8 13.4 1.2 1.8 4.7 0.0 8.8 3.8 0.3 0.1 0.0 0.7 1.3 6.9 1.5 2.5 0.0 0.7 1.5 0.1 0.5 1.4 12.7 8.4 1.6 1.5 0.4 6.3 0.0 0.3 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 34.6 0.0 0.5 1.3 0.0 2.4 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.1 PCDH7 "BH-Pcdh, PPP1R120" ENSG00000169851 "Protocadherin 7" O60245 4 30720415-31146805 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 66.6;Basal keratinocytes: 75.6;Cardiomyocytes: 73.6;Collecting duct cells: 61.1;Urothelial cells: 51.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 16.7;RH-30: 47.0;RT4: 24.8" "Low region specificity" "Detected in all" "HPA011866, HPA046521" Uncertain Enhanced "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA011866: AB_1855047, HPA046521: AB_2679682" "unprognostic (1.87e-1)" "unprognostic (8.88e-2)" "unprognostic (4.48e-2)" "unprognostic (3.32e-1)" "unprognostic (1.38e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-2)" "prognostic unfavorable (6.46e-5)" "unprognostic (1.96e-1)" "unprognostic (8.39e-2)" "unprognostic (1.02e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-4)" "prognostic unfavorable (6.42e-4)" "unprognostic (1.55e-1)" "unprognostic (7.65e-2)" "unprognostic (1.56e-2)" 2.0 3.2 11.9 4.9 11.5 0.4 3.0 1.2 25.3 23.2 18.4 1.7 34.3 3.1 15.3 22.9 13.0 8.9 7.4 16.7 13.4 11.9 2.2 1.2 2.8 1.4 8.0 11.0 4.5 1.1 0.5 0.8 0.5 11.7 9.9 7.3 6.2 1.6 32.2 0.9 10.1 5.3 23.7 5.3 15.3 14.2 1.2 4.4 0.0 3.9 1.3 1.4 20.1 7.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 5.6 7.8 11.7 11.5 0.0 1.4 0.0 0.7 0.3 0.7 10.2 0.0 0.0 0.0 0.0 5.8 0.5 14.7 1.3 0.0 16.7 0.0 10.6 0.0 12.1 0.2 0.0 6.8 3.4 0.3 4.2 6.9 2.8 0.0 0.0 0.0 3.4 0.0 0.0 0.0 3.4 3.5 1.5 0.0 47.0 0.0 0.3 24.8 0.3 0.1 0.1 0.4 0.5 3.3 0.7 2.6 0.0 9.5 2.4 2.6 0.0 0.0 0.0 0.0 7.4 0.0 6.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 11.5 1.2 24.9 13.4 11.9 8.0 11.0 11.7 4.4 0.0 0.0 0.0 66.6 75.6 29.7 73.6 0.0 13.4 3.4 61.1 0.0 0.1 0.0 0.1 12.1 4.8 0.0 0.0 0.6 0.1 7.7 12.5 1.1 0.0 0.3 9.5 0.0 12.9 0.6 7.9 0.3 0.8 20.3 0.0 0.0 1.3 15.4 0.0 26.9 0.0 2.9 0.0 12.2 1.1 2.4 33.8 0.1 0.0 0.0 51.1 PCDH8 "ARCADLIN, PAPC" ENSG00000136099 "Protocadherin 8" O95206 13 52842889-52848641 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 20.6" "Cell type enriched" "Detected in some" 7 "Muller glia cells: 31.8" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AF22: 23.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010509 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA010509: AB_10601384" "unprognostic (3.50e-3)" "unprognostic (6.48e-2)" "unprognostic (1.40e-1)" "unprognostic (9.11e-4)" "unprognostic (2.12e-2)" "unprognostic (1.97e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-1)" "unprognostic (3.59e-1)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" 0.8 0.9 11.5 1.1 18.6 0.8 0.8 0.4 20.6 0.9 1.0 1.1 0.0 0.9 1.0 0.8 0.8 0.8 0.8 0.8 18.2 4.8 0.8 0.8 0.9 0.8 3.6 8.4 0.8 0.8 0.8 1.4 0.8 0.8 1.7 0.9 0.8 0.8 0.8 1.4 0.8 1.1 0.9 0.9 0.8 1.2 2.3 2.5 0.0 1.4 0.0 0.8 0.9 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 18.6 0.4 20.6 18.2 4.8 3.6 8.4 0.8 2.5 0.0 0.0 0.0 2.5 0.1 4.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.4 0.0 0.9 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 1.3 PCDH9 ENSG00000184226 "Protocadherin 9" Q9HC56 13 66302834-67230445 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 16.5;brain: 47.0" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 324.5;Cardiomyocytes: 94.6;Horizontal cells: 187.5;Muller glia cells: 87.9" "Cancer enriched" "Detected in single" 8 "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive B-cell: 16.5" "Lineage enriched" "Detected in many" 7 "B-cells: 16.5" "Cell line enhanced" "Detected in many" "AF22: 12.6;LHCN-M2: 20.8;TIME: 24.1;U-698: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015581 Approved Nucleoplasm,Centrosome NA NA 1300000 "Nucleoplasm, Centrosome" "HPA015581: AB_1855048" "unprognostic (1.77e-1)" "unprognostic (8.36e-2)" "unprognostic (9.12e-3)" "unprognostic (4.42e-5)" "unprognostic (7.54e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-1)" "unprognostic (1.38e-1)" "unprognostic (2.35e-1)" "unprognostic (8.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.14e-1)" "unprognostic (8.47e-4)" "unprognostic (6.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.35e-4)" 4.5 3.2 18.4 1.1 24.7 4.1 1.5 6.7 47.0 1.8 1.3 7.8 0.0 0.9 1.0 2.1 1.0 1.1 2.4 5.7 15.0 10.0 3.5 2.3 2.3 1.4 21.4 11.0 1.4 2.0 0.7 1.3 0.7 16.6 2.5 1.3 0.0 1.0 5.6 2.0 0.9 1.0 1.2 11.0 1.6 1.7 1.6 18.9 0.7 1.8 0.0 1.4 1.1 0.6 16.5 1.0 2.5 0.0 0.7 0.1 0.2 0.0 9.5 12.6 0.0 3.4 2.6 0.0 1.9 0.1 1.3 0.5 0.0 0.0 2.7 0.0 1.4 0.4 0.0 1.0 0.3 0.6 0.0 5.0 0.1 0.1 0.0 3.3 0.3 0.1 6.3 0.3 1.5 2.5 0.3 1.0 1.1 0.3 0.1 20.8 0.7 5.7 0.0 0.1 0.2 1.2 8.7 0.4 0.0 0.2 0.0 1.6 0.6 0.0 0.1 0.1 0.3 0.0 0.0 24.1 0.7 0.6 2.9 1.0 3.7 0.0 31.7 5.4 0.0 2.5 2.5 0.0 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 16.5 0.1 0.1 0.1 0.7 0.0 1.0 0.0 0.2 18.4 24.7 6.7 24.6 15.0 10.0 21.4 11.0 16.6 18.9 17.9 45.8 7.2 2.3 1.6 324.5 94.6 0.0 0.0 7.9 5.2 19.6 0.1 8.3 1.7 3.0 2.9 0.0 0.0 0.0 0.2 8.7 2.6 1.1 3.4 0.2 187.5 60.1 19.0 2.2 2.2 27.3 1.0 10.1 0.0 0.2 87.9 0.2 0.3 13.8 0.6 25.3 6.5 25.0 4.7 5.8 0.3 0.0 1.7 0.4 0.7 PCDHA1 ENSG00000204970 "Protocadherin alpha 1" Q9Y5I3 5 140786136-141012347 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.1;testis: 3.1" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ito cells: 1.3;Sertoli cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "T-47d: 14.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035969 Enhanced Approved "Plasma membrane" "Secreted - unknown location" NA NA "Plasma membrane" "HPA035969: AB_10673492" "unprognostic (2.76e-5)" "unprognostic (1.19e-1)" "unprognostic (3.74e-2)" "unprognostic (1.09e-4)" "unprognostic (7.38e-2)" "unprognostic (2.86e-2)" "unprognostic (2.26e-3)" "unprognostic (1.25e-2)" "unprognostic (1.91e-2)" "unprognostic (1.81e-1)" "unprognostic (9.01e-5)" "unprognostic (2.46e-2)" "unprognostic (1.91e-1)" "unprognostic (7.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.77e-3)" "unprognostic (1.29e-1)" 0.2 1.5 4.6 0.2 4.4 0.1 0.2 3.3 7.1 0.2 0.3 0.7 0.5 0.1 0.2 0.2 0.4 0.1 5.0 3.7 0.6 0.1 0.2 0.3 3.4 0.2 0.2 1.0 1.4 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.6 0.2 3.4 0.2 0.3 3.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.4 1.0 0.0 0.2 1.8 0.3 14.4 0.5 0.0 1.6 1.0 0.7 0.1 0.0 0.1 0.0 0.4 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA10 "CNR8, CNRN8, CNRS8, CRNR8, PCDH-ALPHA10" ENSG00000250120 "Protocadherin alpha 10" Q9Y5I2 5 140855883-141012344 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 7.0;Cone photoreceptor cells: 7.9;Horizontal cells: 7.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "EFO-21: 20.2" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (4.24e-2)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (4.70e-2)" "unprognostic (4.19e-1)" "unprognostic (2.36e-1)" "unprognostic (6.46e-2)" "unprognostic (8.24e-2)" "unprognostic (8.10e-2)" "unprognostic (5.28e-2)" "unprognostic (2.65e-1)" "unprognostic (6.14e-3)" "unprognostic (1.93e-2)" "unprognostic (3.57e-3)" "unprognostic (5.21e-2)" "unprognostic (3.03e-1)" "unprognostic (1.10e-1)" 2.1 1.7 6.1 1.1 6.6 0.6 2.4 8.0 20.3 3.0 0.9 4.9 0.9 1.1 4.5 6.3 0.5 2.7 3.1 0.8 7.1 2.7 4.3 0.6 2.1 0.7 7.2 3.6 2.8 7.8 0.8 11.2 0.5 6.1 1.6 0.9 1.9 3.2 1.0 0.5 0.7 1.8 4.0 6.9 0.7 1.1 1.9 8.2 0.0 5.0 0.0 0.5 0.7 0.7 0.6 0.4 1.5 0.3 0.6 0.3 0.0 0.0 0.2 0.4 2.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.3 1.6 0.8 0.0 0.1 0.0 4.1 0.3 0.0 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.1 0.3 0.3 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.6 0.2 0.3 1.5 0.6 0.2 0.4 0.1 0.0 6.1 6.6 8.0 6.9 7.1 2.7 7.2 3.6 6.1 8.2 0.0 1.0 0.0 0.3 0.0 7.0 0.5 2.5 0.0 0.0 0.0 7.9 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 7.9 1.7 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 1.7 0.0 0.0 0.4 2.6 0.0 0.3 1.0 0.2 0.0 0.0 0.0 0.0 0.2 PCDHA11 "CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11" ENSG00000249158 "Protocadherin alpha 11" Q9Y5I1 5 140868183-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.3;parathyroid gland: 4.7" "Cell type enhanced" "Detected in single" 20 "Bipolar cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 16.8;EFO-21: 8.8;MCF7: 4.5;T-47d: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077160 Approved "Vesicles,Cell Junctions,Cytoplasmic bodies" NA NA "Vesicles, Cell Junctions" "Cytoplasmic bodies" "HPA077160: AB_2686827" "unprognostic (1.54e-2)" "unprognostic (1.83e-3)" "unprognostic (2.75e-1)" "unprognostic (2.59e-1)" "unprognostic (6.98e-3)" "unprognostic (1.36e-1)" "unprognostic (9.28e-3)" "unprognostic (2.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (3.13e-4)" "unprognostic (9.91e-5)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (3.26e-2)" 0.1 0.6 1.0 0.1 1.6 0.0 0.2 7.0 9.3 1.3 0.0 0.0 0.6 0.1 0.0 0.2 1.0 0.0 0.8 1.0 1.2 0.0 0.8 0.0 0.3 0.0 3.3 4.7 1.6 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.0 16.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 8.8 0.0 0.9 0.0 0.2 1.1 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.5 0.4 0.0 1.0 0.0 0.1 0.0 4.5 0.0 0.0 3.7 0.8 3.2 0.0 0.0 0.0 0.4 1.9 0.8 2.2 0.0 1.8 0.4 2.4 6.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA12 PCDH-ALPHA12 ENSG00000251664 "Protocadherin alpha 12" Q9UN75 5 140875302-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 26.8;Bipolar cells: 11.2;Cone photoreceptor cells: 5.9" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 14.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.2;AN3-CA: 4.1;hTCEpi: 6.4;PC-3: 7.8;RT4: 7.7;SH-SY5Y: 4.4" HPA035812 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA035812: AB_2674796" "unprognostic (3.95e-2)" "unprognostic (7.74e-2)" "unprognostic (7.55e-2)" "unprognostic (3.87e-2)" "unprognostic (2.74e-2)" "unprognostic (2.24e-2)" "unprognostic (2.08e-2)" "unprognostic (4.29e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-4)" "unprognostic (3.18e-4)" "unprognostic (1.11e-1)" "unprognostic (3.21e-3)" "unprognostic (6.97e-2)" 1.0 1.7 0.9 0.3 1.2 0.0 0.9 14.6 3.7 3.5 0.4 1.1 0.0 0.1 1.0 0.5 0.2 1.9 4.3 0.3 1.0 0.7 3.8 1.7 5.7 0.2 0.5 0.8 0.3 2.4 0.9 4.6 0.0 2.3 0.4 0.1 1.5 5.7 0.3 0.1 0.2 0.2 0.6 0.8 0.2 0.3 2.1 0.2 0.0 3.4 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 2.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 2.4 2.6 7.8 0.0 0.0 0.0 0.3 7.7 0.3 4.4 0.0 0.9 0.1 0.5 1.6 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.2 14.6 3.7 1.0 0.7 0.5 0.8 2.3 0.2 26.8 3.2 0.0 0.0 0.0 11.2 0.4 5.1 0.0 0.0 1.8 5.9 0.0 0.0 0.9 1.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.3 0.0 0.4 0.2 2.9 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 PCDHA13 "CNR5, CNRN5, CNRS5, CRNR5, PCDH-ALPHA13" ENSG00000239389 "Protocadherin alpha 13" Q9Y5I0 5 140882208-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 5.6;parathyroid gland: 12.2" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Bipolar cells: 2.5;Club cells: 1.2;Horizontal cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AN3-CA: 2.7;PC-3: 9.0;WM-115: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.07e-1)" "unprognostic (5.25e-2)" "unprognostic (5.58e-2)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (1.01e-2)" "unprognostic (1.14e-1)" "unprognostic (8.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.48e-2)" "unprognostic (2.64e-3)" "unprognostic (5.53e-2)" "unprognostic (1.36e-1)" 1.0 0.9 2.1 0.6 2.3 0.2 0.6 5.6 5.3 1.0 0.2 2.3 0.0 0.3 0.8 1.2 0.2 0.5 2.4 0.3 1.7 1.6 0.7 1.2 0.8 0.6 1.1 3.8 0.2 1.9 12.2 1.2 0.2 1.0 0.6 0.2 2.7 1.0 0.2 0.3 0.2 0.2 0.5 1.1 0.3 0.3 1.6 1.0 0.0 1.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 9.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 0.8 1.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.3 5.6 5.3 1.7 1.6 1.1 3.8 1.0 1.0 3.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 PCDHA2 ENSG00000204969 "Protocadherin alpha 2" Q9Y5H9 5 140794852-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.7;SH-SY5Y: 2.8;T-47d: 2.7;WM-115: 2.3" HPA035653 Uncertain NA NA "HPA035653: AB_10670969" "unprognostic (3.54e-2)" "unprognostic (5.87e-2)" "unprognostic (3.27e-2)" "unprognostic (8.39e-3)" "unprognostic (4.61e-2)" "unprognostic (4.16e-3)" "unprognostic (1.23e-1)" "unprognostic (4.30e-2)" "unprognostic (3.35e-3)" "unprognostic (5.64e-6)" "unprognostic (2.17e-2)" "unprognostic (7.20e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-3)" "unprognostic (3.42e-1)" 1.1 1.4 3.7 0.3 4.4 0.2 1.7 7.3 4.5 1.1 0.5 1.2 0.0 0.8 3.5 0.2 0.2 1.1 1.6 0.8 3.8 1.6 1.5 0.2 0.9 0.5 2.8 4.9 1.9 1.7 0.5 4.1 0.2 3.1 1.2 0.3 0.1 0.8 0.2 0.6 0.7 0.9 1.0 1.3 0.6 1.0 2.5 3.8 0.0 0.6 0.0 0.2 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 9.7 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.5 2.8 0.0 0.6 0.4 0.8 2.7 0.0 0.2 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 4.4 7.3 4.5 3.8 1.6 2.8 4.9 3.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA3 PCDH-ALPHA3 ENSG00000255408 "Protocadherin alpha 3" Q9Y5H8 5 140801028-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.3;pituitary gland: 9.9" "Cell type enhanced" "Detected in single" 21 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.8;AF22: 2.4;SH-SY5Y: 2.4;T-47d: 14.4;WM-115: 3.6" NA NA "unprognostic (5.21e-2)" "unprognostic (2.77e-2)" "unprognostic (7.20e-3)" "unprognostic (2.69e-1)" "unprognostic (1.62e-1)" "unprognostic (7.83e-2)" "unprognostic (2.72e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-2)" "unprognostic (7.10e-2)" "unprognostic (5.68e-3)" "unprognostic (3.09e-3)" "unprognostic (1.72e-2)" "unprognostic (7.25e-3)" "unprognostic (8.41e-2)" "unprognostic (5.66e-3)" "unprognostic (2.67e-2)" 2.0 3.8 3.1 0.7 5.0 0.2 2.2 10.3 5.8 2.6 1.4 2.6 0.3 1.0 5.9 1.4 0.9 2.3 2.6 0.9 2.8 3.1 3.4 0.6 2.6 0.9 3.7 2.5 4.9 4.8 0.6 9.9 0.4 3.7 2.2 1.0 1.3 1.0 1.8 0.6 0.6 1.4 2.1 6.4 0.9 1.1 2.9 4.8 0.0 2.6 0.4 0.4 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.1 2.4 0.0 0.3 1.0 0.6 14.4 0.0 0.5 0.1 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.0 10.3 5.6 2.8 3.1 3.7 2.5 3.7 4.8 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 PCDHA4 "CNR1, CNRN1, CRNR1, PCDH-ALPHA4" ENSG00000204967 "Protocadherin alpha 4" Q9UN74 5 140806929-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Ciliated cells: 5.3;granulocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 9.1;AF22: 8.9;EFO-21: 7.7;T-47d: 7.7" "Low region specificity" "Detected in all" "HPA043180, HPA073478" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA043180: AB_10806381, HPA073478: AB_2686608" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (2.85e-1)" "unprognostic (5.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.14e-2)" "unprognostic (2.56e-1)" "unprognostic (7.90e-3)" "unprognostic (7.14e-3)" "unprognostic (7.00e-2)" "unprognostic (5.06e-3)" "unprognostic (6.94e-5)" "unprognostic (5.01e-3)" "unprognostic (6.21e-2)" "unprognostic (3.98e-1)" "unprognostic (6.29e-3)" "unprognostic (4.79e-2)" 0.9 0.8 5.1 0.9 6.5 3.2 1.7 12.1 8.7 2.1 1.1 1.6 0.4 0.9 2.3 2.0 0.6 1.6 5.1 1.2 4.5 3.2 2.0 0.6 1.7 1.5 1.9 2.1 1.1 4.1 1.0 1.4 0.7 3.9 1.8 1.1 0.4 1.1 1.3 1.1 2.0 0.9 1.1 3.0 1.1 1.0 1.4 2.4 0.0 1.3 0.1 0.7 1.3 0.8 1.5 1.3 2.0 0.7 0.8 1.1 0.0 0.2 9.1 8.9 0.4 0.1 0.3 0.3 0.2 0.1 0.1 0.1 0.2 1.8 0.3 7.7 0.2 0.4 0.3 0.0 0.1 0.2 0.2 0.2 0.4 0.6 0.3 0.1 0.3 0.5 0.4 2.4 0.2 0.4 0.6 0.5 0.4 0.2 1.2 0.3 0.2 0.2 0.3 2.5 1.9 1.3 0.2 0.2 0.3 0.3 0.4 0.4 3.8 0.1 2.0 0.8 1.6 7.7 0.3 0.9 2.0 1.3 0.7 0.2 0.5 0.2 0.2 0.3 0.4 0.8 1.8 0.7 0.7 1.1 0.4 0.8 0.8 0.8 0.7 0.3 1.5 0.8 1.1 2.0 0.8 0.7 1.3 0.6 0.0 5.1 6.5 12.1 6.6 4.5 3.2 1.9 2.1 3.9 2.4 3.0 1.3 0.0 0.5 0.0 0.9 0.8 0.0 5.3 1.2 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.7 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.3 PCDHA5 "CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5" ENSG00000204965 "Protocadherin alpha 5" Q9Y5H7 5 140821604-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 13.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 2.2;Horizontal cells: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.6;EFO-21: 7.5;T-47d: 7.7;WM-115: 2.8" "Low region specificity" "Detected in many" HPA044557 Approved Approved "Nuclear speckles,Plasma membrane,Mitochondria" NA NA "Plasma membrane" "Nuclear speckles, Mitochondria" "HPA044557: AB_10970597" "unprognostic (4.95e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-1)" "unprognostic (8.81e-4)" "unprognostic (5.10e-2)" "unprognostic (6.25e-3)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (2.46e-2)" "unprognostic (4.49e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-4)" "unprognostic (9.30e-4)" "unprognostic (1.07e-1)" "unprognostic (1.39e-1)" "unprognostic (8.17e-5)" "unprognostic (2.11e-1)" 0.9 1.2 3.4 0.5 3.6 0.6 0.6 13.6 10.2 0.6 0.6 0.4 0.0 0.5 1.2 0.5 0.4 0.5 1.1 0.3 1.6 2.0 1.1 0.4 0.7 0.4 1.3 5.1 0.6 1.2 0.4 2.5 0.4 2.3 0.6 0.5 0.0 0.4 0.4 0.4 0.5 0.5 0.7 1.1 0.4 0.7 0.9 0.1 0.0 0.5 0.0 0.3 0.5 0.2 0.6 0.6 1.6 0.5 0.3 0.3 0.2 0.0 2.6 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.1 7.7 0.1 0.1 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.5 0.5 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.6 0.3 0.3 1.6 0.3 0.4 0.6 0.2 0.2 3.4 3.6 13.6 7.2 1.6 2.0 1.3 5.1 2.3 0.1 0.0 2.2 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA6 "CNR2, CNRS2, CRNR2, PCDH-ALPHA6" ENSG00000081842 "Protocadherin alpha 6" Q9UN73 5 140827958-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.7;pituitary gland: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.0;EFO-21: 12.6;hTERT-RPE1: 3.3;U-2 OS: 5.2;WM-115: 7.5" "HPA059326, HPA078110" Enhanced Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA059326: AB_2683980, HPA078110: AB_2732371" "unprognostic (1.15e-1)" "unprognostic (7.00e-2)" "unprognostic (5.07e-1)" "unprognostic (2.79e-1)" "unprognostic (4.39e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-4)" "unprognostic (4.23e-3)" "unprognostic (8.38e-2)" "unprognostic (2.55e-1)" "unprognostic (1.23e-3)" "unprognostic (3.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.66e-3)" "unprognostic (2.56e-1)" "unprognostic (5.66e-3)" "unprognostic (3.55e-2)" 1.1 1.8 2.9 0.8 7.1 0.4 1.6 10.2 10.7 1.9 0.7 2.3 0.0 1.2 2.9 2.3 0.4 1.6 1.6 0.5 3.8 3.8 2.3 0.4 1.1 0.7 4.6 4.1 2.1 3.7 4.7 11.2 0.4 3.6 1.3 0.7 1.6 0.7 0.5 0.4 0.6 1.3 1.4 3.4 0.8 0.7 1.4 3.2 0.0 0.9 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 2.1 1.3 0.2 0.6 0.0 2.0 0.0 5.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.1 10.2 9.6 3.8 3.8 4.6 4.1 3.6 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA7 "CNR4, CNRS4, CRNR4" ENSG00000204963 "Protocadherin alpha 7" Q9UN72 5 140834248-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 10.1;testis: 2.9" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 1.4;Horizontal cells: 1.6;Spermatocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 2.0;NTERA-2: 3.2;SCLC-21H: 2.0;SK-BR-3: 2.8;SK-MEL-30: 3.6;U-2 OS: 2.4;WM-115: 3.5" NA NA "unprognostic (1.99e-1)" "unprognostic (8.54e-2)" "unprognostic (2.67e-1)" "unprognostic (5.28e-2)" "unprognostic (3.05e-1)" "unprognostic (7.08e-2)" "unprognostic (9.29e-3)" "unprognostic (4.11e-3)" "unprognostic (7.20e-2)" "unprognostic (3.18e-3)" "unprognostic (3.12e-4)" "unprognostic (9.54e-4)" "unprognostic (6.86e-5)" "unprognostic (5.34e-4)" "unprognostic (2.88e-1)" "unprognostic (3.72e-1)" "unprognostic (1.14e-1)" 0.9 1.1 0.9 0.6 2.3 0.2 1.0 10.1 6.8 0.6 0.8 3.2 0.0 1.2 1.3 0.9 0.2 0.6 1.5 0.6 1.8 1.1 0.8 0.3 1.0 0.5 2.2 1.8 1.4 1.1 0.7 1.4 0.4 4.3 0.6 0.6 0.3 1.1 0.4 0.2 0.5 1.0 1.3 3.7 0.3 0.9 2.9 0.4 0.0 0.7 0.0 0.3 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.9 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.3 0.6 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 3.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 2.8 3.6 1.4 0.9 0.0 0.5 0.5 2.4 0.6 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.3 10.1 6.8 1.8 1.1 2.2 1.8 4.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 PCDHA8 ENSG00000204962 "Protocadherin alpha 8" Q9Y5H6 5 140841187-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 18.3;SCLC-21H: 5.1" HPA044585 Uncertain NA NA "HPA044585: AB_10793953" "unprognostic (1.11e-2)" "unprognostic (1.15e-2)" "unprognostic (1.35e-1)" "unprognostic (1.95e-1)" "unprognostic (4.20e-2)" "unprognostic (9.67e-2)" "unprognostic (8.58e-3)" "unprognostic (7.87e-4)" "unprognostic (5.62e-3)" "unprognostic (2.22e-2)" "unprognostic (5.48e-1)" "unprognostic (1.20e-2)" 0.2 1.6 1.0 0.2 2.3 0.2 0.2 6.2 4.7 0.4 0.4 1.4 0.0 0.3 0.8 0.2 0.3 0.3 0.4 0.2 1.2 1.2 0.5 0.3 0.4 0.3 1.0 3.6 0.7 0.9 0.2 1.8 0.3 2.8 0.3 0.5 0.7 0.5 0.2 0.2 0.2 0.4 0.7 1.1 0.2 0.2 1.7 1.3 0.0 0.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 18.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.1 2.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.3 6.2 4.7 1.2 1.2 1.0 3.6 2.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA9 "KIAA0345, PCDH-ALPHA9" ENSG00000204961 "Protocadherin alpha 9" Q9Y5H5 5 140847463-141012344 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 1.8;brain: 3.1;pancreas: 3.4;testis: 3.5" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 2.7;Early spermatids: 1.3;Horizontal cells: 1.6;Spermatocytes: 1.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 11.6" NA NA "unprognostic (1.53e-3)" "unprognostic (1.13e-1)" "unprognostic (7.54e-4)" "unprognostic (1.28e-2)" "unprognostic (4.65e-2)" "unprognostic (1.48e-1)" "unprognostic (5.20e-3)" "unprognostic (6.49e-3)" "unprognostic (1.31e-4)" "unprognostic (1.82e-1)" "unprognostic (8.79e-2)" "unprognostic (6.77e-2)" "unprognostic (1.19e-1)" 0.2 0.4 0.4 0.1 0.5 0.6 0.0 3.1 1.8 0.4 0.0 0.0 0.3 0.4 0.0 0.1 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.3 0.2 3.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.9 0.1 0.0 3.5 0.2 0.0 0.0 0.0 0.9 0.5 1.8 0.4 0.7 0.5 0.2 0.0 0.1 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 11.6 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.3 0.4 0.4 0.5 0.3 0.4 0.4 0.3 0.4 0.2 0.9 0.4 0.5 1.8 0.7 0.4 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926369-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "parathyroid gland: 33.3" "Cell type enhanced" "Detected in some" 27 "Alveolar cells type 1: 6.0;Bipolar cells: 1.7;Ciliated cells: 1.4;Rod photoreceptor cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.7;EFO-21: 3.7;hTCEpi: 11.3;PC-3: 6.4;SCLC-21H: 5.0" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles No No "Nucleoplasm, Nucleoli" Vesicles "HPA052775: AB_2681942" "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.3 0.4 0.9 0.3 1.0 0.0 0.0 2.0 2.8 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.0 1.0 1.6 0.2 0.1 0.8 1.0 1.1 0.0 1.5 33.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.8 0.4 0.0 0.0 0.2 0.1 0.5 0.2 0.2 0.1 0.0 0.0 8.7 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 1.1 0.0 0.3 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 11.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 6.4 0.0 0.0 0.0 0.5 0.4 5.0 2.4 0.0 0.7 0.0 1.2 0.5 0.0 0.0 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.2 0.1 0.0 0.0 6.0 0.3 0.0 0.0 0.0 1.7 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PCDHAC2 PCDH-ALPHA-C2 ENSG00000243232 "Protocadherin alpha subfamily C, 2" Q9Y5I4 5 140966235-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 14.1;parathyroid gland: 52.5" "Cell type enhanced" "Detected in some" 17 "Ciliated cells: 2.7;Ito cells: 2.5;Rod photoreceptor cells: 1.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AN3-CA: 36.9" HPA076190 Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA076190: AB_2686785" "unprognostic (1.47e-1)" "unprognostic (3.58e-3)" "unprognostic (2.59e-1)" "unprognostic (5.31e-4)" "unprognostic (3.89e-1)" "unprognostic (1.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-1)" "unprognostic (2.13e-2)" "unprognostic (2.45e-1)" "unprognostic (1.41e-1)" "unprognostic (2.30e-1)" "unprognostic (4.46e-4)" "unprognostic (9.90e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-3)" 1.1 1.7 5.7 1.0 9.2 0.5 0.7 13.6 14.1 1.5 0.9 2.3 0.0 0.7 1.2 0.6 0.6 0.8 3.2 1.2 4.5 5.2 0.9 1.3 2.5 2.2 2.9 6.4 0.7 0.9 52.5 3.1 2.2 3.8 0.9 0.9 2.7 1.1 0.7 0.6 0.6 0.7 1.4 2.0 2.1 1.0 2.4 1.7 0.0 1.6 0.0 1.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.7 36.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 1.5 0.0 0.7 4.0 0.0 0.0 0.1 0.0 8.4 0.0 0.5 0.0 0.0 0.1 5.5 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 1.3 0.0 0.0 0.0 1.3 0.0 1.6 6.6 0.0 0.0 0.1 0.8 1.4 0.2 0.0 0.7 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.2 13.6 14.1 4.5 5.2 2.9 6.4 3.8 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 PCDHB1 PCDH-BETA1 ENSG00000171815 "Protocadherin beta 1" Q9Y5F3 5 141051135-141059344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.9" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 1.4;Basal glandular cells: 1.1;Cardiomyocytes: 2.2;Ciliated cells: 4.0;Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053921 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA053921: AB_2682310" "unprognostic (5.54e-2)" "unprognostic (1.60e-2)" "unprognostic (9.01e-4)" "unprognostic (8.65e-2)" "unprognostic (8.00e-2)" "unprognostic (7.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (8.17e-5)" "unprognostic (3.38e-2)" "unprognostic (9.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.77e-4)" 0.1 0.3 0.3 0.1 0.5 1.0 0.1 0.1 0.2 0.5 0.5 0.4 0.1 0.6 0.1 1.8 0.0 0.1 0.4 0.4 0.7 0.1 0.2 0.4 0.2 0.1 1.1 0.7 1.9 0.0 0.1 0.0 0.5 0.0 4.9 0.8 0.5 0.0 0.3 0.3 0.8 1.8 0.3 0.0 0.1 0.1 1.3 0.7 2.5 0.6 1.0 0.6 0.2 0.8 0.4 0.8 1.1 0.2 0.2 1.1 1.1 0.2 0.1 0.1 1.6 1.4 1.1 1.6 0.3 1.1 1.5 0.0 0.1 0.2 0.9 1.2 1.2 1.9 0.7 0.1 1.4 1.2 0.2 0.3 0.2 0.2 1.7 0.2 1.0 0.8 2.6 0.2 1.4 0.7 0.9 1.2 1.2 0.4 1.2 1.0 0.9 0.1 1.0 2.2 0.8 0.1 1.8 1.3 1.2 0.6 0.5 1.2 1.0 0.7 0.8 0.6 1.5 0.6 1.0 1.1 1.1 1.2 2.3 0.6 0.7 0.5 0.4 0.5 0.7 0.5 0.4 0.2 1.3 0.6 0.5 2.5 1.0 0.4 0.7 0.3 0.2 0.0 1.4 0.0 1.1 0.0 0.2 2.2 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 PCDHB10 ENSG00000120324 "Protocadherin beta 10" Q9UN67 5 141192353-141195642 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 8.4;granulocytes: 4.6;Intestinal endocrine cells: 4.1;Peritubular cells: 3.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 7.3;ASC TERT1: 7.1;EFO-21: 15.2;U-2197: 7.6" HPA013445 Uncertain NA NA "HPA013445: AB_1855054" "unprognostic (1.08e-1)" "unprognostic (8.41e-2)" "unprognostic (4.03e-2)" "unprognostic (1.51e-2)" "unprognostic (1.94e-1)" "unprognostic (7.30e-2)" "unprognostic (1.81e-2)" "unprognostic (2.74e-1)" "unprognostic (2.61e-2)" "unprognostic (3.96e-3)" "unprognostic (2.16e-1)" "unprognostic (3.25e-1)" "unprognostic (5.40e-3)" "unprognostic (4.56e-2)" "unprognostic (3.11e-2)" "unprognostic (1.76e-1)" "unprognostic (1.83e-3)" 4.2 5.4 5.7 1.9 15.5 0.5 3.9 5.8 14.3 5.1 4.5 5.3 0.4 1.8 8.8 5.2 2.9 3.3 4.7 3.2 5.7 5.1 2.5 1.1 4.1 1.2 4.2 5.8 6.1 1.6 6.7 8.2 2.5 7.6 5.1 2.5 2.7 2.3 4.7 1.7 1.8 2.1 8.8 6.4 2.0 2.1 1.8 4.8 0.0 1.9 0.4 1.0 6.9 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 4.0 7.3 7.1 0.3 0.4 3.9 0.1 0.3 0.0 0.3 0.2 15.2 1.1 3.1 0.1 0.8 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.8 2.7 0.0 0.0 3.8 0.3 0.0 0.0 4.6 1.4 0.1 0.1 0.1 0.1 0.0 0.2 0.8 2.6 0.0 0.5 0.0 2.8 5.8 4.6 0.2 0.6 0.5 3.1 0.3 1.5 3.9 2.3 7.6 1.1 0.0 0.0 0.0 4.8 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 15.5 5.8 12.9 5.7 5.1 4.2 5.8 7.6 4.8 0.0 0.3 0.0 0.0 0.0 8.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 1.7 0.0 0.0 0.8 0.0 1.0 0.0 4.6 0.0 0.1 0.0 4.1 0.6 0.0 0.4 1.1 0.0 0.0 0.0 0.0 1.5 0.1 0.0 3.9 0.0 0.3 0.0 1.2 1.9 0.0 0.4 0.1 0.0 0.0 0.3 PCDHB11 "ME2, PCDH-BETA11" ENSG00000197479 "Protocadherin beta 11" Q9Y5F2 5 141199582-141203779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Bipolar cells: 2.7;Peritubular cells: 3.2;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 8.2;EFO-21: 11.8;U-2 OS: 4.3" HPA045042 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045042: AB_2679194" "unprognostic (1.32e-1)" "unprognostic (3.47e-2)" "unprognostic (7.21e-2)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (1.56e-1)" "unprognostic (2.82e-2)" "unprognostic (1.42e-1)" "unprognostic (6.78e-2)" "unprognostic (1.29e-2)" "unprognostic (1.07e-1)" "unprognostic (2.89e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" "unprognostic (1.37e-2)" "unprognostic (9.79e-2)" "unprognostic (6.47e-3)" 13.6 2.4 2.8 2.0 4.1 1.1 3.4 8.8 5.0 8.6 3.1 1.4 0.0 1.4 4.9 3.4 4.1 3.1 3.1 3.0 1.4 1.8 5.0 1.3 2.9 1.0 1.5 3.7 11.0 12.0 15.8 3.6 2.2 3.0 4.5 1.7 6.8 3.3 3.6 2.0 2.9 1.8 5.1 1.6 2.2 2.9 2.6 1.3 0.0 2.8 2.3 1.1 5.5 4.2 1.2 1.0 2.8 0.9 1.4 0.8 0.1 0.0 0.2 2.5 8.2 0.1 0.3 1.8 0.2 0.8 0.0 0.0 0.0 0.2 0.0 11.8 0.7 0.7 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.2 0.3 0.3 0.0 0.0 1.0 0.1 0.1 0.1 2.0 0.4 0.2 0.0 0.2 0.3 0.0 0.4 0.0 3.2 0.0 0.1 0.3 3.4 0.5 1.8 0.2 1.1 0.4 1.9 0.0 0.5 0.2 4.3 3.3 0.1 0.1 0.1 0.1 2.2 0.2 2.1 2.2 0.9 0.8 0.8 0.5 0.5 0.6 0.6 0.5 0.3 1.2 0.5 0.7 2.8 1.4 0.4 1.0 0.4 0.1 2.8 4.1 8.8 5.0 1.4 1.8 1.5 3.7 3.0 1.3 3.0 0.3 0.0 0.7 0.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.9 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.0 0.0 1.7 0.0 0.0 1.7 1.1 0.0 3.2 0.5 0.2 6.5 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.6 PCDHB12 PCDH-BETA12 ENSG00000120328 "Protocadherin beta 12" Q9Y5F1 5 141208697-141212571 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 3.2;Intestinal endocrine cells: 1.7;Melanocytes: 3.3;Peritubular cells: 2.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.8;ASC diff: 4.7;EFO-21: 5.4;RH-30: 5.8;U-2 OS: 4.4;U-2197: 4.4" HPA045042 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045042: AB_2679194" "unprognostic (1.43e-2)" "unprognostic (3.22e-3)" "unprognostic (4.18e-3)" "unprognostic (8.43e-2)" "unprognostic (3.95e-3)" "unprognostic (7.87e-3)" "unprognostic (1.46e-1)" "unprognostic (2.95e-2)" "unprognostic (3.63e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (2.94e-2)" "unprognostic (4.37e-3)" "unprognostic (3.22e-3)" "unprognostic (4.97e-3)" "unprognostic (3.83e-2)" "unprognostic (6.41e-3)" 4.2 2.5 4.4 1.9 5.0 0.4 3.4 9.1 7.5 5.8 3.3 2.5 1.5 1.3 8.0 3.5 1.8 4.9 3.9 3.9 3.1 2.2 2.6 1.5 3.6 0.9 3.0 6.4 8.3 4.0 3.6 13.9 2.0 3.7 4.5 1.8 3.2 1.9 3.9 1.8 1.6 1.7 6.8 3.9 2.6 2.1 3.1 2.7 0.0 1.9 1.2 0.9 3.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.8 4.7 2.7 0.7 0.1 3.4 0.3 0.4 0.0 0.0 0.0 5.4 0.5 2.5 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 1.2 0.0 0.0 1.3 0.4 0.0 0.0 1.2 1.2 0.3 0.0 0.0 0.1 0.0 1.0 0.9 5.8 0.0 0.0 0.0 2.8 1.6 0.0 0.0 1.0 0.4 3.7 0.8 0.3 0.7 4.4 4.4 0.1 0.0 0.0 0.0 2.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 5.0 9.1 7.5 3.1 2.2 3.0 6.4 3.7 2.7 0.0 0.6 0.0 0.0 0.3 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.3 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.1 0.0 1.7 0.6 0.0 0.0 1.1 0.0 3.3 0.0 0.0 1.4 0.4 0.0 2.5 0.0 0.3 0.0 0.5 0.9 0.0 0.1 0.0 0.0 0.0 0.0 PCDHB13 PCDH-BETA13 ENSG00000187372 "Protocadherin beta 13" Q9Y5F0 5 141213919-141218979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 6 "Bipolar cells: 3.4;Cholangiocytes: 2.5;Exocrine glandular cells: 2.7;Horizontal cells: 3.2;Melanocytes: 3.3;Muller glia cells: 2.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 6.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.7" "Cell line enhanced" "Detected in many" "EFO-21: 7.8;T-47d: 15.1;U-2197: 12.3" NA NA "unprognostic (9.91e-3)" "unprognostic (3.34e-2)" "unprognostic (8.89e-2)" "unprognostic (2.06e-3)" "unprognostic (2.06e-1)" "unprognostic (1.29e-1)" "unprognostic (9.59e-2)" "unprognostic (3.55e-2)" "unprognostic (6.06e-2)" "unprognostic (2.61e-3)" "unprognostic (3.07e-1)" "unprognostic (1.13e-1)" "unprognostic (4.49e-2)" "unprognostic (2.80e-2)" "unprognostic (3.99e-2)" "unprognostic (8.19e-2)" "unprognostic (6.93e-3)" 2.1 2.9 1.0 0.6 1.4 0.0 2.1 1.7 2.3 3.2 1.8 0.0 3.4 2.6 1.4 2.0 3.3 2.8 1.0 1.0 1.6 0.9 1.5 0.2 0.7 3.1 4.2 1.5 3.3 2.5 2.4 1.0 2.8 2.3 0.5 3.8 0.4 2.7 1.2 1.4 1.4 1.8 1.7 0.1 1.5 1.6 1.2 0.5 6.7 0.5 0.4 0.6 0.0 0.0 0.2 1.9 1.4 5.0 5.4 0.4 0.3 2.5 0.7 1.5 0.0 2.1 0.0 7.8 1.8 2.6 0.5 1.8 0.0 0.5 0.0 0.1 0.0 1.0 0.3 0.1 0.0 0.9 0.4 1.4 0.1 0.1 2.3 0.7 0.2 0.3 1.9 2.4 0.3 0.2 0.1 0.4 0.0 0.2 5.7 0.9 0.0 0.1 0.1 1.8 0.7 2.5 0.2 0.8 0.5 15.1 0.1 2.3 0.6 1.5 12.3 0.0 0.0 0.1 0.0 3.5 0.1 3.8 1.8 0.5 1.7 0.4 0.4 0.3 0.7 0.4 0.4 0.1 1.2 0.6 0.6 6.7 0.4 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.7 3.4 1.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.5 0.0 0.0 2.7 0.0 0.6 0.1 0.0 0.4 0.1 3.2 0.0 0.6 0.0 0.0 0.9 0.0 3.3 0.0 0.0 2.6 0.8 0.0 1.1 0.8 0.3 0.0 0.5 0.5 0.2 0.6 0.0 0.0 0.0 0.3 PCDHB14 PCDH-BETA14 ENSG00000120327 "Protocadherin beta 14" Q9Y5E9 5 141222932-141227759 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 12.7;Horizontal cells: 12.7;Muller glia cells: 8.3;Peritubular cells: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 14.2;SiHa: 11.4;U-2197: 8.2" "Low region specificity" "Detected in all" "HPA007692, HPA045248" Uncertain Approved Vesicles NA NA Vesicles "HPA007692: AB_2667896, HPA045248: AB_10959599" "unprognostic (2.57e-3)" "unprognostic (1.96e-1)" "unprognostic (1.34e-1)" "unprognostic (8.97e-2)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" "unprognostic (2.11e-2)" "unprognostic (2.38e-2)" "unprognostic (6.60e-2)" "unprognostic (2.57e-2)" "unprognostic (1.13e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (6.09e-4)" "unprognostic (2.58e-1)" "unprognostic (3.12e-2)" "unprognostic (3.77e-2)" "unprognostic (3.90e-2)" 5.3 5.5 6.6 2.7 9.4 0.9 5.7 9.3 13.9 8.7 5.7 6.8 0.8 1.7 11.5 7.6 5.2 5.3 5.9 6.0 6.8 4.7 3.8 2.9 4.0 1.6 3.8 6.6 6.9 6.0 14.2 14.2 3.7 6.1 6.7 3.2 5.4 4.8 6.3 3.2 10.3 2.2 7.8 4.3 3.1 3.3 3.2 4.0 0.0 3.0 4.3 1.6 7.1 4.9 0.3 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.0 3.3 6.0 5.4 6.4 0.4 0.5 5.3 0.5 1.6 0.1 1.0 0.2 4.4 1.4 2.8 0.3 0.7 1.0 0.5 0.0 0.1 0.0 1.3 0.1 0.2 0.2 0.2 1.1 4.7 0.1 0.2 4.7 0.6 0.1 0.0 5.7 2.3 0.5 0.4 0.0 0.4 0.0 1.1 3.5 4.0 0.0 0.1 0.2 7.4 14.2 11.4 0.3 1.2 0.5 6.1 0.4 1.7 2.1 1.9 8.2 2.1 0.0 0.1 0.1 4.4 0.1 3.5 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.2 0.3 0.7 0.0 0.0 0.0 0.1 0.0 6.6 9.4 9.3 13.9 6.8 4.7 3.8 6.6 6.1 4.0 0.0 3.7 0.0 0.9 0.3 12.7 2.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 4.4 2.2 0.0 0.0 2.1 0.0 3.5 0.9 0.0 0.9 0.1 12.7 3.4 3.1 0.0 0.5 3.1 0.0 0.0 0.0 0.4 8.3 2.1 0.0 8.1 0.6 1.0 0.0 3.1 1.5 0.1 2.5 0.0 0.0 0.0 0.7 PCDHB15 PCDH-BETA15 ENSG00000113248 "Protocadherin beta 15" Q9Y5E8 5 141245349-141249365 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 4.2;Early spermatids: 5.6;Horizontal cells: 4.8;Peritubular cells: 3.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AF22: 9.3;LHCN-M2: 7.7;WM-115: 7.5" "HPA007172, CAB026471, HPA074676" Uncertain Approved Mitochondria NA NA Mitochondria "CAB026471: , HPA007172: AB_1079576, HPA074676: AB_2732263" "unprognostic (1.39e-1)" "unprognostic (1.58e-1)" "unprognostic (7.37e-3)" "unprognostic (1.75e-1)" "unprognostic (2.06e-2)" "unprognostic (6.19e-2)" "unprognostic (1.60e-1)" "unprognostic (4.12e-2)" "unprognostic (1.87e-2)" "unprognostic (7.58e-2)" "unprognostic (7.01e-2)" "unprognostic (6.00e-2)" "unprognostic (9.37e-2)" "unprognostic (1.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" 8.6 3.6 7.9 5.5 8.4 0.6 4.0 15.1 17.1 8.5 5.3 8.0 0.3 1.5 12.9 6.0 3.5 7.2 4.7 8.6 5.9 4.1 3.8 2.6 5.4 2.0 4.9 6.0 13.6 5.7 2.7 5.7 3.6 8.9 6.4 2.6 3.7 3.1 5.1 2.9 2.6 2.7 9.1 9.4 5.6 4.8 9.1 7.6 0.0 4.5 4.4 1.6 5.6 5.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.1 9.3 1.2 2.5 2.6 0.1 0.7 1.8 0.1 0.5 0.0 0.5 0.0 1.8 1.4 2.4 0.2 0.2 0.0 0.3 0.0 0.0 0.0 1.0 0.3 0.3 0.0 0.0 1.2 2.2 0.1 0.3 2.4 0.4 0.0 0.1 1.7 7.7 0.0 0.0 0.2 2.3 0.0 0.1 0.3 0.6 0.0 0.6 0.0 0.5 1.3 0.3 0.5 2.5 1.3 0.4 0.0 0.0 0.7 1.0 2.9 0.1 0.1 1.2 0.0 1.2 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 8.4 15.1 7.3 5.9 4.1 4.9 6.0 8.9 7.6 0.0 0.0 0.0 0.1 0.1 4.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.7 0.0 0.0 1.3 0.0 0.5 0.1 0.0 0.0 0.1 4.8 0.0 0.0 0.0 2.0 0.6 0.0 1.7 0.0 0.0 1.5 1.0 0.0 3.2 0.3 0.5 0.0 2.0 1.8 0.1 0.5 0.0 0.0 0.0 0.2 PCDHB16 "KIAA1621, ME1, PCDH-BETA16, PCDH3X, PCDHB8a" ENSG00000272674 "Protocadherin beta 16" Q9NRJ7 5 141181399-141186399 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 13.4;Horizontal cells: 7.9;Muller glia cells: 6.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 12.2;LHCN-M2: 6.5;T-47d: 6.8;U-138 MG: 26.9;U-2197: 7.2;U-87 MG: 6.4" HPA014668 Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA014668: AB_1855055" "unprognostic (3.44e-3)" "unprognostic (4.03e-2)" "unprognostic (8.14e-2)" "unprognostic (8.60e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-2)" "unprognostic (1.17e-1)" "unprognostic (4.03e-2)" "unprognostic (3.13e-2)" "unprognostic (7.55e-3)" "unprognostic (3.49e-2)" "unprognostic (9.57e-2)" "unprognostic (3.55e-2)" "unprognostic (7.49e-3)" "unprognostic (2.00e-2)" "unprognostic (7.92e-3)" "unprognostic (2.83e-3)" 3.7 2.6 2.1 1.4 2.7 0.2 2.5 9.7 3.1 8.4 1.1 5.3 0.0 0.4 6.4 6.2 3.3 2.8 2.5 4.5 1.8 2.5 1.0 3.2 0.5 1.7 0.4 9.8 2.6 10.9 17.5 1.5 3.4 6.2 1.1 7.1 2.2 1.1 3.6 1.5 1.1 3.5 2.5 1.1 0.5 2.3 5.0 0.0 3.1 0.0 0.3 6.5 3.3 0.9 1.0 1.4 0.6 0.9 0.8 0.1 0.0 0.0 0.6 12.2 5.5 3.9 0.3 0.5 2.8 0.0 0.2 0.1 0.2 0.0 4.5 0.6 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.0 0.1 0.1 0.0 1.1 6.5 0.3 0.0 0.0 0.9 0.0 0.1 0.0 2.3 0.0 0.3 0.1 0.4 1.7 0.2 0.4 2.1 0.3 6.8 0.0 0.3 26.9 1.3 7.2 1.3 0.0 0.0 0.0 6.4 0.0 3.4 0.7 0.5 0.4 0.6 0.5 0.3 0.6 0.5 0.6 0.3 0.9 0.8 0.6 1.4 0.9 0.6 1.0 0.5 0.1 3.0 1.0 0.0 0.0 0.7 13.4 1.2 2.5 0.0 0.0 1.8 0.0 0.0 1.7 0.7 1.0 2.7 0.0 0.0 4.1 0.0 3.8 0.1 0.0 0.0 0.1 7.9 1.7 1.3 0.3 1.1 4.4 0.0 0.0 0.0 0.0 6.3 1.7 0.0 5.3 0.6 1.1 0.0 3.5 4.1 0.0 1.3 0.0 0.0 0.0 0.0 PCDHB2 PCDH-BETA2 ENSG00000112852 "Protocadherin beta 2" Q9Y5E7 5 141094578-141098703 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 9 "Melanocytes: 3.3;Spermatocytes: 7.1;Spermatogonia: 4.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 13.7;AN3-CA: 29.4;EFO-21: 16.7;U-138 MG: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007548 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA007548: AB_2667859" "unprognostic (2.94e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-4)" "unprognostic (1.31e-1)" "unprognostic (3.03e-3)" "unprognostic (7.01e-2)" "unprognostic (5.52e-2)" "unprognostic (2.24e-1)" "unprognostic (3.99e-1)" "unprognostic (2.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (6.99e-4)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (4.84e-4)" 7.3 3.0 3.4 1.6 8.6 0.8 5.5 5.7 13.3 3.9 4.4 7.0 0.0 2.1 6.7 2.1 4.0 2.8 4.4 4.3 4.1 1.9 2.9 0.8 6.2 1.0 3.2 5.1 4.3 2.7 0.9 5.3 2.4 4.8 5.9 2.8 4.0 3.8 1.7 1.9 4.3 2.6 4.3 8.4 1.6 1.9 12.1 5.0 0.0 2.8 1.2 0.9 4.4 2.6 0.2 0.2 0.8 0.1 0.5 0.4 0.3 0.2 1.9 13.7 29.4 3.8 1.8 6.3 0.5 2.1 0.0 0.0 0.3 0.1 0.5 16.7 0.9 3.3 0.0 0.6 0.1 0.0 0.2 0.4 0.0 0.0 3.8 0.0 0.0 1.4 0.9 0.0 0.0 0.2 0.6 0.3 1.6 0.4 0.4 4.0 0.1 3.7 0.0 6.0 0.2 3.9 0.0 10.1 0.1 1.5 0.0 7.5 2.1 0.0 1.8 4.3 8.0 8.3 2.4 1.5 12.9 3.9 6.0 1.9 0.2 0.0 0.1 2.8 0.1 7.7 0.5 0.1 0.0 0.4 0.1 0.0 0.1 0.4 0.1 0.0 0.2 0.1 0.2 0.8 0.5 0.1 0.2 0.0 0.3 3.4 8.6 5.7 11.0 4.1 1.9 3.2 5.1 4.8 5.0 0.0 0.3 0.0 0.9 0.7 2.9 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.5 1.4 1.3 0.0 0.0 0.3 0.0 1.6 0.9 0.0 0.0 0.1 1.6 1.2 0.0 0.0 0.4 1.1 0.0 3.3 0.0 0.2 2.6 0.3 0.0 1.4 0.4 1.2 0.0 0.8 7.1 4.7 0.4 0.0 0.0 0.0 0.4 PCDHB3 PCDH-BETA3 ENSG00000113205 "Protocadherin beta 3" Q9Y5E6 5 141100473-141103827 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.3" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 12.4;HAP1: 3.8;SH-SY5Y: 16.5;U-138 MG: 5.8" "Low region specificity" "Detected in all" HPA050296 Uncertain Supported Vesicles NA NA Vesicles "HPA050296: AB_2681078" "unprognostic (2.72e-2)" "unprognostic (7.47e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-4)" "unprognostic (9.34e-3)" "unprognostic (3.42e-2)" "unprognostic (2.29e-2)" "unprognostic (3.17e-1)" "unprognostic (1.37e-1)" "unprognostic (3.34e-1)" "unprognostic (8.52e-3)" "unprognostic (3.45e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-3)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (5.18e-4)" 5.7 4.6 3.1 2.6 9.3 0.4 5.9 3.8 6.2 4.8 2.5 2.2 1.3 1.4 8.0 3.0 1.3 3.1 3.1 3.6 3.8 3.0 4.9 0.8 3.3 1.0 3.0 3.8 5.6 3.9 4.4 17.3 1.8 4.0 5.4 2.1 3.4 2.4 2.4 1.9 2.0 2.1 3.8 3.0 1.5 1.8 11.6 2.0 0.0 2.1 2.3 0.7 2.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.4 2.1 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.2 1.8 0.0 3.8 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.3 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.6 16.5 0.0 0.2 0.0 0.6 2.1 0.1 0.0 5.8 0.8 0.6 0.3 0.3 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.3 3.8 6.2 3.8 3.0 3.0 3.8 4.0 2.0 0.0 0.0 0.0 0.1 0.0 1.1 0.4 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.3 0.7 0.6 0.0 0.0 0.2 0.0 0.5 0.6 0.0 0.0 0.0 7.9 0.0 0.6 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.8 0.5 0.0 0.7 0.0 0.2 0.0 0.5 1.4 0.9 0.3 0.0 0.0 0.0 0.3 PCDHB4 PCDH-BETA4 ENSG00000081818 "Protocadherin beta 4" Q9Y5E5 5 141121799-141125623 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 5.1;Horizontal cells: 7.9;Peritubular cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "T-reg: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Group enriched" "Detected in some" 5 "SCLC-21H: 13.0;SH-SY5Y: 8.8" HPA014466 Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Intermediate filaments" "HPA014466: AB_1855058" "unprognostic (2.60e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (8.60e-3)" "unprognostic (4.03e-1)" "unprognostic (6.44e-2)" "unprognostic (2.44e-1)" "unprognostic (8.66e-2)" "unprognostic (1.52e-1)" "unprognostic (6.70e-3)" "unprognostic (1.44e-1)" "unprognostic (2.82e-3)" "unprognostic (1.11e-3)" "unprognostic (2.17e-1)" "unprognostic (3.32e-4)" "unprognostic (5.18e-3)" 7.1 5.3 13.0 2.0 12.0 0.6 5.9 11.3 11.4 8.0 3.4 12.9 0.1 1.9 12.3 9.1 4.0 5.8 5.7 4.3 10.9 6.3 4.1 1.3 5.1 1.4 13.1 11.3 9.9 18.2 7.3 5.1 0.9 11.0 6.1 2.7 3.7 5.0 5.1 3.8 3.1 2.6 7.9 21.1 2.0 2.6 1.6 12.3 0.0 2.8 1.5 1.1 5.6 5.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 2.1 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 13.0 8.8 0.0 0.0 0.0 0.4 0.4 0.1 0.0 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 13.0 12.0 11.3 11.4 10.9 6.3 13.1 11.3 11.0 12.3 0.0 0.3 0.0 0.4 1.0 5.1 0.6 0.0 4.0 4.5 0.0 0.0 0.0 0.0 0.4 0.0 3.0 0.0 0.0 1.4 0.0 3.8 0.9 0.0 0.0 0.1 7.9 0.0 4.3 0.0 0.0 1.4 0.0 1.7 0.0 0.0 3.5 0.4 0.0 6.0 0.0 0.6 0.0 3.1 1.1 0.2 1.8 0.0 0.0 0.0 0.2 PCDHB5 "DKFZp586B0217, PCDH-BETA5" ENSG00000113209 "Protocadherin beta 5" Q9Y5E4 5 141135218-141138625 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 4.5;Spermatocytes: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.0;GAMG: 8.9;NTERA-2: 11.3;RH-30: 9.0;SCLC-21H: 10.6;SuSa: 14.6;T-47d: 11.2;U-138 MG: 21.0;U-2 OS: 9.4;WM-115: 9.3" "Low region specificity" "Detected in all" "HPA013191, HPA067473" Approved Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA013191: AB_1855059, HPA067473: " "unprognostic (2.21e-1)" "unprognostic (4.71e-2)" "unprognostic (4.05e-3)" "unprognostic (1.81e-1)" "unprognostic (2.84e-2)" "unprognostic (5.23e-2)" "unprognostic (2.27e-2)" "unprognostic (1.76e-1)" "unprognostic (9.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.06e-3)" "unprognostic (6.65e-2)" "unprognostic (3.14e-2)" "unprognostic (1.55e-3)" 3.8 4.6 8.1 1.6 10.7 0.7 3.6 7.7 11.0 9.0 2.9 7.9 3.6 1.2 10.4 9.2 2.5 7.5 4.9 4.9 7.9 4.1 6.6 2.3 4.0 1.1 3.6 7.1 14.9 11.2 6.3 7.6 1.6 6.4 7.6 1.4 6.9 5.6 5.9 3.0 1.9 1.5 5.7 5.2 2.2 2.4 6.1 5.9 0.0 6.6 0.7 1.0 4.4 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.6 12.0 0.2 0.9 0.5 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 6.2 0.0 8.9 0.0 6.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.5 0.0 0.0 0.0 2.4 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 9.0 0.0 0.0 0.0 10.6 0.3 0.0 0.1 3.6 14.6 11.2 2.6 0.0 21.0 9.4 3.4 0.0 0.0 0.0 0.0 1.1 0.0 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.1 10.7 7.7 10.5 7.9 4.1 3.6 7.1 6.4 5.9 0.0 0.0 0.0 1.5 0.0 3.7 0.6 2.5 0.0 0.0 1.8 0.0 0.0 0.0 2.4 4.5 0.1 0.0 0.0 3.1 0.0 1.0 0.9 0.0 0.2 0.0 3.2 0.0 0.6 0.0 2.7 2.8 0.0 0.0 0.0 0.0 4.3 3.1 0.0 4.2 0.2 0.7 0.0 1.5 10.3 0.0 0.1 0.0 0.0 0.0 0.6 PCDHB6 PCDH-BETA6 ENSG00000113211 "Protocadherin beta 6" Q9Y5E3 5 141150022-141153287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 13.4" "Cell type enriched" "Detected in some" 7 "Spermatocytes: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 16.9;SH-SY5Y: 7.2;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029566, HPA075308" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029566: AB_10601385, HPA075308: " "unprognostic (3.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.81e-1)" "unprognostic (8.05e-2)" "unprognostic (7.65e-3)" "unprognostic (2.82e-1)" "unprognostic (1.73e-3)" "unprognostic (9.64e-3)" "unprognostic (8.62e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (6.33e-2)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.60e-4)" "unprognostic (2.31e-2)" "unprognostic (7.08e-3)" "unprognostic (6.52e-2)" 2.5 2.4 3.9 1.0 5.1 0.4 2.5 4.2 8.4 2.3 1.5 2.6 0.0 0.6 4.5 3.7 0.7 2.1 1.4 1.6 3.5 1.9 1.6 1.4 1.7 0.7 2.6 3.6 3.7 1.5 13.4 6.4 1.5 2.9 1.5 0.9 0.7 2.5 1.5 1.4 2.4 1.0 3.0 3.3 1.5 0.9 5.4 3.1 0.0 1.1 1.0 0.7 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 16.9 0.2 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 7.2 0.0 0.1 3.6 0.4 5.4 2.2 0.0 0.6 1.3 7.6 0.0 0.0 0.0 0.0 3.9 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.1 4.2 8.4 3.5 1.9 2.6 3.6 2.9 3.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.0 0.2 0.0 1.2 9.9 0.1 0.4 0.0 0.0 0.0 0.0 PCDHB7 PCDH-BETA7 ENSG00000113212 "Protocadherin beta 7" Q9Y5E2 5 141172619-141176383 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 32.2;Late spermatids: 14.3;Muller glia cells: 6.1;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 5.5;EFO-21: 6.6;U-138 MG: 4.4;U-2197: 13.0;U-87 MG: 4.5;WM-115: 4.4" "Low region specificity" "Detected in all" HPA059271 Approved NA NA "HPA059271: AB_2683962" "unprognostic (2.13e-1)" "unprognostic (4.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.97e-1)" "unprognostic (5.95e-2)" "unprognostic (3.69e-4)" "unprognostic (1.04e-2)" "unprognostic (2.78e-2)" "unprognostic (8.42e-2)" "unprognostic (1.32e-1)" "unprognostic (1.57e-3)" "unprognostic (2.29e-1)" "unprognostic (1.83e-3)" "unprognostic (2.35e-2)" "unprognostic (2.34e-1)" "unprognostic (1.48e-1)" "unprognostic (5.78e-4)" 5.8 2.5 4.0 2.7 3.4 0.4 4.3 3.7 4.9 8.1 3.1 8.9 0.0 1.5 11.6 5.0 1.4 5.0 4.6 3.6 4.0 1.8 3.0 1.4 4.9 1.9 3.0 2.7 7.5 1.5 1.6 8.1 1.1 4.5 4.8 1.7 7.0 1.5 3.4 1.4 1.6 2.3 9.0 3.9 3.6 1.8 3.6 5.1 0.0 3.3 0.9 1.0 6.2 5.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.6 5.5 2.7 0.0 0.3 0.7 0.1 0.1 0.0 0.1 0.0 6.6 0.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 1.9 1.3 0.4 0.0 1.0 0.0 2.9 0.0 0.9 4.4 0.8 13.0 0.1 0.0 0.0 0.0 4.5 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 3.7 4.9 4.0 1.8 3.0 2.7 4.5 5.1 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 32.2 0.6 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.1 1.6 0.0 1.3 0.0 14.3 0.9 0.0 0.0 0.0 0.0 6.1 0.0 0.0 1.8 0.0 0.2 6.5 1.2 2.8 0.5 0.6 0.1 0.0 0.0 0.0 PCDHB8 "PCDH-BETA8, PCDH3I" ENSG00000120322 "Protocadherin beta 8" Q9UN66 5 141177790-141180529 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 26 "Early spermatids: 2.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 14.0;T-47d: 20.8;U-138 MG: 8.2;U-2197: 22.8" HPA057773 Uncertain NA NA "HPA057773: AB_2683525" "unprognostic (1.16e-3)" "unprognostic (1.56e-1)" "unprognostic (5.33e-2)" "unprognostic (1.72e-1)" "unprognostic (7.56e-2)" "unprognostic (2.02e-2)" "unprognostic (5.72e-3)" "unprognostic (5.82e-4)" "unprognostic (3.54e-2)" "unprognostic (5.52e-3)" "unprognostic (1.95e-2)" "unprognostic (2.42e-1)" "unprognostic (2.62e-2)" "unprognostic (1.11e-2)" "unprognostic (8.09e-2)" "unprognostic (3.12e-2)" "unprognostic (6.30e-4)" 2.3 1.2 0.9 0.3 1.3 0.0 1.5 0.8 2.7 1.3 0.8 0.0 3.7 1.8 0.9 1.1 1.7 1.5 1.1 0.6 1.3 0.1 1.8 0.0 0.8 2.9 1.5 1.2 2.2 0.4 0.9 0.3 0.6 0.8 0.1 0.9 0.2 1.9 1.4 0.3 0.3 2.5 0.5 0.0 0.5 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 2.6 1.7 0.1 0.1 5.1 0.0 0.0 0.0 0.0 0.0 14.0 0.0 4.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.9 0.0 0.2 0.1 1.1 4.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 5.5 0.0 0.0 0.0 4.1 1.0 0.0 0.0 0.7 0.0 20.8 0.0 0.5 8.2 4.2 22.8 0.0 0.0 0.0 0.0 2.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 PCDHB9 "PCDH-BETA9, PCDH3H" ENSG00000177839 "Protocadherin beta 9" Q9Y5E1 5 141187127-141191541 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 19.7;Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 10.8;ASC TERT1: 10.0;SH-SY5Y: 14.8" HPA013445 Uncertain NA NA "HPA013445: AB_1855054" "unprognostic (1.85e-2)" "unprognostic (3.27e-2)" "unprognostic (2.73e-1)" "unprognostic (8.97e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.12e-1)" "unprognostic (6.78e-3)" "unprognostic (1.34e-2)" "unprognostic (4.46e-2)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (1.86e-4)" "unprognostic (1.71e-1)" "unprognostic (9.80e-2)" "unprognostic (1.17e-1)" "unprognostic (8.01e-2)" 1.9 1.9 5.3 0.3 4.1 0.3 1.6 1.8 10.9 3.6 1.0 3.2 0.0 0.2 2.8 4.7 0.9 2.3 1.6 2.0 5.9 0.9 0.2 1.4 0.2 1.2 3.1 4.7 1.7 2.1 6.6 1.1 4.1 1.1 0.6 1.2 1.4 0.8 0.7 0.9 1.0 2.6 4.6 0.6 0.5 1.2 2.5 0.0 0.8 0.3 0.2 0.7 1.0 0.5 0.2 1.9 0.2 0.9 1.3 0.0 0.0 0.0 0.9 6.2 10.8 10.0 0.3 0.1 3.6 0.4 0.6 0.0 1.1 0.4 4.1 0.1 2.9 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.9 0.0 0.0 2.0 0.0 0.1 0.0 2.7 3.0 0.9 0.5 0.7 0.4 0.0 0.4 2.8 5.6 0.0 0.6 0.1 2.1 14.8 0.6 0.1 1.0 0.4 2.9 0.2 0.9 6.0 0.5 5.0 1.2 0.1 0.0 0.0 3.3 0.2 2.2 1.1 0.2 0.5 0.2 0.1 0.1 0.2 0.4 1.3 0.0 0.5 0.3 0.3 1.9 0.9 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.2 0.0 19.7 0.2 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 9.5 0.0 1.3 0.3 0.0 1.4 0.0 0.0 0.0 0.0 2.8 0.2 0.0 1.8 0.2 0.7 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 "Protocadherin gamma subfamily A, 1" Q9Y5H4 5 141330571-141512981 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Bipolar cells: 1.6;Cardiomyocytes: 1.7;Horizontal cells: 3.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 7.0;T-47d: 11.5;WM-115: 5.2" "Low region specificity" "Detected in many" "HPA008755, HPA010580, HPA036547" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798" "unprognostic (9.50e-4)" "unprognostic (2.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.42e-3)" "unprognostic (3.39e-1)" "unprognostic (3.97e-2)" "unprognostic (2.42e-1)" "unprognostic (5.61e-3)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-3)" "unprognostic (4.76e-2)" "unprognostic (1.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-3)" 1.4 1.3 2.7 0.9 11.7 1.0 1.1 6.8 7.9 1.4 1.2 2.7 0.5 1.0 2.8 3.9 1.3 1.1 0.8 3.9 3.5 2.8 1.2 0.5 1.2 1.0 2.5 2.5 2.9 2.5 2.8 6.1 2.3 5.4 1.5 0.9 2.4 1.1 1.0 1.7 1.5 0.6 1.8 2.4 1.1 0.8 2.7 1.1 0.0 1.3 0.6 0.7 1.2 0.9 1.2 0.9 2.7 0.5 0.8 1.0 0.2 0.1 0.4 0.5 1.9 1.2 2.1 0.3 1.7 1.1 0.5 1.0 0.5 0.2 0.5 2.8 1.1 0.9 0.2 0.2 0.3 1.1 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.2 1.8 0.5 0.0 0.7 3.4 0.1 0.3 0.2 0.8 7.0 0.1 0.2 0.8 0.3 0.1 0.3 3.1 2.7 0.3 0.3 0.3 1.8 2.1 0.3 0.9 1.7 0.5 11.5 0.4 0.8 3.3 0.7 1.6 0.4 0.3 1.0 0.2 3.9 0.2 5.2 2.7 0.5 0.5 0.7 0.4 0.4 0.7 0.7 0.5 0.2 1.2 1.0 0.8 1.1 0.8 0.5 0.9 0.6 0.2 2.7 11.7 6.8 6.1 3.5 2.8 2.5 2.5 5.4 1.1 3.0 0.0 0.0 0.0 0.0 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 "Protocadherin gamma subfamily A, 10" Q9Y5H3 5 141412987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 33.7" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 27.0;Cone photoreceptor cells: 15.7;Horizontal cells: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 12.2;HSkMC: 13.8;T-47d: 16.3;U-2197: 9.6" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077276" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077276: " "unprognostic (2.92e-1)" "unprognostic (2.17e-4)" "unprognostic (1.63e-1)" "unprognostic (3.33e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-2)" "unprognostic (9.99e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.64e-3)" "unprognostic (2.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.06e-1)" "unprognostic (8.83e-3)" 5.2 4.2 7.9 1.6 11.4 1.2 2.7 2.4 33.7 3.6 2.9 9.8 1.2 2.4 3.0 2.4 4.3 3.6 3.7 2.3 9.1 4.4 2.0 6.5 3.5 1.7 5.1 7.2 3.6 1.9 1.4 2.4 7.4 5.3 3.6 2.6 4.9 4.1 4.6 2.0 4.7 2.9 3.1 6.7 2.5 4.7 2.0 6.5 0.0 4.9 1.5 3.3 2.5 3.5 0.9 1.1 1.5 0.7 0.8 1.0 0.2 0.0 0.0 12.2 6.2 5.4 2.3 5.8 2.1 0.1 3.0 4.8 0.3 0.7 0.7 8.1 3.0 0.2 0.3 2.9 1.9 2.4 0.8 0.0 0.0 0.3 0.0 2.2 1.2 0.2 13.8 0.3 2.0 0.8 0.3 1.1 0.3 0.0 0.1 7.4 0.0 0.1 0.3 1.2 0.0 0.1 0.1 1.0 0.0 2.1 0.1 1.6 0.6 0.3 0.0 0.3 3.0 16.3 1.5 2.7 5.6 0.3 9.6 0.1 0.2 0.9 0.1 2.9 0.0 0.3 1.5 0.3 0.3 1.0 0.4 1.0 0.6 0.4 0.6 0.1 0.9 0.4 0.9 0.9 0.8 0.7 1.1 0.3 0.2 7.9 11.4 2.4 8.5 9.1 4.4 5.1 7.2 5.3 6.5 0.0 1.3 0.0 1.8 0.1 27.0 2.3 2.5 0.0 2.3 1.8 15.7 1.7 0.0 0.9 0.0 2.1 0.4 0.0 1.2 1.1 1.2 3.2 1.1 1.1 0.8 22.3 1.2 3.1 0.0 0.0 3.1 0.3 1.7 0.0 1.1 8.7 2.1 0.0 2.1 0.0 5.2 6.5 1.1 0.3 0.7 0.4 0.3 0.0 0.8 0.9 PCDHGA11 PCDH-GAMMA-A11 ENSG00000253873 "Protocadherin gamma subfamily A, 11" Q9Y5H2 5 141421047-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 1.9;Horizontal cells: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "ASC diff: 12.0;ASC TERT1: 13.0;GAMG: 22.7;hTERT-RPE1: 33.8;WM-115: 20.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.13e-2)" "unprognostic (1.78e-3)" "unprognostic (9.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.68e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.16e-3)" "unprognostic (1.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.97e-1)" "unprognostic (2.22e-1)" "unprognostic (3.03e-2)" "unprognostic (3.74e-2)" "unprognostic (3.54e-1)" "unprognostic (4.34e-3)" "unprognostic (1.89e-1)" 3.4 2.5 7.4 2.8 9.4 0.5 2.1 4.1 8.5 2.4 2.5 8.5 0.0 1.2 2.6 1.7 3.1 2.1 2.1 3.4 11.6 1.9 1.9 1.2 2.3 1.8 4.5 5.2 3.8 2.3 1.3 1.9 8.3 5.0 2.5 1.5 3.3 2.8 3.4 2.8 6.6 1.2 3.3 4.9 1.6 1.8 2.2 7.1 0.1 3.4 0.6 1.7 1.7 2.2 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 1.1 12.0 13.0 0.4 2.6 5.0 2.0 3.2 0.0 0.1 0.3 4.3 2.6 22.7 1.7 0.0 0.3 3.2 0.0 1.1 0.0 0.0 0.0 2.0 0.2 0.0 9.3 0.1 3.5 0.0 33.8 3.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 5.0 0.2 1.5 3.6 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 7.4 9.4 4.1 8.5 11.6 1.9 4.5 5.2 5.0 7.1 0.0 0.6 0.0 0.1 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PCDHGA12 "CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12" ENSG00000253159 "Protocadherin gamma subfamily A, 12" O60330 5 141430589-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 3.5;Cardiomyocytes: 1.8;Ito cells: 1.3" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 7.7;BJ hTERT+: 12.9;fHDF/TERT166: 19.1;HHSteC: 6.3;HSkMC: 14.3;TIME: 6.1" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.17e-3)" "unprognostic (2.71e-2)" "unprognostic (1.04e-2)" "unprognostic (2.67e-1)" "unprognostic (2.74e-1)" "unprognostic (5.06e-2)" "unprognostic (1.99e-1)" "unprognostic (9.01e-3)" "unprognostic (1.19e-1)" "unprognostic (4.65e-4)" "unprognostic (2.98e-1)" "unprognostic (3.02e-1)" "unprognostic (1.28e-4)" "unprognostic (8.30e-3)" "unprognostic (1.57e-1)" "unprognostic (2.42e-1)" "unprognostic (6.85e-3)" 5.1 12.7 14.8 2.8 18.9 0.7 2.4 4.7 13.8 4.9 1.8 8.6 0.6 1.4 5.4 2.3 3.5 2.7 11.3 6.5 15.7 5.6 3.1 2.8 6.5 1.6 4.7 7.3 6.2 3.6 2.0 2.7 6.5 8.4 3.5 1.7 3.4 1.7 4.9 1.9 5.1 1.5 5.3 8.4 3.7 2.2 1.6 12.4 0.4 3.0 0.6 1.7 4.5 3.6 3.7 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.6 1.2 0.1 7.7 12.9 0.0 0.0 0.0 0.0 0.4 0.0 19.1 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 14.3 0.0 3.8 0.0 0.0 4.5 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 6.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 14.8 18.9 4.7 10.4 15.7 5.6 4.7 7.3 8.4 12.4 0.0 0.0 0.0 0.2 0.0 3.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.4 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 "Protocadherin gamma subfamily A, 2" Q9Y5H1 5 141338760-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 2.7;Cardiomyocytes: 1.6;Leydig cells: 1.1;Peritubular cells: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.8;BJ: 5.4;fHDF/TERT166: 6.3;HSkMC: 5.0;hTERT-RPE1: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA038625" Approved Approved "Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480" "unprognostic (2.43e-3)" "unprognostic (2.10e-2)" "unprognostic (1.32e-2)" "unprognostic (4.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.14e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.45e-3)" "unprognostic (9.68e-3)" "unprognostic (1.04e-2)" "unprognostic (1.18e-2)" "unprognostic (2.23e-4)" 5.1 4.3 6.7 2.1 8.0 0.6 4.2 5.2 12.6 6.6 2.6 4.6 1.0 0.9 6.5 5.7 2.4 5.5 5.5 11.1 6.5 4.6 3.3 2.4 4.6 1.1 6.0 2.3 15.3 8.4 9.2 10.6 2.2 7.8 5.3 1.4 13.8 3.3 5.8 2.6 2.9 1.4 5.2 5.6 1.9 2.1 10.4 3.5 0.0 4.3 1.2 1.1 3.2 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 3.9 9.8 0.1 5.4 2.1 0.5 0.9 0.1 0.1 0.1 0.7 6.3 0.8 0.2 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.0 0.2 0.1 0.3 5.8 2.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.3 0.2 0.8 0.0 0.3 0.7 0.0 3.6 0.1 0.5 0.7 0.0 3.3 0.9 0.5 0.3 0.1 0.0 0.4 0.0 2.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 8.0 5.2 7.2 6.5 4.6 6.0 2.3 7.8 3.5 0.0 0.0 0.0 0.1 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.5 0.3 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PCDHGA3 PCDH-GAMMA-A3 ENSG00000254245 "Protocadherin gamma subfamily A, 3" Q9Y5H0 5 141343829-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 2.4;Cardiomyocytes: 1.1;Horizontal cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 11.2;BJ: 3.7;EFO-21: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.47e-2)" "unprognostic (4.79e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.53e-2)" "unprognostic (1.03e-1)" "unprognostic (2.35e-1)" "unprognostic (1.85e-1)" "unprognostic (7.44e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (2.32e-3)" "unprognostic (7.12e-3)" "unprognostic (3.31e-2)" "unprognostic (2.52e-4)" 4.0 4.5 11.7 1.4 10.5 0.7 2.5 6.9 13.7 4.7 1.3 7.9 0.0 0.7 4.5 3.5 1.5 2.9 3.5 12.2 8.5 5.8 2.5 2.5 2.6 1.0 6.6 7.7 8.6 3.6 1.8 6.3 5.7 8.7 3.0 1.3 4.6 2.9 3.2 1.5 1.9 1.1 3.6 6.0 1.5 1.2 5.2 3.8 0.0 3.3 1.3 1.0 1.7 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.1 0.2 1.5 0.0 3.7 0.3 0.0 0.1 0.0 0.0 0.1 9.2 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.4 0.1 0.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 10.5 6.9 13.7 8.5 5.8 6.6 7.7 8.7 3.8 0.0 0.0 0.0 0.1 0.0 2.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 PCDHGA4 PCDH-GAMMA-A4 ENSG00000262576 "Protocadherin gamma subfamily A, 4" Q9Y5G9 5 141355025-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 7 "T-cells: 1.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.3;BJ: 5.7;HSkMC: 6.0;HUVEC TERT2: 5.7;U-87 MG: 8.2" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.27e-2)" "unprognostic (4.55e-3)" "unprognostic (2.00e-2)" "unprognostic (6.54e-4)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-2)" "unprognostic (5.62e-2)" "unprognostic (3.76e-1)" "unprognostic (6.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.94e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.31e-4)" 5.4 4.7 6.5 1.8 8.3 0.5 3.0 8.5 11.2 4.8 2.0 10.4 1.5 1.2 5.0 3.0 1.9 3.4 3.1 4.8 6.3 5.9 2.0 2.7 3.6 0.9 5.6 8.1 5.8 6.7 8.5 3.4 2.8 6.1 4.1 1.4 3.5 4.3 4.2 1.5 1.8 1.2 5.0 5.9 1.3 1.4 2.7 4.0 0.0 2.6 2.7 0.9 2.3 2.5 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 1.0 0.6 4.5 10.3 0.0 5.7 4.6 0.3 1.1 0.0 0.1 1.0 2.0 4.8 1.8 0.1 0.2 0.2 0.6 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.4 6.0 0.2 0.1 0.0 3.5 5.7 0.0 0.2 0.3 2.4 0.8 0.3 0.2 0.2 0.0 0.3 0.3 1.6 0.1 0.3 0.0 0.8 1.7 0.3 0.3 1.1 0.5 2.2 0.0 3.7 2.4 0.7 3.2 0.5 0.2 0.3 0.2 8.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.3 8.5 9.3 6.3 5.9 5.6 8.1 6.1 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 10.6;Horizontal cells: 9.5;Sertoli cells: 6.5" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "ASC diff: 18.9;ASC TERT1: 7.5" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 4.0 2.7 6.1 1.8 9.1 0.9 3.9 19.1 9.6 9.0 2.7 7.7 4.1 1.0 7.6 3.2 3.3 4.7 4.5 4.9 6.9 4.0 1.5 1.2 3.3 1.3 3.2 3.8 6.6 1.7 3.3 3.7 2.7 4.6 5.6 1.6 4.1 2.5 4.0 1.5 3.0 1.5 4.3 6.3 1.4 1.7 1.7 3.7 0.0 1.8 0.9 1.0 2.5 4.2 0.9 0.8 1.6 0.6 1.9 0.7 0.2 0.0 0.5 0.3 0.1 18.9 7.5 0.0 0.8 0.2 0.1 0.4 0.0 0.0 0.9 0.4 0.3 1.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 1.8 0.2 0.0 0.0 0.4 0.6 0.0 0.1 0.6 0.8 0.3 0.5 0.7 0.1 0.0 0.3 0.9 0.7 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.3 0.3 1.6 0.0 1.0 0.7 0.2 1.0 0.7 0.1 1.0 0.1 0.3 0.2 0.8 1.5 0.6 0.6 0.7 0.3 0.3 0.6 0.6 0.4 0.1 0.9 0.7 0.7 1.6 1.9 0.2 0.8 0.4 0.2 6.1 9.1 19.1 9.6 6.9 4.0 3.2 3.8 4.6 3.7 0.0 0.6 0.0 0.6 0.1 10.6 1.6 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.3 1.1 0.0 0.1 9.5 0.0 1.8 0.3 0.0 3.4 0.0 0.0 0.0 0.0 3.3 0.2 0.0 1.8 0.0 1.1 6.5 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 "Protocadherin gamma subfamily A, 6" Q9Y5G7 5 141373914-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 9.7;Cardiomyocytes: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 5.8;SCLC-21H: 11.2;T-47d: 6.5;WM-115: 14.0" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (4.49e-2)" "unprognostic (8.91e-3)" "unprognostic (5.45e-2)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (3.86e-3)" "unprognostic (2.02e-2)" "unprognostic (5.26e-2)" "unprognostic (7.44e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-3)" 4.1 3.8 6.1 2.3 8.4 0.8 2.9 19.6 10.8 7.9 3.4 8.3 2.9 1.0 6.9 4.7 2.6 4.3 3.6 3.7 5.0 4.3 2.8 1.7 3.3 1.4 2.9 4.7 9.7 2.5 2.5 4.5 6.9 3.3 4.0 1.6 5.8 4.1 5.3 2.1 4.7 1.5 6.1 2.8 2.8 1.7 2.2 2.9 0.2 3.8 1.2 1.5 4.6 3.6 1.3 0.7 2.8 0.6 0.5 0.8 0.2 0.1 0.4 3.2 0.5 1.6 5.4 0.1 2.3 0.8 1.2 1.2 0.0 0.2 2.2 3.1 3.7 1.2 0.5 0.1 0.5 0.8 0.0 0.3 0.0 0.3 0.3 0.9 0.1 0.1 5.8 0.4 0.3 0.1 1.1 1.8 0.1 0.3 1.3 0.4 0.5 0.7 1.8 0.3 0.1 0.1 1.5 0.4 0.0 0.4 0.1 11.2 0.9 0.1 0.3 0.7 0.7 6.5 0.1 5.5 0.9 0.4 0.9 0.8 0.4 1.8 0.4 0.9 0.8 14.0 1.8 0.6 0.3 0.8 0.3 0.3 0.8 0.6 0.2 0.1 1.3 0.3 0.5 2.8 0.5 0.3 0.7 0.5 0.2 6.1 8.4 19.6 10.8 5.0 4.3 2.9 4.7 3.3 2.9 0.0 2.1 0.5 0.5 0.0 9.7 4.5 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.0 0.0 1.3 0.1 0.3 0.4 0.0 0.5 0.1 1.6 0.0 1.8 0.0 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 2.1 0.0 1.0 0.0 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.1 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 3.5;Cardiomyocytes: 1.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ hTERT+: 17.3;hTERT-RPE1: 9.3;SH-SY5Y: 15.5;T-47d: 6.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 1.7 2.0 3.1 1.3 9.0 0.6 2.1 5.3 14.9 3.5 3.0 7.1 2.1 1.0 4.2 4.1 2.2 3.3 1.9 3.0 5.1 3.3 3.2 1.9 2.2 1.0 5.1 6.6 4.7 2.5 4.6 3.4 4.8 5.4 3.7 1.5 5.8 2.6 3.3 1.6 3.8 1.2 3.0 6.3 1.3 1.4 2.1 5.1 0.0 6.6 1.5 1.0 2.4 2.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 1.9 0.0 5.8 9.9 0.0 2.6 17.3 3.5 5.2 0.0 0.0 0.4 4.3 0.5 0.1 0.1 0.0 0.1 2.9 0.0 0.3 0.0 0.4 0.1 1.0 0.0 0.0 4.3 0.1 0.0 0.6 9.3 1.4 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 15.5 0.0 0.1 0.1 3.3 6.8 0.0 5.2 0.1 0.1 2.5 0.0 0.1 1.5 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.0 5.3 7.7 5.1 3.3 5.1 6.6 5.4 5.1 0.0 0.0 0.0 0.4 0.0 3.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 PCDHGA8 "KIAA0327, PCDH-GAMMA-A8" ENSG00000253767 "Protocadherin gamma subfamily A, 8" Q9Y5G5 5 141390157-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 7.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 10.4;Cardiomyocytes: 2.5;Horizontal cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 2.9;neutrophil: 2.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.9" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.28e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (4.10e-2)" "unprognostic (7.68e-2)" "unprognostic (2.30e-2)" "unprognostic (1.83e-2)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.35e-2)" "unprognostic (1.49e-3)" "unprognostic (7.59e-2)" "unprognostic (3.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.99e-3)" 0.6 0.7 0.8 0.7 0.6 2.5 0.7 2.3 2.2 1.2 1.2 1.0 7.1 0.4 2.3 1.5 2.1 0.7 0.9 2.0 1.4 0.5 0.5 0.9 1.1 0.7 0.5 0.4 2.6 0.6 0.2 1.9 1.4 3.5 0.9 0.8 0.4 0.8 0.5 2.2 2.5 1.1 0.7 1.6 0.7 0.7 1.0 1.3 1.1 2.4 0.4 0.6 0.6 1.2 0.7 0.4 2.9 0.4 0.5 0.3 0.1 0.3 0.2 1.1 0.6 1.1 2.6 0.6 2.4 1.5 1.7 0.7 0.2 0.4 1.1 1.0 1.8 0.3 0.4 0.0 0.0 1.3 0.3 0.2 0.3 0.5 0.3 0.1 0.4 0.8 1.4 0.1 0.5 0.1 0.5 0.4 0.2 0.2 0.9 0.2 0.2 0.5 0.7 2.6 0.0 0.1 1.0 0.2 0.1 0.1 0.3 0.7 0.6 0.3 0.9 0.4 2.4 1.2 1.7 2.5 2.6 0.9 0.6 0.2 0.3 0.3 0.4 1.3 0.4 1.3 2.9 0.4 0.5 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.2 0.3 2.8 0.5 0.3 0.4 0.2 0.1 0.8 0.6 2.3 2.2 1.4 0.5 0.5 0.4 3.5 1.3 0.0 1.1 0.0 0.8 0.0 10.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 3.2 0.0 0.6 0.8 0.0 2.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.4 0.0 1.7 0.0 0.2 0.6 0.9 0.0 0.0 0.0 0.0 0.4 PCDHGA9 PCDH-GAMMA-A9 ENSG00000261934 "Protocadherin gamma subfamily A, 9" Q9Y5G4 5 141402932-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 3.7;Club cells: 1.2;Horizontal cells: 3.2;Muller glia cells: 1.3" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 4.1;HSkMC: 4.6;hTERT-RPE1: 19.1;TIME: 5.0;U-87 MG: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.98e-2)" "unprognostic (7.47e-3)" "unprognostic (9.86e-3)" "unprognostic (2.22e-1)" "unprognostic (4.68e-2)" "unprognostic (4.96e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-3)" "unprognostic (2.26e-1)" "unprognostic (1.79e-1)" "unprognostic (4.48e-3)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-2)" 5.6 5.4 12.0 2.6 12.6 0.9 3.7 11.5 17.3 6.9 2.7 11.2 0.1 2.1 7.6 3.9 4.8 6.3 6.5 3.2 10.3 8.5 3.0 2.8 5.0 2.1 9.6 7.1 9.1 3.0 3.8 3.0 3.6 10.9 5.2 2.7 7.7 3.8 7.3 1.9 5.5 2.0 5.9 13.0 3.6 2.9 2.0 5.9 0.0 4.6 1.4 2.5 4.8 3.7 0.5 0.3 1.0 0.5 0.2 1.0 0.0 0.0 0.2 0.7 1.8 0.1 0.3 0.2 0.8 0.0 0.7 0.7 0.3 0.4 1.4 4.1 2.2 0.3 0.1 0.1 0.2 0.8 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.3 4.6 0.2 0.4 0.3 19.1 1.1 0.1 0.1 0.2 0.4 0.4 0.2 0.5 0.2 0.1 0.0 0.2 0.5 0.0 0.2 0.2 0.5 1.2 0.4 0.1 0.6 0.5 1.1 0.5 5.0 0.3 0.3 0.1 2.7 0.2 0.1 0.1 5.8 0.1 1.0 1.0 0.5 0.3 1.0 0.3 0.6 0.3 0.4 0.2 0.1 0.5 0.4 0.7 1.0 0.2 0.2 0.3 0.1 0.0 12.0 12.6 11.5 16.2 10.3 8.5 9.6 7.1 10.9 5.9 0.0 0.0 0.0 0.1 0.2 3.7 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 "Protocadherin gamma subfamily B, 1" Q9Y5G3 5 141350102-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 32.2;pituitary gland: 13.7" "Group enriched" "Detected in some" 17 "Early spermatids: 5.4;Late spermatids: 5.9;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 14.7;ASC TERT1: 7.7;hTERT-RPE1: 8.0;T-47d: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076182" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody" Yes No "Vesicles, Plasma membrane" "Nucleoplasm, Focal adhesion sites, Midbody" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783" "unprognostic (1.53e-2)" "unprognostic (1.94e-3)" "unprognostic (3.21e-1)" "unprognostic (4.38e-3)" "unprognostic (2.98e-1)" "unprognostic (8.36e-3)" "unprognostic (2.37e-1)" "unprognostic (9.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.78e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-2)" "unprognostic (1.93e-1)" "unprognostic (7.63e-3)" 2.3 2.7 8.2 1.4 7.5 1.0 2.1 4.3 32.2 2.5 1.4 9.4 0.1 1.2 3.7 2.0 1.7 1.9 2.1 2.2 7.6 5.7 2.1 1.3 2.4 1.2 5.5 5.0 4.1 2.8 1.4 13.7 1.6 7.0 2.5 1.4 2.6 1.7 3.1 1.1 1.4 1.3 3.0 6.9 1.4 1.2 1.5 5.6 0.0 2.5 0.0 1.2 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 2.0 1.8 0.0 14.7 7.7 0.1 1.4 3.6 0.5 0.8 0.2 0.5 0.5 4.7 0.5 3.5 0.6 0.4 0.2 0.5 0.0 0.9 0.0 0.2 1.3 0.2 0.0 0.1 1.2 0.0 0.0 0.0 8.0 0.1 0.0 0.2 0.2 3.3 1.8 0.4 0.3 0.2 0.0 0.0 0.0 2.7 0.1 0.0 0.0 1.1 0.8 0.0 0.9 0.1 1.5 9.6 0.0 1.1 0.2 1.6 1.2 0.0 0.0 2.6 0.3 2.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.5 4.3 9.6 7.6 5.7 5.5 5.0 7.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB2 PCDH-GAMMA-B2 ENSG00000253910 "Protocadherin gamma subfamily B, 2" Q9Y5G2 5 141360042-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Cancer enriched" "Detected in many" 5 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077526" Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" Nucleoplasm "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077526: AB_2732350" "unprognostic (7.14e-3)" "unprognostic (8.79e-3)" "unprognostic (3.21e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.67e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-4)" "unprognostic (2.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.78e-1)" "unprognostic (1.05e-1)" "unprognostic (8.46e-3)" "unprognostic (4.59e-2)" "unprognostic (2.57e-1)" "unprognostic (3.06e-2)" "unprognostic (1.29e-1)" "unprognostic (3.36e-4)" 4.9 3.6 11.3 2.2 9.7 0.9 3.7 8.7 12.2 7.2 2.4 11.6 0.3 1.2 9.2 3.2 3.2 5.6 6.2 4.6 9.3 7.0 2.7 2.7 5.4 1.4 7.0 8.6 9.0 2.6 7.5 3.0 3.9 7.3 4.4 2.8 3.1 2.4 4.4 1.9 2.9 2.1 5.0 7.0 2.2 2.0 1.8 7.8 0.1 2.6 1.3 1.4 2.8 3.3 0.9 0.9 0.5 0.0 0.0 0.7 0.0 0.1 0.3 2.1 0.2 14.4 10.5 0.1 2.2 3.0 0.6 3.4 0.0 0.3 3.8 1.0 1.7 7.5 0.5 0.5 0.3 1.0 0.0 0.2 0.0 0.3 0.4 0.6 0.2 0.2 2.7 0.5 0.2 0.1 4.9 1.7 0.1 0.2 1.2 8.5 0.4 2.9 0.6 0.1 0.9 0.9 7.8 2.7 0.2 0.2 0.3 1.6 1.7 0.2 0.4 0.4 1.6 3.1 0.2 6.0 3.0 0.7 4.6 3.9 0.2 2.2 0.7 3.3 1.0 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.4 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.0 0.9 0.0 0.0 11.3 9.7 8.7 10.6 9.3 7.0 7.0 8.6 7.3 7.8 0.0 0.3 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB3 PCDH-GAMMA-B3 ENSG00000262209 "Protocadherin gamma subfamily B, 3" Q9Y5G1 5 141370264-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 13.5;ASC TERT1: 10.9;TIME: 6.8" "HPA008755, HPA010580, HPA035822, HPA035823" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA035822: , HPA035823: AB_2674802" "unprognostic (6.93e-3)" "unprognostic (9.10e-4)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (7.83e-2)" "unprognostic (1.92e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.81e-2)" "unprognostic (3.11e-1)" "unprognostic (3.62e-2)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" 4.1 1.7 3.3 1.6 6.5 0.5 3.1 3.5 5.6 3.0 3.0 7.2 0.7 0.7 4.9 3.7 3.3 3.3 2.9 4.6 3.3 2.3 2.9 2.0 2.5 3.7 1.9 3.8 5.2 4.2 4.6 5.4 2.3 2.6 2.6 2.2 3.1 6.6 2.6 1.9 3.3 1.4 4.3 2.9 2.4 2.3 1.5 2.8 0.3 3.4 3.2 3.5 2.7 4.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.5 0.3 13.5 10.9 0.2 1.4 2.5 0.9 1.1 0.0 0.0 2.2 0.4 4.3 0.8 0.6 0.0 0.3 0.7 0.0 0.3 0.0 0.3 0.1 0.6 0.1 0.0 2.7 0.6 0.2 0.1 0.2 1.2 0.0 0.3 1.0 0.3 0.4 0.7 1.1 0.1 0.0 0.1 1.9 0.7 0.0 0.2 0.1 3.0 0.6 0.0 0.1 0.3 0.4 0.8 0.0 6.8 0.6 0.1 0.7 0.7 0.3 2.1 0.2 0.6 0.6 1.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 6.5 3.5 5.6 3.3 2.3 1.9 3.8 2.6 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB4 "CDH20, FIB2, PCDH-GAMMA-B4" ENSG00000253953 "Protocadherin gamma subfamily B, 4" Q9UN71 5 141387698-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 2: 1.1;Horizontal cells: 1.6" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "NK-cell: 1.6" "Lineage enriched" "Detected in single" 7 "NK-cells: 1.6" "Cell line enhanced" "Detected in some" "BJ hTERT+: 28.6;SuSa: 10.9;TIME: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.33e-1)" "unprognostic (1.83e-3)" "unprognostic (2.91e-1)" "unprognostic (1.18e-1)" "unprognostic (1.23e-2)" "unprognostic (9.25e-3)" "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.70e-2)" "unprognostic (2.62e-1)" "unprognostic (1.13e-1)" "unprognostic (3.27e-2)" 2.4 2.2 2.4 0.7 4.2 0.0 1.2 1.8 2.1 2.6 1.4 0.2 3.2 3.5 1.1 2.1 0.8 2.8 2.3 4.1 2.9 3.3 2.1 0.0 1.8 5.1 1.9 3.0 2.5 6.2 2.6 0.7 3.0 3.1 1.2 3.4 0.3 1.9 2.0 0.6 0.4 0.9 3.6 0.2 1.6 2.0 0.0 0.2 0.0 0.0 1.6 0.2 0.2 0.0 0.7 7.1 0.0 4.6 5.9 0.8 6.8 28.6 2.9 1.9 0.0 0.0 0.2 5.5 0.2 0.1 2.0 0.0 0.0 3.2 0.0 0.0 0.0 0.1 1.6 1.8 0.0 0.0 5.7 0.0 2.7 0.0 0.1 4.4 0.0 0.2 0.0 0.0 0.0 0.6 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 10.9 3.6 2.6 14.3 3.9 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB5 PCDH-GAMMA-B5 ENSG00000276547 "Protocadherin gamma subfamily B, 5" Q9Y5G0 5 141397987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 11.2" "Group enriched" "Detected in some" 4 "Bipolar cells: 1.7;Ciliated cells: 1.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 32.8;ASC TERT1: 24.8;BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (2.71e-3)" "unprognostic (1.95e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (2.35e-1)" "unprognostic (1.20e-1)" "unprognostic (3.64e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.29e-1)" "unprognostic (1.69e-4)" "unprognostic (9.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.25e-4)" 2.1 1.9 0.8 0.3 3.2 0.0 3.6 2.0 4.3 1.4 0.4 2.5 1.9 0.0 2.1 2.5 1.1 2.1 0.8 1.9 0.0 1.6 3.1 6.8 2.6 0.9 1.5 4.9 2.8 11.2 2.1 9.5 1.5 2.2 0.2 3.7 3.2 3.2 1.4 2.6 0.0 1.9 3.0 0.5 0.7 1.0 2.2 0.8 3.5 0.0 0.7 1.9 1.4 0.5 0.2 0.0 0.3 0.0 1.9 0.1 0.0 1.2 0.1 0.0 32.8 24.8 0.6 8.7 0.0 14.2 16.0 1.4 4.7 4.9 11.4 9.6 0.0 6.6 0.0 3.6 8.0 0.0 1.4 0.0 0.0 0.0 3.4 0.0 3.1 8.7 0.7 0.8 4.6 6.1 4.3 0.0 0.1 0.0 0.4 3.7 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.8 2.6 0.0 0.0 0.0 0.0 0.0 1.0 9.2 0.0 4.4 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.3 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.7 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 "Protocadherin gamma subfamily B, 6" Q9Y5F9 5 141408021-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 6.4;Cone photoreceptor cells: 5.9;Horizontal cells: 9.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 18.6;EFO-21: 6.3;HSkMC: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (2.63e-1)" "unprognostic (7.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-2)" "unprognostic (3.51e-1)" "unprognostic (1.11e-1)" "unprognostic (4.77e-2)" "unprognostic (9.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.27e-1)" "unprognostic (1.21e-2)" "unprognostic (7.71e-4)" 6.7 7.2 8.8 2.6 9.9 1.6 4.4 6.1 26.6 5.8 4.1 10.1 0.3 1.8 7.2 5.7 3.0 5.1 4.4 4.6 8.9 5.7 3.2 9.4 4.4 2.2 6.9 4.4 13.3 5.2 16.1 4.7 6.8 5.9 4.0 2.3 9.0 5.3 5.9 5.7 4.7 2.2 4.8 4.1 4.0 2.5 2.1 6.7 0.3 6.1 1.9 2.1 4.2 5.1 0.8 0.5 3.2 0.4 0.5 0.9 0.2 0.0 0.1 18.6 0.2 0.6 0.7 0.9 1.7 0.0 0.4 1.0 0.2 0.3 1.5 6.3 1.0 0.3 0.3 0.0 0.4 1.2 0.0 0.3 0.0 0.2 0.1 1.5 0.1 0.1 4.3 2.1 0.9 0.1 0.2 0.6 0.4 0.1 0.3 0.1 0.3 0.1 1.2 0.8 0.0 0.0 0.2 0.1 0.1 3.0 0.2 0.2 0.3 0.0 0.1 0.1 0.4 1.5 0.4 3.0 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.9 1.1 0.4 0.2 0.9 0.3 0.2 0.6 0.4 0.2 0.1 0.8 0.4 0.3 3.2 0.5 0.3 0.5 0.2 0.2 8.8 9.9 6.1 7.9 8.9 5.7 6.9 4.4 5.9 6.7 3.0 0.3 0.0 1.3 0.0 6.4 2.5 0.0 1.4 2.3 0.0 5.9 0.1 0.0 0.4 0.0 0.9 0.0 0.0 1.1 0.1 0.4 0.6 0.0 0.8 0.2 9.5 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 3.3 1.6 0.0 1.1 0.0 2.4 0.0 1.0 0.2 0.3 0.1 0.1 0.0 0.0 0.6 PCDHGB7 "ME6, PCDH-GAMMA-B7" ENSG00000254122 "Protocadherin gamma subfamily B, 7" Q9Y5F8 5 141417645-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Bipolar cells: 7.4;Horizontal cells: 3.2" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "AN3-CA: 38.8;HSkMC: 12.3;hTERT-RPE1: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.22e-2)" "unprognostic (2.55e-2)" "unprognostic (7.39e-3)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (8.40e-2)" "unprognostic (4.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.88e-2)" "unprognostic (3.05e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-2)" 10.1 9.8 12.6 3.8 13.5 0.8 8.0 19.1 12.9 10.2 7.0 16.1 1.2 2.3 11.6 5.0 6.8 7.8 9.2 8.5 14.5 7.9 5.4 3.5 11.6 2.6 10.4 7.3 17.3 5.5 9.5 5.3 11.0 9.4 8.3 3.8 15.5 7.1 12.0 5.6 6.8 3.2 10.5 20.1 5.3 4.5 4.2 14.3 0.6 8.4 3.0 2.3 4.6 6.9 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 38.8 0.9 0.1 0.4 2.5 0.3 0.9 1.9 0.0 2.3 0.3 2.1 5.1 0.3 0.6 0.0 0.4 0.9 0.0 0.2 0.0 0.0 0.0 2.9 0.2 0.0 12.3 0.3 0.7 0.4 32.9 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 4.3 0.8 0.0 0.1 0.0 4.2 5.8 0.1 0.0 0.0 0.5 0.4 0.4 5.0 4.7 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 12.6 13.5 19.1 12.9 14.5 7.9 10.4 7.3 9.4 14.3 3.0 2.2 0.0 0.5 0.3 7.4 1.1 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 0.1 1.0 0.0 0.0 0.4 0.1 0.8 0.3 1.1 0.0 0.1 3.2 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.1 0.7 0.0 1.8 0.2 0.4 0.0 1.4 0.0 0.1 0.4 0.0 0.0 0.0 0.1 PCDHGC3 "PC-43, PC43, PCDH-GAMMA-C3, PCDH2" ENSG00000240184 "Protocadherin gamma subfamily C, 3" Q9UN70 5 141475947-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 99.3" "Group enriched" "Detected in some" 7 "Bipolar cells: 6.9;Horizontal cells: 11.1;Muller glia cells: 4.9" "Group enriched" "Detected in all" 6 "glioma: 55.0;melanoma: 20.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "plasmacytoid DC: 15.2" "Lineage enriched" "Detected in single" 22 "dendritic cells: 15.2" "Cell line enhanced" "Detected in many" "ASC diff: 43.5;ASC TERT1: 41.7;HSkMC: 40.8;U-138 MG: 52.4;WM-115: 78.0" "HPA008755, HPA010580, HPA077289" Approved Approved "Plasma membrane" NA NA 74000 "Plasma membrane" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077289: AB_2686832" "unprognostic (2.52e-1)" "unprognostic (4.83e-3)" "unprognostic (1.17e-1)" "unprognostic (6.76e-2)" "unprognostic (3.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (6.19e-4)" "unprognostic (2.03e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (8.18e-4)" "unprognostic (3.72e-2)" "unprognostic (5.66e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (6.00e-4)" 14.9 15.0 52.8 7.0 49.0 0.5 11.2 30.1 99.3 28.0 8.7 38.9 2.4 3.8 20.6 27.6 12.8 15.7 14.6 11.0 40.2 25.2 7.1 8.0 20.9 4.2 32.0 24.9 16.6 4.4 18.8 7.9 17.7 25.8 17.1 10.2 17.3 8.4 20.1 5.8 18.3 5.6 19.8 28.1 5.3 6.6 4.8 24.1 0.9 5.4 6.4 7.1 8.6 11.1 0.6 15.2 0.0 0.0 0.0 0.1 0.0 2.8 1.6 10.8 2.9 43.5 41.7 0.1 14.2 37.9 7.0 7.6 0.0 2.7 9.4 9.2 24.7 26.5 10.3 1.4 4.4 6.7 0.0 4.3 0.0 0.2 0.2 13.4 0.1 0.3 40.8 6.8 10.6 8.7 25.8 4.7 0.0 0.0 0.3 17.7 5.2 0.2 1.0 0.4 0.1 0.0 6.3 21.9 0.0 3.7 3.0 3.5 15.4 3.8 0.1 23.3 4.0 8.8 13.1 5.7 52.4 2.7 10.2 15.3 0.0 0.1 0.1 12.5 0.0 78.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 15.2 0.0 0.0 52.8 49.0 30.1 38.9 40.2 25.2 32.0 24.9 25.8 24.1 0.0 0.0 0.0 0.4 0.2 6.9 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.9 0.6 0.0 0.0 0.2 0.1 0.7 0.3 0.0 0.0 0.2 11.1 0.0 0.6 0.3 0.4 1.1 0.0 0.0 0.0 0.0 4.9 0.5 0.0 0.4 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.5 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 23.6" "Cell type enhanced" "Detected in single" 32 "Horizontal cells: 3.2" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "REH: 9.3;SCLC-21H: 7.9;SH-SY5Y: 15.2;SuSa: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.7 2.9 5.7 0.7 9.5 0.5 0.8 23.6 21.9 1.0 1.1 2.3 0.0 0.6 0.9 1.2 0.8 1.0 1.0 1.3 4.1 10.1 0.6 0.6 1.0 0.9 3.3 4.5 0.8 1.2 0.8 1.3 0.8 8.6 0.8 0.8 1.9 1.0 0.7 1.2 1.5 0.7 0.9 2.3 0.8 0.7 1.5 0.8 0.0 0.7 0.0 1.0 0.6 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.2 0.2 0.8 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.2 0.9 0.9 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.0 1.5 0.0 0.0 9.3 0.5 0.0 0.0 0.1 7.9 15.2 0.1 0.0 0.2 11.2 0.1 0.3 0.1 0.8 0.1 0.2 0.7 0.2 0.0 0.2 0.6 0.1 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.5 23.6 15.6 4.1 10.1 3.3 4.5 8.6 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489121-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 43.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.0;SuSa: 8.4;U-138 MG: 16.0;U-251 MG: 6.8;U-87 MG: 9.8" "Group enriched" "Detected in many" 5 "amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4" "HPA008755, HPA010580, HPA076140" Supported Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 1.0 1.1 7.4 1.1 34.5 0.9 1.1 3.0 43.7 1.1 1.0 2.8 0.0 0.9 1.4 1.3 1.0 1.2 1.2 2.8 11.8 2.8 0.9 0.9 1.1 0.9 2.2 10.0 1.1 1.0 1.0 1.1 1.0 2.3 1.3 1.0 0.0 0.9 1.6 1.6 1.5 0.9 2.0 0.8 1.0 1.0 1.3 1.1 0.0 1.0 0.0 1.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.7 0.2 0.8 0.6 0.5 0.6 0.0 0.0 0.5 1.6 2.4 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.5 0.0 5.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.9 0.8 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 8.4 0.1 0.2 0.1 16.0 0.2 0.2 6.8 0.0 0.0 0.0 9.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 34.5 3.0 39.2 11.8 2.8 2.2 10.0 2.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCGF3 "DONG1, FLJ36550, MGC40413, RNF3, RNF3A" ENSG00000185619 "Polycomb group ring finger 3" Q3KNV8 4 705748-770640 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061879 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA061879: AB_2684631" "unprognostic (1.24e-1)" "unprognostic (2.77e-1)" "unprognostic (2.62e-1)" "unprognostic (1.06e-2)" "unprognostic (1.66e-1)" "prognostic favorable (3.73e-4)" "unprognostic (2.76e-2)" "unprognostic (4.21e-2)" "unprognostic (9.52e-2)" "unprognostic (1.47e-2)" "prognostic favorable (1.44e-4)" "unprognostic (2.36e-2)" "unprognostic (6.84e-3)" "unprognostic (2.53e-1)" "unprognostic (2.20e-1)" "unprognostic (1.96e-1)" "prognostic favorable (5.25e-4)" 17.3 29.0 18.2 22.0 18.8 28.0 18.9 31.4 21.8 17.7 15.2 12.4 21.4 24.3 20.9 19.1 17.9 17.5 18.1 14.0 16.5 11.2 14.6 15.3 17.8 18.2 17.2 17.5 28.6 15.3 6.5 20.0 21.3 15.3 20.5 11.9 15.1 20.4 15.8 15.5 55.8 22.5 15.2 11.8 26.4 20.8 18.0 16.9 20.8 21.3 19.2 17.6 15.3 20.0 7.3 7.2 6.9 11.6 6.9 5.4 3.5 11.4 10.4 19.2 21.9 8.8 9.1 23.7 15.6 8.6 12.9 13.1 11.4 12.7 8.3 10.5 15.0 13.1 8.0 8.9 12.7 9.8 10.8 9.6 11.8 12.2 20.0 10.8 8.0 15.8 11.4 17.0 11.2 5.1 8.5 16.4 15.2 16.2 6.8 12.5 12.8 21.5 28.5 12.7 7.8 18.9 21.4 12.2 5.2 7.6 18.9 27.5 20.7 8.1 8.7 8.3 13.0 17.0 11.5 19.6 12.6 10.2 10.4 20.0 16.5 13.9 12.9 9.9 12.9 23.2 5.5 11.6 4.7 5.4 7.5 4.8 6.7 3.4 3.4 5.1 7.3 4.3 3.0 6.9 6.9 3.5 7.2 5.0 3.5 18.2 18.8 31.4 21.8 16.5 11.2 17.2 17.5 15.3 16.9 11.9 30.3 15.9 14.9 22.6 11.8 16.7 22.9 9.4 18.2 8.7 11.8 11.7 3.3 18.4 44.6 21.8 17.2 0.0 17.2 22.3 17.3 17.4 16.1 12.1 10.7 6.4 18.5 25.8 11.0 39.8 15.3 17.1 21.9 10.0 21.7 9.2 26.4 14.4 14.5 8.8 7.9 6.5 16.9 20.1 24.3 25.1 19.8 13.8 18.7 25.2 PCLO "ACZ, DKFZp779G1236, KIAA0559" ENSG00000186472 "Piccolo presynaptic cytomatrix protein" Q9Y6V0 7 82754013-83162930 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 95.6;Cone photoreceptor cells: 123.7;Horizontal cells: 81.0;Intestinal endocrine cells: 57.6;Rod photoreceptor cells: 84.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "REH: 62.4;U-2 OS: 71.7" "Low region specificity" "Detected in all" "HPA015858, HPA029579, CAB079012" Approved Supported Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles, Plasma membrane" "CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044" "unprognostic (1.32e-2)" "unprognostic (1.99e-1)" "unprognostic (9.33e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (4.49e-3)" "unprognostic (6.14e-2)" "unprognostic (4.61e-2)" "unprognostic (1.82e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-1)" "unprognostic (4.79e-6)" "unprognostic (5.15e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-5)" "unprognostic (6.62e-5)" 3.1 7.9 8.8 0.8 26.3 0.4 4.7 50.3 19.4 3.2 3.9 1.6 0.4 2.9 1.0 7.3 2.3 2.0 1.9 2.2 9.8 5.7 8.2 0.6 1.8 0.6 4.6 12.6 1.9 4.0 11.4 19.2 1.0 9.1 4.9 3.5 3.6 2.5 5.0 0.6 2.6 2.4 0.7 5.3 1.1 2.9 4.5 4.4 0.0 8.4 0.0 0.8 1.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 1.9 0.1 1.4 0.5 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.4 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.2 1.1 62.4 1.0 0.0 0.4 0.2 1.2 0.8 0.0 0.6 0.1 0.3 0.8 0.1 0.0 0.0 71.7 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.8 26.3 50.3 19.4 9.8 5.7 4.6 12.6 9.1 4.4 8.9 14.1 0.0 8.3 2.3 95.6 24.6 20.4 9.4 18.2 1.8 123.7 0.9 6.6 4.6 9.0 4.1 14.6 0.0 4.4 0.3 0.4 5.3 0.0 0.0 1.3 81.0 57.6 0.0 0.0 5.6 2.6 0.0 0.0 0.0 12.3 17.5 2.5 14.4 6.0 16.7 84.6 0.0 0.3 3.9 13.8 3.0 0.6 0.0 7.7 4.8 PCNX1 "KIAA0805, KIAA0995, PCNX, PCNXL1, pecanex" ENSG00000100731 "Pecanex homolog 1" Q96RV3 14 70907405-71115382 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 27.5;Ciliated cells: 17.4;granulocytes: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053532 Approved Nucleoplasm NA NA Nucleoplasm "HPA053532: AB_2682180" "unprognostic (1.96e-1)" "unprognostic (2.46e-1)" "unprognostic (2.01e-1)" "unprognostic (2.62e-1)" "unprognostic (2.21e-1)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-2)" "unprognostic (4.16e-2)" "unprognostic (5.56e-2)" "prognostic favorable (4.05e-5)" "unprognostic (9.01e-3)" "unprognostic (2.90e-1)" "unprognostic (8.11e-2)" "unprognostic (7.37e-2)" 18.2 32.2 14.0 18.8 19.8 20.0 17.4 16.3 21.2 15.7 18.5 14.5 8.8 10.2 18.7 10.3 12.2 14.5 13.2 16.2 11.4 8.1 16.1 14.7 20.2 21.4 14.1 13.1 27.1 12.3 26.3 22.3 11.5 12.0 12.8 10.3 16.8 11.7 12.3 22.8 12.0 18.7 17.1 12.4 22.2 14.1 26.4 13.3 16.4 16.1 10.2 16.7 16.6 17.3 2.3 4.1 11.2 2.0 1.9 10.5 1.6 12.6 8.9 10.3 6.4 17.5 11.8 5.7 13.5 13.6 10.6 14.9 8.8 5.7 9.1 4.7 13.8 8.3 12.7 11.0 10.9 16.1 27.7 4.2 1.7 5.7 9.3 10.6 13.7 4.7 12.1 9.7 10.6 19.1 13.2 10.5 9.4 0.7 13.2 12.2 10.2 6.5 12.5 5.2 5.6 4.9 5.9 11.8 2.7 7.3 9.5 4.3 6.7 10.3 6.2 7.6 11.0 5.5 13.1 12.4 19.6 21.9 6.3 9.7 8.0 4.1 7.6 12.1 11.3 6.8 2.8 2.0 1.8 4.0 1.1 5.5 1.6 6.9 4.1 0.5 2.3 3.0 4.6 11.2 1.9 0.7 4.1 10.5 1.6 14.0 19.8 16.3 21.2 11.4 8.1 14.1 13.1 12.0 13.3 14.9 27.5 0.0 0.0 0.0 0.0 0.0 0.0 17.4 11.4 8.7 0.0 5.1 1.7 7.9 0.0 0.0 0.0 0.0 4.6 5.3 0.0 0.0 14.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 7.2 0.0 0.0 7.4 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 PCNX2 "FLJ11383, KIAA0435, PCNXL2" ENSG00000135749 "Pecanex homolog 2" A6NKB5 1 232983435-233295713 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 29.6" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 8.9;Ciliated cells: 8.1;Club cells: 12.5;Collecting duct cells: 12.2;Distal tubular cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013815, HPA014427" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA013815: AB_2236561, HPA014427: AB_1855081" "unprognostic (3.15e-1)" "unprognostic (5.61e-3)" "unprognostic (1.92e-2)" "unprognostic (1.44e-2)" "unprognostic (2.54e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-2)" "unprognostic (1.71e-1)" "unprognostic (4.25e-2)" "unprognostic (3.79e-1)" "unprognostic (2.40e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.27e-5)" "unprognostic (1.12e-1)" "unprognostic (2.92e-2)" "unprognostic (1.49e-2)" "unprognostic (1.29e-1)" 4.7 4.7 11.4 7.5 16.8 4.2 7.7 29.6 23.1 4.9 3.9 6.3 4.2 3.4 6.6 14.0 5.2 9.0 8.1 2.3 11.9 8.2 5.4 1.2 4.7 9.4 8.0 13.1 11.4 5.2 8.6 18.6 2.4 14.3 6.2 4.8 6.0 6.0 8.1 5.6 6.3 5.6 5.2 5.8 5.3 5.8 5.5 5.5 4.0 7.9 3.4 8.8 6.0 5.7 1.5 1.8 0.9 0.9 0.8 3.1 1.1 3.8 9.4 5.1 0.1 8.4 9.2 1.5 2.3 6.8 2.4 4.3 3.0 4.7 8.1 5.5 6.3 9.0 6.4 2.3 6.7 5.7 6.8 6.9 0.1 4.8 0.0 3.8 2.6 1.6 7.0 5.9 4.8 19.1 8.3 4.5 6.1 0.0 4.3 2.4 2.3 7.4 0.2 16.5 3.3 5.7 0.1 1.4 1.1 4.4 6.0 8.8 7.3 3.4 1.5 1.4 3.0 3.4 0.7 1.7 6.8 4.4 7.7 7.6 5.2 5.4 0.1 6.2 3.0 7.8 0.9 0.9 0.4 3.1 0.5 2.4 1.5 2.5 2.9 1.8 1.3 1.1 2.1 0.7 0.8 0.7 0.6 2.7 1.1 11.4 16.8 29.6 23.1 11.9 8.2 8.0 13.1 14.3 5.5 8.9 5.1 0.0 0.0 0.0 0.0 0.0 0.0 8.1 12.5 12.2 0.0 0.3 6.6 5.1 0.0 0.0 0.0 0.0 2.9 1.1 0.0 0.0 1.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.8 0.0 0.0 4.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PCNX3 "FLJ22427, PCNXL3" ENSG00000197136 "Pecanex homolog 3" Q9H6A9 11 65615773-65637439 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 8.3;Collecting duct cells: 12.2;Ductal cells: 8.4;Exocrine glandular cells: 7.5;Hofbauer cells: 7.7;Pancreatic endocrine cells: 10.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018084 Uncertain Approved Cytosol NA NA Cytosol "HPA018084: AB_1855083" "unprognostic (9.93e-2)" "unprognostic (1.33e-1)" "unprognostic (5.46e-2)" "unprognostic (1.09e-2)" "unprognostic (2.54e-1)" "unprognostic (1.70e-2)" "unprognostic (3.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (7.69e-3)" "unprognostic (7.06e-2)" "unprognostic (2.44e-2)" "unprognostic (8.52e-3)" "unprognostic (6.51e-3)" "unprognostic (1.93e-1)" "unprognostic (2.32e-2)" "unprognostic (4.82e-1)" 11.0 14.0 11.6 17.0 12.5 20.4 11.8 18.1 16.8 10.3 14.4 13.5 15.6 18.4 16.4 12.6 15.4 13.9 13.6 9.0 11.9 7.1 12.4 18.8 15.1 17.6 12.6 10.6 13.1 18.1 13.9 13.9 16.1 11.7 13.0 7.8 12.1 16.9 13.3 8.2 14.5 18.8 12.1 11.1 18.0 15.3 26.6 11.7 21.6 15.3 8.8 14.2 13.7 10.9 2.6 3.3 6.0 2.5 1.7 3.6 1.3 12.0 18.2 6.7 16.5 5.2 4.1 15.2 8.6 7.5 8.4 6.2 8.7 13.8 8.9 16.7 7.6 11.5 19.9 7.1 9.9 2.5 7.5 12.5 11.6 16.9 7.1 5.9 11.3 14.3 7.7 5.0 8.3 6.6 3.8 8.2 9.5 13.3 7.6 4.9 18.0 9.5 8.8 13.6 5.2 11.7 13.5 6.0 11.6 3.7 19.6 8.3 12.4 9.1 12.1 10.2 3.1 21.2 7.8 11.6 14.7 13.9 12.1 8.6 12.5 7.4 8.0 11.7 5.5 12.8 6.0 2.5 1.5 3.6 1.2 3.0 1.5 2.0 2.1 1.3 2.6 1.5 2.1 3.5 1.7 1.7 3.3 0.8 1.3 11.6 12.5 18.1 16.8 11.9 7.1 12.6 10.6 11.7 11.7 6.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 12.2 0.0 5.6 0.0 8.4 0.0 0.0 0.0 0.0 7.5 4.6 0.0 0.0 4.7 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.6 0.0 0.0 10.6 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 PCNX4 "C14orf135, PCNXL4" ENSG00000126773 "Pecanex homolog 4" Q63HM2 14 60091911-60169133 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 62.9;Club cells: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002076, HPA003390" Uncertain Approved Cytosol NA NA Cytosol "HPA002076: AB_1078322, HPA003390: AB_2066703" "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (1.89e-1)" "unprognostic (9.87e-2)" "unprognostic (2.18e-1)" "unprognostic (2.94e-1)" "unprognostic (3.83e-3)" "unprognostic (2.01e-1)" "unprognostic (1.54e-1)" "unprognostic (3.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.81e-1)" "prognostic favorable (6.84e-5)" "unprognostic (2.13e-1)" "unprognostic (2.08e-1)" "unprognostic (4.14e-2)" "unprognostic (8.59e-2)" 12.0 16.5 13.6 14.7 18.2 9.1 14.3 19.4 18.6 18.8 10.2 15.2 14.0 8.2 21.2 13.6 10.4 22.7 14.2 17.8 12.7 13.6 20.6 11.1 12.2 11.0 12.5 12.4 27.4 12.1 26.3 39.8 13.7 16.1 21.3 11.2 17.7 12.7 17.2 15.2 13.0 11.3 16.2 14.5 13.1 10.0 23.0 11.6 24.6 16.5 11.1 11.7 11.6 13.9 7.3 7.7 5.3 8.1 13.4 11.4 5.3 40.1 6.3 12.1 8.2 10.4 12.3 5.4 13.4 22.0 16.1 20.3 6.7 12.2 7.2 5.6 11.2 13.2 5.3 8.1 7.9 27.4 9.1 3.7 11.4 4.6 5.2 22.0 11.8 8.3 9.9 5.5 11.1 18.9 13.0 7.5 16.6 5.8 10.1 25.0 5.3 16.3 4.2 6.2 4.6 8.1 9.5 15.5 2.9 8.9 5.5 9.1 10.7 12.5 4.9 9.7 7.2 10.9 5.2 14.9 33.1 25.3 7.8 10.3 3.3 3.2 9.6 12.6 4.2 16.0 4.8 6.9 5.3 8.7 7.2 11.4 7.3 6.3 7.5 7.0 5.5 7.2 8.0 3.2 13.4 8.1 7.7 6.2 5.3 13.6 18.2 19.4 18.6 12.7 13.6 12.5 12.4 16.1 11.6 14.9 22.2 0.0 0.0 0.0 0.0 0.0 0.0 62.9 35.2 24.4 0.0 14.5 14.9 16.8 0.0 0.0 0.0 0.0 11.2 6.9 0.0 0.0 14.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 18.0 0.0 0.0 15.8 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 PCSK1N "BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII" ENSG00000102109 "Proprotein convertase subtilisin/kexin type 1 inhibitor" Q9UHG2 X 48831094-48835633 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.9;kidney: 72.9;pituitary gland: 127.7" "Group enriched" "Detected in many" 5 "Intestinal endocrine cells: 2932.5;Proximal tubular cells: 1024.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 3.0;memory CD4 T-cell: 6.5;memory CD8 T-cell: 6.3;naive CD4 T-cell: 2.7;naive CD8 T-cell: 8.2;T-reg: 2.1" "Lineage enriched" "Detected in single" 77 "T-cells: 8.2" "Cell line enhanced" "Detected in some" "HEK 293: 20.0;PC-3: 50.7;SCLC-21H: 20.1;SH-SY5Y: 18.6;SiHa: 17.6;U-266/84: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003925, HPA064734" Enhanced Supported Approved Vesicles "Secreted to blood" NA NA 5300000 Vesicles "HPA003925: AB_1079582, HPA064734: AB_2685339" "unprognostic (2.44e-3)" "unprognostic (5.86e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (3.36e-1)" "unprognostic (4.76e-3)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (1.50e-3)" "unprognostic (2.79e-3)" "prognostic favorable (1.36e-4)" "unprognostic (3.34e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" 4.1 27.5 49.1 2.6 72.7 2.1 2.2 15.6 70.3 3.2 9.8 10.8 1.5 12.4 4.4 10.9 2.1 2.3 2.8 2.7 38.5 74.9 72.9 2.1 2.6 2.2 33.5 29.0 2.2 20.0 12.4 127.7 2.3 32.9 4.6 2.7 6.6 2.8 3.1 2.2 2.8 8.5 2.7 18.3 2.4 26.0 3.8 9.8 0.0 2.2 0.0 2.1 2.1 0.5 0.1 0.0 0.0 0.0 0.0 8.2 0.8 0.0 1.8 0.0 5.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.6 0.0 1.4 0.2 0.0 0.3 0.0 0.0 20.0 0.0 0.0 3.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 2.7 0.0 50.7 0.0 0.0 0.1 0.4 0.0 20.1 18.6 17.6 0.0 1.4 0.2 0.0 0.0 0.0 0.0 7.8 0.0 1.6 4.6 23.4 0.1 0.1 0.0 0.5 0.0 0.0 0.0 1.1 0.0 3.0 0.0 6.5 6.3 0.0 0.1 2.7 8.2 0.0 0.0 0.0 0.0 2.1 0.8 49.1 72.7 15.6 70.3 38.5 74.9 33.5 29.0 32.9 9.8 0.0 0.0 2.2 1.5 14.1 134.7 1.0 5.1 1.4 0.0 369.9 49.1 0.5 235.4 7.5 11.6 0.5 12.9 0.0 0.6 43.5 6.2 36.6 0.0 0.0 1.5 413.2 2932.5 0.0 0.0 41.9 3.1 2.7 54.0 0.0 16.6 54.9 36.6 411.7 6.7 1024.2 101.7 0.0 16.5 18.2 20.6 10.0 1.6 3.2 10.1 2.6 PCSK5 "PC5, PC6, SPC6" ENSG00000099139 "Proprotein convertase subtilisin/kexin type 5" Q92824 9 75890644-76362339 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Pregnancy "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 157.6;intestine: 71.5" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 67.7;Horizontal cells: 52.4;Muller glia cells: 43.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "basophil: 157.6;neutrophil: 57.4" "Lineage enriched" "Detected in all" 12 "granulocytes: 157.6" "Cell line enhanced" "Detected in many" "BEWO: 15.9;HaCaT: 22.2;RH-30: 14.7;RPTEC TERT1: 20.6;U-2 OS: 32.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031072 Approved Supported "Golgi apparatus" "Secreted to blood" NA NA "Golgi apparatus" "HPA031072: AB_10602190" "unprognostic (3.28e-2)" "unprognostic (1.44e-1)" "unprognostic (4.13e-4)" "unprognostic (4.08e-2)" "unprognostic (7.43e-3)" "unprognostic (3.17e-1)" "unprognostic (2.07e-3)" "unprognostic (9.39e-2)" "unprognostic (1.15e-1)" "unprognostic (5.92e-2)" "unprognostic (2.81e-2)" "unprognostic (6.80e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (2.99e-1)" "unprognostic (3.21e-2)" "unprognostic (3.22e-2)" "unprognostic (1.77e-5)" 15.8 3.8 2.9 13.7 2.8 1.5 9.5 2.4 3.2 8.5 51.8 2.9 4.5 19.7 6.5 13.9 9.6 7.8 22.9 6.7 3.8 2.4 3.7 1.9 7.7 5.6 2.3 3.1 17.2 3.4 9.5 3.2 7.7 3.5 4.5 6.7 3.3 5.0 5.8 4.0 4.8 71.5 6.9 3.5 2.5 3.3 5.1 2.4 18.0 6.4 14.2 4.5 7.1 11.4 11.7 12.2 157.6 4.4 12.6 12.7 0.8 1.1 0.8 2.4 1.6 1.5 0.5 15.9 2.2 0.2 0.1 0.0 8.4 0.9 0.3 0.6 0.3 0.0 22.2 1.1 0.6 0.1 0.2 1.9 2.9 1.6 0.7 0.4 0.8 1.3 3.0 0.2 0.5 0.2 0.1 4.6 1.5 3.3 1.0 1.6 5.3 3.3 5.0 10.8 1.9 0.9 0.6 14.7 0.9 20.6 1.2 0.2 0.2 3.3 0.7 0.2 4.8 1.2 3.6 3.6 0.7 32.2 1.8 0.9 0.2 0.1 0.4 2.5 1.2 12.2 157.6 4.2 16.2 9.7 2.3 8.3 8.8 9.8 8.9 1.9 11.7 9.9 12.7 57.4 12.6 4.4 12.2 8.4 0.8 2.9 2.8 2.4 3.2 3.8 2.4 2.3 3.1 3.5 2.4 6.0 4.5 0.0 4.1 5.8 4.4 3.7 10.2 17.4 20.5 5.2 0.0 1.4 0.0 5.2 19.6 8.9 67.7 0.0 5.4 25.1 17.5 1.4 0.0 0.9 2.8 52.4 1.2 14.1 4.0 31.4 19.0 3.4 1.7 3.6 8.8 43.7 7.8 17.5 23.7 3.3 1.2 19.4 8.2 1.1 1.5 2.6 2.1 6.4 16.1 0.7 PCSK7 "LPC, PC7, PC8, SPC7" ENSG00000160613 "Proprotein convertase subtilisin/kexin type 7" Q16549 11 117204337-117232525 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 231.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.11e-2)" "unprognostic (2.90e-2)" "unprognostic (8.33e-3)" "unprognostic (4.24e-2)" "unprognostic (1.32e-1)" "unprognostic (2.77e-2)" "unprognostic (1.56e-1)" "unprognostic (2.60e-1)" "unprognostic (1.96e-1)" "unprognostic (2.41e-1)" "unprognostic (8.80e-2)" "unprognostic (1.09e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.00e-1)" "unprognostic (3.03e-2)" 19.4 11.6 11.9 28.7 13.9 11.3 14.4 12.9 16.5 15.0 44.8 15.4 13.4 20.4 47.9 9.4 27.3 23.9 20.7 12.2 10.4 5.2 9.9 11.5 14.5 19.7 18.7 14.1 11.5 14.9 6.2 12.8 18.3 13.3 24.0 17.7 9.6 14.1 11.4 12.8 11.4 20.3 9.2 9.7 16.8 28.4 6.3 13.9 17.8 10.4 13.7 25.3 34.6 13.0 12.7 4.2 4.2 5.3 19.6 19.7 8.7 5.6 10.6 8.7 8.1 9.6 7.3 7.2 22.2 9.1 10.2 9.8 23.8 34.8 9.0 22.2 15.9 12.5 19.9 9.8 13.2 6.4 14.0 9.1 13.4 15.4 7.0 11.5 8.5 21.5 13.9 8.2 13.7 9.2 12.0 17.5 10.8 8.3 8.2 14.3 8.2 11.3 9.8 7.3 26.1 10.4 8.3 7.1 11.4 12.3 13.7 11.4 13.7 16.2 21.0 3.0 15.7 13.0 7.7 16.2 24.4 8.1 13.7 14.6 5.6 3.4 5.7 7.9 12.3 14.6 3.9 3.3 4.2 19.5 4.7 16.4 12.7 15.2 17.8 3.7 9.6 11.0 12.7 2.8 19.6 5.3 4.2 19.7 8.7 11.9 13.9 12.9 16.5 10.4 5.2 18.7 14.1 13.3 13.9 44.7 45.9 100.9 39.4 62.3 108.5 5.6 35.7 10.7 37.5 45.4 231.7 39.5 5.0 25.4 4.9 36.5 104.5 0.0 47.7 31.2 39.3 31.0 32.4 24.3 28.3 82.6 60.0 73.1 48.0 4.8 31.1 49.7 50.6 28.9 75.0 24.9 52.6 133.5 37.4 5.9 164.4 71.1 70.4 43.5 23.2 82.4 52.3 171.5 88.7 50.6 PDCD1 "CD279, hSLE1, PD-1, PD1, SLEB2" ENSG00000188389 "Programmed cell death 1" Q15116 2 241849881-241858908 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Apoptosis, Immunity" "FDA approved drug targets, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.6;lymphoid tissue: 21.5" "Cell type enriched" "Detected in some" 9 "T-cells: 15.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 4.1;MAIT T-cell: 3.9;memory CD4 T-cell: 6.8;memory CD8 T-cell: 11.6;T-reg: 3.5" "Lineage enriched" "Detected in single" 93 "T-cells: 11.6" "Group enriched" "Detected in some" 7 "MOLT-4: 9.5;RPMI-8226: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035981, CAB038418, CAB076386" Enhanced NA NA "CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664" "unprognostic (2.90e-3)" "unprognostic (4.50e-3)" "unprognostic (7.78e-2)" "prognostic favorable (9.44e-5)" "unprognostic (7.18e-3)" "unprognostic (1.31e-3)" "unprognostic (3.83e-2)" "unprognostic (7.33e-2)" "unprognostic (5.82e-3)" "unprognostic (3.75e-2)" "unprognostic (6.57e-2)" "unprognostic (3.94e-1)" "prognostic unfavorable (3.48e-7)" "unprognostic (1.20e-2)" "unprognostic (3.10e-1)" "unprognostic (5.35e-2)" "unprognostic (5.06e-3)" 1.4 0.4 0.0 21.5 0.7 3.0 0.5 0.1 0.3 1.2 1.9 0.0 0.0 0.4 0.5 1.6 2.0 0.8 1.7 9.2 0.2 0.5 1.3 0.5 5.6 16.6 0.1 0.3 0.7 1.0 0.2 1.9 0.3 0.4 1.3 0.2 1.2 3.0 0.5 0.2 0.2 4.9 0.4 0.3 9.5 1.9 0.4 0.2 16.6 1.9 3.0 20.1 1.3 0.8 0.1 0.0 0.0 0.0 0.0 11.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.5 9.5 0.0 0.0 0.0 0.0 0.0 0.1 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 3.9 0.1 6.8 11.6 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 3.5 1.5 0.0 0.7 0.1 0.1 0.2 0.5 0.1 0.3 0.4 0.2 0.0 1.1 0.0 0.2 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 15.9 0.0 0.0 PDCD1LG2 "B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2" ENSG00000197646 "Programmed cell death 1 ligand 2" Q9BQ51 9 5510570-5571254 "Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 15.1;monocytes: 45.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 25.9;BJ hTERT+: 40.8;HDLM-2: 31.1;TIME: 18.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA013411 Approved Uncertain Cytosol "Secreted - unknown location" NA NA 34000000 Cytosol "HPA013411: AB_1855102" "unprognostic (3.93e-2)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (6.68e-3)" "unprognostic (7.66e-2)" "unprognostic (6.77e-2)" "unprognostic (5.72e-2)" "unprognostic (2.91e-1)" "unprognostic (1.68e-1)" "unprognostic (4.37e-3)" "unprognostic (5.79e-2)" "unprognostic (5.29e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (5.00e-2)" "unprognostic (4.66e-2)" "unprognostic (2.01e-1)" "unprognostic (7.51e-3)" 15.2 1.8 1.2 7.7 1.4 0.2 9.5 0.7 1.2 7.0 1.9 2.3 0.0 0.8 2.9 7.2 3.9 3.8 4.0 5.8 1.2 1.3 2.5 6.4 13.3 10.8 1.6 0.5 4.1 1.8 0.5 1.1 12.9 1.9 5.0 2.5 2.4 2.9 1.7 5.5 3.6 2.5 4.6 3.7 19.5 1.9 4.2 1.2 8.1 3.5 3.5 8.1 6.0 5.4 0.5 0.9 4.1 3.6 0.0 3.0 0.7 2.1 0.0 0.0 0.0 1.8 2.1 0.0 25.9 40.8 12.5 15.2 0.0 0.1 0.0 0.1 10.5 1.8 0.2 0.0 3.5 12.5 31.1 0.0 0.0 0.0 0.0 10.1 0.0 0.0 1.9 0.0 5.8 6.9 3.6 8.2 0.0 0.0 3.1 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 18.0 9.0 0.5 4.3 7.1 0.4 0.0 0.0 5.1 0.0 1.1 4.1 0.9 0.0 1.4 3.6 1.9 0.5 2.2 0.9 0.9 0.3 0.0 1.0 2.0 0.0 0.5 0.0 3.0 0.7 1.2 1.4 0.7 1.2 1.2 1.3 1.6 0.5 1.9 1.2 6.0 0.3 0.8 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 1.9 0.0 0.0 0.2 15.1 2.1 0.1 3.5 0.0 2.8 0.0 0.0 6.7 4.3 0.0 5.5 2.2 1.7 45.9 0.0 0.0 2.1 0.0 2.1 0.0 0.0 0.0 1.4 0.0 0.0 0.9 0.7 0.0 0.0 0.0 PDE3A CGI-PDE ENSG00000172572 "Phosphodiesterase 3A" Q14432 12 20369245-20684381 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 62.2" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 41.0;Cardiomyocytes: 107.8;Horizontal cells: 49.3;Smooth muscle cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;HEL: 14.6;HeLa: 39.5;HUVEC TERT2: 7.1;SH-SY5Y: 14.8;U-138 MG: 11.4" "Low region specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 35.4" "HPA014492, HPA074258" Approved Approved "Plasma membrane" NA NA 23000 "Plasma membrane" "HPA014492: AB_1855120, HPA074258: " "unprognostic (2.59e-2)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (3.23e-1)" "unprognostic (2.27e-1)" "unprognostic (1.21e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-2)" "unprognostic (8.14e-2)" "unprognostic (1.49e-1)" "unprognostic (4.25e-1)" "unprognostic (3.37e-1)" "prognostic unfavorable (1.72e-6)" "unprognostic (5.58e-2)" "unprognostic (5.94e-2)" "unprognostic (4.28e-2)" "unprognostic (2.76e-4)" 7.1 1.0 1.7 4.7 2.0 0.0 3.8 3.5 1.4 7.8 15.9 1.0 2.0 2.1 7.8 3.5 9.1 4.9 5.5 62.2 1.6 1.4 3.7 1.8 3.9 3.3 1.9 1.1 7.1 6.5 1.0 2.8 13.8 2.7 6.3 9.0 12.0 7.8 4.2 2.0 1.4 21.4 6.0 1.8 2.1 5.5 2.3 0.7 0.0 2.8 1.9 0.9 4.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 7.9 0.0 1.8 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.6 39.5 0.2 0.6 0.0 0.0 1.8 0.0 0.4 0.1 0.1 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.0 0.0 0.0 2.2 0.0 0.1 14.8 0.0 0.0 0.0 3.5 0.0 0.0 0.2 11.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.7 2.0 3.5 1.4 1.6 1.4 1.9 1.1 2.7 0.7 0.0 0.0 0.0 0.1 0.2 41.0 107.8 5.1 0.0 1.2 0.0 0.0 0.0 0.0 3.7 0.2 2.2 24.6 0.0 0.4 0.0 3.5 0.5 16.2 0.0 0.5 49.3 4.1 0.6 0.0 0.0 1.4 0.0 1.7 0.0 7.4 2.5 0.5 24.6 0.7 2.6 2.2 6.5 51.8 0.2 0.4 0.3 0.0 0.0 13.9 0.2 PDE3B HcGIP1 ENSG00000152270 "Phosphodiesterase 3B" Q13370 11 14643723-14872044 "Enzymes, FDA approved drug targets, Predicted membrane proteins" Angiogenesis Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 42.6" "Cell type enhanced" "Detected in many" 7 "granulocytes: 34.7;Hepatocytes: 50.5;Spermatocytes: 45.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 19.2" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 5.0;T-cells: 8.7" "Cell line enhanced" "Detected in many" "HL-60: 13.6;Karpas-707: 15.7;THP-1: 16.7;U-266/70: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056111 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA056111: AB_2683041" "unprognostic (1.05e-1)" "unprognostic (2.86e-2)" "unprognostic (4.12e-2)" "unprognostic (2.76e-3)" "unprognostic (4.25e-1)" "unprognostic (1.84e-3)" "unprognostic (3.40e-2)" "unprognostic (3.24e-2)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "prognostic favorable (7.91e-4)" "unprognostic (1.77e-1)" "unprognostic (2.33e-2)" "unprognostic (1.39e-2)" "unprognostic (3.42e-1)" "unprognostic (2.47e-1)" "unprognostic (9.03e-3)" 42.6 1.0 2.3 12.6 2.2 6.7 17.0 19.2 3.0 2.9 21.8 0.9 0.8 2.2 0.9 1.4 2.6 1.0 6.9 4.7 2.2 2.1 2.4 18.2 10.2 14.1 1.6 1.6 0.9 7.3 0.3 5.1 5.5 1.5 10.7 8.1 1.9 16.5 1.3 0.8 0.9 6.3 9.7 2.1 8.7 3.0 12.5 0.8 7.8 1.2 2.3 7.1 10.5 4.5 0.3 0.4 5.0 1.2 0.1 8.7 1.8 0.0 1.5 3.4 5.5 6.8 0.0 1.3 0.4 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 1.6 0.0 5.1 0.0 0.0 0.1 11.3 0.1 8.3 10.2 2.4 13.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 4.0 11.9 15.7 0.0 0.1 2.7 6.6 4.6 1.8 2.5 6.5 1.5 10.3 0.0 1.1 5.2 9.7 1.3 8.8 3.0 1.6 0.0 16.7 0.0 0.0 0.8 0.0 0.0 17.7 5.4 0.4 0.1 2.3 1.0 0.0 0.7 2.9 1.4 0.7 2.9 0.3 4.2 3.2 0.4 0.2 8.7 7.5 5.0 0.1 1.2 0.1 4.2 1.8 2.3 2.2 19.2 3.0 2.2 2.1 1.6 1.6 1.5 0.8 14.9 9.9 1.9 0.8 0.2 0.4 8.2 0.0 6.7 11.4 1.8 0.0 1.0 1.7 0.0 12.4 2.2 2.6 23.3 4.3 1.9 8.5 3.4 34.7 50.5 6.3 0.0 1.2 7.4 14.0 10.1 1.4 12.3 0.0 1.0 13.1 4.5 2.9 17.5 8.5 1.9 0.3 0.0 0.1 45.1 11.1 0.1 2.1 11.7 9.7 0.9 PDE6B "CSNB3, CSNBAD2, PDEB, rd1, RP40" ENSG00000133256 "Phosphodiesterase 6B" P35913 4 625584-670782 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Congenital stationary night blindness, Disease mutation, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2;retina: 64.2" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 453.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;JURKAT: 11.8;MOLT-4: 20.5;REH: 11.1;SCLC-21H: 14.0;SH-SY5Y: 8.2;U-266/84: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA054148, HPA059929" Enhanced Approved Cytosol NA NA Cytosol "HPA054148: AB_2682401, HPA059929: AB_2684166" "unprognostic (2.43e-2)" "unprognostic (1.33e-4)" "unprognostic (2.45e-4)" "unprognostic (7.18e-3)" "unprognostic (1.88e-2)" "unprognostic (5.04e-3)" "unprognostic (7.32e-3)" "prognostic favorable (5.34e-4)" "unprognostic (9.70e-2)" "unprognostic (1.14e-1)" "unprognostic (1.37e-2)" "unprognostic (2.33e-2)" "unprognostic (4.09e-2)" "unprognostic (1.67e-2)" "unprognostic (2.26e-1)" "unprognostic (2.41e-3)" "unprognostic (1.85e-1)" 1.6 1.9 12.1 4.6 19.1 6.7 3.8 2.3 13.2 2.3 1.3 30.2 1.5 0.8 2.5 3.9 1.4 9.6 3.2 5.2 18.1 10.2 4.6 0.7 4.2 12.0 29.6 9.8 2.6 1.4 9.1 3.2 2.6 14.5 2.5 1.0 64.2 3.5 2.9 0.7 1.8 2.2 2.1 20.2 8.7 2.5 3.6 22.4 4.3 11.4 0.2 8.3 4.1 1.1 16.5 14.1 11.2 5.8 10.2 13.1 7.1 0.0 0.2 0.8 0.4 0.2 0.3 0.2 0.0 0.0 0.5 1.4 0.0 0.1 0.2 8.0 0.2 0.7 0.1 1.7 0.4 0.0 0.1 0.0 0.6 0.2 0.0 4.1 0.1 0.3 0.5 0.1 2.4 0.0 0.5 0.7 11.8 0.1 0.6 0.0 0.2 20.5 0.2 6.5 0.4 0.2 11.1 0.2 0.4 1.4 0.9 14.0 8.2 0.0 0.3 0.1 3.3 0.4 0.0 0.2 0.1 0.8 0.1 0.3 5.4 15.2 0.2 0.2 0.2 0.1 11.2 4.2 0.6 11.5 5.8 10.5 10.0 7.7 7.9 6.6 16.5 12.2 13.1 1.1 10.2 5.6 14.1 11.4 7.1 12.1 19.1 2.3 10.0 18.1 10.2 29.6 9.8 14.5 22.4 3.0 5.3 4.5 1.2 0.3 18.2 3.7 0.0 16.0 5.7 0.0 78.5 0.1 1.7 5.1 0.4 1.8 0.0 0.0 0.6 0.2 0.8 0.9 3.5 0.0 9.2 11.1 1.7 2.5 3.9 0.0 1.4 3.4 3.3 7.2 0.2 20.9 0.7 0.0 1.4 6.7 453.5 0.0 0.2 3.9 2.7 0.3 0.2 7.0 0.1 0.6 PDGFRA "CD140a, GAS9, PDGFR2" ENSG00000134853 "Platelet derived growth factor receptor alpha" P16234 4 54229097-54298247 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 81.5" "Group enriched" "Detected in many" 9 "Fibroblasts: 171.4;Leydig cells: 416.6;Peritubular cells: 384.4" "Cancer enhanced" "Detected in all" "glioma: 30.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 82.8;ASC TERT1: 38.8;BJ hTERT+: 48.0;fHDF/TERT166: 33.4;HHSteC: 28.0;HSkMC: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004947, CAB018143" Supported Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 150000 "Nucleoplasm, Plasma membrane, Cell Junctions" "CAB018143: AB_2162351, HPA004947: AB_2732399" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "unprognostic (4.59e-3)" "unprognostic (1.60e-1)" "unprognostic (8.92e-2)" "prognostic favorable (9.33e-4)" "unprognostic (1.24e-1)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (2.18e-2)" "unprognostic (2.18e-1)" "unprognostic (7.01e-2)" "prognostic unfavorable (9.79e-6)" "unprognostic (9.58e-3)" "unprognostic (9.87e-2)" "unprognostic (2.16e-2)" "unprognostic (1.72e-3)" 35.0 12.4 12.6 16.1 7.6 0.9 17.2 2.4 20.1 33.2 19.1 9.2 6.4 9.6 27.6 14.6 21.9 22.5 16.2 15.3 8.9 7.4 22.8 8.4 24.1 26.9 9.2 4.0 81.5 6.8 1.6 2.1 25.1 7.2 18.6 15.2 19.2 8.5 8.3 11.9 7.0 17.4 19.7 8.8 51.6 13.6 19.0 9.3 0.5 11.3 12.8 4.3 35.9 24.6 0.9 0.4 2.5 0.4 0.3 0.8 0.3 0.0 0.0 0.2 0.1 82.8 38.8 0.1 4.3 48.0 0.0 0.1 11.5 0.0 0.1 0.1 33.4 0.1 0.1 3.3 0.0 0.0 0.4 0.1 0.1 0.1 0.2 28.0 0.0 0.0 70.4 0.0 5.5 0.0 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 6.7 0.0 0.1 0.0 0.3 0.1 0.0 0.1 15.2 0.5 16.6 0.0 0.0 0.0 0.1 0.4 0.0 0.3 2.5 0.4 0.2 0.5 0.2 0.2 0.6 0.8 0.4 0.0 0.9 0.7 0.4 2.3 0.3 0.3 0.4 0.2 0.3 12.6 7.6 2.4 7.3 8.9 7.4 9.2 4.0 7.2 9.3 0.0 0.3 0.9 0.3 15.1 0.7 4.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 2.9 1.6 3.3 0.0 0.0 5.8 1.2 171.4 0.4 0.0 0.8 2.8 0.0 0.0 38.1 0.6 3.7 416.6 1.6 21.9 8.2 0.0 18.3 12.2 0.0 384.4 0.0 0.4 0.0 13.2 1.1 3.5 13.8 1.1 0.0 0.0 0.8 PDGFRB "CD140b, JTK12, PDGFR, PDGFR1" ENSG00000113721 "Platelet derived growth factor receptor beta" P09619 5 150113837-150155872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Chemotaxis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "Sertoli cells: 1267.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.9;non-classical monocyte: 4.1" "Group enriched" "Detected in many" 8 "monocytes: 4.1;T-cells: 2.9" "Group enriched" "Detected in some" 4 "ASC diff: 173.0;ASC TERT1: 59.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003842, CAB018144, HPA028499" Enhanced Supported "Golgi apparatus,Vesicles" NA NA 35000000 Vesicles "Golgi apparatus" "CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018" "unprognostic (4.75e-2)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (3.27e-1)" "unprognostic (5.61e-2)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (2.12e-2)" "unprognostic (2.57e-3)" "unprognostic (6.72e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.87e-8)" "unprognostic (3.13e-3)" "unprognostic (1.25e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (8.11e-4)" 61.8 10.4 8.3 11.0 9.1 0.5 66.1 4.6 10.4 73.1 15.7 6.7 6.9 5.1 44.3 17.3 21.7 26.1 51.7 24.2 8.2 3.9 17.0 4.6 28.9 21.5 7.9 8.1 46.5 7.5 10.4 7.7 46.4 7.7 24.2 6.3 22.9 11.2 19.3 29.8 20.3 11.2 29.8 5.0 19.6 9.2 21.5 6.7 1.4 21.4 16.0 7.3 23.6 35.1 0.4 0.1 0.0 4.1 0.0 2.9 0.6 0.0 0.0 1.0 0.0 173.0 59.9 0.4 6.0 25.1 4.2 7.1 0.6 0.0 0.0 0.8 17.3 2.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.4 24.5 0.0 0.0 27.0 0.0 5.8 0.0 13.5 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 6.8 2.2 2.9 0.3 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 2.9 0.6 0.0 0.4 0.1 0.8 0.1 0.1 0.0 1.3 0.0 0.0 4.1 0.0 0.0 0.6 8.3 9.1 4.6 10.4 8.2 3.9 7.9 8.1 7.7 6.7 0.0 0.6 0.0 0.5 21.3 5.0 13.4 0.0 1.4 0.0 1.8 3.9 0.6 0.0 0.0 0.8 16.2 0.0 0.0 0.0 1.0 68.8 0.6 0.0 1.5 1.4 0.0 0.0 6.7 0.0 4.7 153.1 2.2 23.6 1.0 0.0 74.9 0.1 0.0 191.6 0.0 1.1 1267.6 273.4 1.1 1.5 13.4 0.7 1.0 0.4 0.9 PDIA4 "ERP70, ERP72" ENSG00000155660 "Protein disulfide isomerase family A member 4" P13667 7 149003062-149028641 "Enzymes, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 164.3" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 542.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006139, HPA006140, CAB017368" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 12000000 "Endoplasmic reticulum" "CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257" "unprognostic (1.98e-1)" "unprognostic (1.62e-2)" "unprognostic (1.77e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (9.69e-4)" "unprognostic (1.97e-2)" "unprognostic (1.81e-1)" "unprognostic (2.11e-2)" "unprognostic (5.11e-2)" "unprognostic (3.24e-3)" "unprognostic (6.08e-3)" "unprognostic (3.20e-2)" "prognostic unfavorable (5.20e-9)" "unprognostic (1.03e-1)" "unprognostic (1.53e-1)" "unprognostic (6.76e-2)" "unprognostic (2.51e-1)" 17.6 13.0 7.7 25.6 11.9 7.4 27.4 5.1 7.9 25.5 20.9 12.1 28.8 18.2 19.4 46.3 15.2 20.8 28.1 16.9 7.3 8.0 27.7 164.3 19.1 29.1 11.6 6.2 19.4 76.3 7.0 19.1 24.7 12.0 18.0 21.9 7.8 36.4 26.5 5.8 10.1 21.3 17.8 13.9 27.9 23.7 11.5 11.3 19.2 89.8 11.9 24.3 17.4 22.6 26.6 63.3 16.2 21.2 21.5 35.9 34.5 32.4 30.9 33.6 93.9 30.7 21.9 48.7 45.7 30.6 26.2 42.8 25.6 87.8 23.4 102.6 37.5 72.2 21.3 22.6 43.3 23.1 16.6 13.3 11.2 8.9 56.1 41.2 25.5 31.7 21.5 19.4 28.7 23.1 34.2 53.2 12.0 18.3 63.8 23.0 35.5 24.3 29.1 50.1 66.4 18.0 16.0 26.1 56.6 30.6 25.5 10.7 28.2 41.5 29.9 15.9 41.9 17.0 19.7 29.0 20.7 11.7 50.1 32.1 48.6 21.8 16.4 48.3 30.2 70.3 16.2 20.1 12.1 34.3 21.2 35.9 26.6 22.6 26.7 19.4 15.1 21.5 22.7 2.7 21.5 21.0 63.3 16.6 34.5 7.7 11.9 5.1 7.9 7.3 8.0 11.6 6.2 12.0 11.3 26.8 33.4 29.0 71.4 30.8 3.3 20.4 96.8 65.6 44.3 40.1 3.9 152.3 13.3 102.2 2.7 35.1 89.5 46.7 79.9 277.0 90.5 103.6 57.6 542.5 131.4 0.0 59.1 95.8 80.7 3.2 54.7 53.4 82.7 48.7 104.5 19.3 96.2 87.1 40.3 54.4 6.1 32.3 34.2 53.4 71.9 25.0 192.7 54.6 97.0 59.2 PDPN "aggrus, Gp38, GP40, PA2.26, T1A-2" ENSG00000162493 Podoplanin Q86YL7 1 13583465-13617957 "Predicted membrane proteins" "Cell shape" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.8" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 98.3;Fibroblasts: 108.5;monocytes: 202.8;Muller glia cells: 85.7;Peritubular cells: 59.1" "Cancer enhanced" "Detected in many" "testis cancer: 102.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.1" "Cell line enhanced" "Detected in some" "AF22: 30.3;EFO-21: 72.6;HAP1: 50.4;HHSteC: 44.7;NTERA-2: 23.3;SuSa: 25.2;TIME: 48.3" "HPA007534, HPA007949, CAB008376" Enhanced Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA "Plasma membrane" "Cell Junctions, Mitochondria" "CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: " "unprognostic (1.75e-1)" "unprognostic (3.19e-2)" "unprognostic (6.03e-2)" "unprognostic (3.61e-2)" "unprognostic (2.73e-2)" "unprognostic (1.05e-2)" "unprognostic (3.85e-2)" "unprognostic (5.23e-2)" "unprognostic (9.21e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-2)" "unprognostic (5.62e-3)" "unprognostic (9.20e-3)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" "unprognostic (2.78e-2)" 27.7 2.0 6.3 29.8 10.9 0.5 30.3 5.0 6.7 21.4 12.8 11.0 4.1 2.5 16.8 15.3 8.9 19.8 23.7 18.6 5.7 6.5 1.9 0.8 17.8 10.4 10.0 2.4 18.4 3.9 0.7 2.3 71.8 13.5 11.3 6.4 26.6 6.0 8.6 21.9 10.0 7.6 18.6 17.5 0.7 15.1 9.7 7.9 3.2 5.7 9.7 9.9 27.3 28.9 0.4 0.2 3.1 0.4 0.3 0.4 0.1 0.0 0.0 30.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 72.6 1.7 0.0 0.1 50.4 9.0 0.0 0.1 9.2 0.0 0.0 0.0 44.7 0.0 0.0 6.1 16.8 3.8 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.1 48.3 8.5 7.3 0.1 0.0 0.0 0.0 0.1 18.1 0.0 0.0 1.0 0.4 0.6 0.2 0.2 0.2 0.4 0.3 0.3 0.2 0.4 0.4 0.3 3.1 0.3 0.2 0.2 0.2 0.1 6.3 10.9 5.0 4.8 5.7 6.5 10.0 2.4 13.5 7.9 98.3 9.1 0.0 29.7 12.9 1.2 6.9 0.0 6.7 29.6 0.0 3.9 1.8 0.0 0.4 0.5 7.4 0.0 0.0 0.0 1.6 108.5 3.5 1.1 0.0 6.5 0.0 0.0 7.4 0.0 0.4 18.7 4.1 6.8 202.8 0.0 85.7 0.5 0.0 59.1 0.0 2.8 0.0 6.2 0.9 8.6 6.0 2.4 0.0 0.0 3.4 PDZD8 "bA129M16.2, FLJ34427, PDZK8" ENSG00000165650 "PDZ domain containing 8" Q8NEN9 10 117277274-117375467 "Predicted intracellular proteins" "Host-virus interaction, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 61.7" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 174.2;Late spermatids: 366.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 52.1" "Low region specificity" "Detected in all" "HPA015716, HPA051610" Uncertain Approved "Nucleoli fibrillar center,Plasma membrane" "Intracellular and membrane" NA NA "Nucleoli fibrillar center" "Plasma membrane" "HPA015716: AB_1855162, HPA051610: AB_2681549" "unprognostic (1.12e-1)" "unprognostic (2.87e-1)" "unprognostic (9.65e-3)" "unprognostic (2.75e-2)" "unprognostic (6.29e-2)" "unprognostic (3.36e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.53e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.90e-2)" "unprognostic (5.37e-3)" "unprognostic (7.60e-3)" "unprognostic (1.44e-2)" "unprognostic (3.18e-2)" "unprognostic (2.01e-2)" 8.1 7.8 12.2 5.1 13.3 61.7 8.2 8.7 12.9 9.1 14.8 11.4 32.8 14.0 10.7 15.1 11.4 7.7 10.3 7.0 12.0 10.4 13.5 21.1 7.4 3.7 14.7 7.4 10.1 20.1 18.9 8.6 6.0 12.9 7.3 12.0 6.3 12.4 21.3 6.7 6.6 13.7 7.6 14.8 5.0 10.6 23.2 12.4 8.9 7.5 5.4 4.2 8.0 15.3 1.0 1.7 5.7 2.0 2.5 2.5 0.5 5.2 9.0 3.3 6.3 5.7 5.1 1.8 5.0 4.4 2.3 1.8 4.5 7.0 6.2 4.6 7.6 2.6 7.9 5.7 5.4 4.5 3.9 5.1 52.1 3.7 4.4 4.2 21.7 4.9 5.0 6.4 4.1 12.3 8.5 4.0 5.1 4.7 6.5 5.6 2.1 4.2 2.8 2.6 2.7 8.1 3.4 12.7 2.6 6.7 3.8 2.6 4.2 5.4 2.3 3.9 3.1 1.6 3.2 6.4 3.8 4.2 6.8 8.6 3.5 2.9 4.5 4.7 10.0 3.3 2.7 1.4 5.7 2.2 1.1 2.5 0.9 1.8 1.8 1.7 1.0 1.5 2.0 5.6 2.5 2.0 1.3 0.8 0.5 12.2 13.3 8.7 12.9 12.0 10.4 14.7 7.4 12.9 12.4 11.9 27.8 8.8 17.7 26.4 29.3 16.7 43.3 38.8 25.0 17.4 21.6 8.3 8.3 27.0 174.2 17.8 23.8 23.3 70.7 5.7 19.5 25.1 41.7 45.8 6.8 30.2 32.4 16.5 12.3 366.0 21.9 15.2 21.9 9.0 31.7 24.9 56.7 21.0 26.9 23.1 40.1 25.8 18.9 16.9 29.3 28.2 5.6 18.7 39.0 34.2 PDZK1IP1 "DD96, MAP17, SPAP" ENSG00000162366 "PDZK1 interacting protein 1" Q13113 1 47183593-47191044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "kidney: 281.3" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 4006.8" "Cancer enhanced" "Detected in all" "renal cancer: 340.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "EFO-21: 31.5;RPTEC TERT1: 104.5" "Not detected" "Not detected" HPA014907 Enhanced Approved "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "HPA014907: AB_1855166" "unprognostic (2.97e-1)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "prognostic unfavorable (6.92e-4)" "unprognostic (8.14e-3)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.65e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (3.45e-4)" "unprognostic (2.64e-2)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (1.75e-3)" "unprognostic (1.89e-1)" 2.7 1.2 0.6 2.4 0.6 3.9 4.1 0.6 0.6 9.2 9.1 0.6 0.6 2.2 1.3 4.8 30.4 2.9 23.9 0.7 0.5 0.0 281.3 1.6 7.2 0.5 0.6 0.5 2.3 16.8 0.0 0.6 3.2 0.6 2.1 3.4 0.8 33.9 12.4 0.7 19.9 9.5 0.5 0.5 0.7 9.0 1.4 0.6 1.1 1.0 18.3 18.5 4.1 8.3 0.1 0.5 2.1 1.1 0.2 0.3 42.4 11.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.6 0.0 31.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 104.5 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.1 0.2 0.0 0.5 0.3 42.4 0.6 0.6 0.6 0.6 0.5 0.0 0.6 0.5 0.6 0.6 71.5 39.6 6.7 11.1 12.6 0.0 0.0 359.2 6.7 34.2 221.6 0.0 0.0 351.5 818.0 0.0 1.6 60.9 140.2 656.9 0.0 0.9 37.3 10.4 1.0 0.2 0.0 38.1 2.5 0.3 0.0 3.1 1.5 8.5 21.6 123.8 0.5 959.8 81.8 0.0 4006.8 0.0 0.0 2.3 0.0 0.1 47.2 0.7 1.5 119.5 16.8 PEAR1 "FLJ00193, JEDI, MEGF12" ENSG00000187800 "Platelet endothelial aggregation receptor 1" Q5VY43 1 156893698-156916434 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 26.3;Erythroid cells: 23.3;Ito cells: 34.4;Leydig cells: 41.1;Peritubular cells: 33.6;Sertoli cells: 25.8;Smooth muscle cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.1;HBEC3-KT: 13.8;HHSteC: 10.4;HUVEC TERT2: 24.4;TIME: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035217 Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA 35000000 "Nucleoplasm, Cell Junctions" Centrosome "HPA035217: AB_10669902" "unprognostic (1.02e-1)" "unprognostic (1.84e-5)" "unprognostic (4.77e-2)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.48e-1)" "unprognostic (5.62e-2)" "unprognostic (5.93e-2)" "unprognostic (1.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.17e-1)" "unprognostic (5.04e-1)" "prognostic unfavorable (4.31e-4)" "unprognostic (1.20e-2)" "unprognostic (3.37e-3)" "unprognostic (8.51e-2)" "unprognostic (2.64e-2)" 18.5 7.1 1.8 3.0 5.1 2.8 29.2 1.2 2.9 16.5 5.8 2.7 6.3 2.3 15.9 10.5 6.6 8.9 10.3 11.1 2.7 1.8 6.8 3.8 12.0 10.1 3.2 2.1 10.6 3.2 1.7 3.9 15.5 3.7 9.6 1.4 15.5 4.1 5.5 11.4 4.4 4.1 9.6 3.1 12.2 4.1 8.1 1.5 0.6 10.5 5.8 2.1 6.7 11.5 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.2 1.3 0.4 0.0 0.0 1.8 0.0 5.4 9.1 2.2 1.3 0.1 0.2 0.0 0.2 4.0 0.2 0.1 0.0 13.8 0.6 0.0 0.0 6.7 0.2 0.3 10.4 0.0 0.0 5.4 0.0 3.1 0.7 0.5 24.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.0 0.0 39.2 0.0 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 1.8 5.1 1.2 2.9 2.7 1.8 3.2 2.1 3.7 1.5 0.0 5.6 0.0 0.0 0.8 1.3 5.6 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.1 26.3 0.0 23.3 0.3 0.1 5.1 0.1 1.1 0.0 0.4 0.0 1.7 34.4 1.3 1.9 41.1 0.4 5.0 0.0 1.0 0.3 0.9 0.0 33.6 0.0 0.2 25.8 14.6 0.7 1.1 1.0 0.2 0.0 0.0 0.1 PEBP4 "CORK1, hPEBP4, MGC22776" ENSG00000134020 "Phosphatidylethanolamine binding protein 4" Q96S96 8 22713251-23000000 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 85.8;skeletal muscle: 124.6" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 101.3;Alveolar cells type 2: 146.5;Cardiomyocytes: 105.2;Muller glia cells: 177.5" "Group enriched" "Detected in many" 13 "lung cancer: 11.4;prostate cancer: 23.7;thyroid cancer: 35.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.7;neutrophil: 2.7;NK-cell: 2.6" "Group enriched" "Detected in many" 19 "B-cells: 2.7;granulocytes: 2.7;NK-cells: 2.6" "Cell line enriched" "Detected in some" 6 "U-266/70: 9.5" HPA025064 Uncertain "Secreted in other tissues" NA NA 200000000 "HPA025064: AB_1855174" "unprognostic (1.34e-2)" "unprognostic (2.97e-2)" "unprognostic (4.11e-2)" "unprognostic (3.66e-1)" "unprognostic (3.35e-1)" "unprognostic (4.78e-2)" "unprognostic (1.66e-4)" "unprognostic (1.18e-2)" "unprognostic (2.60e-1)" "unprognostic (1.74e-1)" "unprognostic (3.90e-2)" "unprognostic (8.76e-3)" "unprognostic (9.70e-8)" "unprognostic (1.13e-2)" "unprognostic (2.56e-1)" "unprognostic (3.48e-1)" "unprognostic (4.59e-1)" 2.7 0.9 2.2 0.2 4.9 0.2 0.9 1.0 1.9 0.3 0.2 2.4 0.8 0.1 0.3 85.8 1.6 0.5 0.6 43.8 2.2 5.1 0.6 0.7 31.8 0.3 10.8 0.8 0.4 7.4 0.4 4.7 0.2 7.8 10.4 0.2 18.9 12.3 0.8 124.6 0.3 0.2 0.2 1.0 0.2 1.7 1.4 2.5 0.0 22.3 16.6 2.3 0.2 0.0 2.7 0.1 2.7 0.0 2.6 0.1 0.0 0.0 0.0 0.1 0.1 0.5 0.7 0.1 0.0 0.7 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.1 0.0 0.2 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.5 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.4 0.0 0.0 2.7 2.6 0.0 0.1 0.0 0.0 2.2 4.9 1.0 1.9 2.2 5.1 10.8 0.8 7.8 2.5 101.3 146.5 0.0 0.9 1.6 10.4 105.2 0.0 5.3 13.6 1.8 2.0 0.6 3.3 0.0 27.5 2.1 0.0 0.0 8.3 0.1 1.0 11.1 7.0 0.6 1.1 9.5 0.0 3.1 0.0 19.3 3.1 1.1 1.7 0.0 0.0 177.5 0.3 0.0 10.3 1.8 7.3 0.0 3.1 2.2 0.7 0.6 0.0 0.7 0.0 0.9 PECAM1 CD31 ENSG00000261371 "Platelet and endothelial cell adhesion molecule 1" 17 64319415-64413776 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 77.7;blood: 88.4;placenta: 65.7" "Cell type enhanced" "Detected in many" 23 "Endothelial cells: 481.1;Ito cells: 205.6;Kupffer cells: 91.8" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 88.4" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 121.0;TIME: 83.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004690 Enhanced NA NA "HPA004690: AB_1078462" "unprognostic (2.79e-1)" "unprognostic (2.14e-1)" "unprognostic (2.79e-2)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (4.42e-3)" "unprognostic (2.84e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-1)" "unprognostic (7.25e-2)" "unprognostic (4.53e-2)" "unprognostic (9.68e-2)" "prognostic unfavorable (8.98e-5)" "unprognostic (9.72e-3)" "unprognostic (9.57e-2)" "unprognostic (1.56e-1)" "unprognostic (4.16e-2)" 77.7 2.5 2.2 10.2 3.3 3.8 26.5 1.2 3.6 14.2 9.2 1.6 3.7 3.5 15.2 7.6 12.3 4.7 12.2 13.8 2.2 13.4 3.5 50.2 10.7 3.0 0.3 7.4 2.3 2.7 1.2 65.7 3.7 10.2 4.9 4.6 2.9 3.0 21.2 2.0 4.8 11.6 2.8 13.9 3.4 6.4 2.0 7.8 15.7 10.0 7.8 15.2 16.2 5.0 21.0 53.3 88.4 5.2 10.0 24.2 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 121.0 5.3 0.3 9.1 0.0 0.0 4.9 1.2 0.0 0.0 1.3 0.2 2.4 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.4 83.3 0.1 0.0 0.1 0.0 0.5 0.9 1.0 0.2 1.0 0.0 6.2 34.8 28.9 2.8 57.2 2.7 3.6 0.3 6.7 21.0 5.0 5.4 10.0 53.3 5.2 88.4 12.0 0.2 24.2 14.9 44.7 12.6 0.5 0.0 0.0 17.1 0.0 13.4 5.7 8.7 0.0 0.4 0.0 0.2 0.6 481.1 0.0 0.0 0.2 3.5 1.1 1.0 8.1 0.9 47.0 0.0 0.0 205.6 91.8 0.5 2.3 71.5 0.0 12.6 0.0 0.1 0.1 0.0 1.8 0.5 0.9 0.0 0.3 0.1 0.2 0.0 0.7 20.3 0.0 0.9 PEMT "PEMPT, PEMT2" ENSG00000133027 "Phosphatidylethanolamine N-methyltransferase" Q9UBM1 17 17505563-17591708 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 95.7;liver: 103.5" "Cell type enhanced" "Detected in many" 12 "Hepatocytes: 168.4;Peritubular cells: 326.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042375, HPA073930" Approved Supported "Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol" NA NA "Endoplasmic reticulum, Mitochondria" "Vesicles, Cytosol" "HPA042375: AB_10796905, HPA073930: " "unprognostic (1.39e-2)" "unprognostic (3.43e-1)" "unprognostic (2.43e-2)" "prognostic favorable (6.77e-6)" "unprognostic (2.85e-1)" "unprognostic (7.14e-2)" "unprognostic (1.31e-1)" "unprognostic (1.28e-1)" "unprognostic (3.89e-1)" "unprognostic (3.41e-2)" "unprognostic (5.47e-3)" "unprognostic (2.67e-1)" "unprognostic (8.63e-3)" "unprognostic (2.08e-1)" "unprognostic (2.10e-1)" "unprognostic (6.66e-2)" "unprognostic (7.60e-2)" 21.8 7.5 5.6 2.8 6.2 4.2 26.5 2.9 8.1 16.1 6.1 6.4 13.2 7.4 8.7 95.7 5.6 10.5 4.7 5.3 5.3 6.1 8.5 103.5 5.5 6.7 6.3 4.8 7.7 11.4 4.4 5.7 7.1 6.2 7.3 2.2 7.3 12.7 12.9 7.4 7.3 5.8 4.0 6.4 2.8 4.6 19.1 3.2 3.8 9.9 6.3 5.4 3.9 5.2 12.8 17.0 1.6 23.4 15.1 14.4 11.6 14.2 27.3 7.2 18.8 15.4 10.8 10.8 9.1 8.2 12.5 9.9 15.9 9.7 12.5 16.6 9.3 9.4 17.0 10.6 5.5 3.2 9.2 37.0 6.2 14.9 22.8 17.0 5.5 9.3 11.0 11.5 8.3 12.7 4.2 6.7 17.6 5.9 5.3 5.5 27.2 9.8 9.9 10.1 27.3 22.4 9.2 11.6 11.4 10.3 5.3 7.2 17.2 6.5 4.4 16.3 14.5 6.7 2.1 5.8 12.3 12.4 20.5 7.9 7.3 4.9 2.2 11.4 7.7 10.1 1.0 23.4 1.1 10.1 20.8 14.4 12.6 13.2 12.7 17.0 12.8 10.6 11.9 1.6 15.1 14.2 15.5 12.0 11.6 5.6 6.2 2.9 8.1 5.3 6.1 6.3 4.8 6.2 3.2 14.9 13.7 17.0 16.7 16.3 4.4 12.5 12.7 16.0 26.1 26.2 0.0 16.2 14.9 26.3 2.2 18.3 14.6 0.0 33.6 18.8 27.5 23.7 12.7 168.4 21.4 4.8 66.0 9.2 11.1 6.8 87.8 10.8 20.3 1.0 24.8 26.7 26.0 10.5 326.0 21.4 4.8 6.5 30.9 11.1 18.5 15.8 12.2 7.0 22.8 16.6 PERP "dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW" ENSG00000112378 "PERP, TP53 apoptosis effector" Q96FX8 6 138088505-138107511 "Predicted membrane proteins" "Apoptosis, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 250.2;skin 1: 157.9;tongue: 230.6" "Cell type enhanced" "Detected in many" 14 "Basal keratinocytes: 2942.7;Suprabasal keratinocytes: 5094.7;Urothelial cells: 1450.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 21.3" "Group enriched" "Detected in many" 9 "granulocytes: 21.3;T-cells: 5.6" "Cell line enhanced" "Detected in many" "HaCaT: 37.9;hTCEpi: 142.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA022269 Enhanced NA NA "HPA022269: AB_1855219" "prognostic unfavorable (5.46e-4)" "unprognostic (2.90e-1)" "unprognostic (1.94e-1)" "unprognostic (5.18e-2)" "unprognostic (2.82e-2)" "unprognostic (1.27e-1)" "unprognostic (6.28e-3)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.92e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.05e-5)" "unprognostic (4.02e-2)" "unprognostic (6.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (1.94e-1)" "unprognostic (1.51e-2)" 4.2 1.6 1.0 2.7 1.2 0.0 25.5 1.3 0.9 51.9 12.5 0.5 7.1 6.3 6.4 11.7 250.2 7.7 15.6 14.7 1.2 1.5 4.4 28.0 8.4 1.7 1.3 0.3 3.3 11.5 5.0 3.3 31.5 1.6 17.5 5.0 2.4 46.6 7.9 1.4 157.9 23.4 7.1 1.3 0.6 8.4 1.9 0.6 6.7 8.7 230.6 113.6 14.0 57.8 1.4 0.0 21.3 0.0 0.0 5.6 0.8 10.2 11.5 0.0 1.1 8.1 8.6 24.0 16.7 18.9 2.4 1.7 9.4 21.2 0.0 6.0 4.2 19.9 37.9 2.0 30.2 0.5 16.1 9.4 0.0 11.5 8.8 5.8 0.0 0.0 6.4 142.2 0.2 15.5 13.8 9.4 0.6 0.1 4.5 0.2 7.1 0.0 0.5 4.9 24.5 6.2 0.0 3.8 0.0 16.1 12.0 4.0 0.0 17.7 9.5 8.1 11.6 5.3 2.1 11.2 4.2 1.6 4.5 0.0 1.4 1.8 0.0 3.3 0.0 8.8 21.3 0.0 0.0 3.0 0.0 5.2 1.4 3.8 2.6 0.0 0.4 0.4 1.7 0.2 0.0 0.0 0.0 5.6 0.8 1.0 1.2 1.3 0.9 1.2 1.5 1.3 0.3 1.6 0.6 196.5 66.8 11.7 1261.9 2942.7 3.4 114.6 234.4 397.5 227.5 146.5 15.7 849.6 53.0 494.4 1.4 53.7 255.2 0.0 273.4 823.5 67.6 524.2 10.4 153.4 71.8 3.2 141.3 9.8 2.2 2.0 9.8 5.1 332.3 18.0 159.9 23.8 453.2 273.5 2.5 10.1 25.6 6.5 122.7 1.8 0.9 5094.7 689.2 31.2 162.2 1450.6 PET117 CSRP2BP ENSG00000232838 "PET117 homolog" Q6UWS5 20 18137873-18143169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA047716 Approved "Intracellular and membrane" NA NA "HPA047716: AB_2680128" "unprognostic (1.34e-2)" "unprognostic (2.83e-1)" "unprognostic (3.94e-1)" "unprognostic (2.02e-1)" "unprognostic (2.39e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (4.76e-6)" "unprognostic (7.74e-2)" "unprognostic (1.25e-1)" "unprognostic (3.13e-2)" "unprognostic (4.90e-1)" "unprognostic (2.78e-1)" "prognostic favorable (4.15e-4)" "unprognostic (3.73e-1)" "unprognostic (4.63e-1)" "unprognostic (2.52e-1)" "unprognostic (1.92e-1)" 10.9 19.0 19.9 9.1 23.5 9.3 13.3 16.0 28.6 11.8 15.4 14.4 13.2 23.4 12.9 15.6 10.6 12.2 12.2 13.8 18.5 16.4 21.8 16.1 10.8 12.7 18.8 17.7 14.0 18.9 19.4 17.5 11.4 15.2 16.4 15.7 11.5 12.0 12.1 25.3 11.2 17.7 13.2 18.3 10.1 26.3 13.6 10.2 12.2 13.8 10.3 10.2 10.6 8.6 16.5 24.5 6.5 17.1 12.8 22.3 10.7 18.7 17.5 7.8 8.7 10.2 8.7 20.2 11.2 10.4 12.2 11.7 15.9 16.3 14.7 15.8 9.9 22.0 10.9 12.5 19.5 13.0 4.1 11.9 14.1 10.2 33.6 15.1 18.6 14.1 11.5 12.7 11.8 12.6 10.4 10.5 15.1 10.8 11.0 10.8 16.5 14.7 18.7 11.5 21.1 18.2 9.9 22.7 20.1 13.2 11.2 13.5 12.0 14.8 26.3 26.0 17.6 16.1 13.6 9.6 11.9 8.7 11.8 16.5 13.9 23.5 18.8 5.5 5.8 10.9 2.0 16.1 6.5 13.5 13.9 15.7 15.8 15.8 15.9 14.4 16.5 22.3 17.1 1.0 12.8 17.1 24.5 12.4 10.7 19.9 23.5 16.0 28.6 18.5 16.4 18.8 17.7 15.2 10.2 17.9 8.8 8.2 14.3 3.4 16.6 11.2 33.1 8.1 13.6 15.7 3.9 25.7 28.2 16.4 0.8 7.1 18.1 0.0 23.0 29.0 10.0 16.9 8.1 23.7 13.1 22.3 15.1 4.9 11.9 3.3 15.0 7.7 6.8 11.8 16.6 10.5 25.4 10.5 6.3 42.0 11.9 6.5 8.1 10.4 30.7 5.5 10.9 8.7 20.3 10.5 PEX10 RNF69 ENSG00000157911 "Peroxisomal biogenesis factor 10" O60683 1 2403964-2413797 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 144.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049458, HPA049755" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA049458: AB_2680775, HPA049755: AB_2680867" "prognostic favorable (4.50e-6)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (1.81e-2)" "unprognostic (2.91e-1)" "unprognostic (9.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (1.95e-1)" "prognostic favorable (4.16e-6)" "unprognostic (4.78e-2)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (1.42e-1)" 14.6 18.7 20.5 6.2 19.9 5.6 16.3 7.6 24.6 9.8 9.2 23.1 6.6 10.1 7.6 13.6 10.6 11.4 8.3 12.9 17.8 15.5 12.0 12.1 8.3 7.6 19.2 13.5 13.0 19.4 12.5 12.2 10.2 16.0 15.4 7.0 11.4 17.4 12.3 22.1 10.8 9.0 6.6 21.3 8.9 10.1 17.3 12.6 6.0 10.5 11.8 9.0 8.1 6.8 7.4 11.5 2.2 10.7 4.5 6.4 4.8 12.2 10.2 8.0 8.9 5.8 6.7 7.4 6.5 7.5 10.8 7.8 16.3 18.5 6.4 17.2 8.5 7.1 9.5 7.3 12.0 5.0 10.3 14.1 4.8 10.5 32.4 11.2 8.6 2.6 6.6 6.3 7.9 10.9 6.8 9.1 7.7 5.9 8.0 9.5 16.0 8.0 4.1 6.8 6.7 20.5 6.6 8.2 13.3 11.6 4.2 12.5 9.6 7.7 11.6 21.1 4.9 10.1 3.4 8.8 9.9 4.4 15.1 8.6 11.7 4.8 5.8 11.4 6.7 7.8 1.9 6.9 2.2 5.2 10.7 6.0 7.4 4.5 6.4 11.5 6.9 5.2 3.9 1.6 4.5 8.7 9.8 2.5 4.8 20.5 19.9 7.6 24.6 17.8 15.5 19.2 13.5 16.0 12.6 3.0 4.1 5.4 10.8 7.8 15.7 0.7 10.2 8.1 4.5 14.0 0.0 22.0 29.9 19.3 42.4 9.2 9.3 0.0 26.3 21.1 10.8 12.5 0.0 8.2 20.4 12.7 12.7 4.9 10.5 144.2 9.8 10.3 21.9 26.2 9.1 39.6 17.3 3.5 12.7 20.2 9.7 0.0 8.5 24.9 16.2 5.4 23.0 4.4 14.9 9.1 PEX11A "MGC119947, MGC138534, PEX11-ALPHA" ENSG00000166821 "Peroxisomal biogenesis factor 11 alpha" O75192 15 89677764-89690783 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.67e-1)" "unprognostic (2.58e-1)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (3.73e-2)" "prognostic unfavorable (2.57e-4)" "unprognostic (1.40e-1)" "unprognostic (6.17e-2)" "unprognostic (6.80e-3)" "unprognostic (2.82e-2)" "unprognostic (2.38e-1)" "unprognostic (3.24e-1)" "unprognostic (2.74e-2)" "unprognostic (1.10e-2)" "unprognostic (5.44e-2)" "unprognostic (4.82e-2)" "unprognostic (1.32e-2)" 20.0 10.0 13.1 5.4 11.7 0.8 18.0 6.1 10.9 6.6 14.4 7.7 27.1 13.9 5.8 9.6 5.8 8.8 8.1 8.8 13.0 6.9 10.4 32.8 5.4 2.1 6.5 7.7 11.9 10.8 8.8 8.5 3.2 8.4 16.3 10.7 8.1 9.2 21.9 18.6 4.4 15.7 7.0 5.6 3.4 9.6 12.5 10.6 1.4 11.0 3.7 3.7 11.2 12.5 3.2 3.5 4.4 1.8 5.6 7.3 3.1 5.9 3.6 2.8 0.2 14.6 5.3 2.3 3.0 5.1 4.5 7.4 2.5 7.2 2.7 3.3 3.4 6.4 8.0 0.0 4.5 5.2 4.3 10.1 4.1 4.0 3.5 10.5 2.7 1.4 6.5 5.6 2.6 4.4 3.5 3.1 2.7 0.0 1.1 3.3 6.0 0.0 0.3 1.6 12.1 6.7 0.0 0.0 2.4 3.7 4.0 2.0 5.3 9.5 32.9 8.7 5.3 8.7 2.6 2.8 2.9 3.0 8.0 2.3 3.2 5.4 0.1 7.3 0.3 2.6 2.3 1.4 4.4 7.3 1.8 4.2 3.2 3.7 4.1 3.5 2.0 4.6 5.3 1.6 5.6 1.3 0.8 3.3 3.1 13.1 11.7 6.1 10.9 13.0 6.9 6.5 7.7 8.4 10.6 6.0 5.9 0.0 8.0 1.5 7.9 6.9 10.2 17.4 7.9 5.2 2.0 8.0 5.0 5.2 18.7 2.7 18.0 0.0 4.0 6.0 4.3 12.1 1.1 32.6 3.4 17.5 3.5 4.3 1.8 27.5 4.9 0.9 3.3 1.0 9.6 13.7 6.5 11.5 2.5 9.0 8.5 0.0 3.1 15.4 7.0 1.8 2.3 1.3 10.9 9.5 PEX11B ENSG00000131779 "Peroxisomal biogenesis factor 11 beta" O96011 1 145911350-145918837 "Disease related genes, Predicted membrane proteins" "Peroxisome biogenesis" "Peroxisome biogenesis disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA017150, HPA050104" Supported Supported Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA017150: , HPA050104: AB_2681017" "unprognostic (4.59e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.29e-1)" "unprognostic (3.62e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.67e-4)" "prognostic favorable (6.85e-4)" "unprognostic (1.19e-1)" "unprognostic (4.08e-2)" "unprognostic (2.10e-1)" "unprognostic (8.48e-2)" "unprognostic (6.96e-2)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (7.62e-3)" "unprognostic (4.28e-1)" 12.0 17.3 25.9 13.3 29.5 8.5 24.4 25.1 39.6 19.9 18.2 17.3 21.3 18.4 16.2 27.2 21.6 20.1 14.7 17.9 25.8 28.1 25.4 19.8 14.9 18.4 24.0 20.3 19.7 23.2 20.4 16.4 17.3 26.9 18.2 21.7 15.7 19.0 20.9 23.7 20.6 17.2 16.1 14.7 18.7 18.4 18.0 14.8 21.4 20.3 17.2 25.3 16.7 13.9 42.5 42.8 32.0 29.6 29.5 37.0 34.1 11.2 10.3 9.2 9.1 21.5 16.9 9.5 11.4 15.2 15.0 11.6 4.7 13.2 10.6 12.4 16.2 7.3 13.8 8.0 17.0 10.5 11.8 6.0 6.5 6.8 12.2 30.4 19.4 12.0 22.2 21.3 10.1 10.0 19.3 19.0 14.9 11.8 17.6 23.6 17.9 14.9 18.5 3.3 24.1 12.8 13.8 13.8 23.1 25.7 8.0 6.4 10.5 8.6 16.6 10.4 9.6 23.0 30.3 16.9 10.1 8.1 13.2 8.3 19.0 21.9 15.0 17.1 11.0 6.9 32.0 29.6 20.6 28.7 26.3 31.2 42.5 32.9 31.0 32.0 37.2 37.0 33.5 14.7 29.5 25.8 42.8 34.8 34.1 25.9 29.5 25.1 39.6 25.8 28.1 24.0 20.3 26.9 14.8 14.9 10.1 11.9 7.5 17.2 7.2 11.8 17.8 12.0 6.8 38.4 0.0 31.7 38.1 11.9 9.5 11.7 16.7 0.0 12.2 11.2 11.8 8.1 3.5 27.2 19.8 4.8 12.2 12.9 18.1 15.7 13.0 11.3 20.3 31.5 18.1 12.6 12.4 14.0 18.7 27.8 4.5 6.5 6.2 34.7 19.1 19.3 16.7 11.8 14.5 8.6 PEX11G ENSG00000104883 "Peroxisomal biogenesis factor 11 gamma" Q96HA9 19 7476875-7497449 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 51.6;Late spermatids: 50.5;Proximal tubular cells: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069817 Uncertain NA NA "HPA069817: AB_2686207" "unprognostic (2.26e-2)" "unprognostic (6.44e-2)" "unprognostic (1.47e-2)" "prognostic favorable (3.60e-4)" "unprognostic (1.01e-1)" "unprognostic (4.09e-3)" "prognostic favorable (3.27e-4)" "unprognostic (4.84e-2)" "unprognostic (1.97e-1)" "unprognostic (3.16e-1)" "unprognostic (2.32e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.83e-9)" "unprognostic (1.21e-3)" "unprognostic (1.67e-1)" "unprognostic (1.56e-1)" "unprognostic (1.19e-2)" 4.8 10.0 4.3 2.2 4.5 1.8 4.0 2.4 5.7 2.6 5.6 6.4 7.3 10.7 2.9 12.7 3.6 5.5 7.8 2.8 4.0 3.5 7.7 17.8 3.5 3.1 5.1 5.7 4.7 8.1 2.6 4.0 2.9 4.8 5.1 2.6 7.1 6.4 9.1 2.8 4.4 9.2 2.6 4.9 4.1 6.1 22.4 3.6 1.5 5.1 3.0 3.8 3.8 2.6 2.7 2.8 14.1 3.3 6.4 1.4 1.6 2.6 5.1 1.2 4.5 3.6 2.1 6.9 1.5 1.0 1.2 1.2 1.9 8.9 1.5 8.5 0.7 1.9 4.6 0.9 1.6 0.4 0.7 1.9 0.9 1.4 0.5 3.2 0.1 5.3 4.2 1.9 1.1 1.7 0.9 0.8 4.4 2.3 0.1 1.4 1.4 0.9 0.9 0.3 4.1 3.0 0.2 0.3 0.2 3.2 3.4 3.3 3.0 2.3 0.5 0.6 0.7 7.3 1.7 0.0 0.2 0.7 4.4 0.2 2.7 1.8 0.9 0.8 0.1 0.9 14.1 3.3 12.0 1.4 3.1 0.9 2.1 1.0 0.5 2.8 2.7 1.0 0.8 10.3 6.4 2.8 1.8 0.3 1.6 4.3 4.5 2.4 5.7 4.0 3.5 5.1 5.7 4.8 3.6 0.0 8.6 1.3 5.2 2.9 2.4 1.2 7.6 28.1 2.3 3.5 2.0 2.3 14.9 7.1 51.6 2.5 16.2 0.0 3.2 2.7 3.9 2.5 0.0 31.6 14.4 0.0 5.2 6.2 6.7 50.5 4.0 2.3 3.3 1.8 9.9 6.0 4.4 9.7 3.5 36.7 2.8 6.5 3.4 26.8 2.8 2.4 1.1 1.3 10.4 2.2 PEX2 "PAF-1, PMP35, PXMP3, RNF72, ZWS3" ENSG00000164751 "Peroxisomal biogenesis factor 2" P28328 8 76980258-77001044 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 112.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010983, HPA011410, HPA027729" Approved Supported Vesicles NA NA Vesicles "HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416" "unprognostic (6.42e-2)" "unprognostic (2.90e-2)" "unprognostic (4.64e-2)" "unprognostic (2.35e-1)" "unprognostic (9.91e-2)" "unprognostic (2.33e-1)" "unprognostic (6.19e-2)" "unprognostic (2.22e-1)" "unprognostic (3.16e-2)" "unprognostic (1.37e-1)" "unprognostic (2.85e-2)" "unprognostic (2.07e-2)" "unprognostic (9.57e-3)" "unprognostic (2.48e-1)" "unprognostic (9.49e-2)" "unprognostic (3.06e-2)" "unprognostic (1.09e-3)" 21.3 30.9 25.4 17.9 23.8 17.3 30.7 20.7 24.6 24.3 23.8 24.1 65.7 22.5 25.7 24.3 21.6 24.1 18.0 22.1 26.9 20.7 31.3 25.3 20.4 27.8 29.8 18.3 20.5 26.4 21.2 32.6 17.4 25.9 25.8 22.9 24.9 28.7 63.6 32.4 17.4 27.2 25.7 30.5 23.1 27.0 14.7 30.9 32.2 34.4 19.0 23.4 24.2 23.5 17.3 17.1 52.4 22.9 28.3 22.3 24.2 27.3 9.3 15.1 15.2 16.1 20.3 7.9 20.6 23.5 15.9 17.6 5.8 24.6 15.6 30.7 18.4 13.0 10.6 10.3 15.6 19.4 28.8 8.5 19.0 8.6 8.9 10.9 15.7 15.1 22.8 13.3 12.0 14.4 25.0 17.3 25.3 10.4 15.0 16.6 8.2 27.6 9.4 8.9 39.2 8.4 5.1 12.0 12.9 18.4 19.4 5.3 14.0 13.2 60.2 11.2 13.5 18.8 11.4 17.2 14.6 19.2 18.8 10.2 27.9 16.1 27.2 18.6 8.4 16.1 52.4 20.3 35.8 22.3 20.8 19.9 17.3 15.6 17.9 16.9 17.2 20.6 19.6 14.1 28.3 22.9 17.1 17.4 24.2 25.4 23.8 20.7 24.6 26.9 20.7 29.8 18.3 25.9 30.9 44.7 18.5 25.9 28.0 16.1 26.4 23.8 28.1 24.1 19.4 26.2 11.8 35.4 112.7 45.9 2.4 15.7 28.0 0.0 43.3 19.6 25.8 30.4 17.4 29.7 24.1 12.7 27.7 17.2 35.1 5.9 27.3 21.5 27.0 32.5 33.2 49.5 36.5 29.1 33.6 53.7 29.7 6.5 24.8 13.5 17.6 18.3 29.1 41.1 26.4 33.0 PF4 "CXCL4, SCYB4" ENSG00000163737 "Platelet factor 4" P02776 4 73981077-73982124 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Chemotaxis "Cytokine, Heparin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 50.5;bone marrow: 46.8;heart muscle: 46.0;lymphoid tissue: 42.6" "Cell type enhanced" "Detected in some" 18 "Intestinal endocrine cells: 12.9;Pancreatic endocrine cells: 6.2;Undifferentiated cells: 5.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.4" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "basophil: 18.3;neutrophil: 16.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 18.3" "Cell line enriched" "Detected in some" 10 "HEL: 30.4" "CAB026008, HPA052485" Enhanced "Secreted to blood" NA NA 7700000 "CAB026008: , HPA052485: AB_2681847" "unprognostic (4.14e-4)" "unprognostic (1.00e-2)" "unprognostic (2.49e-1)" "unprognostic (1.96e-4)" "unprognostic (7.58e-2)" "unprognostic (1.42e-1)" "unprognostic (7.55e-2)" "unprognostic (2.04e-1)" "unprognostic (9.02e-3)" "unprognostic (1.84e-2)" "unprognostic (3.03e-2)" "unprognostic (9.54e-5)" "unprognostic (2.55e-1)" "unprognostic (8.77e-2)" "unprognostic (9.69e-2)" "unprognostic (4.81e-2)" 0.7 0.4 0.2 0.7 0.9 46.8 0.8 0.2 0.3 0.3 1.1 0.0 0.0 0.1 0.2 0.4 0.2 0.5 0.8 46.0 0.8 0.3 0.5 1.7 9.1 3.3 2.6 0.3 3.0 0.4 0.1 0.4 4.8 1.9 0.2 0.9 1.0 0.4 0.2 1.0 0.2 0.3 0.2 0.9 42.6 0.9 0.6 0.0 0.0 1.8 0.9 0.1 1.0 3.0 0.3 1.9 18.3 1.4 0.0 0.3 50.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 30.4 0.0 0.0 1.5 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 1.4 0.4 0.3 0.3 0.3 0.0 0.0 0.0 0.5 0.3 0.2 0.1 16.5 0.0 1.1 1.9 0.2 50.5 0.2 0.9 0.2 0.3 0.8 0.3 2.6 0.3 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 1.8 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 0.0 12.9 1.8 2.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 5.1 0.1 PFKP "PFK-C, PFKF" ENSG00000067057 "Phosphofructokinase, platelet" Q01813 10 3066333-3137712 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 368.5;Late spermatids: 396.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018257, HPA056484" Uncertain Supported Cytosol No No 4500000 Cytosol "HPA018257: AB_10960391, HPA056484: AB_2683147" "unprognostic (1.16e-1)" "unprognostic (2.41e-3)" "unprognostic (5.79e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.55e-4)" "prognostic unfavorable (8.72e-6)" "unprognostic (1.36e-3)" "unprognostic (2.38e-1)" "unprognostic (8.51e-2)" "unprognostic (2.37e-2)" "unprognostic (8.82e-2)" "unprognostic (6.02e-3)" "unprognostic (2.60e-2)" "unprognostic (9.74e-2)" "unprognostic (2.06e-1)" "unprognostic (4.54e-3)" 14.6 7.9 29.6 22.0 28.9 9.2 8.1 34.2 61.4 9.7 20.5 11.5 7.9 26.8 19.2 11.0 36.0 12.8 19.8 62.0 29.3 32.9 20.0 2.8 9.2 18.2 22.2 29.8 9.3 8.8 1.5 16.8 8.8 21.3 20.3 19.4 14.7 13.4 36.5 24.4 16.5 31.1 34.3 21.1 11.3 20.7 71.8 14.8 9.6 19.3 11.7 13.3 26.9 15.6 8.9 12.5 16.2 4.7 14.3 20.4 8.9 47.8 67.3 4.5 0.1 4.5 9.5 58.8 29.8 10.7 30.2 36.4 70.9 50.9 5.7 23.8 21.4 28.0 38.9 23.0 46.5 31.8 16.1 17.7 20.7 32.4 3.8 10.7 8.3 34.8 4.4 10.5 31.7 15.8 45.8 58.1 24.3 5.7 0.2 33.4 37.4 28.3 9.0 7.4 21.0 23.6 22.2 7.5 23.1 32.7 18.8 12.4 10.7 21.1 18.0 26.4 56.5 14.8 13.1 69.9 20.6 11.1 62.1 32.4 32.7 29.5 20.5 52.9 16.0 12.6 16.2 4.7 1.6 15.9 2.3 12.6 8.2 15.9 14.8 8.0 8.9 6.0 9.5 0.7 14.3 0.9 12.5 20.4 8.9 29.6 28.9 34.2 51.7 29.3 32.9 22.2 29.8 21.3 14.8 3.0 6.5 16.7 44.9 25.4 38.3 113.1 10.2 21.4 27.3 61.1 51.1 2.1 36.5 101.2 368.5 28.8 46.6 0.0 9.2 171.9 17.4 35.9 56.4 0.8 28.5 39.7 35.7 14.1 12.6 396.4 6.9 16.2 18.6 21.6 19.5 104.9 80.1 28.1 6.3 2.1 105.7 12.9 30.8 39.9 3.2 19.7 22.2 27.3 24.5 48.7 PFN2 ENSG00000070087 "Profilin 2" P35080 3 149964904-150050788 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 89.7" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 391.3;Muller glia cells: 211.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035611, CAB037073" Enhanced NA NA "CAB037073: AB_1079600, HPA035611: AB_10672870" "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.07e-3)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.77e-2)" "prognostic unfavorable (3.42e-4)" "prognostic unfavorable (2.19e-7)" "unprognostic (4.11e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-2)" "unprognostic (2.96e-3)" "unprognostic (4.86e-3)" "unprognostic (6.82e-2)" "unprognostic (1.25e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.99e-1)" 9.2 13.9 59.1 6.7 49.6 1.3 12.8 35.1 89.7 14.5 10.3 22.8 11.6 8.8 21.4 54.1 9.0 33.8 12.5 15.4 64.8 39.9 39.8 8.7 6.6 2.6 36.1 44.6 21.8 11.7 15.7 12.9 7.4 33.6 23.4 10.0 11.7 15.8 23.9 75.0 2.9 11.7 20.5 30.5 5.5 8.5 9.4 15.9 2.3 34.4 9.1 3.7 15.2 6.8 2.7 0.3 1.5 0.3 1.6 9.7 3.1 76.1 26.6 64.0 26.2 14.3 48.9 17.1 24.5 37.2 38.7 45.1 9.9 61.6 0.0 51.8 53.5 67.1 0.8 26.5 34.8 56.3 2.4 15.7 0.8 14.5 28.3 19.1 4.2 1.2 30.7 29.5 38.0 49.6 41.4 22.5 12.4 0.2 3.1 40.1 28.2 3.6 0.2 27.9 0.5 35.2 4.2 47.6 0.3 28.5 38.9 34.8 35.9 12.1 5.8 32.9 46.4 9.3 0.6 16.2 18.5 26.0 30.7 31.5 4.1 0.3 2.0 40.0 0.2 22.5 1.2 0.3 0.5 2.9 0.1 6.0 2.7 6.3 5.3 0.1 1.5 9.7 5.7 1.5 1.6 0.1 0.3 1.6 3.1 59.1 49.6 35.1 87.5 64.8 39.9 36.1 44.6 33.6 15.9 6.0 5.8 3.7 35.9 8.8 49.5 43.7 17.8 87.0 28.4 129.1 17.7 12.7 391.3 40.2 41.5 12.8 18.6 0.0 24.2 9.3 48.3 55.3 8.1 10.6 2.8 25.4 116.4 20.9 1.5 20.9 68.4 4.9 33.7 8.2 29.0 211.2 14.6 22.1 90.9 120.7 30.8 12.9 44.3 20.5 17.4 6.6 8.6 2.2 31.2 22.7 PGAM5 "BXLBv68, MGC5352" ENSG00000247077 "PGAM family member 5, mitochondrial serine/threonine protein phosphatase" Q96HS1 12 132710819-132722734 "Enzymes, Predicted intracellular proteins" Necrosis Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036978, HPA036979, CAB068215" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "CAB068215: AB_2665674, HPA036978: AB_10964347, HPA036979: AB_10960559" "unprognostic (9.57e-2)" "unprognostic (2.00e-2)" "unprognostic (3.83e-2)" "unprognostic (3.11e-2)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.13e-6)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (5.67e-2)" "unprognostic (1.23e-1)" "unprognostic (6.92e-2)" "unprognostic (6.42e-3)" "unprognostic (1.63e-2)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (5.53e-2)" 12.2 16.5 11.7 14.3 14.0 12.5 18.6 14.6 22.1 8.4 13.9 8.3 9.9 13.6 10.4 9.9 22.0 11.5 13.4 22.6 14.2 12.1 13.9 26.3 8.5 17.6 9.9 11.8 11.9 30.2 8.1 9.6 10.3 10.4 10.1 10.4 8.5 16.0 11.4 27.4 15.2 12.0 10.2 7.5 13.0 11.7 13.6 5.1 17.6 16.3 17.4 14.5 11.6 12.9 4.0 6.7 7.7 3.1 3.3 3.7 1.4 19.2 37.1 7.9 22.3 5.6 4.5 18.6 9.9 6.2 16.7 9.4 46.2 11.2 24.9 18.4 8.6 8.6 16.9 37.2 18.7 6.9 12.2 29.3 29.9 17.4 24.1 12.7 28.3 17.5 5.6 13.8 19.5 21.1 5.5 12.2 20.4 37.4 10.3 6.5 34.9 38.3 28.3 30.1 16.9 26.3 29.4 8.8 19.9 10.8 26.8 29.1 16.4 17.2 24.2 10.7 6.6 30.6 15.7 10.5 8.5 18.6 17.1 24.1 21.6 31.7 35.8 11.1 23.2 14.2 7.7 2.4 0.7 2.5 2.5 3.7 3.6 2.9 2.8 2.0 4.0 2.9 3.6 2.0 3.3 3.1 6.7 2.0 1.4 11.7 14.0 14.6 22.1 14.2 12.1 9.9 11.8 10.4 5.1 3.0 6.7 6.7 10.3 10.2 9.2 12.6 20.4 4.0 0.0 5.2 13.7 5.6 5.0 4.0 12.9 5.3 6.3 0.0 6.7 12.5 3.3 9.0 0.0 21.9 6.4 6.4 12.6 4.3 6.9 15.9 5.5 4.8 3.3 2.8 8.9 3.9 6.9 5.8 6.3 9.0 12.2 6.5 5.5 9.8 9.4 15.2 5.1 4.4 14.0 11.6 PGAP1 "Bst1, FLJ12377, SPG67" ENSG00000197121 "Post-GPI attachment to proteins 1" Q75T13 2 196833004-196927796 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.21e-1)" "unprognostic (9.15e-2)" "unprognostic (5.89e-2)" "unprognostic (3.82e-2)" "unprognostic (1.81e-1)" "unprognostic (5.55e-3)" "unprognostic (2.50e-2)" "unprognostic (6.95e-2)" "unprognostic (6.51e-2)" "unprognostic (1.41e-2)" "unprognostic (2.59e-3)" "unprognostic (9.61e-2)" "unprognostic (7.16e-3)" "unprognostic (1.21e-1)" "unprognostic (7.88e-2)" "unprognostic (9.03e-3)" "unprognostic (1.91e-2)" 6.7 15.2 14.3 2.2 26.9 3.5 7.5 15.5 14.7 4.1 5.5 4.6 1.6 6.8 5.8 6.2 4.9 3.9 3.1 4.4 11.5 12.4 3.4 2.6 5.9 2.2 5.6 11.4 13.0 6.2 5.7 25.8 6.1 9.6 6.4 5.5 5.3 3.1 4.7 2.7 21.6 7.9 4.4 6.4 2.8 3.9 2.9 7.2 0.9 4.3 2.5 2.4 5.6 5.4 0.9 0.4 0.8 0.4 0.5 3.0 0.1 1.4 0.6 14.4 7.8 6.6 4.0 2.4 1.7 1.4 1.1 1.2 0.7 1.5 1.7 2.2 2.5 2.3 2.6 3.7 4.0 1.7 8.0 4.8 1.1 3.5 3.7 1.8 2.3 1.8 2.8 2.9 1.7 2.1 7.4 6.0 5.4 0.2 2.8 4.0 0.5 2.1 3.0 6.7 2.2 3.2 3.3 3.6 0.4 2.3 12.7 11.9 9.5 1.2 1.8 2.0 9.0 1.8 0.9 7.0 4.9 2.1 2.4 2.4 2.6 1.3 2.3 3.7 1.0 4.8 0.3 0.4 0.6 0.9 0.1 0.7 0.6 2.7 2.7 0.4 0.9 2.3 1.9 0.8 0.5 0.1 0.2 3.0 0.1 14.3 26.9 15.5 12.3 11.5 12.4 5.6 11.4 9.6 7.2 3.0 1.6 2.2 11.8 30.6 39.9 6.4 2.5 9.4 5.7 24.4 23.6 28.1 0.0 1.2 3.9 8.3 5.2 0.0 3.2 7.8 16.9 6.9 4.6 4.5 5.3 12.7 37.4 5.5 2.4 3.0 13.3 2.0 6.8 0.0 12.4 21.5 1.1 8.7 14.9 1.9 42.3 6.5 25.8 8.4 7.5 26.2 13.3 2.2 13.8 9.6 PGAP2 "CWH43-N, FRAG1, MRT21" ENSG00000148985 "Post-GPI attachment to proteins 2" Q9UHJ9 11 3797724-3826371 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "GPI-anchor biosynthesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 117.3" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 62.9;Early spermatids: 124.4;Late spermatids: 246.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063099 Approved Approved Microtubules NA NA Microtubules "HPA063099: AB_2684940" "unprognostic (1.94e-1)" "unprognostic (1.14e-1)" "unprognostic (2.19e-1)" "unprognostic (3.18e-2)" "unprognostic (5.13e-2)" "unprognostic (6.06e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (3.07e-1)" "unprognostic (1.11e-1)" "unprognostic (6.44e-2)" "unprognostic (3.85e-2)" "unprognostic (4.66e-3)" "unprognostic (4.13e-2)" "unprognostic (2.17e-2)" "unprognostic (2.67e-2)" 4.9 9.5 7.6 7.3 8.2 5.2 6.9 5.0 10.6 7.3 12.3 12.4 18.3 10.2 7.4 117.3 20.0 11.1 8.1 9.3 8.0 6.3 8.6 17.1 9.5 8.6 6.9 8.8 7.1 30.8 12.6 9.1 10.7 5.6 10.1 7.9 12.5 14.5 19.6 6.4 25.0 16.7 4.9 8.9 6.6 7.5 17.7 8.4 15.0 14.1 14.6 15.3 7.7 10.4 11.2 8.7 15.9 8.0 8.7 17.0 7.5 12.5 17.2 8.4 7.6 7.5 14.5 13.3 5.2 4.5 7.8 7.0 14.6 22.2 13.6 6.0 3.8 4.6 21.2 13.3 14.5 7.6 16.5 14.5 8.3 7.5 17.9 5.3 10.5 10.9 11.5 20.4 5.6 19.3 5.0 8.7 18.4 17.5 20.3 8.0 18.8 12.9 9.0 15.7 26.7 10.4 20.2 1.0 13.1 14.6 15.2 11.1 11.0 9.4 25.2 5.6 10.3 20.9 4.6 8.2 4.8 4.6 11.4 3.2 12.7 13.9 10.1 6.3 7.2 9.2 1.9 5.8 5.0 8.8 8.0 10.8 11.0 12.6 10.7 8.7 11.2 17.0 11.3 15.9 8.7 8.0 5.9 11.5 7.5 7.6 8.2 5.0 10.6 8.0 6.3 6.9 8.8 5.6 8.4 11.9 8.8 5.1 11.3 28.2 13.3 11.1 10.2 17.4 6.8 12.2 21.6 62.9 1.7 10.5 124.4 10.0 13.1 0.0 18.5 14.0 7.4 10.2 8.1 11.6 13.9 3.2 2.9 3.7 7.0 246.9 8.1 6.1 5.0 11.8 8.5 7.8 12.8 5.8 6.3 7.8 9.1 6.5 7.6 17.7 19.2 25.0 24.5 6.4 20.8 12.4 PGAP3 "CAB2, MGC9753, PER1, PERLD1, PP1498" ENSG00000161395 "Post-GPI attachment to proteins 3" Q96FM1 17 39671122-39696797 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "OE19: 133.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016591 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA016591: AB_1855203" "unprognostic (1.29e-1)" "unprognostic (8.64e-2)" "unprognostic (1.65e-1)" "unprognostic (6.53e-3)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "prognostic favorable (3.94e-4)" "unprognostic (1.61e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.57e-2)" "unprognostic (7.79e-2)" "prognostic favorable (3.89e-4)" "unprognostic (5.16e-2)" "unprognostic (1.31e-1)" "unprognostic (9.05e-2)" "unprognostic (1.94e-2)" 6.8 8.2 8.9 7.6 14.3 3.4 10.2 6.4 17.3 11.3 19.2 10.0 15.1 12.5 8.3 16.5 16.2 14.0 19.7 9.9 11.3 7.3 13.7 20.7 9.5 6.5 6.3 10.7 9.7 22.7 16.0 10.1 39.2 6.1 11.2 11.7 14.2 16.7 15.6 5.0 16.0 20.7 7.3 5.5 8.1 13.4 9.0 7.3 4.4 20.3 8.7 15.8 8.1 8.9 7.8 5.3 4.0 10.5 9.0 15.1 6.3 0.6 1.6 1.3 1.2 1.4 1.4 1.3 0.7 1.7 1.1 1.0 0.9 4.0 0.6 3.3 1.3 0.3 2.1 0.4 0.4 0.5 1.4 1.3 0.8 0.9 1.5 1.8 2.1 2.2 2.6 2.6 0.5 1.1 1.3 0.3 0.3 0.7 1.6 1.0 1.4 0.4 1.9 1.3 133.7 0.3 0.5 0.8 1.9 1.8 2.0 1.2 0.8 1.9 22.9 1.1 0.1 1.9 2.0 0.5 1.2 1.3 0.6 0.5 1.4 0.3 0.2 1.4 0.8 1.3 2.4 6.7 4.0 15.1 10.5 8.3 7.8 10.6 12.3 5.3 7.6 10.5 10.1 1.7 9.0 3.8 3.6 5.1 6.3 8.9 14.3 6.4 17.3 11.3 7.3 6.3 10.7 6.1 7.3 3.0 12.2 0.0 3.5 3.4 12.1 5.2 12.7 4.0 9.1 14.0 7.9 6.8 1.7 6.0 0.1 4.3 16.0 0.0 9.6 5.2 6.7 4.9 9.2 7.7 4.0 12.7 8.1 4.3 2.7 0.0 2.8 3.5 1.7 1.8 16.3 7.8 5.1 11.5 1.4 3.5 21.6 0.0 2.3 0.7 2.0 2.5 8.7 1.7 13.0 2.5 PGRMC1 HPR6.6 ENSG00000101856 "Progesterone receptor membrane component 1" O00264 X 119236245-119244466 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 163.9" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 412.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002877, HPA064724" Enhanced Supported "Nucleoli,Endoplasmic reticulum" NA NA 6000000 "Endoplasmic reticulum" Nucleoli "HPA002877: AB_1079602, HPA064724: " "unprognostic (6.97e-2)" "unprognostic (1.99e-1)" "unprognostic (1.72e-1)" "unprognostic (4.35e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (1.58e-3)" "unprognostic (9.28e-2)" "unprognostic (4.66e-2)" "unprognostic (6.20e-2)" "unprognostic (3.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-3)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 25.0 46.0 37.7 11.9 36.9 5.6 60.2 21.8 37.8 36.2 30.5 30.9 42.9 27.0 39.9 71.4 15.0 38.9 20.1 10.0 38.6 50.4 58.7 163.9 15.6 8.8 38.1 29.6 24.7 10.9 23.8 15.5 12.3 35.3 33.5 22.5 22.1 17.5 53.7 5.7 12.5 42.9 22.0 46.9 10.0 18.9 14.2 27.1 6.9 24.7 12.2 7.7 21.3 17.3 3.6 9.9 11.4 11.8 4.8 8.0 28.7 27.3 17.3 34.0 39.1 73.6 35.3 22.1 41.3 48.2 22.0 27.4 20.9 33.6 7.9 45.3 42.8 25.7 21.9 37.1 17.3 29.7 8.4 42.6 8.9 16.6 23.4 12.3 14.5 4.8 36.3 9.8 26.7 13.9 16.3 14.1 9.5 9.3 4.9 25.7 29.2 10.9 10.7 89.1 30.0 29.2 13.0 21.3 11.4 29.0 20.9 31.8 14.2 30.2 50.3 16.2 34.3 11.6 9.3 10.9 15.3 22.6 54.1 38.9 5.2 9.5 8.5 41.9 23.2 29.2 9.2 11.8 11.4 5.5 11.3 7.3 3.6 7.5 8.0 9.9 3.1 7.7 6.3 5.7 4.8 10.0 7.1 7.6 28.7 37.7 36.9 21.8 37.2 38.6 50.4 38.1 29.6 35.3 27.1 116.1 75.0 12.3 114.6 83.6 185.1 15.3 109.5 124.5 78.5 69.8 64.8 71.9 58.0 77.8 2.7 78.8 222.6 23.3 64.6 112.3 104.2 108.1 39.3 412.3 46.0 62.0 55.4 54.6 35.5 4.9 159.3 45.1 97.8 14.4 77.2 101.7 56.7 112.1 170.8 277.5 72.5 103.5 130.8 27.1 70.9 76.7 51.9 21.5 125.9 110.4 PGRMC2 "DG6, PMBP" ENSG00000164040 "Progesterone receptor membrane component 2" O15173 4 128269237-128288829 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 229.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 87.8" "Low region specificity" "Detected in all" "HPA041172, HPA058652" Approved Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA 64000 "Nuclear bodies, Plasma membrane, Cytosol" "HPA041172: AB_2677345, HPA058652: AB_2683786" "unprognostic (6.16e-2)" "unprognostic (1.35e-1)" "unprognostic (1.41e-2)" "prognostic favorable (3.62e-4)" "unprognostic (6.03e-2)" "unprognostic (6.57e-3)" "unprognostic (2.53e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (8.24e-2)" "unprognostic (9.04e-2)" "unprognostic (3.80e-2)" "prognostic favorable (9.60e-4)" "unprognostic (3.12e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-2)" "unprognostic (6.03e-2)" 47.9 29.5 18.3 13.3 20.4 12.8 38.3 17.7 19.3 27.3 46.6 14.8 42.5 46.8 26.1 20.2 32.8 21.1 31.2 27.2 18.4 18.4 36.5 64.7 22.4 13.6 17.4 18.5 24.1 41.6 25.6 34.4 95.6 18.0 29.4 24.8 22.0 29.8 33.4 17.9 46.0 69.1 29.5 16.3 16.7 35.1 19.3 19.2 15.3 33.1 15.7 16.2 35.1 33.8 3.2 6.0 4.7 2.5 2.6 4.8 1.4 23.4 8.6 16.0 12.8 69.4 36.5 16.1 32.2 36.0 23.9 32.0 8.9 24.2 16.5 37.8 41.4 27.8 13.7 14.6 15.9 30.1 9.4 8.4 11.1 22.8 16.9 87.8 16.0 8.3 28.7 32.3 20.0 24.8 55.8 21.4 10.8 18.4 20.9 34.3 7.2 14.8 7.4 12.5 28.5 7.8 11.9 12.8 11.3 35.3 8.3 12.6 12.0 18.0 20.5 18.3 27.5 15.7 7.3 39.6 20.2 16.5 20.7 14.9 24.2 19.6 17.7 22.1 14.4 13.8 4.7 2.5 4.6 3.9 2.1 1.9 3.2 4.8 3.9 1.4 2.7 4.4 4.0 2.2 2.6 1.8 6.0 4.7 1.4 18.3 20.4 17.7 19.3 18.4 18.4 17.4 18.5 18.0 19.2 50.6 34.2 23.8 45.7 89.0 20.4 51.2 48.4 24.1 39.8 41.8 9.8 66.3 24.9 50.1 71.9 50.2 83.0 70.0 64.9 109.7 60.6 46.0 11.5 114.3 31.8 11.1 34.1 27.6 12.7 27.3 42.8 25.2 64.1 18.0 64.6 72.5 60.7 56.1 35.3 99.8 34.3 12.9 59.7 27.7 25.9 97.7 229.9 23.5 49.5 29.8 PHEX "HPDR, HPDR1, HYP, HYP1, PEX, XLH" ENSG00000102174 "Phosphate regulating endopeptidase homolog X-linked" P78562 X 22032441-22251310 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" Biomineralization "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 8.3;lung: 6.7" "Cell type enhanced" "Detected in some" 21 "Basal glandular cells: 5.2;Horizontal cells: 15.9" "Cancer enhanced" "Detected in some" "thyroid cancer: 5.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 37 "plasmacytoid DC: 8.3" "Lineage enriched" "Detected in single" 37 "dendritic cells: 8.3" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.8;HUVEC TERT2: 4.4;PC-3: 4.8;TIME: 4.9;U-87 MG: 10.6;WM-115: 4.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (2.01e-2)" "unprognostic (2.69e-1)" "unprognostic (2.43e-1)" "unprognostic (1.05e-3)" "unprognostic (1.22e-1)" "unprognostic (3.04e-2)" "unprognostic (2.25e-3)" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (1.21e-2)" "unprognostic (7.53e-2)" "unprognostic (7.45e-2)" "unprognostic (9.84e-8)" "unprognostic (1.18e-1)" "unprognostic (1.58e-1)" "prognostic favorable (2.51e-4)" "unprognostic (7.68e-2)" 0.3 0.0 1.8 1.9 1.1 0.0 1.7 0.9 1.1 0.8 0.9 0.8 0.3 1.2 5.0 0.3 0.4 0.1 2.0 0.3 1.5 1.8 0.3 0.3 6.7 3.4 2.0 0.3 3.9 0.3 0.0 0.3 0.3 5.0 1.3 0.0 0.3 2.8 0.9 0.3 0.1 1.4 3.9 3.8 3.4 0.0 0.3 0.3 1.3 4.8 0.3 4.3 0.5 0.6 0.1 8.3 0.0 0.0 0.0 0.2 0.0 0.3 0.8 0.2 0.1 0.1 0.4 0.0 0.0 0.1 0.1 0.3 1.3 0.1 0.1 1.3 0.1 0.2 0.1 0.0 5.8 0.3 0.0 0.1 0.1 0.5 0.0 0.1 0.1 0.2 2.2 1.1 1.1 3.4 0.2 4.4 0.4 0.0 0.5 0.5 0.0 0.0 0.2 0.0 0.0 4.8 0.0 1.0 0.0 0.6 0.2 0.1 0.2 0.4 2.5 0.8 0.6 2.9 0.0 4.9 1.0 0.2 0.6 0.8 0.0 0.1 0.0 10.6 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 8.3 0.0 0.0 1.8 1.1 0.9 1.1 1.5 1.8 2.0 0.3 5.0 0.3 0.0 0.0 0.0 5.2 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.4 0.2 1.7 0.0 1.0 0.1 0.5 1.6 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 1.7 0.0 1.7 0.0 0.0 0.8 0.7 0.0 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.1 0.7 0.0 0.0 2.7 PHLDB2 "FLJ21791, LL5b, LL5beta" ENSG00000144824 "Pleckstrin homology like domain family B member 2" Q86SQ0 3 111732497-111976517 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 104.0" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 138.6;Basal keratinocytes: 222.0;Smooth muscle cells: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 32.4;HaCaT: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035146, HPA035147" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035146: AB_10600927, HPA035147: AB_2674492" "unprognostic (2.83e-2)" "unprognostic (4.93e-3)" "unprognostic (2.15e-2)" "unprognostic (8.01e-2)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (5.14e-2)" "unprognostic (2.20e-2)" "unprognostic (1.43e-1)" "unprognostic (9.03e-2)" "unprognostic (2.00e-2)" "unprognostic (3.53e-1)" "prognostic favorable (7.03e-8)" "unprognostic (3.24e-3)" "unprognostic (3.47e-2)" "unprognostic (1.53e-1)" "unprognostic (2.83e-1)" 15.5 3.8 1.3 13.2 1.9 0.4 9.9 1.6 2.9 13.9 22.8 1.4 8.4 2.8 17.4 10.1 10.7 10.7 9.1 21.7 1.3 1.2 36.6 24.6 14.4 2.2 2.1 1.9 8.5 6.4 0.9 5.3 104.0 7.1 16.7 4.4 6.9 7.0 14.3 6.0 5.8 6.5 49.3 2.4 7.9 11.4 4.3 0.4 1.7 5.9 6.8 2.3 33.8 17.8 1.0 1.0 0.4 0.1 1.7 5.6 1.3 32.4 3.6 20.4 0.0 6.6 10.9 8.4 18.8 9.2 12.5 14.8 10.2 2.4 0.0 19.8 7.2 12.6 33.8 0.3 12.1 22.8 0.5 0.4 0.0 8.7 3.3 7.2 0.0 0.1 12.8 7.2 8.6 16.0 14.1 20.0 0.3 0.0 0.1 3.7 0.0 1.3 0.0 8.2 0.3 6.3 2.8 26.3 0.0 7.4 7.8 0.5 1.5 18.5 0.3 1.9 11.7 0.6 0.1 17.4 3.4 28.6 9.0 4.5 1.7 0.0 0.0 3.4 0.0 6.4 0.2 0.0 0.0 5.2 0.0 3.7 0.4 3.6 5.6 0.1 1.0 0.0 2.3 0.4 1.7 0.1 1.0 0.8 1.3 1.3 1.9 1.6 2.9 1.3 1.2 2.1 1.9 7.1 0.4 74.5 9.8 2.4 138.6 222.0 0.1 94.0 25.5 5.3 12.5 31.4 2.0 21.1 19.9 56.7 10.2 32.4 0.0 0.0 17.6 42.7 33.9 48.7 6.9 28.4 3.0 0.0 10.4 43.6 3.2 3.9 13.3 3.2 21.9 1.8 3.4 0.0 37.0 0.0 21.2 28.0 0.3 12.9 129.6 0.3 2.1 100.2 55.8 7.0 1.4 85.9 PHTF1 PHTF ENSG00000116793 "Putative homeodomain transcription factor 1" Q9UMS5 1 113696831-113759489 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 138.9;Late spermatids: 106.5;Spermatocytes: 106.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059486 Approved "Nucleoli,Nuclear bodies" No No "Nuclear bodies" Nucleoli "HPA059486: " "unprognostic (1.52e-1)" "unprognostic (3.33e-1)" "unprognostic (2.58e-2)" "unprognostic (4.54e-2)" "unprognostic (5.92e-2)" "unprognostic (1.62e-2)" "unprognostic (6.55e-2)" "unprognostic (1.30e-1)" "unprognostic (3.30e-3)" "unprognostic (1.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" 6.5 10.4 11.5 7.9 8.6 19.5 11.8 31.6 15.1 7.1 5.4 4.0 7.6 4.5 6.6 9.6 3.4 13.1 8.8 8.2 10.1 12.4 8.9 10.1 10.8 11.9 8.2 12.9 4.0 8.2 15.3 20.9 8.5 10.4 5.8 6.5 8.2 5.2 6.9 5.5 2.4 4.9 8.4 6.4 10.5 8.0 33.8 6.6 3.4 6.1 2.4 7.7 8.1 6.3 3.0 4.5 6.0 2.6 4.3 5.7 1.7 12.8 6.7 19.1 10.1 9.5 8.6 5.0 11.8 15.7 10.6 17.4 7.3 10.4 3.7 16.8 8.2 7.8 7.1 7.2 4.7 12.2 15.2 7.2 8.9 14.1 8.4 7.9 10.9 12.6 7.2 1.3 14.2 3.1 15.4 19.5 0.0 5.3 17.1 12.8 19.0 0.1 11.0 15.1 4.8 10.9 11.5 28.7 7.4 17.0 5.6 13.5 12.4 13.2 6.5 7.0 10.4 2.6 8.9 20.6 8.4 11.6 15.4 11.4 23.9 24.2 6.9 20.6 9.5 22.7 3.0 2.6 4.9 3.0 1.3 2.3 3.0 3.7 3.7 4.5 1.6 0.1 2.6 6.0 4.3 1.7 3.0 5.7 1.7 11.5 8.6 31.6 15.1 10.1 12.4 8.2 12.9 10.4 6.6 6.0 10.9 21.0 6.3 2.2 28.1 7.4 15.3 49.5 10.3 5.2 51.1 17.2 8.3 9.9 138.9 17.6 2.7 23.3 18.2 7.7 11.1 7.1 20.8 7.6 10.9 27.0 18.4 9.2 13.2 106.5 7.5 9.8 5.0 10.8 2.7 5.3 15.5 0.0 8.5 5.4 45.4 0.0 11.4 106.3 31.1 1.5 22.1 18.7 2.9 6.5 PHTF2 DKFZp434D166 ENSG00000006576 "Putative homeodomain transcription factor 2" Q8N3S3 7 77798792-77957503 "Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "non-classical monocyte: 18.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012312 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012312: AB_2668649" "unprognostic (1.96e-1)" "unprognostic (2.60e-3)" "unprognostic (4.04e-1)" "unprognostic (1.44e-1)" "unprognostic (5.70e-2)" "unprognostic (1.99e-3)" "unprognostic (5.36e-3)" "unprognostic (2.81e-2)" "unprognostic (1.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (3.09e-7)" "unprognostic (8.28e-3)" "unprognostic (2.28e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (5.53e-2)" 7.5 4.5 5.6 15.1 8.6 7.7 5.9 8.7 10.3 7.0 5.9 8.9 5.3 3.2 7.3 4.6 6.4 5.7 7.8 9.1 7.0 5.2 5.4 4.7 6.8 13.7 7.0 6.3 7.4 4.7 27.7 8.2 11.4 9.3 5.9 5.1 4.7 5.7 6.9 67.0 5.5 7.8 8.5 8.2 12.1 4.7 9.1 5.8 9.2 5.7 18.2 15.5 7.9 6.3 6.7 2.1 9.2 18.2 3.8 6.2 2.0 15.2 7.0 9.6 19.5 8.4 9.3 8.0 27.0 24.7 16.2 18.4 11.9 12.4 13.7 2.2 20.9 17.6 12.7 13.7 7.0 23.1 9.2 10.9 5.6 7.7 3.5 9.2 7.4 15.5 5.5 6.7 9.4 14.2 10.4 5.7 7.7 9.1 24.4 17.2 9.6 6.0 4.8 8.7 4.3 8.3 6.1 19.5 11.2 4.4 20.6 9.3 13.0 15.1 17.2 9.8 14.8 18.2 5.8 5.7 27.9 15.0 15.6 15.8 11.5 13.4 17.1 8.8 12.0 24.0 9.2 2.1 3.4 1.5 9.2 3.0 6.7 4.7 1.4 2.1 4.2 1.4 1.5 1.2 3.8 18.2 1.0 6.2 2.0 5.6 8.6 8.7 10.3 7.0 5.2 7.0 6.3 9.3 5.8 6.0 17.5 23.8 17.3 14.2 7.8 21.5 15.3 9.4 9.1 7.0 11.8 11.2 0.0 4.0 10.8 9.0 5.3 0.0 5.8 7.0 14.7 6.5 37.1 4.3 10.4 3.2 5.2 23.4 33.1 4.4 11.2 29.4 10.1 1.8 6.0 4.0 6.0 5.8 12.7 1.8 9.3 12.9 12.8 22.9 32.2 15.6 12.4 35.5 4.5 20.4 PI16 "CD364, dJ90K10.5, MGC45378, MSMBBP" ENSG00000164530 "Peptidase inhibitor 16" Q6UXB8 6 36948263-36964837 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 87.2" "Cell type enhanced" "Detected in many" 20 "Fibroblasts: 45.7;Leydig cells: 190.7;Peritubular cells: 140.7" "Cancer enhanced" "Detected in many" "glioma: 15.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 29.9" "Lineage enriched" "Detected in many" 5 "T-cells: 29.9" "Cell line enriched" "Detected in some" 6 "JURKAT: 26.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA076574 Approved "Secreted to blood" NA NA 3600000000 "HPA076574: AB_2732314" "unprognostic (6.24e-3)" "unprognostic (6.00e-3)" "unprognostic (7.34e-2)" "unprognostic (9.53e-2)" "unprognostic (3.38e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-2)" "unprognostic (5.06e-2)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (3.25e-2)" "unprognostic (4.46e-2)" "unprognostic (1.59e-3)" "unprognostic (5.82e-2)" "unprognostic (2.31e-1)" "unprognostic (1.28e-1)" "unprognostic (8.76e-2)" 22.2 1.7 2.9 1.4 8.8 0.3 27.9 0.7 4.5 62.7 4.5 21.4 22.5 0.8 11.1 27.0 10.5 5.3 17.4 43.1 4.6 3.5 0.8 0.5 3.7 1.1 9.0 3.9 2.8 2.5 0.6 3.3 1.2 9.3 15.0 3.4 87.2 4.0 14.2 5.5 19.8 2.0 55.5 13.7 0.8 8.5 8.3 9.3 0.1 8.3 8.7 4.8 32.7 49.8 0.7 0.2 0.2 0.0 5.7 29.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.3 0.2 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 26.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.3 9.8 2.9 0.0 0.7 3.4 1.0 0.2 5.7 0.0 0.2 29.9 1.7 2.9 8.8 0.7 4.5 4.6 3.5 9.0 3.9 9.3 9.3 0.0 1.0 0.0 0.1 19.2 0.0 3.2 0.0 0.0 1.2 1.8 0.0 0.0 1.7 0.0 10.5 2.7 0.0 0.0 0.0 0.0 45.7 0.1 0.0 0.0 0.1 0.0 0.0 17.2 0.0 14.4 190.7 1.0 10.1 0.0 0.0 0.0 0.1 0.0 140.7 0.2 0.0 0.0 2.2 1.9 1.1 16.2 0.1 0.0 0.0 0.1 PI3 "cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14" ENSG00000124102 "Peptidase inhibitor 3" P19957 20 45174876-45176544 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6" "Cell type enhanced" "Detected in many" 21 "Enterocytes: 69.5;Exocrine glandular cells: 290.8;Pancreatic endocrine cells: 135.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 2666.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 1121 "neutrophil: 157.1" "Lineage enriched" "Detected in single" 1571 "granulocytes: 157.1" "Group enriched" "Detected in some" 5 "EFO-21: 26.6;HaCaT: 32.3;OE19: 29.6;PC-3: 55.0" "CAB009449, HPA017737" Enhanced Approved "Plasma membrane" "Secreted to blood" NA NA 2100000 "Plasma membrane" "CAB009449: AB_2252354, HPA017737: AB_1848107" "prognostic favorable (6.94e-4)" "unprognostic (3.61e-2)" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (7.34e-2)" "unprognostic (1.85e-1)" "unprognostic (3.20e-3)" "unprognostic (5.53e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.84e-6)" "prognostic unfavorable (6.89e-4)" "unprognostic (8.54e-3)" "prognostic unfavorable (1.94e-8)" "unprognostic (1.23e-1)" "unprognostic (7.38e-2)" "unprognostic (1.04e-2)" "unprognostic (5.91e-3)" 0.4 0.0 0.2 8.8 0.2 0.0 0.7 0.2 0.2 85.3 9.3 0.2 0.4 0.1 7.7 0.2 200.8 0.3 4.8 0.6 0.2 0.0 0.3 0.6 3.1 0.8 0.2 0.2 0.3 0.4 0.0 0.2 0.6 0.3 1.0 3.7 0.3 35.6 0.4 0.2 6.4 3.2 0.6 0.2 1.4 0.7 5.1 0.2 23.4 0.2 468.6 173.5 1.6 118.7 0.0 0.0 157.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.9 0.6 0.4 26.6 0.0 0.3 32.3 0.0 6.6 0.0 0.3 0.0 0.1 2.0 0.2 0.0 0.2 0.0 0.0 6.3 5.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 29.6 55.0 0.0 0.2 0.0 6.3 0.1 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 0.2 0.3 3.2 0.0 0.2 0.1 0.4 0.1 4.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.0 11.3 0.5 5.2 0.1 0.0 0.0 7.6 0.0 13.6 17.4 0.0 0.0 0.0 14.9 0.1 0.1 69.5 0.0 290.8 0.0 0.3 25.8 4.6 0.0 0.1 0.0 16.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.4 0.0 135.9 29.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.0 33.5 18.7 PIANP "C12orf53, DKFZp547D2210, PANP" ENSG00000139200 "PILR alpha associated neural protein" Q8IYJ0 12 6693792-6700800 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.7" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 13.9;Horizontal cells: 17.5;Peritubular cells: 13.1" "Cancer enhanced" "Detected in many" "glioma: 14.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 7 "T-cells: 2.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 7.9;HAP1: 7.8;hTERT-RPE1: 13.1;NTERA-2: 16.5;SH-SY5Y: 15.6;U-2 OS: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010631 Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA010631: AB_10603680" "unprognostic (1.82e-1)" "unprognostic (9.21e-3)" "unprognostic (1.62e-2)" "unprognostic (7.65e-2)" "unprognostic (1.34e-1)" "unprognostic (3.03e-2)" "unprognostic (6.58e-2)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (6.41e-3)" "unprognostic (1.92e-2)" "unprognostic (3.89e-1)" "unprognostic (3.30e-3)" "unprognostic (3.26e-3)" "unprognostic (1.16e-1)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" 1.5 8.3 28.0 2.2 55.7 1.2 1.5 27.4 52.8 7.2 2.7 2.6 0.5 1.9 11.6 4.1 1.8 2.2 3.3 1.5 19.5 26.2 1.5 1.1 1.5 2.4 11.0 20.9 1.8 1.7 1.2 4.0 1.5 9.0 3.4 2.0 1.7 2.2 8.7 1.3 1.7 2.2 8.1 4.6 1.6 2.1 4.4 8.3 0.0 1.4 0.0 1.7 1.8 2.5 0.3 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.4 5.9 1.1 0.2 0.3 0.2 1.5 7.9 4.1 3.7 0.1 0.2 0.1 0.0 2.8 0.6 0.2 7.8 0.2 2.0 0.2 1.0 0.3 0.2 0.0 0.2 0.3 0.2 1.0 0.0 1.6 0.0 13.1 0.0 2.4 0.0 0.2 0.3 0.2 0.2 0.2 16.5 0.0 0.0 1.1 0.0 0.1 0.1 0.1 2.1 15.6 0.0 0.1 0.0 1.1 0.0 0.0 0.0 4.3 8.7 4.4 1.1 0.2 0.0 0.3 5.8 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.7 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.0 55.7 27.4 27.8 19.5 26.2 11.0 20.9 9.0 8.3 0.0 0.0 0.0 0.0 0.2 13.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 17.5 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 13.1 0.0 3.0 0.0 1.4 0.1 4.5 0.1 0.1 0.0 0.0 0.0 PIEZO1 "FAM38A, KIAA0233" ENSG00000103335 "Piezo type mechanosensitive ion channel component 1" Q92508 16 88715338-88785220 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 68.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047185 Uncertain NA NA "HPA047185: AB_2679973" "unprognostic (1.76e-1)" "prognostic unfavorable (2.37e-4)" "unprognostic (1.77e-1)" "unprognostic (1.12e-2)" "unprognostic (4.08e-2)" "unprognostic (2.34e-2)" "unprognostic (2.64e-2)" "prognostic unfavorable (2.36e-5)" "unprognostic (4.39e-2)" "prognostic unfavorable (3.78e-4)" "unprognostic (3.51e-2)" "unprognostic (3.05e-2)" "prognostic unfavorable (8.89e-7)" "unprognostic (2.04e-1)" "unprognostic (3.59e-2)" "unprognostic (2.86e-2)" "unprognostic (3.74e-1)" 34.6 7.3 5.7 19.2 9.8 24.2 59.0 5.7 6.5 13.8 25.2 7.4 20.3 7.5 13.6 8.2 16.5 12.4 15.4 7.2 6.7 4.3 15.8 18.1 21.2 14.7 10.3 2.5 9.1 6.9 7.0 2.1 17.8 9.1 15.9 4.9 11.9 15.7 16.7 4.2 15.4 12.9 29.2 8.9 18.6 13.2 3.0 7.5 6.7 10.5 9.9 13.3 17.8 39.3 2.5 9.4 3.1 11.6 0.9 8.5 3.6 10.5 10.8 1.7 8.2 7.4 8.1 41.0 25.8 11.5 9.5 3.7 15.6 17.7 8.7 18.1 12.4 4.7 22.8 3.6 9.3 1.9 8.5 14.5 14.7 18.8 12.3 11.2 6.6 2.4 6.6 5.1 7.4 6.2 5.6 11.5 14.6 19.9 11.2 5.5 68.2 8.1 23.0 3.8 5.0 6.7 19.6 2.4 21.8 4.3 15.6 3.3 0.9 33.7 17.8 4.5 1.8 24.3 19.4 30.9 22.9 13.2 15.3 13.0 2.3 5.1 5.3 18.1 11.9 13.5 1.7 5.1 3.1 8.5 9.3 7.9 2.5 6.1 5.5 9.4 2.5 1.0 2.7 0.1 0.9 11.6 1.7 4.7 3.6 5.7 9.8 5.7 6.5 6.7 4.3 10.3 2.5 9.1 7.5 68.5 20.3 5.2 12.3 16.9 0.8 4.5 15.3 4.0 11.4 55.8 15.7 4.4 0.0 30.6 1.3 34.8 7.4 0.0 18.7 24.2 14.2 35.0 8.1 17.8 20.8 3.2 20.2 47.9 19.0 1.0 5.2 15.0 15.1 10.0 23.0 1.1 57.8 14.8 2.5 3.7 3.3 0.0 8.9 0.4 2.7 13.9 4.2 10.2 8.0 13.9 PIEZO2 "C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771" ENSG00000154864 "Piezo type mechanosensitive ion channel component 2" Q9H5I5 18 10666483-11148762 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Cell type enhanced" "Detected in some" 10 "Cholangiocytes: 10.2;Ciliated cells: 13.4;Early spermatids: 23.3;Ito cells: 22.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.6;BJ hTERT+ SV40 Large T+: 10.7;BJ hTERT+ SV40 Large T+ RasG12V: 14.9;HeLa: 23.8;U-266/70: 15.2;U-698: 9.9" "Low region specificity" "Detected in single" "HPA015986, HPA031974, HPA040616" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043" "unprognostic (1.36e-1)" "unprognostic (1.92e-1)" "unprognostic (9.21e-2)" "unprognostic (2.53e-2)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.87e-2)" "unprognostic (4.34e-3)" "unprognostic (6.55e-2)" "unprognostic (3.89e-2)" "unprognostic (6.06e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.57e-7)" "unprognostic (1.12e-3)" "unprognostic (1.09e-1)" "unprognostic (9.04e-2)" "unprognostic (1.83e-2)" 0.9 0.3 3.1 0.9 2.3 0.0 1.9 0.1 3.6 0.9 3.3 0.0 0.3 1.6 5.8 0.8 5.9 0.0 5.2 2.1 0.9 4.5 7.4 0.5 5.8 0.6 1.7 0.0 0.6 0.0 3.4 1.3 0.0 3.3 0.0 0.8 0.9 1.9 10.3 2.7 1.4 0.9 1.3 0.2 4.6 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.2 9.6 0.0 0.0 0.0 0.0 0.5 2.8 10.7 14.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 6.9 0.0 0.3 0.0 23.8 5.6 3.4 0.0 0.0 0.0 0.2 2.7 0.7 0.1 3.3 0.3 0.0 0.2 1.7 0.0 0.1 0.0 3.0 4.1 0.0 0.0 0.0 4.2 0.0 3.3 8.3 0.0 0.1 0.0 0.5 4.5 0.0 2.7 0.0 0.0 3.8 0.2 0.5 15.2 0.1 9.9 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.4 0.7 0.0 1.4 10.2 13.4 1.2 0.0 0.0 0.0 0.0 0.1 23.3 0.9 0.0 0.0 0.2 0.0 3.1 0.1 4.7 4.5 0.7 0.0 0.0 22.1 4.0 8.6 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.4 0.0 0.4 0.6 0.3 0.0 0.0 0.0 PIGA GPI3 ENSG00000165195 "Phosphatidylinositol glycan anchor biosynthesis class A" P37287 X 15319451-15335580 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001174 Approved NA NA "HPA001174: AB_2666220" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "unprognostic (5.90e-2)" "unprognostic (7.92e-2)" "unprognostic (2.05e-1)" "unprognostic (2.16e-1)" "unprognostic (2.99e-3)" "unprognostic (2.24e-2)" "unprognostic (7.37e-3)" "unprognostic (3.93e-3)" "prognostic unfavorable (7.64e-4)" "unprognostic (1.85e-3)" "unprognostic (5.97e-3)" "unprognostic (2.24e-1)" "unprognostic (3.94e-1)" "unprognostic (2.12e-2)" "unprognostic (1.18e-2)" 6.9 6.1 6.8 5.0 8.6 16.1 7.0 7.6 10.0 6.0 6.8 9.6 5.8 3.5 6.2 7.5 9.9 5.6 7.8 6.2 8.0 5.4 7.5 11.0 14.4 5.9 9.6 6.4 7.0 9.9 8.5 5.2 10.8 16.7 5.9 7.5 7.0 11.5 9.1 4.2 10.9 4.8 5.2 10.2 5.7 7.2 5.3 9.4 4.7 8.6 8.5 8.7 11.6 6.6 2.9 3.9 16.7 7.6 1.5 4.4 2.4 12.5 7.8 8.1 4.1 2.4 2.5 6.7 3.3 5.2 7.3 7.0 8.5 5.5 5.9 2.7 2.6 8.5 5.0 13.4 11.0 11.9 5.3 9.2 5.0 9.6 5.0 4.2 7.1 2.6 3.4 7.4 9.4 14.9 2.2 4.6 4.7 5.4 6.3 4.4 7.9 8.0 2.6 4.2 4.7 8.6 2.8 11.7 9.3 5.2 8.5 5.6 8.7 6.6 5.9 12.7 8.3 6.0 6.3 3.8 5.4 2.2 12.0 6.6 4.8 6.2 9.1 8.4 5.1 6.9 16.7 3.6 3.9 2.7 6.0 3.8 2.9 4.4 2.7 3.9 2.2 4.0 3.1 5.2 1.5 7.6 2.5 3.8 2.4 6.8 8.6 7.6 10.0 8.0 5.4 9.6 6.4 16.7 9.4 17.9 84.7 1.9 34.4 26.3 3.4 6.7 2.5 17.4 22.7 3.5 0.0 4.8 10.0 6.3 3.5 4.5 5.4 23.3 5.1 8.2 10.6 28.9 32.4 4.3 7.5 3.2 10.3 2.5 6.9 3.2 2.8 13.8 27.0 1.8 3.7 3.7 7.9 4.5 2.8 4.7 2.5 12.9 19.6 1.6 3.9 48.1 23.5 6.4 4.1 49.8 PIGB ENSG00000069943 "Phosphatidylinositol glycan anchor biosynthesis class B" Q92521 15 55318960-55355648 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039929 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039929: AB_10673539" "unprognostic (1.91e-2)" "unprognostic (7.45e-2)" "unprognostic (3.00e-1)" "unprognostic (2.03e-2)" "unprognostic (2.96e-2)" "unprognostic (4.65e-2)" "unprognostic (2.04e-1)" "unprognostic (3.37e-3)" "unprognostic (7.52e-2)" "unprognostic (3.52e-2)" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.30e-1)" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (4.24e-2)" 9.5 11.9 5.7 13.0 11.9 11.2 10.4 3.9 9.3 7.1 8.5 8.2 6.6 9.1 10.5 13.2 11.1 9.5 10.0 6.3 5.9 5.9 12.4 10.3 8.8 20.1 6.9 6.8 8.7 8.1 19.2 12.5 8.7 8.6 9.7 9.4 13.0 9.6 8.4 3.2 8.1 11.6 7.0 8.9 14.2 9.3 17.4 6.0 11.5 16.3 6.2 16.2 10.7 9.3 8.4 8.1 20.1 11.5 5.6 8.9 6.4 7.5 8.7 4.0 3.1 4.4 9.0 5.7 6.3 12.7 7.1 11.4 3.8 7.9 7.3 8.4 8.8 11.0 12.7 2.5 6.6 6.0 7.3 5.7 7.2 10.9 4.7 7.9 20.5 6.3 9.4 8.2 5.6 7.2 9.1 8.8 6.6 8.5 6.2 9.4 6.6 2.5 8.0 2.5 5.8 4.4 3.2 3.9 16.7 11.0 8.3 2.3 4.5 5.8 9.4 11.0 3.8 10.1 14.9 6.7 9.6 3.2 2.5 12.7 6.2 11.1 6.5 8.5 23.1 6.9 10.5 8.9 4.1 8.3 10.4 8.9 8.4 8.3 8.6 8.1 5.4 7.0 7.8 20.1 5.6 11.5 6.3 8.6 6.4 5.7 11.9 3.9 9.3 5.9 5.9 6.9 6.8 8.6 6.0 8.9 7.4 8.6 8.7 4.0 2.7 2.6 2.5 8.1 12.5 0.0 11.8 10.0 1.7 6.2 16.8 4.5 5.2 0.0 9.7 9.3 4.1 4.1 8.1 3.8 7.5 1.6 6.3 7.4 6.5 2.4 1.4 6.3 3.3 8.2 3.7 3.1 5.9 4.2 1.4 8.2 9.1 6.5 4.7 2.6 3.0 3.4 5.5 8.6 3.7 3.3 PIGBOS1 ENSG00000225973 "PIGB opposite strand 1" A0A0B4J2F0 15 55317184-55319161 "Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 35.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Intracellular and membrane" NA NA "prognostic favorable (4.19e-4)" "unprognostic (1.61e-1)" "unprognostic (1.25e-1)" "unprognostic (5.58e-3)" "unprognostic (1.21e-1)" "unprognostic (3.41e-1)" "unprognostic (1.84e-1)" "unprognostic (1.33e-2)" "unprognostic (3.08e-2)" "unprognostic (2.31e-1)" "unprognostic (3.27e-2)" "unprognostic (2.58e-3)" "unprognostic (4.62e-3)" "unprognostic (7.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.30e-1)" "unprognostic (4.96e-1)" 6.7 5.8 3.9 7.3 6.4 11.0 7.1 4.1 10.6 4.4 6.2 7.4 6.4 6.9 7.3 7.4 5.1 6.6 8.2 6.6 4.0 9.7 9.2 7.4 11.5 7.9 4.9 6.8 13.4 4.5 9.1 8.3 6.4 5.8 5.6 7.3 6.2 4.3 5.5 4.6 8.0 6.0 5.5 7.8 7.1 5.2 7.1 9.1 12.6 4.4 5.8 7.1 7.3 20.3 26.7 35.9 27.1 19.5 27.7 16.6 7.6 7.6 6.7 4.6 9.1 10.6 8.7 8.7 7.8 6.3 4.5 4.1 5.3 9.9 10.0 5.2 11.2 6.8 2.4 4.3 4.2 12.8 3.7 16.8 7.0 8.0 7.5 11.4 14.4 8.6 7.8 4.4 4.5 9.1 7.3 9.3 20.1 9.4 5.8 6.4 5.8 23.3 3.8 8.5 4.3 8.2 6.2 18.1 5.7 5.0 5.0 8.4 5.2 7.8 25.0 9.1 8.0 27.4 7.4 10.3 12.4 6.0 11.9 10.1 26.6 8.4 9.2 25.8 10.9 28.1 27.0 35.9 16.7 19.9 15.4 18.8 20.3 17.7 20.8 20.3 27.7 20.2 27.5 19.5 27.1 26.7 24.9 16.6 26.8 16.3 25.8 12.8 0.0 13.5 6.0 10.2 34.8 18.2 17.4 5.9 29.2 33.2 21.7 15.6 15.8 17.3 46.7 34.1 29.3 12.4 16.7 6.9 29.7 33.5 17.5 28.9 25.8 24.3 3.4 27.6 29.1 0.0 32.5 16.3 17.9 24.2 17.6 18.4 37.3 19.5 32.3 13.0 14.6 16.4 0.0 19.9 23.0 15.5 7.8 PIGC ENSG00000135845 "Phosphatidylinositol glycan anchor biosynthesis class C" Q92535 1 172370189-172444086 "Enzymes, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036663 Uncertain NA NA "HPA036663: AB_10669912" "unprognostic (3.35e-1)" "unprognostic (3.01e-1)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (2.65e-1)" "unprognostic (3.72e-3)" "prognostic unfavorable (4.49e-4)" "unprognostic (7.25e-2)" "unprognostic (2.20e-2)" "unprognostic (4.69e-2)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.43e-8)" "unprognostic (1.09e-1)" "unprognostic (1.77e-1)" "unprognostic (6.04e-2)" "unprognostic (1.90e-1)" 13.8 13.1 10.0 9.0 11.2 14.4 13.9 11.3 12.3 14.4 12.3 9.0 20.9 9.3 14.5 26.1 11.6 15.1 12.1 14.1 8.4 10.2 11.5 12.5 9.0 13.1 12.0 6.6 14.9 16.4 9.2 11.6 14.4 9.6 17.1 12.3 13.2 12.7 15.7 14.8 21.3 15.8 13.5 9.9 12.4 10.5 13.5 9.8 14.2 15.8 10.8 12.3 11.0 10.8 18.9 12.5 27.4 14.5 25.1 33.8 19.2 17.7 15.3 20.9 14.2 15.8 14.4 15.6 11.6 13.0 20.1 17.6 13.7 26.1 9.6 17.1 13.8 15.9 19.2 13.6 16.8 16.2 21.1 15.7 11.7 14.6 17.1 17.6 23.9 15.4 21.5 20.2 14.4 15.9 15.7 12.7 18.5 17.6 18.4 16.1 9.1 18.1 21.4 21.5 36.5 21.5 15.0 17.0 17.0 30.9 13.2 10.9 20.9 16.8 19.9 26.1 30.9 17.6 17.1 11.6 12.8 21.5 15.6 12.3 12.3 17.4 15.0 9.2 15.7 24.2 27.4 14.5 27.3 19.4 13.5 16.4 18.9 22.7 20.4 12.5 16.7 33.8 24.2 9.5 25.1 14.1 12.4 19.8 19.2 10.0 11.2 11.3 12.3 8.4 10.2 12.0 6.6 9.6 9.8 8.9 10.1 18.2 17.0 11.9 14.3 17.9 15.3 20.1 7.9 27.9 7.9 53.2 28.2 27.8 72.4 18.6 18.4 23.3 35.8 42.5 35.1 14.9 7.0 12.5 31.2 19.1 7.5 19.6 25.3 53.5 43.7 17.2 25.3 25.2 19.3 18.1 26.8 22.6 38.2 18.2 14.2 32.3 18.5 28.9 16.0 16.7 19.8 26.6 20.4 14.1 PIGF ENSG00000151665 "Phosphatidylinositol glycan anchor biosynthesis class F" Q07326 2 46580937-46617119 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051389 Uncertain NA NA "HPA051389: AB_2681464" "unprognostic (3.85e-3)" "unprognostic (5.42e-2)" "unprognostic (1.11e-3)" "unprognostic (8.18e-2)" "unprognostic (2.56e-1)" "unprognostic (4.52e-3)" "prognostic unfavorable (1.39e-5)" "unprognostic (4.97e-2)" "unprognostic (9.29e-3)" "unprognostic (6.08e-2)" "unprognostic (5.89e-2)" "unprognostic (9.40e-2)" "unprognostic (1.02e-1)" "unprognostic (7.30e-3)" "unprognostic (1.84e-1)" "unprognostic (6.04e-2)" "unprognostic (6.71e-2)" 14.4 30.9 18.5 13.9 19.3 6.9 17.7 13.6 17.9 14.0 17.3 19.0 19.6 16.3 20.1 29.4 17.1 15.3 14.8 12.4 16.6 19.4 20.8 15.9 13.6 11.8 20.6 12.8 13.2 21.0 17.7 37.8 15.5 21.5 14.9 19.8 14.9 28.6 13.4 16.4 11.4 16.5 8.3 25.4 15.2 14.9 25.0 23.0 11.0 25.8 15.3 14.7 18.4 13.5 13.6 17.8 9.2 15.9 9.5 13.2 6.0 13.9 8.1 17.7 9.1 22.6 24.5 10.9 15.3 10.7 7.2 7.4 4.0 10.4 7.1 31.0 11.2 15.5 11.2 16.5 12.6 14.6 23.6 17.4 16.3 6.3 22.0 13.0 10.0 11.7 16.8 19.0 10.9 16.0 21.3 19.5 7.5 14.5 19.6 26.6 3.5 7.8 9.5 14.0 28.6 13.4 7.9 14.8 17.5 20.9 13.9 12.1 13.9 7.3 10.5 18.4 14.7 5.8 11.1 11.7 9.0 10.3 13.5 15.4 9.4 12.4 12.3 9.3 18.6 19.6 3.0 12.3 9.2 9.8 15.9 10.1 11.1 11.3 9.3 12.9 13.6 8.8 11.1 5.3 9.5 15.0 17.8 13.2 6.0 18.5 19.3 13.6 17.9 16.6 19.4 20.6 12.8 21.5 23.0 8.9 14.4 18.2 34.3 22.7 30.1 2.8 25.5 20.1 23.9 19.2 27.5 33.3 29.9 22.6 50.0 27.0 15.7 0.0 26.5 45.0 20.9 34.7 18.5 22.6 33.3 35.0 16.7 20.9 22.9 18.6 13.8 20.0 28.7 22.6 26.6 50.6 20.3 28.1 15.2 27.1 24.7 6.5 15.5 84.4 41.1 29.7 27.0 14.4 32.9 38.3 PIGG "FLJ20265, GPI7, LAS21" ENSG00000174227 "Phosphatidylinositol glycan anchor biosynthesis class G" Q5H8A4 4 499210-540196 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015997 Uncertain NA NA "HPA015997: AB_2164679" "unprognostic (3.87e-2)" "unprognostic (5.32e-2)" "unprognostic (5.78e-3)" "unprognostic (2.77e-2)" "unprognostic (2.25e-1)" "unprognostic (1.34e-1)" "unprognostic (3.20e-3)" "unprognostic (3.48e-2)" "unprognostic (4.68e-1)" "unprognostic (2.64e-1)" "unprognostic (7.01e-3)" "unprognostic (6.61e-3)" "unprognostic (9.09e-2)" "unprognostic (1.83e-2)" "unprognostic (1.51e-1)" "unprognostic (4.27e-3)" "unprognostic (2.97e-2)" 16.2 22.0 12.8 19.8 19.7 11.3 17.1 21.3 23.2 13.3 15.6 23.2 21.5 18.8 23.2 28.7 16.7 15.6 17.4 11.5 13.6 12.5 15.5 13.0 15.5 16.5 20.3 16.0 22.1 18.6 31.1 22.9 16.7 17.2 16.9 16.5 19.5 20.9 19.1 10.7 26.6 17.5 19.3 21.8 17.7 17.5 19.9 17.6 16.2 21.9 9.6 15.1 19.5 15.0 4.2 9.2 16.4 7.5 8.1 9.0 4.5 10.7 12.0 10.9 9.2 20.0 14.4 17.2 14.3 17.2 15.4 18.2 12.2 25.6 4.4 10.4 18.0 28.0 14.4 10.3 14.0 14.1 4.2 11.1 11.2 14.6 9.5 14.0 15.4 16.9 16.1 23.4 14.1 7.8 16.6 11.6 8.9 12.3 10.3 13.6 6.6 8.6 13.3 17.4 11.7 16.4 9.5 6.7 6.7 14.5 14.9 10.9 13.9 10.4 10.8 9.9 10.8 17.4 13.9 17.8 15.9 7.4 7.8 22.1 8.3 10.8 7.1 13.5 11.4 19.5 16.4 5.9 4.7 7.2 7.5 8.3 4.2 5.7 6.9 9.2 3.6 6.2 5.0 4.3 8.1 5.3 8.0 9.0 4.5 12.8 19.7 21.3 23.2 13.6 12.5 20.3 16.0 17.2 17.6 14.9 9.3 5.1 8.9 7.9 10.4 6.5 2.5 14.7 18.2 8.7 3.9 14.4 0.0 14.3 1.6 10.3 12.4 0.0 15.6 12.3 8.1 11.6 12.7 8.3 8.2 7.9 10.4 6.7 11.6 0.4 12.7 10.7 8.5 13.6 7.5 15.1 14.5 10.1 12.0 5.7 10.3 19.4 6.2 9.7 9.3 5.5 19.3 10.0 8.6 12.2 PIGH GPI-H ENSG00000100564 "Phosphatidylinositol glycan anchor biosynthesis class H" Q14442 14 67581955-67600287 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Autism spectrum disorder, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 94.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031624 Approved NA NA "HPA031624: AB_10601046" "unprognostic (1.59e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (5.80e-2)" "unprognostic (3.47e-2)" "unprognostic (8.25e-3)" "unprognostic (8.69e-3)" "unprognostic (3.26e-3)" "unprognostic (1.19e-1)" "unprognostic (2.73e-1)" "unprognostic (6.17e-3)" "unprognostic (1.39e-1)" "prognostic favorable (2.68e-7)" "unprognostic (7.42e-2)" "unprognostic (1.42e-2)" "unprognostic (7.00e-2)" "unprognostic (3.73e-1)" 9.7 22.7 15.1 8.8 15.9 18.6 18.5 21.5 18.8 21.8 10.1 11.9 11.5 10.3 10.6 30.6 10.2 9.2 15.6 12.5 14.0 17.2 28.0 18.3 9.1 11.0 19.5 11.3 16.7 21.4 56.0 9.4 17.9 17.8 24.1 9.8 21.0 19.9 17.2 19.5 12.7 12.7 13.1 19.2 11.1 12.2 23.6 14.5 13.5 31.5 7.4 10.5 10.8 10.7 31.8 14.4 24.4 20.4 23.5 29.9 16.8 13.7 9.0 8.7 18.0 19.4 7.5 7.4 7.5 9.4 10.7 10.5 14.4 4.8 9.6 7.7 5.2 18.1 10.1 15.2 10.9 12.0 14.2 20.2 9.8 7.7 14.7 15.3 7.2 12.0 10.8 14.1 8.1 12.5 3.3 6.8 16.5 22.1 6.8 7.8 11.9 10.5 12.0 1.6 19.1 24.5 3.6 8.7 5.6 11.4 11.5 10.9 13.1 5.8 11.3 18.6 6.7 12.9 7.3 3.5 10.9 13.8 14.0 9.0 12.9 8.3 6.5 8.4 15.4 15.0 17.9 12.6 24.4 23.1 16.6 29.9 29.6 24.4 21.5 12.3 31.8 25.7 24.0 6.0 23.5 20.4 14.4 22.3 16.8 15.1 15.9 21.5 18.8 14.0 17.2 19.5 11.3 17.8 14.5 3.0 10.2 10.9 19.0 18.3 35.8 4.2 15.3 10.7 4.5 21.0 33.4 26.9 24.9 16.6 9.6 17.3 10.7 0.0 32.6 23.2 21.6 21.6 6.9 14.7 19.9 25.4 6.9 9.8 6.7 6.0 19.8 10.9 33.7 3.6 13.1 94.1 19.6 8.6 19.8 21.6 35.0 0.0 19.4 59.5 54.8 18.2 47.1 19.2 14.7 14.8 PIGK "GPI8, hGPI8" ENSG00000142892 "Phosphatidylinositol glycan anchor biosynthesis class K" Q92643 1 77088990-77219430 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056383, HPA057040" Uncertain "Intracellular and membrane" NA NA "HPA056383: AB_2683109, HPA057040: AB_2683319" "unprognostic (2.43e-2)" "unprognostic (2.60e-1)" "unprognostic (4.07e-2)" "unprognostic (2.24e-2)" "unprognostic (3.65e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (4.68e-4)" "unprognostic (1.07e-1)" "unprognostic (5.19e-1)" "unprognostic (1.12e-1)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (1.76e-2)" "unprognostic (3.37e-1)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "unprognostic (8.12e-3)" 14.5 17.4 13.8 8.0 20.4 10.2 17.1 14.8 22.9 14.2 11.4 17.4 9.6 9.2 14.6 13.8 10.7 13.0 13.6 20.0 15.4 17.7 25.4 19.0 12.3 10.6 17.7 11.7 13.7 14.1 24.9 23.1 11.2 23.8 15.9 12.9 11.2 11.9 12.9 11.9 7.6 11.6 14.5 19.9 14.7 11.6 9.6 17.2 14.6 22.3 8.1 9.8 12.9 9.4 5.2 7.6 7.6 4.4 8.9 12.8 6.3 5.7 6.8 5.6 7.1 32.4 24.4 9.1 11.7 16.1 12.3 17.7 5.6 5.9 5.0 12.1 20.7 14.7 5.2 7.1 10.0 22.5 10.4 7.3 6.8 7.3 5.2 7.2 15.1 6.1 14.7 5.4 13.1 11.4 14.8 18.1 6.3 8.3 17.4 18.9 3.9 4.7 6.1 5.0 6.5 11.3 5.6 16.5 6.4 15.7 4.2 4.8 4.5 11.1 10.1 12.7 9.7 4.8 8.7 10.3 19.9 7.8 10.7 11.9 7.9 11.0 5.1 14.8 19.2 7.8 6.9 4.1 7.6 8.3 4.4 8.4 5.2 8.5 7.0 7.6 4.1 10.7 9.5 2.0 8.9 4.2 5.2 12.8 6.3 13.8 20.4 14.8 22.9 15.4 17.7 17.7 11.7 23.8 17.2 8.9 7.8 11.5 13.1 8.5 13.1 18.9 22.9 20.1 9.1 38.4 2.0 16.1 3.3 18.9 1.5 17.3 6.5 0.0 18.7 28.7 19.2 13.7 17.3 24.6 18.1 7.9 10.4 16.5 14.3 2.2 18.1 11.1 18.6 8.2 11.9 15.7 11.7 7.0 25.8 18.8 7.2 51.8 21.2 56.1 20.2 10.5 12.7 18.1 11.2 10.8 PIGL ENSG00000108474 "Phosphatidylinositol glycan anchor biosynthesis class L" Q9Y2B2 17 16217191-16351797 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "GPI-anchor biosynthesis" Hydrolase "Deafness, Disease mutation, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012739 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" No No "Nucleoplasm, Cytosol" "HPA012739: AB_1855367" "unprognostic (3.07e-2)" "unprognostic (2.65e-1)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (7.70e-2)" "unprognostic (6.14e-2)" "unprognostic (9.39e-5)" "unprognostic (1.11e-2)" "unprognostic (1.15e-2)" "unprognostic (1.63e-2)" "unprognostic (6.37e-3)" "prognostic unfavorable (2.57e-4)" "prognostic unfavorable (1.47e-4)" "unprognostic (3.19e-2)" "unprognostic (2.13e-1)" "unprognostic (3.38e-1)" "unprognostic (2.75e-3)" 17.3 12.6 11.1 14.3 18.8 8.6 18.0 14.6 15.6 12.9 13.0 17.6 12.8 17.1 19.8 20.2 12.6 13.1 12.7 8.8 8.5 7.5 11.2 18.5 12.5 12.0 14.5 10.7 16.5 16.5 11.9 18.1 10.3 13.6 14.0 14.4 15.5 14.8 16.3 13.4 20.0 15.8 10.1 9.7 12.3 14.8 11.1 13.6 13.7 15.7 11.1 20.4 10.9 12.3 5.2 7.4 5.5 3.7 5.4 9.3 3.3 7.9 11.4 7.7 6.3 11.0 10.4 3.2 4.4 5.3 7.5 13.3 11.6 10.2 3.9 9.1 4.3 4.5 11.6 9.5 5.6 10.7 8.3 24.8 7.7 7.9 13.8 11.8 3.3 5.0 8.8 14.7 13.0 14.8 7.6 8.5 13.1 9.1 5.0 5.9 7.9 6.0 7.7 3.0 15.9 5.9 5.9 6.5 11.2 8.4 4.3 4.1 5.8 4.6 3.3 9.0 20.8 3.5 3.0 5.5 6.8 4.2 4.4 12.5 3.5 0.1 6.3 8.4 8.2 4.2 0.0 3.7 5.5 6.5 3.2 5.6 5.2 8.5 5.0 2.7 4.4 9.3 7.5 0.0 5.4 2.4 7.4 6.7 3.3 11.1 18.8 14.6 15.6 8.5 7.5 14.5 10.7 13.6 13.6 8.9 16.0 3.7 8.0 3.9 11.3 1.7 7.6 10.7 12.5 12.2 9.8 13.3 5.0 5.6 2.1 5.8 6.8 0.0 6.4 6.1 6.0 6.8 4.7 9.4 4.5 6.4 7.5 3.1 2.7 1.9 7.2 5.1 3.3 1.8 10.0 6.7 7.4 7.0 10.6 4.4 12.3 0.0 6.6 13.7 8.3 5.3 8.0 8.7 10.8 8.8 PIGM GPI-MT-I ENSG00000143315 "Phosphatidylinositol glycan anchor biosynthesis class M" Q9H3S5 1 160024953-160031991 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047418 Uncertain NA NA "HPA047418: AB_2680039" "unprognostic (1.55e-2)" "unprognostic (1.91e-1)" "unprognostic (1.37e-1)" "unprognostic (1.58e-1)" "unprognostic (9.89e-2)" "unprognostic (2.88e-2)" "unprognostic (2.69e-3)" "unprognostic (1.52e-1)" "unprognostic (3.85e-2)" "prognostic favorable (3.27e-4)" "unprognostic (2.63e-2)" "unprognostic (2.77e-2)" "unprognostic (3.01e-2)" "unprognostic (8.55e-2)" "unprognostic (1.69e-1)" "unprognostic (2.06e-2)" "unprognostic (1.50e-1)" 6.5 9.1 7.4 6.7 9.9 2.9 9.7 7.7 8.7 7.9 6.7 17.1 8.8 7.8 7.3 11.7 8.0 7.3 7.7 6.2 7.6 6.7 7.7 14.9 6.6 7.1 17.3 5.2 8.8 18.3 14.9 10.4 6.2 12.6 11.3 7.9 10.2 10.5 9.1 3.0 9.8 8.4 5.8 21.8 8.0 9.1 9.6 12.5 14.9 11.0 3.1 7.5 7.8 6.1 6.2 10.4 8.3 14.6 9.5 10.6 7.7 5.0 4.6 5.7 8.2 7.5 6.3 1.9 7.7 4.9 5.1 4.8 2.5 9.5 3.6 6.3 5.0 4.4 10.4 6.2 6.2 6.6 7.6 6.6 8.3 6.0 3.7 4.6 10.6 6.5 5.6 4.1 6.1 4.8 4.5 4.3 8.0 4.4 6.8 5.9 8.5 6.8 5.7 5.9 9.5 6.6 2.2 5.8 15.7 5.6 7.0 8.0 12.4 8.4 9.9 6.0 5.7 18.7 12.7 6.0 6.8 6.0 10.1 4.7 12.4 13.6 0.2 6.2 5.5 7.5 8.3 14.6 5.6 8.1 11.4 8.4 5.8 8.3 6.4 8.8 6.2 10.6 8.3 2.6 9.5 14.2 10.4 8.5 7.7 7.4 9.9 7.7 8.7 7.6 6.7 17.3 5.2 12.6 12.5 11.9 16.6 6.1 4.5 3.8 14.8 3.7 20.4 13.4 17.0 15.7 9.8 6.5 1.7 11.1 4.3 8.4 7.5 0.0 15.9 3.1 6.7 5.8 4.7 19.2 6.4 15.9 12.1 12.9 12.7 2.3 7.8 5.8 8.5 3.6 13.9 38.7 10.4 3.5 8.5 5.5 11.7 19.4 4.4 24.7 8.3 4.0 1.5 4.8 11.1 3.0 PIGN "MDC4, PIG-N" ENSG00000197563 "Phosphatidylinositol glycan anchor biosynthesis class N" O95427 18 61905255-62187118 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 13 "Alveolar cells type 1: 300.7;Alveolar cells type 2: 289.2;Ciliated cells: 257.0;Club cells: 244.5;granulocytes: 147.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039922, HPA040374" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039922: AB_10805597, HPA040374: AB_10794738" "unprognostic (1.93e-2)" "unprognostic (1.71e-1)" "prognostic favorable (6.51e-4)" "unprognostic (1.03e-1)" "unprognostic (9.99e-2)" "unprognostic (3.99e-2)" "unprognostic (1.23e-1)" "unprognostic (3.99e-1)" "unprognostic (1.64e-2)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.81e-1)" "unprognostic (1.78e-1)" "unprognostic (6.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.75e-2)" "unprognostic (2.71e-1)" 12.6 14.1 8.3 10.2 13.2 13.7 13.5 10.5 12.4 15.1 13.2 16.6 12.2 12.0 18.3 12.7 33.2 9.2 11.0 12.8 9.6 7.8 11.2 15.9 9.0 9.5 10.4 8.8 12.9 16.6 19.7 27.2 17.1 11.9 15.2 15.7 14.7 20.3 13.7 15.2 19.0 12.7 9.6 15.4 9.3 17.4 16.2 12.2 18.6 15.3 12.7 18.6 16.8 18.1 13.1 13.4 14.8 10.0 16.3 11.5 4.5 16.7 10.1 10.0 12.7 12.5 17.0 13.4 16.7 13.1 10.9 13.1 13.0 17.1 18.5 24.4 12.6 9.8 23.2 13.4 14.1 17.3 15.4 9.0 11.3 15.5 10.2 9.0 23.1 13.2 9.9 9.5 11.0 12.9 11.9 13.7 13.3 13.3 27.8 12.0 15.2 11.5 7.0 16.9 13.3 9.4 12.4 18.7 17.9 13.5 25.8 11.4 11.8 22.2 15.7 7.0 29.1 25.0 14.8 15.6 22.2 16.3 8.8 12.4 29.5 27.4 9.2 12.2 13.2 21.6 11.4 10.0 7.6 9.6 8.5 9.9 10.3 9.7 9.2 10.8 13.1 11.2 11.5 14.8 16.3 9.0 13.4 7.8 4.5 8.3 13.2 10.5 12.4 9.6 7.8 10.4 8.8 11.9 12.2 300.7 289.2 3.4 7.8 7.1 6.5 7.7 17.8 257.0 244.5 10.4 3.9 7.7 1.7 9.6 3.9 5.3 5.9 0.0 8.3 8.5 5.8 12.6 147.5 11.3 8.7 6.4 6.4 11.6 5.9 5.3 6.6 7.5 3.3 8.2 13.4 8.0 8.7 10.5 3.5 3.7 6.8 6.5 4.1 18.4 4.7 14.9 8.7 5.0 11.9 10.7 PIGO "DKFZp434M222, FLJ00135" ENSG00000165282 "Phosphatidylinositol glycan anchor biosynthesis class O" Q8TEQ8 9 35088688-35096601 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014905 Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA014905: AB_1855369" "unprognostic (1.41e-2)" "unprognostic (1.06e-1)" "unprognostic (4.03e-1)" "unprognostic (3.54e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-1)" "unprognostic (6.98e-3)" "unprognostic (4.14e-2)" "unprognostic (5.08e-2)" "unprognostic (2.25e-1)" "unprognostic (3.63e-1)" "unprognostic (1.54e-1)" "prognostic favorable (3.05e-10)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (5.23e-3)" "unprognostic (3.81e-2)" 9.4 16.6 7.2 8.7 11.7 5.4 11.6 12.6 15.6 10.8 11.5 17.8 15.6 14.1 14.0 13.6 12.6 15.8 13.4 9.5 7.4 6.4 16.1 15.2 10.6 13.8 9.0 10.1 15.9 17.5 47.3 13.4 27.6 11.5 13.1 13.2 18.0 17.5 17.4 7.6 10.0 12.9 10.7 11.0 14.2 13.9 16.5 9.7 11.3 20.0 8.3 13.4 13.6 9.9 7.4 13.7 8.0 8.8 7.1 10.0 4.1 15.9 27.4 7.8 11.2 7.0 7.9 14.0 6.8 11.9 16.5 13.5 10.1 16.3 9.0 12.4 8.1 23.0 11.7 13.1 21.3 10.0 9.9 8.4 5.4 17.9 7.6 13.7 7.3 9.4 9.6 23.6 14.6 24.1 13.1 8.5 13.5 5.9 12.9 13.5 8.8 8.5 8.3 5.0 10.0 11.3 8.9 6.3 9.8 18.1 11.1 6.6 8.9 9.4 23.4 5.3 9.0 17.5 4.8 5.1 12.1 10.7 6.5 12.4 7.9 11.6 3.8 13.1 5.4 15.0 7.0 6.7 8.0 9.2 8.8 9.3 5.0 5.1 10.0 13.7 7.4 6.5 7.6 2.4 7.1 5.9 9.5 7.6 4.1 7.2 11.7 12.6 15.6 7.4 6.4 9.0 10.1 11.5 9.7 3.0 11.5 5.2 4.4 2.3 9.1 2.4 20.4 13.4 7.9 15.7 2.0 17.4 0.0 11.1 0.7 3.1 10.6 0.0 12.1 13.5 3.1 3.6 6.9 11.1 10.0 11.1 2.9 4.9 6.3 1.0 4.0 3.9 3.3 8.2 7.8 14.9 8.2 7.0 2.8 5.6 10.9 6.5 2.5 17.4 7.0 1.8 18.9 7.2 8.5 3.1 PIGP "DCRC, DSCR5, DSRC" ENSG00000185808 "Phosphatidylinositol glycan anchor biosynthesis class P" P57054 21 37059170-37073170 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 193.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026921 Uncertain Approved Vesicles Yes No Vesicles "HPA026921: AB_1847874" "unprognostic (4.47e-3)" "unprognostic (9.45e-2)" "unprognostic (3.03e-1)" "unprognostic (2.40e-1)" "unprognostic (2.85e-2)" "unprognostic (1.92e-2)" "unprognostic (1.92e-2)" "unprognostic (5.54e-2)" "unprognostic (1.55e-1)" "unprognostic (1.22e-2)" "unprognostic (4.21e-3)" "unprognostic (1.12e-2)" "unprognostic (1.96e-2)" "unprognostic (1.93e-1)" "unprognostic (5.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.55e-2)" 20.0 30.3 12.3 7.9 13.4 4.2 18.0 6.9 14.3 13.1 13.8 15.6 23.1 9.9 11.7 60.6 12.5 13.9 15.2 27.8 12.3 15.2 19.0 27.4 14.7 9.9 16.1 9.8 15.0 45.4 23.9 28.9 16.2 17.9 21.3 14.3 16.6 22.2 17.4 25.0 7.0 12.8 24.0 24.8 10.1 14.8 19.3 8.4 16.3 20.3 17.3 9.9 17.2 9.2 18.2 16.7 1.7 11.1 8.7 19.3 8.7 9.1 4.4 9.2 5.6 16.7 10.9 6.1 7.4 13.7 6.7 7.6 5.8 19.4 12.6 16.6 11.2 30.3 7.4 7.6 8.4 7.1 13.1 13.2 28.6 5.5 8.0 10.1 8.4 6.3 9.9 16.0 12.1 15.2 15.7 11.5 28.6 17.0 22.6 14.8 6.1 11.2 9.3 7.0 26.2 10.7 11.0 4.7 13.3 16.9 5.1 19.0 11.4 20.9 15.8 28.1 12.8 13.5 18.5 6.0 5.0 2.4 5.8 6.7 30.1 32.7 14.4 14.4 10.8 16.3 0.2 7.1 1.7 11.3 10.4 14.0 18.2 14.5 12.1 11.1 15.3 19.3 16.7 1.0 8.7 11.1 16.7 10.7 8.7 12.3 13.4 6.9 14.3 12.3 15.2 16.1 9.8 17.9 8.4 26.8 36.1 32.3 46.9 29.3 19.4 74.2 43.3 56.2 26.1 41.8 9.8 49.2 76.3 48.2 68.0 32.1 27.7 0.0 62.5 46.0 37.9 46.4 16.1 77.3 60.5 15.9 43.1 32.5 40.6 54.3 63.9 44.6 35.4 37.9 52.5 26.5 65.1 55.4 32.9 92.2 26.6 64.7 43.9 193.5 109.2 23.1 43.7 28.8 53.6 46.5 PIGQ "GPI1, hGPI1" ENSG00000007541 "Phosphatidylinositol glycan anchor biosynthesis class Q" Q9BRB3 16 566995-584136 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039105, HPA039828, HPA061414" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: AB_2684508" "unprognostic (1.23e-2)" "unprognostic (6.12e-3)" "unprognostic (2.81e-1)" "unprognostic (2.65e-2)" "unprognostic (1.09e-2)" "unprognostic (2.42e-1)" "unprognostic (9.58e-2)" "unprognostic (8.05e-2)" "unprognostic (2.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (8.98e-2)" "prognostic favorable (2.53e-6)" "unprognostic (2.73e-1)" "unprognostic (2.60e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" 13.9 15.7 12.8 8.7 13.9 48.4 8.4 12.8 20.6 8.4 9.7 11.4 16.7 15.4 10.9 23.3 7.2 10.0 13.6 7.4 10.5 11.1 18.9 12.5 13.0 6.2 9.1 13.2 10.4 29.3 18.1 15.3 8.4 9.4 11.2 4.1 15.4 15.5 17.6 12.4 12.8 8.1 5.5 7.2 10.3 13.6 15.3 8.2 11.8 18.4 4.2 7.9 9.8 6.7 5.6 10.5 5.9 6.0 5.5 5.3 3.9 8.6 13.0 4.6 6.5 3.0 1.8 8.7 9.0 3.5 3.9 4.3 9.1 8.0 4.5 11.8 2.0 3.5 13.8 2.1 4.0 0.8 13.1 19.0 6.9 14.1 6.4 5.8 6.0 6.5 3.3 6.0 6.5 1.3 2.6 3.6 8.5 15.5 2.6 1.3 11.2 11.1 6.9 6.3 1.8 13.4 21.6 3.9 10.5 3.5 3.5 8.4 13.2 10.3 4.7 6.6 1.5 10.7 4.2 8.7 6.6 8.4 7.5 6.3 10.0 2.9 3.6 2.2 3.3 6.5 1.2 4.8 3.0 5.3 5.6 4.6 4.4 4.6 5.1 4.9 5.6 5.1 3.1 5.9 5.5 6.0 10.5 4.2 3.9 12.8 13.9 12.8 20.6 10.5 11.1 9.1 13.2 9.4 8.2 14.9 20.7 3.0 6.7 4.2 12.5 7.3 0.0 17.4 9.1 38.4 3.9 8.9 3.3 16.0 23.2 7.0 20.0 46.7 15.1 7.4 9.1 8.5 8.1 14.3 8.2 9.5 19.4 5.5 7.3 44.6 6.9 7.4 15.1 5.4 11.8 17.5 12.5 9.9 6.7 11.5 12.9 0.0 9.5 27.2 12.6 4.3 4.9 6.9 11.0 3.5 PIGR ENSG00000162896 "Polymeric immunoglobulin receptor" P01833 1 206928518-206946466 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 139.0;intestine: 320.1;salivary gland: 398.1" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 2375.7;Mucus-secreting cells: 2056.5;Paneth cells: 2331.9;Undifferentiated cells: 3429.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 731.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "EFO-21: 28.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006154, CAB009454, HPA012012" Enhanced "Intracellular and membrane" NA NA 1900000000 "CAB009454: AB_2164819, HPA006154: AB_1855370, HPA012012: AB_1855371" "prognostic favorable (1.22e-5)" "unprognostic (7.42e-2)" "unprognostic (4.78e-3)" "prognostic favorable (2.57e-4)" "unprognostic (2.31e-2)" "unprognostic (6.71e-2)" "unprognostic (1.13e-1)" "unprognostic (3.07e-2)" "unprognostic (6.45e-2)" "unprognostic (1.19e-1)" "unprognostic (5.23e-2)" "unprognostic (2.13e-1)" "prognostic favorable (5.08e-5)" "unprognostic (1.83e-1)" "unprognostic (1.41e-1)" "unprognostic (6.92e-3)" "unprognostic (3.39e-2)" 0.3 0.3 0.3 74.2 0.3 0.0 6.9 0.3 0.3 35.1 232.8 0.6 0.4 158.9 2.6 0.5 2.6 0.7 139.0 0.3 0.3 0.3 52.5 5.0 25.1 0.3 0.3 0.3 0.6 4.2 0.0 0.9 0.4 0.3 3.0 75.6 0.4 398.1 0.6 0.4 0.4 320.1 2.0 0.3 0.4 25.3 0.6 0.3 0.4 0.4 23.9 22.5 4.9 0.6 3.4 1.1 1.4 0.5 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 28.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 1.4 0.2 0.0 0.0 0.2 0.0 5.0 0.1 1.3 0.6 2.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.4 0.2 0.3 1.0 0.0 0.1 0.0 1.4 0.5 0.3 0.4 0.2 0.5 3.4 0.3 0.3 1.1 3.4 0.5 0.5 1.4 0.5 0.3 0.9 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 86.4 488.0 21.0 2.7 0.2 0.0 0.8 662.5 127.2 379.9 102.9 0.0 0.0 14.9 60.9 0.0 0.5 2375.7 0.0 58.6 0.0 0.0 57.7 51.8 26.7 0.3 0.0 410.4 1.8 1.5 0.0 0.0 3.2 1.7 1.0 2056.5 0.0 144.1 2331.9 0.0 262.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3429.8 34.0 PIGS ENSG00000087111 "Phosphatidylinositol glycan anchor biosynthesis class S" Q96S52 17 28553383-28571872 "Plasma proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018149 Approved NA NA "HPA018149: AB_1855373" "unprognostic (2.29e-2)" "unprognostic (1.37e-2)" "unprognostic (3.89e-1)" "unprognostic (2.52e-1)" "unprognostic (6.61e-2)" "unprognostic (3.82e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (1.65e-1)" "unprognostic (9.09e-2)" "unprognostic (2.25e-3)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (2.90e-2)" "unprognostic (1.23e-1)" "unprognostic (8.06e-3)" "unprognostic (1.65e-1)" "prognostic unfavorable (5.31e-4)" 13.2 11.6 10.9 8.3 15.3 13.7 11.3 22.0 18.3 9.7 16.0 13.7 9.6 16.4 12.6 11.4 19.0 13.6 12.8 20.2 10.0 9.1 18.8 6.3 11.5 15.4 9.7 12.9 11.3 17.3 17.0 9.1 10.9 14.0 11.5 9.9 16.8 12.0 11.3 21.0 14.9 23.6 11.0 10.1 13.7 15.5 14.9 9.0 14.9 17.6 9.4 12.2 12.7 11.9 6.2 16.4 14.4 13.0 8.0 7.7 7.9 5.9 14.2 3.1 10.0 7.1 7.0 9.3 5.6 6.1 7.5 10.6 14.0 3.8 4.8 8.5 7.6 5.1 8.4 5.9 7.3 2.6 12.2 34.0 7.4 10.8 4.9 8.1 10.6 13.7 7.4 5.5 3.5 5.0 4.4 12.0 5.0 21.4 4.6 6.1 11.0 6.6 7.5 2.5 7.1 5.5 4.6 18.4 9.6 4.5 7.6 14.0 9.2 9.9 16.3 7.1 3.7 13.1 8.0 10.4 3.8 5.1 5.7 6.8 6.3 11.0 3.8 6.1 10.3 6.2 9.3 13.0 14.4 7.6 11.4 6.9 6.2 4.8 7.2 16.4 4.5 6.5 4.7 4.3 8.0 7.9 10.8 7.7 7.9 10.9 15.3 22.0 18.3 10.0 9.1 9.7 12.9 14.0 9.0 41.7 18.4 9.7 9.7 7.3 20.7 36.9 5.1 12.0 10.3 43.6 60.9 29.9 10.0 37.2 6.9 14.6 37.0 0.0 23.0 45.5 9.9 13.2 3.5 5.9 27.0 49.3 39.1 27.0 27.5 9.7 22.2 19.1 6.8 25.2 27.9 15.8 17.5 11.5 21.2 16.5 54.5 6.5 12.3 46.2 44.5 10.9 30.4 21.8 24.2 9.7 PIGT ENSG00000124155 "Phosphatidylinositol glycan anchor biosynthesis class T" Q969N2 20 45416067-45456934 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (6.06e-2)" "unprognostic (4.60e-3)" "unprognostic (7.63e-2)" "unprognostic (6.00e-2)" "unprognostic (6.18e-3)" "unprognostic (6.68e-2)" "unprognostic (7.34e-3)" "unprognostic (1.17e-1)" "unprognostic (2.70e-2)" "unprognostic (3.32e-1)" "prognostic favorable (2.51e-4)" "unprognostic (5.48e-2)" "unprognostic (7.60e-2)" "unprognostic (9.21e-2)" "unprognostic (5.66e-2)" "unprognostic (1.06e-1)" "unprognostic (3.43e-2)" 35.8 36.6 14.8 20.8 27.0 34.8 33.0 18.2 42.8 40.6 43.0 58.4 24.9 27.6 46.7 52.0 24.8 35.5 36.1 63.8 19.0 21.0 36.5 44.4 27.9 22.1 39.7 20.4 34.2 51.9 53.1 32.7 40.0 33.6 28.1 46.2 34.7 33.6 34.1 38.0 29.1 35.2 40.9 33.2 25.6 35.7 34.5 30.0 20.7 32.6 27.2 26.7 33.2 28.9 11.0 36.1 23.8 31.8 20.5 23.4 27.9 15.7 21.3 7.2 27.4 45.7 33.0 14.6 18.9 35.1 26.5 20.8 40.3 25.1 9.5 24.8 28.7 21.6 29.3 9.4 26.0 16.1 5.2 12.4 9.5 19.9 21.4 21.6 19.1 38.7 25.0 24.6 21.8 23.0 38.0 24.9 8.4 12.8 34.2 22.7 36.3 8.3 14.4 6.1 45.6 38.4 6.9 22.5 32.8 21.6 11.0 12.0 15.5 36.4 35.7 18.1 13.8 31.4 34.4 20.6 62.6 29.1 11.7 26.2 18.1 27.6 6.0 40.0 14.7 28.2 16.9 30.0 23.8 23.4 31.8 17.2 11.0 16.6 21.5 36.1 10.2 14.7 16.9 11.6 20.5 28.4 27.4 22.2 27.9 14.8 27.0 18.2 42.8 19.0 21.0 39.7 20.4 33.6 30.0 38.7 25.6 36.6 35.3 26.7 17.1 144.4 43.3 34.8 28.4 41.8 13.7 53.8 11.6 95.7 25.7 50.4 91.6 0.0 101.2 63.1 72.5 39.2 32.4 35.1 69.3 36.5 63.0 45.4 48.8 59.4 56.1 37.3 84.4 40.5 121.3 22.9 66.4 42.1 52.6 20.7 11.9 64.7 44.2 57.7 99.9 24.3 43.6 52.0 96.0 43.4 PIGU "bA346K17.2, CDC91L1, GAB1" ENSG00000101464 "Phosphatidylinositol glycan anchor biosynthesis class U" Q9H490 20 34560542-34698790 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041706, HPA046766" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041706: AB_2677627, HPA046766: AB_2679794" "unprognostic (1.87e-2)" "unprognostic (1.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.83e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (1.64e-1)" "unprognostic (8.42e-3)" "unprognostic (7.94e-3)" "unprognostic (2.69e-1)" "unprognostic (9.86e-2)" "unprognostic (8.82e-3)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (5.27e-2)" "unprognostic (4.21e-3)" 16.8 17.6 18.9 12.9 23.6 10.0 15.2 15.7 26.5 14.7 21.5 43.0 10.8 13.3 21.8 22.8 20.0 28.2 12.7 17.4 21.4 20.2 18.4 16.3 11.3 11.6 21.5 11.9 23.9 16.2 34.4 21.7 17.3 26.9 14.1 24.9 20.1 17.9 15.9 16.4 14.0 14.2 19.6 30.5 11.1 11.5 22.1 18.1 16.5 14.7 15.9 19.5 14.2 15.0 10.0 10.8 9.4 6.3 12.1 15.0 6.7 11.7 15.0 19.1 14.0 12.6 15.2 19.2 12.1 14.5 20.6 18.2 27.7 25.1 15.2 19.8 11.9 26.4 22.0 17.4 22.9 21.0 6.2 9.4 34.2 9.9 31.1 11.7 20.8 8.2 13.4 14.8 11.8 13.5 9.5 14.8 15.0 17.1 13.5 17.4 13.2 17.6 21.2 9.6 26.8 22.7 12.8 24.0 24.3 18.2 11.0 12.3 11.6 22.7 41.2 14.8 11.2 22.7 14.7 8.7 33.9 12.1 18.3 12.1 9.1 12.7 10.1 20.7 21.8 14.6 9.4 4.4 1.9 13.4 6.3 12.2 9.2 12.4 15.0 10.8 10.0 12.7 12.5 0.9 12.1 5.3 10.6 11.2 6.7 18.9 23.6 15.7 26.5 21.4 20.2 21.5 11.9 26.9 18.1 8.9 3.7 1.5 11.9 3.9 8.5 5.2 12.7 26.8 9.1 10.4 15.7 33.8 1.7 16.1 13.6 5.0 10.3 0.0 15.2 23.8 8.0 10.0 8.1 6.7 13.7 1.6 9.8 8.6 5.6 11.0 5.2 3.5 1.7 6.4 13.8 8.1 9.8 21.0 7.4 8.4 9.5 19.4 12.0 31.9 12.2 5.1 17.7 7.0 22.1 7.6 PIGV FLJ20477 ENSG00000060642 "Phosphatidylinositol glycan anchor biosynthesis class V" Q9NUD9 1 26787472-26798398 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 65.1;Spermatocytes: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054181 Approved "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA054181: " "unprognostic (2.08e-1)" "unprognostic (6.53e-2)" "unprognostic (1.32e-3)" "unprognostic (1.96e-2)" "unprognostic (2.02e-2)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.61e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (8.40e-2)" "unprognostic (4.44e-2)" "prognostic favorable (7.60e-7)" "unprognostic (1.71e-1)" "unprognostic (4.24e-1)" "unprognostic (8.92e-2)" "unprognostic (5.96e-3)" 6.2 14.6 8.1 5.3 8.9 4.6 9.2 6.1 10.3 10.5 7.5 9.9 9.3 7.3 8.3 14.7 8.7 10.6 8.9 4.4 7.2 6.6 10.6 24.6 6.8 5.1 11.6 6.8 9.0 13.5 15.8 13.5 9.3 9.7 11.5 8.4 6.6 9.9 10.6 5.0 10.1 10.7 7.1 7.5 7.2 7.7 31.3 10.0 7.2 20.0 8.2 7.8 9.3 7.6 8.3 9.7 23.5 12.9 18.0 19.1 9.2 9.4 5.7 4.6 4.0 8.9 11.0 3.9 6.5 15.4 6.2 7.6 3.1 19.6 5.6 5.9 8.1 6.9 16.9 2.4 7.6 7.7 9.5 4.0 4.9 7.6 7.8 10.0 8.9 12.1 11.4 31.6 8.5 10.4 13.2 4.7 9.1 8.9 9.0 11.1 5.3 4.4 5.0 6.9 13.9 4.6 3.2 5.3 10.6 9.8 2.4 6.6 3.5 6.4 3.2 6.3 8.3 11.0 4.4 7.8 11.2 4.8 5.4 2.2 3.2 2.1 3.0 9.2 9.5 6.6 23.5 10.3 7.7 13.3 10.1 19.1 7.4 9.0 13.0 9.7 8.3 9.1 11.1 12.5 18.0 12.9 3.8 7.7 9.2 8.1 8.9 6.1 10.3 7.2 6.6 11.6 6.8 9.7 10.0 3.0 5.9 6.7 10.3 3.8 2.9 1.8 2.5 8.1 1.2 7.0 7.9 22.6 6.6 6.3 40.4 5.0 6.1 23.3 4.0 12.3 8.7 6.7 0.0 14.1 8.1 7.9 3.4 7.4 4.7 65.1 6.6 4.0 6.8 10.0 6.5 10.3 4.6 2.9 9.2 7.9 2.7 0.0 5.1 82.9 13.9 3.6 11.8 6.1 9.8 5.8 PIGW "FLJ37433, Gwt1" ENSG00000277161 "Phosphatidylinositol glycan anchor biosynthesis class W" Q7Z7B1 17 36535020-36539310 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023499 Approved "Plasma membrane" No Yes "Plasma membrane" "HPA023499: " "unprognostic (4.96e-3)" "unprognostic (3.84e-2)" "unprognostic (5.40e-3)" "unprognostic (7.39e-2)" "unprognostic (2.32e-1)" "unprognostic (7.71e-2)" "unprognostic (8.14e-3)" "unprognostic (1.05e-1)" "unprognostic (1.89e-1)" "unprognostic (4.62e-2)" "unprognostic (1.98e-1)" "unprognostic (3.29e-1)" "unprognostic (1.73e-2)" "unprognostic (1.41e-1)" "unprognostic (8.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.88e-1)" 3.0 2.4 2.5 4.9 2.9 3.0 4.5 1.8 6.4 2.5 3.8 2.4 0.4 3.3 3.2 4.4 5.7 2.0 2.7 3.5 2.3 6.7 12.0 2.9 4.7 3.6 2.2 4.3 4.8 3.3 6.0 2.6 6.3 2.1 4.8 3.7 3.7 2.8 6.5 5.0 3.9 3.1 3.2 4.3 3.3 3.4 2.2 4.0 4.1 8.1 5.5 2.4 1.2 4.4 6.2 1.1 4.9 4.8 5.8 3.3 7.3 9.7 6.8 6.2 2.9 2.6 8.9 8.9 3.9 8.1 6.7 8.5 7.7 11.0 2.7 4.9 8.9 10.4 11.9 5.0 11.1 6.1 12.6 9.5 6.1 6.8 2.3 19.5 10.5 3.0 5.8 8.9 4.0 1.8 4.5 3.6 16.0 7.0 5.6 5.4 9.6 5.8 9.7 4.3 6.6 8.6 16.0 10.8 4.3 9.7 13.5 10.2 12.7 4.7 6.3 6.4 17.0 3.0 6.1 13.9 16.9 13.4 15.7 5.9 18.6 13.2 3.7 9.9 12.5 1.1 2.8 0.5 3.6 4.2 5.6 2.5 4.7 3.6 6.2 4.4 5.8 5.2 0.9 4.8 4.9 2.9 2.4 3.3 3.0 1.9 1.5 7.4 3.1 2.0 1.2 10.2 2.7 3.4 0.0 0.0 5.2 6.6 4.6 0.1 2.8 1.4 0.0 5.5 5.1 3.7 4.9 0.0 5.3 4.0 3.2 1.2 1.3 2.1 0.2 2.6 2.7 0.0 2.8 3.5 5.6 4.7 3.1 2.1 3.8 2.7 0.0 3.1 2.6 7.3 5.9 3.4 4.3 5.0 4.8 PIGX FLJ20522 ENSG00000163964 "Phosphatidylinositol glycan anchor biosynthesis class X" Q8TBF5 3 196639775-196736007 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 34.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029409, HPA073301" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029409: AB_10610280, HPA073301: " "unprognostic (8.83e-2)" "prognostic favorable (2.12e-4)" "unprognostic (2.14e-1)" "unprognostic (2.42e-3)" "unprognostic (9.25e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.45e-5)" "unprognostic (1.91e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.02e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.53e-1)" "unprognostic (1.46e-1)" "unprognostic (2.01e-1)" 19.1 13.7 25.1 12.7 25.5 9.3 19.2 16.9 25.8 13.1 15.5 13.1 7.8 12.3 15.2 18.5 16.6 12.6 12.7 13.9 23.2 25.4 18.1 12.5 15.6 27.0 24.8 13.4 10.9 16.0 28.1 18.2 17.7 14.5 18.6 17.1 16.3 12.9 18.5 18.6 12.3 11.8 17.1 21.7 18.4 10.6 9.0 14.2 24.6 15.5 10.6 14.7 13.6 10.7 1.7 3.2 34.5 4.4 3.6 2.1 1.5 22.3 10.2 13.4 9.4 14.2 10.8 7.6 10.1 12.2 12.4 12.9 9.8 14.6 11.0 33.9 10.1 15.4 12.3 11.4 9.6 15.4 10.0 10.6 9.1 7.1 6.6 13.1 10.2 17.0 8.1 15.0 10.0 9.5 9.9 6.7 18.0 6.2 22.1 11.3 20.3 26.3 13.3 6.0 17.8 11.6 14.3 15.8 15.9 12.8 7.5 13.0 14.4 17.0 11.7 13.9 10.5 40.5 9.5 3.5 11.9 5.2 13.0 15.5 27.9 32.1 20.8 10.8 12.6 12.3 15.5 3.0 34.5 1.5 4.4 1.3 1.7 1.4 2.1 3.2 1.7 1.6 1.4 8.6 3.6 4.4 1.4 1.7 1.5 25.1 25.5 16.9 25.8 23.2 25.4 24.8 13.4 14.5 14.2 17.9 21.8 19.9 24.6 15.1 31.0 10.7 20.4 9.4 11.4 27.9 45.2 17.1 29.9 6.9 19.9 15.7 18.7 0.0 4.9 17.4 22.4 27.9 11.5 14.4 17.0 31.8 15.1 17.8 18.3 17.2 25.9 19.4 20.3 10.8 17.7 33.8 5.4 14.4 32.9 29.9 34.6 25.8 19.4 21.4 33.5 13.9 9.7 17.8 26.3 16.3 PIGY MGC14156 ENSG00000255072 "Phosphatidylinositol glycan anchor biosynthesis class Y" Q3MUY2 4 88521573-88521789 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "blood: 38.4;intestine: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 6.5;GAMG: 12.0;hTEC/SVTERT24-B: 8.0;hTERT-RPE1: 6.5;JURKAT: 6.0;MOLT-4: 13.6;OE19: 23.5;SuSa: 6.6" HPA059018 Uncertain NA NA "HPA059018: AB_2683884" 1.4 2.9 0.5 1.1 1.2 1.1 1.2 1.8 1.4 2.0 10.6 1.1 2.1 1.1 1.7 1.1 1.1 1.6 0.1 0.3 1.1 1.7 1.1 1.1 1.1 1.3 1.4 1.1 1.2 1.1 1.1 1.1 1.1 1.1 3.1 1.1 1.1 1.1 2.3 1.2 1.3 1.1 1.5 1.1 1.4 1.3 24.8 38.4 21.0 26.6 24.3 33.1 35.9 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 8.0 0.0 6.5 0.0 6.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 16.3 26.0 21.0 27.3 26.6 28.5 24.8 27.9 27.5 38.4 19.8 30.1 29.1 4.5 24.3 21.6 14.2 33.1 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIGZ "FLJ12768, MGC52163, SMP3" ENSG00000119227 "Phosphatidylinositol glycan anchor biosynthesis class Z" Q86VD9 3 196946343-196969060 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 26.5" "Group enriched" "Detected in many" 4 "Enterocytes: 66.9;Mucus-secreting cells: 56.2;Paneth cells: 75.0;Undifferentiated cells: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.3" "Group enriched" "Detected in many" 8 "dendritic cells: 1.6;granulocytes: 1.4;monocytes: 3.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058599, HPA059920" Approved NA NA "HPA058599: AB_2683771, HPA059920: AB_2684162" "unprognostic (1.46e-1)" "unprognostic (3.18e-3)" "unprognostic (1.06e-2)" "unprognostic (3.31e-2)" "unprognostic (3.90e-2)" "unprognostic (8.16e-2)" "unprognostic (4.25e-3)" "unprognostic (4.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.44e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (1.02e-1)" "unprognostic (3.93e-2)" "unprognostic (8.38e-5)" "unprognostic (5.02e-3)" 6.6 3.1 5.7 5.3 8.6 1.9 3.4 18.5 16.3 3.3 26.5 3.2 2.0 2.9 2.3 1.7 3.2 2.8 4.5 6.4 5.3 7.5 1.6 1.6 3.1 2.0 4.4 6.4 0.8 5.9 2.7 2.9 2.1 10.8 4.6 24.5 4.3 4.7 4.6 10.0 4.5 7.4 5.3 2.8 1.8 3.1 1.4 3.0 3.2 1.7 2.8 2.1 9.9 2.9 0.1 1.6 1.4 3.3 0.0 0.2 0.3 2.0 1.4 0.8 3.3 9.3 4.5 0.9 3.0 8.6 2.3 1.9 1.9 1.7 0.3 6.1 6.8 1.6 3.5 0.2 0.4 0.6 0.6 0.4 0.9 0.7 7.4 4.4 0.0 3.4 4.5 6.6 0.3 1.1 2.6 2.9 5.5 0.2 2.6 2.3 3.6 0.3 1.7 0.1 2.5 1.1 0.5 0.1 0.6 3.6 3.8 1.3 1.5 4.3 0.4 1.6 0.4 8.5 3.0 7.0 1.9 0.5 5.5 1.0 1.2 0.2 0.1 0.4 1.2 0.7 0.0 1.1 0.8 0.2 3.3 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 1.4 0.0 1.4 0.3 0.0 0.3 5.7 8.6 18.5 16.3 5.3 7.5 4.4 6.4 10.8 3.0 0.0 0.6 3.7 8.0 6.9 6.1 6.5 2.5 1.4 1.2 8.7 2.0 0.0 5.0 1.9 1.7 4.4 66.9 0.0 3.2 0.0 2.3 9.3 5.7 7.3 1.7 14.3 13.3 12.3 4.9 3.1 3.7 1.1 8.5 2.8 56.2 1.5 2.8 75.0 6.0 2.1 6.9 0.0 8.5 0.5 0.1 4.4 0.1 1.9 35.8 10.1 PIK3IP1 "HGFL, MGC17330" ENSG00000100100 "Phosphoinositide-3-kinase interacting protein 1" Q96FE7 22 31281593-31292534 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.0" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 107.7;T-cells: 127.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 82.0" "Lineage enriched" "Detected in many" 6 "T-cells: 82.0" "Cell line enhanced" "Detected in many" "RT4: 14.2;SK-BR-3: 15.7;U-698: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 8600000 "unprognostic (1.02e-1)" "unprognostic (1.97e-3)" "unprognostic (1.58e-1)" "unprognostic (4.84e-2)" "unprognostic (8.19e-2)" "unprognostic (1.61e-3)" "unprognostic (5.78e-2)" "unprognostic (1.63e-3)" "unprognostic (2.82e-1)" "unprognostic (1.40e-1)" "unprognostic (1.99e-1)" "unprognostic (9.95e-3)" "unprognostic (1.28e-2)" "unprognostic (2.65e-3)" "unprognostic (4.42e-2)" "unprognostic (8.68e-2)" "prognostic favorable (3.80e-4)" 24.0 22.9 17.3 31.8 22.8 21.4 19.5 33.2 22.7 11.8 15.3 22.3 13.2 10.5 18.7 10.7 12.4 12.9 15.8 19.5 19.1 12.4 13.9 5.7 26.2 64.1 19.9 15.0 12.4 5.8 11.3 8.0 14.6 18.0 13.8 9.7 13.3 27.3 20.2 14.2 27.1 29.7 14.9 20.7 36.8 14.3 13.7 22.5 38.8 29.5 7.7 45.1 21.9 12.6 13.5 0.9 5.6 4.8 8.3 82.0 29.1 0.3 0.2 0.5 0.1 7.2 12.8 0.6 1.8 5.7 0.1 0.7 0.2 12.2 9.3 6.9 2.8 0.7 7.9 0.0 3.4 0.1 1.5 1.1 0.2 1.4 1.4 2.4 0.7 0.5 12.4 5.0 0.1 0.1 11.4 3.8 1.4 0.5 11.7 0.9 0.8 0.1 1.4 0.5 1.4 0.3 0.7 0.5 6.8 3.1 14.2 0.7 1.5 0.6 15.7 0.8 6.8 1.3 1.3 11.7 0.0 2.7 0.2 0.0 5.6 2.4 20.0 0.3 1.6 0.2 5.6 2.7 2.4 12.9 3.4 15.2 5.9 33.3 18.2 0.9 13.5 82.0 51.1 1.1 8.3 4.8 0.3 37.5 29.1 17.3 22.8 33.2 22.7 19.1 12.4 19.9 15.0 18.0 22.5 41.7 10.5 49.9 17.1 9.2 27.4 10.3 10.2 16.0 18.2 29.6 9.8 25.6 1.7 36.6 1.1 17.5 7.4 0.0 9.3 3.4 15.3 18.4 29.0 0.8 36.9 6.4 8.1 31.9 29.9 2.1 22.7 13.8 11.8 12.6 12.2 107.7 34.1 7.4 29.0 5.6 7.8 6.5 7.6 7.4 22.0 10.0 10.3 127.6 9.0 33.3 PILRA FDF03 ENSG00000085514 "Paired immunoglobin like type 2 receptor alpha" Q9UKJ1 7 100367530-100400099 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "blood: 138.4" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 82.8;Kupffer cells: 85.3;Leydig cells: 48.6;Macrophages: 111.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 138.4" "Group enriched" "Detected in many" 5 "granulocytes: 138.4;monocytes: 87.3" "Cell line enhanced" "Detected in some" "ASC diff: 21.0;HMC-1: 18.8;NB-4: 14.2" HPA056132 Approved "Secreted to blood" NA NA "HPA056132: AB_2683048" "unprognostic (5.53e-2)" "prognostic favorable (2.99e-4)" "unprognostic (7.61e-2)" "unprognostic (2.88e-1)" "unprognostic (2.20e-1)" "unprognostic (5.88e-2)" "unprognostic (1.44e-1)" "unprognostic (2.85e-1)" "unprognostic (3.01e-3)" "unprognostic (9.95e-2)" "unprognostic (8.57e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.47e-2)" "unprognostic (3.17e-2)" "unprognostic (1.99e-1)" "unprognostic (4.80e-2)" 18.6 5.4 7.2 32.3 7.2 19.4 8.2 15.6 6.2 6.1 4.5 10.6 2.3 3.8 4.8 10.0 2.6 7.5 8.4 6.5 7.7 4.4 8.5 8.0 31.9 30.1 11.0 2.6 5.7 5.1 4.3 9.2 13.2 11.9 6.6 4.9 7.1 3.1 4.1 2.5 2.6 3.9 8.6 18.4 29.5 3.1 6.4 10.7 3.3 5.3 1.1 3.3 9.8 5.4 0.1 24.0 138.4 87.3 0.5 0.2 22.9 0.2 0.3 0.4 0.5 21.0 1.4 0.1 0.1 1.0 0.1 0.3 0.0 0.3 0.4 1.2 0.3 0.2 0.6 0.1 0.1 0.0 1.0 0.7 0.4 0.8 0.1 0.2 0.8 18.8 1.5 0.3 0.1 0.4 0.0 0.2 1.7 0.2 1.2 0.1 0.6 1.4 14.2 0.4 0.3 0.2 0.4 0.0 0.3 0.8 0.4 0.5 0.2 0.0 5.2 0.4 0.1 0.1 4.3 0.4 0.9 0.9 0.6 0.2 1.8 1.4 0.4 0.2 1.6 0.3 21.3 48.4 1.4 0.2 70.2 0.1 0.1 0.0 0.0 24.0 0.0 0.0 0.1 138.4 0.5 87.3 0.4 0.1 22.9 7.2 7.2 15.6 6.2 7.7 4.4 11.0 2.6 11.9 10.7 3.0 14.3 5.9 0.2 1.5 3.3 0.4 5.1 4.0 5.7 1.8 3.9 0.4 23.2 0.1 0.4 1.4 0.0 0.0 0.3 0.6 1.3 0.5 9.3 1.5 82.8 1.6 0.0 3.1 85.3 1.5 48.6 111.8 1.7 19.8 1.1 1.9 0.3 0.0 20.1 0.6 2.4 0.0 0.3 0.5 1.3 0.6 0.7 0.8 0.9 0.2 PILRB "FDFACT1, FDFACT2" ENSG00000121716 "Paired immunoglobin-like type 2 receptor beta" Q9UKJ0 7 100352176-100367733 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 80.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 51.1;neutrophil: 34.8" "Group enriched" "Detected in many" 8 "granulocytes: 51.1;monocytes: 16.8" "Cell line enhanced" "Detected in all" "SK-BR-3: 81.3" HPA026750 Approved Approved Mitochondria "Intracellular and membrane" NA Yes Mitochondria "HPA026750: AB_10670828" "unprognostic (8.33e-3)" "unprognostic (9.31e-2)" "unprognostic (1.32e-2)" "unprognostic (9.15e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (3.62e-2)" "unprognostic (3.17e-1)" "unprognostic (1.20e-1)" "unprognostic (8.76e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.85e-3)" "unprognostic (1.66e-1)" "unprognostic (4.40e-2)" "unprognostic (3.35e-3)" 10.6 11.3 8.2 11.2 8.2 11.2 10.2 25.2 10.3 9.9 8.2 8.2 8.2 11.4 10.3 12.6 8.2 10.0 8.8 8.2 8.2 5.0 18.6 17.6 8.2 13.2 8.2 8.2 12.1 12.9 19.0 27.6 9.8 8.2 13.6 10.2 8.2 12.0 10.7 12.3 15.8 10.1 8.2 10.5 16.7 9.2 80.1 8.2 8.2 18.3 8.2 11.0 9.9 8.2 0.3 4.3 51.1 16.8 4.0 2.9 4.7 14.0 11.9 13.7 23.7 15.2 3.5 13.3 8.5 3.8 6.1 6.0 8.4 16.4 11.5 16.3 4.4 10.9 15.1 7.5 9.0 4.2 9.4 11.1 10.6 39.9 7.2 3.4 10.6 27.6 4.4 10.6 8.2 16.8 7.6 5.1 17.2 11.3 28.0 4.2 19.0 16.7 55.3 5.9 11.8 6.3 9.8 4.0 11.7 27.5 23.1 12.8 9.2 7.2 81.3 10.1 15.3 14.2 16.5 12.2 21.8 13.9 13.9 11.0 16.9 21.5 13.9 6.1 15.9 12.8 4.1 8.5 51.1 2.9 14.0 1.7 0.1 0.3 1.8 4.3 0.3 0.3 0.7 34.8 4.0 16.8 0.1 0.1 4.7 8.2 8.2 25.2 10.3 8.2 5.0 8.2 8.2 8.2 8.2 35.7 41.6 25.1 19.4 14.0 37.1 1.1 63.7 37.5 42.1 14.0 64.8 10.8 1.7 5.8 13.5 16.4 15.8 0.0 4.9 9.6 8.9 14.5 23.3 62.2 8.5 71.5 28.3 17.8 14.3 9.1 68.4 12.3 18.6 10.0 23.8 26.5 6.4 17.3 48.1 3.4 60.9 25.8 12.0 43.6 9.8 11.8 13.2 66.0 24.8 10.8 PIP4P1 "C14orf9, MGC26684, TMEM55B" ENSG00000165782 "Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1" Q86T03 14 20457719-20461612 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 66.6;Hofbauer cells: 47.2;Syncytiotrophoblasts: 139.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048528 Approved NA NA "HPA048528: AB_2680427" "unprognostic (1.84e-1)" "unprognostic (6.23e-2)" "unprognostic (1.81e-1)" "unprognostic (7.07e-2)" "unprognostic (2.04e-1)" "unprognostic (8.51e-2)" "unprognostic (1.71e-2)" "unprognostic (3.37e-3)" "unprognostic (4.94e-2)" "unprognostic (1.33e-1)" "unprognostic (7.78e-3)" "unprognostic (1.85e-1)" "prognostic favorable (1.01e-4)" "unprognostic (4.80e-2)" "unprognostic (1.47e-1)" "unprognostic (7.53e-2)" "unprognostic (1.96e-1)" 15.9 16.8 19.7 15.1 24.7 42.2 15.6 23.8 41.0 14.4 19.2 22.9 12.6 17.9 15.6 29.3 16.5 16.4 18.0 15.9 20.2 23.5 18.7 17.7 17.3 16.8 18.9 22.2 15.3 21.1 28.4 20.0 22.6 28.5 16.1 16.5 20.3 16.1 17.2 22.2 22.1 22.1 16.7 17.0 22.0 18.0 13.3 18.5 14.2 17.7 12.8 20.8 17.5 14.0 13.3 10.6 6.9 3.3 4.6 6.6 2.4 10.3 16.3 11.0 12.8 17.3 10.7 20.3 9.8 19.4 13.5 16.5 9.6 16.9 9.3 8.5 12.4 39.5 10.9 13.4 10.9 12.0 12.3 9.9 6.7 7.8 14.1 23.6 12.3 13.8 13.9 14.9 15.6 16.0 12.4 12.5 14.5 5.6 19.1 11.2 11.8 16.7 10.9 7.3 16.4 22.5 12.4 10.6 6.1 12.7 23.4 15.9 11.8 10.1 16.7 12.6 9.9 8.4 11.7 8.6 12.4 15.8 18.6 8.8 21.5 27.5 13.3 8.6 9.5 13.5 1.3 3.3 6.9 4.7 2.4 4.0 13.3 5.6 5.1 4.1 11.3 6.4 6.6 4.2 4.6 2.0 10.6 4.2 2.4 19.7 24.7 23.8 41.0 20.2 23.5 18.9 22.2 28.5 18.5 8.9 8.1 0.0 0.0 0.0 0.0 0.0 0.0 9.4 5.7 21.0 0.0 66.6 16.6 31.2 0.0 0.0 0.0 0.0 35.5 31.3 0.0 0.0 3.5 0.0 47.2 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 22.6 0.0 0.0 27.8 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 139.8 0.0 0.0 0.0 PIP4P2 "DKFZp762O076, TMEM55A" ENSG00000155099 "Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2" Q8N4L2 8 90993796-91041064 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 27.7;Distal tubular cells: 41.4;Extravillous trophoblasts: 27.3;Hofbauer cells: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 36.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 36.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014591 Approved NA NA 57000 "HPA014591: AB_1858124" "unprognostic (6.09e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (8.45e-2)" "unprognostic (1.23e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.54e-4)" "prognostic unfavorable (3.76e-5)" "unprognostic (3.76e-2)" "unprognostic (1.08e-1)" "unprognostic (7.58e-2)" "unprognostic (4.42e-1)" "unprognostic (6.95e-2)" "unprognostic (7.25e-2)" "prognostic unfavorable (8.01e-4)" "unprognostic (1.59e-1)" "unprognostic (9.05e-2)" "unprognostic (7.99e-2)" 15.8 18.6 18.7 9.1 19.5 35.2 11.7 21.4 31.7 14.2 16.5 11.1 7.3 4.4 15.0 7.1 8.5 8.6 15.5 26.0 18.2 23.5 13.7 5.7 8.1 11.8 22.8 20.0 16.1 4.8 14.6 13.4 12.2 25.5 12.3 7.2 17.4 10.1 18.6 16.7 8.0 6.6 18.6 25.4 11.2 9.6 9.7 21.1 7.1 9.4 6.9 7.7 13.3 10.5 1.5 5.3 36.2 5.6 1.2 2.4 2.9 2.6 1.6 9.4 5.9 15.3 18.1 1.9 11.4 13.5 5.8 8.6 1.0 4.4 5.1 1.5 10.9 5.8 0.6 2.2 3.7 7.6 4.7 4.6 8.1 1.7 0.8 13.8 1.9 7.3 10.0 2.4 7.3 5.4 15.5 5.5 1.5 4.0 17.0 20.1 1.8 5.4 4.8 4.9 0.0 5.9 2.2 3.8 6.1 8.1 1.6 1.0 5.3 0.7 3.6 13.9 6.6 0.1 3.3 8.3 10.4 4.3 6.0 4.8 6.8 4.1 3.1 18.0 3.4 13.9 0.3 5.6 5.3 0.8 2.6 1.3 1.5 1.8 0.9 5.3 1.1 2.4 1.0 36.2 1.2 1.0 3.1 1.5 2.9 18.7 19.5 21.4 31.7 18.2 23.5 22.8 20.0 25.5 21.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 5.7 8.7 0.0 27.7 41.4 15.5 0.0 0.0 0.0 0.0 7.7 27.3 0.0 0.0 8.1 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 6.4 0.0 0.0 11.2 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 PIPOX LPIPOX ENSG00000179761 "Pipecolic acid and sarcosine oxidase" Q9P0Z9 17 28950513-29057220 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "kidney: 33.5;liver: 114.3" "Group enriched" "Detected in many" 6 "Hepatocytes: 183.0;Proximal tubular cells: 123.0" "Group enriched" "Detected in many" 13 "glioma: 15.5;liver cancer: 73.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "AF22: 12.5;Hep G2: 37.6;NTERA-2: 24.8;RH-30: 35.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 390000 "unprognostic (8.02e-2)" "unprognostic (3.50e-4)" "unprognostic (3.03e-1)" "unprognostic (6.25e-3)" "unprognostic (1.52e-1)" "unprognostic (5.01e-2)" "unprognostic (1.95e-3)" "unprognostic (1.15e-2)" "unprognostic (2.17e-1)" "unprognostic (3.45e-1)" "prognostic favorable (1.49e-4)" "unprognostic (2.39e-1)" "unprognostic (3.13e-3)" "unprognostic (2.58e-3)" "unprognostic (2.01e-1)" "unprognostic (2.79e-2)" "unprognostic (1.22e-1)" 0.2 0.2 2.4 0.2 3.1 0.1 0.2 2.2 2.9 0.2 1.4 3.8 0.0 3.1 0.4 5.8 0.5 2.1 0.8 0.2 3.5 2.5 33.5 114.3 0.3 0.3 3.6 3.1 0.3 0.2 0.3 0.2 1.0 4.0 0.5 0.3 0.2 0.2 0.9 0.1 0.2 2.6 0.6 1.7 0.3 0.2 0.2 0.7 0.0 0.1 0.0 0.2 0.3 0.1 0.7 4.7 3.7 0.7 0.9 1.9 0.7 0.0 0.0 12.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.2 0.1 37.6 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.2 24.8 0.7 0.0 0.1 35.8 0.7 0.0 0.0 4.0 1.2 0.1 0.0 0.2 2.1 0.0 1.5 0.0 0.0 0.0 0.0 1.6 0.3 4.2 0.1 0.0 0.2 1.2 1.8 0.7 0.7 0.8 0.5 0.9 0.3 0.5 1.2 4.7 0.7 0.3 1.9 3.7 0.9 0.3 0.4 0.8 0.7 2.4 3.1 2.2 2.9 3.5 2.5 3.6 3.1 4.0 0.7 0.0 1.1 2.2 0.2 0.2 1.7 0.4 5.1 0.0 0.0 0.0 3.9 0.1 8.3 0.0 1.3 0.6 0.7 0.0 0.2 4.4 0.4 0.3 5.7 183.0 1.2 0.0 1.2 2.5 3.5 1.5 0.3 1.7 0.0 3.6 0.0 24.0 0.0 0.0 1.1 123.0 1.3 0.0 0.4 0.0 1.0 0.1 0.3 0.5 0.0 0.1 PIRT ENSG00000233670 "Phosphoinositide interacting regulator of transient receptor potential channels" P0C851 17 10822475-10838445 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.3;brain: 24.8;intestine: 7.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 40 "glioma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA042337 Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA042337: AB_10794795" "unprognostic (2.95e-1)" "unprognostic (2.19e-2)" "unprognostic (7.57e-2)" "unprognostic (6.58e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (2.85e-3)" 0.4 7.3 9.9 3.2 14.0 0.3 0.3 5.6 5.2 0.4 6.3 10.8 0.0 2.9 0.4 0.4 0.8 0.9 0.7 0.3 13.1 11.6 0.3 0.3 0.4 0.3 12.5 2.3 0.4 0.3 0.3 0.1 0.3 24.8 0.4 7.5 0.0 0.4 0.4 0.4 0.4 5.2 2.5 19.9 0.3 4.9 0.5 12.8 0.0 0.3 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 14.0 5.6 5.2 13.1 11.6 12.5 2.3 24.8 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PJVK DFNB59 ENSG00000204311 Pejvakin Q0ZLH3 2 178451346-178461409 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.2" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 10.8;Club cells: 3.4;Distal tubular cells: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 6.5" "Cell line enhanced" "Detected in many" "SuSa: 11.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042621 Approved Mitochondria No No Mitochondria "HPA042621: AB_10797503" "unprognostic (4.01e-2)" "unprognostic (4.28e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-1)" "unprognostic (7.21e-3)" "unprognostic (9.36e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-1)" "unprognostic (8.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.90e-3)" "unprognostic (9.13e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (1.22e-1)" "unprognostic (1.47e-1)" "unprognostic (2.41e-2)" "unprognostic (8.06e-3)" 2.2 1.4 2.5 1.0 3.5 0.7 4.4 1.3 3.7 2.1 1.5 1.2 3.5 0.7 3.5 7.2 2.2 2.6 2.6 1.0 2.7 2.2 2.1 2.2 1.0 1.3 2.8 4.4 7.0 1.0 1.4 3.9 1.0 2.0 2.3 0.9 2.4 2.1 2.7 2.7 3.5 1.3 1.7 2.7 1.0 0.9 35.2 1.3 1.0 2.3 1.7 1.2 1.6 1.2 1.5 6.5 0.6 0.3 0.4 1.3 0.1 0.4 2.7 3.5 2.8 4.7 5.2 1.8 2.2 2.2 2.0 3.1 1.0 4.5 3.1 2.3 1.3 1.6 1.4 2.5 1.4 1.3 1.0 0.9 1.0 3.7 0.6 4.5 0.8 0.2 4.9 3.4 2.2 4.9 5.8 2.3 6.1 0.5 2.0 2.3 0.4 2.9 1.9 4.2 0.3 1.1 3.9 2.6 1.9 3.1 1.4 2.5 2.1 1.0 0.5 0.8 11.0 1.0 0.9 1.5 2.3 0.9 0.7 0.2 6.4 4.0 1.0 1.1 1.7 0.9 0.0 0.3 0.0 0.3 0.2 0.4 0.8 0.4 0.2 0.1 1.5 1.3 0.7 0.6 0.4 0.0 6.5 0.0 0.1 2.5 3.5 1.3 3.7 2.7 2.2 2.8 4.4 2.0 1.3 6.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.8 0.0 0.9 3.3 1.1 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PKD1 "PBP, Pc-1, TRPP1" ENSG00000008710 "Polycystin 1, transient receptor potential channel interacting" P98161 16 2088710-2135898 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.3" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 112.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB046448 Approved NA NA 120000 "CAB046448: AB_2163360" "unprognostic (1.95e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (1.35e-1)" "unprognostic (1.79e-1)" "prognostic favorable (3.35e-4)" "unprognostic (1.98e-2)" "unprognostic (1.02e-2)" "unprognostic (1.81e-1)" "unprognostic (1.22e-2)" "prognostic favorable (3.38e-5)" "unprognostic (7.86e-2)" "unprognostic (4.07e-1)" "unprognostic (3.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.78e-2)" "unprognostic (2.81e-1)" 4.5 4.6 2.6 2.3 3.6 1.5 1.4 45.3 7.9 2.8 5.1 1.8 5.4 0.7 2.6 3.4 1.8 7.1 3.5 4.2 0.7 0.6 2.2 1.3 1.9 6.8 3.3 1.2 11.3 1.7 3.7 0.4 4.3 5.4 18.0 7.8 2.8 3.3 1.5 2.7 2.6 2.2 1.0 0.3 3.1 1.8 0.1 0.1 0.0 0.1 0.0 0.4 0.7 3.0 6.5 3.6 8.2 6.3 6.9 7.1 10.6 4.4 3.1 3.1 5.9 2.3 4.6 6.8 5.4 3.3 7.7 1.0 1.6 1.2 5.4 5.3 2.8 16.7 2.3 12.6 3.9 5.9 6.4 5.3 5.7 3.5 4.3 2.4 4.9 4.1 4.7 2.0 5.0 5.5 11.9 3.3 1.2 5.0 15.7 5.9 6.8 1.6 2.1 15.2 17.0 9.6 6.4 6.6 1.4 5.2 13.4 5.4 9.8 8.0 7.3 7.7 6.9 3.1 5.1 5.5 3.7 6.1 0.0 0.1 0.0 0.4 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.7 11.9 13.5 4.6 8.8 21.6 62.9 21.4 5.1 18.7 7.9 8.7 39.3 5.1 8.3 4.7 53.2 15.2 8.6 0.0 2.7 2.9 19.8 8.0 8.1 21.3 4.5 112.8 29.3 14.1 7.3 8.2 25.6 7.4 21.9 3.6 11.8 30.3 3.7 2.9 43.2 7.3 34.4 32.3 21.7 11.4 15.3 17.6 2.6 6.9 13.4 5.4 PKD1L1 PRO19563 ENSG00000158683 "Polycystin 1 like 1, transient receptor potential channel interacting" Q8TDX9 7 47774652-47948491 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" Heterotaxy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 13.4;tongue: 16.7" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 3.1;Early spermatids: 11.4;Ito cells: 2.5;Late spermatids: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "T-47d: 6.5;U-266/70: 17.1;U-266/84: 6.1" "Not detected" "Not detected" "HPA020422, HPA022424" Uncertain NA NA "HPA020422: AB_1855434, HPA022424: AB_1855435" "unprognostic (5.47e-2)" "unprognostic (5.33e-3)" "unprognostic (1.49e-2)" "unprognostic (9.74e-2)" "unprognostic (4.03e-2)" "unprognostic (6.31e-2)" "unprognostic (2.52e-2)" "unprognostic (1.11e-1)" "unprognostic (9.63e-3)" "unprognostic (7.96e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" "unprognostic (1.88e-4)" "unprognostic (1.88e-3)" "unprognostic (2.56e-1)" "unprognostic (2.50e-1)" "unprognostic (1.90e-1)" 5.4 0.2 1.0 2.3 1.8 0.2 1.6 1.3 1.1 1.2 0.8 0.7 0.1 2.0 2.5 1.6 0.9 0.6 1.0 7.4 0.8 1.5 0.5 1.1 13.4 1.2 0.9 0.1 0.6 0.3 0.1 1.2 2.0 1.0 0.3 0.9 10.0 2.6 0.1 6.4 0.7 0.7 1.7 1.0 0.8 0.4 3.8 0.1 0.9 1.2 16.7 1.4 2.2 1.4 0.0 0.2 0.0 0.8 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.2 0.0 0.1 0.3 0.1 6.5 0.0 0.0 0.0 0.9 0.0 0.0 17.1 6.1 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 1.8 1.3 1.1 0.8 1.5 0.9 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.1 3.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.0 1.6 0.0 2.5 0.0 2.5 0.3 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 PKD1L3 ENSG00000277481 "Polycystin 1 like 3, transient receptor potential channel interacting" Q7Z443 16 71929538-71999978 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.9;smooth muscle: 2.9;testis: 2.1" "Cell type enhanced" "Detected in single" 18 "Cardiomyocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.75e-1)" "unprognostic (1.55e-1)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-2)" "unprognostic (7.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.74e-1)" "unprognostic (9.90e-4)" "unprognostic (2.22e-1)" "unprognostic (1.35e-6)" "unprognostic (6.71e-2)" "unprognostic (1.73e-1)" "unprognostic (1.25e-1)" "unprognostic (1.93e-3)" 0.6 0.5 0.1 2.9 0.1 0.3 0.1 0.1 0.1 0.1 1.0 0.1 0.1 0.7 0.1 0.1 0.1 0.5 0.1 0.2 0.1 0.1 1.2 0.2 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 1.9 2.9 0.1 0.4 0.2 2.1 0.1 0.1 0.1 0.1 0.1 1.2 0.1 0.7 0.0 0.2 0.0 0.6 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.6 0.2 0.1 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.4 0.0 0.5 0.0 0.8 0.0 0.3 0.4 0.0 0.0 0.9 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 PKD2 "Pc-2, PC2, PKD4, TRPP2" ENSG00000118762 "Polycystin 2, transient receptor potential cation channel" Q13563 4 88007668-88077777 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway" "Calcium channel, Ion channel, Potassium channel, Voltage-gated channel" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 66.3;Peritubular cells: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 36.9;BJ hTERT+: 56.1;fHDF/TERT166: 44.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004544, HPA015794" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB004544: AB_672377, HPA015794: AB_1855437" "unprognostic (2.01e-1)" "unprognostic (3.57e-2)" "unprognostic (1.22e-1)" "unprognostic (6.83e-2)" "unprognostic (9.71e-2)" "unprognostic (1.97e-1)" "unprognostic (3.17e-2)" "unprognostic (1.88e-1)" "unprognostic (8.64e-2)" "unprognostic (1.08e-1)" "unprognostic (6.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.17e-3)" "unprognostic (3.54e-3)" "unprognostic (1.07e-1)" "unprognostic (1.12e-2)" "unprognostic (2.51e-1)" 18.4 13.6 8.2 7.7 10.9 5.0 15.1 15.1 10.7 31.4 19.4 15.5 18.5 5.6 42.7 9.8 13.9 25.7 15.3 12.8 9.0 5.2 27.5 7.9 13.4 5.5 12.6 6.4 27.0 9.8 21.9 8.1 12.8 9.2 15.6 7.3 14.1 7.4 22.3 5.4 6.2 9.6 29.3 7.2 5.4 14.8 9.9 12.0 5.5 10.2 3.3 4.9 13.9 21.4 0.5 1.3 4.8 0.8 1.0 1.4 0.4 1.9 10.9 12.3 6.3 28.6 19.1 3.6 36.9 56.1 17.3 17.3 0.5 3.4 1.0 8.1 44.4 6.6 2.4 2.2 5.5 15.2 5.5 1.9 1.7 5.6 1.1 15.9 4.2 3.5 15.8 2.5 13.5 7.3 23.7 7.8 2.0 0.2 2.9 15.0 3.7 2.9 2.0 6.4 1.4 1.8 5.6 7.3 1.5 15.4 4.6 2.5 5.5 6.8 0.3 8.7 13.0 2.6 3.2 12.0 16.4 3.6 4.6 4.9 2.4 0.7 1.2 9.7 0.6 15.0 4.8 0.5 0.9 0.8 0.8 1.4 0.5 0.8 0.6 0.3 0.5 0.9 0.6 0.9 1.0 0.3 1.3 0.4 0.4 8.2 10.9 15.1 10.7 9.0 5.2 12.6 6.4 9.2 12.0 3.0 4.6 1.4 4.2 6.5 14.6 6.3 20.4 16.0 10.3 66.3 9.8 8.7 0.0 10.3 0.3 11.2 0.7 0.0 3.3 3.5 23.9 4.3 1.1 6.8 10.3 25.4 6.4 20.9 4.9 0.7 21.3 8.3 21.9 9.0 2.7 20.1 3.0 5.7 47.7 14.7 1.5 25.8 20.6 0.7 0.9 5.8 2.3 0.7 2.6 2.5 PKD2L1 "PCL, PKD2L, PKDL, TRPP3" ENSG00000107593 "Polycystin 2 like 1, transient receptor potential cation channel" Q9P0L9 10 100288154-100330486 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.2;lymphoid tissue: 12.0" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 15.0;Hofbauer cells: 12.4;Horizontal cells: 57.2;Late spermatids: 15.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 2.7;intermediate monocyte: 3.0;non-classical monocyte: 2.3" "Lineage enriched" "Detected in single" 5 "monocytes: 3.0" "Cell line enhanced" "Detected in some" "Karpas-707: 1.6;NB-4: 1.8;PC-3: 2.0;RT4: 1.1;SK-MEL-30: 1.6;U-266/70: 1.0;U-266/84: 2.8;U-937: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" CAB022621 Uncertain NA NA "CAB022621: " "unprognostic (2.67e-1)" "unprognostic (3.66e-7)" "unprognostic (8.07e-3)" "unprognostic (4.38e-2)" "unprognostic (4.70e-2)" "unprognostic (5.31e-2)" "unprognostic (2.19e-1)" "unprognostic (2.85e-2)" "unprognostic (2.01e-1)" "unprognostic (9.25e-2)" "unprognostic (1.55e-1)" "unprognostic (9.37e-2)" "unprognostic (1.49e-4)" "unprognostic (3.00e-1)" "unprognostic (2.05e-2)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" 0.3 0.3 0.4 0.6 3.7 1.3 1.4 0.1 6.2 0.1 1.5 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 2.0 0.3 0.5 2.7 4.0 2.3 0.5 4.0 0.2 0.2 0.0 0.2 0.7 1.3 0.4 2.2 1.0 0.3 0.0 0.1 0.1 0.8 0.0 1.5 12.0 0.1 2.3 0.0 0.3 0.1 0.0 2.9 0.4 0.1 0.2 0.3 0.6 3.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 1.6 0.0 0.0 0.0 1.8 0.0 1.0 2.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.8 0.0 0.0 1.4 0.0 0.0 2.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.6 0.0 2.3 0.0 0.0 0.4 0.4 3.7 0.1 6.2 2.0 0.3 0.5 4.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 12.4 57.2 0.0 0.6 6.6 15.9 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PKD2L2 TRPP5 ENSG00000078795 "Polycystin 2 like 2, transient receptor potential cation channel" Q9NZM6 5 137887968-137942747 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 7.5;testis: 29.3" "Group enriched" "Detected in many" 5 "Early spermatids: 25.9;Spermatocytes: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 5.9;U-266/70: 4.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA041903, HPA043634" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA041903: AB_2677734, HPA043634: AB_2678591" "unprognostic (7.53e-3)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (3.59e-1)" "unprognostic (4.04e-1)" "unprognostic (1.21e-2)" "unprognostic (3.06e-1)" "unprognostic (1.40e-4)" "unprognostic (1.64e-2)" "unprognostic (2.13e-2)" "unprognostic (3.00e-2)" "unprognostic (5.85e-2)" "unprognostic (1.05e-3)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" 0.5 1.5 2.0 0.6 2.5 2.2 1.2 1.7 1.9 0.5 0.3 0.7 0.7 0.3 0.5 1.0 0.5 0.4 0.6 1.7 1.0 0.8 0.4 0.3 0.4 1.3 1.2 1.3 0.6 1.1 0.0 1.5 0.2 1.8 0.5 0.1 0.2 0.7 0.0 3.3 0.8 0.3 0.0 0.7 1.0 0.6 29.3 0.4 0.0 1.0 0.0 0.2 0.4 0.6 3.9 3.5 7.5 1.7 1.9 1.9 0.8 1.6 1.2 0.2 0.1 0.4 0.5 1.8 0.6 0.0 0.0 0.0 0.1 3.2 2.3 3.5 0.0 0.1 0.7 0.1 0.0 0.1 1.5 1.1 1.3 4.2 0.1 0.0 0.4 1.8 0.1 0.2 0.0 0.0 0.7 0.6 3.3 1.5 5.9 0.8 0.5 1.1 2.4 0.6 0.1 1.0 0.0 0.1 0.0 0.0 2.3 0.8 0.9 1.5 0.2 0.9 0.7 0.4 0.5 0.5 1.0 1.8 0.7 1.0 4.6 3.4 0.4 2.3 0.7 1.8 7.1 1.7 3.0 1.8 1.2 1.0 2.5 1.6 1.4 0.9 3.9 1.9 1.7 7.5 1.9 1.0 3.5 1.1 0.8 2.0 2.5 1.7 1.9 1.0 0.8 1.2 1.3 1.8 0.4 3.0 2.1 0.5 1.6 1.9 2.3 1.5 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.1 25.9 0.8 0.0 0.0 0.0 0.1 1.3 1.3 1.1 0.2 0.2 3.2 0.0 1.3 0.6 4.7 0.6 0.2 3.3 0.0 0.0 0.9 0.1 0.0 0.4 0.2 3.9 0.0 1.2 19.5 2.2 1.0 0.1 0.7 0.0 0.5 PKDCC "SgK493, Vlk" ENSG00000162878 "Protein kinase domain containing, cytoplasmic" Q504Y2 2 42048020-42058528 "Enzymes, Predicted secreted proteins" "Differentiation, Osteogenesis, Protein transport, Transport" "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Intestinal endocrine cells: 69.1;Leydig cells: 127.4;Peritubular cells: 105.4;Rod photoreceptor cells: 93.6;Undifferentiated cells: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 31.2;ASC diff: 24.8;CACO-2: 36.9;HHSteC: 21.3;RH-30: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026427, HPA026442, HPA026526" Approved "Secreted to blood" NA NA 10000 "HPA026427: AB_10600773, HPA026442: AB_10601237, HPA026526: AB_10602416" "unprognostic (6.77e-2)" "unprognostic (3.35e-1)" "unprognostic (1.04e-2)" "unprognostic (3.59e-3)" "unprognostic (8.31e-2)" "unprognostic (1.11e-1)" "unprognostic (2.18e-2)" "unprognostic (5.79e-3)" "unprognostic (1.04e-2)" "unprognostic (1.32e-1)" "unprognostic (3.20e-1)" "unprognostic (6.09e-2)" "unprognostic (2.14e-2)" "unprognostic (9.08e-2)" "unprognostic (2.62e-1)" "unprognostic (4.73e-3)" "unprognostic (2.58e-3)" 21.4 5.7 1.9 8.4 1.8 0.8 18.9 0.3 4.7 20.8 13.7 1.7 6.3 9.3 17.6 16.0 9.2 10.0 29.6 17.0 2.3 0.7 4.7 3.5 8.0 3.7 3.7 0.3 43.6 3.3 0.9 3.2 3.2 2.6 13.0 5.2 17.0 38.6 5.6 40.2 1.7 7.7 26.2 2.3 4.6 4.8 14.1 2.3 4.2 3.1 13.1 2.1 22.8 23.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.0 5.5 31.2 24.8 0.3 2.0 0.1 0.0 0.4 0.6 36.9 0.0 0.0 0.1 0.6 0.7 0.0 0.5 0.0 0.0 3.0 1.3 0.0 1.3 9.8 21.3 0.0 0.4 2.1 0.1 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.1 0.1 0.0 0.1 9.1 2.5 0.6 0.0 10.8 0.0 0.0 0.0 1.1 1.9 0.5 0.0 0.0 6.7 0.0 0.2 0.0 0.2 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.8 0.3 4.7 2.3 0.7 3.7 0.3 2.6 2.3 17.9 0.3 0.5 0.2 2.9 2.1 8.1 2.5 0.0 0.0 1.8 15.7 0.4 0.0 1.8 1.1 1.9 11.8 0.0 1.2 1.2 21.1 0.9 0.0 2.6 0.6 0.0 69.1 3.7 0.3 2.6 127.4 0.2 1.7 0.0 11.8 20.3 1.2 14.0 105.4 3.2 93.6 12.9 8.5 0.5 1.2 1.6 0.2 0.0 34.2 0.1 PKDREJ ENSG00000130943 "Polycystin family receptor for egg jelly" Q9NTG1 22 46255663-46263355 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 13.8" "Cell type enhanced" "Detected in some" 14 "Collecting duct cells: 1.8;Cone photoreceptor cells: 3.9;Early spermatids: 1.8;Late spermatids: 1.9;Spermatocytes: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;U-2 OS: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA034587 Enhanced NA NA "HPA034587: AB_10670570" "unprognostic (9.48e-3)" "unprognostic (1.09e-1)" "unprognostic (3.51e-2)" "unprognostic (1.25e-1)" "unprognostic (6.11e-2)" "unprognostic (5.06e-4)" "unprognostic (1.13e-1)" "unprognostic (2.99e-1)" "unprognostic (8.48e-2)" "unprognostic (2.59e-1)" "unprognostic (6.17e-3)" "unprognostic (3.41e-1)" "unprognostic (3.36e-2)" "unprognostic (1.18e-1)" "unprognostic (1.49e-1)" "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.2 0.2 0.5 0.3 0.2 0.3 0.3 0.4 2.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.4 0.0 0.3 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.3 1.5 0.5 0.2 0.2 0.2 0.2 13.8 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.8 0.1 0.5 1.6 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.2 0.1 0.8 0.1 0.0 0.1 0.2 0.0 0.0 0.0 2.1 0.9 0.2 0.0 0.4 0.1 0.4 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.5 1.5 0.4 0.0 1.2 0.4 0.6 0.3 0.1 0.0 0.3 1.5 0.0 0.0 0.3 0.9 1.9 0.6 0.4 1.0 0.5 0.0 0.4 0.2 0.2 1.9 0.1 0.3 0.9 0.1 0.1 0.1 1.8 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 1.8 3.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 5.8 0.4 0.5 0.0 0.0 0.2 0.0 PKHD1 "ARPKD, FCYT, FPC, TIGM1" ENSG00000170927 "PKHD1, fibrocystin/polyductin" P08F94 6 51615300-52087625 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 19.8;kidney: 49.4;pancreas: 32.9" "Group enriched" "Detected in some" 5 "Cholangiocytes: 56.0;Collecting duct cells: 43.6;Early spermatids: 167.1;Late spermatids: 63.8" "Group enriched" "Detected in some" 5 "pancreatic cancer: 1.4;renal cancer: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA031227 Enhanced NA NA "HPA031227: AB_10602068" "unprognostic (6.34e-3)" "unprognostic (5.51e-2)" "unprognostic (8.80e-3)" "unprognostic (1.35e-1)" "unprognostic (3.80e-2)" "unprognostic (1.29e-2)" "unprognostic (4.03e-2)" "unprognostic (6.42e-2)" "unprognostic (7.08e-2)" "unprognostic (2.44e-2)" "unprognostic (1.02e-2)" "unprognostic (2.62e-2)" "prognostic favorable (9.74e-8)" "unprognostic (2.33e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.48e-2)" 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.0 5.6 0.0 0.1 19.8 0.1 0.1 6.3 0.1 0.1 0.1 49.4 2.5 0.1 0.0 0.1 0.0 0.1 32.9 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 1.2 0.1 0.4 0.1 0.1 0.1 0.1 0.5 1.4 0.0 0.0 0.1 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.5 15.8 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 56.0 0.0 0.0 43.6 0.0 0.1 1.7 11.7 167.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 2.6 0.1 0.0 0.0 0.0 0.0 63.8 2.0 0.0 5.0 0.0 0.0 1.9 2.9 0.0 0.4 17.7 0.0 0.0 0.0 1.4 1.8 0.0 0.0 0.0 0.0 0.1 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 35.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 35.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" Yes No "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: AB_2674363, HPA057913: AB_2732617" "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 21.9 20.7 12.2 21.2 13.7 33.5 27.6 25.6 16.6 28.6 39.3 12.6 15.1 22.9 20.0 20.2 28.2 17.1 13.3 16.2 10.3 8.9 15.9 15.9 26.0 16.4 13.7 8.7 27.2 18.9 24.6 29.7 20.8 13.3 19.6 23.6 14.1 19.5 25.1 15.9 17.5 49.0 17.5 12.5 18.0 15.9 12.4 16.2 29.1 20.3 14.4 13.1 21.9 22.0 4.0 3.7 35.7 4.5 1.4 3.0 1.0 23.7 9.3 18.5 11.1 12.4 14.1 12.0 14.1 13.0 15.8 16.5 9.9 17.1 9.4 16.8 13.4 19.5 18.8 18.0 10.7 21.7 3.3 13.1 6.9 19.4 8.4 10.9 6.8 2.1 11.6 11.1 12.4 15.0 12.6 18.0 7.5 11.5 6.9 17.0 4.8 7.8 5.9 9.3 9.0 10.9 7.5 28.2 3.8 14.0 46.8 9.0 5.9 21.1 12.2 18.1 14.6 9.1 6.2 16.8 13.5 12.1 17.2 14.7 3.8 3.2 6.4 5.6 6.7 5.0 4.9 4.5 6.8 2.6 2.5 2.3 3.3 2.3 2.4 2.1 4.0 3.0 2.6 35.7 1.4 3.2 3.7 1.8 1.0 12.2 13.7 25.6 16.6 10.3 8.9 13.7 8.7 13.3 16.2 38.7 52.6 24.5 42.6 42.9 83.6 41.1 40.8 45.5 39.8 66.3 84.4 37.5 10.0 51.4 2.1 51.2 79.8 70.0 52.5 29.4 35.1 52.3 15.1 32.6 20.4 62.0 42.5 51.0 34.3 2.9 50.3 29.0 30.4 41.5 55.9 64.3 62.0 87.7 45.3 22.4 151.6 38.8 29.8 35.8 18.8 45.8 31.2 21.0 50.9 118.4 PLA2G10 GXPLA2 ENSG00000069764 "Phospholipase A2 group X" O15496 16 14672545-14694669 "Enzymes, Predicted secreted proteins, RAS pathway related proteins" "Lipid metabolism, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 9.4;stomach 1: 13.0" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 54.8;Exocrine glandular cells: 106.2;Extravillous trophoblasts: 45.9;Mucus-secreting cells: 110.3;Paneth cells: 80.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.6;CAPAN-2: 4.2;OE19: 4.6;SK-BR-3: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041893 Uncertain "Secreted in other tissues" NA NA "HPA041893: AB_10794495" "unprognostic (8.44e-3)" "unprognostic (2.37e-1)" "unprognostic (6.72e-2)" "prognostic favorable (5.74e-5)" "unprognostic (1.62e-2)" "unprognostic (3.16e-2)" "unprognostic (5.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.77e-2)" "unprognostic (2.72e-1)" "unprognostic (4.81e-2)" "unprognostic (2.39e-1)" "unprognostic (2.12e-1)" "unprognostic (4.08e-2)" "unprognostic (1.03e-1)" "unprognostic (2.30e-2)" "unprognostic (9.97e-3)" 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.3 9.4 2.4 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.2 7.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 13.0 2.1 0.0 0.0 2.8 0.0 0.9 0.5 2.0 0.5 0.1 0.4 0.1 0.1 0.9 0.1 0.1 0.0 0.1 2.6 0.1 0.0 0.0 0.0 0.6 4.2 0.3 0.4 0.0 0.1 2.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.0 0.1 0.8 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.2 0.7 0.0 1.9 0.3 0.2 0.4 4.6 0.1 0.8 0.3 0.2 0.0 0.3 0.6 0.5 1.0 2.6 0.3 0.3 0.4 0.4 0.8 0.0 0.3 0.1 0.0 0.7 2.1 0.7 0.6 0.1 0.1 0.1 0.5 0.5 0.3 0.4 0.3 0.1 0.2 0.4 0.5 0.9 0.3 0.3 2.0 0.1 0.3 0.3 0.1 0.1 32.8 17.2 0.0 0.7 0.0 0.0 0.0 10.2 32.1 9.1 1.8 0.0 0.4 0.0 0.3 0.3 0.0 54.8 0.0 106.2 45.9 0.0 1.9 0.0 0.0 0.8 0.0 12.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 110.3 0.0 15.5 80.4 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.5 0.0 23.8 12.6 PLA2G16 "AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754." ENSG00000176485 "Phospholipase A2 group XVI" P53816 11 63573195-63616883 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 113.6" "Cell type enhanced" "Detected in many" 9 "monocytes: 759.2;Proximal tubular cells: 471.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 52.4" "Group enriched" "Detected in many" 5 "dendritic cells: 52.4;T-cells: 16.0" "Cell line enhanced" "Detected in many" "A549: 32.7;ASC diff: 37.1;CAPAN-2: 59.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011749, HPA058997" Uncertain Supported Mitochondria NA NA Mitochondria "HPA011749: , HPA058997: AB_2683874" "unprognostic (5.18e-2)" "unprognostic (3.67e-2)" "unprognostic (7.92e-2)" "unprognostic (3.89e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.13e-1)" "unprognostic (3.06e-2)" "unprognostic (6.97e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (5.58e-6)" "unprognostic (6.38e-2)" "unprognostic (1.93e-3)" "unprognostic (1.62e-1)" "unprognostic (1.75e-1)" "prognostic favorable (2.54e-5)" "unprognostic (2.35e-1)" 113.6 15.2 32.0 4.4 39.4 1.6 33.9 4.8 30.2 6.1 7.2 46.6 6.1 4.0 5.0 11.5 5.9 13.9 12.9 39.0 37.6 25.2 24.7 28.9 13.5 4.5 58.4 22.2 30.9 13.2 15.1 8.1 16.2 30.5 5.9 3.7 8.8 10.1 13.2 37.8 2.4 7.5 8.0 70.4 6.4 10.2 17.8 48.9 0.1 17.1 11.1 2.3 8.0 4.7 2.1 52.4 0.4 6.2 5.3 16.0 6.4 20.6 32.7 0.9 0.0 37.1 6.4 6.0 0.7 6.6 5.5 2.7 7.4 59.7 0.0 13.8 1.6 18.0 1.0 30.9 1.6 4.2 25.5 1.2 0.3 7.8 1.2 22.1 0.0 0.3 3.8 0.1 13.6 0.5 22.0 8.6 0.0 0.3 2.3 5.8 3.6 0.0 0.1 2.6 13.0 10.6 0.0 0.0 2.0 17.3 2.9 0.4 2.4 4.4 12.5 6.8 14.0 27.1 1.0 12.6 2.4 0.1 8.3 1.8 9.8 6.4 0.0 9.9 0.0 0.2 0.0 6.2 0.0 16.0 2.4 8.8 2.1 3.7 11.6 1.7 0.3 1.2 9.4 0.4 5.3 0.1 52.4 2.4 6.4 32.0 39.4 4.8 21.9 37.6 25.2 58.4 22.2 30.5 48.9 95.3 77.4 17.6 17.3 10.3 10.6 128.7 96.8 113.8 45.5 109.9 3.9 112.1 96.2 54.1 56.9 116.5 22.2 0.0 99.5 300.4 35.3 29.0 56.6 210.7 56.9 38.1 3.4 165.7 48.0 16.0 28.7 51.4 25.3 759.2 4.5 120.3 123.3 14.4 20.5 471.4 17.2 12.9 42.8 135.2 4.9 8.2 243.0 69.8 1.7 59.6 PLA2G2A "PLA2B, PLA2L" ENSG00000188257 "Phospholipase A2 group IIA" P14555 1 19975431-19980416 "Enzymes, FDA approved drug targets, Predicted secreted proteins, RAS pathway related proteins" "Inflammatory response, Lipid metabolism, Phospholipid metabolism" "Antimicrobial, Bacteriolytic enzyme, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 377.9" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 366.3;Exocrine glandular cells: 945.9;Glandular cells: 937.5;Paneth cells: 354.3;Undifferentiated cells: 591.0" "Cancer enhanced" "Detected in all" "prostate cancer: 875.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "Hep G2: 23.4;OE19: 64.1;RT4: 21.5" "Not detected" "Not detected" HPA015236 Enhanced "Secreted to blood" NA NA 1000000 290000 "HPA015236: AB_10601047" "unprognostic (2.33e-2)" "unprognostic (1.28e-1)" "unprognostic (2.79e-2)" "unprognostic (7.85e-3)" "unprognostic (8.71e-2)" "unprognostic (9.27e-2)" "unprognostic (2.02e-1)" "unprognostic (1.80e-1)" "prognostic favorable (1.49e-4)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (3.77e-15)" "unprognostic (2.72e-2)" "unprognostic (9.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.51e-1)" 25.2 1.0 0.0 13.1 0.0 0.6 14.0 0.0 0.6 1.4 63.9 0.0 0.1 35.0 0.7 22.7 31.5 11.7 2.4 105.4 0.0 0.0 1.6 377.9 3.0 6.5 0.0 0.0 35.6 2.4 0.6 0.5 15.5 0.0 27.1 68.2 6.1 9.5 1.0 30.6 5.0 99.0 39.7 0.0 0.6 4.0 9.8 0.0 0.0 16.0 8.9 19.3 39.0 72.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.1 0.0 0.0 0.0 0.6 0.0 21.5 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 4.1 6.7 10.0 12.4 0.0 7.2 5.1 2.7 6.8 0.0 0.0 2.8 1.7 0.0 3.0 8.4 366.3 0.0 945.9 3.3 308.9 937.5 4.6 51.6 8.2 0.0 59.8 35.0 6.0 7.5 158.5 4.9 13.5 0.0 270.5 0.0 3.6 354.3 1.1 0.0 0.0 0.0 11.3 0.5 0.1 14.6 5.7 8.4 591.0 9.1 PLA2G2D sPLA2S ENSG00000117215 "Phospholipase A2 group IID" Q9UNK4 1 20111939-20119566 "Enzymes, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 39.9" "Group enriched" "Detected in some" 10 "Kupffer cells: 2.2;Melanocytes: 5.0" "Cancer enriched" "Detected in many" 6 "testis cancer: 25.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 6.6;naive B-cell: 5.6;plasmacytoid DC: 3.4" "Group enriched" "Detected in many" 5 "B-cells: 6.6;dendritic cells: 3.4" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 13.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted - unknown location" NA NA "prognostic favorable (4.35e-4)" "prognostic favorable (8.15e-5)" "unprognostic (3.88e-3)" "prognostic favorable (9.74e-4)" "unprognostic (1.78e-1)" "unprognostic (2.56e-3)" "unprognostic (1.98e-1)" "unprognostic (1.60e-2)" "unprognostic (1.82e-5)" "unprognostic (7.51e-4)" "unprognostic (2.50e-2)" "unprognostic (1.22e-1)" "unprognostic (4.64e-3)" "unprognostic (1.05e-1)" "unprognostic (2.85e-1)" "unprognostic (8.08e-2)" "unprognostic (2.60e-1)" 0.4 0.3 0.3 38.8 0.3 0.0 0.4 0.3 0.3 0.3 0.9 0.0 0.0 0.3 0.3 0.2 0.4 0.5 0.4 0.3 0.3 0.3 0.4 0.4 1.0 39.9 0.3 0.0 0.3 0.3 0.0 0.3 0.2 0.0 0.4 1.2 0.1 5.0 0.3 0.3 0.3 7.7 0.0 0.3 18.1 0.6 0.3 0.0 6.6 0.7 0.5 33.0 2.5 0.3 6.6 3.4 1.0 0.2 0.3 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 13.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.3 0.2 2.1 0.1 0.2 0.1 0.1 0.0 1.0 0.2 0.2 0.1 0.1 0.1 6.6 0.1 0.1 0.1 5.6 0.1 0.1 0.4 0.3 0.1 3.4 0.0 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 PLA2G2E ENSG00000188784 "Phospholipase A2 group IIE" Q9NZK7 1 19920009-19923617 "Enzymes, Predicted secreted proteins, RAS pathway related proteins" "Inflammatory response, Lipid metabolism, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "lymphoid tissue: 7.7;skin 1: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.9;CAPAN-2: 1.2;OE19: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA064085 Uncertain "Secreted - unknown location" NA NA "HPA064085: AB_2685188" "unprognostic (9.56e-2)" "unprognostic (3.71e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLA2R1 "CLEC13C, PLA2-R, PLA2G1R, PLA2IR" ENSG00000153246 "Phospholipase A2 receptor 1" Q13018 2 159932006-160062610 "Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 46.1" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 31.4;Muller glia cells: 30.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 19.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 9.2;ASC TERT1: 12.5;BJ hTERT+: 9.9;hTERT-RPE1: 16.5;TIME: 28.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB068217, CAB068218" Approved Approved Cytosol "Secreted to blood" NA NA 99000 Cytosol "CAB068217: AB_2665660, CAB068218: AB_2665661" "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (4.91e-3)" "unprognostic (6.01e-2)" "unprognostic (9.71e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (9.38e-3)" "unprognostic (4.30e-3)" "unprognostic (2.82e-1)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (2.62e-1)" "unprognostic (6.58e-2)" "unprognostic (2.02e-1)" 4.6 2.1 0.6 2.3 1.1 0.0 9.4 19.5 1.9 11.3 7.0 1.0 2.4 2.4 17.8 4.7 4.7 4.8 6.9 2.7 0.7 1.0 15.0 0.9 2.3 1.8 0.8 0.7 8.7 0.8 14.5 2.6 6.6 3.3 3.3 2.0 7.8 46.1 2.0 0.8 9.6 9.4 5.7 2.5 3.0 1.6 1.3 0.2 0.3 27.6 6.6 5.1 4.5 9.4 0.6 0.6 2.3 0.8 1.0 0.6 0.2 0.1 1.0 0.3 0.0 9.2 12.5 0.0 4.1 9.9 0.8 1.1 0.0 2.1 0.0 0.2 4.3 0.9 2.0 0.0 3.0 0.8 0.0 0.0 0.0 6.9 0.0 0.7 0.0 0.0 5.0 3.3 1.2 1.3 16.5 5.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.9 0.4 0.0 0.0 7.2 1.3 0.0 1.1 1.6 0.1 28.7 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.5 0.5 0.5 0.6 0.5 0.4 0.3 0.3 0.6 0.6 0.6 2.3 1.0 0.8 0.6 0.4 0.2 0.6 1.1 19.5 1.9 0.7 1.0 0.8 0.7 3.3 0.2 6.0 3.2 0.0 2.2 8.4 0.8 3.6 5.1 6.7 2.3 31.4 0.0 4.3 0.0 0.7 0.0 3.6 2.6 0.0 1.8 1.1 6.7 2.3 1.1 0.0 0.5 15.9 1.2 8.0 0.0 0.9 15.0 0.0 6.8 0.0 6.1 30.3 3.2 5.8 15.6 1.1 1.1 6.5 2.2 0.0 0.6 4.6 1.3 0.0 6.5 2.2 PLB1 "FLJ30866, PLB" ENSG00000163803 "Phospholipase B1" Q6P1J6 2 28457145-28643788 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "intestine: 66.7" "Group enriched" "Detected in many" 7 "Early spermatids: 22.5;Extravillous trophoblasts: 20.1;granulocytes: 5.7;Hofbauer cells: 10.2;Kupffer cells: 12.3;Late spermatids: 11.8;Macrophages: 8.7;Syncytiotrophoblasts: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 14 "classical monocyte: 3.1;eosinophil: 3.3;intermediate monocyte: 4.9;myeloid DC: 6.4;neutrophil: 9.9;non-classical monocyte: 5.2" "Group enriched" "Detected in many" 40 "dendritic cells: 6.4;granulocytes: 9.9;monocytes: 5.2" "Cell line enhanced" "Detected in some" "BEWO: 5.8;OE19: 12.0;RT4: 4.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" NA NA "unprognostic (2.18e-2)" "unprognostic (2.49e-1)" "unprognostic (6.58e-2)" "unprognostic (1.42e-1)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (4.91e-3)" "unprognostic (4.74e-2)" "unprognostic (4.48e-2)" "unprognostic (2.03e-2)" "unprognostic (1.53e-1)" "unprognostic (2.17e-1)" "unprognostic (2.61e-9)" "unprognostic (2.48e-2)" "unprognostic (2.19e-2)" "unprognostic (4.99e-2)" "unprognostic (8.03e-2)" 0.9 3.3 0.7 1.0 2.1 2.9 1.0 0.6 0.7 0.9 0.8 0.6 0.6 0.2 0.8 1.7 1.3 0.7 0.9 1.4 0.6 0.9 0.8 0.6 0.7 0.6 0.8 0.6 0.6 0.6 0.0 0.7 1.3 0.7 1.0 1.1 0.7 0.6 0.9 0.9 5.2 66.7 1.7 0.8 2.8 0.5 1.2 0.6 0.6 1.2 0.9 0.6 0.9 0.6 0.0 6.4 9.9 5.2 0.0 0.1 1.1 0.6 0.1 3.8 0.1 0.8 0.6 5.8 0.1 1.5 0.4 0.3 3.8 0.4 0.4 0.4 0.6 1.7 0.8 0.0 3.1 0.3 0.2 0.0 0.3 0.6 0.7 1.3 0.7 0.3 0.6 1.8 0.6 1.0 0.7 1.0 0.0 0.0 0.1 1.1 0.0 0.0 0.5 0.1 12.0 0.8 0.0 0.6 0.0 1.7 4.3 1.7 0.3 0.1 0.2 0.3 0.3 0.0 2.0 0.4 0.4 1.1 0.2 0.2 0.8 0.2 0.0 1.3 2.9 0.1 0.0 3.1 3.3 0.0 4.9 0.0 0.0 0.1 0.0 6.4 0.0 0.0 0.0 9.9 0.0 5.2 0.3 0.1 1.1 0.7 2.1 0.6 0.7 0.6 0.9 0.8 0.6 0.7 0.6 0.0 1.1 0.0 0.8 0.3 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.4 1.7 0.9 22.5 0.3 1.7 0.0 0.8 20.1 0.5 0.3 5.7 0.0 10.2 0.0 1.2 0.6 12.3 11.8 1.1 8.7 0.0 0.0 1.1 0.6 0.9 0.2 0.7 0.0 0.0 0.0 0.0 0.9 0.2 0.4 6.9 0.5 0.3 1.4 PLBD2 p76 ENSG00000151176 "Phospholipase B domain containing 2" Q8NHP8 12 113358566-113391625 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 71.7" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 110.2;Late spermatids: 268.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 68.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017163 Approved "Intracellular and membrane" NA NA 890000 "HPA017163: AB_1853029" "unprognostic (8.28e-2)" "unprognostic (1.97e-1)" "unprognostic (1.50e-2)" "unprognostic (4.13e-1)" "unprognostic (2.36e-3)" "unprognostic (7.59e-3)" "unprognostic (5.92e-3)" "unprognostic (2.39e-2)" "unprognostic (2.35e-1)" "unprognostic (3.85e-2)" "unprognostic (1.24e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.58e-11)" "unprognostic (7.55e-3)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (5.48e-2)" 20.5 71.7 9.8 10.3 15.6 5.1 15.3 10.3 23.0 14.6 7.6 17.1 5.3 5.3 11.5 17.6 7.7 9.6 13.2 20.1 8.7 14.5 8.8 19.8 11.0 10.3 13.6 11.0 33.1 16.1 12.6 28.4 8.2 28.8 12.2 8.7 11.7 9.9 11.1 14.9 12.2 6.1 17.5 12.7 8.8 7.7 33.2 10.7 2.0 10.1 7.1 6.9 13.0 8.3 0.9 6.6 0.7 6.2 1.6 3.1 2.9 5.1 9.5 4.1 15.7 68.0 38.1 5.6 10.9 21.8 7.7 9.7 8.1 3.1 2.4 9.1 29.7 12.7 5.6 3.9 6.5 8.7 4.8 2.8 4.2 5.9 9.6 21.3 5.0 13.1 32.0 8.6 9.3 5.6 23.8 12.0 2.2 12.6 5.9 11.9 8.8 0.9 5.4 4.5 4.2 4.2 4.0 4.3 6.4 9.1 7.2 4.2 4.1 15.1 11.9 6.6 7.5 7.8 4.9 19.2 18.4 7.1 18.4 6.3 3.0 5.4 3.0 30.6 4.3 10.7 0.1 6.2 0.4 2.5 4.0 2.2 0.9 2.9 3.1 6.6 0.9 2.2 2.8 0.7 1.6 2.9 2.5 1.5 2.9 9.8 15.6 10.3 23.0 8.7 14.5 13.6 11.0 28.8 10.7 8.9 8.3 5.6 3.8 4.7 9.4 8.9 5.1 4.0 1.2 1.8 5.9 3.9 0.0 16.9 110.2 5.6 4.7 0.0 12.1 9.5 10.6 6.9 10.3 13.4 29.6 19.1 5.1 6.2 21.6 268.4 37.4 14.3 20.3 56.9 3.5 4.3 11.6 2.9 45.3 4.3 4.8 6.5 8.2 8.3 7.2 1.6 3.7 3.3 4.0 2.8 PLD3 HU-K4 ENSG00000105223 "Phospholipase D family member 3" Q8IV08 19 40348456-40380439 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 638.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 149.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 149.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012800, CAB020812" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA 490000 "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB020812: , HPA012800: AB_1855330" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.64e-3)" "unprognostic (2.56e-3)" "unprognostic (2.06e-3)" "unprognostic (2.68e-1)" "unprognostic (4.52e-2)" "unprognostic (3.89e-2)" "unprognostic (1.09e-1)" "unprognostic (4.60e-2)" "prognostic favorable (6.44e-4)" "unprognostic (4.34e-2)" "prognostic favorable (2.21e-4)" "unprognostic (3.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-2)" "unprognostic (6.42e-2)" 45.7 57.5 44.6 23.1 79.0 12.8 21.9 35.5 126.1 31.2 23.5 25.4 17.1 22.6 26.3 35.0 18.3 30.0 30.8 33.0 46.4 73.4 22.1 25.6 49.7 25.2 44.7 53.9 44.8 42.5 32.9 122.1 38.9 62.2 29.6 16.1 31.6 35.3 37.2 27.4 24.2 23.5 25.6 28.6 48.9 23.0 17.0 19.3 11.9 20.6 11.2 12.9 27.3 20.7 3.6 23.0 149.2 24.6 9.7 7.8 16.8 14.1 43.7 28.3 44.5 78.9 37.6 21.6 35.1 35.8 25.5 29.2 8.3 16.0 6.1 36.9 30.5 8.3 6.6 6.8 13.8 11.2 22.9 24.9 6.6 15.0 10.4 53.9 2.7 75.9 71.5 28.9 19.4 13.4 42.8 21.4 10.1 23.3 24.9 18.3 18.5 4.8 13.1 18.5 23.2 9.0 6.1 21.6 25.2 13.1 10.6 20.3 33.8 16.8 10.4 18.8 30.9 14.3 47.6 37.6 21.5 10.3 18.2 7.8 26.0 27.7 6.3 34.6 11.0 13.3 149.2 24.6 35.3 7.8 12.8 6.4 3.6 6.2 6.9 23.0 3.1 6.5 6.5 2.5 9.7 5.7 3.3 6.1 16.8 44.6 79.0 35.5 126.1 46.4 73.4 44.7 53.9 62.2 19.3 29.8 62.9 34.4 70.6 31.5 98.5 18.5 25.5 12.0 28.4 54.1 31.4 137.8 18.3 50.7 5.8 46.8 52.7 0.0 51.3 94.8 142.4 49.1 59.9 35.8 638.2 114.4 69.9 90.9 219.8 8.6 140.4 84.2 87.7 44.1 36.8 99.5 49.7 41.2 135.1 30.0 39.3 19.4 53.1 13.9 57.5 29.2 163.8 35.4 34.5 52.0 PLD4 C14orf175 ENSG00000166428 "Phospholipase D family member 4" Q96BZ4 14 104924816-104937790 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "blood: 229.9" "Group enriched" "Detected in some" 4 "B-cells: 25.7;Hofbauer cells: 28.1;Macrophages: 25.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 229.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 229.9" "Group enriched" "Detected in some" 5 "HMC-1: 34.9;RPMI-8226: 25.0;THP-1: 63.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051512 Uncertain NA NA 2000000 "HPA051512: AB_2681515" "unprognostic (4.50e-3)" "unprognostic (1.78e-4)" "unprognostic (7.12e-2)" "unprognostic (5.30e-3)" "unprognostic (5.54e-2)" "unprognostic (2.91e-3)" "unprognostic (2.56e-1)" "unprognostic (4.76e-3)" "unprognostic (1.45e-3)" "unprognostic (1.19e-3)" "unprognostic (3.45e-3)" "unprognostic (3.89e-1)" "unprognostic (6.90e-3)" "unprognostic (8.94e-2)" "unprognostic (2.83e-1)" "unprognostic (1.28e-2)" "unprognostic (2.41e-1)" 0.7 1.6 8.9 6.7 8.8 15.0 1.9 5.7 10.0 1.5 1.3 23.1 0.1 5.6 1.5 0.5 1.1 2.8 3.5 0.8 8.7 8.4 1.2 0.9 2.6 14.4 14.5 3.4 0.9 1.6 1.0 2.8 1.2 9.0 2.1 0.8 1.5 4.6 2.3 0.5 0.9 5.5 0.9 19.0 11.6 3.5 0.8 9.2 2.7 1.0 0.0 11.2 3.9 0.9 14.7 229.9 43.4 17.7 1.7 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 3.0 0.0 0.0 0.0 8.8 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 2.8 43.4 0.0 11.9 0.1 14.7 0.0 0.0 35.1 12.3 0.1 0.0 0.6 1.7 17.7 229.9 0.0 4.4 8.9 8.8 5.7 9.6 8.7 8.4 14.5 3.4 9.0 9.2 0.0 0.0 25.7 0.1 0.3 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.4 0.1 3.5 0.0 28.1 1.6 0.0 0.0 1.3 2.5 0.0 25.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 6.5 0.4 0.7 0.1 0.4 0.2 0.0 0.0 0.0 PLD5 FLJ40773 ENSG00000180287 "Phospholipase D family member 5" Q8N7P1 1 242082986-242524696 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 54.8;retina: 37.7" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 6.3;Horizontal cells: 3.2;Late spermatids: 9.5;Leydig cells: 4.6" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Region enriched" "Detected in all" 4 "cerebellum: 54.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 4.0;AF22: 14.0;HDLM-2: 6.9;SH-SY5Y: 3.9;U-2 OS: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028389, HPA050367" Approved Vesicles,Mitochondria,Cytosol No No Mitochondria "Vesicles, Cytosol" "HPA028389: AB_10602145, HPA050367: AB_2681105" "unprognostic (5.20e-2)" "unprognostic (1.05e-1)" "unprognostic (9.14e-2)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (8.77e-2)" "unprognostic (4.36e-1)" "unprognostic (1.95e-1)" "unprognostic (2.08e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-5)" "unprognostic (2.79e-2)" "unprognostic (4.46e-1)" "unprognostic (3.44e-3)" "unprognostic (2.18e-1)" 1.1 5.4 5.0 0.4 3.7 0.4 1.6 54.8 7.6 2.2 0.8 7.7 0.0 0.4 3.5 0.9 1.6 1.8 0.8 0.8 4.4 4.6 1.5 0.5 0.8 3.3 5.4 2.5 6.6 3.1 1.4 7.2 1.5 12.7 2.7 0.6 37.7 2.2 9.3 0.8 0.6 0.5 2.9 6.0 2.2 0.8 4.2 6.2 0.0 1.0 0.0 1.5 0.4 1.0 0.4 0.2 1.0 0.2 0.3 0.4 0.0 0.0 4.0 14.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.2 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.4 0.3 0.4 1.0 0.3 0.2 0.2 0.2 0.0 5.0 3.7 54.8 5.5 4.4 4.6 5.4 2.5 12.7 6.2 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 9.5 4.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.5 0.0 0.7 0.5 0.2 0.1 0.2 0.0 0.0 0.0 PLD6 ENSG00000179598 "Phospholipase D family member 6" Q8N2A8 17 17200995-17206315 "Predicted membrane proteins" "Differentiation, Lipid degradation, Lipid metabolism, Meiosis, Spermatogenesis" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.1" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 15.6;Spermatogonia: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.6;NK-cells: 5.0;T-cells: 11.4" "Cell line enhanced" "Detected in many" "HAP1: 25.9;REH: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA049345 Approved NA NA "HPA049345: AB_2680722" "unprognostic (1.71e-1)" "unprognostic (6.80e-3)" "unprognostic (3.21e-2)" "unprognostic (1.39e-1)" "unprognostic (2.95e-2)" "unprognostic (8.21e-2)" "unprognostic (1.31e-1)" "unprognostic (7.83e-2)" "unprognostic (9.01e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.32e-1)" "unprognostic (1.04e-1)" "unprognostic (6.08e-2)" "unprognostic (1.56e-1)" "unprognostic (3.51e-1)" "unprognostic (2.24e-1)" 5.0 5.9 4.8 2.3 12.5 2.4 5.1 18.2 9.6 6.7 5.8 4.5 2.9 2.3 4.4 7.2 2.6 6.5 3.6 5.5 4.9 8.1 3.4 4.6 2.5 5.2 5.0 4.1 10.4 16.2 6.8 6.3 3.7 5.6 7.5 2.5 5.1 4.5 6.5 3.7 3.2 2.2 3.4 4.0 3.0 3.7 37.1 1.7 2.0 3.3 1.7 4.1 5.9 3.3 5.6 1.3 0.5 0.4 5.0 11.4 4.0 4.2 3.3 0.1 3.8 1.5 0.6 0.2 1.3 2.2 2.5 1.5 3.9 1.3 9.5 2.1 1.4 1.5 1.2 25.9 0.7 2.4 5.9 7.5 9.1 2.5 6.9 6.7 6.8 3.8 1.3 2.8 1.5 6.2 2.9 0.6 4.5 8.1 0.2 2.9 5.5 5.0 9.6 0.0 4.9 4.6 19.2 1.9 6.9 2.3 0.3 15.0 6.1 1.7 2.5 4.5 2.9 2.4 11.0 0.7 0.1 0.2 5.6 2.7 1.2 4.4 0.0 3.1 7.0 5.3 0.3 0.4 0.2 2.8 0.3 9.2 5.6 10.7 5.6 0.1 4.3 11.4 5.1 0.5 5.0 0.2 1.3 7.6 4.0 4.8 12.5 18.2 9.6 4.9 8.1 5.0 4.1 5.6 1.7 3.0 3.5 2.9 4.1 4.8 4.6 5.6 2.5 5.3 2.3 1.8 0.0 3.4 1.7 0.9 6.0 0.5 0.5 0.0 0.6 0.9 2.4 3.6 1.1 1.7 2.4 6.4 1.2 0.6 0.3 1.6 4.0 0.0 3.3 1.0 1.7 5.8 0.9 0.0 4.6 1.1 1.2 0.0 1.4 15.6 25.4 1.4 0.7 3.8 1.2 0.9 PLGRKT "AD025, C9orf46, FLJ14688, MDS030, Plg-RKT" ENSG00000107020 "Plasminogen receptor with a C-terminal lysine" Q9HBL7 9 5357973-5437878 "Predicted intracellular proteins" "Chemotaxis, Inflammatory response, Plasminogen activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 74.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008214, HPA011144" Supported Uncertain Mitochondria NA NA Mitochondria "HPA008214: AB_1078363, HPA011144: AB_1078364" "prognostic favorable (5.56e-4)" "unprognostic (5.31e-2)" "unprognostic (2.96e-2)" "unprognostic (9.67e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (1.72e-1)" "unprognostic (1.89e-2)" "unprognostic (3.85e-2)" "unprognostic (5.45e-3)" "unprognostic (2.19e-2)" "unprognostic (1.84e-1)" "prognostic favorable (5.09e-5)" "unprognostic (1.45e-2)" "unprognostic (1.47e-1)" "unprognostic (1.01e-1)" "unprognostic (2.02e-1)" 11.3 15.6 10.6 12.9 12.1 6.8 15.5 8.7 17.6 11.4 24.0 12.6 11.8 25.6 9.6 17.3 16.4 11.9 9.3 34.5 8.9 7.5 23.1 13.9 13.3 36.5 9.9 9.8 9.2 10.9 7.8 10.1 16.7 14.1 10.6 28.4 13.1 10.7 10.5 30.5 12.1 20.6 15.6 13.3 12.0 11.9 7.4 10.1 18.2 15.2 26.3 14.8 10.7 9.9 14.1 12.9 59.3 7.2 14.1 21.4 13.5 16.3 4.7 9.9 7.1 6.4 9.0 0.0 8.0 9.0 7.0 8.1 0.0 7.4 3.8 4.3 6.0 10.3 3.8 6.8 22.2 14.7 74.5 4.3 29.4 4.0 5.2 14.0 8.8 7.0 9.8 8.1 6.5 13.4 6.0 10.0 12.7 1.6 26.8 16.9 3.6 9.4 10.0 6.4 13.4 2.8 6.0 4.9 11.9 15.8 3.5 7.9 10.3 7.9 12.7 15.1 7.4 10.2 12.5 7.1 8.9 10.9 7.7 15.5 5.1 7.4 7.7 15.4 5.6 5.0 59.3 5.7 10.7 13.6 7.2 16.9 14.1 17.3 17.9 8.1 11.8 16.7 16.5 6.7 14.1 4.8 12.9 21.4 13.5 10.6 12.1 8.7 17.6 8.9 7.5 9.9 9.8 14.1 10.1 11.9 26.7 19.3 18.6 23.5 10.6 52.9 22.9 46.8 23.9 21.0 0.0 76.9 92.9 68.8 0.6 17.9 129.2 23.3 44.8 96.5 28.0 25.8 88.9 24.3 72.3 9.5 25.5 17.2 19.0 1.5 15.3 35.1 32.1 139.7 115.7 18.3 64.0 135.5 18.7 58.8 11.6 0.0 20.9 11.9 8.5 26.5 55.0 34.1 97.8 17.5 PLIN1 PLIN ENSG00000166819 "Perilipin 1" O60240 15 89664365-89679427 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adipose tissue: 187.5;breast: 62.6" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 49.1" "Cancer enhanced" "Detected in many" "breast cancer: 8.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 176 "ASC diff: 70.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024299, CAB033821, CAB037333" Enhanced Uncertain Peroxisomes NA NA 8900 Peroxisomes "CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467" "unprognostic (4.62e-2)" "unprognostic (2.22e-1)" "unprognostic (2.13e-1)" "unprognostic (1.67e-1)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (9.89e-3)" "unprognostic (3.54e-1)" "unprognostic (7.01e-2)" "unprognostic (2.13e-2)" "unprognostic (8.00e-3)" "unprognostic (2.28e-3)" "unprognostic (2.62e-6)" "unprognostic (5.56e-2)" "unprognostic (1.22e-1)" "unprognostic (1.63e-1)" "unprognostic (4.85e-2)" 187.5 2.6 1.8 7.1 1.3 0.3 62.6 0.8 0.8 0.3 10.6 1.6 0.4 0.4 0.3 1.9 0.5 0.4 7.4 8.3 2.7 0.6 0.6 5.8 0.3 2.8 0.8 1.5 0.4 1.4 0.3 0.1 0.3 1.0 0.4 1.1 0.0 7.6 1.5 7.2 2.2 2.2 0.6 0.4 0.3 0.5 1.6 1.8 0.0 0.7 8.0 0.3 1.5 1.5 0.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 70.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.8 1.3 0.8 0.7 2.7 0.6 0.8 1.5 1.0 1.8 0.0 0.0 0.0 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 49.1 0.0 0.0 0.0 1.8 1.3 4.9 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 5.4 0.2 0.4 0.0 0.0 0.0 0.7 PLLP "PMLP, TM4SF11" ENSG00000102934 Plasmolipin Q9Y342 16 57248547-57284687 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 92.3" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 150.3;Collecting duct cells: 85.5;Pancreatic endocrine cells: 76.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "naive CD4 T-cell: 15.1;naive CD8 T-cell: 5.7" "Lineage enriched" "Detected in many" 8 "T-cells: 15.1" "Cell line enhanced" "Detected in many" "EFO-21: 12.6;Hep G2: 34.8;OE19: 34.6;RPTEC TERT1: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041862 Enhanced NA NA "HPA041862: AB_2677712" "unprognostic (7.96e-2)" "unprognostic (2.07e-3)" "unprognostic (3.86e-2)" "prognostic favorable (2.80e-4)" "unprognostic (3.19e-1)" "unprognostic (1.42e-1)" "unprognostic (9.56e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (5.64e-2)" "unprognostic (6.99e-3)" "unprognostic (2.83e-2)" "prognostic favorable (6.21e-9)" "unprognostic (2.06e-2)" "unprognostic (9.06e-3)" "unprognostic (3.86e-1)" "unprognostic (3.32e-2)" 3.5 2.3 35.9 1.8 46.1 1.8 7.8 5.6 45.6 15.6 12.0 92.3 13.1 20.2 4.3 2.0 10.1 14.3 16.8 2.8 52.5 26.8 19.2 3.6 22.1 1.8 42.3 25.0 1.4 28.4 4.7 1.1 2.1 32.3 3.2 8.1 3.5 25.3 18.7 2.6 25.5 19.5 2.0 46.2 6.1 42.8 3.0 40.3 0.0 7.0 1.4 3.3 6.9 5.8 1.2 0.5 1.9 1.1 0.6 15.1 2.2 0.7 2.5 3.2 0.6 0.0 0.0 1.6 0.5 0.1 0.1 0.1 7.0 3.0 0.2 12.6 0.0 0.8 2.3 1.5 2.2 0.0 0.7 1.2 3.2 1.4 34.8 0.4 0.3 0.9 0.1 0.5 0.0 0.2 1.7 3.6 0.8 0.6 0.9 0.0 0.9 0.4 0.8 2.7 34.6 1.0 0.4 0.6 0.6 14.9 7.5 0.7 1.3 0.8 1.0 1.4 1.0 5.2 1.1 2.6 0.6 0.7 0.4 0.6 0.7 0.7 0.4 0.7 0.2 2.1 1.3 1.1 0.6 0.8 0.5 0.6 0.7 2.1 0.6 0.2 1.2 15.1 5.7 1.9 0.6 0.4 0.5 0.6 2.2 35.9 46.1 5.6 41.1 52.5 26.8 42.3 25.0 32.3 40.3 59.6 24.5 1.3 16.9 12.4 2.2 2.5 150.3 1.4 14.8 85.5 2.0 1.6 13.3 52.2 0.7 13.8 36.4 0.0 62.6 1.1 1.9 5.8 3.5 3.4 0.7 4.8 1.2 7.4 0.6 0.8 4.4 2.2 3.3 1.8 19.1 0.5 76.9 48.4 20.8 24.4 6.4 0.0 3.8 1.9 1.5 37.4 0.9 2.1 21.5 6.7 PLN "CMD1P, PLB" ENSG00000198523 Phospholamban P26678 6 118548298-118560730 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 337.5" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 2230.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "eosinophil: 1.3;naive CD4 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.3;Karpas-707: 1.6;NB-4: 1.8;SuSa: 1.7;U-2197: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005597, HPA026900" Enhanced NA NA "CAB005597: AB_2252716, HPA026900: AB_1855314" "unprognostic (2.49e-1)" "unprognostic (5.67e-2)" "unprognostic (1.96e-3)" "unprognostic (4.81e-2)" "unprognostic (1.20e-1)" "unprognostic (5.54e-2)" "unprognostic (2.35e-3)" "unprognostic (4.66e-2)" "unprognostic (3.97e-1)" "unprognostic (8.98e-2)" "unprognostic (8.98e-2)" "unprognostic (3.28e-1)" "prognostic unfavorable (4.11e-4)" "unprognostic (2.98e-3)" "unprognostic (1.80e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (5.59e-4)" 9.0 1.8 0.4 2.7 0.5 0.0 5.4 0.4 0.6 22.3 22.2 0.0 9.8 2.0 21.1 22.3 27.3 11.6 29.8 337.5 0.4 0.5 6.4 0.4 5.3 0.8 0.7 1.4 18.6 0.5 0.1 0.4 0.1 1.4 14.4 3.9 0.0 1.6 6.0 68.4 1.5 14.0 30.8 1.2 0.6 6.5 12.3 0.0 0.0 2.8 23.7 0.8 32.2 6.6 0.3 0.0 1.3 0.4 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.3 0.0 0.2 0.0 0.0 0.3 0.6 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.3 0.5 0.2 0.1 0.0 0.2 0.2 1.6 0.1 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.7 0.2 0.8 0.4 0.1 0.0 1.7 0.4 0.0 0.5 0.3 0.2 1.3 0.3 0.2 0.3 0.4 0.0 1.0 0.1 0.0 0.4 1.3 0.1 0.0 0.3 0.1 0.4 0.0 0.0 0.3 1.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.6 0.4 0.5 0.7 1.4 1.4 0.0 0.0 0.0 0.0 0.0 3.8 1.6 2230.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 71.2 0.4 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.7 0.9 0.3 3.3 0.0 0.0 0.0 0.1 0.0 11.0 0.0 0.2 271.7 280.1 1.1 0.4 1.4 0.0 0.0 0.0 0.4 PLOD2 LH2 ENSG00000152952 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2" O00469 3 146069440-146163653 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.1" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 109.4;Pancreatic endocrine cells: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Cell line enhanced" "Detected in many" "HBF TERT88: 82.6;hTERT-RPE1: 93.9;U-87 MG: 73.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB025898, HPA069126" Approved Uncertain Nucleoli,Cytosol "Intracellular and membrane" NA NA "Nucleoli, Cytosol" "CAB025898: , HPA069126: " "unprognostic (8.68e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (2.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.34e-2)" "unprognostic (1.29e-3)" "prognostic unfavorable (7.64e-10)" "prognostic unfavorable (1.42e-4)" "unprognostic (2.97e-2)" "unprognostic (3.36e-2)" "unprognostic (6.27e-3)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.99e-11)" "prognostic unfavorable (2.83e-4)" "unprognostic (6.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.41e-3)" 36.7 14.1 11.2 18.0 12.1 0.7 28.5 7.9 13.5 8.8 25.2 5.1 8.3 21.6 14.8 7.5 12.0 8.0 22.3 16.6 12.5 8.2 16.4 73.1 9.3 3.0 10.7 4.8 17.7 14.4 13.9 7.8 41.0 13.0 11.1 16.1 7.2 7.7 11.3 4.8 3.2 24.7 24.2 19.4 3.2 13.6 6.3 10.9 6.1 47.6 3.5 3.0 21.8 28.7 0.0 0.0 1.5 0.3 0.0 0.0 1.9 16.4 11.8 3.7 1.2 13.5 14.5 9.4 58.5 17.9 31.9 60.2 0.9 1.7 0.0 11.4 9.9 14.6 3.5 4.3 50.3 82.6 0.0 6.8 4.1 11.5 8.2 34.7 0.0 0.0 25.4 7.2 27.6 13.5 93.9 44.0 0.0 5.4 0.2 56.3 6.0 0.0 0.0 2.3 0.0 5.1 0.0 2.4 0.0 13.4 0.8 1.8 0.0 46.6 5.0 4.9 18.1 13.6 0.5 55.2 39.5 12.0 12.5 34.9 17.9 2.5 0.0 73.6 0.0 7.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 11.2 12.1 7.9 13.5 12.5 8.2 10.7 4.8 13.0 10.9 14.9 10.7 0.5 5.9 6.3 14.5 10.6 61.1 12.0 13.6 26.2 33.4 6.8 8.3 62.8 0.4 21.2 46.1 0.0 45.9 109.4 34.5 8.1 0.0 50.8 4.7 0.0 19.0 18.4 1.5 1.3 12.0 2.7 13.5 1.0 18.3 65.1 83.0 31.5 4.6 6.9 22.4 19.4 38.1 8.0 16.3 4.8 15.7 0.7 21.3 5.4 PLP1 "GPM6C, PLP, SPG2" ENSG00000123560 "Proteolipid protein 1" P60201 X 103773718-103792619 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "brain: 463.6" "Cell type enriched" "Detected in some" 16 "Melanocytes: 376.2" "Group enriched" "Detected in many" 22 "glioma: 160.5;melanoma: 75.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "plasmacytoid DC: 2.3" "Lineage enriched" "Detected in single" 9 "dendritic cells: 2.3" "Group enriched" "Detected in some" 5 "SK-MEL-30: 67.9;WM-115: 40.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004128 Enhanced NA NA "HPA004128: AB_1079635" "unprognostic (5.72e-2)" "unprognostic (1.77e-2)" "unprognostic (2.27e-2)" "unprognostic (4.09e-3)" "unprognostic (1.32e-1)" "unprognostic (3.95e-2)" "unprognostic (2.57e-2)" "unprognostic (1.02e-1)" "unprognostic (5.92e-2)" "unprognostic (2.28e-2)" "unprognostic (1.21e-1)" "unprognostic (1.62e-5)" "unprognostic (4.91e-2)" "unprognostic (1.86e-1)" "unprognostic (3.46e-2)" "unprognostic (1.16e-2)" 3.6 5.6 90.6 2.8 109.9 1.9 3.1 8.9 463.6 3.9 5.7 208.1 0.0 3.3 3.6 3.5 4.2 2.5 4.0 5.0 143.8 73.8 2.1 2.1 2.1 2.0 174.8 42.2 3.0 2.2 17.9 0.3 1.9 124.4 3.6 5.4 0.0 3.4 9.3 2.2 7.3 5.1 7.0 453.8 2.0 2.8 9.2 145.2 0.0 2.0 0.0 2.0 2.7 0.8 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.9 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 40.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 90.6 109.9 8.9 68.1 143.8 73.8 174.8 42.2 124.4 145.2 0.0 0.0 0.0 0.4 14.2 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 3.8 0.9 0.0 0.0 0.1 0.0 0.0 5.5 0.0 2.0 6.9 0.0 376.2 0.0 0.0 23.1 0.0 0.0 2.8 0.0 1.2 0.0 1.0 0.5 0.2 2.3 0.0 0.0 0.0 0.0 PLP2 "A4, A4-LSB, MGC126187" ENSG00000102007 "Proteolipid protein 2" Q04941 X 49171926-49175239 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042415 Approved NA NA 710000 "HPA042415: AB_10796907" "unprognostic (1.40e-1)" "unprognostic (6.67e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (3.32e-5)" "unprognostic (3.79e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-3)" "unprognostic (4.14e-2)" "unprognostic (2.58e-2)" "unprognostic (9.99e-2)" "unprognostic (1.19e-2)" "unprognostic (1.66e-1)" "prognostic unfavorable (5.55e-10)" "unprognostic (1.66e-1)" "unprognostic (1.25e-1)" "unprognostic (1.29e-2)" "unprognostic (2.30e-1)" 32.2 39.3 2.6 24.8 3.5 61.7 29.1 4.4 2.9 64.3 40.1 5.9 20.7 13.4 50.7 31.0 123.4 22.2 24.4 26.7 3.0 4.1 30.8 33.0 42.5 40.3 4.9 3.1 44.8 116.5 5.8 28.3 22.8 8.1 46.7 25.7 13.1 24.2 25.1 46.2 74.9 36.4 65.9 6.8 26.3 23.5 17.8 3.2 34.9 12.6 121.1 93.8 59.2 48.5 34.6 102.5 55.6 40.5 9.7 37.3 27.1 69.0 43.4 0.0 0.1 18.1 54.0 0.4 37.3 29.7 45.9 34.8 16.0 32.9 25.3 9.2 27.3 46.0 58.7 34.6 68.6 29.1 63.7 14.0 9.3 62.9 0.4 29.0 17.4 41.7 24.1 68.0 59.6 70.1 43.0 34.7 8.4 7.1 32.1 33.0 45.6 1.9 44.5 0.4 34.1 61.2 6.3 40.4 72.1 61.5 50.0 9.4 16.3 52.1 20.7 31.6 0.6 45.4 10.0 38.9 26.4 25.4 46.2 61.0 13.8 12.7 6.6 62.6 46.8 61.3 55.6 40.5 20.9 9.3 14.7 15.8 34.6 33.4 17.5 43.6 21.1 17.2 14.4 47.8 9.7 9.0 102.5 37.3 27.1 2.6 3.5 4.4 2.9 3.0 4.1 4.9 3.1 8.1 3.2 68.5 33.9 132.7 253.0 390.6 0.2 24.6 48.4 75.0 60.3 76.8 0.0 2.3 18.3 339.7 12.6 40.9 116.8 0.0 439.0 21.4 160.3 68.4 86.6 6.8 151.3 0.0 107.1 41.7 184.6 13.5 157.3 170.4 212.6 50.5 174.7 15.2 432.9 168.9 57.3 4.3 1.1 122.9 178.8 1.4 1.1 441.3 5.4 137.1 292.0 292.5 PLPP1 "LPP1, PAP-2a, PPAP2A" ENSG00000067113 "Phospholipid phosphatase 1" O14494 5 55424854-55535050 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Ito cells: 254.8;Leydig cells: 203.1" "Cancer enhanced" "Detected in all" "prostate cancer: 200.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 93.3;fHDF/TERT166: 28.4;HMC-1: 48.9;HSkMC: 35.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033331, HPA047815" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB033331: AB_2168044, HPA047815: AB_2680164" "unprognostic (1.22e-1)" "unprognostic (1.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.55e-2)" "unprognostic (2.52e-1)" "unprognostic (1.36e-1)" "prognostic favorable (6.06e-4)" "unprognostic (2.81e-1)" "unprognostic (2.20e-1)" "unprognostic (4.05e-3)" "unprognostic (2.43e-2)" "unprognostic (1.05e-1)" "unprognostic (4.37e-3)" "prognostic unfavorable (5.77e-4)" "unprognostic (3.94e-2)" "unprognostic (1.66e-1)" "unprognostic (3.11e-2)" 56.3 26.7 12.5 14.8 14.6 0.6 57.9 10.6 18.5 34.5 30.9 26.1 18.0 17.3 36.8 26.0 18.4 20.4 61.0 33.7 13.4 10.8 34.5 42.0 15.9 17.3 20.8 10.1 16.5 17.6 16.9 10.1 22.4 21.4 82.0 24.7 29.8 9.8 24.0 18.4 16.6 25.4 39.6 28.2 10.2 21.7 18.1 14.5 4.4 32.7 9.6 10.0 43.1 18.1 5.4 13.6 3.3 0.7 2.7 9.5 1.6 2.0 4.9 1.4 2.9 93.3 10.9 2.0 4.4 12.4 2.4 5.8 3.4 3.6 2.0 4.2 28.4 6.7 1.3 5.1 2.5 2.8 1.3 4.0 0.2 2.1 4.2 14.7 0.5 48.9 35.8 5.3 3.6 2.2 4.9 4.0 1.9 0.0 5.7 4.9 1.2 1.3 1.0 3.3 0.2 4.0 0.4 2.4 0.1 9.3 15.9 1.8 1.2 4.4 0.9 2.6 6.4 3.2 0.3 4.9 0.8 1.5 3.7 3.1 3.5 1.4 2.4 3.3 0.2 4.0 0.0 0.4 3.3 1.5 0.4 1.6 5.4 5.2 3.2 1.9 3.4 9.5 7.5 0.3 2.7 0.7 13.6 2.2 1.6 12.5 14.6 10.6 18.5 13.4 10.8 20.8 10.1 21.4 14.5 6.0 10.3 3.9 48.9 0.0 5.2 0.0 15.3 4.0 10.3 27.9 2.0 2.2 5.0 22.3 30.3 45.0 26.9 0.0 24.7 9.6 32.8 109.6 25.6 50.5 11.0 1.6 1.2 254.8 14.9 19.1 203.1 3.6 0.0 7.2 23.2 14.3 28.1 29.4 83.1 24.5 4.8 58.2 0.0 47.0 18.1 0.0 4.1 4.3 14.9 41.0 PLPP2 "LPP2, PAP-2c, PPAP2C" ENSG00000141934 "Phospholipid phosphatase 2" O43688 19 281040-291504 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 188.5;Ciliated cells: 167.3;Ductal cells: 295.2;Rod photoreceptor cells: 190.0;Urothelial cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.4;MAIT T-cell: 9.4" "Lineage enriched" "Detected in single" 52 "T-cells: 9.4" "Cell line enhanced" "Detected in many" "A549: 34.1;CAPAN-2: 37.1;OE19: 63.6" "Low region specificity" "Detected in many" HPA055540 Uncertain Approved Mitochondria NA NA Mitochondria "HPA055540: AB_2682839" "prognostic unfavorable (4.55e-4)" "unprognostic (8.91e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.21e-8)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.83e-3)" "unprognostic (5.48e-2)" "unprognostic (1.59e-1)" "unprognostic (5.67e-2)" "unprognostic (1.18e-3)" "unprognostic (3.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-3)" 1.4 4.7 8.3 5.3 20.9 0.2 17.5 2.0 11.1 30.4 18.2 28.1 13.4 27.5 7.7 4.1 9.1 38.1 31.2 1.5 13.6 7.1 4.7 1.1 3.7 0.8 37.1 6.5 2.4 19.8 0.6 4.1 1.8 16.6 10.7 15.3 6.7 45.8 19.0 0.3 19.0 21.9 3.3 26.0 1.4 22.2 2.2 25.8 0.7 2.2 5.9 5.0 12.1 5.7 0.0 0.1 0.1 0.0 0.0 9.4 0.3 20.0 34.1 0.5 0.0 0.0 0.1 0.0 2.0 0.0 6.3 4.9 9.8 37.1 0.0 21.9 2.9 0.0 11.1 0.0 4.4 2.9 0.2 0.6 0.0 13.7 0.0 7.6 0.0 1.3 1.3 1.9 3.2 4.3 13.9 1.0 0.0 0.1 0.0 0.0 22.8 0.1 0.0 15.2 63.6 0.0 0.0 0.0 0.5 16.0 3.2 4.3 10.2 5.6 9.4 14.7 1.5 12.3 0.6 1.1 13.9 9.2 0.1 14.8 0.1 23.3 16.5 3.9 0.0 11.4 0.0 0.0 0.0 4.4 0.0 9.4 0.0 2.0 2.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 8.3 20.9 2.0 11.1 13.6 7.1 37.1 6.5 16.6 25.8 6.0 6.9 0.0 113.1 0.0 17.7 0.0 188.5 167.3 64.8 21.0 9.8 0.2 3.3 295.2 0.2 3.3 108.1 0.0 125.6 5.1 0.0 71.8 1.1 0.4 0.9 15.9 8.2 0.0 1.3 1.4 0.0 1.3 0.0 4.6 39.9 12.1 100.4 109.1 0.0 1.0 190.0 0.0 0.0 0.3 28.1 0.0 0.7 0.0 113.0 167.4 PLPP3 "LPP3, PAP-2b, PPAP2B" ENSG00000162407 "Phospholipid phosphatase 3" O14495 1 56494747-56645301 "Enzymes, Plasma proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Ito cells: 854.4;Leydig cells: 1011.7;Peritubular cells: 374.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 168.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 5.4;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 7 "B-cells: 5.4" "Cell line enhanced" "Detected in many" "ASC diff: 105.3;ASC TERT1: 52.6;HSkMC: 65.0;U-2197: 95.5" "HPA028892, HPA072751" Uncertain Supported "Golgi apparatus" NA Yes "Golgi apparatus" "HPA028892: AB_10602149, HPA072751: AB_2686555" "unprognostic (2.50e-2)" "unprognostic (3.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.65e-1)" "unprognostic (2.71e-1)" "unprognostic (2.22e-3)" "unprognostic (5.86e-3)" "unprognostic (7.25e-2)" "unprognostic (1.59e-1)" "unprognostic (3.75e-2)" "unprognostic (3.91e-2)" "unprognostic (3.08e-1)" "prognostic favorable (4.59e-4)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (3.54e-2)" "unprognostic (2.09e-1)" 46.4 17.2 29.0 10.8 30.7 4.2 39.1 13.5 27.5 102.7 15.5 33.8 22.1 8.1 32.7 36.9 20.8 36.7 24.0 23.3 39.9 13.5 30.2 57.7 24.3 6.7 19.2 30.1 27.9 12.2 30.7 7.2 70.9 20.0 37.7 14.4 34.7 22.4 58.7 16.6 24.4 12.5 32.9 16.5 7.9 18.7 23.4 29.7 5.2 107.1 19.4 6.7 35.8 44.0 5.4 0.0 0.8 0.3 0.0 0.0 0.2 0.4 1.5 2.0 0.2 105.3 52.6 5.0 5.5 5.6 5.1 2.5 4.4 0.8 0.7 0.6 8.3 5.7 0.8 0.3 0.1 1.0 0.0 1.3 0.1 0.6 6.1 2.5 0.0 0.0 65.0 0.4 4.9 4.1 3.6 4.8 0.0 0.4 0.0 5.5 0.4 0.0 0.0 6.2 1.2 6.1 0.0 0.0 0.2 0.8 4.6 0.0 4.1 1.7 2.3 0.5 6.4 0.7 0.0 3.0 25.8 2.1 95.5 0.2 0.0 0.0 0.0 4.5 0.2 1.8 0.0 0.3 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 4.5 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.2 29.0 30.7 13.5 27.5 39.9 13.5 19.2 30.1 20.0 29.7 23.8 20.5 11.5 20.0 0.0 3.2 0.0 56.0 8.1 23.9 21.0 0.0 102.0 18.3 16.0 5.7 50.7 10.7 23.3 7.9 10.3 54.5 13.7 3.5 84.4 36.2 0.0 2.4 854.4 45.1 12.0 1011.7 10.2 0.0 1.0 10.3 146.0 8.7 7.0 374.8 18.2 2.5 135.8 0.0 4.3 2.5 0.0 179.8 4.3 7.8 16.5 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120456954-120589855 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5;kidney: 12.6" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 12.7;Distal tubular cells: 6.6;Early spermatids: 7.1;Late spermatids: 7.9;Leydig cells: 17.8;Peritubular cells: 7.4;Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 62.8;U-251 MG: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA045188: AB_2679246" "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.6 1.7 11.4 1.2 13.6 4.9 3.1 11.6 18.2 3.4 1.2 12.1 1.0 0.7 1.7 2.7 0.9 1.2 11.3 0.7 15.9 17.4 12.6 2.8 0.5 0.6 15.5 6.0 0.6 0.6 0.4 0.5 0.6 26.5 3.0 0.8 0.0 2.0 6.1 0.4 1.7 0.8 1.5 19.1 0.5 1.2 11.1 12.5 0.0 1.5 0.0 0.5 0.8 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.8 1.7 1.0 0.0 1.0 0.0 0.0 8.0 6.3 0.1 0.7 0.1 0.9 1.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.0 62.8 6.5 0.0 0.7 1.6 0.7 0.0 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.0 3.3 0.0 0.6 0.1 0.5 0.0 0.5 3.5 1.4 0.0 9.0 7.2 4.0 0.3 34.8 0.0 0.0 0.0 6.6 0.0 1.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.6 11.6 10.0 15.9 17.4 15.5 6.0 26.5 12.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 12.7 0.0 0.0 3.5 0.0 0.0 6.6 0.0 7.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 2.5 0.0 7.9 17.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 7.4 7.6 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.3 PLPP5 "DPPL1, HTPAP, PPAPDC1B" ENSG00000147535 "Phospholipid phosphatase 5" Q8NEB5 8 38263130-38269243 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 77.8" "Cell type enhanced" "Detected in many" 4 "Glandular cells: 138.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "memory B-cell: 37.2;naive B-cell: 65.4" "Lineage enriched" "Detected in all" 5 "B-cells: 65.4" "Cell line enhanced" "Detected in many" "RPMI-8226: 51.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055777 Approved Vesicles NA NA Vesicles "HPA055777: AB_2682915" "unprognostic (4.54e-2)" "unprognostic (2.51e-3)" "unprognostic (3.66e-2)" "prognostic favorable (1.48e-5)" "unprognostic (1.80e-2)" "unprognostic (1.27e-2)" "unprognostic (5.58e-2)" "prognostic favorable (8.72e-5)" "unprognostic (9.79e-2)" "prognostic favorable (2.42e-5)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "prognostic unfavorable (8.33e-10)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (1.57e-2)" 5.5 9.3 6.9 11.9 7.9 4.8 8.8 7.5 6.7 11.2 11.5 3.9 33.9 14.4 5.7 30.9 6.6 10.2 21.0 4.6 6.1 6.1 9.6 20.3 7.5 12.0 4.5 5.1 8.4 77.8 4.2 29.9 8.3 6.7 27.9 12.8 16.2 52.0 36.5 2.3 4.7 18.4 5.2 3.5 12.8 16.1 4.6 4.4 3.8 11.9 5.0 14.8 8.0 6.7 65.4 5.3 13.3 3.6 4.3 5.0 3.7 5.5 11.1 6.6 13.5 13.0 12.7 9.1 15.8 19.9 8.1 10.6 5.1 8.5 0.4 13.5 16.3 11.7 6.2 5.4 11.5 6.9 3.5 3.5 9.8 4.7 14.8 22.1 2.8 11.8 9.9 12.0 11.2 14.8 14.3 13.1 13.1 0.4 25.5 9.8 11.4 6.3 4.7 10.0 22.5 3.8 6.9 4.9 51.3 20.2 7.2 5.2 8.0 6.5 10.1 9.2 6.1 21.6 5.5 7.8 5.7 5.0 9.6 4.1 15.8 10.4 1.6 15.8 7.5 9.8 13.3 2.7 4.5 3.0 2.7 5.0 37.2 3.9 3.8 2.5 65.4 2.0 1.9 1.6 4.3 3.6 5.3 3.4 3.7 6.9 7.9 7.5 6.7 6.1 6.1 4.5 5.1 6.7 4.4 8.9 44.0 74.7 61.1 0.0 5.3 0.0 38.2 101.7 39.8 71.5 15.7 39.2 36.5 59.1 22.7 13.5 17.2 0.0 78.1 37.8 35.3 138.3 29.1 20.7 32.8 58.8 43.3 16.5 9.1 6.2 16.4 24.8 0.0 10.0 73.6 37.6 56.5 36.8 8.9 20.3 3.5 12.9 0.0 24.7 4.3 0.0 73.7 17.0 51.4 46.1 PLPP6 "FLJ46512, FLJ90191, PDP1, PPAPDC2" ENSG00000205808 "Phospholipid phosphatase 6" Q8IY26 9 4662315-4665258 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 74.5;Late spermatids: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HDLM-2: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018096 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA018096: AB_1855609" "unprognostic (2.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.03e-1)" "unprognostic (4.36e-3)" "unprognostic (1.17e-1)" "unprognostic (4.38e-2)" "unprognostic (6.95e-3)" "unprognostic (1.33e-1)" "unprognostic (5.26e-2)" "unprognostic (9.06e-2)" "unprognostic (2.20e-2)" "unprognostic (1.45e-1)" "prognostic favorable (3.99e-4)" "unprognostic (2.56e-1)" "unprognostic (2.28e-2)" "unprognostic (2.87e-2)" "unprognostic (5.88e-2)" 4.0 8.3 4.4 7.2 6.8 1.1 7.3 11.9 9.7 5.7 9.4 6.2 4.2 10.2 4.9 13.2 9.2 4.1 9.7 3.0 4.9 4.8 6.3 20.0 4.7 8.3 8.6 6.3 4.2 19.2 8.7 5.5 13.1 9.4 16.9 10.0 4.7 10.4 8.5 2.2 8.6 15.4 3.3 4.9 7.1 10.7 8.4 3.4 16.2 7.2 6.9 9.6 7.4 5.5 4.3 5.1 8.5 5.1 4.7 13.0 5.1 3.9 4.1 4.4 5.4 3.6 4.0 4.4 2.7 3.5 2.2 2.5 1.0 2.6 3.8 1.1 2.6 5.5 4.9 3.1 3.8 2.3 47.7 2.9 7.6 3.9 5.4 3.2 2.7 5.7 4.4 3.1 1.7 3.8 2.9 3.3 4.3 1.3 4.0 2.8 4.2 2.5 7.2 4.0 4.0 1.4 2.5 0.0 2.9 3.8 4.5 11.1 5.6 3.2 2.9 1.6 5.7 4.1 6.1 3.8 2.0 1.7 2.6 1.7 0.8 3.0 1.0 3.1 1.9 1.8 8.5 5.1 4.1 4.2 4.4 4.6 3.5 7.4 6.3 5.1 4.3 13.0 9.2 2.1 4.7 4.9 3.9 10.0 5.1 4.4 6.8 11.9 9.7 4.9 4.8 8.6 6.3 9.4 3.4 6.0 2.4 3.4 2.0 0.0 6.8 0.0 5.1 0.0 2.3 1.8 2.0 14.4 1.7 10.9 74.5 1.4 8.5 0.0 12.1 2.1 0.0 7.1 0.0 13.2 5.4 3.2 10.5 4.3 5.3 33.5 2.6 2.2 0.0 1.8 8.4 3.8 8.7 7.4 4.6 2.6 4.3 0.0 0.0 0.6 1.0 0.0 8.7 1.5 6.4 2.6 PLPP7 "C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3" ENSG00000160539 "Phospholipid phosphatase 7 (inactive)" Q8NBV4 9 131289459-131359022 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 29.0;skeletal muscle: 107.3" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 16.8;Horizontal cells: 7.9;Leydig cells: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 11.0;ASC diff: 11.6;ASC TERT1: 8.8;SCLC-21H: 11.3;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070252 Uncertain Approved Nucleoplasm,Vesicles No No Vesicles Nucleoplasm "HPA070252: AB_2686242" "unprognostic (2.19e-1)" "unprognostic (3.07e-1)" "unprognostic (3.07e-2)" "unprognostic (2.71e-1)" "unprognostic (8.78e-2)" "unprognostic (7.03e-2)" "unprognostic (1.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.65e-1)" "unprognostic (3.96e-3)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (3.69e-2)" "unprognostic (1.10e-2)" "unprognostic (7.85e-2)" "unprognostic (9.72e-3)" 3.6 3.7 3.3 1.7 4.6 1.2 2.8 7.7 8.2 2.3 3.2 4.6 0.0 1.5 2.5 3.1 2.5 2.0 2.3 29.0 3.6 3.9 1.9 1.1 1.5 1.3 3.7 4.2 3.9 1.8 1.1 1.7 1.4 3.7 2.6 1.3 2.0 1.6 2.6 107.3 1.3 1.6 2.9 3.2 1.7 1.4 2.2 3.2 0.0 1.2 22.6 1.2 2.1 1.6 1.3 4.6 0.0 5.2 2.3 0.5 1.9 0.0 0.0 2.2 11.0 11.6 8.8 2.3 1.7 1.2 0.3 0.0 0.0 0.0 0.0 0.3 4.4 2.5 0.0 0.2 0.0 0.1 0.0 1.9 0.0 0.1 3.5 2.9 0.0 0.0 3.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 11.3 8.7 0.0 0.1 0.0 0.3 0.3 2.7 0.1 0.1 0.8 0.5 0.0 0.0 0.4 0.0 1.9 0.0 1.7 0.0 5.2 0.0 0.0 3.3 0.0 1.0 0.0 0.0 4.6 1.3 0.4 0.5 0.0 2.3 2.8 2.0 0.0 1.9 3.3 4.6 7.7 8.2 3.6 3.9 3.7 4.2 3.7 3.2 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 1.8 2.0 0.0 1.7 0.0 0.9 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.5 7.9 0.0 1.8 0.8 1.3 4.6 0.4 0.0 0.0 0.0 2.3 0.4 0.0 3.5 1.9 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLPPR1 "FLJ20300, LPPR1, MGC26189, PRG-3" ENSG00000148123 "Phospholipid phosphatase related 1" Q8TBJ4 9 101028709-101325135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 38.5;kidney: 24.4" "Group enriched" "Detected in some" 4 "Distal tubular cells: 31.5;Proximal tubular cells: 27.8" "Group enriched" "Detected in some" 5 "glioma: 11.1;liver cancer: 5.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Hep G2: 5.8;SCLC-21H: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014760, HPA014968, HPA014979" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130" "unprognostic (1.08e-2)" "unprognostic (2.79e-1)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (7.33e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.37e-4)" "unprognostic (2.09e-1)" "unprognostic (1.14e-1)" "unprognostic (9.86e-4)" "unprognostic (1.44e-1)" "unprognostic (1.65e-6)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (4.83e-2)" 0.8 0.9 12.6 0.7 38.5 0.7 1.4 1.7 24.4 1.0 0.9 7.6 0.0 0.8 0.8 5.2 0.8 1.0 0.9 0.8 12.7 7.0 24.4 5.0 2.8 0.7 7.5 5.5 0.7 1.1 0.7 0.1 0.8 5.3 1.0 1.0 0.1 1.1 0.8 0.8 0.8 0.8 0.8 10.2 0.7 0.9 1.5 9.3 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.9 10.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 38.5 1.7 6.4 12.7 7.0 7.5 5.5 5.3 9.3 0.0 4.6 0.0 0.0 0.0 2.2 0.0 2.5 0.0 1.2 0.0 0.0 0.0 31.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.4 0.1 0.0 1.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 27.8 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PLPPR2 "LPPR2, PRG-4" ENSG00000105520 "Phospholipid phosphatase related 2" Q96GM1 19 11355386-11365698 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 32.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 32.3" "Cell line enhanced" "Detected in many" "U-2197: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048973 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA048973: AB_2680580" "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.90e-1)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (7.10e-2)" "unprognostic (1.37e-1)" "unprognostic (9.60e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.82e-4)" "unprognostic (2.23e-1)" "prognostic unfavorable (7.46e-11)" "unprognostic (1.99e-2)" "unprognostic (1.46e-1)" "unprognostic (4.37e-2)" "unprognostic (1.17e-1)" 12.0 17.1 32.5 10.5 39.9 14.1 6.6 17.7 51.2 14.0 11.1 10.8 5.1 6.0 12.7 8.4 8.4 9.7 13.7 10.4 37.0 22.3 5.5 18.0 10.0 5.4 11.8 17.9 15.2 12.4 11.7 22.7 11.5 12.3 18.5 5.1 11.8 13.1 15.1 23.1 16.2 5.7 16.8 10.5 10.6 9.3 7.6 9.4 0.5 7.7 4.4 3.3 9.8 8.1 0.0 2.9 32.3 7.2 0.0 0.3 2.3 8.8 5.5 3.0 12.6 12.8 12.3 0.8 15.8 14.7 9.8 10.1 1.0 1.6 1.7 9.4 20.1 2.0 1.6 1.7 4.7 5.3 4.6 3.2 0.5 3.8 1.0 6.7 0.5 18.0 11.0 8.6 8.4 1.6 14.2 6.6 2.8 8.5 14.1 8.2 13.1 0.2 2.4 3.3 3.0 30.7 0.2 0.4 4.8 4.6 4.2 3.3 10.9 6.6 5.7 3.3 1.0 8.2 11.3 7.6 22.2 4.7 37.5 8.3 8.8 5.4 0.6 21.6 8.1 8.7 0.8 7.2 3.7 0.3 6.7 0.0 0.0 0.1 0.0 2.9 0.0 0.1 0.0 32.3 0.0 4.4 0.1 0.3 2.3 32.5 39.9 17.7 51.2 37.0 22.3 11.8 17.9 12.3 9.4 6.0 8.8 0.5 5.5 0.0 5.1 0.0 7.6 2.7 2.3 3.5 11.8 0.5 1.7 6.2 11.0 6.9 0.0 0.0 7.6 2.1 2.1 16.2 2.3 6.7 4.0 7.9 16.4 8.0 9.7 8.2 13.3 3.9 0.0 0.0 2.5 15.3 7.5 0.0 15.6 1.3 6.3 6.5 0.0 1.8 4.9 0.0 2.4 0.0 0.8 4.1 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821977 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6" "Cell type enhanced" "Detected in single" 21 "Horizontal cells: 1.6" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Group enriched" "Detected in some" 6 "NB-4: 24.1;THP-1: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: AB_2681787, HPA057034: AB_2683316" "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.7 0.7 20.5 1.2 30.0 18.2 2.1 0.1 21.3 0.9 0.7 0.7 0.0 0.7 1.3 0.7 0.7 12.6 1.1 0.7 14.4 13.1 0.7 0.7 2.6 0.9 3.9 14.9 1.0 0.7 0.7 0.1 0.8 4.7 0.9 0.7 0.1 0.7 0.8 0.9 0.8 1.0 0.7 1.1 0.9 0.9 3.0 3.1 0.0 0.7 0.0 0.7 0.8 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 5.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.0 0.1 0.9 0.0 0.0 0.0 2.1 0.0 0.6 0.0 0.2 1.7 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.4 0.0 24.1 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.1 0.0 0.0 2.7 2.2 51.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 3.9 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 30.0 0.1 21.3 14.4 13.1 3.9 14.9 4.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 PLPPR4 "KIAA0455, LPPR4, PHP1, PRG-1" ENSG00000117600 "Phospholipid phosphatase related 4" Q7Z2D5 1 99263953-99309590 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 55.3" "Group enriched" "Detected in some" 5 "Horizontal cells: 28.6;Muller glia cells: 25.5" "Cancer enhanced" "Detected in many" "glioma: 7.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "non-classical monocyte: 2.1" "Lineage enriched" "Detected in single" 22 "monocytes: 2.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 20.3;BJ hTERT+ SV40 Large T+ RasG12V: 7.9;fHDF/TERT166: 6.8;SH-SY5Y: 15.3;U-138 MG: 7.6;U-87 MG: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.32e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-2)" "unprognostic (1.67e-2)" "unprognostic (2.95e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-2)" "unprognostic (9.09e-2)" "unprognostic (9.70e-3)" "unprognostic (3.36e-2)" "unprognostic (2.21e-1)" "unprognostic (7.25e-12)" "unprognostic (1.67e-5)" "unprognostic (3.47e-1)" "unprognostic (1.34e-2)" "unprognostic (1.16e-3)" 3.0 1.7 25.1 1.2 25.8 0.8 1.8 2.0 55.3 4.6 1.5 2.6 0.0 1.2 1.7 1.7 3.2 1.3 6.0 1.4 39.2 10.8 1.4 0.8 3.5 1.5 5.2 16.7 0.8 1.5 1.7 9.0 1.9 6.1 1.1 1.9 0.6 1.4 1.3 1.2 4.6 1.5 2.1 2.2 1.3 1.1 5.2 2.7 0.0 1.5 0.4 1.7 7.0 1.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.3 0.0 0.0 3.9 20.3 4.5 7.9 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.1 0.0 0.0 0.0 12.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 25.1 25.8 2.0 33.8 39.2 10.8 5.2 16.7 6.1 2.7 0.0 1.1 0.0 0.0 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.6 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 25.5 0.0 0.0 1.4 0.6 4.3 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 PLPPR5 "LPPR5, PAP2, PAP2D, PRG5" ENSG00000117598 "Phospholipid phosphatase related 5" Q32ZL2 1 98890245-99005032 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 18.6;testis: 5.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 7.2;Horizontal cells: 3.2" "Group enriched" "Detected in some" 13 "glioma: 2.7;renal cancer: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "PC-3: 12.3;SH-SY5Y: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018072, HPA059085" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA018072: AB_1854958, HPA059085: AB_2732631" "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.22e-4)" "unprognostic (1.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" 0.5 1.8 7.8 0.7 8.7 0.5 0.5 0.8 18.6 1.4 0.6 2.1 0.0 0.7 0.7 0.5 0.6 0.5 0.6 0.5 8.0 6.6 0.7 0.5 0.7 0.5 2.5 4.5 0.6 1.6 0.5 0.3 0.5 3.6 0.6 0.8 1.8 0.5 1.0 0.9 0.6 0.7 0.6 1.0 0.5 0.7 5.5 1.8 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 12.3 0.0 0.0 0.0 0.5 0.1 0.4 22.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 8.7 0.8 11.6 8.0 6.6 2.5 4.5 3.6 1.8 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.7 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 PLVAP "FELS, gp68, PV-1, PV1" ENSG00000130300 "Plasmalemma vesicle associated protein" Q9BX97 19 17351448-17377350 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.3" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 20.4;Endothelial cells: 32.1;Ito cells: 41.7;Melanocytes: 21.9;Suprabasal keratinocytes: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 22.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 22.1" "Cell line enriched" "Detected in some" 28 "EFO-21: 112.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA002279 Supported Approved "Plasma membrane,Centrosome,Cytosol" NA NA 53000 Cytosol "Plasma membrane, Centrosome" "HPA002279: AB_1079636" "unprognostic (3.19e-1)" "unprognostic (8.22e-2)" "unprognostic (7.87e-2)" "unprognostic (2.38e-2)" "unprognostic (1.93e-2)" "unprognostic (2.49e-3)" "unprognostic (4.17e-3)" "unprognostic (1.01e-1)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" "unprognostic (8.96e-2)" "unprognostic (4.24e-3)" "unprognostic (4.70e-3)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (8.17e-2)" 128.3 9.8 0.8 16.4 0.9 0.0 56.3 0.4 1.5 28.7 29.8 3.2 12.8 20.2 32.0 19.8 27.4 16.6 43.1 18.9 1.1 0.4 33.7 4.6 13.1 34.6 0.9 0.5 14.3 22.9 13.8 16.1 12.6 2.7 26.1 5.2 26.3 16.0 10.4 20.7 11.5 23.7 13.5 1.2 77.8 22.1 9.5 0.7 3.8 88.3 13.9 15.2 30.1 87.7 0.0 22.1 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.0 0.0 0.4 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 22.1 0.0 0.3 0.8 0.9 0.4 1.5 1.1 0.4 0.9 0.5 2.7 0.7 6.0 0.0 0.0 0.7 20.4 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.7 32.1 0.0 0.0 2.3 0.1 5.6 1.4 0.0 0.0 1.4 0.0 0.0 41.7 2.7 0.6 0.0 3.8 21.9 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 10.8 0.4 0.4 14.6 0.1 0.0 0.0 1.7 PLXDC1 "TEM3, TEM7" ENSG00000161381 "Plexin domain containing 1" Q8IUK5 17 39063303-39154394 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Bipolar cells: 313.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 13.2;MOLT-4: 4.1;U-87 MG: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012805 Approved "Intracellular and membrane" NA NA 6000000 "HPA012805: AB_1857893" "unprognostic (4.28e-1)" "unprognostic (3.55e-1)" "unprognostic (2.56e-2)" "unprognostic (2.15e-1)" "unprognostic (9.50e-2)" "unprognostic (1.13e-2)" "unprognostic (2.35e-2)" "unprognostic (2.23e-2)" "unprognostic (4.07e-3)" "unprognostic (6.07e-3)" "unprognostic (4.62e-3)" "unprognostic (8.69e-2)" "prognostic unfavorable (9.15e-8)" "unprognostic (9.37e-3)" "unprognostic (1.72e-2)" "unprognostic (2.42e-1)" "unprognostic (2.33e-2)" 6.1 3.5 6.6 5.7 13.8 1.4 10.0 13.3 13.8 6.9 5.1 5.0 5.9 2.4 15.1 7.8 14.6 10.4 17.1 18.4 7.6 6.3 3.7 1.0 5.0 6.0 7.8 6.3 18.2 4.3 1.3 3.1 2.7 7.5 5.2 3.7 19.7 4.0 6.6 8.4 5.1 5.0 13.2 3.7 2.3 4.5 6.0 4.8 27.8 3.4 10.5 10.8 5.9 5.2 0.3 2.0 1.0 0.3 2.2 4.9 1.6 0.1 0.0 0.2 2.1 0.4 0.0 0.3 0.2 13.2 1.0 0.6 0.2 3.1 0.2 0.3 0.4 0.1 0.3 0.3 0.2 0.7 0.1 1.1 0.4 1.0 0.1 0.3 0.5 0.1 0.5 0.2 0.5 0.1 0.2 0.0 1.3 0.1 0.9 0.1 1.5 4.1 0.4 0.5 0.1 0.0 0.5 0.7 0.5 0.0 0.1 2.1 0.2 0.1 0.3 0.0 0.3 0.3 0.3 0.0 1.6 0.9 0.6 0.3 0.2 0.1 0.2 8.6 0.6 0.2 0.5 0.3 0.2 3.8 0.1 3.3 0.2 1.3 1.4 0.0 0.3 4.9 4.9 1.0 2.2 0.1 2.0 0.1 1.6 6.6 13.8 13.3 13.8 7.6 6.3 7.8 6.3 7.5 4.8 0.0 12.2 0.0 0.8 4.6 313.9 3.2 0.0 2.7 3.4 0.0 19.6 0.1 0.0 0.0 1.8 3.4 0.0 0.0 0.2 0.1 12.1 0.8 1.1 0.0 0.1 6.4 0.0 0.6 1.0 5.5 0.6 3.5 6.8 8.2 0.0 12.0 0.1 0.0 1.1 0.0 23.0 45.3 22.1 0.5 0.6 3.9 0.0 4.3 0.0 0.4 PLXDC2 "FLJ14623, TEM7R" ENSG00000120594 "Plexin domain containing 2" Q6UX71 10 19816239-20289856 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 92.7;Ito cells: 94.5;Kupffer cells: 87.5;Macrophages: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 21.2;intermediate monocyte: 12.6;myeloid DC: 13.3;neutrophil: 31.4;non-classical monocyte: 12.7" "Group enriched" "Detected in many" 14 "dendritic cells: 13.3;granulocytes: 31.4;monocytes: 21.2" "Cell line enhanced" "Detected in some" "HHSteC: 12.7;U-2197: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017268, HPA070793" Approved Supported "Nuclear bodies" No No 560000000 "Nuclear bodies" "HPA017268: AB_10965928, HPA070793: AB_2686313" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (3.05e-1)" "unprognostic (3.31e-2)" "unprognostic (2.99e-1)" "unprognostic (1.94e-2)" "unprognostic (1.57e-1)" "unprognostic (5.32e-2)" "unprognostic (7.52e-2)" "unprognostic (1.89e-1)" "unprognostic (1.35e-1)" "unprognostic (5.44e-2)" "unprognostic (3.91e-3)" "unprognostic (8.71e-2)" "unprognostic (3.35e-1)" "unprognostic (2.66e-2)" 31.7 13.1 15.9 8.2 20.6 5.5 25.5 3.8 12.4 14.5 9.1 17.9 11.5 4.9 14.2 9.2 11.1 11.5 20.4 14.5 16.8 8.3 12.9 3.9 21.9 5.4 26.1 9.6 11.3 4.2 17.0 5.6 5.5 16.7 10.3 5.7 8.7 9.8 9.7 6.1 21.1 8.0 18.0 27.7 10.5 6.0 7.8 22.7 0.4 10.5 12.3 3.6 11.9 17.7 0.0 13.3 31.4 21.2 1.5 1.1 5.4 0.0 0.0 3.4 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 1.4 1.1 0.0 0.0 0.5 1.8 5.4 0.3 12.7 0.0 0.0 4.3 0.3 0.0 1.5 5.6 0.0 0.0 0.1 1.2 0.6 0.7 0.3 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.1 1.4 0.2 0.0 1.2 0.5 0.6 0.0 5.0 2.7 29.9 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.0 21.2 4.1 0.5 12.6 1.1 0.0 0.0 0.1 13.3 0.0 0.0 0.0 31.4 1.5 12.7 0.6 0.0 5.4 15.9 20.6 3.8 12.4 16.8 8.3 26.1 9.6 16.7 22.7 14.9 9.9 11.0 20.8 32.6 32.3 8.5 20.4 4.0 13.6 5.2 7.9 1.0 0.0 5.5 2.0 30.8 6.6 0.0 0.0 7.7 34.8 7.3 30.1 2.5 92.7 1.6 2.9 94.5 87.5 0.7 17.8 96.7 6.8 34.3 22.7 23.8 1.1 15.8 53.7 21.6 65.0 19.4 3.9 1.4 0.9 33.2 1.0 3.2 7.1 13.2 PLXNA1 "NOV, PLXN1" ENSG00000114554 "Plexin A1" Q9UIW2 3 126988594-127037392 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007499, CAB012483" Uncertain Supported Nucleoplasm,Cytosol NA NA 2600000 Nucleoplasm Cytosol "CAB012483: , HPA007499: AB_1079637" "unprognostic (1.87e-1)" "unprognostic (1.11e-1)" "unprognostic (4.38e-2)" "unprognostic (1.19e-2)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "prognostic unfavorable (4.13e-6)" "unprognostic (1.79e-2)" "unprognostic (9.06e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (3.77e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (5.64e-5)" "unprognostic (4.50e-3)" "unprognostic (7.62e-3)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 4.6 2.1 4.4 3.8 2.5 0.0 3.1 5.2 9.3 3.6 2.5 2.5 2.5 1.6 3.8 5.2 3.7 3.3 2.7 10.2 6.2 5.3 2.5 5.3 6.3 3.1 2.9 5.0 5.0 4.9 18.7 2.5 4.9 3.9 3.7 0.7 2.5 7.9 4.1 5.6 8.8 2.5 2.9 2.5 5.6 2.3 5.2 2.5 2.5 3.2 2.5 2.5 3.5 12.6 0.6 0.0 0.0 0.9 0.0 1.1 0.5 18.0 8.6 9.5 7.5 12.6 14.1 15.2 10.8 9.2 6.2 6.2 28.5 8.5 2.0 16.3 11.6 8.4 28.0 4.9 21.2 2.6 2.9 7.7 0.2 5.0 7.3 8.3 2.1 1.5 14.1 14.9 11.5 9.0 6.3 3.1 6.1 10.4 3.8 6.6 10.6 4.2 4.0 9.2 5.7 7.7 5.6 24.4 5.6 5.4 36.5 8.5 9.3 7.8 7.5 10.3 6.5 12.0 13.7 11.4 10.0 12.9 18.2 11.3 2.3 1.5 3.9 14.3 4.1 10.5 0.0 0.0 0.0 0.7 0.1 1.1 0.5 0.6 0.3 0.0 0.6 0.3 0.4 0.0 0.0 0.9 0.0 0.8 0.5 4.4 2.5 5.2 9.3 6.2 5.3 2.9 5.0 3.9 2.5 44.7 2.6 1.5 4.5 14.1 3.8 10.9 2.5 5.3 18.2 12.2 3.9 16.8 0.0 7.4 1.2 4.3 5.1 0.0 6.0 2.1 11.4 4.7 0.0 1.0 11.3 19.1 9.2 2.5 5.6 0.8 7.2 2.8 8.5 1.8 4.5 2.4 12.9 2.9 6.0 1.1 2.9 6.5 9.5 6.3 9.2 14.1 6.1 0.0 3.9 5.0 PLXNA2 "FLJ11751, FLJ30634, KIAA0463, OCT, PLXN2" ENSG00000076356 "Plexin A2" O75051 1 208022242-208244320 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 39.9" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 235.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 18.8;HaCaT: 19.3;HUVEC TERT2: 24.6;TIME: 56.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009763 Approved NA NA 580000 "CAB009763: AB_2166388" "unprognostic (8.25e-2)" "unprognostic (3.91e-2)" "unprognostic (8.85e-2)" "unprognostic (2.77e-2)" "unprognostic (8.66e-2)" "unprognostic (2.07e-1)" "unprognostic (1.97e-2)" "unprognostic (4.84e-2)" "unprognostic (6.88e-3)" "unprognostic (7.06e-2)" "unprognostic (2.61e-1)" "unprognostic (8.41e-2)" "unprognostic (4.49e-3)" "unprognostic (1.26e-1)" "unprognostic (5.40e-2)" "unprognostic (1.27e-2)" "unprognostic (2.40e-1)" 7.2 2.4 8.3 2.9 11.8 1.0 3.9 27.5 14.7 4.7 10.5 2.5 2.0 8.2 5.4 3.0 13.2 4.6 7.0 6.0 9.7 4.0 4.3 2.7 12.0 1.6 3.7 10.9 16.9 39.9 2.0 2.8 10.2 6.7 4.2 8.8 5.7 3.7 4.5 7.6 10.8 9.0 12.0 2.9 1.7 11.0 1.2 3.9 0.4 7.2 4.7 4.4 8.3 9.1 0.2 0.7 1.1 0.7 0.0 0.4 0.2 2.1 1.3 2.4 0.3 2.7 5.4 18.8 1.7 1.1 1.0 0.1 0.0 0.0 0.0 3.5 1.3 0.4 19.3 0.0 10.9 0.3 0.6 0.3 0.0 2.3 1.2 1.1 0.0 0.0 1.4 3.5 0.8 5.1 0.7 24.6 0.0 0.0 0.0 10.7 0.2 0.0 0.0 0.3 3.8 3.3 0.0 2.5 1.6 2.0 1.3 0.7 4.4 2.0 1.6 2.0 4.9 0.1 0.0 56.5 0.4 0.6 2.0 3.5 0.1 0.0 0.0 2.3 0.0 0.9 0.0 0.7 1.1 0.2 0.2 0.3 0.0 0.0 0.2 0.7 0.2 0.0 0.4 1.0 0.0 0.3 0.0 0.0 0.2 8.3 11.8 27.5 14.7 9.7 4.0 3.7 10.9 6.7 3.9 26.8 25.8 2.0 10.2 4.2 1.0 3.9 10.2 12.0 39.8 0.0 2.0 5.0 1.7 3.6 0.6 31.8 40.9 0.0 13.3 2.1 9.8 4.5 5.8 4.9 2.5 235.2 8.7 29.4 3.5 0.0 9.2 2.2 5.0 1.0 27.3 0.3 17.0 37.7 6.3 1.1 2.5 6.5 5.9 0.6 0.6 9.3 1.6 1.0 24.2 22.6 PLXNA4 "DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B" ENSG00000221866 "Plexin A4" Q9HCM2 7 132123332-132648688 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.2;breast: 34.7" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 9.9;Cardiomyocytes: 9.5;Collecting duct cells: 12.2;Cone photoreceptor cells: 15.7;Early spermatids: 9.9;Leydig cells: 13.0;Muller glia cells: 10.0" "Cancer enhanced" "Detected in many" "glioma: 3.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 6.1" "Cell line enhanced" "Detected in some" "ASC diff: 15.0;HMC-1: 10.0;hTERT-RPE1: 12.9;RH-30: 10.7;TIME: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029919, HPA052141, HPA075592" Approved Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA029919: AB_10671093, HPA052141: AB_2681745, HPA075592: AB_2732297" "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.61e-6)" "unprognostic (5.76e-2)" "unprognostic (1.21e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-2)" "unprognostic (2.19e-1)" "unprognostic (7.99e-2)" "unprognostic (7.64e-2)" "unprognostic (1.14e-1)" "unprognostic (1.69e-5)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" "unprognostic (5.90e-2)" "unprognostic (1.42e-3)" 23.2 5.1 8.7 3.5 9.0 1.1 34.7 3.9 15.1 16.2 2.0 1.0 0.8 1.5 2.3 1.0 7.7 3.0 4.2 6.9 9.7 7.2 2.0 1.3 1.8 2.5 4.0 6.6 6.2 1.0 1.0 1.6 6.7 6.6 1.4 2.1 0.7 1.2 2.4 1.7 4.1 1.4 5.1 1.5 2.4 2.8 2.4 1.8 0.0 3.3 0.0 1.3 2.1 9.4 0.0 6.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.1 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 10.0 0.1 0.0 0.0 0.0 12.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 10.7 1.1 0.0 0.0 0.2 5.6 0.0 0.0 0.0 0.1 0.0 0.0 32.6 3.3 0.1 0.7 0.2 0.0 0.0 0.0 3.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.0 6.1 0.0 0.0 8.7 9.0 3.9 15.1 9.7 7.2 4.0 6.6 6.6 1.8 0.0 0.0 0.0 0.1 0.6 9.9 9.5 0.0 0.0 0.0 12.2 15.7 0.0 0.0 0.0 9.9 0.7 0.0 0.0 0.0 0.1 5.4 0.2 1.1 0.0 0.1 0.0 1.2 1.8 0.0 5.9 13.0 0.0 6.8 0.0 0.0 10.0 0.4 0.0 6.7 0.3 1.4 0.0 1.4 0.2 0.1 1.1 0.0 0.0 0.0 0.5 PLXNC1 "CD232, VESPR" ENSG00000136040 "Plexin C1" O60486 12 94148723-94307675 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.5;retina: 40.6" "Cell type enhanced" "Detected in many" 14 "Kupffer cells: 41.4;Macrophages: 32.1;Melanocytes: 91.1" "Cancer enhanced" "Detected in all" "melanoma: 24.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.2" "Group enriched" "Detected in many" 4 "granulocytes: 14.2;monocytes: 6.7" "Cell line enhanced" "Detected in many" "HAP1: 15.3;Karpas-707: 11.9;SK-MEL-30: 19.0;U-266/70: 30.1;U-266/84: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066899 Approved Mitochondria NA NA 82000 Mitochondria "HPA066899: AB_2685743" "unprognostic (1.49e-1)" "unprognostic (4.01e-2)" "unprognostic (5.60e-2)" "unprognostic (1.99e-1)" "unprognostic (2.33e-1)" "unprognostic (3.24e-2)" "unprognostic (4.67e-3)" "unprognostic (2.80e-2)" "unprognostic (3.49e-1)" "unprognostic (4.64e-2)" "unprognostic (1.78e-2)" "unprognostic (2.38e-1)" "unprognostic (4.02e-2)" "unprognostic (5.33e-3)" "unprognostic (3.19e-2)" "unprognostic (6.85e-3)" "unprognostic (5.48e-2)" 6.6 7.5 7.1 16.1 6.9 12.6 3.9 16.8 8.6 8.0 5.1 3.1 0.8 3.1 7.3 2.2 4.9 4.3 8.3 4.1 6.3 15.2 3.2 2.0 15.2 43.5 4.5 7.7 13.0 2.3 0.5 6.3 7.5 5.2 4.3 5.4 40.6 3.7 3.7 2.9 6.6 5.0 5.7 4.9 28.6 3.4 12.1 3.3 8.6 3.3 2.7 10.2 9.6 6.5 2.4 2.5 14.2 6.7 0.9 1.7 1.5 0.4 0.2 1.2 0.2 0.7 0.5 0.1 0.6 0.8 0.8 2.4 4.1 0.0 9.8 0.0 0.9 0.7 0.0 15.3 0.6 0.5 6.8 0.3 0.5 0.2 2.7 8.5 2.0 3.4 8.4 0.0 0.9 0.4 1.0 0.0 0.9 0.2 11.9 0.2 0.1 0.4 1.0 2.5 0.1 0.5 1.6 0.4 5.3 0.0 0.7 1.0 0.7 0.1 0.1 19.0 3.1 0.0 1.6 0.3 0.2 1.1 0.1 0.3 30.1 31.3 0.6 0.1 5.3 0.6 0.0 3.0 12.2 1.4 5.2 1.6 2.4 1.6 1.7 2.5 1.4 1.4 1.5 14.2 0.9 6.7 0.9 1.0 1.5 7.1 6.9 16.8 8.6 6.3 15.2 4.5 7.7 5.2 3.3 3.0 3.7 11.2 0.2 5.5 2.1 3.7 2.5 4.0 0.0 0.0 0.0 0.1 1.7 0.2 6.7 1.8 0.2 0.0 0.5 0.1 2.6 0.2 16.1 0.8 19.6 0.0 19.0 9.8 41.4 5.9 1.4 32.1 91.1 19.8 1.6 0.0 0.4 0.0 3.2 3.1 0.6 6.5 1.4 1.5 1.2 1.4 0.1 3.2 1.0 0.1 PLXND1 KIAA0620 ENSG00000004399 "Plexin D1" Q9Y4D7 3 129555175-129606818 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 69.9;Ito cells: 161.4;Kupffer cells: 82.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 11.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 71.9;HSkMC: 52.3;HUVEC TERT2: 61.2;TIME: 71.7" "Group enriched" "Detected in many" 6 "amygdala: 37.7;basal ganglia: 29.6;cerebral cortex: 27.0;hippocampal formation: 28.7" "Low region specificity" "Detected in many" CAB020819 Approved NA NA 58000000 "CAB020819: " "unprognostic (8.97e-3)" "unprognostic (1.95e-1)" "unprognostic (6.30e-2)" "unprognostic (8.35e-2)" "unprognostic (1.28e-2)" "unprognostic (3.00e-3)" "unprognostic (6.35e-2)" "unprognostic (4.51e-2)" "unprognostic (3.69e-1)" "unprognostic (3.02e-3)" "unprognostic (3.78e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (5.93e-7)" "unprognostic (1.30e-1)" "unprognostic (3.21e-2)" "unprognostic (3.17e-2)" "unprognostic (1.00e-2)" 35.3 13.5 10.8 17.4 19.5 11.0 47.9 2.7 14.3 31.7 9.7 18.5 7.2 3.0 21.1 16.2 10.9 20.0 19.6 25.8 9.3 8.2 16.2 14.5 33.0 37.0 25.9 7.2 10.5 8.4 11.9 7.2 54.6 14.4 11.2 8.7 31.9 8.2 14.2 10.4 9.5 11.6 26.1 19.1 22.1 9.4 7.0 17.4 28.6 18.0 14.4 11.2 19.1 16.8 0.0 3.9 0.1 11.7 2.8 7.6 1.5 1.6 10.1 8.4 2.8 71.9 31.0 17.4 7.4 21.8 4.6 5.3 2.3 1.4 0.3 32.1 26.6 2.3 0.1 4.5 0.1 1.3 0.3 0.5 6.9 5.1 10.5 8.2 2.2 1.9 52.3 0.3 4.7 0.5 6.6 61.2 0.3 2.4 0.2 6.1 5.3 0.4 7.5 2.0 0.4 1.4 8.1 5.7 8.6 1.8 0.4 4.9 0.2 1.8 0.6 2.8 20.2 2.7 10.3 71.7 3.8 5.2 0.1 5.5 0.3 0.3 3.3 1.3 5.0 3.3 0.0 11.7 0.0 1.9 5.3 7.6 0.0 1.4 1.5 3.0 0.0 0.0 0.2 0.1 2.8 4.9 3.9 0.0 1.5 10.8 19.5 2.7 14.3 9.3 8.2 25.9 7.2 14.4 17.4 3.0 25.6 9.3 0.2 7.1 0.0 5.3 10.2 1.4 2.3 0.0 0.0 6.1 0.0 1.6 1.0 55.4 0.0 0.0 3.1 13.2 18.4 0.4 21.9 2.5 69.9 0.0 12.6 161.4 82.1 0.7 35.9 27.3 8.5 23.4 2.2 6.0 2.6 0.0 13.1 0.2 0.0 32.3 22.6 0.4 3.8 3.9 4.5 10.2 0.4 0.4 PM20D1 "Cps1, FLJ32569" ENSG00000162877 "Peptidase M20 domain containing 1" Q6GTS8 1 205828022-205850132 "Enzymes, Predicted secreted proteins" "Hydrolase, Lyase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "pancreas: 103.5" "Group enriched" "Detected in some" 6 "Exocrine glandular cells: 18.7;Proximal tubular cells: 5.8" "Cancer enriched" "Detected in some" 32 "urothelial cancer: 30.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.5" "Lineage enriched" "Detected in single" 5 "T-cells: 4.5" "Cell line enriched" "Detected in single" 9 "Karpas-707: 6.6" "Low region specificity" "Detected in all" "Secreted to digestive system" NA NA 3000000 "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.30e-1)" "unprognostic (4.07e-2)" "unprognostic (4.83e-1)" "unprognostic (4.08e-3)" "unprognostic (1.17e-3)" "unprognostic (3.11e-1)" "unprognostic (1.20e-1)" "unprognostic (5.50e-2)" "unprognostic (5.81e-2)" "unprognostic (4.57e-2)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (1.68e-2)" 0.5 0.0 0.0 0.5 0.2 0.0 0.6 0.1 0.4 0.0 0.2 0.6 0.4 0.0 0.2 0.3 0.0 0.1 0.0 0.3 0.3 0.0 3.2 0.1 0.2 0.5 0.2 0.0 0.3 103.5 0.0 0.0 0.1 0.4 0.8 0.0 0.3 0.2 0.4 0.0 14.3 0.1 0.1 0.1 0.4 1.2 0.2 0.1 0.1 0.1 0.1 0.4 1.5 0.3 0.3 0.0 0.8 0.2 0.0 4.5 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.7 0.0 1.3 0.3 0.9 2.4 0.0 0.2 0.3 0.9 0.0 0.0 0.2 0.0 4.5 1.0 0.0 0.2 0.1 0.4 0.3 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.7 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 5.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PMCH MCH ENSG00000183395 "Pro-melanin concentrating hormone" P20382 12 102196459-102197845 "Predicted secreted proteins" "Differentiation, Spermatogenesis" "Developmental protein, Hormone, Neuropeptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 124.8" "Group enriched" "Detected in some" 5 "Exocrine glandular cells: 1.6;monocytes: 1.8" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.8" "Region enriched" "Detected in some" 27 "hypothalamus: 124.8" "Cell type enriched" "Detected in some" 8 "T-reg: 11.3" "Lineage enriched" "Detected in single" 81 "T-cells: 11.3" "Cell line enriched" "Detected in some" 8 "HDLM-2: 31.3" "Group enriched" "Detected in some" 131 "hypothalamus: 737.6;thalamus: 373.6" "Region enriched" "Detected in some" 30 "hypothalamus: 98.6" "HPA046055, HPA061884" Enhanced Supported "Secreted to blood" NA NA 274000 "HPA046055: AB_2679517, HPA061884: AB_2684632" "unprognostic (3.23e-3)" "unprognostic (8.04e-2)" "unprognostic (3.96e-4)" "unprognostic (2.09e-2)" "unprognostic (1.75e-1)" "unprognostic (7.73e-2)" "unprognostic (4.31e-3)" "unprognostic (1.43e-2)" "unprognostic (3.18e-3)" "unprognostic (4.51e-2)" "unprognostic (1.21e-1)" "unprognostic (2.16e-6)" "unprognostic (1.17e-2)" "unprognostic (1.93e-1)" "unprognostic (5.10e-2)" "unprognostic (3.53e-2)" 0.1 0.0 0.3 2.1 2.0 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 1.1 1.0 0.0 0.2 0.6 0.8 124.8 0.1 0.1 0.2 6.4 0.4 0.1 0.1 0.1 0.0 1.4 0.2 4.5 0.2 0.0 0.1 0.2 0.1 0.1 0.9 0.1 0.1 0.9 1.1 2.0 0.2 0.7 1.0 0.1 0.1 1.7 0.2 0.1 0.0 0.0 0.0 0.0 0.1 11.3 0.0 0.3 0.1 0.3 0.3 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.0 31.3 0.1 0.5 0.6 0.3 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.2 3.8 0.4 0.7 0.1 0.0 0.0 0.6 1.0 0.5 0.5 1.2 0.3 0.6 1.2 0.0 0.2 0.3 0.4 0.4 0.6 0.1 0.3 0.2 0.1 0.4 0.4 0.4 0.1 0.5 0.1 0.6 0.4 0.4 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.3 0.0 0.3 2.0 0.1 0.1 0.8 124.8 0.4 0.1 4.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 PMEL "D12S53E, gp100, Pmel17, SI, SIL, SILV" ENSG00000185664 "Premelanosome protein" P40967 12 55954105-55973317 "Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 230.1" "Cell type enriched" "Detected in many" 34 "Melanocytes: 1396.9" "Cancer enriched" "Detected in many" 500 "melanoma: 2481.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 66 "SK-MEL-30: 442.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031649 Enhanced Supported "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA 14000000 "Endoplasmic reticulum" "Golgi apparatus" "HPA031649: AB_2673976" "unprognostic (4.63e-1)" "unprognostic (8.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.60e-1)" "unprognostic (5.90e-2)" "unprognostic (6.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.46e-3)" "unprognostic (6.44e-2)" "unprognostic (1.21e-1)" "unprognostic (5.12e-2)" "unprognostic (3.98e-1)" "prognostic favorable (3.70e-4)" "unprognostic (2.86e-2)" "unprognostic (1.54e-1)" "unprognostic (7.60e-2)" "unprognostic (1.04e-1)" 0.9 0.1 0.4 0.4 0.5 0.4 3.4 0.4 0.5 38.2 1.0 0.4 0.5 0.4 11.8 0.4 0.4 0.2 0.6 0.5 0.4 0.0 0.6 1.8 0.7 1.9 0.4 0.4 1.6 0.6 0.9 0.4 0.9 0.4 0.5 0.2 230.1 1.1 0.4 0.6 46.8 0.6 1.3 0.8 0.4 0.2 1.5 0.4 0.4 0.4 0.6 0.6 0.5 0.8 1.3 2.3 2.1 1.4 0.2 1.9 0.6 0.7 0.0 0.2 0.0 4.5 0.0 6.6 0.0 0.0 0.1 0.1 0.6 0.3 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 442.3 0.2 0.2 0.4 0.0 0.0 0.3 0.0 0.4 0.1 0.5 0.1 0.0 0.1 0.0 0.0 1.4 0.7 0.3 0.0 1.9 1.3 0.5 0.4 0.0 0.9 1.1 0.1 2.1 0.2 0.4 2.3 0.4 0.6 0.4 0.5 0.4 0.5 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.3 0.0 0.6 40.8 0.0 0.2 2.5 0.0 2.3 0.0 0.0 8.0 0.0 1.3 6.7 0.6 1.3 0.0 2.0 12.0 2.4 0.7 0.0 2.4 1.5 0.0 0.0 0.0 0.3 4.1 11.2 0.3 1396.9 1.0 1.5 0.3 0.9 0.0 0.7 2.1 0.0 0.0 0.5 3.0 2.7 8.9 20.8 0.0 1.5 0.3 PMEPA1 "STAG1, TMEPAI" ENSG00000124225 "Prostate transmembrane protein, androgen induced 1" Q969W9 20 57648392-57711536 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Signal transduction inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 60.4;prostate: 67.3" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 306.3;Glandular cells: 287.7;Muller glia cells: 308.1;Pancreatic endocrine cells: 506.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "naive B-cell: 5.2;plasmacytoid DC: 18.4" "Group enriched" "Detected in many" 7 "B-cells: 5.2;dendritic cells: 18.4" "Cell line enhanced" "Detected in many" "SiHa: 40.4;U-2 OS: 26.3;U-251 MG: 92.9;WM-115: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072291 Supported Vesicles "Intracellular and membrane" NA NA Vesicles "HPA072291: AB_2686509" "unprognostic (2.72e-3)" "prognostic unfavorable (2.45e-4)" "unprognostic (5.77e-2)" "unprognostic (1.73e-1)" "unprognostic (6.61e-2)" "unprognostic (2.11e-3)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.73e-5)" "unprognostic (5.53e-1)" "unprognostic (1.32e-3)" "unprognostic (7.83e-3)" "unprognostic (2.02e-1)" "prognostic unfavorable (2.87e-7)" "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (9.87e-3)" "prognostic unfavorable (7.60e-4)" 27.0 7.8 7.5 10.6 34.8 1.3 9.5 2.6 12.6 60.4 10.8 11.0 4.2 4.4 22.1 6.7 7.1 7.7 21.8 10.7 7.5 8.6 5.3 1.7 8.5 4.5 10.2 5.9 6.2 18.6 2.6 5.6 3.0 12.1 67.3 5.7 21.3 11.6 13.3 17.4 6.8 7.6 17.6 8.1 4.0 5.3 3.2 9.1 1.3 5.4 6.0 6.2 8.4 13.0 5.2 18.4 0.1 0.3 0.0 1.6 0.4 6.0 14.8 0.4 0.7 0.4 0.0 0.1 0.9 0.0 0.3 0.1 0.2 19.2 0.0 3.5 1.4 10.4 23.5 0.3 19.8 0.2 0.1 0.8 0.0 4.1 0.0 0.3 0.0 0.1 0.2 11.1 0.8 2.4 3.3 2.5 13.3 0.1 0.2 1.2 12.5 0.7 0.1 1.8 2.9 1.9 0.0 7.2 2.1 4.8 0.0 3.5 2.7 40.4 24.0 2.8 1.1 3.7 0.7 6.4 3.6 26.3 0.3 92.9 1.1 0.1 0.0 1.6 0.2 46.8 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.6 0.2 0.0 5.2 1.6 0.9 0.1 0.0 0.0 18.4 0.4 0.4 7.5 34.8 2.6 12.6 7.5 8.6 10.2 5.9 12.1 9.1 53.6 35.4 14.7 85.0 148.4 56.2 22.6 114.7 0.0 14.8 10.4 2.0 0.0 3.3 306.3 1.1 39.7 9.5 0.0 53.6 2.0 27.8 287.7 60.9 0.0 5.6 1.6 9.7 16.0 3.4 1.4 2.8 6.7 30.4 10.0 11.5 308.1 506.6 17.5 20.5 1.3 6.6 71.1 116.0 0.0 6.8 156.0 0.1 1.9 9.2 71.5 PMIS2 IFITMD9 ENSG00000283758 "PMIS2, transmembrane protein" 19 35586161-35587296 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 43 "testis: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "NTERA-2: 1.2;U-138 MG: 2.6" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PMP22 "GAS3, HNPP, Sp110" ENSG00000109099 "Peripheral myelin protein 22" Q01453 17 15229777-15265357 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes, Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 386.3;Hofbauer cells: 428.7;Leydig cells: 300.3;Melanocytes: 325.6;Peritubular cells: 231.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 14.1;eosinophil: 22.9;plasmacytoid DC: 12.8" "Group enriched" "Detected in many" 20 "dendritic cells: 12.8;granulocytes: 22.9" "Cell line enhanced" "Detected in many" "ASC diff: 67.7;HMC-1: 53.5;SuSa: 64.1;WM-115: 81.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.00e-1)" "unprognostic (1.65e-1)" "unprognostic (2.21e-1)" "unprognostic (4.63e-1)" "unprognostic (5.57e-3)" "unprognostic (2.28e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" "unprognostic (3.74e-1)" "unprognostic (4.33e-2)" "unprognostic (7.70e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.83e-2)" "unprognostic (5.45e-2)" "unprognostic (2.88e-1)" "unprognostic (1.08e-2)" 66.8 20.9 27.1 22.4 31.4 2.4 43.5 5.7 34.2 69.1 46.0 96.5 11.7 16.7 43.7 28.4 31.3 37.9 40.8 47.5 33.0 17.9 9.0 5.3 47.7 14.0 72.6 22.7 34.9 8.3 3.5 6.7 77.5 42.9 28.0 32.4 39.4 19.2 35.0 91.3 27.0 95.2 48.6 63.9 10.0 25.1 16.5 44.9 1.6 26.4 25.8 8.6 51.6 39.0 0.0 12.8 22.9 0.9 0.0 0.0 0.4 1.3 8.0 11.3 12.2 67.7 28.6 2.5 11.5 11.8 10.2 7.2 8.3 0.2 0.0 1.4 31.1 4.1 0.1 13.4 0.1 3.2 0.0 2.9 0.6 15.6 2.9 36.3 0.0 53.5 24.8 0.2 6.2 0.3 13.1 11.5 0.7 4.3 0.2 6.3 0.9 0.1 0.4 0.7 0.7 12.2 3.7 7.3 0.0 10.6 0.8 0.0 7.2 3.0 0.0 28.8 64.1 0.0 0.1 14.2 2.7 9.2 39.8 11.1 0.0 0.0 0.0 15.1 0.0 81.6 14.1 0.9 22.9 0.0 0.5 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.1 12.8 0.0 0.4 27.1 31.4 5.7 33.4 33.0 17.9 72.6 22.7 42.9 44.9 26.8 17.3 0.0 7.0 80.0 1.3 61.8 2.5 5.3 12.5 0.0 0.0 7.8 3.3 3.3 9.8 106.8 13.8 0.0 3.0 21.5 386.3 3.8 115.6 0.8 428.7 0.0 4.6 67.5 17.7 6.2 300.3 63.3 325.6 19.8 11.0 57.5 1.6 5.8 231.6 0.8 1.1 226.4 152.7 2.8 4.1 90.1 15.9 1.0 6.6 1.8 PNKD "BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, PDC, PKND1, TAHCCP2" ENSG00000127838 "Paroxysmal nonkinesigenic dyskinesia" Q8N490 2 218270392-218346793 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 431.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010134, HPA017068" Approved Enhanced Mitochondria NA NA 31000 Mitochondria "HPA010134: AB_1079645, HPA017068: AB_1855495" "unprognostic (3.15e-3)" "unprognostic (1.80e-2)" "unprognostic (5.86e-3)" "unprognostic (1.89e-2)" "unprognostic (1.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.81e-2)" "unprognostic (1.54e-1)" "unprognostic (1.37e-1)" "unprognostic (7.51e-2)" "unprognostic (3.29e-1)" "unprognostic (7.67e-2)" "prognostic unfavorable (5.13e-5)" "unprognostic (7.98e-2)" "unprognostic (2.17e-1)" "unprognostic (9.61e-2)" "unprognostic (1.44e-3)" 21.8 28.3 33.2 15.9 41.0 13.4 16.4 26.6 51.1 29.8 27.5 14.3 28.9 18.1 14.6 37.0 13.3 28.3 30.4 37.3 31.0 26.5 42.4 107.0 23.4 34.2 33.2 23.6 18.1 18.8 22.3 15.6 28.1 26.8 34.8 25.1 15.9 27.3 27.1 33.8 12.9 15.9 16.6 25.7 18.0 29.5 23.3 20.6 11.6 29.7 15.3 16.3 19.0 13.4 64.0 32.7 44.9 35.4 38.4 43.3 38.9 15.3 20.2 14.8 23.2 22.3 18.9 27.4 9.7 21.0 23.1 26.0 33.1 15.2 18.0 19.5 16.1 25.5 16.0 28.5 18.2 16.2 37.4 35.6 26.3 37.0 48.9 24.4 16.9 11.7 25.7 18.0 15.7 4.6 15.5 24.9 14.3 19.3 23.6 20.4 44.2 22.0 40.5 14.7 35.6 20.7 21.7 14.9 15.1 26.5 23.4 14.4 12.1 6.9 47.4 27.5 16.6 15.7 16.5 15.3 9.6 16.5 11.3 13.2 9.8 10.0 19.4 24.4 28.0 11.6 33.7 35.4 44.9 32.1 34.1 30.4 64.0 35.1 38.3 32.7 52.0 38.8 37.3 9.8 38.4 31.0 30.4 43.3 38.9 33.2 41.0 26.6 51.1 31.0 26.5 33.2 23.6 26.8 20.6 65.5 73.4 56.6 80.2 49.0 53.5 126.7 104.4 100.4 62.6 186.7 5.9 149.0 431.0 54.5 7.7 70.9 168.7 0.0 43.7 85.9 107.8 126.2 56.5 206.0 114.9 33.4 116.6 73.1 82.4 10.5 95.5 48.6 129.9 72.1 149.8 127.6 39.4 144.0 116.7 212.9 34.8 90.5 76.9 45.9 44.3 54.5 64.6 55.8 176.1 86.0 PNPLA2 "ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2" ENSG00000177666 "Patatin like phospholipase domain containing 2" Q96AD5 11 818902-825573 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 158.1;breast: 155.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055173, HPA062602, HPA075175" Approved Enhanced "Nucleoplasm,Lipid droplets" NA NA "Lipid droplets" Nucleoplasm "HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: " "unprognostic (2.11e-2)" "unprognostic (3.37e-2)" "unprognostic (5.87e-3)" "unprognostic (2.51e-2)" "unprognostic (8.97e-3)" "unprognostic (1.68e-2)" "unprognostic (6.39e-2)" "unprognostic (3.28e-2)" "unprognostic (3.00e-1)" "unprognostic (5.61e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.46e-1)" "unprognostic (4.09e-1)" "unprognostic (2.07e-2)" 158.1 7.2 1.6 9.4 1.8 11.2 155.2 2.7 2.3 4.1 35.9 1.5 3.8 5.6 4.5 7.8 8.6 4.3 7.2 12.6 1.7 1.1 15.6 7.4 11.3 4.5 1.6 1.6 4.9 11.8 2.5 4.2 11.6 1.8 5.2 1.5 1.9 8.1 8.1 25.0 6.1 23.1 3.0 2.1 4.9 8.2 4.0 1.5 1.5 11.3 4.8 5.1 13.0 18.6 4.2 6.5 18.7 8.5 3.6 5.3 3.6 10.5 8.3 1.7 4.5 65.2 5.8 11.2 11.3 9.1 7.1 6.3 7.1 10.7 6.3 6.7 8.5 4.4 9.5 2.6 4.7 2.2 8.1 23.1 8.7 3.7 11.3 21.4 6.0 11.0 11.4 6.1 4.7 5.5 7.3 5.8 4.7 7.4 6.4 6.3 6.2 8.0 13.1 5.0 10.8 17.9 7.7 3.8 14.1 7.0 2.4 6.4 8.5 21.0 17.9 6.5 1.1 7.7 6.9 10.4 6.4 5.0 4.1 5.1 24.7 15.2 5.3 16.1 8.5 4.4 9.3 8.5 18.7 3.6 5.5 3.5 4.2 4.6 5.2 5.7 3.6 5.3 4.3 7.7 3.6 6.0 6.5 3.9 3.6 1.6 1.8 2.7 1.9 1.7 1.1 1.6 1.6 1.8 1.5 6.0 16.9 27.0 63.2 39.3 8.8 42.3 63.7 5.3 13.6 48.8 7.9 56.2 28.2 55.9 14.2 38.0 114.0 23.3 57.3 27.0 25.2 72.1 11.5 41.9 27.6 11.1 49.4 84.1 28.5 4.2 44.8 24.9 40.5 27.9 80.0 34.7 98.9 112.2 36.7 37.9 7.5 64.7 32.2 42.2 28.2 36.0 141.7 36.2 41.4 167.2 PNPLA4 "DXS1283E, GS2, iPLA2eta" ENSG00000006757 "Patatin like phospholipase domain containing 4" P41247 X 7898247-7927739 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 81.2;Proximal tubular cells: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003656 Approved "Intracellular and membrane" NA NA "HPA003656: AB_1079033" "unprognostic (2.97e-1)" "unprognostic (2.45e-1)" "unprognostic (4.17e-3)" "unprognostic (3.08e-2)" "prognostic unfavorable (5.29e-4)" "prognostic unfavorable (5.37e-4)" "unprognostic (3.15e-1)" "unprognostic (2.05e-1)" "unprognostic (9.42e-2)" "unprognostic (6.30e-2)" "unprognostic (7.83e-2)" "unprognostic (2.27e-1)" "prognostic favorable (2.23e-12)" "unprognostic (5.23e-2)" "unprognostic (6.71e-3)" "unprognostic (6.30e-2)" "unprognostic (2.12e-1)" 11.3 18.1 12.6 6.0 18.8 4.7 13.9 5.0 11.5 8.9 8.9 8.5 13.3 11.2 9.2 11.4 13.2 15.0 6.2 24.0 10.9 11.9 26.5 39.8 5.8 6.3 12.0 8.7 14.0 21.0 13.3 17.0 4.7 12.2 8.0 7.5 13.1 18.9 10.7 40.9 10.8 10.5 7.4 11.2 5.4 11.5 7.8 10.6 7.2 23.6 21.1 8.9 6.6 9.5 13.2 18.3 7.6 10.4 9.0 10.3 8.4 18.4 7.6 1.2 19.0 0.4 0.2 5.1 5.7 0.6 10.0 6.2 7.6 6.8 5.8 0.0 1.8 0.1 10.9 0.0 19.3 17.1 0.2 13.5 4.1 14.7 15.9 12.7 7.2 6.1 13.0 19.8 5.1 11.9 2.4 6.9 0.2 16.2 0.2 0.1 4.8 0.1 7.2 20.1 12.8 16.1 0.1 0.1 6.4 13.2 8.4 11.0 5.5 17.4 7.2 9.8 22.6 11.2 5.4 3.9 0.1 5.0 15.3 0.1 8.8 0.1 11.0 0.1 0.0 1.6 5.2 9.8 7.6 5.4 10.4 6.2 12.3 7.8 5.9 18.3 13.2 10.3 9.8 0.7 9.0 9.7 13.5 4.8 8.4 12.6 18.8 5.0 11.5 10.9 11.9 12.0 8.7 12.2 10.6 8.9 12.2 10.2 12.9 10.5 11.3 43.9 22.9 26.8 9.1 19.2 0.0 24.2 81.2 29.5 2.3 11.6 26.5 0.0 42.6 18.0 10.3 13.5 8.1 58.6 26.3 9.5 19.0 13.5 7.2 2.2 15.3 11.0 16.9 17.2 30.1 29.0 29.8 28.1 19.1 97.0 12.8 6.5 11.3 15.9 21.3 14.6 11.7 5.2 34.5 13.7 PNPLA6 "iPLA2delta, NTE, SPG39, sws" ENSG00000032444 "Patatin like phospholipase domain containing 6" Q8IY17 19 7534004-7561764 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 82.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007522, HPA064773" Uncertain Approved "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA007522: AB_1079649, HPA064773: " "unprognostic (2.73e-1)" "unprognostic (1.02e-1)" "unprognostic (1.52e-1)" "unprognostic (3.23e-2)" "unprognostic (2.78e-1)" "prognostic favorable (5.25e-4)" "unprognostic (3.53e-3)" "unprognostic (1.50e-1)" "unprognostic (2.07e-2)" "unprognostic (1.62e-1)" "prognostic favorable (3.51e-5)" "unprognostic (3.36e-1)" "prognostic favorable (7.53e-4)" "unprognostic (3.10e-3)" "unprognostic (3.50e-1)" "unprognostic (3.25e-1)" "unprognostic (2.17e-1)" 12.9 19.7 25.9 25.0 29.3 22.3 17.8 22.1 35.8 10.2 15.9 26.1 10.0 26.3 13.7 6.3 16.4 12.6 14.0 12.0 22.6 19.1 17.1 13.7 30.4 17.6 36.3 19.2 12.5 14.2 15.6 21.6 13.9 29.2 13.4 8.9 15.8 13.7 14.3 27.0 15.3 28.7 14.5 23.5 28.3 12.2 31.3 33.0 7.1 14.7 6.1 8.8 15.9 14.7 3.8 7.3 21.8 19.0 5.0 3.9 4.1 13.2 31.9 6.3 15.2 11.0 16.0 14.5 17.2 17.7 13.4 12.4 7.4 18.3 10.9 29.3 22.2 8.3 17.0 5.3 16.2 6.9 26.6 12.3 7.2 17.0 5.6 12.7 8.0 22.5 13.8 9.4 17.2 10.0 21.3 26.4 13.0 5.9 15.1 11.9 6.2 8.8 10.5 6.9 6.2 29.3 7.1 3.8 12.8 11.9 12.6 8.0 13.9 14.6 6.6 18.7 8.9 5.9 11.5 27.9 16.3 9.6 22.3 18.0 17.9 11.5 4.8 27.4 9.5 15.2 7.9 6.1 21.8 3.5 12.1 3.5 3.8 2.5 3.8 7.3 2.8 2.2 2.9 1.9 5.0 19.0 2.4 3.9 4.1 25.9 29.3 22.1 35.8 22.6 19.1 36.3 19.2 29.2 33.0 6.0 11.8 6.5 2.7 4.2 10.9 8.6 17.8 8.1 6.8 31.4 25.5 14.9 1.7 13.7 60.0 10.8 52.1 0.0 6.1 12.2 4.1 4.5 11.5 19.2 24.9 20.6 16.7 10.4 55.8 82.5 8.9 23.8 8.5 10.0 13.4 10.6 8.4 12.9 7.1 17.0 16.2 0.0 6.2 58.2 10.0 4.8 10.4 10.0 14.0 3.1 PNPLA7 "C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2" ENSG00000130653 "Patatin like phospholipase domain containing 7" Q6ZV29 9 137459953-137550534 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 16.6" "Cancer enhanced" "Detected in many" "prostate cancer: 9.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6;T-reg: 3.5" "Group enriched" "Detected in many" 5 "B-cells: 3.6;T-cells: 3.5" "Cell line enriched" "Detected in some" 23 "HMC-1: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009130 Uncertain Uncertain "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA009130: AB_2268411" "unprognostic (1.49e-1)" "unprognostic (1.40e-2)" "unprognostic (3.61e-3)" "unprognostic (2.38e-2)" "unprognostic (3.68e-2)" "unprognostic (6.69e-3)" "unprognostic (2.72e-3)" "unprognostic (5.14e-4)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "prognostic favorable (2.24e-5)" "unprognostic (1.09e-1)" "unprognostic (2.23e-3)" "unprognostic (2.42e-1)" "unprognostic (6.80e-2)" "unprognostic (8.81e-2)" "unprognostic (3.45e-3)" 9.3 5.6 10.6 2.8 11.0 2.8 6.3 17.0 11.4 6.4 4.5 6.7 3.8 3.1 7.6 2.1 2.2 5.8 4.7 4.8 8.4 2.6 2.3 7.4 4.1 5.4 9.7 9.7 9.7 17.7 3.3 7.1 1.1 6.6 14.7 2.1 5.4 18.7 4.8 19.1 15.4 4.8 7.2 6.7 5.4 9.6 1.8 11.6 0.4 7.6 4.2 2.8 7.8 3.7 3.6 0.7 0.0 0.4 0.0 3.5 0.5 0.0 0.5 0.1 0.2 0.4 0.3 0.2 0.4 0.4 0.1 0.1 0.0 0.2 0.3 0.4 0.2 0.2 0.1 0.0 0.0 0.0 0.8 0.4 0.4 0.4 0.1 0.3 0.2 43.9 0.6 0.1 0.1 0.0 0.7 0.0 0.0 0.0 1.2 0.0 0.8 0.1 0.8 0.0 0.6 0.5 1.0 0.7 1.3 0.0 0.2 0.8 0.2 0.0 0.3 0.1 0.1 1.9 0.6 0.3 0.0 0.1 0.2 0.0 0.4 0.1 0.1 0.6 0.4 0.0 0.0 0.4 0.0 0.8 0.3 0.0 0.8 0.5 0.4 0.7 3.6 1.2 0.9 0.0 0.0 0.1 0.4 3.5 0.5 10.6 11.0 17.0 11.4 8.4 2.6 9.7 9.7 6.6 11.6 8.9 5.1 3.7 1.0 1.3 2.5 3.2 2.5 1.4 3.4 1.8 5.9 0.1 0.0 0.4 0.3 0.7 3.5 0.0 0.0 0.2 1.0 3.5 6.9 6.7 2.1 4.8 16.6 2.5 2.5 0.2 4.0 0.9 0.0 1.8 7.4 3.5 0.8 5.8 1.8 0.8 9.1 0.0 0.9 1.6 1.4 2.9 0.0 0.0 1.8 0.7 PODXL "Gp200, PC, PCLP" ENSG00000128567 "Podocalyxin like" O00592 7 131500262-131558217 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 82.5;Endothelial cells: 112.3;Rod photoreceptor cells: 186.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 34.6;NTERA-2: 46.7;SuSa: 47.0;TIME: 52.2;U-251 MG: 20.8" "HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220" Enhanced Supported "Vesicles,Plasma membrane,Centriolar satellite" NA NA 43000000 "Plasma membrane, Centriolar satellite" Vesicles "CAB016169: AB_628165, CAB062558: AB_2665627, CAB068219: AB_2665618, CAB068220: AB_2665619, HPA002110: AB_1855512, HPA045507: AB_2679356" "unprognostic (1.26e-1)" "unprognostic (7.68e-2)" "unprognostic (8.28e-3)" "unprognostic (6.46e-3)" "unprognostic (5.16e-3)" "unprognostic (5.85e-2)" "unprognostic (1.63e-2)" "unprognostic (1.05e-1)" "unprognostic (7.95e-3)" "unprognostic (3.52e-1)" "unprognostic (9.20e-3)" "unprognostic (3.40e-1)" "prognostic favorable (2.89e-4)" "unprognostic (2.56e-1)" "unprognostic (8.78e-3)" "unprognostic (3.55e-2)" "unprognostic (1.03e-1)" 8.8 4.9 8.2 3.8 8.9 0.8 7.6 4.8 13.5 11.7 5.0 4.6 16.0 2.8 14.5 2.7 4.4 22.1 7.9 19.3 6.7 6.7 30.6 3.0 14.7 2.6 7.2 5.9 6.1 20.4 7.5 4.0 12.5 15.2 4.5 3.7 15.5 9.1 27.8 5.7 3.8 4.8 12.8 8.1 2.9 4.6 3.5 6.6 0.0 14.0 5.2 2.5 6.1 8.3 1.1 0.3 2.2 0.3 0.4 0.8 0.3 4.8 2.3 4.0 1.8 0.1 0.0 0.3 0.6 0.5 1.8 0.7 11.8 7.6 0.0 11.3 34.6 5.2 3.5 3.9 0.0 1.2 0.6 1.9 0.0 14.4 0.1 0.0 0.4 0.3 0.0 0.0 6.2 0.0 0.7 13.9 0.1 1.2 0.2 1.4 1.4 0.0 0.0 46.7 0.6 4.7 2.0 7.0 1.5 0.2 2.1 3.6 0.8 4.2 0.5 0.0 47.0 0.4 0.1 52.2 0.7 2.8 7.1 20.8 0.3 0.4 0.1 2.6 1.9 4.1 0.7 0.3 2.2 0.6 0.2 0.5 0.3 0.5 0.8 0.0 1.1 0.4 0.4 1.1 0.4 0.2 0.3 0.4 0.3 8.2 8.9 4.8 13.5 6.7 6.7 7.2 5.9 15.2 6.6 6.0 13.5 1.9 0.8 4.6 8.2 18.5 0.0 4.0 9.1 26.2 82.5 0.5 0.0 4.1 0.6 112.3 0.7 0.0 15.7 0.3 3.0 2.6 2.3 0.4 0.3 4.8 2.4 44.2 0.8 0.9 4.4 3.2 5.0 1.0 11.0 8.5 29.1 0.0 0.4 0.6 186.1 0.0 4.7 0.2 0.7 2.8 0.6 1.0 1.8 2.0 PODXL2 "endoglycan, PODLX2" ENSG00000114631 "Podocalyxin like 2" Q9NZ53 3 127629181-127672809 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.8" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 84.6;Horizontal cells: 77.9;Intestinal endocrine cells: 61.0;Late spermatids: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 32.6;SCLC-21H: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024934, HPA042265" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "CAB024934: , HPA042265: AB_2677920" "unprognostic (2.07e-2)" "unprognostic (2.34e-1)" "unprognostic (7.02e-2)" "unprognostic (1.07e-2)" "unprognostic (9.74e-2)" "unprognostic (1.79e-2)" "unprognostic (8.97e-3)" "unprognostic (1.81e-1)" "unprognostic (3.89e-1)" "unprognostic (2.67e-1)" "unprognostic (4.05e-3)" "unprognostic (3.48e-1)" "unprognostic (2.91e-1)" "unprognostic (1.90e-1)" "unprognostic (2.67e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-3)" 3.0 16.1 19.1 2.6 19.7 1.8 8.1 31.4 42.8 3.0 8.3 9.0 1.6 6.6 4.5 2.5 2.8 4.3 4.4 2.5 22.2 37.3 4.5 1.6 2.1 2.2 21.3 17.5 10.8 12.0 1.2 20.9 1.3 31.5 12.0 7.6 8.7 21.4 2.4 2.8 4.6 6.1 2.0 17.0 2.1 12.2 16.4 7.7 0.6 4.1 1.6 2.7 2.1 0.9 1.6 2.6 0.1 0.8 0.2 2.7 0.7 0.1 3.9 10.8 25.6 0.0 0.0 16.0 1.2 0.0 2.3 0.4 8.0 0.4 9.5 9.7 0.1 3.5 0.0 8.8 0.0 0.2 0.0 18.1 0.2 9.0 8.1 0.3 21.5 22.0 0.4 1.9 0.0 0.0 6.1 0.6 0.0 12.4 0.0 0.8 4.8 0.1 0.0 16.2 2.2 19.1 0.0 0.3 32.6 3.2 1.1 48.6 27.3 11.6 24.8 21.1 1.1 6.3 10.9 0.1 0.0 5.0 0.4 7.5 0.0 0.0 7.4 0.2 14.0 7.1 0.0 0.2 0.0 0.8 0.8 1.1 1.6 2.7 0.7 0.0 1.3 1.3 0.6 0.1 0.2 0.0 2.6 1.7 0.7 19.1 19.7 31.4 33.8 22.2 37.3 21.3 17.5 31.5 7.7 0.0 0.6 0.0 3.7 4.8 84.6 0.4 0.0 1.4 0.0 8.7 29.5 1.9 1.7 5.5 45.3 0.6 8.0 0.0 17.9 3.1 4.6 10.6 1.1 0.5 1.1 77.9 61.0 0.6 0.6 110.3 8.1 0.7 20.3 12.6 18.4 17.7 13.0 18.2 5.3 3.3 35.4 6.5 5.3 18.6 51.7 4.8 1.3 0.0 19.5 2.2 POM121 "DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A" ENSG00000196313 "POM121 transmembrane nucleoporin" Q96HA1 7 72879365-72951440 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB003710, HPA043809, HPA049817" Approved Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896" "unprognostic (2.33e-1)" "unprognostic (3.05e-2)" "unprognostic (9.71e-2)" "unprognostic (5.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.06e-1)" "unprognostic (1.40e-1)" "unprognostic (6.38e-2)" "unprognostic (7.07e-3)" "unprognostic (3.08e-2)" "unprognostic (3.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.85e-1)" "unprognostic (3.66e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-3)" "unprognostic (2.40e-1)" 19.4 15.2 14.5 16.0 17.7 35.0 14.4 25.9 22.0 13.1 16.6 16.0 14.2 19.5 17.9 14.8 15.8 15.8 14.9 11.8 11.7 10.0 14.0 16.6 13.3 18.7 10.8 12.7 18.6 23.3 14.9 20.6 15.4 13.4 18.6 11.4 20.2 17.4 11.7 18.4 17.0 19.1 12.1 12.7 19.0 16.3 17.3 13.5 24.5 19.5 15.2 22.3 15.8 14.5 3.7 4.3 3.7 3.6 4.5 5.2 2.6 17.1 12.6 15.7 35.3 8.5 7.0 13.1 12.3 10.5 12.3 10.7 22.2 10.9 23.7 4.0 10.6 13.7 13.2 15.6 11.9 13.8 20.5 31.1 17.7 12.6 14.7 8.7 36.6 22.6 9.2 8.5 16.3 15.0 8.0 9.1 13.8 48.4 17.8 12.0 13.2 21.8 23.3 16.5 9.6 15.3 20.0 12.3 20.0 6.2 15.1 22.5 19.8 10.8 20.8 11.0 11.0 17.3 19.3 12.8 22.1 13.6 17.4 24.6 21.4 19.8 34.4 12.9 23.5 21.8 0.1 2.3 3.7 5.2 1.4 3.0 3.0 3.3 3.8 2.6 3.7 3.0 4.3 2.6 4.5 3.6 4.3 1.7 2.6 14.5 17.7 25.9 22.0 11.7 10.0 10.8 12.7 13.4 13.5 35.7 28.2 12.7 8.8 22.3 31.1 4.4 25.5 17.4 20.5 17.4 92.3 14.5 5.0 10.8 6.8 14.2 16.9 23.3 14.7 10.9 16.5 15.7 16.1 20.3 13.8 38.1 17.2 17.8 15.8 4.2 13.8 18.3 18.6 7.2 19.6 18.3 17.2 10.5 16.6 5.4 23.8 12.9 15.9 14.2 11.8 27.0 16.2 18.1 19.0 18.4 POM121C ENSG00000272391 "POM121 transmembrane nucleoporin C" 7 75416787-75486271 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 64.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043809, HPA049817" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA043809: AB_2678680, HPA049817: AB_2680896" "unprognostic (9.11e-2)" "unprognostic (1.27e-1)" "unprognostic (2.85e-1)" "unprognostic (1.44e-1)" "unprognostic (3.51e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-2)" "unprognostic (4.97e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-3)" "unprognostic (2.03e-1)" "unprognostic (5.06e-2)" "unprognostic (2.40e-1)" "unprognostic (2.35e-1)" "unprognostic (1.44e-2)" "unprognostic (4.00e-2)" 5.5 5.5 6.5 9.9 8.4 11.0 4.5 11.2 7.4 5.9 5.1 5.8 6.5 4.5 7.0 7.5 6.6 5.9 6.0 5.3 6.8 6.9 6.3 5.0 10.3 4.3 4.4 8.4 7.5 7.7 10.1 6.6 5.4 5.4 5.2 9.3 6.5 5.3 5.7 5.5 6.2 6.2 4.6 6.7 5.3 4.6 6.3 13.1 7.0 7.3 12.0 6.6 5.0 3.5 3.4 3.9 1.6 2.7 3.8 1.7 15.8 13.3 18.4 35.2 6.9 7.8 12.1 11.6 10.7 9.5 9.2 15.9 10.3 28.1 4.8 12.6 14.9 14.4 15.6 14.3 15.7 18.9 21.6 13.9 15.3 10.6 9.2 36.8 19.8 6.6 9.1 14.4 10.8 14.0 9.6 11.7 38.9 15.8 15.3 16.0 22.4 18.7 14.6 12.3 15.1 20.2 12.3 14.4 5.2 21.7 20.6 27.0 13.4 21.4 9.4 17.4 18.6 13.1 10.6 23.1 12.5 16.8 23.9 16.9 19.8 34.8 15.0 18.9 21.2 0.6 1.2 1.3 3.8 1.6 3.3 2.6 2.9 1.1 0.9 3.5 1.5 1.9 3.9 2.7 1.0 3.4 0.5 1.7 32.8 22.1 15.2 8.3 16.0 29.4 10.1 30.6 21.4 28.4 12.2 64.8 11.5 5.0 11.7 1.5 15.8 11.4 0.0 14.9 8.4 12.0 18.1 7.0 12.3 10.2 23.8 27.5 12.9 17.3 2.9 16.7 15.5 6.8 7.2 13.8 20.6 15.0 3.5 14.5 8.6 28.6 12.9 12.1 14.0 12.3 16.2 14.2 20.1 16.9 19.0 POMGNT1 "FLJ20277, LGMD2O, MEB, MGAT1.2" ENSG00000085998 "Protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)" Q8WZA1 1 46188682-46220305 "Disease related genes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044518 Approved NA NA 6300000 "HPA044518: AB_10795985" "unprognostic (4.59e-3)" "unprognostic (1.59e-1)" "unprognostic (2.13e-1)" "unprognostic (1.80e-1)" "unprognostic (2.24e-1)" "unprognostic (3.20e-1)" "prognostic unfavorable (3.52e-4)" "unprognostic (1.82e-1)" "unprognostic (5.74e-2)" "unprognostic (5.37e-2)" "prognostic favorable (4.27e-4)" "unprognostic (5.86e-2)" "unprognostic (4.39e-2)" "unprognostic (4.99e-3)" "unprognostic (1.72e-1)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" 12.8 17.8 17.9 8.2 26.7 2.8 14.3 12.9 21.6 13.9 9.7 29.5 11.1 12.4 11.7 19.1 9.2 15.8 12.4 43.6 18.8 16.7 19.1 19.2 13.8 7.1 39.4 18.0 10.0 17.2 47.1 19.4 16.6 24.7 21.1 10.7 13.0 13.8 17.2 29.7 13.3 11.3 16.3 36.3 11.7 12.5 16.1 25.0 7.7 22.4 7.5 9.1 11.3 9.0 3.2 6.4 1.6 5.2 9.4 6.2 1.9 12.3 13.3 16.3 15.7 18.0 19.7 21.1 16.7 28.2 22.8 18.0 7.5 10.4 11.5 27.7 27.7 39.0 7.1 11.6 23.9 13.7 15.0 13.2 9.1 11.9 11.3 15.8 7.0 8.9 19.8 31.3 25.5 23.8 41.1 23.2 15.9 10.7 7.5 37.2 8.6 12.3 5.0 13.5 7.1 18.7 9.0 16.7 10.7 20.1 15.4 6.2 22.2 15.4 17.9 23.3 24.5 11.9 9.9 16.8 17.2 15.3 19.4 31.9 18.9 21.0 5.3 26.2 6.9 18.2 0.0 1.6 1.6 5.1 2.8 3.5 2.1 3.4 4.0 2.2 3.2 6.2 4.8 0.0 9.4 5.2 6.4 3.3 1.9 17.9 26.7 12.9 21.6 18.8 16.7 39.4 18.0 24.7 25.0 11.9 45.5 9.8 35.8 7.4 40.4 36.8 20.4 21.4 33.0 33.2 47.1 21.1 11.6 38.1 28.2 13.4 14.6 0.0 34.5 23.8 14.1 34.3 25.5 18.4 13.6 25.4 25.9 8.6 11.0 10.4 18.7 11.0 23.6 25.2 11.8 23.2 31.7 14.4 12.4 17.7 36.4 12.9 15.5 5.0 11.0 6.6 19.6 13.1 15.8 26.0 POMK "FLJ23356, SgK196" ENSG00000185900 "Protein-O-mannose kinase" Q9H5K3 8 43093506-43123434 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 1.4;Club cells: 2.3;Melanocytes: 1.7;monocytes: 1.8;Spermatogonia: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013321 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA013321: AB_2668809" "unprognostic (1.66e-2)" "unprognostic (1.12e-2)" "unprognostic (1.27e-1)" "unprognostic (4.37e-2)" "unprognostic (1.29e-1)" "unprognostic (4.62e-2)" "unprognostic (5.56e-2)" "unprognostic (2.42e-1)" "unprognostic (2.50e-1)" "unprognostic (8.10e-2)" "unprognostic (1.23e-3)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (7.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.10e-2)" 4.7 5.5 9.8 5.6 14.3 12.5 5.1 12.3 18.6 6.9 4.8 8.3 2.2 4.5 6.9 4.4 7.1 6.2 4.8 3.8 7.7 7.0 3.4 4.5 5.5 6.0 4.8 11.1 5.8 9.3 6.3 7.4 6.1 10.5 5.6 5.9 6.1 6.8 4.0 6.2 7.1 5.6 6.4 6.7 7.6 6.8 7.1 7.2 7.5 7.4 3.2 7.4 4.6 5.0 2.6 2.6 6.7 2.9 1.0 3.3 1.3 3.5 7.6 5.8 15.2 2.8 3.5 5.5 2.1 3.2 5.5 4.1 5.5 9.2 5.0 4.7 3.8 2.3 5.9 8.3 6.4 5.4 1.9 1.4 14.0 5.6 2.5 2.0 4.7 7.9 3.8 2.7 7.4 5.3 1.7 5.4 7.1 3.3 14.9 3.7 1.6 10.0 2.0 11.9 2.1 1.0 6.8 6.8 2.9 1.5 9.9 5.6 4.2 9.1 3.2 3.0 4.4 9.8 3.3 7.5 8.4 8.5 8.7 4.2 4.9 8.6 9.4 3.6 3.2 10.0 0.8 2.9 1.9 2.3 2.4 3.3 1.8 1.3 1.3 2.6 2.6 1.8 2.3 6.7 1.0 1.5 2.5 1.1 1.3 9.8 14.3 12.3 18.6 7.7 7.0 4.8 11.1 10.5 7.2 0.0 0.3 0.0 0.1 0.3 1.4 0.3 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 1.8 0.0 0.5 0.3 0.0 0.0 0.0 0.8 0.0 0.1 0.4 1.4 0.1 0.5 0.0 0.2 0.1 POMT1 LGMD2K ENSG00000130714 "Protein O-mannosyltransferase 1" Q9Y6A1 9 131502902-131523806 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 49.7;Spermatocytes: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065252 Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA065252: AB_2685445" "unprognostic (2.00e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (5.09e-3)" "unprognostic (1.67e-1)" "unprognostic (7.97e-2)" "unprognostic (5.35e-3)" "unprognostic (1.14e-1)" "unprognostic (9.76e-3)" "unprognostic (2.84e-1)" "prognostic favorable (3.90e-5)" "unprognostic (8.36e-2)" "prognostic favorable (4.68e-5)" "unprognostic (2.41e-2)" "unprognostic (1.61e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-1)" 9.5 12.3 21.6 10.6 18.8 10.2 10.2 34.2 22.4 10.0 12.1 16.9 14.6 11.2 15.0 14.6 8.8 14.6 13.0 15.2 25.8 17.9 13.8 12.8 10.6 13.2 15.0 16.5 17.2 16.9 17.1 18.0 12.9 15.2 16.0 11.6 13.3 19.5 17.1 28.2 16.6 11.9 12.1 13.4 12.3 10.7 49.9 13.4 8.7 11.6 5.5 11.0 7.8 9.5 2.8 5.1 3.4 3.8 3.8 10.8 4.9 6.7 10.8 9.9 16.6 12.7 10.3 17.8 7.8 9.7 12.5 8.6 11.4 9.5 2.1 9.5 18.0 5.7 15.3 12.1 8.5 6.6 11.1 17.2 3.9 25.5 7.9 15.0 10.0 8.7 7.2 7.7 8.3 2.8 14.8 10.8 13.8 6.8 11.5 12.5 18.0 9.4 22.9 5.7 5.6 13.6 10.9 9.3 16.1 11.0 2.0 11.2 9.9 13.3 15.5 7.8 6.7 22.7 10.1 11.7 9.9 2.1 17.9 6.6 7.2 6.2 3.5 5.9 18.8 8.1 0.0 3.8 3.4 7.4 3.6 10.8 2.8 7.2 7.4 5.1 2.7 6.7 5.5 0.5 3.8 3.3 3.1 7.6 4.9 21.6 18.8 34.2 22.4 25.8 17.9 15.0 16.5 15.2 13.4 8.9 20.2 7.3 4.8 3.9 11.9 8.5 10.2 4.0 6.8 12.2 7.9 18.5 1.7 9.9 49.7 7.1 12.3 0.0 5.8 10.1 7.1 5.3 2.3 9.7 9.1 20.6 7.5 6.7 5.3 24.3 8.1 5.7 5.0 10.0 8.2 14.1 7.3 3.5 9.6 9.0 16.9 6.5 6.0 57.0 7.9 2.6 14.6 6.9 8.0 2.0 POMT2 LGMD2N ENSG00000009830 "Protein O-mannosyltransferase 2" Q9UKY4 14 77274956-77320884 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003663 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003663: AB_1079655" "unprognostic (2.15e-1)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.40e-4)" "unprognostic (7.10e-3)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-3)" "unprognostic (1.94e-3)" "unprognostic (8.50e-3)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.75e-3)" "unprognostic (3.46e-2)" 6.7 10.8 10.4 6.8 11.4 3.8 7.7 12.5 13.3 6.8 6.3 18.0 9.8 4.6 6.9 17.1 5.7 8.7 6.9 7.7 9.3 7.7 8.1 8.3 6.2 3.0 11.7 6.2 7.6 10.6 14.7 16.1 11.4 9.7 7.3 5.8 8.2 10.1 12.3 17.0 4.3 4.6 7.8 8.4 5.2 5.6 30.9 14.4 2.5 11.5 4.9 3.8 5.7 5.0 1.4 1.9 0.8 1.9 0.0 1.7 0.4 10.4 13.4 13.0 14.7 9.3 7.5 10.4 9.2 7.6 13.8 11.8 6.6 9.4 3.1 7.5 8.6 19.1 11.7 6.1 9.2 9.6 4.6 8.3 1.9 6.6 5.4 11.4 2.1 6.3 7.6 9.8 12.9 12.6 9.6 8.0 3.1 4.9 7.3 9.0 20.6 3.6 10.1 3.7 14.5 11.3 3.5 12.7 2.8 14.3 7.7 11.0 10.8 6.0 10.2 7.7 8.9 10.5 4.4 6.6 10.4 16.4 12.0 8.0 4.8 9.4 1.4 5.3 3.2 9.1 0.0 0.4 0.0 1.7 1.9 0.4 1.4 0.0 0.3 0.9 0.2 0.1 0.0 0.8 0.0 0.8 1.9 0.0 0.4 10.4 11.4 12.5 13.3 9.3 7.7 11.7 6.2 9.7 14.4 6.0 3.2 2.2 2.3 2.7 6.5 4.0 5.1 0.0 0.0 1.8 15.7 5.0 0.0 6.6 8.0 2.8 3.9 0.0 6.4 8.6 6.0 3.5 2.3 4.4 4.8 7.9 17.2 3.1 2.4 12.1 1.7 2.2 1.7 3.6 3.0 8.2 5.8 1.9 3.9 3.0 15.0 0.0 3.9 9.8 8.5 1.6 4.8 0.0 2.6 1.4 PON2 ENSG00000105854 "Paraoxonase 2" Q15165 7 95404863-95435329 "Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 81.0" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 257.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "myeloid DC: 22.1" "Lineage enriched" "Detected in many" 4 "dendritic cells: 22.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025430, HPA029193" Enhanced "Secreted to blood" NA NA 350000000 "CAB025430: , HPA029193: AB_10602148" "unprognostic (1.43e-1)" "prognostic unfavorable (1.43e-5)" "unprognostic (3.80e-1)" "unprognostic (4.14e-1)" "unprognostic (3.89e-2)" "unprognostic (3.77e-3)" "unprognostic (1.19e-3)" "unprognostic (9.87e-3)" "unprognostic (9.54e-2)" "unprognostic (2.53e-1)" "unprognostic (1.58e-2)" "unprognostic (2.80e-1)" "prognostic unfavorable (4.30e-8)" "unprognostic (1.40e-1)" "unprognostic (6.43e-2)" "unprognostic (7.99e-3)" "unprognostic (2.56e-1)" 17.0 42.2 54.1 7.5 59.1 3.3 23.1 25.4 52.2 16.5 24.0 29.7 7.4 28.2 16.6 22.7 10.2 15.0 18.9 13.1 57.2 31.4 23.9 81.0 33.1 4.5 41.4 31.0 10.6 7.2 10.9 15.0 34.3 34.8 14.7 31.1 9.9 8.5 17.2 4.3 19.4 19.1 18.4 44.2 7.3 8.8 9.6 40.1 1.8 13.6 5.1 11.2 13.7 8.1 0.9 22.1 0.5 5.2 5.0 3.5 3.0 9.6 60.7 49.4 26.7 6.9 15.3 13.9 19.8 23.2 15.4 16.8 13.7 22.2 0.0 27.8 19.5 29.6 6.5 9.0 15.2 17.6 0.1 11.8 4.9 36.5 45.2 11.0 0.0 6.8 22.1 17.6 8.3 11.3 31.6 31.9 0.0 3.2 0.2 45.4 8.8 0.0 5.4 9.7 25.9 14.1 0.0 23.3 2.3 47.7 7.6 3.4 10.6 28.2 31.5 19.0 29.8 9.3 3.2 34.7 23.2 16.9 7.8 19.0 5.2 6.0 0.0 21.7 4.5 30.2 0.0 5.2 0.5 3.5 2.6 3.1 0.9 1.3 3.2 22.1 0.4 1.9 2.4 0.0 5.0 1.2 5.3 0.6 3.0 54.1 59.1 25.4 34.3 57.2 31.4 41.4 31.0 34.8 40.1 119.1 85.8 10.2 37.2 14.9 3.9 25.4 71.4 37.5 67.1 80.3 0.0 66.3 8.3 132.9 1.4 51.7 71.3 70.0 44.3 257.9 23.1 23.4 13.9 127.1 35.6 36.5 12.1 36.8 21.8 2.0 15.0 30.4 106.3 20.8 37.6 174.2 71.8 87.7 20.5 39.6 7.9 19.4 40.1 1.9 5.5 14.1 42.1 9.2 65.6 18.4 PON3 ENSG00000105852 "Paraoxonase 3" Q15166 7 95359944-95396368 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 148.0" "Cell type enriched" "Detected in many" 14 "Hepatocytes: 460.4" "Group enriched" "Detected in many" 9 "liver cancer: 30.8;lung cancer: 7.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 12 "NK-cells: 1.1" "Cell line enhanced" "Detected in some" "A549: 20.2;CACO-2: 6.5;CAPAN-2: 4.9;Hep G2: 22.4;T-47d: 12.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA014848, CAB025250" Enhanced "Secreted to blood" NA NA 1760000000 350000000 "CAB025250: , HPA014848: AB_1855540" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (6.28e-3)" "unprognostic (5.52e-3)" "unprognostic (1.36e-1)" "unprognostic (4.87e-1)" "unprognostic (1.44e-3)" "unprognostic (6.32e-2)" "unprognostic (1.11e-1)" "unprognostic (6.44e-3)" "unprognostic (9.14e-2)" "unprognostic (7.18e-3)" "unprognostic (8.30e-9)" "unprognostic (1.66e-1)" "unprognostic (1.04e-2)" "unprognostic (8.29e-2)" "unprognostic (5.12e-2)" 0.4 0.7 0.3 0.1 0.6 0.0 6.9 0.2 0.5 0.9 1.0 0.3 2.3 1.5 0.2 1.2 0.2 0.4 0.7 0.4 0.7 0.3 0.7 148.0 4.0 0.0 0.4 0.2 2.4 7.1 0.0 15.5 0.2 0.5 0.2 0.4 0.8 21.4 5.5 0.1 1.8 1.7 0.1 0.3 0.2 0.5 3.6 0.4 0.4 1.5 0.0 1.1 0.5 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.2 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 4.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 12.6 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.5 0.7 0.3 0.4 0.2 0.5 0.4 6.0 32.1 1.4 0.7 0.8 0.0 0.3 25.5 8.1 14.8 3.5 0.0 1.5 1.7 0.2 9.0 0.5 4.0 0.0 1.8 1.9 2.6 2.2 0.0 460.4 0.2 0.0 0.0 8.6 7.0 3.6 7.5 0.0 13.5 0.0 2.3 3.0 1.5 0.0 2.8 5.2 0.0 0.0 0.1 17.7 13.6 1.1 1.1 0.5 2.3 0.3 POPDC2 POP2 ENSG00000121577 "Popeye domain containing 2" Q9HBU9 3 119636457-119665324 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 90.5" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 250.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "SH-SY5Y: 26.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA024255 Enhanced NA NA "HPA024255: AB_1855545" "unprognostic (1.13e-1)" "unprognostic (1.17e-3)" "unprognostic (8.91e-3)" "unprognostic (9.48e-2)" "unprognostic (5.56e-2)" "unprognostic (7.64e-2)" "unprognostic (2.73e-2)" "unprognostic (2.43e-1)" "unprognostic (3.18e-2)" "unprognostic (1.72e-2)" "unprognostic (5.86e-3)" "unprognostic (1.80e-1)" "unprognostic (1.24e-2)" "unprognostic (6.26e-3)" "unprognostic (1.66e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-2)" 1.3 0.3 0.2 1.0 0.2 0.0 0.6 0.3 0.2 1.8 16.0 0.2 7.6 0.6 2.0 1.3 3.3 1.8 6.1 90.5 0.2 0.0 0.5 0.3 0.3 1.4 0.2 0.3 0.8 0.7 0.1 0.2 0.3 0.3 5.0 1.5 0.3 0.6 13.4 12.1 0.4 2.2 12.6 0.2 0.5 2.4 0.5 0.2 0.3 0.5 3.8 0.8 10.2 1.1 0.9 0.7 2.1 3.0 0.3 2.2 0.4 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 26.1 0.0 0.0 0.4 2.5 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.7 0.0 0.1 0.1 0.2 0.5 2.1 0.1 1.3 0.9 0.1 1.1 0.3 1.1 1.0 0.1 0.9 2.2 0.7 0.1 0.3 3.0 0.7 1.6 0.4 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.3 0.3 0.2 0.0 0.3 0.0 0.2 0.3 2.4 250.7 0.0 2.7 1.2 0.0 0.0 0.4 0.0 0.4 0.2 3.6 0.3 0.0 0.2 0.1 1.4 0.7 1.1 0.0 1.3 1.6 2.9 1.3 1.2 0.4 1.1 2.2 0.0 2.8 0.6 1.2 0.7 0.0 1.8 0.3 2.8 58.2 8.5 0.5 0.4 0.5 1.0 1.0 0.4 0.2 POPDC3 "bA355M14.1, MGC22671, POP3" ENSG00000132429 "Popeye domain containing 3" Q9HBV1 6 105158280-105179995 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "heart muscle: 23.9;skeletal muscle: 68.9" "Cell type enhanced" "Detected in some" 27 "Cardiomyocytes: 40.0;Early spermatids: 75.0;Late spermatids: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 25.2;LHCN-M2: 11.9;RH-30: 13.4;U-87 MG: 12.0;WM-115: 11.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA012514 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA012514: " "unprognostic (2.17e-1)" "unprognostic (2.15e-2)" "unprognostic (3.65e-1)" "unprognostic (1.14e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.79e-4)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (5.12e-3)" "unprognostic (2.37e-1)" "unprognostic (2.83e-9)" "unprognostic (6.25e-2)" "unprognostic (1.24e-1)" "unprognostic (3.75e-3)" "unprognostic (1.33e-2)" 0.9 0.8 2.2 1.4 4.5 0.6 2.5 0.4 6.8 0.8 1.4 2.1 0.8 0.7 1.3 2.2 2.1 0.7 1.1 23.9 3.7 2.3 0.6 0.6 0.7 0.7 6.1 3.5 0.7 0.6 0.6 3.2 1.2 4.0 1.2 0.6 1.9 1.0 0.8 68.9 0.6 0.6 0.6 3.6 0.6 1.6 3.6 4.0 0.0 0.8 8.8 0.6 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.4 0.1 2.4 6.3 0.5 2.4 2.6 4.3 5.2 0.0 1.4 0.0 1.0 4.9 25.2 0.0 1.2 1.1 3.6 0.0 2.6 0.0 0.9 0.0 0.1 0.0 0.0 2.5 0.2 6.9 0.9 1.2 0.3 0.0 2.6 7.3 11.9 0.0 0.0 0.9 2.8 0.0 4.1 0.4 13.4 0.0 0.0 0.0 6.1 11.0 0.0 0.0 8.6 1.5 0.0 4.7 5.4 2.6 0.0 1.7 9.0 0.0 0.0 0.0 12.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.5 0.4 6.8 3.7 2.3 6.1 3.5 4.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 75.0 0.0 0.0 0.0 0.0 1.1 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.6 0.6 0.0 0.0 3.6 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 1.6 1.4 0.0 0.1 0.0 0.0 0.0 POR "CYPOR, FLJ26468" ENSG00000127948 "Cytochrome p450 oxidoreductase" P16435 7 75899200-75986855 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 443.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 74.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004372, HPA010136" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB004372: AB_627391, HPA010136: AB_1079657" "unprognostic (1.89e-1)" "unprognostic (1.53e-1)" "unprognostic (2.81e-3)" "unprognostic (8.67e-2)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (4.32e-2)" "unprognostic (1.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (9.31e-2)" "unprognostic (1.71e-1)" "unprognostic (3.94e-2)" "unprognostic (9.89e-2)" 12.8 48.2 7.4 7.5 10.8 3.6 15.0 5.3 16.4 11.0 20.8 9.6 32.1 24.9 9.0 8.2 13.4 12.8 9.9 8.4 7.1 7.2 12.0 78.4 13.7 9.9 5.2 10.1 14.4 12.8 12.1 18.5 18.6 7.1 9.3 5.3 10.8 7.8 58.7 13.1 10.0 24.3 7.0 5.2 11.7 9.8 22.4 5.0 8.2 33.3 9.9 8.6 9.8 10.2 5.7 20.6 26.7 18.4 11.2 9.9 13.9 12.8 28.2 12.9 24.0 48.9 18.6 21.6 5.4 17.7 10.2 14.3 21.1 57.3 12.3 5.0 11.7 34.8 6.3 16.9 8.5 4.4 10.5 12.5 5.7 8.3 39.0 34.0 5.7 10.2 38.1 10.7 13.4 9.8 8.2 9.4 6.1 17.0 5.3 9.1 18.9 6.1 10.2 16.1 20.2 16.0 8.8 8.5 13.2 11.5 15.6 13.5 12.9 14.5 74.1 19.5 7.6 21.2 9.6 8.5 9.6 10.6 14.4 10.6 5.2 8.0 8.4 13.6 8.7 12.3 26.7 18.4 25.3 9.9 17.7 8.3 5.4 8.4 9.2 20.6 5.7 8.4 7.1 24.3 11.2 13.0 5.8 8.7 13.9 7.4 10.8 5.3 16.4 7.1 7.2 5.2 10.1 7.1 5.0 35.7 31.2 12.6 24.7 15.1 30.1 9.3 56.0 78.9 37.5 69.8 11.8 88.1 1.7 55.5 13.2 25.3 144.8 0.0 25.7 71.6 24.8 20.8 24.3 443.8 58.9 14.3 19.0 27.6 38.6 6.1 70.2 40.5 11.8 16.2 29.0 33.2 24.3 119.3 105.7 27.5 21.8 64.7 30.9 14.7 32.6 12.8 161.6 20.0 36.8 40.7 PORCN "DHOF, MG61, por, PORC, PPN" ENSG00000102312 "Porcupine O-acyltransferase" Q9H237 X 48508962-48520814 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Pancreatic endocrine cells: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 61.3;LHCN-M2: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049215, HPA058413" Enhanced Approved Vesicles NA NA Vesicles "HPA049215: , HPA058413: AB_2683711" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (1.26e-3)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (2.35e-1)" 4.6 31.4 9.1 4.4 14.1 3.6 4.4 20.0 15.4 12.6 4.6 7.2 12.2 3.4 10.1 3.2 13.9 7.0 6.2 13.4 10.9 9.2 3.3 1.7 5.0 6.6 7.1 8.8 4.9 4.6 6.9 4.1 4.0 8.4 5.0 2.5 7.6 5.8 16.4 5.9 6.8 2.9 6.3 5.5 4.8 5.4 5.4 5.9 2.6 8.5 4.7 5.9 6.5 5.4 4.1 7.2 13.7 5.8 7.8 12.0 4.7 4.4 5.3 1.3 9.3 5.7 3.4 0.5 1.3 2.7 2.0 1.4 0.6 6.8 0.3 5.6 2.8 2.3 6.0 1.9 61.3 0.6 2.8 0.6 0.7 3.2 1.3 8.5 0.7 8.0 4.4 7.2 5.9 12.8 4.8 1.8 2.2 0.3 4.2 21.3 1.2 0.7 0.9 1.7 1.3 3.6 1.3 1.6 6.9 3.4 1.7 1.5 2.3 10.7 2.0 2.0 0.9 2.3 0.3 1.1 5.3 2.8 12.8 2.3 3.7 2.0 0.5 15.3 1.6 3.0 13.7 5.8 7.1 12.0 5.2 9.4 3.7 8.0 10.0 7.2 4.1 5.4 8.1 1.2 7.8 4.2 3.9 5.2 4.7 9.1 14.1 20.0 14.4 10.9 9.2 7.1 8.8 8.4 5.9 6.0 3.2 3.0 4.4 3.5 12.7 2.7 2.5 4.0 4.5 15.7 17.7 0.0 1.7 5.2 0.2 3.5 0.0 0.0 8.6 1.1 4.1 2.3 5.7 1.0 3.1 7.9 5.8 4.9 2.8 0.0 5.2 2.9 3.3 2.8 2.0 9.3 22.6 1.5 3.9 0.7 15.7 6.5 4.7 1.0 3.4 3.3 6.9 6.5 1.2 5.6 PPAN-P2RY11 ENSG00000243207 "PPAN-P2RY11 readthrough" 19 10106223-10114780 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.3" "Group enriched" "Detected in many" 8 "NK-cells: 2.3;T-cells: 1.2" "Low cell line specificity" "Detected in many" HPA014232 Uncertain NA NA "HPA014232: AB_1854883" "unprognostic (4.81e-1)" "unprognostic (5.85e-2)" "unprognostic (3.18e-1)" "unprognostic (3.11e-2)" "unprognostic (3.54e-1)" "unprognostic (1.61e-1)" "unprognostic (4.85e-2)" "unprognostic (2.01e-1)" "unprognostic (5.27e-3)" "unprognostic (1.15e-1)" "unprognostic (1.15e-1)" "unprognostic (2.23e-1)" "unprognostic (9.20e-2)" "unprognostic (5.85e-3)" "unprognostic (2.34e-1)" 6.6 3.4 5.0 6.0 8.0 10.7 5.9 7.1 7.7 7.9 9.0 5.0 2.4 6.5 5.8 5.0 5.7 9.3 3.6 3.3 4.7 4.5 4.3 6.9 4.7 7.8 4.8 5.0 7.8 9.2 2.8 6.6 4.3 4.7 7.6 4.0 4.3 7.2 6.2 9.2 10.9 6.2 5.1 3.7 9.5 6.5 7.2 6.6 8.3 7.1 5.9 9.1 7.2 5.4 0.0 0.1 0.1 0.2 2.3 1.2 0.4 1.7 1.5 1.0 3.6 2.0 2.1 7.2 1.1 1.2 1.0 1.8 1.7 1.3 6.8 1.2 0.8 0.3 2.8 2.0 3.3 0.5 3.3 8.6 3.4 2.4 0.5 2.7 2.3 8.1 3.7 3.8 1.4 3.5 1.7 0.9 2.7 2.1 6.0 0.9 4.3 2.9 8.5 5.3 3.2 1.1 6.0 2.4 2.8 2.0 2.6 4.1 7.3 0.2 1.6 7.3 0.1 1.6 5.8 1.6 3.0 1.1 5.2 1.2 10.1 8.0 2.1 3.1 8.9 3.4 0.0 0.0 0.0 0.8 0.2 0.5 0.0 0.1 1.2 0.1 0.0 0.1 0.6 0.1 2.3 0.1 0.0 0.0 0.4 5.0 8.0 7.1 7.6 4.7 4.5 4.8 5.0 4.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPBP "b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1" ENSG00000163736 "Pro-platelet basic protein" P02775 4 73987038-73988197 "Plasma proteins, Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Cytokine, Growth factor, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 206.7;bone marrow: 67.0;lymphoid tissue: 60.0" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Ductal cells: 3.4;Kupffer cells: 8.8;Pancreatic endocrine cells: 4.1" "Cancer enriched" "Detected in many" 7 "colorectal cancer: 86.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 9 "basophil: 30.0;neutrophil: 18.4" "Lineage enriched" "Detected in many" 11 "granulocytes: 30.0" "Cell line enhanced" "Detected in some" "HBEC3-KT: 4.1;HEL: 12.0;RPTEC TERT1: 2.8" "Low region specificity" "Detected in all" "HPA008354, CAB017624" Supported "Secreted to blood" NA NA 24500000 3500000000 "CAB017624: AB_1127132, HPA008354: AB_1847353" "unprognostic (2.13e-1)" "prognostic unfavorable (6.17e-4)" "unprognostic (7.69e-2)" "unprognostic (1.67e-1)" "unprognostic (4.37e-2)" "unprognostic (3.13e-1)" "unprognostic (2.79e-1)" "unprognostic (6.98e-3)" "unprognostic (2.58e-1)" "unprognostic (4.21e-2)" "unprognostic (1.81e-1)" "unprognostic (2.88e-1)" "unprognostic (2.38e-3)" "unprognostic (1.49e-1)" "unprognostic (2.90e-1)" "unprognostic (2.15e-3)" "unprognostic (2.59e-2)" 1.4 0.6 0.4 0.6 1.7 67.0 0.6 0.2 0.4 0.5 0.2 0.1 0.0 0.1 0.3 0.5 0.5 0.8 0.9 35.7 0.3 0.3 0.5 1.9 13.3 0.1 1.6 0.0 6.0 0.4 0.1 0.5 8.7 1.3 0.6 0.2 0.4 0.5 0.1 1.0 0.3 0.2 0.2 1.3 60.0 0.3 0.5 0.0 0.0 2.2 0.9 0.1 1.7 11.0 0.3 2.6 30.0 1.8 0.2 0.5 206.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 30.0 1.8 1.1 0.2 0.6 0.3 0.1 0.1 0.0 1.0 0.3 0.5 0.1 18.4 0.2 0.5 2.6 0.2 206.7 0.4 1.7 0.2 0.4 0.3 0.3 1.6 0.0 1.3 0.0 3.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.8 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 1.3 8.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PPFIA1 "LIP.1, LIPRIN" ENSG00000131626 "PTPRF interacting protein alpha 1" Q13136 11 70270700-70385312 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 163.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 80.2;SK-MEL-30: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017032, HPA042271" Uncertain Supported "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "CAB017032: , HPA042271: AB_2677923" "unprognostic (1.89e-1)" "unprognostic (1.28e-2)" "unprognostic (6.27e-2)" "unprognostic (9.92e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.58e-4)" "unprognostic (7.20e-3)" "unprognostic (2.20e-1)" "unprognostic (3.02e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (8.26e-4)" "unprognostic (1.14e-1)" "prognostic favorable (3.76e-4)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (2.14e-2)" 28.9 18.6 20.9 17.5 20.8 20.8 40.5 22.8 24.1 15.9 18.3 27.7 18.5 15.5 26.2 20.4 19.4 16.9 23.9 19.3 19.7 12.0 18.1 15.5 25.4 15.9 18.9 17.8 21.0 17.7 21.2 34.1 24.9 20.7 13.8 16.3 21.9 19.0 18.5 38.7 24.2 17.8 18.4 30.0 14.7 15.6 29.8 22.5 17.0 25.2 10.0 13.6 18.7 18.6 2.6 2.8 10.0 4.8 1.1 2.2 1.0 80.2 10.8 10.0 6.7 9.3 5.8 10.6 9.4 7.7 11.7 7.8 20.5 7.2 7.5 12.3 7.5 12.0 11.6 8.4 8.1 10.1 5.0 5.9 6.0 11.3 6.5 9.5 7.9 7.4 7.4 13.0 15.1 12.4 9.4 7.5 6.4 10.1 6.1 10.2 10.9 5.4 4.7 5.9 17.1 9.3 6.3 25.1 6.5 5.7 11.0 9.7 6.6 14.0 17.7 46.1 10.8 11.9 8.4 10.3 11.8 9.2 16.3 10.0 7.5 4.7 10.5 9.8 5.5 13.7 0.0 3.6 1.7 1.3 1.9 2.2 2.6 2.2 1.9 2.8 2.3 1.7 1.0 10.0 1.1 4.8 2.8 2.1 1.0 20.9 20.8 22.8 21.4 19.7 12.0 18.9 17.8 20.7 22.5 23.8 49.3 8.8 18.7 24.4 31.5 23.0 22.9 26.8 25.0 17.4 29.5 30.5 10.0 19.2 163.8 25.1 26.3 0.0 17.6 12.0 18.6 32.7 8.1 19.8 21.9 31.8 25.8 20.3 35.7 71.1 25.6 27.2 20.3 20.8 17.6 75.0 27.2 20.3 24.1 18.0 43.9 19.4 21.9 47.9 72.2 29.0 62.1 17.3 16.9 36.9 PPIB "CYPB, OI9" ENSG00000166794 "Peptidylprolyl isomerase B" P23284 15 64155812-64163205 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Isomerase, Rotamase" "Disease mutation, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011487, HPA012720" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum" "Secreted to blood" No No 120000000 "Endoplasmic reticulum" Nucleoplasm "CAB011487: AB_443295, HPA012720: AB_1847399" "unprognostic (3.00e-3)" "unprognostic (5.65e-3)" "unprognostic (2.81e-1)" "prognostic favorable (1.56e-5)" "unprognostic (1.65e-1)" "unprognostic (1.07e-3)" "unprognostic (3.69e-2)" "unprognostic (1.27e-2)" "unprognostic (7.19e-2)" "unprognostic (8.80e-3)" "unprognostic (2.87e-1)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.02e-11)" "unprognostic (7.05e-2)" "unprognostic (3.77e-2)" "unprognostic (1.82e-1)" "unprognostic (3.90e-2)" 56.9 64.3 23.9 49.3 26.9 54.9 48.1 15.1 32.1 75.3 44.1 35.4 102.8 42.0 64.2 106.9 48.0 54.8 58.1 44.5 23.8 27.3 89.5 285.9 57.2 63.8 29.7 19.6 67.5 193.7 26.7 71.8 120.2 27.5 51.0 47.7 36.2 123.3 95.4 19.5 33.1 57.5 54.3 30.7 78.0 47.7 27.2 29.5 53.7 154.3 45.7 69.1 49.2 51.7 63.5 191.6 41.0 51.1 44.9 71.6 87.1 39.7 50.0 45.2 102.6 158.3 91.9 39.8 94.9 124.7 75.2 89.4 71.9 73.8 38.0 77.2 147.0 76.4 64.9 82.5 63.8 38.8 24.1 31.1 53.6 55.2 94.1 166.0 53.4 48.5 84.6 68.8 43.8 106.9 93.2 90.8 18.2 37.3 132.4 56.9 63.5 16.3 82.0 39.4 110.7 32.2 31.2 48.0 193.7 78.0 62.0 25.6 40.3 43.5 74.8 69.1 69.6 44.7 163.5 55.8 75.2 62.3 42.0 64.0 71.9 69.6 39.9 70.2 86.1 75.0 41.0 51.1 33.9 71.6 39.2 71.5 63.5 50.5 58.1 67.4 38.0 33.0 44.2 25.5 44.9 25.2 191.6 40.1 87.1 23.9 26.9 15.1 32.1 23.8 27.3 29.7 19.6 27.5 29.5 116.1 168.3 153.4 361.8 142.3 26.7 0.7 280.2 128.5 194.5 258.2 29.5 546.5 76.3 534.3 16.2 209.5 301.3 70.0 495.6 1107.3 581.4 486.2 176.7 431.7 566.9 42.9 284.9 371.4 213.7 20.8 422.5 284.2 266.6 285.9 313.7 126.6 471.5 326.7 369.5 231.9 33.9 226.4 234.9 37.1 72.8 126.6 935.7 261.7 353.5 357.9 PPIC CYPC ENSG00000168938 "Peptidylprolyl isomerase C" P45877 5 123023250-123036741 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Fibroblasts: 273.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039163 Approved "Intracellular and membrane" NA NA 5700000 "HPA039163: AB_2676374" "unprognostic (7.81e-2)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" "unprognostic (7.44e-2)" "unprognostic (2.03e-1)" "unprognostic (7.49e-2)" "prognostic unfavorable (4.78e-4)" "unprognostic (1.39e-1)" "unprognostic (1.37e-2)" "unprognostic (3.88e-3)" "unprognostic (1.67e-1)" "unprognostic (1.31e-1)" "unprognostic (3.37e-1)" "unprognostic (1.70e-1)" "unprognostic (2.38e-1)" "unprognostic (4.27e-2)" "unprognostic (2.43e-2)" 22.5 13.7 3.3 10.8 3.6 0.0 29.9 1.6 4.2 24.3 30.0 3.6 26.6 15.7 20.4 32.7 35.5 9.0 25.8 43.7 4.0 2.7 27.4 24.0 16.3 9.0 3.7 2.1 13.3 24.3 8.7 5.8 28.3 10.0 17.8 22.0 5.3 25.9 18.0 18.4 12.0 35.2 37.9 5.4 8.9 13.5 8.0 3.2 2.5 42.7 29.6 12.9 31.5 21.5 0.0 1.1 0.0 0.1 0.0 0.3 0.0 4.7 4.1 1.6 33.9 58.9 27.1 6.7 13.4 10.5 7.0 14.4 6.8 31.8 0.0 23.8 35.9 21.0 5.3 4.6 16.8 5.6 0.0 8.2 6.7 15.4 7.8 15.1 0.0 3.7 16.9 12.9 8.1 8.6 12.6 14.4 0.0 1.8 0.0 5.0 27.9 0.0 0.0 2.9 29.2 7.2 0.0 3.6 0.0 22.0 16.3 2.1 3.7 26.2 12.7 2.8 20.5 17.9 15.0 15.9 13.4 8.4 4.6 5.7 0.0 0.0 0.0 11.6 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.3 0.0 3.3 3.6 1.6 4.2 4.0 2.7 3.7 2.1 10.0 3.2 29.8 13.9 0.9 43.9 42.1 13.9 38.9 53.5 25.4 14.8 69.8 3.9 50.1 24.9 171.5 1.0 100.3 130.1 0.0 111.8 45.8 273.0 38.3 1.1 48.9 36.5 0.0 12.2 66.9 4.8 3.5 104.2 7.7 30.4 5.4 148.2 1.8 98.5 178.9 94.0 64.2 3.8 38.8 61.4 26.6 14.1 43.2 20.9 2.2 72.5 66.5 PPIL3 CyPJ ENSG00000240344 "Peptidylprolyl isomerase like 3" Q9H2H8 2 200870907-200889303 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040765, HPA062187" Approved Approved Nucleoplasm,Nucleoli NA NA 35000 Nucleoplasm Nucleoli "HPA040765: AB_2677125, HPA062187: AB_2684706" "unprognostic (8.96e-3)" "unprognostic (6.07e-2)" "unprognostic (5.34e-2)" "unprognostic (8.16e-2)" "unprognostic (2.69e-2)" "unprognostic (9.61e-2)" "unprognostic (8.31e-2)" "unprognostic (8.05e-2)" "unprognostic (1.40e-2)" "prognostic favorable (1.19e-4)" "unprognostic (5.23e-2)" "unprognostic (6.60e-2)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" "unprognostic (2.21e-2)" "unprognostic (4.87e-2)" 12.4 17.9 18.1 15.5 19.2 24.2 21.1 20.1 20.2 19.4 16.4 18.4 21.1 12.7 17.2 24.3 25.4 19.1 15.9 17.6 17.5 21.8 15.9 19.4 15.9 23.7 20.0 11.8 31.4 16.7 11.9 17.4 15.5 23.0 19.5 16.6 16.3 13.8 15.8 13.4 14.7 15.7 16.8 23.2 20.2 15.7 18.2 13.0 26.3 23.7 19.4 25.5 28.6 13.6 23.4 21.7 18.7 14.1 20.6 20.6 10.7 8.0 7.1 22.1 9.6 17.3 37.2 7.2 12.8 13.9 14.8 15.0 5.2 15.2 7.7 13.6 13.8 17.4 10.6 7.7 15.6 13.3 16.3 18.5 32.5 19.9 35.1 8.9 31.1 16.5 13.5 15.3 12.1 19.1 25.0 9.8 15.3 25.7 18.9 18.8 12.8 23.9 24.8 13.5 8.1 11.5 9.1 12.4 12.1 19.4 12.4 9.2 8.5 12.9 12.3 20.6 27.1 10.2 14.2 13.4 21.3 12.1 12.6 10.5 20.7 19.6 36.3 16.3 13.9 13.5 18.7 12.7 12.7 12.7 10.8 18.5 23.4 15.6 13.7 21.7 18.9 19.1 20.6 3.0 20.6 14.1 17.9 20.1 10.7 18.1 19.2 20.1 20.2 17.5 21.8 20.0 11.8 23.0 13.0 0.0 11.5 24.3 38.6 28.2 12.5 17.8 17.8 21.4 11.4 15.7 9.8 45.1 48.0 20.2 14.8 15.7 12.9 0.0 14.0 44.2 34.2 17.7 25.4 15.7 41.6 3.2 9.1 16.0 41.1 2.7 33.9 45.8 27.0 23.4 25.0 17.1 18.9 24.6 26.5 45.3 10.5 19.4 29.4 36.5 22.3 40.5 25.7 32.6 29.2 23.7 PPM1L PP2CE ENSG00000163590 "Protein phosphatase, Mg2+/Mn2+ dependent 1L" Q5SGD2 3 160755602-161078907 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 59.9;Cardiomyocytes: 33.6;Cone photoreceptor cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "HDLM-2: 35.6;U-266/70: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019891, HPA019953" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA019891: AB_1855631, HPA019953: AB_2170360" "prognostic unfavorable (4.90e-4)" "unprognostic (7.29e-3)" "unprognostic (2.01e-1)" "unprognostic (2.59e-2)" "unprognostic (8.03e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (1.63e-2)" "unprognostic (2.49e-2)" "unprognostic (1.92e-1)" "unprognostic (4.51e-2)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (9.13e-3)" "unprognostic (2.07e-1)" 7.7 8.5 7.4 3.5 11.5 3.3 6.3 15.8 23.2 11.3 7.0 5.5 1.1 3.0 6.2 3.7 8.7 6.1 12.6 9.9 6.3 7.8 8.4 6.0 4.6 1.9 8.0 10.1 3.7 5.4 33.6 26.3 11.5 13.8 9.6 5.9 5.6 18.9 3.7 25.7 7.6 3.6 16.4 4.6 3.4 8.4 2.8 3.7 5.6 14.4 9.6 3.5 16.6 10.8 0.7 1.3 4.9 7.6 1.1 2.6 2.0 1.2 0.8 4.1 2.1 2.4 0.0 2.5 0.2 0.1 0.4 0.1 0.2 0.2 0.2 0.4 0.1 0.9 3.7 3.4 0.2 0.1 35.6 3.6 3.5 3.3 0.4 0.1 2.1 4.1 0.4 1.6 0.1 0.2 0.3 0.2 1.7 0.1 5.6 0.0 1.9 0.8 0.2 2.3 6.5 0.8 4.2 0.7 0.8 0.1 3.8 4.9 4.2 2.0 2.4 0.1 1.4 2.7 2.1 0.2 0.4 0.4 0.3 1.3 35.6 0.1 2.0 0.6 1.8 0.8 0.7 2.3 4.9 2.6 5.5 0.2 0.2 0.6 1.7 1.3 0.7 1.0 1.8 0.2 1.1 7.6 0.8 0.0 2.0 7.4 11.5 15.8 17.9 6.3 7.8 8.0 10.1 13.8 3.7 6.0 2.4 0.0 5.2 7.7 59.9 33.6 10.2 13.4 5.7 1.8 33.4 2.4 0.0 1.5 1.1 2.4 3.8 0.0 3.7 1.6 7.0 6.0 0.0 14.9 5.9 6.4 13.3 0.6 12.4 0.4 4.6 7.2 3.3 2.8 7.6 9.3 1.7 7.0 4.9 3.3 10.1 0.0 11.2 1.5 3.1 7.5 2.2 2.9 4.9 18.0 PPP1R3A "GM, PPP1R3" ENSG00000154415 "Protein phosphatase 1 regulatory subunit 3A" Q16821 7 113876777-114075920 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "heart muscle: 24.1;skeletal muscle: 69.4;tongue: 75.4" "Cell type enriched" "Detected in some" 13 "Cardiomyocytes: 136.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 64 "THP-1: 18.1" "Region enriched" "Detected in single" 19 "thalamus: 1.2" "Not detected" "Not detected" "HPA070440, HPA073138" Enhanced NA NA "HPA070440: , HPA073138: " "unprognostic (8.96e-3)" 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.7 0.0 0.0 24.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.4 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 75.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 PPP1R3F Hb2E ENSG00000049769 "Protein phosphatase 1 regulatory subunit 3F" Q6ZSY5 X 49269843-49301461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 35.3;Horizontal cells: 46.1;Rod photoreceptor cells: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "T-reg: 15.3" "Lineage enriched" "Detected in single" 16 "T-cells: 15.3" "Cell line enhanced" "Detected in many" "GAMG: 18.0;HDLM-2: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000244, HPA000918" Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA000244: AB_2665949, HPA000918: AB_2268692" "unprognostic (6.69e-2)" "unprognostic (2.87e-2)" "unprognostic (4.98e-4)" "unprognostic (1.83e-2)" "unprognostic (6.48e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-1)" "unprognostic (5.17e-2)" "unprognostic (1.91e-2)" "unprognostic (2.89e-1)" "prognostic favorable (1.85e-6)" "unprognostic (5.99e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "unprognostic (2.76e-1)" "unprognostic (7.96e-2)" "unprognostic (1.55e-1)" 3.0 7.6 15.9 3.7 13.8 2.7 2.3 17.2 21.2 4.3 3.5 7.6 4.5 2.4 4.7 15.9 5.4 6.7 3.6 16.1 16.0 13.1 3.3 2.8 3.4 4.6 12.3 5.4 7.5 2.6 4.4 8.6 2.4 9.1 4.6 1.7 5.3 5.3 6.1 24.0 3.1 3.1 4.1 11.3 5.1 2.9 4.5 7.3 3.5 5.5 1.9 3.0 3.5 4.8 0.4 0.3 0.0 0.9 0.4 15.3 0.5 2.4 5.0 4.4 4.9 6.1 4.4 2.1 2.9 4.5 1.9 3.1 3.5 2.9 2.9 0.6 2.1 18.0 3.9 1.7 1.2 1.0 15.8 5.5 0.3 2.9 0.3 4.0 0.4 1.8 3.0 3.6 2.0 1.6 4.5 0.5 4.0 0.7 1.2 2.3 8.7 1.1 3.9 13.6 0.6 9.5 6.4 3.8 0.9 1.9 1.1 5.2 4.5 1.5 0.5 7.4 9.8 4.5 2.5 2.3 5.5 1.1 4.8 2.1 3.6 4.5 1.9 1.8 6.2 6.9 0.0 0.2 0.0 0.2 0.4 1.0 0.4 3.0 1.0 0.2 0.1 2.4 1.1 0.0 0.4 0.9 0.3 15.3 0.5 15.9 13.8 17.2 19.3 16.0 13.1 12.3 5.4 9.1 7.3 0.0 0.3 0.5 2.5 1.6 35.3 13.7 0.0 2.7 0.0 3.5 7.9 0.8 6.6 0.4 0.1 1.9 0.0 0.0 0.2 0.1 3.0 1.6 0.0 0.8 0.6 46.1 2.9 1.8 0.0 0.4 4.4 0.9 0.0 0.0 0.0 9.7 0.4 0.0 2.8 4.9 15.4 0.0 3.9 0.5 5.6 1.1 1.0 1.5 0.0 2.2 PPT2 ENSG00000221988 "Palmitoyl-protein thioesterase 2" Q9UMR5 6 32153441-32163680 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 15.7;Syncytiotrophoblasts: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 16.0;EFO-21: 11.8;HEK 293: 20.4;MCF7: 8.7;RPTEC TERT1: 10.1;SK-MEL-30: 13.3;SuSa: 10.4" HPA000414 Supported Vesicles "Intracellular and membrane" NA NA Vesicles "HPA000414: " "unprognostic (1.90e-2)" "unprognostic (1.09e-1)" "unprognostic (2.95e-1)" "prognostic unfavorable (5.03e-5)" "unprognostic (1.62e-1)" "unprognostic (6.75e-3)" "unprognostic (2.92e-3)" "unprognostic (6.41e-3)" "unprognostic (7.12e-2)" "unprognostic (2.56e-3)" "unprognostic (5.28e-3)" "unprognostic (1.12e-2)" "unprognostic (2.75e-3)" "unprognostic (5.09e-2)" "unprognostic (2.94e-1)" "unprognostic (4.89e-2)" "unprognostic (1.24e-3)" 8.5 13.1 10.4 9.3 10.6 3.0 9.6 21.9 11.8 16.1 10.5 13.1 11.7 15.8 13.8 14.9 13.7 14.2 10.6 12.3 10.7 7.5 17.8 13.1 14.3 6.6 12.2 7.7 25.1 7.0 3.1 7.7 14.3 9.8 10.5 9.6 16.1 7.2 11.4 19.1 30.9 6.9 10.4 7.1 11.8 15.2 6.4 11.5 11.5 7.4 13.2 8.1 13.9 12.0 0.2 0.0 0.3 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 16.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.8 0.0 4.8 1.6 2.6 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.1 0.0 1.2 1.3 0.0 7.4 0.0 0.4 1.0 8.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.1 7.0 0.2 13.3 10.4 0.0 0.4 0.0 0.0 6.0 0.0 0.0 0.5 7.1 0.9 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.4 0.0 10.4 10.6 21.9 11.8 10.7 7.5 12.2 7.7 9.8 11.5 0.0 0.3 0.0 2.7 3.0 12.0 5.8 2.5 0.0 3.4 3.5 15.7 11.6 1.7 1.4 0.2 4.6 1.3 0.0 2.6 7.8 4.8 1.0 0.0 3.9 2.4 3.2 4.7 4.9 1.5 1.0 3.7 1.4 6.8 0.0 2.9 7.5 1.3 3.4 2.8 2.3 5.2 0.0 4.7 3.1 4.5 1.9 19.5 1.3 2.8 1.3 PQLC1 FLJ22378 ENSG00000122490 "PQ loop repeat containing 1" Q8N2U9 18 79902420-79951664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 150.7;Late spermatids: 119.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051666 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051666: AB_2681567" "unprognostic (6.03e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-1)" "unprognostic (6.45e-2)" "unprognostic (3.94e-2)" "unprognostic (2.07e-2)" "unprognostic (1.39e-1)" "unprognostic (2.47e-1)" "unprognostic (2.50e-1)" "unprognostic (4.58e-2)" "unprognostic (1.02e-2)" "unprognostic (4.34e-1)" "unprognostic (1.40e-3)" "unprognostic (2.00e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.70e-2)" 31.3 12.5 17.4 12.4 16.6 28.3 23.0 12.5 27.0 9.4 16.9 12.3 9.6 8.9 13.4 12.0 20.0 10.8 13.2 13.8 21.3 12.6 16.5 56.7 14.3 14.2 13.0 13.8 9.9 23.8 8.0 8.5 9.5 14.2 10.8 7.1 19.9 21.4 10.1 29.6 19.2 10.0 12.4 7.5 14.0 10.1 22.9 9.7 8.7 25.8 14.4 13.6 11.7 15.8 1.7 7.2 3.8 3.8 2.0 2.5 1.9 16.5 5.7 5.8 11.3 13.1 8.5 8.0 10.9 7.5 8.8 8.3 7.5 9.0 6.9 4.3 9.8 5.1 17.0 8.0 11.6 2.3 21.5 11.7 8.8 8.0 20.2 15.7 20.9 22.3 9.4 11.6 8.0 3.1 4.5 7.5 7.7 3.3 5.7 4.5 12.6 10.3 22.5 1.9 2.2 15.5 18.5 6.1 11.6 5.9 11.9 17.3 7.8 8.2 10.5 12.0 1.6 6.2 23.0 9.4 13.4 13.8 7.1 8.2 3.0 4.6 9.0 10.3 25.5 5.9 0.7 3.8 3.8 1.7 3.8 1.0 1.7 1.7 0.8 4.0 1.5 2.1 2.5 2.5 2.0 3.1 7.2 1.5 1.9 17.4 16.6 12.5 27.0 21.3 12.6 13.0 13.8 14.2 9.7 23.8 16.5 28.9 22.8 35.4 28.8 10.5 15.3 4.0 6.8 5.2 70.7 11.6 1.7 8.6 85.6 20.5 37.1 0.0 12.8 11.6 14.5 23.0 19.5 150.7 31.2 87.4 15.5 18.4 32.9 119.4 18.4 20.5 18.6 7.2 29.7 21.7 13.1 35.1 22.3 16.5 33.4 6.5 19.8 8.6 10.2 44.2 17.4 8.6 26.2 38.7 PQLC2 FLJ20320 ENSG00000040487 "PQ loop repeat containing 2" Q6ZP29 1 19312326-19329300 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 31.3;Syncytiotrophoblasts: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057810 Approved Supported Vesicles NA NA Vesicles "HPA057810: AB_2683535" "unprognostic (7.84e-3)" "unprognostic (6.56e-2)" "unprognostic (6.54e-2)" "prognostic favorable (3.50e-4)" "unprognostic (3.77e-3)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.64e-5)" "unprognostic (2.61e-1)" "unprognostic (4.47e-2)" "unprognostic (1.04e-1)" "unprognostic (1.42e-3)" "unprognostic (3.82e-2)" "unprognostic (4.70e-3)" "unprognostic (8.64e-2)" "unprognostic (2.07e-1)" "unprognostic (6.56e-2)" "unprognostic (4.46e-2)" 10.9 19.9 11.7 8.5 12.3 18.4 9.4 28.8 16.2 12.2 13.1 16.8 8.6 16.9 11.5 15.5 9.2 8.8 11.1 9.3 10.6 11.2 11.9 20.3 12.1 11.1 14.3 9.1 10.9 19.4 10.0 19.4 24.8 14.4 11.7 7.7 18.9 12.1 11.0 10.9 15.3 16.2 9.3 12.2 12.2 13.3 13.8 10.9 6.2 14.0 9.2 10.5 8.0 9.0 5.1 16.7 7.8 10.1 2.9 3.4 3.5 8.1 8.6 8.1 12.9 7.9 7.5 10.3 10.3 14.2 14.4 12.3 12.5 10.4 2.6 13.5 7.5 20.1 6.2 7.9 9.2 6.5 5.5 9.6 2.0 7.4 13.4 22.7 1.7 3.6 12.3 9.7 20.4 6.5 8.1 5.5 4.7 14.7 6.1 13.8 7.3 1.1 5.7 7.8 2.9 7.7 4.5 10.2 4.6 10.9 5.4 10.0 8.4 7.7 5.2 19.7 7.6 8.8 20.3 7.3 12.1 7.0 20.4 9.1 10.7 7.4 1.4 14.8 10.2 9.8 0.9 8.7 7.8 3.2 7.1 2.4 5.1 3.4 2.7 11.1 5.0 1.0 2.1 5.4 2.9 10.1 16.7 3.1 3.5 11.7 12.3 28.8 16.2 10.6 11.2 14.3 9.1 14.4 10.9 3.0 6.5 6.0 2.9 1.6 11.6 2.2 5.1 2.7 5.7 5.2 5.9 23.5 5.0 14.8 0.4 3.7 9.1 0.0 10.2 15.3 6.1 4.3 3.5 9.8 31.3 6.4 9.9 1.8 6.9 2.3 5.8 7.5 3.3 9.0 5.9 9.8 13.8 5.8 3.2 4.3 8.6 0.0 3.6 7.2 4.1 2.6 50.6 4.3 6.6 2.0 PQLC3 "C2orf22, MGC33602" ENSG00000162976 "PQ loop repeat containing 3" Q8N755 2 11155198-11178874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 30.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061607 Approved Cytosol NA NA Cytosol "HPA061607: AB_2797264" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (2.19e-1)" "unprognostic (5.55e-2)" "unprognostic (1.65e-2)" "unprognostic (2.16e-1)" "unprognostic (1.09e-3)" "unprognostic (9.11e-2)" "unprognostic (3.14e-1)" "unprognostic (2.24e-1)" "unprognostic (4.93e-3)" "unprognostic (2.93e-1)" "unprognostic (1.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.21e-1)" "unprognostic (2.34e-1)" "unprognostic (4.00e-2)" 26.9 21.3 5.1 16.5 6.2 4.2 16.7 2.4 6.2 22.2 14.4 11.3 8.6 5.6 19.7 27.0 18.1 15.4 19.5 14.9 5.4 5.1 20.6 9.8 21.0 26.9 7.9 5.8 20.7 33.3 5.3 5.4 15.5 7.8 18.5 10.5 15.5 14.1 11.2 14.0 9.8 16.5 19.8 13.1 26.3 12.7 12.0 5.7 12.0 17.6 13.0 15.0 15.7 14.7 11.4 36.9 37.0 46.9 14.4 18.4 33.0 3.1 10.8 2.0 6.1 30.8 21.1 7.3 6.6 8.7 3.1 3.7 2.0 12.5 1.1 5.0 12.9 13.6 4.1 3.1 3.4 3.2 20.0 1.6 3.0 1.4 1.3 12.3 1.5 9.3 15.3 11.6 2.0 4.5 6.9 7.0 7.1 2.8 7.0 8.5 14.3 2.2 3.0 4.3 11.2 3.8 2.8 3.3 3.4 11.6 5.4 0.7 3.4 5.6 17.6 12.4 9.3 15.7 5.5 9.9 4.5 1.9 4.8 1.8 12.0 8.7 0.5 11.9 7.1 8.8 15.1 37.3 37.0 18.4 45.7 16.1 11.4 18.2 18.0 36.9 7.7 10.1 13.9 2.3 14.4 46.9 7.1 18.2 33.0 5.1 6.2 2.4 6.2 5.4 5.1 7.9 5.8 7.8 5.7 23.8 6.2 18.0 19.8 22.2 1.7 2.4 20.4 12.0 14.8 50.6 15.7 16.2 8.3 32.7 0.5 17.5 10.7 0.0 56.6 70.6 37.3 19.5 12.7 10.9 53.1 1.6 6.4 38.6 87.8 0.7 43.4 62.1 55.6 84.8 10.7 4.5 41.4 3.5 55.5 11.7 0.9 58.2 38.7 2.1 18.5 20.5 9.4 45.9 11.5 16.9 PRAC2 "C17orf93, HOXB-AS5, HOXB13-AS1, NCRNA00253" ENSG00000229637 "Prostate cancer susceptibility candidate 2" D3DTV9 17 48723168-48724758 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "intestine: 11.2;prostate: 12.8;urinary bladder: 3.4" "Cell type enhanced" "Detected in some" 8 "Basal glandular cells: 28.5;Early spermatids: 35.3;Glandular cells: 28.1;Intestinal endocrine cells: 30.7;Late spermatids: 33.5;Undifferentiated cells: 22.4;Urothelial cells: 19.2" "Cancer enriched" "Detected in many" 8 "prostate cancer: 26.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "PC-3: 32.0;REH: 12.5" "Intracellular and membrane" NA NA "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (4.26e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-2)" "unprognostic (9.98e-2)" "unprognostic (3.27e-2)" "unprognostic (9.77e-2)" "unprognostic (8.97e-2)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 5.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 12.8 11.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.8 32.0 12.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 0.0 5.9 0.0 0.0 0.0 0.4 28.1 0.0 0.0 0.1 0.0 30.7 0.0 0.0 33.5 0.3 0.0 0.0 0.0 17.4 0.0 0.0 8.6 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 22.4 19.2 PRADC1 "C2orf7, hPAP21, MGC13004, PAP21" ENSG00000135617 "Protease associated domain containing 1" Q9BSG0 2 73228006-73233238 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 59.4" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051066 Approved "Secreted to blood" NA NA "HPA051066: AB_2681333" "unprognostic (2.94e-1)" "unprognostic (1.93e-2)" "unprognostic (1.22e-1)" "unprognostic (1.12e-1)" "unprognostic (9.23e-2)" "unprognostic (3.93e-2)" "unprognostic (8.54e-2)" "unprognostic (9.08e-3)" "unprognostic (2.60e-2)" "unprognostic (1.73e-1)" "unprognostic (1.09e-3)" "unprognostic (9.99e-3)" "unprognostic (3.56e-2)" "unprognostic (2.96e-1)" "unprognostic (4.89e-1)" "unprognostic (1.93e-1)" "unprognostic (9.23e-2)" 10.3 12.0 11.6 5.6 13.9 4.2 22.5 9.3 13.3 6.2 12.3 6.7 6.6 13.6 4.5 9.5 9.1 4.1 6.4 37.3 10.6 7.7 11.8 23.3 6.4 14.4 10.6 7.3 3.9 39.7 4.8 8.3 4.7 10.9 6.6 12.0 6.9 25.6 8.7 59.4 6.7 16.2 13.1 9.6 8.5 8.7 9.6 7.0 4.1 7.8 22.2 5.8 7.5 5.7 6.2 25.6 11.6 33.8 13.3 10.5 15.0 8.2 7.0 7.0 13.4 22.0 8.6 9.3 13.8 6.5 14.2 8.2 19.5 8.8 9.1 8.0 16.1 12.8 7.8 11.1 9.6 10.1 13.7 10.0 13.7 10.0 14.6 6.8 7.2 13.7 11.1 5.9 12.7 6.8 4.1 13.1 16.6 11.9 20.0 16.2 17.5 20.0 13.7 2.1 39.3 28.2 11.6 27.3 28.6 7.9 8.1 14.6 4.8 6.6 18.3 6.4 7.9 9.7 6.5 6.8 16.5 6.5 14.1 12.4 21.0 15.8 8.2 10.6 15.9 6.7 4.1 12.3 11.6 9.1 28.9 7.4 6.1 8.9 8.5 12.7 6.2 8.4 7.4 1.6 13.3 33.8 25.6 10.5 15.0 11.6 13.9 9.3 13.3 10.6 7.7 10.6 7.3 10.9 7.0 8.9 5.8 9.3 10.2 13.9 13.7 52.0 15.3 6.7 5.7 14.0 7.9 22.4 61.3 20.8 39.5 14.7 47.7 0.0 40.8 39.3 23.7 7.9 28.8 55.1 42.8 11.1 31.0 30.7 18.1 109.7 15.5 14.2 15.1 1.0 41.5 20.9 19.4 28.1 15.2 56.4 20.4 32.3 14.7 23.2 19.6 21.0 11.3 11.3 48.1 8.2 PRAF2 "JM4, Yip6a" ENSG00000243279 "PRA1 domain family member 2" O60831 X 49071156-49074071 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 125.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002859, HPA005504, CAB011655" Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "CAB011655: , HPA002859: AB_1079672, HPA005504: AB_2667340" "unprognostic (1.50e-1)" "prognostic favorable (7.42e-4)" "unprognostic (1.17e-2)" "unprognostic (1.32e-2)" "unprognostic (4.29e-1)" "unprognostic (3.67e-1)" "prognostic unfavorable (1.66e-6)" "prognostic favorable (2.81e-4)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "prognostic favorable (4.88e-6)" "unprognostic (8.39e-3)" "prognostic unfavorable (5.83e-6)" "unprognostic (4.96e-2)" "unprognostic (1.69e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" 13.5 17.5 25.0 12.3 26.9 6.7 9.0 18.0 39.7 28.1 11.8 26.3 12.6 6.0 22.1 125.1 7.3 15.6 12.3 12.9 25.3 29.9 12.4 6.9 11.5 11.3 26.1 18.9 20.1 6.2 19.7 31.0 9.8 25.5 12.2 10.0 13.0 7.5 29.4 6.8 7.6 6.6 33.2 23.1 10.9 9.2 17.7 17.0 14.4 13.3 3.8 11.9 12.6 10.7 14.6 6.7 16.4 6.4 16.8 29.4 11.1 4.5 9.6 11.3 14.4 40.6 24.7 1.5 16.4 17.1 11.1 12.3 0.5 1.5 0.4 3.9 35.4 9.2 4.3 0.4 8.9 12.4 8.4 12.8 3.6 12.5 0.4 41.6 2.3 7.1 31.3 7.6 21.1 15.4 23.0 17.0 11.5 0.5 1.3 19.4 8.4 15.1 2.9 6.3 2.2 0.6 8.3 6.2 1.0 16.5 1.3 7.5 18.8 13.7 7.1 9.3 10.3 6.9 1.6 10.3 8.6 11.4 18.4 4.7 20.4 5.1 3.7 20.7 4.2 13.3 16.4 5.9 7.9 18.3 6.4 20.7 14.6 20.1 16.1 6.7 13.6 18.1 19.4 15.4 16.8 4.8 2.6 29.4 11.1 25.0 26.9 18.0 39.7 25.3 29.9 26.1 18.9 25.5 17.0 11.9 7.7 10.0 12.1 6.8 21.7 5.1 12.7 10.7 9.1 10.4 11.8 2.9 10.0 14.9 2.9 30.3 1.3 0.0 5.0 10.4 36.2 8.7 16.1 2.5 5.8 15.9 9.8 23.9 4.6 3.5 35.4 7.7 13.5 3.6 3.4 26.4 4.6 0.0 38.9 15.8 6.7 19.4 40.1 10.7 3.9 6.5 8.1 25.3 1.3 8.1 PRCP "HUMPCP, PCP" ENSG00000137509 Prolylcarboxypeptidase P42785 11 82823502-82970584 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ito cells: 392.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 99.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017065, HPA071115" Approved Supported Vesicles "Intracellular and membrane" NA NA 34000000 Vesicles "HPA017065: AB_1855676, HPA071115: " "unprognostic (3.24e-1)" "unprognostic (2.25e-1)" "unprognostic (1.76e-1)" "unprognostic (1.51e-1)" "unprognostic (2.54e-1)" "unprognostic (1.33e-2)" "unprognostic (9.22e-2)" "unprognostic (1.42e-1)" "unprognostic (7.97e-2)" "unprognostic (2.61e-1)" "unprognostic (2.70e-1)" "unprognostic (1.88e-2)" "prognostic favorable (2.65e-6)" "unprognostic (7.16e-2)" "unprognostic (1.73e-2)" "unprognostic (3.49e-1)" "unprognostic (4.07e-1)" 32.6 45.9 25.0 21.5 22.2 13.1 69.5 19.4 23.8 38.8 17.9 17.9 27.6 11.0 30.7 35.5 32.2 24.6 25.6 66.3 25.8 18.9 52.4 52.5 38.1 95.1 27.0 14.8 27.8 23.4 30.6 19.3 59.8 34.9 25.1 18.4 25.1 38.1 34.5 10.3 26.2 15.7 32.8 45.0 25.1 16.8 17.4 17.7 9.8 27.9 24.2 31.7 39.4 30.1 13.1 50.0 31.2 27.9 12.1 6.2 14.7 7.5 8.3 12.8 25.7 99.0 36.4 15.0 16.2 28.9 15.5 22.8 20.5 15.7 10.9 23.7 23.5 17.6 12.0 11.6 10.7 18.2 9.7 8.4 7.8 11.6 12.7 18.5 7.0 28.6 26.5 8.3 16.2 15.3 38.1 51.4 6.0 8.3 15.4 15.9 3.4 1.0 25.0 7.4 18.5 7.7 5.7 22.2 13.0 21.7 14.0 5.3 11.6 22.2 12.8 9.1 19.7 15.4 9.6 13.3 18.3 18.4 15.8 7.9 14.5 24.6 9.8 7.5 8.5 9.4 15.5 26.4 17.4 5.3 27.9 6.1 9.9 5.3 5.8 50.0 13.1 4.4 6.2 31.2 12.1 21.2 8.9 5.0 14.7 25.0 22.2 19.4 23.8 25.8 18.9 27.0 14.8 34.9 17.7 17.9 14.6 43.2 35.5 27.8 10.0 19.8 43.3 5.3 12.5 59.3 2.0 49.3 24.9 28.4 24.0 120.7 4.9 0.0 10.6 99.1 49.9 26.3 12.7 56.8 72.6 15.9 18.9 392.8 149.3 39.4 40.9 76.3 67.4 54.1 18.6 57.0 10.0 7.0 43.5 76.8 4.3 64.7 26.8 23.6 5.7 30.6 44.3 25.4 19.9 33.8 PRDX4 AOE37-2 ENSG00000123131 "Peroxiredoxin 4" Q13162 X 23664262-23686399 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "liver: 127.6;pancreas: 320.8" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 604.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008659, CAB027389, CAB047362, HPA067039" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 11000000 "Endoplasmic reticulum, Cytosol" "CAB008659: AB_1620984, CAB027389: , CAB047362: , HPA067039: " "unprognostic (3.82e-2)" "unprognostic (6.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.06e-3)" "unprognostic (1.64e-1)" "unprognostic (1.65e-2)" "unprognostic (1.29e-3)" "unprognostic (1.08e-1)" "unprognostic (8.32e-2)" "unprognostic (3.75e-2)" "unprognostic (2.97e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.33e-6)" "unprognostic (7.44e-2)" "unprognostic (1.29e-1)" "unprognostic (3.56e-1)" "unprognostic (4.10e-2)" 11.6 14.8 3.8 7.0 6.4 3.9 11.2 3.3 5.4 13.2 10.7 6.5 17.4 8.9 11.5 10.5 13.1 9.6 12.9 17.6 3.8 4.0 11.8 127.6 8.9 16.9 7.2 4.0 14.6 320.8 6.1 15.8 21.9 7.4 9.3 11.4 8.0 25.4 14.1 7.8 7.2 10.6 8.8 8.1 12.6 12.8 25.2 6.1 4.7 12.0 10.0 15.0 10.8 8.7 27.9 31.4 2.0 39.3 24.1 22.7 21.3 23.9 33.1 14.0 27.1 76.5 39.1 19.7 32.3 35.2 29.4 42.8 34.6 30.2 20.6 15.2 41.8 34.1 29.1 40.3 20.0 28.1 12.6 77.5 14.6 29.2 43.8 31.9 18.8 13.9 41.4 26.0 28.5 28.7 32.0 36.7 6.9 28.2 76.2 27.1 35.7 9.6 29.5 48.4 47.1 48.6 13.3 35.1 116.3 26.2 8.4 20.6 17.5 29.8 35.3 23.8 80.2 37.3 24.0 24.2 21.0 13.8 54.0 24.2 25.0 30.2 22.1 37.5 24.4 29.8 1.7 20.6 2.0 17.8 32.2 21.8 27.9 22.7 18.6 31.4 16.2 16.4 16.7 1.5 24.1 39.3 22.0 22.1 21.3 3.8 6.4 3.3 5.4 3.8 4.0 7.2 4.0 7.4 6.1 53.6 69.3 34.3 72.4 53.0 14.1 33.1 117.2 62.9 56.9 47.1 7.9 283.9 8.3 219.7 305.3 87.4 33.6 23.3 310.3 449.8 156.0 130.0 41.6 497.8 155.7 11.1 56.3 100.1 55.2 604.6 233.8 49.6 189.0 103.6 79.9 51.0 268.1 31.6 135.4 36.5 17.9 142.3 69.0 183.9 270.0 45.7 216.3 25.4 110.8 64.0 PREB SEC12 ENSG00000138073 "Prolactin regulatory element binding" Q9HCU5 2 27130756-27134675 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 89.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013582, HPA014133" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA013582: AB_1855694, HPA014133: AB_1855695" "unprognostic (2.32e-1)" "unprognostic (2.11e-1)" "unprognostic (2.66e-2)" "unprognostic (1.61e-1)" "unprognostic (2.01e-2)" "unprognostic (1.21e-2)" "unprognostic (4.96e-3)" "unprognostic (1.44e-1)" "unprognostic (9.89e-2)" "unprognostic (1.21e-3)" "unprognostic (1.24e-2)" "unprognostic (2.69e-1)" "unprognostic (2.33e-3)" "unprognostic (5.13e-2)" "unprognostic (4.14e-2)" "unprognostic (5.25e-2)" "unprognostic (1.28e-2)" 18.7 17.1 11.4 14.4 12.3 7.9 15.7 13.8 16.9 18.5 15.5 14.9 29.1 13.4 23.6 51.1 15.1 17.6 14.2 19.5 13.8 12.5 21.2 70.1 12.9 15.3 13.0 11.8 27.3 31.5 13.8 17.0 21.5 12.9 16.2 13.2 14.8 42.3 22.4 46.3 11.0 17.3 19.4 11.6 19.8 14.9 15.6 10.1 17.6 19.6 16.3 19.5 15.1 14.2 22.1 35.1 45.8 28.3 28.9 27.0 27.2 15.4 15.5 9.0 14.3 19.6 7.6 16.8 11.2 11.2 16.3 11.5 14.5 9.7 19.2 11.9 11.0 17.6 8.9 17.6 14.0 8.9 14.4 16.1 15.7 7.8 31.3 29.1 17.9 14.9 7.5 17.0 15.3 17.6 8.0 10.5 15.4 11.5 17.3 13.9 17.9 16.6 13.9 9.4 20.0 16.5 15.7 18.1 89.8 10.8 8.2 20.4 11.0 10.8 22.3 16.0 8.4 10.0 30.9 6.2 8.7 12.7 7.5 12.5 38.6 16.1 23.2 14.6 20.5 16.5 28.2 28.3 45.8 24.7 23.4 27.0 22.1 21.1 25.0 29.5 20.1 20.5 21.1 12.0 28.9 24.3 35.1 22.8 27.2 11.4 12.3 13.8 16.9 13.8 12.5 13.0 11.8 12.9 10.1 14.9 10.1 22.3 8.5 16.0 12.0 14.1 20.4 1.4 3.4 19.2 11.8 39.5 29.9 25.3 2.8 9.0 22.4 0.0 31.0 52.2 16.7 13.3 24.1 28.8 33.7 6.4 8.1 13.5 17.2 6.0 21.9 12.8 18.6 16.2 13.2 20.3 27.2 17.5 42.1 21.4 9.6 32.3 19.8 29.8 46.7 15.2 64.8 24.9 17.0 11.2 PRIMA1 PRIMA ENSG00000175785 "Proline rich membrane anchor 1" Q86XR5 14 93718298-93788481 "Predicted membrane proteins" "Neurotransmitter degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 26.2" "Cell type enriched" "Detected in some" 11 "Muller glia cells: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 7.5;Hep G2: 4.8;NTERA-2: 3.0;SCLC-21H: 13.2;SH-SY5Y: 7.5" "Region enhanced" "Detected in many" "basal ganglia: 16.2" "Low region specificity" "Detected in all" "HPA046671, HPA060047" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoli, Cytosol" "HPA046671: AB_2679744, HPA060047: AB_2684194" "unprognostic (3.60e-2)" "unprognostic (1.97e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.03e-2)" "unprognostic (3.73e-2)" "unprognostic (1.07e-1)" "unprognostic (5.81e-2)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (8.94e-2)" "unprognostic (6.61e-3)" "prognostic unfavorable (2.62e-7)" "unprognostic (2.33e-2)" "unprognostic (2.67e-1)" "unprognostic (7.94e-4)" "unprognostic (4.57e-3)" 4.6 6.0 4.2 5.9 16.7 0.4 2.4 4.5 8.2 7.7 26.2 21.7 4.2 4.6 7.9 7.9 13.7 10.7 3.3 4.8 5.8 3.3 1.2 0.7 1.0 0.7 20.2 4.0 6.9 1.2 0.6 0.3 2.2 15.5 8.6 7.6 9.9 4.6 10.2 0.7 2.1 11.6 14.9 24.3 0.7 12.1 1.8 14.7 0.0 1.3 0.9 4.4 4.7 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 7.5 0.0 0.0 0.2 0.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 13.2 7.5 0.4 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 16.7 4.5 8.2 5.8 3.3 20.2 4.0 15.5 14.7 0.0 0.0 0.0 1.0 0.5 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.4 2.6 0.0 0.0 0.0 0.0 33.7 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.1 PRLH PRH ENSG00000071677 "Prolactin releasing hormone" P81277 2 237566574-237567175 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.1;heart muscle: 4.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;MCF7: 4.4;RPMI-8226: 3.7;SK-BR-3: 1.8;T-47d: 2.1;U-87 MG: 2.4" "Group enriched" "Detected in some" 58 "hypothalamus: 13.4;pons and medulla: 22.5" "Region enriched" "Detected in single" 13 "pons and medulla: 5.1" HPA014976 Approved "Secreted - unknown location" NA NA "HPA014976: AB_2732413" "unprognostic (8.28e-4)" "unprognostic (3.22e-2)" "unprognostic (5.42e-2)" 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.5 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.0 2.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRLHR "GPR10, PrRPR" ENSG00000119973 "Prolactin releasing hormone receptor" P49683 10 118589989-118595699 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 11.3;brain: 10.6;cervix, uterine: 8.3;pituitary gland: 11.8;smooth muscle: 8.1" "Cell type enriched" "Detected in single" 15 "Horizontal cells: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 4 "SH-SY5Y: 3.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA039361 Enhanced NA NA "HPA039361: AB_10673527" "unprognostic (1.83e-1)" "unprognostic (2.62e-3)" "unprognostic (1.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" 0.2 11.3 1.4 0.2 3.0 0.2 0.1 3.2 5.1 8.3 0.2 0.8 0.0 0.3 5.4 0.2 0.2 0.4 0.2 0.1 0.6 4.0 0.1 0.2 0.2 0.1 3.4 0.9 0.1 0.5 0.1 11.8 0.1 10.6 0.3 0.2 0.1 0.2 1.4 0.2 0.2 0.2 8.1 0.5 0.2 0.5 0.2 1.0 0.0 0.2 0.0 0.1 0.1 5.4 0.5 0.4 1.3 0.3 0.7 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.1 3.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.5 0.3 0.2 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.5 0.3 0.2 1.3 0.7 0.3 0.4 0.0 0.0 1.4 3.0 3.2 1.9 0.6 4.0 3.4 0.9 10.6 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PRLR ENSG00000113494 "Prolactin receptor" P16471 5 35048756-35230589 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.3;placenta: 45.7;seminal vesicle: 42.7" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 26.1;Proximal tubular cells: 41.8;Syncytiotrophoblasts: 40.4" "Cancer enriched" "Detected in many" 9 "breast cancer: 20.6" "Region enriched" "Detected in many" 7 "pons and medulla: 54.3" "Group enriched" "Detected in some" 4 "classical monocyte: 2.7;intermediate monocyte: 2.8" "Lineage enriched" "Detected in single" 11 "monocytes: 2.8" "Cell line enriched" "Detected in some" 18 "T-47d: 93.7" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA "unprognostic (3.81e-2)" "unprognostic (2.41e-1)" "unprognostic (2.37e-2)" "unprognostic (6.04e-2)" "unprognostic (5.05e-2)" "unprognostic (8.21e-2)" "unprognostic (3.99e-2)" "unprognostic (7.94e-2)" "unprognostic (4.89e-2)" "unprognostic (1.67e-3)" "unprognostic (4.84e-4)" "unprognostic (2.50e-3)" "unprognostic (4.15e-3)" "unprognostic (1.89e-1)" "unprognostic (1.12e-1)" "unprognostic (9.84e-5)" "unprognostic (1.24e-1)" 0.5 13.3 1.8 0.2 5.6 0.3 13.3 0.4 1.4 23.5 5.3 10.7 36.6 3.5 25.1 10.0 1.1 2.1 2.0 0.6 7.6 2.4 17.8 5.9 0.6 0.0 0.6 0.2 3.2 4.3 11.5 15.7 45.7 54.3 3.2 3.0 0.5 1.8 42.7 0.4 2.6 10.1 6.4 0.7 0.4 3.3 2.0 0.4 0.1 0.5 0.5 0.0 1.4 6.2 0.0 0.2 0.1 2.8 0.0 0.0 0.3 0.0 0.0 0.1 0.7 0.0 0.7 0.1 0.4 0.3 0.8 0.3 0.1 0.0 0.0 0.0 0.5 0.3 0.0 1.0 0.0 0.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.2 0.0 0.2 93.7 0.7 0.0 0.5 0.5 0.1 0.3 0.0 0.0 0.0 0.9 0.0 0.2 0.1 2.7 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 1.8 5.6 0.4 1.4 7.6 2.4 0.6 0.2 54.3 0.4 0.0 1.3 0.0 0.3 2.6 0.0 0.8 2.5 0.0 0.0 3.5 0.0 26.1 6.6 0.8 0.0 0.2 12.7 0.0 4.4 2.6 3.5 2.2 0.0 9.7 7.5 0.0 8.2 0.6 1.3 0.0 8.1 0.6 0.0 9.0 16.5 0.0 2.4 20.9 12.0 41.8 0.0 0.0 3.8 0.0 0.1 4.4 40.4 0.0 19.8 0.1 PRND "dJ1068H6.4, DOPPEL, DPL, PrPLP" ENSG00000171864 "Prion like protein doppel" Q9UKY0 20 4721910-4728460 "Predicted membrane proteins, Transporters" Fertilization Prion "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 80.2" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 1.7;Late spermatids: 7.4;Leydig cells: 2.0;Spermatogonia: 1.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Region enriched" "Detected in single" 28 "pons and medulla: 6.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 2.2;NTERA-2: 3.2;U-698: 1.3" "Not detected" "Not detected" HPA043373 Enhanced NA NA "HPA043373: AB_2678450" "unprognostic (1.69e-1)" "unprognostic (3.66e-2)" "unprognostic (2.24e-2)" "unprognostic (8.46e-2)" "unprognostic (3.40e-2)" "unprognostic (3.47e-3)" "unprognostic (3.01e-1)" "unprognostic (6.41e-2)" "unprognostic (2.00e-2)" "unprognostic (1.56e-1)" "unprognostic (3.10e-1)" "unprognostic (5.85e-2)" "unprognostic (2.02e-3)" "unprognostic (6.11e-2)" "unprognostic (2.86e-1)" "unprognostic (2.45e-2)" "unprognostic (1.63e-3)" 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 1.1 0.7 0.2 0.0 2.5 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 6.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.1 80.2 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.9 0.5 2.2 0.5 0.6 0.4 0.1 0.2 0.4 0.1 0.3 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.3 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.2 0.3 0.0 0.0 0.6 0.1 0.3 2.2 0.5 0.0 1.1 0.2 0.2 0.1 0.3 3.2 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.3 0.4 0.0 0.1 0.1 0.2 0.3 0.1 0.4 0.3 0.7 0.4 0.1 0.3 0.1 1.3 0.2 0.2 0.0 2.2 0.5 0.5 0.3 0.3 0.2 0.6 0.4 0.2 0.2 0.9 0.3 0.3 1.4 0.6 0.5 0.5 0.3 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 2.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.0 0.0 0.0 0.1 PRNP "AltPrP, CD230, CJD, GSS, PRIP, PRP" ENSG00000171867 "Prion protein" P04156 20 4686236-4701590 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Growth arrest" Prion "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 366.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 108.1" "Lineage enriched" "Detected in all" 6 "granulocytes: 108.1" "Cell line enhanced" "Detected in many" "WM-115: 116.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042754, HPA043398" Enhanced Approved "Nuclear membrane,Vesicles,Cytosol" "Intracellular and membrane" NA NA 2200000 "Nuclear membrane, Cytosol" Vesicles "HPA042754: AB_10964203, HPA043398: AB_2678461" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.96e-4)" "prognostic unfavorable (4.64e-4)" "prognostic unfavorable (2.52e-4)" "unprognostic (1.94e-2)" "prognostic unfavorable (7.41e-5)" "unprognostic (7.60e-3)" "unprognostic (2.50e-1)" "unprognostic (7.12e-2)" "unprognostic (3.44e-1)" "unprognostic (1.04e-1)" "unprognostic (6.75e-2)" "unprognostic (7.28e-3)" "unprognostic (3.37e-1)" "unprognostic (2.04e-1)" "unprognostic (1.69e-2)" 24.6 27.3 63.4 14.2 73.1 19.8 30.5 87.5 116.1 42.0 43.4 61.6 8.5 10.6 36.3 17.7 23.0 24.1 31.4 54.1 64.6 48.9 38.5 22.2 22.2 14.7 47.2 65.6 49.6 11.8 20.7 24.9 18.7 71.6 43.8 20.9 34.1 17.1 45.0 21.8 26.7 13.5 40.8 53.1 20.3 18.1 19.1 51.4 2.9 25.6 11.8 16.4 27.0 22.3 4.6 10.5 108.1 11.7 3.6 16.7 10.0 24.6 20.3 4.6 7.2 37.9 23.2 4.1 40.8 58.9 19.8 20.2 6.7 19.1 4.5 9.5 79.5 44.9 57.4 5.1 55.6 37.2 3.7 4.4 0.0 2.3 21.0 46.6 8.0 1.8 21.0 80.2 84.7 66.2 29.2 17.0 3.3 2.4 16.0 22.8 5.5 3.1 4.9 3.8 10.8 30.2 3.8 12.4 4.1 9.9 4.4 5.5 0.8 11.6 16.2 58.0 6.7 3.3 4.2 25.5 32.3 14.8 18.0 33.2 7.4 14.9 15.0 26.0 5.9 116.2 108.1 11.7 0.8 11.9 9.7 16.7 4.2 9.8 9.4 10.5 4.6 5.8 6.8 0.7 3.6 7.6 3.7 11.4 10.0 63.4 73.1 87.5 90.4 64.6 48.9 47.2 65.6 71.6 51.4 74.5 42.1 34.0 181.6 366.5 230.5 189.4 33.1 26.8 70.5 31.4 110.0 6.3 10.0 50.5 4.7 46.7 2.0 0.0 12.7 5.7 171.5 79.9 168.6 29.7 58.0 42.9 28.7 42.4 184.5 8.0 132.6 109.3 160.3 13.6 4.9 133.0 16.9 2.9 159.8 69.9 78.9 12.9 124.6 28.3 4.3 248.5 12.0 52.2 6.9 105.0 PROCR "CCD41, CD201, EPCR" ENSG00000101000 "Protein C receptor" Q9UNN8 20 35172073-35216240 "Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 77.8" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 89.9;Sertoli cells: 168.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 66.3;HUVEC TERT2: 103.3;TIME: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039461 Enhanced NA NA 1600000000 "HPA039461: AB_10673359" "unprognostic (1.51e-1)" "unprognostic (1.03e-1)" "unprognostic (4.12e-2)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (4.69e-2)" "unprognostic (4.69e-2)" "unprognostic (1.84e-1)" "unprognostic (1.52e-1)" "unprognostic (4.76e-2)" "unprognostic (5.22e-2)" "unprognostic (4.27e-1)" "prognostic unfavorable (7.62e-6)" "unprognostic (3.37e-2)" "unprognostic (2.29e-1)" "unprognostic (1.05e-1)" "unprognostic (2.19e-2)" 51.0 11.9 2.3 10.1 3.2 4.4 24.6 2.9 2.3 16.8 25.0 3.1 14.1 8.7 27.7 44.5 19.4 17.3 13.4 27.4 2.7 2.4 11.7 3.8 10.6 30.3 3.1 2.1 19.3 11.5 2.7 4.7 77.8 7.4 15.5 12.3 16.4 4.2 14.0 17.7 10.4 14.0 20.0 5.8 22.1 10.4 9.1 2.0 0.6 12.1 13.0 3.9 25.8 14.9 1.6 7.3 4.1 1.7 3.4 14.6 2.0 2.5 14.9 0.0 1.6 16.4 13.4 3.4 3.5 15.2 5.8 11.3 19.1 12.9 0.4 10.9 3.5 16.1 8.1 3.4 22.1 4.8 0.1 4.6 5.4 3.6 0.7 4.0 0.2 66.3 11.4 8.3 27.2 22.7 8.5 103.3 0.1 1.9 0.7 5.9 0.8 0.1 0.2 2.1 3.1 15.3 0.1 2.8 0.0 9.8 0.9 0.4 0.2 1.9 4.0 3.1 1.9 1.3 0.8 61.1 14.9 7.5 5.6 5.8 0.0 0.1 0.1 17.1 5.5 3.1 4.1 1.5 0.9 8.3 1.7 14.6 1.0 2.6 5.2 7.3 1.6 0.7 6.3 4.1 3.4 1.4 1.2 2.0 2.0 2.3 3.2 2.9 2.3 2.7 2.4 3.1 2.1 7.4 2.0 0.0 15.9 0.5 14.5 12.4 0.4 1.6 0.0 2.7 7.9 5.2 0.0 9.5 1.7 26.8 0.3 47.6 1.4 0.0 14.7 89.9 27.3 3.7 59.2 1.5 20.7 1.6 5.8 47.9 1.2 1.0 14.4 7.7 3.3 2.8 0.0 0.2 13.9 0.0 2.5 4.2 0.4 168.1 43.8 3.7 7.2 7.3 57.7 6.7 1.6 9.0 PROKR1 "GPR73, GPR73a, PKR1, ZAQ" ENSG00000169618 "Prokineticin receptor 1" Q8TCW9 2 68643589-68658247 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 3.3;epididymis: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.5" "Lineage enhanced" "Detected in single" "monocytes: 1.5" "Cell line enhanced" "Detected in some" "HMC-1: 2.2;NTERA-2: 6.7;SCLC-21H: 1.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA029396 Uncertain NA NA "HPA029396: AB_10610285" "unprognostic (5.46e-2)" "unprognostic (1.60e-2)" "unprognostic (8.75e-2)" "unprognostic (4.99e-4)" "unprognostic (1.18e-1)" "unprognostic (2.55e-3)" "unprognostic (1.07e-1)" "unprognostic (2.91e-2)" "unprognostic (1.85e-1)" "unprognostic (4.52e-2)" "unprognostic (1.89e-1)" "unprognostic (9.72e-2)" "unprognostic (8.96e-7)" "unprognostic (4.07e-2)" "unprognostic (2.53e-1)" "unprognostic (4.19e-1)" "unprognostic (7.22e-2)" 3.3 2.6 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PROKR2 "dJ680N4.3, GPR73b, GPR73L1, GPRg2, KAL3, PKR2" ENSG00000101292 "Prokineticin receptor 2" Q8NFJ6 20 5302040-5314369 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.7;brain: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory CD8 T-cell: 1.6;neutrophil: 1.1" "Group enriched" "Detected in many" 8 "granulocytes: 1.1;T-cells: 1.6" "Cell line enhanced" "Detected in some" "HaCaT: 1.6;NTERA-2: 3.3;SCLC-21H: 1.2;SH-SY5Y: 6.5" "Region enhanced" "Detected in many" "olfactory region: 20.9" "Low region specificity" "Detected in all" HPA047281 Uncertain NA NA "HPA047281: AB_10960057" "unprognostic (1.36e-1)" "unprognostic (1.69e-1)" 0.0 0.0 0.4 0.0 0.5 3.7 0.1 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.5 0.4 0.0 0.0 0.0 1.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 1.4 0.1 0.0 0.1 0.0 0.3 0.3 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 1.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PROM1 "AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4" ENSG00000007062 "Prominin 1" O43490 4 15963076-16084378 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 52.4;salivary gland: 71.0" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 547.8;Rod photoreceptor cells: 281.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 13.9;CACO-2: 25.6;CAPAN-2: 10.9;EFO-21: 25.1;NTERA-2: 37.2;RPTEC TERT1: 34.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA004922, CAB011525, HPA031053" Enhanced NA NA "CAB011525: AB_470302, HPA004922: AB_1846238, HPA031053: AB_2673713" "unprognostic (6.33e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-1)" "unprognostic (3.39e-1)" "unprognostic (2.81e-1)" "unprognostic (2.16e-1)" "unprognostic (2.39e-1)" "unprognostic (6.64e-2)" "unprognostic (2.18e-2)" "unprognostic (2.17e-1)" "unprognostic (1.21e-2)" "unprognostic (9.06e-2)" "prognostic favorable (2.56e-5)" "unprognostic (2.16e-2)" "unprognostic (1.02e-1)" "unprognostic (9.38e-2)" "unprognostic (1.17e-1)" 0.5 0.5 2.5 11.5 2.2 1.3 11.2 1.0 2.2 20.1 13.8 2.3 1.6 5.2 4.7 3.1 1.8 1.9 12.6 2.7 3.1 2.1 30.2 1.6 3.6 0.1 2.3 0.6 1.6 10.7 0.0 1.8 12.7 2.1 1.6 7.4 52.4 71.0 2.9 0.7 1.1 13.5 1.7 1.8 0.6 10.9 5.0 0.9 0.3 1.7 3.8 10.2 3.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 10.9 0.3 25.1 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 37.2 0.0 0.0 1.0 0.0 0.0 34.5 0.1 4.3 1.5 0.0 0.8 1.0 1.4 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.5 2.2 1.0 2.2 3.1 2.1 2.3 0.6 2.1 0.9 3.0 3.7 0.0 0.1 0.0 10.1 7.9 30.6 93.7 22.7 78.5 547.8 0.4 0.0 51.2 32.2 2.5 26.6 0.0 14.0 0.1 0.0 0.9 0.0 0.0 0.1 9.5 42.7 0.6 0.0 34.0 2.8 0.7 0.0 1.0 9.2 47.2 32.3 24.9 6.0 1.4 281.4 0.0 0.3 1.2 0.7 0.0 0.1 0.0 18.0 0.9 PROM2 ENSG00000155066 "Prominin 2" Q8N271 2 95274453-95291308 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 45.9;Collecting duct cells: 31.4;Urothelial cells: 37.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 23.8;CAPAN-2: 42.0;HaCaT: 22.6;hTCEpi: 24.6;MCF7: 18.6;RT4: 25.6;SK-BR-3: 36.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB046005, HPA063728" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB046005: AB_2284371, HPA063728: AB_2685104" "prognostic unfavorable (2.16e-4)" "unprognostic (1.60e-1)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.55e-6)" "unprognostic (1.46e-2)" "unprognostic (4.59e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-2)" 0.3 0.2 0.5 2.9 0.6 0.0 9.3 1.1 0.5 11.4 5.2 0.3 22.2 4.4 1.4 22.5 42.6 2.2 37.2 0.5 0.6 0.5 18.8 0.4 1.3 0.3 0.6 0.3 1.5 8.6 8.1 1.5 12.5 0.3 11.6 4.2 0.3 35.6 20.0 1.3 26.7 2.6 2.7 0.7 0.4 11.5 1.8 0.3 1.7 5.7 21.6 22.2 20.0 14.8 0.0 0.2 0.6 0.0 0.0 0.3 0.0 23.8 0.0 0.0 0.2 0.1 0.0 12.1 0.0 0.0 0.1 0.1 0.2 42.0 0.0 0.0 0.0 0.0 22.6 0.0 13.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 24.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 18.6 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 25.6 0.2 0.0 0.0 36.7 0.0 0.3 11.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.2 0.0 0.5 0.6 1.1 0.5 0.6 0.5 0.6 0.3 0.3 0.3 3.0 3.4 0.0 20.8 6.0 0.2 1.4 45.9 6.7 11.4 31.4 3.9 15.3 10.0 12.0 0.4 0.0 2.6 0.0 9.6 2.3 0.8 11.1 0.0 0.0 2.0 0.0 3.5 0.0 0.0 1.1 0.3 0.0 6.8 1.0 10.5 0.0 12.7 7.0 0.7 0.0 0.9 0.0 1.0 0.7 0.0 11.2 9.4 0.0 12.4 37.6 PROS1 PROS ENSG00000184500 "Protein S" P07225 3 93873033-93974066 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis" "Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 114.6" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 266.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 6 "pons and medulla: 24.2" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 42.8;ASC TERT1: 31.9;HSkMC: 28.9;hTERT-RPE1: 24.2;SK-MEL-30: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007724, HPA023974, CAB032610" Approved "Secreted to blood" NA NA 22500000000 3400000000 "CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738" "unprognostic (2.00e-2)" "unprognostic (2.81e-2)" "unprognostic (9.21e-2)" "unprognostic (8.03e-3)" "unprognostic (3.35e-2)" "unprognostic (2.41e-1)" "unprognostic (6.48e-2)" "unprognostic (3.07e-1)" "unprognostic (5.18e-2)" "unprognostic (3.12e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (8.35e-4)" "unprognostic (4.90e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.42e-5)" 16.0 3.9 2.5 3.8 3.8 0.1 15.5 0.8 2.8 7.4 8.0 4.1 2.8 3.9 7.6 9.5 10.9 8.5 11.3 30.2 4.0 3.1 17.6 114.6 17.3 13.7 4.3 1.8 23.9 2.7 10.1 6.2 10.2 24.2 6.8 8.5 9.3 5.6 4.3 5.6 8.5 6.5 8.3 4.8 8.8 4.9 5.5 2.2 0.1 10.6 6.9 3.3 8.0 9.5 0.0 0.8 1.9 0.8 0.1 0.4 6.8 0.3 2.4 2.5 10.3 42.8 31.9 0.8 1.5 3.5 0.8 3.1 6.1 0.9 0.2 9.3 2.3 7.8 0.1 0.8 0.6 1.1 0.1 2.7 16.6 1.1 17.0 3.6 0.6 0.8 28.9 0.6 1.8 0.6 24.2 3.5 2.1 11.5 0.2 16.6 0.2 0.1 0.0 2.0 1.5 2.4 0.3 2.0 0.0 9.0 0.0 3.8 7.0 1.8 0.0 46.2 0.8 0.1 8.1 3.0 6.8 1.5 3.7 0.8 0.0 0.1 0.0 21.2 10.6 9.9 0.0 0.8 0.7 0.1 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 1.9 0.1 0.2 0.0 0.2 6.8 2.5 3.8 0.8 2.8 4.0 3.1 4.3 1.8 24.2 2.2 59.6 29.8 3.7 2.9 13.2 0.6 40.3 12.7 76.3 12.5 1.8 9.8 0.6 3.3 5.6 2.3 47.0 2.6 0.0 4.0 0.6 62.0 4.7 29.0 266.4 9.9 1.6 15.1 69.3 24.7 4.0 26.4 7.7 18.6 1.0 14.6 22.0 3.9 7.0 34.6 36.2 7.8 12.9 26.2 0.2 0.5 29.1 1.4 4.5 13.3 2.0 PRPF38B "FLJ10330, NET1" ENSG00000134186 "Pre-mRNA processing factor 38B" Q5VTL8 1 108692323-108701803 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053255 Approved NA NA "HPA053255: AB_2682093" "unprognostic (2.13e-3)" "unprognostic (9.66e-2)" "unprognostic (9.67e-2)" "unprognostic (4.57e-2)" "unprognostic (5.00e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (2.26e-4)" "unprognostic (3.28e-3)" "unprognostic (3.77e-3)" "unprognostic (9.49e-3)" "unprognostic (1.34e-1)" "unprognostic (9.44e-3)" "prognostic unfavorable (2.03e-4)" "unprognostic (6.97e-2)" "unprognostic (1.64e-1)" "unprognostic (1.42e-1)" "unprognostic (2.26e-1)" 18.4 18.3 17.2 36.4 21.3 47.6 37.4 46.3 21.7 19.7 23.3 12.0 19.8 19.8 19.2 22.8 19.9 16.2 19.0 14.7 16.9 13.9 15.1 17.9 27.0 34.5 23.0 12.2 19.0 23.0 17.9 24.9 19.7 18.6 22.7 19.6 9.9 20.0 31.6 21.0 19.5 24.7 15.6 26.6 33.1 18.9 12.9 21.4 44.1 19.9 15.6 26.2 23.0 29.8 19.1 21.9 24.1 15.9 26.0 21.2 9.7 21.8 8.9 19.7 13.6 12.7 10.9 17.5 21.8 10.0 11.2 12.7 16.5 10.3 30.6 12.2 7.4 7.7 19.4 19.4 12.3 17.3 16.9 19.2 23.5 26.9 16.5 12.5 31.6 19.5 6.7 17.7 11.3 23.8 15.2 9.4 13.9 28.8 22.9 12.7 16.5 23.5 26.6 22.8 10.6 14.9 22.7 42.0 12.6 11.7 18.9 19.4 14.4 16.3 18.7 23.1 13.5 9.4 21.5 15.3 21.3 16.0 16.9 19.5 20.4 13.7 29.0 18.8 24.2 22.1 16.1 15.9 20.0 20.3 15.6 21.2 16.3 18.6 16.1 17.9 19.1 17.2 17.3 24.1 26.0 13.2 21.9 18.5 9.7 17.2 21.3 46.3 21.7 16.9 13.9 23.0 12.2 18.6 21.4 98.3 141.8 125.3 169.8 219.1 73.8 60.0 94.3 91.0 151.2 57.6 127.6 72.8 11.6 62.1 9.6 101.8 68.8 46.7 57.6 89.7 89.7 128.1 98.4 47.3 69.8 35.0 91.2 89.0 101.6 8.5 91.7 178.5 99.5 108.2 70.4 62.1 59.5 75.9 79.9 12.4 73.8 45.3 105.0 97.9 61.8 231.6 73.3 173.0 79.4 196.2 PRPH2 "CACD2, rd2, RDS, RP7, TSPAN22" ENSG00000112619 "Peripherin 2" P23942 6 42696600-42722574 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Sensory transduction, Vision" "Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 117.8" "Group enriched" "Detected in some" 13 "Cone photoreceptor cells: 245.4;Rod photoreceptor cells: 471.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.4" "Cell line enhanced" "Detected in some" "ASC diff: 4.3;ASC TERT1: 4.9;fHDF/TERT166: 7.1;HHSteC: 11.0;HSkMC: 8.5;LHCN-M2: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA029458 Enhanced NA NA "HPA029458: AB_10602193" "unprognostic (2.37e-1)" "unprognostic (4.88e-2)" "unprognostic (6.67e-2)" "unprognostic (8.43e-2)" "unprognostic (1.15e-1)" "unprognostic (2.87e-3)" "unprognostic (4.73e-1)" "unprognostic (1.85e-1)" "unprognostic (6.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (3.18e-2)" "unprognostic (7.07e-4)" "unprognostic (1.13e-3)" "unprognostic (1.59e-1)" "unprognostic (8.42e-2)" "unprognostic (8.96e-3)" 1.0 0.8 1.5 1.0 1.0 0.0 1.0 1.0 4.8 1.7 2.0 1.0 1.0 0.3 2.3 2.3 1.0 0.9 1.2 1.4 1.1 3.0 1.0 1.0 1.2 1.0 1.1 1.0 3.4 2.0 6.9 2.7 1.0 1.0 1.4 0.8 117.8 1.0 1.3 14.4 0.0 1.1 2.3 1.0 1.0 1.0 3.5 1.0 1.0 5.2 1.0 1.0 1.0 1.0 0.6 0.3 3.4 0.6 0.2 0.8 0.0 0.0 0.0 0.0 0.0 4.3 4.9 1.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 11.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.3 0.0 0.4 0.2 0.8 0.2 0.3 0.0 0.3 0.6 0.4 0.2 2.5 0.2 0.6 0.0 0.3 0.0 1.5 1.0 1.0 3.0 1.1 3.0 1.1 1.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 23.7 0.6 0.0 0.0 0.0 0.0 245.4 0.0 3.3 0.1 0.0 0.2 0.0 0.0 0.2 0.0 1.4 0.2 0.0 0.0 0.0 11.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 28.3 0.7 0.0 1.8 0.0 471.5 0.0 1.5 2.5 0.1 0.3 0.1 0.0 0.0 0.0 PRR7 MGC10772 ENSG00000131188 "Proline rich 7, synaptic" Q8TB68 5 177446445-177456286 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 41.2;Suprabasal keratinocytes: 58.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 17.4;SK-MEL-30: 16.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046636 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA046636: AB_2679730" "unprognostic (3.69e-1)" "unprognostic (9.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (4.08e-2)" "unprognostic (7.94e-3)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (4.75e-2)" "unprognostic (5.86e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (1.98e-4)" "unprognostic (8.84e-3)" "unprognostic (2.22e-1)" "unprognostic (3.76e-2)" "unprognostic (1.69e-1)" 1.9 2.4 12.5 3.2 22.0 15.1 1.7 4.1 28.5 1.1 2.9 9.8 0.0 2.9 1.7 1.3 1.9 3.2 1.9 1.1 14.1 7.6 1.5 2.2 2.0 3.6 4.8 8.4 1.2 4.0 2.6 6.2 1.3 6.2 2.0 1.4 4.7 5.2 1.5 1.7 8.8 2.6 1.2 4.4 4.9 4.6 3.2 4.6 1.2 1.2 0.8 2.3 1.5 0.9 3.2 3.0 10.8 0.6 2.0 7.3 1.5 7.2 2.8 0.8 5.7 0.0 0.4 2.5 3.4 0.6 1.0 1.3 0.6 3.9 7.0 9.0 0.5 2.9 6.1 0.4 3.1 0.4 6.1 9.0 2.1 2.7 2.1 0.6 4.2 5.1 0.6 1.3 0.4 0.2 0.9 0.4 2.7 1.1 5.0 0.9 9.7 3.5 10.7 1.4 1.1 17.4 9.9 2.6 7.0 1.2 0.6 14.1 10.1 1.3 3.4 16.1 0.0 3.0 0.6 2.6 5.7 9.7 5.1 8.2 2.7 1.5 3.4 5.6 6.8 4.1 2.4 0.1 10.8 3.0 0.5 7.3 2.1 3.4 5.1 0.1 3.2 3.2 4.1 4.8 2.0 0.6 3.0 2.5 1.5 12.5 22.0 4.1 28.5 14.1 7.6 4.8 8.4 6.2 4.6 3.0 0.0 13.7 25.0 38.5 12.6 1.2 10.2 0.0 1.2 7.0 0.0 0.9 8.3 10.1 10.8 4.5 7.1 0.0 9.4 0.7 3.9 23.6 27.5 2.8 1.4 6.4 41.2 1.8 2.2 9.7 0.9 2.9 27.0 1.0 9.4 15.2 9.0 7.8 2.1 9.8 13.1 0.0 9.8 3.3 11.7 58.5 1.1 25.5 9.1 15.4 PRRG1 PRGP1 ENSG00000130962 "Proline rich and Gla domain 1" O14668 X 37349275-37457295 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.4" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078129 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA078129: AB_2686878" "unprognostic (8.82e-2)" "prognostic unfavorable (4.65e-4)" "unprognostic (8.34e-2)" "unprognostic (2.08e-3)" "unprognostic (1.92e-1)" "unprognostic (5.11e-3)" "unprognostic (2.24e-2)" "unprognostic (7.23e-3)" "unprognostic (1.01e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (8.21e-2)" "prognostic favorable (2.05e-7)" "unprognostic (1.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.48e-1)" 11.6 5.5 12.0 3.1 22.0 0.7 5.8 2.6 18.7 6.7 5.7 35.9 4.6 4.1 6.2 2.5 5.9 4.0 12.4 8.5 17.9 10.7 14.9 10.7 6.3 2.5 31.0 9.9 6.2 2.6 1.2 2.3 10.6 21.3 5.1 6.0 3.0 3.9 11.6 19.3 3.1 4.3 7.5 43.4 4.0 3.4 2.4 23.7 0.0 11.6 2.9 1.6 5.9 4.5 0.6 0.2 2.6 1.7 0.2 0.4 0.1 15.0 3.4 2.8 2.8 9.4 7.6 1.2 6.4 8.6 2.3 4.0 8.2 9.7 0.0 11.1 5.0 4.3 4.9 7.6 4.8 4.0 0.0 2.4 2.7 3.6 2.8 11.5 0.0 3.5 11.8 4.0 4.5 3.8 4.6 11.9 0.0 1.2 0.0 8.0 1.1 0.0 0.0 3.3 2.4 7.2 0.0 6.2 0.0 39.4 0.7 0.0 0.0 4.7 7.5 2.8 7.7 0.0 1.6 8.5 3.6 2.2 7.0 1.9 0.0 0.0 0.0 3.6 0.0 3.3 2.6 1.7 0.1 0.2 0.5 0.2 0.6 0.1 0.3 0.1 0.4 0.2 0.4 0.8 0.2 0.2 0.2 0.2 0.1 12.0 22.0 2.6 13.9 17.9 10.7 31.0 9.9 21.3 23.7 6.0 3.4 0.0 4.2 10.1 1.8 7.6 12.7 0.0 0.0 31.4 0.0 5.5 6.6 5.9 0.6 16.5 5.6 0.0 2.7 11.7 8.7 5.9 1.1 15.3 3.8 17.5 2.9 14.7 5.1 0.0 4.4 1.4 3.3 1.0 4.8 1.9 12.9 8.0 2.5 7.3 0.2 6.5 5.6 0.9 3.6 5.5 8.7 0.0 4.1 7.4 PRRG2 PRGP2 ENSG00000126460 "Proline rich and Gla domain 2" O14669 19 49580646-49591015 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 38.8;Paneth cells: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.7;OE19: 13.8;RT4: 9.0;SK-BR-3: 10.5;T-47d: 11.4;U-266/84: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010702 Approved Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Nucleoli" Cytosol "HPA010702: AB_1079693" "unprognostic (2.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (1.04e-2)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (5.60e-1)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.67e-1)" "prognostic favorable (3.82e-9)" "unprognostic (4.89e-2)" "unprognostic (1.46e-1)" "unprognostic (6.58e-3)" "unprognostic (3.68e-2)" 0.9 0.4 0.5 1.1 0.6 0.0 4.8 1.1 1.3 4.0 14.3 0.4 17.5 8.3 1.9 9.6 13.7 3.3 9.8 0.7 0.5 0.4 15.0 12.1 5.2 0.4 0.7 0.4 1.9 13.4 13.8 16.1 8.6 0.7 5.4 5.3 0.7 24.9 14.6 1.2 10.1 23.2 1.4 0.5 1.0 7.1 1.7 0.4 2.1 21.9 9.8 7.8 4.2 4.2 1.2 4.2 2.1 0.9 0.0 1.4 0.4 8.4 0.3 0.2 0.7 1.0 0.0 3.6 0.2 0.0 0.3 0.3 1.7 11.7 0.5 1.3 0.1 0.2 6.8 0.2 6.6 0.3 0.8 0.9 0.4 0.5 0.6 0.7 0.3 0.9 0.7 5.8 0.2 0.2 0.6 2.6 0.7 0.2 0.6 0.0 1.8 0.1 0.7 0.5 13.8 1.1 0.2 0.3 6.6 5.2 9.0 1.9 0.2 1.0 10.5 0.1 0.9 11.4 0.1 0.4 0.7 0.5 0.3 0.1 4.1 13.7 0.4 0.1 0.2 0.3 0.0 0.9 0.4 1.4 0.1 0.7 1.2 0.6 0.6 0.1 0.7 0.8 0.7 2.1 0.0 0.7 4.2 0.6 0.4 0.5 0.6 1.1 1.3 0.5 0.4 0.7 0.4 0.7 0.4 6.0 12.0 1.3 12.1 3.7 1.9 0.8 10.2 4.0 9.1 12.2 2.0 11.6 3.3 27.3 0.7 6.2 38.8 0.0 29.0 5.4 0.8 11.8 2.3 4.9 2.1 4.8 15.5 0.6 3.2 0.0 0.3 2.3 1.7 12.6 13.9 0.8 24.3 31.6 0.0 12.1 3.7 0.0 1.8 0.5 1.5 4.1 10.6 0.8 14.2 12.8 PRRG3 TMG3 ENSG00000130032 "Proline rich and Gla domain 3" Q9BZD7 X 151695124-151705924 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.4;epididymis: 10.3" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 16.4;Cardiomyocytes: 5.0;Melanocytes: 6.8;Suprabasal keratinocytes: 19.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 2.0;NTERA-2: 3.0;SuSa: 7.5;U-2197: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060566 Uncertain NA NA "HPA060566: AB_2684321" "unprognostic (1.85e-1)" "unprognostic (1.21e-1)" "unprognostic (7.71e-2)" "unprognostic (1.77e-2)" "unprognostic (4.42e-4)" "unprognostic (7.24e-2)" "unprognostic (2.29e-2)" "unprognostic (1.28e-1)" "unprognostic (2.06e-2)" "unprognostic (5.11e-2)" "unprognostic (3.01e-2)" "unprognostic (2.26e-1)" "unprognostic (1.98e-2)" "unprognostic (7.69e-2)" "unprognostic (4.64e-2)" "unprognostic (1.57e-1)" "unprognostic (1.84e-2)" 3.1 0.2 5.6 1.2 12.4 0.4 2.0 1.0 10.2 9.2 1.1 1.0 0.1 0.3 3.0 10.3 4.0 1.0 3.3 1.6 5.3 11.6 0.4 0.1 2.0 0.2 3.2 5.3 3.9 0.1 0.4 1.3 1.3 5.3 1.1 1.0 1.4 1.3 0.4 3.3 2.5 0.5 2.4 1.2 2.6 0.6 0.6 0.7 0.1 0.7 0.6 0.4 1.4 2.4 1.2 1.4 3.8 1.8 2.4 1.4 1.0 0.1 0.1 0.2 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.3 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 2.0 0.2 0.1 0.2 1.6 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.1 0.4 3.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.7 0.3 0.0 0.2 0.0 7.5 0.1 0.1 0.0 0.4 0.3 1.7 0.1 0.1 1.0 0.0 0.2 0.1 0.1 3.8 1.3 1.3 1.2 1.2 1.4 1.1 0.9 0.9 1.0 1.2 1.3 1.1 3.1 2.4 1.8 1.4 1.1 1.0 5.6 12.4 1.0 10.2 5.3 11.6 3.2 5.3 5.3 0.7 0.0 0.0 0.0 0.3 16.4 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 19.7 0.0 0.0 0.0 0.1 PRRG4 TMG4 ENSG00000135378 "Proline rich and Gla domain 4" Q9BZD6 11 32829943-32858123 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 110.4;Glandular cells: 119.2;Suprabasal keratinocytes: 123.7;Urothelial cells: 139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "neutrophil: 13.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 13.2" "Cell line enhanced" "Detected in many" "HaCaT: 31.0;hTCEpi: 16.7;SK-BR-3: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009040, HPA024566" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA009040: AB_1079694, HPA024566: AB_2237712" "unprognostic (3.30e-1)" "unprognostic (3.68e-2)" "unprognostic (1.14e-1)" "unprognostic (6.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (3.45e-2)" "unprognostic (2.06e-1)" "unprognostic (4.13e-1)" "unprognostic (3.24e-2)" "unprognostic (2.22e-3)" "unprognostic (3.22e-1)" "unprognostic (2.26e-3)" "unprognostic (3.16e-2)" "unprognostic (1.99e-1)" "unprognostic (2.41e-1)" "unprognostic (1.26e-2)" 1.4 1.4 1.1 3.3 1.7 2.8 7.9 0.7 0.8 7.5 15.7 1.0 13.5 5.3 2.0 5.8 27.6 3.9 5.6 2.1 1.5 1.5 15.7 16.7 10.3 0.5 2.6 0.1 2.0 3.3 1.3 10.6 22.0 1.7 8.9 4.6 2.2 12.7 17.1 1.0 15.4 15.8 1.7 1.7 2.2 3.9 1.0 1.8 3.5 21.0 20.1 12.0 5.6 16.6 0.3 0.5 13.2 2.6 0.3 0.2 0.5 7.4 0.3 0.0 0.1 0.1 0.0 3.2 0.0 3.8 0.9 1.6 3.6 7.4 0.0 0.2 0.0 2.0 31.0 0.8 1.9 0.3 0.2 5.1 1.5 1.1 0.2 0.0 0.6 1.4 0.2 16.7 0.3 0.1 1.3 0.0 0.0 0.0 0.5 0.3 3.4 0.6 3.4 0.3 6.1 0.9 0.0 0.0 0.9 5.7 9.6 1.1 0.1 5.2 13.0 1.6 1.0 9.4 7.3 0.1 0.4 0.5 1.7 0.7 3.4 2.4 0.0 0.9 4.3 1.4 0.7 2.6 0.2 0.1 0.9 0.1 0.1 0.1 0.1 0.5 0.3 0.1 0.2 13.2 0.3 0.8 0.2 0.1 0.5 1.1 1.7 0.7 0.8 1.5 1.5 2.6 0.1 1.7 1.8 26.8 23.1 2.7 81.1 110.4 0.0 0.8 68.8 29.4 19.4 45.4 0.0 20.2 6.6 26.3 0.4 8.2 42.2 0.0 31.9 15.7 6.0 119.2 0.0 42.4 7.6 1.6 13.2 7.4 30.5 0.0 0.3 8.0 11.8 40.5 25.7 0.0 21.2 14.4 1.4 17.0 0.0 6.5 5.2 2.6 3.8 123.7 68.5 2.5 38.2 139.3 PRRT1 "C6orf31, IFITMD7, NG5" ENSG00000204314 "Proline rich transmembrane protein 1" Q99946 6 32148359-32153083 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 41.1" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 64.7;Cardiomyocytes: 82.2;Horizontal cells: 30.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Group enriched" "Detected in some" 4 "HEK 293: 1.5;SK-MEL-30: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055149, HPA059099" Enhanced NA NA "HPA055149: AB_2682717, HPA059099: AB_2732632" "unprognostic (1.40e-2)" "unprognostic (1.35e-1)" "unprognostic (2.10e-3)" "unprognostic (3.87e-3)" "unprognostic (2.89e-1)" "unprognostic (4.74e-2)" "unprognostic (5.51e-3)" "unprognostic (5.93e-2)" "unprognostic (1.49e-1)" "unprognostic (1.58e-2)" "unprognostic (8.08e-5)" "unprognostic (2.99e-1)" "unprognostic (2.22e-2)" "unprognostic (8.59e-2)" "unprognostic (9.40e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-2)" 2.6 4.8 23.9 2.4 25.3 2.2 2.2 35.8 41.1 2.5 2.5 4.9 0.0 2.6 2.6 2.1 2.1 2.4 2.3 2.3 24.4 10.5 2.4 2.2 2.2 2.2 4.9 27.1 6.1 2.4 2.3 3.2 2.5 11.7 2.8 2.3 1.8 2.3 2.7 2.4 2.4 2.4 2.3 3.0 2.4 2.9 2.6 7.7 0.0 2.2 0.0 2.1 2.2 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.8 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.5 0.8 0.1 0.0 5.6 0.0 0.2 0.0 0.1 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 23.9 25.3 35.8 41.1 24.4 10.5 4.9 27.1 11.7 7.7 0.0 0.0 0.0 8.0 3.5 64.7 82.2 7.6 0.0 0.0 1.8 9.8 5.0 1.7 0.0 0.9 4.5 3.3 0.0 0.0 0.8 3.8 4.6 0.0 2.4 0.9 30.2 8.6 3.1 0.3 1.0 5.8 0.3 3.3 0.0 3.7 15.1 0.3 2.5 6.0 0.0 8.0 0.0 12.7 0.5 1.6 2.4 3.0 0.9 4.5 4.8 PRRT1B IFITMD8 ENSG00000283526 "Proline rich transmembrane protein 1B" 9 131545514-131558620 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "fallopian tube: 9.0;lung: 16.0;pancreas: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "A549: 16.0;BEWO: 10.7;MCF7: 4.2;T-47d: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.5 4.7 0.0 0.0 0.3 0.6 1.0 0.0 9.0 3.9 0.0 0.0 1.3 6.1 16.0 0.0 0.0 0.0 1.7 7.6 1.7 0.0 0.1 0.1 3.4 2.0 0.0 0.0 1.7 0.0 0.0 2.9 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 16.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRRT2 "DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC" ENSG00000167371 "Proline rich transmembrane protein 2" Q7Z6L0 16 29811382-29815892 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Dystonia, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 86.7" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 79.8;Cone photoreceptor cells: 29.5;Leydig cells: 33.4;Peritubular cells: 37.8;Rod photoreceptor cells: 40.1" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 7.3" "Lineage enriched" "Detected in single" 11 "NK-cells: 7.3" "Cell line enhanced" "Detected in many" "AF22: 19.8;hTERT-RPE1: 12.2;REH: 15.1;U-138 MG: 13.7" "HPA014447, HPA019203, HPA048045" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: " "unprognostic (7.60e-3)" "unprognostic (3.00e-1)" "unprognostic (8.32e-3)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (1.19e-3)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "unprognostic (9.30e-2)" "unprognostic (1.93e-1)" "unprognostic (4.45e-2)" "unprognostic (3.26e-2)" "unprognostic (3.43e-8)" "unprognostic (1.22e-1)" "unprognostic (1.17e-1)" "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" 3.7 7.2 27.2 2.8 40.5 0.8 2.1 86.7 53.6 10.1 6.0 6.0 3.1 6.2 20.7 8.3 4.4 10.2 10.3 5.3 18.9 13.0 2.1 0.9 5.7 3.5 5.5 33.2 35.7 2.4 8.6 17.6 7.1 18.0 16.2 2.6 5.2 4.6 14.4 4.3 3.1 6.8 10.3 7.4 1.8 7.3 9.9 10.2 0.0 2.8 0.3 1.6 5.1 10.7 0.2 0.0 0.5 0.2 7.3 0.6 0.3 0.3 1.2 19.8 7.4 1.0 3.7 0.5 2.4 4.0 0.8 0.9 1.1 2.3 0.2 0.4 3.2 0.6 2.0 2.7 0.4 0.3 5.2 1.6 1.3 8.8 0.8 0.2 0.0 0.3 3.4 0.1 1.4 0.1 12.2 1.0 0.6 0.2 1.6 0.6 3.3 0.5 0.6 5.7 0.0 1.0 15.1 1.1 0.4 0.1 0.7 4.3 4.5 0.2 2.9 0.4 3.2 7.3 0.1 1.1 13.7 4.8 0.8 1.3 3.4 0.4 0.1 5.4 0.1 0.5 0.5 0.0 0.1 0.2 0.1 0.3 0.1 0.6 0.4 0.0 0.2 0.4 0.2 0.2 7.3 0.2 0.0 0.1 0.3 27.2 40.5 86.7 53.6 18.9 13.0 5.5 33.2 18.0 10.2 3.0 0.0 0.0 1.3 1.0 79.8 0.8 0.0 6.7 1.2 0.0 29.5 1.5 1.7 1.1 1.7 2.0 9.6 0.0 1.4 0.6 9.3 1.4 0.0 0.0 0.3 19.1 5.8 2.5 0.0 6.3 33.4 0.0 0.0 1.0 2.0 6.5 2.3 10.5 37.8 0.2 40.1 6.5 13.2 2.4 3.2 0.4 2.2 0.0 1.7 1.0 PRRT3 FLJ33674 ENSG00000163704 "Proline rich transmembrane protein 3" Q5FWE3 3 9945542-9952394 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 23.6;Rod photoreceptor cells: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 12.7;MCF7: 16.1;SK-BR-3: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035127, HPA035128, HPA069859" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 18000 "Plasma membrane" Nucleoplasm "HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: " "unprognostic (1.55e-1)" "unprognostic (8.41e-2)" "unprognostic (3.42e-1)" "unprognostic (2.38e-3)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.15e-4)" "unprognostic (2.27e-3)" "unprognostic (1.37e-2)" "unprognostic (2.76e-2)" "unprognostic (2.20e-3)" "unprognostic (3.60e-1)" "unprognostic (1.01e-4)" "unprognostic (2.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (2.09e-1)" 1.4 2.9 8.4 1.8 11.9 2.1 2.0 13.4 26.0 2.4 1.4 4.2 0.0 1.0 2.0 2.2 1.7 10.8 1.9 1.6 5.9 3.2 1.5 0.9 1.4 1.8 2.7 8.3 2.9 2.9 24.7 6.9 0.8 11.4 4.0 0.8 1.8 2.0 2.9 1.5 2.5 1.2 1.7 2.3 1.5 1.5 3.9 3.2 1.2 3.4 0.0 2.0 2.1 1.8 1.8 1.5 0.9 0.6 1.7 3.8 1.0 0.2 0.7 2.6 3.4 12.7 1.7 0.8 1.2 2.4 1.5 3.3 0.2 2.4 1.3 0.3 3.0 1.5 0.2 0.9 3.2 0.6 6.8 1.4 0.5 1.3 0.0 1.3 0.3 1.2 3.2 0.2 1.2 0.5 7.1 0.6 4.3 0.7 3.4 1.8 16.1 3.0 0.2 6.2 0.1 1.5 1.8 0.3 1.3 0.7 0.2 4.9 3.2 1.2 24.2 0.4 1.0 6.5 0.3 0.6 0.3 3.5 0.6 0.9 4.4 4.5 0.4 8.0 0.2 0.9 0.9 0.6 0.5 3.3 0.3 3.7 1.6 3.4 3.3 0.2 1.8 3.8 3.5 0.8 1.7 0.4 1.5 0.6 1.0 8.4 11.9 13.4 26.0 5.9 3.2 2.7 8.3 11.4 3.2 0.0 1.3 3.0 3.6 2.4 23.6 2.5 7.6 8.1 1.2 10.4 13.7 0.6 3.3 2.6 3.1 2.8 4.2 0.0 4.4 0.4 4.8 3.6 1.1 2.4 3.1 14.3 10.9 1.8 1.3 2.7 5.2 2.1 1.7 17.2 4.7 9.8 3.2 0.0 2.5 6.2 22.5 0.0 4.7 9.7 5.7 1.9 0.3 4.6 3.6 2.0 PRRT4 ENSG00000224940 "Proline rich transmembrane protein 4" C9JH25 7 128350325-128361685 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 49.0" "Cell type enriched" "Detected in some" 8 "Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 72.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA046373, HPA052681" Uncertain Approved "Nucleoplasm,Peroxisomes,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Peroxisomes, Plasma membrane" "HPA046373: AB_2679642, HPA052681: AB_2681912" "unprognostic (1.72e-1)" "unprognostic (4.55e-2)" "unprognostic (5.36e-3)" "unprognostic (1.20e-4)" "unprognostic (2.60e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (5.62e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-4)" "unprognostic (9.11e-2)" "unprognostic (3.73e-4)" "unprognostic (5.28e-3)" "unprognostic (9.09e-2)" "unprognostic (1.22e-2)" "unprognostic (1.27e-2)" 12.1 1.9 2.0 5.9 11.3 49.0 6.8 6.5 3.1 1.6 2.7 0.6 0.0 0.6 0.7 0.5 1.9 1.0 1.1 2.4 1.7 6.2 0.5 0.7 0.8 0.6 1.6 2.4 1.0 0.6 0.8 0.0 0.6 2.9 0.8 0.7 3.4 1.9 1.3 4.2 1.5 0.8 1.0 2.8 1.3 1.6 0.7 1.5 0.7 0.7 1.7 1.0 2.0 3.2 0.0 0.4 0.4 0.4 0.0 1.5 0.4 0.0 0.0 0.1 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.3 0.7 14.1 0.3 0.0 0.0 3.9 0.2 0.3 0.0 0.0 0.1 72.0 0.1 0.0 0.1 0.5 0.0 1.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.5 0.7 0.4 0.0 0.0 0.4 0.0 0.4 2.0 11.3 6.5 3.1 1.7 6.2 1.6 2.4 2.9 1.5 0.0 0.0 0.0 0.0 0.6 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 9.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.3 0.2 0.0 0.0 0.0 PRSS16 TSSP ENSG00000112812 "Serine protease 16" Q9NQE7 6 27247701-27256624 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 14 "lymphoid tissue: 242.8" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 36.3;Syncytiotrophoblasts: 26.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4" "Group enriched" "Detected in many" 39 "B-cells: 5.4;T-cells: 2.3" "Cell line enhanced" "Detected in many" "hTCEpi: 19.9;RPMI-8226: 10.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (1.50e-1)" "unprognostic (6.95e-2)" "unprognostic (1.91e-2)" "unprognostic (1.51e-1)" "unprognostic (2.21e-2)" "unprognostic (1.74e-2)" "unprognostic (9.21e-3)" "unprognostic (1.57e-1)" "unprognostic (7.89e-2)" "prognostic favorable (6.46e-5)" "unprognostic (1.57e-1)" "unprognostic (3.49e-2)" "unprognostic (5.42e-2)" "unprognostic (1.95e-1)" "unprognostic (5.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.62e-2)" 0.9 0.5 0.9 0.9 0.9 0.0 3.6 0.9 0.9 2.0 3.3 0.9 0.9 2.3 0.9 9.3 3.6 3.3 2.1 0.9 0.9 0.0 1.4 0.9 2.4 0.9 0.9 0.9 1.2 17.1 6.4 1.8 2.1 0.9 1.8 4.1 0.9 4.3 2.5 0.9 2.9 2.8 0.9 0.9 0.9 3.9 0.9 0.9 242.8 8.7 0.9 0.9 2.0 1.1 5.4 0.0 0.0 0.0 0.0 2.3 0.4 3.0 0.2 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 3.4 4.6 0.0 0.7 0.0 0.0 1.5 2.5 3.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 2.0 0.5 0.0 19.9 0.0 4.0 0.5 0.0 1.6 2.3 1.9 0.0 1.2 0.4 0.0 0.7 1.9 0.5 0.0 0.0 10.7 2.3 3.4 0.0 0.0 1.3 3.0 0.0 4.6 1.9 0.8 0.0 0.0 0.8 0.0 0.0 0.7 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 2.0 5.4 2.3 1.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.9 0.9 0.9 0.9 0.9 0.0 0.9 0.9 0.9 0.9 8.9 7.7 0.8 9.8 5.7 0.0 0.4 7.6 2.7 3.4 14.0 0.0 36.3 1.7 6.8 0.5 0.3 16.0 0.0 15.6 21.7 0.4 6.6 5.7 0.0 3.4 0.0 4.1 0.0 0.3 0.0 0.6 0.0 5.0 0.0 17.5 1.0 10.5 19.8 0.0 0.2 0.0 0.0 0.7 1.0 5.3 5.6 26.5 0.0 14.5 7.4 PRSS45 TESSP5 ENSG00000188086 "Serine protease 45" Q7RTY3 3 46742092-46744755 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 7.6;skeletal muscle: 6.7" "Cell type enhanced" "Detected in some" 14 "Late spermatids: 1.1;Melanocytes: 1.7;Spermatocytes: 1.9;Spermatogonia: 1.2" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 19 "naive B-cell: 1.9" "Lineage enriched" "Detected in single" 19 "B-cells: 1.9" "Cell line enhanced" "Detected in some" "Daudi: 1.1;HHSteC: 2.4;OE19: 1.7;SuSa: 1.1" HPA060284 Uncertain NA NA "HPA060284: AB_2684242" "unprognostic (4.55e-3)" "unprognostic (3.49e-2)" "unprognostic (1.07e-2)" "unprognostic (2.50e-1)" "unprognostic (6.07e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (6.20e-2)" "unprognostic (1.54e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-4)" "unprognostic (2.33e-2)" "unprognostic (6.60e-3)" "unprognostic (1.27e-2)" "unprognostic (1.57e-2)" "unprognostic (2.15e-1)" "unprognostic (5.97e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.5 0.2 0.1 0.2 7.6 0.1 0.8 0.0 0.2 0.0 0.0 0.9 0.7 0.2 0.1 0.0 0.3 1.3 2.0 0.5 0.1 0.5 0.0 0.5 0.3 6.7 0.3 0.0 0.0 0.0 0.0 0.2 1.6 3.2 0.0 0.4 0.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.0 0.0 0.0 PRTG "FLJ25756, IGDCC5" ENSG00000166450 Protogenin Q2VWP7 15 55611546-55743090 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 16.5;thyroid gland: 23.9" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 180.6;Rod photoreceptor cells: 63.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 18 "monocytes: 1.7" "Group enriched" "Detected in some" 7 "AF22: 47.4;SuSa: 57.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA032138 Approved "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA032138: AB_10669675" "unprognostic (2.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.32e-1)" "unprognostic (4.64e-2)" "unprognostic (2.07e-2)" "unprognostic (4.96e-4)" "unprognostic (1.82e-4)" "unprognostic (1.31e-1)" "unprognostic (3.19e-1)" "unprognostic (4.76e-3)" "unprognostic (1.37e-1)" "unprognostic (5.32e-2)" "unprognostic (5.67e-2)" "unprognostic (2.42e-6)" "unprognostic (8.81e-2)" "unprognostic (3.17e-2)" "unprognostic (2.70e-1)" 1.3 2.2 1.5 1.1 1.8 0.6 2.4 1.2 2.2 4.7 1.4 3.6 1.1 0.7 11.0 4.6 0.7 2.4 1.0 1.3 1.6 1.6 2.6 0.6 5.0 0.6 3.0 2.0 4.5 0.6 6.4 2.7 6.5 4.3 1.4 0.9 16.5 0.9 1.4 3.9 0.6 0.9 2.9 3.5 0.5 1.5 6.5 2.3 0.0 23.9 0.8 0.9 1.2 1.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 1.0 47.4 1.0 0.0 0.0 4.8 0.4 1.4 1.2 1.7 7.9 0.2 0.0 2.0 0.0 1.8 0.0 0.1 0.1 1.7 0.0 2.5 0.3 0.3 3.0 0.3 0.3 0.0 0.1 0.0 0.5 0.8 0.9 0.8 0.0 0.8 0.0 0.7 0.6 0.0 0.0 1.9 0.0 1.1 0.0 7.5 0.0 0.9 0.1 0.6 2.7 0.4 0.6 2.6 57.9 0.2 0.1 0.0 0.6 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.5 1.8 1.2 2.2 1.6 1.6 3.0 2.0 4.3 2.3 8.9 13.2 0.0 0.0 0.2 9.5 4.6 0.0 0.0 4.5 15.7 180.6 18.0 0.0 0.0 13.5 5.3 0.0 0.0 0.2 4.2 1.9 0.1 0.0 0.0 1.5 0.0 0.0 2.5 0.0 18.8 4.9 0.0 0.0 0.0 0.0 2.8 0.4 0.0 2.5 1.1 63.9 0.0 1.0 7.2 13.4 0.0 5.0 0.0 0.0 0.1 PRUNE2 "A214N16.3, bA214N16.3, BMCC1, BNIPXL, C9orf65, KIAA0367" ENSG00000106772 "Prune homolog 2" Q8WUY3 9 76611376-76906087 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 89.3" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 47.7;Intestinal endocrine cells: 52.1;Mucus-secreting cells: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 21.9;LHCN-M2: 34.3;RH-30: 29.7;RPTEC TERT1: 16.8" "Low region specificity" "Detected in all" "HPA022470, HPA031079" Uncertain NA NA "HPA022470: AB_1845832, HPA031079: AB_10603230" "unprognostic (1.21e-1)" "unprognostic (3.65e-2)" "unprognostic (6.06e-2)" "unprognostic (2.13e-2)" "unprognostic (3.23e-1)" "unprognostic (2.43e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-2)" "unprognostic (3.60e-1)" "unprognostic (8.69e-2)" "unprognostic (2.11e-2)" "unprognostic (9.79e-2)" "prognostic favorable (1.37e-6)" "unprognostic (7.75e-2)" "unprognostic (1.06e-1)" "unprognostic (3.25e-3)" "unprognostic (3.80e-4)" 6.1 18.3 14.1 10.2 28.9 2.6 3.1 47.9 34.5 7.8 45.6 16.4 18.5 5.8 23.9 14.9 26.4 19.0 12.8 5.6 14.6 13.8 12.1 2.2 4.5 2.6 30.4 14.8 3.6 4.0 4.2 22.3 3.7 18.9 37.2 14.9 11.3 10.2 50.8 7.8 2.3 12.5 89.3 19.5 3.8 21.3 4.2 29.5 0.0 1.4 4.6 2.6 38.1 13.8 0.7 1.9 1.8 2.8 1.2 0.6 0.7 0.0 0.0 0.6 0.0 21.9 10.6 0.0 0.7 1.5 2.5 6.1 0.1 0.0 0.1 1.6 1.8 5.6 0.0 0.0 0.0 7.6 0.1 1.2 2.5 1.5 0.0 3.6 0.0 0.1 12.3 0.0 11.1 0.3 6.4 5.9 0.1 0.0 8.7 34.3 0.0 1.8 0.7 1.6 0.0 0.0 0.2 29.7 0.1 16.8 0.0 7.3 0.0 0.0 0.1 2.0 1.2 0.0 0.3 4.9 6.0 0.3 14.3 0.4 9.3 1.2 0.0 4.8 0.1 0.0 1.2 2.2 0.3 0.1 2.8 0.6 0.0 0.2 0.0 1.9 0.7 0.0 0.0 1.8 1.2 1.2 0.4 0.0 0.7 14.1 28.9 47.9 20.7 14.6 13.8 30.4 14.8 18.9 29.5 0.0 0.6 0.0 0.4 2.1 47.7 4.9 0.0 17.4 1.2 10.4 0.0 0.0 1.7 0.0 12.1 3.6 2.1 0.0 0.4 0.1 2.1 6.3 0.0 0.0 2.9 14.3 52.1 20.3 3.0 24.7 0.9 3.1 5.0 0.0 27.0 10.0 0.5 5.8 1.4 16.1 5.4 0.0 8.4 2.3 1.5 1.3 0.0 0.0 2.8 0.4 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes No "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853" "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favorable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 16.3 15.3 21.0 13.4 34.9 19.2 15.7 15.5 24.7 16.5 26.2 66.1 9.5 26.6 14.2 15.4 19.0 12.6 17.1 9.9 28.6 18.2 19.7 16.9 16.9 10.8 42.1 20.7 13.5 15.0 21.8 9.2 22.7 31.8 13.6 25.6 15.0 16.8 13.4 13.0 24.7 27.9 14.6 61.9 14.6 16.3 16.8 39.7 15.4 19.7 8.7 15.9 17.2 13.5 9.0 24.4 38.1 34.0 11.7 10.5 17.1 14.4 22.2 20.8 8.3 29.1 20.8 18.9 21.3 24.5 21.9 27.6 27.6 36.2 9.4 14.1 20.2 17.9 38.5 17.5 16.1 23.9 21.5 10.8 10.8 15.1 13.4 26.9 10.8 21.1 21.3 29.4 18.1 22.4 20.0 17.5 10.6 12.0 19.2 20.4 28.7 8.2 14.1 9.0 25.7 16.5 10.5 17.7 12.0 30.4 30.7 11.6 15.5 23.2 21.8 18.9 19.7 27.0 24.3 18.5 22.3 18.4 18.1 10.0 12.6 18.4 9.6 18.7 13.2 13.5 29.2 27.1 27.1 7.2 30.8 7.0 7.2 7.0 5.9 24.4 9.0 6.6 6.4 38.1 11.7 34.0 12.8 10.5 17.1 21.0 34.9 15.5 24.7 28.6 18.2 42.1 20.7 31.8 39.7 26.8 35.7 14.6 21.9 25.3 16.5 10.1 20.4 22.7 26.1 22.7 37.3 22.8 5.0 24.3 8.6 20.3 63.6 0.0 23.2 24.7 22.1 24.7 17.4 18.6 27.3 12.7 15.5 13.5 47.8 10.0 15.3 43.2 15.1 33.3 34.1 13.6 29.5 51.8 14.5 13.3 27.4 25.8 18.4 21.6 13.7 28.9 41.8 20.3 36.6 44.4 PSEN2 "AD3L, AD4, PS2, STM2" ENSG00000143801 "Presenilin 2" P49810 1 226870184-226896105 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013634, HPA038005" Supported Nucleoplasm NA NA Nucleoplasm "CAB013634: , HPA038005: " "unprognostic (3.40e-2)" "unprognostic (4.73e-3)" "unprognostic (2.94e-1)" "unprognostic (3.86e-2)" "unprognostic (6.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.72e-2)" "unprognostic (1.31e-1)" "unprognostic (9.98e-2)" "unprognostic (2.73e-2)" "unprognostic (8.25e-3)" "unprognostic (8.53e-3)" "unprognostic (8.45e-2)" "unprognostic (1.17e-1)" "unprognostic (8.36e-2)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" 8.9 13.2 9.5 5.9 7.9 1.2 8.1 16.6 10.7 9.2 9.2 5.9 7.3 9.4 16.4 9.0 9.4 8.7 12.0 9.7 6.5 10.8 7.8 7.7 9.0 11.6 8.1 9.3 13.1 31.6 14.0 15.2 7.6 14.8 12.8 6.9 15.9 9.6 13.4 22.1 6.8 12.2 17.0 4.9 10.6 7.1 21.8 5.3 1.4 6.0 7.2 7.0 9.0 7.2 5.1 7.7 19.4 18.7 12.3 3.4 3.1 9.0 13.6 4.0 12.6 5.5 1.8 6.7 7.7 15.1 9.6 7.4 10.6 11.7 0.1 10.4 9.8 6.6 4.6 7.1 7.3 3.9 9.7 13.1 6.1 9.6 6.9 9.3 4.8 10.1 5.4 8.2 11.5 6.3 6.8 4.4 0.0 10.5 4.1 5.6 7.6 0.1 5.5 12.4 11.3 11.2 0.1 14.8 14.5 8.5 7.7 7.1 11.8 6.2 17.1 30.5 11.8 14.7 6.1 4.8 6.8 5.8 6.2 9.6 16.6 24.4 0.4 12.2 1.5 9.0 19.4 5.7 12.1 3.2 6.5 3.4 5.1 1.1 2.9 7.7 2.6 0.6 1.7 1.2 12.3 18.7 0.6 1.4 3.1 9.5 7.9 16.6 10.7 6.5 10.8 8.1 9.3 14.8 5.3 14.9 13.3 3.0 4.2 1.4 6.0 7.5 12.7 2.7 3.4 5.2 0.0 12.2 1.7 11.0 1.9 7.7 6.7 0.0 15.7 4.3 7.6 4.8 13.9 6.8 16.3 15.9 5.8 23.4 5.3 0.9 6.6 8.3 32.1 30.7 4.3 20.0 11.9 5.8 12.4 6.0 5.4 6.5 4.7 0.7 4.5 1.6 38.3 2.5 4.1 3.9 PSENEN PEN2 ENSG00000205155 "Presenilin enhancer gamma-secretase subunit" Q9NZ42 19 35745114-35747519 "Disease related genes, Predicted membrane proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Ciliated cells: 571.5;Spermatocytes: 347.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047435 Enhanced NA NA "HPA047435: AB_2680047" "unprognostic (1.96e-2)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.64e-1)" "unprognostic (2.01e-1)" "unprognostic (2.79e-1)" "unprognostic (1.03e-3)" "unprognostic (3.21e-2)" "unprognostic (1.41e-1)" "unprognostic (3.51e-3)" "unprognostic (2.30e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (8.70e-4)" "unprognostic (6.85e-2)" "unprognostic (1.80e-1)" "unprognostic (2.10e-1)" "unprognostic (5.41e-3)" 16.8 22.9 25.5 14.7 24.0 12.5 23.1 8.1 27.6 26.1 22.8 30.0 26.6 16.3 19.7 56.6 23.1 95.2 19.5 20.8 24.3 25.5 40.2 51.7 21.8 20.4 23.4 19.2 20.4 27.8 21.4 21.1 17.1 24.0 17.7 26.6 21.4 34.9 23.6 17.4 15.1 23.3 19.6 25.5 21.7 17.5 100.3 17.7 23.3 28.2 20.3 24.3 16.5 14.7 19.7 58.0 92.5 39.8 14.2 23.8 33.8 22.9 47.3 18.7 22.3 37.5 23.1 11.2 12.4 28.3 29.7 31.8 12.8 45.1 12.7 30.5 25.4 19.7 13.8 17.0 22.1 27.8 19.4 13.4 8.6 11.5 12.1 33.2 13.5 15.0 23.6 39.4 34.2 28.0 25.9 28.8 24.4 13.1 29.1 32.7 26.6 15.1 15.8 14.7 54.9 12.5 14.7 7.7 22.5 58.3 12.0 15.9 24.9 17.0 35.7 10.6 27.4 23.3 29.8 11.3 22.5 13.4 15.5 19.7 21.5 25.1 14.6 39.2 12.7 17.9 19.3 36.4 32.6 23.8 39.8 22.4 19.7 17.6 20.3 26.7 18.1 13.6 17.3 92.5 14.2 31.1 58.0 17.6 33.8 25.5 24.0 8.1 27.6 24.3 25.5 23.4 19.2 24.0 17.7 35.7 33.9 66.6 51.0 34.5 11.1 31.7 50.9 571.5 66.0 122.1 13.7 81.9 51.4 130.6 116.2 57.6 94.2 23.3 131.7 112.4 63.0 51.0 56.6 38.9 142.6 6.4 67.4 46.6 56.9 109.2 50.6 84.7 67.4 75.7 56.7 44.7 134.0 101.7 38.2 163.1 12.0 51.8 52.6 347.5 29.7 42.3 87.1 58.9 59.1 69.5 PTAFR ENSG00000169403 "Platelet activating factor receptor" P25105 1 28147166-28193936 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 98.3" "Group enriched" "Detected in many" 7 "granulocytes: 73.9;Hofbauer cells: 62.8;Kupffer cells: 70.6;Macrophages: 55.7;Pancreatic endocrine cells: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7" "Group enriched" "Detected in many" 5 "granulocytes: 98.3;monocytes: 28.2" "Group enriched" "Detected in some" 4 "HBEC3-KT: 14.7;HMC-1: 53.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027543 Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "HPA027543: AB_10610287" "unprognostic (2.22e-2)" "unprognostic (2.59e-2)" "unprognostic (6.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.75e-1)" "unprognostic (3.74e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.23e-1)" "unprognostic (2.39e-1)" "unprognostic (1.60e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.59e-2)" "unprognostic (5.48e-2)" "unprognostic (1.38e-2)" 5.6 2.3 2.4 16.2 1.9 20.3 2.4 0.6 2.0 6.9 3.4 1.6 3.5 1.8 2.8 1.4 16.8 2.8 7.5 3.5 2.1 2.3 6.4 1.8 9.2 6.1 4.1 1.0 1.5 2.7 0.9 0.7 3.5 1.8 2.6 3.4 0.6 3.4 2.6 1.1 2.8 5.0 3.8 5.1 15.4 2.3 2.2 1.1 2.3 1.4 22.2 21.7 5.9 3.6 1.5 13.2 98.3 28.2 0.0 0.1 10.1 7.7 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 2.2 0.5 0.0 0.0 0.1 5.3 0.2 14.7 0.3 0.1 0.2 2.9 0.0 0.3 0.0 0.7 53.6 0.0 2.4 0.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 7.2 0.2 0.2 0.1 0.1 0.0 0.0 3.6 0.8 0.1 0.0 0.0 7.3 0.0 0.2 0.1 2.0 0.0 0.1 0.3 0.0 0.0 0.5 0.4 2.1 0.0 0.9 0.2 5.9 28.2 98.3 0.0 8.9 0.1 1.5 0.0 0.0 13.2 0.7 0.0 0.0 85.7 0.0 3.5 0.1 0.1 10.1 2.4 1.9 0.6 2.0 2.1 2.3 4.1 1.0 1.8 1.1 6.0 7.9 4.3 1.5 5.8 1.2 2.0 2.5 6.7 2.3 1.8 2.0 0.5 0.0 8.8 0.0 5.9 0.2 0.0 4.6 0.4 2.2 0.4 73.9 0.8 62.8 0.0 0.0 1.8 70.6 0.0 0.6 55.7 0.0 4.6 0.0 0.2 55.1 0.0 0.0 0.0 0.8 0.0 0.9 2.1 0.5 2.5 1.3 1.0 0.0 8.6 PTCH1 "BCNS, NBCCS, PTCH" ENSG00000185920 "Patched 1" Q13635 9 95442980-95517057 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Cancer-related genes, Disease mutation, Holoprosencephaly, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 17 "Late spermatids: 165.3;Leydig cells: 176.9;Peritubular cells: 417.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 8.9" "Lineage enriched" "Detected in many" 8 "T-cells: 8.9" "Cell line enhanced" "Detected in many" "NTERA-2: 15.8;WM-115: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013717, HPA075072" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB013717: , HPA075072: AB_2686733" "unprognostic (1.46e-1)" "unprognostic (1.06e-1)" "unprognostic (3.16e-1)" "unprognostic (1.79e-2)" "unprognostic (3.22e-2)" "unprognostic (9.01e-2)" "unprognostic (2.13e-1)" "unprognostic (3.54e-3)" "unprognostic (2.63e-1)" "unprognostic (8.66e-3)" "unprognostic (1.52e-2)" "unprognostic (2.82e-1)" "unprognostic (1.13e-6)" "unprognostic (8.63e-2)" "unprognostic (4.40e-2)" "unprognostic (2.76e-1)" "unprognostic (2.82e-1)" 4.1 3.8 6.7 6.0 9.5 0.7 7.9 21.0 6.4 28.5 12.5 6.1 8.0 7.8 16.2 4.2 3.0 7.4 13.2 2.8 7.0 6.6 4.9 2.2 7.1 4.5 9.5 3.2 5.2 10.8 3.4 4.0 3.7 6.9 6.9 12.3 11.2 6.9 9.5 2.7 4.3 10.9 8.5 5.1 3.8 12.1 14.3 7.9 1.0 6.3 1.9 3.2 11.3 6.9 1.0 0.0 0.0 0.0 0.3 8.9 1.8 5.1 2.5 10.9 6.8 1.6 2.7 6.2 1.0 0.9 1.2 0.7 2.5 2.5 4.1 1.8 1.9 2.3 11.8 6.2 0.8 0.7 4.0 4.1 0.0 2.5 1.1 1.5 0.1 2.3 2.5 1.3 1.1 0.8 2.3 2.2 1.8 3.6 4.8 0.5 1.0 0.0 1.6 15.8 3.7 1.0 0.0 8.3 2.1 0.8 0.7 7.5 3.7 3.7 3.6 1.6 10.6 0.9 1.1 0.5 1.4 7.2 7.3 0.7 9.7 8.4 2.7 2.0 2.0 37.6 0.0 0.0 0.0 8.9 0.0 5.3 1.0 1.7 3.8 0.0 0.3 2.8 3.2 0.0 0.3 0.0 0.0 1.4 1.8 6.7 9.5 21.0 6.4 7.0 6.6 9.5 3.2 6.9 7.9 0.0 5.4 0.9 2.8 3.5 17.4 5.1 10.2 1.4 2.3 0.0 39.3 2.0 5.0 2.5 80.9 3.7 1.3 0.0 3.5 1.6 6.9 5.8 1.1 1.0 0.7 19.1 20.8 3.1 0.8 165.3 176.9 0.8 11.8 0.0 11.2 71.0 2.6 3.5 417.9 1.1 13.5 38.8 4.2 3.3 33.2 3.9 1.1 4.3 5.0 1.1 PTCH2 ENSG00000117425 "Patched 2" Q9Y6C5 1 44819844-44843063 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "parathyroid gland: 82.4;salivary gland: 44.3;testis: 32.0" "Cell type enhanced" "Detected in many" 15 "Leydig cells: 99.8;Peritubular cells: 64.0" "Cancer enhanced" "Detected in many" "testis cancer: 9.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (6.54e-5)" "unprognostic (1.05e-1)" "unprognostic (7.29e-3)" "unprognostic (3.65e-3)" "unprognostic (3.89e-1)" "unprognostic (7.42e-3)" "unprognostic (3.01e-1)" "unprognostic (2.94e-2)" "unprognostic (1.51e-1)" "unprognostic (8.67e-2)" "prognostic favorable (5.74e-5)" "unprognostic (2.92e-1)" "unprognostic (5.74e-6)" "unprognostic (1.55e-2)" "unprognostic (4.86e-2)" "unprognostic (6.31e-2)" "unprognostic (6.81e-2)" 2.5 1.9 8.0 2.4 5.2 6.0 2.2 9.7 7.2 2.5 2.0 1.2 1.3 1.5 6.7 1.9 1.3 2.7 2.4 3.3 6.2 6.1 1.0 1.2 1.2 2.2 2.5 5.8 19.1 1.1 82.4 6.8 1.0 6.0 1.8 1.4 4.6 44.3 1.7 2.0 2.3 1.3 6.6 5.5 1.8 1.2 32.0 5.2 0.0 3.1 2.4 1.3 2.2 2.3 3.4 7.6 3.3 3.8 2.0 2.4 0.5 0.3 0.4 1.6 3.7 1.3 1.4 1.4 1.2 2.4 0.8 0.7 0.4 0.5 1.5 0.7 0.6 0.8 0.1 1.6 0.1 0.3 3.2 2.8 0.9 1.2 1.1 0.4 0.9 1.8 0.5 0.6 1.5 0.1 2.5 0.2 1.5 1.0 1.6 0.1 0.8 1.8 3.0 0.5 0.1 0.6 1.4 0.3 0.7 0.3 0.1 2.2 0.9 0.4 0.6 1.0 0.9 0.3 1.8 0.2 0.3 0.9 1.9 0.7 2.7 15.3 4.5 0.9 4.4 0.5 3.3 3.8 0.3 1.1 2.0 2.4 2.2 1.4 1.4 2.5 3.4 1.7 1.3 1.3 2.0 1.8 7.6 0.7 0.5 8.0 5.2 9.7 7.2 6.2 6.1 2.5 5.8 6.0 5.2 0.0 1.4 20.6 0.4 0.5 0.6 0.9 7.6 1.4 1.2 1.8 2.0 1.9 0.0 3.2 1.4 1.6 8.4 0.0 1.6 1.4 3.4 0.5 0.0 5.9 6.3 7.9 11.1 1.3 23.6 4.3 99.8 3.4 0.0 2.8 4.9 1.9 2.6 0.0 64.0 0.0 1.0 12.9 3.3 3.4 2.7 1.4 1.9 3.8 5.6 0.1 PTCHD1 FLJ30296 ENSG00000165186 "Patched domain containing 1" Q96NR3 X 23334016-23404372 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Autism, Autism spectrum disorder" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.8" "Cell type enhanced" "Detected in some" 14 "Leydig cells: 6.1;Sertoli cells: 12.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 27.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 3.4;RT4: 3.2;SuSa: 1.6;WM-115: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046110 Uncertain NA NA "HPA046110: AB_2679541" "unprognostic (1.50e-2)" "unprognostic (1.36e-2)" "unprognostic (7.43e-3)" "unprognostic (1.14e-2)" "unprognostic (1.15e-1)" "unprognostic (1.90e-1)" "unprognostic (1.14e-4)" "unprognostic (2.13e-1)" "unprognostic (1.48e-1)" "unprognostic (2.78e-1)" "unprognostic (2.13e-1)" "unprognostic (3.50e-1)" "unprognostic (3.19e-2)" "unprognostic (3.68e-4)" "unprognostic (5.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" 1.6 2.3 6.6 0.9 5.5 0.7 6.0 27.8 8.9 6.2 8.4 1.0 3.5 1.4 5.1 2.1 4.5 0.9 0.8 0.8 5.3 2.7 0.8 0.6 1.2 0.6 3.1 5.8 0.8 0.8 0.5 1.7 0.5 6.5 4.4 2.9 0.0 1.8 11.7 1.1 0.8 1.8 10.2 2.6 1.4 3.4 1.1 3.8 0.0 1.0 0.0 0.6 5.4 2.9 0.7 0.4 1.2 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.4 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 1.2 0.1 0.4 0.0 1.5 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 10.6 1.2 0.3 0.4 0.3 0.2 0.2 0.3 0.3 0.2 0.1 0.7 0.3 0.3 1.0 0.3 0.2 0.4 0.1 0.0 6.6 5.5 27.8 6.5 5.3 2.7 3.1 5.8 6.5 3.8 0.0 1.3 0.0 2.0 0.2 1.3 1.7 0.0 2.7 3.4 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.2 0.0 2.0 2.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.4 12.9 2.3 0.5 1.5 0.0 1.8 0.0 0.0 0.7 PTCHD4 "C6orf138, dJ402H5.2, FLJ41841, PTCH53" ENSG00000244694 "Patched domain containing 4" Q6ZW05 6 47878028-48068689 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 1.4;Collecting duct cells: 1.8" "Group enriched" "Detected in some" 6 "melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 10.1;BEWO: 13.5;Hep G2: 22.5;LHCN-M2: 10.7;SuSa: 22.9;TIME: 11.4;WM-115: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041276 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041276: AB_10796570" "unprognostic (1.35e-4)" "unprognostic (1.66e-2)" "unprognostic (3.25e-1)" "unprognostic (3.11e-3)" "unprognostic (1.07e-2)" "unprognostic (1.57e-3)" "unprognostic (7.94e-2)" "unprognostic (3.59e-3)" "unprognostic (2.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.49e-6)" "unprognostic (5.03e-4)" "unprognostic (9.84e-2)" "unprognostic (1.57e-2)" "unprognostic (5.56e-3)" 2.1 0.7 4.6 0.1 7.4 0.2 1.3 2.7 11.3 3.8 1.2 0.3 0.0 0.6 1.7 3.7 1.9 3.2 1.4 1.4 2.2 1.3 2.2 2.1 3.1 0.2 1.4 5.5 1.1 1.1 0.4 3.9 1.9 1.8 2.3 1.2 1.6 2.1 6.4 0.6 0.3 0.4 1.9 1.3 0.2 0.5 0.9 0.8 0.0 3.6 0.0 0.3 2.8 1.3 0.4 0.4 0.8 0.2 0.1 0.2 0.0 0.0 0.0 10.1 0.0 1.7 5.0 13.5 1.5 3.2 0.1 0.4 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 22.5 0.5 0.0 0.0 7.4 7.2 0.0 0.1 5.4 1.5 2.3 0.0 0.0 10.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.5 0.0 0.0 0.0 22.9 0.0 0.0 11.4 2.5 1.6 0.0 0.2 0.0 0.0 0.0 3.4 0.0 9.9 0.8 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.1 0.2 0.4 0.0 0.0 4.6 7.4 2.7 11.3 2.2 1.3 1.4 5.5 1.8 0.8 0.0 0.6 0.0 0.0 0.1 0.4 0.2 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PTCRA "PT-ALPHA, PTA" ENSG00000171611 "Pre T cell antigen receptor alpha" Q6ISU1 6 42915989-42925835 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "blood: 74.1;lymphoid tissue: 129.5" "Group enriched" "Detected in some" 4 "Hofbauer cells: 18.2;Kupffer cells: 8.0;Melanocytes: 5.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 39 "plasmacytoid DC: 74.1" "Lineage enriched" "Detected in many" 39 "dendritic cells: 74.1" "Group enriched" "Detected in some" 9 "MOLT-4: 29.5;SK-MEL-30: 10.0" NA NA "unprognostic (5.50e-2)" "unprognostic (3.37e-2)" "unprognostic (2.77e-1)" "unprognostic (1.64e-1)" "unprognostic (2.83e-2)" "unprognostic (6.57e-4)" "unprognostic (7.18e-2)" "unprognostic (4.24e-2)" "unprognostic (8.16e-2)" "unprognostic (1.11e-2)" "unprognostic (2.73e-1)" "unprognostic (2.84e-4)" "unprognostic (1.16e-1)" "unprognostic (4.89e-1)" "unprognostic (3.22e-2)" "unprognostic (3.09e-2)" "unprognostic (1.45e-1)" 0.5 0.2 0.1 0.5 0.1 2.9 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.4 5.0 5.2 0.5 0.1 0.1 0.1 0.0 0.1 1.1 0.1 0.3 0.1 0.1 0.5 0.1 0.1 0.0 0.3 0.1 0.8 9.7 0.0 0.1 0.1 129.5 0.1 0.1 4.4 0.1 0.1 0.0 74.1 1.8 0.1 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 1.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 74.1 0.0 6.6 0.1 0.1 0.1 0.1 0.2 0.2 0.5 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 18.2 0.0 0.0 0.6 8.0 0.0 0.0 1.4 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 PTDSS1 "KIAA0024, PSS1, PSSA" ENSG00000156471 "Phosphatidylserine synthase 1" P48651 8 96261715-96336995 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016852 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA016852: AB_1855878" "unprognostic (1.44e-1)" "unprognostic (1.71e-1)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (7.48e-2)" "unprognostic (5.68e-3)" "prognostic unfavorable (1.08e-5)" "prognostic unfavorable (9.83e-4)" "unprognostic (2.79e-1)" "unprognostic (1.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.19e-1)" "unprognostic (2.29e-3)" "unprognostic (4.78e-2)" "unprognostic (1.79e-1)" "unprognostic (4.08e-2)" "unprognostic (3.55e-2)" 8.2 7.9 8.0 8.1 14.7 10.2 10.4 10.2 15.0 9.7 8.3 5.1 22.5 10.6 8.4 7.8 9.6 7.0 7.9 20.1 8.6 9.9 9.5 12.8 7.8 21.8 7.1 8.0 9.6 12.1 23.2 4.9 10.8 9.6 5.7 7.4 5.2 8.8 29.8 10.1 10.4 8.3 9.0 6.0 11.8 8.1 5.1 3.6 20.7 11.0 7.7 11.8 9.3 6.8 3.6 6.1 9.4 3.7 5.0 4.6 7.8 10.4 8.1 1.4 3.9 2.9 6.1 2.4 7.6 10.5 7.3 5.1 3.0 3.0 17.2 7.0 7.1 1.5 4.3 9.9 7.6 11.4 8.8 7.1 16.9 15.7 1.6 3.0 12.4 5.9 5.1 7.3 10.2 7.2 1.8 4.7 5.3 8.4 8.9 6.6 3.0 9.6 1.9 2.2 3.4 7.6 7.7 7.3 13.0 4.1 8.9 6.1 2.5 2.8 2.5 1.1 1.7 5.9 4.2 8.3 6.6 4.1 4.6 8.7 1.8 9.3 8.4 4.1 13.1 5.4 9.4 3.7 2.1 2.8 2.5 4.0 2.6 4.6 3.4 6.1 3.6 4.0 2.9 1.3 5.0 2.4 1.8 2.6 7.8 8.0 14.7 10.2 15.0 8.6 9.9 7.1 8.0 9.6 3.6 17.9 10.8 40.8 14.5 28.0 8.9 88.9 22.9 2.7 14.8 10.4 9.8 67.1 1.7 16.6 53.9 21.0 13.3 23.3 38.8 47.5 19.7 14.5 32.3 28.4 42.1 4.8 5.2 19.0 42.5 34.9 21.6 30.4 18.6 17.2 15.0 4.8 21.4 5.8 24.4 15.9 4.3 0.0 17.6 10.3 16.6 29.4 67.6 35.2 29.4 13.6 PTDSS2 PSS2 ENSG00000174915 "Phosphatidylserine synthase 2" Q9BVG9 11 448268-491399 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 114.3;Late spermatids: 274.1;Spermatocytes: 83.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038928, HPA038929" Approved NA NA "HPA038928: AB_10672832, HPA038929: AB_2676274" "unprognostic (3.41e-1)" "unprognostic (2.52e-1)" "unprognostic (2.07e-1)" "unprognostic (5.75e-3)" "unprognostic (3.19e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.12e-9)" "unprognostic (6.18e-2)" "unprognostic (1.09e-1)" "unprognostic (1.89e-2)" "unprognostic (1.41e-3)" "unprognostic (6.41e-2)" "unprognostic (1.11e-2)" "unprognostic (3.39e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" 14.6 15.5 14.8 8.0 15.3 6.2 14.9 20.0 19.9 12.2 10.1 19.3 13.6 5.2 11.9 12.0 9.3 14.2 10.8 15.9 15.4 13.1 19.8 11.2 10.4 7.8 15.6 12.0 17.6 17.6 35.2 10.4 14.9 13.7 11.9 7.1 13.5 12.2 14.6 18.6 8.3 7.2 13.1 17.3 9.1 11.7 32.0 15.1 10.6 16.5 8.3 6.6 12.7 10.2 0.1 1.2 0.0 1.3 0.8 1.8 0.0 8.5 7.9 7.1 10.6 6.3 10.4 9.2 7.4 8.8 9.3 8.5 2.1 5.9 4.6 6.3 9.1 8.5 14.0 8.6 11.5 4.6 7.7 36.2 5.7 5.7 4.4 12.1 7.7 5.0 11.8 8.8 3.3 5.8 8.4 7.3 5.3 16.7 1.5 7.2 0.8 7.4 7.1 10.5 6.7 19.2 7.8 8.1 2.1 6.7 1.4 11.0 6.0 10.3 6.6 8.0 8.2 2.4 4.3 9.2 4.5 3.0 2.3 4.7 5.9 2.4 2.0 7.8 3.6 3.1 0.0 0.5 0.0 1.1 1.3 0.3 0.0 0.1 0.2 0.5 0.1 0.7 1.8 0.0 0.8 0.2 1.2 0.3 0.0 14.8 15.3 20.0 19.0 15.4 13.1 15.6 12.0 13.7 15.1 0.0 6.7 6.7 7.0 4.2 36.0 12.3 2.5 1.4 5.7 7.0 27.5 16.5 5.0 11.5 114.3 6.7 9.1 0.0 11.0 19.1 10.1 9.3 0.0 5.0 14.0 20.6 15.4 8.0 4.6 274.1 15.8 5.6 5.0 6.4 7.6 26.9 11.2 5.8 14.5 14.9 26.2 6.5 9.2 83.2 19.8 4.4 14.5 3.9 6.9 5.6 PTGDR "DP, DP1, PTGDR1" ENSG00000168229 "Prostaglandin D2 receptor" Q13258 14 52267713-52276724 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Mast cell degranulation" "G-protein coupled receptor, Receptor, Transducer" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.1" "Group enriched" "Detected in some" 5 "T-cells: 31.9;Undifferentiated cells: 11.2" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "pons and medulla: 13.9" "Group enriched" "Detected in many" 5 "gdT-cell: 25.4;MAIT T-cell: 12.7;memory CD8 T-cell: 15.2;naive CD8 T-cell: 8.9;NK-cell: 30.1" "Group enriched" "Detected in many" 30 "NK-cells: 30.1;T-cells: 25.4" "Group enriched" "Detected in some" 4 "ASC diff: 1.4;HSkMC: 1.6;REH: 2.4;U-138 MG: 1.8" "Low region specificity" "Detected in many" HPA049668 Enhanced NA NA "HPA049668: " "unprognostic (9.32e-3)" "unprognostic (3.31e-2)" "unprognostic (1.00e-2)" "unprognostic (2.04e-3)" "unprognostic (4.80e-2)" "unprognostic (2.70e-2)" "unprognostic (3.11e-3)" "unprognostic (5.00e-2)" "unprognostic (9.38e-3)" "unprognostic (4.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (5.60e-8)" "unprognostic (1.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.02e-2)" "unprognostic (5.89e-2)" 3.9 0.9 0.7 9.6 2.5 1.8 9.3 1.4 1.4 5.5 10.0 0.7 0.9 1.1 4.1 2.2 2.1 2.5 4.9 2.3 0.8 0.8 1.5 1.8 3.4 8.9 1.0 3.5 2.3 0.8 0.8 4.5 0.4 13.9 2.1 12.8 11.2 2.6 3.5 0.9 1.3 2.4 2.0 3.6 10.9 2.0 0.9 0.8 1.8 2.5 0.1 3.1 3.3 3.2 0.0 0.0 0.9 0.1 30.1 25.4 4.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 25.4 0.0 12.7 0.0 3.5 15.2 0.0 0.0 0.6 8.9 0.9 30.1 0.1 0.0 0.0 4.1 0.7 2.5 1.4 1.4 0.8 0.8 1.0 3.5 13.9 0.8 3.0 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 1.2 3.1 2.1 0.0 0.0 0.2 1.7 0.0 4.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 31.9 11.2 0.0 PTGDR2 "CD294, CRTH2, DP2, GPR44" ENSG00000183134 "Prostaglandin D2 receptor 2" Q9Y5Y4 11 60850940-60855971 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;lymphoid tissue: 28.1" "Cell type enhanced" "Detected in some" 17 "Cone photoreceptor cells: 2.0;granulocytes: 4.6;Intestinal endocrine cells: 1.2;Mucus-secreting cells: 1.3;Smooth muscle cells: 1.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 35.1;eosinophil: 51.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 51.8" "Cell line enhanced" "Detected in some" "HEL: 10.5;Hep G2: 5.1;HMC-1: 6.7;K-562: 4.3;MOLT-4: 3.4;NB-4: 15.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014259 Uncertain NA NA "HPA014259: AB_1849304" "unprognostic (9.77e-2)" "unprognostic (1.35e-3)" "unprognostic (5.45e-3)" "unprognostic (1.69e-1)" "unprognostic (1.90e-1)" "unprognostic (1.85e-3)" "unprognostic (1.70e-1)" "unprognostic (2.30e-4)" "unprognostic (2.61e-1)" "unprognostic (7.92e-2)" "unprognostic (8.68e-3)" "unprognostic (1.52e-1)" "unprognostic (1.32e-2)" "unprognostic (1.52e-1)" "unprognostic (3.31e-1)" "unprognostic (1.49e-1)" "unprognostic (4.99e-2)" 1.2 0.3 3.9 2.3 8.0 0.4 2.8 2.3 8.2 1.7 10.7 4.0 0.3 7.5 0.9 0.6 1.4 1.5 1.6 5.1 4.3 2.8 0.5 0.7 1.4 1.9 4.9 5.9 0.5 1.1 5.9 0.6 1.9 5.7 0.9 7.4 0.6 0.5 0.5 11.3 1.0 10.8 0.9 2.2 1.1 13.3 0.5 0.8 28.1 0.4 5.6 0.6 1.1 0.4 0.0 1.2 51.8 7.8 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.4 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 10.5 0.0 5.1 1.2 0.0 6.7 2.2 0.1 0.0 0.0 0.0 0.0 0.3 4.3 0.0 0.0 0.1 3.4 15.2 0.0 0.1 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 35.1 0.0 51.8 0.0 2.5 0.0 0.0 0.3 0.2 1.2 0.0 0.0 0.0 0.1 0.0 7.8 0.2 0.3 0.4 3.9 8.0 2.3 8.2 4.3 2.8 4.9 5.9 5.7 0.8 0.0 0.0 0.0 0.0 0.3 0.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 PTGER1 EP1 ENSG00000160951 "Prostaglandin E receptor 1" P34995 19 14472466-14475362 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 13.6;lymphoid tissue: 14.2" "Cell type enriched" "Detected in some" 75 "Collecting duct cells: 188.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.5;NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 5.4;NB-4: 2.9;PC-3: 7.2;SH-SY5Y: 4.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (3.44e-2)" "unprognostic (3.31e-1)" "unprognostic (2.68e-1)" "unprognostic (3.50e-4)" "unprognostic (8.69e-2)" "unprognostic (5.58e-2)" "unprognostic (2.39e-2)" "unprognostic (3.19e-2)" "unprognostic (2.05e-1)" "unprognostic (3.53e-2)" "unprognostic (1.41e-1)" "unprognostic (1.42e-1)" "unprognostic (7.74e-8)" "unprognostic (1.19e-1)" "unprognostic (4.41e-2)" "unprognostic (4.27e-3)" "unprognostic (4.88e-2)" 0.7 1.4 1.1 2.7 1.3 0.2 1.5 0.6 1.2 1.3 1.5 0.1 0.0 1.2 0.4 0.3 1.7 1.0 0.4 3.1 0.4 0.4 13.6 0.5 4.9 6.7 1.8 0.0 1.6 1.8 0.2 1.4 0.3 1.0 0.5 0.3 0.3 0.3 0.4 0.7 0.2 1.9 1.4 0.1 14.2 3.2 0.4 0.6 0.0 0.7 0.0 0.3 0.6 1.3 0.0 0.4 0.0 1.5 2.6 1.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 5.4 0.0 0.3 0.6 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 2.9 0.3 0.0 7.2 0.8 0.0 0.2 0.0 0.1 0.5 4.2 0.1 0.1 0.2 0.0 0.2 0.4 1.3 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.2 1.1 1.3 0.6 1.2 0.4 0.4 1.8 0.0 1.0 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.8 2.5 0.0 0.0 188.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.5 0.3 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.0 0.2 PTGER2 EP2 ENSG00000125384 "Prostaglandin E receptor 2" P43116 14 52314305-52328606 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 40.3" "Cell type enhanced" "Detected in many" 18 "granulocytes: 19.7;Kupffer cells: 20.5;T-cells: 80.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 12.5;ASC TERT1: 33.6;HHSteC: 21.3;HL-60: 12.0;HSkMC: 26.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (1.48e-1)" "unprognostic (2.48e-2)" "unprognostic (1.36e-2)" "unprognostic (4.04e-3)" "unprognostic (1.55e-2)" "unprognostic (3.24e-1)" "unprognostic (3.11e-3)" "unprognostic (1.79e-1)" "unprognostic (2.42e-1)" "unprognostic (1.20e-3)" "unprognostic (1.18e-1)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (8.48e-3)" "unprognostic (5.26e-3)" "unprognostic (6.71e-2)" "unprognostic (5.74e-2)" 8.2 1.2 0.4 9.4 0.5 21.8 9.3 0.4 0.5 22.1 8.7 0.6 2.9 4.0 13.6 5.5 5.4 4.5 6.5 4.8 0.4 0.6 5.5 2.8 8.8 15.9 1.1 0.3 8.2 1.1 0.0 1.4 14.1 1.8 19.4 4.3 10.9 4.1 2.6 1.8 1.6 14.9 3.2 1.1 20.4 11.8 4.1 0.3 4.4 2.2 1.1 3.0 6.0 6.0 0.0 5.6 9.8 17.1 19.7 40.3 17.4 0.7 0.2 0.0 0.0 12.5 33.6 0.1 1.0 0.1 1.1 1.3 0.0 0.0 0.0 0.9 0.7 0.0 4.5 0.0 0.2 1.6 0.0 6.0 0.0 0.3 0.0 21.3 12.0 0.1 26.9 0.5 2.7 0.4 3.6 0.0 0.0 0.0 0.0 6.3 0.5 0.0 0.4 0.5 2.0 4.1 0.0 0.0 0.0 9.6 0.0 0.4 10.5 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.4 0.7 7.7 0.0 0.0 0.0 0.0 2.8 6.7 0.1 1.8 11.2 9.8 33.8 8.9 40.3 0.0 28.7 35.2 5.6 0.0 7.2 21.8 1.5 19.7 17.1 0.2 13.4 17.4 0.4 0.5 0.4 0.5 0.4 0.6 1.1 0.3 1.8 0.3 3.0 1.7 0.9 0.2 1.5 0.0 1.5 0.0 8.1 0.0 3.5 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.2 16.9 0.8 19.7 0.4 10.4 0.0 5.8 4.3 20.5 0.0 3.7 15.1 3.3 4.6 4.9 0.0 0.9 0.0 2.8 0.0 0.0 0.0 5.2 0.0 0.1 1.4 0.2 80.9 0.4 0.1 PTGER3 EP3 ENSG00000050628 "Prostaglandin E receptor 3" P43115 1 70852353-71047808 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 71.2;endometrium 1: 65.2" "Cell type enriched" "Detected in many" 10 "Distal tubular cells: 190.6" "Group enriched" "Detected in some" 7 "breast cancer: 4.1;renal cancer: 9.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 49 "basophil: 22.4" "Lineage enriched" "Detected in single" 49 "granulocytes: 22.4" "Cell line enhanced" "Detected in some" "ASC diff: 15.2;HAP1: 10.8;HDLM-2: 16.3;HEL: 7.8;T-47d: 37.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010689 Uncertain NA NA "HPA010689: AB_1855883" "unprognostic (1.53e-3)" "unprognostic (3.48e-1)" "unprognostic (1.11e-1)" "unprognostic (3.86e-3)" "unprognostic (1.47e-1)" "unprognostic (3.37e-2)" "unprognostic (4.80e-2)" "unprognostic (2.01e-2)" "unprognostic (1.24e-1)" "unprognostic (4.64e-3)" "unprognostic (1.54e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (8.83e-3)" "unprognostic (1.86e-1)" "unprognostic (1.92e-2)" "unprognostic (1.41e-4)" 32.5 3.0 3.9 6.8 0.7 0.0 71.2 0.2 1.7 7.8 6.3 0.1 3.0 0.5 65.2 16.6 1.7 4.8 11.3 2.6 0.6 2.0 41.5 0.3 0.6 2.2 0.4 1.4 2.4 10.7 0.0 0.4 0.5 1.6 3.3 1.0 0.1 15.5 3.7 0.5 6.2 1.8 31.9 0.5 0.3 9.1 4.0 0.0 0.0 0.7 3.2 0.7 4.4 5.7 0.0 0.4 22.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.2 0.3 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 10.8 0.0 0.0 16.3 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.1 0.0 0.1 37.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 0.0 22.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.7 0.2 1.7 0.6 2.0 0.4 1.4 1.6 0.0 0.0 0.3 0.0 0.2 4.4 1.1 0.8 0.0 0.0 0.0 19.2 0.0 0.0 190.6 2.3 0.8 0.9 0.0 0.0 0.0 2.2 2.0 1.5 9.2 0.0 0.1 3.2 2.4 1.3 0.0 0.4 1.1 2.8 8.5 1.0 0.0 0.2 0.0 0.0 0.0 3.3 0.0 6.5 5.1 0.1 0.0 6.6 0.1 0.0 0.0 0.1 PTGER4 EP4 ENSG00000171522 "Prostaglandin E receptor 4" P35408 5 40679498-40693735 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 57.2" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 54.4;Macrophages: 56.4;monocytes: 52.3;T-cells: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 19.1;HUVEC TERT2: 13.5;LHCN-M2: 13.2;RT4: 19.2;THP-1: 12.8;TIME: 24.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA011226, HPA012756" Approved NA NA "HPA011226: AB_1855885, HPA012756: AB_1855884" "unprognostic (1.79e-2)" "unprognostic (6.53e-3)" "unprognostic (9.43e-3)" "unprognostic (6.77e-3)" "unprognostic (1.44e-1)" "unprognostic (7.16e-2)" "unprognostic (7.28e-3)" "unprognostic (1.86e-2)" "unprognostic (2.19e-1)" "unprognostic (2.83e-1)" "unprognostic (1.02e-1)" "unprognostic (2.76e-1)" "unprognostic (3.61e-2)" "unprognostic (2.17e-1)" "unprognostic (2.48e-2)" "unprognostic (1.44e-1)" "prognostic favorable (2.48e-4)" 10.3 5.1 1.4 12.8 1.2 34.7 6.9 0.4 0.8 8.5 24.8 1.7 1.1 9.4 4.8 2.8 6.0 6.1 14.5 9.0 1.1 1.3 8.4 3.7 16.5 16.6 2.2 0.1 4.3 57.2 0.3 1.6 2.3 2.1 7.0 7.9 4.1 3.6 1.0 7.4 4.0 28.7 6.6 4.5 18.2 8.9 2.1 1.2 23.3 3.3 5.7 9.5 11.6 6.2 1.3 5.4 9.3 15.6 2.5 11.4 4.1 1.6 0.3 0.0 0.0 8.2 9.8 0.0 0.1 0.6 0.5 0.3 0.0 0.5 0.2 0.1 0.0 8.6 1.2 0.1 3.0 0.8 19.1 0.4 0.0 0.6 0.0 7.5 7.0 1.4 1.0 0.5 4.9 2.0 1.1 13.5 6.8 0.0 4.6 13.2 0.0 7.0 3.2 0.0 0.3 2.9 4.8 1.3 0.6 1.8 19.2 0.0 0.0 0.3 0.6 0.0 0.3 3.0 12.8 24.3 2.6 0.0 0.0 0.6 0.0 0.1 0.9 1.1 5.3 0.6 3.5 4.5 9.3 11.4 12.8 6.6 1.3 6.9 7.1 5.4 1.3 4.2 6.1 8.7 2.5 15.6 0.8 5.5 4.1 1.4 1.2 0.4 0.8 1.1 1.3 2.2 0.1 2.1 1.2 11.9 13.6 11.5 5.6 54.4 0.0 3.6 0.0 8.1 7.9 7.0 0.0 0.2 0.0 0.9 2.4 8.6 18.8 0.0 6.7 0.6 8.2 9.2 9.3 0.2 30.8 0.0 12.5 3.7 32.1 1.1 0.9 56.4 18.6 52.3 35.0 0.0 2.8 23.2 0.4 0.0 0.2 0.0 10.6 3.6 1.3 26.6 0.2 69.2 16.6 0.8 PTGES "MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12" ENSG00000148344 "Prostaglandin E synthase" O14684 9 129738331-129753047 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 118.4;Extravillous trophoblasts: 226.1;Fibroblasts: 92.9;Syncytiotrophoblasts: 231.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "basophil: 16.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 16.8" "Cell line enhanced" "Detected in many" "ASC diff: 30.0;BEWO: 31.9;GAMG: 57.8;HaCaT: 41.7;SK-BR-3: 30.6;U-2197: 79.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA045064 Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA045064: AB_10795889" "unprognostic (2.92e-3)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (2.54e-2)" "unprognostic (1.94e-3)" "unprognostic (1.25e-1)" "unprognostic (5.38e-3)" "unprognostic (1.24e-3)" "unprognostic (2.92e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (7.97e-5)" "unprognostic (2.22e-1)" "unprognostic (4.66e-2)" "unprognostic (9.78e-3)" "unprognostic (3.19e-2)" "unprognostic (1.30e-1)" "unprognostic (5.20e-2)" 17.0 0.6 1.1 6.2 1.7 3.0 16.7 1.1 1.8 11.9 4.2 0.8 59.8 1.2 2.0 9.1 8.7 2.7 4.1 4.2 2.1 3.5 3.9 0.4 3.5 3.1 1.3 0.7 2.7 0.6 6.3 0.7 51.7 2.1 11.2 2.0 2.9 16.3 182.9 2.5 19.8 3.7 4.8 1.4 1.3 3.4 9.9 0.6 2.3 1.7 6.6 14.1 14.5 15.0 0.0 0.1 16.8 3.2 0.0 0.0 0.1 0.2 18.7 0.0 8.9 30.0 10.4 31.9 1.4 12.3 0.2 0.3 0.9 13.7 0.0 0.5 3.4 57.8 41.7 0.1 1.4 0.1 0.0 0.1 0.0 13.3 0.0 0.7 0.0 0.0 6.1 9.7 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 8.9 1.6 0.0 0.0 0.0 1.0 19.9 0.1 0.7 16.7 30.6 0.1 1.3 16.0 0.0 0.0 0.0 0.0 79.1 0.0 0.0 0.0 0.0 15.7 0.0 0.1 16.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 3.2 0.0 0.0 0.1 1.1 1.7 1.1 1.8 2.1 3.5 1.3 0.7 2.1 0.6 0.0 0.0 0.0 8.2 15.9 0.0 0.0 0.0 0.0 4.5 3.5 0.0 118.4 1.7 10.6 0.4 0.3 0.0 0.0 1.0 226.1 92.9 6.9 1.1 0.0 15.4 0.0 7.0 0.0 0.0 0.0 0.3 3.8 13.5 12.6 6.4 0.0 5.7 0.0 0.0 0.5 0.0 0.0 11.2 0.3 0.0 37.6 231.0 0.0 0.3 38.2 PTGFR FP ENSG00000122420 "Prostaglandin F receptor" P43088 1 78303884-78539749 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 10.1;Club cells: 23.9;Fibroblasts: 9.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 10.1" "Cell type enriched" "Detected in single" 13 "classical monocyte: 1.3" "Lineage enriched" "Detected in single" 13 "monocytes: 1.3" "Group enriched" "Detected in some" 7 "ASC TERT1: 79.7;HSkMC: 24.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.14e-2)" "unprognostic (1.35e-2)" "unprognostic (5.89e-3)" "unprognostic (6.03e-2)" "unprognostic (5.63e-2)" "unprognostic (1.45e-3)" "unprognostic (7.61e-2)" "unprognostic (2.25e-1)" "unprognostic (9.90e-2)" "unprognostic (8.46e-4)" "unprognostic (2.21e-1)" "unprognostic (5.34e-2)" "unprognostic (2.16e-4)" "unprognostic (3.21e-4)" "unprognostic (8.48e-2)" "unprognostic (2.16e-2)" "unprognostic (1.21e-3)" 13.0 4.1 1.1 5.2 1.8 0.0 8.7 0.3 1.0 8.3 3.8 0.3 2.1 0.9 27.2 7.0 6.1 5.3 8.8 7.7 10.1 3.3 5.6 3.6 2.3 1.1 0.5 0.3 14.5 1.5 0.0 0.5 7.7 0.6 12.9 2.7 1.8 6.5 2.1 6.9 7.3 3.0 21.3 0.7 0.8 2.7 4.0 0.0 0.0 2.1 13.4 4.3 20.3 15.9 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 7.6 79.7 0.0 5.7 5.5 2.0 0.7 0.0 0.0 0.0 0.0 3.4 1.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 24.9 0.0 0.5 5.0 5.2 0.0 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.4 1.4 0.6 0.4 0.3 0.0 0.0 0.1 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 1.8 0.3 1.0 10.1 3.3 0.5 0.3 0.6 0.0 0.0 10.1 0.0 0.0 5.7 0.8 0.4 5.1 6.7 23.9 8.7 0.0 0.0 3.3 3.3 5.7 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 5.1 5.2 0.2 5.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 1.0 0.6 0.0 4.1 0.2 0.0 0.0 0.0 PTGFRN "CD315, CD9P-1, EWI-F, FLJ11001, FPRP, KIAA1436, SMAP-6" ENSG00000134247 "Prostaglandin F2 receptor inhibitor" Q9P2B2 1 116910057-116990358 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 58.7;Cardiomyocytes: 78.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 31.3;U-87 MG: 46.2;WM-115: 34.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017074 Approved NA NA 86000 "HPA017074: AB_1855888" "unprognostic (1.18e-1)" "unprognostic (2.11e-3)" "unprognostic (3.03e-1)" "unprognostic (8.58e-2)" "unprognostic (3.20e-1)" "unprognostic (2.91e-2)" "unprognostic (1.48e-3)" "unprognostic (3.39e-2)" "unprognostic (1.76e-2)" "unprognostic (7.28e-2)" "unprognostic (2.77e-2)" "unprognostic (5.28e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.61e-1)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "unprognostic (4.15e-2)" 6.9 14.9 3.7 8.4 4.7 0.0 6.3 1.2 6.6 17.1 26.2 2.5 10.1 6.5 23.9 10.7 23.5 17.8 20.5 29.5 3.0 2.6 3.4 5.3 4.4 1.7 2.8 6.1 15.6 17.1 4.0 3.5 24.6 3.2 13.3 13.2 8.1 13.3 15.0 2.4 12.4 15.3 27.8 3.0 2.5 8.7 6.3 2.2 2.8 5.9 13.5 9.7 15.2 15.3 0.0 3.0 0.0 1.1 0.3 0.9 0.3 11.8 3.1 5.7 13.2 1.0 2.6 0.8 0.8 1.3 4.8 1.8 2.1 2.6 0.0 11.2 3.2 3.9 21.2 12.7 22.7 3.0 0.1 7.7 0.8 7.7 3.3 0.3 0.0 1.2 11.9 20.6 0.6 11.4 6.8 9.2 1.3 4.8 0.0 7.2 15.1 0.0 1.6 6.6 1.0 0.0 0.0 31.3 0.0 16.0 9.8 2.8 6.5 24.4 17.3 6.8 10.5 15.0 3.7 23.6 7.0 10.6 11.5 7.5 0.0 0.0 0.0 46.2 0.0 34.2 0.0 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.7 0.3 3.7 4.7 1.2 6.6 3.0 2.6 2.8 6.1 3.2 2.2 3.0 5.1 0.0 9.1 58.7 4.4 78.3 12.7 5.3 4.5 3.5 0.0 0.4 1.7 26.5 4.7 10.6 12.9 0.0 27.4 4.1 12.5 11.3 0.0 10.4 3.7 0.0 13.4 2.5 6.7 4.0 17.8 3.4 8.5 4.6 21.7 1.3 25.1 3.5 28.3 0.7 0.1 19.4 12.1 0.5 5.7 39.5 0.7 0.5 23.3 12.6 PTGIR IP ENSG00000160013 "Prostaglandin I2 receptor" P43119 19 46620468-46625118 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.7;lung: 35.1" "Cell type enriched" "Detected in many" 4 "monocytes: 249.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 10 "classical monocyte: 12.6;intermediate monocyte: 27.7;myeloid DC: 9.1;non-classical monocyte: 15.5" "Group enriched" "Detected in many" 12 "dendritic cells: 9.1;monocytes: 27.7" "Cell line enhanced" "Detected in some" "BJ: 8.5;BJ hTERT+: 9.7;fHDF/TERT166: 12.0;HDLM-2: 5.9;HEL: 22.0;HHSteC: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.79e-1)" "unprognostic (1.95e-1)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (1.03e-1)" "unprognostic (3.49e-3)" "unprognostic (4.22e-2)" "unprognostic (6.09e-2)" "unprognostic (2.12e-1)" "unprognostic (7.45e-2)" "unprognostic (4.47e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.09e-8)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (1.16e-1)" "unprognostic (5.66e-2)" 7.8 6.3 0.4 8.0 0.6 3.8 3.0 0.1 0.6 6.5 6.0 1.2 1.4 2.7 5.0 2.7 4.5 2.7 6.4 16.0 0.6 0.3 9.0 9.6 35.1 6.5 0.8 0.7 6.9 3.5 0.1 1.2 6.3 1.1 3.2 1.4 3.3 2.5 1.3 12.2 3.0 3.7 4.1 0.5 11.3 4.5 1.6 0.8 3.5 14.5 3.4 4.3 10.2 6.5 0.5 9.1 0.5 27.7 0.0 1.5 7.2 0.0 0.0 0.0 0.0 0.1 4.6 0.0 8.5 9.7 1.2 3.5 0.0 0.0 0.0 0.7 12.0 0.1 0.0 0.0 0.0 0.7 5.9 0.0 22.0 0.0 0.0 5.9 0.0 0.0 1.4 0.0 3.1 0.2 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.4 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.5 0.0 12.6 0.0 0.0 27.7 0.2 0.5 0.1 0.0 9.1 0.3 1.5 0.0 0.5 0.0 15.5 0.8 1.4 7.2 0.4 0.6 0.1 0.6 0.6 0.3 0.8 0.7 1.1 0.8 0.0 1.1 4.5 0.9 3.8 0.5 0.8 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.1 0.1 2.6 0.0 0.0 0.3 0.1 8.9 0.8 3.5 0.0 2.6 0.0 0.0 5.5 6.0 0.0 2.0 14.1 6.8 249.7 0.0 0.0 0.5 0.0 0.0 0.0 0.6 6.5 58.0 0.1 0.4 3.9 0.2 0.9 0.0 0.3 PTGIS "CYP8A1, PGIS" ENSG00000124212 "Prostaglandin I2 synthase" Q16647 20 49503874-49568146 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Lyase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 88.2" "Group enriched" "Detected in many" 8 "Ito cells: 78.5;Leydig cells: 24.7;Peritubular cells: 98.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 17.8;ASC TERT1: 17.9;U-2197: 55.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009517, HPA014193, HPA052244" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574" "unprognostic (7.68e-2)" "unprognostic (1.90e-1)" "unprognostic (5.09e-3)" "unprognostic (1.38e-2)" "unprognostic (1.80e-2)" "unprognostic (1.74e-1)" "unprognostic (1.21e-2)" "unprognostic (1.29e-2)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (2.45e-2)" "unprognostic (5.22e-2)" "prognostic unfavorable (4.74e-8)" "unprognostic (2.29e-2)" "unprognostic (7.61e-2)" "unprognostic (4.89e-3)" "prognostic unfavorable (9.99e-5)" 18.2 2.5 0.6 8.0 1.3 0.1 28.3 0.2 1.6 23.3 14.6 0.5 6.5 1.7 36.5 21.7 13.2 32.0 36.3 23.8 0.3 0.5 3.0 3.8 7.5 1.6 0.5 0.9 51.2 1.3 0.2 0.5 1.0 1.0 27.2 3.7 3.2 3.7 4.6 7.0 3.2 4.4 88.2 1.4 0.3 8.7 16.2 0.3 0.0 6.7 5.6 1.7 64.2 36.1 1.0 0.8 2.7 0.6 0.8 0.5 0.1 0.0 0.0 0.7 0.0 17.8 17.9 0.2 0.3 2.1 0.0 0.0 0.0 0.0 0.0 7.1 5.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.3 0.0 0.2 0.0 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.9 55.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.6 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.1 1.0 0.4 0.5 2.7 0.8 0.3 0.8 0.2 0.1 0.6 1.3 0.2 1.6 0.3 0.5 0.5 0.9 1.0 0.3 3.0 2.4 0.0 0.6 3.3 0.8 3.4 0.0 4.0 3.4 3.5 0.0 0.3 0.0 0.4 1.7 3.8 0.0 0.0 0.0 0.1 8.3 0.3 0.0 0.6 0.3 0.0 0.0 78.5 1.5 2.2 24.7 0.7 1.7 0.0 0.0 0.3 0.7 0.0 98.6 0.0 4.6 0.0 2.5 0.7 1.1 4.3 0.2 0.5 0.0 0.6 PTGS1 "COX1, PGHS-1, PTGHS" ENSG00000095303 "Prostaglandin-endoperoxide synthase 1" P23219 9 122370530-122395703 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Dioxygenase, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 211.4;urinary bladder: 163.9" "Cell type enriched" "Detected in many" 4 "granulocytes: 205.3" "Cancer enhanced" "Detected in all" "ovarian cancer: 53.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 13.0;granulocytes: 14.4;monocytes: 8.5" "Cell line enhanced" "Detected in some" "ASC diff: 28.8;ASC TERT1: 22.8;BJ: 27.9;BJ hTERT+: 38.1;HEL: 17.5;HMC-1: 74.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002834, CAB020315" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 25000000 "Golgi apparatus" Vesicles "CAB020315: , HPA002834: AB_1079711" "unprognostic (4.20e-1)" "unprognostic (6.23e-2)" "unprognostic (1.08e-2)" "unprognostic (2.27e-2)" "unprognostic (5.88e-2)" "unprognostic (2.00e-2)" "unprognostic (1.22e-3)" "unprognostic (3.32e-1)" "unprognostic (2.24e-1)" "unprognostic (3.16e-2)" "unprognostic (1.23e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (4.03e-2)" "unprognostic (1.78e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (9.35e-4)" 4.5 1.1 1.8 9.1 3.1 2.6 2.5 0.5 2.7 2.6 35.3 4.6 3.0 3.9 2.5 1.6 25.7 16.7 9.4 4.9 1.9 1.6 3.9 1.8 4.0 1.4 3.5 0.7 3.6 1.0 0.7 2.4 0.8 2.5 60.9 9.3 1.5 1.9 2.3 0.7 55.9 6.5 211.4 4.9 3.6 7.8 1.0 3.1 0.4 1.5 5.3 4.2 163.9 19.5 2.5 13.0 14.4 8.5 1.9 0.1 13.7 0.0 0.1 0.1 0.0 28.8 22.8 0.0 27.9 38.1 0.2 0.2 0.0 0.0 1.0 1.3 4.7 0.0 1.7 0.1 2.5 0.2 0.0 0.0 17.5 0.1 0.0 8.3 1.2 74.3 11.6 0.3 1.4 0.0 0.0 10.3 0.0 0.0 0.0 0.5 0.0 0.0 1.5 0.4 0.0 0.1 0.0 0.3 2.0 3.6 0.0 0.1 0.1 0.1 2.3 0.0 0.1 0.0 2.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 7.6 0.0 12.0 7.6 14.4 0.0 8.5 0.0 1.7 0.0 0.0 13.0 2.5 0.0 0.0 3.5 1.9 6.1 0.9 0.1 13.7 1.8 3.1 0.5 2.7 1.9 1.6 3.5 0.7 2.5 3.1 0.0 10.0 0.9 2.4 8.9 0.0 1.1 0.0 1.4 2.3 40.1 0.0 0.1 0.0 0.5 0.0 6.0 0.0 0.0 0.4 0.2 4.7 1.9 205.3 0.0 25.3 0.0 1.7 36.8 10.7 0.0 1.4 22.9 3.3 4.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 51.3 0.3 0.7 0.5 0.6 PTH1R "PTHR, PTHR1" ENSG00000160801 "Parathyroid hormone 1 receptor" Q03431 3 46877746-46903799 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 90.4" "Cell type enhanced" "Detected in many" 20 "Distal tubular cells: 81.2;Proximal tubular cells: 259.5;Sertoli cells: 135.8" "Cancer enhanced" "Detected in many" "renal cancer: 18.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 51.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075879 Enhanced NA NA "HPA075879: " "unprognostic (1.26e-1)" "unprognostic (7.09e-2)" "unprognostic (2.24e-5)" "unprognostic (7.46e-2)" "unprognostic (3.46e-1)" "unprognostic (5.02e-2)" "unprognostic (3.84e-3)" "unprognostic (5.47e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (7.51e-2)" "unprognostic (8.44e-2)" "prognostic favorable (6.79e-6)" "unprognostic (4.22e-3)" "unprognostic (1.50e-1)" "unprognostic (1.35e-4)" "unprognostic (6.62e-3)" 8.5 17.9 4.2 1.4 5.9 0.8 5.0 3.7 5.0 6.2 2.3 5.2 1.1 1.5 4.5 2.5 2.3 3.8 2.8 4.3 5.5 3.9 90.4 13.4 4.1 6.9 6.0 5.0 5.4 1.6 1.0 0.9 10.1 4.7 3.2 1.2 3.4 1.5 3.0 4.0 2.6 1.8 4.6 4.1 9.6 1.5 2.2 5.7 0.0 1.2 0.6 1.0 2.8 5.5 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 7.2 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 2.3 0.0 51.7 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.2 5.9 3.7 5.0 5.5 3.9 6.0 5.0 4.7 5.7 0.0 0.0 0.5 0.0 1.1 0.7 2.2 0.0 0.0 0.0 31.4 0.0 0.5 81.2 0.0 8.7 1.5 0.0 0.0 0.5 48.7 10.8 0.0 0.0 0.4 1.8 1.6 0.0 22.1 1.5 22.5 5.5 0.0 0.0 0.0 0.0 3.0 0.2 0.0 2.1 259.5 0.6 135.8 3.1 0.7 1.3 0.6 0.7 0.0 0.0 0.1 PTH2 TIP39 ENSG00000142538 "Parathyroid hormone 2" Q96A98 19 49422414-49423441 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "blood: 2.4;brain: 4.1;testis: 1.7" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 1.6;Late spermatids: 1.1;Muller glia cells: 2.6;Spermatocytes: 1.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 18 "B-cells: 2.4" "Cell line enhanced" "Detected in some" "Hep G2: 1.4;REH: 3.8;SCLC-21H: 3.3;U-266/84: 1.1;U-937: 1.0" "Region enriched" "Detected in single" 10 "olfactory region: 3.5" "Region enriched" "Detected in many" 4 "cerebellum: 36.9" "Secreted in brain" NA NA "unprognostic (3.41e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 1.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 PTH2R PTHR2 ENSG00000144407 "Parathyroid hormone 2 receptor" P49190 2 208359714-208854503 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 8.6;brain: 8.9;salivary gland: 8.2" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 11.8;Distal tubular cells: 6.6;Proximal tubular cells: 12.3;Rod photoreceptor cells: 23.9" "Cancer enhanced" "Detected in many" "renal cancer: 6.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 11.7;HEL: 16.6;HL-60: 4.1;SH-SY5Y: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010655 Approved NA NA "HPA010655: AB_2668333" "unprognostic (4.76e-3)" "unprognostic (1.39e-3)" "unprognostic (1.64e-1)" "unprognostic (5.78e-2)" "unprognostic (3.77e-1)" "unprognostic (8.28e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (3.45e-2)" "unprognostic (2.14e-2)" "unprognostic (1.70e-1)" "unprognostic (1.09e-3)" "unprognostic (2.54e-3)" "unprognostic (6.87e-2)" "unprognostic (1.30e-2)" "unprognostic (1.37e-2)" 2.5 0.9 6.0 0.6 3.5 8.6 2.1 0.2 8.6 0.2 0.2 0.0 0.0 0.0 1.6 4.9 0.2 0.2 0.2 0.2 8.9 4.3 0.5 1.4 0.3 0.3 0.5 4.3 0.1 1.4 0.0 1.0 2.7 0.1 1.2 0.1 0.0 8.2 1.4 0.1 0.3 0.2 1.2 0.4 0.4 0.1 1.7 0.0 0.0 0.2 0.1 0.2 0.2 0.2 1.4 0.6 0.9 1.3 0.0 0.8 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.7 1.3 0.8 1.4 0.0 0.0 0.0 1.0 0.4 0.0 0.9 0.0 0.9 0.6 0.0 0.4 6.0 3.5 0.2 8.6 8.9 4.3 0.5 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 5.2 11.8 0.5 6.6 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 12.3 23.9 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 PTK7 CCK4 ENSG00000112655 "Protein tyrosine kinase 7 (inactive)" Q13308 6 43076268-43161719 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Wnt signaling pathway" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "Early spermatids: 314.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "plasmacytoid DC: 13.8" "Lineage enriched" "Detected in many" 9 "dendritic cells: 13.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003222 Approved "Secreted to blood" NA NA 10000000 "HPA003222: AB_1079713" "unprognostic (1.80e-1)" "unprognostic (7.49e-3)" "unprognostic (6.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.65e-1)" "unprognostic (1.15e-2)" "unprognostic (5.85e-3)" "unprognostic (9.81e-3)" "unprognostic (1.47e-3)" "unprognostic (7.15e-2)" "unprognostic (5.11e-3)" "unprognostic (8.17e-2)" "unprognostic (3.37e-2)" "unprognostic (1.73e-1)" "unprognostic (3.61e-1)" "unprognostic (9.12e-2)" "unprognostic (5.70e-3)" 5.4 1.8 1.4 3.5 3.4 0.8 12.2 3.5 4.9 30.9 4.8 3.4 8.9 2.1 37.7 36.9 11.7 14.3 14.5 3.5 2.2 3.9 10.1 0.8 18.7 4.3 1.3 2.7 42.6 16.3 9.0 9.0 20.9 4.2 18.2 3.3 13.9 15.0 10.9 0.4 13.6 3.4 16.4 3.2 12.4 4.6 14.9 1.4 28.7 19.3 8.1 6.2 9.5 17.6 0.0 13.8 0.3 0.0 0.7 1.5 0.8 2.1 0.6 21.1 35.0 22.7 23.3 30.0 22.6 36.5 19.8 25.4 19.0 7.6 0.0 17.9 26.3 14.4 24.5 9.4 21.5 12.6 0.1 11.7 2.0 4.3 25.5 34.5 0.0 0.1 33.3 19.5 26.1 8.3 34.6 2.5 8.5 1.3 0.0 9.0 1.6 7.6 3.0 9.8 0.2 1.7 7.7 30.0 0.0 15.3 10.5 12.1 23.0 3.6 0.3 11.7 23.2 12.9 4.6 1.6 21.2 13.4 0.1 12.2 0.1 0.2 0.7 4.9 0.0 3.5 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 1.5 0.2 0.7 0.0 13.8 0.0 0.8 1.4 3.4 3.5 4.9 2.2 3.9 1.3 2.7 4.2 1.4 14.9 12.5 0.0 16.8 15.3 1.4 1.6 2.5 2.7 6.8 12.2 53.0 18.9 1.7 19.2 314.6 1.0 0.2 0.0 6.2 1.9 31.6 10.9 1.1 0.0 3.1 0.0 20.7 1.8 0.0 38.8 17.0 1.1 15.1 1.0 1.2 19.8 8.6 3.5 17.3 0.5 1.7 12.9 9.5 2.4 18.5 9.2 6.9 0.7 2.6 9.7 PTN "HBGF8, HBNF, NEGF1" ENSG00000105894 Pleiotrophin P21246 7 137227341-137343865 "Cancer-related genes, Predicted secreted proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 160.7" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 182.0;Extravillous trophoblasts: 368.5;Fibroblasts: 184.0;Horizontal cells: 497.4;Leydig cells: 159.9;Muller glia cells: 523.9;Peritubular cells: 174.3;Syncytiotrophoblasts: 161.7" "Cancer enriched" "Detected in all" 11 "glioma: 514.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "AF22: 190.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017685, HPA073913" Enhanced Supported "Endoplasmic reticulum" "Secreted to blood" NA NA 167000 1800000 "Endoplasmic reticulum" "CAB017685: AB_1128556, HPA073913: " "unprognostic (1.51e-2)" "unprognostic (7.87e-2)" "unprognostic (5.44e-2)" "unprognostic (4.23e-2)" "unprognostic (1.92e-1)" "unprognostic (7.19e-2)" "unprognostic (2.81e-2)" "unprognostic (7.29e-2)" "unprognostic (1.30e-1)" "unprognostic (1.09e-2)" "unprognostic (3.86e-1)" "unprognostic (1.22e-2)" "prognostic favorable (1.35e-4)" "unprognostic (2.34e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-2)" 7.8 6.6 55.5 2.0 43.3 0.9 27.7 38.6 58.5 30.7 7.2 26.9 9.9 2.5 25.2 18.7 25.0 7.2 18.2 29.4 42.3 29.7 12.7 3.4 6.5 2.6 31.6 27.0 7.2 3.4 160.7 52.5 11.8 31.4 38.5 7.7 19.0 12.0 18.1 1.5 3.6 4.0 17.7 23.4 12.4 5.4 16.8 23.3 1.3 5.1 8.7 5.3 7.7 18.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 190.8 2.3 0.0 0.1 15.6 4.9 14.6 2.7 3.8 0.0 0.0 0.0 0.0 6.4 1.7 0.1 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 1.8 0.0 2.7 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 14.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.9 13.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 4.2 3.7 0.2 10.6 0.0 0.0 0.0 13.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 43.3 38.6 42.0 42.3 29.7 31.6 27.0 31.4 23.3 0.0 0.0 0.0 1.3 20.6 19.5 14.2 0.0 2.7 4.5 1.8 5.9 182.0 8.3 1.2 11.9 8.4 0.0 0.0 0.0 368.5 184.0 17.1 0.0 0.0 18.1 497.4 0.0 8.6 0.3 8.3 159.9 1.4 42.2 0.0 0.0 523.9 0.2 0.0 174.3 5.1 27.0 58.2 33.4 1.8 1.5 12.2 161.7 0.0 0.0 2.0 PTPN1 PTP1B ENSG00000196396 "Protein tyrosine phosphatase, non-receptor type 1" P18031 20 50510321-50585241 "Enzymes, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 211.4;monocytes: 327.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009329, HPA012542, CAB015217" Approved Enhanced "Endoplasmic reticulum" NA NA 11000 "Endoplasmic reticulum" "CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915" "unprognostic (1.67e-1)" "unprognostic (7.78e-2)" "unprognostic (1.48e-1)" "unprognostic (1.05e-2)" "unprognostic (1.14e-1)" "unprognostic (3.44e-2)" "unprognostic (2.98e-3)" "unprognostic (3.95e-2)" "unprognostic (2.40e-2)" "unprognostic (6.47e-3)" "unprognostic (5.87e-2)" "unprognostic (1.67e-1)" "unprognostic (1.66e-2)" "unprognostic (6.70e-2)" "unprognostic (2.99e-2)" "unprognostic (1.49e-1)" "unprognostic (2.58e-2)" 22.1 22.2 12.1 31.9 16.0 35.3 17.9 12.9 16.6 18.2 17.8 18.8 14.2 10.5 20.0 16.6 23.2 17.1 18.0 20.5 15.8 9.0 43.8 16.7 42.7 36.1 14.1 14.1 21.8 12.2 31.2 18.8 28.3 18.7 20.0 14.8 21.0 16.3 15.0 41.0 18.6 21.9 16.9 15.8 45.3 17.5 23.5 13.3 26.9 15.7 13.9 42.8 20.0 18.4 15.9 9.4 18.8 16.4 3.9 10.7 6.4 21.1 10.7 12.9 8.9 8.5 11.7 18.4 14.2 13.6 41.9 15.3 31.3 44.6 10.5 25.3 13.1 16.5 18.8 10.2 40.9 26.7 15.5 9.1 14.8 10.4 16.5 16.9 15.4 20.4 13.6 28.7 18.9 23.3 18.4 24.0 12.8 25.8 9.7 22.7 11.8 16.5 12.2 6.8 11.7 14.7 14.7 15.0 10.0 24.1 15.9 10.4 11.9 20.4 26.0 23.0 11.3 16.8 16.5 35.6 36.6 14.7 16.4 17.6 10.6 8.5 12.8 22.9 10.5 13.5 12.0 5.6 18.8 10.7 9.5 7.9 15.9 9.0 8.2 5.5 13.7 7.7 8.3 12.2 3.9 16.4 9.4 7.1 6.4 12.1 16.0 12.9 16.6 15.8 9.0 14.1 14.1 18.7 13.3 211.4 72.3 67.9 44.4 76.4 23.0 27.2 10.2 32.1 47.8 34.9 45.2 41.8 19.9 20.5 47.2 26.1 20.4 0.0 16.9 17.3 21.4 26.7 67.2 18.6 32.9 41.3 17.9 37.4 28.2 22.4 13.0 52.2 35.4 327.4 13.7 13.8 28.9 11.5 11.3 59.6 25.9 19.4 34.0 20.7 24.3 41.3 45.4 43.7 15.5 55.1 PTPN2 "PTPT, TC-PTP, TCELLPTP, TCPTP" ENSG00000175354 "Protein tyrosine phosphatase, non-receptor type 2" P17706 18 12785478-12929643 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015004, HPA046176" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA015004: AB_2669131, HPA046176: AB_2679569" "unprognostic (5.83e-3)" "unprognostic (8.50e-2)" "unprognostic (5.85e-2)" "unprognostic (7.21e-3)" "unprognostic (8.94e-3)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (1.68e-1)" "unprognostic (2.37e-3)" "prognostic favorable (1.37e-4)" "unprognostic (1.06e-2)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.20e-8)" "unprognostic (3.19e-1)" "unprognostic (6.84e-3)" "unprognostic (2.17e-1)" "unprognostic (4.61e-3)" 16.7 12.5 12.6 27.0 14.3 33.7 19.9 32.6 19.2 14.7 15.0 7.8 17.8 12.9 12.2 14.9 17.0 13.7 15.7 12.8 13.1 6.8 13.6 20.5 21.6 30.3 15.3 10.3 22.1 28.2 10.4 27.2 13.3 13.8 14.4 17.1 7.9 26.3 16.0 13.1 16.0 15.3 11.8 24.7 24.2 13.1 9.4 15.9 61.3 14.7 11.7 28.9 16.5 15.8 29.1 32.8 19.9 28.0 31.7 29.2 19.6 12.0 7.4 8.6 2.8 9.9 17.8 8.4 8.1 18.0 17.4 15.6 16.0 17.5 19.0 13.7 8.3 19.5 7.3 14.0 22.2 22.9 7.3 8.4 13.4 6.4 16.6 13.6 31.5 12.8 14.9 21.1 15.8 31.4 10.7 8.8 20.8 13.0 25.9 13.9 13.8 31.4 26.0 10.3 49.8 8.6 10.6 13.6 21.5 14.6 19.4 15.5 8.0 16.4 9.7 14.0 9.6 8.1 18.1 6.7 22.1 21.3 16.4 17.4 8.3 8.3 27.5 10.4 17.3 9.2 11.5 28.0 19.9 21.0 24.6 28.2 29.1 24.8 23.1 32.8 20.3 18.3 20.0 10.2 31.7 22.8 28.0 29.2 19.6 12.6 14.3 32.6 19.2 13.1 6.8 15.3 10.3 13.8 15.9 32.8 62.4 68.6 84.1 53.1 42.4 13.2 38.2 33.5 60.3 14.0 98.2 46.3 11.6 47.9 16.6 28.1 29.6 23.3 59.5 44.8 31.3 89.2 55.4 27.0 47.0 14.3 31.0 16.5 81.8 19.2 27.0 82.9 21.9 111.8 30.9 14.8 39.1 38.6 24.1 17.3 84.6 19.4 21.1 15.4 50.3 43.8 67.9 68.2 36.2 140.6 PTPN5 "PTPSTEP, STEP, STEP61" ENSG00000110786 "Protein tyrosine phosphatase, non-receptor type 5" P54829 11 18727928-18792721 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "brain: 70.0" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 2.4;Distal tubular cells: 1.7;Endothelial cells: 2.4" "Group enriched" "Detected in some" 6 "glioma: 1.6;testis cancer: 2.0" "Region enhanced" "Detected in many" "basal ganglia: 70.0" "Cell type enriched" "Detected in single" 9 "basophil: 1.5" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HMC-1: 3.7;NTERA-2: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031014, HPA072091" Supported Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA031014: AB_10669550, HPA072091: AB_2686487" "unprognostic (1.23e-1)" "unprognostic (2.91e-2)" "unprognostic (8.93e-3)" "unprognostic (1.09e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-2)" "unprognostic (5.83e-3)" "unprognostic (3.59e-1)" "unprognostic (4.91e-2)" "unprognostic (2.59e-1)" "unprognostic (2.00e-1)" "unprognostic (3.58e-1)" "unprognostic (8.44e-4)" "unprognostic (4.21e-3)" "unprognostic (3.90e-2)" "unprognostic (9.39e-2)" "unprognostic (8.49e-2)" 2.5 1.6 16.3 1.1 70.0 1.1 1.2 0.9 47.5 1.5 1.1 0.4 0.0 1.1 1.2 1.0 1.3 1.7 1.4 4.3 9.1 8.6 1.1 0.9 2.7 1.1 3.5 16.0 2.5 1.2 1.5 0.5 0.9 6.1 1.6 1.4 0.0 1.3 1.7 1.8 1.0 1.4 1.4 2.1 1.3 1.3 3.4 9.3 0.0 1.2 0.0 1.0 1.5 0.3 0.1 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.1 0.0 3.7 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 5.8 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.4 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 70.0 0.9 25.1 9.1 8.6 3.5 16.0 6.1 9.3 0.0 0.0 0.0 0.0 0.1 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 PTPRA "HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA" ENSG00000132670 "Protein tyrosine phosphatase, receptor type A" P18433 20 2864184-3039076 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029412, CAB034366, HPA069480" Approved Approved Nucleoplasm,Vesicles NA NA 21000 Vesicles Nucleoplasm "CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: AB_2686141" "unprognostic (1.39e-1)" "unprognostic (2.05e-1)" "unprognostic (4.58e-2)" "unprognostic (2.39e-3)" "unprognostic (1.15e-1)" "unprognostic (1.62e-1)" "unprognostic (5.43e-3)" "unprognostic (5.34e-2)" "unprognostic (1.55e-1)" "unprognostic (3.24e-1)" "unprognostic (7.33e-2)" "unprognostic (1.16e-1)" "prognostic favorable (3.29e-6)" "unprognostic (1.25e-1)" "unprognostic (4.02e-1)" "unprognostic (1.60e-2)" "unprognostic (4.19e-1)" 21.9 18.5 55.6 14.3 48.6 16.4 23.3 44.5 56.0 29.7 19.7 37.5 9.4 14.7 26.3 18.7 22.7 26.5 21.3 14.0 45.9 41.1 22.1 13.5 21.6 16.9 38.0 46.7 28.6 14.9 41.5 23.4 29.0 52.5 23.5 20.0 18.5 16.7 21.8 8.2 21.0 15.3 25.7 52.6 17.9 16.3 27.4 30.4 20.6 32.4 8.5 20.4 22.9 19.2 7.7 5.7 7.9 6.7 6.2 11.0 3.7 21.0 12.9 37.2 11.4 41.2 75.1 7.9 15.8 31.0 19.6 24.1 15.3 29.2 13.8 12.5 21.2 19.8 22.6 15.0 22.6 22.2 21.3 9.6 19.6 5.4 19.4 14.7 19.7 9.3 33.5 23.5 16.2 17.1 24.2 27.1 19.9 19.7 17.7 19.4 8.6 22.7 22.3 14.3 18.9 10.3 17.4 18.0 17.2 16.7 16.3 20.6 19.7 15.3 26.1 23.5 16.9 16.3 16.9 19.4 17.6 8.7 19.5 13.9 13.0 18.0 18.2 8.1 18.7 16.4 7.9 4.8 7.5 11.0 4.8 9.0 7.7 7.4 7.9 3.7 5.1 7.4 9.0 6.0 6.2 6.7 5.7 8.1 3.7 55.6 48.6 44.5 56.0 45.9 41.1 38.0 46.7 52.5 30.4 20.8 16.3 29.4 29.9 14.1 87.6 6.5 45.9 17.4 27.3 43.6 29.5 25.3 23.2 13.3 11.8 26.9 31.5 23.3 13.4 35.4 36.1 29.8 23.0 28.0 33.5 66.7 42.6 43.6 35.2 12.5 55.8 21.8 35.4 10.8 27.0 77.3 13.8 25.8 46.0 19.2 55.1 38.8 26.4 51.2 75.4 15.1 27.3 39.5 26.2 27.6 PTPRC "CD45, GP180, LCA, T200" ENSG00000081237 "Protein tyrosine phosphatase, receptor type C" 1 198638457-198757476 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 116.9;lymphoid tissue: 172.5" "Cell type enhanced" "Detected in many" 12 "B-cells: 266.4;granulocytes: 232.9;Kupffer cells: 338.8;Macrophages: 290.3;T-cells: 539.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 47.1;HEL: 26.6;HL-60: 24.0;JURKAT: 61.5;MOLT-4: 35.5;THP-1: 19.7;U-266/70: 22.0;U-266/84: 20.0;U-698: 28.2;U-937: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000052, HPA000440, CAB002800, CAB056154, CAB068221" Enhanced Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377" "unprognostic (1.51e-2)" "unprognostic (1.24e-2)" "unprognostic (5.10e-3)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (3.17e-2)" "unprognostic (1.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.08e-2)" "unprognostic (3.95e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (6.41e-2)" "unprognostic (7.06e-2)" 9.8 2.9 3.4 48.0 6.2 36.1 4.3 1.3 3.5 3.1 5.6 2.8 0.5 4.9 2.9 3.9 4.8 5.6 8.8 4.9 3.9 4.5 4.4 5.2 27.5 93.2 7.9 1.3 2.9 2.1 0.3 2.5 4.5 5.3 4.2 5.8 3.3 10.7 1.0 1.7 2.5 22.2 4.5 13.2 89.3 6.5 2.3 5.3 172.5 4.6 3.9 53.2 13.1 3.7 28.5 42.8 94.7 103.8 53.7 76.1 116.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 26.6 0.0 0.0 0.0 24.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 61.5 0.5 0.7 0.0 0.0 35.5 14.5 0.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.1 0.0 0.0 19.7 0.3 0.0 0.2 0.1 0.1 22.0 20.0 28.2 0.0 21.5 0.1 20.8 52.0 56.3 76.1 99.7 64.5 28.5 52.9 72.7 42.8 26.8 60.2 60.3 94.7 53.7 103.8 6.4 54.6 116.9 3.4 6.2 1.3 3.5 3.9 4.5 7.9 1.3 5.3 5.3 41.7 86.9 266.4 0.7 14.1 0.0 4.1 7.6 21.4 26.1 1.8 0.0 0.4 0.0 0.0 2.0 11.9 0.1 23.3 0.0 0.5 8.9 0.9 232.9 3.0 90.3 0.0 1.2 14.1 338.8 1.5 1.1 290.3 20.3 120.0 0.2 0.0 0.1 0.0 0.0 1.7 0.2 6.5 4.3 0.2 0.2 13.2 0.7 539.1 0.5 0.9 PTPRCAP "CD45-AP, LPAP" ENSG00000213402 "Protein tyrosine phosphatase, receptor type C associated protein" Q14761 11 67435510-67438067 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 104.7;lymphoid tissue: 149.8" "Cell type enhanced" "Detected in some" 32 "Basal keratinocytes: 11.3;Melanocytes: 37.1;Suprabasal keratinocytes: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 40.0;HDLM-2: 28.0;HL-60: 16.4;MOLT-4: 23.7;NB-4: 113.3;U-698: 28.1" "Region enhanced" "Detected in single" "basal ganglia: 0.5" "Low region specificity" "Detected in some" HPA043734 Enhanced "Intracellular and membrane" NA NA "HPA043734: AB_10962214" 1.8 1.2 1.0 79.2 1.3 8.5 1.6 1.8 0.6 2.6 10.1 0.4 0.4 5.5 1.9 1.8 5.9 3.0 6.2 1.5 1.0 0.8 3.9 2.3 6.9 71.4 1.2 0.3 1.9 1.4 0.2 1.7 1.1 0.4 3.8 1.0 1.5 14.6 0.9 1.3 1.1 21.5 0.6 1.8 56.5 8.4 2.5 0.3 149.8 5.0 4.2 67.1 3.0 2.1 104.7 50.3 4.1 0.4 45.5 97.2 58.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 16.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.1 4.2 0.0 0.4 23.7 113.3 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 28.1 0.0 0.0 0.0 1.2 0.3 4.1 97.2 0.3 82.7 80.5 60.5 85.6 0.7 104.7 44.9 68.9 2.0 45.5 0.4 50.3 78.4 58.1 1.0 1.3 1.8 0.6 1.0 0.8 1.2 0.3 0.4 0.3 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 PTPRD "HPTP, PTPD" ENSG00000153707 "Protein tyrosine phosphatase, receptor type D" P23468 9 8314246-10612723 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;parathyroid gland: 37.5" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 110.1;Intestinal endocrine cells: 34.0;Muller glia cells: 44.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 23.5;HAP1: 5.1;HSkMC: 8.0;NTERA-2: 5.7;RH-30: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054829 Uncertain Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 2500000 Vesicles Nucleoplasm "HPA054829: AB_2682618" "unprognostic (4.74e-1)" "unprognostic (4.79e-2)" "unprognostic (1.44e-2)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (9.90e-2)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (1.91e-2)" "unprognostic (2.13e-2)" "unprognostic (7.52e-3)" "unprognostic (2.62e-1)" "prognostic favorable (7.45e-6)" "unprognostic (3.56e-4)" "unprognostic (7.59e-2)" "unprognostic (4.84e-2)" "unprognostic (3.08e-3)" 2.6 1.7 19.7 1.5 19.2 1.1 1.1 27.9 32.1 5.6 5.4 21.7 0.2 4.0 3.6 1.8 1.5 3.6 2.6 3.0 18.0 13.5 11.4 4.2 3.4 0.9 17.9 22.3 12.7 1.7 37.5 4.4 9.4 15.1 3.3 5.3 1.9 1.1 2.0 1.0 1.2 4.6 2.8 29.7 1.4 1.7 2.5 18.5 0.0 3.2 0.0 1.0 2.7 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 23.5 0.0 0.3 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 2.6 4.8 0.6 0.0 0.0 0.0 0.2 8.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 5.7 0.0 1.5 2.9 8.7 0.0 2.1 0.0 4.0 0.3 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.7 19.2 27.9 32.1 18.0 13.5 17.9 22.3 15.1 18.5 0.0 2.7 0.0 0.2 0.5 110.1 4.6 25.5 0.0 2.3 5.2 15.7 0.3 0.0 2.5 13.0 0.4 10.1 0.0 0.0 0.1 7.6 1.7 0.0 12.8 1.0 4.8 34.0 1.3 0.6 3.7 14.7 0.0 0.0 0.0 14.3 44.7 0.3 3.5 0.0 22.3 7.4 0.0 3.7 1.1 1.1 0.6 0.2 0.0 5.2 0.0 PTPRE PTPE ENSG00000132334 "Protein tyrosine phosphatase, receptor type E" P23469 10 127907061-128085855 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 91.0" "Cell type enhanced" "Detected in many" 10 "Kupffer cells: 141.1;Macrophages: 249.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 91.0;plasmacytoid DC: 65.7" "Group enriched" "Detected in all" 11 "dendritic cells: 65.7;granulocytes: 91.0;monocytes: 25.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 18.8;HUVEC TERT2: 19.8;NB-4: 14.9;TIME: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015870, HPA021872" Supported Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA015870: AB_1855759, HPA021872: AB_1855760" "unprognostic (5.23e-2)" "unprognostic (1.37e-1)" "unprognostic (1.99e-1)" "unprognostic (7.11e-2)" "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (6.50e-2)" "unprognostic (4.49e-2)" "unprognostic (2.11e-1)" "unprognostic (2.56e-2)" "unprognostic (8.71e-3)" "unprognostic (2.00e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (1.52e-1)" "unprognostic (6.71e-3)" "unprognostic (2.49e-2)" "unprognostic (5.59e-2)" 16.8 18.5 12.5 24.0 12.5 39.5 11.0 7.4 15.3 4.8 9.2 14.5 1.6 9.6 5.1 8.1 8.8 6.2 10.7 12.3 15.0 12.2 4.4 4.8 22.5 20.0 12.5 6.5 4.3 3.1 3.4 6.5 8.0 9.8 4.5 9.8 4.8 7.0 3.1 1.9 4.9 12.7 7.7 14.3 26.4 7.7 4.3 10.9 11.4 6.6 6.1 12.2 10.0 5.0 1.2 65.7 91.0 25.5 4.0 5.4 4.9 1.9 0.4 0.2 0.0 1.2 0.2 3.6 0.0 0.0 0.8 1.7 0.8 12.0 1.5 1.3 1.0 2.6 1.1 1.0 5.7 0.3 1.8 0.9 0.1 0.7 0.0 2.0 7.4 5.6 0.4 3.3 2.9 5.9 18.8 19.8 4.9 0.0 0.9 1.2 1.8 2.2 14.9 0.1 2.1 0.7 8.8 1.2 2.9 3.3 8.5 0.0 1.2 3.4 0.6 0.1 0.9 0.3 9.4 37.4 0.8 0.8 3.7 4.1 0.4 0.6 2.1 5.5 5.8 0.0 17.4 25.5 19.3 5.4 9.0 3.2 0.9 2.4 3.6 13.3 1.2 1.7 2.9 91.0 4.0 6.8 65.7 3.5 4.9 12.5 12.5 7.4 12.7 15.0 12.2 12.5 6.5 9.8 10.9 77.4 67.6 24.7 47.2 52.9 2.6 15.1 5.1 9.4 33.0 3.5 0.0 33.6 0.0 4.3 1.6 49.4 12.3 0.0 4.0 40.5 9.9 8.3 30.1 1.3 53.6 0.0 6.4 46.1 141.1 1.7 0.6 249.1 23.6 4.6 14.4 0.0 28.7 11.5 0.4 1.9 0.8 0.0 8.1 0.5 1.4 56.6 14.2 52.4 10.2 34.4 PTPRF LAR ENSG00000142949 "Protein tyrosine phosphatase, receptor type F" P10586 1 43525187-43623666 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Heparin-binding, Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 261.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 54.6;SK-BR-3: 62.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012710 Uncertain Approved "Golgi apparatus" "Intracellular and membrane" NA NA 95000000 "Golgi apparatus" "HPA012710: AB_1855933" "unprognostic (8.20e-2)" "unprognostic (2.41e-2)" "unprognostic (3.01e-2)" "unprognostic (9.17e-2)" "unprognostic (8.34e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (4.59e-1)" "unprognostic (1.51e-1)" "unprognostic (4.97e-2)" "unprognostic (4.68e-2)" "unprognostic (7.07e-2)" "unprognostic (1.99e-2)" "prognostic favorable (7.03e-4)" "unprognostic (2.33e-1)" "unprognostic (3.19e-2)" "unprognostic (2.58e-1)" 37.1 5.5 22.4 10.4 18.1 0.9 30.7 6.8 19.5 14.2 34.3 16.8 34.4 30.7 12.3 33.4 41.4 32.2 20.0 6.3 17.2 15.0 12.0 45.6 15.7 5.8 17.2 18.5 10.4 25.3 17.5 10.3 38.1 16.1 30.9 23.1 5.9 41.9 23.6 2.9 46.8 35.5 16.8 11.2 2.0 21.8 4.3 15.8 4.6 12.5 11.7 14.9 21.4 21.3 0.9 0.0 0.2 0.0 0.0 0.0 0.7 31.0 14.9 9.7 11.5 2.2 0.1 54.6 17.8 7.1 14.7 12.6 15.8 42.3 0.0 5.0 7.8 11.9 24.3 11.3 39.2 17.9 0.3 14.1 0.1 10.2 14.3 6.9 0.2 0.2 2.3 22.6 21.2 35.2 18.6 21.9 1.5 4.7 1.4 5.4 17.9 0.2 0.2 14.8 17.2 4.1 10.8 17.3 0.7 5.7 46.9 14.6 5.4 17.7 62.4 2.3 26.9 18.1 3.3 17.1 0.3 23.6 1.5 23.7 0.6 0.5 0.0 1.4 0.7 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 22.4 18.1 6.8 19.5 17.2 15.0 17.2 18.5 16.1 15.8 145.9 89.7 2.2 43.9 55.8 11.0 4.0 152.8 81.7 63.7 82.0 41.2 48.4 0.0 138.1 4.0 7.0 185.3 0.0 104.8 261.2 17.9 82.4 4.7 141.8 12.4 174.8 96.9 9.2 4.3 6.9 6.4 5.4 11.8 4.6 152.5 28.3 148.7 95.1 6.7 13.9 28.0 0.0 11.0 8.0 34.8 79.8 55.4 2.2 124.5 65.3 PTPRG "PTPG, RPTPG" ENSG00000144724 "Protein tyrosine phosphatase, receptor type G" P23470 3 61561569-62297613 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 91.5;Horizontal cells: 146.2;Ito cells: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 36.2;HSkMC: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000546, HPA064237" Uncertain Approved "Plasma membrane" NA NA 520000000 "Plasma membrane" "HPA000546: , HPA064237: AB_2685221" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (3.26e-1)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (5.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.10e-6)" "unprognostic (9.91e-2)" "unprognostic (3.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" 22.2 18.0 12.9 10.1 10.7 1.2 26.1 8.1 16.4 17.2 13.9 5.2 12.0 5.6 15.8 19.0 6.4 13.1 15.7 12.4 24.5 9.9 20.2 8.2 38.9 10.2 8.3 10.5 16.6 6.0 58.6 11.9 13.1 15.1 11.3 8.9 23.3 7.9 17.2 19.2 6.6 8.4 17.4 12.7 9.2 8.7 11.4 5.0 0.1 21.7 7.0 3.2 10.0 14.6 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 11.7 0.0 36.2 18.5 5.7 7.2 11.8 7.7 10.4 5.4 0.2 0.2 4.2 8.5 6.1 0.1 5.6 5.6 12.2 0.6 3.2 0.5 0.0 6.2 12.2 3.0 0.0 26.8 2.3 10.9 13.2 2.5 8.3 0.8 0.0 7.2 6.9 3.1 0.0 0.0 7.2 0.0 0.0 4.7 3.6 0.2 7.9 3.3 0.9 1.9 1.7 0.0 2.8 5.0 0.0 0.1 18.9 10.8 10.3 17.2 6.0 2.3 2.6 0.0 8.2 1.3 13.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 12.9 10.7 8.1 16.4 24.5 9.9 8.3 10.5 15.1 5.0 11.9 25.9 0.8 5.2 8.1 91.5 10.4 7.6 2.7 5.7 21.0 5.9 7.6 5.0 7.9 2.9 41.3 11.0 0.0 1.6 0.6 33.6 7.0 0.0 26.0 15.0 146.2 23.6 89.0 2.2 2.5 61.5 1.8 16.9 1.0 7.6 38.3 4.5 7.0 53.4 13.3 4.8 71.1 52.3 1.0 6.1 4.3 10.5 0.9 11.0 2.2 PTPRH SAP-1 ENSG00000080031 "Protein tyrosine phosphatase, receptor type H" Q9HD43 19 55181248-55209506 "Enzymes, Predicted membrane proteins" Apoptosis "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "gallbladder: 29.6;intestine: 84.3;lymphoid tissue: 21.2" "Cell type enhanced" "Detected in many" 18 "Enterocytes: 106.7;Paneth cells: 38.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.5" "Lineage enhanced" "Detected in single" "monocytes: 1.5" "Cell line enhanced" "Detected in many" "HHSteC: 9.1;K-562: 10.6;OE19: 22.4;SK-MEL-30: 15.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA042300 Approved Mitochondria NA NA Mitochondria "HPA042300: AB_10796900" "unprognostic (1.87e-1)" "unprognostic (1.10e-1)" "unprognostic (2.59e-1)" "unprognostic (7.57e-3)" "unprognostic (5.01e-3)" "unprognostic (8.14e-2)" "unprognostic (1.15e-1)" "unprognostic (1.96e-3)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-11)" "unprognostic (4.08e-3)" "unprognostic (2.47e-1)" "unprognostic (1.52e-2)" "unprognostic (1.57e-1)" 0.5 8.9 0.5 5.2 0.7 0.0 0.5 0.5 1.0 0.7 39.9 0.6 0.5 30.1 0.5 0.5 0.6 0.0 29.6 0.5 1.3 1.6 0.6 7.8 0.6 0.5 3.0 0.5 0.6 2.8 0.0 3.0 0.6 0.5 1.0 9.6 0.6 0.5 0.5 0.5 0.0 84.3 0.7 6.9 21.2 10.2 0.5 0.5 0.5 0.5 1.0 0.8 1.1 2.4 0.0 0.7 0.0 1.5 0.0 0.0 0.0 4.9 3.0 0.0 1.2 1.0 2.7 0.0 0.1 2.7 0.5 1.1 1.3 7.0 0.0 0.2 0.5 6.2 0.0 0.0 0.0 0.6 0.0 0.1 0.4 0.1 3.5 9.1 0.0 3.6 0.7 2.2 1.7 2.7 0.3 0.1 0.0 10.6 0.5 0.0 0.0 0.0 0.2 0.0 22.4 7.2 0.0 0.0 0.3 0.0 0.0 0.3 0.7 0.0 3.1 15.9 0.0 0.0 1.4 0.0 0.7 1.1 0.3 0.0 0.0 2.6 0.0 0.8 0.1 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.7 0.5 0.5 1.3 1.6 3.0 0.5 0.5 0.5 0.0 0.0 0.0 2.4 1.5 0.0 0.6 20.4 0.0 0.0 1.8 0.0 0.0 0.0 11.7 0.0 0.2 106.7 0.0 22.9 0.0 0.2 3.1 0.0 5.1 0.2 15.9 4.6 1.3 0.0 0.0 0.0 0.8 0.0 1.0 14.0 0.2 20.1 38.6 0.0 0.0 0.3 0.0 0.4 0.0 0.2 1.0 0.1 0.0 15.6 17.9 PTPRJ "CD148, DEP1, HPTPeta" ENSG00000149177 "Protein tyrosine phosphatase, receptor type J" Q12913 11 47980558-48170841 "CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 67.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.2" "Group enriched" "Detected in all" 4 "granulocytes: 12.2;monocytes: 5.3" "Cell line enhanced" "Detected in many" "EFO-21: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006026 Approved "Intracellular and membrane" NA NA 840000000 "HPA006026: AB_1078446" "unprognostic (1.46e-1)" "unprognostic (2.21e-1)" "unprognostic (1.55e-1)" "unprognostic (3.83e-2)" "unprognostic (3.20e-2)" "unprognostic (2.99e-2)" "unprognostic (6.58e-2)" "unprognostic (2.15e-1)" "unprognostic (9.64e-3)" "unprognostic (3.79e-3)" "unprognostic (5.16e-2)" "unprognostic (1.89e-1)" "prognostic favorable (1.13e-5)" "unprognostic (1.09e-2)" "unprognostic (7.98e-2)" "unprognostic (9.18e-2)" "unprognostic (2.00e-1)" 5.6 3.7 10.4 17.7 13.9 22.6 5.6 4.9 9.5 6.1 9.0 8.8 12.3 8.4 3.9 7.6 2.9 5.0 6.7 5.2 9.5 9.2 13.3 12.2 12.2 22.6 10.8 9.4 3.0 9.1 21.1 14.5 20.3 8.3 7.8 8.1 12.9 12.9 9.0 4.6 4.3 13.4 5.5 6.7 33.0 13.8 3.1 9.9 6.7 18.8 0.9 9.7 6.0 3.9 1.0 1.8 12.2 5.3 1.2 2.1 0.9 3.5 13.5 5.9 3.2 0.9 2.1 2.0 3.6 2.7 6.4 4.8 0.8 20.0 3.3 25.5 9.2 9.6 2.7 9.3 0.9 7.8 21.9 2.5 0.9 16.7 1.2 5.8 1.2 20.8 1.5 0.3 1.7 0.5 15.3 3.9 0.2 1.2 2.2 2.2 7.7 0.0 7.5 4.6 11.5 2.1 0.8 0.7 1.7 24.8 5.3 4.0 1.2 10.1 5.7 9.1 4.5 6.4 9.2 12.5 5.0 5.3 10.0 11.0 0.5 0.7 5.5 5.8 3.8 18.3 0.9 1.5 3.4 2.1 2.5 1.4 1.0 1.2 1.5 1.0 0.7 1.0 1.3 12.2 1.2 5.3 1.8 1.1 0.9 10.4 13.9 4.9 9.4 9.5 9.2 10.8 9.4 8.3 9.9 8.9 21.3 8.0 8.8 0.2 11.1 3.1 17.8 8.1 22.7 36.6 5.9 1.5 0.0 6.5 4.2 2.2 28.4 0.0 4.3 0.6 3.0 20.5 12.8 14.0 26.2 9.5 12.1 2.5 67.6 4.0 0.3 20.6 1.7 10.8 8.5 11.5 8.7 28.1 0.4 10.9 1.0 0.0 3.9 0.2 3.2 0.3 1.6 13.8 5.7 5.4 PTPRK R-PTP-kappa ENSG00000152894 "Protein tyrosine phosphatase, receptor type K" Q15262 6 127968779-128520674 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6" "Group enriched" "Detected in many" 7 "B-cells: 4.8;T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054056, HPA054822" Uncertain Supported "Vesicles,Plasma membrane,Cell Junctions" NA NA 13000000 "Cell Junctions" "Vesicles, Plasma membrane" "HPA054056: AB_2682359, HPA054822: AB_2682614" "unprognostic (3.15e-2)" "unprognostic (1.07e-2)" "unprognostic (5.79e-3)" "unprognostic (4.95e-3)" "unprognostic (1.89e-2)" "unprognostic (7.26e-2)" "unprognostic (3.27e-1)" "unprognostic (6.06e-2)" "unprognostic (2.04e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (1.46e-1)" "prognostic favorable (9.33e-5)" "unprognostic (2.10e-1)" "unprognostic (1.55e-1)" "unprognostic (2.59e-1)" "unprognostic (9.32e-2)" 12.0 5.2 18.6 10.7 20.3 1.2 20.9 4.7 24.4 12.2 21.9 25.6 11.2 25.7 12.1 10.3 9.1 13.2 29.6 11.4 17.2 12.6 13.3 23.6 17.4 5.7 20.5 19.3 15.6 25.7 11.4 12.2 17.4 14.9 16.3 23.4 3.9 18.3 17.5 9.1 13.5 27.4 14.6 17.1 6.4 24.6 2.7 23.7 15.3 10.1 6.5 7.6 18.4 15.1 4.8 0.0 0.0 0.0 0.4 1.6 0.2 4.5 4.9 2.9 0.2 6.2 8.3 3.0 12.3 23.8 5.1 4.6 8.1 3.8 0.0 3.7 11.3 14.8 12.9 3.1 9.7 7.2 13.6 4.9 0.1 7.5 11.2 7.6 0.0 0.4 6.1 9.0 10.6 14.5 13.3 13.8 4.4 0.0 0.2 12.4 9.1 6.9 0.0 3.1 8.3 6.3 24.8 6.3 0.8 12.6 9.3 15.5 0.0 12.7 14.2 0.7 3.5 3.9 0.3 23.4 8.0 5.6 15.5 11.1 0.1 1.6 0.0 10.2 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.0 4.8 0.4 1.6 0.0 0.4 0.0 0.0 0.1 0.2 18.6 20.3 4.7 24.4 17.2 12.6 20.5 19.3 14.9 23.7 23.8 27.4 9.7 78.6 56.3 3.1 19.3 76.5 18.7 33.0 17.4 3.9 21.8 0.0 51.8 3.4 46.7 63.1 0.0 53.2 4.5 30.5 99.0 1.1 36.5 5.1 9.5 42.2 8.0 1.0 2.1 15.8 1.8 16.9 2.8 41.3 7.0 84.8 57.5 17.0 11.2 0.6 58.2 35.8 3.6 5.8 33.2 22.4 1.0 48.9 100.5 PTPRM "hR-PTPu, PTPRL1, RPTPU" ENSG00000173482 "Protein tyrosine phosphatase, receptor type M" P28827 18 7566782-8406861 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Endothelial cells: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 7.2" "Group enriched" "Detected in many" 50 "dendritic cells: 2.7;T-cells: 7.2" "Cell line enhanced" "Detected in many" "ASC diff: 35.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003891, CAB022442, CAB022443" Supported Approved "Plasma membrane" NA NA 76000000 "Plasma membrane" "CAB022442: , CAB022443: , HPA003891: AB_2667073" "unprognostic (2.59e-1)" "prognostic unfavorable (8.65e-5)" "unprognostic (4.89e-2)" "unprognostic (1.00e-1)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (3.41e-2)" "unprognostic (7.62e-2)" "unprognostic (2.74e-2)" "unprognostic (1.56e-2)" "unprognostic (9.64e-2)" "unprognostic (5.63e-2)" "unprognostic (3.11e-3)" "unprognostic (9.41e-2)" "unprognostic (2.63e-2)" "prognostic favorable (1.07e-4)" 31.4 14.1 9.5 6.3 22.2 0.6 23.6 10.4 17.2 11.0 13.6 6.2 28.1 4.7 15.4 10.9 8.1 13.6 18.1 33.5 10.5 15.0 16.9 6.5 22.0 7.8 8.5 12.0 15.7 7.6 16.3 21.9 18.3 23.2 10.6 6.6 18.3 7.4 21.8 26.0 7.3 8.7 14.1 9.3 12.1 11.0 12.2 9.1 2.9 31.1 7.3 6.3 18.6 25.3 0.0 2.7 0.0 0.0 0.0 7.2 1.4 1.5 11.4 5.5 0.0 35.1 24.4 13.3 14.0 12.3 9.4 14.0 10.4 2.4 0.0 13.8 16.7 0.2 0.1 0.0 4.9 13.1 0.1 2.5 0.0 7.6 5.0 10.0 0.0 0.1 27.6 10.3 5.2 14.9 18.1 9.4 0.0 0.0 4.8 7.5 0.2 4.5 0.1 0.9 3.3 2.5 0.1 4.7 21.1 23.1 19.6 0.5 3.0 0.4 0.0 11.7 9.1 0.0 0.0 9.7 19.4 12.2 9.2 2.4 0.4 0.1 0.0 16.6 0.0 3.6 0.0 0.0 0.0 4.5 0.0 1.8 0.0 6.0 7.2 0.1 0.0 1.7 3.1 0.0 0.0 0.0 2.7 1.0 1.4 9.5 22.2 10.4 17.2 10.5 15.0 8.5 12.0 23.2 9.1 41.7 29.0 0.9 6.8 5.4 24.2 24.1 17.8 22.7 9.1 5.2 2.0 10.4 1.7 15.5 24.0 47.4 0.5 0.0 7.1 2.7 10.2 7.0 2.3 20.2 8.2 0.0 1.7 38.1 8.0 34.9 2.6 5.2 28.7 1.0 1.3 2.8 12.6 0.3 4.9 11.3 1.9 6.5 8.0 3.6 9.8 2.5 10.5 2.5 0.8 5.4 PTPRN "IA-2, ICA512" ENSG00000054356 "Protein tyrosine phosphatase, receptor type N" Q16849 2 219289623-219309648 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Receptor "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.6;pancreas: 28.9;pituitary gland: 43.4" "Group enriched" "Detected in some" 13 "Bipolar cells: 48.9;Cone photoreceptor cells: 56.9;Horizontal cells: 92.2;Intestinal endocrine cells: 45.2;Rod photoreceptor cells: 31.1" "Group enriched" "Detected in some" 12 "glioma: 5.3;pancreatic cancer: 18.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "U-2 OS: 20.3;U-87 MG: 75.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007152, HPA007179" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA007152: AB_2667759, HPA007179: AB_1079714" "unprognostic (1.43e-1)" "unprognostic (1.33e-4)" "unprognostic (2.91e-3)" "unprognostic (5.83e-3)" "prognostic unfavorable (1.45e-7)" "unprognostic (3.64e-2)" "unprognostic (1.24e-4)" "unprognostic (1.58e-3)" "unprognostic (1.02e-1)" "unprognostic (6.20e-4)" "unprognostic (1.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.28e-10)" "unprognostic (1.43e-2)" "unprognostic (2.49e-1)" "unprognostic (1.10e-2)" "unprognostic (8.61e-2)" 1.7 22.3 19.3 4.7 35.7 1.7 1.3 17.3 89.6 1.2 2.4 2.5 0.0 2.5 1.5 1.2 1.5 1.3 1.5 1.4 21.6 40.1 1.5 1.2 1.4 1.3 14.4 19.8 1.3 28.9 1.2 43.4 1.4 22.0 1.4 1.9 3.1 1.2 1.3 1.2 2.0 2.5 2.4 3.5 1.3 6.0 1.4 2.1 0.0 1.5 0.0 1.2 2.7 0.0 0.1 0.3 0.2 0.0 0.0 0.6 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.3 1.3 2.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.1 2.5 0.0 6.2 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 3.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.2 75.5 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.6 3.7 19.3 35.7 17.3 54.0 21.6 40.1 14.4 19.8 22.0 2.1 0.0 0.0 0.0 0.1 0.1 48.9 1.7 0.0 0.0 0.0 0.0 56.9 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 92.2 45.2 0.0 0.0 0.2 0.3 0.0 1.7 0.0 0.0 4.1 4.3 0.0 0.0 0.0 31.1 0.0 0.3 2.2 2.3 0.1 0.0 0.0 0.0 0.0 PTPRO "GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2" ENSG00000151490 "Protein tyrosine phosphatase, receptor type O" Q16827 12 15322397-15597399 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1;intestine: 28.5;kidney: 21.6" "Cell type enhanced" "Detected in some" 7 "Bipolar cells: 16.3;Collecting duct cells: 15.7;Hofbauer cells: 22.6;Horizontal cells: 23.8;Kupffer cells: 17.2;monocytes: 19.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 8.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 5.2;intermediate monocyte: 10.5;memory B-cell: 8.3;myeloid DC: 7.4;naive B-cell: 7.0;naive CD4 T-cell: 2.9;non-classical monocyte: 10.5;plasmacytoid DC: 9.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "GAMG: 13.0;NTERA-2: 8.2;SCLC-21H: 5.0;SH-SY5Y: 9.9;THP-1: 4.1" "Region enhanced" "Detected in many" "olfactory region: 215.3" "Low region specificity" "Detected in all" HPA034525 Enhanced "Intracellular and membrane" NA NA "HPA034525: AB_10669785" "unprognostic (3.68e-2)" "unprognostic (3.49e-1)" "unprognostic (9.64e-2)" "unprognostic (1.25e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-1)" "unprognostic (5.93e-3)" "unprognostic (5.37e-2)" "unprognostic (2.03e-1)" "unprognostic (3.72e-2)" "unprognostic (2.00e-1)" "unprognostic (5.43e-2)" "unprognostic (4.89e-2)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 3.3 1.2 16.2 3.1 26.1 0.6 1.1 1.0 15.3 1.7 10.4 1.5 0.0 2.0 4.5 2.1 0.8 1.2 1.6 0.7 11.3 10.6 21.6 1.6 6.7 3.2 4.8 8.8 0.7 0.6 0.6 3.8 4.4 4.0 0.7 28.5 1.1 0.8 1.1 0.5 0.7 1.9 7.1 2.6 3.6 1.0 0.9 3.5 0.0 0.5 0.0 3.5 1.7 0.5 8.3 9.5 0.0 10.5 0.1 2.9 2.7 0.0 0.1 0.5 0.3 0.5 0.1 0.2 0.0 0.0 0.8 2.0 0.0 0.0 0.3 0.1 0.0 13.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.3 0.1 0.2 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 8.2 1.7 0.0 0.0 0.0 0.0 0.1 0.2 5.0 9.9 1.2 0.0 0.1 0.1 0.1 4.1 0.0 0.1 0.3 0.0 0.3 1.2 0.0 0.4 0.1 0.3 1.5 0.0 5.2 0.0 0.0 10.5 0.0 8.3 1.7 0.4 7.4 7.0 2.9 1.3 0.0 0.1 10.5 9.5 1.3 2.7 16.2 26.1 1.0 15.3 11.3 10.6 4.8 8.8 4.0 3.5 0.0 0.3 4.5 0.8 0.2 16.3 0.6 0.0 0.0 3.4 15.7 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 22.6 23.8 3.5 1.8 17.2 0.0 0.6 9.2 0.0 19.0 2.6 0.3 0.1 3.5 0.4 0.0 4.6 0.0 0.4 0.3 1.0 0.4 0.2 0.0 11.2 0.7 PTPRQ DFNB84 ENSG00000139304 "Protein tyrosine phosphatase, receptor type Q" 12 80402178-80680271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6;urinary bladder: 19.2" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 14.9;Club cells: 7.9;Early spermatids: 7.0;Late spermatids: 3.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 24 "basal ganglia: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.4;BJ: 6.2;HBF TERT88: 4.4;RH-30: 4.9;RT4: 5.4;SiHa: 3.1;U-2197: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA053245 Uncertain Approved Cytosol No NA Cytosol "HPA053245: AB_2682087" "unprognostic (9.10e-2)" "unprognostic (1.63e-1)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (1.37e-1)" "unprognostic (1.93e-2)" "unprognostic (1.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-2)" "unprognostic (1.78e-1)" "unprognostic (4.47e-11)" "unprognostic (8.51e-3)" "unprognostic (1.47e-1)" "unprognostic (1.73e-2)" "unprognostic (2.66e-2)" 4.6 0.2 0.3 1.0 12.6 0.0 5.2 0.2 0.3 1.7 1.3 0.0 1.6 0.0 0.5 4.7 1.6 4.1 0.5 1.3 0.4 0.5 6.5 0.2 5.4 2.1 0.2 0.0 0.9 0.6 0.0 1.1 6.4 0.0 6.5 0.0 0.0 0.4 0.5 0.5 0.3 0.2 4.0 0.2 0.2 0.2 5.8 0.0 0.0 3.9 0.0 0.6 19.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.4 0.0 6.2 1.3 1.9 1.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.9 0.0 0.8 0.2 0.5 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 5.4 0.0 0.0 3.1 0.1 0.0 0.3 0.3 0.0 0.0 0.5 0.1 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.6 0.2 0.3 0.4 0.5 0.2 0.0 0.0 0.0 14.9 0.6 0.0 1.5 0.0 0.0 1.7 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 PTPRR "EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ" ENSG00000153233 "Protein tyrosine phosphatase, receptor type R" Q15256 12 70638073-70920843 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 56.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 11.2;Club cells: 5.7;Enterocytes: 7.3;Horizontal cells: 15.9;Paneth cells: 11.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 56.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HDLM-2: 14.3;RT4: 27.4" "Region enriched" "Detected in all" 5 "cerebellum: 100.5" "Low region specificity" "Detected in all" "CAB011461, HPA011851, HPA071067" Uncertain Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340" "unprognostic (4.98e-2)" "unprognostic (1.91e-2)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "unprognostic (3.63e-3)" "unprognostic (3.48e-5)" "unprognostic (5.44e-3)" "unprognostic (1.77e-3)" "unprognostic (1.13e-1)" "unprognostic (9.01e-2)" "unprognostic (1.37e-3)" "unprognostic (8.06e-2)" "unprognostic (1.10e-2)" "unprognostic (1.92e-2)" "unprognostic (4.78e-2)" "unprognostic (2.72e-1)" "prognostic favorable (1.40e-5)" 0.4 3.8 18.8 1.6 11.3 0.3 0.4 56.1 20.9 0.5 11.2 0.1 0.0 5.1 8.4 0.3 0.4 0.5 1.9 0.4 8.6 4.9 0.4 0.4 0.4 0.4 1.3 13.2 0.4 0.6 0.3 0.9 0.7 3.3 0.5 7.8 0.8 0.4 2.1 0.4 0.4 11.3 4.9 3.1 0.4 4.4 0.4 1.4 0.0 0.4 0.0 0.3 4.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 27.4 0.1 4.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.8 11.3 56.1 20.9 8.6 4.9 1.3 13.2 3.3 1.4 0.0 0.0 0.0 0.1 0.5 11.2 2.5 0.0 0.0 5.7 0.0 0.0 0.0 0.0 2.1 1.7 1.5 7.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 15.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 1.9 11.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.4 0.3 PTPRS ENSG00000105426 "Protein tyrosine phosphatase, receptor type S" Q13332 19 5158495-5340803 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Heparin-binding, Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 54.1;Melanocytes: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 82 "plasmacytoid DC: 13.4" "Lineage enriched" "Detected in single" 82 "dendritic cells: 13.4" "Cell line enhanced" "Detected in many" "AN3-CA: 41.4;HaCaT: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054747 Approved "Plasma membrane,Cytosol" "Secreted - unknown location" NA NA 92000000 "Plasma membrane, Cytosol" "HPA054747: AB_2682591" "unprognostic (8.14e-2)" "unprognostic (4.59e-3)" "unprognostic (2.57e-2)" "unprognostic (9.20e-2)" "unprognostic (2.15e-1)" "unprognostic (6.96e-3)" "unprognostic (6.85e-2)" "unprognostic (2.36e-1)" "unprognostic (3.12e-3)" "unprognostic (1.86e-1)" "prognostic favorable (1.07e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (2.80e-1)" "unprognostic (1.45e-1)" "unprognostic (4.05e-1)" "unprognostic (3.46e-2)" 59.1 17.3 14.4 9.4 14.8 3.1 32.0 27.6 53.3 28.7 11.4 29.6 14.4 4.6 21.4 15.4 13.3 24.0 22.2 18.6 15.9 15.1 10.7 6.9 13.9 8.6 20.5 12.1 29.2 38.4 10.5 16.6 4.3 12.0 23.1 3.6 28.9 21.5 20.1 11.9 23.8 6.5 17.5 13.8 8.3 12.7 10.8 18.7 4.4 21.1 7.2 7.5 19.1 22.7 0.0 13.4 0.0 0.0 0.0 0.1 0.0 3.7 21.3 19.2 41.4 8.8 7.2 2.5 6.4 7.7 7.8 6.4 0.2 2.0 0.0 15.3 10.8 6.2 42.1 5.1 0.0 3.5 0.4 8.2 0.0 8.7 13.2 4.0 0.0 4.8 7.6 1.8 1.6 0.3 10.2 0.2 2.6 5.9 0.0 3.1 15.7 1.6 4.0 10.8 0.1 9.1 0.0 4.2 0.0 1.6 7.5 14.8 20.3 6.1 1.1 11.7 3.9 7.4 1.6 0.9 7.0 12.1 16.0 7.8 2.1 0.0 12.2 3.6 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 14.4 14.8 27.6 17.6 15.9 15.1 20.5 12.1 12.0 18.7 6.0 0.6 3.2 32.4 54.1 33.8 10.9 12.7 1.4 2.3 12.2 2.0 0.5 8.3 1.4 2.3 10.2 0.0 0.0 0.8 23.7 30.9 35.7 0.0 18.3 1.5 11.1 2.9 28.3 0.3 2.9 43.1 1.4 75.9 0.0 0.0 37.3 0.5 0.0 33.9 2.4 7.7 12.9 39.2 7.2 5.3 32.0 0.8 0.0 0.0 21.1 PTPRT "KIAA0283, RPTPrho" ENSG00000196090 "Protein tyrosine phosphatase, receptor type T" O14522 20 42072752-43189970 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 23.5;fallopian tube: 17.0" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 40.8;Ciliated cells: 33.5;Early spermatids: 10.0;Late spermatids: 9.9" "Cancer enhanced" "Detected in many" "breast cancer: 5.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.6;RPMI-8226: 1.2;SCLC-21H: 2.9;U-266/70: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017336, CAB069423" Approved NA NA "CAB069423: AB_1622602, HPA017336: AB_1855943" "unprognostic (7.17e-3)" "unprognostic (1.02e-1)" "unprognostic (5.61e-3)" "unprognostic (1.08e-2)" "unprognostic (5.95e-2)" "unprognostic (3.71e-2)" "unprognostic (1.97e-1)" "unprognostic (1.31e-2)" "unprognostic (6.93e-2)" "unprognostic (2.00e-1)" "unprognostic (1.37e-6)" "unprognostic (3.16e-1)" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" 0.6 0.8 5.0 0.6 11.1 0.5 4.6 1.6 23.5 1.6 0.7 0.9 0.0 1.2 0.5 1.8 0.5 17.0 0.7 0.8 4.7 6.5 0.6 0.9 2.1 1.0 2.2 12.6 0.5 0.9 0.5 4.1 4.6 5.1 0.8 0.6 0.5 2.0 4.6 0.5 0.8 1.0 0.5 1.4 0.7 1.8 2.8 0.9 4.9 0.5 0.0 1.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 11.1 1.6 22.6 4.7 6.5 2.2 12.6 5.1 0.9 0.0 0.6 0.0 0.0 0.8 40.8 1.1 0.0 33.5 1.2 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 4.8 0.0 7.4 0.3 9.9 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 PTPRU "FMI, hPTP-J, PCP-2, PTP, PTPRO" ENSG00000060656 "Protein tyrosine phosphatase, receptor type U" Q92729 1 29236516-29326813 "Enzymes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 40.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB011476, HPA039832" Approved NA NA "CAB011476: AB_442989, HPA039832: AB_10793923" "unprognostic (7.81e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-3)" "unprognostic (6.13e-2)" "prognostic unfavorable (7.92e-4)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.17e-1)" "unprognostic (1.83e-2)" "unprognostic (1.13e-1)" "unprognostic (4.55e-3)" "unprognostic (3.39e-3)" "unprognostic (6.83e-2)" "unprognostic (1.19e-2)" "unprognostic (6.82e-2)" "unprognostic (4.92e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-1)" 6.0 3.2 3.1 1.7 5.8 0.6 16.0 6.7 12.7 24.8 3.7 2.6 6.1 1.3 9.5 4.7 3.9 14.5 7.0 8.9 4.5 5.1 3.9 7.0 11.4 1.2 5.2 5.3 12.2 12.0 12.1 8.1 14.3 21.4 11.0 2.3 18.7 11.3 17.9 14.7 7.3 1.7 6.5 6.6 2.4 4.5 4.4 0.9 0.3 4.9 2.1 2.0 12.2 17.6 0.4 0.0 0.0 0.5 0.0 0.2 0.0 3.2 4.4 0.2 0.6 12.4 0.4 40.5 3.4 3.1 0.1 0.2 3.8 14.4 0.5 6.9 0.6 0.4 17.5 16.1 11.2 0.0 0.2 8.1 0.6 5.0 16.0 5.2 0.0 0.7 5.7 6.1 0.0 1.0 4.8 0.1 2.0 0.1 0.5 3.2 5.3 0.2 0.1 6.6 6.4 2.0 0.0 4.7 0.2 5.0 16.2 13.7 17.8 3.5 11.0 2.4 2.9 6.5 0.7 2.9 0.6 4.0 1.1 0.4 0.3 0.4 0.0 8.0 0.7 0.8 0.0 0.2 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.1 5.8 6.7 12.7 4.5 5.1 5.2 5.3 21.4 0.9 8.9 12.8 0.0 6.2 1.3 3.6 3.4 0.0 6.7 11.4 5.2 11.8 16.4 0.0 5.6 0.5 0.7 0.0 0.0 2.3 9.3 5.1 5.4 1.1 4.5 2.1 0.0 0.0 1.8 1.2 1.1 4.4 0.3 8.5 0.0 0.0 17.4 5.3 0.0 6.7 0.2 40.7 6.5 3.8 1.2 6.1 0.5 7.6 0.0 0.0 8.6 PTPRZ1 "phosphacan, PTP18, PTPRZ, PTPZ, RPTPB" ENSG00000106278 "Protein tyrosine phosphatase, receptor type Z1" P23471 7 121873089-122062036 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 118.1" "Cell type enhanced" "Detected in some" 17 "Club cells: 27.3;Horizontal cells: 62.0;Muller glia cells: 107.0" "Cancer enriched" "Detected in many" 14 "glioma: 175.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 94.3;NTERA-2: 26.3;WM-115: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015103 Enhanced Approved Vesicles,Cytosol "Secreted in brain" NA NA 950000 Cytosol Vesicles "HPA015103: AB_1855946" "unprognostic (8.49e-4)" "unprognostic (3.96e-3)" "unprognostic (4.11e-2)" "unprognostic (1.37e-1)" "unprognostic (9.18e-2)" "unprognostic (2.41e-2)" "unprognostic (8.30e-3)" "unprognostic (3.78e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (9.17e-4)" "unprognostic (1.83e-1)" "unprognostic (8.72e-6)" "unprognostic (2.00e-1)" "unprognostic (2.16e-1)" "unprognostic (8.77e-2)" "prognostic unfavorable (9.36e-4)" 2.0 2.5 33.1 2.3 44.1 1.5 4.0 15.4 118.1 2.4 2.2 19.3 0.0 1.9 1.6 2.0 7.0 1.7 1.9 2.0 39.6 15.9 1.6 1.6 2.1 1.5 18.6 17.8 2.0 3.3 1.5 1.6 1.6 67.6 2.1 2.3 0.8 2.4 2.0 1.5 19.3 1.9 2.4 76.6 2.1 9.8 1.7 23.6 0.0 1.5 1.8 3.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 1.1 0.0 0.1 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 44.1 15.4 39.6 39.6 15.9 18.6 17.8 67.6 23.6 0.0 1.0 0.0 5.6 22.3 14.1 0.8 0.0 17.4 27.3 0.0 3.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 1.1 1.1 0.0 0.0 0.1 62.0 0.0 0.0 0.0 0.4 0.3 0.0 18.6 0.0 0.0 107.0 0.6 0.0 0.0 0.0 6.2 0.0 0.4 0.0 0.2 18.7 0.2 0.0 0.0 7.4 PTRH2 "BIT1, CFAP37, CGI-147, PTH2" ENSG00000141378 "Peptidyl-tRNA hydrolase 2" Q9Y3E5 17 59674636-59707626 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Apoptosis Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012897 Supported Supported Mitochondria NA NA Mitochondria "HPA012897: AB_1855949" "unprognostic (2.26e-1)" "unprognostic (2.80e-2)" "unprognostic (1.02e-2)" "unprognostic (3.89e-2)" "unprognostic (1.31e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (6.38e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (2.72e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.01e-8)" "unprognostic (5.43e-3)" "unprognostic (6.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.49e-2)" 15.9 22.9 17.1 12.4 17.1 9.9 20.7 12.5 22.1 15.6 17.2 11.8 16.3 11.6 14.3 36.7 16.4 13.8 13.1 12.6 19.3 17.8 14.8 34.7 12.1 12.5 16.7 15.2 14.2 19.9 10.3 18.3 13.6 21.0 15.9 20.7 8.1 13.7 18.7 23.3 11.4 11.0 16.8 17.1 15.5 14.3 15.7 18.1 9.0 11.8 13.5 16.9 13.0 10.5 15.6 21.6 12.6 29.3 13.1 15.5 13.0 18.9 36.2 11.7 10.6 22.2 19.1 12.5 18.3 16.1 15.7 23.0 23.4 14.9 13.8 27.8 15.3 26.9 18.9 25.1 23.6 22.9 26.5 34.1 24.6 18.8 42.8 34.3 21.7 14.0 21.5 30.7 24.3 28.3 11.2 26.1 9.7 27.4 15.4 23.3 45.8 18.5 17.7 10.0 49.3 28.7 10.1 19.6 20.1 26.1 27.3 15.1 19.6 9.4 10.3 22.4 14.0 24.1 15.5 17.1 20.5 20.7 12.2 19.8 20.0 22.2 20.4 13.5 13.6 15.6 1.9 25.8 1.1 9.2 24.4 12.4 15.6 10.8 10.4 18.5 13.1 15.5 11.1 12.6 13.1 29.3 21.6 12.3 13.0 17.1 17.1 12.5 22.1 19.3 17.8 16.7 15.2 21.0 18.1 14.9 12.8 13.4 31.9 32.5 3.3 14.8 7.6 30.8 50.0 10.4 3.9 22.1 10.0 25.9 17.7 18.3 9.1 0.0 22.0 20.6 19.7 23.3 22.0 27.3 15.2 7.9 6.4 11.6 7.3 7.9 16.1 18.7 13.5 10.0 9.7 6.6 25.9 13.9 9.2 13.2 3.2 12.9 21.7 16.7 11.4 31.1 26.5 8.3 13.2 31.5 PTTG1IP "C21orf1, C21orf3, PBF" ENSG00000183255 "PTTG1 interacting protein" P53801 21 44849585-44873903 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034146, HPA061827" Uncertain Supported Nucleoplasm NA NA 380000 Nucleoplasm "CAB034146: AB_1568894, HPA061827: AB_2684620" "unprognostic (1.78e-2)" "prognostic unfavorable (8.61e-4)" "unprognostic (5.24e-3)" "unprognostic (3.18e-2)" "unprognostic (1.68e-2)" "unprognostic (2.03e-2)" "unprognostic (3.59e-2)" "unprognostic (1.22e-2)" "unprognostic (1.98e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (9.30e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (5.40e-4)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.90e-1)" 47.1 52.1 46.7 33.6 48.7 29.6 53.3 20.9 38.7 50.1 47.2 57.0 29.3 43.6 53.2 47.6 36.2 40.4 50.9 59.9 51.8 31.0 75.6 71.9 58.2 38.8 59.6 30.2 49.6 39.8 23.4 27.3 111.6 43.0 40.5 41.4 50.0 46.0 57.7 30.8 32.1 72.8 51.8 45.8 38.8 58.9 35.2 52.6 19.8 62.4 25.1 25.3 48.2 60.0 5.3 40.5 58.1 35.6 12.5 16.8 37.2 31.0 17.5 20.8 19.7 40.8 23.8 16.9 28.5 40.6 23.1 22.3 37.7 42.7 4.2 108.8 44.3 55.5 14.4 9.5 18.2 22.3 7.3 10.5 33.1 11.0 33.0 39.8 12.6 11.3 36.6 30.0 25.1 17.5 46.3 49.6 11.6 16.6 11.2 71.3 13.4 9.1 12.9 22.0 45.1 22.1 9.1 21.3 20.5 99.6 10.9 15.7 24.3 31.6 34.8 61.6 26.4 26.9 21.2 68.0 29.3 17.1 22.7 43.6 10.7 10.0 5.4 19.7 28.4 26.2 58.1 35.6 20.8 10.3 28.9 16.8 5.3 13.4 10.8 40.5 5.0 13.0 8.9 49.4 12.5 30.4 18.4 16.8 37.2 46.7 48.7 20.9 35.7 51.8 31.0 59.6 30.2 43.0 52.6 366.3 135.9 29.8 68.7 45.1 14.1 137.7 73.9 242.2 240.0 137.9 5.9 181.6 41.4 311.5 36.3 156.9 223.5 0.0 105.1 61.5 84.2 101.0 76.5 97.8 96.5 11.1 76.1 106.2 71.4 76.2 66.7 89.8 82.7 81.2 82.0 66.8 225.0 140.3 93.0 67.3 14.0 64.7 78.7 66.8 49.6 37.5 306.6 30.5 75.0 159.3 PVR "CD155, HVED, Necl-5, NECL5, PVS, Tage4" ENSG00000073008 "Poliovirus receptor" P15151 19 44643798-44663583 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 65.6" "Cell type enhanced" "Detected in many" 5 "Pancreatic endocrine cells: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 5 "dendritic cells: 5.6;monocytes: 8.1" "Cell line enhanced" "Detected in many" "TIME: 53.4" "HPA012568, HPA064739" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Secreted - unknown location" NA NA 940000000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA012568: AB_1846248, HPA064739: " "unprognostic (2.90e-3)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.36e-1)" "unprognostic (2.34e-1)" "unprognostic (7.89e-2)" "unprognostic (2.45e-3)" "unprognostic (3.06e-2)" "prognostic unfavorable (9.30e-4)" "unprognostic (9.05e-3)" "unprognostic (1.69e-1)" "unprognostic (2.09e-3)" "unprognostic (2.64e-3)" "unprognostic (1.69e-1)" "unprognostic (4.97e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-3)" "prognostic unfavorable (2.75e-4)" 10.0 13.9 7.4 7.5 8.1 4.7 9.2 11.0 11.0 6.5 10.6 6.5 4.1 13.7 11.3 5.7 6.6 8.8 9.2 23.5 5.8 10.0 10.6 65.6 14.8 2.4 6.0 6.5 10.4 15.9 9.9 20.7 15.5 9.7 10.4 7.7 6.6 8.5 6.9 19.8 5.5 13.0 11.1 7.0 4.8 12.3 6.0 7.2 2.3 8.5 10.8 3.7 8.3 6.7 0.0 5.6 1.2 8.1 0.6 0.4 2.2 21.8 15.3 1.5 6.1 1.9 2.3 2.6 36.9 10.3 12.1 13.9 8.9 9.3 0.0 21.2 10.7 21.2 14.4 5.2 14.0 8.1 2.6 10.1 3.9 9.6 6.0 12.9 1.5 8.4 2.9 6.9 10.7 21.0 12.1 13.1 2.3 1.8 0.0 5.6 1.9 1.3 1.3 3.4 7.4 11.3 0.0 7.0 2.0 26.0 6.7 6.6 7.7 23.4 14.7 5.2 1.7 8.3 3.7 53.4 14.7 18.1 10.8 28.8 0.0 2.1 0.0 11.7 7.5 8.3 0.0 6.4 0.0 0.2 6.6 0.0 0.0 0.0 0.4 5.6 0.0 0.2 0.1 1.2 0.6 8.1 0.5 0.0 2.2 7.4 8.1 11.0 11.0 5.8 10.0 6.0 6.5 9.7 7.2 14.9 28.0 4.5 12.8 3.2 6.9 11.2 20.4 2.7 18.2 1.8 2.0 2.4 3.3 43.0 8.5 13.5 11.9 0.0 30.3 30.1 5.4 11.3 1.1 36.5 7.4 1.6 12.6 7.4 9.2 10.2 5.2 7.8 1.7 25.2 9.7 1.3 48.8 14.4 14.9 2.8 3.3 0.0 17.8 3.4 1.5 4.8 0.8 0.0 10.6 6.5 PVRIG "C7orf15, CD112R, MGC2463" ENSG00000213413 "PVR related immunoglobulin domain containing" Q6DKI7 7 100218241-100221490 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 51.7;lymphoid tissue: 21.0" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 1.1;granulocytes: 2.3;Horizontal cells: 3.2;T-cells: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 32 "gdT-cell: 43.5;MAIT T-cell: 51.7;memory B-cell: 24.8;memory CD4 T-cell: 28.9;memory CD8 T-cell: 42.9;naive B-cell: 19.3;naive CD4 T-cell: 32.6;naive CD8 T-cell: 32.2;NK-cell: 42.9;T-reg: 22.8" "Group enriched" "Detected in many" 37 "B-cells: 24.8;NK-cells: 42.9;T-cells: 51.7" "Group enriched" "Detected in some" 26 "Daudi: 36.9;JURKAT: 21.8;MOLT-4: 40.2;U-698: 11.9" "Low region specificity" "Detected in all" HPA047497 Uncertain Approved "Nucleoli,Endoplasmic reticulum" NA NA "Nucleoli, Endoplasmic reticulum" "HPA047497: AB_2680069" "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.21e-3)" "unprognostic (5.13e-2)" "unprognostic (9.89e-2)" "unprognostic (1.53e-3)" "unprognostic (1.35e-3)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.81e-1)" "unprognostic (5.58e-2)" "unprognostic (5.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.17e-1)" "unprognostic (2.43e-2)" "unprognostic (4.12e-1)" "unprognostic (2.71e-3)" 0.5 0.1 0.4 5.6 0.7 1.2 0.4 0.4 1.1 0.4 0.5 0.7 0.4 0.5 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.0 0.5 0.9 0.9 15.9 0.4 0.4 0.6 0.5 0.0 0.4 0.4 0.8 0.4 0.0 0.4 0.7 0.4 2.0 0.0 8.9 0.4 0.4 21.0 1.4 0.6 0.4 18.0 0.5 0.4 4.2 1.0 0.4 24.8 0.2 1.0 0.1 42.9 51.7 17.5 0.1 0.8 0.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 21.8 0.0 0.1 0.0 0.1 40.2 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.1 0.1 0.0 43.5 0.1 51.7 24.8 28.9 42.9 0.1 19.3 32.6 32.2 1.0 42.9 0.1 0.2 22.8 17.5 0.4 0.7 0.4 0.4 0.4 0.0 0.4 0.4 0.8 0.4 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 PXDN "D2S448, D2S448E, KIAA0230, MG50, PRG2, PXN" ENSG00000130508 Peroxidasin Q92626 2 1631887-1744852 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 60.8" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 40.8;Ito cells: 86.5;Sertoli cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 57.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA012375 Approved "Secreted to extracellular matrix" NA NA 4000000 "HPA012375: AB_1855965" "unprognostic (4.37e-2)" "prognostic unfavorable (6.28e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (8.16e-3)" "unprognostic (1.91e-1)" "unprognostic (1.92e-2)" "unprognostic (3.15e-3)" "unprognostic (6.50e-3)" "unprognostic (1.34e-2)" "unprognostic (6.78e-2)" "unprognostic (2.23e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.18e-1)" "unprognostic (7.33e-3)" "unprognostic (5.54e-3)" 36.4 3.2 2.6 13.1 2.0 0.5 60.8 0.3 3.7 15.5 17.7 2.7 5.1 4.3 20.4 8.9 7.4 9.7 12.9 16.2 2.0 2.6 5.8 6.9 14.3 8.5 1.8 1.4 19.2 2.1 1.5 6.5 18.3 3.6 15.2 5.0 7.6 7.3 6.8 8.4 3.7 8.4 41.0 2.6 13.7 7.8 5.8 1.2 4.3 5.9 4.8 3.4 26.3 20.1 0.5 2.0 0.0 0.0 0.0 1.1 0.1 6.6 2.3 12.6 0.0 35.7 32.8 9.6 39.9 31.7 17.5 19.2 0.0 0.1 0.0 57.3 39.4 0.8 1.4 0.0 24.5 22.3 0.1 0.4 0.0 24.9 0.0 35.4 0.1 0.0 36.1 7.2 19.7 14.9 53.1 42.9 6.2 0.0 0.0 24.7 3.9 1.1 1.3 10.2 0.0 9.1 2.2 44.1 0.1 20.5 0.0 0.0 23.3 0.0 12.9 0.0 26.4 4.7 0.1 41.6 28.9 14.3 1.0 30.7 0.0 33.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.5 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 2.0 0.0 0.1 2.6 2.0 0.3 2.7 2.0 2.6 1.8 1.4 3.6 1.2 6.0 2.9 0.0 2.3 2.6 1.4 5.3 7.6 2.7 0.0 1.8 0.0 0.6 0.0 7.9 33.3 40.8 0.0 0.0 0.0 7.7 15.2 12.9 1.1 0.8 1.6 0.0 1.7 86.5 9.7 24.5 24.7 1.1 6.8 1.0 0.8 11.2 0.8 0.0 14.2 0.0 0.7 45.3 26.2 1.8 10.1 2.5 1.1 0.0 0.0 1.0 PXMP2 PMP22 ENSG00000176894 "Peroxisomal membrane protein 2" Q9NR77 12 132687606-132704991 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.9" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 191.4;Hepatocytes: 515.6;Proximal tubular cells: 287.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.12e-2)" "unprognostic (7.96e-2)" "unprognostic (4.70e-3)" "unprognostic (1.14e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.84e-4)" "unprognostic (7.39e-3)" "unprognostic (2.83e-1)" "unprognostic (2.44e-2)" "unprognostic (3.02e-1)" "unprognostic (2.60e-1)" "unprognostic (1.88e-1)" "prognostic favorable (2.75e-4)" "unprognostic (9.89e-2)" "unprognostic (5.52e-2)" "unprognostic (3.71e-3)" "unprognostic (3.04e-1)" 5.7 4.1 6.5 6.5 5.3 6.7 10.3 3.4 7.6 3.4 18.1 3.8 7.4 17.4 4.3 7.9 5.3 5.0 14.1 16.3 5.3 3.7 18.4 78.9 3.6 5.0 4.4 6.1 6.8 32.3 2.5 2.4 2.7 4.4 5.4 13.3 4.6 9.0 3.6 12.8 4.3 25.9 3.9 3.2 3.5 22.9 4.2 4.6 13.8 7.9 5.8 4.4 4.6 4.1 3.3 9.9 4.3 1.9 2.2 4.4 1.9 24.0 10.1 15.2 14.1 9.2 7.1 8.9 8.6 8.0 18.8 16.7 12.2 9.3 15.0 10.5 12.3 6.6 17.2 20.2 10.9 10.3 8.5 32.1 13.3 18.2 13.4 18.0 9.8 6.0 9.3 9.1 7.7 6.2 13.1 5.0 23.1 22.9 11.8 9.8 21.8 31.0 15.5 14.9 28.4 14.0 32.0 16.4 12.3 13.8 10.2 29.0 9.4 18.6 9.8 11.8 12.3 26.3 22.7 5.8 9.3 21.7 8.0 14.3 10.7 10.3 24.0 10.3 14.1 7.3 0.0 1.9 4.3 3.8 0.8 3.7 3.3 3.1 3.9 3.3 3.3 3.0 2.5 0.9 2.2 0.9 9.9 4.4 1.9 6.5 5.3 3.4 7.6 5.3 3.7 4.4 6.1 4.4 4.6 3.0 4.5 6.7 18.1 7.4 5.1 33.1 147.7 0.0 3.4 24.4 3.9 37.1 140.9 15.6 15.2 9.0 191.4 0.0 9.0 32.9 16.1 31.2 4.6 515.6 27.8 0.0 18.0 36.8 18.3 24.3 28.7 8.0 11.8 1.0 64.3 21.8 13.0 122.2 32.9 287.1 5.0 19.4 10.5 15.3 20.7 9.4 23.8 7.5 155.8 17.5 PXYLP1 "ACPL2, FLJ23751" ENSG00000155893 "2-phosphoxylose phosphatase 1" Q8TE99 3 141228726-141367753 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 89.2" "Cell type enhanced" "Detected in many" 16 "Collecting duct cells: 43.6;Early spermatids: 163.2;Late spermatids: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017243 Uncertain "Intracellular and membrane" NA NA "HPA017243: AB_1844509" "unprognostic (9.55e-2)" "unprognostic (3.48e-3)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (8.45e-2)" "unprognostic (8.04e-3)" "unprognostic (4.05e-3)" "unprognostic (5.43e-2)" "unprognostic (1.27e-1)" "unprognostic (6.95e-2)" "unprognostic (5.07e-3)" "unprognostic (4.67e-2)" "unprognostic (1.29e-2)" "unprognostic (5.20e-2)" "unprognostic (1.37e-1)" "unprognostic (8.56e-2)" "unprognostic (8.17e-3)" 4.1 4.4 9.1 3.8 11.8 3.2 5.5 3.8 13.2 6.5 3.7 5.9 23.7 3.8 8.6 89.2 2.2 5.8 5.4 8.9 6.6 6.6 5.1 3.5 4.9 9.0 4.5 7.4 6.5 8.6 8.6 6.5 10.8 5.2 6.7 4.0 5.2 5.1 20.7 3.3 4.2 4.7 4.8 5.4 3.8 5.5 13.7 4.6 28.0 4.3 1.9 6.1 6.0 4.5 0.5 3.8 7.2 4.1 13.0 16.8 6.3 3.4 3.6 15.6 12.3 6.2 5.4 3.7 2.3 5.9 6.1 8.5 6.0 1.2 0.2 3.3 5.4 1.3 0.8 16.4 1.5 5.9 11.1 10.8 1.2 4.9 4.7 13.2 3.0 0.6 5.0 7.0 1.8 0.6 7.7 0.4 11.8 0.5 1.4 2.8 2.9 16.3 3.9 6.5 8.5 2.0 2.3 9.1 2.1 4.3 14.9 6.8 12.1 6.1 1.9 5.0 3.0 6.5 1.8 0.7 7.9 4.7 5.3 2.2 3.3 0.2 0.5 7.3 4.2 6.9 7.2 4.1 6.2 9.9 2.8 6.4 0.5 5.7 6.6 3.8 0.4 16.8 13.5 2.8 13.0 1.3 1.3 3.0 6.3 9.1 11.8 3.8 13.2 6.6 6.6 4.5 7.4 5.2 4.6 8.9 8.3 0.8 3.8 0.0 2.2 6.7 2.5 5.3 3.4 43.6 5.9 1.6 0.0 3.0 163.2 1.5 2.6 0.0 3.3 5.9 3.1 6.0 2.3 3.0 0.6 6.4 4.1 0.6 1.9 68.3 18.7 1.4 0.0 2.8 2.2 6.0 3.3 8.6 14.2 9.5 5.4 12.9 1.7 31.9 9.4 0.0 0.9 2.5 3.7 5.5 PYCR1 P5C ENSG00000183010 "Pyrroline-5-carboxylate reductase 1" P32322 17 81932384-81942412 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis, Stress response" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "pancreas: 56.1;salivary gland: 53.3;stomach 1: 16.6" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 55.5;Extravillous trophoblasts: 46.4;Mucus-secreting cells: 41.0;Pancreatic endocrine cells: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 7.7" "Group enriched" "Detected in many" 7 "B-cells: 7.7;dendritic cells: 3.3;T-cells: 3.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047660 Approved NA NA "HPA047660: AB_2680115" "unprognostic (1.12e-2)" "unprognostic (2.13e-2)" "unprognostic (7.04e-2)" "unprognostic (7.27e-2)" "unprognostic (9.86e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (2.80e-1)" "unprognostic (9.36e-3)" "unprognostic (6.65e-2)" "unprognostic (3.02e-3)" "unprognostic (7.12e-2)" "prognostic unfavorable (7.33e-12)" "unprognostic (7.98e-2)" "unprognostic (1.56e-1)" "unprognostic (1.12e-2)" "unprognostic (5.92e-2)" 2.1 1.3 4.3 5.0 5.0 4.0 6.9 2.1 4.3 10.4 9.1 2.3 10.1 5.6 4.2 2.2 6.4 3.5 5.7 3.5 3.5 3.6 2.4 3.1 4.9 2.3 6.0 2.0 7.6 56.1 0.0 7.6 8.3 6.4 10.4 5.6 1.5 53.3 4.7 3.4 1.8 4.8 4.6 2.9 2.4 16.6 8.7 4.0 1.7 3.3 4.5 6.4 4.9 4.0 7.7 3.3 0.0 0.4 0.6 3.0 2.2 19.1 20.5 11.7 43.3 6.9 13.3 22.4 32.2 15.9 10.4 14.0 23.4 21.6 29.4 7.2 34.4 6.2 8.4 27.5 12.2 6.2 7.6 3.4 17.3 10.6 63.2 41.5 11.4 13.4 11.3 24.5 12.7 33.6 12.2 17.6 24.0 55.6 27.4 6.5 67.8 12.1 9.2 9.8 53.1 31.8 0.1 19.7 37.0 9.3 7.0 45.0 31.7 6.7 38.0 41.0 9.1 39.1 21.3 12.9 10.1 38.9 17.0 11.9 34.6 24.0 27.3 10.8 0.1 33.2 0.0 0.3 0.0 0.5 0.4 0.7 7.7 1.3 0.4 2.3 3.5 3.0 2.3 0.0 0.6 0.0 3.3 0.5 2.2 4.3 5.0 2.1 3.6 3.5 3.6 6.0 2.0 6.4 4.0 0.0 3.8 3.7 8.2 6.3 0.2 0.6 0.0 1.4 3.4 3.5 0.0 1.7 0.0 14.6 10.8 3.5 4.1 0.0 55.5 46.4 23.5 32.3 4.6 1.7 4.3 3.2 10.4 4.3 0.0 25.5 6.9 0.0 8.5 1.0 41.0 0.1 48.3 20.1 3.5 1.3 0.0 0.0 3.1 24.5 15.2 5.3 3.2 1.0 37.6 7.4 PYY PYY1 ENSG00000131096 "Peptide YY" P10082 17 43952738-44004469 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 40.0" "Cell type enriched" "Detected in some" 360 "Intestinal endocrine cells: 18684.3" "Group enriched" "Detected in many" 8 "endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 7.9" "Region enriched" "Detected in single" 22 "pons and medulla: 1.4" "Not detected" "Not detected" "HPA010973, CAB016734" Enhanced "Secreted to blood" NA NA 87100 "CAB016734: AB_876471, HPA010973: AB_1855194" "unprognostic (8.17e-3)" "unprognostic (5.41e-2)" "unprognostic (9.93e-2)" "unprognostic (1.81e-3)" "unprognostic (2.48e-4)" "unprognostic (5.26e-2)" "unprognostic (4.14e-2)" "unprognostic (1.80e-2)" "unprognostic (1.75e-2)" "unprognostic (1.54e-2)" "unprognostic (2.91e-1)" "unprognostic (1.29e-1)" "unprognostic (5.69e-3)" "unprognostic (3.77e-2)" "unprognostic (1.79e-1)" "unprognostic (1.41e-1)" "unprognostic (1.20e-1)" 0.1 0.8 0.1 2.0 0.2 0.0 0.2 0.1 0.1 0.1 40.0 0.1 0.1 1.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.5 0.1 20.6 0.1 0.1 0.3 0.1 0.0 24.8 0.1 0.1 0.1 0.1 1.0 0.1 4.2 0.2 0.1 0.1 0.1 0.1 0.9 0.1 0.0 0.1 0.0 0.4 0.0 0.2 0.6 0.7 1.3 1.0 1.7 0.2 1.2 0.3 1.4 0.8 1.3 0.9 0.7 1.6 1.4 1.1 0.7 1.1 0.4 0.9 3.2 0.6 1.8 0.5 0.2 1.2 0.5 7.9 2.3 0.4 1.3 0.6 1.7 0.3 0.7 0.4 1.3 1.2 1.7 0.5 1.0 1.6 1.2 0.7 0.4 0.3 0.2 2.1 0.1 1.3 0.3 0.7 0.0 2.1 1.1 1.2 0.1 1.3 1.6 1.4 0.3 1.1 0.1 1.2 0.2 1.8 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 27.6 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 18684.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 51.9 0.0 0.0 25.9 0.0 0.0 0.0 0.0 0.0 2.3 4.5 0.1 0.0 0.0 32.3 0.0 QARS ENSG00000172053 "Glutaminyl-tRNA synthetase" P47897 3 49095932-49105135 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Epilepsy, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 438.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036986, HPA036987" Enhanced Enhanced Cytosol No No 21000 Cytosol "HPA036986: AB_10672344, HPA036987: AB_2675418" "prognostic favorable (1.43e-4)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (1.10e-2)" "unprognostic (5.13e-3)" "unprognostic (6.62e-3)" "unprognostic (6.53e-3)" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (2.51e-1)" "unprognostic (4.33e-1)" "unprognostic (9.14e-2)" "prognostic favorable (5.60e-6)" "unprognostic (2.73e-3)" "unprognostic (1.65e-1)" "unprognostic (2.74e-2)" "unprognostic (3.11e-1)" 20.9 16.3 9.7 19.3 10.2 18.4 22.7 15.8 13.2 17.6 27.3 13.1 27.7 17.2 12.3 19.8 35.1 16.4 20.0 22.0 9.8 9.6 27.1 26.0 15.0 33.9 12.4 7.2 21.6 33.8 20.3 13.7 25.7 9.6 16.2 29.9 15.2 31.7 28.7 33.3 26.7 31.8 16.7 11.2 21.1 16.9 30.1 11.3 36.8 16.5 34.8 33.3 19.4 18.5 20.4 40.0 8.9 32.3 21.8 24.0 19.6 18.8 19.2 32.1 45.9 41.3 44.9 33.1 21.0 48.1 41.7 41.0 24.3 24.5 58.4 13.5 34.8 23.4 24.0 45.5 34.6 30.0 16.6 36.3 46.0 30.8 42.3 21.8 37.4 28.4 47.3 30.3 32.1 27.3 44.8 45.5 34.2 20.5 26.0 30.5 10.1 26.9 33.6 27.5 38.6 30.0 17.8 27.0 43.0 28.0 28.1 11.8 32.8 18.6 47.3 28.9 33.0 39.2 43.7 26.2 19.0 27.0 31.3 23.4 22.4 38.1 32.8 19.5 33.7 12.0 8.9 23.1 8.7 13.5 32.3 18.1 20.4 16.8 14.9 40.0 15.2 15.5 15.4 2.6 21.8 26.1 16.9 24.0 19.6 9.7 10.2 15.8 13.2 9.8 9.6 12.4 7.2 9.6 11.3 20.8 57.3 55.9 52.1 59.8 10.1 50.4 40.8 22.7 35.2 38.4 9.8 160.6 58.0 67.5 150.2 50.3 110.2 23.3 94.9 127.6 48.0 47.5 38.1 41.8 85.6 19.1 62.3 50.3 98.5 438.0 54.4 55.2 45.5 120.0 127.2 20.6 67.1 71.9 34.3 63.0 13.0 45.3 43.4 18.4 46.6 75.3 156.4 69.2 176.8 57.2 QPCTL FLJ20084 ENSG00000011478 "Glutaminyl-peptide cyclotransferase like" Q9NXS2 19 45692483-45703989 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 4.0;Early spermatids: 4.4;granulocytes: 5.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040797 Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA040797: AB_10794148" "unprognostic (6.50e-2)" "unprognostic (4.14e-2)" "unprognostic (2.09e-1)" "unprognostic (7.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.26e-1)" "unprognostic (8.41e-3)" "unprognostic (2.30e-2)" "unprognostic (9.46e-2)" "unprognostic (1.69e-1)" "unprognostic (3.14e-2)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.15e-8)" "unprognostic (1.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.02e-2)" "unprognostic (5.71e-2)" 6.3 10.2 8.2 9.6 10.2 13.3 7.8 10.3 13.5 9.6 11.6 6.3 9.6 11.2 7.6 10.2 11.4 8.6 15.9 5.0 8.9 10.8 7.9 18.2 11.8 10.7 7.3 8.0 11.2 10.7 9.5 10.8 9.6 10.8 10.8 9.5 7.7 13.5 10.8 3.2 12.4 7.9 6.1 6.4 12.9 9.5 5.9 5.0 9.7 17.1 7.5 13.2 11.9 6.4 3.1 3.6 5.1 2.1 4.1 4.3 1.2 10.2 7.0 5.6 23.0 5.6 2.7 4.2 6.7 9.7 9.5 15.8 7.4 7.7 12.7 7.3 7.3 10.0 6.5 6.9 7.4 5.9 3.5 8.8 4.6 9.0 14.8 9.4 4.7 8.2 4.9 9.1 7.9 11.6 7.0 8.4 7.6 6.2 22.1 5.9 8.2 4.3 5.6 4.0 8.6 4.0 5.2 4.1 10.1 10.9 4.9 5.3 3.3 6.8 5.6 11.4 2.6 4.3 7.3 5.4 4.9 8.1 5.1 6.4 20.7 12.3 11.9 16.9 10.8 3.8 3.1 2.0 0.9 4.3 2.1 3.0 3.1 2.1 1.4 2.4 2.8 2.1 2.8 5.1 4.1 1.3 3.6 1.4 1.2 8.2 10.2 10.3 13.5 8.9 10.8 7.3 8.0 10.8 5.0 0.0 1.0 0.0 1.0 1.1 1.1 0.8 0.0 4.0 1.2 0.0 0.0 0.6 0.0 0.3 4.4 0.1 0.7 0.0 0.3 1.0 0.7 1.1 5.7 1.0 0.8 1.6 0.0 0.0 0.3 0.6 0.0 1.3 1.7 1.0 0.2 0.5 0.5 0.0 0.0 0.1 2.5 0.0 0.8 1.1 0.2 1.0 0.7 1.3 0.6 0.4 QRFPR GPR103 ENSG00000186867 "Pyroglutamylated RFamide peptide receptor" Q96P65 4 121329312-121381059 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 6.9;heart muscle: 4.6" "Cell type enhanced" "Detected in some" 29 "Cardiomyocytes: 3.2;Early spermatids: 1.6" "Cancer enriched" "Detected in some" 6 "renal cancer: 5.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 5.3;hTERT-HME1: 7.2;JURKAT: 2.3;RPTEC TERT1: 4.6;SCLC-21H: 2.9;U-2 OS: 7.8;WM-115: 4.4" "Low region specificity" "Detected in many" HPA050236 Approved NA NA "HPA050236: " "unprognostic (1.24e-2)" "unprognostic (2.30e-1)" "unprognostic (1.93e-2)" "unprognostic (3.21e-1)" "unprognostic (2.77e-1)" "unprognostic (3.21e-4)" "unprognostic (2.71e-1)" "unprognostic (5.77e-3)" "unprognostic (5.37e-2)" "unprognostic (6.33e-2)" "unprognostic (2.12e-1)" "prognostic favorable (3.09e-4)" "unprognostic (3.09e-1)" "unprognostic (2.57e-1)" "unprognostic (1.61e-1)" 1.6 1.2 0.7 0.3 1.9 0.0 0.5 0.1 2.0 0.3 0.2 0.3 0.0 0.0 0.2 1.1 0.8 0.1 1.1 4.6 1.3 6.9 3.2 0.2 0.1 0.0 0.8 0.8 0.4 0.0 1.0 0.8 0.2 4.9 0.6 0.1 3.3 0.0 2.3 0.1 0.0 0.4 0.2 2.6 0.0 1.3 0.7 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 7.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 4.6 0.0 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 7.8 0.0 0.0 0.1 1.8 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.9 0.1 2.0 1.3 6.9 0.8 0.8 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 QSOX1 QSCN6 ENSG00000116260 "Quiescin sulfhydryl oxidase 1" O00391 1 180154834-180204030 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 172.2" "Cell type enriched" "Detected in many" 8 "Extravillous trophoblasts: 1528.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 197.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA056243 Supported "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 3200000000 "Golgi apparatus" Vesicles "HPA056243: AB_2683077" "unprognostic (1.13e-1)" "unprognostic (2.62e-3)" "unprognostic (2.46e-1)" "unprognostic (2.49e-2)" "unprognostic (2.00e-2)" "unprognostic (2.73e-1)" "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.94e-1)" "unprognostic (3.12e-2)" "unprognostic (5.07e-2)" "unprognostic (2.80e-3)" "prognostic unfavorable (1.86e-5)" "unprognostic (3.25e-1)" "unprognostic (2.14e-1)" "unprognostic (3.53e-2)" "unprognostic (1.40e-1)" 15.9 18.7 8.0 14.5 9.5 30.1 12.6 7.3 13.6 23.5 25.3 13.8 24.9 19.8 17.8 44.9 36.8 18.9 91.9 54.4 10.1 9.0 15.4 23.1 42.3 19.5 8.5 9.1 46.5 59.8 6.2 13.5 172.2 13.4 28.0 24.5 12.1 20.6 19.4 18.4 12.3 19.0 33.9 15.5 13.4 52.8 50.3 9.1 6.7 7.8 18.2 18.3 35.8 26.1 2.9 19.2 20.4 25.5 8.0 7.1 11.4 42.1 6.0 1.4 18.0 18.4 38.1 71.7 44.9 45.4 38.4 27.1 0.7 13.6 0.6 27.9 35.9 5.3 9.2 1.7 12.1 18.8 2.5 2.7 1.3 3.5 1.8 197.7 4.6 13.0 20.3 5.5 40.9 49.1 50.6 56.5 3.1 1.9 6.6 25.2 7.3 0.9 8.6 4.9 29.2 17.3 1.8 3.3 1.1 6.3 12.0 5.2 5.3 13.1 17.9 8.7 3.4 3.2 21.9 66.5 48.1 18.9 32.2 37.9 4.8 7.9 1.1 18.3 14.8 14.4 5.8 25.5 9.5 7.1 14.7 5.3 2.9 4.8 5.0 19.2 1.8 4.4 4.3 20.4 8.0 13.1 3.9 5.5 11.4 8.0 9.5 7.3 13.6 10.1 9.0 8.5 9.1 13.4 9.1 53.6 87.2 7.8 26.2 12.2 9.8 43.7 68.8 14.7 43.3 68.0 23.6 13.2 0.0 189.3 48.3 38.6 47.7 0.0 114.6 1528.4 54.2 30.1 25.3 1.5 63.8 6.4 44.4 101.9 45.4 16.5 164.5 43.6 42.2 44.1 163.8 43.9 172.2 143.8 66.8 9.5 6.5 32.3 17.5 20.9 25.4 8.7 129.1 15.0 96.4 58.0 QSOX2 "DKFZp762A2013, QSCN6L1, SOXN" ENSG00000165661 "Quiescin sulfhydryl oxidase 2" Q6ZRP7 9 136206333-136245841 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012716, HPA017280" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 5700000 "Golgi apparatus" Nucleoplasm "HPA012716: AB_2173315, HPA017280: AB_2669565" "unprognostic (7.29e-2)" "unprognostic (7.35e-3)" "unprognostic (6.23e-2)" "unprognostic (5.28e-2)" "unprognostic (1.49e-1)" "unprognostic (4.46e-3)" "unprognostic (1.10e-3)" "unprognostic (4.48e-2)" "unprognostic (1.20e-1)" "unprognostic (4.06e-3)" "unprognostic (5.96e-2)" "unprognostic (2.56e-2)" "prognostic unfavorable (9.64e-6)" "unprognostic (1.23e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.10e-2)" 7.2 8.0 8.4 15.9 14.1 16.0 7.3 30.3 10.6 5.8 5.8 9.4 8.9 6.0 8.1 13.2 5.6 8.1 5.5 7.0 7.6 7.1 7.0 9.2 6.5 19.1 11.0 6.7 9.4 21.7 12.1 29.2 5.8 9.6 6.1 6.7 7.9 6.5 4.9 5.1 12.4 10.3 8.1 7.1 14.6 7.6 11.7 10.1 8.3 12.1 6.0 16.7 5.4 6.4 3.4 0.8 1.6 0.3 0.4 0.8 0.2 7.0 17.1 14.2 18.8 8.0 9.8 17.9 8.9 10.0 17.5 16.1 12.7 15.3 10.8 14.8 12.0 32.2 22.8 16.8 12.9 14.2 15.9 8.4 5.8 28.3 14.0 11.4 17.2 8.9 7.8 13.2 17.3 21.1 7.7 12.8 11.4 14.0 29.3 9.2 11.9 6.3 11.5 16.8 21.2 10.9 11.8 18.5 17.7 6.0 6.3 15.2 11.5 14.1 11.2 7.5 9.7 8.0 10.1 7.3 21.3 15.4 17.4 20.3 10.4 13.8 23.8 14.2 9.1 19.8 1.6 0.3 0.7 0.5 0.0 0.8 1.9 0.6 0.2 0.1 3.4 0.2 0.4 0.1 0.4 0.0 0.8 0.3 0.2 8.4 14.1 30.3 10.6 7.6 7.1 11.0 6.7 9.6 10.1 8.9 6.4 6.9 2.5 5.0 16.1 3.1 0.0 8.1 5.7 5.2 17.7 1.2 1.7 3.3 4.9 7.0 1.1 0.0 3.4 2.5 4.7 4.8 1.1 3.4 2.0 4.8 15.6 2.5 4.8 4.7 5.5 2.7 0.0 1.0 4.9 2.8 3.5 0.0 6.7 1.9 8.2 6.5 5.7 16.8 26.4 10.0 0.8 3.1 3.4 3.3 RABAC1 "PRA1, PRAF1, YIP3" ENSG00000105404 "Rab acceptor 1" Q9UI14 19 41956681-41959390 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019320, HPA029171" Supported Approved "Nuclear membrane,Nucleoli fibrillar center" NA NA "Nuclear membrane" "Nucleoli fibrillar center" "CAB019320: , HPA029171: AB_10602121" "unprognostic (7.70e-2)" "unprognostic (5.18e-2)" "unprognostic (1.11e-1)" "unprognostic (2.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.20e-1)" "unprognostic (1.58e-1)" "unprognostic (1.93e-1)" "unprognostic (3.41e-2)" "unprognostic (1.19e-2)" "unprognostic (3.32e-3)" "unprognostic (9.69e-2)" "unprognostic (1.76e-1)" "unprognostic (8.92e-2)" "unprognostic (2.31e-1)" "unprognostic (6.97e-2)" "unprognostic (7.45e-2)" 44.2 45.4 42.3 36.7 42.5 29.6 43.5 30.9 53.1 43.6 40.5 32.0 45.3 47.8 46.8 32.4 36.2 30.4 39.8 32.2 39.5 45.9 46.0 92.3 35.7 53.0 44.7 33.4 37.5 88.1 18.5 48.6 51.0 39.9 33.8 19.1 23.3 68.8 40.5 52.2 31.6 43.4 32.0 38.4 32.2 60.6 28.3 31.9 38.8 56.1 28.7 32.4 31.4 47.5 54.5 59.6 114.0 58.1 33.2 57.2 64.1 17.3 47.7 6.9 17.9 47.0 27.0 9.1 51.7 27.4 12.7 17.9 8.4 11.4 50.2 26.8 30.6 7.3 13.0 4.2 16.2 5.3 18.5 28.0 7.3 14.0 14.5 25.2 6.4 20.3 26.2 16.2 8.6 6.3 16.6 17.7 14.2 3.2 65.4 11.7 26.7 11.2 5.8 8.4 24.9 31.0 15.3 14.8 9.7 12.1 13.0 12.7 18.5 13.6 29.6 12.5 5.6 11.1 5.4 34.3 22.8 15.1 22.1 7.4 58.2 19.4 17.4 33.0 12.0 24.5 86.2 58.1 76.4 57.2 30.5 48.1 54.5 52.0 49.8 33.8 49.9 35.3 47.6 114.0 33.2 29.6 59.6 55.8 64.1 42.3 42.5 30.9 53.1 39.5 45.9 44.7 33.4 39.9 31.9 119.1 107.6 134.8 132.5 110.7 54.7 56.9 175.8 84.3 81.9 172.7 15.7 168.6 116.0 298.8 157.9 238.6 301.1 23.3 264.4 410.9 312.7 240.5 140.7 234.8 161.0 54.0 187.1 255.9 127.0 499.8 284.2 161.6 384.6 285.9 338.7 137.5 343.3 280.5 236.2 262.8 46.9 226.4 277.1 222.3 127.0 119.2 227.2 151.3 250.8 152.9 RABGAP1 "GAPCenA, TBC1D11" ENSG00000011454 "RAB GTPase activating protein 1" Q9Y3P9 9 122940833-123104866 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041651, HPA064860, HPA072273" Enhanced Enhanced Cytosol NA NA Cytosol "HPA041651: AB_10794673, HPA064860: AB_2685372, HPA072273: AB_2686504" "prognostic unfavorable (8.09e-4)" "unprognostic (3.45e-1)" "unprognostic (3.85e-3)" "unprognostic (3.90e-1)" "unprognostic (4.16e-2)" "unprognostic (1.16e-1)" "unprognostic (1.53e-1)" "unprognostic (3.75e-2)" "unprognostic (5.19e-2)" "unprognostic (3.52e-2)" "unprognostic (1.88e-2)" "unprognostic (2.76e-1)" "prognostic favorable (6.06e-6)" "unprognostic (1.39e-1)" "unprognostic (2.75e-1)" "unprognostic (8.72e-2)" "unprognostic (3.05e-2)" 16.9 12.6 24.2 12.5 31.0 5.1 17.1 16.9 36.3 18.8 27.6 19.5 16.4 9.5 23.6 20.9 25.5 18.2 15.2 20.0 22.4 20.8 16.2 9.0 15.0 14.0 23.9 25.0 19.6 12.6 29.1 17.7 18.5 23.9 24.1 18.6 19.4 18.1 25.4 23.7 17.3 12.8 25.6 23.0 13.5 17.8 16.4 17.5 11.4 31.2 8.6 16.2 22.9 16.4 4.1 3.9 6.1 5.5 2.1 4.5 1.4 8.9 12.0 19.0 15.7 22.0 18.0 11.7 9.4 17.0 14.6 13.7 13.9 8.8 12.4 7.5 14.6 19.5 30.5 12.1 11.8 15.8 11.5 7.3 9.7 19.4 10.5 18.9 7.8 8.4 17.3 18.1 12.5 14.2 21.1 16.5 12.4 8.3 9.5 17.5 19.9 10.2 6.2 7.0 25.8 9.3 16.9 34.7 10.5 12.2 10.0 10.7 8.3 16.8 15.2 8.6 14.9 28.9 4.3 12.6 12.4 7.4 13.6 9.4 9.3 15.1 13.0 11.7 4.0 10.8 6.1 3.6 4.3 2.6 5.5 2.0 3.0 2.7 2.3 2.8 4.1 4.5 2.9 5.6 2.1 2.4 3.9 3.1 1.4 24.2 31.0 16.9 36.3 22.4 20.8 23.9 25.0 23.9 17.5 23.8 43.2 18.2 20.2 16.0 47.9 39.5 10.2 33.5 34.2 10.4 47.1 17.8 3.3 9.1 11.8 24.1 12.7 0.0 12.8 7.4 18.2 30.8 13.9 13.7 13.6 54.0 16.3 27.0 26.4 10.7 37.7 15.9 13.5 18.0 17.1 36.5 10.0 10.5 48.4 9.0 35.9 84.1 32.0 71.1 34.5 15.2 34.8 8.7 14.4 15.5 RABGAP1L "FLJ38519, HHL, KIAA0471, TBC1D18" ENSG00000152061 "RAB GTPase activating protein 1 like" "B7ZAP0, Q5R372" 1 174159410-174995308 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 89.4" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 201.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 46.9;Karpas-707: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054695 Uncertain NA NA "HPA054695: AB_2682577" "unprognostic (2.57e-2)" "unprognostic (7.77e-2)" "unprognostic (6.78e-2)" "unprognostic (6.89e-3)" "unprognostic (1.54e-2)" "unprognostic (6.96e-3)" "unprognostic (8.55e-2)" "prognostic favorable (1.16e-4)" "unprognostic (2.66e-2)" "unprognostic (3.51e-2)" "unprognostic (2.66e-2)" "unprognostic (1.98e-1)" "unprognostic (9.14e-3)" "unprognostic (6.69e-2)" "unprognostic (2.14e-1)" "unprognostic (5.03e-2)" "unprognostic (2.46e-1)" 9.9 5.4 27.2 19.9 22.7 16.2 9.5 31.4 34.1 9.6 11.8 9.5 8.9 12.8 9.0 10.4 11.2 11.5 13.1 89.4 21.2 14.5 10.2 9.6 15.3 22.2 13.7 26.1 18.0 13.4 10.8 25.1 22.2 19.0 7.5 12.8 15.0 13.3 6.8 6.0 10.0 16.3 8.2 28.0 15.8 13.3 16.9 10.7 9.6 7.4 5.4 27.9 15.1 8.8 10.7 16.0 31.0 48.9 22.6 12.1 9.3 5.3 2.8 2.2 2.4 6.0 8.8 4.8 6.4 5.6 2.8 3.8 2.6 19.6 46.9 4.5 4.9 3.3 6.9 1.8 4.3 4.0 13.0 3.0 11.7 4.0 4.2 3.7 5.2 4.8 6.9 2.9 2.1 3.0 4.8 6.2 4.5 6.9 31.1 4.5 1.9 4.0 5.0 13.2 7.2 1.7 14.1 4.3 15.6 5.5 24.6 6.3 3.8 6.0 10.2 4.1 7.0 5.0 6.2 8.6 3.8 3.4 4.0 3.7 27.1 8.8 29.4 4.0 3.5 2.7 4.4 15.0 31.0 8.1 24.3 7.1 10.7 10.0 9.8 11.8 7.9 5.0 7.5 26.5 22.6 48.9 16.0 12.1 9.3 27.2 22.7 31.4 34.1 21.2 14.5 13.7 26.1 19.0 10.7 68.5 88.4 30.5 10.8 11.0 34.9 201.7 40.8 68.3 33.0 31.4 29.5 32.3 11.6 21.9 81.5 11.7 30.6 0.0 31.8 8.0 14.7 11.5 23.2 13.0 33.4 20.6 47.2 21.5 41.5 91.0 14.4 28.4 15.1 93.8 38.8 15.8 24.3 36.0 17.7 11.7 21.3 6.5 14.7 37.9 17.7 11.4 23.6 48.4 25.8 19.6 RAD51B "hREC2, R51H2, RAD51L1, REC2" ENSG00000182185 "RAD51 paralog B" O15315 14 67819779-68730218 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016191, HPA051869" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "CAB016191: AB_2238209, HPA051869: AB_2681644" "unprognostic (9.10e-3)" "unprognostic (5.45e-2)" "unprognostic (4.92e-1)" "unprognostic (6.65e-2)" "unprognostic (2.38e-2)" "unprognostic (4.85e-2)" "unprognostic (6.42e-3)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (6.80e-3)" "unprognostic (1.47e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-1)" "unprognostic (2.49e-2)" "unprognostic (6.79e-2)" "unprognostic (8.13e-3)" 5.1 4.9 4.2 4.6 10.1 9.2 8.2 2.0 5.6 8.2 4.3 11.6 11.2 1.7 10.8 13.8 7.0 6.0 6.4 3.4 5.6 3.2 4.3 3.2 5.0 6.6 9.2 4.0 10.0 5.7 8.0 10.0 8.0 7.5 7.0 4.0 9.4 18.7 3.8 2.4 7.1 5.8 6.7 7.3 6.9 3.7 3.4 7.3 12.6 4.9 4.6 12.1 7.7 8.3 13.6 6.6 14.0 5.9 7.8 10.1 4.8 12.2 4.9 5.4 3.3 5.1 8.7 3.4 6.2 4.8 6.9 8.9 3.4 16.7 15.2 4.1 3.8 8.0 11.1 3.4 10.0 9.5 6.7 3.5 7.2 4.4 2.7 2.7 6.1 7.3 4.4 7.7 7.9 8.4 3.2 6.2 11.3 5.8 7.1 5.6 9.6 11.8 2.1 3.2 11.9 4.9 13.4 6.5 5.5 5.4 3.5 3.7 2.4 5.0 1.8 10.8 6.7 8.4 5.5 1.6 8.5 8.2 6.6 5.1 3.4 3.5 12.0 4.7 10.7 4.8 14.0 5.9 5.4 8.6 4.7 7.1 13.6 8.2 9.2 6.5 11.5 10.1 9.7 0.7 7.8 4.5 6.6 9.1 4.8 4.2 10.1 2.0 5.6 5.6 3.2 9.2 4.0 7.5 7.3 0.0 0.6 3.9 4.8 6.0 1.3 1.5 0.0 1.4 2.3 1.8 7.9 4.8 3.3 1.8 1.5 3.6 1.4 0.0 1.2 5.5 2.5 3.4 4.6 0.6 5.7 1.6 4.6 0.6 4.3 1.3 3.4 3.6 8.5 10.0 2.7 5.1 1.1 0.0 4.2 1.6 5.9 0.0 2.0 3.8 3.2 6.0 3.3 2.5 1.3 3.1 RAET1E "bA350J20.7, LETAL, ULBP4" ENSG00000164520 "Retinoic acid early transcript 1E" Q8TD07 6 149883375-149898102 "Predicted intracellular proteins, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 39.7;lymphoid tissue: 22.5;tongue: 19.8" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 1.9;Early spermatids: 5.0;Late spermatids: 4.2;Suprabasal keratinocytes: 5.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HBEC3-KT: 15.9;HeLa: 21.8;hTCEpi: 15.8;SiHa: 7.5;U-87 MG: 6.8" HPA054022 Supported "Focal adhesion sites,Cytosol" "Intracellular and membrane" NA NA "Focal adhesion sites" Cytosol "HPA054022: AB_2797250" "unprognostic (1.67e-2)" "unprognostic (2.10e-1)" "unprognostic (3.49e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "unprognostic (2.71e-2)" "unprognostic (1.36e-3)" "unprognostic (4.80e-4)" "unprognostic (1.11e-1)" "unprognostic (3.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (7.47e-5)" "unprognostic (2.41e-2)" "unprognostic (3.18e-2)" "unprognostic (3.17e-2)" "unprognostic (1.06e-1)" 1.6 0.5 0.2 0.5 0.2 0.0 1.4 0.2 0.2 10.4 0.3 0.2 0.2 0.2 0.8 0.6 39.7 0.6 0.2 0.2 0.2 0.0 2.8 0.2 0.6 0.2 0.2 0.2 0.6 0.2 0.1 0.2 0.5 0.2 0.4 0.3 0.2 7.0 0.2 0.7 14.6 0.3 0.3 0.2 0.6 0.2 0.5 0.3 0.3 0.2 19.8 22.5 1.3 12.6 0.6 0.4 2.3 0.6 0.5 0.7 0.1 1.5 0.9 0.0 0.0 0.2 1.3 0.1 0.1 0.9 0.1 0.3 0.0 3.7 0.0 2.1 3.1 2.0 1.7 0.0 15.9 0.2 0.4 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.3 15.8 0.9 3.3 0.5 0.1 0.0 0.0 1.3 0.9 0.1 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.2 0.3 0.7 0.2 0.0 7.5 2.0 0.0 0.0 1.1 0.0 3.0 1.1 0.4 0.1 0.9 0.0 0.0 0.0 6.8 0.3 0.0 2.0 0.6 0.4 0.4 0.3 0.2 0.2 0.6 0.3 0.1 0.6 0.7 0.4 2.3 0.5 0.2 0.4 0.3 0.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.9 1.9 0.6 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 1.8 RAET1L ENSG00000155918 "Retinoic acid early transcript 1L" Q5VY80 6 150018334-150025532 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 31.4;lymphoid tissue: 15.3;tongue: 25.1" "Group enriched" "Detected in some" 4 "Basal glandular cells: 5.9;Basal keratinocytes: 5.7;Glandular cells: 6.9;Suprabasal keratinocytes: 14.9;Urothelial cells: 6.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.1" "Region enriched" "Detected in single" 4 "amygdala: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HaCaT: 19.7" NA NA "unprognostic (1.80e-1)" "unprognostic (1.63e-1)" "unprognostic (2.15e-1)" "unprognostic (1.84e-1)" "unprognostic (4.24e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.09e-4)" "unprognostic (8.34e-2)" "unprognostic (1.37e-1)" "unprognostic (2.26e-2)" "unprognostic (7.48e-2)" "unprognostic (1.46e-2)" "unprognostic (2.49e-1)" "unprognostic (1.29e-1)" "unprognostic (5.14e-2)" "unprognostic (7.43e-3)" 0.0 0.1 1.1 0.0 0.1 0.0 0.3 0.0 0.2 6.1 0.1 0.0 0.0 0.0 0.3 0.0 31.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.5 0.1 0.1 2.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 25.1 15.3 0.2 8.8 0.0 0.0 0.0 0.0 0.0 0.6 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 1.8 0.0 1.1 19.7 0.5 0.5 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 3.3 0.0 0.0 0.0 3.8 0.9 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.3 0.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.9 0.0 0.0 0.0 6.4 RAMP1 ENSG00000132329 "Receptor activity modifying protein 1" O60894 2 237858893-237912114 "FDA approved drug targets, Predicted membrane proteins" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 91.6;pancreas: 94.7" "Cell type enhanced" "Detected in many" 18 "Exocrine glandular cells: 240.1;monocytes: 755.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 16 "NK-cell: 30.0" "Lineage enriched" "Detected in many" 16 "NK-cells: 30.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.1;HDLM-2: 37.9;PC-3: 44.2;SH-SY5Y: 55.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057814 Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA057814: AB_2683536" "unprognostic (1.13e-2)" "unprognostic (5.96e-2)" "unprognostic (3.03e-3)" "unprognostic (3.69e-1)" "unprognostic (4.29e-1)" "unprognostic (1.75e-1)" "prognostic favorable (7.61e-4)" "unprognostic (2.54e-1)" "unprognostic (3.49e-1)" "unprognostic (5.45e-3)" "unprognostic (2.32e-1)" "unprognostic (1.43e-1)" "unprognostic (2.46e-3)" "prognostic unfavorable (1.68e-4)" "unprognostic (1.74e-1)" "unprognostic (3.98e-2)" "unprognostic (2.08e-3)" 3.5 13.8 22.4 9.4 23.9 1.2 1.6 7.8 22.5 34.1 38.8 9.9 8.9 24.9 91.6 21.7 8.9 29.1 19.0 61.7 19.6 15.4 3.1 13.4 3.1 3.3 18.0 12.7 8.4 94.7 1.0 1.6 4.5 14.6 25.5 3.5 1.5 1.5 25.1 62.4 2.4 14.4 51.8 19.5 2.4 14.2 4.3 17.1 0.0 1.1 5.4 2.0 18.3 14.0 0.1 0.4 0.2 0.0 30.0 1.8 1.4 7.9 0.0 0.1 0.0 3.4 5.3 0.3 0.5 0.9 0.5 0.4 0.0 13.1 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.0 37.9 1.0 0.0 0.0 0.2 10.7 0.0 0.0 4.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.7 0.0 0.3 0.1 0.0 44.2 0.0 0.4 0.2 0.0 0.0 0.4 55.7 0.8 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.2 0.1 0.2 30.0 0.0 0.0 0.0 1.4 22.4 23.9 7.8 15.3 19.6 15.4 18.0 12.7 14.6 17.1 0.0 1.0 0.5 11.4 10.3 2.1 136.4 91.7 14.7 9.1 10.4 0.0 2.1 0.0 55.5 0.2 4.2 4.9 0.0 240.1 7.5 28.8 73.7 1.1 137.8 18.7 1.6 110.7 51.5 4.0 0.4 7.8 6.3 60.8 755.6 26.2 3.3 79.4 4.0 10.6 0.0 2.3 6.5 86.3 0.0 4.9 5.1 1.9 3.2 6.6 3.8 RAMP2 ENSG00000131477 "Receptor activity modifying protein 2" O60895 17 42758447-42763041 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Endothelial cells: 348.5;Ito cells: 252.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 18 "dendritic cells: 6.4" "Cell line enhanced" "Detected in many" "ASC diff: 47.1;EFO-21: 31.4;HUVEC TERT2: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052020 Approved Vesicles NA NA Vesicles "HPA052020: AB_2681697" "unprognostic (8.64e-2)" "unprognostic (2.12e-2)" "unprognostic (8.03e-2)" "unprognostic (1.16e-2)" "unprognostic (5.24e-2)" "unprognostic (4.13e-3)" "unprognostic (2.68e-2)" "unprognostic (1.04e-1)" "unprognostic (4.50e-2)" "unprognostic (5.18e-2)" "unprognostic (1.02e-2)" "unprognostic (6.79e-2)" "unprognostic (1.28e-2)" "unprognostic (6.96e-3)" "unprognostic (4.42e-2)" "unprognostic (2.20e-1)" "unprognostic (1.25e-1)" 48.6 7.1 8.6 7.6 9.6 0.2 43.4 3.4 15.4 35.1 9.7 10.8 6.1 5.2 49.5 24.2 19.5 17.0 20.4 23.9 9.6 8.5 18.8 14.6 51.5 17.3 13.8 7.7 17.3 9.6 5.6 6.1 56.1 12.5 24.9 9.1 71.1 12.8 12.2 16.2 15.6 11.5 30.9 8.8 15.6 9.2 10.9 3.0 3.9 20.0 30.1 11.7 13.2 23.1 0.0 6.4 0.0 0.1 0.0 0.3 0.0 0.0 0.4 1.9 0.0 47.1 2.4 1.5 0.3 0.7 3.9 1.9 4.3 0.0 0.0 31.4 1.1 0.2 0.0 1.8 0.0 3.3 0.0 0.0 0.0 0.3 1.3 1.2 0.0 0.0 1.7 0.0 0.6 0.1 1.3 14.1 0.5 0.0 0.1 0.2 0.0 0.2 0.3 9.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.9 3.9 1.1 0.0 6.4 1.9 0.4 1.2 2.6 7.6 2.8 0.2 0.9 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.3 0.0 8.6 9.6 3.4 15.4 9.6 8.5 13.8 7.7 12.5 3.0 0.0 10.1 5.1 4.4 30.6 0.1 1.7 0.0 0.0 1.2 3.5 0.0 1.0 3.3 0.7 1.1 348.5 0.0 0.0 0.6 1.2 42.9 4.5 0.0 0.9 2.8 0.0 4.1 252.3 12.4 3.1 35.9 3.2 21.9 4.6 0.0 8.9 0.0 0.0 20.5 0.4 1.6 6.5 9.5 11.2 60.0 24.1 1.3 2.5 0.0 4.1 RAMP3 ENSG00000122679 "Receptor activity modifying protein 3" O60896 7 45157791-45186302 "FDA approved drug targets, Predicted membrane proteins" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 8 "Endothelial cells: 183.2;Ito cells: 555.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.7" "Lineage enhanced" "Detected in single" "granulocytes: 2.7" "Cell line enriched" "Detected in some" 7 "Karpas-707: 7.6" "Group enriched" "Detected in many" 5 "cerebellum: 69.9;cerebral cortex: 50.2;thalamus: 191.1" "Low region specificity" "Detected in all" NA NA "unprognostic (1.62e-3)" "prognostic favorable (2.89e-4)" "unprognostic (4.85e-2)" "unprognostic (6.88e-3)" "unprognostic (3.68e-2)" "unprognostic (1.44e-3)" "prognostic favorable (2.50e-6)" "unprognostic (1.14e-1)" "unprognostic (2.35e-1)" "unprognostic (3.19e-1)" "unprognostic (2.79e-2)" "unprognostic (9.49e-2)" "unprognostic (1.09e-2)" "unprognostic (1.20e-2)" "unprognostic (2.43e-1)" "unprognostic (1.91e-1)" "unprognostic (9.21e-2)" 34.7 10.4 5.4 11.0 3.8 0.1 23.7 1.7 5.9 17.0 8.3 10.0 5.0 5.3 14.2 7.2 12.1 7.4 18.3 34.6 5.5 7.5 23.9 12.6 53.7 24.5 11.4 2.3 6.6 6.5 10.6 8.4 6.2 16.6 11.0 4.7 26.5 7.8 8.3 13.9 7.5 9.1 13.1 37.3 4.1 8.3 6.3 6.4 1.0 24.3 14.5 15.6 18.6 17.9 0.0 0.1 2.7 0.0 0.0 0.7 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.6 0.0 0.0 0.2 0.6 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.7 0.3 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.7 5.4 3.8 1.7 5.9 5.5 7.5 11.4 2.3 16.6 6.4 0.0 3.4 4.5 0.4 14.4 0.6 7.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 183.2 0.0 0.0 0.6 0.0 5.1 0.4 0.0 5.9 0.4 0.0 0.0 555.5 44.3 4.7 1.1 1.7 25.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 6.2 0.3 0.9 12.7 0.0 1.9 0.0 0.4 RAP1B "DKFZp586H0723, K-REV, RAL1B" ENSG00000127314 "RAP1B, member of RAS oncogene family" P61224 12 68610839-68671901 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.20e-1)" "unprognostic (1.47e-3)" "unprognostic (1.11e-1)" "unprognostic (1.20e-1)" "unprognostic (4.15e-2)" "unprognostic (7.23e-2)" "unprognostic (1.60e-3)" "unprognostic (1.48e-1)" "unprognostic (5.83e-2)" "unprognostic (1.80e-1)" "unprognostic (2.01e-2)" "unprognostic (2.86e-1)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.08e-1)" "unprognostic (8.86e-2)" "unprognostic (7.86e-2)" "unprognostic (3.22e-1)" 46.7 31.4 19.0 38.0 27.2 58.0 43.7 16.1 20.5 29.5 33.2 21.9 29.0 19.8 38.7 27.9 26.6 26.9 31.8 27.1 21.5 20.1 36.9 33.8 44.1 60.3 22.5 19.9 34.2 20.8 13.1 23.4 52.1 26.1 31.1 27.6 20.9 24.3 34.9 21.3 25.7 31.1 35.5 27.1 52.7 26.8 51.8 21.2 45.1 26.2 20.2 42.1 44.5 29.7 23.3 30.0 47.7 66.2 68.8 56.0 101.6 29.2 20.0 23.6 20.1 50.0 40.2 21.6 62.7 38.3 41.6 31.7 26.6 19.7 41.5 36.2 87.0 19.2 17.1 22.2 30.6 59.2 73.3 19.2 107.3 23.9 17.8 58.6 41.2 63.0 40.1 31.4 44.6 53.9 33.9 45.3 35.1 37.9 68.4 41.5 18.8 38.5 53.2 26.7 12.9 29.1 34.7 28.0 31.0 31.6 73.2 9.2 14.4 31.6 19.1 30.4 28.3 24.5 48.8 49.8 37.9 17.0 42.4 34.1 35.1 64.7 50.4 35.0 28.5 32.2 47.7 32.6 30.6 56.0 61.2 36.1 23.3 34.6 48.3 30.0 19.9 37.7 50.9 23.4 68.8 66.2 15.2 27.6 101.6 19.0 27.2 16.1 20.5 21.5 20.1 22.5 19.9 26.1 21.2 74.5 75.9 84.0 50.6 261.6 13.4 12.5 22.9 87.0 78.5 76.8 21.6 29.3 92.9 140.7 73.0 79.3 96.2 23.3 114.5 63.0 64.9 54.5 146.4 28.8 70.4 31.8 181.8 86.5 103.3 30.4 35.9 233.8 178.8 316.6 54.0 24.1 139.4 91.2 34.3 143.1 21.4 6.5 193.6 29.8 44.3 260.3 129.2 191.8 51.1 89.9 RARG "NR1B3, RARC" ENSG00000172819 "Retinoic acid receptor gamma" P13631 12 53210567-53232980 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 49.4;skin 1: 52.1" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 30.3;Suprabasal keratinocytes: 48.8;Urothelial cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 17.0" "Group enriched" "Detected in all" 4 "dendritic cells: 5.6;T-cells: 17.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 33.3;MCF7: 35.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053883 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA053883: AB_2682292" "unprognostic (7.29e-2)" "unprognostic (1.95e-2)" "unprognostic (6.11e-2)" "prognostic unfavorable (3.68e-6)" "unprognostic (2.53e-1)" "unprognostic (5.43e-2)" "unprognostic (2.28e-1)" "unprognostic (1.08e-2)" "unprognostic (3.54e-3)" "unprognostic (7.21e-3)" "unprognostic (3.78e-3)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.08e-6)" "unprognostic (5.41e-3)" "unprognostic (1.98e-2)" "unprognostic (5.94e-3)" "unprognostic (7.41e-2)" 4.8 5.0 2.7 7.0 3.6 1.3 10.8 6.3 3.8 26.8 6.3 1.8 7.3 1.0 14.6 6.0 49.4 10.6 8.6 6.9 3.0 1.4 3.7 1.9 7.4 6.7 2.4 2.3 12.6 2.7 4.2 2.8 4.4 1.6 11.3 3.4 10.3 9.5 10.6 2.6 52.1 3.0 9.7 1.5 4.7 6.0 3.9 1.7 2.3 7.3 30.6 26.8 10.9 19.8 1.8 5.6 1.5 2.5 1.7 17.0 2.9 7.2 8.0 1.8 16.9 18.9 16.2 0.5 7.6 16.6 10.0 7.9 2.7 33.3 0.1 4.2 30.6 5.4 24.5 6.1 14.6 2.5 1.9 3.1 1.0 6.1 2.3 8.0 0.0 3.0 12.0 21.5 9.5 2.1 25.3 4.2 1.5 0.2 3.2 3.9 35.1 0.4 0.3 5.4 9.8 14.2 2.3 0.6 5.8 3.0 12.0 1.5 7.6 15.5 16.8 10.2 2.4 14.5 0.4 4.5 12.0 5.7 7.9 0.4 1.5 0.8 0.5 14.8 1.2 17.0 1.5 2.5 0.7 6.6 0.8 17.0 1.8 5.7 4.8 5.6 0.6 4.8 4.1 0.0 1.7 0.0 0.4 1.5 2.9 2.7 3.6 6.3 3.8 3.0 1.4 2.4 2.3 1.6 1.7 3.0 6.5 0.0 19.4 30.3 0.7 2.8 5.1 0.0 2.3 3.5 2.0 7.2 0.0 8.7 0.0 6.9 0.4 0.0 4.5 0.7 19.6 11.9 1.1 0.0 2.3 0.0 1.7 20.9 5.2 0.2 4.9 2.8 8.5 1.8 1.6 2.9 9.8 3.5 4.9 0.6 4.9 6.5 12.2 0.4 4.1 48.8 1.5 5.7 5.2 33.4 RARRES3 "HRASLS4, TIG3" ENSG00000133321 "Retinoic acid receptor responder 3" Q9UL19 11 63536809-63546462 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 86.6" "Cell type enhanced" "Detected in many" 9 "Proximal tubular cells: 687.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 60.2;HHSteC: 22.0;HSkMC: 22.0;RPTEC TERT1: 30.5;SK-BR-3: 46.1;U-266/70: 23.0" NA NA "prognostic favorable (1.35e-5)" "prognostic favorable (4.00e-4)" "unprognostic (4.12e-2)" "unprognostic (1.37e-1)" "unprognostic (3.30e-1)" "unprognostic (2.45e-2)" "unprognostic (2.11e-1)" "unprognostic (6.91e-2)" "unprognostic (1.78e-1)" "unprognostic (2.92e-2)" "prognostic unfavorable (6.26e-6)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (3.42e-1)" "unprognostic (2.11e-1)" "unprognostic (9.36e-3)" "unprognostic (2.64e-1)" 13.3 5.9 15.0 16.4 14.6 4.6 30.9 3.1 10.6 13.7 32.7 12.9 12.5 25.1 16.0 18.6 12.1 29.7 21.0 7.3 11.7 10.2 86.6 31.8 36.5 23.5 12.1 10.8 23.1 8.2 0.2 7.9 5.8 8.7 25.0 16.8 9.8 25.4 23.5 7.1 2.6 50.0 12.6 15.0 21.6 18.0 5.4 11.4 24.0 66.4 8.5 17.0 14.3 7.5 10.9 6.6 30.8 15.4 33.3 66.1 63.1 5.8 3.6 0.0 0.1 5.5 19.1 1.3 0.5 10.1 7.7 7.0 0.1 60.2 0.9 5.1 1.0 6.1 1.6 1.3 1.0 1.6 9.9 0.0 0.3 0.4 0.0 22.0 0.1 0.2 22.0 0.1 2.9 0.0 16.2 0.9 2.0 0.0 7.7 1.1 0.0 14.1 1.1 0.0 0.9 0.5 6.4 0.0 0.4 30.5 1.2 0.0 0.0 1.2 46.1 2.4 0.3 5.4 0.4 1.7 0.5 0.0 1.1 0.2 23.0 0.3 0.2 2.3 3.6 0.4 30.8 11.3 7.1 63.6 15.4 47.3 10.9 47.6 66.1 6.6 7.2 41.5 53.7 8.4 33.3 12.5 0.8 35.7 63.1 15.0 14.6 3.1 10.6 11.7 10.2 12.1 10.8 8.7 11.4 291.8 62.1 57.5 128.0 17.3 0.2 5.0 76.5 232.9 87.6 82.0 0.0 11.3 252.0 40.6 0.1 30.9 264.6 0.0 98.0 19.1 35.1 48.0 63.4 78.1 25.0 0.0 20.1 56.4 44.3 1.1 68.7 43.5 13.5 14.4 46.4 43.6 91.5 259.6 19.1 687.8 1.1 6.5 15.5 0.4 0.0 11.2 25.2 276.7 11.5 252.0 RBFOX3 "FOX-3, HRNBP3, NeuN" ENSG00000167281 "RNA binding fox-1 homolog 3" A6NFN3 17 79089345-79516148 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.4;seminal vesicle: 21.5" "Cell type enhanced" "Detected in many" 12 "Glandular cells: 12.8;Peritubular cells: 9.9;Spermatogonia: 21.3" "Cancer enhanced" "Detected in some" "prostate cancer: 1.1" "Region enhanced" "Detected in all" "cerebellum: 60.4" "Cell type enhanced" "Detected in single" "gdT-cell: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A549: 13.2;NTERA-2: 11.9;SCLC-21H: 19.2;U-2 OS: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030790, HPA075862, CAB078782" Enhanced Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB078782: , HPA030790: AB_10602305, HPA075862: " "unprognostic (2.84e-1)" "unprognostic (1.88e-1)" "unprognostic (4.10e-2)" "unprognostic (9.23e-3)" "unprognostic (8.85e-2)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (1.09e-1)" "unprognostic (7.72e-2)" "unprognostic (1.50e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (3.22e-15)" "unprognostic (8.92e-3)" "unprognostic (1.92e-1)" "unprognostic (1.61e-1)" "unprognostic (1.88e-1)" 0.5 1.0 10.2 0.6 23.5 0.6 0.2 60.4 33.2 0.5 15.2 0.3 0.2 1.5 9.3 3.0 8.3 1.0 0.3 0.3 8.6 3.3 0.4 0.2 0.3 0.4 1.8 3.5 0.3 0.5 0.2 0.9 0.3 5.5 13.2 2.2 0.2 0.2 21.5 0.3 0.3 1.3 8.1 2.3 0.4 0.5 7.2 5.6 0.2 0.3 0.2 0.2 15.2 1.0 0.7 0.2 0.0 0.7 0.0 1.4 0.2 0.0 13.2 0.2 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 11.9 0.0 0.2 0.2 0.5 0.0 0.0 0.0 19.2 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 9.0 0.5 0.0 0.8 0.0 0.3 0.4 0.3 0.0 0.0 0.7 0.0 1.4 0.3 0.0 0.7 0.1 0.4 0.2 0.7 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.2 10.2 23.5 60.4 19.5 8.6 3.3 1.8 3.5 5.5 5.6 0.0 0.0 0.0 4.7 1.8 2.5 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.8 0.4 0.0 0.0 0.0 0.1 1.0 12.8 0.0 0.0 0.1 4.8 0.0 0.0 0.8 7.1 0.3 0.7 5.0 0.0 0.0 1.0 0.0 0.0 9.9 0.0 3.3 0.0 2.3 0.7 21.3 1.3 0.1 2.1 0.0 2.0 RBM3 IS1-RNPL ENSG00000102317 "RNA binding motif protein 3" P98179 X 48574449-48579066 "Predicted intracellular proteins" "Stress response" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Exocrine glandular cells: 1250.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003624, CAB062559" Enhanced Enhanced Nucleoplasm NA NA 24000 Nucleoplasm "CAB062559: AB_2665621, HPA003624: AB_10602123" "unprognostic (1.07e-2)" "unprognostic (1.14e-3)" "prognostic favorable (3.07e-7)" "unprognostic (1.65e-3)" "unprognostic (2.87e-1)" "unprognostic (4.05e-2)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (9.37e-2)" "unprognostic (1.63e-2)" "unprognostic (2.65e-2)" "unprognostic (2.02e-2)" "unprognostic (6.18e-2)" "unprognostic (1.10e-1)" "unprognostic (5.05e-2)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 71.2 25.5 12.6 43.0 13.9 59.0 52.2 16.4 22.5 44.7 32.7 20.9 16.4 23.9 38.5 58.2 46.4 32.9 36.4 44.8 12.2 12.3 53.5 32.9 36.8 115.8 15.0 15.2 38.6 43.2 15.2 19.1 62.2 30.5 21.0 36.0 43.4 39.7 25.0 59.1 56.2 37.8 33.0 23.6 48.4 27.2 27.2 7.4 73.6 24.0 76.8 67.6 46.4 30.1 32.9 56.5 6.4 44.2 29.9 31.8 45.7 20.2 28.4 30.9 32.3 7.7 40.7 19.3 26.4 46.1 66.0 46.1 28.5 53.7 41.8 8.4 53.4 12.9 17.7 26.9 36.0 52.9 38.8 35.7 21.0 46.5 25.4 28.2 57.6 42.9 31.4 25.7 22.2 21.5 8.5 58.5 22.3 11.7 32.5 45.6 34.2 47.8 31.5 17.0 5.4 40.0 46.2 31.6 31.7 28.4 33.7 12.3 30.5 26.4 34.7 28.8 15.5 45.9 57.3 78.8 21.6 35.0 74.7 43.9 16.1 17.6 47.0 32.4 34.6 43.9 5.8 38.4 6.2 27.0 44.2 31.8 32.9 27.6 26.7 56.5 20.5 28.2 27.4 6.4 29.9 37.5 39.1 28.6 45.7 12.6 13.9 16.4 22.5 12.2 12.3 15.0 15.2 30.5 7.4 154.9 140.4 318.0 135.2 461.5 60.5 71.4 114.7 91.0 153.6 50.6 45.2 435.3 149.2 258.9 4.9 222.6 136.8 70.0 1250.6 594.7 406.0 86.3 255.6 72.3 381.7 39.7 237.4 173.7 454.7 10.5 227.6 401.8 496.0 551.0 243.6 125.2 635.6 224.5 138.6 113.6 76.3 129.4 465.6 25.6 174.8 443.8 409.2 335.1 293.7 176.9 RCE1 "FACE-2, FACE2, hRCE1, RCE1A, RCE1B" ENSG00000173653 "Ras converting CAAX endopeptidase 1" Q9Y256 11 66842835-66846546 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074124 Approved NA NA "HPA074124: " "unprognostic (1.11e-1)" "unprognostic (7.23e-2)" "unprognostic (1.15e-1)" "unprognostic (8.16e-3)" "unprognostic (3.11e-1)" "unprognostic (6.40e-3)" "unprognostic (1.98e-3)" "unprognostic (7.69e-3)" "unprognostic (1.39e-1)" "unprognostic (9.14e-3)" "unprognostic (2.35e-3)" "unprognostic (5.31e-3)" "unprognostic (1.06e-1)" "unprognostic (4.48e-3)" "unprognostic (2.17e-2)" "unprognostic (1.04e-1)" "unprognostic (4.28e-2)" 12.3 9.0 7.6 11.9 9.4 19.5 15.9 27.5 9.4 10.8 13.0 9.2 9.3 11.3 10.9 11.8 15.9 9.6 9.7 5.9 6.6 9.4 13.7 7.4 9.7 17.6 8.9 5.1 13.2 23.9 10.2 12.6 20.8 5.6 13.7 9.5 11.2 14.9 13.9 5.6 22.1 13.0 6.7 5.0 12.0 10.2 17.1 5.4 14.8 14.3 10.5 13.6 9.9 9.9 11.4 22.0 12.2 17.9 10.0 17.1 12.4 10.7 12.1 7.4 6.9 4.6 4.1 16.2 5.7 5.6 8.9 8.1 22.6 23.3 8.1 10.8 5.4 15.0 19.4 8.6 8.6 5.3 9.7 9.6 7.3 8.5 8.7 16.5 9.2 11.0 6.5 16.6 10.1 9.0 7.0 7.3 11.6 10.0 12.9 4.5 20.7 13.3 18.3 21.6 21.1 12.4 10.7 5.3 15.9 9.8 5.9 9.2 8.3 8.0 11.2 35.3 7.7 13.1 7.9 4.3 12.4 9.3 13.3 8.8 6.9 7.0 9.0 8.3 9.8 8.9 12.2 15.6 10.7 13.7 17.9 12.5 11.4 11.5 17.1 14.4 9.0 9.4 14.3 5.1 10.0 15.3 22.0 4.8 12.4 7.6 9.4 27.5 9.4 6.6 9.4 8.9 5.1 5.6 5.4 0.0 4.5 16.1 22.5 27.7 8.9 1.4 10.2 2.7 4.5 15.7 27.5 46.9 3.3 23.0 7.7 10.5 12.3 0.0 23.8 50.4 13.2 13.3 8.1 2.4 20.4 3.2 10.3 8.0 9.1 17.1 6.4 11.8 13.5 14.4 12.8 5.7 23.5 19.5 6.0 7.1 17.4 12.9 11.3 10.3 26.6 21.8 49.0 14.9 15.0 21.6 RDH10 SDR16C4 ENSG00000121039 "Retinol dehydrogenase 10" Q8IZV5 8 73294612-73325281 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 134.3" "Group enriched" "Detected in many" 5 "Collecting duct cells: 193.7;Muller glia cells: 296.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.4" "Group enriched" "Detected in many" 5 "granulocytes: 4.4;T-cells: 2.3" "Cell line enhanced" "Detected in many" "ASC diff: 46.8;BJ: 33.5;CACO-2: 29.9;HDLM-2: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049199 Supported "Lipid droplets" NA NA "Lipid droplets" "HPA049199: AB_2680673" "unprognostic (1.78e-1)" "unprognostic (1.23e-1)" "unprognostic (8.86e-2)" "unprognostic (2.52e-1)" "unprognostic (2.45e-2)" "unprognostic (1.13e-2)" "unprognostic (1.14e-1)" "unprognostic (2.80e-2)" "unprognostic (7.87e-2)" "unprognostic (7.98e-2)" "unprognostic (1.18e-3)" "unprognostic (8.88e-3)" "unprognostic (1.13e-2)" "unprognostic (4.38e-2)" "unprognostic (1.67e-1)" "unprognostic (2.98e-3)" "unprognostic (6.23e-2)" 18.3 3.2 2.7 9.5 3.3 0.7 11.8 1.7 2.8 8.2 18.7 2.9 10.0 13.6 5.9 5.8 9.4 4.4 21.9 9.6 2.3 2.4 19.6 37.5 8.7 4.8 4.1 1.7 4.9 14.8 3.7 17.9 20.9 8.7 12.4 6.4 134.3 22.6 5.7 3.4 4.4 34.1 14.0 6.9 5.6 15.3 8.0 2.1 2.0 3.5 7.3 6.5 12.8 6.5 0.6 0.7 4.4 0.6 0.2 2.3 0.5 4.2 12.2 1.3 5.6 46.8 3.4 12.4 33.5 5.4 1.3 2.2 29.9 12.1 2.9 4.4 18.7 2.0 11.1 6.1 4.8 2.7 33.6 15.4 5.2 12.0 9.2 1.8 2.4 5.7 2.0 6.2 5.2 4.9 5.9 4.9 2.9 5.9 4.3 2.2 1.8 2.5 1.0 1.6 25.8 6.0 2.2 1.4 1.7 9.1 6.0 0.8 1.0 2.8 20.9 1.7 1.8 4.1 1.3 7.4 2.0 3.4 9.2 2.5 2.8 2.9 2.4 1.6 2.2 4.6 4.4 0.6 1.1 1.2 0.3 0.7 0.6 1.3 1.4 0.7 0.1 2.3 1.2 0.8 0.2 0.5 0.2 0.7 0.5 2.7 3.3 1.7 1.8 2.3 2.4 4.1 1.7 8.7 2.1 11.9 28.0 0.0 8.6 11.9 3.0 8.1 30.6 20.1 18.2 193.7 21.6 15.7 3.3 12.8 53.9 10.3 25.7 0.0 15.2 16.8 18.4 19.0 2.3 35.0 16.7 3.2 4.1 1.8 4.0 5.2 2.6 6.0 16.9 0.0 13.1 296.7 39.0 25.9 3.5 18.6 10.4 0.0 8.2 9.3 5.3 12.2 35.1 2.2 14.1 16.0 RDH11 "ARSDR1, MDT1, SDR7C1" ENSG00000072042 "Retinol dehydrogenase 11 (all-trans/9-cis/11-cis)" Q8TC12 14 67676801-67695814 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Cataract, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 204.2" "Cell type enhanced" "Detected in all" 7 "Glandular cells: 335.2;Muller glia cells: 352.2" "Cancer enriched" "Detected in all" 13 "prostate cancer: 286.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB046011 Enhanced "Intracellular and membrane" NA NA 9100000 "CAB046011: AB_11129613" "unprognostic (1.38e-1)" "unprognostic (6.86e-3)" "unprognostic (1.77e-1)" "prognostic favorable (2.62e-4)" "unprognostic (6.06e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (9.29e-2)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (3.58e-2)" "unprognostic (2.91e-2)" "unprognostic (1.27e-1)" "prognostic favorable (1.30e-7)" "unprognostic (1.65e-1)" "unprognostic (1.68e-1)" "unprognostic (2.18e-1)" "unprognostic (4.74e-2)" 8.8 24.9 18.3 8.9 19.0 5.1 10.8 15.7 25.3 13.0 10.8 24.3 16.1 12.3 13.0 31.4 13.6 9.3 15.6 7.2 18.5 19.9 40.7 51.6 12.6 7.2 21.8 16.6 11.4 15.3 28.7 13.1 8.3 31.1 204.2 12.0 40.4 16.2 13.5 3.6 11.2 10.2 15.8 32.5 10.8 11.6 10.3 15.8 12.5 24.2 8.1 9.5 14.8 11.4 11.5 17.0 62.4 19.7 14.4 20.8 28.2 47.8 21.8 19.4 22.0 31.0 28.2 16.2 18.2 36.1 22.9 41.6 18.1 58.3 8.3 14.1 17.1 28.6 38.4 27.9 40.2 31.3 16.7 11.3 17.2 11.6 17.9 29.9 6.3 12.6 26.3 26.7 29.8 25.3 17.5 26.1 23.1 13.4 27.5 20.8 25.4 18.5 9.9 10.9 13.0 25.1 14.1 24.0 11.9 52.4 24.7 20.2 16.9 19.2 24.3 25.4 16.5 27.2 10.0 20.1 24.7 28.2 10.5 13.0 13.0 10.3 10.8 32.1 17.7 20.0 62.4 19.7 28.2 18.7 16.1 20.4 11.3 20.5 18.5 14.5 11.5 20.8 20.1 3.3 14.4 16.9 17.0 17.6 28.2 18.3 19.0 15.7 25.3 18.5 19.9 21.8 16.6 31.1 15.8 23.8 57.7 45.5 30.5 10.2 50.0 15.5 73.9 22.7 28.4 45.4 47.1 23.0 6.6 75.7 1.9 38.4 22.6 46.7 73.5 33.5 32.0 335.2 28.8 124.8 32.2 74.7 41.6 54.0 39.8 5.1 40.0 33.9 33.7 38.7 21.8 352.2 48.1 34.5 52.6 56.8 94.6 45.3 30.9 19.1 14.3 16.8 53.1 30.8 15.7 29.3 RDH14 "PAN2, SDR7C4" ENSG00000240857 "Retinol dehydrogenase 14" Q9HBH5 2 18554723-18560680 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056686, HPA078577" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA056686: AB_2683209, HPA078577: " "unprognostic (5.79e-2)" "unprognostic (3.96e-2)" "unprognostic (1.64e-1)" "unprognostic (7.03e-2)" "unprognostic (1.99e-2)" "unprognostic (8.71e-3)" "unprognostic (1.11e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.83e-3)" "unprognostic (6.41e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-1)" "unprognostic (8.98e-2)" "unprognostic (1.58e-2)" "unprognostic (4.32e-2)" "unprognostic (3.69e-2)" 13.8 16.2 10.7 8.7 14.3 5.1 14.0 14.2 15.4 11.3 14.1 11.0 9.6 12.7 16.2 14.3 16.0 12.7 11.0 29.0 12.2 10.4 23.0 22.1 12.5 14.6 11.7 9.0 11.7 21.0 23.5 13.5 14.2 13.2 20.7 12.0 10.6 13.8 13.1 27.8 9.9 16.3 22.9 10.3 15.4 15.9 11.1 8.8 17.4 18.1 13.6 10.7 18.1 17.9 9.9 7.6 7.2 2.0 3.7 7.6 1.6 18.6 5.9 5.0 4.1 15.1 16.1 16.8 11.4 11.7 10.3 10.3 4.6 9.7 18.4 6.8 6.8 13.4 10.2 7.2 13.3 12.1 10.2 19.8 7.2 6.5 13.8 12.9 8.7 9.8 12.2 13.6 10.0 15.7 14.5 9.5 7.5 12.8 6.3 16.9 6.0 7.5 15.4 13.5 14.3 16.9 11.0 13.6 7.9 20.2 12.2 7.7 13.4 6.2 13.7 16.2 10.9 6.8 5.0 9.5 14.7 9.1 11.6 13.5 17.9 14.7 13.7 10.5 6.0 11.5 1.7 1.8 7.2 4.4 2.0 7.6 7.4 5.1 6.3 2.3 9.9 7.3 6.0 0.8 3.7 1.9 7.6 5.8 1.6 10.7 14.3 14.2 15.4 12.2 10.4 11.7 9.0 13.2 8.8 14.9 10.9 21.4 26.0 21.8 22.4 43.0 22.9 2.7 6.8 15.7 5.9 40.0 26.6 32.8 16.1 17.9 14.0 0.0 30.8 42.8 33.7 31.0 12.7 26.8 21.0 14.3 12.7 17.2 15.1 9.4 61.9 14.8 21.9 22.6 27.1 25.0 23.9 32.3 42.1 30.5 18.0 32.3 30.7 71.9 28.2 16.3 38.2 17.5 29.8 23.7 RDM1 "MGC33977, RAD52B" ENSG00000278023 "RAD52 motif containing 1" Q8NG50 17 35918066-35930773 "Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.7;lymphoid tissue: 6.2;testis: 24.0" "Group enriched" "Detected in some" 16 "Early spermatids: 50.7;Late spermatids: 58.2;Spermatocytes: 19.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 5.7" "Group enriched" "Detected in many" 14 "NK-cells: 1.5;T-cells: 5.7" "Cell line enhanced" "Detected in many" "CACO-2: 10.2;JURKAT: 14.1;T-47d: 16.7" "Low region specificity" "Detected in all" "HPA024794, HPA067546" Enhanced Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA024794: AB_1856039, HPA067546: AB_2732769" "unprognostic (9.36e-2)" "unprognostic (2.40e-2)" "unprognostic (8.00e-2)" "unprognostic (4.57e-3)" "unprognostic (1.91e-2)" "unprognostic (1.26e-1)" "unprognostic (2.06e-4)" "unprognostic (5.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.71e-2)" "unprognostic (2.58e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-8)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (7.00e-3)" "unprognostic (1.53e-1)" 0.0 0.0 0.9 0.9 1.2 0.6 0.0 0.0 1.8 0.0 0.9 0.1 0.0 1.3 0.2 0.7 0.3 0.1 0.3 0.0 1.0 0.1 0.0 0.1 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.2 0.2 1.7 0.0 0.0 0.0 0.0 1.1 1.5 0.1 0.2 0.1 1.1 24.0 0.0 6.2 0.3 0.0 2.8 0.0 0.0 0.1 0.2 0.0 0.0 1.5 5.7 0.3 5.7 6.8 1.3 2.4 0.1 0.0 2.1 1.4 0.1 0.8 1.3 10.2 5.7 6.3 2.8 0.4 3.8 0.9 3.9 1.7 3.9 1.5 8.0 4.1 1.8 0.0 0.0 0.2 2.9 0.0 0.7 0.5 0.4 1.0 0.1 14.1 1.8 0.0 0.5 2.3 2.2 2.2 0.9 5.0 2.5 0.7 0.0 0.0 1.5 3.3 4.6 0.8 1.8 1.7 2.5 3.7 16.7 0.3 0.0 0.1 2.0 0.0 0.4 5.3 1.9 2.2 3.3 2.3 1.0 0.0 0.0 0.0 1.4 0.0 2.3 0.1 1.6 5.7 0.2 0.0 0.0 0.7 0.0 1.5 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 50.7 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.0 0.4 1.4 0.0 1.2 0.6 0.0 58.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 19.7 2.6 0.0 0.6 0.0 0.6 0.3 RECK "hRECK, ST15" ENSG00000122707 "Reversion inducing cysteine rich protein with kazal motifs" O95980 9 36036433-36124451 "Plasma proteins, Predicted membrane proteins" "Wnt signaling pathway" "Protease inhibitor, Serine protease inhibitor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 55.3;ASC TERT1: 44.3;BJ: 17.2;BJ hTERT+: 24.7;fHDF/TERT166: 15.2;HSkMC: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025109, HPA071729" Supported Supported "Plasma membrane" NA NA 37000000 "Plasma membrane" "CAB025109: , HPA071729: AB_2686438" "unprognostic (3.42e-1)" "unprognostic (4.01e-3)" "unprognostic (5.50e-2)" "unprognostic (5.05e-4)" "unprognostic (8.87e-2)" "unprognostic (8.47e-2)" "unprognostic (2.24e-1)" "unprognostic (2.23e-1)" "unprognostic (3.75e-2)" "unprognostic (1.51e-2)" "unprognostic (9.06e-2)" "unprognostic (8.48e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (7.31e-4)" "unprognostic (2.68e-2)" "unprognostic (1.50e-2)" "unprognostic (3.60e-2)" 15.9 8.9 6.9 6.3 8.2 1.5 31.7 9.1 7.8 18.9 10.2 8.5 6.2 4.3 18.4 7.5 13.7 12.0 15.6 11.3 8.4 4.9 6.9 6.7 16.7 6.1 8.3 4.9 17.2 3.9 3.7 7.8 12.7 8.3 12.3 7.6 10.5 7.8 8.9 5.7 8.7 7.7 17.3 7.9 8.1 9.8 7.9 8.5 8.4 10.5 9.8 6.2 17.8 16.8 3.5 3.7 1.2 5.5 3.6 8.9 3.1 0.3 0.6 2.1 1.1 55.3 44.3 0.0 17.2 24.7 1.2 3.0 0.0 0.0 0.6 1.6 15.2 1.0 0.1 0.4 0.3 1.7 1.0 0.9 0.6 0.7 0.0 4.4 0.0 3.0 19.7 0.4 1.9 0.7 5.0 3.8 1.3 0.0 0.5 3.2 0.0 1.6 0.2 0.7 0.0 0.5 1.7 1.6 0.0 0.8 0.0 0.2 1.2 0.3 0.2 0.6 2.3 0.0 2.3 11.7 2.4 0.9 1.5 0.9 0.7 0.8 0.7 1.5 2.2 1.5 1.2 3.3 0.9 5.4 3.5 6.1 1.7 7.1 5.7 3.7 3.5 8.9 6.4 0.5 3.6 5.5 2.1 3.2 3.1 6.9 8.2 9.1 7.8 8.4 4.9 8.3 4.9 8.3 8.5 3.0 4.8 7.8 2.6 6.4 14.3 1.6 2.5 4.0 2.3 3.5 13.7 0.7 0.0 5.5 30.6 14.3 0.0 0.0 1.3 6.3 15.6 4.0 9.2 0.8 13.1 7.9 5.8 25.8 8.4 31.4 17.3 7.0 3.3 6.4 1.4 17.7 1.8 0.0 16.6 1.5 7.6 0.0 9.9 25.9 24.0 6.6 0.7 8.5 0.9 1.0 REEP1 "C2orf23, FLJ13110, SPG31, Yip2a" ENSG00000068615 "Receptor accessory protein 1" Q9H902 2 86213993-86338083 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 38.6" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 22.1;Ciliated cells: 21.4;Extravillous trophoblasts: 23.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 37.5;HAP1: 8.1;RPMI-8226: 8.4;SCLC-21H: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058061 Enhanced NA NA "HPA058061: AB_2683591" "unprognostic (1.94e-2)" "unprognostic (1.61e-3)" "unprognostic (2.03e-2)" "unprognostic (2.60e-1)" "unprognostic (2.29e-2)" "unprognostic (5.10e-2)" "unprognostic (6.63e-2)" "unprognostic (9.07e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "unprognostic (6.15e-2)" "unprognostic (2.35e-1)" "unprognostic (2.56e-2)" "unprognostic (6.77e-2)" "unprognostic (2.94e-2)" "unprognostic (1.19e-1)" "unprognostic (1.07e-3)" 3.4 6.3 10.1 2.0 16.1 0.5 5.1 6.8 29.4 2.4 19.2 2.5 2.2 4.4 9.8 3.9 6.1 8.3 3.8 9.9 9.0 20.4 2.3 1.5 2.8 0.9 13.9 10.2 1.1 9.1 10.0 7.7 2.5 21.1 6.3 5.1 4.9 1.0 12.6 16.0 1.5 4.5 19.5 4.1 1.9 4.8 38.6 3.0 0.0 1.2 1.8 1.0 10.2 3.4 0.4 0.5 0.2 0.0 0.0 0.6 0.7 0.0 0.0 1.2 1.6 0.0 0.0 37.5 0.0 0.0 2.5 0.3 1.3 0.0 0.0 1.7 0.0 1.9 2.7 8.1 0.0 2.2 0.0 4.4 0.0 2.9 0.2 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.0 0.0 3.6 8.4 0.2 0.1 17.7 1.7 1.8 0.9 0.1 0.8 2.8 0.5 0.0 0.0 1.3 0.7 3.3 4.0 2.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.0 0.5 0.0 0.7 10.1 16.1 6.8 19.7 9.0 20.4 13.9 10.2 21.1 3.0 8.9 0.3 0.5 0.2 1.8 10.8 22.1 2.5 21.4 4.5 0.0 2.0 1.1 1.7 3.7 12.3 3.2 0.0 0.0 5.2 23.2 0.8 1.8 0.0 0.0 0.7 3.2 4.6 17.8 1.5 10.4 2.3 0.9 1.7 1.0 0.0 13.0 4.6 0.0 3.2 4.2 15.1 19.4 12.2 5.0 2.2 1.0 5.5 0.0 0.4 0.3 REEP2 "C5orf19, SGC32445, SPG72, Yip2d" ENSG00000132563 "Receptor accessory protein 2" Q9BRK0 5 138439017-138446969 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.9" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 50.6;Cone photoreceptor cells: 66.8;Horizontal cells: 46.1;Rod photoreceptor cells: 59.8" "Cancer enriched" "Detected in many" 9 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 21 "dendritic cells: 1.0;T-cells: 3.2" "Cell line enhanced" "Detected in many" "AN3-CA: 41.9;SCLC-21H: 17.6;SH-SY5Y: 19.8;U-87 MG: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031813, HPA076571" Enhanced Approved Cytosol NA NA Cytosol "HPA031813: AB_2674054, HPA076571: " "prognostic favorable (7.83e-5)" "unprognostic (1.11e-2)" "unprognostic (3.97e-6)" "unprognostic (3.70e-3)" "prognostic unfavorable (6.65e-4)" "unprognostic (5.43e-2)" "unprognostic (1.62e-2)" "unprognostic (1.04e-1)" "prognostic favorable (9.31e-4)" "unprognostic (5.93e-2)" "unprognostic (3.70e-3)" "unprognostic (9.78e-2)" "unprognostic (6.54e-3)" "unprognostic (7.54e-2)" "unprognostic (1.47e-3)" "unprognostic (6.19e-3)" "unprognostic (1.13e-3)" 5.2 10.9 27.2 3.4 27.2 1.2 2.0 37.0 58.9 3.0 4.4 5.9 0.4 2.8 3.7 2.6 5.6 2.8 3.6 10.5 29.3 32.1 1.6 1.0 1.5 1.4 27.9 19.6 3.5 2.9 2.8 13.9 1.6 25.8 6.1 3.3 7.9 2.1 9.9 15.6 2.0 3.1 13.6 9.7 1.2 2.2 4.5 6.3 0.0 1.4 0.5 1.5 4.1 1.1 0.0 1.0 0.0 0.0 0.0 3.2 0.3 0.2 3.1 12.0 41.9 1.8 4.7 0.0 3.6 1.7 4.9 5.7 2.2 0.4 0.0 0.6 4.4 0.1 0.2 11.4 2.3 3.8 1.2 10.1 0.0 0.8 5.4 4.4 0.0 0.0 1.5 0.1 2.8 0.2 8.9 1.0 11.7 0.0 3.0 1.6 1.8 1.0 0.7 7.4 0.0 0.1 4.0 1.1 0.0 0.9 0.0 17.6 19.8 1.2 0.0 3.0 3.2 1.1 0.4 0.1 2.8 2.9 2.7 6.7 7.8 4.9 0.3 15.8 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 3.2 0.3 27.2 27.2 37.0 35.6 29.3 32.1 27.9 19.6 25.8 6.3 0.0 0.0 0.0 0.8 0.6 50.6 8.7 0.0 0.0 0.0 1.8 66.8 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.1 46.1 4.6 0.6 0.0 4.7 0.0 0.0 0.0 0.0 0.0 16.1 0.1 0.0 2.5 0.2 59.8 0.0 3.4 0.4 3.0 0.4 0.0 0.0 0.0 0.1 REEP3 "C10orf74, Yip2b" ENSG00000165476 "Receptor accessory protein 3" Q6NUK4 10 63521363-63625123 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 295.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.85e-2)" "unprognostic (7.07e-3)" "unprognostic (2.89e-2)" "unprognostic (6.25e-2)" "unprognostic (3.50e-3)" "prognostic unfavorable (7.83e-4)" "prognostic unfavorable (3.19e-4)" "unprognostic (1.13e-2)" "unprognostic (9.33e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (1.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.89e-2)" "unprognostic (6.82e-2)" "unprognostic (2.18e-1)" "unprognostic (4.06e-2)" 17.2 14.3 12.0 6.7 17.2 1.1 13.0 27.9 11.4 18.0 19.0 31.2 18.1 19.6 16.5 12.0 12.4 7.8 11.1 9.7 14.4 8.1 12.0 18.0 14.4 5.6 26.1 6.6 8.4 9.4 26.5 11.7 17.2 16.2 15.9 12.3 10.4 13.3 17.5 5.7 10.7 31.7 18.3 24.8 7.4 15.2 15.0 20.0 4.3 15.0 4.2 6.0 16.3 10.4 3.3 5.2 3.3 7.4 2.8 8.4 2.4 18.6 8.4 7.8 7.5 29.0 28.9 8.8 14.3 23.7 10.9 15.5 11.8 29.0 1.7 5.4 20.7 3.6 22.1 3.1 20.0 19.4 5.6 6.4 3.9 3.8 7.5 18.8 4.3 0.1 24.2 15.7 15.3 23.3 27.2 18.9 2.3 1.9 8.5 19.8 5.6 3.1 6.7 2.7 3.5 18.0 5.6 5.3 3.5 15.6 11.0 2.3 7.9 13.2 13.0 12.0 11.6 12.8 10.0 14.2 10.5 3.2 9.4 10.9 7.3 11.1 2.6 9.5 0.0 10.9 0.1 5.3 3.3 2.8 7.4 5.9 3.3 6.1 4.2 4.8 2.7 2.4 3.3 2.4 2.8 4.8 5.2 8.4 2.4 12.0 17.2 27.9 11.4 14.4 8.1 26.1 6.6 16.2 20.0 26.8 25.4 21.6 75.2 57.4 13.1 24.3 38.2 26.8 22.7 78.5 25.5 56.1 24.9 62.3 295.1 61.0 120.2 0.0 63.3 84.1 59.4 160.7 9.2 60.6 40.7 19.1 41.2 58.3 33.4 54.7 98.1 44.9 37.1 19.8 36.2 16.3 116.5 52.6 117.4 39.3 22.1 97.0 84.8 33.0 8.9 64.0 98.2 21.0 23.2 157.9 REEP4 "C8orf20, FLJ22246, FLJ22277, PP432, Yip2c" ENSG00000168476 "Receptor accessory protein 4" Q9H6H4 8 22138020-22141951 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 93.5;Syncytiotrophoblasts: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042683 Approved Approved Cytosol No Yes Cytosol "HPA042683: AB_2571730" "unprognostic (2.38e-1)" "unprognostic (9.96e-3)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (3.41e-2)" "unprognostic (7.75e-2)" "prognostic unfavorable (4.14e-5)" "unprognostic (1.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" "unprognostic (7.15e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.88e-5)" "unprognostic (5.72e-2)" "unprognostic (1.06e-1)" "unprognostic (2.25e-1)" "unprognostic (6.65e-2)" 6.3 4.3 3.9 9.2 6.2 18.1 22.9 2.3 4.3 12.8 11.9 6.9 4.0 8.4 5.6 5.4 39.8 5.5 11.1 4.5 3.4 2.9 5.2 6.4 18.0 16.5 7.2 2.5 4.9 11.0 3.2 5.6 35.8 5.7 9.2 8.8 4.5 11.0 6.0 3.0 43.1 8.6 5.2 7.5 19.9 12.3 19.1 6.8 14.5 10.8 20.4 24.9 12.4 20.8 4.4 17.7 25.9 23.6 9.8 10.9 10.2 12.3 25.7 8.3 13.0 3.6 3.6 14.7 11.1 6.3 14.6 13.3 14.8 12.6 15.1 14.6 6.1 12.9 32.0 9.9 19.2 7.5 8.4 11.3 16.2 13.6 15.1 3.9 7.4 25.1 3.3 37.1 11.1 9.4 4.7 8.9 18.4 12.7 52.8 7.5 19.0 19.1 26.9 12.0 18.9 16.1 10.8 6.9 30.9 6.6 13.3 6.7 12.3 9.0 10.5 16.0 5.8 20.8 11.3 9.1 9.7 15.8 21.6 15.6 12.1 9.1 9.9 10.9 16.8 19.2 17.7 23.6 25.9 10.9 23.0 8.5 4.4 9.6 9.1 17.7 2.2 4.5 5.9 6.8 9.8 15.3 6.9 6.1 10.2 3.9 6.2 2.3 4.3 3.4 2.9 7.2 2.5 5.7 6.8 3.0 8.6 6.7 15.8 24.8 5.4 1.4 7.6 2.7 5.7 12.2 2.0 42.2 0.0 21.3 7.0 6.7 17.0 93.5 13.4 42.8 9.8 4.1 10.3 4.9 49.9 0.0 16.7 13.5 40.7 7.4 8.3 23.4 3.3 11.8 28.1 2.1 18.6 28.6 7.8 1.8 1.6 12.9 10.3 28.2 16.8 34.4 78.7 13.1 29.0 18.3 REEP5 "C5orf18, D5S346, DP1, TB2, Yip2e" ENSG00000129625 "Receptor accessory protein 5" Q00765 5 112876379-112922539 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003895, HPA069960" Approved Supported "Endoplasmic reticulum" NA NA 13000 "Endoplasmic reticulum" "HPA003895: AB_1845723, HPA069960: AB_2686221" "unprognostic (3.26e-3)" "unprognostic (2.60e-1)" "unprognostic (2.71e-1)" "prognostic favorable (5.23e-6)" "unprognostic (8.29e-2)" "unprognostic (1.44e-2)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (2.85e-1)" "unprognostic (3.75e-2)" "unprognostic (7.75e-2)" "unprognostic (5.90e-2)" "prognostic favorable (2.05e-5)" "unprognostic (2.88e-2)" "unprognostic (4.14e-2)" "unprognostic (1.83e-1)" "unprognostic (3.24e-2)" 22.7 35.7 39.7 14.2 47.9 7.3 46.2 33.9 65.2 32.3 21.6 23.1 33.2 17.1 19.7 45.7 16.7 22.1 20.6 42.3 37.9 45.8 50.9 50.6 26.6 13.9 37.8 37.2 25.0 56.7 45.5 21.8 41.3 72.7 34.8 20.7 20.7 49.0 32.4 31.9 20.8 18.9 18.5 33.1 19.0 22.0 10.0 21.7 6.3 84.6 20.1 18.1 22.0 19.9 38.8 42.8 55.3 63.4 23.4 39.1 44.7 19.5 17.0 6.4 13.8 30.6 27.0 21.5 18.1 17.8 19.6 20.0 14.4 26.7 7.6 35.9 22.3 19.9 19.3 14.5 28.7 20.7 37.2 19.1 8.1 13.6 11.4 28.4 6.6 14.1 17.7 28.8 15.9 15.9 21.1 24.4 6.5 4.7 17.5 26.2 18.5 3.0 11.8 8.9 12.7 12.3 4.1 18.0 22.2 51.7 21.5 11.4 8.7 24.5 49.2 17.8 18.2 56.6 12.0 25.6 17.6 6.6 24.1 24.7 18.6 22.7 6.5 30.6 12.2 9.0 34.7 50.7 49.3 33.6 54.7 35.3 38.8 27.2 31.9 42.8 32.4 12.6 23.3 55.3 23.4 63.4 31.2 39.1 44.7 39.7 47.9 33.9 65.2 37.9 45.8 37.8 37.2 72.7 21.7 154.9 81.7 96.8 143.7 82.7 81.7 184.9 124.9 96.4 99.0 184.9 84.4 245.6 69.6 243.7 114.2 118.6 82.0 0.0 360.9 269.2 175.7 189.5 105.2 181.1 246.4 82.6 113.3 107.4 124.9 21.8 107.6 190.0 195.7 116.4 93.7 87.2 282.5 138.2 125.9 116.5 66.5 109.9 132.3 117.2 39.2 88.8 409.6 104.6 92.3 181.0 REEP6 "C19orf32, DP1L1, FLJ25383, Yip2f" ENSG00000115255 "Receptor accessory protein 6" Q96HR9 19 1490747-1497927 "Disease related genes, Predicted membrane proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 90.8;liver: 119.0;testis: 71.2" "Cell type enriched" "Detected in many" 5 "Late spermatids: 2546.7" "Cancer enhanced" "Detected in all" "liver cancer: 114.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 16.1;Hep G2: 15.4;K-562: 42.7;T-47d: 35.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA003895, HPA048015" Enhanced Supported "Endoplasmic reticulum" NA NA 26000 "Endoplasmic reticulum" "HPA003895: AB_1845723, HPA048015: AB_2680233" "unprognostic (1.21e-1)" "unprognostic (1.56e-1)" "unprognostic (7.76e-2)" "unprognostic (1.63e-3)" "unprognostic (3.24e-1)" "unprognostic (2.43e-2)" "unprognostic (1.92e-1)" "unprognostic (6.85e-2)" "unprognostic (7.38e-2)" "unprognostic (4.56e-1)" "unprognostic (1.49e-1)" "unprognostic (1.93e-1)" "unprognostic (1.40e-2)" "unprognostic (2.17e-1)" "unprognostic (8.08e-2)" "unprognostic (2.83e-1)" "unprognostic (5.38e-2)" 2.4 20.1 4.1 0.7 5.9 0.6 3.9 3.1 6.0 1.4 41.7 2.8 4.4 60.2 1.0 5.7 2.7 1.4 7.6 0.9 4.5 1.9 6.1 119.0 0.6 0.7 2.6 2.1 1.7 10.1 0.5 2.2 0.7 2.1 4.9 0.7 27.4 5.6 11.8 0.7 1.7 90.8 1.1 1.6 0.6 1.3 71.2 1.1 0.3 1.6 1.1 2.1 3.2 1.2 1.0 4.2 0.1 4.8 5.8 7.1 2.3 2.0 2.5 0.8 10.5 1.6 0.5 11.7 0.5 0.1 0.5 0.5 16.1 6.6 1.1 3.7 0.3 0.7 2.1 2.7 0.1 0.2 0.5 1.1 6.1 0.3 15.4 1.2 0.4 2.0 1.3 1.1 0.0 0.3 0.9 0.3 1.4 42.7 1.5 0.1 8.1 0.5 1.3 3.9 5.9 5.7 1.6 0.3 2.7 3.0 0.9 0.2 5.8 2.8 4.1 1.7 0.4 35.7 1.6 0.9 0.8 1.7 2.5 0.4 5.1 1.4 0.1 3.6 2.6 2.3 0.0 1.5 0.0 7.1 1.7 3.8 0.1 2.1 1.5 2.5 1.0 2.8 3.2 0.1 5.8 4.8 4.2 2.0 2.3 4.1 5.9 3.1 6.0 4.5 1.9 2.6 2.1 2.1 1.1 3.0 2.7 3.4 6.8 6.1 23.2 1.6 86.6 5.3 6.8 5.2 31.4 55.0 6.6 28.9 512.6 2.8 17.0 0.0 61.1 7.5 2.5 15.7 10.3 229.1 8.2 22.3 5.8 4.3 5.7 2546.7 31.7 4.3 28.7 1.8 10.4 27.6 24.6 6.0 15.6 36.0 217.9 19.4 2.6 24.2 30.4 5.8 30.1 5.1 11.0 11.2 RELL1 ENSG00000181826 "RELT like 1" Q8IUW5 4 37590800-37686376 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 16.1" "Cell line enhanced" "Detected in many" "RH-30: 33.2;TIME: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013377 Approved Supported "Plasma membrane,Microtubules" NA NA "Plasma membrane, Microtubules" "HPA013377: AB_1844403" "unprognostic (1.70e-1)" "unprognostic (1.70e-1)" "unprognostic (4.78e-2)" "unprognostic (5.30e-2)" "unprognostic (6.80e-2)" "unprognostic (7.28e-2)" "unprognostic (7.35e-2)" "unprognostic (2.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.46e-1)" "unprognostic (3.41e-1)" "unprognostic (7.88e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (6.15e-2)" "unprognostic (1.71e-2)" 21.1 3.0 5.5 6.2 9.7 28.8 19.3 6.4 6.5 8.4 10.4 6.5 2.8 7.2 8.3 7.8 9.8 7.3 9.7 12.1 5.1 5.0 4.9 5.5 10.4 14.6 9.1 2.1 8.9 4.0 2.6 3.2 20.7 17.9 6.2 7.5 8.1 5.3 5.0 10.1 11.5 8.6 11.1 28.2 10.9 14.7 4.1 5.3 6.0 18.1 9.6 6.6 15.6 13.3 0.1 3.2 16.1 4.0 0.9 1.7 1.3 2.9 3.8 9.2 6.5 6.4 5.3 7.3 5.2 5.4 4.6 5.8 11.6 3.6 0.6 4.0 4.8 6.7 2.8 3.0 5.5 7.2 0.0 1.5 1.2 3.2 9.9 3.8 4.3 3.0 7.2 4.5 5.6 5.6 1.8 18.3 2.3 2.2 3.0 3.4 2.4 4.5 2.3 1.8 3.1 1.1 1.6 33.2 1.5 4.5 4.3 2.0 5.7 4.8 3.6 4.6 1.9 12.3 1.5 21.8 9.3 5.4 7.0 5.8 1.5 1.6 4.9 8.4 6.8 7.0 0.0 4.0 2.5 1.3 0.8 1.2 0.1 1.2 1.1 1.6 0.0 1.1 1.7 16.1 0.9 0.5 3.2 1.1 1.3 5.5 9.7 6.4 6.5 5.1 5.0 9.1 2.1 17.9 5.3 8.9 1.9 2.4 1.2 3.0 0.4 1.7 10.2 4.0 5.7 0.0 0.0 1.0 0.0 2.6 5.2 6.4 5.1 0.0 7.3 3.0 2.1 2.3 2.3 0.8 2.3 3.2 1.2 8.0 2.8 4.0 3.4 3.1 1.7 2.8 1.1 4.9 9.3 1.9 5.6 0.0 1.5 12.9 2.8 1.2 0.1 4.1 4.3 5.7 0.6 3.8 RELL2 "C5orf16, FLJ90583" ENSG00000164620 "RELT like 2" Q8NC24 5 141636950-141641077 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6;parathyroid gland: 27.6" "Cell type enhanced" "Detected in many" 16 "Horizontal cells: 62.0;Spermatocytes: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 18.3;JURKAT: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077928 Uncertain Vesicles NA NA Vesicles "HPA077928: " "unprognostic (3.27e-2)" "unprognostic (8.46e-2)" "unprognostic (2.12e-1)" "unprognostic (4.95e-3)" "unprognostic (1.91e-3)" "unprognostic (7.12e-2)" "unprognostic (1.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.69e-2)" "unprognostic (2.12e-2)" "unprognostic (6.76e-4)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (7.85e-2)" "unprognostic (8.74e-3)" "unprognostic (4.31e-2)" "unprognostic (6.58e-2)" 2.0 4.5 6.9 2.4 12.3 2.2 2.3 12.5 27.6 1.4 2.3 2.3 0.0 2.5 1.3 1.8 2.7 1.2 2.4 1.6 10.8 14.5 3.3 1.8 2.7 4.7 17.8 8.4 1.1 2.2 27.6 9.4 7.4 24.9 2.2 2.1 1.7 3.7 1.8 1.0 4.2 1.8 2.2 3.8 5.4 2.3 4.6 2.5 4.6 2.8 1.7 5.0 2.9 0.9 2.5 7.8 1.2 3.5 0.1 5.4 1.9 0.8 2.8 2.8 5.2 2.2 0.7 1.3 2.3 4.4 7.7 11.5 10.3 1.0 0.1 1.1 3.5 16.3 4.2 2.5 10.0 2.0 2.5 1.6 6.3 6.0 5.1 3.6 2.0 18.3 1.4 6.3 7.1 5.2 1.6 2.1 20.3 2.2 3.3 1.7 1.3 3.7 0.7 3.2 3.7 1.4 0.2 0.6 4.3 2.4 2.5 4.6 5.0 2.1 10.1 1.7 0.4 3.5 4.7 1.8 5.9 2.6 4.7 4.0 1.9 5.2 14.8 3.2 8.8 3.7 0.0 1.4 0.0 3.0 3.5 1.1 2.5 3.2 3.0 2.3 1.5 2.9 1.6 1.2 0.1 2.5 7.8 5.4 1.9 6.9 12.3 12.5 27.6 10.8 14.5 17.8 8.4 24.9 2.5 0.0 1.1 1.4 1.1 4.0 4.8 0.2 2.5 0.0 0.0 1.8 11.8 0.2 1.7 2.5 1.3 2.2 2.6 0.0 2.3 3.3 1.0 3.0 0.0 0.2 3.7 62.0 1.2 0.6 4.9 2.7 0.6 2.8 6.8 0.0 1.5 6.4 1.9 3.5 1.4 4.7 7.0 0.0 1.4 18.6 6.0 3.8 5.1 5.9 0.6 1.8 RELT "FLJ14993, TNFRSF19L" ENSG00000054967 "RELT, TNF receptor" Q969Z4 11 73376264-73397474 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Receptor "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 92.2" "Cell type enhanced" "Detected in many" 5 "Macrophages: 37.2;monocytes: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062824, HPA071518" Supported Nucleoplasm NA NA Nucleoplasm "HPA062824: AB_2684875, HPA071518: AB_2686408" "unprognostic (3.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.80e-3)" "unprognostic (9.92e-3)" "unprognostic (1.67e-3)" "unprognostic (1.17e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-1)" "unprognostic (8.42e-2)" "unprognostic (4.13e-2)" "prognostic unfavorable (4.07e-11)" "unprognostic (1.64e-1)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (1.69e-1)" 3.5 2.2 3.5 11.7 8.8 92.2 2.8 3.5 5.7 1.4 2.1 7.4 0.0 2.7 1.9 2.5 3.2 1.6 4.1 5.3 4.0 5.2 2.0 2.0 8.4 18.2 8.3 3.9 1.5 1.6 1.8 3.1 4.1 13.9 1.7 2.0 2.3 4.6 1.3 22.1 2.5 5.6 2.8 14.3 18.1 2.5 3.0 4.6 4.8 1.8 3.9 9.0 3.3 2.1 4.7 6.8 12.1 19.2 0.3 1.1 3.1 5.7 5.8 4.5 4.5 0.5 0.7 5.1 6.4 4.0 7.4 4.5 5.5 2.5 10.6 21.0 4.1 5.9 8.5 2.8 3.1 2.7 6.4 5.4 10.0 7.2 2.0 1.3 9.9 17.6 0.7 1.3 7.8 2.0 1.7 2.6 5.3 7.5 14.1 2.0 5.4 7.1 10.3 4.1 4.5 7.2 14.1 7.9 9.2 1.5 2.5 6.0 5.7 5.4 4.9 6.6 1.1 2.7 8.6 3.6 9.3 6.6 15.4 11.3 4.9 3.9 11.6 5.7 9.8 9.8 0.4 7.0 12.1 0.5 14.3 1.1 4.7 0.6 1.0 6.8 3.7 0.8 0.4 11.6 0.3 19.2 6.8 0.2 3.1 3.5 8.8 3.5 5.7 4.0 5.2 8.3 3.9 13.9 4.6 6.0 2.1 15.9 11.9 23.6 1.9 2.2 0.0 1.4 3.4 0.0 11.8 1.4 0.0 3.5 0.7 2.3 2.1 0.0 0.7 9.4 6.6 7.8 25.3 0.0 20.4 28.6 3.4 0.6 23.5 1.0 0.0 37.2 5.0 30.7 0.6 10.0 4.1 0.6 0.0 0.4 2.0 6.5 7.8 2.7 7.5 15.9 17.6 7.5 1.3 14.8 RER1 ENSG00000157916 "Retention in endoplasmic reticulum sorting receptor 1" O15258 1 2391775-2405444 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037240, HPA051400" Supported Supported "Golgi apparatus" No No "Golgi apparatus" "CAB037240: AB_2179604, HPA051400: AB_2681469" "unprognostic (2.90e-2)" "unprognostic (3.35e-2)" "unprognostic (3.17e-2)" "unprognostic (2.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.07e-1)" "unprognostic (1.53e-2)" "unprognostic (1.24e-1)" "unprognostic (2.28e-1)" "unprognostic (2.72e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.23e-8)" "unprognostic (1.01e-1)" "unprognostic (5.41e-2)" "unprognostic (1.06e-1)" "unprognostic (3.27e-2)" 31.2 59.8 21.6 26.6 24.8 21.2 40.5 22.6 31.1 30.6 40.2 34.6 34.6 34.1 34.0 39.4 63.0 27.0 44.2 31.3 21.0 18.0 44.9 125.8 28.3 39.6 26.8 24.8 31.3 55.8 29.8 31.8 44.8 23.5 30.0 47.5 29.7 57.7 36.9 36.7 35.5 51.5 32.3 24.6 38.6 34.3 35.7 25.3 26.9 36.6 38.5 41.7 28.3 37.3 40.6 62.3 86.1 63.0 36.3 57.3 65.4 38.6 22.0 26.5 29.7 48.9 58.2 19.7 57.5 52.7 52.1 52.4 31.0 60.2 27.3 48.7 59.1 42.0 41.9 30.6 35.4 66.6 34.1 28.2 30.4 46.6 29.7 52.9 33.6 38.2 47.0 36.1 54.1 48.2 35.9 47.6 31.7 36.3 47.2 60.6 27.5 23.8 24.7 17.3 61.8 53.5 28.0 25.9 35.3 46.6 18.7 21.9 25.2 32.2 76.5 45.3 30.8 30.3 25.1 32.7 40.8 23.0 71.8 42.3 44.9 50.1 49.2 43.0 49.5 20.6 46.5 58.5 66.4 50.3 63.0 46.1 40.6 44.7 53.7 53.9 35.1 33.9 41.6 86.1 36.3 61.8 62.3 57.3 65.4 21.6 24.8 22.6 31.1 21.0 18.0 26.8 24.8 23.5 25.3 59.6 41.3 58.1 71.7 47.3 32.8 32.7 132.5 52.2 29.6 99.5 31.4 203.2 56.3 181.2 360.0 58.9 205.6 23.3 226.7 261.7 88.8 117.1 42.8 225.6 195.4 35.0 35.1 84.1 102.8 329.3 76.5 85.4 59.1 129.8 124.7 70.9 203.8 136.3 71.5 98.0 50.2 109.9 61.4 191.9 119.0 58.6 391.3 76.7 138.8 108.5 RET "CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51" ENSG00000165731 "Ret proto-oncogene" P07949 10 43077027-43130351 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 63.9" "Cell type enriched" "Detected in some" 44 "Horizontal cells: 74.7" "Cancer enhanced" "Detected in many" "breast cancer: 11.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 6.7" "Group enriched" "Detected in many" 13 "dendritic cells: 2.1;monocytes: 6.7" "Cell line enhanced" "Detected in some" "MCF7: 18.0;NB-4: 11.8;SH-SY5Y: 91.8;THP-1: 27.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "midbrain: 95.5" "CAB002581, HPA008356, HPA008495" Approved Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" No NA 260000 "Golgi apparatus, Cytosol" "Plasma membrane" "CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: " "unprognostic (7.94e-2)" "unprognostic (3.68e-2)" "unprognostic (4.49e-1)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (9.13e-4)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (2.86e-1)" "unprognostic (2.01e-1)" "unprognostic (1.54e-3)" "unprognostic (4.43e-1)" "unprognostic (9.35e-5)" "unprognostic (1.64e-3)" "unprognostic (8.28e-2)" "unprognostic (3.67e-3)" "unprognostic (2.02e-2)" 1.8 15.2 1.1 1.8 1.3 0.7 1.2 4.1 9.0 1.9 3.1 0.9 1.1 1.5 0.9 0.6 1.2 0.7 1.0 1.2 1.5 5.8 1.0 11.7 0.7 0.8 17.5 1.2 0.8 1.3 63.9 6.3 0.8 16.8 2.2 1.5 2.8 13.6 2.0 4.5 1.1 2.6 1.1 2.8 0.6 2.1 2.0 0.0 0.1 0.8 5.1 0.6 1.9 1.4 0.2 2.1 0.0 6.7 0.0 0.3 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 11.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 91.8 0.0 0.0 0.0 0.1 1.3 27.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 6.7 2.1 0.3 0.4 1.1 1.3 4.1 9.0 1.5 5.8 17.5 1.2 16.8 0.0 0.0 0.3 0.0 0.5 0.2 0.1 1.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 1.7 1.0 1.2 1.1 0.8 0.1 74.7 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.4 1.1 0.5 0.0 0.0 0.0 0.1 RETREG1 "FAM134B, FLJ20152, JK1" ENSG00000154153 "Reticulophagy regulator 1" Q9H6L5 5 16473038-16617058 "Disease related genes, Predicted membrane proteins" Autophagy "Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 45.0;skeletal muscle: 78.5" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 68.5;Exocrine glandular cells: 51.0;Pancreatic endocrine cells: 69.1;Proximal tubular cells: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 4.0;T-cells: 4.4" "Cell line enhanced" "Detected in many" "ASC diff: 16.3;GAMG: 12.6;HSkMC: 18.1;RPTEC TERT1: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012077 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA012077: AB_2668621" "unprognostic (1.63e-2)" "unprognostic (1.98e-1)" "unprognostic (1.80e-2)" "unprognostic (1.84e-2)" "unprognostic (4.96e-2)" "unprognostic (9.17e-3)" "unprognostic (2.66e-2)" "unprognostic (1.90e-1)" "unprognostic (4.35e-2)" "unprognostic (4.41e-2)" "unprognostic (1.37e-2)" "unprognostic (1.48e-1)" "prognostic favorable (5.25e-10)" "unprognostic (3.75e-1)" "unprognostic (9.96e-2)" "unprognostic (5.62e-2)" "unprognostic (2.58e-1)" 9.8 2.0 8.5 3.7 11.2 1.1 8.7 9.6 19.6 7.4 12.4 14.9 0.3 6.5 2.3 5.4 2.0 4.1 7.1 45.0 11.2 9.4 30.3 21.8 4.9 3.1 13.2 11.4 1.7 19.0 17.7 8.0 6.7 18.5 5.9 16.9 1.5 3.9 3.0 78.5 5.6 12.8 1.5 16.8 1.6 6.1 5.7 15.4 14.1 3.6 12.5 2.3 2.0 4.4 0.9 0.1 4.0 0.4 0.1 4.4 0.6 0.8 0.3 0.1 2.1 16.3 2.0 9.5 0.1 2.1 1.9 2.6 1.4 0.1 0.2 1.5 0.0 12.6 2.4 4.8 0.5 0.6 2.4 2.1 0.0 7.2 0.0 0.1 3.1 0.0 18.1 7.4 0.3 2.0 4.7 0.0 9.3 0.0 0.1 0.7 0.6 11.9 0.0 0.5 2.1 0.3 1.9 0.0 0.7 16.6 0.5 10.8 1.2 0.6 0.7 7.8 1.2 3.6 1.4 0.0 1.5 0.2 4.0 1.8 0.4 0.0 0.0 9.3 10.7 3.9 4.0 0.4 0.1 0.6 0.0 1.6 0.0 1.5 0.8 0.1 0.9 4.4 2.7 2.3 0.1 0.1 0.0 1.9 0.6 8.5 11.2 9.6 14.4 11.2 9.4 13.2 11.4 18.5 15.4 68.5 7.5 0.0 0.0 0.0 0.0 0.0 0.0 34.8 18.2 41.8 0.0 39.1 14.9 25.9 0.0 0.0 0.0 0.0 51.0 2.5 0.0 0.0 1.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.8 0.0 0.0 69.1 0.0 0.0 147.8 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 RETREG2 "C2orf17, FAM134A, MAG-2, MGC3035" ENSG00000144567 "Reticulophagy regulator family member 2" Q8NC44 2 219176225-219185479 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 43.6;Ductal cells: 36.6;Exocrine glandular cells: 41.9;Extravillous trophoblasts: 32.2;Hofbauer cells: 31.4;Pancreatic endocrine cells: 35.3;Proximal tubular cells: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011170, HPA011844" Approved Approved Cytosol NA NA Cytosol "HPA011170: AB_1845713, HPA011844: AB_2668544" "unprognostic (2.63e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (7.95e-4)" "unprognostic (1.03e-1)" "unprognostic (2.88e-2)" "unprognostic (2.58e-3)" "prognostic unfavorable (1.49e-4)" "unprognostic (8.74e-2)" "unprognostic (9.61e-2)" "unprognostic (1.34e-2)" "unprognostic (4.37e-2)" "unprognostic (2.36e-1)" "unprognostic (4.29e-3)" "unprognostic (4.45e-2)" "unprognostic (4.47e-2)" "unprognostic (1.53e-2)" "unprognostic (3.70e-2)" 14.8 22.4 27.8 14.8 34.2 23.8 22.3 38.5 56.9 20.9 20.0 24.1 20.0 18.6 19.9 28.8 18.7 23.8 18.9 10.8 28.2 28.7 31.2 24.0 17.4 18.1 26.6 35.7 32.7 29.5 38.0 20.2 16.6 26.7 18.4 23.5 20.0 20.7 19.1 10.6 19.5 18.1 20.7 21.5 17.4 17.6 61.4 16.5 15.1 28.0 12.8 19.7 18.6 24.7 6.8 5.8 21.1 7.3 4.2 8.7 2.9 12.5 13.4 11.6 17.5 44.0 18.7 12.3 15.4 26.7 18.8 16.4 13.4 21.7 10.3 15.5 29.0 38.7 16.3 13.9 13.8 20.8 14.4 11.6 13.7 18.6 22.1 25.3 14.8 19.0 20.2 36.2 21.1 20.4 32.5 16.9 11.2 9.4 23.8 26.0 18.5 8.9 16.1 8.5 16.1 15.7 11.4 12.8 8.3 15.5 14.8 16.6 17.1 9.9 19.2 36.4 18.9 16.0 16.5 13.3 21.1 11.4 29.8 11.5 24.1 13.7 11.6 22.1 14.8 11.6 8.5 5.7 5.3 8.5 7.3 7.8 6.8 7.0 8.7 3.8 5.8 6.4 8.1 21.1 4.2 6.6 5.8 8.1 2.9 27.8 34.2 38.5 56.9 28.2 28.7 26.6 35.7 26.7 16.5 14.9 13.6 0.0 0.0 0.0 0.0 0.0 0.0 4.0 11.4 43.6 0.0 25.1 18.3 36.6 0.0 0.0 0.0 0.0 41.9 32.2 0.0 0.0 4.7 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 19.8 0.0 0.0 35.3 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.0 0.0 RETREG3 "DKFZp686B1036, FAM134C, FLJ33806" ENSG00000141699 "Reticulophagy regulator family member 3" Q86VR2 17 42579513-42610623 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 28.0;Collecting duct cells: 29.6;Exocrine glandular cells: 21.8;Pancreatic endocrine cells: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016492 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" Cytosol "HPA016492: AB_1853027" "unprognostic (6.79e-2)" "unprognostic (1.29e-2)" "unprognostic (2.78e-1)" "prognostic favorable (1.61e-4)" "unprognostic (5.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.53e-2)" "unprognostic (2.21e-1)" "unprognostic (2.61e-1)" "unprognostic (2.58e-2)" "unprognostic (1.00e-2)" "unprognostic (2.51e-1)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.24e-1)" "unprognostic (5.68e-1)" "unprognostic (9.64e-3)" "unprognostic (5.43e-2)" 23.2 17.4 11.9 15.8 15.6 5.8 16.3 23.1 21.9 17.0 18.8 13.2 15.5 13.1 25.4 20.9 21.6 15.0 20.8 10.0 11.2 12.3 16.0 28.7 16.2 19.0 11.3 9.8 17.4 43.2 19.6 16.5 29.4 13.7 19.4 16.1 32.5 24.6 14.1 18.5 31.1 17.5 15.7 7.8 24.0 17.1 27.2 8.5 29.9 17.8 16.7 26.3 14.8 17.1 14.1 7.8 22.6 11.4 13.7 27.8 16.6 6.6 20.6 9.0 14.7 23.3 13.0 13.0 9.5 12.9 11.3 13.3 9.7 14.3 14.6 13.4 15.4 11.6 26.0 11.6 14.2 11.0 15.6 11.1 5.9 12.6 17.2 16.0 10.1 15.3 19.8 19.6 12.4 12.6 12.6 12.1 10.8 12.1 14.5 8.9 11.5 14.8 14.8 5.7 12.5 5.1 8.1 14.1 14.9 12.9 21.4 16.3 11.2 10.2 8.3 14.4 17.4 23.7 7.9 15.3 12.3 7.6 12.1 9.0 25.1 29.8 13.0 11.2 6.5 9.3 22.6 8.0 17.7 24.2 10.0 21.2 13.0 20.0 23.0 7.8 14.1 19.8 22.2 7.2 13.7 11.4 7.7 27.8 16.6 11.9 15.6 23.1 21.9 11.2 12.3 11.3 9.8 13.7 8.5 23.8 28.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 11.4 29.6 0.0 17.6 6.6 15.5 0.0 0.0 0.0 0.0 21.8 13.6 0.0 0.0 7.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 12.6 0.0 0.0 25.9 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 RETSAT FLJ20296 ENSG00000042445 "Retinol saturase" Q6NUM9 2 85342088-85354620 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 86.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 209.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 65.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007961, HPA046513" Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA007961: AB_1079802, HPA046513: AB_2679680" "unprognostic (6.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.29e-1)" "unprognostic (5.84e-3)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "prognostic favorable (4.23e-4)" "unprognostic (1.89e-1)" "unprognostic (2.16e-1)" "unprognostic (3.59e-2)" "unprognostic (1.77e-2)" "unprognostic (1.59e-1)" "prognostic favorable (1.95e-10)" "unprognostic (2.73e-2)" "unprognostic (5.34e-1)" "unprognostic (8.24e-3)" "unprognostic (9.90e-2)" 65.7 24.8 7.7 9.8 9.1 0.9 35.6 5.6 9.3 7.4 46.5 12.4 12.7 49.0 6.8 12.3 16.7 5.0 17.7 7.3 7.4 5.7 20.6 51.9 7.2 5.1 10.2 7.7 5.5 11.5 13.1 3.5 5.7 8.9 10.1 22.6 10.0 12.5 7.6 24.3 14.3 86.1 7.0 12.7 4.0 18.2 9.2 10.1 3.5 27.2 13.9 9.3 9.9 9.0 3.8 5.6 5.3 10.0 6.5 9.2 4.1 16.2 9.4 5.5 12.7 65.6 12.3 7.1 11.9 14.7 7.2 10.2 6.5 11.4 5.7 9.8 9.4 5.8 13.6 7.3 20.7 7.1 7.0 5.0 2.8 7.8 15.9 15.8 5.4 6.3 16.1 28.4 9.3 12.4 16.8 12.0 5.0 2.9 13.7 13.5 3.4 3.9 2.8 1.7 16.4 11.6 2.5 10.8 7.4 12.8 9.5 2.6 4.4 10.0 19.1 32.3 3.8 9.0 0.9 9.4 8.2 4.5 7.6 6.2 7.4 6.9 2.3 10.0 6.5 5.6 0.0 5.1 2.4 7.0 5.5 9.2 3.8 5.6 8.8 5.6 2.5 3.8 4.0 5.3 6.5 10.0 4.0 5.8 4.1 7.7 9.1 5.6 9.3 7.4 5.7 10.2 7.7 8.9 10.1 26.8 23.5 2.2 8.5 10.1 3.5 18.5 20.4 9.4 10.3 12.2 17.7 9.6 0.0 19.1 27.2 9.2 209.6 0.0 31.4 5.6 6.6 11.3 10.4 39.3 8.7 11.1 10.4 8.0 9.9 41.4 13.6 7.5 28.7 9.0 43.9 8.2 29.0 59.4 11.7 15.6 4.3 0.0 7.8 2.6 3.0 13.0 7.1 8.9 33.1 8.4 RFNG ENSG00000169733 "RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" Q9Y644 17 82047902-82051831 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011564, HPA031673" Uncertain Approved Nucleoplasm No No 450000 Nucleoplasm "HPA011564: AB_1079803, HPA031673: AB_2673989" "unprognostic (4.17e-3)" "unprognostic (7.60e-3)" "unprognostic (2.87e-3)" "unprognostic (2.49e-1)" "unprognostic (2.05e-1)" "unprognostic (2.65e-2)" "unprognostic (1.62e-1)" "unprognostic (9.86e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "prognostic favorable (4.81e-4)" "unprognostic (1.20e-1)" "unprognostic (6.96e-3)" "unprognostic (1.77e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (4.14e-2)" 19.5 13.0 13.8 9.3 13.3 11.7 43.8 14.3 13.8 11.4 11.8 9.0 22.7 14.9 13.5 20.9 13.4 16.3 17.0 12.2 11.6 8.7 12.5 34.5 16.7 10.1 11.2 8.0 19.7 26.6 4.1 10.7 8.2 9.9 11.8 4.8 10.6 27.3 20.4 32.6 13.3 12.7 12.9 8.5 8.9 13.2 12.8 10.6 5.7 12.6 10.5 7.6 12.4 12.8 3.4 3.4 4.3 5.0 0.4 6.3 1.5 9.5 9.5 2.8 9.6 7.2 6.3 12.3 8.9 5.2 4.3 3.4 5.8 6.8 2.2 6.4 14.1 8.8 5.3 1.9 7.7 0.9 2.9 10.0 3.2 2.3 23.6 35.5 1.2 7.1 11.5 5.2 7.3 12.5 8.4 8.0 7.5 4.0 8.4 3.4 11.7 7.1 3.3 2.8 6.4 10.0 5.0 3.4 5.0 4.8 5.8 5.0 12.4 3.4 5.8 26.3 3.2 16.1 6.8 3.0 6.8 9.2 6.4 4.8 11.3 2.1 2.3 8.5 2.0 5.8 2.3 5.0 4.3 4.1 1.4 1.5 2.5 2.8 4.3 3.4 3.4 2.8 1.9 2.0 0.4 1.5 2.7 6.3 1.5 13.8 13.3 14.3 13.8 11.6 8.7 11.2 8.0 9.9 10.6 6.0 11.3 5.2 11.2 8.7 28.3 10.0 7.6 4.0 3.4 22.7 23.6 4.8 6.6 7.0 2.9 9.2 17.1 0.0 12.8 2.8 17.9 13.2 1.1 42.9 8.3 11.1 10.9 17.8 9.7 8.5 20.1 6.1 10.1 2.8 13.3 30.4 11.9 17.3 18.7 28.9 24.4 0.0 7.0 17.9 3.1 8.9 3.1 7.5 11.1 7.0 RFT1 CDG1N ENSG00000163933 "RFT1 homolog" Q96AA3 3 53088483-53130462 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA060327, HPA069022" Approved Approved Vesicles NA NA Vesicles "HPA060327: AB_2684253, HPA069022: AB_2732126" "unprognostic (5.74e-2)" "unprognostic (1.31e-1)" "unprognostic (1.35e-3)" "unprognostic (5.16e-3)" "unprognostic (2.08e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (1.09e-1)" "unprognostic (1.22e-1)" "unprognostic (2.70e-1)" "unprognostic (2.81e-2)" "unprognostic (9.26e-2)" "unprognostic (6.48e-2)" "unprognostic (1.96e-1)" "unprognostic (1.22e-1)" "unprognostic (5.06e-2)" "unprognostic (3.54e-2)" 12.9 19.1 10.8 13.8 14.7 7.2 13.2 11.0 19.2 11.9 11.7 17.0 9.6 10.2 16.2 14.0 16.9 13.0 11.0 12.4 10.2 7.4 10.1 17.7 11.6 15.3 10.5 10.5 15.5 43.7 15.4 9.4 13.8 10.6 11.0 13.8 13.4 18.6 11.3 7.0 13.4 10.5 11.6 11.5 14.5 12.8 23.8 11.1 16.8 15.2 9.1 16.3 12.5 12.1 16.5 27.5 25.9 23.1 11.7 14.5 13.6 16.2 15.4 10.6 16.9 12.5 13.3 22.1 14.8 13.9 25.9 23.7 15.2 32.1 21.5 9.3 14.2 24.4 17.5 23.9 24.2 23.0 20.2 10.5 21.2 11.2 15.0 21.9 19.3 12.5 14.0 20.5 34.8 25.2 11.5 16.4 22.6 11.1 19.7 17.0 16.5 18.1 11.4 21.2 28.4 20.3 7.5 10.2 32.6 14.3 11.0 6.0 8.2 18.3 13.5 13.3 12.0 10.1 27.6 10.8 24.1 15.6 16.4 29.0 12.5 15.0 16.3 17.2 24.8 25.1 25.9 23.1 9.9 13.3 22.4 13.4 12.2 12.5 13.6 24.1 16.5 14.5 14.5 7.7 11.7 15.5 27.5 10.9 13.6 10.8 14.7 11.0 19.2 10.2 7.4 10.5 10.5 10.6 11.1 3.0 3.0 0.8 9.0 4.4 3.9 5.9 10.2 5.3 4.5 8.7 3.9 35.2 1.7 14.2 1.0 5.8 4.3 0.0 18.4 27.2 7.5 7.0 2.3 9.5 19.8 4.8 2.4 10.4 8.7 1.4 8.1 4.7 6.8 10.8 6.7 4.9 11.3 10.2 5.6 4.8 6.1 0.0 2.8 9.3 9.6 3.8 20.3 6.4 10.0 6.4 RGR RP44 ENSG00000148604 "Retinal G protein coupled receptor" P47804 10 84245053-84259960 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "retina: 228.3" "Cell type enriched" "Detected in some" 36 "Muller glia cells: 1479.5" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 4.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "midbrain: 30.1;olfactory region: 95.6;thalamus: 30.2" NA NA "unprognostic (9.28e-2)" "unprognostic (1.05e-1)" "unprognostic (1.37e-1)" "unprognostic (9.53e-2)" "unprognostic (4.57e-2)" "unprognostic (1.57e-1)" "unprognostic (1.59e-1)" "unprognostic (1.97e-1)" 0.4 0.4 6.6 0.5 6.1 1.3 0.6 0.4 18.1 0.5 0.4 0.6 0.0 0.3 0.5 1.1 0.6 0.3 0.3 0.3 3.0 2.2 0.4 0.4 0.4 0.6 3.2 1.3 0.5 0.3 0.2 0.4 0.4 1.1 0.5 0.6 228.3 0.6 0.4 0.6 1.1 0.5 0.2 0.2 0.5 0.4 1.2 0.7 0.0 0.4 0.0 0.3 0.3 0.0 0.9 0.9 2.2 0.8 1.0 0.7 0.1 0.6 0.7 0.8 1.6 0.5 0.5 0.4 0.4 0.4 1.0 0.4 1.5 0.2 0.8 0.7 1.2 1.3 1.2 0.3 0.7 0.2 0.5 0.2 0.3 3.0 1.0 0.2 1.4 1.7 0.3 0.7 0.5 1.2 2.6 0.3 0.7 0.6 1.4 0.0 1.2 0.5 0.9 1.5 0.2 0.2 0.5 0.5 1.5 0.0 1.5 0.3 0.4 1.0 0.7 1.4 1.2 0.2 0.1 4.0 1.6 2.1 0.8 0.3 1.2 0.2 1.2 0.3 1.3 1.0 1.0 0.8 0.8 0.6 0.8 0.4 0.8 0.7 0.5 0.3 0.9 0.6 0.6 2.2 1.0 0.4 0.9 0.2 0.1 6.6 6.1 0.4 7.3 3.0 2.2 3.2 1.3 1.1 0.7 0.0 0.0 0.0 0.0 0.0 19.7 0.3 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 7.9 0.3 0.0 0.0 0.0 0.0 1479.5 0.0 0.0 0.0 0.0 40.8 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 RGS9BP "FLJ45744, PERRS, R9AP, RGS9" ENSG00000186326 "Regulator of G protein signaling 9 binding protein" Q6ZS82 19 32675407-32678300 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 38.3;skeletal muscle: 15.8" "Group enriched" "Detected in some" 13 "Bipolar cells: 30.8;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 70.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 6.8" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;memory CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 10.7;HMC-1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA049791 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA049791: AB_2680884" "unprognostic (2.82e-2)" "unprognostic (6.99e-3)" "unprognostic (2.44e-3)" "unprognostic (1.20e-7)" "unprognostic (1.49e-1)" "unprognostic (1.21e-2)" "unprognostic (1.17e-2)" "unprognostic (1.32e-1)" "unprognostic (2.80e-1)" "unprognostic (6.71e-2)" "unprognostic (6.74e-2)" "unprognostic (3.89e-2)" "unprognostic (1.63e-3)" "unprognostic (2.29e-1)" "unprognostic (8.22e-2)" "unprognostic (5.23e-2)" "unprognostic (5.34e-2)" 0.4 0.5 0.8 0.3 1.1 0.3 0.4 0.2 0.7 0.3 0.4 1.4 0.2 0.4 0.3 0.6 1.1 0.4 0.3 6.7 1.0 0.8 0.9 0.3 0.9 0.3 1.1 0.3 0.3 0.4 0.4 0.6 0.4 6.8 1.3 0.3 38.3 0.5 0.6 15.8 0.6 0.3 7.4 1.3 0.4 0.4 0.9 0.9 0.1 0.4 4.3 0.3 2.3 1.0 0.0 0.3 0.0 0.9 0.5 1.5 0.0 0.2 0.2 0.0 0.9 0.5 0.2 0.5 0.0 0.5 0.4 0.2 0.2 0.3 0.4 0.5 0.1 0.5 0.1 1.8 0.1 0.1 0.5 0.2 10.7 0.3 0.0 0.2 0.3 2.8 0.0 0.5 0.0 0.4 0.2 0.0 0.1 0.9 1.5 0.2 0.5 0.0 1.7 0.0 0.1 2.0 0.2 0.4 0.2 0.0 0.1 0.4 0.1 0.0 1.1 0.1 0.0 1.1 0.5 0.0 0.5 0.7 0.2 0.3 0.6 0.7 0.1 0.3 0.6 0.8 0.0 0.3 0.0 1.4 0.9 0.0 0.0 0.2 1.5 0.3 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.8 1.1 0.2 0.7 1.0 0.8 1.1 0.3 6.8 0.9 0.0 0.0 0.0 0.1 0.0 30.8 3.9 0.0 0.0 0.0 1.8 53.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 1.6 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.4 70.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 RGSL1 RGSL2 ENSG00000121446 "Regulator of G protein signaling like 1" A5PLK6 1 182409192-182560599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 22.6" "Group enriched" "Detected in some" 34 "Early spermatids: 91.5;Late spermatids: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;T-47d: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (1.33e-1)" "unprognostic (5.20e-2)" "unprognostic (2.07e-1)" "unprognostic (6.47e-2)" "unprognostic (4.45e-1)" "unprognostic (1.64e-1)" "unprognostic (2.69e-5)" "unprognostic (2.93e-1)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 91.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.0 0.0 RHAG "CD241, RH50A, SLC42A1" ENSG00000112077 "Rh associated glycoprotein" Q02094 6 49605158-49636884 "CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "bone marrow: 54.1" "Cell type enriched" "Detected in some" 50 "Erythroid cells: 116.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 190 "HEL: 87.8;K-562: 86.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046051, HPA055331" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA046051: , HPA055331: AB_2682785" "unprognostic (8.16e-2)" "unprognostic (6.86e-2)" "unprognostic (1.25e-3)" "unprognostic (1.65e-1)" 1.2 0.2 0.0 1.1 0.5 54.1 3.2 0.0 0.1 2.3 1.0 0.5 1.7 0.2 0.4 0.1 2.6 0.5 0.8 5.3 0.0 0.0 0.1 0.7 3.3 0.1 0.0 0.0 0.1 0.2 0.1 0.1 5.8 0.1 1.3 0.2 0.0 0.2 0.5 0.4 0.1 0.9 0.1 0.0 4.5 0.6 0.2 0.0 1.7 1.8 0.0 0.1 0.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 116.8 0.2 0.3 0.0 0.0 2.3 0.0 0.4 0.0 0.0 1.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RHBDD1 DKFZp547E052 ENSG00000144468 "Rhomboid domain containing 1" Q8TEB9 2 226835581-226999215 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Differentiation, Spermatogenesis" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013972, HPA057125" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA013972: AB_2178629, HPA057125: AB_2683343" "unprognostic (1.42e-1)" "unprognostic (5.37e-2)" "unprognostic (3.26e-1)" "unprognostic (5.23e-2)" "unprognostic (2.57e-1)" "unprognostic (2.91e-1)" "unprognostic (1.17e-2)" "unprognostic (2.07e-2)" "unprognostic (1.18e-1)" "unprognostic (9.40e-2)" "unprognostic (4.74e-3)" "unprognostic (4.97e-2)" "unprognostic (1.16e-1)" "unprognostic (1.79e-1)" "unprognostic (1.09e-1)" "unprognostic (9.77e-2)" "unprognostic (3.04e-2)" 12.7 14.8 10.8 16.7 16.0 11.0 13.6 8.3 13.0 13.8 14.3 21.2 9.4 11.0 20.6 16.3 13.6 15.4 12.4 14.5 11.4 9.0 13.6 16.9 12.6 17.7 17.6 11.0 18.8 20.4 18.6 17.1 10.5 13.0 15.7 12.4 13.1 14.3 15.5 13.9 13.0 17.5 15.6 16.5 17.3 13.2 25.6 14.7 56.6 17.3 8.8 18.9 18.7 15.4 19.9 16.6 9.8 15.5 8.8 12.5 8.5 5.2 4.5 4.8 7.4 14.6 14.6 0.0 12.5 10.0 6.2 7.1 3.9 9.1 4.9 10.4 12.6 9.0 6.1 0.0 13.0 11.8 12.5 5.0 7.2 2.9 3.4 15.7 7.6 4.2 13.6 19.0 11.8 25.7 7.2 4.7 13.0 19.3 12.9 6.4 10.0 12.9 3.9 0.0 6.1 4.8 5.6 0.0 7.1 5.0 6.3 4.7 3.6 6.8 2.4 9.2 9.5 6.9 8.8 6.2 2.8 6.3 10.7 3.5 14.4 6.7 35.4 9.1 9.3 8.2 8.1 11.1 9.8 6.1 15.5 9.7 17.3 9.6 7.5 13.7 19.9 10.8 8.9 2.5 8.8 10.3 16.6 12.5 8.5 10.8 16.0 8.3 13.0 11.4 9.0 17.6 11.0 13.0 14.7 11.9 5.4 22.9 7.2 4.6 6.3 14.0 2.5 4.0 7.9 10.4 15.7 6.0 3.3 6.1 12.7 5.8 5.0 0.0 8.0 3.3 5.2 9.4 8.1 11.3 4.6 11.1 1.7 3.1 9.2 13.7 5.2 5.0 11.8 1.8 7.1 9.3 7.2 0.0 6.3 2.9 5.9 0.0 7.2 12.9 7.1 4.8 4.7 6.5 3.7 7.7 RHBDD2 "NPD007, RHBDL7" ENSG00000005486 "Rhomboid domain containing 2" Q6NTF9 7 75842602-75888926 "Enzymes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 233.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045074, HPA051960" Uncertain Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA045074: AB_10965705, HPA051960: AB_2681673" "unprognostic (2.75e-1)" "unprognostic (3.89e-2)" "prognostic unfavorable (3.31e-5)" "unprognostic (9.79e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (2.05e-2)" "unprognostic (1.18e-2)" "unprognostic (2.37e-3)" "unprognostic (1.55e-1)" "unprognostic (2.75e-1)" "unprognostic (5.11e-2)" "unprognostic (1.87e-2)" "prognostic favorable (8.68e-6)" "unprognostic (3.73e-1)" "unprognostic (6.53e-2)" "unprognostic (1.89e-1)" "unprognostic (1.03e-1)" 12.3 50.9 44.3 9.2 64.6 12.1 12.1 14.4 68.3 17.9 11.9 18.5 43.8 18.2 8.5 31.8 14.2 22.6 12.5 14.1 48.5 69.1 18.5 21.7 22.1 8.9 33.6 29.9 12.3 23.6 81.3 56.5 10.6 37.1 15.8 9.1 23.0 22.8 57.3 6.0 14.4 12.5 7.0 16.2 9.5 15.3 15.5 10.7 9.5 34.3 4.2 7.6 10.0 9.6 11.1 13.5 76.4 14.0 13.2 27.4 12.2 7.5 25.0 11.2 22.7 6.6 4.3 4.7 4.6 18.1 10.5 8.9 13.5 20.9 2.9 4.1 8.7 22.9 12.3 7.4 5.4 3.2 8.6 14.7 2.5 15.8 12.9 18.2 4.3 23.6 9.4 13.3 11.7 5.3 16.2 6.7 19.4 5.8 18.6 8.9 50.4 8.1 24.1 11.0 14.9 14.3 6.0 7.8 21.7 17.2 13.6 14.9 29.7 17.1 36.3 17.4 9.0 23.7 8.2 6.2 16.4 13.7 10.8 9.4 15.4 5.3 4.5 16.4 6.8 20.0 76.4 14.0 17.6 18.9 13.9 16.6 11.1 21.3 16.7 13.5 10.8 18.0 15.3 24.0 13.2 7.9 11.1 27.4 12.2 44.3 64.6 14.4 68.3 48.5 69.1 33.6 29.9 37.1 10.7 38.7 29.3 20.0 41.3 20.6 34.2 7.7 53.5 46.8 39.8 82.0 31.4 45.1 16.6 79.5 128.0 23.5 40.6 0.0 89.9 35.2 36.2 52.9 189.3 34.5 39.0 17.5 86.2 65.7 29.1 233.4 39.4 32.1 57.3 21.6 32.4 62.9 61.3 31.6 49.5 44.0 27.9 6.5 24.7 38.5 29.7 20.7 43.5 43.7 23.9 42.0 RHBDD3 "C22orf3, PTAG" ENSG00000100263 "Rhomboid domain containing 3" Q9Y3P4 22 29259852-29268209 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043979 Approved Approved Microtubules NA NA Microtubules "HPA043979: AB_10960539" "unprognostic (9.38e-2)" "unprognostic (1.19e-2)" "unprognostic (1.22e-1)" "prognostic favorable (2.67e-6)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.13e-3)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (8.46e-2)" "unprognostic (4.42e-3)" "unprognostic (1.80e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (2.11e-3)" "unprognostic (1.84e-1)" "unprognostic (1.03e-1)" "unprognostic (3.42e-3)" 9.6 16.2 9.0 6.8 10.0 7.9 4.9 13.0 10.1 6.7 7.9 8.1 15.8 14.0 8.8 12.7 6.2 9.0 8.2 7.3 8.9 10.3 7.7 16.4 5.6 8.6 9.2 6.7 6.2 15.4 5.5 11.7 10.9 8.9 11.5 2.7 11.4 10.9 14.2 12.1 7.6 9.7 5.3 8.7 8.2 8.4 17.6 6.9 7.1 8.9 3.5 4.5 5.3 4.1 2.4 13.2 2.2 5.7 3.8 4.7 3.1 3.1 5.3 3.1 8.9 1.0 1.7 17.3 2.0 2.8 2.6 3.2 4.7 7.2 9.0 9.0 2.0 1.5 10.0 1.8 1.6 0.3 11.5 14.4 3.2 4.2 6.0 11.2 7.3 8.3 4.8 4.5 1.1 3.1 1.8 3.5 3.7 3.8 5.9 1.8 6.4 4.6 11.0 14.1 2.0 6.2 8.2 5.6 10.1 1.1 3.3 6.7 3.5 7.1 7.5 8.2 0.8 5.0 6.1 4.9 7.0 3.1 2.9 3.0 14.7 4.4 10.4 2.9 3.1 5.8 0.0 5.7 2.2 3.2 4.7 3.8 2.4 3.1 4.7 5.6 1.3 2.4 3.3 1.8 3.8 4.5 13.2 4.6 3.1 9.0 10.0 13.0 10.1 8.9 10.3 9.2 6.7 8.9 6.9 6.0 6.5 0.0 9.0 5.5 17.8 7.9 12.7 6.7 4.5 14.0 5.9 37.5 0.0 14.8 6.6 7.4 21.0 0.0 17.4 15.1 14.2 14.3 0.0 13.9 22.3 15.9 8.1 16.0 11.4 5.6 13.0 6.6 6.8 10.8 10.2 13.3 12.1 17.3 11.3 5.7 21.4 6.5 7.2 26.8 25.8 5.3 32.0 7.2 14.5 8.0 RHBDF1 "C16orf8, Dist1, EGFR-RS, FLJ2235, iRhom1" ENSG00000007384 "Rhomboid 5 homolog 1" Q96CC6 16 58059-76355 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077399 Uncertain Vesicles NA NA Vesicles "HPA077399: " "unprognostic (2.62e-1)" "unprognostic (2.86e-2)" "unprognostic (4.76e-2)" "unprognostic (4.04e-2)" "unprognostic (1.51e-2)" "unprognostic (3.69e-2)" "unprognostic (5.60e-3)" "unprognostic (4.54e-3)" "unprognostic (4.51e-2)" "unprognostic (1.02e-1)" "unprognostic (7.81e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.49e-5)" "unprognostic (4.81e-2)" "unprognostic (1.87e-1)" "unprognostic (8.36e-2)" "unprognostic (4.22e-2)" 12.7 3.7 6.2 11.5 9.3 0.3 17.7 3.5 6.2 21.8 10.8 6.1 6.7 5.6 13.0 10.4 17.5 10.6 17.2 15.9 7.0 2.8 8.2 3.8 17.8 4.1 6.9 4.9 18.8 9.6 9.8 4.3 26.5 7.3 19.6 5.5 15.9 20.1 13.5 13.4 22.4 7.5 14.6 5.8 6.1 9.2 7.1 3.1 1.2 11.2 15.7 10.1 16.0 19.4 0.0 0.5 0.0 1.7 0.0 0.4 0.0 4.3 7.0 4.0 9.3 15.9 19.7 13.3 11.9 22.5 8.4 8.1 9.5 15.2 0.2 5.0 12.7 4.3 13.8 2.0 8.0 1.4 0.1 2.2 0.1 7.0 2.6 17.8 0.1 7.7 16.4 8.5 21.8 3.6 15.0 12.8 0.0 1.6 0.2 13.3 24.2 0.0 1.4 3.6 9.1 6.0 0.1 4.8 0.3 9.4 4.4 0.1 1.0 3.4 13.2 7.4 5.2 20.4 1.5 13.3 13.4 9.4 10.3 3.2 0.1 0.2 0.1 9.3 0.2 20.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.2 9.3 3.5 6.2 7.0 2.8 6.9 4.9 7.3 3.1 17.9 3.8 0.0 8.9 6.1 0.9 8.1 20.4 1.4 6.8 8.7 62.8 14.0 0.0 19.1 0.5 9.5 5.3 0.0 6.9 14.1 18.2 19.2 0.0 2.6 1.9 0.0 0.0 6.2 0.3 0.9 18.1 0.3 15.1 0.0 8.3 5.7 19.4 7.2 13.1 2.1 4.3 12.9 12.9 0.2 2.5 4.8 25.6 0.5 2.9 9.4 RHBDF2 "FLJ22341, iRhom2, RHBDL5, RHBDL6, TOC, TOCG" ENSG00000129667 "Rhomboid 5 homolog 2" Q6PJF5 17 76470891-76501790 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Growth factor binding" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 44.0;Kupffer cells: 43.5;monocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 35.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA018080 Uncertain NA NA "HPA018080: AB_2178634" "unprognostic (1.19e-1)" "unprognostic (8.71e-2)" "unprognostic (1.59e-2)" "unprognostic (5.11e-3)" "unprognostic (4.33e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-3)" "unprognostic (9.79e-3)" "unprognostic (2.55e-1)" "unprognostic (1.72e-1)" "unprognostic (4.49e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (3.96e-11)" "unprognostic (5.24e-2)" "unprognostic (2.14e-2)" "unprognostic (1.61e-2)" "unprognostic (1.14e-1)" 18.7 7.6 11.6 29.1 17.5 25.9 11.2 3.2 11.5 6.7 6.8 16.4 1.8 6.3 5.4 5.0 16.7 7.5 11.0 6.0 12.8 7.1 9.5 5.2 17.1 24.5 18.2 3.8 6.3 18.9 4.7 4.4 9.9 15.3 6.6 4.6 7.0 9.4 4.7 8.9 19.4 18.2 6.0 23.4 31.6 8.5 4.0 15.3 3.5 8.9 8.1 26.8 10.7 10.0 12.5 9.3 10.7 12.2 4.5 8.2 6.5 16.6 19.0 0.6 5.4 0.1 0.5 14.0 4.3 13.0 3.8 4.6 5.5 22.4 17.8 14.4 4.9 19.1 14.1 3.1 19.5 3.0 3.2 5.8 1.2 1.3 9.1 13.0 0.7 2.7 2.5 10.2 8.6 9.9 7.3 9.5 2.8 2.2 8.6 2.3 13.5 1.9 2.0 3.2 10.8 11.1 4.6 0.1 35.1 8.5 6.0 4.2 6.1 4.2 14.4 18.8 3.9 11.9 5.1 14.5 0.3 7.2 0.3 4.9 21.5 10.1 15.0 11.8 5.5 12.9 3.9 11.6 3.7 8.2 12.2 5.7 12.5 2.3 5.8 5.9 7.7 1.4 3.4 10.7 4.5 10.4 9.3 1.2 6.5 11.6 17.5 3.2 11.5 12.8 7.1 18.2 3.8 15.3 15.3 6.0 8.6 44.0 11.5 15.7 3.2 2.8 20.4 1.4 2.3 3.5 2.0 0.8 0.0 18.3 0.4 11.3 1.3 0.0 8.4 1.7 5.4 7.1 0.0 2.5 32.4 0.0 1.7 9.8 43.5 0.4 0.9 35.6 10.1 46.9 3.4 1.6 13.0 3.5 0.4 1.5 0.9 6.5 3.4 0.4 5.3 25.6 1.4 14.9 6.9 15.8 RHBDL1 "RHBDL, RRP" ENSG00000103269 "Rhomboid like 1" O75783 16 675666-678268 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 12.0;Cone photoreceptor cells: 11.8;Horizontal cells: 14.3;Rod photoreceptor cells: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 3.4" "Group enriched" "Detected in many" 20 "B-cells: 2.2;NK-cells: 1.3;T-cells: 3.4" "Cell line enhanced" "Detected in many" "HeLa: 9.3;MCF7: 9.8;U-266/70: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030359, HPA030360, HPA046593" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711" "prognostic favorable (8.12e-4)" "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.45e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-2)" "unprognostic (3.27e-2)" "unprognostic (1.94e-1)" "unprognostic (2.78e-1)" "unprognostic (6.60e-3)" "unprognostic (2.74e-2)" "unprognostic (3.97e-2)" "unprognostic (5.63e-3)" "unprognostic (5.89e-2)" "unprognostic (1.27e-1)" "unprognostic (8.30e-3)" "unprognostic (1.49e-2)" 1.7 6.3 10.0 1.1 8.3 2.3 0.7 21.3 14.5 1.3 2.2 1.3 2.2 5.8 1.3 1.7 1.1 1.0 1.2 2.4 8.4 9.9 3.9 1.2 0.8 1.1 5.5 7.2 0.9 6.2 2.2 4.4 1.1 4.6 1.5 1.1 1.5 6.1 2.6 0.8 3.1 5.9 0.7 2.2 0.6 4.5 2.2 1.9 0.7 0.6 0.6 0.5 0.8 0.5 2.2 0.1 0.0 0.0 1.3 3.4 0.7 1.8 2.3 1.3 2.0 1.0 2.7 6.9 0.8 1.3 0.4 0.1 4.8 1.3 0.7 1.6 0.5 0.2 1.2 0.1 0.4 0.0 1.7 8.7 1.0 9.3 1.9 1.0 1.7 1.3 1.8 3.3 0.3 0.0 1.0 0.1 3.1 1.3 1.3 0.1 9.8 0.4 4.7 1.3 2.5 0.7 8.3 1.2 1.8 0.1 1.6 1.7 2.3 1.0 0.5 2.2 0.9 3.6 4.9 0.5 2.8 2.6 0.9 0.6 11.9 1.6 2.3 1.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.4 0.3 0.0 0.5 0.5 0.2 0.0 1.3 0.0 0.1 1.2 0.7 10.0 8.3 21.3 14.5 8.4 9.9 5.5 7.2 4.6 1.9 0.0 0.0 0.0 4.2 1.9 12.0 0.8 0.0 8.1 1.2 0.0 11.8 0.2 0.0 0.7 2.0 0.0 3.9 0.0 0.5 0.2 0.9 1.4 0.0 0.8 0.3 14.3 2.4 0.6 1.2 1.1 1.4 0.0 0.0 0.0 4.5 2.0 1.0 3.6 2.5 7.4 35.2 0.0 0.5 0.7 2.1 1.6 0.2 0.0 4.7 1.6 RHBDL2 FLJ20435 ENSG00000158315 "Rhomboid like 2" Q9NX52 1 38885807-38941799 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.9" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 26.3;Pancreatic endocrine cells: 31.9;Suprabasal keratinocytes: 24.8;Undifferentiated cells: 31.4;Urothelial cells: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 8.2;CAPAN-2: 26.6;HaCaT: 13.8;RT4: 26.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA043807 Approved NA NA "HPA043807: AB_10961118" "unprognostic (3.34e-2)" "unprognostic (2.96e-1)" "unprognostic (4.57e-2)" "unprognostic (2.56e-1)" "unprognostic (7.26e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-3)" "unprognostic (5.81e-2)" "unprognostic (2.36e-1)" "unprognostic (2.87e-1)" "unprognostic (4.07e-3)" "unprognostic (1.23e-1)" "unprognostic (7.47e-9)" "unprognostic (1.11e-2)" "unprognostic (2.46e-1)" "unprognostic (4.12e-2)" "unprognostic (4.20e-2)" 1.4 0.0 2.9 6.7 2.7 0.0 1.5 0.4 4.0 5.5 14.9 1.7 0.4 0.7 1.9 0.7 18.9 0.7 6.9 4.9 4.2 2.1 0.5 0.4 2.1 1.5 4.9 0.7 1.2 2.4 0.0 0.4 1.0 1.6 3.1 14.7 0.8 8.2 0.4 0.4 13.4 0.9 0.9 7.9 0.6 12.3 8.4 0.4 1.3 0.4 12.2 16.4 6.9 8.2 1.7 2.1 5.3 1.7 0.9 0.9 0.7 8.2 3.3 0.2 0.1 0.1 1.0 0.9 0.4 0.1 0.6 0.1 0.5 26.6 0.2 1.9 3.8 2.4 13.8 0.0 4.9 0.3 0.1 0.1 0.1 2.0 1.8 0.5 0.0 0.3 0.6 0.6 4.0 0.0 2.5 0.8 0.2 0.0 0.2 0.5 0.0 0.0 0.1 0.2 0.9 0.7 0.1 0.1 0.0 0.0 26.8 0.2 0.1 2.8 6.8 0.2 0.3 3.5 0.2 0.5 3.0 0.3 0.2 0.2 0.2 0.3 0.3 2.6 0.4 0.1 3.6 1.7 1.1 0.8 1.1 0.4 1.7 0.6 0.5 1.9 1.1 0.7 0.7 5.3 0.9 0.7 2.1 0.9 0.7 2.9 2.7 0.4 1.5 4.2 2.1 4.9 0.7 1.6 0.4 0.0 0.3 0.0 6.7 15.8 2.4 0.4 2.5 9.4 6.8 3.5 0.0 0.4 0.0 11.2 2.8 1.1 26.3 0.0 14.2 0.2 2.3 11.4 4.6 0.0 0.2 1.6 2.4 1.3 0.0 0.4 0.6 0.0 1.7 1.0 21.0 1.5 31.9 23.0 0.0 0.0 1.6 6.5 2.0 0.0 0.0 24.8 0.6 0.0 31.4 36.7 RHBDL3 "RHBDL4, VRHO" ENSG00000141314 "Rhomboid like 3" P58872 17 32266176-32324661 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7" "Group enriched" "Detected in some" 9 "Horizontal cells: 96.9;Rod photoreceptor cells: 33.8" "Cancer enhanced" "Detected in some" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.9;AF22: 5.9;GAMG: 6.8;HDLM-2: 8.0;NTERA-2: 8.7;U-2 OS: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059607 Uncertain NA NA "HPA059607: AB_2684081" "unprognostic (7.70e-2)" "unprognostic (3.71e-2)" "unprognostic (2.36e-2)" "unprognostic (6.95e-2)" "unprognostic (2.91e-1)" "unprognostic (2.83e-2)" "unprognostic (2.22e-1)" "unprognostic (1.93e-1)" "unprognostic (1.85e-3)" "unprognostic (1.13e-1)" "unprognostic (1.82e-3)" "unprognostic (1.75e-2)" "unprognostic (4.19e-2)" "unprognostic (2.18e-3)" "unprognostic (2.11e-1)" "unprognostic (1.23e-1)" "unprognostic (8.87e-2)" 1.0 8.2 6.8 1.2 7.4 0.7 1.1 11.3 23.7 1.4 1.2 2.9 3.3 0.9 2.0 1.9 1.3 4.4 0.9 9.7 10.1 6.6 0.8 0.6 0.7 0.7 9.1 4.6 3.4 1.1 0.6 1.9 1.0 6.7 2.1 1.4 3.9 1.0 5.6 0.6 0.9 0.9 1.8 3.6 0.6 0.9 2.5 4.0 0.0 0.6 0.0 0.8 1.9 1.1 0.8 0.0 0.0 0.0 0.0 0.3 0.3 0.0 5.9 5.9 4.6 0.9 0.0 0.1 0.3 0.6 1.9 1.9 0.1 0.0 0.0 0.4 0.7 6.8 0.1 1.6 0.0 0.5 8.0 2.3 1.0 4.0 0.3 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.3 0.0 0.3 0.5 0.0 0.5 0.1 0.2 0.0 8.7 0.0 0.0 1.0 0.0 0.0 0.0 3.2 0.1 1.5 0.8 0.1 0.1 2.2 0.4 0.1 0.0 0.0 6.1 0.2 2.9 0.0 0.0 0.0 0.3 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 6.8 7.4 11.3 15.6 10.1 6.6 9.1 4.6 6.7 4.0 0.0 0.0 0.0 0.6 0.3 6.0 4.3 0.0 0.0 0.0 0.0 5.9 1.3 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.4 96.9 0.0 0.6 0.8 1.5 0.9 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.0 0.0 33.8 0.0 1.0 0.0 0.9 0.1 0.5 0.0 0.0 0.5 RHBG SLC42A2 ENSG00000132677 "Rh family B glycoprotein (gene/pseudogene)" Q9H310 1 156369212-156385219 "Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 23.2;kidney: 16.9;ovary: 5.9" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 21.0;Distal tubular cells: 16.6;Early spermatids: 10.7;Late spermatids: 8.6" "Group enriched" "Detected in some" 5 "liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1" "Region enriched" "Detected in some" 15 "cerebellum: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 65 "CACO-2: 4.8;Hep G2: 5.7;RT4: 10.0" "Low region specificity" "Detected in all" "HPA042726, HPA048489" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA042726: AB_2678131, HPA048489: AB_2680417" "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" "unprognostic (4.55e-3)" "unprognostic (5.04e-2)" "unprognostic (2.95e-2)" "unprognostic (3.76e-3)" "unprognostic (2.00e-1)" "unprognostic (1.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.45e-1)" "unprognostic (3.72e-1)" "unprognostic (3.63e-2)" "unprognostic (4.91e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-3)" "prognostic favorable (8.06e-4)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 23.2 0.1 0.3 0.3 0.0 1.0 0.0 0.1 0.0 2.2 0.0 0.0 0.1 0.1 0.1 16.9 3.3 0.1 0.0 0.1 0.1 5.9 0.2 0.0 0.1 0.0 1.5 0.1 0.0 0.0 0.1 0.4 0.1 1.0 0.3 0.0 0.1 0.1 0.1 1.2 0.0 0.0 0.1 1.1 1.2 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 23.2 0.1 0.1 0.1 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 21.0 0.0 0.0 16.6 0.3 10.7 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 4.3 0.1 0.0 0.0 0.0 0.0 8.6 0.3 0.0 0.0 1.0 0.0 1.1 0.1 0.0 0.4 0.9 0.0 0.0 0.0 2.2 0.4 0.4 0.0 0.0 0.0 0.0 RHCE "CD240CE, RH" ENSG00000188672 "Rh blood group CcEe antigens" P18577 1 25362249-25430192 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 40.5" "Cell type enriched" "Detected in some" 33 "Erythroid cells: 210.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.4" "Cell line enriched" "Detected in some" 5 "HEL: 44.7" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (1.37e-1)" "unprognostic (3.53e-1)" "unprognostic (2.38e-1)" "unprognostic (6.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.91e-2)" "unprognostic (7.01e-2)" "unprognostic (3.12e-2)" "unprognostic (3.81e-2)" "unprognostic (1.35e-1)" "unprognostic (6.08e-2)" "unprognostic (4.61e-2)" "unprognostic (5.77e-5)" "unprognostic (1.38e-1)" "unprognostic (3.94e-2)" "unprognostic (7.15e-3)" "unprognostic (1.63e-1)" 0.6 0.8 2.0 0.6 5.1 40.5 0.9 3.3 4.7 0.8 0.7 3.5 1.0 0.7 0.7 5.2 1.4 1.6 0.8 2.1 2.6 1.5 0.8 2.2 0.7 1.0 2.1 2.5 0.9 9.6 0.5 4.0 1.6 5.9 1.6 0.8 2.2 8.4 0.8 1.9 1.1 0.6 0.5 2.9 2.1 0.8 2.6 1.4 1.2 1.1 1.2 0.8 0.5 0.6 0.1 0.2 2.4 0.2 0.1 0.3 0.9 0.1 0.0 0.1 0.2 0.4 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.7 0.3 0.5 0.5 0.0 0.1 0.0 0.1 0.1 0.2 0.0 44.7 0.0 0.0 0.6 0.0 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.3 8.7 0.2 0.2 0.4 0.0 0.3 0.9 0.3 0.2 0.1 0.1 1.2 0.0 0.0 0.3 0.4 0.1 0.1 0.5 0.4 0.2 0.0 0.0 0.1 0.0 0.4 0.0 2.6 0.6 0.5 1.5 0.4 0.2 2.4 0.2 0.6 0.3 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.2 0.0 1.0 0.1 0.0 0.1 0.3 0.9 2.0 5.1 3.3 4.7 2.6 1.5 2.1 2.5 5.9 1.4 0.0 0.0 0.0 0.5 0.5 3.3 0.4 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.8 0.0 0.0 210.2 0.2 0.4 0.2 0.4 4.6 0.4 0.2 6.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.7 0.0 2.5 6.5 0.0 2.8 5.1 1.3 0.7 0.0 0.1 0.7 RHCG "C15orf6, PDRC2, RHGK, SLC42A3" ENSG00000140519 "Rh family C glycoprotein" Q9UBD6 15 89471398-89496613 "Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 304.0;lymphoid tissue: 185.9;tongue: 115.4;vagina: 91.8" "Group enriched" "Detected in some" 4 "Muller glia cells: 63.6;Urothelial cells: 75.2" "Cancer enhanced" "Detected in many" "cervical cancer: 152.9;head and neck cancer: 154.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.0;hTCEpi: 4.5;RT4: 4.5;SK-MEL-30: 2.7" "Region enriched" "Detected in some" 5 "olfactory region: 10.4" "Low region specificity" "Detected in many" "HPA041874, HPA043317" Enhanced NA NA "HPA041874: AB_2677719, HPA043317: AB_2678424" "unprognostic (1.60e-1)" "unprognostic (4.28e-2)" "unprognostic (1.52e-1)" "unprognostic (3.86e-3)" "unprognostic (1.98e-2)" "unprognostic (9.39e-3)" "unprognostic (2.07e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (1.07e-1)" "unprognostic (9.82e-2)" "unprognostic (1.39e-2)" "unprognostic (4.84e-2)" "unprognostic (2.55e-3)" "unprognostic (2.68e-1)" "unprognostic (2.80e-2)" "unprognostic (2.27e-1)" "unprognostic (9.45e-3)" 0.3 0.3 0.2 0.2 0.2 0.2 0.3 0.0 0.5 60.6 0.2 0.0 0.0 0.2 4.4 0.2 304.0 0.3 0.3 0.3 0.2 0.0 8.6 0.3 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.0 0.2 0.1 0.3 0.2 0.1 37.3 0.3 0.2 0.7 0.2 0.3 0.2 0.2 0.2 0.3 0.0 0.0 0.2 115.4 185.9 0.5 91.8 0.6 0.3 0.0 0.2 0.0 0.6 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.6 1.6 0.6 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 4.5 0.3 0.3 0.8 0.0 2.7 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.6 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.6 0.1 0.1 0.6 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.2 0.0 0.3 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 8.8 1.1 0.8 0.4 0.0 0.0 0.0 14.0 0.0 0.0 13.3 1.1 1.6 0.0 0.0 0.0 0.3 0.0 0.1 7.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 63.6 1.2 4.0 0.0 0.0 2.4 0.0 0.4 0.1 0.1 15.6 0.0 0.0 0.0 75.2 RHD "CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI" ENSG00000187010 "Rh blood group D antigen" Q02161 1 25272393-25330445 "Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.0;bone marrow: 16.5;salivary gland: 7.1" "Cell type enriched" "Detected in some" 20 "Erythroid cells: 23.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.0" "Group enriched" "Detected in some" 6 "HEL: 28.2;K-562: 8.7" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (4.75e-3)" "unprognostic (7.70e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.09e-2)" "unprognostic (4.84e-2)" "unprognostic (1.11e-2)" "unprognostic (5.25e-2)" "unprognostic (1.11e-2)" "unprognostic (1.91e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (4.96e-3)" "unprognostic (1.93e-1)" "unprognostic (8.09e-2)" "unprognostic (5.53e-2)" "unprognostic (4.92e-3)" 0.3 0.3 0.3 0.5 0.5 16.5 0.3 1.5 1.4 0.6 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.4 0.9 0.3 0.2 0.3 0.3 2.5 0.8 0.3 0.3 0.9 0.3 0.1 0.4 0.3 1.1 0.5 0.0 0.3 7.1 0.3 4.1 2.5 0.4 0.3 0.4 1.8 0.3 0.5 0.3 0.3 0.4 2.3 0.3 0.3 0.3 2.0 0.6 10.0 1.4 1.4 1.4 1.2 0.1 0.0 0.2 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.1 28.2 0.7 0.2 0.0 0.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 8.7 0.7 0.0 0.1 0.2 0.2 3.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.5 0.3 0.1 0.2 0.1 0.1 0.2 0.5 0.4 0.5 0.2 0.4 0.1 0.3 0.1 0.1 0.5 0.2 0.1 4.9 1.4 2.8 1.0 0.6 1.1 1.3 1.3 0.8 0.2 2.0 1.4 1.3 10.0 1.4 0.8 0.6 0.9 1.2 0.3 0.5 1.5 1.4 0.3 0.2 0.3 0.3 1.1 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 23.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 RHEX "C1orf186, FLJ16052" ENSG00000263961 "Regulator of hemoglobinization and erythroid cell expansion" Q6ZWK4 1 206052723-206102459 "Predicted membrane proteins" "Differentiation, Erythrocyte maturation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 117.7" "Cell type enriched" "Detected in some" 14 "granulocytes: 308.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 42.8;ovarian cancer: 41.1" "Cell type enriched" "Detected in some" 51 "basophil: 117.7" "Lineage enriched" "Detected in many" 51 "granulocytes: 117.7" "Cell line enriched" "Detected in some" 5 "HMC-1: 189.5" "Low region specificity" "Detected in all" HPA037859 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA037859: AB_10697084" "unprognostic (9.26e-3)" "unprognostic (1.91e-2)" "unprognostic (9.66e-2)" "unprognostic (1.65e-2)" "unprognostic (2.06e-2)" "unprognostic (5.27e-3)" "unprognostic (9.55e-2)" "unprognostic (3.04e-3)" "unprognostic (2.36e-1)" "unprognostic (1.31e-2)" "unprognostic (1.35e-1)" "unprognostic (7.20e-3)" "unprognostic (1.89e-2)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (3.77e-2)" "unprognostic (2.80e-3)" 4.3 0.0 0.0 3.9 0.0 0.0 1.8 0.0 0.0 13.1 3.1 0.0 12.1 0.9 6.2 8.2 3.4 1.6 16.2 0.4 0.0 6.8 1.8 5.2 4.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 9.4 3.3 2.9 0.0 16.9 1.5 0.2 4.0 7.0 0.0 0.4 2.4 1.1 0.0 0.6 0.0 1.7 2.5 4.3 10.0 0.3 2.2 117.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.1 0.0 8.6 189.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 38.1 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 117.7 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 19.2 0.0 1.5 1.7 2.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 308.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RHO "CSNBAD1, OPN2, RP4" ENSG00000163914 Rhodopsin P08100 3 129528640-129535169 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Congenital stationary night blindness, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 151 "retina: 415.0" "Cell type enriched" "Detected in some" 7 "Rod photoreceptor cells: 2822.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebellum: 1.6;cerebral cortex: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013440, CAB022486, CAB034887, CAB034888" Enhanced NA NA "CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844" "unprognostic (4.32e-2)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "unprognostic (1.83e-1)" "unprognostic (2.87e-1)" "unprognostic (1.94e-1)" "unprognostic (9.19e-11)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (2.91e-1)" 0.2 0.0 0.0 0.0 0.3 0.0 0.1 1.6 2.7 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.1 415.0 0.3 0.2 0.0 1.8 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 2.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 290.1 0.6 0.0 0.0 0.0 0.0 428.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 206.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 393.2 0.0 0.0 0.0 0.0 2822.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RHOT1 "ARHT1, FLJ11040, MIRO-1" ENSG00000126858 "Ras homolog family member T1" Q8IXI2 17 32142454-32253374 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010687, CAB068223, CAB068224" Supported NA NA "CAB068223: AB_2665691, CAB068224: AB_2665692, HPA010687: AB_1079813" "unprognostic (3.28e-2)" "unprognostic (4.02e-3)" "unprognostic (6.85e-2)" "unprognostic (3.53e-1)" "unprognostic (1.57e-2)" "unprognostic (5.49e-2)" "unprognostic (1.59e-3)" "unprognostic (1.59e-2)" "unprognostic (7.02e-3)" "unprognostic (1.29e-1)" "unprognostic (1.38e-1)" "unprognostic (5.05e-1)" "unprognostic (1.01e-2)" "unprognostic (2.97e-2)" "unprognostic (2.58e-1)" "unprognostic (3.90e-1)" "unprognostic (4.08e-2)" 17.0 26.6 20.9 14.4 21.8 16.0 17.7 23.0 26.7 16.3 15.1 12.7 13.8 10.1 16.2 14.5 15.8 12.8 10.2 23.9 23.2 19.3 17.4 15.4 16.5 11.0 19.1 25.8 19.5 14.7 28.7 19.2 17.2 17.5 16.8 10.7 14.0 14.8 22.7 21.9 21.5 15.6 16.3 21.8 10.7 13.8 11.8 17.4 18.2 24.5 12.1 9.5 14.3 22.1 4.9 8.5 8.6 9.3 5.2 3.7 4.0 7.8 14.9 13.2 13.2 15.6 17.2 7.6 12.9 11.2 14.8 15.7 7.5 5.1 9.9 13.2 11.0 15.5 14.1 18.7 7.6 17.6 7.9 14.7 11.5 9.6 11.0 22.9 16.2 8.7 9.3 24.0 12.1 15.5 23.5 12.2 20.8 26.8 8.8 12.5 5.8 28.3 11.7 9.8 9.4 7.0 15.9 20.2 17.8 10.0 4.5 11.8 10.7 13.9 7.9 21.4 16.0 19.8 20.4 9.0 10.2 10.5 11.5 9.0 12.7 12.1 11.2 12.0 14.5 17.1 4.6 9.3 8.6 3.4 7.7 3.7 3.2 3.6 3.4 8.5 4.9 2.9 3.6 5.1 5.2 7.0 2.5 2.1 4.0 20.9 21.8 23.0 26.7 23.2 19.3 19.1 25.8 17.5 17.4 26.8 28.4 15.2 12.1 23.0 57.8 32.1 7.6 12.0 18.2 15.7 66.8 24.6 28.2 13.7 15.5 14.9 13.8 0.0 11.6 16.8 18.6 10.7 26.5 13.9 29.4 54.0 16.3 20.3 48.9 16.9 27.9 26.2 15.1 10.8 9.9 118.0 12.8 13.5 22.6 18.2 54.6 25.8 20.6 42.3 32.4 46.3 19.0 12.8 14.0 8.5 RHOT2 "ARHT2, C16orf39, MIRO-2" ENSG00000140983 "Ras homolog family member T2" Q8IXI1 16 668086-674174 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 249.4;Rod photoreceptor cells: 288.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012624, HPA012895" Approved Supported Mitochondria NA NA Mitochondria "HPA012624: AB_1856272, HPA012895: AB_1856271" "unprognostic (1.59e-1)" "unprognostic (8.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.50e-2)" "unprognostic (1.09e-1)" "prognostic favorable (5.01e-4)" "unprognostic (4.68e-3)" "unprognostic (4.66e-2)" "unprognostic (3.41e-2)" "unprognostic (7.55e-2)" "unprognostic (7.87e-3)" "unprognostic (3.25e-1)" "prognostic favorable (5.43e-4)" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (1.24e-1)" "unprognostic (2.17e-2)" 15.2 22.8 19.9 26.4 22.3 25.8 16.4 33.3 22.6 14.6 27.2 14.7 19.5 29.5 16.4 27.6 17.3 17.3 28.5 26.5 18.4 11.5 21.8 23.0 15.7 23.4 20.1 20.5 17.3 25.1 18.1 25.3 17.7 19.9 23.3 8.9 30.5 31.7 20.2 21.9 25.3 25.1 13.8 10.4 27.0 24.5 15.8 15.3 20.2 22.1 14.6 20.8 16.6 16.3 11.0 16.4 16.9 18.6 8.7 20.1 13.2 9.4 18.2 10.6 16.4 5.3 5.6 18.9 15.8 7.4 13.5 10.3 25.3 14.5 10.6 11.3 6.4 4.7 17.8 7.5 15.0 3.5 15.1 31.1 12.6 22.5 18.1 9.8 11.6 17.3 9.0 12.9 10.0 5.9 7.9 9.6 14.6 22.9 8.9 7.1 38.6 12.2 12.8 26.2 8.2 12.6 28.3 11.9 22.1 8.6 18.0 23.0 27.2 14.9 19.7 8.6 6.3 20.3 18.2 15.4 10.6 17.0 8.9 11.4 23.9 15.1 14.8 6.9 11.0 15.0 4.5 16.1 16.9 20.1 18.6 12.2 10.1 16.0 15.9 15.9 11.0 12.2 10.3 13.8 8.7 14.3 16.4 18.0 13.2 19.9 22.3 33.3 22.6 18.4 11.5 20.1 20.5 19.9 15.3 29.8 28.0 27.6 25.8 30.0 90.3 21.7 30.6 17.4 15.9 27.9 249.4 51.8 18.3 35.5 4.3 24.8 52.3 0.0 31.1 43.7 26.8 20.0 50.7 31.0 31.5 81.0 41.2 21.5 34.9 4.0 25.0 26.4 27.0 56.9 37.2 36.1 33.9 37.1 24.1 19.5 288.4 51.8 33.5 28.6 51.3 27.7 56.1 51.2 38.3 20.5 RIC3 "AYST720, FLJ11608, PRO1385" ENSG00000166405 "RIC3 acetylcholine receptor chaperone" Q7Z5B4 11 8106093-8169055 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 168.2;Cone photoreceptor cells: 135.5;Rod photoreceptor cells: 208.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "GAMG: 3.2;HMC-1: 3.7;NTERA-2: 6.8;SCLC-21H: 11.6;SH-SY5Y: 8.0;SuSa: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065016 Approved "Intracellular and membrane" NA NA "HPA065016: AB_2685404" "unprognostic (2.51e-3)" "unprognostic (2.32e-1)" "unprognostic (1.21e-1)" "unprognostic (6.98e-4)" "unprognostic (3.22e-2)" "unprognostic (1.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.43e-2)" "unprognostic (1.59e-2)" "unprognostic (1.48e-2)" "unprognostic (4.45e-4)" "unprognostic (1.28e-1)" "unprognostic (2.23e-9)" "unprognostic (4.37e-2)" "unprognostic (5.53e-2)" "unprognostic (1.35e-1)" "unprognostic (2.52e-2)" 2.1 14.5 14.6 8.2 18.5 2.6 8.6 25.3 20.8 4.7 7.0 8.4 11.3 2.9 11.6 28.0 5.0 8.1 4.9 8.2 9.8 10.5 6.6 2.2 4.7 9.3 9.8 17.0 17.4 12.0 22.7 23.2 1.0 16.4 15.3 3.3 9.8 13.1 14.7 6.7 17.4 5.7 9.3 10.1 6.9 6.2 7.7 9.9 0.4 17.1 1.9 8.8 7.7 4.0 12.8 1.5 2.9 1.5 1.8 6.9 0.8 0.0 1.2 2.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 3.2 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.6 0.0 0.0 0.0 3.7 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.2 6.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 11.6 8.0 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 1.2 0.2 1.6 0.7 0.0 0.0 0.1 0.0 0.1 2.9 0.6 1.2 2.2 0.8 1.5 11.0 4.6 2.4 0.6 12.8 6.9 5.9 1.8 1.8 1.5 1.5 2.5 0.8 14.6 18.5 25.3 19.1 9.8 10.5 9.8 17.0 16.4 9.9 6.0 13.3 79.3 48.3 32.3 168.2 11.8 20.4 25.4 30.7 22.7 135.5 0.3 0.0 27.5 1.8 3.3 0.0 23.3 24.9 0.3 3.8 35.3 23.2 4.9 0.2 90.6 7.5 1.3 0.6 1.5 31.1 2.8 11.8 2.8 1.3 61.0 15.9 0.3 43.9 1.5 208.7 0.0 2.7 51.4 36.1 34.6 0.5 12.2 0.0 34.1 RMDN2 "FAM82A, FAM82A1, FLJ32954, RMD2" ENSG00000115841 "Regulator of microtubule dynamics 2" Q96LZ7 2 37923187-38067142 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 38.4" "Group enriched" "Detected in many" 6 "Early spermatids: 207.9;Late spermatids: 131.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 17.7" "HPA034705, HPA034706" Enhanced Supported "Golgi apparatus,Mitotic spindle,Cytosol" Yes No "Mitotic spindle, Cytosol" "Golgi apparatus" "HPA034705: AB_2674292, HPA034706: AB_10696362" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.76e-1)" "unprognostic (3.06e-2)" "prognostic favorable (2.63e-4)" "unprognostic (7.85e-2)" "unprognostic (9.96e-2)" "unprognostic (7.50e-2)" "unprognostic (1.94e-1)" "unprognostic (2.88e-2)" "unprognostic (5.08e-3)" "unprognostic (1.20e-1)" "unprognostic (4.34e-3)" "unprognostic (3.34e-1)" 4.6 38.4 6.1 8.7 6.8 1.9 8.9 6.2 8.2 6.3 9.7 1.8 5.9 6.8 7.0 9.2 3.7 4.3 5.5 4.6 5.9 3.5 6.6 24.0 8.2 3.3 3.2 5.1 3.2 4.2 3.2 8.6 3.1 4.6 8.1 8.7 5.2 5.7 10.2 5.0 2.9 14.7 7.7 4.8 14.1 4.6 15.6 4.0 2.1 4.7 3.6 2.1 4.3 9.0 7.5 6.0 4.8 8.0 6.3 6.1 2.3 3.4 3.9 2.7 1.7 12.1 12.4 1.6 7.3 9.3 3.6 3.8 1.0 11.4 2.4 3.2 10.8 2.3 3.9 0.9 4.9 4.6 4.7 2.7 4.0 1.6 3.4 6.3 0.0 4.1 17.7 3.8 5.0 0.7 6.1 2.0 1.2 4.8 2.0 6.5 1.3 0.8 4.1 5.2 6.6 3.9 0.0 0.7 0.4 9.5 3.1 2.1 7.9 5.7 0.6 6.4 2.3 1.2 5.5 2.8 5.1 5.4 2.7 2.8 3.9 6.8 4.8 6.0 0.9 5.1 0.0 4.9 1.0 4.0 8.0 6.1 7.5 1.9 2.5 3.3 5.0 2.0 4.3 4.8 6.3 6.1 6.0 0.2 2.3 6.1 6.8 6.2 8.2 5.9 3.5 3.2 5.1 4.6 4.0 26.8 23.5 5.4 7.2 2.2 3.7 3.6 7.6 13.4 27.3 5.2 2.0 1.7 6.6 4.2 207.9 3.6 21.2 0.0 3.4 0.8 7.3 2.5 15.1 12.9 4.4 4.8 4.6 3.7 6.5 131.8 8.6 4.4 5.0 1.8 11.2 5.8 2.4 7.0 5.6 5.9 2.2 6.5 3.9 3.9 3.7 2.0 0.7 3.8 15.9 2.0 RMDN3 "FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3" ENSG00000137824 "Regulator of microtubule dynamics 3" Q96TC7 15 40735884-40755851 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009975, HPA074840" Supported Enhanced "Cytokinetic bridge,Mitochondria" Yes No Mitochondria "Cytokinetic bridge" "HPA009975: AB_1078811, HPA074840: " "unprognostic (2.54e-2)" "unprognostic (3.53e-1)" "unprognostic (2.35e-2)" "unprognostic (3.97e-3)" "unprognostic (1.50e-1)" "unprognostic (2.50e-3)" "unprognostic (2.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.94e-3)" "prognostic favorable (6.70e-8)" "unprognostic (1.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.79e-3)" "unprognostic (2.04e-3)" 22.9 17.3 29.0 12.4 26.4 16.0 15.5 22.6 29.6 15.2 14.6 20.7 9.3 34.4 10.2 10.5 14.9 15.4 14.7 12.1 27.2 21.1 14.7 28.4 27.8 11.1 26.0 29.3 12.0 21.6 17.6 7.3 15.3 18.4 14.1 6.7 10.6 25.3 13.4 12.7 12.9 39.6 9.6 29.4 9.8 14.4 12.2 22.9 7.8 16.1 11.6 8.5 13.6 10.4 7.6 25.5 2.5 9.7 28.1 14.4 10.6 8.4 7.7 9.3 16.0 7.7 7.3 16.2 22.0 8.6 15.7 11.5 27.7 9.5 7.2 29.4 11.3 11.0 29.2 10.3 16.4 0.6 18.9 14.7 23.1 22.6 13.6 29.0 15.5 18.5 14.1 14.8 11.0 9.2 6.6 10.5 14.4 24.2 20.0 5.9 17.1 11.6 10.0 7.4 20.7 15.4 18.3 11.2 16.7 11.5 14.3 22.4 8.2 17.5 23.7 8.1 3.2 18.5 16.9 16.4 17.1 12.2 22.8 18.4 15.3 17.8 11.5 12.1 16.5 18.6 1.9 6.2 2.5 14.4 8.2 12.6 7.6 10.5 13.0 6.8 6.7 8.2 8.9 1.0 28.1 9.7 25.5 9.1 10.6 29.0 26.4 22.6 26.9 27.2 21.1 26.0 29.3 18.4 22.9 29.8 25.5 4.5 14.2 14.0 19.2 7.0 10.2 26.8 21.6 17.4 3.9 36.6 1.7 25.3 2.0 16.5 16.9 0.0 19.5 23.1 16.9 15.9 18.5 30.9 113.0 17.5 4.7 17.8 15.6 3.1 15.5 10.9 18.6 11.8 11.5 20.0 17.9 14.4 13.4 13.3 15.2 6.5 11.4 31.1 42.8 10.5 52.5 18.5 18.8 19.0 RNASE1 "RAC1, RNS1" ENSG00000129538 "Ribonuclease A family member 1, pancreatic" P07998 14 20801228-20803278 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "pancreas: 809.6" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 863.6;Alveolar cells type 2: 748.9;Hofbauer cells: 1257.5;Ito cells: 532.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 8.0;myeloid DC: 16.1" "Group enriched" "Detected in many" 9 "dendritic cells: 16.1;monocytes: 8.0" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 74.4;OE19: 16.9;RT4: 29.1;TIME: 38.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001140 Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" NA NA 1500000000 Vesicles Nucleoplasm "HPA001140: AB_1079816" "unprognostic (2.32e-2)" "unprognostic (3.16e-2)" "unprognostic (9.51e-3)" "unprognostic (7.77e-2)" "unprognostic (6.93e-2)" "unprognostic (1.28e-1)" "unprognostic (3.42e-3)" "unprognostic (6.59e-3)" "unprognostic (4.69e-2)" "unprognostic (7.92e-2)" "unprognostic (6.32e-2)" "unprognostic (3.56e-2)" "unprognostic (5.14e-3)" "unprognostic (1.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.43e-2)" "unprognostic (1.67e-1)" 79.2 48.4 28.7 12.0 38.5 1.6 59.7 4.0 32.2 21.3 33.7 57.8 63.6 16.8 13.6 49.1 19.3 24.3 37.5 70.3 41.2 21.6 33.8 8.6 94.3 23.5 39.0 16.0 19.2 809.6 6.7 4.1 79.0 25.1 23.0 39.8 106.4 15.9 35.6 31.7 10.8 20.6 26.6 52.3 34.5 87.9 86.5 27.1 7.8 11.2 14.3 7.2 29.0 10.9 0.0 16.1 1.3 8.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 74.4 0.0 7.2 0.1 0.0 0.0 0.0 0.5 0.3 16.9 0.0 0.0 0.0 0.3 0.0 29.1 0.3 0.3 0.0 0.2 0.0 0.5 0.0 0.0 38.7 0.0 0.7 0.5 0.0 0.1 0.0 0.0 1.0 0.0 1.0 1.3 8.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 2.0 28.7 38.5 4.0 32.2 41.2 21.6 39.0 16.0 25.1 27.1 863.6 748.9 16.1 0.9 31.6 0.0 58.9 40.8 58.9 295.7 15.7 0.0 12.0 0.0 8.2 17.6 308.3 107.7 0.0 270.1 10.2 30.9 1.4 23.3 4.9 1257.5 1.6 46.9 532.2 311.7 43.1 29.7 100.6 38.8 4.6 398.3 0.8 308.4 78.7 10.3 0.3 1.8 97.0 15.6 7.0 5.3 24.6 21.6 7.5 165.1 1.7 RNASE10 "RAH1, RNASE9" ENSG00000182545 "Ribonuclease A family member 10 (inactive)" Q5GAN6 14 20505537-20511169 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Fertilization" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "head and neck cancer: 2.0;testis cancer: 1.8" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 9.0;U-2 OS: 14.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA052593 Uncertain "Secreted in male reproductive system" NA NA "HPA052593: AB_2681878" "unprognostic (2.48e-3)" "unprognostic (2.22e-1)" "unprognostic (2.46e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (5.91e-3)" "unprognostic (5.03e-3)" "unprognostic (5.58e-3)" "unprognostic (4.20e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-3)" "unprognostic (1.11e-1)" "unprognostic (7.88e-4)" "unprognostic (1.58e-1)" "unprognostic (3.62e-1)" "unprognostic (8.76e-2)" "unprognostic (2.58e-1)" 3.1 3.2 0.9 2.3 1.1 1.4 1.2 1.4 2.0 1.5 1.0 2.5 3.5 1.6 2.0 3.0 0.7 0.9 1.0 1.0 1.5 2.4 2.5 0.9 1.1 2.6 1.1 0.5 1.7 1.1 1.8 0.2 1.4 0.9 3.0 4.2 2.7 0.5 1.3 1.9 1.7 3.4 1.6 0.2 1.8 1.7 0.9 1.3 3.5 1.3 0.6 0.5 0.1 5.5 2.7 1.1 2.6 0.3 0.6 3.6 0.3 0.6 0.1 0.4 1.8 1.6 0.8 1.8 0.7 0.8 2.9 0.0 0.3 0.2 2.3 0.9 0.1 1.9 0.9 0.8 0.3 2.8 0.9 2.0 0.2 3.0 0.5 1.4 1.0 1.3 3.2 0.0 1.5 0.9 1.6 0.8 0.8 0.4 4.3 0.4 3.3 0.9 2.3 1.6 1.9 9.0 2.3 1.0 1.3 2.2 0.9 0.6 1.0 14.8 1.2 1.1 3.1 1.4 0.4 1.1 0.8 1.2 3.5 0.5 0.0 0.5 0.4 0.4 0.9 0.4 0.2 0.1 0.8 0.2 0.5 2.1 0.6 1.3 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 RNASE4 RAB1 ENSG00000258818 "Ribonuclease A family member 4" P34096 14 20684100-20701215 "Plasma proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "liver: 366.2" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 43.7;Intestinal endocrine cells: 64.6;Mucus-secreting cells: 108.1" "Cancer enhanced" "Detected in many" "liver cancer: 6.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 17.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 30.3;ASC TERT1: 34.3;Hep G2: 42.7;HSkMC: 20.4;OE19: 28.5" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 27000000 "unprognostic (1.07e-1)" "unprognostic (3.46e-1)" "unprognostic (5.21e-2)" "unprognostic (3.18e-4)" "unprognostic (1.20e-1)" "unprognostic (7.05e-2)" "prognostic favorable (9.62e-5)" "unprognostic (1.43e-1)" "unprognostic (2.22e-2)" "unprognostic (6.88e-2)" "unprognostic (3.71e-2)" "unprognostic (1.29e-1)" "unprognostic (3.46e-1)" "unprognostic (2.54e-2)" "unprognostic (1.57e-1)" "unprognostic (9.16e-2)" "unprognostic (4.27e-2)" 29.6 1.7 1.5 5.7 1.8 0.2 28.7 1.0 1.2 25.2 16.3 2.5 12.3 4.9 19.2 18.4 14.7 15.7 23.4 10.3 2.3 1.0 18.9 366.2 12.8 5.2 3.0 1.4 30.8 16.3 3.8 3.0 4.4 2.7 30.4 15.0 10.5 35.0 14.2 7.1 10.6 13.6 17.4 3.8 3.2 19.2 13.2 1.9 0.3 8.4 10.5 7.3 25.1 26.3 4.0 9.7 0.5 17.0 0.4 2.5 5.0 0.8 4.0 0.8 0.0 30.3 34.3 0.1 3.3 7.5 0.5 1.4 1.0 1.1 0.0 0.8 7.5 1.9 0.7 0.4 0.8 0.6 5.3 0.4 0.0 0.9 42.7 3.4 0.4 0.1 20.4 1.9 0.5 3.4 10.9 3.9 1.2 0.0 3.7 2.2 0.5 0.2 0.0 0.1 28.5 3.3 0.1 0.6 1.1 0.7 0.7 0.0 0.1 1.2 0.6 0.8 1.4 0.9 0.1 4.0 0.9 0.5 1.2 0.1 0.7 0.9 0.1 1.4 0.3 0.8 0.1 17.0 0.0 0.6 0.9 0.8 4.0 1.1 0.4 9.7 2.2 0.2 0.4 0.5 0.4 0.1 2.3 2.5 5.0 1.5 1.8 1.0 1.2 2.3 1.0 3.0 1.4 2.7 1.9 35.7 15.5 4.2 1.3 2.5 0.0 0.3 22.9 16.0 6.8 3.5 0.0 0.2 0.0 22.2 0.1 1.3 33.7 0.0 19.7 0.3 4.8 1.8 1.1 43.7 1.7 0.0 64.6 5.5 10.3 0.0 11.5 1.9 3.3 1.0 108.1 0.8 15.7 14.0 3.9 8.4 0.2 0.0 7.2 0.2 0.0 3.6 0.3 1.0 34.8 1.0 RNASE6 "RAD1, RNaseK6, RNS6" ENSG00000169413 "Ribonuclease A family member k6" Q93091 14 20781051-20782467 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 117.6" "Cell type enhanced" "Detected in many" 23 "B-cells: 117.8;Hofbauer cells: 181.1;Kupffer cells: 514.5;Macrophages: 188.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 117.6" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 7 "RPMI-8226: 33.8" "Low region specificity" "Detected in many" HPA000698 Approved "Secreted to blood" NA NA 2300000 "HPA000698: AB_2181340" "unprognostic (5.04e-2)" "unprognostic (5.21e-3)" "unprognostic (3.59e-2)" "unprognostic (4.05e-2)" "unprognostic (1.74e-1)" "unprognostic (7.31e-2)" "unprognostic (7.91e-2)" "unprognostic (2.29e-1)" "unprognostic (4.45e-1)" "unprognostic (1.65e-1)" "unprognostic (2.04e-1)" "unprognostic (2.73e-1)" "unprognostic (2.85e-3)" "unprognostic (9.62e-2)" "unprognostic (5.60e-3)" "unprognostic (3.46e-2)" "unprognostic (5.54e-2)" 25.0 10.8 7.8 19.3 10.3 7.3 11.9 1.8 7.7 10.7 9.1 7.9 4.6 5.7 5.5 25.9 4.7 7.2 14.6 11.2 7.0 6.5 10.6 8.2 16.4 51.0 10.9 3.3 4.3 4.9 1.3 4.1 13.9 9.8 6.0 10.8 6.9 9.5 5.6 2.7 4.9 23.4 7.2 24.0 49.3 5.8 5.7 10.3 12.8 4.2 3.3 25.5 14.7 4.5 42.2 117.6 33.8 52.0 3.6 1.4 26.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.8 2.5 0.3 0.1 0.0 0.0 1.0 2.2 0.0 0.0 0.0 0.1 0.0 33.8 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 33.8 52.0 1.1 0.5 12.2 1.2 28.9 1.4 0.6 49.4 42.2 0.6 0.1 19.0 3.6 0.1 117.6 0.1 26.8 7.8 10.3 1.8 7.7 7.0 6.5 10.9 3.3 9.8 10.3 6.0 12.7 117.8 0.1 3.9 0.0 0.4 22.9 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.6 2.2 0.8 23.3 0.0 1.5 2.7 0.3 0.0 2.1 181.1 0.0 0.0 11.1 514.5 0.7 2.6 188.7 20.3 1.8 0.3 0.0 0.0 10.5 0.7 0.4 0.4 12.9 0.7 0.0 0.8 3.3 1.8 8.9 2.8 0.8 RNASE7 RAE1 ENSG00000165799 "Ribonuclease A family member 7" Q9H1E1 14 21042226-21044234 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 38.3;lymphoid tissue: 41.0;tongue: 21.4" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 23.3;Cholangiocytes: 12.7;Urothelial cells: 17.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 15.4;hTCEpi: 6.7;hTERT-HME1: 33.4" "HPA005690, CAB062560, CAB068225" Enhanced "Secreted in other tissues" NA NA "CAB062560: AB_2665595, CAB068225: AB_2665594, HPA005690: AB_1079819" "unprognostic (1.13e-2)" "unprognostic (3.21e-1)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.71e-1)" "unprognostic (8.27e-2)" "unprognostic (7.80e-2)" "unprognostic (8.73e-2)" "unprognostic (3.28e-1)" "unprognostic (1.15e-1)" "unprognostic (2.25e-2)" "unprognostic (1.94e-1)" "unprognostic (2.17e-2)" "unprognostic (1.74e-1)" "unprognostic (8.23e-2)" "unprognostic (3.24e-1)" "unprognostic (3.42e-1)" 0.1 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.3 38.3 0.0 4.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.5 0.2 0.0 3.5 0.2 0.2 14.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.3 0.1 21.4 41.0 0.6 7.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 15.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.8 0.0 0.4 12.7 0.0 0.0 0.0 0.0 1.1 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 4.5 0.0 0.0 17.0 RNASEK MGC71993 ENSG00000219200 "Ribonuclease K" Q6P5S7 17 7012417-7014532 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 97.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044708 Uncertain NA NA "HPA044708: AB_10962051" "unprognostic (7.59e-2)" "unprognostic (2.22e-2)" "unprognostic (5.63e-2)" "unprognostic (5.92e-2)" "unprognostic (9.73e-3)" "unprognostic (4.82e-2)" "unprognostic (3.65e-1)" "unprognostic (1.55e-1)" "unprognostic (1.44e-1)" "unprognostic (6.50e-3)" "prognostic favorable (1.92e-4)" "unprognostic (2.93e-3)" "unprognostic (1.72e-3)" "unprognostic (1.81e-1)" "unprognostic (1.77e-2)" "unprognostic (1.14e-1)" "unprognostic (2.33e-3)" 61.6 116.2 79.8 55.0 81.4 86.1 114.0 49.9 121.1 56.4 50.2 41.5 64.3 54.0 50.7 51.3 60.4 67.0 65.9 90.9 79.4 95.6 92.6 85.2 111.9 141.9 76.7 69.2 57.2 72.7 61.5 98.7 56.3 76.3 53.3 41.6 51.0 69.4 64.6 74.0 60.1 50.2 50.5 82.8 80.7 51.0 61.3 34.7 62.8 64.6 56.6 55.5 63.2 47.0 52.7 92.8 191.8 97.9 34.9 39.2 73.7 33.2 55.9 25.3 43.1 66.0 59.9 22.6 34.6 62.2 45.9 52.1 23.5 31.6 23.9 35.1 67.3 54.2 50.1 31.0 42.6 24.8 48.0 81.5 23.6 45.6 38.0 75.8 14.7 117.7 74.6 51.8 53.9 30.9 50.5 54.3 26.2 20.5 51.4 54.7 31.5 20.2 49.2 17.4 27.1 48.9 24.0 14.5 27.3 59.2 29.9 13.0 46.5 29.4 21.1 61.2 25.9 27.3 26.9 49.2 48.5 21.0 59.7 43.3 42.0 41.0 10.2 75.4 34.4 39.3 67.6 97.9 114.1 35.0 86.6 34.7 52.7 39.2 35.4 73.9 49.1 31.9 30.5 191.8 34.9 81.4 92.8 38.4 73.7 79.8 81.4 49.9 121.1 79.4 95.6 76.7 69.2 76.3 34.7 53.6 59.1 23.1 6.8 18.2 14.5 0.4 10.2 97.7 78.5 5.2 39.3 4.5 3.3 14.4 4.5 17.3 18.2 0.0 4.8 2.6 14.5 9.2 50.0 14.0 12.8 11.1 12.7 25.8 72.0 4.1 8.3 36.6 20.3 38.7 7.7 8.9 12.8 12.7 6.0 3.0 32.2 25.8 10.3 3.7 0.7 19.1 9.8 32.4 9.3 10.5 RNASEK-C17orf49 ENSG00000161939 "RNASEK-C17orf49 readthrough" 17 7012635-7017520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.3" "Group enriched" "Detected in many" 8 "Alveolar cells type 1: 59.6;Alveolar cells type 2: 63.9;Ciliated cells: 103.1;Club cells: 56.9;granulocytes: 55.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 5.3;THP-1: 6.3;U-87 MG: 6.9" "HPA022961, HPA024457" Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (4.08e-2)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (9.37e-5)" "unprognostic (4.19e-1)" "unprognostic (1.71e-1)" "unprognostic (7.91e-2)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.77e-3)" "unprognostic (8.26e-3)" "unprognostic (8.58e-3)" "unprognostic (3.00e-1)" "unprognostic (2.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.78e-1)" 4.8 4.8 2.8 3.5 3.5 5.3 2.9 3.6 4.0 2.0 2.8 0.4 1.5 1.4 4.9 3.3 2.3 2.7 3.2 6.3 2.5 3.3 6.6 14.5 16.7 20.3 2.9 2.4 2.4 7.9 1.4 4.7 2.5 1.8 1.8 1.4 0.4 1.6 5.0 4.2 1.9 6.3 2.3 1.7 9.1 1.6 6.4 0.7 4.1 2.0 4.6 3.4 2.3 1.6 1.9 4.0 7.5 4.3 0.9 1.7 2.8 1.2 3.6 0.5 0.5 0.0 0.0 1.1 2.3 1.9 2.8 2.2 2.3 1.1 1.9 0.2 0.0 0.3 0.6 0.7 5.3 0.8 0.0 4.4 0.0 2.9 1.0 2.8 0.0 0.6 0.0 0.0 1.6 0.0 0.4 0.7 0.2 0.6 0.0 0.0 1.2 1.9 2.3 2.3 0.5 1.2 1.4 0.0 0.0 0.8 0.7 0.5 1.8 0.0 0.0 0.2 0.3 0.6 6.3 0.0 0.0 0.2 3.5 1.0 0.0 0.8 0.2 6.9 0.5 0.0 3.6 4.3 3.4 1.2 3.0 1.7 1.9 1.5 0.8 3.8 1.8 1.4 1.2 7.5 0.9 3.1 4.0 0.9 2.8 2.8 3.5 3.6 4.0 2.5 3.3 2.9 2.4 1.8 0.7 59.6 63.9 0.0 0.0 0.3 0.0 0.0 0.0 103.1 56.9 0.0 0.0 0.2 3.3 6.7 0.0 0.1 2.9 0.0 7.0 0.1 0.2 0.1 55.8 0.0 0.6 0.0 5.2 0.6 1.2 0.0 0.3 1.0 0.0 8.2 4.7 0.0 6.7 6.8 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.7 0.0 2.7 0.1 RNF103 "hkf-1, KF1, ZFP103" ENSG00000239305 "Ring finger protein 103" O00237 2 86603393-86623866 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 9.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057922 Approved NA NA "HPA057922: AB_2683555" "unprognostic (4.41e-1)" "unprognostic (1.56e-1)" "unprognostic (6.04e-2)" "unprognostic (3.26e-1)" "unprognostic (3.20e-2)" "unprognostic (1.79e-1)" "unprognostic (7.42e-2)" "unprognostic (8.37e-2)" "unprognostic (4.06e-1)" "unprognostic (1.13e-2)" "unprognostic (6.21e-2)" "unprognostic (1.44e-1)" "unprognostic (3.54e-3)" "unprognostic (1.50e-1)" "unprognostic (1.77e-1)" "unprognostic (3.67e-2)" "prognostic favorable (6.77e-5)" 13.2 13.5 18.0 9.8 20.6 9.8 18.5 38.3 24.6 15.8 28.1 16.9 9.6 15.6 18.8 39.7 11.7 12.7 23.3 29.5 16.7 15.9 13.1 43.8 8.6 8.5 17.8 10.6 13.2 20.2 23.8 12.2 16.2 14.7 20.5 14.2 14.5 13.8 16.1 17.7 10.4 27.2 17.9 21.8 8.1 18.7 13.7 16.5 11.9 9.0 8.8 8.3 13.4 11.5 1.4 1.6 9.9 0.9 3.0 3.4 0.9 5.6 7.7 3.9 6.0 18.0 11.7 6.4 8.1 12.5 4.2 5.7 4.4 9.7 9.4 9.9 12.2 15.3 6.9 5.2 6.4 6.4 7.8 7.1 5.3 3.5 9.8 17.1 1.8 8.0 17.0 13.5 6.2 7.8 15.1 12.6 4.5 1.9 5.7 11.5 6.9 4.0 4.7 1.8 11.2 5.5 2.5 16.9 5.5 15.4 8.9 6.2 6.4 9.6 21.5 8.0 5.2 8.2 4.4 14.2 8.2 3.9 8.2 4.8 19.9 6.6 6.3 6.5 3.0 3.9 6.5 0.7 9.9 1.1 0.9 1.5 1.4 1.6 2.4 1.6 1.4 1.9 1.3 1.5 3.0 0.6 1.0 3.4 0.9 18.0 20.6 38.3 24.6 16.7 15.9 17.8 10.6 14.7 16.5 8.9 12.6 8.5 27.7 42.8 14.8 30.8 22.9 17.4 15.9 19.2 3.9 10.6 1.7 14.0 14.5 16.6 43.9 23.3 24.9 6.3 29.6 44.0 18.4 58.4 8.3 17.5 30.5 23.4 11.8 7.0 23.6 10.6 10.1 2.8 35.6 17.5 25.0 38.6 21.5 12.8 8.8 6.5 25.8 21.5 13.0 38.6 34.2 6.4 20.1 37.4 RNF103-CHMP3 RNF103-VPS24 ENSG00000249884 "RNF103-CHMP3 readthrough" 2 86505668-86721122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 19 "Club cells: 2.3;granulocytes: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 15.7" "HPA015673, HPA073383" Uncertain NA NA "HPA015673: AB_1858761, HPA073383: AB_2732224" "unprognostic (3.77e-2)" "unprognostic (5.47e-2)" "unprognostic (8.91e-4)" "unprognostic (9.64e-3)" "unprognostic (1.39e-1)" "unprognostic (8.67e-2)" "unprognostic (1.03e-4)" "unprognostic (3.21e-3)" "unprognostic (1.00e-1)" "unprognostic (7.56e-2)" "unprognostic (5.83e-3)" "unprognostic (7.12e-2)" "unprognostic (8.90e-3)" "unprognostic (4.68e-2)" "unprognostic (6.56e-2)" "unprognostic (6.45e-2)" "unprognostic (6.94e-3)" 1.2 0.6 2.6 6.0 4.5 7.7 2.6 1.6 5.6 1.0 2.2 0.4 0.0 1.4 2.6 5.0 1.5 1.3 1.0 8.6 2.2 2.1 3.6 6.9 3.4 3.0 1.4 0.0 1.2 2.5 0.0 0.7 1.3 1.0 1.2 0.7 1.6 1.0 2.4 4.6 0.7 2.6 0.7 0.9 2.8 2.0 2.6 0.1 0.5 0.7 3.3 3.5 2.0 0.6 3.3 4.4 4.7 0.9 1.5 1.2 0.5 1.9 0.5 1.3 1.4 1.4 0.0 2.2 1.7 0.9 0.9 1.4 1.7 2.7 3.1 1.1 1.0 15.7 0.8 0.4 0.5 0.4 2.1 0.8 1.1 0.0 1.3 0.3 1.3 1.8 1.1 0.2 0.5 1.5 1.6 0.2 3.5 1.1 1.6 1.8 0.5 2.5 1.2 0.0 0.8 0.3 6.2 2.9 0.1 0.2 1.6 2.4 2.1 2.3 2.5 0.9 0.3 0.3 1.6 0.7 0.8 5.4 1.1 1.2 2.5 0.5 2.7 1.1 1.8 0.3 0.0 0.7 0.6 0.4 0.9 1.2 3.1 0.9 1.0 0.9 3.3 0.4 0.3 4.7 1.5 0.1 4.4 0.5 0.5 2.6 4.5 1.6 3.3 2.2 2.1 1.4 0.0 1.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 RNF112 "BFP, ZNF179" ENSG00000128482 "Ring finger protein 112" Q9ULX5 17 19411125-19417276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.5" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 3.2;Fibroblasts: 3.0;Muller glia cells: 7.7;Peritubular cells: 3.5;Sertoli cells: 6.5" "Cancer enriched" "Detected in some" 8 "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2;fHDF/TERT166: 4.8;SCLC-21H: 4.8;SH-SY5Y: 8.4;U-87 MG: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015970 Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA015970: AB_1859103" "unprognostic (1.16e-1)" "unprognostic (3.74e-1)" "unprognostic (8.43e-5)" "unprognostic (3.65e-2)" "unprognostic (2.96e-2)" "unprognostic (6.02e-2)" "unprognostic (1.27e-1)" "unprognostic (2.88e-1)" "unprognostic (4.26e-1)" "unprognostic (5.02e-2)" "unprognostic (3.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.31e-9)" "unprognostic (1.32e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" "unprognostic (4.24e-1)" 2.5 8.1 11.3 2.3 15.9 0.6 1.8 47.5 29.1 1.2 3.6 1.4 0.0 2.9 2.0 6.9 1.1 1.5 4.4 2.3 12.4 8.2 1.2 0.7 1.7 1.4 3.9 14.1 1.3 0.8 0.5 1.9 1.1 3.1 10.2 4.4 1.6 1.3 3.5 2.1 1.9 3.6 3.5 2.9 1.7 2.1 2.0 3.7 0.0 0.9 0.0 0.8 2.8 1.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.2 4.2 0.1 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 4.8 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 3.4 0.0 0.0 1.7 0.2 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.0 4.8 8.4 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 27.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 15.9 47.5 15.9 12.4 8.2 3.9 14.1 3.1 3.7 0.0 0.0 0.0 0.0 0.9 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.3 3.5 0.0 0.4 6.5 1.5 1.1 0.7 0.9 0.2 0.0 0.1 0.1 RNF121 FLJ11099 ENSG00000137522 "Ring finger protein 121" Q9H920 11 71928701-71997597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046041 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA046041: AB_10965850" "unprognostic (1.36e-2)" "unprognostic (8.84e-2)" "unprognostic (9.72e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.38e-2)" "unprognostic (1.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (6.54e-2)" "unprognostic (1.85e-2)" "unprognostic (1.90e-1)" "prognostic favorable (2.72e-6)" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (2.57e-2)" "unprognostic (1.70e-1)" 9.8 14.1 18.5 14.0 14.9 6.5 14.1 18.5 16.6 12.6 13.0 12.4 22.4 18.5 17.9 26.3 10.6 14.3 10.8 13.1 11.7 11.7 20.2 16.9 9.4 8.9 12.4 13.4 15.0 15.6 24.1 19.4 18.9 12.1 13.5 13.1 15.7 18.0 19.5 19.2 11.8 18.7 14.1 10.1 10.1 12.8 16.3 13.6 8.9 15.6 8.1 15.3 11.9 10.4 5.9 6.9 8.8 5.5 5.6 7.0 5.1 4.9 10.8 11.1 8.2 10.8 8.5 7.8 9.2 9.9 14.6 15.4 21.0 11.0 4.6 8.1 10.3 14.2 11.7 12.2 11.1 15.8 6.6 7.1 7.7 10.5 10.3 8.0 6.7 6.6 8.0 9.9 15.8 9.5 15.8 26.0 7.3 11.6 4.9 12.8 11.2 4.5 7.7 7.7 22.5 11.0 5.8 23.5 4.3 16.5 9.7 7.9 8.5 11.9 10.2 16.7 12.3 11.8 4.9 16.1 10.4 9.8 6.9 7.7 6.0 5.4 5.2 9.0 4.4 9.1 8.8 4.1 4.0 5.6 5.5 7.0 5.9 4.7 4.5 3.9 2.2 5.3 5.9 2.1 5.6 3.9 6.9 3.9 5.1 18.5 14.9 18.5 16.6 11.7 11.7 12.4 13.4 12.1 13.6 6.0 14.0 12.6 8.9 7.8 15.3 7.9 12.7 6.7 4.5 19.2 19.6 28.1 6.6 23.5 3.1 4.9 16.2 23.3 28.0 22.0 10.8 9.4 6.9 12.1 12.5 9.5 9.2 8.0 5.7 2.0 12.0 10.2 10.1 17.2 10.4 17.5 24.0 9.9 11.7 16.5 17.5 19.4 9.0 21.6 17.7 5.1 26.0 12.8 8.3 8.2 RNF122 FLJ12526 ENSG00000133874 "Ring finger protein 122" Q9H9V4 8 33547755-33567125 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 66.3" "Cell type enhanced" "Detected in many" 5 "Ito cells: 5.5;Kupffer cells: 6.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 39.7;Karpas-707: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003888 Uncertain NA NA "HPA003888: AB_1079822" "unprognostic (2.36e-2)" "unprognostic (3.13e-1)" "unprognostic (2.09e-2)" "unprognostic (9.19e-3)" "unprognostic (2.46e-1)" "unprognostic (8.78e-3)" "unprognostic (1.71e-2)" "unprognostic (5.46e-1)" "unprognostic (3.33e-1)" "unprognostic (1.82e-1)" "unprognostic (6.95e-2)" "prognostic favorable (5.37e-4)" "prognostic unfavorable (4.50e-7)" "unprognostic (4.45e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (7.15e-2)" 23.6 14.6 2.3 15.9 5.9 6.5 13.4 16.7 4.4 8.3 8.2 3.2 3.1 2.5 8.8 10.3 9.3 20.0 13.3 28.5 6.7 2.1 4.4 7.1 25.0 10.1 4.3 0.7 66.3 5.6 3.4 3.2 2.8 12.3 12.8 5.1 5.5 5.1 5.8 31.9 6.4 8.3 14.4 14.4 13.3 7.9 9.6 2.5 8.1 4.3 17.3 11.4 20.6 11.8 5.0 14.2 7.4 9.9 1.8 1.6 0.3 0.3 2.1 10.6 4.4 0.9 0.3 1.4 0.6 1.0 1.3 2.2 0.3 0.4 4.9 3.2 1.6 1.8 0.4 2.3 0.9 0.7 0.3 39.7 1.0 0.5 2.8 0.6 0.3 8.1 1.0 0.8 0.7 0.5 2.2 4.2 4.3 1.0 25.7 1.1 0.9 4.3 3.3 5.8 1.5 1.2 4.7 2.0 3.8 1.5 0.6 2.1 11.9 0.7 0.3 1.6 3.9 0.4 1.3 2.4 1.8 1.7 3.3 0.7 10.3 5.8 9.0 1.1 1.3 0.2 4.6 0.9 7.4 1.5 4.5 1.3 2.9 0.9 1.1 0.8 5.0 1.5 1.6 6.7 1.8 9.9 14.2 0.6 0.3 2.3 5.9 16.7 4.4 6.7 2.1 4.3 0.7 12.3 2.5 0.0 1.1 1.5 0.5 3.8 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.0 3.5 0.3 0.0 0.6 0.4 4.1 0.3 0.0 0.0 1.4 0.0 0.0 5.5 6.0 0.8 1.4 2.2 0.0 0.0 0.4 0.8 0.9 0.8 1.1 0.6 1.4 0.0 4.1 0.0 0.9 1.8 0.0 0.7 0.6 1.0 RNF128 "FLJ23516, GRAIL" ENSG00000133135 "Ring finger protein 128, E3 ubiquitin protein ligase" Q8TEB7 X 106693794-106796993 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.6;liver: 48.4;thyroid gland: 38.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 62.5;Cholangiocytes: 61.1;Enterocytes: 52.7;Hepatocytes: 73.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 16.5;CAPAN-2: 13.6;Hep G2: 11.6;OE19: 36.6;RPTEC TERT1: 12.0;RT4: 34.2;WM-115: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019675 Uncertain NA NA "HPA019675: AB_2670225" "unprognostic (1.78e-1)" "unprognostic (1.44e-2)" "unprognostic (1.23e-1)" "unprognostic (1.88e-3)" "unprognostic (1.92e-4)" "unprognostic (2.14e-3)" "unprognostic (2.37e-2)" "unprognostic (1.02e-1)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (1.55e-2)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.07e-7)" "unprognostic (1.11e-2)" "unprognostic (7.61e-2)" "unprognostic (6.30e-2)" "unprognostic (5.30e-3)" 1.4 20.6 2.4 2.2 7.2 0.0 3.0 0.7 4.2 0.5 24.4 0.9 0.4 24.2 0.2 2.2 4.0 0.3 27.2 0.6 2.8 5.1 24.4 48.4 6.7 0.0 2.4 2.1 0.7 14.5 0.0 11.0 10.5 4.0 3.4 7.8 0.0 25.4 0.8 3.0 3.6 54.6 0.9 1.1 0.2 17.9 0.3 1.0 1.1 38.4 2.3 2.7 10.2 3.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 4.1 0.0 0.0 0.0 1.4 0.7 16.5 0.0 0.1 0.0 0.0 7.2 13.6 0.0 0.0 0.2 0.1 5.1 0.0 0.0 0.0 0.0 8.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 36.6 0.1 0.0 0.0 0.0 12.0 34.2 0.0 0.0 0.0 0.9 0.8 0.1 0.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 6.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 7.2 0.7 4.2 2.8 5.1 2.4 2.1 4.0 1.0 62.5 15.8 0.0 5.7 6.1 0.0 0.5 61.1 9.4 20.5 31.4 0.0 18.2 0.0 9.8 0.0 0.1 52.7 0.0 13.5 2.1 0.4 1.8 0.0 73.1 1.6 0.0 23.8 0.6 3.8 0.0 0.0 0.2 3.3 0.0 36.5 0.0 21.8 22.4 0.0 21.1 0.0 0.0 0.2 0.0 2.2 4.5 13.8 0.0 23.4 7.4 RNF13 RZF ENSG00000082996 "Ring finger protein 13" O43567 3 149812708-149962139 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 72.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064784 Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA064784: AB_2685350" "unprognostic (1.27e-1)" "unprognostic (2.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.93e-2)" "unprognostic (1.80e-1)" "unprognostic (9.64e-2)" "unprognostic (8.49e-2)" "unprognostic (4.36e-3)" "unprognostic (1.72e-1)" "unprognostic (1.25e-1)" "unprognostic (6.94e-3)" "unprognostic (1.13e-1)" "prognostic favorable (2.00e-8)" "unprognostic (2.95e-1)" "unprognostic (4.11e-2)" "unprognostic (2.17e-1)" "unprognostic (1.79e-1)" 24.0 21.3 30.6 19.0 39.4 9.8 28.5 19.9 30.4 19.0 17.7 39.9 16.2 14.3 16.8 33.7 16.8 15.9 20.4 16.4 40.5 29.7 35.8 39.2 31.7 19.6 60.9 26.8 18.1 19.6 23.5 14.9 32.4 40.7 25.5 20.3 19.5 36.1 20.9 18.0 18.4 16.3 20.4 102.2 25.5 17.0 12.5 51.2 13.3 32.1 18.8 15.9 21.4 16.5 8.8 15.7 72.4 31.5 7.8 8.5 14.6 19.7 12.3 8.3 9.5 32.8 20.1 13.9 10.9 28.2 10.6 15.8 10.8 28.4 8.2 16.0 13.4 19.5 18.8 11.1 14.0 14.9 10.0 8.1 9.9 5.7 10.5 21.8 10.6 14.1 21.2 26.6 8.9 24.2 12.8 11.7 7.9 3.1 16.7 9.4 11.1 7.6 7.0 5.5 19.1 9.6 5.5 8.9 34.8 20.5 9.2 4.4 12.7 9.0 13.6 35.2 6.8 25.9 11.2 12.2 14.4 5.8 15.2 7.0 28.4 18.7 16.9 12.1 9.9 7.7 12.9 20.3 16.6 6.8 25.2 8.5 8.8 7.6 7.6 15.7 8.3 7.3 7.5 72.4 7.8 31.5 11.2 8.3 14.6 30.6 39.4 19.9 29.2 40.5 29.7 60.9 26.8 40.7 51.2 101.3 59.5 39.3 61.2 65.4 43.7 25.6 38.2 34.8 61.4 45.4 27.5 86.4 36.5 54.3 2.2 62.6 27.6 0.0 62.0 65.2 68.3 63.5 58.9 46.6 172.6 20.6 19.4 77.3 168.9 4.7 70.5 155.4 97.8 42.3 26.4 85.9 48.5 29.6 82.7 59.8 32.2 90.5 50.9 19.7 29.6 63.2 43.8 51.0 24.3 45.5 RNF130 "G1RZFP, GOLIATH, GP" ENSG00000113269 "Ring finger protein 130" Q86XS8 5 179911651-180072118 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 270.4;Kupffer cells: 303.4;Macrophages: 212.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 17.0;classical monocyte: 38.1;eosinophil: 24.6;intermediate monocyte: 27.5;myeloid DC: 31.1;neutrophil: 68.1;non-classical monocyte: 23.8;plasmacytoid DC: 22.9" "Group enriched" "Detected in all" 11 "dendritic cells: 31.1;granulocytes: 68.1;monocytes: 38.1" "Cell line enhanced" "Detected in many" "HMC-1: 41.5" "Low region specificity" "Detected in all" HPA014499 Approved NA NA "HPA014499: AB_1856328" "unprognostic (2.01e-1)" "prognostic favorable (6.32e-4)" "unprognostic (2.43e-1)" "unprognostic (1.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.62e-2)" "unprognostic (2.83e-1)" "unprognostic (2.02e-3)" "unprognostic (2.93e-2)" "unprognostic (1.78e-1)" "unprognostic (4.00e-2)" "unprognostic (2.81e-1)" "unprognostic (1.14e-1)" "unprognostic (8.41e-2)" "unprognostic (4.17e-2)" "unprognostic (4.32e-1)" "unprognostic (1.38e-2)" 36.3 16.3 23.5 16.3 32.5 29.5 24.0 19.0 25.3 26.0 16.7 56.0 19.0 10.6 18.5 12.0 10.6 19.5 21.9 17.0 27.8 21.1 20.7 64.4 25.5 19.1 50.2 20.3 21.7 28.6 11.0 16.7 19.8 30.3 16.3 16.1 15.8 30.6 28.3 17.3 7.9 12.1 22.2 58.2 20.4 20.5 7.3 38.8 2.5 14.3 6.3 10.3 20.7 13.3 1.2 31.1 68.1 38.1 4.0 2.0 20.3 8.0 5.9 29.0 21.2 28.3 15.4 5.5 6.3 7.9 6.9 7.5 1.9 6.9 0.0 19.5 11.0 12.3 0.8 20.1 12.8 7.6 0.1 17.9 15.9 3.2 4.1 7.2 3.8 41.5 14.5 6.8 0.5 3.9 17.4 11.2 16.4 3.2 0.1 6.9 12.2 7.2 12.3 7.9 1.5 9.0 16.2 6.7 0.0 8.7 1.4 17.6 7.9 11.7 6.4 24.3 12.3 9.2 9.1 8.7 11.7 4.7 8.2 6.7 0.0 6.2 1.6 1.5 30.5 9.1 17.0 38.1 24.6 2.0 27.5 1.9 1.2 0.9 1.0 31.1 1.2 1.0 1.2 68.1 4.0 23.8 22.9 0.1 20.3 23.5 32.5 19.0 25.3 27.8 21.1 50.2 20.3 30.3 38.8 17.9 25.0 20.3 17.8 12.6 26.9 27.4 73.9 65.6 22.7 40.1 49.1 10.0 19.9 43.4 9.6 42.9 21.0 0.0 67.5 13.5 39.8 43.3 79.8 129.2 270.4 6.4 15.6 43.0 303.4 14.4 33.9 212.8 30.4 45.1 37.0 18.1 46.5 35.1 45.3 34.2 17.7 45.3 40.1 8.6 27.9 11.3 7.3 17.3 61.0 17.1 RNF133 ENSG00000188050 "Ring finger protein 133" Q8WVZ7 7 122697712-122699156 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "testis: 28.3" "Group enriched" "Detected in some" 104 "Early spermatids: 461.8;Late spermatids: 540.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.1;MCF7: 1.5;NTERA-2: 1.2;PC-3: 1.1;U-266/70: 1.1" "Not detected" "Not detected" NA NA "unprognostic (2.82e-1)" "unprognostic (2.52e-2)" "unprognostic (1.77e-1)" "unprognostic (3.04e-2)" "unprognostic (2.45e-3)" "unprognostic (1.67e-1)" "unprognostic (8.87e-3)" "unprognostic (3.56e-2)" "unprognostic (3.72e-1)" "unprognostic (3.29e-3)" "unprognostic (1.26e-1)" "unprognostic (1.02e-2)" "unprognostic (7.76e-2)" "unprognostic (1.10e-1)" "unprognostic (2.39e-1)" "unprognostic (2.37e-2)" "unprognostic (7.61e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.6 0.3 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 4.1 0.0 1.5 0.0 0.0 1.2 0.5 1.1 0.0 0.0 0.8 0.0 0.4 0.6 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 461.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 540.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.8 1.5 0.0 0.0 0.0 0.0 0.0 RNF139 "HRCA1, RCA1, TRC8" ENSG00000170881 "Ring finger protein 139" Q8WU17 8 124474738-124487914 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Ubl conjugation pathway" "Receptor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 12 "Early spermatids: 763.4;Late spermatids: 690.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001202 Approved NA NA "HPA001202: AB_1079824" "unprognostic (3.28e-3)" "unprognostic (2.92e-2)" "unprognostic (5.16e-2)" "unprognostic (5.43e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-3)" "unprognostic (2.71e-2)" "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.54e-4)" "unprognostic (9.85e-2)" "unprognostic (1.53e-2)" "unprognostic (1.62e-1)" "unprognostic (2.75e-1)" "unprognostic (7.75e-2)" "unprognostic (1.45e-1)" 15.1 17.3 10.4 9.5 12.2 54.5 13.4 12.0 17.1 14.2 10.9 14.0 9.4 6.2 15.3 10.0 12.2 14.2 11.0 11.4 10.4 10.8 11.4 17.7 11.3 14.2 12.4 11.5 17.1 10.3 7.6 10.6 18.4 9.9 12.8 10.4 10.2 10.3 10.5 15.2 12.6 11.3 14.2 12.2 11.8 11.2 60.3 13.3 16.8 11.2 9.6 10.4 14.8 10.7 9.2 9.4 11.8 11.7 8.6 13.9 8.0 13.2 8.9 10.7 10.5 23.6 18.8 8.8 11.9 22.7 10.0 13.0 5.7 11.1 13.7 14.0 15.4 7.2 9.8 9.1 14.6 15.0 19.0 11.5 20.4 5.9 11.8 18.0 9.6 11.8 16.1 21.2 10.6 28.8 13.7 13.4 12.7 14.3 21.1 11.8 35.9 16.2 6.9 7.5 26.6 12.6 6.5 7.9 13.7 18.8 17.0 4.5 11.7 15.5 39.0 16.8 8.4 18.7 10.5 10.5 6.7 15.5 11.3 13.3 17.1 18.2 12.4 10.5 16.3 6.7 3.3 7.4 11.8 11.6 4.7 13.9 9.2 10.8 13.2 9.4 8.5 10.8 11.3 10.8 8.6 11.7 5.1 13.2 8.0 10.4 12.2 12.0 17.1 10.4 10.8 12.4 11.5 9.9 13.3 3.0 6.7 27.4 55.8 58.7 13.6 14.1 33.1 5.3 5.7 21.0 5.9 34.4 10.0 17.2 763.4 21.8 13.6 0.0 15.7 43.0 28.5 26.2 20.7 28.2 22.9 15.9 20.8 16.0 27.6 690.0 27.3 26.6 33.7 19.0 17.2 19.8 18.3 7.0 25.5 12.9 22.3 19.4 53.6 37.9 24.2 61.6 63.2 26.2 16.8 48.5 RNF144A "hUIP4, KIAA0161, RNF144, UBCE7IP4" ENSG00000151692 "Ring finger protein 144A" P50876 2 6917392-7068286 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.5" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.7" "Group enriched" "Detected in many" 7 "granulocytes: 8.7;T-cells: 4.1" "Cell line enhanced" "Detected in many" "HEL: 15.2;HMC-1: 51.6;SH-SY5Y: 15.7;SK-MEL-30: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049939 Approved Supported Vesicles NA NA Vesicles "HPA049939: AB_2680960" "unprognostic (1.78e-1)" "unprognostic (2.53e-3)" "unprognostic (8.37e-2)" "prognostic unfavorable (6.00e-4)" "unprognostic (6.57e-2)" "prognostic favorable (6.96e-4)" "unprognostic (7.04e-6)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "unprognostic (5.64e-1)" "unprognostic (9.11e-2)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (7.32e-5)" "unprognostic (1.30e-2)" "unprognostic (3.01e-1)" "unprognostic (1.82e-3)" 12.9 28.8 13.3 4.2 21.2 12.1 11.1 45.5 20.7 17.3 5.2 28.7 9.0 3.0 26.0 8.3 4.7 8.4 7.5 8.0 15.6 11.6 7.5 1.8 5.7 7.9 26.5 12.2 20.0 29.7 21.5 12.5 6.2 13.2 8.7 5.7 5.9 4.0 7.4 8.7 5.7 4.1 12.2 21.8 21.1 2.8 5.0 27.1 3.4 3.2 1.2 5.8 5.8 6.5 0.1 0.2 8.7 0.1 0.8 4.1 0.6 0.3 2.2 12.0 2.4 2.7 5.6 9.2 0.0 0.0 0.4 1.1 0.0 0.2 1.1 1.3 0.1 3.5 0.2 3.9 0.0 0.0 0.6 1.0 15.2 0.1 4.5 0.1 0.3 51.6 8.9 0.0 0.8 0.0 0.0 0.0 3.9 6.5 0.2 0.0 1.9 7.8 0.6 4.4 0.3 5.4 6.1 8.7 1.0 0.4 3.9 3.9 15.7 0.2 1.6 15.4 1.6 0.7 1.0 0.0 1.6 4.1 4.2 1.7 4.1 1.3 0.0 6.0 3.4 5.6 1.5 0.1 8.7 2.1 0.0 3.0 0.1 2.1 1.5 0.2 0.1 4.1 2.8 0.4 0.8 0.0 0.0 0.8 0.6 13.3 21.2 45.5 20.3 15.6 11.6 26.5 12.2 13.2 27.1 3.0 3.4 0.5 0.7 2.2 3.6 10.6 2.5 2.7 3.4 0.0 70.7 1.7 1.7 2.7 5.7 7.0 4.2 23.3 5.0 2.7 5.3 3.5 9.2 0.8 3.8 9.5 24.5 28.3 1.0 10.4 4.0 1.0 23.6 1.0 2.5 7.2 4.5 9.1 9.9 0.0 42.2 0.0 3.8 1.6 6.0 1.4 0.9 6.4 2.9 0.2 RNF144B "bA528A10.3, IBRDC2, P53RFP" ENSG00000137393 "Ring finger protein 144B" Q7Z419 6 18387350-18468874 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Basal keratinocytes: 563.5;Suprabasal keratinocytes: 1312.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 28.8" "Group enriched" "Detected in many" 9 "dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8" "Cell line enhanced" "Detected in many" "Daudi: 55.9;EFO-21: 15.4;hTCEpi: 17.8;HUVEC TERT2: 16.5;TIME: 16.5;U-698: 47.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046013, HPA054127, HPA072469" Uncertain Approved Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: " "unprognostic (2.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.48e-3)" "unprognostic (5.89e-2)" "unprognostic (1.18e-2)" "unprognostic (6.55e-2)" "unprognostic (2.87e-3)" "unprognostic (2.44e-2)" "unprognostic (2.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "unprognostic (3.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" 16.3 2.0 4.6 11.1 6.8 15.7 21.1 5.1 7.5 8.0 4.2 2.8 4.6 1.5 6.8 7.5 9.4 9.0 6.8 8.7 5.3 4.3 13.8 11.4 39.0 11.1 8.3 2.3 4.2 3.7 3.0 2.3 11.1 8.8 12.8 2.3 8.3 16.9 6.2 36.8 19.2 3.7 4.9 9.2 37.1 4.3 3.3 6.9 5.8 32.9 11.4 12.2 7.3 6.6 2.0 7.9 15.6 28.8 0.2 0.7 2.6 1.3 0.2 0.1 0.0 0.0 0.6 2.9 1.5 1.7 3.3 3.6 0.0 0.1 55.9 15.4 0.6 0.2 4.8 0.0 4.7 4.7 0.2 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.8 17.8 1.3 4.0 1.5 16.5 1.2 0.0 0.0 0.8 0.5 0.4 0.0 0.5 0.1 0.3 0.2 0.5 3.3 10.0 3.1 0.5 0.0 0.3 7.1 5.3 0.4 8.4 0.1 16.5 2.6 0.5 0.2 0.3 0.0 0.0 47.0 0.3 0.1 0.2 0.1 9.1 5.1 0.2 16.4 0.7 2.0 0.3 0.3 5.6 1.6 0.7 0.4 15.6 0.2 28.8 7.9 0.2 2.6 4.6 6.8 5.1 7.5 5.3 4.3 8.3 2.3 8.8 6.9 41.7 12.9 4.2 36.0 563.5 0.9 10.4 10.2 21.4 36.4 36.6 2.0 9.7 16.6 8.2 1.6 32.1 1.0 0.0 7.7 2.9 12.4 85.1 3.5 17.4 13.8 0.0 1.2 28.8 98.2 1.6 1.1 68.0 57.3 44.1 1.3 16.0 6.0 2.9 2.8 16.3 1.0 0.0 10.1 1.7 2.6 1312.2 1.3 3.2 2.4 20.3 RNF145 FLJ31951 ENSG00000145860 "Ring finger protein 145" Q96MT1 5 159157409-159210053 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036562 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA036562: AB_10696657" "unprognostic (1.57e-1)" "unprognostic (9.02e-3)" "unprognostic (4.11e-2)" "unprognostic (3.88e-2)" "unprognostic (3.24e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (1.64e-6)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.54e-1)" "unprognostic (3.53e-1)" "unprognostic (1.67e-1)" "unprognostic (8.92e-3)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" 13.3 20.1 23.9 15.6 23.0 7.1 24.1 30.2 27.3 11.3 11.7 5.7 5.3 4.7 12.6 13.6 26.7 11.4 20.8 16.8 22.0 8.4 8.2 6.1 30.7 36.3 17.5 9.7 14.1 6.0 26.9 29.0 21.9 18.5 11.8 12.6 10.2 17.8 14.8 5.5 14.9 11.0 13.8 12.4 12.7 11.2 7.9 18.0 12.4 14.3 8.0 19.6 19.3 15.7 8.9 2.7 14.4 2.6 2.1 6.2 1.3 20.3 20.1 31.0 37.2 32.8 14.6 6.0 16.3 28.5 15.1 24.6 6.9 16.9 7.0 29.4 14.3 28.8 26.7 24.4 21.5 26.7 28.8 8.7 14.7 22.9 5.7 14.1 9.7 14.1 9.0 38.9 14.1 20.7 21.2 14.8 17.1 14.6 27.1 14.2 0.5 11.0 3.0 13.4 6.4 10.3 14.7 13.5 14.0 20.2 7.0 11.3 20.9 16.5 17.7 26.8 22.1 12.4 8.9 15.8 17.0 15.6 13.6 28.9 6.0 8.3 6.5 19.8 12.1 36.3 2.8 2.6 14.4 3.2 2.5 3.7 8.9 4.7 3.8 1.9 4.4 6.2 4.3 9.7 2.1 2.2 2.7 5.7 1.3 23.9 23.0 30.2 27.3 22.0 8.4 17.5 9.7 18.5 18.0 104.2 213.5 76.8 93.4 109.1 103.7 10.0 79.0 48.2 106.9 34.9 55.0 2.7 16.6 63.7 22.1 50.7 48.5 46.7 99.7 20.5 58.0 100.6 68.1 16.3 39.0 108.1 52.0 127.7 90.9 29.9 42.8 54.8 62.4 223.6 41.8 63.1 90.1 51.8 48.8 8.4 48.6 45.3 49.5 14.9 33.0 86.9 9.2 73.0 57.2 150.2 RNF148 MGC35222 ENSG00000235631 "Ring finger protein 148" Q8N7C7 7 122701664-122702967 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 31.0" "Cell type enriched" "Detected in some" 9 "Early spermatids: 297.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 7.4;MCF7: 2.8;OE19: 1.6;RPMI-8226: 1.8;SK-BR-3: 1.6" "Not detected" "Not detected" NA NA "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (3.19e-1)" "unprognostic (1.21e-2)" "unprognostic (2.85e-1)" "unprognostic (3.23e-2)" "unprognostic (1.04e-2)" "unprognostic (9.81e-2)" "unprognostic (8.48e-2)" "unprognostic (2.14e-2)" "unprognostic (2.18e-1)" "unprognostic (2.37e-1)" "unprognostic (3.33e-2)" "unprognostic (2.24e-2)" "unprognostic (1.24e-1)" "unprognostic (6.63e-2)" "unprognostic (1.09e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 31.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.3 0.0 0.0 7.4 0.0 2.8 0.0 0.0 1.0 1.6 0.8 0.0 0.0 1.8 0.0 0.6 0.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 1.3 0.1 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 297.0 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.8 0.0 34.3 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 6.5 0.0 1.6 1.6 0.0 0.0 0.0 0.0 0.1 RNF149 FLJ90504 ENSG00000163162 "Ring finger protein 149" Q8NC42 2 101271219-101308701 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 123.7" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 255.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 123.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 123.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011424 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA011424: AB_1079825" "unprognostic (2.56e-2)" "unprognostic (4.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (3.17e-2)" "unprognostic (5.17e-3)" "unprognostic (4.16e-2)" "unprognostic (4.77e-3)" "unprognostic (5.61e-2)" "unprognostic (1.43e-2)" "unprognostic (5.69e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.04e-8)" "unprognostic (1.39e-1)" "unprognostic (6.16e-2)" "unprognostic (2.70e-1)" "prognostic favorable (2.91e-4)" 20.3 13.4 7.9 29.0 10.9 32.9 13.5 7.9 10.8 12.5 16.6 10.8 11.4 12.3 11.3 12.8 28.9 14.3 14.5 12.1 9.5 9.4 15.1 19.6 24.5 47.4 13.7 6.2 14.3 21.1 14.3 10.6 19.4 11.2 11.1 12.0 12.8 15.8 8.1 8.8 20.2 16.8 9.6 13.9 65.0 13.8 15.2 9.7 17.0 12.7 13.1 24.4 14.9 17.2 2.1 9.3 123.7 21.3 2.3 9.0 9.9 9.7 5.8 4.4 5.5 16.5 16.6 25.7 12.1 15.9 16.4 18.5 14.5 25.8 2.9 14.7 11.9 21.7 19.9 6.2 12.3 15.3 8.4 8.5 6.0 5.1 24.5 22.1 6.5 9.8 15.1 20.3 19.4 12.9 12.6 29.8 6.4 5.3 9.1 16.4 8.3 8.7 6.5 3.0 13.2 10.5 5.7 7.3 11.2 19.3 23.9 5.8 4.3 7.3 18.1 17.5 5.0 4.9 8.8 19.7 8.3 4.7 12.4 2.6 18.4 10.8 0.1 2.7 9.1 6.1 5.8 13.0 14.8 8.2 20.4 7.4 2.1 7.3 8.1 4.8 1.5 5.1 5.3 123.7 2.3 21.3 9.3 9.0 9.9 7.9 10.9 7.9 10.8 9.5 9.4 13.7 6.2 11.2 9.7 44.7 56.9 34.7 63.4 68.3 20.3 10.6 48.4 24.1 23.9 52.4 53.0 48.5 1.7 48.9 61.2 33.8 33.9 0.0 36.5 60.6 44.7 62.7 37.1 38.9 76.7 7.9 8.2 28.8 255.2 27.7 28.4 171.2 38.8 16.2 35.9 11.9 49.2 36.6 18.4 25.1 19.7 58.2 44.3 31.2 36.2 80.0 107.1 69.8 31.9 137.0 RNF150 KIAA1214 ENSG00000170153 "Ring finger protein 150" Q9ULK6 4 140859807-141212877 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 45.5;Cardiomyocytes: 62.2;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 67.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 13.8;fHDF/TERT166: 17.7;SH-SY5Y: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037987 Uncertain "Intracellular and membrane" NA NA "HPA037987: AB_10669512" "prognostic favorable (1.41e-4)" "unprognostic (1.95e-2)" "unprognostic (8.26e-3)" "unprognostic (2.41e-2)" "unprognostic (3.31e-1)" "unprognostic (5.38e-2)" "unprognostic (2.38e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (9.32e-2)" "unprognostic (3.10e-3)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (3.88e-3)" "unprognostic (9.68e-2)" "unprognostic (1.32e-3)" "unprognostic (2.41e-2)" 12.3 14.4 9.2 4.1 26.2 0.9 7.6 13.2 9.6 12.2 18.9 2.5 5.1 1.5 14.1 13.0 8.3 14.5 4.4 18.6 8.0 5.1 10.3 1.5 2.0 3.6 3.2 6.7 12.8 2.8 0.9 18.1 2.6 4.7 10.2 4.8 17.2 30.3 13.6 18.9 1.6 5.0 19.2 4.4 7.7 6.3 2.3 3.8 0.6 7.3 5.9 3.7 12.4 5.8 0.1 0.9 0.4 1.1 0.1 0.1 0.1 0.2 0.3 3.2 2.9 13.8 1.0 0.1 5.6 2.3 1.8 0.8 0.0 0.1 0.0 0.7 17.7 0.1 0.0 7.1 0.1 1.0 0.0 3.4 0.0 7.9 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.2 1.1 0.0 3.5 0.0 0.1 0.6 0.1 3.6 0.1 1.8 0.0 1.3 2.1 8.3 0.1 1.9 0.0 1.5 25.7 0.4 0.2 1.2 1.7 0.1 0.0 0.0 9.1 3.8 5.9 2.5 0.2 0.0 0.0 0.1 0.0 6.7 0.4 1.1 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.9 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.0 0.1 9.2 26.2 13.2 9.6 8.0 5.1 3.2 6.7 4.7 3.8 0.0 0.3 0.0 0.6 1.0 45.5 62.2 2.5 0.0 3.4 10.4 106.0 0.5 1.7 0.3 3.0 1.9 0.0 0.0 0.5 0.1 2.7 0.9 0.0 0.0 0.5 25.4 1.7 2.5 0.6 1.1 26.4 0.5 0.0 0.0 0.0 11.5 0.1 0.0 17.0 1.1 67.8 12.9 18.4 0.0 1.5 0.5 0.3 0.0 0.0 0.0 RNF152 FLJ39176 ENSG00000176641 "Ring finger protein 152" Q8N8N0 18 61808063-61894247 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 53.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 71.0;Proximal tubular cells: 104.4;Sertoli cells: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 16.3;HBEC3-KT: 8.7;SH-SY5Y: 10.1;TIME: 10.1;U-138 MG: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.30e-2)" "unprognostic (1.97e-2)" "unprognostic (1.64e-1)" "unprognostic (8.55e-3)" "unprognostic (2.05e-1)" "unprognostic (2.09e-1)" "unprognostic (2.96e-3)" "unprognostic (3.62e-1)" "unprognostic (1.51e-2)" "unprognostic (8.13e-2)" "unprognostic (5.14e-2)" "unprognostic (6.73e-2)" "prognostic favorable (1.13e-8)" "prognostic unfavorable (2.85e-5)" "unprognostic (3.26e-2)" "unprognostic (2.82e-2)" "unprognostic (4.83e-2)" 8.3 3.9 2.4 2.3 6.8 1.5 8.8 19.1 3.8 8.5 7.4 4.0 6.2 2.2 8.6 10.4 4.5 3.9 8.0 6.5 2.5 3.1 53.7 28.3 7.8 1.2 4.1 1.4 3.8 3.1 4.7 2.6 6.6 7.7 4.7 6.7 3.4 11.8 6.8 4.6 9.6 9.8 4.6 4.2 1.3 5.7 3.9 4.5 0.0 5.1 4.9 2.0 5.0 11.6 0.5 0.4 1.7 0.4 0.6 0.4 0.2 0.0 0.0 3.5 0.8 3.4 0.5 0.0 2.3 7.1 0.5 0.4 0.0 0.1 0.1 0.7 3.6 0.1 16.3 4.4 8.7 1.0 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.1 0.5 6.0 2.8 1.7 1.6 6.5 0.0 0.0 0.0 1.0 0.7 0.6 0.0 0.2 0.5 0.0 0.2 2.3 0.0 0.3 2.6 3.0 10.1 0.0 6.4 1.1 3.2 3.9 0.0 10.1 16.5 1.7 0.0 0.3 0.0 0.0 0.0 0.5 0.0 5.5 1.7 0.3 0.4 0.2 0.3 0.3 0.3 0.3 0.3 0.2 0.5 0.4 0.4 1.5 0.6 0.4 0.4 0.3 0.2 2.4 6.8 19.1 3.8 2.5 3.1 4.1 1.4 7.7 4.5 0.0 0.0 0.0 21.4 37.5 13.4 2.5 12.7 0.0 2.3 19.2 0.0 0.4 39.7 2.0 0.2 16.3 37.1 0.0 2.4 0.1 8.3 7.3 0.0 71.0 0.1 20.6 15.5 5.5 2.2 0.0 8.1 2.2 27.0 0.0 4.9 3.7 1.1 31.6 17.3 104.4 3.6 64.7 48.4 0.1 0.1 28.4 0.2 0.0 11.8 18.8 RNF167 DKFZP566H073 ENSG00000108523 "Ring finger protein 167" Q9H6Y7 17 4940008-4945222 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049810 Approved Approved "Vesicles,Mitotic spindle,Centriolar satellite,Cytosol" NA NA "Vesicles, Cytosol" "Mitotic spindle, Centriolar satellite" "HPA049810: AB_2680894" "unprognostic (1.13e-1)" "unprognostic (5.12e-2)" "unprognostic (2.29e-3)" "unprognostic (1.63e-2)" "unprognostic (3.43e-2)" "unprognostic (7.32e-2)" "unprognostic (2.18e-1)" "unprognostic (6.77e-2)" "unprognostic (7.46e-2)" "unprognostic (2.07e-2)" "prognostic favorable (2.03e-6)" "unprognostic (2.16e-1)" "prognostic favorable (4.47e-4)" "unprognostic (7.62e-2)" "unprognostic (1.93e-1)" "unprognostic (3.26e-1)" "unprognostic (1.12e-1)" 30.5 45.9 45.8 32.1 47.0 40.7 38.3 37.9 67.9 44.3 43.5 54.6 49.2 42.7 43.1 55.8 51.6 44.0 47.4 40.1 43.1 39.9 44.1 84.1 35.6 38.7 43.7 43.6 42.6 52.4 52.8 40.7 49.0 41.2 43.6 46.7 38.5 49.1 51.7 56.5 51.6 51.1 42.4 46.4 47.1 42.7 42.0 33.1 53.9 55.1 47.3 47.6 48.1 40.7 25.6 18.2 54.4 26.7 27.6 53.0 37.9 24.2 35.2 15.3 18.8 37.8 18.9 22.9 15.0 21.0 31.7 25.1 24.5 11.2 17.9 29.2 24.8 15.8 37.3 26.6 29.2 23.7 17.3 42.8 30.6 44.4 24.1 28.6 14.4 64.6 22.1 46.1 33.0 31.4 19.9 20.4 26.7 11.9 61.3 25.3 17.3 22.7 17.9 18.3 25.7 22.6 15.7 15.3 22.3 36.5 20.4 12.1 15.0 13.8 23.7 20.0 22.4 22.6 14.7 12.5 19.0 12.6 17.0 28.5 20.4 20.6 5.9 26.1 20.8 19.8 22.4 21.4 54.4 53.0 22.6 41.1 25.6 40.6 52.7 18.2 24.0 28.5 42.3 52.1 27.6 26.7 18.0 37.7 37.9 45.8 47.0 37.9 67.9 43.1 39.9 43.7 43.6 41.2 33.1 0.0 3.8 37.8 33.1 60.9 40.7 13.4 66.2 2.7 2.3 47.1 19.6 101.9 48.0 68.5 41.4 35.8 73.2 46.7 58.4 102.1 39.8 31.4 13.9 83.9 52.2 17.5 30.5 38.1 36.1 68.6 45.1 42.0 37.1 57.7 40.4 45.0 52.7 40.3 50.5 53.1 25.5 38.8 27.8 111.1 83.5 72.8 104.7 90.0 54.4 39.3 RNF170 "ADSA, DKFZP564A022, SNAX1" ENSG00000120925 "Ring finger protein 170" Q96K19 8 42849637-42897290 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050931, HPA054621" Uncertain NA NA "HPA050931: AB_2681279, HPA054621: AB_2682545" "unprognostic (3.06e-2)" "unprognostic (4.20e-1)" "unprognostic (9.54e-2)" "unprognostic (6.37e-2)" "unprognostic (4.59e-2)" "unprognostic (2.84e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (3.23e-2)" "unprognostic (1.17e-1)" "unprognostic (2.59e-1)" "unprognostic (3.03e-2)" "unprognostic (1.61e-3)" "unprognostic (4.13e-3)" "unprognostic (2.00e-1)" "unprognostic (1.49e-1)" "unprognostic (2.13e-1)" 8.9 13.6 14.3 8.7 17.0 2.2 13.0 15.3 18.8 8.6 10.9 17.5 15.0 10.2 9.8 15.6 14.5 9.7 9.5 8.1 13.7 14.3 17.0 19.4 9.3 8.4 15.7 18.2 13.4 10.8 15.5 16.6 19.0 19.7 11.5 11.7 12.5 12.0 11.5 10.5 14.9 11.3 7.9 21.8 8.8 10.6 7.8 14.2 5.5 29.4 8.0 9.6 10.4 10.6 8.5 11.1 2.6 7.2 5.6 8.0 5.9 6.9 11.3 11.6 5.8 19.0 19.6 7.0 8.4 11.6 7.9 8.6 5.4 22.8 8.4 10.2 7.9 14.3 6.0 6.1 8.3 6.8 5.8 6.5 9.8 5.0 5.7 10.6 1.2 7.1 17.0 13.0 6.0 12.5 10.3 8.5 9.5 8.8 10.1 12.6 2.1 10.3 5.7 5.5 14.9 4.0 5.4 15.5 4.8 12.8 6.8 3.1 9.1 7.9 5.6 14.0 11.9 14.7 5.7 12.2 8.6 3.8 11.4 2.6 16.3 15.5 9.5 11.7 4.1 8.6 1.7 7.2 2.6 4.0 7.1 5.6 8.5 6.3 6.9 10.7 5.1 7.7 5.5 0.7 5.6 6.5 11.1 8.0 5.9 14.3 17.0 15.3 18.8 13.7 14.3 15.7 18.2 19.7 14.2 44.7 18.6 13.8 11.8 6.8 43.6 9.2 17.8 34.8 29.6 22.7 84.4 38.5 14.9 18.4 0.7 13.4 20.6 0.0 24.4 15.7 15.4 9.9 9.2 19.6 20.2 20.6 12.6 19.6 14.6 1.8 14.1 11.0 8.5 19.0 16.3 30.7 24.2 23.2 19.4 20.3 68.8 12.9 10.3 13.1 19.4 10.0 26.1 14.9 17.5 12.2 RNF175 FLJ34190 ENSG00000145428 "Ring finger protein 175" Q8N4F7 4 153710125-153760235 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.3" "Cell type enriched" "Detected in some" 5 "Early spermatids: 52.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 26 "classical monocyte: 2.4;intermediate monocyte: 1.7;myeloid DC: 1.7;naive CD4 T-cell: 4.0;neutrophil: 4.5;non-classical monocyte: 3.6;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 7.9;HSkMC: 5.2;REH: 6.7;SH-SY5Y: 6.7;THP-1: 16.1;U-87 MG: 3.9" HPA035837 Uncertain NA NA "HPA035837: AB_10601609" "unprognostic (3.23e-2)" "unprognostic (4.12e-2)" "unprognostic (3.34e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (3.11e-4)" "unprognostic (9.00e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-4)" "unprognostic (1.17e-1)" "unprognostic (2.96e-3)" "unprognostic (6.30e-3)" "unprognostic (1.42e-1)" "unprognostic (3.63e-4)" "unprognostic (7.25e-3)" "unprognostic (3.27e-1)" "unprognostic (1.28e-1)" "unprognostic (7.66e-2)" 2.7 4.8 8.6 5.4 14.3 9.5 1.3 9.3 17.3 5.4 0.8 1.4 0.8 0.8 0.8 2.0 1.5 0.6 2.2 4.4 9.0 12.1 0.6 0.5 2.2 2.2 6.4 9.8 0.5 1.1 0.4 3.0 0.6 13.0 4.7 0.6 0.6 3.4 6.7 0.5 1.6 0.9 0.6 2.5 3.4 0.8 2.8 1.8 0.0 0.6 0.3 1.3 1.8 1.5 0.0 1.7 4.5 3.6 0.0 4.0 1.2 0.1 0.0 7.9 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.7 0.0 0.0 6.7 0.0 0.3 0.0 0.1 0.0 6.7 0.0 0.0 0.2 0.1 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.9 0.0 0.0 2.4 0.0 0.0 1.7 0.0 0.0 0.1 0.0 1.7 0.0 4.0 0.1 4.5 0.0 3.6 0.0 1.1 1.2 8.6 14.3 9.3 17.3 9.0 12.1 6.4 9.8 13.0 1.8 0.0 0.3 0.0 0.0 0.3 0.2 1.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 52.2 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.1 10.2 0.0 1.4 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.3 1.4 1.4 0.3 0.0 0.0 0.0 0.1 RNF180 ENSG00000164197 "Ring finger protein 180" Q86T96 5 64165844-64372869 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 54.0" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 31.9;Muller glia cells: 32.9;Sertoli cells: 38.8" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006897 Approved Approved Cytosol NA NA Cytosol "HPA006897: AB_1856348" "unprognostic (7.46e-2)" "unprognostic (3.90e-3)" "unprognostic (3.19e-2)" "unprognostic (8.62e-2)" "unprognostic (2.45e-1)" "unprognostic (2.72e-1)" "unprognostic (5.57e-2)" "unprognostic (2.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.37e-3)" "unprognostic (3.68e-2)" "prognostic favorable (6.81e-5)" "unprognostic (2.01e-2)" "unprognostic (3.35e-2)" "unprognostic (1.81e-2)" "unprognostic (9.81e-3)" 8.1 8.1 9.9 3.1 12.8 1.6 6.3 6.0 13.0 10.1 7.1 5.5 20.1 3.4 12.7 11.8 6.9 8.1 7.3 10.4 7.4 10.6 12.4 7.2 6.1 3.4 9.4 9.3 12.0 6.6 54.0 16.1 2.0 10.7 11.5 3.0 11.3 7.3 16.4 4.4 6.6 3.2 15.0 11.0 5.1 5.0 8.1 7.1 0.0 20.6 2.5 2.4 10.9 7.9 2.4 1.0 4.2 1.8 2.0 4.2 0.3 0.0 0.1 1.3 0.0 0.0 0.0 0.3 1.1 0.5 1.1 0.6 0.0 0.1 0.0 0.1 0.8 0.6 0.2 0.0 0.5 0.2 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.2 0.1 2.7 0.0 0.1 5.0 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.5 0.0 1.3 0.1 3.3 25.4 1.9 0.3 0.3 0.1 0.0 0.3 0.0 1.7 1.3 0.1 0.1 0.0 3.2 0.1 2.9 0.0 0.0 0.0 0.5 0.0 3.6 3.0 1.8 4.2 1.9 0.6 2.5 1.4 3.0 3.2 0.6 2.4 4.2 3.9 2.6 2.0 0.8 1.0 1.8 0.3 9.9 12.8 6.0 11.7 7.4 10.6 9.4 9.3 10.7 7.1 14.9 10.5 0.0 6.5 4.0 16.5 9.6 12.7 2.7 7.9 15.7 13.7 0.0 6.6 4.5 3.7 5.6 0.0 0.0 2.3 0.1 2.5 5.0 0.0 5.4 0.1 11.1 1.2 12.3 1.2 5.5 31.9 0.2 5.0 0.0 1.6 32.9 2.8 0.6 23.7 14.3 17.3 38.8 17.9 15.4 9.7 6.5 0.0 0.0 0.1 3.8 RNF182 MGC33993 ENSG00000180537 "Ring finger protein 182" Q8N6D2 6 13924446-13980302 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.9;brain: 17.6" "Group enriched" "Detected in some" 4 "Bipolar cells: 16.5;Horizontal cells: 14.3;Muller glia cells: 15.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 37.0;RPTEC TERT1: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012309 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA012309: AB_1856349" "unprognostic (1.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.66e-5)" "unprognostic (6.16e-2)" "unprognostic (2.08e-1)" "unprognostic (9.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.71e-2)" "unprognostic (4.21e-1)" "unprognostic (6.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (9.33e-5)" "unprognostic (6.66e-3)" "unprognostic (1.33e-3)" "unprognostic (1.26e-1)" 1.2 0.7 7.6 0.6 6.2 12.9 1.2 16.6 17.6 1.2 0.7 7.5 2.0 0.8 1.6 2.5 1.0 2.7 0.9 1.0 11.0 7.3 2.6 0.5 5.7 0.8 6.8 8.5 1.1 3.6 0.5 2.0 2.9 14.3 0.9 0.6 2.2 1.9 4.7 0.9 0.8 1.1 1.0 5.1 0.5 0.6 7.0 2.9 0.0 3.0 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.8 5.3 0.0 1.8 2.3 0.3 2.7 3.7 7.5 7.3 0.1 0.0 0.0 0.0 2.9 8.2 0.0 6.2 0.0 13.8 0.0 2.0 0.1 37.0 0.0 0.0 0.0 0.0 1.2 0.0 11.6 0.1 8.7 0.1 1.5 0.2 0.0 5.2 0.0 0.0 0.9 3.0 0.0 10.3 1.5 1.3 0.4 29.7 0.0 6.4 6.1 0.2 0.0 10.4 2.0 0.0 1.0 2.8 9.2 2.0 0.1 6.1 0.0 0.0 0.0 6.2 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.2 16.6 12.1 11.0 7.3 6.8 8.5 14.3 2.9 0.0 0.0 0.0 0.0 0.2 16.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 14.3 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 15.3 0.1 0.0 0.0 0.5 1.2 6.5 0.8 3.0 1.9 0.0 0.2 0.0 0.0 0.0 RNF183 MGC4734 ENSG00000165188 "Ring finger protein 183" Q96D59 9 113297093-113303376 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 19.0;kidney: 9.5" "Cell type enhanced" "Detected in some" 16 "Cholangiocytes: 7.6;Collecting duct cells: 5.2;Intestinal endocrine cells: 8.1;Proximal tubular cells: 18.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 20.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA057675 Uncertain NA NA "HPA057675: AB_2683499" "unprognostic (1.23e-2)" "unprognostic (3.17e-1)" "unprognostic (1.11e-1)" "prognostic favorable (7.95e-6)" "unprognostic (2.56e-1)" "unprognostic (1.75e-2)" "unprognostic (1.54e-3)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.98e-1)" "prognostic favorable (3.51e-4)" "unprognostic (5.50e-2)" "unprognostic (8.84e-2)" "unprognostic (9.61e-2)" "unprognostic (2.53e-3)" 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 1.9 0.2 0.2 1.2 19.0 5.1 1.2 6.2 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.8 0.3 6.9 0.2 0.0 0.1 0.1 0.0 0.0 0.0 3.7 4.3 0.1 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.3 7.6 0.0 0.0 5.2 0.0 0.0 1.7 0.3 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.2 2.1 0.0 0.4 18.3 2.7 0.0 0.1 3.4 1.1 0.0 0.0 0.0 1.5 0.8 RNF185 FLJ38628 ENSG00000138942 "Ring finger protein 185" Q96GF1 22 31160183-31207019 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.50e-1)" "unprognostic (1.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.33e-1)" "unprognostic (3.65e-3)" "unprognostic (4.76e-3)" "unprognostic (2.60e-3)" "unprognostic (1.12e-2)" "unprognostic (3.97e-1)" "unprognostic (2.56e-1)" "unprognostic (2.61e-1)" "unprognostic (9.41e-2)" "prognostic favorable (4.82e-5)" "unprognostic (3.04e-1)" "unprognostic (1.63e-1)" "unprognostic (2.86e-1)" "unprognostic (1.10e-1)" 18.3 16.1 15.2 11.6 20.3 6.8 18.4 16.7 23.4 19.4 17.0 24.3 14.4 15.6 21.8 20.2 20.5 18.3 13.6 15.6 14.7 15.6 27.6 39.7 14.4 11.1 15.9 14.6 21.2 23.5 32.5 24.3 19.8 20.9 30.5 17.3 24.1 27.0 23.5 18.0 22.9 24.4 22.8 16.4 14.4 18.0 11.8 15.1 12.6 39.9 14.4 18.0 19.4 18.5 10.3 12.6 21.5 15.1 15.4 14.0 13.0 9.6 5.7 11.1 12.5 22.5 15.1 10.6 11.5 22.3 15.8 21.5 6.3 4.6 9.2 6.5 20.3 14.0 6.1 10.5 11.9 16.4 9.1 11.4 4.0 5.5 7.7 31.6 9.6 6.2 16.1 42.9 11.1 25.8 14.5 13.2 9.8 4.6 11.0 18.9 6.8 8.3 5.5 4.9 20.0 6.3 8.6 11.0 10.7 11.4 8.4 4.9 9.9 8.4 11.2 16.8 11.9 7.7 6.4 9.2 11.3 8.1 13.0 5.6 15.4 12.5 11.7 14.8 6.2 9.0 15.0 14.6 8.0 12.4 15.1 14.0 10.3 12.7 13.8 12.6 9.0 12.9 11.8 21.5 15.4 12.2 4.7 13.6 13.0 15.2 20.3 16.7 23.4 14.7 15.6 15.9 14.6 20.9 15.1 20.8 9.3 8.3 9.7 8.0 10.1 5.1 12.7 12.0 10.3 17.4 7.9 10.4 18.3 13.4 16.1 8.7 13.4 0.0 12.9 17.5 8.9 12.2 5.7 24.3 12.1 7.9 16.1 27.0 8.1 14.3 6.9 8.8 8.5 11.8 12.0 10.9 13.9 12.7 14.9 18.7 6.7 6.5 8.2 7.0 9.1 9.4 31.1 6.9 7.7 7.4 RNF186 FLJ20225 ENSG00000178828 "Ring finger protein 186" Q9NXI6 1 19814029-19815278 "Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 25.8;intestine: 59.0;kidney: 44.0;pancreas: 30.5" "Group enriched" "Detected in some" 5 "Intestinal endocrine cells: 83.2;Mucus-secreting cells: 32.9;Paneth cells: 108.7;Proximal tubular cells: 98.1;Undifferentiated cells: 113.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034547, HPA035558" Enhanced NA NA "HPA034547: AB_10670975, HPA035558: AB_2674678" "unprognostic (1.66e-2)" "unprognostic (2.49e-2)" "unprognostic (3.89e-1)" "unprognostic (5.93e-3)" "unprognostic (1.77e-3)" "unprognostic (3.23e-1)" "unprognostic (3.05e-1)" "unprognostic (3.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.76e-1)" "unprognostic (1.40e-1)" "unprognostic (8.60e-3)" 0.2 0.1 0.1 7.8 0.1 0.0 0.8 0.1 0.1 0.2 38.2 0.0 0.5 47.1 0.2 25.8 0.2 0.2 0.1 0.1 0.1 0.1 44.0 0.7 0.1 0.0 0.1 0.0 0.3 30.5 0.0 0.2 0.0 0.0 0.6 5.4 0.0 0.2 0.0 0.1 0.2 59.0 0.0 0.1 0.2 0.2 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.2 0.0 0.0 0.5 6.2 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 4.9 0.0 0.0 17.2 0.0 16.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 83.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 7.1 108.7 0.0 98.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.9 0.1 RNF19A "DKFZp566B1346, dorfin, RNF19" ENSG00000034677 "Ring finger protein 19A, RBR E3 ubiquitin protein ligase" Q9NV58 8 100257060-100336218 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 203.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 60.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011455, HPA023652" Approved NA NA "CAB011455: AB_2180446, HPA023652: AB_1847836" "unprognostic (2.55e-1)" "unprognostic (1.13e-1)" "unprognostic (1.84e-1)" "unprognostic (7.09e-2)" "unprognostic (3.36e-1)" "unprognostic (2.12e-2)" "unprognostic (7.96e-2)" "unprognostic (8.92e-2)" "unprognostic (1.13e-1)" "unprognostic (5.97e-2)" "unprognostic (5.20e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (7.99e-5)" "unprognostic (8.44e-2)" "unprognostic (8.19e-2)" "unprognostic (2.02e-1)" "prognostic favorable (3.28e-5)" 28.2 13.8 30.2 21.8 20.8 34.9 26.7 16.3 29.5 40.6 22.8 26.4 11.4 17.0 29.4 19.0 17.6 24.7 30.8 20.1 28.7 16.1 23.0 33.9 28.4 35.2 19.7 25.2 24.8 20.3 14.5 15.7 18.6 23.6 20.7 19.2 11.5 19.8 14.2 23.0 26.6 38.5 32.7 30.1 22.7 21.5 35.4 27.7 25.1 17.0 14.7 29.5 33.9 23.7 13.5 11.4 17.6 10.5 4.8 14.4 4.5 8.6 5.6 4.9 5.6 9.3 8.1 6.4 7.8 7.4 7.4 6.8 3.0 5.8 5.1 14.3 7.9 3.4 6.1 3.8 5.7 10.1 21.5 3.1 8.6 25.8 4.3 7.8 1.7 5.5 8.0 8.8 5.9 11.2 9.0 11.3 5.7 4.7 60.1 7.2 4.3 7.8 2.8 1.7 5.8 5.2 3.2 3.4 10.0 20.2 13.6 3.9 8.4 8.1 4.9 7.5 10.7 4.3 6.7 11.2 8.6 6.8 6.3 4.7 29.2 18.7 3.5 5.6 5.7 5.1 17.6 7.5 6.5 14.4 5.6 9.0 13.5 11.8 10.8 4.6 12.7 6.1 8.8 16.6 4.8 10.5 11.4 12.0 4.5 30.2 20.8 16.3 29.5 28.7 16.1 19.7 25.2 23.6 27.7 47.6 39.3 23.5 84.9 35.6 27.9 35.0 84.1 108.4 101.2 41.8 56.9 8.1 6.6 52.3 151.8 52.5 38.7 46.7 35.2 12.6 44.8 62.3 40.6 34.1 19.7 55.6 20.0 30.7 27.9 203.2 54.1 30.2 20.3 9.0 22.2 41.1 43.0 24.6 64.7 42.5 45.0 19.4 28.3 63.0 44.7 52.8 6.9 48.4 18.2 101.9 RNF19B "FLJ90005, IBRDC3" ENSG00000116514 "Ring finger protein 19B" Q6ZMZ0 1 32936445-32964685 "Enzymes, Predicted membrane proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 54.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 16.1" "Cell line enhanced" "Detected in all" "Daudi: 39.3;Karpas-707: 47.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049587, HPA063640" Approved Approved Cytosol NA NA Cytosol "HPA049587: AB_2680826, HPA063640: " "unprognostic (2.83e-2)" "unprognostic (1.77e-2)" "unprognostic (1.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.78e-2)" "prognostic favorable (3.39e-4)" "prognostic unfavorable (5.41e-6)" "unprognostic (8.78e-2)" "unprognostic (5.02e-1)" "unprognostic (1.69e-1)" "unprognostic (9.85e-2)" "unprognostic (1.38e-1)" "prognostic favorable (4.39e-5)" "unprognostic (2.58e-2)" "unprognostic (4.93e-2)" "unprognostic (3.30e-1)" "unprognostic (1.23e-2)" 8.6 11.3 8.0 13.1 10.5 36.4 12.0 14.1 14.1 9.9 13.2 10.1 4.8 14.1 10.8 6.9 23.3 7.9 10.1 8.5 6.0 7.2 12.0 6.5 13.8 12.9 9.6 9.3 7.1 7.0 6.4 5.7 9.4 10.2 7.4 15.3 9.0 10.8 5.7 10.2 13.6 15.5 10.6 8.0 9.0 7.4 54.7 8.3 6.8 8.2 11.1 16.7 11.3 12.8 1.3 1.3 16.1 2.0 0.8 1.6 0.7 6.7 5.2 4.5 4.1 2.7 3.9 30.0 3.1 3.8 5.7 6.1 6.1 20.3 39.3 5.5 4.1 7.0 9.7 5.5 7.5 5.2 14.4 3.6 3.4 4.1 6.1 8.8 5.2 7.2 3.1 14.0 12.5 15.4 6.6 11.9 3.9 4.2 47.3 5.5 2.2 3.4 6.4 7.2 7.7 5.9 4.6 6.4 4.0 4.4 9.8 7.1 3.6 10.0 3.4 22.4 11.5 2.9 7.6 13.0 3.1 4.3 7.8 5.4 11.3 5.7 13.9 4.5 5.3 4.6 5.3 2.0 3.5 1.6 1.8 1.2 1.2 1.4 0.8 1.3 1.3 0.4 0.6 16.1 0.8 1.5 0.6 1.5 0.7 8.0 10.5 14.1 14.1 6.0 7.2 9.6 9.3 10.2 8.3 11.9 4.1 1.9 20.3 41.0 4.4 12.0 15.3 6.7 2.3 7.0 2.0 11.0 1.7 9.3 30.1 8.7 34.3 0.0 9.9 5.4 7.1 22.8 4.6 3.4 12.6 3.2 10.9 3.7 20.2 18.4 2.0 28.7 5.0 43.3 16.5 2.0 19.2 17.5 3.5 7.1 7.4 0.0 5.4 29.3 12.6 28.4 6.2 3.2 10.5 35.3 RNF217 "C6orf172, dJ84N20.1, IBRDC1, MGC26996" ENSG00000146373 "Ring finger protein 217" Q8TC41 6 124962545-125092633 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 63.3" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.9;myeloid DC: 1.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029598 Uncertain NA NA "HPA029598: AB_10602297" "unprognostic (2.96e-2)" "unprognostic (2.34e-3)" "unprognostic (8.07e-2)" "unprognostic (8.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.06e-2)" "unprognostic (1.06e-1)" "unprognostic (7.22e-3)" "unprognostic (4.94e-2)" "unprognostic (6.69e-2)" "unprognostic (2.47e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (4.60e-5)" "unprognostic (8.29e-4)" "unprognostic (2.16e-1)" "unprognostic (7.52e-2)" "prognostic unfavorable (1.92e-4)" 9.6 3.5 3.3 4.2 4.7 10.5 14.6 3.8 3.5 8.0 7.7 5.7 6.4 2.3 5.9 5.6 6.2 7.5 12.1 6.5 3.8 1.7 2.5 6.3 7.3 3.7 4.3 2.9 11.5 3.8 63.3 4.0 12.0 3.4 6.4 2.3 6.0 6.0 6.9 10.1 10.9 3.1 13.0 2.3 2.6 4.5 7.4 5.7 0.1 7.4 3.6 1.6 8.7 13.6 0.0 1.2 0.6 1.9 0.3 0.2 0.3 4.1 4.3 1.5 0.5 5.4 2.1 8.6 5.7 7.7 3.9 5.1 0.0 3.9 0.0 8.0 5.4 8.9 6.0 0.9 5.1 5.5 0.0 4.8 2.3 6.4 1.3 5.2 0.0 0.2 5.9 4.8 2.9 8.6 4.6 4.4 0.0 11.6 0.0 6.8 0.0 0.0 0.0 1.3 0.0 1.1 0.1 6.0 0.0 4.0 1.9 0.7 0.0 2.5 0.6 2.2 4.4 4.2 0.7 6.9 3.2 10.4 0.0 12.2 0.0 0.0 0.0 2.4 0.0 3.8 0.6 1.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.0 0.3 3.3 4.7 3.8 3.5 3.8 1.7 4.3 2.9 3.4 5.7 20.8 16.0 0.0 12.7 42.7 6.2 12.5 2.5 5.3 10.3 5.2 15.7 15.2 0.0 6.8 92.0 15.0 1.7 0.0 8.3 23.6 21.6 10.4 1.1 24.6 8.5 20.6 2.9 14.1 12.9 49.9 23.9 13.3 18.6 2.8 3.0 4.0 10.7 0.0 19.8 1.9 5.0 6.5 12.3 1.4 2.6 41.0 15.0 0.5 2.7 9.7 RNF222 ENSG00000189051 "Ring finger protein 222" A6NCQ9 17 8390704-8397826 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 15.7;lymphoid tissue: 9.4;tongue: 13.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 2.2;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 1.3;Syncytiotrophoblasts: 1.0;T-cells: 1.0" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "SK-BR-3: 12.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048916 Uncertain NA NA "HPA048916: AB_2680555" "unprognostic (2.49e-1)" "unprognostic (4.19e-2)" "unprognostic (2.32e-2)" "unprognostic (8.19e-4)" "unprognostic (2.81e-1)" "unprognostic (5.30e-2)" "unprognostic (2.02e-1)" "unprognostic (3.93e-2)" "unprognostic (9.55e-2)" "unprognostic (7.02e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-3)" "unprognostic (5.82e-2)" "unprognostic (6.70e-2)" "unprognostic (5.98e-3)" "unprognostic (3.97e-2)" 0.1 0.0 0.1 0.1 0.1 1.8 0.5 0.1 0.1 3.1 0.1 0.1 0.1 0.0 0.6 0.1 15.7 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.1 1.8 0.1 0.1 6.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 13.6 9.4 0.1 5.5 0.4 0.5 2.0 0.5 0.2 1.0 0.1 1.2 0.0 0.0 0.2 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 12.6 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 1.6 0.5 1.0 0.3 0.2 0.2 0.2 0.3 0.1 0.1 0.4 0.6 1.0 2.0 0.2 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.2 0.0 0.6 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 1.3 1.0 1.0 0.0 0.9 RNF223 ENSG00000237330 "Ring finger protein 223" E7ERA6 1 1070966-1074307 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.8;lymphoid tissue: 17.1;tongue: 14.8" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 16.4;Urothelial cells: 31.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 11.9;CAPAN-2: 8.9;HaCaT: 5.6;MCF7: 19.0;OE19: 5.5;SK-BR-3: 13.0;T-47d: 8.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (4.71e-1)" "unprognostic (2.79e-1)" "unprognostic (1.06e-1)" "prognostic favorable (8.08e-5)" "unprognostic (3.50e-1)" "unprognostic (6.50e-2)" "unprognostic (1.43e-3)" "unprognostic (3.91e-1)" "unprognostic (5.09e-2)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.16e-1)" "unprognostic (4.06e-3)" "unprognostic (1.50e-1)" "unprognostic (1.16e-1)" "unprognostic (4.58e-1)" "unprognostic (9.52e-3)" 0.0 0.0 0.0 1.4 0.0 0.4 0.8 0.0 0.5 8.3 1.4 0.0 0.0 0.4 1.0 0.3 28.8 0.2 1.9 0.0 0.0 0.0 0.6 0.3 0.9 0.1 0.0 0.0 0.0 1.0 0.1 0.0 6.5 0.0 4.2 0.8 0.0 3.3 0.4 0.7 3.5 0.2 2.6 0.0 0.2 7.8 0.1 0.0 0.0 0.2 14.8 17.1 4.9 9.3 0.6 0.6 1.9 0.4 0.3 0.4 0.0 11.9 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.4 8.9 0.0 0.1 0.0 0.1 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.0 0.0 0.1 0.0 5.5 0.2 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.1 13.0 0.2 0.1 8.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.4 0.2 0.3 0.1 0.1 0.3 0.2 0.4 0.0 0.6 0.2 0.4 0.9 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 6.4 0.5 0.0 0.4 0.0 2.7 0.0 1.8 0.0 0.2 0.0 6.7 0.0 0.0 5.1 0.0 2.8 16.4 0.0 4.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 4.3 0.0 9.2 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.2 0.0 2.8 31.4 RNF225 ENSG00000269855 "Ring finger protein 225" M0QZC1 19 58396090-58397079 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "esophagus: 31.6;lymphoid tissue: 16.5;tongue: 21.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.1;SCLC-21H: 1.1;T-47d: 3.3;U-266/84: 1.7" "Low region specificity" "Detected in many" NA NA "unprognostic (3.07e-1)" "unprognostic (6.94e-2)" "unprognostic (3.68e-3)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (1.67e-2)" "unprognostic (1.00e-2)" "unprognostic (1.75e-3)" "unprognostic (1.40e-1)" "unprognostic (3.42e-1)" "unprognostic (9.18e-2)" 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 4.0 0.0 0.0 3.1 0.0 0.0 0.1 31.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 1.4 0.0 0.0 1.9 2.1 0.0 6.2 0.0 0.4 0.0 0.1 0.1 1.1 0.0 0.0 0.2 21.8 16.5 0.3 3.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.9 1.1 0.3 0.0 0.6 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.7 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF24 G1L ENSG00000101236 "Ring finger protein 24" Q9Y225 20 3927309-4015582 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 59.0;bone marrow: 59.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 59.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 59.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011900 Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA011900: AB_10671089" "unprognostic (6.61e-2)" "unprognostic (6.56e-2)" "unprognostic (1.72e-1)" "unprognostic (1.17e-2)" "unprognostic (8.79e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (2.65e-1)" "unprognostic (5.87e-2)" "unprognostic (2.66e-2)" "unprognostic (5.19e-3)" "unprognostic (3.42e-1)" "prognostic unfavorable (2.67e-7)" "unprognostic (1.18e-2)" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (1.24e-1)" 9.1 9.3 13.1 11.6 13.0 59.4 14.8 12.3 16.2 9.2 6.6 8.4 17.0 4.7 9.1 20.6 8.1 8.0 9.3 7.4 13.0 10.5 9.5 3.2 14.5 14.1 10.5 9.9 9.3 5.9 5.3 8.2 5.6 9.4 9.9 5.8 5.4 9.8 14.9 3.2 11.4 5.3 9.0 12.8 14.8 7.6 6.3 7.6 6.3 8.8 4.5 6.0 9.4 15.5 1.1 4.6 59.0 5.8 1.7 1.8 2.4 8.1 3.8 5.5 4.9 21.2 36.2 2.0 6.9 14.8 7.0 10.0 2.5 8.1 1.8 1.5 13.9 10.8 5.5 2.1 7.7 11.7 1.2 1.7 15.3 6.6 2.0 18.6 30.4 6.0 12.0 2.4 18.6 15.8 7.8 6.4 5.3 19.3 4.2 11.2 2.3 5.0 7.5 8.4 7.5 5.4 5.7 4.8 1.4 3.9 4.5 5.3 4.3 19.4 11.8 5.1 8.4 4.1 10.9 9.9 17.4 5.8 11.8 8.2 3.5 3.7 0.7 9.0 10.7 5.4 20.7 5.8 11.8 0.9 2.1 0.9 0.3 1.8 1.4 4.6 1.1 1.2 1.4 59.0 1.7 2.8 0.2 0.8 2.4 13.1 13.0 12.3 13.5 13.0 10.5 10.5 9.9 9.4 7.6 3.0 18.4 11.5 30.7 43.4 16.7 2.0 0.0 2.7 13.6 47.1 15.7 1.6 6.6 30.3 16.2 12.8 1.8 0.0 22.0 5.7 31.1 50.5 4.6 0.9 5.2 36.5 12.5 17.8 24.4 16.4 33.9 23.2 37.1 3.6 4.6 11.8 24.3 2.9 56.6 1.2 8.2 19.4 37.7 13.0 19.4 47.6 2.4 10.1 4.3 39.4 RNF26 MGC2642 ENSG00000173456 "Ring finger protein 26" Q9BY78 11 119334527-119337313 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027620 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA Yes Nucleoplasm "Vesicles, Cytosol" "HPA027620: AB_1856356" "unprognostic (9.23e-3)" "unprognostic (3.54e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (3.40e-1)" "unprognostic (1.07e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (2.14e-2)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (7.24e-3)" "unprognostic (6.22e-2)" "prognostic favorable (3.45e-6)" "unprognostic (9.61e-2)" "unprognostic (3.50e-2)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.73e-4)" 19.0 21.5 13.6 15.4 21.6 25.6 16.9 18.4 38.9 19.8 22.0 17.6 14.5 20.3 31.2 15.6 26.0 24.4 19.8 15.1 17.1 13.8 22.3 28.7 17.3 17.5 15.0 16.6 25.6 18.5 31.4 14.3 27.5 27.2 19.2 18.2 20.2 20.0 28.5 17.6 19.8 21.4 27.0 14.3 19.8 24.3 27.6 13.0 26.7 20.6 14.0 21.1 25.8 18.1 13.8 14.2 7.1 15.5 9.8 16.7 16.2 15.7 17.5 16.4 19.3 16.2 12.8 17.4 17.2 18.6 20.1 15.9 29.5 33.2 14.0 23.8 20.4 30.5 28.8 23.2 25.9 12.6 16.6 12.8 36.8 8.2 24.3 12.4 15.4 15.3 13.3 13.3 25.0 22.6 13.2 15.2 21.7 17.8 22.0 13.8 34.5 14.1 16.0 16.4 18.3 22.4 14.7 16.8 11.1 12.3 11.5 11.7 11.3 13.9 17.6 4.6 16.5 39.9 12.9 10.0 24.3 16.2 12.7 15.6 5.3 8.6 0.1 8.1 26.1 18.9 7.1 15.5 3.9 16.7 14.5 11.0 9.0 12.7 14.5 14.2 13.8 14.5 12.4 1.1 9.8 14.1 8.1 6.6 16.2 13.6 21.6 18.4 38.9 17.1 13.8 15.0 16.6 27.2 13.0 3.0 6.5 9.0 12.0 6.2 9.1 0.5 28.1 2.7 7.9 10.4 2.0 31.3 5.0 17.7 3.4 7.5 10.0 0.0 15.0 54.3 13.5 11.2 7.0 19.8 18.0 4.8 13.2 8.6 9.9 4.9 13.0 8.8 1.7 12.6 10.2 9.7 11.8 10.2 16.6 10.3 7.6 6.5 10.3 12.2 8.3 7.4 20.4 9.6 14.5 8.6 RNF43 "DKFZp781H0392, FLJ20315, URCC" ENSG00000108375 "Ring finger protein 43" Q68DV7 17 58352500-58417595 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 33.4;Mucus-secreting cells: 39.0;Undifferentiated cells: 47.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 41.7" "Region enriched" "Detected in many" 7 "cerebellum: 30.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 13.4;Hep G2: 26.2;OE19: 29.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA008079 Uncertain NA NA "HPA008079: AB_1856371" "unprognostic (2.53e-1)" "unprognostic (1.09e-1)" "unprognostic (7.46e-2)" "unprognostic (2.56e-1)" "unprognostic (1.10e-1)" "unprognostic (4.33e-2)" "unprognostic (1.39e-1)" "unprognostic (3.62e-1)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (5.69e-2)" "unprognostic (3.79e-1)" "prognostic favorable (6.04e-9)" "unprognostic (3.61e-3)" "unprognostic (2.56e-1)" "unprognostic (3.58e-1)" "unprognostic (1.04e-2)" 0.4 9.4 2.2 6.2 3.5 1.9 4.5 30.6 4.3 3.4 26.4 0.9 21.3 18.5 1.7 9.1 10.0 3.9 8.1 3.3 1.9 1.3 8.0 7.0 6.1 2.7 0.8 1.1 1.6 13.2 3.0 13.3 8.7 4.1 8.0 16.3 3.8 13.7 19.0 0.5 8.9 29.0 0.9 0.8 0.9 4.9 3.1 0.7 3.0 1.8 5.7 6.6 4.0 4.4 0.9 1.1 1.7 1.8 5.6 3.6 1.2 0.6 9.3 1.7 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 13.4 4.5 3.8 4.8 0.0 1.1 2.6 0.3 3.6 0.0 7.9 6.5 3.0 0.4 26.2 0.0 3.7 2.7 0.0 7.4 0.0 1.1 0.5 0.0 1.2 0.2 3.3 0.0 0.1 2.0 3.5 0.2 29.2 0.6 6.2 0.0 2.0 3.3 5.1 1.0 0.3 0.8 0.4 0.3 3.2 1.1 1.0 0.0 0.1 1.1 0.0 0.0 3.4 1.6 2.9 0.3 0.4 2.2 1.7 0.2 1.6 3.1 0.8 3.2 0.9 2.5 3.6 0.4 0.9 2.3 3.0 0.8 5.6 1.8 1.1 1.2 1.2 2.2 3.5 30.6 4.3 1.9 1.3 0.8 1.1 4.1 0.7 3.0 6.2 0.5 15.7 8.5 2.4 3.5 10.2 4.0 3.4 17.4 2.0 19.4 13.3 5.6 1.2 0.7 33.4 0.0 2.4 2.2 0.6 8.7 0.0 8.7 2.3 4.8 14.9 0.6 0.6 1.3 0.3 0.7 13.5 2.8 39.0 11.7 4.5 24.6 0.4 2.2 2.8 0.0 0.4 1.1 0.5 5.4 4.9 3.9 47.8 5.4 RNF5 "G16, NG2, RING5, RMA1" ENSG00000204308 "Ring finger protein 5" Q99942 6 32178354-32180793 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 293.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034107, HPA065032" Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB034107: AB_2238618, HPA065032: AB_2685408" "unprognostic (1.94e-1)" "unprognostic (1.31e-1)" "unprognostic (1.49e-1)" "unprognostic (4.45e-3)" "unprognostic (1.35e-2)" "unprognostic (1.23e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (4.07e-1)" "prognostic favorable (2.44e-4)" "unprognostic (1.95e-1)" "unprognostic (8.93e-3)" "unprognostic (2.91e-3)" "unprognostic (8.84e-2)" "unprognostic (9.17e-2)" "unprognostic (2.72e-1)" "unprognostic (2.99e-2)" 9.8 20.6 19.3 9.0 20.6 10.3 14.0 13.6 16.8 11.3 25.7 17.4 14.7 18.1 12.3 14.6 15.9 16.9 13.9 19.2 16.9 12.0 32.7 38.1 14.7 11.6 16.3 14.2 19.0 19.3 7.2 5.8 23.4 12.3 13.1 19.1 12.2 25.3 15.3 24.5 13.4 36.7 13.7 19.7 10.2 14.2 9.6 9.6 10.8 18.0 14.2 12.5 13.2 9.9 6.7 26.9 7.2 6.4 7.5 7.0 6.5 5.3 6.9 4.7 18.1 5.2 3.6 3.7 2.1 2.7 4.7 5.4 9.2 4.5 6.9 7.8 5.2 6.7 4.4 8.8 4.9 5.0 4.3 11.9 5.5 7.8 19.0 6.1 0.0 11.3 3.5 6.6 7.9 6.0 8.6 9.5 12.4 14.1 7.5 6.8 7.5 6.7 15.9 0.0 7.5 2.9 4.6 5.3 9.7 13.3 3.4 4.9 10.2 4.2 4.5 4.7 4.4 9.4 19.4 4.2 5.2 5.1 0.0 8.2 4.1 6.2 8.2 3.6 12.3 3.0 5.1 4.6 7.2 7.0 6.4 6.1 6.7 5.7 6.2 6.6 6.0 6.4 6.3 2.4 7.5 4.5 26.9 5.7 6.5 19.3 20.6 13.6 16.8 16.9 12.0 16.3 14.2 12.3 9.6 17.9 31.3 63.3 54.1 85.1 21.8 54.9 81.5 48.2 43.3 87.2 0.0 66.6 240.4 91.9 15.7 46.6 171.7 70.0 79.3 85.9 60.9 53.6 54.4 112.5 61.3 31.8 70.3 41.7 42.8 15.3 55.0 53.8 81.0 88.4 77.1 59.7 70.4 152.6 68.2 293.3 20.3 64.7 69.2 57.6 36.2 73.8 70.4 52.4 93.3 42.3 RNFT1 PTD016 ENSG00000189050 "Ring finger protein, transmembrane 1" Q5M7Z0 17 59952240-59964761 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.5" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 175.4;Spermatocytes: 283.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013739 Approved Nucleoli NA NA Nucleoli "HPA013739: AB_1856382" "unprognostic (1.61e-1)" "unprognostic (2.83e-1)" "prognostic favorable (6.57e-4)" "unprognostic (3.04e-2)" "unprognostic (6.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "prognostic favorable (7.48e-4)" "unprognostic (5.42e-2)" "unprognostic (3.45e-1)" "unprognostic (8.26e-3)" "unprognostic (9.44e-3)" "unprognostic (1.19e-3)" "unprognostic (1.44e-2)" "unprognostic (2.05e-1)" "prognostic favorable (2.57e-4)" "unprognostic (2.60e-1)" 7.9 6.2 2.8 5.3 4.3 3.8 4.2 5.1 3.7 3.1 4.0 2.4 3.7 5.3 2.7 8.1 4.6 3.2 3.1 4.1 3.1 2.2 4.7 12.0 5.0 4.4 2.9 3.1 3.5 7.5 4.7 6.1 4.4 3.4 4.5 4.8 4.2 5.1 3.0 6.7 2.7 7.6 3.0 3.4 4.1 3.9 45.5 3.0 5.9 6.1 4.3 6.0 5.1 3.7 9.5 10.1 20.2 17.1 8.9 7.7 7.9 4.8 2.2 2.3 3.1 7.6 5.7 4.5 6.2 3.3 4.9 6.0 6.9 1.9 7.2 10.4 5.2 11.1 5.6 7.3 4.7 8.5 6.8 7.9 6.1 5.8 6.2 5.7 9.4 9.4 6.3 2.5 4.6 2.0 2.5 4.9 1.7 17.4 4.5 4.1 6.3 3.8 4.5 0.9 6.6 5.1 5.2 17.5 4.2 3.9 3.5 1.4 2.7 8.9 2.2 12.4 3.2 10.3 17.9 3.5 9.5 8.4 5.5 5.3 6.5 18.1 4.3 6.6 5.3 4.7 17.3 11.8 20.2 5.6 13.9 7.7 9.5 5.2 6.3 10.1 6.1 6.8 6.1 5.7 8.9 17.1 6.7 6.5 7.9 2.8 4.3 5.1 3.7 3.1 2.2 2.9 3.1 3.4 3.0 0.0 6.1 15.9 13.3 10.1 7.7 5.6 2.5 16.0 6.8 8.7 19.6 29.6 5.0 12.0 175.4 7.8 14.4 0.0 12.5 30.4 15.3 14.5 18.5 27.2 40.4 17.5 4.1 11.6 25.1 60.1 8.3 27.8 16.9 36.9 7.6 4.5 12.5 19.3 11.0 8.6 6.8 19.4 8.6 283.8 42.4 8.4 24.1 16.0 10.1 7.2 RNFT2 "FLJ14627, TMEM118" ENSG00000135119 "Ring finger protein, transmembrane 2" Q96EX2 12 116738178-116853631 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.0" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 15.3;Cone photoreceptor cells: 15.7;Early spermatids: 40.0;Late spermatids: 40.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064161 Enhanced Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA064161: AB_2685202" "unprognostic (1.56e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (3.59e-1)" "unprognostic (3.98e-1)" "unprognostic (3.10e-2)" "unprognostic (8.14e-5)" "unprognostic (8.62e-2)" "unprognostic (6.28e-3)" "unprognostic (2.58e-1)" "unprognostic (9.25e-3)" "unprognostic (2.75e-1)" "unprognostic (7.61e-3)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.36e-3)" "unprognostic (4.01e-4)" 1.7 3.2 8.8 2.6 15.1 3.5 1.4 13.6 21.0 1.5 1.6 6.6 0.0 2.0 1.5 4.3 1.5 1.5 1.6 1.4 9.9 12.1 2.0 1.0 1.5 4.1 9.7 9.8 1.7 1.4 2.6 7.5 2.9 19.0 1.2 1.7 3.6 2.6 1.2 2.1 2.7 1.8 1.4 6.2 2.9 1.9 7.0 3.4 2.5 2.1 0.0 4.4 1.2 0.4 4.3 2.2 4.0 1.1 2.8 3.1 0.9 1.5 9.2 4.8 15.6 0.2 0.0 8.0 0.6 0.7 1.9 1.7 3.6 1.8 8.1 2.3 0.1 2.4 1.9 10.2 0.7 1.9 7.6 5.1 1.5 7.4 4.9 2.1 0.6 4.7 0.2 0.2 3.2 1.0 1.6 0.3 5.7 6.2 2.9 0.2 7.8 7.8 1.9 4.8 2.0 1.8 5.1 2.7 4.1 3.7 1.9 7.4 6.7 2.3 1.2 2.2 3.3 7.3 1.8 0.5 1.3 5.3 3.1 3.1 3.7 12.2 8.4 5.9 0.8 1.0 4.0 1.1 1.3 2.0 0.7 0.6 4.3 1.8 1.4 0.6 3.3 2.9 3.1 3.4 2.8 0.8 2.2 1.1 0.9 8.8 15.1 13.6 20.9 9.9 12.1 9.7 9.8 19.0 3.4 0.0 0.3 0.0 0.2 0.0 15.3 0.8 2.5 1.4 0.0 7.0 15.7 2.7 0.0 0.8 40.0 2.1 0.4 0.0 0.2 2.3 0.6 0.3 0.0 0.0 1.8 9.5 4.1 0.0 2.2 40.6 0.6 1.0 1.7 1.0 0.4 6.9 0.7 0.0 1.4 0.8 8.9 0.0 0.4 2.6 3.6 0.0 1.4 0.0 0.6 0.1 ROBO2 KIAA1568 ENSG00000185008 "Roundabout guidance receptor 2" Q9HCK4 3 75906695-77649964 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1" "Group enriched" "Detected in many" 4 "Bipolar cells: 34.7;Horizontal cells: 49.3" "Cancer enhanced" "Detected in many" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 15.2;HEL: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013371 Approved Approved "Nucleoplasm,Centriolar satellite" NA NA 660000 "Nucleoplasm, Centriolar satellite" "HPA013371: AB_1856391" "unprognostic (1.14e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.82e-2)" "unprognostic (5.93e-3)" "unprognostic (3.87e-1)" "unprognostic (2.83e-3)" "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (2.90e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (9.65e-3)" 1.1 3.3 6.4 0.8 13.8 0.3 1.1 19.0 26.1 3.6 1.3 2.2 0.0 0.9 2.9 0.8 6.2 0.4 3.1 1.0 6.3 6.5 2.5 1.8 12.3 1.8 9.6 5.5 9.4 2.2 6.8 2.1 6.4 9.9 1.9 0.8 4.8 2.1 7.8 0.4 3.0 1.2 1.9 7.8 3.6 1.1 4.5 3.6 3.6 0.4 4.2 3.0 2.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 4.0 4.3 0.0 0.1 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 5.0 41.7 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.6 4.7 0.0 0.0 0.5 2.7 6.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 13.8 19.0 11.3 6.3 6.5 9.6 5.5 9.9 3.6 0.0 0.3 0.0 1.5 1.5 34.7 1.9 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.1 7.6 0.0 0.0 0.0 0.1 49.3 0.0 4.3 0.0 1.7 2.8 0.0 0.0 0.0 1.4 0.9 0.3 0.0 5.6 0.0 4.4 0.0 0.8 0.2 0.7 1.0 0.1 0.0 0.0 0.1 ROBO3 "FLJ21044, HGPPS, HGPS, RBIG1" ENSG00000154134 "Roundabout guidance receptor 3" Q96MS0 11 124865386-124881470 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 20.1" "Cell type enhanced" "Detected in many" 11 "Muller glia cells: 42.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "AF22: 20.5" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Low region specificity" "Detected in all" HPA071053 Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA071053: " "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "unprognostic (4.95e-3)" "unprognostic (3.42e-2)" "unprognostic (3.84e-2)" "unprognostic (6.25e-2)" "unprognostic (6.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (7.15e-2)" "unprognostic (3.75e-8)" "unprognostic (7.27e-3)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (4.91e-3)" 2.4 1.5 1.5 0.5 1.4 1.3 1.7 0.5 3.1 0.8 0.9 0.5 0.5 1.9 1.8 20.1 0.5 2.1 0.5 1.5 1.5 0.6 0.7 0.5 1.7 0.8 1.1 1.1 7.4 0.5 0.2 0.5 1.5 1.0 1.0 0.2 1.0 1.7 0.5 2.6 0.2 2.2 4.5 0.7 3.0 0.8 1.0 0.5 0.8 1.1 0.5 0.5 0.5 1.0 0.0 1.3 1.4 0.3 0.0 0.8 0.0 0.0 0.0 20.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.4 0.0 0.1 0.1 0.0 0.8 1.1 0.0 1.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.3 0.4 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 1.3 0.8 0.0 1.5 1.4 0.5 2.7 1.5 0.6 1.1 1.1 1.0 0.5 0.0 5.3 0.0 13.5 2.6 0.6 2.8 0.0 0.0 5.7 12.2 0.0 0.1 0.0 6.6 0.2 10.3 1.1 0.0 0.7 0.1 7.6 6.0 9.2 0.0 1.5 0.0 3.4 4.9 2.1 0.0 12.4 8.5 3.3 1.8 0.9 42.6 1.1 2.9 7.8 0.4 1.7 0.0 4.9 3.2 5.9 0.9 0.1 1.7 2.3 5.6 ROM1 "ROM, TSPAN23" ENSG00000149489 "Retinal outer segment membrane protein 1" Q03395 11 62611722-62615120 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 108.1" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 2384.7" "Cancer enriched" "Detected in all" 6 "glioma: 14.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 17.9;U-266/84: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028910, HPA073279" Enhanced Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA028910: AB_2672824, HPA073279: " "unprognostic (1.54e-2)" "unprognostic (1.37e-2)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-1)" "unprognostic (4.05e-1)" "prognostic favorable (2.20e-4)" "unprognostic (2.20e-1)" "unprognostic (9.87e-2)" "unprognostic (7.65e-3)" "unprognostic (3.50e-2)" "prognostic unfavorable (2.85e-6)" "unprognostic (2.61e-1)" "unprognostic (4.65e-1)" "unprognostic (1.02e-1)" "unprognostic (7.24e-2)" 9.4 4.6 16.3 2.3 15.0 0.9 3.6 5.7 18.8 4.9 3.1 5.1 3.3 2.0 3.8 5.7 4.7 7.4 5.2 2.7 14.7 9.2 2.4 3.2 3.0 2.3 18.1 4.7 13.2 3.2 4.8 2.1 1.6 8.7 3.8 3.0 108.1 2.5 5.9 2.2 3.7 1.7 6.3 21.6 2.5 2.4 3.7 7.7 0.7 3.0 2.2 2.6 3.1 9.2 1.1 0.8 0.8 1.2 5.6 3.2 1.4 2.1 1.2 2.2 4.6 3.2 15.7 0.4 1.4 2.5 3.1 2.0 0.6 3.6 2.0 10.0 8.1 1.3 2.8 1.0 2.8 0.8 3.6 1.8 1.8 5.4 2.6 9.3 0.7 0.6 17.9 4.1 3.2 6.4 10.5 4.8 0.9 2.7 4.6 6.2 5.4 1.1 1.5 0.5 1.1 3.3 1.1 1.8 12.8 3.4 1.2 2.3 3.4 3.5 4.1 1.6 0.3 5.6 0.9 5.4 5.1 1.9 6.0 1.6 2.1 18.8 1.6 9.5 2.1 1.0 0.0 1.2 0.8 0.9 0.3 2.4 0.7 3.2 0.8 0.6 1.1 1.5 1.8 0.4 5.6 1.1 0.8 0.9 1.4 16.3 15.0 5.7 8.4 14.7 9.2 18.1 4.7 8.7 7.7 0.0 4.1 0.0 4.4 3.3 268.3 2.4 0.0 2.7 1.2 5.2 559.6 0.8 1.7 1.3 2.1 8.0 1.6 0.0 2.7 0.2 3.5 2.6 1.1 0.6 1.0 162.1 4.1 11.1 1.8 5.9 17.5 1.0 3.3 1.0 2.8 315.6 1.7 3.4 5.3 4.0 2384.7 0.0 3.4 0.9 2.7 0.9 0.6 0.0 2.9 2.0 ROMO1 "bA353C18.2, C20orf52, MTGMP" ENSG00000125995 "Reactive oxygen species modulator 1" P60602 20 35699272-35700984 "Predicted intracellular proteins, Transporters" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012782 Uncertain NA NA "HPA012782: AB_1845685" "unprognostic (1.55e-1)" "unprognostic (3.86e-2)" "unprognostic (3.00e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-2)" "unprognostic (1.27e-3)" "unprognostic (5.84e-2)" "unprognostic (6.15e-2)" "unprognostic (1.21e-1)" "unprognostic (3.65e-2)" "unprognostic (7.35e-2)" "unprognostic (6.55e-2)" "unprognostic (1.83e-1)" "unprognostic (1.53e-1)" "unprognostic (2.70e-1)" "unprognostic (1.35e-1)" "unprognostic (3.47e-2)" 28.1 38.7 32.0 31.8 27.5 32.4 27.6 10.8 25.2 26.3 36.8 17.5 30.3 35.1 23.4 42.7 38.6 26.2 34.1 86.4 24.8 25.5 43.8 58.6 21.4 24.0 28.7 20.6 23.0 46.8 12.2 34.7 24.1 26.4 24.5 21.9 29.3 46.9 45.2 137.9 23.5 31.0 26.4 24.7 23.7 31.8 30.1 17.4 24.1 33.5 45.2 27.6 31.8 29.3 74.8 140.1 65.4 82.1 47.8 68.2 88.1 31.7 48.2 16.7 20.9 12.1 16.5 29.9 16.9 18.8 25.4 24.9 116.4 27.2 15.3 41.3 11.8 38.8 33.1 8.9 41.6 6.0 8.9 62.3 27.3 55.7 126.6 26.0 16.4 14.5 21.3 19.8 17.9 12.7 12.1 20.3 29.1 21.3 31.7 11.8 91.8 37.1 47.2 27.3 31.6 87.1 24.6 33.6 34.4 23.5 49.7 24.4 25.8 30.6 56.6 30.6 15.7 51.7 37.5 17.7 44.6 25.7 30.0 29.1 53.9 45.6 38.3 39.4 13.5 25.7 65.4 82.1 58.5 56.2 65.2 52.8 74.8 58.5 55.1 76.0 65.5 50.1 56.1 44.5 47.8 60.6 140.1 68.2 88.1 32.0 27.5 10.8 25.2 24.8 25.5 28.7 20.6 26.4 17.4 95.3 176.1 118.3 71.0 105.0 23.0 570.3 318.5 346.6 219.5 244.3 7.9 242.8 341.5 328.0 18.5 164.1 543.2 46.7 496.0 214.3 201.3 104.8 187.2 536.3 194.2 19.1 315.2 192.1 176.3 40.5 120.8 197.3 224.4 348.9 291.8 87.1 470.1 340.1 120.6 547.9 29.4 116.4 195.7 287.5 185.5 133.9 273.3 110.7 265.9 104.0 ROR1 NTRKR1 ENSG00000185483 "Receptor tyrosine kinase like orphan receptor 1" Q01973 1 63774022-64181498 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Receptor, Transferase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 31.2" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 47.6;Intestinal endocrine cells: 20.6;Leydig cells: 25.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "cerebellum: 13.0" "Group enriched" "Detected in some" 5 "NK-cell: 3.3;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 5 "dendritic cells: 1.1;NK-cells: 3.3" "Cell line enhanced" "Detected in many" "ASC diff: 19.8;ASC TERT1: 24.8;CACO-2: 16.9;HHSteC: 18.8;HSkMC: 20.3;NTERA-2: 20.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057016 Approved Microtubules "Intracellular and membrane" NA NA 2800000 Microtubules "HPA057016: " "unprognostic (5.15e-2)" "unprognostic (1.19e-2)" "unprognostic (3.65e-2)" "unprognostic (1.03e-2)" "unprognostic (6.24e-2)" "unprognostic (1.61e-1)" "unprognostic (7.11e-3)" "unprognostic (1.41e-1)" "unprognostic (4.06e-1)" "unprognostic (3.84e-1)" "unprognostic (3.20e-2)" "unprognostic (2.02e-2)" "unprognostic (3.64e-3)" "unprognostic (1.48e-2)" "unprognostic (1.52e-1)" "unprognostic (5.87e-2)" "unprognostic (5.15e-2)" 5.5 1.7 1.3 3.5 2.7 0.4 3.4 13.0 2.8 16.7 8.8 2.2 4.4 2.0 14.2 5.0 4.9 5.5 10.7 10.6 1.3 1.1 3.6 0.8 9.7 1.1 1.0 2.4 8.3 9.8 31.2 3.6 2.9 3.0 10.9 3.9 7.9 2.8 6.3 2.1 4.5 4.1 17.8 1.1 3.1 9.2 2.7 0.9 1.8 1.5 4.6 2.1 10.2 8.8 0.4 1.1 0.1 0.1 3.3 0.1 0.0 7.1 5.6 2.8 0.4 19.8 24.8 1.9 1.4 3.9 0.8 2.0 16.9 2.3 0.1 3.2 3.3 1.4 1.5 0.0 1.3 0.5 0.0 1.8 0.0 0.7 0.2 18.8 0.0 0.0 20.3 5.2 10.4 12.2 4.0 0.3 0.2 0.0 0.1 5.2 0.1 0.1 0.0 20.6 5.2 2.8 0.1 0.1 4.4 4.1 0.1 1.6 6.6 0.4 0.1 2.9 10.0 0.0 0.0 3.9 1.6 2.9 11.0 2.9 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.1 3.3 0.1 1.1 0.0 0.0 1.3 2.7 13.0 2.8 1.3 1.1 1.0 2.4 3.0 0.9 47.6 8.0 0.0 1.8 3.4 1.7 8.5 2.5 1.4 2.3 1.8 0.0 0.2 0.0 5.3 7.8 1.3 0.0 0.0 13.4 0.7 7.6 1.5 0.0 0.0 5.8 0.0 20.6 1.3 0.0 4.7 25.6 0.0 3.3 0.0 2.3 4.9 10.7 0.0 13.8 2.8 0.0 6.5 12.0 0.7 1.2 4.0 0.2 0.0 2.6 0.9 ROR2 "BDB, BDB1, NTRKR2" ENSG00000169071 "Receptor tyrosine kinase like orphan receptor 2" Q01974 9 91563091-91950162 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Basal glandular cells: 9.7;Fibroblasts: 9.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "pons and medulla: 6.6" "Cell type enriched" "Detected in single" 6 "MAIT T-cell: 3.9" "Lineage enriched" "Detected in single" 6 "T-cells: 3.9" "Cell line enhanced" "Detected in many" "AF22: 12.3;HHSteC: 32.4;HSkMC: 26.9;U-266/70: 18.7;U-266/84: 12.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "cerebellum: 13.5" HPA021868 Uncertain NA NA "HPA021868: AB_1856406" "unprognostic (9.38e-3)" "unprognostic (4.69e-1)" "unprognostic (2.26e-1)" "unprognostic (8.48e-3)" "unprognostic (1.23e-1)" "unprognostic (2.38e-1)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (8.03e-2)" "unprognostic (2.03e-1)" "unprognostic (5.76e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (9.86e-7)" "unprognostic (2.16e-3)" "unprognostic (9.13e-2)" "prognostic unfavorable (4.28e-8)" "unprognostic (1.25e-2)" 4.4 4.3 0.7 5.3 1.1 0.0 3.6 0.2 0.8 23.4 20.7 2.9 11.1 1.9 29.1 9.1 8.0 8.1 18.7 8.5 1.0 0.9 2.0 0.5 4.2 0.7 0.3 0.0 19.1 3.1 20.3 1.3 7.1 6.6 20.3 2.1 11.0 1.2 13.1 1.1 2.9 6.2 30.0 0.3 4.7 10.5 5.2 0.3 2.6 7.9 1.9 3.3 23.7 18.1 0.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.1 12.3 0.0 2.7 0.2 3.5 0.2 3.2 2.1 3.9 0.0 0.0 0.0 0.0 0.6 1.9 0.1 2.5 0.0 0.9 0.0 2.0 0.0 9.4 0.0 32.4 0.0 0.0 26.9 0.0 2.8 0.0 0.0 0.0 0.1 6.8 0.0 0.0 0.2 0.0 1.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.6 0.2 0.0 0.0 2.7 7.3 0.1 0.0 0.0 2.4 1.0 0.0 18.7 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.2 0.8 1.0 0.9 0.3 0.0 6.6 0.3 0.0 0.0 0.0 9.7 2.7 1.9 5.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 3.5 1.1 0.0 0.0 1.3 0.1 9.1 8.3 1.1 0.0 0.7 0.0 2.9 0.6 0.0 6.0 5.5 0.0 5.0 2.8 2.8 6.8 0.8 0.0 8.5 0.0 0.2 6.5 3.9 1.0 6.8 1.9 0.3 0.0 0.8 4.4 ROS1 "c-ros-1, MCF3, ROS" ENSG00000047936 "ROS proto-oncogene 1, receptor tyrosine kinase" P08922 6 117288300-117425855 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 38.6;lung: 20.2" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 56.7" "Cancer enriched" "Detected in some" 13 "lung cancer: 6.9" "Group enriched" "Detected in some" 10 "cerebral cortex: 7.4;olfactory region: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "GAMG: 16.3;HSkMC: 8.7;hTCEpi: 18.1;LHCN-M2: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049098, HPA072424" Uncertain Approved Vesicles NA NA Vesicles "HPA049098: AB_2680628, HPA072424: AB_2686519" "unprognostic (8.18e-2)" "unprognostic (4.64e-3)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (7.57e-2)" "unprognostic (2.05e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-1)" "unprognostic (2.79e-2)" "unprognostic (1.00e-2)" "unprognostic (2.42e-1)" "unprognostic (5.20e-2)" "unprognostic (1.56e-12)" "unprognostic (1.09e-2)" "unprognostic (2.81e-1)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" 0.3 0.2 0.2 0.0 0.4 0.0 0.2 0.2 7.4 0.2 0.4 0.0 7.9 0.0 0.2 38.6 0.2 0.2 0.0 0.2 0.2 0.2 0.4 0.2 20.2 0.0 0.2 2.5 0.2 0.2 0.0 0.3 0.7 0.0 0.2 0.3 0.0 0.2 2.3 0.2 0.7 0.3 0.0 0.2 0.2 0.3 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 8.7 18.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.6 0.0 2.2 1.4 0.1 1.7 0.0 0.0 0.0 1.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 7.4 0.2 0.2 0.2 2.5 0.0 0.0 14.9 56.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 RPL37A L37A ENSG00000197756 "Ribosomal protein L37a" P61513 2 216498189-216579180 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065327 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA065327: AB_2685469" "unprognostic (9.94e-3)" "unprognostic (2.17e-1)" "unprognostic (2.99e-1)" "unprognostic (3.19e-1)" "unprognostic (5.12e-3)" "unprognostic (6.92e-2)" "unprognostic (1.76e-2)" "unprognostic (2.67e-1)" "unprognostic (8.26e-2)" "unprognostic (2.33e-1)" "unprognostic (2.62e-1)" "unprognostic (8.84e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.49e-1)" "unprognostic (4.92e-2)" "unprognostic (1.05e-2)" "unprognostic (1.67e-1)" 115.0 109.4 130.0 114.9 104.2 153.1 252.9 78.4 82.8 134.5 129.9 66.0 80.5 79.8 188.5 123.9 154.9 131.5 90.7 154.0 91.2 81.7 81.0 116.7 100.7 283.5 108.6 91.0 281.8 423.2 47.3 84.3 74.1 89.0 134.7 115.2 77.9 265.7 107.8 307.2 159.0 76.6 171.8 98.6 97.6 99.0 130.3 60.1 117.2 123.7 186.1 154.7 137.2 195.1 215.6 197.7 39.6 103.3 119.1 222.5 229.2 81.9 70.2 152.5 102.6 159.6 281.3 113.4 111.8 150.3 114.2 97.7 177.9 80.1 90.7 157.1 137.3 122.8 86.3 144.1 164.9 118.2 103.1 152.7 148.1 127.2 251.1 273.3 162.6 93.3 304.6 347.5 98.7 279.0 313.3 157.3 180.8 115.3 133.2 147.6 165.4 154.1 334.9 176.5 183.8 80.3 112.0 114.6 110.4 159.0 144.6 99.1 111.5 41.3 129.4 254.7 226.8 81.9 281.6 105.4 82.7 90.3 80.9 122.2 141.7 199.6 173.0 92.2 114.0 83.5 39.6 103.3 24.2 122.9 77.1 168.0 215.2 190.4 151.9 143.0 215.6 222.5 198.2 13.5 119.1 63.9 197.7 136.5 229.2 130.0 104.2 78.4 82.8 91.2 81.7 108.6 91.0 89.0 60.1 1113.6 1605.4 4470.7 2849.7 4385.4 480.1 1288.8 2771.9 1195.1 2353.3 1200.4 174.7 2558.5 2674.2 2235.0 3158.6 2255.3 1994.6 1401.6 7324.8 4423.3 2457.1 2614.9 2050.5 4095.4 2673.7 189.1 2525.5 3209.1 4083.5 6452.6 5314.9 2718.4 2706.1 2655.6 4289.5 857.5 5221.5 4229.5 2791.1 2456.8 499.9 1972.6 2514.2 2077.9 1466.6 6429.9 2683.3 2745.2 5422.7 2918.7 RPL9 L9 ENSG00000163682 "Ribosomal protein L9" P32969 4 39452521-39458949 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003372 Approved Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 24000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA003372: AB_1079843" "unprognostic (1.08e-3)" "unprognostic (2.14e-1)" "unprognostic (1.24e-1)" "unprognostic (8.06e-3)" "unprognostic (5.59e-2)" "unprognostic (1.27e-2)" "unprognostic (3.16e-2)" "unprognostic (2.14e-1)" "unprognostic (8.58e-2)" "unprognostic (6.68e-2)" "unprognostic (2.50e-2)" "unprognostic (7.85e-2)" "prognostic unfavorable (7.34e-4)" "unprognostic (1.34e-1)" "unprognostic (2.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-2)" 52.6 35.2 42.2 73.9 44.4 179.1 202.3 35.7 51.6 63.0 59.8 34.5 42.2 69.8 50.4 226.8 49.9 48.1 69.7 58.2 42.3 27.6 47.4 73.2 35.8 48.7 34.7 51.7 158.5 126.2 37.4 44.7 38.7 42.5 47.8 59.1 31.7 93.7 71.4 66.3 62.9 38.8 49.5 34.0 45.2 46.5 56.9 25.9 36.0 63.2 70.1 59.0 46.0 56.6 118.3 72.5 26.2 41.4 63.0 145.0 148.9 3.2 2.8 122.9 2.8 6.6 9.0 4.8 57.9 87.4 72.3 54.8 8.1 65.7 143.5 6.6 58.2 57.3 65.4 5.5 6.3 79.1 52.3 115.6 4.5 24.2 7.8 8.6 9.3 38.0 11.9 181.8 4.4 83.1 107.6 5.5 5.8 109.7 67.0 5.0 4.3 77.9 9.9 109.8 79.6 3.9 71.9 123.2 4.9 89.9 3.8 4.6 49.0 2.0 47.5 7.4 118.9 104.9 6.8 4.1 3.1 4.6 84.1 8.0 103.0 144.6 124.7 83.4 87.3 3.3 26.2 41.4 12.3 52.1 40.1 101.2 118.3 102.2 71.4 57.2 103.8 145.0 111.7 6.9 63.0 31.2 72.5 77.0 148.9 42.2 44.4 35.7 51.6 42.3 27.6 34.7 51.7 42.5 25.9 616.4 695.5 3946.9 4635.1 3670.9 362.7 367.2 1765.6 426.9 687.0 673.4 151.2 2652.9 2316.1 1697.3 1288.9 2348.7 1394.0 817.7 3813.6 4743.2 2040.6 3407.8 885.2 1749.4 2435.4 187.5 1780.1 1927.4 2668.8 1161.7 4462.6 2606.9 1756.2 2952.2 2900.0 510.1 3233.5 2563.6 2250.5 2828.8 405.3 1487.5 2143.4 695.4 462.3 4086.9 2843.5 2427.5 4009.2 4396.5 RPN1 OST1 ENSG00000163902 "Ribophorin I" P04843 3 128619970-128681075 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009748, HPA026828, HPA051520" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA 8200000 "Endoplasmic reticulum" Cytosol "CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521" "unprognostic (4.83e-2)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (7.67e-2)" "unprognostic (2.36e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (4.80e-4)" "unprognostic (2.71e-1)" "unprognostic (2.43e-1)" "unprognostic (2.28e-2)" "unprognostic (4.58e-3)" "unprognostic (2.87e-1)" "unprognostic (7.68e-2)" "unprognostic (7.86e-2)" "unprognostic (1.52e-2)" "unprognostic (1.44e-1)" "unprognostic (9.74e-2)" 52.3 37.5 22.2 26.6 23.8 24.4 48.2 20.9 31.4 45.8 40.8 31.9 58.8 28.5 38.3 110.2 32.2 38.3 38.8 47.1 23.0 28.0 55.4 174.0 47.4 50.6 26.4 18.3 37.8 62.9 43.5 36.9 58.3 24.3 31.4 41.1 28.6 54.1 55.5 34.4 24.0 37.0 33.5 31.8 48.0 33.7 26.9 23.3 34.3 69.1 27.3 36.5 32.7 39.7 26.7 53.1 64.4 43.5 23.4 45.1 53.3 60.5 33.0 27.6 50.7 74.7 50.1 62.5 52.2 68.7 69.4 80.9 68.4 57.1 37.9 49.3 75.3 64.7 61.0 44.5 46.5 68.0 27.2 28.6 66.8 24.6 56.2 82.4 54.2 35.2 41.5 54.4 45.6 67.5 46.5 54.2 28.7 27.5 50.9 45.5 55.4 30.0 59.6 35.0 81.1 30.3 32.9 37.1 91.2 48.1 36.4 42.5 24.5 42.9 44.5 52.8 36.9 47.6 56.1 35.2 35.9 28.1 52.5 38.7 54.9 43.2 40.5 58.9 40.4 51.8 38.8 43.5 35.7 37.3 40.0 45.1 26.7 30.7 33.8 43.5 18.3 19.1 29.2 64.4 23.4 40.2 53.1 30.5 53.3 22.2 23.8 20.9 31.4 23.0 28.0 26.4 18.3 24.3 23.3 56.6 71.5 37.3 71.3 44.0 11.5 35.3 61.1 66.9 47.8 106.4 7.9 108.3 13.3 99.9 13.7 58.2 107.9 46.7 81.2 161.1 79.3 88.0 42.7 155.3 122.7 19.1 41.6 107.4 134.1 20.7 87.2 73.4 55.6 36.9 102.4 27.5 98.9 83.4 60.5 80.2 11.7 45.3 39.6 49.9 59.8 46.7 131.0 50.0 106.2 66.4 RPN2 "RIBIIR, RPN-II, RPNII, SWP1" ENSG00000118705 "Ribophorin II" P04844 20 37178410-37241623 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Extravillous trophoblasts: 520.7;Syncytiotrophoblasts: 519.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008297, CAB019277, HPA025922" Enhanced Supported "Endoplasmic reticulum" NA NA 2800000 "Endoplasmic reticulum" "CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458" "unprognostic (9.59e-3)" "unprognostic (5.22e-2)" "unprognostic (1.66e-2)" "unprognostic (1.06e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.82e-2)" "unprognostic (1.09e-1)" "unprognostic (2.58e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "prognostic unfavorable (1.44e-10)" "unprognostic (2.83e-1)" "unprognostic (6.99e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (2.44e-4)" 29.2 47.6 16.6 24.2 19.6 30.1 34.8 13.2 21.4 34.3 30.5 23.3 52.6 24.0 38.3 70.3 35.1 29.5 34.8 36.3 14.2 14.1 52.9 105.7 38.7 53.0 19.1 14.7 33.3 72.2 38.2 28.7 110.3 19.8 33.3 34.7 43.1 64.6 49.1 32.9 26.0 43.2 30.2 15.6 47.5 35.7 43.5 14.5 27.9 56.8 26.4 42.3 27.8 27.7 48.1 96.3 55.8 70.1 60.8 72.3 92.9 36.7 33.2 34.8 46.3 48.4 36.3 69.1 48.7 57.9 62.4 53.1 105.4 64.5 28.8 59.6 62.7 58.2 53.6 36.0 57.9 56.9 13.4 22.3 32.9 38.8 70.2 46.8 51.9 55.2 34.2 57.9 49.5 51.5 59.7 59.8 27.0 50.4 93.9 43.7 33.2 29.8 53.0 28.1 93.3 47.2 27.2 64.6 94.4 42.8 35.0 28.8 30.8 59.0 142.5 56.6 42.6 70.4 87.3 38.6 70.9 43.2 36.9 42.2 56.5 67.4 30.3 69.5 35.2 57.2 55.8 70.1 45.1 62.8 66.6 72.3 48.1 59.2 62.8 78.7 37.4 53.8 55.5 13.0 60.8 53.7 96.3 52.9 92.9 16.6 19.6 13.2 21.4 14.2 14.1 19.1 14.7 19.8 14.5 110.2 155.8 75.4 110.3 55.0 62.6 70.6 129.9 77.6 87.6 76.8 43.2 403.6 19.9 222.8 23.6 87.5 73.5 93.5 212.6 520.7 89.4 118.5 102.7 173.2 208.9 60.4 60.5 106.8 138.1 22.0 97.2 119.0 86.0 115.4 110.0 140.5 151.9 100.8 104.3 52.6 62.7 84.1 70.1 327.7 305.6 50.6 519.4 74.0 130.8 106.2 RPRM "FLJ90327, REPRIMO" ENSG00000177519 "Reprimo, TP53 dependent G2 arrest mediator homolog" Q9NS64 2 153477338-153478808 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.9" "Cell type enhanced" "Detected in some" 12 "Distal tubular cells: 11.6;Sertoli cells: 12.9" "Group enriched" "Detected in many" 8 "glioma: 6.7;testis cancer: 28.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 19 "T-reg: 1.9" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Group enriched" "Detected in some" 4 "HEK 293: 18.3;MCF7: 20.4;NTERA-2: 14.6;SCLC-21H: 5.4;SH-SY5Y: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (6.66e-2)" "unprognostic (2.69e-1)" "unprognostic (1.08e-1)" "unprognostic (1.72e-2)" "unprognostic (2.48e-2)" "unprognostic (1.11e-1)" "unprognostic (1.62e-2)" "unprognostic (5.19e-1)" "unprognostic (5.51e-2)" "unprognostic (3.09e-3)" "unprognostic (2.58e-1)" "unprognostic (6.19e-2)" "unprognostic (6.38e-4)" "unprognostic (5.21e-2)" "unprognostic (1.25e-2)" "unprognostic (8.61e-2)" 2.8 14.6 21.9 0.7 5.3 0.5 0.6 0.4 17.7 14.2 9.6 1.3 4.2 0.6 17.6 7.3 1.2 4.8 0.5 0.6 4.0 11.2 1.2 0.5 1.3 0.6 1.6 4.2 10.5 0.5 0.5 11.5 0.6 3.8 11.0 1.0 4.2 14.3 9.2 0.6 0.9 0.9 15.8 1.5 1.5 5.3 1.6 1.5 0.0 1.6 0.0 0.6 1.7 1.9 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 18.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 20.4 0.0 0.0 14.6 0.0 0.8 0.0 0.0 0.0 0.0 0.1 5.4 6.1 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 21.9 5.3 0.4 10.5 4.0 11.2 1.6 4.2 3.8 1.5 3.0 0.0 0.0 0.7 0.1 4.1 0.3 0.0 1.4 1.2 1.8 0.0 0.3 11.6 0.0 0.4 0.2 0.0 0.0 1.6 0.6 1.3 1.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.7 0.0 1.6 12.9 0.8 0.1 1.7 0.3 0.7 0.0 0.0 1.0 RPRML MGC43894 ENSG00000179673 "Reprimo like" Q8N4K4 17 46978156-46979248 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 27.0" "Cell type enriched" "Detected in some" 9 "Intestinal endocrine cells: 30.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 2.6;Daudi: 16.2;HEK 293: 5.0;NTERA-2: 2.5;SCLC-21H: 2.5" "Group enriched" "Detected in many" 13 "amygdala: 44.0;basal ganglia: 29.6;cerebral cortex: 41.6;hippocampal formation: 38.9;olfactory region: 24.9" "Region enhanced" "Detected in many" "basal ganglia: 311.4" HPA062668 Uncertain NA NA "HPA062668: AB_2684827" "unprognostic (7.79e-4)" "unprognostic (1.66e-2)" "unprognostic (8.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.31e-1)" "unprognostic (8.93e-4)" "unprognostic (2.78e-2)" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" 0.8 0.6 6.6 0.6 27.0 0.6 0.8 3.6 16.5 0.6 0.8 0.0 0.0 0.8 0.6 2.5 0.6 0.7 0.6 0.6 4.9 1.3 0.7 0.6 0.6 0.6 0.8 10.1 0.6 0.6 0.6 0.1 0.6 0.0 0.8 0.6 0.4 0.7 0.6 3.9 1.0 0.8 0.6 0.0 0.7 1.3 0.7 2.7 0.0 0.6 0.0 0.6 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 2.5 0.0 0.6 0.9 0.3 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 27.0 3.6 11.6 4.9 1.3 0.8 10.1 0.0 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 30.5 0.6 0.0 0.0 0.3 0.0 1.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.2 0.0 RPS23 S23 ENSG00000186468 "Ribosomal protein S23" P62266 5 82273358-82278577 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054853 Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 130000 "Endoplasmic reticulum, Cytosol" "HPA054853: AB_2682625" "unprognostic (1.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (2.70e-2)" "unprognostic (1.28e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (6.61e-2)" "unprognostic (5.80e-2)" "unprognostic (2.24e-1)" "unprognostic (8.29e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (3.87e-2)" "unprognostic (6.47e-2)" "unprognostic (2.22e-1)" "unprognostic (1.67e-1)" 114.6 62.1 72.6 129.7 54.8 139.2 191.8 45.1 53.7 141.2 118.9 46.5 83.5 62.2 131.8 94.1 145.2 118.3 114.4 79.4 61.4 52.9 92.8 134.8 90.1 200.7 74.4 34.7 269.5 211.6 41.6 65.6 94.6 51.9 134.3 89.8 52.9 126.7 84.7 205.4 134.3 97.0 129.6 77.7 150.1 83.8 61.4 51.5 194.5 141.5 171.9 173.8 160.7 165.8 140.7 110.8 11.1 56.6 63.8 136.1 158.2 92.5 36.5 105.3 80.7 177.2 239.7 107.3 89.0 134.9 134.6 134.0 51.2 63.3 218.4 62.4 115.1 83.5 47.7 157.3 255.9 139.9 79.2 88.8 89.3 54.1 49.7 234.1 128.9 64.9 230.0 304.6 102.7 269.9 202.2 173.4 139.1 92.8 68.8 116.2 60.2 142.0 130.9 67.3 49.6 85.1 95.2 150.8 196.3 130.7 39.2 67.7 88.5 45.8 79.8 180.2 109.7 60.6 200.0 123.0 19.2 74.8 46.7 139.7 99.0 144.6 153.5 45.4 167.0 42.1 11.1 56.6 8.7 60.1 52.4 92.2 140.7 103.0 81.1 97.6 130.8 136.1 112.3 6.0 63.8 43.3 110.8 73.4 158.2 72.6 54.8 45.1 53.7 61.4 52.9 74.4 34.7 51.9 51.5 988.6 1141.9 5759.9 4914.2 5245.2 367.5 259.5 2438.2 829.8 1736.9 1080.0 163.0 4238.7 3231.3 2015.9 794.6 3082.6 1557.8 1238.1 4142.3 6097.5 3274.2 3882.5 1615.9 2361.6 3614.8 220.9 1831.3 2502.0 3505.0 1289.5 5717.9 4715.7 2717.9 3404.0 3317.6 563.2 3460.3 2745.9 2903.9 4001.7 470.7 1675.1 2898.4 786.8 872.2 6212.4 4350.9 3718.5 5163.2 5114.9 RRBP1 "ES/130, hES" ENSG00000125844 "Ribosome binding protein 1" Q9P2E9 20 17613678-17682295 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 136.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 18.8;plasmacytoid DC: 23.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009026, HPA011924" Enhanced Enhanced "Endoplasmic reticulum" NA NA 44000 "Endoplasmic reticulum" "HPA009026: AB_1079852, HPA011924: AB_1856476" "unprognostic (1.56e-3)" "unprognostic (2.26e-3)" "unprognostic (8.46e-2)" "prognostic favorable (1.41e-4)" "unprognostic (1.04e-1)" "unprognostic (1.05e-1)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-2)" "unprognostic (3.03e-1)" "unprognostic (5.09e-2)" "unprognostic (6.63e-2)" "unprognostic (9.21e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.38e-4)" 19.9 18.3 6.7 16.1 11.2 5.9 13.8 4.9 7.4 22.1 23.6 17.8 49.5 18.5 16.3 24.4 17.1 12.3 37.3 15.8 7.8 6.3 27.1 88.9 20.5 10.6 13.0 5.6 23.4 136.1 24.7 18.4 51.4 10.4 19.4 16.7 14.8 84.2 56.0 7.7 11.0 32.2 13.0 13.3 20.4 30.0 12.1 12.2 5.0 32.8 11.6 19.2 18.7 18.9 0.9 23.5 18.8 4.7 5.7 2.5 1.5 30.4 21.7 6.5 14.6 30.1 32.7 34.4 47.8 40.2 20.2 27.5 48.3 28.8 11.8 16.1 45.1 20.9 30.7 7.0 38.8 16.6 5.4 5.4 13.6 6.3 49.8 43.3 5.0 17.2 43.1 11.7 32.7 19.4 30.0 19.9 4.2 5.6 11.5 30.3 13.8 1.9 11.5 7.6 67.9 21.0 3.5 17.3 40.5 17.1 10.4 3.3 2.5 27.2 64.6 19.6 14.5 11.3 7.7 35.7 43.3 16.1 22.4 15.7 21.1 16.0 3.9 16.4 5.4 22.0 5.4 4.7 18.8 2.5 2.9 1.7 0.5 0.8 1.4 2.4 0.9 0.8 0.9 4.2 5.7 4.0 23.5 0.7 1.5 6.7 11.2 4.9 7.4 7.8 6.3 13.0 5.6 10.4 12.2 89.3 202.0 34.3 70.6 52.5 17.0 30.9 147.7 131.2 145.6 90.7 29.5 233.8 38.1 171.5 35.2 132.5 313.0 0.0 359.4 194.5 183.3 135.6 113.5 227.0 102.0 23.8 93.1 135.1 51.8 28.3 117.6 73.6 67.4 86.6 259.3 193.4 291.3 208.5 78.1 62.7 35.4 32.3 138.2 74.8 93.6 48.8 445.7 36.3 168.2 180.5 RRH peropsin ENSG00000180245 "Retinal pigment epithelium-derived rhodopsin homolog" O14718 4 109827994-109844604 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "retina: 66.3" "Cell type enriched" "Detected in single" 53 "Muller glia cells: 36.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.3" "Lineage enriched" "Detected in single" 7 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "hTCEpi: 4.1;U-266/84: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.59e-1)" "unprognostic (2.47e-2)" "unprognostic (4.94e-2)" "unprognostic (1.96e-2)" "unprognostic (1.48e-1)" "unprognostic (5.25e-2)" "unprognostic (7.56e-2)" "unprognostic (8.47e-2)" "unprognostic (2.33e-1)" "unprognostic (1.86e-2)" "unprognostic (2.03e-2)" "unprognostic (1.62e-3)" "unprognostic (4.65e-1)" "unprognostic (4.38e-3)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" "unprognostic (3.18e-2)" 0.4 1.4 1.3 0.5 1.2 0.3 2.1 3.7 1.8 0.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.4 0.4 1.2 1.2 1.9 1.0 0.4 0.5 1.2 0.6 0.6 0.5 0.7 0.5 0.4 0.4 0.9 0.8 66.3 0.5 0.7 0.7 2.3 0.4 0.4 0.8 0.5 0.4 0.7 0.4 0.4 0.9 0.4 0.4 0.4 0.4 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.2 0.9 0.7 0.0 0.1 0.0 0.2 0.7 0.1 0.1 0.2 0.3 0.9 0.8 0.3 0.0 0.0 2.2 0.1 0.2 1.0 0.9 0.1 0.0 0.3 0.1 1.5 0.0 0.0 4.1 0.0 0.3 0.4 0.2 0.7 1.0 0.3 0.7 0.1 1.2 1.6 0.5 0.7 0.2 1.0 0.2 0.6 2.1 0.2 1.1 0.3 0.0 0.4 0.1 0.5 0.8 0.5 0.4 0.0 0.3 0.5 0.1 0.6 4.7 0.0 0.3 0.5 1.1 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.1 1.3 1.2 3.7 1.4 1.2 1.2 1.2 0.6 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 RRM2B p53R2 ENSG00000048392 "Ribonucleotide reductase regulatory TP53 inducible subunit M2B" Q7LG56 8 102204502-102239118 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, DNA replication" Oxidoreductase "Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006854, HPA028812" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB006854: , HPA028812: AB_10602246" "unprognostic (7.76e-3)" "unprognostic (4.14e-2)" "unprognostic (9.41e-3)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.28e-1)" "unprognostic (5.51e-2)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (9.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (1.70e-2)" "unprognostic (4.32e-1)" "unprognostic (1.47e-1)" "unprognostic (2.52e-1)" "unprognostic (7.17e-2)" 11.8 18.6 11.7 11.5 11.4 4.3 9.3 8.5 13.5 9.5 10.1 9.8 9.5 10.2 8.2 10.8 8.0 9.7 8.2 11.3 17.5 12.8 17.5 15.1 15.8 12.6 14.9 10.6 9.7 9.5 34.7 24.8 11.6 23.1 11.2 11.1 7.7 9.7 10.9 34.6 7.4 7.6 8.2 26.1 10.6 7.1 6.6 9.4 6.3 37.1 8.1 13.1 10.7 7.0 7.4 6.2 18.3 8.4 3.0 3.3 2.8 5.6 10.0 11.9 7.0 16.8 16.2 9.4 13.0 15.8 7.0 8.2 3.5 4.5 35.8 12.3 14.3 7.1 2.1 5.7 13.2 9.9 5.8 6.2 9.0 4.2 7.5 13.6 2.7 19.2 20.5 24.9 7.7 11.8 16.7 19.6 6.2 6.6 5.5 22.4 5.5 4.7 5.2 6.6 6.1 7.4 3.0 4.8 7.2 16.3 6.4 3.0 5.9 6.8 3.6 7.7 31.0 9.7 6.2 14.9 10.9 21.1 7.5 3.5 5.8 5.3 32.6 16.0 4.2 11.5 10.0 5.1 5.3 2.2 4.5 3.3 5.6 2.0 2.8 6.2 7.4 2.3 2.5 18.3 3.0 8.4 1.8 1.4 2.8 11.7 11.4 8.5 13.5 17.5 12.8 14.9 10.6 23.1 9.4 53.6 24.0 7.2 8.1 17.2 13.1 17.9 20.4 38.8 25.0 38.4 13.7 11.2 21.6 6.2 1.6 16.4 6.4 0.0 7.0 4.9 10.4 10.8 10.5 20.3 11.1 9.5 28.3 18.4 21.8 1.1 13.3 17.8 16.9 7.2 10.3 23.6 5.5 7.0 13.8 18.1 14.7 6.5 10.8 8.2 10.0 16.2 4.0 12.8 11.7 5.4 RTN1 NSP ENSG00000139970 "Reticulon 1" Q16799 14 59595976-59870966 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 144.6" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 227.2" "Cancer enhanced" "Detected in many" "glioma: 19.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9" "Group enriched" "Detected in many" 15 "dendritic cells: 7.9;monocytes: 4.6" "Group enriched" "Detected in some" 4 "HEL: 23.2;SCLC-21H: 28.7;SH-SY5Y: 46.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002745, HPA040945, HPA044249" Enhanced Supported "Nuclear bodies,Endoplasmic reticulum" NA NA 140000 "Endoplasmic reticulum" "Nuclear bodies" "CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874" "unprognostic (9.40e-3)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (4.24e-2)" "unprognostic (3.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (2.79e-1)" "prognostic favorable (3.69e-4)" "unprognostic (5.79e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.75e-1)" "unprognostic (6.71e-2)" "unprognostic (1.62e-2)" 6.3 8.3 27.4 6.1 46.3 1.6 3.0 98.5 144.6 2.6 2.9 11.0 0.0 2.7 2.1 1.6 2.3 8.6 4.4 1.9 32.3 50.7 2.3 1.9 4.8 2.7 21.3 45.9 1.7 3.6 19.2 10.3 2.7 35.1 5.0 3.0 1.2 2.3 2.6 1.6 2.3 3.4 2.7 12.1 10.6 3.6 2.6 10.5 0.0 2.7 0.0 2.3 2.5 0.9 0.0 7.9 0.4 4.6 0.0 0.0 1.0 0.0 0.0 0.3 0.4 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.8 23.2 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 28.7 46.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 3.9 1.1 0.0 2.1 0.0 0.0 0.0 7.7 1.6 0.2 0.0 4.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 1.0 27.4 46.3 98.5 94.7 32.3 50.7 21.3 45.9 35.1 10.5 0.0 0.6 0.0 0.4 4.2 26.8 0.8 2.5 1.4 1.2 0.0 23.6 0.8 0.0 0.0 13.2 0.5 0.2 0.0 0.0 0.7 2.1 6.2 0.0 0.4 15.8 227.2 51.9 0.0 15.9 14.4 2.6 24.4 10.1 1.8 0.0 13.1 2.2 0.0 1.1 0.3 29.4 0.0 2.1 2.1 2.5 5.6 2.1 0.0 0.2 0.3 RTN2 "NSP2, NSPL1, SPG12" ENSG00000125744 "Reticulon 2" O75298 19 45485289-45497061 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "skeletal muscle: 155.7;tongue: 43.2" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 109.9;Extravillous trophoblasts: 125.7;Syncytiotrophoblasts: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 9.1;eosinophil: 3.5;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 11 "dendritic cells: 2.4;granulocytes: 9.1" "Cell line enhanced" "Detected in many" "RH-30: 23.6;RT4: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034941, HPA034948" Approved Approved "Nuclear speckles" NA NA 16000 "Nuclear speckles" "HPA034941: AB_10671358, HPA034948: AB_2674375" "unprognostic (3.08e-1)" "unprognostic (1.42e-1)" "unprognostic (6.68e-3)" "unprognostic (5.07e-3)" "unprognostic (1.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.89e-2)" "unprognostic (3.09e-1)" "unprognostic (6.44e-2)" "unprognostic (5.10e-3)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.58e-6)" "unprognostic (4.34e-1)" "unprognostic (3.23e-1)" "unprognostic (2.21e-1)" "unprognostic (2.03e-1)" 3.4 3.1 6.9 1.9 9.0 1.3 3.4 5.9 10.4 2.5 4.2 1.0 3.7 1.8 3.4 6.7 5.4 2.0 3.5 5.4 7.4 4.8 1.4 1.7 2.6 2.2 4.8 3.7 1.0 2.5 2.2 1.6 11.4 4.6 5.1 1.6 2.6 6.5 4.8 155.7 2.6 1.8 3.3 1.4 2.6 1.9 1.2 1.0 0.0 1.8 43.2 3.5 4.2 1.5 0.1 2.4 9.1 0.5 0.3 0.0 0.5 1.9 2.7 4.6 3.6 7.9 9.8 9.1 4.4 10.7 2.8 5.4 5.4 1.7 1.7 6.2 4.8 2.3 3.7 3.0 2.1 0.8 4.0 4.4 11.8 2.0 4.0 3.4 0.7 13.5 10.7 1.1 1.2 2.2 4.9 5.1 0.4 6.4 3.3 8.3 1.5 0.0 2.2 3.4 8.8 3.5 2.0 23.6 9.4 1.6 23.4 13.0 12.5 0.9 21.7 6.8 4.5 17.1 4.7 4.5 7.9 2.4 0.2 0.9 1.9 4.4 3.9 2.1 2.7 4.0 9.1 0.2 3.5 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.3 0.5 2.4 0.0 0.5 6.9 9.0 5.9 10.4 7.4 4.8 4.8 3.7 4.6 1.0 3.0 7.2 0.0 21.5 5.7 8.9 3.9 5.1 1.4 2.3 3.5 5.9 109.9 0.0 16.6 0.0 10.8 0.3 0.0 6.1 125.7 7.6 19.7 16.1 2.4 23.2 22.3 10.9 20.9 10.0 0.0 5.2 10.6 21.9 10.0 2.0 8.5 9.1 0.0 6.3 0.1 10.6 12.9 10.0 0.4 3.0 3.0 100.5 0.0 0.4 19.5 RTN3 "ASYIP, HAP, NSPL2, NSPLII, RTN3-A1" ENSG00000133318 "Reticulon 3" O95197 11 63681446-63759891 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, ER-Golgi transport, Host-virus interaction, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 122.2;brain: 149.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 122.2" "Group enriched" "Detected in all" 6 "granulocytes: 122.2;monocytes: 42.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015649, HPA015650" Enhanced Supported "Endoplasmic reticulum" NA NA 620000 "Endoplasmic reticulum" "HPA015649: AB_1856498, HPA015650: AB_1856499" "unprognostic (8.11e-3)" "unprognostic (8.51e-2)" "unprognostic (3.61e-2)" "unprognostic (7.88e-3)" "unprognostic (1.41e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.30e-6)" "unprognostic (5.49e-2)" "unprognostic (1.25e-1)" "unprognostic (1.07e-2)" "unprognostic (2.70e-2)" "unprognostic (1.07e-1)" "prognostic favorable (9.87e-4)" "unprognostic (1.60e-2)" "unprognostic (2.54e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-2)" 43.6 19.6 72.2 11.9 71.6 22.3 21.5 55.9 149.6 21.7 20.0 50.2 9.3 12.3 14.8 19.7 12.4 21.0 13.1 12.8 78.3 72.9 22.0 19.9 17.7 7.3 72.6 53.5 11.9 20.7 36.4 14.0 14.1 109.9 12.9 18.8 12.7 30.4 18.9 10.8 22.6 14.6 18.6 66.0 9.2 12.8 10.3 39.2 6.8 40.9 5.1 10.7 13.1 8.9 3.3 14.7 122.2 42.2 4.6 7.4 28.1 31.4 23.3 28.1 26.7 52.0 37.0 11.2 28.6 30.5 25.3 27.2 20.2 69.8 37.2 49.0 42.8 24.4 32.4 40.1 14.1 33.5 29.9 21.4 47.6 34.1 14.1 43.3 42.3 38.4 24.3 41.9 30.8 34.4 42.5 34.2 32.8 26.9 60.5 22.2 25.8 22.4 47.1 32.7 25.7 26.4 29.8 19.6 68.6 49.9 17.8 59.5 34.6 46.4 51.2 53.4 21.0 56.4 34.9 31.8 15.1 20.5 52.5 21.9 38.5 33.2 29.8 58.2 35.3 15.9 40.1 42.2 52.8 4.9 21.1 5.3 3.3 5.0 4.9 14.7 2.3 3.7 4.0 122.2 4.6 25.1 8.8 7.4 28.1 72.2 71.6 55.9 118.2 78.3 72.9 72.6 53.5 109.9 39.2 125.0 58.7 40.2 86.8 128.3 148.4 30.7 73.9 174.0 93.3 232.1 66.8 60.7 24.9 121.1 28.8 64.2 94.1 46.7 101.6 81.1 86.1 70.4 76.1 65.2 130.9 77.9 95.7 66.3 177.0 55.9 73.4 125.9 108.0 117.2 63.4 133.1 92.8 64.7 84.5 45.4 75.4 77.6 79.5 130.3 150.5 127.8 72.3 60.9 84.0 86.5 RTN4 "ASY, KIAA0886, NOGO, NSP-CL" ENSG00000115310 "Reticulon 4" Q9NQC3 2 54972187-55112621 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Muller glia cells: 3179.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 159.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005388, HPA023977" Supported Enhanced "Endoplasmic reticulum" NA NA 13000000 "Endoplasmic reticulum" "CAB005388: AB_2285559, HPA023977: AB_2671391" "unprognostic (1.31e-2)" "unprognostic (1.71e-3)" "unprognostic (6.76e-2)" "unprognostic (1.28e-3)" "unprognostic (1.24e-3)" "prognostic unfavorable (1.00e-4)" "unprognostic (5.79e-2)" "unprognostic (1.84e-3)" "unprognostic (2.47e-1)" "unprognostic (1.97e-1)" "unprognostic (3.91e-3)" "unprognostic (4.38e-1)" "unprognostic (4.41e-2)" "unprognostic (1.29e-2)" "unprognostic (4.99e-2)" "unprognostic (1.27e-1)" "unprognostic (4.91e-2)" 103.7 60.5 75.1 27.9 85.0 19.3 63.6 66.6 105.5 24.8 35.4 52.9 17.5 45.0 29.3 36.0 43.0 26.3 38.5 30.8 71.9 69.7 86.5 103.5 36.2 19.6 84.9 75.8 27.4 23.7 59.9 16.1 33.8 99.0 45.2 35.7 24.7 23.6 38.1 171.1 48.1 55.2 47.4 92.6 20.1 23.5 14.6 62.7 14.7 25.9 47.2 16.5 48.1 35.4 2.8 6.1 33.3 7.7 16.8 15.8 4.4 33.0 24.0 23.5 6.1 80.1 75.2 13.2 110.1 93.6 34.1 31.9 19.7 31.5 7.2 58.6 74.6 57.1 30.1 15.4 44.3 52.1 20.4 11.8 9.9 14.8 31.1 159.5 17.8 5.1 56.3 42.4 46.6 90.9 68.9 63.9 18.3 20.2 16.7 147.0 9.6 21.7 18.2 21.1 7.2 21.5 9.7 31.0 14.9 79.1 39.9 15.5 18.3 25.2 14.8 30.8 42.1 12.6 13.7 90.6 66.7 28.3 26.2 62.9 10.2 8.2 4.6 67.9 20.7 53.6 33.3 4.3 10.9 4.3 4.9 3.5 2.8 6.9 3.8 4.0 1.6 11.7 4.8 7.0 16.8 7.7 6.1 15.8 4.4 75.1 85.0 66.6 105.5 71.9 69.7 84.9 75.8 99.0 62.7 163.8 161.9 100.2 1062.9 943.4 647.1 108.1 226.7 159.3 127.4 642.0 357.4 421.2 247.1 487.4 360.7 341.8 464.3 70.0 283.5 513.5 379.7 775.3 148.7 573.6 570.9 402.0 213.0 178.0 338.1 193.3 155.1 405.6 323.9 461.7 231.2 3179.0 405.8 189.0 212.5 568.0 465.4 213.4 311.0 240.3 85.0 925.9 302.8 121.8 187.3 1082.8 RTP1 "MGC35450, Z3CXXC1" ENSG00000175077 "Receptor transporter protein 1" P59025 3 187197486-187201465 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.5;testis: 1.9" "Group enriched" "Detected in some" 14 "Early spermatids: 1.9;Late spermatids: 1.1;Spermatocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "SuSa: 9.2;T-47d: 5.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.29e-1)" "unprognostic (1.91e-1)" "unprognostic (2.63e-1)" "unprognostic (2.89e-1)" 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 1.3 4.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.8 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.2 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 RTP2 "MGC78665, Z3CXXC2" ENSG00000198471 "Receptor transporter protein 2" Q5QGT7 3 187698259-187702557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 42 "skeletal muscle: 5.7;testis: 3.1" "Cell type enhanced" "Detected in some" 34 "Distal tubular cells: 1.7;Early spermatids: 8.7;Late spermatids: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "SK-BR-3: 6.4" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 27 "olfactory region: 0.3" NA NA "unprognostic (5.86e-2)" "unprognostic (1.12e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 RTP3 "LTM1, TMEM7, Z3CXXC3" ENSG00000163825 "Receptor transporter protein 3" Q9BQQ7 3 46497491-46500949 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 91 "liver: 43.3" "Cell type enriched" "Detected in some" 19 "Hepatocytes: 59.6" "Group enriched" "Detected in some" 17 "liver cancer: 22.9;testis cancer: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SiHa: 15.1" HPA075932 Uncertain Mitochondria NA NA Mitochondria "HPA075932: " "unprognostic (2.09e-1)" "unprognostic (1.64e-1)" "prognostic favorable (3.11e-6)" "unprognostic (1.08e-1)" "unprognostic (1.58e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 15.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 59.6 0.0 0.0 0.0 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 RXFP1 "LGR7, RXFPR1" ENSG00000171509 "Relaxin/insulin like family peptide receptor 1" Q9HBX9 4 158315311-158653372 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.7;placenta: 12.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 9 "endometrial cancer: 3.9" "Group enriched" "Detected in many" 6 "basal ganglia: 10.4;cerebral cortex: 18.5;olfactory region: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 24.2;HEL: 8.0;RPTEC TERT1: 11.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA027067 Approved NA NA "HPA027067: AB_10602127" "unprognostic (3.07e-3)" "unprognostic (3.02e-3)" "unprognostic (1.05e-1)" "unprognostic (2.53e-3)" "unprognostic (2.97e-2)" "unprognostic (4.15e-3)" "unprognostic (6.13e-2)" "unprognostic (6.18e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-6)" "unprognostic (8.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.33e-4)" "unprognostic (3.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.31e-1)" "unprognostic (6.22e-3)" 0.5 6.5 2.1 0.5 10.4 0.2 0.4 0.4 19.7 4.0 0.5 0.0 1.1 0.3 9.0 1.6 0.5 1.3 1.2 0.4 2.0 1.7 2.9 2.1 5.1 0.7 0.8 12.4 0.8 0.6 0.2 0.6 12.2 0.0 1.0 0.3 0.6 0.4 4.2 0.4 0.4 0.9 1.3 0.4 0.6 0.6 0.6 0.0 0.0 2.4 0.0 0.6 0.5 2.2 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.1 10.4 0.4 18.5 2.0 1.7 0.8 12.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.1 0.1 0.0 0.0 0.0 RXFP2 "GPR106, GREAT, INSL3R, LGR8, RXFPR2" ENSG00000133105 "Relaxin/insulin like family peptide receptor 2" Q8WXD0 13 31739542-31803388 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.3;epididymis: 28.4" "Cell type enriched" "Detected in single" 32 "Early spermatids: 5.5" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "basal ganglia: 8.3" "Cell type enriched" "Detected in single" 11 "classical monocyte: 5.0" "Lineage enriched" "Detected in single" 23 "monocytes: 5.0" "Group enriched" "Detected in some" 6 "U-2197: 2.1;U-87 MG: 4.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 7 "basal ganglia: 2.0" NA NA "unprognostic (1.77e-2)" 0.5 3.3 1.5 0.1 8.3 2.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.9 28.4 0.0 1.5 0.1 0.5 0.6 0.5 0.3 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.6 0.0 0.2 0.0 3.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 5.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 5.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.5 8.3 0.0 0.5 0.6 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RXFP3 "GPCR135, RLN3R1, RXFPR3, SALPR" ENSG00000182631 "Relaxin/insulin like family peptide receptor 3" Q9NSD7 5 33936386-33938237 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 3.1;brain: 1.1;pancreas: 1.7;pituitary gland: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPTEC TERT1: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027833 Uncertain NA NA "HPA027833: AB_1849247" "unprognostic (1.93e-2)" "unprognostic (3.66e-1)" "unprognostic (2.89e-1)" "unprognostic (2.86e-1)" "unprognostic (9.68e-2)" "unprognostic (1.72e-1)" "unprognostic (8.67e-3)" 0.0 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RXFP4 "GPCR142, GPR100, RLN3R2, RXFPR4" ENSG00000173080 "Relaxin/insulin like family peptide receptor 4" Q8TDU9 1 155941710-155942949 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 1.8;bone marrow: 1.3;intestine: 5.4" "Cell type enriched" "Detected in some" 16 "Intestinal endocrine cells: 56.0" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;NB-4: 2.0;OE19: 2.7;SK-MEL-30: 1.9;T-47d: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (4.90e-2)" "unprognostic (2.17e-1)" "unprognostic (3.64e-2)" "unprognostic (1.84e-3)" "unprognostic (2.19e-1)" "unprognostic (5.94e-2)" "unprognostic (3.17e-2)" "unprognostic (4.73e-2)" "unprognostic (2.87e-1)" "unprognostic (8.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (3.08e-3)" "unprognostic (1.40e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (3.86e-2)" 0.2 0.0 0.0 0.5 0.1 1.3 0.1 0.7 0.0 0.0 5.2 3.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.4 0.1 0.1 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.6 0.0 0.6 0.4 1.8 1.4 0.7 0.8 0.2 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.3 1.1 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.3 0.5 0.2 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.0 0.2 0.1 2.0 0.2 2.7 0.0 0.2 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.9 1.9 0.0 2.1 0.0 0.6 0.1 0.0 0.0 0.0 0.1 1.2 0.6 1.1 0.2 0.1 0.0 0.9 1.8 0.0 1.1 0.0 0.0 0.5 0.8 0.4 0.6 0.0 0.1 1.1 0.7 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 RXYLT1 "HP10481, TMEM5" ENSG00000118600 "Ribitol xylosyltransferase 1" Q9Y2B1 12 63779803-63809558 "Disease related genes, Predicted intracellular proteins" Transferase "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 25.4;Distal tubular cells: 31.5;Exocrine glandular cells: 26.6;Extravillous trophoblasts: 28.9;Syncytiotrophoblasts: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064014 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA064014: AB_2685176" "unprognostic (1.19e-1)" "unprognostic (3.28e-1)" "unprognostic (2.15e-2)" "unprognostic (3.58e-1)" "unprognostic (1.33e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.24e-5)" "unprognostic (1.47e-2)" "unprognostic (2.09e-3)" "unprognostic (3.17e-1)" "unprognostic (7.03e-2)" "unprognostic (1.39e-1)" "unprognostic (9.33e-2)" "unprognostic (5.27e-2)" "unprognostic (2.29e-2)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" 9.7 19.6 10.3 9.8 11.3 5.7 14.7 8.2 13.6 10.3 9.3 10.6 11.3 7.8 9.2 20.8 9.6 10.9 9.6 21.1 9.8 11.4 15.2 20.1 11.9 14.8 10.7 8.0 17.4 33.4 20.2 19.0 10.5 9.5 12.1 10.1 12.4 17.0 14.5 14.7 11.1 8.2 12.2 13.1 10.6 8.1 16.1 9.0 9.1 17.2 10.7 9.7 11.8 8.1 6.6 7.2 1.8 3.6 4.7 7.0 2.2 7.7 14.3 10.1 8.5 8.8 11.9 11.7 8.7 12.6 13.0 8.6 5.2 7.4 16.6 15.1 9.1 10.5 7.1 12.2 11.1 15.5 17.3 12.4 9.0 4.0 8.2 13.4 13.7 7.9 10.6 11.1 12.6 16.4 12.1 7.2 12.5 10.1 14.2 19.6 12.4 7.4 5.7 6.1 7.1 18.2 7.5 11.7 8.9 12.4 10.2 25.0 4.3 9.1 6.9 17.2 6.6 14.7 6.9 8.3 11.6 12.0 7.2 11.9 9.4 13.5 11.6 7.9 8.3 15.3 1.2 3.1 1.8 4.0 2.9 6.9 6.6 4.4 4.8 3.0 4.2 5.9 4.8 0.6 4.7 3.6 7.2 7.0 2.2 10.3 11.3 8.2 13.6 9.8 11.4 10.7 8.0 9.5 9.0 8.9 5.9 0.0 0.0 0.0 0.0 0.0 0.0 25.4 19.4 15.7 0.0 21.6 31.5 19.6 0.0 0.0 0.0 0.0 26.6 28.9 0.0 0.0 7.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 14.4 0.0 0.0 17.5 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 RYK "D3S3195, JTK5, JTK5A, RYK1" ENSG00000163785 "Receptor-like tyrosine kinase" 3 134065303-134250744 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034117, HPA045503, HPA075430" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "CAB034117: AB_2183048, HPA045503: AB_2679353, HPA075430: AB_2732293" "unprognostic (7.84e-2)" "unprognostic (5.82e-2)" "unprognostic (2.22e-2)" "unprognostic (2.34e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.60e-4)" "unprognostic (2.60e-2)" "unprognostic (6.59e-2)" "unprognostic (1.62e-1)" "unprognostic (1.07e-3)" "unprognostic (9.66e-2)" "unprognostic (2.42e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-1)" "unprognostic (3.43e-1)" "unprognostic (2.85e-2)" 23.8 13.2 8.5 12.1 9.3 6.3 27.5 10.6 9.5 26.5 19.3 12.7 18.2 8.8 25.8 19.1 21.1 16.7 15.8 17.1 8.1 6.7 12.9 12.7 12.4 9.1 10.8 7.3 39.7 17.7 14.1 17.9 18.8 8.6 26.9 12.1 16.4 15.2 21.5 15.3 15.5 13.3 28.6 8.4 13.8 14.3 20.3 10.0 13.6 23.2 11.4 15.2 27.5 31.9 2.8 0.7 6.7 1.6 3.1 4.3 1.1 26.0 6.9 21.9 16.7 28.2 30.1 16.9 17.3 40.2 23.1 26.0 21.9 20.0 5.1 28.8 21.2 22.2 24.4 15.5 21.8 33.1 8.5 7.0 13.5 7.5 14.0 22.1 6.5 11.9 19.9 25.7 14.3 28.8 25.3 19.3 9.0 4.7 2.5 22.6 12.4 9.1 8.5 18.4 21.7 8.3 4.5 16.8 10.7 18.9 19.3 10.7 15.9 21.0 15.3 26.2 14.7 19.1 11.9 14.2 19.2 17.4 20.0 13.9 1.1 1.3 2.8 12.2 11.0 13.5 6.7 1.6 3.1 2.5 1.6 2.9 1.5 4.2 3.0 0.7 2.8 4.3 3.4 0.6 3.1 1.6 0.0 1.0 1.1 8.5 9.3 10.6 9.5 8.1 6.7 10.8 7.3 8.6 10.0 11.9 24.7 11.9 30.3 36.7 18.8 28.1 22.9 5.3 22.7 41.8 27.5 16.4 0.0 14.3 7.9 26.0 12.7 0.0 18.1 11.9 35.7 30.8 17.3 17.4 9.7 12.7 13.4 39.9 17.7 4.0 30.8 14.0 13.5 10.0 21.0 26.7 18.6 17.3 30.8 8.1 37.2 45.3 26.4 27.0 33.8 33.2 9.0 12.5 20.0 36.3 RYR1 "CCO, MHS, MHS1, PPP1R137, RYR" ENSG00000196218 "Ryanodine receptor 1" P21817 19 38433699-38587564 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 231.0" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 46.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 7 "dendritic cells: 5.3;monocytes: 6.3" "Cell line enhanced" "Detected in some" "A549: 5.7;HaCaT: 14.0;hTCEpi: 5.7;RH-30: 11.5;SiHa: 22.8;U-2 OS: 9.6" "Low region specificity" "Detected in some" HPA056416 Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" Cytosol "HPA056416: AB_2683121" "unprognostic (2.22e-3)" "unprognostic (1.91e-3)" "unprognostic (9.59e-2)" "unprognostic (5.34e-4)" "unprognostic (2.50e-1)" "unprognostic (6.00e-2)" "unprognostic (2.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (3.20e-3)" "unprognostic (3.52e-1)" "unprognostic (2.35e-1)" "unprognostic (1.07e-5)" "unprognostic (1.13e-2)" "unprognostic (8.10e-2)" "unprognostic (6.62e-3)" "unprognostic (1.34e-1)" 5.3 0.7 3.0 0.6 1.9 0.4 0.6 2.7 1.7 0.6 0.4 2.7 0.0 0.4 0.4 6.7 3.0 0.6 0.5 0.4 1.8 4.0 0.5 0.4 0.7 0.6 1.5 1.3 0.4 0.4 0.3 0.3 0.6 1.9 0.9 0.4 0.4 2.2 0.6 231.0 2.4 0.5 0.4 1.1 0.6 0.5 1.6 1.9 0.0 1.6 55.1 3.2 0.6 0.5 0.7 5.3 0.1 6.3 0.0 0.6 0.6 0.0 5.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.0 0.3 0.3 4.8 0.0 0.0 14.0 0.2 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.4 1.3 5.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.0 0.0 11.5 1.1 0.6 0.0 0.0 1.1 22.8 0.0 0.0 0.4 0.5 4.3 0.0 0.0 9.6 0.2 0.0 0.3 1.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.4 3.2 0.5 0.4 0.3 0.6 5.3 0.7 0.0 0.0 0.1 0.0 6.3 0.0 0.6 0.6 3.0 1.9 2.7 1.7 1.8 4.0 1.5 1.3 1.9 1.9 0.0 0.6 0.0 3.4 10.1 4.1 3.4 0.0 0.0 0.0 0.0 2.0 0.1 5.0 0.1 5.2 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.0 7.1 1.6 0.0 0.6 1.9 4.7 2.8 4.5 0.0 0.0 0.0 46.0 0.0 0.0 1.8 0.0 1.5 0.0 0.3 5.5 6.9 4.1 0.2 0.0 0.0 0.1 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042205-237833988 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 106.6" "Cell type enriched" "Detected in many" 30 "Cardiomyocytes: 1960.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.8;HEK 293: 10.7;K-562: 3.3;NB-4: 2.7;NTERA-2: 4.0;U-937: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 1.1 0.9 6.2 0.9 18.7 0.5 1.1 14.8 10.5 1.3 1.2 0.0 1.2 0.7 1.1 0.7 1.8 1.0 1.8 106.6 5.7 1.1 0.9 0.9 1.4 0.6 1.0 7.3 2.2 4.2 0.5 2.0 1.1 1.6 2.0 0.8 0.2 0.9 1.4 0.9 1.0 1.0 4.6 1.0 1.0 1.2 1.1 3.0 0.0 2.7 0.0 0.6 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.3 0.0 0.0 0.3 0.6 0.0 0.0 7.8 10.7 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 2.7 4.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 18.7 14.8 10.5 5.7 1.1 1.0 7.3 1.6 3.0 0.0 0.3 0.0 0.0 0.3 65.2 1960.0 0.0 1.4 2.3 1.8 9.8 0.0 0.0 0.0 15.8 1.5 0.0 0.0 2.5 0.0 2.1 0.0 0.0 0.0 0.1 1.6 3.4 1.3 0.0 10.2 1.1 0.0 8.5 0.0 0.0 1.5 0.3 0.0 0.0 0.0 4.7 0.0 18.6 3.2 0.9 0.0 0.0 0.0 0.0 0.0 RYR3 ENSG00000198838 "Ryanodine receptor 3" Q15413 15 33310945-33866121 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 28.8;skeletal muscle: 26.8" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 14.6;granulocytes: 13.9;Horizontal cells: 65.2;Late spermatids: 25.1" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 31 "basophil: 4.0" "Lineage enriched" "Detected in single" 31 "granulocytes: 4.0" "Cell line enhanced" "Detected in some" "A549: 7.0;RH-30: 10.6;RPTEC TERT1: 5.0;SuSa: 4.8" "Low region specificity" "Detected in many" HPA062004 Approved Vesicles NA NA Vesicles "HPA062004: AB_2797267" "unprognostic (5.85e-2)" "unprognostic (1.57e-1)" "unprognostic (5.30e-2)" "unprognostic (1.35e-1)" "unprognostic (1.26e-2)" "unprognostic (8.03e-4)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (7.85e-2)" "unprognostic (7.10e-2)" "unprognostic (8.25e-3)" "unprognostic (2.36e-1)" "unprognostic (2.48e-2)" "unprognostic (1.86e-2)" "unprognostic (1.15e-1)" "unprognostic (3.16e-2)" "unprognostic (1.91e-1)" 1.8 2.0 9.9 1.1 15.4 2.5 2.9 4.9 12.4 2.8 4.5 6.0 0.2 1.5 10.2 1.0 2.7 3.9 1.6 1.0 13.3 3.5 1.2 0.9 1.2 0.9 5.6 6.9 1.7 0.8 28.8 1.2 1.0 10.7 1.8 2.9 0.6 1.4 3.9 26.8 1.2 1.3 7.4 5.9 1.4 1.6 1.6 7.9 0.0 1.1 1.5 1.4 2.1 2.6 0.1 0.0 4.0 0.0 0.0 0.1 0.0 0.3 7.0 1.5 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.6 0.1 0.4 0.6 0.0 2.3 0.2 0.0 0.0 0.0 0.4 0.2 1.4 0.2 0.0 0.0 1.0 0.7 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.4 2.6 0.0 0.4 0.2 0.3 1.1 0.4 0.1 0.5 10.6 0.2 5.0 0.5 0.1 0.5 0.8 0.0 0.2 4.8 0.1 0.3 0.9 0.2 0.1 0.0 0.7 0.3 1.2 0.7 0.5 2.3 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 15.4 4.9 12.4 13.3 3.5 5.6 6.9 10.7 7.9 0.0 0.6 0.0 0.0 0.3 2.4 1.7 0.0 10.7 1.2 0.0 0.0 0.5 0.0 0.0 14.6 0.7 0.0 0.0 0.0 0.6 0.3 0.0 13.9 0.0 0.8 65.2 0.0 0.0 0.0 25.1 0.3 0.4 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.3 0.7 0.0 0.3 0.0 1.0 0.5 0.1 0.0 0.0 0.0 S100A10 "42C, ANX2LG, CAL1L, CLP11, P11" ENSG00000197747 "S100 calcium binding protein A10" P60903 1 151982915-151994390 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 148.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 148.1;monocytes: 89.2;T-cells: 85.4" "Cell line enhanced" "Detected in many" "OE19: 273.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003340, CAB025484" Enhanced Approved Mitochondria Yes No 230000 Mitochondria "CAB025484: , HPA003340: AB_1856531" "unprognostic (2.13e-1)" "unprognostic (1.51e-3)" "unprognostic (1.01e-1)" "unprognostic (3.15e-1)" "unprognostic (6.20e-2)" "prognostic unfavorable (3.33e-4)" "prognostic unfavorable (1.00e-4)" "prognostic unfavorable (2.66e-5)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "prognostic unfavorable (3.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (3.80e-8)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (3.84e-4)" 36.7 19.9 7.3 12.1 9.4 4.5 30.7 7.3 10.7 19.0 42.3 8.4 7.3 23.4 7.3 10.1 87.1 8.5 10.7 16.7 7.3 4.4 19.1 10.2 33.5 7.3 7.3 7.3 11.5 7.3 1.6 7.3 18.7 11.1 8.5 49.8 9.5 21.1 7.3 7.3 21.8 21.7 14.0 9.6 7.3 8.6 61.4 7.3 7.3 7.3 22.1 13.6 8.1 37.7 17.8 148.1 21.4 89.2 25.9 85.4 74.8 63.5 65.2 0.2 13.5 73.8 98.4 48.6 36.0 48.7 32.3 32.8 117.1 88.5 0.0 35.0 62.8 38.3 111.1 18.5 140.1 30.1 11.4 5.3 7.7 29.7 27.4 26.4 2.9 6.7 25.5 118.1 35.2 40.5 29.0 71.4 4.2 0.1 0.1 42.9 55.1 0.5 18.6 8.8 273.2 72.5 0.0 12.6 1.2 136.1 18.9 0.5 0.5 58.8 21.1 27.4 77.4 46.6 7.4 75.8 15.5 38.8 73.4 25.1 1.7 0.3 10.9 91.1 2.6 54.2 21.4 89.2 21.0 33.3 54.4 35.2 17.8 52.6 42.3 148.1 8.6 19.6 29.5 3.2 25.9 46.5 24.2 85.4 74.8 7.3 9.4 7.3 10.7 7.3 4.4 7.3 7.3 11.1 7.3 2373.2 509.0 165.5 824.9 1416.6 10.1 91.6 634.4 507.3 913.4 902.0 3.9 1028.8 1291.5 1817.5 320.0 1052.4 1898.6 46.7 1882.2 473.9 2108.7 1493.1 280.8 168.1 1060.4 15.9 1037.0 742.7 952.8 225.8 599.2 1623.9 1548.8 1432.9 1679.7 14.1 2865.9 3115.1 60.8 287.0 25.8 142.3 345.1 12.6 80.7 1085.7 314.3 441.6 1750.5 1802.8 S1PR1 "CD363, D1S3362, edg-1, EDG1" ENSG00000170989 "Sphingosine-1-phosphate receptor 1" P21453 1 101236888-101241518 "Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "Angiogenesis, Chemotaxis" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 88.9" "Group enriched" "Detected in many" 5 "Endothelial cells: 89.9;Ito cells: 114.2;Muller glia cells: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 19.4;HUVEC TERT2: 54.9;TIME: 30.5;U-251 MG: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010104, HPA075568" Supported Supported Vesicles No NA Vesicles "CAB010104: AB_2238920, HPA075568: AB_2686758" "unprognostic (1.41e-1)" "unprognostic (9.35e-2)" "unprognostic (2.46e-2)" "unprognostic (2.61e-1)" "unprognostic (9.78e-2)" "unprognostic (4.49e-3)" "unprognostic (1.34e-3)" "unprognostic (1.99e-1)" "unprognostic (1.36e-1)" "unprognostic (9.12e-2)" "unprognostic (2.34e-2)" "unprognostic (2.23e-1)" "unprognostic (5.82e-3)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (8.78e-4)" 72.3 8.4 24.7 16.6 26.2 9.7 46.3 21.6 21.8 13.3 10.5 9.5 2.5 5.7 12.1 5.0 14.7 11.5 17.6 43.5 22.9 15.4 8.9 20.5 35.7 24.5 23.2 14.0 7.9 11.0 13.4 4.7 29.6 21.2 8.9 7.0 9.3 7.5 5.6 21.7 8.2 9.8 19.0 11.0 35.2 8.0 5.8 13.9 4.4 17.0 8.7 15.7 15.2 18.5 27.4 0.2 88.9 0.2 33.4 49.8 30.8 3.6 0.0 3.9 0.0 0.4 9.3 0.0 19.4 3.5 11.8 4.2 0.0 0.1 0.0 4.8 6.7 0.0 0.0 0.5 0.2 7.9 1.3 0.4 1.3 0.1 0.0 1.8 0.0 0.8 12.5 0.0 0.0 0.9 0.5 54.9 1.1 0.0 4.0 3.7 0.0 4.6 0.0 1.0 0.1 1.3 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 30.5 2.0 0.7 0.4 37.6 0.3 0.0 0.2 0.2 0.0 0.1 88.9 0.1 4.9 49.8 0.1 40.2 25.1 45.3 44.1 0.2 27.4 35.7 36.2 1.4 33.4 0.2 0.2 26.8 30.8 24.7 26.2 21.6 16.8 22.9 15.4 23.2 14.0 21.2 13.9 0.0 12.8 17.1 0.1 6.8 0.0 16.9 2.5 0.0 2.3 0.0 0.0 5.5 0.0 0.0 0.0 89.9 0.0 0.0 0.0 0.3 8.4 0.5 7.0 6.0 7.6 0.0 0.0 114.2 6.9 0.0 0.9 1.5 5.0 14.4 0.0 38.0 0.0 0.0 0.0 0.0 1.0 0.0 1.4 0.4 0.7 4.4 2.2 9.2 0.0 0.4 S1PR2 "AGR16, DFNB68, EDG5, Gpcr13, H218" ENSG00000267534 "Sphingosine-1-phosphate receptor 2" O95136 19 10221433-10231331 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 75.1;Early spermatids: 83.7;Late spermatids: 119.0;Syncytiotrophoblasts: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 23.7" "Group enriched" "Detected in many" 7 "granulocytes: 23.7;T-cells: 7.4" "Cell line enhanced" "Detected in many" "BEWO: 14.6;Daudi: 25.8;U-266/70: 19.3;U-698: 27.9;WM-115: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014255, HPA014307" Approved Uncertain "Nuclear speckles,Golgi apparatus" NA NA "Golgi apparatus" "Nuclear speckles" "HPA014255: , HPA014307: AB_1847989" "unprognostic (5.38e-3)" "unprognostic (1.83e-3)" "unprognostic (1.20e-1)" "unprognostic (1.26e-2)" "unprognostic (3.31e-2)" "unprognostic (1.05e-3)" "unprognostic (8.50e-2)" "unprognostic (8.71e-2)" "unprognostic (2.84e-1)" "unprognostic (1.70e-1)" "unprognostic (7.40e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (4.36e-10)" "unprognostic (4.91e-2)" "unprognostic (4.56e-2)" "unprognostic (3.11e-1)" "unprognostic (8.09e-2)" 17.1 2.3 1.4 13.7 1.3 0.9 7.2 0.9 1.5 13.3 4.1 1.7 3.9 1.8 8.3 9.2 6.4 7.9 6.5 6.1 1.3 1.5 2.4 9.5 11.2 10.6 1.3 0.0 12.9 2.6 3.9 2.2 31.3 1.7 9.8 2.5 3.2 9.4 5.7 3.4 4.0 3.9 8.7 1.7 2.2 4.2 21.8 1.0 2.0 3.3 6.3 15.6 8.0 12.0 0.3 1.6 23.7 1.9 2.1 7.4 1.2 1.4 0.2 1.7 3.4 9.4 11.5 14.6 2.1 4.4 1.0 2.0 0.9 0.8 25.8 2.5 4.0 1.1 0.8 0.6 1.0 0.7 2.6 1.3 0.6 0.6 0.6 3.1 0.7 0.6 6.3 0.5 1.9 0.6 2.7 0.1 1.3 0.6 5.6 0.6 1.2 0.3 1.2 1.7 0.4 0.8 1.8 0.7 0.9 0.8 1.2 1.2 2.3 1.2 0.7 1.8 1.4 0.6 0.6 0.2 3.5 1.1 7.9 0.6 19.3 9.1 27.9 1.3 1.3 19.1 23.7 1.9 0.4 4.9 1.5 5.9 0.2 6.2 4.6 1.6 0.3 2.6 2.6 0.5 2.1 0.6 0.2 7.4 1.2 1.4 1.3 0.9 1.3 1.3 1.5 1.3 0.0 1.7 1.0 0.0 1.4 0.0 3.5 0.0 0.6 0.4 0.0 0.0 1.2 1.8 2.0 75.1 0.0 3.1 83.7 1.5 0.0 0.0 2.7 13.9 15.8 4.2 0.0 5.9 12.5 0.0 2.4 4.9 0.6 119.0 20.4 4.8 0.0 4.6 0.1 7.1 2.3 0.0 12.4 0.5 0.4 12.9 2.0 1.2 1.1 0.0 57.2 1.5 0.0 2.6 S1PR3 "EDG-3, EDG3" ENSG00000213694 "Sphingosine-1-phosphate receptor 3" Q99500 9 88991447-89005010 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 16.8;Sertoli cells: 64.7;Smooth muscle cells: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "classical monocyte: 9.8" "Lineage enriched" "Detected in single" 23 "monocytes: 9.8" "Cell line enhanced" "Detected in many" "AF22: 35.2;ASC diff: 49.1;ASC TERT1: 49.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "prognostic favorable (5.91e-4)" "unprognostic (3.32e-1)" "prognostic unfavorable (1.30e-4)" "unprognostic (6.91e-3)" "unprognostic (2.02e-1)" "unprognostic (4.41e-2)" "unprognostic (2.77e-2)" "unprognostic (5.22e-2)" "unprognostic (1.94e-2)" "unprognostic (3.15e-1)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (7.91e-6)" "unprognostic (4.43e-2)" "unprognostic (1.48e-2)" "unprognostic (3.93e-2)" "unprognostic (1.37e-1)" 15.5 20.4 4.0 7.8 5.1 2.2 9.6 2.2 3.5 24.1 9.5 7.4 5.1 3.5 12.9 10.0 31.5 16.6 19.0 20.3 4.1 3.7 17.5 14.3 6.2 8.4 8.3 2.8 12.2 9.1 1.0 12.6 12.4 10.8 31.7 2.9 20.1 5.1 10.1 3.1 2.3 7.3 27.8 11.6 12.5 10.0 4.9 3.6 9.4 4.0 4.3 7.3 14.2 29.3 0.1 0.2 0.4 9.8 0.2 0.1 2.6 0.1 5.2 35.2 1.8 49.1 49.9 0.0 7.4 18.4 5.2 5.2 0.0 0.0 0.0 0.1 11.0 5.1 0.0 0.1 5.3 3.5 0.0 0.3 0.0 7.4 0.0 4.2 2.3 0.0 8.9 0.3 6.7 1.2 4.0 9.0 4.7 0.6 0.0 1.4 4.9 4.0 2.4 3.3 0.2 1.8 0.4 0.0 0.0 0.1 2.1 0.4 2.5 6.9 1.7 0.0 7.3 0.8 2.1 17.9 7.8 3.2 8.4 1.2 0.0 0.0 0.0 11.3 2.0 2.7 0.4 9.8 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.2 0.0 2.6 4.0 5.1 2.2 3.5 4.1 3.7 8.3 2.8 10.8 3.6 0.0 1.7 0.0 9.8 9.0 1.1 6.2 0.0 5.3 2.3 1.8 2.0 16.8 0.0 0.3 0.0 5.4 0.0 0.0 0.4 1.2 13.1 5.9 0.0 1.1 2.2 3.2 0.0 1.3 1.9 0.0 3.4 1.6 0.0 0.0 0.0 7.8 1.4 0.0 6.3 1.3 1.5 64.7 19.3 0.0 0.9 2.9 4.6 0.0 0.0 5.4 S1PR4 EDG6 ENSG00000125910 "Sphingosine-1-phosphate receptor 4" O95977 19 3172346-3180332 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.2;bone marrow: 14.9;lymphoid tissue: 35.9" "Cell type enhanced" "Detected in many" 15 "B-cells: 50.4;Hofbauer cells: 26.6;Kupffer cells: 27.5;T-cells: 64.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 11.0;HL-60: 14.7;NB-4: 14.5;REH: 41.0;U-937: 14.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA060601, HPA067232" Supported Mitochondria NA NA Mitochondria "HPA060601: AB_2797261, HPA067232: AB_2797271" "prognostic favorable (3.13e-4)" "prognostic favorable (1.33e-4)" "unprognostic (2.58e-2)" "prognostic favorable (2.22e-4)" "unprognostic (2.98e-2)" "prognostic favorable (1.45e-6)" "unprognostic (1.27e-2)" "unprognostic (8.73e-2)" "unprognostic (1.21e-3)" "unprognostic (6.64e-3)" "unprognostic (3.59e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (2.97e-1)" "unprognostic (1.12e-1)" "unprognostic (2.06e-1)" "unprognostic (6.15e-3)" 2.0 0.5 0.7 8.3 0.3 14.9 1.3 0.6 0.7 0.5 0.9 0.4 0.2 0.8 0.7 0.7 1.2 1.4 0.7 2.1 0.3 0.2 1.2 1.4 6.4 35.9 0.3 0.4 0.7 0.3 0.0 0.2 1.7 0.6 0.7 0.0 1.0 1.3 0.2 1.1 0.4 7.1 0.2 0.5 34.2 3.9 0.3 0.3 10.2 1.5 0.2 10.7 1.9 0.6 14.1 7.3 44.2 15.3 5.4 23.1 7.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 4.7 0.1 0.0 0.0 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.1 0.0 41.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 14.0 0.0 16.4 10.4 27.4 11.8 11.6 10.5 11.3 14.7 11.4 7.3 14.1 12.4 11.9 44.2 5.4 15.3 6.6 23.1 7.2 0.7 0.3 0.6 0.7 0.3 0.2 0.3 0.4 0.6 0.3 3.0 5.8 50.4 0.2 1.1 0.0 0.4 0.0 0.0 2.3 1.8 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.1 0.1 0.2 5.7 0.0 26.6 0.0 0.0 3.1 27.5 0.0 0.0 13.2 1.7 1.8 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.3 0.0 64.7 0.0 0.3 S1PR5 "Edg-8, EDG8" ENSG00000180739 "Sphingosine-1-phosphate receptor 5" Q9H228 19 10512742-10517931 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 62.0;brain: 37.8;skin 1: 25.4" "Cell type enriched" "Detected in some" 12 "T-cells: 52.4" "Group enriched" "Detected in many" 5 "cervical cancer: 11.7;head and neck cancer: 8.0;lung cancer: 3.7;urothelial cancer: 6.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 62.0;MAIT T-cell: 38.0;memory CD8 T-cell: 29.2;naive CD8 T-cell: 23.2" "Lineage enriched" "Detected in many" 8 "T-cells: 62.0" "Cell line enhanced" "Detected in many" "HaCaT: 21.9;HBEC3-KT: 8.4;RT4: 14.3;T-47d: 9.1;U-2 OS: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029683 Enhanced NA NA "HPA029683: AB_10603237" "unprognostic (9.07e-3)" "unprognostic (1.27e-1)" "unprognostic (1.28e-2)" "unprognostic (5.55e-4)" "unprognostic (4.21e-1)" "unprognostic (4.85e-2)" "unprognostic (9.30e-2)" "unprognostic (1.55e-1)" "unprognostic (3.48e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.71e-7)" "unprognostic (2.46e-2)" "unprognostic (2.90e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-1)" 1.4 1.0 10.0 1.6 17.4 21.0 1.1 1.9 15.1 2.7 1.0 37.8 0.0 0.9 1.1 6.9 6.5 1.0 1.0 0.9 15.7 8.0 1.1 2.7 3.0 1.7 28.8 9.3 0.7 0.8 0.6 0.2 2.8 13.9 2.0 0.8 0.7 1.3 1.4 1.4 25.4 1.0 0.9 26.2 11.6 0.9 0.9 21.0 0.0 0.8 0.2 3.3 3.1 5.0 0.1 0.1 0.8 0.1 8.1 62.0 10.2 1.4 2.2 0.4 0.0 0.0 0.1 0.1 0.5 0.3 0.7 0.4 0.2 0.1 0.0 6.0 0.2 1.0 21.9 1.4 8.4 1.6 0.0 1.4 0.2 1.8 0.0 0.0 0.0 0.1 0.0 4.0 2.4 0.4 0.1 0.0 0.0 0.2 0.0 0.0 2.8 0.8 0.0 3.5 0.4 0.4 0.0 1.6 0.0 0.0 14.3 0.0 0.0 3.6 0.0 0.4 1.6 9.1 2.5 0.0 1.1 8.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.2 62.0 0.0 38.0 0.1 7.8 29.2 0.1 0.1 2.4 23.2 0.8 8.1 0.1 0.1 0.1 10.2 10.0 17.4 1.9 15.1 15.7 8.0 28.8 9.3 13.9 21.0 3.0 3.4 0.0 1.6 3.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.2 0.2 0.9 0.2 2.3 0.0 0.2 0.0 0.0 1.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.1 52.4 0.0 0.4 SACM1L "KIAA0851, SAC1" ENSG00000211456 "SAC1 like phosphatidylinositide phosphatase" Q9NTJ5 3 45689056-45745424 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039573, HPA069869" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA 8400000 "Nucleoplasm, Golgi apparatus" "HPA039573: AB_10674983, HPA069869: AB_2686216" "unprognostic (2.07e-1)" "unprognostic (4.08e-1)" "unprognostic (1.36e-3)" "unprognostic (1.14e-1)" "unprognostic (2.31e-2)" "unprognostic (4.34e-2)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" "unprognostic (8.54e-2)" "unprognostic (1.94e-2)" "unprognostic (1.22e-2)" "unprognostic (6.29e-3)" "prognostic favorable (5.47e-7)" "unprognostic (3.50e-1)" "unprognostic (1.62e-1)" "unprognostic (2.50e-1)" "unprognostic (1.33e-2)" 18.4 24.9 22.0 18.9 23.3 14.9 18.2 23.3 26.3 19.0 19.4 16.4 21.2 18.9 22.6 19.3 17.0 18.1 16.6 15.6 21.8 22.8 31.9 22.7 23.2 19.9 20.5 24.9 15.7 18.3 25.1 31.9 21.2 28.7 21.1 20.1 17.7 20.0 18.2 12.7 14.7 20.4 17.0 22.2 20.9 20.5 11.0 19.6 26.8 35.8 8.5 19.7 20.9 20.9 5.8 13.7 13.4 8.7 30.1 14.9 13.4 11.0 8.3 15.5 8.6 26.4 18.1 11.9 17.0 18.1 16.0 13.8 11.0 9.0 18.1 9.8 16.3 20.3 8.7 19.1 11.5 20.6 11.4 11.6 18.6 13.6 10.6 14.2 27.9 22.8 11.9 18.2 16.2 12.5 13.1 10.9 17.6 20.4 18.7 26.2 5.4 23.7 15.3 16.6 12.2 17.0 6.2 8.1 17.0 17.5 16.2 6.1 14.7 11.7 15.5 17.9 16.4 11.6 27.0 12.3 14.6 8.1 14.7 17.5 10.7 26.1 12.9 17.0 43.1 14.5 4.3 8.7 13.4 13.6 7.0 14.9 5.8 9.8 13.6 13.7 5.3 10.1 13.1 7.1 30.1 6.0 5.7 8.2 13.4 22.0 23.3 23.3 26.3 21.8 22.8 20.5 24.9 28.7 19.6 26.8 31.2 19.3 7.8 17.4 22.6 14.0 17.8 10.7 13.6 7.0 29.5 17.8 16.6 9.1 1.3 13.5 15.8 0.0 8.7 9.5 15.3 14.3 16.2 13.1 21.0 31.8 11.5 14.7 19.1 2.4 15.5 17.3 16.9 18.0 8.8 14.1 10.7 17.3 21.5 16.5 21.4 6.5 12.0 10.1 10.9 15.2 15.3 41.7 10.3 8.9 SAMD5 dJ875H10.1 ENSG00000203727 "Sterile alpha motif domain containing 5" Q5TGI4 6 147508927-147737547 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 66.1;Hepatocytes: 23.7;Undifferentiated cells: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 8.7;Hep G2: 33.3;K-562: 22.4;RH-30: 15.7;WM-115: 11.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067811 Uncertain Supported Vesicles No No Vesicles "HPA067811: AB_2685901" "unprognostic (4.16e-2)" "unprognostic (4.52e-2)" "unprognostic (9.65e-3)" "unprognostic (1.41e-2)" "unprognostic (1.82e-2)" "unprognostic (5.88e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (2.31e-1)" "unprognostic (1.54e-1)" "unprognostic (1.61e-2)" "unprognostic (8.55e-3)" "unprognostic (3.09e-2)" "unprognostic (5.40e-3)" "unprognostic (1.72e-1)" "unprognostic (4.51e-2)" "unprognostic (9.82e-3)" "unprognostic (1.50e-1)" 1.6 2.2 1.6 3.4 5.7 0.2 4.9 1.4 4.7 3.9 7.1 0.7 1.9 3.6 10.9 2.2 15.9 1.7 6.6 2.4 2.7 3.4 26.5 12.8 8.0 0.5 1.9 2.2 1.4 2.4 17.3 13.9 14.6 14.1 3.0 10.1 9.8 4.9 3.3 0.8 3.6 5.4 4.0 1.3 1.7 5.5 10.9 2.6 0.0 3.0 6.3 6.5 2.6 3.9 0.7 0.5 1.8 0.4 0.6 0.5 0.1 5.7 0.7 0.8 1.1 0.0 0.0 0.0 1.9 0.7 0.1 0.1 8.7 0.0 0.3 1.9 0.0 0.3 0.0 0.1 1.3 0.2 0.0 1.0 0.4 0.8 33.3 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.0 3.7 0.0 22.4 0.3 2.6 0.0 0.0 0.0 0.1 4.4 1.5 0.0 15.7 3.3 0.0 1.2 0.3 0.0 0.5 0.1 1.5 0.1 0.0 0.0 2.6 0.2 0.8 0.2 0.7 0.0 0.5 0.0 0.0 0.0 11.0 1.8 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.1 0.7 0.5 0.4 1.1 0.6 0.4 0.5 0.2 0.1 1.6 5.7 1.4 4.7 2.7 3.4 1.9 2.2 14.1 2.6 3.0 5.1 0.5 4.1 1.5 66.1 2.4 0.0 0.0 0.0 17.4 2.0 0.1 8.3 1.5 0.3 2.8 4.4 0.0 0.2 0.2 6.6 1.3 0.0 23.7 0.7 0.0 16.3 4.9 1.0 0.5 0.3 0.6 0.0 0.0 9.3 12.1 0.3 0.0 3.2 15.9 2.4 0.0 0.9 0.5 0.1 1.4 0.2 0.0 22.8 3.5 SAMD8 "FLJ25082, SMSr" ENSG00000156671 "Sterile alpha motif domain containing 8" Q96LT4 10 75099586-75182123 "Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 18.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044402 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044402: " "unprognostic (4.32e-1)" "unprognostic (3.14e-1)" "unprognostic (3.24e-2)" "unprognostic (7.87e-2)" "unprognostic (3.37e-2)" "unprognostic (2.77e-2)" "unprognostic (1.61e-2)" "unprognostic (1.39e-1)" "unprognostic (5.29e-1)" "unprognostic (3.12e-2)" "unprognostic (2.70e-1)" "unprognostic (4.69e-2)" "unprognostic (4.16e-3)" "unprognostic (3.89e-2)" "unprognostic (3.76e-1)" "unprognostic (2.53e-1)" "unprognostic (9.26e-3)" 17.6 14.6 18.8 9.3 18.9 20.7 11.9 12.4 34.8 15.6 7.9 20.1 10.2 8.2 15.0 10.1 17.9 9.4 12.5 14.3 18.6 15.9 10.1 10.1 10.7 8.7 22.7 13.8 18.7 7.6 13.0 17.1 14.8 17.4 11.5 7.0 10.9 8.9 11.5 28.3 7.6 9.3 13.7 37.8 10.0 7.7 19.9 15.5 5.5 10.7 7.3 8.6 10.9 18.1 5.7 3.6 18.3 5.9 3.8 3.3 1.5 5.5 5.3 8.1 6.5 17.9 16.6 10.3 10.1 19.3 6.7 9.1 7.9 7.9 4.5 6.7 9.4 7.1 10.1 4.6 6.9 12.0 5.0 6.7 1.8 5.4 5.3 9.9 2.0 4.6 15.9 7.0 12.4 18.0 15.4 9.2 5.1 3.8 7.8 12.8 4.3 3.3 2.5 3.5 3.8 20.9 3.0 7.5 1.6 6.4 4.8 1.2 5.8 9.2 11.0 8.9 9.3 4.6 1.9 15.8 6.6 12.4 8.0 6.6 5.5 4.2 4.3 10.3 4.4 4.2 2.4 3.7 2.2 2.9 4.5 1.9 4.8 3.1 3.3 3.2 5.7 2.7 3.1 18.3 3.8 5.9 3.6 2.8 1.5 18.8 18.9 12.4 21.3 18.6 15.9 22.7 13.8 17.4 15.5 8.9 12.2 13.7 23.3 37.5 19.1 22.6 10.2 25.4 17.0 14.0 13.7 9.1 0.0 9.7 29.4 21.3 9.6 0.0 9.0 9.6 22.6 18.9 12.7 11.6 11.8 17.5 22.4 23.9 16.2 9.0 23.3 27.6 11.8 27.1 3.3 21.8 13.2 8.6 23.7 6.2 31.9 32.3 24.7 47.0 23.4 37.5 56.9 20.1 4.1 32.5 SARAF "MGC8721, TMEM66" ENSG00000133872 "Store-operated calcium entry associated regulatory factor" Q96BY9 8 30063012-30083208 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040400 Supported "Endoplasmic reticulum,Rods & Rings" NA NA 17000 "Endoplasmic reticulum" "Rods & Rings" "HPA040400: AB_2676962" "unprognostic (1.11e-1)" "unprognostic (4.78e-2)" "unprognostic (4.27e-3)" "unprognostic (1.38e-3)" "unprognostic (7.86e-3)" "unprognostic (1.91e-1)" "unprognostic (2.32e-1)" "prognostic favorable (5.28e-4)" "unprognostic (1.98e-1)" "unprognostic (1.74e-2)" "unprognostic (8.03e-2)" "unprognostic (6.70e-3)" "unprognostic (1.06e-2)" "unprognostic (5.09e-2)" "unprognostic (3.88e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-1)" 30.7 80.7 58.1 37.3 69.0 57.8 62.1 45.8 89.0 40.9 32.8 35.8 49.3 26.9 35.0 65.9 20.2 42.9 39.5 34.3 57.5 80.9 38.7 67.0 39.1 77.7 59.1 49.8 60.6 67.8 44.6 48.9 61.6 53.4 45.6 28.1 26.1 69.4 45.5 29.7 18.4 30.7 30.4 62.4 36.4 38.7 21.3 35.4 50.3 50.0 16.0 36.0 35.4 37.3 36.9 30.2 96.2 36.9 29.0 99.7 91.0 21.6 15.4 19.6 13.0 33.6 23.4 14.9 26.8 38.5 23.3 30.2 8.3 24.3 14.7 39.4 29.1 22.5 19.2 19.7 22.2 19.2 7.8 14.3 20.1 11.0 10.7 33.8 6.4 24.0 36.5 41.8 26.2 21.6 37.6 32.4 28.0 23.5 31.4 17.6 8.2 23.5 10.6 17.4 39.9 16.7 19.0 13.0 20.2 32.4 8.8 8.5 30.2 23.4 23.3 30.0 16.0 20.1 13.5 23.0 15.6 44.8 7.1 8.8 22.2 20.2 13.3 38.7 17.5 25.3 96.2 30.1 50.8 41.3 28.9 45.2 27.0 59.4 47.5 30.2 36.9 99.7 67.4 58.4 29.0 36.9 25.1 53.5 91.0 58.1 69.0 45.8 89.0 57.5 80.9 59.1 49.8 53.4 35.4 157.8 151.5 175.3 315.5 0.0 275.4 116.6 183.4 389.5 151.2 200.7 115.8 212.5 107.8 306.4 503.5 140.5 151.8 23.3 314.8 218.5 186.1 398.0 205.8 225.0 268.6 131.9 111.2 216.7 320.6 650.1 202.5 236.8 0.0 172.3 165.1 296.0 289.2 188.4 276.5 210.5 171.0 174.6 120.5 100.9 125.1 0.0 231.6 276.7 147.8 245.7 SAYSD1 "C6orf64, FLJ11101" ENSG00000112167 "SAYSVFN motif domain containing 1" Q9NPB0 6 39104064-39115189 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 52.7" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 85.1;Spermatocytes: 202.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007959 Approved Supported Vesicles NA NA Vesicles "HPA007959: AB_1078359" "unprognostic (2.65e-1)" "unprognostic (1.49e-2)" "unprognostic (2.03e-2)" "unprognostic (2.58e-1)" "unprognostic (3.70e-1)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (1.96e-2)" "unprognostic (6.50e-2)" "unprognostic (1.82e-3)" "unprognostic (5.08e-2)" "unprognostic (9.90e-2)" "unprognostic (2.54e-2)" "unprognostic (1.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.27e-1)" "unprognostic (2.00e-3)" 8.2 7.2 7.2 5.7 8.7 5.9 11.2 7.1 9.0 7.9 7.3 8.1 6.9 8.8 7.9 10.5 6.5 8.1 9.3 6.7 7.3 6.9 8.1 8.3 6.3 8.2 9.3 6.5 8.4 9.5 4.9 6.1 6.1 7.0 8.5 7.2 6.4 11.1 8.0 5.6 6.6 8.6 6.3 7.0 6.8 6.9 52.7 7.3 18.2 8.4 5.1 9.0 6.2 7.7 14.8 9.3 19.4 12.2 11.7 19.1 9.5 11.4 7.4 6.7 7.9 11.1 14.7 6.9 5.3 5.8 6.4 6.8 10.6 8.1 10.4 7.6 6.9 9.1 7.9 5.8 5.0 6.8 6.5 10.5 6.8 4.5 9.2 9.0 7.7 10.3 10.1 12.4 2.5 6.4 4.5 5.9 15.8 11.5 6.4 7.1 15.7 12.2 12.8 5.8 7.5 3.8 1.7 8.1 4.1 13.4 8.1 18.8 7.6 9.2 8.0 8.1 5.6 13.1 10.2 7.6 8.5 6.2 2.6 6.8 0.1 3.2 12.8 4.9 11.2 6.2 7.6 9.0 19.4 12.2 12.2 14.2 13.1 13.3 11.0 9.3 14.8 19.1 15.8 4.3 11.7 11.9 7.4 17.3 9.5 7.2 8.7 7.1 9.0 7.3 6.9 9.3 6.5 7.0 7.3 3.0 5.9 9.3 11.4 13.7 5.5 17.5 17.8 12.0 5.7 17.4 7.9 28.7 14.9 19.4 85.1 11.3 11.8 0.0 18.9 26.3 17.4 17.9 8.1 18.7 23.2 6.4 8.1 3.1 15.6 40.0 19.0 12.2 11.8 9.0 15.0 13.7 14.7 7.0 18.0 23.0 3.6 6.5 10.3 202.1 11.9 14.4 10.3 10.2 18.4 11.5 SC5D SC5DL ENSG00000109929 Sterol-C5-desaturase O75845 11 121292453-121308694 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 143.5" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 117.3;Ito cells: 163.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066283, HPA070248" Enhanced Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" No No "Nucleoplasm, Endoplasmic reticulum" "Plasma membrane, Cytosol" "HPA066283: AB_2685648, HPA070248: AB_2686240" "unprognostic (4.78e-2)" "unprognostic (7.29e-2)" "unprognostic (2.26e-2)" "unprognostic (2.36e-1)" "unprognostic (3.98e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (2.79e-2)" "unprognostic (7.96e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (4.03e-2)" "unprognostic (3.18e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.07e-7)" "unprognostic (4.29e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.98e-1)" 10.9 15.3 16.9 5.5 18.4 2.7 23.3 10.4 26.9 9.4 9.4 17.8 24.5 17.4 6.8 30.1 19.5 7.2 7.4 9.4 18.7 19.6 19.7 143.5 10.1 5.5 20.8 17.8 7.8 8.9 17.5 14.7 6.3 40.8 40.3 8.6 8.2 9.5 24.0 3.9 7.7 13.4 7.6 43.4 4.1 8.8 9.7 16.0 3.7 10.4 8.2 8.1 14.0 14.6 6.0 9.8 7.5 6.3 6.8 10.0 3.8 6.8 3.4 51.8 11.0 20.1 17.5 7.3 7.7 14.5 5.2 9.2 21.6 25.5 6.5 24.4 8.4 41.5 25.7 16.1 19.5 5.1 3.2 22.0 9.6 22.6 17.2 16.4 6.0 3.3 14.3 16.0 16.4 16.9 4.4 7.8 6.4 6.2 9.4 24.0 7.1 2.4 7.9 16.1 19.8 11.0 3.4 13.0 5.5 36.5 30.8 13.7 7.7 17.7 4.0 10.1 36.2 16.2 10.4 14.9 5.0 8.1 8.8 3.6 1.8 2.9 8.7 1.9 13.4 8.6 7.5 4.8 1.2 5.0 6.3 8.5 6.0 6.8 6.0 8.5 6.0 10.0 9.5 0.4 6.8 4.5 9.8 6.9 3.8 16.9 18.4 10.4 26.9 18.7 19.6 20.8 17.8 40.8 16.0 17.9 26.4 26.2 53.7 8.7 21.9 17.8 15.3 14.7 18.2 19.2 29.5 13.8 5.0 17.3 2.2 8.4 23.5 0.0 25.4 14.2 17.3 59.7 17.3 117.3 17.9 22.3 13.8 163.9 25.6 1.0 17.8 15.1 18.6 22.6 12.7 40.5 14.5 11.4 15.9 14.6 29.6 12.9 16.7 6.0 13.0 13.6 15.6 21.7 11.9 45.5 SCAMP1 SCAMP37 ENSG00000085365 "Secretory carrier membrane protein 1" O15126 5 78360583-78479071 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044753, CAB079009" Supported Approved "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Nucleoplasm, Vesicles, Cell Junctions" "CAB079009: , HPA044753: " "unprognostic (8.25e-2)" "unprognostic (3.65e-2)" "unprognostic (1.40e-3)" "unprognostic (5.34e-3)" "unprognostic (2.60e-1)" "unprognostic (2.57e-3)" "unprognostic (5.51e-2)" "unprognostic (3.43e-2)" "unprognostic (1.31e-1)" "unprognostic (8.23e-3)" "unprognostic (2.35e-2)" "unprognostic (2.56e-1)" "prognostic favorable (1.92e-4)" "unprognostic (8.44e-3)" "unprognostic (7.56e-2)" "unprognostic (3.12e-2)" "unprognostic (4.99e-2)" 7.5 8.3 9.2 4.0 19.3 2.4 10.0 12.8 19.5 8.4 6.4 5.4 9.9 5.3 8.7 9.3 8.6 10.7 6.4 8.0 15.8 10.4 6.2 5.9 3.9 6.5 15.8 8.8 8.8 17.5 14.6 7.6 14.6 12.2 7.3 7.6 10.6 11.0 4.7 5.8 5.3 9.1 9.0 3.9 9.6 4.5 7.1 4.1 14.2 3.8 3.7 8.8 6.3 7.9 14.9 15.3 15.8 10.0 9.9 7.4 12.5 9.9 9.9 30.6 13.7 17.7 15.6 11.6 16.9 9.6 21.9 3.7 23.5 18.5 13.1 16.9 27.5 10.2 14.0 21.8 17.2 6.5 13.3 8.5 7.9 7.6 8.8 5.4 6.6 11.6 20.2 10.9 17.3 24.2 14.6 10.4 3.2 13.3 18.2 14.7 9.3 11.5 8.0 5.4 10.2 11.4 16.3 21.1 17.5 14.9 28.1 17.1 10.7 15.2 10.9 10.5 21.1 9.8 14.9 10.6 7.9 11.7 9.7 9.3 11.2 11.5 20.7 20.3 8.8 15.3 11.4 12.8 8.2 12.6 9.9 7.9 9.4 9.8 14.9 6.6 7.8 6.8 7.0 10.0 15.8 4.6 9.1 7.4 23.8 19.0 6.7 28.6 34.8 72.3 33.0 20.4 71.0 26.1 38.4 66.8 10.4 11.6 22.7 31.3 27.8 11.7 23.3 26.3 21.3 31.0 36.1 11.5 13.9 16.8 30.2 34.0 22.1 30.5 12.1 18.7 22.7 28.7 6.4 33.6 43.2 26.4 11.5 26.9 20.5 63.0 12.9 25.0 17.0 20.4 39.5 8.8 13.8 17.0 25.0 SCAMP2 ENSG00000140497 "Secretory carrier membrane protein 2" O15127 15 74843730-74873365 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014699, HPA019194" Approved Supported "Golgi apparatus,Vesicles" NA NA 110000 "Golgi apparatus, Vesicles" "HPA014699: AB_1856605, HPA019194: AB_1856604" "unprognostic (1.74e-1)" "unprognostic (1.27e-2)" "unprognostic (2.05e-1)" "unprognostic (5.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.53e-2)" "unprognostic (7.23e-2)" "unprognostic (9.73e-3)" "unprognostic (7.26e-2)" "unprognostic (8.44e-2)" "unprognostic (1.97e-1)" "prognostic favorable (1.12e-6)" "unprognostic (3.40e-1)" "unprognostic (1.79e-2)" "unprognostic (1.19e-2)" "unprognostic (3.10e-2)" 28.8 27.9 15.7 32.2 21.9 22.6 38.7 7.6 16.5 20.9 37.8 27.6 24.6 37.7 22.5 27.9 54.7 24.7 27.0 18.8 14.8 10.1 34.2 37.8 28.8 42.1 24.2 11.6 20.5 32.1 42.7 17.6 47.8 17.4 20.3 37.1 17.5 56.4 31.9 18.5 36.1 47.5 17.1 20.1 39.4 33.2 29.2 20.1 25.8 29.2 28.3 38.4 21.4 25.8 37.8 59.5 46.9 51.3 36.6 47.0 47.4 12.8 16.8 7.2 11.2 22.1 11.5 21.7 13.2 16.8 14.1 15.2 24.1 30.4 10.6 17.5 19.9 20.4 46.8 21.5 16.5 5.9 41.8 21.1 26.8 9.8 16.5 16.7 13.7 51.7 14.8 29.4 13.3 9.7 11.2 13.7 12.4 8.8 20.1 9.8 19.6 6.9 15.8 7.2 32.2 10.9 12.2 6.7 36.4 16.3 18.5 7.5 7.5 10.8 19.2 12.1 11.1 26.4 22.1 12.7 12.2 7.3 13.1 15.3 13.9 20.4 10.8 11.4 32.5 8.9 46.9 51.3 39.4 46.6 48.3 37.6 37.8 42.7 46.9 37.8 32.5 35.6 38.2 34.6 36.6 50.3 59.5 47.0 47.4 15.7 21.9 7.6 16.5 14.8 10.1 24.2 11.6 17.4 20.1 68.5 27.7 38.8 31.5 15.5 6.0 13.3 12.7 37.5 34.2 38.4 2.0 132.9 13.3 51.4 106.8 33.7 86.4 0.0 81.6 53.9 35.5 43.7 77.3 25.6 142.9 6.4 35.8 25.2 59.2 43.9 29.7 61.4 30.4 45.9 66.5 37.9 72.2 69.1 21.5 40.9 7.7 25.8 22.5 46.6 23.8 19.4 114.1 37.3 57.4 47.7 SCAMP3 C1orf3 ENSG00000116521 "Secretory carrier membrane protein 3" O14828 1 155255979-155262430 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071167 Supported Vesicles NA NA Vesicles "HPA071167: AB_2686352" "unprognostic (4.31e-2)" "unprognostic (1.30e-2)" "unprognostic (1.07e-2)" "unprognostic (2.17e-2)" "unprognostic (5.33e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.92e-5)" "unprognostic (8.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (2.65e-1)" "unprognostic (3.74e-2)" "unprognostic (8.46e-3)" "unprognostic (1.60e-1)" "unprognostic (4.79e-1)" "unprognostic (1.07e-1)" "unprognostic (7.18e-2)" 23.6 41.8 21.0 20.8 25.6 16.8 28.8 22.5 35.5 21.9 19.0 36.1 26.8 24.1 20.7 17.8 27.1 21.9 21.5 37.8 19.8 20.2 33.3 40.8 23.4 25.5 27.1 26.3 22.6 41.5 41.5 20.0 37.0 26.2 23.0 17.3 26.0 33.0 28.1 45.3 30.0 20.9 18.9 30.4 27.0 24.4 14.5 26.4 21.6 27.3 23.6 27.3 23.9 20.8 32.2 32.5 25.6 35.0 29.9 28.7 30.0 13.9 30.0 9.1 18.1 22.2 17.4 9.3 16.8 19.9 19.0 17.9 16.4 19.9 12.9 25.1 19.5 18.6 21.8 13.1 12.7 7.0 17.7 24.0 9.1 19.6 13.3 22.2 17.1 15.5 15.3 16.3 23.8 10.9 12.6 15.8 13.3 16.2 31.4 20.5 27.9 15.8 15.9 17.5 24.0 32.9 13.6 7.4 39.8 11.3 12.5 11.8 23.8 11.7 27.4 19.4 9.0 29.6 26.8 12.9 21.4 12.1 22.0 24.8 41.8 38.8 16.1 21.0 18.4 24.6 25.6 29.0 23.2 28.7 31.1 25.6 32.2 26.6 26.8 31.6 30.5 24.6 26.3 2.6 29.9 35.0 32.5 26.6 30.0 21.0 25.6 22.5 35.5 19.8 20.2 27.1 26.3 26.2 26.4 14.9 36.2 29.6 20.5 34.0 17.4 31.9 28.1 20.1 28.4 31.4 3.9 72.8 8.3 46.2 1.4 29.2 26.9 0.0 60.3 45.7 27.2 20.1 24.3 33.4 50.8 17.5 28.9 28.8 21.0 4.3 15.8 24.5 23.6 54.1 21.9 20.0 40.9 24.3 17.7 21.2 10.5 12.9 21.7 10.7 3.4 35.0 59.6 32.4 24.2 19.7 SCAMP4 FLJ33847 ENSG00000227500 "Secretory carrier membrane protein 4" Q969E2 19 1905214-1926013 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043284 Approved Approved "Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane" NA NA "Golgi apparatus, Vesicles" "Lipid droplets, Plasma membrane" "HPA043284: AB_10806501" "unprognostic (1.60e-1)" "unprognostic (3.62e-1)" "unprognostic (5.04e-2)" "prognostic favorable (4.40e-6)" "unprognostic (2.58e-1)" "unprognostic (4.58e-1)" "prognostic unfavorable (1.92e-5)" "unprognostic (2.04e-1)" "unprognostic (1.58e-1)" "unprognostic (2.55e-1)" "unprognostic (3.01e-3)" "unprognostic (5.66e-2)" "prognostic favorable (3.56e-4)" "unprognostic (6.16e-2)" "unprognostic (1.58e-1)" "unprognostic (3.93e-2)" "unprognostic (1.03e-1)" 17.3 16.5 17.1 16.0 21.7 10.2 18.4 16.5 28.2 19.5 13.2 46.3 21.1 19.3 16.3 20.4 22.0 37.2 19.4 8.5 19.3 19.5 19.9 21.5 19.3 13.9 22.1 14.6 23.7 28.0 12.7 23.2 24.2 27.6 19.5 9.8 21.4 41.1 21.4 9.1 19.2 18.9 12.1 42.1 17.2 21.8 15.9 20.3 10.3 23.8 10.6 18.2 15.7 13.9 6.4 14.2 2.5 5.9 7.1 5.0 3.7 23.1 23.1 10.6 25.7 21.3 13.3 12.6 15.0 14.0 16.5 20.1 18.8 22.3 9.5 14.7 12.0 9.4 27.7 10.0 15.3 6.1 15.0 9.0 6.6 8.2 18.0 27.3 6.6 10.2 20.3 9.7 14.3 8.7 13.5 11.2 10.6 15.0 10.8 9.5 27.8 8.8 12.8 17.3 12.0 7.8 11.0 7.7 14.4 20.3 20.6 15.0 19.8 9.5 22.9 12.6 7.7 22.4 17.3 11.9 20.3 14.1 36.3 15.8 26.3 25.9 8.5 26.9 11.1 13.0 1.9 5.2 2.0 5.0 5.9 2.7 6.4 3.5 3.2 5.7 4.6 2.1 3.7 2.5 7.1 5.0 14.2 2.7 3.7 17.1 21.7 16.5 28.2 19.3 19.5 22.1 14.6 27.6 20.3 8.9 8.2 23.1 21.9 15.1 18.6 2.2 17.8 10.7 5.7 47.1 70.7 33.6 6.6 18.8 0.6 14.4 42.4 23.3 11.0 30.8 21.6 30.1 17.3 10.4 33.3 20.6 18.0 14.7 18.8 0.4 20.1 12.3 20.3 15.4 27.2 30.6 13.6 20.1 16.3 9.0 49.3 0.0 10.8 16.3 29.8 17.7 49.3 13.3 21.0 23.3 SCAMP5 MGC24969 ENSG00000198794 "Secretory carrier membrane protein 5" Q8TAC9 15 74957219-75021496 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 110.4;Cone photoreceptor cells: 117.8;Horizontal cells: 66.7;Intestinal endocrine cells: 60.0;Rod photoreceptor cells: 156.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 24 "plasmacytoid DC: 20.0" "Lineage enriched" "Detected in single" 24 "dendritic cells: 20.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 40.3;SH-SY5Y: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046645 Enhanced NA NA "HPA046645: AB_2679734" "unprognostic (1.37e-1)" "unprognostic (3.30e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-2)" "unprognostic (2.74e-1)" "unprognostic (4.46e-2)" "unprognostic (2.56e-1)" "unprognostic (4.13e-1)" "unprognostic (2.34e-1)" "unprognostic (8.37e-2)" "prognostic favorable (5.67e-5)" "unprognostic (9.82e-2)" "prognostic favorable (1.34e-6)" "unprognostic (7.27e-2)" "unprognostic (3.01e-1)" "unprognostic (1.69e-1)" "unprognostic (3.31e-2)" 2.1 11.1 29.2 2.5 35.7 1.7 2.1 57.5 87.0 1.5 3.3 7.5 0.0 20.6 3.3 2.4 1.3 3.1 3.3 2.8 32.4 32.1 8.9 2.6 1.9 4.0 23.9 27.8 3.6 16.7 27.0 7.4 3.8 31.1 2.6 3.1 10.7 4.1 1.9 0.8 1.6 14.7 2.1 11.9 3.6 8.2 5.6 5.6 0.0 3.8 0.0 5.3 5.5 0.7 0.2 20.0 0.8 0.1 0.3 0.2 0.2 0.6 8.1 1.7 5.7 0.1 0.1 0.2 0.2 0.2 1.8 0.6 2.1 4.0 12.2 3.9 0.4 1.5 0.5 6.9 0.5 0.6 1.9 0.8 1.5 0.8 11.2 1.2 0.3 5.2 0.6 0.9 0.4 0.1 1.2 0.7 4.5 0.1 10.0 0.4 6.6 0.5 4.4 6.0 0.9 3.2 0.2 1.4 2.9 0.4 3.8 40.3 22.5 8.8 6.1 12.2 1.3 3.4 14.8 0.5 0.5 3.9 0.8 0.5 0.9 1.0 1.1 1.4 9.4 2.1 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.8 0.3 0.1 20.0 0.0 0.2 29.2 35.7 57.5 64.8 32.4 32.1 23.9 27.8 31.1 5.6 0.0 0.6 2.2 0.6 0.2 110.4 2.4 10.2 2.7 0.0 5.2 117.8 0.1 1.7 4.0 0.4 0.7 4.2 0.0 36.9 0.1 0.8 0.9 0.0 0.6 10.4 66.7 60.0 9.2 4.7 0.6 2.0 0.5 1.7 0.0 2.0 20.0 9.3 5.8 6.0 10.7 156.4 0.0 1.0 1.7 3.4 0.1 0.1 0.0 1.9 0.4 SCAP KIAA0199 ENSG00000114650 "SREBF chaperone" Q12770 3 47413694-47477126 "Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004713 Approved NA NA "HPA004713: AB_1079868" "unprognostic (4.02e-2)" "unprognostic (2.56e-1)" "unprognostic (1.91e-1)" "unprognostic (4.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.26e-1)" "unprognostic (8.74e-2)" "unprognostic (3.85e-2)" "unprognostic (1.28e-2)" "unprognostic (7.10e-2)" "prognostic favorable (7.14e-4)" "unprognostic (4.07e-2)" "prognostic favorable (4.33e-5)" "unprognostic (3.15e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (7.06e-3)" 11.1 47.4 15.9 10.7 21.4 11.3 15.0 23.7 28.7 13.8 18.2 22.6 13.9 17.8 17.7 14.8 17.8 16.0 14.5 10.9 16.9 11.5 13.5 34.1 11.3 17.1 15.6 12.2 18.8 22.1 26.3 15.2 16.9 17.3 13.1 16.0 19.3 16.0 14.2 15.6 26.2 17.1 14.9 11.6 15.0 15.5 19.5 18.5 18.8 15.4 9.4 12.0 18.5 13.6 6.7 7.7 18.3 6.4 7.5 10.5 4.7 10.6 15.1 16.4 25.3 29.8 15.8 29.2 10.5 15.5 17.6 16.7 20.1 17.6 17.8 15.3 17.8 18.0 11.6 23.0 22.1 18.3 12.2 16.6 30.7 21.2 21.7 29.0 18.3 18.4 19.7 23.8 22.3 24.6 14.2 15.0 17.8 20.8 12.4 14.1 15.1 20.0 27.1 17.1 22.2 22.6 11.8 15.0 21.3 13.9 21.1 11.3 21.2 15.4 19.6 10.2 22.6 17.0 20.2 12.8 16.2 19.4 22.2 14.6 12.3 13.4 10.3 15.3 17.0 11.9 5.8 6.4 6.7 7.8 5.7 10.5 6.6 6.6 7.0 7.7 6.7 7.5 7.3 18.3 7.5 4.5 6.2 8.0 4.7 15.9 21.4 23.7 28.7 16.9 11.5 15.6 12.2 17.3 18.5 0.0 13.6 7.5 8.1 10.3 20.9 12.4 10.2 12.0 12.5 19.2 27.5 18.7 0.0 12.3 11.1 8.8 38.3 0.0 13.0 12.3 12.7 8.4 6.9 39.9 14.1 50.9 11.5 6.7 7.9 21.9 18.1 10.1 23.6 2.8 17.8 17.8 9.6 28.6 20.1 10.5 30.9 32.3 9.2 15.3 23.5 10.2 66.1 10.0 24.1 6.3 SCARA3 "APC7, CSR, CSR1, MSLR1, MSRL1" ENSG00000168077 "Scavenger receptor class A member 3" Q6AZY7 8 27633868-27676776 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 52.2" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 62.8;Cytotrophoblasts: 37.1;Muller glia cells: 54.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 50.6;HeLa: 55.7;HUVEC TERT2: 38.6;U-2 OS: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029861, HPA047386" Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029861: AB_2673225, HPA047386: AB_2680024" "unprognostic (2.24e-1)" "unprognostic (5.36e-3)" "unprognostic (2.68e-3)" "unprognostic (1.36e-1)" "unprognostic (1.48e-2)" "unprognostic (1.17e-1)" "unprognostic (4.31e-1)" "unprognostic (1.60e-1)" "unprognostic (3.58e-2)" "unprognostic (1.45e-1)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (3.41e-2)" "unprognostic (1.78e-2)" "unprognostic (4.95e-2)" "unprognostic (6.31e-3)" "unprognostic (6.03e-3)" 7.5 4.6 16.4 9.0 27.3 0.4 10.6 10.3 26.8 19.9 11.2 7.7 14.2 3.4 33.8 9.4 14.5 52.2 18.4 4.8 16.2 13.0 3.8 2.7 7.8 7.4 16.4 10.3 13.1 2.8 2.2 3.6 11.8 21.2 12.4 5.4 8.6 13.7 42.6 1.1 6.0 5.1 40.5 21.8 2.0 5.9 3.9 12.1 3.2 19.2 4.7 13.2 11.3 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 16.5 2.6 0.0 13.8 50.6 11.5 6.6 10.4 7.2 5.4 6.1 4.3 0.0 15.6 13.3 5.8 12.4 0.0 12.2 3.4 0.0 1.4 4.8 55.7 0.2 1.4 0.0 0.0 21.2 0.7 11.1 0.6 9.6 38.6 1.2 0.0 0.0 4.0 3.0 0.0 0.0 3.5 0.0 6.3 0.0 0.0 0.0 2.2 7.3 0.0 1.7 1.5 8.7 0.0 1.3 8.6 0.1 13.7 5.9 35.7 21.9 3.5 0.0 0.0 0.0 10.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 27.3 10.3 22.5 16.2 13.0 16.4 10.3 21.2 12.1 0.0 0.3 0.0 13.3 3.2 0.4 2.0 7.6 4.0 7.9 62.8 0.0 37.1 0.0 0.2 2.4 3.3 0.0 0.0 0.7 14.6 12.8 2.8 0.0 0.2 4.0 0.0 0.0 12.3 0.3 1.1 14.7 0.8 16.9 1.0 0.0 54.2 1.6 0.0 6.0 0.0 1.1 6.5 13.7 0.2 1.0 3.3 6.9 0.0 0.0 8.6 SCARA5 "FLJ23907, MGC45780, NET33" ENSG00000168079 "Scavenger receptor class A member 5" Q6ZMJ2 8 27869882-27992727 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Iron transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 9 "Leydig cells: 125.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 117 "plasmacytoid DC: 17.3" "Lineage enriched" "Detected in single" 173 "dendritic cells: 17.3" "Cell line enriched" "Detected in some" 20 "ASC diff: 73.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA024661 Approved NA NA 1500000 "HPA024661: AB_1853902" "unprognostic (2.76e-2)" "unprognostic (7.20e-3)" "unprognostic (1.44e-2)" "unprognostic (3.53e-2)" "unprognostic (2.34e-2)" "unprognostic (4.62e-2)" "unprognostic (2.01e-1)" "unprognostic (2.15e-1)" "unprognostic (9.13e-2)" "unprognostic (2.40e-1)" "unprognostic (4.21e-2)" "unprognostic (1.10e-1)" "unprognostic (7.09e-6)" "unprognostic (3.48e-2)" "unprognostic (2.29e-1)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" 26.9 1.7 0.7 4.6 0.5 0.0 18.5 0.6 1.1 9.2 17.3 0.4 14.3 3.8 2.3 31.0 23.6 8.8 13.5 42.4 0.7 0.1 0.8 1.6 8.2 3.6 2.8 0.6 5.2 2.6 0.0 2.3 18.5 4.1 9.8 16.4 34.3 11.4 3.6 6.1 13.0 9.8 37.2 1.4 1.1 11.0 12.3 0.3 0.5 9.1 15.9 2.2 28.4 54.6 0.0 17.3 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 73.9 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.1 0.7 0.5 0.6 1.1 0.7 0.1 2.8 0.6 4.1 0.3 0.0 0.0 0.0 0.0 5.8 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 2.9 0.0 0.0 0.0 0.3 13.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 125.7 0.3 6.8 0.0 0.0 2.0 0.0 0.0 10.6 0.0 0.0 0.0 2.7 0.9 0.9 5.3 0.1 0.0 0.0 0.1 SCARB1 "CD36L1, CLA-1, CLA1, SR-BI, SRB1" ENSG00000073060 "Scavenger receptor class B member 1" Q8WTV0 12 124776856-124882668 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 173.1;liver: 93.7;placenta: 65.9" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 105.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 24.9" "Group enriched" "Detected in many" 5 "dendritic cells: 24.9;monocytes: 6.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066285, CAB070124, HPA072449" Enhanced Approved "Vesicles,Lysosomes,Rods & Rings" NA NA Vesicles "Lysosomes, Rods & Rings" "CAB070124: AB_10107658, HPA066285: AB_2685649, HPA072449: AB_2732201" "unprognostic (9.70e-3)" "unprognostic (4.94e-3)" "unprognostic (1.32e-1)" "unprognostic (4.79e-2)" "unprognostic (1.65e-3)" "unprognostic (4.21e-3)" "prognostic unfavorable (1.83e-5)" "prognostic unfavorable (4.02e-4)" "unprognostic (2.30e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-2)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.49e-5)" "unprognostic (3.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.81e-1)" "unprognostic (4.13e-1)" 21.2 173.1 7.9 3.5 21.4 1.8 25.0 4.3 10.1 4.7 28.6 13.4 1.1 8.8 4.3 3.5 2.8 4.7 8.0 3.2 7.4 5.1 2.2 93.7 5.8 5.3 6.3 5.1 14.3 2.9 3.3 4.4 65.9 9.4 4.3 4.9 10.7 8.6 2.3 3.0 6.3 21.3 4.4 5.7 5.0 2.7 7.7 11.4 0.5 4.0 1.1 5.6 3.6 10.0 3.1 24.9 1.2 6.5 0.2 0.4 2.5 9.3 22.6 7.4 29.1 4.9 10.5 0.0 6.6 7.5 8.2 5.2 27.0 29.9 27.0 19.0 4.4 13.4 14.2 18.8 44.3 3.9 12.9 18.9 7.6 22.4 43.5 16.6 13.0 6.6 17.9 9.0 15.6 11.1 14.0 22.3 4.9 14.3 11.6 1.5 18.5 4.0 17.4 6.7 11.6 23.4 16.9 5.9 53.9 0.7 13.1 13.9 5.4 35.8 48.4 33.5 4.5 27.1 14.7 2.1 1.3 8.8 6.6 10.1 2.7 1.1 4.4 5.3 15.8 12.8 0.0 6.5 0.0 0.2 3.7 0.2 3.1 0.1 0.4 8.2 1.7 0.1 0.1 1.2 0.2 0.5 24.9 0.0 2.5 7.9 21.4 4.3 10.1 7.4 5.1 6.3 5.1 9.4 11.4 3.0 2.4 18.5 3.1 4.9 5.0 4.8 12.7 4.0 1.2 3.5 27.5 8.8 3.3 5.1 13.9 11.2 9.2 23.3 6.6 9.3 5.9 10.5 1.1 105.2 42.5 15.9 10.3 15.4 14.0 10.8 8.3 10.1 45.5 5.4 14.0 52.5 5.9 14.2 4.9 2.4 7.4 0.0 2.1 27.8 1.7 2.8 36.3 2.5 8.8 3.8 SCARB2 "CD36L2, HLGP85, LIMP-2, LIMPII, SR-BII" ENSG00000138760 "Scavenger receptor class B member 2" Q14108 4 76158733-76234536 "Disease related genes, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 18.3;granulocytes: 6.2;monocytes: 15.3" "Cell line enhanced" "Detected in many" "ASC diff: 88.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015415, HPA018014" Supported Approved Cytosol NA NA Cytosol "CAB015415: AB_831511, HPA018014: AB_1852881" "prognostic unfavorable (2.82e-5)" "unprognostic (2.73e-2)" "unprognostic (4.09e-2)" "unprognostic (4.96e-2)" "unprognostic (4.17e-3)" "unprognostic (1.12e-3)" "unprognostic (2.08e-1)" "unprognostic (5.48e-2)" "unprognostic (4.06e-1)" "unprognostic (1.25e-2)" "unprognostic (4.11e-2)" "unprognostic (1.67e-1)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (6.88e-2)" "unprognostic (5.06e-2)" "unprognostic (3.89e-2)" 33.6 20.6 30.7 13.0 32.9 4.1 34.1 22.9 42.8 40.1 34.9 63.7 21.4 22.7 26.8 37.0 20.3 24.9 34.5 29.7 35.7 30.3 29.0 51.6 43.8 21.7 43.9 31.6 37.0 32.3 47.5 14.5 41.0 44.1 44.2 32.7 23.1 40.3 34.1 54.3 16.5 27.6 24.4 70.5 26.7 36.1 16.1 40.7 6.2 39.2 16.5 10.8 31.7 40.3 2.6 18.3 6.2 15.3 0.7 3.0 3.6 5.7 4.6 7.2 13.9 88.2 43.1 6.1 19.3 44.4 16.9 31.4 8.2 15.9 0.0 15.3 41.3 16.3 4.9 5.1 12.0 17.9 24.8 5.8 0.5 4.2 3.9 21.6 3.0 2.0 31.9 12.1 17.9 10.3 39.3 30.2 1.5 2.7 29.2 26.0 8.8 0.2 0.6 1.7 17.1 4.5 3.6 14.7 4.9 11.9 3.8 17.1 17.7 16.5 11.5 16.7 9.4 5.2 3.0 19.9 17.1 8.6 14.1 6.0 27.1 17.0 0.0 19.9 3.9 25.2 6.2 8.8 2.1 1.8 15.3 1.9 2.6 1.5 1.1 5.2 2.0 1.8 3.0 1.5 0.7 14.7 18.3 1.8 3.6 30.7 32.9 22.9 41.1 35.7 30.3 43.9 31.6 44.1 40.7 163.8 38.3 16.4 69.4 21.3 92.5 50.2 96.8 45.5 37.5 94.2 56.9 29.5 6.6 100.8 5.0 72.9 82.1 0.0 63.0 42.1 60.9 149.5 3.5 90.6 138.6 57.2 98.3 91.4 117.9 2.9 42.0 58.7 64.1 26.2 73.9 73.8 79.5 66.0 62.6 27.2 69.7 90.5 54.8 3.4 13.2 29.5 49.7 10.5 48.8 82.4 SCART1 CD163c-alpha ENSG00000214279 "Scavenger receptor family member expressed on T cells 1" Q4G0T1 10 133453928-133523558 "Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.6" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 5.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HMC-1: 7.2;NB-4: 6.7;THP-1: 2.2;U-266/84: 7.3" "Not detected" "Not detected" HPA043101 Supported NA NA "HPA043101: AB_10797026" "unprognostic (4.32e-2)" "unprognostic (2.15e-2)" "unprognostic (1.13e-2)" "unprognostic (2.40e-2)" "unprognostic (7.42e-2)" "unprognostic (8.20e-4)" "unprognostic (1.29e-3)" "unprognostic (4.28e-3)" "unprognostic (2.63e-2)" "unprognostic (1.68e-1)" "unprognostic (2.91e-1)" "unprognostic (2.24e-2)" "unprognostic (6.24e-5)" "unprognostic (8.53e-2)" "unprognostic (1.25e-1)" "unprognostic (5.03e-2)" "unprognostic (1.94e-1)" 0.3 0.2 0.0 0.3 0.5 1.6 0.0 0.4 4.8 0.1 0.3 0.2 0.0 1.3 0.9 0.0 0.4 0.0 0.9 0.0 5.6 0.7 0.2 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.3 0.3 0.0 0.2 0.8 0.4 0.2 0.2 0.7 1.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.1 0.2 0.2 0.0 0.4 0.3 0.8 0.4 0.2 1.2 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.3 0.1 0.1 0.2 0.0 0.3 0.4 0.8 0.1 0.0 0.0 0.2 7.2 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.3 6.7 0.2 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.1 0.4 0.0 0.4 0.5 7.3 1.1 0.0 0.0 0.3 0.8 0.2 0.3 0.3 0.1 1.2 0.3 0.4 0.6 0.1 0.4 0.3 0.4 0.2 0.2 0.4 0.3 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCCPDH "CGI-49, NET11" ENSG00000143653 "Saccharopine dehydrogenase (putative)" Q8NBX0 1 246724047-246768137 "Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 95.3" "Group enriched" "Detected in many" 5 "Early spermatids: 1022.4;Spermatocytes: 461.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 17 "basophil: 95.3" "Lineage enriched" "Detected in all" 22 "granulocytes: 95.3" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 53.5" "Low region specificity" "Detected in all" "HPA050775, HPA076030" Enhanced Approved Vesicles NA NA 2100000 Vesicles "HPA050775: AB_2681231, HPA076030: " "unprognostic (4.25e-1)" "unprognostic (3.11e-1)" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (2.83e-2)" "unprognostic (6.43e-2)" "unprognostic (1.25e-1)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (5.51e-2)" "unprognostic (1.93e-1)" "unprognostic (3.60e-1)" "unprognostic (2.70e-2)" "unprognostic (9.63e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.93e-2)" 14.1 25.8 15.7 6.4 17.5 13.4 11.3 11.3 20.5 10.9 11.7 24.7 8.5 15.1 12.0 8.5 4.8 14.4 9.7 15.8 15.6 19.8 23.0 67.3 9.3 7.3 26.1 15.0 10.6 12.7 15.0 12.7 14.1 21.7 18.1 12.2 7.3 7.4 16.7 23.9 10.7 15.3 10.8 62.1 5.1 12.4 65.1 17.5 8.5 18.2 7.3 4.8 25.0 13.2 1.4 2.3 95.3 3.2 4.2 3.0 2.1 13.1 12.8 9.4 5.6 11.3 14.2 0.1 10.3 14.4 17.4 14.6 7.8 37.0 7.0 13.5 11.8 9.7 4.3 7.9 3.0 17.9 9.7 2.9 11.8 11.7 15.6 10.6 22.9 10.2 9.5 1.4 11.8 1.2 16.5 18.6 14.7 14.7 0.0 17.3 3.1 23.8 29.1 14.1 7.1 10.2 20.1 12.1 0.0 53.5 30.9 10.7 12.0 13.9 0.6 9.1 5.2 10.4 23.9 12.1 8.1 7.2 19.6 26.5 34.7 11.9 4.1 13.8 31.3 10.6 95.3 3.2 5.5 2.5 2.8 3.0 1.4 0.7 2.1 1.3 1.1 1.0 3.0 0.8 4.2 1.8 2.3 0.5 2.1 15.7 17.5 11.3 20.5 15.6 19.8 26.1 15.0 21.7 17.5 6.0 11.5 8.0 36.7 26.8 29.6 33.1 50.9 52.2 17.0 144.8 17.7 28.0 26.6 57.2 1022.4 20.2 47.9 0.0 61.3 13.6 42.0 76.7 57.5 163.4 83.3 6.4 43.0 21.5 44.3 154.3 44.0 20.4 45.5 15.4 25.1 52.2 56.6 28.1 44.6 51.6 30.6 19.4 27.8 461.4 68.6 59.8 70.7 16.7 53.2 149.1 SCD "FADS5, SCDOS" ENSG00000099194 "Stearoyl-CoA desaturase" O00767 10 100347124-100364834 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 300.1;Hepatocytes: 153.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 204.0;CAPAN-2: 141.3" "Low region specificity" "Detected in all" "HPA012107, HPA063921" Approved Enhanced "Endoplasmic reticulum" No Yes "Endoplasmic reticulum" "HPA012107: AB_1856610, HPA063921: AB_2685154" "unprognostic (2.10e-1)" "unprognostic (2.62e-3)" "unprognostic (7.86e-2)" "unprognostic (5.19e-2)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (1.13e-1)" "unprognostic (3.88e-2)" "unprognostic (6.53e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (7.18e-2)" "unprognostic (3.27e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (7.79e-5)" 245.0 21.3 59.8 11.4 32.7 5.5 94.0 12.7 83.9 5.3 10.8 63.6 0.1 21.4 3.7 7.0 13.4 1.7 18.3 109.2 61.5 43.4 5.0 130.8 32.2 23.1 65.1 23.6 12.7 6.1 7.7 1.5 5.3 34.5 24.4 10.1 4.5 24.9 3.7 2.4 3.4 6.1 4.6 130.0 4.2 5.9 12.2 35.4 1.4 2.0 6.9 5.4 3.7 5.0 2.0 5.3 0.2 3.3 2.9 5.1 2.1 31.0 28.6 61.1 41.9 204.0 117.7 12.5 3.3 73.7 8.0 42.8 24.6 141.3 13.1 2.6 7.8 36.6 55.6 33.6 119.4 7.0 4.4 13.9 7.3 18.2 49.2 39.4 10.2 8.0 64.0 36.2 31.1 54.8 21.6 15.2 29.1 20.4 40.1 3.2 48.6 11.6 12.2 21.2 9.1 8.2 5.4 22.6 41.1 34.9 34.9 3.8 14.7 6.6 31.2 64.1 18.5 35.0 22.0 6.0 0.8 9.5 0.7 6.8 11.2 6.0 20.2 14.6 32.0 5.1 0.0 1.5 0.0 3.0 3.3 5.1 1.3 1.2 1.6 5.3 2.0 1.0 2.9 0.2 2.9 0.0 3.0 0.0 2.1 59.8 32.7 12.7 27.9 61.5 43.4 65.1 23.6 34.5 35.4 50.6 300.1 34.7 3.9 3.3 4.0 2.9 35.7 9.4 23.9 0.0 5.9 2.0 0.0 12.5 52.9 9.3 13.7 0.0 59.1 53.1 9.3 26.0 5.8 153.5 29.3 25.4 24.8 41.7 97.6 68.6 3.4 8.2 55.6 17.2 15.7 11.8 21.6 2.9 1.4 3.8 4.7 0.0 4.4 0.9 1.1 1.9 14.5 5.2 16.8 3.5 SCD5 "ACOD4, FADS4, FLJ21032, HSCD5, SCD4" ENSG00000145284 "Stearoyl-CoA desaturase 5" Q86SK9 4 82629539-82798857 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 69.1;brain: 137.3;epididymis: 44.5;ovary: 42.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 92.6;Horizontal cells: 95.3;Muller glia cells: 134.1" "Group enriched" "Detected in all" 6 "glioma: 152.4;thyroid cancer: 38.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 27.5;RPTEC TERT1: 36.3" "Low region specificity" "Detected in all" HPA042380 Uncertain NA NA "HPA042380: AB_10794797" "unprognostic (3.23e-2)" "unprognostic (3.84e-2)" "unprognostic (2.86e-1)" "unprognostic (6.98e-2)" "unprognostic (1.58e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (3.82e-2)" "unprognostic (6.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.04e-1)" "unprognostic (2.37e-2)" "prognostic favorable (2.32e-5)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.88e-3)" "unprognostic (2.92e-2)" 3.0 69.1 61.2 2.7 48.6 2.5 3.0 33.5 137.3 5.9 3.0 50.4 1.8 3.0 6.7 44.5 3.7 9.3 5.1 3.5 49.6 43.4 15.4 2.3 7.5 2.3 58.2 36.3 42.7 18.1 2.2 6.9 4.4 42.0 6.9 3.0 6.3 5.6 12.4 1.7 4.8 3.7 6.2 57.1 3.0 4.3 14.8 43.4 1.2 16.4 0.0 3.0 3.8 2.0 0.9 1.3 3.0 1.2 2.0 7.2 1.8 4.5 2.9 14.7 7.5 8.1 5.3 0.3 27.5 13.6 12.0 9.3 0.3 0.7 8.9 9.6 5.7 3.3 8.0 4.3 3.0 15.2 1.7 1.9 0.4 3.5 0.4 1.2 3.9 2.9 4.1 12.4 2.4 2.1 12.5 19.3 10.4 0.6 1.1 6.3 1.8 16.2 0.9 1.2 0.1 2.0 13.9 8.7 7.0 36.3 4.5 8.3 4.7 4.6 0.4 2.6 1.6 0.6 2.0 23.6 13.0 7.6 4.9 7.4 2.5 1.0 0.9 6.3 4.1 3.7 3.0 1.2 0.4 7.2 0.5 4.6 0.5 1.7 4.3 0.5 0.9 1.5 5.1 2.0 2.0 0.9 1.3 0.4 1.8 61.2 48.6 33.5 41.2 49.6 43.4 58.2 36.3 42.0 43.4 41.7 3.8 0.5 14.0 9.5 79.3 2.0 12.7 12.0 31.8 26.2 23.6 0.7 11.6 71.1 92.6 7.1 0.0 0.0 42.3 0.1 14.4 9.5 0.0 0.0 1.0 95.3 7.5 6.7 1.2 73.6 50.9 1.8 3.3 1.8 0.0 134.1 11.2 0.0 54.8 20.8 12.4 6.5 11.3 3.3 1.4 6.4 0.1 3.9 0.8 8.6 SCG2 "CHGC, SgII, SN" ENSG00000171951 "Secretogranin II" P13521 2 223596940-223602503 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 124.4;Intestinal endocrine cells: 272.8" "Group enriched" "Detected in many" 8 "glioma: 70.0;pancreatic cancer: 52.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 25.5;HSkMC: 21.8;hTERT-RPE1: 21.8;SCLC-21H: 22.2;SH-SY5Y: 9.7;WM-115: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011893, HPA075062" Enhanced Supported Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 54000 "Golgi apparatus" Vesicles "HPA011893: AB_1856656, HPA075062: AB_2732277" "unprognostic (2.93e-2)" "unprognostic (1.44e-2)" "unprognostic (1.23e-3)" "unprognostic (6.82e-4)" "unprognostic (2.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.77e-3)" "unprognostic (6.73e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "prognostic favorable (5.58e-4)" "unprognostic (1.34e-1)" "prognostic unfavorable (7.01e-10)" "unprognostic (2.47e-3)" "unprognostic (4.02e-1)" "unprognostic (1.57e-2)" "unprognostic (1.90e-3)" 3.5 133.0 13.3 11.0 94.1 0.9 0.9 5.6 55.9 1.4 5.4 5.8 0.0 17.3 2.1 0.9 1.0 0.8 2.2 1.4 10.5 79.4 1.0 0.8 1.9 0.9 21.7 11.0 1.3 10.7 1.1 76.5 1.1 57.7 2.1 5.5 1.5 0.9 1.3 0.8 1.0 8.0 5.2 10.3 0.8 8.0 0.9 5.0 0.0 3.1 0.0 0.8 1.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.8 4.0 1.1 25.5 0.1 0.2 0.9 1.8 4.7 0.2 0.4 0.0 0.4 0.3 2.9 0.1 0.1 0.0 2.4 0.0 0.2 0.0 0.2 0.0 0.3 0.3 2.1 21.8 0.1 2.7 0.9 21.8 0.0 0.0 0.1 0.2 2.3 0.1 0.0 0.1 3.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 22.2 9.7 0.0 0.2 1.1 0.8 0.0 0.0 0.0 2.5 1.0 0.1 1.6 0.0 0.0 0.1 0.7 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 13.3 94.1 5.6 23.0 10.5 79.4 21.7 11.0 57.7 5.0 6.0 0.0 0.0 0.2 0.0 124.4 0.2 0.0 1.4 2.3 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 2.9 0.0 0.0 0.1 7.9 272.8 1.3 0.8 0.0 0.6 0.0 1.7 0.0 0.7 11.9 24.2 2.9 0.4 0.0 12.7 0.0 0.5 0.1 0.2 0.1 0.1 0.0 0.3 0.6 SCIMP "C17orf87, DTFT5783, FLJ32580, MGC163426, MGC163428, UNQ5783" ENSG00000161929 "SLP adaptor and CSK interacting membrane protein" Q6UWF3 17 5208961-5234860 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 49.6;lymphoid tissue: 84.9" "Group enriched" "Detected in some" 5 "B-cells: 45.2;Hofbauer cells: 24.0;Kupffer cells: 93.1;Macrophages: 61.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "classical monocyte: 22.3;intermediate monocyte: 47.8;memory B-cell: 30.6;myeloid DC: 16.8;naive B-cell: 23.0;non-classical monocyte: 49.6" "Group enriched" "Detected in many" 8 "B-cells: 30.6;dendritic cells: 16.8;monocytes: 49.6" "Cell line enhanced" "Detected in many" "HeLa: 6.9;U-698: 14.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA006117 Enhanced NA NA "HPA006117: AB_1858633" "unprognostic (2.53e-2)" "unprognostic (7.88e-3)" "unprognostic (1.26e-2)" "unprognostic (5.79e-3)" "unprognostic (1.10e-1)" "unprognostic (3.87e-2)" "unprognostic (7.96e-2)" "unprognostic (1.73e-2)" "unprognostic (4.93e-2)" "unprognostic (2.99e-1)" "unprognostic (1.35e-1)" "unprognostic (8.05e-2)" "unprognostic (3.33e-2)" "unprognostic (2.07e-1)" "unprognostic (4.42e-2)" "unprognostic (1.77e-1)" "unprognostic (9.95e-2)" 6.1 2.8 1.3 19.5 1.5 1.7 1.7 0.9 1.1 1.5 2.3 3.2 0.2 2.0 1.4 2.2 3.8 2.0 3.1 2.5 1.3 1.5 3.2 10.0 10.8 55.1 2.1 0.2 2.4 1.6 0.0 1.5 2.2 3.6 1.9 1.8 2.2 4.5 0.2 1.4 1.1 9.9 2.3 3.9 84.9 1.8 1.0 1.0 3.0 1.5 0.7 31.9 3.6 1.3 30.6 16.8 4.0 49.6 1.1 0.4 11.1 1.2 2.0 3.2 4.7 0.1 0.0 3.4 1.4 0.0 0.0 0.0 0.9 2.7 6.4 1.3 0.0 2.4 1.5 0.0 0.0 0.0 0.9 2.8 2.5 6.9 0.8 0.0 0.4 1.0 0.0 0.3 0.0 0.3 1.8 0.0 5.6 0.1 1.7 0.0 2.1 3.0 1.0 1.5 0.4 2.0 2.7 0.7 0.7 0.0 0.8 2.5 1.1 2.4 0.8 1.7 1.2 3.4 3.1 0.4 0.5 1.7 1.9 0.8 1.0 0.5 14.2 1.9 0.7 0.9 2.5 22.3 0.5 0.3 47.8 0.3 30.6 0.2 0.2 16.8 23.0 0.4 0.3 4.0 1.1 49.6 0.7 0.2 11.1 1.3 1.5 0.9 1.1 1.3 1.5 2.1 0.2 3.6 1.0 0.0 4.1 45.2 0.3 0.3 2.5 0.4 0.0 2.7 1.2 0.0 11.8 0.2 0.0 0.6 0.9 0.6 0.0 0.0 0.7 0.2 0.8 0.4 1.1 1.0 24.0 1.6 0.0 1.8 93.1 0.6 0.3 61.4 0.0 1.0 0.0 0.8 0.4 0.0 0.4 0.7 4.1 0.0 0.4 0.2 0.6 0.4 0.1 0.0 0.0 0.3 SCN10A "hPN3, Nav1.8, PN3, SNS" ENSG00000185313 "Sodium voltage-gated channel alpha subunit 10" Q9Y5Y9 3 38696807-38816217 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "heart muscle: 1.5;testis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HUVEC TERT2: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.57e-2)" "unprognostic (7.85e-2)" "unprognostic (2.09e-4)" "unprognostic (1.42e-1)" "unprognostic (2.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SCN11A "NaN, Nav1.9, SCN12A, SNS-2" ENSG00000168356 "Sodium voltage-gated channel alpha subunit 11" Q9UI33 3 38845769-38950561 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.5;placenta: 5.2" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 4.0;Early spermatids: 5.4;Sertoli cells: 6.5;Spermatocytes: 3.9;Spermatogonia: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.8;HDLM-2: 5.0;SCLC-21H: 1.1;SuSa: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA036746, HPA036747" Uncertain NA NA "HPA036746: AB_10696785, HPA036747: AB_2675287" "unprognostic (6.11e-2)" "unprognostic (5.16e-1)" "unprognostic (1.66e-1)" "unprognostic (4.75e-2)" "unprognostic (4.21e-2)" "unprognostic (2.34e-2)" "unprognostic (2.79e-2)" "unprognostic (5.66e-2)" "unprognostic (4.44e-2)" "unprognostic (5.21e-2)" "unprognostic (2.30e-4)" "unprognostic (1.91e-2)" "unprognostic (5.43e-2)" "unprognostic (5.02e-2)" "unprognostic (2.95e-1)" "unprognostic (3.12e-2)" "unprognostic (8.30e-4)" 0.9 0.2 0.8 0.5 0.8 0.0 0.6 0.1 0.3 0.0 1.1 0.4 0.0 1.4 0.0 0.1 0.1 0.0 0.4 0.5 0.4 0.3 0.0 0.2 0.4 0.0 0.1 0.0 0.4 5.2 0.1 1.3 0.0 0.0 0.1 0.8 1.0 0.5 0.6 7.5 0.0 2.6 0.1 0.1 3.4 0.1 0.2 0.4 0.9 0.1 0.1 0.2 0.0 0.0 0.0 1.8 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.1 0.1 5.0 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.5 1.1 0.6 0.0 0.0 0.0 1.3 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.9 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.8 0.0 4.0 1.2 0.0 0.0 0.2 0.0 0.0 5.4 0.6 0.0 0.0 0.2 0.0 0.6 0.3 0.0 0.2 0.3 0.0 0.0 2.5 0.0 1.0 0.0 0.0 1.7 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.4 6.5 0.9 3.9 6.0 0.6 0.2 0.0 0.0 0.9 SCN1A "FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI" ENSG00000144285 "Sodium voltage-gated channel alpha subunit 1" P35498 2 165984641-166149214 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 33.9" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 26.9;Bipolar cells: 33.9" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC TERT1: 11.6;Hep G2: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078664 Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA078664: AB_2686888" "unprognostic (9.25e-2)" "unprognostic (3.97e-2)" "unprognostic (6.88e-2)" "unprognostic (7.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "unprognostic (4.70e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-1)" "unprognostic (9.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.03e-9)" "unprognostic (6.92e-2)" "unprognostic (3.69e-2)" "unprognostic (5.06e-3)" "unprognostic (6.93e-1)" 1.1 1.3 5.2 1.1 13.6 1.0 1.1 10.3 26.6 1.1 1.1 2.3 0.0 1.0 1.1 1.1 1.0 6.8 1.0 1.1 6.9 8.3 1.1 1.1 5.6 1.0 5.7 9.7 1.0 1.0 1.1 2.9 1.2 33.9 1.1 1.1 0.3 1.0 1.0 1.2 1.1 1.1 1.1 3.6 1.1 1.1 1.4 4.2 0.0 1.1 0.0 1.0 1.1 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 11.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.2 13.6 10.3 26.6 6.9 8.3 5.7 9.7 33.9 4.2 6.0 26.9 0.0 0.0 0.0 33.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SCN1B ENSG00000105711 "Sodium voltage-gated channel beta subunit 1" Q07699 19 35030466-35040449 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 78.5;skeletal muscle: 161.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 35.4;Hofbauer cells: 24.6;Ito cells: 19.0;Kupffer cells: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 13.6;EFO-21: 10.1;TIME: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (8.18e-2)" "unprognostic (1.30e-1)" "unprognostic (1.30e-2)" "unprognostic (6.40e-2)" "unprognostic (1.17e-2)" "unprognostic (2.69e-2)" "unprognostic (4.40e-2)" "unprognostic (1.20e-1)" "unprognostic (3.34e-2)" "unprognostic (4.72e-3)" "prognostic favorable (1.38e-4)" "unprognostic (2.25e-1)" "unprognostic (2.05e-2)" "unprognostic (9.68e-3)" "unprognostic (5.81e-2)" "unprognostic (4.12e-2)" "unprognostic (4.78e-2)" 5.0 5.4 9.3 2.6 16.4 2.1 2.9 45.8 78.5 5.2 2.8 4.5 0.3 2.0 2.7 3.5 5.0 4.3 3.3 24.9 12.7 7.3 2.2 3.3 2.7 2.4 14.3 7.4 2.6 2.4 10.5 2.6 3.5 33.6 2.7 2.4 3.5 2.5 2.9 161.9 2.1 2.5 3.2 7.0 6.7 2.7 2.0 3.0 0.0 2.4 16.1 1.6 3.9 1.5 1.3 1.5 7.0 0.8 1.7 1.7 1.8 0.3 13.6 0.1 0.8 4.2 6.5 0.2 5.5 4.9 2.7 0.7 0.5 0.1 0.2 10.1 5.6 2.5 0.2 0.8 0.6 1.3 0.1 0.7 0.2 1.9 3.4 5.6 0.1 0.1 2.1 0.1 0.3 0.2 5.4 9.1 0.2 0.3 0.1 1.7 1.3 0.2 0.1 0.7 1.2 4.0 0.7 1.4 0.1 0.4 0.1 6.5 3.5 0.7 0.1 1.0 0.5 1.3 0.4 20.4 5.4 5.4 0.2 3.5 0.3 0.4 0.8 3.1 0.6 3.8 7.0 0.8 0.9 1.1 0.4 1.7 0.6 0.6 0.4 1.5 1.3 0.5 0.7 3.1 1.7 0.4 1.1 0.7 1.8 9.3 16.4 45.8 78.5 12.7 7.3 14.3 7.4 33.6 3.0 0.0 3.5 0.0 0.8 1.5 35.4 15.5 0.0 1.4 0.0 0.0 2.0 0.3 8.3 0.3 0.3 5.7 0.0 0.0 2.3 0.6 4.1 1.0 2.3 1.0 24.6 7.9 0.0 19.0 17.1 0.0 6.9 2.9 3.3 4.6 1.1 12.6 1.0 0.0 2.1 1.1 15.5 0.0 2.3 0.3 0.4 1.0 0.8 0.0 0.9 0.1 SCN2A "HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2" ENSG00000136531 "Sodium voltage-gated channel alpha subunit 2" Q99250 2 165194993-165392310 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 68.0" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 48.0;Cone photoreceptor cells: 45.2;Horizontal cells: 14.3" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HSkMC: 3.4;SH-SY5Y: 3.1;U-138 MG: 5.8;U-266/84: 12.0;U-87 MG: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022567 Enhanced NA NA "CAB022567: " "unprognostic (1.16e-1)" "unprognostic (3.56e-4)" "unprognostic (5.28e-2)" "unprognostic (6.12e-3)" "unprognostic (2.97e-1)" "unprognostic (8.62e-3)" "unprognostic (1.18e-1)" "unprognostic (7.25e-3)" "unprognostic (1.40e-1)" "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (5.21e-2)" "unprognostic (3.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.05e-1)" "unprognostic (4.88e-2)" "unprognostic (2.14e-1)" 1.3 3.0 19.1 1.3 36.4 1.1 2.2 68.0 50.3 1.5 1.3 1.1 0.0 1.5 1.9 2.6 1.2 1.3 2.3 1.3 30.3 8.2 4.0 1.4 1.5 1.2 3.8 23.5 1.5 1.3 1.1 8.2 1.3 9.9 1.3 1.3 0.0 1.5 1.8 1.1 1.2 1.5 2.0 3.7 1.3 1.5 1.5 4.1 0.0 1.1 0.0 1.2 1.3 0.5 1.4 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.8 0.0 0.0 2.8 0.0 2.7 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.5 0.1 1.0 0.7 0.0 0.4 0.0 0.4 0.0 0.2 3.4 0.1 0.3 0.0 2.4 0.0 0.0 0.0 0.3 1.5 0.0 0.2 0.0 2.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 2.9 3.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 5.8 0.4 0.3 0.0 0.5 12.0 0.0 3.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 19.1 36.4 68.0 43.7 30.3 8.2 3.8 23.5 9.9 4.1 0.0 1.7 0.0 0.1 0.2 48.0 0.6 0.0 0.0 0.0 10.4 45.2 0.1 5.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 1.3 1.1 0.0 0.0 0.0 0.0 3.7 0.5 0.0 5.6 0.0 3.4 0.0 0.4 0.0 0.6 0.1 0.0 0.0 0.0 0.0 SCN2B ENSG00000149575 "Sodium voltage-gated channel beta subunit 2" O60939 11 118161951-118176673 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 37.0;heart muscle: 17.5;skeletal muscle: 9.7" "Group enriched" "Detected in some" 5 "Bipolar cells: 7.9;Cardiomyocytes: 14.0;Horizontal cells: 12.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.1" "Group enriched" "Detected in some" 5 "HBEC3-KT: 1.5;U-2 OS: 2.6;U-2197: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.01e-2)" "unprognostic (3.50e-2)" "unprognostic (7.58e-2)" "unprognostic (2.12e-2)" "unprognostic (1.41e-2)" "unprognostic (4.02e-1)" "unprognostic (2.71e-4)" "unprognostic (5.17e-2)" "unprognostic (8.59e-2)" "unprognostic (2.77e-1)" "unprognostic (7.89e-2)" "unprognostic (1.61e-2)" "unprognostic (3.51e-2)" "unprognostic (1.27e-2)" "unprognostic (4.35e-2)" "unprognostic (4.55e-1)" "unprognostic (2.88e-3)" 1.8 3.0 14.7 1.4 31.5 1.0 1.9 31.1 37.0 2.9 2.0 3.1 0.0 1.7 3.2 2.9 3.6 2.9 2.7 17.5 22.5 11.6 1.6 1.0 2.5 1.0 8.7 30.6 2.8 1.1 1.0 0.8 1.0 12.8 2.4 1.9 0.4 1.8 2.7 9.7 1.4 2.5 3.5 13.9 1.1 1.3 1.3 6.9 0.0 1.9 0.7 1.0 1.5 0.6 0.3 0.2 2.1 0.3 0.2 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.7 0.1 0.0 0.0 0.1 2.6 6.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 2.1 0.3 0.9 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.2 0.2 1.3 0.2 0.0 0.2 0.1 0.0 14.7 31.5 31.1 37.0 22.5 11.6 8.7 30.6 12.8 6.9 0.0 0.0 0.0 0.5 0.3 7.9 14.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.1 0.0 1.4 0.0 1.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 SCN3A Nav1.3 ENSG00000153253 "Sodium voltage-gated channel alpha subunit 3" Q9NY46 2 165087522-165204067 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 13.6;brain: 28.5;pituitary gland: 13.7" "Cell type enriched" "Detected in some" 4 "Early spermatids: 55.3" "Cancer enriched" "Detected in some" 6 "glioma: 3.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "memory B-cell: 8.4;naive B-cell: 13.6" "Lineage enriched" "Detected in single" 38 "B-cells: 13.6" "Cell line enhanced" "Detected in some" "JURKAT: 4.9;Karpas-707: 8.7;MOLT-4: 24.4;RPTEC TERT1: 12.3;SH-SY5Y: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035396 Approved NA NA "HPA035396: AB_2674607" "unprognostic (1.80e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (1.50e-2)" "unprognostic (6.69e-2)" "unprognostic (1.10e-2)" "unprognostic (4.96e-4)" "unprognostic (2.46e-1)" "unprognostic (1.48e-1)" "unprognostic (1.90e-1)" "unprognostic (1.21e-4)" "unprognostic (4.55e-2)" "unprognostic (5.87e-3)" "unprognostic (2.88e-2)" "unprognostic (6.85e-2)" "unprognostic (2.66e-1)" "unprognostic (4.93e-2)" 2.6 4.0 16.7 1.9 28.5 1.0 2.5 19.6 19.7 2.1 2.1 0.8 0.0 1.2 1.4 0.7 1.5 1.4 1.8 2.1 9.8 11.3 1.8 1.0 1.0 2.7 4.8 9.8 1.8 1.7 2.3 13.7 0.8 9.1 0.9 2.1 0.0 0.7 1.4 0.9 0.5 1.9 1.7 4.0 1.8 2.7 1.8 4.9 2.0 1.3 0.0 3.5 1.7 0.5 13.6 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.2 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.3 0.0 4.9 0.0 8.7 0.1 0.0 24.4 0.0 0.0 0.1 2.0 0.1 1.1 0.0 12.3 0.0 3.1 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.7 0.0 1.3 0.4 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 13.6 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.1 16.7 28.5 19.6 17.2 9.8 11.3 4.8 9.8 9.1 4.9 0.0 0.3 1.9 0.1 0.0 0.8 3.2 0.0 0.0 0.0 1.8 11.8 0.0 0.0 0.1 55.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 8.5 0.0 0.0 5.4 0.3 0.0 1.7 0.0 0.0 0.6 0.2 0.0 0.7 0.0 0.7 12.9 5.2 0.2 0.4 0.1 0.0 0.0 0.0 0.0 SCN3B HSA243396 ENSG00000166257 "Sodium voltage-gated channel beta subunit 3" Q9NY72 11 123629187-123655244 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 70.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 15.3;Early spermatids: 12.8;Horizontal cells: 19.1;Late spermatids: 24.3" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTCEpi: 9.6;RH-30: 4.3;SCLC-21H: 9.5;SH-SY5Y: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041707 Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "HPA041707: AB_2732493" "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (8.13e-4)" "unprognostic (3.93e-3)" "unprognostic (7.05e-2)" "unprognostic (3.29e-3)" "unprognostic (5.64e-2)" "unprognostic (3.34e-4)" "unprognostic (1.72e-1)" "unprognostic (1.13e-2)" "unprognostic (9.16e-4)" "unprognostic (4.01e-1)" "unprognostic (1.89e-4)" "unprognostic (2.01e-2)" "unprognostic (9.01e-2)" "unprognostic (8.23e-2)" "unprognostic (1.43e-2)" 2.2 8.5 17.7 1.5 23.5 1.3 2.0 2.8 70.3 1.6 1.5 1.2 0.0 1.6 1.5 1.5 1.5 1.8 1.4 1.9 26.2 13.2 1.6 1.0 1.4 1.2 5.2 18.8 1.7 1.9 3.9 12.6 1.1 3.8 1.8 1.6 3.7 1.2 1.4 5.8 1.7 1.5 2.1 1.5 1.3 1.4 2.2 1.2 0.0 3.7 0.0 1.2 1.1 0.4 1.2 1.3 2.7 0.6 1.1 0.8 0.1 0.0 0.2 0.3 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.0 3.0 0.1 0.3 1.5 0.4 3.1 0.2 1.0 0.1 0.2 0.1 0.6 0.0 0.5 0.3 0.1 0.0 0.6 0.4 9.6 0.1 0.1 0.0 0.3 0.3 0.4 0.5 0.0 0.1 0.1 0.2 0.8 0.3 0.1 0.2 4.3 0.0 0.0 0.2 9.5 7.2 0.6 0.1 0.0 1.0 0.1 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.6 0.6 0.5 0.6 0.4 0.4 0.7 0.7 0.7 0.3 1.2 0.5 0.8 2.7 1.1 0.5 1.3 0.4 0.1 17.7 23.5 2.8 39.5 26.2 13.2 5.2 18.8 3.8 1.2 0.0 0.3 0.0 0.8 5.0 15.3 1.4 0.0 0.0 0.0 1.8 5.9 0.1 0.0 0.3 12.8 8.7 0.0 0.0 0.9 0.1 1.1 1.0 0.0 0.0 0.2 19.1 4.1 0.6 0.0 24.3 0.0 0.5 0.0 0.0 0.0 8.3 0.4 0.0 0.4 0.1 5.9 6.5 0.7 0.3 1.5 4.8 0.0 0.0 0.0 0.4 SCN4A "HYKPP, HYPP, Nav1.4, SkM1" ENSG00000007314 "Sodium voltage-gated channel alpha subunit 4" P35499 17 63938554-63972918 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 53.7" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 3.4;Ito cells: 3.1;Late spermatids: 2.9" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.2" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Lineage enhanced" "Detected in single" "B-cells: 1.9" "Group enriched" "Detected in some" 11 "REH: 10.1;RH-30: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA053992 Approved "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA053992: AB_2797249" "unprognostic (2.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.57e-2)" "unprognostic (1.78e-3)" "unprognostic (2.80e-2)" "unprognostic (1.63e-2)" "unprognostic (3.87e-4)" "unprognostic (3.84e-3)" "unprognostic (1.61e-1)" "unprognostic (1.36e-1)" "unprognostic (1.59e-3)" "unprognostic (3.15e-2)" "unprognostic (2.70e-2)" "unprognostic (4.38e-3)" "unprognostic (3.46e-1)" "unprognostic (4.15e-1)" "unprognostic (6.45e-2)" 5.9 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.5 0.0 53.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 10.1 31.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.1 0.0 0.0 0.0 0.0 SCN4B LQT10 ENSG00000177098 "Sodium voltage-gated channel beta subunit 4" Q8IWT1 11 118133377-118152888 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;skeletal muscle: 25.6" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 45.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.9;HBEC3-KT: 3.0;NTERA-2: 4.4;SH-SY5Y: 1.7;U-2 OS: 4.0" "Region enriched" "Detected in many" 11 "basal ganglia: 731.2" "Region enhanced" "Detected in many" "basal ganglia: 122.8" HPA017293 Approved NA NA "HPA017293: AB_2184174" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.07e-1)" "unprognostic (9.82e-3)" "unprognostic (9.17e-3)" "unprognostic (1.20e-2)" "unprognostic (1.23e-2)" "unprognostic (1.03e-2)" "unprognostic (3.27e-2)" "unprognostic (1.07e-1)" "unprognostic (2.07e-2)" "unprognostic (2.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.31e-4)" 20.5 5.4 1.9 1.2 36.4 0.1 6.1 11.7 21.7 2.4 2.6 2.0 0.5 2.4 3.7 1.8 5.4 5.5 3.2 11.0 3.1 2.9 1.4 0.6 8.7 2.0 5.3 2.1 0.7 5.0 6.4 2.4 1.9 28.7 2.1 2.2 4.3 2.8 2.6 25.6 3.8 4.6 7.0 5.5 0.5 3.0 0.8 8.7 1.5 10.4 9.5 1.1 3.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.9 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.6 0.3 3.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.7 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 36.4 11.7 21.7 3.1 2.9 5.3 2.1 28.7 8.7 0.0 0.0 0.0 0.3 1.1 1.1 2.8 0.0 6.7 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 3.3 2.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.3 45.3 10.8 0.0 0.6 1.0 0.0 0.0 0.0 0.1 SCN5A "CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1" ENSG00000183873 "Sodium voltage-gated channel alpha subunit 5" Q14524 3 38548057-38649673 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 67.3" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 66.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "LHCN-M2: 22.0;RH-30: 18.3" "Group enriched" "Detected in some" 5 "amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0" "Low region specificity" "Detected in many" HPA063346 Supported "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA063346: " "unprognostic (9.29e-4)" "unprognostic (4.05e-2)" "unprognostic (9.95e-2)" "unprognostic (1.74e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (8.48e-2)" "unprognostic (7.12e-3)" "unprognostic (5.28e-2)" "unprognostic (1.16e-4)" "unprognostic (4.85e-3)" "unprognostic (1.09e-1)" "unprognostic (5.35e-2)" "unprognostic (4.95e-3)" 0.3 0.2 1.3 0.2 0.3 0.4 0.6 0.1 2.3 2.0 0.4 0.0 0.4 0.3 0.9 0.8 0.2 0.4 0.3 67.3 0.5 0.7 0.1 0.1 0.2 0.1 0.1 0.3 0.6 0.2 0.1 0.8 0.3 0.0 1.3 0.2 1.2 0.3 1.6 5.5 0.2 0.3 0.4 0.1 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.1 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.8 0.4 0.0 0.1 0.3 2.7 0.0 0.0 0.0 0.9 0.9 2.7 0.0 0.4 0.0 1.2 0.7 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.5 0.0 1.7 3.6 0.4 0.0 0.0 22.0 1.1 0.0 0.0 2.0 0.0 0.0 0.0 18.3 0.0 0.0 2.4 0.3 2.4 0.0 0.0 0.0 0.7 0.0 0.0 4.4 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.1 2.3 0.5 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 3.1 66.1 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.3 0.9 0.0 0.0 0.0 0.0 1.0 SCN7A "NaG, Nav2.1, Nav2.2, SCN6A" ENSG00000136546 "Sodium voltage-gated channel alpha subunit 7" Q01118 2 166403573-166494326 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 51.9" "Group enriched" "Detected in many" 8 "Leydig cells: 93.5;Peritubular cells: 150.3;Sertoli cells: 148.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 2.1" "Lineage enhanced" "Detected in single" "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "MOLT-4: 2.9;SH-SY5Y: 1.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA072715 Approved NA NA "HPA072715: " "unprognostic (1.22e-1)" "unprognostic (6.42e-3)" "unprognostic (9.72e-2)" "unprognostic (7.43e-2)" "unprognostic (2.18e-1)" "unprognostic (1.78e-1)" "unprognostic (1.86e-1)" "unprognostic (4.00e-3)" "unprognostic (5.21e-2)" "unprognostic (6.84e-3)" "unprognostic (6.88e-2)" "unprognostic (1.27e-1)" "unprognostic (5.80e-2)" "unprognostic (3.71e-2)" "unprognostic (1.47e-2)" "unprognostic (1.35e-1)" "unprognostic (1.22e-4)" 4.9 6.0 1.0 10.4 0.7 0.0 2.9 0.3 0.7 16.2 23.3 0.0 13.0 2.0 24.6 8.1 28.1 7.8 6.8 16.0 0.7 3.6 1.8 1.3 51.9 1.6 3.6 0.5 33.3 3.1 0.3 1.1 8.1 2.6 18.4 6.1 14.0 4.9 11.3 3.7 1.5 6.2 10.5 4.3 5.5 6.4 6.9 0.1 0.5 1.3 4.9 0.2 9.7 7.6 0.0 0.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.5 0.0 0.1 0.1 0.9 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.0 0.7 0.3 0.7 0.7 3.6 3.6 0.5 2.6 0.1 0.0 1.4 0.0 0.1 0.2 11.4 15.4 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 2.0 0.7 0.0 0.0 0.0 0.0 11.0 0.1 16.1 0.0 0.2 0.0 0.0 16.0 0.0 1.6 93.5 0.0 5.0 0.0 0.0 5.2 0.2 0.0 150.3 0.3 1.6 148.8 0.9 0.5 0.1 1.0 0.0 0.0 0.0 0.3 SCN8A "CerIII, CIAT, MED, NaCh6, Nav1.6, PN4" ENSG00000196876 "Sodium voltage-gated channel alpha subunit 8" Q9UQD0 12 51590266-51812864 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 27.6;pituitary gland: 9.7" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 13.7;Cone photoreceptor cells: 9.8;Intestinal endocrine cells: 10.9;Rod photoreceptor cells: 10.5;Spermatogonia: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 12.0;ASC TERT1: 12.7;BJ hTERT+: 11.2;WM-115: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022169, HPA043937, HPA073590" Approved "Vesicles,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Vesicles, Cell Junctions" "CAB022169: , HPA043937: , HPA073590: " "unprognostic (2.96e-2)" "unprognostic (8.49e-2)" "unprognostic (6.93e-2)" "unprognostic (3.52e-6)" "unprognostic (8.13e-2)" "unprognostic (1.51e-2)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.16e-1)" "unprognostic (4.73e-4)" "unprognostic (1.69e-2)" "unprognostic (1.29e-5)" "unprognostic (4.38e-1)" "unprognostic (1.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.75e-2)" 1.1 3.0 9.1 1.5 18.1 1.9 1.9 16.7 27.6 1.0 2.0 1.6 0.0 1.1 1.5 2.0 0.9 1.1 2.5 0.9 12.6 4.5 1.9 4.3 1.0 1.3 3.2 13.7 1.8 3.2 1.5 9.7 0.9 14.8 1.8 2.5 0.9 1.7 1.2 1.0 1.1 1.2 1.0 2.2 1.7 2.7 3.8 1.6 0.0 1.7 0.0 1.2 1.0 0.6 0.4 0.2 0.0 0.0 0.0 1.0 0.0 1.4 1.0 12.0 0.1 1.6 12.7 0.2 6.8 11.2 7.9 7.3 2.0 1.4 0.3 1.6 8.9 3.5 0.0 1.9 0.0 9.3 1.2 0.6 0.1 0.1 0.2 0.1 0.2 0.9 1.7 0.0 5.2 1.1 3.1 8.4 2.8 0.1 0.1 4.9 0.8 2.0 0.1 4.1 0.7 3.8 0.0 0.6 0.0 0.0 0.4 4.8 2.0 3.5 1.8 0.2 1.8 0.3 0.1 2.2 7.7 5.1 2.8 4.3 0.1 0.1 0.0 1.5 1.6 11.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 1.0 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 9.1 18.1 16.7 25.0 12.6 4.5 3.2 13.7 14.8 1.6 0.0 0.0 0.0 0.4 0.0 13.7 1.2 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.2 0.4 0.4 0.0 0.0 0.5 0.0 0.0 0.2 0.0 3.4 0.0 4.8 10.9 1.3 0.0 0.2 0.0 0.0 0.0 0.0 1.3 5.3 0.5 0.0 0.7 0.5 10.5 0.0 0.3 1.9 10.0 0.0 0.0 0.0 0.6 0.1 SCN9A "ETHA, Nav1.7, NE-NA, NENA, PN1" ENSG00000169432 "Sodium voltage-gated channel alpha subunit 9" Q15858 2 166195185-166376001 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Exocrine glandular cells: 27.7;Hofbauer cells: 50.6;Intestinal endocrine cells: 31.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 17 "plasmacytoid DC: 18.6" "Lineage enriched" "Detected in single" 24 "dendritic cells: 18.6" "Cell line enhanced" "Detected in many" "BJ: 17.2;BJ hTERT+: 12.8;HHSteC: 14.8;hTERT-RPE1: 12.0" "Region enriched" "Detected in some" 5 "hypothalamus: 10.9" "Low region specificity" "Detected in all" "CAB013679, HPA061843" Uncertain Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Plasma membrane, Actin filaments, Focal adhesion sites" "CAB013679: , HPA061843: AB_2684625" "unprognostic (2.10e-1)" "unprognostic (2.83e-1)" "unprognostic (1.13e-1)" "unprognostic (8.98e-5)" "unprognostic (1.47e-3)" "unprognostic (9.43e-3)" "unprognostic (2.28e-2)" "unprognostic (2.24e-1)" "unprognostic (2.23e-1)" "unprognostic (3.64e-1)" "unprognostic (1.45e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.69e-3)" "unprognostic (6.74e-2)" "unprognostic (2.46e-2)" "unprognostic (2.46e-1)" 6.6 4.2 3.8 2.8 9.1 4.2 2.7 0.9 4.4 1.8 10.2 0.5 0.1 1.4 0.9 3.8 2.6 1.2 5.8 2.9 2.8 15.9 4.8 8.3 4.5 3.5 4.1 2.3 2.1 4.8 0.6 11.3 9.2 7.3 2.0 7.0 1.7 1.8 1.9 0.9 1.8 4.2 5.2 2.5 12.4 1.7 16.2 0.4 10.3 1.4 1.9 1.2 3.6 1.8 0.0 18.6 0.7 0.1 0.4 0.0 0.0 0.0 1.9 0.1 0.0 7.4 6.5 0.0 17.2 12.8 4.0 1.3 0.5 0.0 0.0 0.0 2.1 0.2 0.0 4.9 0.6 6.6 0.0 1.6 1.3 1.5 1.4 14.8 0.0 0.0 0.4 0.2 6.8 1.3 12.0 0.8 0.9 4.3 5.0 0.6 0.0 2.6 0.0 1.5 0.0 0.5 0.7 2.5 6.5 1.8 7.2 0.8 7.2 0.0 0.0 0.3 3.8 0.2 0.0 0.0 0.0 1.1 0.1 0.3 0.1 0.0 0.0 2.5 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.4 0.1 18.6 0.0 0.0 3.8 9.1 0.9 4.4 2.8 15.9 4.1 2.3 7.3 0.4 11.9 18.4 0.9 0.2 0.9 0.2 1.6 5.1 4.0 7.9 5.2 0.0 0.2 3.3 14.9 1.7 2.2 11.3 0.0 27.7 0.4 1.2 0.2 3.5 6.0 50.6 0.0 31.7 20.3 1.5 1.9 1.1 4.3 3.3 0.0 14.6 1.3 18.8 8.6 0.0 12.2 0.0 0.0 1.0 0.0 0.4 0.4 0.9 0.0 10.7 0.1 SCNN1A "ENaCalpha, SCNN1" ENSG00000111319 "Sodium channel epithelial 1 alpha subunit" P37088 12 6346843-6377730 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 100.4" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 108.2;Mucus-secreting cells: 167.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 8 "pons and medulla: 9.4" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 1.7;neutrophil: 4.4;plasmacytoid DC: 3.0;T-reg: 1.3" "Group enriched" "Detected in many" 5 "dendritic cells: 3.0;granulocytes: 4.4;T-cells: 1.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 71.8;HBEC3-KT: 48.2;hTCEpi: 20.7;RPTEC TERT1: 25.2;RT4: 27.0;SK-BR-3: 23.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA012743 Enhanced NA NA "HPA012743: AB_1856627" "unprognostic (1.68e-1)" "unprognostic (4.16e-2)" "unprognostic (1.62e-1)" "unprognostic (2.19e-1)" "unprognostic (5.16e-2)" "unprognostic (6.77e-3)" "unprognostic (3.09e-2)" "unprognostic (2.62e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (8.86e-4)" "prognostic unfavorable (2.30e-4)" "unprognostic (5.56e-2)" "prognostic favorable (9.21e-8)" "unprognostic (2.38e-1)" "unprognostic (3.93e-2)" "unprognostic (1.16e-1)" "unprognostic (1.01e-2)" 0.9 3.7 0.4 7.5 0.4 0.0 10.1 0.4 0.9 22.0 20.6 2.2 60.9 5.6 8.1 15.7 47.3 19.3 7.0 0.4 1.1 0.1 100.4 2.2 53.6 0.4 0.5 0.4 5.9 14.2 0.0 10.2 1.6 9.4 15.0 21.5 6.2 53.1 55.5 0.6 14.4 11.8 1.0 0.4 0.4 20.3 2.8 0.4 0.9 74.7 21.1 41.3 10.3 13.8 0.0 3.0 4.4 0.5 0.0 1.7 0.3 5.0 0.9 0.0 0.4 0.0 0.1 4.3 0.0 0.0 0.0 0.0 1.4 71.8 0.0 0.1 0.0 0.0 3.3 0.0 48.2 0.0 0.0 0.0 0.0 4.0 0.7 5.2 0.0 0.0 1.2 20.7 0.0 15.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 4.2 9.1 0.1 0.0 0.0 0.1 25.2 27.0 0.3 0.0 0.5 23.3 0.0 4.3 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.0 0.0 0.2 0.6 0.5 0.0 1.7 0.3 4.4 0.0 0.1 3.0 1.3 0.3 0.4 0.4 0.4 0.9 1.1 0.1 0.5 0.4 9.4 0.4 68.5 63.0 0.0 21.9 1.6 0.8 0.8 68.8 26.8 47.8 108.2 3.9 1.2 5.0 41.1 0.4 1.4 57.4 0.0 30.8 0.2 2.4 31.3 2.3 2.4 0.3 1.6 26.0 0.6 1.9 0.2 1.7 2.1 0.0 1.8 167.5 0.3 24.0 47.5 1.4 4.2 1.6 0.0 1.0 1.4 2.1 7.8 1.4 1.9 31.6 33.3 SCNN1B ENaCbeta ENSG00000168447 "Sodium channel epithelial 1 beta subunit" P51168 16 23278231-23381299 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.4" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 92.3;Club cells: 66.0;Collecting duct cells: 54.1;Enterocytes: 54.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 26.4" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 19.4;RT4: 10.4;U-266/70: 32.0;U-266/84: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015612 Uncertain NA NA "HPA015612: AB_1856629" "unprognostic (7.45e-2)" "unprognostic (1.76e-3)" "unprognostic (1.39e-1)" "unprognostic (6.74e-3)" "unprognostic (1.74e-2)" "unprognostic (5.11e-3)" "unprognostic (7.74e-2)" "unprognostic (5.49e-3)" "unprognostic (2.60e-1)" "unprognostic (2.40e-1)" "unprognostic (3.68e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.32e-1)" "unprognostic (4.66e-2)" "unprognostic (3.93e-3)" "unprognostic (1.25e-2)" 35.1 0.2 0.1 4.0 0.2 0.0 21.2 1.1 0.1 28.3 27.2 0.0 1.3 1.3 2.9 2.5 42.4 1.3 3.3 0.6 0.0 0.0 13.0 0.0 31.1 1.3 0.0 0.0 2.0 0.8 0.3 1.6 25.2 0.3 5.7 19.7 0.5 29.7 2.4 3.9 13.2 1.7 4.2 0.1 1.9 8.9 1.6 0.0 0.6 16.2 17.8 15.5 5.6 19.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 4.9 0.0 10.4 0.1 0.0 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 32.0 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.2 1.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 92.3 27.0 2.2 14.0 2.7 0.0 0.8 0.0 10.7 66.0 54.1 0.0 0.7 0.0 0.0 0.0 0.7 54.8 0.0 0.4 0.2 0.2 4.3 8.1 0.0 0.1 0.0 7.5 0.0 0.0 0.0 0.0 0.0 10.1 0.0 7.9 0.0 0.2 9.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 4.6 1.8 0.0 7.6 17.0 SCNN1D "dNaCh, ENaCdelta" ENSG00000162572 "Sodium channel epithelial 1 delta subunit" P51172 1 1280436-1292029 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 9.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/70: 11.4" HPA026884 Enhanced Supported "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA026884: AB_10601501" "unprognostic (2.08e-2)" "unprognostic (2.08e-1)" "unprognostic (7.39e-4)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic favorable (1.60e-4)" "unprognostic (1.44e-2)" "unprognostic (1.81e-1)" "unprognostic (2.08e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.32e-4)" "unprognostic (5.27e-2)" "prognostic unfavorable (6.67e-5)" "unprognostic (3.13e-1)" "unprognostic (4.18e-2)" "unprognostic (2.13e-1)" "unprognostic (7.06e-2)" 3.2 3.8 4.0 1.9 5.1 3.6 1.2 12.8 6.3 1.7 2.0 7.0 3.2 1.1 1.1 3.9 1.5 1.5 4.1 3.3 1.4 3.2 1.5 2.5 3.1 4.6 3.0 0.8 5.9 1.3 2.3 0.2 8.6 2.4 3.9 4.6 5.1 1.0 3.2 3.8 2.4 10.2 1.3 0.7 0.7 1.8 0.5 0.9 0.0 0.2 0.0 0.8 0.2 0.6 5.0 2.0 5.2 1.4 0.8 0.9 3.3 1.0 1.7 1.9 0.9 2.8 3.6 1.8 1.5 2.5 0.8 0.9 0.8 0.3 6.7 3.1 0.4 6.0 1.3 1.4 0.1 3.6 2.3 1.1 2.6 0.0 2.2 0.5 6.5 2.4 8.5 0.4 1.8 1.4 2.4 1.0 0.6 3.7 9.3 0.4 0.8 0.8 0.2 2.7 3.8 1.4 1.5 2.2 0.8 6.6 1.8 1.4 3.2 2.7 5.0 1.1 11.4 0.7 2.9 2.9 6.1 3.6 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.2 3.0 2.9 0.0 0.2 0.7 3.2 4.0 0.0 2.7 2.3 0.0 3.9 0.1 0.0 0.4 9.6 0.0 1.7 0.0 0.4 0.2 1.0 0.1 2.3 2.1 0.3 4.8 1.2 0.6 0.6 3.2 0.9 0.9 0.0 0.0 0.2 2.0 1.2 3.5 1.8 0.6 2.5 0.0 0.9 1.8 2.1 1.4 0.0 0.0 0.6 0.3 SCNN1G "ENaCgamma, SCNEG" ENSG00000166828 "Sodium channel epithelial 1 gamma subunit" P51170 16 23182715-23216883 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.9;salivary gland: 26.8" "Cell type enhanced" "Detected in some" 29 "Alveolar cells type 1: 17.9;Club cells: 21.6;Collecting duct cells: 85.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 15.6" "Region enriched" "Detected in some" 6 "cerebellum: 9.7" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Group enriched" "Detected in some" 7 "hTCEpi: 31.4;RT4: 14.2" "Region enriched" "Detected in single" 13 "cerebellum: 2.8" "Low region specificity" "Detected in all" HPA071194 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA071194: AB_2686359" "unprognostic (2.90e-1)" "unprognostic (5.21e-3)" "unprognostic (5.79e-2)" "unprognostic (4.31e-2)" "unprognostic (1.92e-3)" "unprognostic (1.71e-3)" "unprognostic (1.97e-1)" "unprognostic (4.85e-2)" "unprognostic (7.84e-3)" "unprognostic (1.90e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (3.20e-7)" "unprognostic (2.80e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.17e-3)" 1.1 0.3 0.6 0.2 0.0 0.4 2.5 9.7 0.4 14.0 5.5 0.0 4.8 0.2 3.2 1.7 10.3 0.5 0.2 0.2 1.5 0.0 42.9 0.2 15.6 0.2 0.0 0.3 0.2 3.8 0.2 6.5 0.7 0.7 10.2 1.1 0.0 26.8 12.8 2.2 6.6 0.2 0.3 0.3 0.2 6.9 0.3 0.0 1.5 25.5 3.3 3.9 1.7 11.3 0.3 0.3 1.8 0.2 0.2 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 14.2 1.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.1 1.8 0.2 0.1 0.3 0.1 0.0 0.6 0.0 9.7 0.4 1.5 0.0 0.0 0.3 0.7 0.0 17.9 3.4 0.0 4.0 0.3 0.0 0.8 0.0 2.7 21.6 85.5 0.0 0.1 0.0 1.3 0.0 0.0 0.3 0.0 1.5 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 1.4 SCRG1 SCRG-1 ENSG00000164106 "Stimulator of chondrogenesis 1" O75711 4 173384701-173406380 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.4" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 148.4" "Cancer enriched" "Detected in many" 6 "glioma: 35.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 13 "HSkMC: 6.8;WM-115: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012882 Approved "Secreted in brain" NA NA "HPA012882: AB_1856635" "unprognostic (1.09e-1)" "unprognostic (1.83e-2)" "unprognostic (2.60e-5)" "unprognostic (2.58e-1)" "unprognostic (3.22e-2)" "unprognostic (7.51e-2)" "unprognostic (3.58e-2)" "unprognostic (1.14e-3)" "unprognostic (2.08e-1)" "unprognostic (2.25e-2)" "unprognostic (2.19e-1)" "unprognostic (1.49e-1)" "unprognostic (3.95e-10)" "unprognostic (4.86e-2)" "unprognostic (2.21e-1)" "unprognostic (4.34e-3)" "unprognostic (8.74e-4)" 5.8 3.1 19.2 2.6 18.6 2.2 2.3 6.0 30.6 2.1 2.9 15.9 4.0 2.5 2.5 7.7 2.3 2.1 5.1 3.6 19.9 12.0 1.5 1.4 1.5 1.5 24.9 12.9 1.6 1.8 1.2 1.1 1.6 20.5 6.4 2.7 0.0 3.4 11.6 1.9 2.0 2.0 15.6 33.4 2.4 2.8 16.3 22.5 0.0 1.5 0.3 1.3 4.1 1.0 1.4 1.3 4.4 1.8 1.6 1.0 0.4 0.1 0.0 0.9 0.3 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.8 0.2 0.2 6.8 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.6 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.2 0.3 0.1 0.0 0.1 0.1 0.1 19.8 3.9 1.8 1.2 0.8 1.2 0.6 0.8 0.6 0.7 0.7 1.4 0.8 1.0 4.4 1.6 1.3 1.3 0.5 0.4 19.2 18.6 6.0 16.7 19.9 12.0 24.9 12.9 20.5 22.5 0.0 4.0 0.5 1.0 3.2 11.8 0.8 0.0 1.4 1.2 0.0 35.3 0.2 0.0 0.2 14.9 2.0 0.0 0.0 0.0 0.2 5.2 1.4 9.2 0.0 0.5 15.9 1.2 6.2 3.1 21.8 24.2 1.6 21.9 0.0 0.0 148.4 0.1 0.0 19.4 0.0 30.2 12.9 10.9 1.9 2.2 2.3 0.6 3.9 0.2 0.7 SCTR ENSG00000080293 "Secretin receptor" P47872 2 119439843-119525301 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 13.5;pancreas: 35.3" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 64.4;Ductal cells: 72.3;Exocrine glandular cells: 84.2;Pancreatic endocrine cells: 51.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 15.3" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.8" "Cell line enriched" "Detected in some" 5 "Karpas-707: 8.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 12 "midbrain: 1.2;pons and medulla: 1.3;thalamus: 1.5" HPA007269 Uncertain NA NA "HPA007269: AB_1856640" "unprognostic (1.51e-1)" "unprognostic (2.22e-1)" "unprognostic (4.99e-2)" "unprognostic (5.82e-2)" "unprognostic (1.71e-1)" "unprognostic (4.12e-2)" "unprognostic (1.68e-1)" "unprognostic (1.09e-1)" "unprognostic (1.68e-2)" "unprognostic (9.08e-2)" "unprognostic (7.35e-2)" "unprognostic (2.38e-2)" "unprognostic (6.11e-3)" "unprognostic (1.65e-3)" "unprognostic (1.77e-1)" "unprognostic (2.24e-1)" "unprognostic (4.38e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.2 4.1 0.0 0.0 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.9 0.2 0.2 0.0 0.0 0.0 0.5 0.1 3.8 0.3 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.8 0.0 0.5 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 8.2 0.7 0.5 0.1 0.0 0.9 0.3 0.0 0.1 0.0 1.5 0.3 0.5 0.0 0.3 0.0 0.3 0.0 0.3 0.0 1.1 0.0 0.0 0.4 0.6 0.0 0.9 0.3 0.1 0.0 0.0 0.1 3.8 0.3 0.9 0.3 0.2 0.4 0.3 0.3 0.0 0.0 0.5 0.3 0.2 1.2 0.3 0.3 0.1 0.4 0.0 0.0 64.4 0.0 0.2 0.0 0.0 3.1 0.0 0.0 3.4 5.2 0.0 0.0 10.0 72.3 0.4 0.0 0.0 0.0 84.2 0.0 0.0 0.0 2.3 0.0 0.5 4.8 2.4 0.0 0.0 1.1 0.0 0.0 0.0 2.8 0.0 0.2 51.5 0.0 0.0 0.2 1.1 0.0 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 SCUBE2 "Cegb1, Cegf1, FLJ16792" ENSG00000175356 "Signal peptide, CUB domain and EGF like domain containing 2" Q9NQ36 11 9020391-9138114 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 55.2;Glandular cells: 24.6;Melanocytes: 18.6" "Cancer enhanced" "Detected in all" "breast cancer: 54.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "non-classical monocyte: 3.6" "Lineage enriched" "Detected in single" 5 "monocytes: 3.6" "Cell line enhanced" "Detected in some" "HAP1: 5.1;SK-MEL-30: 7.2;T-47d: 25.1" "Group enriched" "Detected in some" 4 "olfactory region: 5.7;thalamus: 2.9" "HPA006353, HPA029871" Uncertain "Secreted to blood" NA NA 280000 "HPA006353: AB_1856642, HPA029871: AB_10602299" "prognostic favorable (2.41e-4)" "unprognostic (5.72e-3)" "unprognostic (2.91e-1)" "unprognostic (1.76e-2)" "unprognostic (2.73e-1)" "unprognostic (6.12e-4)" "unprognostic (3.11e-1)" "unprognostic (6.39e-2)" "unprognostic (2.08e-1)" "unprognostic (9.39e-2)" "unprognostic (1.54e-2)" "unprognostic (3.04e-1)" "unprognostic (1.94e-2)" "unprognostic (9.12e-4)" "unprognostic (4.35e-1)" "unprognostic (5.94e-2)" "unprognostic (2.88e-1)" 10.4 1.2 2.8 2.5 3.0 0.0 15.6 3.3 1.9 14.3 5.9 1.3 11.8 1.1 6.7 23.8 2.5 8.5 5.6 2.0 3.5 1.6 1.0 0.7 3.2 4.9 1.3 2.1 0.9 12.9 10.4 14.1 9.4 4.1 24.6 1.6 5.7 1.6 10.0 2.9 5.0 6.9 13.2 3.6 2.1 8.7 1.5 0.8 0.7 1.9 2.3 3.8 25.5 6.0 0.0 0.7 0.0 3.6 0.0 0.0 0.3 0.0 0.0 1.4 0.8 0.5 0.5 0.2 1.5 0.7 0.8 0.6 0.3 0.0 0.0 0.6 3.4 0.1 0.0 5.1 0.0 1.3 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.1 1.2 0.0 0.3 0.0 0.3 0.5 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.2 0.4 2.6 0.6 0.9 0.9 0.1 7.2 1.2 25.1 0.0 0.0 0.5 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.3 2.8 3.0 3.3 1.9 3.5 1.6 1.3 2.1 4.1 0.8 14.9 11.6 0.0 55.2 6.5 0.3 0.4 0.0 2.7 10.3 1.8 0.0 0.2 0.0 0.0 3.0 2.1 0.2 0.0 1.5 0.2 4.7 24.6 0.0 0.0 0.8 12.7 1.2 0.0 0.0 2.0 0.3 0.7 18.6 0.0 2.3 0.0 0.1 3.5 0.7 0.0 0.2 0.0 1.0 0.4 0.7 1.6 0.3 0.0 3.2 10.2 SDC1 "CD138, SDC, SYND1, syndecan" ENSG00000115884 "Syndecan 1" P18827 2 20200797-20225433 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 113.2;placenta: 228.8" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 298.1;Hepatocytes: 520.4;Urothelial cells: 356.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 17 "memory B-cell: 3.9" "Lineage enriched" "Detected in single" 40 "B-cells: 3.9" "Cell line enhanced" "Detected in many" "HBEC3-KT: 62.1;hTCEpi: 57.5;U-251 MG: 59.2;U-266/70: 61.4;U-266/84: 129.2" "Group enriched" "Detected in some" 4 "cerebellum: 10.7;olfactory region: 5.9" "Not detected" "Not detected" "CAB002424, HPA006185, HPA067477" Enhanced Approved "Focal adhesion sites" "Secreted to blood" NA NA 63100000 1600000 "Focal adhesion sites" "CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: " "prognostic unfavorable (2.22e-4)" "unprognostic (6.80e-3)" "unprognostic (6.80e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (4.02e-2)" "unprognostic (6.32e-2)" "unprognostic (1.70e-1)" "unprognostic (3.66e-1)" "unprognostic (2.27e-3)" "unprognostic (1.79e-1)" "unprognostic (1.63e-1)" "unprognostic (1.94e-2)" "unprognostic (4.27e-1)" "unprognostic (1.62e-2)" "unprognostic (1.52e-1)" 0.8 3.4 0.5 5.4 0.6 0.0 4.5 0.8 0.7 21.4 18.3 0.5 3.5 14.3 2.3 8.7 103.7 1.6 55.3 0.3 0.4 0.5 68.5 113.2 15.8 6.3 1.9 0.4 1.6 7.0 0.6 0.6 228.8 0.7 13.3 6.2 1.5 16.0 5.2 0.5 69.5 21.9 4.3 0.4 3.7 16.3 2.6 0.4 1.5 3.5 62.3 48.4 30.0 37.7 3.9 0.0 0.0 0.0 0.0 0.0 0.5 31.4 17.6 5.6 14.0 1.5 0.2 17.7 8.8 8.5 8.2 7.0 3.7 19.2 0.0 3.2 6.2 4.5 31.1 2.4 62.1 5.5 0.1 1.6 0.0 1.6 18.8 1.3 1.3 0.1 0.8 57.5 7.4 17.6 11.5 0.9 0.0 0.7 12.3 4.4 18.8 0.0 0.3 5.0 24.0 34.2 0.6 2.0 23.8 10.6 47.2 1.6 13.1 6.6 44.8 2.0 2.3 4.4 0.3 1.3 32.7 10.5 1.2 59.2 61.4 129.2 0.1 9.8 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 0.8 0.7 0.4 0.5 1.9 0.4 0.7 0.4 86.4 91.4 3.0 135.6 101.2 0.1 0.8 298.1 2.7 63.7 40.1 0.0 2.4 26.6 54.9 0.0 1.1 102.7 23.3 19.0 43.0 9.7 42.4 5.8 520.4 2.2 20.6 10.4 6.7 9.6 0.0 0.6 5.4 20.3 1.0 72.0 0.0 67.3 73.7 1.1 68.3 0.0 0.0 7.1 0.7 12.8 200.1 209.7 4.4 66.5 356.0 SDC2 "CD362, fibroglycan, HSPG, HSPG1, SYND2" ENSG00000169439 "Syndecan 2" P34741 8 96493351-96611780 "CD markers, Predicted membrane proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 115.1;thyroid gland: 111.2" "Cell type enhanced" "Detected in many" 5 "Fibroblasts: 194.4;Hepatocytes: 184.9;Smooth muscle cells: 188.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 13.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.9" "Cell line enhanced" "Detected in many" "AF22: 102.6;EFO-21: 48.2;fHDF/TERT166: 44.4;RPTEC TERT1: 53.6;U-138 MG: 49.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025123, HPA044416" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB025123: , HPA044416: AB_2678934" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (3.61e-2)" "unprognostic (6.52e-3)" "unprognostic (4.18e-2)" "unprognostic (2.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.89e-2)" "unprognostic (4.56e-1)" "unprognostic (1.48e-1)" "unprognostic (6.16e-2)" "unprognostic (1.56e-2)" "unprognostic (1.45e-3)" "unprognostic (1.91e-1)" "unprognostic (2.50e-2)" "unprognostic (1.23e-1)" 43.2 9.9 13.9 9.1 16.9 2.5 17.0 12.7 8.4 43.4 18.7 7.3 21.2 5.8 21.9 15.3 13.3 21.0 15.0 19.1 12.0 12.6 23.9 115.1 14.4 4.4 9.7 9.3 45.9 16.8 1.6 24.0 31.3 10.7 25.9 10.7 51.4 6.3 28.1 9.4 6.5 9.6 34.3 9.5 7.5 11.9 8.7 9.3 0.5 111.2 13.8 3.5 35.9 26.3 0.0 1.3 13.9 1.9 0.0 0.2 0.5 0.0 0.0 102.6 0.0 37.1 34.7 0.1 14.8 17.6 8.6 9.6 3.0 0.0 0.0 48.2 44.4 1.2 0.0 17.7 0.2 7.4 0.0 6.9 0.0 9.9 37.7 1.2 0.2 0.4 13.3 0.4 19.5 0.5 33.3 0.3 0.0 9.7 0.0 3.6 0.8 0.0 2.5 10.8 0.0 0.1 0.1 16.1 0.3 53.6 8.7 3.0 8.0 0.0 0.0 0.7 35.9 4.4 11.4 8.0 49.7 15.2 0.2 8.2 0.9 0.0 0.1 15.8 0.0 15.5 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 13.9 0.0 0.1 0.0 0.0 0.5 13.9 16.9 12.7 8.4 12.0 12.6 9.7 9.3 10.7 9.3 53.6 30.2 4.7 67.2 47.9 22.0 25.8 33.1 5.3 3.4 54.1 11.8 1.8 24.9 11.7 25.6 10.2 0.1 23.3 13.2 2.0 194.4 44.9 1.1 184.9 114.7 4.8 3.4 20.3 22.0 14.5 48.6 87.0 59.1 118.2 0.5 18.4 12.7 0.0 98.6 44.8 10.2 32.3 188.5 3.2 57.1 34.4 3.2 3.2 1.2 14.5 SDC3 "N-syndecan, SYND3" ENSG00000162512 "Syndecan 3" O75056 1 30869467-30908761 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Collecting duct cells: 45.4;Kupffer cells: 157.7;Late spermatids: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 52.5;WM-115: 73.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017087, CAB025786, HPA048085" Approved Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256" "unprognostic (1.42e-3)" "unprognostic (5.52e-2)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-2)" "unprognostic (1.87e-1)" "unprognostic (1.79e-3)" "unprognostic (2.83e-1)" "prognostic favorable (2.36e-4)" "unprognostic (9.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (6.45e-2)" "unprognostic (2.74e-1)" "unprognostic (9.80e-3)" "unprognostic (1.46e-1)" 17.9 48.8 35.4 11.6 44.7 1.9 9.2 10.4 53.1 20.4 20.8 21.7 10.9 6.9 25.6 7.1 9.8 13.7 15.9 11.1 26.8 32.2 4.7 11.5 12.0 15.4 36.1 16.4 6.2 4.4 6.1 5.4 9.7 34.1 14.8 8.1 8.2 8.6 29.2 17.7 5.7 9.1 33.1 28.3 45.3 9.3 2.4 15.5 2.6 5.5 1.7 4.2 14.4 6.0 1.2 1.0 3.2 2.5 2.1 1.2 0.9 2.7 2.0 16.3 7.6 12.6 3.0 3.2 6.8 9.7 3.2 2.0 0.3 2.5 0.2 17.3 19.0 4.6 3.7 1.7 1.5 2.1 1.4 1.4 0.0 0.8 0.4 12.1 0.0 1.8 7.3 7.5 0.2 3.2 17.9 4.0 0.7 1.3 0.2 6.2 2.9 0.1 0.1 8.3 1.9 2.4 0.1 15.6 0.6 4.0 2.9 6.4 4.1 8.6 1.2 52.5 10.9 1.2 1.2 4.4 4.0 6.9 0.5 1.5 0.0 0.1 0.2 0.4 0.0 73.1 3.2 1.3 1.0 0.8 2.5 1.2 0.8 0.8 0.9 0.9 1.2 1.0 1.0 2.5 2.1 1.8 1.0 0.9 0.9 35.4 44.7 10.4 29.5 26.8 32.2 36.1 16.4 34.1 15.5 0.0 2.1 0.8 2.8 2.3 8.1 3.2 15.3 0.0 2.3 45.4 0.0 2.1 0.0 9.0 17.7 8.7 0.0 0.0 2.6 2.8 10.0 6.9 0.0 0.2 13.2 0.0 2.9 28.8 157.7 63.3 2.0 2.2 18.6 5.4 0.9 1.5 6.1 0.6 7.4 0.3 25.6 0.0 5.6 0.7 0.4 1.9 3.0 0.0 1.2 3.7 SDC4 "amphiglycan, ryudocan, SYND4" ENSG00000124145 "Syndecan 4" P31431 20 45325288-45348424 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 141.1" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 450.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 75.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005716, CAB013240" Enhanced Approved "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA "Golgi apparatus" "Plasma membrane" "CAB013240: AB_2533250, HPA005716: AB_1080160" "unprognostic (1.34e-2)" "unprognostic (1.80e-1)" "unprognostic (1.71e-2)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (5.93e-2)" "unprognostic (2.68e-1)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.97e-1)" "prognostic favorable (2.44e-7)" "unprognostic (3.00e-1)" "unprognostic (2.18e-1)" "prognostic favorable (2.67e-4)" "unprognostic (7.42e-2)" 15.9 26.2 19.9 15.7 24.3 3.5 40.5 6.9 20.1 20.4 24.8 19.2 9.0 13.3 17.6 14.7 42.4 27.4 26.2 19.5 19.8 12.1 56.6 141.1 56.7 4.8 23.5 20.5 14.7 36.6 6.2 12.5 23.0 30.9 19.5 22.3 21.8 47.6 17.5 25.5 45.5 13.8 38.7 23.0 9.0 46.9 33.7 15.7 2.0 26.5 25.2 23.5 34.4 16.4 0.7 2.8 2.0 3.1 1.4 8.1 1.2 23.0 3.0 1.6 0.1 41.2 25.4 71.1 29.5 40.3 33.5 24.0 35.1 58.9 0.0 13.2 37.1 33.8 30.0 1.2 75.0 40.8 6.6 1.1 0.7 2.4 13.7 44.9 0.1 1.2 34.1 50.4 13.8 33.8 18.6 4.4 0.5 1.1 0.0 19.2 22.9 0.0 2.0 3.0 20.1 9.3 0.0 14.9 0.0 55.0 30.8 0.6 2.3 40.6 25.2 7.2 19.6 18.2 1.4 8.2 25.6 21.3 2.5 19.0 1.2 0.9 0.1 40.2 2.3 15.2 2.0 3.1 0.7 1.3 1.1 4.1 0.6 4.1 1.6 2.8 0.7 0.9 1.1 1.6 1.4 1.1 2.5 8.1 1.2 19.9 24.3 6.9 20.1 19.8 12.1 23.5 20.5 30.9 15.7 271.0 364.7 7.8 299.2 332.0 10.3 49.5 201.2 113.8 195.7 179.7 11.8 27.4 54.7 239.6 0.5 9.0 87.8 0.0 450.4 202.4 50.9 254.2 12.8 232.3 18.5 0.0 52.9 14.7 15.1 2.9 3.7 36.5 72.6 56.9 103.4 8.5 443.3 93.4 4.9 128.2 23.3 0.0 42.6 0.9 2.8 413.3 56.3 18.8 79.5 364.0 SDCBP "MDA-9, SYCL" ENSG00000137575 "Syndecan binding protein" O00560 8 58552924-58582860 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Melanocytes: 843.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 166.5" "Group enriched" "Detected in all" 5 "granulocytes: 166.5;monocytes: 44.8" "Cell line enhanced" "Detected in many" "HHSteC: 100.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012245, HPA023840" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA 1500000 "Nucleoplasm, Cytosol" "Nuclear membrane" "CAB012245: , HPA023840: AB_1857712" "unprognostic (2.39e-2)" "unprognostic (3.34e-2)" "unprognostic (1.84e-2)" "unprognostic (4.45e-2)" "unprognostic (9.15e-2)" "unprognostic (2.60e-3)" "unprognostic (7.14e-2)" "unprognostic (1.04e-3)" "unprognostic (1.11e-1)" "unprognostic (5.68e-2)" "unprognostic (3.05e-2)" "unprognostic (3.01e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.02e-2)" "unprognostic (2.82e-2)" "unprognostic (2.92e-1)" 106.2 32.0 28.5 37.6 45.2 51.5 67.4 20.9 29.0 42.7 28.4 18.8 22.2 19.7 38.4 28.2 37.8 28.0 47.9 36.9 32.1 25.8 41.4 41.7 73.1 49.7 33.4 16.9 35.5 20.1 36.4 16.4 68.5 47.6 35.5 33.6 53.0 41.5 20.7 22.5 24.7 34.3 37.9 39.0 70.1 31.0 25.4 22.2 34.3 44.4 23.4 21.4 50.0 44.2 5.9 21.7 166.5 44.8 3.4 9.8 29.7 14.5 22.6 24.1 12.5 90.5 78.0 10.6 15.0 53.8 21.9 28.8 9.0 30.7 0.0 24.2 20.1 40.3 6.1 13.0 17.3 27.1 2.6 11.1 22.0 20.1 7.2 100.5 5.6 35.8 53.2 23.4 22.0 66.1 34.2 52.4 15.3 10.8 12.9 49.6 3.8 12.3 6.6 15.1 57.5 6.5 6.0 7.3 2.8 34.8 15.3 10.6 19.1 16.0 6.9 73.8 27.9 6.3 15.3 45.0 21.1 9.1 24.9 9.6 3.9 5.2 8.8 53.8 0.0 18.9 52.9 44.8 43.7 5.7 30.0 7.1 5.9 7.6 6.0 21.7 5.4 9.8 7.4 166.5 3.4 26.4 6.0 8.5 29.7 28.5 45.2 20.9 29.0 32.1 25.8 33.4 16.9 47.6 22.2 196.5 114.3 99.6 291.9 300.9 9.9 48.4 58.6 61.6 77.3 195.4 15.7 224.5 190.6 334.0 5.9 318.0 108.1 46.7 256.7 631.9 182.6 258.8 390.0 80.9 683.1 14.3 107.7 330.8 517.6 7.7 216.6 535.9 843.5 212.0 105.0 74.6 227.0 96.2 150.3 153.5 9.7 97.0 282.9 12.5 6.5 151.4 403.9 126.8 84.4 372.9 SDF2L1 "AP000553.C22.4, OTTHUMT00000075032" ENSG00000128228 "Stromal cell derived factor 2 like 1" Q9HCN8 22 21642261-21644298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 72.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005638 Approved "Intracellular and membrane" NA NA "HPA005638: AB_1079888" "unprognostic (1.09e-1)" "unprognostic (2.76e-2)" "unprognostic (6.17e-2)" "prognostic favorable (4.98e-5)" "unprognostic (8.81e-3)" "unprognostic (2.29e-1)" "unprognostic (9.20e-2)" "unprognostic (2.30e-1)" "unprognostic (4.92e-2)" "unprognostic (6.88e-3)" "unprognostic (1.69e-2)" "unprognostic (1.48e-1)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" "unprognostic (1.55e-1)" "unprognostic (1.70e-1)" "unprognostic (2.79e-2)" 7.0 10.9 5.7 19.0 12.4 13.9 15.8 3.6 6.5 8.5 13.3 3.8 18.0 16.0 8.9 15.0 7.6 8.3 9.4 11.2 5.4 7.3 13.3 44.2 11.3 20.7 11.2 3.6 6.7 54.7 6.3 21.6 9.0 12.4 8.5 6.5 5.5 37.0 14.2 4.3 4.5 14.7 5.5 6.0 18.2 18.6 9.9 8.7 8.7 44.2 7.1 11.4 7.8 14.0 32.8 57.5 24.3 27.1 24.6 48.3 27.0 17.1 14.6 3.7 12.3 2.1 2.8 23.2 15.2 3.8 7.3 8.1 15.0 10.3 15.7 13.9 3.6 11.9 14.2 6.9 10.4 2.0 11.4 41.1 11.9 15.5 32.4 12.6 11.9 21.0 2.1 4.5 6.8 7.2 2.5 7.1 8.5 72.4 40.8 3.0 32.5 11.6 17.0 4.1 18.6 25.3 10.8 8.4 13.0 5.0 12.8 7.9 12.2 7.6 13.1 7.8 3.0 12.6 14.2 8.1 3.9 21.8 12.9 9.3 37.7 15.1 11.5 7.7 14.0 11.4 24.3 27.1 11.2 48.3 27.0 36.2 32.8 31.2 43.8 19.2 26.1 24.8 30.0 8.0 24.6 24.8 57.5 31.4 27.0 5.7 12.4 3.6 6.5 5.4 7.3 11.2 3.6 12.4 8.7 23.8 22.0 50.0 90.4 101.4 5.3 23.8 53.5 8.1 11.4 47.1 33.4 93.3 21.6 95.5 41.4 41.9 171.0 163.5 154.7 269.0 72.3 151.7 113.7 248.0 202.6 4.8 178.2 62.0 58.0 25.6 30.0 95.1 200.8 61.3 71.1 40.4 144.5 80.7 15.6 70.8 12.9 38.8 56.7 143.3 239.5 98.2 140.6 71.0 61.7 107.3 SDF4 Cab45 ENSG00000078808 "Stromal cell derived factor 4" Q9BRK5 1 1216908-1232031 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011249, HPA011895, CAB015227" Supported Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA 720000 "Golgi apparatus" "CAB015227: , HPA011249: AB_2668468, HPA011895: " "unprognostic (1.98e-1)" "prognostic unfavorable (5.89e-4)" "unprognostic (3.63e-1)" "unprognostic (2.38e-3)" "unprognostic (5.88e-2)" "unprognostic (7.95e-3)" "unprognostic (3.73e-3)" "unprognostic (1.06e-1)" "unprognostic (2.01e-1)" "unprognostic (8.70e-2)" "unprognostic (1.46e-2)" "unprognostic (1.07e-1)" "unprognostic (8.39e-3)" "unprognostic (1.09e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (3.04e-2)" 34.7 36.0 17.9 37.3 22.7 19.7 56.3 20.6 33.2 30.3 49.9 21.3 46.6 48.5 35.5 53.4 26.2 26.9 57.5 50.8 18.7 18.5 36.3 73.8 55.8 46.2 19.7 21.3 33.1 56.4 25.9 31.1 47.9 18.2 30.3 25.6 26.5 46.7 52.1 30.7 25.5 56.2 27.6 18.0 33.8 32.9 30.0 18.1 20.5 35.1 28.5 19.6 28.5 44.8 11.5 16.0 20.6 15.9 19.6 22.0 7.0 28.5 26.0 14.3 45.5 70.3 35.5 17.2 56.0 51.3 41.2 34.6 30.6 49.9 18.1 43.5 53.9 29.6 29.4 16.4 24.5 12.6 30.3 27.8 31.6 40.0 42.7 32.3 31.9 42.9 43.6 12.7 31.0 17.6 40.4 32.9 12.1 26.0 48.0 20.2 20.6 15.7 32.2 13.1 32.7 34.9 17.5 18.5 47.9 27.3 13.8 52.2 18.5 37.2 44.4 36.8 13.3 23.0 36.6 41.7 42.6 23.1 32.0 31.8 29.6 28.0 29.7 48.4 60.1 18.4 10.4 14.9 20.6 15.0 9.9 11.6 9.4 21.5 22.0 16.0 11.5 12.4 10.7 12.7 19.6 15.9 10.0 16.5 7.0 17.9 22.7 20.6 33.2 18.7 18.5 19.7 21.3 18.2 18.1 20.8 19.2 50.4 64.0 106.5 33.8 30.8 56.0 16.0 25.0 47.1 17.7 104.0 10.0 70.2 29.0 70.3 256.4 46.7 61.6 264.7 99.3 86.2 35.7 97.8 110.9 36.5 63.0 72.4 62.0 26.3 88.3 73.0 158.6 49.5 146.7 55.9 64.2 189.4 71.5 48.8 31.8 58.2 99.4 77.0 64.5 99.9 140.5 71.0 158.0 55.0 SDHC "CYB560, cybL, PGL3" ENSG00000143252 "Succinate dehydrogenase complex subunit C" Q99643 1 161314257-161375340 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport, Tricarboxylic acid cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Distal tubular cells: 658.2;Proximal tubular cells: 706.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.48e-2)" "unprognostic (6.88e-2)" "unprognostic (6.38e-3)" "unprognostic (1.86e-2)" "unprognostic (1.90e-2)" "unprognostic (5.02e-2)" "unprognostic (7.08e-2)" "unprognostic (2.33e-1)" "unprognostic (7.38e-2)" "unprognostic (1.35e-1)" "unprognostic (2.43e-2)" "unprognostic (1.29e-1)" "prognostic favorable (2.20e-4)" "unprognostic (9.14e-2)" "unprognostic (1.52e-1)" "unprognostic (4.19e-3)" "unprognostic (3.77e-1)" 36.8 49.7 25.6 17.1 27.3 14.1 24.1 14.4 36.2 20.6 29.1 31.2 17.0 34.3 22.1 19.7 35.2 21.4 19.3 35.5 21.5 21.8 65.9 75.3 17.8 20.9 28.6 20.1 20.1 17.2 28.8 17.0 19.2 28.0 20.8 28.4 23.9 28.5 21.9 98.0 21.6 33.4 23.2 24.9 21.2 24.3 17.0 16.2 25.7 35.9 45.4 22.4 20.6 19.2 31.3 60.4 28.3 48.2 29.0 38.6 47.9 29.6 21.7 30.6 26.4 40.4 32.3 33.8 32.9 26.2 25.5 19.8 32.1 36.9 8.8 42.8 33.2 22.9 34.7 40.8 34.6 29.7 31.5 40.0 20.4 20.8 32.9 23.0 37.7 21.9 34.1 28.5 29.7 20.0 31.6 26.6 31.4 28.7 8.3 41.1 28.6 26.8 21.8 30.1 66.8 23.0 28.1 29.9 37.4 53.8 29.5 21.4 36.4 39.6 74.6 47.0 38.0 60.9 47.3 23.4 17.8 27.2 25.1 28.4 43.4 53.0 52.2 26.0 24.7 34.4 27.7 48.2 28.3 36.0 44.9 38.6 31.3 32.3 35.5 60.4 30.6 36.3 35.7 23.9 29.0 38.8 44.8 35.2 47.9 25.6 27.3 14.4 36.2 21.5 21.8 28.6 20.1 28.0 16.2 41.7 50.7 84.8 120.9 55.0 71.4 87.7 163.1 97.7 59.1 143.1 60.9 207.5 658.2 185.1 14.4 65.2 106.6 23.3 127.6 211.0 62.7 94.7 56.6 206.9 208.7 68.3 64.2 75.5 101.7 25.9 95.3 83.6 123.2 205.6 95.6 90.0 123.2 105.2 102.6 706.4 61.9 51.8 92.0 89.9 105.2 66.9 257.2 81.0 139.7 129.5 SDK1 FLJ31425 ENSG00000146555 "Sidekick cell adhesion molecule 1" Q7Z5N4 7 3301448-4269000 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Early spermatids: 99.7;Late spermatids: 120.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 28 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 28 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "AF22: 7.9;BEWO: 9.8;RPTEC TERT1: 8.2;RT4: 10.2;SuSa: 9.9;U-2 OS: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA011392 Approved Approved Cytosol NA NA 2700000 Cytosol "HPA011392: AB_1856648" "unprognostic (2.39e-1)" "unprognostic (1.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.83e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.23e-1)" "unprognostic (9.93e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-1)" "prognostic favorable (4.08e-4)" "unprognostic (2.16e-1)" "unprognostic (2.49e-2)" "unprognostic (7.84e-2)" "unprognostic (1.59e-1)" "unprognostic (8.44e-2)" "unprognostic (1.37e-1)" 5.8 1.1 2.2 6.1 1.7 1.4 5.8 0.9 3.1 16.6 6.2 1.4 6.8 1.8 6.1 10.9 2.9 4.5 4.8 1.9 3.4 2.2 3.9 0.7 7.0 8.7 1.6 1.4 4.3 22.4 1.5 6.3 2.9 2.1 6.9 2.4 5.6 2.6 9.4 1.8 2.9 4.2 16.5 1.9 16.3 3.6 7.7 1.9 1.8 1.5 3.6 3.4 9.5 13.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.0 1.7 7.9 0.0 0.0 0.0 9.8 0.0 0.0 0.4 0.0 0.0 0.0 0.1 2.3 0.0 3.1 0.1 0.8 0.0 0.2 0.0 4.6 0.0 0.3 0.2 3.9 0.0 0.0 1.6 0.0 0.3 0.5 0.0 0.6 0.1 0.0 0.0 3.9 2.0 0.0 0.0 2.7 0.1 0.0 5.6 5.5 0.0 8.2 10.2 4.9 7.2 0.0 0.0 0.0 9.9 0.0 2.5 0.2 0.0 12.3 0.0 3.4 0.0 0.0 0.0 0.0 1.6 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 2.2 1.7 0.9 3.1 3.4 2.2 1.6 1.4 2.1 1.9 0.0 4.0 0.0 0.4 1.1 10.0 20.4 2.5 9.4 7.9 5.2 0.0 2.3 0.0 1.0 99.7 0.6 0.0 0.0 4.7 0.8 4.1 0.6 0.0 0.0 0.5 1.6 4.7 1.3 0.0 120.8 1.7 0.5 5.0 0.0 0.5 0.3 3.5 0.0 5.3 1.4 0.7 6.5 2.1 6.6 5.1 0.4 1.6 0.0 0.0 0.3 SDK2 "FLJ10832, KIAA1514" ENSG00000069188 "Sidekick cell adhesion molecule 2" Q58EX2 17 73334384-73644089 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 13.6" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 14.2;Horizontal cells: 19.1;Intestinal endocrine cells: 14.3;Late spermatids: 15.3;Spermatocytes: 12.4;Syncytiotrophoblasts: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.7;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 5 "B-cells: 2.7;dendritic cells: 2.3" "Cell line enhanced" "Detected in some" "AF22: 14.7;BEWO: 12.1;RPMI-8226: 4.8;SuSa: 8.1;U-2 OS: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014725 Approved Nucleoplasm NA NA 2000000 Nucleoplasm "HPA014725: AB_2183303" "unprognostic (7.22e-4)" "unprognostic (5.57e-2)" "unprognostic (1.70e-1)" "unprognostic (7.00e-3)" "unprognostic (1.62e-2)" "unprognostic (3.18e-1)" "unprognostic (3.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.98e-1)" "unprognostic (1.49e-1)" "unprognostic (8.80e-4)" "unprognostic (7.69e-2)" "unprognostic (3.89e-2)" "unprognostic (1.44e-2)" "unprognostic (1.38e-1)" "unprognostic (1.37e-2)" "unprognostic (6.64e-2)" 0.4 0.6 2.1 5.3 1.2 0.7 2.6 0.5 2.7 8.9 0.5 0.6 0.0 0.0 3.1 5.1 0.9 3.5 1.4 3.5 1.7 4.1 1.1 0.5 4.2 4.8 1.6 0.0 0.8 0.4 0.0 1.9 3.7 1.9 2.6 0.3 2.2 2.0 1.4 0.4 0.5 0.5 0.3 3.0 3.6 0.6 13.6 0.0 0.1 1.8 1.1 2.9 0.7 7.2 2.7 2.3 0.0 0.0 0.2 0.5 0.0 0.0 2.1 14.7 4.2 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 3.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.5 0.0 4.8 0.0 0.0 3.3 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 4.4 1.8 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 2.7 0.5 0.4 0.0 0.2 0.0 2.3 0.0 0.0 2.1 1.2 0.5 2.5 1.7 4.1 1.6 0.0 1.9 0.0 0.0 2.4 4.5 3.7 0.8 3.5 2.0 0.0 0.0 2.3 0.0 0.0 3.8 0.0 0.2 10.9 0.3 0.0 0.0 0.2 14.2 1.9 2.3 1.1 0.0 0.6 19.1 14.3 0.0 0.0 15.3 0.6 0.0 1.7 1.8 0.2 7.8 0.0 0.0 0.0 0.0 0.6 0.0 0.9 12.4 3.5 0.1 14.9 0.0 0.0 0.3 SDR42E1 HSPC105 ENSG00000184860 "Short chain dehydrogenase/reductase family 42E, member 1" Q8WUS8 16 81988855-82011488 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 8.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 4.0;NK-cells: 3.6;T-cells: 4.6" "Cell line enhanced" "Detected in some" "HaCaT: 7.5;hTCEpi: 10.8;MCF7: 7.1;RT4: 17.4;SCLC-21H: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014388 Uncertain NA NA "HPA014388: AB_1851226" "unprognostic (2.09e-1)" "unprognostic (4.90e-1)" "unprognostic (9.52e-3)" "unprognostic (3.81e-1)" "unprognostic (3.46e-1)" "unprognostic (1.14e-2)" "unprognostic (1.38e-1)" "unprognostic (2.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.51e-2)" "unprognostic (3.96e-2)" "unprognostic (4.93e-4)" "unprognostic (4.90e-7)" "unprognostic (2.18e-1)" "unprognostic (1.82e-1)" "unprognostic (3.21e-2)" "unprognostic (8.27e-2)" 1.3 0.3 0.2 6.5 0.5 0.3 5.8 0.2 0.2 3.5 12.2 0.0 4.1 7.9 4.6 3.9 11.5 2.1 2.6 2.2 0.2 0.4 7.4 8.3 4.1 3.6 0.2 0.1 0.6 14.3 3.8 14.9 0.3 0.2 3.1 2.2 1.4 18.8 3.4 0.7 16.7 21.3 1.5 0.3 3.8 3.6 7.3 0.1 8.2 6.1 7.3 13.7 4.3 4.7 4.0 0.4 0.8 0.0 3.6 4.6 2.0 3.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.5 0.0 1.5 0.0 0.3 7.5 0.0 5.8 0.0 0.0 0.5 0.0 1.5 0.0 0.1 0.0 0.0 0.3 10.8 1.4 5.5 0.0 0.0 0.0 1.2 0.0 0.8 7.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 2.3 17.4 7.5 0.0 0.2 3.6 0.0 0.2 0.1 0.0 0.2 0.0 4.0 0.0 0.0 3.7 5.0 0.4 0.0 0.0 0.0 0.1 0.0 0.8 1.8 0.0 2.4 4.0 1.5 2.5 0.3 2.1 4.6 3.6 0.1 3.6 0.0 0.4 3.0 2.0 0.2 0.5 0.2 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.0 0.6 1.7 3.5 5.3 0.0 2.4 2.5 4.0 2.3 1.8 0.0 0.4 3.3 8.0 0.9 0.3 3.1 0.0 6.5 0.1 0.5 3.2 0.0 3.0 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.0 1.7 0.0 4.9 0.0 4.9 3.5 0.0 2.1 0.0 0.0 0.3 8.2 3.4 8.0 0.2 1.0 3.3 4.1 SDR42E2 ENSG00000183921 "Short chain dehydrogenase/reductase family 42E, member 2" A6NKP2 16 22165583-22191754 "Predicted membrane proteins" Oxidoreductase "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 6.0;fallopian tube: 5.0;testis: 3.3" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 22.2;Erythroid cells: 23.3;Muller glia cells: 18.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "neutrophil: 6.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.0" "Cell line enriched" "Detected in single" 5 "RPMI-8226: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.03e-3)" "unprognostic (2.80e-1)" "unprognostic (2.06e-1)" "unprognostic (1.72e-4)" "unprognostic (1.85e-1)" "unprognostic (7.07e-2)" "unprognostic (8.77e-2)" "unprognostic (3.72e-1)" "unprognostic (4.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.32e-3)" "unprognostic (2.01e-1)" "unprognostic (7.09e-2)" "unprognostic (4.76e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (6.61e-2)" 0.1 0.1 1.0 0.2 2.1 0.1 0.0 0.0 1.1 0.5 0.0 0.6 0.1 0.1 0.0 5.0 0.2 0.0 1.7 2.4 0.2 0.0 0.4 0.3 0.0 0.3 0.5 0.1 2.2 0.2 0.2 0.1 0.2 0.0 1.5 0.6 0.2 0.0 0.3 0.5 0.1 3.3 0.1 0.0 0.1 0.0 0.8 0.3 6.0 0.8 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.3 0.3 0.4 0.5 0.3 0.4 0.1 0.8 0.3 0.4 6.0 0.3 0.1 0.3 0.3 0.2 0.0 3.7 11.9 0.2 0.7 7.7 1.6 5.1 2.7 0.0 0.0 0.0 0.7 0.0 0.6 1.6 2.1 22.2 23.3 0.4 0.2 1.1 0.9 2.3 3.2 2.1 4.8 2.4 3.7 11.0 1.1 5.5 3.1 1.7 8.2 9.0 18.4 0.2 3.5 1.4 0.2 3.6 0.0 1.0 0.6 0.1 1.5 1.1 8.6 4.7 0.3 SDSL "cSDH, SDS-RS1" ENSG00000139410 "Serine dehydratase like" Q96GA7 12 113422237-113438276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 53.2" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 118.4;Hofbauer cells: 93.1;monocytes: 174.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 6.5;intermediate monocyte: 7.1;myeloid DC: 13.2;plasmacytoid DC: 12.8" "Group enriched" "Detected in many" 8 "dendritic cells: 13.2;monocytes: 7.1" "Cell line enhanced" "Detected in many" "HMC-1: 22.6;MCF7: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005740 Approved Approved Cytosol NA NA Cytosol "HPA005740: AB_10601486" "unprognostic (1.34e-1)" "unprognostic (8.33e-2)" "unprognostic (3.62e-2)" "unprognostic (3.54e-2)" "unprognostic (2.24e-2)" "unprognostic (6.17e-3)" "unprognostic (1.57e-1)" "unprognostic (6.46e-2)" "unprognostic (8.22e-2)" "unprognostic (2.00e-2)" "prognostic favorable (8.58e-4)" "unprognostic (2.93e-1)" "prognostic favorable (3.09e-5)" "unprognostic (2.22e-2)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (7.33e-2)" 3.1 15.3 4.2 3.8 5.1 1.4 2.8 1.5 7.1 2.6 7.1 5.5 6.2 10.0 2.5 9.7 1.3 4.6 5.2 7.2 3.6 6.1 15.5 53.2 2.8 2.8 9.5 4.2 4.6 15.3 5.0 7.6 3.1 7.8 4.2 5.0 4.6 4.9 4.5 2.1 0.7 7.8 2.9 8.8 3.0 5.2 7.0 2.6 1.5 20.3 1.3 1.6 4.0 1.5 1.1 13.2 0.3 7.1 1.3 0.2 1.7 3.6 14.2 2.0 6.0 0.4 0.9 1.4 2.1 0.5 2.2 1.9 6.1 3.8 0.2 10.7 3.4 6.2 3.7 0.9 4.8 0.8 8.6 3.6 9.1 3.4 2.6 12.0 1.1 22.6 1.9 6.8 5.5 8.2 2.6 3.3 0.0 7.1 2.8 2.7 38.7 0.0 4.5 2.1 3.9 6.1 0.0 3.0 6.8 5.9 4.4 0.6 0.2 8.8 10.0 8.5 1.9 12.3 10.4 3.0 2.7 5.3 12.1 1.8 0.6 0.5 0.1 11.6 3.7 3.3 0.1 6.5 0.0 0.0 7.1 0.0 1.1 0.0 0.0 13.2 0.1 0.0 0.0 0.3 1.3 0.9 12.8 0.2 1.7 4.2 5.1 1.5 7.1 3.6 6.1 9.5 4.2 7.8 2.6 0.0 6.1 8.6 2.1 0.8 0.2 15.7 25.5 0.0 0.0 27.9 2.0 11.4 66.3 30.4 0.4 2.9 43.5 23.3 17.7 2.6 3.8 6.0 43.8 118.4 93.1 3.2 30.5 4.9 12.3 1.1 2.6 14.9 3.3 174.9 28.9 19.5 17.4 40.3 5.3 76.8 1.5 0.0 5.7 0.0 0.2 0.5 6.1 4.3 25.5 4.3 SEC11A "SEC11L1, sid2895, SPC18, SPCS4A" ENSG00000140612 "SEC11 homolog A, signal peptidase complex subunit" P67812 15 84669538-84716716 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047533 Approved "Nuclear membrane,Golgi apparatus" NA NA 7400000 "Nuclear membrane" "Golgi apparatus" "HPA047533: AB_2680078" "unprognostic (8.81e-3)" "unprognostic (1.97e-1)" "unprognostic (3.19e-2)" "prognostic favorable (1.94e-5)" "unprognostic (3.39e-2)" "prognostic unfavorable (5.99e-5)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-2)" "unprognostic (6.17e-2)" "unprognostic (6.24e-2)" "unprognostic (1.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.95e-4)" "unprognostic (7.89e-2)" 65.5 43.6 18.7 23.3 17.3 36.4 42.6 11.2 15.5 44.4 38.5 23.0 38.8 20.7 41.8 57.9 40.3 27.3 33.2 30.8 18.7 18.4 56.5 68.2 44.7 41.1 24.7 12.6 55.7 70.9 21.2 41.7 46.0 18.4 44.4 28.0 28.5 43.5 36.2 51.9 23.3 33.3 39.7 31.5 38.4 29.5 28.2 19.7 33.2 74.6 39.3 32.1 49.8 37.8 29.1 44.3 32.6 48.4 34.3 45.9 46.3 23.7 51.3 37.9 58.6 48.1 60.0 29.1 38.0 44.3 31.2 37.4 54.9 59.0 11.8 25.0 46.7 36.9 51.9 52.5 31.9 34.0 29.0 38.8 34.5 58.5 51.6 41.7 25.9 39.1 41.3 40.1 21.5 34.9 50.9 44.1 15.5 34.2 31.8 42.1 55.7 10.6 56.4 40.3 36.1 22.1 13.3 49.0 38.5 70.2 66.7 18.6 41.8 31.6 35.4 85.5 59.4 34.5 60.3 30.0 31.7 23.8 27.0 46.2 31.2 59.2 16.7 34.4 45.7 24.7 20.7 43.8 24.1 28.4 47.3 28.5 29.1 35.4 30.4 43.8 26.6 30.2 30.9 32.6 34.3 48.4 44.3 45.9 46.3 18.7 17.3 11.2 15.5 18.7 18.4 24.7 12.6 18.4 19.7 83.4 82.6 129.4 146.5 95.1 26.0 57.2 214.0 68.3 101.2 122.1 21.6 264.5 202.2 211.7 36.2 236.3 103.8 23.3 215.7 493.0 216.8 157.8 217.7 143.3 324.9 19.1 151.1 167.6 353.0 67.9 277.3 291.4 150.1 267.9 172.8 64.3 169.6 103.7 156.3 255.0 33.2 168.1 121.7 176.8 142.9 104.8 255.7 159.2 214.9 195.4 SEC11C "SEC11L3, SPC21, SPCS4C" ENSG00000166562 "SEC11 homolog C, signal peptidase complex subunit" Q9BY50 18 59139477-59158836 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 132.6" "Cell type enhanced" "Detected in all" 5 "Glandular cells: 405.9;Muller glia cells: 440.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 59.5;Karpas-707: 64.1;RPMI-8226: 129.8;U-266/70: 65.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026816, HPA047533" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Nuclear membrane" "Golgi apparatus" "HPA026816: AB_10602089, HPA047533: AB_2680078" "unprognostic (1.47e-2)" "unprognostic (2.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.44e-2)" "unprognostic (3.13e-3)" "unprognostic (4.48e-3)" "unprognostic (2.95e-1)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.80e-2)" "unprognostic (1.72e-1)" "unprognostic (6.25e-2)" "unprognostic (3.83e-2)" "unprognostic (4.63e-2)" "unprognostic (2.58e-1)" "unprognostic (1.15e-1)" 5.9 18.4 30.1 18.6 29.7 11.3 16.0 14.9 25.2 12.2 18.7 24.4 27.8 27.5 9.1 58.0 10.7 9.2 11.1 7.2 27.7 33.9 19.0 66.8 13.0 22.0 41.8 21.3 7.0 96.8 14.6 46.6 8.1 27.1 48.8 16.4 10.0 132.6 34.1 4.3 7.9 21.1 6.6 51.3 23.6 28.4 6.4 25.3 7.3 35.9 8.6 23.4 18.9 5.9 33.6 50.0 10.6 17.6 17.3 34.4 32.6 8.8 10.7 5.8 9.0 3.6 0.6 7.4 8.0 6.9 9.9 6.0 7.5 4.8 20.3 12.7 4.8 7.3 9.5 9.1 6.0 5.7 59.5 12.5 6.5 7.4 22.9 10.8 21.5 9.9 2.0 14.4 6.1 16.6 2.1 3.2 8.7 7.5 64.1 3.5 10.4 8.8 8.6 5.9 14.7 6.6 8.0 5.7 129.8 6.4 7.4 27.1 10.8 4.8 19.5 27.1 3.3 8.8 15.8 2.6 12.0 5.0 4.2 9.6 65.4 48.1 19.9 12.0 14.6 14.7 10.6 13.1 9.4 25.9 15.5 33.1 33.6 27.3 25.2 13.5 17.4 14.3 19.5 2.0 17.3 17.6 50.0 34.4 32.6 30.1 29.7 14.9 25.2 27.7 33.9 41.8 21.3 27.1 25.3 26.8 96.0 46.9 40.1 29.0 63.6 51.8 132.5 95.0 89.9 57.6 47.1 59.9 74.6 117.2 35.1 52.2 73.8 23.3 229.6 80.5 24.9 405.9 46.2 201.1 102.0 47.7 325.7 35.6 28.2 14.8 11.5 58.2 243.0 32.5 93.2 440.4 146.8 74.8 21.5 86.0 65.5 6.5 40.9 97.2 84.1 39.6 125.2 74.3 75.9 57.4 SEC22A SEC22L2 ENSG00000121542 "SEC22 homolog A, vesicle trafficking protein" Q96IW7 3 123201927-123274130 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.94e-2)" "unprognostic (1.09e-2)" "unprognostic (1.96e-1)" "unprognostic (8.25e-3)" "unprognostic (2.16e-1)" "unprognostic (9.04e-2)" "unprognostic (1.13e-2)" "unprognostic (4.91e-2)" "unprognostic (6.59e-2)" "unprognostic (2.16e-1)" "unprognostic (2.05e-1)" "unprognostic (2.66e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.46e-1)" "unprognostic (1.61e-1)" "unprognostic (3.03e-2)" "unprognostic (5.25e-1)" 14.5 15.8 12.0 12.3 12.2 5.3 15.9 15.7 14.8 14.8 12.2 11.0 13.2 9.0 27.6 15.7 18.0 13.7 13.3 12.2 14.1 9.0 14.8 19.1 16.4 13.0 10.6 10.7 16.0 25.8 13.7 31.1 13.6 12.6 12.6 14.6 13.4 13.7 14.5 8.8 18.9 11.9 17.7 10.6 14.3 12.1 26.3 11.6 17.5 14.9 11.9 17.2 12.6 13.9 14.2 14.2 11.4 14.7 20.4 22.9 12.6 27.9 9.2 13.2 10.9 19.6 19.3 13.6 23.0 16.6 17.6 23.2 8.4 13.7 16.4 17.6 14.6 16.7 18.7 11.8 14.8 27.4 6.7 9.3 11.0 8.4 6.6 20.1 13.8 8.2 13.9 19.2 13.8 14.4 13.5 20.7 12.1 7.1 12.0 16.6 12.2 10.6 8.9 5.0 19.9 18.3 7.8 17.5 14.1 13.8 8.5 10.6 7.8 15.3 10.1 15.2 10.7 21.7 14.5 11.3 12.1 13.3 21.5 14.1 7.3 7.1 23.6 18.1 14.4 19.0 9.8 14.7 11.4 18.6 13.7 22.9 14.2 19.3 20.2 14.2 11.9 21.1 17.2 2.2 20.4 13.0 13.8 19.4 12.6 12.0 12.2 15.7 14.8 14.1 9.0 10.6 10.7 12.6 11.6 3.0 8.9 5.1 15.3 7.4 6.6 5.1 12.7 5.3 11.4 7.0 3.9 23.6 8.3 15.7 23.7 8.3 4.7 0.0 8.9 16.8 10.8 8.9 6.9 7.5 12.1 1.6 7.5 16.0 3.7 13.7 11.2 6.3 5.0 11.8 6.5 6.1 8.9 3.5 6.3 7.1 7.2 19.4 9.2 41.6 9.6 8.3 36.8 10.2 6.6 10.5 SEC22B "ERS-24, sec22b, SEC22L1" ENSG00000265808 "SEC22 homolog B, vesicle trafficking protein (gene/pseudogene)" O75396 1 120150898-120176515 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079017 Approved NA NA 980000 "CAB079017: " "unprognostic (2.21e-1)" "unprognostic (2.29e-2)" "unprognostic (5.02e-2)" "unprognostic (8.52e-2)" "unprognostic (1.13e-1)" "unprognostic (7.88e-2)" "unprognostic (1.54e-1)" "unprognostic (3.08e-1)" "unprognostic (3.30e-2)" "prognostic favorable (4.58e-4)" "unprognostic (1.21e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (3.34e-4)" "unprognostic (5.80e-2)" "unprognostic (2.48e-1)" "unprognostic (1.52e-2)" "unprognostic (2.15e-1)" 11.9 12.0 7.4 8.9 8.3 6.2 10.3 7.6 10.2 12.3 8.5 8.2 15.5 10.0 11.1 18.3 7.3 7.0 10.1 7.7 6.3 10.7 23.6 8.8 9.2 7.6 9.1 10.1 19.6 11.1 25.6 24.8 8.8 11.8 11.2 9.8 19.4 13.4 8.2 6.7 12.4 9.2 7.2 8.9 10.2 7.1 8.3 10.9 11.4 6.3 9.4 11.1 7.8 12.4 16.1 25.1 16.6 14.5 17.8 10.7 9.9 3.3 6.4 9.9 37.0 26.2 8.4 23.5 19.5 16.6 30.8 5.4 4.3 6.3 11.6 14.8 10.1 4.1 6.0 6.3 22.9 8.0 5.6 7.1 18.7 9.3 21.2 9.6 8.7 25.4 8.2 21.4 11.6 29.1 10.2 8.3 4.6 13.6 22.4 19.3 8.9 5.2 9.2 7.0 8.8 8.4 14.9 7.0 12.7 7.6 6.6 7.1 8.4 12.2 12.4 9.7 6.4 11.2 13.9 22.9 10.9 39.7 15.3 9.4 6.4 9.8 35.3 8.6 25.2 17.4 16.6 14.1 13.3 14.9 17.8 12.4 15.0 13.6 10.0 11.0 15.3 17.0 25.1 14.5 13.1 16.1 11.7 10.7 26.8 35.7 29.7 22.2 0.0 30.0 15.7 43.3 18.7 27.3 40.1 31.4 56.3 94.5 35.1 4.1 27.0 42.5 46.7 34.0 57.8 20.6 54.1 50.7 64.8 44.2 11.1 40.8 36.8 48.0 4.2 46.6 36.7 0.0 32.5 67.3 56.4 32.0 24.6 45.3 46.1 137.0 51.8 24.3 20.0 13.5 0.0 91.4 42.0 36.3 29.4 SEC22C "MGC13261, MGC5373, SEC22L3" ENSG00000093183 "SEC22 homolog C, vesicle trafficking protein" Q9BRL7 3 42547969-42601080 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031242 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA031242: " "unprognostic (1.68e-1)" "unprognostic (4.86e-2)" "unprognostic (1.01e-1)" "unprognostic (2.67e-1)" "unprognostic (9.37e-3)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.15e-1)" "unprognostic (3.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.58e-2)" "unprognostic (2.57e-1)" "prognostic favorable (1.35e-7)" "unprognostic (2.59e-1)" "unprognostic (3.30e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-3)" 25.3 20.9 27.6 13.4 30.5 28.0 28.8 19.0 30.5 24.1 21.1 32.8 17.4 28.4 26.2 25.8 16.4 22.2 17.4 22.6 27.5 25.4 22.5 14.1 24.6 18.9 34.7 24.6 29.0 26.6 23.8 23.7 17.7 27.6 36.4 14.5 25.7 23.3 25.1 15.4 14.5 31.6 24.9 49.2 15.8 20.7 32.0 25.6 14.5 23.5 11.8 15.2 18.4 17.6 11.5 10.3 18.8 10.7 9.9 19.4 9.2 12.3 11.6 16.2 14.5 32.5 30.7 4.5 22.4 20.7 21.5 22.7 8.2 18.4 12.0 9.2 23.2 15.5 6.6 12.5 18.9 19.4 16.7 14.2 18.7 19.6 9.3 25.7 10.3 19.2 18.2 23.2 26.9 28.7 20.6 24.5 19.3 18.5 21.1 21.1 8.0 12.3 9.5 10.2 6.8 17.3 6.3 11.5 10.5 17.7 10.1 9.5 13.7 17.1 12.6 15.7 12.4 24.5 9.6 22.3 19.6 15.6 29.7 21.7 17.8 26.9 11.3 21.3 13.2 18.2 8.7 10.7 18.8 13.7 7.7 19.4 11.5 17.7 16.1 9.9 9.8 15.2 13.4 6.0 9.9 8.0 10.3 14.2 9.2 27.6 30.5 19.0 30.5 27.5 25.4 34.7 24.6 27.6 25.6 23.8 25.9 19.9 14.3 13.4 15.4 16.9 25.5 18.7 18.2 10.4 27.5 18.6 34.9 26.6 32.1 31.2 4.2 70.0 28.5 17.2 32.7 23.5 48.5 10.6 28.2 25.4 8.6 27.6 18.3 9.9 30.2 19.3 38.8 45.1 4.4 31.0 23.7 0.0 40.3 22.3 31.8 38.8 31.4 75.8 54.1 8.9 8.8 28.7 6.7 5.4 SEC61A1 ENSG00000058262 "Sec61 translocon alpha 1 subunit" P61619 3 128051641-128071683 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 178.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022076 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB022076: " "unprognostic (1.84e-1)" "unprognostic (8.00e-2)" "unprognostic (8.21e-2)" "prognostic favorable (7.82e-4)" "unprognostic (2.13e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.07e-6)" "unprognostic (2.84e-2)" "unprognostic (4.67e-1)" "unprognostic (1.23e-1)" "unprognostic (3.85e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (6.84e-9)" "unprognostic (2.73e-2)" "unprognostic (3.18e-2)" "unprognostic (8.33e-2)" "unprognostic (2.51e-2)" 28.6 38.2 15.2 23.2 16.2 18.5 38.4 12.8 16.2 45.0 24.2 15.9 77.9 22.1 32.6 52.8 31.1 28.3 34.4 27.6 14.3 13.5 37.6 132.2 33.2 44.9 17.4 10.3 28.5 178.4 31.5 36.5 51.6 15.2 26.2 26.0 19.0 87.1 81.7 22.7 22.7 32.5 31.3 15.4 28.8 33.8 21.2 15.4 22.9 35.5 28.8 36.6 24.2 26.4 13.8 35.6 40.0 25.1 18.7 39.3 29.0 40.1 21.1 21.2 37.7 60.3 52.1 39.1 64.8 75.2 56.5 61.0 40.0 29.3 26.8 39.1 83.6 42.3 35.7 33.2 45.8 54.8 24.2 18.2 30.5 23.6 42.1 88.9 38.7 34.8 57.1 55.4 53.2 68.8 42.8 49.6 18.7 20.0 65.7 65.5 36.6 19.9 12.8 28.6 35.6 29.6 21.0 19.0 52.5 29.4 35.2 24.2 23.7 32.0 30.5 40.8 25.6 28.4 33.1 48.7 44.6 25.3 51.7 30.2 60.1 28.6 38.6 72.9 25.2 57.5 40.0 25.1 19.1 28.3 23.0 39.3 13.8 20.5 24.8 24.7 8.5 13.0 15.0 6.6 18.7 22.4 35.6 13.1 29.0 15.2 16.2 12.8 16.2 14.3 13.5 17.4 10.3 15.2 15.4 29.8 34.5 23.1 22.5 32.7 16.8 12.9 35.7 10.7 20.5 47.1 33.4 56.4 3.3 77.1 35.8 35.6 73.5 23.3 133.3 103.4 63.4 59.6 25.4 101.3 67.9 25.4 70.7 53.4 26.8 17.6 38.0 27.4 32.1 25.2 85.2 24.5 95.2 53.4 41.1 22.6 14.1 32.3 34.0 9.3 15.8 25.7 107.0 25.4 63.1 30.3 SEC61A2 FLJ10578 ENSG00000065665 "Sec61 translocon alpha 2 subunit" Q9H9S3 10 12129637-12169961 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.5" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 33.4;Late spermatids: 23.8;Spermatocytes: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.83e-2)" "unprognostic (2.76e-2)" "unprognostic (1.48e-2)" "unprognostic (1.01e-3)" "unprognostic (4.18e-2)" "unprognostic (1.84e-2)" "unprognostic (1.28e-3)" "unprognostic (1.55e-2)" "unprognostic (2.97e-1)" "unprognostic (3.95e-2)" "prognostic favorable (1.08e-5)" "unprognostic (3.14e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (6.41e-2)" "unprognostic (4.95e-2)" "unprognostic (6.18e-2)" "prognostic favorable (8.75e-4)" 4.0 5.6 14.3 5.1 19.7 14.1 5.3 16.5 33.5 3.8 3.8 20.3 3.2 3.7 7.8 9.2 3.9 4.1 5.2 11.3 16.8 22.1 3.1 7.8 3.8 5.8 15.6 14.6 5.8 3.3 5.5 9.4 4.5 22.7 6.0 5.9 5.7 2.7 6.3 6.9 8.6 3.3 5.9 21.1 4.8 3.6 17.3 9.9 5.0 5.2 1.3 6.1 4.1 3.6 1.3 5.8 4.1 0.5 2.0 2.7 0.4 5.9 10.8 14.1 8.7 6.0 3.7 4.7 6.0 3.3 11.8 12.5 10.2 4.0 2.2 3.3 9.4 15.9 4.9 19.5 7.8 10.2 6.6 7.4 2.7 12.6 7.2 5.9 1.6 6.5 5.5 4.7 21.5 3.4 5.2 3.0 13.3 3.2 6.5 10.0 5.2 5.4 2.7 13.9 5.3 3.3 5.8 5.8 1.4 7.3 6.2 6.7 9.9 8.8 4.7 4.3 11.5 9.0 2.7 5.4 10.3 12.0 13.1 4.1 6.0 8.5 3.5 8.0 2.2 3.1 0.0 0.4 0.3 2.1 0.1 1.9 0.7 1.3 1.3 1.0 1.3 2.7 1.7 4.1 2.0 0.5 5.8 1.9 0.4 14.3 19.7 16.5 26.4 16.8 22.1 15.6 14.6 22.7 9.9 3.0 3.2 7.5 2.3 1.5 13.1 6.5 2.5 1.4 3.4 8.7 7.9 2.8 0.0 2.4 15.5 2.7 1.1 0.0 2.0 2.1 4.1 2.8 2.3 13.2 2.3 33.4 1.2 3.7 1.9 23.8 6.4 2.5 5.0 1.8 1.6 6.9 1.7 2.9 4.2 1.3 13.8 0.0 3.8 28.9 13.9 1.3 2.9 1.9 1.0 1.4 SEC61B ENSG00000106803 "Sec61 translocon beta subunit" P60468 9 99222064-99230615 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "monocytes: 2395.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049407 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA049407: AB_2680750" "unprognostic (1.11e-1)" "unprognostic (5.99e-3)" "unprognostic (3.46e-1)" "prognostic favorable (1.26e-5)" "unprognostic (1.96e-1)" "unprognostic (4.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.09e-1)" "unprognostic (6.67e-2)" "unprognostic (1.87e-2)" "unprognostic (2.90e-2)" "unprognostic (7.07e-2)" "unprognostic (1.22e-1)" "unprognostic (1.84e-1)" "unprognostic (1.57e-1)" "unprognostic (6.87e-2)" "unprognostic (2.75e-1)" 26.2 39.8 20.3 27.1 20.7 41.1 37.2 12.6 20.2 36.5 26.2 15.8 47.9 28.5 32.1 52.7 29.3 26.8 26.4 19.8 19.3 17.7 42.0 153.0 31.9 49.3 19.9 14.8 31.6 175.5 13.6 38.5 36.3 17.7 28.9 19.8 21.3 116.6 50.8 16.9 20.5 31.2 21.0 20.1 41.4 29.7 19.9 16.8 43.8 49.3 29.2 35.9 24.5 24.0 36.9 173.3 71.5 48.5 31.0 52.5 47.1 37.7 37.1 42.9 42.5 42.5 54.5 51.9 56.4 59.3 53.5 46.7 53.0 29.9 51.9 43.2 51.5 58.1 46.8 30.0 45.0 25.8 54.6 41.8 27.1 36.1 74.8 92.7 46.5 34.9 48.6 69.6 42.0 37.6 47.7 65.1 42.6 42.4 101.6 50.3 69.6 42.2 68.1 34.3 90.6 87.3 41.0 36.5 66.9 57.8 27.3 44.7 31.7 31.6 73.6 72.2 35.4 28.5 64.4 45.5 38.3 45.7 63.9 46.8 54.8 36.8 33.2 63.9 30.1 25.2 71.5 48.5 44.5 39.1 38.4 52.5 36.9 43.3 39.3 49.4 25.0 27.5 30.1 40.6 31.0 33.2 173.3 38.3 47.1 20.3 20.7 12.6 20.2 19.3 17.7 19.9 14.8 17.7 16.8 95.3 187.1 256.1 245.3 351.6 50.7 48.6 280.2 210.1 184.2 190.1 29.5 281.8 537.2 460.0 124.8 278.2 231.9 23.3 685.9 442.0 377.2 528.8 210.1 851.3 458.0 50.9 289.9 218.5 275.4 31.8 303.8 326.5 470.7 2395.0 308.0 128.3 615.7 260.3 286.0 654.7 66.5 135.8 230.8 200.9 174.6 387.6 463.2 262.1 249.2 374.6 SEC61G SSS1 ENSG00000132432 "Sec61 translocon gamma subunit" P60059 7 54752250-54759974 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Cancer enhanced" "Detected in all" "glioma: 333.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053196 Uncertain NA NA "HPA053196: AB_2682077" "unprognostic (1.39e-2)" "unprognostic (4.51e-3)" "unprognostic (5.26e-3)" "unprognostic (1.82e-2)" "unprognostic (2.46e-2)" "prognostic unfavorable (4.64e-7)" "prognostic unfavorable (3.85e-6)" "unprognostic (2.09e-2)" "unprognostic (2.17e-1)" "unprognostic (2.34e-2)" "unprognostic (1.75e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (6.60e-8)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (7.95e-3)" "unprognostic (8.43e-2)" 32.5 38.0 31.5 33.4 27.2 35.3 44.2 21.6 27.1 48.0 45.9 18.7 52.6 28.2 35.0 90.5 41.3 29.3 34.4 49.7 26.4 29.0 48.9 99.1 33.3 33.6 27.5 22.4 33.3 114.9 15.9 65.6 45.8 24.5 33.2 45.1 24.0 70.6 55.9 35.1 25.0 42.2 37.3 25.0 40.9 33.8 33.5 23.4 37.9 54.8 56.0 39.1 48.4 30.9 24.2 108.6 37.1 24.1 18.9 34.4 20.7 50.7 29.2 40.8 42.6 41.5 52.3 25.6 80.0 51.0 43.0 77.1 41.0 32.5 43.5 43.0 61.1 89.8 37.6 34.4 57.3 89.9 39.4 30.4 28.5 58.9 46.5 59.2 50.4 28.9 39.3 49.8 43.6 75.1 57.6 56.2 29.1 42.1 105.4 90.8 25.6 25.8 88.8 56.6 64.0 52.3 19.9 24.7 71.4 52.3 30.5 37.5 47.5 33.8 75.9 34.7 73.2 38.8 51.5 46.3 36.3 49.9 148.7 60.9 45.0 41.6 81.6 76.0 30.3 70.5 37.1 23.3 19.4 25.7 22.2 34.4 24.2 29.4 27.2 25.5 17.6 21.0 24.8 7.6 18.9 24.1 108.6 26.8 20.7 31.5 27.2 21.6 27.1 26.4 29.0 27.5 22.4 24.5 23.4 92.3 137.4 198.0 222.1 336.5 44.8 213.4 323.6 111.1 86.4 239.0 7.9 237.6 510.6 588.3 29.8 265.2 458.5 163.5 870.7 578.0 399.6 460.8 145.3 669.9 422.5 22.3 294.3 277.5 340.3 28.5 232.4 327.4 472.3 600.5 452.6 85.0 779.0 403.3 209.3 500.1 30.7 109.9 292.0 299.4 247.4 405.5 424.3 249.0 332.7 285.3 SEC62 "Dtrp1, HTP1, TLOC1" ENSG00000008952 "SEC62 homolog, preprotein translocation factor" Q99442 3 169966635-169998373 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014059, HPA061450" Approved Approved "Endoplasmic reticulum,Intermediate filaments" NA NA "Endoplasmic reticulum" "Intermediate filaments" "HPA014059: AB_1858029, HPA061450: AB_2684524" "unprognostic (8.15e-2)" "unprognostic (6.84e-2)" "unprognostic (2.72e-1)" "unprognostic (4.93e-3)" "unprognostic (5.13e-1)" "unprognostic (1.10e-3)" "unprognostic (1.24e-1)" "unprognostic (4.04e-1)" "unprognostic (6.78e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" "unprognostic (3.15e-1)" "unprognostic (2.83e-2)" "unprognostic (4.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.02e-1)" 33.2 30.8 43.1 18.8 46.0 27.3 22.5 30.3 51.7 28.7 26.6 19.7 33.1 19.6 26.1 47.7 25.5 18.7 20.2 21.0 41.7 40.7 41.7 65.7 25.7 19.5 53.2 25.9 31.9 39.5 37.3 34.7 37.8 53.9 34.0 19.9 10.5 39.7 30.8 22.1 11.2 24.4 32.5 55.1 35.3 30.1 16.3 40.2 17.6 42.3 12.2 21.8 43.7 28.3 38.5 14.9 25.0 15.5 12.7 23.6 11.0 34.3 24.2 19.1 16.8 57.2 30.3 12.0 44.1 32.5 20.6 21.5 25.8 36.3 38.7 49.3 31.5 34.4 32.9 23.4 21.3 32.4 30.2 22.7 26.8 15.1 25.9 41.6 27.1 17.6 30.2 20.5 22.6 22.1 28.3 20.3 12.0 16.4 37.5 24.4 28.7 14.2 14.4 19.5 27.6 15.9 19.1 27.6 52.1 29.5 22.1 19.6 18.5 36.1 39.7 30.1 19.2 59.4 25.0 27.0 29.3 13.3 24.4 35.5 43.5 32.6 60.5 30.7 21.2 27.3 6.4 14.1 25.0 19.4 15.5 22.2 33.2 18.4 19.4 13.0 38.5 23.6 20.9 22.2 12.7 11.6 14.9 16.0 11.0 43.1 46.0 30.3 51.7 41.7 40.7 53.2 25.9 53.9 40.2 220.3 262.7 342.9 200.0 226.0 367.3 496.5 300.7 294.5 280.9 645.6 261.1 203.3 165.8 224.9 14.0 313.8 139.0 771.0 299.5 183.3 350.0 241.8 280.2 977.5 192.3 427.5 250.7 386.1 211.1 22.8 518.6 248.1 264.9 296.6 208.7 387.4 260.2 190.0 409.4 320.7 346.7 291.1 249.2 173.4 114.7 150.7 363.1 201.5 162.6 151.0 SEC63 "DNAJC23, ERdj2, PRO2507, SEC63L" ENSG00000025796 "SEC63 homolog, protein translocation regulator" Q9UGP8 6 107867756-107958189 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Transport" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053295, HPA060535" Supported Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA053295: AB_2682105, HPA060535: AB_2684312" "prognostic unfavorable (3.32e-4)" "prognostic unfavorable (4.01e-4)" "unprognostic (4.08e-1)" "unprognostic (1.56e-1)" "unprognostic (4.36e-3)" "unprognostic (1.51e-2)" "unprognostic (8.33e-3)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" "unprognostic (1.04e-1)" "unprognostic (3.27e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (6.16e-4)" "unprognostic (2.35e-1)" "unprognostic (1.93e-1)" "unprognostic (1.56e-1)" "unprognostic (4.41e-2)" 19.9 26.0 22.2 14.4 20.0 20.2 17.4 17.3 19.2 22.8 17.6 13.9 21.9 11.5 22.4 21.5 16.3 18.6 15.4 19.5 18.4 14.5 14.2 35.2 17.6 10.6 19.2 17.9 30.5 45.8 24.9 32.3 27.9 16.8 20.0 13.3 14.0 46.6 27.2 15.3 14.6 12.6 20.2 20.0 13.7 18.5 21.6 21.5 16.7 36.2 9.3 11.7 24.2 21.4 6.1 9.6 6.3 12.0 9.2 11.1 4.9 11.3 6.9 19.2 23.8 20.1 23.8 17.3 24.3 26.9 11.6 16.6 12.4 14.2 21.2 20.8 21.8 14.4 16.7 13.3 15.6 17.9 25.4 14.7 22.9 11.0 12.7 31.4 26.1 13.6 18.6 25.9 18.6 41.2 21.1 16.2 13.0 19.1 34.3 23.8 9.0 8.1 11.8 15.1 12.1 7.5 26.0 22.7 17.3 14.1 15.1 16.9 19.2 13.4 20.3 24.3 13.7 14.4 38.7 17.4 17.6 10.9 17.5 18.8 13.1 9.6 21.2 19.4 22.9 20.0 6.3 7.3 6.3 7.0 6.3 11.1 6.1 5.9 5.7 7.4 6.1 6.6 5.1 2.5 9.2 12.0 9.6 3.1 4.9 22.2 20.0 17.3 19.2 18.4 14.5 19.2 17.9 16.8 21.5 110.2 115.9 47.7 57.1 75.6 58.2 69.4 73.9 135.1 136.5 50.6 37.3 67.2 10.0 69.3 20.3 58.5 30.2 0.0 109.1 79.1 85.4 76.0 66.0 118.1 56.0 44.5 51.5 63.3 51.7 13.6 98.4 64.0 75.9 27.1 61.3 52.4 75.9 58.8 111.7 36.6 44.0 45.3 91.8 139.3 53.4 69.9 76.1 46.5 54.2 62.9 SECTM1 K12 ENSG00000141574 "Secreted and transmembrane 1" Q8WVN6 17 82321024-82334074 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.9;intestine: 103.1" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 42.8;Kupffer cells: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 45.9" "Group enriched" "Detected in many" 13 "granulocytes: 45.9;monocytes: 16.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.3;BJ hTERT+: 27.5;BJ hTERT+ SV40 Large T+: 21.2;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;PC-3: 21.8;SiHa: 37.5;SK-BR-3: 20.4;U-2197: 28.6" HPA051214 Approved "Secreted - unknown location" NA NA 26000000 "HPA051214: AB_2732565" "unprognostic (2.42e-1)" "unprognostic (2.95e-2)" "unprognostic (1.56e-1)" "unprognostic (2.69e-2)" "unprognostic (4.29e-2)" "unprognostic (1.15e-2)" "unprognostic (4.55e-2)" "unprognostic (9.39e-2)" "unprognostic (3.17e-3)" "unprognostic (7.75e-3)" "unprognostic (2.10e-2)" "unprognostic (1.95e-1)" "unprognostic (4.30e-2)" "unprognostic (1.43e-1)" "unprognostic (4.31e-3)" "unprognostic (2.84e-1)" "unprognostic (1.01e-1)" 13.5 1.8 1.1 15.7 2.1 3.7 10.6 0.7 2.1 6.4 33.2 1.0 1.3 26.2 6.1 4.9 6.1 6.5 4.7 6.1 2.3 0.8 16.8 3.9 11.2 21.7 1.5 0.6 7.8 2.5 0.0 1.3 6.1 3.5 8.6 9.4 2.1 20.2 2.2 4.9 6.6 103.1 5.5 4.2 24.0 9.4 2.1 1.4 2.3 5.1 7.0 7.7 7.8 16.2 0.0 2.3 45.9 16.2 0.0 0.1 1.1 6.0 1.3 0.0 0.4 10.7 27.3 0.5 3.0 27.5 21.2 20.9 0.6 12.5 0.0 0.1 8.9 0.3 18.5 0.0 1.2 0.8 1.9 0.0 2.5 9.5 1.7 8.3 0.0 0.0 11.6 2.8 1.1 0.5 1.5 0.6 0.0 0.0 0.0 13.4 0.2 0.0 0.0 0.0 1.6 21.8 0.0 0.1 0.3 6.1 0.0 1.4 0.1 37.5 20.4 0.4 0.0 1.6 0.5 0.1 2.3 0.2 28.6 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 9.6 0.0 0.1 16.2 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.0 45.9 0.0 14.8 1.0 0.0 1.1 1.1 2.1 0.7 2.1 2.3 0.8 1.5 0.6 3.5 1.4 11.9 3.7 3.9 4.6 8.4 0.0 0.8 0.0 2.7 2.3 1.8 0.0 0.1 0.0 5.2 0.0 1.6 42.8 0.0 8.3 0.7 6.8 16.9 1.1 0.0 6.9 0.0 0.0 1.8 39.9 0.2 4.9 17.6 1.7 1.8 2.3 0.0 8.7 17.5 0.0 2.2 0.0 0.0 3.3 0.0 0.2 3.0 0.2 0.0 1.0 12.0 SEL1L "IBD2, SEL1L1" ENSG00000071537 "SEL1L ERAD E3 ligase adaptor subunit" Q9UBV2 14 81471549-81533861 "Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 121.3" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 116.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 78.4;U-266/84: 66.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024267 Enhanced "Intracellular and membrane" NA NA "HPA024267: AB_1856659" "unprognostic (4.94e-1)" "unprognostic (8.69e-2)" "unprognostic (1.09e-2)" "unprognostic (1.91e-1)" "unprognostic (5.93e-2)" "unprognostic (1.16e-1)" "unprognostic (3.29e-1)" "unprognostic (2.78e-1)" "unprognostic (9.97e-2)" "unprognostic (2.58e-2)" "unprognostic (2.76e-3)" "unprognostic (4.86e-1)" "unprognostic (3.31e-2)" "unprognostic (1.30e-1)" "unprognostic (4.96e-2)" "unprognostic (1.83e-2)" "unprognostic (1.25e-2)" 13.2 8.5 9.5 9.2 11.3 4.9 9.1 6.6 9.4 7.5 10.8 8.4 7.1 11.3 10.9 6.1 6.4 7.7 7.0 8.5 8.1 7.1 9.8 33.5 9.0 7.0 10.4 9.0 7.3 121.3 10.0 6.3 18.2 10.2 10.3 10.2 4.9 9.1 8.3 10.9 7.3 10.7 9.0 10.7 11.2 10.6 3.9 10.5 6.5 17.0 4.3 8.8 10.3 11.4 8.9 12.1 29.3 16.4 10.5 11.4 8.4 7.7 15.6 6.3 8.1 14.2 13.9 11.2 12.3 11.9 7.2 7.7 5.9 12.1 7.9 13.6 14.1 8.8 7.4 4.3 6.9 13.1 12.3 3.1 5.8 5.1 7.3 20.3 11.7 13.9 11.2 16.6 7.2 15.8 10.6 11.7 6.6 3.5 44.7 8.8 9.5 6.6 3.3 2.0 13.0 6.7 4.6 8.9 6.2 5.5 12.1 3.6 5.9 9.6 9.0 10.2 5.6 15.6 7.9 19.5 20.4 11.6 11.3 7.6 78.4 66.2 7.9 22.5 5.4 7.8 16.6 12.9 15.4 11.4 16.4 9.4 8.9 9.0 9.0 12.1 8.3 8.4 9.0 29.3 10.5 13.6 8.9 8.7 8.4 9.5 11.3 6.6 9.4 8.1 7.1 10.4 9.0 10.2 10.5 11.9 32.8 16.4 13.5 23.8 22.8 56.5 20.4 22.7 17.0 26.2 29.5 18.1 5.0 19.4 3.0 31.8 32.5 0.0 39.5 16.9 29.4 37.3 33.5 116.9 28.8 28.6 20.7 41.7 52.2 4.0 21.9 36.6 50.6 18.0 34.9 25.3 38.4 33.7 26.5 19.6 16.4 45.3 26.4 11.1 17.5 22.8 35.0 20.8 23.5 28.0 SEL1L3 KIAA0746 ENSG00000091490 "SEL1L family member 3" Q68CR1 4 25747427-25863760 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 48.0" "Cell type enhanced" "Detected in many" 4 "Mucus-secreting cells: 74.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 45.9" "Group enriched" "Detected in many" 5 "memory B-cell: 20.8;naive B-cell: 20.8;plasmacytoid DC: 17.9" "Group enriched" "Detected in many" 4 "B-cells: 20.8;dendritic cells: 17.9" "Cell line enhanced" "Detected in many" "Daudi: 65.9;OE19: 49.9;U-698: 43.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 191.0" "HPA040045, HPA058792" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040045: AB_10796116, HPA058792: AB_2683822" "unprognostic (1.01e-2)" "unprognostic (2.03e-1)" "unprognostic (3.06e-3)" "unprognostic (1.44e-2)" "unprognostic (2.43e-3)" "unprognostic (1.80e-1)" "unprognostic (1.26e-2)" "unprognostic (1.39e-1)" "unprognostic (5.33e-2)" "unprognostic (7.24e-2)" "unprognostic (1.11e-1)" "unprognostic (5.11e-1)" "unprognostic (4.77e-2)" "unprognostic (7.21e-3)" "unprognostic (1.32e-1)" "unprognostic (2.28e-2)" "prognostic favorable (4.33e-4)" 5.4 3.3 4.0 36.3 5.6 2.3 3.8 45.9 6.4 13.7 19.3 1.5 1.5 19.3 2.2 18.1 6.2 3.6 22.0 2.4 3.3 2.8 6.9 3.6 14.3 27.7 2.1 1.7 3.1 48.0 10.9 2.9 13.7 3.0 4.2 16.7 12.9 23.1 1.0 1.3 1.7 30.3 3.4 2.1 33.5 24.6 2.2 1.1 2.8 12.5 3.8 46.7 14.8 2.2 20.8 17.9 0.4 0.1 3.7 4.3 1.4 4.8 5.3 3.9 1.3 0.6 0.8 0.6 2.4 6.6 1.8 6.0 3.3 22.7 65.9 11.7 16.6 15.9 3.1 2.9 10.5 2.5 3.5 1.7 0.7 8.8 4.5 17.1 9.0 0.4 1.3 8.5 6.6 2.6 7.5 24.8 1.3 4.3 0.0 1.3 3.7 0.0 0.6 11.4 49.9 4.7 0.3 21.7 9.1 14.5 16.4 9.8 1.9 16.1 0.2 1.6 5.7 0.8 11.2 10.8 0.1 7.9 0.1 6.9 0.4 0.1 43.0 30.0 3.8 4.5 0.4 0.1 0.0 2.8 0.0 3.4 20.8 3.5 3.1 0.7 20.8 1.5 2.4 0.3 3.7 0.1 17.9 4.3 1.4 4.0 5.6 45.9 6.4 3.3 2.8 2.1 1.7 3.0 1.1 11.9 29.0 65.6 3.0 0.8 2.1 1.2 63.7 8.1 55.7 3.5 0.0 23.3 0.0 64.6 46.5 8.4 31.3 23.3 28.5 1.3 1.5 12.0 2.3 1.7 4.6 0.0 11.1 13.5 16.0 58.1 1.4 6.4 8.5 15.4 74.5 32.9 37.4 24.6 0.4 9.7 29.0 0.0 1.4 0.6 2.4 1.4 13.7 26.1 35.6 4.2 SELE "CD62E, ELAM, ELAM1, ESEL" ENSG00000007908 "Selectin E" P16581 1 169722641-169764705 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 50.0" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 41.0;Endothelial cells: 101.9;Melanocytes: 43.9;Suprabasal keratinocytes: 41.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HUVEC TERT2: 5.3" "Not detected" "Not detected" CAB002143 Enhanced NA NA 8140000 640000000 "CAB002143: AB_563608" "unprognostic (2.39e-1)" "unprognostic (2.16e-2)" "unprognostic (1.37e-2)" "unprognostic (2.09e-2)" "unprognostic (1.61e-1)" "unprognostic (1.40e-2)" "unprognostic (1.59e-1)" "unprognostic (2.94e-1)" "unprognostic (3.63e-1)" "unprognostic (3.88e-1)" "unprognostic (9.74e-2)" "unprognostic (4.32e-2)" "unprognostic (1.56e-2)" "unprognostic (8.13e-3)" "unprognostic (4.69e-2)" "unprognostic (4.63e-2)" "unprognostic (2.55e-1)" 14.9 2.7 0.9 30.4 1.2 0.2 8.3 0.3 1.0 13.7 2.7 1.9 4.4 0.4 18.1 3.2 6.7 20.1 7.4 4.4 0.9 0.9 2.5 4.9 10.6 2.0 1.2 0.0 9.8 1.4 21.0 3.1 0.9 5.4 21.2 1.9 4.3 2.0 4.6 2.2 3.7 2.4 13.1 4.8 0.2 3.4 5.6 0.5 0.9 9.0 50.0 15.5 16.4 4.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.9 1.2 0.3 1.0 0.9 0.9 1.2 0.0 5.4 0.5 0.0 6.7 0.0 1.0 41.0 0.0 5.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.3 101.9 0.0 0.0 0.0 0.0 12.4 3.2 1.1 5.9 0.0 0.0 0.0 1.8 0.0 1.6 0.0 0.2 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.1 0.0 41.8 0.0 0.0 0.0 0.6 SELENOI "EPT1, KIAA1724, SELI, SEPI" ENSG00000138018 "Selenoprotein I" Q9C0D9 2 26308547-26395891 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 11.9;Collecting duct cells: 21.0;Ductal cells: 9.5;Pancreatic endocrine cells: 11.6;Syncytiotrophoblasts: 13.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064125 Approved NA NA "HPA064125: " "unprognostic (6.29e-2)" "unprognostic (7.46e-2)" "unprognostic (1.38e-3)" "unprognostic (3.05e-3)" "unprognostic (1.50e-1)" "unprognostic (1.39e-2)" "unprognostic (7.44e-3)" "unprognostic (5.00e-3)" "unprognostic (7.79e-2)" "unprognostic (2.55e-2)" "unprognostic (6.65e-2)" "unprognostic (9.40e-2)" "unprognostic (1.52e-2)" "unprognostic (2.95e-1)" "unprognostic (1.76e-1)" "unprognostic (9.87e-3)" "unprognostic (1.42e-2)" 5.5 8.8 10.3 7.0 20.6 13.3 10.8 21.4 22.5 7.1 10.7 14.1 5.0 15.3 5.8 7.6 15.7 5.0 5.6 6.1 14.7 11.3 10.6 28.6 6.7 6.9 9.7 9.4 5.9 11.3 27.2 11.7 8.5 14.9 8.5 11.5 9.2 9.5 6.2 10.1 22.5 22.1 5.2 15.6 6.3 9.1 5.8 11.0 8.0 9.4 9.4 9.1 7.1 9.9 5.4 3.0 0.6 2.5 2.1 5.0 1.0 19.5 12.1 10.0 10.0 6.3 5.1 15.3 9.6 4.4 4.9 5.0 25.4 12.6 22.8 11.7 4.5 10.4 16.1 15.5 8.5 7.1 6.3 7.3 14.4 8.7 14.9 6.0 19.1 4.7 4.0 7.6 10.7 10.7 2.9 4.4 8.3 16.3 8.0 6.4 8.5 11.3 9.6 12.9 10.0 8.3 10.4 23.7 11.6 9.4 15.2 22.0 9.4 8.1 17.3 7.7 8.7 8.3 5.7 7.1 8.3 10.8 10.9 14.7 10.9 26.9 31.2 8.5 11.9 7.4 0.1 1.7 0.0 2.2 2.5 2.3 5.4 2.3 2.9 1.7 2.6 3.0 5.0 0.6 2.1 2.1 3.0 4.1 1.0 10.3 20.6 21.4 22.4 14.7 11.3 9.7 9.4 14.9 11.0 11.9 8.3 0.0 0.0 0.0 0.0 0.0 0.0 4.0 5.7 21.0 0.0 5.1 0.0 9.5 0.0 0.0 0.0 0.0 8.9 4.9 0.0 0.0 1.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.0 11.6 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 SELENOK SELK ENSG00000113811 "Selenoprotein K" Q9Y6D0 3 53884410-53891988 "Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 244.0;Pancreatic endocrine cells: 237.2;Proximal tubular cells: 306.1;Syncytiotrophoblasts: 292.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 78.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 78.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008196 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008196: AB_1856665" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (3.85e-1)" "prognostic favorable (7.18e-4)" "unprognostic (9.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.02e-2)" "prognostic favorable (3.76e-4)" "unprognostic (2.75e-1)" "unprognostic (5.21e-2)" "unprognostic (8.34e-2)" "unprognostic (1.14e-1)" "unprognostic (3.40e-2)" "unprognostic (8.43e-2)" "unprognostic (8.12e-2)" "unprognostic (9.35e-2)" "unprognostic (2.56e-3)" 20.4 33.5 29.2 19.0 30.2 38.8 24.1 19.7 21.7 18.9 20.5 20.9 28.3 17.3 15.8 49.4 15.0 16.3 17.1 43.2 25.3 26.2 27.6 38.5 18.0 15.1 32.8 16.8 24.8 72.6 20.0 33.0 18.4 27.9 19.3 22.1 27.3 34.2 20.6 41.0 11.5 20.4 16.7 30.1 16.9 18.4 16.8 27.4 8.7 37.7 18.6 20.3 20.2 18.7 12.4 13.4 78.6 10.9 9.9 15.2 15.4 8.8 6.0 13.1 9.7 20.3 12.4 15.5 12.7 14.8 15.1 18.6 13.4 13.6 13.3 5.7 8.2 18.8 5.5 14.6 8.5 13.9 23.3 20.8 8.3 27.0 31.7 18.0 10.9 20.0 7.1 15.1 10.9 14.8 10.2 13.6 9.5 8.0 36.1 14.6 10.0 7.0 13.4 13.6 10.8 22.6 4.6 8.2 24.8 18.8 15.4 7.1 20.5 8.1 12.1 12.6 16.0 7.9 18.0 8.6 10.2 11.8 25.4 17.9 24.9 29.2 11.7 15.4 14.3 15.3 78.6 8.9 21.9 15.2 9.4 14.6 12.4 14.1 15.1 7.5 9.9 12.3 14.1 19.6 9.9 10.9 13.4 14.3 15.4 29.2 30.2 19.7 21.6 25.3 26.2 32.8 16.8 27.9 27.4 125.0 114.9 0.0 0.0 0.0 0.0 0.0 0.0 99.0 99.0 141.3 0.0 144.5 160.8 244.0 0.0 0.0 0.0 0.0 174.6 157.8 0.0 0.0 218.6 0.0 145.4 0.0 0.0 0.0 0.0 0.0 0.0 41.2 0.0 130.8 0.0 0.0 237.2 0.0 0.0 306.1 0.0 0.0 0.0 0.0 0.0 0.0 292.8 0.0 0.0 0.0 SELENOM "SELM, SEPM" ENSG00000198832 "Selenoprotein M" Q8WWX9 22 31104772-31120069 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 293.1;Distal tubular cells: 261.9;Exocrine glandular cells: 512.5;Pancreatic endocrine cells: 240.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 23.0;MAIT T-cell: 29.7;memory B-cell: 32.4;memory CD4 T-cell: 38.3;memory CD8 T-cell: 27.4;naive B-cell: 24.2;naive CD4 T-cell: 51.6;naive CD8 T-cell: 30.4;T-reg: 34.7" "Group enriched" "Detected in all" 6 "B-cells: 32.4;T-cells: 51.6" "Cell line enhanced" "Detected in many" "BJ: 40.4;BJ hTERT+: 38.8;HHSteC: 51.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008667, HPA019601" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 110000 "Nucleoplasm, Cytosol" "CAB008667: AB_1622762, HPA019601: AB_1856666" "unprognostic (5.29e-3)" "unprognostic (1.68e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.59e-3)" "unprognostic (1.45e-1)" "unprognostic (1.60e-2)" "unprognostic (1.60e-1)" "unprognostic (3.51e-3)" "unprognostic (8.31e-2)" "prognostic unfavorable (2.55e-6)" "unprognostic (1.32e-2)" "unprognostic (3.80e-1)" "unprognostic (5.20e-2)" "unprognostic (3.19e-2)" 35.9 19.5 19.8 31.3 20.6 2.4 33.4 13.5 20.8 83.5 66.2 9.1 38.3 22.0 67.5 34.2 53.4 46.1 67.2 25.5 19.1 20.6 19.2 6.6 18.2 35.1 20.7 11.7 49.9 38.1 18.1 27.2 22.1 15.9 59.5 10.7 41.4 57.3 89.1 29.4 11.6 24.0 76.2 14.1 18.2 35.2 21.9 8.8 1.4 45.7 12.2 12.8 92.5 36.1 32.4 1.3 2.4 7.5 7.5 51.6 21.9 3.2 6.8 2.0 11.4 19.1 22.4 22.3 40.4 38.8 18.8 13.7 0.2 0.5 0.4 8.4 23.7 8.5 0.3 1.8 2.4 1.3 1.8 6.8 0.7 2.1 3.4 51.1 0.0 3.5 21.8 7.3 8.9 3.4 9.0 2.4 0.6 0.6 3.9 4.7 1.7 0.1 0.4 2.6 3.0 7.3 0.0 0.0 4.6 2.9 0.0 4.4 9.7 12.6 11.2 0.1 0.7 15.5 0.2 8.2 5.7 16.1 21.1 0.0 3.6 1.6 0.2 22.8 0.0 3.6 2.4 2.2 0.9 23.0 3.8 29.7 32.4 38.3 27.4 1.3 24.2 51.6 30.4 1.6 7.5 7.5 0.4 34.7 21.9 19.8 20.6 13.5 20.8 19.1 20.6 20.7 11.7 15.9 8.8 50.6 112.8 0.0 0.0 0.0 0.0 0.0 0.0 37.5 59.1 293.1 0.0 11.2 261.9 97.3 0.0 0.0 0.0 0.0 512.5 132.0 0.0 0.0 27.9 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 74.9 0.0 0.0 240.3 0.0 0.0 109.7 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 SELENOP "SELP, SeP, SEPP, SEPP1" ENSG00000250722 "Selenoprotein P" P49908 5 42799880-42887392 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 248.3;liver: 403.8" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 416.9;Alveolar cells type 2: 429.0;Hofbauer cells: 658.5;Proximal tubular cells: 719.9" "Cancer enhanced" "Detected in all" "liver cancer: 116.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Hep G2: 92.9;HSkMC: 81.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036287 Approved Uncertain "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA 2220000000 2300000000 "Nucleoplasm, Golgi apparatus" "HPA036287: AB_10794618" "unprognostic (7.96e-2)" "unprognostic (2.10e-1)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (6.67e-2)" "unprognostic (6.37e-2)" "unprognostic (9.22e-2)" "unprognostic (2.19e-2)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "prognostic favorable (6.97e-6)" "unprognostic (1.35e-2)" "unprognostic (4.19e-2)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" 53.8 31.4 17.5 13.5 54.6 2.2 41.1 11.9 24.0 34.9 56.8 52.8 24.2 40.9 22.3 39.0 20.5 26.2 44.4 26.6 27.6 17.5 57.5 403.8 55.0 30.4 106.2 16.1 49.1 15.3 18.2 21.4 62.7 63.6 30.5 48.5 27.1 19.5 41.2 16.4 18.1 248.3 16.1 137.1 87.1 21.6 19.6 70.3 6.3 24.5 14.7 11.3 30.0 33.0 2.2 3.6 2.2 0.7 2.7 2.4 1.4 0.1 0.3 1.4 0.1 7.7 2.1 1.4 0.6 1.9 0.0 0.0 2.0 11.0 0.3 6.9 0.2 0.2 0.3 0.0 0.0 0.0 0.4 8.9 0.5 0.0 92.9 4.7 0.5 0.0 81.3 0.1 0.0 0.0 0.3 0.0 0.3 1.0 2.2 4.0 0.2 0.1 1.1 5.4 3.1 0.1 0.2 0.3 15.9 2.1 1.3 0.3 0.5 0.5 2.8 0.2 10.6 21.7 0.1 0.1 0.5 0.3 0.9 0.1 1.5 0.2 0.3 0.3 1.0 0.2 0.3 0.6 1.8 2.2 0.6 2.4 1.6 1.6 1.7 1.2 2.2 2.4 2.0 2.2 2.7 0.7 3.6 1.5 1.4 17.5 54.6 11.9 24.0 27.6 17.5 106.2 16.1 63.6 70.3 416.9 429.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 187.7 118.7 0.0 169.8 167.5 38.5 0.0 0.0 0.0 0.0 45.9 18.4 0.0 0.0 24.4 0.0 658.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.8 0.0 0.0 47.6 0.0 0.0 719.9 0.0 0.0 0.0 0.0 0.0 0.0 94.4 0.0 0.0 0.0 SELENOS "AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP" ENSG00000131871 "Selenoprotein S" Q9BQE4 15 101270817-101277500 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 173.0;Exocrine glandular cells: 166.1;Extravillous trophoblasts: 174.9;Pancreatic endocrine cells: 185.9;Syncytiotrophoblasts: 254.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "plasmacytoid DC: 96.1" "Lineage enriched" "Detected in all" 5 "dendritic cells: 96.1" "Cell line enhanced" "Detected in all" "Karpas-707: 81.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010025 Approved Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA010025: AB_1079900" "unprognostic (1.90e-1)" "unprognostic (4.03e-2)" "unprognostic (1.06e-1)" "prognostic favorable (1.33e-4)" "unprognostic (2.42e-2)" "unprognostic (3.74e-3)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (9.83e-2)" "prognostic favorable (5.19e-4)" "unprognostic (2.42e-3)" "unprognostic (4.42e-1)" "unprognostic (1.11e-1)" "unprognostic (1.52e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" "unprognostic (2.66e-2)" 25.1 34.7 16.3 19.6 17.1 18.0 38.3 11.4 15.6 22.8 33.7 20.7 51.6 33.2 21.6 33.7 24.8 20.5 21.9 35.0 15.6 14.6 30.9 58.2 27.0 24.5 24.6 13.4 19.3 80.9 14.6 27.5 38.2 21.2 23.5 37.8 16.5 58.0 42.1 28.3 20.6 41.5 21.8 26.8 27.5 26.8 44.4 18.7 9.7 34.0 22.5 26.4 21.0 30.9 10.0 96.1 17.5 14.8 14.3 17.2 9.6 9.4 15.1 13.6 12.0 29.8 21.2 11.3 28.9 22.2 20.2 20.4 17.9 23.0 7.2 10.8 25.6 34.0 27.0 14.7 13.0 13.2 13.0 19.6 12.1 13.5 18.5 47.3 9.1 14.1 18.4 37.3 13.5 40.2 15.9 15.0 9.6 12.1 81.9 21.6 15.2 6.6 14.2 10.3 36.4 9.8 8.5 11.1 15.7 20.3 22.7 7.6 19.3 20.1 19.0 40.2 18.7 14.2 20.7 15.9 19.1 12.5 25.6 21.9 59.5 49.7 10.4 20.8 10.9 22.9 17.5 10.8 12.3 16.0 12.9 15.4 10.0 12.4 17.2 9.3 7.0 9.4 14.0 3.7 14.3 14.8 96.1 10.9 9.6 16.3 17.1 11.4 15.6 15.6 14.6 24.6 13.4 21.2 18.7 110.2 99.5 0.0 0.0 0.0 0.0 0.0 0.0 104.4 118.3 146.5 0.0 113.3 26.6 173.0 0.0 0.0 0.0 0.0 166.1 174.9 0.0 0.0 27.9 0.0 109.2 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 160.5 0.0 0.0 185.9 0.0 0.0 69.8 0.0 0.0 0.0 0.0 0.0 0.0 254.0 0.0 0.0 0.0 SELENOT SELT ENSG00000198843 "Selenoprotein T" P62341 3 150602875-150630445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 180.2;Extravillous trophoblasts: 191.0;Hofbauer cells: 214.0;monocytes: 215.6;Syncytiotrophoblasts: 409.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039780 Approved NA NA "HPA039780: AB_10805594" "unprognostic (1.13e-1)" "unprognostic (4.03e-2)" "unprognostic (2.78e-1)" "unprognostic (1.92e-1)" "unprognostic (3.31e-1)" "unprognostic (1.34e-2)" "unprognostic (2.65e-3)" "unprognostic (1.49e-1)" "unprognostic (8.96e-2)" "unprognostic (5.79e-3)" "unprognostic (6.30e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-3)" "unprognostic (4.91e-2)" "unprognostic (4.08e-2)" "unprognostic (1.58e-1)" "unprognostic (3.41e-2)" 29.7 52.6 39.9 32.1 44.1 54.5 31.0 33.9 48.2 29.9 29.7 37.7 26.7 29.7 29.2 41.8 30.3 31.2 23.5 32.7 41.6 47.4 47.0 52.5 31.1 44.5 41.3 28.2 27.7 34.2 30.6 46.6 50.8 48.0 31.8 36.7 30.2 31.5 33.0 30.5 20.0 38.5 33.4 50.0 49.8 28.5 23.6 31.9 32.3 45.7 23.0 43.2 34.3 23.1 32.1 34.0 54.5 43.2 26.5 42.3 71.0 48.7 20.3 13.1 11.7 20.2 19.9 24.8 38.9 28.8 27.0 18.5 32.1 28.8 27.7 39.8 28.8 23.9 16.9 20.4 24.4 41.6 23.1 17.0 28.8 12.4 15.0 22.2 16.9 21.9 17.1 19.6 24.1 21.0 20.1 29.1 12.5 6.6 81.8 39.3 30.0 22.4 9.8 14.0 29.4 21.8 16.1 16.5 46.1 23.3 29.3 14.0 8.6 23.3 14.7 15.4 17.1 28.0 20.3 27.3 14.7 9.2 26.4 35.7 57.3 29.4 38.3 20.0 30.8 12.5 41.9 43.2 36.4 38.5 35.0 42.3 32.1 32.0 35.2 34.0 26.7 25.3 32.0 54.5 26.5 37.7 24.1 33.5 71.0 39.9 44.1 33.9 48.2 41.6 47.4 41.3 28.2 48.0 31.9 56.6 58.2 0.0 0.0 0.0 0.0 0.0 0.0 60.2 53.4 102.9 0.0 180.2 82.9 154.9 0.0 0.0 0.0 0.0 118.0 191.0 0.0 0.0 41.8 0.0 214.0 0.0 0.0 0.0 0.0 0.0 0.0 45.9 0.0 215.6 0.0 0.0 158.1 0.0 0.0 154.8 0.0 0.0 0.0 0.0 0.0 0.0 409.2 0.0 0.0 0.0 SELL "CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR" ENSG00000188404 "Selectin L" P14151 1 169690667-169711698 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 227.5;lymphoid tissue: 77.8" "Group enriched" "Detected in many" 6 "B-cells: 178.5;Kupffer cells: 97.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 7.0;EFO-21: 6.8;JURKAT: 18.6;MOLT-4: 12.8;U-266/70: 24.1;U-698: 11.2;U-937: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002144, HPA051972" Enhanced Uncertain Cytosol NA NA 8100000000 Cytosol "CAB002144: AB_563862, HPA051972: AB_2797242" "prognostic favorable (3.76e-4)" "prognostic favorable (2.25e-4)" "unprognostic (1.52e-2)" "unprognostic (2.89e-2)" "unprognostic (7.87e-3)" "prognostic favorable (6.43e-4)" "unprognostic (1.39e-3)" "unprognostic (3.43e-1)" "unprognostic (2.70e-3)" "prognostic favorable (3.14e-4)" "unprognostic (1.42e-1)" "unprognostic (4.21e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (4.76e-2)" "unprognostic (8.71e-3)" "unprognostic (9.57e-2)" "unprognostic (1.01e-1)" 6.9 0.9 2.0 25.1 4.6 30.3 1.5 1.1 2.5 0.9 1.4 1.1 0.0 0.4 1.0 1.1 4.2 3.2 5.4 4.1 2.5 2.2 2.3 2.5 11.4 77.8 5.2 0.2 0.8 1.0 10.7 7.9 3.4 2.7 1.2 1.3 3.8 12.1 0.1 0.9 0.8 8.8 2.9 5.2 67.7 1.7 1.0 2.3 43.8 1.9 1.3 64.0 8.1 6.1 40.4 40.7 227.5 49.7 130.8 69.5 90.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.2 7.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.8 0.8 0.3 0.0 0.0 0.0 0.0 1.2 18.6 0.0 0.9 0.0 0.8 12.8 0.1 0.0 0.2 0.2 4.9 0.1 0.3 3.9 0.2 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 24.1 0.0 11.2 1.3 7.0 0.1 170.8 49.7 88.6 16.5 11.2 4.5 33.8 30.7 17.0 40.7 40.4 69.5 39.6 227.5 130.8 4.5 32.8 52.7 90.1 2.0 4.6 1.1 2.5 2.5 2.2 5.2 0.2 2.7 2.3 8.9 20.2 178.5 0.3 0.3 0.0 0.3 2.5 2.7 3.4 10.4 0.0 9.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.6 0.8 0.0 9.3 0.4 5.6 0.0 0.0 1.8 97.5 0.0 0.6 7.5 1.7 0.0 0.0 2.3 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 23.8 20.3 0.0 0.5 SELP "CD62, CD62P, GMP140, GRMP, PADGEM, PSEL" ENSG00000174175 "Selectin P" P16109 1 169588849-169630193 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Endothelial cells: 42.8;Ito cells: 14.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "basophil: 6.0;neutrophil: 2.4;T-reg: 8.9" "Group enriched" "Detected in many" 8 "granulocytes: 6.0;T-cells: 8.9" "Group enriched" "Detected in some" 37 "EFO-21: 25.2;HEL: 22.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002145, HPA002655, HPA005990" Enhanced NA NA 830000000 "CAB002145: AB_563984, HPA002655: AB_1078480, HPA005990: AB_1078479" "unprognostic (3.37e-2)" "unprognostic (2.98e-4)" "unprognostic (4.11e-1)" "unprognostic (1.46e-1)" "unprognostic (9.26e-2)" "prognostic favorable (3.12e-4)" "unprognostic (5.30e-4)" "unprognostic (4.14e-2)" "unprognostic (3.59e-1)" "unprognostic (1.74e-1)" "unprognostic (1.93e-2)" "unprognostic (6.61e-2)" "unprognostic (1.19e-1)" "unprognostic (8.24e-3)" "unprognostic (1.74e-2)" "unprognostic (7.85e-3)" "unprognostic (1.66e-1)" 14.2 2.1 0.4 8.4 0.4 1.0 10.9 0.4 0.4 14.8 3.7 0.6 7.5 3.3 10.6 6.2 5.6 7.7 7.0 9.6 0.4 0.4 7.5 4.6 11.3 12.9 0.4 0.4 5.0 1.5 3.8 2.8 7.4 1.3 14.8 2.9 24.7 3.4 4.3 3.7 2.3 5.2 10.5 1.0 1.9 3.5 3.1 0.3 1.4 4.9 7.7 13.0 11.5 27.2 0.9 0.1 6.0 0.5 0.4 8.9 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.0 0.5 0.7 0.0 0.2 0.0 0.9 0.6 0.3 0.0 0.2 0.2 0.1 2.4 0.4 0.0 0.1 8.9 8.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.3 0.3 0.0 5.1 0.0 0.0 3.3 0.0 2.0 2.5 0.0 0.0 1.8 0.0 2.4 0.0 0.0 0.9 42.8 0.0 0.0 0.2 0.0 0.8 0.3 0.0 0.5 0.2 0.0 0.0 14.1 0.0 0.0 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.0 3.4 0.0 0.0 0.0 SELPLG "CD162, PSGL-1" ENSG00000110876 "Selectin P ligand" Q14242 12 108622277-108633959 "Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 126.9;lymphoid tissue: 60.5" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 35.0;Kupffer cells: 84.7;Macrophages: 58.3;monocytes: 101.8;T-cells: 37.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 28.5;HMC-1: 27.7;JURKAT: 22.6;Karpas-707: 43.3;RPMI-8226: 60.2;U-266/70: 70.7;U-266/84: 44.0" "CAB002431, HPA069062" Enhanced NA NA "CAB002431: AB_563509, HPA069062: " "unprognostic (2.32e-2)" "prognostic favorable (1.46e-4)" "unprognostic (3.64e-3)" "unprognostic (1.02e-2)" "unprognostic (6.32e-2)" "prognostic favorable (6.94e-4)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "prognostic favorable (2.92e-4)" "unprognostic (2.26e-1)" "unprognostic (2.12e-2)" "unprognostic (3.24e-1)" "prognostic unfavorable (5.86e-4)" "unprognostic (5.88e-2)" "unprognostic (2.37e-2)" "prognostic favorable (2.74e-4)" "unprognostic (5.44e-2)" 10.6 5.5 11.3 25.3 8.9 10.7 4.2 2.2 12.5 5.8 5.4 27.2 0.1 5.0 2.9 4.1 5.0 6.8 9.6 5.9 12.1 9.6 4.6 3.9 23.3 46.8 16.2 5.4 2.1 2.9 1.3 3.1 7.3 11.5 3.0 5.2 3.4 5.2 2.5 1.8 2.7 10.3 6.7 19.6 60.5 6.0 2.1 13.5 26.0 3.1 2.8 18.0 14.8 3.0 2.2 50.9 126.9 68.4 28.1 63.2 77.1 0.1 0.0 0.3 0.1 0.1 0.3 0.1 1.0 1.0 0.4 0.3 0.0 0.4 0.1 0.3 1.5 0.4 0.0 0.0 0.0 0.3 28.5 0.0 10.1 0.0 0.0 0.0 7.1 27.7 0.4 0.1 0.5 0.1 1.1 0.0 22.6 0.1 43.3 1.3 0.0 5.7 4.1 0.0 0.0 0.3 0.0 0.1 60.2 0.6 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.0 9.1 0.3 0.5 0.1 0.7 0.2 70.7 44.0 1.2 0.3 15.2 0.4 126.9 28.1 88.8 43.8 49.5 35.8 2.0 41.8 37.4 29.4 2.2 32.4 34.1 125.8 28.1 68.4 50.9 63.2 77.1 11.3 8.9 2.2 12.5 12.1 9.6 16.2 5.4 11.5 13.5 3.0 18.0 6.0 0.1 3.1 0.0 2.0 5.1 9.4 4.5 0.0 0.0 0.4 0.0 0.3 6.1 1.1 0.0 0.0 0.2 2.1 3.0 0.1 27.8 0.9 35.0 0.0 0.0 1.8 84.7 7.2 0.3 58.3 6.8 101.8 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 1.4 0.1 0.3 1.6 0.8 37.9 0.0 0.0 SEMA3B "LUCA-1, SemA, sema5, SEMAA, semaV" ENSG00000012171 "Semaphorin 3B" Q13214 3 50267558-50277546 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 147.6" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 151.8;Enterocytes: 193.7;Syncytiotrophoblasts: 93.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "eosinophil: 3.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.3" "Cell line enhanced" "Detected in many" "HeLa: 23.0;Hep G2: 34.8;SK-BR-3: 18.1;WM-115: 56.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA030651 Uncertain "Secreted in other tissues" NA NA 29000 "HPA030651: AB_10602224" "prognostic favorable (1.27e-4)" "unprognostic (6.48e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.68e-1)" "unprognostic (4.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.28e-1)" "unprognostic (1.85e-2)" "unprognostic (4.27e-1)" "unprognostic (7.99e-2)" "unprognostic (7.78e-2)" "unprognostic (3.89e-1)" "unprognostic (8.87e-3)" "unprognostic (1.69e-2)" 3.3 18.8 2.5 2.0 7.4 0.0 1.0 0.3 9.2 9.2 6.0 18.6 2.3 13.3 4.4 3.5 2.5 3.4 5.6 3.4 3.6 7.7 0.0 8.1 0.0 12.9 4.9 2.6 5.6 3.5 0.0 147.6 8.2 2.8 2.8 8.5 1.2 6.8 1.5 0.5 19.7 3.9 5.9 0.3 11.9 0.5 9.5 0.0 1.6 0.6 0.0 1.9 0.6 0.0 0.4 3.3 0.0 0.0 0.0 0.0 4.0 2.6 0.2 2.6 0.2 0.3 0.6 5.3 7.3 1.5 2.6 2.0 10.1 0.0 4.9 5.1 0.0 0.6 0.1 8.5 0.6 0.0 0.2 0.0 23.0 34.8 5.8 0.0 0.2 1.7 0.1 1.7 1.3 6.8 0.0 0.0 0.0 0.6 0.2 7.2 0.0 0.2 0.3 7.5 1.4 0.1 0.4 0.1 2.5 0.4 0.3 1.2 1.3 18.1 2.7 0.8 1.3 0.0 0.1 0.4 5.3 1.4 1.7 1.4 0.0 0.0 2.7 0.0 56.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 151.8 18.1 2.7 7.9 0.0 3.7 11.6 43.3 9.4 34.2 61.1 0.0 3.3 1.7 32.0 9.1 3.6 193.7 0.0 20.4 0.9 22.9 9.4 11.5 0.9 1.7 0.0 9.9 8.0 2.6 14.9 3.7 1.3 0.0 1.0 31.6 18.8 31.2 56.1 2.8 45.3 1.6 6.5 2.1 4.9 4.7 0.0 93.4 0.0 25.9 27.1 SEMA3D "coll-2, Sema-Z2" ENSG00000153993 "Semaphorin 3D" O95025 7 84995553-85186855 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.8;thyroid gland: 33.0" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 137.5;Leydig cells: 48.6;Peritubular cells: 58.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "amygdala: 17.1" "Cell type enriched" "Detected in single" 5 "naive B-cell: 2.0" "Lineage enriched" "Detected in single" 5 "B-cells: 2.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 17.0;HaCaT: 17.3;TIME: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037522 Uncertain Approved "Golgi apparatus,Plasma membrane" "Secreted in other tissues" NA NA 77000 "Golgi apparatus" "Plasma membrane" "HPA037522: AB_10672494" "unprognostic (7.05e-2)" "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (1.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.51e-1)" "unprognostic (7.58e-3)" "unprognostic (4.02e-3)" "unprognostic (9.94e-2)" "unprognostic (5.62e-2)" "unprognostic (1.63e-1)" "unprognostic (9.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (5.25e-3)" 4.1 2.2 17.1 1.9 2.3 0.1 4.3 0.8 2.8 4.6 2.9 1.8 2.5 1.4 1.9 7.4 1.3 3.9 1.4 2.0 3.6 2.7 3.0 1.0 3.6 6.1 2.4 3.1 4.1 0.8 0.4 1.5 0.6 5.4 6.2 2.6 2.6 5.6 2.9 0.7 2.1 2.7 3.2 4.8 33.8 2.4 4.3 2.5 0.0 33.0 0.6 1.1 4.7 3.9 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.3 4.6 5.0 5.4 2.6 0.0 0.0 0.0 1.4 17.0 0.1 17.3 1.9 0.0 3.6 0.0 3.5 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 4.4 6.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 4.5 1.2 5.5 4.0 1.7 0.0 0.1 0.6 0.0 0.0 0.2 8.9 0.2 0.0 26.5 0.0 1.7 0.2 0.0 3.3 1.9 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 17.1 2.3 0.8 2.2 3.6 2.7 2.4 3.1 5.4 2.5 0.0 3.5 0.8 2.3 3.2 1.5 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 137.5 5.2 0.0 0.0 0.2 0.0 6.7 7.1 2.3 0.0 0.9 1.6 25.4 1.8 0.0 14.9 48.6 0.8 11.8 0.0 0.0 0.9 0.0 0.0 58.7 4.5 4.1 0.0 2.1 0.7 0.7 2.0 0.0 0.0 0.1 0.4 SEMA4A "CORD10, FLJ12287, SEMAB, SemB" ENSG00000196189 "Semaphorin 4A" Q9H3S1 1 156147366-156177752 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Angiogenesis, Differentiation, Immunity, Neurogenesis" "Developmental protein" "Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 46.8" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 61.4;Collecting duct cells: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 26.4;eosinophil: 25.2;intermediate monocyte: 29.5;myeloid DC: 40.3;neutrophil: 46.8;non-classical monocyte: 15.6" "Group enriched" "Detected in many" 12 "dendritic cells: 40.3;granulocytes: 46.8;monocytes: 29.5" "Cell line enhanced" "Detected in many" "Karpas-707: 55.9;U-698: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA069136 Supported NA NA 2400000 "HPA069136: AB_2686093" "unprognostic (1.90e-1)" "unprognostic (2.39e-2)" "unprognostic (4.24e-1)" "unprognostic (5.20e-2)" "unprognostic (8.04e-2)" "prognostic favorable (1.09e-4)" "unprognostic (1.97e-1)" "unprognostic (2.50e-2)" "unprognostic (3.51e-1)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (8.20e-4)" "unprognostic (8.77e-2)" "unprognostic (4.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.28e-2)" 4.5 1.0 19.2 21.4 17.6 23.1 6.5 2.9 19.2 5.6 4.7 2.5 10.3 2.6 2.1 37.0 19.8 5.7 8.3 2.9 8.4 12.7 11.6 1.7 11.7 28.7 6.3 12.2 3.6 2.9 1.4 2.5 7.4 4.8 10.2 4.4 24.6 19.5 13.7 1.9 21.6 3.0 2.7 2.7 17.5 7.1 2.5 3.5 11.0 24.0 9.3 30.8 7.3 10.1 3.1 40.3 46.8 29.5 0.9 1.9 11.4 4.5 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 2.9 0.1 0.2 0.0 4.3 0.3 3.6 0.1 1.2 0.0 0.1 0.0 0.1 0.1 6.5 0.4 0.2 3.4 0.0 0.1 0.8 0.3 1.0 0.4 55.9 0.2 5.4 0.0 2.3 1.3 4.4 0.0 0.2 0.1 1.8 6.6 8.8 0.0 0.1 0.0 7.1 0.3 0.6 8.1 8.4 0.3 0.0 0.0 0.0 0.0 10.8 1.0 24.3 0.2 6.3 0.1 3.0 26.4 25.2 0.9 29.5 1.9 3.1 0.3 1.8 40.3 2.8 0.0 0.3 46.8 0.9 15.6 5.8 0.3 11.4 19.2 17.6 2.9 19.2 8.4 12.7 6.3 12.2 4.8 3.5 17.9 61.4 10.7 21.4 20.8 1.0 4.5 10.2 12.0 10.3 38.4 0.0 0.7 1.7 4.9 4.1 3.8 1.0 0.0 0.6 0.4 12.7 13.0 17.3 0.0 15.8 0.0 3.5 7.4 18.6 3.7 1.7 34.4 15.1 16.2 20.4 5.8 1.0 3.5 1.1 0.7 0.3 0.0 5.3 1.9 0.5 24.1 1.5 1.9 18.3 12.4 SEMA4B "KIAA1745, MGC131831, SEMAC, SemC" ENSG00000185033 "Semaphorin 4B" 15 90160604-90229679 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 14.7;naive B-cell: 11.8;neutrophil: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 14.7;granulocytes: 4.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 52.8;RPTEC TERT1: 32.7;RT4: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013372 Approved Approved "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Cell Junctions" "Nucleoplasm, Vesicles" "HPA013372: AB_1856670" "unprognostic (3.33e-2)" "unprognostic (5.96e-2)" "unprognostic (2.23e-2)" "unprognostic (2.50e-2)" "unprognostic (7.78e-2)" "unprognostic (4.48e-2)" "unprognostic (6.34e-3)" "prognostic unfavorable (1.25e-4)" "unprognostic (2.04e-1)" "unprognostic (9.31e-2)" "unprognostic (1.58e-3)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.33e-8)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (3.57e-2)" "unprognostic (7.09e-2)" 7.0 19.8 13.1 13.7 16.7 7.1 13.6 9.1 13.1 16.2 21.7 9.4 18.2 24.0 9.0 12.3 56.7 16.3 20.3 13.8 13.3 7.6 18.6 32.1 11.6 10.0 13.4 11.1 17.0 19.8 9.4 10.8 14.6 15.4 18.1 10.0 15.4 21.3 15.7 4.0 29.0 22.2 13.5 18.8 16.3 22.4 8.3 14.8 12.8 32.7 15.5 27.2 31.6 24.6 14.7 0.9 4.0 2.0 0.3 0.7 1.0 5.9 16.2 1.2 3.8 1.1 0.8 8.9 1.8 4.0 2.3 2.4 1.9 52.8 4.2 20.4 1.3 13.3 28.3 1.0 26.3 1.9 24.0 3.4 5.5 4.0 2.6 4.5 0.6 2.5 3.2 11.5 2.5 5.2 9.6 2.5 1.2 2.6 6.7 1.2 4.4 1.5 2.3 5.5 13.2 14.9 1.8 0.9 9.2 32.7 35.5 3.9 3.9 6.4 10.4 2.4 2.8 7.2 1.7 5.7 1.8 3.4 3.8 4.1 9.7 11.8 2.1 17.4 4.5 1.8 0.0 2.0 0.3 0.7 1.2 0.5 14.7 0.5 0.4 0.9 11.8 0.4 0.5 4.0 0.3 2.0 0.1 0.1 1.0 13.1 16.7 9.1 13.1 13.3 7.6 13.4 11.1 15.4 14.8 14.9 22.7 19.3 32.9 57.8 2.9 5.5 10.2 17.4 40.9 15.7 23.6 11.3 3.3 21.9 0.9 4.5 26.4 0.0 31.3 69.5 4.8 31.7 0.0 11.5 10.7 15.9 4.1 4.3 5.1 0.7 12.0 6.0 5.0 1.0 13.0 31.5 34.3 19.0 11.3 3.3 45.7 19.4 15.5 0.3 3.2 49.9 10.4 4.4 14.9 45.4 SEMA4C "Semacl1, Semaf, SEMAI" ENSG00000168758 "Semaphorin 4C" Q9C0C4 2 96859716-96870757 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 115.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "BEWO: 84.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011090 Approved NA NA 400000 "HPA011090: AB_2185705" "unprognostic (1.25e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (3.53e-5)" "unprognostic (7.10e-2)" "unprognostic (4.46e-2)" "unprognostic (1.57e-2)" "unprognostic (4.20e-3)" "unprognostic (3.08e-1)" "unprognostic (2.16e-1)" "unprognostic (3.56e-2)" "unprognostic (1.82e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (9.50e-7)" "unprognostic (4.78e-3)" "unprognostic (3.09e-1)" "unprognostic (7.31e-2)" "unprognostic (4.08e-1)" 14.2 7.9 7.7 9.0 13.9 2.3 10.6 17.5 22.0 16.7 23.0 27.1 12.9 6.4 23.6 8.2 11.7 19.7 12.5 13.7 9.8 7.5 6.9 7.7 8.9 7.4 25.1 12.2 17.0 7.9 6.1 6.4 33.8 12.8 16.0 5.2 12.8 13.9 18.7 5.2 13.5 8.1 21.6 15.4 22.0 9.7 3.9 14.8 1.8 7.5 6.1 8.4 19.7 20.5 0.0 2.2 1.3 3.7 3.9 2.3 0.9 2.1 3.2 10.5 11.3 2.4 3.1 84.8 3.8 4.7 3.8 3.8 3.2 3.8 0.0 6.3 2.4 3.8 2.3 2.9 1.9 1.8 4.0 3.3 1.4 2.5 6.1 5.5 0.6 3.9 5.2 1.5 3.4 2.9 4.3 2.7 0.7 9.6 3.3 3.6 11.4 0.0 4.9 13.8 0.1 3.1 3.4 5.5 3.7 1.4 4.6 6.5 9.3 3.0 7.1 16.8 8.6 2.4 5.9 0.8 6.2 7.9 8.8 3.9 0.0 0.2 0.0 3.0 4.8 10.3 1.3 0.1 0.0 1.8 0.8 2.3 0.0 0.7 1.3 0.0 0.0 1.4 0.4 0.0 3.9 3.7 2.2 0.8 0.9 7.7 13.9 17.5 22.0 9.8 7.5 25.1 12.2 12.8 14.8 0.0 9.3 0.8 8.9 10.2 27.5 5.9 10.2 5.3 7.9 5.2 9.8 33.3 1.7 8.3 0.4 22.4 0.0 0.0 4.3 115.9 21.7 7.0 1.1 8.6 6.8 14.3 5.2 23.4 6.3 0.6 12.4 4.1 20.3 4.6 5.5 26.8 9.1 0.0 8.5 0.3 37.7 19.4 36.2 0.5 4.5 8.9 37.6 5.0 3.3 4.1 SEMA4D "C9orf164, CD100, coll-4, FLJ39737, SEMAJ" ENSG00000187764 "Semaphorin 4D" Q92854 9 89360787-89498130 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.1;skeletal muscle: 43.3" "Cell type enhanced" "Detected in many" 6 "granulocytes: 41.5;T-cells: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 42.5;HMC-1: 32.8;JURKAT: 29.4;MOLT-4: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015662, HPA023277" Approved NA NA 4100000 "HPA015662: AB_1856671, HPA023277: AB_1856672" "unprognostic (2.94e-2)" "prognostic favorable (4.17e-4)" "unprognostic (1.12e-2)" "unprognostic (8.22e-2)" "unprognostic (1.41e-1)" "unprognostic (1.76e-3)" "unprognostic (1.27e-1)" "unprognostic (1.58e-1)" "unprognostic (7.79e-2)" "unprognostic (2.74e-1)" "unprognostic (3.18e-3)" "unprognostic (1.50e-2)" "unprognostic (2.29e-3)" "unprognostic (3.05e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-1)" "prognostic favorable (4.06e-5)" 3.9 5.6 18.0 18.6 20.7 14.3 3.6 7.7 20.9 4.0 5.9 54.0 3.1 6.1 3.9 7.4 9.3 6.6 7.2 4.9 28.2 18.8 8.4 2.0 6.7 32.0 42.6 15.0 4.1 4.6 4.9 5.3 3.2 27.5 4.9 5.8 2.9 6.7 4.2 43.3 8.8 9.6 3.3 107.1 19.2 9.4 6.1 23.3 25.3 4.9 3.1 27.6 8.3 5.3 2.6 4.6 21.2 4.1 4.7 14.0 7.8 4.0 3.0 2.8 4.1 0.1 0.2 6.4 0.4 0.2 0.8 0.6 2.0 4.5 15.3 1.7 0.0 3.3 2.1 2.5 1.2 0.3 42.5 2.5 6.4 1.0 0.2 0.5 8.5 32.8 0.1 0.9 0.2 0.1 0.1 1.6 29.4 1.5 10.4 0.0 6.6 38.5 10.7 6.9 8.0 0.1 12.3 0.9 4.3 5.5 4.2 6.6 4.4 1.1 3.6 0.1 4.1 3.3 4.6 1.0 0.0 2.6 0.3 1.9 11.7 5.0 2.2 1.9 10.3 2.5 7.3 4.1 20.4 13.3 3.8 8.0 2.6 10.6 11.1 1.5 1.6 12.2 14.0 21.2 4.7 4.1 4.6 9.5 7.8 18.0 20.7 7.7 20.9 28.2 18.8 42.6 15.0 27.5 23.3 6.0 21.5 24.2 2.9 4.0 10.2 14.8 5.1 5.3 9.1 10.4 2.0 7.5 3.3 5.0 1.7 4.9 0.5 0.0 2.9 1.8 4.8 6.7 41.5 1.7 17.0 31.8 1.7 5.5 26.2 2.2 6.9 21.6 1.7 5.4 6.4 8.6 3.2 0.0 14.2 14.4 4.8 0.0 2.1 0.7 22.6 4.6 3.1 50.3 3.3 6.7 SEMA4F "SEMAM, SEMAW" ENSG00000135622 "Ssemaphorin 4F" O95754 2 74654228-74683853 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 11.8;Horizontal cells: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064095, HPA065969" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA Nucleoplasm "Plasma membrane, Centrosome" "HPA064095: AB_2732710, HPA065969: AB_2685590" "unprognostic (9.69e-2)" "unprognostic (8.88e-3)" "unprognostic (1.58e-2)" "prognostic unfavorable (5.94e-5)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.23e-2)" "unprognostic (1.61e-3)" "unprognostic (6.95e-2)" "unprognostic (9.01e-3)" "unprognostic (6.53e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.74e-6)" "unprognostic (2.60e-2)" "unprognostic (8.08e-2)" "prognostic favorable (6.94e-4)" "unprognostic (4.69e-2)" 8.1 5.1 15.5 3.5 15.5 1.3 5.7 12.9 21.3 5.2 3.8 3.3 2.3 1.9 6.6 6.7 2.7 5.6 3.5 4.9 17.2 12.2 4.8 2.1 8.1 5.1 5.3 16.5 9.1 4.6 13.7 10.2 3.5 7.8 5.2 4.2 3.6 5.0 5.7 3.0 4.9 3.0 7.0 5.7 4.7 4.3 7.2 3.8 2.9 4.7 1.3 4.9 3.5 4.7 2.8 0.2 1.4 0.4 2.5 5.6 2.1 6.5 4.4 4.8 6.8 7.8 4.4 3.0 4.5 9.4 8.2 7.6 1.8 3.8 2.2 4.9 7.2 19.8 1.9 7.0 7.7 9.1 5.7 5.9 3.8 1.8 3.6 2.8 0.8 6.1 4.0 6.7 5.5 2.9 18.7 3.5 5.0 0.2 0.1 4.8 1.9 3.5 0.7 2.6 3.7 4.3 0.0 6.2 0.0 6.4 3.0 3.0 7.2 6.6 2.7 8.2 6.0 3.2 0.5 3.8 14.1 6.8 3.4 8.2 5.3 5.2 0.3 17.2 0.3 7.5 0.5 0.2 1.4 5.6 0.1 3.2 2.8 3.0 4.9 0.2 2.1 3.3 3.9 0.8 2.5 0.4 0.1 2.2 2.1 15.5 15.5 12.9 21.3 17.2 12.2 5.3 16.5 7.8 3.8 0.0 6.2 0.0 1.5 0.3 8.8 1.4 10.2 1.4 7.9 5.2 11.8 0.7 1.7 2.0 3.1 1.6 0.4 0.0 1.4 2.0 1.2 1.5 2.3 0.6 0.7 11.1 6.9 2.5 0.0 2.4 0.9 0.7 0.0 1.8 0.7 4.1 2.7 0.9 1.4 0.2 5.7 6.5 0.4 3.1 9.8 0.4 0.3 2.5 1.0 1.1 SEMA4G "FLJ20590, KIAA1619" ENSG00000095539 "Semaphorin 4G" Q9NTN9 10 100969518-100985871 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.0;liver: 33.9" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 42.3;Hepatocytes: 52.1;Mucus-secreting cells: 37.8;Paneth cells: 25.9;Undifferentiated cells: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 13.1;CACO-2: 12.5;Hep G2: 45.8;OE19: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038362, HPA077752" Uncertain Uncertain "Vesicles,Lipid droplets" "Intracellular and membrane" NA NA 840000 "Vesicles, Lipid droplets" "HPA038362: AB_10669524, HPA077752: " "unprognostic (3.90e-3)" "unprognostic (9.43e-3)" "unprognostic (2.84e-1)" "unprognostic (1.13e-2)" "unprognostic (5.55e-2)" "unprognostic (8.11e-2)" "unprognostic (3.28e-1)" "unprognostic (3.71e-2)" "unprognostic (3.63e-1)" "unprognostic (1.41e-2)" "unprognostic (3.09e-2)" "unprognostic (3.14e-1)" "unprognostic (3.93e-2)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.05e-2)" 1.2 5.0 8.2 9.2 5.6 0.2 1.9 17.8 9.0 2.5 34.3 4.9 3.2 25.9 2.1 16.6 1.8 3.1 25.9 1.6 4.9 5.0 9.5 33.9 2.9 1.2 4.2 4.6 9.2 21.3 3.7 4.4 2.2 7.8 8.6 42.3 4.8 4.3 6.1 1.2 7.1 44.0 2.5 2.5 1.8 10.4 2.5 3.7 0.1 9.8 0.5 0.5 2.3 2.4 2.4 1.0 0.4 0.4 0.0 1.3 0.0 0.0 13.1 3.4 1.4 2.1 0.7 2.8 0.5 1.4 0.7 0.7 12.5 2.1 0.2 1.7 0.6 0.2 0.8 3.3 0.6 0.6 0.2 2.0 0.6 1.0 45.8 5.4 0.5 0.4 3.6 0.7 0.6 0.3 9.5 1.8 1.4 1.3 0.1 1.0 0.8 0.2 0.5 0.5 28.1 0.7 1.2 0.3 0.6 3.1 0.4 1.0 5.3 0.4 0.9 1.3 3.9 3.6 0.6 1.2 0.4 1.6 0.4 0.1 0.4 0.2 0.2 0.4 0.4 0.4 0.0 0.4 0.4 0.3 0.0 0.2 2.4 0.4 1.3 1.0 0.6 0.4 0.2 0.0 0.0 0.2 0.3 0.1 0.0 8.2 5.6 17.8 9.0 4.9 5.0 4.2 4.6 7.8 3.7 3.0 1.4 2.9 0.3 0.0 0.7 0.9 17.8 2.7 0.0 0.0 0.0 6.0 0.0 1.8 0.2 0.1 42.3 0.0 2.2 1.2 0.4 2.9 0.0 52.1 0.7 11.1 8.2 2.5 4.6 0.0 2.0 0.0 1.7 0.0 37.8 1.1 2.2 25.9 1.1 5.6 1.2 0.0 0.3 0.1 0.7 0.1 2.4 0.0 30.7 0.4 SEMA5A "SEMAF, semF" ENSG00000112902 "Semaphorin 5A" Q13591 5 9035026-9546075 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 140.0;Horizontal cells: 233.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in single" 11 "dendritic cells: 6.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 29.6;fHDF/TERT166: 17.1;RT4: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004632 Approved NA NA "HPA004632: AB_1079905" "unprognostic (1.48e-1)" "unprognostic (1.68e-2)" "unprognostic (1.40e-2)" "unprognostic (6.67e-2)" "unprognostic (3.65e-1)" "prognostic favorable (2.45e-4)" "unprognostic (7.02e-2)" "unprognostic (1.75e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (3.10e-2)" "unprognostic (8.15e-2)" "prognostic favorable (3.66e-8)" "unprognostic (8.51e-3)" "unprognostic (1.27e-2)" "unprognostic (3.57e-1)" "unprognostic (3.01e-2)" 7.1 2.0 13.2 9.8 11.1 0.4 13.4 2.4 12.5 18.5 12.4 11.9 4.5 4.2 12.5 4.2 5.3 4.5 7.6 12.5 14.5 13.0 15.9 6.7 22.1 11.5 11.8 7.4 2.7 6.1 4.3 8.5 9.4 13.0 4.4 10.6 9.2 4.4 7.3 1.9 6.2 7.2 9.1 12.6 8.1 2.8 1.8 9.9 0.3 3.5 4.5 5.0 10.1 9.7 0.0 6.5 0.2 0.0 0.1 0.5 0.0 0.0 0.0 6.9 0.0 4.8 6.8 0.0 10.7 29.6 2.3 1.2 0.0 0.0 0.0 0.0 17.1 0.1 9.7 0.0 0.6 1.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.3 2.5 10.2 4.9 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.7 5.9 0.5 0.0 0.0 0.4 0.8 31.0 1.4 0.1 0.0 0.0 9.1 2.4 0.0 0.0 0.0 10.6 0.2 0.0 0.2 0.0 0.0 0.0 9.9 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 6.5 0.1 0.0 13.2 11.1 2.4 9.7 14.5 13.0 11.8 7.4 13.0 9.9 140.0 6.4 0.0 4.2 8.1 2.2 37.2 15.3 1.4 17.0 1.8 0.0 1.4 0.0 2.4 21.9 2.1 21.7 0.0 2.0 1.0 24.6 4.5 1.1 3.6 1.2 233.6 5.2 7.4 0.0 35.6 9.5 1.1 32.1 0.0 9.9 50.3 1.6 8.6 13.8 12.3 2.7 38.8 14.2 0.5 0.0 4.3 1.6 0.0 18.2 9.7 SEMA5B "FLJ10372, KIAA1445, SEMAG, SemG" ENSG00000082684 "Semaphorin 5B" Q9P283 3 122909193-123028605 "Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;heart muscle: 11.7" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 2.5;Cardiomyocytes: 3.2;Cholangiocytes: 2.5;Ito cells: 3.1;Muller glia cells: 10.6" "Cancer enhanced" "Detected in many" "renal cancer: 18.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 42.4;NTERA-2: 8.2;SH-SY5Y: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066548 Enhanced Supported Cytosol NA NA Cytosol "HPA066548: AB_2685689" "unprognostic (7.34e-2)" "unprognostic (1.84e-3)" "unprognostic (1.92e-4)" "unprognostic (3.01e-2)" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "unprognostic (4.72e-2)" "unprognostic (1.58e-2)" "unprognostic (7.66e-3)" "unprognostic (2.87e-2)" "unprognostic (4.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (1.31e-3)" "unprognostic (5.96e-2)" "unprognostic (6.12e-2)" "unprognostic (2.12e-1)" 1.5 1.2 12.0 0.7 12.3 0.3 1.1 0.8 13.6 2.1 1.5 4.3 0.4 1.9 2.8 5.5 1.5 3.0 4.7 11.7 13.0 3.3 6.1 1.4 2.2 1.1 2.5 3.3 1.3 3.1 1.1 2.5 5.0 2.0 1.8 1.8 6.0 0.9 3.1 1.6 1.2 1.3 3.8 1.7 0.5 0.7 1.1 5.7 0.1 2.2 2.5 1.3 3.3 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 42.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 11.3 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.0 12.3 0.8 13.2 13.0 3.3 2.5 3.3 2.0 5.7 0.0 0.6 0.0 0.0 0.0 2.5 3.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.3 0.0 0.0 1.0 0.0 10.6 0.0 0.0 0.0 0.0 0.9 0.0 2.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 SEMA6A "HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ" ENSG00000092421 "Semaphorin 6A" Q9H2E6 5 116443616-116574934 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.2" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 93.0;Horizontal cells: 130.3;Ito cells: 160.2;Syncytiotrophoblasts: 291.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 12.9;HAP1: 15.1;NTERA-2: 33.8;SuSa: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031264, HPA031265, HPA031267" Approved Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" NA NA 180000 Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA031264: , HPA031265: AB_10610423, HPA031267: " "unprognostic (3.79e-2)" "unprognostic (3.91e-1)" "unprognostic (1.82e-2)" "unprognostic (6.81e-2)" "unprognostic (2.69e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.39e-4)" "unprognostic (1.64e-1)" "unprognostic (4.71e-2)" "unprognostic (5.82e-2)" "unprognostic (1.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.62e-3)" "unprognostic (1.92e-1)" "unprognostic (6.21e-3)" "unprognostic (7.32e-3)" 12.7 37.4 12.6 4.9 34.7 3.6 10.6 18.7 26.5 6.9 19.6 31.2 0.8 19.2 6.1 3.4 3.9 6.2 12.8 5.0 17.2 12.9 6.1 6.0 17.8 4.5 35.9 13.9 13.1 10.3 2.2 4.4 30.2 32.2 6.6 17.5 2.6 15.1 3.2 7.6 5.6 24.0 6.3 48.2 8.2 5.4 6.6 31.4 0.5 6.7 1.6 2.7 4.6 5.9 1.6 0.7 0.1 0.4 0.0 1.3 0.0 0.1 0.0 10.9 12.9 0.0 0.0 11.3 0.2 0.1 0.0 0.0 0.6 0.4 0.4 0.5 0.1 0.2 0.1 15.1 0.0 0.0 0.4 2.2 0.2 0.2 3.6 0.1 0.1 0.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 1.1 33.8 0.0 0.1 1.9 7.1 0.5 5.6 9.7 3.0 1.1 0.0 0.2 5.8 68.7 4.2 0.7 0.2 1.0 0.9 0.1 0.4 0.2 0.1 0.2 0.1 0.5 4.0 0.0 0.4 0.0 1.2 0.0 0.1 1.6 1.3 0.0 0.3 1.2 0.4 0.5 0.1 0.0 0.2 0.7 0.1 0.0 12.6 34.7 18.7 24.0 17.2 12.9 35.9 13.9 32.2 31.4 0.0 1.1 0.8 0.7 5.8 8.1 6.7 48.4 0.0 0.0 14.0 2.0 93.0 0.0 26.5 9.7 56.5 45.5 0.0 1.1 3.7 16.0 1.5 0.0 0.6 10.8 130.3 26.9 160.2 15.5 1.4 6.1 1.3 23.6 0.0 31.1 5.1 2.5 42.1 1.8 3.7 3.2 0.0 6.2 0.5 1.4 3.6 291.1 1.3 32.4 0.5 SEMA6B "SEM-SEMA-Y, SEMA-VIB, SEMAN, semaZ" ENSG00000167680 "Semaphorin 6B" Q9H3T3 19 4542593-4559808 "Plasma proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.9" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 55.5;Ciliated cells: 32.1;Club cells: 35.2;Endothelial cells: 25.1;granulocytes: 27.8;Horizontal cells: 17.5;Ito cells: 38.1;Macrophages: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 36.4;HMC-1: 60.2;HUVEC TERT2: 24.6;TIME: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025157, HPA055778, HPA058523" Enhanced NA NA 180000 "CAB025157: , HPA055778: AB_2682916, HPA058523: AB_2683741" "unprognostic (4.03e-1)" "unprognostic (9.69e-3)" "unprognostic (6.38e-3)" "unprognostic (2.15e-1)" "unprognostic (1.15e-1)" "unprognostic (7.94e-2)" "unprognostic (2.10e-1)" "unprognostic (4.34e-3)" "unprognostic (6.61e-2)" "unprognostic (1.90e-1)" "unprognostic (4.21e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (3.29e-5)" "unprognostic (1.26e-1)" "unprognostic (1.81e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (9.55e-2)" 23.2 9.3 27.2 12.1 24.2 7.9 9.7 16.9 42.9 3.8 4.7 1.7 0.3 4.8 4.1 3.1 3.6 2.5 7.0 12.8 30.3 11.5 3.7 5.2 13.1 18.6 9.5 0.8 5.1 4.8 1.7 3.1 9.9 11.0 4.3 1.8 2.7 1.4 2.2 9.3 3.3 4.8 7.9 6.4 17.5 2.5 2.5 8.8 0.0 6.0 3.7 2.0 8.3 24.4 0.0 0.0 0.7 0.4 0.0 0.0 0.0 2.0 7.3 0.6 6.3 0.0 0.3 0.1 0.0 0.2 0.7 0.2 0.0 0.6 0.0 7.0 0.0 1.1 1.3 1.8 0.0 0.2 0.0 0.3 0.0 0.1 36.4 0.1 0.0 60.2 2.2 0.0 0.0 0.0 7.5 24.6 0.0 0.4 0.1 0.2 1.8 0.0 0.0 7.9 0.5 0.1 0.1 14.3 0.1 0.5 0.0 5.3 0.5 0.0 0.6 3.8 0.6 0.9 0.3 31.0 0.9 11.6 0.1 5.2 0.4 0.0 0.1 0.2 0.3 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 27.2 24.2 16.9 27.9 30.3 11.5 9.5 0.8 11.0 8.8 26.8 55.5 1.4 1.0 4.1 4.3 1.5 2.5 32.1 35.2 1.8 3.9 0.6 0.0 0.7 0.9 25.1 0.0 0.0 0.2 0.6 5.7 0.9 27.8 5.8 2.9 17.5 0.0 38.1 5.4 0.0 0.6 22.3 6.8 1.0 0.0 1.7 0.1 0.0 0.7 0.1 4.2 0.0 2.2 0.5 2.2 4.4 0.2 3.2 0.0 0.9 SEMA6D "FLJ11598, KIAA1479" ENSG00000137872 "Semaphorin 6D" Q8NFY4 15 47184101-47774223 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.8;placenta: 36.7" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 47.6;Cone photoreceptor cells: 108.0;Enterocytes: 37.0;Horizontal cells: 74.7" "Cancer enhanced" "Detected in many" "glioma: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 13.4;SCLC-21H: 11.9;SH-SY5Y: 11.0;SuSa: 13.2;U-266/70: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043109 Approved "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 480000 "Plasma membrane" "Golgi apparatus" "HPA043109: AB_10793941" "unprognostic (2.00e-1)" "unprognostic (4.62e-2)" "unprognostic (3.10e-2)" "unprognostic (3.83e-3)" "unprognostic (1.38e-1)" "unprognostic (3.85e-2)" "unprognostic (1.98e-1)" "unprognostic (2.17e-3)" "unprognostic (1.24e-1)" "unprognostic (5.36e-2)" "unprognostic (7.96e-4)" "unprognostic (1.42e-1)" "prognostic favorable (5.96e-5)" "unprognostic (3.74e-2)" "unprognostic (8.56e-2)" "unprognostic (3.30e-3)" "unprognostic (2.39e-4)" 5.3 1.9 10.3 3.7 16.7 0.8 5.3 5.4 17.1 5.3 14.7 15.3 4.3 18.9 2.1 2.9 2.0 5.2 4.0 8.3 10.3 11.2 14.2 3.0 8.2 2.2 14.0 13.6 25.0 14.8 16.2 6.1 36.7 15.9 4.8 12.0 10.0 4.4 8.5 15.6 3.1 40.8 3.4 12.7 2.5 3.4 2.6 11.0 0.2 6.3 1.5 1.1 3.1 9.6 0.5 0.0 1.9 0.6 0.0 0.8 0.0 0.0 0.0 2.2 0.0 1.3 1.1 0.2 0.5 13.4 0.3 0.0 0.3 0.1 1.8 0.0 3.4 0.0 7.0 2.8 0.9 0.0 0.9 1.6 0.0 4.1 0.0 3.6 0.0 0.1 1.0 7.3 0.0 0.4 0.0 0.9 4.8 0.1 2.9 0.4 0.7 2.2 0.5 4.2 0.0 0.0 1.3 0.0 2.0 1.0 0.9 11.9 11.0 0.1 0.9 3.7 13.2 0.4 0.0 0.0 6.2 0.3 0.2 0.0 8.8 0.0 2.0 1.6 0.2 1.6 0.0 0.6 0.0 0.5 0.0 0.0 0.5 0.3 0.8 0.0 0.0 0.1 0.2 1.9 0.0 0.0 0.0 0.0 0.0 10.3 16.7 5.4 17.1 10.3 11.2 14.0 13.6 15.9 11.0 47.6 1.0 0.0 4.0 1.8 3.3 9.4 0.0 0.0 3.4 10.4 108.0 14.7 5.0 1.0 0.1 6.7 37.0 0.0 0.2 1.2 6.7 0.9 3.5 0.8 2.3 74.7 16.7 4.9 0.0 0.0 21.6 0.0 8.5 0.0 2.6 14.3 0.4 6.0 12.7 0.2 2.0 0.0 12.2 0.7 5.1 1.0 3.9 0.0 9.8 1.4 SERF1A "4F5, FAM2A, H4F5, SERF1, SMAM1" ENSG00000172058 "Small EDRK-rich factor 1A" O75920 5 70900665-70918530 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 81.1;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 24.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA075271 Uncertain "Nuclear bodies" NA NA "Nuclear bodies" "HPA075271: AB_2686740" "unprognostic (1.14e-1)" "unprognostic (3.00e-2)" "unprognostic (9.58e-2)" "unprognostic (3.07e-1)" "unprognostic (1.73e-1)" "unprognostic (3.81e-3)" "unprognostic (1.29e-3)" "unprognostic (1.40e-2)" "unprognostic (2.55e-2)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (4.13e-2)" "unprognostic (2.11e-1)" "unprognostic (1.98e-2)" "unprognostic (1.22e-2)" "unprognostic (9.53e-2)" 1.3 1.2 6.4 1.8 5.0 3.0 1.5 5.3 7.2 1.2 1.8 0.2 3.1 7.8 1.8 1.1 3.7 1.6 5.4 5.2 4.1 0.4 1.9 3.3 4.9 2.6 2.6 3.2 2.5 0.8 2.4 3.5 2.1 1.2 1.9 2.8 1.4 3.1 3.5 2.4 2.0 2.8 4.4 0.6 5.8 1.6 7.3 2.6 2.8 1.2 2.1 6.3 0.9 3.7 0.3 3.2 4.6 3.0 4.3 6.4 1.0 0.8 0.9 1.4 1.2 1.5 3.2 6.4 2.6 1.8 1.0 1.8 1.1 2.4 1.5 3.2 3.6 2.1 1.7 1.5 0.7 1.3 2.0 1.4 0.7 1.0 3.6 2.6 0.5 0.5 2.0 2.5 1.7 9.7 11.5 2.3 0.3 1.0 0.5 4.6 5.1 3.3 3.0 9.8 2.9 10.2 0.5 10.1 1.5 6.4 1.3 8.8 3.8 1.2 3.0 1.4 0.8 1.0 3.2 1.9 0.5 8.8 1.0 0.3 2.8 4.2 1.2 5.1 4.9 4.0 6.3 0.5 7.3 4.7 3.9 2.8 2.1 0.8 2.6 3.0 0.9 0.0 3.4 0.8 2.0 1.6 2.6 81.1 0.0 6.7 4.5 3.5 23.6 0.2 3.3 1.2 2.0 2.4 2.4 0.0 0.4 0.3 1.3 1.9 2.3 0.0 0.5 0.0 5.2 1.3 0.0 1.0 2.0 0.8 0.0 1.8 1.2 2.3 0.9 2.9 3.5 0.8 24.0 0.0 1.2 3.1 1.3 1.9 0.1 2.9 1.8 0.9 SERF1B "FAM2B, H4F5C" ENSG00000205572 "Small EDRK-rich factor 1B" O75920 5 70025247-70043113 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 8.9;Cardiomyocytes: 34.7;Ciliated cells: 9.4" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 24.2;SiHa: 39.6;SK-MEL-30: 26.3;WM-115: 21.0" HPA075271 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA075271: AB_2686740" "unprognostic (1.00e-1)" "unprognostic (2.52e-4)" "unprognostic (2.60e-2)" "unprognostic (1.07e-2)" "unprognostic (1.61e-1)" "unprognostic (2.32e-1)" "unprognostic (5.98e-2)" "unprognostic (4.92e-3)" "unprognostic (1.48e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-4)" "unprognostic (1.22e-1)" "unprognostic (2.16e-2)" "unprognostic (2.44e-2)" "unprognostic (7.82e-2)" "unprognostic (6.74e-2)" "unprognostic (3.52e-1)" 3.7 2.4 7.6 1.6 8.3 2.6 2.6 5.7 10.4 2.9 3.4 0.9 3.2 22.7 5.0 1.6 4.7 3.1 6.6 6.7 8.4 1.6 3.5 3.2 7.5 2.5 3.9 11.6 4.0 2.0 4.7 3.9 7.8 5.1 4.1 2.7 2.6 10.3 5.5 3.9 5.7 20.5 4.9 1.4 7.9 3.0 7.0 6.4 10.9 4.5 5.7 8.7 1.8 11.8 0.3 1.7 2.3 8.6 6.5 8.5 3.4 6.2 2.2 1.9 0.3 1.2 1.1 24.2 5.3 1.4 3.3 0.9 0.7 3.7 2.9 0.4 6.5 0.4 0.6 0.5 0.7 1.1 0.4 12.9 0.7 0.1 6.6 0.6 0.3 0.4 1.6 0.2 0.1 11.1 6.8 1.7 0.0 0.2 1.2 6.7 4.9 1.3 0.5 8.7 6.4 39.6 1.8 26.3 0.7 17.5 3.2 18.8 10.2 0.7 0.4 0.6 0.7 1.2 9.1 0.6 0.0 21.0 0.3 0.9 10.9 6.4 3.0 6.9 6.0 8.2 5.8 3.5 7.0 8.7 5.8 2.5 5.7 4.5 6.4 5.8 1.8 8.9 2.1 0.0 0.5 0.3 0.0 34.7 0.0 9.4 5.7 0.0 2.0 0.0 1.7 0.2 1.6 0.5 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 1.2 0.0 0.4 0.7 0.4 0.5 0.0 0.0 0.2 0.4 SERINC1 "KIAA1253, TDE1L, TDE2, TMS-2" ENSG00000111897 "Serine incorporator 1" Q9NRX5 6 122443354-122471822 "Plasma proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035738, HPA035739" Uncertain Approved Cytosol NA NA Cytosol "HPA035738: AB_10672990, HPA035739: AB_10669536" "unprognostic (2.83e-3)" "unprognostic (2.68e-3)" "unprognostic (1.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.65e-1)" "unprognostic (2.84e-2)" "unprognostic (2.04e-1)" "unprognostic (7.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.27e-2)" "unprognostic (9.07e-3)" "unprognostic (2.84e-1)" "unprognostic (5.50e-3)" "unprognostic (1.80e-3)" "unprognostic (9.22e-2)" "unprognostic (3.58e-1)" "unprognostic (1.00e-2)" 49.0 62.0 72.0 21.6 74.5 31.4 39.6 67.3 96.4 40.4 25.1 61.5 17.0 23.9 36.7 27.8 23.8 27.0 31.6 39.1 75.5 78.4 48.7 58.1 38.9 20.6 91.6 57.7 42.7 24.4 56.4 32.9 47.0 109.2 36.0 25.2 29.7 22.5 37.8 37.4 20.5 27.2 35.4 120.6 28.4 23.1 15.6 57.5 12.9 50.8 13.0 18.7 33.2 22.8 10.0 12.6 44.1 20.4 17.7 20.7 17.4 7.4 9.2 23.3 21.3 88.4 48.6 12.4 39.2 49.2 21.5 33.4 10.7 20.2 5.0 30.9 44.1 24.7 14.9 13.7 16.9 32.3 15.9 16.3 14.1 15.7 19.5 39.6 14.1 28.2 50.4 33.3 26.7 37.0 49.6 18.5 13.2 14.0 28.5 44.4 8.5 6.3 9.4 7.5 11.7 11.7 7.8 11.5 12.0 46.2 13.1 12.2 22.1 17.3 19.3 26.5 21.6 13.3 19.9 37.7 25.9 11.3 21.2 20.3 21.6 24.1 6.6 34.3 11.5 30.2 44.1 15.0 31.4 16.8 18.8 18.1 10.0 17.6 16.2 12.6 8.7 20.7 17.9 38.9 17.7 20.4 9.9 18.6 17.4 72.0 74.5 67.3 86.9 75.5 78.4 91.6 57.7 109.2 57.5 140.0 86.4 39.7 67.4 58.7 103.2 138.9 89.2 52.2 54.6 73.3 66.8 48.9 8.3 55.1 2.4 116.4 66.3 46.7 42.2 46.7 95.4 88.7 119.2 115.6 64.9 130.3 81.1 105.6 142.0 5.6 117.3 84.8 89.4 25.2 36.8 98.4 63.7 38.6 123.4 38.5 56.5 58.2 75.4 17.9 19.6 65.5 100.1 71.3 29.3 78.2 SERINC2 "FKSG84, PRO0899, TDE2, TDE2L" ENSG00000168528 "Serine incorporator 2" Q96SA4 1 31409565-31434680 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 113.9" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 546.6;Enterocytes: 427.6;Pancreatic endocrine cells: 386.0;Syncytiotrophoblasts: 373.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 12.0" "Lineage enriched" "Detected in many" 4 "dendritic cells: 12.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.3;HaCaT: 53.9;HBEC3-KT: 85.2;hTCEpi: 48.5;RT4: 58.3;SK-BR-3: 48.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA005974 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005974: AB_10603239" "unprognostic (1.41e-1)" "unprognostic (3.70e-3)" "unprognostic (8.78e-3)" "prognostic favorable (1.69e-7)" "unprognostic (6.78e-2)" "unprognostic (5.31e-2)" "prognostic unfavorable (2.11e-4)" "prognostic unfavorable (5.70e-4)" "unprognostic (3.12e-2)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (1.09e-2)" "unprognostic (3.74e-2)" "unprognostic (1.39e-1)" "unprognostic (2.48e-1)" "unprognostic (4.63e-3)" "unprognostic (2.67e-2)" 2.0 6.6 0.6 13.5 1.2 1.1 12.1 0.8 0.8 17.3 32.9 0.8 52.1 27.4 3.7 26.5 32.5 4.3 34.4 2.0 1.0 0.6 57.5 113.9 10.3 7.1 1.8 0.5 1.7 12.9 5.7 5.1 33.9 1.4 17.0 12.8 5.0 58.6 74.4 20.2 14.2 73.0 6.7 1.2 1.7 20.7 3.5 0.8 5.7 13.1 12.7 19.1 31.1 19.9 0.2 12.0 2.3 2.7 0.0 0.0 0.5 13.0 3.1 2.7 8.9 6.0 8.1 7.6 25.2 18.7 1.6 2.0 4.7 47.3 8.6 33.2 23.6 2.0 53.9 0.3 85.2 0.3 0.8 2.0 0.0 2.7 2.4 6.8 0.0 10.1 7.4 48.5 10.4 22.9 7.2 1.0 1.0 0.3 0.0 2.8 2.1 0.3 0.3 2.8 26.1 6.6 0.0 5.4 2.9 9.0 58.3 1.2 6.7 6.4 48.8 1.0 1.4 28.5 1.5 6.2 0.4 2.1 0.2 0.5 0.4 0.3 0.4 0.2 0.2 2.1 0.0 2.7 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 12.0 0.0 0.5 0.6 1.2 0.8 0.8 1.0 0.6 1.8 0.5 1.4 0.8 14.9 6.2 0.5 97.8 11.0 0.0 0.6 127.4 8.1 21.6 111.7 0.0 323.0 61.3 546.6 3.9 4.4 427.6 0.0 288.5 86.2 3.3 137.4 0.0 45.6 43.7 0.0 111.9 8.6 7.6 6.6 2.0 6.8 38.8 83.8 168.4 0.6 386.0 170.9 0.0 57.4 0.0 0.0 1.4 0.6 3.6 18.4 373.5 0.0 116.2 257.8 SERINC3 "AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1" ENSG00000132824 "Serine incorporator 3" Q13530 20 44496221-44522109 "Predicted membrane proteins, Transporters" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 455.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048116 Uncertain NA NA "HPA048116: AB_2680269" "unprognostic (3.16e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (2.60e-1)" "unprognostic (2.74e-1)" "unprognostic (7.34e-2)" "unprognostic (1.85e-3)" "unprognostic (6.26e-2)" "unprognostic (7.41e-2)" "unprognostic (3.11e-1)" "unprognostic (8.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.60e-2)" "unprognostic (1.30e-3)" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (1.27e-1)" "unprognostic (1.64e-2)" 42.5 47.1 35.5 22.8 63.0 21.0 38.9 28.9 80.6 39.0 27.4 52.8 14.8 22.9 31.8 25.4 32.8 28.3 34.2 34.9 40.8 35.2 25.0 45.1 33.0 20.6 40.5 33.9 35.4 24.7 55.9 33.6 55.8 60.9 29.6 31.8 29.4 30.2 33.4 45.3 35.9 25.6 35.2 42.6 26.3 26.2 51.2 33.3 29.2 40.6 20.5 23.8 32.8 28.8 19.6 31.4 58.9 34.5 34.4 34.4 38.7 14.6 15.7 7.5 9.6 66.4 47.8 11.7 30.2 52.5 24.4 22.4 35.4 36.5 10.7 41.2 35.8 27.9 26.5 9.0 30.9 26.0 12.4 10.1 12.5 16.3 17.9 36.0 15.4 27.4 33.8 45.3 24.0 36.0 29.4 23.7 17.5 13.9 31.8 25.5 18.4 15.7 12.2 4.4 19.2 23.9 7.9 11.3 16.3 19.5 16.9 9.5 7.2 28.9 28.3 19.1 11.0 20.2 17.3 30.2 58.1 9.6 25.5 20.9 18.9 20.7 8.2 43.3 10.9 18.1 57.9 30.2 37.9 33.8 31.5 34.4 19.3 29.5 32.8 31.4 19.6 30.6 30.4 58.9 34.4 34.5 28.9 33.1 38.7 35.5 63.0 28.9 80.6 40.8 35.2 40.5 33.9 60.9 33.3 68.5 57.7 38.9 69.7 48.7 35.4 62.4 84.1 45.5 55.7 45.4 33.4 80.2 13.3 67.0 180.5 98.3 50.9 70.0 61.0 74.0 82.1 72.9 98.4 97.2 51.5 42.9 63.8 98.8 68.4 455.0 97.2 53.4 37.1 19.8 58.5 49.9 82.3 52.6 107.1 21.9 28.9 97.0 84.6 177.2 84.8 73.5 138.3 59.8 49.3 65.0 SERINC4 FLJ40363 ENSG00000184716 "Serine incorporator 4" A6NH21 15 43794162-43800221 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "retina: 24.5" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 41.2;Early spermatids: 27.9;Late spermatids: 27.6;Rod photoreceptor cells: 53.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;OE19: 1.9;RT4: 1.4;SCLC-21H: 3.0;U-138 MG: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.5 0.0 0.6 0.2 0.1 0.6 0.4 0.0 0.4 0.3 0.0 0.7 0.7 0.0 0.2 0.2 0.0 0.1 0.3 0.3 0.4 0.0 0.4 0.2 0.8 0.0 0.3 0.0 0.0 0.1 0.2 1.8 0.3 0.3 24.5 0.1 0.1 0.2 0.0 0.3 0.0 0.8 0.0 0.1 5.8 0.0 0.0 0.2 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.6 0.1 0.0 0.0 1.4 3.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 0.3 0.3 0.3 0.8 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.1 4.6 0.0 0.0 0.0 0.0 0.0 41.2 0.1 0.0 0.0 27.9 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.2 4.8 0.0 0.6 0.3 27.6 0.3 0.0 0.0 1.0 0.3 5.5 0.1 0.0 0.0 0.0 53.4 0.0 0.0 4.7 2.6 0.0 0.3 0.0 0.0 0.3 SERINC5 "C5orf12, TPO1" ENSG00000164300 "Serine incorporator 5" Q86VE9 5 80111651-80256079 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 145.8;Urothelial cells: 161.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037898, HPA037899" Supported Supported "Vesicles,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Vesicles, Centrosome" "HPA037898: AB_10673649, HPA037899: AB_2675727" "unprognostic (2.95e-1)" "unprognostic (1.80e-1)" "unprognostic (4.98e-3)" "unprognostic (1.08e-2)" "unprognostic (5.05e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-2)" "unprognostic (8.00e-2)" "unprognostic (2.10e-1)" "unprognostic (2.68e-2)" "unprognostic (7.71e-2)" "unprognostic (1.62e-1)" "unprognostic (1.40e-2)" "unprognostic (4.81e-2)" "unprognostic (8.09e-2)" "unprognostic (4.93e-2)" "unprognostic (9.17e-2)" 6.9 21.1 9.0 7.8 11.2 3.0 6.7 5.3 15.6 10.2 16.3 28.8 11.2 5.1 6.9 12.9 9.7 9.6 8.4 4.1 9.5 7.3 5.3 26.3 8.0 9.3 13.4 7.0 9.8 7.8 4.2 5.3 24.7 12.1 20.3 17.5 3.6 9.8 8.4 3.1 10.9 9.5 4.4 9.7 8.3 9.7 18.9 15.0 7.8 5.2 6.7 12.3 9.3 7.7 0.8 4.0 6.2 6.9 0.4 17.5 4.7 4.9 8.9 3.0 1.9 4.2 4.4 9.1 4.1 2.7 1.8 1.9 18.0 25.9 0.8 4.2 5.2 4.2 14.5 4.1 10.8 2.6 0.7 2.2 0.6 1.1 9.6 1.5 0.6 1.9 5.1 6.0 4.7 12.3 5.1 3.3 24.6 1.6 4.3 4.8 8.6 10.0 2.4 4.2 7.0 3.1 12.0 2.7 1.3 5.3 24.7 0.2 2.9 3.6 8.5 15.9 16.2 3.7 3.1 3.6 5.3 1.5 5.3 5.0 5.6 1.5 13.0 9.9 1.7 21.5 6.2 6.9 4.4 1.6 3.4 1.2 0.5 13.9 4.2 4.0 0.8 17.5 10.5 3.6 0.4 1.0 0.9 4.5 4.7 9.0 11.2 5.3 10.9 9.5 7.3 13.4 7.0 12.1 15.0 56.6 23.8 3.7 42.8 5.7 3.7 7.5 22.9 2.7 23.9 15.7 0.0 14.2 8.3 21.5 1.4 17.5 72.2 0.0 16.8 20.9 20.6 145.8 8.1 74.0 19.5 3.2 57.7 43.0 25.4 4.2 17.0 27.0 5.0 36.1 63.6 60.6 25.3 57.5 37.4 4.6 4.8 32.3 3.8 1.2 7.9 8.5 108.0 16.7 74.3 161.9 SERP1 "FLJ43424, RAMP4" ENSG00000120742 "Stress associated endoplasmic reticulum protein 1" Q9Y6X1 3 150541994-150603228 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 122.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038970 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA038970: AB_2676296" "unprognostic (8.81e-3)" "unprognostic (2.35e-3)" "unprognostic (1.91e-1)" "unprognostic (7.29e-3)" "unprognostic (3.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.57e-2)" "unprognostic (2.35e-3)" "unprognostic (6.16e-2)" "unprognostic (1.77e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.12e-1)" "unprognostic (1.61e-3)" "unprognostic (2.55e-2)" "unprognostic (2.75e-2)" "unprognostic (4.75e-2)" "unprognostic (1.78e-1)" 24.5 34.2 23.1 22.4 22.6 25.4 38.0 12.5 18.4 38.6 26.7 15.6 59.9 21.4 20.2 56.7 29.6 28.1 25.1 15.1 17.4 16.5 27.7 93.6 38.1 47.8 17.5 15.6 31.5 137.6 21.1 33.0 33.2 14.7 32.9 23.8 15.6 103.1 58.9 9.7 18.1 33.5 15.6 18.9 42.9 38.4 17.8 16.0 38.4 51.3 17.3 33.6 31.2 29.8 49.6 67.9 76.4 89.1 36.8 68.2 90.5 33.1 7.1 10.9 8.2 16.0 18.8 25.0 23.7 15.3 13.0 15.3 18.5 14.6 26.8 45.8 17.1 10.8 16.2 17.6 12.2 17.3 16.5 15.2 28.4 6.2 18.7 31.3 25.6 19.1 11.2 22.0 7.5 37.7 14.2 15.1 18.3 13.8 37.9 11.0 14.3 21.6 22.3 20.4 21.0 18.5 28.2 8.3 83.3 15.7 10.7 18.8 16.0 9.1 20.1 35.9 13.7 17.7 25.1 14.6 6.2 11.4 13.3 18.2 122.2 34.9 36.0 11.3 25.2 5.7 62.2 88.3 76.4 52.9 81.8 68.2 49.6 56.9 53.3 67.5 47.9 56.7 52.1 64.4 36.8 89.1 67.9 54.3 90.5 23.1 22.6 12.5 18.4 17.4 16.5 17.5 15.6 14.7 16.0 62.5 139.6 390.1 556.3 477.8 73.3 37.8 160.5 156.6 144.5 164.0 55.0 242.2 310.0 207.9 287.5 159.5 300.1 0.0 263.4 394.7 208.5 631.9 219.9 431.3 345.7 39.7 243.7 217.3 540.1 505.4 203.4 389.3 330.7 232.6 361.6 114.7 332.1 414.1 178.9 241.5 64.5 109.9 173.1 132.7 83.4 518.0 790.1 279.9 304.6 899.5 SERP2 "bA269C23.1, C13orf21" ENSG00000151778 "Stress associated endoplasmic reticulum protein family member 2" Q8N6R1 13 44373665-44397714 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.7" "Group enriched" "Detected in many" 13 "Early spermatids: 499.5;Late spermatids: 180.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "basophil: 6.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.0" "Cell line enhanced" "Detected in some" "LHCN-M2: 5.9;SH-SY5Y: 8.3;U-2197: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038970 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA038970: AB_2676296" "unprognostic (6.55e-2)" "unprognostic (1.55e-1)" "unprognostic (4.10e-2)" "unprognostic (2.06e-1)" "unprognostic (9.62e-2)" "unprognostic (1.72e-2)" "unprognostic (2.85e-1)" "unprognostic (3.48e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (1.34e-3)" "unprognostic (1.12e-2)" "prognostic favorable (1.94e-4)" "unprognostic (1.48e-1)" "unprognostic (6.60e-2)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" 1.7 3.2 30.0 2.0 34.1 0.8 4.0 14.3 40.7 2.7 2.3 3.9 1.3 4.2 4.8 12.4 1.7 3.0 1.8 14.6 24.8 20.9 2.6 1.8 2.0 2.3 19.0 15.6 5.9 2.8 1.9 2.4 1.2 10.1 4.1 2.1 2.0 2.0 5.8 1.4 1.4 3.2 3.4 10.4 1.1 2.4 15.3 6.4 1.2 2.1 0.4 2.1 1.4 1.0 0.0 0.0 6.0 0.0 1.3 0.3 0.2 0.0 0.0 3.4 0.0 0.5 2.9 0.0 0.6 1.0 3.7 2.5 0.0 0.0 0.0 2.9 2.7 0.0 0.1 0.0 0.0 3.6 0.0 0.1 0.6 0.0 0.2 3.2 0.1 0.0 0.4 0.0 2.6 0.0 0.7 0.5 0.0 0.0 0.0 5.9 0.0 0.0 0.3 3.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.9 8.3 0.0 0.4 0.0 0.8 0.0 0.0 0.7 0.0 0.2 7.6 0.0 0.0 0.2 0.0 1.7 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.2 30.0 34.1 14.3 37.2 24.8 20.9 19.0 15.6 10.1 6.4 0.0 1.0 0.0 3.9 1.5 18.6 13.2 7.6 0.0 1.2 8.7 13.7 2.4 14.9 9.3 499.5 2.7 2.9 0.0 11.6 2.3 6.0 5.6 18.4 5.6 0.2 14.3 13.8 2.5 0.0 180.5 12.0 0.6 11.8 1.0 1.9 14.7 4.4 1.7 18.0 5.8 15.3 25.8 5.6 7.9 11.3 0.9 1.7 5.0 2.5 1.4 SERPINA1 "A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1" ENSG00000197249 "Serpin family A member 1" P01009 14 94376747-94390693 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "liver: 3314.2" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 29973.4" "Cancer enriched" "Detected in all" 10 "liver cancer: 3850.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0" "Group enriched" "Detected in many" 5 "granulocytes: 139.3;monocytes: 203.0" "Cell line enriched" "Detected in some" 8 "Hep G2: 326.1" "Region enriched" "Detected in many" 6 "cerebellum: 334.2" "HPA000927, HPA001292, CAB013211, CAB016648, CAB073396" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 2070000000000 210000000000 Vesicles "CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762" "prognostic favorable (1.61e-5)" "unprognostic (3.37e-1)" "prognostic favorable (5.86e-4)" "unprognostic (1.38e-2)" "unprognostic (1.98e-2)" "unprognostic (5.50e-3)" "unprognostic (3.81e-2)" "unprognostic (6.78e-2)" "unprognostic (2.54e-2)" "unprognostic (7.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.54e-1)" "unprognostic (1.23e-2)" "unprognostic (1.89e-1)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (1.96e-1)" 0.9 0.4 0.7 4.9 1.4 3.0 2.4 0.2 0.7 2.6 7.5 0.5 3.1 6.3 0.8 8.6 0.4 0.7 14.2 1.0 0.4 0.5 74.1 3314.2 13.6 5.3 1.0 0.2 0.6 7.4 0.0 0.4 0.8 0.8 0.6 4.1 0.6 0.9 3.6 0.2 0.3 36.2 1.4 1.3 8.9 7.0 0.8 0.8 0.5 0.8 0.2 0.9 0.5 0.6 0.3 33.5 139.3 203.0 0.2 0.3 100.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 12.9 41.0 0.1 1.1 0.0 0.1 0.1 0.0 0.8 0.0 5.0 0.0 0.2 0.1 326.1 0.0 1.1 0.1 0.3 0.4 0.0 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.5 0.1 1.1 0.1 22.1 0.2 0.0 0.1 0.4 0.1 0.1 0.0 19.4 0.2 0.1 0.1 5.1 0.1 0.6 0.2 0.1 0.5 0.3 2.8 0.0 0.4 110.2 29.1 0.2 165.9 0.3 0.3 0.1 0.2 33.5 0.1 0.2 0.1 139.3 0.2 203.0 0.7 0.2 100.0 0.7 1.4 0.2 0.7 0.4 0.5 1.0 0.2 0.8 0.8 32.8 233.5 435.3 1.1 2.1 0.0 2.8 4603.8 45.5 60.3 143.1 0.0 1.4 58.0 1848.5 0.1 6.6 53.3 817.7 189.3 1.7 1.6 5.0 1.1 29973.4 171.4 0.0 11.6 922.6 1276.8 0.0 0.0 188.6 1.7 107.4 659.1 0.3 1376.2 37.4 0.0 447.0 0.2 0.0 5.1 0.0 0.1 1.5 5.4 46.5 24.7 7.1 SERPINA9 "CENTERIN, GCET1, SERPINA11b" ENSG00000170054 "Serpin family A member 9" Q86WD7 14 94462717-94479689 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 37.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.2" "Lineage enhanced" "Detected in single" "monocytes: 1.2" "Cell line enriched" "Detected in single" 64 "Daudi: 39.7" "Region enriched" "Detected in single" 18 "basal ganglia: 64.3" "Secreted to blood" NA NA "unprognostic (1.32e-2)" "unprognostic (1.05e-1)" "unprognostic (1.94e-2)" "unprognostic (3.89e-3)" "unprognostic (6.10e-2)" "unprognostic (6.67e-2)" "unprognostic (1.38e-2)" "unprognostic (1.16e-1)" 0.1 0.1 0.1 37.6 0.1 0.0 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.1 1.8 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.6 0.2 20.3 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.1 6.0 2.7 0.0 0.1 0.6 0.1 0.1 0.0 0.4 0.3 0.3 36.0 0.1 0.2 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINB13 "headpin, HUR7, hurpin, PI13" ENSG00000197641 "Serpin family B member 13" Q9UIV8 18 63586989-63604639 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1" "Group enriched" "Detected in some" 11 "Ciliated cells: 8.1;Club cells: 29.6;Urothelial cells: 8.5" "Cancer enhanced" "Detected in many" "cervical cancer: 45.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 132 "HaCaT: 65.6;hTCEpi: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052630, HPA057129" Enhanced Approved "Nuclear speckles,Cytosol" NA NA 59000 "Nuclear speckles, Cytosol" "HPA052630: AB_2681891, HPA057129: AB_2683347" "unprognostic (3.49e-2)" "unprognostic (3.73e-1)" "unprognostic (1.11e-1)" "unprognostic (7.27e-2)" "unprognostic (2.28e-1)" "unprognostic (4.29e-2)" "unprognostic (2.81e-1)" "unprognostic (6.04e-3)" 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.1 37.7 0.1 0.0 0.0 0.1 3.1 0.1 70.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 10.9 0.1 0.2 5.7 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.0 0.1 107.2 54.2 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 8.1 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 8.5 SERPINB6 "CAP, DFNB91, PI6, PTI" ENSG00000124570 "Serpin family B member 6" P35237 6 2948159-2972165 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 821.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009668, HPA012736" Enhanced Approved Centrosome NA NA 5100000 Centrosome "HPA009668: AB_1079919, HPA012736: AB_1856729" "unprognostic (3.44e-1)" "unprognostic (1.03e-1)" "unprognostic (8.72e-2)" "unprognostic (1.96e-3)" "unprognostic (2.72e-2)" "unprognostic (1.56e-2)" "unprognostic (1.66e-3)" "unprognostic (1.96e-2)" "unprognostic (7.63e-2)" "prognostic favorable (4.81e-4)" "unprognostic (3.51e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.59e-1)" "unprognostic (5.08e-2)" "unprognostic (1.80e-1)" "unprognostic (1.10e-2)" 31.6 38.8 21.1 23.5 34.8 17.3 29.6 13.4 20.8 31.8 44.6 35.2 38.1 54.9 30.3 30.3 36.0 35.9 42.4 58.7 21.1 21.3 32.4 20.1 36.2 45.3 33.7 20.4 45.3 85.3 26.5 23.7 38.5 28.5 37.8 30.9 32.6 23.4 32.6 51.0 12.0 85.5 36.6 32.4 41.4 29.9 55.5 28.9 5.9 32.6 34.2 23.7 31.7 24.5 8.4 30.8 34.2 31.3 23.6 18.6 24.0 30.4 20.0 6.6 27.3 17.9 40.0 20.4 28.5 34.6 22.6 26.4 7.0 22.1 0.2 32.9 32.2 25.8 46.3 18.3 29.0 21.2 40.0 8.3 17.9 23.9 11.8 31.4 0.3 10.9 23.0 20.3 21.5 5.6 39.6 53.5 0.2 23.2 0.5 40.2 21.6 0.2 0.3 3.9 34.7 38.5 2.0 12.3 25.6 28.5 7.4 0.4 16.9 23.4 3.5 31.6 25.6 15.4 14.6 38.2 23.1 8.5 51.3 19.2 0.6 0.1 0.6 17.8 18.0 23.7 13.9 31.3 34.2 16.8 30.4 8.3 8.4 9.5 11.1 30.8 6.9 11.3 18.6 2.8 23.6 24.6 3.1 1.3 24.0 21.1 34.8 13.4 20.8 21.1 21.3 33.7 20.4 28.5 28.9 47.6 66.6 38.9 56.1 18.2 24.1 116.6 30.6 123.1 58.0 71.5 19.6 135.2 84.6 164.5 478.1 107.4 297.6 0.0 298.9 268.0 77.3 94.3 101.6 31.0 159.4 28.6 70.0 185.4 162.5 821.7 77.1 104.2 60.8 173.1 110.7 143.7 252.9 244.7 79.9 156.8 48.0 77.6 110.5 190.3 30.0 23.1 135.0 42.4 162.8 77.4 SERTM1 C13orf36 ENSG00000180440 "Serine rich and transmembrane domain containing 1" A2A2V5 13 36673912-36697839 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.2;endometrium 1: 30.9;fallopian tube: 25.3" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 8.9" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.7" "Group enriched" "Detected in many" 7 "amygdala: 13.9;basal ganglia: 10.1;cerebral cortex: 21.6;hippocampal formation: 26.5;olfactory region: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 2.7;HEK 293: 3.2;NTERA-2: 8.0;SH-SY5Y: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054814, HPA070485" Uncertain Enhanced Vesicles NA NA Vesicles "HPA054814: AB_2682611, HPA070485: AB_2686272" "unprognostic (8.71e-2)" "unprognostic (2.11e-1)" "unprognostic (5.58e-3)" "unprognostic (4.66e-3)" "unprognostic (4.05e-3)" "unprognostic (5.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.63e-2)" "unprognostic (1.00e-8)" "unprognostic (2.51e-2)" "unprognostic (5.60e-2)" "unprognostic (4.44e-2)" 5.0 1.8 13.9 0.5 10.1 0.5 1.2 0.3 30.2 16.4 0.7 1.3 1.8 0.6 30.9 13.5 0.5 25.3 0.5 0.6 26.5 2.0 0.6 0.5 5.6 0.5 1.5 11.6 14.5 0.8 1.0 11.2 0.5 2.4 0.9 0.5 8.2 0.5 1.2 0.5 0.6 0.6 17.4 0.9 0.5 0.9 1.5 0.0 0.0 9.3 0.0 0.5 1.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 3.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 10.1 0.3 21.6 26.5 2.0 1.5 11.6 2.4 0.0 8.9 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 SERTM2 LINC00890 ENSG00000260802 "Serine rich and transmembrane domain containing 2" X 111511662-111522399 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "epididymis: 60.2;seminal vesicle: 38.7" "Cell type enhanced" "Detected in some" 26 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 5.8;granulocytes: 1.1" "Cancer enhanced" "Detected in some" "prostate cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HMC-1: 19.6" "Region enhanced" "Detected in single" "basal ganglia: 3.0" NA NA "unprognostic (9.56e-2)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (2.42e-1)" "unprognostic (2.65e-1)" "unprognostic (3.79e-2)" "unprognostic (5.74e-2)" "unprognostic (1.93e-2)" "unprognostic (4.03e-2)" "unprognostic (3.51e-1)" "unprognostic (8.77e-3)" "unprognostic (3.86e-3)" "unprognostic (1.94e-1)" "unprognostic (2.26e-1)" "unprognostic (9.57e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 15.2 0.5 0.0 9.1 0.0 14.2 60.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.6 1.7 0.5 4.6 0.0 0.1 0.0 38.7 0.0 0.0 0.0 2.2 0.0 2.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.1 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SEZ6 ENSG00000063015 "Seizure related 6 homolog" Q53EL9 17 28954901-29006440 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 60.4;Cone photoreceptor cells: 45.2;Horizontal cells: 41.3;Rod photoreceptor cells: 17.6" "Cancer enriched" "Detected in many" 11 "glioma: 16.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 2.8;neutrophil: 5.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.7" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011777 Enhanced NA NA "HPA011777: AB_1856758" "unprognostic (3.99e-2)" "unprognostic (1.24e-1)" "unprognostic (5.75e-3)" "unprognostic (5.33e-3)" "unprognostic (1.84e-2)" "unprognostic (1.76e-3)" "unprognostic (2.82e-2)" "unprognostic (2.22e-2)" "unprognostic (3.07e-1)" "unprognostic (4.75e-2)" "unprognostic (1.22e-3)" "unprognostic (3.15e-3)" "unprognostic (3.63e-6)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (1.45e-1)" "unprognostic (3.15e-3)" 1.2 2.0 18.8 1.4 67.3 1.6 1.1 43.5 48.2 1.1 1.6 3.1 0.0 2.4 1.1 1.5 1.2 1.2 1.1 1.2 10.5 10.0 1.2 1.1 1.3 1.2 4.9 9.4 1.1 1.9 1.1 4.9 1.2 9.1 1.3 1.8 3.3 1.2 1.2 1.4 1.4 1.4 1.3 2.7 1.2 1.7 1.6 5.4 0.0 1.2 0.0 1.1 1.3 0.0 0.8 0.9 5.7 0.5 0.5 0.9 0.4 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 37.0 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.8 0.5 0.9 0.2 0.5 0.9 0.8 0.4 0.5 0.6 0.5 0.6 0.7 5.7 0.5 0.5 0.9 0.2 0.4 18.8 67.3 43.5 18.8 10.5 10.0 4.9 9.4 9.1 5.4 0.0 0.0 0.0 0.6 0.3 60.4 0.5 0.0 0.0 0.0 0.0 45.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.2 0.2 0.5 9.2 0.0 0.2 41.3 7.0 0.6 3.2 0.0 0.9 2.1 0.0 8.2 0.0 6.0 0.4 0.0 0.0 0.0 17.6 0.0 0.1 0.9 1.3 0.0 0.2 2.1 0.4 0.1 SEZ6L ENSG00000100095 "Seizure related 6 homolog like" Q9BYH1 22 26169474-26383597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 60.8" "Cell type enriched" "Detected in some" 6 "Horizontal cells: 20.6" "Group enriched" "Detected in some" 6 "glioma: 14.6;pancreatic cancer: 3.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 7.4;myeloid DC: 7.2;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 73 "dendritic cells: 7.2;monocytes: 7.4" "Group enriched" "Detected in some" 7 "SCLC-21H: 30.8;SH-SY5Y: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045135 Approved Vesicles NA NA 2400000 Vesicles "HPA045135: AB_2732518" "unprognostic (1.01e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.49e-2)" "unprognostic (6.47e-2)" "unprognostic (4.19e-1)" "unprognostic (1.09e-2)" "unprognostic (5.02e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-3)" "unprognostic (7.80e-2)" "unprognostic (2.40e-6)" "unprognostic (4.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.39e-4)" "unprognostic (3.18e-1)" 1.2 12.5 26.4 1.6 11.3 1.3 1.1 20.1 60.8 2.4 1.3 4.3 0.0 1.5 1.1 1.1 1.1 1.1 1.2 2.5 39.1 23.6 1.1 1.1 1.3 1.1 11.2 25.5 1.1 2.7 1.0 3.8 1.1 15.0 1.3 1.4 0.0 1.3 1.2 1.1 1.2 1.6 1.4 5.3 1.3 2.9 1.4 5.4 0.0 1.2 0.0 1.1 1.2 0.2 0.0 7.2 0.0 7.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.8 8.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.5 26.4 11.3 20.1 29.3 39.1 23.6 11.2 25.5 15.0 5.4 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 20.6 0.0 0.0 0.0 0.7 0.6 0.7 0.0 3.6 0.0 0.5 1.0 0.0 0.4 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 SEZ6L2 "FLJ90517, PSK-1" ENSG00000174938 "Seizure related 6 homolog like 2" Q6UXD5 16 29871159-29899547 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.6;pituitary gland: 36.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 220.8;Cone photoreceptor cells: 174.7;Horizontal cells: 178.0;Intestinal endocrine cells: 127.3;Rod photoreceptor cells: 189.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 30.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064471 Enhanced NA NA 3900000 "HPA064471: AB_2685271" "unprognostic (2.56e-2)" "prognostic unfavorable (7.46e-4)" "prognostic unfavorable (1.31e-4)" "unprognostic (2.11e-1)" "prognostic unfavorable (5.24e-4)" "unprognostic (1.27e-1)" "unprognostic (1.67e-2)" "unprognostic (2.71e-2)" "unprognostic (8.22e-2)" "unprognostic (1.85e-1)" "unprognostic (1.43e-3)" "unprognostic (8.31e-2)" "unprognostic (1.04e-1)" "unprognostic (8.22e-2)" "unprognostic (2.30e-1)" "unprognostic (2.12e-1)" "unprognostic (1.08e-1)" 2.1 21.0 21.0 1.8 27.6 0.8 4.0 42.4 52.6 11.4 4.5 7.7 0.2 9.2 6.1 1.4 1.2 4.2 8.8 1.4 18.5 32.8 3.3 0.9 4.5 1.4 15.6 27.6 2.5 34.7 32.7 36.3 3.2 31.4 13.3 3.6 5.4 18.1 4.7 1.5 2.5 5.5 4.3 12.3 1.8 14.9 7.2 7.4 0.0 1.6 0.0 1.9 4.2 0.9 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.5 4.4 0.3 4.3 0.0 0.2 3.0 5.5 2.6 5.2 2.9 6.5 20.8 2.2 30.5 6.7 4.4 1.9 1.7 1.3 1.6 0.0 3.7 0.3 3.8 13.4 11.6 0.0 13.4 13.0 2.5 6.2 1.7 19.1 0.4 2.0 0.6 13.5 2.6 22.4 0.0 0.0 6.7 7.4 7.7 0.0 0.0 0.6 4.8 1.9 20.3 16.3 1.8 14.3 0.8 3.8 13.4 19.5 0.2 17.6 8.7 0.1 0.3 1.5 1.3 0.1 21.4 3.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.0 21.0 27.6 42.4 52.6 18.5 32.8 15.6 27.6 31.4 7.4 3.0 16.0 0.5 9.3 2.6 220.8 7.8 48.4 0.0 1.2 3.5 174.7 0.2 0.0 46.1 2.1 1.7 15.1 0.0 34.7 2.0 1.9 31.1 1.1 0.0 1.3 178.0 127.3 1.3 0.0 4.0 1.1 0.0 11.8 1.0 28.2 16.4 40.1 21.2 1.8 4.8 189.2 12.9 3.9 5.4 3.8 1.3 1.1 0.0 23.6 8.0 SFRP1 "FRP, FRP-1, SARP2" ENSG00000104332 "Secreted frizzled related protein 1" Q8N474 8 41261958-41309497 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Cardiomyocytes: 175.8;Leydig cells: 535.6;Peritubular cells: 122.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "hTERT-RPE1: 270.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB008116, HPA064870" Approved Approved Nucleoli,Cytosol "Secreted in other tissues" Yes No 1600000 Nucleoli Cytosol "CAB008116: AB_2187070, HPA064870: AB_2685376" "unprognostic (1.23e-3)" "unprognostic (7.01e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-1)" "unprognostic (7.13e-2)" "prognostic favorable (1.55e-4)" "unprognostic (1.79e-1)" "unprognostic (2.69e-3)" "unprognostic (2.15e-2)" "unprognostic (4.67e-3)" "unprognostic (3.52e-3)" "unprognostic (4.74e-2)" "unprognostic (1.72e-2)" "unprognostic (1.75e-2)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (3.12e-4)" 20.1 3.4 4.6 2.4 7.5 0.3 73.2 10.8 5.6 58.4 6.1 15.2 8.0 3.0 35.6 19.3 9.7 25.9 15.5 43.9 7.8 2.5 30.6 1.5 1.8 0.9 4.5 6.7 12.5 1.5 0.6 0.7 9.9 24.1 12.8 7.8 19.3 73.2 27.1 1.9 20.8 5.4 21.4 2.8 5.0 11.0 11.1 13.7 0.0 3.3 18.4 5.1 10.9 41.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 6.3 0.1 5.7 0.3 1.2 10.9 57.4 16.6 15.8 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.8 4.4 23.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 1.0 21.4 1.6 1.6 270.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 17.1 0.0 0.0 0.0 1.3 0.0 35.3 0.0 0.3 1.5 0.4 0.0 3.3 23.2 0.0 0.1 0.1 0.0 1.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 7.5 10.8 5.6 7.8 2.5 4.5 6.7 24.1 13.7 0.0 0.0 0.0 104.7 10.0 1.5 175.8 0.0 0.0 1.2 59.3 2.0 0.7 68.0 3.1 4.8 6.7 0.0 0.0 0.0 55.3 47.0 19.9 0.0 0.0 1.7 1.6 0.0 15.4 0.0 13.0 535.6 1.4 94.5 0.0 0.0 51.5 0.1 0.0 122.4 3.5 1.5 0.0 4.1 1.6 20.6 4.8 0.7 0.0 0.0 8.5 SFT2D1 "C6orf83, MGC19825, pRGR1" ENSG00000198818 "SFT2 domain containing 1" Q8WV19 6 166319728-166342591 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014677 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA014677: AB_2238986" "unprognostic (8.45e-2)" "unprognostic (1.43e-3)" "unprognostic (2.29e-1)" "unprognostic (1.41e-2)" "unprognostic (6.77e-2)" "prognostic unfavorable (7.47e-4)" "prognostic unfavorable (2.19e-5)" "unprognostic (3.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.68e-1)" "unprognostic (6.53e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.59e-4)" "unprognostic (4.20e-2)" "unprognostic (5.05e-2)" "prognostic favorable (5.90e-4)" "unprognostic (2.75e-2)" 21.1 24.6 33.6 21.7 31.8 16.4 24.5 15.6 25.0 20.2 27.9 43.4 23.4 23.5 14.7 37.0 19.6 18.8 18.6 15.6 34.9 26.2 27.6 12.5 27.2 23.9 43.9 18.6 18.3 32.6 13.4 11.8 25.9 27.8 27.3 26.8 15.0 38.0 19.4 11.2 12.5 24.9 16.0 61.2 24.6 27.6 18.3 32.8 20.6 24.9 15.3 23.7 17.1 16.1 25.5 57.6 50.1 30.1 14.9 21.7 24.2 13.3 13.0 10.7 22.4 19.6 17.5 16.8 20.8 17.9 14.7 22.3 27.1 27.5 11.8 15.9 17.0 25.7 16.3 15.6 17.1 22.5 16.3 28.5 13.9 11.0 38.2 17.7 35.2 28.3 16.4 20.4 16.9 14.8 21.2 7.8 19.6 25.7 11.9 22.6 21.5 10.3 60.1 10.5 39.9 12.8 7.3 12.3 27.5 36.0 13.9 2.0 9.3 14.2 23.2 18.5 12.6 12.6 63.7 7.3 9.2 17.7 24.3 21.5 11.4 8.2 12.9 19.5 22.2 22.4 29.5 28.5 34.7 18.1 28.1 11.3 25.5 14.7 15.1 30.4 21.2 15.9 15.9 50.1 14.9 30.1 57.6 21.7 24.2 33.6 31.8 15.6 25.0 34.9 26.2 43.9 18.6 27.8 32.8 38.7 55.2 94.6 100.0 76.8 8.2 23.0 58.6 44.2 44.3 102.9 0.0 131.5 76.3 136.4 33.1 53.4 86.8 23.3 110.4 203.9 98.4 175.7 146.5 20.8 187.8 14.3 27.6 63.3 172.6 14.5 78.9 142.4 94.5 228.2 114.9 23.5 133.8 128.7 44.6 126.0 8.4 84.1 53.6 137.2 79.4 89.8 109.7 82.0 105.5 178.5 SFT2D2 "dJ747L4.C1.2, UNQ512" ENSG00000213064 "SFT2 domain containing 2" O95562 1 168225938-168253025 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 28.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042207 Approved NA NA "HPA042207: AB_10794789" "unprognostic (4.34e-1)" "unprognostic (8.62e-2)" "unprognostic (1.78e-1)" "unprognostic (2.53e-2)" "unprognostic (1.58e-1)" "unprognostic (8.62e-3)" "prognostic unfavorable (4.86e-4)" "unprognostic (2.37e-1)" "unprognostic (1.91e-1)" "unprognostic (8.54e-2)" "unprognostic (4.00e-1)" "unprognostic (1.00e-1)" "unprognostic (2.51e-2)" "unprognostic (2.15e-3)" "unprognostic (9.22e-2)" "unprognostic (1.22e-3)" "unprognostic (1.71e-1)" 16.5 9.2 11.4 12.2 13.5 37.9 14.2 1.9 8.2 16.8 11.3 18.8 9.2 7.0 36.0 13.0 18.3 11.7 10.1 7.5 9.1 7.4 17.6 15.1 12.1 13.2 14.3 6.5 21.3 8.9 13.1 35.3 8.3 12.6 11.6 11.6 9.4 19.9 7.2 5.6 20.5 15.5 14.1 13.7 17.1 9.6 20.6 14.5 19.4 12.9 13.6 23.4 9.7 11.7 4.1 28.6 7.5 13.7 3.5 5.1 3.7 9.9 13.3 5.1 9.4 15.1 8.5 10.7 7.4 5.2 5.6 6.4 13.3 10.2 8.9 11.2 10.3 5.0 33.8 8.8 7.8 7.5 12.4 3.2 7.1 16.2 9.6 8.1 11.0 10.6 9.9 5.9 7.3 6.6 4.3 7.6 12.6 6.4 11.8 6.2 4.1 9.4 8.2 6.2 14.9 2.9 10.5 7.3 7.0 8.2 12.6 3.3 6.3 8.8 11.2 9.1 8.8 8.9 11.0 8.4 7.5 5.6 7.7 9.2 4.6 8.4 13.6 5.8 7.8 7.7 7.5 6.6 2.3 5.1 11.3 3.1 4.1 3.1 3.2 9.1 4.1 2.9 3.2 3.2 3.5 13.7 28.6 3.3 3.7 11.4 13.5 1.9 8.2 9.1 7.4 14.3 6.5 12.6 14.5 41.7 30.7 36.3 13.8 24.8 0.6 3.9 22.9 32.1 31.8 36.6 3.9 8.8 1.7 19.9 50.9 23.3 33.2 23.3 17.9 22.2 30.2 27.0 48.5 50.5 39.8 3.2 30.6 25.8 86.0 103.6 22.5 47.6 40.5 26.2 23.5 12.1 27.4 14.4 31.8 32.2 6.5 25.8 17.8 13.1 7.0 42.2 8.2 24.1 25.7 19.7 SFT2D3 MGC5391 ENSG00000173349 "SFT2 domain containing 3" Q587I9 2 127701508-127705242 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "NK-cell: 2.0" "Lineage enriched" "Detected in single" 7 "NK-cells: 2.0" "Cell line enhanced" "Detected in some" "ASC diff: 8.9;ASC TERT1: 5.2;HHSteC: 6.1;hTCEpi: 8.4;hTERT-HME1: 6.2;RPTEC TERT1: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 4.2 4.4 4.7 2.6 4.3 0.7 11.3 4.6 4.4 9.0 7.4 5.1 4.0 0.7 3.3 13.8 5.0 9.4 5.6 4.5 3.9 3.5 7.1 12.3 3.9 5.5 5.1 1.8 4.6 15.3 11.2 5.5 3.9 2.8 6.9 12.0 5.1 5.3 8.4 2.4 3.6 6.3 6.8 3.9 5.5 6.6 3.6 4.1 8.2 7.0 3.2 10.0 3.4 2.4 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 8.9 5.2 0.0 0.0 4.9 4.9 3.8 0.0 0.0 0.0 0.0 3.6 0.0 0.0 4.1 3.4 3.9 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 4.6 8.4 2.4 6.2 0.0 4.8 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.7 4.3 4.6 4.4 3.9 3.5 5.1 1.8 2.8 4.1 3.0 5.0 3.9 6.9 1.1 6.9 0.0 5.1 2.7 1.2 7.0 15.7 3.6 8.3 2.3 2.8 2.7 4.9 0.0 5.2 3.8 3.9 7.7 1.1 6.0 3.7 7.9 5.2 3.7 5.7 1.2 5.2 4.5 3.3 1.0 10.8 9.1 2.3 7.0 7.1 6.0 9.6 0.0 2.1 8.6 3.6 2.4 2.4 4.8 8.4 5.0 SFTPA2 "COLEC5, SP-A2" ENSG00000185303 "Surfactant protein A2" Q8IWL1 10 79555852-79560402 "Disease related genes, Predicted secreted proteins" "Gaseous exchange" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 225 "lung: 501.0" "Cell type enriched" "Detected in some" 10 "Alveolar cells type 2: 14379.1" "Cancer enriched" "Detected in many" 21 "lung cancer: 863.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 2.2" "Lineage enriched" "Detected in single" 11 "dendritic cells: 2.2" "Group enriched" "Detected in some" 21 "BEWO: 6.5;NB-4: 6.8;RPMI-8226: 21.7;U-2197: 13.1" "CAB002439, HPA042638, HPA045752, HPA049368" Enhanced "Secreted in other tissues" NA NA "CAB002439: AB_564143, HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" "unprognostic (4.99e-2)" "unprognostic (4.38e-2)" "unprognostic (4.29e-2)" "unprognostic (1.05e-1)" "unprognostic (5.78e-2)" "unprognostic (5.08e-1)" "unprognostic (4.94e-2)" "unprognostic (1.68e-3)" "unprognostic (3.10e-1)" "unprognostic (3.56e-2)" "unprognostic (1.20e-1)" "unprognostic (1.33e-1)" "unprognostic (4.69e-3)" 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 501.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.2 0.0 0.1 0.4 0.3 0.1 0.0 0.2 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.8 0.4 0.0 0.0 0.2 0.0 21.7 0.0 0.3 0.2 0.3 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.2 13.1 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1479.9 14379.1 0.0 0.0 0.0 0.0 0.0 0.0 248.9 606.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.7 0.0 0.0 1.0 397.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 SFTPC "BRICD6, PSP-C, SFTP2, SMDP2, SP-C" ENSG00000168484 "Surfactant protein C" P11686 8 22156913-22164479 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Gaseous exchange" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 718 "lung: 664.5" "Cell type enriched" "Detected in some" 10 "Alveolar cells type 2: 80228.9" "Cancer enriched" "Detected in some" 218 "lung cancer: 226.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.4;NB-4: 10.7;SCLC-21H: 4.6;U-2197: 22.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA010928 Enhanced "Secreted in other tissues" NA NA "HPA010928: AB_1857425" "unprognostic (1.84e-1)" "unprognostic (1.96e-1)" "unprognostic (1.44e-1)" "unprognostic (1.13e-1)" "unprognostic (2.97e-1)" "unprognostic (4.97e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (1.32e-2)" 0.1 0.8 0.2 0.3 0.5 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.3 0.1 0.1 0.1 664.5 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.9 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.1 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.7 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.6 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 22.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 0.3 0.1 0.4 0.1 0.9 0.1 7929.7 80228.9 0.0 0.0 1.5 0.0 0.3 0.0 623.7 2602.4 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 909.1 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 SFTPD "COLEC7, SFTP4, SP-D" ENSG00000133661 "Surfactant protein D" P35247 10 79937740-79982614 "Predicted secreted proteins" "Gaseous exchange, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lung: 127.0" "Group enriched" "Detected in many" 14 "Alveolar cells type 1: 408.0;Alveolar cells type 2: 1544.2" "Cancer enriched" "Detected in many" 16 "lung cancer: 106.4" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 11 "intermediate monocyte: 6.4;non-classical monocyte: 21.6" "Lineage enriched" "Detected in many" 17 "monocytes: 21.6" "Cell line enhanced" "Detected in some" "BEWO: 3.3;HaCaT: 2.4;HMC-1: 2.7;hTCEpi: 7.6;MCF7: 3.4;U-2197: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB004578, HPA044582, HPA056768" Enhanced "Secreted in other tissues" NA NA 5500000 "CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232" "unprognostic (3.81e-5)" "unprognostic (7.00e-2)" "unprognostic (1.19e-2)" "unprognostic (1.41e-2)" "unprognostic (4.78e-2)" "unprognostic (1.29e-1)" "unprognostic (1.66e-3)" "unprognostic (6.83e-2)" "unprognostic (3.85e-1)" "unprognostic (2.23e-1)" "unprognostic (5.29e-2)" "unprognostic (2.57e-1)" "unprognostic (4.70e-2)" "unprognostic (2.57e-2)" "unprognostic (2.38e-1)" "unprognostic (1.45e-1)" "unprognostic (8.86e-2)" 0.3 0.3 0.6 0.3 1.1 3.9 0.3 0.3 0.6 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.5 0.5 0.3 0.3 127.0 0.3 0.3 0.3 0.3 0.9 0.3 0.7 0.3 0.3 0.3 0.0 0.3 0.4 0.3 0.3 1.6 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.4 1.2 0.4 0.3 0.3 0.3 0.0 1.2 0.4 21.6 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.2 0.8 0.0 2.4 0.3 0.1 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.2 2.7 0.0 7.6 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 3.4 0.1 1.8 0.8 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.7 0.8 0.1 0.6 0.0 0.4 1.0 0.7 1.5 0.0 0.2 2.6 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.4 0.0 6.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.5 0.6 1.1 0.3 0.6 0.5 0.5 0.3 0.3 0.3 0.3 408.0 1544.2 0.0 0.8 0.8 1.8 0.5 0.0 17.4 68.2 5.2 0.0 0.0 1.7 1.0 5.2 0.3 0.0 0.0 5.2 2.3 1.9 0.8 18.6 0.8 0.1 0.0 0.0 0.0 0.0 8.9 1.1 1.4 0.0 0.0 0.0 2.3 2.0 0.0 0.4 0.2 0.3 0.0 0.2 0.4 0.1 1.6 0.1 0.0 0.0 0.3 SFXN1 "FLJ12876, SLC56A1" ENSG00000164466 "Sideroflexin 1" Q9H9B4 5 175477062-175529742 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "granulocytes: 34.2;T-cells: 16.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019543, HPA063745" Approved Enhanced Mitochondria NA NA Mitochondria "HPA019543: AB_1856789, HPA063745: AB_2685111" "unprognostic (4.77e-3)" "unprognostic (5.26e-2)" "unprognostic (1.54e-2)" "unprognostic (3.62e-3)" "unprognostic (2.35e-1)" "unprognostic (1.30e-2)" "unprognostic (3.59e-2)" "unprognostic (8.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (1.31e-1)" "unprognostic (7.30e-2)" "unprognostic (4.98e-1)" "unprognostic (1.08e-3)" "unprognostic (4.23e-2)" 5.6 14.0 15.2 12.0 20.9 12.9 8.1 20.7 24.5 6.5 18.8 7.9 5.3 13.2 6.5 6.0 12.6 6.6 7.1 9.4 14.5 18.3 28.3 66.8 5.3 17.0 15.3 17.0 13.6 9.7 7.4 11.8 10.4 15.1 7.6 12.5 5.7 7.7 8.0 11.7 6.3 13.4 8.1 15.0 8.2 10.1 5.0 11.0 13.9 7.7 7.3 17.8 11.3 9.1 4.5 3.0 34.2 2.6 4.8 16.0 5.6 10.2 32.6 16.7 18.1 5.7 12.4 26.9 26.3 11.1 22.2 21.5 40.8 20.8 21.5 20.5 13.7 27.4 13.2 31.9 45.8 24.1 52.5 26.7 15.8 29.4 17.8 8.4 30.8 20.0 10.1 9.0 24.6 10.8 13.2 17.0 20.0 22.6 17.1 16.1 36.0 35.9 2.4 13.1 17.4 10.7 30.2 17.1 23.0 8.4 40.4 28.5 18.2 25.3 24.0 12.8 14.4 11.6 10.2 16.5 17.6 27.9 12.9 34.2 21.8 25.6 49.1 28.9 27.8 18.3 34.2 2.1 10.4 11.3 2.6 9.4 4.5 16.0 12.6 3.0 3.8 12.7 12.9 0.6 4.8 1.7 1.4 12.7 5.6 15.2 20.9 20.7 24.5 14.5 18.3 15.3 17.0 15.1 11.0 3.0 15.7 26.8 27.4 17.3 52.5 14.8 12.7 13.4 11.4 17.4 45.2 35.0 21.6 24.5 0.9 12.0 58.5 23.3 16.4 61.7 22.4 20.3 9.2 86.9 14.8 73.1 30.0 7.4 9.4 2.0 43.7 8.0 10.1 7.2 18.2 24.5 26.6 17.5 32.9 46.2 47.8 25.8 27.4 3.0 3.0 18.9 25.9 42.7 18.0 23.5 SFXN2 SLC56A2 ENSG00000156398 "Sideroflexin 2" Q96NB2 10 102714538-102743492 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 31.4;Proximal tubular cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 28.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018150, HPA026834" Enhanced Approved Mitochondria NA NA Mitochondria "HPA018150: AB_1856790, HPA026834: AB_1856791" "unprognostic (1.70e-2)" "prognostic favorable (2.28e-4)" "unprognostic (3.30e-2)" "unprognostic (2.95e-1)" "unprognostic (6.10e-2)" "unprognostic (1.44e-2)" "prognostic favorable (9.95e-4)" "unprognostic (4.24e-2)" "unprognostic (9.69e-2)" "unprognostic (3.98e-2)" "unprognostic (1.32e-1)" "unprognostic (8.98e-3)" "prognostic favorable (2.28e-5)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (3.77e-2)" "prognostic favorable (6.52e-4)" 2.4 3.1 2.3 5.1 5.8 3.8 4.0 2.9 3.5 3.3 4.4 3.7 6.3 3.7 4.8 8.3 2.9 6.0 3.5 1.8 2.4 1.9 24.2 13.7 3.0 10.1 2.8 1.4 8.4 8.1 11.0 9.2 4.7 3.1 4.1 4.3 7.3 17.5 6.4 1.5 2.6 3.3 1.7 1.7 3.3 4.9 2.2 2.5 15.3 7.1 2.0 6.8 3.0 2.3 5.6 3.2 2.5 1.2 3.3 6.3 1.4 3.0 1.5 2.7 2.8 1.0 0.7 3.8 1.0 0.4 1.4 0.7 5.2 1.4 6.6 2.0 0.9 0.7 2.3 0.5 3.5 0.8 1.1 2.1 9.6 2.9 3.2 0.4 5.4 0.8 0.8 0.5 1.3 1.4 1.0 1.2 5.7 4.3 3.1 0.8 2.9 7.9 1.8 1.6 2.9 0.7 4.0 3.3 0.9 1.3 2.4 2.0 2.1 0.9 2.3 0.4 1.1 28.7 1.2 0.9 1.1 3.3 1.4 2.3 3.4 4.5 5.7 1.3 6.6 0.8 2.5 1.2 0.4 3.7 0.5 3.5 1.6 3.9 3.9 1.5 5.6 6.3 5.3 2.5 3.3 0.9 3.2 3.8 1.4 2.3 5.8 2.9 3.5 2.4 1.9 2.8 1.4 3.1 2.5 0.0 8.5 1.5 2.5 0.8 5.0 2.4 0.0 0.0 2.3 1.8 31.4 6.7 8.3 1.7 0.8 1.4 2.0 0.0 2.5 3.0 1.1 3.6 0.0 13.4 7.6 0.0 3.5 5.5 5.6 0.0 2.0 1.6 0.0 1.0 3.4 0.9 1.6 0.0 1.4 24.5 14.4 0.0 1.9 1.2 1.2 1.1 3.8 0.8 7.2 1.0 SFXN3 "SFX3, SLC56A3" ENSG00000107819 "Sideroflexin 3" Q9BWM7 10 101031234-101041244 "Predicted membrane proteins" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008028, HPA048105" Approved Enhanced Mitochondria NA NA 81000 Mitochondria "HPA008028: AB_1079938, HPA048105: AB_2680265" "unprognostic (2.55e-1)" "unprognostic (3.32e-2)" "unprognostic (4.94e-2)" "unprognostic (2.82e-2)" "unprognostic (4.94e-3)" "prognostic unfavorable (3.79e-4)" "unprognostic (3.84e-3)" "unprognostic (8.46e-2)" "unprognostic (1.05e-2)" "unprognostic (9.09e-3)" "unprognostic (1.04e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (3.56e-1)" "unprognostic (3.05e-2)" "unprognostic (3.70e-2)" "unprognostic (1.71e-1)" 14.4 8.1 11.5 8.7 13.9 4.1 10.7 40.2 22.9 14.5 19.0 15.5 13.6 24.4 13.8 17.7 6.5 14.9 12.9 11.3 12.5 9.8 9.2 3.4 16.4 5.4 18.3 13.7 10.6 7.0 17.1 6.9 16.2 18.4 8.8 8.4 9.1 8.4 13.8 2.7 15.7 44.8 19.9 13.7 8.3 8.2 5.6 16.9 4.3 7.5 5.1 5.5 10.7 11.2 2.2 15.7 8.9 14.8 4.3 9.8 8.3 15.2 5.9 0.6 1.8 16.0 17.0 1.6 9.3 32.9 11.9 9.6 9.7 16.8 0.6 8.9 21.7 10.0 11.2 2.8 20.3 5.2 4.2 3.6 1.8 9.8 7.0 11.0 1.4 14.8 11.7 3.0 10.4 9.9 33.2 26.0 4.4 0.1 0.5 19.3 2.5 0.6 2.2 0.7 5.6 14.3 1.4 11.7 4.1 17.5 2.4 3.2 15.9 5.1 0.6 13.8 4.4 4.9 10.8 21.4 10.5 8.3 9.3 4.5 2.4 0.9 0.0 25.6 8.2 8.4 8.9 14.8 7.1 9.8 11.1 7.5 2.2 6.7 6.6 15.7 1.0 4.1 5.1 2.8 4.3 6.1 2.5 7.0 8.3 11.5 13.9 40.2 22.9 12.5 9.8 18.3 13.7 18.4 16.9 11.9 4.0 0.9 4.8 12.4 61.6 2.4 12.7 18.7 3.4 5.2 45.2 0.9 1.7 28.4 54.3 14.7 10.8 0.0 13.5 37.4 14.4 3.9 13.9 0.8 32.6 9.5 5.2 17.2 20.0 97.0 16.1 21.3 32.1 7.2 5.7 7.8 29.0 5.8 13.8 12.3 23.1 12.9 13.0 1.1 0.5 9.5 9.2 13.1 2.5 2.6 SFXN4 SLC56A4 ENSG00000183605 "Sideroflexin 4" Q6P4A7 10 119140767-119165667 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020872 Approved NA NA "HPA020872: AB_1856793" "unprognostic (8.13e-2)" "unprognostic (6.11e-2)" "unprognostic (3.61e-1)" "unprognostic (1.12e-1)" "unprognostic (1.27e-2)" "unprognostic (9.49e-2)" "unprognostic (1.59e-2)" "unprognostic (1.72e-1)" "unprognostic (6.84e-2)" "unprognostic (4.56e-2)" "unprognostic (8.58e-2)" "unprognostic (2.94e-2)" "unprognostic (1.70e-3)" "unprognostic (4.22e-3)" "unprognostic (1.43e-1)" "unprognostic (6.21e-3)" "unprognostic (3.07e-3)" 8.7 26.8 10.7 15.8 21.4 11.8 12.9 16.3 18.6 9.2 17.1 15.6 18.2 15.7 8.9 15.1 13.5 11.7 13.5 25.4 11.5 12.0 21.2 25.7 9.3 10.8 17.0 14.4 12.8 30.2 13.4 14.7 7.5 14.2 12.6 20.7 12.8 22.6 11.1 34.2 7.9 14.0 17.8 12.8 14.6 12.0 10.0 13.7 5.1 20.0 16.7 14.8 11.8 9.8 11.1 17.3 2.0 15.7 5.4 10.8 9.0 11.2 13.1 4.1 21.6 4.9 9.0 16.1 7.2 8.3 9.2 9.5 19.0 19.0 25.0 7.2 6.5 11.9 20.8 25.7 15.3 11.2 13.5 27.8 11.6 8.2 24.9 17.0 20.9 12.2 9.5 14.8 9.9 28.7 9.2 10.7 19.4 17.8 9.0 6.4 13.1 22.1 32.7 5.6 25.1 14.0 22.9 12.7 20.3 13.6 8.5 11.1 8.1 4.9 19.1 27.1 5.4 11.7 13.7 5.2 4.4 10.0 8.5 15.7 21.0 23.8 22.9 7.0 31.0 4.0 2.0 14.6 1.4 5.7 15.7 9.4 11.1 6.9 6.1 17.3 5.9 10.8 8.5 1.7 5.4 12.6 8.7 4.9 9.0 10.7 21.4 16.3 18.6 11.5 12.0 17.0 14.4 14.2 13.7 6.0 3.5 13.7 21.7 10.6 7.4 30.1 17.8 9.4 9.1 14.0 2.0 32.9 49.7 22.5 19.5 8.3 19.6 0.0 20.5 19.0 11.2 14.2 5.7 27.1 25.6 6.4 17.2 6.2 14.2 51.4 8.1 9.8 11.8 6.4 21.4 5.5 17.4 3.5 12.7 46.0 9.5 6.5 9.2 12.2 14.9 8.0 18.3 7.5 43.3 16.9 SFXN5 "BBG-TCC, SLC56A5" ENSG00000144040 "Sideroflexin 5" Q8TD22 2 72942036-73075619 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.3;liver: 31.4" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 100.9;Late spermatids: 111.2;Muller glia cells: 76.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015473, HPA056866" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA015473: AB_1856794, HPA056866: AB_2683261" "unprognostic (7.75e-2)" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-3)" "unprognostic (1.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "prognostic favorable (2.26e-6)" "unprognostic (1.57e-1)" "unprognostic (8.51e-2)" "unprognostic (3.50e-1)" "unprognostic (3.23e-1)" "unprognostic (3.97e-1)" "unprognostic (1.43e-2)" 4.0 10.1 26.1 4.9 24.6 12.8 3.1 10.1 28.3 3.4 6.6 12.9 3.7 7.6 3.2 18.4 2.7 5.2 4.4 3.6 25.3 12.7 12.7 31.4 3.7 3.6 16.0 18.6 2.9 2.7 3.4 3.1 4.5 14.9 5.2 6.8 2.6 2.1 5.4 6.3 3.2 7.3 4.5 9.6 5.2 5.1 2.9 13.3 1.6 4.3 1.7 3.7 5.0 2.1 3.0 4.2 6.4 8.9 5.8 1.3 2.1 3.4 7.4 11.8 9.1 2.8 1.9 4.3 7.0 4.0 11.2 5.9 11.4 8.9 2.1 7.3 7.3 8.1 3.0 9.1 10.1 5.3 8.5 5.9 8.6 7.3 14.9 3.6 4.3 9.4 4.9 2.8 7.8 0.9 4.0 6.5 2.6 7.4 1.8 3.0 6.7 1.2 6.6 14.5 6.7 4.7 8.1 9.7 2.6 6.5 8.2 7.6 2.1 6.5 3.3 2.7 6.7 1.7 2.2 4.7 3.4 11.2 4.8 8.0 3.0 2.9 2.5 11.7 8.1 4.0 4.8 8.9 4.2 0.9 3.9 1.3 1.6 0.5 1.0 4.2 3.0 0.6 0.8 6.4 5.8 4.3 2.9 1.0 2.1 26.1 24.6 10.1 26.3 25.3 12.7 16.0 18.6 14.9 13.3 0.0 4.1 8.8 4.0 4.1 24.0 5.4 5.1 0.0 4.5 34.9 31.4 7.6 3.3 4.4 100.9 6.0 15.1 23.3 7.9 1.9 7.5 2.9 0.0 53.3 10.6 19.1 13.2 8.6 4.0 111.2 9.8 7.0 8.5 10.0 5.8 76.6 6.2 5.3 10.6 20.2 38.4 12.9 7.7 7.9 13.0 8.2 3.5 5.7 6.8 1.6 SGCA "A2, adhalin, ADL, DMDA2, LGMD2D, SCARMD1" ENSG00000108823 "Sarcoglycan alpha" Q16586 17 50164214-50175931 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 144.7" "Cell type enhanced" "Detected in many" 27 "Cardiomyocytes: 113.3;Early spermatids: 135.9;Late spermatids: 458.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 7 "cerebellum: 3.0" "Group enriched" "Detected in some" 5 "intermediate monocyte: 2.4;memory B-cell: 5.3;myeloid DC: 3.8;naive B-cell: 5.2;non-classical monocyte: 3.1" "Group enriched" "Detected in many" 19 "B-cells: 5.3;dendritic cells: 3.8;monocytes: 3.1" "Cell line enriched" "Detected in some" 15 "LHCN-M2: 42.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007537 Uncertain "Intracellular and membrane" NA NA "HPA007537: AB_1079944" "unprognostic (1.34e-1)" "unprognostic (2.30e-2)" "unprognostic (1.89e-3)" "unprognostic (1.25e-1)" "unprognostic (9.87e-2)" "unprognostic (2.43e-2)" "unprognostic (9.25e-2)" "unprognostic (1.22e-2)" "unprognostic (1.15e-1)" "unprognostic (1.91e-1)" "unprognostic (7.01e-2)" "unprognostic (2.57e-1)" "unprognostic (2.07e-3)" "unprognostic (4.96e-2)" "unprognostic (2.16e-1)" "unprognostic (2.95e-1)" "unprognostic (1.15e-2)" 2.8 0.6 0.1 2.5 0.2 0.2 0.8 3.0 0.4 6.8 10.0 0.0 8.6 1.6 7.9 10.5 10.8 3.4 10.7 32.2 0.2 0.1 0.6 0.9 5.7 0.3 0.2 0.3 3.4 0.5 0.2 0.1 1.9 0.4 10.9 1.1 7.1 2.3 8.0 144.7 2.6 3.0 30.3 0.3 0.7 5.7 1.4 0.0 0.0 1.6 39.8 2.3 20.1 4.3 5.3 3.8 0.2 3.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 42.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.8 0.2 0.0 2.4 0.0 5.3 0.0 0.0 3.8 5.2 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.7 0.1 0.2 3.0 0.1 0.2 0.1 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.2 7.7 0.0 113.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 135.9 2.1 0.0 0.0 5.2 0.1 41.4 0.2 0.0 0.0 0.5 0.0 0.0 1.8 0.0 458.2 2.8 1.4 8.5 0.0 0.0 0.0 2.4 0.0 3.5 1.4 0.0 12.9 49.5 2.1 1.5 8.7 0.2 0.0 0.0 0.1 SGCB "A3b, LGMD2E, SGC" ENSG00000163069 "Sarcoglycan beta" Q16585 4 52020706-52038482 "Disease related genes, Predicted membrane proteins" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011422, HPA058656" Enhanced Approved Cytosol NA NA Cytosol "HPA011422: AB_1856795, HPA058656: AB_2683790" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (1.03e-1)" "unprognostic (1.60e-3)" "unprognostic (9.80e-2)" "unprognostic (3.42e-2)" "unprognostic (3.57e-3)" "unprognostic (1.86e-2)" "unprognostic (2.84e-2)" "unprognostic (6.04e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic favorable (5.53e-6)" "unprognostic (3.74e-2)" "unprognostic (1.03e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (7.61e-4)" 17.7 13.2 17.6 5.4 19.0 0.5 8.8 18.6 20.7 14.9 18.3 17.5 3.7 7.7 17.1 7.0 13.2 11.5 11.6 32.4 16.5 14.5 20.5 6.4 9.0 3.4 20.4 12.9 12.6 4.0 29.9 17.5 13.9 17.9 15.4 9.9 7.9 7.8 17.0 54.1 4.4 8.7 21.8 24.7 6.3 9.0 9.2 20.3 0.9 7.9 10.4 2.8 13.5 11.8 4.3 1.7 0.9 2.0 0.5 6.6 2.0 3.4 4.2 8.9 3.3 34.4 26.0 3.2 19.7 25.3 11.1 11.7 1.1 4.7 0.9 3.8 25.8 17.2 1.7 6.6 7.2 11.9 5.7 2.5 0.0 4.0 2.1 14.1 2.0 1.1 28.5 5.1 9.6 5.6 29.1 14.5 3.4 0.0 0.0 23.6 1.3 4.5 0.0 3.2 1.4 6.5 0.0 4.7 0.0 9.3 1.2 5.2 9.1 12.5 0.6 4.3 10.4 1.6 1.2 14.7 16.5 5.5 7.7 17.4 4.8 6.1 1.7 12.1 0.7 18.8 0.4 2.0 0.1 3.9 0.8 3.7 4.3 4.6 4.1 0.9 3.6 3.3 4.1 0.9 0.5 0.6 1.7 6.6 2.0 17.6 19.0 18.6 17.5 16.5 14.5 20.4 12.9 17.9 20.3 29.8 12.5 7.0 23.0 11.8 22.7 71.9 20.4 18.7 12.5 12.2 5.9 4.3 1.7 23.7 46.3 25.1 15.9 0.0 46.3 44.3 51.2 9.7 2.3 14.3 2.6 27.0 15.6 35.0 2.2 132.8 35.9 5.1 25.3 1.8 2.6 22.7 35.3 3.5 85.9 54.8 13.4 45.3 63.4 9.8 15.8 9.3 5.3 7.5 11.3 12.3 SGCD "CMD1L, DAGD, LGMD2F" ENSG00000170624 "Sarcoglycan delta" Q92629 5 155870344-156767788 "Disease related genes, Predicted membrane proteins" "Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 32.6" "Cell type enhanced" "Detected in many" 18 "Cardiomyocytes: 97.2;Cone photoreceptor cells: 51.1;Melanocytes: 23.6" "Cancer enhanced" "Detected in many" "melanoma: 10.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.5;naive CD8 T-cell: 3.1" "Lineage enriched" "Detected in single" 32 "T-cells: 3.1" "Cell line enhanced" "Detected in some" "BJ: 12.7;fHDF/TERT166: 20.2;LHCN-M2: 9.3;RH-30: 15.6;SK-MEL-30: 20.2;U-138 MG: 20.1" "Low region specificity" "Detected in many" NA NA "unprognostic (2.23e-1)" "unprognostic (3.82e-2)" "unprognostic (9.11e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (9.55e-2)" "unprognostic (2.63e-1)" "unprognostic (1.66e-1)" "unprognostic (6.53e-2)" "unprognostic (2.25e-1)" "unprognostic (1.75e-1)" "unprognostic (6.99e-2)" "unprognostic (4.10e-2)" "unprognostic (9.65e-3)" "unprognostic (5.37e-2)" "unprognostic (5.60e-3)" "unprognostic (3.66e-3)" 4.7 5.0 3.5 2.0 4.2 0.1 2.9 1.3 3.1 9.0 7.8 10.8 3.2 1.6 19.8 4.9 7.9 3.8 8.6 32.6 4.5 2.3 1.2 1.9 5.2 0.5 9.2 3.4 10.4 1.0 6.3 1.9 0.6 8.1 7.1 3.5 12.2 2.4 4.9 28.5 2.0 3.9 12.3 10.8 1.4 3.8 1.5 8.2 0.0 16.1 13.9 0.9 7.4 4.1 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 6.2 0.0 0.0 4.4 7.7 0.0 12.7 4.1 0.0 0.1 0.0 0.0 0.0 0.0 20.2 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.4 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 20.1 0.0 3.5 0.0 0.0 0.0 0.0 3.2 0.0 8.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 3.5 4.2 1.3 3.1 4.5 2.3 9.2 3.4 8.1 8.2 0.0 0.3 0.0 0.0 3.2 1.2 97.2 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.2 5.5 0.0 0.0 0.0 0.0 0.0 9.7 0.8 0.0 1.0 0.2 20.6 1.7 4.3 0.0 8.9 17.5 0.9 23.6 0.0 0.0 0.2 0.0 0.0 14.5 0.3 1.1 0.0 4.9 0.0 0.0 2.8 0.1 0.0 0.0 0.0 SGCE DYT11 ENSG00000127990 "Sarcoglycan epsilon" O43556 7 94524204-94656572 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 2.9;memory B-cell: 6.4;naive B-cell: 9.2" "Group enriched" "Detected in many" 4 "B-cells: 9.2;T-cells: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074790 Approved "Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane" Yes No 50000 "Vesicles, Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA074790: AB_2686713" "unprognostic (3.16e-3)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-3)" "unprognostic (1.12e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (1.19e-2)" "unprognostic (2.82e-2)" "unprognostic (6.93e-2)" "unprognostic (3.37e-1)" "unprognostic (6.80e-3)" "unprognostic (9.69e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" 22.4 35.7 16.9 7.5 19.0 0.6 23.2 23.6 18.5 22.5 20.5 16.8 14.0 5.3 23.6 16.8 11.1 17.1 19.0 19.3 17.7 14.3 12.9 8.9 17.3 9.0 21.5 12.9 59.3 12.9 8.7 23.1 31.9 15.0 15.6 9.7 11.2 11.9 22.7 6.1 3.5 8.0 28.1 20.9 15.8 11.2 13.2 17.5 2.9 15.4 6.9 4.4 22.7 16.1 9.2 0.3 0.6 0.1 1.4 2.9 0.5 3.7 11.9 12.0 19.4 19.2 36.0 2.1 14.3 29.0 12.2 18.6 7.4 22.5 3.5 20.4 25.3 25.5 2.5 18.1 6.4 16.7 0.6 9.8 0.3 11.7 8.0 15.0 1.1 0.0 29.1 8.9 18.0 23.5 33.3 8.6 0.0 0.0 28.4 14.2 11.8 0.0 0.0 9.2 2.2 9.4 5.4 14.9 7.5 23.8 3.7 7.6 6.1 0.0 15.9 18.2 14.6 5.5 0.1 0.0 38.8 13.0 3.6 22.1 14.7 18.3 4.3 14.4 0.0 21.8 0.6 0.1 0.1 2.9 0.1 1.2 6.4 0.9 1.4 0.1 9.2 0.3 1.0 0.5 1.4 0.1 0.3 0.2 0.5 16.9 19.0 23.6 18.5 17.7 14.3 21.5 12.9 15.0 17.5 65.5 26.6 5.2 18.8 4.4 16.7 15.1 17.8 22.7 43.3 19.2 3.9 75.6 5.0 31.9 1.1 15.0 0.0 0.0 3.9 20.1 52.5 6.3 2.3 7.2 5.5 19.1 1.2 44.8 4.8 1.9 69.9 2.3 49.0 0.0 0.0 27.8 2.8 0.0 54.8 14.7 28.3 84.1 46.2 9.1 3.4 3.4 69.2 0.9 0.0 2.0 SGCG "A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE" ENSG00000102683 "Sarcoglycan gamma" Q13326 13 23180952-23325165 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 40.9;skeletal muscle: 53.3;tongue: 44.3" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 116.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 38.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA007476 Enhanced NA NA "HPA007476: AB_1079946" "unprognostic (5.19e-2)" "unprognostic (8.28e-2)" "unprognostic (5.15e-3)" "unprognostic (1.64e-4)" "unprognostic (3.00e-3)" "unprognostic (3.61e-2)" "unprognostic (8.14e-3)" "unprognostic (1.46e-1)" "unprognostic (2.29e-1)" "unprognostic (4.49e-1)" "unprognostic (6.05e-2)" "unprognostic (2.23e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (2.98e-3)" "unprognostic (1.07e-1)" 8.6 0.1 0.1 0.2 0.1 0.0 2.9 0.2 0.6 0.1 0.4 0.1 0.1 0.0 0.1 3.8 2.6 0.3 0.3 40.9 0.3 0.1 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.1 1.6 0.1 0.1 0.1 1.2 0.1 0.5 2.1 0.1 53.3 1.3 0.2 0.1 0.1 0.1 0.4 0.6 0.1 0.1 0.7 44.3 3.3 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 38.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.4 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.6 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.0 0.0 116.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.4 6.9 0.2 5.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.4 1.4 12.1 0.9 0.0 0.0 0.0 0.0 SGCZ ZSG1 ENSG00000185053 "Sarcoglycan zeta" Q96LD1 8 14089864-15238339 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.2;ovary: 11.3;pituitary gland: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "amygdala: 5.6;basal ganglia: 9.5;cerebellum: 21.2;cerebral cortex: 6.8;pons and medulla: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.2;REH: 2.5" "Low region specificity" "Detected in many" HPA017585 Uncertain NA NA "HPA017585: AB_1856799" "unprognostic (3.83e-1)" "unprognostic (1.41e-1)" "unprognostic (5.87e-4)" "unprognostic (1.21e-1)" 1.1 0.4 5.6 0.5 9.5 0.6 2.6 21.2 6.8 0.8 0.7 0.0 0.0 0.7 0.9 1.4 0.4 0.5 0.7 0.5 1.4 2.2 1.0 0.7 0.4 0.4 1.3 2.3 11.3 0.7 0.4 7.3 0.5 5.3 0.8 0.5 0.1 0.4 0.6 0.4 0.9 0.5 0.9 3.2 0.5 0.7 1.4 1.1 0.0 0.4 0.0 0.5 1.5 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.6 9.5 21.2 6.8 1.4 2.2 1.3 2.3 5.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SGMS1 "MGC17342, MOB, SMS1, TMEM23" ENSG00000198964 "Sphingomyelin synthase 1" 10 50305586-50625163 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045191 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA045191: AB_10959605" "unprognostic (1.13e-1)" "unprognostic (5.75e-2)" "unprognostic (1.87e-1)" "unprognostic (9.08e-2)" "unprognostic (8.69e-3)" "unprognostic (8.34e-2)" "unprognostic (7.98e-2)" "unprognostic (2.29e-1)" "unprognostic (1.30e-2)" "unprognostic (5.75e-2)" "unprognostic (9.20e-2)" "unprognostic (2.05e-1)" "prognostic favorable (1.95e-7)" "unprognostic (8.38e-2)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" "unprognostic (3.05e-1)" 14.7 19.6 16.9 12.3 19.4 17.6 13.2 17.5 20.1 15.8 12.8 24.0 11.9 11.7 12.5 18.1 13.7 14.8 13.6 16.6 18.2 14.6 17.9 23.5 18.6 11.6 22.9 14.0 16.9 19.1 64.6 22.9 20.7 18.6 17.6 10.7 15.5 19.8 15.8 13.2 25.6 13.7 15.2 31.7 13.6 12.8 9.6 24.9 11.4 21.5 8.7 14.9 15.2 21.3 5.3 3.7 20.1 6.7 7.6 11.0 4.2 16.1 7.7 2.3 5.0 8.2 10.8 10.5 10.8 10.9 7.6 7.2 6.4 16.8 12.0 6.3 14.1 6.9 10.3 5.3 11.3 8.0 10.4 5.6 17.2 10.3 4.8 9.5 3.9 4.3 6.9 13.3 10.1 12.4 4.9 10.7 4.4 33.1 18.0 8.1 6.8 1.7 2.2 5.1 7.4 7.4 2.9 10.3 4.6 11.1 17.1 3.4 2.7 7.9 7.9 4.1 6.6 11.9 1.5 14.9 8.3 10.1 7.9 7.9 6.1 4.8 3.4 10.3 6.5 6.7 2.4 6.7 20.1 3.7 3.4 8.2 5.3 4.9 5.4 3.7 5.0 6.8 4.3 12.5 7.6 2.7 2.3 11.0 4.2 16.9 19.4 17.5 20.1 18.2 14.6 22.9 14.0 18.6 24.9 41.7 27.0 11.0 24.2 48.3 16.3 20.6 7.6 25.4 38.7 27.9 3.9 8.7 13.3 15.3 12.1 17.0 9.3 23.3 18.7 6.6 21.6 31.8 19.7 14.5 23.8 4.8 14.3 20.9 40.7 21.3 15.0 16.6 11.8 5.4 11.2 16.5 10.7 3.5 9.9 7.9 35.9 0.0 15.5 8.1 1.9 72.9 4.1 10.7 11.5 23.2 SGMS2 "MGC26963, SMS2" ENSG00000164023 "Sphingomyelin synthase 2" Q8NHU3 4 107824563-107915047 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 144.6;Ciliated cells: 116.4;Club cells: 131.9;Urothelial cells: 179.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "pons and medulla: 17.0" "Group enriched" "Detected in some" 8 "classical monocyte: 5.7;eosinophil: 3.9;intermediate monocyte: 2.4;myeloid DC: 6.6;non-classical monocyte: 2.0" "Group enriched" "Detected in many" 32 "dendritic cells: 6.6;granulocytes: 3.9;monocytes: 5.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA015076 Supported NA NA "HPA015076: AB_1857298" "unprognostic (7.44e-2)" "unprognostic (2.32e-2)" "unprognostic (2.36e-2)" "unprognostic (1.87e-2)" "unprognostic (7.88e-3)" "unprognostic (9.53e-2)" "unprognostic (5.01e-2)" "unprognostic (1.32e-1)" "unprognostic (4.15e-1)" "unprognostic (1.10e-1)" "unprognostic (1.82e-3)" "unprognostic (3.26e-1)" "prognostic favorable (1.37e-4)" "unprognostic (6.18e-2)" "unprognostic (5.63e-2)" "unprognostic (8.71e-2)" "unprognostic (5.22e-3)" 7.5 3.3 1.9 8.6 2.9 2.1 8.0 1.7 1.9 8.3 22.2 3.4 5.6 11.4 12.5 9.7 14.9 7.5 24.9 7.8 2.5 2.6 13.2 12.6 20.7 6.4 2.7 1.4 5.4 8.4 4.6 48.5 30.7 17.0 8.0 6.4 11.8 14.2 3.2 5.0 4.5 38.1 18.5 4.6 1.5 9.8 8.6 1.0 0.2 22.0 12.2 5.3 10.7 11.2 0.1 6.6 3.9 5.7 0.0 0.1 1.4 10.0 3.8 0.6 2.9 6.7 15.6 0.2 12.4 9.4 5.9 6.2 1.7 21.0 0.7 4.9 19.7 5.1 3.8 7.2 10.9 10.6 2.8 2.8 0.4 8.5 0.6 7.7 6.8 0.0 5.4 7.7 11.5 14.0 12.4 13.0 0.1 0.1 0.2 9.3 3.4 0.2 0.0 0.3 5.9 4.3 0.2 5.0 1.4 15.7 4.9 1.0 0.0 9.5 13.6 1.6 1.6 7.3 0.1 22.1 7.1 11.2 10.1 5.7 0.7 0.2 0.4 9.5 1.6 2.9 0.0 5.7 3.9 0.0 2.4 0.0 0.1 0.0 0.0 6.6 0.1 0.1 0.0 0.5 0.0 2.0 0.0 0.0 1.4 1.9 2.9 1.7 1.9 2.5 2.6 2.7 1.4 17.0 1.0 80.4 97.5 2.7 144.6 49.7 0.4 17.1 28.1 116.4 131.9 15.7 0.0 0.8 3.3 16.4 47.7 9.0 30.7 0.0 16.7 0.6 20.1 102.6 9.3 20.2 5.9 1.6 8.5 4.9 31.9 5.9 2.3 23.7 8.5 1.0 19.0 0.0 26.8 38.6 0.4 9.1 0.0 0.0 30.9 0.5 2.8 63.7 11.6 1.3 9.3 179.5 SGPL1 SPL ENSG00000166224 "Sphingosine-1-phosphate lyase 1" O95470 10 70815961-70881173 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021125, HPA023086" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA021125: AB_1856803, HPA023086: AB_1856804" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (3.07e-2)" "unprognostic (2.13e-1)" "unprognostic (2.34e-1)" "unprognostic (7.60e-2)" "unprognostic (2.98e-2)" "unprognostic (2.88e-1)" "unprognostic (1.06e-1)" "unprognostic (1.70e-2)" "unprognostic (2.12e-1)" "unprognostic (9.52e-2)" "unprognostic (3.42e-1)" "unprognostic (2.14e-1)" "unprognostic (9.21e-2)" "unprognostic (4.68e-3)" 9.6 11.2 12.0 20.2 11.4 4.9 24.4 10.8 10.6 16.2 17.1 16.0 21.9 13.3 15.5 16.8 26.7 13.5 13.4 8.3 11.3 9.8 18.2 27.1 10.4 20.1 11.9 9.5 10.0 34.6 15.4 10.2 11.3 10.4 16.1 15.6 7.6 15.0 19.5 7.6 28.6 32.5 12.1 15.7 22.9 10.3 15.3 11.0 14.7 17.6 12.8 18.0 21.4 26.8 5.6 9.7 8.9 24.8 10.9 11.5 6.6 10.7 14.4 13.9 15.9 3.8 5.0 9.2 6.3 6.8 6.9 9.0 15.6 23.9 9.7 7.5 6.4 6.7 18.2 11.9 12.8 9.9 15.5 6.4 1.0 7.3 18.6 14.5 4.2 8.8 9.4 21.7 9.3 24.5 14.7 4.3 9.2 2.8 8.5 9.8 11.9 5.1 2.8 6.3 14.3 8.0 6.6 10.6 3.6 11.1 45.7 9.5 11.6 12.7 19.5 11.6 11.4 10.1 3.0 8.3 6.3 16.5 4.8 12.1 3.5 4.8 4.5 6.2 7.8 4.4 0.6 11.5 7.9 11.5 20.3 10.4 4.7 7.5 9.4 9.7 5.6 5.7 9.0 8.9 10.9 24.8 5.4 6.8 6.6 12.0 11.4 10.8 10.4 11.3 9.8 11.9 9.5 10.4 11.0 14.9 5.4 9.9 14.9 10.9 6.5 5.6 30.6 14.7 14.8 43.6 19.6 6.6 3.3 32.5 2.3 6.4 38.8 0.0 33.2 10.9 12.4 23.9 14.9 39.5 25.3 14.3 24.1 6.2 30.2 4.5 10.6 15.9 6.8 16.2 20.8 9.3 41.0 17.3 19.1 11.5 8.2 6.5 11.4 19.9 31.5 19.8 5.3 11.4 16.2 20.4 SGPP1 ENSG00000126821 "Sphingosine-1-phosphate phosphatase 1" Q9BX95 14 63684214-63728039 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 49.4" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 48.8;Kupffer cells: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 23.9;U-698: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053149, HPA064908" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA053149: AB_2682057, HPA064908: AB_2797270" "unprognostic (1.57e-2)" "unprognostic (1.04e-2)" "unprognostic (5.40e-3)" "unprognostic (7.82e-2)" "unprognostic (9.09e-2)" "unprognostic (4.30e-2)" "unprognostic (6.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.64e-1)" "unprognostic (7.41e-2)" "unprognostic (1.51e-1)" "unprognostic (3.27e-1)" "unprognostic (8.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-3)" 10.5 12.1 12.1 15.7 11.6 4.3 7.6 14.3 12.9 9.2 9.6 15.1 3.9 6.2 8.4 10.3 5.7 5.9 8.9 5.5 13.1 12.6 24.7 29.4 10.3 18.5 13.0 7.0 7.4 14.1 15.5 6.4 49.4 11.1 9.0 8.7 6.7 5.7 7.0 4.4 4.8 8.9 7.9 19.6 16.5 5.8 8.2 9.8 15.4 7.8 3.7 19.1 8.6 7.3 3.2 0.5 8.8 3.3 0.5 2.0 0.5 10.5 3.4 1.7 4.8 6.2 5.8 20.3 8.7 6.1 5.4 6.1 1.5 6.0 23.9 2.6 4.4 4.5 11.3 2.7 5.1 8.8 9.3 3.1 2.2 2.0 2.4 7.6 3.9 6.9 4.2 8.3 4.7 7.5 5.5 2.6 4.5 1.2 0.7 7.8 3.9 4.5 0.0 1.1 1.7 7.3 1.1 4.7 1.9 8.6 5.3 1.0 2.8 6.1 5.7 4.5 5.4 7.4 1.4 2.9 7.6 5.2 5.3 4.3 5.7 3.5 31.1 5.5 0.0 3.2 8.8 0.3 2.8 1.0 2.3 1.0 3.2 1.0 0.7 0.5 0.8 1.5 1.1 0.4 0.5 3.3 0.3 2.0 0.5 12.1 11.6 14.3 12.9 13.1 12.6 13.0 7.0 11.1 9.8 11.9 14.4 11.2 4.9 8.7 3.5 3.2 25.5 2.7 3.4 48.8 0.0 19.1 0.0 5.2 1.6 5.4 6.7 0.0 7.7 24.8 16.2 8.0 10.5 37.6 19.7 9.5 17.9 8.0 53.2 0.8 5.8 20.6 16.9 3.6 9.4 7.3 11.2 11.6 15.9 20.9 5.1 6.5 19.4 6.7 2.7 11.8 27.6 7.5 8.1 4.8 SGPP2 "FLJ39004, SPP2" ENSG00000163082 "Sphingosine-1-phosphate phosphatase 2" Q8IWX5 2 222424517-222560948 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Urothelial cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.4;EFO-21: 8.2;hTCEpi: 25.9;RPTEC TERT1: 25.6;SCLC-21H: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (2.56e-3)" "unprognostic (1.79e-1)" "unprognostic (8.50e-2)" "unprognostic (2.97e-2)" "unprognostic (1.24e-3)" "unprognostic (5.22e-2)" "unprognostic (9.16e-2)" "unprognostic (2.31e-2)" "unprognostic (3.54e-3)" "unprognostic (6.24e-2)" "prognostic favorable (1.28e-4)" "unprognostic (3.25e-2)" "unprognostic (2.19e-1)" "unprognostic (1.74e-2)" "unprognostic (2.69e-2)" 2.9 7.8 5.4 3.1 12.8 1.2 3.9 14.6 8.4 8.6 16.2 2.2 19.5 12.9 2.2 2.0 19.9 10.4 11.5 5.8 5.0 6.1 16.1 0.7 7.7 2.7 4.4 3.8 1.9 3.7 30.5 12.1 0.3 17.1 2.3 13.4 0.3 8.6 22.1 1.1 16.5 23.5 1.3 3.2 1.4 18.3 1.8 3.3 1.7 16.9 9.8 13.9 8.1 9.3 1.1 0.5 1.3 0.5 0.4 2.3 0.2 0.8 0.8 0.3 0.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 9.4 0.4 8.2 0.0 0.1 0.2 0.2 0.0 0.0 0.2 3.0 0.7 0.2 0.1 0.0 1.0 0.5 0.0 25.9 0.0 0.1 0.0 0.0 0.5 0.2 0.4 0.0 0.5 0.2 0.8 0.3 5.6 0.3 0.4 0.2 0.4 25.6 2.5 10.4 0.4 0.0 1.1 0.1 0.5 0.1 0.1 0.0 0.1 0.3 0.4 0.3 0.3 0.2 0.6 0.1 0.1 0.1 1.3 0.5 0.2 0.4 0.2 1.0 1.1 1.9 0.5 0.0 1.1 0.4 0.2 1.3 0.4 0.2 0.5 2.3 0.2 5.4 12.8 14.6 8.4 5.0 6.1 4.4 3.8 17.1 3.3 3.0 7.8 0.5 2.3 3.3 4.7 4.9 10.2 10.7 11.4 12.2 5.9 0.1 1.7 12.9 6.9 0.1 11.8 0.0 1.6 0.2 0.8 5.6 0.0 0.0 0.2 1.6 1.2 0.0 0.0 2.5 0.6 0.4 0.0 0.0 5.8 1.1 6.9 13.6 0.4 0.2 6.8 0.0 0.2 0.5 0.2 12.5 2.1 0.0 9.3 38.2 SHH "HHG1, HLP3, HPE3, MCOPCB5, SMMCI, TPT, TPTPS" ENSG00000164690 "Sonic hedgehog" Q15465 7 155799986-155812273 "Disease related genes, Predicted intracellular proteins" "Developmental protein, Hydrolase, Protease" "Disease mutation, Holoprosencephaly, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.7;liver: 18.4" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 12.7;Collecting duct cells: 8.7;Hepatocytes: 16.4;Urothelial cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 6.2;GAMG: 28.0;OE19: 6.8;RT4: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA 3600000 "unprognostic (7.17e-2)" "unprognostic (7.68e-3)" "unprognostic (6.70e-2)" "prognostic favorable (8.62e-5)" "unprognostic (1.59e-1)" "unprognostic (2.50e-2)" "unprognostic (2.39e-3)" "unprognostic (1.82e-2)" "unprognostic (1.83e-1)" "unprognostic (2.16e-2)" "unprognostic (3.47e-1)" "unprognostic (1.56e-1)" "unprognostic (1.77e-3)" "unprognostic (2.86e-1)" "unprognostic (2.85e-1)" "unprognostic (3.43e-2)" "unprognostic (2.66e-2)" 0.3 11.9 1.1 1.0 2.4 0.2 0.2 0.6 2.5 6.1 1.7 0.4 4.7 1.9 0.9 9.5 0.3 0.3 27.7 0.2 0.9 3.0 3.8 18.4 2.9 0.1 1.9 0.9 0.2 0.4 0.1 0.4 0.1 5.7 6.0 1.5 0.0 0.2 2.7 0.2 0.4 1.8 5.2 1.7 0.2 13.6 0.3 0.6 0.0 0.2 0.0 0.1 14.1 3.1 0.2 0.8 1.5 0.4 0.4 0.4 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.6 0.0 6.2 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 6.8 2.8 0.0 0.0 0.0 1.4 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.4 0.1 0.2 0.4 0.2 0.2 0.2 0.1 0.2 0.2 0.3 1.5 0.4 0.4 0.8 0.2 0.3 1.1 2.4 0.6 2.5 0.9 3.0 1.9 0.9 5.7 0.6 3.0 5.6 0.0 5.8 0.0 0.4 0.6 12.7 0.0 2.3 8.7 0.0 0.0 0.0 1.3 2.9 0.0 2.5 0.0 0.7 0.1 0.0 0.7 0.0 16.4 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 6.7 0.0 7.4 0.0 0.4 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 7.8 SHISA2 "bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166" ENSG00000180730 "Shisa family member 2" Q6UWI4 13 26044597-26051031 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 12.9;skeletal muscle: 10.2;thyroid gland: 20.8" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 9.6;Basal glandular cells: 8.8;Urothelial cells: 18.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 18.9;JURKAT: 13.2;LHCN-M2: 13.2;NTERA-2: 9.6;RH-30: 30.7;U-2197: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA049752, HPA050172" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA049752: , HPA050172: AB_2681041" "unprognostic (2.08e-2)" "unprognostic (3.00e-1)" "unprognostic (2.41e-1)" "unprognostic (9.71e-2)" "unprognostic (6.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-1)" "prognostic favorable (3.30e-4)" "unprognostic (4.03e-2)" "unprognostic (3.10e-1)" "unprognostic (7.45e-2)" "unprognostic (2.17e-2)" "prognostic favorable (2.43e-4)" "unprognostic (5.56e-3)" "unprognostic (2.09e-1)" "unprognostic (3.46e-1)" "unprognostic (1.51e-2)" 0.3 0.0 0.7 0.0 2.0 0.0 12.9 0.0 0.5 1.5 0.0 0.4 0.0 7.9 0.0 0.0 0.3 0.0 2.0 0.6 3.0 0.0 3.7 0.1 1.1 0.0 0.0 0.0 1.7 0.0 0.4 0.0 1.9 0.0 10.2 1.0 0.3 0.0 3.5 0.0 1.6 0.9 20.8 0.3 0.0 0.0 0.8 0.6 2.2 1.1 1.0 5.6 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.2 2.5 1.0 0.0 0.0 1.2 18.9 0.7 13.2 0.0 0.0 13.2 0.7 1.3 0.3 9.6 5.5 4.8 0.0 30.7 0.1 1.2 4.3 0.3 0.0 0.2 0.0 3.4 2.0 0.4 0.1 1.0 0.0 0.5 19.2 4.2 0.0 0.0 0.0 0.0 0.0 2.6 2.2 0.4 1.7 0.6 0.7 1.0 0.6 1.7 0.7 0.3 0.8 3.9 5.6 1.6 1.0 1.1 0.6 0.7 0.4 0.0 9.6 0.0 8.8 4.7 0.0 0.4 0.0 1.4 0.0 3.5 0.0 0.2 0.0 4.0 1.5 1.2 0.0 0.0 0.2 0.3 0.7 2.4 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.7 0.0 0.2 1.7 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 1.2 0.3 3.6 1.5 0.1 0.0 0.0 18.2 SHISA3 hShisa3 ENSG00000178343 "Shisa family member 3" A0PJX4 4 42397839-42402487 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 30.0" "Group enriched" "Detected in some" 9 "Distal tubular cells: 36.5;Ito cells: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "memory B-cell: 2.1;naive B-cell: 2.4" "Lineage enriched" "Detected in single" 25 "B-cells: 2.4" "Group enriched" "Detected in some" 7 "AN3-CA: 70.7;PC-3: 41.0" "Region enriched" "Detected in single" 24 "olfactory region: 63.3" "Low region specificity" "Detected in some" HPA054754 Approved "Lipid droplets,Cytosol" NA NA Cytosol "Lipid droplets" "HPA054754: AB_2682593" "unprognostic (9.04e-3)" "unprognostic (3.47e-3)" "unprognostic (1.37e-1)" "unprognostic (1.80e-2)" "unprognostic (1.26e-1)" "unprognostic (6.78e-3)" "unprognostic (1.26e-2)" "unprognostic (2.86e-1)" "unprognostic (3.04e-1)" "unprognostic (1.37e-3)" "unprognostic (3.42e-2)" "unprognostic (1.95e-1)" "unprognostic (5.99e-2)" "unprognostic (5.32e-2)" "unprognostic (3.10e-2)" "unprognostic (1.64e-1)" "unprognostic (4.99e-3)" 4.5 2.1 1.0 2.3 3.5 0.1 1.8 0.7 1.3 0.9 5.0 0.1 2.9 2.9 0.3 6.2 8.6 0.4 4.2 12.9 0.9 1.5 30.0 1.0 4.7 15.4 8.3 0.7 1.4 0.3 0.1 0.5 0.2 3.3 2.6 4.1 0.3 1.2 1.5 3.4 0.4 8.4 10.7 1.0 0.6 3.5 2.0 2.2 0.0 4.6 2.6 1.1 6.8 4.7 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 70.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 3.1 0.0 41.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 3.5 0.7 1.3 0.9 1.5 8.3 0.7 3.3 2.2 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 3.5 0.0 0.0 36.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 23.9 0.8 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 SHISA4 "C1orf40, hShisa4, TMEM58" ENSG00000198892 "Shisa family member 4" Q96DD7 1 201888680-201892306 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 175.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "eosinophil: 18.3;intermediate monocyte: 6.4;neutrophil: 8.2;non-classical monocyte: 7.8" "Group enriched" "Detected in many" 9 "granulocytes: 18.3;monocytes: 7.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061273, HPA067885" Uncertain NA NA "HPA061273: AB_2684460, HPA067885: " "unprognostic (1.13e-1)" "unprognostic (3.70e-3)" "unprognostic (1.48e-3)" "unprognostic (2.12e-3)" "unprognostic (6.59e-2)" "unprognostic (8.29e-3)" "unprognostic (7.06e-2)" "unprognostic (5.00e-2)" "unprognostic (2.32e-1)" "unprognostic (1.44e-1)" "unprognostic (8.29e-2)" "unprognostic (2.32e-2)" "unprognostic (1.63e-3)" "unprognostic (1.20e-1)" "unprognostic (1.82e-1)" "unprognostic (1.24e-1)" "unprognostic (2.76e-1)" 5.2 15.8 22.2 3.8 18.8 2.5 3.3 9.6 34.8 4.7 3.3 29.1 2.1 2.7 4.4 4.5 4.0 3.9 4.7 14.7 17.5 14.6 4.1 3.8 4.0 2.7 19.2 14.8 6.8 4.1 4.1 3.8 3.8 21.3 6.2 2.9 7.2 12.1 5.1 175.2 4.2 3.2 4.7 14.0 3.4 3.2 4.2 8.2 0.0 6.3 18.8 2.7 3.9 2.6 0.0 0.7 18.3 7.8 0.0 1.5 0.5 1.1 8.8 1.0 6.3 9.5 5.7 0.9 7.7 12.6 3.2 4.5 1.5 2.3 0.0 10.5 9.5 12.6 2.2 0.1 1.3 2.1 0.9 0.5 0.1 2.6 1.0 6.7 0.0 5.6 5.8 2.8 4.1 2.0 16.6 5.8 0.1 0.0 0.3 5.6 1.0 0.0 0.0 0.6 0.6 10.7 0.1 0.0 1.7 3.1 3.4 0.4 5.7 2.7 1.3 7.8 5.3 3.6 0.7 5.9 4.6 4.5 2.5 3.9 1.5 1.2 0.0 7.4 0.0 7.9 0.0 1.4 18.3 1.5 6.4 0.6 0.0 0.3 0.3 0.7 0.0 0.0 0.3 8.2 0.0 7.8 0.0 0.0 0.5 22.2 18.8 9.6 34.8 17.5 14.6 19.2 14.8 21.3 8.2 0.0 1.7 0.0 3.6 12.6 9.2 18.3 7.6 0.0 2.3 10.4 3.9 1.5 28.2 22.4 0.5 7.4 0.0 0.0 13.5 19.0 16.6 9.5 1.1 3.4 2.9 4.8 1.7 11.6 2.9 1.5 14.7 4.2 21.9 6.4 0.0 19.3 10.6 0.0 27.6 5.0 3.4 19.4 13.3 1.4 0.7 5.9 2.3 2.2 0.0 1.8 SHISA5 "hShisa5, SCOTIN" ENSG00000164054 "Shisa family member 5" Q8N114 3 48467798-48504826 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 220.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042295 Approved NA NA "HPA042295: AB_10794794" "unprognostic (3.52e-3)" "unprognostic (4.79e-2)" "unprognostic (1.71e-1)" "unprognostic (3.98e-2)" "unprognostic (8.58e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (3.72e-6)" "unprognostic (3.82e-3)" "unprognostic (8.76e-3)" "unprognostic (1.21e-3)" "unprognostic (1.39e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (8.64e-5)" "unprognostic (1.11e-1)" "unprognostic (6.08e-3)" "unprognostic (3.81e-3)" "unprognostic (1.74e-2)" 35.7 27.1 31.9 32.0 30.9 28.2 32.1 16.4 39.2 32.5 27.3 23.5 18.8 29.6 35.8 33.8 54.3 43.2 35.0 27.5 26.7 31.5 40.7 57.9 36.4 34.7 22.9 19.8 41.7 23.0 20.5 27.2 84.2 24.7 38.8 20.1 49.1 26.5 37.7 12.9 21.6 35.8 33.3 18.4 43.1 28.0 19.6 18.0 35.5 37.2 28.3 35.2 45.0 34.5 33.2 23.1 127.1 41.6 17.9 47.1 56.0 13.2 27.1 16.0 25.5 30.6 39.2 81.8 22.0 40.4 49.9 37.2 29.7 33.8 18.4 24.2 38.2 47.3 17.6 17.7 28.4 14.0 21.7 12.2 16.7 18.4 23.9 51.5 11.5 32.1 40.1 33.0 40.2 28.0 27.9 37.3 24.8 10.4 22.4 26.6 28.8 12.9 20.7 29.2 19.0 21.8 9.0 7.1 24.9 25.4 85.0 4.8 2.7 14.3 15.4 28.8 28.1 17.7 17.2 29.3 17.9 20.0 30.2 21.0 17.0 13.7 16.0 25.3 22.3 17.3 23.4 41.6 32.8 47.1 36.1 41.7 24.1 39.4 42.9 23.1 33.2 32.2 33.2 127.1 17.9 39.5 17.5 45.8 56.0 31.9 30.9 16.4 39.2 26.7 31.5 22.9 19.8 24.7 18.0 38.7 39.1 53.3 58.0 24.6 20.9 14.5 50.9 37.5 38.7 61.1 15.7 220.5 10.0 70.1 3.7 62.1 47.7 0.0 90.6 183.8 55.4 43.7 33.5 74.4 90.8 6.4 36.4 58.9 49.8 4.4 45.5 49.0 43.9 17.2 44.0 24.4 73.3 24.6 36.7 37.9 4.6 32.3 47.4 4.7 5.9 28.1 100.8 68.2 36.3 39.9 SHISA6 FLJ45455 ENSG00000188803 "Shisa family member 6" Q6ZSJ9 17 11241263-11564063 "Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;cervix, uterine: 22.4" "Group enriched" "Detected in some" 4 "Late spermatids: 9.9;Peritubular cells: 27.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "OE19: 34.1" "Low region specificity" "Detected in many" HPA023440 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA023440: AB_1848945" "unprognostic (1.70e-1)" "unprognostic (2.78e-2)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "prognostic unfavorable (8.41e-4)" "unprognostic (3.11e-2)" "unprognostic (1.71e-1)" "unprognostic (8.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (9.63e-2)" "unprognostic (1.27e-1)" "unprognostic (2.40e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.20e-2)" "unprognostic (2.47e-2)" 2.2 0.7 5.8 0.6 5.5 0.2 1.2 9.8 7.5 22.4 0.9 2.5 1.9 0.4 4.2 2.4 0.9 1.7 0.5 1.1 12.1 9.9 2.5 0.2 1.5 0.2 11.8 2.9 0.6 1.4 6.0 0.0 0.3 13.6 5.9 0.8 0.8 0.2 10.1 1.0 0.5 0.4 1.2 9.6 0.2 6.0 2.9 2.1 0.0 0.7 0.0 0.2 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 9.8 4.9 12.1 9.9 11.8 2.9 13.6 2.1 0.0 0.0 0.0 0.0 0.1 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.1 0.0 1.2 0.0 0.0 9.9 4.6 0.0 1.7 0.0 0.0 0.4 0.0 0.0 27.3 0.0 0.1 0.0 0.1 0.5 1.9 0.1 0.0 0.0 0.0 0.1 SHISA7 ENSG00000187902 "Shisa family member 7" A6NL88 19 55428740-55442863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 24.9" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 1.8;Horizontal cells: 1.6" "Cancer enriched" "Detected in single" 9 "glioma: 2.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 6.7;HMC-1: 7.0;THP-1: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058935 Uncertain Approved Cytosol NA NA Cytosol "HPA058935: AB_2683857" "unprognostic (3.98e-2)" "unprognostic (5.81e-2)" "unprognostic (1.16e-1)" "unprognostic (1.28e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.08e-1)" "unprognostic (4.40e-1)" "unprognostic (7.17e-2)" "unprognostic (2.11e-3)" "unprognostic (1.22e-2)" "unprognostic (6.87e-7)" "unprognostic (7.53e-3)" "unprognostic (2.82e-1)" "unprognostic (3.29e-4)" "unprognostic (4.04e-1)" 0.7 1.7 11.3 0.7 16.7 2.6 0.7 4.0 24.9 0.7 0.8 7.2 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 11.2 8.2 0.7 0.7 0.7 0.7 8.3 3.1 0.7 0.8 0.7 2.4 0.7 5.5 0.7 0.8 0.0 0.7 0.7 0.7 0.8 0.8 0.7 4.0 0.7 0.8 2.2 14.6 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 6.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 1.2 0.6 0.0 1.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 16.7 4.0 10.9 11.2 8.2 8.3 3.1 5.5 14.6 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 SHISA8 "C22orf17, Orf26" ENSG00000234965 "Shisa family member 8" B8ZZ34 22 41909554-41914667 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 42.2" "Cell type enriched" "Detected in some" 114 "Horizontal cells: 451.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 15 "cerebellum: 42.2" "Cell type enhanced" "Detected in single" "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 17 "B-cells: 1.7" "Cell line enriched" "Detected in some" 7 "HEK 293: 20.9" "Group enriched" "Detected in some" 5 "cerebellum: 8.7;olfactory region: 19.4" "Group enriched" "Detected in all" 4 "cerebellum: 61.4;olfactory region: 45.2" HPA059173 Uncertain NA NA "HPA059173: AB_2683938" "unprognostic (8.76e-2)" "unprognostic (2.98e-4)" "unprognostic (1.03e-1)" "prognostic favorable (2.76e-4)" "unprognostic (4.42e-2)" "unprognostic (1.45e-3)" "unprognostic (4.40e-1)" "unprognostic (1.16e-2)" "unprognostic (2.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.45e-3)" "unprognostic (2.16e-1)" "unprognostic (1.12e-1)" "unprognostic (8.59e-2)" "unprognostic (2.60e-2)" "unprognostic (6.22e-4)" "unprognostic (7.84e-2)" 0.1 9.4 0.5 1.6 0.5 0.2 0.1 42.2 2.7 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.3 0.3 0.5 0.2 0.2 0.1 0.1 3.0 0.3 1.7 0.1 0.1 0.1 0.8 0.0 2.2 0.2 0.0 1.5 1.8 0.2 0.8 0.5 0.8 0.0 0.3 2.7 0.7 0.2 0.0 0.0 0.1 0.0 3.8 0.4 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 42.2 2.7 0.5 0.2 0.3 1.7 2.2 0.0 0.0 0.0 2.7 0.0 0.0 4.0 3.6 0.0 0.0 0.0 0.0 3.9 0.0 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 451.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 3.2 0.0 0.0 0.9 1.9 0.0 0.0 0.0 0.0 0.0 SHISA9 ENSG00000237515 "Shisa family member 9" B4DS77 16 12901620-13240413 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 15.3;Ciliated cells: 21.4;Club cells: 12.5;granulocytes: 10.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "EFO-21: 29.8;LHCN-M2: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072399 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA072399: AB_2686517" "unprognostic (1.88e-2)" "unprognostic (3.04e-2)" "unprognostic (2.74e-1)" "unprognostic (1.69e-5)" "unprognostic (2.23e-2)" "unprognostic (2.03e-2)" "unprognostic (5.90e-5)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (1.19e-2)" "unprognostic (3.66e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.53e-4)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" 1.2 4.8 17.2 1.6 23.5 2.7 1.3 0.9 21.3 0.9 3.4 3.6 0.4 1.6 1.1 2.3 1.2 0.7 0.9 1.3 10.2 6.7 3.4 1.4 0.7 1.0 3.3 12.6 1.1 1.3 0.6 1.9 1.0 10.2 6.9 1.8 0.6 1.7 1.4 4.2 1.9 1.7 1.2 2.1 1.0 1.3 1.6 4.0 0.0 3.5 0.0 0.8 0.8 0.9 2.0 1.2 3.9 0.9 1.2 0.9 0.0 0.6 0.3 0.5 0.5 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.3 0.5 0.5 29.8 0.1 0.6 0.5 0.1 0.1 0.1 0.5 0.2 0.7 0.6 0.3 0.0 0.5 0.8 0.9 0.0 0.1 2.1 0.3 0.1 0.5 0.4 1.2 24.2 3.3 0.4 0.7 6.4 0.5 0.3 0.6 0.4 0.3 6.6 1.1 6.4 0.5 0.3 1.0 0.4 3.1 0.8 0.4 0.4 0.6 3.9 0.6 0.4 1.2 1.2 0.6 0.4 0.2 0.8 3.9 0.9 0.4 0.8 0.5 0.6 1.1 0.7 0.8 0.3 2.0 0.9 0.8 3.2 1.2 0.7 1.2 0.7 0.0 17.2 23.5 0.9 18.8 10.2 6.7 3.3 12.6 10.2 4.0 23.8 15.3 0.0 0.5 0.1 0.6 0.8 0.0 21.4 12.5 1.8 0.0 0.0 1.7 0.7 3.8 0.3 0.0 0.0 0.0 0.0 0.2 1.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.2 0.0 0.0 0.0 0.5 0.1 2.9 0.0 0.9 0.3 0.0 0.0 0.2 0.9 0.1 0.1 0.0 0.3 0.5 SHISAL1 KIAA1644 ENSG00000138944 "Shisa like 1" Q3SXP7 22 44243667-44312851 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9" "Cell type enriched" "Detected in single" 4 "Ciliated cells: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SiHa: 17.0;U-2197: 38.7;U-87 MG: 22.5;WM-115: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051178 Uncertain Approved Vesicles,Cytosol No No "Vesicles, Cytosol" "HPA051178: AB_2681374" "unprognostic (4.07e-3)" "unprognostic (9.01e-2)" "unprognostic (1.83e-1)" "unprognostic (1.14e-1)" "unprognostic (6.54e-2)" "unprognostic (1.22e-1)" "unprognostic (7.79e-2)" "unprognostic (2.64e-2)" "unprognostic (8.10e-3)" "unprognostic (1.93e-3)" "unprognostic (1.33e-1)" "unprognostic (1.99e-1)" "unprognostic (1.51e-7)" "unprognostic (1.48e-2)" "unprognostic (2.41e-1)" "unprognostic (1.99e-4)" "unprognostic (1.10e-4)" 0.7 1.3 13.8 1.3 3.6 0.0 0.5 1.6 13.0 22.5 7.7 0.5 6.9 1.4 34.2 4.5 1.5 1.9 2.3 0.5 5.4 9.1 0.5 0.5 0.6 0.5 3.6 0.5 1.7 0.6 0.1 0.8 5.7 0.5 5.8 1.5 0.5 0.5 8.9 0.5 0.4 0.8 31.9 0.5 0.5 0.5 1.5 0.5 0.5 0.5 0.5 0.5 11.9 3.3 0.0 0.1 0.7 0.0 0.2 0.1 0.0 0.0 0.1 1.7 0.6 0.0 0.0 0.0 0.4 1.1 1.1 0.6 0.0 0.0 0.0 0.0 1.0 7.0 0.0 2.3 0.1 0.1 0.0 1.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.9 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.2 0.0 17.0 0.0 0.1 0.2 0.0 0.1 0.0 6.4 1.0 38.7 0.2 0.0 0.0 0.0 22.5 0.0 12.9 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 0.0 13.8 3.6 1.6 11.8 5.4 9.1 3.6 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SHISAL2A "FAM159A, MGC52498" ENSG00000182183 "Shisa like 2A" Q6UWV7 1 52633344-52669683 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 10.8;lymphoid tissue: 25.4" "Cell type enhanced" "Detected in single" 26 "Hofbauer cells: 1.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "hypothalamus: 8.8" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 10.8;NK-cells: 5.7;T-cells: 7.9" "Cell line enhanced" "Detected in some" "Daudi: 5.4;Karpas-707: 13.0;NB-4: 3.7;RPMI-8226: 17.1" "Region enhanced" "Detected in single" "hypothalamus: 4.7" "Low region specificity" "Detected in many" HPA030744 Uncertain NA NA "HPA030744: AB_10963060" "unprognostic (7.94e-6)" "unprognostic (8.50e-3)" "unprognostic (8.29e-3)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (9.67e-4)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (2.22e-2)" "unprognostic (4.45e-2)" "unprognostic (2.98e-2)" "unprognostic (1.20e-1)" "unprognostic (1.31e-3)" "unprognostic (7.27e-2)" "unprognostic (2.79e-1)" "unprognostic (6.50e-2)" "unprognostic (2.64e-2)" 0.6 0.4 1.0 25.4 1.4 3.5 0.5 1.3 2.0 1.3 1.2 1.2 0.0 1.0 1.1 1.9 1.0 0.9 1.3 0.3 0.9 8.8 0.8 0.4 1.2 20.4 2.8 0.2 0.2 0.7 0.0 3.2 0.5 1.2 0.7 0.9 0.6 3.7 1.0 0.7 0.2 5.7 0.6 2.1 12.1 1.2 1.2 0.7 3.5 1.3 0.3 24.0 3.2 0.4 10.8 0.1 1.9 0.0 5.7 7.9 1.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 3.7 2.2 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.5 0.0 1.1 0.0 0.0 0.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 7.9 0.0 4.5 10.7 7.2 6.4 0.1 10.8 5.0 3.1 0.0 5.7 0.0 0.1 2.2 1.8 1.0 1.4 1.3 2.0 0.9 8.8 2.8 0.2 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SHISAL2B FAM159B ENSG00000145642 "Shisa like 2B" A6NKW6 5 64690308-64718090 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 7.3;pancreas: 16.1;stomach 1: 7.7" "Cell type enriched" "Detected in single" 16 "Pancreatic endocrine cells: 1.6" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 3.9" "Group enriched" "Detected in some" 14 "basal ganglia: 1.9;hypothalamus: 7.3;pons and medulla: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NTERA-2: 5.9;RPTEC TERT1: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011778 Enhanced NA NA "HPA011778: AB_1848382" "unprognostic (5.83e-2)" "unprognostic (9.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.84e-2)" "unprognostic (3.25e-1)" "unprognostic (5.01e-2)" "unprognostic (1.49e-1)" "unprognostic (9.12e-2)" "unprognostic (2.97e-1)" "unprognostic (4.84e-2)" "unprognostic (5.36e-5)" "unprognostic (1.44e-1)" "unprognostic (1.98e-1)" "unprognostic (5.60e-1)" "unprognostic (6.99e-2)" 0.1 0.0 0.3 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.3 0.2 0.0 0.2 0.0 0.2 0.0 0.2 16.1 0.0 0.1 0.5 4.9 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.6 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 12.4 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.2 0.3 7.3 0.2 0.0 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SI ENSG00000090402 Sucrase-isomaltase P14410 3 164978898-165078495 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 123 "intestine: 181.4" "Group enriched" "Detected in some" 7 "Enterocytes: 48.7;Mucus-secreting cells: 79.9;Paneth cells: 46.3;Undifferentiated cells: 29.8" "Cancer enhanced" "Detected in some" "stomach cancer: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CACO-2: 4.1;HeLa: 3.2;NB-4: 3.4;RPMI-8226: 4.9;SH-SY5Y: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011897 Enhanced NA NA "HPA011897: AB_1856840" "unprognostic (2.71e-2)" "unprognostic (1.62e-2)" "unprognostic (2.68e-1)" "unprognostic (2.05e-1)" "unprognostic (4.41e-2)" 0.1 0.1 0.1 1.4 0.1 0.0 0.1 0.1 0.1 0.1 93.3 0.0 0.0 94.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 5.4 0.0 0.1 0.0 0.1 0.1 181.4 0.0 0.1 0.1 0.1 0.7 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 79.9 0.0 0.0 46.3 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 29.8 0.0 SIDT1 "FLJ20174, SID-1" ENSG00000072858 "SID1 transmembrane family member 1" Q9NXL6 3 113532296-113629578 "Predicted membrane proteins, Transporters" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.6" "Cell type enhanced" "Detected in many" 8 "B-cells: 13.7;Mucus-secreting cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 11.6;OE19: 12.3;PC-3: 16.4;RT4: 11.4;T-47d: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035862 Approved NA NA "HPA035862: AB_10671110" "unprognostic (4.23e-1)" "prognostic favorable (3.78e-4)" "unprognostic (3.43e-3)" "unprognostic (1.33e-3)" "unprognostic (2.28e-1)" "unprognostic (6.64e-4)" "unprognostic (2.93e-4)" "unprognostic (1.50e-1)" "unprognostic (4.02e-1)" "unprognostic (3.29e-3)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (2.50e-1)" "unprognostic (3.02e-1)" "unprognostic (5.86e-2)" "unprognostic (1.32e-2)" "prognostic favorable (4.09e-5)" 1.8 4.1 7.5 13.6 5.9 4.1 7.8 17.3 11.7 4.7 8.4 5.5 3.7 2.8 1.2 0.7 2.7 2.8 5.1 1.1 7.9 9.2 1.6 1.1 2.7 17.6 4.7 8.5 0.9 1.7 1.5 12.8 1.6 4.7 7.2 14.0 0.4 13.2 9.7 0.8 1.3 8.4 1.3 4.5 11.6 4.9 1.8 1.2 13.2 1.3 0.7 13.3 6.8 1.9 4.9 21.6 0.2 0.4 5.9 4.9 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 1.1 0.0 0.4 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.4 0.0 11.6 3.1 0.1 0.0 12.3 16.4 4.7 0.0 0.4 0.0 11.4 0.1 0.1 0.0 3.3 0.1 0.0 10.8 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 4.9 0.1 4.9 4.9 3.2 3.9 0.9 4.3 4.2 3.5 0.1 5.9 0.0 21.6 2.5 2.1 7.5 5.9 17.3 11.7 7.9 9.2 4.7 8.5 4.7 1.2 6.0 3.5 13.7 1.6 0.3 0.0 0.8 2.5 9.4 3.4 1.8 0.0 0.0 0.0 0.3 2.8 0.7 4.3 0.0 1.0 0.1 0.3 6.3 3.5 0.0 8.7 0.0 9.8 0.6 3.5 1.3 0.0 2.5 5.0 2.8 20.6 0.0 0.7 2.9 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 0.1 8.9 6.3 1.4 SIDT2 CGI-40 ENSG00000149577 "SID1 transmembrane family member 2" Q8NBJ9 11 117178733-117197445 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 83.9" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 25.6;non-classical monocyte: 41.6" "Lineage enriched" "Detected in many" 6 "monocytes: 41.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052352 Approved NA NA "HPA052352: AB_2681797" "unprognostic (3.83e-1)" "unprognostic (4.30e-2)" "unprognostic (9.92e-2)" "unprognostic (1.03e-1)" "unprognostic (3.01e-2)" "unprognostic (1.69e-1)" "unprognostic (3.34e-1)" "unprognostic (1.84e-1)" "unprognostic (1.39e-1)" "unprognostic (3.12e-1)" "unprognostic (2.67e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (4.18e-5)" "unprognostic (2.74e-2)" "unprognostic (2.20e-1)" "unprognostic (4.36e-2)" "unprognostic (5.22e-3)" 23.9 12.1 9.6 12.5 15.9 7.0 23.5 16.2 18.0 12.7 19.2 28.0 19.4 27.1 16.6 14.3 8.7 13.0 15.6 14.9 11.2 10.0 10.0 21.2 29.7 21.3 15.0 14.5 30.6 83.9 12.0 17.4 13.8 17.4 24.5 14.9 14.1 25.5 16.7 11.1 19.5 31.7 18.2 25.4 17.3 35.4 13.8 13.0 6.2 15.4 8.4 12.5 16.1 9.7 7.3 3.5 0.5 41.6 0.4 0.6 2.8 4.2 4.5 5.5 7.8 18.7 16.8 18.4 7.7 10.2 5.0 4.6 12.0 17.2 4.5 12.4 20.3 6.2 4.7 5.3 6.0 4.1 6.7 6.5 3.0 7.9 8.8 9.7 2.7 8.2 20.7 6.7 6.4 6.9 15.3 10.0 5.9 5.9 10.1 11.6 9.3 3.7 3.1 2.6 23.4 3.4 2.8 3.8 12.8 6.5 4.7 1.7 4.1 8.2 20.1 1.3 6.5 16.2 3.2 6.2 6.6 4.3 4.4 1.7 7.1 2.6 4.7 3.7 5.6 4.8 0.1 4.2 0.1 0.6 25.6 0.5 5.7 0.3 0.4 3.5 7.3 0.5 0.4 0.5 0.4 41.6 1.9 0.4 2.8 9.6 15.9 16.2 18.0 11.2 10.0 15.0 14.5 17.4 13.0 6.0 10.5 12.3 19.3 60.1 10.5 6.3 2.5 2.7 4.5 10.4 5.9 7.7 0.0 4.2 5.7 9.5 22.0 0.0 8.4 30.1 16.8 21.1 2.3 17.3 15.7 17.5 10.9 14.7 39.4 8.5 12.4 23.2 18.6 4.6 24.8 7.1 6.8 10.5 12.7 1.5 11.3 19.4 18.9 3.6 4.2 37.5 27.0 7.9 10.2 13.2 SIGIRR "IL-1R8, TIR8" ENSG00000185187 "Single Ig and TIR domain containing" Q6IA17 11 405716-417455 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 67.0" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 346.4;Proximal tubular cells: 462.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023188 Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" "HPA023188: AB_1856856" "unprognostic (6.21e-3)" "prognostic favorable (7.44e-5)" "unprognostic (7.30e-2)" "prognostic favorable (1.34e-5)" "unprognostic (6.85e-2)" "prognostic favorable (9.08e-4)" "unprognostic (4.03e-1)" "unprognostic (1.39e-2)" "unprognostic (8.44e-2)" "unprognostic (1.67e-1)" "unprognostic (2.32e-2)" "unprognostic (1.31e-1)" "prognostic favorable (7.61e-6)" "unprognostic (1.00e-3)" "unprognostic (1.76e-1)" "unprognostic (7.63e-2)" "prognostic favorable (1.54e-5)" 11.0 3.2 11.8 19.3 12.3 18.1 17.7 2.4 12.3 10.7 16.9 11.2 16.2 18.6 11.0 14.5 13.7 16.3 12.8 12.9 11.1 10.1 29.4 67.0 14.9 25.6 11.7 8.5 9.6 22.7 10.0 7.3 6.2 15.6 14.2 9.2 15.2 22.1 13.4 6.4 4.5 20.4 11.2 17.7 28.7 17.7 7.4 10.2 12.4 15.4 8.8 18.0 11.3 13.3 11.4 12.9 17.4 16.7 27.8 38.9 22.8 7.9 21.8 1.3 7.6 1.2 6.5 16.0 1.2 1.8 3.7 3.3 10.0 50.0 2.2 5.9 6.9 0.4 11.5 3.5 4.1 0.6 6.8 13.2 4.3 4.3 0.2 4.0 3.6 7.6 3.5 0.8 0.6 0.5 2.1 10.6 8.7 4.4 0.1 1.0 26.7 10.5 12.3 7.9 16.2 11.9 13.6 0.0 7.8 2.6 5.4 13.5 6.6 0.1 7.4 9.5 3.5 9.4 3.0 12.3 1.2 1.5 1.8 0.0 2.7 4.6 5.5 5.0 8.4 4.2 17.4 13.0 11.2 38.9 13.9 30.9 11.4 32.5 33.7 12.9 8.6 29.8 28.9 7.0 27.8 16.7 4.9 29.9 22.8 11.8 12.3 2.4 12.3 11.1 10.1 11.7 8.5 15.6 10.2 26.8 33.8 47.6 28.4 14.4 8.9 15.9 56.0 56.2 20.5 52.4 11.8 14.2 53.0 49.0 1.0 55.6 127.0 0.0 64.0 7.7 36.0 31.6 40.3 346.4 43.4 25.4 75.7 73.6 54.3 2.9 29.1 39.7 81.0 27.1 78.4 65.1 64.4 129.8 28.0 462.2 18.5 25.8 33.1 7.0 66.2 11.2 8.5 121.8 72.6 38.0 SIGLEC1 "CD169, dJ1009E24.1, FLJ00051, FLJ00055, FLJ00073, FLJ32150, sialoadhesin, SIGLEC-1, SN" ENSG00000088827 "Sialic acid binding Ig like lectin 1" Q9BZZ2 20 3686970-3707128 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Endocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.7" "Group enriched" "Detected in some" 10 "Hofbauer cells: 61.4;Kupffer cells: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "classical monocyte: 4.1;intermediate monocyte: 2.5;myeloid DC: 1.9;plasmacytoid DC: 1.2" "Group enriched" "Detected in many" 20 "dendritic cells: 1.9;monocytes: 4.1" "Cell line enriched" "Detected in single" 18 "THP-1: 6.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA053457 Supported "Intracellular and membrane" NA NA 110000 "HPA053457: AB_2682158" "unprognostic (2.05e-1)" "unprognostic (9.27e-3)" "unprognostic (3.83e-4)" "unprognostic (4.87e-3)" "unprognostic (3.40e-2)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (6.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.68e-1)" "unprognostic (1.40e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (8.69e-5)" "unprognostic (8.71e-2)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" 11.6 8.0 1.5 4.5 2.0 7.0 4.7 1.5 1.9 1.5 4.4 1.5 1.5 2.9 1.5 1.5 3.1 4.2 5.3 3.5 1.5 0.1 2.9 4.9 9.7 35.7 2.1 1.5 1.6 1.5 0.0 1.5 12.2 3.0 1.5 4.1 1.8 6.3 1.5 3.2 1.5 5.9 4.6 1.5 12.0 2.9 1.5 1.5 2.8 1.9 3.4 1.8 4.8 1.7 0.0 1.9 0.0 4.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 2.5 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 1.5 2.0 1.5 1.9 1.5 0.1 2.1 1.5 3.0 1.5 3.0 4.1 0.0 0.0 0.3 0.2 2.0 0.0 0.0 1.2 0.0 2.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.7 0.6 0.0 0.0 0.0 61.4 0.0 0.0 0.0 69.1 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 SIGLEC10 "MGC126774, PRO940, SIGLEC-10, SLG2" ENSG00000142512 "Sialic acid binding Ig like lectin 10" Q96LC7 19 51410021-51417803 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 99.9;lymphoid tissue: 74.6" "Group enriched" "Detected in some" 5 "B-cells: 17.9;granulocytes: 39.2;Kupffer cells: 67.4;Macrophages: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 99.9;intermediate monocyte: 33.9;non-classical monocyte: 66.7" "Group enriched" "Detected in many" 14 "granulocytes: 99.9;monocytes: 66.7" "Cell line enhanced" "Detected in some" "Daudi: 21.3;HDLM-2: 6.5;HEL: 10.9;HMC-1: 8.7;NB-4: 6.7;U-698: 15.7;U-937: 9.0" "CAB025807, HPA027093" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane, Actin filaments" "CAB025807: , HPA027093: AB_1856858" "unprognostic (7.18e-2)" "unprognostic (3.90e-3)" "unprognostic (1.11e-2)" "unprognostic (3.67e-2)" "unprognostic (3.95e-2)" "unprognostic (9.41e-2)" "unprognostic (8.18e-2)" "unprognostic (2.11e-1)" "unprognostic (3.16e-2)" "unprognostic (1.83e-1)" "unprognostic (1.63e-1)" "unprognostic (3.12e-1)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.73e-1)" "unprognostic (1.69e-2)" "unprognostic (1.39e-1)" "unprognostic (9.05e-2)" 2.6 6.2 4.5 24.6 9.8 9.1 1.4 0.7 4.9 2.7 3.7 5.7 0.0 5.3 1.3 0.7 2.2 2.7 2.7 1.6 3.3 3.0 2.6 7.2 7.7 74.6 6.6 1.8 1.2 2.4 0.2 2.5 1.1 7.7 2.6 3.3 0.7 2.3 0.7 0.6 0.9 9.6 3.2 7.4 37.0 3.1 0.9 4.8 2.0 1.2 0.2 13.2 4.8 1.3 5.8 5.1 99.9 66.7 0.0 0.1 4.4 0.1 0.0 0.4 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.0 21.3 0.6 0.0 0.3 0.4 0.0 0.1 0.0 6.5 1.6 10.9 0.2 0.1 0.0 4.9 8.7 0.0 0.0 0.1 0.0 0.1 0.0 1.3 0.5 1.1 0.0 0.4 0.1 6.7 0.6 0.5 0.3 1.4 0.1 0.4 0.0 0.2 0.3 0.3 0.3 0.1 0.2 0.4 0.1 4.0 0.5 0.6 1.0 0.4 0.2 1.0 0.2 15.7 0.4 9.0 0.3 1.5 5.6 99.9 0.1 33.9 0.0 5.8 0.0 0.0 5.1 3.6 0.0 0.0 11.5 0.0 66.7 0.2 0.1 4.4 4.5 9.8 0.7 4.9 3.3 3.0 6.6 1.8 7.7 4.8 3.0 2.2 17.9 0.9 0.1 1.4 0.3 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.1 0.3 1.0 39.2 0.5 7.8 0.0 0.0 0.6 67.4 0.0 0.0 34.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.2 0.3 1.1 0.1 2.2 0.0 0.8 SIGLEC11 ENSG00000161640 "Sialic acid binding Ig like lectin 11" Q96RL6 19 49948985-49961172 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "lymphoid tissue: 11.3;ovary: 36.6" "Cell type enhanced" "Detected in some" 16 "Distal tubular cells: 16.6;Hofbauer cells: 6.3;Ito cells: 8.6;Kupffer cells: 19.6" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 15 "HEL: 15.4" "HPA052132, HPA060278" Approved Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA052132: , HPA060278: AB_2684240" "unprognostic (1.07e-1)" "unprognostic (2.85e-3)" "unprognostic (1.56e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (3.35e-2)" "unprognostic (9.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.20e-1)" "unprognostic (8.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.41e-1)" "unprognostic (9.95e-3)" "unprognostic (5.38e-2)" 0.4 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.1 36.6 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 11.3 1.8 0.5 0.0 0.0 0.3 0.0 0.6 0.5 2.6 3.3 0.8 0.2 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.2 15.4 0.3 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.7 0.6 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.1 0.4 0.2 0.1 0.3 0.1 0.1 0.2 0.3 0.1 0.0 0.2 0.2 0.5 1.0 2.6 0.1 3.3 0.1 0.5 0.2 0.1 0.5 0.6 0.1 0.2 1.4 0.8 3.3 0.3 0.0 0.3 0.0 1.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.2 6.3 0.0 0.0 8.6 19.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.5 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.5 0.1 0.1 0.0 0.0 0.0 SIGLEC12 "S2V, Siglec-12, Siglec-L1, Siglec-XII, SIGLECL1, SLG" ENSG00000254521 "Sialic acid binding Ig like lectin 12 (gene/pseudogene)" Q96PQ1 19 51491357-51501789 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 13.1;lymphoid tissue: 29.6" "Group enriched" "Detected in some" 14 "granulocytes: 2.3;Hofbauer cells: 1.8;Kupffer cells: 2.8;Macrophages: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "classical monocyte: 2.0;eosinophil: 3.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 10 "HMC-1: 54.1;U-937: 28.9" NA NA "unprognostic (1.46e-1)" "unprognostic (2.39e-1)" "unprognostic (3.81e-2)" "unprognostic (9.13e-2)" "unprognostic (9.58e-4)" "unprognostic (1.38e-1)" "unprognostic (3.21e-1)" "unprognostic (1.64e-1)" "unprognostic (1.33e-1)" "unprognostic (3.73e-1)" "unprognostic (1.29e-2)" "unprognostic (6.79e-2)" "unprognostic (9.21e-5)" "unprognostic (2.45e-1)" "unprognostic (1.14e-1)" "unprognostic (3.64e-1)" "unprognostic (1.57e-1)" 2.8 1.0 0.2 6.2 1.2 1.3 0.3 0.1 0.3 0.3 1.5 0.2 0.6 0.4 0.4 0.5 0.6 0.4 1.6 0.7 0.2 0.2 0.4 13.1 5.3 3.9 0.2 0.0 0.3 0.3 0.0 0.2 0.0 0.3 0.5 2.6 0.6 1.2 0.0 0.2 0.2 2.5 3.4 0.3 29.6 0.5 1.4 0.0 2.4 0.2 1.0 1.7 0.6 0.3 0.7 0.8 3.0 2.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.9 0.0 0.0 2.0 3.0 0.0 0.9 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 1.2 0.1 0.3 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.8 0.0 0.0 0.0 2.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SIGLEC14 ENSG00000254415 "Sialic acid binding Ig like lectin 14" Q08ET2 19 51642553-51646801 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 48.7;bone marrow: 13.3;lymphoid tissue: 21.6" "Cell type enhanced" "Detected in some" 22 "Hofbauer cells: 16.1;Kupffer cells: 31.5;Macrophages: 9.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 25.8;intermediate monocyte: 29.7;myeloid DC: 15.9;neutrophil: 48.7;non-classical monocyte: 21.3" "Group enriched" "Detected in many" 6 "dendritic cells: 15.9;granulocytes: 48.7;monocytes: 29.7" "Cell line enriched" "Detected in some" 4 "HMC-1: 47.5" "HPA014377, HPA014428" Uncertain Uncertain "Vesicles,Plasma membrane" NA NA 18000000 Vesicles "Plasma membrane" "HPA014377: AB_2189277, HPA014428: " "unprognostic (3.05e-1)" "unprognostic (1.75e-1)" "unprognostic (6.47e-3)" "unprognostic (1.60e-1)" "unprognostic (3.83e-2)" "unprognostic (1.50e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (9.77e-3)" "unprognostic (9.28e-2)" "unprognostic (6.73e-2)" "unprognostic (1.02e-1)" "unprognostic (4.28e-3)" "unprognostic (8.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.34e-1)" "unprognostic (1.89e-1)" 1.6 1.6 0.6 13.0 0.5 13.3 0.5 0.0 0.3 0.6 0.6 0.0 0.4 0.0 0.2 1.7 1.0 0.8 0.6 0.6 0.4 1.4 5.1 6.2 1.3 0.1 0.3 0.0 0.1 0.9 0.4 0.4 0.7 0.1 0.0 0.0 4.0 0.9 1.9 21.6 0.7 1.3 0.2 7.0 2.2 0.2 4.9 15.9 48.7 29.7 0.1 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.7 47.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 3.6 25.8 0.4 0.0 29.7 0.0 4.9 0.0 0.0 15.9 4.8 0.0 0.0 48.7 0.1 21.3 2.9 0.0 7.6 0.0 1.4 0.9 0.0 0.0 0.0 0.1 2.5 1.4 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 16.1 0.0 0.0 0.0 31.5 0.0 0.3 9.8 0.0 1.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SIGLEC15 "CD33L3, HsT1361" ENSG00000197046 "Sialic acid binding Ig like lectin 15" Q6ZMC9 18 45825512-45844080 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 5.9" "Cell type enhanced" "Detected in some" 16 "Hofbauer cells: 8.2;Pancreatic endocrine cells: 2.1;Urothelial cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 5.9;myeloid DC: 2.1" "Group enriched" "Detected in many" 40 "dendritic cells: 2.1;monocytes: 5.9" "Group enriched" "Detected in some" 7 "PC-3: 8.7;U-87 MG: 26.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053509 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA053509: " "unprognostic (3.89e-3)" "unprognostic (1.87e-2)" "unprognostic (1.77e-1)" "unprognostic (7.18e-3)" "unprognostic (2.27e-1)" "unprognostic (8.07e-2)" "unprognostic (5.91e-2)" "unprognostic (2.71e-1)" "unprognostic (9.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-2)" "unprognostic (7.65e-2)" "unprognostic (6.55e-2)" "unprognostic (1.42e-1)" "unprognostic (6.06e-2)" "unprognostic (4.40e-2)" "prognostic favorable (9.14e-5)" 1.1 0.3 0.1 4.3 0.1 0.0 3.0 0.2 0.1 2.1 0.2 0.0 0.0 1.6 0.3 0.0 0.3 0.3 3.4 1.9 0.1 0.1 0.5 1.4 2.0 0.9 0.1 0.0 0.5 0.2 0.0 0.1 1.1 0.0 1.1 0.1 0.1 0.2 0.2 0.7 0.3 2.5 3.2 0.1 3.7 0.9 0.3 0.0 1.2 0.2 0.0 2.6 4.2 0.2 0.0 2.1 0.0 5.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 8.7 0.9 0.1 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.4 0.0 0.0 0.0 26.3 0.6 0.0 0.0 5.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.4 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.0 8.2 1.6 0.0 1.8 1.8 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.9 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 2.2 SIGLEC5 "CD170, CD33L2, OB-BP2, SIGLEC-5" ENSG00000105501 "Sialic acid binding Ig like lectin 5" O15389 19 51611927-51645545 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 46.7;bone marrow: 13.5" "Group enriched" "Detected in some" 10 "granulocytes: 8.1;Hofbauer cells: 4.6;Kupffer cells: 8.5;Macrophages: 3.2" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.7" "Cell type enhanced" "Detected in many" "neutrophil: 46.7" "Group enriched" "Detected in many" 6 "granulocytes: 46.7;monocytes: 13.7" "Group enriched" "Detected in some" 6 "HMC-1: 35.8;U-937: 14.8" "HPA009085, CAB024900" Supported NA NA "CAB024900: , HPA009085: AB_1079965" "unprognostic (1.83e-1)" "unprognostic (1.94e-1)" "unprognostic (2.02e-2)" "unprognostic (1.03e-2)" "unprognostic (4.39e-2)" "unprognostic (1.62e-2)" "unprognostic (1.73e-1)" "unprognostic (1.01e-1)" "unprognostic (3.28e-1)" "unprognostic (7.44e-2)" "unprognostic (1.01e-1)" "unprognostic (4.05e-1)" "unprognostic (3.71e-4)" "unprognostic (4.37e-2)" "unprognostic (3.55e-3)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" 1.2 0.4 0.4 6.4 0.5 13.5 0.2 0.1 0.2 0.1 0.3 0.0 0.2 0.0 0.2 0.1 0.3 0.3 0.3 0.2 0.2 1.2 1.5 2.5 0.5 0.1 0.2 0.0 0.2 0.5 0.2 0.4 0.4 0.0 0.0 0.1 3.4 0.5 0.7 5.9 0.3 0.7 0.2 1.9 0.8 0.1 0.8 4.7 46.7 13.7 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 3.6 6.4 0.1 0.0 7.5 0.0 0.8 0.0 0.0 4.7 0.7 0.0 0.0 46.7 0.2 13.7 1.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.1 0.0 4.6 0.0 0.0 0.0 8.5 0.0 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 SIGLEC6 "CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6" ENSG00000105492 "Sialic acid binding Ig like lectin 6" O43699 19 51519525-51531856 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "placenta: 87.4" "Group enriched" "Detected in some" 12 "Cytotrophoblasts: 56.9;granulocytes: 52.1;Syncytiotrophoblasts: 157.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 33 "B-cells: 6.5;dendritic cells: 6.8;granulocytes: 2.3" "Cell line enriched" "Detected in some" 7 "HMC-1: 103.0" "HPA008945, HPA009084, HPA018198" Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868" "unprognostic (1.97e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (9.31e-3)" "unprognostic (8.46e-4)" "unprognostic (2.91e-1)" "unprognostic (2.02e-2)" "unprognostic (2.64e-1)" "unprognostic (8.96e-2)" "unprognostic (2.03e-1)" "unprognostic (6.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.15e-2)" "unprognostic (4.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.57e-3)" 1.8 0.0 0.0 5.6 0.0 0.1 0.8 0.0 0.1 1.2 1.7 0.0 0.3 0.9 2.0 1.2 1.5 0.5 8.6 0.4 0.0 0.0 0.4 0.1 4.2 1.5 0.0 0.0 0.1 0.3 0.1 0.1 87.4 0.0 3.7 1.5 0.5 1.4 1.0 0.2 1.3 6.0 3.1 0.0 1.3 1.7 1.0 0.0 0.3 0.2 1.0 2.6 2.2 1.9 6.5 6.8 2.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.2 103.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.4 2.8 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 52.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.8 0.0 0.0 0.0 SIGLEC7 "CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2" ENSG00000168995 "Sialic acid binding Ig like lectin 7" Q9Y286 19 51142299-51153526 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 51.5;lymphoid tissue: 29.4" "Group enriched" "Detected in some" 5 "Hofbauer cells: 29.4;Kupffer cells: 51.3;Macrophages: 24.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 51.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Karpas-707: 31.5;RPMI-8226: 18.3;U-937: 19.4" HPA075513 Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1100000 "Plasma membrane" Vesicles "HPA075513: " "unprognostic (3.14e-1)" "unprognostic (5.87e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (3.90e-2)" "unprognostic (1.85e-1)" "unprognostic (2.53e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (4.95e-2)" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.27e-2)" "unprognostic (6.61e-2)" "unprognostic (1.14e-3)" "unprognostic (2.58e-1)" "unprognostic (2.26e-2)" 6.9 3.7 1.6 10.0 5.8 3.7 3.0 0.3 2.2 0.9 1.6 1.0 0.6 1.4 0.9 2.1 1.1 1.8 2.4 1.9 0.8 1.0 2.8 9.8 4.7 18.4 3.3 0.0 1.3 0.9 0.2 0.9 5.9 2.9 1.0 2.3 0.7 2.3 0.2 0.4 0.5 2.3 3.5 3.3 29.4 1.1 1.8 2.5 0.7 1.0 0.0 2.1 3.2 1.7 0.6 14.9 51.5 32.0 20.0 4.4 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.1 19.4 0.0 0.5 32.0 51.5 2.5 23.0 4.4 0.6 0.0 1.1 14.9 0.0 0.0 1.0 26.8 20.0 9.1 0.6 0.0 15.8 1.6 5.8 0.3 2.2 0.8 1.0 3.3 0.0 2.9 2.5 0.0 2.1 1.4 0.0 0.1 0.0 0.0 0.0 1.4 1.2 1.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.6 29.4 0.0 0.0 7.4 51.3 0.0 1.4 24.5 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.2 0.0 0.0 SIGLEC8 "MGC59785, SAF2, SIGLEC-8, SIGLEC8L" ENSG00000105366 "Sialic acid binding Ig like lectin 8" Q9NYZ4 19 51450847-51458456 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 63.0" "Cell type enriched" "Detected in some" 4 "granulocytes: 42.8" "Cancer enhanced" "Detected in many" "glioma: 7.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 42 "eosinophil: 63.0" "Lineage enriched" "Detected in single" 623 "granulocytes: 63.0" "Cell line enriched" "Detected in some" 45 "HMC-1: 58.8" HPA012556 Uncertain Uncertain Cytosol NA NA Cytosol "HPA012556: AB_1856869" "unprognostic (1.27e-1)" "unprognostic (1.88e-4)" "unprognostic (1.28e-1)" "unprognostic (6.70e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-2)" "unprognostic (7.84e-2)" "unprognostic (2.51e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-1)" "unprognostic (1.10e-1)" "unprognostic (4.19e-1)" "unprognostic (8.62e-3)" "unprognostic (7.18e-2)" "unprognostic (6.02e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" 0.6 6.7 5.8 2.4 8.4 0.7 2.3 0.7 7.0 1.4 2.9 7.4 0.0 2.9 1.0 1.1 1.1 1.1 2.7 0.3 8.6 4.8 0.4 1.6 4.1 9.6 8.3 3.6 0.3 0.7 0.7 1.2 0.1 7.5 1.0 2.8 0.1 1.1 0.9 0.3 0.8 4.5 1.5 14.8 9.2 2.1 0.5 6.2 0.6 0.7 0.0 4.1 2.0 0.7 0.0 0.0 63.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 58.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.5 0.1 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.8 8.4 0.7 5.6 8.6 4.8 8.3 3.6 7.5 6.2 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 42.8 0.0 0.3 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SIGLEC9 CD329 ENSG00000129450 "Sialic acid binding Ig like lectin 9" Q9Y336 19 51124908-51136651 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.7;lymphoid tissue: 25.1" "Group enriched" "Detected in some" 5 "Hofbauer cells: 38.7;Kupffer cells: 36.5;Macrophages: 29.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "classical monocyte: 40.6;intermediate monocyte: 36.5;myeloid DC: 34.1;neutrophil: 42.7;non-classical monocyte: 22.9" "Group enriched" "Detected in many" 12 "dendritic cells: 34.1;granulocytes: 42.7;monocytes: 40.6" "Group enriched" "Detected in some" 10 "Karpas-707: 21.2;RPMI-8226: 14.4" HPA010682 Uncertain NA NA 220000 "HPA010682: AB_1079968" "unprognostic (2.31e-1)" "unprognostic (3.99e-2)" "unprognostic (1.03e-2)" "unprognostic (1.36e-1)" "unprognostic (4.69e-2)" "unprognostic (6.86e-2)" "unprognostic (5.10e-2)" "unprognostic (2.10e-1)" "unprognostic (1.31e-1)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (7.03e-3)" "prognostic unfavorable (6.17e-5)" "unprognostic (6.56e-2)" "unprognostic (7.38e-3)" "unprognostic (2.95e-1)" "unprognostic (1.73e-1)" 8.5 5.7 6.6 17.0 12.6 7.6 7.4 0.9 5.0 1.7 2.5 4.0 0.0 1.6 1.4 2.8 1.1 3.7 4.9 2.9 6.2 2.3 4.5 5.5 9.0 15.8 8.4 0.7 3.2 1.8 5.8 1.5 7.5 8.1 1.6 2.4 1.3 2.3 0.9 0.8 0.9 2.6 6.1 8.8 25.1 2.0 1.9 9.6 0.8 1.4 0.0 2.3 3.7 1.2 0.0 34.1 42.7 40.6 0.5 3.2 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 21.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.8 1.3 0.0 2.5 40.6 0.3 3.2 36.5 1.8 0.0 0.5 1.2 34.1 0.0 0.1 0.6 42.7 0.5 22.9 1.8 0.1 14.4 6.6 12.6 0.9 5.0 6.2 2.3 8.4 0.7 8.1 9.6 0.0 0.3 0.9 0.0 0.5 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.8 38.7 0.0 0.0 4.3 36.5 0.0 4.6 29.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 6.5 0.0 0.0 0.1 0.1 0.2 1.0 0.0 0.0 SIGLECL1 "C19orf75, FLJ40235, SIGLEC23P, SIGLECP7" ENSG00000179213 "SIGLEC family like 1" Q8N7X8 19 51246348-51269330 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 29.7" "Group enriched" "Detected in some" 6 "Early spermatids: 33.0;Late spermatids: 49.4;Spermatocytes: 25.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 2.6" "Group enriched" "Detected in many" 19 "dendritic cells: 2.6;monocytes: 1.0" "Cell line enhanced" "Detected in some" "HDLM-2: 2.2;HEL: 2.6;HMC-1: 2.8;NB-4: 2.2;U-937: 1.8" HPA079471 Enhanced NA NA "HPA079471: " "unprognostic (5.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.0 2.6 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 1.8 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 25.1 6.3 0.0 0.0 0.0 0.0 0.0 SIGMAR1 "OPRS1, SR-BP1" ENSG00000147955 "Sigma non-opioid intracellular receptor 1" Q99720 9 34634722-34637809 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Receptor "Amyotrophic lateral sclerosis, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.1" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 82.3;Hepatocytes: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013470, HPA018002, HPA024071" Enhanced NA NA "CAB013470: AB_2533521, HPA018002: AB_1854802, HPA024071: AB_1854803" "unprognostic (1.39e-1)" "unprognostic (2.64e-1)" "unprognostic (1.56e-1)" "unprognostic (1.95e-1)" "unprognostic (8.06e-2)" "unprognostic (3.71e-2)" "unprognostic (4.89e-2)" "unprognostic (2.50e-2)" "unprognostic (2.58e-2)" "unprognostic (2.01e-3)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (2.78e-2)" "unprognostic (2.46e-1)" "unprognostic (2.39e-1)" "unprognostic (6.44e-3)" "prognostic unfavorable (3.42e-4)" 15.3 19.7 9.2 9.8 14.5 8.5 13.0 9.4 16.1 17.0 18.2 13.4 13.3 23.0 18.6 13.4 18.6 17.4 17.1 12.1 9.4 12.0 14.2 89.1 9.6 14.5 10.7 10.7 20.1 22.9 15.0 8.3 17.8 14.0 18.9 13.2 15.7 12.0 19.6 7.7 16.8 24.9 15.1 9.2 9.8 14.6 9.4 9.3 9.6 11.8 15.0 15.8 16.4 15.2 14.0 23.8 12.4 19.3 13.1 32.6 20.1 41.1 36.5 12.7 41.4 47.0 32.6 16.4 30.0 20.3 26.5 24.5 22.9 18.0 20.2 17.8 32.5 16.8 25.8 16.2 34.0 5.8 35.1 43.7 19.3 54.4 25.0 30.9 33.1 16.8 32.9 36.4 29.1 36.2 14.0 20.0 26.7 7.2 37.4 28.3 0.2 20.1 48.0 15.9 21.8 47.5 23.5 14.2 56.8 24.1 8.2 14.9 16.8 29.8 21.3 15.7 5.2 25.2 22.6 16.8 22.0 17.6 23.2 4.4 10.4 16.4 0.5 22.8 28.8 45.5 10.5 19.1 12.4 22.2 18.4 24.2 14.0 32.6 26.7 23.8 10.8 27.8 22.6 5.4 13.1 19.3 17.5 29.9 20.1 9.2 14.5 9.4 16.1 9.4 12.0 10.7 10.7 14.0 9.3 3.0 9.9 15.9 14.7 16.4 7.7 7.3 15.3 8.1 6.8 7.0 0.0 35.2 0.0 30.9 0.6 12.4 34.1 23.3 29.3 82.3 26.6 19.8 6.9 84.9 34.7 4.8 9.9 14.7 11.0 1.1 25.3 7.9 18.6 11.8 22.5 12.7 25.2 28.5 24.1 11.0 6.2 19.4 20.6 5.7 10.0 18.7 30.6 11.7 37.5 11.6 SIL1 "BAP, MSS, ULG5" ENSG00000120725 "SIL1 nucleotide exchange factor" Q9H173 5 138946720-139293557 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011949 Enhanced "Intracellular and membrane" NA NA 490000 "HPA011949: AB_1856875" "unprognostic (1.06e-1)" "unprognostic (9.01e-2)" "unprognostic (2.04e-1)" "prognostic favorable (4.34e-4)" "prognostic unfavorable (4.27e-4)" "unprognostic (9.12e-3)" "unprognostic (3.60e-1)" "unprognostic (2.45e-1)" "unprognostic (1.33e-1)" "unprognostic (6.91e-2)" "unprognostic (2.31e-2)" "unprognostic (9.46e-2)" "unprognostic (3.21e-3)" "unprognostic (1.59e-1)" "unprognostic (1.65e-1)" "unprognostic (6.79e-2)" "unprognostic (1.22e-2)" 14.8 32.2 10.5 13.1 10.6 12.0 13.0 6.2 10.1 13.8 11.5 10.5 31.5 14.3 15.4 28.9 10.2 12.1 20.8 18.5 9.1 9.2 15.3 43.4 13.9 18.2 10.1 8.6 12.9 64.3 22.6 20.6 35.9 12.8 14.5 7.7 15.6 23.4 41.3 24.3 13.0 9.3 18.6 9.8 11.1 16.6 27.2 10.2 8.1 22.4 8.8 12.2 12.9 10.6 9.3 24.2 8.6 23.8 9.9 8.8 11.6 10.4 10.9 3.6 18.1 28.3 16.4 21.0 17.3 18.9 8.6 18.9 11.4 25.4 3.9 29.6 23.7 10.6 9.5 3.9 24.3 5.3 10.5 6.6 5.1 7.7 12.2 22.4 1.5 23.7 20.2 24.0 15.2 26.3 14.1 13.0 4.9 2.6 42.8 10.4 15.7 3.8 4.5 0.7 12.2 1.3 2.7 2.5 28.3 12.6 5.5 6.3 4.2 14.9 14.4 23.5 8.5 12.4 9.6 9.8 15.5 3.6 5.8 7.4 18.6 9.5 2.5 11.2 12.0 12.8 7.6 22.9 8.6 8.8 23.8 5.3 9.3 6.1 8.2 24.2 6.5 6.1 7.6 2.6 9.9 18.4 17.6 5.4 11.6 10.5 10.6 6.2 10.1 9.1 9.2 10.1 8.6 12.8 10.2 17.9 46.7 17.2 26.7 19.6 9.3 21.3 40.8 42.8 18.2 40.1 35.3 104.6 10.0 48.9 82.0 18.0 42.4 0.0 71.3 88.2 35.0 34.1 59.9 122.1 64.9 23.8 32.1 33.7 39.2 143.8 26.4 33.5 45.5 173.1 39.8 15.8 53.3 29.6 20.8 38.2 26.0 19.4 15.6 86.7 60.5 20.8 128.5 15.2 34.1 25.0 SIRPA "BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2" ENSG00000198053 "Signal regulatory protein alpha" P78324 20 1894167-1940592 "CD markers, Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.2" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 89.1;Macrophages: 65.8;monocytes: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 10.1;eosinophil: 20.9;myeloid DC: 6.3;neutrophil: 23.5" "Group enriched" "Detected in many" 134 "dendritic cells: 6.3;granulocytes: 23.5;monocytes: 10.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 42.9;RPTEC TERT1: 31.1;SK-MEL-30: 36.1" "CAB002776, CAB015122, HPA054437, HPA058511" Enhanced NA NA 170000000 "CAB002776: , CAB015122: AB_677430, HPA054437: AB_2682488, HPA058511: AB_2683738" "unprognostic (9.78e-2)" "unprognostic (2.67e-1)" "unprognostic (3.07e-1)" "unprognostic (1.23e-1)" "unprognostic (5.56e-2)" "unprognostic (1.58e-1)" "unprognostic (1.15e-3)" "unprognostic (4.19e-3)" "unprognostic (3.48e-2)" "unprognostic (2.84e-3)" "unprognostic (3.69e-1)" "unprognostic (3.33e-2)" "unprognostic (2.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.55e-2)" "unprognostic (3.55e-2)" "unprognostic (2.24e-2)" 23.2 21.7 36.9 24.9 38.8 19.9 14.0 39.1 69.2 9.5 6.7 22.8 3.0 14.1 6.4 11.2 7.2 9.1 14.6 11.9 29.3 18.5 9.6 16.1 22.0 10.3 18.8 50.3 9.7 6.1 2.2 5.5 13.8 14.7 4.9 8.2 9.5 15.0 8.9 5.5 13.6 11.7 11.4 18.0 9.6 5.2 3.9 20.4 1.0 4.1 2.2 8.8 13.2 6.9 0.0 6.3 23.5 10.1 0.0 0.0 3.4 3.4 7.6 3.8 7.1 9.3 8.8 0.5 18.3 15.6 5.0 1.5 4.8 0.1 0.0 4.4 42.9 13.5 3.5 3.0 21.3 2.1 0.0 2.1 0.0 0.9 2.6 11.2 7.1 8.8 7.8 10.1 4.2 5.2 14.4 15.5 0.0 0.4 4.7 6.7 0.2 0.0 10.0 4.2 0.0 3.4 0.0 6.8 4.7 31.1 0.0 0.5 1.1 2.5 0.0 36.1 1.4 1.2 22.9 23.1 22.2 11.5 14.3 9.0 0.0 0.0 0.0 6.9 23.0 2.5 0.1 10.1 20.9 0.0 2.7 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 23.5 0.0 1.0 0.4 0.0 3.4 36.9 38.8 39.1 68.6 29.3 18.5 18.8 50.3 14.7 20.4 3.0 9.2 1.9 10.4 12.7 9.3 9.7 30.6 4.0 5.7 8.7 13.7 16.4 1.7 22.9 0.5 10.8 3.8 0.0 1.8 1.6 22.0 5.7 17.3 23.1 89.1 14.3 9.2 17.8 49.1 0.4 4.6 65.8 21.9 84.8 3.3 21.8 15.8 6.5 1.8 12.8 25.2 6.5 5.2 0.3 7.9 5.8 30.6 1.0 3.0 6.5 SIRPB1 "CD172b, SIRP-BETA-1" ENSG00000101307 "Signal regulatory protein beta 1" "O00241, Q5TFQ8" 20 1563521-1620061 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 137.6" "Cell type enhanced" "Detected in some" 19 "Hofbauer cells: 14.8;Kupffer cells: 35.5;Macrophages: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 137.6" "Group enriched" "Detected in many" 6 "granulocytes: 137.6;monocytes: 43.6" "Group enriched" "Detected in some" 4 "HMC-1: 25.3;NB-4: 33.6;THP-1: 26.0" HPA047463 Uncertain Uncertain Vesicles NA NA 33000000 Vesicles "HPA047463: AB_2680057" "unprognostic (1.88e-2)" "unprognostic (6.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (5.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (7.18e-2)" "unprognostic (4.11e-3)" "unprognostic (9.12e-2)" "unprognostic (6.31e-2)" "unprognostic (4.57e-2)" "unprognostic (2.65e-3)" "unprognostic (5.76e-2)" "unprognostic (2.39e-3)" "unprognostic (5.00e-3)" "unprognostic (1.19e-2)" 23.7 1.8 2.3 18.7 5.4 31.9 1.8 2.7 3.2 1.1 1.4 1.9 0.1 1.0 1.0 0.5 0.9 2.5 7.6 7.2 2.3 1.6 1.5 7.5 19.4 19.5 6.6 0.7 1.9 0.9 0.1 1.5 3.8 3.7 1.2 1.2 1.7 1.8 0.6 0.9 0.9 2.6 2.1 7.2 28.7 1.2 1.2 3.9 2.5 0.9 0.4 2.9 4.1 1.9 0.2 15.2 137.6 43.6 0.7 1.0 19.2 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 3.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 25.3 0.0 0.1 0.1 0.0 3.7 0.2 0.5 0.0 0.1 0.2 0.0 0.0 33.6 0.1 0.0 1.5 0.0 0.0 0.0 5.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 26.0 0.7 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.5 6.1 0.1 0.5 43.6 72.5 0.6 36.3 0.9 0.2 0.6 0.5 15.2 0.2 0.8 0.5 137.6 0.7 29.5 14.5 1.0 19.2 2.3 5.4 2.7 3.2 2.3 1.6 6.6 0.7 3.7 3.9 3.0 6.9 0.5 0.0 0.0 0.2 0.4 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.9 0.0 14.8 0.0 0.0 3.1 35.5 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SIRPB2 "dJ776F14.2, PTPN1L, PTPNS1L3" ENSG00000196209 "Signal regulatory protein beta 2" Q5JXA9 20 1470741-1491587 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.5;lymphoid tissue: 21.2" "Cell type enhanced" "Detected in some" 24 "Hofbauer cells: 4.4;Kupffer cells: 18.9;Macrophages: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 13 "classical monocyte: 19.8;eosinophil: 12.3;intermediate monocyte: 12.8;myeloid DC: 8.8;neutrophil: 29.5;non-classical monocyte: 9.7" "Group enriched" "Detected in many" 194 "dendritic cells: 8.8;granulocytes: 29.5;monocytes: 19.8" "Cell line enhanced" "Detected in some" "A-431: 5.3;HBEC3-KT: 4.5;HMC-1: 9.3;hTCEpi: 10.0;HUVEC TERT2: 5.0;THP-1: 8.8;TIME: 4.4;U-937: 9.4" "Low region specificity" "Detected in all" "HPA011548, HPA048032" Uncertain Approved "Nuclear bodies" NA NA 100000 "Nuclear bodies" "HPA011548: AB_2668514, HPA048032: AB_2680236" "unprognostic (3.22e-2)" "unprognostic (5.57e-2)" "unprognostic (2.29e-2)" "unprognostic (2.04e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.75e-1)" "unprognostic (2.38e-1)" "unprognostic (2.43e-1)" "unprognostic (3.50e-5)" "unprognostic (3.59e-3)" "unprognostic (9.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.06e-1)" 8.1 4.2 5.8 15.8 11.0 8.1 5.2 0.8 6.5 2.8 2.4 3.3 0.0 1.3 1.9 4.5 2.6 3.1 5.2 2.7 5.9 3.1 2.6 2.5 9.5 17.3 9.2 1.7 1.4 1.6 0.7 1.4 10.0 7.9 1.8 2.5 2.4 2.8 1.0 1.2 1.5 3.3 5.5 13.1 21.2 2.0 1.8 9.1 1.0 1.7 0.3 4.3 6.4 3.9 0.0 8.8 29.5 19.8 0.0 0.0 6.4 5.3 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 1.3 0.0 4.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.2 9.3 0.0 10.0 0.0 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 8.8 4.4 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 9.4 0.1 1.2 19.8 12.3 0.0 12.8 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 29.5 0.0 9.7 0.3 0.0 6.4 5.8 11.0 0.8 6.5 5.9 3.1 9.2 1.7 7.9 9.1 0.0 0.6 0.5 0.7 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.6 0.4 1.1 0.0 4.4 0.0 0.0 0.6 18.9 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.5 SIRPG "bA77C3.1, CD172g, SIRP-B2, SIRPB2, SIRPgamma" ENSG00000089012 "Signal regulatory protein gamma" Q9P1W8 20 1629152-1657779 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 60.1;lymphoid tissue: 44.0" "Group enriched" "Detected in some" 14 "Early spermatids: 20.5;Late spermatids: 9.7;T-cells: 18.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 60.1" "Lineage enriched" "Detected in many" 6 "T-cells: 60.1" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.5;JURKAT: 12.1;NB-4: 15.0;RT4: 4.0;THP-1: 2.6" NA NA "unprognostic (3.35e-3)" "unprognostic (4.09e-3)" "unprognostic (7.32e-3)" "prognostic favorable (1.05e-6)" "unprognostic (4.23e-3)" "prognostic favorable (2.24e-4)" "unprognostic (4.49e-2)" "unprognostic (1.30e-2)" "prognostic favorable (7.36e-7)" "unprognostic (1.62e-2)" "unprognostic (6.90e-2)" "unprognostic (2.52e-1)" "prognostic unfavorable (1.47e-6)" "unprognostic (1.03e-1)" "unprognostic (2.18e-1)" "unprognostic (1.40e-2)" "unprognostic (2.95e-3)" 0.8 0.4 0.3 11.7 0.3 1.5 0.5 0.3 0.4 0.7 2.3 0.1 0.4 0.9 0.5 0.6 1.4 0.7 2.1 0.4 0.3 0.3 1.1 1.1 1.4 20.5 0.3 0.1 0.7 0.4 0.0 0.3 0.4 0.2 0.9 1.8 0.6 4.6 0.9 0.4 0.4 8.8 0.6 0.4 14.0 1.6 0.4 0.1 44.0 1.3 0.7 21.3 2.9 0.8 0.1 1.1 1.0 0.2 9.5 60.1 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 5.5 0.0 12.1 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.1 12.3 0.1 34.1 0.1 38.4 29.0 0.1 0.1 40.5 33.3 1.0 9.5 0.1 1.1 60.1 16.7 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 9.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 18.7 0.0 0.0 SIT1 SIT ENSG00000137078 "Signaling threshold regulating transmembrane adaptor 1" Q9Y3P8 9 35649295-35650950 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 56.9;lymphoid tissue: 80.9" "Group enriched" "Detected in some" 11 "B-cells: 66.3;T-cells: 47.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 42 "gdT-cell: 21.3;MAIT T-cell: 36.3;memory B-cell: 37.1;memory CD4 T-cell: 45.0;memory CD8 T-cell: 39.8;naive B-cell: 30.9;naive CD4 T-cell: 31.5;naive CD8 T-cell: 31.0;plasmacytoid DC: 33.9;T-reg: 56.9" "Group enriched" "Detected in many" 50 "B-cells: 37.1;dendritic cells: 33.9;T-cells: 56.9" "Group enriched" "Detected in some" 5 "Daudi: 40.3;HDLM-2: 24.9;JURKAT: 21.4;U-698: 36.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA018506 Enhanced NA NA "HPA018506: AB_2669896" "unprognostic (4.28e-3)" "prognostic favorable (6.56e-4)" "unprognostic (8.01e-3)" "prognostic favorable (1.94e-6)" "unprognostic (1.18e-1)" "prognostic favorable (1.14e-4)" "unprognostic (1.75e-2)" "unprognostic (9.34e-3)" "prognostic favorable (8.17e-4)" "unprognostic (2.00e-2)" "unprognostic (1.55e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (1.75e-5)" "unprognostic (2.23e-1)" "unprognostic (1.47e-1)" "unprognostic (8.87e-2)" "unprognostic (6.34e-2)" 0.8 0.4 0.2 13.8 0.2 0.7 0.6 0.2 0.2 0.6 1.3 0.3 0.5 1.3 0.8 0.4 1.8 0.5 1.3 0.9 0.2 0.2 1.2 0.5 1.6 25.4 0.2 0.2 0.4 0.4 0.0 0.3 0.2 0.3 0.7 1.0 0.4 2.3 0.3 0.4 0.4 11.9 0.2 0.4 23.5 2.1 0.3 0.1 80.9 0.9 0.7 17.9 2.6 0.7 37.1 33.9 0.8 0.2 0.1 56.9 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.1 0.2 0.1 21.3 0.1 36.3 37.1 45.0 39.8 0.3 30.9 31.5 31.0 0.8 0.1 0.1 33.9 56.9 19.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.0 0.0 66.3 0.0 4.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 5.3 0.0 0.0 2.5 0.6 0.0 0.0 1.2 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.1 0.2 47.5 0.0 0.0 SLAMF1 "CD150, SLAM" ENSG00000117090 "Signaling lymphocytic activation molecule family member 1" Q13291 1 160608100-160647295 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Cell adhesion, Host-virus interaction, Immunity, Innate immunity, Phagocytosis" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 97.8" "Cell type enhanced" "Detected in some" 18 "Melanocytes: 13.5;monocytes: 38.7;T-cells: 20.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "MAIT T-cell: 24.1" "Group enriched" "Detected in many" 10 "B-cells: 8.8;T-cells: 24.1" "Cell line enriched" "Detected in single" 111 "HDLM-2: 58.4" "CAB002438, HPA069319" Enhanced "Secreted to blood" NA NA 590000 "CAB002438: AB_564011, HPA069319: AB_2732129" "unprognostic (2.99e-3)" "unprognostic (3.33e-4)" "unprognostic (2.93e-4)" "unprognostic (1.38e-4)" "unprognostic (5.87e-2)" "unprognostic (6.06e-5)" "unprognostic (1.64e-2)" "unprognostic (1.70e-3)" "unprognostic (1.69e-2)" "unprognostic (2.74e-4)" "unprognostic (6.12e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-7)" "unprognostic (2.46e-1)" "unprognostic (8.46e-2)" "unprognostic (1.22e-1)" "unprognostic (2.18e-2)" 2.5 0.3 0.3 14.2 0.3 4.4 1.4 0.2 0.3 1.2 2.3 0.4 0.5 2.2 0.5 1.2 2.2 0.8 2.3 1.3 0.2 0.2 2.0 1.0 4.0 14.8 0.2 0.1 0.6 0.9 0.0 0.5 2.3 0.3 1.1 2.1 0.6 4.1 0.6 0.8 1.1 7.6 1.0 0.5 10.6 2.4 0.4 0.2 97.8 1.5 1.9 26.3 3.5 1.1 8.8 1.6 0.2 0.1 0.0 24.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.1 0.0 4.2 0.0 24.1 6.2 17.2 12.1 0.1 8.8 6.6 1.6 0.2 0.0 0.0 1.6 21.5 3.5 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.1 0.3 0.2 0.0 6.9 8.1 0.1 1.8 0.0 0.2 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.3 0.0 0.0 0.0 1.2 6.2 0.0 5.0 13.5 38.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.5 0.1 20.2 0.0 0.0 SLAMF6 "CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000" ENSG00000162739 "SLAM family member 6" Q96DU3 1 160485030-160523262 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.6;lymphoid tissue: 51.9" "Cell type enhanced" "Detected in some" 15 "B-cells: 8.3;Early spermatids: 9.3;Late spermatids: 16.5;T-cells: 20.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 33.3;U-698: 49.0" "HPA051363, HPA051903" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA051363: AB_2681454, HPA051903: AB_2681658" "prognostic favorable (9.42e-4)" "prognostic favorable (2.78e-4)" "unprognostic (8.65e-2)" "prognostic favorable (9.53e-4)" "unprognostic (5.85e-2)" "prognostic favorable (7.34e-5)" "unprognostic (3.16e-3)" "unprognostic (9.78e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.31e-3)" "unprognostic (2.09e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.33e-2)" "unprognostic (8.21e-3)" 3.9 0.8 0.4 21.0 0.4 1.2 1.0 0.4 0.4 1.1 3.8 0.3 0.4 1.1 1.0 0.6 2.3 1.6 2.8 1.2 0.4 0.4 2.1 1.6 4.7 51.9 0.6 0.4 0.6 0.8 0.0 0.6 1.7 0.7 1.4 1.5 1.5 5.6 1.0 0.5 0.7 11.9 0.4 0.8 29.6 2.3 0.9 0.2 12.9 1.8 0.6 30.4 4.1 1.3 15.2 0.3 8.4 1.0 15.9 28.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 0.0 0.0 8.0 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.2 49.0 0.0 0.2 0.0 2.5 0.1 8.4 22.9 0.3 15.8 14.7 14.6 28.6 0.1 15.2 8.2 16.4 1.0 15.9 1.0 0.3 16.8 7.4 0.4 0.4 0.4 0.4 0.4 0.4 0.6 0.4 0.7 0.2 0.0 2.2 8.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.8 0.9 0.0 0.0 3.7 3.8 16.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 20.8 0.0 0.0 SLAMF7 "19A, CD319, CRACC, CS1" ENSG00000026751 "SLAM family member 7" Q9NQ25 1 160739057-160754821 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.9;lymphoid tissue: 45.0" "Cell type enriched" "Detected in many" 5 "monocytes: 204.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "U-266/70: 80.7" "Low region specificity" "Detected in all" "CAB015445, HPA055945, HPA061654" Enhanced Approved Vesicles NA NA 620000 Vesicles "CAB015445: AB_1121905, HPA055945: AB_2682980, HPA061654: AB_2684576" "unprognostic (5.82e-3)" "unprognostic (1.81e-2)" "unprognostic (1.84e-3)" "unprognostic (2.12e-3)" "unprognostic (2.75e-1)" "unprognostic (1.07e-2)" "unprognostic (7.87e-2)" "unprognostic (7.19e-2)" "unprognostic (2.46e-2)" "prognostic favorable (3.93e-4)" "unprognostic (1.08e-1)" "unprognostic (8.13e-2)" "prognostic unfavorable (8.57e-5)" "unprognostic (1.35e-1)" "unprognostic (3.91e-2)" "unprognostic (1.02e-1)" "unprognostic (1.50e-2)" 5.5 1.0 0.7 28.6 0.7 2.3 3.4 0.6 0.7 4.1 11.9 0.2 0.4 11.1 1.9 1.3 6.7 1.6 6.2 1.0 0.7 0.7 2.4 3.1 10.2 24.6 0.8 0.4 2.5 2.2 0.0 0.9 1.3 0.6 1.8 10.2 2.9 15.1 4.8 0.9 2.0 15.8 0.8 1.2 45.0 11.0 1.5 0.4 5.9 2.1 4.2 38.7 11.5 2.6 3.7 27.4 1.1 14.9 17.3 32.9 8.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 2.2 0.0 0.7 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 80.7 6.8 0.0 2.2 0.0 0.0 0.0 1.6 0.3 32.9 11.0 25.4 3.7 3.5 22.4 7.2 0.6 1.1 13.6 1.1 17.3 14.9 27.4 0.0 8.7 0.7 0.7 0.6 0.7 0.7 0.7 0.8 0.4 0.6 0.4 8.9 8.9 20.2 1.4 0.7 0.0 0.8 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 23.3 2.3 0.1 1.1 1.8 8.1 0.0 8.9 0.0 0.0 0.6 6.0 0.0 0.0 12.8 18.6 204.6 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.2 39.5 0.0 3.0 SLAMF8 "BLAME, CD353, SBBI42" ENSG00000158714 "SLAM family member 8" Q9P0V8 1 159826750-159837249 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.1" "Group enriched" "Detected in some" 10 "Hofbauer cells: 37.6;Kupffer cells: 13.7;Macrophages: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 12.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2;HL-60: 3.6;U-138 MG: 5.0;U-87 MG: 2.8;U-937: 2.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA067601 Enhanced NA NA "HPA067601: AB_2685870" "unprognostic (1.04e-1)" "unprognostic (8.80e-3)" "unprognostic (5.12e-2)" "unprognostic (2.14e-3)" "unprognostic (3.07e-2)" "unprognostic (3.22e-2)" "unprognostic (7.87e-2)" "unprognostic (4.29e-1)" "unprognostic (2.20e-2)" "unprognostic (4.56e-2)" "unprognostic (6.47e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.42e-5)" "unprognostic (3.50e-1)" "unprognostic (4.42e-2)" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" 16.9 4.6 1.5 20.1 3.4 0.4 5.4 8.2 1.6 3.1 6.0 1.4 0.6 4.6 1.8 4.2 3.1 3.6 6.1 7.1 5.2 1.7 7.8 2.2 19.6 44.1 4.1 0.7 3.8 2.0 0.1 4.2 5.4 5.0 2.7 7.1 3.0 4.2 1.0 2.2 3.1 7.0 5.4 4.1 22.7 3.1 2.4 2.7 9.7 4.8 3.0 12.7 8.6 2.8 0.0 12.1 0.5 6.6 8.1 3.8 2.8 0.0 0.1 0.0 0.0 0.5 4.2 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 1.8 0.0 0.0 0.0 3.6 0.7 1.4 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.8 0.2 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 1.7 0.0 5.0 0.2 0.0 0.9 0.0 0.0 0.0 2.8 2.6 0.0 0.0 5.1 0.0 3.2 6.6 0.2 0.0 1.1 3.8 12.1 0.0 0.2 2.6 0.5 8.1 0.4 0.1 0.0 2.8 1.5 3.4 8.2 1.6 5.2 1.7 4.1 0.7 5.0 2.7 0.0 2.9 0.0 0.0 1.5 0.2 0.2 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.0 0.0 0.0 37.6 0.0 0.0 0.0 13.7 0.0 0.3 31.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.5 0.8 0.0 0.0 SLAMF9 "CD2F-10, CD84-H1, SF2001" ENSG00000162723 "SLAM family member 9" Q96A28 1 159951492-159954254 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "adipose tissue: 20.3;blood: 5.5" "Group enriched" "Detected in some" 5 "Early spermatids: 8.9;Hofbauer cells: 7.2;Late spermatids: 22.7;Macrophages: 7.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "myeloid DC: 5.5" "Lineage enriched" "Detected in single" 9 "dendritic cells: 5.5" "Cell line enhanced" "Detected in some" "HBEC3-KT: 6.7;HEL: 9.1;PC-3: 3.7;SK-MEL-30: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035153 Uncertain NA NA "HPA035153: AB_10670586" "unprognostic (1.05e-1)" "unprognostic (1.54e-5)" "unprognostic (6.12e-2)" "unprognostic (2.84e-1)" "unprognostic (1.58e-1)" "unprognostic (7.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.22e-2)" "unprognostic (2.46e-1)" "unprognostic (3.54e-4)" "unprognostic (5.27e-4)" "unprognostic (5.47e-2)" "unprognostic (6.17e-5)" "unprognostic (8.97e-3)" "unprognostic (1.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.37e-1)" 20.3 0.0 0.1 2.3 0.1 1.1 0.9 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.7 1.0 0.1 0.4 0.1 0.0 0.1 2.6 1.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.2 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.7 0.2 2.9 0.1 0.5 0.1 0.7 0.5 2.9 0.5 0.1 5.5 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 6.7 0.0 0.0 0.0 9.1 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.6 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 3.7 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.1 4.0 1.0 0.7 1.5 0.0 1.3 1.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 5.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.9 0.0 0.0 0.0 0.2 0.0 0.2 0.8 0.0 2.4 7.2 0.0 0.0 0.0 1.8 22.7 0.3 7.3 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.5 0.0 0.0 0.0 0.6 SLC10A1 NTCP ENSG00000100652 "Solute carrier family 10 member 1" Q14973 14 69775417-69797289 "Predicted membrane proteins, Transporters" "Host-virus interaction, Ion transport, Sodium transport, Symport, Transport" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 121.2" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 130.2" "Cancer enriched" "Detected in some" 79 "liver cancer: 65.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA042727 Approved NA NA "HPA042727: AB_10960691" "unprognostic (3.42e-1)" "unprognostic (9.39e-2)" "unprognostic (1.51e-2)" "unprognostic (2.11e-2)" "unprognostic (1.93e-2)" "unprognostic (6.51e-3)" "prognostic favorable (9.53e-6)" "unprognostic (6.07e-3)" "unprognostic (8.95e-2)" "unprognostic (2.17e-1)" "unprognostic (5.75e-3)" "unprognostic (1.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-1)" "unprognostic (2.45e-1)" "unprognostic (5.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 2.7 0.5 0.1 0.6 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 4.3 0.1 0.6 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.5 0.6 0.3 0.6 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.9 0.1 0.1 0.8 0.5 0.0 0.1 0.4 0.5 1.1 0.1 0.6 0.0 0.3 0.0 0.1 0.9 0.1 0.6 0.1 0.0 0.3 1.7 0.5 0.3 0.4 0.8 0.5 0.2 0.3 1.0 0.6 0.4 2.7 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.4 10.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 130.2 0.1 0.0 0.0 1.8 2.7 3.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SLC10A2 "ASBT, ISBT" ENSG00000125255 "Solute carrier family 10 member 2" Q12908 13 103043998-103066846 "Disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 40.9" "Group enriched" "Detected in some" 29 "Enterocytes: 5.1;Proximal tubular cells: 6.4" "Cancer enriched" "Detected in single" 11 "renal cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;HAP1: 2.5;NB-4: 1.2;U-2197: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA004795 Approved NA NA "HPA004795: AB_1856953" "unprognostic (2.82e-2)" "prognostic favorable (5.78e-5)" "unprognostic (1.64e-2)" "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 2.5 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC10A3 "DXS253E, P3" ENSG00000126903 "Solute carrier family 10 member 3" P09131 X 154487306-154490690 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 9 "basophil: 51.2" "Lineage enriched" "Detected in all" 13 "granulocytes: 51.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021656 Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA021656: AB_1856955" "unprognostic (1.60e-1)" "prognostic favorable (4.53e-4)" "prognostic unfavorable (4.15e-5)" "unprognostic (8.00e-3)" "prognostic unfavorable (9.97e-4)" "unprognostic (5.47e-2)" "unprognostic (2.28e-3)" "unprognostic (9.76e-2)" "unprognostic (1.63e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.22e-4)" "unprognostic (3.42e-1)" "unprognostic (2.52e-3)" "unprognostic (6.23e-2)" "unprognostic (2.99e-1)" "unprognostic (7.29e-2)" "unprognostic (2.99e-2)" 14.5 14.6 3.6 11.6 5.1 22.5 13.4 5.0 8.1 21.5 15.3 8.1 16.3 10.6 25.0 36.1 22.8 15.4 21.1 19.5 6.0 4.6 17.7 6.7 16.3 14.0 5.8 6.2 32.3 25.7 6.1 12.7 40.1 7.6 23.7 6.4 12.4 11.7 13.3 13.7 26.2 13.6 20.1 5.3 13.1 12.6 11.6 4.7 12.6 15.7 23.3 18.6 23.3 18.3 1.6 2.7 51.2 1.7 2.2 3.8 1.8 24.9 10.7 2.9 14.6 10.1 11.0 19.0 18.6 11.4 12.6 12.7 9.5 12.1 19.0 35.4 17.8 16.8 21.5 9.4 9.5 3.4 12.3 4.4 5.9 14.1 7.5 18.6 7.0 9.6 13.7 10.9 11.7 6.3 11.3 8.6 3.3 6.6 18.7 8.2 33.1 3.8 6.3 2.2 12.2 20.8 6.1 7.7 14.4 9.5 9.3 2.6 4.7 11.7 21.3 4.9 3.5 6.8 5.6 11.3 15.0 9.4 34.8 23.5 13.4 12.9 19.6 16.0 14.7 7.7 51.2 1.3 5.6 3.8 1.7 2.9 1.6 2.6 2.8 1.1 1.6 1.9 1.8 1.7 2.2 1.5 2.7 1.8 1.8 3.6 5.1 5.0 8.1 6.0 4.6 5.8 6.2 7.6 4.7 3.0 6.5 11.7 23.8 20.0 2.0 3.6 7.6 4.0 3.4 17.4 5.9 42.9 6.6 15.3 2.4 14.3 14.4 0.0 17.0 52.6 23.3 12.1 12.7 1.6 17.2 3.2 9.8 18.4 7.8 1.0 25.0 10.5 3.3 16.2 14.0 2.3 15.9 15.3 12.4 7.7 1.6 6.5 22.6 1.2 2.7 24.3 86.2 17.5 10.6 24.7 SLC10A4 MGC29802 ENSG00000145248 "Solute carrier family 10 member 4" Q96EP9 4 48483343-48489196 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 12.3;brain: 19.0" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 2.7;Cone photoreceptor cells: 2.0;Early spermatids: 1.4" "Cancer enhanced" "Detected in many" "glioma: 5.9" "Group enriched" "Detected in many" 7 "basal ganglia: 7.3;cerebral cortex: 6.3;hypothalamus: 6.3;midbrain: 19.0;pons and medulla: 15.3" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "HAP1: 10.6;HEL: 4.6;K-562: 10.6;SH-SY5Y: 28.2;THP-1: 4.6" "Group enriched" "Detected in many" 5 "basal ganglia: 19.0;midbrain: 63.0;pons and medulla: 27.5" HPA028835 Uncertain Supported NA NA "HPA028835: AB_10603025" "unprognostic (4.06e-1)" "unprognostic (1.19e-1)" "unprognostic (1.06e-1)" "unprognostic (3.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.46e-2)" "unprognostic (5.41e-2)" "unprognostic (3.67e-1)" "unprognostic (1.86e-1)" "unprognostic (4.08e-3)" "unprognostic (9.98e-3)" "unprognostic (1.46e-1)" "unprognostic (3.50e-1)" "unprognostic (5.14e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (8.73e-2)" 0.4 12.3 1.4 2.7 7.3 3.4 0.5 0.5 6.4 2.9 1.6 0.7 0.0 0.8 0.4 0.2 0.4 0.4 0.6 0.6 1.2 6.3 0.3 0.2 1.1 0.3 19.0 0.8 0.3 0.3 0.4 7.5 0.4 15.3 0.4 1.5 4.0 4.9 0.9 0.9 0.4 1.3 0.6 1.1 0.4 0.8 1.2 0.7 0.0 1.5 0.0 0.3 0.4 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 2.1 0.0 10.6 0.0 0.1 0.0 2.3 4.6 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.1 0.0 0.2 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.7 28.2 0.5 0.0 0.1 0.6 0.0 4.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 7.3 0.5 6.3 1.2 6.3 19.0 0.8 15.3 0.7 0.0 2.7 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.0 SLC10A5 ENSG00000253598 "Solute carrier family 10 member 5" Q5PT55 8 81693607-81696174 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;liver: 10.3" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 6.7;Enterocytes: 5.2;Intestinal endocrine cells: 3.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025966 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA025966: AB_1856959" "unprognostic (6.42e-2)" "unprognostic (3.89e-1)" "unprognostic (1.25e-2)" "unprognostic (2.34e-2)" "unprognostic (8.13e-3)" "unprognostic (1.91e-1)" "unprognostic (5.71e-2)" "unprognostic (5.63e-2)" "unprognostic (3.67e-1)" "unprognostic (2.41e-1)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" "unprognostic (8.95e-2)" "unprognostic (2.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-1)" "unprognostic (2.82e-7)" 0.0 0.3 0.9 0.1 2.3 0.0 0.2 5.1 1.8 0.3 2.5 2.9 0.3 0.9 0.2 0.3 1.4 0.1 0.9 2.1 1.8 10.3 0.3 0.0 0.8 0.4 1.0 0.3 1.9 0.0 0.5 3.5 0.3 0.2 0.1 0.4 3.5 0.2 0.3 0.3 3.4 0.0 0.8 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.7 0.3 0.9 0.9 0.7 1.4 0.7 0.9 0.4 0.3 0.5 0.4 0.5 0.9 1.3 0.2 0.2 0.9 1.1 0.8 1.3 0.7 2.4 1.8 2.6 1.4 0.4 0.1 0.3 0.4 2.2 0.7 1.7 1.5 0.4 0.6 1.6 1.2 1.3 0.7 0.5 1.2 0.4 6.5 0.5 0.3 0.3 0.6 1.2 3.1 2.1 0.9 0.7 0.6 0.3 0.5 1.6 0.6 0.9 1.1 1.5 1.4 1.4 1.5 2.2 0.1 1.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 6.7 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 5.2 0.0 1.0 0.1 0.0 0.2 0.0 2.1 0.0 0.0 3.5 0.6 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.5 1.7 0.0 1.8 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.0 0.4 SLC10A6 SOAT ENSG00000145283 "Solute carrier family 10 member 6" Q3KNW5 4 86823468-86849263 "Predicted membrane proteins" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 20.3;breast: 15.2;skin 1: 17.7" "Group enriched" "Detected in some" 5 "Early spermatids: 62.9;Late spermatids: 160.4" "Group enriched" "Detected in many" 5 "cervical cancer: 3.5;head and neck cancer: 6.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.0;BJ: 4.9;BJ hTERT+: 4.0;HaCaT: 3.7;HBEC3-KT: 1.6;U-266/84: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA016662 Enhanced NA NA "HPA016662: AB_1669899" "unprognostic (2.79e-2)" "unprognostic (1.86e-1)" "unprognostic (1.05e-1)" "unprognostic (8.31e-3)" "unprognostic (5.88e-2)" "unprognostic (8.87e-3)" "unprognostic (1.32e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (7.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-1)" "unprognostic (3.84e-4)" "unprognostic (1.54e-1)" "unprognostic (2.06e-1)" "unprognostic (9.22e-2)" "unprognostic (5.89e-4)" 20.3 0.5 0.6 0.9 0.7 0.0 15.2 0.1 0.6 3.7 1.6 0.0 2.1 0.1 2.0 0.8 12.5 0.8 1.4 1.2 0.4 0.2 0.2 0.2 1.2 0.1 2.7 0.0 0.4 1.1 0.9 3.7 0.3 0.9 0.9 0.4 0.0 2.0 0.5 2.3 17.7 0.4 2.4 1.6 0.3 0.5 4.9 1.1 0.0 1.4 11.2 2.9 4.6 5.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 2.0 0.1 0.2 4.9 4.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 3.7 0.2 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.7 0.1 0.6 0.4 0.2 2.7 0.0 0.9 1.1 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.4 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.4 21.8 0.0 0.0 0.0 0.1 SLC10A7 "C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043" ENSG00000120519 "Solute carrier family 10 member 7" Q0GE19 4 146253975-146521964 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3;granulocytes: 23.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039996 Uncertain NA NA "HPA039996: AB_10673266" "unprognostic (9.44e-2)" "unprognostic (4.03e-1)" "unprognostic (3.39e-3)" "unprognostic (5.07e-2)" "unprognostic (1.01e-1)" "unprognostic (9.02e-2)" "unprognostic (7.96e-2)" "unprognostic (2.54e-1)" "unprognostic (3.55e-1)" "unprognostic (8.53e-2)" "unprognostic (2.68e-3)" "unprognostic (1.24e-1)" "unprognostic (1.43e-2)" "unprognostic (8.99e-2)" "unprognostic (2.79e-1)" "unprognostic (6.69e-2)" "unprognostic (9.57e-2)" 12.0 10.7 8.0 8.1 14.3 8.8 11.3 17.0 10.5 13.5 11.8 10.0 17.4 7.8 13.2 21.4 14.9 9.2 9.7 8.3 8.6 6.4 8.6 17.2 16.0 13.9 10.9 6.9 12.0 14.5 7.9 22.2 15.0 11.2 11.1 16.2 7.8 15.5 16.0 8.8 9.4 10.3 10.3 19.3 11.0 16.3 6.6 11.7 16.8 12.3 9.2 12.8 10.2 12.7 6.7 6.4 11.5 7.7 7.5 7.8 3.7 3.8 1.3 9.5 4.0 7.1 8.5 4.7 4.9 6.4 4.5 4.6 3.6 16.7 7.4 3.4 5.3 2.8 4.0 5.5 6.7 5.4 8.4 2.6 8.9 3.2 6.4 4.5 15.5 14.2 4.1 5.6 5.3 6.8 2.7 8.0 7.7 9.9 19.5 3.2 2.7 11.6 3.7 1.8 8.8 6.4 6.4 6.9 10.1 3.2 2.9 2.9 2.6 3.3 10.0 4.0 5.3 5.9 6.2 4.4 4.0 4.2 6.1 3.3 16.4 17.9 10.1 5.5 6.5 5.7 11.5 5.1 6.8 6.4 7.7 6.6 6.7 6.5 5.8 6.4 4.5 6.0 5.9 0.5 7.5 5.9 4.4 7.8 3.7 8.0 14.3 17.0 10.5 8.6 6.4 10.9 6.9 11.2 11.7 3.0 3.8 3.7 2.8 3.0 5.6 1.6 12.7 9.4 2.3 1.8 3.9 5.7 1.7 3.3 1.4 3.6 4.9 23.3 4.4 11.7 4.9 5.4 23.0 9.0 5.2 7.9 4.6 8.6 6.3 0.7 6.9 3.6 0.0 2.8 11.3 4.3 3.0 2.9 4.6 1.7 11.3 0.0 5.1 5.4 4.1 4.3 5.1 4.8 5.6 3.5 SLC11A1 "LSH, NRAMP, NRAMP1" ENSG00000018280 "Solute carrier family 11 member 1" P49279 2 218382029-218396894 "Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.6;lymphoid tissue: 23.8" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 52.4;Hofbauer cells: 110.2;Kupffer cells: 163.4;Macrophages: 201.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0" "Group enriched" "Detected in many" 11 "dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9" "Cell line enhanced" "Detected in some" "HEL: 3.8;HMC-1: 3.7;NB-4: 3.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA029590, HPA050378, HPA068540" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA029590: AB_10794613, HPA050378: , HPA068540: " "unprognostic (2.64e-1)" "unprognostic (3.05e-2)" "unprognostic (1.46e-2)" "unprognostic (2.34e-2)" "unprognostic (1.99e-2)" "unprognostic (3.83e-2)" "unprognostic (1.04e-3)" "unprognostic (2.06e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (7.29e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (2.58e-8)" "unprognostic (9.55e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-2)" "unprognostic (1.08e-2)" 13.5 4.7 4.3 14.9 13.3 11.6 2.6 0.6 9.3 1.7 1.8 4.6 0.0 1.3 1.3 2.1 1.4 4.1 3.0 6.5 15.0 2.6 2.1 3.2 37.6 19.9 17.1 0.7 2.4 3.3 1.2 1.9 6.2 11.3 1.7 1.0 1.7 2.0 1.2 2.0 1.0 1.2 4.6 18.1 23.8 1.7 2.4 10.3 0.0 1.8 0.2 1.0 7.1 1.3 0.4 2.4 6.0 7.9 0.2 0.4 2.6 0.3 0.7 0.0 0.4 0.1 0.1 0.9 0.0 0.0 0.1 0.2 1.0 2.1 0.2 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.7 0.1 3.8 0.6 0.7 0.1 0.0 3.7 0.3 0.1 0.0 0.2 0.3 0.0 1.2 1.0 0.7 0.1 1.3 0.2 3.1 0.0 0.6 0.2 0.2 0.6 0.4 0.1 0.3 0.8 0.2 0.5 0.4 0.4 0.2 0.3 1.1 0.3 0.7 0.4 0.2 0.0 0.3 0.3 0.7 0.2 0.4 0.4 0.3 7.9 0.6 0.4 5.8 0.3 0.1 0.2 0.2 2.4 0.4 0.4 0.3 6.0 0.2 7.0 0.2 0.2 2.6 4.3 13.3 0.6 9.3 15.0 2.6 17.1 0.7 11.3 10.3 20.8 52.4 3.0 3.9 0.8 3.6 6.3 5.1 17.4 22.7 8.7 0.0 1.6 8.3 0.8 1.2 4.7 1.2 0.0 1.8 7.2 2.4 5.7 24.3 4.7 110.2 1.6 1.2 8.6 163.4 0.4 2.0 201.4 1.7 1.0 4.0 7.6 0.6 0.9 0.7 6.8 3.0 19.4 5.0 0.5 1.7 0.9 6.8 1.7 2.2 2.7 SLC11A2 "DCT1, DMT1, NRAMP2" ENSG00000110911 "Solute carrier family 11 member 2" P49281 12 50979401-51028566 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032139, HPA032140" Uncertain Supported Mitochondria No No Mitochondria "HPA032139: AB_10964213, HPA032140: AB_10962932" "unprognostic (4.40e-3)" "unprognostic (1.41e-2)" "unprognostic (1.50e-1)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.92e-1)" "unprognostic (2.09e-1)" "prognostic favorable (3.07e-6)" "unprognostic (1.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.15e-1)" "unprognostic (7.28e-2)" "unprognostic (2.29e-1)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (2.32e-2)" "unprognostic (2.24e-1)" 11.3 15.1 12.8 9.6 26.2 9.6 20.8 14.7 22.1 20.8 11.3 38.2 8.4 35.3 12.3 12.7 17.3 15.4 12.1 12.9 14.5 14.2 16.1 18.0 18.6 7.9 40.0 15.4 10.4 20.6 29.8 21.7 16.4 29.7 18.0 11.8 18.7 26.9 14.8 17.6 15.6 11.6 11.0 33.1 9.5 12.5 8.7 31.0 15.8 29.9 8.7 16.5 12.9 13.9 4.1 9.8 3.0 9.5 8.3 7.1 4.6 7.7 10.0 13.2 12.1 14.7 12.5 44.4 8.4 30.5 8.0 9.4 12.6 14.6 4.8 16.6 9.4 15.3 10.7 11.9 7.9 9.4 6.9 7.2 11.4 12.1 14.3 15.6 7.7 23.0 13.7 9.9 14.9 15.2 19.6 9.5 9.8 9.8 2.4 9.3 8.9 9.1 5.2 19.6 8.2 6.9 5.9 12.1 8.5 9.7 11.6 9.1 8.1 6.4 19.5 8.5 16.0 21.9 5.1 11.4 8.2 6.9 9.2 4.4 6.0 8.1 2.0 23.1 4.2 3.4 0.7 6.6 2.4 6.4 9.5 5.8 3.6 5.0 6.3 9.8 4.1 7.1 6.6 3.0 8.3 6.0 4.1 3.8 4.6 12.8 26.2 14.7 22.1 14.5 14.2 40.0 15.4 29.7 31.0 35.7 40.3 11.5 22.2 13.7 23.8 12.0 28.1 45.5 43.3 54.1 17.7 20.6 3.3 25.3 0.8 14.3 8.6 70.0 24.8 18.3 17.5 32.8 67.2 38.4 29.8 27.0 15.7 9.8 13.3 1.5 8.9 25.8 25.3 9.0 13.5 27.5 20.6 14.7 8.1 8.8 16.5 6.5 12.4 5.5 12.8 11.7 16.2 7.9 16.1 19.0 SLC12A1 NKCC2 ENSG00000074803 "Solute carrier family 12 member 1" Q13621 15 48178438-48304078 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "kidney: 143.2" "Cell type enriched" "Detected in some" 5 "Distal tubular cells: 177.4" "Cancer enhanced" "Detected in single" "renal cancer: 1.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 1.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.9" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA014967, HPA018107" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA014967: AB_1854503, HPA018107: AB_1854504" "unprognostic (3.52e-2)" "unprognostic (1.30e-2)" "unprognostic (9.65e-2)" "unprognostic (1.74e-2)" "unprognostic (7.77e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-2)" "unprognostic (2.06e-1)" "unprognostic (9.85e-3)" "unprognostic (2.81e-4)" "unprognostic (9.75e-2)" "unprognostic (2.61e-1)" "unprognostic (5.47e-2)" "unprognostic (2.03e-1)" "unprognostic (5.20e-4)" "unprognostic (8.52e-2)" 0.0 0.0 0.3 0.0 1.0 0.0 0.0 1.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 143.2 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.0 0.3 1.0 1.4 1.5 0.1 0.3 0.3 0.4 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 36.6 0.0 0.0 177.4 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SLC12A2 "BSC, BSC2, NKCC1, PPP1R141" ENSG00000064651 "Solute carrier family 12 member 2" P55011 5 128083766-128189688 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 50.7;salivary gland: 61.2" "Cell type enhanced" "Detected in many" 8 "Glandular cells: 203.2;Mucus-secreting cells: 402.7;Undifferentiated cells: 269.5" "Cancer enhanced" "Detected in all" "colorectal cancer: 54.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "OE19: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020130, HPA063697" Approved Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA020130: AB_1854502, HPA063697: AB_2685094" "unprognostic (4.61e-2)" "unprognostic (2.63e-1)" "unprognostic (4.20e-3)" "prognostic favorable (8.60e-4)" "unprognostic (3.99e-1)" "unprognostic (5.65e-3)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (3.30e-1)" "unprognostic (2.95e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-1)" "prognostic favorable (7.09e-4)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.79e-1)" "unprognostic (3.88e-3)" 5.5 11.0 10.8 9.4 24.1 2.7 26.2 11.4 18.1 5.1 28.5 37.2 0.0 24.6 5.7 1.9 3.8 4.1 50.7 4.1 15.5 9.9 4.5 2.9 6.5 3.5 36.1 13.5 5.6 5.3 11.2 5.5 3.3 30.0 14.8 36.3 8.5 61.2 2.1 8.5 23.0 28.8 6.6 27.7 2.9 36.3 5.5 26.7 2.0 5.6 6.8 18.3 4.2 3.6 3.6 9.8 0.5 1.2 3.6 3.0 0.4 4.8 24.1 24.8 9.6 6.2 4.0 5.1 4.5 3.4 3.2 3.4 9.6 7.7 7.2 6.1 3.9 2.9 14.7 4.7 5.2 5.0 7.2 5.9 2.0 4.3 1.4 1.9 2.6 3.6 4.2 1.9 7.2 4.3 2.4 5.3 3.1 3.3 4.9 5.0 5.1 4.6 2.2 2.9 55.9 7.9 2.5 7.0 2.9 3.8 16.5 4.4 2.8 9.1 4.0 3.5 2.8 2.2 1.3 8.8 8.1 5.4 6.1 5.7 4.1 3.7 8.0 4.2 1.5 6.5 0.5 0.7 0.2 1.9 1.2 3.0 2.7 1.8 2.3 0.9 3.6 2.0 2.7 0.3 3.6 0.8 9.8 1.6 0.4 10.8 24.1 11.4 18.1 15.5 9.9 36.1 13.5 30.0 26.7 14.9 37.4 13.4 18.3 20.4 45.1 14.0 99.3 10.7 38.7 31.4 119.8 0.9 1.7 45.3 45.7 23.6 29.9 0.0 41.4 2.1 14.8 203.2 18.4 7.4 3.6 76.3 71.5 6.7 7.3 70.8 79.1 10.2 194.0 0.0 402.7 27.8 49.2 77.2 27.3 9.6 76.9 71.1 24.5 27.0 21.5 26.2 1.1 12.1 269.5 16.9 SLC12A3 NCCT ENSG00000070915 "Solute carrier family 12 member 3" P55017 16 56865207-56915850 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 88.6" "Group enriched" "Detected in some" 9 "Collecting duct cells: 3.5;Distal tubular cells: 5.0;monocytes: 7.2" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 14.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 14.6" "Group enriched" "Detected in some" 10 "BEWO: 10.2;HAP1: 5.6;HeLa: 11.4;SuSa: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA028748 Enhanced NA NA "HPA028748: AB_10603886" "unprognostic (1.54e-3)" "unprognostic (7.09e-5)" "unprognostic (1.35e-1)" "unprognostic (1.41e-2)" "unprognostic (2.91e-1)" "unprognostic (2.38e-4)" "unprognostic (1.81e-1)" "unprognostic (9.70e-2)" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (6.84e-2)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "unprognostic (2.09e-1)" "unprognostic (1.38e-1)" "unprognostic (1.40e-2)" "unprognostic (1.70e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 88.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 14.6 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.7 5.6 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 14.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC12A4 KCC1 ENSG00000124067 "Solute carrier family 12 member 4" Q9UP95 16 67943474-67969601 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 53.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041138 Approved Approved Endosomes NA NA Endosomes "HPA041138: AB_10794544" "unprognostic (5.07e-2)" "unprognostic (6.18e-2)" "unprognostic (1.25e-1)" "unprognostic (2.68e-2)" "unprognostic (9.28e-2)" "unprognostic (1.48e-2)" "unprognostic (4.28e-2)" "unprognostic (3.26e-3)" "unprognostic (9.58e-2)" "unprognostic (1.55e-1)" "unprognostic (2.01e-2)" "unprognostic (1.81e-2)" "prognostic favorable (2.25e-6)" "unprognostic (6.42e-2)" "unprognostic (1.42e-1)" "unprognostic (7.64e-2)" "unprognostic (2.26e-1)" 16.6 18.3 9.2 8.0 8.8 3.1 26.5 7.0 12.7 19.4 16.5 20.1 12.0 5.1 20.7 9.7 11.8 13.8 15.5 24.4 12.2 5.2 10.7 17.1 19.5 6.6 11.4 8.2 14.2 11.9 30.1 8.1 32.6 18.1 17.8 4.3 23.0 10.5 20.7 14.6 16.9 8.6 27.4 10.0 10.2 10.9 17.6 9.8 8.8 21.0 9.1 8.4 16.5 16.6 1.0 2.4 8.3 5.4 2.7 1.6 1.6 5.0 6.8 5.3 10.0 17.6 15.5 28.6 15.6 16.2 13.5 11.8 13.6 8.2 1.8 7.7 21.5 7.5 9.3 2.5 19.3 10.2 1.8 2.0 1.3 8.9 14.9 20.0 0.1 6.4 17.1 12.7 18.1 6.6 15.8 8.3 3.4 4.1 1.5 18.5 0.8 1.9 5.1 4.0 1.5 3.6 2.0 10.0 1.6 7.4 4.4 0.0 3.2 29.7 1.8 2.6 13.8 14.2 2.0 11.2 19.3 13.7 8.5 6.7 9.3 2.3 3.0 11.2 1.4 16.6 8.3 3.9 2.0 1.5 5.4 1.0 0.4 0.9 0.9 2.4 1.0 0.8 0.7 1.4 2.7 3.8 1.1 1.6 1.6 9.2 8.8 7.0 8.6 12.2 5.2 11.4 8.2 18.1 9.8 14.9 7.8 2.2 12.2 9.0 1.0 25.6 2.5 6.7 10.3 14.0 0.0 24.6 0.0 10.9 2.1 14.3 0.0 0.0 7.1 13.5 13.6 12.7 1.1 7.5 6.9 0.0 0.0 14.1 4.6 1.3 18.4 4.4 10.1 16.2 0.0 21.0 12.7 0.0 34.3 3.4 0.8 38.8 27.6 9.7 6.6 4.5 53.1 1.5 0.0 8.6 SLC12A5 "KCC2, KIAA1176" ENSG00000124140 "Solute carrier family 12 member 5" Q9H2X9 20 46021690-46060152 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 64.6" "Group enriched" "Detected in many" 13 "Bipolar cells: 205.2;Cone photoreceptor cells: 361.3;Rod photoreceptor cells: 172.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 13.7;NB-4: 28.3;SK-BR-3: 14.3;U-2 OS: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072058 Enhanced NA NA "HPA072058: AB_2686485" "unprognostic (2.01e-1)" "unprognostic (3.58e-1)" "unprognostic (7.55e-2)" "unprognostic (9.44e-4)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.48e-1)" "unprognostic (5.16e-3)" "unprognostic (3.61e-1)" "unprognostic (2.49e-1)" "unprognostic (6.63e-2)" "unprognostic (3.72e-3)" "unprognostic (5.61e-4)" "unprognostic (8.78e-4)" "unprognostic (3.25e-2)" "unprognostic (9.22e-2)" "unprognostic (1.99e-1)" "unprognostic (2.34e-2)" 1.4 11.2 21.1 2.0 28.8 1.5 1.7 52.1 64.6 2.3 2.1 2.7 0.0 2.2 1.6 2.2 1.3 1.7 1.9 2.1 20.5 19.2 1.4 2.2 2.7 3.1 9.5 32.1 2.0 3.6 1.5 4.8 3.3 15.3 1.5 2.1 4.9 1.9 1.8 1.5 1.5 2.1 1.6 6.3 2.8 3.1 3.4 5.8 0.0 1.3 0.0 2.6 1.2 0.5 1.3 0.2 0.1 1.5 0.7 5.7 1.3 0.0 8.6 3.8 2.8 0.3 0.0 0.8 0.3 0.0 0.0 0.3 1.1 0.0 3.2 13.1 0.2 3.4 0.8 2.5 1.3 0.2 2.0 3.3 2.7 1.6 13.7 1.5 0.0 3.8 0.5 0.0 0.0 0.2 5.9 0.8 3.1 5.1 0.0 0.0 13.0 1.9 28.3 1.4 1.2 4.4 3.2 2.4 0.7 1.3 0.0 4.7 6.7 1.7 14.3 4.1 3.7 5.2 8.1 1.3 1.5 16.3 0.1 0.6 0.0 2.1 4.5 3.5 3.3 0.1 0.0 1.5 0.0 2.6 0.8 1.0 1.0 0.3 0.4 0.2 1.3 5.7 3.2 0.1 0.7 0.2 0.0 3.5 1.3 21.1 28.8 52.1 36.4 20.5 19.2 9.5 32.1 15.3 5.8 0.0 0.0 0.0 0.0 0.5 205.2 0.8 0.0 0.0 0.0 0.0 361.3 1.1 1.7 0.0 1.6 1.6 0.0 0.0 0.2 2.6 0.4 0.4 0.0 0.5 15.2 12.7 19.1 3.7 0.6 3.4 0.0 3.2 5.0 1.0 0.4 12.9 0.5 0.0 0.0 0.2 172.9 0.0 0.4 1.4 2.5 0.5 1.4 0.0 0.4 0.0 SLC12A6 "ACCPN, KCC3" ENSG00000140199 "Solute carrier family 12 member 6" Q9UHW9 15 34229996-34338060 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" Neuropathy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 80.5;Rod photoreceptor cells: 54.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 9.4;neutrophil: 18.5" "Lineage enriched" "Detected in many" 8 "granulocytes: 18.5" "Cell line enhanced" "Detected in many" "HaCaT: 27.2" "Low region specificity" "Detected in all" HPA034563 Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA034563: AB_10603887" "unprognostic (3.53e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (3.60e-1)" "unprognostic (3.55e-2)" "unprognostic (3.41e-2)" "unprognostic (1.36e-1)" "unprognostic (2.88e-1)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.58e-2)" "unprognostic (1.83e-1)" "prognostic favorable (3.33e-6)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (3.87e-2)" "unprognostic (1.41e-1)" 8.7 5.8 7.4 12.4 11.1 27.5 7.0 10.2 14.1 14.7 8.0 12.7 3.6 8.3 6.3 8.7 24.9 4.7 6.3 6.9 6.8 6.9 18.6 4.9 11.5 10.9 9.9 8.4 5.8 5.1 5.4 10.9 5.2 12.5 5.0 7.4 9.7 9.3 4.9 10.5 8.6 10.2 6.0 9.2 11.1 8.0 38.5 10.9 18.2 10.6 8.2 13.6 8.2 21.2 2.0 1.0 18.5 1.4 0.6 2.3 0.7 2.6 3.2 2.0 2.9 6.5 7.6 1.4 4.0 9.3 3.1 4.5 1.8 4.4 1.9 3.7 4.2 2.8 27.2 4.8 3.3 3.7 0.7 3.2 14.6 8.2 4.2 4.0 8.7 16.0 4.4 5.8 9.1 18.4 7.0 9.4 5.2 3.2 4.3 4.2 0.9 0.9 6.9 1.5 2.3 3.5 4.4 3.5 1.8 3.5 6.8 4.4 3.2 4.4 0.1 0.9 4.7 1.9 3.0 5.8 3.6 2.6 12.4 0.9 3.8 4.1 1.2 4.3 6.5 1.5 9.4 1.1 2.3 0.5 1.4 0.3 1.2 0.8 0.7 0.7 2.0 1.3 1.1 18.5 0.6 0.6 1.0 2.3 0.7 7.4 11.1 10.2 14.1 6.8 6.9 9.9 8.4 12.5 10.9 20.8 18.9 18.2 3.9 1.0 12.8 7.4 5.1 5.3 5.7 5.2 80.5 2.5 0.0 4.2 9.2 16.3 10.3 0.0 4.1 1.3 2.0 4.8 4.7 6.7 11.9 7.9 6.4 14.1 38.6 5.3 7.5 14.4 0.0 1.0 7.3 8.0 8.7 12.7 8.1 17.8 54.2 19.4 2.0 38.5 20.4 0.6 0.9 12.8 6.0 20.5 SLC12A7 "DKFZP434F076, KCC4" ENSG00000113504 "Solute carrier family 12 member 7" Q9Y666 5 1050376-1112035 "Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 265.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 25.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041652 Approved Uncertain Cytosol NA NA Cytosol "HPA041652: AB_10793971" "unprognostic (2.22e-2)" "unprognostic (1.56e-1)" "unprognostic (8.92e-2)" "unprognostic (2.86e-1)" "unprognostic (1.69e-2)" "unprognostic (8.72e-2)" "prognostic unfavorable (2.12e-6)" "unprognostic (1.67e-1)" "unprognostic (1.71e-3)" "unprognostic (4.40e-2)" "unprognostic (4.50e-2)" "unprognostic (3.44e-2)" "unprognostic (1.65e-3)" "unprognostic (1.17e-3)" "unprognostic (1.26e-1)" "unprognostic (3.93e-2)" "prognostic favorable (3.16e-5)" 10.1 6.4 5.7 14.1 7.3 4.3 13.0 2.4 8.3 6.5 11.5 5.6 6.6 28.0 7.2 7.6 4.7 8.9 29.4 27.9 6.1 3.8 20.4 31.3 10.0 10.3 5.8 3.2 8.5 12.4 8.2 11.5 3.8 7.9 10.2 7.0 15.5 10.9 8.7 3.2 7.9 20.3 8.2 4.9 17.9 15.2 14.5 7.4 12.2 13.3 5.5 6.9 7.1 34.5 1.4 4.2 0.5 6.9 2.5 2.7 2.2 2.1 6.0 3.3 10.4 0.5 0.5 5.2 0.1 0.7 0.5 0.0 14.3 3.8 0.0 11.8 0.2 4.1 4.4 2.7 3.6 0.0 13.0 3.6 2.8 7.5 4.9 7.6 0.0 6.3 1.1 0.5 0.0 1.1 0.2 3.3 1.3 4.0 0.1 0.0 6.9 8.4 0.0 7.2 8.4 9.6 25.3 14.4 11.8 4.0 8.7 1.8 2.3 3.2 0.0 3.6 2.1 5.8 1.6 2.8 0.0 3.4 0.0 0.0 0.2 0.0 1.4 0.0 0.4 1.7 0.5 3.4 0.0 2.5 5.4 2.6 1.1 2.4 2.7 4.2 1.4 2.5 2.5 0.0 2.5 6.9 1.8 2.4 2.2 5.7 7.3 2.4 8.3 6.1 3.8 5.8 3.2 7.9 7.4 8.9 17.5 5.4 5.2 6.3 17.7 32.1 40.8 10.7 14.8 27.9 2.0 0.2 1.7 23.0 0.3 14.9 28.8 0.0 15.7 0.3 7.3 14.6 8.1 29.2 15.8 265.4 12.7 9.2 20.4 1.3 3.4 12.2 15.1 1.8 16.5 6.6 28.0 17.5 5.3 26.1 2.9 19.4 7.2 0.7 4.5 5.9 0.2 3.3 14.2 13.2 SLC12A8 CCC9 ENSG00000221955 "Solute carrier family 12 member 8" A0AV02 3 125082636-125212864 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;thyroid gland: 20.5" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 22.7;granulocytes: 18.4;Mucus-secreting cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HHSteC: 18.2;OE19: 17.3;U-2197: 35.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031123 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031123: AB_2301872" "unprognostic (4.74e-2)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (5.91e-3)" "unprognostic (7.35e-3)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (3.76e-2)" "unprognostic (1.01e-1)" "unprognostic (7.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.13e-2)" "prognostic unfavorable (5.56e-4)" "unprognostic (7.18e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-2)" 1.1 1.1 11.1 0.7 19.4 0.0 2.0 0.8 7.0 1.2 3.0 1.7 0.4 4.9 0.4 2.9 3.5 1.7 8.1 0.5 3.8 1.2 2.1 5.7 1.9 0.4 1.0 3.6 0.5 9.0 8.2 1.9 2.2 8.6 2.5 4.1 6.2 10.0 0.4 1.8 1.0 3.4 0.4 1.3 0.4 3.8 4.6 2.0 0.4 20.5 0.4 0.7 1.9 1.7 0.2 0.2 1.8 0.5 0.0 0.2 0.0 8.2 0.0 1.4 0.0 1.7 2.4 4.1 0.4 1.0 0.4 0.9 10.7 3.9 0.0 1.0 3.7 1.4 5.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 18.2 0.0 0.6 4.7 5.0 1.4 0.5 9.7 0.0 0.0 0.0 0.3 0.6 2.2 0.0 0.0 5.7 17.3 0.4 0.0 0.1 0.0 4.2 0.6 2.4 0.0 4.8 5.1 0.1 0.6 9.1 0.2 0.1 0.1 0.7 35.3 0.0 0.1 1.0 2.7 1.7 0.0 0.7 1.8 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 19.4 0.8 7.0 3.8 1.2 1.0 3.6 8.6 2.0 0.0 0.3 0.0 1.1 0.9 0.0 1.0 0.0 0.0 1.2 22.7 0.0 0.3 0.0 3.9 0.2 0.0 2.0 0.0 2.9 6.2 1.3 5.0 18.4 6.4 0.8 0.0 5.2 0.0 0.0 0.0 0.0 0.6 0.0 3.6 28.6 0.0 4.3 2.9 0.0 1.1 0.0 0.0 0.3 0.7 0.4 0.3 2.5 0.0 5.0 0.9 SLC12A9 CIP1 ENSG00000146828 "Solute carrier family 12 member 9" Q9BXP2 7 100826820-100867009 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 72.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-BR-3: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067536 Approved NA NA "HPA067536: AB_2732768" "unprognostic (6.53e-2)" "unprognostic (3.65e-1)" "unprognostic (8.75e-3)" "unprognostic (3.11e-3)" "unprognostic (3.47e-2)" "unprognostic (2.37e-2)" "unprognostic (8.38e-3)" "prognostic favorable (5.97e-4)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.00e-4)" "unprognostic (2.47e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (4.92e-4)" "unprognostic (1.52e-2)" "unprognostic (6.00e-2)" "unprognostic (6.74e-3)" "unprognostic (6.38e-2)" 11.3 12.1 10.6 13.4 12.7 10.5 9.0 7.3 14.2 11.0 12.8 26.8 12.7 12.4 11.9 7.5 11.8 10.2 18.2 6.3 11.7 9.8 12.0 9.2 12.7 16.3 18.3 9.6 10.2 16.7 12.5 6.2 21.8 13.8 11.1 9.2 7.6 11.8 11.5 3.7 11.9 13.2 10.3 19.8 19.5 10.8 4.8 13.9 8.8 9.5 6.5 14.5 13.6 8.5 1.3 5.1 2.9 4.0 0.3 0.8 1.6 8.1 6.4 2.1 17.6 6.5 4.0 22.5 4.2 7.8 6.2 8.7 9.0 13.8 5.7 13.5 7.6 9.9 8.7 3.7 8.9 1.6 6.2 6.2 2.1 5.9 6.4 8.1 2.6 9.2 9.6 5.2 4.9 4.9 4.9 11.9 4.6 5.1 3.1 8.6 25.5 2.8 12.6 4.2 16.7 12.9 6.6 2.2 9.0 6.1 7.2 3.6 8.4 4.5 32.2 8.5 3.7 4.0 9.8 7.2 7.6 7.6 12.5 7.3 1.6 6.6 1.9 5.3 8.9 9.1 0.0 2.9 0.0 0.5 3.8 0.8 1.3 0.2 0.3 5.1 1.3 0.5 0.3 2.9 0.3 4.0 2.5 0.6 1.6 10.6 12.7 7.3 14.2 11.7 9.8 18.3 9.6 13.8 13.9 3.0 17.3 13.7 10.7 9.7 4.9 2.0 5.1 2.7 11.4 17.4 2.0 72.5 0.0 11.9 0.4 10.5 12.3 0.0 11.6 19.9 8.9 8.6 1.1 5.5 27.7 6.4 10.9 11.6 16.2 0.6 8.3 23.4 8.5 10.0 11.1 20.0 11.7 23.0 6.0 11.2 6.0 12.9 7.5 1.4 8.2 9.9 42.0 11.5 16.2 10.2 SLC13A1 "NAS1, NaSi-1" ENSG00000081800 "Solute carrier family 13 member 1" Q9BZW2 7 123113531-123199986 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sulfate transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 67.5" "Cell type enriched" "Detected in some" 17 "Proximal tubular cells: 400.4" "Cancer enriched" "Detected in single" 219 "renal cancer: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.0" "Region enriched" "Detected in single" 5 "cerebellum: 0.9" "Low region specificity" "Detected in all" "HPA053615, HPA062714" Enhanced NA NA "HPA053615: AB_2682207, HPA062714: AB_2684846" "unprognostic (1.86e-1)" "prognostic favorable (8.95e-5)" "unprognostic (1.71e-1)" "unprognostic (3.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 67.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.0 0.9 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.8 0.1 0.6 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.0 0.0 0.0 23.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 400.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC13A2 NaDC-1 ENSG00000007216 "Solute carrier family 13 member 2" Q13183 17 28473293-28497781 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 181.4" "Cell type enhanced" "Detected in some" 18 "Cholangiocytes: 28.1;Enterocytes: 37.5;Mucus-secreting cells: 25.2;Proximal tubular cells: 82.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;RPMI-8226: 2.4;SH-SY5Y: 1.2;SK-BR-3: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA014963 Enhanced NA NA "HPA014963: AB_1857096" "unprognostic (8.47e-2)" "unprognostic (7.63e-3)" "unprognostic (4.36e-3)" "unprognostic (2.06e-1)" "unprognostic (2.36e-3)" "unprognostic (3.06e-1)" "unprognostic (2.28e-4)" "unprognostic (1.50e-1)" "unprognostic (1.74e-1)" "unprognostic (1.00e-2)" "prognostic favorable (9.00e-4)" "unprognostic (2.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.50e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 1.4 0.1 0.1 0.1 142.8 0.0 10.7 34.6 0.1 0.5 0.1 0.1 3.4 0.1 0.1 0.1 12.5 0.3 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 1.8 0.0 14.9 17.1 0.1 2.1 181.4 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.7 0.1 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 28.1 0.0 0.0 3.5 11.8 0.0 8.3 0.0 0.0 0.0 37.5 0.0 6.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 25.2 0.0 0.2 8.6 0.0 82.9 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 13.9 0.3 SLC13A3 "NADC3, SDCT2" ENSG00000158296 "Solute carrier family 13 member 3" Q8WWT9 20 46557823-46684467 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 128.6" "Cell type enhanced" "Detected in many" 25 "Cytotrophoblasts: 97.7;Proximal tubular cells: 272.5;Syncytiotrophoblasts: 66.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.0;EFO-21: 11.4;Hep G2: 32.6;HHSteC: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014333, HPA014353, HPA014736" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970" "unprognostic (1.07e-2)" "unprognostic (7.40e-2)" "unprognostic (5.59e-2)" "unprognostic (1.19e-2)" "unprognostic (3.34e-1)" "unprognostic (3.19e-2)" "unprognostic (2.15e-1)" "unprognostic (2.82e-2)" "unprognostic (1.66e-2)" "unprognostic (9.50e-2)" "unprognostic (1.92e-2)" "unprognostic (1.03e-1)" "unprognostic (8.94e-2)" "unprognostic (3.87e-1)" "unprognostic (1.17e-1)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" 0.7 0.9 2.6 0.5 6.2 0.4 0.9 2.5 3.6 0.9 0.5 15.1 0.0 0.4 0.9 0.7 0.6 1.1 0.9 0.6 3.4 3.1 128.6 7.0 0.8 0.5 9.3 2.1 1.8 3.0 0.4 0.6 12.9 6.5 2.3 0.5 8.1 1.7 0.6 0.6 1.0 0.4 0.9 7.8 0.5 1.7 2.7 5.6 0.0 0.8 0.0 0.6 1.0 0.4 0.6 2.4 2.7 0.4 0.7 0.9 0.0 0.0 0.0 0.9 3.3 5.1 4.8 10.0 2.1 1.2 1.1 0.9 0.0 0.0 0.1 11.4 0.1 0.0 1.2 0.0 1.5 2.7 0.0 0.3 3.9 0.2 32.6 11.4 0.0 2.9 6.5 4.5 6.6 3.3 3.2 0.0 0.0 8.7 0.2 0.0 0.3 0.0 0.4 6.1 0.2 0.0 0.1 0.0 0.0 0.7 0.2 0.4 0.1 0.0 2.4 0.5 0.6 1.7 0.1 0.1 0.1 2.4 5.2 0.0 0.3 0.6 0.0 0.4 0.0 0.2 2.7 0.4 0.3 0.9 0.2 0.2 0.4 0.3 0.3 0.1 0.6 0.6 0.6 1.3 0.7 0.3 2.4 0.3 0.0 2.6 6.2 2.5 3.6 3.4 3.1 9.3 2.1 6.5 5.6 0.0 2.1 0.0 1.1 1.1 0.7 0.5 0.0 5.3 0.0 7.0 0.0 97.7 13.3 0.1 17.2 0.2 0.0 0.0 0.8 4.5 1.1 3.2 0.0 11.6 8.1 0.0 0.0 0.0 0.8 22.8 2.8 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.4 272.5 0.2 0.0 0.3 1.1 0.9 0.5 66.4 0.0 0.0 0.5 SLC13A4 "SUT-1, SUT1" ENSG00000164707 "Solute carrier family 13 member 4" Q9UKG4 7 135681237-135729258 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 85.4;placenta: 44.8;retina: 23.5" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 657.3" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 85.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HDLM-2: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048582 Enhanced NA NA "HPA048582: AB_2680450" "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (9.70e-3)" "unprognostic (1.78e-1)" "unprognostic (7.69e-2)" "unprognostic (3.96e-6)" "unprognostic (3.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.56e-3)" "unprognostic (9.23e-2)" "unprognostic (2.89e-1)" "unprognostic (1.87e-1)" "unprognostic (2.30e-6)" "unprognostic (1.53e-1)" "unprognostic (3.07e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" 0.3 0.4 0.7 0.3 1.4 0.3 0.4 4.0 8.9 1.2 0.3 34.0 0.0 0.3 0.4 0.3 4.1 0.8 0.4 0.4 12.3 0.8 0.3 0.4 0.4 0.3 1.4 5.4 0.4 0.5 0.4 1.4 44.8 85.4 0.3 0.3 23.5 1.0 0.4 0.3 0.4 0.3 0.4 5.1 0.3 0.3 5.4 0.5 0.0 0.3 0.0 1.9 0.3 1.8 0.0 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 25.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 2.1 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 1.4 4.0 8.9 12.3 0.8 1.4 5.4 85.4 0.5 0.0 0.0 0.0 0.5 0.0 2.6 1.6 0.0 6.7 0.0 0.0 3.9 99.4 0.0 0.1 0.4 0.3 0.0 0.0 0.0 5.3 1.1 0.4 0.0 0.0 13.1 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.2 0.1 657.3 0.0 0.0 0.3 SLC13A5 "INDY, NACT" ENSG00000141485 "Solute carrier family 13 member 5" Q86YT5 17 6684713-6713567 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 65 "liver: 150.4;salivary gland: 153.9" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 374.3" "Cancer enriched" "Detected in some" 15 "liver cancer: 27.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 61 "Hep G2: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044343 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044343: AB_10961771" "unprognostic (8.46e-3)" "unprognostic (3.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.75e-2)" "unprognostic (7.33e-2)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (8.79e-3)" "unprognostic (1.32e-1)" "unprognostic (3.23e-1)" "unprognostic (1.26e-3)" "unprognostic (1.30e-3)" "unprognostic (3.78e-11)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (2.05e-2)" "unprognostic (2.04e-1)" 0.2 0.8 1.0 0.1 1.9 0.1 0.2 0.6 2.3 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.9 0.1 0.1 0.9 0.7 0.4 150.4 0.1 0.2 0.8 1.2 0.3 0.2 0.1 0.2 0.1 0.6 0.1 0.1 0.0 153.9 0.1 0.1 0.1 0.1 0.1 0.2 0.9 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.9 0.6 2.3 0.9 0.7 0.8 1.2 0.6 0.0 0.0 0.0 7.0 0.6 0.5 0.2 0.6 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 23.3 0.4 0.1 0.0 0.3 0.0 374.3 0.0 0.0 0.0 15.4 21.0 0.0 0.6 0.3 0.0 0.0 0.0 7.4 9.8 0.0 0.0 0.0 1.4 0.0 0.0 0.9 1.5 0.4 0.1 0.0 0.0 0.2 SLC14A1 "HsT1341, JK, RACH1, RACH2" ENSG00000141469 "Solute carrier family 14 member 1 (Kidd blood group)" Q13336 18 45687025-45752520 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 44.5;prostate: 64.7;urinary bladder: 29.6" "Group enriched" "Detected in some" 10 "Basal glandular cells: 246.2;Erythroid cells: 93.5;Glandular cells: 129.8;Urothelial cells: 212.7" "Group enriched" "Detected in many" 5 "glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 2.4;gdT-cell: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2" "Group enriched" "Detected in some" 5 "GAMG: 79.4;RT4: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059570, HPA077233" Supported Supported "Plasma membrane" NA NA "Plasma membrane" "HPA059570: AB_2684066, HPA077233: " "unprognostic (2.04e-1)" "unprognostic (2.56e-3)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (6.86e-2)" "unprognostic (1.84e-2)" "unprognostic (1.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.17e-2)" "unprognostic (9.99e-2)" "unprognostic (2.69e-1)" "unprognostic (1.42e-1)" "unprognostic (3.02e-2)" "unprognostic (2.31e-1)" "unprognostic (1.52e-1)" "unprognostic (9.09e-2)" "unprognostic (6.93e-2)" 2.2 2.1 15.6 1.5 21.5 10.3 2.4 4.6 24.2 2.9 1.6 33.7 0.0 1.9 1.1 1.4 1.1 1.0 8.7 8.2 33.7 11.7 10.1 1.5 4.1 2.4 28.0 23.4 1.0 1.5 1.2 0.4 2.0 44.5 64.7 1.8 0.0 2.6 3.2 3.4 1.7 2.1 3.9 34.9 2.6 2.0 1.0 44.0 0.0 3.6 0.0 2.6 29.6 3.0 0.7 0.3 2.4 0.1 1.8 7.2 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 79.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 1.1 0.0 0.0 0.7 0.3 0.3 0.1 0.1 2.4 2.0 0.0 0.1 0.6 2.0 2.4 0.0 0.7 0.5 3.4 0.4 1.8 0.0 0.3 7.2 1.1 15.6 21.5 4.6 24.2 33.7 11.7 28.0 23.4 44.5 44.0 0.0 1.1 1.3 246.2 0.2 0.3 6.7 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.7 0.0 93.5 0.2 0.0 0.1 129.8 0.0 0.0 0.1 0.0 0.0 17.8 1.2 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 5.7 0.0 212.7 SLC14A2 "HUT2, UT2" ENSG00000132874 "Solute carrier family 14 member 2" Q15849 18 45212995-45683686 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.3;kidney: 5.7" "Cell type enriched" "Detected in some" 5 "Collecting duct cells: 73.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.1" "Cell type enhanced" "Detected in some" "eosinophil: 3.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "U-266/70: 7.2" "Region enriched" "Detected in some" 4 "basal ganglia: 17.9" "Not detected" "Not detected" NA NA "unprognostic (2.33e-1)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.54e-2)" "unprognostic (7.80e-2)" "unprognostic (1.11e-2)" "unprognostic (7.89e-3)" "unprognostic (3.76e-3)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (1.27e-3)" "unprognostic (8.96e-2)" "unprognostic (3.50e-3)" "unprognostic (1.20e-1)" "unprognostic (7.64e-2)" "unprognostic (7.52e-2)" "unprognostic (6.62e-2)" 1.8 1.0 0.0 0.1 0.4 0.6 0.9 0.0 0.7 0.1 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.3 0.1 0.1 5.7 0.0 0.2 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.4 1.2 0.0 0.0 0.2 0.1 1.3 1.0 0.0 0.1 0.1 0.4 0.4 3.3 0.3 0.4 0.8 0.1 0.2 0.4 0.4 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.4 0.4 0.8 0.2 0.1 0.4 0.3 0.0 0.0 0.1 0.4 0.2 0.4 0.7 0.0 0.1 1.1 0.4 0.1 0.1 0.1 0.1 0.4 0.2 0.4 0.3 0.6 0.0 0.3 0.4 0.5 0.3 0.2 0.4 0.3 0.1 0.7 0.1 0.4 0.6 0.1 0.2 0.1 0.1 0.2 0.1 0.3 0.3 0.4 0.3 1.0 0.4 7.2 0.4 0.3 0.4 1.1 0.3 1.4 0.3 3.3 0.3 0.2 0.2 0.4 0.2 0.3 0.1 0.4 0.2 0.3 0.8 0.4 0.2 0.4 0.8 0.1 6.0 14.8 0.0 0.5 0.6 1.2 0.5 0.0 2.7 3.4 73.3 2.0 0.3 0.0 0.0 0.9 0.7 1.1 0.0 0.0 0.2 1.1 0.3 3.5 0.0 0.3 1.6 0.0 1.8 0.3 1.0 0.6 0.8 1.7 0.0 0.3 0.8 0.1 0.0 0.7 0.0 1.7 0.0 0.0 0.5 0.4 0.1 0.7 0.0 0.0 0.4 SLC15A1 "HPECT1, HPEPT1, PEPT1" ENSG00000088386 "Solute carrier family 15 member 1" P46059 13 98683801-98752654 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "intestine: 134.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 30.6;Enterocytes: 51.2;Hepatocytes: 29.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CAPAN-2: 30.1;SK-BR-3: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002827 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002827: AB_1856974" "unprognostic (8.76e-2)" "unprognostic (1.87e-1)" "unprognostic (4.72e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (6.26e-2)" "unprognostic (7.83e-2)" "unprognostic (5.47e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-1)" "unprognostic (6.79e-2)" "unprognostic (6.88e-4)" "unprognostic (2.11e-2)" "unprognostic (2.84e-1)" "unprognostic (2.64e-1)" "unprognostic (9.01e-2)" "unprognostic (3.87e-2)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.1 51.7 0.2 0.3 42.7 1.9 2.2 0.9 0.1 16.6 0.1 0.1 0.1 6.3 8.2 0.2 0.1 0.1 0.1 0.2 7.1 4.3 0.3 1.0 0.3 0.9 0.5 0.2 0.3 0.3 0.1 9.9 134.9 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.7 0.4 0.5 1.9 1.1 1.1 2.3 0.7 1.2 0.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.9 30.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 6.8 0.0 0.0 0.0 1.7 1.7 0.6 0.1 0.3 0.0 29.9 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.7 0.9 0.3 0.8 0.8 0.7 0.7 0.2 1.1 0.9 0.8 2.2 1.2 0.4 1.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 3.0 0.0 0.0 0.1 0.1 0.0 0.4 30.6 1.4 2.3 1.8 0.0 0.0 1.7 9.1 0.0 0.0 51.2 0.0 0.7 0.0 0.0 0.8 0.0 29.9 0.1 0.0 3.5 0.6 0.3 0.0 0.0 0.0 1.7 0.0 1.7 0.0 2.9 5.8 0.0 9.8 0.0 0.0 0.2 0.0 0.2 0.6 0.1 0.0 1.7 0.3 SLC15A2 PEPT2 ENSG00000163406 "Solute carrier family 15 member 2" Q16348 3 121894089-121944102 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 35.2;ductus deferens: 35.8" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 92.3;Club cells: 31.8;Muller glia cells: 64.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 8.4;U-937: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.72e-2)" "prognostic favorable (2.37e-4)" "unprognostic (3.50e-2)" "prognostic favorable (6.96e-4)" "unprognostic (1.80e-2)" "unprognostic (1.78e-1)" "unprognostic (8.03e-3)" "prognostic favorable (6.74e-4)" "unprognostic (3.21e-1)" "unprognostic (1.28e-1)" "unprognostic (9.92e-2)" "unprognostic (1.43e-1)" "unprognostic (5.53e-3)" "unprognostic (1.63e-1)" "unprognostic (2.58e-1)" "unprognostic (2.67e-2)" "unprognostic (4.60e-2)" 1.0 1.2 13.8 1.9 15.0 3.3 3.2 4.0 15.3 35.2 1.8 7.6 35.8 1.5 1.5 26.2 3.6 7.4 4.2 2.0 14.6 5.3 7.4 1.1 12.9 3.6 5.3 12.9 1.0 3.6 2.4 3.6 1.6 6.8 26.5 2.1 15.1 14.6 25.1 0.8 0.7 2.2 0.9 4.0 6.1 1.1 3.9 6.7 0.0 4.6 0.5 3.8 3.6 2.6 4.2 1.6 2.4 2.5 0.3 0.3 0.3 1.9 0.9 1.1 0.4 1.3 0.7 1.4 0.2 0.1 0.5 0.6 1.8 3.2 3.5 0.2 0.1 0.6 2.1 0.8 1.9 0.6 2.8 0.6 5.0 1.3 0.8 0.2 5.3 5.0 1.1 5.5 0.6 0.4 0.6 0.3 1.0 0.8 1.5 0.6 1.4 1.0 8.4 5.8 2.1 0.5 1.2 0.5 1.0 1.3 1.2 0.4 0.4 0.5 0.3 0.1 1.7 0.3 4.7 0.1 0.4 0.3 0.4 0.4 1.9 0.5 5.0 0.6 7.1 0.5 2.4 1.1 0.4 0.3 0.4 0.3 3.3 0.3 0.2 0.3 4.2 0.3 0.3 0.6 0.3 2.5 1.6 0.2 0.3 13.8 15.0 4.0 11.0 14.6 5.3 5.3 12.9 6.8 6.7 92.3 21.4 4.4 2.1 0.5 1.0 1.9 7.6 12.0 31.8 10.4 0.0 2.1 3.3 0.3 0.3 0.8 0.2 0.0 7.5 0.6 0.6 22.7 3.5 0.0 2.1 0.0 0.0 1.3 10.0 0.6 6.1 3.8 0.0 1.0 1.0 64.9 2.6 0.0 4.9 1.1 2.4 0.0 0.1 0.5 0.1 0.5 1.1 0.0 0.6 8.2 SLC15A3 "hPTR3, PHT2" ENSG00000110446 "Solute carrier family 15 member 3" Q8IY34 11 60937084-60952530 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Hofbauer cells: 82.1;monocytes: 92.8;Muller glia cells: 202.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 36.4;BJ hTERT+ SV40 Large T+ RasG12V: 44.2;HHSteC: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047880, HPA057642" Approved Supported Vesicles NA NA Vesicles "HPA047880: AB_10959455, HPA057642: AB_2683487" "unprognostic (5.61e-2)" "prognostic favorable (4.07e-5)" "unprognostic (8.79e-2)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (9.33e-3)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (9.78e-3)" "unprognostic (6.47e-2)" "unprognostic (4.42e-2)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" 27.2 7.5 7.7 23.5 8.3 36.8 9.3 2.0 7.0 11.0 16.3 10.6 8.1 9.0 10.3 7.4 12.0 8.6 15.4 11.1 8.2 5.4 8.9 9.1 30.1 24.2 12.2 5.9 16.1 6.6 1.9 5.0 26.6 9.8 10.2 6.7 13.2 5.8 5.5 4.0 4.2 14.0 9.7 12.6 40.0 9.8 5.0 8.3 8.6 5.6 6.5 19.3 11.4 9.3 5.0 10.8 15.0 12.5 0.1 1.4 2.2 3.4 0.1 1.3 0.0 7.7 5.5 13.4 0.8 13.5 36.4 44.2 0.0 1.7 5.6 0.1 5.9 9.3 1.1 0.0 0.4 1.3 5.6 0.0 0.1 0.1 0.2 21.4 0.2 0.5 3.9 0.1 9.8 0.0 0.1 2.1 0.0 0.0 1.1 2.3 0.2 0.0 0.8 6.4 0.0 0.2 2.4 0.1 1.7 0.0 0.8 0.0 0.0 1.7 6.8 0.6 0.3 2.8 4.3 0.0 0.2 1.1 0.8 0.1 0.0 0.0 3.5 2.3 0.1 9.7 0.0 9.5 0.9 0.1 12.5 0.1 5.0 0.0 0.0 6.0 2.4 1.3 1.4 15.0 0.1 6.4 10.8 0.0 2.2 7.7 8.3 2.0 7.0 8.2 5.4 12.2 5.9 9.8 8.3 8.9 19.9 9.3 0.2 1.4 1.3 1.7 0.0 0.0 2.3 0.0 0.0 3.1 0.0 0.3 5.5 10.1 0.0 0.0 1.9 10.4 4.1 0.2 15.0 2.4 82.1 4.8 0.0 16.0 47.0 2.9 7.5 37.0 1.7 92.8 0.9 202.1 1.2 0.9 4.6 0.0 4.2 12.9 3.5 0.5 0.7 1.3 2.2 0.0 0.9 0.3 SLC15A4 "PHT1, PTR4" ENSG00000139370 "Solute carrier family 15 member 4" Q8N697 12 128793191-128823983 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 67.3;Late spermatids: 84.4;Muller glia cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 20.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016713 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA016713: AB_1856978" "unprognostic (3.12e-1)" "unprognostic (1.00e-1)" "unprognostic (3.63e-2)" "unprognostic (1.10e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (8.45e-4)" "prognostic unfavorable (6.78e-4)" "unprognostic (5.14e-3)" "unprognostic (6.39e-2)" "unprognostic (1.50e-1)" "unprognostic (2.26e-1)" "unprognostic (2.06e-2)" "prognostic unfavorable (7.56e-6)" "unprognostic (1.28e-1)" "unprognostic (2.06e-1)" "unprognostic (2.34e-2)" "unprognostic (2.57e-1)" 12.7 7.0 6.6 11.4 7.3 17.6 10.7 8.7 10.2 11.6 8.8 16.0 4.2 5.4 17.2 5.7 9.1 12.3 10.0 9.8 8.4 5.0 8.1 20.4 10.9 14.8 13.8 6.6 10.4 8.2 8.4 6.2 8.8 9.7 7.4 5.4 16.1 8.4 8.8 35.1 9.7 8.2 12.2 10.2 12.2 7.9 27.8 10.1 29.7 9.1 7.3 17.8 11.9 10.5 2.0 20.1 12.1 2.4 4.2 5.0 1.7 6.2 10.3 2.6 5.7 23.4 15.2 9.7 10.9 9.2 7.9 9.0 4.6 9.1 22.8 5.7 9.5 7.9 7.1 7.2 6.7 8.6 11.1 6.6 3.1 6.2 8.2 24.4 10.5 3.3 9.8 12.4 6.5 17.2 23.5 5.4 4.6 5.1 14.4 16.0 4.3 5.4 2.7 9.3 6.8 6.0 4.6 5.7 8.8 15.2 8.0 4.7 3.9 4.4 8.4 11.6 7.4 11.3 2.9 8.1 8.7 4.9 4.3 6.6 4.8 10.6 10.5 11.7 7.4 0.1 0.0 1.8 4.4 5.0 2.4 2.5 1.9 0.9 2.9 1.1 2.0 1.0 2.5 12.1 4.2 1.0 20.1 0.4 1.7 6.6 7.3 8.7 10.2 8.4 5.0 13.8 6.6 9.7 10.1 17.9 10.1 9.7 6.1 9.2 10.3 8.3 5.1 0.0 6.8 21.0 11.8 4.5 1.7 21.0 67.3 4.8 5.5 0.0 9.4 4.8 9.8 7.2 11.5 16.3 18.7 14.3 10.4 13.5 21.5 84.4 11.5 18.6 23.6 19.0 4.3 87.4 19.6 4.9 12.7 3.7 15.6 6.5 9.2 8.0 10.6 8.0 3.3 19.2 6.1 6.0 SLC15A5 ENSG00000188991 "Solute carrier family 15 member 5" A6NIM6 12 16188485-16277685 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 12 "adipose tissue: 1.9;brain: 1.6;breast: 1.2;testis: 1.4" "Cell type enhanced" "Detected in single" 35 "Early spermatids: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041638 Uncertain NA NA "HPA041638: AB_2677590" "unprognostic (3.68e-3)" "unprognostic (1.64e-1)" "unprognostic (4.89e-6)" "unprognostic (1.34e-1)" "unprognostic (1.72e-3)" 1.9 0.0 1.1 0.0 0.7 0.0 1.2 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC16A1 "MCT, MCT1" ENSG00000155380 "Solute carrier family 16 member 1" P53985 1 112911847-112957013 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 149.2;Muller glia cells: 221.8;Rod photoreceptor cells: 246.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003324, CAB017489, HPA071055, CAB079035" Enhanced Supported Enhanced "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337" "unprognostic (1.19e-1)" "unprognostic (1.61e-2)" "unprognostic (2.97e-1)" "prognostic unfavorable (8.37e-6)" "unprognostic (1.53e-1)" "unprognostic (2.89e-2)" "unprognostic (2.15e-3)" "prognostic unfavorable (4.05e-4)" "unprognostic (6.92e-2)" "unprognostic (6.31e-3)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (6.78e-8)" "unprognostic (1.30e-1)" "unprognostic (2.31e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-3)" 11.6 7.2 17.4 8.7 19.5 3.1 4.4 10.0 24.0 4.6 23.4 12.7 3.3 18.4 19.3 15.1 10.4 8.7 8.3 39.0 19.5 12.3 6.5 26.9 3.2 5.8 19.2 6.5 6.0 1.9 5.6 3.7 18.8 16.6 8.3 18.1 22.8 2.5 6.5 31.4 7.5 9.5 20.0 16.1 4.8 14.5 17.9 22.5 4.9 5.4 17.7 6.2 9.6 6.2 3.0 5.9 0.6 3.2 2.0 11.4 2.4 20.2 4.7 14.6 12.4 10.1 8.6 48.0 10.9 8.3 8.6 13.9 16.0 11.8 22.2 15.3 9.9 6.4 19.4 20.4 20.3 16.3 13.9 20.7 18.2 12.9 18.6 17.9 23.2 1.9 12.0 24.9 12.7 25.0 13.9 20.8 11.6 23.0 14.8 9.6 3.9 13.6 11.7 47.2 5.6 15.2 12.2 23.0 15.3 10.6 0.4 16.2 8.5 21.2 0.6 16.2 21.9 0.9 8.8 14.0 8.3 14.6 16.3 16.1 7.8 6.8 22.4 24.1 14.7 10.2 0.6 3.2 0.0 4.1 2.6 6.3 3.0 4.1 4.4 5.9 2.1 4.4 3.8 0.3 2.0 0.7 1.0 11.4 2.4 17.4 19.5 10.0 24.0 19.5 12.3 19.2 6.5 16.6 22.5 0.0 1.6 15.2 6.7 79.3 17.1 109.7 5.1 0.0 1.2 0.0 149.2 57.9 0.0 2.0 102.1 20.4 27.6 0.0 2.9 62.5 30.5 13.5 9.2 34.7 13.7 19.1 3.4 8.0 9.1 75.6 10.9 4.8 37.1 1.8 14.9 221.8 5.1 5.7 7.1 10.2 246.9 0.0 20.6 35.1 10.2 34.5 38.4 6.9 13.6 0.9 SLC16A10 "MCT10, TAT1" ENSG00000112394 "Solute carrier family 16 member 10" Q8TF71 6 111087503-111231194 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 25.1;skeletal muscle: 33.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 26.2;Melanocytes: 42.2" "Cancer enriched" "Detected in many" 6 "testis cancer: 4.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.7" "Lineage enriched" "Detected in single" 5 "T-cells: 4.7" "Cell line enhanced" "Detected in many" "HAP1: 29.4;HEK 293: 12.7;RPMI-8226: 24.2" "Low region specificity" "Detected in many" HPA016860 Approved Supported "Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" "HPA016860: AB_2189211" "unprognostic (2.03e-1)" "unprognostic (2.08e-1)" "unprognostic (6.11e-2)" "unprognostic (3.56e-4)" "unprognostic (2.24e-1)" "unprognostic (2.15e-1)" "unprognostic (1.64e-1)" "unprognostic (1.89e-1)" "unprognostic (1.86e-3)" "unprognostic (5.22e-1)" "unprognostic (1.74e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-3)" "unprognostic (2.73e-1)" "unprognostic (1.60e-1)" "unprognostic (1.33e-1)" "unprognostic (1.91e-1)" 7.6 4.9 1.8 2.4 5.4 0.4 1.1 9.5 2.0 0.8 4.8 1.7 1.7 7.6 0.7 1.6 0.7 1.1 1.0 2.8 1.8 1.0 8.1 9.8 6.1 1.8 0.8 0.5 1.2 25.1 8.9 1.5 17.4 5.6 1.2 1.3 3.6 3.5 6.0 33.4 12.1 6.0 0.8 1.0 2.7 3.9 3.5 0.8 19.6 2.2 1.5 0.9 4.4 1.4 0.5 0.3 0.8 0.2 0.3 4.7 0.3 0.6 0.6 0.2 1.3 0.0 0.0 2.4 0.0 0.1 0.5 0.8 5.1 0.2 4.1 0.9 0.1 1.4 0.0 29.4 0.0 0.5 0.1 12.7 4.7 0.3 4.8 0.0 5.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 6.8 0.8 0.1 0.0 2.0 6.2 0.7 9.0 0.1 1.9 3.5 4.3 24.2 0.0 0.4 6.8 2.1 0.1 0.6 1.1 2.3 1.2 0.8 0.0 0.1 1.1 0.3 1.6 2.0 0.0 1.1 0.2 3.8 0.5 0.8 0.2 0.1 0.2 0.2 0.2 0.2 1.1 0.3 0.0 0.5 4.7 4.0 0.8 0.3 0.1 0.3 4.0 0.3 1.8 5.4 9.5 2.0 1.8 1.0 0.8 0.5 5.6 0.8 8.9 26.2 0.9 10.0 8.7 6.2 7.7 0.0 1.4 5.7 5.2 2.0 1.1 1.7 0.1 7.2 0.7 3.9 0.0 11.1 1.7 2.5 2.8 1.1 19.7 20.5 1.6 6.3 5.5 13.5 5.2 0.0 14.3 42.2 1.0 2.8 1.7 3.1 0.0 0.0 15.2 0.6 0.0 1.0 9.8 9.8 12.9 1.0 0.5 5.0 0.9 SLC16A11 "FLJ90193, MCT11" ENSG00000174326 "Solute carrier family 16 member 11" Q8NCK7 17 7041630-7043923 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid metabolism, Symport, Transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 11.9;Muller glia cells: 29.4" "Cancer enhanced" "Detected in many" "liver cancer: 12.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 8 "B-cells: 2.9;T-cells: 3.8" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;NB-4: 1.6;U-266/84: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (4.65e-4)" "unprognostic (9.40e-3)" "unprognostic (6.10e-2)" "unprognostic (8.85e-2)" "unprognostic (6.97e-5)" "unprognostic (5.22e-3)" "prognostic favorable (2.56e-4)" "unprognostic (2.22e-3)" "unprognostic (5.38e-2)" "unprognostic (2.58e-1)" "prognostic favorable (1.45e-5)" "unprognostic (1.30e-2)" "prognostic favorable (3.19e-7)" "unprognostic (1.24e-1)" "unprognostic (1.83e-1)" "unprognostic (3.76e-1)" "unprognostic (5.83e-2)" 2.0 1.3 2.1 1.0 2.8 0.5 3.2 2.0 2.8 2.4 2.3 2.4 18.8 1.3 1.8 7.2 1.9 13.5 2.4 2.4 2.0 1.4 3.3 13.4 4.8 2.4 1.4 1.8 6.2 6.1 14.7 4.4 1.3 4.1 3.7 0.6 4.7 14.2 10.7 2.6 5.8 2.1 0.7 1.3 1.9 2.0 3.4 0.7 1.1 11.9 1.8 3.4 2.5 1.4 2.9 0.1 0.0 0.0 0.4 3.8 0.5 0.6 1.4 0.4 1.1 0.3 0.2 0.1 0.4 0.0 0.0 0.0 1.7 0.0 0.5 0.0 0.5 1.1 0.5 0.0 0.0 0.0 1.1 1.0 0.0 0.1 0.4 0.9 0.3 1.2 0.0 0.0 0.0 0.0 0.1 0.3 1.2 0.5 0.0 0.2 0.9 0.3 1.6 0.6 0.1 0.2 0.0 0.1 0.1 0.0 0.3 0.1 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.5 0.0 0.1 1.6 0.1 0.2 0.2 0.0 0.0 0.0 0.0 3.8 0.0 2.0 1.7 0.9 3.5 0.1 2.9 1.7 3.1 0.0 0.4 0.0 0.0 0.0 0.5 2.1 2.8 2.0 2.8 2.0 1.4 1.4 1.8 4.1 0.7 11.9 6.7 3.0 4.4 1.5 0.2 1.7 7.6 6.7 7.9 7.0 0.0 0.0 1.7 2.1 0.1 3.2 0.0 0.0 1.2 0.0 0.9 2.0 0.0 4.0 0.0 0.0 9.2 1.3 0.0 0.0 6.4 0.2 3.3 0.0 0.4 29.4 0.1 0.0 4.6 1.1 1.8 0.0 0.4 1.2 0.6 2.8 0.1 2.9 1.0 7.1 SLC16A12 MCT12 ENSG00000152779 "Solute carrier family 16 member 12" 10 89430299-89556641 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 28.0;kidney: 55.6" "Cell type enhanced" "Detected in many" 12 "Leydig cells: 25.0;Peritubular cells: 25.1;Proximal tubular cells: 55.2" "Cancer enriched" "Detected in many" 10 "renal cancer: 18.0" "Region enriched" "Detected in many" 6 "pons and medulla: 11.7" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "ASC TERT1: 22.8;HSkMC: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037587 Approved Mitochondria NA NA Mitochondria "HPA037587: AB_2732475" "unprognostic (5.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.79e-2)" "unprognostic (2.28e-2)" "unprognostic (3.51e-1)" "unprognostic (5.35e-2)" "unprognostic (2.45e-1)" "unprognostic (1.32e-1)" "unprognostic (1.78e-2)" "unprognostic (2.42e-1)" "unprognostic (9.60e-2)" "unprognostic (2.31e-1)" "prognostic favorable (4.50e-12)" "unprognostic (3.84e-2)" "unprognostic (7.91e-2)" "unprognostic (8.29e-2)" "unprognostic (1.84e-3)" 2.3 1.3 1.0 0.1 0.7 0.0 2.4 1.3 0.6 4.9 1.6 2.6 6.2 0.1 2.0 28.0 0.5 2.2 0.1 4.0 1.8 0.8 55.6 1.0 3.3 0.1 0.8 0.3 1.8 13.3 0.0 5.0 5.9 11.7 1.4 0.1 16.3 0.9 7.9 4.4 1.1 0.8 0.5 0.6 0.1 1.7 2.4 0.3 0.0 3.8 0.7 0.0 1.8 1.5 0.7 0.5 1.8 0.3 0.9 0.3 0.0 0.2 0.0 0.1 0.1 3.0 22.8 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.4 0.1 3.7 0.0 0.0 8.1 0.2 1.1 1.4 1.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.8 0.0 2.7 0.1 0.1 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.8 0.3 0.3 0.2 0.3 0.2 0.3 0.2 0.2 0.0 0.7 0.2 0.3 0.8 0.9 0.1 0.5 0.0 0.0 1.0 0.7 1.3 0.6 1.8 0.8 0.8 0.3 11.7 0.3 3.0 3.8 0.0 1.5 0.0 0.0 2.0 2.5 8.1 4.5 14.0 0.0 14.3 13.3 0.0 3.0 1.1 0.0 0.0 3.7 0.6 1.1 0.8 1.1 1.7 1.1 3.2 17.4 0.6 0.0 3.0 25.0 1.0 0.0 0.0 0.0 0.0 3.5 0.0 25.1 55.2 0.3 12.9 1.4 0.1 0.2 0.3 7.6 0.0 0.0 1.4 SLC16A13 MCT13 ENSG00000174327 "Solute carrier family 16 member 13" Q7RTY0 17 7036075-7040121 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 55.9" "Cell type enhanced" "Detected in some" 7 "Collecting duct cells: 5.2;Hepatocytes: 6.8;T-cells: 4.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 16.9;GAMG: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065245 Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA065245: AB_2685443" "unprognostic (5.61e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (1.78e-1)" "unprognostic (2.22e-3)" "unprognostic (9.53e-2)" "unprognostic (1.62e-1)" "unprognostic (8.72e-2)" "unprognostic (1.81e-1)" "unprognostic (2.60e-1)" "prognostic favorable (1.50e-4)" "unprognostic (2.44e-2)" "unprognostic (7.31e-3)" "unprognostic (9.70e-3)" "unprognostic (3.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.14e-1)" 2.5 1.3 1.4 3.5 0.8 0.2 1.6 1.5 1.0 1.8 4.9 0.7 1.2 8.0 1.1 1.4 5.0 1.5 3.2 1.3 1.2 0.7 12.0 55.9 2.9 7.6 0.8 0.5 1.7 2.8 2.7 1.0 3.3 0.7 1.5 1.3 1.8 3.5 1.5 0.5 4.5 10.2 0.7 0.6 4.8 1.6 0.7 0.3 3.6 3.0 2.4 5.8 1.8 2.4 6.8 2.8 2.4 2.2 2.7 3.9 1.3 9.5 16.9 4.0 2.4 2.5 1.4 1.7 1.0 2.5 2.2 5.0 5.4 10.7 6.1 1.6 1.5 20.0 15.0 3.1 5.2 0.9 7.5 2.1 2.5 1.3 13.0 2.8 0.8 5.8 1.6 6.0 3.3 2.7 2.9 8.9 5.5 2.8 1.7 2.3 4.7 3.6 1.5 1.6 4.9 1.3 1.7 1.4 1.0 2.1 2.7 0.1 1.1 3.0 1.7 1.3 6.2 4.6 1.3 3.3 1.4 3.3 2.3 1.4 3.0 6.3 0.3 4.1 2.2 0.6 0.0 2.0 2.2 3.2 1.9 2.3 2.3 2.9 3.9 2.1 6.8 3.1 2.9 2.4 2.7 2.2 2.8 3.0 1.3 1.4 0.8 1.5 1.0 1.2 0.7 0.8 0.5 0.7 0.3 0.0 1.0 2.2 0.7 0.5 0.1 0.3 0.0 1.4 0.0 5.2 0.0 1.6 0.0 0.8 0.0 1.8 1.5 0.0 0.2 0.4 0.4 0.7 3.5 6.8 0.4 3.2 0.0 2.5 0.3 0.0 0.9 1.7 0.0 1.0 0.3 0.9 0.5 0.0 0.0 1.0 0.4 0.0 0.4 0.0 0.0 1.4 2.1 4.3 0.4 0.9 SLC16A14 "FLJ30794, MCT14" ENSG00000163053 "Solute carrier family 16 member 14" Q7RTX9 2 230034974-230068999 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 4.5;Suprabasal keratinocytes: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 12.0" "Lineage enriched" "Detected in single" 22 "granulocytes: 12.0" "Cell line enhanced" "Detected in many" "HL-60: 16.7;Karpas-707: 11.5;REH: 14.3;RPMI-8226: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040518 Uncertain Approved "Endoplasmic reticulum" No No "Endoplasmic reticulum" "HPA040518: AB_10794877" "unprognostic (2.99e-1)" "unprognostic (1.74e-1)" "unprognostic (2.63e-1)" "unprognostic (1.74e-3)" "unprognostic (2.20e-3)" "unprognostic (2.01e-1)" "unprognostic (4.96e-2)" "unprognostic (1.95e-1)" "unprognostic (3.15e-1)" "unprognostic (5.70e-3)" "unprognostic (1.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.03e-3)" "unprognostic (3.51e-1)" "unprognostic (2.39e-1)" "unprognostic (6.06e-2)" "unprognostic (2.10e-1)" 5.4 5.2 7.0 2.2 11.1 6.6 4.0 14.4 16.2 6.5 4.6 3.2 1.1 1.3 4.9 3.2 5.3 4.1 3.6 3.0 6.9 8.2 1.7 2.5 2.5 1.6 6.2 8.2 10.2 1.1 12.4 1.9 1.6 6.7 5.9 5.0 12.0 20.5 4.7 1.3 13.4 1.6 4.9 4.4 10.1 1.8 2.0 1.3 1.1 2.0 3.4 3.3 3.8 4.8 0.4 0.5 12.0 0.0 0.1 0.4 0.1 2.1 1.3 1.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.4 3.7 1.1 0.1 0.0 6.3 0.1 2.5 0.0 0.2 16.7 0.0 0.4 2.9 0.0 0.0 3.1 0.1 3.4 0.0 11.5 0.2 0.0 1.6 2.1 0.8 0.2 2.0 14.3 0.0 12.9 4.4 1.9 4.8 1.5 3.5 0.0 0.1 0.0 5.7 1.5 0.0 0.0 0.9 2.4 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.0 0.4 0.0 0.3 0.4 0.2 0.0 0.5 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 7.0 11.1 14.4 16.2 6.9 8.2 6.2 8.2 6.7 1.3 0.0 0.0 0.0 0.6 2.3 2.9 3.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.0 4.5 0.0 0.0 0.5 0.0 0.8 0.8 0.0 1.0 0.1 3.2 3.5 3.1 0.3 0.0 1.1 0.0 1.7 0.0 0.0 1.8 0.7 0.0 2.8 0.5 1.1 0.0 1.0 0.2 0.2 4.1 0.2 0.0 1.6 0.2 SLC16A2 "AHDS, DXS128, MCT7, MCT8, MRX22, XPCT" ENSG00000147100 "Solute carrier family 16 member 2" P36021 X 74421461-74533917 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 43.6" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 50.8;Peritubular cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "BJ: 34.4;GAMG: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072719 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA072719: AB_2686552" "prognostic unfavorable (8.88e-5)" "unprognostic (2.48e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-3)" "unprognostic (1.49e-1)" "unprognostic (1.58e-2)" "unprognostic (1.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.48e-1)" "unprognostic (2.54e-1)" "unprognostic (5.67e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (2.15e-2)" "unprognostic (1.89e-1)" "unprognostic (6.89e-3)" "prognostic unfavorable (3.16e-4)" 13.5 24.4 10.9 5.4 12.2 0.7 4.9 5.9 14.3 9.9 5.5 8.4 1.8 4.1 9.4 2.7 5.2 6.7 10.5 10.7 8.0 5.9 9.4 43.6 6.0 1.6 4.2 8.0 14.7 6.6 12.7 12.6 10.0 8.2 9.2 2.6 11.1 5.8 7.0 3.5 2.2 3.0 7.6 4.1 1.9 4.2 1.8 5.1 6.4 13.6 4.3 3.0 5.0 5.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.2 4.0 2.9 16.6 7.9 4.2 0.0 34.4 10.6 14.0 8.0 0.0 0.3 0.0 0.5 13.3 27.0 0.6 0.4 14.6 8.2 2.3 1.3 0.0 0.0 0.0 0.6 0.0 0.0 6.2 3.5 7.2 8.5 5.3 0.0 0.0 0.0 0.0 3.2 0.0 0.2 1.0 11.0 0.0 3.0 6.6 7.9 0.0 6.9 0.0 0.7 5.1 3.8 19.3 0.1 1.0 0.2 0.4 0.0 13.6 3.6 14.9 17.1 0.0 0.0 0.0 15.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 10.9 12.2 5.9 14.3 8.0 5.9 4.2 8.0 8.2 5.1 0.0 1.1 0.0 3.2 0.7 4.5 3.5 5.1 4.0 3.4 3.5 0.0 4.2 3.3 3.7 0.0 2.7 0.0 0.0 2.1 2.7 4.8 3.2 2.3 50.8 0.8 3.2 8.1 2.5 1.5 0.0 14.1 0.0 3.3 1.0 0.0 6.1 3.1 0.0 19.4 5.4 1.1 12.9 5.6 0.1 0.0 1.1 1.7 0.0 0.0 4.8 SLC16A3 "MCT3, MCT4" ENSG00000141526 "Solute carrier family 16 member 3" O15427 17 82228397-82261129 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.2" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 1393.3;Syncytiotrophoblasts: 626.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB017490, HPA021451" Approved Supported "Nuclear membrane,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane" "CAB017490: AB_2189333, HPA021451: AB_1853663" "unprognostic (2.49e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (4.31e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-3)" "unprognostic (4.26e-3)" "prognostic unfavorable (1.19e-7)" "prognostic unfavorable (2.02e-5)" "unprognostic (2.52e-1)" "unprognostic (2.09e-2)" "unprognostic (4.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.71e-7)" "unprognostic (2.27e-1)" "unprognostic (4.00e-2)" "unprognostic (8.00e-2)" "unprognostic (1.36e-2)" 10.4 4.8 3.9 16.9 5.2 11.2 8.8 1.0 5.2 8.0 10.5 3.8 1.7 8.0 4.8 4.7 12.4 5.0 10.4 7.4 4.1 3.8 10.9 3.7 19.0 14.2 9.6 0.6 8.3 3.9 1.4 3.6 36.7 8.4 6.9 4.3 42.9 8.1 4.8 81.2 2.1 8.0 4.5 8.0 17.3 13.9 12.7 6.9 3.9 8.7 7.3 11.0 13.0 7.4 3.7 10.3 40.4 12.4 9.9 6.2 5.4 11.5 5.8 0.1 0.1 2.6 8.3 11.5 48.2 29.7 34.3 38.9 2.7 30.2 0.1 38.0 34.0 29.7 4.1 4.1 69.9 14.4 20.7 0.2 22.0 42.9 50.4 44.2 32.3 27.2 17.1 10.3 23.0 10.6 45.1 18.6 0.4 0.1 6.8 29.7 3.1 0.3 31.8 0.4 4.8 47.0 0.1 0.5 7.6 18.1 0.5 0.7 0.3 46.4 41.3 0.6 4.8 6.0 27.2 32.2 68.4 1.1 1.0 50.3 22.1 0.3 1.0 33.5 20.4 0.6 17.5 12.4 34.6 4.1 11.7 6.2 3.7 3.5 4.6 10.3 2.8 1.8 2.2 40.4 9.9 11.8 6.1 3.0 5.4 3.9 5.2 1.0 5.2 4.1 3.8 9.6 0.6 8.4 6.9 8.9 12.7 14.3 34.8 5.8 9.7 4.8 7.6 14.7 14.8 54.1 3.9 56.0 0.0 116.4 3.0 22.8 93.3 0.0 16.0 1393.3 24.4 12.4 75.9 0.8 262.7 120.8 20.1 17.2 103.7 2.7 2.8 101.0 13.5 232.6 23.8 21.4 199.4 84.2 3.5 3.8 7.4 0.0 14.7 1.6 7.1 5.8 626.2 40.6 16.6 118.3 SLC16A4 "MCT4, MCT5" ENSG00000168679 "Solute carrier family 16 member 4" O15374 1 110362848-110391082 "Predicted membrane proteins" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.4;placenta: 76.5" "Group enriched" "Detected in many" 4 "Collecting duct cells: 68.0;Proximal tubular cells: 176.8" "Cancer enhanced" "Detected in all" "renal cancer: 35.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.0" "Group enriched" "Detected in many" 4 "B-cells: 5.0;granulocytes: 1.3" "Cell line enhanced" "Detected in many" "BEWO: 11.6;BJ hTERT+: 11.7;CAPAN-2: 17.3;HHSteC: 11.6;hTERT-RPE1: 25.2;SK-MEL-30: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046986, HPA060163" Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" NA NA "Microtubules, Cytosol" "Cytokinetic bridge" "HPA046986: AB_2679892, HPA060163: " "unprognostic (2.04e-1)" "unprognostic (1.69e-1)" "unprognostic (2.56e-1)" "unprognostic (2.77e-3)" "unprognostic (1.53e-1)" "unprognostic (2.22e-1)" "unprognostic (2.00e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.70e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.69e-4)" "unprognostic (3.68e-2)" "unprognostic (9.16e-2)" "unprognostic (1.71e-2)" "unprognostic (9.46e-2)" 3.8 2.4 1.9 2.1 2.8 0.6 3.4 2.3 1.7 2.7 4.5 2.9 2.7 4.7 2.3 11.9 4.3 2.4 9.6 4.0 2.6 2.1 61.4 7.9 6.1 1.4 2.7 1.4 21.3 0.8 0.5 3.5 76.5 6.9 3.7 0.9 17.3 1.9 3.2 1.1 0.8 14.0 1.8 3.6 2.0 2.5 4.0 1.8 0.0 8.0 1.3 1.3 3.1 3.0 5.0 0.1 1.3 0.6 0.0 0.7 0.3 0.2 5.5 1.2 1.8 4.0 7.8 11.6 3.0 11.7 1.0 2.9 1.7 17.3 0.3 3.3 9.4 0.1 0.3 0.0 1.1 1.1 0.3 1.4 0.3 1.1 1.7 11.6 0.3 0.3 5.7 0.1 1.7 0.1 25.2 2.4 0.4 0.2 0.6 1.9 0.5 0.2 0.3 0.3 0.0 0.2 0.1 0.8 0.1 2.0 0.2 0.7 0.4 0.3 5.6 17.8 5.6 0.3 0.0 0.2 0.7 0.4 0.2 0.8 0.3 0.0 0.9 0.6 0.2 3.2 0.0 0.6 0.3 0.5 0.2 0.2 5.0 0.6 0.1 0.1 1.0 0.6 0.7 1.3 0.0 0.2 0.0 0.2 0.3 1.9 2.8 2.3 1.7 2.6 2.1 2.7 1.4 6.9 1.8 11.9 17.3 3.2 5.2 2.7 11.1 1.1 15.3 0.0 5.7 68.0 5.9 28.5 3.3 2.9 0.4 4.4 1.3 23.3 0.8 29.3 13.9 2.7 4.7 4.5 3.7 3.2 3.4 3.1 1.0 1.1 16.7 0.8 10.1 1.0 0.9 2.3 1.3 0.2 11.0 176.8 17.7 0.0 5.2 3.0 2.0 3.1 29.4 4.6 0.5 5.0 SLC16A5 "MCT5, MCT6" ENSG00000170190 "Solute carrier family 16 member 5" O15375 17 75087727-75106162 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 45.5;Collecting duct cells: 83.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 8.4;neutrophil: 22.1" "Group enriched" "Detected in many" 6 "granulocytes: 22.1;monocytes: 8.4" "Cell line enhanced" "Detected in many" "A549: 23.1;OE19: 24.8;RPTEC TERT1: 24.7;RT4: 49.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.86e-2)" "unprognostic (1.18e-1)" "unprognostic (1.98e-1)" "unprognostic (2.51e-2)" "unprognostic (2.90e-2)" "unprognostic (2.72e-1)" "unprognostic (6.30e-2)" "unprognostic (2.55e-1)" "unprognostic (1.61e-1)" "unprognostic (5.26e-2)" "unprognostic (8.43e-3)" "unprognostic (8.07e-2)" "unprognostic (9.63e-2)" "unprognostic (3.53e-3)" "unprognostic (5.44e-2)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" 6.0 1.0 0.9 6.3 1.0 4.1 4.9 2.0 1.1 8.9 18.7 1.5 7.5 19.4 6.6 14.6 6.9 9.4 15.3 8.6 1.2 0.9 35.0 2.3 16.9 7.5 1.7 1.2 8.3 4.1 3.6 2.0 30.8 2.3 13.0 5.7 9.5 5.2 15.2 7.9 8.8 30.5 4.7 1.5 6.8 14.6 4.9 1.0 1.8 13.3 9.5 8.8 15.3 11.0 0.7 2.5 22.1 8.4 0.6 1.0 2.4 4.8 23.1 0.4 0.0 1.2 1.5 7.9 2.7 7.0 2.7 1.9 6.0 14.0 0.0 3.3 8.4 0.3 14.0 1.1 3.8 1.0 0.0 0.0 1.7 10.7 3.0 5.5 0.0 0.0 3.7 4.6 2.8 0.0 0.0 5.6 0.2 0.3 0.0 0.2 0.8 0.1 2.4 1.8 24.8 0.0 0.5 0.0 0.1 24.7 49.0 0.0 0.1 6.8 1.6 3.4 4.1 11.4 2.4 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.5 1.5 2.4 8.4 2.1 0.3 3.1 0.2 0.7 0.4 0.1 2.5 0.2 1.0 0.3 22.1 0.6 1.6 0.0 0.4 2.4 0.9 1.0 2.0 1.1 1.2 0.9 1.7 1.2 2.3 1.0 35.7 30.9 0.0 6.8 2.3 0.0 4.8 7.6 45.5 30.7 83.7 0.0 16.4 5.0 5.3 41.8 2.9 30.7 0.0 1.2 3.2 3.3 9.6 6.9 0.0 6.1 0.0 6.4 17.2 8.4 26.5 0.6 5.4 6.8 4.6 11.9 0.0 0.7 19.8 0.0 1.8 0.0 0.0 1.9 0.3 1.7 1.1 16.4 0.5 10.1 13.3 SLC16A6 "MCT6, MCT7" ENSG00000108932 "Solute carrier family 16 member 6" O15403 17 68267026-68291267 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 32.5" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 21.6;Kupffer cells: 17.4;Rod photoreceptor cells: 39.6" "Group enriched" "Detected in many" 6 "breast cancer: 10.9;melanoma: 11.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 13 "SK-MEL-30: 107.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA054459, HPA066328" Uncertain Approved Vesicles NA NA Vesicles "HPA054459: AB_2682494, HPA066328: AB_2685660" "unprognostic (2.53e-2)" "unprognostic (2.09e-3)" "unprognostic (8.41e-2)" "unprognostic (6.94e-2)" "unprognostic (3.10e-1)" "unprognostic (5.26e-3)" "unprognostic (5.08e-3)" "unprognostic (5.39e-2)" "unprognostic (1.63e-3)" "unprognostic (1.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.44e-2)" "unprognostic (8.78e-2)" "unprognostic (2.23e-1)" "unprognostic (8.16e-3)" "unprognostic (2.09e-2)" "unprognostic (9.46e-2)" 7.8 3.4 3.0 6.6 6.3 8.1 6.2 3.7 6.2 2.2 0.8 3.1 9.8 0.9 2.8 32.5 12.4 1.5 1.6 1.4 3.2 4.2 0.9 1.4 9.7 4.6 4.7 1.4 1.8 1.2 0.4 2.4 2.4 6.9 0.8 1.0 13.0 3.5 11.0 10.3 4.2 1.2 0.9 2.7 6.3 1.1 2.2 0.9 1.5 3.3 6.6 7.9 3.7 3.3 0.6 2.7 8.5 4.7 1.1 2.9 1.2 0.4 0.3 0.1 0.1 0.1 0.1 3.1 0.1 3.9 0.3 0.2 0.1 0.5 3.5 0.3 0.0 0.0 0.1 0.6 0.0 0.1 1.0 0.2 0.2 0.4 4.5 0.7 1.2 0.2 0.1 0.0 0.2 0.2 0.3 0.1 0.5 0.2 0.8 0.0 3.9 1.6 0.7 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.3 0.8 0.0 0.1 2.1 107.0 0.8 3.1 0.7 0.5 1.2 0.2 0.1 0.3 0.8 3.1 3.2 8.1 0.9 0.5 1.1 4.7 0.3 2.9 4.4 1.5 0.6 1.2 2.3 2.7 0.3 0.8 1.6 8.5 1.1 2.2 0.6 2.6 1.2 3.0 6.3 3.7 6.2 3.2 4.2 4.7 1.4 6.9 0.9 0.0 4.5 0.8 0.1 0.2 4.8 0.6 0.0 2.7 6.8 8.7 21.6 0.1 0.0 0.0 0.5 0.9 0.0 0.0 0.0 8.6 0.9 0.2 1.1 0.0 5.5 0.0 0.0 1.3 17.4 0.0 0.0 12.8 10.1 1.0 0.0 5.8 0.0 0.0 1.8 0.2 39.6 0.0 0.1 1.6 0.4 0.4 0.3 5.7 0.0 0.0 SLC16A7 MCT2 ENSG00000118596 "Solute carrier family 16 member 7" O60669 12 59596067-59789855 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 34.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 116.7;Cholangiocytes: 104.4;Early spermatids: 85.1;Late spermatids: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 64.5" HPA005911 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005911: AB_1853659" "unprognostic (1.52e-2)" "unprognostic (9.47e-3)" "unprognostic (9.48e-2)" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (5.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (8.39e-2)" "unprognostic (9.79e-2)" "prognostic favorable (8.85e-5)" "unprognostic (2.19e-3)" "unprognostic (3.11e-1)" "unprognostic (9.35e-2)" "unprognostic (2.45e-2)" 20.1 10.0 2.2 9.2 4.3 4.5 9.2 6.4 8.3 5.4 4.8 1.1 1.1 2.2 8.6 2.7 12.3 4.4 8.9 34.7 2.0 1.9 16.4 5.7 9.4 12.1 3.2 3.3 4.7 13.7 2.2 9.5 2.1 5.5 3.8 3.7 2.7 6.2 2.6 4.2 9.4 4.6 10.5 3.7 16.8 12.8 6.2 2.3 12.8 4.0 8.6 9.4 9.7 8.5 5.8 2.8 0.3 9.1 3.0 7.2 2.4 0.1 2.3 0.5 0.3 10.7 16.3 0.1 9.9 6.4 3.4 3.1 0.2 5.9 5.1 2.3 16.7 3.2 0.5 0.6 1.2 5.2 1.4 0.3 9.2 10.4 0.3 5.6 14.9 0.1 8.4 3.2 0.9 9.8 6.1 1.2 6.2 0.1 11.2 5.5 2.1 4.3 2.2 0.6 1.0 3.1 0.3 0.0 2.4 7.6 14.4 2.6 0.6 0.0 0.2 4.7 0.6 0.3 1.8 0.0 8.1 2.7 14.8 0.3 10.8 0.1 8.6 9.3 0.0 1.3 0.3 2.0 0.0 5.4 3.7 7.2 2.4 4.3 4.8 2.1 5.8 4.9 6.9 0.2 3.0 9.1 2.8 4.8 2.4 2.2 4.3 6.4 8.3 2.0 1.9 3.2 3.3 5.5 2.3 26.8 21.3 14.7 5.7 9.0 23.7 116.7 104.4 24.1 15.9 43.6 9.8 0.2 19.9 46.2 85.1 7.1 0.7 0.0 57.0 0.2 12.5 1.9 9.3 10.5 3.0 7.9 0.0 11.1 27.7 90.6 6.4 8.4 3.3 1.8 24.4 1.3 30.7 0.0 9.6 1.0 5.3 6.5 16.0 4.1 3.0 11.0 0.6 20.8 0.9 2.8 SLC16A8 "MCT3, REMP" ENSG00000100156 "Solute carrier family 16 member 8" O95907 22 38078134-38084093 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 70.9" "Cell type enhanced" "Detected in some" 9 "Leydig cells: 4.0;Melanocytes: 5.0;Spermatogonia: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.1;RT4: 4.5;SiHa: 6.5;T-47d: 7.8;U-266/70: 11.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075017 Enhanced Approved "Intermediate filaments,Focal adhesion sites" No NA "Focal adhesion sites" "Intermediate filaments" "HPA075017: AB_2732276" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (5.07e-6)" "unprognostic (2.99e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-2)" "unprognostic (2.99e-2)" "unprognostic (1.74e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.63e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-4)" "unprognostic (7.69e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (9.71e-5)" 1.6 2.6 1.9 0.8 5.1 1.2 0.8 0.8 3.3 0.8 0.8 0.8 0.8 0.5 1.3 0.8 1.1 1.2 2.7 2.9 2.7 2.9 0.8 0.8 0.8 0.9 2.8 0.8 0.8 2.1 0.0 2.6 0.8 1.3 4.0 0.0 70.9 10.0 0.8 1.9 4.2 0.8 0.8 3.7 1.8 2.3 2.0 0.8 0.8 0.9 0.8 0.8 1.6 0.8 0.0 0.0 0.0 0.0 0.5 0.6 0.0 1.4 0.7 1.2 0.2 0.0 0.0 6.1 0.5 0.0 0.0 0.0 1.3 3.5 0.4 1.7 0.0 0.1 0.8 0.0 0.0 0.0 0.0 1.9 0.3 1.0 0.1 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 1.6 0.0 4.0 0.0 0.0 1.4 0.1 0.1 2.0 0.0 0.0 0.0 4.5 2.0 0.3 6.5 0.3 1.0 0.6 7.8 0.2 0.0 0.0 3.6 0.3 0.0 11.5 1.6 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 5.1 0.8 1.2 2.7 2.9 2.8 0.8 1.3 0.8 0.0 0.0 0.0 0.5 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.8 0.0 0.0 1.3 0.3 1.6 4.0 0.0 5.0 0.0 0.0 0.9 0.2 0.0 2.1 0.0 0.5 0.0 0.9 0.9 4.1 0.6 0.0 0.0 0.0 0.1 SLC16A9 "C10orf36, FLJ43803, MCT9" ENSG00000165449 "Solute carrier family 16 member 9" Q7RTY1 10 59650761-59736002 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 58.0;kidney: 70.9" "Cell type enriched" "Detected in many" 7 "Proximal tubular cells: 218.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.9;SuSa: 8.8;U-251 MG: 8.3;U-937: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049286 Approved Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA049286: AB_2680699" "unprognostic (3.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-3)" "unprognostic (1.76e-2)" "unprognostic (5.96e-2)" "unprognostic (3.50e-3)" "unprognostic (5.01e-2)" "unprognostic (2.11e-3)" "unprognostic (5.99e-2)" "unprognostic (4.60e-2)" "prognostic favorable (2.56e-6)" "unprognostic (7.57e-3)" "unprognostic (1.27e-2)" "unprognostic (3.72e-1)" "unprognostic (1.94e-1)" 0.7 58.0 5.7 2.0 4.6 0.7 0.9 9.9 4.4 8.2 4.6 9.6 1.6 0.3 12.6 2.2 5.3 8.6 3.3 1.4 10.0 2.6 70.9 1.1 0.6 0.8 6.7 5.5 13.4 1.3 11.8 6.4 0.2 8.2 3.2 6.4 5.2 1.6 4.2 9.2 0.5 0.8 3.0 6.0 14.3 2.4 3.4 6.5 0.0 11.2 4.4 3.1 0.9 4.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 4.2 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.6 0.0 0.0 0.7 8.7 0.0 0.0 0.0 1.4 0.1 0.2 0.0 0.1 1.8 0.0 0.4 0.1 0.0 2.3 0.1 0.3 4.4 6.1 0.1 0.4 3.3 2.3 0.0 16.4 1.6 7.5 2.7 0.2 5.7 0.0 0.2 2.8 7.9 0.1 0.3 0.0 8.8 2.8 3.6 2.6 0.4 0.9 0.1 8.3 0.0 0.0 0.0 0.0 14.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.7 4.6 9.9 4.3 10.0 2.6 6.7 5.5 8.2 6.5 0.0 0.0 0.0 1.1 0.1 4.7 2.8 0.0 4.0 9.1 7.0 0.0 0.0 21.6 0.7 0.1 0.0 17.7 0.0 0.0 0.8 1.2 12.7 0.0 0.0 0.1 3.2 19.3 0.0 10.5 0.4 12.7 0.0 3.3 1.0 15.5 11.2 0.2 30.3 11.3 218.2 0.8 0.0 2.8 0.3 0.1 0.1 0.0 0.0 12.8 5.7 SLC17A1 "NAPI-1, NPT1" ENSG00000124568 "Solute carrier family 17 member 1" Q14916 6 25782897-25832059 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 56 "kidney: 67.6;liver: 17.9" "Cell type enriched" "Detected in some" 4 "Proximal tubular cells: 44.6" "Group enriched" "Detected in some" 150 "liver cancer: 7.6;renal cancer: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 389 "RPTEC TERT1: 38.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050513 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA050513: AB_2681152" "unprognostic (6.98e-2)" "unprognostic (2.99e-1)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (2.71e-3)" "unprognostic (1.32e-1)" "unprognostic (2.37e-1)" "unprognostic (4.74e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 67.6 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 44.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC17A2 NPT3 ENSG00000112337 "Solute carrier family 17 member 2" O00624 6 25912754-25930726 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 333 "liver: 80.2" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 29.7" "Cancer enriched" "Detected in some" 8 "liver cancer: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "Hep G2: 9.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA038270 Uncertain NA NA "HPA038270: AB_10672511" "prognostic favorable (8.54e-4)" "unprognostic (1.90e-2)" "unprognostic (4.14e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 SLC17A3 NPT4 ENSG00000124564 "Solute carrier family 17 member 3" O00476 6 25833066-25882286 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 62.3" "Cell type enriched" "Detected in some" 10 "Proximal tubular cells: 127.1" "Cancer enriched" "Detected in some" 17 "renal cancer: 57.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 1.1;MAIT T-cell: 1.9;memory CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Cell line enriched" "Detected in single" 217 "RPTEC TERT1: 51.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.31e-3)" "unprognostic (1.56e-2)" "unprognostic (2.51e-1)" "unprognostic (4.65e-2)" "unprognostic (5.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.07e-1)" "unprognostic (2.34e-1)" "unprognostic (1.34e-1)" "unprognostic (4.49e-1)" 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 62.3 13.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.9 0.0 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 6.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.4 0.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC17A4 KIAA2138 ENSG00000146039 "Solute carrier family 17 member 4" Q9Y2C5 6 25754699-25781191 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "gallbladder: 14.9;intestine: 24.6;liver: 27.2;pancreas: 14.2" "Group enriched" "Detected in some" 4 "Cholangiocytes: 86.6;Enterocytes: 45.7;Hepatocytes: 37.5;Paneth cells: 43.2" "Group enriched" "Detected in some" 6 "liver cancer: 11.0;renal cancer: 7.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 7 "RPTEC TERT1: 5.8" "Not detected" "Not detected" HPA055564 Approved NA NA "HPA055564: AB_2682852" "unprognostic (6.52e-2)" "unprognostic (5.64e-3)" "unprognostic (1.72e-1)" "unprognostic (2.43e-1)" "unprognostic (1.19e-3)" "unprognostic (1.40e-1)" "unprognostic (1.38e-1)" "unprognostic (7.27e-3)" 0.2 0.0 0.2 1.8 0.2 0.0 0.2 0.2 0.2 0.2 12.8 0.2 0.2 14.8 0.2 0.4 0.2 0.1 14.9 0.2 0.2 0.1 2.2 27.2 0.2 0.2 0.2 0.2 0.2 14.2 0.0 0.2 0.2 0.2 0.2 14.2 0.2 0.2 0.2 0.2 0.0 24.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.0 1.3 0.1 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.4 0.0 0.1 0.8 5.8 0.0 0.2 0.4 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.3 0.0 0.2 0.1 0.1 0.2 0.0 0.3 0.0 0.1 1.3 0.1 0.1 0.0 0.1 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 86.6 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.8 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 37.5 0.1 0.0 12.6 0.6 1.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.2 43.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 SLC17A5 "AST, ISSD, NSD, SD, SIALIN, SIASD, SLD" ENSG00000119899 "Solute carrier family 17 member 5" Q9NRA2 6 73593379-73654155 "Disease related genes, Predicted membrane proteins" "Amino-acid transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "parathyroid gland: 155.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 41.7;ASC TERT1: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044479 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA044479: " "unprognostic (6.48e-3)" "unprognostic (7.95e-3)" "unprognostic (9.23e-2)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (2.59e-3)" "unprognostic (4.44e-2)" "unprognostic (4.18e-2)" "unprognostic (2.60e-1)" "unprognostic (3.14e-2)" "unprognostic (8.29e-2)" "unprognostic (4.59e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "prognostic favorable (3.52e-4)" "unprognostic (1.09e-1)" 7.2 5.8 6.4 2.9 6.8 2.9 9.6 6.3 6.8 4.9 7.8 4.7 12.5 6.5 5.1 17.2 5.0 3.4 6.2 6.2 4.5 6.7 24.3 13.2 7.6 4.9 5.0 4.5 3.4 8.7 155.6 9.3 12.6 6.7 6.9 8.6 6.6 15.5 8.6 3.5 4.8 12.9 4.6 5.9 4.3 6.0 4.1 4.7 3.0 30.5 2.6 7.1 5.9 4.3 5.2 9.9 12.4 10.6 12.0 9.4 6.0 2.8 3.8 3.9 6.2 41.7 31.1 5.2 9.3 23.5 2.5 8.9 2.5 6.9 2.6 4.5 13.1 5.9 5.0 5.4 2.3 4.5 1.8 6.3 1.1 2.1 5.9 8.4 2.1 4.4 14.2 3.5 5.7 4.0 10.7 6.4 3.5 2.7 2.9 8.8 1.9 0.8 1.2 2.8 11.9 2.3 1.9 4.8 11.1 6.6 7.9 1.5 2.7 1.9 5.6 5.4 6.0 2.5 13.2 9.3 1.2 1.1 5.0 2.2 8.2 11.4 0.7 4.2 4.6 3.7 12.4 10.6 4.2 8.5 9.7 8.3 5.2 9.4 8.1 9.9 3.7 7.8 8.6 7.4 12.0 6.0 7.4 8.2 6.0 6.4 6.8 6.3 6.8 4.5 6.7 5.0 4.5 6.7 4.7 20.8 20.2 7.8 12.1 8.5 7.8 5.3 15.3 14.7 9.1 48.8 27.5 14.4 3.3 12.2 27.9 15.0 21.9 0.0 11.9 12.0 22.1 30.0 13.9 31.0 53.7 0.0 11.6 25.8 26.5 32.1 6.9 22.4 10.1 7.2 42.3 7.3 16.7 17.5 10.6 30.8 24.7 0.0 8.0 11.1 2.3 9.8 19.1 7.9 15.0 18.6 SLC17A6 "DNPI, VGLUT2" ENSG00000091664 "Solute carrier family 17 member 6" Q9P2U8 11 22338097-22379503 "Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 75.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 1.3;Horizontal cells: 1.6;Muller glia cells: 1.3;Rod photoreceptor cells: 2.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "hypothalamus: 20.2;pons and medulla: 75.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 222 "SCLC-21H: 26.6" "Group enriched" "Detected in many" 5 "basal ganglia: 54.1;hypothalamus: 163.2;midbrain: 206.4;pons and medulla: 90.5;thalamus: 180.7" "Low region specificity" "Detected in all" "CAB037130, HPA039226, CAB078204" Supported Supported NA NA "CAB037130: AB_477611, CAB078204: AB_2665794, HPA039226: AB_2676400" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" 0.5 0.5 7.6 0.5 1.1 0.5 0.5 0.2 13.8 0.5 0.5 1.3 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 1.1 20.2 0.5 0.5 0.5 0.5 7.1 2.1 0.5 1.5 0.5 5.3 0.5 75.2 0.5 0.5 1.4 0.5 0.5 0.5 0.5 0.5 0.5 5.9 0.5 0.5 0.5 0.0 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 1.1 0.2 8.4 1.1 20.2 7.1 2.1 75.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC17A7 "BNPI, VGLUT1" ENSG00000104888 "Solute carrier family 17 member 7" Q9P2U7 19 49429401-49442360 "Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "brain: 150.0" "Group enriched" "Detected in some" 27 "Bipolar cells: 377.4;Cone photoreceptor cells: 347.5;Rod photoreceptor cells: 343.9" "Cancer enriched" "Detected in some" 6 "glioma: 7.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 21.2;K-562: 6.7;REH: 3.9;SCLC-21H: 4.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 281.0;cerebellum: 378.0;cerebral cortex: 391.3;hippocampal formation: 626.6" "CAB037183, HPA050458, HPA063679" Enhanced Supported NA NA "CAB037183: AB_261840, HPA050458: AB_2681134, HPA063679: AB_2685086" "unprognostic (1.79e-1)" "unprognostic (3.35e-1)" "unprognostic (1.29e-1)" "unprognostic (1.52e-2)" "unprognostic (9.12e-2)" "unprognostic (3.03e-2)" "unprognostic (1.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.30e-1)" "unprognostic (2.70e-3)" "unprognostic (8.32e-2)" "unprognostic (6.61e-2)" "unprognostic (4.26e-12)" "unprognostic (8.36e-4)" "unprognostic (4.27e-1)" "unprognostic (1.35e-2)" "unprognostic (6.17e-3)" 2.1 1.2 58.3 1.0 27.6 1.0 1.7 52.7 150.0 1.3 1.3 1.5 0.0 1.1 1.2 1.2 1.4 1.3 1.3 1.4 74.3 1.7 1.1 1.0 1.1 1.3 6.0 36.4 1.0 1.0 1.0 0.1 1.0 20.0 1.0 1.2 9.1 1.1 1.1 1.4 1.6 1.3 1.2 0.9 1.0 1.1 1.5 0.0 0.0 1.2 0.0 1.2 1.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.4 1.7 0.3 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.2 0.3 0.5 1.3 0.1 1.9 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.1 0.3 0.0 0.4 0.0 0.3 6.7 1.0 0.0 0.2 0.0 0.1 0.0 0.2 0.3 3.9 0.1 0.1 0.0 0.0 4.9 0.4 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 2.4 0.9 0.0 0.4 0.3 0.3 0.6 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.3 27.6 52.7 76.0 74.3 1.7 6.0 36.4 20.0 0.0 0.0 0.0 0.0 0.1 1.1 377.4 2.4 0.0 0.0 0.0 0.0 347.5 0.1 0.0 0.0 4.0 0.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 11.1 0.0 0.0 0.0 0.0 6.1 0.3 1.7 0.0 0.0 13.3 0.1 0.0 0.4 0.0 343.9 6.5 2.8 1.0 2.3 0.5 0.0 0.0 0.0 0.0 SLC17A8 "DFNA25, VGLUT3" ENSG00000179520 "Solute carrier family 17 member 8" Q8NDX2 12 100357079-100422059 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Hearing, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 10.7;intestine: 12.4;lymphoid tissue: 3.9" "Group enriched" "Detected in some" 4 "Enterocytes: 4.1;Extravillous trophoblasts: 1.7;Kupffer cells: 3.5;Paneth cells: 1.4" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 2.1;RPTEC TERT1: 1.1;SuSa: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB079058 Supported NA NA "CAB079058: " "unprognostic (4.52e-3)" "unprognostic (2.18e-1)" "unprognostic (8.56e-2)" "unprognostic (1.32e-3)" "unprognostic (3.65e-1)" "unprognostic (7.67e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-2)" "unprognostic (8.89e-2)" "unprognostic (3.55e-1)" 0.1 0.3 2.0 0.1 3.7 0.1 0.1 0.0 10.7 0.1 1.1 0.0 0.0 1.8 0.4 0.2 0.1 1.0 0.1 0.1 6.9 2.2 0.3 1.2 0.2 0.1 0.8 1.0 0.2 0.2 0.1 0.4 1.0 3.6 0.1 1.0 1.7 0.1 0.1 0.1 0.1 12.4 0.1 0.5 0.1 0.2 0.4 0.1 3.9 0.1 0.0 0.1 0.6 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.4 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 2.0 3.7 0.0 10.7 6.9 2.2 0.8 1.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 SLC17A9 "C20orf59, FLJ23412, VNUT" ENSG00000101194 "Solute carrier family 17 member 9" Q9BYT1 20 62952647-62969585 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Exocytosis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.7" "Cell type enhanced" "Detected in many" 11 "B-cells: 28.5;Hepatocytes: 35.4;Hofbauer cells: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 7.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 16.0;CACO-2: 14.8;Hep G2: 30.7;NB-4: 16.5;RPMI-8226: 15.9;U-937: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA047470 Approved Nucleoplasm NA NA Nucleoplasm "HPA047470: AB_2680060" "unprognostic (2.65e-3)" "unprognostic (2.13e-1)" "unprognostic (7.08e-2)" "unprognostic (1.97e-1)" "unprognostic (4.33e-3)" "unprognostic (5.33e-2)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (1.00e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "prognostic unfavorable (2.78e-15)" "unprognostic (6.06e-3)" "unprognostic (5.51e-2)" "unprognostic (5.96e-2)" "unprognostic (1.06e-1)" 4.2 1.3 1.6 11.4 3.4 11.9 2.2 0.4 1.4 1.9 4.8 0.6 0.1 6.4 1.7 1.2 1.5 2.1 7.3 1.5 1.5 0.7 1.5 42.7 5.7 6.6 4.8 0.0 1.9 3.4 0.0 2.5 1.9 3.4 1.6 3.8 1.1 3.6 1.2 3.4 0.9 3.9 1.4 3.9 10.5 10.7 0.8 2.9 0.5 1.4 0.5 11.8 5.6 2.4 4.0 4.2 0.0 2.7 7.3 1.3 1.2 0.0 0.0 0.0 0.1 0.1 1.3 0.0 16.0 4.6 5.3 8.4 14.8 0.0 11.5 0.0 12.8 0.0 0.0 2.3 0.0 1.2 0.0 0.0 5.0 0.4 30.7 3.6 9.0 0.0 1.2 0.0 6.3 0.0 0.0 3.4 0.0 0.0 6.7 0.0 0.0 0.3 16.5 0.0 5.7 0.0 11.9 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 1.1 0.0 0.0 0.5 0.0 2.3 0.1 6.2 0.0 19.4 0.0 0.0 1.6 0.0 1.3 2.7 0.9 4.0 0.0 0.6 4.2 3.2 0.0 0.6 0.0 7.3 0.6 0.0 0.1 1.2 1.6 3.4 0.4 1.4 1.5 0.7 4.8 0.0 3.4 2.9 0.0 0.6 28.5 0.0 0.8 0.2 1.2 12.7 0.0 1.2 0.0 0.0 0.3 0.0 0.2 0.6 0.7 1.6 0.0 0.3 0.6 5.8 0.5 4.7 35.4 16.2 0.0 2.9 2.5 4.0 0.0 1.1 9.1 5.0 1.0 7.7 0.0 1.1 0.0 0.7 0.0 0.0 0.0 3.1 0.3 0.9 1.0 0.7 4.1 9.1 0.4 SLC18A1 "CGAT, VAT1, VMAT1" ENSG00000036565 "Solute carrier family 18 member A1" P54219 8 20144855-20183206 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 25.4;intestine: 10.8" "Cell type enriched" "Detected in some" 37 "Intestinal endocrine cells: 133.5" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.8" "Region enriched" "Detected in single" 4 "midbrain: 2.0" "Group enriched" "Detected in some" 12 "intermediate monocyte: 2.3;non-classical monocyte: 6.0" "Lineage enriched" "Detected in single" 18 "monocytes: 6.0" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 39.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA006877, HPA063797" Enhanced NA NA "HPA006877: AB_2667690, HPA063797: AB_2685125" "unprognostic (8.03e-4)" "unprognostic (1.02e-1)" "unprognostic (3.75e-3)" "unprognostic (3.50e-1)" "unprognostic (6.61e-2)" "unprognostic (3.09e-3)" "unprognostic (1.67e-1)" "unprognostic (2.16e-2)" "unprognostic (3.45e-2)" "unprognostic (1.48e-1)" "unprognostic (1.32e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-2)" "unprognostic (8.25e-2)" "unprognostic (4.41e-2)" "unprognostic (2.06e-1)" "unprognostic (1.05e-1)" 0.0 25.4 0.2 0.8 0.1 0.0 0.0 0.0 0.2 0.2 8.8 1.3 1.3 1.4 0.4 0.0 0.0 0.0 0.7 0.1 0.1 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 1.0 2.7 0.0 0.0 2.8 0.0 0.0 10.8 0.0 0.1 0.3 1.1 0.2 0.0 0.2 0.2 0.0 0.1 1.3 0.4 0.0 0.3 0.2 6.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 2.2 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 6.0 0.0 0.0 0.3 0.2 0.1 0.0 0.2 0.1 0.4 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 133.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 SLC18A2 "SVAT, SVMT, VMAT2" ENSG00000165646 "Solute carrier family 18 member A2" Q05940 10 117241073-117279430 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.3;brain: 28.3;cervix, uterine: 31.2" "Cell type enriched" "Detected in some" 22 "granulocytes: 603.6" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 10 "hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5" "Cell type enriched" "Detected in some" 13 "basophil: 26.3" "Lineage enriched" "Detected in many" 13 "granulocytes: 26.3" "Cell line enriched" "Detected in some" 20 "HMC-1: 91.2" "Region enhanced" "Detected in many" "midbrain: 75.4" "Group enriched" "Detected in all" 5 "midbrain: 143.8;pons and medulla: 34.7" HPA073224 Enhanced Approved Vesicles,Centrosome NA NA "Vesicles, Centrosome" "HPA073224: AB_2732222" "unprognostic (1.49e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (9.00e-2)" "unprognostic (2.85e-1)" "unprognostic (5.33e-3)" "unprognostic (2.23e-1)" "unprognostic (1.71e-2)" "unprognostic (1.40e-1)" "unprognostic (4.55e-2)" "unprognostic (2.00e-1)" "unprognostic (6.06e-3)" "unprognostic (7.94e-5)" "unprognostic (2.95e-2)" "unprognostic (2.31e-1)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" 1.7 13.9 1.7 3.1 2.0 2.0 2.0 1.7 1.6 31.2 2.3 0.5 2.2 1.5 11.2 4.9 3.0 1.1 15.9 1.0 1.9 9.0 1.1 3.3 7.6 1.5 28.3 0.2 9.7 3.7 0.5 1.6 2.1 26.5 10.8 3.4 3.1 1.0 4.0 1.1 5.8 2.5 5.4 2.9 0.5 3.5 1.5 0.3 14.1 0.6 3.4 2.9 3.1 5.4 0.0 2.0 26.3 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.6 0.0 0.0 0.0 0.2 91.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.1 0.0 0.1 0.4 0.0 26.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 2.0 0.0 1.1 1.7 2.0 1.7 1.6 1.9 9.0 28.3 0.2 26.5 0.3 8.9 27.6 0.0 0.0 1.6 0.6 0.2 0.0 1.4 4.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.4 603.6 0.0 0.7 0.0 8.5 11.6 1.8 0.0 0.6 0.6 1.7 0.0 0.0 0.3 0.1 0.0 4.6 0.0 0.7 0.0 0.2 0.2 0.1 2.4 0.0 0.0 0.0 0.0 SLC18A3 VACHT ENSG00000187714 "Solute carrier family 18 member A3" Q16572 10 49610301-49612720 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.9" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 1.1;Syncytiotrophoblasts: 1.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 7 "basal ganglia: 8.8;hypothalamus: 3.4;pons and medulla: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 12.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 14 "basal ganglia: 17.7;pons and medulla: 20.9" CAB079011 Supported NA NA "CAB079011: " "unprognostic (2.14e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (9.39e-2)" "unprognostic (4.55e-2)" "unprognostic (3.00e-1)" "unprognostic (5.85e-3)" "unprognostic (7.56e-2)" "unprognostic (1.16e-1)" 0.1 0.3 0.0 2.2 8.8 0.1 0.1 0.0 0.5 0.1 1.5 0.0 1.1 1.3 0.3 0.1 0.1 0.1 0.2 0.1 0.0 3.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.7 3.4 11.9 0.4 0.3 1.4 0.4 0.6 0.2 0.1 1.9 1.5 3.1 0.1 1.2 0.2 1.2 0.2 0.1 0.0 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 12.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.8 0.0 0.5 0.0 3.4 0.1 0.0 11.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 SLC18B1 "C6orf192, dJ55C23.6" ENSG00000146409 "Solute carrier family 18 member B1" Q6NT16 6 132769370-132798553 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 48.4;Hofbauer cells: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 24.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029747, HPA049659" Approved Supported "Golgi apparatus,Cytosol" NA NA Cytosol "Golgi apparatus" "HPA029747: AB_10600797, HPA049659: AB_2680843" "unprognostic (1.84e-2)" "unprognostic (3.94e-1)" "unprognostic (4.22e-2)" "unprognostic (2.85e-1)" "unprognostic (2.41e-2)" "prognostic favorable (3.55e-4)" "prognostic unfavorable (7.90e-4)" "unprognostic (1.53e-1)" "unprognostic (2.39e-1)" "unprognostic (4.09e-1)" "unprognostic (6.97e-3)" "unprognostic (1.13e-1)" "prognostic favorable (9.24e-4)" "unprognostic (7.20e-3)" "unprognostic (1.08e-1)" "unprognostic (2.08e-2)" "unprognostic (7.88e-2)" 9.3 7.3 26.2 6.0 21.9 4.5 11.0 13.1 20.6 9.4 9.5 18.8 3.1 14.4 7.0 7.8 10.7 10.1 11.5 4.2 21.6 15.8 11.8 6.0 5.7 7.2 19.5 10.8 7.4 7.8 13.0 6.9 15.5 17.0 5.0 11.4 7.4 11.7 4.9 4.8 10.5 10.4 5.8 21.7 7.0 14.9 2.3 16.3 8.3 10.1 5.9 8.6 10.6 5.5 7.5 15.6 0.6 11.3 2.8 9.4 6.5 4.0 3.8 6.5 0.0 0.8 2.4 4.0 1.4 4.5 2.9 9.3 8.4 8.3 0.1 5.8 0.9 5.1 11.3 8.8 9.9 2.3 5.9 16.6 2.1 7.0 10.2 5.0 1.9 0.2 6.5 9.5 4.6 10.0 5.9 9.3 13.2 23.7 1.6 2.4 5.7 6.1 0.2 8.6 9.0 5.4 9.8 7.1 6.6 24.1 7.1 13.1 0.0 7.8 15.5 12.4 3.9 5.3 0.0 4.3 1.3 3.4 1.3 3.8 5.1 0.4 0.2 7.1 0.2 1.0 0.0 11.3 0.5 3.7 2.5 6.7 5.5 5.7 5.2 15.6 7.5 8.2 5.6 0.6 2.8 0.2 12.1 9.4 6.5 26.2 21.9 13.1 20.6 21.6 15.8 19.5 10.8 17.0 16.3 0.0 6.2 5.9 8.2 9.0 4.1 2.6 48.4 12.0 10.3 26.2 2.0 41.0 8.3 26.3 0.1 5.1 3.9 0.0 13.2 16.4 5.1 7.2 0.0 11.9 51.1 0.0 15.6 22.1 19.4 0.0 6.4 7.8 13.5 2.8 11.9 8.5 15.1 3.5 4.2 5.0 3.3 0.0 3.3 0.2 0.4 9.5 23.8 4.9 16.6 11.5 SLC19A1 "FOLT, RFC1" ENSG00000173638 "Solute carrier family 19 member 1" P41440 21 45493572-45544411 "Cancer-related genes, Predicted membrane proteins, Transporters" "Antiport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.6" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 133.1;Syncytiotrophoblasts: 303.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 37.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 37.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024802 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA024802: AB_10602892" "unprognostic (4.31e-3)" "prognostic unfavorable (4.15e-4)" "unprognostic (5.23e-2)" "unprognostic (2.02e-1)" "unprognostic (3.11e-1)" "unprognostic (3.04e-2)" "unprognostic (7.34e-2)" "unprognostic (2.87e-3)" "unprognostic (4.04e-2)" "unprognostic (4.09e-2)" "unprognostic (2.85e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.07e-10)" "unprognostic (1.44e-1)" "unprognostic (2.31e-1)" "unprognostic (7.97e-5)" "unprognostic (3.10e-1)" 9.0 7.8 7.1 8.2 13.5 10.5 12.5 9.6 8.9 5.0 9.7 6.0 9.4 31.2 4.3 4.6 2.3 4.6 3.5 3.2 7.1 6.1 4.7 14.1 13.9 14.1 8.7 4.4 8.1 5.4 1.8 3.5 32.9 11.5 4.7 2.0 17.8 6.0 3.5 3.5 6.1 16.5 2.3 5.9 11.7 5.7 3.4 3.4 11.8 9.6 2.8 4.1 3.1 3.1 0.9 4.9 37.6 6.4 0.4 1.1 2.4 10.6 9.7 1.9 7.9 0.6 0.8 15.9 5.0 0.8 4.6 2.9 22.4 9.9 9.9 9.9 1.2 3.9 5.5 3.9 3.6 1.1 9.1 19.3 20.8 5.2 15.5 2.7 13.5 3.2 1.0 2.8 4.9 1.6 1.3 3.8 10.6 24.8 4.3 1.6 11.9 18.3 12.6 11.4 4.7 11.3 25.0 2.2 28.7 2.1 6.4 11.8 10.4 5.6 9.3 4.3 2.7 7.0 16.0 4.6 6.0 7.5 1.6 8.1 1.8 6.6 9.0 2.7 22.1 4.8 0.6 6.4 8.5 0.3 6.0 1.1 0.9 0.5 0.7 4.9 0.3 0.8 0.5 37.6 0.4 3.7 1.5 1.0 2.4 7.1 13.5 9.6 8.9 7.1 6.1 8.7 4.4 11.5 3.4 44.7 4.6 0.8 1.7 2.2 18.0 2.4 2.5 1.4 10.3 0.0 0.0 133.1 0.0 7.8 3.3 2.8 9.3 0.0 4.2 16.2 2.9 3.6 1.1 10.9 24.0 7.9 0.0 1.8 11.6 3.2 6.1 5.9 3.3 0.0 3.1 8.6 6.8 5.3 10.6 1.9 3.6 0.0 3.8 1.2 4.1 1.4 303.1 2.2 7.6 0.9 SLC19A2 "THTR1, TRMA" ENSG00000117479 "Solute carrier family 19 member 2" O60779 1 169463909-169486003 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 75.7" "Cell type enhanced" "Detected in many" 12 "Suprabasal keratinocytes: 44.2;Syncytiotrophoblasts: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006119, HPA016599" Uncertain Approved Cytosol NA NA Cytosol "HPA006119: AB_1079996, HPA016599: AB_1857005" "prognostic favorable (8.41e-4)" "unprognostic (8.82e-2)" "unprognostic (1.90e-1)" "unprognostic (3.29e-3)" "prognostic favorable (2.90e-4)" "unprognostic (4.45e-2)" "unprognostic (9.69e-2)" "unprognostic (1.45e-1)" "unprognostic (2.86e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "unprognostic (1.65e-1)" "prognostic favorable (2.70e-5)" "unprognostic (1.08e-1)" "unprognostic (2.09e-1)" "unprognostic (3.60e-2)" "unprognostic (2.14e-2)" 23.1 11.1 1.9 5.3 4.4 4.8 14.2 7.4 6.1 5.9 5.4 2.8 2.7 2.1 5.0 9.0 7.5 10.0 17.5 14.8 2.7 2.1 8.6 23.4 9.2 3.1 2.8 1.7 10.3 14.4 6.8 16.3 22.1 4.7 9.4 2.8 16.4 10.4 4.6 75.7 7.5 6.6 11.3 3.7 1.8 9.4 7.3 1.8 3.6 7.9 21.6 3.9 10.4 9.8 1.4 1.9 3.0 4.6 2.6 3.3 0.7 4.5 3.2 7.3 5.7 22.8 8.4 16.2 3.6 2.7 3.0 4.2 13.1 4.8 4.0 4.2 2.4 5.5 4.9 8.8 5.4 3.3 11.5 8.2 3.8 10.4 11.9 12.4 9.6 3.8 9.9 7.9 4.8 12.3 4.2 4.4 7.1 15.4 2.6 5.0 3.0 4.9 4.3 16.6 8.8 4.9 0.0 15.8 4.6 7.9 9.7 6.4 8.6 5.0 8.7 17.8 8.7 5.5 6.3 3.7 3.6 5.0 4.4 7.1 3.6 3.3 1.3 5.3 3.7 4.7 0.0 1.7 3.0 0.9 0.7 3.3 1.4 1.1 2.1 1.9 1.2 3.1 3.0 1.1 2.6 4.6 0.7 1.0 0.7 1.9 4.4 7.4 6.1 2.7 2.1 2.8 1.7 4.7 1.8 8.9 17.1 0.9 13.6 26.3 4.7 24.0 7.6 13.4 11.4 5.2 2.0 19.6 0.0 7.1 4.4 2.3 6.3 0.0 4.6 3.0 20.6 10.4 10.3 23.1 6.2 6.4 8.6 0.6 3.7 0.4 6.4 5.7 20.3 0.0 4.4 2.6 8.2 5.7 4.6 1.8 4.7 0.0 9.4 3.4 3.4 44.2 130.8 1.5 4.7 21.3 SLC19A3 THTR2 ENSG00000135917 "Solute carrier family 19 member 3" Q9BZV2 2 227683763-227718031 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.2;breast: 78.2;placenta: 27.5" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 134.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 14.3;BEWO: 7.4;CACO-2: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038898 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA038898: AB_10673481" "unprognostic (3.37e-2)" "unprognostic (3.59e-5)" "unprognostic (1.95e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (4.67e-2)" "unprognostic (3.12e-3)" "unprognostic (7.28e-2)" "unprognostic (8.20e-2)" "unprognostic (1.68e-1)" "unprognostic (1.71e-2)" "unprognostic (7.01e-3)" 48.2 0.6 2.2 1.8 2.4 1.2 78.2 1.5 1.9 0.5 6.1 1.0 0.5 7.7 0.6 0.4 0.6 0.6 8.9 1.9 2.3 2.4 2.1 16.0 5.6 1.3 3.0 0.7 0.9 1.3 0.2 0.3 27.5 2.6 0.5 1.6 0.7 0.9 0.2 0.7 1.6 4.5 0.5 2.6 0.5 0.5 0.6 1.5 0.0 0.5 0.4 0.4 1.0 2.3 2.6 1.8 8.6 1.8 4.3 1.1 0.4 0.3 1.6 0.3 1.0 14.3 0.4 7.4 0.1 0.2 0.3 0.6 18.7 0.5 0.4 0.2 0.1 4.6 0.5 0.5 0.5 0.8 0.1 1.2 0.1 1.0 0.8 1.7 0.2 0.2 3.3 0.4 0.1 0.9 0.3 0.0 0.3 0.2 0.9 0.0 1.8 0.1 0.7 3.2 0.6 0.3 0.3 0.2 0.2 0.2 0.3 1.1 0.1 0.6 2.1 0.5 2.7 0.3 0.2 0.5 0.5 0.5 4.2 0.4 0.2 0.1 0.7 1.4 0.3 0.5 8.6 1.8 1.7 1.0 1.2 0.6 1.6 0.8 0.9 0.4 2.6 1.0 1.1 6.1 4.3 1.1 1.8 0.4 0.4 2.2 2.4 1.5 1.9 2.3 2.4 3.0 0.7 2.6 1.5 8.9 3.2 0.0 0.4 0.0 2.9 0.3 0.0 0.0 0.0 1.8 0.0 45.5 1.7 1.7 0.3 0.5 6.4 0.0 0.0 7.0 0.9 0.3 0.0 11.4 4.6 0.0 1.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.8 0.6 0.0 0.0 2.2 0.1 0.0 1.0 0.0 0.1 0.0 134.3 0.0 5.6 0.3 SLC1A1 "EAAC1, EAAT3" ENSG00000106688 "Solute carrier family 1 member 1" P43005 9 4490444-4587469 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.4;kidney: 31.2" "Cell type enhanced" "Detected in many" 19 "Alveolar cells type 1: 151.8;Cholangiocytes: 35.7;Enterocytes: 37.3;Hepatocytes: 62.7;Proximal tubular cells: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 2.9" "Lineage enriched" "Detected in single" 30 "T-cells: 2.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 13.9;HDLM-2: 31.6;HUVEC TERT2: 14.9;RPTEC TERT1: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062356 Enhanced NA NA "HPA062356: " "unprognostic (1.28e-2)" "unprognostic (2.37e-2)" "unprognostic (6.83e-3)" "unprognostic (3.07e-3)" "unprognostic (2.04e-2)" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" "unprognostic (4.28e-2)" "unprognostic (1.58e-1)" "unprognostic (2.71e-1)" "unprognostic (1.35e-2)" "unprognostic (1.25e-2)" "prognostic favorable (2.86e-8)" "unprognostic (2.68e-1)" "unprognostic (9.49e-2)" "unprognostic (7.78e-2)" "unprognostic (2.64e-1)" 3.3 1.4 8.6 3.4 10.2 0.3 2.9 4.7 12.4 4.0 17.9 2.7 0.5 21.0 4.0 28.8 1.7 1.9 16.3 2.0 10.0 10.2 31.2 29.1 12.8 1.8 8.6 5.8 0.7 1.8 0.4 5.2 5.1 6.7 4.3 6.6 1.9 3.1 2.4 2.2 1.2 40.4 5.6 5.3 0.5 3.4 0.8 4.4 0.0 25.0 1.8 5.0 3.5 1.3 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.9 0.7 4.4 11.5 13.9 3.9 4.7 9.8 1.5 1.4 7.8 0.2 6.1 0.3 2.4 1.8 0.0 1.6 2.6 1.3 31.6 2.1 0.0 6.6 0.0 0.4 0.4 0.0 0.9 0.1 5.6 0.0 0.7 14.9 0.1 0.0 0.0 1.0 0.1 0.0 0.1 1.9 4.7 0.8 0.0 0.0 0.0 31.0 2.7 1.0 0.9 0.3 1.7 0.0 3.7 0.6 0.2 8.0 2.3 0.1 4.4 1.3 0.0 0.0 0.0 10.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 8.6 10.2 4.7 11.7 10.0 10.2 8.6 5.8 6.7 4.4 151.8 2.7 0.8 1.0 0.0 0.7 0.8 35.7 4.0 9.1 0.0 0.0 0.0 3.3 5.5 3.5 7.0 37.3 0.0 0.7 0.0 0.9 1.7 0.0 62.7 0.1 0.0 0.0 3.1 2.1 6.1 0.3 0.1 0.0 0.0 6.5 0.8 5.8 8.6 0.0 37.2 0.9 0.0 1.1 0.0 0.2 0.5 0.1 0.8 4.8 0.2 SLC1A2 "EAAT2, GLT-1" ENSG00000110436 "Solute carrier family 1 member 2" P43004 11 35251205-35420063 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 160.9" "Cell type enhanced" "Detected in many" 14 "Cone photoreceptor cells: 139.4;Early spermatids: 85.3;Rod photoreceptor cells: 160.3;Syncytiotrophoblasts: 225.3" "Cancer enriched" "Detected in some" 5 "glioma: 28.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.5;BJ hTERT+: 4.9;fHDF/TERT166: 3.4;Hep G2: 5.7;NTERA-2: 6.4;SCLC-21H: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002574, HPA009172, HPA067499" Enhanced NA NA "CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499: " "unprognostic (8.00e-2)" "unprognostic (5.71e-3)" "unprognostic (1.39e-1)" "unprognostic (2.77e-2)" "unprognostic (1.33e-1)" "unprognostic (5.65e-3)" "unprognostic (1.39e-2)" "unprognostic (9.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.65e-2)" "unprognostic (1.79e-3)" "unprognostic (2.35e-1)" "unprognostic (8.33e-4)" "unprognostic (6.34e-2)" "unprognostic (8.06e-2)" "unprognostic (5.24e-2)" "unprognostic (3.49e-2)" 1.7 4.1 65.1 1.9 79.4 1.8 3.7 7.2 160.9 2.0 1.7 9.8 0.0 1.8 2.1 1.8 1.7 1.7 1.7 2.1 47.6 11.7 1.7 20.5 1.9 2.5 15.2 43.1 1.6 4.2 1.6 0.4 2.1 27.6 1.7 1.7 0.0 3.9 1.7 1.7 2.3 1.6 1.8 17.2 1.8 2.6 2.4 16.3 0.0 1.7 0.0 2.4 1.7 0.3 1.1 0.7 3.9 0.7 1.2 0.9 0.4 0.0 0.2 1.1 0.1 0.5 4.5 0.0 1.1 4.9 0.2 0.3 0.2 0.0 0.1 0.1 3.4 0.2 0.3 0.0 0.0 0.4 0.0 0.0 0.4 0.5 5.7 0.2 0.6 0.2 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 2.2 0.0 0.0 6.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 3.3 0.5 0.0 2.3 0.0 0.3 1.1 0.0 0.6 0.2 0.2 0.5 0.1 0.6 0.0 0.0 1.1 0.0 0.3 3.9 0.7 0.8 0.5 0.3 0.3 0.4 0.5 0.4 0.7 1.1 0.9 0.7 2.1 1.2 0.4 0.6 0.4 0.4 65.1 79.4 7.2 64.9 47.6 11.7 15.2 43.1 27.6 16.3 3.0 3.7 0.0 0.0 2.6 48.2 2.8 0.0 1.4 0.0 0.0 139.4 14.9 0.0 0.1 85.3 0.3 0.0 0.0 2.9 0.8 2.6 0.4 0.0 5.4 3.1 6.4 0.0 0.0 0.0 59.1 0.0 0.5 1.7 55.1 0.0 10.6 0.7 0.0 0.0 0.0 160.3 0.0 1.0 0.2 1.2 1.0 225.3 0.0 0.0 0.1 SLC1A3 "EA6, EAAT1, GLAST" ENSG00000079215 "Solute carrier family 1 member 3" P43003 5 36606355-36688334 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 188.6" "Cell type enriched" "Detected in many" 9 "Muller glia cells: 579.8" "Cancer enriched" "Detected in all" 21 "glioma: 168.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4" "Group enriched" "Detected in many" 39 "dendritic cells: 3.4;monocytes: 4.3" "Cell line enhanced" "Detected in many" "AF22: 21.5;CACO-2: 34.7;HaCaT: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002573, HPA037467, HPA037468" Enhanced Supported Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371" "unprognostic (1.23e-1)" "unprognostic (2.15e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (7.70e-2)" "unprognostic (3.89e-3)" "unprognostic (2.36e-1)" "unprognostic (1.24e-1)" "unprognostic (2.84e-2)" "unprognostic (4.17e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.17e-2)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" 17.3 10.3 76.1 5.9 70.6 3.1 6.3 45.8 188.6 6.9 3.2 26.3 0.0 2.1 2.8 2.3 7.2 5.4 5.9 12.0 57.9 27.3 3.1 3.6 4.7 8.6 32.7 39.6 8.6 4.0 2.6 3.7 12.7 28.5 3.3 2.6 1.9 3.0 4.4 7.6 5.5 2.3 4.1 29.4 5.8 2.9 2.7 33.6 0.0 2.6 0.7 4.5 4.8 1.2 0.0 3.4 0.0 4.3 0.0 0.0 0.8 0.4 0.1 21.5 1.9 2.2 6.0 13.8 0.0 0.0 0.8 1.9 34.7 1.7 0.0 10.5 0.3 0.3 26.3 6.3 2.8 0.9 0.3 12.9 0.0 0.1 0.0 0.4 0.4 0.1 11.1 13.0 5.3 2.2 0.4 0.0 0.4 0.0 0.1 3.6 0.0 0.0 0.1 2.5 0.0 2.2 0.0 0.1 0.0 0.0 1.4 1.8 0.0 2.1 6.3 0.3 10.5 0.0 1.0 0.0 1.9 3.2 0.0 7.6 0.0 0.0 0.0 8.8 14.5 4.9 0.0 4.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.8 76.1 70.6 45.8 57.8 57.9 27.3 32.7 39.6 28.5 33.6 3.0 0.3 0.5 10.4 9.5 7.7 33.9 0.0 5.3 1.2 0.0 2.0 25.3 0.0 0.4 0.6 1.1 0.0 0.0 0.0 13.5 11.8 3.2 0.0 0.2 38.2 3.2 0.0 1.3 63.4 1.9 4.0 11.0 6.8 3.6 0.0 579.8 0.3 0.0 0.0 0.0 11.3 6.5 4.7 0.2 0.1 6.1 7.7 0.0 0.0 3.3 SLC1A4 "ASCT1, SATT" ENSG00000115902 "Solute carrier family 1 member 4" P43007 2 64988477-65023865 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Melanocytes: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 72.7;U-266/70: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034963, HPA034964" Approved Enhanced Centrosome NA NA Centrosome "HPA034963: AB_2797223, HPA034964: AB_2674386" "unprognostic (7.61e-2)" "prognostic favorable (3.59e-4)" "unprognostic (2.49e-1)" "unprognostic (3.19e-3)" "unprognostic (1.26e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.23e-5)" "unprognostic (1.26e-2)" "unprognostic (2.10e-1)" "unprognostic (3.16e-2)" "unprognostic (2.28e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (4.87e-4)" "unprognostic (6.37e-3)" "unprognostic (4.14e-2)" "unprognostic (3.53e-2)" "unprognostic (1.98e-2)" 6.0 20.3 31.4 7.6 34.4 10.3 12.7 8.8 43.1 13.5 8.3 8.1 6.1 5.6 11.7 7.8 6.5 4.7 3.8 5.1 20.6 23.5 1.9 11.1 4.5 8.7 17.1 21.2 12.2 28.4 6.1 10.3 6.0 15.4 9.1 7.8 12.1 5.7 6.9 29.6 15.9 5.1 11.3 5.8 6.3 7.0 7.8 8.5 15.7 5.3 11.5 15.8 5.4 7.8 1.1 8.4 2.0 10.1 5.5 3.9 1.4 3.7 2.9 1.7 8.8 3.8 2.5 2.4 7.1 3.5 3.0 5.1 0.8 0.5 12.2 1.6 11.1 3.7 10.8 3.4 0.9 3.1 4.9 1.3 6.3 3.5 7.5 8.1 10.6 5.9 1.1 18.8 4.0 6.2 1.0 1.8 12.3 4.9 30.9 2.1 3.3 9.0 7.0 1.2 4.9 3.5 3.3 0.4 30.3 1.2 1.9 7.5 3.6 4.4 4.0 72.7 0.8 4.8 11.7 0.4 4.1 4.9 7.9 4.3 34.0 16.8 29.6 6.0 21.4 21.7 0.0 2.3 2.0 1.0 5.3 1.4 1.1 1.1 1.8 4.4 0.3 0.0 1.0 0.0 5.5 10.1 8.4 3.9 1.4 31.4 34.4 8.8 25.9 20.6 23.5 17.1 21.2 15.4 8.5 0.0 2.4 14.5 2.0 17.7 5.4 4.4 2.5 4.0 1.2 1.8 31.4 0.9 0.0 1.4 23.4 4.5 0.7 0.0 8.1 1.1 5.6 2.5 6.9 10.9 17.4 6.4 8.1 9.2 4.5 34.0 10.3 9.5 81.0 5.4 6.2 14.7 8.6 0.0 28.0 1.2 16.5 0.0 9.0 1.1 0.6 5.4 2.1 2.5 4.4 0.9 SLC1A5 "AAAT, ASCT2, M7V1, RDRC" ENSG00000105281 "Solute carrier family 1 member 5" Q15758 19 46774883-46788594 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Host-virus interaction, Symport, Transport" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 134.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 34.6" "Group enriched" "Detected in many" 4 "dendritic cells: 34.6;monocytes: 22.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA035239, HPA035240" Enhanced Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA035239: AB_10670587, HPA035240: AB_10604092" "unprognostic (8.26e-3)" "unprognostic (6.38e-2)" "unprognostic (7.24e-2)" "unprognostic (7.94e-2)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.66e-8)" "unprognostic (2.08e-1)" "unprognostic (1.06e-2)" "unprognostic (9.82e-2)" "unprognostic (9.40e-3)" "unprognostic (9.57e-3)" "prognostic unfavorable (1.18e-7)" "unprognostic (1.28e-2)" "unprognostic (6.30e-2)" "unprognostic (1.06e-2)" "unprognostic (9.83e-2)" 39.3 5.7 3.4 16.0 5.4 16.2 45.0 0.9 3.0 20.7 15.8 5.0 50.4 4.9 14.3 33.7 33.9 18.1 31.2 10.0 4.5 2.2 23.7 4.1 23.4 17.7 8.2 0.9 33.3 24.6 0.2 9.1 25.8 4.9 35.2 13.8 5.2 99.0 55.7 6.9 18.6 12.1 23.1 5.3 19.8 17.9 21.7 6.1 14.9 6.5 28.4 25.9 48.3 44.9 7.0 34.6 0.9 22.4 6.9 5.6 7.4 23.8 44.1 10.6 16.0 27.7 23.6 25.1 34.1 39.0 25.6 37.2 40.0 27.0 26.2 16.7 84.6 14.7 38.5 30.9 40.5 19.1 17.3 28.0 43.4 16.9 37.5 71.7 30.2 25.6 38.3 101.3 30.0 76.2 8.6 13.6 35.0 45.8 69.4 13.6 40.6 13.8 81.3 18.5 85.5 19.4 15.7 12.0 37.2 14.3 52.2 16.4 12.0 16.8 46.0 36.5 8.6 26.5 39.9 10.1 15.4 24.7 12.0 27.7 43.1 41.6 21.8 29.0 37.7 37.7 0.0 11.5 0.9 5.3 19.9 4.4 7.0 3.1 3.7 17.8 2.5 0.7 2.3 0.3 6.9 22.4 34.6 5.6 7.4 3.4 5.4 0.9 3.0 4.5 2.2 8.2 0.9 4.9 6.1 0.0 15.9 11.9 134.3 51.3 0.1 19.9 20.4 4.0 7.9 0.0 0.0 80.4 3.3 26.8 14.6 17.1 22.0 93.5 55.3 97.4 44.3 44.4 28.8 0.5 33.9 0.0 10.3 26.4 16.8 10.3 17.5 27.3 18.6 10.8 88.4 0.6 35.9 74.6 18.4 23.9 0.8 6.5 22.6 4.4 4.3 24.7 20.4 20.8 50.3 96.8 SLC1A6 EAAT4 ENSG00000105143 "Solute carrier family 1 member 6" P48664 19 14950034-15022990 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 52.1;testis: 23.3" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 12.3;Early spermatids: 29.3;Horizontal cells: 22.3;Late spermatids: 27.3;Syncytiotrophoblasts: 33.4" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 5.2" "Region enriched" "Detected in many" 5 "cerebellum: 52.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 6.6;NTERA-2: 5.4;U-698: 24.6" "Region enriched" "Detected in many" 6 "cerebellum: 152.9" "Low region specificity" "Detected in all" "HPA041505, HPA044066" Enhanced Supported Supported "Plasma membrane,Intermediate filaments" NA NA "Plasma membrane" "Intermediate filaments" "HPA041505: AB_2677520, HPA044066: AB_2678796" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.94e-3)" "unprognostic (8.90e-2)" "unprognostic (6.52e-4)" "unprognostic (1.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.11e-2)" "unprognostic (9.92e-2)" "unprognostic (1.35e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (6.88e-6)" 0.4 0.5 3.2 0.5 9.6 1.2 0.8 52.1 12.8 0.4 0.5 0.6 0.0 0.6 0.8 4.2 0.4 0.5 0.5 0.4 4.8 4.0 0.4 0.5 0.5 0.5 1.6 3.4 0.6 0.9 0.6 0.0 4.3 3.0 0.9 0.6 0.1 0.7 0.9 0.5 9.2 0.5 0.5 1.4 0.7 0.5 23.3 0.9 0.0 0.6 0.0 0.6 0.4 0.0 2.0 0.7 2.2 0.7 0.5 0.6 0.1 0.1 0.1 0.3 0.3 0.2 0.2 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.2 6.6 0.1 0.1 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.6 0.1 0.5 0.0 0.3 5.4 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.2 0.2 2.6 0.0 1.1 0.3 0.1 0.0 0.3 1.0 0.2 0.1 0.4 0.1 24.6 0.1 0.3 0.1 1.6 0.7 0.5 0.6 0.4 0.4 1.0 0.5 0.3 0.3 2.0 0.6 0.6 2.2 0.5 0.4 0.7 0.3 0.1 3.2 9.6 52.1 6.5 4.8 4.0 1.6 3.4 3.0 0.9 0.0 0.0 0.0 0.6 2.9 12.3 1.6 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 29.3 0.0 0.0 0.0 0.3 8.5 1.0 0.2 0.0 0.0 0.4 22.3 0.0 0.0 0.0 27.3 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.7 0.0 0.3 1.7 1.5 5.9 33.4 0.0 0.0 0.1 SLC1A7 EAAT5 ENSG00000162383 "Solute carrier family 1 member 7" O00341 1 53087179-53142632 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "retina: 70.1" "Group enriched" "Detected in some" 17 "Bipolar cells: 228.0;Cone photoreceptor cells: 66.8;Rod photoreceptor cells: 66.6" "Cancer enhanced" "Detected in many" "lung cancer: 3.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "gdT-cell: 5.7;memory CD8 T-cell: 2.2;naive CD8 T-cell: 2.6" "Lineage enriched" "Detected in single" 58 "T-cells: 5.7" "Cell line enriched" "Detected in some" 9 "HHSteC: 24.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA049124 Enhanced NA NA "HPA049124: AB_2680643" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (9.48e-4)" "unprognostic (2.31e-1)" "unprognostic (8.73e-2)" "unprognostic (1.52e-2)" "unprognostic (6.26e-3)" "unprognostic (4.35e-1)" "unprognostic (1.45e-2)" "unprognostic (1.59e-1)" "unprognostic (7.65e-2)" "unprognostic (1.19e-3)" "unprognostic (2.58e-3)" "unprognostic (5.43e-2)" "unprognostic (8.12e-2)" "unprognostic (4.70e-3)" 2.0 0.2 1.1 0.6 0.6 0.0 1.2 0.6 0.7 0.9 1.0 0.7 0.6 4.1 1.3 1.2 2.1 2.2 9.6 2.9 1.7 1.1 0.7 2.8 0.9 0.6 1.2 0.6 3.8 0.6 0.0 0.6 0.6 1.1 0.9 0.0 70.1 0.6 0.6 2.1 1.2 5.3 0.6 1.3 0.6 1.1 0.9 0.6 0.6 0.6 0.6 0.6 2.5 0.9 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.1 0.8 1.1 0.6 0.6 0.7 1.7 1.1 1.2 0.6 1.1 0.6 0.0 0.6 0.0 0.0 0.0 228.0 0.4 0.0 0.0 0.0 0.0 66.8 0.1 0.0 0.0 0.0 0.0 7.0 0.0 1.3 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.7 5.2 0.0 2.9 1.1 0.2 66.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC20A1 "Glvr-1, GLVR1, PiT-1" ENSG00000144136 "Solute carrier family 20 member 1" Q8WUM9 2 112645857-112663827 "Predicted membrane proteins, Transporters" "Host-virus interaction, Phosphate transport, Symport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 198.3;Enterocytes: 165.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 87.9;U-87 MG: 85.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019279, HPA035834" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB019279: , HPA035834: AB_2674809" "unprognostic (1.81e-1)" "unprognostic (2.18e-1)" "unprognostic (5.38e-2)" "unprognostic (4.03e-3)" "unprognostic (1.39e-1)" "prognostic unfavorable (6.56e-5)" "unprognostic (1.50e-2)" "unprognostic (3.38e-2)" "unprognostic (2.32e-2)" "unprognostic (1.39e-1)" "unprognostic (7.43e-3)" "unprognostic (1.44e-1)" "prognostic unfavorable (3.44e-5)" "unprognostic (6.85e-2)" "unprognostic (1.09e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-3)" 23.4 9.9 11.9 38.8 16.0 51.3 18.9 25.6 29.1 9.4 42.7 10.6 4.7 12.3 11.7 8.6 11.0 12.2 22.7 17.0 12.0 12.3 16.3 40.2 23.1 27.6 13.5 16.8 7.7 25.7 7.4 13.3 59.8 20.6 15.3 19.1 17.8 10.4 12.2 25.6 10.2 21.8 13.1 15.5 23.8 13.8 13.3 9.1 19.0 12.8 9.5 22.4 21.6 14.4 3.8 17.9 12.3 25.2 19.9 27.1 13.0 10.9 9.0 11.8 9.5 9.0 22.1 9.1 29.6 35.5 13.2 17.2 13.7 27.1 19.9 16.4 11.0 51.3 11.5 12.9 22.5 19.4 10.9 13.2 16.9 9.2 13.0 13.4 9.6 30.0 11.2 8.9 46.6 32.7 87.9 16.8 8.6 31.3 20.9 57.2 4.3 13.1 37.4 19.8 5.1 24.4 12.4 10.6 5.6 19.1 50.8 10.8 10.2 14.9 9.1 20.4 5.5 9.3 6.9 36.4 24.3 16.0 8.4 22.9 8.7 22.4 16.7 85.5 9.3 29.3 3.8 14.5 12.3 24.2 25.2 27.1 3.8 10.4 17.4 10.9 2.1 8.3 13.1 6.1 19.9 14.7 17.9 6.0 13.0 11.9 16.0 25.6 29.1 12.0 12.3 13.5 16.8 20.6 9.1 11.9 32.9 31.8 53.3 100.2 60.0 31.1 22.9 36.1 31.8 8.7 198.3 36.6 11.6 14.7 0.9 44.4 165.9 23.3 12.2 11.8 33.2 30.0 24.3 49.9 25.2 19.1 34.2 46.1 48.3 2.0 3.4 60.3 25.3 8.2 39.4 21.5 21.0 83.4 4.6 3.8 74.9 0.0 22.1 4.8 17.4 54.1 62.1 52.4 51.1 43.9 SLC20A2 "Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1" ENSG00000168575 "Solute carrier family 20 member 2" Q08357 8 42416475-42541926 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction, Ion transport, Phosphate transport, Sodium transport, Symport, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 90.6" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 151.7;Urothelial cells: 128.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 48.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026540 Approved NA NA "HPA026540: AB_1855408" "prognostic unfavorable (7.67e-4)" "unprognostic (3.22e-1)" "unprognostic (3.24e-2)" "unprognostic (2.27e-2)" "unprognostic (2.12e-2)" "unprognostic (2.95e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-1)" "unprognostic (2.95e-1)" "unprognostic (7.62e-2)" "unprognostic (2.06e-1)" "unprognostic (3.43e-2)" "prognostic favorable (1.01e-4)" "unprognostic (2.13e-1)" "unprognostic (1.27e-1)" "unprognostic (5.86e-2)" "unprognostic (4.95e-2)" 7.3 5.2 12.2 6.3 17.8 2.3 8.0 24.2 22.2 8.5 14.2 28.6 4.9 28.0 10.9 6.8 19.4 15.4 9.4 37.3 16.7 17.3 11.3 23.1 9.3 4.1 22.4 14.4 5.7 30.2 15.1 8.1 8.3 32.8 8.4 11.8 19.0 90.6 11.6 69.9 12.6 18.2 12.1 21.6 4.7 8.8 11.1 18.3 5.6 48.6 19.8 10.5 14.6 11.5 3.2 5.2 3.1 3.0 9.6 7.5 4.1 18.0 5.0 6.9 5.7 3.9 3.3 15.3 16.6 28.9 8.6 21.5 13.4 48.3 6.1 19.6 14.9 4.9 29.7 3.8 16.9 15.3 1.5 3.1 9.7 1.8 7.6 5.6 3.4 4.4 3.6 15.4 8.9 8.8 6.1 4.2 4.9 9.3 5.0 16.3 5.0 6.1 5.6 6.8 17.6 3.2 5.2 7.5 6.4 7.9 17.8 1.8 7.1 4.5 7.8 4.5 5.7 6.3 6.0 13.1 18.7 6.4 4.4 9.0 3.3 7.4 4.4 5.8 6.8 10.1 3.1 3.0 0.3 5.6 2.2 6.3 3.1 6.0 5.2 5.2 3.2 7.5 5.6 1.2 9.6 1.9 3.0 5.8 4.1 12.2 17.8 24.2 19.9 16.7 17.3 22.4 14.4 32.8 18.3 26.8 15.2 6.4 151.7 87.8 13.6 54.5 15.3 64.3 14.8 15.7 15.7 19.5 11.6 26.9 7.6 15.8 30.9 0.0 26.9 19.4 12.7 56.3 3.5 28.4 9.1 6.4 11.5 6.2 7.6 7.5 6.6 6.9 10.1 9.0 10.7 16.4 37.9 12.9 11.0 5.0 10.0 6.5 16.0 3.6 4.3 65.0 21.3 8.5 10.0 128.7 SLC22A1 OCT1 ENSG00000175003 "Solute carrier family 22 member 1" O15245 6 160121789-160158718 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "liver: 175.8" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 709.2" "Cancer enriched" "Detected in some" 81 "liver cancer: 83.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "neutrophil: 7.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 7.3" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 0.7" "Not detected" "Not detected" HPA029846 Approved NA NA "HPA029846: AB_10603026" "unprognostic (8.28e-2)" "unprognostic (2.10e-1)" "unprognostic (7.80e-2)" "unprognostic (2.68e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-2)" "prognostic favorable (1.35e-5)" "unprognostic (2.28e-1)" "unprognostic (8.61e-2)" "unprognostic (3.35e-1)" "unprognostic (9.11e-2)" "unprognostic (9.94e-2)" "unprognostic (1.46e-7)" "unprognostic (1.58e-1)" "unprognostic (1.24e-1)" "unprognostic (4.72e-2)" "unprognostic (8.07e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 175.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 7.3 0.3 0.0 0.5 0.0 0.0 0.9 0.9 1.8 1.6 0.6 0.7 0.4 0.2 0.5 0.5 1.4 0.4 0.5 1.0 0.1 3.1 0.3 0.0 1.8 0.7 1.5 0.9 0.6 0.6 2.4 0.0 1.5 1.1 0.0 2.0 0.0 1.0 0.3 0.1 0.9 0.5 0.3 0.3 0.2 0.0 1.1 0.0 0.3 0.7 0.0 1.8 1.5 0.2 0.9 0.6 0.0 2.5 0.0 1.6 1.5 0.3 0.1 0.0 0.6 0.7 1.7 1.2 1.4 2.8 0.9 0.2 1.0 0.3 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.1 7.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.3 43.3 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 709.2 0.1 0.0 0.0 14.1 12.6 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.7 1.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 2.9 0.0 0.1 SLC22A10 "hOAT5, OAT5" ENSG00000184999 "Solute carrier family 22 member 10" Q63ZE4 11 63137867-63369718 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 32 "liver: 41.7" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 15.5" "Cancer enriched" "Detected in single" 14 "liver cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.17e-2)" "unprognostic (9.77e-2)" "unprognostic (7.07e-3)" "unprognostic (7.46e-4)" "unprognostic (7.62e-3)" "unprognostic (2.87e-1)" "unprognostic (1.56e-1)" "unprognostic (6.52e-2)" "unprognostic (4.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A11 OAT4 ENSG00000168065 "Solute carrier family 22 member 11" Q9NSA0 11 64555626-64572875 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "epididymis: 22.2;kidney: 47.6;placenta: 64.7" "Group enriched" "Detected in some" 17 "Cytotrophoblasts: 554.5;Syncytiotrophoblasts: 1271.5" "Group enriched" "Detected in some" 14 "liver cancer: 3.7;renal cancer: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.8;CACO-2: 1.1;Hep G2: 3.4;SuSa: 1.9" "Not detected" "Not detected" HPA026076 Enhanced NA NA "HPA026076: AB_1854756" "unprognostic (8.21e-5)" "unprognostic (3.29e-2)" "unprognostic (3.57e-1)" "unprognostic (1.57e-1)" "unprognostic (3.20e-2)" "unprognostic (4.57e-3)" "unprognostic (3.48e-1)" "unprognostic (1.93e-1)" "unprognostic (4.86e-2)" "unprognostic (4.51e-2)" "unprognostic (7.56e-2)" "unprognostic (1.13e-1)" "prognostic favorable (3.68e-5)" "unprognostic (4.62e-2)" "unprognostic (6.52e-2)" "unprognostic (3.50e-2)" "unprognostic (8.24e-3)" 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 4.4 0.0 0.1 22.2 0.1 0.1 0.0 0.1 0.1 0.1 47.6 0.4 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.1 64.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 554.5 5.0 0.0 1.0 0.0 0.0 0.0 0.3 13.6 0.6 0.0 0.0 0.0 44.6 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 54.2 0.0 0.0 0.0 0.0 0.1 0.0 1271.5 0.0 0.0 0.0 SLC22A12 "OAT4L, RST, URAT1" ENSG00000197891 "Solute carrier family 22 member 12" Q96S37 11 64590641-64602353 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 349 "kidney: 70.1" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 149.1" "Group enriched" "Detected in some" 207 "liver cancer: 4.0;renal cancer: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA024575 Enhanced NA NA "HPA024575: AB_1858650" "unprognostic (5.88e-2)" "unprognostic (2.33e-1)" "prognostic favorable (2.63e-4)" "unprognostic (6.19e-2)" "unprognostic (3.91e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A13 "OAT10, OCTL1, OCTL3, ORCTL3" ENSG00000172940 "Solute carrier family 22 member 13" Q9Y226 3 38265812-38278315 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 16.4" "Cell type enriched" "Detected in single" 23 "Proximal tubular cells: 6.5" "Cancer enriched" "Detected in single" 7 "renal cancer: 0.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.3" "Lineage enriched" "Detected in single" 5 "T-cells: 2.3" "Cell line enhanced" "Detected in some" "HeLa: 2.2" "Low region specificity" "Detected in all" "HPA035603, HPA035962" Enhanced NA NA "HPA035603: AB_10672869, HPA035962: AB_2674890" "unprognostic (2.73e-2)" "unprognostic (6.70e-2)" "unprognostic (2.80e-1)" "unprognostic (5.68e-2)" "unprognostic (7.13e-3)" "unprognostic (3.50e-3)" "unprognostic (6.83e-2)" "unprognostic (1.49e-1)" "unprognostic (3.48e-1)" "unprognostic (2.09e-1)" "unprognostic (3.04e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-5)" "unprognostic (3.39e-1)" "unprognostic (1.96e-2)" "unprognostic (5.24e-2)" "unprognostic (2.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 16.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.1 0.3 0.0 2.3 0.0 0.2 0.5 0.1 0.7 0.4 0.5 0.1 0.3 0.0 0.2 0.3 0.0 0.5 0.9 0.2 0.1 0.6 0.8 0.5 0.7 0.1 0.4 0.1 0.0 2.2 0.0 0.1 0.0 0.8 0.0 0.5 0.1 1.5 0.8 0.0 0.9 0.0 0.1 1.1 0.1 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.2 0.0 1.2 0.1 0.1 0.0 0.5 0.0 0.4 0.1 0.1 0.0 0.3 0.7 1.2 0.3 0.3 0.4 0.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.4 0.1 0.3 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A14 "OCTL2, ORCTL4" ENSG00000144671 "Solute carrier family 22 member 14" Q9Y267 3 38282294-38318575 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 13.2" "Group enriched" "Detected in some" 44 "Early spermatids: 57.6;Late spermatids: 81.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "neutrophil: 1.4;plasmacytoid DC: 1.2" "Group enriched" "Detected in many" 13 "dendritic cells: 1.2;granulocytes: 1.4" "Cell line enhanced" "Detected in some" "hTCEpi: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (6.26e-2)" "unprognostic (6.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.17e-1)" "unprognostic (6.25e-2)" "unprognostic (4.78e-2)" "unprognostic (2.33e-1)" "unprognostic (1.52e-1)" "unprognostic (1.07e-1)" "unprognostic (4.97e-2)" "unprognostic (4.81e-2)" "unprognostic (1.69e-1)" "unprognostic (3.57e-4)" "unprognostic (2.19e-1)" "unprognostic (4.02e-2)" "unprognostic (1.69e-1)" "unprognostic (2.35e-1)" 0.1 0.0 0.2 0.0 0.3 0.5 0.0 1.6 0.9 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.3 1.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.2 13.2 0.0 0.0 0.0 0.0 0.0 1.2 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.7 0.7 1.3 0.2 0.1 0.6 0.4 1.0 1.6 0.1 0.0 0.4 0.9 0.5 0.8 0.0 0.0 0.1 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.9 2.9 0.0 0.8 1.1 0.1 1.1 0.0 0.0 0.7 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.4 0.7 0.1 1.4 0.0 0.0 1.9 0.0 1.1 0.6 0.3 0.3 0.3 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 57.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 81.6 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.1 SLC22A15 FLIPT1 ENSG00000163393 "Solute carrier family 22 member 15" Q8IZD6 1 115976498-116070054 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.6;brain: 27.8" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 10.7;Cone photoreceptor cells: 9.8;Kupffer cells: 8.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Group enriched" "Detected in many" 7 "granulocytes: 3.9;monocytes: 2.9" "Cell line enhanced" "Detected in many" "hTCEpi: 21.1;hTERT-HME1: 27.9;NB-4: 15.2;THP-1: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019785 Uncertain NA NA "HPA019785: AB_1857011" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.01e-3)" "unprognostic (5.62e-2)" "unprognostic (5.22e-2)" "unprognostic (5.85e-5)" "unprognostic (8.91e-3)" "unprognostic (1.81e-1)" "unprognostic (4.97e-2)" "unprognostic (5.15e-2)" "unprognostic (9.06e-2)" "unprognostic (7.29e-3)" "unprognostic (8.78e-3)" "unprognostic (3.44e-1)" "unprognostic (9.97e-4)" "unprognostic (1.30e-1)" 2.9 4.5 7.0 3.2 14.1 34.6 2.3 8.6 11.1 2.6 2.1 27.8 0.7 1.7 1.9 2.2 5.5 2.4 2.9 6.1 9.9 8.0 4.9 1.3 6.3 1.7 20.0 8.1 2.0 4.2 7.5 4.5 2.9 15.1 2.8 2.7 2.5 4.6 2.7 0.8 11.8 1.7 1.7 14.1 3.5 4.8 1.8 17.6 0.0 4.0 0.8 1.9 2.5 4.6 0.5 0.3 3.9 2.9 0.2 0.0 0.3 1.6 0.1 1.2 0.0 2.2 2.7 0.8 2.7 3.9 1.6 2.9 0.0 0.3 1.8 2.9 1.3 1.4 2.5 2.0 5.5 1.6 0.0 1.3 1.8 1.9 0.2 7.3 2.7 2.5 2.7 21.1 0.0 27.9 0.1 0.0 0.0 0.1 0.0 2.7 1.5 0.0 15.2 1.7 1.5 1.3 0.0 0.0 0.0 2.3 0.9 1.3 1.1 4.6 0.9 7.8 1.9 0.2 16.5 0.0 2.9 1.6 0.5 0.6 2.8 2.6 0.2 3.1 4.5 4.6 1.0 2.5 0.9 0.0 0.7 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 3.9 0.2 2.9 0.0 0.0 0.3 7.0 14.1 8.6 11.1 9.9 8.0 20.0 8.1 15.1 17.6 0.0 10.7 0.8 2.9 2.5 2.1 7.5 0.0 4.0 2.3 5.2 9.8 0.5 1.7 1.1 0.6 0.0 0.0 0.0 0.3 0.3 1.3 0.8 1.1 0.0 2.9 7.9 8.1 1.3 8.6 0.0 0.9 5.9 1.7 1.0 0.2 0.8 1.7 0.2 0.4 0.1 2.0 0.0 1.0 0.2 0.2 2.6 0.0 0.5 0.4 0.9 SLC22A16 "CT2, FLIPT2, OAT6, OKB1" ENSG00000004809 "Solute carrier family 22 member 16" Q86VW1 6 110424687-110476641 "Predicted membrane proteins" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 9.5;bone marrow: 16.0;parathyroid gland: 9.6;testis: 26.4" "Group enriched" "Detected in some" 5 "Early spermatids: 28.2;Erythroid cells: 23.3;Late spermatids: 23.1;Spermatocytes: 35.7" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 0.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 9.5" "Group enriched" "Detected in many" 66 "dendritic cells: 5.1;granulocytes: 5.0;monocytes: 9.5" "Group enriched" "Detected in some" 18 "NB-4: 9.8;REH: 9.0;THP-1: 31.3;U-937: 18.4" "Low region specificity" "Detected in all" HPA036902 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA036902: AB_10672274" "unprognostic (1.01e-1)" "unprognostic (1.88e-2)" "unprognostic (5.11e-3)" "unprognostic (2.19e-3)" "unprognostic (2.70e-4)" "unprognostic (1.45e-1)" "unprognostic (8.15e-2)" "unprognostic (6.93e-2)" "unprognostic (1.48e-2)" "unprognostic (4.98e-2)" "unprognostic (1.02e-3)" "unprognostic (2.49e-1)" "unprognostic (2.61e-6)" "unprognostic (5.78e-4)" "unprognostic (2.72e-2)" "unprognostic (2.74e-2)" "unprognostic (2.65e-2)" 3.5 0.2 0.2 0.4 0.2 16.0 0.2 0.1 0.2 0.1 0.7 0.0 0.0 0.0 4.9 0.8 0.1 0.3 0.7 0.1 0.2 0.1 1.1 0.3 1.6 0.0 0.2 0.0 0.9 0.1 9.6 0.1 0.3 0.2 0.2 0.0 0.0 0.6 0.0 0.2 0.3 0.1 1.6 0.2 0.8 0.2 26.4 0.0 2.2 0.1 0.8 0.1 0.1 0.1 0.0 5.1 5.0 9.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 18.4 0.0 5.0 9.5 1.6 0.0 2.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.2 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 23.3 0.0 0.1 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.2 23.1 1.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 35.7 0.2 0.4 0.0 0.0 0.0 0.0 SLC22A17 "BOCT, BOIT, NGALR" ENSG00000092096 "Solute carrier family 22 member 17" Q8WUG5 14 23346306-23352912 "Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 112.4" "Cell type enhanced" "Detected in many" 13 "Horizontal cells: 190.7;Muller glia cells: 81.5;Rod photoreceptor cells: 64.5" "Cancer enhanced" "Detected in all" "glioma: 51.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.1;naive CD4 T-cell: 3.6;naive CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 26 "T-cells: 3.6" "Cell line enhanced" "Detected in many" "AN3-CA: 20.8;ASC diff: 17.3;SH-SY5Y: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002728 Uncertain NA NA "HPA002728: AB_1079998" "unprognostic (9.34e-2)" "unprognostic (2.34e-1)" "unprognostic (2.31e-2)" "unprognostic (6.23e-3)" "unprognostic (2.85e-2)" "unprognostic (1.07e-1)" "unprognostic (2.31e-2)" "unprognostic (1.26e-2)" "unprognostic (4.23e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.73e-4)" "unprognostic (1.78e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (3.50e-2)" "unprognostic (1.23e-2)" "unprognostic (3.87e-2)" 6.0 24.2 32.9 4.0 63.4 1.6 7.0 40.7 112.4 12.1 5.6 27.4 2.4 4.5 8.0 10.1 4.7 10.2 7.6 9.1 35.6 69.4 8.6 2.0 5.0 3.8 28.5 27.3 11.0 14.5 13.3 39.4 5.3 33.1 21.9 3.5 13.2 20.5 24.4 2.1 6.6 6.6 7.7 21.8 3.6 6.1 6.6 22.1 0.0 10.8 0.1 2.6 4.2 4.8 0.1 0.0 0.0 0.0 0.0 3.6 0.2 0.0 1.2 13.0 20.8 17.3 9.1 2.0 4.5 8.9 1.7 1.3 0.1 1.2 0.0 1.7 8.4 4.0 0.2 0.6 0.5 0.1 0.0 0.7 2.9 0.0 0.1 9.3 0.0 2.9 11.8 0.8 2.0 0.0 7.5 0.5 5.6 0.0 0.1 2.7 1.9 0.1 0.1 7.1 0.0 0.0 0.0 0.5 0.1 0.0 1.2 12.3 24.2 3.7 0.0 0.0 2.8 2.4 0.4 0.0 1.9 5.6 10.4 0.0 0.0 2.0 0.0 1.2 0.0 7.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.1 3.6 1.8 0.0 0.0 0.0 0.0 0.0 0.2 32.9 63.4 40.7 64.3 35.6 69.4 28.5 27.3 33.1 22.1 0.0 2.4 0.0 18.6 11.2 49.9 9.0 5.1 5.3 9.1 19.2 41.2 1.8 1.7 0.6 0.3 6.8 0.0 0.0 1.2 4.1 14.9 27.1 4.6 0.8 0.8 190.7 20.0 17.8 0.8 1.3 19.5 2.2 6.8 1.0 0.0 81.5 2.4 0.0 40.3 13.5 64.5 0.0 20.0 0.9 2.1 9.5 4.0 0.0 0.0 4.6 SLC22A18 "BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5" ENSG00000110628 "Solute carrier family 22 member 18" Q96BI1 11 2899721-2925246 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 71.4;liver: 44.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 511.8;Late spermatids: 354.1;Paneth cells: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.6;Karpas-707: 20.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA067812, HPA071461" Enhanced NA NA "HPA067812: AB_2685902, HPA071461: AB_2686401" "unprognostic (1.10e-1)" "unprognostic (1.14e-1)" "unprognostic (4.80e-1)" "unprognostic (7.75e-2)" "unprognostic (7.92e-3)" "unprognostic (2.67e-1)" "unprognostic (8.25e-2)" "unprognostic (4.21e-1)" "unprognostic (2.56e-2)" "unprognostic (3.48e-2)" "unprognostic (9.35e-2)" "unprognostic (8.60e-2)" "unprognostic (8.36e-2)" "unprognostic (9.51e-2)" "unprognostic (5.97e-3)" "unprognostic (1.55e-1)" "unprognostic (2.82e-1)" 3.5 1.6 0.5 11.4 1.2 1.4 3.2 0.1 2.0 2.6 36.6 0.8 2.9 36.7 3.1 15.2 6.1 4.7 21.9 8.5 0.9 1.1 18.2 44.3 8.7 8.3 1.0 1.7 2.9 3.0 4.1 1.5 4.9 1.3 4.0 3.7 4.2 8.6 4.3 1.0 6.5 71.4 3.7 1.2 4.7 8.1 2.8 0.8 3.1 8.1 7.6 5.4 4.5 4.4 2.1 8.9 21.7 15.0 2.7 4.6 6.0 1.4 8.7 0.0 4.9 0.9 1.4 3.6 2.9 5.2 1.7 3.0 5.1 21.6 0.6 9.2 3.9 3.7 4.7 0.2 0.4 0.4 4.3 0.7 0.1 2.1 4.6 9.6 0.0 4.0 4.0 0.9 1.4 0.3 1.5 0.0 3.0 0.1 20.1 0.9 4.4 0.1 0.6 0.5 7.0 1.9 1.5 0.0 2.7 0.8 3.0 0.1 1.6 1.1 12.6 10.4 0.1 2.4 2.5 0.2 1.3 2.8 4.0 0.2 3.6 0.8 0.2 5.3 2.7 5.0 15.3 15.0 12.6 3.5 14.3 2.0 2.1 2.8 2.5 8.9 1.3 1.5 2.2 21.7 2.7 10.8 6.4 4.6 6.0 0.5 1.2 0.1 2.0 0.9 1.1 1.0 1.7 1.3 0.8 6.0 8.1 3.9 17.1 6.5 1.2 8.6 71.4 16.0 9.1 26.2 0.0 70.1 6.6 24.6 135.4 3.2 511.8 0.0 7.7 17.5 12.2 13.4 16.1 138.4 40.5 0.0 19.0 6.2 27.6 354.1 9.8 18.7 18.6 14.4 72.1 5.0 15.7 245.4 7.1 76.4 1.0 0.0 11.3 1.9 2.4 7.8 151.6 15.3 106.9 17.1 SLC22A2 OCT2 ENSG00000112499 "Solute carrier family 22 member 2" O15244 6 160171061-160277638 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 61.8" "Group enriched" "Detected in some" 13 "Distal tubular cells: 77.9;Proximal tubular cells: 187.0" "Cancer enriched" "Detected in single" 493 "renal cancer: 30.8" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.8;SuSa: 1.0;U-2197: 3.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA008549, CAB068236, CAB068237" Enhanced NA NA "CAB068236: AB_2665668, CAB068237: AB_2665669, HPA008549: " "unprognostic (1.01e-1)" "unprognostic (3.67e-1)" "unprognostic (2.26e-1)" "unprognostic (3.67e-2)" "unprognostic (4.24e-1)" "unprognostic (3.33e-1)" "unprognostic (2.51e-2)" "unprognostic (3.30e-1)" "unprognostic (1.42e-2)" "unprognostic (1.15e-4)" "unprognostic (1.41e-1)" "unprognostic (3.68e-1)" "prognostic favorable (1.85e-7)" "unprognostic (1.65e-2)" "unprognostic (8.20e-2)" "unprognostic (4.11e-1)" "unprognostic (2.45e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.1 61.8 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.3 0.2 1.9 0.1 0.0 2.7 0.0 0.6 0.3 0.0 0.1 0.1 6.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.3 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.2 1.0 0.2 0.1 0.0 0.2 0.0 3.8 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.5 0.0 0.3 0.1 0.0 0.0 0.2 0.6 0.3 0.2 0.1 0.8 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 10.4 0.0 0.0 77.9 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 187.0 0.0 0.0 0.3 0.0 0.1 0.3 0.1 0.0 0.0 0.0 SLC22A23 "C6orf85, FLJ22174" ENSG00000137266 "Solute carrier family 22 member 23" A1A5C7 6 3268962-3457022 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 73.9;Late spermatids: 171.9;Mucus-secreting cells: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014697 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA014697: AB_1844371" "unprognostic (4.58e-2)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "prognostic favorable (6.57e-4)" "unprognostic (5.16e-3)" "unprognostic (3.25e-3)" "unprognostic (1.40e-1)" "unprognostic (4.53e-3)" "unprognostic (9.74e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (2.39e-4)" "unprognostic (8.91e-2)" "unprognostic (4.30e-1)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" 7.4 2.2 9.0 4.6 16.2 8.1 9.3 8.4 14.8 5.6 17.4 30.8 3.4 19.6 3.6 11.8 16.8 11.3 7.5 2.2 11.0 8.1 6.9 12.6 8.0 3.9 28.6 8.7 3.0 14.9 14.8 6.5 8.3 17.8 14.2 14.4 5.7 10.0 2.8 5.9 14.9 20.3 3.0 17.5 4.6 26.0 7.2 21.0 5.2 4.1 9.8 9.9 3.8 9.9 0.1 0.7 0.8 0.3 0.3 1.4 1.9 2.4 5.6 12.5 13.9 4.4 5.0 16.0 0.4 0.1 0.7 0.3 12.5 0.4 0.6 1.4 2.7 11.1 3.6 2.5 6.6 0.2 2.0 7.7 5.8 2.1 11.0 0.6 0.3 0.4 1.2 13.0 12.1 0.6 2.6 0.4 3.2 5.2 3.3 0.4 2.9 0.5 1.4 4.3 13.7 2.3 1.3 0.8 9.9 0.0 15.3 1.4 0.2 3.3 4.8 4.1 13.3 18.5 0.1 3.1 7.3 2.3 9.4 1.5 7.5 0.1 0.2 12.8 0.4 4.4 0.0 0.3 0.0 0.4 0.0 0.2 0.0 1.0 0.4 0.2 0.1 1.4 0.9 0.8 0.3 0.2 0.7 0.0 1.9 9.0 16.2 8.4 14.8 11.0 8.1 28.6 8.7 17.8 21.0 6.0 13.7 0.5 4.2 10.3 7.9 2.4 10.2 33.5 17.0 5.2 7.9 12.2 0.0 2.5 73.9 8.4 29.0 23.3 7.0 0.9 1.4 19.2 0.0 10.0 9.8 0.0 4.1 6.7 8.0 171.9 1.7 2.0 3.3 10.8 52.1 9.1 5.7 14.4 0.7 2.4 3.4 0.0 0.9 2.1 1.1 11.0 7.7 1.0 22.6 3.9 SLC22A24 "MGC34821, NET46" ENSG00000197658 "Solute carrier family 22 member 24" Q8N4F4 11 63079940-63144221 "Predicted membrane proteins, Transporters" "Ion transport, Lipid metabolism, Steroid metabolism, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "kidney: 10.5" "Cell type enriched" "Detected in single" 30 "Proximal tubular cells: 8.4" "Cancer enriched" "Detected in single" 11 "renal cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045015 Uncertain NA NA "HPA045015: AB_2679183" "unprognostic (5.72e-3)" "unprognostic (1.80e-7)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A25 "HIMTP, MGC120420, UST6" ENSG00000196600 "Solute carrier family 22 member 25" Q6T423 11 63163776-63229652 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 165 "liver: 16.5" "Cell type enriched" "Detected in single" 9 "Hepatocytes: 5.8" "Cancer enriched" "Detected in single" 66 "liver cancer: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039390 Uncertain NA NA "HPA039390: AB_10671996" "unprognostic (3.19e-2)" "unprognostic (2.38e-1)" "unprognostic (4.51e-1)" "prognostic favorable (7.04e-4)" "unprognostic (1.01e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A3 "EMT, OCT3" ENSG00000146477 "Solute carrier family 22 member 3" O75751 6 160348268-160452581 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 98.6" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 62.8;Hepatocytes: 56.3;Leydig cells: 31.4;Pancreatic endocrine cells: 33.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 17.6;HeLa: 23.6;Hep G2: 14.7;hTERT-RPE1: 6.2;OE19: 7.5;RPTEC TERT1: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029750 Approved Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA029750: AB_10603888" "unprognostic (8.61e-2)" "prognostic unfavorable (7.19e-5)" "unprognostic (4.14e-1)" "unprognostic (1.49e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (3.36e-2)" "unprognostic (9.74e-2)" "unprognostic (9.36e-4)" "unprognostic (1.33e-2)" "unprognostic (2.58e-2)" "unprognostic (7.28e-2)" "unprognostic (7.96e-2)" "unprognostic (5.21e-2)" "unprognostic (8.13e-4)" "prognostic unfavorable (7.26e-4)" 4.1 6.9 1.0 2.1 1.3 0.0 5.2 1.8 0.9 7.6 4.1 0.9 4.1 0.2 14.2 11.8 4.1 9.0 9.0 1.1 1.2 1.3 2.4 15.2 12.7 9.7 2.2 0.9 10.3 1.3 0.0 0.9 17.8 1.9 18.9 0.6 0.9 34.5 23.0 98.6 5.1 2.7 10.8 4.4 0.3 2.9 3.4 0.6 0.4 3.4 5.7 2.1 3.2 7.3 0.0 0.0 0.8 0.0 0.1 1.5 0.0 0.0 17.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.2 0.0 0.0 0.0 23.6 14.7 0.8 0.0 0.0 0.5 4.5 2.2 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 7.5 4.9 0.0 0.0 0.0 9.0 0.0 0.0 0.0 1.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.0 1.0 1.3 1.8 0.9 1.2 1.3 2.2 0.9 1.9 0.6 14.9 62.8 0.0 0.3 4.1 0.0 1.6 5.1 1.4 10.3 0.0 0.0 0.4 5.0 9.1 0.4 0.3 0.7 0.0 2.5 0.2 11.0 3.4 2.3 56.3 0.6 0.0 0.0 0.0 0.6 0.9 31.4 1.5 3.3 0.0 0.4 0.0 33.9 0.0 23.0 2.1 0.0 0.0 11.4 0.2 0.1 5.8 0.3 0.0 0.4 0.7 SLC22A31 ENSG00000259803 "Solute carrier family 22 member 31" 16 89195761-89201664 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 21 "brain: 39.3;lung: 50.7;pancreas: 69.7" "Cell type enriched" "Detected in some" 6 "Alveolar cells type 2: 129.3" "Group enriched" "Detected in many" 9 "liver cancer: 6.1;lung cancer: 26.2;thyroid cancer: 20.4" "Region enriched" "Detected in some" 23 "cerebellum: 39.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 23.7;Hep G2: 19.0;NB-4: 9.7;RPMI-8226: 11.4;THP-1: 6.2" NA NA "unprognostic (2.71e-3)" "unprognostic (2.53e-1)" "unprognostic (5.02e-3)" "unprognostic (6.82e-2)" "unprognostic (8.20e-2)" "unprognostic (1.95e-1)" "unprognostic (3.00e-2)" "unprognostic (1.93e-2)" "unprognostic (2.12e-1)" "unprognostic (2.67e-1)" "unprognostic (8.98e-2)" "unprognostic (1.09e-1)" "unprognostic (8.26e-4)" "unprognostic (2.74e-1)" "unprognostic (2.05e-1)" "unprognostic (2.72e-3)" "unprognostic (1.89e-1)" 0.1 0.3 0.0 0.3 0.4 1.1 0.1 39.3 0.1 0.3 0.5 0.0 0.0 0.6 0.2 0.5 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.3 50.7 2.5 0.0 0.0 0.7 69.7 0.1 0.0 0.1 1.7 0.2 0.1 0.4 0.7 0.2 0.1 0.3 0.3 0.1 0.3 1.0 0.5 1.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.0 1.1 0.0 0.0 23.7 0.1 0.0 0.0 0.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 19.0 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.0 9.7 0.6 0.2 2.4 0.0 2.6 11.4 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.1 0.2 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 39.3 0.1 0.1 0.0 0.0 0.0 1.7 0.0 6.0 129.3 0.0 0.0 0.0 0.0 0.4 0.0 4.0 14.8 0.0 0.0 0.0 0.0 0.1 20.8 0.0 0.0 0.0 4.2 0.1 0.0 0.2 8.1 0.2 0.6 0.0 0.0 0.6 0.3 23.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 2.8 0.1 0.0 0.0 0.0 0.0 SLC22A4 "DFNB60, MGC34546, OCTN1" ENSG00000197208 "Solute carrier family 22 member 4" Q9H015 5 132294443-132344206 "Disease related genes, Predicted membrane proteins" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Ciliated cells: 89.7;Erythroid cells: 70.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 23.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 23.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 35.1;U-138 MG: 14.9" "Region enhanced" "Detected in all" "cerebellum: 72.4" "Low region specificity" "Detected in all" "CAB015468, HPA036974" Approved Approved Mitochondria NA NA Mitochondria "CAB015468: , HPA036974: AB_2732474" "unprognostic (1.33e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (8.42e-3)" "unprognostic (6.17e-2)" "unprognostic (6.22e-3)" "unprognostic (4.17e-3)" "unprognostic (3.33e-1)" "unprognostic (1.30e-1)" "unprognostic (9.79e-2)" "unprognostic (1.95e-3)" "unprognostic (7.82e-2)" "unprognostic (1.74e-2)" "unprognostic (2.31e-3)" "unprognostic (1.20e-1)" "unprognostic (1.95e-2)" "unprognostic (4.06e-2)" 2.7 4.1 3.5 3.8 5.0 22.4 3.1 3.1 4.7 2.4 5.9 4.4 1.8 4.6 2.1 3.2 0.8 14.7 2.6 3.0 3.9 4.9 15.4 1.6 7.2 3.8 3.2 2.0 5.0 1.0 7.7 6.9 6.8 12.6 5.4 3.1 13.8 2.6 4.1 9.2 1.7 18.1 1.5 9.9 7.7 2.2 0.9 2.7 0.5 1.0 2.7 0.8 2.5 2.2 0.0 1.7 23.0 3.5 0.0 0.0 0.6 1.1 1.7 0.1 0.4 0.8 0.6 0.5 7.6 35.1 5.9 6.1 0.7 1.9 0.3 2.1 4.4 4.4 1.9 0.0 1.2 4.1 1.4 0.2 0.1 3.3 0.1 0.6 2.3 0.0 1.4 0.2 3.2 3.0 2.1 2.5 0.2 3.0 4.0 4.5 0.6 0.0 5.4 0.2 0.1 1.9 0.0 0.4 0.2 0.9 0.1 0.5 0.2 8.3 0.5 0.2 0.2 0.3 1.4 3.1 14.9 1.4 5.8 1.9 0.0 1.5 0.0 4.4 2.7 1.7 0.0 3.5 3.5 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 23.0 0.0 0.2 0.2 0.0 0.6 3.5 5.0 3.1 4.7 3.9 4.9 3.2 2.0 12.6 2.7 3.0 0.0 0.0 1.0 0.7 1.6 0.8 2.5 89.7 13.6 0.0 0.0 0.6 0.0 3.2 0.0 2.1 5.3 70.0 0.3 1.6 1.4 2.2 0.0 0.0 4.2 3.2 1.2 0.6 1.5 0.0 0.6 4.3 0.0 0.0 0.4 1.5 1.2 1.4 0.0 4.9 0.3 0.0 1.0 0.4 0.2 0.4 2.1 0.0 1.1 0.9 SLC22A5 "CDSP, OCTN2, SCD" ENSG00000197375 "Solute carrier family 22 member 5" O76082 5 132369752-132395614 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.3;skeletal muscle: 93.6" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 22.3;SiHa: 23.0" HPA063062 Approved Mitochondria NA NA Mitochondria "HPA063062: AB_2684934" "unprognostic (3.88e-1)" "unprognostic (1.69e-1)" "unprognostic (2.19e-2)" "prognostic favorable (2.87e-5)" "unprognostic (5.37e-3)" "unprognostic (1.18e-1)" "unprognostic (1.50e-2)" "unprognostic (9.24e-2)" "unprognostic (1.57e-1)" "unprognostic (5.09e-2)" "prognostic favorable (7.36e-4)" "unprognostic (3.53e-2)" "prognostic favorable (8.36e-4)" "unprognostic (1.12e-2)" "unprognostic (2.98e-2)" "unprognostic (2.17e-2)" "unprognostic (1.17e-2)" 3.0 4.7 4.0 1.9 4.9 0.6 4.4 9.0 4.2 4.4 10.6 3.6 15.0 11.8 3.6 12.6 2.5 7.4 5.2 7.2 3.8 3.8 42.3 4.5 2.3 1.5 3.5 3.2 3.9 5.2 17.9 8.5 8.1 3.9 8.2 8.3 5.9 4.2 21.8 93.6 3.5 19.6 2.9 3.8 1.7 4.4 2.5 2.7 1.0 5.0 3.2 2.4 3.9 3.2 1.4 6.4 0.4 4.1 1.5 4.0 2.1 3.6 8.7 0.5 7.0 2.8 1.3 12.1 1.6 1.8 2.8 3.9 6.4 7.5 1.7 3.8 1.6 8.1 8.7 5.8 4.3 3.3 2.2 7.1 0.9 22.3 2.9 4.7 1.4 1.5 1.3 8.1 1.9 9.9 4.8 0.7 3.2 4.0 1.1 2.6 6.2 2.1 1.4 0.6 6.3 3.8 0.8 0.0 9.4 8.4 9.1 3.0 2.1 23.0 18.0 4.4 1.9 8.3 1.8 0.4 0.5 2.5 5.9 2.0 3.8 7.4 0.1 1.8 3.6 1.6 0.0 4.1 0.0 2.6 2.2 2.8 1.4 2.4 3.1 6.4 1.4 2.6 3.0 0.4 1.5 0.7 0.6 4.0 2.1 4.0 4.9 9.0 4.2 3.8 3.8 3.5 3.2 3.9 2.7 8.9 5.1 2.7 5.9 6.8 6.5 5.2 20.4 6.7 3.4 15.7 11.8 16.6 1.7 8.8 1.4 3.0 46.4 0.0 4.5 4.8 4.0 12.8 0.0 5.9 4.0 9.5 6.9 1.3 8.7 2.3 6.1 2.6 5.0 0.0 12.6 8.7 5.4 25.9 3.9 23.2 7.4 0.0 1.9 7.2 2.5 5.5 6.9 2.9 16.1 7.8 SLC22A6 "OAT1, PAHT, ROAT1" ENSG00000197901 "Solute carrier family 22 member 6" Q4U2R8 11 62936385-62984983 "FDA approved drug targets, Predicted membrane proteins, Transporters" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "kidney: 94.2" "Cell type enriched" "Detected in some" 14 "Proximal tubular cells: 213.4" "Cancer enriched" "Detected in single" 102 "renal cancer: 18.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA074559, CAB075704" Enhanced NA NA "CAB075704: , HPA074559: AB_2732260" "unprognostic (2.42e-2)" "unprognostic (2.25e-3)" "unprognostic (4.43e-1)" 0.2 0.2 0.8 0.2 1.3 0.2 0.2 0.4 1.4 0.2 0.2 0.7 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 1.8 94.2 0.2 0.2 0.2 2.4 0.6 0.2 0.2 0.2 0.1 0.2 4.1 0.2 0.2 9.4 0.2 0.2 0.2 0.2 0.2 0.2 2.4 0.2 0.2 0.2 0.5 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.4 1.4 0.8 1.8 2.4 0.6 4.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 213.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A7 "NLT, OAT2" ENSG00000137204 "Solute carrier family 22 member 7" Q9Y694 6 43295694-43305538 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 88.9" "Group enriched" "Detected in some" 16 "Hepatocytes: 185.6;Proximal tubular cells: 86.1" "Cancer enriched" "Detected in some" 37 "liver cancer: 81.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 4 "B-cells: 1.2" "Cell line enriched" "Detected in single" 19 "Hep G2: 14.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA030220 Approved NA NA "HPA030220: AB_10603027" "unprognostic (9.17e-2)" "unprognostic (9.73e-4)" "unprognostic (2.13e-1)" "prognostic favorable (5.48e-6)" "unprognostic (1.45e-1)" "unprognostic (1.54e-3)" "unprognostic (1.74e-2)" "prognostic favorable (8.98e-4)" "unprognostic (1.29e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.8 88.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.3 2.5 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.6 0.0 0.0 0.0 1.8 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A8 OAT3 ENSG00000149452 "Solute carrier family 22 member 8" Q8TCC7 11 62989154-63015839 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Detoxification, Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 341 "brain: 33.7;kidney: 127.3;retina: 93.5" "Cell type enriched" "Detected in some" 30 "Proximal tubular cells: 197.4" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Region enriched" "Detected in some" 25 "pons and medulla: 33.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "EFO-21: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044174 Enhanced NA NA "HPA044174: AB_10963058" "unprognostic (5.35e-4)" "unprognostic (4.66e-1)" "unprognostic (6.88e-3)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 1.0 0.1 0.1 3.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 127.3 0.1 0.1 0.1 0.1 1.3 0.1 0.1 0.1 0.2 0.1 33.7 0.1 0.1 93.5 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 1.0 0.7 0.1 0.1 1.3 33.7 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.8 0.0 0.0 0.0 5.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A9 "FLJ23666, OAT4, OAT7, UST3" ENSG00000149742 "Solute carrier family 22 member 9" Q8IVM8 11 63369789-63410294 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 32.2" "Cell type enhanced" "Detected in some" 30 "Cholangiocytes: 2.5;granulocytes: 4.6;Hepatocytes: 12.7" "Cancer enriched" "Detected in single" 166 "liver cancer: 19.3" "Region enhanced" "Detected in single" "cerebral cortex: 1.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 2.1;Karpas-707: 1.9;U-266/70: 2.4" NA NA "unprognostic (2.45e-1)" "unprognostic (7.24e-2)" "unprognostic (8.86e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (2.17e-1)" "unprognostic (2.71e-1)" "unprognostic (3.09e-2)" 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 2.8 0.8 0.9 0.5 0.3 0.4 0.5 0.0 0.6 0.2 0.0 0.9 0.0 0.3 0.1 0.2 0.2 0.4 0.5 0.2 0.1 0.1 0.4 0.0 0.5 0.1 1.3 0.3 0.3 0.5 2.1 0.0 0.1 0.5 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.3 1.9 0.1 0.6 0.3 0.9 0.7 0.1 0.2 0.1 1.1 0.1 0.0 0.5 0.1 0.2 0.0 0.3 0.2 0.0 0.4 0.5 0.0 0.5 0.3 0.6 0.3 2.4 0.5 1.0 0.3 0.6 0.3 2.8 0.8 0.7 0.4 0.5 0.2 0.5 0.2 0.3 0.2 1.0 0.4 0.5 2.2 0.9 0.2 0.6 0.3 0.3 0.4 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 4.6 12.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 SLC23A1 "SLC23A2, SVCT1, YSPL3" ENSG00000170482 "Solute carrier family 23 member 1" Q9UHI7 5 139367196-139384553 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 24.8;intestine: 94.3;liver: 25.4" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 18.7;Hepatocytes: 17.5;Proximal tubular cells: 25.1" "Group enriched" "Detected in many" 5 "endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 7.8;Hep G2: 11.1;JURKAT: 13.0;Karpas-707: 9.2;RPMI-8226: 9.0;U-266/70: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA047612 Enhanced NA NA "HPA047612: AB_2680102" "unprognostic (4.00e-3)" "unprognostic (2.66e-3)" "unprognostic (2.63e-2)" "unprognostic (1.75e-3)" "unprognostic (1.93e-1)" "unprognostic (6.36e-6)" "unprognostic (7.41e-2)" "unprognostic (6.55e-2)" "unprognostic (5.88e-2)" "unprognostic (3.90e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-2)" "unprognostic (4.16e-2)" "unprognostic (1.55e-2)" "unprognostic (3.65e-3)" 0.3 0.0 0.3 0.5 0.5 0.8 0.3 0.3 0.3 2.3 22.1 0.3 0.8 11.6 0.3 1.6 0.3 24.8 1.8 0.3 0.3 0.3 18.0 25.4 0.6 0.4 0.3 0.3 0.4 0.9 0.0 0.3 0.3 0.4 2.7 0.3 0.3 1.0 0.6 0.3 1.0 94.3 0.3 0.3 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.2 4.4 0.7 0.1 0.0 0.3 0.0 0.2 1.8 0.3 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 7.8 1.0 4.7 2.5 0.0 0.1 0.2 0.0 0.0 0.1 6.7 0.1 0.1 0.6 11.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 13.0 0.1 9.2 0.0 0.1 4.6 0.8 0.1 0.7 0.1 5.6 0.2 9.0 0.4 0.3 0.2 0.3 0.2 1.6 0.0 0.6 4.3 0.1 0.3 0.3 0.2 0.1 0.0 14.3 1.7 6.2 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.0 1.2 0.2 0.0 0.7 0.0 0.1 4.4 0.3 0.0 0.3 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 18.7 3.4 0.0 3.9 0.4 5.0 0.1 0.0 0.0 5.1 0.0 0.2 0.0 0.0 1.3 0.0 17.5 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.5 0.0 25.1 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.7 0.1 SLC23A2 "KIAA0238, SLC23A1, SVCT2, YSPL2" ENSG00000089057 "Solute carrier family 23 member 2" Q9UGH3 20 4852356-5010293 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 55.6" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 215.7;Cone photoreceptor cells: 108.0;Horizontal cells: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052825, HPA059314" Approved Uncertain "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA052825: AB_2681965, HPA059314: AB_2683975" "unprognostic (3.83e-1)" "unprognostic (1.08e-2)" "unprognostic (1.95e-3)" "unprognostic (1.64e-3)" "unprognostic (8.05e-2)" "unprognostic (2.09e-1)" "prognostic favorable (3.35e-4)" "unprognostic (6.22e-3)" "unprognostic (2.08e-1)" "unprognostic (6.36e-3)" "prognostic favorable (7.14e-5)" "unprognostic (1.57e-1)" "unprognostic (1.60e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "prognostic favorable (6.08e-5)" 6.6 55.6 14.7 6.1 17.5 5.4 6.3 15.9 27.2 8.6 4.6 19.3 4.0 5.0 9.5 7.1 4.6 12.4 7.8 5.4 14.4 14.5 6.0 27.7 7.4 7.2 14.9 16.6 29.4 7.5 15.1 12.5 25.1 16.4 9.0 5.0 22.1 4.2 8.4 2.6 8.5 6.3 7.8 17.5 11.7 7.1 8.5 11.4 5.3 18.6 2.2 7.4 18.7 6.4 4.2 6.0 3.1 2.5 0.8 2.8 2.0 10.7 12.7 17.0 6.4 12.0 6.8 21.7 4.6 6.3 5.4 5.1 6.5 12.3 4.9 5.0 6.4 15.5 10.4 4.7 12.6 10.3 3.0 8.5 6.8 2.2 24.4 6.8 9.5 4.0 5.7 7.3 13.7 8.2 11.5 7.9 8.1 4.6 4.2 7.2 4.0 10.3 5.3 6.0 8.6 7.8 9.6 11.2 7.3 3.0 17.6 5.7 6.4 8.8 9.3 32.7 6.3 5.1 5.6 6.8 12.3 5.7 14.7 8.8 5.9 10.9 13.2 4.3 5.7 19.3 0.0 2.5 0.2 2.8 1.8 2.6 4.2 2.2 2.0 3.6 2.9 2.1 2.1 3.1 0.8 2.1 6.0 1.3 2.0 14.7 17.5 15.9 25.3 14.4 14.5 14.9 16.6 16.4 11.4 6.0 7.4 9.5 4.0 6.5 215.7 5.5 20.4 4.0 13.6 14.0 108.0 3.6 0.0 4.0 3.5 7.7 0.5 0.0 4.7 4.8 8.9 5.5 8.1 58.7 9.5 81.0 6.9 22.1 27.3 7.0 18.7 8.3 15.1 7.2 1.5 26.4 2.9 5.1 27.6 1.3 64.3 12.9 5.6 0.5 9.6 5.4 3.3 7.1 3.1 10.1 SLC23A3 "FLJ31168, SVCT3, Yspl1" ENSG00000213901 "Solute carrier family 23 member 3" Q6PIS1 2 219161465-219170095 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "intestine: 36.5;kidney: 32.4" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 6.7;Proximal tubular cells: 8.9" "Cancer enriched" "Detected in some" 9 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 9.0;U-266/70: 6.6" "Region enhanced" "Detected in some" "cerebral cortex: 1.3" "Not detected" "Not detected" HPA019059 Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA019059: AB_1857017" "unprognostic (2.49e-2)" "unprognostic (6.65e-2)" "unprognostic (2.05e-4)" "unprognostic (6.97e-2)" "unprognostic (8.41e-2)" "unprognostic (1.22e-2)" "unprognostic (9.07e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (4.35e-2)" "unprognostic (3.10e-1)" "unprognostic (6.12e-4)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (2.41e-2)" "unprognostic (3.34e-1)" "unprognostic (6.52e-5)" 0.4 0.0 0.3 2.3 0.3 0.0 0.5 0.3 0.5 0.8 14.9 0.3 0.3 5.3 1.1 0.3 0.9 0.5 0.3 0.3 0.3 0.0 32.4 3.1 0.7 0.3 0.3 0.3 1.0 0.4 0.5 0.3 0.5 0.3 1.4 0.8 0.3 0.4 0.3 0.3 1.1 36.5 0.3 0.3 0.4 0.5 0.3 0.3 0.3 1.3 0.3 0.4 0.6 1.3 0.8 0.0 0.0 0.8 0.0 0.5 0.0 0.9 0.4 0.2 1.1 4.0 2.2 0.8 2.2 0.6 0.4 1.3 2.4 1.6 0.5 0.8 1.5 0.1 3.2 0.7 0.3 0.6 1.9 1.8 2.1 1.9 0.2 0.7 0.2 0.9 0.7 9.0 0.9 2.9 3.6 1.2 1.2 0.3 0.9 0.6 0.3 0.1 1.0 0.0 0.8 0.2 0.5 0.6 0.8 3.1 3.7 0.5 1.0 0.2 0.0 2.4 1.1 0.9 1.1 2.6 2.1 1.4 2.2 0.7 6.6 0.3 2.9 0.6 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.3 0.3 0.3 0.5 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 2.0 1.1 1.3 0.8 0.3 2.5 0.0 0.0 1.8 0.0 0.2 1.7 0.2 0.0 0.7 6.7 0.0 0.0 0.1 0.6 1.4 0.0 0.5 0.2 0.0 1.7 0.6 0.3 0.0 1.4 0.4 1.7 1.0 2.8 1.9 0.2 3.1 1.1 8.9 0.1 0.0 0.8 0.0 0.1 1.4 0.3 0.0 1.6 0.7 SLC24A1 "CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX" ENSG00000074621 "Solute carrier family 24 member 1" O60721 15 65611366-65660995 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision" "Congenital stationary night blindness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "retina: 91.1" "Cell type enriched" "Detected in many" 11 "Rod photoreceptor cells: 301.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA039370 Enhanced Approved Microtubules NA NA Microtubules "HPA039370: AB_10960279" "unprognostic (9.47e-2)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.66e-3)" "unprognostic (6.39e-3)" "unprognostic (4.64e-1)" "unprognostic (8.82e-2)" "unprognostic (1.86e-1)" "unprognostic (4.69e-2)" "unprognostic (3.94e-1)" "unprognostic (2.01e-1)" "unprognostic (9.91e-2)" "prognostic favorable (2.33e-6)" "unprognostic (8.45e-2)" "unprognostic (9.22e-2)" "unprognostic (3.04e-2)" "unprognostic (1.96e-2)" 6.2 5.3 4.5 7.7 5.0 2.6 9.3 7.0 3.4 8.9 5.0 5.6 7.5 3.7 10.6 12.2 4.2 9.0 6.2 4.1 4.7 4.1 7.9 4.7 12.0 6.0 5.3 2.6 9.7 6.6 6.5 6.1 8.9 4.0 6.0 4.1 91.1 6.4 8.3 3.8 8.5 4.5 5.0 6.8 7.8 4.2 10.8 3.2 6.9 9.0 4.6 4.8 6.0 5.3 3.8 2.6 4.7 1.5 2.3 1.8 0.4 1.5 3.1 3.3 3.0 5.0 8.4 4.1 3.9 4.2 3.8 2.5 1.4 6.6 2.1 12.9 3.7 1.3 4.2 3.9 4.2 2.3 2.1 2.9 4.6 2.3 6.8 7.2 3.0 6.3 7.1 6.2 2.1 12.8 5.4 6.6 4.9 4.8 7.2 6.2 6.4 1.9 2.8 4.3 13.5 1.2 2.0 1.0 1.4 5.8 6.0 1.6 2.3 1.0 2.9 8.0 4.8 6.2 4.2 9.4 3.9 3.9 1.5 2.6 2.9 5.2 2.5 4.1 6.5 3.3 4.7 1.5 2.1 1.4 1.3 1.8 1.4 1.5 1.2 1.1 3.8 1.1 1.5 1.7 2.3 0.6 2.6 0.3 0.4 4.5 5.0 7.0 3.4 4.7 4.1 5.3 2.6 4.0 3.2 6.0 3.2 1.4 1.2 1.3 26.9 1.9 0.0 4.0 5.7 0.0 25.5 3.3 0.0 1.1 1.1 7.0 2.8 0.0 1.1 2.0 1.5 1.1 2.3 1.5 1.7 19.1 1.7 4.3 2.2 1.8 2.8 1.5 1.7 0.0 2.2 23.4 1.7 0.0 2.1 0.5 301.7 0.0 1.4 10.4 6.4 0.9 2.1 0.8 2.1 0.8 SLC24A2 NCKX2 ENSG00000155886 "Solute carrier family 24 member 2" Q9UI40 9 19507452-19786928 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 31.8" "Group enriched" "Detected in some" 18 "Bipolar cells: 68.2;Cone photoreceptor cells: 257.2;Horizontal cells: 92.2" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "K-562: 5.7;NTERA-2: 2.0;SCLC-21H: 5.2;U-87 MG: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.30e-1)" "unprognostic (8.57e-2)" "unprognostic (4.20e-1)" "unprognostic (1.05e-2)" "unprognostic (3.33e-2)" "unprognostic (1.48e-2)" "unprognostic (8.46e-2)" "unprognostic (8.37e-2)" "unprognostic (1.27e-1)" "unprognostic (1.50e-2)" "unprognostic (6.51e-2)" "unprognostic (1.57e-2)" "unprognostic (2.08e-4)" "unprognostic (1.58e-1)" "unprognostic (2.11e-3)" "unprognostic (1.51e-2)" 0.2 6.1 4.0 0.2 11.2 0.3 0.1 2.4 31.8 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.3 0.2 8.9 4.0 0.3 0.2 0.1 0.2 8.2 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 10.7 0.2 0.2 0.4 0.2 0.1 0.2 0.0 1.2 1.0 2.6 1.3 1.7 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 5.7 0.2 0.1 0.3 0.0 0.1 2.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 5.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.2 0.0 0.0 6.8 0.0 0.1 2.6 0.8 0.9 0.7 0.8 1.0 0.9 0.8 0.6 0.5 1.2 1.1 1.0 2.0 1.7 1.3 1.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 68.2 1.7 0.0 0.0 0.0 0.0 257.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 92.2 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.4 0.0 7.7 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.0 SLC24A3 ENSG00000185052 "Solute carrier family 24 member 3" Q9HC58 20 19212646-19722937 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 18.2;granulocytes: 26.5;Late spermatids: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 53 "basophil: 7.1;eosinophil: 3.3" "Lineage enriched" "Detected in single" 72 "granulocytes: 7.1" "Cell line enriched" "Detected in some" 4 "HMC-1: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043400, HPA045497" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA043400: AB_2678462, HPA045497: AB_2679349" "unprognostic (8.74e-2)" "unprognostic (1.13e-2)" "unprognostic (1.16e-1)" "unprognostic (1.41e-1)" "unprognostic (7.40e-2)" "unprognostic (2.09e-1)" "unprognostic (2.40e-1)" "unprognostic (7.62e-2)" "unprognostic (3.04e-2)" "unprognostic (3.25e-2)" "unprognostic (1.05e-1)" "unprognostic (5.40e-2)" "unprognostic (1.21e-3)" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (6.08e-4)" "unprognostic (7.36e-3)" 7.0 2.5 10.9 4.6 11.0 1.0 3.6 7.4 9.2 17.6 8.9 5.5 7.0 2.9 26.3 19.0 15.3 17.2 14.5 1.7 27.1 12.0 1.2 0.6 6.2 1.5 4.5 3.4 14.8 1.2 7.9 1.6 3.0 5.3 8.5 4.1 5.5 6.1 13.8 26.4 5.2 4.4 21.7 2.9 1.7 2.7 1.7 3.1 0.9 2.5 11.0 4.9 8.1 20.7 0.0 0.0 7.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 6.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.2 0.0 0.0 0.4 0.0 41.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 4.8 0.0 0.3 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 10.9 11.0 7.4 6.5 27.1 12.0 4.5 3.4 5.3 3.1 3.0 0.6 0.0 1.0 1.0 9.4 0.4 0.0 0.0 2.3 1.8 0.0 5.4 0.0 0.0 18.2 0.1 0.0 0.0 0.0 0.3 1.5 0.7 26.5 0.0 0.6 1.6 7.5 0.6 0.0 14.9 3.4 0.0 0.0 0.0 2.6 2.9 0.1 0.9 3.9 0.0 1.4 0.0 3.1 0.5 0.4 3.6 2.9 0.0 0.6 2.7 SLC24A4 NCKX4 ENSG00000140090 "Solute carrier family 24 member 4" Q8NFF2 14 92322581-92501483 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.6;brain: 28.1" "Group enriched" "Detected in some" 8 "Bipolar cells: 223.9;Cone photoreceptor cells: 188.5" "Group enriched" "Detected in some" 5 "glioma: 0.5;melanoma: 0.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 7.9;intermediate monocyte: 11.6;non-classical monocyte: 9.4" "Lineage enriched" "Detected in many" 5 "monocytes: 11.6" "Cell line enhanced" "Detected in some" "Daudi: 2.7;SCLC-21H: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063206 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA063206: " "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.18e-1)" "unprognostic (1.06e-1)" "unprognostic (3.43e-3)" "unprognostic (1.34e-1)" "unprognostic (2.04e-3)" "unprognostic (3.40e-2)" "unprognostic (1.32e-1)" "unprognostic (2.48e-3)" "unprognostic (3.21e-1)" "unprognostic (1.48e-3)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-2)" "unprognostic (1.58e-2)" 1.8 1.0 4.9 3.8 6.0 8.6 0.6 1.1 11.7 0.8 0.9 9.6 6.3 0.9 0.6 0.7 0.8 0.8 1.9 0.9 4.7 3.2 0.5 0.7 2.3 2.7 10.8 4.7 1.0 0.6 0.5 1.8 1.2 28.1 0.7 1.0 4.6 0.7 1.2 2.4 0.8 1.2 1.4 14.2 5.0 0.9 2.9 5.7 0.0 0.6 0.0 1.4 1.5 0.8 0.1 2.3 1.3 11.6 0.2 0.2 2.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.6 2.7 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.7 0.4 0.4 0.2 0.0 0.2 0.3 0.0 0.2 0.3 0.0 0.2 0.0 0.2 0.1 0.6 0.0 0.4 0.0 0.3 1.1 0.0 0.3 0.1 0.1 0.3 0.0 0.3 5.2 0.0 0.2 0.2 0.5 0.1 0.3 1.2 0.6 0.2 1.5 0.3 0.1 0.4 0.1 0.1 0.2 0.3 0.3 0.2 7.9 0.0 0.0 11.6 0.2 0.0 0.0 0.0 2.3 0.1 0.0 0.0 1.3 0.2 9.4 0.4 0.0 2.0 4.9 6.0 1.1 7.3 4.7 3.2 10.8 4.7 28.1 5.7 0.0 3.4 0.0 0.1 0.0 223.9 1.2 0.0 1.4 0.0 0.0 188.5 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 3.5 0.0 0.0 1.8 26.6 4.6 0.3 4.0 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.0 8.2 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 SLC24A5 "JSX, OCA6" ENSG00000188467 "Solute carrier family 24 member 5" Q71RS6 15 48120972-48142672 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport" Albinism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 71.9" "Cell type enriched" "Detected in some" 4 "Melanocytes: 72.6" "Cancer enriched" "Detected in single" 162 "melanoma: 8.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 751 "SK-MEL-30: 75.0" "Group enriched" "Detected in some" 5 "hippocampal formation: 3.3;pons and medulla: 4.4;thalamus: 1.7" "Low region specificity" "Detected in all" NA NA "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.35e-1)" "unprognostic (1.92e-3)" 0.1 0.1 0.5 0.1 0.6 0.1 0.6 1.5 0.5 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.4 0.1 0.5 1.0 0.3 0.1 0.2 0.1 1.7 0.1 0.1 0.1 0.1 1.5 0.1 0.4 0.1 0.1 71.9 0.2 0.1 0.1 15.4 0.7 0.1 0.6 0.1 0.1 3.0 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.6 1.5 0.5 0.5 1.0 1.7 0.1 0.4 0.4 0.0 0.3 0.0 0.0 2.2 6.1 0.3 0.0 1.4 0.0 0.0 2.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 3.8 0.0 0.0 72.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 SLC25A17 PMP34 ENSG00000100372 "Solute carrier family 25 member 17" O43808 22 40769630-40819399 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052708, HPA060972" Approved Supported Peroxisomes NA NA Peroxisomes "HPA052708: AB_2681924, HPA060972: AB_2684400" "unprognostic (2.75e-1)" "unprognostic (1.11e-3)" "unprognostic (1.91e-3)" "unprognostic (2.44e-2)" "unprognostic (2.61e-1)" "unprognostic (1.96e-2)" "unprognostic (2.85e-3)" "unprognostic (2.16e-1)" "unprognostic (1.72e-1)" "unprognostic (1.63e-3)" "unprognostic (8.44e-2)" "unprognostic (2.72e-1)" "unprognostic (5.59e-2)" "unprognostic (8.54e-2)" "unprognostic (1.55e-1)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" 9.7 15.0 10.2 10.2 10.9 3.3 16.8 12.9 14.1 11.8 7.2 12.2 7.5 6.4 22.4 22.6 8.7 13.7 7.4 5.5 10.4 13.4 18.6 19.7 9.0 11.8 10.3 7.7 26.5 12.4 14.3 13.0 14.9 11.9 12.6 8.7 9.5 11.4 10.3 4.6 10.9 7.1 12.1 11.4 8.8 8.9 12.1 9.5 12.6 14.7 10.4 11.2 7.1 8.7 10.2 6.8 5.9 4.9 10.3 11.7 6.4 13.4 7.4 12.6 11.0 8.0 9.7 10.3 12.2 13.4 19.5 21.5 10.8 5.1 15.9 7.5 12.0 11.1 10.8 18.3 10.1 20.0 16.3 24.5 17.8 11.5 11.1 11.3 20.5 9.5 9.6 13.5 17.2 11.1 9.0 11.8 13.3 25.7 7.6 15.8 11.5 12.3 13.2 10.6 19.1 12.3 13.5 19.6 23.2 16.1 11.4 8.7 7.9 25.2 15.5 15.0 12.8 12.9 6.1 6.9 11.0 15.1 9.7 11.0 8.4 16.3 15.1 12.0 10.4 11.9 5.9 4.4 5.1 7.0 4.9 9.2 10.2 8.1 7.5 5.7 9.5 11.7 9.3 1.8 10.3 3.9 6.8 10.8 6.4 10.2 10.9 12.9 14.1 10.4 13.4 10.3 7.7 11.9 9.5 17.9 7.4 10.7 13.0 14.7 11.7 3.1 7.6 12.0 17.0 12.2 7.9 34.1 18.3 16.2 6.5 9.3 6.3 0.0 15.3 27.0 16.0 15.6 4.7 21.2 11.5 11.1 5.8 5.5 7.3 8.5 25.0 7.6 15.1 25.2 3.3 10.6 14.6 5.8 25.1 15.9 7.0 32.3 10.8 37.1 36.6 15.1 23.9 10.0 7.7 13.3 SLC25A18 ENSG00000182902 "Solute carrier family 25 member 18" Q9H1K4 22 17563439-17590994 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adipose tissue: 13.1;brain: 49.0;liver: 50.0" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 15.9;Ciliated cells: 28.1;Hepatocytes: 67.6" "Group enriched" "Detected in some" 5 "glioma: 10.6;liver cancer: 11.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 5.7;BEWO: 12.9" "Low region specificity" "Detected in all" HPA068110 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA068110: " "unprognostic (2.15e-1)" "unprognostic (6.07e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "unprognostic (3.79e-1)" "unprognostic (3.98e-2)" "unprognostic (1.00e-1)" "unprognostic (1.89e-1)" "unprognostic (1.45e-2)" "unprognostic (2.72e-2)" "unprognostic (8.70e-4)" "unprognostic (1.44e-1)" "unprognostic (3.92e-2)" "unprognostic (1.67e-2)" "unprognostic (1.29e-1)" "unprognostic (5.24e-2)" "unprognostic (1.62e-1)" 13.1 2.2 33.2 1.5 28.0 1.2 2.7 7.5 49.0 1.4 1.4 13.3 0.0 1.5 1.7 1.4 1.5 1.7 2.1 2.3 33.3 15.7 1.8 50.0 1.5 1.5 25.6 19.1 1.9 1.8 1.7 0.0 1.3 17.8 4.8 1.3 0.0 1.6 1.6 2.5 1.4 1.4 1.8 14.9 1.9 1.5 3.4 21.6 0.0 1.5 0.0 1.3 1.4 0.0 0.4 0.4 2.1 0.6 0.0 0.5 0.1 0.5 0.9 3.4 0.6 5.7 0.0 12.9 0.4 0.0 0.0 0.0 0.3 0.3 0.3 0.4 0.0 3.7 1.1 0.1 0.0 0.0 0.4 1.4 0.5 0.4 0.8 2.3 0.5 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.6 0.4 0.0 0.6 0.1 0.8 2.9 1.3 2.1 4.2 1.2 0.0 0.1 0.6 1.2 0.5 0.4 0.6 1.0 2.6 3.7 1.4 0.2 0.2 0.5 0.3 0.4 1.4 1.7 0.0 2.7 0.3 0.5 0.0 0.4 2.1 0.4 0.6 0.0 0.4 0.5 0.1 0.3 0.2 0.1 0.3 0.5 0.0 0.2 0.4 0.1 0.1 33.2 28.0 7.5 25.7 33.3 15.7 25.6 19.1 17.8 21.6 26.8 15.9 0.0 0.2 0.0 0.5 1.4 0.0 28.1 12.5 0.0 0.0 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.5 4.6 5.8 67.6 0.2 0.0 0.0 2.5 4.6 0.6 0.9 0.7 0.0 0.0 0.0 1.4 0.0 0.0 2.5 0.6 3.2 0.0 0.0 2.7 4.8 0.1 1.5 0.0 0.0 0.1 SLC25A2 ORNT2 ENSG00000120329 "Solute carrier family 25 member 2" Q9BXI2 5 141302629-141304045 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 12.6" "Group enriched" "Detected in some" 9 "Early spermatids: 8.6;Late spermatids: 8.3;Spermatocytes: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 1.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA042146 Uncertain NA NA "HPA042146: AB_2677874" "unprognostic (1.55e-1)" "unprognostic (3.53e-1)" "unprognostic (4.63e-2)" "unprognostic (4.30e-1)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (4.72e-3)" "unprognostic (2.81e-1)" "unprognostic (2.62e-2)" "unprognostic (6.69e-2)" "unprognostic (1.17e-1)" "unprognostic (8.82e-10)" "unprognostic (2.56e-1)" "unprognostic (1.87e-1)" "unprognostic (1.26e-2)" "unprognostic (1.14e-1)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 12.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 1.4 0.0 0.5 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 2.2 0.7 0.0 0.0 0.0 0.0 0.0 SLC25A20 "CAC, CACT" ENSG00000178537 "Solute carrier family 25 member 20" O43772 3 48856931-48898993 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 57.8;liver: 58.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 38.0;Hepatocytes: 55.2;monocytes: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 35.4;RPMI-8226: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016862, HPA029863" Approved Approved Mitochondria,Cytosol NA NA 13000 "Mitochondria, Cytosol" "HPA016862: AB_1857028, HPA029863: AB_10602893" "unprognostic (1.02e-1)" "unprognostic (1.84e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (5.18e-2)" "unprognostic (3.97e-2)" "unprognostic (1.03e-1)" "unprognostic (5.96e-3)" "unprognostic (4.06e-1)" "unprognostic (1.73e-1)" "unprognostic (1.36e-2)" "unprognostic (2.51e-1)" "unprognostic (3.71e-3)" "unprognostic (3.34e-1)" "unprognostic (5.12e-1)" "unprognostic (4.22e-2)" "unprognostic (3.49e-2)" 11.9 13.7 6.7 5.6 7.3 3.4 10.2 3.0 5.6 3.3 19.7 4.7 5.2 25.0 4.7 3.1 3.3 5.0 9.9 37.1 7.3 4.6 16.8 58.3 6.6 4.9 8.5 5.1 2.7 16.8 5.9 5.1 3.3 5.8 5.0 9.1 5.4 7.4 3.7 27.4 4.0 32.2 5.7 5.5 8.8 7.5 4.4 6.6 9.1 5.5 5.5 5.9 4.5 9.8 9.4 33.3 57.8 29.0 17.3 28.4 24.7 1.4 4.5 3.6 5.0 11.5 4.4 0.7 8.0 4.3 5.6 5.8 5.6 6.9 6.6 5.7 12.6 6.8 1.4 8.8 3.5 4.2 16.8 4.2 9.2 7.0 7.1 5.2 9.6 17.8 5.6 4.0 7.5 1.2 2.2 7.2 10.1 8.2 35.4 7.3 3.7 10.5 4.8 1.8 8.1 10.2 3.8 2.1 48.7 6.0 3.5 1.4 5.1 7.4 0.0 4.0 5.2 11.3 4.5 5.8 6.4 1.1 9.3 5.8 13.1 9.1 7.7 9.1 6.8 8.4 13.8 29.0 57.8 28.4 21.0 18.1 9.4 16.1 20.8 27.0 7.8 12.7 21.3 13.5 17.3 21.4 33.3 16.1 24.7 6.7 7.3 3.0 5.6 7.3 4.6 8.5 5.1 5.8 6.6 6.0 2.4 7.5 2.3 1.5 1.1 31.1 7.6 5.3 2.3 0.0 5.9 1.7 3.3 3.2 1.1 3.1 38.0 0.0 3.7 1.9 4.1 2.4 1.1 55.2 15.8 0.0 7.0 9.2 13.2 1.0 9.8 7.5 1.7 40.5 10.8 2.8 4.0 13.5 11.7 12.5 1.1 0.0 2.2 7.1 7.0 1.1 1.0 13.8 12.8 2.0 SLC25A22 "EIEE3, FLJ13044, GC1, NET44" ENSG00000177542 "Solute carrier family 25 member 22" Q9H936 11 790475-798333 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.0;pancreas: 43.0" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 147.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 44.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014662 Approved Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA014662: AB_10600808" "unprognostic (1.01e-2)" "unprognostic (2.12e-1)" "unprognostic (7.28e-2)" "unprognostic (4.68e-2)" "unprognostic (2.09e-3)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (8.67e-3)" "unprognostic (4.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.97e-3)" "unprognostic (2.61e-2)" "unprognostic (8.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" 4.9 5.2 23.3 8.3 19.0 5.7 2.7 32.2 45.0 3.5 4.1 3.4 2.5 10.3 3.2 2.3 4.4 5.0 3.8 3.2 27.8 13.2 4.1 14.2 4.6 7.5 9.6 22.8 4.8 43.0 4.0 13.4 4.4 13.5 5.2 2.9 4.6 11.4 4.2 1.1 5.8 8.5 3.3 2.8 5.3 6.8 6.6 2.6 3.5 3.1 3.0 5.1 4.5 2.4 2.5 3.1 4.0 5.7 3.6 7.2 2.3 23.4 15.2 8.9 8.0 3.8 6.8 8.4 11.2 9.4 12.5 7.9 15.0 16.1 7.0 8.4 9.3 14.2 20.8 9.8 13.5 2.8 13.2 18.1 6.4 7.5 9.2 16.2 10.4 10.9 6.8 8.2 9.5 10.2 3.9 5.7 8.3 13.1 11.1 5.5 14.2 10.8 9.8 19.3 14.5 23.4 12.8 4.9 16.6 7.4 3.9 44.3 19.9 6.4 15.5 8.0 1.4 7.5 5.3 5.6 14.0 9.4 6.4 10.5 9.7 5.7 9.0 16.8 9.3 8.3 0.0 2.4 4.0 6.6 5.6 4.2 2.5 4.1 7.2 3.1 2.1 2.5 4.2 1.5 3.6 5.7 0.9 2.2 2.3 23.3 19.0 32.2 37.4 27.8 13.2 9.6 22.8 13.5 2.6 6.0 10.4 2.2 6.3 11.2 147.0 1.8 5.1 2.7 4.5 8.7 31.4 5.9 3.3 22.2 11.5 4.9 7.0 0.0 17.0 8.9 7.4 13.6 2.3 15.3 4.0 41.3 12.5 1.8 1.8 5.6 4.4 2.6 3.3 6.4 7.3 13.4 14.1 7.0 4.6 5.6 29.9 0.0 6.1 1.4 6.3 11.7 2.6 5.2 5.0 8.1 SLC25A23 "APC2, FLJ30339, MGC2615" ENSG00000125648 "Solute carrier family 25 member 23" Q9BV35 19 6436079-6465203 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009675, HPA050883" Approved Supported Mitochondria NA NA Mitochondria "HPA009675: AB_2668252, HPA050883: AB_2681260" "unprognostic (3.51e-1)" "unprognostic (1.53e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.05e-2)" "unprognostic (3.65e-3)" "unprognostic (3.43e-2)" "unprognostic (1.31e-3)" "unprognostic (1.27e-1)" "unprognostic (3.82e-1)" "unprognostic (1.30e-1)" "unprognostic (3.25e-1)" "prognostic favorable (1.10e-12)" "unprognostic (8.95e-2)" "unprognostic (3.20e-1)" "unprognostic (5.44e-2)" "unprognostic (4.22e-1)" 12.1 13.0 68.2 5.2 97.6 0.4 6.3 21.5 51.7 12.5 22.3 17.6 10.3 18.2 13.0 11.9 31.2 16.1 10.1 36.2 66.2 25.1 17.9 13.0 11.3 4.0 25.6 33.1 15.8 10.0 24.5 5.5 2.2 28.0 14.3 23.5 12.2 32.1 20.3 37.0 11.9 18.6 30.7 16.9 4.3 9.9 3.7 25.9 1.2 29.2 9.7 14.1 16.8 9.3 2.5 0.9 0.8 0.0 0.7 4.5 0.9 20.0 8.1 11.8 37.1 15.9 7.0 5.4 5.8 9.6 11.4 13.8 20.4 13.4 11.2 14.3 14.7 12.5 17.1 24.0 14.0 9.1 0.0 20.2 8.1 17.2 16.2 14.8 0.5 19.2 20.0 12.3 10.1 4.4 23.3 11.9 12.5 23.3 14.3 2.2 14.6 7.0 11.5 8.5 21.6 25.0 3.4 3.2 17.2 30.5 3.6 0.8 11.6 4.2 25.8 10.7 13.4 13.5 17.8 4.1 3.6 15.4 0.9 3.8 2.6 3.5 9.9 1.6 19.1 5.6 0.8 0.0 0.0 4.5 0.0 1.1 2.5 2.7 2.3 0.4 1.0 4.0 3.4 0.0 0.7 0.0 0.9 2.6 0.9 68.2 97.6 21.5 51.7 66.2 25.1 25.6 33.1 28.0 25.9 8.9 18.1 7.0 8.3 9.3 9.8 34.8 48.4 1.4 4.5 43.6 7.9 1.2 16.6 52.9 16.5 5.5 100.4 0.0 24.8 1.5 5.8 13.9 6.9 27.0 2.1 7.9 13.3 12.9 2.1 45.5 17.5 2.2 16.9 1.8 35.6 14.6 40.3 35.4 27.6 22.6 16.4 12.9 6.2 0.3 3.2 20.5 0.7 4.3 23.9 24.3 SLC25A25 "KIAA1896, MCSC, PCSCL" ENSG00000148339 "Solute carrier family 25 member 25" Q6KCM7 9 128068201-128109245 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 119.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020381 Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA "Vesicles, Mitochondria" "HPA020381: AB_1857037" "unprognostic (4.62e-2)" "unprognostic (2.66e-2)" "unprognostic (2.56e-2)" "unprognostic (1.59e-1)" "unprognostic (2.89e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.01e-4)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.60e-2)" "unprognostic (4.96e-2)" "unprognostic (3.70e-2)" "prognostic favorable (4.65e-6)" "unprognostic (1.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.66e-3)" "unprognostic (1.42e-2)" 29.2 15.8 7.3 8.1 12.8 5.5 10.6 8.8 20.0 14.4 7.2 6.3 20.0 7.9 14.6 8.2 22.7 17.5 31.6 5.6 7.6 9.0 9.5 48.4 12.4 6.7 7.5 8.0 13.6 52.6 12.1 19.0 7.6 15.0 8.5 5.5 13.6 7.6 63.5 31.3 9.5 10.0 17.3 8.7 7.8 10.5 7.3 5.3 5.4 10.8 20.2 9.7 8.6 9.6 2.9 4.6 3.8 8.4 1.5 7.6 3.9 5.7 6.1 8.6 12.4 6.5 5.6 5.7 12.0 11.2 10.1 6.7 10.9 6.1 7.5 3.7 5.5 5.6 10.3 6.8 3.9 3.8 8.7 5.6 4.3 12.2 6.5 10.4 5.0 10.0 7.2 3.8 9.9 7.3 3.3 6.8 12.6 15.6 16.2 6.3 13.9 8.7 5.1 8.7 18.7 9.5 8.7 7.4 15.7 3.9 6.0 21.4 9.2 12.6 8.1 16.7 3.5 8.9 2.9 4.3 11.5 6.8 8.6 11.8 14.2 24.8 8.0 7.8 2.7 9.4 3.8 2.3 1.2 4.8 7.3 2.4 1.7 5.3 4.8 4.6 2.9 4.5 7.6 0.4 1.5 8.4 1.5 3.9 3.9 7.3 12.8 8.8 20.0 7.6 9.0 7.5 8.0 15.0 5.3 20.8 41.7 5.2 37.8 23.2 18.1 2.0 33.1 21.4 9.1 19.2 119.8 8.5 10.0 10.3 0.3 33.7 36.7 23.3 10.0 10.4 16.9 26.9 8.1 58.9 8.4 17.5 49.5 19.0 13.3 0.6 8.6 18.9 20.3 18.0 17.3 12.8 10.0 28.1 7.8 8.6 65.5 19.4 63.4 4.1 8.6 37.6 19.2 8.7 15.3 47.7 SLC25A26 ENSG00000144741 "Solute carrier family 25 member 26" Q70HW3 3 66133610-66388116 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026887 Supported Supported Mitochondria NA NA Mitochondria "HPA026887: AB_2189921" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (7.83e-2)" "unprognostic (7.94e-2)" "unprognostic (5.38e-2)" "unprognostic (1.53e-1)" "unprognostic (3.54e-1)" "unprognostic (9.21e-2)" "unprognostic (8.43e-2)" "prognostic favorable (1.73e-5)" "unprognostic (4.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-1)" 11.8 12.9 20.2 8.5 14.8 13.3 16.5 7.9 27.2 10.3 12.6 15.8 9.2 9.7 11.1 12.9 14.3 13.1 10.1 19.5 16.9 12.8 15.7 22.7 10.0 15.2 17.6 11.8 20.0 21.2 16.2 11.6 11.9 14.6 10.8 13.4 12.6 16.1 12.6 29.8 16.5 11.0 16.8 14.3 11.4 12.7 18.3 12.6 12.0 19.0 14.2 12.9 13.4 10.8 12.0 12.2 3.6 7.1 10.5 14.4 9.1 6.3 6.2 3.8 7.7 8.5 8.8 8.0 5.3 10.2 7.2 6.8 8.1 8.5 6.5 3.2 9.7 8.8 4.7 4.4 9.9 7.4 6.8 10.3 9.9 4.9 11.7 10.2 13.8 8.4 12.0 19.7 5.7 13.8 6.9 5.3 13.2 4.4 8.7 8.6 7.9 5.8 15.9 11.1 14.4 3.6 6.0 6.9 11.0 5.9 4.7 2.9 8.9 7.7 6.7 12.6 7.0 5.6 10.9 6.0 7.6 7.2 9.5 9.3 12.9 16.8 8.4 10.5 13.2 8.2 1.3 6.8 3.6 10.9 7.1 9.9 12.0 12.1 11.1 12.2 10.2 14.4 12.3 0.4 10.5 4.1 11.6 11.1 9.1 20.2 14.8 7.9 27.2 16.9 12.8 17.6 11.8 14.6 12.6 29.8 20.3 23.3 31.4 31.8 17.7 96.8 20.4 13.4 12.5 17.4 11.8 29.9 29.9 25.2 20.6 19.7 19.1 0.0 38.7 36.6 33.9 31.6 18.5 34.2 26.5 11.1 17.9 9.2 19.0 19.2 15.0 17.8 35.4 20.8 25.5 22.4 26.4 14.0 20.5 46.3 21.5 19.4 29.5 21.4 30.2 32.1 27.3 46.5 33.0 33.6 SLC25A3 PHC ENSG00000075415 "Solute carrier family 25 member 3" Q00325 12 98593591-98606379 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 233.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045709 Supported Mitochondria NA NA 5500000 Mitochondria "HPA045709: AB_10965843" "unprognostic (1.16e-2)" "unprognostic (4.68e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-1)" "unprognostic (1.56e-2)" "unprognostic (6.38e-2)" "unprognostic (3.25e-3)" "unprognostic (9.41e-2)" "unprognostic (4.98e-2)" "unprognostic (6.43e-2)" "unprognostic (5.65e-2)" "unprognostic (7.40e-2)" "prognostic favorable (8.11e-7)" "unprognostic (3.45e-1)" "unprognostic (2.99e-1)" "unprognostic (8.66e-3)" "unprognostic (4.72e-2)" 35.7 71.2 23.6 38.3 27.2 24.6 48.9 25.1 50.2 29.8 69.6 22.4 33.8 53.9 38.5 35.9 54.6 30.1 55.1 233.5 22.9 25.3 60.2 72.6 47.0 75.5 27.8 26.0 39.6 59.7 55.5 29.1 34.2 31.6 33.8 53.3 30.9 53.5 33.5 190.6 33.8 76.0 46.7 19.6 35.6 51.4 16.9 15.1 42.0 41.5 125.8 44.4 38.5 31.9 46.8 82.3 33.4 78.5 43.3 56.6 76.3 74.7 58.4 77.5 64.2 70.6 117.4 99.9 65.6 87.5 85.1 71.2 104.8 39.3 102.2 39.0 79.5 38.5 64.4 78.6 88.7 89.8 38.4 62.7 60.9 43.1 69.5 86.9 71.3 48.4 111.0 79.4 61.8 88.9 128.1 120.1 53.0 65.6 30.3 101.4 55.8 66.1 79.6 71.7 64.7 96.0 75.6 80.8 113.4 110.0 75.1 39.8 53.4 78.5 70.7 108.3 68.5 95.5 78.0 80.7 47.4 44.8 52.0 65.6 51.4 60.4 71.5 37.4 42.1 61.0 24.4 59.5 33.4 40.1 77.2 47.4 46.8 45.7 44.3 82.3 33.3 47.9 45.3 26.4 43.3 78.5 50.3 56.6 76.3 23.6 27.2 25.1 50.2 22.9 25.3 27.8 26.0 31.6 15.1 199.5 265.4 295.0 454.5 334.1 211.9 1401.5 384.7 145.9 192.2 204.1 74.6 677.0 741.1 434.4 31.9 273.0 744.3 163.5 762.2 755.9 400.5 371.4 205.5 373.5 527.3 276.5 300.1 249.2 430.8 19.5 236.2 288.2 415.0 543.8 392.0 226.4 536.4 501.2 241.1 802.3 176.2 297.5 387.5 94.1 178.4 316.8 681.4 269.7 620.6 559.0 SLC25A31 "ANT4, DKFZP434N1235" ENSG00000151475 "Solute carrier family 25 member 31" Q9H0C2 4 127730378-127774299 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 687 "testis: 68.6" "Cell type enriched" "Detected in some" 9 "Spermatocytes: 113.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTCEpi: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015064, HPA016841, HPA046835, HPA071684" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.70e-1)" "unprognostic (5.32e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 113.2 11.9 0.0 0.0 0.0 0.0 0.0 SLC25A33 "BMSC-MCP, MGC4399, PNC1" ENSG00000171612 "Solute carrier family 25 member 33" Q9BSK2 1 9539482-9585179 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 318.7;Late spermatids: 434.0;Spermatocytes: 229.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049982 Uncertain NA NA "HPA049982: AB_2680981" "unprognostic (1.61e-1)" "prognostic favorable (4.86e-4)" "unprognostic (2.94e-2)" "unprognostic (4.80e-2)" "unprognostic (1.89e-1)" "unprognostic (6.75e-2)" "unprognostic (5.18e-2)" "prognostic favorable (7.02e-4)" "unprognostic (1.88e-3)" "unprognostic (1.07e-1)" "unprognostic (8.59e-2)" "unprognostic (2.77e-1)" "unprognostic (4.55e-3)" "unprognostic (7.27e-2)" "unprognostic (1.19e-1)" "unprognostic (4.25e-2)" "unprognostic (3.77e-2)" 14.6 5.3 11.3 3.8 15.3 11.0 13.0 8.4 20.6 4.1 6.6 6.5 3.5 3.4 4.6 18.9 4.5 3.5 5.6 6.1 9.4 12.2 13.9 15.1 6.1 4.6 15.1 8.7 3.3 8.5 4.5 6.4 2.3 12.6 6.3 5.6 10.5 7.0 3.8 16.8 2.6 3.4 4.1 10.4 3.3 4.7 16.0 7.0 4.2 7.6 2.8 5.1 4.1 2.5 2.0 1.6 6.1 1.1 1.3 1.9 0.4 4.4 2.1 5.9 9.1 4.8 2.8 3.8 4.3 4.1 7.3 6.5 4.6 3.5 12.9 5.3 3.5 7.7 1.9 14.8 2.9 9.1 9.9 9.3 12.7 3.0 17.9 10.5 12.6 10.1 3.3 5.1 7.3 3.5 1.8 4.3 9.7 12.3 6.8 4.1 4.6 7.9 8.7 7.3 8.2 4.9 10.8 6.2 8.3 4.6 2.5 10.3 6.7 4.9 15.0 12.7 5.4 5.5 9.3 1.9 4.7 6.1 6.2 5.5 8.1 14.9 21.9 3.4 14.1 5.6 6.1 0.9 0.3 1.5 1.1 1.0 2.0 1.1 0.9 1.6 1.0 1.9 1.9 1.3 1.3 1.0 1.5 0.2 0.4 11.3 15.3 8.4 20.6 9.4 12.2 15.1 8.7 12.6 7.0 3.0 12.5 21.1 88.7 45.7 12.9 6.9 28.1 6.7 6.8 8.7 49.1 10.2 169.1 11.4 318.7 15.5 10.2 0.0 13.0 34.4 13.9 74.4 24.1 53.3 18.4 9.5 63.7 9.8 7.2 434.0 9.2 21.8 30.4 10.0 22.0 142.8 9.5 8.6 9.6 19.9 46.4 6.5 36.0 229.6 117.3 31.2 32.8 12.1 24.7 85.3 SLC25A34 DKFZp781A10161 ENSG00000162461 "Solute carrier family 25 member 34" Q6PIV7 1 15736405-15741396 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 38.8;skeletal muscle: 22.2" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 16.0;Paneth cells: 5.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 10.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069806 Approved Mitochondria NA NA Mitochondria "HPA069806: AB_2686202" "unprognostic (2.06e-1)" "unprognostic (4.72e-1)" "unprognostic (1.15e-1)" "unprognostic (2.43e-1)" "unprognostic (2.58e-1)" "unprognostic (8.08e-3)" "unprognostic (1.98e-2)" "unprognostic (9.92e-2)" "unprognostic (1.55e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-4)" "unprognostic (5.74e-2)" "unprognostic (6.10e-2)" "unprognostic (4.02e-1)" "unprognostic (1.82e-1)" "unprognostic (4.04e-2)" "unprognostic (2.40e-4)" 2.5 2.4 1.2 0.9 1.9 2.8 0.7 10.4 1.8 1.1 25.9 0.8 0.5 13.5 1.7 1.4 1.6 1.3 3.6 13.3 1.5 1.2 7.3 3.9 1.1 1.1 0.7 1.8 2.4 18.6 0.6 2.1 1.2 1.5 1.1 1.9 3.7 11.1 0.8 22.2 0.8 38.8 1.0 1.1 1.9 1.4 2.3 1.2 0.5 1.9 11.0 1.9 0.7 1.1 0.7 0.5 2.0 0.5 2.2 4.1 1.1 0.7 0.5 3.5 1.6 1.7 0.7 1.5 0.5 0.3 0.8 0.6 1.4 1.9 0.9 0.8 0.7 1.8 0.7 0.6 0.6 0.8 1.2 0.7 1.5 1.1 0.5 0.6 0.4 2.2 0.8 2.7 1.0 0.5 2.2 0.4 4.6 0.6 3.2 0.6 1.8 3.7 2.0 2.9 0.4 1.0 1.9 3.1 1.0 0.3 0.1 0.7 2.8 0.8 1.0 7.4 3.4 1.9 2.5 1.7 1.7 2.2 2.3 0.6 3.8 3.5 0.7 0.6 2.2 1.4 1.2 0.5 0.4 1.4 0.2 3.1 0.5 3.0 2.0 0.2 0.7 4.1 2.3 2.0 2.2 0.2 0.5 1.3 1.1 1.2 1.9 10.4 1.8 1.5 1.2 0.7 1.8 1.5 1.2 0.0 0.0 0.0 0.3 0.2 2.5 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.7 16.0 0.0 0.2 0.2 0.7 0.3 0.0 2.1 1.2 3.2 3.4 2.5 2.6 0.4 0.9 0.1 0.0 1.8 2.4 1.7 0.2 5.3 0.4 3.0 1.4 0.0 0.9 0.5 0.6 0.1 1.1 0.0 4.1 0.4 SLC25A36 "FLJ10618, PNC2" ENSG00000114120 "Solute carrier family 25 member 36" Q96CQ1 3 140941830-140979933 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027036 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoplasm "HPA027036: AB_1857048" "unprognostic (4.12e-2)" "unprognostic (9.98e-2)" "unprognostic (2.86e-1)" "unprognostic (1.37e-1)" "unprognostic (6.52e-2)" "unprognostic (3.46e-1)" "unprognostic (9.00e-2)" "unprognostic (1.71e-2)" "unprognostic (1.99e-2)" "unprognostic (2.47e-2)" "unprognostic (3.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.20e-1)" "unprognostic (2.34e-1)" "unprognostic (6.03e-2)" "prognostic favorable (1.55e-4)" 20.2 16.9 14.9 13.4 20.5 36.5 25.2 18.7 31.3 23.5 19.4 18.3 17.3 22.3 25.6 37.3 12.2 25.1 13.7 29.5 15.9 19.0 29.0 3.1 22.4 18.6 15.6 16.7 32.6 33.9 29.7 26.3 19.1 21.6 20.6 14.8 21.1 17.5 17.7 60.6 16.2 17.2 20.4 18.5 14.1 23.6 24.4 12.2 15.4 23.7 15.1 12.7 20.7 18.5 17.0 14.9 15.7 13.1 18.1 16.6 10.9 23.8 5.4 17.5 14.3 16.1 20.6 22.1 9.0 11.5 10.1 14.3 14.9 11.4 19.9 22.4 7.6 14.5 16.0 21.2 8.8 20.7 15.2 17.2 16.4 13.0 9.4 24.2 23.4 10.2 23.2 29.6 7.4 22.7 22.7 10.6 14.7 8.7 12.9 14.7 10.3 13.9 16.1 17.4 5.9 10.1 15.1 15.6 28.2 11.9 8.2 11.3 18.5 12.2 22.2 39.1 16.0 15.4 13.3 10.7 14.1 7.9 24.9 8.6 26.2 17.0 23.2 18.2 9.8 6.9 10.5 10.4 15.7 11.4 13.1 13.3 17.0 11.7 12.5 14.9 16.0 16.6 15.7 1.8 18.1 13.1 10.9 10.2 10.9 14.9 20.5 18.7 31.3 15.9 19.0 15.6 16.7 21.6 12.2 92.3 107.7 22.2 58.2 60.7 96.5 82.2 38.2 133.8 62.6 68.0 125.7 48.2 54.7 22.9 5.0 40.0 22.6 0.0 33.6 33.4 49.8 72.0 63.6 0.4 22.8 87.4 57.0 29.4 35.2 11.5 55.3 36.5 54.0 29.7 27.0 70.1 26.8 17.5 55.9 52.8 122.5 58.2 54.2 29.3 61.1 47.6 41.3 41.1 40.3 64.7 SLC25A38 FLJ20551 ENSG00000144659 "Solute carrier family 25 member 38" Q96DW6 3 39383324-39397351 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041027 Approved NA NA "HPA041027: AB_10794403" "unprognostic (3.82e-2)" "unprognostic (3.27e-2)" "unprognostic (1.96e-1)" "unprognostic (6.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.58e-1)" "unprognostic (1.25e-1)" "unprognostic (1.21e-2)" "unprognostic (3.94e-2)" "unprognostic (1.94e-1)" "unprognostic (1.26e-2)" "unprognostic (5.54e-2)" "prognostic favorable (1.58e-5)" "unprognostic (1.73e-1)" "unprognostic (1.47e-1)" "unprognostic (2.06e-1)" "prognostic favorable (7.29e-4)" 14.0 24.6 12.2 18.2 17.1 38.1 20.9 16.7 21.9 17.2 17.8 11.9 22.2 16.0 21.3 18.2 13.3 17.8 18.2 12.9 12.0 15.3 18.0 35.9 14.7 22.5 12.8 16.2 29.1 41.3 27.2 21.7 12.8 13.4 21.3 24.1 15.1 15.5 18.4 30.0 10.6 16.4 17.0 11.3 18.9 21.3 17.7 13.0 24.7 39.8 12.5 21.5 20.5 22.7 21.6 8.1 12.4 4.2 23.2 22.7 11.9 9.7 15.6 10.3 17.3 24.2 20.1 12.9 14.0 19.1 20.3 18.5 10.7 2.3 27.4 8.3 12.9 17.3 7.6 22.9 16.4 15.3 17.5 18.4 21.2 13.8 15.7 32.5 14.9 14.5 25.2 19.4 19.5 39.6 19.0 13.1 21.9 18.9 17.3 15.1 14.0 17.8 26.5 27.6 14.6 18.1 6.5 11.0 18.9 15.9 18.6 10.3 13.1 4.8 27.6 13.5 19.8 14.0 14.1 11.2 16.3 11.1 23.5 19.8 23.2 36.5 16.7 12.4 19.6 10.3 12.4 4.2 7.7 17.7 2.5 20.4 21.6 18.3 19.4 6.4 19.0 19.6 19.0 0.6 23.2 3.4 8.1 22.7 11.9 12.2 17.1 16.7 21.9 12.0 15.3 12.8 16.2 13.4 13.0 20.8 27.2 29.7 11.4 10.2 13.9 15.3 17.8 13.4 6.8 26.2 5.9 28.2 18.3 13.7 5.2 9.0 18.2 0.0 14.6 27.5 14.4 13.3 21.9 24.1 13.2 4.8 12.1 10.4 9.8 6.3 14.4 8.3 11.8 13.6 25.4 16.3 12.3 21.0 12.7 15.4 10.3 6.5 15.6 10.4 4.7 8.9 16.2 36.2 26.0 7.2 SLC25A39 "CGI-69, FLJ22407" ENSG00000013306 "Solute carrier family 25 member 39" Q9BZJ4 17 44319625-44324870 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Heme biosynthesis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Distal tubular cells: 416.1;Erythroid cells: 584.0;Late spermatids: 585.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026785 Approved NA NA "HPA026785: AB_10601715" "unprognostic (8.10e-2)" "unprognostic (2.46e-1)" "unprognostic (1.41e-2)" "unprognostic (1.29e-1)" "unprognostic (6.04e-2)" "unprognostic (2.35e-3)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.95e-1)" "unprognostic (1.29e-1)" "unprognostic (1.05e-1)" "prognostic favorable (3.58e-5)" "unprognostic (1.67e-2)" "unprognostic (2.26e-1)" "unprognostic (2.22e-1)" "unprognostic (3.21e-2)" 14.6 36.5 17.8 19.0 19.4 101.0 21.9 15.4 18.1 18.8 29.8 17.4 22.9 30.2 16.0 20.5 43.2 19.1 24.5 19.3 16.4 18.5 58.8 69.8 25.0 29.8 18.6 15.6 25.1 63.3 27.2 24.6 33.5 17.1 23.4 19.9 20.6 39.9 26.5 13.7 25.6 28.7 13.5 17.6 28.8 23.8 39.7 16.2 18.0 46.4 36.4 29.3 16.8 18.6 34.0 35.2 11.2 27.4 43.9 30.2 31.0 44.3 28.2 8.8 37.0 17.2 13.4 30.9 14.8 13.4 19.3 14.9 27.8 21.5 23.9 26.2 20.9 34.3 22.9 27.5 44.9 6.8 27.9 44.1 12.5 25.5 50.6 18.8 21.7 27.5 20.2 40.0 18.0 23.3 17.5 19.7 36.3 36.7 38.2 16.2 83.9 27.3 21.2 17.3 34.1 78.2 33.0 24.4 68.4 33.2 23.7 60.0 22.4 17.1 27.4 30.0 17.0 52.6 18.6 14.0 25.3 35.6 43.2 28.9 24.0 28.8 21.9 22.8 17.0 15.3 11.2 19.5 9.4 26.6 27.3 30.2 34.0 28.9 28.6 30.5 25.3 29.9 27.4 2.9 43.9 27.4 35.2 26.6 31.0 17.8 19.4 15.4 18.1 16.4 18.5 18.6 15.6 17.1 16.2 8.9 23.1 46.2 55.8 47.4 17.1 21.2 45.9 18.7 26.1 66.3 9.8 75.3 416.1 140.7 181.7 45.0 106.3 584.0 271.0 134.5 37.6 112.5 31.3 61.9 122.6 12.7 62.7 26.4 47.0 585.1 36.8 47.7 87.7 148.7 86.5 37.5 164.8 80.6 36.4 185.1 14.0 19.4 41.2 103.7 99.4 56.6 98.2 55.8 137.6 83.2 SLC25A4 "ANT1, PEO2, PEO3, T1" ENSG00000151729 "Solute carrier family 25 member 4" P12235 4 185143241-185150382 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction, Transport" "Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 4236.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (4.19e-2)" "unprognostic (1.06e-2)" "unprognostic (3.11e-1)" "unprognostic (8.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.90e-3)" "unprognostic (8.25e-2)" "unprognostic (1.26e-2)" "unprognostic (7.87e-2)" "unprognostic (1.60e-1)" "prognostic favorable (3.41e-4)" "unprognostic (2.05e-1)" "prognostic favorable (0.00e+0)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (1.73e-1)" "unprognostic (8.28e-3)" 3.0 4.2 6.9 2.0 10.8 1.4 3.1 19.4 14.4 2.6 6.6 3.7 2.9 2.8 3.0 3.4 6.7 3.7 3.5 163.7 7.4 7.3 8.3 4.3 3.0 2.0 6.3 6.1 3.6 3.0 4.6 4.6 2.2 12.8 6.2 3.4 7.9 4.4 8.5 92.5 2.3 4.1 5.5 4.5 2.1 5.3 3.1 2.3 0.0 4.6 62.4 3.4 4.4 2.1 3.5 3.0 0.4 0.0 0.7 4.1 1.5 0.7 3.3 2.7 5.5 3.0 0.3 5.0 2.7 0.9 3.3 3.3 7.1 1.8 2.4 2.0 3.3 2.6 2.6 10.4 2.9 2.2 4.0 8.9 1.6 4.9 8.3 6.1 1.4 1.6 2.2 7.1 5.1 1.4 7.8 2.4 4.2 3.8 1.9 2.0 5.1 1.6 3.2 4.4 2.3 7.1 2.6 1.4 3.3 7.5 5.1 8.8 6.7 3.2 1.4 12.6 5.1 2.6 1.2 1.8 0.2 1.5 1.7 3.5 7.9 3.6 3.1 2.4 0.3 3.0 0.0 0.0 0.0 4.1 0.0 3.1 3.5 1.4 3.5 0.1 2.2 1.2 3.0 0.4 0.7 0.0 3.0 1.2 1.5 6.9 10.8 19.4 14.1 7.4 7.3 6.3 6.1 12.8 2.3 80.4 55.4 33.5 125.8 39.2 174.4 4236.1 140.1 112.4 42.1 68.0 98.2 59.7 837.3 68.4 15.8 25.9 41.2 0.0 65.1 47.9 24.6 55.0 11.5 83.9 50.1 151.0 51.6 24.5 7.6 7.7 43.1 7.9 180.5 15.4 35.7 473.2 51.1 24.6 106.1 140.9 178.4 103.5 194.8 24.0 35.3 15.8 33.9 10.7 48.8 46.9 SLC25A43 ENSG00000077713 "Solute carrier family 25 member 43" Q8WUT9 X 119399060-119454478 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035188, HPA078530" Uncertain Approved Cytosol NA NA Cytosol "HPA035188: AB_10602400, HPA078530: " "unprognostic (6.05e-3)" "unprognostic (1.48e-1)" "unprognostic (9.92e-2)" "prognostic unfavorable (3.76e-5)" "unprognostic (4.99e-3)" "unprognostic (1.59e-2)" "unprognostic (3.26e-2)" "unprognostic (2.74e-2)" "unprognostic (7.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.80e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.06e-8)" "unprognostic (2.63e-1)" "unprognostic (2.62e-1)" "unprognostic (1.96e-2)" "unprognostic (4.92e-2)" 12.7 3.0 4.4 11.1 3.7 1.3 11.8 5.9 3.8 8.9 12.3 4.3 5.6 12.8 8.0 7.3 23.5 5.8 6.3 6.0 5.1 3.4 11.4 11.3 10.4 9.5 3.8 2.7 7.8 15.6 4.0 3.0 7.3 5.8 8.5 14.2 7.4 12.8 4.4 6.3 14.0 13.3 7.7 8.2 9.0 7.9 4.3 4.3 1.9 5.7 9.6 16.2 8.9 12.9 4.3 6.3 0.2 10.7 6.6 3.2 1.4 13.6 10.1 0.7 4.0 14.0 21.2 5.4 7.5 9.6 6.1 5.9 5.2 6.9 1.5 4.6 21.0 18.4 10.1 7.9 7.1 5.5 11.8 2.4 4.9 3.3 7.0 8.7 4.6 5.2 8.7 12.6 10.1 8.5 8.7 7.5 2.7 0.9 7.3 7.0 24.4 0.0 6.5 4.6 7.2 15.9 1.2 0.0 2.0 10.1 4.7 0.6 0.0 10.2 21.6 12.0 3.4 3.8 4.6 10.4 10.0 2.9 10.8 11.6 0.1 5.7 3.3 10.0 7.7 8.8 0.0 3.4 0.2 1.0 5.1 1.8 4.3 2.0 3.2 6.3 3.6 1.1 1.9 0.0 6.6 10.7 1.6 1.6 1.4 4.4 3.7 5.9 3.8 5.1 3.4 3.8 2.7 5.8 4.3 6.0 8.9 6.0 5.9 6.9 0.1 1.4 0.0 1.4 6.8 3.5 0.0 8.9 8.3 3.6 0.0 7.3 16.9 0.0 7.9 6.7 9.3 3.1 8.1 4.9 9.7 0.0 7.0 6.2 6.5 0.0 7.5 9.9 10.1 11.8 10.3 0.0 12.1 8.6 5.3 7.0 0.1 0.0 13.3 0.4 2.2 12.2 5.7 7.2 10.3 5.1 SLC25A44 "FLJ90431, KIAA0446" ENSG00000160785 "Solute carrier family 25 member 44" Q96H78 1 156193932-156212796 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 115.9;Late spermatids: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065411 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA065411: AB_2685486" "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-1)" "unprognostic (2.44e-3)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.72e-2)" "unprognostic (8.92e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "prognostic favorable (2.49e-4)" "unprognostic (3.37e-2)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (2.67e-1)" "unprognostic (8.13e-2)" "unprognostic (2.37e-1)" 14.3 9.0 15.9 9.3 23.1 10.2 8.9 18.6 31.9 9.1 10.4 19.7 6.6 16.8 8.1 11.1 9.0 7.8 10.7 10.6 16.1 16.7 25.9 31.2 10.6 8.7 14.4 18.1 7.1 8.3 17.7 10.9 7.8 22.5 8.7 11.1 9.3 7.0 9.5 12.8 9.1 13.9 10.8 13.5 13.3 8.4 8.9 12.1 10.6 9.7 6.0 11.2 9.7 7.9 3.7 6.3 33.8 9.1 4.2 4.9 5.6 10.3 17.7 8.7 11.5 19.0 10.3 6.8 11.1 16.4 20.3 16.6 17.3 9.4 8.2 9.8 16.6 11.0 15.5 31.7 13.1 18.0 9.4 10.6 7.5 11.3 10.4 14.5 9.7 13.8 14.4 11.5 20.5 12.4 9.8 16.4 10.2 7.8 13.6 13.9 18.6 10.1 6.9 20.5 19.8 18.4 6.5 8.8 14.0 26.5 12.3 13.6 18.3 13.0 23.6 14.8 16.0 17.8 15.9 13.2 11.7 9.9 13.1 13.2 14.0 10.6 12.5 12.9 10.2 11.5 6.5 8.4 8.7 4.7 9.1 4.9 3.7 3.8 4.4 6.3 2.4 3.1 3.7 33.8 4.2 7.1 2.8 3.3 5.6 15.9 23.1 18.6 31.9 16.1 16.7 14.4 18.1 22.5 12.1 11.9 24.8 12.3 4.8 24.6 12.6 30.7 7.6 4.0 14.8 8.7 19.6 4.3 5.0 5.4 115.9 11.7 9.2 0.0 4.9 3.3 17.9 6.1 4.7 29.8 6.5 19.1 5.8 10.4 8.6 71.2 6.6 12.2 11.8 1.8 8.5 7.2 4.9 5.8 5.3 13.9 8.8 19.4 12.2 9.1 7.7 29.7 6.9 7.5 7.5 6.3 SLC25A45 ENSG00000162241 "Solute carrier family 25 member 45" Q8N413 11 65375192-65383701 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 60.5" "Cell type enhanced" "Detected in many" 5 "B-cells: 32.2;T-cells: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 13.8;Karpas-707: 18.7;RPMI-8226: 13.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA050821 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA050821: AB_2681249" "unprognostic (3.73e-2)" "unprognostic (2.19e-3)" "unprognostic (8.44e-4)" "unprognostic (6.17e-3)" "unprognostic (2.57e-2)" "unprognostic (2.84e-7)" "unprognostic (7.57e-3)" "unprognostic (4.59e-2)" "unprognostic (1.44e-1)" "unprognostic (4.06e-2)" "prognostic favorable (2.83e-4)" "unprognostic (1.96e-1)" "unprognostic (1.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.54e-1)" "unprognostic (6.18e-2)" "unprognostic (1.43e-1)" 2.2 1.8 2.1 4.0 2.3 3.1 3.2 1.0 2.6 1.7 4.5 4.0 4.7 4.1 1.0 5.4 1.5 1.3 1.3 2.8 2.5 1.1 3.9 7.7 5.3 9.4 1.8 2.3 1.3 60.5 4.2 4.7 1.2 2.3 2.5 1.2 3.5 5.0 1.3 4.1 2.0 11.0 1.5 2.3 9.6 1.9 2.4 2.0 5.8 9.0 2.8 8.2 1.9 1.7 10.8 19.2 6.0 10.1 13.5 11.4 2.5 0.3 4.7 0.2 6.9 1.3 0.6 3.5 0.8 2.1 0.4 0.4 1.0 2.2 4.1 3.9 1.9 1.8 0.6 0.5 0.3 0.0 13.8 1.0 4.5 2.5 0.3 0.8 1.4 4.8 1.6 0.1 0.5 0.4 0.4 0.7 8.0 0.6 18.7 0.7 1.5 3.3 0.1 0.3 0.2 2.2 6.1 0.9 13.6 0.7 0.0 2.3 3.1 1.4 3.7 0.7 0.4 1.9 0.7 1.3 0.5 1.8 4.5 0.3 7.8 4.9 1.2 1.4 1.0 2.7 6.0 5.5 3.9 7.9 9.0 8.4 8.9 7.0 7.5 5.7 10.8 11.4 8.5 3.3 13.5 10.1 19.2 6.3 2.5 2.1 2.3 1.0 2.6 2.5 1.1 1.8 2.3 2.3 2.0 0.0 3.5 32.2 5.2 2.5 9.0 5.5 10.2 17.4 4.5 12.2 0.0 1.4 0.0 4.9 5.2 2.9 23.9 0.0 4.7 1.0 3.3 7.8 4.6 12.1 6.3 6.4 6.4 7.4 7.0 3.3 6.4 13.8 5.0 18.0 12.9 7.7 4.3 8.6 3.5 6.2 0.3 6.5 2.5 2.3 0.2 1.8 1.3 35.9 7.4 3.5 SLC25A48 "FLJ44862, HDMCP" ENSG00000145832 "Solute carrier family 25 member 48" Q6ZT89 5 135579202-135889770 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.4;kidney: 11.7;skeletal muscle: 12.8" "Cell type enhanced" "Detected in some" 26 "Distal tubular cells: 8.3;Enterocytes: 4.5;Proximal tubular cells: 27.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 5.0;HEK 293: 4.2;HEL: 4.1;RPMI-8226: 3.7;SCLC-21H: 3.9;U-2 OS: 5.1" HPA014674 Uncertain Approved "Intermediate filaments,Actin filaments" NA NA "Intermediate filaments" "Actin filaments" "HPA014674: AB_1859512" "unprognostic (2.09e-1)" "unprognostic (2.24e-1)" "unprognostic (6.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.96e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-7)" "unprognostic (9.13e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" 1.0 0.8 10.8 1.0 13.0 0.9 1.6 1.3 18.8 0.9 2.0 10.3 0.0 2.0 1.0 0.7 1.3 0.7 0.9 0.9 11.9 8.1 11.7 1.3 0.7 1.0 22.4 4.1 0.7 3.3 0.8 0.4 1.1 5.6 1.3 1.8 0.0 3.5 0.6 12.8 3.2 4.1 0.7 5.4 0.9 0.8 1.2 15.2 0.0 1.0 0.5 0.7 0.8 0.3 0.6 1.0 2.1 1.0 0.8 0.7 0.2 0.4 0.3 0.1 0.3 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.4 0.7 0.1 0.4 0.0 0.1 0.5 5.0 0.0 0.0 0.7 4.2 4.1 0.6 0.8 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.5 0.1 0.0 0.0 1.7 0.8 0.0 0.1 0.1 0.0 3.7 0.3 0.6 3.9 0.4 0.7 0.5 1.0 1.3 1.8 0.6 0.5 0.4 5.1 0.3 0.2 1.7 0.5 0.2 0.4 0.4 0.3 2.1 0.3 0.7 0.5 0.5 0.6 0.5 0.5 0.4 0.3 0.6 0.6 0.7 1.5 0.8 1.0 1.0 0.5 0.2 10.8 13.0 1.3 9.9 11.9 8.1 22.4 4.1 5.6 15.2 0.0 0.0 0.0 0.0 2.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.8 0.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.2 0.1 2.9 0.0 27.1 0.1 0.0 0.0 0.1 0.5 0.6 0.1 0.0 1.6 0.1 SLC25A5 "2F1, ANT2, T2, T3" ENSG00000005022 "Solute carrier family 25 member 5" P05141 X 119468400-119471319 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Chromosome partition, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 2147.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA 7800000 Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (1.25e-2)" "prognostic favorable (7.35e-4)" "prognostic favorable (7.47e-4)" "unprognostic (1.48e-1)" "unprognostic (4.58e-2)" "unprognostic (1.45e-2)" "unprognostic (2.73e-2)" "unprognostic (1.36e-1)" "unprognostic (6.52e-2)" "unprognostic (2.47e-1)" "unprognostic (1.60e-1)" "unprognostic (2.17e-1)" "prognostic favorable (8.06e-6)" "unprognostic (1.41e-1)" "unprognostic (2.65e-1)" "unprognostic (4.36e-2)" "unprognostic (3.03e-1)" 26.0 28.9 26.8 32.2 29.5 36.5 36.6 21.8 39.0 23.0 74.1 16.3 26.0 120.7 22.5 18.3 64.1 17.5 39.5 31.4 22.5 18.8 80.7 71.0 38.3 53.8 27.2 23.8 18.1 128.2 22.5 14.6 30.7 24.2 18.9 84.9 20.1 58.3 21.5 16.6 42.1 157.5 33.6 20.5 34.3 68.2 16.8 17.1 87.0 31.1 59.9 47.0 30.8 33.8 51.6 97.8 18.5 113.2 33.4 48.0 84.9 82.0 78.9 30.9 53.1 19.8 29.2 57.4 30.7 33.5 64.8 58.0 65.5 52.1 104.2 41.3 29.4 46.8 57.8 75.8 64.1 59.2 27.5 73.1 35.1 47.7 46.6 25.1 95.3 58.0 31.7 72.1 66.7 42.6 24.7 67.2 53.7 28.1 43.2 35.3 182.7 84.3 96.8 65.0 112.7 127.2 46.3 39.1 80.8 49.3 66.0 37.4 35.4 52.7 80.3 62.1 32.9 33.1 48.3 27.9 30.7 44.4 68.3 110.0 50.7 62.9 83.4 33.9 97.5 49.5 10.1 68.1 18.5 20.7 113.2 23.9 51.6 30.1 26.9 97.8 39.7 30.1 28.3 11.3 33.4 84.9 53.9 48.0 84.9 26.8 29.5 21.8 39.0 22.5 18.8 27.2 23.8 24.2 17.1 151.8 244.7 335.6 401.9 724.7 105.3 125.5 328.6 187.4 221.8 177.9 56.9 945.1 2147.0 467.3 2.7 209.6 1628.0 163.5 919.2 321.7 246.2 228.4 191.3 343.1 785.8 25.4 385.2 119.1 477.4 13.9 134.6 447.5 519.6 300.2 755.1 85.2 524.3 956.2 104.0 1138.1 131.4 129.4 460.4 8.9 116.7 839.4 1329.0 292.0 958.7 657.9 SLC25A53 MCART6 ENSG00000269743 "Solute carrier family 25 member 53" Q5H9E4 X 104099214-104157027 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Daudi: 7.2;Karpas-707: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034959 Uncertain NA NA "HPA034959: AB_10602025" "unprognostic (4.70e-2)" "unprognostic (1.16e-2)" "unprognostic (7.16e-3)" "unprognostic (5.94e-2)" "unprognostic (2.68e-2)" "unprognostic (5.23e-2)" "unprognostic (1.98e-1)" "unprognostic (5.49e-3)" "unprognostic (4.45e-3)" "unprognostic (7.94e-2)" "unprognostic (9.76e-5)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (3.48e-2)" "unprognostic (1.74e-1)" "unprognostic (3.53e-1)" "unprognostic (1.76e-2)" 2.8 2.4 3.2 5.6 4.6 2.8 2.1 6.3 8.6 3.9 2.5 2.8 5.7 3.1 5.1 3.4 2.2 1.9 2.9 2.8 3.6 1.8 1.6 2.0 8.8 3.1 2.7 3.2 4.4 1.2 5.8 1.4 3.6 4.6 2.9 3.1 3.0 5.0 1.5 2.1 3.8 4.8 4.2 6.6 3.1 3.9 4.5 1.4 2.7 0.8 8.4 4.7 9.0 1.7 0.5 3.0 0.5 1.0 2.9 0.7 0.1 0.1 2.1 1.3 0.1 0.0 0.1 0.2 0.1 0.3 0.2 0.1 0.0 7.2 0.2 0.1 0.4 0.1 2.4 0.0 0.2 0.6 1.0 0.8 0.2 0.2 0.2 1.4 0.8 0.4 0.1 0.3 0.0 0.4 0.5 0.8 0.2 17.1 0.1 0.1 0.3 0.1 2.7 0.1 0.5 2.9 1.1 0.3 0.3 0.2 1.9 2.7 0.1 0.1 0.1 0.4 0.1 0.1 0.4 0.2 1.0 0.1 0.5 0.2 0.0 2.6 0.1 1.9 0.5 0.9 0.4 0.8 1.3 0.5 2.9 1.7 1.2 2.4 0.5 1.4 0.4 1.6 3.0 1.0 0.3 0.3 1.8 0.7 6.0 2.9 11.5 6.5 4.6 3.0 11.7 2.5 14.7 2.3 8.7 0.0 3.1 21.6 3.5 2.6 4.5 15.9 70.0 5.2 3.6 3.8 8.3 6.9 21.2 9.4 3.2 6.9 4.9 9.8 0.4 2.8 7.2 1.7 12.6 8.3 3.5 6.4 21.0 2.8 11.0 7.8 0.0 4.4 2.3 2.1 5.0 5.1 12.8 4.3 11.5 SLC25A6 "ANT3, ANT3Y, MGC17525" ENSG00000169100 "Solute carrier family 25 member 6" P12236 X 1386152-1392724 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 85.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA 7200000 Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (1.13e-1)" "unprognostic (1.65e-2)" "unprognostic (4.79e-2)" "unprognostic (1.45e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.01e-3)" "unprognostic (1.34e-1)" "unprognostic (8.07e-2)" "unprognostic (1.48e-1)" "unprognostic (1.37e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (4.57e-3)" 18.5 19.7 12.1 12.2 14.0 23.7 14.4 8.2 12.2 9.8 16.5 28.9 14.3 4.8 16.4 10.4 7.0 9.4 10.3 8.2 18.4 5.4 11.1 14.4 9.4 25.6 38.7 10.1 14.0 8.6 12.4 8.8 45.0 12.5 6.1 14.9 23.3 7.7 5.8 15.4 19.2 2.4 16.3 9.5 14.2 11.2 62.2 85.7 3.7 69.0 30.1 43.6 71.2 22.2 48.7 34.6 35.3 24.0 46.8 37.5 34.1 32.7 25.2 25.1 64.4 27.2 82.8 27.6 22.4 38.0 14.5 23.2 40.7 7.9 20.7 73.8 45.2 33.4 73.5 56.3 32.5 55.2 77.2 75.0 19.7 29.0 32.7 37.3 26.1 31.5 19.5 24.6 47.4 60.1 62.3 43.9 8.8 65.7 30.4 28.6 64.2 30.7 56.0 56.6 88.9 23.1 70.1 97.0 21.0 38.9 67.0 42.7 25.7 14.4 50.2 34.0 50.6 8.1 55.8 3.8 31.4 13.9 2.4 58.1 3.7 29.4 69.0 43.6 62.2 40.4 34.8 85.7 47.5 38.1 37.2 3.0 30.1 67.9 41.0 38.7 71.2 137.0 195.3 871.5 1042.4 1022.6 282.9 87.0 257.4 128.5 280.9 300.1 92.3 1322.2 1405.9 633.0 8.9 418.0 863.0 303.7 1275.3 963.9 807.0 855.9 337.0 132.8 1090.5 228.8 892.0 411.9 1235.3 26.5 618.4 976.3 715.3 1354.4 1107.0 100.8 835.0 866.6 344.4 1021.3 199.6 336.3 860.1 13.3 52.8 1155.2 1458.6 553.5 1380.0 1328.6 SLC26A1 "EDM4, SAT-1" ENSG00000145217 "Solute carrier family 26 member 1" Q9H2B4 4 979073-993440 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 17.1;liver: 45.4" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 3.3;Hepatocytes: 9.0;Proximal tubular cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 13.3;HMC-1: 9.1;T-47d: 9.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA041654 Uncertain Approved Microtubules NA NA Microtubules "HPA041654: AB_10796350" "unprognostic (1.96e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-1)" "unprognostic (4.91e-2)" "unprognostic (1.74e-1)" "unprognostic (2.67e-4)" "unprognostic (5.13e-2)" "unprognostic (5.82e-2)" "unprognostic (2.16e-1)" "unprognostic (3.88e-2)" "unprognostic (1.53e-3)" "unprognostic (2.92e-2)" "prognostic favorable (1.19e-4)" "unprognostic (1.18e-2)" "unprognostic (2.22e-1)" "unprognostic (1.27e-1)" "unprognostic (1.65e-3)" 1.1 6.5 1.4 1.7 1.7 1.5 1.6 4.6 2.7 1.3 7.4 1.1 1.1 6.5 1.4 1.9 1.1 1.1 2.6 1.1 1.4 1.5 17.1 45.4 1.1 1.7 1.1 1.1 1.6 4.0 0.0 2.1 1.1 1.1 1.8 0.0 1.1 4.2 1.1 1.5 3.1 10.5 1.1 1.1 2.4 4.0 1.1 1.1 1.1 2.0 1.1 1.1 1.1 1.1 0.4 0.3 7.0 0.6 1.1 1.8 0.7 1.3 2.3 0.0 1.8 0.2 0.4 4.2 1.9 0.1 0.0 0.0 4.5 2.6 0.7 2.3 0.0 1.8 1.3 0.1 0.0 0.0 2.6 0.9 3.4 3.1 13.3 0.2 2.1 9.1 0.6 0.2 0.1 0.0 1.0 0.3 2.9 3.5 0.0 0.4 2.9 1.3 3.6 1.0 1.7 7.2 7.3 0.0 0.3 0.7 5.1 0.2 1.4 0.5 0.2 1.2 0.4 9.2 1.4 2.1 4.8 1.0 4.8 1.3 7.0 3.2 1.2 1.7 4.4 2.1 7.0 0.6 0.4 0.4 0.3 0.8 0.4 1.2 0.9 0.2 0.1 0.8 1.8 0.0 1.1 0.3 0.3 1.6 0.7 1.4 1.7 4.6 1.6 1.4 1.5 1.1 1.1 1.1 1.1 0.0 0.6 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 1.3 0.0 0.3 3.3 0.2 0.1 1.1 9.0 0.6 0.0 0.0 1.3 0.3 0.0 0.9 0.0 1.7 0.0 0.6 0.2 0.6 0.2 0.4 8.5 0.1 0.0 0.3 0.0 0.1 0.1 0.7 0.0 0.6 0.1 SLC26A10 ENSG00000135502 "Solute carrier family 26 member 10" Q8NG04 12 57619527-57626151 "Predicted membrane proteins, Transporters" "Antiport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 8.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 9.1;Peritubular cells: 4.9" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Region enhanced" "Detected in single" "cerebellum: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.0;HEK 293: 3.5;NTERA-2: 5.6;RH-30: 4.4;SH-SY5Y: 7.9;U-266/70: 5.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA044719 Uncertain NA NA "HPA044719: AB_10962362" "unprognostic (1.16e-1)" "unprognostic (1.21e-2)" "unprognostic (8.57e-2)" "unprognostic (8.82e-2)" "unprognostic (1.86e-1)" "unprognostic (1.89e-2)" "unprognostic (7.92e-2)" "unprognostic (1.45e-1)" "unprognostic (3.12e-2)" "unprognostic (1.89e-1)" "unprognostic (6.12e-5)" "unprognostic (3.22e-3)" "unprognostic (2.65e-12)" "unprognostic (1.28e-2)" "unprognostic (3.80e-1)" "unprognostic (7.34e-3)" "unprognostic (1.40e-1)" 2.0 0.7 0.4 0.5 0.9 0.0 0.4 3.8 0.9 0.4 0.8 0.4 0.4 0.0 2.9 1.2 0.4 1.9 1.8 8.5 0.4 0.2 0.4 0.4 0.4 0.5 0.4 0.4 0.9 0.4 0.0 0.4 0.4 0.4 2.1 0.5 0.4 0.8 1.6 2.6 0.1 1.1 1.9 0.4 0.7 0.6 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.0 0.0 0.0 0.5 1.1 0.2 0.7 0.3 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.7 0.0 0.2 0.0 3.5 0.4 0.2 0.7 0.7 0.0 0.1 0.0 0.0 0.5 0.0 0.4 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 4.4 0.0 0.0 0.0 2.3 7.9 0.0 0.0 0.5 0.4 0.1 0.6 0.0 0.6 1.3 0.7 0.0 5.4 0.5 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 3.8 0.9 0.4 0.2 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.3 9.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.9 0.0 0.8 0.0 1.7 0.5 0.2 0.4 0.1 0.0 0.0 0.0 SLC26A11 ENSG00000181045 "Solute carrier family 26 member 11" Q86WA9 17 80219699-80253500 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 37.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029893 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA029893: AB_10600809" "unprognostic (5.86e-2)" "unprognostic (6.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (1.55e-5)" "unprognostic (3.80e-2)" "unprognostic (2.63e-3)" "prognostic unfavorable (1.82e-6)" "unprognostic (2.05e-2)" "unprognostic (3.54e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.43e-5)" "unprognostic (2.86e-1)" "unprognostic (3.50e-1)" "unprognostic (9.54e-3)" "unprognostic (8.40e-2)" "unprognostic (8.69e-2)" "unprognostic (7.32e-2)" 9.9 30.9 10.2 10.2 19.3 16.3 8.4 9.1 18.0 11.6 8.2 12.6 14.1 8.7 11.6 14.6 6.9 9.2 10.0 5.1 9.4 30.5 12.4 6.9 12.8 14.3 10.5 17.4 18.3 7.9 14.9 25.6 21.1 17.2 11.8 5.1 15.6 12.2 14.8 6.5 13.1 11.9 11.6 9.3 17.3 7.3 4.8 7.3 1.8 18.1 4.9 6.7 9.8 14.1 0.4 1.3 0.1 2.3 0.1 4.9 1.9 0.5 8.2 9.7 7.5 4.9 3.6 11.2 4.7 5.9 10.6 6.6 9.4 1.7 0.1 9.6 4.9 7.7 3.1 5.4 3.5 4.2 11.2 9.7 0.0 10.4 8.7 12.9 0.0 1.5 6.6 5.7 5.1 2.3 1.0 8.9 1.9 4.0 11.9 6.2 7.7 0.4 0.2 4.3 2.3 8.0 0.4 1.0 4.3 9.6 9.0 3.8 11.9 4.7 11.8 12.2 15.8 14.1 0.2 6.6 8.6 5.0 7.3 0.5 13.5 5.1 1.3 4.4 0.0 6.8 0.0 2.3 0.0 1.8 0.9 2.6 0.4 3.2 2.6 1.3 0.2 4.9 2.0 0.1 0.1 0.3 0.0 4.0 1.9 10.2 19.3 9.1 18.0 9.4 30.5 10.5 17.4 17.2 7.3 6.0 12.0 0.9 9.3 4.0 28.0 2.0 0.0 2.7 5.7 12.2 55.0 12.2 1.7 6.3 0.4 14.1 3.9 0.0 5.3 7.0 8.2 9.4 1.1 2.0 14.0 3.2 9.8 6.2 5.9 0.2 15.8 8.3 3.3 2.8 2.5 21.0 3.9 3.5 11.7 4.8 37.6 32.3 4.7 0.2 1.5 4.1 21.7 5.7 2.8 5.2 SLC26A2 "DTD, DTDST" ENSG00000155850 "Solute carrier family 26 member 2" P50443 5 149960737-149993455 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 81.9" "Cell type enriched" "Detected in many" 4 "Syncytiotrophoblasts: 676.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 24.2;RPTEC TERT1: 55.5;TIME: 28.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041957, HPA058090" Enhanced Approved Vesicles NA NA Vesicles "HPA041957: AB_10795646, HPA058090: AB_2683602" "unprognostic (6.64e-2)" "unprognostic (1.53e-1)" "unprognostic (3.03e-2)" "prognostic favorable (7.29e-4)" "unprognostic (2.59e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (4.66e-4)" "unprognostic (2.59e-1)" "unprognostic (5.64e-2)" "unprognostic (1.19e-1)" "unprognostic (7.43e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.70e-1)" "unprognostic (1.77e-1)" "unprognostic (8.12e-2)" "unprognostic (1.06e-1)" 8.5 15.6 2.6 23.2 3.7 1.3 4.7 6.3 2.3 3.8 81.9 3.0 29.4 5.4 4.8 14.2 8.3 3.1 2.6 3.1 2.5 2.6 3.8 1.6 6.8 5.3 3.7 2.3 5.1 2.9 21.4 11.1 16.9 7.6 6.1 75.0 4.9 27.9 36.7 11.2 6.0 13.4 4.3 5.5 3.0 2.4 2.8 3.0 5.2 2.7 4.4 13.0 4.1 2.8 1.6 1.7 7.0 3.3 2.5 3.0 1.1 3.3 3.0 3.8 6.2 4.6 3.3 0.9 3.1 2.8 2.5 3.1 15.7 1.8 2.5 24.2 3.3 6.1 2.4 3.6 7.3 4.6 2.0 2.3 3.2 2.4 1.8 3.5 5.9 5.5 3.6 4.3 4.2 5.5 6.3 6.0 3.2 0.8 2.6 10.6 1.0 2.2 3.1 1.2 1.1 4.8 3.3 5.9 1.3 55.5 14.7 1.1 2.9 5.5 1.3 9.4 3.1 2.6 3.5 28.5 5.9 4.4 5.1 3.7 1.8 2.4 1.5 5.4 7.2 8.4 7.0 1.1 0.8 2.5 0.8 3.0 1.3 1.5 2.1 1.7 1.6 2.1 2.2 1.0 2.5 3.3 1.7 2.6 1.1 2.6 3.7 6.3 2.3 2.5 2.6 3.7 2.3 7.6 3.0 41.7 13.7 7.5 12.5 4.0 16.1 6.7 7.6 6.7 14.8 31.4 15.7 160.9 1.7 5.2 17.7 15.3 151.8 0.0 8.6 5.2 16.0 21.5 87.8 2.4 26.4 6.4 20.3 16.5 13.8 9.9 16.1 12.2 86.0 16.2 37.7 15.0 9.4 147.9 11.7 4.4 80.3 0.0 10.2 9.2 10.2 4.4 676.5 9.6 53.2 4.9 SLC26A3 "CLD, DRA" ENSG00000091138 "Solute carrier family 26 member 3" P40879 7 107765467-107803225 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 53.5;intestine: 110.1;lymphoid tissue: 42.8" "Cell type enriched" "Detected in some" 11 "Enterocytes: 543.6" "Cancer enriched" "Detected in many" 14 "colorectal cancer: 52.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.3;CACO-2: 1.9;NB-4: 1.5;RPMI-8226: 7.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA036055 Approved NA NA "HPA036055: AB_10602401" "unprognostic (1.26e-2)" "unprognostic (1.28e-1)" "unprognostic (1.12e-2)" "unprognostic (2.69e-1)" "unprognostic (4.02e-1)" "unprognostic (4.09e-2)" "unprognostic (3.05e-3)" "unprognostic (6.31e-2)" "unprognostic (1.68e-2)" "unprognostic (1.20e-1)" "unprognostic (1.14e-1)" "unprognostic (2.05e-2)" "unprognostic (8.85e-2)" "unprognostic (8.01e-2)" "unprognostic (5.52e-2)" "unprognostic (2.54e-2)" "unprognostic (3.58e-3)" 0.3 0.3 0.3 42.8 0.3 0.0 6.1 0.3 0.3 0.4 110.1 0.2 0.3 58.4 0.3 1.2 0.3 0.6 53.5 0.3 0.3 0.3 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.3 0.0 0.3 0.2 0.2 0.5 92.7 0.2 0.3 14.4 0.3 0.3 106.5 1.2 0.3 0.3 0.4 0.3 0.2 0.2 0.3 0.2 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 48.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 543.6 0.0 0.0 0.0 0.0 0.2 27.5 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 26.7 0.0 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.4 0.0 SLC26A4 "DFNB4, PDS" ENSG00000091137 "Solute carrier family 26 member 4" O43511 7 107660635-107717809 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "thyroid gland: 79.2" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 11.4;Glandular cells: 8.7;Intestinal endocrine cells: 7.0;Melanocytes: 6.8" "Cancer enriched" "Detected in some" 8 "thyroid cancer: 37.6" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "naive B-cell: 3.1" "Lineage enriched" "Detected in single" 5 "B-cells: 3.1" "Cell line enhanced" "Detected in some" "HDLM-2: 3.5;hTERT-RPE1: 8.3;LHCN-M2: 4.6" "Region enriched" "Detected in some" 4 "hippocampal formation: 10.6" "Low region specificity" "Detected in all" HPA042860 Approved NA NA "HPA042860: AB_10796680" "unprognostic (1.19e-2)" "unprognostic (4.84e-2)" "unprognostic (5.44e-2)" "unprognostic (8.44e-2)" "unprognostic (3.25e-2)" "unprognostic (3.26e-2)" "unprognostic (6.69e-2)" "unprognostic (1.85e-1)" "unprognostic (5.72e-2)" "unprognostic (9.58e-2)" "unprognostic (1.60e-1)" "unprognostic (1.03e-1)" "unprognostic (6.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.41e-2)" "unprognostic (1.39e-1)" 0.1 0.0 0.8 0.2 0.5 0.0 0.2 0.0 2.9 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.2 3.3 0.0 0.2 0.0 0.1 0.6 0.1 0.1 0.1 0.1 0.0 0.0 1.8 0.0 1.4 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 79.2 0.0 0.1 0.8 0.1 3.1 0.1 0.1 0.2 0.1 0.5 0.3 0.7 0.3 0.5 0.0 0.7 1.5 0.4 0.3 0.2 0.3 0.1 0.0 0.1 0.1 2.5 0.3 0.0 0.2 0.5 0.2 0.1 3.5 0.9 0.0 0.3 0.2 0.4 0.4 1.1 0.0 0.9 0.4 0.0 8.3 0.1 0.8 0.0 0.4 4.6 0.7 0.0 0.4 0.0 0.0 0.8 0.2 1.3 0.0 0.0 0.1 2.5 0.1 0.0 0.0 1.7 0.2 0.0 0.4 0.7 0.7 0.5 0.2 2.8 0.7 0.7 0.3 0.8 0.4 1.7 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 3.1 0.0 0.1 0.1 0.1 0.2 0.1 0.5 0.3 0.8 0.5 0.0 1.4 0.5 0.2 0.1 0.6 0.0 0.0 3.0 11.4 0.0 0.6 1.4 5.6 0.7 0.0 1.4 4.5 0.0 2.0 0.2 0.0 0.1 2.6 0.7 0.0 0.0 0.0 0.1 1.1 8.7 4.7 0.0 0.2 1.6 7.0 0.6 0.3 2.0 0.9 1.4 6.8 1.0 0.0 0.4 0.1 0.0 1.1 0.0 1.1 0.0 0.9 1.7 0.3 1.3 0.0 1.0 0.0 1.2 SLC26A5 "DFNB61, PRES" ENSG00000170615 "Solute carrier family 26 member 5" P58743 7 103352730-103446177 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell shape, Hearing" "Motor protein" "Deafness, Non-syndromic deafness" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 20.4" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 6.0;Ciliated cells: 4.0;Ito cells: 3.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 8 "cerebellum: 20.4" "Cell type enriched" "Detected in single" 8 "basophil: 2.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "Karpas-707: 2.9;PC-3: 2.6;U-2197: 1.8" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 8 "basal ganglia: 9.5" NA NA "unprognostic (3.86e-2)" "unprognostic (5.13e-2)" "unprognostic (6.38e-3)" "unprognostic (2.76e-2)" "unprognostic (1.02e-2)" "unprognostic (5.09e-2)" "unprognostic (2.36e-1)" "unprognostic (3.56e-4)" "unprognostic (4.21e-3)" "unprognostic (8.92e-3)" "unprognostic (2.82e-1)" "unprognostic (2.97e-1)" "unprognostic (3.67e-5)" "unprognostic (3.05e-1)" "unprognostic (2.81e-1)" "unprognostic (2.94e-2)" "unprognostic (2.69e-3)" 1.3 1.0 0.6 0.3 0.7 2.3 3.1 20.4 0.8 0.6 0.3 0.5 0.0 0.9 0.5 0.0 0.2 0.4 0.2 0.4 0.8 0.4 0.7 0.9 2.2 1.2 1.3 0.4 0.4 0.7 2.5 4.6 0.1 2.6 3.1 0.1 0.9 1.4 1.0 0.6 2.2 0.5 1.2 2.9 0.9 3.2 0.9 0.2 0.0 1.8 0.0 0.2 3.2 0.4 0.2 0.0 2.7 0.1 0.3 0.1 0.0 0.2 0.0 0.3 0.7 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.1 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.2 0.9 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 2.9 0.0 1.2 0.8 0.3 0.1 0.5 2.6 0.3 0.1 0.4 0.0 0.8 0.9 1.5 0.3 0.3 0.0 0.6 0.7 0.0 0.0 0.6 0.6 1.8 0.4 0.8 0.4 0.4 0.2 0.2 0.3 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.7 20.4 0.8 0.8 0.4 1.3 0.4 2.6 0.2 6.0 1.6 0.0 0.0 0.2 0.1 0.8 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.6 SLC26A6 DKFZp586E1422 ENSG00000225697 "Solute carrier family 26 member 6" Q9BXS9 3 48625723-48635493 "Plasma proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 43.3;Mucus-secreting cells: 32.0;Paneth cells: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048363 Approved Uncertain Cytosol NA NA Cytosol "HPA048363: AB_2680371" "unprognostic (1.54e-1)" "unprognostic (4.94e-2)" "unprognostic (3.34e-1)" "unprognostic (3.15e-2)" "unprognostic (2.15e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.92e-4)" "unprognostic (2.39e-1)" "unprognostic (2.35e-1)" "unprognostic (2.04e-1)" "unprognostic (4.09e-1)" "unprognostic (9.66e-3)" "prognostic unfavorable (1.53e-5)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "unprognostic (1.55e-1)" "unprognostic (3.58e-2)" 5.3 5.7 6.4 12.3 9.8 18.8 5.7 6.8 6.9 6.3 24.8 6.0 7.3 9.7 6.8 7.4 6.5 4.7 6.3 6.7 4.9 3.1 13.6 6.2 7.8 7.4 9.4 3.1 6.7 14.9 6.8 5.8 6.5 9.3 10.2 25.4 7.7 9.6 7.4 8.8 6.7 19.5 6.8 4.8 10.6 19.7 7.7 9.9 7.7 5.5 5.4 6.3 5.1 6.6 0.9 8.8 5.2 10.7 0.5 3.3 4.5 4.5 5.1 7.3 8.2 23.1 11.6 6.2 7.5 9.9 14.6 15.7 9.7 4.2 6.5 2.6 6.4 16.2 6.1 6.8 6.9 4.2 4.8 6.8 5.9 14.5 18.7 16.8 2.8 9.2 15.8 24.8 9.9 7.2 12.6 4.5 6.7 4.5 7.4 3.5 5.4 5.4 14.8 10.4 12.5 9.9 2.8 2.7 7.9 10.7 4.5 1.8 3.5 9.8 12.1 14.1 10.6 6.3 10.5 3.6 6.3 5.3 8.5 17.1 8.8 9.2 2.9 5.3 11.1 15.9 5.2 10.7 2.1 3.1 10.0 2.8 0.9 1.9 2.0 8.8 0.2 1.1 1.6 1.5 0.5 8.9 5.0 3.3 4.5 6.4 9.8 6.8 6.9 4.9 3.1 9.4 3.1 9.3 9.9 3.0 5.1 0.8 2.4 2.9 1.5 6.4 2.5 2.7 1.2 1.8 13.7 7.5 0.0 2.5 1.2 2.9 43.3 0.0 5.6 13.1 4.3 1.9 0.0 4.2 6.2 4.8 19.5 5.5 5.2 0.7 3.4 7.0 5.0 4.6 32.0 2.0 5.2 36.6 8.9 5.1 6.4 0.0 5.7 2.5 5.7 3.0 8.8 3.8 23.5 0.8 SLC26A7 SUT2 ENSG00000147606 "Solute carrier family 26 member 7" Q8TE54 8 91209494-91398152 "Predicted membrane proteins" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "thyroid gland: 194.5" "Group enriched" "Detected in some" 5 "Collecting duct cells: 22.7;Distal tubular cells: 11.6;Intestinal endocrine cells: 43.5;Ito cells: 15.4" "Group enriched" "Detected in some" 11 "renal cancer: 8.7;thyroid cancer: 32.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.7;EFO-21: 1.3;HAP1: 3.0;HEK 293: 1.7;U-266/70: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (5.84e-2)" "unprognostic (8.04e-3)" "unprognostic (4.15e-3)" "unprognostic (1.51e-1)" "unprognostic (2.39e-3)" "unprognostic (2.94e-3)" "unprognostic (1.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.41e-2)" "unprognostic (8.26e-2)" "unprognostic (4.82e-2)" "unprognostic (3.31e-2)" "unprognostic (2.07e-1)" "unprognostic (5.19e-3)" "unprognostic (6.83e-3)" 0.3 0.1 0.1 0.4 0.1 0.0 0.2 0.1 0.2 1.6 0.2 0.0 0.2 0.0 1.4 0.2 0.3 0.1 0.1 0.3 0.1 0.1 13.0 0.1 0.1 1.7 0.1 0.0 0.1 0.3 0.1 0.3 4.4 0.7 0.1 0.0 8.6 0.8 0.1 0.2 0.2 0.1 0.0 0.3 0.1 1.5 0.2 0.0 0.0 194.5 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 1.3 0.0 0.0 0.0 3.0 0.1 0.2 0.0 1.7 0.3 0.1 0.0 0.0 0.0 1.2 0.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.8 0.0 0.6 3.1 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.7 0.0 0.0 1.0 0.0 0.3 0.2 0.0 0.8 0.0 0.0 0.0 22.7 0.0 0.0 11.6 0.0 4.4 0.6 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.1 0.0 43.5 15.4 0.6 1.0 3.4 0.0 3.3 0.0 0.7 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.2 0.0 SLC26A8 ENSG00000112053 "Solute carrier family 26 member 8" Q96RN1 6 35943514-36024868 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 65.2" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 26.1;Late spermatids: 8.8;Spermatocytes: 42.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 5.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;RT4: 2.9;T-47d: 1.0;THP-1: 2.3;TIME: 1.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA038081 Enhanced NA NA "HPA038081: AB_10670653" "unprognostic (8.18e-2)" "unprognostic (1.74e-1)" "unprognostic (6.71e-2)" "unprognostic (1.31e-2)" "unprognostic (2.46e-1)" "unprognostic (7.07e-3)" "unprognostic (2.93e-1)" "unprognostic (6.31e-2)" "unprognostic (1.11e-1)" "unprognostic (1.11e-1)" "unprognostic (1.85e-1)" "unprognostic (3.78e-1)" "unprognostic (4.63e-6)" "unprognostic (7.14e-2)" "unprognostic (4.24e-1)" "unprognostic (2.31e-1)" "unprognostic (5.24e-8)" 0.3 0.2 1.3 0.5 2.2 3.7 0.3 4.2 1.8 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 2.1 0.2 0.2 0.2 1.1 0.7 1.7 0.2 0.3 0.2 0.1 0.2 1.9 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.6 0.9 0.2 65.2 0.1 0.1 0.4 0.0 0.2 0.2 0.0 0.0 0.2 5.4 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.4 0.0 0.0 0.8 2.9 0.8 0.0 0.0 0.0 0.1 0.2 1.0 2.3 1.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 1.3 2.2 4.2 1.8 0.8 2.1 0.7 1.7 1.9 0.1 3.0 1.4 0.0 0.3 0.3 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.8 0.1 0.0 0.0 0.6 1.2 8.8 0.9 0.4 1.7 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 42.9 0.3 0.1 0.2 0.0 0.0 0.1 SLC26A9 ENSG00000174502 "Solute carrier family 26 member 9" Q7LBE3 1 205913048-205943460 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "salivary gland: 108.4" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 2: 51.6;Cardiomyocytes: 25.8;Proximal tubular cells: 10.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.6;Hep G2: 4.7;OE19: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA051485 Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "HPA051485: AB_2681503" "unprognostic (1.55e-2)" "unprognostic (2.70e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-1)" "unprognostic (1.83e-2)" "prognostic favorable (8.55e-5)" "unprognostic (1.26e-1)" "unprognostic (1.68e-1)" "unprognostic (3.49e-1)" "unprognostic (8.07e-2)" "unprognostic (8.85e-2)" "unprognostic (3.41e-1)" "unprognostic (2.43e-1)" "unprognostic (2.19e-1)" "unprognostic (1.05e-1)" "unprognostic (7.45e-3)" "unprognostic (2.01e-1)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.3 0.1 6.4 0.1 0.1 0.0 0.1 0.1 5.5 0.1 0.1 0.1 0.1 0.5 0.0 0.3 0.1 0.1 0.1 0.0 0.1 108.4 0.1 0.1 1.9 0.1 0.1 0.1 0.1 17.8 0.1 0.1 0.2 0.4 1.1 2.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 3.0 51.6 0.0 0.0 0.0 0.0 25.8 0.0 4.0 4.5 1.8 0.0 0.0 1.7 2.9 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 SLC27A1 "ACSVL5, FATP, FATP1, FLJ00336, MGC71751" ENSG00000130304 "Solute carrier family 27 member 1" Q6PCB7 19 17468769-17506168 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 17.6;SK-MEL-30: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076520 Approved "Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane" "Mitochondria, Cytosol" "HPA076520: AB_2732311" "unprognostic (1.48e-3)" "unprognostic (3.03e-2)" "unprognostic (5.72e-3)" "unprognostic (5.84e-2)" "unprognostic (2.16e-3)" "unprognostic (4.36e-2)" "unprognostic (8.56e-2)" "unprognostic (3.36e-2)" "unprognostic (9.03e-2)" "unprognostic (1.85e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "prognostic favorable (4.70e-4)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" 14.5 14.3 13.1 5.2 13.9 2.0 9.3 20.1 19.3 11.8 6.4 44.1 10.1 4.6 8.9 6.4 5.9 14.7 11.0 18.3 12.9 10.0 5.2 5.2 8.5 6.7 22.0 17.2 23.2 14.5 26.1 9.8 7.5 16.1 11.0 2.6 9.6 26.7 13.0 24.2 13.7 3.7 5.5 13.4 7.1 10.9 9.6 19.3 1.3 9.9 4.7 5.3 6.9 8.8 0.5 7.4 0.3 9.9 1.7 3.2 4.6 3.6 1.8 2.5 6.1 17.6 9.8 2.1 2.6 7.0 3.0 4.5 0.2 11.3 1.2 5.0 4.4 2.8 4.4 0.2 4.1 0.7 1.4 0.8 0.7 0.2 1.3 3.4 0.3 4.0 9.0 2.9 3.0 1.2 12.5 2.0 2.4 0.4 0.7 1.9 1.5 2.0 2.9 0.7 3.6 3.2 2.8 2.0 0.8 1.9 1.1 0.8 1.8 1.8 0.9 29.1 1.6 3.2 0.9 1.2 5.9 3.9 4.7 1.8 2.5 1.8 0.4 6.1 3.2 4.1 0.0 9.9 0.3 1.7 4.7 3.2 0.5 1.2 2.1 7.2 0.3 1.6 2.1 0.0 1.7 1.8 7.4 0.7 4.6 13.1 13.9 20.1 19.3 12.9 10.0 22.0 17.2 16.1 19.3 3.0 14.0 1.5 14.9 6.0 8.2 16.7 10.2 4.0 9.1 8.7 25.5 3.7 1.7 9.3 0.7 4.7 0.1 0.0 4.1 14.7 9.7 10.3 2.3 5.8 24.7 6.4 5.2 9.2 20.6 1.7 19.8 9.1 8.5 5.4 2.6 9.7 4.9 0.0 11.0 2.7 17.6 6.5 5.2 8.1 4.3 4.0 1.9 6.1 1.3 7.0 SLC27A2 "ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS" ENSG00000140284 "Solute carrier family 27 member 2" O14975 15 50182196-50236395 "Enzymes, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 168.1" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 236.8;Hepatocytes: 188.9;Proximal tubular cells: 112.0" "Cancer enhanced" "Detected in many" "liver cancer: 49.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 27 "basophil: 27.3" "Lineage enriched" "Detected in many" 27 "granulocytes: 27.3" "Cell line enhanced" "Detected in many" "A549: 17.9;HaCaT: 32.2;HL-60: 23.1;OE19: 36.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 6 "hippocampal formation: 2.5" HPA026089 Enhanced NA NA "HPA026089: AB_1857060" "unprognostic (3.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (2.10e-2)" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (4.06e-3)" "unprognostic (3.33e-1)" "unprognostic (1.89e-1)" "unprognostic (6.38e-3)" "unprognostic (4.83e-2)" "unprognostic (1.82e-1)" "prognostic favorable (7.48e-6)" "unprognostic (5.01e-3)" "unprognostic (4.08e-1)" "unprognostic (1.22e-2)" "prognostic favorable (6.40e-4)" 1.1 8.1 0.7 4.1 0.8 1.2 3.4 1.5 1.0 0.5 4.2 0.4 1.3 2.5 0.2 17.5 1.2 2.6 1.3 0.2 1.1 1.1 39.4 168.1 1.7 0.8 0.3 1.0 0.7 6.3 2.0 10.4 7.4 3.0 1.2 4.0 3.2 0.6 0.3 0.2 0.6 5.3 0.1 0.3 0.4 0.4 0.7 0.1 0.1 1.0 0.2 1.3 1.4 0.8 0.1 0.0 27.3 0.0 1.0 0.5 0.2 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.5 9.3 2.5 0.0 0.2 0.4 0.2 32.2 8.2 0.2 0.8 12.6 10.1 13.2 16.6 8.3 0.1 23.1 9.5 0.0 0.7 0.0 0.0 0.0 0.0 6.1 4.0 0.0 0.0 2.9 0.6 15.6 0.6 36.0 0.6 0.0 0.0 0.6 1.7 16.3 14.9 0.9 3.1 0.4 0.0 0.4 1.7 8.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 27.3 0.0 0.4 0.4 0.0 0.4 0.1 0.4 0.4 0.0 0.1 0.1 0.1 0.2 1.0 0.0 0.0 0.5 0.2 0.7 0.8 1.5 1.0 1.1 1.1 0.3 1.0 3.0 0.1 0.0 0.6 0.9 0.8 0.9 0.7 0.3 0.0 54.9 6.8 8.7 0.0 236.8 10.0 0.3 0.4 0.1 20.6 0.0 1.7 2.6 0.0 1.8 5.8 188.9 14.3 1.6 4.1 3.7 2.5 0.0 0.3 0.1 0.0 0.0 18.6 0.5 1.6 28.1 0.0 112.0 1.5 0.0 0.1 1.8 2.5 0.3 45.9 4.3 21.1 4.4 SLC27A3 "ACSVL3, FATP3, MGC4365" ENSG00000143554 "Solute carrier family 27 member 3" Q5K4L6 1 153774354-153780157 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ito cells: 131.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7" "Cell line enhanced" "Detected in many" "ASC diff: 35.6;HaCaT: 12.5;MCF7: 18.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA006935, HPA067508" Enhanced Enhanced "Endoplasmic reticulum" Yes No "Endoplasmic reticulum" "HPA006935: AB_1080003, HPA067508: AB_2685857" "unprognostic (1.88e-1)" "unprognostic (2.66e-2)" "unprognostic (1.34e-1)" "unprognostic (3.57e-2)" "unprognostic (2.70e-2)" "unprognostic (4.85e-2)" "unprognostic (6.08e-2)" "unprognostic (3.18e-2)" "unprognostic (4.22e-2)" "unprognostic (3.39e-2)" "prognostic favorable (5.23e-4)" "unprognostic (4.67e-2)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.95e-1)" "unprognostic (4.41e-1)" "unprognostic (2.59e-1)" "unprognostic (2.08e-1)" 20.7 3.7 4.9 6.4 4.3 3.7 15.0 7.5 6.6 11.1 11.6 3.6 7.9 3.5 10.1 39.1 9.4 9.5 9.2 7.0 3.5 2.4 12.2 19.5 21.1 7.0 3.5 4.7 13.6 5.7 4.5 6.7 9.7 3.3 11.6 6.1 4.6 7.7 9.7 3.6 11.0 6.8 10.5 1.8 6.9 14.4 15.4 3.4 3.5 8.6 10.3 5.5 9.7 9.4 0.6 5.9 13.7 8.7 2.2 2.2 2.5 4.0 0.2 1.7 0.8 35.6 6.9 3.1 1.5 3.0 0.6 0.8 2.3 1.8 0.5 4.2 1.7 0.3 12.5 1.7 1.4 0.4 0.3 2.3 0.8 2.2 1.0 4.3 1.4 2.9 4.6 4.7 0.2 0.9 0.6 4.8 0.2 0.4 0.7 0.2 18.8 0.1 4.1 4.1 8.6 1.9 7.1 0.3 0.4 1.0 0.5 3.5 3.9 0.8 8.3 1.5 2.4 2.2 4.1 1.1 0.8 1.7 4.4 0.0 1.3 1.2 0.1 2.0 4.8 0.6 7.2 8.7 13.7 2.1 7.3 1.5 0.5 1.0 2.2 5.9 0.6 0.5 1.1 1.7 2.2 7.2 1.0 0.3 2.5 4.9 4.3 7.5 6.6 3.5 2.4 3.5 4.7 3.3 3.4 17.9 43.8 4.5 9.1 10.4 0.8 2.5 38.2 0.0 7.9 3.5 0.0 24.4 0.0 3.1 0.4 20.2 2.5 0.0 6.4 10.1 17.3 4.2 25.3 25.9 29.3 1.6 4.1 131.3 31.9 2.4 17.5 32.9 21.9 45.1 16.0 1.5 3.7 33.6 13.4 3.4 1.0 6.5 12.8 1.1 3.4 6.8 7.3 15.9 9.1 2.6 SLC27A4 "ACSVL4, FATP4" ENSG00000167114 "Solute carrier family 27 member 4" Q6P1M0 9 128340646-128361470 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 56.1" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 75.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007293, CAB009771" Approved Approved Vesicles NA NA Vesicles "CAB009771: AB_2270540, HPA007293: AB_1857062" "unprognostic (7.25e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-1)" "unprognostic (3.92e-3)" "unprognostic (3.74e-2)" "unprognostic (2.03e-1)" "unprognostic (1.85e-3)" "unprognostic (1.31e-3)" "unprognostic (4.51e-1)" "unprognostic (4.69e-2)" "unprognostic (7.72e-2)" "unprognostic (5.07e-2)" "prognostic favorable (2.61e-5)" "unprognostic (7.29e-3)" "unprognostic (2.11e-1)" "unprognostic (3.45e-2)" "unprognostic (8.01e-3)" 7.7 7.1 9.9 7.0 13.6 2.5 4.9 9.4 26.5 6.5 25.7 15.8 5.2 54.0 6.6 5.6 26.1 4.4 9.8 7.7 11.6 15.9 17.7 20.8 5.8 5.0 14.8 9.6 5.6 11.3 9.8 5.4 5.8 21.9 5.7 8.3 6.7 7.5 7.3 6.7 24.3 56.1 8.1 11.6 5.1 8.6 13.2 7.9 6.8 12.7 15.2 14.9 8.5 9.5 3.7 7.2 2.6 6.2 1.9 8.1 3.3 10.2 20.1 10.3 13.2 15.7 4.8 11.8 8.7 5.5 10.1 7.3 14.4 10.1 9.6 7.0 9.3 12.1 35.2 12.4 10.0 3.1 9.6 19.1 5.7 17.7 12.5 8.5 10.5 9.2 6.3 13.7 10.4 8.3 4.5 11.4 13.0 13.5 6.7 9.2 25.2 12.4 10.1 4.6 23.2 32.0 15.2 10.1 17.8 17.2 15.5 17.9 9.8 14.5 26.7 9.5 5.4 13.3 4.0 16.7 12.1 11.8 13.2 10.7 6.0 8.5 3.1 12.3 6.3 13.6 0.0 4.1 2.6 8.1 5.6 6.1 3.7 5.2 6.4 7.2 1.7 4.1 4.3 1.6 1.9 6.2 6.4 3.6 3.3 9.9 13.6 9.4 26.5 11.6 15.9 14.8 9.6 21.9 7.9 0.0 1.4 3.0 1.2 2.5 9.3 2.8 7.6 1.4 0.0 8.7 11.8 4.9 1.7 12.4 2.2 3.3 75.1 0.0 13.8 5.7 3.8 2.4 9.2 15.5 9.9 7.9 12.6 4.9 7.1 3.6 1.1 2.9 1.7 12.6 14.0 4.8 20.8 31.7 3.9 8.1 6.2 6.5 2.7 8.8 6.9 5.4 4.3 1.7 12.4 2.6 SLC27A5 "ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2" ENSG00000083807 "Solute carrier family 27 member 5" Q9Y2P5 19 58479512-58512413 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" "Ligase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 157.6" "Group enriched" "Detected in many" 6 "Early spermatids: 114.0;Hepatocytes: 338.0;Late spermatids: 303.5" "Cancer enriched" "Detected in all" 26 "liver cancer: 49.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA007292, CAB056160, CAB068239" Enhanced NA NA "CAB056160: AB_2665590, CAB068239: AB_2665592, HPA007292: AB_1857064" "unprognostic (5.97e-2)" "unprognostic (9.12e-2)" "unprognostic (9.95e-2)" "unprognostic (6.36e-3)" "unprognostic (2.52e-1)" "unprognostic (7.46e-2)" "prognostic favorable (1.57e-4)" "unprognostic (1.04e-1)" "unprognostic (1.85e-2)" "unprognostic (2.46e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.66e-4)" "unprognostic (2.27e-1)" "unprognostic (3.33e-2)" "unprognostic (7.80e-2)" "unprognostic (2.16e-1)" 1.3 2.0 5.4 1.4 5.3 1.1 2.0 1.9 3.9 1.7 1.0 1.7 1.2 1.0 1.1 1.1 1.4 2.6 1.1 1.3 3.7 3.8 1.9 157.6 0.9 1.4 4.3 2.5 1.4 2.6 1.1 1.3 0.8 3.4 1.4 0.8 1.3 2.7 2.1 1.4 1.1 0.9 1.5 2.7 1.1 1.1 2.3 3.0 1.4 1.8 0.6 1.4 1.1 1.6 13.3 10.8 2.2 3.0 9.6 18.7 8.9 16.0 22.0 3.9 4.1 3.7 3.9 2.4 0.9 2.1 3.1 4.3 1.7 3.5 20.9 2.7 1.1 0.6 3.4 4.5 14.1 1.3 9.7 14.9 14.0 22.9 18.3 5.6 7.3 5.0 4.5 2.4 0.4 8.5 5.3 1.5 15.9 12.9 0.0 3.7 13.1 18.1 15.5 2.4 13.5 12.9 9.1 0.1 28.4 10.1 7.6 5.4 7.3 0.0 21.7 4.7 1.1 6.4 6.4 1.2 0.0 2.8 0.0 1.8 13.8 15.4 8.5 4.5 13.7 0.8 0.0 2.4 2.2 8.7 3.0 18.7 13.3 11.2 11.4 6.5 8.9 13.9 14.3 0.3 9.6 2.1 10.8 13.3 8.9 5.4 5.3 1.9 3.9 3.7 3.8 4.3 2.5 3.4 3.0 0.0 8.2 11.5 13.1 8.0 11.5 5.6 22.9 9.4 5.7 5.2 0.0 6.4 33.2 10.3 114.0 11.9 1.3 0.0 13.3 2.3 7.6 17.0 4.7 338.0 9.1 9.5 9.7 15.4 11.3 303.5 10.0 8.9 15.1 1.8 3.5 6.1 7.4 0.0 8.9 39.7 7.6 6.5 15.5 8.8 13.2 12.3 2.9 10.2 4.7 12.1 SLC28A1 CNT1 ENSG00000156222 "Solute carrier family 28 member 1" O00337 15 84884654-84945796 "Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "intestine: 32.7;kidney: 35.6;liver: 43.8" "Group enriched" "Detected in some" 5 "Hepatocytes: 34.1;Hofbauer cells: 40.6;Proximal tubular cells: 88.5" "Group enriched" "Detected in some" 63 "liver cancer: 10.9;renal cancer: 33.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "A-431: 3.5;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.6;SK-BR-3: 1.8;SuSa: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019551, HPA056247" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nuclear speckles, Cytosol" "HPA019551: AB_2670187, HPA056247: " "unprognostic (3.81e-2)" "unprognostic (1.60e-1)" "unprognostic (2.22e-1)" "unprognostic (7.49e-2)" "unprognostic (5.08e-2)" "unprognostic (7.08e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (2.18e-2)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (1.35e-1)" "unprognostic (7.42e-2)" "unprognostic (7.72e-3)" "unprognostic (6.65e-2)" "unprognostic (1.55e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 5.0 0.1 0.1 17.3 0.1 1.5 0.1 0.1 0.1 0.5 0.1 0.1 35.6 43.8 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 32.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.5 0.3 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.5 0.0 0.9 0.1 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.1 0.4 0.1 1.8 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 7.6 1.4 0.0 7.0 0.0 0.4 10.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 34.1 40.6 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 88.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 SLC28A2 "CNT2, HCNT2, HsT17153, SPNT1" ENSG00000137860 "Solute carrier family 28 member 2" O43868 15 45252230-45277845 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "gallbladder: 28.7;intestine: 49.3" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 26.0;Paneth cells: 17.3;Undifferentiated cells: 59.6" "Cancer enhanced" "Detected in many" "stomach cancer: 3.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 4.3;NB-4: 2.3" "Low region specificity" "Detected in all" "HPA046068, HPA055623" Enhanced NA NA "HPA046068: AB_2679523, HPA055623: AB_2682866" "unprognostic (2.75e-1)" "unprognostic (2.34e-2)" "unprognostic (1.62e-3)" "unprognostic (5.46e-2)" "unprognostic (1.13e-1)" "unprognostic (6.85e-2)" "unprognostic (6.31e-2)" "unprognostic (1.59e-2)" "unprognostic (1.61e-1)" "unprognostic (6.40e-4)" "unprognostic (3.34e-3)" "unprognostic (2.63e-1)" "unprognostic (1.28e-2)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.44e-2)" "unprognostic (8.95e-2)" 0.1 0.3 0.2 0.1 0.2 0.0 0.2 0.2 0.2 0.8 18.5 0.2 0.1 25.7 0.4 0.1 0.3 0.2 28.7 0.1 0.2 0.2 1.0 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.2 1.6 0.1 0.2 13.8 0.1 0.1 0.1 0.1 0.2 49.3 0.1 0.2 0.1 8.5 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.6 0.2 1.3 0.5 0.6 0.7 0.0 0.1 0.3 0.1 0.1 0.0 0.1 4.3 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.5 0.6 0.2 0.0 0.0 0.7 0.0 0.1 0.2 0.6 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.2 1.5 0.0 0.1 0.3 2.3 0.2 0.9 0.3 0.2 0.4 1.3 0.0 0.2 1.1 1.6 0.0 0.1 0.3 0.6 0.2 0.6 0.3 0.4 0.5 1.2 0.2 0.8 0.2 0.3 0.4 0.6 0.3 1.3 0.2 0.1 0.4 0.1 0.2 0.5 0.3 0.1 0.2 0.6 0.4 0.7 0.2 0.6 0.5 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 7.2 0.9 0.2 0.1 2.7 0.4 12.7 8.1 7.9 0.0 2.0 11.0 0.0 0.0 0.4 0.4 26.0 0.0 0.0 1.6 0.4 0.2 8.1 0.0 0.8 1.6 13.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.6 0.5 0.0 17.3 0.7 0.3 4.6 0.0 0.0 1.9 1.7 0.3 3.9 0.9 59.6 0.1 SLC28A3 CNT3 ENSG00000197506 "Solute carrier family 28 member 3" Q9HAS3 9 84275457-84340683 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 34.8;pancreas: 24.6;seminal vesicle: 29.1" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 7.6;Ductal cells: 17.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 16 "pons and medulla: 6.0" "Cell type enhanced" "Detected in single" "intermediate monocyte: 2.7" "Lineage enriched" "Detected in single" 6 "monocytes: 2.7" "Cell line enriched" "Detected in some" 7 "HMC-1: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023311, HPA024729" Approved NA NA "HPA023311: AB_1857067, HPA024729: AB_1857069" "prognostic favorable (3.37e-4)" "unprognostic (1.28e-2)" "unprognostic (3.01e-1)" "unprognostic (2.50e-1)" "unprognostic (2.79e-1)" "unprognostic (1.82e-3)" "unprognostic (3.74e-1)" "unprognostic (2.04e-1)" "unprognostic (3.34e-2)" "unprognostic (2.20e-1)" "unprognostic (5.06e-2)" "unprognostic (4.13e-2)" "unprognostic (1.54e-7)" "unprognostic (1.03e-1)" "unprognostic (9.87e-2)" "unprognostic (8.75e-2)" "unprognostic (4.03e-2)" 5.1 0.0 0.1 0.8 0.3 9.9 10.2 0.1 0.1 1.2 1.3 0.7 34.8 1.0 0.8 2.8 4.5 2.6 12.2 0.6 0.3 0.2 0.2 0.4 1.1 0.1 0.1 0.1 2.0 24.6 0.0 2.5 0.1 6.0 1.0 2.9 0.6 12.5 29.1 0.1 9.8 2.0 0.1 0.1 0.4 0.8 0.5 0.1 0.9 0.2 6.4 3.3 0.3 1.4 0.2 0.0 0.0 2.7 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 3.9 0.4 0.9 0.5 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 36.9 0.0 0.3 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.3 0.0 5.5 0.0 0.1 3.7 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.2 0.1 0.3 0.1 0.1 0.3 0.2 0.1 0.1 6.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.7 7.6 4.0 1.2 1.8 0.0 0.1 0.0 17.3 1.0 0.0 0.3 0.0 2.6 0.1 0.1 0.1 1.1 0.0 1.9 0.0 2.9 0.0 2.4 1.3 0.0 0.7 0.0 1.8 3.4 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 0.1 0.0 2.4 0.1 SLC29A1 ENT1 ENSG00000112759 "Solute carrier family 29 member 1 (Augustine blood group)" Q99808 6 44219505-44234151 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 117.2" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 192.2;Extravillous trophoblasts: 188.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 25 "eosinophil: 117.2" "Lineage enriched" "Detected in many" 25 "granulocytes: 117.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012384 Approved NA NA "HPA012384: AB_1857073" "unprognostic (1.82e-2)" "unprognostic (1.41e-2)" "unprognostic (1.81e-1)" "unprognostic (2.49e-3)" "unprognostic (2.76e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.96e-4)" "unprognostic (1.38e-2)" "unprognostic (4.60e-2)" "unprognostic (9.02e-2)" "unprognostic (1.34e-1)" 42.9 40.9 5.8 9.4 9.6 17.9 57.2 10.4 15.2 21.2 35.8 5.9 6.9 5.2 19.8 11.7 22.8 14.9 24.4 46.8 5.4 6.4 14.7 23.2 15.3 14.4 5.5 8.4 12.5 35.8 8.7 15.2 23.2 9.8 21.4 7.4 18.0 15.7 8.4 53.0 23.8 12.4 39.0 5.3 11.4 33.0 8.8 4.8 53.9 18.8 17.2 11.1 28.7 20.7 0.5 4.7 117.2 4.5 0.3 0.9 0.7 16.5 16.5 11.8 19.0 18.2 1.7 70.5 12.2 4.8 17.1 11.7 18.0 6.8 33.7 12.3 3.6 10.6 20.6 21.1 14.7 10.4 19.1 19.4 29.1 11.4 23.3 2.9 32.7 28.1 2.2 3.8 25.1 8.8 34.8 42.9 27.6 39.3 19.9 9.3 18.2 26.9 21.9 17.9 42.9 11.1 18.0 23.8 40.8 10.0 9.7 15.2 19.6 3.5 11.9 8.6 12.7 16.1 20.7 64.9 9.4 15.4 12.7 23.1 13.6 17.7 43.0 5.7 26.7 11.3 1.8 1.4 117.2 0.6 4.5 0.4 0.5 0.3 0.4 0.8 0.3 0.1 0.3 0.2 0.3 3.6 4.7 0.9 0.7 5.8 9.6 10.4 15.2 5.4 6.4 5.5 8.4 9.8 4.8 0.0 10.9 0.8 7.7 9.5 9.0 38.3 20.4 8.1 6.8 7.0 13.7 192.2 3.3 21.3 0.4 24.6 0.5 0.0 50.3 188.6 38.1 6.0 8.1 12.1 53.2 4.8 30.0 19.6 23.3 1.5 30.5 11.7 33.7 11.8 2.4 4.7 45.0 3.1 50.5 0.9 10.8 90.5 16.5 0.3 10.0 13.7 35.1 3.5 5.3 6.8 SLC29A2 "DER12, ENT2, HNP36" ENSG00000174669 "Solute carrier family 29 member 2" Q14542 11 66362521-66372214 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.9" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 1.6;dendritic cells: 1.6;T-cells: 4.1" "Cell line enhanced" "Detected in many" "BEWO: 16.7;CAPAN-2: 21.4;K-562: 16.1;T-47d: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018168 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA018168: AB_1857077" "unprognostic (3.20e-2)" "unprognostic (4.50e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.37e-1)" "unprognostic (5.08e-2)" "unprognostic (5.64e-2)" "unprognostic (1.60e-1)" "unprognostic (1.96e-1)" "unprognostic (2.09e-1)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "prognostic favorable (2.78e-4)" "unprognostic (2.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.13e-1)" "unprognostic (6.38e-3)" 5.4 1.3 2.5 2.8 3.2 1.2 13.2 10.3 5.1 1.9 4.0 3.1 4.8 5.6 1.2 5.2 2.7 3.0 3.2 9.0 2.9 3.3 6.4 1.5 3.4 2.5 3.3 3.5 1.0 7.8 11.3 5.9 3.3 7.0 4.2 2.3 2.2 6.0 6.3 68.9 1.9 4.3 0.9 1.7 2.0 6.6 0.9 2.0 1.6 4.2 18.0 2.5 1.5 2.2 1.6 1.6 0.2 0.1 0.1 4.1 1.2 5.8 4.4 3.5 0.7 0.3 0.0 16.7 0.2 0.0 0.2 0.3 7.0 21.4 2.6 5.5 0.0 1.1 5.9 3.3 4.2 0.0 0.1 9.6 5.7 5.4 0.5 0.7 9.5 0.1 0.3 1.7 0.6 1.9 1.7 0.3 2.0 16.1 0.0 0.0 12.1 0.7 13.4 10.1 7.3 4.6 0.7 0.0 12.1 8.9 4.4 7.1 3.2 0.3 9.2 0.6 0.4 26.0 2.1 0.0 0.1 5.8 0.1 0.0 0.1 0.3 0.2 0.4 0.2 0.2 0.0 0.1 0.0 3.5 0.0 1.1 0.6 2.2 4.1 0.8 1.6 4.1 4.1 0.2 0.1 0.1 1.6 0.4 1.2 2.5 3.2 10.3 5.1 2.9 3.3 3.3 3.5 7.0 2.0 3.0 4.6 1.4 4.4 0.6 2.5 9.7 5.1 5.3 7.9 14.0 11.8 40.5 3.3 4.3 0.0 0.7 2.1 0.0 5.8 12.3 1.0 2.8 4.6 0.5 3.8 4.8 2.4 0.0 0.6 0.0 0.0 0.0 0.0 1.0 8.5 2.3 3.2 3.5 0.4 0.6 3.3 0.0 2.3 0.1 0.2 0.0 11.3 1.3 10.7 2.5 SLC29A3 "ENT3, FLJ11160" ENSG00000198246 "Solute carrier family 29 member 3" Q9BZD2 10 71319258-71381423 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 36.0;Extravillous trophoblasts: 36.5;Hofbauer cells: 32.2;Syncytiotrophoblasts: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 19.8;Hep G2: 22.0;RT4: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046085, HPA054976, HPA057905" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550" "unprognostic (1.73e-1)" "unprognostic (2.38e-3)" "unprognostic (3.23e-3)" "unprognostic (1.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (6.07e-6)" "unprognostic (1.28e-1)" "unprognostic (4.71e-1)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (5.53e-5)" "unprognostic (3.37e-1)" "unprognostic (1.36e-1)" "prognostic favorable (1.16e-4)" "unprognostic (3.43e-3)" 11.3 4.0 6.4 6.6 8.3 1.9 6.8 3.2 12.6 8.3 6.1 11.3 2.4 4.1 12.1 4.6 3.5 9.4 7.4 3.6 8.0 5.5 3.9 12.5 11.1 10.5 9.8 6.5 15.8 7.4 7.1 2.8 24.6 6.7 8.3 6.0 4.6 7.5 5.4 2.1 3.7 4.9 8.9 8.0 9.4 8.9 4.9 7.7 9.3 6.7 1.3 6.2 18.4 10.0 3.6 19.3 2.8 12.9 5.7 4.0 5.6 1.2 7.4 1.1 4.7 4.2 3.3 19.8 1.4 1.4 0.4 0.2 8.1 5.2 4.3 4.0 2.8 2.0 11.7 3.4 1.9 0.0 3.4 3.3 1.3 0.6 22.0 2.0 1.0 2.8 3.2 8.1 0.2 0.3 0.9 1.9 5.3 3.9 4.1 0.5 11.4 2.7 2.1 2.5 11.4 2.7 3.4 0.4 3.4 1.7 17.5 5.6 5.9 3.9 12.8 1.0 3.5 1.9 2.3 3.1 0.1 2.4 1.3 0.0 1.1 1.8 2.4 5.1 14.5 0.8 2.8 12.9 1.4 4.0 10.1 3.4 3.6 3.2 3.6 19.3 1.5 2.6 3.6 1.0 5.7 6.3 13.6 3.4 5.6 6.4 8.3 3.2 12.6 8.0 5.5 9.8 6.5 6.7 7.7 3.0 0.6 0.5 1.7 0.2 1.1 0.6 2.5 2.7 3.4 0.0 0.0 36.0 0.0 4.3 3.3 1.1 1.3 0.0 7.9 36.5 2.6 2.8 2.3 4.9 32.2 0.0 1.7 3.7 7.8 10.5 2.6 9.5 1.7 10.0 2.7 2.4 6.6 11.5 1.4 1.4 0.2 0.0 0.3 0.5 4.7 0.0 26.5 1.0 2.7 1.2 SLC29A4 "ENT4, FLJ34923" ENSG00000164638 "Solute carrier family 29 member 4" Q7RTT9 7 5274369-5306870 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.7" "Group enriched" "Detected in many" 8 "Horizontal cells: 158.9;Intestinal endocrine cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 24.5;SH-SY5Y: 35.6;U-2 OS: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052829 Approved "Microtubules,Cytokinetic bridge" Yes No "Microtubules, Cytokinetic bridge" "HPA052829: AB_2681967" "unprognostic (6.04e-2)" "unprognostic (1.22e-2)" "unprognostic (8.49e-5)" "unprognostic (2.53e-1)" "unprognostic (1.47e-3)" "unprognostic (4.24e-2)" "unprognostic (9.59e-3)" "unprognostic (2.05e-1)" "unprognostic (2.55e-2)" "unprognostic (5.73e-2)" "prognostic favorable (4.52e-4)" "unprognostic (2.06e-1)" "unprognostic (3.02e-2)" "unprognostic (3.24e-2)" "unprognostic (2.63e-2)" "unprognostic (1.29e-3)" "unprognostic (6.60e-2)" 35.7 8.3 7.6 2.5 6.4 0.8 6.5 4.2 9.7 2.0 2.5 2.0 0.3 4.5 2.4 5.3 1.3 4.2 1.8 1.7 9.4 15.7 3.4 3.8 1.2 1.8 12.2 5.4 3.2 13.0 0.5 1.6 0.8 7.0 3.0 2.0 11.5 1.1 1.0 2.1 1.4 5.4 2.0 3.1 1.1 7.1 1.3 1.1 0.3 4.3 0.3 0.7 2.3 0.5 1.3 1.1 4.3 1.1 4.3 1.3 0.3 0.0 10.6 6.3 24.5 0.3 0.1 1.2 0.9 0.0 0.8 0.4 6.0 0.2 0.0 1.2 0.9 4.1 0.1 2.4 0.2 0.2 0.0 1.3 0.1 0.3 8.7 1.9 0.1 1.5 0.8 8.2 0.1 0.4 1.5 0.7 2.2 1.7 0.1 0.6 5.2 0.9 0.4 8.0 0.7 0.6 4.0 1.0 0.9 1.6 0.2 4.2 35.6 0.6 2.2 0.4 5.7 2.7 2.8 0.3 8.8 12.3 0.8 0.2 0.5 0.0 0.0 1.1 0.3 3.9 2.0 1.1 0.6 0.8 0.5 1.3 0.7 0.5 0.7 0.4 1.3 0.7 0.9 4.3 4.3 0.5 1.1 0.3 0.3 7.6 6.4 4.2 9.7 9.4 15.7 12.2 5.4 7.0 1.1 3.0 0.3 0.0 0.2 0.1 1.8 2.3 0.0 1.4 0.0 0.0 15.7 0.2 0.0 4.3 0.0 0.0 1.3 0.0 0.2 0.2 1.1 2.2 0.0 0.6 0.4 158.9 98.9 0.0 0.0 0.4 0.3 0.0 0.0 0.0 2.2 4.4 1.9 0.0 0.4 0.0 1.3 0.0 0.9 0.3 6.0 0.3 0.2 0.0 0.6 0.0 SLC2A1 "CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR" ENSG00000117394 "Solute carrier family 2 member 1" P11166 1 42925375-42959176 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 194.0" "Cell type enhanced" "Detected in many" 20 "Cytotrophoblasts: 686.5;Extravillous trophoblasts: 412.9;Syncytiotrophoblasts: 2076.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 44.8;CACO-2: 72.7;Hep G2: 49.6" "Low region specificity" "Detected in all" "CAB002759, HPA031345, HPA058494" Enhanced Supported Enhanced "Plasma membrane" No No 36000000 "Plasma membrane" "CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734" "unprognostic (3.60e-2)" "unprognostic (5.85e-3)" "unprognostic (7.59e-2)" "unprognostic (1.31e-2)" "unprognostic (4.10e-3)" "unprognostic (3.22e-2)" "prognostic unfavorable (3.65e-8)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.10e-1)" "unprognostic (4.84e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (1.87e-1)" "prognostic unfavorable (4.55e-9)" "unprognostic (1.11e-1)" "unprognostic (9.49e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.05e-4)" 4.2 3.7 12.4 3.9 16.9 45.2 4.1 6.7 15.5 15.2 4.8 15.1 4.3 2.4 7.6 3.4 28.8 8.5 8.6 5.0 15.4 13.7 7.6 2.1 2.4 5.3 18.2 5.0 3.4 3.7 7.3 2.9 194.0 15.5 5.2 3.3 44.2 8.4 7.9 1.8 42.1 2.9 2.5 17.8 3.4 5.5 2.5 12.5 1.8 4.0 11.5 12.0 22.2 24.5 8.4 14.7 1.3 0.2 3.0 7.5 2.7 10.7 15.6 12.8 3.2 1.5 0.5 44.8 7.1 15.4 8.8 12.9 72.7 30.1 4.1 21.2 2.1 6.2 10.1 2.8 16.5 3.9 2.4 2.6 6.7 9.0 49.6 4.5 3.6 1.9 1.9 12.7 5.5 5.9 26.0 1.4 3.5 15.0 0.9 3.9 19.2 1.7 2.5 8.2 5.3 3.9 1.6 4.1 5.7 8.0 5.2 6.8 4.8 8.3 26.3 3.1 19.2 1.1 4.6 3.2 8.0 5.8 1.4 16.0 0.7 1.5 2.5 15.8 2.6 6.5 0.3 0.2 1.3 7.5 0.2 6.9 8.4 4.1 5.1 2.9 7.3 3.2 4.7 1.0 3.0 0.1 14.7 4.7 2.7 12.4 16.9 6.7 15.5 15.4 13.7 18.2 5.0 15.5 12.5 0.0 2.6 23.8 35.5 254.3 8.1 23.0 25.5 28.1 9.1 26.2 62.8 686.5 5.0 47.8 4.0 9.9 16.8 303.7 10.3 412.9 42.1 25.5 5.8 1.3 74.8 4.8 17.6 0.6 1.3 0.0 7.2 3.2 20.3 61.3 13.7 394.9 72.4 18.7 13.8 1.6 31.1 0.0 20.2 0.0 1.7 208.3 2076.2 17.3 9.0 98.7 SLC2A10 GLUT10 ENSG00000197496 "Solute carrier family 2 member 10" O95528 20 46709487-46736347 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 51.5" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 33.5;Hepatocytes: 41.2;Mucus-secreting cells: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 13.8" "Lineage enriched" "Detected in single" 44 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "ASC diff: 19.5;HSkMC: 24.2;OE19: 20.0;SK-MEL-30: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041015 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA041015: AB_2677252" "unprognostic (8.94e-3)" "unprognostic (2.62e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (6.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.06e-2)" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (3.63e-3)" "unprognostic (1.25e-2)" "unprognostic (1.05e-1)" "unprognostic (3.00e-1)" "unprognostic (5.96e-2)" 4.7 4.6 2.6 4.3 3.3 0.1 8.7 2.1 3.1 11.4 6.7 2.7 6.7 2.6 5.4 6.6 4.8 5.6 10.2 6.7 3.3 1.4 2.6 51.5 4.8 3.4 2.2 2.0 7.1 22.9 15.0 4.2 8.3 3.8 18.0 8.8 9.8 11.5 11.0 2.1 2.4 3.0 9.7 2.3 1.9 12.4 3.4 1.0 0.8 18.1 4.5 4.6 7.1 5.7 0.0 0.0 13.8 0.0 0.3 0.0 0.0 0.0 0.0 4.7 4.8 19.5 16.7 14.3 9.1 12.4 4.2 5.1 0.3 16.0 0.0 6.9 16.5 0.0 0.1 0.0 0.4 2.0 0.0 0.1 1.3 0.0 7.6 13.8 0.0 0.0 24.2 0.4 2.6 0.0 4.9 1.7 0.0 0.1 0.0 7.2 16.6 0.0 0.4 1.7 20.0 1.2 0.0 0.7 0.0 0.0 4.3 0.0 0.7 1.8 3.0 24.8 3.5 2.3 3.7 1.0 9.1 4.0 7.2 1.1 0.1 0.0 0.0 0.0 0.0 1.9 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.6 3.3 2.1 3.1 3.3 1.4 2.2 2.0 3.8 1.0 6.0 4.6 0.0 6.8 0.6 0.0 2.2 10.2 33.5 11.4 1.8 0.0 1.9 0.0 5.2 0.1 4.1 2.2 0.0 4.9 12.8 11.7 28.1 5.8 41.2 0.9 0.0 3.5 9.2 2.8 0.9 24.5 0.3 1.7 0.0 60.1 5.6 5.1 2.9 16.3 0.7 0.5 12.9 3.9 0.4 0.2 0.9 1.7 0.0 6.6 10.2 SLC2A11 "GLUT10, GLUT11" ENSG00000133460 "Solute carrier family 2 member 11" Q9BYW1 22 23856703-23886309 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 280.8;Rod photoreceptor cells: 194.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 12.0" "HPA042960, HPA071184" Uncertain Uncertain "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA042960: AB_2678241, HPA071184: AB_2686355" "unprognostic (1.31e-1)" "unprognostic (1.14e-1)" "unprognostic (3.69e-2)" "unprognostic (6.97e-2)" "unprognostic (7.93e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-2)" "unprognostic (1.60e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "prognostic favorable (3.83e-4)" "unprognostic (2.32e-1)" "prognostic favorable (5.77e-7)" "unprognostic (1.25e-1)" "unprognostic (1.70e-1)" "unprognostic (3.85e-1)" "unprognostic (6.29e-2)" 4.3 7.8 8.5 6.1 15.3 3.5 6.2 22.9 17.0 4.1 4.9 6.4 17.2 3.9 7.7 9.0 2.8 5.0 5.2 8.5 11.0 13.4 19.5 4.9 4.5 7.1 9.5 10.9 6.6 28.8 18.6 14.0 21.0 9.7 7.6 6.0 10.4 6.1 11.4 13.6 4.2 4.8 10.4 9.6 5.3 6.1 4.5 6.2 1.6 9.2 2.4 6.4 4.5 5.3 2.2 4.6 1.5 1.1 1.2 1.6 0.3 2.6 1.3 1.7 7.6 1.6 3.4 0.7 1.6 2.0 1.8 1.3 1.8 1.8 3.4 0.9 2.2 1.6 2.2 3.2 0.9 0.9 2.3 2.9 1.7 2.8 2.6 2.5 1.6 1.8 1.3 3.2 2.7 2.3 8.4 0.7 2.7 0.7 7.6 1.0 2.8 0.3 0.7 2.5 1.7 2.1 4.6 0.2 3.8 5.6 0.7 4.1 2.3 0.8 12.0 2.7 2.1 6.2 0.8 0.5 0.7 1.2 0.7 0.8 7.1 1.9 3.3 1.5 1.2 1.8 1.5 0.4 0.9 0.9 1.1 0.7 2.1 0.8 0.8 0.2 2.2 1.6 1.1 1.2 1.2 0.7 4.6 0.2 0.3 8.5 15.3 22.9 17.0 11.0 13.4 9.5 10.9 9.7 6.2 17.9 12.9 16.6 8.2 2.9 57.0 29.0 7.6 8.1 4.5 24.4 280.8 7.0 11.6 4.7 5.9 3.3 3.4 0.0 4.9 7.6 4.5 8.0 2.3 5.8 5.2 35.0 10.4 4.9 3.1 8.5 8.6 4.2 3.3 2.8 4.9 15.4 3.5 2.9 9.2 20.7 194.1 0.0 6.2 3.9 5.1 2.8 16.7 7.5 7.3 5.4 SLC2A12 "GLUT12, GLUT8" ENSG00000146411 "Solute carrier family 2 member 12" Q8TD20 6 133988697-134052636 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 46.6" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 9.4;Glandular cells: 11.7;Muller glia cells: 11.4;Syncytiotrophoblasts: 30.7" "Cancer enriched" "Detected in many" 6 "prostate cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.3;myeloid DC: 1.0" "Group enriched" "Detected in many" 6 "dendritic cells: 1.0;monocytes: 1.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.4;hTERT-RPE1: 13.5;SuSa: 22.1;U-2 OS: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031593, HPA031594" Approved Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA031593: AB_10600810, HPA031594: AB_2673948" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (1.69e-2)" "unprognostic (5.55e-3)" "unprognostic (2.18e-1)" "unprognostic (6.02e-2)" "unprognostic (2.24e-3)" "unprognostic (2.54e-2)" "unprognostic (2.08e-2)" "unprognostic (3.69e-2)" "unprognostic (2.38e-1)" "unprognostic (1.83e-1)" "unprognostic (2.33e-3)" "unprognostic (3.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.04e-2)" "unprognostic (1.55e-3)" 0.9 1.2 5.2 0.4 6.7 0.1 1.5 14.6 5.5 4.8 3.0 7.1 4.9 8.1 9.7 2.6 7.0 3.4 3.0 11.4 6.5 2.8 6.7 7.9 3.4 0.2 3.4 5.2 1.5 1.3 1.2 2.5 1.9 19.7 27.0 1.4 46.6 5.2 11.2 4.2 3.9 11.9 14.8 1.6 0.3 14.4 0.5 3.3 0.6 0.6 1.9 2.7 6.7 2.0 0.0 1.0 0.0 1.3 0.0 0.1 0.1 2.1 0.7 1.8 0.0 1.4 0.7 0.1 1.3 5.4 0.7 3.0 0.0 7.4 0.2 1.1 0.1 5.5 5.6 0.0 0.5 1.0 0.0 4.7 0.0 0.6 0.1 0.2 0.0 0.0 1.0 0.5 0.6 0.1 13.5 0.4 0.3 0.4 0.6 0.1 0.6 0.1 0.1 1.6 0.0 0.5 0.0 0.9 2.0 1.6 0.7 0.2 0.5 0.0 1.7 0.0 22.1 0.0 0.0 0.0 0.2 8.0 0.2 0.7 2.8 2.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.1 5.2 6.7 14.6 5.5 6.5 2.8 3.4 5.2 19.7 3.3 0.0 4.8 0.0 0.8 1.8 0.1 5.7 0.0 9.4 2.3 0.0 0.0 1.9 3.3 1.2 0.0 0.4 0.0 0.0 0.2 0.5 0.3 11.7 0.0 0.9 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.8 2.9 1.4 0.3 0.5 0.0 0.1 0.0 0.0 1.6 30.7 0.0 0.3 1.4 SLC2A13 HMIT ENSG00000151229 "Solute carrier family 2 member 13" Q96QE2 12 39755021-40106089 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.7;parathyroid gland: 43.0" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 87.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006584, HPA061679" Enhanced Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA006584: AB_1849755, HPA061679: " "unprognostic (1.66e-1)" "unprognostic (2.52e-1)" "unprognostic (1.11e-1)" "unprognostic (9.62e-2)" "unprognostic (1.04e-1)" "unprognostic (3.31e-1)" "unprognostic (4.06e-2)" "unprognostic (1.20e-1)" "unprognostic (5.71e-2)" "unprognostic (1.83e-1)" "unprognostic (1.65e-1)" "unprognostic (2.25e-2)" "unprognostic (2.12e-3)" "unprognostic (4.07e-2)" "unprognostic (6.34e-2)" "unprognostic (1.24e-2)" "unprognostic (9.16e-2)" 3.8 7.2 9.8 3.3 18.0 1.2 3.0 4.0 27.7 13.0 7.4 2.8 0.3 6.0 5.9 5.3 3.7 2.9 4.0 4.9 8.2 14.1 10.7 6.2 3.7 1.9 14.9 11.0 3.1 5.0 43.0 11.1 4.6 4.8 3.0 6.8 2.4 4.2 2.6 1.2 2.1 8.3 4.7 2.7 2.3 5.6 2.0 4.1 0.6 2.2 0.9 1.4 3.9 3.9 2.0 0.1 1.5 0.5 0.6 0.9 0.0 0.6 3.6 2.6 1.2 18.5 7.7 5.3 5.8 4.1 2.6 3.4 0.0 1.7 2.2 4.3 4.6 3.6 0.3 1.8 1.8 2.2 1.9 5.4 1.7 9.1 1.3 2.9 4.9 2.9 3.8 1.7 1.2 2.2 1.5 1.2 2.2 0.7 5.7 5.9 0.6 0.7 4.1 2.9 0.0 2.5 0.0 4.0 1.2 4.8 2.2 3.3 3.4 2.3 4.5 1.5 4.1 2.5 4.3 1.1 3.5 1.3 12.4 3.4 4.5 0.1 1.4 6.4 2.8 2.2 0.0 0.5 1.5 0.4 0.2 0.3 0.1 0.4 0.9 0.0 2.0 0.2 0.5 0.8 0.6 0.1 0.1 0.1 0.0 9.8 18.0 4.0 19.8 8.2 14.1 14.9 11.0 4.8 4.1 8.9 17.1 4.7 1.7 3.7 4.3 3.5 10.2 5.3 2.3 8.7 0.0 5.0 0.0 4.3 2.5 5.2 35.1 0.0 10.9 2.1 7.1 2.7 10.3 8.5 7.2 87.4 19.5 8.0 7.9 2.1 21.3 7.4 15.1 6.4 21.3 2.0 8.7 29.4 7.1 6.4 1.3 6.5 6.1 0.9 1.9 4.5 3.1 4.4 11.1 1.4 SLC2A14 "GLUT14, SLC2A3P3" ENSG00000173262 "Solute carrier family 2 member 14" Q8TDB8 12 7812512-7891148 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis, Sugar transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 52.4" "Cell type enriched" "Detected in many" 7 "Spermatocytes: 60.6" "Cancer enriched" "Detected in single" 35 "testis cancer: 7.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.9" "Cell line enhanced" "Detected in some" "BEWO: 12.6;CACO-2: 20.4;Hep G2: 5.3;SuSa: 25.2" HPA006539 Supported Approved "Plasma membrane" NA NA "Plasma membrane" "HPA006539: AB_1078984" "unprognostic (2.52e-1)" "unprognostic (4.74e-3)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (1.82e-3)" "unprognostic (8.62e-2)" "unprognostic (7.15e-2)" "unprognostic (1.89e-1)" "unprognostic (9.91e-3)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "unprognostic (8.46e-4)" "unprognostic (3.92e-2)" "unprognostic (3.41e-1)" "unprognostic (3.26e-2)" "unprognostic (1.22e-2)" 0.4 3.1 0.1 0.1 0.6 3.0 0.4 0.1 0.2 0.4 0.4 0.3 0.1 0.0 0.3 0.8 0.8 0.1 0.3 0.1 0.2 0.3 0.1 2.0 0.2 0.2 0.1 0.1 2.7 7.4 0.0 0.6 0.5 0.3 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.0 52.4 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.6 0.4 6.9 0.7 1.3 1.7 0.2 0.0 0.3 0.3 0.2 0.2 0.6 12.6 0.0 0.0 0.0 0.2 20.4 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.1 0.5 5.3 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.9 0.1 0.0 0.1 0.1 0.1 2.3 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.4 0.0 25.2 0.0 1.3 0.3 0.1 0.5 0.3 0.1 0.1 0.1 0.2 0.3 0.0 0.3 5.5 0.7 1.8 1.0 0.2 1.2 0.5 1.0 0.8 0.4 0.6 0.7 0.9 6.9 1.3 0.2 0.3 1.7 0.2 0.1 0.6 0.1 0.2 0.2 0.3 0.1 0.1 0.3 0.2 0.0 0.6 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 3.7 2.3 0.0 0.0 1.3 0.9 1.9 0.0 9.2 0.4 0.2 0.0 0.0 8.0 4.4 0.9 0.3 3.1 1.7 0.0 0.0 0.0 0.5 5.8 2.5 0.0 0.4 0.0 4.2 60.6 2.7 0.1 0.3 3.2 0.0 0.0 SLC2A2 GLUT2 ENSG00000163581 "Solute carrier family 2 member 2" P11168 3 170996348-171026750 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 77.4;liver: 172.8" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 433.3" "Cancer enriched" "Detected in some" 12 "liver cancer: 105.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 68 "CACO-2: 7.3;Hep G2: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB010444, HPA028997" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB010444: AB_641068, HPA028997: AB_2672860" "unprognostic (9.56e-2)" "unprognostic (1.24e-1)" "prognostic favorable (2.63e-5)" "unprognostic (3.10e-1)" "unprognostic (1.02e-1)" "unprognostic (2.95e-2)" "unprognostic (6.31e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 27.9 0.0 0.0 10.8 0.1 0.2 0.1 0.1 3.8 0.1 0.1 0.1 15.3 172.8 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 77.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.6 0.0 0.0 0.0 0.0 0.0 1.7 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 433.3 0.0 0.0 0.0 6.7 8.9 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 49.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 SLC2A3 GLUT3 ENSG00000059804 "Solute carrier family 2 member 3" P11169 12 7919230-7936275 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 166.3" "Cell type enhanced" "Detected in many" 7 "granulocytes: 462.0" "Cancer enriched" "Detected in all" 7 "testis cancer: 107.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 30.2;neutrophil: 55.6" "Lineage enriched" "Detected in all" 9 "granulocytes: 55.6" "Group enriched" "Detected in many" 5 "BEWO: 143.6;CACO-2: 154.0;SuSa: 113.9" "CAB002763, HPA006539" Approved Approved "Plasma membrane" NA NA 33000000 "Plasma membrane" "CAB002763: , HPA006539: AB_1078984" "unprognostic (9.20e-2)" "unprognostic (9.63e-3)" "prognostic unfavorable (8.58e-4)" "unprognostic (2.65e-1)" "unprognostic (5.29e-3)" "unprognostic (2.16e-3)" "unprognostic (1.12e-1)" "unprognostic (8.27e-2)" "unprognostic (2.35e-1)" "unprognostic (3.83e-2)" "unprognostic (8.47e-3)" "unprognostic (5.40e-2)" "prognostic unfavorable (6.36e-8)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.70e-1)" "unprognostic (1.14e-2)" "unprognostic (2.91e-3)" 48.8 10.0 9.5 25.2 10.5 166.3 26.4 13.1 24.3 9.4 10.0 6.8 1.8 4.2 10.3 8.2 13.2 8.0 25.6 22.8 10.8 13.6 10.3 14.1 32.4 12.8 13.3 3.3 18.8 6.1 6.9 10.9 43.9 13.7 15.0 6.9 14.8 3.8 3.9 13.6 7.4 5.8 18.7 15.4 16.4 7.0 10.6 12.5 3.3 15.7 7.0 13.6 51.8 10.5 1.8 2.4 55.6 4.6 3.6 6.4 3.5 0.0 0.7 6.6 2.5 2.4 8.5 143.6 2.3 2.5 2.3 5.4 154.0 1.0 0.1 0.0 1.6 3.2 0.0 0.2 0.3 4.2 4.5 0.1 8.9 0.6 20.2 6.7 3.2 13.0 3.5 0.2 6.1 2.8 5.4 2.1 0.7 4.1 2.1 2.1 0.0 0.2 3.4 29.1 0.1 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.0 113.9 0.0 0.4 2.1 2.9 1.5 5.6 0.2 0.0 6.2 0.4 8.5 1.5 1.5 30.2 4.6 7.0 6.4 0.5 5.3 1.8 4.4 4.9 2.4 1.7 2.8 3.8 55.6 3.6 0.2 0.1 5.8 3.5 9.5 10.5 13.1 13.3 10.8 13.6 13.3 3.3 13.7 12.5 134.0 147.7 116.7 2.9 115.1 27.9 8.4 7.6 18.7 48.9 3.5 58.9 41.5 0.0 0.2 2.4 227.7 0.0 0.0 0.0 218.4 149.1 3.8 462.0 1.0 97.9 4.8 1.2 85.3 85.8 1.9 9.5 229.2 173.7 1.0 0.0 19.2 0.8 0.2 7.4 1.2 68.8 116.4 236.4 1.4 0.6 71.6 93.1 133.8 0.0 2.8 SLC2A4 GLUT4 ENSG00000181856 "Solute carrier family 2 member 4" P14672 17 7281667-7288257 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 37.2;skeletal muscle: 76.8;tongue: 33.5" "Cell type enhanced" "Detected in many" 26 "Cardiomyocytes: 120.2;Sertoli cells: 32.3;Smooth muscle cells: 25.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Lineage enhanced" "Detected in single" "dendritic cells: 1.7" "Cell line enriched" "Detected in some" 4 "Hep G2: 10.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" CAB016544 Enhanced NA NA "CAB016544: AB_629533" "unprognostic (2.53e-1)" "unprognostic (7.40e-3)" "unprognostic (2.27e-1)" "unprognostic (8.12e-4)" "unprognostic (2.40e-1)" "unprognostic (6.28e-2)" "unprognostic (1.70e-2)" "unprognostic (1.66e-2)" "unprognostic (1.35e-1)" "unprognostic (3.83e-2)" "unprognostic (9.66e-2)" "unprognostic (2.24e-2)" "unprognostic (1.34e-3)" "unprognostic (4.23e-2)" "unprognostic (3.10e-1)" "unprognostic (2.30e-2)" "unprognostic (2.07e-2)" 9.9 1.4 0.6 1.8 0.7 1.1 6.4 0.0 0.6 4.7 13.9 0.2 4.0 1.0 4.2 7.0 11.8 3.2 2.9 37.2 0.3 0.1 0.7 1.2 0.5 0.7 0.8 0.1 1.9 0.4 2.9 1.2 0.8 0.5 6.3 1.4 6.4 4.6 3.8 76.8 0.9 3.3 23.5 0.2 0.2 3.8 1.5 0.0 0.0 1.2 33.5 1.6 18.6 1.6 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.2 0.0 1.8 1.5 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.6 0.1 1.2 0.2 0.0 0.8 0.8 0.3 0.2 0.1 0.0 1.8 0.0 0.3 10.8 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 1.1 0.6 0.2 0.0 0.4 0.0 0.2 0.8 0.2 0.1 2.4 0.6 0.8 0.0 0.1 0.0 1.0 0.0 1.3 0.0 1.8 0.8 0.1 0.0 0.0 1.5 0.0 0.2 0.6 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.7 0.0 0.6 0.3 0.1 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.7 1.5 0.0 120.2 0.0 0.0 0.0 0.0 0.0 0.3 6.6 0.1 5.7 1.5 0.8 0.0 0.0 0.0 0.4 0.5 0.0 2.0 0.1 0.0 0.0 1.8 0.0 3.6 0.0 0.0 6.8 0.0 0.5 5.6 0.1 0.2 8.1 0.2 0.0 32.3 25.1 2.1 2.7 1.0 0.8 0.0 1.0 0.3 SLC2A5 GLUT5 ENSG00000142583 "Solute carrier family 2 member 5" P22732 1 9035107-9088478 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.7;intestine: 84.1" "Group enriched" "Detected in many" 4 "Early spermatids: 42.2;Late spermatids: 12.6;Paneth cells: 28.8;Proximal tubular cells: 18.8;Spermatocytes: 44.4" "Group enriched" "Detected in many" 6 "glioma: 11.0;renal cancer: 11.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "naive B-cell: 19.7" "Lineage enriched" "Detected in many" 7 "B-cells: 19.7" "Group enriched" "Detected in some" 5 "Daudi: 51.3;THP-1: 13.0;U-266/70: 41.3;U-698: 48.2;U-937: 18.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA005449, HPA075145" Enhanced NA NA "HPA005449: AB_1078985, HPA075145: " "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (8.00e-3)" "unprognostic (2.25e-2)" "unprognostic (6.13e-2)" "unprognostic (2.61e-1)" "unprognostic (1.47e-2)" "unprognostic (5.35e-2)" "unprognostic (4.18e-1)" "unprognostic (6.85e-2)" "unprognostic (3.77e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.44e-5)" "unprognostic (8.56e-2)" "unprognostic (2.07e-1)" "unprognostic (8.19e-3)" "unprognostic (8.61e-2)" 5.2 2.2 10.3 4.1 15.0 36.7 3.7 1.1 9.9 2.4 50.4 9.2 0.7 44.8 0.8 4.9 2.5 1.5 0.6 1.4 8.6 6.0 16.2 0.6 0.9 8.1 14.1 2.4 1.6 0.6 0.5 1.9 2.1 10.4 6.7 1.6 0.8 1.8 2.4 25.1 3.1 84.1 1.9 17.8 3.1 0.7 30.2 15.4 0.0 0.8 3.7 7.3 1.8 2.5 19.7 0.7 3.0 2.1 0.6 0.3 0.8 0.1 0.0 0.0 0.1 0.2 0.3 0.2 0.0 0.2 0.0 0.1 0.4 0.0 51.3 0.0 0.1 0.0 0.1 0.4 0.0 0.1 6.6 0.0 0.0 0.9 0.0 0.1 0.8 0.5 0.8 0.7 0.1 0.0 0.8 0.0 0.0 0.1 0.7 0.0 0.0 0.3 2.8 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.6 0.1 0.1 0.1 0.1 0.2 0.0 0.0 13.0 0.0 0.8 0.2 0.1 0.0 41.3 0.0 48.2 0.1 18.5 0.1 3.0 2.1 0.2 0.2 0.5 0.1 3.4 0.2 0.2 0.7 19.7 0.3 0.2 2.2 0.6 0.1 0.4 0.1 0.8 10.3 15.0 1.1 9.9 8.6 6.0 14.1 2.4 10.4 15.4 0.0 0.0 6.7 1.8 1.8 0.0 1.7 0.0 0.0 0.0 1.8 0.0 0.0 6.6 0.1 42.2 0.5 2.6 0.0 0.0 1.0 0.5 0.6 1.1 0.0 4.2 0.0 1.2 0.0 1.2 12.6 2.6 1.8 0.0 1.0 2.2 0.2 0.4 28.8 0.4 18.8 0.0 6.5 0.3 44.4 3.4 0.5 0.5 0.0 2.5 0.1 SLC2A6 "GLUT6, GLUT9, HSA011372" ENSG00000160326 "Solute carrier family 2 member 6" Q9UGQ3 9 133471095-133479137 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.7;brain: 17.3" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 49.1;granulocytes: 45.2;monocytes: 68.5;Rod photoreceptor cells: 45.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 27.7" "Group enriched" "Detected in many" 4 "dendritic cells: 7.0;granulocytes: 15.6;monocytes: 27.7" "Cell line enhanced" "Detected in many" "HDLM-2: 15.7;HMC-1: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042272, CAB046014" Uncertain NA NA "CAB046014: AB_2270444, HPA042272: AB_2677924" "unprognostic (2.12e-1)" "unprognostic (1.49e-1)" "unprognostic (1.87e-3)" "unprognostic (1.71e-3)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (8.82e-4)" "unprognostic (1.26e-1)" "unprognostic (2.23e-1)" "unprognostic (5.93e-2)" "unprognostic (1.05e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (1.02e-11)" "unprognostic (7.24e-2)" "unprognostic (3.43e-2)" "unprognostic (9.36e-2)" "unprognostic (6.28e-3)" 3.8 3.1 7.2 12.7 8.3 10.5 2.1 8.1 16.3 1.4 2.5 4.3 0.0 3.3 2.3 3.1 1.8 1.4 3.6 3.0 9.1 12.1 2.3 2.7 7.4 10.8 12.4 9.1 1.7 3.2 1.1 1.8 2.5 17.3 1.6 2.1 2.9 2.2 2.2 2.1 1.9 4.9 3.3 7.3 10.6 4.0 2.2 2.4 1.7 1.6 0.0 7.1 4.9 1.1 4.0 7.0 15.6 27.7 0.4 0.6 3.1 2.5 4.7 1.7 5.1 1.0 1.5 1.3 2.6 4.5 2.7 2.7 2.3 3.7 2.1 6.6 2.6 12.6 4.1 1.1 3.2 0.6 15.7 0.8 2.6 3.5 2.7 3.4 0.0 37.0 2.1 0.5 4.0 0.5 0.2 2.7 2.5 0.4 2.2 1.9 6.1 1.5 2.7 2.5 1.2 5.6 1.0 2.8 11.7 3.8 7.5 2.0 2.7 3.9 2.1 1.3 1.0 8.0 1.1 6.9 6.5 2.5 6.8 2.1 1.1 0.8 3.0 1.6 0.6 1.4 15.6 7.2 0.7 0.6 14.6 0.4 4.0 0.1 0.4 6.4 3.9 0.2 0.5 0.4 0.4 27.7 7.0 0.1 3.1 7.2 8.3 8.1 16.3 9.1 12.1 12.4 9.1 17.3 2.4 3.0 5.5 19.9 1.3 0.3 24.3 2.0 5.1 2.7 0.0 3.5 49.1 0.3 0.0 32.4 6.3 4.7 1.8 0.0 7.9 0.5 1.9 1.1 45.2 0.0 4.6 22.3 3.5 2.5 19.2 1.3 0.9 31.5 3.3 68.5 1.5 3.9 16.6 31.7 0.0 0.0 45.6 32.3 7.2 2.2 6.6 0.4 0.2 3.8 1.2 0.5 SLC2A7 GLUT7 ENSG00000197241 "Solute carrier family 2 member 7" Q6PXP3 1 9003300-9026345 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "intestine: 19.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in single" "Daudi: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039931 Uncertain NA NA "HPA039931: AB_10671046" "unprognostic (4.19e-2)" "unprognostic (3.68e-1)" "unprognostic (1.96e-2)" "unprognostic (2.20e-1)" "unprognostic (1.05e-2)" "unprognostic (3.43e-1)" "unprognostic (9.05e-2)" "unprognostic (5.69e-4)" "unprognostic (5.09e-2)" "unprognostic (7.12e-2)" "unprognostic (1.60e-1)" "unprognostic (3.35e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 7.2 0.0 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 19.3 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.4 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC2A8 "GLUT8, GLUTX1" ENSG00000136856 "Solute carrier family 2 member 8" Q9NY64 9 127397138-127408424 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 119.6;Late spermatids: 229.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 33.8" "Lineage enriched" "Detected in all" 5 "dendritic cells: 33.8" "Cell line enhanced" "Detected in many" "CACO-2: 46.6;Hep G2: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011935 Uncertain Approved Vesicles NA NA Vesicles "HPA011935: AB_1849760" "unprognostic (6.49e-2)" "prognostic favorable (2.57e-6)" "unprognostic (9.13e-2)" "unprognostic (1.85e-3)" "unprognostic (4.23e-2)" "unprognostic (9.43e-3)" "unprognostic (2.62e-1)" "unprognostic (1.30e-1)" "unprognostic (6.33e-2)" "unprognostic (1.36e-1)" "prognostic favorable (9.86e-6)" "unprognostic (1.70e-1)" "prognostic favorable (6.55e-6)" "unprognostic (4.25e-2)" "unprognostic (3.55e-1)" "unprognostic (1.59e-3)" "unprognostic (2.04e-3)" 10.9 24.5 11.4 13.3 11.3 3.5 10.4 15.0 15.2 9.0 19.8 11.7 37.0 17.7 9.5 17.4 8.7 6.0 9.4 9.8 10.4 9.3 8.7 25.7 8.1 7.3 12.5 10.2 6.7 12.1 5.7 5.5 13.2 8.7 18.5 6.5 12.5 9.4 28.3 22.6 11.6 17.0 44.1 10.3 11.3 13.1 30.6 9.3 1.2 9.1 6.9 4.3 42.4 9.1 2.4 33.8 6.9 5.6 1.2 6.3 2.0 1.8 7.2 3.2 7.2 0.0 0.0 10.2 2.8 1.9 4.5 2.7 46.6 1.7 2.8 6.4 1.5 7.2 9.7 3.9 4.5 1.1 2.6 6.2 0.4 5.7 27.5 4.2 0.0 3.0 0.1 4.2 0.4 1.8 2.2 3.5 3.9 2.9 6.3 1.8 13.1 0.0 0.0 5.2 10.2 11.3 1.0 4.5 7.8 4.2 19.3 5.4 3.7 6.7 11.5 2.5 4.3 7.4 1.6 3.0 0.0 4.7 0.3 6.2 19.5 18.2 4.2 3.1 0.0 3.4 0.0 3.0 6.9 4.9 5.6 3.5 2.3 1.6 3.3 4.6 2.4 0.3 1.2 0.2 1.2 5.1 33.8 6.3 2.0 11.4 11.3 15.0 15.2 10.4 9.3 12.5 10.2 8.7 9.3 8.9 9.6 5.4 6.1 9.8 11.1 6.1 7.6 5.3 4.5 5.2 9.8 66.2 13.3 12.0 119.6 7.4 15.1 23.3 14.7 10.8 11.6 11.0 6.9 23.6 59.6 6.4 11.6 12.9 12.4 229.4 10.0 8.2 25.3 8.2 13.3 14.9 15.9 21.5 11.0 12.2 7.7 12.9 8.1 38.0 10.9 9.3 56.3 6.9 15.6 5.5 SLC2A9 "Glut9, GLUTX, URATv1" ENSG00000109667 "Solute carrier family 2 member 9" Q9NRM0 4 9771153-10054936 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 43.4" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 16.4;Proximal tubular cells: 47.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 20.6;myeloid DC: 16.7" "Group enriched" "Detected in many" 31 "dendritic cells: 16.7;monocytes: 20.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 29.6;Hep G2: 14.2;hTCEpi: 12.5;THP-1: 12.5;U-937: 8.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA066229, HPA075669" Enhanced NA NA "HPA066229: AB_2685639, HPA075669: " "unprognostic (3.21e-1)" "unprognostic (8.99e-3)" "unprognostic (1.25e-2)" "unprognostic (2.01e-1)" "unprognostic (2.14e-2)" "unprognostic (2.56e-2)" "unprognostic (8.94e-2)" "unprognostic (6.94e-2)" "unprognostic (2.86e-2)" "unprognostic (1.28e-2)" "unprognostic (3.16e-1)" "unprognostic (2.23e-1)" "prognostic favorable (1.32e-11)" "unprognostic (1.01e-1)" "unprognostic (3.88e-2)" "unprognostic (3.17e-3)" "unprognostic (1.20e-1)" 5.6 2.8 1.0 1.3 2.0 1.2 3.2 0.6 1.2 2.6 10.4 2.3 5.7 7.8 1.7 12.0 5.8 2.6 1.7 2.7 1.0 0.9 43.4 17.7 4.7 2.8 1.9 0.7 1.5 1.3 1.5 1.8 8.8 2.1 4.6 1.1 4.1 10.8 15.6 1.1 2.4 12.0 1.4 4.1 3.0 1.2 1.3 2.3 3.0 2.9 3.4 3.9 7.1 3.9 0.2 16.7 0.6 20.6 0.1 0.2 4.9 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.2 1.5 0.0 2.2 0.4 0.0 4.5 0.0 29.6 0.0 4.8 0.1 0.0 0.0 14.2 1.0 0.1 4.0 2.2 12.5 0.0 3.1 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.2 1.4 0.0 0.2 0.1 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 20.6 0.4 0.1 4.1 0.2 0.2 0.2 0.0 16.7 0.1 0.1 0.0 0.6 0.1 0.4 6.6 0.1 4.9 1.0 2.0 0.6 1.2 1.0 0.9 1.9 0.7 2.1 2.3 0.0 0.0 1.4 11.1 0.8 0.0 2.1 0.0 4.0 3.4 3.5 2.0 16.4 3.3 0.4 3.9 1.4 2.9 0.0 0.9 1.3 1.1 1.0 1.1 4.9 9.3 0.0 0.0 2.5 6.5 2.8 0.0 10.2 0.0 1.0 0.8 0.8 0.4 0.0 0.4 47.2 0.4 0.0 1.0 0.7 1.2 0.5 7.1 0.5 1.0 8.8 SLC30A1 "ZNT1, ZRC1" ENSG00000170385 "Solute carrier family 30 member 1" Q9Y6M5 1 211571568-211578742 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 53.3" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 83.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015275, HPA049000" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA015275: AB_1857083, HPA049000: AB_2680593" "unprognostic (1.13e-1)" "unprognostic (2.67e-3)" "unprognostic (6.94e-2)" "unprognostic (1.81e-3)" "unprognostic (3.47e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-2)" "unprognostic (1.82e-3)" "unprognostic (4.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.42e-3)" "unprognostic (4.78e-2)" "unprognostic (2.23e-2)" "unprognostic (3.03e-1)" "unprognostic (2.55e-1)" "unprognostic (1.02e-1)" "unprognostic (4.53e-2)" 11.4 16.6 9.3 7.5 11.4 15.5 17.3 5.2 13.6 13.0 15.3 6.9 4.9 17.2 7.1 7.6 9.0 9.2 12.9 6.1 9.7 7.9 13.4 53.3 12.0 3.5 9.5 8.0 9.5 8.9 8.8 4.8 9.3 8.7 7.3 8.9 7.7 5.9 9.2 3.6 13.9 28.1 7.5 8.3 10.7 6.4 12.5 5.5 3.1 11.0 5.2 4.4 7.7 8.4 0.5 2.5 3.9 4.2 1.3 1.7 1.0 4.7 6.9 3.8 4.9 16.6 7.7 33.7 13.0 9.6 6.9 6.9 3.0 22.6 2.6 11.4 11.9 9.6 8.1 5.7 7.5 8.3 6.7 4.3 2.1 14.1 6.9 9.3 7.4 4.8 11.5 19.0 8.8 14.4 10.4 4.2 1.6 8.4 12.5 8.5 4.3 1.4 4.6 11.7 5.1 5.5 4.5 1.8 9.6 21.5 12.7 3.8 6.7 12.7 6.7 29.0 7.5 3.4 9.7 6.8 5.2 12.1 17.3 10.3 5.5 8.4 2.2 4.8 7.5 4.5 3.9 3.9 1.3 1.2 4.2 1.7 0.5 0.9 0.8 2.5 0.3 0.9 1.2 0.4 1.3 3.2 1.7 0.8 1.0 9.3 11.4 5.2 13.6 9.7 7.9 9.5 8.0 8.7 5.5 8.9 9.8 5.1 7.2 25.3 10.9 17.9 17.8 6.7 2.3 34.9 5.9 9.8 1.7 5.4 21.7 18.0 37.9 46.7 10.7 27.0 15.0 12.6 4.7 83.9 29.4 6.4 9.1 15.4 33.3 2.8 9.2 15.1 20.3 5.4 23.6 26.5 7.9 31.7 7.1 29.5 8.5 6.5 11.6 33.0 9.4 40.4 20.5 10.2 20.5 11.4 SLC30A10 "DKFZp547M236, ZnT-10, ZNT8, ZRC1" ENSG00000196660 "Solute carrier family 30 member 10" Q6XR72 1 219685427-219958647 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation, Dystonia, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 33.4" "Group enriched" "Detected in some" 6 "Early spermatids: 23.4;Enterocytes: 12.9;Hepatocytes: 19.8;Late spermatids: 27.7" "Cancer enriched" "Detected in some" 14 "liver cancer: 7.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.4;HEL: 2.2;Hep G2: 4.3;K-562: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064547 Enhanced NA NA "HPA064547: AB_2732715" "unprognostic (7.88e-2)" "unprognostic (1.07e-2)" "unprognostic (1.02e-1)" "unprognostic (7.25e-2)" "unprognostic (1.75e-2)" "unprognostic (3.74e-3)" "unprognostic (6.96e-2)" "unprognostic (3.72e-2)" "unprognostic (1.41e-1)" "unprognostic (1.95e-2)" "unprognostic (5.10e-2)" "unprognostic (3.10e-3)" "unprognostic (4.47e-7)" "unprognostic (3.16e-1)" "unprognostic (6.11e-2)" "unprognostic (6.19e-3)" "unprognostic (5.72e-2)" 0.3 0.3 2.9 0.7 3.5 0.4 0.3 1.8 3.9 0.3 7.1 1.9 0.0 5.9 0.3 0.3 0.3 0.3 0.5 0.3 3.5 1.6 0.3 33.4 0.3 0.3 1.7 1.7 0.6 0.3 0.3 0.4 0.4 2.5 0.3 1.7 0.6 0.3 0.3 0.3 0.3 6.8 0.3 0.8 0.3 0.3 1.9 1.9 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.4 2.2 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.5 1.8 3.9 3.5 1.6 1.7 1.7 2.5 1.9 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 23.4 0.0 12.9 0.0 0.0 0.2 0.0 0.0 0.0 19.8 0.1 0.0 0.0 0.6 0.6 27.7 1.1 0.0 1.7 0.0 0.1 3.4 0.0 3.2 1.4 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.2 0.0 0.6 0.0 SLC30A2 ZNT2 ENSG00000158014 "Solute carrier family 30 member 2" Q9BRI3 1 26037252-26046133 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 78.0;placenta: 20.0" "Cell type enhanced" "Detected in many" 16 "Cytotrophoblasts: 23.2;Exocrine glandular cells: 18.5;Proximal tubular cells: 27.2;Syncytiotrophoblasts: 71.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 19.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "BEWO: 4.7;RPTEC TERT1: 10.6;WM-115: 6.5" "Region enriched" "Detected in single" 5 "olfactory region: 1.5" "Not detected" "Not detected" HPA017979 Approved Vesicles NA NA Vesicles "HPA017979: AB_1857085" "unprognostic (4.87e-2)" "unprognostic (6.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.79e-3)" "unprognostic (1.11e-1)" "unprognostic (2.37e-2)" "unprognostic (2.25e-2)" "unprognostic (2.59e-1)" "unprognostic (3.67e-2)" "unprognostic (1.02e-1)" "unprognostic (6.99e-2)" "unprognostic (1.10e-1)" "prognostic favorable (2.86e-6)" "unprognostic (9.38e-2)" "unprognostic (3.50e-2)" "unprognostic (1.17e-1)" "unprognostic (3.01e-2)" 0.1 0.7 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.0 1.3 1.1 0.1 0.1 4.0 2.2 0.1 0.1 10.4 0.1 0.2 0.1 0.1 0.1 0.1 78.0 0.1 0.1 20.0 0.1 0.3 0.0 2.0 1.0 1.4 1.7 0.4 0.6 0.1 0.1 0.1 0.1 0.4 0.1 0.1 12.8 0.2 0.1 0.5 0.1 1.5 1.1 3.1 1.0 1.5 0.9 0.4 0.2 0.2 0.2 1.0 0.3 0.1 4.7 0.4 0.2 0.1 0.1 0.9 1.0 0.2 0.9 0.1 0.2 0.9 0.2 0.3 0.1 0.6 0.3 0.6 0.7 0.1 0.1 0.6 0.7 0.0 0.2 0.1 0.1 0.3 0.0 0.3 0.6 1.5 0.1 0.8 0.5 0.9 0.8 0.4 0.2 0.3 0.7 0.7 10.6 0.4 0.9 0.5 0.6 1.1 0.4 1.6 0.7 0.5 0.6 0.7 1.2 0.6 0.3 1.1 0.6 0.8 0.5 0.6 6.5 3.1 1.0 0.4 0.9 0.4 0.5 0.7 0.6 0.8 0.2 1.5 0.6 0.8 3.1 1.5 0.5 1.1 0.5 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.0 4.0 0.0 0.7 0.3 2.4 5.1 15.3 0.0 0.0 8.7 0.0 23.2 5.0 6.8 0.0 0.5 0.4 0.0 18.5 2.4 0.6 0.6 4.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 1.8 0.1 0.5 5.4 0.0 0.0 27.2 1.8 6.5 0.9 0.2 0.4 0.6 71.2 0.0 0.6 0.7 SLC30A3 ZNT3 ENSG00000115194 "Solute carrier family 30 member 3" Q99726 2 27253684-27275817 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 28.7;epididymis: 41.0;testis: 19.5" "Group enriched" "Detected in some" 18 "Cardiomyocytes: 8.1;Early spermatids: 13.1;Late spermatids: 29.1;Peritubular cells: 14.2;Spermatocytes: 18.7;Spermatogonia: 9.4" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 9 "amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.0;HAP1: 8.8;Hep G2: 11.7;REH: 19.0;RH-30: 9.9" "Group enriched" "Detected in many" 5 "amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6" "Group enriched" "Detected in many" 7 "amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9" "HPA060505, HPA067637, CAB079044" Enhanced Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Nucleoli, Cytosol" "CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875" "unprognostic (2.05e-4)" "unprognostic (1.17e-1)" "unprognostic (6.84e-4)" "unprognostic (5.26e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (1.43e-2)" "unprognostic (2.93e-2)" "unprognostic (2.64e-2)" "unprognostic (3.05e-1)" "unprognostic (2.20e-1)" "unprognostic (1.89e-1)" "unprognostic (4.65e-12)" "unprognostic (3.23e-2)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (2.63e-4)" 0.5 1.9 15.8 0.5 11.4 0.5 0.4 0.4 28.7 0.5 0.5 0.0 1.9 0.4 0.5 41.0 0.4 0.7 0.4 5.0 10.2 0.8 0.4 0.5 0.5 0.8 1.1 12.1 0.5 0.4 0.6 0.4 0.4 1.6 0.6 0.5 0.7 0.4 0.9 0.4 0.4 0.5 0.5 0.7 0.5 0.4 19.5 0.0 0.0 0.4 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 1.1 0.0 1.5 0.0 0.2 0.1 0.0 0.0 1.0 1.0 0.3 0.4 0.0 0.0 0.0 8.0 0.2 8.8 0.0 0.2 0.0 1.0 5.0 0.2 11.7 0.2 0.1 2.0 0.0 0.0 0.5 0.0 0.1 0.7 2.4 1.4 0.0 0.1 3.8 0.0 0.3 1.5 0.2 0.0 19.0 9.9 1.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.0 0.7 0.0 0.2 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 15.8 11.4 0.4 28.7 10.2 0.8 1.1 12.1 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 29.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.3 18.7 9.4 0.1 0.1 0.0 0.0 0.0 SLC30A4 ZNT4 ENSG00000104154 "Solute carrier family 30 member 4" O14863 15 45479611-45522807 "Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 47.7" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 59.6;Late spermatids: 60.4" "Cancer enriched" "Detected in all" 20 "prostate cancer: 34.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018178 Uncertain NA NA "HPA018178: AB_1857087" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (3.71e-1)" "unprognostic (9.49e-2)" "unprognostic (1.98e-1)" "unprognostic (3.29e-2)" "unprognostic (6.15e-2)" "unprognostic (9.74e-2)" "unprognostic (7.38e-3)" "unprognostic (1.51e-1)" "prognostic favorable (6.02e-4)" "unprognostic (2.66e-2)" "unprognostic (4.72e-3)" "unprognostic (1.29e-2)" "unprognostic (9.83e-2)" "unprognostic (8.28e-3)" "unprognostic (2.01e-3)" 3.7 2.9 6.2 4.5 11.3 1.6 4.1 6.7 8.1 3.7 8.8 7.0 2.3 8.5 4.3 4.1 5.6 3.4 3.1 3.0 5.2 3.8 5.5 3.6 2.9 3.6 6.9 4.9 3.9 2.8 6.8 3.0 4.6 5.1 47.7 4.4 3.1 2.7 3.5 2.4 3.6 19.9 4.7 4.5 4.0 3.0 15.8 9.0 1.0 6.2 1.8 4.5 3.1 4.4 7.1 0.5 2.6 0.3 2.4 4.3 1.0 2.0 2.6 0.7 5.6 10.2 7.2 0.5 5.4 4.9 3.3 4.7 0.3 1.8 8.0 1.8 5.5 1.3 1.5 2.4 2.5 3.0 1.9 2.2 0.2 2.6 0.2 6.6 0.2 4.2 6.0 4.1 4.3 1.1 5.1 3.8 3.8 1.2 4.6 6.1 0.9 2.7 0.4 0.2 0.4 0.5 4.2 4.8 1.2 2.7 0.5 1.9 2.8 3.5 4.0 0.9 0.9 3.5 0.3 7.1 4.9 2.8 5.9 1.8 8.6 6.2 2.0 2.1 0.3 3.7 2.6 0.3 0.3 4.3 0.2 3.9 3.8 2.9 2.4 0.3 7.1 2.9 4.2 1.1 2.4 0.3 0.5 0.4 1.0 6.2 11.3 6.7 8.1 5.2 3.8 6.9 4.9 5.1 9.0 3.0 3.8 3.2 2.0 6.1 2.6 2.3 0.0 1.4 0.0 1.8 15.7 0.7 0.0 1.0 59.6 5.0 13.6 0.0 1.0 0.2 7.2 30.7 1.1 2.4 2.5 12.7 1.2 7.4 1.8 60.4 5.8 5.8 6.8 9.0 5.1 4.9 0.6 14.4 7.8 8.4 2.2 6.5 5.9 29.4 16.8 5.6 0.2 4.4 2.9 1.4 SLC30A5 "FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1" ENSG00000145740 "Solute carrier family 30 member 5" Q8TAD4 5 69093646-69131069 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035373 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA035373: AB_10794630" "unprognostic (9.81e-3)" "unprognostic (3.33e-1)" "unprognostic (2.82e-2)" "unprognostic (8.16e-2)" "unprognostic (1.65e-1)" "unprognostic (3.88e-2)" "unprognostic (1.16e-3)" "unprognostic (2.47e-2)" "unprognostic (4.65e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (2.92e-1)" "unprognostic (1.49e-1)" "unprognostic (2.53e-2)" "unprognostic (2.07e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" 19.4 22.1 14.4 19.4 15.7 13.3 29.7 14.9 18.5 25.0 20.9 13.2 33.7 19.7 24.3 32.4 20.5 20.3 23.5 25.4 14.5 15.4 28.6 39.2 24.3 23.7 15.5 13.1 25.4 50.5 29.6 38.1 34.3 13.9 24.5 19.8 17.6 36.8 35.3 17.1 21.2 25.0 18.1 13.2 20.1 20.3 18.1 12.7 22.1 33.5 18.8 19.6 18.2 28.9 8.3 13.2 12.4 6.9 5.6 9.1 3.3 15.7 12.2 11.4 20.0 30.1 23.2 36.2 25.0 22.7 15.8 24.2 11.2 19.8 20.9 31.9 17.0 27.7 17.0 15.8 18.9 26.8 24.9 18.2 23.3 15.4 18.3 24.2 14.6 26.0 15.6 25.1 16.2 19.4 22.2 15.3 14.5 14.0 25.0 20.1 19.9 19.2 30.4 12.9 10.7 14.0 15.4 14.5 37.7 23.6 14.8 20.4 16.2 19.8 19.9 33.9 16.6 19.2 32.5 13.9 10.3 13.4 25.7 24.7 22.7 27.9 16.3 20.3 26.6 25.4 12.4 6.7 10.7 6.1 6.8 6.5 8.3 9.1 8.9 8.4 6.3 8.4 7.1 5.9 5.6 6.9 13.2 6.1 3.3 14.4 15.7 14.9 18.5 14.5 15.4 15.5 13.1 13.9 12.7 17.9 15.5 9.0 22.6 16.7 13.9 26.2 12.7 14.7 14.8 24.4 21.6 35.4 24.9 18.8 5.2 16.6 12.3 23.3 23.5 60.9 24.0 28.7 41.4 17.4 19.6 7.9 12.7 19.0 17.3 6.7 22.5 16.4 13.5 12.6 24.9 13.4 17.8 21.0 20.8 16.1 22.6 25.8 20.9 9.9 14.9 18.7 43.1 20.3 21.7 24.2 SLC30A6 "FLJ31101, ZNT6" ENSG00000152683 "Solute carrier family 30 member 6" Q6NXT4 2 32165841-32224379 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055032, HPA057328" Uncertain Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA055032: AB_2682677, HPA057328: AB_2683411" "unprognostic (5.61e-2)" "unprognostic (9.11e-3)" "unprognostic (1.05e-3)" "prognostic unfavorable (6.55e-4)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.58e-6)" "unprognostic (2.98e-1)" "unprognostic (9.47e-2)" "unprognostic (1.88e-1)" "unprognostic (3.30e-3)" "unprognostic (7.05e-2)" "unprognostic (3.06e-2)" "unprognostic (3.51e-1)" "unprognostic (3.00e-1)" "unprognostic (1.13e-1)" "unprognostic (1.90e-1)" 15.9 17.9 10.3 11.9 13.1 5.4 15.3 21.1 13.7 16.6 14.4 14.2 10.6 12.6 22.5 12.1 16.8 13.8 13.5 13.5 10.6 8.7 17.9 18.4 14.3 17.9 17.3 8.1 17.8 23.7 15.7 19.8 18.1 13.2 13.7 15.3 14.8 17.2 12.4 18.8 15.2 14.3 14.1 20.1 16.2 14.9 12.8 15.9 21.3 17.8 9.9 18.8 15.0 14.2 4.3 3.9 12.5 3.1 9.2 6.1 2.6 18.3 13.8 14.2 12.4 18.1 16.3 15.8 17.3 17.1 14.2 13.0 10.7 17.4 8.8 11.5 13.7 16.4 11.6 16.9 11.9 18.2 17.7 9.4 19.1 7.9 13.6 11.6 20.0 11.9 12.1 18.7 19.1 15.4 14.5 11.4 6.3 16.1 11.8 16.2 6.8 10.5 9.2 21.4 20.7 7.3 9.4 17.2 12.9 15.7 16.2 10.7 16.3 13.6 14.7 13.6 13.9 8.1 9.2 9.7 18.2 10.1 11.9 20.3 16.1 27.9 13.1 16.2 15.7 18.3 12.5 3.1 2.6 3.6 2.7 4.9 4.3 3.3 4.0 3.9 3.8 5.0 4.6 3.5 9.2 3.0 3.2 6.1 2.6 10.3 13.1 21.1 13.7 10.6 8.7 17.3 8.1 13.2 15.9 8.9 6.9 8.8 4.1 8.0 4.9 3.5 10.2 4.0 1.2 7.0 5.9 17.2 5.0 6.6 1.6 9.8 7.2 0.0 7.4 12.5 9.8 7.6 3.5 15.5 9.4 1.6 3.5 9.2 6.3 0.4 6.1 6.4 8.5 4.6 8.5 6.3 8.0 7.0 7.4 7.9 6.1 12.9 5.1 11.1 8.9 5.5 23.0 5.0 9.8 4.3 SLC30A7 "ZNT7, ZnTL2" ENSG00000162695 "Solute carrier family 30 member 7" Q8NEW0 1 100896076-100981753 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018034 Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA018034: AB_1857089" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (8.05e-3)" "unprognostic (1.79e-1)" "unprognostic (2.50e-1)" "unprognostic (3.18e-1)" "unprognostic (2.89e-3)" "unprognostic (1.24e-1)" "unprognostic (1.61e-1)" "unprognostic (1.11e-3)" "unprognostic (2.78e-2)" "unprognostic (1.95e-1)" "unprognostic (5.46e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" "unprognostic (3.37e-1)" 15.6 14.2 5.0 13.1 6.4 10.3 12.7 7.4 7.6 13.3 10.8 6.2 17.2 10.8 13.3 13.7 10.8 9.4 13.2 9.3 5.9 5.6 13.0 43.1 18.1 25.6 7.7 4.6 10.5 19.1 17.1 17.7 25.2 9.2 11.9 14.7 10.8 17.5 18.1 5.7 12.6 15.8 9.0 8.1 16.2 13.3 7.5 6.4 24.7 13.2 10.9 17.4 10.5 11.1 5.5 8.2 13.9 14.9 8.4 10.7 5.9 10.9 5.7 6.2 13.6 13.2 13.5 15.7 7.2 19.3 8.8 11.6 5.8 7.9 4.4 15.7 14.7 7.0 10.9 7.2 10.7 13.5 6.9 4.5 8.6 9.7 10.4 14.8 11.3 9.2 15.4 6.9 14.8 18.1 8.5 14.2 8.4 5.2 19.3 11.9 4.9 8.2 5.7 6.6 5.5 7.1 4.1 11.1 5.7 7.8 12.8 3.4 6.7 12.9 14.5 9.3 4.9 7.2 6.3 15.3 20.8 8.0 19.2 11.5 13.1 6.9 4.9 21.2 9.3 5.5 13.9 10.7 7.4 10.7 10.4 9.2 5.3 9.9 8.4 8.2 5.5 8.9 9.6 5.3 8.4 14.9 7.7 7.2 5.9 5.0 6.4 7.4 7.6 5.9 5.6 7.7 4.6 9.2 6.4 29.8 16.3 25.1 16.5 50.9 8.9 3.2 15.3 10.7 12.5 22.7 5.9 26.3 1.7 20.8 0.6 24.6 16.0 0.0 23.0 19.6 25.5 36.1 36.9 38.5 19.8 4.8 21.9 35.0 29.4 0.9 15.8 29.5 30.4 14.4 32.0 7.8 29.1 24.6 15.6 16.2 12.4 6.5 22.3 6.2 7.6 55.8 34.9 29.8 20.1 24.8 SLC30A8 "ZnT-8, ZNT8" ENSG00000164756 "Solute carrier family 30 member 8" Q8IWU4 8 116950273-117176714 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pancreas: 37.1" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 3.0;Late spermatids: 5.4;Pancreatic endocrine cells: 8.2;Spermatogonia: 3.0" "Group enriched" "Detected in some" 28 "breast cancer: 10.6;pancreatic cancer: 15.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 34 "U-266/70: 30.5;U-266/84: 21.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA076165 Enhanced NA NA "HPA076165: AB_2732304" "unprognostic (2.14e-2)" "unprognostic (1.48e-2)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (5.38e-2)" "unprognostic (5.57e-2)" "unprognostic (4.38e-1)" "unprognostic (3.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.66e-2)" "unprognostic (6.51e-3)" "unprognostic (2.15e-2)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (9.16e-3)" 0.1 0.0 0.1 0.1 0.4 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.1 0.1 0.1 0.1 37.1 0.0 0.3 0.1 0.1 0.1 0.0 5.0 6.4 0.1 0.1 0.3 0.4 0.1 0.1 0.1 0.6 2.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.5 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 30.5 21.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 1.5 0.0 0.0 0.0 1.4 3.0 0.0 0.0 0.0 0.0 0.0 SLC30A9 "C4orf1, GAC63, HUEL, ZNT9" ENSG00000014824 "Solute carrier family 30 member 9" Q6PML9 4 41990472-42090457 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transcription, Transcription regulation, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004014 Approved NA NA "HPA004014: AB_1080005" "unprognostic (4.26e-2)" "unprognostic (2.20e-1)" "unprognostic (1.31e-3)" "unprognostic (1.44e-2)" "unprognostic (1.14e-1)" "unprognostic (1.01e-1)" "unprognostic (3.19e-2)" "unprognostic (1.82e-1)" "unprognostic (2.63e-2)" "unprognostic (1.43e-1)" "unprognostic (1.55e-1)" "unprognostic (6.99e-2)" "prognostic favorable (2.86e-14)" "unprognostic (4.67e-2)" "unprognostic (1.34e-1)" "unprognostic (2.22e-2)" "unprognostic (1.39e-2)" 11.0 20.4 23.6 11.2 28.8 7.0 18.1 24.2 32.4 16.5 17.0 12.8 15.3 16.1 13.8 21.8 12.5 13.3 11.5 33.4 22.7 24.4 38.2 17.9 11.6 9.0 22.7 23.7 15.1 16.6 30.4 32.6 12.2 27.7 18.3 18.4 11.5 15.0 16.4 17.1 12.6 15.5 11.5 19.2 11.9 16.1 8.8 15.4 12.0 22.5 15.8 10.0 11.8 11.6 4.0 7.1 6.2 6.5 5.9 5.5 3.9 8.5 4.3 14.2 16.1 11.0 15.4 8.1 11.9 14.4 10.5 12.5 4.4 11.2 8.8 8.7 13.6 13.5 4.4 11.9 9.8 15.0 3.0 7.2 10.1 7.6 7.3 19.5 13.8 7.3 12.2 10.1 8.9 11.7 16.9 11.3 9.0 13.5 4.2 18.2 4.1 7.9 13.2 10.9 13.3 6.0 4.0 12.9 7.2 21.2 7.2 15.9 17.9 8.4 9.4 10.5 10.6 12.0 10.5 12.1 12.3 7.2 12.3 13.7 8.3 6.3 8.4 16.8 11.8 10.7 6.2 5.3 3.0 3.6 6.5 4.2 4.0 4.2 4.6 7.1 3.8 5.5 4.3 2.6 5.9 5.0 5.1 4.7 3.9 23.6 28.8 24.2 32.4 22.7 24.4 22.7 23.7 27.7 15.4 44.7 38.5 16.7 19.2 13.5 33.9 83.2 25.5 49.5 34.2 36.6 23.6 37.0 87.9 31.8 3.9 18.8 23.6 0.0 31.7 28.0 22.1 27.9 33.5 23.6 21.4 47.7 32.1 22.7 21.0 6.9 19.2 20.3 23.6 28.9 35.3 24.3 29.0 10.5 21.2 80.0 36.5 6.5 23.1 11.7 14.9 19.8 41.3 14.9 36.5 19.2 SLC31A1 "COPT1, CTR1, hCTR1" ENSG00000136868 "Solute carrier family 31 member 1" O15431 9 113221562-113264492 "Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 55.7;salivary gland: 57.9" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 81.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 13.0;intermediate monocyte: 16.2;myeloid DC: 9.9;neutrophil: 5.0;non-classical monocyte: 17.0" "Group enriched" "Detected in all" 4 "dendritic cells: 9.9;granulocytes: 5.0;monocytes: 17.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013810 Approved NA NA "HPA013810: AB_1857095" "unprognostic (1.22e-2)" "unprognostic (1.74e-1)" "unprognostic (4.29e-2)" "unprognostic (5.48e-3)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" "unprognostic (7.58e-2)" "unprognostic (2.30e-1)" "unprognostic (2.51e-1)" "unprognostic (7.18e-2)" "unprognostic (3.61e-1)" "prognostic favorable (2.20e-6)" "unprognostic (1.22e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (2.51e-2)" 7.8 12.1 5.0 4.9 6.1 4.6 6.0 3.7 6.7 10.6 16.2 6.7 21.2 20.7 4.9 7.8 9.8 4.8 5.7 5.8 5.0 4.9 15.4 55.7 8.8 3.5 5.6 4.0 6.3 11.4 5.8 9.4 7.9 7.4 10.3 8.1 8.5 57.9 21.7 3.0 14.3 41.8 4.6 5.8 8.6 9.3 4.7 5.0 2.6 6.3 6.8 9.8 5.8 5.2 1.0 9.9 5.0 17.0 2.5 2.0 4.3 8.2 8.9 7.3 16.0 16.7 12.0 26.9 14.6 22.3 10.1 11.9 12.6 7.2 6.4 5.9 12.5 12.9 20.4 13.7 8.3 11.4 5.6 7.7 5.3 7.9 14.1 40.9 9.6 8.1 14.4 18.9 13.1 21.5 6.8 9.2 7.5 12.0 12.0 9.6 8.7 6.5 4.9 11.8 31.6 10.0 6.8 19.1 6.4 9.3 10.3 6.9 9.0 14.1 28.3 38.2 10.7 14.4 8.3 8.4 7.6 4.7 15.2 8.7 7.2 14.7 9.0 12.6 9.1 8.9 1.3 13.0 1.5 1.5 16.2 2.0 1.0 1.0 1.5 9.9 0.9 1.2 1.1 5.0 2.5 17.0 1.4 1.1 4.3 5.0 6.1 3.7 6.7 5.0 4.9 5.6 4.0 7.4 5.0 32.8 31.0 8.2 8.3 13.5 12.2 7.0 17.8 25.4 40.9 5.2 31.4 14.3 8.3 15.5 0.2 8.4 47.6 0.0 23.5 21.7 15.1 32.7 4.7 81.5 41.2 6.4 8.6 12.3 27.6 0.5 5.8 27.2 11.8 11.8 14.4 11.3 18.9 11.8 6.7 23.2 11.2 6.5 12.2 11.9 34.9 13.8 18.8 2.5 16.6 16.2 SLC31A2 "COPT2, CTR2, hCTR2" ENSG00000136867 "Solute carrier family 31 member 2" O15432 9 113150942-113164137 "Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.2;salivary gland: 125.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 80.2;Kupffer cells: 82.1;Macrophages: 93.6;monocytes: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2" "Group enriched" "Detected in many" 36 "dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2" "Cell line enhanced" "Detected in many" "ASC diff: 22.2;hTCEpi: 33.7;hTERT-HME1: 23.1;LHCN-M2: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014861 Approved Approved "Nuclear speckles,Plasma membrane,Intermediate filaments" NA NA "Nuclear speckles" "Plasma membrane, Intermediate filaments" "HPA014861: AB_1857098" "unprognostic (2.26e-1)" "unprognostic (7.20e-2)" "unprognostic (3.79e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (4.81e-3)" "unprognostic (5.63e-2)" "unprognostic (3.31e-2)" "unprognostic (2.24e-1)" "unprognostic (3.44e-2)" "unprognostic (1.47e-1)" "unprognostic (1.86e-1)" "unprognostic (6.05e-3)" "unprognostic (1.76e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" "unprognostic (8.89e-2)" 15.7 8.0 10.0 8.1 20.5 7.0 8.5 3.2 15.0 3.0 8.4 45.1 27.1 5.2 2.0 6.0 4.6 3.0 4.5 3.4 18.2 9.4 9.8 11.2 10.0 6.2 34.3 10.5 2.8 7.8 17.9 1.2 10.2 22.3 2.1 4.4 1.0 125.5 21.8 6.7 18.5 9.9 3.8 48.5 14.1 4.5 5.4 26.2 1.2 2.8 2.9 5.8 3.9 4.1 0.3 21.2 54.5 60.2 0.2 1.2 13.4 5.5 2.5 1.4 2.0 22.2 9.1 4.8 4.2 5.4 5.1 4.9 1.8 1.7 0.3 0.8 3.5 8.3 20.6 2.0 12.0 4.8 2.8 0.8 0.3 1.2 2.9 8.5 2.2 1.2 10.2 33.7 11.9 23.1 2.7 2.7 2.7 1.6 3.0 26.6 5.3 2.1 1.3 0.7 2.8 2.3 0.4 20.1 0.4 1.7 3.4 1.3 2.2 5.8 17.8 1.7 1.2 6.4 2.0 2.5 2.8 1.9 9.2 3.6 1.9 3.9 0.2 8.8 2.9 2.8 0.8 36.6 3.6 0.9 50.5 1.2 0.2 1.0 1.0 21.2 0.3 0.8 0.8 54.5 0.2 60.2 0.5 0.6 13.4 10.0 20.5 3.2 15.0 18.2 9.4 34.3 10.5 22.3 26.2 8.9 8.6 18.0 5.3 33.0 6.9 0.4 2.5 10.7 5.7 1.8 33.4 80.2 3.3 10.7 2.3 6.7 17.4 0.0 6.6 5.8 13.3 7.9 0.0 18.7 55.9 6.4 3.4 17.2 82.1 2.0 14.7 93.6 0.0 89.2 3.2 8.2 13.8 7.0 8.9 17.4 9.1 19.4 8.9 30.6 5.1 33.5 36.0 8.3 3.5 4.2 SLC32A1 "bA122O1.1, VGAT, VIAAT" ENSG00000101438 "Solute carrier family 32 member 1" Q9H598 20 38724462-38729372 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 38.3" "Cell type enriched" "Detected in some" 14 "Horizontal cells: 55.6" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 20 "dendritic cells: 1.9" "Group enriched" "Detected in some" 12 "MOLT-4: 5.5;SH-SY5Y: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037156, HPA058859, HPA059985" Enhanced Supported NA NA "CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187" "unprognostic (1.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (6.57e-2)" 1.0 1.1 4.6 1.0 38.3 1.5 1.0 4.9 25.8 1.0 1.0 0.8 0.0 1.0 1.0 1.0 1.0 1.1 1.0 1.0 3.9 9.7 1.0 1.0 1.0 1.0 4.4 6.8 1.0 1.1 1.0 4.1 1.0 10.4 1.0 1.0 0.7 1.0 1.0 1.0 1.0 1.1 1.0 4.4 1.0 1.0 1.6 7.9 0.0 1.0 0.0 1.0 1.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 4.6 38.3 4.9 11.9 3.9 9.7 4.4 6.8 10.4 7.9 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 SLC33A1 "ACATN, AT-1, AT1, SPG42" ENSG00000169359 "Solute carrier family 33 member 1" O00400 3 155821024-155854456 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Cataract, Deafness, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042430, HPA060345" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA042430: AB_10806238, HPA060345: AB_2732647" "unprognostic (5.12e-3)" "unprognostic (7.78e-2)" "unprognostic (1.13e-2)" "unprognostic (7.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.73e-2)" "unprognostic (9.57e-2)" "unprognostic (5.65e-2)" "unprognostic (6.61e-2)" "unprognostic (4.36e-2)" "unprognostic (1.19e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-2)" "unprognostic (2.92e-1)" "unprognostic (4.73e-2)" "unprognostic (5.74e-2)" 11.3 17.3 6.5 9.9 8.6 3.1 12.1 9.4 9.4 18.8 13.1 10.5 29.9 11.3 14.0 22.9 11.8 12.3 11.5 12.9 7.8 6.7 19.4 38.3 12.8 13.6 9.4 5.6 13.6 42.4 18.8 24.6 13.9 8.9 15.0 10.5 9.2 26.6 33.9 7.0 9.4 15.2 10.4 8.2 11.9 12.4 8.9 8.8 14.9 26.1 5.8 10.7 10.2 11.6 6.0 16.7 12.1 8.3 6.9 10.8 6.0 14.9 10.4 5.4 6.7 20.0 17.3 10.2 11.2 15.0 13.6 13.4 5.9 16.0 7.7 18.1 9.1 14.2 12.7 9.3 11.0 15.4 10.9 9.6 8.0 5.0 11.6 29.0 8.8 7.1 13.8 22.1 7.2 28.1 15.2 14.9 7.3 6.4 18.6 12.2 9.5 3.5 5.2 5.2 12.6 10.0 4.0 6.0 23.1 13.9 9.5 6.3 5.2 9.4 21.9 19.9 8.0 6.9 11.2 15.4 8.0 4.0 14.7 11.7 21.9 7.7 8.1 11.5 7.2 11.4 12.1 8.3 6.0 9.4 6.5 10.8 6.0 6.8 7.4 10.7 4.1 6.5 6.3 1.8 6.9 6.3 16.7 6.1 6.0 6.5 8.6 9.4 9.4 7.8 6.7 9.4 5.6 8.9 8.8 20.8 20.6 11.9 10.4 7.9 16.4 21.8 22.9 21.4 18.2 10.4 25.5 15.7 5.0 13.3 10.1 11.3 14.8 0.0 13.5 23.4 14.7 16.8 11.5 43.1 17.3 17.5 12.0 18.4 16.2 9.1 17.3 15.9 11.8 14.4 14.7 17.2 15.0 3.5 20.1 15.5 19.9 12.9 17.2 17.2 7.2 8.3 31.5 15.8 12.1 9.1 SLC34A1 "NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2" ENSG00000131183 "Solute carrier family 34 member 1" Q06495 5 177379235-177398848 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "kidney: 94.5" "Cell type enriched" "Detected in some" 16 "Proximal tubular cells: 128.7" "Cancer enriched" "Detected in single" 12 "renal cancer: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Group enriched" "Detected in some" 12 "HEL: 6.7;U-937: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051255, HPA077175" Approved Approved "Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol" Yes NA "Nuclear speckles, Plasma membrane" "Nucleoplasm, Mitotic spindle, Cytosol" "HPA051255: AB_2681409, HPA077175: " "unprognostic (1.17e-1)" "unprognostic (3.33e-3)" "unprognostic (1.49e-1)" "unprognostic (3.49e-2)" "unprognostic (1.56e-3)" "unprognostic (2.28e-1)" "unprognostic (4.50e-2)" "unprognostic (4.43e-3)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (5.95e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 7.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 SLC34A2 NAPI-3B ENSG00000157765 "Solute carrier family 34 member 2" O95436 4 25648011-25678748 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lung: 259.9;seminal vesicle: 69.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 443.7;Alveolar cells type 2: 1050.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 585.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 81 "BEWO: 12.6;EFO-21: 47.7;RPTEC TERT1: 34.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037989, HPA066474" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA037989: AB_10670536, HPA066474: " "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.38e-1)" "unprognostic (4.25e-2)" "unprognostic (7.33e-2)" "unprognostic (9.83e-2)" "unprognostic (2.37e-2)" "unprognostic (6.60e-3)" "unprognostic (6.27e-2)" "unprognostic (1.89e-2)" "unprognostic (5.77e-2)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (3.25e-1)" "unprognostic (6.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.93e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 3.2 0.2 0.1 13.0 0.1 0.0 24.7 2.9 6.9 2.1 0.5 13.0 3.4 0.1 0.1 0.1 10.8 0.5 259.9 0.0 0.1 0.0 2.9 4.4 0.0 0.6 2.6 0.8 0.3 0.0 1.6 27.4 69.1 0.1 0.7 2.1 0.0 0.1 0.1 0.4 0.5 0.0 0.4 27.9 0.1 1.9 0.0 0.1 0.4 0.2 1.9 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.9 0.5 0.2 0.3 0.3 0.1 0.2 0.1 0.1 0.0 0.4 0.3 0.2 1.5 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.8 0.0 443.7 1050.6 0.0 0.1 0.0 0.0 0.6 40.8 125.8 178.6 19.2 0.0 1.6 5.0 57.7 3.5 0.0 0.0 0.0 7.1 0.0 0.0 3.5 26.7 0.0 0.2 0.0 0.0 0.0 0.0 14.0 1.1 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 2.9 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 SLC34A3 "FLJ38680, NPTIIc" ENSG00000198569 "Solute carrier family 34 member 3" Q8N130 9 137230757-137236554 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 10.4;kidney: 14.8" "Cell type enriched" "Detected in some" 12 "Proximal tubular cells: 20.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.0;HDLM-2: 3.7;HeLa: 4.0;MCF7: 9.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA023776 Enhanced NA NA "HPA023776: AB_1857102" "unprognostic (2.69e-1)" "unprognostic (4.16e-1)" "unprognostic (9.08e-3)" "unprognostic (1.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-3)" "unprognostic (1.75e-2)" "unprognostic (1.05e-2)" "unprognostic (9.84e-3)" "unprognostic (2.05e-2)" "unprognostic (2.20e-2)" "unprognostic (5.94e-2)" "unprognostic (1.94e-2)" "unprognostic (9.12e-2)" "unprognostic (5.80e-2)" "unprognostic (2.20e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 3.6 0.5 0.2 0.2 0.2 0.0 14.8 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.0 1.6 0.2 0.2 0.2 0.0 0.2 1.2 0.2 0.2 0.3 10.4 0.2 0.2 0.2 0.4 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.7 2.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.5 6.0 0.4 0.2 0.0 0.1 3.0 0.0 0.0 0.0 3.7 0.2 0.0 4.0 2.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.4 0.7 0.0 9.7 0.1 0.1 0.6 1.1 1.2 1.3 0.5 0.0 0.0 0.5 0.0 1.5 0.6 1.4 0.3 0.7 3.4 0.1 0.4 0.5 0.4 1.9 0.1 1.1 0.5 0.4 0.8 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC35A1 "CMPST, hCST" ENSG00000164414 "Solute carrier family 35 member A1" P78382 6 87470623-87512336 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Mucus-secreting cells: 73.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.04e-2)" "unprognostic (1.93e-1)" "unprognostic (6.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.82e-1)" "unprognostic (4.07e-2)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (1.58e-2)" "unprognostic (3.01e-3)" "unprognostic (7.26e-2)" "unprognostic (3.85e-1)" "prognostic unfavorable (2.70e-6)" "unprognostic (2.85e-1)" "unprognostic (8.51e-2)" "unprognostic (5.48e-2)" "unprognostic (1.04e-1)" 11.0 18.0 14.0 9.2 19.8 6.3 20.5 24.1 22.9 19.2 25.3 10.0 8.0 12.0 20.1 15.1 10.0 13.6 12.7 10.6 15.2 13.8 15.7 20.8 24.2 10.3 16.3 11.6 15.8 11.6 13.0 24.4 12.6 21.4 24.9 31.6 13.1 19.4 11.4 9.1 15.9 14.5 18.9 12.2 14.0 18.8 8.1 14.5 18.6 14.2 8.2 11.8 17.4 12.0 9.4 24.6 21.6 28.4 8.7 15.1 17.2 2.0 5.0 9.1 10.7 24.9 22.8 7.3 6.1 5.4 5.1 7.1 4.3 37.8 7.6 7.5 7.5 14.2 8.1 10.9 4.9 6.6 10.8 8.1 8.6 6.8 7.6 16.4 11.1 6.0 11.6 12.0 6.0 11.8 12.1 12.2 11.2 11.0 12.6 7.5 19.0 3.0 16.9 4.9 26.0 8.2 9.6 8.9 8.1 15.8 8.8 6.0 6.6 11.2 21.1 9.7 10.9 18.7 22.9 11.3 7.4 5.0 8.1 4.9 9.4 13.6 2.8 6.2 19.9 10.5 21.6 28.4 11.6 9.8 22.1 15.1 9.4 10.6 11.9 24.6 8.7 13.6 12.6 7.0 8.7 21.5 9.1 13.6 17.2 14.0 19.8 24.1 22.9 15.2 13.8 16.3 11.6 21.4 14.5 41.7 25.2 6.9 15.8 13.2 6.9 5.2 17.8 16.0 10.3 15.7 11.8 20.9 6.6 8.2 5.8 14.3 15.8 0.0 7.9 15.9 17.7 17.6 21.8 17.4 14.5 11.1 14.5 47.3 30.6 4.9 15.3 13.6 20.3 10.8 73.6 18.1 8.5 14.0 18.0 9.3 6.4 19.4 16.5 7.5 9.7 12.9 23.0 13.8 25.5 7.4 SLC35A2 "UGALT, UGAT, UGT, UGT1, UGT2, UGTL" ENSG00000102100 "Solute carrier family 35 member A2" P78381 X 48903180-48911958 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036087 Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA036087: AB_10604093" "prognostic unfavorable (3.16e-4)" "unprognostic (3.34e-1)" "unprognostic (4.88e-3)" "unprognostic (1.11e-1)" "unprognostic (8.15e-3)" "unprognostic (4.25e-3)" "prognostic unfavorable (9.64e-5)" "unprognostic (3.47e-1)" "unprognostic (2.50e-1)" "unprognostic (1.63e-1)" "unprognostic (1.94e-3)" "unprognostic (9.58e-2)" "unprognostic (3.16e-2)" "prognostic favorable (8.23e-4)" "unprognostic (1.38e-1)" "unprognostic (1.61e-1)" "unprognostic (5.13e-2)" 11.4 17.2 10.5 9.7 12.2 10.9 21.9 5.9 18.4 16.2 22.7 20.5 13.4 13.5 11.5 24.2 17.2 23.1 14.3 12.8 10.3 10.9 18.8 43.6 14.5 18.9 12.0 9.7 10.6 30.6 18.8 16.2 29.8 12.7 14.1 23.1 10.3 16.9 14.7 12.9 15.9 13.0 9.0 13.8 12.1 19.8 8.8 10.3 8.8 13.3 12.5 13.0 11.3 11.4 7.5 18.5 24.2 15.7 7.8 10.9 6.9 20.5 23.7 8.1 11.5 17.4 14.1 11.9 21.2 20.7 21.2 25.6 25.5 36.3 7.7 10.1 23.2 29.0 29.6 21.8 16.3 17.6 10.2 14.7 8.5 14.9 19.9 20.3 16.2 18.4 15.0 27.6 18.7 17.7 12.1 12.4 11.1 16.1 12.8 15.7 19.5 7.9 13.4 16.8 23.1 28.9 8.5 14.5 23.6 19.2 16.8 9.4 15.2 22.1 24.0 12.1 15.9 35.2 12.7 8.9 12.8 13.1 23.0 11.9 20.0 13.6 8.5 15.5 13.3 15.8 11.4 14.4 24.2 10.2 15.7 10.9 7.5 9.2 9.6 17.5 7.3 5.8 10.6 15.9 7.8 10.6 18.5 8.8 6.9 10.5 12.2 5.9 18.4 10.3 10.9 12.0 9.7 12.7 10.3 8.9 17.1 6.7 10.5 12.6 4.5 4.2 10.2 20.1 6.8 15.7 0.0 27.3 3.3 23.0 2.5 11.9 18.8 23.3 28.6 22.7 14.8 16.6 2.3 14.9 21.4 6.4 12.2 12.3 10.1 1.0 9.2 11.9 10.1 30.7 30.3 9.4 20.7 17.5 10.3 10.5 4.6 6.5 7.3 5.6 4.1 15.3 40.2 9.6 17.4 22.6 SLC35A3 ENSG00000117620 "Solute carrier family 35 member A3" Q9Y2D2 1 99969351-100035637 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 139.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015253 Uncertain NA NA "HPA015253: AB_1857106" "unprognostic (1.05e-1)" "unprognostic (2.69e-1)" "unprognostic (1.57e-3)" "unprognostic (5.89e-2)" "unprognostic (9.64e-2)" "unprognostic (1.61e-1)" "unprognostic (1.72e-1)" "unprognostic (4.02e-2)" "unprognostic (2.59e-2)" "unprognostic (1.47e-1)" "unprognostic (1.76e-3)" "unprognostic (1.69e-1)" "unprognostic (1.02e-1)" "unprognostic (1.49e-3)" "unprognostic (2.32e-1)" "unprognostic (2.73e-2)" "unprognostic (9.34e-2)" 10.7 9.4 6.5 16.7 6.8 5.9 16.2 7.4 8.9 12.4 31.4 5.5 16.2 29.1 10.5 10.8 14.9 9.5 12.5 7.1 5.4 4.8 13.2 21.9 18.0 10.9 7.0 6.3 7.9 13.8 12.8 8.6 12.2 9.6 14.4 32.7 6.0 22.3 21.9 7.5 10.0 41.0 15.3 7.6 6.3 19.9 5.1 5.6 24.7 15.3 7.9 8.1 13.9 13.0 4.3 9.0 6.4 3.7 7.7 5.2 3.2 17.4 4.7 4.3 4.5 9.8 8.6 17.3 15.6 9.5 6.2 9.0 3.1 9.5 9.4 19.6 9.0 8.7 10.1 8.1 7.0 14.2 11.5 5.9 8.5 6.7 7.4 6.2 13.5 1.0 4.6 7.9 7.4 14.6 7.4 7.1 7.5 14.0 14.1 12.5 4.3 8.9 7.1 5.3 10.0 15.9 2.8 13.2 5.9 11.3 10.1 5.6 3.1 10.8 20.9 8.2 4.2 12.7 10.3 8.2 9.4 8.5 20.7 8.3 8.4 9.8 7.0 15.0 8.5 3.9 6.4 3.6 2.0 4.2 3.7 4.7 4.3 4.2 4.9 3.1 3.4 5.2 4.4 1.2 7.7 2.9 9.0 4.8 3.2 6.5 6.8 7.4 8.9 5.4 4.8 7.0 6.3 9.6 5.6 74.5 25.8 14.7 19.1 22.1 16.3 7.4 22.9 64.3 35.2 52.4 19.6 15.3 6.6 14.1 3.5 17.5 139.9 0.0 13.4 24.2 13.2 46.0 16.2 42.7 12.4 9.5 19.0 23.9 17.4 0.0 12.4 12.9 8.5 9.0 96.8 16.0 18.6 71.9 12.4 28.5 22.5 6.5 15.1 11.9 5.7 26.0 19.5 21.8 78.5 31.8 SLC35A4 ENSG00000176087 "Solute carrier family 35 member A4" "L0R6Q1, Q96G79" 5 140564456-140569103 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062210 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA062210: AB_2684712" "unprognostic (3.01e-3)" "unprognostic (1.35e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-2)" "unprognostic (1.91e-3)" "unprognostic (9.63e-2)" "unprognostic (3.61e-2)" "unprognostic (9.32e-2)" "unprognostic (1.78e-2)" "unprognostic (2.87e-1)" "prognostic favorable (4.56e-5)" "unprognostic (2.96e-2)" "unprognostic (3.04e-2)" "unprognostic (2.06e-2)" "unprognostic (1.55e-1)" 22.0 30.4 12.3 18.6 17.1 8.4 19.6 14.0 21.8 18.2 25.5 24.9 22.6 19.2 18.2 19.8 30.3 20.6 26.0 25.7 13.1 10.3 35.1 39.2 23.1 22.5 16.0 11.1 19.0 28.3 28.2 14.9 24.6 19.4 20.4 26.5 20.5 32.6 15.9 54.3 28.3 30.6 19.8 13.0 28.5 21.7 30.5 15.3 26.0 29.2 28.0 27.5 18.3 18.0 15.4 32.8 15.8 36.9 26.9 27.6 32.4 15.5 46.7 18.7 35.2 25.7 16.1 27.9 22.7 15.3 27.7 29.2 56.5 18.0 46.0 28.1 21.3 32.3 17.2 0.0 33.1 23.8 55.9 25.6 34.4 45.6 0.2 18.3 33.6 26.0 21.3 25.9 27.5 24.7 13.0 23.7 22.8 26.6 46.5 27.4 28.8 35.0 14.6 12.7 22.4 23.9 26.1 37.9 39.9 20.7 30.8 20.9 27.9 28.7 47.8 22.3 19.2 39.7 14.4 27.7 24.9 17.4 24.7 25.4 19.3 45.3 19.3 18.4 38.0 28.9 7.5 26.9 15.8 27.6 36.9 26.3 14.3 22.1 24.7 32.8 15.4 25.9 23.0 9.9 26.9 33.3 12.0 14.7 32.4 12.3 17.1 14.0 21.8 13.1 10.3 16.0 11.1 19.4 15.3 11.9 24.8 21.9 20.2 9.3 12.2 23.8 43.3 6.7 17.0 15.7 3.9 26.8 38.1 28.1 58.7 14.7 37.1 0.0 30.4 42.8 19.5 22.2 20.7 19.5 28.5 12.7 24.2 27.6 21.1 94.4 11.5 15.8 16.9 31.5 27.2 20.3 31.1 21.0 11.7 31.1 8.5 32.3 12.6 5.4 16.4 10.2 25.5 20.3 28.7 29.1 SLC35A5 FLJ20730 ENSG00000138459 "Solute carrier family 35 member A5" Q9BS91 3 112561709-112585577 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035519, HPA057964" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA035519: AB_10601487, HPA057964: AB_2683566" "unprognostic (7.89e-2)" "unprognostic (2.33e-1)" "unprognostic (7.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (7.09e-2)" "unprognostic (1.45e-1)" "unprognostic (4.78e-2)" "unprognostic (8.60e-3)" "unprognostic (2.60e-1)" "unprognostic (8.21e-2)" "unprognostic (3.51e-1)" "prognostic favorable (4.10e-5)" "unprognostic (2.26e-1)" "unprognostic (1.97e-1)" "unprognostic (8.05e-2)" "unprognostic (3.42e-1)" 13.4 17.7 19.4 11.2 22.1 4.4 13.0 14.2 24.1 15.0 13.6 32.7 9.7 14.9 15.2 15.0 13.0 13.3 13.8 9.6 22.9 22.0 18.2 18.0 12.8 12.4 37.8 19.5 16.9 12.6 17.9 17.6 17.2 27.5 14.8 14.8 14.4 11.7 13.4 5.5 8.0 15.5 14.1 42.9 12.7 12.5 15.4 26.6 11.6 23.8 6.4 13.1 13.2 10.4 12.0 15.2 15.7 20.1 5.2 11.5 7.8 11.3 10.3 17.6 10.7 23.1 22.0 10.2 18.5 13.5 16.0 18.3 7.6 13.0 10.3 15.9 16.2 18.1 14.3 12.8 8.9 20.1 7.7 6.3 12.9 9.9 6.7 19.1 11.5 12.4 19.1 17.8 14.1 8.7 20.1 14.2 7.9 7.4 12.7 21.9 4.0 8.7 7.3 11.9 13.0 11.0 7.7 6.6 10.6 19.7 8.5 10.3 14.0 12.0 5.9 21.0 12.7 7.9 8.1 15.9 23.3 12.8 5.0 8.5 8.9 12.8 17.9 17.3 9.6 17.0 8.4 12.6 15.7 8.9 19.8 8.3 12.0 8.5 7.0 15.2 11.5 11.5 9.4 11.2 5.2 20.1 7.2 8.4 7.8 19.4 22.1 14.2 24.1 22.9 22.0 37.8 19.5 27.5 26.6 3.0 8.5 10.0 7.0 5.7 12.3 4.7 10.2 5.3 6.8 14.0 0.0 30.6 8.3 6.8 94.9 12.4 12.4 0.0 6.7 20.1 15.1 7.4 13.9 10.2 15.8 35.0 7.5 12.9 19.1 17.6 15.8 9.1 25.3 11.8 10.7 18.5 6.5 12.9 16.3 12.3 14.0 25.8 9.9 15.4 10.0 5.8 24.9 10.9 8.5 2.7 SLC35B1 UGTREL1 ENSG00000121073 "Solute carrier family 35 member B1" P78383 17 49700943-49709014 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048655, HPA057418" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA048655: AB_2680481, HPA057418: AB_2683432" "unprognostic (1.35e-1)" "unprognostic (2.15e-2)" "unprognostic (1.09e-3)" "unprognostic (6.36e-2)" "unprognostic (8.31e-2)" "unprognostic (2.86e-3)" "unprognostic (6.17e-3)" "unprognostic (4.39e-2)" "unprognostic (2.47e-2)" "unprognostic (4.00e-3)" "unprognostic (3.37e-2)" "unprognostic (4.42e-2)" "prognostic unfavorable (5.69e-7)" "unprognostic (6.28e-2)" "unprognostic (7.88e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-2)" 8.5 8.3 8.4 7.4 11.8 8.0 10.7 8.2 14.0 9.3 13.0 9.3 9.2 13.7 7.6 26.5 9.4 9.9 7.3 15.8 8.6 9.2 16.0 46.7 10.1 16.0 9.8 7.9 7.5 22.3 13.5 13.2 12.4 9.9 7.4 13.1 8.4 22.4 12.7 33.7 9.2 27.3 8.0 8.1 10.2 9.3 9.1 7.1 6.5 19.7 13.8 10.8 9.9 6.7 6.6 25.0 8.1 15.1 7.0 9.5 7.9 13.6 22.9 17.2 27.0 15.8 9.9 19.5 14.5 23.6 30.9 24.8 47.3 16.0 9.5 34.0 20.1 18.6 10.2 27.1 17.3 33.9 11.6 19.8 12.0 15.1 27.7 27.6 22.5 11.4 10.1 19.0 22.2 27.8 7.9 19.0 15.6 11.7 27.4 21.2 27.8 16.5 14.6 7.6 25.6 25.9 11.1 18.6 25.7 15.1 14.5 14.9 19.1 8.5 6.8 9.9 19.3 21.8 15.4 8.1 23.6 10.5 25.2 19.0 14.5 23.8 14.2 15.4 17.1 20.6 8.1 15.1 5.0 9.5 13.5 6.9 6.6 6.5 8.9 16.7 3.6 6.6 6.0 6.7 7.0 9.1 25.0 7.4 7.9 8.4 11.8 8.2 14.0 8.6 9.2 9.8 7.9 9.9 7.1 14.9 27.2 30.7 36.3 19.8 25.8 35.5 20.4 30.8 31.8 26.2 33.4 49.1 29.9 55.6 40.4 35.0 41.9 0.0 89.2 91.8 36.1 53.6 41.5 49.5 66.9 20.6 48.6 22.7 21.3 11.3 27.9 37.0 35.4 45.9 30.5 41.4 64.2 27.5 19.4 37.9 30.4 12.9 15.3 44.2 33.8 22.0 67.3 35.2 36.0 37.4 SLC35B2 UGTrel4 ENSG00000157593 "Solute carrier family 35 member B2" Q8TB61 6 44254096-44257890 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029638 Approved Approved Vesicles NA NA Vesicles "HPA029638: AB_10602402" "prognostic unfavorable (7.90e-4)" "unprognostic (2.47e-3)" "unprognostic (2.30e-1)" "unprognostic (1.39e-2)" "unprognostic (2.36e-1)" "unprognostic (1.65e-2)" "prognostic unfavorable (8.59e-5)" "unprognostic (3.84e-1)" "unprognostic (2.51e-1)" "unprognostic (7.03e-3)" "unprognostic (4.27e-2)" "prognostic favorable (6.07e-4)" "unprognostic (3.60e-2)" "unprognostic (1.13e-1)" "unprognostic (4.07e-1)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" 18.0 28.2 14.8 12.6 15.0 10.7 17.7 16.2 24.8 18.3 18.9 35.8 19.0 13.0 22.6 23.4 14.3 18.6 27.1 17.7 15.2 10.9 32.3 35.5 16.1 12.9 17.1 14.6 16.7 38.1 27.4 11.1 26.1 19.8 19.0 20.2 23.8 49.6 20.4 17.5 15.6 16.4 20.5 24.7 18.4 20.6 16.3 18.7 12.2 19.3 17.8 17.6 19.6 14.3 12.9 14.4 21.8 8.6 10.8 21.1 10.2 23.1 13.3 16.7 32.0 27.5 29.1 12.2 25.4 42.1 25.0 30.8 11.7 21.6 5.2 22.9 31.4 26.9 22.1 11.4 28.6 17.6 15.3 14.7 10.4 10.5 13.9 25.7 22.2 17.0 29.8 30.1 23.0 11.3 34.6 18.3 11.9 14.9 22.4 29.9 27.2 8.2 18.6 7.4 69.9 15.5 8.2 10.8 26.4 27.0 17.2 20.8 20.0 12.5 13.9 28.6 10.9 25.8 20.4 18.1 19.7 13.1 19.6 22.1 17.3 19.7 12.1 26.3 17.7 40.0 21.8 8.6 13.2 21.1 6.5 17.8 12.9 11.9 16.1 7.7 7.7 11.0 14.2 0.7 10.8 2.3 14.4 9.6 10.2 14.8 15.0 16.2 24.8 15.2 10.9 17.1 14.6 19.8 18.7 6.0 11.5 22.3 25.5 11.9 9.7 6.7 43.3 5.3 11.4 26.2 2.0 50.8 11.6 69.2 0.4 9.8 13.7 0.0 64.7 44.1 30.6 27.0 34.6 15.3 32.9 9.5 18.9 16.0 9.9 1.2 21.6 10.0 50.6 32.5 20.3 42.2 56.9 27.4 18.7 11.5 12.5 0.0 16.7 15.2 67.3 12.2 29.4 13.1 29.9 18.4 SLC35B3 "C6orf196, CGI-19, dJ453H5.1, PAPST2" ENSG00000124786 "Solute carrier family 35 member B3" Q9H1N7 6 8413068-8435611 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054661, HPA057801" Approved NA NA "HPA054661: AB_2682561, HPA057801: AB_2683532" "unprognostic (2.84e-1)" "unprognostic (1.52e-1)" "unprognostic (1.10e-2)" "unprognostic (1.34e-1)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (1.19e-1)" "unprognostic (4.93e-2)" "unprognostic (5.23e-3)" "unprognostic (5.00e-2)" "unprognostic (9.45e-2)" "unprognostic (9.27e-2)" "unprognostic (3.43e-1)" "unprognostic (2.32e-1)" "unprognostic (2.20e-1)" "unprognostic (3.08e-3)" "unprognostic (3.88e-3)" 12.2 12.1 12.1 11.3 22.6 4.0 13.7 11.4 15.8 14.2 23.5 12.5 27.0 16.0 11.9 43.2 12.4 10.9 16.3 12.3 13.5 10.2 18.5 22.2 12.6 12.5 20.0 11.9 10.2 22.0 17.6 16.0 18.7 15.9 14.6 24.7 8.5 19.0 35.4 6.4 13.0 27.1 10.8 20.5 16.4 18.3 9.6 17.5 13.1 20.1 10.0 13.3 15.9 14.9 10.4 9.7 10.2 13.7 19.7 13.0 8.8 11.3 7.5 8.4 12.9 19.3 24.9 6.2 26.0 21.4 9.7 12.9 23.0 10.0 8.8 16.9 19.5 14.2 7.9 8.0 7.2 15.6 13.6 8.6 4.3 5.4 11.5 19.5 7.6 10.4 18.5 11.1 11.0 11.7 13.7 12.9 6.3 9.7 3.6 19.7 9.0 4.9 9.1 5.6 13.0 8.1 4.8 7.2 10.0 23.3 11.4 8.0 6.5 7.8 5.6 12.6 22.5 4.8 13.3 13.0 17.0 4.8 10.9 12.3 9.7 17.3 6.0 8.8 7.2 20.2 10.2 10.1 9.1 10.6 8.9 13.0 8.2 11.1 11.4 9.7 10.4 12.9 10.8 9.5 19.7 13.7 4.6 12.0 8.8 12.1 22.6 11.4 15.8 13.5 10.2 20.0 11.9 15.9 17.5 6.0 11.7 8.1 11.9 11.9 4.2 8.8 15.3 26.8 10.3 27.9 3.9 18.1 6.6 17.9 5.2 15.8 24.7 0.0 21.6 24.2 23.9 20.6 5.8 22.4 17.4 9.5 14.3 19.0 15.5 5.9 14.4 10.1 20.3 17.2 40.9 5.1 15.7 35.3 11.3 22.6 2.7 12.9 18.6 32.1 17.7 15.4 13.7 8.7 28.3 18.2 SLC35B4 "FLJ14697, YEA4" ENSG00000205060 "Solute carrier family 35 member B4" Q969S0 7 134289332-134317051 "Predicted membrane proteins" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 50.1;Cytotrophoblasts: 73.7;Syncytiotrophoblasts: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049779 Approved NA NA "HPA049779: AB_2680878" "unprognostic (1.84e-1)" "unprognostic (1.94e-2)" "unprognostic (7.19e-2)" "unprognostic (2.49e-2)" "unprognostic (1.77e-3)" "unprognostic (3.47e-2)" "unprognostic (3.23e-2)" "unprognostic (1.25e-2)" "unprognostic (1.57e-1)" "unprognostic (3.32e-2)" "unprognostic (6.88e-3)" "unprognostic (1.86e-1)" "unprognostic (2.24e-3)" "unprognostic (3.18e-2)" "unprognostic (2.86e-1)" "unprognostic (9.81e-2)" "unprognostic (1.00e-1)" 7.8 10.1 9.6 7.4 16.8 2.7 5.3 22.4 21.6 6.8 5.4 10.8 4.8 4.5 9.4 10.1 5.0 6.8 6.1 4.0 10.1 12.4 15.9 11.6 5.1 6.3 9.4 9.6 10.3 4.0 6.4 6.7 17.5 12.7 8.4 5.7 9.9 3.8 10.0 3.5 4.9 5.9 10.8 8.6 6.5 5.2 6.9 8.6 6.8 5.4 2.0 7.2 6.4 4.3 3.2 6.5 1.3 4.6 4.0 5.7 2.9 3.8 12.8 11.3 16.8 11.0 9.3 5.8 9.7 8.1 8.6 7.3 4.9 3.6 12.9 3.3 10.4 11.3 4.1 16.6 8.6 14.4 8.1 12.4 8.7 7.5 6.5 8.1 12.2 7.9 8.1 3.7 10.3 8.8 6.5 8.3 9.0 8.4 4.8 12.9 3.4 10.8 9.0 23.3 3.9 11.6 7.9 9.9 6.3 4.8 4.7 4.0 23.2 8.6 2.9 10.6 9.8 1.6 7.0 9.2 11.3 3.7 6.7 9.5 15.9 21.8 15.0 20.1 11.6 12.9 1.3 3.4 0.7 3.8 4.6 5.7 3.1 3.5 4.7 6.5 3.2 3.4 5.0 0.4 4.0 3.5 4.5 3.7 2.9 9.6 16.8 22.4 21.6 10.1 12.4 9.4 9.6 12.7 8.6 8.9 4.8 6.4 4.8 1.9 50.1 5.3 7.6 8.1 9.1 1.8 43.2 73.7 10.0 7.7 1.5 8.7 3.1 0.0 4.6 21.6 9.3 4.4 1.1 14.4 18.3 39.7 4.1 4.9 8.6 2.9 10.3 8.6 5.0 3.6 3.8 16.4 6.9 3.1 11.7 13.6 20.5 6.5 4.2 10.8 21.7 2.9 69.6 7.1 3.1 3.4 SLC35C1 "FLJ11320, FUCT1" ENSG00000181830 "Solute carrier family 35 member C1" Q96A29 11 45804072-45813015 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.7" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 49.8;Enterocytes: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064001 Enhanced Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA064001: AB_2685171" "unprognostic (2.62e-2)" "unprognostic (5.16e-2)" "unprognostic (7.82e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (8.22e-2)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "unprognostic (4.09e-2)" "unprognostic (2.73e-1)" "unprognostic (7.68e-2)" "unprognostic (1.83e-3)" "unprognostic (2.18e-1)" "prognostic favorable (3.64e-4)" "unprognostic (2.30e-2)" 14.9 4.8 5.1 7.2 4.5 1.5 14.3 4.4 7.3 7.0 13.8 4.4 4.9 17.4 7.1 3.2 22.5 6.1 8.8 5.3 5.4 3.9 6.0 74.7 7.1 7.1 3.9 3.6 4.9 11.4 4.9 7.8 10.5 5.6 6.0 9.8 3.6 15.5 7.0 8.5 3.4 17.4 6.8 5.0 6.5 13.4 7.4 4.8 5.6 5.2 7.0 10.9 9.4 8.6 4.7 8.3 9.9 10.5 4.3 16.7 8.6 5.2 13.7 3.1 8.0 10.2 10.3 10.5 11.6 10.0 6.7 7.5 6.2 8.7 5.0 5.5 13.1 10.0 14.0 6.5 6.8 3.2 13.0 7.8 2.8 11.0 11.2 22.4 5.5 8.7 12.3 8.2 5.1 5.6 8.1 8.8 5.1 6.3 7.5 7.1 11.5 2.8 4.2 13.9 19.4 19.4 3.8 5.2 11.8 7.5 13.3 3.1 4.5 8.6 8.3 4.7 3.4 7.4 2.9 13.3 14.1 8.2 24.8 8.2 5.5 12.9 2.5 10.1 7.2 7.7 5.0 10.2 9.9 10.2 10.5 11.1 4.7 16.7 13.4 8.3 3.6 8.5 7.4 1.6 4.3 6.9 7.2 10.8 8.6 5.1 4.5 4.4 7.3 5.4 3.9 3.9 3.6 5.6 4.8 0.0 9.1 3.0 8.5 3.2 1.7 49.8 25.5 8.1 4.5 5.2 2.0 12.0 0.0 18.1 3.4 7.6 46.6 0.0 37.1 12.3 11.0 8.0 2.3 37.2 13.3 3.2 9.2 6.7 7.1 4.1 6.1 5.3 1.7 9.0 30.4 2.5 36.3 43.2 5.3 3.5 1.0 0.0 5.2 4.3 3.3 2.0 12.8 5.2 19.9 16.9 SLC35C2 "bA394O2.1, C20orf5, CGI-15, OVCOV1" ENSG00000080189 "Solute carrier family 35 member C2" Q9NQQ7 20 46345980-46364458 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027011 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA027011: AB_2672082" "unprognostic (7.25e-2)" "unprognostic (1.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.27e-2)" "unprognostic (1.06e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.34e-1)" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (4.05e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.68e-4)" "unprognostic (9.31e-2)" "unprognostic (7.15e-2)" "unprognostic (1.18e-2)" "unprognostic (3.88e-1)" 16.8 25.9 19.4 26.7 24.0 25.6 17.5 30.3 25.0 19.1 19.3 22.8 21.3 22.0 19.2 20.9 23.4 24.3 20.2 13.5 19.0 12.9 20.7 26.7 17.4 22.9 19.9 13.6 21.0 30.5 18.0 23.7 29.8 17.7 23.6 12.2 28.9 30.9 17.3 13.4 25.6 20.7 15.8 19.3 26.1 21.6 19.6 23.3 19.7 23.0 13.5 23.4 19.1 19.3 17.4 42.9 26.8 21.9 18.3 28.3 23.5 14.3 17.4 8.1 6.4 11.3 10.9 15.0 7.8 14.9 8.8 10.5 24.3 22.9 9.6 26.8 9.3 11.9 20.3 4.6 17.7 3.3 7.8 13.6 8.5 10.6 19.4 21.5 11.0 10.1 15.7 22.7 12.5 14.6 9.7 7.3 10.6 13.3 17.7 6.5 34.8 7.8 16.5 10.5 15.4 16.9 7.3 8.7 18.6 11.1 14.2 12.0 16.6 7.3 38.1 24.4 5.2 22.5 19.3 7.0 22.7 14.5 11.4 12.4 23.7 19.4 9.9 25.7 12.6 10.1 19.0 21.9 26.8 23.8 21.5 22.2 17.4 24.4 24.0 23.9 16.9 28.3 25.5 19.5 18.3 16.7 42.9 22.1 23.5 19.4 24.0 30.3 25.0 19.0 12.9 19.9 13.6 17.7 23.3 14.9 15.5 28.6 25.7 12.8 31.2 5.9 17.8 12.0 18.2 26.2 39.3 80.2 11.6 34.0 4.6 13.5 26.5 0.0 53.8 43.9 23.9 32.4 14.9 23.7 33.9 17.5 20.2 28.3 19.1 4.3 17.8 17.0 20.3 45.1 31.2 21.9 31.3 30.6 18.0 15.4 29.4 19.4 14.4 15.6 21.0 14.4 66.2 25.9 27.7 28.5 SLC35D1 "KIAA0260, UGTREL7" ENSG00000116704 "Solute carrier family 35 member D1" Q9NTN3 1 66999332-67054099 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.4" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.91e-2)" "unprognostic (3.69e-2)" "unprognostic (1.20e-3)" "prognostic unfavorable (7.47e-4)" "unprognostic (2.63e-1)" "unprognostic (6.53e-2)" "unprognostic (2.49e-2)" "prognostic unfavorable (6.55e-4)" "unprognostic (2.12e-3)" "unprognostic (6.39e-2)" "unprognostic (6.75e-2)" "unprognostic (2.07e-1)" "unprognostic (7.65e-2)" "unprognostic (1.55e-1)" "unprognostic (2.43e-1)" "unprognostic (4.08e-3)" "unprognostic (3.20e-1)" 4.0 6.3 5.1 7.5 7.0 4.7 4.7 6.6 5.5 6.2 16.2 7.5 4.8 9.9 5.4 3.8 5.3 4.4 4.4 3.8 4.7 3.8 8.1 50.4 3.8 5.7 7.4 4.0 6.4 7.2 6.4 8.7 6.0 5.4 5.6 17.3 7.1 3.9 4.0 6.9 6.2 14.3 5.4 4.0 4.0 8.0 4.1 5.6 11.1 5.1 4.0 6.4 5.8 6.5 2.3 1.8 9.7 2.4 5.1 4.3 1.4 5.0 2.9 8.9 7.5 9.3 10.8 10.6 11.3 15.0 8.2 5.8 6.2 1.2 15.6 5.0 8.9 9.7 7.7 6.1 7.2 10.4 15.5 2.8 11.6 6.1 12.2 7.8 13.1 7.7 10.5 16.1 9.7 6.9 13.3 3.1 6.6 7.0 8.3 19.9 1.7 8.0 4.1 3.7 13.6 4.0 6.2 18.4 1.7 3.8 9.6 1.1 4.0 17.1 5.3 7.2 5.2 4.4 9.8 3.4 15.4 3.6 9.4 10.8 17.4 9.0 8.7 11.0 2.0 6.5 9.7 1.5 4.0 3.4 1.1 4.2 2.3 2.6 2.7 1.8 1.7 3.7 3.3 0.3 5.1 2.4 1.0 4.3 1.4 5.1 7.0 6.6 5.5 4.7 3.8 7.4 4.0 5.4 5.6 6.0 2.1 4.3 4.7 4.8 6.9 2.6 33.1 6.7 2.3 5.2 11.8 30.4 0.0 2.8 37.3 4.2 36.7 23.3 8.6 4.0 7.2 5.6 4.6 84.4 6.2 6.4 14.5 6.7 9.2 6.6 5.8 3.8 1.7 1.0 14.9 21.0 7.2 14.4 4.2 8.4 8.7 0.0 3.9 7.6 6.7 6.8 13.6 6.9 13.4 7.4 SLC35D2 "SQV7L, UGTrel8" ENSG00000130958 "Solute carrier family 35 member D2" Q76EJ3 9 96320706-96383710 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 37.6" HPA064047 Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA064047: AB_2685182" "unprognostic (3.67e-1)" "unprognostic (5.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.16e-2)" "unprognostic (3.17e-1)" "unprognostic (8.86e-3)" "unprognostic (4.25e-3)" "unprognostic (2.24e-2)" "unprognostic (4.12e-1)" "unprognostic (5.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.63e-1)" "unprognostic (1.74e-2)" "unprognostic (1.33e-2)" "unprognostic (2.04e-1)" "unprognostic (1.99e-2)" "unprognostic (1.44e-1)" 8.7 6.1 5.9 7.8 13.6 4.6 8.8 1.6 10.8 7.9 23.8 21.2 4.2 30.7 8.3 8.7 8.7 7.8 16.2 7.3 7.8 5.2 20.1 27.9 13.2 17.6 13.7 4.7 10.5 26.0 8.0 5.1 10.5 9.2 8.0 22.6 13.1 8.5 5.3 2.8 5.7 39.6 11.2 14.3 6.5 18.7 5.1 9.8 2.7 14.3 5.0 7.5 10.0 8.0 1.5 2.4 1.6 1.4 1.9 5.3 1.0 11.3 8.9 5.6 11.5 7.1 14.7 10.6 5.1 10.8 7.9 6.7 18.2 37.6 0.2 8.5 4.5 18.6 16.5 7.7 8.0 7.0 5.3 6.3 4.1 3.7 31.2 10.5 0.0 0.0 12.0 9.5 6.1 17.4 15.6 17.2 0.0 7.6 0.1 8.7 7.7 0.0 0.0 4.9 21.2 10.3 0.0 0.0 0.0 18.8 6.9 2.1 13.1 4.4 8.9 22.6 19.4 5.6 8.2 15.3 5.5 5.9 7.9 4.9 0.0 0.3 0.0 11.3 0.0 7.5 1.6 1.4 1.0 1.8 1.0 2.4 1.5 2.2 3.5 2.4 0.3 0.7 1.7 0.1 1.9 0.8 0.1 5.3 1.0 5.9 13.6 1.6 10.8 7.8 5.2 13.7 4.7 9.2 9.8 8.9 8.3 0.9 7.2 4.6 0.5 6.9 30.6 6.7 5.7 12.2 2.0 23.1 10.0 6.1 0.1 11.3 52.6 0.0 21.1 37.7 5.0 13.5 4.6 41.4 17.3 1.6 9.2 10.4 16.1 0.2 10.0 9.4 16.9 7.2 45.1 7.7 22.3 38.6 5.6 18.0 3.5 12.9 7.6 1.5 1.9 4.6 22.2 8.4 27.7 13.9 SLC35D3 FRCL1 ENSG00000182747 "Solute carrier family 35 member D3" Q5M8T2 6 136922264-136925639 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.9;retina: 16.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.3" "Group enriched" "Detected in some" 4 "basal ganglia: 9.9;hypothalamus: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 18.7" "Group enriched" "Detected in many" 5 "basal ganglia: 26.6;olfactory region: 10.4" "Region enriched" "Detected in many" 6 "basal ganglia: 24.4" "HPA030431, HPA067497" Uncertain Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA030431: AB_10601716, HPA067497: AB_2685854" "unprognostic (6.56e-2)" "unprognostic (2.97e-1)" "unprognostic (1.43e-1)" "unprognostic (5.45e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-2)" "unprognostic (2.48e-1)" "unprognostic (9.94e-2)" "unprognostic (7.36e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (4.45e-1)" "unprognostic (1.03e-1)" 0.1 4.9 0.0 0.4 9.9 1.2 0.1 0.0 0.4 2.0 0.4 0.4 0.0 0.7 0.1 0.0 0.6 0.1 0.1 0.4 0.0 4.8 4.0 0.0 2.1 0.0 1.7 0.0 0.8 1.2 0.0 0.0 0.1 0.5 4.3 0.6 16.4 0.2 0.1 0.0 0.2 1.3 0.3 0.0 0.2 3.2 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 18.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 9.9 0.0 0.4 0.0 4.8 1.7 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 SLC35E1 FLJ14251 ENSG00000127526 "Solute carrier family 35 member E1" Q96K37 19 16549831-16572382 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016570, HPA062214" Approved Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA016570: AB_2190214, HPA062214: AB_2684713" "unprognostic (1.76e-2)" "unprognostic (2.81e-1)" "unprognostic (7.31e-2)" "unprognostic (2.92e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.35e-2)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (9.07e-2)" "unprognostic (3.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.21e-2)" "unprognostic (1.27e-1)" "unprognostic (2.54e-1)" "unprognostic (3.75e-2)" 15.2 12.7 11.9 9.3 12.3 10.3 13.5 11.7 19.2 15.1 12.4 8.7 22.4 9.7 11.3 10.3 14.2 11.2 13.7 12.6 9.3 9.7 11.6 20.1 13.5 9.5 8.3 7.9 11.9 34.5 25.8 14.4 23.9 10.7 17.9 9.4 11.4 23.7 21.4 23.1 14.3 13.4 10.0 5.9 9.7 17.0 6.4 7.2 14.0 13.8 12.3 13.9 15.2 14.1 5.9 3.2 7.9 5.0 4.5 5.2 2.9 17.9 7.1 5.1 11.3 19.0 14.8 12.0 13.1 14.0 10.7 12.7 8.3 12.9 9.4 21.1 20.3 10.6 12.0 13.8 14.6 12.3 10.7 20.0 8.5 8.2 9.8 15.2 14.0 10.3 11.8 17.3 11.9 17.8 14.0 10.3 10.9 13.1 12.7 14.2 17.0 10.2 6.5 5.9 16.7 24.1 9.9 7.8 11.0 11.0 11.6 8.6 8.5 9.0 14.5 8.0 6.6 10.1 6.9 11.3 14.3 7.1 19.3 15.0 16.5 17.5 10.6 21.2 14.9 8.8 5.0 3.9 7.9 4.1 2.5 5.2 5.9 4.3 3.6 2.7 2.8 3.2 2.5 4.8 4.5 5.0 3.2 4.8 2.9 11.9 12.3 11.7 19.2 9.3 9.7 8.3 7.9 10.7 7.2 35.7 43.9 15.8 12.5 19.5 27.6 13.7 33.1 14.7 33.0 27.9 33.4 10.8 0.0 17.8 2.8 14.6 18.1 0.0 31.7 22.5 12.7 25.9 8.1 24.2 15.2 28.6 17.7 23.4 21.8 2.7 15.8 19.4 8.5 8.2 25.5 20.8 33.5 14.0 19.8 8.6 25.4 6.5 12.3 10.9 15.4 22.6 27.2 20.2 15.5 26.8 SLC35E2 KIAA0447 ENSG00000215790 "Solute carrier family 35 member E2" P0CK97 1 1724838-1745999 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 22.1;Ciliated cells: 10.7;Club cells: 11.4;Horizontal cells: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA006118, HPA062711" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA006118: , HPA062711: AB_2684844" "unprognostic (3.03e-1)" "unprognostic (2.56e-1)" "unprognostic (4.54e-3)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (1.28e-4)" "unprognostic (9.52e-4)" "unprognostic (6.57e-2)" "unprognostic (2.36e-1)" "unprognostic (1.28e-1)" "unprognostic (9.15e-3)" "unprognostic (4.86e-1)" "unprognostic (2.05e-1)" "unprognostic (2.83e-1)" "unprognostic (8.41e-2)" "unprognostic (2.43e-3)" "unprognostic (4.87e-4)" 3.0 4.1 8.0 5.2 5.1 0.6 3.0 9.8 6.2 4.0 3.0 2.9 1.6 4.9 6.0 10.5 4.5 5.8 7.6 3.0 5.0 3.5 2.5 2.4 4.8 11.6 4.4 4.7 5.5 3.5 6.9 5.9 3.5 4.0 3.6 5.4 3.6 9.1 1.6 4.7 6.4 4.8 3.7 3.7 6.8 6.2 6.2 5.5 5.5 3.5 3.8 4.3 4.3 7.7 5.0 5.2 6.4 3.4 3.1 6.5 3.2 1.6 1.6 5.4 11.5 11.2 11.0 3.6 7.4 15.3 7.0 9.0 4.6 15.1 4.9 1.3 1.7 1.7 7.5 1.4 2.9 7.6 6.8 1.7 6.4 7.5 1.2 2.3 1.3 7.2 8.8 3.7 1.2 6.3 5.8 2.1 9.2 2.1 2.2 1.3 1.2 1.9 3.2 1.0 0.9 1.9 3.7 5.0 1.0 7.4 5.3 15.2 3.1 2.2 9.2 8.8 1.3 17.9 3.6 9.6 7.3 1.5 2.2 0.4 3.0 0.4 1.6 5.2 3.9 1.2 6.4 3.4 2.1 5.5 2.6 6.5 4.5 4.8 5.3 1.5 5.0 5.5 4.8 4.0 3.1 1.6 5.2 4.5 3.2 8.0 5.1 9.8 6.2 5.0 3.5 4.4 4.7 4.0 5.5 26.8 22.1 0.0 0.5 0.5 5.1 0.0 2.5 10.7 11.4 0.0 2.0 0.8 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.4 1.0 0.4 2.3 0.8 0.6 12.7 0.0 1.8 0.6 0.0 2.8 0.3 0.0 0.0 0.7 1.2 0.0 0.0 3.2 0.0 3.9 0.0 0.0 0.7 1.3 1.5 0.2 4.9 1.2 0.4 SLC35E2B ENSG00000189339 "Solute carrier family 35 member E2B" P0CK96 1 1659529-1692728 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045641, HPA062711" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045641: AB_2679402, HPA062711: AB_2684844" "unprognostic (9.00e-2)" "unprognostic (2.13e-1)" "unprognostic (8.74e-3)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "prognostic favorable (7.64e-4)" "unprognostic (1.18e-1)" "unprognostic (4.09e-2)" "unprognostic (5.70e-2)" "unprognostic (5.83e-2)" "unprognostic (2.04e-2)" "unprognostic (2.20e-1)" "unprognostic (2.92e-1)" "unprognostic (2.68e-2)" "unprognostic (6.61e-2)" "unprognostic (2.54e-2)" "prognostic favorable (5.15e-4)" 7.4 9.7 11.3 5.8 9.3 6.4 14.2 15.5 14.5 8.1 15.4 9.7 15.4 12.5 10.2 10.5 6.8 9.0 9.8 5.0 11.7 7.5 7.7 14.2 8.6 18.8 10.0 8.5 15.0 16.6 6.5 14.4 11.0 9.2 9.7 7.3 8.7 12.1 10.2 10.4 10.5 12.1 13.6 7.1 12.8 8.2 3.9 12.6 8.5 9.8 7.2 10.2 7.3 13.0 4.8 8.7 6.8 3.9 4.5 9.5 5.0 6.1 7.7 27.5 19.4 15.4 14.7 6.9 3.4 8.0 4.0 4.1 3.5 8.4 8.3 12.4 16.4 9.9 4.5 10.9 5.9 3.5 11.7 10.3 12.3 13.7 9.9 15.3 11.6 10.0 13.7 13.8 10.7 12.0 21.4 16.8 16.0 14.6 14.9 9.3 3.8 15.2 13.2 9.5 5.1 9.1 12.7 5.8 14.4 9.9 3.4 18.6 23.8 12.7 11.2 20.1 12.5 9.0 15.8 12.4 11.5 6.1 4.9 4.1 12.5 9.6 17.5 9.1 21.1 8.1 1.7 3.9 3.3 8.3 3.5 8.9 4.3 6.8 9.5 2.8 4.8 8.1 6.7 6.8 4.5 2.5 8.7 6.4 5.0 11.3 9.3 15.5 14.5 11.7 7.5 10.0 8.5 9.2 12.6 11.9 27.0 23.5 6.5 6.5 33.6 15.3 35.7 13.4 27.3 3.5 72.6 11.2 0.0 5.0 0.8 18.6 25.2 0.0 5.3 7.3 19.3 8.4 22.0 18.1 8.9 28.6 24.5 30.1 33.0 1.3 28.1 8.0 11.8 6.4 23.6 12.3 4.8 17.5 25.1 2.2 66.3 6.5 9.5 6.1 15.5 8.4 7.3 30.6 26.7 6.7 SLC35E3 BLOV1 ENSG00000175782 "Solute carrier family 35 member E3" Q7Z769 12 68746106-68793964 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 19.2;U-698: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049403 Uncertain NA NA "HPA049403: AB_2680747" "unprognostic (1.49e-1)" "unprognostic (6.47e-2)" "unprognostic (2.19e-1)" "prognostic favorable (1.78e-4)" "unprognostic (1.61e-2)" "unprognostic (2.49e-1)" "unprognostic (1.26e-4)" "unprognostic (2.64e-1)" "unprognostic (2.65e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-2)" "unprognostic (6.98e-2)" "unprognostic (6.85e-3)" "unprognostic (1.48e-1)" "unprognostic (3.22e-2)" "unprognostic (2.89e-3)" "unprognostic (1.80e-1)" 8.1 12.3 7.9 7.2 11.9 12.0 12.4 14.1 13.7 8.2 6.2 18.9 3.5 5.7 7.4 9.6 8.7 5.5 5.8 6.2 8.9 7.4 8.0 12.7 7.6 9.2 13.9 10.6 8.7 9.8 7.7 6.7 5.8 14.4 10.2 5.9 9.7 11.8 5.8 7.3 14.5 5.5 7.4 15.7 8.2 9.2 5.7 11.0 18.8 6.9 5.3 9.0 8.0 6.6 4.4 3.7 9.5 3.8 3.6 4.6 1.5 2.2 2.4 3.7 2.3 4.8 2.2 3.4 2.0 4.1 4.6 2.0 4.9 2.8 10.5 1.3 4.1 3.0 3.2 2.1 4.2 2.8 2.3 3.7 4.5 3.0 8.1 3.5 2.3 2.3 4.8 3.2 5.7 2.9 3.3 3.7 3.6 2.3 3.9 4.6 3.4 2.9 7.3 3.7 1.5 3.5 19.2 5.9 2.6 3.4 5.5 2.9 5.0 4.0 3.2 2.6 3.8 5.7 1.1 2.7 5.6 2.3 3.2 2.1 8.6 4.2 19.5 6.7 2.0 2.9 4.7 3.3 4.2 4.0 3.1 4.6 3.1 3.2 3.2 2.4 4.4 3.6 2.9 9.5 3.6 3.8 3.7 2.7 1.5 7.9 11.9 14.1 13.7 8.9 7.4 13.9 10.6 14.4 11.0 11.9 24.8 17.1 19.2 7.0 61.6 12.9 10.2 26.8 21.6 17.4 37.3 21.6 5.0 16.2 3.2 12.8 7.1 0.0 19.5 20.0 16.0 14.6 17.4 20.2 13.6 41.3 12.6 14.7 21.1 1.7 14.1 26.5 6.8 19.0 8.4 28.1 16.8 5.8 21.5 11.3 61.9 25.8 12.0 9.6 13.5 6.6 10.4 29.9 12.3 14.9 SLC35E4 ENSG00000100036 "Solute carrier family 35 member E4" Q6ICL7 22 30635652-30669016 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 20.2;testis: 22.5" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 93.5;Late spermatids: 68.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 15.0;U-2197: 14.5;U-87 MG: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049558 Approved Approved Cytosol NA NA Cytosol "HPA049558: AB_2680817" "unprognostic (2.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.05e-1)" "unprognostic (1.01e-2)" "unprognostic (4.99e-2)" "unprognostic (2.04e-1)" "unprognostic (3.03e-4)" "unprognostic (5.71e-2)" "unprognostic (7.85e-2)" "unprognostic (1.76e-1)" "unprognostic (1.05e-2)" "unprognostic (2.39e-2)" "unprognostic (3.45e-7)" "unprognostic (2.77e-3)" "unprognostic (1.77e-1)" "unprognostic (2.24e-2)" "unprognostic (8.05e-3)" 4.0 2.5 5.6 3.3 11.8 3.4 2.6 4.0 11.4 2.7 5.9 8.1 2.1 2.7 4.2 3.5 4.5 3.1 2.9 5.6 5.2 4.7 2.0 1.1 2.4 2.1 13.0 6.3 2.8 4.1 3.1 2.8 1.6 6.6 2.9 4.2 2.4 2.6 3.5 20.2 7.3 2.5 3.5 2.6 2.4 3.8 22.5 10.1 0.0 2.0 6.6 2.1 3.6 7.6 0.7 3.6 1.6 2.8 2.1 3.2 0.9 6.5 2.9 1.1 2.2 3.0 7.7 0.6 4.3 3.8 3.0 2.8 0.2 1.8 0.4 2.3 4.4 4.2 4.2 1.9 2.5 1.5 15.0 2.1 0.1 2.1 0.2 4.3 0.3 1.8 2.4 1.1 11.9 3.7 4.7 10.1 0.5 0.6 2.0 4.6 1.9 0.2 1.3 1.3 1.9 10.9 1.2 2.2 0.2 1.4 0.5 6.0 2.3 4.4 1.9 2.1 0.5 1.3 0.5 13.4 12.7 4.0 14.5 4.1 0.6 0.5 0.2 15.5 0.2 3.3 1.6 2.1 0.3 0.9 2.8 1.4 0.3 2.1 3.2 3.6 0.7 2.1 1.7 0.8 2.1 2.2 1.0 2.3 0.9 5.6 11.8 4.0 11.4 5.2 4.7 13.0 6.3 6.6 10.1 0.0 1.0 0.9 2.0 12.9 8.8 1.6 0.0 8.1 1.2 1.8 21.6 0.0 0.0 3.2 93.5 4.9 2.6 0.0 2.1 0.4 3.7 1.5 1.1 0.0 1.7 11.1 2.4 4.9 0.3 68.4 3.1 4.5 3.3 2.8 2.6 17.3 1.9 5.7 3.5 0.3 9.3 0.0 4.1 21.8 3.4 16.7 0.1 2.5 4.4 1.4 SLC35F1 "C6orf169, dJ230I3.1" ENSG00000196376 "Solute carrier family 35 member F1" Q5T1Q4 6 117907526-118317676 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 41.9" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 11.0;Early spermatids: 10.7;Horizontal cells: 15.9;Late spermatids: 17.4;Melanocytes: 13.5;Muller glia cells: 27.9" "Group enriched" "Detected in some" 16 "glioma: 15.1;melanoma: 3.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 9 "AF22: 23.9;WM-115: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019576 Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA019576: AB_2190216" "unprognostic (1.46e-1)" "unprognostic (5.67e-2)" "unprognostic (7.08e-2)" "unprognostic (1.37e-3)" "unprognostic (3.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.39e-1)" "unprognostic (4.04e-1)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (4.44e-3)" "unprognostic (2.19e-1)" "unprognostic (8.83e-4)" "unprognostic (3.04e-3)" "unprognostic (6.03e-2)" "unprognostic (8.32e-2)" "unprognostic (2.02e-1)" 2.8 2.7 13.8 2.1 14.5 0.9 1.2 3.6 41.9 1.7 3.5 4.3 0.0 1.6 2.7 5.5 1.8 1.5 1.8 5.3 10.4 10.2 1.7 1.0 1.1 1.0 9.3 15.3 1.4 1.4 1.0 0.6 1.0 5.6 2.3 2.3 2.6 1.7 2.9 1.2 1.6 1.8 2.6 4.1 1.6 1.4 1.8 5.6 0.0 1.8 0.0 1.0 1.4 2.6 0.2 0.6 1.0 0.1 0.3 0.9 0.1 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.2 0.0 2.9 3.4 0.0 0.0 0.1 0.0 40.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.0 0.3 0.0 0.6 0.0 0.1 13.8 14.5 3.6 17.4 10.4 10.2 9.3 15.3 5.6 5.6 0.0 0.0 0.0 0.0 0.3 11.0 4.3 0.0 0.0 2.3 0.0 2.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.1 15.9 0.0 0.0 0.0 17.4 0.6 0.0 13.5 0.0 0.0 27.9 0.0 0.0 1.1 0.0 1.8 0.0 0.7 0.9 1.2 0.0 0.0 0.0 0.0 0.0 SLC35F2 FLJ13018 ENSG00000110660 "Solute carrier family 35 member F2" Q8IXU6 11 107790991-107928293 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 43.2" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 40.9;Suprabasal keratinocytes: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 54.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048185, HPA050695, HPA060150" Enhanced Approved Mitochondria NA NA Mitochondria "HPA048185: AB_2680304, HPA050695: AB_2681217, HPA060150: " "unprognostic (7.73e-2)" "unprognostic (3.28e-3)" "unprognostic (8.37e-3)" "unprognostic (5.77e-2)" "unprognostic (1.38e-3)" "unprognostic (3.07e-2)" "unprognostic (7.26e-2)" "prognostic unfavorable (4.03e-4)" "unprognostic (6.22e-2)" "unprognostic (8.20e-2)" "prognostic unfavorable (5.92e-6)" "unprognostic (1.24e-1)" "unprognostic (4.10e-2)" "unprognostic (1.34e-1)" "unprognostic (7.33e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" 3.0 2.5 2.4 7.4 2.2 1.3 2.7 2.1 2.4 7.4 8.1 1.8 3.8 8.4 2.6 4.8 5.0 6.2 5.9 2.4 3.7 2.6 5.6 2.0 4.0 7.7 2.4 2.2 3.4 3.4 0.3 2.6 9.7 1.9 10.6 9.8 5.2 43.2 2.7 2.3 8.5 7.4 1.8 4.2 2.7 2.8 3.7 2.3 1.8 3.2 6.7 6.9 3.4 3.7 9.3 5.9 0.5 0.2 2.9 11.2 1.6 8.5 5.6 0.6 7.9 4.7 7.0 8.1 2.0 1.1 5.3 6.8 24.2 9.0 14.2 20.3 5.9 28.6 17.9 11.3 18.1 10.5 11.8 10.4 7.9 5.5 10.0 7.7 18.5 4.0 4.8 10.5 17.5 37.9 15.9 27.6 11.3 20.7 5.9 3.7 5.1 7.6 17.8 6.0 18.9 54.7 15.5 7.2 18.6 28.3 7.8 13.8 5.8 6.4 14.9 3.9 7.9 11.0 3.9 20.5 9.7 16.1 0.2 20.4 15.4 17.4 15.6 6.2 5.9 6.3 0.1 0.2 0.0 2.8 0.1 7.3 9.3 4.8 4.9 5.9 6.1 1.8 2.5 0.5 2.9 0.0 0.3 11.2 1.6 2.4 2.2 2.1 2.4 3.7 2.6 2.4 2.2 1.9 2.3 8.9 1.0 11.1 30.1 40.9 1.1 0.5 0.0 0.0 15.9 3.5 11.8 0.7 3.3 10.1 0.3 5.8 14.0 0.0 7.2 13.5 5.1 19.0 2.3 0.0 5.0 0.0 5.8 0.0 0.8 0.9 0.9 3.9 21.9 6.4 10.2 1.3 17.0 10.5 2.5 5.5 7.5 6.5 4.1 0.3 4.9 44.0 3.8 2.5 22.6 15.2 SLC35F3 FLJ37712 ENSG00000183780 "Solute carrier family 35 member F3" Q8IY50 1 233904933-234324516 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in some" 9 "Basal glandular cells: 2.4;Distal tubular cells: 3.3;Exocrine glandular cells: 3.0;Glandular cells: 1.7;Intestinal endocrine cells: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 49 "plasmacytoid DC: 7.1" "Lineage enriched" "Detected in single" 69 "dendritic cells: 7.1" "Cell line enriched" "Detected in some" 7 "HDLM-2: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051327, HPA061582" Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" Nucleoli "HPA051327: AB_2681443, HPA061582: AB_2684563" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.26e-1)" "unprognostic (8.62e-2)" "unprognostic (2.69e-5)" "unprognostic (3.38e-2)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (3.86e-2)" "unprognostic (9.09e-2)" "unprognostic (1.57e-3)" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (3.62e-1)" "unprognostic (3.58e-1)" 0.8 3.5 4.6 1.3 26.0 0.7 6.8 25.1 16.7 1.4 0.8 0.5 0.0 0.8 1.0 2.5 1.6 1.7 0.8 0.6 5.4 4.6 1.6 0.6 1.2 2.4 4.8 6.6 0.6 3.6 4.6 2.8 0.7 4.1 2.0 0.8 0.0 6.6 1.1 1.1 0.8 0.9 1.1 4.8 1.0 2.5 1.1 4.3 0.5 1.9 0.3 1.9 0.8 0.6 0.0 7.1 0.0 0.1 0.0 0.0 0.0 1.4 3.9 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.1 0.3 0.0 3.6 0.0 49.4 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.4 0.0 0.0 0.0 3.6 0.0 2.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 7.1 0.0 0.0 4.6 26.0 25.1 11.6 5.4 4.6 4.8 6.6 4.1 4.3 0.0 0.0 0.0 2.4 0.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.8 0.6 0.0 0.0 0.0 3.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.7 1.3 0.1 0.0 0.0 0.0 0.0 SLC35F4 "C14orf36, FLJ37712" ENSG00000151812 "Solute carrier family 35 member F4" A4IF30 14 57563922-57982194 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 29.5;seminal vesicle: 10.5" "Cell type enhanced" "Detected in some" 24 "Cone photoreceptor cells: 3.9;Early spermatids: 5.9;Peritubular cells: 2.8;Rod photoreceptor cells: 14.2" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "cerebellum: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.5;U-87 MG: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043853 Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA043853: AB_10963083" "unprognostic (2.37e-1)" "unprognostic (2.10e-1)" "unprognostic (3.56e-1)" "unprognostic (2.66e-4)" "unprognostic (4.88e-2)" "unprognostic (8.64e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-2)" "unprognostic (3.94e-2)" "unprognostic (1.39e-1)" "unprognostic (4.03e-3)" "unprognostic (3.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.68e-3)" "unprognostic (9.23e-2)" 0.1 0.1 1.2 0.1 4.9 0.1 0.1 29.5 1.1 1.0 0.2 0.1 0.5 0.2 1.5 0.2 0.1 0.2 0.5 0.1 0.9 2.2 0.4 0.1 0.1 0.1 0.8 1.2 0.3 0.1 0.1 0.2 0.1 2.9 3.5 0.1 2.4 0.1 10.5 0.1 0.1 0.4 1.1 1.3 0.1 0.1 2.7 0.7 0.0 2.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.9 29.5 1.1 0.9 2.2 0.8 1.2 2.9 0.7 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 2.8 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC35F5 FLJ22004 ENSG00000115084 "Solute carrier family 35 member F5" Q8WV83 2 113705011-113756823 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034828, HPA049229" Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA034828: AB_2674350, HPA049229: AB_2680682" "unprognostic (1.59e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (8.37e-2)" "unprognostic (3.87e-3)" "unprognostic (5.62e-2)" "unprognostic (4.73e-3)" "unprognostic (3.94e-2)" "unprognostic (5.68e-2)" "unprognostic (1.19e-1)" "unprognostic (1.63e-2)" "unprognostic (1.93e-2)" "unprognostic (1.77e-1)" "prognostic favorable (1.71e-5)" "unprognostic (1.64e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (4.83e-2)" 20.0 46.8 7.9 11.7 9.2 3.6 13.8 10.6 9.0 16.9 18.1 15.0 18.9 14.5 14.2 12.6 20.4 10.7 14.9 20.0 8.2 7.9 44.7 29.5 15.0 12.7 10.4 5.0 19.1 23.6 21.6 20.6 24.6 11.7 16.1 16.5 14.1 23.4 16.9 20.0 15.1 32.4 13.1 9.6 12.6 13.7 12.6 10.3 9.2 33.1 14.6 16.7 14.1 16.7 3.4 6.8 5.8 9.1 6.2 4.3 3.2 9.9 9.4 5.1 2.8 47.8 33.3 15.2 16.5 17.4 10.6 15.8 18.7 18.4 9.3 21.3 21.2 27.1 9.2 9.1 8.6 14.7 3.7 3.7 6.5 6.5 16.5 16.4 9.4 17.7 28.8 11.5 13.5 19.2 16.9 11.2 2.5 8.3 9.1 22.5 6.9 2.8 4.8 5.0 11.7 7.7 3.9 10.3 5.9 37.4 13.5 1.6 3.8 12.2 13.2 9.2 10.2 10.4 5.4 10.0 16.8 8.9 8.7 5.2 6.1 8.1 6.3 13.0 5.3 10.9 5.8 5.4 3.7 2.9 8.0 3.8 3.3 2.6 3.1 6.8 3.4 2.9 2.1 4.3 6.2 9.1 3.0 4.3 3.2 7.9 9.2 10.6 9.0 8.2 7.9 10.4 5.0 11.7 10.3 20.8 16.6 2.4 27.7 22.6 10.8 21.0 22.9 20.1 28.4 69.8 21.6 39.1 10.0 25.8 21.3 12.6 39.7 0.0 25.0 60.1 22.6 31.6 24.2 22.1 24.5 4.8 13.9 10.4 14.3 11.0 11.5 11.2 8.5 19.0 23.1 20.9 21.3 26.6 13.1 35.7 17.6 0.0 12.2 42.6 11.7 29.6 55.5 10.4 21.3 29.8 SLC35F6 "ANT2BP, C2orf18, FLJ20555, TANGO9" ENSG00000213699 "Solute carrier family 35 member F6" Q8N357 2 26764284-26781231 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 48.6;Karpas-707: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034655 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA034655: AB_10696359" "unprognostic (2.26e-1)" "unprognostic (7.45e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-1)" "unprognostic (7.71e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.11e-4)" "prognostic unfavorable (3.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.35e-1)" "unprognostic (3.24e-1)" "unprognostic (2.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.07e-2)" "unprognostic (9.95e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-2)" 37.3 24.1 9.7 10.5 11.7 6.5 42.2 8.3 15.6 17.9 14.5 16.0 12.4 10.4 14.1 14.0 25.2 12.5 14.4 15.0 10.4 11.6 37.4 25.4 15.3 22.0 12.3 9.3 20.4 12.6 13.1 12.2 26.6 11.9 15.3 9.0 13.8 16.7 14.2 16.7 30.9 14.7 15.4 11.4 14.8 16.3 11.7 9.1 10.5 24.1 20.4 15.5 13.8 18.2 3.1 7.1 7.8 19.0 8.6 8.8 5.9 8.3 14.7 4.5 11.4 15.5 7.0 6.9 4.7 7.3 6.1 5.6 9.2 16.0 2.2 8.0 6.6 15.1 10.4 6.4 9.5 4.3 3.8 3.1 2.5 5.6 7.7 48.6 2.7 12.8 11.1 9.8 6.9 23.2 2.8 7.1 3.4 4.7 42.8 6.1 13.5 3.4 2.4 2.5 6.0 3.9 3.0 12.9 3.5 16.2 6.7 3.4 4.5 8.0 13.1 8.5 3.9 4.9 2.8 6.4 8.0 8.5 10.9 5.2 8.3 10.4 4.3 8.6 4.6 7.2 7.0 12.0 5.3 8.8 16.5 5.0 3.1 6.1 8.0 7.1 2.5 4.2 6.0 7.8 8.6 19.0 5.5 3.8 5.9 9.7 11.7 8.3 15.6 10.4 11.6 12.3 9.3 11.9 9.1 11.9 8.0 6.7 11.8 15.0 17.3 11.2 25.5 5.3 7.9 31.4 5.9 22.1 6.6 29.6 1.5 19.2 18.8 0.0 33.5 20.1 22.4 12.8 1.1 19.2 46.2 14.3 8.7 28.8 43.7 1.1 17.0 26.4 27.0 10.8 8.7 18.9 38.9 9.1 11.3 49.9 9.7 25.8 29.9 3.7 6.5 22.5 31.8 13.8 9.7 10.6 SLC35G1 "C10orf60, FLJ33990, TMEM20" ENSG00000176273 "Solute carrier family 35 member G1" Q2M3R5 10 93893973-93956062 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 73.5;retina: 24.6" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 34.2;Peritubular cells: 34.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.6;T-cells: 3.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.94e-2)" "unprognostic (1.90e-1)" "unprognostic (9.48e-2)" "unprognostic (1.65e-1)" "unprognostic (7.90e-4)" "unprognostic (8.89e-2)" "unprognostic (9.01e-3)" "unprognostic (1.15e-2)" "unprognostic (9.47e-2)" "unprognostic (7.90e-2)" "unprognostic (2.09e-1)" "unprognostic (4.30e-2)" "unprognostic (1.65e-2)" "unprognostic (2.29e-3)" "unprognostic (3.28e-1)" "unprognostic (3.02e-1)" "unprognostic (2.30e-1)" 1.4 1.7 0.7 2.7 1.9 0.5 1.1 1.2 1.4 1.0 29.0 0.8 0.7 52.2 1.9 0.9 2.2 1.1 1.1 2.4 0.8 0.6 0.8 5.1 1.1 1.5 0.6 1.0 1.9 11.6 1.0 3.7 0.9 4.5 1.1 4.7 24.6 2.1 0.9 1.3 2.2 73.5 1.9 0.7 1.4 3.3 4.4 0.4 1.5 2.1 1.6 1.0 1.4 1.5 0.6 0.3 2.6 0.4 0.0 3.8 1.0 7.9 7.7 3.6 4.4 1.1 3.3 5.3 7.3 8.4 6.3 8.5 6.0 5.9 5.1 3.1 4.5 4.7 14.0 8.0 2.6 10.5 6.6 9.2 4.1 4.7 4.7 1.9 7.9 8.2 3.2 2.6 5.4 3.1 2.2 2.8 4.4 3.8 3.1 4.3 2.6 3.9 1.4 4.8 2.7 9.8 0.0 6.1 2.0 3.2 7.1 4.5 4.2 9.7 4.6 5.7 3.3 5.0 2.3 3.8 5.4 9.1 9.3 7.1 3.6 3.4 1.8 3.4 0.0 3.8 0.0 0.4 2.6 0.4 0.4 1.6 0.4 3.0 1.8 0.3 0.6 3.2 2.0 0.2 0.0 0.0 0.3 3.8 1.0 0.7 1.9 1.2 1.4 0.8 0.6 0.6 1.0 4.5 0.4 3.0 3.8 0.5 1.9 2.7 3.9 2.8 5.1 1.4 1.2 7.0 3.9 2.7 3.3 2.4 15.6 3.5 34.2 0.0 8.3 5.0 3.5 1.0 0.0 5.5 1.9 1.6 4.1 4.9 3.7 6.8 15.8 0.7 5.0 3.6 3.6 5.0 3.0 10.2 34.3 1.3 2.4 0.0 1.7 7.7 8.3 1.6 0.7 2.2 4.3 1.6 SLC35G2 "DKFZp564K2464, MGC3295, TMEM22" ENSG00000168917 "Solute carrier family 35 member G2" Q8TBE7 3 136818647-136855892 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 36.2;Endothelial cells: 26.0;Ito cells: 26.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 1.6;memory CD8 T-cell: 3.5;naive CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 16 "T-cells: 3.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 34.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052054, HPA064728" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA052054: AB_2681709, HPA064728: AB_2685336" "unprognostic (1.04e-1)" "unprognostic (1.46e-2)" "unprognostic (6.91e-4)" "unprognostic (2.56e-4)" "unprognostic (5.34e-2)" "unprognostic (6.73e-2)" "unprognostic (1.16e-5)" "unprognostic (1.83e-3)" "unprognostic (1.12e-1)" "unprognostic (6.39e-2)" "unprognostic (1.49e-2)" "unprognostic (3.32e-1)" "prognostic unfavorable (1.16e-7)" "unprognostic (1.00e-2)" "unprognostic (1.69e-1)" "unprognostic (1.07e-2)" "unprognostic (2.30e-2)" 20.2 24.6 10.6 3.7 12.0 1.3 18.3 16.6 17.4 8.1 3.6 6.4 6.6 2.2 6.7 8.1 4.1 5.0 8.7 7.6 11.6 15.2 4.3 7.1 6.0 3.3 10.9 10.5 5.3 13.3 6.7 15.9 11.7 11.3 4.8 3.8 3.2 2.7 4.8 2.8 3.0 2.4 8.5 12.4 3.1 3.1 17.2 4.9 0.9 8.8 2.1 2.5 8.2 9.3 0.2 0.0 0.0 0.1 0.0 3.5 0.3 1.7 4.9 5.0 2.2 10.1 8.2 0.0 7.8 34.1 11.7 17.7 4.6 2.6 0.0 6.0 8.0 18.7 0.6 5.9 0.3 10.9 0.0 1.6 1.4 6.0 2.8 12.9 0.0 0.0 11.6 0.9 10.2 2.8 8.6 8.7 3.1 0.8 0.0 14.9 0.0 2.1 1.5 1.1 0.0 3.7 1.8 3.3 0.0 10.0 0.4 8.3 5.5 6.3 0.0 10.7 1.8 0.0 0.8 5.9 8.7 2.2 3.8 8.4 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.5 0.0 0.1 3.5 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.3 10.6 12.0 16.6 17.0 11.6 15.2 10.9 10.5 11.3 4.9 11.9 6.5 2.7 3.7 3.0 5.4 2.0 0.0 1.4 10.3 1.8 11.8 1.0 1.7 2.7 36.2 26.0 0.5 0.0 9.3 1.1 11.0 3.3 2.3 1.8 0.6 6.4 4.1 26.4 1.0 19.8 9.2 3.5 3.3 3.6 0.6 6.8 9.1 0.0 2.8 0.4 4.7 6.5 7.2 22.7 9.4 2.6 1.8 4.8 0.6 1.8 SLC35G3 "AMAC1, FLJ40154, TMEM21A" ENSG00000164729 "Solute carrier family 35 member G3" Q8N808 17 35192520-35194523 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.1;skeletal muscle: 1.4;testis: 6.5" "Cell type enriched" "Detected in some" 8 "Early spermatids: 16.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.1" "Lineage enriched" "Detected in single" 31 "T-cells: 3.1" "Not detected" "Not detected" NA NA "unprognostic (1.88e-1)" "unprognostic (2.67e-1)" "unprognostic (6.17e-3)" "unprognostic (3.83e-1)" "unprognostic (6.24e-2)" "unprognostic (3.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.9 3.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 SLC35G4 "AMAC1L1, SLC35G4P" ENSG00000236396 "Solute carrier family 35 member G4" P0C7Q5 18 11609596-11610612 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC35G5 "AMAC, AMAC1L2" ENSG00000177710 "Solute carrier family 35 member G5" Q96KT7 8 11330888-11332208 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 5.5" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 8.2;Rod photoreceptor cells: 3.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "TIME: 2.4" NA NA "unprognostic (7.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.05e-1)" "unprognostic (9.67e-2)" "unprognostic (2.60e-4)" "unprognostic (6.48e-3)" "unprognostic (4.09e-1)" "unprognostic (5.79e-2)" "unprognostic (1.06e-1)" "unprognostic (3.61e-1)" "unprognostic (3.61e-2)" "unprognostic (3.44e-1)" "unprognostic (2.06e-6)" "unprognostic (7.88e-2)" "unprognostic (1.63e-1)" "unprognostic (2.34e-1)" "unprognostic (2.04e-3)" 0.0 0.2 0.4 0.7 0.5 1.3 0.0 0.5 0.4 0.3 0.6 0.1 0.2 0.2 0.4 0.2 0.5 1.1 0.5 0.6 0.5 0.3 0.5 0.8 0.6 0.2 0.9 0.0 0.8 0.1 1.1 0.2 0.3 0.0 1.9 1.2 0.6 0.1 0.5 1.4 0.5 5.5 0.6 0.5 0.3 0.4 0.4 1.7 0.1 0.8 0.0 2.1 0.0 0.3 0.0 0.2 0.8 0.7 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.3 0.2 0.8 0.8 0.3 0.6 0.1 0.2 0.2 0.4 0.1 0.5 1.5 0.1 0.0 0.1 0.8 1.1 0.4 0.0 0.0 0.3 0.1 0.7 0.8 0.7 1.1 0.8 0.3 0.3 0.5 0.4 0.7 0.6 0.5 0.6 0.1 0.7 0.9 1.4 1.6 0.1 0.2 0.5 0.5 0.0 2.4 0.5 0.8 0.7 0.3 0.5 0.6 1.0 0.3 0.4 0.7 0.1 0.3 0.0 2.1 0.1 0.2 0.0 0.8 0.0 0.6 0.4 0.4 0.1 0.1 0.0 0.8 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.2 0.1 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.4 1.6 0.0 1.8 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.4 0.0 3.2 0.0 0.0 1.1 0.4 0.1 0.0 0.0 0.4 0.3 SLC35G6 "AMAC1L3, TMEM21B" ENSG00000259224 "Solute carrier family 35 member G6" P0C7Q6 17 7481332-7483496 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 8.5" "Cell type enriched" "Detected in some" 6 "Early spermatids: 26.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 1.1;HeLa: 3.7;U-138 MG: 1.2" NA NA "unprognostic (3.81e-2)" "unprognostic (5.10e-2)" "unprognostic (2.05e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (1.65e-3)" "unprognostic (3.29e-1)" "unprognostic (9.19e-3)" "unprognostic (1.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.13e-1)" "unprognostic (5.21e-2)" "unprognostic (3.79e-2)" "unprognostic (2.01e-2)" 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.0 0.0 0.0 1.1 0.9 1.1 0.3 0.0 0.3 0.0 0.0 0.7 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.1 3.7 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.2 1.2 0.1 0.6 0.4 0.1 0.2 0.1 0.4 0.2 0.1 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.1 1.1 0.3 0.1 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.8 0.0 0.0 1.0 0.3 0.1 0.0 0.0 0.0 0.0 SLC36A1 "LYAAT-1, PAT1, TRAMD3" ENSG00000123643 "Solute carrier family 36 member 1" Q7Z2H8 5 151437046-151492381 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.3" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 49.3;Enterocytes: 37.0;Kupffer cells: 22.4;Late spermatids: 21.6;Paneth cells: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 15.9;classical monocyte: 6.6;neutrophil: 14.5" "Group enriched" "Detected in many" 5 "granulocytes: 15.9;monocytes: 6.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035937 Approved NA NA "HPA035937: AB_10672995" "unprognostic (5.49e-2)" "unprognostic (4.04e-2)" "unprognostic (1.24e-1)" "unprognostic (8.27e-3)" "unprognostic (1.91e-1)" "unprognostic (2.02e-1)" "prognostic unfavorable (6.30e-5)" "unprognostic (1.86e-1)" "unprognostic (2.44e-1)" "unprognostic (1.29e-3)" "unprognostic (5.08e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.83e-6)" "unprognostic (2.66e-2)" "unprognostic (1.03e-2)" "unprognostic (2.49e-1)" "unprognostic (1.42e-1)" 5.6 4.7 5.1 6.0 11.1 19.3 4.4 43.3 15.3 3.8 11.1 5.0 11.6 32.5 4.6 3.8 5.4 3.8 8.3 3.7 4.2 4.1 7.3 3.5 6.0 4.5 6.0 6.8 4.0 6.5 32.1 6.3 4.4 13.9 9.9 17.5 4.1 5.1 7.6 7.6 3.9 28.7 5.2 4.1 9.2 4.8 11.2 5.0 7.1 3.7 3.6 4.2 7.2 4.5 1.7 2.1 15.9 6.6 0.3 1.9 0.8 3.9 6.8 3.6 2.4 9.0 6.6 19.3 11.5 6.4 8.0 9.0 15.6 5.8 9.1 6.8 13.7 8.5 9.7 11.3 7.1 7.9 2.5 9.8 2.8 11.1 5.2 11.6 6.7 15.5 4.8 8.3 6.7 4.4 2.2 7.0 5.0 6.4 8.0 6.7 4.3 1.9 3.4 3.5 4.9 6.4 0.0 8.6 3.6 2.1 5.9 3.2 6.2 7.1 8.6 4.1 7.6 6.5 9.8 7.0 10.7 6.0 17.3 6.4 3.8 5.3 5.9 6.8 11.8 7.0 15.9 6.6 2.5 1.2 2.8 0.8 1.6 1.1 1.9 2.1 1.7 0.9 0.8 14.5 0.3 2.8 0.4 1.1 0.8 5.1 11.1 43.3 15.3 4.2 4.1 6.0 6.8 13.9 5.0 0.0 1.7 0.0 1.0 1.3 1.2 2.2 7.6 0.0 1.2 1.8 2.0 0.5 0.0 1.6 49.3 1.0 37.0 0.0 1.7 7.2 2.3 2.8 1.1 1.7 12.1 1.6 0.0 4.9 22.4 21.6 4.6 3.8 1.7 1.0 6.1 0.8 1.6 21.0 11.0 3.9 0.8 0.0 1.9 0.5 1.9 1.1 0.2 2.1 6.9 1.8 SLC36A2 "PAT2, TRAMD1, tramdorin" ENSG00000186335 "Solute carrier family 36 member 2" Q495M3 5 151314978-151347590 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1" "Cell type enriched" "Detected in some" 9 "Proximal tubular cells: 44.0" "Cancer enriched" "Detected in single" 9 "renal cancer: 0.5" "Region enhanced" "Detected in single" "midbrain: 1.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 1.9;NB-4: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA044002, HPA062229" Enhanced NA NA "HPA044002: AB_10964214, HPA062229: AB_2684717" "unprognostic (3.47e-1)" "unprognostic (3.40e-1)" "unprognostic (2.26e-2)" "unprognostic (6.23e-2)" "unprognostic (8.38e-3)" "unprognostic (4.66e-3)" "unprognostic (3.03e-1)" "unprognostic (7.73e-2)" "unprognostic (1.92e-2)" "unprognostic (2.11e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-3)" "unprognostic (1.43e-1)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" "unprognostic (3.89e-2)" 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 2.6 0.5 0.1 0.0 0.2 0.1 0.1 60.3 0.1 0.1 0.0 1.2 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.0 1.1 2.0 0.0 36.8 0.1 0.1 0.0 0.2 0.1 0.1 0.7 0.0 0.0 0.1 16.1 1.4 0.1 0.1 2.1 1.5 4.3 0.8 1.5 0.9 0.3 0.1 0.3 0.4 0.7 0.3 0.1 1.0 0.4 0.0 0.1 0.0 0.6 0.3 0.8 0.3 0.2 0.3 0.4 0.0 0.7 0.0 1.5 1.5 0.3 0.8 0.3 0.0 1.9 0.5 0.1 0.1 0.0 0.0 0.0 0.5 0.5 0.1 1.4 0.2 0.3 0.4 2.0 1.2 0.0 0.2 0.5 0.4 0.2 0.2 0.1 0.4 0.4 0.1 1.2 0.0 0.2 0.3 0.3 0.5 0.2 0.2 1.2 0.2 0.5 0.2 0.4 0.3 0.3 0.1 3.2 0.8 0.9 0.7 0.6 0.6 1.1 0.6 0.6 0.2 2.1 0.7 0.9 4.3 1.5 0.6 1.5 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC36A3 "PAT3, TRAMD2, tramdorin2" ENSG00000186334 "Solute carrier family 36 member 3" Q495N2 5 151276762-151303766 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 14.5" "Group enriched" "Detected in some" 57 "Early spermatids: 47.0;Late spermatids: 85.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.41e-1)" "unprognostic (5.38e-1)" "unprognostic (7.01e-2)" "unprognostic (2.13e-1)" "unprognostic (2.20e-2)" "unprognostic (3.98e-1)" "unprognostic (2.57e-2)" "unprognostic (2.18e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.2 0.3 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 SLC36A4 "FLJ38932, PAT4" ENSG00000180773 "Solute carrier family 36 member 4" Q6YBV0 11 93144171-93197964 "Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017887 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA017887: AB_2190238" "unprognostic (1.23e-2)" "unprognostic (1.08e-1)" "unprognostic (2.17e-3)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" "unprognostic (8.77e-2)" "unprognostic (1.08e-3)" "unprognostic (7.83e-3)" "unprognostic (3.06e-2)" "unprognostic (7.97e-2)" "unprognostic (2.09e-2)" "unprognostic (8.04e-3)" "unprognostic (7.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.74e-1)" "unprognostic (9.45e-3)" "unprognostic (4.20e-2)" 8.0 11.0 16.0 12.6 19.3 24.1 6.5 20.7 20.2 8.0 7.3 8.7 2.1 3.0 10.4 3.6 7.8 6.2 8.4 9.2 14.2 14.8 13.7 11.0 8.2 7.0 16.8 10.3 8.6 8.0 8.0 17.2 8.7 17.6 7.5 9.4 5.4 5.4 9.1 3.4 5.9 4.2 11.5 20.0 5.7 6.4 6.0 13.4 5.6 12.7 2.3 9.2 8.6 7.7 1.6 2.9 8.1 7.7 0.8 2.6 1.8 5.1 9.3 19.0 3.8 6.7 13.7 10.7 9.0 15.0 13.4 16.3 7.4 17.0 6.3 5.2 8.3 7.0 6.4 5.8 3.3 12.3 10.5 6.8 7.2 19.5 4.9 5.3 18.1 10.8 6.6 10.4 7.7 4.9 6.3 7.1 9.0 0.6 0.1 13.6 1.3 7.9 13.7 7.6 2.0 9.4 3.6 11.3 2.6 4.5 7.7 17.6 22.9 13.1 5.1 3.2 14.5 9.3 5.3 7.9 25.3 7.8 14.9 13.0 2.6 5.2 0.0 5.7 7.6 13.0 0.2 7.7 8.1 1.3 3.9 1.8 1.3 1.0 1.6 2.9 1.6 2.6 1.7 2.5 0.8 2.5 1.1 0.8 1.8 16.0 19.3 20.7 20.2 14.2 14.8 16.8 10.3 17.6 13.4 11.9 8.6 18.2 35.2 27.2 21.1 7.7 12.7 21.4 6.8 19.2 21.6 9.5 29.9 19.1 1.7 18.0 0.7 0.0 37.9 21.2 11.6 37.1 4.6 6.4 13.1 25.4 26.5 10.4 59.0 3.1 16.7 44.6 20.3 10.0 17.4 13.3 27.9 5.8 14.5 12.3 23.0 6.5 17.6 6.2 2.7 28.0 13.6 10.7 4.3 23.7 SLC37A1 ENSG00000160190 "Solute carrier family 37 member 1" P57057 21 42496008-42581440 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 45.9" "Group enriched" "Detected in many" 4 "Early spermatids: 254.9;Late spermatids: 218.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 48.5;MCF7: 19.3;OE19: 20.9;SK-BR-3: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030418, CAB034154" Approved NA NA "CAB034154: AB_2190373, HPA030418: AB_10601602" "unprognostic (1.44e-2)" "unprognostic (2.93e-2)" "unprognostic (2.12e-1)" "prognostic favorable (9.22e-5)" "unprognostic (1.59e-2)" "unprognostic (1.42e-1)" "unprognostic (1.38e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-1)" "unprognostic (7.99e-2)" "unprognostic (5.94e-2)" "unprognostic (1.86e-2)" "unprognostic (2.16e-1)" "unprognostic (4.08e-2)" "unprognostic (7.94e-2)" "prognostic favorable (3.43e-5)" "unprognostic (1.61e-2)" 4.7 6.6 7.2 15.8 5.3 7.5 7.3 8.0 6.1 6.3 28.6 2.7 5.1 31.0 2.4 10.6 9.8 6.9 18.4 2.3 3.4 4.9 4.7 4.0 8.0 6.1 3.5 4.6 3.9 4.8 2.2 14.0 9.7 3.9 10.8 13.7 5.5 14.5 9.0 6.4 4.6 45.9 3.0 7.1 7.0 16.7 16.8 3.3 9.3 9.3 4.4 16.2 7.1 5.9 7.8 13.1 23.0 10.5 4.1 6.7 4.0 5.2 2.1 0.5 1.0 0.0 0.1 4.6 0.2 0.0 0.2 0.1 1.2 10.7 3.7 5.5 0.0 3.3 2.1 1.0 2.7 0.0 1.7 2.6 48.5 1.8 0.1 1.3 1.0 4.8 0.2 1.6 0.0 0.1 0.0 1.6 4.2 0.9 5.2 0.0 19.3 3.6 2.6 3.7 20.9 1.2 3.7 0.0 0.1 4.5 10.0 5.7 0.7 3.1 16.9 1.2 0.5 6.3 5.4 2.8 0.0 1.0 0.0 0.0 10.0 6.1 3.6 0.0 8.0 0.5 2.1 3.2 23.0 5.2 8.6 6.7 7.8 3.6 4.6 4.6 5.4 3.1 4.3 3.8 4.1 10.5 13.1 1.8 4.0 7.2 5.3 8.0 6.1 3.4 4.9 3.5 4.6 3.9 3.3 17.9 23.0 14.6 7.2 1.9 2.7 3.2 20.4 22.7 10.3 12.2 5.9 5.4 0.0 21.7 254.9 4.6 47.1 0.0 27.2 4.9 3.2 22.1 1.1 4.9 7.7 3.2 28.9 4.9 6.4 218.7 6.6 5.1 6.8 21.6 37.8 37.2 27.4 56.0 2.5 1.1 4.1 0.0 3.3 25.0 4.6 1.4 7.2 7.5 35.5 16.1 SLC37A2 FLJ00171 ENSG00000134955 "Solute carrier family 37 member 2" Q8TED4 11 125063067-125090312 "Predicted membrane proteins, Transporters" "Antiport, Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.2;salivary gland: 85.6" "Group enriched" "Detected in many" 7 "Hofbauer cells: 32.3;Kupffer cells: 15.9;Macrophages: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "classical monocyte: 8.0;intermediate monocyte: 9.9;myeloid DC: 3.7;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 12 "dendritic cells: 3.7;monocytes: 11.9" "Cell line enhanced" "Detected in some" "A-431: 12.7;CAPAN-2: 27.2;hTCEpi: 12.2;hTERT-HME1: 29.3;U-138 MG: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014948 Uncertain NA NA "HPA014948: AB_2190374" "unprognostic (8.47e-2)" "unprognostic (4.85e-1)" "unprognostic (9.64e-2)" "unprognostic (2.91e-2)" "unprognostic (7.88e-2)" "unprognostic (2.84e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-1)" "unprognostic (2.06e-2)" "unprognostic (1.30e-1)" "unprognostic (2.15e-2)" "unprognostic (3.11e-1)" "unprognostic (6.61e-2)" "unprognostic (1.94e-3)" "unprognostic (1.66e-3)" "unprognostic (7.01e-2)" "unprognostic (3.24e-2)" 7.1 26.4 1.0 47.2 1.4 0.0 3.4 0.4 1.0 2.5 3.6 3.5 0.5 3.7 0.7 2.0 7.2 1.0 2.4 2.3 1.3 0.7 1.0 2.7 7.2 6.4 1.5 0.3 1.8 0.7 0.0 0.6 3.2 1.5 2.0 4.6 2.4 85.6 0.6 0.4 16.3 4.6 1.3 1.7 10.2 0.8 0.7 1.2 1.4 0.6 3.3 3.1 6.6 6.5 0.1 3.7 0.6 11.9 0.0 0.0 3.1 12.7 0.0 0.2 0.0 0.3 0.4 0.0 0.4 1.2 0.4 1.2 0.1 27.2 0.0 3.9 0.1 1.0 6.7 0.2 7.2 1.8 0.3 0.2 2.9 0.2 0.6 0.0 0.0 0.1 0.3 12.2 1.2 29.3 0.7 0.7 0.2 0.1 0.1 1.3 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.9 0.2 0.3 6.6 0.0 0.1 2.3 0.0 0.8 0.2 0.0 0.6 1.5 20.9 0.0 0.2 0.5 0.3 0.4 0.0 0.7 0.7 1.6 0.0 8.0 0.0 0.0 9.9 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.6 0.0 11.9 0.0 0.0 3.1 1.0 1.4 0.4 1.0 1.3 0.7 1.5 0.3 1.5 1.2 0.0 1.1 1.4 1.2 0.2 1.4 0.8 0.0 0.0 2.3 0.0 2.0 0.5 0.0 0.1 1.3 0.8 0.0 0.0 0.0 0.6 0.3 0.8 2.3 0.0 32.3 0.0 0.0 1.8 15.9 1.7 0.9 9.3 0.0 0.0 0.0 0.5 0.1 0.0 1.1 0.0 0.7 0.0 0.4 2.2 1.0 0.6 2.9 0.7 0.0 2.6 SLC37A3 DKFZp761N0624 ENSG00000157800 "Solute carrier family 37 member 3" Q8NCC5 7 140293693-140404433 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.39e-1)" "prognostic unfavorable (9.54e-4)" "unprognostic (1.44e-1)" "unprognostic (5.59e-2)" "unprognostic (2.69e-2)" "unprognostic (2.35e-1)" "prognostic unfavorable (4.78e-5)" "unprognostic (1.97e-1)" "unprognostic (2.94e-1)" "unprognostic (3.78e-2)" "unprognostic (2.84e-2)" "unprognostic (1.54e-1)" "unprognostic (2.16e-2)" "unprognostic (3.31e-1)" "unprognostic (3.82e-1)" "unprognostic (1.49e-1)" "unprognostic (5.50e-2)" 11.7 6.9 8.4 6.2 13.6 6.6 14.1 14.0 15.0 18.7 16.3 9.1 5.1 8.7 31.5 16.1 7.7 15.6 12.3 8.5 10.1 7.9 10.2 8.2 10.5 5.0 8.4 12.3 14.6 20.4 20.0 17.4 13.9 10.6 9.8 16.1 10.4 26.6 8.6 5.0 8.7 10.4 21.6 9.6 10.6 11.6 6.8 8.6 10.0 13.8 6.8 9.2 13.5 12.0 2.5 3.2 12.8 3.9 5.6 8.6 4.0 7.8 13.2 13.8 24.2 20.0 22.0 16.5 11.8 13.9 8.2 12.3 10.5 17.1 1.1 15.0 10.6 21.1 6.5 8.4 14.3 12.6 17.7 12.2 1.3 3.4 10.6 16.8 0.0 4.5 16.9 14.8 8.6 10.2 14.4 12.5 7.0 7.8 3.3 12.6 15.1 7.5 0.7 20.4 19.0 8.3 4.0 3.7 3.6 15.7 16.1 13.5 16.9 3.3 13.4 12.9 15.5 7.2 0.7 14.3 9.4 6.9 23.6 12.0 6.4 11.8 3.0 9.9 0.1 21.5 6.3 3.9 3.7 7.4 2.2 4.1 2.5 8.0 5.6 3.2 2.0 8.6 6.4 12.8 5.6 1.3 1.0 8.6 4.0 8.4 13.6 14.0 15.0 10.1 7.9 8.4 12.3 10.6 8.6 8.9 11.3 4.7 35.2 13.5 9.3 4.3 12.7 10.7 15.9 12.2 9.8 15.5 1.7 19.3 0.9 11.2 12.4 0.0 23.4 22.0 24.6 26.5 8.1 6.6 3.4 12.7 20.7 16.0 5.9 1.1 18.7 4.1 18.6 3.6 21.2 3.1 24.0 10.5 12.7 4.6 9.2 6.5 12.2 3.6 6.5 10.8 11.0 9.6 13.6 33.9 SLC37A4 "G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d" ENSG00000137700 "Solute carrier family 37 member 4" 11 119024114-119030906 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.2" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 183.4;Hepatocytes: 134.8;Muller glia cells: 96.7;Proximal tubular cells: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 16.4;HEK 293: 17.3;Hep G2: 21.6;MCF7: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038939, HPA038940" Enhanced Approved Mitochondria NA NA Mitochondria "HPA038939: AB_2676279, HPA038940: AB_2676280" "unprognostic (4.77e-2)" "unprognostic (3.49e-1)" "unprognostic (2.08e-2)" "unprognostic (2.35e-2)" "unprognostic (4.70e-2)" "unprognostic (6.95e-3)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (4.08e-2)" "unprognostic (8.27e-3)" "unprognostic (4.72e-2)" "unprognostic (3.89e-1)" "unprognostic (1.98e-1)" "unprognostic (4.04e-2)" "unprognostic (2.60e-1)" "unprognostic (4.34e-2)" "unprognostic (5.39e-2)" 2.1 3.7 4.8 4.8 3.7 1.4 3.7 7.8 5.9 1.7 5.0 2.7 13.6 26.0 2.6 15.9 2.5 4.0 6.9 4.6 3.7 4.9 29.6 42.2 3.3 4.7 3.7 3.1 3.3 15.5 5.9 2.2 3.3 2.3 4.3 5.3 3.0 4.6 13.6 27.7 2.0 6.7 1.9 3.1 3.4 1.8 4.5 1.4 2.9 3.3 3.3 2.4 1.7 2.3 1.2 0.7 2.7 3.7 2.0 4.1 1.2 0.4 7.2 2.6 1.9 4.7 1.9 1.5 0.2 5.9 1.6 4.1 16.4 1.2 1.8 4.0 2.3 3.4 0.4 1.1 8.2 2.5 2.1 17.3 5.4 1.6 21.6 1.7 3.1 0.9 0.0 2.3 0.8 4.4 6.6 5.4 0.4 2.1 4.8 2.7 15.1 0.1 6.9 0.1 1.6 8.6 4.4 0.0 8.5 1.8 7.6 3.3 3.3 0.0 0.4 2.7 3.5 3.2 2.3 0.0 0.0 2.6 0.1 2.8 0.8 1.3 0.5 0.7 7.9 0.7 0.0 1.9 2.7 3.3 3.7 2.8 1.2 1.9 4.1 0.7 1.1 1.6 2.3 0.0 2.0 1.5 0.2 2.1 1.2 4.8 3.7 7.8 5.9 3.7 4.9 3.7 3.1 2.3 1.4 3.0 5.6 6.7 7.2 1.5 6.4 3.6 183.4 8.1 4.5 15.7 0.0 22.4 26.6 25.4 9.2 6.3 26.5 23.3 22.1 16.5 3.7 9.0 0.0 134.8 24.5 15.9 23.7 21.5 9.1 1.9 8.9 7.0 3.3 16.2 17.5 96.7 18.6 24.6 9.9 134.4 11.0 0.0 4.1 7.1 22.6 2.4 12.7 4.6 37.7 5.1 SLC38A1 "ATA1, NAT2, SAT1" ENSG00000111371 "Solute carrier family 38 member 1" Q9H2H9 12 46183063-46270017 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 374.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 77.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039460, HPA052272" Uncertain Supported NA NA "HPA039460: , HPA052272: AB_2681781" "unprognostic (8.92e-3)" "unprognostic (3.23e-2)" "unprognostic (9.47e-2)" "prognostic unfavorable (4.76e-6)" "unprognostic (1.00e-1)" "unprognostic (3.74e-1)" "prognostic unfavorable (6.95e-8)" "unprognostic (2.01e-3)" "unprognostic (1.38e-1)" "unprognostic (4.19e-3)" "unprognostic (2.44e-2)" "unprognostic (3.99e-2)" "unprognostic (1.19e-2)" "unprognostic (1.17e-1)" "unprognostic (2.56e-1)" "unprognostic (3.00e-1)" "unprognostic (5.55e-2)" 5.3 3.1 9.2 18.4 14.9 11.7 44.8 28.7 24.1 7.8 23.1 15.2 26.0 8.7 13.4 5.4 14.3 10.9 9.0 23.7 11.9 16.5 11.5 5.8 7.7 30.5 12.6 13.3 9.9 21.0 51.9 22.5 45.0 24.7 16.2 20.5 7.1 14.1 29.9 62.9 15.8 16.8 14.6 22.4 15.6 17.9 1.3 8.7 26.5 22.5 16.6 27.1 14.5 8.5 21.2 15.4 8.8 0.3 22.2 26.5 14.4 15.2 15.9 5.7 21.4 2.6 0.9 29.3 12.2 19.9 5.5 8.8 27.2 15.1 34.9 23.3 14.8 17.2 23.4 19.1 25.0 10.4 21.5 10.1 2.4 26.4 10.1 22.7 24.5 0.9 4.5 38.5 1.7 67.3 13.9 12.4 22.6 12.6 29.3 17.5 19.0 21.7 4.3 21.2 0.0 24.9 19.6 1.4 24.3 21.7 21.9 23.0 15.9 25.3 31.1 14.3 23.2 18.1 18.1 26.0 4.3 4.1 0.1 12.4 28.0 24.0 77.9 14.0 48.3 3.7 0.3 0.3 8.8 19.4 0.0 26.5 17.9 20.3 22.3 12.0 21.2 23.8 21.2 0.8 22.2 0.1 15.4 21.4 14.4 9.2 14.9 28.7 21.1 11.9 16.5 12.6 13.3 24.7 8.7 32.8 36.5 89.1 59.0 86.8 374.0 184.5 40.8 29.4 33.0 202.4 133.5 88.8 3.3 51.7 0.1 21.5 54.6 0.0 40.0 70.3 12.8 33.7 3.5 5.9 10.4 7.9 38.9 4.9 9.7 0.0 2.0 19.2 25.3 7.2 68.9 47.9 44.6 40.3 0.7 1.0 55.9 0.0 40.3 0.0 0.4 107.3 155.3 109.7 62.4 59.6 SLC38A10 "MGC15523, PP1744" ENSG00000157637 "Solute carrier family 38 member 10" Q9HBR0 17 81245000-81295547 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021374, HPA023161, HPA024631" Enhanced Enhanced "Golgi apparatus" NA NA 44000000 "Golgi apparatus" "HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860" "unprognostic (2.18e-2)" "unprognostic (1.54e-1)" "unprognostic (7.40e-2)" "unprognostic (3.00e-3)" "unprognostic (2.06e-2)" "unprognostic (1.69e-1)" "unprognostic (2.12e-1)" "unprognostic (2.63e-1)" "unprognostic (1.84e-1)" "unprognostic (1.92e-2)" "prognostic favorable (2.92e-4)" "unprognostic (8.39e-2)" "prognostic unfavorable (5.34e-7)" "unprognostic (6.55e-2)" "unprognostic (3.15e-1)" "unprognostic (1.31e-1)" "unprognostic (2.45e-1)" 22.8 18.6 8.1 17.0 11.3 18.5 43.0 9.9 10.2 15.8 23.8 13.8 22.0 21.8 17.4 30.7 13.2 15.2 28.4 17.3 7.4 9.2 18.0 59.2 24.6 23.7 11.6 6.7 23.7 55.1 6.8 30.2 23.2 10.0 16.0 6.5 15.1 33.3 26.1 8.7 11.2 26.2 10.9 10.4 21.0 19.1 25.0 12.3 20.2 25.9 10.3 15.8 18.4 13.0 6.6 10.0 17.2 15.4 4.6 9.8 7.9 17.3 30.5 5.3 28.1 20.6 9.7 31.9 21.4 19.3 13.1 15.5 14.1 29.2 13.3 24.5 14.7 14.5 21.0 5.4 10.7 4.9 13.3 16.0 13.4 10.9 23.9 18.4 13.1 32.1 16.8 8.0 11.8 7.7 10.7 25.1 9.7 9.9 20.6 9.8 22.1 8.0 22.5 5.3 16.1 15.1 13.0 11.2 13.4 9.2 16.4 10.3 26.7 17.2 10.8 23.3 7.8 15.4 27.5 24.6 21.2 12.4 15.8 11.4 18.1 7.9 7.6 12.6 20.4 21.7 11.0 10.2 17.2 8.1 12.0 9.8 6.6 7.8 9.8 6.3 6.6 5.4 5.8 8.2 4.6 15.4 10.0 5.5 7.9 8.1 11.3 9.9 10.2 7.4 9.2 11.6 6.7 10.0 12.3 23.8 35.2 11.2 10.8 7.3 11.5 14.7 40.8 6.7 18.2 10.4 17.7 47.8 5.0 33.0 17.9 21.0 56.4 0.0 23.2 52.2 22.1 16.5 15.0 66.3 42.5 23.8 43.3 27.6 39.2 46.8 30.5 26.6 13.5 19.0 55.6 28.3 24.6 42.1 25.8 20.3 9.1 32.3 15.3 16.7 21.5 6.4 52.3 17.5 40.8 10.0 SLC38A11 "AVT2, FLJ39822" ENSG00000169507 "Solute carrier family 38 member 11" Q08AI6 2 164896186-164955525 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 35.6" "Cell type enhanced" "Detected in some" 27 "Intestinal endocrine cells: 167.1;Sertoli cells: 71.1;Smooth muscle cells: 32.0" "Cancer enriched" "Detected in many" 5 "prostate cancer: 7.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 54 "memory B-cell: 2.7;naive B-cell: 7.9" "Lineage enriched" "Detected in single" 79 "B-cells: 7.9" "Cell line enriched" "Detected in some" 9 "BJ hTERT+: 75.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043432 Uncertain NA NA "HPA043432: AB_10793948" "unprognostic (1.52e-1)" "unprognostic (2.59e-1)" "unprognostic (4.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.41e-1)" "unprognostic (1.69e-2)" "unprognostic (6.28e-3)" "unprognostic (3.53e-2)" "unprognostic (2.41e-1)" "unprognostic (2.12e-1)" "unprognostic (1.15e-3)" "unprognostic (1.99e-1)" "prognostic favorable (2.00e-8)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "unprognostic (2.43e-2)" "unprognostic (2.36e-2)" 1.8 3.9 5.1 1.4 8.0 0.4 1.1 1.4 9.7 2.7 1.5 2.7 6.5 5.4 2.1 35.6 1.3 1.2 19.1 1.1 5.6 4.0 7.2 2.5 0.6 2.8 5.8 2.6 0.6 2.7 2.1 11.7 0.5 22.1 9.9 2.7 15.6 1.0 15.9 1.8 0.8 2.6 2.1 2.4 11.2 10.2 1.1 3.2 0.0 2.1 2.9 1.4 2.1 1.5 7.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.7 75.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 8.0 1.4 9.7 5.6 4.0 5.8 2.6 22.1 3.2 0.0 0.0 2.0 0.2 0.0 0.0 0.7 20.4 0.0 0.0 3.5 0.0 0.4 0.0 1.6 1.4 0.0 0.5 0.0 0.5 0.4 0.2 4.0 0.0 3.0 0.0 0.0 167.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 1.2 2.9 0.0 1.9 0.0 71.1 32.0 0.0 0.0 0.3 1.3 0.0 0.4 0.1 SLC38A2 "ATA2, KIAA1382, SAT2, SNAT2" ENSG00000134294 "Solute carrier family 38 member 2" Q96QD8 12 46358189-46372867 "Predicted membrane proteins" "Amino-acid transport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Basal keratinocytes: 993.3;Suprabasal keratinocytes: 942.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 135.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035180 Approved Uncertain Vesicles NA NA Vesicles "HPA035180: AB_10669901" "unprognostic (6.61e-3)" "unprognostic (2.87e-2)" "unprognostic (4.88e-2)" "unprognostic (2.51e-2)" "unprognostic (2.96e-1)" "unprognostic (1.00e-2)" "unprognostic (7.78e-2)" "unprognostic (5.50e-3)" "unprognostic (1.20e-1)" "unprognostic (3.79e-1)" "unprognostic (9.24e-3)" "unprognostic (1.75e-1)" "unprognostic (1.47e-1)" "unprognostic (5.08e-2)" "unprognostic (3.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.68e-2)" 44.7 45.4 19.9 23.3 34.5 27.0 72.0 34.5 40.6 36.2 25.5 23.6 20.0 11.6 45.2 16.2 47.1 36.6 46.8 39.2 24.2 14.0 27.4 102.9 51.9 34.5 54.4 15.2 49.3 27.3 54.3 16.2 76.6 32.6 25.7 17.8 17.7 36.6 20.3 47.8 69.5 25.1 40.4 60.0 28.6 29.2 19.7 43.8 40.7 32.0 35.6 26.2 36.0 49.3 12.1 24.7 17.9 13.5 30.0 15.3 12.7 8.4 20.0 17.4 47.6 40.5 40.9 12.6 40.1 103.1 35.2 29.1 11.9 16.1 0.0 54.0 68.5 23.5 29.2 12.1 37.3 34.5 6.8 6.8 11.0 24.4 36.6 62.3 8.9 11.7 40.9 81.3 22.2 135.9 86.7 29.8 12.4 10.8 17.1 62.4 10.6 10.9 13.1 14.8 0.0 20.9 9.9 12.9 21.0 21.5 19.1 11.5 9.9 27.1 7.6 24.4 19.7 15.4 20.9 49.0 16.9 13.4 7.2 6.3 19.7 18.6 10.4 16.3 32.4 8.3 17.9 13.5 10.5 14.3 7.8 11.1 12.1 12.0 14.2 20.8 11.9 15.2 15.3 10.5 30.0 10.1 24.7 13.9 12.7 19.9 34.5 34.5 40.6 24.2 14.0 54.4 15.2 32.6 43.8 77.4 94.1 77.1 114.9 993.3 38.3 137.9 99.3 25.4 56.9 54.1 66.8 40.9 5.0 36.4 4.2 142.4 78.6 186.9 43.6 41.4 160.4 157.7 78.7 245.9 47.8 50.9 73.5 233.9 166.5 5.0 243.7 110.6 237.8 20.8 107.5 73.3 64.3 63.0 79.9 22.3 73.5 278.1 220.9 7.2 14.7 942.6 32.2 136.8 67.6 105.8 SLC38A3 "G17, SN1" ENSG00000188338 "Solute carrier family 38 member 3" Q99624 3 50205246-50221486 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 107.8" "Group enriched" "Detected in many" 7 "Bipolar cells: 86.1;Cone photoreceptor cells: 176.7;Hepatocytes: 93.4;Muller glia cells: 75.9;Rod photoreceptor cells: 112.3" "Cancer enriched" "Detected in many" 9 "liver cancer: 140.0" "Cell type enhanced" "Detected in some" "basophil: 5.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Hep G2: 32.4;SCLC-21H: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031871 Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA031871: AB_2674080" "unprognostic (2.14e-1)" "unprognostic (2.10e-1)" "unprognostic (8.60e-2)" "unprognostic (6.19e-4)" "unprognostic (7.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.34e-2)" "unprognostic (2.30e-2)" "unprognostic (4.68e-3)" "unprognostic (1.46e-1)" "unprognostic (2.06e-1)" "unprognostic (5.71e-2)" "unprognostic (1.23e-3)" "unprognostic (1.90e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.96e-1)" 0.7 0.3 3.4 0.3 5.2 0.5 0.7 2.4 10.5 0.3 0.3 10.3 0.0 0.7 0.4 0.4 0.6 0.4 0.4 2.0 4.1 1.5 107.8 0.3 0.4 3.4 4.0 2.4 11.6 1.8 0.7 0.6 7.8 0.4 0.3 22.2 0.9 0.3 10.4 0.5 0.4 0.3 4.7 0.3 0.9 0.7 5.2 0.0 0.6 1.9 0.4 0.3 0.0 1.1 1.0 5.6 0.8 1.5 0.8 0.2 0.0 0.0 0.8 4.9 0.0 0.0 1.3 0.0 0.0 0.9 0.4 2.9 0.1 0.1 0.8 0.0 0.2 0.0 1.3 0.0 0.6 0.1 0.4 0.0 0.6 32.4 0.1 0.3 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.4 0.5 0.1 0.0 0.4 0.3 0.0 0.1 0.2 10.8 0.9 0.5 0.1 0.0 1.5 1.3 0.2 0.0 0.2 0.9 0.0 0.7 0.3 0.0 0.1 0.1 0.2 0.1 5.6 0.8 0.9 0.6 0.2 0.4 0.7 0.5 0.4 0.2 1.1 0.6 0.8 3.3 1.5 0.2 1.0 0.4 0.2 0.0 0.0 1.9 0.1 0.0 86.1 2.8 15.3 0.0 0.0 0.0 176.7 0.2 0.0 0.7 0.1 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 93.4 0.1 7.9 3.4 0.0 3.3 0.0 2.0 0.0 0.0 1.0 0.0 75.9 0.8 0.0 0.4 1.4 112.3 0.0 0.0 1.0 1.8 0.0 1.1 0.0 0.0 0.0 SLC38A4 "ATA3, NAT3, PAAT" ENSG00000139209 "Solute carrier family 38 member 4" Q969I6 12 46764761-46832408 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "liver: 128.2" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 251.9" "Cancer enriched" "Detected in many" 14 "liver cancer: 61.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basophil: 3.0;NK-cell: 1.9" "Group enriched" "Detected in many" 8 "granulocytes: 3.0;NK-cells: 1.9" "Cell line enhanced" "Detected in some" "ASC diff: 8.8;LHCN-M2: 21.7;RH-30: 7.2;RT4: 42.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (3.81e-2)" "unprognostic (7.46e-3)" "unprognostic (5.22e-3)" "unprognostic (1.75e-2)" "unprognostic (3.12e-1)" "unprognostic (1.11e-1)" "prognostic favorable (5.37e-4)" "unprognostic (3.06e-2)" "unprognostic (2.57e-3)" "unprognostic (1.75e-2)" "unprognostic (1.95e-1)" "unprognostic (6.06e-2)" "unprognostic (2.84e-2)" "unprognostic (1.89e-2)" "unprognostic (8.28e-2)" "unprognostic (6.31e-3)" "unprognostic (2.21e-2)" 0.2 0.1 0.1 1.4 0.0 0.0 0.1 0.1 0.2 0.1 0.9 0.0 0.3 0.0 1.7 0.1 0.6 0.1 0.3 1.1 0.0 0.0 5.9 128.2 0.1 0.0 0.0 0.0 0.1 2.1 0.0 0.0 1.0 0.1 0.4 0.2 0.1 0.3 0.0 2.9 0.4 0.1 1.4 0.0 0.3 0.0 0.2 0.0 0.2 0.2 0.4 0.2 0.7 0.0 0.1 0.3 3.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 8.8 1.1 1.7 1.0 2.8 0.9 0.9 0.5 2.0 0.0 1.7 3.7 0.0 0.5 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 2.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 21.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 7.2 0.0 0.0 42.4 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.3 15.3 0.0 0.0 1.8 0.0 2.0 0.0 0.0 0.2 0.1 1.0 0.0 0.0 0.4 1.9 0.4 0.0 251.9 0.4 0.0 0.0 3.1 3.9 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.6 0.0 SLC38A5 "JM24, SN2" ENSG00000017483 "Solute carrier family 38 member 5" Q8WUX1 X 48458537-48470256 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 87.7" "Cell type enhanced" "Detected in many" 14 "Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 35.6;HBEC3-KT: 54.3;HeLa: 53.5;hTCEpi: 40.4;Karpas-707: 47.8;RPMI-8226: 87.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047411 Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" Cytosol "HPA047411: AB_10964355" "unprognostic (2.81e-1)" "unprognostic (4.87e-2)" "unprognostic (7.92e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-3)" "unprognostic (1.26e-1)" "unprognostic (7.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.52e-1)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.13e-4)" "unprognostic (2.99e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (1.27e-3)" "unprognostic (1.45e-1)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" 1.5 0.9 5.3 4.7 7.1 17.3 0.9 3.5 11.6 4.0 4.9 7.7 0.1 5.1 1.8 1.3 3.7 2.0 1.5 2.4 6.9 5.7 0.7 0.4 9.4 3.3 7.0 2.7 3.7 87.7 0.4 0.4 2.8 14.6 5.1 6.4 1.5 4.4 3.7 0.4 8.0 3.5 2.8 7.3 4.8 4.5 0.5 4.6 2.4 7.9 3.6 3.4 4.8 3.1 7.4 8.3 0.3 0.4 5.4 16.2 5.7 23.0 0.0 0.0 0.2 0.4 2.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 24.2 0.0 10.2 0.0 35.6 27.6 54.3 0.0 7.7 0.0 13.1 53.5 16.6 4.0 26.8 0.0 3.8 40.4 0.5 0.1 0.0 0.4 5.9 24.1 47.8 5.4 0.0 5.8 9.3 12.5 0.0 0.1 21.3 0.1 87.9 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.1 0.0 1.1 0.7 0.1 0.0 0.0 0.0 0.0 0.1 8.7 0.2 0.1 0.1 0.0 0.2 0.2 11.5 0.4 16.2 7.4 12.6 10.8 1.5 4.7 6.0 7.7 0.3 5.4 0.0 8.3 13.0 5.7 5.3 7.1 3.5 11.6 6.9 5.7 7.0 2.7 14.6 4.6 0.0 1.1 0.8 1.6 23.7 0.6 0.4 0.0 1.4 0.0 5.2 17.7 0.1 0.0 4.9 0.4 3.1 2.3 23.3 67.4 0.4 5.6 0.9 4.6 0.4 2.5 0.0 0.0 0.0 0.0 0.7 2.3 1.1 8.5 2.8 12.3 0.0 93.7 3.5 1.1 0.0 0.2 0.0 1.0 0.0 0.0 7.4 0.0 8.5 19.1 0.9 SLC38A6 NAT-1 ENSG00000139974 "Solute carrier family 38 member 6" Q8IZM9 14 60981114-61083733 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 130.6;Hofbauer cells: 89.9;Late spermatids: 97.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018508 Approved Approved "Plasma membrane,Cell Junctions,Microtubules" NA NA "Cell Junctions" "Plasma membrane, Microtubules" "HPA018508: AB_2190518" "unprognostic (7.08e-2)" "unprognostic (4.14e-2)" "unprognostic (1.75e-1)" "unprognostic (3.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (9.47e-6)" "unprognostic (9.89e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-2)" "unprognostic (2.20e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (1.37e-5)" "unprognostic (1.73e-1)" "unprognostic (4.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-1)" 26.1 16.9 8.3 6.7 16.6 4.0 11.4 9.7 14.0 8.1 7.1 5.2 5.5 4.5 10.0 20.5 5.0 8.4 14.4 5.4 8.8 8.6 16.9 9.2 12.2 9.6 8.6 10.9 9.9 6.1 23.8 21.5 13.7 14.3 8.1 10.1 10.9 11.7 6.4 4.1 4.6 5.6 8.0 7.6 10.8 6.4 10.9 6.5 8.8 9.7 7.1 7.2 11.6 8.1 2.4 5.2 0.2 8.6 0.7 5.2 3.4 7.1 10.0 3.2 5.9 33.9 12.3 2.2 5.4 16.2 5.1 4.8 2.5 19.6 1.7 9.3 4.9 10.8 6.3 3.1 5.5 4.8 2.4 1.4 3.0 4.1 6.5 11.1 1.5 5.8 9.7 2.3 5.0 5.9 21.1 6.8 2.7 4.1 3.7 17.9 4.0 2.7 3.9 2.0 4.3 6.6 0.5 9.5 5.5 15.0 4.0 1.5 1.2 4.5 3.3 8.7 4.7 4.7 2.6 7.2 8.0 3.4 9.3 3.0 0.7 2.1 0.6 16.4 1.3 6.3 0.0 8.4 0.1 2.2 8.6 2.6 2.4 4.0 2.9 4.4 2.2 3.3 4.3 0.2 0.7 5.4 5.2 5.2 3.4 8.3 16.6 9.7 14.0 8.8 8.6 8.6 10.9 14.3 6.5 20.8 4.1 2.7 10.8 4.6 18.5 2.8 5.1 34.8 5.7 5.2 21.6 5.0 1.7 4.1 130.6 6.7 2.2 0.0 2.5 7.9 8.5 6.5 5.8 4.0 89.9 4.8 4.1 3.7 20.7 97.9 10.0 19.2 5.0 1.8 2.3 14.2 6.0 2.0 5.6 16.8 25.0 0.0 6.6 15.1 10.6 2.5 5.6 4.4 2.8 5.9 SLC38A7 FLJ10815 ENSG00000103042 "Solute carrier family 38 member 7" Q9NVC3 16 58665109-58685104 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Early spermatids: 273.8;Late spermatids: 600.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041777 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041777: AB_10796782" "unprognostic (2.16e-3)" "unprognostic (2.30e-2)" "unprognostic (6.23e-3)" "prognostic favorable (6.87e-4)" "unprognostic (3.49e-1)" "unprognostic (8.08e-3)" "unprognostic (9.76e-3)" "unprognostic (6.34e-3)" "unprognostic (1.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.77e-1)" "unprognostic (4.90e-2)" "prognostic favorable (2.87e-4)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (7.50e-2)" "unprognostic (4.93e-3)" 7.0 11.1 10.6 6.7 10.0 2.7 7.2 7.7 13.7 6.2 5.3 10.6 6.8 4.8 6.0 7.4 6.0 4.2 6.5 13.8 7.2 7.2 7.4 12.1 5.2 4.3 6.1 11.0 4.7 5.0 16.9 10.2 8.4 8.3 5.2 6.9 8.9 6.1 5.6 9.6 5.3 4.9 8.5 5.8 10.3 5.4 27.1 6.6 4.2 8.0 8.1 5.1 6.5 6.3 2.8 6.1 2.5 8.6 2.3 5.2 6.6 4.4 7.0 6.9 10.6 14.4 8.7 13.0 10.5 12.2 14.8 10.3 6.5 6.9 2.8 6.0 14.6 11.9 10.8 6.6 7.3 8.8 1.8 6.0 3.2 5.8 10.5 21.9 6.6 9.2 17.4 15.4 10.3 6.8 8.0 15.1 6.7 9.4 4.3 10.7 5.3 2.6 3.9 7.5 4.7 10.4 9.6 7.5 7.6 6.5 10.2 5.1 7.7 15.8 10.8 4.6 9.7 5.1 2.8 11.8 8.1 6.2 14.0 3.1 6.3 4.1 3.2 11.0 4.0 6.0 0.2 8.6 2.5 5.2 8.4 3.1 1.9 3.3 3.8 6.1 2.8 2.7 2.9 0.8 2.3 7.5 2.1 2.2 6.6 10.6 10.0 7.7 13.7 7.2 7.2 6.1 11.0 8.3 6.6 3.0 4.1 0.5 3.9 3.4 9.7 11.2 2.5 4.0 3.4 10.4 11.8 7.3 3.3 12.6 273.8 4.7 3.9 0.0 7.4 7.9 5.7 3.0 1.1 8.5 31.3 15.9 12.6 8.6 8.6 600.3 8.9 7.1 8.5 2.8 3.6 8.0 10.5 3.5 8.1 4.6 7.1 6.5 5.1 6.2 6.1 3.8 12.8 1.8 5.1 2.7 SLC38A8 ENSG00000166558 "Solute carrier family 38 member 8" A6NNN8 16 84009667-84042636 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.1;liver: 4.5" "Group enriched" "Detected in some" 8 "Early spermatids: 2.8;Late spermatids: 9.5" "Cancer enriched" "Detected in single" 14 "melanoma: 6.5" "Group enriched" "Detected in some" 5 "amygdala: 6.1;cerebral cortex: 2.6;hypothalamus: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.5;HMC-1: 2.2;SCLC-21H: 8.7;SK-MEL-30: 1.3;SuSa: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (9.69e-2)" "unprognostic (6.16e-2)" "unprognostic (8.00e-3)" "unprognostic (6.40e-2)" "unprognostic (1.03e-1)" "unprognostic (8.20e-3)" "unprognostic (1.89e-1)" "unprognostic (7.70e-2)" "unprognostic (2.59e-1)" "unprognostic (2.16e-2)" "unprognostic (3.54e-2)" "unprognostic (1.37e-1)" "unprognostic (1.45e-1)" 0.2 0.1 6.1 0.2 0.6 0.0 0.2 0.2 2.9 0.2 0.2 0.2 0.2 0.3 0.2 2.2 0.2 0.0 0.2 1.4 0.6 2.5 0.2 4.5 0.2 0.2 0.7 0.2 0.2 1.3 0.5 1.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 2.3 2.4 0.2 2.1 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.1 0.0 0.0 1.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.6 0.2 2.6 0.6 2.5 0.7 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 9.5 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 SLC38A9 FLJ90709 ENSG00000177058 "Solute carrier family 38 member 9" Q8NBW4 5 55625845-55773194 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 44.2" "Cell type enhanced" "Detected in many" 20 "Cytotrophoblasts: 168.8;Early spermatids: 189.6;Syncytiotrophoblasts: 518.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043785, HPA061702" Uncertain Supported Vesicles NA NA Vesicles "HPA043785: AB_10961859, HPA061702: " "unprognostic (4.80e-2)" "unprognostic (1.18e-1)" "unprognostic (3.26e-2)" "prognostic unfavorable (7.24e-5)" "unprognostic (2.49e-1)" "unprognostic (8.19e-2)" "unprognostic (8.35e-2)" "unprognostic (7.95e-2)" "unprognostic (5.47e-2)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" "unprognostic (4.87e-1)" "unprognostic (4.18e-3)" "unprognostic (1.76e-1)" "unprognostic (2.25e-1)" "unprognostic (2.84e-2)" "unprognostic (1.12e-1)" 7.2 6.3 8.2 6.9 8.0 5.2 6.8 9.9 9.7 6.4 7.5 9.2 6.7 6.6 7.5 5.9 9.0 5.8 7.1 3.9 6.2 6.4 6.7 13.5 6.4 8.4 9.4 6.4 6.9 18.2 10.1 11.8 44.2 8.6 5.9 8.5 6.7 7.6 5.3 5.2 6.2 7.1 7.2 8.8 8.9 7.7 15.8 8.5 13.3 7.1 5.7 11.4 8.7 6.9 10.8 10.8 7.4 11.8 8.9 10.0 6.4 8.1 8.3 6.9 9.3 9.6 9.9 49.9 6.8 9.6 8.3 13.7 13.3 11.2 13.3 11.6 5.6 13.6 10.1 9.3 8.0 10.9 7.1 8.7 4.2 8.9 8.9 15.4 7.5 5.1 12.0 9.7 9.2 10.8 6.0 9.3 8.7 9.1 8.9 7.7 6.9 9.4 7.2 12.8 3.1 7.5 7.2 11.6 13.4 11.2 6.5 3.8 6.1 7.0 4.3 11.6 10.1 9.4 15.3 12.6 1.7 5.6 12.2 7.1 9.6 19.6 8.0 4.3 7.7 4.7 4.8 11.8 7.4 7.8 10.2 10.0 10.8 6.3 9.0 10.8 6.2 9.2 7.7 2.9 8.9 7.5 10.8 8.1 6.4 8.2 8.0 9.9 9.7 6.2 6.4 9.4 6.4 8.6 8.5 6.0 1.9 9.5 3.9 2.9 5.4 2.0 15.3 4.0 7.9 8.7 7.9 168.8 1.7 7.8 189.6 6.8 4.0 0.0 9.9 52.8 5.4 4.1 2.3 18.4 23.0 1.6 4.1 9.8 10.6 73.4 6.9 8.2 5.0 8.2 5.0 5.1 9.5 7.0 4.6 5.7 7.9 6.5 4.5 14.0 4.3 3.0 518.4 8.7 5.2 4.2 SLC39A1 "ZIP1, ZIRTL" ENSG00000143570 "Solute carrier family 39 member 1" Q9NY26 1 153959099-153968184 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 292.9;Extravillous trophoblasts: 244.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.27e-2)" "prognostic unfavorable (4.83e-4)" "unprognostic (1.13e-1)" "unprognostic (2.63e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (5.26e-5)" "prognostic unfavorable (4.12e-7)" "unprognostic (2.36e-2)" "unprognostic (2.62e-2)" "unprognostic (4.41e-1)" "unprognostic (4.83e-3)" "unprognostic (1.93e-1)" "unprognostic (5.10e-3)" "unprognostic (2.54e-2)" "unprognostic (1.23e-1)" "unprognostic (5.51e-2)" "unprognostic (6.68e-2)" 32.5 31.8 12.5 20.6 19.3 3.8 28.0 11.1 14.0 21.8 24.1 16.6 18.2 15.9 28.7 20.8 25.6 20.8 31.9 25.5 13.2 9.3 39.0 53.7 34.7 19.5 20.7 10.1 28.1 27.8 20.7 13.0 65.5 16.2 29.5 17.2 20.1 21.9 22.3 18.6 25.6 22.4 22.2 18.6 28.1 23.6 14.9 17.4 15.2 46.9 24.5 18.5 23.7 28.5 17.4 22.3 26.9 34.7 11.1 14.1 20.4 24.1 27.9 22.8 19.2 21.6 22.2 50.1 15.7 38.1 26.2 29.0 41.1 62.4 9.4 50.3 21.5 21.9 54.4 23.1 23.8 15.0 29.4 18.7 12.8 29.7 18.1 24.7 9.7 14.9 26.8 22.2 20.6 20.6 24.5 18.7 10.9 12.0 11.0 21.0 49.2 9.8 12.5 32.3 49.8 22.1 11.1 19.8 11.4 41.0 17.5 10.2 23.9 29.6 76.1 27.1 30.6 40.8 20.8 16.9 24.3 22.1 17.2 22.5 13.3 17.0 12.1 17.3 7.7 32.1 5.9 27.3 7.8 14.1 30.6 8.8 13.9 10.7 10.6 22.3 17.4 11.7 10.6 26.9 11.1 34.7 20.2 10.1 20.4 12.5 19.3 11.1 14.0 13.2 9.3 20.7 10.1 16.2 17.4 8.9 3.5 16.6 81.5 50.3 7.0 11.8 50.9 5.3 3.4 50.6 2.0 292.9 11.6 174.0 0.7 65.7 26.4 0.0 99.6 244.0 77.9 82.7 36.8 23.7 103.7 17.5 18.5 31.3 47.4 2.0 44.8 38.9 45.5 117.2 28.0 38.0 101.5 25.9 58.4 35.1 5.8 45.3 63.7 14.4 23.2 46.7 128.0 19.2 32.9 64.0 SLC39A10 "DKFZp564L2123, FLJ90515, KIAA1265" ENSG00000196950 "Solute carrier family 39 member 10" Q9ULF5 2 195575977-195737702 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.0;thyroid gland: 39.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036512, HPA036513, HPA066087" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 49000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613" "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (5.33e-2)" "unprognostic (1.33e-3)" "prognostic favorable (1.46e-5)" "unprognostic (7.40e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (2.10e-2)" "unprognostic (8.73e-2)" "unprognostic (2.84e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (8.46e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-2)" "unprognostic (3.68e-1)" "unprognostic (2.47e-2)" "unprognostic (6.89e-2)" 6.6 10.9 16.0 6.0 24.8 3.7 6.2 10.8 41.0 9.8 3.8 4.2 4.9 3.6 9.4 3.3 3.5 8.5 7.6 4.7 15.0 11.2 7.8 2.1 6.3 6.5 8.5 24.4 7.4 5.7 5.8 5.7 10.7 15.7 16.7 4.0 1.4 4.8 6.5 3.3 5.7 5.7 6.7 10.2 14.4 4.3 7.9 6.2 10.6 39.9 1.7 6.4 6.1 4.9 9.4 18.4 19.3 2.7 11.0 4.6 1.5 2.9 9.9 18.9 5.2 3.7 8.8 9.8 13.7 6.7 6.6 3.3 14.8 10.6 4.1 20.9 7.8 5.1 4.2 11.5 12.6 8.4 2.1 8.6 4.6 15.4 12.1 4.1 16.8 1.9 5.2 1.8 7.3 8.4 23.4 14.8 4.2 13.3 5.8 10.6 2.8 4.8 5.2 22.0 17.2 7.8 11.3 6.6 10.2 28.8 4.9 7.3 10.0 13.7 28.0 7.2 34.5 4.5 10.5 14.5 12.1 14.0 7.9 7.1 2.0 1.2 2.4 9.7 7.9 12.2 19.3 2.7 1.9 4.5 2.5 3.5 6.8 4.0 3.7 3.3 9.4 3.5 4.6 0.5 11.0 1.8 18.4 3.9 1.5 16.0 24.8 10.8 39.7 15.0 11.2 8.5 24.4 15.7 6.2 3.0 10.9 18.2 9.3 22.8 21.9 7.3 7.6 6.7 29.6 34.9 7.9 41.3 1.7 17.6 23.2 27.0 2.9 23.3 9.5 54.8 20.3 18.5 12.7 2.5 21.6 7.9 15.0 24.5 18.1 11.5 17.5 29.7 6.8 8.2 5.1 15.6 17.5 2.9 17.7 14.9 19.9 12.9 13.8 47.8 27.0 17.9 19.6 21.5 4.5 6.4 SLC39A11 C17orf26 ENSG00000133195 "Solute carrier family 39 member 11" Q8N1S5 17 72645949-73092712 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 49.0;Mucus-secreting cells: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 48.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021455 Approved Nucleoplasm NA NA Nucleoplasm "HPA021455: AB_2670710" "unprognostic (2.29e-2)" "unprognostic (2.75e-1)" "unprognostic (1.25e-1)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (1.82e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (3.45e-3)" "unprognostic (2.30e-1)" "unprognostic (1.57e-3)" "unprognostic (5.26e-2)" "unprognostic (1.17e-1)" "unprognostic (4.96e-3)" "unprognostic (3.85e-2)" 10.4 7.4 12.4 7.8 17.9 10.7 10.8 5.3 14.4 9.3 13.3 19.8 6.6 11.5 4.8 9.6 13.0 5.6 8.6 4.2 13.3 6.3 7.9 21.9 8.2 4.8 27.8 6.6 2.8 23.8 3.1 3.8 7.0 15.3 5.3 13.8 6.7 16.6 5.2 3.7 11.2 12.7 5.7 15.7 6.5 27.6 4.1 22.5 6.0 20.6 3.6 8.6 8.3 7.6 6.0 14.9 9.8 16.2 8.7 6.9 6.3 4.3 7.9 0.9 3.8 6.9 5.6 5.4 4.6 4.1 2.1 2.9 2.9 19.7 5.4 4.8 4.7 3.4 3.7 1.3 2.3 3.3 5.8 2.8 5.0 2.1 3.4 4.1 5.3 48.4 4.8 4.5 4.4 2.6 2.3 2.2 2.8 2.6 6.8 2.7 6.1 3.4 11.6 0.7 13.3 3.4 2.3 3.6 4.5 3.5 4.5 2.2 3.1 2.5 18.7 2.8 3.9 12.8 7.4 1.8 4.2 4.0 3.6 2.8 5.5 2.5 3.8 6.9 10.8 2.4 5.5 16.2 9.8 6.9 15.4 4.6 6.0 5.3 5.2 14.9 3.9 3.8 5.2 2.5 8.7 11.9 10.5 6.5 6.3 12.4 17.9 5.3 14.4 13.3 6.3 27.8 6.6 15.3 22.5 0.0 4.6 3.7 4.4 3.9 2.3 2.0 7.6 6.7 7.9 3.5 0.0 4.7 0.0 6.8 19.2 3.6 19.9 23.3 12.3 14.7 3.6 5.1 29.9 25.0 25.0 4.8 8.1 4.3 15.5 49.0 3.7 7.6 10.1 15.4 73.3 3.9 8.3 20.4 3.2 9.8 1.5 12.9 6.1 1.9 2.5 3.9 4.1 3.2 14.7 6.3 SLC39A12 FLJ30499 ENSG00000148482 "Solute carrier family 39 member 12" Q504Y0 10 17951839-18043292 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "brain: 42.3;retina: 19.2" "Cell type enriched" "Detected in some" 30 "Muller glia cells: 85.4" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.43e-2)" "unprognostic (2.67e-1)" "unprognostic (3.30e-1)" "unprognostic (8.70e-2)" "unprognostic (1.02e-1)" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.40e-6)" "unprognostic (1.94e-1)" "unprognostic (8.11e-2)" "unprognostic (3.76e-2)" 1.2 1.0 13.7 1.0 14.6 0.9 2.3 2.2 31.2 0.9 1.0 14.8 0.0 0.9 0.9 0.9 0.9 0.9 0.9 1.0 21.4 5.5 0.9 0.9 1.0 0.9 9.9 5.6 0.9 1.2 0.9 1.5 1.1 42.3 1.0 1.1 19.2 1.0 0.9 0.9 0.9 0.9 1.0 1.5 1.0 0.9 1.4 8.7 0.0 0.9 0.0 0.9 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.3 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 14.6 2.2 17.5 21.4 5.5 9.9 5.6 42.3 8.7 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.5 0.3 0.0 0.0 0.0 0.0 85.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 SLC39A13 FLJ25785 ENSG00000165915 "Solute carrier family 39 member 13" Q96H72 11 47407132-47416501 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 11 "Early spermatids: 250.1;Late spermatids: 701.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043971 Approved NA NA "HPA043971: AB_10959744" "unprognostic (7.84e-2)" "unprognostic (1.02e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.18e-1)" "unprognostic (8.56e-3)" "unprognostic (3.81e-2)" "unprognostic (7.44e-3)" "unprognostic (1.36e-1)" "unprognostic (5.40e-2)" "prognostic unfavorable (2.73e-5)" "unprognostic (1.39e-2)" "unprognostic (2.04e-2)" "prognostic favorable (1.96e-4)" "unprognostic (3.16e-1)" "unprognostic (1.73e-1)" "unprognostic (8.61e-2)" "unprognostic (4.12e-1)" 17.0 19.2 14.1 19.7 17.0 6.3 15.1 25.6 21.8 17.8 18.6 18.8 12.4 12.1 32.1 20.2 17.1 18.5 19.0 35.5 16.1 10.3 39.9 17.6 23.2 14.8 18.5 15.0 21.3 20.7 19.0 21.0 34.5 15.5 20.5 6.3 23.8 20.0 24.9 19.8 27.1 12.0 22.8 10.6 15.3 16.1 25.9 16.4 9.8 18.7 9.3 10.4 19.5 15.7 5.8 5.0 6.5 14.4 6.7 13.2 5.2 7.4 6.6 7.8 8.7 19.1 26.8 2.2 30.0 22.2 16.8 19.2 2.6 5.1 2.9 8.2 22.5 16.6 12.6 2.3 20.1 4.7 8.4 8.8 1.5 15.7 5.3 28.7 2.5 3.7 22.3 14.5 10.6 8.7 21.1 17.9 5.6 1.4 6.4 18.0 6.6 5.4 3.7 3.7 6.3 9.9 6.6 11.4 2.9 28.4 3.6 6.9 12.5 9.0 16.1 8.4 3.0 10.7 3.8 24.9 25.7 11.9 29.3 13.6 5.0 1.6 1.2 28.4 3.6 18.6 2.0 3.6 3.0 13.2 13.7 8.8 4.5 8.7 9.3 4.6 5.8 8.3 6.8 6.5 6.7 14.4 5.0 4.5 5.2 14.1 17.0 25.6 21.8 16.1 10.3 18.5 15.0 15.5 16.4 8.9 5.4 2.2 16.0 16.3 23.6 15.5 10.2 1.4 5.7 27.9 11.8 8.4 8.3 29.6 250.1 17.6 4.0 0.0 18.1 14.1 34.0 9.3 5.7 5.0 17.2 30.2 9.2 19.0 4.8 701.9 30.5 10.7 18.6 44.1 7.3 15.8 25.0 6.2 37.8 7.3 15.8 45.3 20.3 12.5 5.7 3.6 16.4 8.6 5.5 6.7 SLC39A14 "KIAA0062, NET34, ZIP14" ENSG00000104635 "Solute carrier family 39 member 14" Q15043 8 22367249-22434129 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Disease mutation, Dystonia, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 135.5;pancreas: 77.2" "Cell type enriched" "Detected in many" 8 "Hepatocytes: 491.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BJ hTERT+: 66.5" "Low region specificity" "Detected in all" "HPA016508, HPA056732" Enhanced Approved "Endoplasmic reticulum,Golgi apparatus,Plasma membrane" NA NA 950000 "Endoplasmic reticulum, Golgi apparatus, Plasma membrane" "HPA016508: AB_1857148, HPA056732: " "unprognostic (1.67e-1)" "unprognostic (6.67e-3)" "prognostic favorable (5.00e-5)" "unprognostic (9.83e-3)" "unprognostic (9.21e-3)" "unprognostic (8.99e-3)" "unprognostic (1.99e-1)" "unprognostic (2.91e-2)" "unprognostic (4.95e-2)" "unprognostic (5.66e-2)" "unprognostic (6.64e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.79e-7)" "unprognostic (4.88e-2)" "unprognostic (8.73e-2)" "unprognostic (1.63e-2)" "unprognostic (1.11e-3)" 15.0 16.1 2.6 7.7 5.4 0.1 45.5 2.4 6.1 3.6 13.7 1.9 2.8 31.6 6.7 2.8 3.9 5.6 9.8 41.1 2.8 2.4 10.4 135.5 4.8 5.3 3.7 1.9 10.6 77.2 3.0 6.4 4.0 9.2 5.1 11.4 4.1 20.2 4.4 46.1 4.4 18.2 14.1 4.7 2.3 16.2 5.9 2.8 0.7 25.1 2.1 1.4 11.3 19.0 5.0 1.8 2.5 0.5 2.9 8.7 3.9 10.4 13.9 3.9 7.8 14.0 11.8 8.5 15.0 66.5 23.5 37.1 46.2 9.9 10.4 8.5 17.6 61.2 11.5 19.2 18.7 38.8 10.8 11.0 8.3 11.1 46.5 33.3 5.7 9.1 12.5 15.3 41.6 29.1 11.9 10.4 7.5 7.2 10.7 11.9 4.8 8.6 3.6 23.7 16.6 10.7 12.3 7.3 22.2 8.6 4.5 6.6 10.3 15.3 6.6 31.0 8.7 5.2 8.3 5.7 29.2 14.9 18.4 15.4 6.2 5.6 13.6 41.3 7.6 17.0 0.0 0.5 2.5 8.3 0.1 8.7 5.0 4.8 6.3 1.8 2.6 5.7 7.6 0.2 2.9 0.1 0.8 3.8 3.9 2.6 5.4 2.4 6.1 2.8 2.4 3.7 1.9 9.2 2.8 3.0 4.8 3.7 8.8 29.7 7.1 50.1 50.9 0.0 3.4 7.0 2.0 0.2 1.7 48.7 0.4 31.6 63.6 0.0 63.9 2.1 30.9 17.2 0.0 491.4 1.5 46.1 32.0 31.9 15.9 1.8 22.2 1.6 42.2 4.6 51.4 4.6 55.6 28.8 39.3 21.4 7.4 0.0 46.7 0.0 2.4 18.3 0.5 4.9 33.7 9.8 SLC39A2 ZIP2 ENSG00000165794 "Solute carrier family 39 member 2" Q9NP94 14 20999255-21001871 "Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8" "Cell type enriched" "Detected in some" 4 "Muller glia cells: 21.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 67 "HaCaT: 23.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA030489, HPA073231" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" NA NA "Plasma membrane" "Cytoplasmic bodies" "HPA030489: AB_10601488, HPA073231: " "unprognostic (2.76e-2)" "unprognostic (4.86e-2)" "unprognostic (9.72e-2)" "unprognostic (2.37e-1)" "unprognostic (2.46e-1)" "unprognostic (2.71e-1)" "unprognostic (3.42e-1)" "unprognostic (1.70e-1)" "unprognostic (4.43e-1)" "unprognostic (6.20e-3)" "unprognostic (3.31e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-2)" "unprognostic (1.91e-1)" "unprognostic (5.80e-2)" "unprognostic (3.71e-1)" "unprognostic (2.30e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 1.3 0.3 0.4 5.6 1.2 0.0 44.3 0.0 0.8 0.0 13.0 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.4 0.2 1.0 0.2 8.5 0.8 0.4 2.7 50.6 0.1 23.8 0.1 0.2 0.1 0.1 0.0 0.1 0.0 1.3 0.1 6.1 3.3 1.2 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 23.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.8 4.2 SLC39A3 ZIP3 ENSG00000141873 "Solute carrier family 39 member 3" Q9BRY0 19 2732204-2740152 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 234.7;Late spermatids: 338.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042139, HPA058526" Uncertain Approved Vesicles NA NA Vesicles "HPA042139: AB_10793875, HPA058526: AB_2683743" "unprognostic (1.81e-1)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "prognostic favorable (9.76e-5)" "unprognostic (2.26e-1)" "unprognostic (2.44e-2)" "unprognostic (9.88e-3)" "unprognostic (1.01e-1)" "unprognostic (6.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.37e-3)" "unprognostic (4.07e-2)" "unprognostic (1.75e-3)" "unprognostic (9.22e-3)" "unprognostic (6.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.80e-2)" 11.1 15.5 13.3 8.3 18.0 23.9 13.3 10.6 28.0 12.7 10.8 14.0 8.3 10.2 14.3 19.5 10.5 14.6 10.5 11.7 14.4 13.0 11.0 23.6 9.0 11.7 11.5 12.9 11.0 11.9 17.8 15.5 10.6 14.9 10.8 8.8 10.7 12.4 11.7 11.2 8.1 9.4 14.0 11.1 12.9 9.3 50.1 8.8 13.0 12.5 6.8 9.4 14.2 7.8 24.4 38.0 29.6 17.5 13.1 17.5 15.4 11.9 9.7 7.3 18.0 15.2 10.4 7.4 8.7 10.3 16.1 16.5 10.5 7.8 7.4 5.6 14.9 12.8 9.7 11.2 11.6 10.1 0.0 8.0 32.5 7.2 10.5 16.8 26.9 47.6 9.3 18.8 11.9 9.8 5.8 8.2 13.9 35.6 33.1 10.8 7.7 13.2 20.2 7.8 10.6 12.9 17.5 4.8 22.0 7.6 9.3 10.1 9.2 7.6 5.4 18.1 4.9 9.5 35.3 5.0 11.3 6.2 17.5 12.6 9.0 14.1 7.0 8.5 90.6 13.4 16.4 17.5 29.6 17.5 16.1 15.4 24.4 15.4 14.9 23.4 24.4 12.9 14.5 7.8 13.1 15.5 38.0 9.7 15.4 13.3 18.0 10.6 28.0 14.4 13.0 11.5 12.9 14.9 8.8 3.0 3.2 33.4 14.3 9.2 19.5 6.7 28.1 5.3 5.7 7.0 7.9 32.9 14.9 40.6 234.7 14.4 18.4 70.0 53.8 46.9 22.6 24.4 25.3 27.7 57.4 46.1 23.1 17.2 18.1 338.5 19.8 24.6 23.6 28.9 16.6 28.8 36.0 20.3 26.2 18.0 15.4 25.8 15.1 118.7 27.5 8.5 22.1 20.0 23.4 14.6 SLC39A4 "AEZ, AWMS2, ZIP4" ENSG00000147804 "Solute carrier family 39 member 4" Q6P5W5 8 144409742-144416895 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 77.7" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 153.2;Proximal tubular cells: 139.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "CAPAN-2: 17.7;Hep G2: 45.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.59e-1)" "unprognostic (2.35e-3)" "unprognostic (9.16e-2)" "unprognostic (3.84e-2)" "unprognostic (5.63e-3)" "unprognostic (1.46e-1)" "unprognostic (5.40e-2)" "unprognostic (1.54e-1)" "unprognostic (1.61e-1)" "unprognostic (3.28e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-1)" "prognostic favorable (9.04e-4)" "unprognostic (2.78e-2)" "unprognostic (3.97e-1)" "unprognostic (9.04e-3)" "unprognostic (1.87e-1)" 0.2 0.0 0.5 1.1 0.2 0.1 0.2 0.2 1.1 0.2 73.9 0.2 0.2 42.1 0.2 0.4 0.2 0.3 0.7 0.2 0.2 0.0 8.3 0.4 1.3 0.2 0.2 0.2 1.5 0.6 0.0 0.3 0.4 0.2 0.4 0.1 0.2 0.5 0.2 0.2 0.0 77.7 0.2 0.2 0.2 1.2 0.4 0.2 0.2 2.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 17.7 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 2.9 0.4 0.7 0.1 45.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 1.0 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.2 0.4 0.9 0.0 0.2 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.2 1.1 0.2 0.0 0.2 0.2 0.2 0.2 17.9 22.7 23.4 28.9 16.7 0.1 5.6 22.9 26.8 13.6 40.1 0.0 15.3 43.1 36.9 1.1 9.8 153.2 23.3 37.2 53.2 13.5 30.9 36.9 22.7 29.1 3.2 40.9 7.4 15.7 1.3 7.5 21.5 20.3 27.1 76.6 7.1 53.4 115.8 6.0 139.9 1.0 6.5 11.4 1.6 32.4 26.2 9.4 12.9 78.9 35.2 SLC39A5 ENSG00000139540 "Solute carrier family 39 member 5" Q6ZMH5 12 56230049-56237846 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 77.8;liver: 38.2;pancreas: 101.1" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 110.0;Enterocytes: 260.0;Hepatocytes: 140.6;Mucus-secreting cells: 92.0;Paneth cells: 142.5;Proximal tubular cells: 149.4;Undifferentiated cells: 142.6" "Cancer enhanced" "Detected in many" "liver cancer: 36.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 51 "CACO-2: 22.8;Hep G2: 32.9" "Region enhanced" "Detected in single" "basal ganglia: 0.9" "Not detected" "Not detected" HPA018423 Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA018423: AB_1857154" "unprognostic (5.94e-3)" "unprognostic (8.29e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-7)" "unprognostic (1.73e-1)" "unprognostic (7.79e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.93e-3)" "prognostic favorable (5.05e-4)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.96e-4)" 0.2 0.1 0.2 4.1 0.2 0.0 0.2 0.2 0.2 0.2 40.5 0.2 0.2 48.6 0.2 2.3 0.2 0.1 5.9 0.2 0.2 0.1 22.5 38.2 0.2 0.2 0.2 0.2 0.2 101.1 0.0 0.2 0.2 0.2 0.2 9.1 0.2 0.2 0.2 0.2 0.1 77.8 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 22.8 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 32.9 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.1 0.1 0.2 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 2.2 0.0 0.6 0.6 0.2 12.7 0.0 0.0 3.5 110.0 0.0 16.6 0.3 0.4 0.1 260.0 0.0 17.7 0.0 0.1 0.1 0.0 140.6 0.1 0.0 24.3 2.5 1.3 0.0 0.0 0.0 0.0 1.0 92.0 0.5 12.1 142.5 0.0 149.4 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 142.6 0.0 SLC39A6 LIV-1 ENSG00000141424 "Solute carrier family 39 member 6" Q13433 18 36108532-36129385 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 212.3" "Cancer enhanced" "Detected in all" "breast cancer: 361.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042377 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA042377: AB_2677968" "unprognostic (7.60e-2)" "unprognostic (2.27e-2)" "unprognostic (5.50e-3)" "unprognostic (2.58e-3)" "unprognostic (1.02e-1)" "unprognostic (4.87e-3)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (1.18e-1)" "unprognostic (3.19e-1)" "unprognostic (4.50e-2)" "unprognostic (7.63e-3)" "unprognostic (2.16e-1)" "unprognostic (4.74e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" 11.1 12.6 14.3 8.6 13.4 4.3 63.5 19.4 14.7 15.7 8.7 16.0 68.7 4.1 24.7 24.5 9.8 27.7 10.3 8.2 14.2 17.5 12.3 7.7 7.9 8.2 18.3 8.7 30.5 15.5 32.1 23.9 52.5 16.0 55.2 5.9 25.1 15.5 51.5 7.7 22.6 5.7 12.7 21.7 11.2 8.1 9.9 13.5 8.0 15.7 10.7 11.3 23.8 20.2 12.6 25.2 22.2 14.6 12.9 15.6 9.7 10.4 13.2 31.7 18.6 33.5 24.8 8.3 28.5 33.8 19.1 22.5 7.3 11.6 11.3 14.4 27.4 13.3 25.5 27.6 26.7 29.1 25.1 10.0 4.9 18.6 10.6 21.3 16.5 12.4 22.6 59.1 29.0 25.3 17.6 2.8 9.4 2.5 22.8 26.8 16.0 16.2 3.7 7.6 5.7 7.5 16.8 18.1 14.8 21.3 35.2 33.4 29.4 35.1 10.3 48.1 13.6 14.0 7.8 4.6 46.7 7.8 8.8 14.3 21.5 20.8 8.6 16.1 11.7 24.5 19.5 9.8 22.2 13.0 14.6 15.6 12.6 11.1 11.5 12.2 12.3 9.8 14.2 7.5 12.9 13.7 25.2 12.2 9.7 14.3 13.4 19.4 12.4 14.2 17.5 18.3 8.7 16.0 13.5 35.7 16.0 13.7 44.4 40.8 40.2 16.6 10.2 42.8 60.3 40.1 31.4 5.4 1.7 46.8 16.8 10.8 2.8 0.0 32.7 50.5 40.3 212.3 23.1 7.9 18.4 22.3 24.5 7.4 15.6 14.6 34.5 25.1 64.1 24.4 6.7 35.8 34.0 0.0 44.9 13.9 25.8 38.8 37.6 43.4 22.9 65.1 19.9 16.0 4.1 55.4 SLC39A7 "D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7" ENSG00000112473 "Solute carrier family 39 member 7" Q92504 6 33200445-33204439 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053999 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA053999: AB_2682338" "unprognostic (3.63e-2)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (3.24e-2)" "unprognostic (8.95e-2)" "unprognostic (2.51e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (4.87e-2)" "unprognostic (9.92e-2)" "unprognostic (7.20e-3)" "unprognostic (3.29e-1)" "unprognostic (2.40e-1)" "unprognostic (1.99e-2)" "unprognostic (4.80e-1)" "unprognostic (1.50e-1)" "unprognostic (8.22e-3)" "unprognostic (1.12e-2)" 14.7 25.1 9.0 12.1 9.5 6.1 15.8 11.9 11.9 24.7 19.8 12.2 43.3 17.3 20.1 24.6 14.4 13.6 25.6 20.7 8.7 8.9 24.6 55.1 20.2 11.6 12.6 9.6 14.4 49.2 37.1 24.2 43.8 18.8 22.8 22.9 16.8 48.0 41.7 10.4 11.3 18.8 20.1 10.6 15.2 21.1 9.5 10.7 9.9 28.2 14.4 17.0 16.6 13.9 2.6 3.4 6.2 2.8 4.2 5.1 2.1 8.5 9.9 15.2 14.1 22.9 15.7 13.3 22.9 30.1 17.8 21.0 16.2 8.3 6.4 11.2 25.5 13.8 9.7 11.5 13.5 15.9 8.1 10.2 10.9 11.6 20.8 16.6 10.8 13.2 14.8 11.4 15.7 17.0 17.6 14.2 6.8 11.9 10.5 12.2 9.7 5.9 6.3 6.5 12.5 9.1 6.4 8.9 10.6 11.9 10.7 9.9 8.0 9.3 22.0 12.5 9.6 21.3 10.1 14.0 16.4 10.0 12.2 15.2 16.5 14.5 5.7 9.9 10.3 18.1 6.2 2.4 2.3 5.1 2.8 4.8 1.8 3.2 3.9 2.3 2.6 2.9 3.3 2.4 4.2 1.6 3.4 3.0 2.1 9.0 9.5 11.9 11.9 8.7 8.9 12.6 9.6 18.8 10.7 23.8 33.3 14.5 25.7 32.1 27.2 29.7 28.1 22.7 33.0 24.4 27.5 88.4 5.0 60.8 0.6 33.7 62.8 23.3 75.1 113.6 62.0 56.4 19.7 31.1 38.7 11.1 24.3 29.4 17.0 1.9 42.6 23.9 38.8 27.9 109.3 41.2 56.0 56.2 40.3 20.1 22.2 19.4 33.9 7.9 10.6 35.8 141.1 27.4 54.4 33.5 SLC39A8 BIGM103 ENSG00000138821 "Solute carrier family 39 member 8" Q9C0K1 4 102251041-102431258 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 67.3;salivary gland: 54.6" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 723.6;Alveolar cells type 2: 227.4;Extravillous trophoblasts: 184.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 45.5;HL-60: 33.1;Karpas-707: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038832, HPA038833" Approved NA NA "HPA038832: AB_2676226, HPA038833: AB_10670910" "prognostic favorable (6.69e-4)" "unprognostic (1.29e-2)" "prognostic favorable (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (6.50e-2)" "unprognostic (9.59e-2)" "unprognostic (6.07e-2)" "unprognostic (2.74e-1)" "unprognostic (1.20e-3)" "unprognostic (6.32e-2)" "unprognostic (5.46e-3)" "unprognostic (2.78e-2)" "prognostic favorable (6.34e-6)" "unprognostic (3.25e-1)" "unprognostic (6.54e-2)" "unprognostic (6.40e-2)" "unprognostic (7.13e-3)" 22.0 2.0 3.7 11.4 5.5 10.3 6.1 2.8 4.3 31.4 18.1 2.2 1.1 2.1 3.9 7.3 1.7 7.2 2.6 17.8 4.3 3.5 6.2 18.4 67.3 8.6 5.1 1.6 5.4 42.1 25.7 6.7 44.8 5.9 5.7 14.9 4.3 54.6 2.3 1.8 5.1 3.4 3.0 8.8 6.5 2.5 2.3 3.2 7.5 4.9 2.3 5.6 5.8 6.0 3.1 2.7 1.0 1.5 11.5 10.5 3.4 5.5 5.5 1.2 0.0 4.6 10.6 2.9 0.6 45.5 1.7 2.7 0.2 20.6 5.4 6.0 0.1 5.7 0.4 3.8 1.2 1.0 9.3 11.3 14.1 11.6 0.1 1.8 33.1 4.8 5.6 1.4 0.8 2.6 4.5 0.6 13.4 14.1 49.4 8.8 3.7 11.9 15.5 3.7 7.5 5.4 3.0 0.0 17.6 9.6 2.1 1.6 4.0 15.5 0.2 1.5 1.1 3.8 12.4 3.1 5.5 2.1 11.2 8.7 22.1 9.2 25.6 9.1 21.7 5.0 0.0 1.5 1.0 5.6 1.0 9.8 1.3 10.5 9.0 2.7 3.1 7.9 5.4 0.1 11.5 0.3 1.0 3.9 3.4 3.7 5.5 2.8 4.3 4.3 3.5 5.1 1.6 5.9 3.2 723.6 227.4 10.4 9.5 10.4 0.8 22.6 7.6 1.4 27.3 5.2 3.9 12.1 10.0 1.9 0.3 8.0 3.3 23.3 28.2 184.5 25.7 10.8 3.5 22.1 43.3 3.2 23.1 6.7 29.8 0.4 1.1 25.3 27.0 16.2 72.2 4.5 16.3 7.0 1.1 8.1 1.2 6.5 14.6 2.7 5.9 6.0 50.7 13.8 56.9 6.8 SLC39A9 FLJ11274 ENSG00000029364 "Solute carrier family 39 member 9" Q9NUM3 14 69398015-69462388 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 62.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007921, HPA075390" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA007921: AB_1080007, HPA075390: AB_2686748" "unprognostic (2.37e-1)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (4.35e-2)" "unprognostic (1.10e-1)" "unprognostic (5.50e-2)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.75e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.05e-6)" "unprognostic (1.20e-1)" "unprognostic (1.83e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" 15.8 22.2 19.5 11.3 19.2 8.8 24.8 15.0 26.3 19.5 25.5 22.4 20.6 20.8 19.1 25.6 22.3 16.5 16.7 14.5 18.9 19.1 31.2 52.9 15.7 13.0 17.8 13.7 16.3 28.0 24.5 24.6 29.7 17.1 19.4 22.7 17.0 65.2 24.2 7.7 16.7 27.8 16.3 19.3 16.3 19.8 17.4 14.1 18.3 22.4 13.7 19.2 14.5 14.6 9.9 17.2 12.5 14.8 9.2 12.5 9.2 29.4 23.2 14.9 15.0 25.6 19.9 13.4 18.1 21.0 15.5 17.9 17.4 27.9 24.0 13.2 20.9 7.9 24.3 16.2 17.0 19.6 16.2 8.7 15.2 13.2 13.2 19.2 11.2 21.6 16.0 27.2 14.2 21.4 16.6 16.2 20.4 11.6 24.0 18.0 16.4 16.7 12.1 11.9 24.7 16.5 16.9 21.0 15.6 20.9 32.2 15.3 25.1 17.5 30.6 10.5 12.0 43.0 18.3 17.2 28.4 20.3 11.8 12.3 26.4 14.7 18.5 26.8 12.8 23.1 11.9 14.8 12.5 11.7 14.1 12.5 9.9 10.2 11.5 17.2 7.7 10.3 11.2 12.0 9.2 13.0 8.3 7.4 9.2 19.5 19.2 15.0 26.3 18.9 19.1 17.8 13.7 17.1 14.1 17.9 13.0 13.7 6.6 10.8 7.2 7.0 20.4 12.0 10.3 15.7 5.9 12.4 5.0 12.6 13.3 14.6 36.8 0.0 21.6 13.5 14.1 18.8 11.5 62.5 14.0 9.5 28.3 23.4 21.5 15.1 12.0 9.3 6.8 10.0 31.8 10.4 22.1 20.1 12.0 14.6 11.0 6.5 12.9 11.8 6.4 10.9 14.9 8.2 22.3 12.4 SLC3A1 "ATR1, CSNU1, D2H, NBAT, RBAT" ENSG00000138079 "Solute carrier family 3 member 1" Q07837 2 44275458-44321494 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 66.0;kidney: 191.5;pancreas: 36.8" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 256.0" "Cancer enriched" "Detected in many" 7 "renal cancer: 61.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 17 "RPTEC TERT1: 49.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038360, HPA071102" Enhanced Approved "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA038360: AB_2675975, HPA071102: AB_2732171" "unprognostic (1.67e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (1.43e-2)" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (2.76e-2)" "unprognostic (1.34e-1)" "unprognostic (3.90e-1)" "unprognostic (8.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "prognostic favorable (3.67e-7)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (3.77e-1)" "unprognostic (1.58e-4)" 0.2 0.1 0.2 0.7 0.2 0.0 0.2 0.7 0.2 0.3 28.4 0.1 0.1 18.8 1.3 4.6 0.2 0.2 17.9 0.1 0.2 0.2 191.5 5.3 0.2 0.1 0.2 0.1 0.2 36.8 0.0 0.2 0.5 0.1 0.3 3.7 0.2 0.1 0.1 0.2 0.2 66.0 0.1 0.2 0.2 0.3 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.2 4.0 1.3 2.0 1.3 1.6 2.7 0.3 0.0 0.9 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.9 0.2 0.0 0.1 0.2 49.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.1 1.3 1.3 1.0 2.6 1.3 1.9 1.9 2.5 1.4 0.4 4.0 2.5 2.7 2.0 1.6 0.6 1.3 0.9 0.3 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 0.1 0.1 3.0 1.0 1.5 0.2 0.0 12.5 0.3 63.7 0.0 0.0 40.1 9.8 0.0 53.0 18.3 10.9 0.0 32.7 0.0 12.6 0.0 0.2 1.4 0.0 2.8 0.1 20.6 0.0 0.6 0.0 3.3 1.1 0.0 0.0 2.8 3.8 1.6 3.4 7.2 0.4 256.0 11.9 0.0 0.1 0.7 0.3 0.1 0.1 0.0 8.0 0.5 SLC3A2 "4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE" ENSG00000168003 "Solute carrier family 3 member 2" P08195 11 62856102-62888875 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Syncytiotrophoblasts: 652.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 132.2;SiHa: 134.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010455, HPA017980" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 210000000 "Plasma membrane" Nucleoplasm "CAB010455: AB_638288, HPA017980: AB_2669723" "unprognostic (1.79e-1)" "unprognostic (9.61e-3)" "unprognostic (3.59e-1)" "unprognostic (7.87e-3)" "unprognostic (2.06e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (2.09e-3)" "unprognostic (2.62e-1)" "unprognostic (4.16e-2)" "unprognostic (2.29e-2)" "unprognostic (3.71e-1)" "prognostic favorable (8.22e-4)" "unprognostic (2.92e-2)" "unprognostic (5.52e-3)" "unprognostic (3.49e-3)" "prognostic unfavorable (1.48e-4)" 28.5 30.8 34.6 23.0 36.8 62.4 30.8 18.7 34.8 26.0 26.8 25.3 30.4 34.3 29.2 41.2 31.2 23.8 19.9 14.7 31.3 27.1 71.4 31.8 33.5 17.8 37.8 24.1 29.9 39.2 138.6 19.3 75.5 32.9 28.3 13.9 52.5 39.0 27.5 32.5 32.1 33.8 19.6 38.0 21.9 28.2 33.4 30.8 13.6 33.7 33.4 22.2 20.6 56.6 16.6 73.9 11.6 36.2 20.3 39.8 37.3 16.4 69.3 7.1 22.0 8.6 6.9 65.6 28.6 11.0 15.0 13.3 66.2 31.2 18.1 31.8 16.8 28.7 57.0 12.9 56.2 8.0 32.9 12.2 13.0 50.5 29.2 79.9 15.2 19.0 15.1 132.2 18.3 56.1 5.5 8.7 39.4 25.0 40.1 9.2 79.2 15.6 19.4 11.8 20.5 23.5 16.2 10.7 35.4 10.5 9.2 12.1 5.8 134.7 50.5 97.2 12.0 18.1 19.9 16.0 15.3 22.8 22.4 20.1 49.9 55.3 57.4 15.0 23.9 43.6 8.5 36.2 11.6 30.1 34.8 39.8 14.4 27.7 30.8 22.1 16.6 23.5 25.2 7.5 20.3 27.6 73.9 26.2 37.3 34.6 36.8 18.7 34.7 31.3 27.1 37.8 24.1 32.9 30.8 44.7 40.7 54.9 229.6 193.7 59.3 10.9 20.4 36.1 40.9 47.1 62.8 187.9 28.2 148.4 23.7 94.0 85.3 93.5 129.2 134.7 88.4 145.6 82.0 22.5 178.6 50.9 80.9 70.6 47.5 19.5 28.1 97.7 212.6 153.3 33.1 212.1 128.6 31.6 28.7 161.8 52.2 6.5 137.2 12.6 29.8 131.6 652.9 75.6 40.7 193.5 SLC40A1 "FPN1, HFE4, IREG1, MTP1, SLC11A3" ENSG00000138449 "Solute carrier family 40 member 1" Q9NP59 2 189560579-189583758 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 126.4;lymphoid tissue: 170.2" "Group enriched" "Detected in many" 5 "Kupffer cells: 1044.2;Syncytiotrophoblasts: 2060.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 64.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 93.2;CACO-2: 21.3;HEL: 75.5;HMC-1: 19.9;T-47d: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065634 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA065634: AB_2685524" "unprognostic (1.28e-2)" "unprognostic (1.73e-2)" "unprognostic (9.41e-2)" "unprognostic (1.83e-2)" "unprognostic (8.00e-3)" "unprognostic (1.36e-2)" "unprognostic (1.66e-1)" "unprognostic (6.22e-2)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "unprognostic (6.43e-2)" "unprognostic (6.44e-2)" "prognostic favorable (8.55e-5)" "unprognostic (4.66e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.11e-2)" 18.2 126.4 3.9 10.1 5.5 3.9 47.4 1.8 3.5 20.0 25.7 3.7 13.9 34.4 24.7 24.3 6.3 25.9 25.2 37.1 4.1 4.3 14.4 42.1 45.9 170.2 5.1 1.9 50.9 24.0 4.6 9.8 51.3 6.4 18.4 15.8 11.6 10.2 16.6 12.3 4.9 44.7 13.6 5.8 76.4 11.3 16.2 3.5 17.0 20.8 6.4 8.8 11.1 20.4 0.1 22.7 64.7 20.8 0.8 17.3 20.1 0.0 1.3 0.1 0.0 93.2 0.6 4.5 0.0 1.1 0.3 0.5 21.3 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.3 75.5 0.3 7.8 0.3 0.2 19.9 6.5 0.0 0.2 0.0 2.1 2.2 2.9 7.7 0.2 1.1 0.0 3.1 4.9 0.2 16.0 0.3 0.0 0.8 0.4 0.9 3.1 0.1 0.9 0.1 6.2 0.0 7.4 36.8 1.1 0.0 0.1 2.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 20.8 32.9 0.4 4.7 0.6 0.0 11.3 1.0 22.7 0.1 17.3 3.7 64.7 0.8 0.4 3.7 1.0 20.1 3.9 5.5 1.8 3.5 4.1 4.3 5.1 1.9 6.4 3.5 116.1 32.3 28.1 45.3 8.1 3.7 37.5 142.7 53.5 39.8 31.4 3.9 335.3 41.4 23.9 6.9 30.8 119.4 70.0 64.9 10.7 46.3 32.2 9.2 223.5 72.3 6.4 17.9 211.8 1044.2 4.7 112.2 26.2 8.5 1.8 50.3 9.6 51.2 77.2 55.2 100.1 43.2 64.7 18.1 5.0 0.9 7.0 2060.1 8.4 30.8 19.7 SLC41A1 MgtE ENSG00000133065 "Solute carrier family 41 member 1" Q8IVJ1 1 205789093-205813748 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 78.1;pancreas: 36.8" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 157.4;Cone photoreceptor cells: 47.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014721, HPA015138" Uncertain Approved Mitochondria NA NA Mitochondria "HPA014721: , HPA015138: AB_1857160" "unprognostic (1.18e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.77e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (2.37e-3)" "unprognostic (5.23e-2)" "unprognostic (5.53e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-2)" "unprognostic (4.46e-2)" "unprognostic (3.09e-3)" "unprognostic (2.60e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (1.65e-1)" 6.0 7.2 6.2 4.0 7.3 3.3 3.4 9.0 8.3 3.6 3.9 10.8 4.0 1.6 5.0 5.9 3.8 7.3 4.7 78.1 7.2 3.8 6.1 1.2 5.3 4.5 7.8 4.9 7.5 36.8 5.8 3.6 2.6 6.9 5.1 1.5 5.8 2.8 4.8 26.5 2.6 2.7 4.0 8.5 3.3 6.6 11.6 7.3 2.1 11.2 11.9 4.5 5.2 5.0 1.8 0.0 0.1 0.3 1.0 4.6 2.0 10.8 9.6 6.1 9.7 7.6 7.5 8.3 11.2 11.0 11.4 10.1 4.8 6.2 15.7 7.1 10.2 9.5 11.3 5.9 8.2 3.9 28.8 9.0 3.8 9.5 0.7 7.3 0.0 11.0 9.5 6.9 13.0 9.3 9.5 7.0 12.8 7.0 6.6 9.1 6.7 7.0 1.1 7.2 2.9 4.4 8.3 18.3 3.8 2.6 13.5 5.1 6.5 8.6 7.7 7.0 5.3 5.5 4.0 8.7 13.6 8.8 12.4 11.6 22.0 14.6 5.2 10.6 5.0 8.4 0.0 0.1 0.1 3.6 0.3 4.6 1.5 3.4 3.4 0.0 1.8 3.2 3.3 0.0 1.0 0.0 0.0 3.3 2.0 6.2 7.3 9.0 8.3 7.2 3.8 7.8 4.9 6.9 7.3 3.0 16.5 12.6 19.3 18.4 12.9 157.4 10.2 9.4 12.5 0.0 47.1 1.7 1.7 8.2 1.5 20.4 0.0 0.0 9.4 12.7 8.0 15.4 6.9 1.8 2.7 17.5 5.8 4.3 2.2 1.7 9.2 3.2 8.5 0.0 0.8 18.0 8.8 0.6 8.9 13.7 21.3 0.0 19.4 6.8 15.0 15.8 2.6 8.5 1.0 20.0 SLC41A2 DKFZP434K0427 ENSG00000136052 "Solute carrier family 41 member 2" Q96JW4 12 104802553-104958744 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 37.1;liver: 54.1" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 33.6;Hepatocytes: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "myeloid DC: 4.4;plasmacytoid DC: 13.0" "Lineage enriched" "Detected in single" 14 "dendritic cells: 13.0" "Cell line enhanced" "Detected in many" "HDLM-2: 29.6;SK-BR-3: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038658 Approved NA NA "HPA038658: AB_10671747" "unprognostic (7.19e-2)" "unprognostic (4.38e-3)" "unprognostic (1.94e-2)" "unprognostic (2.38e-1)" "unprognostic (6.06e-3)" "unprognostic (3.05e-2)" "prognostic favorable (9.94e-4)" "unprognostic (1.35e-1)" "unprognostic (3.68e-1)" "unprognostic (3.65e-1)" "unprognostic (4.20e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.35e-4)" "unprognostic (1.50e-1)" "unprognostic (1.04e-1)" "unprognostic (1.72e-2)" "unprognostic (5.30e-2)" 6.1 7.0 3.8 5.2 3.9 0.5 7.1 9.2 5.4 4.9 19.9 2.3 15.9 14.5 3.0 7.9 1.6 2.1 6.8 3.0 2.9 5.5 4.6 54.1 4.5 2.0 2.8 4.0 4.2 12.0 5.7 21.5 16.1 3.4 2.2 7.2 2.0 5.9 14.9 0.9 1.6 37.1 4.0 2.4 1.9 16.8 4.3 2.1 1.0 5.8 0.3 2.7 2.2 2.7 0.6 13.0 0.3 0.2 0.3 0.9 0.3 6.0 13.8 0.5 2.9 11.8 8.6 5.5 4.3 7.0 3.0 5.1 8.6 5.9 2.5 4.7 8.4 11.0 0.6 3.1 1.4 5.6 29.6 7.8 0.2 5.5 3.8 2.6 0.9 3.4 2.9 1.2 3.2 0.9 6.5 3.8 1.6 0.2 6.5 0.5 2.8 1.2 0.0 1.3 10.9 4.4 0.5 6.0 5.9 11.9 0.2 5.5 1.4 7.3 24.4 1.2 2.2 9.5 0.0 1.1 4.5 3.2 4.8 4.8 7.8 9.6 3.2 7.2 0.5 3.1 0.2 0.2 0.0 0.2 0.1 0.9 0.6 0.2 0.1 4.4 0.3 0.4 0.2 0.3 0.3 0.1 13.0 0.1 0.3 3.8 3.9 9.2 5.4 2.9 5.5 2.8 4.0 3.4 2.1 17.9 8.1 6.0 2.6 2.2 2.8 0.8 20.4 1.4 4.5 7.0 0.0 1.4 0.0 23.5 21.0 1.4 29.0 0.0 33.6 15.7 9.3 3.9 0.0 45.9 5.4 4.8 1.2 1.3 2.2 3.4 2.0 9.7 0.0 31.5 8.3 2.6 26.2 8.7 6.0 6.2 0.0 0.0 5.0 2.9 1.9 1.9 7.6 1.0 9.7 4.7 SLC41A3 FLJ20473 ENSG00000114544 "Solute carrier family 41 member 3" Q96GZ6 3 126006355-126101561 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045847 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA045847: AB_2679472" "unprognostic (1.77e-1)" "unprognostic (3.35e-2)" "unprognostic (1.11e-1)" "unprognostic (3.37e-2)" "unprognostic (7.68e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (1.36e-1)" "unprognostic (3.23e-2)" "unprognostic (2.82e-3)" "unprognostic (5.74e-2)" "unprognostic (3.57e-1)" "prognostic favorable (6.04e-7)" "unprognostic (1.26e-1)" "unprognostic (5.88e-2)" "unprognostic (2.85e-1)" "unprognostic (7.54e-2)" 11.2 20.2 21.3 10.7 20.7 5.3 22.2 29.8 43.4 18.6 10.6 12.6 12.1 10.1 21.1 32.9 10.8 24.0 16.3 17.1 17.9 20.6 14.0 8.5 9.5 14.3 17.1 16.5 31.2 17.6 19.7 16.9 10.9 21.4 12.5 10.9 18.6 16.7 14.5 25.5 10.7 8.9 17.1 11.7 8.8 10.7 30.5 6.0 27.7 18.0 11.5 10.4 12.3 11.9 9.0 8.6 9.3 8.2 13.0 18.8 5.6 17.7 7.3 12.1 10.2 34.5 20.3 18.3 10.2 17.7 14.2 16.8 9.7 16.2 13.0 19.3 20.1 15.4 14.0 4.4 17.7 12.4 12.6 13.9 7.1 13.8 14.0 28.6 12.8 7.9 19.7 21.7 8.5 17.6 20.9 19.5 16.1 5.9 10.9 18.6 9.5 14.1 10.5 9.2 23.6 11.5 7.5 12.5 17.6 16.9 13.2 9.4 10.2 15.7 5.1 43.1 11.9 5.1 17.3 13.4 13.2 10.2 20.1 11.4 8.3 6.7 6.3 12.0 5.7 12.1 9.3 5.7 3.9 11.2 8.2 9.1 9.0 10.6 11.5 8.6 8.4 9.2 8.7 1.2 13.0 5.1 8.4 18.8 5.6 21.3 20.7 29.8 43.4 17.9 20.6 17.1 16.5 21.4 6.0 14.9 10.4 8.0 20.1 12.2 12.9 12.9 25.5 6.7 14.8 21.0 3.9 30.6 3.3 30.8 27.0 24.2 6.8 0.0 21.8 27.8 22.2 13.0 5.7 5.8 14.0 27.0 20.3 27.0 8.9 12.0 34.8 9.4 13.5 14.4 12.7 23.0 21.6 3.5 51.6 10.9 10.8 25.8 19.6 12.6 38.4 13.4 21.2 17.5 16.6 16.8 SLC43A1 "PB39, POV1, R00504" ENSG00000149150 "Solute carrier family 43 member 1" O75387 11 57484534-57515786 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 27.0;liver: 91.8;pancreas: 100.5" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 40.8;Hepatocytes: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 23.8;NB-4: 28.3;U-937: 27.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018813, HPA018826" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles, Plasma membrane" "HPA018813: AB_1857164, HPA018826: AB_1857165" "unprognostic (3.04e-1)" "unprognostic (1.15e-1)" "unprognostic (9.19e-2)" "prognostic favorable (3.19e-4)" "unprognostic (2.51e-2)" "unprognostic (5.48e-2)" "unprognostic (2.32e-1)" "unprognostic (6.71e-3)" "unprognostic (1.63e-1)" "unprognostic (3.12e-2)" "unprognostic (6.06e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (2.97e-5)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (5.27e-4)" "unprognostic (7.30e-2)" 4.7 3.3 0.8 2.2 0.8 9.3 7.4 0.7 1.3 6.0 4.8 0.9 3.9 2.5 5.0 6.8 4.1 3.3 27.0 3.2 0.7 0.6 3.4 91.8 2.9 3.3 0.8 1.1 6.5 100.5 0.1 1.3 1.8 0.7 6.2 2.8 11.4 14.9 2.1 7.5 5.6 2.6 7.0 0.9 2.5 7.6 3.1 0.7 0.8 7.4 2.9 3.1 7.6 3.5 3.1 8.2 8.1 6.0 6.9 11.1 5.2 0.4 0.6 0.7 8.0 10.5 7.7 0.1 4.2 5.4 1.2 3.1 2.5 1.1 23.0 1.1 3.1 1.5 0.3 7.1 0.4 1.5 1.1 1.8 11.8 0.2 23.8 13.8 20.7 2.9 9.7 1.7 2.0 9.3 2.9 5.3 13.8 16.5 4.3 1.5 0.8 0.1 28.3 2.6 10.4 5.4 19.7 3.9 10.2 0.2 0.0 9.4 1.4 0.7 0.1 9.2 0.2 0.6 10.5 2.1 1.2 2.9 10.6 0.6 4.8 1.5 13.5 0.6 27.3 1.6 8.1 6.0 0.7 11.1 2.4 9.5 3.1 5.2 8.0 8.2 1.7 5.1 7.2 0.5 6.9 0.1 1.9 9.1 5.2 0.8 0.8 0.7 1.3 0.7 0.6 0.8 1.1 0.7 0.7 0.0 8.2 0.8 1.6 6.3 5.0 4.9 40.8 1.4 1.2 0.0 0.0 0.1 3.3 2.5 22.9 4.6 0.9 23.3 30.5 0.4 5.4 1.9 3.5 109.6 6.1 0.0 5.8 14.7 7.6 11.8 14.4 1.8 5.0 0.0 6.1 0.0 18.0 0.0 7.4 0.0 0.3 6.5 6.2 0.5 0.4 3.1 0.1 6.4 9.8 0.9 SLC43A2 MGC34680 ENSG00000167703 "Solute carrier family 43 member 2" Q8N370 17 1569267-1628886 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 92.7" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 312.2;Syncytiotrophoblasts: 788.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021564 Enhanced NA NA "HPA021564: AB_1857169" "unprognostic (5.95e-3)" "unprognostic (4.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.42e-2)" "unprognostic (2.58e-2)" "unprognostic (2.80e-2)" "unprognostic (1.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.49e-2)" "unprognostic (2.80e-1)" "prognostic favorable (1.05e-6)" "unprognostic (1.96e-1)" "prognostic favorable (5.40e-5)" "unprognostic (1.84e-1)" "unprognostic (4.14e-2)" "unprognostic (1.01e-1)" "unprognostic (2.20e-1)" 5.5 2.7 5.4 13.7 5.7 12.2 3.6 14.8 11.9 2.6 2.6 5.0 2.1 7.0 2.1 4.1 1.4 5.9 3.9 1.6 5.6 7.2 15.8 3.0 6.8 8.3 5.1 3.8 2.3 1.6 1.5 6.2 92.7 5.8 2.8 2.4 4.9 4.0 3.5 23.2 1.3 11.6 4.7 3.5 8.9 2.8 1.5 1.3 5.0 5.8 2.2 3.5 5.0 1.3 1.3 3.1 15.0 5.4 0.5 0.3 2.0 0.9 2.6 0.8 7.6 1.6 1.3 10.4 0.5 0.3 1.8 0.8 15.5 1.7 4.5 5.2 0.8 0.7 1.8 4.6 0.9 0.3 0.0 0.4 0.8 2.3 3.9 1.9 0.1 1.4 1.6 1.4 1.1 0.5 0.2 7.3 0.5 1.9 0.0 0.3 3.6 9.2 0.9 0.8 2.4 0.3 2.6 0.0 5.3 3.5 8.9 3.1 1.6 2.3 6.3 0.2 3.4 6.3 5.4 9.5 0.2 1.1 2.0 0.6 0.5 9.4 2.2 0.4 0.9 0.2 2.5 5.4 5.3 0.3 4.6 0.1 1.3 0.2 0.2 3.1 1.2 0.2 0.2 15.0 0.5 4.5 1.7 0.2 2.0 5.4 5.7 14.8 11.9 5.6 7.2 5.1 3.8 5.8 1.3 14.9 40.5 18.3 5.4 4.2 22.8 2.7 15.3 21.4 22.7 34.9 23.6 312.2 16.6 21.0 2.9 4.5 16.2 0.0 6.3 29.6 10.2 7.2 11.5 1.3 81.4 19.1 10.9 16.5 88.0 1.9 10.0 84.8 0.0 73.9 12.2 23.6 6.4 21.6 8.5 19.3 35.8 0.0 5.7 3.1 3.2 3.8 788.9 3.8 10.0 4.2 SLC43A3 "DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1" ENSG00000134802 "Solute carrier family 43 member 3" Q8NBI5 11 57406954-57427580 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 149.9;thyroid gland: 69.0" "Cell type enhanced" "Detected in many" 5 "granulocytes: 63.7;Hofbauer cells: 71.5;Sertoli cells: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 71.0;HMC-1: 62.7;RPMI-8226: 80.1;WM-115: 76.4" "Region enriched" "Detected in many" 4 "olfactory region: 12.7" "Low region specificity" "Detected in all" "HPA030551, HPA077244" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA030551: AB_10604094, HPA077244: AB_2732335" "unprognostic (2.64e-1)" "unprognostic (7.63e-2)" "unprognostic (9.67e-3)" "unprognostic (7.41e-3)" "unprognostic (6.59e-3)" "unprognostic (5.30e-3)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (1.36e-1)" "unprognostic (2.26e-1)" "unprognostic (5.73e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (3.97e-13)" "unprognostic (8.16e-2)" "unprognostic (1.77e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-1)" 32.3 6.3 2.5 12.4 4.3 18.8 16.8 2.2 3.0 11.9 9.6 3.6 2.4 2.7 10.1 6.5 12.6 8.9 11.4 12.5 3.1 1.5 4.2 149.9 16.5 8.8 4.0 1.8 16.0 7.2 1.2 1.8 5.1 3.4 11.6 4.2 9.4 12.2 3.1 15.4 11.0 6.2 10.3 4.7 11.6 6.9 6.8 2.3 10.4 69.0 11.5 13.8 20.3 15.4 2.7 23.6 6.1 36.8 1.1 7.8 14.0 40.0 0.0 2.3 0.0 7.8 11.5 0.1 3.1 13.3 4.6 7.9 0.0 8.8 23.1 1.4 7.3 2.4 23.1 6.7 4.1 9.3 0.1 0.0 36.0 13.7 0.0 15.9 71.0 62.7 34.5 0.1 44.6 0.5 3.3 12.9 10.7 41.1 22.4 17.8 0.0 14.9 45.6 3.5 0.0 0.7 30.9 0.4 80.1 11.0 0.0 5.5 0.0 8.8 0.2 37.4 0.2 3.4 10.8 6.8 0.2 12.0 30.4 8.7 0.0 0.1 5.8 27.5 25.8 76.4 3.2 28.8 6.1 5.7 34.5 6.5 2.7 4.0 7.8 23.6 2.0 3.1 3.2 2.5 1.1 36.8 23.6 6.9 14.0 2.5 4.3 2.2 3.0 3.1 1.5 4.0 1.8 3.4 2.3 14.9 41.4 4.5 6.7 41.6 0.5 2.8 30.6 5.3 34.2 1.8 0.0 0.5 0.0 47.0 1.0 23.3 0.0 0.0 5.5 2.2 20.2 3.4 63.7 53.8 71.5 0.0 0.0 11.6 17.3 1.4 9.2 55.1 28.7 0.0 0.5 0.9 10.9 0.0 11.7 0.0 0.0 64.7 18.4 1.0 0.2 15.4 0.7 15.0 0.6 2.5 SLC44A1 "CD92, CDw92, CHTL1, CTL1" ENSG00000070214 "Solute carrier family 44 member 1" Q8WWI5 9 105244622-105439171 "CD markers, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 111.6" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 73.5;ASC TERT1: 58.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064714, HPA074007" Enhanced Supported Nucleoplasm,Mitochondria NA NA 270000 Mitochondria Nucleoplasm "HPA064714: AB_2685334, HPA074007: " "unprognostic (3.49e-1)" "unprognostic (2.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.54e-3)" "unprognostic (4.77e-2)" "unprognostic (1.74e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (4.49e-4)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (1.64e-3)" "unprognostic (6.20e-2)" "prognostic favorable (1.85e-4)" "unprognostic (2.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-2)" 8.7 7.4 40.0 6.4 48.8 5.3 14.6 7.2 37.0 9.9 26.7 69.5 10.2 12.0 8.8 18.4 10.1 8.5 11.0 6.9 50.0 29.6 12.0 20.3 9.8 4.6 64.3 21.3 8.0 8.0 20.5 3.9 12.3 38.2 6.6 26.9 4.6 6.0 14.8 4.8 11.4 14.0 9.5 111.6 4.8 18.9 2.3 59.4 2.3 24.0 5.1 7.9 12.4 7.9 2.4 3.7 2.5 5.4 8.7 1.8 1.6 6.9 5.8 1.6 1.9 73.5 58.1 5.0 5.8 15.3 3.8 5.1 6.2 18.5 9.2 3.0 22.0 4.3 13.8 4.7 8.4 6.5 8.0 3.8 11.5 4.1 7.7 4.9 2.2 5.9 32.2 6.9 7.3 6.6 9.8 12.0 4.8 0.3 19.2 4.3 9.8 9.1 2.6 8.9 12.3 5.6 1.9 6.1 6.9 5.2 16.3 7.7 3.0 8.2 9.1 8.2 9.9 9.0 6.9 10.2 3.8 3.4 4.1 4.2 14.8 9.8 6.9 7.4 5.0 5.0 2.5 5.4 1.1 1.1 2.1 0.8 2.0 1.2 0.8 3.7 2.4 1.8 0.6 1.0 8.7 1.2 1.3 1.1 1.6 40.0 48.8 7.2 29.8 50.0 29.6 64.3 21.3 38.2 59.4 32.8 21.6 15.9 31.4 62.7 7.6 9.3 56.0 14.7 9.1 101.2 221.9 44.4 3.3 16.4 2.4 38.4 140.4 0.0 31.4 7.9 49.9 25.3 98.1 132.6 20.0 6.4 151.0 54.0 50.8 2.9 101.8 39.6 70.9 122.6 158.5 6.7 33.4 123.8 75.0 23.3 44.8 38.8 27.0 1.4 1.7 65.0 59.0 15.3 134.8 29.5 SLC44A2 CTL2 ENSG00000129353 "Solute carrier family 44 member 2" Q8IWA5 19 10602457-10644559 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 210.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 62.3;SK-BR-3: 60.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003228, HPA070799" Approved Approved "Vesicles,Cell Junctions" NA NA 78000 "Vesicles, Cell Junctions" "HPA003228: AB_1080009, HPA070799: AB_2686314" "unprognostic (6.35e-3)" "unprognostic (5.75e-2)" "unprognostic (4.34e-1)" "unprognostic (3.06e-3)" "unprognostic (4.38e-2)" "unprognostic (8.41e-3)" "unprognostic (1.64e-1)" "unprognostic (2.52e-1)" "unprognostic (2.66e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (6.01e-4)" "unprognostic (8.63e-2)" "prognostic favorable (1.71e-5)" "unprognostic (1.28e-1)" "unprognostic (1.67e-1)" "unprognostic (8.21e-3)" "unprognostic (3.61e-2)" 29.3 14.2 25.1 21.4 28.3 23.4 31.6 24.2 33.9 24.7 23.0 40.7 21.7 10.5 21.0 17.3 31.8 24.8 24.9 29.1 21.2 17.9 29.4 9.1 39.4 46.7 26.1 18.4 14.2 16.5 21.6 8.6 114.9 31.8 19.9 20.3 36.6 22.1 28.8 51.6 29.0 19.1 19.3 37.5 49.4 44.0 51.6 21.2 30.4 26.9 26.4 39.2 29.0 26.3 19.0 17.8 86.0 45.9 13.1 21.8 22.8 62.3 1.5 14.0 8.3 21.2 13.1 39.9 13.6 33.4 22.4 26.5 14.0 29.9 12.6 18.2 37.6 2.7 48.3 2.1 10.4 14.5 0.3 1.8 8.0 7.9 0.5 23.5 0.1 6.8 14.1 13.9 8.4 7.4 18.3 17.1 5.9 3.8 2.1 34.0 45.9 6.6 6.1 4.9 18.5 5.6 14.2 19.9 0.5 7.3 33.2 1.3 8.4 10.7 60.1 1.5 15.2 23.4 0.6 15.6 10.1 3.6 12.0 3.4 0.8 1.4 12.4 2.5 5.6 11.2 22.9 7.2 39.3 21.8 19.6 17.2 17.7 15.1 16.5 3.7 19.0 16.5 16.8 86.0 13.1 45.9 17.8 16.5 22.8 25.1 28.3 24.2 33.9 21.2 17.9 26.1 18.4 31.8 21.2 50.6 29.0 40.2 16.9 8.7 11.9 32.2 20.4 16.0 39.8 87.2 13.7 107.9 1.7 38.7 130.7 26.0 27.4 46.7 39.5 210.6 15.5 11.6 19.7 0.9 32.0 3.2 9.2 66.9 28.0 20.6 35.9 7.7 5.0 4.6 17.2 33.6 29.3 37.4 53.0 3.8 2.9 58.2 18.6 3.0 2.7 7.4 78.1 41.7 20.9 16.5 SLC44A3 "CTL3, MGC45474" ENSG00000143036 "Solute carrier family 44 member 3" Q8N4M1 1 94820342-94895246 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 5.2" "Lineage enriched" "Detected in single" 52 "T-cells: 5.2" "Cell line enhanced" "Detected in many" "OE19: 14.8;RPTEC TERT1: 43.5;RT4: 29.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047433 Enhanced NA NA "HPA047433: AB_2680046" "unprognostic (8.06e-2)" "unprognostic (7.65e-2)" "unprognostic (4.63e-3)" "unprognostic (3.57e-2)" "unprognostic (1.53e-2)" "unprognostic (2.37e-1)" "unprognostic (1.14e-1)" "unprognostic (4.03e-2)" "unprognostic (1.94e-1)" "unprognostic (1.46e-1)" "unprognostic (5.78e-2)" "unprognostic (2.44e-2)" "prognostic favorable (7.63e-5)" "unprognostic (9.09e-2)" "unprognostic (8.28e-2)" "unprognostic (5.95e-2)" "unprognostic (3.31e-3)" 1.8 7.3 9.1 6.1 8.3 0.0 5.3 6.6 5.6 5.9 19.8 3.9 4.5 16.5 4.8 5.1 6.6 5.1 16.3 4.5 6.3 5.0 21.4 3.9 6.7 0.4 6.1 3.6 2.7 22.2 5.3 22.2 3.9 5.8 7.2 22.9 9.5 16.0 8.5 1.6 3.7 17.2 2.9 5.4 0.5 17.9 1.6 4.2 2.6 5.4 0.9 4.1 11.0 6.3 0.0 0.0 0.0 0.0 0.0 5.2 0.1 9.5 1.3 0.3 0.0 1.1 1.4 6.7 0.1 1.4 0.3 1.6 8.9 2.4 0.0 6.6 0.1 3.0 3.2 1.4 2.3 0.6 0.0 1.7 0.0 0.5 0.7 0.4 0.0 0.0 4.3 2.1 0.7 0.0 2.7 0.1 0.0 0.0 0.0 0.6 1.4 0.0 0.1 0.4 14.8 0.3 0.7 0.3 0.5 43.5 29.0 4.5 7.3 0.4 4.6 3.2 3.3 2.6 0.3 0.0 0.2 1.5 0.6 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.1 8.3 6.6 5.6 6.3 5.0 6.1 3.6 5.8 4.2 23.8 7.9 0.0 27.4 2.7 0.5 6.5 33.1 4.0 3.4 12.2 0.0 13.2 13.3 27.9 20.6 1.0 14.8 0.0 24.6 0.5 5.2 16.6 1.1 1.6 1.1 0.0 15.6 0.6 0.3 2.5 4.6 0.7 5.0 1.8 32.8 14.5 30.4 31.6 10.3 28.4 0.2 0.0 2.1 0.1 0.2 3.3 5.6 0.0 40.5 25.0 SLC44A4 "C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT" ENSG00000204385 "Solute carrier family 44 member 4" Q53GD3 6 31863192-31879046 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 34.6;intestine: 65.7" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 245.0;Enterocytes: 364.2;Exocrine glandular cells: 194.5;Glandular cells: 195.5;Mucus-secreting cells: 268.8;Paneth cells: 234.4" "Cancer enhanced" "Detected in many" "prostate cancer: 222.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.0" "Cell line enriched" "Detected in some" 5 "OE19: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA046977, HPA054176" Enhanced NA NA "HPA046977: AB_2679887, HPA054176: AB_2682404" "unprognostic (5.84e-2)" "unprognostic (4.90e-2)" "unprognostic (3.86e-3)" "unprognostic (4.85e-3)" "unprognostic (2.75e-2)" "prognostic favorable (3.54e-4)" "unprognostic (2.65e-3)" "unprognostic (2.44e-3)" "unprognostic (3.08e-1)" "unprognostic (2.45e-1)" "unprognostic (2.89e-2)" "unprognostic (1.89e-1)" "prognostic favorable (1.06e-6)" "unprognostic (1.37e-2)" "unprognostic (2.48e-1)" "unprognostic (4.54e-2)" "prognostic favorable (6.06e-4)" 0.3 2.4 0.2 11.2 0.3 0.2 2.1 0.2 0.3 5.9 43.6 0.3 7.6 23.7 2.9 3.0 0.6 10.9 34.6 0.2 0.2 0.0 20.4 0.3 9.1 0.6 0.2 0.2 4.9 7.3 0.0 5.0 5.1 0.5 25.7 8.6 0.3 12.0 4.4 0.2 0.1 65.7 1.2 0.2 0.6 23.7 0.8 0.2 0.4 0.5 0.7 4.2 6.3 1.9 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 13.2 0.0 0.1 0.0 0.4 0.0 2.0 0.0 0.2 0.0 1.1 0.0 0.1 0.4 0.3 2.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.0 0.2 0.2 0.5 0.2 20.8 29.0 6.7 17.5 0.5 0.0 0.3 30.6 245.0 54.6 62.8 0.0 0.2 3.3 91.8 2.2 0.5 364.2 0.0 194.5 0.3 1.8 195.5 2.3 0.0 0.5 0.0 44.9 0.0 0.0 2.9 1.4 2.0 0.0 2.8 268.8 0.4 123.2 234.4 0.4 56.6 0.6 0.0 0.4 0.2 0.2 0.4 0.6 0.0 158.0 88.5 SLC44A5 "CTL5, MGC34032" ENSG00000137968 "Solute carrier family 44 member 5" Q8NCS7 1 75202131-75611116 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.6" "Group enriched" "Detected in some" 7 "Early spermatids: 63.4;Late spermatids: 27.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 7.2;RPTEC TERT1: 7.1;SH-SY5Y: 11.1;SuSa: 11.8;TIME: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047455, HPA051011" Uncertain Approved Cytosol NA NA Cytosol "HPA047455: AB_2680054, HPA051011: AB_2681309" "unprognostic (9.00e-2)" "unprognostic (1.91e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-3)" "unprognostic (4.57e-1)" "unprognostic (1.69e-1)" "unprognostic (1.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (5.78e-3)" "unprognostic (6.41e-2)" "unprognostic (9.19e-2)" "prognostic unfavorable (6.52e-4)" "unprognostic (1.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.68e-2)" "unprognostic (4.30e-1)" 1.0 0.4 2.4 1.0 1.5 0.0 6.3 1.0 3.6 1.0 1.8 1.0 1.0 0.9 1.0 1.0 7.7 3.7 1.0 2.2 2.8 2.8 2.0 1.0 1.0 1.0 2.3 1.0 1.0 1.8 5.6 3.7 3.8 1.0 1.0 2.9 1.0 1.6 1.0 1.5 11.3 1.0 1.0 1.0 1.0 1.3 32.6 1.0 1.0 1.0 1.0 1.8 2.2 1.9 3.2 0.3 0.6 0.3 0.5 1.1 0.3 0.2 0.2 4.5 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.2 0.0 0.0 2.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 4.5 0.6 1.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.8 0.4 2.4 2.6 0.0 0.0 1.7 0.0 4.5 2.9 0.6 0.0 0.0 2.1 7.1 4.8 1.0 11.1 0.0 4.6 0.0 11.8 0.2 0.0 13.7 0.4 1.2 0.0 1.4 2.0 1.9 3.0 0.2 0.0 0.7 0.4 0.3 0.2 0.4 0.1 0.9 3.2 0.8 1.1 0.1 2.4 0.6 0.4 0.6 0.5 0.2 0.3 0.6 0.3 2.4 1.5 1.0 3.4 2.8 2.8 2.3 1.0 1.0 1.0 0.0 0.6 0.0 0.6 1.6 3.7 0.6 0.0 2.7 1.2 0.0 0.0 6.8 0.0 0.1 63.4 0.4 0.4 0.0 0.8 3.2 0.2 0.8 0.0 0.0 1.0 0.0 2.4 3.1 0.0 27.3 0.9 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.2 5.8 3.2 0.0 0.2 3.1 SLC45A1 DNB5 ENSG00000162426 "Solute carrier family 45 member 1" Q9Y2W3 1 8317826-8344167 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Symport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.0" "Cell type enhanced" "Detected in some" 7 "Bipolar cells: 6.7;Horizontal cells: 9.5;Muller glia cells: 5.7;Peritubular cells: 5.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 7.1" "Group enriched" "Detected in many" 7 "monocytes: 7.1;T-cells: 1.8" "Cell line enhanced" "Detected in some" "ASC diff: 5.9;GAMG: 4.2;HHSteC: 7.8;U-87 MG: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078818 Enhanced NA NA "HPA078818: " "unprognostic (1.77e-3)" "unprognostic (1.37e-2)" "unprognostic (4.32e-3)" "unprognostic (8.32e-2)" "unprognostic (3.22e-3)" "unprognostic (1.56e-1)" "unprognostic (4.96e-2)" "unprognostic (2.09e-1)" "unprognostic (1.20e-1)" "unprognostic (1.43e-1)" "unprognostic (1.39e-3)" "unprognostic (3.18e-1)" "unprognostic (5.67e-2)" "unprognostic (8.53e-3)" "unprognostic (2.16e-1)" "unprognostic (1.70e-1)" "unprognostic (2.51e-3)" 5.0 6.6 8.5 2.4 15.3 1.1 2.6 13.8 24.0 6.0 4.4 5.4 2.1 2.5 6.8 3.6 3.9 5.2 4.3 3.1 6.0 7.9 4.3 1.1 2.0 2.1 6.1 12.4 4.4 4.1 4.1 8.1 1.9 13.1 4.9 2.2 3.2 1.5 7.7 4.0 1.7 2.8 4.3 4.6 4.4 2.6 3.8 4.6 0.0 2.4 0.8 1.5 3.6 3.3 0.6 0.2 0.0 7.1 0.0 1.8 0.7 0.0 2.7 0.5 1.1 5.9 3.9 0.1 0.2 1.2 0.4 0.8 0.0 0.4 0.0 0.2 0.8 4.2 0.0 0.1 0.3 0.1 2.3 0.0 0.0 0.2 0.0 7.8 0.0 2.2 2.0 0.2 0.9 0.0 1.4 0.6 0.6 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.0 1.7 0.0 1.2 0.0 0.0 0.0 2.0 2.8 0.0 0.0 0.0 0.2 0.2 0.0 2.5 0.1 0.5 2.3 0.4 0.0 0.0 0.0 10.1 0.0 0.1 0.0 0.2 0.0 1.3 1.3 1.8 0.6 0.9 0.9 0.2 0.1 0.6 0.6 0.0 0.0 7.1 0.0 0.6 0.7 8.5 15.3 13.8 24.0 6.0 7.9 6.1 12.4 13.1 4.6 0.0 0.0 0.5 1.2 0.3 6.7 0.8 0.0 0.0 0.0 1.8 3.9 0.0 0.0 0.5 1.9 0.9 0.0 0.0 0.2 0.0 0.9 1.0 0.0 0.0 0.1 9.5 0.0 1.3 0.0 4.0 3.1 0.0 0.0 0.0 0.0 5.7 0.1 0.0 5.3 0.6 4.4 6.5 2.9 0.2 0.0 0.3 0.0 0.0 0.0 0.3 SLC45A2 "AIM-1, MATP, OCA4" ENSG00000164175 "Solute carrier family 45 member 2" Q9UMX9 5 33944616-33984730 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Sensory transduction, Vision" "Albinism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 39.9" "Cell type enhanced" "Detected in some" 31 "Early spermatids: 2.4;Late spermatids: 3.1;Melanocytes: 11.8" "Cancer enriched" "Detected in some" 18 "melanoma: 47.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 27 "SK-MEL-30: 37.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.97e-1)" "unprognostic (3.99e-2)" "unprognostic (3.55e-1)" "unprognostic (2.39e-2)" "unprognostic (2.36e-2)" "unprognostic (1.09e-1)" "unprognostic (8.45e-2)" "unprognostic (5.34e-3)" "unprognostic (4.06e-2)" "unprognostic (8.45e-2)" "unprognostic (7.39e-4)" "unprognostic (1.40e-2)" "unprognostic (1.84e-3)" "unprognostic (1.55e-1)" "unprognostic (1.50e-3)" "unprognostic (2.48e-2)" "unprognostic (3.39e-1)" 0.2 0.0 0.3 0.2 0.4 0.0 0.2 0.7 0.4 0.2 1.1 0.2 0.2 0.0 0.5 0.2 0.2 0.4 0.3 1.5 0.4 0.6 0.8 3.1 0.2 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.8 1.2 39.9 0.2 0.2 0.4 4.5 0.2 0.3 0.4 0.2 0.6 2.8 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 37.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.4 0.4 0.6 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 11.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 SLC45A3 "IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein" ENSG00000158715 "Solute carrier family 45 member 3" Q96JT2 1 205657851-205680459 "Cancer-related genes, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "prostate: 115.0" "Group enriched" "Detected in many" 11 "Glandular cells: 50.8;granulocytes: 117.6" "Cancer enriched" "Detected in all" 49 "prostate cancer: 539.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 226 "basophil: 22.6" "Lineage enriched" "Detected in single" 226 "granulocytes: 22.6" "Cell line enriched" "Detected in some" 30 "HMC-1: 141.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019073, HPA019075" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA019073: AB_1857177, HPA019075: AB_1857179" "unprognostic (1.80e-1)" "unprognostic (1.08e-3)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.04e-5)" "unprognostic (6.93e-2)" "unprognostic (2.36e-2)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-2)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (3.16e-1)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "prognostic favorable (7.33e-5)" 0.8 1.5 2.5 1.5 6.2 0.7 0.8 0.4 5.8 1.9 2.1 19.0 0.0 2.1 0.9 0.6 0.9 1.1 1.8 0.7 4.2 2.0 1.1 4.0 1.7 1.6 13.2 1.6 1.0 0.7 0.5 1.9 0.6 7.2 115.0 1.6 0.2 0.9 0.7 2.2 0.9 2.1 0.8 12.4 5.0 6.4 1.4 11.1 0.0 0.5 0.7 0.7 1.5 0.4 0.0 0.0 22.6 0.0 0.0 0.0 0.2 1.5 0.5 0.4 0.4 0.0 0.0 0.3 0.2 0.0 0.5 0.4 1.1 2.9 0.4 0.7 0.0 0.5 0.5 0.2 0.5 0.0 0.6 0.4 4.7 0.1 0.3 0.3 0.8 141.5 0.0 0.1 0.3 0.0 0.3 1.6 0.7 0.7 0.2 0.2 0.3 0.1 1.3 2.0 2.7 1.7 0.1 0.7 0.2 0.6 2.2 0.2 0.5 0.2 3.5 0.6 0.4 0.8 0.2 1.5 0.2 1.6 0.5 1.1 0.0 0.1 0.0 0.3 0.2 1.1 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 6.2 0.4 5.8 4.2 2.0 13.2 1.6 7.2 11.1 0.0 5.6 1.3 1.1 0.0 0.2 1.7 5.1 2.7 1.2 1.8 0.0 0.4 0.0 1.8 0.1 0.6 3.4 0.0 0.5 0.1 0.6 50.8 117.6 4.9 2.0 0.0 0.0 0.0 0.6 0.0 1.7 0.9 0.0 1.0 7.4 0.2 2.4 7.0 1.4 1.8 0.0 6.5 1.0 0.0 1.5 0.1 0.0 0.0 4.4 0.8 SLC45A4 KIAA1126 ENSG00000022567 "Solute carrier family 45 member 4" Q5BKX6 8 141207166-141308305 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 32.9;Collecting duct cells: 47.1;Cone photoreceptor cells: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "eosinophil: 9.4;neutrophil: 8.6" "Lineage enriched" "Detected in single" 19 "granulocytes: 9.4" "Cell line enhanced" "Detected in many" "HMC-1: 15.6;OE19: 23.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023154 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023154: AB_2191204" "unprognostic (7.79e-3)" "unprognostic (1.06e-1)" "unprognostic (4.30e-2)" "unprognostic (1.44e-1)" "unprognostic (6.06e-2)" "unprognostic (3.96e-2)" "unprognostic (1.26e-1)" "unprognostic (4.49e-3)" "unprognostic (1.02e-1)" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "prognostic favorable (1.73e-6)" "unprognostic (8.79e-3)" "unprognostic (1.13e-1)" "unprognostic (1.77e-2)" "unprognostic (2.40e-2)" 5.6 3.9 6.9 7.6 7.0 10.2 4.3 10.0 19.1 14.2 6.6 2.7 8.5 5.4 6.7 8.9 5.0 11.6 6.9 9.3 8.2 5.9 12.2 1.6 10.1 7.6 5.1 8.4 5.0 14.2 5.4 20.6 17.8 11.5 9.5 3.9 11.4 15.6 16.3 6.4 7.4 6.0 4.3 3.0 6.8 24.4 28.5 2.9 6.6 8.7 1.8 6.4 7.8 4.4 0.0 0.4 9.4 0.1 0.2 0.5 0.1 3.7 8.6 3.1 4.9 0.2 0.2 13.8 2.1 1.3 1.9 1.5 5.4 10.0 0.8 9.4 0.8 2.7 3.1 1.7 1.0 0.9 5.9 2.5 2.4 2.5 0.0 1.5 0.9 15.6 0.7 1.4 1.5 0.8 0.4 1.3 4.0 4.6 0.6 0.5 9.2 8.4 1.9 4.1 23.2 3.5 2.6 0.2 2.4 6.8 6.8 4.9 3.9 2.3 0.8 3.6 2.2 1.6 5.6 0.7 0.0 2.1 3.3 4.1 3.1 9.9 1.0 1.9 3.7 3.6 1.3 0.1 9.4 0.2 0.1 0.2 0.0 0.2 0.5 0.1 0.0 0.2 0.2 8.6 0.2 0.1 0.4 0.2 0.1 6.9 7.0 10.0 19.1 8.2 5.9 5.1 8.4 11.5 2.9 8.9 10.1 0.0 5.7 2.4 32.9 11.1 10.2 17.4 6.8 47.1 51.1 7.1 0.0 6.2 9.5 1.4 9.5 0.0 2.4 0.6 2.0 6.0 1.1 0.0 5.6 3.2 2.4 0.6 2.7 4.1 2.0 2.7 3.3 0.0 6.3 2.8 5.6 5.8 2.1 3.3 9.3 0.0 2.1 4.2 1.9 2.0 13.6 1.5 3.3 9.5 SLC46A1 "HCP1, MGC9564, PCFT" ENSG00000076351 "Solute carrier family 46 member 1" Q96NT5 17 28394756-28407197 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.7" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 25.6;Hepatocytes: 24.9;Hofbauer cells: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "CACO-2: 67.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011614 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB011614: AB_2270597" "unprognostic (1.10e-1)" "unprognostic (8.62e-2)" "unprognostic (1.40e-1)" "unprognostic (7.59e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (9.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.36e-2)" "unprognostic (1.94e-1)" "unprognostic (3.80e-2)" "unprognostic (1.04e-3)" "unprognostic (6.15e-2)" "unprognostic (2.10e-3)" "unprognostic (2.16e-1)" "unprognostic (2.94e-1)" "unprognostic (2.15e-1)" "unprognostic (1.04e-1)" 3.1 17.8 4.6 2.5 7.0 1.3 5.1 13.2 5.2 2.9 43.8 5.2 9.4 45.4 2.2 4.5 1.8 6.7 3.0 2.2 4.4 6.0 3.8 17.9 3.2 4.9 4.0 4.0 4.4 5.0 8.1 7.8 5.0 5.0 3.7 2.7 6.1 5.7 5.8 2.0 2.0 52.7 2.6 4.6 4.9 2.3 2.2 4.2 2.2 4.0 0.4 1.2 2.4 2.4 2.7 2.6 7.1 5.9 2.9 1.7 0.8 1.7 7.4 2.5 4.1 2.0 0.4 7.8 2.1 1.5 1.7 2.0 67.6 2.1 0.2 1.2 1.1 5.0 5.8 2.8 4.7 1.5 4.3 6.6 0.0 4.6 5.7 0.7 0.0 3.4 1.0 8.7 1.8 5.4 2.4 0.1 0.6 2.8 0.4 0.3 2.3 0.0 0.2 1.5 1.7 1.0 0.1 2.0 0.8 1.3 3.9 6.6 3.5 14.5 6.8 0.9 3.6 5.3 1.1 0.2 0.2 3.0 0.4 2.2 3.1 3.5 0.1 0.4 0.4 1.6 7.1 1.6 1.1 0.8 5.9 1.4 2.7 0.9 0.7 2.6 1.7 1.0 1.7 2.3 2.9 4.3 1.1 1.6 0.8 4.6 7.0 13.2 5.2 4.4 6.0 4.0 4.0 5.0 4.2 11.9 4.0 3.2 1.9 0.3 25.6 1.8 15.3 4.0 1.2 7.0 3.9 16.6 0.0 2.8 3.4 1.0 1.3 0.0 3.9 7.3 3.1 2.2 1.1 24.9 21.1 19.1 1.2 2.5 13.0 13.5 3.7 3.9 0.0 1.0 2.1 1.6 3.5 0.9 3.2 4.1 5.6 6.5 1.0 0.0 0.2 0.3 3.7 0.0 1.2 1.4 SLC46A2 "Ly110, TSCOT" ENSG00000119457 "Solute carrier family 46 member 2" Q9BY10 9 112878920-112890913 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 21.1;lymphoid tissue: 31.8;skin 1: 22.3" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 35.7;Kupffer cells: 13.2" "Cancer enhanced" "Detected in some" "lung cancer: 1.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "classical monocyte: 17.0;intermediate monocyte: 8.7" "Lineage enriched" "Detected in many" 4 "monocytes: 17.0" "Cell line enhanced" "Detected in some" "U-138 MG: 1.1;U-2197: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA020098 Approved NA NA "HPA020098: AB_2670363" "unprognostic (1.26e-1)" "unprognostic (5.15e-3)" "unprognostic (1.10e-2)" "unprognostic (1.53e-3)" "unprognostic (3.57e-3)" "unprognostic (2.10e-2)" "unprognostic (4.56e-1)" "unprognostic (2.18e-1)" "unprognostic (8.10e-2)" "unprognostic (1.50e-3)" "unprognostic (3.50e-1)" "unprognostic (1.38e-1)" "unprognostic (1.77e-2)" "unprognostic (2.37e-1)" "unprognostic (2.71e-2)" "unprognostic (1.83e-1)" "unprognostic (7.82e-2)" 0.2 0.1 0.1 0.5 0.1 0.0 1.0 1.1 0.5 17.7 0.1 0.0 21.1 0.0 3.6 10.4 1.4 0.1 0.3 0.1 0.1 0.3 0.2 0.2 17.1 1.9 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.8 0.0 0.1 0.4 9.9 0.1 22.3 0.2 0.6 0.2 1.0 0.1 1.5 0.0 31.8 0.1 0.0 0.3 5.4 0.7 0.0 3.8 0.2 17.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.2 0.1 0.2 0.0 0.0 1.1 0.0 1.1 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.2 0.0 6.5 0.1 0.0 4.1 0.1 0.1 1.1 0.5 0.1 0.3 0.1 0.2 0.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.4 2.5 1.4 2.3 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 13.2 1.6 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SLC46A3 "DKFZp686A1775, FLJ42613" ENSG00000139508 "Solute carrier family 46 member 3" Q7Z3Q1 13 28700064-28718970 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 62.9;liver: 50.0" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 58.8;Hepatocytes: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 20.5;T-47d: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039930 Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039930: AB_10673263" "unprognostic (5.16e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (2.61e-1)" "unprognostic (3.88e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "prognostic favorable (7.09e-4)" "unprognostic (3.13e-1)" "unprognostic (3.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.69e-2)" "unprognostic (7.35e-2)" "unprognostic (1.14e-1)" "unprognostic (5.60e-2)" "unprognostic (9.14e-3)" "unprognostic (6.47e-3)" 6.9 14.2 3.8 5.9 5.7 1.4 6.4 7.6 6.5 8.3 19.6 6.9 2.8 24.0 5.2 7.4 3.1 4.1 12.7 8.1 4.2 4.2 10.4 50.0 6.0 11.4 4.7 3.9 5.0 5.5 4.2 18.2 5.0 6.6 5.3 10.1 17.4 10.3 5.6 8.2 4.0 62.9 4.5 5.1 11.6 4.8 9.3 3.7 11.8 6.8 3.0 6.9 6.1 4.7 9.1 10.4 22.6 15.9 5.6 11.2 7.4 0.0 2.0 0.0 5.5 4.5 1.8 0.1 2.0 11.1 2.2 3.2 0.1 4.7 3.8 3.7 2.8 8.4 0.4 2.5 1.0 3.3 2.8 4.9 2.5 0.0 0.0 8.4 0.0 3.3 7.2 2.1 3.3 5.4 2.2 4.0 11.3 2.7 0.0 10.5 2.0 6.2 0.4 0.2 5.6 1.7 2.6 9.9 0.1 20.5 0.6 0.9 0.3 0.0 10.2 4.0 2.4 15.0 3.3 1.5 1.1 2.1 0.3 11.7 3.1 1.5 0.5 0.6 0.0 2.0 22.6 8.0 3.0 9.8 11.5 8.4 6.6 7.9 9.6 10.4 9.1 11.2 10.6 8.2 5.6 15.9 9.7 9.2 7.4 3.8 5.7 7.6 6.5 4.2 4.2 4.7 3.9 6.6 3.7 0.0 4.8 5.1 0.0 1.6 22.0 7.7 17.8 10.7 1.2 8.7 7.9 0.5 1.7 11.8 3.0 8.9 58.8 0.0 4.9 0.2 5.4 0.6 24.4 50.6 9.7 20.6 3.5 19.6 25.4 1.7 1.4 14.5 6.8 4.6 7.0 14.1 3.8 5.8 2.1 8.4 9.5 0.0 2.8 2.3 0.5 1.5 0.6 10.0 10.0 0.1 SLC47A1 "FLJ10847, MATE1" ENSG00000142494 "Solute carrier family 47 member 1" Q96FL8 17 19495385-19579034 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.6;kidney: 51.1;liver: 44.9" "Group enriched" "Detected in many" 4 "Hepatocytes: 40.8;Proximal tubular cells: 54.2" "Cancer enhanced" "Detected in many" "renal cancer: 37.4" "Region enhanced" "Detected in many" "pons and medulla: 11.4" "Group enriched" "Detected in some" 7 "eosinophil: 12.2;plasmacytoid DC: 6.9" "Group enriched" "Detected in many" 7 "dendritic cells: 6.9;granulocytes: 12.2" "Cell line enhanced" "Detected in many" "A549: 13.2;AN3-CA: 10.6;Hep G2: 25.4;U-266/70: 19.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021987 Enhanced NA NA "HPA021987: AB_1857185" "unprognostic (1.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.54e-8)" "unprognostic (7.87e-2)" "unprognostic (8.34e-2)" "unprognostic (2.92e-2)" "prognostic favorable (1.88e-5)" "unprognostic (4.84e-2)" "unprognostic (6.89e-2)" "unprognostic (6.75e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.06e-5)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.91e-2)" "unprognostic (9.40e-2)" 2.2 45.6 0.8 0.4 2.2 1.1 0.6 1.0 3.1 13.2 1.2 3.7 1.3 0.7 7.6 12.2 0.9 2.4 1.7 3.5 4.7 0.5 51.1 44.9 3.0 3.5 0.9 2.5 5.0 0.2 0.2 7.2 0.3 11.4 2.6 0.5 4.3 1.1 5.5 12.1 10.4 0.6 3.5 2.3 1.9 0.5 15.5 0.6 0.9 4.7 5.7 1.2 0.6 4.5 0.1 6.9 12.2 1.3 0.0 0.7 0.4 0.0 13.2 0.4 10.6 0.3 0.0 0.0 0.4 0.3 1.6 1.5 0.0 0.4 0.1 2.5 1.9 5.3 0.0 4.7 0.3 0.4 0.0 6.2 0.1 7.0 25.4 0.1 0.1 0.3 0.2 2.4 1.2 0.2 1.8 3.7 0.0 0.0 0.0 0.0 1.8 0.0 0.2 1.4 0.1 0.5 0.1 0.1 0.1 0.0 0.8 2.5 2.2 4.3 0.0 1.1 3.7 4.5 1.2 0.0 0.1 0.5 0.2 1.2 19.8 7.8 0.0 0.5 0.1 2.3 0.2 1.3 12.2 0.3 1.0 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.7 0.3 0.0 0.2 6.9 0.0 0.4 0.8 2.2 1.0 3.1 4.7 0.5 0.9 2.5 11.4 0.6 6.0 3.0 0.0 2.2 4.1 0.3 3.8 5.1 1.4 0.0 1.8 0.0 0.0 3.3 0.1 11.3 0.7 0.0 0.0 0.0 0.0 2.3 1.3 5.7 40.8 1.5 0.0 0.0 0.0 1.6 2.7 3.4 0.6 1.7 0.0 0.0 1.2 0.0 0.0 1.4 54.2 0.7 6.5 1.0 0.2 0.7 5.8 0.0 0.0 0.0 1.3 SLC47A2 "FLJ31196, MATE2, MATE2-K" ENSG00000180638 "Solute carrier family 47 member 2" Q86VL8 17 19678288-19718979 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 55.5" "Cell type enriched" "Detected in some" 13 "Proximal tubular cells: 69.0" "Cancer enhanced" "Detected in some" "renal cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.9;HeLa: 1.5;hTCEpi: 6.7" "Not detected" "Not detected" NA NA "unprognostic (4.52e-3)" "unprognostic (8.28e-3)" "unprognostic (1.54e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (8.95e-4)" "unprognostic (5.22e-2)" "unprognostic (2.72e-1)" "unprognostic (1.99e-2)" "unprognostic (3.29e-2)" "unprognostic (1.51e-1)" "unprognostic (1.36e-3)" "unprognostic (7.77e-2)" "unprognostic (1.04e-3)" "unprognostic (4.33e-2)" "unprognostic (1.61e-1)" "unprognostic (6.44e-2)" "unprognostic (5.71e-2)" 0.2 0.3 3.0 0.1 4.4 0.1 0.3 0.2 0.4 0.1 0.2 10.3 0.6 0.2 0.2 6.5 0.2 8.6 0.1 0.3 6.2 5.5 55.5 0.1 0.1 0.1 1.1 0.1 0.6 0.1 0.1 0.0 0.1 12.8 0.1 0.1 0.7 0.1 0.3 0.7 1.8 0.4 0.2 2.0 0.1 0.1 0.2 2.8 0.0 0.3 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 1.2 0.0 0.2 1.9 0.0 0.1 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 6.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.8 0.0 0.3 0.0 0.1 0.3 0.5 0.2 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 3.0 4.4 0.2 0.4 6.2 5.5 1.1 0.1 12.8 2.8 0.0 0.0 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.0 5.2 0.0 0.1 5.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 69.0 0.2 0.0 0.3 0.5 0.2 0.3 0.0 0.0 0.0 0.1 SLC48A1 "FLJ20489, hHRG-1, HRG1" ENSG00000211584 "Solute carrier family 48 member 1" Q6P1K1 12 47753916-47782753 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 90.7" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 42.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065396, HPA073994" Approved Supported Vesicles NA NA Vesicles "HPA065396: , HPA073994: " "unprognostic (9.60e-2)" "prognostic favorable (4.27e-4)" "unprognostic (1.13e-2)" "unprognostic (1.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (9.39e-5)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (9.88e-2)" "unprognostic (1.54e-2)" "unprognostic (6.63e-3)" "prognostic favorable (1.34e-6)" "unprognostic (1.45e-1)" "unprognostic (5.96e-2)" "unprognostic (1.52e-1)" "unprognostic (2.72e-2)" 16.2 13.5 27.8 5.0 33.5 7.7 10.7 12.5 39.5 13.1 8.3 90.7 6.7 5.6 11.9 12.7 13.9 21.9 11.5 12.8 32.7 20.8 18.5 6.3 11.7 4.9 44.1 27.9 35.6 10.6 24.3 6.4 13.2 38.6 9.3 8.2 7.4 13.2 18.1 16.7 14.7 5.3 12.7 44.5 11.3 7.7 5.1 39.7 4.9 35.6 6.1 6.0 9.9 7.6 7.1 8.5 23.7 11.9 1.2 5.4 4.0 4.5 14.2 2.2 17.0 14.9 6.4 5.0 3.3 7.3 3.1 3.2 4.5 12.4 2.8 42.7 9.1 6.3 18.2 2.9 3.8 2.4 23.1 2.8 19.3 11.9 6.1 8.5 5.1 11.5 3.8 7.7 4.5 5.5 16.4 8.8 7.9 5.0 11.3 2.0 9.5 2.4 5.2 1.5 8.5 7.0 2.4 0.6 15.1 12.6 12.2 2.9 1.3 4.4 5.5 3.1 4.3 18.4 4.8 4.8 4.5 6.0 8.4 2.3 9.1 5.6 0.8 5.8 24.5 2.6 0.0 11.9 7.8 3.6 8.5 3.2 7.1 4.4 3.7 8.5 6.3 5.4 4.4 23.7 1.2 4.8 1.6 3.4 4.0 27.8 33.5 12.5 39.5 32.7 20.8 44.1 27.9 38.6 39.7 8.9 9.1 3.7 8.4 6.0 10.5 14.3 10.2 1.4 5.7 48.8 2.0 8.0 19.9 8.5 7.7 21.5 6.7 0.0 8.5 1.7 9.9 11.0 1.1 10.4 20.5 14.3 8.1 12.9 14.9 10.4 30.2 9.3 5.0 40.5 12.9 19.3 6.7 7.0 21.5 27.0 10.3 6.5 8.5 4.3 9.6 10.5 3.0 2.5 7.6 10.1 SLC49A3 "FLJ22269, LP2561, MFSD7" ENSG00000169026 "Solute carrier family 49 member 3" Q6UXD7 4 681829-689441 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Collecting duct cells: 14.0;Ductal cells: 14.4;Extravillous trophoblasts: 28.5;Hofbauer cells: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 7.5;SK-BR-3: 7.4;T-47d: 23.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043593 Uncertain NA NA "HPA043593: AB_10959611" "unprognostic (1.10e-2)" "unprognostic (1.91e-1)" "unprognostic (8.77e-2)" "unprognostic (4.70e-2)" "unprognostic (9.40e-2)" "unprognostic (1.84e-3)" "unprognostic (2.22e-1)" "unprognostic (1.56e-2)" "unprognostic (1.83e-1)" "unprognostic (2.56e-1)" "unprognostic (9.22e-2)" "unprognostic (2.08e-1)" "prognostic favorable (2.66e-5)" "unprognostic (8.35e-2)" "unprognostic (4.92e-2)" "unprognostic (7.48e-2)" "unprognostic (1.11e-1)" 13.8 3.3 4.8 5.4 3.1 3.8 13.9 4.6 4.5 4.7 6.5 1.7 4.1 7.4 4.2 10.0 7.5 3.5 5.0 8.9 1.8 1.5 7.7 8.8 17.6 9.2 2.4 2.4 2.8 8.7 11.1 2.4 4.1 3.6 5.3 2.8 7.4 10.6 2.8 2.9 9.6 7.2 4.2 3.0 9.7 9.8 23.6 2.2 2.2 9.2 4.6 2.8 4.9 5.2 0.0 0.6 4.2 1.8 1.2 0.3 0.9 0.1 0.1 2.4 1.7 1.7 3.9 7.5 0.8 0.0 0.8 0.5 0.4 5.1 0.1 0.2 3.9 0.4 0.2 0.0 0.0 0.2 0.5 0.4 1.4 0.6 0.2 0.7 0.0 1.1 2.4 0.0 3.2 0.0 0.0 1.1 0.2 0.3 0.5 0.0 0.1 0.1 0.5 0.2 0.4 0.3 0.0 0.3 0.5 0.0 0.3 0.8 0.6 0.0 7.4 0.4 0.4 23.1 1.4 0.3 0.7 0.2 0.3 0.2 2.5 1.3 0.1 0.3 0.6 0.0 0.0 1.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.2 1.2 0.7 0.0 0.3 0.9 4.8 3.1 4.6 4.5 1.8 1.5 2.4 2.4 3.6 2.2 3.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 14.0 0.0 0.6 1.7 14.4 0.0 0.0 0.0 0.0 0.3 28.5 0.0 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 5.4 0.0 0.0 5.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 SLC4A1 "AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR" ENSG00000004939 "Solute carrier family 4 member 1 (Diego blood group)" P02730 17 44248385-44268141 "Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Blood group antigen" "Disease mutation, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 95.7;placenta: 32.7" "Cell type enriched" "Detected in some" 66 "Erythroid cells: 1261.4" "Cancer enriched" "Detected in single" 91 "renal cancer: 16.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 0.4" "Low region specificity" "Detected in all" "HPA015584, CAB034438, HPA063911" Enhanced NA NA 160000000 "CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151" "unprognostic (1.36e-1)" "unprognostic (1.42e-1)" "unprognostic (3.36e-1)" "unprognostic (2.44e-2)" "unprognostic (2.32e-2)" "unprognostic (1.56e-2)" "unprognostic (1.55e-1)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (1.58e-1)" "unprognostic (6.72e-3)" "unprognostic (1.19e-1)" "unprognostic (9.28e-3)" "unprognostic (1.93e-2)" "unprognostic (2.18e-1)" "unprognostic (1.94e-1)" "unprognostic (2.13e-1)" 0.9 0.1 0.3 0.2 0.4 95.7 0.2 0.8 0.2 0.1 0.1 0.6 0.0 0.2 0.1 0.4 0.6 0.2 0.2 2.6 0.2 0.3 18.6 1.3 12.9 0.8 0.6 0.1 2.8 0.1 0.0 0.6 32.7 0.9 0.6 0.1 1.2 0.1 0.1 1.2 0.2 0.1 0.0 1.0 8.4 0.1 0.3 0.0 0.7 1.9 0.0 0.2 3.9 11.8 1.8 1.4 6.3 1.2 2.9 1.5 0.7 1.3 0.5 1.4 1.7 0.6 0.7 1.0 0.3 0.4 0.3 0.8 1.4 3.2 0.7 0.6 0.3 0.4 1.4 0.5 0.5 1.1 1.3 1.3 1.7 1.6 2.2 0.0 0.8 2.3 0.8 0.5 0.8 0.8 0.5 0.2 0.6 4.8 3.5 0.4 0.6 1.0 3.5 0.9 0.7 0.5 2.5 0.7 1.9 0.3 0.8 2.2 1.0 1.3 1.4 0.5 0.7 2.5 1.8 1.0 2.4 2.1 1.4 1.4 1.0 2.3 1.1 1.6 2.2 1.1 6.1 1.0 2.0 1.1 0.9 1.0 1.1 1.0 0.9 0.5 1.8 1.5 1.2 6.3 2.9 1.2 1.4 0.7 0.7 0.3 0.4 0.8 0.2 0.2 0.3 0.6 0.1 0.9 0.0 6.0 1.1 0.0 0.9 0.0 0.4 0.7 0.0 0.0 1.2 19.2 0.0 0.3 3.3 0.0 0.5 0.0 0.0 1261.4 0.0 0.9 0.3 0.4 0.0 0.0 1.3 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.9 0.4 0.0 0.7 0.0 0.0 0.5 SLC4A10 "NBCn2, NCBE" ENSG00000144290 "Solute carrier family 4 member 10" Q6U841 2 161424332-161985282 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 31.2;brain: 48.1" "Cell type enriched" "Detected in some" 12 "Bipolar cells: 116.7" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "MAIT T-cell: 31.2" "Lineage enriched" "Detected in single" 78 "T-cells: 31.2" "Cell line enriched" "Detected in some" 11 "Karpas-707: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034755, HPA076725" Enhanced NA NA "HPA034755: AB_10670296, HPA076725: " "unprognostic (4.64e-4)" "unprognostic (3.88e-1)" "unprognostic (2.88e-2)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "unprognostic (7.89e-3)" "unprognostic (5.99e-4)" "unprognostic (1.12e-1)" "unprognostic (2.27e-1)" "unprognostic (1.64e-1)" "unprognostic (2.50e-2)" "unprognostic (9.27e-2)" "unprognostic (5.65e-2)" "unprognostic (9.23e-3)" "unprognostic (1.87e-1)" "unprognostic (2.10e-3)" "unprognostic (2.26e-1)" 1.0 3.7 21.6 1.9 24.1 1.2 1.3 14.9 48.1 1.1 3.3 2.1 0.0 1.4 1.0 2.8 1.0 1.8 1.5 1.0 20.4 10.8 1.0 1.3 1.1 1.1 4.3 29.6 1.0 2.9 1.0 4.4 1.0 17.7 1.3 2.7 1.7 1.0 1.1 1.0 1.0 1.5 1.1 1.9 3.0 1.3 1.4 3.5 0.0 1.0 0.0 1.5 1.3 0.3 0.0 0.0 0.0 0.0 0.4 31.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.0 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.2 0.0 31.2 0.0 0.6 3.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 21.6 24.1 14.9 37.9 20.4 10.8 4.3 29.6 17.7 3.5 0.0 0.0 0.0 0.0 0.0 116.7 0.4 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 1.8 1.2 8.4 0.0 0.0 0.0 0.0 2.2 2.4 0.1 0.0 0.0 0.0 6.7 0.0 0.0 0.9 0.2 0.0 0.0 4.4 0.0 0.0 SLC4A11 "BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1" ENSG00000088836 "Solute carrier family 4 member 11" Q8NBS3 20 3227417-3239559 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Symport, Transport" "Corneal dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 34.4;thyroid gland: 42.7" "Cell type enriched" "Detected in some" 4 "Collecting duct cells: 106.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 1.4;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 36.0;Hep G2: 21.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA018120, HPA058377" Uncertain Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA018120: AB_1857186, HPA058377: " "unprognostic (2.33e-1)" "prognostic favorable (9.03e-4)" "unprognostic (1.18e-2)" "unprognostic (3.05e-2)" "unprognostic (1.00e-1)" "unprognostic (6.52e-2)" "unprognostic (9.66e-3)" "unprognostic (3.73e-2)" "unprognostic (3.10e-3)" "unprognostic (1.52e-3)" "unprognostic (2.94e-1)" "unprognostic (2.64e-1)" "prognostic favorable (6.21e-6)" "unprognostic (7.37e-2)" "unprognostic (4.30e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-3)" 0.8 3.1 3.3 0.8 4.9 0.3 2.4 2.1 2.8 8.6 0.2 1.3 0.8 0.1 0.9 2.0 7.5 1.1 2.2 0.5 3.0 0.6 11.4 0.1 1.3 0.9 1.4 1.1 0.6 0.1 0.4 2.4 0.3 1.8 2.2 0.3 1.1 34.4 5.8 3.5 5.3 0.3 0.2 1.4 0.3 1.9 3.2 1.2 0.2 42.7 3.3 5.1 2.6 2.1 0.0 0.7 0.0 1.4 0.0 1.1 0.4 5.4 7.8 0.9 4.1 2.7 0.7 11.1 2.7 1.7 1.4 0.8 0.5 7.2 0.0 3.2 0.9 3.4 36.0 4.2 8.5 0.2 0.0 1.7 0.3 3.4 21.0 1.7 1.9 7.0 0.3 3.5 1.7 1.6 1.2 3.6 5.0 0.7 5.0 1.4 3.5 0.2 0.2 6.2 6.7 10.6 1.2 5.3 1.7 8.7 15.3 0.4 2.5 1.4 9.0 0.2 2.9 3.4 3.4 6.1 1.1 3.7 0.2 1.3 0.2 0.3 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.7 0.0 0.3 0.0 0.0 0.0 1.4 0.0 1.1 0.4 3.3 4.9 2.1 2.8 3.0 0.6 1.4 1.1 1.8 1.2 0.0 0.0 0.0 1.7 0.7 0.1 1.2 0.0 5.3 2.3 106.4 0.0 0.0 0.0 0.7 3.5 0.3 0.0 0.0 0.4 0.1 0.3 2.0 0.0 0.0 0.3 0.0 0.0 1.8 0.3 1.5 0.0 0.0 0.0 1.0 0.1 0.0 2.2 0.6 0.4 0.3 0.0 25.8 0.5 0.6 5.2 0.4 0.0 0.0 0.0 2.6 SLC4A2 "AE2, BND3L, EPB3L1, HKB3, NBND3" ENSG00000164889 "Solute carrier family 4 member 2" P04920 7 151057210-151076527 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.2;retina: 100.7" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 76.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "pons and medulla: 73.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA019339 Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Plasma membrane" Cytosol "HPA019339: AB_1844825" "unprognostic (1.19e-1)" "unprognostic (3.33e-3)" "unprognostic (8.12e-3)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (9.04e-6)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (3.30e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (1.26e-4)" "unprognostic (4.67e-3)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.36e-2)" 9.9 13.5 4.7 10.4 7.4 6.7 10.5 3.0 8.6 12.4 18.6 29.0 6.0 12.1 16.2 6.3 7.7 10.8 14.1 11.9 10.1 3.8 35.5 94.2 12.3 7.2 10.4 4.8 12.6 34.1 30.6 5.3 31.4 73.3 10.5 4.0 100.7 11.9 8.3 8.7 9.5 26.0 10.7 10.4 10.1 27.1 6.5 8.5 8.8 9.7 7.0 5.9 11.7 10.6 2.5 5.6 2.1 4.2 0.5 2.7 1.9 15.9 52.8 10.4 21.4 10.4 6.1 23.8 19.4 10.5 15.9 13.8 30.0 25.6 9.6 42.6 9.2 23.4 15.7 10.6 9.4 2.9 27.6 15.8 12.6 25.7 15.2 17.0 6.5 40.6 8.9 8.3 18.0 4.6 17.1 8.8 13.6 38.9 8.1 12.3 30.6 18.6 11.2 24.7 21.5 19.6 14.7 5.7 11.2 13.0 12.1 8.6 31.2 17.7 33.5 16.5 8.2 13.8 12.8 19.0 21.4 10.9 21.0 28.5 8.8 11.8 5.4 32.7 16.3 42.9 0.0 4.2 2.1 2.7 3.9 1.9 2.5 2.1 1.8 2.4 1.0 2.4 2.4 1.0 0.5 2.5 5.6 1.0 1.9 4.7 7.4 3.0 8.6 10.1 3.8 10.4 4.8 73.3 8.5 8.9 10.9 6.7 4.5 9.8 7.9 3.6 17.8 1.4 2.3 19.2 23.6 28.5 14.9 31.0 0.6 9.8 17.3 0.0 30.9 9.0 16.2 5.0 48.3 31.4 23.1 14.3 26.5 14.7 15.1 1.3 12.7 9.9 25.3 9.0 11.1 22.3 39.3 14.0 18.7 18.9 8.8 12.9 15.5 3.2 7.7 6.0 76.5 8.3 18.9 3.1 SLC4A3 "AE3, SLC2C" ENSG00000114923 "Solute carrier family 4 member 3" P48751 2 219627327-219641980 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 103.6;ovary: 30.2" "Group enriched" "Detected in many" 17 "Cardiomyocytes: 201.0;Horizontal cells: 527.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 36 "myeloid DC: 2.3;plasmacytoid DC: 8.9" "Lineage enriched" "Detected in single" 58 "dendritic cells: 8.9" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063498 Approved Nucleoplasm NA NA Nucleoplasm "HPA063498: AB_2685025" "unprognostic (9.49e-2)" "unprognostic (5.72e-3)" "unprognostic (8.92e-4)" "unprognostic (1.77e-2)" "unprognostic (6.61e-3)" "unprognostic (1.47e-1)" "unprognostic (2.60e-1)" "unprognostic (2.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-1)" "unprognostic (8.15e-3)" "unprognostic (1.97e-1)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.12e-4)" 1.8 5.4 11.8 1.6 22.5 1.2 2.0 8.8 22.0 2.8 1.3 3.0 0.4 1.4 3.4 2.6 2.9 2.7 2.3 103.6 10.4 8.2 1.6 1.0 1.3 1.4 6.5 9.0 30.2 2.7 4.5 9.9 2.5 24.1 4.2 1.1 4.9 3.1 4.3 1.2 1.6 1.3 3.1 1.6 2.6 1.4 4.2 3.5 0.0 1.5 0.0 1.3 1.6 0.9 0.0 8.9 0.0 0.1 0.0 0.0 0.0 6.2 0.2 2.2 6.5 0.4 0.4 4.4 3.9 4.1 5.3 3.8 4.5 3.6 0.0 1.5 1.4 9.2 3.6 1.1 7.1 1.6 0.0 1.0 0.0 0.0 0.1 1.1 0.1 0.3 3.1 6.7 0.0 2.1 13.4 0.0 0.0 0.2 0.0 1.5 2.1 0.0 0.0 3.6 0.2 5.3 0.0 0.0 0.0 3.6 1.5 1.3 6.4 2.5 6.8 3.3 7.5 0.6 1.6 0.0 3.3 5.8 0.0 3.1 0.0 0.0 0.0 2.7 0.0 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 11.8 22.5 8.8 22.0 10.4 8.2 6.5 9.0 24.1 3.5 0.0 0.0 0.0 0.6 0.2 8.9 201.0 0.0 0.0 1.2 1.8 0.0 10.5 1.7 2.8 2.0 0.1 0.0 0.0 1.5 2.5 2.2 0.3 0.0 0.0 1.6 527.6 0.0 0.0 0.0 11.9 14.1 1.1 0.0 1.0 0.0 7.0 1.3 0.0 21.2 0.3 6.7 6.5 1.4 0.5 1.1 0.6 11.6 0.0 0.0 0.0 SLC4A4 "hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5" ENSG00000080493 "Solute carrier family 4 member 4" Q9Y6R1 4 71186757-71572087 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 47.4;pancreas: 113.8" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 107.0;Ductal cells: 81.5;Enterocytes: 173.4;Proximal tubular cells: 149.5" "Group enriched" "Detected in many" 5 "glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.8;memory CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 5 "T-cells: 2.8" "Cell line enhanced" "Detected in some" "BJ: 13.9;fHDF/TERT166: 6.3;hTERT-RPE1: 6.0;RPTEC TERT1: 14.9;U-138 MG: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022493, HPA035628, HPA035629, HPA079220" Enhanced NA NA "CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: " "unprognostic (3.92e-2)" "unprognostic (1.63e-1)" "prognostic favorable (7.69e-4)" "unprognostic (5.32e-2)" "unprognostic (1.01e-1)" "unprognostic (5.09e-2)" "unprognostic (4.24e-2)" "unprognostic (7.49e-2)" "unprognostic (1.46e-1)" "unprognostic (9.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.74e-1)" "prognostic favorable (1.18e-4)" "unprognostic (7.00e-2)" "unprognostic (2.92e-1)" "unprognostic (2.05e-3)" "unprognostic (2.04e-1)" 2.4 0.9 14.3 4.3 19.9 0.7 1.1 18.1 15.2 5.8 17.2 4.5 0.1 22.4 0.8 0.7 1.1 1.0 24.9 2.9 13.1 8.1 47.4 9.4 5.8 0.6 9.7 11.2 1.0 113.8 10.0 4.1 1.6 18.1 14.6 17.1 11.1 1.5 1.1 1.3 0.7 10.4 1.3 21.6 0.9 8.3 0.7 8.0 0.0 9.5 0.0 0.6 2.6 0.9 0.0 0.1 0.0 0.0 0.5 2.8 0.3 0.0 3.6 1.0 0.0 0.0 0.0 0.1 13.9 1.9 2.3 1.8 0.0 0.1 0.0 0.1 6.3 0.6 0.0 0.2 0.0 5.7 0.0 1.8 0.9 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 6.0 0.0 0.9 0.0 0.6 1.2 0.0 4.7 0.2 0.1 0.2 0.0 0.0 0.0 0.9 14.9 4.2 1.0 0.1 0.0 0.0 0.2 1.2 0.0 0.0 0.0 7.9 0.7 5.7 0.6 0.0 0.0 0.0 5.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 1.4 0.0 0.8 2.4 0.1 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.3 14.3 19.9 18.1 12.4 13.1 8.1 9.7 11.2 18.1 8.0 3.0 32.5 1.3 4.2 0.0 0.0 20.1 107.0 14.7 31.8 24.4 0.0 0.2 13.3 81.5 6.6 1.9 173.4 0.0 21.6 0.1 1.1 63.3 1.1 31.7 0.2 0.0 8.2 1.8 0.6 1.0 0.0 1.0 1.7 1.8 66.7 3.3 19.9 56.6 0.0 149.5 1.1 6.5 2.5 0.1 0.4 0.0 0.2 6.9 42.6 7.0 SLC4A5 NBC4 ENSG00000188687 "Solute carrier family 4 member 5" Q9BY07 2 74216242-74343414 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Anion exchange, Ion transport, Sodium transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 109.1" "Cell type enhanced" "Detected in some" 28 "Cone photoreceptor cells: 33.4;Horizontal cells: 158.9;Rod photoreceptor cells: 43.4" "Cancer enriched" "Detected in single" 11 "thyroid cancer: 3.3" "Group enriched" "Detected in many" 5 "cerebellum: 3.4;pons and medulla: 9.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 14.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA036621 Uncertain NA NA "HPA036621: AB_10696779" "unprognostic (1.30e-1)" "unprognostic (3.78e-2)" "unprognostic (2.75e-2)" "unprognostic (1.83e-4)" "unprognostic (3.38e-1)" "unprognostic (2.36e-2)" "unprognostic (2.56e-3)" "unprognostic (5.37e-4)" "unprognostic (1.39e-1)" "unprognostic (2.55e-1)" "unprognostic (1.55e-3)" "unprognostic (3.24e-2)" "unprognostic (1.72e-5)" "unprognostic (1.57e-1)" "unprognostic (1.06e-2)" "unprognostic (8.47e-2)" "unprognostic (9.27e-4)" 1.2 0.4 1.0 0.8 0.8 1.6 1.1 3.4 1.2 0.7 0.8 2.5 0.6 0.3 0.9 1.7 0.6 1.4 0.8 0.7 1.2 1.0 0.7 3.2 1.7 1.0 1.0 0.6 1.3 0.9 1.5 2.3 0.6 9.0 0.9 0.3 109.1 1.3 0.8 1.1 3.7 0.7 0.9 1.6 0.7 0.5 16.1 0.7 1.0 21.4 0.6 0.7 0.9 0.9 2.5 5.8 6.1 0.9 1.7 2.5 0.6 0.4 0.8 1.4 1.4 1.5 2.6 1.9 0.4 1.4 0.8 1.2 0.4 1.0 2.2 0.4 0.0 0.5 0.1 1.6 0.2 0.3 1.9 0.9 3.3 1.4 0.8 0.2 1.1 2.3 0.7 2.0 0.1 0.3 0.7 0.5 1.6 0.7 2.4 0.3 5.2 0.5 2.2 1.1 1.0 0.3 1.1 1.4 0.0 0.3 1.0 1.0 2.1 0.5 1.7 2.3 1.4 1.6 2.2 0.0 1.5 2.4 1.6 0.5 14.6 2.0 1.7 0.9 1.2 0.3 6.1 0.9 0.9 1.5 0.8 1.0 1.8 2.3 2.0 0.6 2.5 2.1 2.5 4.2 1.7 0.3 5.8 2.4 0.6 1.0 0.8 3.4 1.2 1.2 1.0 1.0 0.6 9.0 0.7 3.0 6.7 0.0 0.6 0.6 12.6 0.4 2.5 4.0 4.5 0.0 33.4 0.0 0.0 0.3 0.4 0.8 0.0 0.0 0.6 0.0 0.4 0.8 0.0 0.0 0.1 158.9 0.0 0.0 0.0 0.0 1.1 0.2 1.7 0.0 0.1 2.9 0.2 0.0 0.4 0.0 43.4 0.0 0.4 1.7 1.4 0.4 0.0 0.0 0.0 0.5 SLC4A7 "NBC3, SBC2, SLC4A6" ENSG00000033867 "Solute carrier family 4 member 7" Q9Y6M7 3 27372721-27484420 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 48.5" "Group enriched" "Detected in many" 10 "Cone photoreceptor cells: 691.1;Rod photoreceptor cells: 667.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 38.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022494, HPA035857" Enhanced Supported "Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Plasma membrane" "Focal adhesion sites, Cytosol" "CAB022494: , HPA035857: AB_10795135" "unprognostic (2.94e-2)" "unprognostic (6.34e-2)" "unprognostic (1.80e-3)" "unprognostic (1.91e-1)" "unprognostic (8.48e-3)" "unprognostic (2.68e-1)" "unprognostic (6.79e-4)" "unprognostic (4.13e-2)" "unprognostic (1.40e-1)" "unprognostic (1.64e-1)" "unprognostic (1.83e-1)" "unprognostic (8.58e-3)" "prognostic unfavorable (7.91e-6)" "unprognostic (1.09e-2)" "unprognostic (6.68e-2)" "unprognostic (1.93e-1)" "unprognostic (7.26e-2)" 14.5 5.0 3.2 10.5 4.6 3.3 17.0 4.0 4.8 10.8 38.2 5.0 8.8 48.5 8.1 12.6 8.4 6.5 12.5 9.3 5.0 3.8 15.3 3.7 9.3 10.3 4.8 1.9 9.0 3.3 2.4 4.4 5.6 4.5 10.3 6.9 20.0 8.3 8.4 5.6 5.6 43.4 18.2 5.8 9.7 7.8 6.1 5.5 6.8 6.3 14.7 15.5 15.0 14.9 1.8 2.0 0.1 0.9 2.4 3.9 0.7 5.9 11.1 10.0 4.6 4.7 8.4 7.1 20.2 9.4 7.8 6.1 3.0 3.1 13.5 1.7 7.8 7.5 2.6 9.5 9.8 12.4 11.4 3.1 6.2 7.6 3.2 8.1 14.0 5.4 6.7 4.3 11.8 38.2 16.5 12.8 8.9 4.1 4.8 16.0 2.1 13.9 3.2 6.6 0.7 11.0 9.5 7.9 2.7 18.3 4.2 2.5 6.3 9.2 6.8 3.1 8.9 15.5 5.4 8.9 18.4 5.1 12.7 15.6 1.8 1.9 7.7 16.1 9.9 8.4 0.0 0.5 0.0 3.0 0.6 2.0 1.2 3.8 3.9 1.4 1.8 1.5 2.7 0.1 2.4 0.9 2.0 3.2 0.7 3.2 4.6 4.0 4.8 5.0 3.8 4.8 1.9 4.5 5.5 0.0 12.8 13.2 28.2 26.1 65.7 18.7 15.3 5.3 25.0 59.3 691.1 4.5 8.3 13.6 6.7 25.3 5.8 0.0 6.2 23.0 30.2 41.3 23.1 5.9 16.9 6.4 36.7 14.7 33.1 5.9 8.3 36.7 33.7 20.8 50.6 45.2 13.6 12.7 9.2 10.5 667.4 38.8 32.8 32.4 21.7 26.8 6.8 33.0 12.2 33.6 SLC4A8 NBC3 ENSG00000050438 "Solute carrier family 4 member 8" Q2Y0W8 12 51391317-51515763 "Predicted membrane proteins" "Anion exchange, Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;pituitary gland: 20.0;testis: 15.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 85.2;Cone photoreceptor cells: 168.9;Horizontal cells: 109.7;Spermatocytes: 91.6" "Group enriched" "Detected in some" 6 "breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 17.6;HMC-1: 12.4;SCLC-21H: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077895 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077895: " "unprognostic (4.01e-1)" "unprognostic (8.15e-2)" "unprognostic (2.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.96e-2)" "unprognostic (3.46e-2)" "unprognostic (7.72e-4)" "unprognostic (3.13e-2)" "unprognostic (7.03e-3)" "unprognostic (1.07e-4)" "unprognostic (1.70e-1)" "unprognostic (9.60e-6)" "unprognostic (1.35e-1)" "unprognostic (2.57e-1)" "unprognostic (3.21e-2)" "unprognostic (2.47e-1)" 1.0 6.5 5.8 2.2 13.3 1.7 3.1 9.2 22.9 2.7 1.1 9.8 0.0 1.4 1.2 5.4 0.7 3.7 1.1 1.0 10.9 5.6 3.2 0.8 2.8 3.0 6.0 9.3 7.3 2.4 1.0 20.0 1.0 28.6 1.4 1.4 2.2 1.5 1.7 0.8 1.0 2.0 1.1 4.7 2.2 3.0 15.3 5.1 0.0 0.8 0.0 2.7 1.0 0.7 1.1 2.6 3.4 3.1 1.7 1.7 0.7 0.2 0.8 9.9 0.1 0.4 0.5 17.6 2.7 4.5 4.4 2.8 5.8 0.2 3.6 0.4 3.6 2.4 0.1 3.9 0.2 4.1 0.7 0.5 1.8 0.3 0.0 0.0 0.6 12.4 0.1 0.2 2.2 0.5 2.6 5.1 1.6 0.1 6.4 2.2 2.1 5.2 1.1 4.3 1.1 2.9 0.1 0.0 0.0 0.5 0.1 13.2 8.9 1.0 1.4 0.0 3.2 1.6 0.4 4.7 2.8 1.5 0.2 3.4 3.2 1.0 0.2 3.9 0.5 0.4 1.3 2.1 3.4 1.7 1.4 0.4 0.6 0.6 1.6 2.6 1.1 0.6 1.0 2.3 1.7 3.1 1.0 0.3 0.7 5.8 13.3 9.2 22.9 10.9 5.6 6.0 9.3 28.6 5.1 0.0 8.3 0.5 0.6 0.0 85.2 1.7 0.0 38.8 9.1 1.8 168.9 1.0 6.6 0.1 48.8 1.1 0.3 0.0 1.2 4.3 0.5 1.0 7.0 0.0 2.1 109.7 5.8 0.6 1.2 22.8 2.6 3.3 1.7 0.0 0.2 13.6 0.1 2.9 3.5 0.8 18.4 0.0 0.8 91.6 6.4 0.1 0.3 2.5 0.0 1.0 SLC4A9 AE4 ENSG00000113073 "Solute carrier family 4 member 9" Q96Q91 5 140360202-140375143 "Plasma proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "kidney: 26.7" "Cell type enhanced" "Detected in single" 21 "Distal tubular cells: 1.7" "Cancer enriched" "Detected in single" 8 "renal cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.8;U-698: 2.0" "Region enhanced" "Detected in single" "pons and medulla: 1.0" "Low region specificity" "Detected in all" HPA051307 Uncertain NA NA "HPA051307: AB_2681434" "unprognostic (1.68e-1)" "unprognostic (4.22e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (1.10e-1)" "unprognostic (2.13e-1)" "unprognostic (1.02e-2)" "unprognostic (3.28e-3)" "unprognostic (2.78e-1)" "unprognostic (2.47e-1)" "unprognostic (4.78e-2)" "unprognostic (1.19e-1)" "unprognostic (4.24e-2)" "unprognostic (2.99e-2)" "unprognostic (3.06e-2)" "unprognostic (5.04e-2)" "unprognostic (1.82e-2)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 26.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.6 0.2 0.2 0.0 0.7 0.6 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 3.8 0.0 0.8 0.0 0.4 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.0 1.0 0.5 2.0 0.0 0.1 0.2 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.0 0.0 0.0 0.1 SLC50A1 "HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1" ENSG00000169241 "Solute carrier family 50 member 1" Q9BRV3 1 155135344-155138857 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 115.3;Mucus-secreting cells: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018095 Approved NA NA "HPA018095: AB_1856048" "unprognostic (4.75e-2)" "unprognostic (1.21e-1)" "unprognostic (7.57e-2)" "unprognostic (2.24e-1)" "unprognostic (3.29e-1)" "unprognostic (9.30e-2)" "unprognostic (1.64e-3)" "unprognostic (1.95e-1)" "unprognostic (1.38e-1)" "unprognostic (5.51e-2)" "unprognostic (3.53e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.88e-7)" "unprognostic (4.36e-2)" "unprognostic (1.40e-1)" "unprognostic (3.50e-3)" "unprognostic (4.39e-2)" 11.6 23.4 4.9 16.3 5.7 7.2 13.6 4.2 6.7 13.6 19.8 5.6 28.7 17.2 11.5 49.0 20.3 10.0 21.3 7.5 5.1 7.0 23.8 34.5 22.8 24.3 5.3 4.3 13.6 55.3 12.7 10.3 19.5 6.2 14.4 25.0 11.3 37.5 17.2 4.5 15.9 28.6 9.8 6.1 27.0 19.9 9.3 6.7 12.8 23.4 15.9 25.0 12.4 10.2 32.2 15.3 12.0 18.2 24.0 14.7 15.3 15.8 4.9 5.2 9.4 13.7 13.1 10.7 6.2 16.1 10.5 14.1 8.6 54.8 11.2 17.1 9.1 11.1 22.6 7.1 18.8 8.2 19.6 2.4 9.2 4.6 5.4 21.2 6.1 12.5 14.3 42.7 12.4 30.7 13.7 9.3 5.4 10.1 17.3 10.1 15.6 4.5 8.7 7.0 30.1 16.3 8.6 3.0 33.6 21.3 4.6 9.2 6.9 10.4 21.3 16.9 8.0 44.3 8.8 5.3 7.0 6.1 9.1 3.1 19.6 11.6 9.8 11.3 13.9 6.9 11.3 12.9 12.0 10.4 18.2 12.6 27.1 13.6 12.2 15.3 32.2 14.7 12.9 5.8 24.0 16.8 14.9 13.7 15.3 4.9 5.7 4.2 6.7 5.1 7.0 5.3 4.3 6.2 6.7 20.8 28.1 41.2 17.9 14.3 6.6 4.1 10.2 22.7 26.1 22.7 11.8 31.6 11.6 37.2 0.4 30.6 61.6 23.3 42.8 115.3 23.2 36.2 23.1 16.3 41.3 6.4 22.4 22.1 24.0 1.1 12.4 30.6 27.0 43.3 113.0 6.2 34.6 38.6 5.3 20.4 6.7 6.5 21.7 9.3 5.2 16.2 52.5 27.4 43.3 33.3 SLC51A OSTalpha ENSG00000163959 "Solute carrier family 51 alpha subunit" Q86UW1 3 196211487-196243178 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "intestine: 53.9;liver: 59.5" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 130.2;Leydig cells: 57.0;Peritubular cells: 95.5;Sertoli cells: 142.3" "Cancer enriched" "Detected in many" 7 "liver cancer: 15.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 1.7;neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "REH: 8.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA045488 Enhanced NA NA "HPA045488: " "unprognostic (1.63e-2)" "unprognostic (1.27e-3)" "unprognostic (2.80e-1)" "unprognostic (7.66e-2)" "unprognostic (5.16e-2)" "unprognostic (2.40e-2)" "prognostic favorable (7.54e-4)" "unprognostic (5.02e-2)" "unprognostic (1.07e-1)" "unprognostic (5.98e-3)" "unprognostic (5.41e-2)" "unprognostic (2.90e-2)" "unprognostic (2.73e-2)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.58e-5)" 0.5 2.3 0.3 3.8 0.3 2.4 0.4 0.3 0.4 0.5 12.3 0.4 0.7 13.6 0.4 2.8 0.5 0.5 0.5 0.5 0.3 0.1 2.2 59.5 0.8 0.3 0.3 0.3 0.6 0.3 1.4 0.5 0.3 0.3 0.5 0.1 0.3 0.6 0.3 0.5 1.0 53.9 0.3 0.3 0.8 0.2 1.8 0.3 0.6 0.8 0.3 0.5 0.3 0.7 0.2 0.0 1.7 0.6 0.4 0.6 0.1 1.1 1.7 1.4 1.7 0.0 1.1 0.1 0.8 0.0 0.1 0.0 0.7 0.5 0.1 2.0 1.1 0.1 0.9 0.2 0.0 0.0 0.7 2.9 1.0 0.8 1.8 0.2 1.4 1.4 0.3 0.0 0.2 1.3 1.5 0.2 0.3 0.2 3.3 0.0 0.6 0.1 1.2 0.1 0.4 2.0 8.1 0.1 0.5 0.0 0.9 0.3 0.5 0.5 3.3 0.3 0.4 2.4 0.5 0.6 1.7 0.7 1.3 0.9 3.3 4.0 0.6 1.1 0.7 0.6 0.0 0.2 1.7 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.6 1.6 0.4 0.5 0.0 0.1 0.1 0.3 0.3 0.3 0.4 0.3 0.1 0.3 0.3 0.3 0.3 0.0 0.3 0.0 1.9 3.0 0.5 3.3 2.5 10.7 4.5 0.0 3.9 0.5 3.3 0.3 16.2 1.8 130.2 23.3 0.2 0.3 3.1 1.4 0.0 38.6 0.5 1.6 0.0 4.3 3.8 10.3 57.0 3.3 3.3 0.0 0.4 0.3 0.1 8.6 95.5 4.9 0.9 142.3 2.0 2.1 1.1 2.3 0.8 2.6 0.5 2.6 SLC51B OSTbeta ENSG00000186198 "Solute carrier family 51 beta subunit" Q86UW2 15 65045370-65053396 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 85.0" "Cell type enriched" "Detected in many" 6 "Enterocytes: 518.3" "Cancer enhanced" "Detected in many" "liver cancer: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 16.9;EFO-21: 11.3;Hep G2: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008398, HPA008533" Enhanced Approved Vesicles,Mitochondria No NA Mitochondria Vesicles "HPA008398: , HPA008533: AB_1854824" "unprognostic (6.18e-2)" "unprognostic (6.75e-3)" "unprognostic (1.66e-1)" "unprognostic (1.31e-2)" "unprognostic (5.88e-2)" "unprognostic (9.49e-2)" "unprognostic (9.77e-3)" "unprognostic (1.81e-2)" "unprognostic (3.35e-2)" "unprognostic (2.76e-1)" "unprognostic (2.24e-1)" "unprognostic (4.34e-2)" "prognostic favorable (8.46e-5)" "unprognostic (5.87e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.17e-2)" 0.4 0.5 0.4 3.8 0.6 0.0 0.4 0.4 0.8 14.0 34.9 0.4 0.4 28.1 0.9 3.3 0.4 1.0 0.5 0.4 0.5 0.6 7.5 2.4 1.6 0.4 0.6 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.8 9.5 0.4 0.4 0.8 0.4 0.1 85.0 0.4 0.4 0.4 0.2 4.1 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.7 0.1 0.0 0.5 0.3 0.0 1.4 0.2 0.8 0.0 0.1 0.4 0.0 0.0 0.2 0.0 16.9 0.0 0.1 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 14.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.4 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.8 0.4 0.0 0.6 0.5 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.5 0.0 0.3 0.2 0.0 0.0 0.1 0.3 0.7 0.0 0.1 0.0 0.0 0.3 0.4 0.6 0.4 0.4 0.5 0.6 0.6 0.4 0.4 0.4 0.0 0.6 1.5 0.1 0.0 0.0 0.0 2.5 10.7 0.0 0.0 0.0 0.0 11.6 0.0 48.8 0.0 518.3 0.0 0.0 0.0 0.0 0.0 4.6 1.5 0.1 0.0 1.7 0.6 0.0 9.7 0.3 0.0 0.0 0.0 7.7 0.0 0.0 84.2 0.0 54.0 0.0 6.5 0.0 1.5 0.4 0.0 0.1 0.0 19.7 0.0 SLC52A1 "FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1" ENSG00000132517 "Solute carrier family 52 member 1" Q9NWF4 17 5032600-5052009 "Disease related genes, Predicted membrane proteins" Transport "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 25.6;placenta: 34.6" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 685.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.5;BEWO: 3.8;EFO-21: 3.6;HMC-1: 9.0;SK-BR-3: 5.1;T-47d: 3.0" NA NA "unprognostic (8.81e-3)" "prognostic favorable (9.54e-4)" "unprognostic (9.34e-2)" "unprognostic (7.30e-4)" "unprognostic (6.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (3.82e-3)" "unprognostic (1.72e-1)" "unprognostic (2.36e-1)" "unprognostic (1.15e-1)" "unprognostic (7.19e-2)" "unprognostic (5.17e-5)" "unprognostic (1.37e-1)" "unprognostic (1.03e-1)" "unprognostic (4.07e-2)" "unprognostic (6.60e-2)" 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.3 0.6 1.0 20.0 0.2 0.6 24.4 0.5 0.1 1.5 0.8 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.2 0.1 1.0 0.1 34.6 0.3 1.4 0.1 0.1 0.5 0.3 0.1 7.4 25.6 0.1 0.1 0.6 0.0 0.7 0.1 0.6 0.2 0.4 0.7 2.5 1.0 1.4 0.6 3.7 0.6 1.4 1.2 0.3 0.2 4.5 0.1 0.2 0.2 0.2 3.8 0.0 0.0 0.6 0.6 0.1 0.2 0.3 3.6 0.1 0.7 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.7 0.3 0.1 0.1 9.0 0.1 0.1 0.2 0.1 0.2 0.2 0.7 0.1 1.2 0.0 0.3 0.5 0.4 0.4 0.1 0.2 0.1 0.0 0.3 0.1 1.4 0.1 0.3 0.8 5.1 0.1 0.2 3.0 1.4 0.6 0.3 1.1 0.1 0.2 0.3 0.1 0.3 0.2 0.1 0.5 2.6 0.6 0.9 0.7 0.4 0.6 0.6 0.9 1.2 0.2 1.4 1.1 0.8 3.7 1.4 0.4 0.6 0.5 0.3 0.1 0.2 0.3 0.6 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.3 0.0 1.3 1.0 0.0 0.6 0.0 8.1 0.0 0.0 0.0 134.6 0.0 0.0 0.1 0.1 5.7 0.0 0.0 10.3 1.1 0.3 0.0 0.0 13.6 0.0 1.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.9 1.5 685.8 0.0 1.1 0.7 SLC52A2 "D15Ertd747e, FLJ11856, GPCR41, GPR172A, hRFT3, PAR1, RFVT2" ENSG00000185803 "Solute carrier family 52 member 2" Q9HAB3 8 144354135-144361286 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Host cell receptor for virus entry, Receptor" "Deafness, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 51.0" "Low region specificity" "Detected in all" HPA063036 Approved NA NA "HPA063036: AB_2684928" "unprognostic (7.80e-3)" "prognostic unfavorable (7.55e-4)" "unprognostic (2.15e-1)" "unprognostic (2.94e-1)" "unprognostic (3.09e-2)" "unprognostic (3.94e-2)" "prognostic unfavorable (2.04e-6)" "unprognostic (7.74e-3)" "unprognostic (9.20e-2)" "unprognostic (2.24e-2)" "unprognostic (4.85e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (3.12e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" 16.0 12.8 7.3 13.2 8.8 9.9 23.7 19.2 10.5 10.9 18.1 7.5 19.3 19.6 10.7 19.9 14.6 7.4 16.3 8.0 7.7 9.0 14.7 12.4 10.7 10.7 13.0 5.9 10.6 22.4 7.9 10.9 19.5 9.5 10.8 9.3 7.2 21.3 14.1 7.0 12.6 17.8 8.5 7.9 15.2 16.8 17.0 7.4 11.5 12.4 11.6 14.6 8.6 13.1 7.7 9.0 9.2 7.4 5.7 6.3 1.9 12.8 18.5 2.6 6.9 4.9 3.7 13.4 9.9 7.0 9.0 7.2 14.7 15.5 6.1 16.3 7.1 6.6 15.3 4.4 7.6 1.9 7.5 10.5 10.6 10.6 13.3 16.0 3.9 9.1 5.1 9.2 8.2 6.8 4.4 5.2 5.8 14.5 7.8 4.7 37.4 6.0 10.3 5.6 16.0 51.0 11.2 3.1 13.8 7.3 9.5 8.2 9.8 12.2 12.7 11.4 2.5 10.0 5.1 7.4 7.4 16.8 18.4 14.2 3.9 5.4 4.6 12.2 9.7 8.5 1.2 4.2 9.2 5.9 6.1 3.7 4.2 4.7 6.3 5.2 7.7 4.6 3.1 1.4 5.7 7.4 9.0 5.7 1.9 7.3 8.8 19.2 10.5 7.7 9.0 13.0 5.9 9.5 7.4 6.0 5.4 19.3 19.4 27.7 10.9 2.5 12.7 4.0 14.8 12.2 2.0 74.0 0.0 60.6 2.5 20.6 60.0 0.0 58.0 74.5 27.7 31.3 10.3 4.0 47.5 11.1 16.7 17.8 14.8 4.2 11.8 20.9 28.7 55.1 32.0 13.5 64.4 42.1 18.7 12.9 8.9 19.4 26.4 31.7 39.6 31.6 43.9 20.8 38.1 32.6 SLC52A3 "bA371L19.1, C20orf54, hRFT2, RFVT3" ENSG00000101276 "Solute carrier family 52 member 3" Q9NQ40 20 760080-776015 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.5" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 22.7;Cytotrophoblasts: 15.8;Enterocytes: 25.3;Syncytiotrophoblasts: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 25.9;OE19: 17.9;RT4: 6.0;SK-BR-3: 9.5;T-47d: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049391, HPA059078" Approved NA NA "HPA049391: AB_2680743, HPA059078: AB_2732630" "unprognostic (4.53e-2)" "unprognostic (1.11e-1)" "unprognostic (8.60e-2)" "unprognostic (7.84e-2)" "unprognostic (1.29e-1)" "unprognostic (9.03e-3)" "unprognostic (2.12e-3)" "unprognostic (1.43e-3)" "unprognostic (1.15e-2)" "unprognostic (4.36e-2)" "unprognostic (4.39e-3)" "unprognostic (4.82e-2)" "unprognostic (2.04e-3)" "prognostic favorable (5.51e-6)" "unprognostic (3.04e-1)" "unprognostic (2.21e-1)" "unprognostic (1.44e-1)" 2.0 0.4 7.3 1.4 5.9 0.5 2.8 3.5 9.0 2.6 9.6 2.1 12.0 13.1 1.8 1.9 4.6 2.0 3.0 3.3 6.6 4.2 10.0 0.4 1.4 0.7 5.6 1.3 1.2 2.2 0.6 0.5 6.7 7.3 7.9 6.3 0.5 5.5 15.8 1.0 1.7 16.3 1.5 4.7 0.4 5.2 32.5 6.0 0.0 0.7 1.2 0.9 4.7 2.2 1.1 0.7 2.4 0.6 1.1 0.8 0.4 3.3 0.9 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.3 25.9 0.0 3.8 0.0 0.2 3.8 0.0 2.8 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 17.9 2.3 0.0 0.0 0.3 0.0 6.0 0.0 0.1 3.8 9.5 0.0 0.4 11.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.5 0.4 0.2 0.4 0.5 0.4 0.4 0.1 1.1 0.4 0.8 2.2 1.1 0.4 0.7 0.3 0.4 7.3 5.9 3.5 9.0 6.6 4.2 5.6 1.3 7.3 6.0 8.9 1.9 0.0 2.2 0.6 0.4 0.4 0.0 0.0 3.4 22.7 2.0 15.8 1.7 5.6 0.7 2.9 25.3 0.0 1.6 0.7 0.2 5.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.0 0.9 0.3 1.7 0.0 4.9 0.0 4.1 14.4 0.4 0.0 0.0 0.0 0.2 0.5 0.7 1.0 43.6 0.0 9.3 6.2 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043032-32113029 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "intestine: 274.9" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 111.5;Cholangiocytes: 117.2;Early spermatids: 40.8;Late spermatids: 54.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "OE19: 27.0" "Region enriched" "Detected in single" 26 "cerebellum: 8.6" "Not detected" "Not detected" "CAB015467, HPA051805, HPA055106" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Nuclear membrane, Cytosol" "CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favorable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.2 0.0 0.2 1.3 0.2 0.0 1.5 0.2 0.2 2.2 181.5 0.2 2.9 95.5 0.3 0.8 1.9 0.0 14.1 24.5 0.2 0.0 1.0 0.9 0.3 0.2 0.2 0.2 0.2 0.4 0.0 1.0 0.2 0.2 0.8 1.6 0.2 5.7 3.5 0.2 4.6 274.9 0.2 0.2 0.7 1.2 0.8 0.2 0.2 0.2 3.5 1.5 0.2 2.0 0.3 0.1 0.6 0.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 27.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.8 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 1.8 0.6 0.0 111.5 117.2 0.0 4.5 0.0 0.0 0.0 0.0 2.4 40.8 0.0 26.1 0.0 1.2 0.0 0.2 19.7 0.0 0.0 0.0 0.0 24.5 0.0 0.0 54.9 1.1 0.0 0.0 0.0 8.7 0.0 0.6 14.7 1.4 1.9 0.0 0.0 0.0 4.2 0.5 4.8 0.0 0.0 19.6 4.8 SLC5A10 SGLT5 ENSG00000154025 "Solute carrier family 5 member 10" A0PJK1 17 18950345-19022595 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 70.6" "Group enriched" "Detected in some" 4 "Late spermatids: 20.1;Proximal tubular cells: 51.2" "Cancer enriched" "Detected in some" 11 "renal cancer: 6.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "intermediate monocyte: 3.0;non-classical monocyte: 7.9" "Lineage enriched" "Detected in many" 7 "monocytes: 7.9" "Cell line enriched" "Detected in some" 5 "U-937: 11.0" "Not detected" "Not detected" HPA052014 Uncertain NA NA "HPA052014: AB_2681694" "unprognostic (3.74e-1)" "unprognostic (2.92e-1)" "unprognostic (3.04e-2)" "unprognostic (6.11e-2)" "unprognostic (6.56e-2)" "unprognostic (3.36e-4)" "unprognostic (7.36e-2)" "unprognostic (2.39e-1)" "unprognostic (1.52e-1)" "unprognostic (8.94e-2)" "unprognostic (3.24e-2)" "unprognostic (1.53e-1)" "unprognostic (1.09e-2)" "unprognostic (3.43e-2)" "unprognostic (2.61e-2)" "unprognostic (2.75e-2)" "unprognostic (2.11e-1)" 0.1 0.1 0.1 0.5 0.1 1.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.7 0.1 0.0 70.6 0.4 0.3 0.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 15.1 0.1 0.1 0.1 0.7 1.1 0.1 0.2 3.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.4 1.2 0.1 7.9 0.0 0.6 0.5 0.0 0.0 0.1 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.1 1.8 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.5 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.0 0.1 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 11.0 0.0 0.1 0.0 0.0 0.1 3.0 0.0 0.4 0.3 0.0 1.2 0.3 0.6 0.2 0.0 0.0 7.9 0.0 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.3 8.7 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.3 0.0 20.1 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 51.2 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 SLC5A11 "KST1, SGLT6, SMIT2" ENSG00000158865 "Solute carrier family 5 member 11" Q8WWX8 16 24845841-24911628 "Predicted membrane proteins" "Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 48.0;intestine: 21.8" "Group enriched" "Detected in some" 4 "Enterocytes: 1.7;Paneth cells: 2.9;Proximal tubular cells: 5.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 18.9;Karpas-707: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035331 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035331: AB_10601489" "unprognostic (2.57e-1)" "unprognostic (7.90e-3)" "unprognostic (1.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.90e-2)" "unprognostic (8.08e-2)" "unprognostic (2.85e-1)" "unprognostic (2.85e-3)" "unprognostic (6.68e-2)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (1.58e-1)" "unprognostic (8.07e-2)" "unprognostic (1.45e-3)" 0.6 0.6 4.3 0.6 21.8 0.5 2.8 1.9 11.2 0.6 1.7 29.7 0.0 10.9 0.6 0.5 0.5 0.6 1.4 0.7 12.1 7.4 9.9 1.0 0.6 0.7 48.0 2.4 0.6 0.5 0.5 0.2 0.5 18.3 0.6 0.8 0.0 0.6 0.8 0.7 0.5 21.8 0.5 34.7 0.6 0.6 0.8 22.9 0.0 0.6 0.0 0.7 0.6 0.1 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.3 21.8 1.9 8.0 12.1 7.4 48.0 2.4 18.3 22.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 5.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 SLC5A12 "MGC52019, SMCT2" ENSG00000148942 "Solute carrier family 5 member 12" Q1EHB4 11 26667019-26723427 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 60.8;kidney: 90.3" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 145.9" "Cancer enriched" "Detected in single" 26 "renal cancer: 9.0" "Region enriched" "Detected in single" 7 "basal ganglia: 1.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA060904 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060904: AB_2684385" "unprognostic (3.69e-3)" "unprognostic (6.92e-2)" "unprognostic (1.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.01e-2)" "unprognostic (9.35e-3)" "unprognostic (4.21e-3)" "unprognostic (4.49e-2)" "unprognostic (2.36e-3)" "unprognostic (1.71e-1)" "unprognostic (2.03e-2)" "unprognostic (3.43e-1)" "unprognostic (2.91e-3)" "unprognostic (1.34e-1)" "unprognostic (8.53e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.1 0.0 11.3 0.0 0.2 1.7 0.0 18.5 0.0 0.0 0.0 3.4 0.1 0.1 90.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.8 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.8 1.0 0.7 0.9 0.7 0.1 0.4 0.1 0.2 0.6 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.6 0.2 0.6 0.8 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.7 0.1 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.4 5.2 0.1 0.3 0.2 0.5 3.8 0.7 0.1 0.1 0.0 0.6 0.1 1.1 2.0 0.3 1.7 0.2 0.0 7.8 2.8 0.5 0.6 0.4 0.2 0.4 0.2 2.3 0.7 0.2 0.2 0.0 0.0 1.0 0.5 0.1 0.6 0.7 0.4 1.1 0.4 0.4 0.5 1.5 0.7 0.6 0.4 0.9 0.6 0.8 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 3.5 0.0 0.1 8.3 0.0 0.7 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.3 0.0 145.9 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 SLC5A2 SGLT2 ENSG00000140675 "Solute carrier family 5 member 2" P31639 16 31483002-31490860 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "kidney: 33.7" "Group enriched" "Detected in some" 11 "Early spermatids: 46.9;Late spermatids: 103.8;Proximal tubular cells: 139.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.6" "Group enriched" "Detected in many" 16 "NK-cells: 1.4;T-cells: 1.6" "Cell line enhanced" "Detected in some" "BEWO: 1.2;EFO-21: 2.0;Hep G2: 2.6;NB-4: 1.3;U-2 OS: 1.2;U-266/84: 1.8;U-937: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041603 Enhanced NA NA "HPA041603: AB_10960540" "unprognostic (1.61e-1)" "unprognostic (2.95e-1)" "unprognostic (2.84e-1)" "unprognostic (3.00e-2)" "unprognostic (8.04e-2)" "unprognostic (8.23e-3)" "unprognostic (1.49e-1)" "unprognostic (2.25e-3)" "unprognostic (2.57e-1)" "unprognostic (1.12e-2)" "unprognostic (6.43e-2)" "unprognostic (2.47e-1)" "unprognostic (1.42e-3)" "unprognostic (5.88e-2)" "unprognostic (2.14e-1)" "unprognostic (4.18e-2)" "unprognostic (3.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.6 0.6 0.1 0.4 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.3 1.2 0.1 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.6 0.5 0.0 0.0 0.5 0.1 0.0 1.4 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.0 0.3 0.0 1.4 0.0 8.7 0.0 0.2 6.6 0.7 46.9 0.0 0.3 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 103.8 2.0 0.4 0.0 0.0 0.2 0.0 0.7 0.0 1.4 139.8 0.0 0.0 0.0 3.2 0.9 0.3 0.1 0.0 0.6 0.0 SLC5A3 "SMIT, SMIT1" ENSG00000198743 "Solute carrier family 5 member 3" P53794 21 34073570-34106262 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 46.0" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 130.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029791 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA029791: AB_10601892" "unprognostic (9.70e-2)" "unprognostic (4.99e-2)" "unprognostic (2.23e-1)" "unprognostic (7.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.54e-2)" "unprognostic (4.48e-3)" "unprognostic (1.63e-1)" "unprognostic (3.02e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.98e-5)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.21e-1)" "unprognostic (8.60e-2)" 10.1 9.5 10.5 7.3 11.0 3.6 26.6 8.0 10.1 6.5 7.6 4.6 9.4 5.0 11.3 9.1 7.5 8.5 4.9 6.8 11.6 6.8 46.0 9.5 8.5 7.6 11.7 4.7 9.0 5.8 6.3 6.6 15.8 13.6 7.0 8.8 11.3 6.4 6.9 7.8 10.1 7.4 5.9 14.7 4.9 7.8 10.6 9.0 5.9 42.7 4.4 8.0 6.5 22.1 0.8 2.3 0.7 1.0 1.0 2.6 0.7 6.3 5.7 11.9 8.4 10.0 8.2 5.7 7.2 22.1 4.5 6.9 9.4 13.9 10.2 5.9 14.6 8.5 3.3 14.4 4.1 7.7 10.6 3.7 10.6 5.3 3.1 2.6 4.5 4.5 3.9 10.7 12.3 4.9 13.9 2.7 8.5 10.4 2.4 11.6 4.3 4.8 3.7 6.0 2.4 5.6 4.9 2.1 4.6 17.8 8.9 6.2 2.9 15.0 4.0 3.4 7.4 2.4 4.8 2.6 8.9 6.9 16.9 2.9 12.7 10.9 7.7 17.9 6.6 5.9 0.0 1.0 0.2 2.6 0.9 2.1 0.8 1.4 1.7 0.9 0.8 1.9 2.6 0.7 1.0 0.4 2.3 0.4 0.7 10.5 11.0 8.0 10.1 11.6 6.8 11.7 4.7 13.6 9.0 14.9 12.2 8.0 40.9 0.0 28.5 7.6 12.7 16.0 23.9 130.9 19.6 21.2 18.3 3.4 8.6 4.5 28.0 0.0 4.5 15.7 10.7 71.1 41.4 15.3 12.8 35.0 47.1 6.7 12.1 5.2 6.1 9.8 0.0 24.4 48.3 6.0 5.8 46.0 19.4 6.5 20.8 12.9 2.2 12.1 18.9 0.0 23.6 17.3 26.6 32.3 SLC5A4 "DJ90G24.4, SAAT1, SGLT3" ENSG00000100191 "Solute carrier family 5 member 4" Q9NY91 22 32218476-32255341 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "intestine: 73.6" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 10 "melanoma: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "SK-MEL-30: 25.2" "Low region specificity" "Detected in all" NA NA "unprognostic (1.93e-1)" "unprognostic (1.57e-1)" "unprognostic (3.10e-3)" "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.85e-3)" "unprognostic (2.97e-2)" "unprognostic (3.80e-2)" "unprognostic (3.58e-2)" "unprognostic (1.06e-1)" "unprognostic (2.65e-3)" "unprognostic (4.50e-1)" "unprognostic (1.99e-5)" "unprognostic (2.34e-1)" "unprognostic (1.63e-1)" "unprognostic (2.28e-1)" "unprognostic (2.69e-1)" 1.2 0.1 0.4 0.4 0.4 0.1 1.6 0.4 0.5 1.2 41.7 0.4 0.4 18.0 1.8 0.4 0.4 1.2 0.6 0.9 0.5 0.6 1.0 0.4 2.5 0.4 0.6 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.9 0.1 0.4 0.4 0.4 0.4 0.3 73.6 1.5 0.6 0.6 0.2 0.7 0.4 0.4 2.4 0.4 0.4 0.4 1.3 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 25.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.5 0.5 0.6 0.6 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 SLC5A5 NIS ENSG00000105641 "Solute carrier family 5 member 5" Q92911 19 17871973-17895174 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 31.5;salivary gland: 66.8;stomach 1: 32.7" "Group enriched" "Detected in some" 6 "Ciliated cells: 5.3;Club cells: 7.9;Spermatogonia: 7.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 12 "pons and medulla: 31.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "BEWO: 16.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022364, HPA049055" Enhanced NA NA "CAB022364: , HPA049055: AB_2680614" "unprognostic (2.72e-2)" "unprognostic (8.94e-2)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (1.81e-1)" "unprognostic (4.02e-2)" "unprognostic (2.57e-1)" "unprognostic (1.94e-2)" "unprognostic (3.07e-1)" "unprognostic (2.01e-2)" "unprognostic (3.03e-1)" "unprognostic (3.93e-2)" "unprognostic (5.51e-8)" "unprognostic (1.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.54e-2)" "unprognostic (3.23e-1)" 0.0 0.0 0.1 0.1 0.4 0.1 0.1 2.4 2.3 5.1 0.1 9.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.0 1.7 0.1 0.1 0.0 0.2 0.2 0.3 2.7 0.0 0.1 0.0 0.2 0.0 31.5 0.1 0.0 5.5 66.8 0.0 0.2 0.2 0.3 0.0 1.9 0.2 32.7 0.4 0.1 0.0 7.1 0.0 0.1 0.0 0.1 1.3 0.8 2.5 1.4 1.0 4.3 0.9 0.0 0.0 0.1 0.1 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.5 0.0 0.2 0.2 0.7 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.1 0.5 0.0 0.2 1.2 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 3.7 0.0 2.5 0.6 0.4 1.1 1.4 1.3 1.0 3.2 0.6 0.8 1.3 4.3 3.2 2.2 1.0 0.4 0.4 2.0 0.9 0.1 0.4 2.4 2.3 1.7 0.1 0.3 2.7 31.5 0.1 0.0 1.1 0.0 0.0 0.3 0.0 0.6 0.0 5.3 7.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.9 0.3 0.0 0.5 0.0 0.0 SLC5A6 SMVT ENSG00000138074 "Solute carrier family 5 member 6" Q9Y289 2 27199587-27212958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.0;placenta: 51.7" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 98.8;Extravillous trophoblasts: 89.2;monocytes: 78.5;Syncytiotrophoblasts: 190.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 69.3;SK-BR-3: 74.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036958 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA036958: AB_10672343" "unprognostic (5.85e-2)" "unprognostic (8.32e-3)" "unprognostic (1.38e-1)" "unprognostic (2.61e-3)" "unprognostic (9.38e-2)" "unprognostic (7.14e-2)" "unprognostic (3.20e-3)" "unprognostic (7.92e-2)" "unprognostic (6.96e-2)" "unprognostic (9.80e-2)" "unprognostic (2.05e-2)" "unprognostic (7.46e-2)" "prognostic unfavorable (3.60e-7)" "unprognostic (2.40e-3)" "unprognostic (1.20e-2)" "unprognostic (4.56e-3)" "unprognostic (4.18e-2)" 20.9 4.6 5.0 7.6 8.5 8.5 15.9 7.9 8.1 4.0 6.4 5.6 6.4 10.9 7.4 36.7 5.5 5.9 6.3 3.5 5.3 5.7 5.9 64.0 6.0 6.4 7.0 8.1 5.6 6.0 4.5 4.2 51.7 7.1 4.8 6.6 5.6 6.7 10.6 7.9 4.6 7.6 4.9 4.4 4.8 4.8 17.5 6.1 5.8 5.1 4.3 13.0 4.6 10.1 6.8 10.0 2.0 9.0 6.3 10.4 5.8 16.7 17.4 11.1 14.6 10.3 3.7 69.3 6.1 4.1 9.3 6.4 25.6 6.0 11.6 9.3 3.3 10.1 9.4 23.7 7.0 6.5 9.0 13.9 20.6 7.4 39.2 12.2 26.4 10.8 12.9 6.0 11.4 8.9 2.6 8.3 9.5 30.1 4.8 5.9 34.4 8.9 12.9 32.0 19.4 6.4 15.1 13.1 16.8 5.3 16.1 9.4 13.9 6.6 74.6 8.8 11.3 16.6 5.7 3.8 10.3 14.1 6.2 16.3 8.0 18.3 18.5 5.6 18.6 14.4 0.1 6.5 2.0 8.5 7.3 10.4 6.8 8.3 8.2 9.7 6.7 8.5 10.1 0.3 6.3 9.0 10.0 8.2 5.8 5.0 8.5 7.9 8.1 5.3 5.7 7.0 8.1 7.1 6.1 0.0 4.1 13.4 6.8 7.1 4.5 5.9 7.6 4.0 2.3 7.0 3.9 98.8 1.7 9.6 11.6 3.8 6.0 0.0 7.0 89.2 5.4 7.1 0.0 36.0 19.5 11.1 5.2 7.4 10.0 25.3 6.6 6.5 0.0 78.5 6.8 3.9 6.2 2.9 13.1 3.6 3.4 12.9 5.9 31.1 18.5 5.5 190.6 7.5 13.3 6.4 SLC5A7 "CHT1, hCHT" ENSG00000115665 "Solute carrier family 5 member 7" Q9GZV3 2 107986523-108013994 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport" "Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 45.1" "Group enriched" "Detected in some" 13 "Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Club cells: 5.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Group enriched" "Detected in some" 13 "basal ganglia: 13.8;pons and medulla: 45.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "RT4: 8.9;SCLC-21H: 2.6" "Group enriched" "Detected in many" 4 "basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1" "Region enhanced" "Detected in some" "pons and medulla: 26.3" HPA046105 Approved "Nuclear bodies,Cell Junctions,Intermediate filaments" NA NA "Cell Junctions, Intermediate filaments" "Nuclear bodies" "HPA046105: " "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-3)" "unprognostic (7.10e-2)" "unprognostic (1.66e-1)" "unprognostic (3.39e-4)" "unprognostic (1.05e-2)" "unprognostic (9.78e-3)" "unprognostic (6.42e-2)" "unprognostic (1.61e-2)" 0.3 2.4 0.1 1.6 13.8 0.0 0.3 0.1 0.4 3.3 5.2 0.1 0.3 2.3 1.6 0.7 1.0 0.2 0.5 1.2 0.2 2.2 0.9 0.2 0.9 0.0 0.3 0.5 0.8 0.5 0.0 0.1 0.0 45.1 0.8 2.5 1.0 0.9 4.2 0.1 0.1 2.5 3.1 10.0 0.1 1.7 0.3 0.8 0.0 4.0 0.3 0.1 4.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 0.1 0.4 0.2 2.2 0.3 0.5 45.1 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 SLC5A8 AIT ENSG00000256870 "Solute carrier family 5 member 8" Q8N695 12 101155493-101210407 "Predicted membrane proteins" "Apoptosis, Ion transport, Sodium transport, Symport, Transport" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix, uterine: 14.3;kidney: 13.8;thyroid gland: 21.2" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 2: 7.7;Horizontal cells: 9.5;Intestinal endocrine cells: 30.3;Proximal tubular cells: 10.3" "Cancer enhanced" "Detected in many" "renal cancer: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "SK-BR-3: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "prognostic favorable (9.04e-6)" "unprognostic (1.84e-1)" "unprognostic (1.17e-2)" "unprognostic (1.27e-3)" "unprognostic (1.24e-1)" "unprognostic (5.20e-1)" "unprognostic (1.16e-2)" "prognostic favorable (1.97e-4)" "unprognostic (6.16e-2)" "unprognostic (2.30e-2)" "unprognostic (2.87e-2)" 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 14.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.8 0.0 1.9 0.0 0.0 0.3 1.0 0.0 0.0 0.1 0.0 0.6 0.9 0.0 1.4 3.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 21.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.6 0.0 0.0 7.7 0.0 0.0 0.0 4.0 0.6 0.0 1.4 1.2 1.8 0.0 0.0 1.7 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 9.5 30.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.1 SLC5A9 SGLT4 ENSG00000117834 "Solute carrier family 5 member 9" Q2M3M2 1 48222685-48248644 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 77.3" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 20.8;Early spermatids: 5.8;granulocytes: 4.6;Late spermatids: 7.9" "Cancer enhanced" "Detected in many" "liver cancer: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Hep G2: 18.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA050263 Approved "Actin filaments,Cytosol" NA NA "Actin filaments" Cytosol "HPA050263: " "unprognostic (3.09e-3)" "unprognostic (1.89e-1)" "unprognostic (6.75e-2)" "unprognostic (5.66e-2)" "unprognostic (2.36e-1)" "unprognostic (1.35e-3)" "unprognostic (3.64e-2)" "unprognostic (4.59e-2)" "unprognostic (3.60e-2)" "unprognostic (1.59e-1)" "unprognostic (7.42e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (4.56e-1)" "unprognostic (2.11e-1)" "unprognostic (4.30e-3)" "unprognostic (1.06e-2)" 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 33.0 0.1 0.8 26.0 0.1 7.2 0.1 0.2 2.2 0.1 0.0 0.0 3.1 4.9 2.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.0 1.0 77.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 1.0 0.0 0.0 0.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 1.7 0.4 5.8 0.0 0.7 0.0 0.2 0.0 0.0 0.1 4.6 4.5 0.1 0.0 0.0 0.0 1.2 7.9 0.3 0.0 0.0 0.0 0.6 0.0 0.1 1.1 0.4 3.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 SLC6A1 "GABATHG, GABATR, GAT1" ENSG00000157103 "Solute carrier family 6 member 1" P30531 3 10992186-11039249 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 56.2;liver: 75.6" "Cell type enhanced" "Detected in some" 16 "Cholangiocytes: 17.8;Hepatocytes: 24.5;Muller glia cells: 41.9;Sertoli cells: 12.9" "Group enriched" "Detected in some" 16 "glioma: 16.1;liver cancer: 24.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013341, CAB022293" Enhanced Uncertain Mitochondria No NA Mitochondria "CAB022293: , HPA013341: AB_1849509" "unprognostic (1.66e-3)" "unprognostic (1.30e-3)" "unprognostic (4.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.53e-1)" "unprognostic (2.53e-1)" "prognostic favorable (3.20e-4)" "unprognostic (1.05e-1)" "unprognostic (4.27e-2)" "unprognostic (8.26e-2)" "unprognostic (2.90e-1)" "unprognostic (2.69e-1)" "prognostic unfavorable (5.05e-6)" "unprognostic (7.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.35e-1)" "unprognostic (5.34e-2)" 1.8 2.1 32.2 1.6 31.0 3.0 1.8 15.1 56.2 2.0 1.7 25.4 0.0 1.7 1.9 3.9 4.3 2.4 2.3 3.3 22.2 16.6 2.1 75.6 2.5 1.7 22.7 25.3 2.4 1.4 9.3 1.0 2.0 17.0 2.1 1.8 1.7 1.6 5.0 3.3 1.7 1.7 1.8 13.7 1.9 1.7 4.4 14.3 0.5 1.9 0.0 1.7 1.9 0.9 1.0 0.8 1.2 0.3 0.2 0.8 0.2 0.8 0.6 1.9 1.3 1.5 0.4 1.1 0.7 0.2 0.8 1.1 1.5 1.0 1.6 0.3 0.4 1.8 1.3 2.3 0.9 0.7 0.2 1.8 1.3 4.6 2.8 0.7 2.2 2.3 1.1 0.2 0.2 1.3 0.5 0.3 1.7 1.1 3.7 0.2 1.1 0.7 1.8 0.8 1.2 1.4 1.2 0.2 0.1 0.6 1.8 0.8 0.3 1.0 0.7 0.2 1.1 1.0 1.0 0.3 0.8 0.5 0.7 0.7 1.1 0.3 1.2 0.9 1.7 0.4 0.3 0.3 1.1 0.5 0.1 0.8 0.9 0.6 0.5 0.3 1.0 0.3 0.5 1.2 0.2 0.3 0.8 0.3 0.2 32.2 31.0 15.1 41.5 22.2 16.6 22.7 25.3 17.0 14.3 0.0 0.3 0.0 0.0 0.2 1.8 1.4 17.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 24.5 0.0 0.0 0.0 0.0 1.0 0.2 5.2 0.0 0.0 0.0 0.0 41.9 0.0 0.0 9.6 0.1 3.3 12.9 2.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC6A11 GAT3 ENSG00000132164 "Solute carrier family 6 member 11" P48066 3 10816200-10940733 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 37.0;esophagus: 10.5;skin 1: 11.5" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 7.9;Extravillous trophoblasts: 6.2;Muller glia cells: 21.8;Peritubular cells: 6.3" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 4.7;HaCaT: 12.7;Hep G2: 14.6;hTCEpi: 11.5;NTERA-2: 6.4;SH-SY5Y: 4.4;T-47d: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037981 Supported Supported Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA037981: AB_10671383" "unprognostic (6.04e-2)" "unprognostic (8.01e-2)" "unprognostic (1.21e-7)" "unprognostic (8.60e-2)" "unprognostic (8.68e-2)" "unprognostic (9.72e-3)" "unprognostic (6.39e-3)" "unprognostic (9.77e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (8.78e-2)" "unprognostic (1.51e-3)" "unprognostic (6.06e-2)" "unprognostic (4.44e-2)" "unprognostic (9.83e-2)" "unprognostic (2.31e-2)" 0.8 0.8 11.5 0.7 14.1 0.8 2.9 3.1 23.0 0.9 0.8 5.0 0.0 0.7 1.7 1.1 10.5 1.8 0.7 0.8 8.4 24.5 0.7 0.9 0.8 0.7 37.0 5.9 0.8 1.0 0.7 0.2 1.6 35.4 2.3 0.8 0.4 1.1 0.7 1.0 11.5 0.8 1.0 10.4 1.5 0.7 3.4 9.2 0.0 0.8 0.2 1.1 1.3 0.7 0.5 0.3 1.2 0.4 0.2 0.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 12.7 0.0 2.1 0.0 0.0 0.2 0.2 0.0 14.6 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.8 4.4 3.7 0.1 0.0 0.1 4.8 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.5 0.2 0.2 1.2 0.2 0.4 0.3 0.3 0.0 11.5 14.1 3.1 14.7 8.4 24.5 37.0 5.9 35.4 9.2 0.0 0.0 0.0 0.2 1.1 7.9 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 0.2 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 21.8 0.3 0.0 6.3 0.0 1.3 0.0 0.0 0.2 1.5 3.1 0.8 0.0 0.0 1.5 SLC6A12 BGT-1 ENSG00000111181 "Solute carrier family 6 member 12" P48065 12 190077-214570 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 22.1;liver: 59.3" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 43.6;Hepatocytes: 17.4;monocytes: 17.2" "Cancer enhanced" "Detected in many" "renal cancer: 11.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 57 "classical monocyte: 6.6;intermediate monocyte: 6.4;myeloid DC: 2.9;neutrophil: 3.7;non-classical monocyte: 8.6" "Group enriched" "Detected in many" 51 "dendritic cells: 2.9;granulocytes: 3.7;monocytes: 8.6" "Cell line enhanced" "Detected in some" "Hep G2: 8.4;RPTEC TERT1: 17.0;SuSa: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034973 Approved Approved Vesicles NA NA Vesicles "HPA034973: AB_10610427" "unprognostic (3.48e-1)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (1.70e-1)" "unprognostic (1.09e-1)" "unprognostic (1.88e-2)" "unprognostic (8.30e-2)" "unprognostic (6.96e-3)" "unprognostic (2.70e-2)" "unprognostic (1.85e-2)" "unprognostic (3.68e-1)" "prognostic favorable (2.70e-6)" "unprognostic (2.30e-1)" "unprognostic (4.92e-4)" "unprognostic (3.35e-1)" "unprognostic (4.31e-4)" 0.6 0.8 6.3 1.3 12.9 0.6 0.8 6.6 14.7 0.9 1.0 4.3 0.0 3.7 1.3 5.6 0.5 3.0 1.2 0.7 7.2 4.6 22.1 59.3 2.2 0.8 8.1 4.9 0.7 1.3 0.6 0.3 0.9 9.4 0.6 1.8 0.2 0.6 0.5 0.5 0.7 1.1 1.2 3.1 0.8 2.3 1.6 8.8 0.0 4.5 0.0 0.7 0.9 0.2 0.0 2.9 3.7 8.6 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 1.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 8.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 17.0 0.1 0.0 0.5 0.0 0.0 0.1 3.7 0.3 0.5 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.0 6.6 0.0 0.0 6.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 3.7 0.0 8.6 0.0 0.0 1.9 6.3 12.9 6.6 14.7 7.2 4.6 8.1 4.9 9.4 8.8 0.0 0.3 0.9 0.0 0.1 0.0 0.4 0.0 0.0 0.0 43.6 0.0 0.0 1.7 0.0 3.6 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 17.4 2.4 0.0 0.0 1.3 0.3 3.4 0.6 1.8 0.0 17.2 1.2 6.3 0.0 0.0 0.0 6.8 0.2 6.5 0.0 0.5 1.7 0.4 0.7 0.0 0.8 0.0 SLC6A13 GAT2 ENSG00000010379 "Solute carrier family 6 member 13" Q9NSD5 12 220621-262873 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 77.6;retina: 95.9" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 261.2" "Cancer enriched" "Detected in some" 18 "renal cancer: 32.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 10.0;SuSa: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036449, HPA052726" Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Nucleoli, Cytosol" "HPA036449: AB_2675130, HPA052726: AB_2681927" "unprognostic (8.45e-3)" "unprognostic (4.20e-1)" "unprognostic (5.44e-2)" "unprognostic (1.64e-5)" "unprognostic (1.13e-1)" "unprognostic (8.02e-2)" "unprognostic (1.32e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (7.21e-4)" "unprognostic (2.93e-1)" "unprognostic (1.25e-3)" "unprognostic (3.79e-2)" "unprognostic (2.62e-1)" "unprognostic (6.23e-2)" "unprognostic (1.91e-1)" 0.6 0.5 3.0 0.4 5.8 0.5 0.5 2.1 5.8 0.5 0.5 2.5 0.0 1.8 0.5 0.9 0.4 4.2 0.5 1.0 3.1 2.4 77.6 13.2 0.9 0.5 3.4 4.1 0.5 0.4 0.4 1.0 0.5 4.8 0.5 0.5 95.9 0.5 0.5 0.6 0.6 0.8 0.4 5.7 0.5 0.5 1.1 2.1 0.0 4.9 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 0.0 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 1.3 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.4 0.4 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 10.0 0.1 0.1 0.0 0.1 0.0 0.9 3.7 0.0 0.0 0.3 0.2 1.0 0.0 0.4 1.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.3 3.0 5.8 2.1 5.8 3.1 2.4 3.4 4.1 4.8 2.1 0.0 1.1 0.5 0.0 0.0 0.2 1.3 0.0 1.4 0.0 17.4 2.0 0.0 41.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.7 0.0 0.0 0.0 0.6 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 261.2 0.8 0.0 0.0 0.5 0.5 0.0 0.2 0.0 0.0 0.0 SLC6A14 ENSG00000268104 "Solute carrier family 6 member 14" Q9UN76 X 116436622-116461458 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" Obesity "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 100.3;Club cells: 33.0;Exocrine glandular cells: 28.5;Pancreatic endocrine cells: 101.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 3.8;Hep G2: 8.2;OE19: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA003193 Uncertain Approved Vesicles NA NA Vesicles "HPA003193: AB_2190122" "unprognostic (3.06e-2)" "unprognostic (3.55e-2)" "unprognostic (8.49e-2)" "unprognostic (1.00e-3)" "unprognostic (1.30e-3)" "unprognostic (1.49e-2)" "unprognostic (7.41e-3)" "unprognostic (3.67e-3)" "unprognostic (2.66e-1)" "unprognostic (1.83e-2)" "prognostic unfavorable (9.74e-4)" "unprognostic (1.34e-2)" "unprognostic (3.89e-2)" "unprognostic (2.08e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" 0.0 0.0 0.0 1.5 0.0 0.0 5.9 0.0 0.0 6.3 0.8 0.0 11.8 0.4 0.1 0.0 1.8 0.0 1.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.2 0.5 0.3 0.0 26.3 5.8 0.0 1.1 0.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 23.5 1.2 1.0 1.0 0.4 0.2 1.1 0.4 0.3 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 3.8 8.2 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.2 0.0 0.5 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.2 0.0 1.4 0.5 0.0 0.0 0.1 0.0 1.1 0.4 0.5 0.4 0.1 0.3 0.4 0.2 0.2 0.1 0.4 0.3 0.3 0.4 0.3 0.2 0.2 0.1 0.0 20.8 100.3 0.0 0.1 0.1 0.0 0.2 0.0 10.7 33.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.2 0.0 28.5 0.0 0.0 5.2 3.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.1 0.0 101.5 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1.0 3.2 SLC6A15 "FLJ10316, hv7-3, NTT73, SBAT1, V7-3" ENSG00000072041 "Solute carrier family 6 member 15" Q9H2J7 12 84859488-84913615 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 18.0;Horizontal cells: 11.1;Melanocytes: 30.4;Rod photoreceptor cells: 10.2" "Cancer enhanced" "Detected in some" "melanoma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 31.1;ASC TERT1: 19.2;hTERT-HME1: 43.9;SCLC-21H: 30.0;SK-MEL-30: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008609 Uncertain Approved Nucleoli,Vesicles NA NA Nucleoli Vesicles "HPA008609: AB_1857190" "unprognostic (1.01e-4)" "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (6.65e-6)" "unprognostic (1.25e-2)" "unprognostic (2.92e-1)" "unprognostic (7.65e-3)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (7.69e-4)" "unprognostic (2.57e-2)" "unprognostic (3.80e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-3)" 1.4 4.5 18.0 2.2 16.2 1.0 2.3 17.8 31.0 1.7 2.2 5.4 0.0 1.4 2.8 1.1 6.7 1.2 1.3 1.0 10.9 18.2 1.5 1.0 1.3 1.1 10.3 16.9 2.1 1.0 1.0 5.6 8.9 14.7 1.8 1.8 9.2 1.4 1.5 1.0 4.9 2.1 1.6 4.9 1.1 1.3 3.6 12.8 0.0 2.0 1.8 1.8 1.1 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 3.6 0.0 31.1 19.2 0.0 0.0 6.5 0.5 0.3 0.0 0.0 0.0 0.0 0.2 4.1 0.4 0.0 8.3 0.0 0.0 9.5 0.0 1.5 0.0 11.5 0.0 0.2 10.7 16.0 4.2 43.9 8.5 0.1 0.0 0.0 0.0 7.9 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 7.8 0.0 9.9 22.1 0.1 0.0 0.0 0.0 4.7 2.5 0.0 0.0 0.0 0.0 0.0 8.2 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.0 16.2 17.8 18.6 10.9 18.2 10.3 16.9 14.7 12.8 0.0 0.0 0.0 0.0 2.4 18.0 0.4 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 1.3 0.1 0.0 0.0 0.1 11.1 0.0 0.0 0.0 0.2 0.0 0.0 30.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 10.2 0.0 0.2 0.1 0.4 0.5 0.2 0.0 0.0 0.0 SLC6A16 NTT5 ENSG00000063127 "Solute carrier family 6 member 16" Q9GZN6 19 49289638-49325225 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "testis: 102.2" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 81.2;Late spermatids: 36.5;Spermatocytes: 90.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.3;SuSa: 10.0" HPA076812 Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA076812: AB_2686816" "unprognostic (1.98e-1)" "unprognostic (7.15e-3)" "unprognostic (6.39e-3)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.83e-3)" "unprognostic (7.89e-2)" "unprognostic (7.92e-2)" "unprognostic (1.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.55e-3)" "unprognostic (1.63e-1)" "unprognostic (3.23e-2)" "unprognostic (3.31e-1)" "unprognostic (2.10e-1)" "unprognostic (8.93e-2)" "unprognostic (4.18e-2)" 1.5 0.4 0.8 1.1 0.9 1.9 1.0 0.8 0.8 1.3 1.1 0.8 0.8 0.3 1.5 1.0 0.8 2.0 1.0 0.8 0.8 0.3 2.0 3.6 1.6 3.1 0.8 0.8 2.9 2.6 0.7 0.8 1.3 0.8 1.8 0.3 0.9 0.8 1.2 0.8 0.7 1.2 0.8 0.8 1.7 1.0 102.2 0.8 0.8 1.1 0.8 2.4 0.8 1.2 7.8 2.1 4.8 3.7 3.8 3.1 2.2 0.0 6.8 17.3 6.2 0.3 2.8 3.1 0.9 1.4 0.6 1.9 0.4 0.5 8.0 1.1 0.7 0.3 0.2 1.9 0.3 2.1 1.3 2.0 0.7 0.7 1.5 1.3 0.5 2.9 2.7 1.1 1.3 0.9 5.1 1.5 1.4 1.5 1.1 2.2 1.5 0.4 0.5 6.1 0.3 0.9 0.3 4.2 1.5 0.9 0.0 0.2 0.3 2.7 0.1 0.6 10.0 2.8 0.2 8.6 1.4 6.6 4.0 0.0 3.8 4.0 7.2 0.1 1.9 0.4 0.4 0.8 4.8 3.1 2.2 3.0 7.8 1.1 3.1 0.8 4.5 2.7 1.8 4.0 3.8 3.7 2.1 1.7 2.2 0.8 0.9 0.8 0.8 0.8 0.3 0.8 0.8 0.8 0.8 0.0 0.6 3.7 0.8 1.3 6.3 1.2 2.5 17.4 0.0 1.8 2.0 0.0 10.0 0.6 81.2 3.9 0.0 0.0 0.5 0.0 1.6 0.4 1.1 4.9 0.7 0.0 0.0 1.3 0.3 36.5 3.4 0.8 5.0 0.0 0.0 0.5 0.3 0.0 3.2 0.0 1.3 0.0 7.2 90.2 2.1 1.1 0.0 0.5 0.0 0.2 SLC6A17 ENSG00000197106 "Solute carrier family 6 member 17" Q9H1V8 1 110150486-110202202 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 53.5" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 2.1;Melanocytes: 10.1;Rod photoreceptor cells: 3.6" "Cancer enriched" "Detected in some" 9 "melanoma: 17.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008043, HPA008044" Enhanced Approved Mitochondria NA NA Mitochondria "HPA008043: , HPA008044: AB_1857192" "unprognostic (1.13e-1)" "unprognostic (1.37e-3)" "unprognostic (5.52e-3)" "unprognostic (3.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (6.11e-3)" "unprognostic (3.87e-3)" "unprognostic (1.70e-2)" "unprognostic (1.80e-1)" "unprognostic (1.68e-2)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (9.76e-2)" "unprognostic (1.38e-3)" "unprognostic (1.68e-3)" 1.4 7.8 9.3 1.2 18.3 1.1 1.3 21.8 53.5 1.0 1.1 2.3 0.0 1.0 1.0 2.1 1.3 1.0 1.1 1.0 11.2 14.9 2.1 0.9 1.0 0.9 6.0 16.2 1.0 2.6 1.0 12.4 1.8 19.5 1.0 1.0 2.6 1.2 1.0 1.0 7.6 1.1 1.1 1.8 1.0 1.8 2.4 0.7 0.0 1.3 0.0 0.9 1.0 0.1 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.3 0.4 1.7 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.6 4.8 1.5 28.3 0.8 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 5.7 0.0 2.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 9.3 18.3 21.8 37.3 11.2 14.9 6.0 16.2 19.5 0.7 0.0 0.0 0.0 0.0 0.5 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 10.1 0.0 0.0 0.5 0.3 0.0 0.0 0.0 3.6 0.0 0.4 0.0 1.1 0.4 0.1 0.0 0.0 0.0 SLC6A18 "FLJ31236, Xtrp2" ENSG00000164363 "Solute carrier family 6 member 18" Q96N87 5 1225355-1246189 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 32 "kidney: 14.1" "Group enriched" "Detected in some" 71 "Distal tubular cells: 6.6;Proximal tubular cells: 21.3" "Cancer enriched" "Detected in single" 44 "renal cancer: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA011885 Enhanced NA NA "HPA011885: AB_1857198" "unprognostic (2.02e-1)" "unprognostic (5.69e-3)" "unprognostic (2.90e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.0 0.4 0.6 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC6A19 ENSG00000174358 "Solute carrier family 6 member 19" Q695T7 5 1201595-1225117 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 167.3" "Group enriched" "Detected in some" 6 "Cholangiocytes: 63.7;Enterocytes: 25.3;Proximal tubular cells: 65.4" "Cancer enhanced" "Detected in many" "renal cancer: 7.9;stomach cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 14.4;HEL: 17.6;OE19: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037415, HPA043207" Enhanced NA NA "HPA037415: AB_10672346, HPA043207: AB_2678363" "unprognostic (1.26e-1)" "unprognostic (1.01e-3)" "unprognostic (6.04e-2)" "unprognostic (3.64e-1)" "prognostic favorable (4.14e-6)" "unprognostic (1.37e-1)" "unprognostic (7.36e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 55.3 0.0 0.0 44.6 0.1 0.0 0.1 0.1 30.0 0.1 0.1 0.1 28.7 0.5 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.5 1.7 0.0 0.1 0.0 0.1 0.1 167.3 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 4.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 63.7 0.0 1.2 1.8 0.0 0.0 1.7 0.0 0.1 0.0 25.3 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 5.8 0.0 65.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 SLC6A2 "NAT1, NET, NET1, SLC6A5" ENSG00000103546 "Solute carrier family 6 member 2" P23975 16 55655604-55706192 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.4;placenta: 41.8" "Group enriched" "Detected in some" 5 "Early spermatids: 3.2;Extravillous trophoblasts: 6.9;Late spermatids: 3.7;Spermatocytes: 10.4;Syncytiotrophoblasts: 4.7" "Cancer enhanced" "Detected in some" "liver cancer: 1.9" "Region enriched" "Detected in single" 27 "pons and medulla: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "SH-SY5Y: 107.1" "Region enriched" "Detected in some" 4 "pons and medulla: 8.2" "Region enriched" "Detected in single" 32 "pons and medulla: 23.1" "HPA004057, HPA076311, CAB078195" Enhanced Supported Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307" "unprognostic (9.58e-3)" "unprognostic (5.48e-2)" "unprognostic (1.26e-4)" "unprognostic (4.07e-1)" "unprognostic (4.16e-1)" "unprognostic (8.38e-2)" "unprognostic (2.97e-2)" "unprognostic (3.29e-1)" "unprognostic (2.31e-1)" "unprognostic (3.27e-1)" "unprognostic (2.12e-2)" "unprognostic (2.95e-2)" "unprognostic (1.72e-1)" "unprognostic (6.02e-2)" "unprognostic (8.48e-2)" "unprognostic (1.43e-2)" 2.4 20.4 0.3 0.1 0.1 0.0 1.8 0.1 0.3 3.2 0.3 0.3 0.1 0.0 4.5 7.2 0.8 0.4 0.4 0.1 0.1 0.0 0.4 1.0 0.5 0.1 0.1 0.1 0.2 0.1 0.0 0.1 41.8 9.7 0.5 0.1 0.1 1.6 1.7 0.1 11.4 0.4 1.0 0.2 0.1 0.2 8.3 0.2 0.1 0.2 0.9 0.5 0.5 1.7 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 107.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.1 0.0 0.1 0.1 9.7 0.2 0.0 0.0 0.0 0.1 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 6.9 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.1 0.4 4.7 0.0 0.0 0.0 SLC6A20 "XT3, Xtrp3" ENSG00000163817 "Solute carrier family 6 member 20" Q9NP91 3 45755450-45796535 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 14.3;intestine: 25.5;retina: 51.3" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 5.3;Cholangiocytes: 12.7;Ductal cells: 10.1;Pancreatic endocrine cells: 6.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 6.1" "Cell type enhanced" "Detected in some" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HaCaT: 3.1;OE19: 7.1;SuSa: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029873 Uncertain NA NA "HPA029873: AB_10602403" "unprognostic (1.57e-1)" "unprognostic (5.26e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-2)" "unprognostic (1.48e-1)" "unprognostic (9.43e-3)" "unprognostic (3.26e-2)" "unprognostic (4.33e-3)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (1.68e-3)" "unprognostic (1.46e-1)" "prognostic favorable (1.55e-5)" "unprognostic (2.87e-1)" "unprognostic (1.23e-1)" "unprognostic (7.55e-2)" "unprognostic (2.09e-2)" 0.3 0.1 0.3 0.6 0.8 0.5 0.7 1.5 2.2 2.4 11.2 3.0 0.4 22.3 1.3 1.7 0.1 0.4 14.3 0.1 0.5 0.4 3.3 0.2 1.9 0.2 1.0 1.7 0.1 5.1 0.0 2.0 0.1 6.1 1.0 0.2 51.3 1.3 0.1 0.9 0.6 25.5 0.3 1.5 0.1 4.7 0.4 0.3 0.0 0.1 0.4 0.1 0.2 0.3 0.8 0.7 2.6 0.2 0.5 0.4 0.1 0.2 0.4 0.4 0.4 0.1 0.0 0.5 0.1 0.0 0.0 0.0 1.6 1.4 0.2 1.1 0.0 0.3 3.1 0.1 0.0 0.2 0.1 0.2 1.3 1.2 0.2 0.0 0.0 0.2 0.1 0.7 0.0 0.1 0.2 0.0 0.5 0.2 0.5 0.0 0.3 0.5 0.3 1.4 7.1 0.3 0.5 0.1 0.4 0.2 0.3 0.4 0.4 1.5 0.2 0.0 10.3 0.3 0.1 0.1 0.5 0.4 0.4 0.3 0.8 0.3 0.1 0.2 0.3 0.1 1.0 0.2 0.2 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.8 0.4 0.3 2.6 0.5 0.1 0.7 0.1 0.1 0.3 0.8 1.5 2.2 0.5 0.4 1.0 1.7 6.1 0.3 0.0 5.3 0.0 0.4 0.5 0.0 0.8 12.7 0.0 2.3 0.0 0.0 0.0 0.0 10.1 0.5 0.0 2.6 0.0 0.2 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 6.2 0.0 1.1 1.4 0.0 0.0 0.2 0.2 0.1 0.3 0.0 0.0 0.4 0.4 SLC6A3 "DAT, DAT1" ENSG00000142319 "Solute carrier family 6 member 3" Q01959 5 1392790-1445430 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 48.4" "Cell type enriched" "Detected in single" 5 "Alveolar cells type 2: 2.9" "Cancer enriched" "Detected in some" 18 "renal cancer: 25.7" "Region enriched" "Detected in some" 47 "midbrain: 48.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 1.2;RPMI-8226: 2.1;SCLC-21H: 3.8" "Group enriched" "Detected in some" 8 "midbrain: 96.4;thalamus: 31.8" "Region enriched" "Detected in single" 138 "midbrain: 362.2" "HPA012763, HPA013602, CAB016249, CAB078172" Enhanced Supported Approved Vesicles NA NA Vesicles "CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484" "unprognostic (2.25e-4)" "unprognostic (2.22e-1)" "unprognostic (8.45e-2)" "unprognostic (5.24e-2)" "unprognostic (7.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.64e-5)" "unprognostic (9.31e-2)" "unprognostic (7.89e-2)" "unprognostic (4.81e-2)" "unprognostic (1.30e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (3.40e-7)" "unprognostic (6.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.22e-2)" "unprognostic (4.74e-2)" 0.2 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.7 0.0 0.0 0.0 0.3 1.1 0.8 0.1 0.8 0.6 0.1 0.0 0.6 0.3 0.0 3.4 0.0 48.4 0.0 1.5 0.0 0.0 0.0 0.1 1.0 0.7 0.0 1.7 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.8 0.0 2.4 2.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 0.0 0.1 3.8 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.6 48.4 0.0 1.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 SLC6A4 "5-HTT, HTT, OCD1, SERT1" ENSG00000108576 "Solute carrier family 6 member 4" P31645 17 30194319-30236002 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 25.0;lung: 50.5" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 90.5;Syncytiotrophoblasts: 89.0" "Cancer enhanced" "Detected in some" "breast cancer: 2.3" "Region enriched" "Detected in single" 36 "pons and medulla: 11.2" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CACO-2: 5.5;Hep G2: 14.7" "Region enriched" "Detected in some" 5 "midbrain: 69.9" "Low region specificity" "Detected in all" "HPA054723, HPA071354, HPA074728" Supported Supported Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA054723: , HPA071354: , HPA074728: AB_2686708" "unprognostic (7.45e-2)" "unprognostic (7.13e-2)" "unprognostic (2.26e-1)" "unprognostic (3.72e-4)" "unprognostic (2.07e-1)" "unprognostic (8.42e-3)" "unprognostic (2.73e-2)" "unprognostic (3.39e-2)" "unprognostic (3.37e-3)" "unprognostic (1.17e-3)" "unprognostic (2.70e-3)" "unprognostic (1.16e-1)" "unprognostic (8.78e-2)" "unprognostic (4.98e-2)" "unprognostic (1.76e-1)" "unprognostic (4.05e-2)" "unprognostic (7.18e-2)" 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.1 6.3 0.1 0.3 1.6 0.9 0.1 0.7 0.1 0.1 0.3 0.1 50.5 0.1 0.1 0.1 0.1 0.6 0.0 0.1 11.3 11.2 0.1 0.0 0.2 0.7 0.1 0.1 0.4 25.0 0.4 0.1 0.1 0.5 0.3 0.1 0.1 0.2 0.1 0.3 0.1 0.3 0.0 0.1 1.0 0.2 0.4 0.3 2.3 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 14.7 1.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.0 1.0 0.0 0.7 0.8 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 1.0 0.4 0.2 0.1 0.0 2.3 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 11.2 0.1 14.9 5.3 0.0 0.4 0.1 0.2 0.8 0.0 1.4 3.4 1.8 0.0 90.5 0.0 0.0 2.3 0.5 1.0 0.0 0.0 7.0 1.6 0.3 2.3 0.0 8.4 0.0 0.0 2.5 0.6 1.0 0.3 0.4 0.0 0.0 0.0 0.5 0.5 0.0 0.4 0.3 0.9 0.0 1.4 0.0 0.4 0.3 89.0 0.0 0.0 0.3 SLC6A5 "GLYT2, NET1" ENSG00000165970 "Solute carrier family 6 member 5" Q9Y345 11 20599400-20659285 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 21.3" "Group enriched" "Detected in some" 27 "Early spermatids: 20.8;Late spermatids: 40.6" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "pons and medulla: 21.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 2.6" "Region enriched" "Detected in some" 9 "pons and medulla: 51.6" "Region enriched" "Detected in some" 9 "pons and medulla: 33.2" CAB079052 Supported NA NA "CAB079052: " "unprognostic (6.94e-2)" "unprognostic (2.28e-1)" "unprognostic (4.75e-2)" 0.0 0.1 0.1 0.1 0.0 0.0 0.0 3.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 5.1 0.1 0.1 0.0 0.0 0.0 0.0 2.2 0.0 21.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 6.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.4 0.3 0.1 0.1 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 SLC6A6 TAUT ENSG00000131389 "Solute carrier family 6 member 6" P31641 3 14402576-14489349 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 76.4" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 538.0;Rod photoreceptor cells: 502.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 33.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 33.2" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 45.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015028, HPA016488" Enhanced Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "HPA015028: AB_1857200, HPA016488: AB_1857202" "unprognostic (8.25e-2)" "unprognostic (7.29e-3)" "unprognostic (2.63e-2)" "prognostic favorable (5.22e-5)" "prognostic unfavorable (5.75e-8)" "unprognostic (4.14e-2)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.58e-1)" "unprognostic (2.56e-1)" "unprognostic (3.81e-1)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-2)" "unprognostic (9.65e-2)" "unprognostic (1.90e-1)" 10.2 25.9 5.7 18.0 16.5 46.4 8.1 11.1 12.2 11.3 9.5 8.7 3.6 8.5 14.5 4.4 7.0 7.0 14.5 23.2 5.6 4.6 16.6 2.3 18.6 12.9 18.0 7.6 31.3 2.8 3.8 9.6 18.0 13.3 5.0 4.1 76.4 15.7 7.7 26.6 16.8 22.2 8.2 11.1 20.3 14.0 4.0 12.6 6.2 10.4 11.3 11.2 8.8 6.1 1.6 1.9 33.2 6.9 0.7 3.9 2.3 4.6 17.3 6.2 4.7 8.1 2.5 12.8 7.0 27.8 8.3 6.1 6.3 8.0 13.5 6.4 11.0 12.0 3.7 4.2 5.7 7.4 1.5 5.2 12.8 22.7 9.4 0.2 3.5 27.8 1.3 1.7 7.6 2.0 7.2 9.0 6.3 7.1 2.7 7.3 4.9 9.8 6.8 9.6 6.5 5.0 7.0 7.4 21.1 45.5 9.7 11.5 4.1 5.2 2.8 1.5 24.4 10.7 1.9 22.7 10.6 5.7 2.6 5.0 3.0 3.4 5.0 24.7 6.9 32.4 2.5 5.1 5.0 1.3 4.2 0.7 1.6 1.4 1.7 1.9 0.9 0.2 0.3 33.2 0.7 6.9 0.7 3.9 2.3 5.7 16.5 11.1 12.2 5.6 4.6 18.0 7.6 13.3 12.6 6.0 22.1 4.7 11.2 43.8 102.1 3.6 2.5 12.0 12.5 19.2 538.0 2.2 0.0 9.6 17.0 16.1 0.7 0.0 7.1 12.8 16.4 5.5 12.7 0.4 26.7 9.5 13.8 11.6 62.5 13.3 16.1 47.4 16.9 129.0 2.9 28.2 21.5 2.9 16.3 26.3 502.9 0.0 8.2 0.5 1.5 20.8 4.2 22.4 1.2 10.6 SLC6A7 PROT ENSG00000011083 "Solute carrier family 6 member 7" Q99884 5 150189957-150222788 "Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 40.2" "Cell type enhanced" "Detected in some" 18 "Enterocytes: 2.1;Intestinal endocrine cells: 3.5;Mucus-secreting cells: 4.8;Paneth cells: 8.6;Undifferentiated cells: 3.4" "Cancer enhanced" "Detected in single" "colorectal cancer: 0.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.6;HeLa: 1.8;SK-BR-3: 1.4;U-87 MG: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028907 Uncertain NA NA "HPA028907: AB_10602404" "unprognostic (3.01e-1)" "unprognostic (1.97e-2)" "unprognostic (3.70e-2)" "unprognostic (1.42e-3)" "unprognostic (1.09e-2)" "unprognostic (1.82e-4)" "unprognostic (6.42e-2)" "unprognostic (1.35e-1)" "unprognostic (1.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.55e-1)" "unprognostic (3.50e-1)" "unprognostic (3.73e-4)" "unprognostic (8.11e-2)" "unprognostic (5.46e-2)" "unprognostic (2.73e-1)" "unprognostic (3.70e-3)" 0.5 0.4 3.9 1.0 9.7 0.4 0.5 40.2 22.4 0.6 5.7 0.3 0.0 2.6 0.5 0.6 0.4 0.4 0.5 0.5 6.5 4.5 0.4 0.4 0.5 0.7 1.3 14.5 0.4 0.5 0.4 0.2 0.4 1.6 0.4 7.7 0.0 0.8 0.4 0.5 0.5 4.9 0.7 1.4 0.4 0.4 0.5 0.0 0.0 0.4 0.0 0.7 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 9.7 40.2 22.4 6.5 4.5 1.3 14.5 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 3.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.8 0.0 0.1 8.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 3.4 0.1 SLC6A8 "CRTR, CT1" ENSG00000130821 "Solute carrier family 6 member 8" P48029 X 153688099-153696593 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 127.1;Enterocytes: 208.5;Horizontal cells: 112.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 2.6" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.6" "Cell line enhanced" "Detected in many" "AN3-CA: 42.8;SK-BR-3: 44.4" NA NA "unprognostic (5.80e-2)" "unprognostic (1.24e-1)" "unprognostic (2.39e-2)" "unprognostic (9.98e-2)" "unprognostic (1.47e-1)" "unprognostic (7.16e-2)" "unprognostic (1.59e-2)" "unprognostic (1.59e-2)" "unprognostic (2.08e-1)" "unprognostic (2.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (7.39e-4)" "unprognostic (2.87e-1)" 17.6 19.5 26.3 5.8 39.0 19.3 7.3 23.9 31.9 6.1 26.8 36.6 7.6 32.4 11.2 9.1 20.0 10.6 20.2 53.1 29.3 16.1 27.3 1.9 3.1 1.9 55.6 22.0 5.1 8.3 17.0 7.2 22.6 25.8 12.8 20.2 20.9 31.8 24.9 76.4 28.0 48.3 13.5 28.2 5.1 11.0 16.7 38.9 4.6 2.8 11.0 5.0 40.4 10.1 0.5 0.0 2.6 0.2 0.0 0.0 0.1 40.6 1.7 12.5 42.8 4.0 2.8 2.9 6.1 10.1 7.9 9.8 5.2 0.5 0.0 4.7 7.3 9.3 15.1 25.0 21.0 4.9 0.7 23.8 0.1 14.1 15.5 13.9 0.3 2.8 5.9 4.5 7.9 28.7 15.0 3.9 0.2 9.9 0.6 4.4 2.4 0.2 0.9 12.8 8.1 17.9 1.9 1.4 0.5 8.6 7.9 16.1 18.0 8.9 44.4 28.8 3.0 8.6 6.2 3.9 13.1 20.9 16.8 18.0 1.5 0.7 0.4 29.3 1.2 13.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 26.3 39.0 23.9 30.4 29.3 16.1 55.6 22.0 25.8 38.9 0.0 3.4 2.7 10.6 20.6 127.1 89.0 25.5 8.1 0.0 5.2 104.1 11.0 3.3 3.6 0.6 5.6 208.5 23.3 18.9 27.8 11.2 21.2 4.6 0.8 4.3 112.8 24.9 4.9 1.3 2.2 8.3 1.6 23.6 5.4 32.8 17.4 55.3 41.8 7.8 49.9 48.6 32.3 15.3 2.9 2.8 13.7 76.0 0.0 15.7 17.6 SLC6A9 GLYT1 ENSG00000196517 "Solute carrier family 6 member 9" P48067 1 43991500-44031467 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.2;skin 1: 38.2" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 26.6;Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 5 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "HaCaT: 23.9;hTCEpi: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013977 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA013977: AB_1849835" "unprognostic (2.73e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.50e-4)" "unprognostic (5.98e-2)" "unprognostic (6.83e-3)" "unprognostic (3.06e-2)" "unprognostic (9.72e-2)" "unprognostic (1.85e-2)" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (5.93e-4)" "unprognostic (5.36e-3)" "unprognostic (1.59e-1)" "unprognostic (2.53e-1)" "unprognostic (1.20e-2)" 2.9 22.8 8.8 4.6 18.3 8.6 5.4 5.5 14.3 6.0 7.9 38.1 2.6 2.5 6.2 1.5 16.5 9.6 4.9 1.3 9.9 10.0 2.0 4.9 5.6 1.4 29.5 4.5 4.0 7.8 2.1 1.0 1.7 26.8 2.6 6.2 24.0 7.9 6.1 1.3 38.2 5.6 8.9 42.2 1.1 3.5 1.2 26.3 0.0 4.9 7.2 4.3 6.6 10.9 0.2 0.0 0.2 0.1 0.0 1.4 0.2 7.3 5.5 2.7 7.0 4.4 1.5 6.2 5.9 15.9 9.6 11.9 1.8 2.9 0.1 0.6 16.3 0.0 23.9 4.2 4.7 1.9 0.0 0.7 6.5 13.1 2.1 20.2 1.4 0.3 4.5 41.9 4.7 11.2 6.0 0.2 4.7 5.0 18.8 0.4 4.0 1.0 0.0 2.1 2.8 7.4 0.8 0.0 8.4 0.9 0.8 1.7 1.6 3.0 13.7 2.7 0.7 3.6 3.9 0.1 1.1 4.5 0.9 3.0 20.8 14.3 1.6 3.6 0.0 1.4 0.0 0.0 0.2 0.4 0.1 0.2 0.2 0.4 0.0 0.0 0.0 1.4 0.3 0.2 0.0 0.0 0.0 0.0 0.2 8.8 18.3 5.5 9.4 9.9 10.0 29.5 4.5 26.8 26.3 0.0 1.3 0.9 0.7 6.6 26.6 0.6 5.1 8.1 0.0 1.8 15.7 0.4 0.0 3.2 5.8 0.4 9.8 70.0 7.9 0.7 0.9 1.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.4 1.4 0.0 3.3 1.8 2.9 1.2 4.2 2.0 1.4 1.0 10.2 6.5 6.3 0.0 0.4 11.3 0.5 0.0 1.3 2.5 SLC7A1 "ATRC1, CAT-1, ERR, HCAT1, REC1L" ENSG00000139514 "Solute carrier family 7 member 1" P30825 13 29509410-29595688 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 42.8" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039721, HPA077838" Approved NA NA "HPA039721: AB_10672893, HPA077838: " "unprognostic (1.85e-1)" "unprognostic (1.04e-3)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (3.95e-3)" "unprognostic (2.43e-2)" "unprognostic (1.36e-3)" "unprognostic (2.02e-3)" "unprognostic (4.98e-2)" "unprognostic (1.23e-2)" "unprognostic (7.45e-2)" "unprognostic (9.14e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (3.20e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-1)" "unprognostic (7.37e-3)" 5.7 4.5 8.5 9.0 11.7 8.6 7.0 8.7 19.6 8.1 8.7 10.7 7.5 9.0 7.3 9.6 42.8 6.9 4.8 6.2 12.2 10.4 4.3 2.4 4.4 7.1 11.4 7.7 5.3 26.6 2.9 6.4 12.9 20.0 7.2 6.8 6.1 16.2 12.6 2.1 14.8 12.9 8.1 11.9 5.7 10.0 8.8 6.9 5.3 8.6 27.7 16.2 6.4 8.3 2.0 3.7 0.5 2.8 0.8 3.3 1.7 12.2 9.9 8.7 17.5 4.5 9.0 9.9 26.2 17.5 22.7 16.9 20.0 21.6 24.3 7.1 39.9 25.4 56.3 15.1 18.5 30.0 22.8 9.0 18.2 10.8 10.8 23.4 26.4 12.0 11.4 39.6 25.2 29.9 5.3 11.1 27.8 11.6 11.4 9.5 16.5 19.2 7.1 8.3 21.8 6.6 13.3 18.0 13.9 14.4 8.2 29.7 14.1 14.9 14.6 23.7 5.7 6.4 22.5 10.4 17.9 12.5 15.7 18.7 12.8 9.2 27.7 14.3 10.7 18.0 0.0 1.1 0.5 3.3 1.2 2.7 2.0 2.4 2.7 1.8 1.4 1.9 3.1 0.0 0.8 2.8 3.7 1.9 1.7 8.5 11.7 8.7 15.9 12.2 10.4 11.4 7.7 20.0 6.9 0.0 5.3 14.9 42.8 44.3 15.1 6.7 10.2 5.3 12.5 68.0 15.7 0.4 1.7 19.5 0.2 14.3 16.1 23.3 49.3 31.4 9.3 41.6 6.9 0.8 6.1 23.8 29.9 3.7 4.3 0.4 5.8 5.2 8.5 4.6 28.0 3.4 45.4 24.5 3.5 0.0 17.8 6.5 9.9 0.5 2.1 30.6 3.3 4.9 24.5 38.1 SLC7A10 asc-1 ENSG00000130876 "Solute carrier family 7 member 10" Q9NS82 19 33208664-33225850 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.9;brain: 13.6;breast: 15.6" "Group enriched" "Detected in some" 5 "Muller glia cells: 1.8;Spermatogonia: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 4.3;HHSteC: 2.6;HSkMC: 3.7;THP-1: 8.4;U-2 OS: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041884, HPA057036" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041884: AB_10794494, HPA057036: AB_2683317" "unprognostic (1.85e-2)" "unprognostic (1.69e-3)" "unprognostic (2.79e-2)" "unprognostic (1.79e-6)" "unprognostic (1.16e-1)" "unprognostic (2.08e-1)" "unprognostic (1.31e-1)" "unprognostic (4.98e-3)" "unprognostic (4.64e-2)" "unprognostic (1.96e-1)" "unprognostic (3.28e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-2)" "unprognostic (1.34e-3)" "unprognostic (8.91e-2)" "unprognostic (3.47e-1)" "unprognostic (2.18e-2)" 40.9 1.0 9.8 1.9 13.6 1.0 15.6 2.4 12.1 1.0 2.2 0.8 0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.1 4.7 6.2 1.3 1.0 1.0 1.2 7.6 5.0 1.0 1.2 1.0 0.0 1.2 9.0 1.0 1.0 8.4 2.3 1.0 1.0 1.1 1.0 1.1 0.8 1.0 1.0 1.4 1.8 0.0 1.4 0.0 1.4 1.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 8.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 9.8 13.6 2.4 12.1 4.7 6.2 7.6 5.0 9.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.0 0.0 SLC7A11 xCT ENSG00000151012 "Solute carrier family 7 member 11" Q9UPY5 4 138164097-138242349 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2" "Cell type enhanced" "Detected in many" 13 "Glandular cells: 37.7;monocytes: 90.2;Muller glia cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 3.8" "Lineage enriched" "Detected in single" 8 "dendritic cells: 3.8" "Cell line enhanced" "Detected in many" "hTCEpi: 28.6;TIME: 31.4;WM-115: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064215 Approved Vesicles NA NA Vesicles "HPA064215: AB_2685213" "unprognostic (3.55e-3)" "unprognostic (4.64e-3)" "unprognostic (2.43e-2)" "unprognostic (7.18e-3)" "unprognostic (2.59e-1)" "unprognostic (8.80e-3)" "unprognostic (2.07e-8)" "unprognostic (1.98e-2)" "unprognostic (1.09e-2)" "prognostic favorable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (4.07e-2)" "unprognostic (2.22e-8)" "unprognostic (3.81e-2)" "unprognostic (3.76e-2)" "unprognostic (2.29e-2)" "unprognostic (1.54e-2)" 1.1 0.9 16.3 4.7 15.8 2.2 1.5 8.2 26.0 2.4 2.0 17.9 0.0 1.5 1.3 13.4 3.3 8.9 3.8 2.5 17.4 6.9 0.9 0.9 2.3 1.5 12.6 16.8 1.7 5.4 1.0 1.2 2.1 17.2 2.0 2.8 0.3 1.6 1.0 0.8 1.9 1.4 1.0 27.2 1.4 9.2 2.2 14.0 0.0 8.9 6.0 2.2 4.0 0.8 0.1 3.8 0.4 0.0 0.1 0.0 0.0 1.6 13.8 6.2 4.8 1.3 1.7 1.7 7.6 5.3 1.7 4.0 1.5 5.8 3.1 10.0 26.5 9.4 2.2 3.3 6.5 7.4 5.9 0.7 2.2 13.1 3.4 20.6 5.8 2.1 4.1 28.6 4.9 22.1 2.6 21.6 3.2 3.0 8.2 9.1 1.2 0.8 0.5 1.2 8.1 3.9 0.9 2.0 3.6 1.0 6.6 2.5 0.5 3.3 0.9 11.7 1.4 1.5 12.4 31.4 2.3 6.5 3.4 6.0 6.9 3.1 3.2 3.9 3.2 46.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 3.8 0.0 0.0 16.3 15.8 8.2 15.9 17.4 6.9 12.6 16.8 17.2 14.0 0.0 5.9 3.7 7.0 4.0 4.0 3.6 2.5 1.4 3.4 0.0 2.0 2.2 0.0 3.6 2.1 1.6 1.1 0.0 21.4 0.5 1.0 37.7 4.6 0.4 0.5 1.6 25.9 3.7 0.0 0.4 2.3 9.0 5.0 90.2 5.4 48.4 27.4 1.1 2.1 0.0 1.9 0.0 1.0 0.7 0.7 2.8 0.9 0.0 1.3 11.1 SLC7A13 "AGT-1, XAT2" ENSG00000164893 "Solute carrier family 7 member 13" Q8TCU3 8 86214052-86321146 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "kidney: 31.7" "Cell type enhanced" "Detected in some" 31 "Collecting duct cells: 1.8;Distal tubular cells: 3.3;Proximal tubular cells: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.34e-1)" "unprognostic (2.62e-1)" "unprognostic (1.12e-1)" "unprognostic (2.96e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 31.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.6 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.0 1.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC7A14 "KIAA1613, PPP1R142" ENSG00000013293 "Solute carrier family 7 member 14" Q8TBB6 3 170459584-170586074 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.4;pituitary gland: 14.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 31.5;Horizontal cells: 27.0" "Group enriched" "Detected in some" 11 "glioma: 0.8;pancreatic cancer: 0.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "LHCN-M2: 7.2;SCLC-21H: 7.2;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045929 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Cytosol" "Nucleoplasm, Plasma membrane" "HPA045929: AB_2679501" "unprognostic (1.00e-1)" "unprognostic (9.56e-2)" "unprognostic (1.03e-1)" "unprognostic (4.15e-2)" "unprognostic (1.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.16e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-1)" "unprognostic (6.68e-3)" "unprognostic (6.36e-2)" "unprognostic (3.03e-6)" "unprognostic (1.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.71e-2)" "unprognostic (3.24e-3)" 1.1 5.8 12.1 1.9 17.7 1.4 1.1 14.9 33.4 1.0 1.8 8.0 0.0 1.6 1.1 1.2 1.1 1.1 1.3 1.1 11.5 12.1 1.3 1.2 1.1 1.1 6.7 12.8 1.3 2.4 1.1 14.5 1.1 11.8 1.2 1.9 0.1 1.1 1.1 1.2 1.3 1.7 1.3 9.0 1.1 1.5 1.3 6.3 0.0 1.1 0.0 1.1 1.1 0.3 1.0 0.6 2.1 0.5 0.7 0.6 0.1 0.0 0.0 0.4 0.1 1.3 2.0 0.1 0.6 0.2 0.8 0.8 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 1.8 0.0 0.1 1.3 0.8 0.2 0.1 0.0 0.2 7.2 0.0 0.0 0.2 1.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 7.2 2.1 0.0 0.1 0.0 0.3 0.1 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 2.1 0.5 0.5 0.4 0.3 0.3 0.8 0.3 0.3 0.1 1.0 0.6 0.5 1.2 0.7 0.3 0.6 0.3 0.1 12.1 17.7 14.9 16.9 11.5 12.1 6.7 12.8 11.8 6.3 3.0 2.1 0.0 0.3 0.3 31.5 0.8 0.0 5.3 4.5 0.0 2.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.5 0.2 2.3 1.0 0.0 27.0 1.7 0.0 0.0 0.4 2.0 0.9 3.3 0.0 0.0 1.8 0.1 0.0 2.5 0.0 3.9 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 SLC7A2 "ATRC2, CAT-2, HCAT2" ENSG00000003989 "Solute carrier family 7 member 2" P52569 8 17497088-17570573 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 230.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 67.7;RT4: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009277 Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA009277: AB_2668229" "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (1.13e-2)" "unprognostic (1.06e-1)" "unprognostic (5.20e-2)" "unprognostic (7.24e-3)" "unprognostic (3.11e-1)" "unprognostic (1.76e-1)" "unprognostic (4.49e-1)" "unprognostic (1.34e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (2.65e-7)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.46e-2)" "unprognostic (8.98e-2)" "unprognostic (1.79e-1)" 10.6 3.8 8.6 1.4 3.4 0.1 18.0 2.5 8.3 11.5 2.5 2.4 2.9 0.8 6.4 11.8 3.7 13.6 5.1 9.7 6.8 0.9 3.8 68.1 3.3 2.8 4.4 3.5 35.1 32.2 78.2 3.0 29.0 9.1 4.9 1.5 13.0 2.4 3.3 57.8 3.3 2.0 4.3 10.9 1.8 3.3 7.7 3.5 0.0 14.3 10.4 1.2 3.4 6.4 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.9 0.3 10.4 0.0 0.1 11.3 0.0 7.0 0.5 0.6 3.3 0.0 0.0 2.4 0.0 1.5 0.0 7.5 1.7 2.4 0.0 3.9 0.0 8.1 7.2 67.7 3.1 0.0 9.1 1.4 8.8 8.4 0.0 3.2 0.0 0.0 0.0 7.9 11.0 0.4 3.6 3.8 2.3 0.9 0.0 5.2 5.4 0.8 17.4 0.1 1.4 0.5 0.2 3.1 8.0 0.0 0.3 7.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.6 3.4 2.5 8.3 6.8 0.9 4.4 3.5 9.1 3.5 11.9 63.8 0.0 6.1 7.3 1.8 14.3 33.1 84.3 27.3 7.0 33.4 17.0 0.0 4.5 10.8 5.2 0.1 0.0 79.6 13.8 18.2 28.5 2.3 230.6 4.7 0.0 84.5 6.7 6.9 17.4 35.1 1.5 3.3 1.0 2.2 15.0 29.6 0.0 26.2 1.8 38.5 58.2 52.8 0.4 0.4 3.3 21.7 2.5 2.6 1.8 SLC7A3 "ATRC3, CAT-3, FLJ14541" ENSG00000165349 "Solute carrier family 7 member 3" Q8WY07 X 70925582-70931125 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 45.5" "Group enriched" "Detected in some" 6 "Early spermatids: 5.3;Late spermatids: 1.9" "Cancer enriched" "Detected in some" 12 "testis cancer: 43.0" "Region enhanced" "Detected in many" "hypothalamus: 6.7" "Cell type enriched" "Detected in single" 16 "naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Group enriched" "Detected in some" 4 "HAP1: 20.7;NTERA-2: 42.6;SuSa: 53.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.42e-4)" "unprognostic (4.30e-4)" "unprognostic (3.59e-3)" "unprognostic (1.81e-2)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (3.66e-1)" "unprognostic (9.18e-3)" "unprognostic (1.89e-1)" "unprognostic (7.99e-5)" "unprognostic (1.31e-2)" "unprognostic (5.42e-4)" "unprognostic (3.57e-2)" 0.1 0.0 1.0 0.1 1.0 1.3 1.4 0.1 2.1 2.0 0.1 1.1 0.8 0.1 9.1 6.2 0.7 2.7 0.1 0.0 1.2 6.7 0.2 0.0 0.1 0.5 0.5 0.5 1.7 0.0 0.0 0.6 0.0 1.2 10.4 0.0 0.5 0.2 9.4 0.0 0.0 0.3 4.6 0.2 0.1 5.6 2.4 0.4 45.5 0.0 0.2 0.5 4.0 1.4 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 42.6 0.0 0.0 8.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 1.0 1.0 0.1 2.1 1.2 6.7 0.5 0.5 1.2 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 SLC7A4 "CAT-4, HCAT3, VH" ENSG00000099960 "Solute carrier family 7 member 4" O43246 22 21028718-21032840 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.6;testis: 29.1" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 6.0;Cytotrophoblasts: 9.1;granulocytes: 4.6;Mucus-secreting cells: 7.9;Syncytiotrophoblasts: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.4;naive CD8 T-cell: 2.4" "Group enriched" "Detected in many" 18 "NK-cells: 1.0;T-cells: 2.4" "Cell line enriched" "Detected in some" 21 "BEWO: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA031023 Enhanced NA NA "HPA031023: AB_10669669" "unprognostic (1.02e-3)" "unprognostic (4.34e-2)" "unprognostic (6.75e-2)" "unprognostic (1.27e-1)" "unprognostic (3.82e-2)" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.91e-2)" "unprognostic (3.68e-2)" "unprognostic (2.51e-2)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (9.69e-2)" "unprognostic (2.87e-1)" "unprognostic (1.62e-1)" "unprognostic (1.32e-2)" "unprognostic (4.00e-3)" 2.7 3.5 2.2 0.4 3.8 0.1 2.6 6.0 5.9 2.8 1.8 0.4 1.4 1.7 1.5 0.7 8.5 1.6 4.1 1.2 2.7 7.1 0.2 0.3 1.4 1.2 2.4 4.3 0.3 0.4 0.1 5.1 19.6 2.4 4.1 1.4 3.3 4.3 5.3 0.6 1.9 2.0 0.6 0.6 0.9 2.4 29.1 0.4 0.2 0.1 1.3 2.1 2.4 0.7 0.0 0.0 0.0 0.0 1.0 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 57.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.4 0.0 0.2 1.2 0.0 0.0 0.1 2.4 0.0 1.0 0.0 0.0 0.0 0.8 2.2 3.8 6.0 5.9 2.7 7.1 2.4 4.3 2.4 0.4 6.0 3.4 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.1 0.0 0.1 0.0 0.4 2.8 0.1 0.4 4.6 0.0 1.2 0.0 1.2 1.8 0.0 1.3 1.7 0.0 0.0 0.0 7.9 1.8 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.2 0.0 8.5 0.0 0.6 0.1 SLC7A5 "CD98, D16S469E, E16, LAT1, MPE16" ENSG00000103257 "Solute carrier family 7 member 5" Q01650 16 87830023-87869488 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 71.2" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 70.0;granulocytes: 68.9;Intestinal endocrine cells: 82.6;Smooth muscle cells: 85.8;Syncytiotrophoblasts: 89.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 15.9" "Lineage enriched" "Detected in many" 11 "dendritic cells: 15.9" "Cell line enhanced" "Detected in many" "HBEC3-KT: 108.7;hTCEpi: 186.8;MCF7: 101.2;SiHa: 153.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052673, HPA056077" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "HPA052673: AB_2681909, HPA056077: AB_2683031" "unprognostic (2.71e-3)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-1)" "unprognostic (3.22e-2)" "unprognostic (2.99e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (6.86e-2)" "unprognostic (4.46e-2)" "unprognostic (1.27e-1)" "unprognostic (3.17e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.93e-2)" "unprognostic (5.52e-3)" "unprognostic (1.64e-2)" "unprognostic (7.19e-3)" 8.2 3.2 18.3 14.7 24.5 71.2 4.3 15.9 45.8 7.9 4.6 16.7 8.9 6.2 5.3 30.4 38.7 3.3 6.4 8.2 19.8 22.1 3.6 9.7 3.8 11.1 23.9 9.6 5.1 12.1 1.5 9.0 28.4 23.4 4.3 3.4 34.9 11.5 15.4 11.2 10.7 5.7 4.8 17.7 6.4 12.7 34.9 19.8 3.7 4.2 16.7 15.0 11.5 7.7 0.5 15.9 0.6 0.0 0.2 1.4 0.4 14.9 56.6 1.1 15.9 0.4 0.9 40.8 12.0 4.3 7.3 4.7 36.9 21.4 13.7 10.6 15.2 2.5 67.4 11.7 108.7 5.1 14.3 5.9 11.2 53.1 26.4 17.1 10.4 20.7 3.0 186.8 9.0 66.8 2.4 1.4 48.5 16.7 15.3 5.8 101.2 12.5 15.3 5.2 9.4 13.8 12.2 4.3 20.9 8.1 1.2 9.1 3.6 153.4 30.7 32.9 10.8 14.1 13.8 1.1 2.6 17.1 10.6 9.3 20.0 16.3 59.1 10.1 25.9 24.4 0.6 0.0 0.0 1.0 0.0 1.2 0.5 0.5 0.8 0.3 0.0 0.1 0.4 0.1 0.2 0.0 15.9 1.4 0.4 18.3 24.5 15.9 28.1 19.8 22.1 23.9 9.6 23.4 19.8 0.0 1.1 16.4 11.1 65.1 12.7 2.8 2.5 0.0 0.0 1.8 15.7 12.4 0.0 16.8 0.8 4.3 1.7 70.0 8.0 28.4 10.4 13.9 68.9 14.5 8.2 9.5 82.6 2.5 3.5 4.0 1.7 6.6 37.1 2.8 2.8 13.3 19.5 0.2 1.4 0.5 50.1 0.0 85.8 1.7 2.5 32.9 89.8 8.6 1.6 26.1 SLC7A6 "KIAA0245, LAT-2, LAT3, y+LAT-2" ENSG00000103064 "Solute carrier family 7 member 6" Q92536 16 68264516-68301823 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.8" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 38.7;Syncytiotrophoblasts: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050713 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA050713: AB_2681218" "unprognostic (6.35e-2)" "unprognostic (4.63e-2)" "unprognostic (1.41e-1)" "unprognostic (1.40e-2)" "unprognostic (2.41e-1)" "unprognostic (5.02e-2)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (1.89e-3)" "unprognostic (7.82e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.84e-4)" 25.9 7.6 5.4 12.9 6.7 6.9 18.7 9.0 8.0 5.3 7.1 3.4 6.7 3.6 5.5 14.0 4.0 7.1 4.7 13.1 5.3 3.3 5.4 2.3 9.8 16.3 3.3 4.6 3.0 3.2 2.5 11.1 16.3 5.4 6.6 10.8 9.0 5.8 5.1 58.8 8.4 9.4 8.3 3.4 9.4 5.3 5.2 3.7 31.8 15.0 8.0 19.6 5.7 8.0 7.2 16.2 5.9 3.6 6.7 12.6 1.7 9.4 9.7 7.2 7.7 21.4 12.8 20.3 11.1 8.1 16.6 13.9 41.3 7.2 18.8 8.8 14.2 4.8 14.5 14.0 13.9 18.1 3.8 10.0 10.0 19.1 13.1 3.9 11.8 9.1 8.6 12.2 12.9 6.5 5.3 11.1 9.8 14.7 3.4 9.0 5.1 15.3 8.2 5.4 6.4 3.5 19.5 4.5 15.8 5.8 8.3 10.6 5.8 32.1 9.0 3.8 6.3 13.5 6.4 16.3 11.0 8.4 9.2 13.9 7.2 13.5 21.5 7.0 8.7 7.4 2.5 3.6 3.0 4.9 1.7 6.1 6.6 7.3 4.6 3.4 7.2 12.6 7.4 5.9 6.7 1.4 16.2 3.1 1.7 5.4 6.7 9.0 8.0 5.3 3.3 3.3 4.6 5.4 3.7 38.7 16.8 11.1 8.0 17.4 3.7 17.3 0.0 8.1 3.4 17.4 35.3 20.4 0.0 3.0 4.0 9.0 4.2 0.0 3.4 1.6 10.5 3.0 4.6 1.3 12.0 9.5 2.4 7.4 6.7 14.6 5.5 7.5 10.1 3.6 8.9 2.1 4.1 6.2 3.5 0.3 2.6 0.0 7.3 14.2 9.4 19.2 40.0 17.5 6.9 2.3 SLC7A7 "LPI, y+LAT-1" ENSG00000155465 "Solute carrier family 7 member 7" Q9UM01 14 22773222-22829820 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 63.8;intestine: 93.5;kidney: 67.3" "Cell type enhanced" "Detected in many" 13 "Hofbauer cells: 200.4;Kupffer cells: 312.3;Macrophages: 142.1;Proximal tubular cells: 254.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 59.5;non-classical monocyte: 63.8" "Lineage enriched" "Detected in many" 4 "monocytes: 63.8" "Cell line enhanced" "Detected in some" "BEWO: 44.5;CACO-2: 72.0;EFO-21: 15.6;OE19: 63.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA036227 Enhanced NA NA "HPA036227: AB_10696653" "unprognostic (1.34e-1)" "unprognostic (7.65e-2)" "unprognostic (4.25e-2)" "unprognostic (2.52e-1)" "unprognostic (6.12e-2)" "unprognostic (3.69e-2)" "unprognostic (7.84e-3)" "unprognostic (1.47e-1)" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (2.60e-3)" "unprognostic (7.15e-2)" "prognostic unfavorable (6.28e-6)" "unprognostic (2.68e-3)" "unprognostic (1.86e-2)" "unprognostic (2.61e-1)" "unprognostic (1.12e-1)" 10.4 2.8 1.9 8.3 3.1 3.6 3.2 0.7 2.7 2.6 48.0 4.1 0.2 24.1 2.7 2.3 2.1 4.6 7.6 3.0 2.2 1.6 67.3 6.5 15.3 20.5 3.7 1.0 2.6 2.7 26.3 1.0 6.5 3.2 2.7 3.4 2.1 3.3 0.9 1.6 1.8 93.5 3.5 4.5 32.4 3.0 13.4 2.7 2.1 2.8 0.8 5.7 4.1 3.6 3.0 14.6 5.4 63.8 0.0 0.1 17.8 0.0 2.4 0.2 0.1 0.4 0.8 44.5 0.5 3.6 0.1 0.3 72.0 7.3 3.5 15.6 0.3 0.2 2.7 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.7 2.1 0.3 0.3 1.6 0.2 0.2 0.1 0.3 5.5 0.2 0.0 2.8 0.5 0.1 0.0 0.3 0.7 63.3 0.0 0.6 7.8 2.1 0.1 0.2 0.0 0.1 0.1 0.1 0.5 2.1 0.1 1.7 0.3 0.1 0.3 0.1 0.1 0.6 0.1 1.8 0.2 0.1 0.0 0.0 41.2 0.1 0.0 59.5 0.0 3.0 0.0 0.0 14.6 2.3 0.1 0.0 5.4 0.0 63.8 0.5 0.1 17.8 1.9 3.1 0.7 2.7 2.2 1.6 3.7 1.0 3.2 2.7 11.9 10.3 23.7 0.1 0.9 0.0 0.8 58.6 9.4 4.5 3.5 0.0 1.0 10.0 6.7 40.8 4.5 8.6 0.0 5.8 4.5 4.8 0.2 1.1 1.3 200.4 0.0 1.2 22.1 312.3 7.5 3.4 142.1 5.0 34.3 0.4 0.5 7.3 0.0 0.0 254.4 1.2 6.5 2.8 12.2 1.7 0.4 1.5 5.0 0.3 0.0 SLC7A8 "LAT2, LPI-PC1" ENSG00000092068 "Solute carrier family 7 member 8" Q9UHI5 14 23125295-23183674 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 204.0" "Cell type enhanced" "Detected in many" 6 "Ito cells: 97.0;Kupffer cells: 71.7;Proximal tubular cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 7.6;eosinophil: 13.2;naive CD8 T-cell: 3.5" "Group enriched" "Detected in many" 46 "granulocytes: 13.2;T-cells: 3.5" "Cell line enhanced" "Detected in many" "AF22: 21.2;ASC diff: 22.3;BEWO: 38.9;CACO-2: 21.5;K-562: 40.6;NTERA-2: 21.2;SuSa: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046015, HPA051950, HPA060672" Enhanced NA NA "CAB046015: AB_2239464, HPA051950: AB_2681670, HPA060672: AB_2684340" "unprognostic (1.50e-1)" "unprognostic (1.52e-1)" "unprognostic (2.88e-1)" "unprognostic (1.03e-2)" "unprognostic (1.12e-2)" "unprognostic (3.03e-2)" "prognostic unfavorable (1.97e-4)" "prognostic favorable (3.15e-4)" "unprognostic (1.24e-1)" "unprognostic (2.37e-1)" "unprognostic (1.39e-3)" "unprognostic (9.44e-2)" "unprognostic (7.00e-2)" "unprognostic (2.96e-2)" "unprognostic (8.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.52e-4)" 10.5 5.9 4.6 3.0 6.6 1.3 11.0 10.9 10.7 12.7 5.9 2.5 28.2 11.7 23.0 7.2 13.2 21.7 6.2 3.1 7.8 3.0 37.6 3.0 6.2 5.8 2.4 5.6 33.7 9.1 204.0 16.7 19.8 6.9 13.0 5.1 31.2 9.5 50.9 23.6 11.2 8.8 7.5 1.9 10.0 19.3 10.5 4.7 0.3 12.8 5.2 4.9 15.2 14.5 0.1 0.0 13.2 0.1 0.0 3.5 1.7 0.4 0.0 21.2 0.0 22.3 2.7 38.9 2.1 8.5 0.0 0.6 21.5 1.1 0.1 0.3 4.6 2.2 3.6 2.8 1.1 0.1 0.0 2.0 0.1 0.0 0.0 8.7 0.0 12.1 19.2 10.7 0.3 0.2 5.0 1.7 1.9 40.6 0.0 0.4 0.3 0.0 0.2 21.2 4.0 15.8 0.0 0.2 4.0 0.2 7.9 2.6 0.1 0.0 3.7 10.0 25.5 13.5 0.1 0.1 0.7 0.5 0.2 0.0 0.1 4.6 0.0 2.4 0.0 0.1 7.6 0.1 13.2 0.0 0.1 1.1 0.1 0.9 0.1 0.0 0.0 0.9 3.5 0.4 0.0 0.0 0.0 0.5 1.7 4.6 6.6 10.9 10.7 7.8 3.0 2.4 5.6 6.9 4.7 14.9 16.7 2.9 22.2 2.7 28.0 5.1 0.0 0.0 13.6 15.7 0.0 14.7 5.0 1.3 1.8 1.3 12.9 0.0 2.1 2.2 8.7 34.8 4.7 0.4 47.4 25.4 31.8 97.0 71.7 1.7 8.9 9.7 18.6 0.0 30.8 48.5 3.9 3.5 7.4 98.9 4.2 0.0 3.1 0.3 0.6 2.6 34.6 1.3 18.9 31.8 SLC7A9 CSNU3 ENSG00000021488 "Solute carrier family 7 member 9" P82251 19 32830509-32869766 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 63.3;kidney: 26.4" "Cell type enriched" "Detected in some" 5 "Proximal tubular cells: 55.5" "Group enriched" "Detected in some" 7 "liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "BEWO: 4.9;CACO-2: 11.3;Hep G2: 11.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042591 Enhanced NA NA "HPA042591: AB_10962500" "unprognostic (4.12e-2)" "unprognostic (5.40e-2)" "unprognostic (6.19e-2)" "unprognostic (3.37e-3)" "unprognostic (1.69e-1)" "unprognostic (1.54e-1)" "unprognostic (4.17e-2)" "unprognostic (3.87e-2)" "unprognostic (1.49e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" "unprognostic (2.39e-1)" "unprognostic (9.69e-2)" "unprognostic (5.97e-2)" "unprognostic (3.20e-1)" "unprognostic (4.94e-3)" "unprognostic (5.10e-5)" 0.1 0.0 0.1 0.3 0.2 0.0 0.1 0.3 0.2 0.2 20.1 0.1 0.1 30.5 0.1 1.1 0.1 0.2 0.1 0.1 0.1 0.1 26.4 11.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 63.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 4.9 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.3 0.0 2.7 0.0 5.2 3.9 0.1 1.7 0.0 0.7 0.0 0.0 0.0 6.6 6.5 0.0 0.0 0.0 10.5 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 55.5 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 SLC8A1 NCX1 ENSG00000183023 "Solute carrier family 8 member A1" P32418 2 40097270-40611053 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 67.7" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 601.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 25.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 25.2" "Cell line enhanced" "Detected in many" "BJ: 15.4;fHDF/TERT166: 37.3;hTERT-HME1: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022694, HPA070007" Uncertain Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane" "CAB022694: , HPA070007: AB_2686227" "unprognostic (2.46e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-2)" "unprognostic (7.57e-6)" "unprognostic (1.56e-1)" "unprognostic (3.94e-1)" "unprognostic (2.28e-2)" "unprognostic (4.60e-2)" "unprognostic (1.31e-1)" "unprognostic (7.71e-2)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.66e-2)" "unprognostic (7.04e-3)" "unprognostic (3.93e-2)" "unprognostic (5.46e-2)" "unprognostic (6.77e-2)" 3.9 2.9 7.7 4.4 14.3 1.4 2.0 3.5 15.3 5.5 7.3 1.8 7.1 3.3 12.2 3.9 4.0 3.9 5.3 67.7 7.7 6.6 11.0 2.2 3.7 2.5 5.2 8.2 2.1 1.5 1.1 1.9 6.8 7.6 12.2 3.4 1.0 1.5 17.2 1.5 2.1 3.6 20.5 2.8 4.4 2.5 1.4 2.5 0.1 1.6 0.0 1.3 9.8 2.8 0.0 2.4 25.2 6.0 0.0 0.0 0.5 1.5 1.2 1.1 0.1 1.7 3.6 0.0 15.4 6.0 5.1 3.3 0.0 2.5 0.0 1.2 37.3 5.5 0.6 0.3 2.5 5.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 5.9 10.9 2.3 0.4 0.0 0.0 0.2 6.5 0.0 0.4 0.0 0.8 0.1 2.1 4.1 8.1 0.0 1.8 0.2 1.7 0.3 0.0 0.0 0.0 5.6 0.0 0.3 5.2 4.8 0.1 0.0 1.6 0.8 0.0 0.0 0.8 0.9 0.7 0.0 4.9 0.0 0.0 5.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 25.2 0.0 6.0 0.1 0.0 0.5 7.7 14.3 3.5 15.3 7.7 6.6 5.2 8.2 7.6 2.5 3.0 3.2 2.9 0.0 1.1 50.8 601.5 2.5 0.0 1.2 33.2 3.9 0.4 0.0 0.0 0.8 3.3 0.0 0.0 0.0 1.4 4.8 0.1 0.0 0.0 28.3 0.0 0.0 20.3 56.6 0.7 0.0 46.7 1.7 1.0 0.6 35.9 0.1 0.0 7.8 0.1 6.9 12.9 19.6 0.2 0.4 2.8 0.9 0.0 0.0 0.0 SLC8A2 "KIAA1087, NCX2" ENSG00000118160 "Solute carrier family 8 member A2" Q9UPR5 19 47428017-47472168 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.9" "Cell type enriched" "Detected in some" 8 "Bipolar cells: 16.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NTERA-2: 4.4;SCLC-21H: 12.5;SH-SY5Y: 6.7;SiHa: 5.2;U-2 OS: 8.1" "Group enriched" "Detected in many" 4 "amygdala: 80.3;basal ganglia: 95.4;cerebral cortex: 125.2;hippocampal formation: 110.1" "Low region specificity" "Detected in all" "HPA050818, HPA054671" Enhanced NA NA "HPA050818: AB_2681248, HPA054671: AB_2682568" "unprognostic (3.75e-2)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (4.32e-2)" "unprognostic (1.34e-1)" "unprognostic (6.00e-3)" "unprognostic (1.38e-1)" "unprognostic (2.79e-1)" "unprognostic (1.34e-1)" "unprognostic (8.95e-2)" "unprognostic (4.77e-2)" "unprognostic (2.04e-2)" "unprognostic (2.81e-3)" "unprognostic (6.13e-2)" "unprognostic (9.40e-2)" "unprognostic (1.53e-1)" "unprognostic (1.63e-2)" 1.2 4.0 16.6 1.0 18.1 0.9 0.9 50.9 50.7 1.0 2.4 1.8 1.0 1.3 5.4 1.0 2.3 2.2 1.1 0.9 21.4 6.8 1.0 0.9 0.9 0.9 2.1 21.1 0.9 10.3 0.9 3.2 1.0 2.0 1.4 1.4 0.0 1.2 4.4 0.9 1.0 1.2 5.5 2.0 1.0 1.3 1.9 1.2 0.0 1.0 0.0 0.9 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 4.4 0.6 0.0 0.0 0.0 0.0 0.4 0.1 12.5 6.7 5.2 0.6 0.4 0.4 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 18.1 50.9 34.6 21.4 6.8 2.1 21.1 2.0 1.2 0.0 0.0 0.0 0.1 0.0 16.2 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.9 0.0 0.3 1.1 1.7 0.0 0.1 0.0 0.0 0.1 SLC8A3 NCX3 ENSG00000100678 "Solute carrier family 8 member A3" P57103 14 70044217-70189070 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 17.0;skeletal muscle: 32.1" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 33.9" "Cancer enriched" "Detected in single" 8 "glioma: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.0;LHCN-M2: 7.3;SH-SY5Y: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.65e-1)" "unprognostic (5.53e-2)" "unprognostic (1.18e-2)" "unprognostic (1.51e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.69e-1)" "unprognostic (3.46e-3)" "unprognostic (4.74e-2)" "unprognostic (1.64e-1)" "unprognostic (1.45e-3)" "unprognostic (8.53e-2)" "unprognostic (5.86e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (3.38e-1)" 0.7 2.8 6.1 1.2 6.1 1.0 0.9 3.8 17.0 1.4 1.1 3.1 0.0 1.1 0.9 1.0 1.1 0.7 1.3 1.5 5.8 8.2 0.6 0.6 1.6 1.0 4.7 7.1 0.6 1.0 0.6 1.5 0.7 6.4 1.2 1.1 1.5 0.6 0.8 32.1 0.8 1.2 1.2 2.8 0.7 1.2 0.8 1.9 0.0 0.6 4.9 0.9 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 23.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 6.1 6.1 3.8 10.6 5.8 8.2 4.7 7.1 6.4 1.9 0.0 1.1 0.0 0.0 0.1 33.9 1.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 8.1 0.0 0.1 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC8B1 "FLJ22233, NCKX6, NCLX, SLC24A6" ENSG00000089060 "Solute carrier family 8 member B1" Q6J4K2 12 113298759-113359493 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sensory transduction, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040668 Approved NA NA "HPA040668: AB_10793861" "prognostic favorable (9.52e-4)" "unprognostic (1.58e-1)" "unprognostic (1.27e-1)" "unprognostic (4.30e-1)" "unprognostic (1.93e-2)" "unprognostic (2.80e-3)" "unprognostic (1.90e-1)" "unprognostic (6.52e-2)" "unprognostic (1.84e-1)" "unprognostic (2.68e-2)" "unprognostic (2.60e-1)" "unprognostic (5.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.54e-3)" "unprognostic (9.39e-2)" "unprognostic (1.14e-1)" "prognostic favorable (5.02e-4)" 12.6 43.9 7.2 15.0 9.5 12.0 11.0 5.5 7.8 11.8 11.1 9.0 7.9 7.7 9.0 10.9 9.3 7.2 10.4 9.2 6.5 3.7 10.6 18.6 12.2 26.2 8.2 4.5 35.1 13.2 5.5 9.3 15.5 7.0 10.0 7.5 6.2 10.4 9.6 7.1 11.2 14.1 9.3 9.6 20.8 7.6 13.9 8.0 29.5 8.2 8.1 14.4 8.4 10.8 3.1 11.4 18.5 14.7 3.3 18.8 8.4 12.4 2.7 1.6 3.6 8.5 5.9 5.4 4.0 12.6 5.7 5.6 2.9 10.4 3.4 9.4 5.9 4.9 10.1 5.2 3.0 2.7 7.8 1.5 6.4 6.1 3.1 14.1 16.7 14.4 6.0 9.0 6.5 2.8 4.9 13.0 12.6 13.5 1.7 3.2 2.8 5.1 13.5 2.9 4.3 7.1 1.9 2.2 3.9 6.1 17.7 0.1 2.9 11.8 23.8 2.8 2.4 3.7 6.6 26.9 3.9 4.7 11.2 2.5 2.1 5.0 2.5 4.9 9.4 3.1 2.4 9.6 18.5 5.0 14.7 6.4 2.2 9.2 4.9 11.4 3.1 18.8 8.6 6.3 3.3 14.1 8.5 10.9 8.4 7.2 9.5 5.5 7.8 6.5 3.7 8.2 4.5 7.0 8.0 11.9 13.0 4.2 11.4 3.9 1.1 3.3 7.6 4.0 7.9 12.2 9.8 7.1 5.0 11.7 1.3 9.0 25.1 0.0 15.3 7.2 8.7 13.6 20.8 10.2 20.0 0.0 4.7 3.7 16.4 1.3 22.7 20.0 1.7 15.4 12.0 3.2 17.9 13.6 26.5 3.2 0.7 32.3 11.3 0.7 3.8 6.1 8.9 7.5 9.3 15.3 SLC9A1 "APNH, NHE1, PPP1R143" ENSG00000090020 "Solute carrier family 9 member A1" P19634 1 27098815-27166981 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Deafness, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 60.7" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022371, HPA048532, HPA052891" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981" "unprognostic (6.18e-2)" "unprognostic (1.59e-1)" "unprognostic (2.21e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (7.47e-4)" "unprognostic (2.70e-2)" "unprognostic (4.33e-3)" "unprognostic (3.18e-2)" "unprognostic (9.74e-2)" "prognostic unfavorable (7.10e-4)" "unprognostic (3.44e-2)" "unprognostic (6.95e-2)" "unprognostic (2.05e-2)" "unprognostic (1.27e-2)" "unprognostic (1.60e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-2)" 7.1 11.3 7.5 9.9 10.1 7.3 8.4 11.7 18.9 8.7 14.0 5.0 26.9 20.7 10.6 6.8 10.3 7.1 24.4 13.4 4.6 5.3 7.3 2.4 11.2 5.8 5.0 6.7 6.9 6.4 13.4 8.0 42.5 14.8 8.5 10.2 10.1 60.7 55.4 3.8 9.2 24.7 8.1 3.9 10.5 45.6 8.3 4.9 6.0 8.0 6.5 9.0 18.8 8.4 0.9 0.6 5.5 1.5 0.4 4.2 1.8 13.7 4.7 4.5 4.5 10.2 7.4 27.6 11.3 17.3 9.9 10.8 5.7 9.0 6.2 9.7 14.7 4.8 17.2 4.4 28.0 6.2 7.4 4.1 9.5 3.1 2.4 31.1 5.5 7.2 9.2 13.6 16.7 23.3 7.2 16.4 4.4 2.6 6.1 14.5 8.2 2.8 2.9 6.2 17.0 9.8 5.1 4.0 2.9 5.2 20.8 5.2 1.6 9.5 13.0 5.7 4.8 6.0 3.5 17.6 10.6 4.2 9.8 6.2 5.5 3.5 1.8 11.3 6.2 6.1 0.1 1.5 1.5 1.9 0.9 4.2 0.2 2.2 2.0 0.6 0.9 1.4 1.7 5.5 0.4 1.5 0.1 0.8 1.8 7.5 10.1 11.7 18.9 4.6 5.3 5.0 6.7 14.8 4.9 6.0 17.9 5.2 16.2 27.7 6.3 11.3 10.2 0.0 3.4 10.4 0.0 30.0 0.0 8.5 26.9 7.1 52.0 0.0 10.9 16.2 11.0 8.8 26.5 1.0 11.5 19.1 12.0 8.0 4.9 9.7 8.6 6.6 6.8 1.8 12.3 10.8 19.4 22.0 12.4 1.3 3.6 6.5 8.7 1.4 3.4 22.0 44.3 6.7 14.3 16.3 SLC9A2 NHE2 ENSG00000115616 "Solute carrier family 9 member A2" Q9UBY0 2 102619707-102711318 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 16.8;intestine: 16.1;stomach 1: 19.8" "Cell type enhanced" "Detected in some" 10 "Early spermatids: 19.1;Enterocytes: 23.6;Late spermatids: 22.4;Mucus-secreting cells: 26.9;Paneth cells: 40.3;Undifferentiated cells: 31.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.8;OE19: 25.9;RT4: 11.9;SK-BR-3: 10.5;T-47d: 13.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035121, HPA035122" Approved Supported "Cell Junctions" NA NA "Cell Junctions" "HPA035121: AB_10602894, HPA035122: AB_2674477" "unprognostic (1.53e-2)" "unprognostic (8.05e-3)" "unprognostic (6.00e-2)" "unprognostic (3.00e-3)" "unprognostic (3.12e-1)" "unprognostic (1.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.86e-1)" "unprognostic (1.55e-1)" "unprognostic (1.23e-1)" "unprognostic (2.37e-2)" "unprognostic (1.97e-1)" "unprognostic (1.40e-3)" "unprognostic (1.60e-1)" "unprognostic (7.51e-2)" "unprognostic (1.39e-2)" "unprognostic (1.70e-1)" 0.2 0.4 0.9 10.8 1.4 0.0 1.0 0.5 1.9 1.0 15.0 0.6 8.4 4.6 0.2 5.8 0.5 0.2 16.8 0.2 1.5 1.0 4.6 0.2 0.2 0.0 0.9 0.7 0.2 0.2 0.1 1.7 0.0 1.8 4.5 16.1 0.9 3.7 11.7 4.4 1.3 9.5 0.4 1.3 0.2 19.8 5.3 0.6 1.0 0.6 1.8 3.1 2.8 0.2 0.0 0.0 0.3 0.0 0.3 0.1 0.0 6.8 4.3 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.1 0.0 2.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.3 2.1 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 5.3 0.0 0.0 0.1 25.9 3.6 0.0 0.0 0.0 0.8 11.9 0.0 0.0 0.0 10.5 0.0 0.0 13.2 0.0 0.0 0.0 0.5 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.9 1.4 0.5 1.9 1.5 1.0 0.9 0.7 1.8 0.6 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.0 0.0 8.7 0.0 0.4 0.0 0.2 19.1 0.0 23.6 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.0 9.4 0.0 0.0 22.4 0.6 0.0 0.0 0.0 26.9 0.5 4.9 40.3 0.0 1.0 0.0 0.0 0.3 0.7 0.1 0.5 0.2 0.0 31.4 0.7 SLC9A3 NHE3 ENSG00000066230 "Solute carrier family 9 member A3" P48764 5 470458-524332 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 65.8;intestine: 85.1;kidney: 43.6" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 1: 14.9;Club cells: 10.3;Collecting duct cells: 15.7;Proximal tubular cells: 38.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 28.2" "Region enriched" "Detected in single" 14 "cerebellum: 4.6" "Not detected" "Not detected" "HPA036493, HPA036669" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA036493: AB_10673353, HPA036669: AB_10670843" "unprognostic (1.27e-1)" "unprognostic (4.88e-1)" "unprognostic (9.35e-3)" "unprognostic (1.11e-1)" "unprognostic (2.37e-1)" "unprognostic (3.35e-1)" "unprognostic (2.51e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (8.49e-4)" "unprognostic (5.18e-2)" "unprognostic (1.29e-1)" "unprognostic (3.69e-2)" "unprognostic (3.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (1.24e-2)" "unprognostic (1.32e-1)" 0.6 0.6 0.5 16.2 1.0 0.0 0.6 4.2 0.9 0.9 27.5 0.7 1.1 12.7 0.9 3.4 2.4 0.8 65.8 0.6 0.6 0.6 43.6 0.5 0.5 0.9 0.9 0.7 0.8 1.1 0.6 0.9 0.5 1.2 1.4 2.3 1.2 2.1 0.8 0.7 4.2 85.1 1.1 0.6 0.5 22.7 1.1 0.5 0.6 0.7 2.4 2.7 0.8 2.0 1.9 2.0 0.2 1.2 3.5 6.8 2.9 4.2 3.8 7.0 7.4 1.7 2.0 5.5 4.2 2.5 5.2 3.3 9.3 4.9 10.2 5.5 1.9 3.8 7.0 3.9 2.5 2.5 28.2 7.3 4.6 16.5 3.4 2.6 3.4 5.9 2.7 5.2 2.3 3.5 2.6 1.5 4.2 6.1 5.4 1.8 6.6 3.7 16.7 2.6 12.2 6.3 5.6 6.6 5.3 1.8 3.6 7.9 3.3 12.6 3.5 2.6 3.2 8.0 2.7 1.9 6.0 5.3 4.1 2.7 9.1 3.6 5.8 3.8 15.3 3.8 0.0 1.2 0.1 4.3 0.5 3.8 1.6 5.6 4.1 1.4 1.9 6.8 5.2 0.2 3.5 0.4 2.0 4.2 2.9 0.5 1.0 4.2 0.9 0.6 0.6 0.9 0.7 1.2 0.5 14.9 4.3 0.0 0.0 0.0 0.0 0.6 0.0 5.3 10.3 15.7 0.0 0.0 5.0 7.5 0.0 0.0 1.0 0.0 7.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 8.2 0.0 0.0 6.5 0.0 0.0 38.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC9A4 NHE4 ENSG00000180251 "Solute carrier family 9 member A4" Q6AI14 2 102473303-102533972 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9" "Cell type enriched" "Detected in some" 8 "Collecting duct cells: 24.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 3.9;OE19: 11.4;RT4: 7.1" "Group enriched" "Detected in some" 18 "hippocampal formation: 11.6;olfactory region: 8.3" "Not detected" "Not detected" HPA036096 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA036096: AB_2674939" "unprognostic (1.41e-1)" "unprognostic (3.76e-2)" "unprognostic (9.31e-2)" "unprognostic (3.09e-3)" "unprognostic (7.58e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (5.35e-1)" "unprognostic (9.44e-3)" "unprognostic (3.26e-2)" "unprognostic (1.30e-1)" "unprognostic (2.46e-2)" "unprognostic (3.12e-1)" "unprognostic (5.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.98e-2)" 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.3 0.0 1.1 0.1 0.0 1.3 0.1 23.2 0.2 0.1 0.1 12.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.7 0.0 0.0 3.7 2.4 0.7 0.2 0.2 0.0 0.1 0.1 33.9 0.3 0.0 0.2 0.1 0.5 0.4 0.6 0.2 1.5 0.9 1.8 0.8 1.2 1.2 0.1 0.2 0.2 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.4 0.1 2.4 0.0 0.3 0.3 0.0 0.0 0.0 3.9 0.1 0.2 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.9 0.0 0.4 0.1 0.1 1.1 11.4 0.4 0.2 0.5 0.3 0.0 7.1 0.2 0.2 0.1 0.4 0.0 0.3 0.2 0.1 0.5 0.4 1.1 0.7 0.2 0.2 0.2 0.0 0.5 0.1 0.1 1.6 0.7 1.1 1.2 0.6 0.8 0.8 0.9 0.9 0.5 1.5 1.0 1.2 1.8 1.2 0.8 0.9 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 3.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 2.7 1.2 24.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 SLC9A5 NHE5 ENSG00000135740 "Solute carrier family 9 member A5" Q14940 16 67237683-67272190 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5;lymphoid tissue: 14.5" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 15.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-138 MG: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041004, HPA041329" Uncertain Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA041004: AB_10794433, HPA041329: AB_10794373" "unprognostic (8.90e-2)" "unprognostic (9.70e-2)" "unprognostic (3.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (5.17e-2)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-3)" "unprognostic (4.84e-2)" "unprognostic (9.85e-11)" "unprognostic (9.21e-2)" "unprognostic (1.95e-1)" "unprognostic (8.12e-3)" "unprognostic (9.07e-2)" 1.7 1.7 2.9 1.1 8.8 0.5 1.1 13.5 8.6 0.9 1.4 0.5 3.6 1.3 1.1 3.2 0.6 0.6 1.9 2.3 2.9 3.6 1.1 0.6 2.9 2.1 2.1 2.3 1.4 1.5 0.5 0.6 1.7 4.3 1.0 1.1 0.5 1.0 2.5 1.7 4.2 0.9 0.6 2.7 14.5 0.8 3.3 1.2 0.0 1.0 0.0 1.3 1.6 0.4 1.5 0.8 1.0 0.5 0.6 0.9 0.1 0.5 4.1 3.7 1.2 6.8 4.7 0.4 1.3 5.8 3.4 3.1 0.2 2.9 0.0 0.8 1.6 1.7 0.2 1.0 0.7 1.3 1.2 1.2 3.2 0.3 0.9 0.8 1.4 6.7 5.3 1.4 1.9 0.4 6.3 0.7 1.2 0.7 1.9 2.2 2.3 0.1 0.3 2.5 0.2 0.4 0.0 0.8 0.9 0.6 0.7 2.1 0.9 3.5 0.2 1.8 0.9 1.4 0.3 1.0 8.8 1.4 1.6 0.6 3.6 0.9 1.8 6.3 0.7 2.2 0.0 0.4 0.0 0.0 0.0 0.6 1.5 0.4 0.9 0.1 0.0 0.4 0.4 1.0 0.6 0.5 0.8 0.0 0.1 2.9 8.8 13.5 8.6 2.9 3.6 2.1 2.3 4.3 1.2 3.0 3.2 0.0 0.1 0.6 1.9 1.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.1 0.6 0.4 0.0 0.0 0.1 15.9 1.2 2.5 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.3 0.4 0.0 2.1 0.0 0.6 0.0 0.7 1.7 1.1 0.6 0.0 0.0 0.2 0.1 SLC9A6 "KIAA0267, NHE6" ENSG00000198689 "Solute carrier family 9 member A6" Q92581 X 135973841-136047269 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.1" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059445, HPA059590" Enhanced Supported Vesicles NA NA Vesicles "HPA059445: AB_2684021, HPA059590: AB_2684075" "unprognostic (1.35e-1)" "unprognostic (8.28e-3)" "unprognostic (4.36e-1)" "unprognostic (4.93e-2)" "unprognostic (1.84e-1)" "unprognostic (1.19e-1)" "unprognostic (2.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (7.07e-2)" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (4.49e-2)" "unprognostic (5.06e-2)" 4.3 5.7 16.4 4.7 27.6 4.0 3.1 15.3 35.1 5.2 5.2 7.8 1.6 7.5 5.7 3.2 5.6 5.2 4.8 7.2 19.1 24.3 6.2 3.9 5.7 4.7 15.0 15.6 7.4 3.3 9.3 8.6 4.0 22.3 3.6 5.5 4.6 3.3 4.6 5.5 4.1 6.5 6.5 9.5 4.8 5.2 5.1 4.0 3.6 5.9 1.7 5.8 4.7 3.2 5.3 6.8 3.2 8.4 5.9 13.9 6.0 13.2 7.0 7.4 2.7 10.5 10.2 13.3 10.7 11.5 9.2 19.5 6.1 10.6 9.9 24.4 12.3 13.7 7.9 9.6 9.6 13.4 7.7 8.7 2.7 11.2 3.6 5.5 7.7 9.4 5.6 8.5 15.2 7.5 6.6 7.8 9.7 4.9 14.1 10.1 5.8 10.2 2.2 4.2 4.9 9.5 6.9 11.0 10.0 6.6 6.6 6.6 5.0 7.7 0.8 6.2 6.6 3.2 6.0 11.1 11.5 8.2 17.0 13.7 6.8 15.1 8.7 7.0 13.2 6.4 2.2 6.0 3.2 8.1 8.4 13.9 5.3 9.5 7.9 6.8 4.0 10.6 7.9 2.6 5.9 6.6 4.3 8.0 6.0 16.4 27.6 15.3 25.9 19.1 24.3 15.0 15.6 22.3 4.0 3.0 4.8 4.2 1.3 6.6 13.4 8.1 17.8 0.0 1.2 12.2 7.9 2.2 0.0 4.0 0.6 4.6 8.0 0.0 5.1 2.1 4.7 2.1 1.1 7.8 8.9 46.1 10.3 8.6 12.9 0.9 5.2 8.8 8.5 2.8 3.4 13.2 4.6 5.8 4.2 4.9 7.0 0.0 4.9 5.0 12.3 5.9 2.4 7.7 5.0 2.2 SLC9A7 NHE7 ENSG00000065923 "Solute carrier family 9 member A7" Q96T83 X 46599252-46759172 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Potassium transport, Sodium transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 42.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048938, HPA075385" Approved Supported Vesicles NA NA Vesicles "HPA048938: AB_2680565, HPA075385: AB_2686747" "unprognostic (2.77e-1)" "unprognostic (4.68e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (8.58e-4)" "prognostic unfavorable (8.14e-4)" "unprognostic (2.16e-2)" "unprognostic (2.73e-3)" "unprognostic (5.26e-3)" "unprognostic (1.28e-2)" "unprognostic (9.25e-2)" "unprognostic (5.30e-2)" "unprognostic (1.11e-1)" "unprognostic (2.08e-1)" "unprognostic (7.20e-2)" "unprognostic (2.62e-1)" "unprognostic (1.57e-1)" "unprognostic (1.13e-1)" 1.7 7.2 4.4 3.8 42.0 4.4 7.9 7.0 12.4 1.8 1.2 1.8 1.2 1.7 1.2 3.8 3.2 2.5 2.2 2.3 3.3 7.1 3.3 4.1 1.8 7.8 3.6 4.3 6.3 4.6 11.5 13.6 1.4 12.7 6.5 1.3 2.3 7.3 2.9 10.0 2.9 2.7 1.0 2.7 4.7 8.2 1.3 8.2 2.8 6.9 1.7 8.2 2.3 2.2 4.3 6.0 2.1 0.6 1.4 0.7 0.5 7.0 5.4 0.8 2.4 0.9 5.4 3.1 6.7 8.4 4.0 3.3 5.5 7.7 15.5 2.1 10.7 7.9 3.3 5.2 7.6 7.4 8.1 2.8 1.6 2.1 2.2 3.3 0.7 12.8 3.4 1.0 11.4 7.6 19.2 5.7 5.4 0.1 0.3 5.5 10.6 1.7 0.8 3.7 3.4 6.5 6.9 0.3 0.2 3.1 7.9 5.8 0.7 3.4 5.2 1.5 6.8 6.9 0.3 0.3 8.7 2.9 1.3 3.9 1.6 0.4 7.8 12.3 0.1 2.8 1.0 0.6 0.3 0.6 0.6 0.4 3.4 0.7 0.3 2.4 4.3 0.4 0.5 2.1 1.4 0.6 6.0 0.7 0.5 4.4 42.0 7.0 8.3 3.3 7.1 3.6 4.3 12.7 8.2 3.0 8.0 17.9 7.5 0.6 10.1 4.5 2.5 0.0 3.4 15.7 3.9 5.5 0.0 15.3 0.0 0.5 0.0 0.0 12.2 0.3 0.4 18.2 0.0 4.9 6.6 12.7 2.4 0.6 4.7 0.4 0.9 9.1 1.7 9.0 1.0 6.6 12.5 0.0 0.4 1.7 3.4 6.5 0.8 0.0 0.9 0.9 6.1 0.5 0.8 11.2 SLC9A8 "KIAA0939, NHE8" ENSG00000197818 "Solute carrier family 9 member A8" Q9Y2E8 20 49812713-49892242 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-BR-3: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033682 Approved NA NA "CAB033682: AB_2270441" "unprognostic (1.90e-1)" "unprognostic (1.90e-1)" "unprognostic (6.11e-2)" "unprognostic (2.73e-2)" "unprognostic (2.58e-1)" "unprognostic (1.29e-2)" "unprognostic (4.49e-2)" "unprognostic (3.22e-1)" "unprognostic (3.96e-2)" "unprognostic (5.89e-2)" "unprognostic (1.60e-2)" "unprognostic (2.32e-1)" "unprognostic (2.19e-2)" "unprognostic (1.96e-2)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (5.28e-2)" 9.0 14.0 7.6 11.4 13.9 29.8 8.9 10.3 15.1 8.4 9.1 14.0 7.7 9.7 12.2 10.6 16.0 8.6 9.4 6.8 7.3 7.8 8.4 16.2 9.5 10.6 6.6 8.0 7.2 13.5 11.7 12.4 7.2 11.9 9.1 9.0 15.4 13.7 7.9 19.5 7.3 9.8 9.0 8.1 13.9 12.8 19.6 5.8 13.6 11.9 8.4 18.6 11.4 7.6 2.2 1.4 7.1 1.7 0.8 2.5 1.4 4.3 7.9 3.5 3.5 4.5 2.9 9.0 4.5 6.1 8.6 4.1 5.6 9.8 5.2 5.8 6.4 7.0 9.7 3.7 4.5 4.4 4.5 2.0 2.5 5.0 2.8 6.3 4.5 6.3 5.4 5.2 4.5 9.2 4.5 3.6 6.9 4.9 5.4 5.2 4.7 4.1 3.1 2.9 6.5 3.7 3.1 4.2 3.7 5.1 4.7 3.6 3.1 7.4 27.8 5.6 2.5 9.0 7.5 5.5 11.7 6.5 5.7 4.3 8.3 3.6 3.8 16.0 6.1 4.8 2.8 1.4 3.6 2.3 1.1 2.5 1.6 1.7 2.0 1.4 2.2 1.8 1.1 7.1 0.8 1.7 0.7 1.2 1.4 7.6 13.9 10.3 15.1 7.3 7.8 6.6 8.0 11.9 5.8 11.9 9.1 3.0 3.8 2.3 5.5 4.4 2.5 12.0 11.4 3.5 13.7 4.9 1.7 5.1 2.1 4.3 10.5 0.0 5.5 3.3 3.3 6.3 21.9 13.9 4.4 6.4 6.4 6.2 10.0 5.3 3.4 4.1 1.7 4.6 7.1 5.2 7.7 6.0 4.6 3.5 9.5 0.0 3.4 6.5 6.5 1.6 2.9 6.9 6.6 6.7 SLC9A9 "FLJ35613, NHE9" ENSG00000181804 "Solute carrier family 9 member A9" Q8IVB4 3 143265222-143848531 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 23.3;Hofbauer cells: 42.3;Ito cells: 25.2;Kupffer cells: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 10.6;ASC TERT1: 13.8;HSkMC: 9.6;Karpas-707: 33.4;RPMI-8226: 15.5;U-266/70: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058234 Approved NA NA 41000 "HPA058234: AB_2683648" "unprognostic (8.22e-2)" "unprognostic (6.88e-2)" "unprognostic (7.23e-3)" "unprognostic (1.65e-1)" "unprognostic (3.65e-2)" "unprognostic (7.05e-2)" "unprognostic (1.24e-1)" "prognostic favorable (8.18e-4)" "unprognostic (2.66e-1)" "unprognostic (1.35e-3)" "unprognostic (7.73e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (5.57e-7)" "unprognostic (5.01e-2)" "unprognostic (4.69e-2)" "unprognostic (1.56e-1)" "unprognostic (4.28e-2)" 17.4 8.4 16.8 11.4 25.9 2.7 7.7 4.5 17.2 10.6 9.6 17.2 2.0 4.5 6.2 5.7 18.0 9.2 13.4 8.2 14.7 11.7 3.7 9.9 8.3 17.5 23.0 7.4 11.8 2.2 1.9 6.5 21.3 18.3 12.9 8.6 4.6 7.1 12.8 3.5 10.3 9.3 12.1 27.5 16.9 7.3 2.9 24.1 10.7 5.7 7.1 17.8 17.3 10.8 4.4 8.7 0.7 10.8 3.9 9.3 4.7 0.3 0.3 0.4 0.5 10.6 13.8 0.1 0.5 3.5 0.2 1.7 0.0 0.1 1.6 0.1 1.6 0.9 0.4 0.5 1.0 0.4 6.8 0.1 0.9 0.2 0.0 1.2 0.4 0.7 9.6 2.8 0.3 0.5 0.6 0.1 1.2 0.0 33.4 2.2 0.0 0.8 0.0 0.1 0.0 0.2 1.3 0.1 15.5 0.0 0.2 0.2 0.0 0.8 0.0 0.0 0.2 0.1 0.3 0.0 1.3 0.3 1.5 0.7 15.6 0.0 0.0 2.3 0.2 0.6 0.1 6.6 0.7 5.2 10.8 4.5 3.7 5.5 8.1 8.7 4.4 3.1 4.6 0.5 3.9 9.2 0.6 9.3 4.7 16.8 25.9 4.5 17.2 14.7 11.7 23.0 7.4 18.3 24.1 0.0 1.4 3.7 9.4 3.3 0.1 1.1 0.0 1.4 2.3 3.5 2.0 0.4 0.0 0.8 3.9 2.8 0.0 23.3 0.2 0.3 9.4 12.5 0.0 0.0 42.3 0.0 0.0 25.2 24.1 2.7 8.6 9.6 6.8 19.8 0.0 3.7 1.0 0.0 6.7 0.4 0.0 0.0 3.1 0.2 0.2 4.4 0.9 10.2 0.0 4.8 SLC9B1 "NHA1, NHEDC1" ENSG00000164037 "Solute carrier family 9 member B1" Q4ZJI4 4 102885048-103019739 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Fertilization, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 43.1" "Group enriched" "Detected in many" 7 "Early spermatids: 118.1;Late spermatids: 86.8;Spermatocytes: 121.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA058971, HPA065520" Supported "Centriolar satellite,Mitochondria" NA NA Mitochondria "Centriolar satellite" "HPA058971: AB_2683865, HPA065520: AB_2685502" "unprognostic (4.87e-3)" "unprognostic (2.38e-1)" "unprognostic (1.18e-1)" "unprognostic (8.26e-4)" "unprognostic (2.53e-1)" "unprognostic (3.39e-1)" "unprognostic (5.06e-4)" "unprognostic (5.85e-2)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.07e-3)" "unprognostic (7.68e-2)" "unprognostic (3.03e-2)" "unprognostic (3.33e-1)" "unprognostic (1.85e-1)" "unprognostic (5.66e-5)" "unprognostic (5.78e-2)" 1.1 1.1 1.1 1.1 3.1 0.9 0.9 1.4 2.0 0.9 0.8 3.7 0.0 0.8 2.6 2.3 0.7 0.9 1.6 0.9 1.6 1.0 0.8 0.7 1.1 2.4 2.4 1.1 1.5 1.3 1.2 2.4 0.9 3.1 1.1 0.8 2.8 0.7 0.9 0.7 1.9 0.8 0.7 4.4 1.0 0.8 43.1 2.3 4.2 1.1 0.0 1.7 1.2 0.9 2.0 1.9 0.6 0.6 0.4 4.9 0.6 0.4 0.0 2.2 3.3 4.4 3.3 0.7 0.8 1.1 0.0 0.2 0.0 0.2 1.7 0.6 1.7 0.7 0.0 1.7 0.9 1.5 3.2 2.3 2.5 2.0 0.0 0.0 0.7 0.5 0.5 1.0 0.0 1.8 0.9 1.3 4.5 1.2 1.7 1.7 1.3 1.0 2.2 0.8 0.5 0.0 2.7 1.8 0.5 0.9 0.5 2.1 5.0 0.6 0.8 2.5 1.5 0.4 1.7 0.7 0.9 0.3 1.0 1.1 5.5 4.0 1.4 1.2 1.0 2.4 0.6 0.6 0.1 1.5 0.4 1.7 1.8 1.2 1.8 0.7 2.0 4.9 2.8 0.3 0.4 0.3 1.9 1.7 0.6 1.1 3.1 1.4 2.0 1.6 1.0 2.4 1.1 3.1 2.3 3.0 1.0 1.9 0.5 1.1 1.9 0.8 0.0 0.0 0.0 0.0 15.7 0.4 1.7 0.3 118.1 0.7 0.0 0.0 0.4 0.2 1.5 0.8 0.0 0.0 1.1 3.2 0.0 0.6 4.1 86.8 4.9 0.8 1.7 1.8 0.0 2.7 0.7 0.0 2.8 0.6 5.0 0.0 1.4 121.2 8.1 0.5 0.5 1.0 0.0 0.5 SLC9B2 "FLJ23984, NHA2, NHEDC2" ENSG00000164038 "Solute carrier family 9 member B2" Q86UD5 4 103019868-103085829 "Predicted membrane proteins, Transporters" "Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.6" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 25.5;Exocrine glandular cells: 60.7;Hepatocytes: 33.1;Pancreatic endocrine cells: 60.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047008 Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "HPA047008: AB_2679901" "unprognostic (1.85e-1)" "unprognostic (5.43e-2)" "unprognostic (2.68e-1)" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.43e-2)" "unprognostic (3.78e-2)" "unprognostic (3.26e-1)" "unprognostic (2.53e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (2.51e-5)" "unprognostic (2.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (2.35e-5)" 7.3 7.9 8.8 6.3 13.3 5.3 5.5 16.5 24.5 5.6 5.0 5.2 0.4 2.0 8.5 4.2 4.7 5.9 9.8 5.5 8.9 12.5 1.9 45.6 3.3 7.2 10.3 13.4 8.0 2.4 1.2 8.8 5.2 20.8 5.6 3.9 8.3 2.1 6.7 4.5 3.7 3.0 9.8 9.8 4.6 5.7 4.8 4.7 2.5 2.6 1.8 6.9 5.5 8.5 5.6 1.7 0.0 0.1 12.2 6.3 1.8 2.6 1.3 3.1 6.5 15.7 13.1 0.0 12.0 4.8 2.0 1.9 1.3 1.7 16.9 2.1 13.9 2.7 0.8 7.1 5.0 2.8 14.8 4.9 16.9 4.2 12.2 8.4 11.8 5.3 11.5 6.8 4.2 14.7 6.7 8.6 4.8 5.7 12.4 6.2 1.0 9.5 7.3 2.4 0.0 3.8 0.0 3.4 7.4 5.8 1.0 10.8 9.7 5.4 1.4 3.5 0.9 1.5 7.9 10.5 4.5 2.7 7.0 4.1 10.6 7.6 12.3 5.3 10.4 1.7 0.0 0.1 0.0 5.1 0.0 6.3 5.6 5.6 4.5 0.9 3.6 3.4 4.2 0.0 12.2 0.1 1.7 2.4 1.8 8.8 13.3 16.5 21.2 8.9 12.5 10.3 13.4 20.8 4.7 0.0 0.3 6.5 2.6 4.2 8.9 2.4 7.6 0.0 1.2 0.0 25.5 0.3 0.0 5.5 10.6 8.7 0.0 0.0 60.7 2.0 8.8 2.0 1.1 33.1 1.3 7.9 2.9 4.3 1.5 5.0 5.2 2.3 10.1 6.4 0.6 0.6 60.5 0.0 4.9 1.0 2.0 6.5 10.5 1.8 4.3 3.3 0.2 4.6 0.0 0.9 SLC9C1 "NHE, SLC9A10" ENSG00000172139 "Solute carrier family 9 member C1" Q4G0N8 3 112140887-112294258 "Predicted membrane proteins, Transporters" "Antiport, Differentiation, Ion transport, Sodium transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 25.5" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "AF22: 1.0;HaCaT: 1.5;Karpas-707: 1.0;REH: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (4.79e-2)" "unprognostic (2.92e-1)" "unprognostic (1.57e-3)" "unprognostic (9.56e-2)" "unprognostic (3.92e-2)" "unprognostic (1.24e-1)" "unprognostic (4.40e-2)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.98e-2)" "unprognostic (1.65e-2)" "unprognostic (8.32e-2)" "unprognostic (5.89e-2)" "unprognostic (9.62e-3)" "unprognostic (3.25e-1)" 0.3 0.1 0.1 1.4 0.2 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.4 0.0 0.2 0.1 0.1 0.3 1.7 0.5 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.3 1.2 0.0 0.8 0.7 0.4 0.1 0.1 0.3 0.2 1.1 0.1 4.0 1.0 0.2 0.3 0.4 0.3 25.5 0.0 1.0 0.5 0.5 0.4 0.3 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.5 0.3 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.4 0.0 0.3 0.0 0.0 0.0 SLC9C2 "MGC43026, SLC9A11" ENSG00000162753 "Solute carrier family 9 member C2 (putative)" Q5TAH2 1 173500464-173603094 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 24.9" "Cell type enhanced" "Detected in some" 13 "Club cells: 2.3;Cone photoreceptor cells: 5.9;Early spermatids: 4.2;Late spermatids: 2.3;Spermatocytes: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.7" "Group enriched" "Detected in some" 4 "BEWO: 1.8;THP-1: 3.7" "Low region specificity" "Detected in all" "HPA059122, HPA079529" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA059122: , HPA079529: " "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (8.52e-2)" "unprognostic (5.88e-3)" "unprognostic (3.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-3)" "unprognostic (1.19e-1)" "unprognostic (4.21e-2)" "unprognostic (4.92e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-6)" "unprognostic (1.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.98e-1)" "unprognostic (1.81e-1)" 0.4 0.1 0.3 0.0 1.3 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.5 0.0 0.1 0.4 0.0 1.7 0.0 0.1 0.5 0.3 0.2 0.0 0.4 0.1 0.0 0.4 0.8 0.3 0.1 0.4 0.5 0.5 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.1 0.3 1.0 0.3 24.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 1.3 0.0 1.6 0.5 0.3 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.3 0.0 5.9 0.1 0.0 0.0 4.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.4 0.0 0.1 0.0 0.0 0.0 SLCO1A2 "OATP, OATP-A, OATP1A2, SLC21A3" ENSG00000084453 "Solute carrier organic anion transporter family member 1A2" P46721 12 21264600-21419594 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5" "Cell type enriched" "Detected in some" 9 "Alveolar cells type 1: 32.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 13.3;RPMI-8226: 9.2;SuSa: 14.2;U-266/70: 19.8;U-266/84: 8.0" "Low region specificity" "Detected in all" HPA071152 Supported "Plasma membrane" No No "Plasma membrane" "HPA071152: AB_2686350" "unprognostic (5.43e-3)" "unprognostic (2.33e-1)" "unprognostic (1.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.53e-1)" "unprognostic (3.82e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (8.82e-2)" "unprognostic (1.66e-4)" "unprognostic (2.52e-2)" "unprognostic (3.20e-1)" "unprognostic (1.24e-1)" 0.2 0.1 3.3 0.0 3.4 0.0 3.6 3.4 17.9 0.1 0.1 1.9 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.9 4.1 2.5 1.1 11.2 2.7 0.6 3.0 4.0 0.2 2.3 0.5 0.5 1.2 9.7 0.7 0.0 14.2 14.5 0.0 0.4 0.4 0.2 0.0 2.9 0.4 0.4 1.6 1.4 0.0 0.3 0.0 0.3 0.4 0.1 1.3 0.7 4.3 0.4 1.1 2.3 0.2 2.0 0.5 0.8 0.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 2.9 1.7 0.1 2.1 0.1 0.0 0.2 0.2 0.1 0.4 0.5 0.7 0.0 0.4 1.1 0.0 0.3 0.2 0.0 1.3 0.1 0.1 1.2 0.1 0.4 3.4 1.4 0.0 2.0 0.3 0.1 13.3 1.5 0.1 0.1 0.2 9.2 0.0 2.0 1.8 2.3 0.0 0.2 0.2 14.2 2.6 0.7 0.0 0.0 1.4 0.6 0.3 19.8 8.0 0.1 0.2 0.2 0.1 0.6 0.4 0.3 1.4 0.3 2.3 1.3 2.2 1.5 0.1 1.0 2.1 1.6 4.3 1.1 0.1 0.7 1.8 0.2 3.3 3.4 3.4 5.0 4.1 2.5 3.0 4.0 9.7 1.4 32.8 1.9 0.0 0.0 0.0 0.0 0.4 0.0 2.7 0.0 1.8 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 0.0 SLCO1B1 "LST-1, OATP-C, OATP1B1, SLC21A6" ENSG00000134538 "Solute carrier organic anion transporter family member 1B1" Q9Y6L6 12 21131202-21239246 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 618 "liver: 121.0" "Cell type enriched" "Detected in some" 39 "Hepatocytes: 71.0" "Cancer enriched" "Detected in some" 96 "liver cancer: 52.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.2;A549: 1.9;HeLa: 2.9;NTERA-2: 2.6;RPMI-8226: 3.5;SuSa: 5.6" HPA050892 Supported NA NA "HPA050892: AB_2681265" "unprognostic (5.45e-1)" "unprognostic (1.82e-4)" "unprognostic (2.43e-3)" "unprognostic (1.96e-3)" "unprognostic (1.80e-1)" "unprognostic (2.41e-1)" "unprognostic (8.82e-2)" "unprognostic (5.63e-2)" "unprognostic (3.86e-2)" "unprognostic (3.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.6 0.0 0.7 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.6 0.8 0.0 0.4 0.0 0.8 0.0 0.0 1.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.0 0.0 0.0 0.0 1.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SLCO1B3 "OATP1B3, OATP8, SLC21A8" ENSG00000111700 "Solute carrier organic anion transporter family member 1B3" Q9NPD5 12 20810702-20916911 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 88.1" "Cell type enriched" "Detected in some" 20 "Hepatocytes: 91.8" "Cancer enhanced" "Detected in many" "liver cancer: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 35.8;A549: 9.8;CAPAN-2: 7.1;GAMG: 7.8;HeLa: 8.1;PC-3: 9.8;U-2 OS: 8.5" "HPA004943, HPA050892" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA004943: AB_1854758, HPA050892: AB_2681265" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (6.95e-2)" "unprognostic (1.63e-2)" "unprognostic (1.89e-2)" "unprognostic (7.09e-2)" "unprognostic (3.08e-2)" "unprognostic (1.54e-2)" "unprognostic (7.37e-2)" "unprognostic (1.50e-1)" "unprognostic (6.61e-3)" "unprognostic (2.36e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 88.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.1 0.0 2.5 0.0 7.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 91.8 0.0 0.0 0.0 0.6 1.9 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 SLCO1B7 "LST3, SLC21A21" ENSG00000205754 "Solute carrier organic anion transporter family member 1B7 (putative)" G3V0H7 12 21015696-21092745 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "breast: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.0;A549: 4.1;CAPAN-2: 4.4;HeLa: 4.2;U-2 OS: 3.0" HPA050892 Uncertain NA NA "HPA050892: AB_2681265" "unprognostic (8.82e-3)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 28.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.0 4.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 1.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.4 0.2 0.7 0.6 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 3.0 0.5 0.3 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLCO1C1 "OATP-F, OATP1, OATP1C1, SLC21A14" ENSG00000139155 "Solute carrier organic anion transporter family member 1C1" Q9NYB5 12 20695355-20753386 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 32.4;retina: 15.3" "Group enriched" "Detected in some" 4 "Early spermatids: 5.8;Late spermatids: 10.3;Muller glia cells: 4.9" "Cancer enriched" "Detected in single" 17 "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "HeLa: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.15e-1)" "unprognostic (8.18e-4)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (4.64e-1)" "unprognostic (3.16e-2)" "unprognostic (1.76e-1)" "unprognostic (7.32e-2)" "unprognostic (8.89e-2)" "unprognostic (1.23e-1)" "unprognostic (4.38e-2)" "unprognostic (2.70e-2)" "unprognostic (2.37e-4)" "unprognostic (1.56e-3)" "unprognostic (1.51e-1)" "unprognostic (3.35e-1)" "unprognostic (1.76e-2)" 3.5 1.2 11.6 1.0 16.2 0.9 1.2 1.1 32.4 0.9 1.4 6.2 0.0 1.1 0.9 1.3 1.2 0.9 2.1 1.5 10.4 2.8 1.1 0.9 1.2 1.2 6.5 8.0 0.9 1.0 1.5 5.5 1.0 20.3 1.0 1.3 15.3 1.1 1.0 0.9 1.2 1.6 1.2 4.9 0.9 1.0 3.3 8.1 0.0 1.7 0.2 1.4 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 16.2 1.1 11.5 10.4 2.8 6.5 8.0 20.3 8.1 0.0 0.0 0.0 0.0 0.1 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 10.3 1.7 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.4 0.0 0.1 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 SLCO2A1 "MATR1, OATP2A1, PGT, SLC21A2" ENSG00000174640 "Solute carrier organic anion transporter family member 2A1" Q92959 3 133932696-134052184 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 112.9;seminal vesicle: 147.1" "Group enriched" "Detected in many" 5 "Endothelial cells: 38.0;Ito cells: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 15 "dendritic cells: 1.5" "Cell line enriched" "Detected in some" 4 "EFO-21: 45.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA013742 Enhanced NA NA "HPA013742: AB_2668877" "unprognostic (4.39e-3)" "unprognostic (2.84e-1)" "unprognostic (1.33e-1)" "prognostic favorable (9.69e-4)" "unprognostic (8.53e-2)" "unprognostic (2.32e-3)" "prognostic favorable (9.24e-5)" "unprognostic (1.92e-1)" "unprognostic (1.29e-1)" "unprognostic (7.60e-2)" "unprognostic (2.04e-2)" "unprognostic (6.87e-2)" "unprognostic (5.63e-3)" "prognostic unfavorable (3.25e-4)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (3.07e-2)" 9.3 14.7 1.0 6.0 1.0 0.0 6.2 0.4 1.6 13.9 8.1 1.5 112.9 3.7 18.4 4.5 7.8 11.5 15.3 10.1 0.7 0.5 32.9 4.2 56.8 10.6 0.7 1.2 7.2 9.2 16.1 6.5 40.3 1.8 13.7 7.2 15.1 8.2 147.1 1.5 4.5 10.1 13.6 3.0 17.7 8.3 3.0 0.6 4.6 33.6 8.6 9.0 10.5 7.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 2.0 0.2 0.0 0.0 0.0 0.0 45.0 0.4 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 1.2 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 2.8 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 2.1 0.7 0.0 1.9 0.0 0.0 10.5 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.0 1.0 0.4 1.6 0.7 0.5 0.7 1.2 1.8 0.6 0.0 4.5 3.2 8.7 4.5 0.0 2.2 2.5 1.4 2.3 3.5 0.0 0.2 0.0 0.9 0.6 38.0 7.4 0.0 2.9 2.0 1.0 1.5 1.1 0.2 0.2 0.0 1.2 74.3 1.0 0.8 0.3 0.2 0.0 0.0 1.5 0.0 10.3 3.6 0.0 1.7 0.0 0.0 1.0 0.5 0.2 1.5 0.7 0.0 0.4 2.0 SLCO2B1 "OATP-B, OATP2B1, SLC21A9" ENSG00000137491 "Solute carrier organic anion transporter family member 2B1" O94956 11 75100563-75206549 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 98.1" "Group enriched" "Detected in many" 5 "Hepatocytes: 171.3;Hofbauer cells: 103.0;Kupffer cells: 116.2;Macrophages: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 36.0;GAMG: 8.9;Hep G2: 8.1;HMC-1: 10.9;OE19: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020659 Uncertain NA NA "HPA020659: AB_1857219" "unprognostic (8.25e-2)" "unprognostic (5.30e-2)" "unprognostic (2.02e-2)" "unprognostic (3.57e-1)" "unprognostic (3.40e-1)" "unprognostic (1.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (2.00e-3)" "unprognostic (1.99e-1)" "unprognostic (2.09e-1)" "unprognostic (9.75e-3)" "unprognostic (2.54e-2)" "unprognostic (4.57e-3)" "unprognostic (1.04e-1)" "unprognostic (3.87e-2)" 21.4 15.2 15.0 13.4 23.1 1.4 7.8 4.8 15.8 8.6 12.9 22.8 0.8 18.0 5.8 7.7 8.8 8.3 12.3 7.1 15.6 11.9 9.6 98.1 24.9 21.4 23.9 7.4 4.9 9.6 3.7 4.0 18.3 17.7 4.9 10.4 9.1 6.3 4.7 2.6 3.0 21.2 10.9 24.1 23.6 6.5 4.4 21.3 4.0 6.8 3.6 11.8 12.5 4.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.4 0.0 5.9 0.3 8.1 0.0 0.4 10.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.1 3.6 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 1.0 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.6 0.6 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 23.1 4.8 15.8 15.6 11.9 23.9 7.4 17.7 21.3 0.0 12.8 1.5 0.0 1.6 1.6 2.0 20.4 1.4 3.4 0.0 0.0 0.6 1.7 0.0 2.4 12.9 20.2 0.0 0.2 2.1 1.8 0.0 23.0 171.3 103.0 0.0 0.0 3.1 116.2 1.1 10.0 55.1 0.0 3.6 4.4 0.3 0.1 14.0 9.9 7.0 0.2 0.0 0.3 0.5 0.2 0.4 2.1 0.7 9.3 0.0 SLCO3A1 "OATP-D, OATP3A1, SLC21A11" ENSG00000176463 "Solute carrier organic anion transporter family member 3A1" Q9UIG8 15 91853695-92172435 "Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 87.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.2;HaCaT: 39.7;HMC-1: 23.4;RPMI-8226: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066327 Approved NA NA "HPA066327: AB_2732743" "unprognostic (1.05e-3)" "prognostic favorable (8.61e-4)" "unprognostic (5.40e-2)" "prognostic unfavorable (6.57e-6)" "unprognostic (1.03e-1)" "unprognostic (7.39e-2)" "unprognostic (2.16e-1)" "unprognostic (1.57e-1)" "unprognostic (2.52e-1)" "unprognostic (1.84e-1)" "unprognostic (1.42e-2)" "unprognostic (1.49e-2)" "unprognostic (2.64e-2)" "unprognostic (3.06e-2)" "unprognostic (1.86e-1)" "unprognostic (7.17e-2)" "unprognostic (1.62e-2)" 11.1 8.5 12.3 8.6 19.2 10.6 7.9 7.8 18.4 6.8 4.6 32.8 6.6 2.7 4.5 4.8 9.2 7.7 8.3 24.3 19.5 10.9 7.1 4.1 14.7 7.3 27.0 10.0 4.2 3.2 22.6 5.4 1.7 17.2 4.2 4.9 7.7 4.0 8.9 5.4 15.1 3.5 6.7 31.9 11.5 3.9 15.5 25.0 0.8 10.1 3.2 7.9 8.4 9.3 0.2 2.0 9.5 3.2 0.4 3.2 0.7 4.0 5.0 5.9 0.1 9.0 5.5 0.0 1.6 1.4 0.6 0.1 0.0 26.2 4.9 2.2 0.5 3.8 39.7 1.1 2.6 0.0 3.5 0.1 11.2 9.1 0.0 0.4 0.2 23.4 2.4 2.8 1.2 3.1 2.3 0.0 1.5 0.0 0.0 0.0 0.7 0.0 2.0 1.5 0.0 0.7 0.0 0.4 17.7 5.6 4.1 0.8 1.4 4.3 0.4 0.0 0.9 0.0 3.4 0.0 1.4 2.0 0.0 4.2 10.8 6.3 4.8 1.8 6.9 2.5 5.2 3.2 8.2 1.9 2.4 1.4 0.2 2.0 2.2 2.0 0.0 0.7 0.8 9.5 0.4 1.9 0.0 3.2 0.7 12.3 19.2 7.8 18.4 19.5 10.9 27.0 10.0 17.2 25.0 44.7 23.5 1.9 22.8 34.7 25.0 33.9 28.1 14.7 18.2 48.8 3.9 0.0 1.7 24.0 87.8 19.9 1.6 0.0 7.9 0.0 15.0 14.4 22.0 0.5 4.8 0.0 36.2 31.9 17.3 29.6 4.6 28.3 10.1 12.6 4.7 4.5 6.8 8.6 2.8 0.2 2.9 38.8 42.4 22.8 10.2 52.6 0.0 16.6 6.9 34.6 SLCO4A1 "OATP-E, OATP4A1, SLC21A12" ENSG00000101187 "Solute carrier organic anion transporter family member 4A1" Q96BD0 20 62642445-62685785 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Extravillous trophoblasts: 195.5;Melanocytes: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.3" "Group enriched" "Detected in many" 5 "B-cells: 2.3;dendritic cells: 2.6;T-cells: 4.3" "Cell line enhanced" "Detected in many" "PC-3: 56.2;RPTEC TERT1: 53.9" "Region enriched" "Detected in single" 5 "cerebellum: 7.5" "Low region specificity" "Detected in some" "HPA030669, HPA030670" Uncertain Supported "Cell Junctions" NA NA "Cell Junctions" "HPA030669: AB_10601163, HPA030670: AB_10670033" "unprognostic (8.94e-2)" "unprognostic (2.01e-1)" "unprognostic (3.41e-1)" "unprognostic (2.46e-3)" "unprognostic (3.34e-2)" "unprognostic (1.12e-1)" "unprognostic (2.84e-3)" "prognostic unfavorable (4.74e-4)" "unprognostic (4.94e-2)" "unprognostic (1.21e-2)" "unprognostic (3.49e-3)" "unprognostic (1.53e-1)" "unprognostic (1.49e-1)" "unprognostic (2.84e-3)" "unprognostic (9.27e-2)" "unprognostic (1.53e-1)" "unprognostic (1.25e-1)" 25.0 5.2 16.4 5.3 22.4 3.9 27.2 11.3 23.8 5.0 6.4 1.6 4.3 4.2 5.5 2.3 24.1 5.2 5.6 18.1 19.0 9.2 16.6 3.1 29.4 5.7 18.1 2.3 3.1 5.4 13.8 1.2 11.9 24.8 2.8 5.5 7.1 20.1 4.1 19.2 16.5 4.4 3.6 9.8 4.5 14.9 3.3 16.5 0.5 4.5 4.0 8.7 7.4 18.5 2.3 2.6 0.0 0.5 0.0 4.3 0.7 4.1 5.3 0.2 3.1 0.7 0.6 7.6 1.3 4.7 4.1 1.4 8.9 4.2 4.9 12.9 0.1 2.8 6.1 4.7 0.3 1.5 0.5 2.7 5.9 6.0 6.5 0.0 4.5 1.9 0.0 1.8 0.0 1.8 1.2 0.7 3.0 4.6 1.3 0.0 4.1 4.6 17.6 1.4 20.5 56.2 8.4 0.3 7.2 53.9 3.9 5.0 7.2 1.1 1.2 4.5 2.0 0.2 2.1 0.8 0.1 3.0 2.0 7.6 2.6 4.2 3.0 11.2 6.5 0.7 0.0 0.0 0.0 0.2 0.5 0.0 2.3 0.5 0.1 2.6 2.0 0.7 0.3 0.0 0.0 0.1 0.0 4.3 0.7 16.4 22.4 11.3 23.8 19.0 9.2 18.1 2.3 24.8 16.5 3.0 2.2 5.7 0.7 24.3 13.2 3.6 2.5 1.4 1.2 24.4 29.5 1.6 0.0 4.0 0.3 26.3 2.1 0.0 2.2 195.5 4.1 2.1 0.0 0.0 5.0 0.0 0.0 17.8 9.9 0.4 0.3 8.4 57.3 0.0 5.1 4.2 7.7 2.3 0.7 4.2 43.2 0.0 6.6 0.2 4.2 14.1 19.7 3.2 6.8 6.3 SLCO4C1 "OATP-H, OATP4C1, OATPX, SLC21A20" ENSG00000173930 "Solute carrier organic anion transporter family member 4C1" Q6ZQN7 5 102233986-102296549 "Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 55.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 38.8;Proximal tubular cells: 28.3" "Cancer enriched" "Detected in many" 5 "renal cancer: 22.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Group enriched" "Detected in many" 5 "granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3" "Cell line enhanced" "Detected in some" "Karpas-707: 8.1;RPTEC TERT1: 45.9;U-937: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058249 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA058249: " "unprognostic (1.63e-2)" "unprognostic (2.47e-2)" "unprognostic (4.48e-4)" "unprognostic (5.70e-6)" "unprognostic (7.43e-2)" "unprognostic (7.71e-3)" "unprognostic (3.24e-3)" "unprognostic (2.05e-3)" "unprognostic (2.13e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-3)" "unprognostic (5.83e-2)" "prognostic favorable (1.12e-4)" "unprognostic (3.29e-2)" "unprognostic (1.07e-1)" "unprognostic (5.91e-2)" "unprognostic (8.22e-2)" 0.4 0.4 0.3 0.7 0.7 5.4 0.3 0.2 1.8 0.3 1.9 0.0 5.2 1.4 0.2 0.6 0.3 0.3 1.6 1.1 0.3 0.4 55.9 5.2 11.0 0.2 0.3 1.0 0.3 0.9 0.0 0.7 0.1 0.2 0.4 0.5 0.0 3.2 11.8 0.3 0.6 2.1 0.0 0.3 1.6 0.4 1.3 0.0 1.5 1.0 0.3 0.1 0.7 1.1 0.1 0.4 10.0 1.1 2.6 4.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.5 45.9 0.0 0.3 0.2 0.0 0.1 0.0 1.1 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 11.6 0.0 7.9 1.1 7.5 4.3 0.0 0.4 0.0 0.7 2.3 0.4 0.1 0.2 1.5 10.0 2.6 0.0 0.3 0.0 1.0 0.3 0.7 0.2 1.8 0.3 0.4 0.3 1.0 0.2 0.0 6.0 38.8 0.0 0.1 0.0 0.0 0.3 0.0 4.0 6.8 5.2 0.0 0.0 1.7 0.2 8.3 0.0 1.2 0.0 0.7 0.0 0.0 0.0 5.7 5.5 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 28.3 0.0 0.0 0.0 1.7 0.7 0.0 0.0 2.2 1.2 0.3 SLCO5A1 "OATP-J, OATP5A1, OATPRP4, SLC21A15" ENSG00000137571 "Solute carrier organic anion transporter family member 5A1" Q9H2Y9 8 69667047-69835064 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2" "Group enriched" "Detected in many" 6 "Bipolar cells: 12.4;Cardiomyocytes: 13.6;Glandular cells: 10.0;Intestinal endocrine cells: 15.0;monocytes: 36.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HAP1: 9.0;NTERA-2: 6.0;RPMI-8226: 5.7;SCLC-21H: 6.5;U-266/70: 3.5" "Group enriched" "Detected in some" 7 "basal ganglia: 2.3;olfactory region: 8.2" HPA025062 Uncertain Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA025062: AB_1857220" "unprognostic (1.30e-3)" "unprognostic (7.35e-3)" "unprognostic (4.13e-2)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (5.70e-2)" "unprognostic (1.46e-2)" "unprognostic (1.51e-1)" "unprognostic (2.37e-4)" "unprognostic (1.75e-1)" "unprognostic (4.48e-4)" "unprognostic (1.74e-2)" "unprognostic (2.92e-6)" "unprognostic (2.20e-1)" "unprognostic (1.23e-1)" "unprognostic (2.13e-1)" "unprognostic (4.50e-2)" 0.7 0.2 0.5 1.5 0.7 1.5 0.2 0.1 0.8 0.3 0.4 0.1 0.0 0.4 0.5 1.5 1.0 0.5 0.4 21.4 0.7 0.7 0.2 0.4 0.3 4.1 0.3 0.3 0.2 0.7 0.0 4.7 0.0 0.5 4.2 0.7 0.6 0.9 0.0 13.9 0.3 0.7 0.2 0.2 0.8 0.3 0.4 0.0 9.5 0.5 16.2 1.7 0.9 0.2 1.7 0.1 0.7 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.0 0.0 0.0 2.4 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.1 6.0 0.0 0.9 1.0 0.9 5.7 0.1 0.0 6.5 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.6 0.1 1.2 3.5 0.6 0.0 0.3 0.0 1.7 0.7 0.0 0.1 0.3 0.0 0.0 0.5 0.1 0.2 0.0 1.7 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.0 0.5 0.7 0.1 0.7 0.7 0.7 0.3 0.3 0.5 0.0 3.0 0.0 1.9 1.1 0.2 12.4 13.6 0.0 0.0 1.2 0.0 2.0 0.0 0.0 1.5 0.4 0.7 0.0 0.0 1.2 0.0 0.6 10.0 0.0 0.0 0.1 1.6 15.0 0.0 0.0 0.4 0.0 0.3 0.0 36.9 1.6 0.3 2.4 0.0 0.0 0.0 0.2 0.0 1.0 0.9 1.7 0.4 0.0 0.0 0.9 0.7 SLCO6A1 "CT48, MGC26949, OATP6A1, OATPY" ENSG00000205359 "Solute carrier organic anion transporter family member 6A1" Q86UG4 5 102371782-102499016 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 93 "testis: 39.2" "Group enriched" "Detected in some" 6 "Early spermatids: 111.3;Spermatocytes: 59.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.8;SuSa: 4.2;U-266/84: 1.4" "Low region specificity" "Detected in some" HPA054126 Enhanced NA NA "HPA054126: AB_2682390" "unprognostic (1.17e-1)" "unprognostic (2.59e-1)" "unprognostic (4.37e-2)" "unprognostic (4.65e-1)" "unprognostic (1.84e-1)" "unprognostic (2.60e-2)" "unprognostic (6.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.6 1.8 0.1 0.7 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 59.8 2.6 0.0 0.0 0.0 0.0 0.0 SLFN12L ENSG00000205045 "Schlafen family member 12 like" Q6IEE8 17 35464249-35537861 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.4" "Cell type enriched" "Detected in some" 7 "T-cells: 20.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 9.5;MAIT T-cell: 8.8;memory CD4 T-cell: 6.3;memory CD8 T-cell: 8.0;naive CD4 T-cell: 4.8;naive CD8 T-cell: 5.2;NK-cell: 6.8;T-reg: 4.7" "Group enriched" "Detected in many" 7 "NK-cells: 6.8;T-cells: 9.5" "Cell line enhanced" "Detected in some" "HDLM-2: 19.9;Karpas-707: 14.1;U-266/70: 5.0;U-266/84: 4.4" HPA024447 Uncertain NA NA "HPA024447: AB_1856614" "unprognostic (1.93e-3)" "unprognostic (2.10e-4)" "unprognostic (3.77e-2)" "unprognostic (2.67e-2)" "unprognostic (8.18e-3)" "unprognostic (2.98e-5)" "unprognostic (4.59e-3)" "unprognostic (2.75e-2)" "unprognostic (6.82e-2)" "unprognostic (1.67e-2)" "unprognostic (9.51e-2)" "unprognostic (1.78e-1)" "unprognostic (2.25e-6)" "unprognostic (2.30e-1)" "unprognostic (3.88e-2)" "unprognostic (7.02e-2)" "unprognostic (8.88e-3)" 7.2 0.9 1.0 11.2 1.2 6.6 2.7 0.8 1.4 1.6 3.0 0.9 1.2 3.9 3.6 3.0 2.3 2.0 3.8 1.4 1.1 1.1 1.8 1.8 9.1 10.6 1.7 0.5 1.3 1.2 0.5 1.0 0.6 2.9 1.8 2.0 2.1 6.2 1.3 0.9 1.2 7.0 1.1 1.9 18.4 3.0 0.8 1.1 5.8 2.8 2.1 16.3 2.3 2.0 0.4 0.3 1.1 0.4 6.8 9.5 1.9 0.5 0.2 0.2 0.2 0.1 0.0 0.2 0.2 0.0 0.6 1.5 0.1 0.4 0.5 0.1 0.0 0.1 0.3 0.0 0.0 0.8 19.9 0.1 1.2 0.7 0.1 0.0 0.4 0.2 0.3 0.1 0.2 0.0 0.1 0.1 0.1 0.3 14.1 0.1 0.0 0.4 0.3 0.2 0.0 0.1 0.1 0.2 0.2 0.3 0.2 0.3 0.1 0.4 0.1 0.1 0.2 0.1 1.9 0.5 0.3 1.2 0.5 0.2 5.0 4.4 0.1 0.2 0.3 0.6 0.8 0.4 0.9 9.5 0.1 8.8 0.3 6.3 8.0 0.3 0.4 4.8 5.2 1.1 6.8 0.1 0.3 4.7 1.9 1.0 1.2 0.8 1.4 1.1 1.1 1.7 0.5 2.9 1.1 3.0 2.4 0.0 0.5 0.2 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 20.6 0.0 0.2 SLITRK1 "KIAA1910, LRRC12" ENSG00000178235 "SLIT and NTRK like family member 1" Q96PX8 13 83877205-83882393 "Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 30.6" "Cell type enriched" "Detected in some" 6 "Bipolar cells: 6.6" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 7.6;AF22: 3.2;LHCN-M2: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074835 Enhanced "Secreted in brain" NA NA 270000 "HPA074835: " "unprognostic (2.29e-1)" "unprognostic (4.32e-1)" "unprognostic (4.71e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (7.95e-2)" 0.9 1.3 16.7 0.9 9.5 0.9 1.0 2.0 30.6 1.2 1.0 6.3 0.0 1.0 1.0 1.0 0.9 0.9 1.0 0.9 16.9 7.3 1.0 0.9 0.9 0.9 7.3 14.9 0.9 3.1 0.9 3.1 0.9 5.8 0.9 1.0 0.1 1.0 1.4 1.0 0.9 0.9 0.9 3.7 0.9 1.0 1.0 8.5 0.0 0.9 0.0 0.9 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 3.2 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 9.5 2.0 21.5 16.9 7.3 7.3 14.9 5.8 8.5 0.0 0.0 0.0 0.0 0.0 6.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLITRK2 "CXorf1, CXorf2, KIAA1854, SLITL1, TMEM257" ENSG00000185985 "SLIT and NTRK like family member 2" "Q9H156, O96002" X 145817832-145829856 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.1" "Cell type enriched" "Detected in some" 9 "Muller glia cells: 226.8" "Cancer enhanced" "Detected in some" "glioma: 5.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 35 "HAP1: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 26000 "unprognostic (2.13e-1)" "unprognostic (1.12e-1)" "unprognostic (2.73e-3)" "unprognostic (6.79e-6)" "unprognostic (3.39e-1)" "unprognostic (1.68e-1)" "unprognostic (2.89e-4)" "unprognostic (6.23e-2)" "unprognostic (3.60e-1)" "unprognostic (1.29e-1)" "unprognostic (1.50e-2)" "unprognostic (3.53e-2)" "unprognostic (4.13e-8)" "unprognostic (3.12e-3)" "unprognostic (2.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.14e-2)" 1.6 1.5 12.8 1.2 16.4 0.9 1.2 4.3 25.1 1.7 1.2 13.3 0.0 1.1 1.1 1.1 1.1 4.9 1.1 1.6 12.1 3.5 1.4 1.0 2.2 1.6 11.3 9.2 1.1 1.8 0.9 1.1 0.9 10.4 1.4 1.4 5.6 1.3 8.5 1.2 3.9 1.3 1.5 12.6 7.4 1.0 1.2 11.5 0.0 1.1 0.0 0.9 1.3 1.1 0.3 0.3 1.5 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.4 0.2 0.2 0.3 0.1 0.2 0.2 0.0 0.3 0.3 0.2 0.6 0.4 0.3 0.3 0.2 0.0 12.8 16.4 4.3 14.6 12.1 3.5 11.3 9.2 10.4 11.5 0.0 0.0 0.0 0.0 1.0 4.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 6.4 1.7 1.8 0.0 0.0 0.0 0.0 25.3 0.0 0.0 226.8 0.0 0.0 0.0 0.0 9.5 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 SLITRK3 KIAA0848 ENSG00000121871 "SLIT and NTRK like family member 3" O94933 3 165186720-165197109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;liver: 12.8" "Group enriched" "Detected in some" 9 "Bipolar cells: 4.5;Hepatocytes: 2.4" "Cancer enriched" "Detected in single" 22 "glioma: 7.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.6;HAP1: 5.5;Karpas-707: 1.6;SCLC-21H: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017636, HPA048042" Enhanced Approved Mitochondria No NA 1400000 Mitochondria "HPA017636: AB_1857232, HPA048042: AB_2732542" "unprognostic (8.91e-2)" "unprognostic (1.44e-1)" "unprognostic (4.08e-2)" "unprognostic (1.96e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-1)" "unprognostic (9.59e-2)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" "unprognostic (2.22e-1)" "unprognostic (6.74e-3)" "unprognostic (5.03e-1)" "unprognostic (2.38e-1)" "unprognostic (8.03e-4)" 0.6 0.6 7.4 2.0 12.0 0.4 0.5 10.6 17.4 9.9 3.0 1.5 0.3 1.1 12.1 2.0 7.6 12.6 0.8 1.0 13.2 5.5 0.6 12.8 0.9 0.5 3.7 6.5 2.5 0.4 0.4 0.3 0.4 4.2 3.3 3.1 0.3 0.8 9.6 0.9 0.5 1.5 6.2 2.3 0.4 0.8 1.0 2.4 0.0 0.6 0.0 0.5 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 1.1 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 12.0 10.6 15.7 13.2 5.5 3.7 6.5 4.2 2.4 0.0 0.0 0.0 0.0 0.0 4.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLITRK4 DKFZp547M2010 ENSG00000179542 "SLIT and NTRK like family member 4" Q8IW52 X 143622790-143635777 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 15.7;brain: 21.8" "Cell type enhanced" "Detected in many" 14 "Leydig cells: 46.1;Melanocytes: 20.3;Peritubular cells: 15.2;Sertoli cells: 25.8" "Cancer enhanced" "Detected in many" "renal cancer: 3.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "basophil: 11.4;classical monocyte: 4.7;intermediate monocyte: 3.0;myeloid DC: 3.7;non-classical monocyte: 3.2" "Group enriched" "Detected in many" 67 "dendritic cells: 3.7;granulocytes: 11.4;monocytes: 4.7" "Cell line enhanced" "Detected in some" "HeLa: 8.2;HHSteC: 4.3;LHCN-M2: 3.1;T-47d: 12.5;U-2 OS: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000431 Enhanced Uncertain Microtubules NA NA 320000 Microtubules "HPA000431: AB_2665991" "unprognostic (1.72e-1)" "unprognostic (2.11e-2)" "unprognostic (2.63e-2)" "unprognostic (1.15e-3)" "unprognostic (4.09e-1)" "unprognostic (1.75e-2)" "unprognostic (3.79e-3)" "unprognostic (1.21e-1)" "unprognostic (1.97e-2)" "unprognostic (1.86e-1)" "unprognostic (3.64e-2)" "unprognostic (9.61e-2)" "unprognostic (6.02e-2)" "unprognostic (1.02e-5)" "unprognostic (1.29e-2)" "unprognostic (7.75e-2)" "unprognostic (9.23e-3)" 5.9 15.7 13.6 0.6 12.1 1.7 3.3 21.3 21.8 8.5 1.0 0.2 0.1 0.3 2.1 4.7 1.1 1.1 0.6 3.0 17.0 1.2 5.1 0.8 1.1 0.6 1.2 16.1 6.1 1.5 0.1 0.8 0.7 5.0 2.6 0.6 0.0 1.7 2.3 6.9 3.3 1.0 1.6 2.7 0.9 1.0 1.8 1.7 0.0 1.3 0.0 0.2 1.1 1.1 0.0 3.7 11.4 4.7 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 4.3 0.6 0.8 2.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 1.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 4.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.9 13.6 12.1 21.3 21.8 17.0 1.2 1.2 16.1 5.0 1.7 0.0 0.0 0.0 0.5 10.6 1.8 1.0 0.0 0.0 0.0 3.5 0.0 0.0 1.7 0.0 0.2 0.3 0.0 0.0 1.3 0.0 5.1 1.3 0.0 0.0 3.3 0.0 0.0 0.0 6.5 1.5 46.1 4.9 20.3 0.0 0.0 0.0 1.0 0.0 15.2 0.8 0.3 25.8 8.2 0.3 0.6 10.2 0.0 0.0 0.0 0.5 SLITRK5 "bA364G4.2, KIAA0918, LRRC11" ENSG00000165300 "SLIT and NTRK like family member 5" O94991 13 87672615-87696272 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 11.5;Horizontal cells: 20.6;Muller glia cells: 6.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 11.2;HeLa: 5.5;hTERT-RPE1: 5.1;U-138 MG: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013843 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA013843: AB_1857233" "unprognostic (1.92e-1)" "unprognostic (1.01e-2)" "unprognostic (3.82e-1)" "unprognostic (7.11e-4)" "unprognostic (6.94e-2)" "unprognostic (8.57e-3)" "unprognostic (1.63e-1)" "unprognostic (8.58e-3)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.10e-2)" "unprognostic (1.81e-2)" "unprognostic (2.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" 0.1 0.3 3.3 0.1 6.8 0.1 0.2 3.1 9.2 0.4 0.2 0.0 0.1 1.0 0.2 6.7 0.1 0.1 4.8 4.2 0.0 0.0 0.2 0.1 2.6 0.6 0.8 0.0 0.0 0.0 1.8 0.3 7.4 3.1 0.2 0.2 0.0 0.0 1.0 0.1 0.5 0.2 2.0 0.3 0.0 0.4 0.7 1.4 1.6 0.3 1.4 0.4 0.1 0.0 1.2 11.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 2.9 0.0 0.0 0.0 2.0 1.3 5.5 0.0 0.8 0.0 0.0 2.5 0.2 0.0 1.0 5.1 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 2.7 0.0 1.4 1.0 0.3 0.2 0.4 0.0 1.7 0.3 0.0 0.3 0.0 0.0 0.8 2.6 0.0 3.9 0.0 0.0 0.6 1.7 0.0 0.0 3.5 0.1 1.1 1.1 0.3 0.4 0.4 0.2 0.4 0.4 0.4 0.3 0.1 0.7 0.4 0.3 1.6 1.4 0.3 1.4 0.2 0.1 0.0 0.6 0.0 1.7 0.1 11.5 1.6 0.0 2.7 0.0 0.0 3.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.1 1.1 0.0 0.0 20.6 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 1.5 6.5 0.0 0.0 4.6 0.0 1.6 0.0 0.1 5.0 0.1 0.0 0.0 0.0 0.0 0.9 SLITRK6 FLJ22774 ENSG00000184564 "SLIT and NTRK like family member 6" Q9H5Y7 13 85792787-85806683 "Disease related genes, Predicted membrane proteins" "Hearing, Sensory transduction, Vision" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 14.0;Ciliated cells: 69.6;Club cells: 25.0" "Cancer enhanced" "Detected in many" "breast cancer: 21.1" "Group enriched" "Detected in many" 4 "basal ganglia: 11.1;cerebellum: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 13.5;OE19: 10.9;RT4: 46.2;WM-115: 10.9" "Region enhanced" "Detected in many" "thalamus: 24.7" "Low region specificity" "Detected in many" "HPA014491, HPA014513" Uncertain Supported "Plasma membrane" NA NA 9500 "Plasma membrane" "HPA014491: AB_10601603, HPA014513: AB_2669026" "unprognostic (6.14e-2)" "unprognostic (5.21e-3)" "unprognostic (1.40e-1)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "prognostic unfavorable (8.52e-4)" "unprognostic (6.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.69e-1)" "unprognostic (4.82e-2)" "unprognostic (7.60e-2)" "unprognostic (7.92e-2)" "unprognostic (3.31e-5)" "unprognostic (5.60e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (2.51e-2)" 0.4 0.3 0.3 2.7 11.1 0.0 2.9 4.9 0.3 1.0 4.5 0.0 0.2 2.8 0.7 3.4 3.6 0.3 1.1 1.9 0.3 1.3 0.3 1.1 3.1 0.0 0.6 0.0 0.3 0.4 0.0 0.4 4.1 0.8 24.2 5.8 1.7 22.8 1.8 0.3 4.5 7.2 22.4 0.4 0.2 1.2 0.5 1.8 0.0 0.6 3.4 0.7 27.8 5.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 13.5 0.0 1.6 1.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 10.9 0.9 0.1 0.0 0.0 0.0 46.2 0.4 0.5 0.2 0.0 0.0 0.8 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.1 4.9 0.3 0.3 1.3 0.6 0.0 0.8 1.8 0.0 2.6 0.0 4.8 3.4 14.0 0.3 0.0 69.6 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 8.9 0.0 0.0 0.0 0.4 1.1 1.1 0.0 0.4 0.0 1.4 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 3.1 SLMAP "KIAA1601, SLAP" ENSG00000163681 "Sarcolemma associated protein" Q14BN4 3 57755450-57929168 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 133.6;urinary bladder: 114.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 272.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002357, HPA002358" Enhanced Approved "Endoplasmic reticulum" NA NA 12000 "Endoplasmic reticulum" "HPA002357: AB_1080023, HPA002358: AB_1080021" "unprognostic (3.70e-1)" "unprognostic (2.87e-2)" "unprognostic (1.82e-3)" "unprognostic (3.43e-2)" "unprognostic (3.34e-1)" "unprognostic (6.18e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (7.98e-4)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (2.59e-3)" "unprognostic (1.06e-1)" "prognostic favorable (1.58e-6)" "unprognostic (8.18e-2)" "unprognostic (1.93e-1)" "unprognostic (1.92e-2)" "unprognostic (6.08e-2)" 10.6 10.7 7.0 22.4 11.1 7.4 12.0 10.2 7.2 26.5 50.3 5.8 24.7 9.8 43.0 19.5 44.0 21.3 15.0 58.2 6.5 5.6 8.0 7.8 8.0 7.2 6.9 6.0 21.4 5.8 16.0 8.0 7.7 6.8 47.8 12.2 8.7 8.6 37.7 26.1 9.4 23.3 133.6 6.0 7.2 27.2 14.9 6.8 11.2 11.1 12.1 6.3 114.2 26.4 5.9 5.1 15.8 5.5 7.1 5.9 4.5 22.1 12.5 10.7 15.4 16.1 16.2 14.6 20.5 21.2 14.4 13.9 30.0 33.0 14.9 9.8 16.3 25.8 12.2 19.1 27.3 18.9 16.4 10.9 25.8 17.7 23.5 15.7 25.5 14.4 11.7 21.9 17.7 33.0 18.6 16.4 15.1 21.0 13.5 14.7 7.2 17.4 13.1 16.1 16.1 24.3 7.2 11.7 14.8 29.4 24.2 6.1 7.2 26.7 20.3 12.6 14.7 11.0 16.2 19.4 15.9 12.7 20.1 26.5 15.7 26.7 20.3 14.3 22.3 14.9 7.5 5.5 15.8 5.9 3.6 4.9 5.9 4.6 5.0 5.1 4.5 5.4 5.5 13.4 7.1 3.6 2.9 5.1 4.5 7.0 11.1 10.2 7.2 6.5 5.6 6.9 6.0 6.8 6.8 35.7 34.1 6.2 37.6 81.7 24.0 272.3 33.1 29.4 29.6 31.4 47.1 15.6 16.6 39.8 28.6 23.2 38.0 0.0 29.8 10.7 23.5 70.4 3.5 20.3 13.9 30.2 13.8 16.0 19.4 17.7 30.2 18.8 27.0 11.8 24.3 98.5 46.3 29.2 67.5 24.5 32.2 51.8 116.9 81.2 26.8 64.1 13.6 23.0 23.4 106.8 SLN "MGC12301, MGC125854, MGC125855" ENSG00000170290 Sarcolipin O00631 11 107707378-107719693 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 446.6" "Group enriched" "Detected in some" 21 "Cardiomyocytes: 248.9;Muller glia cells: 330.7" "Group enriched" "Detected in many" 13 "glioma: 21.6;head and neck cancer: 22.4;prostate cancer: 4.5" "Region enhanced" "Detected in some" "basal ganglia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.7;HSkMC: 6.0;Karpas-707: 2.8;PC-3: 2.7;SuSa: 6.2;U-2 OS: 2.7" "Region enriched" "Detected in some" 5 "basal ganglia: 19.0" "Not detected" "Not detected" CAB011628 Approved Microtubules NA NA Microtubules "CAB011628: AB_2195046" "unprognostic (6.85e-2)" "unprognostic (6.18e-8)" "unprognostic (2.60e-1)" "unprognostic (3.66e-2)" "unprognostic (2.40e-3)" "unprognostic (4.12e-3)" "unprognostic (5.28e-3)" "unprognostic (1.31e-2)" "unprognostic (2.76e-1)" "unprognostic (6.35e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.52e-9)" "unprognostic (3.27e-2)" "unprognostic (2.54e-1)" "unprognostic (5.09e-4)" "unprognostic (3.77e-2)" 4.8 0.5 0.2 0.0 1.9 0.0 0.1 0.4 1.0 0.0 0.2 0.0 0.0 0.0 0.0 5.3 9.1 0.1 0.0 72.9 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.1 2.3 0.0 0.4 4.3 0.0 446.6 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.9 40.1 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.1 0.6 1.1 0.1 0.2 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.3 0.3 6.0 0.0 0.8 0.0 0.4 0.0 0.0 0.1 2.8 0.0 0.4 0.3 0.4 0.1 0.1 2.7 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.1 0.0 6.2 0.0 0.0 0.0 0.0 2.7 0.0 0.2 1.1 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 1.9 0.4 1.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 1.7 248.9 0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 7.3 0.0 0.0 0.0 0.4 1.7 0.5 0.0 0.0 0.0 0.3 3.2 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 330.7 0.2 0.0 0.4 0.1 14.1 0.0 0.4 0.0 0.0 1.3 4.8 0.0 0.0 0.0 SMAD2 "JV18-1, MADH2, MADR2" ENSG00000175387 "SMAD family member 2" Q15796 18 47808957-47931146 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cone photoreceptor cells: 200.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025507, HPA067203, CAB073546" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "CAB025507: , CAB073546: , HPA067203: AB_2685803" "unprognostic (1.55e-1)" "unprognostic (2.49e-1)" "unprognostic (1.43e-2)" "unprognostic (9.82e-3)" "unprognostic (9.88e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.91e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-3)" "unprognostic (6.46e-2)" "unprognostic (4.91e-2)" "unprognostic (9.20e-3)" "unprognostic (2.68e-1)" "unprognostic (6.13e-2)" "unprognostic (3.20e-2)" "unprognostic (6.28e-2)" 38.5 39.2 29.0 26.2 25.9 19.6 31.4 19.5 28.9 28.8 34.2 29.4 28.9 21.5 26.6 26.3 33.5 28.8 25.7 31.1 26.1 27.1 26.4 20.9 28.3 23.8 30.9 24.3 36.6 28.1 25.7 24.4 34.8 28.6 27.8 29.8 31.7 29.7 28.7 33.9 28.0 26.4 34.6 35.4 34.1 26.3 29.2 26.2 60.7 46.1 23.6 31.5 35.1 35.7 12.0 21.8 28.9 24.7 24.5 25.9 19.7 22.2 32.0 19.5 18.9 31.2 38.2 22.3 24.3 29.2 25.4 29.7 12.2 21.4 34.6 17.5 30.8 35.6 24.6 21.9 27.1 34.1 37.6 11.2 29.4 48.3 19.8 36.4 40.8 30.1 28.2 35.0 21.7 50.3 29.6 28.0 28.2 13.6 29.0 31.2 14.5 28.0 19.6 9.6 1.1 7.6 20.5 28.5 23.6 57.0 38.4 18.1 21.2 29.2 20.1 23.8 19.9 15.2 27.2 31.3 37.7 21.8 10.2 17.6 28.5 27.3 30.2 26.1 27.9 27.5 28.9 22.6 25.0 16.9 24.7 21.2 12.0 23.1 20.9 21.8 9.4 25.8 19.8 22.7 24.5 20.8 15.5 25.9 19.7 29.0 25.9 19.5 28.9 26.1 27.1 30.9 24.3 28.6 26.2 41.7 29.7 22.0 39.2 48.3 44.4 40.0 40.8 30.8 45.5 73.3 200.3 37.8 33.2 31.7 53.8 44.7 32.0 46.7 38.2 33.2 34.3 51.4 20.8 22.6 38.9 33.4 49.0 57.7 52.1 97.0 38.6 38.2 49.0 44.1 42.5 37.9 37.5 24.6 50.2 32.1 82.1 32.3 35.9 26.3 39.6 54.1 58.1 38.1 35.7 55.8 SMAGP "hSMAGP, MGC149453, MGC149454" ENSG00000170545 "Small cell adhesion glycoprotein" Q0VAQ4 12 51244558-51270890 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.4" "Group enriched" "Detected in many" 9 "Cytotrophoblasts: 1087.3;Syncytiotrophoblasts: 704.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 39.4;OE19: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039711 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA039711: AB_10674985" "unprognostic (2.55e-3)" "unprognostic (2.63e-1)" "unprognostic (3.96e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.01e-1)" "unprognostic (1.63e-3)" "unprognostic (6.26e-2)" "unprognostic (7.48e-2)" "unprognostic (9.11e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.46e-1)" "prognostic favorable (2.24e-4)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.99e-2)" "unprognostic (1.52e-1)" 7.5 6.9 0.9 11.3 1.7 0.9 26.3 1.1 1.3 13.1 22.6 0.9 5.3 6.9 8.0 13.6 53.4 3.2 21.8 6.0 1.0 1.0 10.9 4.3 17.6 14.2 1.5 0.4 5.2 14.9 4.6 1.9 50.0 3.0 4.8 24.3 2.6 10.2 6.9 3.6 12.6 8.5 3.4 4.3 11.5 14.1 4.8 0.7 1.2 4.2 28.7 33.1 7.9 24.6 22.5 2.6 8.6 3.7 12.3 9.5 3.5 23.3 7.2 0.8 0.8 3.2 12.7 39.4 18.0 18.1 9.2 5.7 14.2 24.6 0.2 3.2 11.1 3.4 8.3 5.1 6.9 12.9 1.1 4.1 3.1 0.9 4.7 8.9 0.7 3.0 8.2 5.3 19.9 18.0 21.1 22.1 6.0 2.4 1.3 14.8 20.6 3.8 2.8 3.6 47.5 27.9 0.2 0.3 0.8 13.3 5.4 0.9 1.1 3.9 15.8 2.8 9.9 13.6 1.2 7.7 10.3 9.8 0.5 10.9 0.4 0.6 0.4 15.1 7.7 5.5 1.9 3.7 6.4 9.5 2.4 6.1 22.5 4.2 6.9 2.6 17.6 3.9 7.0 8.6 12.3 2.6 1.5 2.7 3.5 0.9 1.7 1.1 1.3 1.0 1.0 1.5 0.4 3.0 0.7 0.0 18.8 28.2 46.4 19.3 1.2 1.1 53.5 8.1 12.5 15.7 0.0 1087.3 41.4 27.1 6.5 53.4 61.6 0.0 95.9 65.5 13.8 46.6 12.7 5.8 83.3 1.6 19.7 38.1 5.4 2.1 12.0 6.7 13.5 5.4 100.2 2.5 97.3 73.7 9.2 15.3 1.2 25.8 8.1 5.2 28.8 26.0 704.6 15.2 97.4 72.3 SMCO2 "C12orf70, LOC341346" ENSG00000165935 "Single-pass membrane protein with coiled-coil domains 2" A6NFE2 12 27466810-27502185 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 2.3;testis: 3.1" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 9.8;Late spermatids: 3.6;Urothelial cells: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;HDLM-2: 5.6" "Not detected" "Not detected" HPA014366 Uncertain NA NA "HPA014366: AB_1845544" "unprognostic (2.64e-2)" "unprognostic (3.11e-1)" "unprognostic (1.33e-2)" "unprognostic (4.10e-2)" "unprognostic (4.44e-3)" "unprognostic (1.98e-2)" "unprognostic (7.86e-3)" "unprognostic (5.44e-3)" "unprognostic (2.81e-1)" "unprognostic (8.86e-2)" "unprognostic (9.21e-5)" "unprognostic (2.59e-1)" "unprognostic (7.02e-3)" "unprognostic (5.48e-2)" "unprognostic (3.01e-1)" "unprognostic (3.65e-1)" "unprognostic (1.69e-1)" 0.2 0.3 0.2 1.7 0.1 0.1 0.4 0.3 0.5 0.1 0.4 0.0 0.1 0.0 2.3 0.0 0.8 0.0 0.3 0.4 0.0 0.7 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.1 2.1 0.0 0.4 0.0 0.0 1.5 3.1 0.0 1.9 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.2 0.1 0.0 0.2 2.5 0.2 0.1 0.1 1.8 0.0 3.8 0.0 0.9 0.0 1.3 0.6 0.2 0.6 1.1 5.6 0.0 0.2 1.0 0.0 0.0 2.1 0.4 1.2 0.6 0.8 3.2 1.0 2.0 0.8 0.0 1.6 0.0 0.3 0.9 2.3 1.0 1.5 2.0 0.9 0.0 0.0 0.6 0.8 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.7 1.7 0.7 1.9 3.1 0.1 0.3 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 9.8 0.0 0.0 0.0 0.7 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 1.7 SMCO3 "C12orf69, LOC440087" ENSG00000179256 "Single-pass membrane protein with coiled-coil domains 3" A2RU48 12 14804650-14814182 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 13.3" "Group enriched" "Detected in some" 6 "Collecting duct cells: 1.8;Distal tubular cells: 5.0;Ito cells: 5.5;Proximal tubular cells: 6.1" "Cancer enhanced" "Detected in some" "prostate cancer: 3.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "AN3-CA: 6.4;HHSteC: 2.1;HUVEC TERT2: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA040574, HPA047804" Uncertain NA NA "HPA040574: AB_2677026, HPA047804: AB_2680160" "unprognostic (1.16e-1)" "unprognostic (2.09e-4)" "unprognostic (2.40e-4)" "unprognostic (5.10e-2)" "unprognostic (3.88e-2)" "unprognostic (6.45e-2)" "unprognostic (4.43e-2)" "unprognostic (2.86e-2)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" "unprognostic (7.31e-2)" "unprognostic (3.66e-2)" "unprognostic (1.48e-8)" "unprognostic (2.85e-1)" "unprognostic (7.53e-3)" "unprognostic (2.05e-1)" "unprognostic (1.38e-1)" 1.3 0.8 0.2 0.2 0.2 0.3 0.6 0.2 0.4 13.3 0.6 0.2 0.2 0.0 1.3 0.7 0.8 0.8 3.7 2.3 0.2 0.1 6.6 2.8 4.3 0.9 0.6 0.7 1.2 0.6 3.1 0.7 4.0 1.4 2.1 0.1 5.1 0.2 3.2 2.2 0.3 0.4 0.2 2.5 3.3 0.4 0.6 0.2 0.2 8.5 0.9 0.2 1.1 1.6 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.1 0.5 6.4 0.7 0.0 0.6 0.8 0.0 0.0 0.0 0.3 0.7 0.2 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.3 0.5 0.6 0.3 2.1 0.0 0.1 1.5 0.0 0.0 0.6 0.4 1.9 0.7 0.3 0.2 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.5 0.3 0.0 0.3 0.2 0.2 0.2 0.0 0.5 1.1 1.6 0.4 0.0 0.5 0.7 0.1 0.1 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.2 0.2 0.4 0.2 0.1 0.6 0.7 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 5.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SMCO4 "C11orf75, FN5" ENSG00000166002 "Single-pass membrane protein with coiled-coil domains 4" Q9NRQ5 11 93478472-93543508 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 124.3" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 179.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 49.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041120 Uncertain NA Yes "HPA041120: AB_2677309" "unprognostic (7.45e-2)" "unprognostic (1.70e-3)" "unprognostic (2.54e-1)" "unprognostic (1.01e-2)" "unprognostic (1.58e-1)" "unprognostic (6.47e-2)" "unprognostic (8.56e-2)" "unprognostic (1.93e-1)" "unprognostic (3.43e-1)" "unprognostic (5.51e-1)" "unprognostic (4.23e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (5.81e-7)" "unprognostic (1.61e-1)" "unprognostic (3.05e-1)" "unprognostic (1.55e-2)" "unprognostic (5.01e-2)" 6.1 19.0 4.3 10.0 7.3 1.6 6.2 2.5 4.5 5.0 10.6 4.5 11.5 16.1 5.4 4.6 5.5 9.4 9.3 13.4 4.5 7.9 10.9 33.5 9.0 9.1 6.2 4.0 6.4 17.9 1.1 15.7 3.5 5.7 13.1 8.0 6.0 124.3 10.3 6.2 5.5 21.2 4.8 5.0 16.7 12.2 9.9 4.5 5.4 34.3 3.1 8.6 3.7 5.1 4.2 29.7 11.4 57.3 5.6 5.4 15.7 3.3 6.3 9.3 2.7 3.5 5.5 6.2 9.1 2.6 4.3 7.8 11.2 14.6 9.1 11.3 8.4 6.4 1.9 8.5 1.1 2.5 25.6 7.7 2.2 11.8 25.7 3.6 8.8 11.3 5.4 5.1 2.0 1.6 4.9 7.0 32.0 5.3 49.1 1.4 7.0 8.9 17.4 9.9 25.4 9.3 17.2 5.9 4.6 7.9 8.3 1.5 7.9 7.5 11.0 0.7 11.7 4.3 12.2 3.9 4.5 16.8 15.0 8.2 1.9 0.2 7.1 3.3 17.2 1.7 6.8 51.3 1.2 0.8 57.3 3.5 4.2 5.4 1.5 28.8 3.0 0.7 0.6 11.4 5.6 52.1 29.7 2.0 15.7 4.3 7.3 2.5 4.5 4.5 7.9 6.2 4.0 5.7 4.5 23.8 20.2 13.7 30.3 29.1 1.9 27.1 56.0 8.1 15.9 47.1 0.0 3.7 179.1 29.8 88.0 22.2 95.7 0.0 61.8 8.5 23.4 137.8 2.3 84.7 133.0 3.2 43.1 12.9 81.9 100.6 11.8 67.0 28.7 35.1 107.8 4.5 39.2 115.8 9.9 48.8 1.4 6.5 11.8 5.9 41.5 18.6 4.0 10.2 59.6 20.7 SMDT1 "C22orf32, DDDD, dJ186O1.1, EMRE" ENSG00000183172 "Single-pass membrane protein with aspartate rich tail 1" Q9H4I9 22 42079691-42084284 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032117, HPA060340" Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA032117: AB_10601093, HPA060340: AB_2684257" "unprognostic (1.11e-2)" "unprognostic (1.46e-3)" "unprognostic (5.77e-2)" "prognostic favorable (5.32e-8)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (1.03e-1)" "unprognostic (2.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.84e-2)" "prognostic favorable (5.87e-4)" "unprognostic (2.96e-1)" "prognostic favorable (2.36e-9)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (9.72e-3)" 8.7 12.3 20.3 14.6 18.0 15.3 19.9 19.5 17.9 15.2 12.9 10.2 14.7 11.0 13.0 20.2 16.4 15.7 10.7 21.3 15.8 16.2 14.1 18.4 10.1 14.4 16.3 12.4 23.2 21.6 11.3 12.9 9.8 9.9 16.4 12.1 15.5 37.0 15.9 26.4 10.4 18.0 9.8 13.3 10.6 12.9 10.9 7.9 15.2 23.4 18.7 16.1 14.9 16.9 5.4 5.0 2.3 3.5 2.9 5.9 3.0 2.2 1.5 3.1 3.7 5.7 4.1 2.4 0.8 4.1 5.1 4.4 2.9 2.2 5.8 1.0 4.3 1.4 2.6 4.0 4.3 3.3 1.5 6.6 1.9 3.2 4.1 7.1 3.5 2.5 3.2 7.3 2.0 4.3 2.9 5.0 2.1 3.1 5.1 3.5 5.9 4.9 5.3 1.1 5.7 3.3 4.3 2.7 8.4 6.4 2.6 3.8 2.5 2.0 4.6 5.0 1.6 3.9 3.8 2.0 2.2 2.4 1.9 1.5 3.5 3.8 6.9 3.3 3.4 1.6 2.3 3.5 1.6 2.7 1.7 3.7 3.7 5.4 2.8 5.0 5.4 5.9 3.9 0.3 2.9 2.5 3.8 3.0 3.0 20.3 18.0 19.5 17.9 15.8 16.2 16.3 12.4 9.9 7.9 77.4 85.3 270.8 168.6 148.1 59.5 296.6 234.4 179.3 92.1 193.7 19.6 251.6 485.7 138.8 92.3 121.8 346.2 0.0 174.6 167.3 105.2 269.9 91.0 309.5 220.1 52.4 331.5 110.5 164.5 80.6 175.2 186.8 200.8 116.4 276.7 86.2 148.7 295.1 140.0 446.7 82.0 122.9 137.7 196.7 54.5 239.6 258.2 167.5 271.3 230.0 SMIM1 Vel ENSG00000235169 "Small integral membrane protein 1 (Vel blood group)" B2RUZ4 1 3772761-3775982 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Erythroid cells: 607.3;Proximal tubular cells: 216.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 10 "eosinophil: 26.7" "Lineage enriched" "Detected in many" 11 "granulocytes: 26.7" "Group enriched" "Detected in many" 4 "HEL: 37.3;Hep G2: 16.1;K-562: 18.7" "Low region specificity" "Detected in all" HPA069088 Enhanced NA NA 420000 "HPA069088: AB_2686080" "unprognostic (9.50e-3)" "unprognostic (7.19e-4)" "unprognostic (5.40e-2)" "unprognostic (2.10e-2)" "unprognostic (2.50e-3)" "unprognostic (3.25e-1)" "unprognostic (2.63e-3)" "unprognostic (2.13e-2)" "unprognostic (2.31e-2)" "unprognostic (9.85e-2)" "unprognostic (2.90e-1)" "unprognostic (1.87e-1)" "unprognostic (2.25e-2)" "unprognostic (7.10e-2)" "unprognostic (2.91e-2)" "unprognostic (5.56e-2)" "unprognostic (1.32e-2)" 1.6 2.2 0.9 0.7 1.3 27.8 2.2 2.2 1.7 6.1 2.9 3.4 9.1 1.0 1.7 7.7 3.7 2.1 3.7 23.5 1.7 1.6 8.4 6.6 2.4 3.4 2.1 1.7 8.0 5.5 2.0 9.3 2.7 3.0 9.0 0.3 5.6 18.5 17.2 1.3 1.1 1.3 4.9 4.0 2.1 3.3 23.5 1.6 0.5 6.9 1.1 1.5 4.6 4.2 2.5 0.3 26.7 1.2 0.1 2.5 1.4 0.1 0.6 0.8 1.6 0.0 0.0 2.8 0.4 0.6 0.0 0.0 1.7 2.0 0.1 3.8 0.0 0.1 0.8 0.3 0.7 0.0 3.4 2.0 37.3 0.0 16.1 1.3 0.0 0.7 1.1 0.5 0.2 0.3 1.6 0.0 0.1 18.7 0.6 0.0 3.6 0.0 1.1 0.2 1.7 3.6 0.0 0.0 5.3 1.9 0.4 0.9 3.6 0.1 3.8 2.7 0.3 3.9 2.1 0.3 0.0 0.5 0.0 0.0 1.6 0.5 0.1 0.0 0.0 0.1 2.6 1.2 26.7 0.7 0.6 0.3 1.6 1.0 0.3 0.3 2.5 2.5 1.1 1.9 0.1 0.2 0.3 0.7 1.4 0.9 1.3 2.2 1.7 1.7 1.6 2.1 1.7 3.0 1.6 6.0 16.1 6.0 9.8 1.4 0.2 48.0 10.2 2.7 11.4 15.7 0.0 20.7 71.3 11.7 8.1 2.3 1.1 607.3 12.4 16.7 7.2 11.2 1.1 43.2 8.2 1.6 5.2 3.1 4.0 18.0 9.2 3.7 40.5 0.0 2.9 20.1 16.0 0.0 9.2 216.9 0.9 0.0 4.2 3.9 15.8 1.0 5.6 4.3 3.5 5.7 SMIM10 CXorf69 ENSG00000184785 "Small integral membrane protein 10" "Q96HG1, P0DMW3" X 134990938-134992473 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Endothelial cells: 22.2;Smooth muscle cells: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 6.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 19.1" NA NA "unprognostic (2.66e-2)" "unprognostic (1.91e-2)" "unprognostic (3.07e-2)" "unprognostic (1.79e-3)" "unprognostic (3.23e-2)" "unprognostic (2.22e-4)" "unprognostic (3.63e-2)" "unprognostic (5.03e-2)" "unprognostic (2.26e-1)" "unprognostic (1.09e-3)" "unprognostic (1.25e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (3.69e-6)" "unprognostic (1.59e-2)" "unprognostic (2.25e-1)" "unprognostic (2.13e-1)" "unprognostic (9.28e-2)" 12.6 10.8 6.9 4.7 7.1 10.0 14.8 2.8 4.4 15.5 9.8 5.3 4.3 2.9 12.9 11.0 13.7 11.5 9.9 13.5 6.8 8.1 7.8 1.9 5.9 7.4 11.2 7.8 17.1 2.7 41.0 7.4 3.7 11.6 22.6 4.6 12.5 5.2 11.6 6.9 2.6 5.7 20.2 18.6 13.6 5.4 31.4 6.0 0.2 8.5 4.3 2.1 19.1 17.7 1.5 0.2 3.5 0.6 6.6 0.4 0.2 0.0 0.0 0.0 0.0 9.0 10.9 3.2 4.5 14.9 2.7 4.1 3.7 0.0 0.0 12.0 4.6 13.6 0.0 8.3 0.0 3.9 12.4 8.0 13.2 17.2 0.0 8.0 11.8 2.7 14.5 0.0 8.0 0.0 3.6 2.1 0.0 6.5 0.0 9.5 0.0 0.0 19.1 0.0 0.0 0.0 0.0 1.1 0.0 0.7 2.4 2.4 0.0 5.5 0.0 8.2 0.2 0.0 8.7 0.4 6.8 4.5 14.4 6.3 0.0 0.0 0.0 5.3 13.2 2.5 2.8 0.6 3.5 0.0 0.4 0.4 0.0 0.0 0.1 0.2 1.5 0.0 0.2 0.0 6.6 0.3 0.0 0.0 0.2 6.9 7.1 2.8 4.4 6.8 8.1 11.2 7.8 11.6 6.0 3.0 5.1 0.0 6.1 1.5 3.1 12.1 0.0 4.0 6.8 1.8 0.0 0.6 3.3 3.1 2.2 22.2 0.0 0.0 1.1 0.7 10.0 1.2 9.2 0.0 5.3 1.6 0.0 10.4 3.2 5.9 17.3 2.3 18.6 0.0 0.0 10.1 1.3 0.0 17.0 1.3 1.1 6.5 31.6 3.6 2.5 0.9 0.5 0.0 0.0 1.1 SMIM11A "C21orf51, FAM165B, SMIM11" ENSG00000205670 "Small integral membrane protein 11A" P58511 21 34375480-34407866 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 3.0;Ciliated cells: 4.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA051321 Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA051321: AB_2681440" "unprognostic (2.62e-2)" "unprognostic (4.28e-2)" "unprognostic (1.27e-1)" "unprognostic (5.86e-3)" "unprognostic (1.90e-1)" "unprognostic (1.66e-1)" "unprognostic (3.04e-1)" "unprognostic (4.48e-2)" "unprognostic (1.13e-1)" "unprognostic (2.74e-1)" "unprognostic (8.84e-2)" "unprognostic (4.83e-3)" 2.1 6.7 7.8 1.4 7.4 1.0 5.0 4.4 9.5 2.9 4.1 2.2 4.3 6.0 1.4 6.3 4.8 8.8 6.9 6.1 5.1 4.5 5.0 3.3 6.7 5.0 3.8 5.2 4.1 2.4 3.7 6.2 4.8 2.9 16.4 2.6 4.6 3.7 6.5 3.7 17.0 1.7 12.1 5.0 4.3 2.2 4.6 6.5 6.3 4.8 3.4 11.8 3.6 7.7 8.9 0.0 6.0 6.3 5.3 0.0 0.0 4.7 5.8 6.1 6.2 7.6 14.8 4.3 0.4 10.2 5.7 0.0 0.1 8.5 27.3 17.1 3.2 0.0 3.6 4.8 3.9 7.3 0.1 9.1 0.0 4.9 5.9 10.3 9.3 13.7 12.5 3.7 5.7 2.2 3.8 12.6 13.9 17.6 4.9 7.2 20.8 2.6 2.4 5.3 10.5 0.1 8.7 12.4 4.5 15.8 5.1 0.0 14.3 1.7 4.1 10.3 10.6 13.0 5.2 4.4 6.9 7.0 0.3 3.0 6.3 1.8 4.8 2.7 4.6 3.4 5.0 6.5 2.5 4.6 2.5 0.7 3.4 1.2 1.2 11.8 3.6 3.0 1.6 0.0 0.3 0.0 0.2 0.0 0.0 4.0 1.2 0.0 0.0 0.3 1.7 1.1 0.4 0.0 0.0 0.0 0.6 0.3 0.0 0.3 0.0 1.1 0.6 0.0 1.2 1.3 0.3 0.0 0.0 1.3 0.0 0.0 0.9 0.2 0.9 0.0 0.4 1.4 0.4 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.7 0.1 SMIM11B ENSG00000273590 "Small integral membrane protein 11B" Q8TCY0 21 7744962-7777853 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 19.7" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 14.9;Ciliated cells: 20.1;Club cells: 7.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA051321 Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA051321: AB_2681440" "unprognostic (1.99e-1)" "unprognostic (1.78e-1)" "unprognostic (1.35e-1)" 2.2 1.9 1.4 1.4 2.5 0.6 1.8 1.0 2.3 2.8 4.9 1.5 0.3 1.1 5.8 4.0 4.0 0.3 2.2 3.4 0.9 0.0 0.2 1.8 0.0 1.1 2.1 5.4 0.8 0.7 0.9 0.8 1.7 0.0 1.1 0.4 1.2 19.7 11.2 10.3 11.6 9.5 17.6 10.5 14.3 0.5 8.6 17.5 13.2 16.2 10.4 8.0 11.5 5.7 6.5 0.5 4.0 12.4 4.8 11.3 9.4 2.1 16.2 12.7 2.5 4.6 9.5 20.3 10.7 8.3 13.8 22.0 8.9 16.1 9.1 6.4 10.7 9.7 3.6 10.2 23.5 20.6 7.5 5.9 10.5 16.6 12.7 10.5 0.1 9.6 5.3 17.8 18.2 3.4 15.7 0.8 16.3 7.6 13.1 5.9 6.7 6.9 9.4 0.4 6.7 3.6 2.4 10.5 9.1 19.2 11.7 29.0 9.2 5.0 11.6 10.3 14.1 8.7 16.1 16.0 14.7 14.8 11.2 19.7 17.6 15.7 3.1 9.5 9.1 10.8 13.9 10.5 14.9 3.5 0.0 0.5 0.0 0.8 0.0 0.0 20.1 7.9 0.0 0.0 0.2 3.3 0.4 0.2 0.0 0.1 0.0 0.3 0.2 0.0 0.2 4.7 0.4 0.4 0.0 0.0 0.6 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.4 1.0 0.1 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.4 0.3 SMIM12 "C1orf212, FLJ90372" ENSG00000163866 "Small integral membrane protein 12" Q96EX1 1 34712737-34859816 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065331 Approved Approved Mitochondria NA NA Mitochondria "HPA065331: AB_2685470" "unprognostic (2.21e-1)" "unprognostic (2.26e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (2.64e-1)" "unprognostic (2.05e-1)" "unprognostic (5.71e-2)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "prognostic favorable (1.15e-5)" "unprognostic (7.33e-2)" "unprognostic (6.70e-2)" "unprognostic (3.58e-2)" "unprognostic (2.52e-2)" 26.6 28.8 16.4 19.0 21.9 16.0 21.0 14.2 27.1 12.2 22.6 14.2 12.4 22.6 14.8 15.5 22.4 13.9 15.7 25.5 15.6 21.7 31.7 61.5 17.1 21.4 19.0 18.7 13.3 25.5 10.9 15.3 19.3 19.8 11.3 21.8 15.4 17.3 16.8 32.2 15.7 23.1 23.9 13.8 19.2 17.0 13.7 13.1 20.3 18.1 20.1 20.1 15.7 16.8 25.7 38.5 54.4 35.1 25.5 36.6 35.3 21.7 16.7 18.8 13.6 24.6 19.4 13.0 23.7 20.7 30.7 26.6 16.8 27.8 22.9 21.4 24.3 24.2 22.0 23.8 31.8 23.6 27.8 16.7 40.7 26.8 20.0 22.9 44.3 24.1 29.4 31.2 33.2 27.0 11.1 31.2 20.0 28.9 31.3 27.0 15.8 21.4 22.9 30.3 17.1 21.8 18.3 18.4 29.8 27.1 22.9 18.0 14.2 22.0 20.8 33.3 24.7 14.1 12.6 29.3 21.1 21.6 32.2 27.8 17.6 24.2 23.2 19.8 26.5 13.8 36.4 34.7 54.4 31.1 35.1 36.6 25.4 29.2 33.9 38.5 25.7 24.4 31.4 22.8 25.5 28.0 27.6 32.5 35.3 16.4 21.9 14.2 27.1 15.6 21.7 19.0 18.7 19.8 13.1 23.8 12.5 54.1 17.0 60.7 14.8 28.3 56.0 26.8 17.0 21.0 9.8 43.4 72.9 68.9 51.5 46.6 46.3 70.0 73.0 49.7 30.1 24.0 23.1 74.6 73.0 19.1 20.9 44.2 34.6 23.8 13.8 47.4 37.1 111.8 21.6 21.4 68.8 33.2 21.9 69.5 14.5 12.9 67.9 35.2 22.7 66.0 48.5 47.4 34.9 38.3 SMIM13 C6orf228 ENSG00000224531 "Small integral membrane protein 13" P0DJ93 6 11094033-11138733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 66.6;Syncytiotrophoblasts: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065706 Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA "Nucleoplasm, Nuclear membrane, Golgi apparatus" "HPA065706: AB_2685539" "unprognostic (6.89e-2)" "unprognostic (1.22e-1)" "unprognostic (1.58e-1)" "unprognostic (7.11e-3)" "unprognostic (4.01e-1)" "unprognostic (2.57e-1)" "unprognostic (3.59e-2)" "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (6.66e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.04e-2)" "unprognostic (2.76e-1)" "unprognostic (9.22e-2)" "unprognostic (3.45e-2)" 5.7 4.2 7.5 2.8 13.0 2.0 4.5 13.3 26.4 4.3 3.2 7.7 1.1 3.1 4.6 3.2 8.5 3.0 3.7 5.7 6.5 2.8 3.9 8.7 5.2 2.3 9.5 8.3 3.8 3.2 7.6 2.8 11.4 14.3 4.3 3.3 2.8 5.3 4.6 9.1 13.7 3.9 4.7 4.9 5.1 3.4 9.4 8.1 1.7 3.9 2.1 2.6 3.3 4.9 0.5 2.4 1.3 0.4 1.2 1.0 0.4 5.7 5.0 7.8 6.5 8.1 9.2 8.1 16.2 7.0 8.4 9.4 6.6 1.9 7.3 22.1 5.2 8.3 5.1 16.1 5.7 15.1 4.0 11.7 7.5 5.6 5.2 10.8 13.9 1.8 11.0 15.9 8.6 11.3 6.6 8.8 6.6 10.6 3.0 15.8 3.2 5.9 8.1 3.6 3.9 4.4 7.9 14.3 10.1 5.1 4.6 18.1 10.0 3.4 11.2 18.9 11.3 2.7 5.8 12.5 12.7 9.2 5.2 10.8 5.6 18.7 10.4 3.0 5.9 19.4 1.3 0.3 0.3 1.0 0.4 0.8 0.5 0.4 0.5 0.6 0.3 0.1 0.9 0.1 1.2 0.3 2.4 0.6 0.4 7.5 13.0 13.3 19.6 6.5 2.8 9.5 8.3 14.3 8.1 11.9 1.0 11.2 14.5 66.6 17.0 10.5 5.1 1.4 2.3 10.4 19.6 24.9 3.3 4.9 6.3 10.5 4.0 0.0 6.5 30.2 12.4 11.5 10.4 20.8 12.3 28.6 3.5 7.4 5.3 3.8 2.6 9.5 15.1 4.6 6.9 7.1 7.9 3.5 3.9 6.6 13.9 0.0 10.3 11.3 17.0 34.5 54.5 6.9 7.4 14.0 SMIM14 "C4orf34, FLJ13289" ENSG00000163683 "Small integral membrane protein 14" Q96QK8 4 39546330-39639090 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 520.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 19.4;Daudi: 75.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051299 Uncertain NA NA "HPA051299: AB_2681429" "unprognostic (3.13e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-2)" "prognostic favorable (2.63e-4)" "unprognostic (6.48e-2)" "prognostic favorable (3.00e-6)" "prognostic favorable (3.47e-4)" "unprognostic (2.67e-2)" "unprognostic (1.54e-1)" "unprognostic (8.30e-2)" "unprognostic (1.22e-1)" "unprognostic (7.18e-2)" "prognostic favorable (2.07e-4)" "unprognostic (6.66e-2)" "unprognostic (1.33e-1)" "unprognostic (9.50e-2)" "unprognostic (4.92e-3)" 13.6 34.5 13.0 10.0 12.2 2.4 18.1 13.2 14.5 20.9 19.8 16.1 28.2 7.6 10.0 22.1 12.9 13.4 12.0 7.4 13.3 14.8 14.9 59.9 11.9 18.5 15.5 10.1 13.7 35.5 12.9 23.8 8.2 18.4 18.3 19.3 12.4 26.8 27.9 4.2 8.6 11.4 10.4 17.0 12.8 23.4 9.2 12.3 4.3 16.4 6.6 23.2 11.6 11.6 32.4 30.3 13.2 17.4 12.1 6.8 11.7 2.9 5.2 2.6 2.6 17.9 19.4 4.5 3.9 5.5 1.9 2.7 1.8 11.6 75.6 3.9 4.8 3.1 1.2 0.6 0.9 1.7 1.2 0.5 0.0 2.1 2.7 5.5 0.4 0.6 7.0 3.5 2.0 1.3 7.3 2.8 2.2 0.6 2.4 3.2 9.3 0.6 1.3 1.3 14.6 3.5 2.8 0.1 0.6 4.0 2.8 1.8 2.3 4.8 6.9 1.6 1.1 5.6 0.9 10.3 4.7 0.9 5.8 0.7 7.5 1.4 0.3 7.6 0.7 1.7 13.2 17.4 7.9 6.1 14.6 6.8 30.9 4.5 5.6 18.4 32.4 3.3 5.0 12.4 12.1 13.8 30.3 2.4 11.7 13.0 12.2 13.2 14.5 13.3 14.8 15.5 10.1 18.4 12.3 53.6 102.0 236.2 66.6 43.8 80.2 14.9 63.7 133.8 83.0 99.5 33.4 33.5 71.3 76.7 228.5 48.4 147.6 0.0 127.3 41.6 65.2 244.8 45.0 520.6 40.9 87.4 101.8 47.3 76.7 22.9 104.7 68.2 43.9 121.8 388.9 95.4 175.2 123.8 117.0 86.4 45.1 58.2 45.0 74.8 24.4 52.2 87.1 32.0 89.7 87.6 SMIM15 "C5orf43, DKFZP686E2158" ENSG00000188725 "Small integral membrane protein 15" Q7Z3B0 5 61157709-61162474 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.18e-1)" "unprognostic (2.56e-1)" "unprognostic (2.33e-2)" "unprognostic (3.82e-1)" "unprognostic (3.32e-2)" "unprognostic (6.03e-2)" "unprognostic (9.83e-3)" "unprognostic (4.43e-2)" "unprognostic (2.44e-2)" "unprognostic (4.09e-1)" "unprognostic (5.08e-2)" "unprognostic (1.72e-1)" "unprognostic (5.34e-3)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.89e-1)" "prognostic favorable (9.23e-4)" 15.8 23.5 20.1 16.7 20.5 12.9 19.4 13.9 17.2 19.8 31.6 14.8 20.3 27.7 17.9 22.0 31.9 21.0 24.1 16.3 18.9 18.1 29.8 29.8 15.7 17.8 21.0 14.4 23.7 26.2 19.2 21.7 26.8 18.6 21.3 28.0 15.1 22.1 22.4 8.4 14.0 39.9 15.8 23.7 24.5 30.3 12.5 20.4 27.7 28.1 16.1 21.7 20.8 20.6 20.5 24.9 12.9 33.8 26.8 25.9 17.0 29.2 25.1 16.5 26.8 16.0 19.2 17.0 24.8 27.4 24.9 33.6 21.7 44.8 14.3 43.3 25.8 32.8 17.1 0.0 29.7 29.4 30.0 13.4 22.5 19.2 20.9 31.5 16.5 21.3 22.6 27.7 30.8 35.3 19.1 19.9 18.1 26.3 19.7 27.8 30.7 8.4 0.2 20.3 12.0 29.5 3.0 20.5 32.8 26.8 35.3 22.9 22.0 28.5 15.4 29.7 12.1 29.0 18.1 22.7 15.0 24.0 18.9 31.3 20.2 34.8 26.7 20.6 9.2 30.7 12.9 28.0 9.3 17.9 33.8 20.0 20.5 20.0 20.4 24.9 17.0 24.4 16.7 5.6 26.8 25.7 20.0 25.9 17.0 20.1 20.5 13.9 17.2 18.9 18.1 21.0 14.4 18.6 20.4 53.6 29.6 42.4 91.9 77.0 23.5 15.7 30.6 36.1 46.6 40.1 7.9 61.9 114.4 56.5 18.9 24.9 64.2 0.0 54.2 51.7 47.6 87.2 23.1 33.4 64.9 38.1 53.0 24.5 36.9 18.6 42.8 39.3 38.8 29.7 65.5 47.2 59.2 97.9 39.6 71.8 20.2 25.8 28.1 13.9 12.0 72.3 39.7 28.7 64.3 130.0 SMIM17 ENSG00000268182 "Small integral membrane protein 17" P0DL12 19 56643145-56655766 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in many" 6 "brain: 26.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "Cell line enhanced" "Detected in some" "AF22: 5.4;HEK 293: 5.3;RH-30: 4.2;SCLC-21H: 4.9" "HPA071857, HPA071861" Enhanced Approved Vesicles NA NA Vesicles "HPA071857: AB_2686461, HPA071861: AB_2686462" "unprognostic (1.32e-1)" "unprognostic (2.82e-1)" "unprognostic (1.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.62e-1)" "unprognostic (4.57e-2)" "unprognostic (5.84e-2)" "unprognostic (3.00e-2)" "unprognostic (2.51e-1)" "unprognostic (6.50e-2)" "unprognostic (4.64e-2)" "unprognostic (9.02e-3)" "unprognostic (3.46e-3)" "unprognostic (6.26e-2)" "unprognostic (1.01e-1)" "unprognostic (3.71e-3)" "unprognostic (7.51e-3)" 1.8 1.2 7.0 0.6 10.4 0.8 2.4 4.5 17.3 0.9 1.1 0.9 0.0 1.0 2.2 4.8 1.2 1.5 1.0 1.7 6.0 13.8 1.3 0.8 1.3 0.7 5.9 7.7 1.8 1.2 0.5 2.2 1.1 26.5 1.7 1.2 0.4 1.3 2.6 1.1 1.9 0.7 1.4 2.7 1.0 0.7 1.6 0.1 0.0 1.1 0.0 0.8 0.5 0.5 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.3 0.0 5.4 1.5 1.2 0.9 1.1 0.7 0.6 1.3 0.3 0.0 0.2 0.4 0.8 0.3 0.5 0.3 0.1 0.4 0.7 0.0 5.3 3.1 0.6 0.8 0.8 2.5 0.4 1.7 0.7 0.0 1.5 1.1 0.5 2.9 0.1 0.0 1.1 0.0 2.8 0.4 0.0 0.0 0.6 1.5 4.2 0.1 0.7 0.0 4.9 1.0 1.3 0.1 0.8 0.9 0.0 0.8 0.8 1.9 0.2 0.5 0.5 0.3 0.8 1.3 0.6 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 10.4 4.5 17.3 6.0 13.8 5.9 7.7 26.5 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM18 ENSG00000253457 "Small integral membrane protein 18" P0DKX4 8 30638600-30646064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 18.8;pituitary gland: 10.7" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 9.9;Horizontal cells: 4.8;Rod photoreceptor cells: 2.7" "Cancer enriched" "Detected in single" 8 "glioma: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066648 Supported Uncertain Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA066648: AB_2685697" "unprognostic (2.19e-2)" "unprognostic (9.37e-2)" "unprognostic (3.31e-1)" "unprognostic (4.24e-2)" "unprognostic (1.66e-1)" "unprognostic (2.60e-1)" "unprognostic (7.29e-2)" "unprognostic (4.70e-1)" "unprognostic (8.91e-3)" "unprognostic (1.05e-1)" "unprognostic (2.36e-1)" "unprognostic (6.08e-2)" "unprognostic (4.01e-3)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (4.14e-1)" 0.6 3.2 5.2 0.7 6.6 2.7 0.6 18.8 18.7 0.6 0.7 0.4 0.0 0.6 0.7 0.6 0.7 0.7 0.8 0.9 10.9 10.7 2.9 0.7 0.6 0.6 5.7 7.5 0.7 1.8 0.6 10.7 0.6 11.7 0.7 0.8 0.2 0.6 0.6 0.6 0.7 0.7 0.6 4.6 0.7 0.8 0.7 1.4 0.0 0.7 0.0 0.6 0.6 0.0 2.9 4.1 3.0 2.3 0.2 4.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.4 0.0 0.0 0.0 3.0 1.9 1.9 3.7 1.3 3.6 2.9 2.3 2.1 0.9 2.9 3.0 4.3 2.1 0.2 2.3 4.1 2.9 0.3 5.2 6.6 18.8 9.7 10.9 10.7 5.7 7.5 11.7 1.4 0.0 0.0 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM19 C8orf40 ENSG00000176209 "Small integral membrane protein 19" Q96E16 8 42541155-42555193 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011145, HPA074830" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA011145: AB_1078360, HPA074830: " "unprognostic (2.12e-2)" "unprognostic (2.33e-3)" "unprognostic (4.01e-2)" "unprognostic (1.85e-2)" "unprognostic (1.42e-1)" "unprognostic (6.68e-3)" "unprognostic (7.04e-3)" "unprognostic (1.76e-2)" "unprognostic (4.84e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (2.67e-2)" "prognostic favorable (1.74e-6)" "unprognostic (5.10e-2)" "unprognostic (9.70e-3)" "unprognostic (9.64e-2)" "unprognostic (2.93e-3)" 23.7 26.9 20.2 19.2 17.2 12.7 31.2 21.1 23.9 17.5 23.2 12.4 25.2 14.0 16.1 39.3 23.2 27.3 27.9 41.9 18.2 15.6 35.6 61.9 22.1 23.4 17.4 16.5 21.5 40.2 18.0 12.8 16.0 13.6 17.7 16.7 17.7 42.7 20.4 50.6 19.8 31.3 26.6 17.2 18.0 19.5 26.4 9.8 21.4 34.9 30.8 15.8 26.5 13.2 28.1 41.4 25.7 17.0 29.7 29.2 15.2 13.4 10.0 22.0 18.9 13.5 16.1 7.0 10.4 14.4 8.6 10.2 2.4 30.1 14.8 4.4 8.8 20.8 9.7 11.4 6.8 8.9 11.8 9.5 12.6 6.8 5.3 27.6 8.8 3.2 13.2 5.9 7.1 23.0 16.6 7.7 17.6 9.9 34.1 8.5 13.1 6.4 13.4 26.0 31.6 6.9 7.3 15.7 24.9 21.6 10.0 4.6 16.9 10.7 11.6 31.5 12.4 24.5 16.9 9.6 5.4 4.6 14.7 6.8 32.5 17.9 19.5 22.8 14.3 14.2 25.7 17.0 11.5 19.3 12.4 23.2 28.1 24.9 23.5 25.1 27.5 23.9 22.9 6.0 29.7 10.3 41.4 29.2 15.2 20.2 17.2 21.1 23.9 18.2 15.6 17.4 16.5 13.6 9.8 20.8 35.8 32.7 56.6 40.6 24.7 70.6 53.5 119.1 50.0 31.4 5.9 73.7 170.8 60.6 134.0 42.9 36.0 23.3 111.2 54.1 58.6 43.9 39.3 132.8 69.1 22.3 15.6 37.4 37.1 52.2 63.9 47.1 87.7 68.5 72.2 41.5 70.1 73.6 55.9 175.5 10.3 25.8 44.8 48.8 35.6 43.3 39.5 44.9 75.4 48.0 SMIM2 "C13orf44, MGC5590" ENSG00000139656 "Small integral membrane protein 2" Q9BVW6 13 44143543-44161257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 15.9" "Cell type enriched" "Detected in some" 8 "Early spermatids: 36.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 4.4;OE19: 12.1" "Low region specificity" "Detected in many" "HPA026891, HPA077071" Enhanced Uncertain "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA026891: AB_10602924, HPA077071: " "unprognostic (4.34e-2)" "unprognostic (8.70e-2)" "unprognostic (1.07e-1)" "unprognostic (4.87e-5)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (3.26e-1)" "unprognostic (1.26e-1)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.10e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (1.05e-2)" 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.2 0.8 0.9 0.1 2.9 0.1 0.2 0.3 1.2 0.2 0.2 0.9 0.4 0.1 0.0 0.2 0.1 0.7 0.0 0.3 0.2 0.2 0.0 0.6 0.0 1.0 0.1 2.2 0.2 0.2 0.1 0.4 15.9 0.1 0.0 0.2 0.1 0.5 0.0 0.0 0.2 1.8 0.4 0.0 0.9 0.8 0.9 0.2 0.0 0.0 1.1 0.0 4.4 1.0 0.0 1.5 0.2 1.7 1.1 0.0 1.2 2.7 0.0 1.7 1.2 0.0 1.7 0.0 1.9 0.0 1.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.2 1.1 0.0 0.7 12.1 1.2 1.0 0.0 0.2 0.0 0.5 2.3 1.2 3.4 1.5 2.2 1.9 0.0 0.2 0.4 0.0 0.8 1.2 0.2 0.0 0.0 0.7 1.3 0.4 0.8 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 SMIM20 "C4orf52, MITRAC7, PNX" ENSG00000250317 "Small integral membrane protein 20" Q8N5G0 4 25861830-25929874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016552 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA016552: AB_1859536" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" "unprognostic (1.78e-1)" "unprognostic (6.52e-3)" "unprognostic (1.55e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-3)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.02e-1)" "unprognostic (5.42e-2)" "unprognostic (2.86e-1)" "prognostic favorable (8.97e-5)" "unprognostic (5.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.53e-1)" "unprognostic (5.12e-3)" 14.9 20.5 21.8 15.6 26.7 7.1 25.0 11.4 28.0 12.9 16.4 8.3 12.8 24.1 13.7 46.4 11.9 15.1 22.5 33.7 17.9 16.2 27.1 22.7 18.5 26.0 19.2 14.3 19.5 50.0 8.7 10.0 9.5 22.8 13.6 16.1 11.3 20.4 15.7 51.3 6.9 23.8 24.0 22.6 12.7 18.8 17.7 13.5 9.3 21.3 15.3 14.5 14.5 15.9 27.1 21.4 13.3 20.3 18.1 31.1 18.2 12.9 10.9 14.6 14.1 16.2 35.4 19.6 12.7 15.4 10.9 14.0 9.6 23.1 21.4 22.1 14.0 22.7 3.8 17.0 16.2 15.3 12.1 13.5 12.3 7.9 18.3 27.6 14.6 8.2 25.0 32.6 13.9 21.2 21.4 8.4 14.5 19.7 7.0 13.4 8.3 15.8 24.9 27.6 17.3 16.3 13.1 19.1 13.7 24.3 9.5 18.9 17.6 8.1 5.7 27.9 16.8 11.8 20.9 13.9 11.9 14.1 13.3 16.1 13.8 11.3 22.4 18.0 15.6 15.0 13.3 18.2 8.4 15.7 20.3 20.5 27.1 22.7 19.7 20.5 26.8 31.1 24.7 9.2 18.1 15.2 21.4 23.2 18.2 21.8 26.7 11.4 28.0 17.9 16.2 19.2 14.3 22.8 13.5 8.9 35.3 39.7 30.7 19.5 7.0 54.2 58.6 29.4 35.2 34.9 7.9 53.4 111.0 55.9 8.3 17.8 60.0 0.0 54.3 51.6 39.2 34.0 10.4 52.1 61.7 1.6 18.6 19.0 49.0 18.9 34.8 47.0 42.2 36.1 53.7 55.6 48.1 35.1 45.3 134.2 16.1 71.1 36.2 42.9 40.5 16.9 36.6 25.9 63.5 25.3 SMIM21 C18orf62 ENSG00000206026 "Small integral membrane protein 21" Q3B7S5 18 75409476-75427703 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 48 "testis: 8.2" "Group enriched" "Detected in some" 53 "Early spermatids: 54.0;Late spermatids: 36.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2197: 1.3;U-87 MG: 5.1" HPA041686 Enhanced NA NA "HPA041686: AB_10961179" "unprognostic (7.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 1.3 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 SMIM22 ENSG00000267795 "Small integral membrane protein 22" K7EJ46 16 4788397-4796491 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 1586.1;Mucus-secreting cells: 1138.7;Paneth cells: 989.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "CAPAN-2: 68.7;OE19: 58.6;RT4: 25.3;SCLC-21H: 17.9;SK-BR-3: 51.6" "Not detected" "Not detected" HPA077331 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA077331: AB_2686834" "unprognostic (6.55e-2)" "unprognostic (4.12e-2)" "unprognostic (4.84e-2)" "unprognostic (3.69e-3)" "unprognostic (7.82e-2)" "unprognostic (3.84e-2)" "unprognostic (4.63e-2)" "unprognostic (2.67e-2)" "unprognostic (6.20e-2)" "unprognostic (3.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (1.73e-3)" 0.8 0.0 0.8 14.4 0.8 0.2 10.9 0.8 0.8 10.8 47.0 0.9 37.8 27.5 2.5 12.1 2.6 18.0 28.1 0.8 0.8 0.0 6.2 0.9 6.8 0.8 0.8 0.8 2.8 36.2 0.0 12.1 4.1 0.8 10.2 28.1 0.8 42.2 35.3 0.8 2.2 54.3 1.7 0.8 0.8 41.7 27.2 0.8 1.0 0.9 2.8 4.5 18.5 3.6 1.9 1.5 3.9 1.3 0.9 1.6 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 68.7 0.0 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.1 0.2 58.6 0.0 0.1 0.1 5.8 0.3 25.3 17.9 0.3 0.1 51.6 0.0 0.1 4.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.1 3.9 1.3 1.6 1.3 0.5 0.6 0.7 1.3 0.6 0.3 1.9 1.6 0.7 3.3 0.9 0.6 1.5 0.9 0.3 0.8 0.8 0.8 0.8 0.8 0.0 0.8 0.8 0.8 0.8 44.7 91.2 2.2 16.6 1.9 3.3 0.4 239.5 456.4 104.6 237.3 0.0 3.6 21.6 209.7 33.3 0.4 1586.1 0.0 336.4 0.4 0.3 47.7 18.4 0.0 0.3 1.6 452.3 0.0 0.0 89.0 0.6 2.7 21.9 9.0 1138.7 0.5 428.0 989.0 1.1 55.8 4.1 0.0 0.2 15.1 0.4 1.9 3.1 0.0 572.8 123.6 SMIM24 "C19orf77, HSPC323" ENSG00000095932 "Small integral membrane protein 24" O75264 19 3473986-3480542 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 160.8;intestine: 204.2;kidney: 76.9" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 1384.0" "Cancer enhanced" "Detected in many" "renal cancer: 78.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "NK-cell: 8.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 42.4;HEL: 20.0;Hep G2: 31.7;MOLT-4: 30.2;OE19: 50.3;REH: 16.6;U-937: 23.7" "Low region specificity" "Detected in many" "HPA045046, HPA056027" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045046: AB_10964444, HPA056027: AB_2683012" "unprognostic (2.18e-4)" "unprognostic (4.63e-1)" "unprognostic (5.68e-2)" "unprognostic (9.60e-2)" "unprognostic (1.93e-1)" "unprognostic (6.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (1.64e-1)" "unprognostic (2.85e-1)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.13e-10)" "unprognostic (1.68e-2)" "unprognostic (2.14e-1)" "unprognostic (8.36e-2)" "unprognostic (3.11e-2)" 0.2 0.1 0.7 0.6 0.9 7.0 0.3 0.2 2.2 0.2 137.0 0.4 2.4 71.4 0.2 160.8 0.3 0.3 46.7 0.3 0.4 0.5 76.9 7.2 0.3 0.3 0.4 0.6 0.3 1.6 0.0 0.9 0.2 0.3 0.3 2.0 0.2 0.3 0.4 0.2 0.3 204.2 0.2 0.6 0.4 24.8 1.2 0.3 8.8 0.2 0.2 0.2 0.2 0.2 3.2 2.4 3.0 0.0 8.6 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 42.4 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.2 31.7 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 30.2 4.2 0.0 50.3 0.0 16.6 0.0 1.1 0.4 0.0 0.4 0.6 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.7 0.0 23.7 0.0 3.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.1 0.6 0.7 1.7 0.0 8.6 0.0 2.4 2.1 1.1 0.7 0.9 0.2 2.2 0.4 0.5 0.4 0.6 0.3 0.3 0.0 0.0 1.7 0.1 0.0 12.1 0.2 229.3 0.0 0.0 55.8 25.5 0.0 202.2 3.9 5.0 0.0 64.6 23.3 11.3 0.1 0.0 0.3 1.1 8.5 0.1 0.0 133.5 0.6 0.8 11.2 0.3 0.0 0.0 1.0 34.7 2.7 11.1 51.8 0.0 1384.0 32.6 0.0 0.0 0.7 0.4 0.0 0.0 1.0 35.7 0.2 SMIM26 "LINC00493, LOC388789" ENSG00000232388 "Small integral membrane protein 26" A0A096LP01 20 18567347-18569563 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 330.0;Proximal tubular cells: 358.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068733 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA068733: AB_2686024" "unprognostic (1.20e-2)" "unprognostic (5.85e-2)" "unprognostic (2.83e-1)" "unprognostic (8.06e-2)" "unprognostic (2.68e-1)" "unprognostic (1.65e-1)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.67e-3)" "unprognostic (2.16e-1)" "unprognostic (2.68e-2)" "unprognostic (2.40e-2)" "unprognostic (2.02e-1)" "unprognostic (3.18e-1)" "prognostic favorable (7.84e-5)" 6.8 13.2 8.4 6.8 11.6 9.9 15.6 9.2 13.2 8.8 8.8 5.0 11.9 8.6 9.0 20.4 9.3 11.2 10.8 15.0 9.2 13.2 16.4 6.7 13.4 9.2 10.9 17.2 29.4 6.9 10.6 7.4 14.7 9.5 9.7 6.9 16.8 15.7 32.3 7.7 10.9 11.7 8.9 6.2 8.3 5.4 10.8 7.7 12.0 18.7 9.6 11.4 12.6 49.2 52.0 75.1 42.9 29.6 49.8 37.5 23.6 30.7 23.0 24.2 21.3 29.3 27.3 17.7 20.9 20.5 23.5 19.0 27.3 23.4 20.3 18.9 36.9 26.0 21.7 28.8 23.3 10.0 27.5 31.1 14.3 62.5 40.8 20.4 23.9 24.9 38.5 23.2 37.5 35.7 30.7 29.0 22.8 22.0 25.3 29.0 24.0 56.3 13.3 44.5 37.2 15.7 27.3 32.0 45.9 23.7 23.2 24.7 18.5 35.8 68.1 21.3 26.2 30.1 16.0 14.5 15.3 17.9 18.5 21.4 51.7 26.0 13.1 13.2 10.9 34.8 42.9 32.2 33.2 36.2 34.7 49.2 45.0 37.6 52.0 45.1 49.8 46.7 75.1 29.6 33.3 48.6 45.4 37.5 119.1 61.5 0.0 0.0 0.0 0.0 0.0 0.0 160.6 66.0 162.3 0.0 177.5 330.0 123.9 0.0 0.0 0.0 0.0 185.9 113.7 0.0 0.0 32.5 0.0 161.8 0.0 0.0 0.0 0.0 0.0 0.0 33.4 0.0 115.4 0.0 0.0 172.0 0.0 0.0 358.7 0.0 0.0 0.0 0.0 0.0 0.0 173.9 0.0 0.0 0.0 SMIM27 "C9orf133, TOPORS-AS1" ENSG00000235453 "Small integral membrane protein 27" 9 32551144-32568621 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in many" 6 "blood: 102.4" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 54.9;Distal tubular cells: 101.2;Proximal tubular cells: 50.5" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 102.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 102.4" "Low cell line specificity" "Detected in all" NA NA "prognostic favorable (4.18e-5)" "prognostic favorable (6.11e-4)" "unprognostic (1.47e-1)" "unprognostic (5.30e-2)" "unprognostic (4.88e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-1)" "unprognostic (4.74e-3)" "unprognostic (8.58e-2)" "prognostic favorable (8.39e-4)" "prognostic favorable (7.33e-5)" "unprognostic (1.30e-1)" "prognostic favorable (3.46e-4)" "unprognostic (7.64e-2)" "unprognostic (3.14e-1)" "unprognostic (2.38e-2)" "unprognostic (2.14e-3)" 4.0 6.9 5.0 4.3 12.2 7.9 5.6 4.8 11.0 4.0 4.0 2.4 4.4 4.8 2.2 7.8 2.3 4.0 2.1 8.6 5.1 6.2 3.9 5.6 8.8 5.7 5.8 3.7 11.5 3.7 5.5 2.1 8.9 4.4 1.6 4.0 5.9 4.6 13.8 2.1 3.9 4.5 11.4 6.6 5.1 16.2 6.1 4.5 2.8 4.7 4.1 2.6 0.0 18.4 8.4 102.4 7.6 13.3 22.0 9.9 7.1 4.1 7.5 6.7 3.3 10.0 4.1 3.8 5.6 2.9 5.9 1.0 2.0 5.5 5.5 5.4 5.3 2.9 5.1 3.3 4.2 10.7 11.4 27.2 12.4 9.1 7.6 6.7 4.7 7.3 5.3 2.8 6.7 8.4 6.6 18.1 3.8 14.0 5.2 5.5 11.8 27.5 9.2 7.3 7.8 6.2 3.5 9.8 6.8 3.8 5.6 6.9 9.0 3.5 4.6 9.5 2.8 5.9 3.8 2.1 5.6 2.7 3.7 15.7 12.0 19.5 12.5 4.1 1.8 13.6 7.3 47.4 12.7 7.2 16.9 17.6 18.3 14.7 6.1 18.4 22.0 19.0 102.4 13.3 7.6 8.4 18.3 9.9 26.8 29.6 0.0 0.0 0.0 0.0 0.0 0.0 54.9 17.0 27.9 0.0 21.4 101.2 16.2 0.0 0.0 0.0 0.0 28.2 10.1 0.0 0.0 23.3 0.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 10.8 0.0 0.0 21.1 0.0 0.0 50.5 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 SMIM28 ENSG00000262543 "Small integral membrane protein 28" A0A1B0GU29 6 138377905-138383075 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 9 "intestine: 6.2;lymphoid tissue: 2.4;smooth muscle: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.1;SCLC-21H: 2.4" NA NA "unprognostic (2.50e-2)" "unprognostic (5.48e-2)" 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 6.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.0 1.5 1.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM29 "C6orf1, LBH, MGC57858" ENSG00000186577 "Small integral membrane protein 29" Q86T20 6 34246380-34249470 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 67.8" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 61.3;Ductal cells: 41.8;Hofbauer cells: 88.6;monocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA037659, HPA037660" Uncertain NA NA "HPA037659: AB_2675591, HPA037660: AB_10671881" "unprognostic (2.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.35e-2)" "unprognostic (2.10e-1)" "unprognostic (3.23e-1)" "unprognostic (1.93e-3)" "unprognostic (1.36e-2)" "unprognostic (2.62e-1)" "unprognostic (4.12e-2)" "prognostic favorable (7.98e-4)" "unprognostic (9.32e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (3.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.16e-2)" "unprognostic (3.66e-1)" 9.6 18.5 42.0 10.4 21.8 9.9 12.4 14.8 36.8 10.5 7.6 15.2 4.6 7.1 9.1 24.4 13.3 11.5 12.3 19.0 34.6 34.4 7.9 6.0 13.3 13.5 35.7 16.5 8.8 10.7 7.0 12.2 10.0 25.7 9.7 4.8 12.5 7.5 13.6 7.8 29.2 6.7 8.3 23.9 15.2 9.4 5.2 14.0 5.8 15.2 8.3 11.0 16.0 9.3 22.4 10.4 67.8 15.0 9.8 15.8 11.0 8.9 9.9 2.0 11.7 24.7 20.6 2.0 9.2 19.5 8.5 10.4 2.4 3.4 5.0 7.4 8.2 16.1 5.5 3.7 8.8 2.5 12.9 6.4 3.7 2.5 6.8 13.7 4.4 23.3 11.2 8.4 12.0 12.8 10.8 13.6 3.8 4.8 25.0 19.3 5.7 4.6 8.0 0.7 10.9 7.3 1.6 1.3 7.7 10.2 11.5 9.5 4.5 0.9 6.6 24.0 1.7 4.8 5.2 10.0 19.4 5.3 22.4 7.7 15.9 22.4 1.6 11.4 8.7 28.3 15.3 15.0 67.8 15.8 10.7 10.3 22.4 12.6 13.5 10.4 21.8 8.7 12.5 38.7 9.8 7.6 8.8 15.3 11.0 42.0 21.8 14.8 36.8 34.6 34.4 35.7 16.5 25.7 14.0 8.9 9.9 0.0 0.0 0.0 0.0 0.0 0.0 18.7 12.5 29.6 0.0 30.4 61.3 41.8 0.0 0.0 0.0 0.0 20.4 10.4 0.0 0.0 11.6 0.0 88.6 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 77.5 0.0 0.0 25.6 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.0 SMIM3 "C5orf62, MSTP150, NID67" ENSG00000256235 "Small integral membrane protein 3" Q9BZL3 5 150777946-150796734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 24.4;blood: 22.3;bone marrow: 11.4;pancreas: 45.7" "Cell type enhanced" "Detected in many" 8 "granulocytes: 87.8;Sertoli cells: 135.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 64.2;ASC TERT1: 31.4;LHCN-M2: 29.1;U-87 MG: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075345 Approved Vesicles NA NA Vesicles "HPA075345: AB_2686744" "unprognostic (2.33e-1)" "unprognostic (4.05e-2)" "unprognostic (1.35e-2)" "unprognostic (2.70e-2)" "unprognostic (9.45e-2)" "unprognostic (5.65e-2)" "unprognostic (4.57e-3)" "unprognostic (1.47e-1)" "unprognostic (3.90e-1)" "unprognostic (2.05e-2)" "unprognostic (9.71e-3)" "unprognostic (3.46e-3)" "prognostic unfavorable (1.15e-8)" "unprognostic (3.87e-3)" "unprognostic (1.31e-2)" "unprognostic (2.16e-1)" "unprognostic (1.46e-3)" 24.4 5.4 6.1 3.3 5.6 11.4 3.9 3.3 6.2 2.2 3.1 1.8 0.7 1.3 3.0 2.9 2.2 3.0 3.3 3.4 2.6 1.2 2.9 1.1 3.6 0.7 3.0 1.0 3.2 45.7 1.2 1.8 6.4 6.2 3.2 2.3 1.3 1.8 3.3 2.5 2.2 3.9 3.7 2.6 1.9 2.9 1.7 4.3 1.8 2.7 0.7 0.7 3.8 1.8 0.3 18.4 22.3 13.3 3.6 7.2 11.6 2.0 0.6 1.1 9.4 64.2 31.4 2.4 8.0 17.2 2.9 11.9 3.1 5.4 0.0 0.4 8.2 2.0 1.6 1.8 1.7 4.4 0.0 0.5 2.9 0.4 1.4 11.4 2.9 21.2 26.3 3.6 8.3 3.8 19.3 0.9 7.2 0.8 0.0 29.1 1.5 4.1 4.0 0.5 1.6 1.9 2.3 0.1 0.0 3.1 1.5 0.2 0.7 1.1 0.1 2.3 1.3 3.9 18.1 1.5 13.2 2.4 10.3 4.1 0.0 0.0 0.0 47.7 11.1 1.6 17.9 13.3 22.3 7.2 5.3 4.3 0.3 5.1 4.9 6.2 0.0 5.0 4.3 13.9 3.6 4.8 18.4 0.7 11.6 6.1 5.6 3.3 6.2 2.6 1.2 3.0 1.0 6.2 4.3 6.0 10.4 0.5 56.6 0.0 0.7 6.6 10.2 0.0 4.5 7.0 0.0 7.7 11.6 6.6 0.6 6.7 2.3 0.0 28.1 4.8 19.3 11.1 87.8 0.4 39.0 0.0 4.6 12.9 26.7 0.6 13.0 15.3 0.0 34.3 34.3 42.1 14.9 0.0 34.6 7.1 0.7 135.8 63.1 0.0 0.5 0.0 6.8 10.2 6.2 43.2 SMIM30 LINC00998 ENSG00000214194 "Small integral membrane protein 30" A4D0T7 7 113116718-113118613 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 351.5;Hofbauer cells: 207.3;Proximal tubular cells: 287.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.25e-1)" "unprognostic (1.73e-3)" "unprognostic (6.77e-2)" "unprognostic (1.04e-2)" "unprognostic (2.44e-3)" "unprognostic (3.89e-3)" "prognostic unfavorable (1.02e-4)" "unprognostic (7.25e-2)" "unprognostic (5.00e-3)" "unprognostic (7.07e-3)" "unprognostic (6.80e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (7.21e-4)" "unprognostic (2.46e-2)" "unprognostic (1.82e-1)" "unprognostic (2.63e-1)" "unprognostic (1.35e-1)" 16.1 19.7 19.0 7.8 19.8 2.8 14.2 11.8 12.6 11.6 12.6 9.2 7.7 9.3 9.3 22.1 21.2 9.2 13.9 58.3 16.8 13.7 30.4 16.4 13.6 9.8 16.8 8.5 12.6 12.0 20.2 21.7 18.6 11.6 11.8 10.7 11.2 16.5 9.5 38.1 5.8 19.2 13.9 19.3 25.3 11.2 11.6 12.3 9.8 27.7 13.9 8.8 15.6 8.8 13.1 23.4 7.5 11.1 12.5 14.3 9.8 11.1 5.6 13.6 11.8 24.7 39.3 0.0 13.5 22.4 14.5 22.8 5.8 19.6 13.3 16.9 16.8 25.5 7.1 13.3 29.8 35.6 8.8 26.5 30.4 8.3 9.6 16.5 40.7 0.1 29.5 28.8 22.3 11.5 26.9 22.7 14.3 40.0 12.6 47.0 5.7 17.3 44.6 14.0 16.9 15.5 11.1 32.7 36.3 27.9 14.7 20.5 15.0 10.2 20.5 31.3 24.7 13.9 27.3 13.0 23.7 12.0 26.7 20.0 18.8 23.1 47.8 31.0 37.5 33.1 1.3 10.2 7.5 11.1 11.1 12.2 13.1 12.7 11.5 16.1 11.3 12.2 12.1 0.4 12.5 8.8 23.4 14.3 9.8 19.0 19.8 11.8 12.6 16.8 13.7 16.8 8.5 11.6 12.3 47.6 55.1 0.0 0.0 0.0 0.0 0.0 0.0 60.2 60.3 120.4 0.0 70.2 351.5 92.2 0.0 0.0 0.0 0.0 61.5 59.6 0.0 0.0 30.2 0.0 207.3 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 77.5 0.0 0.0 75.7 0.0 0.0 287.3 0.0 0.0 0.0 0.0 0.0 0.0 34.8 0.0 0.0 0.0 SMIM31 LINC01207 ENSG00000248771 "Small integral membrane protein 31" 4 164754064-164803795 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "intestine: 42.7" "Group enriched" "Detected in some" 5 "Exocrine glandular cells: 81.2;Pancreatic endocrine cells: 87.7" "Cancer enhanced" "Detected in many" "prostate cancer: 8.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 3.3;RPTEC TERT1: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted - unknown location" NA NA "unprognostic (2.84e-1)" "unprognostic (1.18e-1)" "unprognostic (2.47e-2)" "unprognostic (1.87e-4)" "unprognostic (2.95e-2)" "unprognostic (1.78e-1)" "unprognostic (4.17e-2)" "unprognostic (4.82e-1)" "unprognostic (9.47e-2)" "unprognostic (5.63e-3)" 0.0 0.0 0.1 4.0 0.0 0.2 0.6 0.0 0.0 3.1 25.4 0.0 0.0 13.7 0.7 0.2 0.1 0.0 6.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 9.8 9.8 0.0 2.1 0.0 0.0 0.0 42.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 1.1 1.4 3.1 0.5 1.3 0.5 0.0 0.4 3.3 0.2 0.8 0.2 0.4 0.9 0.3 0.1 0.3 0.3 1.2 0.4 0.6 0.3 0.2 0.2 0.8 0.1 0.4 0.1 0.3 0.4 0.1 0.4 0.3 0.4 0.6 0.9 0.3 0.3 0.2 0.2 0.1 0.0 0.5 0.5 1.5 0.0 0.6 0.4 1.4 0.4 1.7 0.1 0.6 0.2 1.4 4.5 0.6 0.5 0.2 0.4 0.5 0.6 0.5 0.4 0.7 0.4 0.5 0.2 0.8 0.5 1.8 0.4 0.7 0.8 0.7 1.2 3.1 0.5 0.6 0.4 0.3 0.4 0.4 0.4 0.4 0.2 1.1 0.5 0.5 2.8 1.3 0.4 1.4 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 18.7 17.0 3.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 81.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SMIM32 ENSG00000271824 "Small integral membrane protein 32" 5 136191468-136193134 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 9 "brain: 7.8;gallbladder: 9.8;intestine: 12.3;kidney: 26.2" "Cell type enriched" "Detected in some" 8 "Proximal tubular cells: 233.2" "Cancer enhanced" "Detected in many" "renal cancer: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HaCaT: 2.3;SCLC-21H: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.35e-5)" "unprognostic (3.08e-1)" "unprognostic (7.74e-2)" "unprognostic (7.79e-2)" "unprognostic (2.11e-2)" "unprognostic (9.13e-2)" "prognostic favorable (1.63e-4)" "unprognostic (1.86e-2)" "unprognostic (1.75e-2)" "prognostic favorable (6.13e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-2)" "unprognostic (2.78e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-3)" "unprognostic (8.05e-2)" 0.0 0.0 0.0 1.2 2.2 0.0 0.0 0.0 7.8 0.0 5.1 0.0 0.0 12.3 0.0 0.0 0.0 0.0 9.8 0.0 0.6 26.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.4 0.1 0.0 0.0 0.2 0.0 8.3 0.0 0.0 0.0 1.5 0.0 1.4 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 6.1 0.6 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 233.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SMIM33 ENSG00000283288 "Small integral membrane protein 33" 5 139470778-139474772 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 3.5;intestine: 5.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 2.2;T-cells: 3.5" "Cell line enhanced" "Detected in some" "JURKAT: 2.0;U-937: 2.7" "Not detected" "Not detected" NA NA 0.0 0.0 0.4 0.4 0.0 0.0 1.2 3.9 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 2.2 0.3 0.1 0.6 3.5 0.5 0.5 0.5 0.4 0.3 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.5 0.4 0.3 0.0 0.4 0.2 0.1 0.0 0.6 0.3 0.3 0.1 0.3 0.1 0.0 0.3 0.4 0.1 0.0 0.1 0.1 0.0 2.0 0.1 0.3 0.1 0.4 1.2 0.9 0.1 0.2 0.1 0.6 0.0 0.2 0.2 0.2 0.7 0.4 0.1 0.9 0.0 0.1 0.6 0.7 1.1 0.0 0.3 0.4 0.2 0.3 0.1 0.2 0.1 2.7 0.5 0.1 0.1 0.0 2.3 0.0 3.5 0.3 3.1 2.2 0.0 0.1 0.8 0.4 0.3 0.6 0.0 2.2 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM34A ENSG00000243627 "Small integral membrane protein 34A" A8MWV9 21 34418715-34423966 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 4.5;SK-MEL-30: 1.2;U-87 MG: 1.0" HPA029085 Uncertain NA NA "HPA029085: AB_10669867" 0.3 0.1 0.3 0.3 0.5 0.2 2.9 1.6 0.3 0.4 0.3 0.3 0.3 0.0 0.3 0.3 0.3 2.1 0.3 0.6 0.3 0.2 9.6 0.5 0.9 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.7 0.3 0.3 0.3 0.7 1.0 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.7 0.0 0.6 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.5 1.6 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM34B ENSG00000278961 "Small integral membrane protein 34B" A8MWV9 21 7784482-7793954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 4.5;kidney: 16.1" "Group enriched" "Detected in some" 7 "Ciliated cells: 12.0;Distal tubular cells: 5.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 3.1;myeloid DC: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 6.5;SK-MEL-30: 2.7;U-87 MG: 2.5" HPA029085 Uncertain NA NA "HPA029085: AB_10669867" 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.4 16.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 3.1 0.6 0.0 0.0 0.4 1.1 0.2 0.2 0.0 0.0 0.0 0.3 0.2 1.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 2.7 0.0 1.2 0.3 0.0 0.0 0.5 0.4 0.0 1.2 0.1 0.0 2.5 0.3 0.1 0.0 0.5 3.1 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM35 TMPRSS4-AS1 ENSG00000255274 "Small integral membrane protein 35" 11 118003634-118088299 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 7 "blood: 4.6;bone marrow: 3.1;kidney: 3.4;lymphoid tissue: 1.7" "Cell type enriched" "Detected in single" 18 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Karpas-707: 14.6;RPMI-8226: 9.1" "Group enriched" "Detected in some" 5 "basal ganglia: 1.1;olfactory region: 4.3" NA NA "unprognostic (8.83e-2)" "unprognostic (3.42e-2)" "unprognostic (2.64e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-4)" "unprognostic (2.92e-1)" "unprognostic (1.09e-1)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" 0.0 0.0 1.2 3.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.4 0.1 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.5 0.0 1.7 0.8 0.1 0.5 1.2 4.6 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 9.1 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.0 0.9 0.0 0.0 1.7 0.7 1.1 0.7 0.4 0.0 0.6 0.1 1.2 0.5 0.8 4.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM36 ENSG00000261873 "Small integral membrane protein 36" 17 55448433-55511444 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 5 "retina: 29.3" "Group enriched" "Detected in some" 18 "Ciliated cells: 1.4;Club cells: 2.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in some" NA NA "unprognostic (2.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.8 2.9 0.8 1.2 0.7 0.6 0.1 0.5 0.2 0.2 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.3 0.9 0.0 0.0 0.0 0.3 0.0 0.4 1.0 0.9 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.3 0.8 0.0 0.0 0.4 0.3 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.8 0.5 0.7 0.6 0.1 0.0 0.6 0.6 0.0 1.3 0.5 0.4 0.5 0.3 0.4 0.2 0.5 0.4 0.7 0.2 2.9 0.8 0.8 0.6 0.6 0.5 0.5 0.5 0.5 0.3 1.4 0.6 0.7 2.4 1.2 0.7 0.8 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM37 "LINC00116, NCRNA00116" ENSG00000175701 "Small integral membrane protein 37" Q8NCU8 2 110211529-110245420 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 39.5;skeletal muscle: 119.5" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 113.4;Distal tubular cells: 213.9;Proximal tubular cells: 184.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.74e-2)" "unprognostic (1.86e-1)" "unprognostic (7.68e-2)" "unprognostic (6.99e-2)" "unprognostic (2.04e-1)" "unprognostic (2.64e-1)" "unprognostic (3.49e-3)" "unprognostic (8.20e-2)" "unprognostic (9.10e-2)" "unprognostic (6.08e-2)" "unprognostic (5.08e-3)" "unprognostic (8.27e-2)" "unprognostic (1.97e-1)" "unprognostic (2.93e-2)" "unprognostic (1.04e-1)" "unprognostic (8.80e-2)" "unprognostic (1.95e-2)" 5.1 4.6 3.6 3.3 5.1 1.2 6.3 1.6 5.7 3.1 4.8 0.9 2.8 7.0 1.9 9.8 6.6 2.4 2.5 15.0 3.3 7.4 8.4 2.9 3.9 3.2 3.3 2.2 5.2 2.4 1.2 2.0 4.8 4.2 1.9 1.9 5.9 6.2 119.5 2.8 5.4 2.9 2.3 3.5 4.3 2.5 2.8 1.8 6.1 19.2 2.5 3.9 3.8 31.8 39.5 3.4 28.8 20.4 37.1 20.0 0.1 37.5 4.2 4.6 4.4 5.4 25.1 15.2 11.6 18.1 11.9 25.3 11.8 5.0 29.7 4.0 25.2 15.8 3.9 16.6 2.8 21.4 15.8 3.0 9.2 20.8 18.7 10.3 15.5 14.2 19.9 15.2 0.0 9.8 15.6 15.2 8.3 12.4 8.4 37.6 14.4 35.6 10.3 11.7 11.0 1.5 8.5 14.9 10.7 22.9 9.1 6.0 8.4 29.0 16.6 2.7 8.0 17.7 12.5 17.9 24.9 17.3 22.6 21.2 13.5 1.4 18.7 16.4 12.6 2.4 28.8 3.4 31.0 28.5 34.8 27.9 34.8 33.2 29.0 31.8 37.1 37.0 1.4 20.4 16.7 39.5 29.9 20.0 32.8 32.1 0.0 0.0 0.0 0.0 0.0 0.0 45.5 25.0 113.4 0.0 38.5 213.9 61.0 0.0 0.0 0.0 0.0 87.3 23.9 0.0 0.0 31.4 0.0 71.3 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 50.5 0.0 0.0 80.6 0.0 0.0 184.3 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 SMIM4 C3orf78 ENSG00000168273 "Small integral membrane protein 4" Q8WVI0 3 52534013-52579237 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 90.6" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 211.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047771 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA047771: AB_2680150" "unprognostic (3.76e-3)" "unprognostic (3.19e-2)" "unprognostic (4.54e-2)" "unprognostic (4.89e-1)" "unprognostic (2.40e-1)" "unprognostic (1.48e-2)" "unprognostic (9.89e-2)" "prognostic favorable (1.78e-5)" "unprognostic (3.25e-2)" "unprognostic (4.25e-2)" "prognostic favorable (5.00e-4)" "unprognostic (6.35e-2)" "prognostic favorable (1.63e-4)" "unprognostic (8.72e-3)" "unprognostic (2.28e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-2)" 11.1 47.3 6.8 9.3 12.0 4.1 15.9 10.3 13.4 6.0 8.7 3.2 16.0 7.5 5.2 16.3 5.5 5.0 13.0 90.6 8.4 6.1 12.2 9.3 21.7 26.5 8.5 6.9 19.1 28.3 6.2 22.1 4.1 17.4 10.6 6.7 10.5 25.8 19.1 66.8 6.7 7.9 17.0 9.1 5.7 8.5 14.1 7.6 1.8 17.3 30.8 5.3 7.0 5.3 13.7 26.2 8.8 24.7 11.0 16.9 10.4 23.0 8.1 9.5 24.0 11.2 5.8 19.4 10.5 4.9 12.1 10.6 9.9 6.2 10.0 4.8 4.4 12.2 12.2 3.1 8.4 4.9 6.6 24.6 9.4 23.2 19.9 17.0 11.1 13.1 12.5 5.2 10.2 7.4 6.6 11.0 11.0 12.4 15.0 8.1 10.0 10.3 15.6 16.1 12.7 17.3 7.1 9.1 19.7 6.7 10.1 10.3 13.0 20.5 6.8 19.8 5.6 7.0 9.4 9.7 6.7 22.0 31.6 21.3 17.5 19.0 21.9 36.8 20.9 9.2 3.5 24.7 8.8 10.8 18.7 10.5 13.7 15.6 13.2 26.2 12.5 16.9 15.2 0.9 11.0 7.5 14.0 14.9 10.4 6.8 12.0 10.3 13.4 8.4 6.1 8.5 6.9 17.4 7.6 44.7 44.8 30.4 29.5 24.2 16.1 211.3 61.1 62.9 77.3 50.6 11.8 35.0 180.8 36.8 15.8 36.5 60.3 0.0 74.3 16.7 27.7 17.7 56.7 143.5 98.6 3.2 76.2 60.8 84.6 8.0 60.1 52.8 35.4 17.2 57.4 43.6 50.1 28.1 95.1 134.6 12.7 45.3 51.1 7.7 15.8 30.2 23.1 25.9 67.6 18.2 SMIM5 C17orf109 ENSG00000204323 "Small integral membrane protein 5" Q71RC9 17 75633434-75641404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.2" "Group enriched" "Detected in many" 5 "Collecting duct cells: 118.7;Distal tubular cells: 77.9;Erythroid cells: 233.6;Urothelial cells: 102.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 51 "plasmacytoid DC: 54.2" "Lineage enriched" "Detected in many" 51 "dendritic cells: 54.2" "Cell line enhanced" "Detected in some" "HEL: 3.1;MCF7: 14.3;OE19: 3.8;SK-BR-3: 6.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065332, HPA071268" Approved Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA065332: AB_2685471, HPA071268: AB_2686377" "unprognostic (6.97e-2)" "prognostic favorable (5.52e-4)" "unprognostic (2.13e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (1.05e-4)" "unprognostic (3.29e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-1)" "unprognostic (2.66e-2)" "unprognostic (3.52e-3)" "unprognostic (1.10e-1)" "prognostic favorable (1.12e-4)" "unprognostic (2.64e-1)" "unprognostic (4.94e-2)" "unprognostic (8.26e-2)" "unprognostic (2.58e-1)" 0.4 0.6 2.1 1.8 10.7 9.9 1.4 1.1 7.5 4.0 4.4 23.5 2.1 9.8 0.7 0.8 14.3 5.5 4.7 5.1 3.7 2.2 13.6 0.5 2.5 1.1 8.8 4.8 1.3 1.1 0.4 1.1 1.9 16.9 1.9 2.8 2.5 8.4 2.2 0.4 7.8 9.5 2.1 10.1 2.4 11.0 0.9 8.9 0.4 9.3 0.9 3.6 4.4 7.3 0.0 54.2 1.0 0.0 0.0 0.0 4.0 2.5 1.7 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.2 3.1 0.4 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.2 14.3 0.1 0.1 0.1 3.8 0.2 0.4 0.5 0.1 0.0 2.8 1.2 0.1 0.0 6.4 0.0 0.5 0.9 0.2 0.1 0.3 0.2 0.1 0.2 0.3 0.0 0.1 0.1 0.7 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 54.2 0.0 4.0 2.1 10.7 1.1 7.5 3.7 2.2 8.8 4.8 16.9 8.9 8.9 6.5 0.0 6.3 1.0 1.2 19.3 10.2 25.4 2.3 118.7 2.0 1.2 77.9 1.8 0.1 1.3 13.2 233.6 0.5 4.2 2.4 6.1 0.0 0.0 0.6 0.0 13.8 2.5 0.0 0.0 0.6 0.6 6.8 0.0 8.2 3.2 6.4 10.5 1.4 0.8 1.8 0.0 0.4 0.5 0.4 7.3 27.5 1.3 1.7 102.7 SMIM6 C17orf110 ENSG00000259120 "Small integral membrane protein 6" P0DI80 17 75646243-75647977 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 22.0;fallopian tube: 19.1;stomach 1: 26.5;testis: 20.6" "Group enriched" "Detected in many" 4 "Early spermatids: 508.7;Late spermatids: 1038.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 22.0" "Lineage enriched" "Detected in single" 46 "dendritic cells: 22.0" "Cell line enhanced" "Detected in some" "A549: 12.6;CACO-2: 4.1;EFO-21: 9.8;HEL: 7.1;OE19: 11.6;RPTEC TERT1: 4.5" HPA065721 Uncertain Approved Nucleoplasm Yes NA Nucleoplasm "HPA065721: AB_2685546" "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (7.07e-2)" "prognostic favorable (1.49e-4)" "unprognostic (3.42e-1)" "unprognostic (1.22e-2)" "unprognostic (6.53e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-3)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "unprognostic (8.06e-2)" "prognostic favorable (4.09e-4)" "unprognostic (2.77e-1)" "unprognostic (1.38e-1)" "unprognostic (2.58e-2)" "prognostic favorable (1.64e-4)" 0.2 0.1 2.4 0.6 4.1 0.6 0.1 0.6 6.1 1.8 5.3 12.3 3.2 7.9 0.9 2.2 0.2 19.1 15.8 0.1 4.0 2.1 13.5 5.2 1.8 0.3 5.3 4.1 0.4 7.3 1.7 0.1 0.4 5.4 0.3 5.5 0.1 0.2 2.9 0.1 0.2 9.4 0.0 9.1 0.2 26.5 20.6 3.1 0.0 0.1 0.2 0.2 1.1 0.8 0.0 22.0 0.0 0.0 0.4 0.0 0.2 0.7 12.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.1 3.9 0.0 9.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 7.1 0.3 3.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.2 4.5 2.1 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 22.0 0.0 0.2 2.4 4.1 0.6 6.1 4.0 2.1 5.3 4.1 5.4 3.1 3.0 1.9 0.8 3.2 0.1 0.0 0.0 30.6 44.2 6.8 33.2 0.0 0.0 116.0 27.9 508.7 0.1 26.2 0.0 14.7 2.6 0.2 1.8 0.0 5.4 0.6 0.0 189.1 0.0 0.0 1038.8 6.1 1.0 0.0 2.8 36.2 0.0 37.4 84.2 1.8 15.7 0.0 6.5 0.1 4.9 2.1 0.0 3.4 0.0 3.1 8.4 SMIM7 "C19orf42, MGC2747" ENSG00000214046 "Small integral membrane protein 7" Q9BQ49 19 16630751-16660442 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043127 Uncertain Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA043127: AB_10806378" "unprognostic (6.61e-2)" "unprognostic (1.61e-2)" "unprognostic (1.90e-1)" "unprognostic (3.71e-2)" "unprognostic (2.52e-1)" "unprognostic (2.28e-1)" "unprognostic (9.65e-2)" "unprognostic (1.79e-2)" "unprognostic (6.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.75e-1)" "unprognostic (1.76e-3)" "unprognostic (8.29e-3)" "unprognostic (2.94e-1)" "unprognostic (2.29e-1)" "unprognostic (8.38e-2)" "unprognostic (7.64e-2)" 24.6 26.2 20.5 16.9 27.1 12.0 25.5 30.0 32.1 23.4 19.1 28.1 30.4 18.8 25.7 43.2 19.7 23.2 20.1 21.8 19.6 19.7 28.8 32.4 20.1 21.1 22.1 21.2 31.7 39.6 29.8 23.0 28.6 22.7 27.2 26.0 29.2 40.6 25.9 19.6 22.9 20.0 22.3 26.7 23.3 23.1 22.4 15.8 20.6 34.1 18.1 22.7 19.3 23.0 21.8 31.0 15.4 30.4 15.2 17.7 16.5 18.9 13.0 16.0 12.6 22.9 19.7 13.2 17.0 16.3 15.5 13.6 12.0 25.0 12.9 23.9 17.2 15.4 13.5 14.3 19.5 17.7 12.1 12.2 12.6 11.9 11.9 8.9 18.3 16.6 14.2 12.2 13.0 13.9 14.3 15.6 11.0 17.0 19.6 19.8 28.8 12.3 16.8 13.7 30.3 19.6 13.8 11.3 12.2 15.4 20.2 5.8 14.4 13.1 11.8 15.9 8.9 17.9 26.9 12.1 16.5 11.7 42.8 27.2 17.5 24.9 17.3 18.0 24.0 20.0 14.4 30.4 15.4 17.7 26.5 14.4 21.8 17.3 15.7 23.8 21.3 16.8 15.9 14.2 15.2 28.0 31.0 17.6 16.5 20.5 27.1 30.0 32.1 19.6 19.7 22.1 21.2 22.7 15.8 62.5 60.5 87.1 54.8 30.3 69.0 32.3 45.9 45.5 45.5 54.1 90.3 122.2 109.5 72.5 10.8 49.4 63.9 23.3 74.9 85.4 64.1 63.4 49.6 76.9 99.9 60.4 70.0 64.4 77.0 15.6 82.3 59.6 45.5 96.4 58.9 84.5 74.9 77.2 78.1 97.6 112.1 71.1 57.0 86.0 82.7 31.2 130.8 47.3 55.5 45.2 SMIM8 "C6orf162, dJ102H19.2, DKFZP586E1923" ENSG00000111850 "Small integral membrane protein 8" Q96KF7 6 87322583-87399749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007401, HPA067453" Approved Approved Vesicles NA NA Vesicles "HPA007401: AB_1078357, HPA067453: AB_2685844" "unprognostic (2.54e-1)" "unprognostic (5.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.90e-1)" "unprognostic (1.56e-2)" "unprognostic (3.16e-2)" "unprognostic (3.09e-2)" "unprognostic (6.17e-2)" "unprognostic (5.31e-2)" "unprognostic (6.12e-3)" "unprognostic (1.86e-5)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (2.01e-1)" "unprognostic (3.06e-2)" "unprognostic (2.86e-2)" "unprognostic (4.01e-1)" 7.8 9.0 13.3 6.3 14.6 9.0 9.1 15.6 15.6 7.4 8.3 7.6 8.5 8.8 11.4 12.2 6.5 7.1 4.7 10.3 17.9 12.5 10.4 12.0 5.6 9.1 12.0 10.8 10.5 8.0 6.1 19.2 5.8 11.9 7.9 8.1 7.8 7.2 7.3 16.2 5.4 7.9 11.3 10.2 6.5 6.3 7.4 8.0 11.0 7.5 4.7 6.5 6.5 8.7 16.0 8.9 13.4 8.4 7.7 18.7 8.5 4.3 3.9 8.0 13.8 4.7 5.3 3.5 4.9 3.8 4.2 8.0 2.7 4.1 9.0 5.9 4.9 7.2 5.5 6.3 3.7 8.0 8.0 6.9 13.1 4.4 5.3 4.4 13.6 4.8 5.0 5.1 4.2 4.5 4.7 5.9 11.6 14.7 15.2 4.6 3.3 8.2 10.9 4.9 6.5 6.0 13.2 11.9 5.1 5.3 4.3 13.7 5.7 7.2 4.3 7.8 7.7 3.9 13.8 5.7 2.2 6.3 9.3 4.7 6.8 11.0 5.9 7.1 6.6 6.5 5.2 8.1 13.1 10.7 7.7 10.6 16.0 12.6 12.8 8.9 10.4 18.7 16.2 13.4 7.7 8.4 7.5 15.5 8.5 13.3 14.6 15.6 15.6 17.9 12.5 12.0 10.8 11.9 8.0 11.9 4.3 15.9 17.9 12.2 25.0 38.9 12.7 13.4 12.5 22.7 35.3 14.8 38.1 8.8 15.3 13.4 7.7 0.0 9.1 10.5 15.1 10.1 4.7 12.1 12.7 35.0 8.2 19.0 14.6 12.1 14.7 12.8 8.5 10.8 9.5 23.3 6.9 14.0 19.4 18.3 23.0 25.8 12.5 18.9 21.6 12.9 12.5 13.1 17.6 10.7 SMIM9 CXorf68 ENSG00000203870 "Small integral membrane protein 9" A6NGZ8 X 154823348-154834662 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 4 "testis: 4.1" "Group enriched" "Detected in some" 7 "Early spermatids: 19.8;Late spermatids: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 1.6" HPA060970 Uncertain NA NA "HPA060970: AB_2684399" "unprognostic (2.63e-5)" 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 0.0 0.0 SMLR1 ENSG00000256162 "Small leucine rich protein 1" H3BR10 6 130827406-130837135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "intestine: 33.8;liver: 67.3" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 193.4" "Cancer enriched" "Detected in some" 20 "liver cancer: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "Hep G2: 42.5" "Low region specificity" "Detected in all" HPA066060 Uncertain NA NA "HPA066060: AB_2685607" "unprognostic (1.73e-1)" "unprognostic (7.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.32e-2)" "unprognostic (2.35e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (6.43e-3)" "unprognostic (2.68e-3)" "unprognostic (3.29e-1)" 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 14.0 0.0 0.0 7.8 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.1 2.3 67.3 0.1 0.0 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.1 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 193.4 0.1 0.0 0.0 1.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 15.3 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SMO "FZD11, SMOH" ENSG00000128602 "Smoothened, frizzled class receptor" Q99835 7 129188872-129213545 "Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 10.4;Leydig cells: 19.2;Muller glia cells: 15.1;Peritubular cells: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.3;AN3-CA: 37.6;NTERA-2: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011446 Approved NA NA "CAB011446: " "unprognostic (2.48e-2)" "unprognostic (2.69e-2)" "unprognostic (7.09e-2)" "unprognostic (1.10e-1)" "unprognostic (8.16e-2)" "unprognostic (2.02e-1)" "unprognostic (3.63e-1)" "unprognostic (5.89e-2)" "unprognostic (5.38e-3)" "unprognostic (1.59e-1)" "unprognostic (1.17e-2)" "unprognostic (8.74e-3)" "unprognostic (1.62e-1)" "unprognostic (5.15e-3)" "unprognostic (2.09e-1)" "unprognostic (2.25e-1)" "unprognostic (2.61e-2)" 4.0 4.1 4.2 3.8 4.8 0.5 7.4 5.3 4.6 18.2 5.8 5.1 9.2 2.5 20.9 18.7 10.3 11.4 10.0 5.2 8.4 3.7 10.6 13.7 2.4 2.0 4.3 4.5 23.0 7.1 14.4 13.5 2.6 9.0 18.4 2.2 17.2 9.4 12.8 3.5 16.6 3.5 9.8 7.0 2.0 4.2 7.9 3.4 5.3 9.2 6.8 4.6 6.3 17.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.0 20.3 37.6 0.5 0.1 6.4 2.2 2.9 4.5 2.6 6.1 0.1 0.0 6.2 4.5 10.2 12.4 12.2 0.7 1.7 0.0 9.9 3.9 0.0 9.8 2.5 0.1 0.0 7.4 5.0 1.4 0.0 9.0 2.6 11.2 0.6 0.0 1.4 0.0 10.3 0.0 28.8 0.0 2.3 15.0 8.7 0.0 2.3 0.0 0.6 13.6 0.0 0.0 5.3 8.1 4.9 2.6 0.0 0.3 6.5 7.8 4.3 0.4 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 4.8 5.3 4.6 8.4 3.7 4.3 4.5 9.0 3.4 0.0 0.0 0.0 2.3 1.6 0.6 1.2 2.5 0.0 4.5 10.4 0.0 0.3 1.7 3.2 0.3 0.4 0.0 0.0 1.0 0.3 4.4 2.8 0.0 5.1 3.3 0.0 0.0 1.3 1.3 0.9 19.2 0.4 0.0 1.0 0.0 15.1 1.9 0.0 20.5 3.7 0.3 6.5 2.1 0.0 0.4 2.5 0.5 0.0 0.0 0.4 SMOC2 SMAP2 ENSG00000112562 "SPARC related modular calcium binding 2" Q9H3U7 6 168441151-168673445 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Leydig cells: 298.0;Peritubular cells: 723.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "naive B-cell: 3.3" "Lineage enriched" "Detected in single" 7 "B-cells: 3.3" "Cell line enhanced" "Detected in some" "AF22: 9.5;EFO-21: 3.3;RPMI-8226: 12.6;RPTEC TERT1: 4.5;SuSa: 11.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (3.23e-1)" "unprognostic (5.29e-2)" "unprognostic (3.70e-2)" "unprognostic (1.53e-2)" "unprognostic (2.43e-2)" "unprognostic (1.31e-1)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (4.41e-1)" "unprognostic (1.40e-2)" "unprognostic (2.60e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.16e-6)" "unprognostic (3.50e-2)" "unprognostic (2.68e-1)" "unprognostic (6.35e-2)" "unprognostic (6.20e-3)" 17.9 3.4 1.9 17.2 5.0 0.0 26.2 0.8 2.3 37.3 11.7 2.5 5.0 5.1 57.7 40.6 17.9 34.4 73.2 25.3 1.9 1.7 3.0 1.3 5.3 4.8 2.7 2.9 45.0 8.5 1.8 1.5 5.4 6.0 22.3 6.4 76.2 6.9 15.1 21.8 8.0 9.4 53.9 1.6 1.3 50.0 31.1 1.3 2.3 13.6 12.3 3.5 36.8 11.4 3.3 0.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 9.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 1.2 0.0 0.0 0.0 0.0 12.6 4.5 0.0 2.0 0.4 0.0 0.4 0.1 11.2 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 5.0 0.8 2.3 1.9 1.7 2.7 2.9 6.0 1.3 0.0 1.7 0.0 6.1 9.8 2.8 7.0 0.0 4.0 3.4 10.4 0.0 2.0 0.0 0.0 2.3 3.5 1.6 0.0 0.0 1.6 18.5 5.5 0.0 0.0 1.2 0.0 18.9 4.3 0.0 5.7 298.0 0.6 3.3 0.0 3.0 0.4 0.1 0.0 723.1 0.0 0.6 45.3 73.7 2.7 4.5 2.4 2.2 0.0 12.5 0.6 SMPD1 ASM ENSG00000166311 "Sphingomyelin phosphodiesterase 1" P17405 11 6390431-6394998 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Disease mutation, Neurodegeneration, Niemann-Pick disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 155.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 41.6;fHDF/TERT166: 41.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 2000000 "unprognostic (8.76e-2)" "unprognostic (2.66e-1)" "unprognostic (6.99e-2)" "unprognostic (2.28e-3)" "prognostic unfavorable (7.72e-5)" "unprognostic (9.46e-2)" "unprognostic (1.46e-1)" "unprognostic (4.90e-2)" "unprognostic (8.06e-2)" "unprognostic (1.72e-1)" "prognostic favorable (7.47e-4)" "unprognostic (4.35e-2)" "prognostic favorable (4.57e-6)" "unprognostic (4.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" "unprognostic (1.71e-1)" 14.7 21.4 12.4 10.9 18.7 5.4 10.7 17.2 32.4 14.5 17.4 30.6 15.7 14.3 12.2 15.0 11.6 7.9 18.5 26.8 14.5 13.2 47.1 77.5 17.1 10.7 17.4 15.9 12.9 19.9 35.4 23.8 23.1 21.6 17.6 12.9 23.3 21.5 18.5 20.9 19.7 15.8 14.9 17.8 11.7 13.3 7.4 14.1 18.8 20.2 10.3 11.8 12.5 11.4 3.2 1.8 3.4 2.7 6.8 11.4 3.1 4.6 3.7 2.8 7.6 41.6 21.7 5.0 17.6 27.3 8.0 9.7 6.4 3.3 1.2 8.2 41.0 17.4 1.9 2.4 3.6 3.8 5.9 2.8 1.4 6.0 1.7 18.6 1.0 11.0 28.6 6.9 7.4 5.0 29.6 17.6 0.5 2.5 8.8 17.1 4.7 0.0 1.8 1.1 6.5 6.6 0.3 1.6 1.9 6.9 1.7 4.9 2.8 7.9 5.5 10.8 3.8 2.1 1.9 15.2 29.9 3.2 17.3 4.1 11.3 12.0 0.9 27.7 3.0 13.3 1.8 2.7 3.4 6.9 2.1 5.6 1.6 5.9 5.5 1.4 3.2 11.3 11.4 2.7 6.8 0.6 1.8 4.8 3.1 12.4 18.7 17.2 32.4 14.5 13.2 17.4 15.9 21.6 14.1 23.8 15.6 18.0 17.3 7.0 11.9 31.1 22.9 2.7 9.1 24.4 23.6 33.4 10.0 42.6 42.2 13.5 58.4 0.0 33.0 11.7 31.4 37.7 10.4 72.3 30.5 19.1 22.8 27.6 12.7 155.2 10.6 8.6 52.3 4.6 17.5 16.4 24.7 17.5 12.7 60.8 4.9 0.0 24.5 1.2 1.8 6.9 28.7 20.3 10.9 12.0 SMPD2 "ISC1, nSMase" ENSG00000135587 "Sphingomyelin phosphodiesterase 2" O60906 6 109440763-109443919 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 151.6;Late spermatids: 248.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA018110, HPA018125" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" NA NA "Vesicles, Plasma membrane" "Cell Junctions" "HPA018110: AB_1857292, HPA018125: AB_1857293" "unprognostic (1.61e-1)" "unprognostic (8.01e-2)" "unprognostic (1.97e-1)" "unprognostic (8.79e-3)" "unprognostic (3.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (7.08e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" "prognostic favorable (1.00e-3)" "unprognostic (3.60e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" "unprognostic (1.45e-2)" "prognostic favorable (1.70e-4)" 6.0 6.8 4.2 20.2 4.9 8.5 8.5 5.4 6.4 9.0 12.6 9.8 16.4 10.5 6.1 16.0 17.2 17.4 12.6 5.1 4.9 3.7 10.2 7.8 8.4 9.4 4.7 4.2 6.7 15.5 17.9 8.8 19.5 4.8 10.1 10.2 8.4 16.6 11.9 3.3 16.9 15.4 7.8 4.3 10.1 11.1 35.1 4.7 18.3 10.5 13.5 23.0 6.3 10.1 18.3 13.4 9.3 7.8 6.2 8.0 5.3 8.9 10.4 5.5 8.6 9.7 5.3 18.3 3.0 11.2 7.6 7.2 9.8 7.3 4.9 6.4 6.4 16.0 11.5 5.5 13.2 4.6 6.2 14.2 5.7 10.7 6.0 8.1 6.2 6.7 5.6 15.3 6.7 13.3 8.5 6.9 8.7 11.0 8.7 3.7 12.9 10.0 13.5 1.5 11.9 5.0 7.1 2.6 5.3 13.7 15.3 7.2 6.0 5.7 17.9 13.5 4.6 5.7 12.0 4.4 3.4 4.9 2.7 11.2 5.9 1.5 3.1 6.6 6.0 6.0 5.7 7.8 9.3 6.6 7.5 7.3 12.8 7.4 8.0 10.2 18.3 5.6 5.7 2.3 6.2 6.6 13.4 7.2 5.3 4.2 4.9 5.4 6.4 4.9 3.7 4.7 4.2 4.8 4.7 11.9 7.4 4.2 8.5 8.8 1.3 2.0 12.7 58.9 7.9 12.2 3.9 8.2 1.7 14.7 151.6 3.8 27.2 0.0 17.1 16.1 6.0 12.7 0.0 3.2 8.5 0.0 8.1 4.3 6.6 248.2 8.6 10.8 8.5 11.8 21.2 2.3 13.7 24.6 8.5 7.9 5.2 12.9 2.8 36.6 10.6 16.3 14.2 4.9 13.8 13.7 SMPD3 NSMASE2 ENSG00000103056 "Sphingomyelin phosphodiesterase 3" Q9NY59 16 68358325-68448688 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Lipid metabolism, Sphingolipid metabolism" "Developmental protein, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.5;intestine: 46.4;lymphoid tissue: 73.0" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 284.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "plasmacytoid DC: 44.5" "Lineage enriched" "Detected in many" 7 "dendritic cells: 44.5" "Cell line enhanced" "Detected in some" "HMC-1: 9.6;MOLT-4: 13.6;RPMI-8226: 11.3;SCLC-21H: 13.1" "Region enhanced" "Detected in many" "basal ganglia: 103.1" "Low region specificity" "Detected in all" "CAB033885, HPA065535, HPA069383" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB033885: AB_1126788, HPA065535: , HPA069383: " "unprognostic (1.21e-1)" "prognostic favorable (7.72e-4)" "unprognostic (5.61e-3)" "prognostic favorable (3.86e-4)" "unprognostic (2.46e-1)" "unprognostic (5.85e-4)" "unprognostic (7.87e-2)" "unprognostic (8.12e-3)" "unprognostic (2.77e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (1.81e-1)" "unprognostic (1.04e-3)" "unprognostic (5.02e-3)" "unprognostic (2.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.93e-3)" 3.5 2.3 6.0 3.1 18.3 1.8 1.6 9.4 15.4 1.0 9.6 2.5 0.0 46.4 1.7 0.7 1.8 2.7 17.2 1.2 8.7 3.6 0.9 3.8 2.1 3.5 2.5 5.0 2.7 1.9 0.7 10.7 0.8 3.9 2.2 5.8 4.3 2.2 0.9 1.8 8.1 42.7 1.2 1.4 3.0 18.6 4.2 4.4 73.0 1.3 1.3 4.3 1.6 1.2 0.6 44.5 6.1 0.0 0.0 0.7 0.3 0.3 0.7 0.3 0.1 0.0 0.0 5.3 0.4 0.0 0.4 0.1 2.9 0.9 0.4 0.5 0.2 0.2 1.1 0.0 0.0 0.1 0.3 0.7 0.1 2.1 0.3 0.0 0.0 9.6 0.0 0.0 0.0 0.2 0.5 0.0 0.9 0.8 0.3 0.3 0.2 13.6 2.6 0.6 4.6 0.1 0.6 0.2 11.3 0.0 0.1 13.1 2.6 0.4 1.5 0.6 0.3 1.0 0.9 0.0 0.4 0.8 1.4 0.1 2.2 1.1 0.2 0.2 0.9 0.2 1.0 0.0 6.1 0.7 0.0 0.1 0.6 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 44.5 0.5 0.3 6.0 18.3 9.4 15.4 8.7 3.6 2.5 5.0 3.9 4.4 3.0 0.6 0.0 1.4 0.1 39.5 2.5 5.1 16.0 1.2 0.0 0.0 0.0 0.0 0.9 6.0 0.0 51.1 0.0 0.8 0.2 0.3 3.7 0.0 5.0 0.2 284.4 24.8 0.0 0.6 13.0 14.1 0.0 0.0 0.0 25.6 0.8 1.2 43.0 43.2 0.0 3.3 0.0 0.0 5.4 0.3 0.9 0.0 5.0 18.7 4.7 SMPD4 "FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3" ENSG00000136699 "Sphingomyelin phosphodiesterase 4" Q9NXE4 2 130151392-130182750 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046279, HPA049426" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA046279: AB_2679611, HPA049426: AB_2680762" "unprognostic (5.02e-2)" "unprognostic (9.61e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.47e-5)" "unprognostic (1.69e-1)" "unprognostic (8.80e-2)" "prognostic unfavorable (8.37e-6)" "unprognostic (3.27e-2)" "unprognostic (1.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (1.73e-4)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.74e-1)" "unprognostic (2.28e-1)" "unprognostic (1.47e-3)" "unprognostic (2.09e-1)" 13.2 16.1 12.4 17.1 20.7 39.1 14.8 22.1 25.1 19.9 15.8 31.4 15.3 15.5 22.5 14.1 19.3 19.5 12.7 13.4 13.2 16.0 14.3 18.5 14.7 20.5 21.3 12.2 22.2 22.2 24.1 31.2 24.3 19.5 16.3 16.7 17.7 17.1 15.2 17.0 17.5 15.2 18.3 16.0 16.4 14.5 23.6 21.6 27.9 22.8 19.6 27.1 16.9 16.6 10.5 9.8 14.5 11.4 11.7 15.2 9.7 32.0 15.8 20.0 14.8 10.3 7.6 26.1 17.1 12.7 25.2 21.1 45.8 16.5 20.9 15.2 17.1 14.4 18.2 25.5 22.6 17.5 27.7 24.7 23.5 17.0 36.3 8.8 26.2 15.0 8.8 15.2 28.3 11.3 9.3 14.5 20.9 29.2 17.0 14.1 17.3 27.4 13.2 30.7 13.7 21.1 29.1 15.2 22.7 10.7 15.2 27.8 15.6 16.8 20.6 7.5 11.6 14.0 11.5 11.2 21.6 21.0 14.1 20.0 14.8 16.6 28.1 19.5 15.0 15.3 1.8 9.3 14.5 13.9 11.4 15.2 9.5 10.4 12.4 9.8 10.5 10.2 11.4 4.5 11.7 8.0 6.4 9.4 9.7 12.4 20.7 22.1 25.1 13.2 16.0 21.3 12.2 19.5 21.6 3.0 9.9 10.2 9.1 13.4 20.0 3.2 5.1 6.7 6.8 7.0 11.8 19.8 8.3 8.1 17.4 7.4 7.1 0.0 10.5 21.1 10.3 8.6 5.8 13.5 12.1 14.3 12.6 9.8 9.4 32.6 13.6 6.5 15.1 5.4 12.5 7.8 11.0 9.1 17.3 5.6 15.1 0.0 8.0 24.0 22.0 18.1 13.0 12.8 12.1 7.9 SNAP23 "HsT17016, SNAP23A, SNAP23B" ENSG00000092531 "Synaptosome associated protein 23" O00161 15 42491233-42545356 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 273.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 102.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001214, CAB037083, CAB037317" Approved Supported "Plasma membrane" NA NA 12000000 "Plasma membrane" "CAB037083: AB_477494, CAB037317: AB_261925, HPA001214: AB_1080037" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (3.76e-3)" "unprognostic (2.42e-2)" "unprognostic (1.65e-1)" "unprognostic (9.67e-3)" "unprognostic (1.60e-1)" "unprognostic (2.60e-1)" "unprognostic (2.93e-1)" "unprognostic (7.31e-2)" "unprognostic (1.36e-1)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (8.95e-2)" "unprognostic (1.10e-1)" "unprognostic (3.93e-2)" 29.9 24.0 15.2 28.4 20.5 14.3 28.6 11.1 17.5 20.8 30.8 21.6 27.7 23.0 38.9 18.6 20.3 21.3 18.7 24.6 16.6 11.7 22.8 23.0 28.0 35.4 27.3 10.5 24.6 19.8 10.4 17.7 81.6 18.9 24.1 24.5 16.3 37.0 25.8 32.8 15.3 40.8 22.8 23.4 41.6 22.1 25.1 21.3 20.1 20.3 18.1 35.1 25.5 53.7 17.2 22.9 102.0 36.3 10.3 11.5 23.0 17.5 7.9 15.0 14.6 24.7 19.5 23.1 22.1 16.7 13.1 15.9 25.7 6.9 8.5 29.2 13.6 14.4 15.0 16.6 12.9 18.6 14.4 9.6 40.6 8.6 24.1 17.9 16.3 39.1 15.5 10.2 11.7 20.1 18.7 50.2 19.6 30.4 8.8 17.8 6.0 19.4 16.9 12.7 25.3 6.1 35.7 8.9 14.0 18.4 15.9 2.4 9.6 15.9 14.6 14.0 23.9 21.0 23.5 39.4 13.3 18.1 15.9 21.8 19.1 33.8 45.5 16.0 33.2 17.1 30.2 24.7 102.0 8.4 36.3 9.8 17.2 8.9 8.2 22.9 15.4 11.5 8.8 56.2 10.3 34.4 9.5 9.8 23.0 15.2 20.5 11.1 17.5 16.6 11.7 27.3 10.5 18.9 21.3 104.2 26.2 49.8 68.2 45.1 7.4 14.3 22.9 41.5 19.4 19.2 19.6 58.5 48.0 63.9 163.9 67.1 52.1 0.0 45.9 88.6 49.1 68.2 79.9 24.3 76.0 4.8 14.3 67.5 97.9 273.8 36.2 83.7 42.2 120.8 68.8 14.6 83.4 48.0 57.0 61.4 19.1 51.8 45.7 15.6 6.5 33.6 119.1 47.7 32.9 54.8 SNN ENSG00000184602 Stannin O75324 16 11668414-11679159 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Cell type enhanced" "Detected in many" 7 "monocytes: 71.3;Muller glia cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 31.5;REH: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011055 Approved Uncertain Cytosol NA NA Cytosol "HPA011055: AB_1857326" "unprognostic (1.94e-1)" "unprognostic (7.26e-2)" "unprognostic (2.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (1.85e-6)" "unprognostic (4.51e-2)" "unprognostic (3.45e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (2.14e-1)" "prognostic favorable (1.83e-5)" "unprognostic (4.91e-2)" "unprognostic (2.09e-1)" "unprognostic (3.58e-1)" "unprognostic (4.72e-2)" 29.2 16.6 34.7 10.0 51.5 11.0 13.7 27.2 52.2 6.9 4.4 11.2 1.8 4.9 6.8 11.5 10.5 5.9 12.0 13.2 33.0 15.5 7.0 5.1 9.2 15.0 29.8 25.2 9.8 4.7 4.5 4.6 4.5 15.6 8.1 3.3 6.9 9.9 12.9 29.1 4.5 4.4 6.6 15.2 17.4 4.6 2.2 11.4 6.1 9.5 4.8 14.2 9.3 6.1 7.0 9.0 24.1 20.3 0.3 3.0 7.4 3.0 2.9 31.5 8.5 20.9 6.0 3.0 1.3 2.8 3.8 3.8 4.7 2.1 3.1 12.9 4.3 6.7 6.0 9.4 3.7 2.9 0.8 2.1 10.4 3.2 6.2 5.6 0.7 6.3 5.2 17.2 2.0 4.2 5.4 7.0 9.3 1.6 5.0 3.5 5.1 8.3 2.3 16.3 3.8 2.1 29.4 4.2 21.7 3.5 9.0 18.8 7.6 7.1 9.4 4.6 12.9 3.8 6.2 6.2 4.4 9.2 25.7 1.3 2.0 1.3 7.4 2.6 8.9 5.5 0.0 9.5 6.9 0.3 16.3 0.3 7.0 1.6 0.7 9.0 6.8 3.0 2.1 24.1 0.3 20.3 3.6 0.9 7.4 34.7 51.5 27.2 39.3 33.0 15.5 29.8 25.2 15.6 11.4 0.0 6.7 34.4 17.9 16.4 6.5 14.3 10.2 4.0 3.4 5.2 0.0 1.0 21.6 15.0 0.6 14.3 0.0 0.0 16.3 19.9 8.2 15.5 13.8 2.4 17.7 6.4 5.1 20.3 27.0 0.0 4.6 26.4 20.3 71.3 0.2 90.5 13.6 0.0 14.5 4.4 5.9 6.5 26.7 0.3 2.1 16.7 1.1 5.7 0.4 9.1 SNORC "ASCL830, C2orf82, UNQ830" ENSG00000182600 "Secondary ossification center associated regulator of chondrocyte maturation" Q6UX34 2 232857270-232878708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.9;breast: 19.6" "Group enriched" "Detected in some" 4 "Distal tubular cells: 5.0;Pancreatic endocrine cells: 9.1;Proximal tubular cells: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "basophil: 6.3" "Lineage enriched" "Detected in single" 18 "granulocytes: 6.3" "Cell line enriched" "Detected in some" 14 "Hep G2: 36.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA052824 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "HPA052824: AB_2681964" "unprognostic (4.58e-3)" "unprognostic (1.31e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (3.06e-1)" "unprognostic (4.71e-1)" "unprognostic (1.23e-3)" "unprognostic (3.52e-1)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (4.30e-7)" "unprognostic (1.83e-3)" "unprognostic (8.15e-2)" "unprognostic (1.58e-2)" "unprognostic (1.33e-2)" 1.4 1.5 4.8 0.8 6.4 1.5 19.6 2.8 9.0 0.3 2.4 9.3 0.0 2.7 0.7 2.0 0.3 0.4 0.3 0.4 8.8 7.8 1.2 2.1 1.3 1.7 11.9 7.0 0.5 4.2 0.7 0.3 0.9 9.1 3.0 1.1 0.0 3.2 0.6 2.8 10.8 2.0 0.6 27.9 1.4 1.3 6.2 7.4 0.0 0.9 0.0 0.5 0.5 0.0 0.0 0.0 6.3 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.9 0.6 1.0 1.5 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.4 0.1 0.3 0.3 0.0 0.0 0.0 0.4 1.3 0.3 0.2 36.4 0.5 0.0 1.1 0.0 0.9 0.2 0.5 0.4 1.0 0.4 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 1.4 0.2 0.3 0.2 0.0 0.5 0.1 0.5 0.2 0.0 1.3 0.6 0.0 1.6 0.5 0.1 0.5 0.5 0.4 2.4 2.5 0.1 0.0 0.8 0.2 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.4 2.8 9.0 8.8 7.8 11.9 7.0 9.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.5 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 SNRNP40 "HPRP8BP, PRP8BP, PRPF8BP, SPF38, WDR57" ENSG00000060688 "Small nuclear ribonucleoprotein U5 subunit 40" Q96DI7 1 31259568-31296782 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026527, HPA027345" Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA026527: AB_1858814, HPA027345: AB_2239703" "unprognostic (2.31e-3)" "unprognostic (5.63e-2)" "unprognostic (5.24e-3)" "unprognostic (1.36e-1)" "unprognostic (1.14e-3)" "unprognostic (1.28e-2)" "prognostic unfavorable (4.73e-6)" "unprognostic (2.14e-2)" "unprognostic (2.43e-2)" "unprognostic (2.50e-1)" "unprognostic (1.22e-1)" "unprognostic (8.57e-2)" "unprognostic (2.34e-2)" "unprognostic (1.78e-2)" "unprognostic (5.93e-2)" "unprognostic (4.31e-2)" "unprognostic (6.24e-2)" 20.2 23.1 13.2 19.6 20.2 25.2 21.2 24.1 21.8 20.9 20.1 30.0 20.9 16.2 25.6 23.0 23.4 23.0 15.4 17.8 14.3 15.4 18.8 19.1 17.4 31.6 31.5 14.0 26.7 15.8 15.0 20.2 21.9 23.5 20.8 22.8 20.2 17.9 22.4 22.6 20.8 19.9 22.0 22.3 27.3 18.7 31.3 21.3 44.0 24.4 17.0 38.2 20.0 19.4 33.7 32.8 27.5 33.8 36.7 44.3 47.8 20.8 15.7 29.6 24.3 14.8 12.3 20.3 17.6 17.5 32.3 32.1 22.6 21.4 27.3 17.4 13.9 16.6 20.1 44.5 21.1 33.5 29.0 32.8 40.3 22.7 24.7 18.4 44.1 18.4 11.4 16.9 31.5 23.8 10.8 26.1 24.2 37.4 16.3 18.6 15.0 32.5 26.0 52.9 21.2 22.9 25.9 41.7 21.1 13.8 17.3 20.2 19.8 28.0 14.7 33.2 28.7 14.5 28.3 18.0 18.2 26.6 25.1 33.4 13.3 16.3 37.7 14.8 41.5 29.5 26.0 26.7 27.5 37.2 33.8 42.6 33.7 36.4 36.6 32.8 30.9 39.2 44.3 5.9 36.7 30.3 27.9 37.4 47.8 13.2 20.2 24.1 21.8 14.3 15.4 31.5 14.0 23.5 21.3 3.0 6.7 41.0 44.7 47.2 13.7 11.8 20.4 10.7 6.8 15.7 17.7 100.1 36.5 28.8 5.4 33.3 13.5 0.0 31.5 71.3 44.7 26.1 34.5 20.3 49.1 9.5 33.5 29.4 20.6 3.6 24.7 27.9 40.5 47.7 16.9 22.6 27.7 21.0 32.2 34.6 19.3 32.3 34.3 68.7 67.1 47.9 51.3 42.4 31.1 33.6 SNX13 "KIAA0713, RGS-PX1" ENSG00000071189 "Sorting nexin 13" Q9Y5W8 7 17790761-17940501 "Predicted membrane proteins" "Protein transport, Transport" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 264.8;Late spermatids: 161.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.26e-2)" "unprognostic (7.40e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-1)" "unprognostic (9.02e-2)" "unprognostic (3.25e-1)" "unprognostic (2.52e-1)" "unprognostic (4.39e-1)" "unprognostic (1.23e-1)" "unprognostic (2.21e-1)" "unprognostic (7.85e-2)" "unprognostic (5.58e-2)" "prognostic favorable (5.98e-6)" "unprognostic (8.12e-2)" "unprognostic (6.96e-2)" "unprognostic (4.07e-1)" "unprognostic (1.46e-1)" 22.4 22.8 20.4 18.0 22.7 7.7 22.5 23.4 29.1 22.0 22.2 19.1 20.3 17.0 24.2 23.6 16.2 18.0 16.5 21.3 20.1 19.0 24.4 15.5 19.8 17.7 19.4 18.3 25.5 20.6 36.2 31.2 26.4 25.1 23.9 24.4 15.1 22.4 18.6 28.2 17.7 18.3 20.7 24.9 17.7 19.5 16.2 21.1 21.8 30.2 15.2 12.6 20.0 22.8 2.6 2.5 5.9 4.5 2.5 3.6 1.5 6.8 3.2 6.3 8.2 16.9 16.4 7.4 6.9 11.0 5.6 6.7 2.8 7.1 7.6 4.7 7.8 12.0 7.5 4.8 6.4 9.2 1.4 5.6 2.7 6.5 3.7 10.6 6.5 5.1 11.7 12.2 5.3 9.0 11.3 8.0 5.4 5.8 6.4 10.0 3.2 4.7 8.4 5.9 8.9 5.8 3.5 6.5 4.0 12.1 10.7 5.4 5.7 6.4 14.9 6.1 13.0 7.9 11.4 7.3 8.7 4.2 11.5 8.1 12.9 4.8 6.0 12.3 4.5 12.4 2.6 2.8 3.5 2.2 4.5 3.6 2.6 2.0 1.6 2.5 1.9 2.8 2.3 5.9 2.5 3.4 1.6 1.3 1.5 20.4 22.7 23.4 29.1 20.1 19.0 19.4 18.3 25.1 21.1 20.8 30.9 14.9 12.0 9.4 18.7 37.1 10.2 28.1 33.0 12.2 41.2 27.2 11.6 10.3 264.8 19.1 21.2 23.3 11.2 12.1 17.3 18.7 18.5 13.0 20.1 15.9 19.0 37.4 22.0 161.7 21.9 22.6 5.0 13.6 14.0 18.4 10.7 25.9 16.6 16.5 23.1 25.8 18.6 31.3 19.6 10.5 42.9 10.0 13.5 14.6 SNX14 RGS-PX2 ENSG00000135317 "Sorting nexin 14" Q9Y5W7 6 85505496-85594156 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 165.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017639 Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA017639: AB_1857345" "unprognostic (1.16e-2)" "unprognostic (3.29e-2)" "unprognostic (2.19e-2)" "unprognostic (1.52e-2)" "unprognostic (5.23e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (1.92e-2)" "unprognostic (3.45e-2)" "unprognostic (4.60e-1)" "unprognostic (1.57e-2)" "unprognostic (3.14e-2)" "unprognostic (2.37e-2)" "unprognostic (1.10e-3)" "unprognostic (1.02e-1)" "unprognostic (1.38e-1)" "unprognostic (1.87e-3)" "unprognostic (4.72e-3)" 23.4 25.9 19.9 16.0 21.9 16.6 26.7 25.2 30.1 20.1 23.3 16.1 17.8 17.7 23.8 37.0 17.1 17.8 17.4 17.4 19.5 24.2 33.2 41.0 23.8 17.7 21.6 18.0 17.9 27.7 27.2 35.5 29.6 30.8 21.1 22.2 19.9 17.7 20.2 9.6 17.1 31.0 15.8 20.7 24.6 26.8 49.1 17.1 16.1 26.1 11.2 18.2 22.6 15.1 8.9 16.4 20.0 24.1 13.4 13.3 8.9 15.0 9.2 15.1 22.1 34.5 25.4 15.8 19.3 26.7 15.2 23.5 16.6 25.5 19.8 23.9 24.8 29.7 20.4 10.3 19.9 24.1 17.5 6.1 21.6 12.8 24.8 28.5 20.2 22.5 22.1 15.1 17.7 18.0 28.2 27.0 7.8 21.9 17.2 32.9 17.5 1.2 38.7 6.1 23.6 10.4 8.1 30.8 9.4 37.0 27.9 6.6 15.1 11.8 26.1 17.9 20.9 16.2 36.3 24.0 12.0 7.5 15.0 20.0 17.3 27.4 7.3 24.7 23.9 24.2 18.1 13.6 20.0 13.3 20.3 10.0 8.9 9.0 11.9 16.4 8.8 8.2 10.3 6.3 13.4 24.1 4.8 10.2 8.9 19.9 21.9 25.2 30.1 19.5 24.2 21.6 18.0 30.8 17.1 86.4 38.0 17.1 16.6 13.1 35.5 12.3 17.8 32.1 28.4 21.0 53.0 44.7 5.0 28.9 45.3 24.0 24.4 0.0 36.5 25.9 25.0 15.8 30.1 26.6 31.1 14.3 30.6 27.6 34.8 10.7 18.1 25.4 27.0 39.7 28.0 32.8 30.0 24.6 27.6 23.7 39.0 19.4 21.6 165.5 8.4 12.9 47.3 25.3 25.3 15.2 SNX19 "CHET8, KIAA0254" ENSG00000120451 "Sorting nexin 19" Q92543 11 130875436-130916509 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013447 Uncertain Approved Mitochondria NA NA Mitochondria "HPA013447: AB_1857347" "unprognostic (8.79e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (1.56e-1)" "unprognostic (2.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.17e-2)" "unprognostic (9.19e-2)" "unprognostic (3.43e-2)" "unprognostic (4.05e-2)" "unprognostic (2.89e-1)" "unprognostic (4.97e-2)" "prognostic favorable (3.56e-5)" "unprognostic (1.05e-1)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (1.55e-2)" 22.3 23.1 24.0 16.9 30.6 10.0 17.2 18.0 38.0 17.1 23.8 35.6 25.3 17.1 22.9 32.5 17.9 19.8 20.4 22.6 22.8 22.2 24.1 25.6 17.5 15.3 31.0 15.3 20.6 26.6 32.9 28.5 18.5 28.0 21.7 22.2 23.7 23.1 27.2 26.4 19.0 17.8 26.0 30.8 18.5 22.3 36.2 28.2 24.6 31.1 12.1 18.1 23.0 16.4 5.9 5.4 11.3 6.6 3.6 6.2 5.2 6.7 7.5 9.6 13.4 29.0 20.4 6.4 18.0 21.4 9.1 9.5 8.4 13.0 6.4 12.6 19.9 20.3 12.3 1.4 12.9 11.7 10.3 5.8 11.7 7.4 0.0 21.0 0.0 9.1 23.2 16.0 9.3 10.2 18.8 11.1 8.8 10.3 0.0 19.4 4.9 9.4 7.7 2.9 16.8 9.5 7.2 9.1 3.7 9.9 12.2 9.4 8.8 7.7 12.4 6.1 7.8 22.0 7.3 14.7 12.8 9.5 10.5 10.5 2.2 0.0 0.0 5.3 7.7 14.6 11.3 6.0 4.4 4.8 6.4 6.2 5.9 4.7 5.7 5.3 4.4 5.6 4.4 3.6 3.6 6.6 5.4 4.1 5.2 24.0 30.6 18.0 38.0 22.8 22.2 31.0 15.3 28.0 28.2 23.8 6.4 10.9 5.9 3.5 22.7 17.9 22.9 14.7 13.6 22.7 9.8 7.7 8.3 10.2 23.3 9.3 11.8 0.0 14.0 4.7 7.4 8.7 18.4 18.8 8.9 15.9 10.9 15.4 11.9 35.0 12.7 10.3 3.3 2.8 10.6 21.3 13.4 11.4 14.9 8.7 37.1 12.9 8.3 31.9 11.5 3.8 11.7 6.5 8.5 9.1 SOAT1 "ACAT, SOAT, STAT" ENSG00000057252 "Sterol O-acyltransferase 1" P35610 1 179293714-179358680 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 87.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009533, HPA047171" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB009533: AB_633499, HPA047171: AB_2679967" "unprognostic (3.29e-2)" "unprognostic (7.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.81e-3)" "unprognostic (7.81e-3)" "unprognostic (3.29e-1)" "unprognostic (9.00e-2)" "unprognostic (9.84e-2)" "unprognostic (1.06e-1)" "unprognostic (5.45e-3)" "unprognostic (7.02e-3)" "unprognostic (4.67e-3)" "unprognostic (9.64e-2)" "unprognostic (4.67e-2)" "unprognostic (1.82e-1)" 23.9 87.4 4.1 8.3 5.7 7.0 9.6 2.9 4.0 6.8 7.2 5.6 7.8 5.5 8.2 6.0 3.4 8.3 9.8 5.7 5.5 4.1 12.1 8.8 18.6 13.0 6.2 2.3 10.8 15.5 8.1 14.6 11.6 4.9 13.1 6.9 9.6 51.1 8.9 4.1 5.8 7.0 7.5 10.5 13.6 8.1 6.8 4.9 4.0 6.2 2.9 7.2 9.4 8.7 6.6 24.3 19.8 26.8 18.5 16.0 14.8 20.4 9.6 7.9 11.7 30.9 16.9 42.5 9.9 17.5 22.0 25.7 9.8 23.4 11.6 15.7 18.0 26.8 7.5 25.1 5.9 23.8 13.2 5.2 5.4 8.1 10.2 12.7 9.2 2.1 13.3 3.8 25.7 22.1 9.3 9.4 14.3 11.6 6.0 34.2 4.3 9.8 3.0 3.8 3.3 3.2 12.2 10.3 6.8 19.4 12.8 2.4 6.2 15.3 6.5 5.7 9.8 6.8 6.3 8.9 26.2 12.6 28.6 21.8 8.5 31.0 9.9 10.4 5.0 48.5 19.6 26.8 0.7 14.0 17.0 13.5 6.6 13.1 13.1 24.3 5.5 12.7 12.6 19.8 18.5 11.1 4.4 16.0 14.8 4.1 5.7 2.9 4.0 5.5 4.1 6.2 2.3 4.9 4.9 20.8 33.1 10.4 8.5 8.9 7.2 5.6 22.9 48.2 14.8 19.2 13.7 14.8 1.7 33.4 19.5 13.0 7.9 0.0 21.9 46.9 18.6 33.8 13.9 21.9 69.5 6.4 57.5 21.5 66.9 10.8 30.2 63.1 21.9 44.1 27.7 6.8 20.1 10.5 24.4 12.8 13.0 25.8 13.0 5.6 8.2 4.5 7.3 27.9 16.8 6.5 SOAT2 ACAT2 ENSG00000167780 "Sterol O-acyltransferase 2" O75908 12 53103518-53124538 "Enzymes, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "intestine: 60.8" "Cell type enhanced" "Detected in single" 15 "Club cells: 1.2" "Group enriched" "Detected in some" 8 "liver cancer: 5.2;testis cancer: 5.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MAIT T-cell: 3.7;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.7;naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 7 "T-cells: 3.7" "Group enriched" "Detected in some" 5 "CACO-2: 9.8;Hep G2: 21.4;U-266/70: 7.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.53e-1)" "unprognostic (2.72e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (1.30e-4)" "unprognostic (3.88e-3)" "unprognostic (9.26e-2)" "unprognostic (4.20e-2)" "unprognostic (1.32e-1)" "unprognostic (3.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.53e-1)" "unprognostic (1.83e-2)" "unprognostic (9.05e-2)" "unprognostic (2.37e-1)" "unprognostic (7.58e-3)" "unprognostic (3.28e-1)" 0.5 0.0 0.2 0.2 0.2 0.2 0.6 0.2 0.2 0.9 16.4 0.2 0.2 12.3 0.7 0.3 0.2 0.9 0.4 0.2 0.2 0.0 0.6 4.2 0.2 0.6 0.2 0.2 0.4 0.2 0.0 0.3 0.2 0.2 0.6 0.0 0.2 0.4 0.2 0.2 0.4 60.8 0.2 0.3 2.2 0.3 0.2 0.2 0.2 0.4 0.2 0.3 0.3 1.1 0.0 0.0 0.0 0.3 0.5 3.7 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.4 0.4 9.8 0.1 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.9 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.3 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 7.1 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.7 0.0 1.5 2.7 0.0 0.0 0.4 1.5 0.0 0.5 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 SOGA3 "C6orf174, dJ403A15.3" ENSG00000214338 "SOGA family member 3" Q5TF21 6 127472794-127519191 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;pituitary gland: 11.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 1.4;Horizontal cells: 3.2;Rod photoreceptor cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 6 "T-cells: 2.3" "Cell line enhanced" "Detected in some" "AF22: 7.5;SCLC-21H: 24.3;SH-SY5Y: 13.9" "HPA035388, HPA035389" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035388: AB_2674601, HPA035389: AB_10669857" "unprognostic (1.70e-1)" "unprognostic (3.56e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (8.58e-3)" "unprognostic (8.45e-2)" "unprognostic (7.31e-4)" "unprognostic (5.65e-3)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" "unprognostic (1.59e-1)" "unprognostic (3.30e-2)" "unprognostic (1.72e-1)" "unprognostic (8.26e-3)" 0.8 2.8 5.0 1.8 5.3 0.4 0.4 11.4 15.3 1.0 0.8 3.7 0.0 0.5 2.1 0.2 2.0 1.0 1.9 0.8 4.2 4.5 0.6 0.6 1.7 0.8 6.7 5.0 3.3 1.7 0.2 11.9 1.2 7.9 1.1 0.6 0.7 1.1 0.5 0.3 1.0 1.9 0.6 11.4 1.4 3.9 1.8 4.3 0.0 1.9 0.0 0.3 1.6 0.8 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.2 3.3 7.5 1.1 0.0 0.6 0.3 0.7 0.9 0.9 2.4 0.2 0.3 0.4 0.2 0.1 6.2 0.0 0.8 0.0 0.7 0.7 0.1 0.6 0.0 0.1 0.0 0.2 0.1 1.2 0.0 3.7 0.0 0.8 0.0 1.1 0.3 0.2 0.5 0.5 4.9 0.0 3.4 0.0 0.8 0.4 1.8 0.0 0.1 0.0 24.3 13.9 0.0 0.0 0.2 0.9 0.0 0.3 0.2 6.0 1.2 0.4 1.7 0.2 0.1 0.1 4.5 1.1 5.9 0.0 0.0 0.0 0.3 0.0 0.4 0.3 2.3 0.8 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.0 5.3 11.4 8.2 4.2 4.5 6.7 5.0 7.9 4.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 SORCS1 sorCS1 ENSG00000108018 "Sortilin related VPS10 domain containing receptor 1" Q8WY21 10 106573663-107164534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 18.5" "Cell type enriched" "Detected in some" 4 "Muller glia cells: 59.3" "Cancer enhanced" "Detected in some" "melanoma: 3.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 24 "intermediate monocyte: 2.4" "Lineage enriched" "Detected in single" 24 "monocytes: 2.4" "Group enriched" "Detected in some" 12 "RH-30: 33.9;SH-SY5Y: 44.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011948 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA011948: AB_1857366" "unprognostic (5.86e-3)" "unprognostic (8.45e-3)" "unprognostic (1.55e-2)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (2.92e-2)" "unprognostic (3.52e-2)" "unprognostic (5.58e-2)" "unprognostic (6.82e-3)" "unprognostic (5.81e-2)" "unprognostic (6.48e-4)" "unprognostic (2.51e-2)" "unprognostic (8.89e-3)" "unprognostic (2.22e-1)" "unprognostic (2.69e-4)" 1.4 5.8 6.0 4.5 14.1 0.4 1.8 0.5 13.2 2.2 10.7 1.1 1.9 1.4 2.1 1.2 2.0 3.2 2.8 4.2 2.6 4.7 8.0 0.5 0.5 1.9 2.1 6.6 1.2 3.0 0.6 1.2 0.4 3.3 2.7 3.6 6.5 2.4 4.9 0.8 2.3 4.5 2.7 2.1 1.7 3.4 2.3 2.7 0.2 18.5 1.1 2.7 4.7 3.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 33.9 0.0 0.0 0.0 0.0 44.4 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 14.1 0.5 11.3 2.6 4.7 2.1 6.6 3.3 2.7 0.0 0.3 0.0 0.0 0.6 1.8 1.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 14.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.3 3.4 0.0 0.0 1.7 0.0 0.0 59.3 0.1 0.0 0.4 2.2 1.7 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 SORCS2 KIAA1329 ENSG00000184985 "Sortilin related VPS10 domain containing receptor 2" Q96PQ0 4 7192538-7742836 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1" "Cell type enhanced" "Detected in many" 19 "Bipolar cells: 66.5;Muller glia cells: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.6;HaCaT: 16.6;HMC-1: 12.5;RPMI-8226: 7.4;SiHa: 12.0;THP-1: 7.0;U-937: 7.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061916 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA061916: AB_2684636" "unprognostic (1.38e-1)" "unprognostic (6.32e-2)" "unprognostic (1.91e-2)" "unprognostic (4.37e-2)" "unprognostic (4.91e-3)" "unprognostic (1.82e-2)" "unprognostic (4.60e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.17e-3)" "unprognostic (5.37e-2)" "unprognostic (2.09e-1)" "unprognostic (7.27e-3)" 4.9 2.6 12.0 6.4 16.6 3.3 1.8 4.8 22.4 13.8 4.0 32.1 3.2 3.1 6.0 8.2 4.7 3.5 7.1 3.2 10.7 6.9 7.4 5.2 8.3 2.0 9.9 11.2 7.4 1.7 0.8 2.7 0.9 11.2 7.5 2.6 7.5 2.6 5.3 2.4 1.9 4.2 11.5 11.2 1.3 1.9 3.4 11.3 0.8 6.2 2.2 2.7 5.2 3.7 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.9 1.1 0.2 0.1 0.0 0.0 0.2 0.0 1.4 0.4 0.1 0.5 0.0 6.6 4.2 1.1 16.6 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.2 0.1 0.0 12.5 0.2 3.7 5.2 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.7 0.0 1.3 7.4 0.2 0.0 0.7 0.6 12.0 0.0 0.0 0.7 0.0 7.0 0.0 4.3 1.3 0.0 0.1 0.0 0.0 0.0 1.4 7.3 0.2 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 12.0 16.6 4.8 17.7 10.7 6.9 9.9 11.2 11.2 11.3 3.0 13.7 0.0 0.2 0.1 66.5 2.0 0.0 2.7 7.9 5.2 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.2 0.2 1.6 0.0 0.0 0.3 10.2 11.8 0.3 1.7 0.0 0.0 31.9 0.7 0.0 7.4 0.7 2.4 0.0 0.5 0.1 0.1 0.4 0.0 0.0 0.0 0.4 SORCS3 "KIAA1059, SORCS" ENSG00000156395 "Sortilin related VPS10 domain containing receptor 3" Q9UPU3 10 104641101-105265235 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 5.8;brain: 19.1" "Cell type enriched" "Detected in some" 7 "Early spermatids: 11.2" "Group enriched" "Detected in some" 13 "glioma: 1.8;renal cancer: 2.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "naive CD4 T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "HaCaT: 1.6;RPTEC TERT1: 4.6;SH-SY5Y: 1.0;SuSa: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.39e-2)" "unprognostic (8.47e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-1)" "unprognostic (1.98e-1)" "unprognostic (3.63e-1)" "unprognostic (4.78e-1)" "unprognostic (1.84e-1)" "unprognostic (3.01e-1)" "prognostic unfavorable (5.72e-4)" "unprognostic (2.63e-2)" "unprognostic (1.97e-1)" 1.1 5.8 5.4 0.8 15.5 0.7 0.9 2.9 19.1 1.2 0.9 2.3 0.0 0.7 1.0 0.7 0.8 0.7 1.1 0.7 6.3 8.5 1.3 0.6 0.6 0.7 2.0 8.1 2.7 0.6 0.6 3.0 0.6 3.4 0.8 0.9 0.0 0.9 0.9 0.6 1.0 1.1 1.1 2.3 0.6 0.9 2.9 2.0 0.0 0.6 0.0 0.8 0.6 0.2 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.1 1.0 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.4 15.5 2.9 12.7 6.3 8.5 2.0 8.1 3.4 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.0 0.0 SORL1 "C11orf32, gp250, LR11, LRP9, SorLA, SorLA-1" ENSG00000137642 "Sortilin related receptor 1" Q92673 11 121452203-121633693 "Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Endocytosis, Transport" Receptor "Alzheimer disease, Amyloidosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 365.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 43.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 43.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 44.0;Daudi: 20.6;OE19: 28.1;RT4: 31.1;U-698: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011500, HPA031321" Uncertain "Secreted to blood" NA NA "CAB011500: AB_443414, HPA031321: AB_2673826" "unprognostic (1.54e-1)" "unprognostic (1.74e-1)" "unprognostic (4.08e-2)" "unprognostic (9.53e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-2)" "unprognostic (1.59e-2)" "unprognostic (1.59e-3)" "unprognostic (1.74e-1)" "unprognostic (1.86e-2)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.80e-7)" "unprognostic (2.48e-1)" "unprognostic (1.87e-1)" "unprognostic (5.07e-2)" "unprognostic (1.21e-2)" 5.6 5.0 17.3 17.0 24.9 30.7 10.5 28.3 40.8 34.8 12.7 36.0 9.9 8.6 4.5 7.2 5.7 29.4 5.8 3.0 22.4 18.7 15.0 41.4 10.0 14.8 28.6 21.9 7.3 6.1 19.9 17.7 2.1 24.0 16.0 12.7 6.4 14.7 20.0 1.5 3.9 13.0 3.8 27.8 21.3 7.9 4.1 23.4 11.1 10.3 0.2 16.3 15.8 6.7 2.0 5.6 43.8 5.4 6.7 10.8 6.1 0.4 2.4 2.2 0.3 0.0 0.0 2.3 0.1 0.7 0.1 0.0 3.6 44.0 20.6 2.6 0.5 3.3 14.6 2.8 2.1 0.0 0.0 0.8 0.0 3.2 5.0 0.0 8.7 0.0 0.0 2.4 0.0 8.1 1.2 0.0 2.6 0.0 0.2 0.0 2.9 2.0 4.5 2.7 28.1 3.3 2.3 0.1 0.4 4.9 31.1 1.6 0.4 4.6 6.6 0.0 5.2 6.5 2.8 0.1 0.0 1.6 0.3 0.0 0.0 0.0 42.8 0.0 11.7 0.1 13.0 5.4 19.1 8.0 2.3 10.8 0.7 9.0 7.2 2.2 2.0 8.6 7.6 43.8 6.7 2.8 5.6 6.3 6.1 17.3 24.9 28.3 40.8 22.4 18.7 28.6 21.9 24.0 23.4 6.0 24.6 10.4 32.9 3.9 40.9 9.0 25.5 10.7 27.3 75.0 365.2 0.4 0.0 6.5 0.9 3.2 87.9 0.0 0.6 0.6 5.9 40.6 11.5 98.3 41.1 47.7 5.8 27.0 56.2 1.8 72.2 49.6 3.3 19.8 48.5 34.5 4.5 87.7 54.5 0.9 28.0 0.0 12.0 0.7 21.5 2.0 0.3 55.8 35.3 25.8 SORT1 "Gp95, NT3" ENSG00000134243 "Sortilin 1" Q99523 1 109309568-109397951 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Endocytosis, Osteogenesis, Transport" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.1;epididymis: 75.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 9.0;non-classical monocyte: 10.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006889, CAB011498" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA 7170000 "Golgi apparatus, Cytosol" "Plasma membrane" "CAB011498: AB_2192606, HPA006889: AB_1080056" "unprognostic (2.10e-2)" "unprognostic (7.46e-2)" "prognostic favorable (7.74e-6)" "unprognostic (4.12e-1)" "unprognostic (9.41e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.23e-4)" "unprognostic (3.34e-3)" "unprognostic (4.27e-2)" "unprognostic (9.44e-2)" "unprognostic (2.42e-2)" "unprognostic (1.28e-2)" "unprognostic (1.23e-3)" "unprognostic (1.45e-2)" "unprognostic (2.15e-1)" "unprognostic (3.95e-1)" "unprognostic (4.46e-3)" 22.9 6.5 24.0 6.2 35.5 10.1 15.5 6.4 40.6 10.1 15.2 50.3 18.1 11.5 11.9 75.2 22.0 14.8 9.5 31.8 45.2 19.8 21.1 3.7 19.2 3.6 57.9 22.8 3.6 9.3 24.2 5.7 22.9 27.1 10.3 14.4 12.2 11.8 24.8 36.4 8.3 11.3 14.6 71.1 5.4 9.5 21.6 42.2 1.1 22.5 5.1 5.4 8.7 8.2 0.0 4.5 2.3 10.0 0.4 0.0 1.7 11.8 4.7 11.9 14.5 34.8 6.9 34.3 8.8 14.1 8.7 9.3 12.2 4.4 0.1 11.3 3.7 6.4 2.9 14.0 6.9 12.5 0.3 6.6 3.2 7.7 13.1 13.6 0.0 10.7 17.3 1.1 10.6 2.3 23.3 1.3 9.9 24.4 1.2 12.1 12.5 8.3 0.2 4.4 5.3 2.0 9.3 28.1 5.7 16.6 8.6 12.2 7.0 5.2 34.5 37.0 17.7 14.5 2.0 0.3 1.8 7.1 0.3 14.7 11.8 9.6 0.0 3.1 0.0 7.6 0.0 7.1 2.3 0.0 9.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.9 0.4 10.0 1.6 0.0 1.7 24.0 35.5 6.4 33.9 45.2 19.8 57.9 22.8 27.1 42.2 35.7 42.8 0.0 4.2 1.1 14.6 83.1 33.1 22.7 18.2 71.5 33.4 26.8 5.0 23.3 53.4 7.3 49.9 0.0 20.8 26.7 6.1 10.7 7.0 22.5 27.9 12.7 16.1 4.3 36.7 56.4 8.1 24.8 20.3 20.8 30.9 20.4 21.0 17.5 46.7 9.9 42.2 32.3 31.1 51.1 20.4 1.6 30.8 1.8 19.9 10.8 SOX1 ENSG00000182968 "SRY-box 1" O00570 13 112067647-112070488 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.9;testis: 3.7" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 3.6;Melanocytes: 3.3;Spermatogonia: 2.1" "Group enriched" "Detected in some" 6 "colorectal cancer: 0.9;glioma: 2.3;melanoma: 2.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AF22: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.12e-1)" "unprognostic (4.95e-2)" "unprognostic (1.71e-3)" "unprognostic (6.03e-2)" "unprognostic (6.41e-2)" "unprognostic (4.85e-1)" "unprognostic (5.93e-2)" 0.5 0.5 5.3 0.5 5.8 0.4 0.9 2.5 9.9 0.4 0.6 2.6 0.0 0.7 0.4 0.4 0.4 0.4 0.4 0.4 3.5 7.0 0.4 0.4 0.4 0.4 2.5 2.4 0.4 0.4 0.4 0.2 0.4 3.1 0.4 0.5 2.7 0.6 0.5 0.4 1.5 0.4 0.4 4.8 0.4 0.5 3.7 0.3 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.8 2.5 7.8 3.5 7.0 2.5 2.4 3.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 SP4 "HF1B, MGC130008, MGC130009, SPR-1" ENSG00000105866 "Sp4 transcription factor" Q02446 7 21428034-21514822 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010246, HPA040395" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB010246: AB_2194481, HPA040395: AB_2676959" "unprognostic (1.57e-1)" "unprognostic (1.09e-1)" "unprognostic (6.04e-2)" "unprognostic (8.28e-2)" "unprognostic (9.14e-2)" "unprognostic (8.51e-2)" "unprognostic (1.09e-2)" "unprognostic (7.85e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.15e-3)" "unprognostic (1.89e-1)" "unprognostic (6.04e-3)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "unprognostic (6.18e-2)" "unprognostic (7.80e-3)" 5.8 4.7 7.9 8.9 11.0 10.2 6.3 25.9 9.5 8.6 4.4 6.4 3.8 3.1 9.2 5.8 4.1 7.8 4.6 6.5 8.3 6.1 5.4 3.4 6.0 11.7 8.6 6.9 19.8 5.2 17.1 11.8 3.7 6.7 7.3 4.3 6.0 5.0 5.7 10.5 5.0 5.6 5.3 6.8 9.1 4.9 6.0 10.0 27.0 13.1 4.8 11.2 6.8 6.3 5.4 1.5 7.2 1.8 3.5 8.3 3.1 2.2 1.7 5.1 8.1 1.5 1.0 1.5 2.3 1.7 2.7 3.7 3.5 2.7 9.2 1.4 1.5 7.2 2.8 7.5 2.2 5.3 2.7 2.8 4.8 3.3 1.5 1.1 4.0 5.7 1.1 1.9 2.9 3.3 1.4 5.4 6.7 6.0 7.0 2.2 1.0 9.3 2.9 12.3 4.3 2.1 20.9 8.7 3.3 0.9 1.6 6.6 8.2 5.3 2.4 1.8 5.1 2.6 2.9 2.3 4.4 5.5 2.7 4.2 9.3 7.3 14.4 2.5 6.4 6.1 4.3 0.8 7.2 6.8 0.9 8.3 3.7 6.4 6.6 0.9 5.4 7.6 7.1 1.9 3.5 1.8 1.5 7.6 3.1 7.9 11.0 25.9 9.5 8.3 6.1 8.6 6.9 6.7 10.0 3.0 7.0 5.0 11.4 11.2 15.9 7.6 10.2 1.4 7.9 0.0 7.9 1.0 0.0 1.7 5.5 5.8 1.1 0.0 1.8 1.0 6.1 7.1 4.7 4.0 1.5 17.5 10.3 11.6 6.5 4.1 5.2 5.9 6.8 2.8 1.8 9.8 1.4 8.6 6.3 1.4 18.8 0.0 4.1 7.9 8.3 9.7 1.3 14.6 2.8 4.3 SPAAR "LINC00961, SPAR" ENSG00000235387 "Small regulatory polypeptide of amino acid response" A0A1B0GVQ0 9 35909483-35937153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 12.2;breast: 13.7;testis: 16.5" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 1.1;Club cells: 1.2;Proximal tubular cells: 2.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.1" "Group enriched" "Detected in some" 13 "HUVEC TERT2: 22.6;TIME: 26.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.17e-1)" "unprognostic (2.19e-2)" "unprognostic (1.91e-2)" "unprognostic (7.00e-3)" "unprognostic (4.23e-2)" "unprognostic (2.61e-3)" "unprognostic (6.95e-2)" "unprognostic (1.00e-1)" "unprognostic (3.40e-3)" "unprognostic (3.17e-1)" "unprognostic (1.01e-1)" "unprognostic (7.72e-2)" "unprognostic (7.12e-3)" "unprognostic (1.67e-2)" "unprognostic (3.04e-1)" "unprognostic (1.27e-1)" "unprognostic (3.22e-1)" 12.2 0.6 1.4 0.7 2.4 0.0 13.7 0.3 1.2 0.2 0.9 0.3 0.8 0.3 0.5 0.3 0.6 0.4 0.8 5.6 1.4 3.5 1.3 4.6 0.4 1.4 0.1 0.2 0.5 0.1 0.4 6.9 1.9 0.3 0.4 0.9 0.8 0.5 6.2 0.0 0.6 0.8 1.3 0.4 0.3 16.5 1.4 0.0 1.1 1.2 0.0 0.3 2.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.0 22.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 26.4 0.0 0.6 1.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPACA1 SAMP32 ENSG00000118434 "Sperm acrosome associated 1" Q9HBV2 6 88047789-88066832 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 99 "testis: 49.2" "Cell type enriched" "Detected in some" 26 "Early spermatids: 646.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026744, HPA043297" Enhanced NA NA "HPA026744: AB_2194642, HPA043297: AB_2678413" "unprognostic (4.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 646.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 6.5 0.0 22.2 4.4 0.0 0.0 0.0 0.0 0.0 SPACA6 "LET7EH, LINC00085, NCRNA00085, SPACA6P" ENSG00000182310 "Sperm acrosome associated 6" W5XKT8 19 51689128-51712387 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.6;testis: 9.0" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 5.0;Collecting duct cells: 17.4;Distal tubular cells: 6.6;Proximal tubular cells: 13.2" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "memory CD4 T-cell: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 2.9;HEK 293: 6.4;HeLa: 2.2;U-87 MG: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.43e-1)" "unprognostic (6.12e-2)" "unprognostic (5.80e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (7.13e-2)" "unprognostic (1.45e-1)" "unprognostic (8.01e-3)" "unprognostic (1.96e-1)" "unprognostic (8.10e-3)" "unprognostic (1.06e-1)" "unprognostic (2.82e-3)" "unprognostic (9.29e-2)" "prognostic unfavorable (1.98e-10)" "unprognostic (6.64e-3)" "unprognostic (1.98e-1)" "unprognostic (6.05e-2)" "unprognostic (1.14e-2)" 1.3 0.7 2.3 0.2 2.8 0.2 0.2 6.6 1.8 0.6 0.5 2.0 0.0 0.2 4.0 0.9 0.8 0.7 0.6 0.2 2.5 0.7 0.2 1.4 0.5 2.3 0.8 1.3 1.7 0.2 2.9 3.2 3.1 1.6 0.4 0.0 0.5 1.3 1.6 0.2 0.6 1.4 1.2 0.7 0.5 9.0 1.2 0.0 0.3 0.3 0.2 0.4 1.3 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.9 0.8 0.6 0.0 0.0 0.0 0.3 0.7 0.0 0.6 2.9 0.0 1.1 0.0 0.4 0.0 0.1 2.2 0.2 0.6 0.0 0.0 6.4 0.7 2.2 0.0 0.8 0.0 0.7 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.1 0.1 0.0 0.0 1.1 0.6 1.3 0.8 1.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 17.4 0.0 0.0 6.6 1.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 1.4 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPAG4 "CT127, SUN4" ENSG00000061656 "Sperm associated antigen 4" Q9NPE6 20 35615892-35621049 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 54.3" "Group enriched" "Detected in many" 5 "Early spermatids: 155.3;Late spermatids: 107.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 16.9;hTERT-RPE1: 12.4;U-87 MG: 30.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA048393, HPA061789" Approved NA NA "HPA048393: AB_2680385, HPA061789: AB_2684609" "unprognostic (1.05e-1)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.09e-5)" "prognostic favorable (9.52e-8)" "prognostic unfavorable (6.31e-5)" "unprognostic (1.05e-1)" "unprognostic (2.56e-3)" "unprognostic (1.21e-2)" "unprognostic (2.29e-1)" "unprognostic (4.77e-2)" "unprognostic (4.49e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.28e-4)" "unprognostic (3.59e-2)" "unprognostic (1.66e-1)" "unprognostic (1.79e-1)" "prognostic favorable (6.66e-4)" 1.7 2.9 1.6 4.8 1.4 3.8 3.7 0.4 5.3 2.7 13.9 0.2 3.3 4.0 1.5 4.4 2.8 2.5 3.4 2.6 1.1 2.0 3.1 3.0 3.2 4.9 1.3 1.6 5.2 54.3 3.2 5.0 7.0 2.3 2.6 2.0 2.8 4.5 2.5 0.4 0.4 3.4 1.2 2.9 6.9 4.6 16.9 1.5 0.0 1.3 0.0 7.5 7.2 1.8 0.9 3.9 0.0 0.7 0.0 1.0 0.4 2.3 1.0 0.5 1.4 1.3 0.6 6.7 1.0 1.2 0.9 1.4 2.4 5.1 0.2 16.9 1.3 4.1 0.7 0.3 3.2 1.1 2.5 0.5 1.9 2.3 2.4 6.6 1.3 3.4 3.2 0.6 1.0 0.8 12.4 1.9 0.7 0.5 4.7 2.4 4.9 0.5 3.7 0.0 4.4 4.6 0.3 0.5 6.6 1.7 1.0 0.3 2.4 1.1 0.8 1.8 0.3 3.4 0.6 2.0 4.8 0.7 1.0 1.0 9.1 3.5 1.9 30.6 0.5 0.7 0.0 0.1 0.0 0.0 0.7 0.5 0.9 0.1 0.4 0.4 0.0 0.5 0.0 0.0 0.0 0.0 3.9 1.0 0.4 1.6 1.4 0.4 5.3 1.1 2.0 1.3 1.6 2.3 1.5 0.0 0.3 2.2 0.9 0.3 2.6 1.5 0.0 0.0 1.2 0.0 2.0 1.3 0.0 8.1 155.3 3.6 0.3 0.0 6.5 11.2 1.8 1.0 4.6 4.3 1.3 1.6 4.1 5.5 1.9 107.6 1.7 1.2 25.3 3.6 0.3 14.0 19.0 0.9 2.8 3.1 1.9 0.0 2.5 14.1 0.7 0.1 16.9 2.9 0.4 3.0 SPAG9 "CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1" ENSG00000008294 "Sperm associated antigen 9" O60271 17 50962174-51120865 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 6.3;neutrophil: 13.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040446, HPA061458" Enhanced Enhanced "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA040446: AB_10671691, HPA061458: AB_2684528" "unprognostic (1.36e-1)" "unprognostic (6.61e-2)" "unprognostic (6.04e-3)" "unprognostic (4.65e-2)" "unprognostic (3.52e-2)" "unprognostic (9.73e-2)" "unprognostic (8.13e-2)" "unprognostic (3.72e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" "unprognostic (2.83e-2)" "unprognostic (9.71e-2)" "unprognostic (2.23e-3)" "unprognostic (2.27e-2)" "unprognostic (9.53e-2)" "unprognostic (7.67e-2)" "prognostic unfavorable (8.10e-4)" 21.6 16.4 32.1 12.5 42.6 15.8 13.8 32.7 46.6 15.9 15.6 44.8 7.6 14.0 19.6 9.1 20.7 12.3 18.8 15.1 33.1 25.5 23.6 22.8 20.5 8.7 55.7 25.9 22.2 21.0 25.8 14.6 21.8 37.1 13.2 14.1 12.2 9.9 14.4 39.6 14.2 14.2 19.1 50.2 12.1 10.5 33.3 55.2 8.5 28.2 9.5 10.6 15.0 13.6 1.0 1.3 13.4 1.3 0.5 1.8 0.4 17.5 19.7 25.3 12.3 24.1 21.4 22.4 14.4 14.2 16.2 20.3 17.7 12.1 9.5 10.1 23.7 32.8 15.2 16.5 12.1 30.3 14.4 19.7 7.9 15.6 13.1 18.1 11.4 9.3 15.4 14.1 21.9 39.3 15.6 13.3 4.8 17.4 10.6 22.9 8.8 7.1 4.8 6.7 11.8 25.6 8.2 28.3 8.3 14.9 33.5 19.7 27.4 12.7 11.9 13.1 16.0 9.7 13.6 18.4 45.4 10.7 34.9 21.1 15.1 21.6 15.6 15.5 6.8 15.7 6.3 1.3 0.8 1.4 0.8 1.0 1.0 1.2 1.3 1.3 1.0 0.7 0.9 13.4 0.5 0.5 1.1 1.8 0.4 32.1 42.6 32.7 34.9 33.1 25.5 55.7 25.9 37.1 55.2 122.1 93.5 25.1 151.7 146.5 92.9 57.2 38.2 30.8 36.4 24.4 117.8 34.3 23.2 46.7 183.2 86.7 70.8 0.0 49.5 23.5 89.4 131.0 41.6 44.8 33.0 63.5 66.9 68.7 43.2 94.6 70.5 64.9 67.4 46.9 27.4 30.1 70.3 31.6 62.9 65.7 82.4 64.7 72.1 210.4 52.0 150.7 116.1 31.6 25.1 163.9 SPAM1 "HYAL5, PH-20, SPAG15" ENSG00000106304 "Sperm adhesion molecule 1" P38567 7 123925237-123971414 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 38 "testis: 19.6" "Group enriched" "Detected in some" 58 "Early spermatids: 169.9;Late spermatids: 83.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.0;SuSa: 1.5" "Not detected" "Not detected" HPA017984 Enhanced NA NA "HPA017984: AB_1857413" "unprognostic (2.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 169.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 83.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 1.1 0.0 2.2 0.0 0.0 0.0 SPAST "ADPSP, FSP2, KIAA1083, SPG4" ENSG00000021574 Spastin Q9UBP0 2 32063547-32157637 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis" "Allosteric enzyme, Developmental protein, Isomerase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017311 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA017311: AB_1857415" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (5.33e-2)" "unprognostic (3.90e-2)" "unprognostic (3.75e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.26e-2)" "unprognostic (2.35e-2)" "unprognostic (7.39e-2)" "unprognostic (5.98e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (5.71e-2)" "unprognostic (3.04e-1)" "unprognostic (1.53e-2)" "unprognostic (1.13e-1)" 12.7 9.6 18.4 14.8 16.4 13.4 9.8 21.1 21.9 14.7 12.7 15.1 12.5 11.5 12.3 8.7 11.1 10.4 10.2 6.2 20.2 18.5 9.4 14.6 9.7 18.9 20.6 10.0 15.1 10.9 11.8 12.3 11.5 17.5 10.3 12.0 6.8 9.3 13.7 15.4 11.5 17.6 11.6 27.0 15.5 9.7 14.4 14.6 21.5 13.4 6.2 13.8 11.3 10.1 5.0 7.1 9.5 9.0 6.6 7.6 4.3 10.8 7.8 12.9 12.6 8.1 9.6 11.6 6.0 8.9 6.3 5.7 10.6 9.5 19.0 5.6 8.3 9.3 7.7 12.7 6.1 7.8 12.7 7.6 20.8 4.2 12.9 7.4 14.5 14.7 5.3 8.1 8.1 7.7 7.7 13.9 6.2 17.0 6.4 6.9 4.6 23.3 12.2 13.4 12.1 4.6 12.4 18.1 12.3 8.6 6.8 18.3 19.7 10.2 8.7 10.0 11.0 5.6 10.0 12.1 7.0 10.8 6.2 7.0 9.7 18.0 15.4 7.6 12.6 8.4 3.4 6.3 6.7 3.6 9.0 5.2 5.0 5.8 5.6 7.1 3.9 5.9 6.0 9.5 6.6 6.3 3.2 7.6 4.3 18.4 16.4 21.1 15.8 20.2 18.5 20.6 10.0 17.5 14.6 8.9 4.1 4.2 5.3 8.5 14.5 7.5 7.6 13.4 6.8 5.2 21.6 7.6 0.0 5.6 2.5 8.7 9.7 0.0 7.0 6.2 5.0 7.3 9.3 10.9 8.8 9.5 10.4 6.2 14.6 6.4 8.1 16.6 1.7 8.2 10.1 8.0 8.4 8.4 9.6 6.5 14.3 0.0 8.1 15.4 22.2 11.4 6.8 7.5 8.4 5.5 SPATA3 TSARG1 ENSG00000173699 "Spermatogenesis associated 3" Q8NHX4 2 230990324-231025055 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "testis: 82.0" "Cell type enriched" "Detected in some" 5 "Late spermatids: 3891.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 3.6;U-698: 1.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 11 "cerebellum: 11.0" HPA018254 Enhanced NA NA "HPA018254: AB_1857419" "unprognostic (6.94e-3)" "unprognostic (6.98e-2)" "unprognostic (9.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 1.5 0.2 0.2 0.3 0.0 0.1 0.3 0.2 0.1 0.0 0.2 3.6 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.5 0.1 1.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.4 0.3 0.1 0.0 0.1 0.0 0.9 0.0 0.2 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.8 0.0 0.3 0.2 0.0 1.1 0.3 0.1 0.1 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.4 0.2 0.3 0.2 0.2 0.1 0.3 0.3 0.0 0.2 0.5 0.0 0.0 1.5 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 761.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3891.5 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 6.5 0.0 21.5 10.9 0.0 0.0 0.0 0.0 0.0 SPATA31A1 "C9orf36, C9orf36A, DKFZP434B204, FAM75A1, FAM75A2, SPATA31A2" ENSG00000204849 "SPATA31 subfamily A member 1" 9 39355669-39361959 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 103 "testis: 10.2" "Cell type enriched" "Detected in some" 8 "Early spermatids: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 33 "U-2197: 3.3" NA NA "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 SPATA31A3 "DKFZp434B204, FAM75A3" ENSG00000275969 "SPATA31 subfamily A member 3" Q5VYP0 9 66986304-66992583 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 81 "testis: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A5 FAM75A5 ENSG00000276581 "SPATA31 subfamily A member 5" Q5VU36 9 60914374-60920650 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 30 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A6 FAM75A6 ENSG00000185775 "SPATA31 subfamily A member 6" Q5VVP1 9 42183659-42189882 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "testis: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AF22: 1.0" NA NA "unprognostic (2.23e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A7 "FAM75A4, FAM75A7, SPATA31A4" ENSG00000276040 "SPATA31 subfamily A member 7" Q8IWB4 9 61190003-61196280 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 57 "testis: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31D1 "FAM75D1, FLJ46321" ENSG00000214929 "SPATA31 subfamily D member 1" Q6ZQQ2 9 81988772-81995256 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 134 "testis: 13.3" "Cell type enriched" "Detected in some" 6 "Early spermatids: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HDLM-2: 3.7" HPA047897 Uncertain NA NA "HPA047897: AB_2680204" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 SPATA31D3 "FAM75D3, FLJ44082" ENSG00000186788 "SPATA31 subfamily D member 3" P0C874 9 81943586-81950038 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 99 "testis: 9.9" "Cell type enriched" "Detected in some" 13 "Early spermatids: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31D4 "FAM75D4, FLJ43859" ENSG00000189357 "SPATA31 subfamily D member 4" 9 81928514-81934948 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 78 "testis: 7.8" "Cell type enriched" "Detected in some" 15 "Early spermatids: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA9 "FLJ35906, NYD-SP16" ENSG00000145757 "Spermatogenesis associated 9" Q9BWV2 5 95652181-95698711 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.5" "Group enriched" "Detected in some" 15 "Early spermatids: 467.1;Late spermatids: 349.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 20 "eosinophil: 2.0" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "ASC diff: 2.7;HaCaT: 2.8;NB-4: 2.3;THP-1: 4.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA010848, HPA076967" Approved Approved Mitochondria NA NA Mitochondria "HPA010848: AB_1857422, HPA076967: " "unprognostic (4.46e-2)" "unprognostic (4.02e-2)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (9.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.33e-2)" "unprognostic (2.08e-1)" "unprognostic (3.27e-2)" "unprognostic (7.58e-2)" "unprognostic (1.28e-2)" "unprognostic (3.08e-2)" "unprognostic (9.49e-13)" "unprognostic (3.39e-1)" "unprognostic (2.37e-1)" "unprognostic (1.26e-2)" "unprognostic (2.87e-2)" 0.9 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 29.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 2.7 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.1 0.0 0.5 0.3 0.8 2.8 0.0 0.0 0.0 0.2 0.5 1.8 0.2 0.0 0.6 0.6 0.5 1.6 0.0 0.6 0.0 0.9 0.6 1.1 1.7 0.0 2.1 0.0 0.7 2.3 0.8 0.1 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.4 0.5 0.0 4.0 0.0 0.7 0.2 0.5 0.4 0.0 0.2 0.0 0.0 0.4 1.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 467.1 0.0 0.0 0.0 0.0 27.7 0.4 0.2 0.0 0.0 1.1 1.6 0.0 0.0 0.3 349.3 3.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.2 0.0 0.2 0.0 0.5 3.6 2.9 0.1 3.5 0.0 0.0 0.1 SPCS1 "HSPC033, SPC1, SPC12, YJR010C-A" ENSG00000114902 "Signal peptidase complex subunit 1" Q9Y6A9 3 52704955-52711146 "Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046091, HPA055273" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA046091: AB_10959614, HPA055273: AB_2682768" "unprognostic (5.47e-2)" "unprognostic (4.04e-1)" "prognostic favorable (9.28e-4)" "unprognostic (5.93e-2)" "unprognostic (6.88e-2)" "unprognostic (1.10e-2)" "unprognostic (3.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (5.56e-2)" "unprognostic (3.89e-1)" "unprognostic (1.15e-1)" "prognostic favorable (2.90e-4)" "unprognostic (5.96e-2)" "unprognostic (1.80e-1)" "unprognostic (3.58e-1)" "unprognostic (3.09e-2)" 31.0 53.4 39.7 28.5 41.5 27.5 42.2 24.2 55.3 39.1 46.3 40.8 46.3 47.8 34.9 53.2 39.1 33.9 35.6 39.4 38.0 47.0 62.3 98.7 37.1 68.9 47.2 38.1 34.7 112.1 30.5 48.8 50.9 41.7 41.0 41.6 38.4 87.7 57.8 43.2 34.3 53.4 34.2 48.3 37.4 45.7 57.1 25.5 42.6 55.2 38.3 52.0 36.6 30.2 40.2 123.4 48.5 27.8 22.2 34.1 43.1 21.5 20.5 19.5 25.2 31.5 25.7 32.5 30.0 27.5 27.2 24.5 21.4 31.6 23.1 13.2 27.1 26.0 20.8 19.7 28.0 26.5 30.8 23.7 27.3 34.0 29.8 35.6 37.8 45.2 21.0 36.8 30.0 32.7 22.3 22.0 29.0 23.2 73.4 27.7 20.9 29.9 38.4 37.1 53.1 42.6 12.2 18.2 116.3 40.0 26.6 14.1 31.8 29.5 31.7 39.8 18.0 35.4 43.4 20.8 24.6 23.1 44.0 35.3 81.0 120.8 32.6 38.1 41.8 32.0 45.3 26.0 48.5 27.8 26.0 32.8 40.2 34.1 30.5 28.4 29.0 32.2 32.8 19.8 22.2 27.8 123.4 33.9 43.1 39.7 41.5 24.2 55.3 38.0 47.0 47.2 38.1 41.7 25.5 59.6 94.5 189.7 185.2 139.0 485.2 136.5 219.1 186.0 126.3 294.8 111.9 309.5 306.7 288.1 445.8 151.7 198.8 93.5 296.3 331.3 163.9 238.4 205.7 300.1 274.6 96.9 161.0 125.8 194.0 878.2 200.2 191.2 361.0 334.6 203.8 220.7 242.0 238.9 180.4 563.8 195.8 161.7 195.7 623.3 495.0 161.2 293.7 203.7 226.0 258.6 SPCS2 KIAA0102 ENSG00000118363 "Signal peptidase complex subunit 2" Q15005 11 74949247-74979031 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013386 Approved Approved Nucleoplasm NA NA 220000 Nucleoplasm "HPA013386: AB_1857426" "unprognostic (2.43e-1)" "unprognostic (7.01e-2)" "unprognostic (1.65e-2)" "unprognostic (7.09e-3)" "unprognostic (9.30e-2)" "unprognostic (2.31e-2)" "unprognostic (7.04e-3)" "unprognostic (9.61e-2)" "unprognostic (8.83e-2)" "unprognostic (2.02e-3)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (5.70e-2)" "unprognostic (1.37e-1)" "unprognostic (8.62e-2)" 21.8 32.8 29.1 25.8 29.2 13.4 28.7 20.0 26.8 36.5 30.4 26.8 49.5 23.2 32.3 61.6 23.3 25.8 21.4 25.2 29.8 27.5 30.0 46.5 24.0 25.3 33.4 33.5 24.0 75.5 41.6 26.7 28.5 32.9 29.2 31.1 18.6 55.9 34.9 26.4 17.2 24.0 24.8 33.4 30.1 26.5 24.2 27.6 20.3 43.9 14.9 38.7 23.8 21.4 78.2 89.7 86.4 45.9 47.9 65.4 71.8 22.3 26.3 35.2 31.5 31.0 20.9 19.2 32.1 31.4 29.6 26.0 51.7 50.8 36.4 40.7 27.1 35.4 41.3 30.4 23.5 37.0 30.0 22.3 36.9 32.0 42.6 35.3 39.1 26.0 18.5 30.7 24.9 41.0 26.1 28.3 26.9 42.4 95.0 26.8 34.0 27.8 25.0 21.5 88.9 25.1 34.7 54.2 82.5 34.1 37.4 28.6 28.7 32.0 43.1 105.2 25.5 41.7 30.0 22.8 33.8 21.0 35.0 28.3 40.6 41.0 67.6 13.9 27.8 34.1 86.4 45.9 41.3 58.3 44.4 65.4 78.2 54.0 55.9 43.4 62.1 41.4 49.6 29.6 47.9 38.2 89.7 50.9 71.8 29.1 29.2 20.0 26.8 29.8 27.5 33.4 33.5 32.9 27.6 80.4 121.2 168.1 276.8 270.4 92.5 52.0 203.8 105.7 150.2 226.8 49.1 294.6 160.8 248.0 23.5 169.0 110.2 186.9 251.0 262.7 270.0 340.7 151.3 327.2 251.3 90.6 120.3 149.8 135.4 21.2 222.9 194.9 494.3 215.6 135.9 198.0 231.8 129.8 183.9 236.3 72.2 168.1 200.5 94.2 127.2 200.6 388.7 197.1 133.3 256.7 SPCS3 "FLJ22649, PRO3567, SPC22/23, SPC3, YLR066W" ENSG00000129128 "Signal peptidase complex subunit 3" P61009 4 176319964-176332245 "Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 88.1" "Low region specificity" "Detected in all" HPA053180 Approved NA NA "HPA053180: AB_2682071" "unprognostic (4.30e-2)" "unprognostic (1.38e-1)" "unprognostic (5.20e-3)" "prognostic favorable (8.89e-6)" "unprognostic (1.79e-1)" "unprognostic (2.98e-2)" "unprognostic (1.50e-3)" "unprognostic (1.79e-2)" "unprognostic (4.78e-3)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.58e-2)" "unprognostic (2.85e-1)" "unprognostic (2.26e-1)" "unprognostic (4.92e-2)" "unprognostic (2.16e-2)" "unprognostic (1.44e-1)" 20.3 14.2 15.5 24.5 15.8 29.3 30.0 18.3 24.9 26.2 25.3 12.6 40.9 17.3 23.5 27.4 18.2 19.2 20.0 24.4 14.1 14.5 18.1 41.3 25.4 38.2 18.9 17.5 15.8 85.0 21.2 24.9 26.3 14.6 17.6 19.8 11.0 52.4 37.4 17.4 16.2 18.6 26.4 21.2 29.5 24.5 8.3 12.9 19.1 32.5 16.1 23.8 22.4 19.5 8.0 17.1 26.2 14.6 13.0 16.3 12.8 14.6 4.9 13.7 11.2 19.6 34.8 14.5 29.0 27.9 17.0 14.7 5.3 32.4 28.3 6.0 16.7 8.9 10.2 12.9 21.4 25.9 19.0 5.7 24.4 8.0 12.1 20.0 36.5 21.6 21.0 23.6 15.0 14.6 19.1 25.0 13.8 15.7 88.1 23.3 8.9 22.2 13.9 9.3 10.4 4.9 11.0 21.3 24.6 20.9 10.7 10.9 10.0 30.3 22.7 13.3 12.4 7.3 17.1 23.2 12.6 12.6 11.2 13.2 40.9 12.1 35.6 26.8 18.5 17.3 26.2 12.2 10.3 12.3 14.6 16.3 8.0 11.5 11.1 9.2 5.3 9.7 12.0 12.2 13.0 11.6 17.1 8.9 12.8 15.5 15.8 18.3 24.9 14.1 14.5 18.9 17.5 14.6 12.9 50.6 81.3 47.6 49.0 50.8 32.2 67.8 40.8 42.8 54.6 27.9 25.5 58.7 18.3 68.9 48.1 87.5 44.5 116.8 117.4 151.8 62.7 93.0 89.0 104.2 140.2 22.3 43.0 92.1 105.2 14.2 20.8 125.0 104.6 64.9 66.2 31.5 141.6 34.5 15.9 52.2 28.5 12.9 51.2 75.3 39.6 57.0 154.2 63.7 42.2 96.6 SPEM1 "C17orf83, FLJ40081" ENSG00000181323 "Spermatid maturation 1" Q8N4L4 17 7420360-7421632 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "testis: 61.9" "Cell type enriched" "Detected in some" 5 "Late spermatids: 3850.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;hTEC/SVTERT24-B: 1.2;U-2 OS: 3.3" "Low region specificity" "Detected in single" NA NA "unprognostic (1.28e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.1 0.5 0.2 0.0 0.3 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 3.3 0.4 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 833.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3850.1 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 6.5 0.0 11.5 4.0 0.0 0.0 0.0 0.0 0.0 SPEM2 C17orf74 ENSG00000184560 "SPEM family member 2" Q0P670 17 7425615-7427568 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 45.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.3;hTEC/SVTERT24-B: 1.0;U-2 OS: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA023649 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA023649: AB_1845606" "unprognostic (3.00e-1)" "unprognostic (3.88e-1)" "unprognostic (1.12e-4)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPEM3 ENSG00000283439 "SPEM family member 3" 17 7428863-7432762 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 73 "testis: 43.2" "Cell type enriched" "Detected in single" 17 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.1" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPG7 "CAR, CMAR, SPG5C" ENSG00000197912 "SPG7, paraplegin matrix AAA peptidase subunit" Q9UQ90 16 89490719-89557768 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.42e-1)" "unprognostic (1.72e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.22e-4)" "unprognostic (4.10e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-1)" "unprognostic (1.50e-1)" "unprognostic (1.54e-1)" "unprognostic (2.33e-1)" "prognostic favorable (4.91e-4)" "unprognostic (3.56e-2)" "unprognostic (7.01e-2)" "unprognostic (1.44e-2)" "unprognostic (2.58e-1)" "unprognostic (1.71e-1)" "prognostic favorable (4.25e-4)" 14.6 23.6 15.6 11.7 19.9 14.5 17.5 25.2 33.2 14.2 14.9 19.1 19.5 18.0 18.3 16.1 14.2 13.9 15.9 34.3 15.6 15.6 22.3 24.5 14.1 16.2 13.9 23.7 21.6 22.1 17.9 21.0 10.2 19.3 15.9 14.0 16.5 17.4 18.1 75.6 27.9 17.7 17.8 16.9 17.8 16.5 24.1 12.9 13.3 28.4 18.4 16.1 16.6 13.4 6.6 5.0 7.9 4.9 7.2 6.4 2.0 5.5 15.2 7.9 14.1 15.1 9.3 6.2 14.9 10.4 8.7 5.2 12.0 11.6 8.7 16.0 9.2 8.4 14.9 10.7 11.1 9.5 5.0 13.4 4.2 7.6 21.8 6.6 3.5 5.7 5.2 7.7 5.4 6.3 12.5 12.1 10.3 9.5 3.7 8.2 10.9 7.6 12.8 14.0 13.1 11.0 14.1 13.9 5.3 8.4 8.5 8.5 5.6 21.8 3.8 4.5 9.0 12.4 9.1 18.9 6.9 9.6 4.8 6.9 6.2 9.8 7.6 8.9 10.1 8.2 7.9 4.9 7.4 5.6 4.7 5.4 3.3 3.5 2.8 5.0 6.6 6.4 4.3 7.2 7.2 3.3 4.9 3.6 2.0 15.6 19.9 25.2 33.2 15.6 15.6 13.9 23.7 19.3 12.9 44.7 49.6 31.3 24.6 14.2 52.0 39.7 25.5 26.8 43.3 33.2 90.3 32.7 16.6 35.1 57.2 38.6 49.1 23.3 22.6 24.1 28.8 23.0 19.8 33.4 28.0 38.1 35.7 52.2 37.1 16.2 39.7 32.7 20.3 39.7 41.2 36.4 31.8 45.6 31.5 18.3 70.5 6.5 29.3 44.2 37.0 15.7 21.6 38.3 44.4 23.8 SPI1 "OF, PU.1, SFPI1, SPI-1, SPI-A" ENSG00000066336 "Spi-1 proto-oncogene" P17947 11 47354860-47378576 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 100.3;lymphoid tissue: 70.2" "Group enriched" "Detected in many" 5 "Hofbauer cells: 391.4;Kupffer cells: 374.7;Macrophages: 436.5;monocytes: 317.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 45.4;neutrophil: 24.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 45.4" "Cell line enhanced" "Detected in some" "HEL: 19.2;HL-60: 33.6;HMC-1: 62.7;NB-4: 56.7;THP-1: 44.2;U-698: 17.9;U-937: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004079, HPA044653" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB004079: AB_10692379, HPA044653: AB_2679036" "unprognostic (4.45e-2)" "unprognostic (3.31e-3)" "unprognostic (2.92e-2)" "unprognostic (1.66e-2)" "unprognostic (5.97e-2)" "unprognostic (3.33e-2)" "unprognostic (5.28e-2)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (2.79e-1)" "unprognostic (3.36e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.20e-1)" "unprognostic (4.95e-2)" "unprognostic (2.40e-1)" "unprognostic (4.92e-2)" 24.4 8.1 6.7 35.7 15.2 100.3 9.0 1.5 6.6 3.6 5.2 8.6 0.0 7.6 3.2 6.2 4.0 8.5 7.7 15.7 5.6 5.1 5.8 11.9 37.2 51.1 12.6 1.6 6.1 3.5 0.9 3.6 10.1 9.6 4.5 3.9 3.9 6.4 2.6 3.3 5.0 10.5 7.6 12.1 70.2 5.8 5.4 10.5 9.6 3.7 2.7 16.8 9.1 5.7 1.0 4.6 45.4 9.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 33.6 62.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 56.7 0.0 0.0 0.0 10.3 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 44.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 17.9 0.0 25.0 0.0 3.6 5.4 45.4 0.0 7.8 0.0 1.0 0.0 0.0 4.6 0.8 0.0 0.0 24.8 0.0 9.1 0.2 0.0 1.5 6.7 15.2 1.5 6.6 5.6 5.1 12.6 1.6 9.6 10.5 3.0 0.6 71.3 0.5 9.3 1.5 2.0 7.6 1.4 1.2 5.2 0.0 1.9 16.6 0.0 5.9 2.2 0.3 0.0 0.3 2.5 5.9 0.4 34.5 1.3 391.4 0.0 4.1 11.1 374.7 20.0 1.7 436.5 10.1 317.4 0.1 4.0 0.0 0.0 0.0 1.3 1.0 12.9 2.1 5.5 2.5 8.7 3.5 2.5 0.4 0.4 SPIN3 TDRD27 ENSG00000204271 "Spindlin family member 3" Q5JUX0 X 56818298-56995827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 7.0;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 17.0" "Low region specificity" "Detected in all" HPA000727 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA000727: AB_2196121" "unprognostic (3.12e-3)" "unprognostic (2.32e-1)" "unprognostic (7.45e-3)" "prognostic unfavorable (3.49e-4)" "unprognostic (1.20e-2)" "unprognostic (1.67e-2)" "unprognostic (6.85e-4)" "prognostic favorable (6.79e-4)" "unprognostic (1.70e-2)" "unprognostic (1.30e-1)" "unprognostic (2.48e-2)" "unprognostic (1.16e-2)" "unprognostic (1.02e-2)" "unprognostic (6.53e-2)" "unprognostic (8.51e-2)" "unprognostic (1.98e-2)" "prognostic favorable (6.30e-4)" 5.7 7.6 10.5 4.8 10.7 0.4 9.4 28.6 14.2 7.8 4.6 7.3 9.2 4.8 10.4 8.3 4.5 7.4 5.5 3.8 9.2 6.6 5.3 5.0 5.4 6.7 6.6 10.3 11.3 10.2 4.4 12.4 4.1 9.6 10.4 7.0 6.5 7.5 7.5 4.2 4.7 6.6 7.6 5.0 6.1 7.5 4.3 8.3 0.3 6.0 1.4 6.9 8.2 6.2 2.7 1.6 3.3 1.5 4.7 4.5 2.2 4.3 6.4 3.6 0.0 7.0 6.2 2.8 3.8 2.0 2.6 3.0 3.7 5.5 0.0 2.6 3.2 7.3 5.1 5.6 2.3 3.2 0.0 1.3 0.5 17.0 2.6 3.8 0.0 4.8 5.4 4.7 2.7 4.3 4.0 1.6 0.0 2.6 8.5 4.4 2.8 0.0 3.5 7.4 2.5 6.1 0.0 3.1 1.7 3.4 5.1 7.3 5.0 4.0 3.9 4.1 5.9 9.7 1.0 1.1 4.4 6.7 7.2 2.0 3.5 2.5 0.0 4.3 0.0 3.3 3.3 1.0 1.9 0.2 1.5 1.7 2.7 3.9 1.6 1.6 0.9 4.5 1.1 0.0 4.7 0.1 0.2 1.0 2.2 10.5 10.7 28.6 13.4 9.2 6.6 6.6 10.3 9.6 8.3 0.0 3.0 0.0 3.6 0.2 2.0 1.0 2.5 1.4 3.4 7.0 0.0 1.9 1.7 3.2 0.0 1.1 0.8 0.0 2.4 1.7 1.8 1.6 1.1 1.1 0.8 1.6 0.0 1.8 1.8 0.0 3.7 1.0 1.7 1.8 0.7 1.0 3.1 0.0 2.5 2.7 2.4 6.5 1.4 0.0 0.0 0.4 0.3 0.0 1.1 2.0 SPINK13 "HESPINTOR, LiESP6, MGC149260, SPINK5L3" ENSG00000214510 "Serine peptidase inhibitor, Kazal type 13 (putative)" Q1W4C9 5 148268180-148286254 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7" "Group enriched" "Detected in some" 7 "Leydig cells: 36.8;Peritubular cells: 25.1" "Group enriched" "Detected in some" 6 "cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "HeLa: 102.0" HPA036456 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" Nucleoplasm "HPA036456: AB_10673496" "unprognostic (5.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.44e-1)" "unprognostic (2.51e-1)" "unprognostic (1.22e-1)" "unprognostic (1.41e-2)" "unprognostic (6.43e-3)" "unprognostic (1.25e-3)" "unprognostic (5.01e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (4.03e-10)" "unprognostic (4.31e-2)" "unprognostic (1.72e-1)" "unprognostic (2.43e-1)" "unprognostic (2.95e-2)" 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 2.2 0.0 85.5 0.0 0.4 86.8 0.1 1.0 0.1 0.8 0.0 0.1 2.1 0.0 0.1 0.1 0.0 0.0 1.4 0.4 0.0 1.0 0.1 0.0 4.0 0.0 0.0 0.1 26.7 0.1 0.2 0.0 0.1 0.0 0.0 2.9 2.7 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 102.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 5.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 1.7 0.0 25.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPINK14 SPINK5L2 ENSG00000196800 "Serine peptidase inhibitor, Kazal type 14 (putative)" Q6IE38 5 148169733-148175398 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "breast: 2.7;intestine: 3.6;liver: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA "unprognostic (4.98e-2)" "unprognostic (3.44e-1)" "unprognostic (1.94e-2)" "unprognostic (2.96e-2)" "unprognostic (5.69e-1)" "unprognostic (1.48e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 1.5 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 3.6 1.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SPINK2 HUSI-II ENSG00000128040 "Serine peptidase inhibitor, Kazal type 2" P20155 4 56809860-56821742 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "epididymis: 376.2" "Group enriched" "Detected in many" 9 "Early spermatids: 772.8;Late spermatids: 1064.2;Spermatocytes: 1687.5" "Group enriched" "Detected in some" 5 "lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 6 "NK-cell: 43.3" "Lineage enriched" "Detected in many" 6 "NK-cells: 43.3" "Cell line enriched" "Detected in some" 4 "U-266/70: 44.5" "CAB020824, HPA026813" Enhanced "Secreted to blood" NA NA "CAB020824: , HPA026813: AB_1857446" "unprognostic (5.56e-3)" "unprognostic (3.60e-1)" "unprognostic (7.54e-2)" "unprognostic (2.35e-2)" "unprognostic (1.54e-1)" "unprognostic (1.60e-1)" "prognostic favorable (2.82e-4)" "unprognostic (9.83e-2)" "unprognostic (6.62e-2)" "unprognostic (9.40e-3)" "unprognostic (2.06e-1)" "unprognostic (2.49e-1)" "unprognostic (4.10e-3)" "unprognostic (3.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.87e-2)" 0.2 0.1 0.2 0.5 0.2 0.7 0.3 0.1 0.3 0.4 0.4 0.0 85.2 0.0 0.2 376.2 0.1 0.2 0.0 2.2 0.3 0.3 0.2 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.0 1.4 0.0 1.1 1.1 0.1 0.0 0.6 49.9 0.5 0.2 0.5 0.0 0.2 0.6 0.2 85.5 0.0 0.3 0.2 0.0 0.2 1.3 1.3 3.9 0.4 1.3 0.0 43.3 7.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.3 1.3 8.6 0.2 0.0 0.0 0.0 0.0 2.0 0.0 2.8 0.1 1.5 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 44.5 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.2 0.0 0.2 2.3 1.7 1.8 0.4 3.9 3.9 7.3 0.3 43.3 0.0 0.2 0.1 2.0 0.2 0.2 0.1 0.3 0.3 0.3 0.2 0.0 1.1 0.0 0.0 0.0 4.5 12.1 1.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 772.8 0.1 0.2 0.0 0.0 0.2 0.5 9.5 1.1 0.0 0.1 0.0 1.7 0.0 0.0 1064.2 35.1 0.2 11.8 0.0 5.3 1.4 0.0 9.3 23.0 0.0 0.0 12.9 1.0 1687.5 136.3 0.3 0.0 7.5 1.7 2.2 SPINK6 "BUSI2, MGC21394, UNQ844" ENSG00000178172 "Serine peptidase inhibitor, Kazal type 6" Q6UWN8 5 148202794-148215137 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;cervix, uterine: 7.2;tongue: 7.1;vagina: 8.6" "Cell type enhanced" "Detected in some" 19 "Basal keratinocytes: 1.3;Hofbauer cells: 2.6" "Group enriched" "Detected in many" 6 "cervical cancer: 21.4;head and neck cancer: 21.0" "Region enriched" "Detected in single" 78 "cerebellum: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 84 "HeLa: 244.9;SiHa: 117.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011039 Uncertain "Secreted - unknown location" NA NA "HPA011039: AB_2668412" "unprognostic (2.92e-2)" "unprognostic (2.97e-2)" "unprognostic (2.65e-1)" "unprognostic (4.87e-2)" "prognostic favorable (7.16e-4)" "unprognostic (2.49e-2)" "unprognostic (4.04e-1)" "unprognostic (1.80e-2)" "unprognostic (2.09e-2)" "unprognostic (2.22e-2)" "unprognostic (1.29e-2)" "unprognostic (7.29e-2)" 1.9 1.1 0.1 0.1 0.1 0.0 0.9 10.6 0.1 7.2 1.6 0.1 0.1 0.0 0.1 3.7 5.9 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.6 0.1 0.1 0.8 0.1 5.0 0.2 0.1 0.5 0.1 0.9 0.1 0.1 0.0 0.2 0.1 1.6 0.1 7.1 0.1 0.4 8.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 244.9 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 10.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 2.6 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 SPINK9 ENSG00000204909 "Serine peptidase inhibitor, Kazal type 9" Q5DT21 5 148321203-148339849 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "tongue: 65.0" "Group enriched" "Detected in some" 54 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 27.5;Ciliated cells: 26.8;Club cells: 27.3;granulocytes: 9.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 18.5;U-266/84: 19.6" "Low region specificity" "Detected in single" HPA038288 Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA "Nucleoplasm, Vesicles" "HPA038288: AB_10795400" "unprognostic (1.84e-1)" "unprognostic (4.87e-3)" "unprognostic (2.88e-1)" "unprognostic (9.02e-2)" "unprognostic (5.49e-3)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (2.82e-2)" "unprognostic (1.91e-2)" "unprognostic (3.93e-1)" "unprognostic (2.01e-1)" "unprognostic (3.99e-2)" "unprognostic (1.90e-1)" 1.0 2.3 2.3 2.2 4.0 6.2 1.0 1.3 3.2 1.0 1.2 1.0 1.0 1.1 2.0 1.5 1.5 0.5 1.0 2.3 2.2 3.3 1.3 1.0 1.0 1.9 1.5 1.0 1.4 1.4 0.5 1.4 2.5 1.0 1.8 1.2 1.0 1.0 1.0 2.4 2.7 1.7 1.0 1.1 1.1 2.0 3.8 1.0 2.7 1.0 65.0 1.1 1.2 1.0 3.4 2.7 10.7 2.9 5.8 2.8 0.2 11.1 2.1 2.9 3.0 0.4 1.1 2.4 3.0 0.1 0.2 0.5 4.6 8.6 3.3 18.5 0.2 1.6 2.3 0.9 0.6 0.8 4.7 2.2 6.5 6.9 2.0 0.2 2.3 2.7 0.1 0.6 0.3 0.1 1.7 0.0 2.3 3.9 14.4 0.4 9.5 2.2 3.4 11.4 4.2 4.4 2.9 2.9 3.6 1.4 9.1 5.2 6.0 3.0 6.5 2.0 8.3 10.6 2.1 7.0 3.4 10.7 3.3 3.5 9.1 19.6 3.3 2.8 2.0 4.6 10.7 2.9 1.3 1.8 1.6 2.1 1.3 2.0 2.1 0.7 3.4 2.6 2.8 10.5 5.8 2.8 2.7 1.3 0.2 2.3 4.0 1.3 3.2 2.2 3.3 1.5 1.0 1.0 1.0 14.9 27.5 0.0 0.1 0.0 0.0 0.3 0.0 26.8 27.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 SPINT1 "HAI, MANSC2" ENSG00000166145 "Serine peptidase inhibitor, Kunitz type 1" O43278 15 40844018-40858207 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 121.0" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 913.5;Syncytiotrophoblasts: 1399.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 52.1;HaCaT: 59.5;hTCEpi: 42.4;RT4: 48.2;SK-BR-3: 89.3;T-47d: 42.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006903, HPA031178" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 3400000 "Plasma membrane, Cytosol" Nucleoplasm "HPA006903: AB_1079038, HPA031178: AB_2732463" "prognostic unfavorable (6.97e-4)" "unprognostic (1.00e-3)" "unprognostic (3.00e-3)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (3.19e-1)" "unprognostic (5.94e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-3)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.01e-1)" "prognostic favorable (1.37e-7)" "unprognostic (5.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.45e-3)" "unprognostic (2.17e-2)" 2.2 0.5 0.9 11.6 1.2 0.0 12.6 2.9 0.8 12.9 64.4 1.2 38.6 31.9 3.6 25.5 71.1 6.4 30.7 0.8 0.8 0.7 27.9 1.5 18.5 3.7 0.9 0.6 3.4 25.0 28.8 9.7 85.5 1.3 17.5 17.9 3.2 50.8 24.0 0.6 39.1 121.0 2.3 1.0 3.1 17.6 1.9 0.7 4.8 15.4 26.9 44.3 12.8 21.5 5.1 19.0 15.3 10.9 3.6 1.8 3.8 19.0 0.1 0.0 0.1 0.0 0.0 52.1 0.3 0.4 0.6 0.3 30.4 32.0 0.0 22.8 0.0 0.5 59.5 4.9 28.6 0.4 0.1 1.6 0.8 0.5 1.6 0.3 3.3 15.1 0.0 42.4 0.6 2.7 0.5 2.3 1.9 0.4 0.1 0.0 14.8 0.1 2.5 5.9 32.2 2.8 1.9 0.0 3.7 28.8 48.2 12.8 0.6 1.4 89.3 2.3 9.6 42.7 2.5 0.0 0.0 0.3 0.1 0.0 0.1 3.6 0.1 0.1 2.5 0.1 0.0 10.9 7.9 0.3 9.3 0.5 5.1 1.8 0.8 19.0 3.9 0.7 0.2 15.3 3.6 9.6 2.3 0.2 3.8 0.9 1.2 2.9 0.8 0.8 0.7 0.9 0.6 1.3 0.7 53.6 17.1 2.7 86.0 67.5 0.0 0.4 109.5 4.0 18.2 127.4 0.0 913.5 21.6 354.0 0.5 0.7 428.8 0.0 224.2 67.1 7.5 132.0 10.3 0.4 125.6 0.0 141.5 0.0 13.6 0.8 3.4 17.8 13.5 101.8 147.7 0.0 241.9 199.9 0.0 40.0 0.1 0.0 5.2 0.6 5.2 76.9 1399.8 2.2 145.0 168.6 SPINT2 "HAI-2, Kop" ENSG00000167642 "Serine peptidase inhibitor, Kunitz type 2" O43291 19 38244035-38292614 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 1193.1;Syncytiotrophoblasts: 1181.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 77.2;CAPAN-2: 114.0;OE19: 138.0;RPTEC TERT1: 85.0;SK-BR-3: 74.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011101, CAB018969" Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" No NA "Plasma membrane, Intermediate filaments, Cytosol" "CAB018969: , HPA011101: AB_1079039" "unprognostic (5.13e-2)" "unprognostic (1.06e-3)" "unprognostic (1.40e-1)" "unprognostic (6.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.03e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.04e-1)" "prognostic favorable (3.41e-4)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.94e-2)" "unprognostic (2.68e-2)" 1.5 7.2 11.9 15.1 14.0 10.7 29.2 14.3 20.8 24.0 46.3 4.7 63.2 38.3 7.1 44.9 60.6 30.4 51.8 3.3 10.4 22.9 47.5 2.8 25.6 10.3 9.3 14.6 15.3 78.7 30.2 82.7 77.3 11.0 29.6 40.3 15.3 143.1 61.6 0.7 41.7 82.3 13.1 5.6 9.4 34.1 87.0 2.8 15.0 95.6 32.0 37.5 27.1 25.0 23.1 73.9 70.7 17.9 2.6 13.2 17.6 77.2 56.1 0.2 0.3 0.0 0.0 36.8 1.5 0.1 0.1 0.2 39.7 114.0 0.6 6.2 0.4 0.1 25.6 4.0 55.0 0.1 0.7 4.6 14.5 1.4 0.0 0.0 0.1 0.0 0.0 63.5 0.0 26.9 6.8 0.1 13.4 0.3 0.0 0.1 59.9 2.2 0.2 5.6 138.0 15.8 7.9 0.0 34.7 85.0 65.9 21.2 0.3 23.0 74.8 0.2 23.2 33.4 9.6 0.0 0.1 0.4 0.3 0.3 5.3 6.7 4.3 0.1 1.0 0.1 57.2 17.9 70.7 0.5 12.5 1.1 20.0 6.5 3.2 41.7 23.1 13.2 11.9 7.8 2.6 8.4 73.9 2.5 17.6 11.9 14.0 14.3 20.8 10.4 22.9 9.3 14.6 11.0 2.8 342.4 185.3 64.0 449.2 334.9 13.5 2.4 313.4 305.1 279.8 530.4 5.9 1193.1 86.2 726.2 49.0 27.7 770.2 23.3 582.2 418.7 47.4 567.4 114.2 0.9 201.0 3.2 346.3 19.6 47.0 43.3 17.5 123.0 84.4 555.5 581.5 122.0 696.1 614.1 15.9 155.0 17.0 51.8 17.6 285.2 308.8 374.4 1181.8 32.3 502.6 795.6 SPINT4 "C20orf137, dJ601O1.1" ENSG00000149651 "Serine peptidase inhibitor, Kunitz type 4" Q6UDR6 20 45722351-45725830 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "epididymis: 134.6" "Cell type enriched" "Detected in single" 11 "Rod photoreceptor cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NB-4: 4.6;U-87 MG: 2.0" HPA046703 Enhanced "Secreted in male reproductive system" NA NA "HPA046703: AB_2732530" "unprognostic (3.61e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 11.5 0.0 0.1 134.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 2.1 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPN "CD43, GPL115, LSN" ENSG00000197471 Sialophorin P16150 16 29662979-29670876 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 52.1;bone marrow: 33.1;lung: 25.0;lymphoid tissue: 79.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 22.9;Erythroid cells: 23.3;granulocytes: 42.7;Hofbauer cells: 27.4;Kupffer cells: 21.5;Macrophages: 52.4;T-cells: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 52.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 56.1;HL-60: 49.8;HMC-1: 28.1;K-562: 17.4;MOLT-4: 19.3;REH: 17.4;THP-1: 27.0;U-937: 35.5" "CAB002666, HPA055244" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB002666: , HPA055244: AB_2682756" "prognostic favorable (1.40e-4)" "unprognostic (1.63e-3)" "unprognostic (3.14e-2)" "prognostic favorable (3.08e-5)" "unprognostic (2.68e-2)" "unprognostic (2.49e-3)" "unprognostic (4.02e-2)" "unprognostic (4.17e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.70e-1)" "unprognostic (4.67e-2)" "unprognostic (2.68e-1)" "unprognostic (2.61e-2)" "unprognostic (4.52e-2)" "unprognostic (4.14e-2)" "unprognostic (5.85e-2)" "unprognostic (4.72e-2)" 5.7 1.0 1.2 12.9 2.7 33.1 1.6 0.7 1.5 1.3 2.8 2.6 0.0 2.3 1.5 0.6 1.9 1.7 2.8 3.9 1.2 1.4 1.8 1.9 25.0 18.3 3.7 0.2 1.0 1.6 0.2 1.0 0.8 2.3 1.6 2.6 1.6 5.0 0.6 0.8 1.6 6.8 1.0 4.6 15.9 2.0 0.6 1.9 79.7 1.6 1.7 17.4 2.6 1.4 1.0 8.8 3.5 52.1 17.5 26.5 10.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.1 0.0 0.4 0.0 49.8 28.1 0.0 0.0 0.0 0.0 0.0 0.0 10.9 17.4 13.7 0.1 0.0 19.3 12.5 0.0 0.0 0.0 17.4 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.1 0.0 0.0 0.0 0.0 0.1 1.0 7.3 0.0 35.5 0.0 2.4 5.5 3.5 26.5 24.3 14.5 1.0 10.7 18.1 8.8 0.3 7.6 13.2 0.9 17.5 52.1 7.0 9.1 10.7 1.2 2.7 0.7 1.5 1.2 1.4 3.7 0.2 2.3 1.9 8.9 22.9 9.3 0.5 1.9 0.6 5.1 0.0 2.7 4.5 1.8 0.0 0.2 0.0 0.0 0.0 0.7 0.0 23.3 0.0 0.3 2.6 0.4 42.7 0.9 27.4 1.6 0.0 4.3 21.5 0.0 0.0 52.4 1.7 1.8 0.0 0.4 0.0 0.0 0.0 0.3 1.9 0.0 1.7 0.2 0.6 1.8 0.2 85.3 0.0 0.7 SPNS1 "HSpin1, LAT, nrs, PP2030, SPIN1, SPINL" ENSG00000169682 "Sphingolipid transporter 1 (putative)" Q9H2V7 16 28974221-28984548 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041995, HPA042988" Enhanced Approved "Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol" NA NA Vesicles "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA041995: AB_10959609, HPA042988: AB_10964587" "unprognostic (3.54e-2)" "unprognostic (4.57e-4)" "unprognostic (2.15e-1)" "unprognostic (2.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.66e-1)" "unprognostic (7.86e-5)" "unprognostic (1.01e-1)" "unprognostic (2.00e-1)" "unprognostic (1.27e-1)" "unprognostic (4.12e-2)" "unprognostic (3.02e-3)" "unprognostic (8.85e-7)" "unprognostic (1.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.26e-3)" "unprognostic (1.12e-2)" 23.4 23.9 14.5 22.0 15.9 38.3 24.2 21.0 22.8 18.2 22.1 24.1 20.1 26.9 25.1 21.3 20.9 17.1 26.8 16.1 14.9 12.1 24.1 28.3 33.4 22.6 15.4 17.0 18.3 20.8 29.5 17.2 40.7 15.4 20.1 12.6 19.8 20.8 22.8 21.3 30.9 22.3 26.3 14.5 27.3 20.7 22.3 17.2 31.0 22.0 24.5 17.2 21.2 19.5 3.1 15.6 7.2 23.5 4.2 7.9 10.1 10.3 24.5 9.3 21.6 17.9 9.9 26.5 11.6 12.0 19.4 17.4 22.3 24.9 6.6 28.6 10.4 16.1 22.0 15.0 12.8 7.0 7.6 25.5 9.6 23.9 27.7 30.4 10.6 20.7 16.5 17.2 20.9 8.9 11.4 17.8 12.4 21.5 12.0 9.7 27.7 11.6 30.4 21.9 8.4 16.2 14.7 11.2 29.6 10.5 10.1 16.7 21.6 8.2 24.7 18.0 8.1 24.6 12.9 15.0 15.8 12.0 22.0 8.9 18.2 14.3 6.2 20.2 16.3 12.7 6.4 18.2 7.2 6.0 23.5 5.0 3.1 6.0 7.9 15.6 2.8 6.2 4.1 3.3 4.2 15.7 6.5 6.8 10.1 14.5 15.9 21.0 22.8 14.9 12.1 15.4 17.0 15.4 17.2 6.0 7.4 9.0 18.6 18.9 27.1 0.4 10.2 12.0 3.4 19.2 27.5 55.8 11.6 51.1 1.5 21.6 16.8 0.0 39.5 59.8 27.5 13.4 20.9 12.1 87.9 25.4 11.7 19.6 37.6 1.9 21.0 27.5 32.1 26.2 18.9 29.6 34.8 14.0 15.6 13.5 33.9 6.5 15.3 17.2 28.3 19.8 73.0 22.5 23.8 17.0 SPNS2 ENSG00000183018 "Sphingolipid transporter 2" Q8IVW8 17 4498838-4539035 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 45.9" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 25.5;Collecting duct cells: 21.0;Endothelial cells: 25.3;Proximal tubular cells: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;NK-cell: 1.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;NK-cells: 1.2" "Cell line enhanced" "Detected in some" "BEWO: 11.0;RPTEC TERT1: 57.9;SK-BR-3: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068717 Uncertain NA NA "HPA068717: AB_2686021" "unprognostic (3.03e-2)" "unprognostic (4.76e-2)" "unprognostic (8.08e-2)" "unprognostic (3.53e-2)" "unprognostic (2.78e-1)" "unprognostic (6.30e-3)" "unprognostic (1.10e-3)" "unprognostic (2.33e-1)" "unprognostic (1.70e-1)" "unprognostic (1.63e-3)" "unprognostic (2.99e-2)" "unprognostic (2.98e-2)" "unprognostic (4.48e-2)" "unprognostic (2.20e-2)" "unprognostic (1.68e-1)" "unprognostic (2.19e-2)" "unprognostic (6.89e-2)" 9.8 2.1 10.3 5.8 13.6 7.9 8.6 5.3 19.5 8.2 4.9 22.6 0.0 13.1 5.4 2.1 45.9 4.6 13.8 7.2 11.0 7.8 31.2 3.3 16.1 5.4 21.3 10.9 1.8 7.3 2.3 1.3 9.0 25.0 3.2 3.2 11.6 11.2 3.2 5.0 13.8 8.5 5.8 12.3 9.1 21.7 2.0 15.7 0.0 5.2 10.9 15.7 8.4 13.1 0.0 0.2 1.2 0.0 1.2 0.2 0.0 3.2 0.4 0.0 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.1 2.8 0.1 4.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.6 0.0 0.0 0.0 1.3 0.0 5.7 0.0 6.0 0.1 0.2 0.0 0.1 57.9 0.2 1.9 0.0 0.0 26.9 0.0 1.9 0.9 2.5 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.3 1.2 0.0 0.0 0.0 0.0 10.3 13.6 5.3 19.5 11.0 7.8 21.3 10.9 25.0 15.7 6.0 8.8 0.0 0.2 1.5 0.6 0.8 25.5 1.4 12.5 21.0 0.0 0.1 1.7 14.3 0.2 25.3 1.3 0.0 2.7 14.8 1.7 4.6 0.0 5.6 0.9 6.4 0.0 14.7 0.8 0.0 0.6 0.7 1.7 0.0 10.8 0.3 11.9 0.0 0.4 23.7 0.7 0.0 2.3 0.5 0.4 2.0 1.6 0.0 0.4 1.4 SPNS3 MGC29671 ENSG00000182557 "Sphingolipid transporter 3 (putative)" Q6ZMD2 17 4433688-4488208 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 51.8;bone marrow: 23.1;lymphoid tissue: 15.1" "Group enriched" "Detected in many" 5 "Proximal tubular cells: 44.0;T-cells: 27.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 51.8;plasmacytoid DC: 25.1" "Group enriched" "Detected in many" 24 "dendritic cells: 25.1;granulocytes: 51.8" "Cell line enhanced" "Detected in some" "JURKAT: 12.9;MOLT-4: 4.6;NB-4: 15.6;THP-1: 16.9;U-937: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA023928 Uncertain NA NA "HPA023928: AB_1844393" "unprognostic (4.39e-2)" "unprognostic (8.10e-5)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.94e-4)" "unprognostic (2.86e-2)" "unprognostic (1.96e-2)" "unprognostic (1.81e-2)" "unprognostic (6.46e-2)" "unprognostic (1.37e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (8.09e-4)" "unprognostic (6.18e-2)" "unprognostic (6.57e-2)" "unprognostic (4.13e-2)" "unprognostic (9.69e-2)" 0.3 0.5 1.1 2.0 0.9 23.1 0.3 0.5 1.6 0.4 1.3 3.7 0.0 0.6 0.5 0.1 0.4 0.7 0.7 0.7 1.2 1.6 0.4 0.3 1.2 1.3 2.4 0.1 0.2 0.3 0.1 0.5 0.1 2.0 0.5 0.2 0.0 1.3 0.5 0.1 0.5 0.8 0.2 4.2 2.9 0.3 1.3 2.2 15.1 0.2 0.0 1.6 0.3 0.3 0.0 25.1 51.8 1.5 0.0 0.2 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 1.0 0.0 0.0 4.6 15.6 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.1 0.0 13.0 0.0 0.0 1.5 51.8 0.1 0.3 0.1 0.0 0.0 0.2 11.5 0.0 0.0 0.2 0.2 0.0 0.0 25.1 0.0 1.0 1.1 0.9 0.5 1.6 1.2 1.6 2.4 0.1 2.0 2.2 3.0 1.4 3.2 0.1 1.1 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 3.3 1.8 0.6 0.0 1.0 0.0 0.0 4.2 0.1 0.4 0.0 0.0 1.2 0.0 0.0 0.6 3.3 1.5 0.0 7.6 1.7 0.0 1.4 0.0 0.7 0.3 0.0 44.0 0.0 0.0 0.4 0.0 0.0 0.4 0.2 27.1 1.2 0.4 SPOCK3 testican-3 ENSG00000196104 "SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3" Q9BQ16 4 166733384-167234796 "Predicted intracellular proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 46.8;parathyroid gland: 184.6" "Group enriched" "Detected in some" 4 "Bipolar cells: 45.8;Ciliated cells: 12.0;Club cells: 18.2;Early spermatids: 12.6;Horizontal cells: 14.3" "Cancer enhanced" "Detected in many" "prostate cancer: 7.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 3.3;intermediate monocyte: 1.8;myeloid DC: 4.5;plasmacytoid DC: 1.4" "Group enriched" "Detected in many" 12 "dendritic cells: 4.5;monocytes: 3.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.2;hTERT-RPE1: 9.9;PC-3: 3.9;RH-30: 10.4;SCLC-21H: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (3.54e-2)" "unprognostic (8.69e-2)" "unprognostic (2.90e-3)" "unprognostic (1.20e-1)" "unprognostic (4.09e-4)" "unprognostic (3.75e-1)" "unprognostic (1.97e-2)" "unprognostic (1.44e-1)" "unprognostic (1.88e-1)" "unprognostic (3.94e-4)" "unprognostic (8.92e-2)" "unprognostic (4.18e-3)" "unprognostic (2.62e-2)" "unprognostic (2.48e-1)" "unprognostic (3.60e-3)" "unprognostic (1.64e-1)" 1.2 10.0 21.7 1.3 30.4 1.1 1.1 5.8 23.2 1.4 1.4 32.2 2.2 1.4 2.2 8.0 1.2 1.5 1.2 1.2 31.3 21.4 1.2 1.2 1.2 1.2 45.4 15.9 7.8 1.3 184.6 0.3 1.1 27.4 28.1 1.3 0.0 1.2 14.1 1.2 1.1 1.6 2.1 46.8 1.2 1.4 1.3 42.9 0.0 1.1 0.9 1.2 1.9 0.3 0.0 4.5 0.0 3.3 0.3 0.0 1.1 0.0 2.4 0.3 0.0 0.0 0.0 0.4 0.0 3.2 0.1 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.1 0.6 0.2 0.3 0.0 1.6 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 9.9 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.4 0.0 3.9 0.0 10.4 0.6 0.0 1.5 4.5 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.3 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.0 3.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.0 1.1 21.7 30.4 5.8 22.8 31.3 21.4 45.4 15.9 27.4 42.9 0.0 0.0 0.0 1.1 0.0 45.8 0.9 0.0 12.0 18.2 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.1 0.0 4.0 1.1 0.0 0.1 14.3 0.0 0.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.4 0.0 5.1 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.6 SPPL2A "IMP3, PSL2" ENSG00000138600 "Signal peptide peptidase like 2A" Q8TCT8 15 50702266-50765808 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036062, HPA067304" Enhanced Supported Vesicles NA NA Vesicles "HPA036062: AB_10611670, HPA067304: AB_2685820" "unprognostic (1.66e-1)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (5.82e-3)" "unprognostic (3.71e-1)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" "unprognostic (1.88e-1)" "unprognostic (2.22e-2)" "unprognostic (6.36e-2)" "unprognostic (2.04e-2)" "unprognostic (4.00e-2)" "unprognostic (3.11e-2)" "unprognostic (2.26e-2)" "unprognostic (1.44e-2)" "unprognostic (6.96e-2)" "unprognostic (3.66e-1)" 20.5 23.5 6.9 18.0 8.6 15.0 23.3 6.2 8.1 16.4 29.3 10.8 15.3 24.9 14.5 17.9 18.7 13.0 14.9 37.6 7.8 5.3 23.3 44.8 19.2 23.9 8.3 6.1 13.2 32.7 61.0 11.8 32.2 14.4 14.7 26.9 14.9 21.7 15.5 63.1 15.8 39.2 20.5 8.5 21.2 18.3 10.2 7.4 21.6 15.6 17.4 17.7 19.7 13.9 9.8 19.4 24.0 27.3 11.9 15.4 22.4 15.4 26.9 10.5 13.8 41.4 24.7 16.5 24.9 41.8 22.9 32.7 31.1 17.9 9.6 18.6 48.7 34.4 23.3 12.6 15.1 25.6 19.6 7.7 18.2 18.4 16.0 34.2 11.3 29.8 21.4 27.8 18.9 30.6 17.0 22.5 10.5 13.7 37.8 30.2 35.6 5.3 4.3 4.5 24.8 6.1 6.5 16.2 21.1 31.4 36.0 8.4 9.5 15.0 29.0 16.8 22.0 20.6 22.4 27.4 37.0 14.9 23.7 29.3 15.4 26.3 10.6 16.7 19.0 25.3 21.2 26.9 24.0 15.4 24.6 9.7 9.8 12.6 13.9 19.4 9.3 7.2 11.5 19.4 11.9 27.3 17.1 15.4 22.4 6.9 8.6 6.2 8.1 7.8 5.3 8.3 6.1 14.4 7.4 44.7 34.7 37.5 70.0 38.2 14.8 64.5 58.6 29.4 37.5 64.6 19.6 118.1 19.9 75.9 11.3 46.7 152.1 0.0 145.2 68.6 45.2 72.3 45.0 111.7 79.3 7.9 36.9 43.0 60.6 5.6 41.4 67.0 30.4 170.5 66.7 31.2 103.1 123.8 34.3 42.8 17.0 25.8 39.1 30.5 14.8 33.9 171.1 48.4 59.7 82.4 SPPL2B "IMP4, KIAA1532, PSL1" ENSG00000005206 "Signal peptide peptidase like 2B" Q8TCT7 19 2328615-2354806 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 82.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005592, HPA039292" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA "Nucleoplasm, Plasma membrane" Centrosome "CAB005592: AB_325074, HPA039292: AB_2676429" "unprognostic (4.16e-2)" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "prognostic favorable (5.00e-5)" "unprognostic (2.34e-1)" "unprognostic (1.54e-3)" "unprognostic (1.74e-1)" "unprognostic (7.93e-3)" "unprognostic (3.00e-1)" "unprognostic (1.72e-1)" "prognostic favorable (1.33e-4)" "unprognostic (3.29e-3)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.26e-2)" "unprognostic (2.45e-1)" "unprognostic (3.02e-1)" "unprognostic (3.40e-2)" 5.4 4.6 5.0 11.7 5.4 11.7 4.0 6.9 6.9 3.4 9.0 7.9 9.6 19.3 4.7 10.0 3.2 5.2 9.8 3.3 5.6 4.2 3.9 3.5 10.3 7.1 4.7 3.4 13.8 6.3 11.0 6.8 7.1 4.7 3.9 6.0 10.5 8.7 7.5 8.7 16.2 5.0 7.0 8.1 13.8 20.1 6.4 9.3 3.0 3.7 5.7 2.3 2.0 14.4 17.4 9.3 7.7 6.2 8.2 5.9 8.3 13.4 5.8 10.2 4.8 4.9 14.8 11.0 3.2 4.0 4.3 9.4 9.6 8.0 10.4 5.1 3.8 11.3 1.9 3.8 1.2 9.3 8.4 5.3 21.0 12.5 9.0 9.3 7.0 7.1 4.3 3.8 2.7 6.3 5.6 16.8 8.6 20.5 2.4 9.3 10.1 11.9 10.8 7.5 5.5 16.9 3.0 22.1 4.4 21.1 10.3 9.8 11.0 6.7 8.4 3.9 11.2 15.7 12.5 7.4 5.3 18.6 8.6 27.1 9.7 8.4 9.2 10.9 12.8 9.3 7.7 7.0 6.6 7.5 4.8 9.0 6.0 6.5 9.4 14.4 7.8 8.2 3.4 6.2 5.1 17.4 5.9 5.9 3.0 15.0 22.0 6.2 0.0 23.4 5.1 28.1 20.1 9.1 24.4 45.2 44.0 1.7 13.7 36.9 9.0 59.3 0.0 10.0 18.3 4.6 7.2 6.9 10.6 10.4 30.2 39.1 14.7 9.5 82.4 13.8 5.3 0.0 5.4 51.1 13.7 10.1 30.8 14.9 6.2 39.6 0.0 8.1 41.9 12.4 0.0 35.8 4.5 38.9 4.3 SPPL2C IMP5 ENSG00000185294 "Signal peptide peptidase like 2C" Q8IUH8 17 45844835-45847072 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "testis: 45.0" "Group enriched" "Detected in some" 132 "Early spermatids: 211.9;Late spermatids: 461.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "cerebellum: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.70e-4)" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 211.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 461.7 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 SPPL3 "DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4" ENSG00000157837 "Signal peptide peptidase like 3" Q8TCT6 12 120762510-120904371 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004194, HPA059958" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA004194: AB_2667171, HPA059958: AB_2684179" "unprognostic (3.29e-1)" "unprognostic (2.29e-2)" "unprognostic (3.39e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-1)" "unprognostic (7.96e-3)" "prognostic unfavorable (1.29e-5)" "unprognostic (3.17e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (2.44e-1)" "unprognostic (2.66e-1)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (7.54e-2)" "unprognostic (9.40e-2)" 17.8 15.3 18.9 12.8 23.1 13.9 19.4 21.8 31.4 25.2 20.4 25.6 18.4 14.0 23.1 13.3 39.5 23.3 18.2 13.9 17.4 18.3 18.3 14.9 20.8 21.5 19.2 20.6 25.9 19.6 42.4 14.3 21.9 16.5 16.9 21.7 19.1 19.2 22.7 13.8 48.3 18.5 23.5 17.1 19.0 14.2 34.7 20.8 25.2 24.7 22.2 20.6 19.8 29.3 4.1 6.3 7.3 2.9 2.8 4.4 1.5 12.4 12.5 18.9 11.8 25.0 16.9 13.3 9.6 28.6 20.7 16.7 12.9 12.8 11.5 0.1 16.7 18.4 15.3 19.2 20.7 21.5 9.1 11.8 9.8 7.4 9.8 26.5 11.3 12.8 17.0 33.2 17.7 16.7 24.6 20.3 17.8 10.8 5.8 17.8 11.0 15.1 9.1 12.6 11.7 8.8 9.0 15.9 8.2 16.2 35.5 13.0 14.0 18.3 8.4 14.4 21.1 25.5 7.9 15.1 9.6 13.2 5.9 7.1 13.5 24.2 11.2 14.3 9.4 15.9 7.3 2.9 2.6 3.2 2.8 4.4 3.2 4.0 4.0 4.9 4.1 3.9 4.3 5.5 2.8 2.4 6.3 3.1 1.5 18.9 23.1 21.8 31.4 17.4 18.3 19.2 20.6 16.5 20.8 17.9 17.3 21.4 28.0 48.9 33.5 17.7 17.8 8.1 13.6 38.4 25.5 32.4 1.7 16.9 6.4 28.1 32.5 0.0 21.2 21.9 34.3 27.4 4.6 27.7 32.0 35.0 26.0 32.5 31.3 6.2 26.4 27.5 25.3 13.6 36.3 27.5 19.2 31.7 32.9 18.7 22.1 12.9 21.7 48.8 40.1 74.0 54.0 16.0 33.6 30.8 SPTLC1 "hLCB1, HSAN1, HSN1, LCB1, SPTI" ENSG00000090054 "Serine palmitoyltransferase long chain base subunit 1" O15269 9 92000087-92115384 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 76.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010860, CAB018747, HPA063907" Supported Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.47e-1)" "unprognostic (3.51e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-2)" "unprognostic (3.03e-2)" "unprognostic (4.22e-3)" "unprognostic (1.27e-1)" "unprognostic (4.06e-1)" "unprognostic (3.55e-3)" "unprognostic (8.37e-2)" "prognostic favorable (1.36e-6)" "unprognostic (1.13e-1)" "unprognostic (2.41e-2)" "unprognostic (4.28e-1)" "unprognostic (1.49e-1)" 16.4 17.7 13.3 11.4 17.1 9.9 16.8 19.9 17.6 20.3 17.2 20.9 18.1 14.0 17.3 15.1 30.5 19.2 15.5 11.4 13.9 15.3 19.0 13.5 14.8 10.6 18.0 12.2 35.3 15.8 23.6 23.1 28.3 20.5 14.5 18.8 12.0 18.5 13.3 9.4 20.1 17.8 15.1 20.8 10.7 16.0 19.8 14.1 9.7 26.2 16.0 16.5 17.4 20.9 9.3 21.0 21.1 22.1 10.2 15.2 16.0 18.4 16.8 11.6 9.7 28.4 22.2 20.1 19.4 24.9 16.8 18.3 10.5 38.7 10.2 12.4 24.6 20.4 48.5 12.5 16.5 19.6 11.8 7.3 9.4 9.5 10.2 21.4 15.5 12.7 19.9 20.0 17.4 18.9 16.0 15.3 11.0 21.9 12.7 19.1 19.9 9.7 3.8 15.6 20.9 12.2 10.8 14.1 7.8 16.7 11.3 9.4 8.8 26.2 20.1 11.8 14.5 10.3 9.2 19.4 16.4 12.7 18.8 13.5 9.2 12.6 5.7 19.6 7.7 19.6 14.6 22.1 11.9 11.5 21.6 11.0 8.9 11.6 11.6 21.0 9.3 14.2 10.7 21.1 10.2 19.2 10.8 15.2 16.0 13.3 17.1 19.9 17.6 13.9 15.3 18.0 12.2 20.5 14.1 35.7 41.3 10.3 9.6 9.4 8.1 3.7 2.5 40.2 35.2 34.9 13.7 10.9 8.3 46.0 76.8 8.7 7.7 0.0 49.5 11.1 12.2 7.8 23.2 4.4 9.7 6.4 2.4 6.7 6.5 22.6 5.8 22.2 11.8 28.9 6.2 11.3 47.8 4.0 5.6 22.6 7.9 12.9 10.3 33.1 25.8 8.0 18.2 11.4 6.0 13.2 SPTLC2 "hLCB2a, KIAA0526, LCB2, LCB2A" ENSG00000100596 "Serine palmitoyltransferase long chain base subunit 2" O15270 14 77505997-77616773 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027552 Approved Mitochondria Yes No Mitochondria "HPA027552: AB_10601717" "unprognostic (3.16e-1)" "unprognostic (2.82e-2)" "unprognostic (1.24e-1)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (1.46e-2)" "unprognostic (3.09e-1)" "unprognostic (4.05e-1)" "unprognostic (1.98e-2)" "unprognostic (2.51e-1)" "prognostic favorable (6.69e-8)" "unprognostic (1.29e-2)" "unprognostic (2.35e-1)" "unprognostic (4.94e-2)" "unprognostic (1.32e-1)" 30.0 12.8 15.4 11.4 27.0 27.3 25.6 6.9 18.5 15.3 17.0 32.4 8.5 13.4 10.2 7.6 22.8 13.7 11.1 7.8 20.8 14.1 17.1 7.2 12.2 17.5 33.1 13.3 10.2 7.6 12.8 9.8 18.8 21.2 8.2 18.8 6.0 16.6 9.6 5.5 11.3 15.8 11.0 47.6 23.5 18.8 4.7 34.9 10.0 10.3 8.8 12.0 13.2 17.1 4.8 18.2 15.1 18.2 10.0 4.2 6.9 12.1 8.0 6.1 6.7 6.3 8.0 10.5 18.1 13.4 12.5 13.1 10.1 27.1 12.1 4.6 18.3 6.4 15.0 16.3 10.1 19.0 5.3 4.8 34.4 6.2 6.0 5.4 3.5 11.4 5.2 5.0 8.1 9.1 7.1 17.5 8.4 6.7 5.9 7.1 10.5 9.1 11.9 4.0 19.2 7.2 9.9 6.3 4.1 14.4 27.3 5.9 7.5 6.5 21.8 6.8 11.3 26.8 6.4 11.0 11.5 8.2 4.2 4.1 3.3 5.5 8.2 7.6 12.4 6.5 8.8 18.2 15.1 3.8 13.8 3.5 4.1 3.2 4.2 18.2 4.8 2.2 3.6 11.2 10.0 16.7 6.5 3.3 6.9 15.4 27.0 6.9 18.5 20.8 14.1 33.1 13.3 21.2 34.9 26.8 23.5 25.0 21.1 28.7 13.3 7.3 10.2 24.1 27.3 45.4 33.4 10.3 1.7 21.2 1.4 32.3 28.5 46.7 14.2 10.9 16.6 24.2 49.7 6.6 21.7 4.8 12.7 57.1 63.4 1.5 13.6 29.2 18.6 15.4 36.9 10.3 24.7 28.1 14.9 9.1 18.8 32.3 8.6 6.7 16.0 25.5 5.5 22.7 27.5 47.7 SPTLC3 "C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L" ENSG00000172296 "Serine palmitoyltransferase long chain base subunit 3" Q9NUV7 20 13008979-13169103 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 154.0" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 22.9;Syncytiotrophoblasts: 38.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "pons and medulla: 10.5" "Group enriched" "Detected in some" 5 "MAIT T-cell: 3.0;NK-cell: 4.1" "Group enriched" "Detected in many" 13 "NK-cells: 4.1;T-cells: 3.0" "Cell line enhanced" "Detected in many" "Karpas-707: 16.4;RPTEC TERT1: 21.8;U-2197: 15.2;U-87 MG: 28.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA044247, HPA048079" Enhanced Approved Microtubules NA NA Microtubules "HPA044247: AB_2678872, HPA048079: AB_2680252" "unprognostic (6.81e-2)" "unprognostic (7.76e-2)" "unprognostic (4.46e-2)" "unprognostic (1.25e-3)" "unprognostic (5.43e-2)" "unprognostic (2.12e-1)" "unprognostic (5.70e-2)" "unprognostic (7.99e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (5.08e-2)" "prognostic favorable (4.51e-7)" "unprognostic (2.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.18e-1)" 3.2 4.5 1.3 1.6 2.2 0.0 4.3 1.7 1.7 4.3 5.0 2.2 4.4 8.3 4.8 9.6 5.6 3.4 5.8 4.8 2.0 1.5 15.6 11.9 5.7 0.7 2.5 2.2 4.3 3.8 10.2 4.2 154.0 10.5 4.5 3.8 3.8 7.8 5.8 1.0 25.1 9.0 3.0 6.9 1.9 2.2 4.2 1.4 5.7 24.3 3.6 1.9 4.8 6.0 0.0 0.2 0.1 0.0 4.1 3.0 0.2 0.7 1.1 0.9 0.0 7.1 10.3 5.5 0.0 1.5 1.0 4.1 8.9 4.5 0.0 0.5 0.2 9.0 12.2 0.0 3.4 1.4 0.0 0.0 0.0 2.8 12.6 0.6 0.0 0.1 5.8 10.7 4.0 1.4 3.8 0.7 2.1 0.0 16.4 11.5 0.2 0.0 0.0 0.0 1.0 1.4 1.1 2.0 7.2 21.8 8.7 0.0 0.1 0.1 1.1 0.0 1.6 9.1 0.2 1.6 4.6 1.5 15.2 1.0 0.1 0.0 0.0 28.8 0.0 0.0 0.1 0.0 0.0 0.5 0.0 3.0 0.0 0.4 0.1 0.0 0.0 0.7 0.1 0.1 4.1 0.0 0.2 0.0 0.2 1.3 2.2 1.7 1.7 2.0 1.5 2.5 2.2 10.5 1.4 6.0 18.2 0.0 4.8 2.2 0.0 15.1 5.1 4.0 6.8 8.7 0.0 22.9 6.6 2.2 15.0 2.2 4.9 0.0 3.8 10.5 7.2 3.4 1.1 18.7 2.5 0.0 0.0 0.6 2.5 8.5 3.4 0.9 0.0 0.0 4.7 13.6 2.5 8.0 2.5 11.9 0.0 0.0 0.3 0.9 0.1 1.9 38.6 1.3 6.1 1.8 SPTSSA "C14orf147, ssSPTa" ENSG00000165389 "Serine palmitoyltransferase small subunit A" Q969W0 14 34432789-34462356 "Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Melanocytes: 413.3;Suprabasal keratinocytes: 387.9;Syncytiotrophoblasts: 428.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 57.0" "Low region specificity" "Detected in all" NA NA "unprognostic (1.16e-1)" "unprognostic (3.23e-3)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (6.24e-3)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (4.00e-1)" "unprognostic (3.19e-2)" "unprognostic (2.44e-2)" "unprognostic (6.64e-2)" "unprognostic (1.19e-1)" "unprognostic (1.24e-2)" "unprognostic (2.40e-1)" "unprognostic (3.25e-1)" "unprognostic (5.86e-2)" 16.1 50.5 12.9 13.2 15.1 3.5 25.9 10.0 11.1 15.2 24.7 14.2 32.3 13.5 13.7 23.1 24.1 14.8 20.8 18.4 12.8 13.9 20.6 30.9 38.4 7.9 19.8 8.1 20.8 11.7 7.6 10.7 27.1 18.8 15.7 24.2 9.8 33.7 44.9 33.5 15.4 23.2 22.5 32.0 10.8 15.6 8.1 15.2 3.2 18.0 23.8 10.2 19.8 18.2 4.7 10.9 8.6 21.2 11.2 3.8 10.8 20.2 11.8 11.9 4.4 19.9 13.9 14.1 13.7 8.5 10.8 13.1 9.6 12.2 17.0 12.3 7.7 7.9 8.7 10.6 11.6 17.2 8.9 6.6 10.7 24.2 46.5 15.7 13.9 6.3 12.9 18.7 7.9 13.0 8.4 12.7 4.9 7.6 18.4 9.5 21.4 5.7 14.2 9.1 9.8 14.8 7.5 57.0 12.4 13.4 9.0 7.8 10.3 31.3 27.6 21.2 9.7 12.5 15.2 13.4 8.5 5.6 8.7 10.1 15.3 10.1 12.5 5.8 12.5 9.5 8.6 21.2 2.7 3.3 16.5 3.2 4.7 3.0 3.1 10.9 4.3 3.2 3.8 1.1 11.2 13.4 3.9 2.9 10.8 12.9 15.1 10.0 11.1 12.8 13.9 19.8 8.1 18.8 15.2 134.0 92.6 37.6 165.0 359.9 43.8 26.0 66.2 26.8 88.7 83.7 9.8 222.5 131.0 156.6 0.9 55.4 75.4 0.0 84.9 93.2 107.1 109.9 32.3 71.0 70.3 38.1 47.7 53.4 70.2 2.3 42.3 66.7 413.3 45.9 63.6 34.0 74.1 74.6 56.6 75.8 26.0 45.3 140.1 1.9 3.6 387.9 428.5 28.7 80.2 130.5 SPTSSB "ADMP, C3orf57, ssSPTb" ENSG00000196542 "Serine palmitoyltransferase small subunit B" Q8NFR3 3 161344792-161372880 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 68.6;skin 1: 27.5;stomach 1: 42.0" "Cell type enhanced" "Detected in some" 13 "Exocrine glandular cells: 42.0;Glandular cells: 74.2;Melanocytes: 43.9;Suprabasal keratinocytes: 31.9;Urothelial cells: 53.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 24.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 12 "NK-cell: 68.6" "Lineage enriched" "Detected in many" 12 "NK-cells: 68.6" "Group enriched" "Detected in some" 10 "MCF7: 159.0;RT4: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047712 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA047712: AB_2680127" "unprognostic (2.09e-1)" "unprognostic (4.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "unprognostic (1.34e-2)" "unprognostic (4.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (5.10e-2)" "unprognostic (6.37e-3)" "unprognostic (2.72e-1)" "unprognostic (4.08e-2)" "unprognostic (5.37e-4)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (9.51e-3)" 1.4 0.4 2.0 0.7 3.4 0.5 6.4 8.9 18.5 4.0 0.9 1.6 0.0 0.5 1.0 0.4 5.1 0.6 1.5 0.4 2.2 2.2 0.7 0.6 0.3 1.0 2.0 6.2 0.4 1.5 0.3 0.3 0.3 12.0 12.4 0.8 0.2 8.0 0.4 0.4 27.5 0.5 1.4 1.1 1.1 42.0 0.3 0.4 0.1 0.4 2.1 1.7 23.5 5.4 0.0 0.0 0.2 0.0 68.6 5.6 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.0 0.0 0.0 0.6 9.7 1.8 0.0 0.0 0.0 0.0 42.2 0.2 1.7 0.0 5.7 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.6 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.2 68.6 0.0 0.0 0.0 0.5 2.0 3.4 8.9 18.5 2.2 2.2 2.0 6.2 12.0 0.4 0.0 0.0 0.0 17.2 3.4 1.5 0.3 2.5 0.0 0.0 3.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 42.0 0.0 0.4 74.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.9 0.0 1.6 0.0 16.3 0.0 0.0 0.0 1.3 0.0 2.7 0.0 0.0 31.9 0.1 0.9 0.0 53.8 SPTY2D1OS SPTY2D1-AS1 ENSG00000247595 "SPTY2D1 opposite strand" 11 18588781-18610255 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 18 "testis: 70.2" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 5.2;Distal tubular cells: 19.9;Proximal tubular cells: 6.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 7.0;HeLa: 10.2" "Secreted in male reproductive system" NA NA "unprognostic (1.07e-1)" "unprognostic (1.24e-1)" "unprognostic (8.60e-3)" "unprognostic (5.14e-2)" "unprognostic (6.61e-2)" "unprognostic (9.32e-2)" "unprognostic (4.44e-7)" "unprognostic (1.75e-1)" "unprognostic (1.39e-2)" "unprognostic (7.83e-2)" "unprognostic (5.36e-2)" "unprognostic (6.50e-3)" "unprognostic (5.41e-4)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (1.48e-2)" 0.1 0.2 0.1 0.1 0.1 0.0 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.1 3.9 0.1 0.1 0.1 0.1 0.0 70.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.6 2.6 1.0 1.0 2.4 0.8 0.7 7.0 2.8 3.8 2.5 3.7 3.5 0.5 0.8 1.4 1.7 5.2 2.0 1.2 0.4 0.6 1.5 1.4 0.0 0.0 0.0 2.1 2.5 0.7 10.2 6.5 0.4 0.9 2.3 1.4 0.5 0.3 2.3 1.9 1.4 0.0 1.9 0.6 0.5 2.4 0.4 2.6 1.9 1.6 4.3 0.3 0.9 0.4 2.8 2.8 0.9 0.5 2.6 0.1 0.1 1.0 1.4 0.4 1.4 2.7 2.2 1.5 0.3 0.1 0.3 0.0 1.1 1.3 1.8 1.3 1.0 2.6 1.0 0.2 2.4 0.3 0.6 0.3 0.2 0.9 0.4 0.6 2.4 1.0 0.5 0.6 1.5 0.8 3.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 5.2 0.0 0.8 19.9 2.9 0.0 0.0 0.0 0.0 4.1 0.9 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 2.7 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 SPX "C12orf39, MGC10946, NPQ, spexin" ENSG00000134548 "Spexin hormone" Q9BT56 12 21526307-21537377 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 34.3;brain: 14.4;breast: 23.1" "Group enriched" "Detected in some" 4 "Distal tubular cells: 72.9;Proximal tubular cells: 131.0" "Cancer enhanced" "Detected in many" "renal cancer: 13.5" "Region enriched" "Detected in some" 9 "pons and medulla: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 14.1;HBEC3-KT: 7.2;hTERT-HME1: 9.8;SuSa: 11.2;U-2 OS: 4.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "cerebral cortex: 65.0;hippocampal formation: 70.8;olfactory region: 47.5;pons and medulla: 40.3" "Secreted to blood" NA NA 2650000 "unprognostic (2.78e-2)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (1.81e-2)" "unprognostic (2.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.86e-1)" "unprognostic (1.04e-1)" "unprognostic (2.11e-2)" "unprognostic (5.89e-2)" "unprognostic (1.21e-2)" "unprognostic (1.95e-1)" "prognostic favorable (1.31e-6)" "unprognostic (2.37e-3)" "unprognostic (9.78e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-2)" 34.3 0.0 0.2 0.0 0.3 0.0 23.1 0.1 1.4 0.0 2.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 1.5 0.4 0.7 7.1 0.7 0.2 0.5 1.5 0.0 0.0 7.8 0.0 0.0 12.7 14.4 0.0 0.0 0.0 6.4 0.0 1.3 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.2 1.3 2.7 0.4 0.0 0.1 0.0 0.1 0.6 0.5 0.0 0.0 0.2 1.5 0.0 0.5 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.8 14.1 0.0 0.5 0.2 0.0 0.2 0.0 0.0 7.2 0.8 0.0 0.0 2.7 0.0 0.0 0.7 0.0 0.0 3.0 0.3 0.1 9.8 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.4 11.2 0.0 0.0 0.0 0.0 4.6 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.6 0.0 1.5 0.2 0.3 0.1 0.3 0.4 0.7 1.5 0.0 14.4 0.2 0.0 0.0 0.5 0.0 0.0 3.4 24.8 0.0 0.0 0.0 24.4 0.0 0.0 72.9 0.2 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 1.0 0.0 1.7 4.0 0.0 0.0 131.0 0.5 0.0 0.3 0.0 0.4 0.0 0.3 0.0 0.0 0.0 SQLE ENSG00000104549 "Squalene epoxidase" Q14534 8 124998497-125022283 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018038, HPA020762" Enhanced Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA018038: AB_2669753, HPA020762: AB_2670512" "unprognostic (1.37e-2)" "unprognostic (6.26e-3)" "unprognostic (5.12e-2)" "unprognostic (9.51e-3)" "unprognostic (4.63e-1)" "prognostic unfavorable (7.42e-4)" "unprognostic (4.76e-3)" "prognostic unfavorable (4.67e-4)" "unprognostic (3.45e-2)" "unprognostic (7.21e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (7.51e-2)" "prognostic unfavorable (5.70e-4)" "unprognostic (9.71e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-3)" "unprognostic (7.74e-3)" 4.6 15.7 11.1 9.9 13.9 10.4 12.1 8.9 19.9 15.1 11.5 28.8 4.4 15.8 8.9 5.1 40.3 10.0 6.3 4.2 15.4 14.5 7.8 38.1 16.0 8.6 10.8 9.7 17.5 6.3 16.5 9.5 24.7 28.5 13.8 10.1 9.3 10.4 4.7 1.3 23.8 8.7 6.6 36.0 5.6 11.5 29.3 18.7 9.8 5.7 24.2 15.0 5.3 21.6 15.1 12.4 1.2 9.7 9.5 9.0 6.1 25.8 10.0 60.2 17.3 18.7 31.8 6.1 6.8 21.0 9.3 17.1 13.6 37.9 17.8 9.9 8.4 37.4 19.8 25.1 37.7 10.8 14.7 53.0 50.9 6.8 34.7 27.6 5.9 15.0 21.7 40.4 27.7 22.9 6.0 10.1 12.6 29.0 34.7 7.5 42.7 20.6 7.5 24.9 17.8 6.9 9.1 11.0 24.3 65.6 29.8 18.8 9.5 14.0 45.0 14.0 20.2 12.0 15.6 9.9 3.8 13.6 4.5 6.0 6.3 12.8 24.4 6.4 18.2 6.6 1.2 5.1 0.5 9.0 8.5 4.4 13.6 5.4 8.3 12.4 15.1 7.5 7.8 0.1 9.5 9.7 8.8 5.6 6.1 11.1 13.9 8.9 16.4 15.4 14.5 10.8 9.7 28.5 18.7 56.6 84.1 38.7 41.4 20.4 26.3 6.1 28.1 108.4 52.4 50.6 47.1 81.6 6.6 50.5 18.8 11.2 44.6 46.7 73.0 111.6 54.5 79.8 41.4 15.7 48.5 139.8 30.4 12.3 13.0 9.6 22.2 16.0 20.3 154.1 29.4 23.5 64.9 21.0 10.3 2.9 47.5 25.8 29.0 131.6 152.1 77.9 181.6 17.5 20.4 100.4 SRD5A1 ENSG00000145545 "Steroid 5 alpha-reductase 1" P18405 5 6633343-6674386 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Differentiation, Sexual differentiation" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 75.4;monocytes: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051402 Approved NA NA "HPA051402: AB_2681470" "unprognostic (1.40e-2)" "unprognostic (1.33e-2)" "unprognostic (2.30e-3)" "prognostic unfavorable (8.73e-6)" "unprognostic (9.38e-3)" "unprognostic (8.90e-2)" "unprognostic (3.78e-2)" "unprognostic (5.90e-2)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (7.70e-3)" "unprognostic (1.54e-1)" "unprognostic (1.56e-3)" "unprognostic (3.01e-1)" "unprognostic (2.24e-1)" "unprognostic (1.59e-1)" "unprognostic (5.47e-2)" 2.4 3.3 7.7 2.9 8.2 3.2 14.8 9.2 11.8 5.6 5.2 5.3 0.7 5.7 3.1 4.6 24.2 2.9 4.0 1.9 9.3 7.5 6.4 42.4 3.0 3.5 6.2 5.5 4.1 4.3 3.0 1.9 2.1 13.4 2.6 3.6 2.4 5.0 2.1 2.2 17.5 10.4 2.6 3.1 2.9 3.9 2.7 2.9 3.3 2.4 15.3 12.1 2.6 10.1 1.9 3.7 7.0 3.3 1.3 1.3 1.3 5.6 5.5 7.4 6.3 7.1 7.0 3.4 5.4 4.2 5.4 3.4 5.5 5.0 6.8 9.0 7.9 8.8 9.1 6.0 3.6 5.8 4.2 2.6 2.1 13.9 3.4 3.3 3.0 1.8 5.1 10.4 3.8 3.0 4.0 2.6 2.7 3.6 6.3 6.9 6.6 1.4 3.5 4.7 3.7 4.4 4.7 5.7 2.0 7.2 5.2 14.0 6.3 16.6 7.4 5.1 7.7 3.0 0.9 5.5 8.2 4.1 13.3 6.8 3.4 4.5 2.4 6.8 3.6 7.4 7.0 3.3 1.4 1.0 2.4 0.7 1.7 1.0 1.3 3.7 1.9 0.9 1.0 2.0 1.3 2.6 1.8 1.1 1.3 7.7 8.2 9.2 11.8 9.3 7.5 6.2 5.5 13.4 2.9 3.0 2.4 8.2 5.5 16.5 4.4 2.4 5.1 8.1 2.3 5.2 3.9 0.7 6.6 9.1 7.8 3.1 7.8 0.0 4.1 6.1 3.7 6.5 1.1 75.4 12.0 6.4 2.4 4.3 19.6 1.9 3.1 7.9 6.8 55.1 5.6 3.5 6.5 8.7 7.4 19.5 3.7 0.0 4.2 2.7 2.6 26.6 0.7 4.4 11.7 9.6 SRD5A2 ENSG00000277893 "Steroid 5 alpha-reductase 2" P31213 2 31522480-31581067 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Differentiation, Sexual differentiation" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 17.9;liver: 30.9;prostate: 28.4" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 13.4;Early spermatids: 70.2;Hepatocytes: 14.7;Late spermatids: 41.4" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BJ hTERT+: 2.9;RT4: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.75e-3)" "unprognostic (2.00e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-3)" "unprognostic (5.92e-3)" "unprognostic (3.37e-2)" "unprognostic (2.79e-3)" "unprognostic (6.56e-2)" "unprognostic (9.10e-2)" "unprognostic (1.39e-2)" "unprognostic (3.06e-2)" "unprognostic (9.79e-3)" "unprognostic (6.61e-6)" "unprognostic (4.37e-2)" "unprognostic (2.04e-1)" "unprognostic (3.85e-1)" "unprognostic (3.48e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 10.1 0.0 0.2 17.9 0.0 10.4 0.0 0.0 0.0 0.0 30.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.3 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.4 2.5 13.4 1.2 0.0 0.0 0.0 0.0 0.0 70.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 14.7 0.0 0.0 0.0 0.0 0.0 41.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.2 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 4.7 SRD5A3 "FLJ13352, SRD5A2L, SRD5A2L1" ENSG00000128039 "Steroid 5 alpha-reductase 3" Q9H8P0 4 55346109-55373096 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Cataract, Congenital disorder of glycosylation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 92.9;Extravillous trophoblasts: 88.2;Pancreatic endocrine cells: 133.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 42.6" "Low region specificity" "Detected in all" HPA027006 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA027006: AB_1857469" "unprognostic (1.12e-2)" "unprognostic (1.01e-1)" "unprognostic (4.02e-2)" "prognostic favorable (9.39e-4)" "unprognostic (1.50e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (1.80e-6)" "unprognostic (9.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.81e-2)" "unprognostic (3.29e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.85e-10)" "unprognostic (4.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-2)" "unprognostic (9.52e-2)" 13.8 12.2 11.5 5.9 13.4 6.6 17.8 7.3 18.3 22.9 11.3 20.3 3.5 6.9 13.8 9.6 24.4 5.9 22.6 10.5 13.2 10.7 12.3 15.0 12.4 10.1 15.5 12.0 3.5 26.8 14.0 7.0 8.8 13.6 8.9 10.9 6.8 16.3 6.6 5.8 15.6 8.3 6.2 22.1 6.9 13.8 4.0 15.3 10.0 7.6 9.9 12.1 12.1 12.1 5.9 28.4 10.3 25.2 3.6 9.2 10.3 4.8 3.2 5.8 5.5 19.5 12.5 2.9 5.3 6.2 2.2 3.6 3.2 10.1 11.5 6.0 8.3 6.2 3.8 4.1 4.9 2.8 3.3 7.3 6.3 3.6 8.6 5.2 11.6 3.5 11.4 9.1 3.8 3.5 4.8 9.0 21.5 10.7 25.8 12.6 6.3 17.0 5.1 7.3 27.6 4.3 5.5 1.8 6.5 7.4 5.2 9.0 5.0 5.6 42.6 3.8 6.0 5.2 10.2 4.4 14.2 2.6 1.0 4.0 13.8 7.6 4.2 18.0 16.0 13.8 10.3 16.5 4.9 7.9 25.1 9.2 5.9 6.0 7.4 14.1 5.2 5.3 7.1 0.8 3.6 25.2 28.4 5.8 10.3 11.5 13.4 7.3 18.3 13.2 10.7 15.5 12.0 13.6 15.3 8.9 15.7 3.0 9.5 12.0 4.6 4.6 45.9 12.0 12.5 5.2 3.9 22.7 3.3 67.0 2.0 14.3 8.4 0.0 92.9 88.2 17.0 22.1 13.9 17.1 62.0 9.5 11.5 17.8 20.9 0.0 1.7 27.9 23.6 24.4 19.3 18.6 133.4 5.8 5.3 12.2 3.8 12.9 9.5 2.1 18.8 26.0 6.3 4.9 20.9 49.7 SRP14 "ALURBP, MGC14326" ENSG00000140319 "Signal recognition particle 14" P37108 15 40035739-40039188 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053738, HPA065118" Approved Nucleoplasm,Nucleoli NA NA 400000 Nucleoli Nucleoplasm "HPA053738: , HPA065118: " "unprognostic (2.52e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-3)" "unprognostic (1.01e-2)" "unprognostic (1.04e-1)" "unprognostic (5.39e-3)" "unprognostic (2.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (7.99e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "prognostic favorable (5.31e-4)" "unprognostic (2.20e-1)" "unprognostic (8.03e-3)" "unprognostic (1.41e-3)" "unprognostic (4.94e-2)" 63.0 81.2 100.0 46.0 102.8 85.9 75.4 65.4 91.3 87.8 62.6 67.9 54.7 50.7 83.0 115.7 75.6 87.8 64.2 114.2 80.7 95.4 107.2 79.6 52.2 60.8 103.5 86.3 99.1 59.1 69.6 82.3 68.8 84.3 84.1 65.0 61.0 71.3 66.4 107.5 44.4 65.7 67.2 86.5 67.5 56.0 43.4 68.9 58.7 98.9 56.6 65.0 80.9 72.7 78.7 151.5 111.2 69.3 63.6 96.4 135.1 24.2 30.4 73.8 55.1 55.3 50.1 36.0 44.7 47.4 38.8 39.9 54.7 20.8 20.4 46.6 54.2 62.1 39.3 58.6 46.5 36.8 48.6 41.9 48.6 97.1 64.0 42.4 43.2 39.7 52.1 53.3 32.1 39.4 73.9 65.2 55.9 50.8 37.4 62.0 36.8 63.8 51.0 40.2 94.1 55.2 43.9 33.7 34.3 83.7 72.4 53.8 48.0 45.1 44.8 29.3 47.6 61.6 80.2 56.1 45.2 30.7 42.6 32.6 30.5 85.1 50.5 43.9 47.2 41.8 76.2 69.3 111.2 68.5 62.5 66.4 78.7 77.7 76.3 74.5 66.1 75.4 72.8 60.7 63.6 56.5 151.5 96.4 135.1 100.0 102.8 65.4 91.3 80.7 95.4 103.5 86.3 84.3 68.9 428.8 342.1 635.3 745.6 592.5 436.3 765.2 639.5 717.4 483.4 943.9 117.8 766.6 2161.9 1141.2 204.6 898.5 667.3 467.2 948.8 912.5 754.8 783.4 543.5 639.1 894.6 328.9 532.2 609.5 565.3 236.1 962.8 751.5 749.0 1439.1 546.1 918.4 1056.2 782.0 927.8 1642.5 369.6 614.4 716.0 645.9 602.6 620.9 634.6 518.4 577.5 829.8 SRPRB "APMCF1, SR-beta" ENSG00000144867 "SRP receptor beta subunit" Q9Y5M8 3 133784033-133825772 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 104.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011173 Approved Approved "Plasma membrane" NA NA 54000 "Plasma membrane" "HPA011173: AB_1857484" "unprognostic (5.44e-2)" "unprognostic (1.32e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-2)" "unprognostic (2.61e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (1.99e-1)" "unprognostic (3.60e-2)" "unprognostic (6.07e-3)" "unprognostic (8.45e-2)" "unprognostic (1.31e-2)" "unprognostic (3.79e-2)" "unprognostic (5.08e-2)" "unprognostic (7.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.26e-2)" 10.4 15.7 8.7 10.2 9.3 5.8 12.5 5.2 10.2 14.4 11.3 5.1 33.2 8.9 8.0 25.6 16.8 9.1 11.0 10.9 9.0 10.7 17.2 56.3 9.2 17.3 10.4 7.7 8.9 104.0 11.7 15.6 7.7 8.8 9.5 13.4 7.6 53.3 29.9 10.6 8.6 7.4 10.3 7.4 9.5 12.5 14.7 5.4 6.3 16.5 10.2 13.7 8.7 10.4 15.4 20.0 3.8 15.2 14.3 29.0 18.0 12.1 9.9 6.3 20.0 26.3 18.3 11.8 25.8 13.5 14.4 12.5 18.0 9.5 23.1 38.2 19.7 14.5 17.8 19.6 13.9 13.7 15.6 15.7 20.7 9.8 17.0 32.0 32.3 16.8 16.5 23.5 13.1 38.8 8.0 12.2 11.8 17.5 26.9 15.4 17.7 11.1 15.4 11.9 32.4 17.1 13.5 11.7 49.3 17.3 8.4 20.8 8.6 19.8 18.4 7.2 5.0 20.9 15.0 12.1 14.2 8.4 22.3 13.8 34.7 34.5 34.9 12.7 21.5 15.8 3.8 11.6 1.4 21.4 15.2 29.0 15.4 18.3 19.0 13.2 13.4 18.0 21.2 0.8 14.3 9.9 20.0 10.6 18.0 8.7 9.3 5.2 10.2 9.0 10.7 10.4 7.7 8.8 5.4 14.9 22.3 15.6 21.0 33.5 6.2 22.2 43.3 20.1 19.4 34.9 11.8 58.0 10.0 42.5 49.3 24.9 15.5 0.0 58.0 60.5 38.5 38.7 32.3 77.2 46.0 6.4 30.9 17.8 19.9 31.5 29.7 19.3 33.7 10.0 36.2 15.6 40.9 21.0 26.2 24.9 8.8 12.9 23.7 52.8 41.9 27.6 43.3 20.8 32.9 21.4 SRR "ILV1, ISO1" ENSG00000167720 "Serine racemase" Q9GZT4 17 2303383-2325260 "Enzymes, Predicted intracellular proteins" "Allosteric enzyme, Isomerase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007529, CAB015343" Approved Approved Vesicles NA NA Vesicles "CAB015343: AB_2195009, HPA007529: AB_2667853" "unprognostic (2.96e-1)" "unprognostic (7.86e-2)" "unprognostic (6.01e-2)" "prognostic favorable (6.20e-5)" "unprognostic (3.05e-1)" "unprognostic (1.57e-2)" "unprognostic (4.32e-2)" "unprognostic (9.97e-2)" "unprognostic (9.09e-2)" "unprognostic (4.85e-2)" "prognostic favorable (8.16e-4)" "unprognostic (5.17e-2)" "prognostic favorable (2.45e-6)" "unprognostic (6.14e-2)" "unprognostic (1.99e-1)" "unprognostic (1.89e-1)" "unprognostic (5.84e-2)" 11.6 12.6 17.1 7.7 14.7 13.9 16.7 12.2 24.9 8.4 10.4 13.9 11.4 7.9 10.9 11.3 12.9 10.0 9.6 12.6 15.2 13.0 10.3 9.0 10.9 7.0 12.6 15.6 9.8 14.8 11.0 9.7 6.5 12.4 9.6 8.8 10.6 11.9 9.3 16.9 13.4 7.5 15.0 13.2 7.3 9.2 13.8 9.0 13.4 13.8 6.1 6.0 12.1 7.3 9.7 15.5 5.2 12.6 13.9 13.5 8.7 7.3 13.5 24.4 9.1 13.3 14.1 11.9 15.7 9.8 10.4 10.8 12.4 9.3 13.9 2.1 16.2 7.7 15.6 6.7 5.8 13.3 16.1 13.1 7.2 9.9 4.7 13.4 2.0 4.0 11.9 5.9 23.2 11.2 12.1 15.2 14.8 7.4 10.2 23.1 4.3 14.2 2.7 5.1 7.0 10.1 23.5 27.7 6.4 12.0 3.4 4.8 12.3 13.6 1.7 7.1 8.3 10.7 5.0 11.9 11.2 7.9 12.7 9.3 9.0 12.2 2.5 20.0 6.7 15.2 2.4 8.2 5.2 9.5 8.7 9.9 9.7 12.3 10.1 15.5 8.9 10.4 13.5 1.0 13.9 12.6 10.4 8.9 8.7 17.1 14.7 12.2 24.9 15.2 13.0 12.6 15.6 12.4 9.0 3.0 3.0 1.4 3.9 2.6 7.6 3.6 0.0 5.3 3.4 1.8 0.0 4.2 11.6 8.3 1.1 3.2 2.2 0.0 6.0 3.1 4.6 2.4 0.0 2.6 8.0 15.9 1.7 8.0 3.2 1.0 3.7 3.6 5.0 13.6 2.8 10.8 5.8 0.0 4.9 4.9 5.3 0.0 3.8 14.0 4.7 2.0 2.9 2.5 3.1 2.0 SSBP4 ENSG00000130511 "Single stranded DNA binding protein 4" Q9BWG4 19 18418864-18434562 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071780 Approved Nucleoplasm NA NA Nucleoplasm "HPA071780: " "unprognostic (2.81e-2)" "unprognostic (8.47e-3)" "unprognostic (4.94e-1)" "unprognostic (1.14e-1)" "unprognostic (1.52e-1)" "unprognostic (2.44e-2)" "unprognostic (3.38e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-1)" "unprognostic (7.85e-2)" "prognostic favorable (1.01e-4)" "unprognostic (3.32e-2)" "prognostic unfavorable (2.04e-10)" "unprognostic (4.50e-2)" "unprognostic (1.97e-1)" "unprognostic (4.26e-2)" "unprognostic (1.05e-2)" 20.7 15.9 25.4 17.6 39.9 12.2 8.7 16.3 30.1 15.1 12.5 8.0 15.3 16.7 19.9 8.5 8.7 23.2 7.4 8.6 21.1 15.2 9.7 8.2 14.8 16.2 7.7 16.2 15.0 16.1 6.9 28.6 12.7 10.0 13.3 5.0 11.9 12.4 24.1 25.6 11.6 20.1 8.0 5.7 35.5 23.3 12.1 11.4 11.7 11.1 6.9 9.9 7.2 10.3 10.8 5.4 0.5 17.8 3.4 9.4 3.2 11.6 9.0 8.6 15.2 1.6 6.1 12.1 16.4 3.3 3.7 3.9 3.7 13.0 10.3 14.4 3.5 4.0 13.5 2.2 3.0 1.5 11.0 25.2 18.0 11.0 8.3 6.7 8.3 33.2 5.2 2.4 2.3 0.9 5.1 10.9 20.2 36.0 5.1 1.1 17.5 22.1 27.7 7.0 5.5 26.5 15.2 6.9 10.5 5.6 3.7 15.3 26.3 2.5 7.8 21.6 1.7 8.5 19.6 13.8 6.3 16.7 38.2 10.4 7.6 2.2 6.8 16.5 26.2 12.7 0.0 4.3 0.2 9.4 10.8 6.4 10.8 7.9 8.1 5.4 8.7 4.7 8.1 0.5 3.4 17.8 3.4 4.1 3.2 25.4 39.9 16.3 30.1 21.1 15.2 7.7 16.2 10.0 11.4 6.0 18.1 39.5 27.2 15.2 13.5 5.2 7.6 76.3 19.4 50.6 23.6 17.6 21.6 11.4 7.1 33.8 5.6 0.0 18.2 37.9 45.1 23.7 36.9 10.6 31.0 39.7 57.5 23.9 27.9 21.3 54.1 31.1 18.6 8.2 16.9 21.3 11.8 10.5 48.4 17.3 14.1 38.8 35.9 18.2 59.4 12.8 15.8 51.1 17.8 24.0 SSH1 KIAA1298 ENSG00000084112 "Slingshot protein phosphatase 1" Q8WYL5 12 108778192-108857590 "Enzymes, Predicted intracellular proteins" "Actin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019845 Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA019845: AB_1857497" "unprognostic (1.18e-3)" "unprognostic (3.00e-1)" "unprognostic (2.49e-1)" "unprognostic (2.70e-2)" "unprognostic (9.40e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (5.80e-5)" "unprognostic (3.28e-2)" "unprognostic (3.69e-2)" "unprognostic (1.72e-3)" "unprognostic (7.12e-2)" "unprognostic (3.42e-1)" "unprognostic (1.71e-2)" "unprognostic (1.41e-1)" "unprognostic (8.66e-2)" "unprognostic (9.55e-2)" "unprognostic (6.22e-2)" 7.3 7.8 8.5 7.4 8.1 10.6 9.3 20.3 8.8 7.4 8.5 6.8 13.1 4.4 9.8 7.9 7.6 8.2 8.3 10.1 8.0 6.9 5.8 7.4 10.1 8.7 7.7 5.2 7.9 8.0 9.7 6.8 7.8 8.4 6.5 6.5 15.0 5.9 8.0 21.4 7.1 6.5 10.4 8.1 8.6 7.1 5.2 6.6 2.0 7.0 7.9 6.6 10.0 13.3 1.8 2.0 5.7 4.0 2.1 2.9 1.2 5.1 6.8 4.5 3.5 8.5 7.3 4.0 6.6 14.2 6.1 5.4 3.4 2.5 2.4 4.7 15.5 10.4 5.1 2.7 11.2 5.0 5.0 2.6 5.7 3.1 2.1 4.6 2.9 15.2 10.0 3.8 5.5 12.3 15.1 5.6 3.0 1.3 2.0 15.9 2.9 3.3 4.2 3.1 2.0 5.5 2.4 5.3 3.2 2.4 9.2 3.3 4.5 5.8 1.6 12.8 6.5 2.1 2.6 4.4 10.9 4.7 6.5 3.8 3.9 3.5 3.0 5.7 2.4 34.4 4.2 2.4 4.8 2.9 4.0 2.7 1.6 1.5 2.5 1.6 1.8 1.4 1.6 5.7 2.1 3.2 2.0 1.7 1.2 8.5 8.1 20.3 8.8 8.0 6.9 7.7 5.2 8.4 6.6 8.9 17.3 4.7 15.4 8.4 10.6 21.2 12.7 8.1 14.8 14.0 15.7 4.7 5.0 7.7 1.6 37.5 3.5 0.0 7.0 3.7 10.3 7.2 19.7 13.4 11.2 11.1 5.2 25.8 24.7 2.6 6.1 17.8 11.8 43.3 6.6 8.8 10.1 0.0 12.0 4.9 20.7 6.5 17.6 1.1 6.6 7.9 1.9 15.4 5.7 12.2 SSMEM1 "C7orf45, FLJ40316" ENSG00000165120 "Serine rich single-pass membrane protein 1" Q8WWF3 7 130207860-130216843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 31.7" "Cell type enriched" "Detected in some" 13 "Early spermatids: 346.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 1.7;U-87 MG: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.08e-1)" "unprognostic (1.79e-1)" "unprognostic (5.24e-1)" "unprognostic (2.24e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.3 0.2 0.5 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.8 0.9 0.1 0.2 0.2 0.3 0.2 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 346.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 9.3 2.7 0.0 0.0 0.0 0.0 0.0 SSPN "KRAG, SPN1, SPN2" ENSG00000123096 Sarcospan Q14714 12 26121991-26299290 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Leydig cells: 172.0;Peritubular cells: 251.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "memory B-cell: 29.7" "Lineage enriched" "Detected in many" 21 "B-cells: 29.7" "Cell line enhanced" "Detected in many" "ASC diff: 13.0;hTERT-RPE1: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066432 Approved "Nucleoplasm,Nuclear membrane" No No "Nuclear membrane" Nucleoplasm "HPA066432: AB_2685669" "unprognostic (4.82e-2)" "unprognostic (1.63e-1)" "unprognostic (2.03e-1)" "unprognostic (6.49e-2)" "unprognostic (2.04e-1)" "unprognostic (2.45e-1)" "unprognostic (6.11e-2)" "unprognostic (1.44e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (2.77e-5)" "unprognostic (2.64e-3)" "unprognostic (3.86e-2)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" 12.5 6.8 13.9 6.6 12.6 0.1 11.5 16.5 11.4 24.9 12.7 11.1 4.1 2.7 14.6 10.3 11.4 15.0 14.3 26.2 21.0 6.1 3.8 1.4 5.4 4.5 17.2 8.7 21.5 4.7 2.9 4.8 2.5 20.9 14.5 7.3 7.8 6.8 21.1 38.7 3.6 6.3 20.1 20.4 4.9 6.7 5.8 19.0 3.2 10.0 15.4 6.5 18.2 10.8 29.7 0.0 1.4 0.0 0.0 0.2 0.3 0.3 0.7 2.0 0.0 13.0 7.4 0.1 3.8 5.3 0.5 1.5 0.0 4.7 0.0 0.8 5.2 3.0 1.5 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 4.6 0.4 1.7 0.4 46.8 0.2 0.0 0.0 0.0 4.0 0.8 0.2 1.1 4.4 0.2 1.2 0.1 5.3 1.4 1.2 4.0 0.2 3.8 1.4 0.3 3.7 2.1 0.4 0.1 1.4 1.8 1.0 1.8 0.9 0.1 0.5 0.0 2.8 0.0 4.6 0.0 0.0 1.2 0.0 0.0 0.2 29.7 0.0 0.0 0.0 6.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 13.9 12.6 16.5 11.4 21.0 6.1 17.2 8.7 20.9 19.0 3.0 2.7 20.9 16.5 12.0 1.7 79.0 7.6 6.7 19.4 17.4 0.0 63.3 5.0 8.5 3.3 8.3 8.4 0.0 6.5 5.6 56.4 10.8 0.0 0.0 12.1 6.4 4.7 8.6 0.0 3.1 172.0 7.9 18.6 32.5 9.1 35.9 2.4 7.0 251.4 2.2 2.6 38.8 42.9 0.3 0.9 6.1 23.2 1.0 5.8 17.1 SSR1 TRAPA ENSG00000124783 "Signal sequence receptor subunit 1" P43307 6 7268306-7347446 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011276, HPA017062" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA011276: AB_1857503, HPA017062: AB_1857505" "unprognostic (2.27e-1)" "unprognostic (2.10e-1)" "unprognostic (5.98e-3)" "unprognostic (1.57e-2)" "unprognostic (3.10e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (7.83e-2)" "unprognostic (2.27e-2)" "unprognostic (4.72e-2)" "unprognostic (1.68e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.79e-6)" "unprognostic (3.17e-1)" "unprognostic (2.56e-2)" "unprognostic (6.51e-3)" "unprognostic (2.19e-2)" 37.8 38.5 22.5 35.8 25.7 37.3 29.9 30.8 24.1 41.6 26.9 28.6 35.7 27.4 33.2 34.2 38.7 25.7 27.7 27.8 21.6 29.8 41.4 99.0 30.0 41.7 25.1 18.8 36.5 53.6 21.7 40.3 37.1 24.7 26.0 33.3 25.9 55.8 39.9 24.2 21.8 31.5 32.6 31.4 40.1 28.2 18.6 24.6 32.0 36.8 28.2 34.6 34.3 26.0 22.8 60.3 33.8 50.3 24.9 33.9 54.1 20.0 20.5 15.9 29.3 43.2 30.8 24.8 46.4 38.3 31.7 38.3 27.9 16.7 27.1 82.1 47.3 29.2 18.1 19.0 26.5 43.9 28.3 16.1 28.9 24.1 58.0 44.9 53.2 32.8 27.2 29.2 36.3 74.8 24.5 34.8 13.6 32.3 32.7 34.8 24.1 14.5 14.0 13.4 22.7 23.3 19.8 20.0 101.4 27.7 28.7 21.5 10.0 28.2 15.6 43.1 50.1 25.3 23.6 30.8 34.2 26.1 26.4 39.6 33.8 50.1 21.9 16.6 30.1 62.4 33.8 50.3 33.2 26.9 36.8 33.9 22.8 30.1 30.1 60.3 17.7 28.8 28.8 28.4 24.9 31.1 42.0 31.8 54.1 22.5 25.7 30.8 24.1 21.6 29.8 25.1 18.8 24.7 24.6 26.8 37.9 78.9 52.1 69.0 70.6 38.3 91.7 32.1 53.4 123.9 94.2 69.1 13.3 83.2 10.0 65.3 48.5 23.3 89.4 184.0 80.1 92.1 46.2 127.8 119.1 66.7 59.8 77.3 135.2 9.6 72.8 143.0 89.4 55.1 89.0 65.4 68.5 31.6 68.6 56.7 95.4 25.8 62.9 44.0 54.3 65.9 101.8 73.0 76.6 57.0 SSR2 "TLAP, TRAPB" ENSG00000163479 "Signal sequence receptor subunit 2" P43308 1 156009048-156020959 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.93e-1)" "unprognostic (3.86e-2)" "unprognostic (9.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.05e-1)" "unprognostic (4.84e-2)" "prognostic unfavorable (2.86e-4)" "unprognostic (7.35e-2)" "unprognostic (4.55e-2)" "unprognostic (2.04e-3)" "unprognostic (1.05e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (1.28e-1)" "unprognostic (4.64e-1)" "unprognostic (4.55e-2)" "unprognostic (1.30e-1)" 37.4 62.1 17.8 30.6 23.9 36.7 49.6 14.5 27.1 54.6 44.0 23.6 42.5 24.5 57.9 85.9 40.3 35.8 46.8 28.2 16.2 14.4 49.2 77.1 41.3 65.2 16.9 15.6 81.3 168.9 18.7 30.5 50.1 17.4 52.2 44.8 34.8 89.2 39.9 29.4 34.0 42.0 37.4 17.5 45.4 42.6 33.3 14.9 76.1 53.3 32.1 59.9 49.6 37.2 60.1 63.1 82.8 61.7 60.4 78.0 136.9 30.8 25.0 43.0 74.2 70.8 79.6 31.1 49.0 85.3 67.2 69.3 29.2 53.6 27.5 45.6 92.7 25.6 35.0 29.6 38.5 65.2 25.6 30.1 18.7 28.4 36.8 54.6 48.6 35.9 63.1 48.2 48.1 67.5 61.5 86.0 31.5 17.8 79.0 67.5 45.9 24.5 37.6 59.6 74.1 38.3 21.1 26.6 92.8 44.4 24.0 33.4 83.6 35.1 81.4 52.7 51.0 50.4 92.1 41.3 28.9 28.7 27.2 47.2 98.2 47.0 33.1 40.0 39.8 47.9 82.8 61.7 48.8 68.0 45.7 78.0 60.1 73.6 69.6 53.9 50.1 75.4 66.0 53.0 60.4 41.2 63.1 59.1 136.9 17.8 23.9 14.5 27.1 16.2 14.4 16.9 15.6 17.4 14.9 157.8 126.0 294.8 183.3 214.9 39.7 35.3 224.2 44.2 116.0 113.4 31.4 367.9 119.3 418.1 40.6 152.0 181.4 0.0 498.3 593.2 367.3 202.3 184.5 121.8 318.4 17.5 220.2 184.1 230.2 62.7 263.2 289.4 283.5 296.6 251.7 76.4 380.4 228.0 199.4 221.7 35.5 161.7 208.3 203.6 67.9 208.0 476.9 318.1 250.0 213.5 SSR3 TRAPG ENSG00000114850 "Signal sequence receptor subunit 3" Q9UNL2 3 156540140-156555184 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014906 Approved NA NA "HPA014906: AB_2195736" "unprognostic (4.11e-1)" "unprognostic (3.50e-1)" "unprognostic (5.49e-2)" "unprognostic (5.46e-2)" "unprognostic (5.74e-2)" "prognostic unfavorable (3.43e-4)" "prognostic unfavorable (4.46e-7)" "unprognostic (1.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.87e-2)" "unprognostic (2.19e-3)" "unprognostic (6.68e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (3.23e-2)" "unprognostic (2.92e-2)" "unprognostic (1.39e-2)" "unprognostic (8.29e-2)" 30.8 33.0 17.7 21.8 19.4 14.2 31.7 13.6 20.6 46.9 25.3 22.4 77.9 18.9 36.4 59.8 24.1 33.4 21.2 42.2 17.0 17.6 44.6 89.1 27.2 30.6 21.2 12.9 33.8 153.1 14.8 37.4 26.6 23.0 23.6 28.9 23.7 90.0 82.3 19.9 14.3 22.7 34.9 26.2 28.7 25.8 26.0 18.9 17.7 38.3 23.4 25.7 24.6 23.4 25.6 51.4 29.1 40.3 20.1 32.3 21.5 47.5 9.9 12.5 15.7 42.4 39.9 13.3 70.6 39.0 35.7 49.9 19.7 23.3 16.0 31.4 45.6 32.7 22.4 20.5 82.4 85.5 19.0 9.9 28.5 6.8 20.0 45.1 29.7 13.7 35.6 30.3 59.7 121.2 34.4 43.2 13.6 15.7 58.9 100.3 14.0 10.1 6.8 15.5 27.4 20.3 14.5 20.9 103.9 32.3 11.3 10.2 8.5 18.3 27.1 37.9 20.6 28.3 15.4 56.0 48.5 23.1 37.4 77.9 54.3 21.2 27.3 28.8 25.1 27.8 29.1 27.8 21.8 20.5 32.3 32.3 25.6 22.1 25.4 37.2 14.7 14.9 17.8 9.6 20.1 40.3 51.4 25.0 21.5 17.7 19.4 13.6 20.6 17.0 17.6 21.2 12.9 23.0 18.9 101.3 135.9 87.1 116.1 74.4 30.6 141.9 122.3 61.6 117.2 69.8 29.5 103.0 92.9 200.0 71.4 90.5 72.2 210.2 199.1 383.2 142.4 205.1 93.5 200.3 348.4 23.8 68.2 133.2 196.5 22.2 199.0 201.2 138.3 223.6 140.9 89.4 235.6 60.4 209.7 184.1 31.2 71.1 74.1 120.7 68.6 68.8 158.0 102.6 121.2 105.2 SSTR1 ENSG00000139874 "Somatostatin receptor 1" P30872 14 38207999-38213067 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.0;intestine: 14.3;stomach 1: 22.8" "Group enriched" "Detected in some" 5 "Cholangiocytes: 5.1;Enterocytes: 9.0;Hepatocytes: 6.4;Intestinal endocrine cells: 17.4;Ito cells: 9.8;Mucus-secreting cells: 8.0;Paneth cells: 8.7;Undifferentiated cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 47.9;BJ hTERT+: 13.3;BJ hTERT+ SV40 Large T+: 8.8;fHDF/TERT166: 28.3;HeLa: 10.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003207, HPA031506" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA003207: , HPA031506: AB_2673913" "unprognostic (1.40e-1)" "unprognostic (1.37e-1)" "unprognostic (3.36e-1)" "unprognostic (2.50e-3)" "unprognostic (4.34e-2)" "unprognostic (9.90e-2)" "unprognostic (3.66e-3)" "unprognostic (1.91e-1)" "unprognostic (6.16e-3)" "unprognostic (3.20e-2)" "unprognostic (1.72e-2)" "unprognostic (9.19e-2)" "prognostic favorable (4.28e-4)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" "unprognostic (3.28e-2)" 0.7 0.4 6.8 0.6 6.9 0.0 0.6 0.5 15.0 0.9 3.7 0.6 0.1 14.3 1.0 0.6 0.4 0.7 0.5 0.8 4.3 10.4 2.2 6.7 5.5 0.1 6.8 4.0 0.6 3.8 0.1 1.4 2.8 2.8 1.2 2.5 0.2 0.2 0.5 0.7 0.4 8.2 0.6 1.3 0.7 22.8 0.1 0.7 0.1 0.3 0.1 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 47.9 13.3 8.8 0.7 0.5 0.0 0.0 0.0 28.3 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.0 10.9 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 1.9 0.0 1.4 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 6.9 0.5 15.0 4.3 10.4 6.8 4.0 2.8 0.7 0.0 0.0 0.0 0.0 0.2 0.6 0.6 5.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.8 9.0 0.0 0.7 0.0 0.6 0.1 0.0 6.4 0.0 0.0 17.4 9.8 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.3 8.7 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 6.0 0.0 SSTR2 ENSG00000180616 "Somatostatin receptor 2" P30874 17 73165012-73176633 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 49.1;Intestinal endocrine cells: 34.5;Sertoli cells: 32.3;Smooth muscle cells: 97.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 17.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007264 Uncertain Supported Cytosol NA NA Cytosol "HPA007264: AB_1080053" "unprognostic (2.13e-3)" "unprognostic (2.61e-3)" "unprognostic (7.43e-2)" "unprognostic (9.37e-3)" "unprognostic (6.25e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-3)" "unprognostic (7.46e-2)" "unprognostic (2.96e-1)" "unprognostic (6.55e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.04e-7)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (3.71e-3)" "unprognostic (2.95e-2)" 4.5 7.4 6.1 2.3 15.8 2.5 4.2 23.1 26.6 1.4 2.2 0.5 0.6 3.3 1.9 4.1 1.5 2.3 1.8 2.2 9.3 5.3 13.6 3.3 1.4 2.7 2.6 13.1 1.5 2.0 1.4 5.7 1.0 4.9 2.8 2.7 1.1 1.8 3.6 1.7 1.9 2.5 2.2 3.3 8.3 7.2 1.4 1.9 0.3 2.3 0.0 2.9 2.0 1.9 1.4 1.0 4.7 0.9 0.9 1.0 0.3 0.3 0.5 0.6 1.2 0.2 0.2 0.7 0.2 0.3 0.5 0.5 0.5 0.5 0.7 0.3 0.1 1.4 0.5 0.1 0.1 0.2 0.6 1.0 0.6 1.1 0.5 0.1 0.4 2.3 0.2 0.1 0.2 0.1 0.3 0.0 0.7 0.7 1.2 0.2 0.6 0.4 1.3 1.6 0.2 0.6 0.7 0.9 0.4 0.4 0.6 17.2 1.5 0.3 0.3 0.2 1.0 2.2 0.3 0.3 0.4 2.2 0.6 0.3 0.8 0.4 1.6 0.3 1.8 0.4 3.8 0.9 1.2 1.0 0.7 0.8 0.8 0.8 0.8 0.3 1.4 0.8 0.9 4.7 0.9 0.8 1.0 0.5 0.3 6.1 15.8 23.1 22.1 9.3 5.3 2.6 13.1 4.9 1.9 6.0 2.4 0.0 3.0 1.0 49.1 2.6 0.0 1.4 2.3 1.8 3.9 0.4 0.0 0.0 7.0 4.0 0.0 0.0 0.0 0.3 2.2 3.0 2.3 0.8 1.1 6.4 34.5 3.7 1.0 3.0 0.9 2.6 5.0 1.8 7.2 1.7 0.6 0.0 0.7 17.4 3.9 32.3 97.1 0.7 1.9 1.0 0.8 1.5 0.4 3.1 SSTR3 ENSG00000278195 "Somatostatin receptor 3" P32745 22 37204238-37212322 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.1;lymphoid tissue: 29.6;testis: 11.3" "Cell type enriched" "Detected in single" 5 "Late spermatids: 1.9" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.9" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.9;naive CD8 T-cell: 3.0" "Lineage enriched" "Detected in single" 10 "T-cells: 3.9" "Group enriched" "Detected in some" 11 "RPMI-8226: 22.3;SCLC-21H: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022647 Approved NA NA "CAB022647: " "unprognostic (1.63e-2)" "unprognostic (5.58e-3)" "unprognostic (1.32e-2)" "unprognostic (3.18e-2)" "unprognostic (7.03e-2)" "unprognostic (6.26e-5)" "unprognostic (1.11e-1)" "unprognostic (1.72e-2)" "unprognostic (1.90e-2)" "unprognostic (8.95e-2)" "unprognostic (3.88e-3)" "unprognostic (2.93e-1)" "unprognostic (1.51e-7)" "unprognostic (1.55e-1)" "unprognostic (1.24e-2)" "unprognostic (5.61e-3)" "unprognostic (1.06e-2)" 0.1 0.8 2.8 1.9 1.9 0.9 0.1 2.7 11.1 0.0 0.5 0.2 0.0 2.6 1.9 0.2 0.1 0.1 0.1 0.0 5.6 0.1 0.0 0.1 3.5 0.0 7.9 5.8 3.9 0.0 6.4 0.0 7.9 0.2 0.6 0.0 0.6 0.1 0.0 0.0 1.0 2.2 4.3 1.2 0.5 11.3 0.1 29.6 0.0 0.0 2.0 0.3 0.0 0.3 0.1 0.1 0.0 0.0 3.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 8.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 3.9 3.0 0.1 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 SSTR4 ENSG00000132671 "Somatostatin receptor 4" P31391 20 23035386-23036812 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Low region specificity" "Detected in many" HPA064252 Uncertain NA NA "HPA064252: AB_2685227" 0.0 0.0 1.7 0.0 1.1 0.0 0.0 3.0 3.8 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 1.3 0.4 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSTR5 ENSG00000162009 "Somatostatin receptor 5" P35346 16 1078781-1080142 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 8.2;lymphoid tissue: 5.2;pituitary gland: 9.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "Hep G2: 9.4;PC-3: 35.0" "Group enriched" "Detected in some" 5 "basal ganglia: 4.2;hypothalamus: 2.7" "Low region specificity" "Detected in all" HPA066503 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA066503: AB_2685679" "unprognostic (2.16e-2)" "unprognostic (7.31e-2)" "unprognostic (3.69e-2)" "unprognostic (2.39e-2)" "unprognostic (2.14e-1)" "unprognostic (9.89e-3)" "unprognostic (1.72e-2)" "unprognostic (1.72e-2)" "unprognostic (2.06e-1)" "unprognostic (2.05e-1)" "unprognostic (4.09e-2)" 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.4 0.4 0.0 0.7 0.6 0.9 0.5 0.0 8.2 2.9 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 9.0 0.0 0.0 1.1 0.0 0.0 1.1 0.9 0.1 0.1 0.8 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 5.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 35.0 0.0 1.3 0.3 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ST14 "HAI, MT-SP1, PRSS14, SNC19, TMPRSS14" ENSG00000149418 "Suppression of tumorigenicity 14" Q9Y5Y6 11 130159562-130210376 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 94.1" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 295.9;Mucus-secreting cells: 176.7;Paneth cells: 178.5;Urothelial cells: 230.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 18.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.2" "Cell line enhanced" "Detected in some" "CACO-2: 36.0;CAPAN-2: 72.5;HaCaT: 50.8;OE19: 38.5;RPMI-8226: 47.5;SK-BR-3: 33.6;T-47d: 50.8;U-698: 34.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA047014 Approved Nucleoplasm,Vesicles NA NA 220000 "Nucleoplasm, Vesicles" "HPA047014: AB_2679902" "unprognostic (1.17e-1)" "unprognostic (1.15e-1)" "unprognostic (9.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.20e-1)" "unprognostic (3.97e-2)" "unprognostic (5.29e-1)" "unprognostic (3.21e-1)" "unprognostic (1.03e-3)" "unprognostic (2.25e-1)" "prognostic favorable (5.03e-11)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.28e-2)" "unprognostic (5.60e-2)" 10.1 1.8 0.7 21.9 1.8 0.5 5.5 0.8 1.4 8.9 48.6 0.5 23.8 33.8 2.8 16.9 38.9 9.7 32.4 1.1 0.5 0.5 30.5 3.2 9.5 7.5 1.8 0.6 3.6 34.3 8.4 9.5 12.7 1.5 12.1 15.4 0.7 25.1 15.8 0.7 17.8 94.1 1.2 1.8 4.0 16.7 2.1 1.5 5.2 24.0 20.1 28.4 8.3 14.9 3.8 18.2 2.3 2.7 0.0 0.1 0.8 26.4 0.0 0.0 0.1 0.0 0.0 14.4 0.0 0.0 0.0 0.0 36.0 72.5 26.1 2.7 0.0 0.0 50.8 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.1 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.1 0.2 38.5 0.1 0.0 0.0 47.5 4.7 21.7 2.9 0.0 0.2 33.6 0.0 0.2 50.8 5.1 0.0 0.0 0.4 0.1 0.1 0.0 0.0 34.6 0.0 8.0 0.0 0.0 2.7 2.3 0.0 1.5 0.1 3.8 0.0 0.0 4.5 2.3 0.0 0.0 0.3 0.0 0.2 18.2 0.0 0.8 0.7 1.8 0.8 1.4 0.5 0.5 1.8 0.6 1.5 1.5 29.8 25.8 9.3 31.0 36.4 0.0 0.8 38.2 17.4 20.5 59.3 0.0 40.3 3.3 108.8 27.9 0.4 295.9 0.0 80.1 11.6 2.6 89.5 11.5 1.9 60.1 0.0 118.5 0.0 25.4 11.5 1.7 19.0 6.8 8.2 176.7 0.0 114.4 178.5 0.7 10.5 0.0 6.5 1.4 0.2 0.1 38.3 33.2 1.3 155.8 230.3 ST3GAL1 "SIAT4A, SIATFL, ST3GalA.1, ST3O" ENSG00000008513 "ST3 beta-galactoside alpha-2,3-sialyltransferase 1" Q11201 8 133454848-133571940 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 143.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 47.7;RT4: 36.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040466 Approved "Intracellular and membrane" NA NA 290000 "HPA040466: AB_10805712" "unprognostic (1.36e-2)" "unprognostic (1.11e-2)" "unprognostic (6.66e-2)" "unprognostic (1.83e-3)" "unprognostic (5.53e-3)" "unprognostic (4.43e-2)" "unprognostic (4.79e-2)" "unprognostic (2.66e-1)" "unprognostic (1.97e-1)" "unprognostic (1.04e-1)" "unprognostic (3.55e-3)" "unprognostic (1.10e-1)" "unprognostic (1.83e-3)" "unprognostic (1.67e-2)" "unprognostic (3.29e-2)" "unprognostic (8.64e-3)" "unprognostic (2.95e-2)" 14.4 14.4 5.1 11.8 3.6 10.2 7.8 3.7 6.5 9.8 5.4 4.1 18.1 1.8 8.5 11.8 9.0 9.0 17.0 35.4 4.2 3.4 23.1 44.5 11.9 12.4 4.7 2.5 10.3 8.2 4.4 7.6 49.8 6.4 7.1 2.9 11.2 18.2 15.1 20.9 4.0 6.5 12.3 3.9 17.3 9.4 5.0 1.4 6.3 40.2 7.9 16.8 14.0 14.3 22.7 7.0 21.3 9.8 21.9 19.9 9.5 4.7 2.5 1.0 2.9 10.3 5.4 5.3 5.4 13.1 2.1 1.6 4.4 5.3 1.1 3.7 9.9 1.0 1.4 3.4 4.0 1.9 13.3 0.6 9.9 7.6 8.8 7.9 2.0 7.9 6.3 2.0 7.5 4.2 9.7 9.2 2.6 0.1 15.3 1.5 5.0 2.8 2.7 0.7 25.6 47.7 3.3 1.3 8.1 0.9 36.7 0.2 0.8 2.4 8.2 2.5 5.8 1.5 2.7 8.9 6.5 10.3 5.6 2.3 18.9 13.6 1.2 14.7 6.9 6.6 20.5 4.7 21.3 14.4 4.5 13.3 12.8 14.6 16.4 2.9 22.7 19.9 18.5 8.6 21.9 9.8 7.0 8.9 9.5 5.1 3.6 3.7 6.5 4.2 3.4 4.7 2.5 6.4 1.4 6.0 58.6 36.0 6.4 5.0 7.4 59.9 12.7 8.1 21.6 1.8 2.0 8.2 5.0 34.3 2.8 41.9 0.0 23.3 21.6 34.2 37.0 10.6 8.1 143.6 32.3 57.2 0.0 33.7 44.5 0.9 33.9 42.2 13.5 78.5 0.4 10.1 25.8 0.0 67.5 39.3 21.7 12.9 32.2 0.2 1.9 3.0 22.1 43.7 0.0 37.3 ST3GAL2 "SIAT4B, ST3GalA.2, ST3GALII" ENSG00000157350 "ST3 beta-galactoside alpha-2,3-sialyltransferase 2" Q16842 16 70375978-70439237 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017270 Approved Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA017270: AB_1857523" "unprognostic (2.76e-2)" "unprognostic (6.33e-2)" "unprognostic (3.41e-1)" "unprognostic (1.35e-1)" "unprognostic (4.99e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (1.14e-2)" "unprognostic (2.21e-1)" "unprognostic (1.91e-2)" "prognostic favorable (2.33e-4)" "unprognostic (9.54e-2)" "prognostic unfavorable (3.34e-6)" "unprognostic (7.42e-2)" "unprognostic (8.83e-3)" "unprognostic (4.64e-2)" "unprognostic (5.20e-2)" 12.6 9.1 9.3 17.2 11.9 14.3 8.9 24.1 10.6 11.3 8.8 5.1 9.3 9.2 13.9 5.6 5.8 9.0 6.8 9.2 10.4 6.0 8.8 12.9 9.3 14.9 5.1 4.7 13.6 4.2 8.8 7.2 8.8 6.8 7.5 4.7 9.9 4.9 9.0 33.3 6.0 10.5 12.0 4.0 17.7 5.4 9.6 5.9 16.0 6.6 4.9 12.6 9.1 12.0 3.2 14.3 11.2 2.2 2.8 4.2 1.1 1.4 8.5 7.4 9.8 4.0 5.4 1.7 6.0 6.4 6.7 3.3 5.1 3.3 4.1 10.8 6.5 6.0 1.0 2.9 2.5 3.2 9.7 4.7 17.5 3.5 7.6 4.9 6.4 28.9 4.1 1.4 6.8 1.2 8.2 9.2 7.1 23.9 4.0 3.7 0.7 6.7 17.5 10.0 2.8 4.6 12.9 2.8 5.5 4.5 1.1 3.3 9.7 15.1 0.3 6.6 8.0 1.6 7.1 9.8 8.5 10.2 3.6 4.4 8.4 3.3 8.4 9.3 5.4 11.9 2.7 2.0 5.7 2.0 2.2 1.9 1.7 2.4 2.2 1.0 3.2 4.2 3.3 11.2 2.8 1.3 14.3 2.7 1.1 9.3 11.9 24.1 10.6 10.4 6.0 5.1 4.7 6.8 5.9 8.9 6.9 13.0 3.6 3.0 15.1 5.6 10.2 1.4 2.3 8.7 13.7 3.7 0.0 5.4 14.0 13.1 5.1 46.7 3.8 1.6 10.6 2.2 17.3 11.5 11.6 17.5 12.7 14.7 10.0 25.8 10.9 14.4 1.7 23.4 4.0 5.1 2.4 0.0 7.8 5.0 10.2 6.5 7.1 5.4 8.1 2.0 1.5 8.6 5.2 1.8 ST3GAL3 "MRT12, SIAT6" ENSG00000126091 "ST3 beta-galactoside alpha-2,3-sialyltransferase 3" Q11203 1 43705824-43931165 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 71.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051102 Uncertain "Intracellular and membrane" NA NA "HPA051102: AB_2681344" "unprognostic (8.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (3.20e-1)" "unprognostic (9.72e-2)" "unprognostic (7.01e-2)" "unprognostic (4.39e-2)" "unprognostic (2.33e-2)" "unprognostic (1.38e-3)" "unprognostic (7.00e-2)" "unprognostic (3.68e-3)" "unprognostic (1.67e-2)" "unprognostic (1.30e-1)" "unprognostic (4.35e-1)" "unprognostic (6.60e-2)" 11.6 9.0 13.0 8.9 16.5 9.9 12.8 15.5 20.4 9.0 10.3 9.0 8.0 3.2 10.8 10.7 8.7 8.3 7.2 16.9 12.8 13.9 6.7 9.1 7.2 7.6 12.0 10.4 13.3 7.5 6.9 10.9 6.7 11.6 8.8 5.1 9.0 8.0 13.9 71.5 7.4 3.8 15.9 7.7 6.0 5.9 14.5 10.3 3.2 8.1 17.8 4.8 8.1 7.0 7.1 7.0 5.8 4.2 4.7 7.6 6.1 2.4 1.9 14.2 6.7 11.2 14.2 1.8 9.3 19.4 8.7 8.4 1.6 4.0 4.5 4.8 11.9 4.8 2.3 1.2 6.1 10.5 5.3 3.2 8.6 6.0 4.6 9.4 3.9 4.3 7.5 4.6 6.4 14.0 16.7 6.8 11.2 5.1 8.4 16.1 1.6 4.0 7.4 5.6 0.6 5.0 6.7 1.9 3.0 7.0 1.6 5.8 8.5 3.7 1.4 8.1 6.0 2.1 18.8 6.5 5.2 2.4 8.5 9.4 6.7 3.8 4.2 7.7 9.4 9.6 2.9 4.2 2.5 6.8 2.5 6.1 4.5 4.4 5.1 3.0 7.1 7.6 5.7 5.8 4.7 3.7 7.0 5.2 6.1 13.0 16.5 15.5 20.4 12.8 13.9 12.0 10.4 11.6 10.3 6.0 20.0 0.9 2.8 3.0 8.5 22.8 2.5 6.7 3.4 3.5 0.0 2.1 5.0 2.6 16.4 7.4 0.2 0.0 2.1 1.2 7.4 2.0 23.1 9.0 2.6 17.5 2.4 4.3 2.4 10.2 3.4 4.6 3.3 3.6 1.2 3.9 2.3 0.0 11.0 5.6 16.1 19.4 7.2 5.2 3.8 1.1 0.8 3.5 1.6 7.9 ST3GAL4 "CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ" ENSG00000110080 "ST3 beta-galactoside alpha-2,3-sialyltransferase 4" Q11206 11 126355640-126440344 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 74.2" "Cell type enriched" "Detected in many" 9 "Syncytiotrophoblasts: 804.9" "Cancer enhanced" "Detected in all" "melanoma: 57.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6" "Group enriched" "Detected in many" 11 "dendritic cells: 29.6;granulocytes: 31.3" "Cell line enhanced" "Detected in many" "SK-MEL-30: 45.3;WM-115: 102.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049827 Approved "Intracellular and membrane" NA NA "HPA049827: AB_2680900" "unprognostic (8.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (6.93e-2)" "unprognostic (8.33e-2)" "unprognostic (3.80e-2)" "unprognostic (2.71e-3)" "unprognostic (1.90e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (3.16e-3)" "unprognostic (2.79e-2)" "unprognostic (1.28e-1)" "unprognostic (8.36e-3)" "unprognostic (8.78e-3)" 7.8 38.0 6.2 6.5 12.2 7.8 12.9 4.0 13.6 8.3 27.0 26.4 5.1 2.0 6.0 42.1 25.5 6.0 11.4 26.5 8.6 6.2 16.7 11.5 12.4 9.0 18.7 9.0 39.3 5.1 0.8 5.6 74.2 13.8 12.1 31.5 35.7 14.4 8.0 1.9 5.6 3.8 11.0 23.0 17.0 4.8 18.8 12.4 2.2 6.1 4.3 10.1 21.1 13.2 0.1 29.6 31.3 2.6 1.2 1.7 1.8 4.9 4.1 3.2 2.7 9.5 7.9 8.0 5.7 11.1 5.2 3.6 2.4 8.5 1.4 4.3 9.0 17.7 7.7 6.7 3.7 4.1 5.3 1.9 12.6 10.2 2.7 6.2 15.0 25.8 6.3 6.0 7.8 12.4 9.6 6.9 5.5 7.8 3.8 6.4 20.2 4.7 15.4 2.0 31.9 26.8 4.9 9.9 0.6 1.2 14.2 6.1 3.9 6.3 38.2 45.3 2.2 13.3 10.0 2.5 12.5 2.8 8.8 10.7 0.3 0.8 0.7 5.7 23.0 102.8 31.3 1.6 0.2 1.7 2.6 1.6 0.1 0.6 1.1 6.6 0.0 0.1 0.8 22.8 1.2 1.2 29.6 0.0 1.8 6.2 12.2 4.0 13.6 8.6 6.2 18.7 9.0 13.8 12.4 8.9 1.1 3.7 5.3 9.4 4.2 26.6 7.6 1.4 4.5 29.6 9.8 90.3 41.4 4.3 1.1 9.8 34.8 0.0 5.6 59.0 44.0 13.8 41.5 8.9 16.2 4.8 5.1 36.8 4.1 3.8 70.5 7.2 74.2 10.8 43.5 5.0 7.3 93.0 88.1 3.4 8.3 12.9 23.6 1.4 3.8 5.8 804.9 12.2 8.8 13.1 ST3GAL5 "SIAT9, SIATGM3S, ST3GalV" ENSG00000115525 "ST3 beta-galactoside alpha-2,3-sialyltransferase 5" Q9UNP4 2 85837120-85905199 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 40.1" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 80.4;Alveolar cells type 2: 105.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 41.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 26.2;RT4: 22.2;SK-MEL-30: 18.4;U-266/84: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034708, HPA040425, HPA068928" Uncertain Approved Vesicles NA NA Vesicles "HPA034708: AB_10601594, HPA040425: AB_2676978, HPA068928: AB_2686060" "unprognostic (7.90e-2)" "unprognostic (1.61e-2)" "unprognostic (3.84e-2)" "unprognostic (2.93e-2)" "unprognostic (1.27e-1)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (5.81e-3)" "unprognostic (1.38e-1)" "unprognostic (6.45e-2)" "unprognostic (5.03e-3)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.25e-7)" "unprognostic (2.22e-1)" "unprognostic (5.74e-2)" "prognostic favorable (4.99e-4)" "prognostic favorable (4.48e-4)" 8.0 40.1 15.3 7.2 18.5 4.1 4.2 9.9 34.9 3.3 3.8 18.8 0.0 2.7 8.0 2.9 2.9 4.9 11.8 2.1 14.8 12.0 2.4 7.0 18.0 11.5 14.0 13.4 7.2 2.9 1.5 7.4 24.1 18.1 4.8 5.0 18.7 4.8 2.2 9.5 5.0 3.4 6.2 18.0 11.1 4.1 9.0 13.4 5.5 36.7 0.4 6.9 30.9 7.8 2.5 1.1 1.3 6.1 1.4 1.8 0.5 0.1 12.8 1.2 26.2 10.9 5.9 3.9 2.8 8.6 2.7 2.4 0.2 9.3 0.3 0.1 4.8 1.2 0.5 1.7 3.0 3.4 0.1 1.5 0.2 0.5 0.4 8.7 0.1 3.8 3.3 0.4 1.0 0.4 4.9 6.5 3.5 0.3 14.5 8.8 0.8 0.8 1.4 0.1 4.4 0.0 1.6 8.3 5.1 1.4 22.2 1.8 1.8 0.1 0.0 18.4 2.7 0.1 0.5 2.1 0.0 1.3 0.0 0.2 14.6 19.3 0.2 2.1 2.6 13.2 0.9 1.8 0.1 1.4 6.1 1.8 2.5 0.8 0.9 1.1 1.5 0.7 0.8 1.3 1.4 5.1 0.4 0.3 0.5 15.3 18.5 9.9 21.9 14.8 12.0 14.0 13.4 18.1 13.4 80.4 105.8 40.9 24.7 4.9 49.5 1.6 30.6 14.7 50.0 3.5 55.0 0.3 3.3 8.1 9.5 5.2 0.0 0.0 14.5 0.5 10.3 8.0 33.5 15.5 30.3 68.3 6.4 33.2 46.9 8.7 7.5 25.6 30.4 12.6 0.0 52.2 6.7 0.0 1.8 2.9 41.0 0.0 5.0 6.9 20.0 3.3 0.2 19.7 0.0 5.1 ST3GAL6 "SIAT10, ST3GALVI" ENSG00000064225 "ST3 beta-galactoside alpha-2,3-sialyltransferase 6" Q9Y274 3 98732236-98821201 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 46.7" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 61.5;Hepatocytes: 74.4;Melanocytes: 62.4" "Cancer enhanced" "Detected in many" "melanoma: 17.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 20.7;neutrophil: 25.8" "Group enriched" "Detected in many" 144 "dendritic cells: 10.6;granulocytes: 25.8;monocytes: 7.7" "Group enriched" "Detected in many" 4 "RPMI-8226: 36.4;SK-MEL-30: 43.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018792 Approved NA NA 3000000 "HPA018792: AB_10964349" "unprognostic (1.25e-1)" "unprognostic (1.21e-1)" "unprognostic (1.88e-3)" "unprognostic (4.17e-2)" "unprognostic (5.20e-3)" "unprognostic (3.82e-2)" "unprognostic (1.23e-2)" "unprognostic (2.30e-3)" "unprognostic (2.40e-1)" "unprognostic (2.99e-1)" "unprognostic (2.48e-1)" "unprognostic (4.32e-1)" "unprognostic (3.91e-3)" "unprognostic (6.15e-3)" "unprognostic (9.44e-2)" "unprognostic (9.47e-3)" "unprognostic (6.79e-4)" 11.5 7.5 5.9 3.6 8.3 2.4 6.0 14.4 8.2 4.9 3.6 6.7 1.9 2.2 2.4 11.3 2.4 6.0 2.4 21.8 7.1 5.9 12.2 46.7 7.1 3.5 9.5 4.3 1.7 4.7 1.1 4.6 20.1 10.1 3.5 3.0 6.3 15.9 2.3 6.5 14.4 2.2 2.3 17.4 3.0 4.6 1.8 7.4 14.3 3.1 2.2 2.8 1.6 1.9 0.0 10.6 25.8 7.7 0.0 0.1 1.8 0.1 0.5 0.8 1.1 1.3 0.4 5.0 0.1 0.6 0.5 0.9 3.3 0.2 2.4 1.3 0.0 1.8 0.8 1.5 0.8 0.4 0.0 1.0 0.1 0.2 5.9 5.8 5.0 9.5 0.6 0.0 1.4 2.7 9.1 5.7 1.0 0.0 2.5 0.5 0.0 0.8 8.6 1.4 0.0 1.4 0.4 0.6 36.4 1.3 0.0 1.5 7.8 2.0 0.2 43.1 1.5 0.1 9.0 4.2 1.1 0.9 0.3 0.4 9.7 0.7 0.0 1.9 7.2 4.0 7.4 7.7 20.7 0.0 4.1 0.0 0.0 0.0 0.0 10.6 0.0 0.1 0.0 25.8 0.0 2.0 2.4 0.0 1.8 5.9 8.3 14.4 8.2 7.1 5.9 9.5 4.3 10.1 7.4 11.9 35.7 2.2 2.8 10.2 1.0 33.9 5.1 32.1 1.2 3.5 7.9 36.5 11.6 4.9 0.2 13.4 0.0 0.0 1.8 61.5 2.2 4.8 36.0 74.4 33.3 0.0 15.4 33.2 23.8 0.2 2.6 39.4 62.4 44.1 0.0 0.6 4.2 0.0 6.3 9.0 2.6 6.5 2.0 0.0 0.4 11.2 22.5 0.0 0.0 0.9 ST6GAL1 SIAT1 ENSG00000073849 "ST6 beta-galactoside alpha-2,6-sialyltransferase 1" P15907 3 186930485-187078553 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 161.4" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 225.1;Hepatocytes: 512.9;Ito cells: 264.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 32.6;U-266/70: 104.1;U-266/84: 133.1;U-698: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015018, CAB016122" Supported "Secreted to blood" NA NA 15000000 580000 "CAB015018: AB_629203, CAB016122: AB_627178" "unprognostic (5.85e-3)" "unprognostic (4.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.62e-1)" "unprognostic (2.64e-1)" "unprognostic (2.44e-2)" "unprognostic (1.38e-3)" "unprognostic (3.43e-2)" "unprognostic (3.17e-1)" "unprognostic (2.20e-1)" "unprognostic (3.99e-1)" "unprognostic (1.43e-1)" "unprognostic (1.91e-2)" "unprognostic (7.30e-3)" "unprognostic (1.25e-1)" "unprognostic (1.16e-1)" "unprognostic (1.93e-2)" 10.6 6.5 11.8 16.7 15.4 4.0 10.5 2.8 11.8 19.1 11.4 22.7 4.2 4.3 8.6 4.3 4.4 8.6 5.7 10.6 10.7 7.6 19.1 161.4 10.9 27.6 18.2 7.6 4.5 4.1 20.5 5.7 5.5 13.7 19.5 14.2 5.4 17.7 4.6 5.7 4.5 12.6 5.8 22.3 27.0 8.5 2.4 15.1 19.4 19.4 4.0 41.6 13.2 14.3 33.6 4.6 6.9 8.9 8.5 29.3 16.9 0.7 0.7 3.1 2.3 0.2 0.0 4.8 0.2 0.4 0.1 0.3 0.2 0.2 32.6 2.7 0.0 1.2 1.4 19.2 2.0 0.2 1.6 0.8 1.3 0.1 15.9 0.1 3.0 10.3 0.2 4.1 0.0 1.8 2.8 11.3 3.3 6.6 3.1 1.0 1.4 2.2 2.1 6.9 1.6 1.0 5.3 0.0 1.0 1.4 0.0 5.0 0.5 0.2 3.7 8.5 4.7 5.4 2.2 4.3 0.0 0.4 0.0 0.3 104.1 133.1 48.5 0.1 6.1 11.3 6.9 2.7 1.1 16.5 5.2 15.0 32.7 18.2 13.8 4.6 33.6 29.3 20.2 1.3 8.5 8.9 4.2 14.2 16.9 11.8 15.4 2.8 11.8 10.7 7.6 18.2 7.6 13.7 15.1 41.7 20.6 118.9 14.7 3.5 0.0 22.2 86.6 24.1 44.3 225.1 0.0 0.3 0.0 14.5 0.3 29.9 4.1 23.3 0.8 3.1 1.9 58.6 10.4 512.9 16.4 0.0 90.6 264.6 52.6 0.7 0.3 13.4 6.8 5.4 3.3 0.0 6.7 5.8 0.7 0.5 1.1 0.0 5.1 0.0 0.2 1.4 0.6 20.0 28.1 28.2 ST6GAL2 "KIAA1877, SIAT2, St6gal2, St6GalII" ENSG00000144057 "ST6 beta-galactoside alpha-2,6-sialyltransferase 2" Q96JF0 2 106801600-106887108 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7;thyroid gland: 34.0" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 7.7;Ito cells: 2.5;Mucus-secreting cells: 2.3" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 5.7;hTERT-RPE1: 7.2;NTERA-2: 4.9;PC-3: 6.4;RPMI-8226: 10.2;SCLC-21H: 6.8;U-138 MG: 8.3;U-266/70: 10.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014459 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA014459: AB_1857528" "unprognostic (2.08e-1)" "unprognostic (5.80e-2)" "unprognostic (1.55e-1)" "unprognostic (4.63e-2)" "unprognostic (6.44e-3)" "unprognostic (1.62e-1)" "unprognostic (2.35e-2)" "unprognostic (1.10e-2)" "unprognostic (1.29e-4)" "unprognostic (4.56e-3)" "unprognostic (7.04e-2)" "unprognostic (1.84e-2)" "unprognostic (7.01e-4)" "unprognostic (4.70e-4)" "unprognostic (4.06e-2)" "unprognostic (2.83e-1)" "unprognostic (2.07e-2)" 1.2 0.7 14.1 0.7 5.6 1.5 1.3 2.3 16.7 2.1 1.5 4.1 1.7 0.7 3.7 1.9 2.7 1.2 12.7 1.9 5.4 4.0 1.1 3.4 1.2 0.9 3.8 7.1 0.9 0.5 0.5 0.3 2.3 4.2 1.6 3.3 0.0 1.6 1.6 0.7 1.3 0.7 2.8 1.9 0.6 0.9 7.9 1.5 0.0 34.0 1.6 0.8 1.5 1.4 0.7 0.6 1.8 0.5 1.0 0.7 0.5 0.0 5.7 3.1 0.1 0.0 0.0 0.1 0.3 0.0 1.3 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.0 7.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 4.9 0.0 6.4 0.0 0.0 10.2 0.2 0.0 6.8 4.4 0.0 0.1 0.0 0.3 0.0 0.1 0.0 8.3 0.1 0.2 0.0 10.9 0.2 0.1 0.0 0.0 0.0 1.4 0.5 0.4 0.6 0.3 0.5 0.4 0.4 0.5 0.2 0.7 0.5 0.7 1.8 1.0 0.3 0.6 0.5 0.5 14.1 5.6 2.3 14.8 5.4 4.0 3.8 7.1 4.2 1.5 0.0 0.0 0.0 0.1 0.8 7.7 1.2 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.2 0.0 1.2 2.5 0.0 0.0 0.3 0.0 0.0 0.0 2.3 0.8 0.0 0.0 0.7 0.6 0.5 0.0 1.4 0.0 1.3 0.0 0.2 0.0 1.2 0.0 ST6GALNAC1 "SIAT7A, ST6GalNAcI" ENSG00000070526 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1" Q9NSC7 17 76624761-76643838 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 69.4" "Cell type enriched" "Detected in many" 6 "Mucus-secreting cells: 708.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 11.2;naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 25 "T-cells: 11.2" "Group enriched" "Detected in some" 4 "K-562: 23.7;OE19: 44.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014767, HPA014975" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 1200000 "Golgi apparatus" Nucleoplasm "HPA014767: , HPA014975: AB_1857529" "unprognostic (4.59e-2)" "unprognostic (8.60e-3)" "unprognostic (5.32e-3)" "unprognostic (1.86e-3)" "unprognostic (6.31e-3)" "prognostic favorable (2.54e-5)" "unprognostic (1.39e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.58e-2)" "unprognostic (8.64e-3)" "unprognostic (2.81e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (5.87e-3)" "unprognostic (5.58e-2)" 1.4 0.3 1.2 13.9 2.6 0.7 1.3 0.8 3.2 20.4 50.9 3.1 0.3 19.8 6.3 1.8 19.6 1.5 26.6 4.1 1.6 1.3 0.4 1.1 5.7 1.1 1.8 1.2 2.0 1.1 0.1 0.4 1.7 3.7 2.6 69.4 0.1 20.8 1.4 0.9 0.6 49.0 1.9 1.5 6.0 23.9 4.0 0.6 0.0 0.5 4.5 21.6 1.9 2.6 0.0 0.0 0.4 0.0 0.0 11.2 1.1 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 4.4 0.0 0.0 4.9 0.0 1.3 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 23.7 0.0 0.0 0.0 0.1 0.0 0.0 44.4 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.2 0.2 0.0 0.0 4.2 0.0 0.4 0.0 0.0 0.0 1.4 1.1 1.2 2.6 0.8 3.2 1.6 1.3 1.8 1.2 3.7 0.6 14.9 6.9 0.0 5.2 0.1 0.0 1.5 30.6 112.4 76.2 0.0 0.0 0.1 0.0 1.6 0.2 14.2 50.8 0.0 16.6 0.1 0.6 3.2 0.0 0.0 0.2 0.0 31.7 4.3 0.0 0.5 1.4 0.3 0.0 0.0 708.1 0.0 27.0 66.2 0.0 0.0 1.1 0.0 0.1 0.3 0.0 0.1 0.1 0.0 108.2 20.7 ST6GALNAC2 "SIAT7, SIAT7B, SIATL1, ST6GalNAII, STHM" ENSG00000070731 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2" Q9UJ37 17 76565379-76586956 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 78.2" "Group enriched" "Detected in many" 11 "Early spermatids: 447.7;Late spermatids: 1248.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 19.2" "Cell type enriched" "Detected in some" 9 "neutrophil: 23.5" "Lineage enriched" "Detected in many" 20 "granulocytes: 23.5" "Cell line enhanced" "Detected in some" "BEWO: 9.6;HaCaT: 11.8;HBEC3-KT: 10.7;hTCEpi: 30.0;MCF7: 11.6;SK-MEL-30: 39.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (8.93e-3)" "unprognostic (5.86e-3)" "unprognostic (1.67e-2)" "unprognostic (5.18e-3)" "unprognostic (3.37e-2)" "unprognostic (3.79e-2)" "unprognostic (8.79e-2)" "unprognostic (1.95e-1)" "unprognostic (5.37e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.57e-1)" "unprognostic (5.17e-3)" "unprognostic (3.85e-2)" "unprognostic (2.84e-2)" "unprognostic (1.66e-1)" "unprognostic (1.33e-1)" 4.3 1.7 0.6 2.7 1.8 0.4 7.0 0.4 1.3 8.6 7.2 6.0 3.6 0.4 2.6 8.8 17.2 28.3 2.1 4.6 2.1 1.3 10.6 1.3 11.3 1.7 4.0 1.0 5.0 3.6 1.5 2.1 18.3 19.2 6.7 3.4 78.2 6.6 6.1 11.3 27.3 2.5 4.7 3.7 2.0 3.5 17.1 1.3 0.7 17.7 12.4 6.9 8.3 7.6 0.0 0.2 23.5 1.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.2 0.0 9.6 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.7 0.0 11.8 0.1 10.7 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 30.0 0.0 3.4 1.4 0.0 0.0 0.0 0.0 0.1 11.6 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 3.2 0.1 0.0 1.3 0.0 39.0 0.6 7.6 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.1 2.6 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 23.5 0.0 0.1 0.0 0.0 0.1 0.6 1.8 0.4 1.3 2.1 1.3 4.0 1.0 19.2 1.3 0.0 1.0 0.5 34.2 29.2 6.0 4.8 5.1 9.4 6.8 0.0 25.5 7.7 0.0 0.1 447.7 3.1 1.3 0.0 0.0 15.3 3.4 4.5 1.1 0.8 2.8 0.0 0.0 9.2 5.6 1248.1 6.9 2.4 62.4 1.0 3.4 71.0 0.1 0.0 6.7 0.3 74.9 19.4 3.1 8.4 4.4 26.5 8.8 2.2 1.5 31.0 ST6GALNAC3 SIAT7C ENSG00000184005 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3" Q8NDV1 1 76074719-76634601 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 23 "Endothelial cells: 21.6;Ito cells: 57.1;Kupffer cells: 11.7;Muller glia cells: 11.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 18.6;HUVEC TERT2: 23.6;SK-MEL-30: 32.2;TIME: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054566, HPA055399" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054566: AB_2682526, HPA055399: AB_2682806" "unprognostic (7.85e-2)" "unprognostic (1.78e-1)" "unprognostic (2.99e-2)" "unprognostic (2.70e-4)" "unprognostic (2.76e-2)" "unprognostic (2.21e-2)" "unprognostic (6.55e-3)" "unprognostic (7.31e-2)" "unprognostic (2.14e-1)" "unprognostic (4.57e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (9.97e-4)" "unprognostic (3.33e-4)" "unprognostic (5.44e-2)" "unprognostic (1.92e-1)" "unprognostic (3.44e-4)" 20.7 2.9 7.0 3.6 13.0 5.3 13.9 3.8 9.7 4.3 4.0 13.4 2.0 1.8 10.7 2.1 3.8 4.2 4.7 7.8 8.8 6.0 14.9 3.9 7.5 5.1 16.3 3.6 4.7 2.2 12.6 4.3 5.7 12.9 2.5 4.7 2.8 2.3 3.5 3.3 1.9 2.7 8.3 19.0 3.0 3.0 1.2 12.5 0.0 23.2 1.5 1.7 5.5 5.2 5.9 3.0 5.2 8.3 0.4 1.9 2.6 0.1 0.0 18.6 0.0 0.3 0.0 0.0 0.0 2.2 0.3 0.2 6.0 0.0 0.3 1.2 0.1 1.2 0.0 0.0 0.2 0.1 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.5 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 1.4 0.0 0.9 0.8 0.0 0.0 0.0 1.4 4.6 0.0 0.0 32.2 4.5 0.0 0.1 10.4 0.1 1.5 0.0 1.7 0.0 0.0 0.0 0.0 4.2 2.8 0.0 8.3 3.7 0.0 2.9 0.0 3.3 0.5 0.8 3.0 5.9 1.9 1.9 5.2 0.4 5.3 0.0 0.0 2.6 7.0 13.0 3.8 9.7 8.8 6.0 16.3 3.6 12.9 12.5 3.0 1.0 1.3 0.1 0.2 3.0 1.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.4 0.8 0.0 0.0 57.1 11.7 0.4 0.0 1.5 5.0 0.0 0.3 11.0 0.2 3.2 0.0 0.0 0.5 0.0 0.3 0.2 0.4 0.4 0.1 0.0 0.0 0.1 ST6GALNAC4 "SIAT3C, SIAT7D, ST6GALNACIV" ENSG00000136840 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4" Q9H4F1 9 127907886-127917038 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;pancreas: 61.0" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "plasmacytoid DC: 58.8" "Lineage enriched" "Detected in many" 9 "dendritic cells: 58.8" "Cell line enhanced" "Detected in many" "HDLM-2: 35.5;RPMI-8226: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009042 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA009042: AB_1079963" "unprognostic (2.05e-3)" "unprognostic (2.32e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-2)" "unprognostic (3.18e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (8.63e-7)" "unprognostic (1.62e-2)" "unprognostic (4.26e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.04e-1)" "unprognostic (3.04e-1)" "prognostic unfavorable (8.39e-4)" "unprognostic (1.30e-3)" "unprognostic (2.72e-1)" "unprognostic (2.64e-2)" "unprognostic (2.03e-2)" 8.0 7.8 5.6 7.9 5.6 26.2 12.1 9.8 8.5 9.2 9.3 4.8 28.9 11.7 8.7 9.6 6.9 8.7 12.2 18.4 5.2 3.4 9.4 5.0 13.5 9.7 4.2 4.7 14.9 61.0 2.4 9.4 4.3 4.8 6.1 5.4 4.8 9.3 30.0 12.6 4.0 9.7 6.1 3.9 18.2 7.2 4.3 4.7 4.7 6.3 5.9 12.5 8.9 8.3 6.7 58.8 0.8 3.2 4.3 3.4 2.4 3.2 5.5 1.4 7.0 9.9 7.6 1.0 5.6 6.2 5.7 3.3 3.1 5.9 20.5 8.5 7.0 8.1 7.9 2.9 5.9 0.9 35.5 2.4 6.5 17.6 11.6 12.1 0.5 6.8 9.2 6.3 5.1 4.6 4.6 15.2 3.9 4.6 13.7 2.7 1.5 1.2 0.7 1.6 10.5 13.6 6.2 3.7 50.3 5.8 0.1 12.0 2.7 8.1 17.6 1.0 0.5 3.6 4.2 10.8 4.7 5.4 14.6 8.7 22.4 11.5 6.4 9.4 2.9 0.6 0.8 2.1 0.0 2.9 1.9 3.3 6.7 1.8 3.4 2.8 4.9 2.3 3.1 0.2 4.3 3.2 58.8 3.3 2.4 5.6 5.6 9.8 8.5 5.2 3.4 4.2 4.7 4.8 4.7 8.9 24.5 43.4 11.9 1.9 2.4 10.3 10.2 5.3 4.5 1.8 0.0 0.9 1.7 14.0 0.1 10.8 19.6 23.3 12.5 14.4 11.9 2.0 8.1 1.5 22.1 0.0 65.1 4.9 11.4 0.0 16.1 8.5 6.8 12.6 13.1 14.1 11.9 6.5 40.3 17.3 1.7 12.9 8.9 0.2 1.3 2.8 3.8 10.2 16.4 10.0 ST6GALNAC5 "MGC3184, SIAT7E, ST6GalNAcV" ENSG00000117069 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5" Q9BVH7 1 76867441-77065711 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4" "Cell type enriched" "Detected in some" 7 "Alveolar cells type 1: 50.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.9" "Group enriched" "Detected in many" 4 "amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.1;fHDF/TERT166: 10.9;HaCaT: 5.2;SH-SY5Y: 7.9;U-2 OS: 9.0;U-251 MG: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA065593, HPA070354" Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA065593: AB_2685515, HPA070354: AB_2686260" "unprognostic (1.32e-1)" "unprognostic (5.96e-2)" "unprognostic (1.72e-1)" "unprognostic (1.49e-2)" "unprognostic (2.82e-2)" "unprognostic (2.04e-2)" "unprognostic (4.67e-2)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-1)" "unprognostic (1.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.10e-2)" "unprognostic (5.90e-3)" "unprognostic (9.66e-2)" "unprognostic (6.88e-2)" "unprognostic (1.69e-2)" 0.7 10.1 22.1 5.2 22.3 0.4 4.2 0.6 12.7 2.9 3.4 0.3 0.0 1.4 0.9 0.7 3.7 6.9 12.6 1.4 29.4 2.7 0.7 0.6 12.1 1.6 3.0 14.2 6.5 0.8 0.4 8.5 0.9 4.7 4.2 2.7 5.8 1.5 1.6 0.6 1.0 2.1 10.2 0.8 1.0 3.7 1.2 0.2 0.0 0.6 0.0 1.4 4.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.4 0.0 9.1 0.0 0.0 0.0 0.0 0.8 3.2 2.6 0.8 0.0 0.2 0.0 0.0 10.9 0.0 5.2 0.0 0.1 2.8 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.7 0.6 0.0 0.1 2.5 7.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 9.0 0.0 5.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.1 22.3 0.6 12.7 29.4 2.7 3.0 14.2 4.7 0.2 50.6 0.3 0.0 0.0 0.0 7.3 0.4 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.6 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.1 ST6GALNAC6 "SIAT7F, ST6GALNACVI" ENSG00000160408 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6" Q969X2 9 127885321-127905408 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 94.1;Mucus-secreting cells: 109.4;Paneth cells: 153.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "NK-cells: 12.7;T-cells: 16.0" "Cell line enhanced" "Detected in many" "ASC diff: 52.7" HPA018890 Approved "Intracellular and membrane" NA NA "HPA018890: AB_1857531" "unprognostic (2.27e-1)" "unprognostic (5.23e-2)" "unprognostic (2.81e-1)" "unprognostic (4.54e-2)" "unprognostic (1.81e-2)" "unprognostic (5.71e-2)" "unprognostic (1.36e-1)" "unprognostic (4.84e-2)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.24e-3)" "unprognostic (3.31e-2)" "unprognostic (3.29e-1)" "unprognostic (1.10e-2)" "unprognostic (9.85e-2)" "unprognostic (3.46e-2)" "unprognostic (2.67e-2)" 39.3 12.9 45.1 9.7 40.8 7.7 59.6 23.4 37.4 17.2 44.5 8.7 18.6 5.5 14.8 27.3 21.0 31.1 17.8 22.8 38.2 17.0 13.2 18.1 23.5 13.7 18.3 28.3 39.4 19.1 12.7 7.8 10.8 13.6 12.8 72.9 9.6 14.5 22.0 18.9 9.8 9.8 21.9 9.6 18.7 12.1 6.9 15.9 2.3 9.6 9.1 11.2 16.7 29.2 3.3 1.1 2.7 2.8 12.7 16.0 6.5 3.6 3.3 6.5 11.7 52.7 28.5 2.5 9.3 21.4 13.6 11.2 5.5 3.1 3.7 4.1 21.2 9.4 6.2 8.4 6.9 6.3 17.7 4.7 3.9 5.4 5.6 13.8 1.1 6.4 28.9 8.5 9.9 4.4 19.2 13.5 3.7 3.6 4.6 17.5 3.1 2.3 6.1 2.8 3.5 5.9 7.3 8.1 4.5 10.9 0.7 4.1 6.1 6.4 2.6 2.4 4.7 3.1 7.8 8.1 8.1 4.9 8.9 5.1 5.6 3.4 6.9 7.6 1.3 2.8 2.7 0.7 0.1 16.0 1.1 11.7 3.3 10.3 11.5 1.0 2.6 6.5 8.4 0.4 12.7 2.8 1.1 15.3 6.5 45.1 40.8 23.4 37.4 38.2 17.0 18.3 28.3 13.6 15.9 3.0 7.0 15.2 14.5 20.6 18.2 7.0 7.6 4.0 2.3 0.0 5.9 3.2 0.0 0.4 1.7 22.5 94.1 23.3 0.3 6.5 34.0 11.5 6.9 24.2 10.8 23.8 37.0 35.0 6.9 4.7 61.5 5.8 23.6 2.8 109.4 31.6 0.4 153.1 57.3 0.0 6.4 84.1 72.1 1.0 4.3 23.5 3.0 29.8 56.2 15.7 ST7 "ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7" ENSG00000004866 "Suppression of tumorigenicity 7" Q9NRC1 7 116953238-117230103 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 107.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 52.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038325, HPA038326" Approved Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA038325: AB_10671740, HPA038326: AB_10672644" "unprognostic (3.40e-2)" "unprognostic (1.04e-1)" "unprognostic (1.33e-1)" "unprognostic (4.70e-2)" "unprognostic (1.09e-1)" "unprognostic (8.18e-2)" "unprognostic (3.32e-2)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (4.45e-3)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "prognostic favorable (3.39e-5)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (8.41e-2)" "unprognostic (3.40e-2)" 11.1 20.0 12.9 5.0 18.0 12.0 12.3 63.0 25.7 16.7 10.7 9.2 21.6 9.8 12.3 31.2 8.5 15.8 10.0 19.8 10.9 12.3 23.1 31.5 20.0 5.4 11.1 18.7 15.9 30.8 17.6 30.1 21.8 14.9 11.7 10.1 11.0 24.9 19.3 10.1 9.7 9.7 11.3 8.1 9.1 13.5 15.9 8.2 2.9 23.8 7.6 7.0 10.0 9.8 2.6 6.2 1.6 3.3 7.6 10.6 3.2 13.1 7.6 12.4 10.8 14.4 9.9 5.7 10.4 13.2 10.7 16.0 10.2 15.6 3.4 11.4 9.1 16.3 10.8 10.6 11.1 14.6 4.6 15.3 10.3 12.7 9.0 10.0 11.6 17.7 7.6 11.3 13.9 9.7 10.5 11.2 2.3 15.2 24.8 10.1 7.6 0.1 8.9 12.0 17.0 9.1 2.9 8.4 14.5 11.5 7.0 18.6 15.2 11.8 52.1 13.8 10.0 4.5 9.6 8.5 12.6 5.0 13.6 10.2 15.7 11.9 13.0 10.2 10.4 12.6 1.6 3.3 0.4 8.3 1.2 5.9 2.6 5.1 7.3 6.2 0.9 3.5 3.6 0.1 7.6 1.2 6.2 10.6 3.2 12.9 18.0 63.0 25.7 10.9 12.3 11.1 18.7 14.9 8.2 20.8 30.2 7.2 7.2 6.6 10.2 10.1 12.7 4.0 12.5 5.2 0.0 17.1 5.0 5.8 107.8 6.7 2.6 0.0 11.6 18.9 8.8 8.0 18.5 22.6 7.9 3.2 3.5 6.2 13.0 35.2 10.3 5.8 6.8 9.0 5.9 11.8 8.4 3.4 5.6 14.6 0.6 0.0 6.1 14.0 5.6 4.8 17.7 3.1 3.9 7.8 ST7L "FAM4B, FLJ20284, ST7R, STLR" ENSG00000007341 "Suppression of tumorigenicity 7 like" Q8TDW4 1 112523518-112620825 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.0" "Group enriched" "Detected in many" 5 "Early spermatids: 151.6;Late spermatids: 193.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042324, HPA075418" Uncertain Approved Centrosome NA NA Centrosome "HPA042324: AB_10794273, HPA075418: AB_2686749" "unprognostic (2.99e-2)" "unprognostic (1.07e-2)" "prognostic favorable (8.34e-5)" "prognostic unfavorable (8.96e-4)" "unprognostic (3.30e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-6)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.16e-4)" "prognostic favorable (3.04e-5)" "unprognostic (2.98e-2)" "unprognostic (6.91e-2)" "unprognostic (5.72e-2)" "unprognostic (4.12e-3)" "unprognostic (3.68e-2)" "unprognostic (3.26e-2)" "unprognostic (3.27e-2)" 7.7 9.3 5.7 5.5 9.0 8.6 8.2 12.1 7.9 8.1 6.9 10.0 7.2 5.5 10.0 7.8 6.1 7.9 6.0 8.6 5.6 5.9 6.3 7.6 5.7 5.3 6.1 5.1 9.4 11.6 5.2 12.8 6.4 6.3 7.3 8.0 9.4 7.0 9.0 10.2 8.9 6.2 7.9 6.4 5.2 5.8 49.0 7.0 4.6 11.8 4.6 5.6 6.8 7.7 4.2 3.5 0.3 2.1 6.9 5.2 1.9 4.8 1.5 8.7 6.1 11.9 11.8 2.1 6.3 4.8 2.7 4.0 2.8 4.8 2.1 2.6 2.5 8.1 3.4 10.2 8.1 4.1 3.1 6.0 5.9 7.6 1.8 6.8 5.0 6.4 2.2 2.0 3.1 6.4 6.4 8.7 7.4 3.4 6.9 11.0 1.9 2.6 2.0 3.9 2.3 5.3 4.2 4.6 0.8 5.5 6.0 6.4 3.9 3.4 4.7 4.4 1.6 3.6 3.0 8.3 6.2 6.1 8.0 6.0 1.8 1.3 2.1 5.6 8.0 13.5 0.1 1.8 0.2 2.4 2.1 3.9 4.2 3.6 1.8 1.7 1.8 5.2 2.8 0.3 6.9 1.6 3.5 2.4 1.9 5.7 9.0 12.1 7.9 5.6 5.9 6.1 5.1 6.3 7.0 20.8 8.1 4.5 14.2 15.0 16.4 6.1 20.4 12.0 13.6 8.7 5.9 11.0 8.3 7.6 151.6 11.9 5.1 0.0 7.4 5.7 9.2 11.9 8.1 6.8 7.5 23.8 5.2 4.9 7.8 193.4 16.7 7.5 20.3 4.6 9.5 19.1 6.4 3.5 15.2 5.7 22.0 19.4 7.6 33.6 11.3 15.9 5.1 8.7 9.7 9.3 ST8SIA1 "SIAT8, SIAT8A" ENSG00000111728 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1" Q92185 12 22063773-22437041 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.2" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 43.2;granulocytes: 32.4;Muller glia cells: 41.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;T-cells: 3.0" "Cell line enhanced" "Detected in some" "AF22: 9.1;ASC TERT1: 6.0;hTERT-RPE1: 4.2;RPTEC TERT1: 4.6;SK-MEL-30: 8.3;WM-115: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026775 Approved NA NA "HPA026775: AB_1857534" "unprognostic (1.98e-1)" "unprognostic (5.76e-3)" "unprognostic (1.79e-1)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-3)" "unprognostic (1.76e-2)" "unprognostic (1.07e-2)" "unprognostic (3.07e-1)" "unprognostic (1.99e-1)" "unprognostic (6.37e-3)" "unprognostic (2.80e-2)" "unprognostic (1.07e-8)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (5.28e-2)" "unprognostic (3.16e-2)" 1.7 7.6 7.0 5.3 6.2 2.3 5.9 20.2 13.0 3.5 5.4 2.3 2.3 0.4 4.5 1.4 3.0 2.3 2.4 4.4 7.6 8.5 1.1 0.6 3.8 8.6 7.6 6.5 2.6 1.2 7.2 0.6 0.4 9.4 6.6 3.5 1.5 3.2 4.4 1.0 4.3 2.1 6.3 10.9 2.7 2.1 1.0 4.8 0.2 1.4 0.5 9.2 6.7 3.1 0.3 0.2 1.2 0.2 0.3 3.0 0.6 0.1 0.5 9.1 0.0 1.4 6.0 0.9 0.0 0.0 0.1 0.4 0.3 0.1 1.1 0.0 0.0 0.2 0.4 0.0 0.2 0.6 0.0 0.0 1.1 0.1 0.1 0.0 0.3 0.1 0.5 0.9 0.1 0.9 4.2 0.2 0.1 0.0 0.6 0.2 0.0 1.2 0.3 2.3 3.5 0.0 0.0 0.2 0.2 4.6 0.0 0.1 0.2 0.0 0.1 8.3 0.3 0.7 0.1 0.0 0.7 0.9 0.1 1.4 0.7 0.5 0.7 1.4 0.1 9.0 1.2 0.2 0.2 0.4 0.1 0.9 0.1 2.9 2.3 0.1 0.3 0.4 1.0 0.9 0.3 0.2 0.2 3.0 0.6 7.0 6.2 20.2 13.0 7.6 8.5 7.6 6.5 9.4 4.8 0.0 2.6 0.0 0.4 3.9 7.5 3.1 0.0 8.1 2.3 0.0 43.2 3.0 1.7 0.0 5.3 0.7 0.0 0.0 0.0 10.1 3.0 3.7 32.4 0.0 0.7 4.8 0.0 0.0 0.0 3.0 0.3 0.0 11.8 0.0 0.0 41.7 0.0 0.0 0.0 0.2 2.8 0.0 1.2 3.9 5.5 2.0 3.1 4.3 0.0 0.1 ST8SIA2 "HsT19690, SIAT8B, ST8SIA-II, STX" ENSG00000140557 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2" Q92186 15 92393828-92468728 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 17.7;heart muscle: 10.0" "Group enriched" "Detected in some" 12 "Cardiomyocytes: 4.5;Muller glia cells: 2.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "pons and medulla: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 22.2;LHCN-M2: 6.5;RH-30: 10.1;RPMI-8226: 7.3;SH-SY5Y: 4.3;WM-115: 6.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054518, HPA057819" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA054518: AB_2682514, HPA057819: " "unprognostic (4.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.26e-1)" "unprognostic (9.32e-3)" "unprognostic (1.03e-1)" "unprognostic (2.87e-2)" "unprognostic (2.32e-1)" "unprognostic (1.28e-5)" "unprognostic (3.91e-2)" "unprognostic (5.39e-3)" "unprognostic (1.59e-2)" "unprognostic (4.44e-3)" "unprognostic (4.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-1)" "unprognostic (3.00e-1)" 0.3 1.1 1.3 0.2 2.2 0.1 1.2 1.5 3.7 2.6 0.3 0.0 0.0 0.1 1.3 2.5 0.4 0.1 0.7 10.0 3.0 3.6 0.3 0.1 0.1 0.2 2.2 1.4 0.1 0.1 0.1 0.9 0.1 17.7 0.3 0.2 1.0 0.8 0.5 2.1 0.1 0.4 0.2 0.2 0.1 0.2 0.8 0.1 2.5 0.2 1.5 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.2 0.0 3.5 0.0 0.0 0.0 10.1 7.3 0.0 0.0 0.5 4.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.7 0.3 0.0 0.2 0.8 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.2 1.5 2.6 3.0 3.6 2.2 1.4 17.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ST8SIA3 SIAT8C ENSG00000177511 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3" O43173 18 57350813-57371731 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 24.0" "Group enriched" "Detected in some" 9 "Bipolar cells: 30.1;Horizontal cells: 60.4" "Group enriched" "Detected in some" 11 "glioma: 0.9;pancreatic cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "NTERA-2: 6.0;SCLC-21H: 10.3;SH-SY5Y: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063398, HPA066783" Enhanced Supported "Golgi apparatus" No NA "Golgi apparatus" "HPA063398: AB_2685004, HPA066783: AB_2685721" "unprognostic (1.75e-1)" "unprognostic (7.85e-2)" "unprognostic (1.41e-2)" "unprognostic (5.50e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.82e-1)" 0.1 4.5 3.4 0.1 12.0 0.0 0.0 7.9 24.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 1.1 0.0 3.8 4.8 0.1 0.2 0.1 0.0 1.2 0.0 4.2 0.0 3.5 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 11.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 1.6 5.1 0.0 0.0 0.0 2.0 0.0 0.0 0.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 ST8SIA5 SIAT8E ENSG00000101638 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5" O15466 18 46667821-46759257 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 12.8;brain: 36.4" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 6.9;Collecting duct cells: 1.8;Early spermatids: 2.7;Late spermatids: 5.2" "Cancer enriched" "Detected in single" 8 "glioma: 2.6" "Region enhanced" "Detected in many" "cerebellum: 36.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "WM-115: 52.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043813, HPA046771" Approved Approved "Plasma membrane,Midbody" NA NA "Plasma membrane, Midbody" "HPA043813: AB_2678683, HPA046771: AB_2679798" "unprognostic (3.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-4)" "unprognostic (2.99e-2)" "unprognostic (4.83e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (1.36e-1)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.55e-2)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" 0.6 12.8 3.6 0.6 7.8 0.9 0.5 36.4 16.1 0.5 0.5 1.0 0.0 0.7 0.5 0.9 0.4 0.7 0.6 7.2 4.0 1.8 1.5 0.4 0.5 0.5 2.0 6.9 0.7 0.4 4.9 0.7 0.4 4.1 0.6 0.5 0.0 0.4 0.5 8.2 0.7 0.5 0.5 2.5 0.5 0.7 0.9 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.8 0.4 1.5 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.1 0.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 52.9 1.0 0.4 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.0 0.8 0.3 0.3 1.5 0.5 0.2 0.4 0.1 0.0 3.6 7.8 36.4 16.1 4.0 1.8 2.0 6.9 4.1 0.7 0.0 0.0 0.0 0.0 0.0 1.0 6.9 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.4 0.0 0.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 ST8SIA6 SIAT8F ENSG00000148488 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6" P61647 10 17318383-17454330 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 17.5" "Group enriched" "Detected in some" 7 "Endothelial cells: 8.7;granulocytes: 10.3;Ito cells: 15.4;Melanocytes: 8.5" "Cancer enhanced" "Detected in some" "breast cancer: 5.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "HMC-1: 108.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011635, HPA072708" Uncertain Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA011635: AB_2194921, HPA072708: " "unprognostic (4.86e-3)" "unprognostic (7.01e-2)" "unprognostic (5.85e-3)" "unprognostic (2.21e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" "unprognostic (1.11e-2)" "unprognostic (6.81e-2)" "unprognostic (2.32e-1)" "unprognostic (3.23e-2)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (2.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.43e-1)" "unprognostic (2.22e-1)" "unprognostic (1.07e-3)" 1.8 0.9 3.1 1.0 5.0 4.0 14.4 2.5 3.4 1.1 1.7 3.3 0.4 1.0 1.6 10.4 2.4 1.3 1.9 9.1 3.7 4.4 2.5 2.4 17.5 0.8 8.8 1.7 1.1 0.5 0.3 1.3 3.5 5.5 4.3 1.8 13.7 1.9 0.6 2.0 2.8 1.3 1.3 4.3 1.5 1.0 1.2 2.5 0.0 1.8 0.5 2.0 1.1 3.9 0.9 0.7 3.8 1.4 2.1 5.6 0.9 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 13.3 0.0 0.1 0.0 0.0 108.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 2.5 0.1 0.9 1.3 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.4 1.3 2.5 0.4 0.5 0.3 1.2 1.4 0.7 0.9 1.0 1.7 2.9 2.1 0.7 0.6 5.6 0.9 3.1 5.0 2.5 3.4 3.7 4.4 8.8 1.7 5.5 2.5 0.0 0.0 0.0 0.1 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.7 0.0 0.0 0.0 0.0 0.2 1.6 10.3 0.0 0.1 0.0 0.0 15.4 0.8 0.4 0.0 0.0 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 1.0 0.0 0.0 STAB1 "CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1" ENSG00000010327 "Stabilin 1" Q9NY15 3 52495338-52524495 "Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 90.8" "Cell type enriched" "Detected in many" 5 "Ito cells: 1114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 68 "classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8" "Group enriched" "Detected in many" 69 "dendritic cells: 2.8;monocytes: 10.8" "Group enriched" "Detected in some" 47 "HUVEC TERT2: 33.9;NB-4: 46.8;TIME: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005434 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 60000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA005434: AB_1080097" "unprognostic (1.18e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (3.63e-2)" "unprognostic (1.21e-1)" "unprognostic (1.49e-2)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.38e-1)" "unprognostic (4.00e-3)" "unprognostic (2.66e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (3.88e-7)" "unprognostic (3.16e-2)" "unprognostic (9.40e-2)" "unprognostic (4.70e-2)" "unprognostic (1.08e-1)" 39.5 37.6 8.0 26.7 12.8 6.5 41.3 3.2 6.8 13.1 23.4 6.9 4.2 16.1 13.6 26.4 9.7 15.5 16.8 19.7 5.4 4.2 19.2 35.8 21.7 80.7 9.1 2.7 9.9 7.1 4.9 11.9 32.1 10.2 13.5 18.0 23.7 10.4 9.7 8.0 5.1 18.7 18.3 7.2 90.8 11.6 9.7 8.7 2.6 11.9 11.4 11.1 15.9 15.4 0.0 2.8 0.0 10.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 33.9 0.0 0.1 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 6.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 8.0 12.8 3.2 6.8 5.4 4.2 9.1 2.7 10.2 8.7 0.0 6.7 12.3 0.5 5.4 1.0 2.0 12.7 0.0 0.0 3.5 0.0 1.3 0.0 0.0 0.4 14.5 0.0 46.7 0.0 1.5 3.8 0.0 17.4 8.3 103.3 0.0 1.2 1114.7 238.9 1.9 4.0 46.3 11.8 0.0 0.0 0.5 0.0 0.0 19.1 0.3 0.0 19.4 1.5 0.7 1.1 4.3 1.8 4.3 0.0 0.2 STAB2 "DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2" ENSG00000136011 "Stabilin 2" Q8WWQ8 12 103587273-103766727 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 71.3" "Cell type enriched" "Detected in some" 10 "Ito cells: 196.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 16.1;HaCaT: 4.4;RH-30: 2.5" "Not detected" "Not detected" "HPA026871, HPA072699" Enhanced Supported Cytosol NA NA 210000 Cytosol "HPA026871: AB_1857536, HPA072699: " "unprognostic (5.66e-3)" "unprognostic (7.51e-2)" "unprognostic (3.31e-1)" "unprognostic (3.84e-2)" "unprognostic (8.47e-2)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (2.81e-1)" "unprognostic (5.72e-2)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.05e-1)" "unprognostic (9.72e-4)" "unprognostic (1.37e-2)" "unprognostic (5.00e-1)" "unprognostic (1.26e-1)" "unprognostic (2.06e-1)" 0.6 0.2 0.1 0.5 0.1 0.4 0.5 0.1 0.1 0.7 1.4 0.1 0.1 0.1 1.1 1.1 2.5 0.9 0.6 0.4 0.1 0.1 0.1 11.7 0.5 19.9 0.1 0.1 0.4 0.2 0.0 0.2 0.4 0.2 0.5 0.2 0.1 2.1 0.3 0.1 0.2 0.3 0.2 0.1 71.3 0.3 1.5 0.1 0.2 0.7 0.5 0.4 0.3 0.4 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.8 0.2 0.0 0.0 16.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 4.4 0.0 0.0 0.0 0.0 1.1 0.4 0.7 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.1 0.7 0.4 0.5 0.1 2.5 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.1 0.9 0.3 0.1 0.6 0.8 0.4 0.0 1.1 0.2 0.2 0.0 0.3 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.1 0.0 0.0 196.4 19.9 9.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 STARD3 "es64, MLN64" ENSG00000131748 "StAR related lipid transfer domain containing 3" Q14849 17 39637065-39663484 "Cancer-related genes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "SK-BR-3: 89.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017021, HPA024307, HPA073948" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB017021: , HPA024307: , HPA073948: " "unprognostic (1.11e-1)" "unprognostic (2.14e-2)" "unprognostic (6.35e-2)" "unprognostic (8.92e-3)" "unprognostic (2.09e-2)" "unprognostic (2.94e-1)" "prognostic unfavorable (3.60e-5)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (6.25e-3)" "unprognostic (5.88e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (1.33e-1)" "unprognostic (5.22e-2)" "unprognostic (8.51e-3)" "unprognostic (3.00e-2)" 22.2 34.8 23.3 27.5 28.0 33.5 22.8 27.7 30.1 17.1 23.7 38.1 21.7 26.6 20.6 20.7 22.4 25.6 27.7 17.8 21.0 16.8 18.2 24.0 27.0 31.5 28.5 25.7 21.5 32.7 21.9 23.7 26.9 25.7 19.0 9.7 17.9 21.4 26.7 20.8 24.5 34.2 15.8 27.8 32.3 25.3 26.7 26.1 33.0 21.1 15.1 24.8 28.8 18.7 15.3 23.2 35.3 21.2 21.4 25.3 17.4 7.9 12.6 5.7 10.1 6.9 8.4 8.5 6.5 8.5 8.5 7.8 7.4 13.1 7.1 14.2 5.9 10.5 15.2 3.4 7.7 1.9 9.6 12.9 4.8 5.5 8.6 9.7 9.7 10.8 9.1 6.3 9.6 4.6 6.5 8.2 9.9 11.1 9.2 7.8 7.0 9.1 9.2 6.3 5.4 6.9 7.2 9.8 10.5 5.8 9.0 7.2 7.7 4.9 89.9 16.1 4.0 10.6 11.6 7.7 12.0 8.3 13.1 12.2 8.8 10.8 5.7 10.7 10.5 12.3 12.5 21.2 29.3 25.3 19.6 18.5 11.9 18.3 19.0 23.2 15.3 18.4 16.9 35.3 21.4 15.6 10.8 20.4 17.4 23.3 28.0 27.7 30.1 21.0 16.8 28.5 25.7 25.7 26.1 3.0 9.8 21.7 11.2 14.7 13.5 3.0 20.4 5.3 3.4 10.4 35.3 24.1 8.3 20.7 2.3 23.3 21.4 0.0 30.9 31.1 16.0 17.5 18.5 10.6 45.2 17.5 26.4 42.4 36.6 4.1 15.8 20.8 5.0 17.2 11.7 17.0 30.5 15.8 12.4 8.7 13.2 12.9 9.5 8.4 13.9 14.8 33.4 34.8 12.4 16.9 STARD3NL "MENTHO, MGC3251" ENSG00000010270 "STARD3 N-terminal like" O95772 7 38178222-38230671 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019204 Enhanced Supported Vesicles NA NA Vesicles "HPA019204: AB_2197800" "unprognostic (1.55e-3)" "unprognostic (2.80e-3)" "unprognostic (2.22e-1)" "unprognostic (2.58e-1)" "unprognostic (4.37e-2)" "prognostic unfavorable (2.20e-4)" "prognostic unfavorable (1.44e-5)" "unprognostic (9.64e-2)" "unprognostic (1.89e-1)" "unprognostic (5.37e-2)" "prognostic favorable (8.48e-4)" "unprognostic (1.07e-1)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" "unprognostic (8.09e-3)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 18.3 15.6 28.9 15.3 26.5 23.4 20.3 16.1 37.7 23.2 14.6 22.5 11.8 12.7 23.3 19.8 9.6 19.4 15.5 18.2 27.9 36.7 23.8 11.8 22.4 15.8 34.6 19.4 17.8 11.1 9.5 19.7 33.7 29.8 29.3 16.7 16.4 10.0 16.1 10.6 4.5 13.7 22.9 33.1 17.6 11.8 21.7 15.3 13.4 23.2 5.9 10.2 17.3 16.0 14.4 21.0 27.0 23.4 34.2 27.8 20.8 11.5 12.4 27.5 17.8 19.0 19.0 9.6 19.0 19.7 18.8 24.8 9.8 18.4 9.1 19.2 17.3 57.6 12.6 15.1 14.4 28.6 8.2 13.1 18.5 6.9 13.4 16.8 20.3 21.7 17.8 7.1 19.9 15.9 21.6 34.1 25.2 21.0 16.0 28.8 7.1 11.4 32.7 19.4 9.7 9.9 14.1 25.6 4.2 26.3 10.9 11.1 25.9 6.5 17.3 17.9 39.7 12.1 26.9 23.2 12.9 18.5 20.1 26.7 17.1 17.2 3.4 26.2 36.2 41.9 14.4 23.4 27.0 27.8 20.0 12.7 14.4 11.7 20.5 21.0 14.1 9.9 19.4 26.3 34.2 21.5 14.9 11.6 20.8 28.9 26.5 16.1 37.7 27.9 36.7 34.6 19.4 29.8 15.3 17.9 38.9 35.0 46.4 18.4 8.0 15.9 12.7 17.4 15.9 29.6 11.8 43.7 26.6 28.6 97.7 36.8 10.2 0.0 30.1 76.6 25.5 61.8 23.1 10.5 57.9 4.8 20.6 48.5 50.4 71.1 17.0 44.7 25.3 13.6 20.3 25.1 30.1 22.9 24.4 41.1 11.2 12.9 41.8 40.2 33.6 14.2 35.4 46.8 21.1 42.2 STBD1 "FLJ41801, GENX-3414" ENSG00000118804 "Starch binding domain 1" O95210 4 76306026-76311599 "Plasma proteins, Predicted intracellular proteins, Transporters" "Autophagy, Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 16.1;liver: 14.3;skeletal muscle: 34.5" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 12.0;Ductal cells: 5.3;Enterocytes: 4.9;Exocrine glandular cells: 3.5;Pancreatic endocrine cells: 3.5;Paneth cells: 3.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 15.0;Karpas-707: 31.5;U-266/70: 20.4" "Low region specificity" "Detected in many" "HPA011952, HPA012849" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA011952: AB_1847461, HPA012849: AB_1847460" "unprognostic (1.46e-1)" "unprognostic (1.02e-3)" "unprognostic (4.29e-2)" "unprognostic (1.95e-1)" "unprognostic (2.57e-1)" "unprognostic (4.72e-2)" "unprognostic (1.35e-2)" "unprognostic (6.84e-2)" "unprognostic (3.06e-1)" "unprognostic (1.03e-1)" "unprognostic (4.96e-3)" "unprognostic (4.42e-2)" "unprognostic (3.52e-2)" "unprognostic (2.93e-1)" "unprognostic (2.00e-1)" "unprognostic (2.84e-1)" "unprognostic (5.74e-2)" 16.1 1.2 0.1 0.7 0.0 1.9 3.7 0.0 0.5 1.2 2.7 1.2 2.3 0.0 1.6 1.2 1.0 7.1 0.0 0.5 0.7 14.3 2.6 0.0 0.3 1.3 1.9 0.4 0.2 1.2 2.1 1.6 1.2 1.1 34.5 0.0 3.9 2.4 0.6 0.0 2.3 0.5 0.1 0.0 3.4 1.4 0.2 3.2 5.9 3.6 3.7 3.6 1.4 3.8 1.8 0.2 2.4 5.3 1.4 3.3 4.2 2.5 1.6 1.9 1.8 4.5 0.0 3.4 2.7 3.7 2.4 0.7 0.9 0.6 15.0 1.0 0.2 2.3 2.2 0.7 2.1 2.8 0.8 2.7 1.3 0.7 4.1 0.0 0.0 0.1 31.5 2.8 2.5 0.2 1.8 0.4 2.7 2.0 0.0 0.9 2.6 0.9 1.9 0.8 4.4 3.3 4.2 0.0 0.4 1.1 0.7 0.7 3.2 2.0 7.5 2.3 20.4 3.7 0.0 4.4 1.4 1.0 0.3 3.6 5.9 2.7 3.3 1.7 0.2 3.6 3.4 3.2 0.0 0.6 1.1 0.7 3.7 1.6 0.2 0.6 1.4 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 4.9 0.0 3.5 1.1 0.3 0.4 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.0 0.0 3.5 3.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 1.5 0.6 STEAP1 "PRSS24, STEAP" ENSG00000164647 "STEAP family member 1" Q9UHE8 7 90154375-90164829 "Cancer-related genes, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 44.7" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 43.1;Exocrine glandular cells: 33.5;Glandular cells: 64.3;Urothelial cells: 39.0" "Cancer enriched" "Detected in all" 6 "prostate cancer: 94.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 29.6;CAPAN-2: 35.5;U-138 MG: 45.1" HPA030985 Uncertain NA NA "HPA030985: AB_2673686" "unprognostic (2.88e-3)" "unprognostic (2.29e-1)" "unprognostic (1.19e-1)" "unprognostic (3.21e-3)" "unprognostic (9.20e-3)" "unprognostic (2.03e-1)" "unprognostic (1.33e-2)" "unprognostic (6.74e-3)" "unprognostic (6.36e-2)" "unprognostic (6.45e-3)" "unprognostic (8.31e-3)" "unprognostic (3.79e-1)" "unprognostic (2.60e-2)" "unprognostic (4.39e-2)" "unprognostic (2.42e-1)" "unprognostic (6.09e-2)" "unprognostic (1.38e-1)" 19.8 1.5 2.9 16.5 1.4 0.0 26.0 0.9 6.3 5.5 10.0 0.1 0.7 2.7 3.0 4.4 10.0 7.3 8.4 7.1 1.4 0.5 5.3 21.2 9.3 2.9 0.5 2.7 12.4 6.5 0.2 5.8 0.5 1.4 44.7 7.3 1.2 9.8 5.3 3.9 3.3 7.4 13.7 1.4 2.8 7.4 2.1 0.7 0.0 4.6 6.5 3.7 12.5 16.1 0.8 1.7 0.0 0.0 0.0 0.0 0.2 6.8 13.9 0.8 2.5 29.6 24.6 0.2 4.7 5.8 0.6 0.8 10.3 35.5 0.0 0.2 7.7 12.6 1.4 6.0 6.6 1.3 0.0 2.2 0.0 0.1 3.4 1.1 0.0 0.0 17.3 1.0 19.6 10.4 4.6 25.4 2.1 0.3 19.8 8.1 0.1 0.0 0.1 4.2 0.3 6.7 0.0 0.0 0.0 5.6 1.4 0.0 0.3 1.8 0.0 3.1 0.5 7.8 0.1 13.0 45.1 2.3 22.7 5.7 3.7 0.1 0.0 22.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 1.4 0.9 6.3 1.4 0.5 0.5 2.7 1.4 0.7 0.0 0.3 0.0 43.1 3.8 0.0 0.8 0.0 6.7 2.3 1.8 0.0 0.0 0.0 2.1 0.3 2.2 3.5 0.0 33.5 0.1 15.0 64.3 0.0 30.1 0.5 0.0 6.9 1.8 1.0 1.0 0.9 1.8 6.8 0.0 4.1 9.4 29.2 10.5 1.4 13.9 0.2 6.5 5.6 12.6 30.9 1.9 0.2 0.0 13.5 39.0 STEAP1B ENSG00000105889 "STEAP family member 1B" Q6NZ63 7 22419444-22632925 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.6" "Cell type enhanced" "Detected in some" 16 "Horizontal cells: 11.1;monocytes: 20.8;Spermatocytes: 7.2;Spermatogonia: 13.0" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 88 "memory B-cell: 9.9;naive B-cell: 8.6" "Lineage enriched" "Detected in single" 94 "B-cells: 9.9" "Group enriched" "Detected in many" 4 "hTEC/SVTERT24-B: 29.7;HUVEC TERT2: 33.4;K-562: 19.4;WM-115: 36.7" NA NA "unprognostic (7.35e-2)" "unprognostic (2.42e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-3)" "unprognostic (3.96e-2)" "unprognostic (2.18e-1)" "unprognostic (2.31e-5)" "unprognostic (2.29e-3)" "unprognostic (4.96e-2)" "unprognostic (7.37e-3)" "unprognostic (7.38e-2)" "unprognostic (1.27e-2)" "unprognostic (2.85e-10)" "unprognostic (1.06e-4)" "unprognostic (3.46e-2)" "unprognostic (1.35e-1)" "unprognostic (2.21e-3)" 3.5 1.8 5.3 3.9 14.5 0.6 1.8 0.6 9.3 2.3 1.6 13.5 0.8 0.5 0.7 1.4 1.7 1.0 2.2 1.4 5.2 2.9 0.4 0.7 1.4 5.9 14.9 2.7 0.5 1.1 0.8 1.0 3.6 9.0 1.5 1.5 1.0 1.4 2.1 3.2 1.1 1.0 1.9 8.6 6.4 1.1 7.5 15.6 0.6 0.8 0.3 5.5 2.1 3.6 9.9 0.0 0.0 0.0 0.0 0.1 0.4 4.1 0.0 2.9 0.0 1.8 1.9 0.0 2.9 0.4 0.0 0.1 0.0 0.1 0.4 0.9 5.7 1.0 0.0 4.2 0.0 0.2 0.3 0.4 0.0 0.1 0.0 0.2 0.0 0.0 3.5 0.0 29.7 0.0 3.5 33.4 0.1 19.4 1.6 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 2.4 0.4 0.0 0.0 3.4 0.4 0.1 4.5 0.0 0.4 3.8 3.9 7.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.1 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.3 14.5 0.6 9.3 5.2 2.9 14.9 2.7 9.0 15.6 0.0 0.0 4.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 11.1 0.0 0.6 0.3 1.3 0.0 0.1 3.3 20.8 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 7.2 13.0 0.1 0.1 0.0 0.0 0.1 STEAP2 "IPCA-1, PCANAP1, STAMP1, STMP" ENSG00000157214 "STEAP2 metalloreductase" Q8NFT2 7 90167590-90238137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "prostate: 100.2" "Cell type enriched" "Detected in many" 4 "Glandular cells: 110.4" "Cancer enriched" "Detected in many" 12 "prostate cancer: 88.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 13.4;CAPAN-2: 28.9;U-138 MG: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029115, HPA055603" Uncertain Supported Vesicles NA NA Vesicles "HPA029115: AB_10603894, HPA055603: " "unprognostic (6.26e-3)" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-4)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (7.91e-2)" "unprognostic (1.70e-1)" "unprognostic (9.92e-2)" "unprognostic (1.34e-1)" "unprognostic (2.71e-2)" "unprognostic (9.73e-2)" "unprognostic (6.11e-2)" "unprognostic (9.86e-5)" "unprognostic (3.69e-2)" 10.7 4.1 6.2 9.7 14.5 1.3 13.6 8.7 18.2 7.0 8.3 2.3 2.2 5.7 5.4 3.6 9.1 7.5 8.8 9.4 5.1 5.2 6.5 3.6 10.8 1.6 3.2 11.1 19.5 6.4 10.3 17.6 1.4 6.0 100.2 7.0 3.8 6.8 6.7 2.3 3.5 5.9 9.0 2.9 3.0 9.2 2.3 1.6 1.6 5.8 1.2 2.5 10.4 19.9 1.1 0.4 1.3 0.4 0.3 0.2 0.0 1.8 13.4 0.3 3.8 7.2 7.0 0.2 1.6 3.5 0.2 0.5 2.5 28.9 0.0 0.2 4.4 5.4 1.1 2.9 2.1 0.5 0.0 2.9 0.0 0.0 0.7 0.6 0.0 0.0 5.1 0.4 7.0 1.4 5.8 3.6 0.0 0.0 0.2 4.0 0.0 0.0 0.4 5.5 0.0 1.5 0.0 0.0 0.1 6.3 3.9 0.3 1.3 2.1 0.0 0.1 0.6 10.2 0.0 3.0 16.8 3.8 2.3 1.4 0.0 0.0 0.0 7.3 0.0 0.7 1.3 0.4 0.5 0.2 0.2 0.1 1.1 0.1 0.1 0.0 0.4 0.2 0.2 1.2 0.3 0.2 0.4 0.0 0.0 6.2 14.5 8.7 18.2 5.1 5.2 3.2 11.1 6.0 1.6 0.0 0.6 0.0 20.8 4.2 5.1 11.6 17.8 16.0 13.6 12.2 2.0 0.0 0.0 0.6 0.4 1.8 11.8 0.0 6.6 0.0 17.5 110.4 0.0 4.9 0.0 1.6 15.1 2.5 0.0 0.4 14.4 1.7 0.0 0.0 12.5 26.2 8.6 25.8 14.5 8.6 1.2 0.0 6.2 1.0 3.4 4.6 0.0 0.0 12.7 19.6 STEAP3 "dudlin-2, STMP3, TSAP6" ENSG00000115107 "STEAP3 metalloreductase" Q658P3 2 119223831-119265652 "Disease related genes, Predicted membrane proteins" "Apoptosis, Cell cycle, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "liver: 82.3;parathyroid gland: 47.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 30.8;Exocrine glandular cells: 31.3;Hepatocytes: 86.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 4.0;intermediate monocyte: 4.3;myeloid DC: 7.0;NK-cell: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;monocytes: 4.3;NK-cells: 2.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.1;U-87 MG: 46.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050510 Approved Approved Nucleoli,Cytosol NA NA 28000 Cytosol Nucleoli "HPA050510: AB_2681151" "unprognostic (6.51e-2)" "unprognostic (6.48e-2)" "unprognostic (4.89e-2)" "unprognostic (3.45e-2)" "unprognostic (1.94e-3)" "unprognostic (9.07e-2)" "unprognostic (1.99e-2)" "unprognostic (3.04e-1)" "unprognostic (9.75e-2)" "unprognostic (1.58e-3)" "unprognostic (5.08e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.82e-1)" "unprognostic (4.45e-1)" "unprognostic (9.37e-2)" "unprognostic (6.82e-2)" 8.1 2.8 2.5 1.2 4.2 5.1 9.2 3.0 2.2 6.4 6.1 3.0 3.7 7.9 1.3 3.1 5.1 4.0 2.8 6.6 2.9 1.4 3.4 82.3 3.9 4.9 3.9 0.4 5.2 9.0 47.4 5.1 4.3 6.1 4.8 2.4 2.1 12.6 9.1 10.9 3.0 9.8 0.9 6.4 1.0 6.7 1.5 3.2 0.2 3.3 6.9 4.0 4.2 3.7 0.8 7.0 0.7 4.3 2.1 0.2 1.5 6.4 7.7 0.0 2.6 3.8 36.1 6.8 2.0 2.2 4.1 3.7 5.8 8.8 0.0 15.6 11.6 29.3 10.9 3.4 6.8 4.6 0.0 11.0 12.5 7.0 11.5 9.5 3.1 2.4 21.4 12.0 24.2 8.7 28.1 3.5 0.0 6.1 1.3 11.5 6.1 0.0 1.8 10.6 9.9 16.1 0.0 4.5 5.5 5.0 16.3 13.0 2.4 5.7 19.8 1.5 1.6 3.9 4.1 15.0 25.5 14.9 5.4 11.1 0.0 0.0 0.0 46.7 7.9 5.2 0.0 4.0 0.7 0.2 4.3 0.0 0.8 0.0 0.0 7.0 0.2 0.0 0.0 0.1 2.1 0.6 0.3 0.0 1.5 2.5 4.2 3.0 2.2 2.9 1.4 3.9 0.4 6.1 3.2 0.0 6.4 0.5 6.8 1.8 0.1 5.5 5.1 30.8 10.3 0.0 0.0 25.8 0.0 7.9 0.2 2.9 10.9 0.0 31.3 3.0 4.3 4.8 3.5 86.3 11.1 0.0 1.7 0.6 3.8 0.0 1.7 6.4 0.0 0.0 4.6 0.0 17.9 7.8 7.1 0.5 0.0 6.5 2.1 0.2 0.0 1.3 19.8 0.0 9.1 8.1 STEAP4 "FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9" ENSG00000127954 "STEAP4 metalloreductase" Q687X5 7 88270892-88306891 "Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 122.8" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 2: 320.5;Club cells: 178.6;Sertoli cells: 452.7" "Cancer enhanced" "Detected in many" "prostate cancer: 45.9" "Group enriched" "Detected in some" 5 "midbrain: 1.7;pons and medulla: 6.4" "Cell type enriched" "Detected in some" 13 "neutrophil: 48.9" "Lineage enriched" "Detected in many" 13 "granulocytes: 48.9" "Group enriched" "Detected in some" 6 "HSkMC: 39.3;SiHa: 36.9;U-2197: 52.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065201 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA065201: " "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (8.82e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.96e-2)" "prognostic favorable (2.97e-4)" "unprognostic (7.40e-2)" "unprognostic (3.12e-1)" "unprognostic (4.66e-2)" "unprognostic (4.21e-1)" "unprognostic (2.98e-1)" "unprognostic (7.51e-3)" "prognostic unfavorable (5.77e-4)" "unprognostic (1.72e-1)" "unprognostic (2.00e-1)" "unprognostic (4.53e-2)" 122.8 29.3 0.3 12.7 0.8 2.4 55.6 0.6 0.7 15.9 14.0 1.1 5.3 1.4 10.7 22.3 23.7 17.1 9.3 18.7 0.5 0.3 10.8 71.7 27.5 49.4 1.7 0.2 17.8 13.3 12.0 35.1 45.0 6.4 25.8 3.9 4.9 14.6 4.6 22.1 10.5 5.2 13.9 1.8 5.3 5.7 27.3 0.4 0.4 40.9 8.4 5.2 28.4 26.3 0.0 0.3 48.9 3.8 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 39.3 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 36.9 3.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 52.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 0.7 0.3 0.8 0.6 0.7 0.5 0.3 1.7 0.2 6.4 0.4 50.6 320.5 0.0 6.3 8.4 1.1 4.0 0.0 97.7 178.6 0.0 2.0 0.3 0.0 11.7 12.9 8.9 0.0 0.0 8.2 9.0 11.1 62.8 15.1 0.4 2.1 0.0 0.0 19.0 5.1 1.9 106.4 7.7 5.0 0.0 0.0 2.4 16.5 0.0 8.5 0.0 0.2 452.7 115.4 0.9 0.2 16.4 9.2 0.0 0.0 12.2 STIM1 "D11S4896E, GOK" ENSG00000167323 "Stromal interaction molecule 1" Q13586 11 3854527-4093210 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011088, HPA012123, CAB037128, CAB037288" Enhanced Enhanced "Endoplasmic reticulum" NA NA 4900000 "Endoplasmic reticulum" "CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882" "unprognostic (2.06e-1)" "unprognostic (9.75e-2)" "unprognostic (1.34e-1)" "unprognostic (3.85e-3)" "unprognostic (3.13e-2)" "unprognostic (4.12e-1)" "unprognostic (3.43e-1)" "unprognostic (1.59e-1)" "unprognostic (2.25e-1)" "unprognostic (7.41e-2)" "unprognostic (1.86e-1)" "unprognostic (2.88e-2)" "unprognostic (9.35e-2)" "unprognostic (1.40e-1)" "unprognostic (2.73e-1)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" 20.8 9.9 15.5 28.9 19.9 23.1 53.1 14.1 16.8 20.5 21.2 8.5 16.5 9.2 20.6 20.3 35.1 19.8 35.6 14.3 10.3 10.5 13.2 29.0 21.6 34.0 7.7 10.3 21.7 21.2 27.7 9.4 18.1 9.0 18.2 13.7 23.5 46.9 17.0 49.4 22.1 16.0 22.5 8.7 23.2 15.6 20.1 6.0 39.7 34.2 26.6 23.4 19.5 21.7 11.1 8.5 17.1 20.6 17.6 18.2 13.3 14.9 19.4 6.1 10.6 29.0 25.2 8.4 13.5 13.7 9.6 11.9 8.7 5.0 15.9 14.0 18.6 20.1 27.4 7.7 7.9 8.0 13.0 11.6 25.6 7.4 13.1 23.6 20.6 14.9 28.6 19.7 14.0 34.4 13.1 12.5 21.7 15.5 30.3 9.9 3.4 19.4 7.5 2.4 8.3 6.9 4.9 8.7 14.9 15.2 8.8 1.2 5.6 19.2 12.3 7.2 10.3 4.6 11.7 12.8 17.7 5.9 17.2 9.2 32.8 24.7 8.1 14.7 8.7 10.1 12.4 9.5 17.1 17.3 13.0 13.9 7.3 12.6 18.2 8.5 11.1 14.3 12.8 15.2 17.6 20.6 7.5 12.8 13.3 15.5 19.9 14.1 16.7 10.3 10.5 7.7 10.3 9.0 6.0 14.9 8.0 10.3 6.0 14.5 4.9 3.9 12.7 9.4 5.7 5.2 13.7 20.7 1.7 12.2 3.6 14.7 8.6 0.0 12.5 11.0 12.4 10.5 28.9 28.0 13.7 15.9 8.7 20.3 19.4 4.9 25.3 12.4 16.9 5.4 12.9 16.9 10.2 3.5 10.6 3.5 3.6 25.8 18.1 20.9 8.1 19.4 14.5 22.0 7.5 10.3 STIM2 ENSG00000109689 "Stromal interaction molecule 2" Q9P246 4 26857678-27025381 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 73.1;U-698: 34.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036933, CAB037196, HPA057511" Supported NA NA "CAB037196: AB_1841195, HPA036933: AB_2675391, HPA057511: AB_2683453" "unprognostic (7.09e-2)" "unprognostic (8.80e-3)" "unprognostic (1.60e-3)" "unprognostic (2.58e-2)" "unprognostic (2.83e-1)" "unprognostic (5.29e-3)" "prognostic unfavorable (3.97e-5)" "unprognostic (1.53e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "prognostic favorable (5.01e-4)" "unprognostic (6.81e-2)" "unprognostic (1.45e-2)" "unprognostic (2.60e-2)" "unprognostic (7.55e-2)" "unprognostic (3.17e-1)" "unprognostic (2.17e-3)" 13.5 11.0 15.2 23.3 19.9 15.1 16.0 12.0 16.8 12.3 11.9 12.6 10.2 18.0 13.4 20.3 7.6 12.7 22.3 9.6 14.9 8.8 16.9 12.2 17.9 25.1 12.5 13.1 20.7 14.3 10.2 17.3 9.4 18.8 14.7 14.4 25.2 14.8 7.1 8.2 16.0 19.7 9.8 10.2 24.0 14.8 8.7 12.6 19.2 14.6 6.5 23.5 15.9 10.3 7.9 7.3 11.0 7.5 2.7 6.8 1.8 4.5 6.0 5.6 9.0 5.2 3.7 5.8 8.5 3.1 5.9 5.8 4.4 12.6 18.6 4.7 3.5 6.1 4.2 4.1 11.1 5.8 4.4 7.1 5.4 9.1 3.9 4.1 9.9 4.7 4.3 5.0 6.8 3.2 6.0 5.8 6.5 4.7 3.7 11.0 4.9 7.7 9.7 6.1 8.3 8.2 73.1 10.7 4.2 4.1 9.9 11.3 3.9 6.8 4.8 2.5 3.9 2.5 7.2 6.3 7.9 4.2 5.2 6.8 8.9 8.4 34.1 7.9 9.7 11.1 11.0 2.5 1.7 6.0 2.0 3.8 6.0 6.5 5.0 1.7 7.9 6.8 5.9 4.0 2.7 7.5 7.3 3.3 1.8 15.2 19.9 12.0 16.8 14.9 8.8 12.5 13.1 18.8 12.6 11.9 24.0 31.8 12.6 14.5 33.9 8.1 28.1 100.4 19.4 31.4 76.6 9.6 11.6 8.4 8.0 32.1 14.4 0.0 17.7 7.3 8.6 10.8 35.8 9.6 6.8 28.6 43.9 33.7 17.0 5.0 14.1 22.7 8.5 7.2 25.9 22.7 10.0 10.1 6.7 3.3 56.8 19.4 7.8 15.6 24.2 13.6 4.1 34.6 11.5 10.5 STIMATE "MGC52022, TMEM110" ENSG00000213533 "STIM activating enhancer" Q86TL2 3 52836219-52897596 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 17.4;Collecting duct cells: 7.0;Hofbauer cells: 8.1;Proximal tubular cells: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA051855 Uncertain Approved Cytosol NA NA Cytosol "HPA051855: AB_2681639" "unprognostic (1.45e-1)" "unprognostic (7.93e-3)" "unprognostic (2.19e-1)" "unprognostic (2.49e-2)" "unprognostic (2.29e-3)" "unprognostic (3.87e-2)" "unprognostic (9.31e-2)" "unprognostic (7.55e-4)" "unprognostic (3.34e-1)" "unprognostic (6.55e-2)" "unprognostic (3.10e-1)" "unprognostic (4.04e-2)" "unprognostic (1.33e-2)" "unprognostic (1.00e-1)" "unprognostic (1.76e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" 12.0 13.0 8.9 12.0 13.9 26.4 12.8 11.6 16.1 12.5 10.7 17.8 8.8 7.8 14.4 7.9 9.2 17.7 9.6 8.3 9.5 6.7 9.9 34.7 15.2 18.1 9.9 8.1 12.2 19.2 7.7 8.9 7.8 13.0 10.2 6.7 13.0 12.8 11.5 17.9 10.5 10.1 16.5 10.2 14.9 11.2 8.4 9.5 18.0 11.8 6.8 13.2 12.5 12.5 1.7 4.0 1.7 5.8 0.7 4.6 1.4 6.8 6.0 9.2 15.9 20.9 13.3 18.5 10.1 11.3 13.7 12.6 7.3 7.2 6.7 2.0 11.5 13.1 6.5 10.8 9.8 9.6 14.9 8.3 10.9 7.6 11.4 14.0 16.4 8.4 10.5 13.6 15.3 6.9 8.6 11.1 10.9 3.8 6.7 11.4 5.6 8.9 9.2 8.3 5.6 12.3 4.9 7.1 4.5 6.4 8.9 2.0 6.8 10.2 7.0 9.5 5.4 5.9 14.3 11.2 10.9 6.4 14.3 12.0 13.1 8.4 6.3 9.5 16.5 8.3 0.0 3.3 1.7 2.2 5.8 1.8 1.7 3.5 2.4 4.0 1.5 1.9 1.4 0.3 0.7 5.5 2.3 4.6 1.4 8.9 13.9 11.6 16.1 9.5 6.7 9.9 8.1 13.0 9.5 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 17.4 1.2 7.0 0.0 1.5 1.7 2.1 0.0 0.0 0.0 0.0 2.5 5.3 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 2.7 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 STOM "BND7, EPB7, EPB72" ENSG00000148175 Stomatin P27105 9 121338988-121370304 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 373.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 105.9;HHSteC: 57.5;hTCEpi: 86.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010961, HPA011419" Approved Enhanced "Vesicles,Plasma membrane,Cytosol" NA NA 140000000 "Plasma membrane" "Vesicles, Cytosol" "HPA010961: AB_1080111, HPA011419: AB_1080109" "unprognostic (1.11e-1)" "unprognostic (2.15e-2)" "unprognostic (5.27e-2)" "unprognostic (7.93e-2)" "unprognostic (5.68e-3)" "unprognostic (1.65e-2)" "unprognostic (9.20e-3)" "unprognostic (7.86e-2)" "unprognostic (1.76e-1)" "unprognostic (3.59e-2)" "unprognostic (3.32e-1)" "unprognostic (1.26e-1)" "unprognostic (5.23e-2)" "unprognostic (9.15e-3)" "unprognostic (2.27e-2)" "unprognostic (7.82e-2)" "unprognostic (2.99e-2)" 96.0 27.5 29.3 29.7 41.6 89.2 78.6 15.0 19.4 28.7 46.4 23.2 14.6 14.4 35.7 26.7 34.9 28.2 45.2 46.4 27.2 18.5 35.4 114.4 66.0 40.2 24.2 15.1 31.5 11.8 21.0 11.3 77.0 28.1 36.8 16.7 27.7 23.0 28.3 50.6 25.4 25.0 50.4 37.8 48.3 34.5 17.4 23.3 4.4 29.6 25.1 16.1 56.6 51.8 1.4 8.6 5.2 13.2 33.2 43.4 25.8 1.5 9.8 0.8 4.5 105.9 30.4 0.0 26.3 26.2 7.4 11.7 1.3 1.9 12.0 6.5 32.8 4.4 2.6 5.5 24.4 13.2 7.3 2.3 27.9 21.7 3.8 57.5 10.3 5.9 50.4 86.5 11.6 15.4 2.1 26.5 3.7 6.0 16.1 16.1 7.9 0.3 7.9 12.0 0.6 3.1 1.4 0.0 26.1 5.8 0.3 1.0 0.1 22.0 19.5 11.3 8.2 6.7 8.5 33.6 17.2 5.4 17.1 2.4 6.8 7.5 0.7 6.6 10.4 9.2 3.4 8.5 0.9 43.4 13.2 42.8 1.4 22.0 38.9 8.6 1.1 4.1 22.0 5.2 33.2 9.0 1.5 2.0 25.8 29.3 41.6 15.0 19.4 27.2 18.5 24.2 15.1 28.1 23.3 148.9 81.9 21.1 213.5 93.8 3.6 29.1 119.8 124.5 113.7 33.2 5.9 85.6 3.3 48.0 2.7 299.7 8.4 373.8 19.1 46.5 164.1 41.4 34.7 315.8 77.6 3.2 0.0 270.1 169.6 5.7 61.5 72.7 84.4 33.3 0.2 8.0 31.1 14.4 96.9 74.2 4.6 135.8 215.9 21.4 6.8 104.1 144.5 93.2 0.1 170.5 STOML1 "FLJ36370, hUNC-24, SLP-1, STORP" ENSG00000067221 "Stomatin like 1" Q9UBI4 15 73978923-73994622 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042353 Approved Approved Cytosol NA NA Cytosol "HPA042353: AB_10797387" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (7.76e-2)" "unprognostic (4.54e-3)" "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.78e-1)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.30e-3)" "unprognostic (2.26e-3)" "unprognostic (2.14e-1)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.67e-2)" 11.1 10.2 19.2 6.2 18.8 4.2 8.1 7.8 35.3 7.7 6.9 8.3 3.1 5.9 4.6 6.0 7.0 6.2 9.1 14.4 19.0 18.0 4.5 6.1 6.9 8.7 13.4 14.3 9.0 9.9 6.8 8.5 7.9 10.2 7.0 3.7 4.0 7.7 9.7 13.2 7.3 6.5 7.7 12.3 6.3 7.9 6.7 5.9 6.2 10.4 3.6 5.6 6.2 4.4 6.1 11.0 2.2 15.5 6.8 9.4 5.3 3.6 7.0 4.2 5.8 8.6 5.5 3.6 12.0 4.7 6.5 5.5 2.0 20.6 3.7 19.0 9.7 4.9 12.4 4.0 8.4 2.0 12.4 4.4 3.8 5.9 2.3 8.5 2.5 3.1 9.7 6.6 10.3 9.8 5.4 6.1 8.6 9.2 7.2 9.4 5.6 4.7 1.8 2.0 5.7 5.6 2.8 4.3 5.6 13.9 4.1 8.1 5.2 5.4 7.2 7.6 2.8 6.0 2.8 9.3 15.1 4.9 17.2 16.0 7.3 3.5 1.9 13.9 7.8 7.6 0.7 4.0 2.2 5.3 7.0 4.4 4.3 4.4 7.0 6.2 6.1 8.9 9.4 2.0 6.8 15.5 11.0 7.4 5.3 19.2 18.8 7.8 35.3 19.0 18.0 13.4 14.3 10.2 5.9 0.0 2.6 9.5 3.4 2.9 12.3 9.3 2.5 1.4 4.5 7.0 5.9 11.2 1.7 20.5 0.6 7.1 8.0 0.0 16.7 8.1 11.2 5.0 4.6 3.9 9.0 15.9 9.8 4.9 1.8 1.8 8.3 2.3 3.3 2.8 5.7 12.2 17.8 3.6 11.0 5.3 13.7 6.5 5.8 21.9 4.1 1.8 4.7 2.9 5.0 2.0 STOML3 "Epb7.2l, SRO" ENSG00000133115 "Stomatin like 3" Q8TAV4 13 38965925-38991066 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2" "Cell type enriched" "Detected in some" 24 "Ciliated cells: 133.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 39 "AF22: 19.0" "Region enriched" "Detected in some" 6 "olfactory region: 29.0" "Low region specificity" "Detected in all" "HPA012892, HPA071011" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA012892: AB_1857610, HPA071011: AB_2732169" "unprognostic (2.64e-1)" "unprognostic (1.91e-2)" "prognostic favorable (1.49e-4)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "unprognostic (4.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.14e-1)" "unprognostic (2.14e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-2)" "unprognostic (3.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.22e-1)" 0.1 0.1 2.9 0.1 3.8 0.1 0.2 0.0 0.2 1.7 0.2 6.6 0.0 0.2 1.1 8.1 0.1 31.7 0.1 0.1 4.4 4.1 0.1 0.1 9.2 0.1 0.0 0.0 7.6 0.1 0.1 0.0 0.3 9.7 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.6 2.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.8 0.0 0.2 4.4 4.1 0.0 0.0 9.7 2.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 133.8 5.7 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 STRA6 FLJ12541 ENSG00000137868 "Stimulated by retinoic acid 6" Q9BX79 15 74179466-74212267 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport Receptor "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix, uterine: 22.7;placenta: 88.6;retina: 42.8" "Cell type enhanced" "Detected in some" 16 "Extravillous trophoblasts: 11.0;Leydig cells: 6.4;Syncytiotrophoblasts: 22.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 16.6;CAPAN-2: 47.1;SH-SY5Y: 29.3;WM-115: 70.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040839 Approved NA NA "HPA040839: AB_10794881" "unprognostic (1.20e-2)" "unprognostic (4.99e-2)" "unprognostic (3.71e-2)" "unprognostic (3.55e-3)" "unprognostic (1.37e-1)" "unprognostic (2.09e-2)" "unprognostic (4.38e-3)" "unprognostic (1.67e-2)" "unprognostic (9.16e-2)" "unprognostic (1.21e-1)" "unprognostic (5.35e-2)" "unprognostic (3.89e-1)" "unprognostic (7.91e-13)" "unprognostic (2.90e-2)" "unprognostic (2.03e-1)" "unprognostic (1.51e-2)" "unprognostic (1.91e-1)" 0.2 1.6 0.2 0.5 0.3 0.0 1.1 0.2 0.5 22.7 0.1 0.3 1.6 0.0 6.9 2.8 1.0 5.0 0.7 0.3 0.4 0.2 7.3 0.0 0.3 1.1 0.1 0.3 0.6 0.2 0.0 5.3 88.6 0.7 5.0 0.0 42.8 0.6 2.6 0.1 0.4 0.2 0.3 1.5 0.3 0.1 2.8 0.1 0.9 0.2 1.4 1.9 1.8 2.3 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.2 16.6 1.0 0.0 0.0 0.0 2.8 0.5 0.1 0.0 0.0 5.7 47.1 0.0 11.4 0.0 0.4 1.6 0.9 0.0 0.0 0.0 0.1 1.4 0.6 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 3.0 0.2 1.5 0.0 0.0 0.2 0.0 0.0 0.0 1.5 8.9 29.3 0.0 1.7 0.0 1.9 0.1 0.0 0.0 0.1 3.9 0.3 0.7 0.1 0.1 0.0 0.3 0.0 70.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.4 0.4 0.2 0.1 0.3 0.7 0.1 0.0 0.0 0.0 1.0 0.3 0.0 1.0 0.0 4.0 3.4 0.0 0.0 2.0 1.7 0.2 1.2 0.4 0.0 0.0 0.0 11.0 0.9 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 6.4 0.0 1.7 0.0 0.0 0.0 2.8 0.0 3.9 4.1 0.0 0.0 0.4 0.5 0.4 0.0 22.1 0.0 0.0 0.9 STRADB "ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK" ENSG00000082146 "STE20-related kinase adaptor beta" Q9C0K7 2 201387858-201480846 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Erythroid cells: 186.9;Proximal tubular cells: 173.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026549, HPA028520" Approved Uncertain Aggresome,Cytosol NA NA Cytosol Aggresome "HPA026549: AB_1844779, HPA028520: AB_10604100" "unprognostic (6.34e-2)" "unprognostic (2.48e-1)" "unprognostic (2.63e-1)" "unprognostic (3.56e-3)" "unprognostic (4.04e-2)" "unprognostic (7.64e-2)" "unprognostic (1.35e-1)" "unprognostic (1.58e-1)" "unprognostic (2.63e-3)" "unprognostic (2.65e-2)" "unprognostic (6.21e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.08e-1)" "unprognostic (7.83e-2)" "prognostic favorable (4.45e-4)" "unprognostic (4.93e-2)" 13.8 28.6 13.8 7.9 11.7 32.7 9.2 8.8 13.5 6.4 13.7 16.9 4.9 18.8 10.3 9.5 8.9 5.7 7.9 15.2 15.3 11.5 35.2 50.5 7.2 10.1 15.8 11.0 7.8 9.1 3.9 14.1 11.6 12.7 7.1 15.9 10.1 7.1 7.7 48.3 4.4 21.3 7.4 21.0 7.3 4.7 7.8 9.4 8.3 9.7 7.8 7.7 6.2 6.2 24.1 10.4 9.7 8.6 16.3 10.4 9.6 3.9 6.8 11.9 15.2 19.4 24.6 8.4 8.0 14.0 11.2 17.0 9.0 3.8 0.0 5.3 12.7 13.8 4.0 11.5 7.6 20.3 4.6 9.4 4.8 3.2 19.9 14.7 5.6 5.4 20.8 6.9 14.3 12.8 20.9 8.4 9.2 10.2 1.7 60.3 2.1 5.1 9.8 16.0 3.7 7.0 7.0 4.6 2.9 9.5 3.2 2.0 9.8 5.5 4.2 23.6 22.7 2.2 10.8 8.1 6.9 5.3 8.7 6.1 6.7 11.8 1.8 11.6 2.5 6.4 3.4 8.0 9.7 6.0 8.6 5.4 16.7 8.0 8.6 10.4 24.1 10.4 10.3 1.6 16.3 7.5 4.6 9.5 9.6 13.8 11.7 8.8 13.5 15.3 11.5 15.8 11.0 12.7 9.4 8.9 3.4 20.8 6.4 1.9 10.4 29.0 15.3 5.3 3.4 14.0 78.5 41.3 33.2 9.4 3.0 4.9 62.6 186.9 13.6 22.9 10.8 10.0 5.7 77.9 16.8 11.1 16.3 3.1 17.8 5.8 10.0 8.3 15.1 17.2 23.2 13.5 11.0 26.2 3.5 173.8 17.1 6.5 4.1 27.0 44.7 1.3 23.3 9.6 22.7 7.7 STRC DFNB16 ENSG00000242866 Stereocilin Q7RTU9 15 43599563-43618800 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 22.9" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 5.9;Horizontal cells: 3.2;Rod photoreceptor cells: 9.2;Spermatocytes: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.4;hTCEpi: 2.2;JURKAT: 1.7;SCLC-21H: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048083 Enhanced NA NA "HPA048083: AB_2732545" "unprognostic (8.60e-3)" "unprognostic (5.77e-3)" "unprognostic (6.14e-2)" "unprognostic (1.60e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-3)" "unprognostic (1.65e-1)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.84e-2)" "unprognostic (5.92e-3)" "unprognostic (1.99e-4)" "unprognostic (1.58e-1)" "unprognostic (6.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.59e-4)" 0.2 0.5 1.7 0.2 4.2 0.1 0.8 22.9 5.1 0.0 0.2 0.4 0.1 4.7 0.1 0.3 0.2 0.0 2.3 3.2 0.0 0.1 0.1 0.0 1.6 0.4 0.5 0.1 1.7 0.0 0.7 0.2 1.5 0.1 0.4 2.7 0.4 0.0 1.1 0.2 0.2 3.3 0.6 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.1 0.7 0.0 0.0 0.1 1.0 1.4 0.0 0.7 0.0 0.0 0.5 0.6 0.5 2.2 0.0 0.0 0.2 0.0 1.7 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.5 0.0 0.0 0.1 0.1 1.9 0.1 0.0 0.4 0.9 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.2 0.3 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 3.2 0.0 0.6 0.3 0.0 0.0 0.0 1.7 0.0 0.0 1.9 0.2 0.2 0.4 0.0 9.2 0.0 0.0 3.6 0.6 0.4 0.6 0.0 0.0 0.0 STS "ARSC, ARSC1" ENSG00000101846 "Steroid sulfatase" P08842 X 7219456-7354810 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Pregnancy, Steroid metabolism" Hydrolase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "placenta: 258.8" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 78.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 20.3;RPMI-8226: 25.9;U-266/70: 43.0;U-698: 18.0" HPA002904 Enhanced NA NA "HPA002904: AB_1080116" "unprognostic (1.09e-1)" "unprognostic (3.90e-2)" "unprognostic (1.44e-2)" "unprognostic (2.75e-1)" "unprognostic (6.72e-2)" "unprognostic (1.94e-2)" "unprognostic (2.62e-1)" "unprognostic (1.84e-1)" "unprognostic (8.23e-2)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (4.05e-2)" "unprognostic (2.78e-2)" "unprognostic (2.77e-1)" "unprognostic (2.56e-1)" "unprognostic (1.92e-2)" "unprognostic (1.34e-1)" 10.3 2.2 3.0 2.2 3.9 0.0 4.1 2.3 9.0 3.4 3.5 2.3 2.2 0.8 2.4 2.2 2.2 2.6 4.1 3.6 3.9 4.0 2.5 4.7 5.0 2.2 3.8 2.4 2.4 2.2 1.6 2.2 258.8 2.4 2.9 3.0 2.3 2.2 3.3 4.0 2.3 2.4 3.8 2.4 2.2 6.7 2.2 2.3 2.2 2.4 2.2 2.2 4.9 2.7 0.9 1.9 1.9 4.7 1.0 0.7 1.0 4.1 1.3 2.8 0.9 20.3 10.5 15.0 8.4 3.0 2.3 2.1 7.4 3.9 7.7 1.6 6.1 1.8 1.0 1.6 1.4 2.3 0.6 3.2 0.4 4.7 2.1 1.1 1.1 4.4 3.4 0.2 1.4 0.8 1.5 3.4 0.6 0.4 8.1 6.0 0.9 0.6 1.0 1.0 0.0 1.9 1.1 1.6 25.9 5.7 6.0 2.0 1.7 1.7 3.0 0.9 4.8 1.3 0.4 6.0 9.1 0.5 11.6 1.3 43.0 0.0 18.0 2.1 0.9 2.4 0.0 3.2 0.6 0.5 4.7 0.2 0.6 0.2 0.3 1.9 0.9 0.1 0.5 1.9 1.0 2.5 0.3 0.7 1.0 3.0 3.9 2.3 9.0 3.9 4.0 3.8 2.4 2.4 2.3 11.9 2.1 1.5 1.7 0.8 3.1 5.0 2.5 0.0 1.2 1.8 0.0 34.3 0.0 6.9 0.1 4.3 4.1 0.0 17.1 18.7 4.1 7.6 6.9 7.4 6.6 1.6 3.5 2.5 5.9 0.0 2.6 2.7 1.7 2.8 2.3 3.1 8.7 7.4 6.3 1.4 0.8 0.0 4.7 0.0 1.4 0.9 78.6 0.0 2.2 7.4 STT3A "ITM1, MGC9042, STT3-A, TMC" ENSG00000134910 "STT3A, catalytic subunit of the oligosaccharyltransferase complex" P46977 11 125591712-125625215 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 202.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030735 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA030735: AB_10603342" "unprognostic (8.25e-3)" "unprognostic (5.45e-2)" "unprognostic (3.02e-2)" "prognostic favorable (1.32e-4)" "unprognostic (5.10e-2)" "unprognostic (1.72e-2)" "prognostic unfavorable (3.57e-4)" "unprognostic (8.40e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-2)" "unprognostic (8.96e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.60e-2)" "unprognostic (6.38e-2)" "unprognostic (1.28e-1)" "unprognostic (1.82e-2)" 20.6 20.5 8.3 13.1 11.7 8.3 16.9 10.7 13.9 27.8 19.3 17.7 39.6 12.0 30.5 41.4 19.6 20.8 15.1 19.5 8.3 9.1 26.2 67.1 18.7 14.9 9.3 7.7 30.1 59.0 202.3 27.5 35.9 11.6 22.2 17.4 20.8 50.7 41.4 9.5 12.9 19.8 17.1 12.3 21.8 17.7 17.1 6.7 19.2 38.6 13.6 20.8 19.5 18.0 15.0 53.2 27.0 15.5 17.2 27.5 13.4 21.0 19.2 24.5 33.6 46.2 35.8 26.3 38.5 46.0 31.3 39.2 58.2 56.9 27.4 46.7 56.6 44.4 38.9 33.9 33.7 41.7 21.3 18.0 64.5 13.2 40.2 51.1 38.6 30.3 27.6 24.5 43.4 84.8 36.9 34.9 12.3 27.1 41.1 39.5 15.5 15.5 12.3 15.7 42.1 20.9 18.4 20.9 41.2 34.2 32.7 15.2 13.2 27.2 44.5 13.7 30.0 52.2 27.8 31.2 45.2 16.3 19.0 30.2 12.9 15.1 21.1 17.4 39.1 35.8 27.0 15.5 11.6 19.7 14.8 27.5 15.0 19.1 18.2 21.6 11.6 13.8 16.0 5.4 17.2 13.0 53.2 14.1 13.4 8.3 11.7 10.7 13.9 8.3 9.1 9.3 7.7 11.6 6.7 26.8 23.5 18.2 11.3 14.3 10.2 18.6 12.7 14.7 14.8 15.7 19.6 40.7 1.7 26.7 7.6 11.9 13.5 23.3 23.5 56.2 25.7 16.7 16.2 32.7 27.0 1.6 15.0 33.2 22.3 2.6 19.8 13.2 23.6 8.2 32.3 15.2 29.5 14.0 17.7 11.9 13.8 19.4 10.3 29.9 10.9 12.9 38.1 13.3 22.9 12.9 STT3B "FLJ90106, SIMP, STT3-B" ENSG00000163527 "STT3B, catalytic subunit of the oligosaccharyltransferase complex" Q8TCJ2 3 31532638-31637622 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036448, HPA036646" Approved Supported "Endoplasmic reticulum" NA NA 9300 "Endoplasmic reticulum" "HPA036448: AB_2675129, HPA036646: AB_10673472" "unprognostic (2.17e-2)" "unprognostic (2.23e-1)" "prognostic favorable (7.91e-5)" "unprognostic (1.60e-1)" "unprognostic (3.11e-1)" "unprognostic (2.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.44e-1)" "unprognostic (1.04e-1)" "unprognostic (2.60e-1)" "unprognostic (3.26e-3)" "unprognostic (3.68e-2)" "unprognostic (3.86e-2)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" "unprognostic (6.71e-3)" "unprognostic (1.02e-1)" 23.0 30.3 16.0 27.5 16.7 21.7 27.4 15.4 19.4 28.4 25.0 16.9 37.0 18.6 28.4 37.9 28.8 22.4 29.0 27.5 15.1 15.6 28.2 64.1 30.1 36.9 16.5 15.5 62.3 39.4 36.2 20.3 85.9 16.5 26.3 25.1 22.3 25.2 26.3 31.2 19.2 29.2 23.2 19.7 29.4 22.9 36.7 13.6 60.2 44.3 23.4 30.3 27.5 27.7 3.6 7.7 8.4 5.3 8.4 8.5 3.0 16.6 28.0 25.8 27.0 32.5 32.8 56.4 31.3 27.5 23.4 27.2 25.5 36.2 29.0 15.4 28.3 19.3 14.1 23.8 27.1 30.8 81.6 15.7 24.8 28.5 27.1 25.1 53.5 29.7 25.1 29.1 33.3 42.2 36.2 23.6 37.2 13.3 46.5 31.8 9.4 52.3 33.1 20.8 27.9 15.8 54.7 14.0 42.0 27.2 24.1 11.0 13.4 31.0 46.1 18.1 23.0 20.7 28.6 45.9 31.7 20.3 31.3 27.5 29.3 35.1 24.3 28.7 36.8 26.0 2.3 4.6 8.4 4.7 5.3 7.5 3.4 8.5 6.5 4.0 3.6 8.2 6.5 1.7 8.4 3.7 7.7 4.1 3.0 16.0 16.7 15.4 19.4 15.1 15.6 16.5 15.5 16.5 13.6 80.4 51.9 42.7 51.5 60.6 48.3 64.1 56.0 40.2 88.7 41.8 64.8 58.7 11.6 32.8 125.1 35.0 40.6 0.0 38.9 84.1 47.2 61.2 31.1 58.2 50.2 42.9 43.4 38.6 46.8 186.1 33.6 58.1 49.0 9.0 50.8 36.3 38.5 49.1 30.8 26.4 33.6 25.8 38.9 61.2 52.7 54.1 79.8 62.1 51.2 55.9 STUM "C1orf95, DKFZp761P211" ENSG00000203685 "Stum, mechanosensory transduction mediator homolog" Q69YW2 1 226548800-226609214 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.2" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HEL: 25.6" "Group enriched" "Detected in many" 5 "amygdala: 137.0;basal ganglia: 92.5;cerebral cortex: 117.9;hippocampal formation: 203.1;thalamus: 84.4" "Low region specificity" "Detected in many" HPA074381 Approved Cytosol NA NA Cytosol "HPA074381: AB_2732253" "unprognostic (3.23e-3)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (1.94e-1)" "unprognostic (4.09e-2)" "unprognostic (2.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.41e-3)" "unprognostic (3.07e-1)" "unprognostic (5.15e-2)" "unprognostic (7.62e-2)" "unprognostic (3.28e-2)" "prognostic favorable (6.40e-4)" "unprognostic (1.14e-2)" "unprognostic (9.04e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-3)" 2.8 2.2 30.4 2.1 16.2 0.6 3.5 2.4 32.2 3.7 8.1 6.3 0.0 2.8 3.7 3.0 8.9 3.1 1.6 2.5 21.8 7.0 5.8 0.7 1.2 0.9 6.8 15.9 2.7 1.0 1.9 4.2 1.2 18.2 6.2 3.7 1.4 2.0 2.4 5.0 3.7 3.5 8.7 3.0 1.8 1.8 2.0 7.4 0.0 0.8 0.4 1.0 5.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 4.2 0.3 25.6 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.3 0.2 0.0 3.9 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 16.2 2.4 30.0 21.8 7.0 6.8 15.9 18.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 STX10 "hsyn10, SYN10" ENSG00000104915 "Syntaxin 10" O60499 19 13144058-13150383 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035303, HPA056439" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA035303: AB_10671932, HPA056439: AB_2683135" "unprognostic (1.72e-2)" "unprognostic (2.26e-2)" "unprognostic (1.62e-2)" "unprognostic (6.73e-2)" "unprognostic (2.40e-1)" "unprognostic (1.21e-2)" "unprognostic (2.54e-3)" "prognostic favorable (8.26e-4)" "unprognostic (4.09e-1)" "unprognostic (3.66e-2)" "unprognostic (4.57e-2)" "unprognostic (9.21e-2)" "prognostic unfavorable (1.69e-7)" "unprognostic (2.39e-3)" "unprognostic (7.95e-2)" "unprognostic (2.23e-1)" "unprognostic (2.98e-2)" 18.7 23.1 19.3 24.2 21.1 43.7 23.0 30.0 24.7 22.9 28.3 15.8 23.7 32.2 20.1 19.1 33.2 17.9 23.3 26.1 22.0 14.8 22.5 28.8 25.4 26.7 25.1 21.4 22.0 18.8 19.1 19.9 16.7 22.4 20.9 14.5 17.4 31.1 16.6 19.4 32.3 26.7 23.4 18.8 34.4 26.1 7.4 23.0 26.8 25.0 20.8 23.4 22.2 30.3 9.7 28.3 63.4 39.0 6.7 12.0 16.7 28.4 21.6 15.5 40.5 16.4 17.3 5.3 15.9 16.0 14.5 15.7 9.9 25.5 19.5 24.1 19.7 10.7 21.9 13.4 20.4 8.3 32.7 24.2 17.5 44.2 20.1 12.7 20.2 18.8 17.2 17.4 17.5 11.5 19.2 18.4 26.8 9.2 10.0 10.0 27.3 29.5 37.5 16.2 15.3 36.2 33.3 16.0 27.9 13.7 13.4 17.9 37.0 16.8 19.4 36.4 4.8 13.1 19.5 17.1 22.5 11.7 43.2 22.1 23.3 20.6 15.9 29.2 50.6 17.6 8.6 39.0 26.6 11.9 29.1 10.1 8.9 10.6 12.0 28.3 9.7 9.8 9.5 63.4 6.7 32.5 7.7 11.7 16.7 19.3 21.1 30.0 24.7 22.0 14.8 25.1 21.4 22.4 23.0 14.9 16.3 30.0 30.2 31.5 21.2 11.7 17.8 26.8 22.7 19.2 5.9 15.7 23.2 38.4 0.7 25.1 61.0 0.0 48.9 21.5 30.7 20.2 52.0 16.3 76.2 12.7 15.6 25.2 89.7 1.6 23.3 55.9 45.5 56.9 37.6 19.0 44.0 45.6 29.4 22.4 16.1 25.8 33.0 4.8 15.8 37.8 16.2 35.2 44.9 31.1 STX12 "STX13, STX14" ENSG00000117758 "Syntaxin 12" Q86Y82 1 27773183-27824452 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041038, HPA055300" Approved Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" No No "Nucleoplasm, Golgi apparatus, Vesicles" "HPA041038: AB_10794261, HPA055300: AB_2682778" "unprognostic (3.47e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-1)" "unprognostic (8.16e-3)" "unprognostic (2.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.26e-2)" "unprognostic (3.52e-1)" "unprognostic (1.14e-2)" "unprognostic (2.78e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-1)" "unprognostic (1.91e-2)" "unprognostic (8.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "unprognostic (2.24e-1)" 38.5 20.2 32.2 16.3 29.6 6.3 22.9 25.8 35.9 20.3 19.4 27.3 23.5 22.9 20.4 42.1 25.7 15.0 25.9 15.3 31.2 31.9 23.2 18.5 31.2 16.3 35.5 29.0 15.2 19.5 16.7 19.6 21.1 32.3 20.8 21.4 11.6 17.7 22.2 14.2 17.1 20.9 23.1 36.9 20.0 38.7 9.0 19.9 6.3 67.0 11.0 13.9 19.4 14.8 7.6 14.2 10.1 21.7 5.2 6.4 8.3 8.8 4.2 11.5 7.5 21.9 26.7 5.9 18.7 27.6 17.2 19.6 5.2 11.5 9.6 20.1 25.0 7.4 7.4 7.5 9.3 17.3 8.5 9.0 5.5 4.7 5.2 17.2 6.0 11.6 25.0 11.4 24.2 13.9 14.2 27.6 5.6 7.2 9.7 18.7 3.2 5.2 4.6 4.8 13.1 6.0 3.3 9.2 5.8 15.2 14.6 12.9 7.0 8.8 7.6 13.5 9.7 5.2 5.4 29.6 8.8 5.0 19.9 6.4 5.8 4.2 5.6 14.2 9.3 12.3 10.1 19.6 7.5 3.7 21.7 6.4 7.6 4.4 5.7 14.2 6.5 4.9 4.1 9.3 5.2 21.0 7.0 4.4 8.3 32.2 29.6 25.8 31.8 31.2 31.9 35.5 29.0 32.3 19.9 50.6 27.6 22.7 84.1 97.1 42.7 15.9 28.1 17.4 38.7 54.1 29.5 25.5 31.5 43.8 1.6 48.9 48.7 0.0 51.3 28.6 42.2 58.3 22.0 15.5 45.8 25.4 39.6 55.3 69.4 1.5 33.4 58.6 50.6 19.8 27.1 61.7 52.7 46.0 44.6 44.7 48.6 38.8 58.4 14.9 17.5 86.7 65.2 22.3 26.7 83.3 STX16 "hsyn16, SYN16" ENSG00000124222 "Syntaxin 16" O14662 20 58651253-58679526 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041019, HPA042033" Uncertain Enhanced Vesicles NA NA Vesicles "HPA041019: AB_10964273, HPA042033: AB_10963935" "unprognostic (7.52e-2)" "unprognostic (1.91e-1)" "unprognostic (7.96e-2)" "unprognostic (1.35e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (4.18e-4)" "unprognostic (7.32e-2)" "unprognostic (5.11e-2)" "unprognostic (3.51e-2)" "unprognostic (2.80e-3)" "unprognostic (2.41e-2)" "prognostic unfavorable (1.11e-16)" "unprognostic (3.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.56e-1)" "unprognostic (5.89e-2)" 22.1 24.5 41.9 25.3 46.7 36.7 22.3 54.5 43.2 21.9 23.3 35.0 35.9 20.3 30.3 36.9 18.8 26.7 23.4 17.3 36.8 22.4 18.6 20.0 20.5 32.8 43.0 32.8 29.2 23.1 18.5 33.0 20.5 34.0 24.6 21.1 20.9 27.9 28.5 25.9 41.5 23.6 29.4 33.0 31.0 21.7 22.2 42.9 16.6 23.7 15.7 24.7 24.2 24.3 4.7 4.3 14.1 6.2 5.6 6.1 4.0 14.3 8.4 11.1 10.8 20.5 22.0 15.5 17.8 12.1 18.3 11.4 16.4 21.1 16.5 25.0 12.7 23.0 21.4 10.2 21.2 15.3 7.8 10.8 10.3 22.1 19.8 20.4 14.7 23.4 24.3 32.6 12.3 18.8 34.5 18.5 19.6 11.9 14.8 14.7 33.6 11.3 17.8 4.5 11.7 14.4 10.5 10.4 11.4 14.0 10.7 7.4 11.3 18.9 33.3 32.1 19.7 13.3 19.5 19.5 30.3 14.7 11.5 19.6 30.7 14.2 9.2 22.3 11.4 12.6 14.1 6.2 5.2 5.0 5.6 5.6 2.6 4.5 3.5 4.1 4.7 6.1 5.5 14.0 5.6 4.1 4.3 4.8 4.0 41.9 46.7 54.5 43.2 36.8 22.4 43.0 32.8 34.0 42.9 20.8 40.6 22.8 18.7 23.9 60.9 17.1 43.3 45.5 31.8 27.9 80.5 20.1 5.0 13.1 3.2 32.4 21.5 23.3 11.7 13.5 17.7 20.1 18.5 25.2 19.3 39.7 44.3 32.5 32.9 6.5 21.0 31.3 20.3 14.4 28.0 32.0 16.7 27.1 27.3 8.4 50.6 12.9 21.7 39.8 20.2 36.9 14.6 34.6 25.0 16.6 STX17 FLJ20651 ENSG00000136874 "Syntaxin 17" P56962 9 99906633-99970341 "Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001204 Approved Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA001204: AB_1080118" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (8.67e-2)" "unprognostic (2.93e-1)" "unprognostic (6.71e-2)" "unprognostic (1.88e-1)" "unprognostic (2.36e-1)" "unprognostic (1.70e-2)" "unprognostic (9.75e-2)" "unprognostic (1.62e-1)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.62e-5)" "unprognostic (9.48e-2)" "unprognostic (4.32e-2)" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" 15.1 15.8 13.5 16.4 16.3 13.6 16.1 10.8 17.8 19.4 18.5 14.2 29.3 13.4 21.7 25.2 19.9 12.0 14.9 14.5 13.8 13.2 14.3 26.0 13.2 11.9 15.4 14.2 18.2 17.8 25.5 37.1 17.6 14.1 18.2 14.6 16.3 20.6 28.7 28.5 20.6 18.9 20.4 19.1 13.3 15.0 12.0 10.4 17.0 21.8 18.3 15.9 18.8 17.8 7.4 4.9 15.5 8.1 14.3 10.4 4.5 10.7 9.8 10.0 12.0 11.4 11.6 19.9 8.2 12.2 9.3 8.0 12.2 14.4 21.0 8.2 8.7 15.0 12.3 8.3 11.5 7.5 18.3 6.8 13.5 12.9 7.4 13.3 19.8 4.9 11.4 13.4 10.0 15.2 9.8 10.8 18.2 18.7 11.7 7.0 13.1 11.8 5.4 8.8 14.0 7.9 10.1 17.7 9.6 12.3 12.5 5.8 10.3 16.6 12.7 8.1 6.7 12.6 5.5 8.5 6.2 8.8 10.0 6.6 16.6 20.2 4.2 8.7 8.3 6.7 15.5 4.2 7.3 7.4 4.5 10.3 7.4 9.1 8.2 4.9 5.9 10.4 9.8 4.3 14.3 8.1 3.1 4.9 4.5 13.5 16.3 10.8 17.8 13.8 13.2 15.4 14.2 14.1 10.4 14.9 21.7 14.5 18.1 9.4 14.0 16.9 10.2 24.1 22.7 22.7 19.6 20.4 24.9 15.8 40.4 13.7 9.7 0.0 17.1 15.8 11.1 23.3 25.4 23.1 9.2 9.5 24.2 20.9 8.3 24.8 23.9 15.1 8.5 27.1 15.7 20.3 14.1 15.9 17.0 15.7 12.9 38.8 13.9 25.9 16.6 10.7 22.9 16.6 13.1 12.9 STX18 Ufe1 ENSG00000168818 "Syntaxin 18" Q9P2W9 4 4415742-4542346 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 98.6" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "endometrial cancer: 43.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003019 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA003019: AB_1857622" "unprognostic (2.33e-1)" "unprognostic (1.65e-1)" "prognostic favorable (2.84e-4)" "prognostic favorable (6.33e-8)" "unprognostic (4.21e-1)" "unprognostic (6.77e-2)" "unprognostic (6.17e-3)" "unprognostic (2.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-2)" "prognostic favorable (7.03e-4)" "unprognostic (1.92e-2)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" "prognostic favorable (4.69e-4)" 14.0 17.6 12.4 16.0 18.4 9.2 11.0 11.2 15.9 98.6 19.7 19.5 12.2 15.0 46.5 11.9 11.5 38.9 16.1 11.0 11.3 14.2 24.2 14.0 9.8 10.4 14.5 12.3 12.4 18.5 12.2 24.1 17.5 17.3 12.3 11.9 12.7 12.2 14.7 19.0 11.0 19.6 13.5 14.8 14.2 15.0 28.5 10.3 18.1 10.1 9.8 15.0 11.8 12.3 11.2 25.5 7.1 13.0 10.8 13.4 9.3 14.3 9.3 11.1 11.3 9.6 14.0 14.9 16.5 15.2 15.8 13.2 19.6 20.9 19.1 39.8 15.3 14.4 7.8 19.6 9.7 15.6 8.0 9.8 12.0 12.3 23.7 14.3 20.8 10.1 13.1 8.5 13.4 9.8 8.9 13.3 15.4 11.5 17.0 11.2 7.6 18.8 14.8 14.7 11.9 19.4 17.0 8.3 15.2 16.3 8.7 14.1 12.5 12.4 8.3 14.4 10.0 12.2 10.1 15.1 9.6 10.5 8.7 17.7 12.2 18.5 22.0 11.7 16.0 11.9 4.8 10.6 7.1 10.9 10.4 13.4 11.2 10.1 9.9 16.0 9.3 8.5 9.8 2.1 10.8 13.0 25.5 9.1 9.3 12.4 18.4 11.2 15.9 11.3 14.2 14.5 12.3 17.3 10.3 29.8 7.0 10.4 7.5 7.0 20.2 18.3 10.2 34.8 25.0 19.2 19.6 25.1 59.7 27.4 58.7 11.9 28.7 0.0 24.4 16.2 18.5 12.5 8.1 8.3 24.9 9.5 4.7 6.7 14.5 62.0 13.0 16.9 13.5 30.7 19.0 22.5 28.8 24.6 13.8 18.3 16.1 6.5 11.3 58.5 33.4 8.4 26.5 10.7 17.5 10.5 STX1A "HPC-1, p35-1, STX1" ENSG00000106089 "Syntaxin 1A" Q16623 7 73699206-73719672 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Neurotransmitter transport, Transport" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 73.7;pituitary gland: 26.9" "Cell type enhanced" "Detected in many" 13 "Intestinal endocrine cells: 50.6;Pancreatic endocrine cells: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.5;T-reg: 2.4" "Lineage enriched" "Detected in single" 6 "T-cells: 2.5" "Cell line enhanced" "Detected in many" "SCLC-21H: 50.8;U-87 MG: 33.8" "Group enriched" "Detected in many" 5 "amygdala: 253.0;basal ganglia: 94.3;cerebral cortex: 362.2;hippocampal formation: 251.5" "Group enriched" "Detected in all" 8 "amygdala: 69.4;cerebral cortex: 158.6;hippocampal formation: 149.3" "CAB008372, HPA069176" Enhanced Approved "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA Vesicles "Nuclear membrane" "CAB008372: AB_592786, HPA069176: AB_2686098" "unprognostic (5.12e-3)" "prognostic unfavorable (3.63e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (1.94e-5)" "unprognostic (3.12e-3)" "unprognostic (1.88e-1)" "unprognostic (3.02e-8)" "unprognostic (1.11e-2)" "unprognostic (6.97e-2)" "unprognostic (3.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.70e-3)" "unprognostic (4.18e-6)" "unprognostic (2.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-3)" "unprognostic (6.20e-2)" 1.4 5.6 27.4 2.4 20.9 7.6 1.4 33.7 73.7 1.7 2.6 1.3 0.8 3.7 2.8 1.8 1.7 2.3 5.5 1.2 22.0 8.3 1.1 1.2 1.8 1.4 4.0 28.0 2.2 5.7 1.5 26.9 2.2 2.6 1.9 2.1 0.1 1.9 1.8 1.1 1.9 3.5 2.6 1.3 1.3 6.2 2.0 0.7 0.0 1.6 0.0 1.1 2.8 1.1 0.4 0.0 0.1 0.2 0.0 2.5 2.7 1.6 7.5 1.2 3.6 1.6 4.2 0.8 5.1 3.4 2.1 1.4 2.6 4.3 1.9 0.7 3.6 11.8 1.3 1.8 3.2 1.6 3.5 1.4 0.6 2.6 1.5 1.8 0.8 1.8 2.5 1.4 14.8 5.2 9.6 3.7 0.3 1.6 2.3 4.0 3.7 0.6 7.3 0.9 2.8 17.0 0.0 0.8 1.9 1.7 1.3 50.8 8.0 1.5 4.2 1.0 1.5 1.4 0.6 13.8 10.5 3.5 8.1 13.5 1.3 0.8 0.9 33.8 0.7 12.3 0.0 0.2 0.0 2.5 0.0 0.9 0.4 0.4 0.6 0.0 0.1 0.8 0.3 0.1 0.0 0.0 0.0 2.4 2.7 27.4 20.9 33.7 49.9 22.0 8.3 4.0 28.0 2.6 0.7 0.0 3.2 0.0 11.2 3.8 4.5 2.2 5.1 2.7 3.4 1.8 3.9 0.4 0.0 3.1 0.0 0.5 1.8 0.0 3.2 1.6 2.4 9.7 15.0 0.2 0.6 7.9 50.6 1.3 0.8 0.0 1.7 1.7 3.3 0.0 2.4 0.8 18.8 0.3 1.4 0.4 1.8 0.0 2.3 1.7 3.3 2.4 0.6 2.2 1.5 12.9 STX1B "STX1B1, STX1B2" ENSG00000099365 "Syntaxin 1B" P61266 16 30989256-31010661 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 64.9" "Group enriched" "Detected in some" 4 "Horizontal cells: 36.5;Late spermatids: 9.9" "Cancer enriched" "Detected in some" 7 "glioma: 5.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 8.4;hTEC/SVTERT24-B: 10.3;hTERT-RPE1: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079008" Supported Approved Approved "Nuclear membrane,Vesicles" NA NA Vesicles "Nuclear membrane" "CAB079008: , HPA069176: AB_2686098" "unprognostic (1.43e-3)" "unprognostic (5.27e-2)" "unprognostic (2.40e-4)" "unprognostic (3.90e-3)" "unprognostic (3.98e-2)" "unprognostic (1.90e-2)" "unprognostic (2.21e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-1)" "unprognostic (3.72e-3)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (7.93e-2)" "unprognostic (1.57e-2)" 1.6 1.9 12.7 1.9 31.8 1.3 1.8 45.8 64.9 1.2 1.4 2.9 0.0 1.4 2.7 4.2 1.9 1.4 1.3 2.1 10.5 10.0 1.4 2.5 1.2 2.4 6.8 26.2 1.3 1.3 1.3 2.2 1.2 39.3 1.8 1.4 1.0 1.9 2.8 1.3 4.0 1.8 2.5 3.8 2.2 1.3 3.2 4.5 0.0 1.3 0.0 2.3 1.3 0.7 0.6 0.3 1.3 0.4 0.5 1.7 0.1 0.1 2.7 4.3 0.6 0.4 0.2 0.1 3.8 5.8 4.8 8.4 0.0 3.1 0.7 0.2 5.0 0.1 0.7 1.9 0.5 5.8 2.3 0.4 0.3 2.2 2.1 0.3 0.1 2.7 1.5 0.1 10.3 0.9 19.0 0.0 0.9 0.4 0.2 5.0 1.2 1.7 0.2 2.1 0.0 0.3 6.3 0.2 0.1 0.4 0.0 5.9 3.7 0.4 0.2 0.0 0.7 0.7 0.1 0.7 2.8 2.2 0.3 0.2 0.3 0.2 0.3 3.1 0.2 0.0 0.9 0.4 0.7 0.3 0.2 0.1 0.5 1.7 0.3 0.1 0.6 0.3 0.4 1.3 0.5 0.1 0.3 0.2 0.1 12.7 31.8 45.8 60.5 10.5 10.0 6.8 26.2 39.3 4.5 0.0 0.0 0.0 0.0 0.7 3.6 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 5.7 0.5 0.0 0.0 0.3 0.0 0.3 0.1 0.0 4.9 0.6 36.5 0.0 0.6 0.0 9.9 0.3 0.0 0.0 1.0 0.0 1.7 0.2 0.0 1.8 2.1 2.9 0.0 0.5 5.2 1.0 0.5 0.7 0.0 0.0 0.0 STX2 "EPIM, EPM, STX2A, STX2B, STX2C" ENSG00000111450 "Syntaxin 2" P32856 12 130789600-130839266 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 123.8;Late spermatids: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079007" Uncertain Supported Approved "Nuclear membrane,Vesicles" NA NA Vesicles "Nuclear membrane" "CAB079007: , HPA069176: AB_2686098" "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (3.38e-2)" "unprognostic (9.85e-2)" "unprognostic (2.11e-2)" "unprognostic (4.16e-2)" "unprognostic (2.83e-1)" "unprognostic (7.62e-2)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (5.15e-5)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.63e-2)" "unprognostic (3.41e-3)" 15.9 14.5 16.0 15.4 13.4 8.8 27.0 12.5 18.7 13.1 18.8 15.3 8.8 6.1 18.1 15.4 9.6 19.4 14.5 16.4 15.5 11.4 12.2 12.0 18.3 11.9 12.7 12.4 16.0 10.7 11.9 16.3 18.0 17.9 10.2 10.2 9.8 5.2 15.7 6.3 6.1 10.7 23.5 24.8 12.3 11.7 23.2 12.3 9.7 12.6 6.9 9.4 13.5 22.2 2.6 1.6 4.6 2.4 1.4 3.1 0.9 4.7 9.5 13.8 10.8 12.8 29.1 1.4 20.2 16.2 24.9 16.5 2.6 3.3 6.1 3.2 22.1 7.8 1.3 12.6 3.3 26.0 9.3 4.3 3.2 8.3 7.4 13.9 4.7 8.0 10.8 4.1 12.1 9.7 22.0 12.2 6.5 12.8 5.7 21.2 2.8 6.6 4.8 9.2 1.3 13.1 7.0 9.0 3.2 13.7 1.0 13.2 13.0 10.2 0.9 8.5 12.5 3.2 3.1 16.4 14.3 10.1 15.8 8.8 4.2 3.4 4.0 16.5 5.2 11.2 4.6 2.2 2.8 2.4 2.4 2.4 2.6 2.7 2.7 1.5 1.7 2.9 3.1 3.0 1.4 1.2 1.6 1.9 0.9 16.0 13.4 12.5 18.7 15.5 11.4 12.7 12.4 17.9 12.3 20.8 11.3 2.2 1.0 3.1 5.0 13.4 12.7 44.2 11.4 27.9 0.0 1.5 8.3 17.7 123.8 18.3 0.0 23.3 6.4 6.3 25.2 1.9 1.1 13.9 9.6 0.0 6.4 16.5 8.6 61.1 25.9 9.0 13.5 10.0 0.2 8.6 10.4 0.0 23.0 10.0 32.5 12.9 24.7 34.6 27.0 1.3 0.7 7.5 0.2 0.4 STX3 STX3A ENSG00000166900 "Syntaxin 3" Q13277 11 59713456-59805882 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 377.4;Cone photoreceptor cells: 371.1;Rod photoreceptor cells: 377.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 14.3;eosinophil: 28.1;neutrophil: 25.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 28.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 49.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002191, HPA069176" Approved Approved "Nuclear membrane,Vesicles" NA NA Vesicles "Nuclear membrane" "HPA002191: AB_1080165, HPA069176: AB_2686098" "unprognostic (2.24e-2)" "unprognostic (1.97e-2)" "unprognostic (7.96e-3)" "unprognostic (1.02e-1)" "unprognostic (2.84e-2)" "unprognostic (2.36e-3)" "prognostic unfavorable (8.41e-7)" "unprognostic (1.64e-1)" "unprognostic (3.00e-1)" "unprognostic (7.71e-3)" "unprognostic (2.07e-2)" "unprognostic (5.55e-2)" "prognostic favorable (1.14e-6)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" "unprognostic (4.02e-2)" "unprognostic (1.17e-2)" 10.8 16.3 5.3 14.1 8.3 23.4 22.6 11.5 10.7 10.7 19.9 4.9 27.8 23.8 14.2 16.4 12.8 6.8 21.1 9.4 6.2 6.0 25.0 6.4 26.5 15.1 8.7 10.2 12.0 14.8 16.7 21.2 33.6 6.8 12.6 22.9 54.7 16.0 19.8 7.3 11.4 19.7 11.4 7.2 14.5 19.5 11.4 6.2 2.1 12.8 9.3 6.4 11.4 12.2 0.9 2.7 28.1 2.5 0.2 1.4 0.9 12.0 7.1 0.2 3.4 6.2 3.6 9.9 6.5 11.2 15.0 18.7 32.4 11.4 3.4 12.6 4.7 25.7 13.7 18.9 6.7 18.4 3.0 4.0 3.7 5.0 10.0 16.7 12.5 36.6 6.6 14.5 11.6 14.2 9.5 12.0 4.9 32.5 7.1 6.5 7.0 0.1 9.2 18.5 17.6 5.9 4.4 12.6 5.6 28.3 28.8 8.2 12.8 2.8 14.3 49.3 25.5 15.8 8.6 16.7 6.5 14.3 8.9 5.6 8.4 14.6 6.9 9.0 8.3 8.7 14.3 2.5 28.1 1.0 0.7 1.1 0.3 1.4 0.6 2.7 0.9 1.3 0.4 25.7 0.2 0.4 0.4 0.0 0.9 5.3 8.3 11.5 10.7 6.2 6.0 8.7 10.2 6.8 6.2 62.5 29.9 7.8 63.8 45.1 377.4 8.7 28.1 9.4 13.6 10.4 371.1 7.2 14.9 34.0 4.0 29.2 50.3 0.0 22.1 13.8 11.8 83.7 55.6 4.9 14.2 68.3 25.2 21.5 19.0 4.7 3.4 26.8 35.4 12.6 26.9 39.3 38.9 29.4 7.1 51.2 377.2 6.5 14.1 3.9 10.4 52.6 33.9 10.7 21.7 72.9 STX4 "p35-2, STX4A" ENSG00000103496 "Syntaxin 4" Q12846 16 31032889-31042975 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001330 Approved Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA001330: AB_1080167" "unprognostic (2.31e-3)" "prognostic favorable (3.65e-4)" "unprognostic (3.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.75e-3)" "unprognostic (5.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.01e-2)" "unprognostic (3.12e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (2.88e-9)" "unprognostic (6.90e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-1)" "unprognostic (3.26e-2)" 26.5 28.2 28.6 23.8 29.6 14.1 23.5 24.2 28.0 21.4 24.0 24.4 16.9 28.3 24.1 19.8 26.4 19.6 23.7 24.6 26.7 18.0 21.7 25.2 25.8 22.5 38.1 22.3 22.7 19.3 33.6 14.9 27.0 32.4 19.8 22.0 14.0 21.3 21.8 30.3 32.7 26.7 27.7 26.1 31.4 22.7 10.7 31.5 19.2 21.3 17.3 26.7 25.4 29.4 11.9 14.8 20.6 18.2 18.2 14.9 8.6 18.4 26.4 6.0 13.4 20.2 20.6 12.8 17.1 30.2 18.3 18.9 8.1 20.1 12.5 22.2 30.2 21.1 13.4 5.6 19.8 17.5 22.4 16.9 9.0 18.4 22.0 22.9 10.4 30.3 19.6 13.9 31.6 23.6 22.7 24.2 8.7 10.5 14.6 32.4 28.9 9.8 16.1 12.4 13.8 14.2 8.4 17.9 16.3 18.1 13.7 4.9 9.4 15.1 15.5 6.2 8.3 12.4 13.8 25.9 18.5 8.2 20.8 9.5 15.7 12.7 5.5 27.9 16.8 11.2 14.6 17.7 20.6 14.9 18.2 12.9 9.7 12.5 14.5 14.8 11.9 9.5 12.2 18.5 18.2 15.8 8.6 6.8 8.6 28.6 29.6 24.2 28.0 26.7 18.0 38.1 22.3 32.4 31.5 41.7 20.7 21.5 31.3 57.9 6.7 21.4 45.9 34.8 23.9 21.0 11.8 27.3 24.9 50.0 6.2 41.3 69.9 0.0 59.4 32.0 50.3 41.0 59.9 17.0 84.0 4.8 24.6 29.4 48.2 10.8 35.6 88.9 28.7 62.3 35.0 20.7 57.7 47.2 33.2 45.6 5.9 38.8 44.3 6.5 7.9 57.0 27.7 40.5 40.8 30.1 STX5 "SED5, STX5A" ENSG00000162236 "Syntaxin 5" Q13190 11 62806897-62832088 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001358 Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA001358: AB_1080119" "unprognostic (3.51e-2)" "unprognostic (4.23e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-3)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-2)" "unprognostic (3.30e-1)" "unprognostic (1.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-1)" "unprognostic (1.67e-2)" "unprognostic (3.42e-2)" "unprognostic (2.79e-1)" "unprognostic (2.86e-2)" "unprognostic (8.22e-3)" 21.3 20.0 17.5 16.2 17.0 28.3 22.6 33.0 24.2 26.9 19.6 17.6 40.9 17.2 21.6 36.4 22.3 23.7 20.1 17.7 17.6 15.7 22.3 42.6 21.0 17.7 18.6 16.7 29.3 33.7 22.8 20.2 37.4 17.4 27.9 18.2 20.6 47.3 32.2 17.1 26.4 23.0 19.2 16.0 24.0 22.1 16.1 19.7 29.1 33.7 16.4 29.0 22.5 22.3 9.4 10.0 24.9 10.4 9.5 9.7 4.7 17.6 11.3 15.1 13.4 20.9 23.1 14.1 17.4 24.6 29.4 23.8 8.4 17.5 11.3 16.3 24.8 17.4 18.6 13.1 16.6 21.8 26.3 12.6 9.8 15.2 17.2 25.3 11.6 15.0 19.0 18.8 26.1 31.8 22.7 14.2 16.6 8.8 31.5 15.6 21.3 15.7 18.9 5.1 15.9 16.7 16.2 14.7 30.1 13.2 9.3 11.5 9.7 14.1 22.3 26.6 12.1 24.7 15.7 15.3 21.5 11.3 24.7 11.1 28.8 16.2 11.9 17.3 8.2 13.0 8.2 8.8 24.9 8.5 10.4 7.4 8.7 6.7 8.2 8.1 9.4 6.4 6.2 14.0 9.5 9.1 10.0 9.7 4.7 17.5 17.0 33.0 24.2 17.6 15.7 18.6 16.7 17.4 19.7 20.8 27.7 62.4 62.4 59.6 17.5 5.3 17.8 18.7 14.8 10.4 25.5 47.3 24.9 37.5 99.8 34.9 32.1 23.3 52.1 66.0 46.9 54.7 52.9 23.6 41.5 17.5 31.6 25.2 33.5 98.9 36.2 32.1 43.9 64.1 31.6 29.4 37.9 31.7 23.7 26.4 17.6 32.3 51.8 27.9 31.3 56.1 148.5 46.7 21.7 66.2 STX6 ENSG00000135823 "Syntaxin 6" O43752 1 180972712-181023121 "Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038557, HPA038558" Approved Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038557: AB_2676082, HPA038558: AB_10672716" "unprognostic (1.11e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (9.09e-3)" "unprognostic (2.23e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.12e-1)" "unprognostic (6.12e-2)" "unprognostic (4.48e-3)" "unprognostic (4.18e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (1.93e-8)" "unprognostic (2.59e-1)" "unprognostic (1.59e-1)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" 12.2 10.4 17.6 14.1 18.9 2.9 12.4 21.7 25.5 13.4 10.4 15.5 7.2 9.8 11.3 10.7 22.2 10.3 9.6 8.1 18.6 13.2 11.6 6.5 15.3 12.7 18.5 13.1 11.5 5.5 9.2 6.8 15.0 16.1 10.1 11.1 6.4 10.7 9.6 5.7 16.5 9.9 11.8 15.0 11.6 10.5 7.3 20.0 14.1 15.3 7.3 17.8 16.3 15.6 1.7 5.1 5.9 3.6 0.4 3.2 1.4 9.8 11.1 11.0 14.6 11.6 13.7 18.6 12.7 16.4 10.0 8.6 10.3 9.9 10.0 17.6 13.9 6.3 17.7 9.9 22.4 11.8 7.2 7.3 6.7 8.4 10.0 11.5 9.5 8.7 12.4 20.6 16.9 17.5 18.1 20.2 9.4 12.2 7.1 13.3 14.2 9.1 9.0 17.1 12.4 5.6 8.0 13.4 14.4 11.9 24.8 15.6 16.6 13.3 25.7 13.9 19.7 15.6 8.7 16.6 13.9 7.3 12.9 10.1 12.1 6.7 7.3 6.8 9.4 8.1 5.9 3.6 4.5 1.8 2.9 1.9 1.7 2.6 2.7 5.1 1.7 3.2 2.4 3.4 0.4 2.5 1.7 3.2 1.4 17.6 18.9 21.7 19.1 18.6 13.2 18.5 13.1 16.1 20.0 14.9 15.2 3.7 16.3 43.5 11.7 5.6 0.0 13.4 11.4 17.4 5.9 22.0 10.0 9.1 6.4 22.4 7.8 0.0 8.5 21.8 11.5 17.4 11.5 4.3 24.6 7.9 22.4 11.1 21.9 8.0 7.8 30.2 6.8 19.0 12.7 6.0 11.1 14.0 12.4 6.7 10.1 6.5 13.3 4.7 14.5 33.0 17.2 13.3 9.8 18.7 STX7 ENSG00000079950 "Syntaxin 7" O15400 6 132445867-132513198 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 13.0;classical monocyte: 16.5;eosinophil: 15.0;intermediate monocyte: 18.0;memory B-cell: 26.9;myeloid DC: 19.5;naive B-cell: 35.1;neutrophil: 26.4;non-classical monocyte: 18.2;plasmacytoid DC: 23.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001467, CAB062564" Enhanced Supported Lysosomes NA NA 850000 Lysosomes "CAB062564: AB_2665605, HPA001467: AB_1857623" "unprognostic (1.91e-3)" "unprognostic (1.06e-3)" "unprognostic (2.67e-2)" "unprognostic (7.95e-3)" "unprognostic (1.21e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (4.52e-2)" "unprognostic (4.46e-1)" "unprognostic (4.19e-2)" "unprognostic (2.84e-1)" "unprognostic (2.79e-1)" "unprognostic (1.65e-3)" "unprognostic (2.16e-1)" "unprognostic (2.06e-1)" "unprognostic (1.67e-1)" "unprognostic (8.42e-2)" 28.9 14.3 27.8 26.4 24.3 13.0 21.1 27.2 29.4 17.3 21.8 25.0 11.8 25.1 22.2 14.1 23.8 16.0 23.2 23.8 24.9 23.6 35.0 12.6 22.6 47.8 28.3 22.2 22.7 13.0 12.5 13.4 31.9 31.2 18.6 20.5 16.3 20.2 19.3 16.3 17.8 26.7 20.6 42.1 29.0 19.2 8.2 27.7 9.0 21.9 15.2 46.5 21.2 19.9 35.1 23.5 26.4 18.2 2.9 3.9 8.5 7.2 7.3 12.4 8.8 24.9 22.2 9.7 14.3 14.8 14.9 21.6 12.7 12.1 36.0 14.1 17.3 22.2 9.5 10.9 13.2 20.2 12.4 12.9 13.7 6.5 13.4 19.9 9.2 10.4 12.7 12.5 15.2 13.9 20.5 16.2 8.3 14.6 13.0 16.9 10.1 4.2 7.5 4.7 10.6 8.6 10.0 9.6 10.3 24.9 8.4 10.1 3.1 6.4 10.7 38.5 19.2 7.2 8.9 27.9 8.7 8.9 18.9 15.1 12.5 7.2 15.5 12.2 7.5 9.7 13.0 16.5 15.0 3.7 18.0 1.5 26.9 2.7 2.5 19.5 35.1 2.0 2.4 26.4 2.9 18.2 23.5 3.9 8.5 27.8 24.3 27.2 29.4 24.9 23.6 28.3 22.2 31.2 27.7 65.5 32.2 127.2 20.7 37.4 23.0 41.3 66.2 38.8 27.3 40.1 2.0 74.5 54.7 45.9 0.8 40.6 58.7 23.3 27.0 45.9 35.0 20.8 40.3 16.8 146.3 35.0 12.7 36.2 77.1 1.3 28.4 81.6 126.5 65.9 37.5 24.1 46.1 52.0 43.5 107.8 14.7 38.8 38.1 3.0 16.8 36.0 46.3 18.7 25.9 22.4 STX8 CARB ENSG00000170310 "Syntaxin 8" Q9UNK0 17 9250471-9576591 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 209.0;Late spermatids: 802.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001540 Approved Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nuclear bodies, Cytosol" "HPA001540: AB_1080168" "unprognostic (8.68e-2)" "unprognostic (2.29e-2)" "unprognostic (2.53e-1)" "unprognostic (4.14e-3)" "unprognostic (3.36e-1)" "unprognostic (1.58e-2)" "unprognostic (6.91e-2)" "unprognostic (1.19e-1)" "unprognostic (3.12e-1)" "unprognostic (4.91e-2)" "unprognostic (1.86e-3)" "unprognostic (2.54e-1)" "unprognostic (1.45e-2)" "unprognostic (2.89e-2)" "unprognostic (1.89e-1)" "unprognostic (1.77e-2)" "unprognostic (1.51e-1)" 28.6 24.7 26.0 16.5 25.9 23.7 28.1 20.2 33.6 28.3 28.9 23.7 21.9 15.8 36.9 42.5 26.3 19.9 18.1 28.4 20.8 21.1 29.6 29.9 18.7 19.4 23.9 22.4 24.4 30.0 14.9 21.0 20.0 29.0 24.5 23.7 25.8 40.6 26.0 38.4 20.9 20.3 28.4 25.3 19.7 23.2 43.9 20.2 30.0 29.2 17.8 21.4 23.3 23.0 35.4 45.2 48.5 46.2 49.0 59.3 55.7 11.3 19.6 22.5 9.7 27.7 32.2 7.9 16.9 18.0 15.3 19.2 6.8 8.9 13.5 12.9 28.4 17.7 14.9 11.4 23.8 23.3 23.0 16.6 8.4 4.9 14.5 36.9 6.7 18.1 29.2 35.4 15.3 22.9 25.6 19.0 16.4 3.8 6.9 16.7 6.1 13.4 11.6 5.0 14.3 11.0 21.3 16.5 8.4 21.3 10.3 2.0 11.6 9.5 6.0 15.6 27.4 6.7 8.9 23.9 14.9 9.1 8.0 18.3 6.6 6.3 5.8 21.7 14.8 13.8 31.7 46.2 48.5 42.2 38.4 38.4 35.4 45.6 46.5 45.2 32.2 29.2 34.3 14.0 49.0 39.2 38.0 59.3 55.7 26.0 25.9 20.2 33.6 20.8 21.1 23.9 22.4 29.0 20.2 29.8 24.8 41.2 46.2 40.6 15.0 52.6 30.6 28.1 40.9 27.9 11.8 46.4 87.9 54.7 209.0 35.0 37.7 0.0 72.3 39.0 48.3 29.4 53.1 35.8 75.3 6.4 24.0 27.6 43.7 802.8 42.8 53.2 74.2 64.1 37.8 35.2 58.4 54.7 44.6 77.9 19.1 12.9 64.9 40.7 21.3 39.0 36.3 58.6 30.7 36.5 STXBP2 "Hunc18b, UNC18B" ENSG00000076944 "Syntaxin binding protein 2" Q15833 19 7636881-7647873 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 101.5;lymphoid tissue: 101.5" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 332.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 25.5;classical monocyte: 58.1;eosinophil: 35.5;intermediate monocyte: 73.1;myeloid DC: 30.2;neutrophil: 45.6;non-classical monocyte: 101.5" "Group enriched" "Detected in all" 6 "dendritic cells: 30.2;granulocytes: 45.6;monocytes: 101.5" "Cell line enhanced" "Detected in many" "HMC-1: 56.3;U-937: 49.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015564, HPA063868" Approved Enhanced Cytosol No No 53000000 Cytosol "HPA015564: AB_1857626, HPA063868: AB_2685136" "unprognostic (1.20e-2)" "unprognostic (6.17e-3)" "unprognostic (2.85e-2)" "prognostic favorable (2.29e-4)" "unprognostic (2.54e-1)" "unprognostic (1.75e-3)" "prognostic unfavorable (4.65e-4)" "unprognostic (4.22e-3)" "unprognostic (2.35e-1)" "unprognostic (6.25e-2)" "unprognostic (1.79e-1)" "unprognostic (4.99e-2)" "unprognostic (1.51e-1)" "unprognostic (4.62e-2)" "unprognostic (2.85e-1)" "prognostic favorable (7.68e-4)" "prognostic favorable (5.13e-6)" 7.2 7.9 5.5 17.9 9.9 49.5 9.9 2.0 5.8 6.5 17.7 5.4 15.9 19.0 3.0 10.4 23.4 9.6 14.3 18.4 5.2 2.0 20.2 19.0 46.4 61.5 12.2 1.3 4.6 28.0 10.9 9.8 24.9 5.8 16.4 10.5 8.7 24.6 9.7 1.5 15.3 32.0 3.7 16.9 101.5 20.6 22.5 8.0 73.4 19.5 5.4 17.8 11.4 18.0 6.7 30.2 45.6 101.5 9.0 9.9 31.9 24.5 8.7 0.2 0.1 0.0 0.2 17.3 3.1 0.3 0.6 1.7 20.5 15.6 6.5 12.7 2.5 11.4 16.9 0.9 15.0 0.6 27.0 10.5 28.0 10.4 12.1 15.0 18.0 56.3 1.0 15.4 3.0 8.7 0.0 13.2 16.8 17.4 22.3 0.0 15.5 8.8 42.0 6.5 16.0 15.4 9.1 0.0 24.9 12.5 28.5 2.6 0.1 7.6 11.3 0.5 8.5 14.0 46.7 13.8 0.1 5.1 0.3 0.1 24.9 12.3 8.4 0.2 49.4 0.6 25.5 58.1 35.5 9.6 73.1 7.7 6.3 7.3 8.6 30.2 6.7 5.2 6.2 45.6 9.0 101.5 11.5 9.9 31.9 5.5 9.9 2.0 5.8 5.2 2.0 12.2 1.3 5.8 8.0 0.0 7.7 46.2 41.5 20.9 3.5 0.7 40.8 5.3 3.4 33.2 2.0 85.8 28.2 91.9 74.2 5.9 162.4 23.3 104.4 107.0 3.1 43.4 72.5 17.3 155.4 0.0 57.4 21.5 332.1 169.0 1.7 76.6 13.5 138.9 84.0 0.8 109.9 133.3 1.8 54.9 3.9 6.5 1.4 29.3 18.1 18.6 127.9 56.4 58.5 59.5 STYK1 "DKFZp761P1010, NOK, SuRTK106" ENSG00000060140 "Serine/threonine/tyrosine kinase 1" Q6J9G0 12 10618939-10674318 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.8;stomach 1: 16.0" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 8.1;Enterocytes: 12.5;Mucus-secreting cells: 8.3;Paneth cells: 9.5;Undifferentiated cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "NK-cell: 12.5" "Lineage enriched" "Detected in many" 7 "NK-cells: 12.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.5;HDLM-2: 10.9;HMC-1: 12.1;HUVEC TERT2: 16.6;TIME: 15.4" "Region enhanced" "Detected in single" "basal ganglia: 2.3" "Not detected" "Not detected" "HPA040468, HPA048569" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA040468: AB_2676998, HPA048569: AB_2680446" "unprognostic (2.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-1)" "unprognostic (3.11e-2)" "unprognostic (3.35e-2)" "unprognostic (6.85e-2)" "unprognostic (5.08e-3)" "unprognostic (3.37e-1)" "unprognostic (3.50e-1)" "unprognostic (2.21e-3)" "unprognostic (1.02e-1)" "unprognostic (1.70e-14)" "unprognostic (5.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" 0.6 0.3 2.6 2.3 10.6 1.0 3.8 0.1 13.4 2.2 14.4 0.7 0.5 2.1 0.5 1.1 8.9 1.9 6.2 0.1 1.8 1.6 0.5 0.3 1.2 2.4 1.8 4.2 0.4 0.3 0.0 8.4 3.4 2.1 10.6 15.8 0.0 7.8 2.6 0.2 2.6 10.3 0.6 0.6 1.0 16.0 0.3 0.7 0.0 0.4 0.6 2.8 4.3 3.6 0.0 0.0 0.4 0.0 12.5 1.9 0.2 3.0 0.1 0.0 0.4 0.0 0.0 0.9 4.9 0.5 2.3 2.2 1.6 18.5 0.2 3.1 1.2 2.9 0.8 1.0 5.1 4.9 10.9 0.3 0.7 1.3 0.1 0.0 1.4 12.1 0.2 0.3 3.4 0.2 0.4 16.6 0.1 0.2 0.2 5.3 1.7 0.1 0.8 2.7 7.5 1.3 0.0 1.4 0.2 1.6 9.5 0.6 0.0 2.8 2.9 0.0 4.5 2.3 0.3 15.4 0.6 2.6 0.3 0.6 0.0 0.6 0.1 2.1 0.1 3.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.4 12.5 0.0 0.0 0.0 0.2 2.6 10.6 0.1 13.4 1.8 1.6 1.8 4.2 2.1 0.7 0.0 2.1 0.0 0.6 0.2 0.4 0.4 2.5 8.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 12.5 0.0 0.2 0.5 0.0 5.9 1.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 3.6 9.5 0.0 0.0 0.3 0.0 0.1 0.0 0.9 0.9 0.2 0.7 6.8 4.8 SUCNR1 GPR91 ENSG00000198829 "Succinate receptor 1" Q9BXA5 3 151873643-151884619 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 63.1;lymphoid tissue: 23.3" "Group enriched" "Detected in some" 5 "Distal tubular cells: 16.6;Hofbauer cells: 18.9;Kupffer cells: 22.2;Macrophages: 11.8;Proximal tubular cells: 31.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "eosinophil: 2.0;intermediate monocyte: 1.0;non-classical monocyte: 1.7;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 20 "dendritic cells: 2.2;granulocytes: 2.0;monocytes: 1.7" "Group enriched" "Detected in some" 5 "HEL: 28.0;NB-4: 16.2;U-937: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" CAB022745 Uncertain NA NA "CAB022745: " "unprognostic (1.54e-1)" "unprognostic (2.65e-2)" "unprognostic (3.45e-2)" "unprognostic (6.94e-2)" "unprognostic (1.58e-1)" "unprognostic (6.01e-2)" "unprognostic (3.17e-1)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" "unprognostic (1.04e-1)" "unprognostic (8.92e-2)" "unprognostic (2.59e-1)" "unprognostic (1.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.14e-2)" "unprognostic (7.49e-2)" "unprognostic (1.58e-1)" 13.7 1.6 0.6 0.7 0.9 4.7 1.6 0.2 1.2 0.3 0.5 0.7 0.0 0.7 0.4 0.6 0.5 0.3 0.2 2.8 0.4 0.4 63.1 3.6 2.2 3.3 0.6 0.1 0.7 0.4 4.2 0.3 0.2 0.8 0.5 0.5 0.1 1.3 0.0 0.3 0.7 0.5 0.3 0.5 23.3 6.7 0.4 0.0 1.3 14.6 0.8 0.3 0.7 0.3 0.0 2.2 2.0 1.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 4.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.1 2.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 1.7 2.2 0.0 0.2 0.6 0.9 0.2 1.2 0.4 0.4 0.6 0.1 0.8 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.4 0.0 2.7 0.0 3.5 0.0 0.0 16.6 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.2 18.9 0.0 0.0 0.0 22.2 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 SUCO "C1orf9, CH1, OPT, SLP1" ENSG00000094975 "SUN domain containing ossification factor" Q9UBS9 1 172532349-172611833 "Predicted membrane proteins" Osteogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047251 Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA 14000 "Nucleoli fibrillar center, Cytosol" "HPA047251: AB_2679999" "unprognostic (1.28e-2)" "unprognostic (6.38e-3)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.12e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (2.86e-4)" "unprognostic (4.57e-2)" "unprognostic (1.92e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-2)" "unprognostic (5.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.20e-2)" "unprognostic (7.05e-2)" 8.8 9.2 8.0 6.2 9.8 43.4 9.0 7.9 8.4 8.9 7.6 6.5 48.6 6.1 8.1 39.5 8.3 9.9 7.3 8.0 7.6 8.3 11.2 8.0 6.4 5.5 7.5 5.1 13.4 24.7 16.9 24.7 18.2 8.7 9.0 5.9 9.4 13.0 52.5 2.8 8.7 22.9 6.1 8.8 7.1 8.0 14.3 8.0 11.1 11.0 6.0 7.1 10.7 9.1 9.5 7.7 11.3 6.7 10.4 8.9 4.6 13.9 6.3 18.3 16.3 9.4 9.1 20.7 17.0 10.0 10.8 13.3 11.2 15.0 7.0 10.3 9.7 11.1 22.1 7.8 6.7 18.7 4.0 5.6 5.5 3.9 6.8 11.0 8.7 7.9 8.1 6.8 13.3 11.0 33.7 9.3 8.1 3.5 10.0 16.2 3.3 5.8 6.0 16.6 16.1 14.7 5.9 10.6 4.5 16.8 19.6 9.9 12.7 7.8 13.6 14.9 32.9 13.4 9.6 12.2 9.8 10.4 9.4 17.3 15.2 12.2 12.7 9.5 4.6 15.4 9.4 6.6 11.3 8.6 6.0 8.3 8.3 7.8 7.2 5.4 9.5 8.7 8.9 6.1 10.4 6.7 7.7 5.6 4.6 8.0 9.8 7.9 8.4 7.6 8.3 7.5 5.1 8.7 8.0 44.7 22.8 15.2 31.2 23.4 41.5 21.5 7.6 32.1 46.6 26.2 47.1 30.1 3.3 13.2 28.0 22.2 15.8 23.3 27.4 21.5 20.9 37.1 12.8 13.9 11.7 44.5 25.3 11.6 10.8 39.6 42.3 14.1 25.3 16.2 24.1 65.0 22.9 7.0 26.5 11.8 49.4 25.8 15.3 44.7 24.5 23.6 41.3 20.3 9.9 30.9 SULF2 "HSULF-2, KIAA1247, SULF-2" ENSG00000196562 "Sulfatase 2" Q8IWU5 20 47656348-47786616 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 66.2;Peritubular cells: 71.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "basophil: 12.7;classical monocyte: 11.0;intermediate monocyte: 9.2;myeloid DC: 11.5;neutrophil: 17.2;non-classical monocyte: 4.4;plasmacytoid DC: 14.7" "Group enriched" "Detected in many" 88 "dendritic cells: 14.7;granulocytes: 17.2;monocytes: 11.0" "Cell line enhanced" "Detected in many" "EFO-21: 48.4;HaCaT: 32.1;HBEC3-KT: 36.2;hTCEpi: 116.5;MCF7: 94.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002325 Approved "Intracellular and membrane" NA NA 200000 "HPA002325: AB_1080126" "unprognostic (4.06e-2)" "prognostic unfavorable (6.43e-5)" "unprognostic (4.39e-1)" "unprognostic (8.99e-2)" "unprognostic (2.65e-1)" "unprognostic (9.08e-2)" "unprognostic (1.87e-1)" "unprognostic (2.48e-2)" "unprognostic (1.81e-2)" "unprognostic (3.04e-2)" "unprognostic (1.53e-3)" "unprognostic (1.85e-1)" "prognostic unfavorable (4.02e-4)" "unprognostic (7.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.09e-1)" "unprognostic (7.14e-3)" 16.2 3.9 13.3 15.1 11.2 3.7 13.6 7.4 22.4 42.5 17.8 10.8 3.7 11.1 51.8 13.7 30.2 24.4 24.8 15.1 16.8 11.5 21.9 14.2 5.1 24.9 13.0 9.9 58.7 3.4 2.1 17.1 12.4 28.2 10.4 17.3 19.4 11.6 9.1 14.1 9.8 8.2 33.6 6.3 5.4 6.9 13.9 9.3 2.5 13.9 7.9 14.1 16.1 19.4 0.1 14.7 17.2 11.0 0.0 0.1 3.1 0.0 2.8 13.3 0.0 2.8 0.3 1.2 2.2 0.0 0.2 0.4 5.0 6.8 0.5 48.4 2.3 0.7 32.1 3.8 36.2 0.1 0.0 2.8 0.0 3.6 11.2 2.5 0.0 0.7 15.1 116.5 0.2 1.6 0.0 2.5 0.0 0.0 21.5 0.2 94.7 0.0 0.1 2.6 0.0 29.4 0.0 0.0 5.3 28.1 0.1 1.1 0.3 4.6 0.0 0.0 18.2 0.1 0.3 2.4 0.0 0.3 0.0 3.1 0.7 0.2 0.1 0.0 0.0 0.4 12.7 11.0 1.0 0.0 9.2 0.1 0.1 0.0 0.0 11.5 0.1 0.0 0.0 17.2 0.0 4.4 14.7 0.0 3.1 13.3 11.2 7.4 11.0 16.8 11.5 13.0 9.9 28.2 9.3 8.9 11.1 28.2 6.5 9.3 10.1 6.2 12.7 0.0 1.2 15.7 0.0 6.1 0.0 5.2 2.5 48.1 17.1 0.0 1.9 6.4 11.1 6.0 1.1 16.3 4.9 33.4 26.2 45.4 19.8 5.1 26.7 32.0 10.1 53.3 5.9 8.4 3.1 66.2 71.8 13.3 5.2 0.0 8.2 0.9 3.0 7.3 13.7 13.1 20.1 7.4 SUMF2 DKFZp566I1024 ENSG00000129103 "Sulfatase modifying factor 2" Q8NBJ7 7 56064002-56080670 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024040, CAB025743, HPA074892" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" Yes No 730000 "Vesicles, Plasma membrane" "CAB025743: , HPA024040: AB_1857651, HPA074892: " "unprognostic (2.93e-1)" "prognostic unfavorable (6.58e-6)" "unprognostic (2.42e-2)" "prognostic favorable (3.96e-4)" "unprognostic (3.87e-2)" "unprognostic (9.11e-3)" "unprognostic (1.69e-2)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.20e-2)" "unprognostic (1.92e-1)" "unprognostic (7.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.74e-2)" "unprognostic (2.64e-1)" "unprognostic (1.99e-3)" "prognostic unfavorable (7.71e-4)" 26.8 38.3 13.0 17.7 17.0 15.4 26.2 10.9 28.2 35.0 31.9 24.8 35.4 31.1 32.2 32.3 23.8 37.8 51.2 16.8 12.8 11.6 36.0 40.4 30.2 25.9 19.8 18.0 28.6 91.0 34.7 18.3 37.5 20.7 29.5 25.0 25.0 39.7 37.1 14.0 23.6 35.1 27.2 19.6 27.0 32.9 16.2 17.6 29.8 33.3 15.1 25.1 29.1 23.1 21.0 43.1 17.1 28.5 15.7 33.4 28.5 64.4 19.5 8.5 39.3 42.0 29.1 13.2 21.1 29.6 17.8 22.2 10.6 52.4 10.1 18.3 30.2 17.3 32.8 5.1 24.4 11.9 16.5 8.2 6.5 12.8 9.9 27.2 15.9 20.8 23.0 24.0 16.0 27.9 36.2 26.2 18.7 20.6 45.4 28.6 14.2 13.5 18.7 11.6 50.2 9.9 10.9 8.7 65.0 24.3 7.1 10.0 12.2 26.5 56.1 25.9 19.9 56.3 26.5 21.6 16.5 23.6 40.4 18.1 30.9 23.5 15.1 27.1 30.1 52.6 17.1 21.0 7.5 26.2 27.4 33.4 21.0 25.6 26.2 24.8 18.7 28.5 27.7 1.3 15.7 28.5 43.1 26.8 28.5 13.0 17.0 10.9 28.2 12.8 11.6 19.8 18.0 20.7 17.6 53.6 29.1 34.1 31.9 30.0 26.4 8.5 76.5 34.8 25.0 85.5 13.7 39.0 16.6 71.5 2.7 41.8 53.0 23.3 48.6 78.8 43.6 38.3 53.1 70.4 61.1 41.3 57.0 43.0 64.9 5.8 64.5 46.7 50.6 84.8 54.5 25.7 53.3 63.1 44.6 36.9 12.1 51.8 39.4 16.8 23.6 36.6 39.0 50.0 78.0 31.5 SUN1 "FLJ12407, KIAA0810, UNC84A" ENSG00000164828 "Sad1 and UNC84 domain containing 1" O94901 7 816615-896435 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Meiosis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 286.8;Late spermatids: 435.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008346, HPA008461" Enhanced Enhanced "Nuclear membrane" NA NA "Nuclear membrane" "HPA008346: AB_1080462, HPA008461: AB_1080461" "unprognostic (2.70e-2)" "unprognostic (1.51e-2)" "unprognostic (1.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.25e-1)" "unprognostic (2.57e-3)" "unprognostic (1.82e-1)" "unprognostic (1.67e-1)" "unprognostic (4.57e-2)" "unprognostic (3.32e-2)" "unprognostic (1.69e-1)" "unprognostic (8.10e-2)" "unprognostic (1.08e-2)" "unprognostic (1.47e-2)" "unprognostic (4.63e-2)" "unprognostic (1.34e-1)" "unprognostic (9.33e-2)" 29.8 14.5 18.2 17.2 23.6 4.0 26.0 49.6 28.9 31.1 22.5 23.6 18.9 18.1 47.1 22.6 24.2 28.5 20.0 40.8 16.6 14.9 19.4 13.4 19.6 11.6 15.9 21.3 39.6 22.4 37.5 26.8 25.3 18.0 18.8 16.8 27.6 19.5 19.7 56.7 46.1 17.9 33.6 15.3 17.6 23.9 36.4 15.4 11.8 20.1 31.0 17.8 20.3 25.3 8.0 8.1 7.6 10.2 6.7 13.2 6.5 38.7 10.5 12.7 20.6 14.0 20.1 12.4 9.8 16.5 18.3 18.8 8.9 43.8 9.3 10.2 13.4 36.1 48.9 10.3 17.4 17.9 3.9 10.4 3.0 15.4 8.4 18.0 4.6 7.7 10.0 20.8 14.6 24.4 17.1 13.3 5.9 12.5 7.0 18.3 13.4 3.0 7.6 17.6 13.4 12.2 6.6 7.0 8.7 18.7 12.5 24.5 15.9 12.4 25.5 9.4 21.4 20.2 4.7 10.0 16.9 15.4 17.5 16.1 6.5 7.5 5.7 11.6 3.8 23.2 7.6 10.2 2.6 4.7 8.8 5.0 8.0 9.2 5.3 8.1 6.8 13.2 8.2 0.6 6.7 6.3 1.6 7.7 6.5 18.2 23.6 49.6 28.9 16.6 14.9 15.9 21.3 18.0 15.4 41.7 34.2 14.9 83.2 94.7 70.8 83.7 30.6 73.6 47.8 38.4 82.5 26.8 23.2 36.0 286.8 74.1 41.1 23.3 20.1 19.4 40.9 82.0 16.2 36.5 14.8 106.5 39.1 67.5 19.0 435.0 52.9 19.2 40.5 3.6 39.1 23.8 40.3 52.6 40.0 19.3 66.7 64.7 64.5 30.9 48.0 74.9 32.2 15.0 33.0 105.6 SUN2 UNC84B ENSG00000100242 "Sad1 and UNC84 domain containing 2" Q9UH99 22 38734725-38794143 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "T-cells: 112.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001209 Supported Supported "Nuclear membrane" NA Yes "Nuclear membrane" "HPA001209: AB_1080465" "unprognostic (9.76e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" "unprognostic (5.09e-2)" "unprognostic (1.36e-1)" "unprognostic (5.57e-2)" "unprognostic (1.94e-2)" "unprognostic (2.37e-2)" "unprognostic (3.14e-2)" "unprognostic (1.25e-3)" "unprognostic (8.15e-2)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (8.10e-2)" "unprognostic (2.33e-2)" 59.3 22.9 28.7 41.7 58.7 84.6 66.9 17.6 43.8 33.7 33.6 57.5 24.2 29.0 47.3 23.3 41.4 42.5 25.3 32.3 37.8 19.3 24.4 47.1 37.7 56.8 73.6 25.4 44.8 44.1 10.5 14.8 22.7 42.5 31.2 16.3 14.9 39.1 35.0 48.6 31.0 31.6 35.3 37.1 46.3 35.2 30.2 68.0 42.6 26.9 20.1 36.0 47.0 35.9 6.4 6.0 14.0 13.9 13.3 25.5 11.8 25.1 11.7 11.7 13.0 35.7 8.9 15.3 17.3 20.3 20.6 17.5 10.5 28.5 7.9 21.2 24.5 12.7 18.8 3.9 12.8 8.5 27.5 15.8 5.1 12.6 9.4 21.7 17.4 54.3 7.5 10.9 9.8 9.2 13.9 16.3 16.0 6.5 45.0 11.1 8.0 9.6 15.1 1.1 17.8 7.6 16.1 16.4 23.8 5.1 12.3 10.4 3.8 19.3 21.5 10.1 5.7 14.4 32.7 27.3 15.0 13.1 13.1 22.4 33.3 10.4 8.4 27.8 21.0 25.0 14.0 7.4 9.7 25.5 8.8 16.5 6.3 16.2 20.6 6.0 6.4 17.1 20.1 8.0 13.3 13.9 3.7 11.0 11.8 28.7 58.7 17.6 43.8 37.8 19.3 73.6 25.4 42.5 68.0 20.8 22.2 33.6 23.8 16.1 8.4 2.2 35.7 2.7 17.0 31.4 7.9 11.6 3.3 30.6 1.7 29.2 45.1 23.3 41.2 49.9 28.2 22.7 25.3 93.6 23.5 20.6 17.9 30.1 39.8 2.0 56.7 37.5 16.9 3.6 25.6 21.7 45.2 31.3 61.5 16.3 12.4 51.8 34.0 0.9 0.7 15.1 12.4 112.3 17.8 18.0 SURF4 "ERV29, FLJ22993, MGC102753" ENSG00000148248 "Surfeit 4" O15260 9 133361449-133376166 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 272.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064613 Approved NA NA 470000 "HPA064613: AB_2685299" "prognostic unfavorable (5.85e-4)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (2.04e-2)" "unprognostic (3.40e-2)" "prognostic unfavorable (1.47e-5)" "prognostic unfavorable (8.11e-4)" "unprognostic (1.10e-3)" "unprognostic (3.13e-2)" "unprognostic (1.90e-1)" "unprognostic (5.30e-3)" "unprognostic (1.23e-1)" "unprognostic (9.76e-3)" "unprognostic (7.58e-3)" "unprognostic (1.25e-1)" "unprognostic (2.29e-1)" "unprognostic (4.29e-3)" 31.1 33.7 11.4 19.0 15.3 29.1 34.4 9.9 23.4 24.0 36.9 19.3 29.5 40.4 26.6 27.2 24.6 23.5 32.4 24.4 10.9 11.0 28.6 120.0 27.1 26.7 12.6 12.1 27.2 60.3 16.8 29.4 48.7 13.2 22.3 20.0 18.9 65.6 30.8 18.0 19.2 61.5 22.5 13.5 19.8 26.2 26.5 11.5 21.3 35.5 21.0 23.2 20.2 20.6 7.7 18.9 18.8 19.0 13.7 29.7 28.0 14.5 24.3 16.8 23.1 35.6 37.3 32.8 45.3 45.5 32.9 32.6 36.4 21.5 10.2 17.6 63.9 31.9 38.5 19.3 23.9 25.4 21.3 11.2 17.9 23.1 38.6 41.4 30.6 24.3 39.8 22.2 28.2 31.4 26.5 30.2 16.0 21.3 28.3 41.9 32.6 14.6 28.4 18.4 40.5 23.3 10.1 23.2 38.6 25.9 14.2 13.8 16.9 34.0 25.8 23.4 16.7 27.3 18.9 31.7 46.9 16.7 35.4 29.5 14.6 20.4 11.6 43.5 16.6 35.0 18.8 19.0 16.6 27.0 15.7 29.7 7.7 19.2 24.7 16.3 6.3 11.8 18.2 13.8 13.7 14.0 18.9 22.3 28.0 11.4 15.3 9.9 23.4 10.9 11.0 12.6 12.1 13.2 11.5 41.7 40.8 25.7 53.2 54.0 19.6 33.9 20.4 8.1 25.0 33.2 37.3 139.2 16.6 91.6 24.8 37.0 108.9 23.3 102.3 209.4 84.5 89.9 24.3 194.5 78.7 31.8 72.2 60.8 48.4 14.2 63.3 37.8 38.8 50.5 87.5 56.5 101.3 60.4 49.8 44.4 23.7 77.6 66.9 54.4 43.9 54.5 272.0 74.0 55.4 60.0 SUSD1 DKFZP761E1824 ENSG00000106868 "Sushi domain containing 1" Q6UWL2 9 112040785-112175408 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 24.1;monocytes: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 24.9" "Lineage enriched" "Detected in many" 4 "dendritic cells: 24.9" "Cell line enhanced" "Detected in many" "HDLM-2: 22.7;HEL: 25.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048554 Approved Approved Nucleoplasm "Intracellular and membrane" NA NA 530000 Nucleoplasm "HPA048554: AB_2680439" "unprognostic (2.25e-1)" "unprognostic (4.02e-2)" "unprognostic (1.42e-2)" "unprognostic (1.62e-1)" "unprognostic (9.29e-3)" "unprognostic (5.27e-2)" "unprognostic (1.69e-2)" "unprognostic (3.73e-2)" "unprognostic (1.23e-2)" "unprognostic (1.29e-3)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "prognostic favorable (3.63e-6)" "unprognostic (2.14e-3)" "unprognostic (8.38e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" 9.6 13.9 9.1 9.7 13.9 14.1 8.4 3.1 15.3 7.6 10.2 2.7 11.6 8.6 5.7 9.8 4.8 6.7 7.6 11.2 6.1 16.4 15.5 4.4 11.5 15.7 8.3 8.2 3.3 8.1 9.4 8.2 23.3 7.4 5.8 11.4 8.1 10.7 12.8 2.9 3.6 9.9 9.3 5.1 14.5 12.2 5.8 3.5 9.6 5.6 1.4 6.6 13.1 4.6 0.2 24.9 5.8 2.7 1.7 1.6 1.1 1.3 8.5 6.1 0.0 4.5 3.0 19.5 5.4 7.3 7.7 9.9 16.9 11.4 0.1 6.1 9.5 0.5 3.9 2.1 1.0 5.8 22.7 1.8 25.7 6.2 11.4 5.4 6.7 8.3 3.7 0.8 4.3 0.1 5.3 17.9 3.8 13.9 1.1 4.8 1.6 0.9 4.1 2.0 21.0 1.3 5.7 1.4 0.0 1.8 4.5 2.1 5.2 3.0 0.6 0.0 3.5 1.0 7.3 13.6 0.1 2.9 0.8 0.0 0.3 0.3 0.5 5.3 2.6 1.6 3.5 1.4 5.8 1.6 1.6 0.5 0.1 0.4 1.1 1.0 0.2 0.2 1.2 0.5 1.7 2.7 24.9 0.1 1.1 9.1 13.9 3.1 15.3 6.1 16.4 8.3 8.2 7.4 3.5 0.0 4.5 1.5 1.2 0.5 0.0 1.9 2.5 6.7 5.7 12.2 0.0 7.4 0.0 5.6 1.7 2.3 4.7 0.0 6.2 8.8 4.0 1.8 5.7 0.0 14.2 0.0 4.1 10.4 24.1 1.2 0.0 10.8 0.0 18.0 4.5 0.0 8.8 3.5 1.8 1.7 1.6 0.0 3.8 0.3 0.3 0.6 7.2 4.9 5.6 7.3 SUSD2 "BK65A6.2, FLJ22778" ENSG00000099994 "Sushi domain containing 2" Q9UGT4 22 24181259-24189110 "Predicted membrane proteins" Receptor "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 100.1" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 232.3;Alveolar cells type 2: 121.0" "Cancer enhanced" "Detected in all" "testis cancer: 64.5" "Region enhanced" "Detected in many" "pons and medulla: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "SK-BR-3: 138.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA004117 Enhanced Approved "Plasma membrane" NA NA 3600000 "Plasma membrane" "HPA004117: AB_1857674" "unprognostic (5.24e-3)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-2)" "unprognostic (5.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.89e-2)" "unprognostic (5.87e-2)" "unprognostic (1.20e-2)" "unprognostic (9.74e-3)" "unprognostic (8.97e-2)" "prognostic unfavorable (3.29e-5)" "unprognostic (2.72e-2)" "unprognostic (2.82e-2)" "unprognostic (1.88e-2)" "unprognostic (3.33e-3)" 6.0 4.2 0.3 1.4 0.9 0.5 11.3 3.8 1.4 10.5 10.5 2.5 1.3 7.8 7.1 8.3 2.8 6.9 5.3 10.8 0.6 2.9 19.5 1.2 100.1 1.4 0.6 2.6 2.6 2.4 1.3 3.6 3.5 9.6 2.8 1.0 2.2 7.9 4.0 3.0 11.8 32.4 2.4 3.0 1.6 2.5 1.9 0.7 0.1 12.7 5.9 1.5 2.3 4.7 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.7 1.5 0.0 0.0 3.0 3.9 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.2 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.2 0.0 0.0 3.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 2.1 0.1 138.9 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 3.8 1.4 0.6 2.9 0.6 2.6 9.6 0.7 232.3 121.0 0.0 0.2 0.2 0.0 2.8 0.0 5.3 33.0 1.8 0.0 14.1 5.0 0.0 0.0 0.3 1.6 0.0 0.0 0.4 3.5 0.8 3.5 0.0 0.9 0.0 1.7 4.3 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 24.9 0.0 0.0 15.1 0.9 0.9 2.4 22.1 0.0 0.0 0.5 SUSD3 MGC26847 ENSG00000157303 "Sushi domain containing 3" Q96L08 9 93058688-93085138 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 52.8;testis: 64.8" "Cell type enhanced" "Detected in many" 8 "B-cells: 27.5;Hepatocytes: 48.7;Hofbauer cells: 38.0;Proximal tubular cells: 50.4;T-cells: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 51.7;Karpas-707: 11.5;MCF7: 12.5;NB-4: 26.4;RPMI-8226: 28.0;THP-1: 11.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042310 Uncertain NA NA "HPA042310: AB_10796902" "prognostic favorable (5.13e-4)" "unprognostic (5.42e-2)" "unprognostic (3.65e-1)" "unprognostic (8.34e-3)" "unprognostic (9.06e-2)" "unprognostic (2.84e-2)" "unprognostic (2.94e-2)" "unprognostic (7.41e-3)" "unprognostic (5.06e-2)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (3.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.39e-3)" "unprognostic (5.33e-2)" 3.2 1.0 3.3 16.9 3.2 18.7 8.0 1.2 3.2 8.3 3.3 8.5 0.6 2.2 11.6 12.8 1.9 18.2 1.9 1.0 2.4 2.7 18.5 13.9 3.8 25.8 4.0 2.3 20.9 0.8 0.2 3.2 1.4 3.7 1.8 0.9 3.0 7.5 1.5 0.4 1.6 9.7 3.0 5.4 20.2 1.9 64.8 3.1 13.9 2.5 0.8 19.9 3.0 3.7 20.4 9.2 16.7 3.9 2.2 52.8 17.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.1 1.1 0.4 51.7 0.2 0.2 0.0 0.1 0.8 0.0 0.0 4.5 0.0 7.0 0.0 0.8 3.4 0.0 1.6 3.6 0.2 0.0 0.0 0.0 0.0 0.0 2.1 11.5 0.0 12.5 0.0 26.4 0.6 0.4 1.6 2.2 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 6.8 11.9 0.1 0.0 0.0 0.0 0.0 2.3 1.2 3.2 0.0 0.0 0.1 0.1 3.9 16.7 5.7 3.4 6.4 20.4 30.1 10.5 9.2 14.4 52.8 21.3 1.3 2.2 0.6 0.8 39.8 17.0 3.3 3.2 1.2 3.2 2.4 2.7 4.0 2.3 3.7 3.1 0.0 7.9 27.5 0.1 0.6 0.2 0.6 15.3 1.4 0.0 0.0 3.9 0.8 8.3 0.6 2.4 0.4 0.0 0.0 0.2 1.5 1.5 0.6 3.5 48.7 38.0 0.0 0.0 1.8 10.8 9.0 5.2 8.5 1.7 1.0 0.1 0.5 0.4 0.0 4.9 50.4 7.8 0.0 0.9 2.1 2.7 0.3 1.1 30.9 0.4 0.2 SUSD4 FLJ10052 ENSG00000143502 "Sushi domain containing 4" Q5VX71 1 223220819-223364202 "Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.0;esophagus: 33.8" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 26.6;Horizontal cells: 20.6;Leydig cells: 19.0;Urothelial cells: 26.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 7.4;naive CD4 T-cell: 11.7" "Lineage enriched" "Detected in single" 66 "T-cells: 11.7" "Cell line enhanced" "Detected in some" "HaCaT: 7.1;RPTEC TERT1: 8.4;SCLC-21H: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058296 Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA058296: AB_2683672" "unprognostic (2.90e-1)" "unprognostic (2.90e-3)" "unprognostic (1.27e-3)" "prognostic unfavorable (4.28e-4)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (7.53e-3)" "unprognostic (1.82e-3)" "unprognostic (7.94e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-3)" "unprognostic (1.36e-1)" "unprognostic (6.51e-6)" "unprognostic (3.64e-2)" "unprognostic (5.11e-2)" "unprognostic (3.03e-1)" "unprognostic (7.11e-2)" 0.8 5.2 15.9 1.5 33.0 0.9 8.1 9.9 21.3 3.4 0.9 4.0 4.7 1.5 0.9 24.3 33.8 3.6 1.3 9.6 30.6 14.6 13.7 4.0 3.2 1.9 6.8 12.8 27.8 7.6 8.3 16.5 1.0 6.6 4.4 0.8 1.2 13.2 5.7 1.2 3.5 0.9 0.9 2.4 0.8 7.6 5.1 3.8 0.3 1.5 8.1 13.8 2.7 9.1 0.0 0.0 0.0 0.1 0.1 11.7 1.8 4.3 0.4 0.1 0.0 0.0 0.0 0.1 0.6 0.3 0.7 0.5 4.5 1.3 0.0 1.4 0.1 0.0 7.1 0.2 1.1 0.7 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.1 0.0 5.0 0.4 0.0 0.3 3.2 3.1 0.0 0.1 2.1 0.9 0.0 0.1 0.0 8.4 2.0 29.0 0.3 0.0 2.4 0.0 0.6 1.8 0.2 0.0 1.3 5.2 0.0 2.6 0.5 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.1 6.0 0.0 7.4 1.9 0.0 0.0 11.7 2.1 0.0 0.1 0.0 0.0 1.0 1.8 15.9 33.0 9.9 17.9 30.6 14.6 6.8 12.8 6.6 3.8 0.0 4.5 0.0 5.3 0.6 15.9 9.1 0.0 8.1 12.5 15.7 9.8 0.0 26.6 0.6 2.5 0.4 0.0 0.0 6.3 0.0 0.7 6.8 0.0 1.5 2.1 20.6 1.2 0.0 0.0 2.8 19.0 0.1 5.0 0.0 0.0 1.1 2.7 0.0 11.7 0.2 6.1 0.0 1.0 0.5 5.9 1.5 0.0 1.3 0.0 26.8 SUSD5 KIAA0527 ENSG00000173705 "Sushi domain containing 5" O60279 3 33150042-33219215 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Sertoli cells: 32.3;Smooth muscle cells: 13.0" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.9;neutrophil: 1.5" "Group enriched" "Detected in many" 9 "B-cells: 1.9;granulocytes: 1.5" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 14.8;HUVEC TERT2: 36.7;LHCN-M2: 14.2;TIME: 14.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052788 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA 4300000 "Golgi apparatus, Vesicles" "HPA052788: AB_2681948" "unprognostic (1.81e-1)" "unprognostic (1.52e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-3)" "unprognostic (1.39e-3)" "unprognostic (4.05e-2)" "unprognostic (3.72e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-3)" "unprognostic (6.45e-2)" "unprognostic (8.46e-2)" "unprognostic (1.89e-2)" 7.6 2.5 7.0 1.5 6.1 0.4 2.5 2.0 13.2 11.0 2.6 4.6 2.3 1.5 7.0 6.5 2.3 7.9 13.1 5.7 6.4 8.1 2.6 1.1 3.0 4.4 6.9 6.9 6.4 1.2 1.0 1.3 0.5 6.3 1.9 2.2 3.7 1.3 10.7 2.2 2.8 2.7 7.7 4.6 3.9 3.3 4.7 3.3 0.0 5.3 2.9 8.1 3.0 3.5 1.9 0.1 1.5 0.1 0.1 0.1 0.1 0.0 0.5 0.6 0.3 0.8 0.1 0.0 4.5 1.6 14.8 5.0 0.0 0.0 0.0 4.2 1.1 4.6 0.0 6.4 2.1 6.1 0.1 7.1 0.0 1.0 0.0 0.1 0.0 0.0 0.6 1.1 9.5 1.8 7.2 36.7 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 1.1 0.3 0.8 0.9 14.4 0.0 7.0 0.6 2.1 0.0 0.3 0.0 0.1 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.9 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.1 7.0 6.1 2.0 13.2 6.4 8.1 6.9 6.9 6.3 3.3 0.0 0.0 0.0 0.0 0.9 1.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 3.2 0.0 0.6 1.3 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 32.3 13.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 SUSD6 KIAA0247 ENSG00000100647 "Sushi domain containing 6" Q92537 14 69611596-69715142 "Predicted membrane proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030464 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA030464: AB_10601128" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "unprognostic (1.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.46e-2)" "unprognostic (2.17e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-1)" "unprognostic (3.66e-3)" "unprognostic (1.10e-2)" "unprognostic (6.70e-2)" "prognostic favorable (2.16e-4)" "unprognostic (1.10e-2)" "unprognostic (5.35e-2)" "unprognostic (1.30e-2)" "unprognostic (2.34e-1)" 25.4 17.4 9.2 26.0 11.9 40.2 19.5 36.4 12.3 12.1 25.0 15.5 14.8 17.2 13.0 31.0 27.0 16.1 19.6 13.2 11.4 8.4 16.7 11.6 30.9 25.3 15.1 8.2 13.4 20.9 13.7 14.6 14.1 13.9 16.0 13.4 14.6 26.6 17.5 10.6 22.5 36.7 14.0 14.1 30.9 17.3 9.1 12.9 12.7 23.4 14.8 27.4 16.4 15.3 4.1 5.3 23.1 9.1 2.9 4.2 5.0 10.8 2.8 4.1 3.7 8.4 6.2 7.5 6.2 13.1 3.5 3.4 3.3 9.7 12.8 7.0 7.7 2.8 15.3 2.3 12.7 3.3 21.8 1.7 10.4 2.2 5.5 13.6 1.7 27.0 9.9 12.7 5.9 11.1 3.8 7.2 4.0 3.1 11.4 4.9 5.3 2.5 4.5 0.8 6.4 2.9 4.3 3.6 5.1 6.8 5.6 1.7 2.8 5.1 14.8 2.2 3.1 6.0 4.7 11.1 8.2 4.9 5.1 2.5 8.0 1.7 9.1 5.3 5.8 4.3 8.9 7.5 8.3 4.1 7.3 4.2 3.9 3.6 2.5 5.3 4.1 3.5 2.5 23.1 2.9 9.1 3.0 3.2 5.0 9.2 11.9 36.4 12.3 11.4 8.4 15.1 8.2 13.9 12.9 11.9 28.8 5.7 25.4 0.0 16.6 11.8 35.7 20.1 20.5 17.4 19.6 3.8 6.6 22.7 0.6 24.8 36.2 23.3 21.3 1.5 7.9 43.6 8.1 12.8 21.0 14.3 7.0 19.6 57.1 1.5 4.9 22.6 0.0 2.8 14.9 3.8 31.1 21.2 6.3 13.3 21.3 25.8 14.4 4.4 14.6 0.0 7.7 13.8 7.8 41.2 SV2A "KIAA0736, SV2" ENSG00000159164 "Synaptic vesicle glycoprotein 2A" Q7L0J3 1 149903318-149917882 "FDA approved drug targets, Predicted membrane proteins" "Neurotransmitter transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3;parathyroid gland: 34.0" "Group enriched" "Detected in many" 6 "Bipolar cells: 95.8;Horizontal cells: 90.6;Muller glia cells: 25.1" "Cancer enriched" "Detected in many" 6 "glioma: 27.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002226, HPA007863" Enhanced Approved Cytosol NA NA Cytosol "CAB002226: AB_564144, HPA007863: AB_1080135" "unprognostic (8.05e-3)" "unprognostic (3.86e-3)" "unprognostic (2.24e-1)" "unprognostic (5.39e-2)" "unprognostic (2.66e-1)" "unprognostic (2.02e-1)" "unprognostic (6.24e-2)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (2.06e-1)" "unprognostic (9.00e-3)" "unprognostic (1.00e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.44e-2)" "unprognostic (9.86e-2)" "unprognostic (1.95e-2)" "unprognostic (4.81e-3)" 2.0 7.3 20.4 2.8 24.7 4.5 1.5 36.8 75.3 3.2 2.3 4.8 0.9 1.9 5.6 18.0 2.0 3.2 3.2 1.5 22.3 30.5 1.7 1.2 1.8 2.3 21.6 25.1 2.6 1.9 34.0 7.2 1.9 32.9 3.1 2.2 3.1 1.7 3.7 1.1 1.5 2.2 6.6 16.8 2.0 2.0 1.6 6.0 0.3 4.0 0.0 2.0 2.5 1.2 1.2 0.8 2.1 0.7 1.7 2.5 0.6 0.1 0.0 10.3 0.0 1.0 3.0 1.1 4.3 15.2 13.0 18.8 0.3 0.4 0.1 3.9 6.5 13.7 0.2 0.1 0.9 11.2 0.0 2.4 13.5 0.7 0.7 9.9 0.1 0.2 6.8 0.1 20.7 1.5 14.5 1.1 12.4 0.1 14.1 8.5 0.1 13.0 0.6 26.1 0.0 0.0 4.5 6.5 0.2 0.1 0.3 21.6 17.4 0.0 0.1 9.9 10.3 0.1 8.2 0.0 12.1 12.2 0.5 15.8 0.1 0.1 0.0 21.2 0.1 4.8 1.5 0.7 0.4 1.8 0.3 1.9 0.7 1.9 1.1 0.2 1.2 1.0 2.2 2.1 1.7 0.3 0.8 2.5 0.6 20.4 24.7 36.8 40.0 22.3 30.5 21.6 25.1 32.9 6.0 0.0 1.4 0.0 2.0 0.1 95.8 0.6 0.0 1.4 0.0 0.0 3.9 0.3 0.0 0.0 0.3 1.4 0.0 0.0 0.3 0.7 1.5 1.0 0.0 0.0 0.2 90.6 4.1 5.5 0.0 0.0 0.0 0.3 0.0 0.0 0.2 25.1 0.2 0.0 5.3 0.0 11.4 0.0 4.1 1.2 0.8 0.4 0.3 2.5 0.3 0.6 SV2B "HsT19680, KIAA0735" ENSG00000185518 "Synaptic vesicle glycoprotein 2B" Q7L1I2 15 91099950-91301309 "Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 44.2" "Group enriched" "Detected in some" 25 "Bipolar cells: 146.2;Cone photoreceptor cells: 141.4;Muller glia cells: 42.3;Rod photoreceptor cells: 121.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.7;SCLC-21H: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046247 Approved NA NA "HPA046247: AB_10963538" "unprognostic (2.92e-1)" "unprognostic (7.92e-2)" "unprognostic (1.32e-3)" "unprognostic (4.01e-5)" "unprognostic (2.66e-3)" "unprognostic (7.77e-2)" "unprognostic (3.36e-2)" "unprognostic (1.01e-1)" "unprognostic (3.57e-2)" "unprognostic (9.89e-2)" "unprognostic (1.20e-2)" "unprognostic (2.49e-1)" "unprognostic (1.39e-1)" "unprognostic (3.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-2)" "unprognostic (3.10e-4)" 3.5 2.7 13.1 1.4 16.8 1.1 1.6 26.2 44.2 1.2 1.4 1.4 0.0 1.2 1.2 1.3 1.2 1.3 1.4 1.8 19.7 3.3 1.3 1.3 1.4 1.6 5.1 21.3 1.1 3.1 1.1 1.3 1.4 25.6 2.2 1.6 7.3 2.4 1.2 1.7 1.4 1.6 1.3 1.5 1.3 1.4 2.2 0.2 0.0 1.2 0.0 2.7 1.2 0.6 0.6 0.4 1.2 0.3 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 4.7 0.0 0.1 9.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.1 0.2 1.0 0.4 1.2 0.3 0.3 0.2 0.1 0.1 0.6 0.3 0.3 0.0 0.6 0.4 0.3 1.1 0.7 0.1 0.4 0.1 0.0 13.1 16.8 26.2 31.3 19.7 3.3 5.1 21.3 25.6 0.2 0.0 0.0 0.0 0.1 0.3 146.2 2.4 2.5 0.0 0.0 0.0 141.4 0.0 0.0 2.9 4.5 2.5 0.0 0.0 4.6 0.0 0.8 0.2 0.0 0.0 0.1 3.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.3 0.1 0.0 0.0 0.0 121.8 0.0 0.0 3.9 0.2 0.1 0.0 0.0 0.0 0.1 SV2C ENSG00000122012 "Synaptic vesicle glycoprotein 2C" Q496J9 5 76083172-76353939 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 52.2" "Cell type enriched" "Detected in some" 4 "Intestinal endocrine cells: 19.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 52.2;pons and medulla: 26.6" "Cell type enriched" "Detected in single" 14 "basophil: 4.2" "Lineage enriched" "Detected in single" 21 "granulocytes: 4.2" "Group enriched" "Detected in some" 5 "Karpas-707: 12.2;SCLC-21H: 5.0;SH-SY5Y: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040722, HPA040770" Supported Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA040722: AB_10795624, HPA040770: AB_10805828" "unprognostic (7.91e-2)" "unprognostic (2.33e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-2)" "unprognostic (1.07e-1)" "unprognostic (9.93e-2)" "unprognostic (1.09e-2)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (2.34e-2)" "unprognostic (1.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" 0.5 5.5 0.8 1.3 52.2 0.7 1.2 1.2 9.5 0.7 0.8 0.5 0.0 1.0 0.7 0.9 0.6 1.8 0.6 0.8 0.6 8.3 0.4 0.4 0.4 0.5 5.6 1.9 2.6 0.8 0.9 0.8 0.4 26.6 1.0 1.1 1.1 1.7 1.2 0.3 0.7 1.3 1.0 5.8 0.6 1.6 1.0 6.7 0.0 0.5 0.0 0.4 0.6 0.4 0.1 0.1 4.2 0.2 0.1 0.2 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 12.2 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.0 11.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.2 0.8 52.2 1.2 9.5 0.6 8.3 5.6 1.9 26.6 6.7 0.0 0.0 0.0 0.5 0.0 3.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.1 0.0 19.0 0.6 0.0 0.7 0.0 0.0 3.3 0.0 0.5 0.8 0.0 0.0 0.0 0.0 4.4 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 1.1 SVOP DKFZp761H039 ENSG00000166111 "SV2 related protein" Q8N4V2 12 108907741-109021240 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 30.3" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 39.3;Early spermatids: 59.5;Late spermatids: 90.9" "Group enriched" "Detected in some" 9 "glioma: 0.6;pancreatic cancer: 1.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 13 "Karpas-707: 6.3;RPMI-8226: 6.4;SCLC-21H: 3.5;SH-SY5Y: 3.1;U-266/84: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016573 Uncertain NA NA "HPA016573: AB_2197027" "unprognostic (6.88e-2)" "unprognostic (1.10e-1)" "unprognostic (2.09e-1)" "unprognostic (6.51e-3)" "unprognostic (2.18e-2)" "unprognostic (3.79e-1)" "unprognostic (1.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.38e-2)" "unprognostic (4.29e-3)" "unprognostic (3.07e-1)" "unprognostic (4.28e-3)" "unprognostic (3.94e-2)" "unprognostic (2.26e-2)" "unprognostic (6.17e-2)" 0.6 2.9 6.9 0.7 14.0 0.7 0.6 8.2 30.3 0.6 0.8 0.5 0.0 1.3 0.6 0.7 0.6 1.1 0.6 1.1 8.9 1.9 0.7 0.6 0.7 0.6 0.7 10.0 0.6 1.7 0.5 6.8 0.6 6.4 0.8 0.8 1.5 0.6 0.7 0.7 0.6 1.0 0.6 0.8 0.6 1.8 1.0 0.7 0.0 0.7 0.0 0.5 0.6 0.7 0.6 0.4 2.0 0.4 0.9 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 6.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 3.5 3.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 2.9 0.1 0.0 0.1 0.0 1.5 0.4 0.4 0.3 0.2 0.2 0.2 0.3 0.2 0.1 0.6 0.3 0.3 2.0 0.9 0.3 0.4 0.2 0.1 6.9 14.0 8.2 21.6 8.9 1.9 0.7 10.0 6.4 0.7 11.9 11.1 0.0 0.6 0.0 15.9 1.2 0.0 0.0 9.1 1.8 39.3 1.2 0.0 0.0 59.5 0.4 0.0 0.0 0.0 0.1 0.1 0.3 2.3 0.0 0.1 11.1 16.1 1.3 0.0 90.9 0.3 0.4 0.0 0.0 0.0 1.6 0.2 0.0 0.7 0.0 20.4 0.0 0.0 0.5 0.8 0.0 0.7 0.0 0.0 0.3 SVOPL MGC46715 ENSG00000157703 "SVOP like" Q8N434 7 138594285-138701352 "Predicted membrane proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "parathyroid gland: 13.9;salivary gland: 6.5" "Cell type enriched" "Detected in some" 9 "granulocytes: 73.9" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 41 "eosinophil: 4.1" "Lineage enriched" "Detected in single" 41 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "HMC-1: 8.3;NTERA-2: 2.3;RT4: 1.9;T-47d: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA018035 Uncertain NA NA "HPA018035: AB_2197028" "unprognostic (6.70e-5)" "unprognostic (1.96e-1)" "unprognostic (1.67e-1)" "unprognostic (2.49e-1)" "unprognostic (5.24e-2)" "unprognostic (2.38e-1)" "unprognostic (7.69e-3)" "unprognostic (2.59e-3)" "unprognostic (7.16e-2)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (5.03e-3)" "unprognostic (2.22e-4)" "unprognostic (1.18e-1)" "unprognostic (1.17e-1)" "unprognostic (1.51e-1)" "unprognostic (8.51e-2)" 0.0 2.1 0.5 0.0 1.1 0.0 1.2 0.0 0.1 0.3 0.9 0.0 0.0 0.7 0.0 2.3 0.0 0.0 1.0 0.8 2.7 0.0 0.2 0.0 0.2 0.7 0.3 13.9 1.8 0.5 0.1 0.1 6.5 0.7 0.0 0.4 0.0 0.0 0.8 0.0 0.0 1.5 1.0 0.0 0.4 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.3 0.0 0.0 1.0 0.0 0.3 0.0 1.9 0.1 1.0 0.0 0.8 0.0 0.7 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 1.1 0.1 0.6 1.7 0.0 1.4 2.3 1.8 0.0 3.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.4 0.0 73.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 8.0 0.0 0.0 0.7 0.2 0.1 1.6 0.0 0.2 0.3 SYNDIG1 "C20orf39, FLJ14220, IFITMD5, SynDIG1, TMEM90B" ENSG00000101463 "Synapse differentiation inducing 1" Q9H7V2 20 24469199-24666616 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.3;heart muscle: 28.2" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 5.0;Cardiomyocytes: 12.1;Distal tubular cells: 5.0;Peritubular cells: 6.7;Proximal tubular cells: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 8.2;RH-30: 23.3;RPMI-8226: 22.1;SCLC-21H: 5.4;U-87 MG: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044271, HPA059267" Enhanced Vesicles NA NA Vesicles "HPA044271: AB_2732515, HPA059267: AB_2683961" "unprognostic (9.33e-2)" "unprognostic (1.83e-2)" "unprognostic (2.17e-1)" "unprognostic (9.56e-2)" "unprognostic (5.03e-2)" "unprognostic (1.27e-1)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (1.62e-1)" "unprognostic (4.69e-2)" "unprognostic (4.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.94e-2)" "unprognostic (7.75e-3)" "unprognostic (2.21e-1)" "prognostic unfavorable (6.16e-6)" "unprognostic (1.40e-3)" 2.6 1.7 12.5 2.1 12.0 0.7 0.8 21.3 22.7 4.5 1.5 23.3 0.3 1.9 2.6 1.5 0.9 5.1 10.0 28.2 12.8 8.8 6.2 0.7 1.1 2.5 14.5 12.9 1.3 1.4 0.9 0.6 0.9 11.5 3.2 1.6 0.5 0.8 14.8 0.6 0.8 2.8 3.1 22.4 1.4 2.2 1.3 16.6 0.1 5.1 0.0 3.1 2.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 8.2 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 23.3 22.1 0.0 0.0 5.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 12.0 21.3 19.7 12.8 8.8 14.5 12.9 11.5 16.6 0.0 0.0 0.0 0.0 0.0 5.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 6.7 5.4 0.4 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 SYNDIG1L "capucin, IFITMD4, TMEM90A" ENSG00000183379 "Synapse differentiation inducing 1 like" A6NDD5 14 74405893-74426102 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 27 "brain: 78.1;epididymis: 20.1" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 2.4;Bipolar cells: 8.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 78.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.2;NTERA-2: 1.3;SuSa: 1.8;U-266/70: 1.7;U-266/84: 1.9" "Region enriched" "Detected in many" 8 "basal ganglia: 251.1" "Region enriched" "Detected in many" 6 "basal ganglia: 71.7" "HPA042594, HPA048487" Uncertain NA NA "HPA042594: AB_2678069, HPA048487: AB_2680416" "unprognostic (5.75e-2)" "unprognostic (9.96e-3)" "unprognostic (2.25e-2)" "unprognostic (5.51e-2)" "unprognostic (3.08e-3)" "unprognostic (5.72e-2)" "unprognostic (5.83e-2)" "unprognostic (4.51e-2)" "unprognostic (2.83e-2)" "unprognostic (5.74e-2)" "unprognostic (8.85e-2)" "unprognostic (1.63e-1)" "unprognostic (3.85e-2)" "unprognostic (8.56e-2)" "unprognostic (1.50e-1)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" 0.6 0.4 0.3 0.4 78.1 0.2 0.6 0.0 4.0 0.5 0.6 1.1 0.0 0.3 0.6 20.1 0.5 0.4 0.7 0.4 2.4 1.6 0.6 0.3 1.8 0.4 3.5 0.2 0.4 0.5 0.2 0.0 0.3 0.5 0.6 0.6 0.1 0.4 0.6 0.3 0.5 0.9 0.8 0.4 0.4 0.3 0.4 16.6 0.0 0.3 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.9 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.2 0.0 0.5 1.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.7 1.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.3 78.1 0.0 4.0 2.4 1.6 3.5 0.2 0.5 16.6 0.0 2.4 0.0 0.0 0.3 8.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SYNE3 "C14orf139, C14orf49, FLJ25605, LINC00341, NCRNA00341, Nesp3, Nesprin-3, NET53" ENSG00000176438 "Spectrin repeat containing nuclear envelope family member 3" Q6ZMZ3 14 95407266-95475836 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 12.2;bone marrow: 10.0" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 43.7;Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 109.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 25.2;ASC TERT1: 19.8;Karpas-707: 22.3;REH: 17.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055227, HPA077140" Approved Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA055227: AB_2682747, HPA077140: AB_2686826" "unprognostic (4.63e-2)" "unprognostic (6.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.48e-3)" "unprognostic (7.15e-2)" "unprognostic (2.12e-3)" "unprognostic (2.45e-1)" "unprognostic (2.61e-2)" "unprognostic (4.92e-1)" "unprognostic (2.87e-1)" "unprognostic (8.50e-2)" "unprognostic (3.32e-1)" "unprognostic (7.41e-6)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (6.95e-2)" "unprognostic (7.19e-2)" 12.2 2.4 1.2 2.7 1.3 10.0 6.5 0.3 1.2 2.1 1.0 0.6 1.2 0.6 1.1 2.0 1.2 2.8 1.6 1.1 0.4 1.0 2.7 4.0 1.6 3.0 0.1 0.0 0.5 2.1 0.6 1.6 1.9 0.4 1.1 2.8 1.5 1.2 2.6 2.7 0.9 1.6 1.7 4.3 1.6 2.8 3.4 2.6 5.4 5.1 0.9 3.7 2.2 0.6 0.1 0.3 0.5 25.2 19.8 7.6 2.8 4.9 2.7 2.1 4.0 0.7 3.2 0.5 1.3 0.8 0.1 0.6 2.1 1.2 10.6 0.4 2.2 0.5 1.1 3.3 3.3 5.5 5.5 0.7 3.4 2.0 0.2 4.7 1.0 0.1 22.3 2.0 0.7 1.9 3.7 0.1 0.1 1.3 17.6 12.3 6.8 0.3 0.3 0.5 2.7 0.1 0.0 1.3 0.3 1.1 4.9 4.2 2.0 1.2 2.6 0.3 2.7 5.4 3.0 3.9 7.5 14.7 5.4 5.1 0.4 2.2 4.0 2.8 3.4 2.9 2.3 2.1 3.3 3.7 3.0 2.4 0.9 4.1 2.6 2.3 2.2 8.9 19.4 15.7 0.2 2.1 4.2 43.7 0.0 12.0 1.2 0.0 58.9 1.4 0.0 0.0 2.9 11.7 2.1 0.0 0.3 13.8 7.1 0.8 11.5 4.5 3.9 6.4 1.2 3.1 18.0 1.5 12.0 13.3 5.0 1.0 4.1 5.2 0.5 5.8 0.4 0.3 109.0 6.5 9.2 0.5 0.9 0.9 1.6 8.5 1.6 0.2 SYNE4 "C19orf46, DFNB76, FLJ36445, Nesp4, Nesprin-4" ENSG00000181392 "Spectrin repeat containing nuclear envelope family member 4" Q8N205 19 36003299-36008793 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 28.4;Intestinal endocrine cells: 28.6;Syncytiotrophoblasts: 28.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 18.6;Hep G2: 16.1;MCF7: 18.9;SK-BR-3: 23.1;T-47d: 17.6" "Region enriched" "Detected in single" 15 "cerebellum: 7.6" "Not detected" "Not detected" HPA060253 Uncertain NA NA "HPA060253: AB_2684233" "unprognostic (8.54e-2)" "unprognostic (6.48e-2)" "unprognostic (1.32e-2)" "unprognostic (1.24e-1)" "unprognostic (5.54e-2)" "unprognostic (2.42e-3)" "unprognostic (3.76e-2)" "unprognostic (2.03e-2)" "unprognostic (1.93e-1)" "unprognostic (3.15e-2)" "unprognostic (3.36e-3)" "unprognostic (6.02e-2)" "prognostic favorable (8.64e-9)" "unprognostic (1.25e-1)" "unprognostic (2.54e-2)" "unprognostic (4.50e-1)" "unprognostic (1.97e-2)" 0.1 0.2 0.2 0.4 2.7 0.1 6.3 15.3 2.0 3.1 1.8 0.3 16.9 3.5 1.0 10.3 1.3 4.6 3.5 0.1 0.2 4.4 6.5 9.0 4.2 0.1 2.1 0.1 1.0 7.5 14.1 18.1 3.3 10.0 9.5 1.7 1.4 10.9 12.6 0.2 0.9 4.4 0.4 1.0 0.3 2.6 0.3 0.6 1.4 14.4 0.7 1.0 1.3 1.1 0.0 0.0 0.8 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.1 2.4 0.0 0.0 0.1 0.1 18.6 2.1 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.2 0.0 0.2 16.1 0.3 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.1 0.8 0.1 0.1 0.0 18.9 0.3 0.0 0.0 0.1 0.1 0.4 0.0 0.2 1.2 0.6 2.8 0.0 0.0 23.1 0.1 0.0 17.6 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.7 15.3 2.0 0.2 4.4 2.1 0.1 10.0 0.6 6.0 10.8 0.9 16.1 0.5 0.5 0.4 12.7 12.0 10.3 27.9 3.9 28.4 21.6 18.4 0.0 0.1 2.9 0.0 7.6 19.4 0.9 19.6 1.1 10.9 2.2 0.0 28.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 10.0 0.0 12.8 14.4 0.0 16.3 0.4 0.0 0.2 0.0 0.5 0.4 28.4 0.0 6.8 5.8 SYNGR1 ENSG00000100321 "Synaptogyrin 1" O43759 22 39349925-39385588 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.9" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 133.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 21.0;monocytes: 18.9;T-cells: 15.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029673, CAB034277" Enhanced Supported Cytosol NA NA Cytosol "CAB034277: AB_2255766, HPA029673: AB_10670430" "unprognostic (2.68e-3)" "unprognostic (1.84e-3)" "unprognostic (5.90e-2)" "unprognostic (8.51e-2)" "unprognostic (3.74e-1)" "unprognostic (5.98e-3)" "unprognostic (7.39e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-2)" "prognostic favorable (2.41e-4)" "unprognostic (1.16e-1)" "prognostic favorable (4.98e-7)" "unprognostic (1.32e-3)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" "unprognostic (1.04e-1)" 4.4 11.4 19.4 2.7 31.4 39.9 8.0 66.9 62.0 15.6 6.3 8.5 1.0 3.3 9.2 6.5 17.3 9.8 6.1 21.6 31.6 22.3 5.5 2.0 3.3 3.8 17.4 35.1 38.8 14.5 10.3 4.1 3.7 23.5 10.9 2.6 19.5 23.5 10.4 13.4 26.2 3.0 7.2 7.0 4.1 4.8 7.2 5.4 0.7 4.6 4.6 5.2 7.8 9.0 2.4 21.0 0.8 18.9 2.6 15.2 7.8 2.6 4.8 8.7 15.7 0.8 2.3 3.8 11.6 20.5 14.8 13.7 1.0 0.3 0.1 2.7 3.0 1.7 3.7 5.9 0.2 4.5 0.0 18.4 0.2 0.3 0.5 2.5 0.7 5.4 3.4 0.9 4.0 0.0 10.5 0.7 3.4 5.2 0.3 2.3 6.1 2.3 2.1 1.8 2.3 9.3 6.8 0.0 0.7 0.4 7.4 13.8 2.9 3.0 12.6 12.0 3.8 18.6 13.6 0.2 0.0 10.2 0.1 0.0 3.2 0.1 7.3 0.4 14.8 15.8 0.2 18.9 0.3 15.2 5.5 0.9 2.4 0.6 4.4 21.0 2.2 0.7 8.2 0.8 2.6 0.2 15.3 0.1 7.8 19.4 31.4 66.9 62.0 31.6 22.3 17.4 35.1 23.5 5.4 8.9 1.4 11.2 51.4 27.0 109.4 55.7 68.8 1.4 11.4 62.8 25.5 19.6 13.3 38.6 27.1 6.7 0.0 46.7 10.4 12.0 41.0 29.2 2.3 5.0 13.5 44.5 0.0 13.5 15.0 64.1 123.4 10.0 133.3 1.0 0.0 35.9 25.8 0.0 112.1 9.8 36.1 19.4 28.1 74.9 12.1 32.6 11.0 22.3 0.2 63.3 SYNGR2 ENSG00000108639 "Synaptogyrin 2" O43760 17 78168558-78173527 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "monocytes: 1357.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 94.6;OE19: 77.8;SK-BR-3: 88.1;T-47d: 69.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014742 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA014742: AB_2669079" "unprognostic (2.19e-2)" "unprognostic (1.05e-3)" "unprognostic (2.84e-1)" "unprognostic (6.77e-3)" "unprognostic (9.15e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-3)" "unprognostic (4.98e-2)" "unprognostic (1.26e-2)" "unprognostic (1.20e-2)" "unprognostic (9.44e-2)" "unprognostic (4.43e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (4.74e-2)" "unprognostic (5.21e-2)" "unprognostic (3.51e-2)" "unprognostic (1.78e-2)" 28.6 14.5 10.3 29.0 19.2 28.5 29.9 6.8 15.7 17.9 30.0 32.8 19.3 26.8 16.2 19.9 31.2 21.3 32.2 31.8 15.3 10.6 30.7 55.1 36.7 54.9 30.2 11.1 17.6 76.0 7.9 22.7 29.8 17.8 30.8 20.2 15.6 74.1 23.3 80.5 35.6 28.1 15.3 36.7 39.0 35.1 13.9 21.7 24.3 27.9 35.5 49.4 24.2 19.4 101.5 91.2 57.2 106.3 20.1 29.7 68.5 23.7 47.8 1.1 9.8 0.4 0.1 7.2 8.2 6.7 6.1 3.6 28.3 23.5 20.3 18.3 3.6 6.5 34.4 4.7 10.3 2.0 13.5 24.9 6.7 7.6 19.4 9.0 11.2 50.3 0.4 11.3 2.0 6.2 11.5 12.8 6.6 27.7 94.6 0.5 45.7 10.3 9.4 3.3 77.8 19.0 6.0 2.4 52.2 18.4 23.1 7.2 8.1 7.0 88.1 7.9 4.6 69.5 15.9 4.5 0.1 7.7 3.8 10.7 41.3 15.1 10.7 5.3 6.7 1.1 57.2 65.3 22.2 18.4 91.5 21.0 101.5 24.7 21.0 91.2 96.1 22.2 18.0 28.0 20.1 106.3 51.5 29.7 68.5 10.3 19.2 6.8 15.7 15.3 10.6 30.2 11.1 17.8 21.7 119.1 112.7 134.0 115.8 110.2 3.5 52.9 73.9 46.8 83.0 162.3 5.9 150.6 8.3 284.7 3.1 71.4 82.1 46.7 381.9 51.2 37.8 196.6 97.4 40.4 245.4 4.8 69.7 45.4 129.4 1.6 20.4 180.7 70.9 1357.1 240.8 4.4 243.5 129.6 15.9 33.8 3.9 38.8 49.9 11.1 10.5 142.8 150.1 44.6 152.7 185.5 SYNGR3 ENSG00000127561 "Synaptogyrin 3" O43761 16 1989660-1994275 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.3" "Cell type enhanced" "Detected in some" 8 "Cardiomyocytes: 3.9;Horizontal cells: 6.4;monocytes: 4.6;Spermatogonia: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.7;NK-cells: 4.6;T-cells: 2.7" "Cell line enhanced" "Detected in many" "HDLM-2: 25.7;HMC-1: 16.6;Karpas-707: 14.0;SK-BR-3: 17.5;U-266/70: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034278, HPA042842" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB034278: AB_2200905, HPA042842: AB_2678198" "unprognostic (8.89e-3)" "prognostic favorable (6.92e-4)" "unprognostic (6.07e-3)" "unprognostic (2.94e-3)" "unprognostic (2.92e-2)" "unprognostic (8.06e-3)" "unprognostic (2.52e-1)" "unprognostic (5.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.06e-1)" "unprognostic (3.69e-3)" "unprognostic (1.05e-1)" "prognostic favorable (7.12e-7)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.79e-1)" "unprognostic (8.78e-2)" 1.1 11.1 20.3 3.7 21.8 1.6 1.1 24.2 55.3 1.5 2.3 2.6 0.0 2.2 1.0 1.0 1.3 1.1 1.3 1.4 14.6 40.8 1.7 1.0 1.3 4.0 27.1 20.1 1.5 1.0 9.4 3.1 5.4 28.2 1.3 2.2 0.9 2.1 1.1 0.9 1.1 2.5 1.7 4.4 2.2 2.1 4.2 2.0 0.0 1.0 0.0 4.7 1.4 0.2 3.7 0.7 0.0 0.8 4.6 2.7 0.9 0.4 2.1 2.0 0.2 0.2 0.2 2.4 1.0 1.7 0.8 0.7 3.3 1.6 3.2 0.7 0.7 2.2 1.8 2.2 0.3 0.2 25.7 1.5 0.0 2.8 1.6 1.2 0.0 16.6 0.5 0.1 0.0 0.5 3.9 0.2 1.0 9.2 14.0 0.4 2.4 0.1 0.1 10.3 0.3 0.9 0.0 0.3 2.5 1.3 0.0 4.6 5.8 2.3 17.5 0.2 1.1 2.4 0.2 0.4 0.5 8.1 0.0 0.3 22.1 2.5 3.7 0.3 2.9 0.3 0.0 0.8 0.0 0.9 0.3 2.1 3.2 1.7 2.7 0.7 3.7 2.0 0.8 0.0 4.6 0.7 0.0 1.6 0.9 20.3 21.8 24.2 39.3 14.6 40.8 27.1 20.1 28.2 2.0 0.0 1.1 0.0 0.7 0.2 2.6 3.9 0.0 0.0 0.0 0.0 2.0 0.4 1.7 1.7 0.4 0.3 0.0 0.0 0.4 0.6 0.6 0.8 1.1 0.0 0.2 6.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.6 0.4 0.8 1.2 0.0 0.0 0.0 0.5 0.0 0.2 2.3 8.1 0.3 2.6 2.2 0.0 0.6 SYNGR4 ENSG00000105467 "Synaptogyrin 4" O95473 19 48364395-48376376 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 41.5" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 147.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "cerebellum: 4.1" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "A549: 9.1;SCLC-21H: 22.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030075, HPA059286" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA030075: AB_10610559, HPA059286: AB_2683965" "unprognostic (1.58e-2)" "unprognostic (3.44e-2)" "unprognostic (3.18e-2)" "unprognostic (9.49e-4)" "unprognostic (2.51e-2)" "unprognostic (7.10e-2)" "unprognostic (2.52e-3)" "unprognostic (3.72e-3)" "unprognostic (2.87e-2)" "unprognostic (6.19e-2)" "unprognostic (6.69e-2)" "unprognostic (2.41e-2)" "unprognostic (2.02e-7)" "unprognostic (1.06e-2)" "unprognostic (1.74e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" 0.0 0.0 0.2 0.0 0.7 0.0 0.0 4.1 2.0 0.0 0.2 0.0 0.9 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.7 3.0 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.0 41.5 0.0 0.3 0.1 0.0 0.2 0.2 0.0 1.3 0.7 0.1 0.5 0.0 0.9 0.6 0.1 9.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.6 0.2 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.5 2.9 0.5 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 3.4 0.1 0.2 0.5 0.2 0.0 0.6 1.7 0.6 0.0 2.6 0.0 0.0 22.9 0.6 0.1 0.4 0.0 0.0 0.4 0.1 0.1 0.0 0.8 0.0 0.0 3.1 1.0 0.7 0.0 0.2 0.4 0.1 0.5 0.0 0.0 0.0 0.0 1.3 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.7 4.1 0.9 0.2 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.0 8.7 0.0 0.0 18.9 0.9 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 6.5 0.0 147.5 4.5 0.0 0.0 0.0 0.1 0.1 SYNJ2BP Arip2 ENSG00000213463 "Synaptojanin 2 binding protein" P57105 14 70366496-70417061 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000866 Approved Supported Approved Mitochondria NA NA Mitochondria "HPA000866: AB_2276678" "unprognostic (2.68e-1)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "unprognostic (1.28e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.60e-2)" "unprognostic (5.70e-2)" "unprognostic (6.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.44e-2)" "prognostic favorable (1.11e-16)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (5.35e-3)" "unprognostic (1.14e-2)" 12.0 13.8 10.8 8.2 13.0 1.7 11.2 15.8 13.7 11.8 20.1 14.1 14.1 21.0 12.5 10.4 16.3 9.5 11.7 15.7 10.5 8.9 32.0 25.9 10.4 6.8 11.0 6.4 10.3 11.0 28.9 22.2 12.0 13.4 15.3 16.7 11.6 13.2 15.0 27.4 6.7 32.2 15.2 12.4 11.3 16.8 16.9 9.9 7.0 16.9 14.4 7.9 15.4 9.1 4.6 5.1 0.6 5.3 3.8 7.4 1.9 9.7 6.3 11.1 7.4 8.6 10.0 7.8 7.5 7.9 5.4 6.1 6.1 9.2 0.0 7.3 8.7 5.4 8.4 11.1 8.2 12.8 1.3 5.6 3.6 9.7 7.9 7.6 0.0 1.2 7.7 6.8 6.7 3.8 9.6 11.7 4.2 2.1 2.0 9.6 7.0 5.0 1.5 8.1 9.8 7.7 6.3 16.1 2.7 11.7 14.8 8.1 14.2 10.4 8.7 6.1 7.5 16.3 2.5 12.8 12.9 9.0 4.9 6.1 2.7 10.3 0.0 11.4 1.2 10.6 0.6 5.3 0.1 4.3 5.1 4.9 4.6 5.2 5.0 5.1 3.9 7.4 5.9 0.6 3.8 3.3 3.2 3.9 1.9 10.8 13.0 15.8 13.7 10.5 8.9 11.0 6.4 13.4 9.9 35.7 36.9 17.6 23.9 5.4 40.6 75.0 53.5 22.7 35.2 71.5 76.6 33.0 119.3 39.0 15.9 38.3 52.7 0.0 34.4 27.1 19.9 26.7 9.2 42.3 21.8 28.6 19.0 31.3 22.7 5.4 28.1 19.1 13.5 30.7 45.5 35.5 32.5 35.1 38.9 59.1 83.2 25.8 20.2 26.1 10.2 4.3 9.2 29.8 56.5 28.8 SYNPR "MGC26651, SPO" ENSG00000163630 Synaptoporin Q8TBG9 3 63228315-63616921 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 99.9" "Group enriched" "Detected in some" 12 "Horizontal cells: 100.1;Muller glia cells: 40.6" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Region enhanced" "Detected in all" "basal ganglia: 99.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.3;SCLC-21H: 4.3;SH-SY5Y: 1.2;SuSa: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051368, HPA061671" Enhanced NA NA "HPA051368: AB_2681456, HPA061671: AB_2684582" "unprognostic (1.69e-1)" "unprognostic (3.77e-2)" "unprognostic (3.14e-3)" "unprognostic (3.02e-1)" "unprognostic (2.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.50e-1)" "unprognostic (5.32e-2)" "unprognostic (1.82e-1)" "unprognostic (1.89e-1)" 1.1 1.5 13.3 1.3 99.9 1.1 1.1 26.9 58.4 1.2 1.2 1.5 0.0 1.4 1.1 1.2 1.1 1.2 1.2 6.1 20.4 7.6 1.2 1.1 1.1 1.1 4.6 14.4 1.1 1.3 1.1 0.1 1.1 4.3 1.1 1.2 11.9 1.8 1.2 1.1 1.1 1.2 1.2 2.2 1.1 1.8 1.1 4.6 0.0 1.2 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.2 0.0 0.0 0.7 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 99.9 26.9 31.2 20.4 7.6 4.6 14.4 4.3 4.6 0.0 0.0 0.0 0.0 0.0 4.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 100.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.1 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SYP MRX96 ENSG00000102003 Synaptophysin P08247 X 49187804-49200259 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 179.2" "Group enriched" "Detected in many" 4 "Bipolar cells: 496.0;Cone photoreceptor cells: 514.4;Rod photoreceptor cells: 549.6" "Group enriched" "Detected in many" 6 "glioma: 12.8;pancreatic cancer: 5.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 8.7;SCLC-21H: 46.8;SH-SY5Y: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000076, HPA002858, CAB055505, CAB078999" Enhanced Supported NA NA "CAB000076: AB_2315411, CAB055505: AB_564017, CAB078999: , HPA002858: AB_1080153" "unprognostic (2.08e-1)" "unprognostic (8.72e-2)" "unprognostic (1.56e-1)" "unprognostic (5.37e-3)" "unprognostic (4.37e-2)" "unprognostic (2.11e-1)" "unprognostic (1.87e-1)" "unprognostic (6.46e-5)" "unprognostic (8.52e-3)" "unprognostic (1.62e-1)" "unprognostic (3.44e-3)" "unprognostic (8.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.95e-1)" "unprognostic (3.54e-1)" "unprognostic (1.79e-2)" "unprognostic (1.94e-1)" 2.7 21.4 34.5 3.2 42.5 1.9 1.9 53.8 179.2 2.0 3.6 7.2 0.0 7.4 2.2 2.6 2.2 2.0 2.0 2.3 44.4 45.3 2.7 1.8 2.8 2.0 25.5 39.0 2.1 5.2 1.9 17.4 2.0 46.7 2.1 3.5 11.5 2.0 2.1 2.4 2.3 8.1 2.5 15.5 2.4 3.9 2.0 4.0 0.0 2.1 0.0 1.9 1.8 0.2 1.3 1.6 5.3 0.8 0.5 0.7 0.1 0.4 1.7 1.3 2.6 1.5 0.2 0.2 0.1 0.0 0.3 0.3 1.6 0.9 1.4 0.2 0.0 2.0 1.3 1.4 0.1 0.3 2.8 1.6 2.1 0.5 0.5 0.0 0.2 4.8 0.2 0.0 0.2 0.3 0.2 0.1 1.2 8.7 3.4 0.3 0.5 0.7 0.1 4.3 1.1 0.3 0.3 0.2 0.6 0.1 0.2 46.8 16.9 0.5 0.2 0.6 0.4 0.8 0.8 0.2 0.3 1.4 0.4 0.2 0.2 2.8 0.3 0.7 0.5 1.4 1.7 0.8 0.4 0.2 0.7 0.4 0.7 0.5 0.7 0.4 1.3 0.5 0.5 5.3 0.5 0.4 1.6 0.3 0.1 34.5 42.5 53.8 84.8 44.4 45.3 25.5 39.0 46.7 4.0 0.0 3.8 0.8 2.5 2.3 496.0 1.2 5.1 6.7 4.5 8.7 514.4 0.9 0.0 0.8 8.8 5.4 7.8 0.0 2.1 0.5 2.1 1.2 8.1 0.6 1.0 116.0 111.7 6.7 2.4 9.9 3.7 4.5 3.3 2.8 18.4 54.5 1.6 2.3 3.5 0.4 549.6 6.5 4.4 0.4 2.5 2.3 1.1 3.2 6.3 0.8 SYPL1 SYPL ENSG00000008282 "Synaptophysin like 1" Q16563 7 106090503-106112576 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 478.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014141 Approved NA NA "HPA014141: AB_1857716" "unprognostic (8.88e-2)" "unprognostic (8.10e-2)" "unprognostic (3.39e-3)" "unprognostic (1.47e-1)" "unprognostic (4.76e-2)" "unprognostic (4.61e-2)" "unprognostic (8.74e-2)" "unprognostic (9.15e-2)" "unprognostic (3.71e-2)" "unprognostic (2.60e-1)" "unprognostic (1.28e-3)" "unprognostic (1.32e-1)" "prognostic favorable (1.25e-9)" "unprognostic (2.09e-1)" "unprognostic (1.83e-1)" "unprognostic (2.06e-1)" "unprognostic (3.17e-1)" 38.7 27.1 13.5 23.2 20.3 13.0 30.9 8.1 18.9 42.4 31.8 45.3 32.7 17.6 47.7 28.3 60.0 32.3 27.3 28.2 18.3 14.6 46.3 31.4 23.7 40.1 39.9 11.7 32.8 26.0 34.7 13.3 34.1 32.8 38.1 23.6 23.5 54.1 39.0 47.0 31.7 32.6 37.7 87.6 32.0 29.5 41.3 26.4 30.5 50.3 46.4 49.0 43.5 38.6 42.9 10.2 17.9 12.6 21.5 18.6 11.9 36.7 17.1 9.2 15.2 39.8 30.4 13.4 23.2 26.1 21.9 26.8 11.6 65.7 37.1 31.3 28.9 37.2 31.4 14.7 37.5 36.4 10.1 17.4 16.3 11.2 11.3 31.2 27.5 13.5 22.6 48.8 22.9 29.7 29.3 30.0 14.1 16.6 0.0 43.3 31.8 28.9 32.8 10.2 42.6 22.9 3.6 15.5 19.2 46.1 60.2 4.5 10.3 22.4 54.5 22.5 23.1 16.6 22.0 26.8 43.8 22.5 46.5 26.3 17.0 19.6 39.1 19.2 47.8 24.6 17.9 12.6 13.5 4.6 11.7 9.4 42.9 12.3 9.1 10.2 39.8 18.6 11.5 4.9 21.5 9.2 9.9 10.4 11.9 13.5 20.3 8.1 18.9 18.3 14.6 39.9 11.7 32.8 26.4 50.6 56.2 102.7 250.1 152.5 9.0 62.7 150.3 76.3 63.7 177.9 15.7 173.1 96.2 141.4 478.9 138.4 44.1 46.7 94.2 119.4 109.4 180.2 91.0 87.0 81.3 19.1 36.4 132.0 71.7 110.9 88.1 80.2 138.3 11.8 72.6 92.7 105.2 77.6 88.4 191.9 12.0 155.2 131.8 418.1 119.7 151.2 153.9 46.8 82.8 226.9 SYPL2 Mg29 ENSG00000143028 "Synaptophysin like 2" Q5VXT5 1 109466628-109482137 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 102.5;tongue: 25.6" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 8.5;Collecting duct cells: 3.5;Hepatocytes: 4.5;Late spermatids: 8.5;Proximal tubular cells: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 20.2;ASC TERT1: 8.5;BJ: 8.6;BJ hTERT+: 27.3;fHDF/TERT166: 14.1;HAP1: 7.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA076657 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA076657: " "unprognostic (1.82e-2)" "unprognostic (1.81e-1)" "unprognostic (2.90e-4)" "unprognostic (6.63e-2)" "unprognostic (1.35e-1)" "unprognostic (9.36e-3)" "unprognostic (2.84e-2)" "unprognostic (2.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.08e-1)" "prognostic favorable (3.05e-4)" "unprognostic (2.54e-3)" "unprognostic (3.40e-1)" "unprognostic (9.46e-3)" "unprognostic (6.39e-4)" 0.9 3.9 0.8 0.3 0.7 0.1 1.4 0.5 1.2 1.6 1.9 0.3 0.8 0.3 2.5 4.3 1.6 0.4 1.1 7.4 0.8 0.2 6.0 4.7 0.6 0.3 0.3 0.0 1.1 3.2 3.7 0.4 1.2 0.8 1.2 0.5 1.7 1.6 2.2 102.5 0.2 0.6 3.5 0.1 0.4 1.1 6.0 0.2 0.0 5.1 25.6 1.2 2.5 2.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 20.2 8.5 0.0 8.6 27.3 2.7 1.0 0.0 0.0 0.0 0.0 14.1 0.3 0.0 7.3 0.0 0.5 0.0 3.1 0.0 0.2 0.1 0.4 0.0 0.7 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.9 2.1 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.5 1.2 0.8 0.2 0.3 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.2 1.5 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.7 4.9 0.0 0.0 2.3 0.4 1.5 0.0 0.1 0.0 0.0 0.0 SYS1 "C20orf169, dJ453C12.4" ENSG00000204070 "SYS1, golgi trafficking protein" Q8N2H4 20 45361937-45376798 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA046716 Approved NA NA "HPA046716: AB_2679769" "unprognostic (8.24e-2)" "unprognostic (1.19e-1)" "unprognostic (5.58e-2)" "unprognostic (1.51e-2)" "unprognostic (1.04e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (2.10e-2)" "unprognostic (1.63e-2)" "unprognostic (4.77e-1)" "unprognostic (4.66e-3)" "unprognostic (2.33e-1)" "unprognostic (4.28e-2)" "unprognostic (4.90e-2)" "unprognostic (4.38e-2)" "unprognostic (5.38e-3)" "unprognostic (2.01e-2)" 19.2 22.3 17.1 22.7 22.0 24.7 20.8 12.7 29.2 22.3 21.3 22.1 16.1 13.2 25.4 20.5 19.0 38.0 21.6 19.2 17.3 17.5 26.9 34.4 22.0 33.5 21.3 13.3 30.0 30.8 18.6 19.3 17.8 18.6 20.6 16.6 20.2 27.6 23.8 24.1 13.3 20.5 19.2 19.3 17.5 21.5 14.3 20.2 18.1 37.0 10.4 25.7 21.9 20.8 13.8 44.1 17.4 10.0 8.7 16.3 13.0 8.0 14.9 6.2 10.7 19.8 12.3 10.3 8.2 11.9 12.7 10.8 37.0 15.6 4.9 19.6 13.6 15.9 17.4 12.2 14.8 8.7 7.2 7.0 5.7 8.2 19.3 17.0 10.5 12.0 15.1 21.7 14.1 8.6 12.5 12.5 9.1 9.1 7.5 9.0 17.4 8.9 10.6 6.9 9.5 21.0 1.4 7.2 7.7 14.8 6.8 4.8 6.0 12.9 8.2 15.9 6.8 18.5 7.0 7.0 16.4 10.8 8.7 7.9 9.2 5.9 1.9 11.0 7.3 9.1 17.4 10.0 15.1 15.3 9.6 16.1 10.4 14.8 15.6 11.2 13.8 16.3 14.1 12.6 8.7 9.8 44.1 15.4 13.0 17.1 22.0 12.7 29.2 17.3 17.5 21.3 13.3 18.6 20.2 17.9 22.6 22.6 32.4 25.8 22.7 10.8 25.5 62.9 9.1 22.7 27.5 23.6 14.9 30.4 21.1 19.8 31.4 0.0 50.6 35.9 23.6 31.2 26.4 29.7 55.1 19.1 15.4 16.0 34.3 16.6 16.1 31.8 23.6 19.8 18.7 32.4 39.1 16.1 18.0 26.7 34.7 12.9 22.2 14.0 10.9 26.7 43.9 34.6 15.1 32.0 SYT1 "P65, SVP65, SYT" ENSG00000067715 "Synaptotagmin 1" P21579 12 78863993-79452008 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 141.7" "Group enriched" "Detected in many" 9 "Bipolar cells: 1152.5;Cone photoreceptor cells: 842.3;Muller glia cells: 363.8;Rod photoreceptor cells: 831.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.3;memory B-cell: 3.3;naive B-cell: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 21.8;hTERT-RPE1: 20.4;LHCN-M2: 17.5;SH-SY5Y: 16.9;WM-115: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008394, HPA064788" Enhanced Supported NA NA "HPA008394: AB_1857696, HPA064788: AB_2685351" "unprognostic (1.02e-3)" "unprognostic (2.55e-1)" "unprognostic (4.21e-3)" "unprognostic (3.77e-2)" "unprognostic (3.16e-2)" "unprognostic (3.68e-5)" "unprognostic (2.78e-2)" "unprognostic (1.83e-2)" "unprognostic (7.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-1)" "unprognostic (6.14e-3)" "unprognostic (3.05e-8)" "unprognostic (2.89e-2)" "unprognostic (8.26e-2)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" 1.3 11.5 23.9 2.1 31.8 1.3 1.4 44.3 141.7 1.8 2.3 1.8 0.0 1.8 5.6 1.4 1.4 1.4 1.7 1.1 32.4 22.9 2.0 2.0 1.5 1.2 23.1 38.6 3.6 1.2 1.1 1.4 2.3 28.9 4.3 2.5 2.7 1.2 3.8 1.1 1.2 2.6 12.9 2.5 2.2 1.8 1.4 3.6 0.0 1.2 0.0 1.2 1.3 0.7 3.4 0.9 0.0 2.3 0.0 0.0 0.1 0.0 10.2 7.7 0.0 0.7 2.3 0.0 0.7 0.9 0.5 0.6 0.5 0.3 0.0 1.5 0.1 2.8 0.3 0.1 1.2 0.9 0.1 0.4 0.6 0.2 0.0 2.0 0.0 0.1 0.6 0.7 2.8 21.8 20.4 7.3 0.3 0.4 1.2 17.5 1.6 0.9 0.0 5.6 1.1 2.9 0.0 8.0 0.0 0.0 2.9 10.3 16.9 0.0 1.3 0.2 5.5 3.8 0.0 2.9 1.1 0.4 0.0 3.2 1.9 4.1 0.0 2.5 0.0 15.8 0.0 2.3 0.0 0.0 0.2 0.0 3.3 0.0 0.0 0.9 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.9 31.8 44.3 74.8 32.4 22.9 23.1 38.6 28.9 3.6 0.0 1.1 3.7 0.0 0.8 1152.5 0.4 0.0 0.0 2.3 0.0 842.3 4.4 0.0 0.0 0.9 2.2 0.0 0.0 0.2 2.0 0.7 14.4 0.0 0.0 10.4 58.8 93.0 3.1 4.7 2.0 64.2 1.1 1.7 0.0 0.0 363.8 0.1 0.2 4.2 0.0 831.5 0.0 1.0 1.1 5.2 0.5 4.9 0.0 0.0 0.1 SYT10 ENSG00000110975 "Synaptotagmin 10" Q6XYQ8 12 33374238-33439819 "Predicted membrane proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;fallopian tube: 8.1" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 2.0;Club cells: 4.5;Distal tubular cells: 6.6;Ito cells: 2.5;Spermatogonia: 4.5" "Cancer enriched" "Detected in single" 5 "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.8;K-562: 2.2;MCF7: 7.7;NTERA-2: 1.9;RPTEC TERT1: 2.0;RT4: 3.0;SCLC-21H: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA055426 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA055426: AB_2682812" "unprognostic (3.60e-1)" "unprognostic (4.93e-2)" "unprognostic (9.34e-4)" "unprognostic (5.53e-2)" "unprognostic (3.67e-1)" "unprognostic (4.74e-3)" "unprognostic (3.19e-1)" "unprognostic (1.97e-6)" "unprognostic (4.00e-1)" "unprognostic (2.39e-1)" "unprognostic (2.41e-1)" "unprognostic (1.91e-1)" 0.3 1.5 0.6 0.7 10.1 0.1 0.3 0.2 4.1 2.9 3.6 0.9 3.0 1.0 0.3 0.8 0.3 8.1 0.4 0.5 0.8 3.1 3.3 1.4 0.2 0.1 0.6 3.4 0.4 0.2 0.1 5.8 0.2 14.6 1.6 1.6 0.1 1.8 3.2 0.2 0.2 1.3 0.6 2.7 0.2 1.6 0.6 0.3 0.0 0.2 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 7.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 3.0 4.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.1 0.2 4.1 0.8 3.1 0.6 3.4 14.6 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 1.4 4.5 0.0 0.0 0.0 6.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 4.5 0.0 0.1 0.0 0.0 0.0 SYT11 "DKFZp781D015, KIAA0080, MGC10881, MGC17226" ENSG00000132718 "Synaptotagmin 11" Q9BT88 1 155859509-155885199 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 148.3" "Group enriched" "Detected in many" 5 "Bipolar cells: 79.9;Horizontal cells: 84.2;Muller glia cells: 149.4" "Cancer enriched" "Detected in all" 12 "glioma: 117.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 57.3;SCLC-21H: 22.9;SH-SY5Y: 24.9;U-87 MG: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064091 Enhanced NA NA "HPA064091: AB_2685189" "unprognostic (1.83e-1)" "unprognostic (5.99e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.93e-5)" "unprognostic (2.14e-1)" "unprognostic (8.02e-3)" "unprognostic (7.90e-2)" "unprognostic (4.43e-3)" "unprognostic (3.93e-1)" "unprognostic (1.16e-1)" "unprognostic (1.42e-2)" "unprognostic (9.65e-2)" "unprognostic (2.28e-2)" "unprognostic (1.66e-1)" "unprognostic (6.38e-2)" "unprognostic (1.10e-1)" "unprognostic (2.22e-3)" 6.0 13.3 34.4 6.2 52.0 3.3 2.7 35.4 148.3 9.3 5.1 44.5 0.0 3.4 11.5 8.6 4.7 5.2 7.9 8.9 32.9 32.3 4.5 2.4 6.0 7.2 35.9 32.2 9.6 3.2 2.4 11.8 7.0 48.3 8.7 5.4 4.4 2.6 11.3 2.8 2.3 4.3 12.7 42.0 6.9 3.8 4.7 29.0 0.0 2.8 0.0 6.5 7.3 3.3 1.6 5.6 4.1 6.1 5.8 14.4 5.7 0.0 0.2 14.7 0.3 10.8 5.7 0.0 2.7 7.4 2.9 5.3 0.0 0.4 2.8 1.2 9.8 4.5 0.2 1.2 0.0 4.4 13.7 0.2 2.7 0.4 0.0 3.1 1.5 8.5 3.6 0.0 10.5 0.2 16.6 9.3 0.1 0.0 57.3 3.9 0.0 0.1 0.7 9.6 0.0 0.0 0.5 1.5 0.0 0.4 0.0 22.9 24.9 0.4 0.0 3.3 0.3 0.0 0.3 6.9 5.5 3.5 3.7 3.4 15.3 7.4 5.8 27.6 0.0 4.2 4.1 3.8 0.1 14.4 4.8 4.0 1.6 7.6 9.9 5.6 1.4 0.8 7.8 2.1 5.8 6.1 0.3 13.3 5.7 34.4 52.0 35.4 59.4 32.9 32.3 35.9 32.2 48.3 29.0 0.0 0.0 1.7 0.1 0.5 79.9 9.7 0.0 1.4 0.0 1.8 21.6 0.0 0.0 0.8 0.0 13.5 0.0 0.0 0.9 0.1 3.1 0.2 11.5 0.0 4.7 84.2 4.6 2.5 7.9 0.4 2.6 7.9 3.3 12.6 0.0 149.4 2.3 0.0 14.9 0.8 12.7 19.4 8.2 1.1 1.1 0.9 0.0 7.1 0.0 0.2 SYT12 SRG1 ENSG00000173227 "Synaptotagmin 12" Q8IV01 11 67006778-67050863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 29.9;parathyroid gland: 59.4" "Cell type enhanced" "Detected in some" 7 "Basal glandular cells: 3.4;Cholangiocytes: 2.5;Hepatocytes: 4.0" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 26.3;MCF7: 18.1;SiHa: 23.3;SK-BR-3: 11.4;T-47d: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011006, HPA074255" Enhanced NA NA "HPA011006: AB_2286996, HPA074255: " "unprognostic (2.72e-2)" "unprognostic (2.77e-2)" "unprognostic (2.23e-2)" "unprognostic (1.12e-3)" "unprognostic (4.47e-3)" "unprognostic (3.88e-2)" "unprognostic (1.20e-1)" "unprognostic (3.73e-2)" "unprognostic (2.04e-1)" "unprognostic (7.85e-3)" "prognostic unfavorable (4.13e-4)" "unprognostic (2.75e-1)" "unprognostic (9.86e-4)" "unprognostic (4.21e-2)" "unprognostic (7.38e-2)" "unprognostic (2.42e-2)" "unprognostic (9.85e-2)" 1.1 2.2 4.3 0.8 7.9 0.6 4.2 29.9 16.2 0.7 0.6 0.8 3.5 1.2 0.7 6.2 0.9 3.7 1.1 0.8 5.4 4.7 0.7 10.2 0.6 0.7 2.6 5.4 0.7 0.7 59.4 3.4 4.1 6.8 0.9 0.6 0.1 1.8 2.5 0.8 1.2 0.8 0.6 1.3 0.6 0.7 1.3 0.5 0.0 0.6 0.0 0.7 1.4 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.8 1.9 0.7 0.1 0.8 0.1 2.7 0.0 0.0 0.2 0.0 26.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 18.1 0.0 0.0 0.5 0.1 0.9 0.0 0.0 0.0 0.3 0.0 0.2 0.0 23.3 11.4 0.0 0.0 11.4 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 7.9 29.9 16.2 5.4 4.7 2.6 5.4 6.8 0.5 0.0 0.0 0.0 3.4 1.1 0.6 1.1 2.5 0.0 2.3 1.8 0.0 0.2 0.0 2.2 0.2 0.0 0.0 0.0 0.0 1.2 0.4 1.2 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.7 0.0 0.4 0.7 0.4 1.0 1.6 0.0 0.0 1.2 SYT13 KIAA1427 ENSG00000019505 "Synaptotagmin 13" Q7L8C5 11 45240301-45286319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.1;gallbladder: 18.8" "Cell type enriched" "Detected in many" 8 "Intestinal endocrine cells: 323.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "A549: 11.5;NTERA-2: 5.4;RPTEC TERT1: 35.1;SCLC-21H: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046224, HPA056602" Uncertain Supported Vesicles NA NA Vesicles "HPA046224: AB_10961288, HPA056602: AB_2683185" "unprognostic (4.96e-2)" "unprognostic (1.06e-2)" "unprognostic (9.92e-2)" "prognostic unfavorable (7.79e-5)" "unprognostic (1.00e-2)" "unprognostic (4.17e-2)" "unprognostic (3.75e-2)" "unprognostic (9.83e-3)" "unprognostic (2.19e-1)" "unprognostic (7.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.47e-1)" "unprognostic (5.66e-3)" "unprognostic (2.94e-2)" "unprognostic (1.76e-1)" "unprognostic (8.70e-2)" "unprognostic (5.13e-2)" 0.4 4.5 15.8 1.5 15.1 0.4 0.5 19.0 38.1 0.3 10.6 1.2 0.0 10.9 0.6 0.3 0.4 0.5 18.8 4.5 11.8 19.5 8.0 0.6 0.8 0.4 10.6 15.1 0.4 6.4 0.4 9.4 0.4 27.9 2.0 11.2 0.9 1.4 0.4 0.5 0.5 11.1 1.1 2.2 0.5 9.2 1.8 0.3 0.0 1.8 0.0 0.3 0.4 0.2 0.2 0.0 1.4 0.0 0.2 0.2 0.0 0.0 11.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 35.1 0.0 9.3 0.4 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 1.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.0 15.8 15.1 19.0 31.1 11.8 19.5 10.6 15.1 27.9 0.3 0.0 0.0 0.0 0.2 0.0 1.1 8.1 15.3 0.0 0.0 3.5 23.6 0.0 5.0 1.2 3.1 0.0 10.0 0.0 0.5 0.0 0.0 4.2 0.0 0.0 0.0 1.6 323.7 0.0 0.0 8.2 0.3 0.0 0.0 0.0 30.8 0.5 5.3 17.5 0.0 0.3 1.5 0.0 0.0 1.9 0.2 0.0 0.0 0.0 38.3 0.1 SYT14 "FLJ34198, sytXIV" ENSG00000143469 "Synaptotagmin 14" Q8NB59 1 209938174-210171389 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.4;pituitary gland: 31.1;testis: 9.5;thyroid gland: 15.9" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 28.8;Cone photoreceptor cells: 25.5;Horizontal cells: 49.3;Rod photoreceptor cells: 28.8;Spermatogonia: 19.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 13.0;GAMG: 8.8;SCLC-21H: 6.8;TIME: 10.8;U-138 MG: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036963 Supported Vesicles NA NA Vesicles "HPA036963: AB_10670378" "unprognostic (1.38e-4)" "unprognostic (8.62e-3)" "unprognostic (1.93e-1)" "unprognostic (3.90e-4)" "unprognostic (1.97e-1)" "unprognostic (4.43e-5)" "unprognostic (1.92e-1)" "unprognostic (1.88e-2)" "unprognostic (6.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.81e-1)" "unprognostic (4.85e-3)" "unprognostic (2.30e-4)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (3.33e-3)" 0.7 3.2 5.9 0.8 7.4 0.8 0.6 17.4 10.2 0.6 0.7 3.8 0.0 0.7 1.4 0.8 0.6 0.6 0.6 0.6 4.5 2.6 0.9 0.6 0.7 0.7 3.3 5.9 0.8 1.2 0.6 31.1 0.6 5.0 0.8 0.8 1.1 0.6 0.6 0.7 0.7 0.7 0.7 2.4 0.7 0.9 9.5 3.0 0.0 15.9 0.0 0.6 0.6 0.4 2.0 0.8 2.1 0.5 1.1 0.8 0.1 3.3 0.1 0.0 0.0 0.3 0.0 0.0 2.7 13.0 2.7 1.4 0.0 0.2 0.0 0.1 0.3 8.8 4.1 0.0 0.0 3.3 0.5 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 1.9 5.7 1.7 0.5 0.0 0.0 0.0 4.9 0.0 0.0 0.0 4.5 0.0 1.8 0.0 0.1 0.1 0.2 3.0 6.8 3.1 0.0 0.0 5.6 1.0 0.0 0.1 10.8 8.2 3.9 0.7 1.4 0.1 0.1 0.0 0.7 0.0 1.9 2.1 0.4 0.6 0.8 0.2 0.4 0.6 0.5 0.4 0.3 2.0 0.4 0.6 1.8 1.1 0.5 0.8 0.4 0.1 5.9 7.4 17.4 10.2 4.5 2.6 3.3 5.9 5.0 3.0 0.0 0.0 0.0 0.1 0.0 28.8 1.6 0.0 0.0 0.0 0.0 25.5 0.0 3.3 0.1 12.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 49.3 0.0 0.0 0.0 3.2 0.6 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.3 28.8 0.0 0.0 4.9 19.3 0.0 0.0 0.0 0.0 0.1 SYT15 CHR10SYT ENSG00000204176 "Synaptotagmin 15" Q9BQS2 10 46578217-46594173 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 50.6;Alveolar cells type 2: 43.8;Endothelial cells: 14.6;Ito cells: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 26.7" "HPA036971, HPA036972, HPA064559" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (1.64e-2)" "unprognostic (9.28e-3)" "unprognostic (1.54e-1)" "unprognostic (6.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.31e-2)" "unprognostic (5.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.02e-2)" "unprognostic (1.49e-2)" "unprognostic (3.19e-4)" "unprognostic (4.03e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-2)" "unprognostic (1.15e-3)" 4.7 2.4 5.7 6.5 4.8 0.2 3.9 3.1 7.0 11.5 1.6 3.3 1.1 1.3 7.1 3.9 5.3 5.3 3.3 4.3 6.1 4.7 2.9 1.1 13.2 5.3 5.1 2.8 2.4 10.4 4.7 2.3 5.6 11.3 2.7 2.0 7.4 9.2 5.6 2.3 11.4 2.4 3.8 2.7 3.1 1.4 2.4 1.1 1.1 2.7 8.3 4.1 3.1 4.3 1.2 1.8 1.2 3.8 1.8 2.2 1.1 2.3 2.8 1.6 0.7 1.6 1.6 1.9 2.9 4.8 1.9 2.3 5.6 4.8 0.6 1.9 2.5 1.7 8.5 0.0 0.7 2.8 1.2 3.0 1.3 2.4 3.8 5.0 2.6 2.4 3.0 0.9 1.4 3.9 2.4 1.1 1.9 0.6 1.7 0.9 4.0 1.3 4.2 1.1 0.4 0.9 1.7 0.0 1.6 3.0 1.2 0.9 1.2 2.0 26.7 1.3 1.5 3.8 1.3 3.0 0.8 3.0 2.0 1.8 2.3 2.3 2.0 1.8 1.6 0.7 0.0 1.7 1.2 2.2 3.8 2.1 1.0 1.7 1.1 1.8 1.2 1.5 1.9 0.7 1.8 2.3 1.1 0.5 1.1 5.7 4.8 3.1 6.4 6.1 4.7 5.1 2.8 11.3 1.1 50.6 43.8 0.0 2.1 5.5 1.8 3.6 0.0 1.4 3.4 1.8 2.0 0.9 1.7 0.8 0.4 14.6 0.9 0.0 5.0 1.0 3.2 1.8 2.3 1.0 0.1 0.0 1.2 25.2 3.1 0.0 3.4 1.1 3.3 0.0 1.2 0.2 3.5 0.0 3.5 1.9 1.6 6.5 3.3 1.1 0.7 4.8 1.0 0.0 1.3 2.2 SYT16 "CHR14SYT, Strep14, SYT14L, yt14r" ENSG00000139973 "Synaptotagmin 16" Q17RD7 14 61811974-62112550 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.8;testis: 6.8" "Group enriched" "Detected in some" 5 "Early spermatids: 26.4;Late spermatids: 10.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 10.6;hTERT-HME1: 4.3;PC-3: 5.5;RPTEC TERT1: 6.5;RT4: 17.1;U-2 OS: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004199, HPA076871" Enhanced Approved Cytosol NA NA Cytosol "HPA004199: AB_1080156, HPA076871: AB_2732324" "unprognostic (2.55e-2)" "unprognostic (1.43e-2)" "unprognostic (4.12e-1)" "unprognostic (8.88e-4)" "unprognostic (1.41e-1)" "unprognostic (9.08e-2)" "unprognostic (9.57e-2)" "unprognostic (9.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.38e-1)" "unprognostic (1.34e-1)" "unprognostic (3.41e-2)" "unprognostic (1.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.53e-3)" "unprognostic (2.15e-1)" 0.4 1.3 7.2 0.4 17.2 0.6 0.6 0.7 20.8 0.4 0.4 0.4 0.0 0.4 1.0 2.1 0.4 0.7 0.5 0.5 3.3 3.4 0.7 0.4 0.5 0.5 1.6 12.3 0.4 4.0 0.4 1.9 1.1 1.8 4.6 0.4 0.0 0.4 0.6 0.4 0.5 0.5 0.4 0.9 0.5 2.6 6.8 0.7 0.0 0.5 0.0 0.4 0.9 0.6 0.2 0.1 0.6 0.1 0.1 0.2 0.0 10.6 0.2 0.3 0.0 0.0 0.0 0.1 0.7 1.0 1.0 0.6 0.0 0.0 0.1 0.2 0.0 0.6 0.6 0.0 1.0 1.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 5.5 0.0 0.0 0.0 6.5 17.1 0.3 3.0 0.5 0.7 0.0 1.1 0.0 0.0 0.0 2.9 6.9 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.6 0.1 0.1 0.1 0.0 0.0 7.2 17.2 0.7 18.9 3.3 3.4 1.6 12.3 1.8 0.7 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 3.5 2.0 0.3 0.0 0.1 26.4 0.0 0.0 0.0 0.0 0.5 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.4 2.1 0.0 0.1 0.0 0.0 0.1 SYT2 ENSG00000143858 "Synaptotagmin 2" Q8N9I0 1 202590596-202710417 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" Differentiation "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 40.1" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 3.4;Cardiomyocytes: 2.4;Horizontal cells: 3.2;Leydig cells: 3.1;Rod photoreceptor cells: 4.1" "Cancer enriched" "Detected in some" 7 "testis cancer: 3.8" "Group enriched" "Detected in many" 5 "cerebellum: 36.2;cerebral cortex: 14.7;pons and medulla: 40.1" "Cell type enriched" "Detected in single" 8 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "AF22: 12.7;NTERA-2: 8.8;U-2 OS: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA063655 Enhanced Supported NA NA "HPA063655: AB_2685077" "unprognostic (1.32e-2)" "unprognostic (4.99e-2)" "unprognostic (4.89e-2)" "unprognostic (1.03e-2)" "unprognostic (2.21e-1)" "unprognostic (2.24e-2)" "unprognostic (3.00e-1)" "unprognostic (2.35e-3)" "unprognostic (8.81e-3)" "unprognostic (1.17e-1)" "unprognostic (1.53e-2)" "unprognostic (6.33e-2)" "unprognostic (1.56e-2)" "unprognostic (6.23e-2)" "unprognostic (3.26e-1)" "unprognostic (2.54e-1)" "unprognostic (5.17e-3)" 1.1 6.1 0.4 1.1 5.9 0.5 0.3 36.2 14.7 0.6 0.7 0.3 0.0 1.1 1.7 4.1 0.4 0.8 1.1 1.5 0.6 1.5 0.5 0.4 0.6 0.7 5.5 0.4 3.1 0.4 0.2 0.3 0.5 40.1 0.9 0.7 1.6 1.1 0.5 1.1 0.7 1.3 0.5 7.1 1.2 0.7 2.4 1.1 0.0 0.6 0.0 0.5 1.0 0.3 0.1 0.0 2.4 0.1 0.1 0.2 0.0 0.0 0.2 12.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 8.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.4 5.9 36.2 14.7 0.6 1.5 5.5 0.4 40.1 1.1 0.0 0.0 0.0 1.3 0.5 3.4 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.8 0.0 4.1 0.0 0.0 0.2 1.3 0.5 0.1 0.0 0.2 2.0 SYT3 ENSG00000213023 "Synaptotagmin 3" Q9BQG1 19 50621307-50639827 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 24.2" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 2: 4.0;Ciliated cells: 2.7;Collecting duct cells: 1.8;Cone photoreceptor cells: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 10.1;HMC-1: 7.1;JURKAT: 4.1;NTERA-2: 7.3;SH-SY5Y: 8.2;U-2 OS: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.17e-2)" "unprognostic (1.90e-1)" "unprognostic (3.86e-3)" "unprognostic (1.57e-1)" "unprognostic (6.62e-2)" "unprognostic (4.36e-3)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-1)" "unprognostic (1.19e-4)" "unprognostic (1.12e-1)" "unprognostic (3.49e-4)" "unprognostic (1.82e-4)" "unprognostic (3.40e-1)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" 0.9 1.8 8.7 1.0 8.8 0.7 0.8 16.1 24.2 1.0 0.9 1.0 0.0 1.0 0.9 1.1 0.9 0.9 0.8 0.7 10.9 8.9 1.2 0.8 1.1 0.9 6.7 6.6 0.7 2.1 1.0 2.2 2.3 6.3 1.2 0.8 0.3 1.4 1.7 0.8 0.8 1.0 0.9 2.4 0.8 0.8 2.7 2.2 0.0 1.3 0.0 0.9 1.0 0.0 0.0 1.3 0.1 0.0 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.1 0.0 0.5 0.1 0.4 0.0 0.0 0.1 10.1 0.0 0.0 0.0 0.4 0.0 7.1 0.3 0.0 0.0 0.0 0.0 0.2 4.1 1.2 0.0 0.0 3.0 0.0 0.0 7.3 0.2 0.0 2.5 0.0 0.1 0.0 0.0 0.1 8.2 0.4 0.0 0.2 0.1 0.2 2.3 0.0 0.0 5.2 0.0 0.0 0.8 0.1 0.0 0.3 3.7 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.1 8.7 8.8 16.1 16.3 10.9 8.9 6.7 6.6 6.3 2.2 0.0 4.0 0.0 0.0 0.0 1.4 0.5 0.0 2.7 0.0 1.8 3.9 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.9 0.9 0.0 0.1 0.0 0.0 0.0 SYT4 "HsT1192, KIAA1342" ENSG00000132872 "Synaptotagmin 4" Q9H2B2 18 43267878-43277650 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.8;pituitary gland: 31.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 60.4;Cone photoreceptor cells: 21.6;Intestinal endocrine cells: 27.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 74.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010574 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA010574: AB_2668309" "unprognostic (2.91e-3)" "unprognostic (2.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (7.67e-3)" "unprognostic (5.30e-3)" "unprognostic (3.95e-2)" "unprognostic (1.23e-3)" "unprognostic (3.61e-1)" "unprognostic (3.80e-2)" 1.4 17.5 5.7 2.2 24.1 1.0 0.9 60.8 54.6 0.9 1.7 0.9 0.0 1.7 0.9 0.9 1.0 0.9 1.0 1.4 12.9 19.9 1.0 0.9 1.8 1.0 5.9 16.0 1.3 4.7 0.9 31.5 1.0 22.3 1.5 1.7 0.4 1.0 9.8 0.9 1.0 1.7 1.5 5.0 0.9 4.6 2.4 1.4 0.0 1.3 0.0 0.9 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 74.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 24.1 60.8 35.7 12.9 19.9 5.9 16.0 22.3 1.4 0.0 1.4 0.0 0.0 0.1 60.4 2.8 0.0 1.4 4.5 0.0 21.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.6 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.8 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SYT5 ENSG00000129990 "Synaptotagmin 5" O00445 19 55171199-55180441 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 73.0" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 12.6;Intestinal endocrine cells: 55.3;Late spermatids: 27.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 12.3;HMC-1: 27.4;K-562: 9.6;OE19: 41.7;SCLC-21H: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA078390 Enhanced NA NA "HPA078390: AB_2732382" "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "unprognostic (9.76e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (6.54e-4)" "unprognostic (9.85e-2)" "unprognostic (3.24e-3)" "unprognostic (5.94e-2)" "unprognostic (1.36e-3)" "unprognostic (1.82e-1)" "prognostic favorable (5.54e-4)" "unprognostic (1.15e-3)" "unprognostic (3.71e-7)" "unprognostic (7.09e-2)" "unprognostic (5.21e-2)" "unprognostic (4.42e-2)" "unprognostic (3.55e-1)" 1.2 9.8 20.0 2.7 30.9 1.4 1.0 1.3 73.0 1.8 1.7 1.0 0.0 2.2 1.2 1.0 1.2 1.3 1.3 1.1 22.0 18.8 1.1 1.1 1.2 1.2 6.1 19.8 1.1 2.6 1.1 16.3 1.1 8.3 1.1 1.7 0.0 1.1 1.0 1.2 1.4 1.8 1.5 1.9 1.2 2.9 3.5 3.6 0.0 1.2 0.0 1.3 1.1 0.0 1.0 1.8 3.6 0.8 1.1 0.5 0.5 0.1 0.1 0.2 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.5 0.7 12.3 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.0 27.4 0.3 0.1 0.0 0.0 0.0 0.2 0.2 9.6 1.7 0.0 0.2 0.2 0.0 0.0 41.7 1.7 0.0 0.1 0.1 0.0 0.0 7.2 3.2 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.6 0.6 0.8 0.0 0.1 0.5 0.3 0.2 0.0 0.1 3.6 0.8 1.1 0.4 0.5 0.4 0.7 0.3 0.5 1.8 1.0 0.4 0.5 3.4 1.1 0.4 0.8 0.3 0.5 20.0 30.9 1.3 36.6 22.0 18.8 6.1 19.8 8.3 3.6 0.0 0.0 0.0 0.1 0.6 1.2 1.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.3 12.6 0.0 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.0 0.2 6.4 55.3 0.6 0.0 27.9 0.3 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.4 0.0 0.3 0.0 0.4 4.5 2.6 0.1 0.0 0.5 0.3 0.3 SYT6 ENSG00000134207 "Synaptotagmin 6" Q5T7P8 1 114089291-114153919 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.9;kidney: 3.7;pancreas: 11.1" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 5.6;Late spermatids: 9.2;Melanocytes: 3.3;Proximal tubular cells: 2.4" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 21.1;WM-115: 14.9" "Group enriched" "Detected in many" 7 "basal ganglia: 27.9;olfactory region: 87.2" "Low region specificity" "Detected in many" HPA058362 Approved Vesicles NA NA Vesicles "HPA058362: " "unprognostic (7.12e-2)" "unprognostic (2.03e-2)" "unprognostic (3.26e-3)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (2.49e-1)" "unprognostic (4.11e-2)" "unprognostic (3.60e-3)" "unprognostic (1.19e-1)" "unprognostic (4.71e-1)" "unprognostic (5.50e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-1)" "unprognostic (2.11e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-2)" "unprognostic (1.18e-1)" 0.3 2.2 2.6 0.8 6.5 0.3 2.1 0.2 10.4 0.4 0.3 5.1 0.0 0.9 0.4 0.2 0.2 0.3 0.5 0.3 2.3 14.9 3.7 0.3 0.4 0.3 2.8 1.3 2.3 11.1 0.7 0.3 1.4 3.9 1.5 0.6 0.9 1.1 0.2 0.4 0.4 0.5 0.3 4.2 0.3 0.3 0.9 3.3 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.1 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.6 6.5 0.2 9.3 2.3 14.9 2.8 1.3 3.9 3.3 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.2 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 SYT7 "IPCA-7, MGC150517, PCANAP7, SYT-VII" ENSG00000011347 "Synaptotagmin 7" O43581 11 61515313-61581148 "Predicted intracellular proteins, Predicted membrane proteins" Exocytosis Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.4;prostate: 36.9;salivary gland: 37.7" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 19.5;Cytotrophoblasts: 35.9;Glandular cells: 42.2;Hepatocytes: 51.0;Horizontal cells: 20.6;Intestinal endocrine cells: 47.8;Mucus-secreting cells: 24.7;Syncytiotrophoblasts: 55.5" "Cancer enhanced" "Detected in all" "prostate cancer: 54.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 15.3;hTERT-HME1: 40.0;RT4: 16.2;SCLC-21H: 12.9;SK-BR-3: 18.2;T-47d: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012869 Enhanced NA NA "HPA012869: AB_1857698" "unprognostic (7.09e-2)" "unprognostic (8.26e-2)" "unprognostic (2.43e-1)" "unprognostic (2.10e-2)" "unprognostic (5.42e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (4.37e-2)" "unprognostic (5.08e-2)" "unprognostic (2.74e-3)" "unprognostic (1.79e-2)" "unprognostic (1.02e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (2.08e-1)" "unprognostic (1.69e-1)" "unprognostic (2.23e-3)" "unprognostic (2.47e-1)" 2.5 3.7 16.2 1.4 22.7 0.6 6.9 22.8 46.4 2.8 4.0 3.2 0.0 2.1 2.0 1.9 1.9 1.7 1.4 11.1 11.8 7.8 4.4 28.2 1.7 0.8 4.9 23.6 1.2 11.9 2.2 22.2 12.7 8.8 36.9 4.2 2.4 37.7 1.3 2.8 1.6 3.3 1.8 1.5 1.8 3.4 2.5 3.0 0.0 3.5 0.6 0.8 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.7 0.8 0.2 0.0 0.4 6.5 4.6 0.1 15.3 0.2 0.2 1.4 3.0 0.0 0.2 0.1 0.6 3.0 0.4 0.1 0.1 0.1 0.7 0.0 0.6 0.8 0.4 0.0 0.0 0.2 3.6 1.8 40.0 0.0 0.0 0.3 0.0 0.1 0.2 9.5 0.0 0.1 1.0 10.9 6.4 0.0 0.3 0.7 0.0 16.2 12.9 2.3 0.8 18.2 0.1 2.6 17.8 0.0 0.0 3.8 1.4 4.2 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 22.7 22.8 37.5 11.8 7.8 4.9 23.6 8.8 3.0 0.0 0.3 0.0 0.2 0.2 6.6 19.5 0.0 0.0 1.2 5.2 0.0 35.9 5.0 0.8 6.1 2.2 2.1 0.0 1.4 2.2 0.5 42.2 0.0 51.0 3.5 20.6 47.8 3.7 0.6 5.4 3.1 0.0 1.7 0.0 24.7 0.5 1.6 3.5 2.1 0.0 3.1 0.0 0.0 0.3 3.8 0.1 55.5 0.0 1.7 0.6 SYT8 DKFZp434K0322 ENSG00000149043 "Synaptotagmin 8" Q8NBV8 11 1828307-1837521 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 61.8;skin 1: 41.6;urinary bladder: 31.4" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 164.0;Cholangiocytes: 229.3;Extravillous trophoblasts: 178.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 27.8;hTCEpi: 44.2;T-47d: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA052700 Uncertain NA NA "HPA052700: AB_2681920" "unprognostic (1.66e-3)" "unprognostic (2.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.14e-1)" "unprognostic (6.31e-2)" "unprognostic (2.06e-1)" "unprognostic (3.10e-2)" "unprognostic (1.36e-2)" "unprognostic (1.02e-1)" "unprognostic (8.25e-2)" "unprognostic (7.09e-2)" "unprognostic (2.48e-1)" "unprognostic (2.33e-6)" "unprognostic (2.87e-2)" "unprognostic (1.75e-1)" "unprognostic (5.52e-2)" "unprognostic (2.77e-2)" 0.1 0.1 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.7 0.9 0.0 6.8 0.7 0.1 7.3 19.9 0.6 61.8 0.1 0.1 0.0 0.5 0.3 2.3 0.0 0.0 0.0 0.1 7.8 0.0 0.1 5.7 0.0 5.6 0.1 0.3 11.8 4.2 0.1 41.6 3.6 6.3 0.1 0.1 3.1 0.1 0.0 0.0 0.1 19.4 13.3 31.4 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 27.8 0.0 0.0 0.0 0.5 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 44.2 0.0 5.1 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.8 0.0 0.0 0.2 0.0 0.1 0.9 0.0 0.2 0.0 2.4 0.0 0.0 11.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.9 3.8 0.0 5.8 164.0 0.0 0.6 229.3 60.2 42.1 5.2 0.0 22.5 0.0 23.0 0.0 0.1 4.5 0.0 8.3 178.7 5.2 0.8 1.1 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 10.1 0.0 0.6 0.0 21.6 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 41.3 30.8 0.0 1.0 22.4 SYT9 ENSG00000170743 "Synaptotagmin 9" Q86SS6 11 7238778-7469042 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.6" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 10.8;Early spermatids: 13.1;Hepatocytes: 5.0;Late spermatids: 15.3" "Cancer enhanced" "Detected in some" "breast cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEK 293: 8.9;RT4: 15.5;SH-SY5Y: 11.6;TIME: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.47e-1)" "unprognostic (9.41e-2)" "unprognostic (1.39e-5)" "unprognostic (1.63e-1)" "unprognostic (1.12e-1)" "unprognostic (5.50e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.67e-2)" "unprognostic (1.64e-2)" "unprognostic (1.81e-1)" "unprognostic (3.31e-3)" "unprognostic (4.35e-2)" "unprognostic (1.92e-4)" "unprognostic (1.22e-4)" 0.5 6.0 7.5 0.7 7.4 0.5 2.8 23.6 10.2 1.7 0.8 15.5 5.6 0.5 3.8 0.6 0.5 0.9 0.9 1.4 7.5 5.3 6.0 9.8 0.7 0.5 11.1 5.6 0.8 4.0 1.2 5.1 0.5 7.1 3.5 0.7 3.3 0.7 10.5 0.5 0.7 0.8 1.0 7.9 0.5 0.7 2.8 11.5 0.0 3.6 0.0 0.5 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.0 0.0 0.0 0.0 0.0 15.5 2.8 11.6 0.0 0.0 0.0 0.4 0.0 0.0 17.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 7.4 23.6 6.4 7.5 5.3 11.1 5.6 7.1 11.5 0.0 0.0 0.0 0.1 0.0 10.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 0.0 3.2 0.0 0.0 0.3 15.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.2 3.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 SYVN1 "DER3, HRD1" ENSG00000162298 "Synoviolin 1" Q86TM6 11 65121780-65134533 "Enzymes, Predicted membrane proteins" "Stress response, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 56.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005480, HPA024300, CAB037030" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum,Plasma membrane" NA NA Nucleoplasm "Endoplasmic reticulum, Plasma membrane" "CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.22e-1)" "unprognostic (2.17e-2)" "unprognostic (2.85e-2)" "prognostic favorable (6.88e-4)" "unprognostic (7.67e-2)" "unprognostic (2.50e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-2)" "unprognostic (1.56e-2)" "unprognostic (4.89e-1)" "unprognostic (3.85e-2)" "unprognostic (1.16e-1)" 13.8 20.8 11.0 33.0 15.3 13.8 14.9 13.3 19.3 15.1 14.2 21.0 20.2 13.2 16.0 21.1 14.4 16.1 15.3 12.9 11.3 10.0 16.4 78.0 14.2 28.9 18.2 8.7 17.1 68.1 24.4 21.0 20.9 14.4 15.0 15.4 13.3 48.9 22.6 16.7 14.4 19.6 13.6 12.8 27.1 18.3 14.4 14.9 10.3 23.5 8.0 42.2 13.3 12.6 17.5 13.0 11.6 5.4 2.2 5.5 3.8 8.6 11.1 6.7 9.0 17.1 9.8 6.7 9.0 9.3 11.5 8.2 6.0 15.2 49.0 12.3 11.5 15.2 13.5 7.3 9.1 9.5 7.6 5.5 7.7 12.9 13.4 20.8 11.5 14.0 12.4 16.5 10.1 23.0 10.3 7.4 5.2 9.6 25.1 6.7 12.9 5.0 8.3 7.2 9.1 7.7 8.5 5.7 19.7 7.2 8.6 4.4 9.0 8.3 20.7 14.5 6.2 15.4 7.6 7.1 8.0 5.3 14.3 6.0 50.2 34.7 56.6 10.8 5.9 8.9 11.6 5.4 9.3 5.5 3.3 5.0 15.4 3.9 5.1 3.1 17.5 2.9 3.0 5.2 2.2 3.2 13.0 3.6 3.8 11.0 15.3 13.3 19.3 11.3 10.0 18.2 8.7 14.4 14.9 14.9 21.3 22.2 6.0 15.7 10.2 3.4 33.1 9.4 20.5 10.4 31.4 11.5 1.7 10.5 4.3 8.3 15.8 23.3 16.3 12.6 12.1 13.4 1.1 60.4 13.6 12.7 8.1 14.1 14.8 3.5 19.0 11.6 11.8 6.4 25.0 10.8 17.1 12.4 12.4 7.2 17.1 12.9 7.5 21.0 10.9 14.1 35.8 10.2 14.5 11.6 TAAR1 "TA1, TAR1, TRAR1" ENSG00000146399 "Trace amine associated receptor 1" Q96RJ0 6 132644984-132646003 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "stomach 1: 13.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "cervical cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.7;HBF TERT88: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA055614 Approved NA NA "HPA055614: AB_2682862" "unprognostic (2.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.47e-1)" "unprognostic (2.68e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 13.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR2 GPR58 ENSG00000146378 "Trace amine associated receptor 2 (gene/pseudogene)" Q9P1P5 6 132617022-132624275 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.3" "Cell type enhanced" "Detected in single" 35 "Early spermatids: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR5 PNR ENSG00000135569 "Trace amine associated receptor 5" O14804 6 132588673-132589686 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051703 Uncertain NA NA "HPA051703: AB_2681580" 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR6 "TA4, TRAR4" ENSG00000146383 "Trace amine associated receptor 6" Q96RI8 6 132570322-132571359 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "kidney: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "REH: 1.0" "Not detected" "Not detected" NA NA "unprognostic (1.70e-1)" 0.0 0.7 0.9 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR8 "GPR102, TA5, TAR5, TRAR5" ENSG00000146385 "Trace amine associated receptor 8" Q969N4 6 132552693-132553721 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.2" NA NA 0.0 0.6 0.5 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR9 "TA3, TAR3, TRAR3" ENSG00000237110 "Trace amine associated receptor 9 (gene/pseudogene)" Q96RI9 6 132538290-132539336 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "NTERA-2: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TACR1 "NK1R, NKIR, SPR, TAC1R" ENSG00000115353 "Tachykinin receptor 1" P25103 2 75046463-75199700 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.9" "Cell type enhanced" "Detected in some" 18 "Basal keratinocytes: 2.3;Cone photoreceptor cells: 2.0;Melanocytes: 6.8;Rod photoreceptor cells: 2.6;Suprabasal keratinocytes: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 40 "basophil: 4.4" "Lineage enriched" "Detected in single" 40 "granulocytes: 4.4" "Cell line enhanced" "Detected in some" "BJ: 1.3;EFO-21: 3.2;fHDF/TERT166: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074573 Enhanced NA NA "HPA074573: AB_2686701" "unprognostic (5.74e-4)" "unprognostic (2.41e-3)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (1.24e-1)" "unprognostic (8.62e-3)" "unprognostic (1.10e-1)" "unprognostic (3.33e-2)" "unprognostic (4.38e-2)" "unprognostic (1.46e-1)" "unprognostic (2.14e-3)" "unprognostic (1.63e-2)" "unprognostic (5.91e-4)" "unprognostic (1.03e-2)" "unprognostic (2.75e-1)" "unprognostic (1.06e-1)" "unprognostic (2.76e-2)" 23.9 1.0 2.0 1.8 8.5 0.3 8.2 0.3 4.8 15.2 1.9 0.1 1.5 0.8 17.7 3.6 4.8 6.9 2.5 0.9 1.5 2.5 1.5 0.4 2.1 2.9 0.9 1.0 4.2 0.7 1.3 1.1 1.6 2.3 6.1 1.4 0.3 2.6 2.5 2.6 8.7 1.4 6.5 0.9 0.4 1.2 2.0 1.5 0.2 1.1 4.3 3.4 4.8 14.3 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 1.1 0.0 0.5 3.2 2.7 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.8 0.3 0.3 0.6 0.1 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 1.0 0.0 0.8 0.1 0.1 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.0 1.2 0.1 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 8.5 0.3 3.6 1.5 2.5 0.9 1.0 2.3 1.5 0.0 0.0 0.0 0.0 2.3 0.5 0.8 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 1.6 0.1 0.0 0.0 0.1 TACR2 "NK2R, NKNAR, SKR, TAC2R" ENSG00000075073 "Tachykinin receptor 2" P21452 10 69403903-69416867 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.3;smooth muscle: 35.5" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 2.7;Horizontal cells: 6.4;Kupffer cells: 2.2;Leydig cells: 2.6" "Cancer enhanced" "Detected in many" "stomach cancer: 6.7" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SK-MEL-30: 8.7;U-87 MG: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076573 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA076573: AB_2732313" "unprognostic (2.83e-1)" "unprognostic (1.58e-3)" "unprognostic (2.48e-2)" "unprognostic (1.67e-1)" "unprognostic (4.22e-1)" "unprognostic (2.30e-1)" "unprognostic (1.30e-2)" "unprognostic (1.96e-2)" "unprognostic (3.72e-1)" "unprognostic (6.14e-2)" "unprognostic (2.45e-2)" "unprognostic (3.16e-2)" "unprognostic (9.88e-4)" "unprognostic (5.59e-3)" "unprognostic (4.31e-3)" "unprognostic (1.25e-3)" "unprognostic (1.32e-1)" 1.6 0.1 0.5 3.1 0.5 0.1 1.2 0.5 1.1 11.1 56.3 0.2 0.4 4.1 12.3 0.9 19.6 7.2 1.2 1.9 0.5 0.3 0.2 0.5 0.8 0.5 0.2 0.4 2.0 0.8 0.0 0.1 0.1 0.4 14.9 8.2 0.2 0.4 0.9 1.1 0.4 14.2 35.5 0.8 0.5 16.5 0.9 0.5 0.1 0.4 0.8 0.4 19.4 3.1 1.2 2.0 0.5 4.2 0.1 0.8 0.3 2.0 1.2 0.4 0.7 3.1 0.2 0.2 0.5 0.3 0.5 0.7 0.7 0.4 0.2 0.5 0.5 0.7 0.8 0.1 0.1 0.0 0.4 0.5 1.6 0.6 1.9 0.3 0.0 3.1 0.5 0.7 0.0 0.1 0.8 0.2 0.1 0.4 2.5 0.0 0.8 0.1 0.5 0.4 1.7 1.9 0.1 0.0 0.0 0.0 1.0 0.8 0.6 1.3 2.7 8.7 0.4 1.2 0.2 0.8 3.1 0.4 1.3 1.1 1.2 1.3 0.2 5.0 0.3 1.8 0.5 1.5 0.1 0.3 4.2 0.4 1.2 0.8 0.3 2.0 0.6 0.4 0.2 0.2 0.1 1.7 0.3 0.1 0.3 0.5 0.5 0.5 1.1 0.5 0.3 0.2 0.4 0.4 0.5 0.0 0.3 0.0 0.2 0.6 0.2 0.5 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 1.1 6.4 0.0 1.3 2.2 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.3 0.0 1.2 0.2 0.1 0.1 0.0 0.0 0.4 0.4 TACR3 NK3R ENSG00000169836 "Tachykinin receptor 3" P29371 4 103586031-103719816 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.4;urinary bladder: 5.5" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 1.1;Extravillous trophoblasts: 1.8" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 14.4;hypothalamus: 4.1;pons and medulla: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "BEWO: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA009418 Uncertain NA NA "HPA009418: AB_1857727" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (2.29e-1)" "unprognostic (3.50e-1)" "unprognostic (3.21e-1)" "unprognostic (5.52e-1)" "unprognostic (3.80e-1)" "unprognostic (3.42e-2)" "unprognostic (1.72e-2)" 0.1 0.1 14.4 0.1 1.4 0.1 0.4 0.0 2.6 0.1 0.4 0.0 0.0 0.1 0.2 0.4 0.2 0.3 0.3 0.1 1.1 4.1 2.0 0.1 0.9 0.1 1.4 1.0 0.1 0.1 0.1 0.1 0.6 6.3 0.2 0.5 3.2 0.1 0.1 0.7 0.3 0.1 0.1 2.5 0.1 0.5 0.6 0.0 0.0 0.5 0.9 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 1.4 0.0 1.5 1.1 4.1 1.4 1.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TACSTD2 "EGP-1, GA733-1, M1S1, TROP2" ENSG00000184292 "Tumor associated calcium signal transducer 2" P09758 1 58575423-58577773 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Tumor antigen" "Amyloidosis, Corneal dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.9;salivary gland: 56.4" "Cell type enhanced" "Detected in many" 15 "Basal glandular cells: 5162.0;Glandular cells: 2977.4;Urothelial cells: 7434.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 12.4" "Group enriched" "Detected in many" 65 "dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2" "Cell line enhanced" "Detected in some" "A-431: 75.7;CAPAN-2: 102.7;HaCaT: 102.9;RT4: 35.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043104, HPA055067, CAB072852" Enhanced Supported "Nucleoli,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoli, Vesicles" "CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687" "unprognostic (1.80e-2)" "unprognostic (3.08e-1)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (5.70e-2)" "unprognostic (2.15e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (7.91e-2)" "prognostic favorable (3.99e-4)" "unprognostic (7.10e-2)" "unprognostic (2.55e-1)" "unprognostic (6.91e-3)" "unprognostic (2.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.7 17.1 0.0 0.0 23.1 0.0 0.0 1.7 2.6 103.9 2.7 0.9 0.0 0.0 0.0 10.4 0.0 8.0 0.0 0.0 0.0 9.0 0.0 0.0 1.5 15.7 0.0 56.4 12.6 0.0 42.1 0.0 0.0 0.0 0.0 7.3 0.0 0.1 20.6 17.7 36.1 0.0 3.7 12.4 3.2 0.0 0.0 1.8 75.7 0.0 0.0 0.1 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 102.7 0.0 9.9 6.4 0.0 102.9 0.0 18.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 1.1 0.0 4.3 0.0 0.0 0.1 0.0 16.3 0.0 0.1 0.0 16.7 0.1 0.0 0.0 0.0 13.8 35.5 0.0 0.0 3.3 27.4 0.1 0.3 17.9 0.1 4.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 12.4 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.8 321.6 110.2 1.3 5162.0 1324.0 0.0 0.3 287.9 277.1 312.8 1212.6 0.0 74.9 36.5 1546.3 0.0 14.3 0.4 0.0 1122.5 4.7 23.0 2977.4 8.1 0.6 7.6 0.0 0.0 0.6 0.3 0.0 0.0 32.3 108.0 54.1 2.9 0.0 1294.2 4.0 0.0 3.3 0.0 0.0 47.2 0.5 0.9 1339.0 65.6 0.0 0.9 7434.9 TAOK2 "KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2" ENSG00000149930 "TAO kinase 2" Q9UL54 16 29973641-29992261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ito cells: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010650 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA010650: AB_1080204" "unprognostic (7.30e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.87e-5)" "unprognostic (8.46e-2)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.01e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.78e-4)" "unprognostic (3.85e-3)" "prognostic favorable (3.66e-4)" "unprognostic (7.42e-3)" "unprognostic (3.17e-1)" "unprognostic (7.47e-2)" "unprognostic (1.37e-1)" 27.8 24.1 26.2 15.1 26.7 12.3 17.7 29.2 30.6 13.5 13.6 21.5 11.8 18.5 16.8 13.0 12.4 14.1 15.1 17.6 25.0 18.2 13.9 10.4 23.0 14.4 22.1 22.7 15.8 16.3 26.2 18.7 22.5 20.7 13.6 9.6 15.0 17.1 15.9 22.8 20.0 19.3 14.8 14.9 26.3 16.0 21.2 20.2 14.0 15.9 9.8 11.5 12.8 18.0 2.6 3.3 4.8 2.8 2.0 3.2 2.0 11.2 21.5 11.8 18.6 13.9 9.3 18.1 20.7 11.1 14.0 13.1 17.2 15.1 12.2 17.6 14.9 9.4 17.6 10.7 10.4 7.6 18.9 22.7 13.1 21.7 17.2 10.1 12.9 25.3 10.9 9.1 14.9 6.0 9.8 23.4 11.7 11.8 12.4 13.3 20.8 15.0 18.3 11.4 8.4 14.5 27.7 17.1 11.3 8.8 10.6 13.9 11.2 11.8 15.8 6.2 7.9 19.8 14.6 32.6 24.2 11.2 17.1 11.9 18.1 11.6 11.5 14.8 14.8 17.6 1.3 2.8 1.5 2.9 2.7 3.1 2.0 2.9 2.6 1.8 2.6 1.6 1.4 4.8 2.0 1.4 3.3 3.2 2.0 26.2 26.7 29.2 30.6 25.0 18.2 22.1 22.7 20.7 20.2 8.9 11.5 2.2 4.2 9.5 13.3 8.1 5.1 4.0 7.9 8.7 37.3 6.7 1.7 7.6 3.1 27.6 23.3 0.0 10.2 4.8 9.3 5.8 3.5 9.7 8.4 9.5 12.6 44.2 12.4 2.1 11.5 5.5 6.8 4.6 14.9 8.7 12.7 14.2 12.0 6.4 19.2 6.5 7.6 21.1 17.2 8.4 10.1 9.2 13.3 5.7 TAP1 "ABCB2, D6S114E, PSF1, RING4" ENSG00000168394 "Transporter 1, ATP binding cassette subfamily B member" Q03518 6 32845209-32853978 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.3" "Cell type enhanced" "Detected in many" 5 "monocytes: 144.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 16.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009516, HPA072354" Approved Approved "Endoplasmic reticulum,Centriolar satellite" NA NA 110000 "Endoplasmic reticulum, Centriolar satellite" "CAB009516: AB_2303048, HPA072354: AB_2686513" "unprognostic (3.59e-2)" "unprognostic (1.06e-1)" "prognostic favorable (9.01e-4)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.22e-2)" "unprognostic (4.92e-2)" "unprognostic (6.16e-3)" "unprognostic (2.56e-2)" "prognostic favorable (4.07e-4)" "unprognostic (3.02e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (6.58e-5)" "unprognostic (2.07e-2)" "unprognostic (4.69e-2)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" 10.7 7.9 3.8 20.4 5.2 6.1 8.7 3.1 4.9 6.5 12.6 4.5 1.9 9.1 8.2 3.9 10.5 6.4 9.6 6.5 3.5 3.3 6.5 6.4 17.6 26.9 6.4 3.6 5.0 4.4 3.0 3.6 8.7 6.0 9.0 5.4 6.6 9.4 4.4 7.5 15.3 19.5 5.7 5.2 24.2 12.6 5.8 4.9 20.8 13.1 8.9 20.3 6.6 7.6 22.7 8.8 45.3 10.9 14.4 25.3 21.0 2.8 1.8 0.0 1.7 0.9 1.2 16.8 1.5 3.4 7.0 9.5 0.1 3.0 6.0 4.0 1.1 6.5 5.5 1.2 2.5 0.4 10.2 1.6 6.7 1.4 2.3 4.4 0.0 2.4 1.3 2.1 1.9 1.2 0.0 1.7 2.2 0.4 5.7 0.8 1.7 1.1 13.3 0.0 0.6 2.0 5.9 1.2 4.0 9.0 0.5 0.0 0.3 1.6 4.3 5.8 0.3 3.9 12.0 0.9 2.6 1.0 6.4 0.0 7.6 10.6 1.7 1.7 4.0 1.8 27.7 10.6 44.2 15.5 10.9 16.3 22.7 17.5 16.4 8.8 20.9 25.3 19.4 45.3 14.4 10.5 7.2 21.7 21.0 3.8 5.2 3.1 4.9 3.5 3.3 6.4 3.6 6.0 4.9 23.8 29.5 66.8 38.2 66.3 4.1 5.3 35.7 8.1 17.0 5.2 0.0 3.2 5.0 68.6 0.4 41.7 52.4 0.0 65.7 73.1 29.1 47.1 26.5 9.7 45.6 14.3 16.1 26.4 22.4 0.0 12.0 40.0 21.9 144.3 54.7 32.1 71.9 35.1 9.9 5.0 3.0 6.5 44.0 0.9 0.7 66.9 4.0 91.4 30.7 39.7 TAP2 "ABCB3, D6S217E, PSF2, RING11" ENSG00000204267 "Transporter 2, ATP binding cassette subfamily B member" Q03519 6 32821833-32838780 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "monocytes: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.6;U-251 MG: 28.3" HPA001312 Approved Supported "Nuclear speckles,Endoplasmic reticulum" NA NA 14000 "Endoplasmic reticulum" "Nuclear speckles" "HPA001312: AB_1080206" "unprognostic (2.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.28e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.51e-4)" "unprognostic (1.90e-1)" "prognostic unfavorable (5.22e-8)" "unprognostic (5.32e-1)" "unprognostic (4.17e-2)" "unprognostic (2.35e-1)" "unprognostic (4.71e-2)" 12.8 8.4 6.5 22.5 6.9 14.7 9.5 6.3 7.3 8.8 15.0 7.6 3.3 15.3 9.6 5.9 17.4 7.9 11.5 7.7 5.2 6.0 10.8 19.0 18.0 14.0 7.1 6.3 9.7 6.1 2.6 5.8 5.7 7.9 8.2 11.9 7.9 12.1 5.2 5.8 9.6 28.0 7.0 6.1 24.9 7.7 3.3 6.9 25.9 14.7 7.1 20.1 23.6 10.7 0.9 2.8 4.9 5.4 2.9 4.1 1.9 7.9 0.0 0.0 2.3 2.2 3.1 0.0 0.5 1.6 6.2 8.5 2.1 16.3 15.5 3.1 4.0 11.2 8.3 7.1 28.6 2.5 10.5 0.9 1.8 6.1 0.7 1.0 0.0 12.3 0.3 0.4 8.4 13.1 0.0 4.0 0.0 8.6 5.2 0.0 0.6 2.0 1.0 0.3 0.6 4.0 8.4 0.0 5.9 5.2 0.1 0.1 0.0 7.7 16.4 1.6 0.3 0.8 0.0 2.3 8.8 2.0 2.3 28.3 8.1 13.4 14.5 8.1 10.9 1.6 1.7 2.0 1.8 4.1 5.4 2.0 0.9 1.2 2.7 2.0 0.6 1.0 0.6 4.9 2.9 4.1 2.8 1.9 1.9 6.5 6.9 6.3 7.3 5.2 6.0 7.1 6.3 7.9 6.9 0.0 6.9 28.3 12.0 0.0 4.5 2.4 2.5 2.7 6.8 14.0 2.0 1.2 1.7 33.7 0.0 28.7 19.3 0.0 28.6 35.6 4.1 11.3 4.7 5.8 22.4 17.5 3.5 16.0 12.3 0.0 5.2 14.5 0.0 92.8 18.4 18.9 27.4 13.9 5.6 4.7 4.8 0.0 7.5 0.4 1.2 0.0 1.4 24.5 10.3 14.8 TAPBP TAPA ENSG00000231925 "TAP binding protein" O15533 6 33299694-33314387 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007066 Approved NA NA 1100000 "HPA007066: AB_1857769" "prognostic favorable (2.76e-4)" "unprognostic (1.43e-2)" "unprognostic (7.01e-2)" "unprognostic (1.98e-2)" "unprognostic (1.59e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.21e-2)" "prognostic favorable (6.29e-4)" "unprognostic (1.67e-2)" "unprognostic (2.37e-1)" "unprognostic (3.63e-1)" "unprognostic (1.61e-2)" "unprognostic (3.82e-1)" "unprognostic (1.19e-2)" "unprognostic (1.21e-1)" "unprognostic (6.54e-3)" 31.8 24.5 10.5 28.0 12.4 19.3 14.1 13.2 13.6 15.8 41.3 10.1 17.1 44.2 13.2 21.2 23.8 15.0 22.4 22.4 10.5 8.5 26.7 48.7 34.8 20.9 8.9 8.3 17.9 16.5 27.3 13.6 28.8 9.2 21.8 11.0 13.9 20.9 16.6 18.5 16.2 46.6 20.6 7.4 46.8 23.2 10.0 8.6 55.2 40.2 17.8 34.6 19.6 13.8 15.7 15.7 26.9 23.6 25.1 24.0 29.1 0.8 0.5 1.7 3.5 3.8 4.8 17.1 8.1 19.9 10.1 12.0 0.0 30.8 7.0 8.4 11.3 21.7 0.8 0.0 6.8 2.0 18.9 2.3 6.1 3.8 4.8 0.0 7.7 9.9 12.2 5.8 0.2 1.5 8.4 0.1 4.1 0.5 19.0 2.0 3.1 6.9 5.9 0.0 0.0 2.1 1.0 0.1 0.5 3.6 0.4 3.0 0.2 0.2 0.7 3.0 0.7 0.5 0.1 14.0 17.4 4.1 0.5 0.6 23.3 15.8 8.9 11.9 7.8 11.9 21.4 14.0 26.9 24.0 15.7 22.5 15.7 18.1 22.6 15.7 10.1 12.7 16.1 22.2 25.1 23.6 14.9 12.5 29.1 10.5 12.4 13.2 13.6 10.5 8.5 8.9 8.3 9.2 8.6 116.1 102.8 162.9 75.3 68.5 32.2 67.4 107.0 56.2 66.0 68.0 31.4 37.9 11.6 213.0 1.6 83.6 237.4 0.0 245.8 64.2 53.4 99.7 90.0 127.8 112.8 19.1 81.2 66.3 105.9 6.8 30.8 113.3 113.1 275.9 144.3 34.6 201.2 164.1 30.1 28.3 28.6 32.3 48.6 0.5 0.6 49.2 41.1 131.1 100.3 112.9 TAPBPL "FLJ10143, TAPBP-R, TAPBPR" ENSG00000139192 "TAP binding protein like" Q9BX59 12 6451690-6466517 "Predicted intracellular proteins, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 32.9;HDLM-2: 18.8;Karpas-707: 23.7;RPMI-8226: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039545 Uncertain NA NA "HPA039545: AB_10673360" "prognostic favorable (1.98e-4)" "unprognostic (3.56e-1)" "unprognostic (4.58e-2)" "unprognostic (2.30e-1)" "unprognostic (1.32e-1)" "unprognostic (4.61e-2)" "unprognostic (1.91e-1)" "unprognostic (7.64e-2)" "unprognostic (4.07e-2)" "unprognostic (3.18e-1)" "unprognostic (5.66e-2)" "unprognostic (1.40e-1)" "prognostic favorable (6.04e-5)" "unprognostic (3.53e-2)" "unprognostic (7.61e-2)" "unprognostic (6.28e-2)" "prognostic favorable (7.86e-4)" 11.2 11.2 5.4 12.5 7.3 7.2 10.6 2.3 5.7 11.3 23.3 8.6 26.1 22.3 10.9 17.6 8.9 13.4 15.0 14.7 6.6 3.9 15.5 18.1 12.3 10.5 7.8 4.0 9.9 13.1 10.1 10.4 18.2 6.7 10.4 8.6 12.9 24.3 20.9 5.5 7.3 38.5 8.3 7.7 15.5 16.7 4.1 6.0 27.8 20.2 9.1 20.2 11.1 8.9 12.9 26.8 31.7 42.8 36.6 32.6 34.6 3.2 2.3 0.0 1.4 5.5 7.2 6.7 2.1 6.4 2.6 4.3 2.6 32.9 2.7 1.2 2.6 1.6 3.9 0.0 0.5 0.4 18.8 0.0 2.8 1.6 2.8 6.8 2.7 7.7 10.7 1.9 5.1 0.8 1.8 3.9 1.8 0.0 23.7 0.5 7.0 5.4 1.4 0.3 0.2 0.4 5.4 1.6 18.0 2.3 8.9 0.2 0.0 7.8 4.8 0.6 0.0 0.2 6.0 3.7 3.0 1.1 0.7 3.7 3.7 0.9 1.5 5.6 2.6 3.3 31.7 37.3 24.8 32.6 42.8 21.2 12.8 17.5 21.2 26.8 12.9 11.1 20.6 26.9 36.6 33.6 22.2 11.0 34.6 5.4 7.3 2.3 5.7 6.6 3.9 7.8 4.0 6.7 6.0 17.9 12.5 16.7 15.0 7.3 3.9 4.8 10.2 6.7 6.8 33.2 9.8 14.6 0.0 24.8 0.3 12.6 56.7 0.0 48.1 12.2 13.0 15.2 12.7 11.0 30.0 0.0 8.6 7.4 11.9 0.0 14.4 22.6 15.1 25.2 30.4 7.8 24.4 69.1 8.1 9.8 1.7 6.5 7.8 0.4 0.0 6.9 11.6 21.9 29.9 19.4 TAPT1 FLJ90013 ENSG00000169762 "Transmembrane anterior posterior transformation 1" Q6NXT6 4 16160505-16227410 "Disease related genes, Predicted membrane proteins" "Chondrogenesis, Cilium biogenesis/degradation, Differentiation, Host-virus interaction, Osteogenesis" "Developmental protein, Receptor" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 108.0;Late spermatids: 117.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "REH: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042567, HPA048658" Approved Uncertain Vesicles NA NA Vesicles "HPA042567: AB_2678055, HPA048658: AB_2680482" "unprognostic (2.34e-1)" "unprognostic (5.84e-2)" "unprognostic (1.41e-2)" "prognostic favorable (9.75e-4)" "unprognostic (2.43e-1)" "unprognostic (2.56e-2)" "unprognostic (2.32e-3)" "unprognostic (3.15e-3)" "unprognostic (1.54e-1)" "unprognostic (6.30e-2)" "prognostic favorable (5.34e-4)" "unprognostic (7.07e-2)" "prognostic favorable (8.52e-4)" "unprognostic (9.00e-2)" "unprognostic (8.52e-2)" "unprognostic (7.25e-3)" "prognostic favorable (4.18e-4)" 10.2 19.2 18.6 7.4 18.0 26.2 13.1 15.0 17.3 10.2 10.1 20.2 8.2 8.3 15.1 12.2 8.2 10.7 10.8 14.4 17.5 13.5 15.8 35.9 14.7 11.0 20.1 10.8 10.8 9.8 14.4 14.5 17.2 13.5 10.2 10.7 11.3 9.4 11.0 38.0 9.8 12.8 12.0 18.5 11.2 9.2 13.1 19.1 15.3 17.8 7.8 9.9 10.1 16.8 6.5 1.8 2.6 0.7 0.9 2.4 0.7 3.0 2.2 3.8 4.4 5.7 4.4 1.6 5.0 3.7 4.7 5.2 3.0 5.3 19.4 5.4 3.1 6.9 2.5 3.2 2.5 6.0 1.8 4.0 3.8 3.2 3.2 5.5 7.6 4.0 2.7 4.9 4.6 3.4 5.8 2.3 12.1 5.8 9.1 4.5 2.1 11.2 6.2 2.5 5.7 5.3 27.4 5.3 3.5 7.6 3.1 6.3 5.1 4.6 3.9 5.7 2.7 7.2 7.5 4.4 3.9 2.6 2.6 6.3 8.9 7.3 14.8 8.0 19.0 4.5 2.6 0.7 0.2 0.6 0.6 0.2 2.1 1.8 1.0 1.1 6.5 2.4 1.7 1.6 0.9 0.7 1.8 1.3 0.7 18.6 18.0 15.0 16.2 17.5 13.5 20.1 10.8 13.5 19.1 29.8 50.5 7.1 5.3 8.0 20.4 13.4 12.7 17.4 10.3 7.0 108.0 3.6 3.3 6.4 69.0 8.4 8.4 0.0 7.0 2.3 6.6 5.8 2.3 37.6 3.6 66.7 13.8 6.2 7.5 117.7 9.2 11.5 15.1 2.8 10.1 28.6 7.9 8.6 14.2 7.9 54.9 6.5 7.2 23.1 5.5 6.9 5.8 5.9 7.3 5.6 TARM1 ENSG00000248385 "T cell-interacting, activating receptor on myeloid cells 1" B6A8C7 19 54069895-54081365 "Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.1;lymphoid tissue: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 2.8;neutrophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "Cell line enhanced" "Detected in some" "Hep G2: 1.7" "HPA051022, HPA054401" Uncertain NA NA "HPA051022: AB_2681315, HPA054401: AB_2682476" "unprognostic (1.56e-1)" 0.1 0.7 0.1 0.0 0.1 1.2 0.2 0.1 0.4 0.0 0.1 0.0 0.4 0.0 0.1 0.3 0.8 0.1 0.1 0.1 0.1 0.2 0.6 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.1 2.4 0.2 0.7 0.7 0.1 0.0 0.1 0.5 0.3 3.1 0.5 0.6 0.3 0.2 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.3 0.3 0.0 0.0 0.6 1.1 0.4 0.4 0.0 0.6 0.6 0.0 0.4 0.0 0.0 0.4 0.8 0.8 1.7 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.7 0.0 1.0 0.2 0.8 0.4 0.3 0.4 0.2 0.0 0.0 0.6 0.2 1.5 0.4 1.2 0.2 0.0 0.5 0.6 0.0 0.9 0.2 0.1 1.1 0.1 1.1 0.4 0.3 0.0 1.0 0.2 2.8 0.5 0.6 0.3 0.4 0.2 0.1 0.2 0.1 0.2 0.5 0.1 0.3 3.1 0.6 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TAS1R1 "GPR70, T1R1, TR1" ENSG00000173662 "Taste 1 receptor member 1" Q7RTX1 1 6555181-6579757 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "salivary gland: 10.9;testis: 8.7" "Group enriched" "Detected in some" 6 "Early spermatids: 6.0;Late spermatids: 14.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.7;HDLM-2: 4.7;Hep G2: 4.6;LHCN-M2: 3.7;U-698: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034579, HPA034580" Approved NA NA "HPA034579: AB_2674232, HPA034580: AB_10671504" "unprognostic (2.03e-2)" "unprognostic (9.29e-3)" "unprognostic (5.60e-4)" "unprognostic (1.12e-1)" "unprognostic (1.11e-1)" "unprognostic (4.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.53e-4)" "unprognostic (3.89e-2)" "unprognostic (3.15e-1)" "unprognostic (3.26e-2)" "unprognostic (3.17e-1)" "unprognostic (5.45e-3)" "unprognostic (1.67e-1)" "unprognostic (8.26e-2)" "unprognostic (8.28e-2)" "unprognostic (6.22e-2)" 0.4 0.8 0.7 0.1 0.8 1.5 0.4 0.6 1.2 0.7 0.9 0.1 0.1 0.4 0.1 0.1 0.4 0.4 1.0 0.1 1.2 0.2 0.1 0.1 0.6 0.2 0.2 0.1 0.9 0.1 0.0 0.5 0.3 0.5 0.1 0.0 0.7 10.9 2.1 0.6 1.4 0.5 0.1 0.1 1.3 0.5 8.7 0.1 0.1 0.1 2.2 0.5 0.4 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.5 0.1 0.3 0.1 2.7 0.0 0.0 0.3 0.0 0.0 4.7 0.0 0.0 0.1 4.6 0.1 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.7 0.8 0.6 1.2 1.2 0.2 0.2 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.1 0.0 0.0 0.0 0.0 TAS1R2 "GPR71, T1R2, TR2" ENSG00000179002 "Taste 1 receptor member 2" Q8TE23 1 18839599-18859682 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "skin 1: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS1R3 T1R3 ENSG00000169962 "Taste 1 receptor member 3" Q7RTX0 1 1331314-1335306 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 35.2;salivary gland: 17.9" "Group enriched" "Detected in some" 16 "Cardiomyocytes: 3.1;Muller glia cells: 1.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "cerebellum: 1.9" "Cell type enriched" "Detected in single" 37 "memory B-cell: 5.2" "Lineage enriched" "Detected in single" 37 "B-cells: 5.2" "Cell line enhanced" "Detected in some" "Karpas-707: 6.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA053439 Uncertain NA NA "HPA053439: AB_2682150" "unprognostic (1.35e-2)" "unprognostic (1.45e-1)" "unprognostic (6.85e-2)" "unprognostic (9.22e-3)" "unprognostic (2.88e-1)" "unprognostic (1.09e-3)" "unprognostic (4.32e-2)" "unprognostic (2.05e-1)" "unprognostic (6.95e-2)" "unprognostic (4.22e-1)" "unprognostic (8.44e-3)" "unprognostic (7.59e-3)" "unprognostic (8.37e-2)" "unprognostic (1.18e-1)" "unprognostic (2.35e-1)" "unprognostic (1.11e-3)" "unprognostic (1.04e-1)" 0.4 0.4 0.4 1.5 0.4 0.5 0.4 1.9 0.4 0.6 1.4 0.4 1.0 2.0 0.5 35.2 1.9 0.6 0.7 1.4 0.4 0.1 0.5 1.6 0.9 1.6 0.4 0.4 0.4 0.4 0.1 2.6 1.9 0.4 0.4 0.1 0.4 17.9 0.4 1.4 0.2 3.2 0.4 0.4 6.4 0.9 1.6 0.4 0.4 0.8 1.5 2.5 1.0 0.9 5.2 0.1 0.0 0.0 0.0 0.1 0.2 1.4 1.3 0.4 0.5 0.0 0.0 0.7 0.7 0.2 0.2 0.2 0.9 2.9 1.8 0.3 0.0 0.3 0.6 0.0 0.0 0.0 3.7 1.0 0.2 2.6 0.9 0.3 0.0 0.5 0.1 0.2 0.1 0.0 0.3 0.0 0.8 0.5 6.0 0.0 0.9 0.3 0.6 0.8 0.5 3.5 1.0 0.7 0.8 0.0 0.2 2.3 0.4 0.5 2.3 1.9 0.3 2.0 0.4 0.3 0.5 0.2 1.8 0.8 3.7 3.5 0.9 0.2 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.4 1.9 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TAS2R1 "T2R1, TRB7" ENSG00000169777 "Taste 2 receptor member 1" Q9NYW7 5 9628997-9712378 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 13.0" "Group enriched" "Detected in some" 83 "Early spermatids: 40.2;Late spermatids: 54.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.5;OE19: 1.0;U-266/84: 1.8" "Low region specificity" "Detected in some" HPA051879 Uncertain NA NA "HPA051879: AB_2681649" "unprognostic (2.19e-1)" 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 TAS2R10 "T2R10, TRB2" ENSG00000121318 "Taste 2 receptor member 10" Q9NYW0 12 10825317-10826358 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in single" 40 "Cholangiocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.2" "Not detected" "Not detected" NA NA "unprognostic (1.28e-1)" "unprognostic (3.89e-4)" "unprognostic (1.77e-1)" "unprognostic (1.82e-2)" "unprognostic (1.10e-1)" "unprognostic (5.82e-3)" "unprognostic (3.86e-1)" "unprognostic (7.72e-2)" "unprognostic (5.27e-2)" "unprognostic (1.67e-1)" "unprognostic (1.24e-2)" "unprognostic (1.20e-1)" "unprognostic (4.16e-5)" "unprognostic (5.41e-2)" "unprognostic (3.18e-2)" "unprognostic (2.87e-2)" "unprognostic (2.56e-3)" 0.5 2.3 0.1 0.5 0.2 0.0 1.9 1.6 0.4 0.9 0.5 0.2 1.3 1.8 0.0 0.4 0.5 0.4 0.1 0.3 0.5 0.6 0.4 0.8 0.0 1.1 0.7 0.1 1.3 0.2 0.4 0.8 1.1 0.5 0.0 0.8 0.6 0.4 0.0 1.0 0.4 0.2 1.0 0.7 0.2 0.2 0.6 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.5 1.1 0.2 0.9 1.4 0.6 0.3 0.1 0.3 0.4 0.0 0.8 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.2 0.6 0.3 0.9 2.2 0.3 0.0 0.2 0.2 0.2 0.2 0.1 0.0 0.8 0.1 0.1 0.0 0.1 0.3 0.1 0.3 1.5 0.4 0.1 0.1 0.3 0.0 0.1 0.7 0.5 0.1 1.3 0.1 0.0 0.0 0.5 0.0 0.9 0.3 0.3 0.5 0.0 0.8 0.0 0.1 0.5 0.4 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.5 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R13 "T2R13, TRB3" ENSG00000212128 "Taste 2 receptor member 13" Q9NYV9 12 10907926-10909562 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "epididymis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.78e-1)" "unprognostic (3.66e-2)" "unprognostic (1.77e-1)" "unprognostic (5.48e-2)" "unprognostic (1.52e-3)" "unprognostic (6.66e-3)" "unprognostic (4.50e-2)" "unprognostic (8.80e-2)" 0.1 0.3 0.0 0.1 0.1 0.3 0.3 0.7 0.1 0.1 0.1 0.1 0.4 1.4 0.2 0.1 0.1 0.4 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.8 0.4 0.1 0.6 0.2 0.3 0.1 0.6 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.4 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R14 "T2R14, TRB1" ENSG00000212127 "Taste 2 receptor member 14" Q9NYV8 12 10937406-11171573 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 7.0;Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 7.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 4.2" NA NA "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (4.26e-2)" "unprognostic (1.41e-1)" "unprognostic (6.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.46e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-3)" "unprognostic (1.18e-1)" "unprognostic (1.12e-3)" "unprognostic (1.93e-2)" "unprognostic (1.22e-4)" "unprognostic (2.45e-2)" "unprognostic (1.07e-1)" "unprognostic (9.29e-3)" "unprognostic (4.71e-3)" 0.8 1.2 0.7 1.0 1.1 1.4 2.5 6.0 0.8 1.3 1.3 1.3 1.8 5.7 0.5 1.3 0.8 0.6 1.4 0.7 0.7 1.1 1.0 1.2 0.9 3.2 1.1 1.0 2.6 0.9 1.4 1.4 2.1 1.0 1.9 2.2 1.3 1.3 2.0 1.5 0.9 0.5 2.2 1.2 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.5 1.2 0.3 0.4 0.9 0.3 0.7 0.0 0.0 0.2 1.2 0.8 2.1 0.2 0.5 0.6 0.8 0.1 0.5 0.6 1.0 1.1 0.4 1.0 0.6 0.1 0.7 0.3 0.9 0.5 1.6 0.3 1.1 0.7 0.7 1.0 0.0 0.9 0.2 0.4 4.2 1.3 0.3 0.6 0.6 0.7 0.6 1.2 1.2 0.2 1.3 1.1 0.0 0.1 1.1 0.2 0.7 1.0 1.0 0.6 0.4 1.0 0.2 0.2 0.8 0.7 1.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.0 1.3 0.6 0.6 7.0 0.4 0.0 0.0 0.0 0.0 9.8 1.8 3.3 0.6 0.0 0.2 0.2 0.0 0.3 0.4 1.2 0.8 0.0 1.0 1.1 1.6 3.4 1.8 1.5 0.0 2.0 0.7 0.0 0.0 0.7 1.3 0.6 0.0 2.5 0.5 7.1 0.0 1.2 1.0 0.4 0.1 0.5 0.8 0.6 0.3 TAS2R16 T2R16 ENSG00000128519 "Taste 2 receptor member 16" Q9NYV7 7 122994704-122995700 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R19 "T2R19, T2R23, TAS2R23, TAS2R48" ENSG00000212124 "Taste 2 receptor member 19" P59542 12 11021619-11022620 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 1.1" "Cell type enriched" "Detected in single" 5 "T-reg: 1.0" "Lineage enriched" "Detected in single" 5 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "HBF TERT88: 1.3;HDLM-2: 1.1;hTERT-HME1: 2.9;SuSa: 1.2" NA NA "unprognostic (1.90e-2)" "unprognostic (9.54e-2)" "unprognostic (1.83e-1)" "unprognostic (5.18e-3)" "unprognostic (1.84e-1)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (5.73e-2)" "unprognostic (2.35e-1)" "unprognostic (8.76e-2)" "unprognostic (8.26e-2)" "unprognostic (1.94e-2)" "unprognostic (1.57e-8)" "unprognostic (9.08e-2)" "unprognostic (1.58e-1)" "unprognostic (7.96e-2)" "unprognostic (4.32e-1)" 0.3 0.5 0.4 0.3 0.4 0.5 0.7 3.4 0.7 0.5 0.4 0.6 1.1 0.1 0.2 0.7 0.6 1.4 0.6 0.5 0.4 0.2 0.4 0.2 0.4 3.0 0.4 1.1 1.9 0.4 0.6 0.3 0.3 0.6 1.1 0.5 0.3 0.5 0.7 0.4 0.3 0.8 1.0 0.3 0.4 0.5 0.0 0.1 0.0 0.2 0.1 1.0 0.0 0.4 0.0 0.3 0.5 0.0 0.0 0.2 0.0 0.4 0.3 0.7 0.2 0.1 1.0 0.0 0.0 0.3 0.0 0.1 0.0 1.3 1.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.2 0.0 0.1 0.4 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.1 1.2 0.2 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R20 "T2R20, T2R56, TAS2R49" ENSG00000255837 "Taste 2 receptor member 20" P59543 12 10996495-10997875 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA "unprognostic (4.62e-2)" "unprognostic (2.96e-1)" "unprognostic (1.12e-3)" "unprognostic (2.16e-4)" "unprognostic (2.92e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.98e-2)" "unprognostic (5.14e-4)" "unprognostic (6.23e-3)" "unprognostic (1.27e-9)" "unprognostic (2.68e-1)" "unprognostic (3.35e-2)" "unprognostic (1.28e-2)" "unprognostic (6.44e-3)" 1.3 0.8 0.5 1.3 0.5 0.9 2.6 1.7 0.9 1.4 0.9 0.3 1.6 0.2 0.4 1.0 0.4 0.9 1.0 0.4 0.4 1.1 1.3 1.4 0.7 3.5 1.0 1.0 1.9 1.2 1.3 1.4 1.1 1.4 3.0 4.6 1.3 1.0 1.4 1.9 0.6 0.7 1.8 0.8 0.5 1.9 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.9 0.5 0.4 1.5 0.2 0.0 0.5 0.2 0.5 0.2 0.7 1.6 0.1 0.1 0.3 0.6 0.3 0.3 0.6 0.6 0.1 0.7 1.7 1.0 0.7 0.6 0.2 0.7 0.0 0.3 1.4 1.1 0.5 0.6 1.0 0.4 0.1 0.3 0.1 0.3 1.7 0.1 0.0 0.4 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.1 0.5 2.0 0.1 0.4 0.7 1.2 0.7 0.8 1.1 0.0 0.1 0.4 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R3 T2R3 ENSG00000127362 "Taste 2 receptor member 3" Q9NYW6 7 141764097-141765197 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "T-reg: 1.3" "Lineage enriched" "Detected in single" 8 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.9;HAP1: 1.7;HL-60: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (4.11e-2)" "unprognostic (2.27e-1)" "unprognostic (4.40e-2)" "unprognostic (7.38e-2)" "unprognostic (4.04e-1)" "unprognostic (1.51e-2)" "unprognostic (3.62e-2)" "unprognostic (1.53e-1)" 0.1 0.0 0.1 0.0 0.5 0.0 1.9 2.5 0.6 0.6 0.3 0.0 0.6 1.7 0.3 0.9 0.1 0.1 0.1 0.1 0.4 0.0 0.2 1.0 0.0 2.6 0.5 0.7 0.2 0.4 0.2 0.3 0.5 0.0 0.2 1.9 0.5 0.0 0.0 0.3 0.3 0.1 0.5 0.5 0.3 0.5 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.4 0.7 0.2 0.0 2.9 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.3 0.0 0.3 0.6 3.3 0.0 0.4 0.8 0.5 0.3 0.3 0.2 0.4 1.5 0.2 0.2 0.0 0.0 0.2 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.4 0.9 0.3 0.0 0.7 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R30 "T2R30, TAS2R47" ENSG00000256188 "Taste 2 receptor member 30" P59541 12 11132958-11134644 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" 21 "Cone photoreceptor cells: 7.9;Horizontal cells: 3.2;Rod photoreceptor cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.0" NA NA "unprognostic (7.19e-3)" "unprognostic (2.15e-2)" "unprognostic (1.19e-1)" "unprognostic (3.17e-1)" "unprognostic (1.71e-1)" "unprognostic (4.02e-1)" "unprognostic (7.01e-6)" "unprognostic (4.48e-2)" "unprognostic (1.26e-1)" "unprognostic (1.11e-1)" "unprognostic (4.14e-1)" 0.3 0.3 0.2 0.1 0.3 1.0 1.0 1.3 0.6 0.9 0.3 0.2 0.9 0.4 0.2 0.4 0.3 0.4 0.3 0.1 0.2 0.5 0.4 0.5 0.1 1.8 0.3 1.0 0.6 0.5 0.8 0.3 0.4 0.4 0.3 0.7 0.5 0.1 0.2 0.5 0.3 0.6 0.8 0.3 0.4 0.6 0.2 0.5 0.4 0.2 0.2 0.6 0.0 0.4 0.3 0.5 0.6 0.1 0.7 0.1 0.3 0.3 0.1 0.6 0.5 0.1 0.6 0.0 0.2 1.4 0.3 0.0 0.0 0.9 0.6 0.0 0.1 0.2 0.0 0.5 0.5 0.0 1.1 0.1 1.1 2.0 0.8 0.4 1.3 0.2 0.9 0.5 0.6 0.0 0.2 1.6 0.0 0.2 0.0 0.7 0.1 1.1 0.6 0.4 0.3 0.4 0.0 0.0 1.3 0.1 0.0 0.3 1.1 0.7 0.4 0.1 0.1 0.0 0.7 0.3 0.0 0.2 0.4 0.2 0.2 0.6 0.1 0.1 0.1 0.3 0.2 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.5 0.1 0.0 0.0 0.6 0.0 0.1 0.1 1.3 0.0 0.0 0.0 1.2 0.0 7.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.1 3.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 TAS2R31 "T2R31, T2R53, TAS2R44" ENSG00000256436 "Taste 2 receptor member 31" P59538 12 11030387-11031407 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "Cone photoreceptor cells: 3.9" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-HME1: 3.9;SuSa: 1.7" NA NA "unprognostic (2.23e-2)" "unprognostic (3.80e-1)" "unprognostic (2.85e-2)" "unprognostic (4.70e-3)" "unprognostic (2.16e-1)" "unprognostic (9.07e-2)" "unprognostic (3.33e-1)" "unprognostic (2.77e-1)" "unprognostic (2.77e-1)" "unprognostic (1.60e-2)" "unprognostic (2.72e-2)" "unprognostic (4.32e-2)" "unprognostic (7.54e-4)" "unprognostic (2.99e-2)" "unprognostic (1.87e-1)" "unprognostic (6.53e-3)" "unprognostic (1.83e-1)" 0.7 0.8 0.2 0.1 0.3 0.5 1.0 1.4 1.1 0.8 0.3 0.0 1.6 2.2 0.7 0.9 0.4 0.5 0.3 0.3 0.2 0.3 0.7 0.5 0.2 2.8 0.7 1.8 1.6 0.7 0.6 0.1 0.5 0.2 0.2 0.4 0.5 0.5 0.5 0.6 0.3 1.6 1.1 0.1 0.3 0.7 0.1 1.5 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.2 0.6 0.1 0.0 0.0 0.4 0.3 0.0 1.1 0.1 0.2 0.9 0.0 0.0 0.9 0.3 0.0 0.0 0.2 0.6 0.3 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 3.9 0.1 0.1 0.6 0.3 0.5 0.5 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.0 0.1 1.7 0.8 0.0 1.1 1.3 0.2 0.6 0.3 0.0 0.0 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 0.1 0.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R38 "PTC, T2R61" ENSG00000257138 "Taste 2 receptor member 38" P59533 7 141972631-141973773 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "intestine: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.3;NB-4: 1.1;OE19: 1.6;SK-BR-3: 1.1;U-266/70: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA043862, HPA054366" Uncertain NA NA "HPA043862: AB_2678703, HPA054366: AB_2682464" "unprognostic (5.18e-3)" "unprognostic (6.87e-2)" "unprognostic (1.22e-1)" "unprognostic (3.58e-1)" "unprognostic (1.25e-1)" "unprognostic (8.36e-2)" "unprognostic (5.86e-2)" "unprognostic (8.05e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.9 0.1 0.0 0.0 0.0 2.2 0.2 0.0 0.2 0.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R39 ENSG00000236398 "Taste 2 receptor member 39" P59534 7 143183419-143184435 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA053456, HPA060680" Uncertain NA NA "HPA053456: AB_2682157, HPA060680: AB_2684341" 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R4 T2R4 ENSG00000127364 "Taste 2 receptor member 4" Q9NYW5 7 141778442-141780819 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.9" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 12.5;Bipolar cells: 8.9;Club cells: 12.5;granulocytes: 10.5;Horizontal cells: 7.9" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "basophil: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 3.9;NB-4: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (6.15e-3)" "unprognostic (5.80e-2)" "unprognostic (1.57e-1)" "unprognostic (1.39e-2)" "unprognostic (2.25e-1)" "unprognostic (1.55e-3)" "unprognostic (1.00e-2)" "unprognostic (3.86e-2)" "unprognostic (7.95e-3)" "unprognostic (2.06e-1)" "unprognostic (3.76e-3)" "unprognostic (6.15e-3)" "unprognostic (1.04e-5)" "unprognostic (5.58e-2)" "unprognostic (1.35e-1)" "unprognostic (9.87e-2)" "unprognostic (1.18e-1)" 0.2 0.4 0.9 0.5 2.9 0.5 2.6 6.9 1.6 0.6 0.5 0.2 1.7 4.3 0.4 1.3 0.5 0.1 0.9 1.2 0.4 0.2 0.6 1.0 0.7 2.8 0.9 0.5 1.2 0.6 0.6 0.9 1.0 0.6 2.6 4.4 0.9 0.3 0.7 0.8 0.8 0.8 1.0 1.0 0.5 0.6 1.0 0.5 3.6 0.8 1.1 0.8 0.6 0.5 1.5 1.1 0.6 1.0 2.0 0.8 0.4 0.1 0.0 0.4 1.2 0.7 0.9 0.5 0.2 0.1 0.9 1.6 0.8 0.1 0.8 1.0 0.2 1.1 1.3 1.0 3.9 0.8 1.1 1.9 0.1 1.7 0.5 0.4 1.2 1.1 0.3 0.5 0.7 1.4 4.3 1.2 0.3 0.2 0.6 0.5 1.0 0.3 0.7 1.1 0.9 0.3 0.4 0.3 0.5 0.3 1.4 0.8 0.6 0.7 0.4 0.7 1.0 0.4 1.1 0.4 1.6 0.4 3.6 0.8 1.4 0.6 0.3 0.4 0.5 0.5 0.3 0.2 1.0 0.5 0.8 2.4 1.1 0.6 0.5 0.1 0.6 3.0 12.5 0.5 1.2 0.0 8.9 0.3 0.0 5.3 12.5 1.8 5.9 0.8 0.0 0.4 0.2 1.0 0.5 0.0 0.4 0.2 0.6 1.6 10.5 0.6 0.6 7.9 1.2 2.5 0.0 0.0 0.6 0.7 0.0 1.0 0.4 4.4 0.5 0.6 1.4 0.0 3.1 0.0 0.1 1.9 0.9 0.0 0.7 0.0 1.2 0.4 TAS2R40 GPR60 ENSG00000221937 "Taste 2 receptor member 40" P59535 7 143222037-143223079 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "blood: 6.3;lymphoid tissue: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 6.3" "Lineage enriched" "Detected in single" 12 "granulocytes: 6.3" "Cell line enhanced" "Detected in some" "PC-3: 1.0;SK-BR-3: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R41 T2R59 ENSG00000221855 "Taste 2 receptor member 41" P59536 7 143477873-143478796 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA057063 Uncertain NA NA "HPA057063: AB_2683324" 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R42 "hT2R55, T2R24, T2R55, TAS2R55" ENSG00000186136 "Taste 2 receptor member 42" Q7RTR8 12 11185993-11186937 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA036149 Uncertain Approved "Nucleoplasm,Actin filaments,Focal adhesion sites" NA NA "Nucleoplasm, Actin filaments" "Focal adhesion sites" "HPA036149: AB_10672080" "unprognostic (2.45e-2)" "unprognostic (4.17e-2)" 0.0 0.7 0.2 0.2 0.4 0.0 0.0 1.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.0 0.7 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.7 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R43 T2R52 ENSG00000255374 "Taste 2 receptor member 43" P59537 12 11091287-11092313 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "hTERT-HME1: 4.6" NA NA "unprognostic (5.69e-3)" "unprognostic (1.48e-1)" "unprognostic (2.19e-1)" "unprognostic (1.48e-2)" "unprognostic (2.67e-1)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (7.48e-2)" "unprognostic (1.77e-1)" "unprognostic (2.10e-1)" "unprognostic (3.49e-1)" "unprognostic (1.59e-1)" 0.4 0.2 0.0 0.0 0.0 0.6 1.0 1.8 0.0 0.4 0.3 0.0 0.7 1.0 0.2 0.4 0.3 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.0 1.1 0.4 0.8 0.6 0.1 0.3 0.1 0.3 0.7 0.4 0.1 0.6 0.3 0.1 0.6 0.2 0.4 0.5 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R46 T2R54 ENSG00000226761 "Taste 2 receptor member 46" P59540 12 11061365-11062294 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (1.03e-1)" "unprognostic (7.73e-4)" "unprognostic (1.67e-2)" "unprognostic (2.67e-1)" 0.3 0.5 0.0 0.5 0.0 1.0 0.2 1.4 0.1 0.3 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.9 0.4 0.1 0.4 0.1 0.3 0.3 0.1 0.1 0.1 0.8 0.3 0.1 0.2 0.3 0.2 0.4 0.4 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R5 T2R5 ENSG00000127366 "Taste 2 receptor member 5" Q9NYW4 7 141790217-141791367 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 8.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 10.6" HPA053742 Approved "Nucleoplasm,Nucleoli,Cytoplasmic bodies" NA NA "Nucleoplasm, Nucleoli" "Cytoplasmic bodies" "HPA053742: " "unprognostic (5.48e-3)" "unprognostic (3.90e-3)" "unprognostic (6.07e-2)" "unprognostic (8.00e-3)" "unprognostic (7.56e-2)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.71e-1)" "unprognostic (2.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.13e-5)" "unprognostic (1.13e-2)" "unprognostic (8.29e-7)" "unprognostic (1.29e-1)" "unprognostic (3.28e-1)" "unprognostic (6.92e-2)" "unprognostic (1.39e-2)" 1.0 1.0 0.4 1.4 1.1 0.2 3.2 4.9 0.7 2.5 0.9 0.8 2.8 6.1 1.1 3.0 0.8 0.8 0.6 0.7 1.0 0.5 1.1 1.2 0.4 4.6 1.5 0.1 2.9 1.0 1.7 1.2 1.6 1.0 2.6 8.8 1.7 1.2 1.2 1.9 0.7 1.4 1.7 1.2 1.3 2.4 1.0 0.6 0.5 0.2 0.4 1.4 0.1 0.5 0.2 1.4 0.6 0.9 2.7 1.7 0.6 0.6 0.5 0.9 2.1 0.4 1.1 0.9 0.3 0.0 0.3 1.5 0.8 0.3 0.6 1.7 0.3 1.2 2.7 0.9 1.7 1.3 2.3 10.6 1.2 2.9 3.0 1.0 1.5 2.6 0.4 0.1 1.7 0.6 3.9 1.3 0.2 0.3 0.2 0.1 2.8 0.4 0.7 2.0 1.3 0.3 0.4 0.2 1.7 0.1 0.4 0.3 1.0 0.7 0.6 1.2 1.9 0.4 1.4 0.8 0.8 0.5 0.5 0.2 0.0 1.0 0.0 0.0 0.9 0.3 0.4 0.0 1.0 0.9 1.4 0.0 0.4 0.0 0.6 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R50 T2R51 ENSG00000212126 "Taste 2 receptor member 50" P59544 12 10985913-10986912 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.55e-2)" "unprognostic (4.25e-1)" "unprognostic (1.14e-1)" "unprognostic (1.78e-1)" "unprognostic (2.53e-2)" "unprognostic (2.94e-1)" "unprognostic (2.24e-1)" "unprognostic (1.73e-1)" 0.3 0.1 0.0 0.2 0.1 0.4 0.6 1.7 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.6 0.2 0.0 0.3 0.4 0.1 0.0 0.2 0.0 1.0 0.3 0.3 0.1 0.1 0.4 0.1 0.2 0.3 0.3 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R60 T2R60 ENSG00000185899 "Taste 2 receptor member 60" P59551 7 143443453-143444409 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3;liver: 1.4;pancreas: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 2.4;U-937: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA030416 Uncertain NA NA "HPA030416: AB_10603344" "unprognostic (1.78e-2)" "unprognostic (7.98e-2)" 0.1 0.0 0.0 0.4 0.0 0.9 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.2 0.0 0.0 1.3 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 1.0 0.9 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 1.3 0.5 1.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R7 "T2R7, TRB4" ENSG00000121377 "Taste 2 receptor member 7" Q9NYW3 12 10801532-10802627 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R8 "T2R8, TRB5" ENSG00000121314 "Taste 2 receptor member 8" Q9NYW2 12 10806051-10807293 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.4 0.0 0.0 0.2 0.0 0.0 1.0 0.5 0.4 0.0 0.4 0.1 0.5 0.0 0.1 0.2 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R9 "T2R9, TRB6" ENSG00000121381 "Taste 2 receptor member 9" Q9NYW1 12 10809094-10810168 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "cervix, uterine: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.8 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAZ "BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2" ENSG00000102125 Tafazzin Q16635 X 154411518-154421726 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039557 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA039557: AB_10672899" "unprognostic (1.14e-1)" "prognostic favorable (5.70e-4)" "unprognostic (4.94e-3)" "unprognostic (1.43e-1)" "unprognostic (8.29e-2)" "unprognostic (7.84e-2)" "unprognostic (1.56e-2)" "unprognostic (8.21e-3)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "unprognostic (4.68e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (1.22e-7)" "unprognostic (4.00e-3)" "unprognostic (4.20e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" 11.9 8.7 12.1 15.0 13.6 36.8 11.7 12.4 13.5 10.9 15.4 15.6 12.1 13.9 10.8 13.0 15.1 9.9 14.1 25.9 11.0 8.4 13.3 14.0 14.3 17.3 16.7 9.6 12.6 16.3 10.7 8.9 9.1 13.1 11.1 10.8 12.2 12.7 14.5 27.9 18.6 15.0 11.7 12.8 25.4 12.8 3.4 15.1 17.2 11.8 13.4 14.4 10.8 19.5 16.7 14.7 13.8 10.3 12.3 17.2 7.8 11.0 12.5 4.6 5.1 9.0 5.4 8.8 3.9 7.7 6.0 8.3 4.1 13.8 13.1 21.3 5.7 20.0 16.8 6.5 7.2 4.2 11.2 9.6 2.6 8.0 6.4 10.1 5.0 6.2 5.5 13.2 5.2 11.8 5.6 9.0 16.8 5.2 13.9 5.2 6.7 12.6 15.8 1.3 9.7 13.1 10.5 7.0 17.6 8.2 3.2 5.8 8.2 2.5 7.4 10.7 5.0 4.5 8.9 6.5 4.9 6.3 12.0 5.9 32.4 12.8 27.3 6.0 17.6 5.6 5.7 10.3 13.8 12.1 9.3 11.0 11.3 17.2 15.5 14.7 16.7 14.4 12.5 9.4 12.3 7.4 7.3 12.2 7.8 12.1 13.6 12.4 13.5 11.0 8.4 16.7 9.6 13.1 15.1 6.0 10.2 10.7 6.9 9.6 21.3 18.9 12.7 5.3 13.6 8.7 17.7 4.9 5.0 12.0 0.5 15.0 12.3 0.0 14.5 8.0 9.9 5.6 18.4 7.8 21.2 9.5 5.8 16.0 22.1 1.3 10.6 15.9 13.5 23.4 12.9 15.1 10.8 10.2 8.5 4.4 23.8 12.9 9.2 5.1 0.6 9.8 2.4 23.6 13.6 4.8 TBC1D20 "C20orf140, dJ852M4.2" ENSG00000125875 "TBC1 domain family member 20" Q96BZ9 20 435480-462553 "Disease related genes, Predicted membrane proteins" "Host-virus interaction" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 90.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043613 Approved NA NA "HPA043613: AB_10963930" "unprognostic (2.16e-3)" "unprognostic (4.76e-3)" "unprognostic (1.49e-2)" "unprognostic (3.14e-2)" "unprognostic (1.02e-1)" "unprognostic (1.92e-1)" "unprognostic (3.68e-3)" "unprognostic (1.65e-1)" "unprognostic (1.77e-1)" "unprognostic (2.54e-2)" "unprognostic (1.35e-2)" "unprognostic (1.57e-1)" "unprognostic (1.20e-3)" "unprognostic (2.97e-1)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" "unprognostic (9.52e-2)" 21.6 24.8 21.6 13.7 23.0 10.0 30.2 30.3 27.1 27.0 19.3 24.1 24.2 11.6 22.1 25.3 20.5 22.6 17.8 20.6 20.6 18.3 17.9 14.8 25.2 13.5 20.8 21.2 27.7 21.1 30.9 25.4 25.5 21.0 22.6 18.6 20.7 21.0 29.6 21.3 24.0 15.5 29.4 21.4 18.2 17.2 23.1 20.1 16.3 21.9 12.3 16.8 22.2 26.1 2.3 1.7 5.0 2.1 2.0 5.5 1.8 6.6 8.1 8.8 6.9 38.6 17.2 7.2 8.9 17.1 12.2 13.2 6.4 3.0 3.4 1.9 17.7 19.0 6.7 9.7 8.4 12.9 2.1 3.1 5.7 2.4 12.3 21.8 5.3 2.9 16.0 15.0 7.2 6.4 13.8 8.3 6.2 6.6 6.6 13.1 2.9 5.9 7.8 5.2 9.1 6.3 5.0 8.5 4.2 8.8 6.4 8.0 5.9 10.1 16.5 21.5 10.0 5.0 11.3 8.0 11.5 4.2 10.3 6.3 3.5 7.6 2.8 5.6 6.2 7.3 5.0 2.1 3.7 5.5 2.1 3.0 2.3 3.9 5.2 1.6 2.2 3.2 5.0 4.1 2.0 1.6 1.7 2.5 1.8 21.6 23.0 30.3 27.1 20.6 18.3 20.8 21.2 21.0 20.1 11.9 12.8 15.2 10.9 16.5 27.6 14.5 30.6 13.4 7.9 14.0 11.8 13.7 10.0 21.9 41.1 16.8 20.2 23.3 26.4 19.1 20.3 17.0 11.5 17.8 17.0 25.4 15.4 22.7 13.3 90.0 27.3 12.7 13.5 7.2 15.0 21.8 19.1 18.7 33.2 12.1 19.3 19.4 12.8 23.7 33.0 16.6 42.6 16.6 12.5 22.6 TBC1D2B KIAA1055 ENSG00000167202 "TBC1 domain family member 2B" Q9UPU7 15 77984036-78077724 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041833, HPA048174, HPA052663" Approved Enhanced Cytosol NA NA Cytosol "HPA041833: AB_2732494, HPA048174: AB_2680297, HPA052663: AB_2681906" "unprognostic (3.13e-1)" "unprognostic (2.16e-1)" "unprognostic (8.25e-2)" "unprognostic (1.28e-2)" "unprognostic (3.94e-2)" "unprognostic (1.43e-1)" "unprognostic (5.07e-3)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (8.22e-3)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (1.23e-3)" "unprognostic (6.68e-2)" "unprognostic (3.07e-2)" "unprognostic (3.37e-1)" "unprognostic (3.19e-2)" 26.0 14.1 9.3 12.0 10.0 11.9 21.4 8.4 8.4 22.8 16.7 8.4 7.3 7.6 20.2 13.0 9.3 18.2 20.0 7.8 7.7 4.3 8.2 18.3 22.7 12.5 8.3 5.6 31.2 16.6 17.7 7.1 28.9 7.2 13.6 10.8 20.7 8.6 14.0 5.0 10.5 14.3 15.5 9.7 19.9 12.6 11.0 7.3 20.4 10.4 5.8 14.4 17.1 18.4 0.4 3.2 3.7 2.1 3.8 4.2 1.3 5.0 4.0 4.9 4.6 34.4 27.5 8.5 11.7 17.7 11.0 12.2 5.1 2.1 7.8 4.7 9.8 6.1 7.4 10.6 12.9 8.4 14.8 8.2 5.0 3.9 3.4 16.3 12.6 7.6 26.7 9.0 7.3 4.9 16.4 12.4 10.2 2.5 5.4 14.2 5.5 4.6 8.2 3.8 3.9 3.9 7.1 22.4 1.7 5.7 19.4 2.6 7.1 10.9 7.4 13.8 4.7 2.4 13.2 15.2 12.1 8.0 3.8 6.1 9.3 9.7 4.2 4.1 17.0 6.3 0.0 2.1 0.9 3.9 1.8 2.2 0.2 2.6 4.2 1.4 0.4 1.9 1.5 3.7 3.8 0.5 3.2 1.5 1.3 9.3 10.0 8.4 8.4 7.7 4.3 8.3 5.6 7.2 7.3 3.0 12.9 9.7 8.0 8.2 9.7 2.4 12.7 2.7 3.4 5.2 5.9 15.3 0.0 6.9 7.4 12.0 10.6 0.0 8.4 6.3 13.9 8.1 9.2 62.2 16.0 14.3 7.0 28.3 28.3 6.1 39.4 18.9 13.5 12.6 17.8 7.2 11.5 10.5 39.6 2.7 10.0 25.8 8.9 5.0 7.2 8.7 23.8 19.5 15.6 7.6 TBC1D7 "dJ257A7.3, FLJ32666" ENSG00000145979 "TBC1 domain family member 7" Q9P0N9 6 13266542-13328583 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 80.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034748 Approved NA NA "HPA034748: AB_10671232" "unprognostic (9.53e-2)" "unprognostic (8.39e-2)" "unprognostic (3.18e-1)" "unprognostic (1.81e-2)" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (3.95e-3)" "unprognostic (5.54e-2)" "unprognostic (9.30e-2)" "prognostic favorable (4.98e-5)" "unprognostic (4.36e-2)" "unprognostic (1.66e-1)" "prognostic unfavorable (2.03e-7)" "unprognostic (1.57e-1)" "unprognostic (3.46e-2)" "unprognostic (3.48e-1)" "unprognostic (2.78e-2)" 8.8 11.8 14.9 13.2 14.3 21.9 13.7 17.5 19.3 10.7 14.7 12.9 10.0 14.2 8.7 20.9 15.8 6.4 10.4 30.4 14.7 13.6 21.2 16.1 13.2 12.3 14.5 13.5 7.6 10.6 7.5 14.1 14.1 14.1 12.9 16.8 17.7 11.6 10.1 13.5 12.4 10.5 10.1 12.8 11.4 9.2 12.4 11.9 19.4 7.8 14.7 14.8 10.7 10.2 8.7 23.0 23.5 12.0 11.1 7.6 5.6 6.6 6.6 9.5 9.7 7.4 4.3 6.6 2.9 3.4 6.4 7.2 13.3 6.0 4.6 20.0 4.9 14.9 5.4 6.4 7.5 5.8 7.2 7.6 12.8 4.5 11.6 17.3 8.2 19.6 5.8 10.7 7.9 5.1 6.4 10.6 14.9 14.3 6.2 8.0 10.8 10.5 19.9 6.4 8.3 6.4 15.7 4.1 19.6 14.2 9.1 18.5 8.2 7.4 14.6 80.5 19.9 14.1 4.9 7.6 6.6 8.2 3.6 4.1 14.8 42.9 21.9 6.2 8.7 13.3 12.5 12.0 14.0 6.7 10.2 4.3 8.7 5.7 5.9 23.0 7.9 5.3 6.4 23.5 11.1 7.2 22.6 7.6 5.6 14.9 14.3 17.5 19.3 14.7 13.6 14.5 13.5 14.1 11.9 11.9 15.2 14.0 8.2 6.6 6.1 22.7 10.2 6.7 6.8 15.7 3.9 36.1 28.2 14.9 6.9 7.9 9.5 23.3 12.6 18.5 8.0 10.1 9.2 13.2 21.5 9.5 8.6 9.2 15.1 3.8 4.0 20.6 10.1 18.0 18.8 6.5 17.8 17.3 4.9 39.8 8.2 12.9 7.2 12.8 33.5 7.9 39.2 8.7 15.7 11.3 TBL2 "DKFZP43N024, WBSCR13, WS-betaTRP" ENSG00000106638 "Transducin beta like 2" Q9Y4P3 7 73568932-73578791 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 70.5" "Group enriched" "Detected in many" 7 "Early spermatids: 291.7;Late spermatids: 375.4;Spermatocytes: 284.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007477, HPA051533" Supported Cytosol "Secreted in male reproductive system" NA NA Cytosol "HPA007477: AB_1080214, HPA051533: AB_2681523" "unprognostic (9.04e-2)" "unprognostic (6.61e-3)" "unprognostic (4.24e-2)" "unprognostic (1.10e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.24e-3)" "unprognostic (7.50e-2)" "unprognostic (2.87e-1)" "unprognostic (1.90e-1)" "unprognostic (1.74e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.88e-5)" "unprognostic (1.59e-1)" "unprognostic (3.14e-1)" "unprognostic (1.42e-2)" "unprognostic (1.31e-1)" 8.9 12.1 3.7 5.4 3.3 1.8 5.9 2.7 5.3 8.7 6.6 3.4 11.6 6.1 6.5 10.9 7.3 5.5 6.3 5.4 2.5 2.5 6.1 14.2 6.5 4.7 3.5 2.1 10.7 27.0 8.5 7.0 13.0 3.4 6.5 6.9 5.1 16.3 8.0 4.9 6.9 6.3 5.4 3.0 5.4 8.2 70.5 3.7 6.2 11.8 4.2 5.2 8.5 6.2 4.2 14.4 13.2 11.4 8.3 6.7 7.6 12.2 14.0 4.8 7.1 13.2 12.8 6.0 14.7 11.0 5.6 10.1 21.4 13.2 10.0 3.3 12.9 11.9 9.4 10.2 5.9 11.1 3.9 6.9 3.6 7.4 14.0 19.0 7.3 13.3 7.9 10.2 17.1 13.7 10.9 6.4 1.9 14.7 7.9 8.5 11.9 7.1 7.2 5.0 15.0 11.5 4.6 8.7 22.1 7.2 8.6 5.1 8.2 14.6 40.0 9.2 6.6 10.5 5.6 10.8 10.6 5.2 9.8 14.8 15.9 9.9 11.3 13.6 9.0 12.3 13.2 11.4 5.2 6.6 7.9 6.5 3.4 5.6 6.0 14.4 4.2 6.7 4.2 1.0 8.3 7.0 10.8 6.5 7.6 3.7 3.3 2.7 5.3 2.5 2.5 3.5 2.1 3.4 3.7 23.8 9.4 12.3 11.1 4.0 10.0 4.5 12.7 6.7 7.9 5.2 7.9 39.4 1.7 21.8 291.7 9.8 10.9 0.0 26.3 45.4 11.5 14.0 13.9 15.3 26.0 3.2 9.1 12.9 7.5 375.4 21.9 7.9 6.8 23.4 15.7 7.8 21.3 14.4 25.1 5.0 12.9 6.5 8.0 284.6 22.2 3.1 36.3 3.3 14.3 7.5 TBXA2R ENSG00000006638 "Thromboxane A2 receptor" P21731 19 3594506-3606840 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "Ito cells: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 12.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 11.9;U-2197: 8.6;U-937: 7.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA077366 Supported "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA077366: AB_2686836" "unprognostic (1.59e-1)" "unprognostic (3.86e-2)" "unprognostic (1.21e-2)" "unprognostic (1.74e-1)" "unprognostic (8.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.52e-2)" "unprognostic (2.17e-3)" "unprognostic (8.41e-2)" "unprognostic (6.25e-2)" "prognostic favorable (7.17e-4)" "unprognostic (3.89e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (4.32e-2)" "unprognostic (9.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.02e-1)" 8.7 11.8 1.4 3.9 1.6 2.1 3.9 0.5 1.6 13.5 3.8 1.7 3.9 2.6 7.4 4.8 8.0 4.7 6.0 6.8 2.4 1.5 10.1 18.4 6.7 7.3 1.4 1.9 8.3 2.2 2.5 1.7 10.6 2.7 3.6 1.4 5.0 1.7 4.2 3.1 1.8 4.4 6.5 2.1 14.9 3.7 3.4 1.9 2.2 3.9 3.2 1.8 6.8 9.6 12.6 0.3 3.2 0.4 3.1 9.6 3.9 0.1 0.2 0.2 4.1 0.9 2.2 0.7 3.0 0.8 2.3 1.8 0.1 0.3 0.1 4.4 1.2 2.3 0.1 0.9 0.0 0.9 0.2 1.0 2.9 11.9 0.3 1.2 0.0 5.3 1.1 0.0 3.0 0.0 1.7 0.9 0.0 4.5 0.4 0.4 0.2 0.2 1.5 0.1 0.1 2.6 0.1 0.0 0.2 0.0 0.1 0.2 1.7 0.2 0.4 0.1 0.3 1.8 5.1 2.6 4.8 1.1 8.6 2.8 0.2 0.3 0.2 4.0 7.4 1.1 2.9 0.4 0.2 2.6 0.2 0.3 1.8 0.8 2.3 0.0 12.6 4.6 9.6 3.2 3.1 0.2 0.3 0.2 3.9 1.4 1.6 0.5 1.6 2.4 1.5 1.4 1.9 2.7 1.9 0.0 0.0 1.3 0.1 0.5 0.4 0.8 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.1 2.3 0.1 0.0 0.0 0.7 0.0 0.0 35.0 1.2 0.0 0.3 0.0 1.7 0.0 0.0 0.3 0.1 0.0 0.7 0.0 0.1 0.0 3.1 0.1 1.3 0.5 0.1 0.0 0.0 0.0 TCIRG1 "a3, Atp6i, ATP6N1C, ATP6V0A3, OC-116, OC116, TIRC7" ENSG00000110719 "T cell immune regulator 1, ATPase H+ transporting V0 subunit a3" Q13488 11 68039016-68050895 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 102.9;Kupffer cells: 127.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 40.6;RPMI-8226: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038742 Approved Approved Mitochondria NA NA Mitochondria "HPA038742: AB_10795138" "unprognostic (5.35e-2)" "unprognostic (5.01e-2)" "unprognostic (1.81e-2)" "unprognostic (1.50e-2)" "unprognostic (6.98e-3)" "unprognostic (1.25e-1)" "unprognostic (5.07e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "unprognostic (2.47e-2)" "unprognostic (1.36e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.50e-11)" "unprognostic (2.48e-3)" "unprognostic (7.88e-3)" "unprognostic (2.50e-1)" "prognostic favorable (9.45e-6)" 25.8 24.1 5.0 20.1 7.2 39.5 10.2 1.3 5.4 20.1 21.8 3.9 19.9 20.1 14.1 27.1 11.9 12.5 16.4 5.9 2.4 1.6 8.9 25.2 24.1 20.7 7.1 2.2 11.4 69.6 2.6 4.7 14.4 6.9 15.7 4.1 6.8 18.3 11.0 3.5 5.2 25.8 10.8 7.7 44.7 17.4 4.2 5.5 7.5 11.7 8.3 24.3 13.0 13.4 3.3 13.4 40.4 36.8 8.2 4.9 10.7 9.2 17.1 0.2 0.0 7.9 6.2 12.0 18.4 9.0 5.3 5.0 0.3 27.8 0.8 10.1 6.5 8.1 11.7 1.1 7.1 1.1 24.1 0.5 6.4 20.8 5.5 7.3 4.7 40.6 7.2 4.1 6.5 0.4 0.0 3.6 0.3 3.3 2.5 1.7 3.1 0.2 28.2 1.0 13.2 4.3 7.9 0.3 40.4 5.0 5.2 0.9 0.2 7.8 10.2 5.0 1.9 11.1 12.1 12.6 10.3 8.1 28.6 3.3 0.4 0.3 1.3 23.0 7.9 4.9 5.5 16.6 18.8 4.5 28.8 3.7 3.3 3.4 4.9 13.4 2.2 2.0 2.1 40.4 8.2 36.8 9.0 3.3 10.7 5.0 7.2 1.3 5.4 2.4 1.6 7.1 2.2 6.9 5.5 26.8 66.3 28.6 11.5 5.6 0.7 1.2 17.8 29.4 27.3 7.0 0.0 18.1 0.0 29.8 0.3 15.8 46.0 0.0 58.5 45.5 19.9 9.3 48.5 16.3 102.9 0.0 23.0 17.8 127.9 0.2 5.5 82.1 5.0 46.9 25.2 0.9 44.8 87.7 12.4 2.1 0.7 38.8 16.5 0.1 3.0 4.5 22.2 49.4 25.3 17.1 TCTA ENSG00000145022 "T cell leukemia translocation altered" P57738 3 49412206-49416475 "Disease related genes, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007342 Approved Approved Cytosol NA NA Cytosol "HPA007342: AB_2202399" "unprognostic (5.58e-2)" "unprognostic (4.33e-2)" "unprognostic (6.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.17e-2)" "unprognostic (3.35e-2)" "unprognostic (2.18e-1)" "prognostic favorable (6.76e-4)" "unprognostic (3.74e-1)" "unprognostic (3.38e-3)" "unprognostic (1.82e-3)" "unprognostic (1.03e-1)" "prognostic favorable (5.00e-15)" "unprognostic (1.68e-1)" "unprognostic (1.96e-1)" "unprognostic (3.43e-1)" "unprognostic (6.41e-3)" 15.4 29.3 21.8 9.2 21.9 7.9 16.3 12.5 26.1 18.3 16.9 23.1 19.5 14.0 13.6 46.9 12.8 20.1 19.3 13.1 20.6 20.8 35.6 27.2 17.2 14.3 23.2 18.5 19.4 18.5 17.9 28.4 19.1 22.2 25.2 21.8 23.3 16.0 20.0 10.5 7.8 19.4 16.5 25.6 15.1 16.3 9.3 12.8 12.6 34.1 10.2 11.4 13.0 8.9 9.5 10.1 14.6 28.0 13.4 13.0 13.4 5.9 7.3 4.8 7.1 21.2 9.3 6.3 12.3 9.2 12.6 10.6 4.3 6.5 7.1 9.1 29.1 14.5 6.9 9.3 12.4 10.3 10.6 6.4 11.8 9.6 5.5 12.8 5.1 15.6 20.0 13.0 13.9 11.2 12.1 12.9 5.7 4.3 16.3 30.6 5.5 6.1 4.5 3.9 11.3 17.1 3.7 5.2 16.7 21.5 7.9 12.8 4.2 14.7 16.3 13.4 10.1 13.9 4.8 11.7 9.5 5.9 19.6 4.6 9.0 11.8 4.8 22.3 9.0 13.0 12.7 11.5 14.6 13.0 21.9 7.6 8.0 8.4 10.0 6.6 9.5 10.4 11.0 13.2 13.4 28.0 10.1 10.7 13.4 21.8 21.9 12.5 26.1 20.6 20.8 23.2 18.5 22.2 12.8 23.8 17.0 11.9 9.0 2.4 10.1 11.0 25.5 29.4 12.5 26.2 11.8 21.6 39.7 13.5 5.9 10.8 32.5 0.0 10.0 10.1 10.8 18.7 5.7 27.2 21.4 9.5 16.8 12.3 20.2 11.1 14.4 13.1 13.5 16.2 16.3 20.7 12.8 21.0 15.2 42.1 10.7 6.5 15.1 7.2 6.1 4.0 16.7 20.1 15.1 7.0 TCTN3 "C10orf61, DKFZP564D116, JBTS18, TECT3" ENSG00000119977 "Tectonic family member 3" Q6NUS6 10 95663396-95694143 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026987 Approved Approved Microtubules "Intracellular and membrane" NA NA 2600000 Microtubules "HPA026987: AB_10600911" "unprognostic (1.58e-1)" "unprognostic (1.54e-1)" "unprognostic (9.78e-2)" "prognostic favorable (5.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.50e-2)" "unprognostic (8.88e-3)" "unprognostic (1.08e-1)" "unprognostic (3.03e-2)" "unprognostic (9.25e-3)" "unprognostic (3.78e-3)" "unprognostic (7.29e-2)" "unprognostic (4.60e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (9.30e-3)" "unprognostic (1.59e-1)" 14.6 21.4 9.3 16.3 12.7 3.9 17.4 9.4 12.2 18.4 13.4 12.2 21.8 11.6 21.7 41.1 15.6 21.7 20.8 15.1 8.5 9.8 23.1 22.9 19.6 26.0 9.3 7.6 25.9 35.3 52.6 19.3 21.7 13.6 17.8 16.2 21.9 19.8 30.1 7.2 15.7 16.6 16.7 7.9 16.3 14.9 20.7 7.3 11.0 43.7 13.6 15.6 16.7 14.9 18.2 24.6 4.5 13.0 15.1 19.6 11.4 11.9 18.0 16.8 35.0 36.6 29.4 10.8 16.4 33.6 18.7 21.3 13.2 21.6 12.0 14.7 23.3 19.5 18.0 16.7 20.3 21.8 13.0 13.1 4.2 10.3 17.7 19.6 15.2 9.6 24.8 19.0 17.9 29.2 34.6 29.8 10.4 8.1 16.6 24.0 12.5 8.0 12.9 5.5 18.7 13.5 10.2 12.9 13.6 27.2 9.0 5.1 11.0 13.4 7.0 18.5 17.1 27.5 13.4 13.4 15.3 9.9 10.7 18.4 7.4 13.1 7.8 22.4 18.0 7.5 4.5 9.0 3.3 15.7 12.8 19.6 18.2 15.3 16.3 24.6 13.4 16.6 13.8 0.7 15.1 13.0 15.0 11.5 11.4 9.3 12.7 9.4 12.2 8.5 9.8 9.3 7.6 13.6 7.3 17.9 11.5 27.4 20.2 12.8 21.2 6.7 22.9 25.4 12.5 29.6 35.3 43.7 6.6 23.6 10.3 17.3 16.3 0.0 18.0 35.2 23.5 15.4 8.1 16.3 24.6 23.8 13.2 17.8 13.8 9.8 19.2 18.0 15.1 13.6 11.3 43.1 13.7 10.5 23.7 16.7 42.0 12.9 17.6 33.7 39.1 10.0 26.3 14.9 20.0 13.1 TDGF1 "CR, CRIPTO, Cripto-1" ENSG00000241186 "Teratocarcinoma-derived growth factor 1" P13385 3 46574534-46582463 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7" "Cell type enriched" "Detected in some" 18 "Distal tubular cells: 102.8" "Group enriched" "Detected in many" 9 "colorectal cancer: 6.4;testis cancer: 27.1" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 9.5;NTERA-2: 43.2;SuSa: 27.0" "Group enriched" "Detected in many" 5 "cerebellum: 12.5;pons and medulla: 9.1" "Low region specificity" "Detected in single" HPA051928 Uncertain Vesicles,Cytosol "Secreted in other tissues" NA NA Vesicles Cytosol "HPA051928: " "unprognostic (7.84e-3)" "unprognostic (2.00e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (2.80e-2)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (3.61e-1)" "unprognostic (1.72e-2)" "unprognostic (6.77e-2)" "unprognostic (1.74e-1)" "unprognostic (8.76e-3)" "unprognostic (2.01e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" 0.6 3.9 0.6 0.6 0.8 0.0 0.6 0.6 0.6 0.6 2.1 0.6 0.6 0.2 0.7 1.3 0.6 0.0 0.6 0.6 1.0 0.6 9.9 0.8 0.6 0.6 0.9 0.6 9.7 0.6 0.0 0.6 0.6 0.6 0.6 4.3 1.1 0.6 0.6 1.0 0.0 0.6 0.8 1.0 16.7 2.4 0.6 0.6 5.2 2.1 0.6 0.6 0.6 0.6 1.0 0.7 3.7 0.6 1.5 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 9.5 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 43.2 1.7 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.6 0.5 0.5 0.3 0.3 0.6 0.4 0.3 0.1 1.0 0.6 0.4 3.7 1.5 0.4 0.7 0.2 0.1 0.6 0.8 0.6 0.6 1.0 0.6 0.9 0.6 0.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 5.2 0.0 0.0 102.8 0.1 4.3 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 2.4 0.0 0.0 0.7 0.3 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.0 TDRKH TDRD2 ENSG00000182134 "Tudor and KH domain containing" Q9Y2W6 1 151770107-151791416 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, RNA-mediated gene silencing, Spermatogenesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 46.5" "Cell type enhanced" "Detected in many" 10 "Late spermatids: 48.0;Spermatocytes: 46.8;Spermatogonia: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016419, HPA019625" Approved Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA016419: AB_1857870, HPA019625: AB_1857871" "unprognostic (2.27e-3)" "unprognostic (2.89e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.29e-1)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (2.63e-1)" "unprognostic (2.91e-1)" "unprognostic (2.06e-1)" "unprognostic (3.06e-2)" "unprognostic (1.10e-1)" "unprognostic (5.63e-2)" "unprognostic (8.70e-2)" "unprognostic (1.67e-1)" "unprognostic (1.59e-3)" "unprognostic (1.14e-1)" 2.7 3.5 8.8 4.2 10.9 1.6 4.6 18.0 9.9 2.6 3.3 6.3 7.5 2.5 2.0 6.2 2.1 2.4 2.3 3.6 8.8 8.9 3.1 3.7 4.4 5.4 8.1 7.8 1.4 3.5 46.5 5.5 3.7 15.9 6.2 4.3 2.9 6.4 6.7 4.5 2.5 2.5 3.1 7.6 5.9 3.1 19.3 4.9 8.0 7.3 1.0 5.2 3.7 2.0 3.8 5.3 5.3 7.0 7.3 13.1 4.2 6.3 5.5 4.9 11.4 0.3 0.5 4.8 1.1 0.6 3.4 2.3 3.6 9.2 7.4 10.1 0.4 8.1 3.9 7.2 7.5 5.3 19.2 5.1 7.4 1.6 2.5 2.2 1.4 1.2 0.6 3.0 7.3 3.1 1.0 3.6 14.7 5.7 6.7 1.0 17.2 11.7 2.2 3.8 9.5 9.6 1.4 3.1 15.4 6.0 3.1 7.2 11.8 7.9 6.4 7.4 9.4 13.9 5.6 1.4 1.6 2.9 5.0 6.1 13.8 16.9 8.3 7.4 6.0 2.2 5.3 0.9 1.9 8.8 4.3 13.1 3.8 8.2 8.8 2.0 3.6 6.0 7.5 0.7 7.3 7.0 5.3 9.4 4.2 8.8 10.9 18.0 9.9 8.8 8.9 8.1 7.8 15.9 4.9 3.0 8.8 0.9 1.9 0.2 3.4 2.6 0.0 1.4 2.3 7.0 3.9 2.2 1.7 2.5 17.5 1.0 0.1 0.0 2.2 2.5 0.4 1.7 4.6 0.6 4.4 6.4 0.0 1.3 1.3 48.0 0.3 1.3 1.7 3.6 0.9 1.5 1.8 0.0 2.1 1.3 3.0 12.9 1.2 46.8 21.1 0.1 2.1 1.3 1.0 0.9 TECR "GPSN2, MRT14, SC2, TER" ENSG00000099797 "Trans-2,3-enoyl-CoA reductase" Q9NZ01 19 14517085-14565980 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Oxidoreductase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 750.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029780, HPA056488" Supported Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029780: AB_10603348, HPA056488: AB_2683149" "unprognostic (9.73e-2)" "unprognostic (3.69e-3)" "unprognostic (1.55e-1)" "unprognostic (8.08e-3)" "unprognostic (1.20e-1)" "unprognostic (3.96e-2)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.36e-1)" "unprognostic (9.16e-2)" "unprognostic (1.29e-1)" "unprognostic (5.05e-2)" "unprognostic (3.65e-3)" "unprognostic (2.53e-3)" "unprognostic (2.34e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (2.60e-4)" 32.8 43.2 45.0 15.0 43.7 23.0 26.2 51.7 70.8 34.9 26.1 64.5 40.1 37.8 16.5 38.2 89.6 32.4 19.0 22.3 42.9 38.3 29.0 45.9 20.7 17.8 45.6 34.7 25.0 37.0 95.0 20.9 68.5 50.4 23.9 21.7 34.5 69.8 42.0 121.4 89.5 34.8 13.8 53.3 20.0 24.5 59.6 40.2 29.8 33.5 40.7 49.5 18.3 43.8 21.7 30.2 10.7 22.8 34.3 60.6 32.7 36.5 27.3 26.1 29.4 38.1 17.4 27.6 10.7 30.3 34.5 42.9 36.3 42.3 19.6 22.5 22.4 26.7 57.1 27.5 43.5 13.9 32.2 23.6 33.4 40.9 39.9 23.0 23.6 25.5 25.8 34.8 30.3 16.6 17.2 16.2 29.3 21.4 67.8 17.6 46.0 27.8 41.2 27.3 94.0 29.6 25.9 17.0 87.0 46.8 19.7 32.6 20.0 17.9 48.2 22.9 13.6 25.9 46.9 9.4 27.7 11.9 24.0 36.0 20.8 19.9 20.3 28.4 35.6 27.6 9.2 16.0 10.7 32.0 22.8 34.7 21.7 42.0 36.6 27.3 21.0 49.2 38.8 7.2 34.3 17.1 30.2 60.6 32.7 45.0 43.7 51.7 70.8 42.9 38.3 45.6 34.7 50.4 40.2 68.5 70.5 64.7 187.4 150.7 86.7 43.3 104.4 85.6 61.4 157.1 115.8 406.1 48.0 132.1 327.6 56.2 226.7 46.7 199.9 418.2 76.1 121.3 34.7 135.7 163.0 106.5 96.0 70.6 99.0 750.0 67.3 92.0 155.3 61.3 121.5 562.9 101.5 115.2 56.6 150.3 157.6 64.7 100.0 163.9 115.2 209.5 406.6 101.5 176.8 172.7 TECRL "DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL" ENSG00000205678 "Trans-2,3-enoyl-CoA reductase like" Q5HYJ1 4 64275257-64409468 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 131.5" "Cell type enriched" "Detected in single" 16229 "Cardiomyocytes: 1622.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "OE19: 2.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 131.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.2 0.2 1.3 0.0 0.0 0.3 0.0 0.9 0.9 0.6 1.1 0.5 0.2 0.3 1.1 0.0 0.1 0.2 1.1 0.7 0.5 0.3 0.3 0.6 0.5 0.3 0.1 0.4 0.5 0.0 0.7 1.4 1.4 0.2 1.2 0.6 0.1 0.5 0.2 0.3 1.0 0.2 0.3 0.7 1.1 0.2 0.2 0.5 0.8 0.7 2.8 0.2 0.5 0.8 0.4 2.5 0.5 0.2 0.6 0.5 0.1 0.1 1.4 0.4 0.5 0.7 1.1 0.8 0.7 0.8 1.0 0.2 0.7 0.5 0.8 0.6 0.6 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.2 0.2 0.2 1.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1622.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TECTA "DFNA12, DFNA8, DFNB21" ENSG00000109927 "Tectorin alpha" O75443 11 121101173-121191493 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.5" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 1: 3.0;Cone photoreceptor cells: 3.9;Early spermatids: 5.6;Ito cells: 9.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.5;SH-SY5Y: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA018870 Approved "Secreted in other tissues" NA NA "HPA018870: AB_1857879" "unprognostic (1.12e-3)" "unprognostic (2.42e-1)" "unprognostic (1.42e-2)" "unprognostic (1.45e-2)" "unprognostic (4.30e-2)" "unprognostic (3.11e-1)" "unprognostic (3.00e-2)" "unprognostic (3.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.14e-1)" "unprognostic (1.39e-6)" "unprognostic (1.22e-1)" "unprognostic (4.15e-3)" "unprognostic (6.97e-3)" "unprognostic (1.12e-1)" "unprognostic (3.28e-2)" "unprognostic (4.19e-2)" 0.6 1.6 1.1 0.4 3.5 0.4 0.6 2.9 5.5 0.4 0.5 0.2 0.6 1.8 0.1 0.6 0.7 2.1 1.3 2.6 0.7 0.9 1.1 0.2 1.4 1.6 0.7 4.2 2.5 0.6 0.9 0.3 0.5 1.6 1.0 0.2 0.2 0.6 1.0 0.4 0.4 2.0 1.4 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 3.5 1.8 0.1 0.2 0.5 0.5 0.3 0.1 0.2 0.3 0.0 0.2 1.7 0.2 0.2 0.0 0.7 0.0 0.2 0.7 0.9 0.5 0.1 0.0 0.3 0.5 0.3 0.4 0.6 0.1 0.0 0.5 0.4 0.7 0.0 1.2 0.4 0.2 0.2 1.3 0.7 0.0 0.1 0.1 0.6 0.1 0.5 0.1 2.4 5.5 0.3 0.2 0.3 2.3 0.3 0.5 0.0 0.4 0.5 0.2 0.4 1.3 1.3 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.3 0.0 0.1 0.0 1.9 1.7 0.0 0.0 1.2 0.0 3.9 0.0 0.0 0.3 5.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 9.8 0.3 1.6 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 TEDDM1 "EDDM9, Epdd1, HE9, TMEM45C" ENSG00000203730 "Transmembrane epididymal protein 1" Q5T9Z0 1 182398117-182400616 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "epididymis: 128.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 1.3" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 1.2;NB-4: 4.3" "Not detected" "Not detected" NA NA "unprognostic (4.21e-2)" "unprognostic (8.89e-2)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (6.71e-4)" "unprognostic (4.43e-3)" "unprognostic (2.86e-2)" "unprognostic (4.57e-2)" "unprognostic (4.20e-1)" "unprognostic (7.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.39e-2)" "unprognostic (2.47e-2)" "unprognostic (6.99e-3)" 0.1 0.0 0.1 0.1 0.2 0.0 0.4 1.3 0.1 0.5 0.1 0.1 1.8 0.0 0.4 128.3 0.1 0.7 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.0 0.3 0.0 0.3 0.1 0.1 0.4 0.0 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 2.3 0.1 0.1 0.3 0.1 0.1 0.1 0.6 0.9 0.4 3.8 0.5 0.4 0.6 0.1 0.0 0.2 0.1 0.2 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.3 0.8 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.4 0.1 4.3 0.2 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.4 0.3 0.4 0.2 0.1 0.2 0.4 0.4 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 1.3 0.5 1.0 0.6 0.1 0.4 0.1 0.2 0.1 0.1 0.9 0.5 0.3 3.8 0.4 0.5 0.4 0.1 0.1 0.1 0.2 1.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEK "CD202b, TIE-2, TIE2, VMCM, VMCM1" ENSG00000120156 "TEK receptor tyrosine kinase" Q02763 9 27109141-27230175 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 8 "Endothelial cells: 58.3;Ito cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 36.5;NTERA-2: 18.2;TIME: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010359, HPA073265" Approved Supported "Plasma membrane,Centriolar satellite" "Secreted to blood" NA NA 7750000 8300000 "Plasma membrane" "Centriolar satellite" "CAB010359: AB_2203226, HPA073265: AB_2686592" "unprognostic (2.24e-1)" "unprognostic (1.74e-1)" "unprognostic (5.55e-2)" "unprognostic (1.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.26e-3)" "prognostic favorable (2.31e-5)" "unprognostic (7.48e-2)" "unprognostic (1.72e-2)" "unprognostic (1.41e-1)" "unprognostic (5.58e-2)" "unprognostic (2.72e-1)" "prognostic favorable (7.81e-4)" "unprognostic (7.50e-3)" "unprognostic (6.87e-3)" "unprognostic (1.83e-1)" "unprognostic (5.24e-3)" 28.6 7.8 8.1 4.6 5.9 0.4 17.9 3.4 5.4 10.8 4.7 4.6 3.4 3.2 14.5 5.3 6.7 5.9 9.1 13.0 7.1 6.1 25.4 8.7 27.8 2.9 6.9 3.4 6.1 4.5 3.5 4.0 36.3 6.9 5.4 4.7 12.4 3.4 5.5 7.8 3.0 5.3 10.6 5.3 23.4 4.0 3.7 3.5 0.3 9.7 8.4 2.4 6.4 12.4 0.0 0.1 2.2 0.6 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.2 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.0 0.0 0.7 0.0 0.0 0.7 0.0 0.9 0.3 0.0 36.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.8 0.0 0.0 39.6 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 8.1 5.9 3.4 5.4 7.1 6.1 6.9 3.4 6.9 3.5 3.0 2.2 0.0 0.0 1.3 0.0 7.8 0.0 0.0 1.2 1.8 0.0 0.4 0.0 0.0 0.6 58.3 0.0 0.0 0.0 1.5 2.4 0.2 0.0 0.8 0.2 0.0 0.0 110.5 10.4 0.4 0.6 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.2 0.0 0.4 0.0 0.2 1.1 1.1 0.0 0.0 0.0 TENM1 "ODZ1, ODZ3, TEN-M1, TNM" ENSG00000009694 "Teneurin transmembrane protein 1" Q9UKZ4 X 124375903-124963817 "Predicted membrane proteins" "Stress response, Transcription, Transcription regulation" "Neuropeptide, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0;liver: 10.5" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 8.0;Glandular cells: 16.3;granulocytes: 7.0;Hepatocytes: 15.3" "Group enriched" "Detected in many" 5 "glioma: 1.6;prostate cancer: 2.2;renal cancer: 1.6;testis cancer: 1.4;thyroid cancer: 7.0" "Region enriched" "Detected in many" 4 "cerebellum: 17.0" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 4.0;hTERT-HME1: 2.7;MOLT-4: 9.8;RPTEC TERT1: 3.5;SCLC-21H: 3.4;U-138 MG: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002848 Uncertain NA NA "HPA002848: AB_1079523" "unprognostic (1.71e-3)" "unprognostic (8.25e-2)" "unprognostic (3.14e-1)" "unprognostic (8.68e-4)" "unprognostic (5.76e-3)" "unprognostic (3.51e-2)" "unprognostic (7.07e-2)" "unprognostic (2.68e-4)" "unprognostic (6.58e-2)" "unprognostic (1.71e-1)" "unprognostic (4.49e-3)" "unprognostic (3.58e-1)" "unprognostic (2.71e-2)" "unprognostic (4.41e-2)" "unprognostic (1.99e-1)" "unprognostic (3.25e-3)" "unprognostic (4.44e-2)" 1.9 3.0 1.4 0.4 2.4 3.5 1.0 17.0 4.4 0.4 1.1 0.9 0.4 0.1 1.4 2.3 0.4 1.5 2.0 0.4 2.3 2.7 1.8 10.5 0.9 0.9 1.0 4.2 0.4 0.4 0.0 3.5 0.4 3.3 4.8 0.3 1.5 0.9 3.8 0.5 1.6 0.7 1.1 2.6 0.6 0.5 2.3 0.4 0.4 3.1 0.4 0.7 0.4 0.4 0.0 0.0 2.4 0.1 0.6 1.6 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.7 0.0 0.0 2.3 0.0 1.2 0.0 0.0 9.8 0.0 0.5 0.0 1.5 0.0 0.0 0.1 3.5 0.0 3.4 0.0 0.0 0.7 0.0 2.3 0.8 0.0 0.0 5.8 0.2 0.0 0.4 0.3 0.7 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.6 0.0 0.9 0.0 0.9 1.0 0.0 0.0 1.6 1.1 2.4 0.6 0.0 0.0 0.2 0.1 1.4 2.4 17.0 3.9 2.3 2.7 1.0 4.2 3.3 0.4 0.0 0.0 0.0 0.1 3.0 8.0 0.8 2.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 5.4 16.3 7.0 15.3 0.0 6.4 0.0 0.6 0.6 0.0 4.6 0.3 3.3 0.0 0.0 0.5 0.0 0.0 0.0 2.9 0.5 0.0 0.5 0.0 3.4 1.6 0.0 1.0 0.0 0.1 TENM2 "KIAA1127, ODZ2, Ten-M2" ENSG00000145934 "Teneurin transmembrane protein 2" Q9NT68 5 167284799-168264157 "Predicted membrane proteins" "Cell adhesion, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 15.1;heart muscle: 24.7" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 142.6;Horizontal cells: 114.4;Peritubular cells: 58.0" "Cancer enriched" "Detected in many" 6 "head and neck cancer: 15.4" "Region enhanced" "Detected in many" "cerebral cortex: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 26.7;HBEC3-KT: 17.5;HDLM-2: 17.1;U-138 MG: 31.3;U-2 OS: 27.2;U-251 MG: 20.0" "Low region specificity" "Detected in many" "HPA038018, HPA038420, HPA068691" Uncertain Approved Nucleoli No No Nucleoli "HPA038018: , HPA038420: AB_10674682, HPA068691: AB_2686019" "unprognostic (6.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.94e-2)" "unprognostic (9.16e-3)" "unprognostic (3.88e-3)" "unprognostic (3.81e-3)" "unprognostic (5.81e-2)" "unprognostic (2.41e-1)" "unprognostic (4.62e-2)" "unprognostic (2.10e-2)" "unprognostic (3.68e-3)" "unprognostic (4.34e-2)" "unprognostic (4.69e-5)" "unprognostic (3.47e-2)" "unprognostic (1.03e-1)" "unprognostic (5.16e-4)" "prognostic unfavorable (7.52e-4)" 0.2 0.4 2.5 0.0 3.5 0.0 1.8 0.5 15.1 0.6 0.3 0.0 0.0 0.3 0.2 0.4 1.4 0.2 0.3 24.7 6.5 0.9 2.7 1.2 0.3 0.0 0.5 1.7 0.7 0.2 0.0 0.4 0.0 2.3 2.2 0.0 0.2 0.3 1.0 0.2 2.3 0.2 0.0 0.6 0.2 0.3 1.2 0.4 0.0 0.4 0.0 0.9 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 0.0 26.7 0.7 0.0 0.0 17.5 0.3 17.1 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.3 3.1 0.1 2.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 4.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.0 1.5 0.0 0.0 31.3 27.2 0.0 20.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.5 0.5 15.1 6.5 0.9 0.5 1.7 2.3 0.4 0.0 0.0 0.0 0.7 13.2 9.5 142.6 0.0 0.0 1.2 0.0 17.7 0.0 0.0 2.5 20.1 1.3 0.1 0.0 0.2 0.0 0.7 1.1 1.1 4.2 0.1 114.4 0.0 0.0 0.0 13.2 4.0 0.0 1.7 0.0 0.3 2.1 0.0 0.0 58.0 0.0 1.6 0.0 1.7 0.9 1.1 1.5 0.0 0.0 0.0 0.1 TENM3 "KIAA1455, ODZ3, Ten-M3" ENSG00000218336 "Teneurin transmembrane protein 3" Q9P273 4 182143987-182803024 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Bipolar cells: 28.4;Cytotrophoblasts: 88.5;Extravillous trophoblasts: 46.4;Syncytiotrophoblasts: 111.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 24.4;BEWO: 23.3;HDLM-2: 31.7;T-47d: 31.4" "Low region specificity" "Detected in many" HPA047043 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA047043: AB_2679914" "unprognostic (5.79e-2)" "unprognostic (3.01e-2)" "unprognostic (6.62e-2)" "unprognostic (4.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (8.28e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (2.31e-2)" "unprognostic (4.85e-2)" "unprognostic (2.54e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (8.59e-2)" "unprognostic (1.07e-2)" "unprognostic (5.25e-4)" 9.5 10.8 11.3 3.7 12.5 1.0 9.3 8.5 17.8 3.9 8.5 1.5 5.7 2.4 6.4 2.6 2.4 2.9 5.3 3.5 11.8 9.4 2.7 1.4 2.4 2.3 3.5 15.4 8.4 3.2 17.0 15.0 24.5 5.4 8.3 2.5 6.4 2.0 8.0 4.3 1.4 2.5 5.2 6.1 4.8 2.2 4.7 2.3 0.8 12.3 1.8 3.0 3.7 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 24.4 0.1 5.0 8.9 23.3 2.8 1.0 2.5 2.2 12.1 6.3 0.0 0.3 18.8 10.6 1.2 5.8 1.2 2.5 31.7 9.7 0.0 0.0 0.0 0.5 0.0 0.0 11.7 0.4 7.9 5.5 5.7 3.5 0.0 0.0 0.1 3.8 0.8 0.0 0.0 7.8 0.0 1.0 0.0 6.3 0.0 0.0 0.0 10.0 9.3 1.4 0.1 0.0 13.8 31.4 1.2 7.6 20.0 14.4 0.0 14.1 0.0 0.0 0.0 10.5 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 12.5 8.5 17.8 11.8 9.4 3.5 15.4 5.4 2.3 0.0 0.0 0.0 0.2 0.3 28.4 3.3 0.0 0.0 0.0 3.5 3.9 88.5 1.7 0.0 8.3 0.3 0.0 0.0 1.5 46.4 3.1 0.2 0.0 0.6 9.0 4.8 5.1 0.6 0.0 1.8 7.8 0.0 1.7 0.0 0.0 11.8 0.6 0.0 2.5 0.1 2.8 0.0 1.0 3.7 7.1 0.0 111.6 0.0 0.0 0.0 TENM4 "KIAA1302, ODZ4, Ten-M4" ENSG00000149256 "Teneurin transmembrane protein 4" Q6N022 11 78652831-79440948 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 23.0;parathyroid gland: 44.4" "Group enriched" "Detected in some" 5 "Early spermatids: 74.5;Late spermatids: 45.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HSkMC: 8.2;hTERT-RPE1: 8.5;PC-3: 9.4;REH: 8.9;SH-SY5Y: 15.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019521, HPA065961" Approved NA NA "HPA019521: AB_2670171, HPA065961: AB_2685588" "unprognostic (2.81e-1)" "unprognostic (9.25e-2)" "unprognostic (1.64e-1)" "unprognostic (2.96e-3)" "unprognostic (1.87e-1)" "unprognostic (2.48e-1)" "unprognostic (1.18e-2)" "unprognostic (1.24e-1)" "unprognostic (3.01e-1)" "unprognostic (3.79e-1)" "unprognostic (1.01e-1)" "unprognostic (4.71e-1)" "unprognostic (6.51e-3)" "unprognostic (5.40e-3)" "unprognostic (5.64e-2)" "unprognostic (7.07e-2)" "unprognostic (9.81e-3)" 3.2 2.8 14.7 2.2 13.0 1.0 1.6 1.4 16.9 4.4 1.4 3.6 0.0 1.1 2.7 1.2 3.1 3.7 1.5 1.3 11.4 6.3 2.9 1.0 1.4 1.5 3.3 5.7 23.0 1.3 44.4 12.0 1.1 8.3 1.4 1.4 4.8 1.5 1.3 1.4 5.1 1.2 2.2 12.5 1.3 1.5 2.9 5.7 0.6 8.2 2.1 2.5 1.6 2.3 0.3 1.4 0.6 0.6 0.3 0.1 0.0 0.0 0.0 3.0 0.0 3.4 5.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.9 5.7 0.0 1.8 4.4 4.6 0.0 3.8 0.8 0.0 0.0 0.0 0.1 0.0 0.0 8.2 2.0 2.2 4.1 8.5 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.0 1.6 0.2 9.4 8.9 0.0 0.0 5.9 1.0 6.4 15.6 0.0 0.0 0.0 5.8 0.0 0.1 0.4 0.1 1.1 0.1 5.1 0.0 0.0 0.1 6.2 0.0 0.0 0.5 0.6 0.0 0.1 0.3 0.1 0.2 0.1 0.1 1.4 0.3 0.0 0.0 0.6 0.3 0.3 0.3 0.1 0.0 14.7 13.0 1.4 16.9 11.4 6.3 3.3 5.7 8.3 5.7 0.0 0.0 0.0 0.4 0.8 2.6 1.6 5.1 5.3 0.0 0.0 0.0 0.1 0.0 0.4 74.5 0.0 0.0 0.0 0.0 0.1 0.7 0.2 1.1 0.0 0.1 0.0 0.0 0.0 0.3 45.5 4.9 0.2 0.0 0.0 0.0 13.2 0.0 0.0 1.8 0.0 0.3 0.0 0.4 1.7 0.7 1.8 0.1 0.0 0.0 0.5 TEX2 "HT008, KIAA1738, TMEM96" ENSG00000136478 "Testis expressed 2" Q8IWB9 17 64147227-64263301 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 41.1;Late spermatids: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "plasmacytoid DC: 18.1" "Lineage enriched" "Detected in many" 7 "dendritic cells: 18.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020648, HPA057116" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020648: AB_1857908, HPA057116: AB_2683341" "unprognostic (6.13e-2)" "unprognostic (1.35e-1)" "prognostic favorable (3.90e-6)" "unprognostic (1.69e-2)" "unprognostic (3.84e-2)" "unprognostic (8.34e-2)" "unprognostic (6.97e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (2.53e-1)" "unprognostic (8.39e-2)" "unprognostic (1.11e-1)" "unprognostic (7.97e-2)" "unprognostic (7.00e-2)" "unprognostic (1.87e-1)" "unprognostic (4.53e-3)" "unprognostic (5.59e-3)" 11.7 18.1 22.3 5.0 25.1 11.8 14.3 18.9 22.5 14.0 8.8 22.9 4.2 7.3 10.8 8.7 12.6 10.2 15.8 19.2 23.0 20.1 14.6 23.4 10.7 4.1 29.0 13.8 12.0 21.1 27.2 10.7 8.7 20.5 12.3 10.0 46.2 17.7 13.2 28.1 11.1 7.2 10.8 26.3 8.7 9.1 35.7 17.2 4.9 29.3 10.9 4.9 8.1 8.2 0.6 18.1 0.7 2.6 2.6 1.6 1.4 13.2 6.4 4.0 8.2 19.6 11.6 4.9 18.4 20.9 16.8 11.6 6.0 3.3 4.7 4.8 23.3 10.4 6.6 7.2 22.4 19.1 6.8 5.0 31.6 4.4 11.2 7.3 9.1 5.3 8.5 12.4 11.4 23.4 11.9 8.0 8.0 8.6 5.8 12.5 14.9 8.3 4.2 2.3 10.4 11.6 5.1 36.7 6.6 9.7 6.3 6.2 10.2 9.2 23.6 10.1 23.3 11.1 7.9 9.4 15.7 9.2 12.1 10.6 6.0 8.2 3.1 6.2 8.7 14.1 0.0 2.6 0.7 1.4 0.8 1.6 0.3 1.5 1.6 2.5 0.6 1.6 1.5 0.3 2.6 1.5 18.1 1.0 1.4 22.3 25.1 18.9 22.3 23.0 20.1 29.0 13.8 20.5 17.2 3.0 7.2 2.2 5.5 7.8 4.1 28.9 7.6 8.1 5.7 12.2 5.9 2.1 1.7 4.3 41.1 8.7 5.5 0.0 7.1 1.6 6.4 5.5 3.5 28.6 11.1 9.5 11.6 8.6 7.5 38.4 6.1 3.8 6.8 1.8 10.2 6.0 6.1 2.9 12.0 7.9 18.4 0.0 6.1 14.6 9.5 7.9 1.1 2.2 10.6 4.2 TEX261 "MGC32043, TEG-261" ENSG00000144043 "Testis expressed 261" Q6UWH6 2 70985938-70994945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA016631 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA016631: AB_2240434" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (6.17e-4)" "unprognostic (1.05e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (4.23e-4)" "unprognostic (5.52e-3)" "unprognostic (2.40e-1)" "unprognostic (1.75e-2)" "unprognostic (3.15e-2)" "unprognostic (3.70e-3)" "unprognostic (3.36e-1)" "unprognostic (5.59e-2)" "unprognostic (1.78e-1)" "unprognostic (1.02e-1)" "unprognostic (1.99e-1)" 22.9 27.1 14.5 11.1 15.4 9.3 22.2 13.4 21.4 19.9 15.9 21.6 20.9 13.8 17.3 27.2 17.3 20.9 21.2 21.6 14.4 12.0 25.1 36.9 19.8 16.1 17.0 10.9 23.7 50.8 36.1 20.1 19.3 15.0 18.9 18.9 28.7 22.3 21.0 33.5 12.9 23.6 19.6 17.4 16.0 18.4 23.8 15.3 15.5 31.7 14.3 16.3 14.9 13.9 3.8 4.4 12.0 5.3 3.4 6.7 2.8 20.0 19.0 13.3 16.9 40.7 20.8 15.1 23.2 22.2 27.1 17.1 22.2 16.7 16.4 8.8 40.7 25.6 15.2 25.3 27.7 39.5 12.3 21.1 19.6 9.8 23.5 24.0 22.8 16.5 18.7 18.5 26.0 17.8 14.9 27.5 17.1 24.3 10.9 31.6 15.7 19.6 12.6 8.8 32.6 22.4 14.0 41.2 14.1 19.7 17.6 21.9 11.5 24.1 24.1 15.1 9.4 15.6 13.5 22.0 33.4 28.9 17.7 30.8 8.5 7.5 19.5 29.1 30.1 27.9 12.0 5.3 10.0 5.1 5.3 4.3 2.6 5.4 6.7 4.0 3.8 6.2 4.9 4.0 3.4 5.2 4.4 4.3 2.8 14.5 15.4 13.4 21.4 14.4 12.0 17.0 10.9 15.0 15.3 3.0 17.1 18.2 9.4 7.3 13.4 19.8 17.8 1.4 7.9 22.7 35.3 14.3 6.6 21.9 12.0 14.6 19.3 0.0 20.5 14.3 14.1 13.7 2.3 30.4 17.3 7.9 8.1 18.4 15.1 21.6 14.7 8.4 18.6 9.0 17.0 20.6 18.7 13.6 17.3 14.1 68.9 0.0 16.0 46.6 10.9 6.6 15.0 9.2 16.5 7.1 TEX264 "FLJ13935, ZSIG11" ENSG00000164081 "Testis expressed 264" Q9Y6I9 3 51662693-51704323 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 310.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005002, HPA017739" Enhanced Approved Nucleoli,Cytosol "Secreted - unknown location" NA NA "Nucleoli, Cytosol" "CAB005002: AB_425976, HPA017739: AB_1857910" "unprognostic (2.80e-3)" "unprognostic (1.05e-2)" "unprognostic (2.69e-1)" "unprognostic (2.79e-3)" "unprognostic (8.11e-2)" "unprognostic (8.26e-3)" "unprognostic (2.05e-1)" "unprognostic (3.06e-3)" "unprognostic (2.30e-1)" "unprognostic (5.19e-2)" "prognostic favorable (5.67e-4)" "unprognostic (1.83e-1)" "prognostic favorable (7.95e-9)" "unprognostic (4.99e-2)" "unprognostic (3.65e-1)" "unprognostic (3.17e-1)" "unprognostic (4.67e-2)" 15.7 34.6 15.1 15.3 18.7 9.0 20.0 8.6 22.8 17.5 21.3 15.0 36.0 18.7 20.1 25.5 17.7 21.9 24.8 19.0 14.6 15.6 35.9 30.7 17.0 22.6 15.7 17.9 15.8 29.0 29.9 12.3 24.5 12.2 20.3 16.7 22.6 43.6 44.3 16.3 29.5 20.8 16.6 15.8 18.6 19.0 90.8 11.5 16.6 33.9 18.5 15.9 16.7 16.3 33.1 34.5 24.7 36.7 22.8 50.7 41.1 11.8 21.8 3.9 20.1 40.7 19.8 8.0 10.2 24.2 17.0 17.2 11.6 28.2 17.1 7.5 14.6 28.8 11.6 11.0 20.6 8.3 13.7 17.6 16.3 13.6 15.4 36.3 10.2 18.3 26.1 32.9 19.2 19.7 15.5 12.4 13.0 8.5 29.9 17.5 13.7 16.3 23.8 4.3 19.6 24.5 7.9 5.2 32.2 26.8 16.5 5.6 9.2 12.5 34.5 15.7 5.6 16.8 21.7 9.1 17.2 7.2 18.0 13.5 20.9 22.5 8.4 21.0 21.6 17.1 24.7 36.7 21.7 41.9 36.7 41.9 32.2 43.5 39.7 34.5 33.1 36.5 37.0 7.7 22.8 34.7 30.5 50.7 41.1 15.1 18.7 8.6 22.8 14.6 15.6 15.7 17.9 12.2 11.5 32.8 15.0 27.5 46.0 30.9 30.1 22.8 53.5 25.4 28.4 94.2 55.0 125.5 53.0 63.6 30.2 49.7 69.9 0.0 67.2 73.8 45.6 36.2 16.1 51.7 92.2 39.7 31.6 28.3 36.7 48.4 47.2 49.0 62.4 55.9 51.0 59.8 56.9 65.4 46.0 101.0 46.9 25.8 20.0 310.0 58.8 30.9 63.8 52.4 81.7 32.5 TEX28 "CXorf2, fTEX" ENSG00000278057 "Testis expressed 28" O15482 X 154271265-154295853 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 8.7" "Group enriched" "Detected in some" 41 "Early spermatids: 37.0;Late spermatids: 56.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.6;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 4 "T-cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.2 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 TEX29 "bA474D23.1, C13orf16, MGC35169" ENSG00000153495 "Testis expressed 29" Q8N6K0 13 111316184-111344249 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 36.8" "Cell type enriched" "Detected in some" 5 "Early spermatids: 596.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebral cortex: 6.1" "Cell type enhanced" "Detected in some" "eosinophil: 1.8;memory B-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 54 "U-698: 22.4" NA NA "unprognostic (2.93e-1)" "unprognostic (2.26e-2)" "unprognostic (8.62e-4)" "unprognostic (4.56e-1)" "unprognostic (7.26e-2)" "unprognostic (4.93e-1)" "unprognostic (2.08e-2)" "unprognostic (8.51e-2)" "unprognostic (5.45e-2)" "unprognostic (2.43e-1)" "unprognostic (2.78e-2)" "unprognostic (7.86e-2)" "unprognostic (1.13e-9)" "unprognostic (3.41e-1)" "unprognostic (1.51e-1)" "unprognostic (5.07e-2)" "unprognostic (4.21e-2)" 0.3 0.2 2.7 0.3 1.7 0.0 0.3 0.3 6.1 0.3 0.3 0.3 0.3 0.1 0.3 0.5 0.4 0.1 0.3 0.3 0.9 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 0.1 0.5 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.5 0.1 0.4 0.3 0.3 0.3 0.2 36.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.3 0.6 1.8 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 22.4 0.3 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.1 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.1 2.7 1.7 0.3 6.1 0.9 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 596.2 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 114.3 4.4 0.0 0.0 0.0 0.2 0.0 1.7 0.2 3.9 0.0 0.0 0.0 1.2 1.9 3.1 0.4 0.5 0.0 0.0 0.4 TEX38 "ATPAF1-AS1, C1orf223, LOC374973, THEG4" ENSG00000186118 "Testis expressed 38" Q6PEX7 1 46668855-46673594 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "testis: 109.8" "Group enriched" "Detected in some" 114 "Early spermatids: 1833.7;Late spermatids: 4115.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.0;SK-BR-3: 2.2;TIME: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA073711 Uncertain Vesicles NA NA Vesicles "HPA073711: " "unprognostic (8.46e-2)" "unprognostic (1.99e-1)" "unprognostic (3.14e-2)" "unprognostic (8.86e-2)" "unprognostic (6.81e-3)" "unprognostic (3.50e-1)" "unprognostic (1.99e-1)" "unprognostic (9.21e-2)" "unprognostic (5.39e-2)" "unprognostic (4.15e-3)" "unprognostic (4.93e-4)" "unprognostic (2.64e-1)" "unprognostic (5.28e-2)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (7.84e-2)" "unprognostic (3.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 2.5 0.3 0.1 1.6 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.0 1.3 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.8 0.3 0.0 0.5 0.4 0.0 0.6 0.6 0.5 0.1 0.0 0.4 0.1 0.9 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.9 0.0 0.6 0.6 2.0 1.4 1.0 2.2 0.0 1.8 0.8 0.0 2.5 0.3 0.0 1.0 0.2 0.9 0.3 0.6 0.2 0.0 0.2 0.0 0.3 2.5 1.2 0.2 1.6 0.9 0.1 0.9 0.4 0.4 0.9 0.2 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1833.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4115.3 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.4 6.5 0.0 24.7 13.3 0.0 0.0 0.0 0.0 0.0 TEX46 C1orf234 ENSG00000227868 "Testis expressed 46" H3BTG2 1 23010834-23015850 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 39.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 7 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "ASC diff: 3.1;HSkMC: 3.9" "Not detected" "Not detected" NA NA "unprognostic (3.11e-1)" "unprognostic (1.86e-1)" "unprognostic (9.04e-2)" "unprognostic (2.13e-1)" "unprognostic (1.24e-2)" "unprognostic (6.33e-2)" "unprognostic (2.84e-1)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (9.76e-2)" "unprognostic (8.12e-2)" "unprognostic (3.82e-3)" "unprognostic (2.29e-5)" "unprognostic (1.06e-1)" "unprognostic (1.15e-1)" "unprognostic (7.60e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 39.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 1.4 0.5 3.1 0.8 1.4 0.0 0.6 1.1 0.9 0.0 0.8 0.4 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.5 0.0 1.5 0.0 0.0 0.0 0.3 3.9 1.3 0.6 0.8 0.0 0.7 2.3 0.7 0.4 0.7 1.1 0.0 0.7 1.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 2.0 0.0 1.4 0.5 0.2 0.2 1.4 0.0 1.5 0.3 0.5 0.4 0.0 2.4 0.0 0.2 0.4 0.5 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX50 ENSG00000232113 "Testis expressed 50" A0A1B0GTY4 1 173635333-173637134 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 176 "testis: 17.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "GAMG: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX51 ENSG00000237524 "Testis expressed 51" A0A1B0GUA7 2 126898864-126902097 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 79 "testis: 51.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-2197: 3.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFR2 "HFE3, TFRC2" ENSG00000106327 "Transferrin receptor 2" Q9UP52 7 100620416-100642779 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 112.6" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 379.7" "Cancer enriched" "Detected in many" 70 "liver cancer: 136.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 46 "basophil: 5.5;eosinophil: 3.9" "Lineage enriched" "Detected in single" 54 "granulocytes: 5.5" "Group enriched" "Detected in some" 11 "HEL: 28.5;HMC-1: 39.6;K-562: 26.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB016255, HPA017171, HPA073125" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB016255: AB_628395, HPA017171: , HPA073125: " "unprognostic (4.18e-2)" "unprognostic (1.97e-2)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (1.26e-2)" "unprognostic (4.13e-2)" "prognostic favorable (2.48e-4)" "unprognostic (2.29e-2)" "unprognostic (4.49e-2)" "unprognostic (9.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.90e-1)" "unprognostic (1.18e-9)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" "unprognostic (3.28e-1)" "unprognostic (8.18e-2)" 0.1 0.0 0.1 0.1 0.1 5.3 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.3 0.1 0.0 0.1 112.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 2.9 0.0 0.6 39.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 7.8 0.9 0.2 5.3 0.9 12.7 0.0 1.2 0.0 7.9 0.1 0.0 0.4 4.0 0.0 0.0 93.5 0.2 1.1 0.4 0.5 0.0 379.7 0.3 20.6 0.0 7.4 6.9 5.7 0.0 0.5 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 1.8 0.0 0.7 0.7 2.0 0.5 0.1 2.5 0.5 0.6 TFRC "CD71, p90, TFR1" ENSG00000072274 "Transferrin receptor" P02786 3 196027183-196082189 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 110.0" "Cell type enhanced" "Detected in many" 10 "Erythroid cells: 560.6;Syncytiotrophoblasts: 420.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000153, HPA028598" Enhanced Supported Endosomes,Lysosomes "Secreted to blood" NA NA 1310000000 14000000 "Endosomes, Lysosomes" "CAB000153: AB_2533029, HPA028598: AB_10601599" "unprognostic (2.95e-2)" "prognostic unfavorable (3.67e-4)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" "unprognostic (6.75e-2)" "unprognostic (7.88e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (6.92e-2)" "unprognostic (3.30e-3)" "unprognostic (4.35e-2)" "unprognostic (1.34e-2)" "unprognostic (1.14e-2)" "unprognostic (3.63e-3)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (2.96e-4)" "unprognostic (2.62e-2)" 24.3 11.9 11.9 20.6 11.3 73.8 7.6 9.6 17.8 11.8 25.0 9.5 3.8 11.9 12.1 7.5 18.5 11.7 11.4 18.7 9.5 8.3 15.3 13.6 28.1 8.1 7.4 9.5 50.0 7.8 18.0 6.9 110.0 26.5 7.2 19.4 8.5 8.3 5.0 25.6 9.9 37.4 10.9 13.2 7.9 10.0 8.3 6.1 14.3 7.0 10.5 12.9 11.2 8.0 5.7 7.5 2.2 12.4 1.8 6.5 2.1 22.2 20.2 9.3 18.9 20.6 12.0 58.3 31.8 24.2 22.4 37.2 49.3 20.5 22.8 60.4 11.8 49.0 34.3 31.9 10.5 27.5 109.0 10.8 86.4 17.3 22.9 16.3 70.8 17.5 13.5 10.4 19.3 17.4 6.4 7.4 12.6 36.0 21.9 17.5 20.6 23.2 15.0 28.4 29.3 41.5 12.3 13.8 27.3 20.1 56.3 21.3 8.8 30.7 80.8 7.2 16.1 78.4 14.8 9.5 26.7 21.7 23.3 47.6 6.2 48.1 35.6 31.2 19.2 16.1 0.0 1.6 2.2 2.5 7.9 1.7 5.7 2.7 1.7 3.7 3.2 2.5 1.9 0.3 1.8 12.4 7.5 6.5 2.1 11.9 11.3 9.6 17.8 9.5 8.3 7.4 9.5 26.5 6.1 41.7 27.2 29.6 33.6 53.5 48.1 81.5 45.9 28.1 26.1 19.2 139.4 104.0 0.0 43.1 2.6 17.8 72.1 560.6 36.6 18.5 33.8 15.8 22.0 94.1 70.3 12.7 53.9 6.7 33.3 3.9 10.6 89.7 16.9 72.1 50.0 17.3 38.9 52.6 8.1 9.1 42.4 25.8 34.8 22.3 19.3 31.2 420.4 21.8 70.2 22.9 TGFA ENSG00000163235 "Transforming growth factor alpha" P01135 2 70447280-70554193 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 36.6;Pancreatic endocrine cells: 47.6;Urothelial cells: 56.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 6.3;eosinophil: 14.0;neutrophil: 14.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.7" "Cell line enhanced" "Detected in many" "A-431: 24.0;CAPAN-2: 29.7;HBEC3-KT: 25.9;OE19: 19.0;RPTEC TERT1: 26.1;U-87 MG: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042297 Approved Approved Vesicles "Secreted to blood" No No 57900 Vesicles "HPA042297: AB_10793878" "unprognostic (1.23e-1)" "unprognostic (1.06e-3)" "unprognostic (3.57e-3)" "unprognostic (6.39e-2)" "unprognostic (1.41e-1)" "unprognostic (8.49e-3)" "unprognostic (1.52e-1)" "unprognostic (3.00e-3)" "unprognostic (6.69e-2)" "unprognostic (9.21e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (7.74e-2)" "unprognostic (3.70e-2)" "unprognostic (1.60e-1)" "unprognostic (9.21e-2)" "prognostic favorable (1.52e-4)" "unprognostic (9.19e-2)" 2.0 0.5 8.4 4.3 10.7 1.2 6.2 3.5 7.9 5.7 9.4 21.4 0.3 7.4 1.2 2.8 23.8 5.7 14.6 0.8 10.7 6.9 12.4 4.0 3.5 4.2 10.9 5.2 0.5 12.0 1.0 0.8 1.7 9.4 2.2 7.3 9.7 6.3 1.2 0.4 10.8 13.7 1.3 22.5 5.1 7.6 2.3 12.8 0.2 7.4 17.4 12.1 5.4 10.8 0.0 0.6 14.7 0.4 0.2 2.7 0.4 24.0 3.8 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 29.7 0.0 15.3 0.1 4.1 12.9 0.2 25.9 0.0 0.0 0.6 0.0 0.6 2.0 0.0 0.3 0.0 0.0 10.4 0.0 10.2 1.2 0.0 1.9 0.0 0.1 0.0 0.9 0.0 0.5 0.4 19.0 7.3 0.0 0.1 6.3 26.1 9.3 0.2 0.0 2.0 0.0 0.0 0.0 3.3 0.2 0.2 0.1 1.8 0.0 5.3 0.1 0.1 0.0 24.6 0.8 8.9 6.3 0.4 14.0 1.0 0.1 2.7 0.0 0.6 0.6 0.6 0.0 0.3 0.2 14.7 0.2 0.0 0.0 0.0 0.4 8.4 10.7 3.5 7.9 10.7 6.9 10.9 5.2 9.4 12.8 6.0 2.4 0.0 6.5 14.3 1.4 1.4 28.1 12.0 6.8 24.4 0.0 0.0 1.7 36.6 14.8 1.2 14.9 0.0 8.8 0.0 0.5 11.0 5.7 1.5 3.0 0.0 1.2 0.0 2.2 1.4 0.3 3.1 0.0 30.7 5.8 8.6 47.6 8.5 0.0 6.1 0.7 0.0 0.9 0.0 0.2 21.8 0.0 2.2 4.7 56.3 TGFB2 ENSG00000092969 "Transforming growth factor beta 2" P61812 1 218346235-218444619 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Growth factor, Mitogen" "Aortic aneurysm, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 71.5;Muller glia cells: 97.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.3;naive B-cell: 2.6" "Lineage enriched" "Detected in single" 5 "B-cells: 2.6" "Cell line enhanced" "Detected in many" "EFO-21: 21.0;hTERT-RPE1: 56.1;U-2 OS: 20.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 4890000 "unprognostic (7.24e-2)" "unprognostic (7.23e-2)" "unprognostic (6.32e-2)" "unprognostic (2.45e-1)" "unprognostic (1.79e-1)" "unprognostic (3.86e-1)" "unprognostic (3.44e-2)" "unprognostic (1.99e-1)" "unprognostic (2.19e-2)" "unprognostic (2.35e-1)" "unprognostic (1.32e-2)" "unprognostic (1.31e-1)" "unprognostic (2.43e-2)" "unprognostic (2.64e-3)" "unprognostic (1.23e-1)" "unprognostic (4.90e-2)" "unprognostic (6.04e-2)" 2.9 2.6 13.4 3.2 11.4 0.8 7.0 5.2 13.7 12.3 5.2 10.0 7.0 1.6 10.8 7.5 3.6 6.9 3.9 9.5 13.3 6.7 2.9 1.6 12.4 1.6 5.9 9.9 8.1 3.5 4.3 6.3 20.1 10.2 27.8 2.1 11.6 16.9 18.7 6.9 3.8 1.8 8.5 19.0 4.4 2.8 2.1 8.2 0.0 4.8 2.8 1.9 5.2 7.4 2.6 0.5 0.0 0.0 0.0 0.1 0.0 1.3 7.0 0.6 5.5 1.6 0.8 0.0 1.0 0.1 11.2 8.0 1.8 16.9 0.0 21.0 0.0 9.3 3.6 0.4 0.9 11.6 0.0 0.1 0.0 0.6 0.0 17.4 0.0 0.0 0.7 1.9 1.5 5.9 56.1 3.0 0.0 0.0 0.0 10.6 0.1 0.0 0.0 0.5 0.0 0.6 0.0 3.1 0.0 3.6 0.0 0.1 0.0 11.6 1.4 0.2 15.1 1.0 0.4 13.0 7.9 20.8 6.5 10.6 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 11.4 5.2 13.7 13.3 6.7 5.9 9.9 10.2 8.2 71.5 4.6 0.0 5.8 7.7 6.2 3.0 12.7 12.0 14.8 5.2 0.0 0.3 0.0 30.1 16.2 3.5 0.0 0.0 15.1 10.2 15.5 11.6 1.1 0.0 1.2 1.6 0.0 3.1 0.6 22.2 7.5 1.7 11.8 1.8 0.0 97.9 15.5 0.0 13.1 0.3 2.0 0.0 22.4 0.2 0.4 2.5 0.5 0.0 0.0 2.0 TGFB3 "ARVD, ARVD1" ENSG00000119699 "Transforming growth factor beta 3" P10600 14 75958099-75982991 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Growth factor, Mitogen" "Cancer-related genes, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 31.7;Glandular cells: 27.5;Late spermatids: 36.7;Leydig cells: 25.0;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.8" "Lineage enhanced" "Detected in single" "T-cells: 1.8" "Group enriched" "Detected in many" 5 "SK-BR-3: 50.4;T-47d: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA063582 Approved Vesicles "Secreted to blood" NA NA 44800 Vesicles "HPA063582: AB_2685049" "unprognostic (7.84e-2)" "unprognostic (1.89e-1)" "unprognostic (4.32e-3)" "unprognostic (1.29e-1)" "unprognostic (3.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.24e-1)" "unprognostic (9.79e-2)" "unprognostic (2.83e-2)" "unprognostic (1.51e-2)" "unprognostic (5.63e-2)" "unprognostic (4.10e-1)" "prognostic unfavorable (4.01e-7)" "unprognostic (6.38e-3)" "unprognostic (1.10e-1)" "unprognostic (1.22e-2)" "unprognostic (3.27e-3)" 6.9 4.7 10.6 8.4 14.0 0.4 7.8 3.2 8.6 29.2 4.1 6.7 13.1 2.3 10.4 21.4 4.4 4.9 21.5 17.9 11.9 6.6 4.8 12.2 8.6 4.2 16.8 7.0 3.1 11.1 6.8 4.6 31.0 8.4 25.8 3.2 10.0 5.0 12.0 13.3 1.5 2.9 20.7 13.0 2.2 4.5 3.8 8.8 4.2 4.4 5.7 8.2 11.6 6.4 0.4 0.1 0.0 0.0 0.0 1.8 0.2 0.4 0.1 0.5 5.5 1.0 1.3 0.1 0.2 0.4 0.2 0.2 0.3 1.3 0.0 0.4 1.0 0.1 0.3 1.1 0.1 0.1 0.3 0.5 0.0 1.1 0.6 1.3 0.2 0.3 4.6 0.1 0.4 0.1 1.0 1.3 1.1 0.5 2.5 0.3 2.5 0.2 0.2 0.1 0.3 1.9 1.2 1.6 0.2 0.5 0.2 9.1 2.1 1.6 50.4 0.3 0.7 35.3 0.0 0.3 0.8 1.8 0.8 2.2 0.2 0.2 0.1 1.4 0.3 1.3 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.1 0.6 0.0 0.4 1.8 0.5 0.0 0.0 0.0 0.1 0.3 0.2 10.6 14.0 3.2 8.6 11.9 6.6 16.8 7.0 8.4 8.8 0.0 3.2 0.0 1.2 3.9 0.7 3.4 0.0 6.7 2.3 1.8 3.9 0.5 0.0 0.4 17.1 7.5 1.1 0.0 1.2 0.3 31.7 27.5 0.0 0.2 0.8 0.0 0.0 8.0 0.6 36.7 25.0 1.2 10.1 1.0 0.6 1.7 0.4 0.0 12.0 0.3 2.9 32.3 20.6 0.2 1.0 2.8 1.1 1.3 0.4 0.7 TGFBI "BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1" ENSG00000120708 "Transforming growth factor beta induced" Q15582 5 136028895-136063818 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Sensory transduction, Vision" "Amyloidosis, Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Hofbauer cells: 254.4;Kupffer cells: 259.4;Macrophages: 225.7;Pancreatic endocrine cells: 363.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "pons and medulla: 19.7" "Group enriched" "Detected in many" 30 "classical monocyte: 41.9;intermediate monocyte: 27.0;myeloid DC: 28.6;non-classical monocyte: 20.6;plasmacytoid DC: 61.2" "Group enriched" "Detected in many" 43 "dendritic cells: 61.2;monocytes: 41.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 157.9;GAMG: 129.4;HSkMC: 164.8;hTCEpi: 114.6;LHCN-M2: 131.0;U-2197: 114.5;U-87 MG: 219.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA008612, HPA017019" Enhanced "Secreted to blood" NA NA 1400000000 "HPA008612: AB_1857970, HPA017019: AB_2669511" "unprognostic (1.05e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (4.38e-3)" "prognostic favorable (1.17e-4)" "unprognostic (5.21e-3)" "unprognostic (5.53e-3)" "unprognostic (4.60e-2)" "unprognostic (8.71e-3)" "unprognostic (5.45e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (1.42e-3)" "unprognostic (2.26e-1)" "prognostic unfavorable (7.82e-10)" "unprognostic (8.81e-3)" "unprognostic (1.73e-2)" "unprognostic (3.42e-1)" "unprognostic (1.70e-3)" 51.3 16.6 1.8 30.4 3.9 4.3 32.2 1.1 6.5 14.1 24.2 5.2 16.2 9.2 30.2 71.9 21.1 15.2 94.9 53.0 4.1 2.9 21.7 47.5 42.5 65.1 3.7 2.4 27.0 10.5 3.3 23.7 90.0 19.7 27.0 16.9 21.8 21.1 13.1 24.1 63.8 22.4 56.5 10.1 41.6 21.2 18.2 2.1 21.2 12.0 40.1 18.8 46.3 24.4 0.2 61.2 0.9 41.9 1.2 0.3 15.1 5.7 23.6 0.0 0.2 66.7 22.0 0.0 17.6 2.2 12.1 7.3 10.6 74.2 0.0 10.8 157.9 129.4 28.5 0.0 56.7 10.8 0.1 0.0 0.0 28.3 28.6 44.6 0.0 0.2 164.8 114.6 4.5 5.1 43.6 10.3 0.0 0.0 0.2 131.0 0.2 0.0 0.0 0.7 0.2 0.0 0.0 1.2 0.1 5.7 0.5 0.0 0.0 27.8 0.9 0.2 24.0 0.2 6.3 43.5 82.5 3.5 114.5 62.9 0.0 0.0 0.0 219.3 0.0 62.9 0.2 41.9 0.1 0.1 27.0 0.2 0.2 0.2 0.3 28.6 0.0 0.0 0.2 0.9 1.2 20.6 61.2 0.1 15.1 1.8 3.9 1.1 3.0 4.1 2.9 3.7 2.4 19.7 2.1 3.0 25.0 13.3 3.2 106.1 0.1 6.4 7.6 4.0 9.1 1.8 0.0 6.6 0.0 39.9 1.8 14.7 0.0 23.3 98.6 5.6 70.4 0.9 4.7 21.2 254.4 1.6 3.4 32.5 259.4 1.3 9.5 225.7 47.2 8.2 2.0 0.0 363.6 0.0 2.1 1.6 0.2 25.8 143.8 0.2 0.8 48.7 16.2 2.5 0.4 2.0 TGFBR1 "ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI" ENSG00000106799 "Transforming growth factor beta receptor 1" P36897 9 99104038-99154192 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation, Growth regulation" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 114.1;Late spermatids: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 68.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002441, CAB031481, HPA056473" Uncertain Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: AB_2683144" "unprognostic (2.58e-3)" "unprognostic (1.20e-2)" "unprognostic (3.64e-3)" "unprognostic (2.80e-1)" "unprognostic (8.63e-2)" "unprognostic (3.36e-2)" "unprognostic (1.97e-2)" "unprognostic (1.32e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (8.21e-3)" "unprognostic (1.82e-1)" "unprognostic (1.18e-1)" "unprognostic (1.01e-3)" "unprognostic (3.40e-2)" "unprognostic (3.19e-2)" "unprognostic (1.14e-2)" 11.1 6.9 10.3 11.5 14.6 20.0 15.4 12.6 11.3 14.4 20.0 11.0 5.5 7.4 18.8 8.0 13.2 10.9 14.9 9.7 7.8 7.5 16.0 9.8 19.2 18.9 15.8 4.3 13.3 8.8 6.5 13.5 50.9 14.1 12.3 9.2 10.4 10.2 12.2 8.4 6.6 11.0 28.6 17.9 13.9 25.5 11.4 12.4 10.8 7.7 8.1 11.5 13.0 10.2 1.6 2.0 13.1 2.4 4.0 8.3 1.9 3.4 5.2 31.4 9.7 7.3 5.4 4.7 11.7 12.9 11.0 12.3 5.2 2.5 7.6 3.6 9.1 8.7 8.1 10.6 9.1 14.8 19.9 3.3 11.4 5.7 4.6 12.1 7.0 27.9 11.2 9.8 17.1 8.1 6.9 1.9 2.9 15.8 3.2 15.0 5.3 1.0 8.0 6.7 3.2 3.1 2.8 68.5 3.2 2.7 0.8 8.5 9.9 9.1 40.7 12.2 13.5 7.5 9.6 3.6 8.2 7.1 35.0 7.1 3.3 3.3 5.2 17.2 12.1 7.0 13.1 2.4 9.1 8.3 1.6 7.2 1.6 3.6 6.1 2.0 1.3 3.5 6.7 4.9 4.0 1.9 1.4 2.2 1.9 10.3 14.6 12.6 11.3 7.8 7.5 15.8 4.3 14.1 12.4 6.0 9.1 9.3 6.5 20.9 7.2 6.3 5.1 1.4 10.3 57.6 0.0 17.0 0.0 14.1 114.1 14.5 3.3 23.3 27.1 5.9 46.2 13.4 29.9 11.5 43.1 0.0 9.2 8.0 20.9 74.1 8.9 36.3 33.7 19.0 6.6 2.9 25.9 3.5 12.7 12.2 1.6 32.3 22.2 8.0 10.5 14.2 16.2 11.5 7.2 8.4 TGFBR2 "MFS2, TBR-ii, TBRII" ENSG00000163513 "Transforming growth factor beta receptor 2" P37173 3 30606502-30694142 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Apoptosis, Differentiation, Growth regulation" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease mutation, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Endothelial cells: 188.8;Ito cells: 564.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 54.5;ASC TERT1: 82.2;HSkMC: 70.9;LHCN-M2: 67.2;TIME: 61.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB073537 Supported "Plasma membrane" NA NA 560000 "Plasma membrane" "CAB073537: " "unprognostic (1.74e-1)" "unprognostic (1.84e-2)" "unprognostic (3.70e-1)" "unprognostic (3.02e-2)" "unprognostic (1.92e-1)" "unprognostic (2.26e-1)" "unprognostic (1.96e-1)" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (2.24e-2)" "unprognostic (7.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.65e-2)" "unprognostic (4.72e-2)" "unprognostic (1.81e-2)" "unprognostic (8.81e-2)" "unprognostic (8.02e-2)" 91.8 24.6 6.7 24.6 10.3 7.3 88.3 3.6 7.3 36.5 42.6 9.8 18.6 13.2 42.6 23.3 36.2 28.4 42.6 73.5 6.9 5.2 32.6 21.9 52.6 75.7 12.6 3.7 22.2 26.0 17.4 10.3 24.2 9.9 35.2 17.5 27.9 22.5 19.5 34.9 17.0 31.3 37.2 12.0 68.7 26.8 15.4 8.2 19.3 40.9 16.8 26.9 48.0 82.0 5.3 6.8 20.0 6.6 1.4 19.7 3.9 2.5 14.7 0.9 0.0 54.5 82.2 2.5 12.8 18.0 4.4 4.4 3.3 13.6 0.3 46.2 17.1 5.2 5.1 0.6 18.7 7.3 1.0 1.3 1.4 1.7 16.5 23.3 2.3 12.1 70.9 16.6 19.0 18.4 20.2 47.6 1.7 0.3 0.0 67.2 0.2 2.3 1.7 0.4 12.8 5.9 2.1 5.9 0.3 23.6 6.0 0.0 0.9 3.8 1.0 3.6 1.2 0.0 2.5 61.6 21.7 5.4 9.8 4.8 0.5 0.0 2.0 13.0 2.5 8.7 6.9 2.9 20.0 3.5 3.0 3.2 4.0 5.4 4.2 2.6 5.3 19.7 9.1 12.6 1.4 6.6 6.8 1.2 3.9 6.7 10.3 3.6 7.3 6.9 5.2 12.6 3.7 9.9 8.2 134.0 83.8 41.5 14.2 33.2 1.9 64.1 48.4 12.0 53.4 26.2 0.0 5.3 3.3 11.4 2.0 188.8 9.7 0.0 13.8 4.3 48.1 7.3 28.9 45.3 27.1 0.0 8.1 564.1 139.2 2.0 30.5 46.1 28.7 1.8 11.9 0.2 25.3 10.8 44.6 5.6 0.9 32.3 36.0 0.3 1.1 26.7 3.1 39.4 13.0 9.0 TGFBR3 "betaglycan, BGCAN" ENSG00000069702 "Transforming growth factor beta receptor 3" Q03167 1 91680343-91906335 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Fibroblasts: 105.0;Ito cells: 311.2;Leydig cells: 135.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 21.3;MAIT T-cell: 11.6;memory CD4 T-cell: 5.4;memory CD8 T-cell: 11.4;naive CD8 T-cell: 8.0;NK-cell: 9.0" "Group enriched" "Detected in many" 22 "NK-cells: 9.0;T-cells: 21.3" "Cell line enhanced" "Detected in many" "ASC diff: 67.2;ASC TERT1: 32.8;U-2197: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008257, CAB018971" Supported Approved Cytosol "Secreted to blood" NA NA 29000000 Cytosol "CAB018971: , HPA008257: AB_1080258" "unprognostic (7.57e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.36e-4)" "unprognostic (9.39e-3)" "prognostic favorable (4.84e-4)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (1.79e-1)" "unprognostic (9.32e-2)" "unprognostic (1.07e-1)" "prognostic favorable (4.99e-4)" "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (1.08e-2)" 40.1 15.9 3.2 6.8 3.1 1.6 63.5 1.8 4.4 30.1 15.2 3.5 30.0 3.4 17.6 21.0 22.2 17.6 23.3 16.3 3.9 1.9 12.5 11.9 18.4 18.1 2.6 2.0 62.4 8.9 4.4 4.4 25.1 4.5 21.7 5.6 8.8 14.7 46.5 19.2 13.4 9.8 34.4 4.1 27.1 11.1 14.0 3.0 1.1 7.5 6.5 3.1 39.2 42.1 0.0 0.6 0.6 0.6 9.0 21.3 3.9 2.7 2.7 4.1 0.7 67.2 32.8 13.0 2.0 10.2 2.4 2.9 1.2 0.4 0.0 0.5 3.7 1.9 0.4 1.0 0.3 1.8 9.5 2.2 0.0 3.4 11.3 1.4 0.1 0.0 7.9 1.3 5.2 1.2 0.3 1.2 0.0 6.5 0.2 0.7 0.0 0.0 0.0 1.7 1.2 0.9 0.1 1.4 0.5 0.9 16.4 0.1 0.0 1.0 0.0 5.7 1.7 0.3 1.0 3.6 4.0 1.0 22.8 0.4 10.1 0.9 0.0 0.8 0.5 0.5 0.6 0.0 0.0 21.3 0.1 11.6 0.0 5.4 11.4 0.0 0.0 1.7 8.0 0.3 9.0 0.6 0.6 2.4 3.9 3.2 3.1 1.8 4.4 3.9 1.9 2.6 2.0 4.5 3.0 8.9 11.9 3.0 10.4 33.4 0.2 17.3 28.1 6.7 6.8 29.6 2.0 23.5 3.3 1.7 48.3 64.2 0.7 23.3 4.2 9.3 105.0 7.3 2.3 17.8 9.7 0.0 23.1 311.2 19.6 18.5 135.4 3.8 33.7 0.0 0.5 2.2 3.5 0.0 70.0 15.9 0.2 12.9 35.4 0.7 1.7 29.7 48.5 30.5 2.3 5.4 TGFBR3L ENSG00000260001 "Transforming growth factor beta receptor 3 like" H3BV60 19 7916145-7919097 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pituitary gland: 56.6" "Cell type enhanced" "Detected in many" 10 "Sertoli cells: 12.9;T-cells: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 8 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "PC-3: 5.7;REH: 13.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA074356 Enhanced Approved Vesicles NA NA Vesicles "HPA074356: AB_2686681" "unprognostic (1.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (2.63e-1)" "unprognostic (7.65e-2)" "unprognostic (9.51e-3)" "unprognostic (1.09e-1)" "unprognostic (6.96e-2)" "unprognostic (3.41e-2)" "unprognostic (2.81e-1)" "unprognostic (2.04e-1)" "unprognostic (3.50e-3)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (1.06e-1)" "unprognostic (8.62e-3)" 0.3 2.0 1.6 0.2 2.8 0.6 0.3 1.9 6.4 5.0 0.6 0.0 0.3 6.0 2.8 0.5 0.3 0.7 0.2 2.1 0.7 0.8 3.7 4.0 0.3 0.1 0.5 1.7 0.3 0.3 0.9 56.6 0.4 1.9 2.5 0.1 0.6 0.8 0.7 0.3 0.5 5.7 2.0 0.6 0.3 0.4 0.5 0.0 0.0 0.3 0.0 0.1 1.1 0.8 0.1 0.3 0.0 0.1 0.0 2.9 0.1 0.1 0.2 0.1 0.5 0.1 0.0 3.3 2.7 0.0 0.2 0.0 0.5 0.0 0.1 3.0 0.1 0.0 2.0 0.0 0.0 0.0 3.4 1.1 0.5 0.2 0.6 0.2 1.7 0.4 0.2 0.1 0.0 0.0 0.3 0.0 3.0 0.7 0.5 0.0 1.5 1.2 0.2 0.6 0.2 5.7 13.8 0.0 3.1 0.2 0.0 1.0 2.5 0.3 0.0 0.7 0.0 0.9 0.6 0.2 1.8 2.9 2.0 0.9 0.8 0.9 0.8 0.4 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.6 0.1 0.9 1.9 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.3 0.0 0.1 1.6 2.8 1.9 6.4 0.7 0.8 0.5 1.7 1.9 0.0 0.0 0.0 0.8 3.2 1.3 1.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.5 0.0 0.0 0.0 0.2 0.5 1.7 0.6 0.0 2.8 0.2 0.0 0.0 2.5 0.0 3.3 1.1 0.5 5.0 0.0 0.0 2.7 0.4 0.0 1.1 4.4 2.4 12.9 4.2 0.2 0.9 1.3 0.3 6.9 0.0 0.4 TGIF2-C20orf24 ENSG00000259399 "TGIF2-C20orf24 readthrough" 20 36574553-36612384 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 22.1" "Cell type enriched" "Detected in single" 11 "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.38e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (5.58e-2)" "unprognostic (2.62e-2)" "unprognostic (1.94e-1)" "unprognostic (7.39e-2)" "unprognostic (2.22e-2)" "unprognostic (6.57e-3)" "unprognostic (3.97e-2)" "unprognostic (2.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.46e-2)" "unprognostic (2.69e-1)" "unprognostic (2.93e-1)" "unprognostic (3.70e-2)" "unprognostic (1.07e-1)" 2.1 1.4 1.9 8.5 1.9 4.9 2.3 0.9 3.1 3.1 2.1 1.7 0.6 2.1 4.1 2.6 1.4 4.2 1.7 2.2 1.4 1.1 2.0 5.3 2.2 1.8 2.5 1.7 3.8 22.1 3.1 1.3 2.7 1.9 1.9 1.5 2.0 3.2 2.2 2.7 1.5 1.6 4.7 1.6 3.0 1.4 6.1 1.3 4.1 4.0 1.4 5.7 1.3 2.8 3.4 3.6 2.8 2.2 1.9 3.3 0.9 3.7 1.6 20.9 10.5 3.1 1.6 1.5 0.7 4.8 7.3 5.6 8.9 7.8 1.7 2.1 4.3 3.1 1.6 17.7 2.6 11.1 4.8 2.1 4.6 5.4 10.1 1.5 5.4 1.1 1.2 2.9 3.9 7.3 9.3 4.9 9.8 1.3 10.7 1.9 9.4 12.4 2.9 4.4 4.1 0.4 9.3 2.1 7.6 2.9 4.5 2.6 7.0 1.2 9.3 5.3 3.7 8.3 14.9 1.3 2.7 0.9 0.2 2.8 2.4 1.2 6.9 0.2 6.2 4.4 0.0 1.9 0.0 2.6 2.2 2.4 3.4 0.6 0.5 3.6 3.4 3.2 3.3 2.8 1.9 0.4 2.6 0.5 0.9 1.9 1.9 0.9 3.1 1.4 1.1 2.5 1.7 1.9 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TGOLN2 "TGN38, TGN46, TGN48, TGN51, TTGN2" ENSG00000152291 "Trans-golgi network protein 2" O43493 2 85318020-85328425 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB011489, HPA012609, HPA012723" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" NA NA 9800000 "Golgi apparatus" Nucleoplasm "CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975" "unprognostic (3.03e-2)" "unprognostic (1.82e-2)" "unprognostic (2.35e-1)" "unprognostic (4.39e-2)" "unprognostic (3.90e-2)" "unprognostic (2.66e-1)" "unprognostic (5.50e-3)" "unprognostic (2.49e-1)" "unprognostic (2.98e-1)" "unprognostic (1.52e-2)" "unprognostic (5.19e-2)" "unprognostic (2.72e-2)" "unprognostic (6.30e-2)" "unprognostic (2.83e-2)" "unprognostic (3.22e-2)" "unprognostic (2.04e-2)" "unprognostic (5.37e-2)" 40.0 40.7 34.3 38.4 38.0 55.6 36.5 51.7 43.1 33.3 50.0 38.7 31.5 53.2 41.2 31.1 23.9 33.3 44.9 43.2 31.9 34.4 59.6 66.2 44.1 37.4 35.4 36.7 36.1 34.4 39.5 21.8 50.4 35.8 34.0 50.1 26.9 38.9 36.5 23.7 23.7 63.1 36.0 40.3 47.1 36.8 22.3 33.2 31.8 44.8 17.0 37.7 39.9 32.9 9.4 14.9 34.2 34.1 8.6 12.3 22.7 11.3 29.4 12.5 16.5 30.2 31.7 29.2 34.6 40.4 23.5 18.9 24.5 34.5 14.3 27.4 47.8 32.3 18.6 9.0 16.9 39.1 23.3 9.0 20.4 10.4 26.3 16.4 39.5 47.4 23.4 10.8 30.4 18.4 36.6 34.0 12.1 11.8 23.5 34.7 10.3 12.7 20.1 11.1 25.4 12.0 13.5 46.0 10.5 25.3 17.9 11.8 9.8 30.2 22.8 20.0 15.4 12.7 17.8 36.0 50.5 18.8 38.1 41.4 15.3 19.7 13.9 37.4 30.7 32.9 17.6 27.5 23.5 12.3 26.9 9.6 9.4 9.2 8.3 14.9 9.1 9.6 9.1 34.2 8.6 34.1 5.6 7.2 22.7 34.3 38.0 51.7 43.1 31.9 34.4 35.4 36.7 35.8 33.2 95.3 89.8 56.6 49.3 34.0 49.1 62.0 180.9 111.1 77.3 171.0 37.3 50.3 8.3 79.9 4.7 71.6 170.0 0.0 81.2 69.6 67.3 78.0 151.6 221.1 103.3 197.0 86.0 81.6 146.0 5.6 45.8 116.6 57.3 39.7 94.6 52.5 79.1 98.9 65.0 89.4 34.5 64.7 48.7 22.3 32.7 30.6 37.3 74.8 88.0 60.7 THADA "ARMC13, FLJ21877, GITA, KIAA1767" ENSG00000115970 "THADA, armadillo repeat containing" Q6YHU6 2 43230836-43596046 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035191, HPA035192" Uncertain Approved Cytosol NA NA Cytosol "HPA035191: AB_10670290, HPA035192: AB_2674512" "unprognostic (1.20e-1)" "unprognostic (2.95e-1)" "unprognostic (2.07e-1)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (4.26e-1)" "prognostic unfavorable (6.48e-4)" "unprognostic (8.27e-2)" "unprognostic (9.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (4.38e-2)" "unprognostic (1.12e-1)" "unprognostic (3.43e-2)" "unprognostic (5.25e-2)" "unprognostic (2.14e-1)" 15.7 12.5 8.6 14.2 11.9 12.0 15.8 8.8 10.6 15.0 10.6 13.8 20.2 6.6 25.3 16.8 12.8 15.8 9.7 11.8 7.5 7.1 12.6 18.5 13.5 20.0 10.9 6.1 15.8 17.1 27.2 29.9 9.6 10.9 16.4 10.1 12.7 17.7 12.6 12.7 16.2 11.7 12.4 11.4 17.2 11.1 12.3 10.0 23.1 17.9 12.3 23.3 12.6 19.4 4.9 5.2 14.7 4.7 6.5 5.4 2.6 13.1 15.8 7.2 0.2 19.5 16.9 10.4 8.8 7.3 8.4 7.2 9.2 7.9 12.1 15.2 10.5 11.4 12.3 11.1 15.1 14.5 10.0 11.0 8.6 6.3 12.2 6.8 13.3 7.0 11.0 13.8 17.6 23.1 8.8 11.3 4.5 15.3 6.5 10.1 16.5 13.1 14.9 14.4 19.0 9.0 6.1 13.0 9.1 13.2 11.8 9.5 14.8 8.4 8.2 7.9 8.7 8.4 7.0 9.6 13.9 10.2 10.5 15.9 16.5 10.2 13.7 11.2 13.3 11.1 14.7 3.3 1.4 4.5 4.7 4.8 4.8 5.0 5.4 5.2 4.9 4.7 5.3 2.6 6.5 3.4 4.1 5.3 2.6 8.6 11.9 8.8 10.6 7.5 7.1 10.9 6.1 10.9 10.0 17.9 11.8 7.9 15.9 7.6 11.6 7.5 17.8 18.7 14.8 14.0 15.7 6.6 1.7 7.8 16.4 7.1 3.3 0.0 8.4 4.7 8.7 10.7 5.8 14.0 8.8 3.2 7.0 11.6 5.7 7.4 9.2 8.6 3.3 5.4 4.5 6.7 5.9 6.2 8.1 5.4 24.9 0.0 7.5 20.2 12.8 3.9 4.0 7.5 5.6 6.9 THAP6 MGC30052 ENSG00000174796 "THAP domain containing 6" Q8TBB0 4 75513946-75550473 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 108.2;Spermatocytes: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035767 Uncertain Approved Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA035767: AB_10696510" "unprognostic (9.62e-2)" "unprognostic (2.25e-1)" "unprognostic (2.44e-2)" "unprognostic (1.45e-1)" "unprognostic (2.52e-1)" "unprognostic (6.89e-2)" "unprognostic (8.96e-2)" "unprognostic (3.37e-3)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (1.92e-2)" "unprognostic (1.06e-1)" "unprognostic (9.93e-3)" "unprognostic (1.08e-1)" "unprognostic (3.47e-2)" "unprognostic (8.54e-2)" "unprognostic (2.38e-2)" 15.7 14.9 11.5 18.7 17.6 14.4 18.6 21.2 17.0 18.4 17.0 24.4 16.5 14.9 20.2 23.8 15.5 15.6 13.5 17.2 12.0 11.9 17.8 21.9 13.1 17.9 21.9 14.0 19.3 14.9 19.9 30.9 24.3 17.8 18.3 14.5 17.3 17.0 13.3 20.3 20.8 21.1 18.8 19.2 17.8 13.1 26.5 21.3 18.0 20.4 16.9 15.2 16.5 14.3 10.7 7.1 18.5 8.7 6.8 13.6 6.5 6.9 5.0 11.1 7.7 12.7 12.5 6.3 16.6 8.6 8.7 9.1 6.3 17.4 10.1 8.6 5.4 9.8 7.4 9.9 7.9 10.7 11.5 6.9 7.3 8.2 8.0 17.5 9.8 8.3 10.5 13.8 9.9 15.4 14.0 4.7 12.1 12.6 20.9 9.2 8.1 8.9 6.7 6.3 9.7 5.1 8.7 12.2 7.0 8.1 5.9 8.5 8.8 7.8 10.7 9.2 9.7 11.6 8.2 5.7 14.9 9.9 17.2 8.5 18.7 9.2 9.6 10.4 7.9 12.5 14.6 8.7 12.2 9.8 7.5 13.0 8.9 11.9 9.2 7.1 10.7 13.6 10.4 18.5 6.8 8.0 5.9 13.0 6.5 11.5 17.6 21.2 16.5 12.0 11.9 21.9 14.0 17.8 21.3 11.9 8.3 14.8 14.8 7.3 20.4 15.1 10.2 22.7 9.1 21.0 29.5 8.4 13.3 7.2 108.2 7.9 9.3 0.0 5.6 7.9 10.4 10.1 10.4 8.5 6.5 15.9 12.1 8.6 13.9 18.2 13.0 10.9 6.8 6.4 10.3 14.3 6.5 7.8 10.6 10.2 17.2 0.0 9.9 56.5 15.1 5.9 6.4 10.1 7.4 6.4 THBD CD141 ENSG00000178726 Thrombomodulin P07204 20 23045633-23049741 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease mutation, Hemolytic uremic syndrome, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Endothelial cells: 100.4;Leydig cells: 121.1;Peritubular cells: 243.6;Suprabasal keratinocytes: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 17.7" "Group enriched" "Detected in many" 7 "dendritic cells: 7.8;granulocytes: 17.7;monocytes: 6.2" "Cell line enhanced" "Detected in many" "ASC diff: 12.8;CAPAN-2: 19.9;EFO-21: 17.3;HaCaT: 16.7;hTCEpi: 22.0;hTERT-RPE1: 11.9;OE19: 14.8;THP-1: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002425, HPA002982" Supported Approved Nucleoplasm,Cytosol NA NA 5550000 690000 "Nucleoplasm, Cytosol" "CAB002425: AB_563497, HPA002982: AB_1078444" "unprognostic (1.96e-1)" "unprognostic (2.93e-3)" "unprognostic (8.70e-2)" "unprognostic (3.00e-2)" "unprognostic (3.07e-2)" "unprognostic (1.88e-1)" "unprognostic (7.81e-3)" "unprognostic (4.70e-2)" "unprognostic (1.38e-1)" "unprognostic (1.52e-2)" "unprognostic (2.30e-1)" "unprognostic (5.33e-2)" "unprognostic (2.23e-2)" "unprognostic (7.35e-3)" "unprognostic (3.01e-2)" "unprognostic (7.58e-3)" "unprognostic (9.71e-2)" 27.0 6.3 1.4 10.5 6.7 6.9 11.8 1.2 2.7 13.2 14.4 1.4 4.3 2.9 9.7 11.5 21.7 15.8 18.2 24.3 5.0 1.5 7.0 10.0 61.9 26.8 2.5 0.1 10.2 7.2 10.0 10.9 16.4 6.2 6.1 3.3 8.8 6.0 4.2 55.5 32.4 14.1 8.5 7.7 44.4 14.4 15.8 2.4 2.1 18.3 32.2 10.4 14.2 10.4 0.0 7.8 17.7 6.2 1.5 0.0 1.1 5.6 5.0 0.1 0.0 12.8 0.7 0.1 0.1 0.0 0.0 0.0 0.0 19.9 0.0 17.3 1.7 0.8 16.7 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 2.4 0.0 0.1 0.5 22.0 0.3 1.4 11.9 5.6 0.0 2.1 0.0 0.5 0.4 0.0 2.0 0.0 14.8 0.8 0.0 0.0 2.4 0.1 8.1 0.3 0.0 4.7 0.6 8.6 1.6 0.0 12.3 10.9 0.0 0.3 1.6 0.0 0.0 0.0 0.0 1.0 2.9 0.4 0.0 2.8 0.0 0.0 6.2 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 17.7 1.5 5.8 7.8 0.0 1.1 1.4 6.7 1.2 2.7 5.0 1.5 2.5 0.1 6.2 2.4 20.8 30.8 2.2 6.9 30.5 0.0 9.0 0.0 2.7 18.2 0.0 0.0 2.5 0.0 1.4 0.7 100.4 0.0 0.0 0.2 35.7 22.8 3.0 7.0 0.8 14.1 0.0 0.0 52.2 38.0 4.5 121.1 62.8 15.1 1.0 0.0 0.0 5.3 0.0 243.6 0.2 0.0 6.5 63.8 0.2 0.9 86.2 35.5 0.0 0.0 32.5 THEM6 "C8orf55, DSCD75" ENSG00000130193 "Thioesterase superfamily member 6" Q8WUY1 8 142727203-142736927 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 28.9;RT4: 40.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023255 Uncertain Approved "Nuclear speckles,Cytosol" "Secreted - unknown location" NA NA "Nuclear speckles, Cytosol" "HPA023255: AB_1845782" "unprognostic (6.20e-3)" "unprognostic (2.21e-1)" "unprognostic (9.10e-2)" "unprognostic (5.33e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-2)" "unprognostic (1.74e-2)" "unprognostic (6.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.44e-1)" "unprognostic (4.91e-2)" "unprognostic (6.76e-2)" "prognostic favorable (6.66e-7)" "unprognostic (7.02e-3)" "unprognostic (3.55e-2)" "unprognostic (2.39e-2)" "prognostic favorable (4.49e-4)" 11.9 13.9 9.4 5.6 13.4 6.0 21.6 9.0 20.7 10.8 11.8 12.8 16.6 14.4 5.6 7.1 14.9 12.5 15.0 12.6 10.7 11.5 16.7 35.2 11.0 7.4 8.8 11.7 4.5 30.7 13.4 10.0 10.7 11.6 9.8 6.7 10.0 18.5 15.3 11.3 11.7 14.3 4.8 9.3 8.7 15.1 3.0 7.5 10.3 14.4 15.6 10.6 19.7 7.9 6.5 3.8 4.5 7.4 8.4 14.6 7.5 9.9 8.3 1.2 8.7 4.1 1.4 6.1 5.1 4.3 7.9 5.5 5.0 15.0 4.2 11.8 1.9 2.9 23.2 3.7 11.1 1.3 3.4 10.2 3.2 4.7 10.1 4.5 1.8 3.4 2.0 4.0 1.5 2.2 1.6 6.7 6.0 1.5 2.1 1.3 28.9 7.5 0.4 2.0 18.7 27.1 8.8 0.9 9.6 9.4 40.7 19.6 7.7 7.9 23.7 6.5 1.2 11.6 1.5 3.8 3.4 2.5 9.8 0.9 1.4 1.9 1.8 3.5 9.1 4.2 4.5 4.0 2.0 9.7 7.4 14.6 4.6 10.3 12.5 3.8 6.5 12.5 11.5 0.5 8.4 7.1 2.9 9.1 7.5 9.4 13.4 9.0 20.7 10.7 11.5 8.8 11.7 11.6 7.5 8.9 4.3 2.7 7.4 3.2 9.8 5.3 12.7 0.0 3.4 17.4 5.9 12.1 5.0 10.2 1.7 8.1 19.3 0.0 10.2 9.4 4.1 8.0 0.0 18.1 10.2 15.9 30.6 11.6 1.2 12.4 2.6 2.6 5.0 1.8 12.9 14.6 8.4 3.5 3.9 12.3 11.5 0.0 4.2 2.3 7.2 6.8 2.9 8.5 20.4 21.1 THOC1 "HPR1, P84" ENSG00000079134 "THO complex 1" Q96FV9 18 214520-268050 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019096, HPA019687" Enhanced Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA019096: AB_1857979, HPA019687: AB_1857980" "prognostic favorable (8.43e-4)" "unprognostic (2.06e-3)" "unprognostic (1.84e-1)" "unprognostic (3.69e-2)" "unprognostic (8.75e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.83e-5)" "unprognostic (6.74e-3)" "unprognostic (2.49e-3)" "prognostic favorable (2.89e-5)" "unprognostic (3.60e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (1.80e-6)" "unprognostic (2.03e-1)" "unprognostic (2.24e-1)" "unprognostic (3.42e-1)" "prognostic favorable (9.62e-4)" 11.9 9.1 11.8 12.5 14.5 10.7 7.7 19.0 12.5 10.5 10.7 12.3 10.9 10.4 15.5 8.1 13.4 8.2 7.7 8.5 10.9 9.9 11.6 16.5 7.1 17.6 18.1 7.6 9.9 8.1 11.1 23.3 9.6 11.5 8.4 8.7 8.9 10.4 7.6 12.1 9.1 9.4 10.8 14.2 12.8 9.6 26.3 17.7 16.2 9.2 7.8 17.8 14.6 7.8 11.7 11.0 9.1 9.7 9.7 14.2 6.4 12.7 6.9 16.1 13.5 10.2 7.4 20.0 7.0 7.0 15.3 16.0 14.2 8.3 18.2 5.9 9.8 23.0 8.4 20.8 11.7 18.9 5.8 9.0 11.0 9.1 9.5 8.1 25.0 10.2 4.9 7.2 16.3 10.6 6.6 16.3 16.0 24.9 8.7 13.2 9.6 18.2 14.2 15.9 16.5 10.2 25.6 15.5 16.6 8.4 12.5 10.9 8.2 19.7 10.2 11.7 19.2 6.9 17.8 8.2 13.7 14.7 10.9 23.2 7.1 12.2 26.7 11.6 17.3 11.7 9.1 6.7 5.7 9.5 9.7 14.2 11.7 11.6 12.0 11.0 9.5 13.6 13.3 0.7 9.7 7.8 6.5 11.4 6.4 11.8 14.5 19.0 12.5 10.9 9.9 18.1 7.6 11.5 17.7 17.9 9.4 6.2 13.1 11.4 30.6 7.8 2.5 9.4 18.2 10.4 19.6 20.5 13.3 14.2 47.4 13.4 4.5 0.0 7.0 13.3 10.4 10.2 26.5 10.5 13.7 27.0 9.1 7.4 6.3 5.6 17.8 13.1 3.3 10.8 7.1 13.8 10.7 8.7 15.9 6.8 25.5 6.5 11.3 57.7 26.8 8.0 15.7 17.9 13.2 10.8 THSD1 TMTSP ENSG00000136114 "Thrombospondin type 1 domain containing 1" Q9NS62 13 52377167-52406494 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 26.3;Ito cells: 12.9;Spermatocytes: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 12.3;HBEC3-KT: 12.3;hTCEpi: 12.3;hTERT-HME1: 12.6;HUVEC TERT2: 25.6;LHCN-M2: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012611, CAB020796" Uncertain Supported Cytosol "Intracellular and membrane" No No 810000 Cytosol "CAB020796: , HPA012611: AB_1857990" "unprognostic (1.21e-1)" "unprognostic (7.54e-3)" "unprognostic (3.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.31e-1)" "unprognostic (1.54e-2)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (8.87e-2)" "unprognostic (3.35e-1)" "unprognostic (6.10e-3)" "unprognostic (1.55e-1)" "unprognostic (3.05e-3)" "unprognostic (8.44e-2)" "unprognostic (1.31e-1)" "unprognostic (3.35e-2)" "unprognostic (4.90e-2)" 9.7 1.8 8.3 1.8 7.2 0.4 11.1 2.9 6.4 7.6 2.6 1.9 3.6 1.2 6.8 4.9 4.4 5.7 4.9 9.0 8.1 2.2 2.0 2.1 19.8 4.7 2.2 4.6 2.3 1.2 2.5 3.4 16.8 2.1 8.5 2.3 5.5 3.9 3.2 9.7 6.0 2.3 7.4 2.2 6.6 1.9 2.7 1.1 0.7 5.2 5.2 2.5 5.9 4.5 0.3 0.0 0.0 0.0 0.4 0.7 0.0 0.5 2.4 0.2 2.2 2.0 6.7 0.5 5.2 2.6 2.0 3.3 0.0 0.3 0.2 0.6 12.3 2.0 2.7 0.0 12.3 3.2 5.7 1.8 0.3 0.0 0.0 1.2 1.2 0.3 2.6 12.3 9.9 12.6 1.1 25.6 0.7 0.0 0.1 11.7 0.0 0.4 0.2 0.1 0.1 0.5 0.3 2.7 0.0 2.8 0.1 0.0 0.4 0.1 0.0 0.4 0.1 0.2 0.2 5.9 0.6 1.1 0.0 3.8 0.4 0.0 0.0 1.1 0.4 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.5 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.3 7.2 2.9 6.4 8.1 2.2 2.2 4.6 2.1 1.1 0.0 1.4 1.4 0.9 1.3 0.8 2.7 0.0 0.0 1.2 1.8 2.0 4.2 3.3 0.2 0.8 26.3 0.0 0.0 0.6 1.5 2.7 1.3 0.0 1.6 2.4 0.0 0.0 12.9 2.6 0.0 3.1 0.7 5.0 0.0 0.2 1.2 0.2 0.0 3.5 0.8 2.8 6.5 1.9 19.1 9.1 1.4 2.9 1.9 0.4 0.3 THSD4 "ADAMTSL6, FLJ13710, FVSY9334, PRO34005" ENSG00000187720 "Thrombospondin type 1 domain containing 4" Q6ZMP0 15 71096952-71783383 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 60.5" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 104.8;Cardiomyocytes: 53.7;Glandular cells: 73.8;Peritubular cells: 70.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 19.3;ASC TERT1: 18.1;BJ hTERT+: 23.0;T-47d: 18.8;TIME: 28.5;U-2197: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted - unknown location" NA NA "unprognostic (1.59e-1)" "unprognostic (4.38e-2)" "unprognostic (3.14e-2)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (2.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.14e-1)" "unprognostic (7.80e-2)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (9.67e-2)" "unprognostic (1.43e-1)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-2)" "unprognostic (3.01e-3)" 2.4 4.6 1.5 3.6 2.7 0.2 8.5 1.4 3.0 60.5 8.7 2.4 5.1 4.3 19.9 12.8 36.9 20.3 18.7 17.4 2.1 2.0 5.1 3.3 5.0 2.3 2.7 4.2 8.0 8.7 1.2 4.5 12.4 5.3 19.0 4.0 29.7 6.5 8.8 1.6 4.4 8.4 10.6 6.4 1.2 6.2 3.9 1.4 0.0 6.6 13.3 5.3 7.2 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 19.3 0.3 5.6 3.0 18.1 0.0 9.4 23.0 4.9 2.5 0.1 3.7 0.0 7.8 3.3 17.0 7.2 0.7 3.9 3.0 0.8 0.8 0.0 2.0 0.0 1.9 0.0 0.0 1.3 2.9 2.9 11.8 13.4 8.9 0.0 0.0 0.2 4.0 3.8 0.0 0.0 1.7 0.0 3.4 0.0 0.3 0.3 13.0 2.6 0.3 2.4 3.7 4.7 0.0 2.3 18.8 0.0 28.5 0.1 0.4 19.4 5.0 0.0 0.1 0.0 4.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.7 1.4 3.0 2.1 2.0 2.7 4.2 5.3 1.4 17.9 7.0 0.0 104.8 12.4 2.6 53.7 45.9 13.4 5.7 5.2 5.9 0.3 1.7 16.1 6.1 11.9 10.5 0.0 1.6 0.2 10.3 73.8 0.0 10.6 0.2 0.0 2.9 6.7 0.0 11.4 16.1 0.9 8.5 0.0 3.6 0.0 8.6 5.8 70.0 0.3 0.8 0.0 3.8 1.0 1.5 9.5 0.7 0.0 10.9 25.5 THSD7A KIAA0960 ENSG00000005108 "Thrombospondin type 1 domain containing 7A" Q9UPZ6 7 11370357-11832198 "Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 22.5" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 104.8;Cone photoreceptor cells: 106.0;Horizontal cells: 197.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 76 "basophil: 7.5" "Lineage enriched" "Detected in single" 76 "granulocytes: 7.5" "Cell line enhanced" "Detected in some" "A549: 9.7;HUVEC TERT2: 6.5;REH: 6.6;SH-SY5Y: 9.9;THP-1: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000923 Supported "Secreted to blood" NA NA 3000000 "HPA000923: AB_1080271" "unprognostic (3.01e-1)" "unprognostic (7.90e-2)" "unprognostic (3.09e-2)" "unprognostic (1.96e-1)" "unprognostic (5.88e-1)" "unprognostic (3.33e-2)" "unprognostic (1.44e-1)" "unprognostic (9.66e-2)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (2.07e-1)" "unprognostic (8.75e-2)" "prognostic favorable (2.24e-6)" "unprognostic (2.13e-3)" "unprognostic (1.66e-1)" "unprognostic (2.28e-2)" "unprognostic (3.33e-2)" 9.6 2.2 4.7 2.1 5.7 0.6 5.2 2.0 7.2 8.4 2.7 1.0 0.9 1.2 8.3 2.7 1.7 4.8 6.2 2.1 3.8 4.7 17.7 2.0 3.0 1.2 4.6 3.6 6.4 1.4 2.6 9.4 22.5 3.5 8.4 2.1 4.4 1.7 5.5 0.9 1.7 1.5 5.9 4.3 2.3 1.7 2.2 1.9 0.0 4.9 2.5 1.1 4.5 6.8 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 9.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.5 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 6.6 0.0 0.0 0.3 0.1 0.7 9.9 0.0 0.3 0.0 1.6 0.1 17.9 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 5.7 2.0 7.2 3.8 4.7 4.6 3.6 3.5 1.9 20.8 8.0 0.0 1.6 2.4 104.8 1.1 22.9 0.0 4.5 52.4 106.0 14.0 6.6 5.5 1.0 31.5 0.0 0.0 1.9 4.9 9.8 2.1 0.0 1.0 2.0 197.0 40.1 21.5 1.9 0.2 22.5 0.8 11.8 0.0 0.0 22.3 4.4 1.5 1.4 8.6 7.4 0.0 1.4 1.7 0.4 2.0 43.4 0.0 0.5 0.6 THSD7B KIAA1679 ENSG00000144229 "Thrombospondin type 1 domain containing 7B" Q9C0I4 2 136765545-137677717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.2;epididymis: 11.6;retina: 14.9" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 23.6;Horizontal cells: 85.8;Rod photoreceptor cells: 31.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Daudi: 10.3;SCLC-21H: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051416, HPA056745" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051416: AB_2681477, HPA056745: AB_2683224" "unprognostic (4.65e-3)" "unprognostic (2.25e-1)" "unprognostic (8.98e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (6.50e-2)" "unprognostic (7.80e-3)" "unprognostic (2.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.20e-1)" "unprognostic (6.56e-2)" "unprognostic (4.47e-6)" "unprognostic (2.42e-3)" "unprognostic (1.89e-1)" "unprognostic (4.31e-2)" "unprognostic (4.30e-2)" 4.7 0.3 1.7 0.3 1.6 0.1 2.6 0.7 3.2 0.9 0.5 1.1 0.8 0.3 0.9 11.6 1.6 2.8 0.8 1.4 1.8 3.3 2.7 0.6 0.5 0.2 1.8 1.5 0.4 0.3 1.3 3.0 0.7 24.2 2.1 0.3 14.9 1.2 0.7 0.3 0.2 1.5 2.2 3.2 0.2 0.3 1.1 0.3 0.1 2.1 0.0 0.3 0.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.3 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 0.7 3.2 1.8 3.3 1.8 1.5 24.2 0.3 0.0 0.0 0.0 0.4 0.1 1.2 0.6 0.0 0.0 0.0 0.0 23.6 0.0 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 85.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 31.7 6.5 0.3 0.5 0.6 0.0 0.0 0.0 0.0 0.1 TIE1 "JTK14, TIE" ENSG00000066056 "Tyrosine kinase with immunoglobulin like and EGF like domains 1" P35590 1 43300993-43323108 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Endothelial cells: 81.7;Ito cells: 106.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "basophil: 3.4;NK-cell: 5.4" "Group enriched" "Detected in many" 22 "granulocytes: 3.4;NK-cells: 5.4" "Group enriched" "Detected in some" 5 "EFO-21: 28.5;HUVEC TERT2: 63.1;TIME: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 75000000 "unprognostic (1.88e-1)" "unprognostic (1.26e-1)" "unprognostic (7.60e-3)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "unprognostic (1.53e-3)" "unprognostic (1.19e-2)" "unprognostic (7.83e-2)" "unprognostic (2.02e-1)" "unprognostic (9.34e-2)" "unprognostic (1.91e-2)" "unprognostic (2.25e-1)" "unprognostic (1.17e-3)" "unprognostic (2.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.29e-2)" "unprognostic (2.35e-2)" 39.4 5.4 3.9 6.6 6.0 1.0 43.6 2.5 6.0 10.8 8.4 4.5 4.2 4.5 18.6 10.9 7.8 10.2 11.1 15.1 4.9 4.2 9.4 10.8 22.0 13.1 6.4 3.1 7.0 3.0 2.7 5.1 39.9 5.5 8.6 3.0 6.9 6.0 6.9 17.8 4.2 5.8 12.1 5.3 14.8 5.1 5.1 3.8 1.1 13.9 10.2 3.1 9.0 14.7 0.0 0.2 3.4 0.0 5.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 10.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 63.1 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.3 0.0 0.0 2.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 54.8 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.4 0.0 0.1 0.0 0.0 3.9 6.0 2.5 6.0 4.9 4.2 6.4 3.1 5.5 3.8 0.0 6.2 0.0 0.6 1.9 0.3 3.4 0.0 6.7 3.4 0.0 0.0 0.1 0.0 0.0 1.5 81.7 0.0 0.0 0.2 0.1 1.4 0.6 19.7 0.9 0.4 0.0 0.0 106.2 8.6 1.5 2.0 1.6 1.7 0.0 0.0 0.2 0.0 0.0 0.7 0.8 0.7 0.0 0.9 0.7 0.1 1.3 0.2 6.9 0.0 0.6 TIGIT "DKFZp667A205, FLJ39873, VSIG9, VSTM3" ENSG00000181847 "T cell immunoreceptor with Ig and ITIM domains" Q495A1 3 114276913-114310288 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 49.8;lymphoid tissue: 25.9" "Cell type enriched" "Detected in some" 22 "T-cells: 83.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 49.8" "Lineage enriched" "Detected in many" 11 "T-cells: 49.8" "Cell line enhanced" "Detected in some" "HDLM-2: 4.9;Karpas-707: 1.7;NTERA-2: 1.9;U-266/84: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.24e-2)" "prognostic favorable (5.43e-4)" "unprognostic (1.22e-3)" "unprognostic (2.22e-6)" "unprognostic (9.84e-2)" "prognostic favorable (3.96e-4)" "unprognostic (1.18e-1)" "unprognostic (2.57e-2)" "unprognostic (5.50e-4)" "unprognostic (3.51e-3)" "unprognostic (1.78e-1)" "unprognostic (3.15e-1)" "unprognostic (2.30e-8)" "unprognostic (3.54e-2)" "unprognostic (1.33e-1)" "unprognostic (7.62e-2)" "unprognostic (6.18e-3)" 1.4 0.3 0.4 20.2 0.7 0.9 1.1 0.2 0.3 0.5 1.2 0.2 1.2 0.8 1.4 1.1 1.1 0.9 3.8 0.8 0.4 0.7 1.3 1.6 5.0 25.9 0.6 0.3 0.4 0.3 0.0 0.6 0.5 0.4 1.0 1.4 1.1 4.4 1.9 0.6 0.6 8.0 0.3 1.5 13.4 2.0 0.6 0.1 4.3 1.6 1.7 20.2 4.1 1.0 0.4 0.2 0.2 0.0 4.4 49.8 5.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.5 0.3 0.0 0.3 0.0 0.1 0.0 0.5 4.9 0.0 0.1 0.9 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 1.9 0.9 0.0 0.1 1.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.0 0.4 0.5 0.1 0.1 1.4 1.9 0.0 0.9 0.3 0.0 0.0 0.0 0.0 8.5 0.0 0.9 0.4 13.6 25.0 0.0 0.2 1.5 11.4 0.2 4.4 0.0 0.2 49.8 5.4 0.4 0.7 0.2 0.3 0.4 0.7 0.6 0.3 0.4 0.1 0.0 3.5 1.9 0.0 2.7 0.4 0.3 0.0 0.0 2.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 3.7 2.4 0.0 0.0 0.8 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.6 2.9 0.0 83.0 0.0 0.0 TIMD4 ENSG00000145850 "T cell immunoglobulin and mucin domain containing 4" Q96H15 5 156919282-156963255 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "liver: 32.0;lymphoid tissue: 83.9;testis: 58.9" "Group enriched" "Detected in some" 24 "Early spermatids: 1044.9;Late spermatids: 1409.2" "Cancer enriched" "Detected in some" 10 "renal cancer: 6.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 2.3;memory CD8 T-cell: 4.5;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.0;T-reg: 6.4" "Lineage enriched" "Detected in single" 14 "T-cells: 6.4" "Group enriched" "Detected in some" 18 "U-266/70: 46.8;U-266/84: 12.7" "HPA015625, CAB026027" Approved Approved "Plasma membrane" NA NA 18000000 "Plasma membrane" "CAB026027: , HPA015625: AB_1858018" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (3.01e-2)" "unprognostic (1.10e-1)" "unprognostic (3.11e-1)" "unprognostic (3.42e-1)" "unprognostic (8.42e-2)" "unprognostic (1.10e-1)" "unprognostic (6.90e-2)" "prognostic favorable (3.37e-4)" "unprognostic (1.31e-2)" "unprognostic (4.07e-1)" "unprognostic (3.27e-2)" "unprognostic (2.08e-2)" 6.7 0.4 0.4 3.5 0.4 5.3 0.5 0.4 0.4 0.4 1.3 0.0 0.0 0.0 0.4 1.0 1.5 0.4 0.3 0.8 0.4 0.4 1.7 32.0 0.6 83.9 0.5 0.0 0.4 0.4 0.0 0.4 2.8 0.0 1.1 0.1 0.0 6.5 0.0 0.7 0.4 1.1 0.2 0.5 12.5 0.4 58.9 0.0 21.7 0.8 0.2 8.5 5.3 0.4 0.4 0.0 0.0 0.0 0.0 6.4 1.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 46.8 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 2.3 4.5 0.0 0.0 3.0 3.0 0.0 0.0 0.0 0.0 6.4 1.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 1044.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 34.7 0.0 0.0 0.0 52.0 1409.2 13.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.6 0.0 12.9 0.0 10.9 4.3 0.0 0.2 0.0 0.0 0.0 TIMM17A "TIM17, TIM17A" ENSG00000134375 "Translocase of inner mitochondrial membrane 17A" Q99595 1 201955491-201970661 "Cancer-related genes, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010083 Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA010083: AB_10602899" "prognostic unfavorable (1.98e-5)" "unprognostic (3.28e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-3)" "unprognostic (7.58e-2)" "unprognostic (4.15e-2)" "unprognostic (7.45e-2)" "unprognostic (1.64e-2)" "unprognostic (8.54e-3)" "unprognostic (2.02e-2)" "unprognostic (2.01e-1)" "unprognostic (6.45e-3)" "unprognostic (1.21e-1)" "unprognostic (1.44e-2)" "unprognostic (2.81e-1)" 16.6 27.6 22.7 18.7 23.2 16.9 16.8 16.3 29.3 16.5 19.3 9.9 19.2 17.2 15.0 24.1 17.9 11.8 10.7 39.0 32.3 19.6 25.1 53.7 13.5 15.3 20.6 27.0 11.2 18.7 21.5 14.8 17.4 25.0 14.5 21.8 11.7 24.8 17.1 42.1 11.5 13.0 19.6 13.4 14.4 16.3 13.7 14.2 11.3 21.6 30.4 18.9 15.9 12.7 17.6 28.9 16.0 24.9 15.9 20.6 17.8 26.4 27.0 24.5 29.3 20.7 21.7 41.4 42.3 30.3 34.8 31.3 31.6 27.6 36.7 15.6 36.2 25.5 21.2 44.9 25.3 37.5 26.9 28.1 20.2 35.9 29.9 21.4 43.1 21.8 25.0 28.2 35.5 29.8 25.1 36.3 23.2 51.0 20.6 40.8 16.9 23.1 23.4 31.1 26.7 14.6 22.9 28.5 46.0 42.7 25.2 37.0 26.2 25.9 66.4 39.1 32.5 36.7 29.3 29.0 23.3 24.7 27.0 43.9 31.3 33.7 30.8 24.8 32.9 25.9 8.9 19.0 16.0 13.6 24.9 17.5 17.6 14.9 17.2 28.9 12.7 14.2 16.7 4.4 15.9 24.7 19.3 20.6 17.8 22.7 23.2 16.3 29.3 32.3 19.6 20.6 27.0 25.0 14.2 35.7 37.0 55.2 74.7 81.9 22.9 117.0 40.8 46.8 42.1 36.6 33.4 102.6 116.0 97.2 44.4 41.4 33.9 0.0 74.9 170.0 67.6 57.0 54.3 165.4 105.8 33.4 32.6 35.6 45.4 26.9 31.1 72.6 50.6 99.2 41.2 32.7 83.8 23.0 36.0 93.3 25.4 25.8 62.2 38.1 50.8 86.4 222.1 56.4 49.3 91.8 TIMM17B "DXS9822, JM3" ENSG00000126768 "Translocase of inner mitochondrial membrane 17B" O60830 X 48893447-48898143 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029093 Approved Approved Microtubules,Mitochondria NA NA Microtubules Mitochondria "HPA029093: AB_10600913" "unprognostic (7.87e-2)" "prognostic favorable (6.63e-4)" "unprognostic (8.44e-2)" "unprognostic (3.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.89e-3)" "unprognostic (1.44e-1)" "unprognostic (2.01e-1)" "unprognostic (1.14e-2)" "unprognostic (2.04e-1)" "unprognostic (2.16e-1)" "unprognostic (2.67e-2)" "unprognostic (9.40e-2)" "unprognostic (5.24e-3)" "unprognostic (8.67e-2)" "prognostic favorable (7.88e-4)" 14.0 21.1 23.6 15.0 24.2 18.6 16.4 15.1 30.8 16.9 22.3 18.9 13.3 19.2 15.1 19.2 27.4 21.0 19.4 40.6 19.8 17.7 26.2 40.1 19.6 18.3 19.0 15.8 17.8 28.7 19.3 22.9 28.2 15.4 22.4 15.0 19.8 21.5 22.8 54.3 16.1 24.8 15.7 20.5 22.1 18.8 16.7 12.5 36.4 31.1 27.2 19.5 21.6 13.7 36.7 41.5 56.2 41.2 22.9 26.7 35.5 18.5 34.4 21.7 21.2 6.8 5.5 17.9 8.4 13.0 22.4 14.7 30.1 25.3 13.9 13.1 7.4 36.3 14.2 34.0 18.3 8.5 29.2 38.3 10.0 19.7 26.5 19.2 14.7 9.8 7.2 18.4 16.8 22.4 11.2 10.3 24.4 14.7 32.5 10.2 48.3 23.1 36.1 28.0 24.7 32.2 16.4 14.1 49.4 21.9 11.0 21.6 19.3 13.1 21.0 12.5 28.6 45.8 25.9 7.0 10.3 20.2 24.7 14.4 30.1 34.9 16.6 14.3 26.4 12.1 44.4 41.2 56.2 23.4 39.0 26.7 36.7 23.7 26.4 39.5 36.1 23.1 21.2 46.5 22.9 31.5 41.5 23.4 35.5 23.6 24.2 15.1 30.8 19.8 17.7 19.0 15.8 15.4 12.5 23.8 27.5 51.4 44.2 26.9 39.2 36.7 45.9 28.1 17.0 69.8 15.7 89.4 157.5 83.6 4.1 21.6 57.2 46.7 63.8 82.3 26.4 51.5 51.8 47.3 83.3 33.4 78.4 21.5 43.0 6.3 22.2 43.6 42.2 101.8 59.2 31.6 75.0 89.2 21.5 129.9 28.0 32.3 40.1 19.4 36.8 30.1 66.6 44.6 55.4 49.4 TIMM21 "C18orf55, HSPC154, TIM21" ENSG00000075336 "Translocase of inner mitochondrial membrane 21" Q9BVV7 18 74148511-74160530 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 156.9;Distal tubular cells: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010587, HPA051543" Uncertain NA NA "HPA010587: AB_1851244, HPA051543: AB_2681528" "unprognostic (4.88e-1)" "unprognostic (2.20e-2)" "unprognostic (1.16e-1)" "unprognostic (8.61e-2)" "unprognostic (3.81e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (9.22e-5)" "unprognostic (1.42e-1)" "unprognostic (1.59e-2)" "unprognostic (1.93e-2)" "unprognostic (4.79e-3)" "unprognostic (1.55e-3)" "prognostic favorable (1.38e-9)" "unprognostic (2.37e-2)" "unprognostic (5.39e-2)" "unprognostic (1.31e-1)" "unprognostic (6.66e-2)" 13.4 14.0 16.7 10.1 20.3 7.5 11.0 26.2 20.3 8.1 12.7 18.3 8.4 12.9 9.7 13.2 11.1 8.5 6.3 39.2 15.6 14.1 20.3 17.6 7.5 9.5 17.2 13.8 11.6 8.7 14.3 14.1 10.5 18.4 10.3 14.6 10.7 12.1 11.2 45.7 11.5 12.2 10.8 16.2 11.1 10.0 6.9 16.8 8.8 11.2 19.4 10.2 9.3 8.1 13.7 13.4 5.8 14.2 14.3 16.2 7.6 11.8 12.6 11.9 14.6 9.8 8.7 17.5 18.3 6.1 11.1 9.4 9.2 8.7 16.1 5.9 7.1 9.3 19.9 16.3 15.6 18.8 10.1 9.4 6.9 21.9 25.1 5.0 25.7 11.6 8.1 9.4 14.1 9.8 9.1 8.4 9.0 13.8 11.3 13.4 11.9 13.6 21.2 11.4 7.2 23.4 12.9 13.7 20.1 14.5 16.8 12.6 6.9 6.9 17.3 10.9 9.7 12.0 13.4 5.9 26.2 18.5 8.5 18.9 3.5 27.2 17.4 12.8 28.1 18.2 5.8 8.8 5.1 11.6 13.1 13.7 13.7 11.2 9.7 11.1 11.0 14.4 16.2 1.3 14.3 14.2 13.4 8.2 7.6 16.7 20.3 26.2 20.3 15.6 14.1 17.2 13.8 18.4 16.8 11.9 16.2 11.5 8.3 7.1 16.5 156.9 22.9 16.0 13.6 5.2 5.9 24.9 46.4 11.6 1.3 14.3 8.0 23.3 8.1 23.4 16.4 7.6 9.2 16.2 16.9 15.9 13.8 11.1 12.3 0.4 10.6 6.7 1.7 14.4 11.4 19.9 8.1 3.5 11.7 23.0 19.0 6.5 10.8 12.1 11.7 6.9 13.7 5.0 18.7 6.5 TIMM22 "TEX4, TIM22" ENSG00000177370 "Translocase of inner mitochondrial membrane 22" Q9Y584 17 997117-1003671 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045138 Uncertain NA NA "HPA045138: AB_10962055" "unprognostic (2.69e-1)" "unprognostic (3.42e-1)" "unprognostic (2.57e-1)" "unprognostic (8.69e-3)" "unprognostic (3.00e-2)" "unprognostic (2.75e-2)" "unprognostic (2.16e-2)" "unprognostic (9.36e-2)" "unprognostic (2.37e-1)" "unprognostic (1.80e-1)" "prognostic favorable (3.42e-4)" "unprognostic (1.27e-1)" "prognostic favorable (1.41e-4)" "unprognostic (2.45e-1)" "unprognostic (3.04e-1)" "unprognostic (1.04e-1)" "unprognostic (1.70e-3)" 11.3 14.1 11.5 8.9 12.5 9.9 10.8 13.4 22.4 10.3 10.7 8.5 9.5 9.9 11.1 15.4 12.1 11.9 7.4 22.2 11.4 14.7 17.1 11.4 9.6 9.4 12.3 9.4 13.0 16.4 14.5 15.7 15.5 17.2 11.1 9.1 10.6 14.2 11.5 16.8 11.4 10.9 12.3 8.0 14.6 11.1 14.8 7.1 18.4 13.9 12.1 12.3 9.4 9.7 12.7 9.3 7.4 9.7 11.4 14.0 11.2 5.5 9.8 5.2 6.8 7.9 7.4 5.3 7.1 6.1 10.4 9.2 12.5 3.1 5.1 5.5 8.4 5.2 7.2 10.3 9.8 8.6 5.3 12.0 3.7 7.0 6.8 7.7 4.0 3.9 7.3 6.7 10.1 8.4 4.3 10.2 5.8 7.9 5.2 8.5 5.0 6.6 3.4 6.3 4.4 6.9 6.7 2.6 4.0 8.5 4.4 3.7 4.3 6.1 3.6 6.1 5.2 4.4 3.9 7.4 6.3 4.3 7.9 9.7 2.5 2.7 2.9 6.7 5.7 6.0 4.8 8.9 7.4 11.4 9.1 12.7 12.7 12.1 11.5 8.3 12.4 14.0 12.2 2.5 11.4 9.7 9.3 10.4 11.2 11.5 12.5 13.4 22.4 11.4 14.7 12.3 9.4 17.2 7.1 3.0 15.7 33.0 8.8 38.7 25.2 23.1 25.5 4.0 10.3 7.0 31.4 54.7 31.5 31.1 4.2 27.7 11.0 0.0 24.6 50.0 27.5 14.7 3.5 10.2 33.8 25.4 19.5 14.7 9.5 6.8 18.7 16.1 15.1 31.5 11.1 16.5 23.6 7.0 20.1 21.4 40.3 12.9 17.9 33.0 40.5 47.3 51.5 18.5 15.0 9.9 TIMM23 TIM23 ENSG00000265354 "Translocase of inner mitochondrial membrane 23" O14925 10 45972449-46003734 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA031408 Approved Supported Mitochondria NA NA Mitochondria "HPA031408: AB_10600828" "unprognostic (4.09e-2)" "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (1.15e-2)" "prognostic unfavorable (2.77e-5)" "unprognostic (1.74e-1)" "unprognostic (3.90e-2)" "prognostic favorable (6.79e-4)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (3.24e-1)" "unprognostic (7.78e-2)" "unprognostic (5.54e-2)" "unprognostic (7.20e-2)" "unprognostic (2.21e-1)" 5.7 4.6 1.2 6.8 3.8 6.0 13.6 4.1 8.6 2.6 4.2 1.5 5.8 6.1 2.9 7.3 4.2 2.4 3.2 11.5 5.3 6.6 8.3 4.8 9.9 1.6 2.5 2.2 2.8 3.0 3.4 8.1 5.5 3.4 4.1 2.6 7.5 5.2 16.2 2.4 3.5 3.6 2.2 2.5 2.8 17.2 1.4 4.5 4.5 4.0 4.4 3.3 1.7 29.5 39.7 18.5 45.3 26.7 29.8 39.6 40.7 43.0 28.6 28.8 23.8 22.3 27.9 33.7 40.5 41.1 43.7 54.2 32.5 36.5 28.0 35.4 29.5 35.2 43.6 36.0 40.8 27.0 43.0 23.3 32.3 58.2 38.4 43.2 26.1 26.7 32.2 35.1 50.0 17.1 37.9 31.9 41.1 20.6 36.0 40.8 38.5 60.1 34.5 30.2 13.4 29.9 27.6 26.7 46.1 28.6 33.6 30.9 18.7 41.7 33.7 23.1 44.1 25.9 27.8 19.9 34.7 25.4 47.9 22.1 36.4 51.3 37.0 62.6 16.5 15.7 35.6 18.5 28.0 45.3 28.7 29.5 27.1 29.8 39.7 27.9 24.6 27.2 8.2 26.7 39.3 32.8 29.6 39.6 8.9 17.4 24.2 12.4 19.5 13.0 86.5 30.6 28.1 19.4 12.2 7.9 39.3 38.1 39.5 62.9 13.7 15.7 23.3 26.2 38.0 14.2 16.2 26.6 23.3 30.2 0.0 9.8 17.8 17.5 15.7 16.4 18.4 21.9 33.3 15.8 22.1 29.8 14.0 11.0 47.3 9.2 6.5 16.5 85.7 48.5 18.9 29.7 13.8 23.3 16.0 TIMM23B bA592B15.7 ENSG00000204152 "Translocase of inner mitochondrial membrane 23 homolog B" Q5SRD1 10 49942033-49974850 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (8.84e-2)" "unprognostic (2.67e-2)" "unprognostic (5.92e-2)" "unprognostic (4.19e-3)" "unprognostic (9.37e-2)" "unprognostic (7.64e-2)" "unprognostic (2.04e-1)" "unprognostic (1.34e-1)" "unprognostic (3.11e-1)" "unprognostic (1.43e-3)" "unprognostic (4.03e-2)" "unprognostic (3.30e-3)" "unprognostic (5.39e-2)" "unprognostic (9.66e-2)" "unprognostic (1.62e-1)" "unprognostic (4.90e-3)" "unprognostic (1.18e-1)" 5.9 3.5 2.6 4.9 5.8 12.2 8.3 9.2 8.7 3.5 3.9 3.1 4.9 2.7 8.2 2.7 5.3 3.1 3.7 9.2 6.2 2.1 2.0 3.2 9.7 5.2 6.8 6.4 4.8 8.4 0.4 5.0 2.5 6.2 3.0 2.4 2.7 11.7 4.7 14.0 4.0 2.7 9.3 5.1 3.9 3.9 4.2 3.0 1.0 3.2 4.6 3.5 6.8 4.0 4.4 3.9 4.0 4.3 5.2 4.7 4.6 4.0 4.5 3.3 4.8 4.9 2.2 3.9 8.8 7.5 5.0 4.6 6.9 3.3 6.2 3.5 10.0 3.1 5.3 3.4 6.3 2.2 8.7 4.1 4.8 1.8 3.5 5.7 8.5 7.4 6.9 4.6 2.5 12.7 3.6 3.4 8.1 8.8 5.0 4.1 3.2 7.7 6.6 2.7 1.5 5.5 4.7 4.6 2.3 0.8 5.8 5.7 7.7 2.6 5.9 4.4 2.9 4.6 3.1 4.4 3.3 3.6 5.5 6.9 6.6 5.0 16.8 9.9 7.1 2.0 1.0 4.2 4.0 4.7 2.5 4.0 4.4 2.9 3.4 3.9 3.0 3.6 3.8 0.1 5.2 4.3 3.1 2.7 4.6 2.6 5.8 9.2 8.7 6.2 2.1 6.8 6.4 6.2 3.0 17.9 10.4 7.0 7.2 0.0 15.0 5.5 10.2 5.3 10.3 5.2 27.5 4.3 1.7 4.9 0.8 4.7 2.6 0.0 7.1 4.9 7.4 5.8 6.9 8.9 5.0 19.1 0.0 6.7 3.7 1.3 5.2 4.7 0.0 10.8 2.6 9.1 7.2 0.0 8.1 3.1 16.3 6.5 2.1 10.6 8.9 0.0 4.9 7.5 3.0 7.7 TIMM50 TIM50L ENSG00000105197 "Translocase of inner mitochondrial membrane 50" Q3ZCQ8 19 39480412-39493785 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" RNA-binding "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Late spermatids: 445.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048843, HPA056448" Enhanced Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA048843: , HPA056448: AB_2683137" "unprognostic (1.49e-1)" "unprognostic (6.97e-2)" "unprognostic (4.90e-2)" "unprognostic (2.80e-3)" "unprognostic (4.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.11e-2)" "unprognostic (7.91e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-2)" "unprognostic (9.43e-2)" "unprognostic (2.01e-2)" "unprognostic (4.14e-3)" "unprognostic (3.04e-2)" "unprognostic (9.87e-2)" "unprognostic (3.82e-2)" "unprognostic (4.04e-2)" 21.3 20.2 17.9 17.0 25.8 23.0 15.7 14.3 38.2 13.4 18.4 18.0 14.4 18.0 19.0 11.7 22.6 15.8 12.5 42.2 17.6 17.4 23.9 28.0 14.2 16.6 17.8 20.2 16.4 19.8 16.4 13.4 20.0 22.0 15.3 12.0 18.1 18.3 14.6 58.1 14.0 16.1 16.5 12.7 15.1 16.9 40.4 14.7 18.5 24.0 25.5 16.9 16.9 18.2 19.3 27.4 10.3 25.3 17.0 19.9 27.8 26.5 63.9 11.9 29.6 10.5 9.5 21.6 21.0 10.8 25.0 20.4 45.7 18.8 30.1 22.4 14.2 14.0 15.3 23.8 21.7 13.3 26.2 34.6 27.9 18.7 31.6 15.9 54.3 19.3 12.2 15.5 18.7 17.1 7.1 16.2 35.8 44.6 18.1 15.7 35.2 33.2 20.9 20.7 31.3 24.4 33.9 23.7 23.2 17.2 36.7 31.5 17.7 25.3 36.8 43.2 8.6 17.2 29.6 16.2 31.0 28.9 25.5 48.9 17.1 31.4 45.4 23.3 27.3 34.4 10.3 25.3 6.1 16.9 24.0 17.3 19.3 16.2 18.5 27.4 18.1 18.4 17.0 2.1 17.0 22.4 20.6 19.9 27.8 17.9 25.8 14.3 38.2 17.6 17.4 17.8 20.2 22.0 14.7 20.8 24.2 14.2 35.2 23.1 10.0 41.2 22.9 12.0 23.9 24.4 11.8 72.5 56.3 52.0 155.0 24.1 24.2 0.0 44.6 67.0 29.8 28.0 39.2 29.6 59.4 27.0 22.4 19.6 11.8 445.2 21.6 26.0 28.7 22.6 20.3 12.8 42.9 14.4 19.8 53.1 10.4 6.5 34.0 92.9 48.7 23.3 79.1 17.5 42.6 40.9 TIMMDC1 "C3orf1, FLJ22597" ENSG00000113845 "Translocase of inner mitochondrial membrane domain containing 1" Q9NPL8 3 119498532-119525090 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053214, HPA055846" Uncertain Enhanced Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA053214: AB_2682081, HPA055846: AB_2682941" "unprognostic (3.95e-2)" "unprognostic (8.85e-2)" "unprognostic (1.73e-1)" "unprognostic (2.53e-2)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (9.60e-2)" "unprognostic (6.25e-2)" "unprognostic (3.39e-1)" "unprognostic (4.67e-3)" "unprognostic (1.05e-1)" "unprognostic (3.87e-2)" "unprognostic (8.89e-2)" "unprognostic (1.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.05e-1)" 13.6 17.2 18.1 10.4 16.7 5.9 13.8 8.6 16.2 16.4 12.2 20.4 21.5 9.2 13.3 19.4 18.5 13.6 14.9 43.9 15.9 15.4 22.8 20.5 13.0 15.9 20.9 11.9 11.8 12.5 20.4 17.4 21.4 16.4 15.2 14.5 14.0 14.3 21.6 37.2 16.0 15.3 12.7 21.9 14.3 12.3 13.3 15.6 9.9 19.9 20.3 14.5 16.7 11.1 12.4 13.8 16.3 15.5 8.5 15.8 15.5 14.3 13.5 6.7 5.8 26.2 17.7 15.2 4.2 14.1 12.2 14.0 9.1 8.8 10.5 7.3 14.8 8.4 6.8 16.9 13.7 20.0 8.8 6.1 7.7 6.3 10.2 13.8 6.0 5.1 15.5 21.1 9.8 12.8 7.8 17.2 9.9 10.5 10.1 22.4 17.8 6.3 12.7 9.0 12.1 16.8 5.3 4.7 13.8 18.3 7.2 8.9 16.6 4.3 6.6 16.1 9.5 10.8 16.5 8.6 6.9 5.2 6.3 7.3 6.5 6.1 14.3 11.7 15.3 10.8 6.8 13.8 16.3 8.4 13.0 10.1 12.2 8.3 10.3 13.8 12.4 10.4 9.0 3.4 8.5 15.5 11.9 15.8 15.5 18.1 16.7 8.6 16.2 15.9 15.4 20.9 11.9 16.4 15.6 23.8 35.3 16.0 40.6 33.3 24.2 144.4 40.8 61.6 37.5 38.4 13.7 129.0 127.6 61.0 5.3 55.2 40.2 23.3 54.8 92.7 41.0 35.4 40.4 45.5 75.0 20.6 27.6 31.3 30.4 5.2 43.7 39.7 42.2 83.0 41.1 57.9 47.3 40.1 51.2 112.8 25.9 71.1 52.6 99.3 50.0 36.8 148.4 31.6 44.9 43.4 TKFC "DAK, DKFZP586B1621, NET45" ENSG00000149476 "Triokinase and FMN cyclase" Q3LXA3 11 61333210-61353295 "Enzymes, Predicted intracellular proteins" "Kinase, Lyase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 90.2;liver: 42.8" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 92.7;Proximal tubular cells: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 40.5;RPMI-8226: 42.7;T-47d: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039486, HPA048186" Enhanced Approved Nucleoplasm,Cytosol NA NA 4800000 Cytosol Nucleoplasm "HPA039486: AB_10795402, HPA048186: AB_2680305" "unprognostic (4.00e-1)" "unprognostic (3.13e-1)" "unprognostic (7.42e-2)" "prognostic favorable (1.32e-5)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (3.02e-2)" "unprognostic (2.81e-3)" "unprognostic (1.49e-1)" "unprognostic (2.47e-1)" "unprognostic (1.51e-1)" "unprognostic (2.15e-1)" "prognostic favorable (8.38e-5)" "unprognostic (2.07e-2)" "unprognostic (8.96e-2)" "unprognostic (3.30e-1)" "unprognostic (4.02e-1)" 3.1 34.7 3.6 6.1 5.3 5.3 4.6 3.7 7.3 3.4 43.4 7.6 8.0 69.5 4.6 7.8 6.2 5.9 8.8 2.8 3.1 2.6 17.4 42.8 3.5 5.2 3.3 5.3 4.5 9.8 3.0 5.5 3.9 4.4 5.0 2.3 7.3 7.2 7.1 4.6 6.1 90.2 2.6 3.1 5.4 5.7 17.1 3.4 5.5 6.4 6.3 6.7 5.4 3.9 9.7 18.4 5.4 11.4 5.3 10.9 7.8 6.1 15.6 2.7 9.5 3.4 3.7 7.7 3.6 3.9 3.4 2.2 7.1 14.8 7.6 12.6 2.6 3.5 8.6 5.1 6.7 1.1 13.1 6.8 4.7 8.2 40.5 5.9 3.9 7.9 5.9 4.6 3.2 11.2 2.9 3.3 5.3 8.2 14.8 2.4 27.9 3.5 3.6 7.5 5.8 10.7 6.2 4.3 42.7 5.4 10.9 10.6 9.5 6.6 11.6 6.0 1.9 42.8 2.8 4.0 6.7 7.0 5.3 2.1 27.4 22.6 6.9 6.9 3.7 6.1 2.3 11.4 5.4 6.7 6.8 8.6 9.7 7.8 6.5 18.4 9.7 5.6 5.9 0.9 5.3 5.3 9.0 10.9 7.8 3.6 5.3 3.7 7.3 3.1 2.6 3.3 5.3 4.4 3.4 0.0 12.6 6.7 10.8 0.0 12.9 3.4 12.7 20.1 12.5 14.0 13.7 25.7 24.9 15.5 7.9 4.5 5.4 0.0 12.8 4.4 3.0 11.6 7.0 92.7 14.9 7.9 12.9 6.2 18.3 9.3 14.1 5.9 0.0 27.9 13.9 8.7 12.3 18.1 21.2 63.4 16.0 6.5 2.4 39.2 14.5 0.0 12.7 5.7 18.4 10.6 TLCD1 ENSG00000160606 "TLC domain containing 1" Q96CP7 17 28724348-28727935 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 30.5;Syncytiotrophoblasts: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 14 "plasmacytoid DC: 17.7" "Lineage enriched" "Detected in many" 14 "dendritic cells: 17.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042366 Enhanced NA NA "HPA042366: AB_10794419" "unprognostic (1.23e-1)" "unprognostic (3.78e-2)" "unprognostic (8.52e-2)" "unprognostic (3.74e-2)" "unprognostic (1.42e-2)" "unprognostic (1.80e-2)" "prognostic unfavorable (3.28e-4)" "unprognostic (2.82e-1)" "unprognostic (1.04e-1)" "unprognostic (4.47e-3)" "unprognostic (9.96e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (9.05e-5)" "unprognostic (1.56e-1)" "unprognostic (7.56e-2)" "unprognostic (1.86e-2)" "unprognostic (3.93e-2)" 2.7 3.7 10.0 4.5 12.6 1.0 5.3 6.3 9.5 4.5 7.7 3.0 9.0 7.8 1.7 14.4 8.7 14.7 3.2 1.4 8.6 5.7 12.9 12.0 6.0 4.6 7.0 7.7 2.1 12.4 5.0 2.8 9.0 4.8 5.7 8.3 1.6 9.8 9.6 1.8 13.0 5.5 0.9 3.0 2.5 8.6 7.8 1.7 5.3 4.4 9.6 9.3 4.2 3.4 1.2 17.7 1.1 0.8 0.3 0.5 0.4 4.8 22.0 6.0 5.0 4.2 7.7 14.1 4.0 7.1 1.8 2.7 12.2 8.6 1.5 6.3 4.8 8.6 7.7 6.6 12.5 2.9 1.3 6.4 2.5 14.3 14.7 4.5 5.3 0.4 5.2 10.2 6.9 12.2 3.0 1.6 0.5 9.3 0.2 3.2 16.5 0.6 2.1 6.8 16.3 4.0 1.8 2.5 9.1 15.4 8.6 11.5 2.3 8.3 46.2 4.3 9.3 23.0 1.9 1.7 2.0 6.7 3.6 6.4 1.6 1.7 3.4 3.7 3.1 6.4 1.1 0.8 0.1 0.2 0.8 0.5 1.2 0.5 0.3 0.8 0.6 0.2 0.3 0.5 0.3 0.6 17.7 0.3 0.4 10.0 12.6 6.3 9.5 8.6 5.7 7.0 7.7 4.8 1.7 0.0 5.9 1.7 8.1 2.2 0.0 0.7 7.6 14.7 2.3 12.2 0.0 15.4 0.0 8.1 12.6 0.7 6.9 0.0 7.3 30.5 3.5 16.2 0.0 8.7 3.1 1.6 4.6 1.3 0.0 12.2 1.1 2.1 3.3 3.6 7.0 4.7 9.3 2.9 0.4 6.8 0.6 0.0 2.2 23.2 1.7 1.8 27.0 0.0 8.0 24.4 TLCD2 ENSG00000185561 "TLC domain containing 2" A6NGC4 17 1702790-1710438 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 59.3;Cone photoreceptor cells: 121.7;Enterocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 4.1;neutrophil: 2.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.1" "Cell line enhanced" "Detected in many" "ASC diff: 6.6;ASC TERT1: 7.7;HaCaT: 6.3;SiHa: 8.3;T-47d: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046063 Uncertain Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA046063: AB_2679520" "unprognostic (1.78e-1)" "unprognostic (6.71e-2)" "unprognostic (2.56e-2)" "unprognostic (1.20e-1)" "unprognostic (8.64e-3)" "unprognostic (1.64e-1)" "unprognostic (3.32e-1)" "unprognostic (4.04e-2)" "unprognostic (7.94e-2)" "unprognostic (7.74e-2)" "unprognostic (2.29e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.36e-5)" "unprognostic (3.77e-2)" "unprognostic (2.82e-1)" "unprognostic (7.79e-2)" "unprognostic (4.44e-2)" 11.3 9.2 0.5 4.7 1.4 1.7 18.4 0.1 1.5 2.7 9.6 0.3 1.7 7.9 1.8 3.1 6.8 2.7 5.6 4.0 0.6 0.4 2.3 14.8 4.6 0.5 1.2 0.4 4.6 1.2 1.5 0.9 1.6 1.9 4.1 5.4 3.0 2.9 3.6 2.2 2.2 18.4 4.3 1.3 1.1 4.5 0.8 0.5 0.3 2.6 1.2 2.7 4.8 6.3 0.7 0.4 4.1 0.4 0.6 0.5 0.1 0.7 1.5 0.8 2.5 6.6 7.7 0.5 1.3 1.3 0.7 0.5 4.7 2.2 0.1 1.4 2.1 0.7 6.3 1.0 0.6 0.5 0.2 1.1 0.6 2.1 0.4 3.8 0.0 1.7 6.2 2.3 0.8 1.5 2.1 0.5 0.1 0.5 0.3 0.6 1.3 0.0 0.3 0.1 2.3 0.4 0.1 3.7 0.1 0.4 2.2 0.1 0.3 8.3 0.7 1.2 1.1 6.7 0.6 1.8 0.4 2.0 1.4 0.3 0.1 0.0 0.1 0.4 0.2 1.0 4.1 0.4 0.6 0.4 0.2 0.2 0.4 0.5 0.2 0.1 0.7 0.4 0.4 2.7 0.6 0.2 0.4 0.2 0.1 0.5 1.4 0.1 1.5 0.6 0.4 1.2 0.4 1.9 0.5 47.6 59.3 1.4 7.6 0.0 8.1 2.8 15.3 36.1 33.0 10.4 121.7 4.1 0.0 5.8 0.6 8.5 77.5 0.0 8.5 2.5 7.7 6.0 15.1 14.9 4.7 0.0 8.6 17.8 3.9 0.9 12.4 4.3 0.0 1.8 22.4 8.8 11.1 38.7 5.3 0.8 50.0 6.5 2.7 0.2 0.9 0.3 3.3 0.7 26.4 11.7 TLR1 "CD281, KIAA0012, rsc786" ENSG00000174125 "Toll like receptor 1" Q15399 4 38790677-38856817 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.3;lymphoid tissue: 40.4" "Cell type enhanced" "Detected in many" 14 "Hofbauer cells: 14.0;Kupffer cells: 33.2;Macrophages: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 43.3" "Group enriched" "Detected in all" 6 "granulocytes: 43.3;monocytes: 13.1" "Cell line enhanced" "Detected in many" "Daudi: 9.6;HUVEC TERT2: 11.0;RPMI-8226: 11.9;U-698: 17.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (7.82e-2)" "unprognostic (3.35e-3)" "unprognostic (4.02e-2)" "unprognostic (1.19e-1)" "unprognostic (1.71e-1)" "unprognostic (1.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (3.88e-1)" "unprognostic (1.04e-1)" "unprognostic (3.94e-2)" "unprognostic (1.76e-1)" "unprognostic (7.25e-3)" "unprognostic (4.08e-2)" "unprognostic (1.91e-2)" "unprognostic (2.08e-1)" "unprognostic (3.97e-2)" 10.9 4.6 7.1 17.9 11.4 21.0 5.4 2.0 6.0 3.4 3.7 5.9 0.5 4.2 5.8 3.9 3.2 5.3 6.5 4.0 6.5 3.4 4.6 5.8 9.8 26.4 12.9 2.6 7.4 7.7 1.0 4.2 6.6 10.6 3.9 4.6 2.2 11.0 2.5 1.7 3.1 6.7 6.5 19.4 40.4 4.2 1.6 10.9 10.1 2.4 1.7 13.1 6.3 2.8 2.3 4.5 43.3 13.1 1.8 1.1 2.4 0.2 1.7 0.1 0.0 0.2 1.3 0.0 0.0 0.4 0.1 1.0 0.2 4.7 9.6 1.0 0.0 4.7 0.3 0.1 1.2 0.2 1.1 0.5 1.2 0.4 0.0 0.0 1.8 0.5 0.4 0.2 0.4 0.0 0.4 11.0 0.2 1.3 2.9 1.4 0.0 0.4 3.9 0.0 0.0 0.0 6.5 0.1 11.9 1.1 0.0 0.0 1.4 0.0 0.1 0.4 0.1 0.1 2.3 2.8 1.0 0.4 0.1 0.6 1.1 0.1 17.8 2.5 6.6 0.3 0.0 6.8 2.6 1.0 10.4 0.8 2.3 1.1 0.8 4.5 2.0 1.1 0.6 43.3 1.8 13.1 1.5 0.4 2.4 7.1 11.4 2.0 6.0 6.5 3.4 12.9 2.6 10.6 10.9 0.0 1.0 6.4 0.5 0.2 0.2 0.0 0.0 8.1 2.3 1.8 0.0 0.1 1.7 3.9 0.0 2.1 0.2 0.0 3.8 0.2 0.7 1.0 3.5 2.5 14.0 0.0 0.0 0.0 33.2 0.0 0.0 18.2 0.0 2.8 0.3 1.7 1.9 0.0 2.5 1.2 0.2 0.0 0.0 0.1 0.1 0.5 0.1 4.4 1.5 0.9 TLR10 CD290 ENSG00000174123 "Toll like receptor 10" Q9BXR5 4 38772239-38782990 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6" "Cell type enriched" "Detected in some" 18 "B-cells: 39.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory B-cell: 23.5;naive B-cell: 14.9" "Lineage enriched" "Detected in many" 6 "B-cells: 23.5" "Group enriched" "Detected in some" 55 "Daudi: 38.2;REH: 12.8;U-698: 13.7" "Low region specificity" "Detected in all" HPA066755 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA066755: " "unprognostic (5.41e-5)" "unprognostic (2.41e-4)" "unprognostic (1.91e-3)" "unprognostic (8.22e-4)" "unprognostic (6.48e-2)" "unprognostic (9.98e-4)" "unprognostic (9.31e-2)" "unprognostic (8.76e-3)" "unprognostic (4.08e-3)" "unprognostic (7.26e-2)" "unprognostic (8.76e-2)" "unprognostic (6.90e-2)" "unprognostic (2.98e-3)" "unprognostic (3.90e-1)" "unprognostic (1.81e-2)" "unprognostic (3.14e-3)" "unprognostic (1.88e-2)" 0.8 0.5 4.2 24.5 9.4 0.9 0.6 0.6 3.5 0.6 1.0 2.5 0.0 0.9 0.5 0.3 1.7 0.9 1.0 0.5 3.2 1.8 0.8 0.7 1.2 27.0 5.5 0.5 0.5 0.6 0.1 0.7 0.2 4.8 0.8 1.4 0.0 2.6 0.3 0.5 0.5 11.2 0.3 11.3 24.4 1.8 0.4 7.4 2.7 0.9 0.0 31.6 3.2 0.6 23.5 4.0 0.7 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.1 0.2 0.4 0.0 1.5 0.0 23.5 0.0 0.0 3.6 14.9 0.0 0.0 0.7 0.0 1.8 4.0 0.0 0.9 4.2 9.4 0.6 3.5 3.2 1.8 5.5 0.5 4.8 7.4 0.0 1.4 39.2 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.7 0.0 1.2 0.6 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 TLR2 "CD282, TIL4" ENSG00000137462 "Toll like receptor 2" O60603 4 153684070-153705702 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 72.9" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 64.7;Kupffer cells: 106.5;Macrophages: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4" "Group enriched" "Detected in many" 46 "dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5" "Cell line enhanced" "Detected in some" "HL-60: 6.9;HSkMC: 7.5;hTCEpi: 7.5;RPTEC TERT1: 7.7;RT4: 9.5;THP-1: 36.3;U-937: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060231, HPA071546" Supported Nucleoplasm,Mitochondria No NA "Nucleoplasm, Mitochondria" "HPA060231: , HPA071546: " "unprognostic (4.15e-1)" "unprognostic (3.29e-2)" "unprognostic (5.32e-2)" "unprognostic (1.52e-2)" "unprognostic (3.46e-2)" "unprognostic (4.88e-2)" "unprognostic (1.39e-2)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-2)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.87e-2)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (5.93e-3)" 16.3 6.9 6.9 30.0 11.1 34.6 7.3 1.4 5.3 4.7 4.7 3.0 9.3 2.2 3.1 8.0 3.2 7.2 10.0 7.2 6.7 3.3 9.8 7.3 31.1 37.8 12.4 1.4 4.2 5.1 1.1 4.4 6.4 9.9 5.5 1.9 3.3 15.0 9.9 2.5 3.1 4.0 6.6 21.9 29.3 3.9 4.8 9.5 0.9 3.3 1.0 8.5 7.3 3.5 0.2 19.1 72.9 29.5 0.8 0.2 9.3 4.0 0.0 0.2 0.0 0.5 1.6 0.0 0.0 0.3 0.3 0.5 1.9 0.2 0.0 0.4 0.0 0.0 3.6 0.4 0.3 0.2 0.0 0.0 0.1 0.0 0.4 0.0 6.9 0.5 7.5 7.5 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.4 0.0 1.6 0.1 0.0 0.0 7.7 9.5 0.0 0.2 0.4 0.0 1.8 0.2 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.9 0.9 6.2 29.5 0.2 0.0 28.1 0.0 0.0 0.1 0.0 19.1 0.2 0.2 0.0 72.9 0.8 18.4 0.1 0.0 9.3 6.9 11.1 1.4 5.3 6.7 3.3 12.4 1.4 9.9 9.5 6.0 64.7 0.8 1.1 1.0 0.0 1.2 5.1 2.7 12.5 3.5 0.0 0.1 0.0 4.8 0.3 0.6 0.0 0.0 3.2 0.1 0.9 2.0 3.5 0.9 16.3 0.0 0.0 2.5 106.5 0.0 0.6 52.5 1.7 0.0 0.1 0.0 3.1 0.0 0.4 1.0 0.3 12.9 0.4 0.2 0.4 1.0 0.1 0.7 0.0 1.4 TLR3 CD283 ENSG00000164342 "Toll like receptor 3" O15455 4 186069152-186088069 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Receptor, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 48.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 46.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 7.6;memory CD8 T-cell: 8.0" "Group enriched" "Detected in many" 7 "dendritic cells: 2.5;T-cells: 8.0" "Cell line enhanced" "Detected in many" "ASC diff: 11.6;ASC TERT1: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 18.0;CAPAN-2: 28.0;HSkMC: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025658 Enhanced "Intracellular and membrane" NA NA "CAB025658: " "unprognostic (2.13e-2)" "unprognostic (2.15e-1)" "unprognostic (7.26e-2)" "unprognostic (7.47e-3)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (6.39e-3)" "unprognostic (1.56e-2)" "unprognostic (9.28e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (1.17e-1)" "unprognostic (4.72e-3)" "unprognostic (1.18e-1)" "unprognostic (4.52e-3)" "unprognostic (3.89e-2)" "unprognostic (1.83e-1)" 11.9 10.7 3.1 6.8 5.0 0.0 11.1 1.7 3.5 9.9 20.1 3.0 6.8 13.4 5.6 7.3 12.9 7.8 8.6 7.7 3.5 2.6 12.4 11.2 12.2 1.0 3.3 1.9 8.9 8.2 4.8 2.7 48.1 3.0 11.3 9.5 5.0 8.5 10.2 2.3 3.8 34.9 6.5 8.0 7.0 8.2 5.8 4.2 1.2 11.8 7.6 3.0 10.3 14.6 0.0 2.5 0.5 0.0 0.7 8.0 1.1 1.9 0.5 0.3 0.0 11.6 12.1 0.9 0.1 8.4 5.1 18.0 0.0 28.0 0.0 1.1 1.2 10.2 2.9 0.0 5.8 0.9 10.7 0.1 1.7 0.5 0.0 5.1 1.8 0.7 11.9 2.2 6.8 0.3 3.1 2.4 1.8 0.0 0.0 2.9 0.0 2.0 0.0 0.9 0.0 1.0 2.6 0.0 0.1 4.9 2.7 0.0 0.1 1.5 1.2 2.3 0.1 0.3 0.0 1.7 0.9 0.6 0.0 1.2 0.0 0.0 0.0 2.4 1.2 2.0 0.5 0.0 0.0 7.6 0.0 4.3 0.0 1.8 8.0 2.5 0.0 1.2 3.9 0.3 0.7 0.0 0.0 0.2 1.1 3.1 5.0 1.7 3.5 3.5 2.6 3.3 1.9 3.0 4.2 17.9 5.6 1.3 3.2 3.4 0.0 0.8 17.8 2.7 11.4 14.0 0.0 16.9 0.0 6.4 46.2 3.2 14.4 0.0 8.7 4.6 4.0 2.6 2.3 6.4 2.3 0.0 1.2 6.7 0.3 3.8 7.8 2.5 0.0 0.0 6.7 3.8 6.2 8.6 3.5 5.4 0.4 0.0 1.4 0.0 0.4 0.9 16.4 0.0 4.5 5.0 TLR4 "ARMD10, CD284, hToll, TLR-4" ENSG00000136869 "Toll like receptor 4" O00206 9 117704175-117724730 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Age-related macular degeneration, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 31.7;Ito cells: 59.5;Kupffer cells: 88.0;Macrophages: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 30.1" "Group enriched" "Detected in many" 30 "dendritic cells: 7.5;granulocytes: 30.1;monocytes: 21.4" "Cell line enhanced" "Detected in many" "Karpas-707: 29.6;TIME: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004025, HPA049174" Approved Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "Golgi apparatus" "CAB004025: , HPA049174: AB_2680662" "unprognostic (1.60e-1)" "unprognostic (8.34e-2)" "unprognostic (7.22e-2)" "prognostic favorable (6.29e-4)" "unprognostic (3.39e-1)" "unprognostic (7.48e-2)" "unprognostic (8.68e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (5.18e-2)" "unprognostic (8.00e-2)" "unprognostic (9.42e-2)" "unprognostic (4.08e-2)" "unprognostic (8.63e-2)" "prognostic unfavorable (3.79e-4)" "unprognostic (1.09e-2)" "unprognostic (1.96e-2)" 29.2 12.1 15.5 23.5 12.5 17.8 21.9 9.4 10.3 6.9 6.8 10.6 3.0 4.4 5.8 7.7 5.0 6.8 10.6 10.9 19.9 7.5 9.0 16.5 16.0 30.9 12.4 11.4 6.7 3.0 2.9 3.8 22.8 10.5 5.7 7.4 7.2 9.0 3.6 7.4 5.2 6.6 10.4 11.1 41.4 4.5 2.4 13.0 1.1 8.3 5.6 7.5 12.1 16.1 0.6 7.5 30.1 21.4 0.0 0.0 6.9 0.0 0.0 12.7 0.0 5.9 12.0 0.1 5.0 8.8 1.3 0.7 0.0 1.2 1.7 0.2 13.0 3.9 0.0 0.0 1.1 1.9 0.0 0.0 2.7 2.7 0.1 4.4 9.1 0.0 7.4 0.0 2.8 0.3 11.4 15.5 0.0 0.0 29.6 15.4 0.0 0.0 1.8 1.5 1.2 0.6 0.0 14.3 9.3 0.5 14.8 0.0 0.0 3.2 0.0 0.5 1.2 0.0 5.0 21.4 0.7 9.6 0.0 2.4 0.0 0.0 0.0 0.4 9.6 7.6 17.6 21.4 7.2 0.0 19.6 0.0 0.6 0.0 0.0 7.5 0.2 0.0 0.0 30.1 0.0 20.2 0.3 0.0 6.9 15.5 12.5 9.4 10.3 19.9 7.5 12.4 11.4 10.5 13.0 0.0 5.3 1.5 0.1 0.7 0.2 2.5 5.1 2.7 4.5 0.0 0.0 0.2 0.0 0.0 0.0 19.7 0.3 0.0 0.2 0.2 1.9 0.2 15.1 1.8 31.7 0.0 0.0 59.5 88.0 0.0 0.0 33.1 1.7 0.0 0.6 13.8 0.3 1.7 0.0 0.4 0.8 6.5 0.9 0.0 0.2 0.0 0.7 0.0 0.1 2.2 TLR5 "FLJ10052, MGC126430, MGC126431, SLEB1, TIL3" ENSG00000187554 "Toll like receptor 5" O60602 1 223109406-223143282 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 17.8;Collecting duct cells: 21.0;Kupffer cells: 23.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "classical monocyte: 17.0;intermediate monocyte: 15.7;myeloid DC: 12.8;neutrophil: 13.4;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 10 "dendritic cells: 12.8;granulocytes: 13.4;monocytes: 17.0" "Cell line enhanced" "Detected in some" "A-431: 4.4;HaCaT: 6.7;OE19: 3.9;SK-BR-3: 4.3;T-47d: 4.8" "Low region specificity" "Detected in many" CAB009013 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB009013: AB_2240732" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-1)" "unprognostic (2.25e-2)" "unprognostic (3.81e-2)" "unprognostic (3.09e-2)" "unprognostic (6.83e-2)" "unprognostic (1.49e-2)" "unprognostic (2.71e-1)" "unprognostic (4.23e-3)" "unprognostic (1.46e-1)" "unprognostic (3.69e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (1.06e-3)" "unprognostic (5.60e-2)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" 3.8 2.4 5.3 4.8 7.3 0.4 9.7 0.8 5.3 7.1 2.7 3.4 1.7 1.7 2.4 6.2 9.0 5.6 4.8 5.8 5.0 2.6 4.6 2.2 6.5 12.5 7.0 0.8 22.5 5.3 6.6 6.3 3.5 6.8 6.2 2.3 3.2 12.6 2.9 1.4 3.7 2.3 3.7 12.8 6.7 4.5 2.3 8.1 1.2 4.3 3.5 5.7 5.9 7.8 0.1 12.8 13.4 17.0 0.2 1.4 5.7 4.4 0.4 0.7 0.4 0.3 0.0 0.6 0.2 0.0 0.1 0.1 0.0 1.3 0.0 0.9 0.4 0.1 6.7 0.1 0.5 0.4 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.1 1.9 0.5 0.2 1.7 0.9 0.0 0.0 0.6 1.0 0.3 2.5 3.9 0.0 0.1 0.0 0.2 2.1 0.8 1.8 0.4 1.3 4.3 0.1 1.0 4.8 0.0 0.0 0.1 0.1 0.0 1.2 0.2 0.0 0.2 0.0 0.7 0.5 0.0 17.0 0.2 0.1 15.7 0.2 0.1 0.9 0.2 12.8 0.0 1.4 0.4 13.4 0.2 6.3 0.2 0.6 5.7 5.3 7.3 0.8 5.3 5.0 2.6 7.0 0.8 6.8 8.1 3.0 10.5 0.0 5.9 0.5 0.0 1.7 17.8 8.1 15.9 21.0 2.0 1.2 3.3 3.0 3.3 1.0 0.0 0.0 3.4 0.3 5.0 3.3 2.3 0.6 15.6 0.0 1.2 0.6 23.7 4.0 8.6 11.1 3.3 0.0 0.3 1.1 2.0 0.0 8.1 0.0 0.1 0.0 1.4 4.3 4.5 1.4 0.7 0.0 1.2 6.5 TLR6 CD286 ENSG00000174130 "Toll like receptor 6" Q9Y2C9 4 38823715-38856817 "CD markers, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.2;brain: 16.0;lymphoid tissue: 16.2" "Cell type enhanced" "Detected in some" 12 "B-cells: 5.0;Hofbauer cells: 5.9;Kupffer cells: 11.8;Macrophages: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 14.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 12.5;GAMG: 12.9;RPMI-8226: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062733 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA062733: AB_2684853" "unprognostic (9.82e-2)" "unprognostic (4.76e-2)" "unprognostic (3.30e-2)" "unprognostic (3.05e-2)" "unprognostic (1.91e-1)" "unprognostic (1.87e-2)" "unprognostic (1.83e-1)" "unprognostic (4.45e-2)" "unprognostic (9.26e-2)" "unprognostic (1.30e-1)" "unprognostic (1.05e-2)" "unprognostic (2.69e-1)" "unprognostic (7.62e-7)" "unprognostic (4.89e-2)" "unprognostic (1.02e-2)" "unprognostic (7.78e-2)" "unprognostic (2.12e-2)" 2.9 2.7 6.1 10.7 7.9 6.4 2.1 2.0 3.9 1.8 1.6 2.6 0.2 1.7 1.4 2.0 1.8 1.9 3.9 1.5 4.5 1.7 1.7 2.1 5.0 11.2 10.6 1.9 1.6 1.2 0.7 1.9 2.8 7.2 1.6 2.4 0.9 4.3 0.5 0.9 1.7 7.8 2.1 16.0 16.2 2.1 0.8 6.8 1.8 1.5 1.1 14.8 5.8 1.9 1.8 1.8 14.2 2.6 0.3 0.4 0.6 1.4 5.7 0.2 0.1 0.3 6.7 0.0 1.6 6.9 0.7 2.3 0.0 12.5 6.9 2.7 0.3 12.9 0.6 0.1 1.2 1.1 0.0 0.5 3.2 6.9 0.2 0.4 3.5 5.2 2.8 1.3 2.8 1.5 0.2 1.4 1.1 3.5 2.2 3.1 0.0 0.0 6.1 0.2 0.0 0.9 3.4 3.1 9.8 0.4 0.1 0.0 0.1 0.2 0.0 0.9 0.3 0.3 1.8 1.9 2.2 7.5 0.9 2.4 0.1 0.0 5.8 5.1 4.1 1.6 0.0 2.6 0.7 0.2 2.4 0.0 1.8 0.1 0.1 1.8 1.2 0.3 0.2 14.2 0.3 1.2 1.3 0.4 0.6 6.1 7.9 2.0 3.9 4.5 1.7 10.6 1.9 7.2 6.8 0.0 0.0 5.0 1.1 0.6 0.7 1.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 0.2 0.8 0.8 2.3 0.0 5.9 0.0 0.0 0.6 11.8 0.0 0.6 9.5 0.0 1.8 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.4 0.2 0.0 0.6 0.2 0.0 0.0 0.9 TLR7 ENSG00000196664 "Toll like receptor 7" Q9NYK1 X 12867083-12890380 "FDA approved drug targets, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5" "Cell type enhanced" "Detected in some" 16 "Hofbauer cells: 20.2;Macrophages: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 16.0;U-266/70: 16.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059613 Supported NA NA "HPA059613: AB_2684083" "unprognostic (1.22e-1)" "unprognostic (1.09e-2)" "unprognostic (2.36e-3)" "unprognostic (9.29e-2)" "unprognostic (2.06e-1)" "unprognostic (1.06e-2)" "unprognostic (8.27e-2)" "unprognostic (6.20e-3)" "unprognostic (3.75e-1)" "unprognostic (6.91e-2)" "unprognostic (3.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.54e-1)" "unprognostic (4.17e-3)" "unprognostic (1.19e-3)" "unprognostic (1.53e-3)" "unprognostic (1.34e-1)" 2.9 3.1 7.6 7.2 11.3 1.0 7.6 1.7 7.9 2.5 3.3 10.6 0.0 3.2 1.8 2.9 1.8 1.7 5.3 4.1 8.4 5.1 2.2 1.5 7.7 6.9 17.4 2.6 1.6 1.9 1.5 2.2 11.0 12.9 2.2 4.0 1.5 2.7 2.0 1.4 1.4 4.9 3.5 26.5 6.7 3.0 1.5 17.2 7.7 1.7 0.5 9.4 5.2 1.6 6.9 15.7 3.2 8.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 16.5 0.0 3.1 0.0 0.3 0.0 0.2 7.2 3.2 0.0 8.9 0.0 6.9 0.0 0.0 3.7 5.8 0.0 0.0 0.4 0.0 6.8 15.7 0.0 2.2 7.6 11.3 1.7 7.9 8.4 5.1 17.4 2.6 12.9 17.2 0.0 4.6 2.4 1.1 1.1 0.0 0.5 0.0 4.0 1.2 0.0 2.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.0 0.7 1.1 0.0 20.2 0.0 0.0 0.6 2.4 0.0 0.6 14.8 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.1 0.9 0.2 0.0 0.0 1.4 TLR8 CD288 ENSG00000101916 "Toll like receptor 8" Q9NR97 X 12906620-12923169 "CD markers, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.8;lymphoid tissue: 45.6" "Group enriched" "Detected in some" 6 "Kupffer cells: 48.1;Macrophages: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 94 "classical monocyte: 10.0;intermediate monocyte: 9.6;myeloid DC: 5.3;neutrophil: 17.8;non-classical monocyte: 9.2" "Group enriched" "Detected in many" 100 "dendritic cells: 5.3;granulocytes: 17.8;monocytes: 10.0" "Cell line enhanced" "Detected in some" "HMC-1: 1.2;PC-3: 2.8;THP-1: 1.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA001608 Enhanced NA NA "HPA001608: AB_1080295" "unprognostic (1.32e-1)" "unprognostic (6.94e-2)" "unprognostic (3.96e-3)" "unprognostic (4.43e-2)" "unprognostic (9.63e-2)" "unprognostic (2.48e-2)" "unprognostic (2.59e-1)" "unprognostic (6.61e-2)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (3.72e-2)" "unprognostic (2.73e-1)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (4.14e-2)" "unprognostic (1.52e-1)" "unprognostic (5.66e-2)" 8.5 1.4 0.9 16.0 1.5 4.7 1.2 0.7 1.1 1.0 1.5 0.4 0.0 0.6 1.0 3.2 1.0 2.0 2.4 3.0 2.0 1.0 2.0 4.0 13.7 33.0 1.7 0.1 1.1 1.0 0.2 1.0 4.0 1.9 1.4 1.7 0.9 1.2 0.0 1.4 0.8 2.0 3.5 3.3 45.6 1.3 1.2 1.6 3.5 1.0 1.1 2.4 4.2 2.4 0.1 5.3 17.8 10.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.0 0.3 0.0 0.0 10.0 0.0 0.0 9.6 0.0 0.1 0.0 0.0 5.3 0.0 0.0 0.0 17.8 0.0 9.2 0.0 0.0 2.0 0.9 1.5 0.7 1.1 2.0 1.0 1.7 0.1 1.9 1.6 0.0 4.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 0.0 0.6 48.1 0.0 0.0 13.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TLR9 CD289 ENSG00000239732 "Toll like receptor 9" Q9NR96 3 52221080-52226163 "CD markers, FDA approved drug targets, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "blood: 33.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 10 "plasmacytoid DC: 33.8" "Lineage enriched" "Detected in many" 10 "dendritic cells: 33.8" "Group enriched" "Detected in some" 12 "Daudi: 24.7;RPMI-8226: 15.7;U-698: 9.5" NA NA "unprognostic (6.03e-2)" "unprognostic (5.08e-2)" "unprognostic (3.58e-3)" "unprognostic (6.69e-7)" "unprognostic (1.16e-1)" "unprognostic (1.89e-2)" "unprognostic (2.69e-1)" "unprognostic (1.58e-1)" "unprognostic (7.02e-2)" "unprognostic (1.89e-1)" "unprognostic (4.40e-2)" "unprognostic (7.60e-2)" "unprognostic (2.65e-3)" "unprognostic (2.44e-2)" "unprognostic (3.70e-1)" "unprognostic (2.27e-1)" "unprognostic (7.91e-3)" 0.5 0.2 0.0 2.8 0.5 2.5 0.4 4.9 0.4 0.8 1.2 0.7 0.9 0.0 0.2 1.0 0.9 0.3 0.2 0.3 0.3 0.1 0.6 6.5 0.1 2.5 0.0 0.0 0.3 0.1 0.9 0.1 1.4 0.4 1.8 0.1 2.2 0.1 0.4 3.9 0.5 0.3 0.7 3.9 1.2 1.2 3.3 33.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 1.0 0.7 9.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TM2D1 BBP ENSG00000162604 "TM2 domain containing 1" Q9BX74 1 61681046-61725423 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046058, HPA055621" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046058: AB_2679519, HPA055621: AB_2682865" "unprognostic (1.80e-1)" "unprognostic (1.99e-3)" "unprognostic (1.68e-1)" "unprognostic (2.20e-2)" "unprognostic (5.79e-1)" "unprognostic (5.23e-2)" "prognostic unfavorable (2.02e-7)" "unprognostic (1.08e-1)" "unprognostic (1.52e-1)" "unprognostic (1.19e-1)" "unprognostic (2.00e-1)" "unprognostic (2.28e-2)" "unprognostic (1.15e-2)" "unprognostic (4.60e-2)" "unprognostic (1.13e-1)" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" 24.2 30.7 32.5 20.0 42.8 16.2 30.1 24.7 50.1 26.2 22.1 25.3 21.2 16.6 26.3 38.9 19.3 25.1 23.7 36.5 27.9 28.3 32.3 23.5 35.9 27.0 32.7 22.2 31.4 27.6 25.9 24.0 28.8 33.6 28.3 23.9 24.4 23.1 25.6 29.6 16.0 20.1 24.2 45.6 20.3 23.4 27.0 22.3 20.2 33.7 16.6 16.0 21.9 20.5 15.3 22.6 27.2 15.7 14.7 15.2 12.5 11.7 5.8 9.0 7.1 27.5 27.0 11.5 21.1 21.6 10.4 14.0 3.7 15.1 9.6 28.2 17.6 20.9 13.5 11.4 15.3 16.2 15.6 13.4 10.6 9.5 8.2 27.0 15.3 19.0 30.0 26.5 12.0 15.2 25.6 19.7 13.0 12.2 18.7 25.2 3.8 7.7 12.1 9.8 10.5 8.3 6.7 17.0 11.8 30.8 9.3 10.1 12.3 12.6 25.1 37.9 12.6 13.7 16.6 17.4 14.1 7.1 7.8 15.9 15.8 14.5 11.8 24.5 15.0 12.4 26.6 12.6 27.2 11.2 14.6 11.1 15.3 13.0 13.5 11.8 13.0 12.3 14.1 7.6 14.7 15.7 22.6 15.2 12.5 32.5 42.8 24.7 50.1 27.9 28.3 32.7 22.2 33.6 22.3 38.7 38.1 38.9 83.1 69.5 54.4 36.2 38.2 58.9 37.5 75.0 56.9 45.4 33.2 46.4 4.1 53.0 41.7 23.3 39.6 53.3 78.6 77.5 60.0 45.7 45.3 65.2 42.2 74.3 58.7 6.8 73.9 51.2 86.0 39.7 38.7 80.4 42.9 56.0 49.8 58.8 62.9 38.8 59.7 165.1 61.8 66.9 44.7 47.9 41.6 90.1 TM2D2 BLP1 ENSG00000169490 "TM2 domain containing 2" Q9BX73 8 38988808-38996824 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 172.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047152, HPA050547" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles, Plasma membrane" "HPA047152: AB_2679957, HPA050547: AB_2681168" "prognostic unfavorable (7.49e-4)" "unprognostic (1.49e-1)" "prognostic favorable (1.71e-4)" "unprognostic (2.55e-2)" "unprognostic (7.02e-2)" "unprognostic (2.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-2)" "unprognostic (2.43e-3)" "unprognostic (4.58e-2)" "unprognostic (1.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-2)" "unprognostic (8.61e-2)" 21.6 26.2 19.9 14.9 24.3 11.3 24.5 18.8 29.6 21.0 15.3 18.4 25.4 17.5 20.1 27.6 17.2 17.9 22.9 19.4 18.7 20.4 32.6 29.0 21.1 18.1 20.5 17.3 23.3 26.8 25.9 17.5 32.6 25.7 22.8 16.6 22.9 18.8 23.4 14.6 18.5 20.7 17.7 16.4 24.3 19.2 26.1 13.9 11.1 39.7 14.9 14.9 16.7 19.5 14.4 33.5 27.2 18.8 17.4 22.8 19.2 14.0 22.7 10.6 14.6 24.8 16.7 14.6 29.9 18.4 22.7 20.6 17.3 12.2 4.9 23.6 22.1 25.5 15.3 11.2 18.1 24.8 5.9 8.6 11.3 13.3 18.6 22.0 3.3 14.7 20.3 17.8 17.8 8.7 16.6 29.1 8.4 12.4 14.7 30.2 8.7 8.2 11.4 13.4 21.2 9.0 7.0 13.7 8.3 25.9 11.2 3.5 6.9 11.4 8.0 14.7 19.6 19.6 7.1 26.1 18.4 13.8 26.8 15.0 10.3 22.7 8.7 14.0 7.7 12.8 27.2 16.2 14.5 18.0 18.8 19.6 14.3 21.2 19.6 17.0 14.4 20.2 19.6 4.5 17.4 15.6 33.5 22.8 19.2 19.9 24.3 18.8 29.6 18.7 20.4 20.5 17.3 25.7 13.9 11.9 14.3 17.6 48.8 31.1 21.6 15.1 30.6 20.1 20.5 48.8 19.6 78.2 24.9 57.6 44.6 26.6 11.9 0.0 33.5 82.1 36.1 49.2 21.9 33.7 172.6 22.3 9.9 66.3 32.3 35.5 33.4 33.8 25.3 106.4 10.7 40.2 58.6 15.2 23.3 48.2 29.3 0.0 18.1 33.0 59.4 13.6 66.8 22.0 14.9 50.4 TM2D3 "BLP2, FLJ22604" ENSG00000184277 "TM2 domain containing 3" Q9BRN9 15 101621444-101652391 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054064 Uncertain Approved Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA054064: AB_2682366" "unprognostic (1.41e-1)" "unprognostic (8.76e-2)" "unprognostic (2.06e-2)" "unprognostic (2.55e-3)" "unprognostic (1.15e-1)" "unprognostic (8.37e-2)" "unprognostic (2.29e-1)" "unprognostic (8.62e-2)" "unprognostic (2.51e-2)" "unprognostic (5.40e-2)" "unprognostic (4.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (2.92e-2)" "unprognostic (2.63e-1)" "unprognostic (3.78e-2)" "unprognostic (2.78e-2)" 17.8 25.1 32.8 14.1 33.1 15.4 26.0 30.7 46.7 24.9 16.9 21.3 15.3 15.2 26.3 29.1 15.3 22.5 18.7 28.3 35.3 49.8 20.6 32.8 17.5 23.0 28.2 35.8 37.6 28.2 23.5 25.7 19.6 26.8 21.5 15.6 19.1 20.9 24.0 22.6 16.8 15.0 20.7 22.7 17.0 15.8 20.6 19.1 16.0 29.1 14.2 19.2 19.2 16.1 21.4 14.3 38.4 20.2 24.1 24.1 18.0 8.5 21.3 11.4 20.6 32.9 24.5 14.0 11.3 18.8 13.5 15.1 11.4 24.4 14.0 15.7 15.4 22.7 20.2 17.7 14.6 10.7 13.3 39.0 20.9 18.5 19.3 21.7 16.2 25.0 20.3 29.6 8.1 16.9 18.9 18.5 18.2 17.1 21.2 21.2 17.3 11.8 17.2 17.6 38.9 7.2 14.5 14.5 21.7 27.2 22.6 15.4 14.1 15.6 16.6 22.5 20.5 15.7 21.5 14.7 14.3 14.7 9.5 12.4 20.1 29.7 15.1 12.1 20.4 11.7 14.8 20.2 38.4 21.7 19.9 24.1 15.5 17.9 16.5 14.3 21.4 23.9 22.1 34.4 24.1 15.0 12.1 18.0 18.0 32.8 33.1 30.7 46.7 35.3 49.8 28.2 35.8 26.8 19.1 23.8 33.2 37.0 49.5 58.8 44.9 33.5 22.9 16.0 28.4 40.1 31.4 64.8 16.6 54.9 5.7 52.5 22.0 0.0 37.4 54.4 51.9 46.9 24.3 51.6 29.9 65.2 25.9 53.4 45.9 8.8 68.1 37.2 25.3 39.7 23.1 57.0 28.6 23.2 59.1 32.7 43.7 71.1 42.7 85.4 85.7 48.4 76.1 47.2 25.4 34.6 TM4SF1 "L6, M3S1" ENSG00000169908 "Transmembrane 4 L six family member 1" P30408 3 149369022-149377865 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 4692.6;Glandular cells: 2223.6;Pancreatic endocrine cells: 1835.5;Urothelial cells: 5293.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 71.8;hTERT-RPE1: 98.5;HUVEC TERT2: 64.8;LHCN-M2: 69.8;OE19: 70.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002760, HPA002823" Uncertain NA NA "CAB002760: , HPA002823: AB_1079221" "unprognostic (1.94e-1)" "unprognostic (2.25e-2)" "unprognostic (5.20e-2)" "unprognostic (4.79e-2)" "unprognostic (2.89e-2)" "unprognostic (2.47e-3)" "unprognostic (3.85e-3)" "unprognostic (2.74e-2)" "unprognostic (5.09e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (4.01e-4)" "unprognostic (4.06e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (4.67e-2)" "unprognostic (2.10e-1)" "unprognostic (2.67e-1)" "prognostic unfavorable (3.43e-6)" 72.7 16.9 10.2 11.8 15.5 0.3 44.3 6.4 11.6 33.6 16.3 8.2 4.0 8.6 32.0 35.5 89.2 18.2 54.2 37.5 10.2 10.0 26.9 22.8 111.0 10.9 13.2 2.9 26.0 54.3 3.9 5.2 50.8 17.6 26.0 14.0 20.4 45.4 7.8 29.6 14.8 15.9 21.5 13.1 35.8 25.9 14.4 11.8 1.7 17.0 76.0 48.4 32.4 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 36.5 39.0 0.0 0.1 12.1 46.4 0.0 11.6 46.6 2.5 0.9 15.6 71.8 0.0 37.4 2.3 57.6 44.2 0.2 8.2 2.4 0.1 0.0 0.6 42.4 51.7 4.4 0.0 0.0 4.5 2.1 17.8 8.8 98.5 64.8 0.0 0.0 0.0 69.8 0.0 0.0 0.0 0.1 70.9 17.7 0.0 0.0 0.0 46.3 5.5 0.0 0.0 4.9 2.6 0.4 0.6 0.0 0.1 40.9 24.2 4.2 0.4 24.5 0.0 0.0 0.0 35.2 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.2 15.5 6.4 11.6 10.2 10.0 13.2 2.9 17.6 11.8 536.0 334.5 11.8 4692.6 246.9 0.0 21.3 221.7 149.9 565.3 54.1 0.0 0.4 0.0 1034.2 4.3 1040.2 30.7 23.3 1399.4 0.7 167.3 2223.6 29.1 22.1 1.6 0.0 37.5 904.2 35.1 4.7 236.8 42.2 285.1 45.9 2.1 0.0 1835.5 0.9 165.5 0.2 0.0 316.9 211.2 1.4 1.2 221.8 1.1 4.8 7.1 5293.1 TM4SF18 L6D ENSG00000163762 "Transmembrane 4 L six family member 18" Q96CE8 3 149318498-149334414 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Endothelial cells: 155.8;Ito cells: 174.3" "Cancer enhanced" "Detected in all" "renal cancer: 17.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 29.6;EFO-21: 62.5;GAMG: 12.4;HUVEC TERT2: 20.7;NTERA-2: 14.9" "Low region specificity" "Detected in all" "HPA053639, HPA069378" Approved Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA053639: , HPA069378: AB_2686133" "unprognostic (2.25e-1)" "unprognostic (3.68e-1)" "unprognostic (4.76e-2)" "unprognostic (1.08e-1)" "unprognostic (9.11e-3)" "unprognostic (1.05e-2)" "prognostic favorable (8.63e-4)" "unprognostic (2.84e-1)" "unprognostic (6.13e-3)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (1.75e-1)" "unprognostic (5.71e-2)" "unprognostic (3.56e-3)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.97e-1)" 17.9 4.8 7.1 4.0 8.8 0.1 14.4 3.7 7.3 7.9 3.5 1.7 4.7 3.1 7.6 7.2 5.4 5.6 9.0 10.8 8.4 6.2 26.6 9.7 7.4 8.0 9.3 1.5 5.4 8.0 4.2 7.4 14.1 12.3 9.1 2.9 11.9 3.5 5.6 9.3 2.7 3.9 12.3 7.4 34.6 3.5 2.6 8.2 0.6 12.0 5.7 4.0 6.0 5.8 0.9 0.6 1.2 0.4 2.8 0.5 0.0 0.0 29.6 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 62.5 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.9 20.7 0.0 0.0 0.0 1.9 0.2 0.0 0.0 14.9 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 2.6 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.7 1.2 0.4 0.4 0.3 0.2 0.1 0.5 0.4 0.2 0.0 0.9 0.4 0.5 0.5 2.8 0.3 0.6 0.1 0.0 7.1 8.8 3.7 7.3 8.4 6.2 9.3 1.5 12.3 8.2 0.0 4.1 2.2 0.0 2.9 0.1 1.1 7.6 1.4 0.0 1.8 0.0 0.0 8.3 21.2 0.3 155.8 0.0 0.0 0.2 0.0 0.9 1.0 1.1 0.6 0.1 0.0 0.0 174.3 13.0 1.0 2.0 0.2 1.7 1.0 0.0 0.6 1.2 0.0 6.3 25.4 0.0 0.0 2.1 0.0 0.2 2.5 0.0 1.3 0.0 0.4 TM4SF19 ENSG00000145107 "Transmembrane 4 L six family member 19" Q96DZ7 3 196319342-196338503 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "adipose tissue: 69.9" "Cell type enriched" "Detected in some" 9 "Hofbauer cells: 78.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 14.8;memory CD8 T-cell: 3.8;naive CD8 T-cell: 5.4" "Lineage enriched" "Detected in single" 19 "T-cells: 14.8" "Cell line enriched" "Detected in some" 12 "GAMG: 100.5" NA NA "unprognostic (9.90e-2)" "unprognostic (1.17e-2)" "unprognostic (3.60e-2)" "unprognostic (1.89e-2)" "unprognostic (1.67e-1)" "unprognostic (7.19e-2)" "unprognostic (8.90e-5)" "unprognostic (8.86e-3)" "unprognostic (1.30e-1)" "unprognostic (3.21e-2)" "unprognostic (1.85e-1)" "unprognostic (2.86e-1)" "unprognostic (1.06e-3)" "unprognostic (4.23e-2)" "unprognostic (4.20e-3)" "unprognostic (2.60e-1)" "unprognostic (1.18e-3)" 69.9 0.4 0.4 0.7 0.4 0.9 4.5 0.4 0.5 2.1 0.4 0.4 0.4 0.0 0.4 0.6 5.0 0.3 0.8 0.4 0.4 0.1 0.4 0.8 4.9 0.6 0.4 0.4 1.2 0.4 0.0 0.4 1.1 0.4 0.6 0.1 0.4 2.2 0.4 2.1 3.2 0.4 0.4 0.4 0.8 0.6 8.2 0.4 0.5 1.0 2.0 1.3 0.9 2.1 0.3 0.5 0.6 0.4 0.8 14.8 1.4 3.4 1.6 0.1 0.1 0.2 1.1 0.1 0.0 1.0 0.3 0.7 0.0 1.9 0.0 0.6 0.0 100.5 0.5 0.0 0.3 0.2 0.1 0.0 0.1 0.4 0.0 0.2 0.2 0.1 0.1 0.3 4.4 7.4 0.0 0.0 0.2 2.1 0.2 1.1 0.2 0.0 0.1 0.0 0.0 8.4 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.1 0.0 0.3 4.4 3.6 0.6 2.0 0.1 1.2 0.0 4.7 0.1 0.1 0.6 0.3 0.4 14.8 0.4 0.1 0.1 1.4 3.8 0.1 0.3 0.8 5.4 0.6 0.8 0.1 0.5 0.3 1.4 0.4 0.4 0.4 0.5 0.4 0.1 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 78.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 3.8 0.0 0.3 0.0 0.0 0.0 TM4SF20 "FLJ22800, TCCE518" ENSG00000168955 "Transmembrane 4 L six family member 20" Q53R12 2 227362156-227381995 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 86 "intestine: 147.8" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 33.2;Enterocytes: 27.7;Late spermatids: 61.3;Paneth cells: 11.5" "Group enriched" "Detected in many" 6 "colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 7.2;RPMI-8226: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051838, HPA063184, HPA065531" Uncertain Supported "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506" "unprognostic (4.68e-2)" "unprognostic (1.13e-1)" "unprognostic (8.75e-2)" "unprognostic (4.96e-2)" "unprognostic (2.84e-2)" "unprognostic (1.63e-1)" "unprognostic (2.51e-1)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-3)" "unprognostic (7.76e-2)" "unprognostic (2.60e-2)" "unprognostic (3.04e-3)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 46.5 0.0 0.0 73.5 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.1 0.1 147.8 0.2 0.1 0.1 0.1 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.1 1.2 1.1 0.5 1.7 0.7 0.0 0.1 7.2 0.2 0.1 0.0 0.0 1.3 0.9 0.1 0.0 0.0 1.4 0.5 0.2 0.1 0.4 0.2 0.2 0.0 0.0 0.1 0.1 0.4 0.0 1.3 0.2 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.4 0.8 0.3 0.0 0.1 1.6 0.3 0.1 0.1 0.5 0.1 4.5 0.1 0.3 0.6 1.7 1.1 0.1 0.0 0.1 0.3 0.1 0.3 0.6 0.3 2.0 0.2 0.5 0.3 0.4 0.2 0.2 0.2 0.8 0.5 0.1 0.7 0.3 0.3 0.7 0.4 0.4 0.0 1.1 0.7 0.5 1.1 1.7 0.1 1.2 0.4 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 11.5 0.7 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.2 0.0 TM4SF4 il-TMP ENSG00000169903 "Transmembrane 4 L six family member 4" P48230 3 149473974-149503281 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 196.0;intestine: 126.4;liver: 81.8" "Cell type enriched" "Detected in many" 5 "Cholangiocytes: 2236.9" "Group enriched" "Detected in many" 10 "liver cancer: 249.4;pancreatic cancer: 130.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.3" "Lineage enriched" "Detected in single" 13 "monocytes: 1.3" "Group enriched" "Detected in some" 6 "A549: 15.4;OE19: 14.2;RPTEC TERT1: 24.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046430 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046430: AB_2679662" "unprognostic (1.91e-2)" "unprognostic (1.71e-1)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.98e-1)" "unprognostic (7.60e-2)" "unprognostic (1.83e-1)" "unprognostic (4.66e-2)" "unprognostic (1.91e-2)" "unprognostic (4.97e-1)" 0.3 0.3 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 68.2 0.0 0.0 70.3 0.2 0.1 0.3 0.3 196.0 0.2 0.2 0.2 0.4 81.8 0.3 0.0 0.2 0.0 0.2 24.2 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.2 126.4 0.0 0.2 0.3 2.3 0.3 0.0 0.0 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.3 0.2 0.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.6 0.1 14.2 0.0 0.0 0.3 0.9 24.0 0.0 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 0.0 3.4 2236.9 0.0 1.2 0.0 0.0 0.0 0.0 20.8 0.8 0.0 2.6 23.3 1.7 0.1 0.0 0.0 0.0 475.7 0.1 0.0 2.9 8.0 11.0 0.0 0.0 0.0 0.0 1.8 0.9 0.0 7.6 0.0 0.0 2.1 0.0 0.0 1.1 3.6 0.1 0.0 0.1 0.0 0.1 0.1 TM4SF5 ENSG00000142484 "Transmembrane 4 L six family member 5" O14894 17 4771884-4783213 "Predicted membrane proteins" "Cell cycle" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "intestine: 80.9;liver: 69.8" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 55.9;Hepatocytes: 125.4;Intestinal endocrine cells: 110.5;Mucus-secreting cells: 76.1;Paneth cells: 190.0" "Cancer enriched" "Detected in many" 9 "liver cancer: 219.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 5 "monocytes: 1.1" "Group enriched" "Detected in some" 13 "CACO-2: 23.4;Hep G2: 40.5;OE19: 25.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA055674 Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA055674: " "unprognostic (1.81e-1)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (4.44e-2)" "unprognostic (9.33e-2)" "unprognostic (3.57e-2)" "unprognostic (1.95e-1)" "unprognostic (5.21e-3)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 45.1 0.1 0.1 50.5 0.1 0.2 0.1 0.1 7.0 0.1 0.1 0.1 3.1 69.8 0.1 0.1 0.1 0.1 0.1 0.9 4.1 0.1 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 80.9 0.1 0.1 0.1 8.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 23.4 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 40.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 25.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 25.5 0.0 0.0 1.8 0.0 0.0 5.0 1.1 1.5 0.0 55.9 0.0 8.1 1.2 0.0 0.0 4.6 125.4 0.1 0.0 110.5 6.2 3.2 1.3 0.0 0.0 0.0 0.0 76.1 0.0 4.9 190.0 0.0 47.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.9 34.5 0.0 TM6SF1 ENSG00000136404 "Transmembrane 6 superfamily member 1" Q9BZW5 15 83107407-83144854 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.3;skeletal muscle: 37.8" "Cell type enhanced" "Detected in many" 9 "granulocytes: 43.8;Hofbauer cells: 47.4;Kupffer cells: 39.6;Macrophages: 43.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 44.3;neutrophil: 26.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 44.3" "Cell line enhanced" "Detected in some" "HEL: 9.3;HHSteC: 22.1;HUVEC TERT2: 11.7;JURKAT: 15.7;TIME: 30.4;U-698: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016051, HPA056857" Uncertain NA NA "HPA016051: AB_2203924, HPA056857: AB_2683259" "unprognostic (8.09e-2)" "unprognostic (1.31e-1)" "unprognostic (2.87e-2)" "unprognostic (4.67e-1)" "unprognostic (1.96e-1)" "unprognostic (1.43e-1)" "unprognostic (6.46e-2)" "unprognostic (3.52e-3)" "unprognostic (1.73e-1)" "unprognostic (1.70e-2)" "unprognostic (2.80e-1)" "unprognostic (2.55e-1)" "prognostic favorable (6.79e-4)" "unprognostic (1.15e-2)" "unprognostic (4.65e-3)" "unprognostic (2.60e-2)" "unprognostic (1.70e-1)" 9.6 3.4 4.9 4.9 6.8 4.7 11.2 4.4 13.9 4.0 3.0 6.8 0.9 2.3 3.2 4.1 2.4 3.4 3.9 9.2 7.2 6.7 2.9 2.5 10.6 9.0 8.0 7.1 2.1 1.5 1.8 1.7 7.2 10.0 2.5 2.9 3.4 3.2 1.9 37.8 1.7 2.6 3.8 12.5 5.2 2.1 4.1 3.7 0.6 9.9 3.5 3.0 4.9 2.4 0.2 4.6 44.3 7.8 1.0 1.2 2.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.2 9.3 0.0 0.0 22.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 11.7 15.7 0.4 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.8 0.2 0.0 6.5 30.4 0.3 0.4 0.0 0.1 0.9 0.0 7.0 0.0 1.2 0.0 14.1 7.8 44.3 1.2 3.3 0.0 0.0 0.1 0.1 4.6 0.2 0.0 0.1 26.4 1.0 1.4 0.6 0.0 2.8 4.9 6.8 4.4 13.9 7.2 6.7 8.0 7.1 10.0 3.7 0.0 8.9 0.5 0.0 2.2 1.1 1.2 2.5 1.4 1.2 0.0 0.0 0.2 0.0 0.1 9.8 10.5 0.0 0.0 1.8 0.3 0.7 0.0 43.8 0.0 47.4 0.0 0.0 5.5 39.6 6.3 0.9 43.7 3.3 5.4 0.0 0.4 0.3 0.0 0.0 0.0 1.1 0.0 0.4 14.9 2.2 1.5 0.2 5.0 0.0 0.0 TM6SF2 Lpr4 ENSG00000213996 "Transmembrane 6 superfamily member 2" Q9BZW4 19 19264364-19273391 "Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 89.4" "Group enriched" "Detected in some" 6 "Enterocytes: 20.0;Hepatocytes: 25.1;Paneth cells: 34.5" "Cancer enhanced" "Detected in many" "liver cancer: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 3.4;HHSteC: 4.9;LHCN-M2: 3.8;NTERA-2: 2.6;SH-SY5Y: 4.4;SuSa: 2.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA066026 Uncertain NA NA "HPA066026: AB_2685598" "unprognostic (2.41e-1)" "unprognostic (4.81e-3)" "unprognostic (1.49e-1)" "unprognostic (1.15e-3)" "unprognostic (3.29e-1)" "unprognostic (2.35e-1)" "unprognostic (1.39e-3)" "unprognostic (4.00e-2)" "unprognostic (4.15e-2)" "unprognostic (4.53e-4)" "unprognostic (9.55e-3)" "unprognostic (4.37e-2)" "unprognostic (1.38e-1)" "unprognostic (1.61e-1)" "unprognostic (4.56e-2)" "unprognostic (1.51e-1)" "unprognostic (6.15e-2)" 0.1 0.1 0.2 0.2 0.1 0.0 0.3 0.3 0.3 0.6 43.2 0.2 0.2 36.8 0.4 1.7 0.2 0.2 1.0 0.4 0.2 0.5 3.2 18.5 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.5 0.5 0.9 0.4 0.2 0.4 0.0 0.1 89.4 0.2 0.1 0.1 1.1 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.4 0.1 2.1 1.2 1.0 1.3 1.0 0.1 0.0 1.0 1.8 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 3.4 4.9 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.8 2.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 4.4 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.3 0.2 0.5 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 20.0 0.0 0.2 0.2 0.6 0.0 4.6 25.1 0.1 0.0 0.0 1.3 0.3 0.0 0.6 0.0 1.7 0.0 1.1 0.0 0.1 34.5 0.4 4.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 TM7SF2 "ANG1, DHCR14A, NET47" ENSG00000149809 "Transmembrane 7 superfamily member 2" O76062 11 65111845-65116384 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.1" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 176.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 22.1;RPTEC TERT1: 25.4;T-47d: 49.4" "Low region specificity" "Detected in all" "HPA030691, HPA072704" Enhanced Supported "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA030691: AB_10602480, HPA072704: AB_2686551" "unprognostic (1.62e-1)" "unprognostic (5.23e-2)" "unprognostic (1.70e-2)" "unprognostic (1.78e-1)" "unprognostic (5.74e-2)" "unprognostic (1.10e-1)" "unprognostic (5.98e-2)" "unprognostic (6.06e-2)" "unprognostic (5.72e-2)" "unprognostic (1.74e-2)" "unprognostic (7.06e-2)" "unprognostic (1.69e-1)" "prognostic favorable (8.49e-8)" "unprognostic (8.77e-2)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.44e-2)" 27.7 78.1 6.9 2.2 12.5 2.0 10.0 5.6 21.7 4.7 3.1 22.4 5.1 4.8 1.5 11.0 11.5 6.4 8.5 28.2 7.4 6.6 8.3 38.6 5.1 1.7 10.3 9.6 13.5 22.6 11.8 6.2 2.2 13.2 19.8 2.3 5.4 28.5 3.3 3.3 17.9 2.8 1.3 7.3 1.9 8.8 5.3 8.8 1.9 7.4 13.6 10.4 2.6 6.1 7.4 22.6 1.8 1.0 7.3 7.6 3.0 2.6 3.6 8.5 12.2 3.4 0.2 5.4 0.6 1.3 1.0 1.1 8.8 12.4 5.4 9.6 0.4 0.3 4.3 3.7 6.0 0.7 5.2 1.9 3.3 1.0 17.7 6.9 1.3 3.7 1.5 1.8 4.9 0.6 4.0 0.9 10.3 1.9 4.2 0.3 22.1 2.3 5.8 4.6 5.6 4.1 7.2 0.4 12.7 25.4 3.9 9.6 10.8 0.4 9.3 2.1 5.6 49.4 3.6 0.6 0.1 1.3 1.2 0.8 9.6 6.0 3.1 0.8 2.1 0.3 0.5 1.0 1.8 5.5 0.8 4.3 7.1 3.5 4.5 0.9 7.4 7.6 5.5 0.7 7.3 0.5 22.6 3.1 3.0 6.9 12.5 5.6 21.7 7.4 6.6 10.3 9.6 13.2 8.8 8.9 36.6 11.1 5.3 1.6 15.6 89.9 50.9 6.7 5.7 41.8 9.8 64.7 14.9 20.7 26.9 4.5 21.7 0.0 24.2 1.7 3.3 37.3 6.9 79.7 12.7 23.8 57.1 4.3 6.3 49.4 9.2 3.5 11.8 13.6 16.5 176.3 28.8 11.5 2.1 62.4 21.2 12.9 2.3 10.9 9.4 6.0 68.7 8.5 12.4 8.4 TM7SF3 ENSG00000064115 "Transmembrane 7 superfamily member 3" Q9NS93 12 26973195-27014434 "Predicted intracellular proteins, Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 123.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057640 Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA057640: " "unprognostic (4.24e-1)" "unprognostic (1.90e-2)" "unprognostic (1.04e-3)" "unprognostic (8.80e-2)" "unprognostic (5.82e-2)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (5.79e-2)" "unprognostic (2.86e-1)" "unprognostic (1.28e-1)" "unprognostic (1.01e-2)" "unprognostic (1.16e-1)" "prognostic favorable (1.32e-4)" "unprognostic (1.24e-2)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (1.58e-1)" 12.0 27.6 12.1 8.1 17.4 18.5 15.9 7.9 18.9 12.4 17.2 18.1 13.1 10.7 10.9 16.6 27.8 12.7 16.4 10.6 11.7 11.6 69.8 39.9 15.9 15.0 13.0 11.6 12.1 52.6 15.4 33.2 11.0 10.7 14.5 19.7 20.5 21.9 14.2 5.8 15.4 12.8 13.2 13.9 12.0 14.9 11.0 10.6 31.2 14.1 12.3 17.1 15.3 16.5 10.5 10.6 16.0 6.9 11.8 11.4 3.9 8.4 20.1 12.0 14.5 18.3 12.1 63.1 10.5 17.0 8.6 14.9 11.1 36.2 11.4 13.5 9.8 7.8 9.3 12.5 70.9 12.0 11.1 7.4 17.0 25.3 21.0 12.1 61.3 12.0 7.4 60.5 18.5 16.7 26.3 22.7 30.9 7.3 7.8 13.0 17.3 29.9 35.7 24.4 32.7 12.0 28.0 18.9 20.1 15.0 38.7 2.0 10.7 12.9 6.9 18.4 59.2 19.1 13.0 8.5 7.6 12.4 20.7 12.9 4.7 12.1 21.3 14.6 20.9 11.4 8.6 6.9 16.0 6.0 6.9 5.7 7.3 7.6 7.8 10.2 10.5 10.9 7.2 7.8 11.8 3.5 10.6 11.4 3.9 12.1 17.4 7.9 18.9 11.7 11.6 13.0 11.6 10.7 10.6 11.9 22.2 20.8 43.3 25.5 44.9 8.6 94.3 5.3 25.0 40.1 41.2 35.0 14.9 48.9 75.7 18.9 16.7 23.3 35.2 13.0 17.5 22.1 13.9 37.8 34.8 22.3 12.7 15.4 19.7 123.7 14.4 20.3 62.4 21.6 21.2 29.6 27.4 31.6 21.5 79.2 34.9 6.5 12.8 6.2 26.2 24.3 13.6 20.3 29.9 34.1 TM9SF1 "HMP70, MP70" ENSG00000100926 "Transmembrane 9 superfamily member 1" O15321 14 24189143-24195687 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 45.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA059249 Supported Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA059249: AB_2683959" "unprognostic (3.27e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (9.31e-2)" "unprognostic (1.48e-1)" "unprognostic (3.84e-2)" "unprognostic (1.19e-2)" "unprognostic (4.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.62e-3)" "unprognostic (2.44e-1)" "unprognostic (4.24e-1)" "unprognostic (2.20e-1)" "unprognostic (4.18e-3)" 13.3 20.4 6.3 10.9 6.6 3.4 14.0 5.4 8.1 18.5 15.6 10.4 33.1 10.7 17.7 21.8 14.1 23.4 18.4 14.6 6.2 6.0 24.5 46.4 17.0 14.6 6.2 7.1 17.6 39.9 27.4 12.3 25.1 6.5 16.9 9.4 15.6 31.8 36.0 10.1 12.0 16.8 13.6 5.9 12.7 14.7 10.3 5.6 9.6 32.3 12.9 12.1 12.8 12.4 10.6 25.8 18.0 13.6 14.5 10.8 8.6 9.5 16.0 7.1 5.5 14.1 11.0 11.1 18.7 21.3 22.5 25.3 8.0 18.6 5.7 12.5 15.9 10.7 21.5 4.4 11.3 12.3 9.5 7.5 4.4 8.3 16.5 9.9 8.1 10.3 12.8 15.9 14.2 8.2 10.9 12.8 3.2 5.2 11.0 13.4 15.0 4.8 5.6 3.3 13.5 18.9 7.2 10.5 9.5 7.8 13.0 7.2 8.3 22.6 10.2 9.1 5.4 9.6 3.6 12.8 19.7 9.0 10.3 11.7 15.5 11.8 4.1 6.6 4.5 13.4 17.2 13.6 15.2 10.0 10.9 10.8 10.2 9.9 8.7 15.0 10.6 9.2 8.7 18.0 14.5 10.4 25.8 9.9 8.6 6.3 6.6 5.4 8.1 6.2 6.0 6.2 7.1 6.5 5.6 14.9 4.0 3.9 5.0 3.0 4.2 1.0 5.1 45.5 7.9 1.8 13.7 8.2 0.0 6.6 9.3 6.0 4.2 0.0 4.3 8.1 5.9 6.7 2.3 4.3 3.7 0.0 1.7 4.9 1.0 3.8 4.9 3.2 1.7 5.4 2.3 6.1 4.6 4.2 4.2 2.3 6.6 6.5 6.2 5.6 5.1 4.1 10.0 4.5 3.7 3.5 TM9SF2 P76 ENSG00000125304 "Transmembrane 9 superfamily member 2" Q99805 13 99446311-99564006 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005657 Supported NA NA "HPA005657: AB_1080303" "unprognostic (9.77e-3)" "unprognostic (3.51e-2)" "unprognostic (2.85e-2)" "unprognostic (1.09e-2)" "unprognostic (3.76e-1)" "prognostic unfavorable (6.40e-4)" "unprognostic (5.96e-2)" "unprognostic (1.54e-1)" "unprognostic (1.97e-1)" "unprognostic (2.99e-2)" "unprognostic (1.66e-1)" "unprognostic (5.19e-2)" "prognostic favorable (5.21e-7)" "unprognostic (6.49e-2)" "unprognostic (8.55e-2)" "unprognostic (2.20e-2)" "unprognostic (2.21e-1)" 28.8 35.4 24.0 23.3 30.0 20.6 34.6 22.0 33.1 40.5 42.6 28.4 44.4 43.8 33.1 46.5 34.5 29.5 30.2 25.7 22.7 26.8 44.9 83.9 42.6 49.6 21.4 24.9 28.0 65.6 42.0 47.4 60.9 26.6 38.2 47.1 31.4 59.2 48.4 22.5 28.3 57.4 24.9 27.9 36.5 38.2 36.3 21.7 29.4 47.6 24.8 33.8 40.8 28.7 22.4 38.9 61.9 43.5 17.5 26.1 35.9 39.2 12.2 16.6 23.5 50.2 30.6 23.9 26.8 33.5 19.1 30.0 19.8 50.7 15.2 22.3 32.1 19.6 39.6 17.6 23.4 26.2 17.0 12.7 18.9 21.4 21.1 26.6 49.1 22.0 23.9 29.2 16.5 17.1 29.7 24.0 15.9 18.8 15.3 22.4 13.2 12.2 19.2 14.5 71.7 15.4 10.3 13.4 16.4 39.5 29.3 15.8 19.4 15.4 62.5 19.4 33.7 38.1 59.4 23.5 15.4 11.4 15.4 16.5 21.3 24.8 6.2 36.3 25.5 22.3 38.1 38.5 41.3 15.1 43.5 18.9 22.4 18.3 16.9 34.2 14.6 17.1 15.6 61.9 17.5 41.3 38.9 26.1 35.9 24.0 30.0 22.0 33.1 22.7 26.8 21.4 24.9 26.6 21.7 77.4 61.2 41.0 47.9 36.4 20.0 34.4 81.5 105.7 86.4 82.0 17.7 82.4 10.0 84.4 109.4 53.7 104.0 46.7 89.6 106.7 61.2 80.2 53.1 153.2 100.7 20.6 79.7 89.0 138.5 30.7 46.3 76.0 69.2 45.1 144.6 47.3 77.9 122.8 49.1 58.9 22.6 19.4 57.7 95.8 54.7 45.7 143.4 35.8 100.6 91.9 TM9SF3 SMBP ENSG00000077147 "Transmembrane 9 superfamily member 3" Q9HD45 10 96518109-96587452 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039609 Approved Approved "Golgi apparatus,Vesicles" NA NA 320000 Vesicles "Golgi apparatus" "HPA039609: AB_10673535" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (1.43e-2)" "unprognostic (5.11e-2)" "unprognostic (4.95e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-2)" "unprognostic (3.09e-2)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (4.14e-3)" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (8.28e-3)" "unprognostic (6.18e-2)" 28.4 23.9 19.6 31.0 19.3 12.8 24.5 16.0 18.9 29.3 54.2 16.5 49.9 42.9 31.5 27.3 28.4 23.7 57.7 37.3 19.5 19.2 28.7 50.8 25.2 17.0 20.8 13.5 31.3 33.6 27.4 20.3 50.7 18.7 35.6 35.7 18.5 43.0 57.9 18.4 22.4 60.0 21.4 26.3 25.6 69.6 15.4 18.3 27.1 33.1 16.1 26.6 34.7 34.4 3.3 11.2 7.7 3.6 5.5 6.5 2.4 35.3 24.2 26.9 37.6 39.4 29.5 32.3 48.9 36.3 21.2 17.6 28.9 70.0 26.1 27.2 43.2 26.8 33.5 24.3 27.0 40.0 29.2 20.9 23.2 21.4 22.7 29.7 47.4 27.1 27.1 27.3 30.0 52.1 64.6 23.3 24.1 23.0 30.2 32.3 16.1 18.3 18.3 17.1 58.0 14.9 22.8 34.0 20.4 30.2 26.3 12.5 28.1 25.9 24.9 24.9 33.6 42.9 18.0 40.7 26.5 22.5 26.5 44.7 31.3 35.5 24.2 36.0 33.2 18.4 7.7 3.6 5.5 5.8 3.5 6.5 3.3 6.2 6.3 4.3 2.2 4.8 6.0 4.2 5.5 3.5 11.2 6.0 2.4 19.6 19.3 16.0 18.9 19.5 19.2 20.8 13.5 18.7 18.3 47.6 38.4 61.0 98.4 103.7 51.1 59.3 117.2 33.5 64.8 134.3 53.0 66.4 18.3 67.7 13.2 79.4 171.7 23.3 126.1 84.8 99.2 200.9 40.3 110.7 53.4 55.6 118.9 75.5 84.6 9.5 86.3 61.4 97.8 28.9 300.1 50.1 110.9 118.1 77.4 50.6 47.5 64.7 95.1 44.1 44.5 105.5 117.9 54.9 188.1 132.3 TM9SF4 "dJ836N17.2, KIAA0255" ENSG00000101337 "Transmembrane 9 superfamily member 4" Q92544 20 32109506-32167258 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064099 Approved NA NA "HPA064099: AB_2685190" "unprognostic (3.10e-2)" "unprognostic (9.03e-3)" "unprognostic (1.02e-1)" "prognostic unfavorable (6.37e-6)" "unprognostic (3.85e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (1.37e-1)" "unprognostic (3.23e-3)" "unprognostic (1.91e-1)" "unprognostic (6.65e-2)" "unprognostic (7.68e-2)" "unprognostic (6.98e-3)" "unprognostic (7.66e-2)" "unprognostic (1.45e-1)" "unprognostic (1.04e-1)" "unprognostic (4.23e-2)" 20.3 26.2 18.1 23.5 27.7 11.6 21.1 29.8 38.5 23.4 25.7 25.4 21.8 23.7 31.4 25.7 34.4 29.3 22.2 24.1 16.0 20.6 22.5 36.9 21.7 17.7 14.7 20.9 26.8 28.2 52.4 26.6 34.6 21.3 23.9 30.8 22.4 39.6 32.2 26.4 29.4 24.7 26.2 14.9 21.4 23.6 27.2 15.7 18.7 21.6 19.0 24.1 25.9 25.0 7.8 19.3 9.9 28.9 8.3 12.1 13.9 19.0 13.6 15.6 17.8 30.7 25.1 20.1 15.8 24.0 22.2 21.8 40.1 23.7 13.4 30.1 25.7 34.9 31.6 17.5 33.8 19.3 7.6 9.8 30.7 11.7 30.0 27.2 14.7 17.7 26.3 25.8 16.8 27.2 27.4 19.7 16.1 19.3 25.0 17.3 20.2 14.8 11.1 13.9 23.2 16.7 14.2 22.0 16.6 19.3 13.5 13.3 15.5 29.4 19.4 16.9 21.6 24.3 17.0 16.0 40.8 12.7 21.5 19.2 25.4 20.8 12.6 32.3 49.1 18.2 9.9 21.7 4.4 9.9 23.3 12.1 7.8 8.8 11.2 19.3 6.8 9.8 8.3 5.6 8.3 28.9 6.3 8.5 13.9 18.1 27.7 29.8 38.5 16.0 20.6 14.7 20.9 21.3 15.7 23.8 25.1 8.2 15.5 6.3 11.8 12.9 10.2 24.1 28.4 8.7 15.7 25.1 1.7 16.5 41.7 16.9 24.2 0.0 15.9 18.5 17.6 16.8 8.1 23.2 20.3 7.9 13.4 15.4 15.1 45.1 15.5 18.8 6.8 10.0 32.5 15.7 17.3 28.1 10.3 13.5 12.0 6.5 13.0 20.0 9.4 9.9 31.5 13.8 23.5 17.9 TMBIM1 "LFG3, PP1201, RECS1" ENSG00000135926 "Transmembrane BAX inhibitor motif containing 1" Q969X1 2 218274192-218292586 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 85.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012093, HPA070824" Approved Supported Vesicles NA NA Vesicles "HPA012093: AB_1858056, HPA070824: AB_2686317" "unprognostic (4.36e-2)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (1.73e-3)" "unprognostic (2.34e-3)" "unprognostic (3.81e-3)" "unprognostic (8.91e-3)" "unprognostic (5.58e-3)" "unprognostic (9.85e-2)" "unprognostic (3.76e-3)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.69e-1)" "prognostic favorable (3.38e-4)" "unprognostic (1.22e-1)" "unprognostic (4.63e-2)" "unprognostic (2.75e-2)" "unprognostic (4.50e-1)" 64.3 34.6 26.5 22.1 45.0 23.0 84.3 11.0 38.3 35.7 42.2 43.1 33.7 41.8 35.0 30.0 86.8 25.1 50.3 34.6 21.0 17.2 50.7 69.3 46.7 34.3 37.5 13.7 27.9 87.6 31.3 15.0 92.7 40.9 31.6 40.1 23.9 40.1 43.7 53.2 49.5 70.6 41.2 50.3 22.7 57.8 13.2 32.5 9.4 66.4 42.1 36.3 57.7 54.5 17.0 19.6 60.3 43.5 13.0 24.0 33.6 26.9 9.7 0.5 7.2 63.1 26.6 29.0 26.5 32.7 15.7 18.1 24.8 66.9 6.2 19.3 38.9 29.9 46.1 9.0 59.4 15.5 22.2 3.7 39.0 6.7 29.8 28.6 0.5 38.5 25.2 55.8 32.1 41.0 16.8 16.6 1.0 24.3 11.6 27.3 1.1 0.4 6.7 0.4 55.7 8.8 0.9 4.3 4.8 21.1 85.0 0.5 0.5 8.7 32.5 18.4 6.0 8.7 5.9 25.1 28.2 7.8 13.0 9.6 5.6 6.5 2.7 27.8 6.2 15.9 60.3 27.7 59.9 24.0 36.2 20.5 17.0 22.0 19.5 19.6 14.0 14.7 15.8 35.5 13.0 43.5 5.3 23.5 33.6 26.5 45.0 11.0 38.3 21.0 17.2 37.5 13.7 40.9 32.5 68.5 24.6 28.7 69.9 72.6 1.9 23.1 86.6 8.1 29.6 66.3 0.0 126.2 11.6 144.8 0.6 46.0 183.5 23.3 245.6 121.5 63.2 108.4 48.5 40.1 94.3 0.0 21.8 25.2 35.2 1.9 50.0 57.9 43.9 14.4 54.8 22.4 239.0 105.2 55.9 32.3 1.7 12.9 47.2 0.7 12.3 88.3 235.9 34.8 41.2 229.1 TMBIM4 "CGI-119, GAAP, LFG4, S1R, ZPRO" ENSG00000155957 "Transmembrane BAX inhibitor motif containing 4" Q9HC24 12 66135846-66170072 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA077642 Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA077642: AB_2686849" "unprognostic (5.41e-2)" "unprognostic (1.27e-1)" "unprognostic (3.19e-1)" "unprognostic (8.14e-2)" "unprognostic (2.69e-2)" "unprognostic (5.62e-2)" "unprognostic (7.18e-3)" "unprognostic (8.51e-2)" "unprognostic (2.49e-1)" "unprognostic (1.33e-2)" "unprognostic (3.36e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.68e-2)" "unprognostic (3.75e-2)" "unprognostic (2.20e-3)" 47.2 57.3 18.4 31.2 23.8 22.2 40.1 9.2 21.0 34.8 36.5 30.8 39.8 24.1 42.5 40.3 32.2 33.7 31.7 37.2 18.9 19.9 56.2 66.7 46.8 48.6 27.3 14.4 41.6 63.5 30.6 48.2 42.5 27.2 34.5 29.5 44.8 56.4 39.7 29.1 24.9 45.8 37.0 34.2 55.7 39.1 66.7 22.5 39.6 54.3 32.0 38.1 36.8 31.6 30.6 38.9 100.3 60.9 18.8 26.1 61.1 13.1 17.3 11.1 20.3 37.9 35.7 11.7 20.5 35.9 16.0 13.0 8.9 21.9 12.4 24.5 28.8 12.0 21.9 5.6 18.1 10.4 20.0 7.4 23.9 8.9 10.3 19.3 28.8 31.0 25.0 26.3 7.8 8.8 22.5 24.3 14.3 17.5 44.9 26.3 21.6 10.9 10.0 13.3 20.6 17.6 5.8 7.4 13.8 35.7 22.0 5.6 13.5 23.3 43.6 27.3 10.1 40.9 39.9 29.3 19.9 7.4 14.3 12.0 23.3 12.6 8.8 27.2 28.3 23.4 51.4 56.7 53.9 21.9 55.6 21.9 30.6 22.9 22.4 38.9 28.8 26.1 23.0 100.3 18.8 60.9 25.9 23.2 61.1 18.4 23.8 9.2 21.0 18.9 19.9 27.3 14.4 27.2 22.5 140.0 123.5 60.5 48.9 0.0 46.5 31.6 0.0 182.0 121.7 232.1 43.2 122.1 87.9 183.7 222.5 73.0 105.9 0.0 295.0 97.7 70.5 78.3 171.3 0.0 189.1 42.9 71.7 0.0 0.0 105.9 96.7 181.8 0.0 136.1 134.7 96.6 178.8 186.2 85.6 171.1 56.2 58.2 40.1 301.5 37.0 0.0 109.4 0.0 147.8 52.1 TMBIM6 "BAXI1, BI-1, TEGT" ENSG00000139644 "Transmembrane BAX inhibitor motif containing 6" P55061 12 49707725-49764934 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy, Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 2191.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017378 Approved NA NA "HPA017378: AB_2669604" "prognostic unfavorable (3.54e-4)" "unprognostic (6.25e-2)" "unprognostic (1.90e-2)" "unprognostic (6.52e-2)" "unprognostic (8.46e-3)" "prognostic unfavorable (1.91e-4)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" "unprognostic (1.22e-2)" "unprognostic (6.25e-2)" "unprognostic (5.91e-2)" "unprognostic (3.80e-1)" "prognostic favorable (1.00e-5)" "unprognostic (1.95e-1)" "unprognostic (9.27e-2)" "unprognostic (1.28e-1)" "unprognostic (1.54e-2)" 73.3 78.3 57.3 33.4 60.1 34.9 54.9 31.5 56.7 57.1 68.5 84.0 73.0 60.2 46.0 86.7 70.5 57.1 57.5 36.7 47.0 46.1 146.2 245.5 62.2 36.1 56.9 38.2 52.8 88.9 54.6 29.3 69.2 55.1 51.6 65.0 55.1 131.6 59.5 41.3 37.0 123.7 38.4 65.4 53.5 68.0 45.2 50.8 52.5 117.0 42.6 55.8 54.7 42.1 47.1 65.7 139.2 80.5 49.1 69.8 158.0 57.5 50.1 40.9 37.4 118.7 66.0 51.0 43.6 83.6 56.9 52.2 80.6 166.4 36.3 74.5 85.1 59.7 63.3 35.5 64.0 62.1 52.2 38.2 57.7 38.4 39.3 72.0 65.9 95.7 66.7 150.1 63.6 92.9 80.8 47.1 45.0 51.9 150.5 64.9 56.1 33.7 40.0 42.5 69.8 38.5 28.7 40.9 61.4 86.3 87.9 31.7 20.8 58.5 77.5 49.1 55.2 97.3 70.1 44.2 52.4 40.0 35.1 37.8 65.0 65.5 31.1 73.2 31.1 25.5 79.0 80.5 85.6 66.5 80.1 69.8 47.1 60.6 65.9 65.4 41.4 54.0 61.2 139.2 49.1 79.7 65.7 59.1 158.0 57.3 60.1 31.5 56.7 47.0 46.1 56.9 38.2 55.1 50.8 443.7 382.6 246.5 431.6 231.8 227.2 183.8 608.9 568.8 390.2 516.5 108.0 351.1 111.0 761.8 1344.0 309.2 1092.3 140.2 713.9 744.7 268.9 579.3 248.6 2191.3 569.6 170.0 283.3 377.5 527.1 1530.3 267.2 425.0 234.5 566.3 551.0 486.2 743.7 520.2 270.1 658.8 131.4 168.1 298.1 317.6 224.2 205.4 745.0 292.8 412.7 569.2 TMC1 "DFNA36, DFNB11, DFNB7" ENSG00000165091 "Transmembrane channel like 1" Q8TDI8 9 72521608-72838230 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Hearing, Ion transport, Transport" "Ion channel" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 3.0" "Cell type enhanced" "Detected in some" 8 "Cytotrophoblasts: 3.3;Early spermatids: 3.7;Glandular cells: 3.2;Urothelial cells: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.4;HAP1: 10.5;NTERA-2: 4.3;SuSa: 1.6;U-266/84: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.36e-2)" "unprognostic (1.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.19e-3)" "unprognostic (3.97e-1)" "unprognostic (5.67e-4)" "unprognostic (1.63e-1)" "unprognostic (1.91e-1)" "unprognostic (2.10e-2)" "unprognostic (3.74e-1)" "unprognostic (3.94e-2)" "unprognostic (2.12e-1)" "unprognostic (2.67e-3)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.94e-2)" "unprognostic (1.31e-1)" 0.2 0.0 0.9 0.0 0.7 0.0 0.2 0.2 1.1 3.0 0.0 0.0 0.2 1.3 0.7 0.7 0.2 0.0 0.7 0.5 1.4 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.3 0.2 0.0 0.0 0.0 1.5 0.0 0.0 1.1 0.0 0.3 1.6 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 10.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.4 0.0 0.0 0.0 1.8 0.0 3.3 0.0 0.1 3.7 0.4 0.0 0.0 0.5 2.1 0.4 3.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.0 1.0 0.0 0.9 0.4 0.0 0.0 2.9 0.0 0.0 0.4 1.2 3.0 0.0 2.2 0.0 0.0 5.9 TMC2 "C20orf145, dJ686C3.3" ENSG00000149488 "Transmembrane channel like 2" Q8TDI7 20 2536607-2641784 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 8.1;pituitary gland: 3.2" "Cell type enriched" "Detected in some" 6 "Late spermatids: 9.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Cell line enhanced" "Detected in single" "ASC diff: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (4.73e-2)" "unprognostic (1.87e-1)" "unprognostic (5.88e-2)" "unprognostic (8.30e-4)" "unprognostic (2.86e-3)" "unprognostic (3.00e-1)" "unprognostic (1.13e-2)" "unprognostic (1.07e-2)" "unprognostic (4.54e-1)" "unprognostic (1.41e-2)" "unprognostic (4.05e-5)" "unprognostic (2.90e-1)" "unprognostic (3.21e-7)" "unprognostic (2.47e-2)" "unprognostic (2.56e-1)" "unprognostic (1.93e-1)" "unprognostic (5.74e-2)" 2.3 0.4 0.3 0.3 0.8 0.0 0.7 8.1 0.4 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.9 0.0 0.2 0.9 0.0 0.0 3.0 0.2 0.1 0.5 0.1 0.1 3.2 0.1 0.0 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.0 2.5 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.1 0.2 0.4 0.3 0.2 3.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 TMC3 ENSG00000188869 "Transmembrane channel like 3" Q7Z5M5 15 81331217-81374213 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 15 "parathyroid gland: 66.9" "Cell type enhanced" "Detected in single" 24 "Distal tubular cells: 1.7" "Cancer enhanced" "Detected in single" "breast cancer: 0.5" "Region enhanced" "Detected in some" "pons and medulla: 1.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040265, HPA040510" Enhanced Supported Cytosol NA NA Cytosol "HPA040265: AB_10795379, HPA040510: AB_10796123" "unprognostic (1.17e-2)" "unprognostic (3.43e-1)" "unprognostic (3.14e-1)" "unprognostic (8.33e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (4.85e-3)" "unprognostic (2.20e-2)" "unprognostic (3.12e-2)" "unprognostic (1.77e-1)" "unprognostic (6.20e-5)" "unprognostic (2.32e-1)" "unprognostic (1.97e-7)" "unprognostic (1.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.26e-1)" "unprognostic (5.96e-2)" 0.0 0.1 0.0 1.7 0.0 0.3 0.2 0.4 1.4 1.5 1.5 0.0 0.0 0.2 0.8 4.6 0.7 0.8 0.2 0.2 0.0 0.1 0.1 1.3 0.0 0.1 0.0 0.0 0.2 0.2 66.9 1.5 0.7 1.6 1.0 0.1 0.4 0.2 2.9 0.0 0.2 0.5 1.7 1.9 0.1 0.8 3.0 0.0 0.0 1.5 0.0 0.0 1.3 3.6 1.6 0.7 0.2 0.2 0.2 1.8 0.7 0.9 1.0 0.5 2.7 0.4 0.2 1.9 0.8 0.3 0.2 0.3 0.7 1.9 2.3 0.1 0.0 2.4 0.7 0.3 0.2 0.1 1.7 1.4 1.9 1.1 0.9 0.3 1.5 1.1 0.5 0.1 0.4 0.3 1.2 0.0 2.8 0.6 2.8 0.2 0.8 1.0 1.4 1.5 0.8 0.9 0.7 1.0 4.3 0.2 0.6 1.1 2.0 0.9 1.0 2.0 0.6 2.3 1.1 0.4 1.5 1.8 1.3 0.5 4.6 1.8 1.4 1.1 2.5 0.9 0.1 0.0 0.2 0.7 0.1 0.6 1.2 0.8 0.4 0.1 1.6 1.8 1.3 0.2 0.2 0.2 0.7 0.9 0.7 0.0 0.0 0.4 1.4 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 TMC4 ENSG00000167608 "Transmembrane channel like 4" 19 54160108-54173250 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 45.8;seminal vesicle: 49.1" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 180.2;Paneth cells: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.4;neutrophil: 1.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "OE19: 13.2;T-47d: 24.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048635 Approved Approved Vesicles NA NA Vesicles "HPA048635: AB_2680470" "unprognostic (7.55e-2)" "unprognostic (1.66e-1)" "unprognostic (4.20e-2)" "unprognostic (1.49e-1)" "unprognostic (7.04e-2)" "unprognostic (1.68e-1)" "unprognostic (4.82e-2)" "unprognostic (2.19e-2)" "unprognostic (1.03e-1)" "unprognostic (2.68e-3)" "unprognostic (7.59e-2)" "unprognostic (3.09e-1)" "prognostic favorable (1.54e-8)" "unprognostic (6.70e-2)" "unprognostic (2.48e-1)" "unprognostic (8.94e-2)" "unprognostic (1.79e-2)" 1.2 0.4 0.8 4.7 1.2 0.0 6.5 0.5 0.7 3.7 31.0 0.0 32.0 19.7 2.0 16.2 2.9 8.7 21.8 1.7 0.9 0.8 11.8 0.8 9.6 0.0 0.8 0.0 3.8 25.0 0.3 11.1 6.9 0.0 8.6 7.5 0.0 34.5 49.1 0.8 1.3 45.8 0.8 0.6 0.3 8.2 0.6 0.0 1.0 17.1 2.8 5.6 6.7 2.7 0.0 0.0 1.5 1.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.0 0.0 0.8 1.2 0.5 0.7 0.9 0.8 0.8 0.0 0.0 0.0 26.8 25.9 0.5 19.7 2.2 0.3 1.6 58.6 71.0 25.0 43.6 0.0 19.8 11.6 62.6 0.0 1.3 180.2 0.0 57.0 5.4 1.9 25.5 5.7 1.0 3.3 0.0 40.0 1.8 2.2 0.0 1.1 2.8 1.7 1.8 82.2 0.1 44.7 96.5 0.7 21.6 0.2 25.8 9.9 0.1 2.3 1.5 19.6 2.1 71.7 32.6 TMC5 FLJ13593 ENSG00000103534 "Transmembrane channel like 5" Q6UXY8 16 19410496-19499113 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 108.7" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 547.4;Club cells: 299.1;Pancreatic endocrine cells: 236.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.3;OE19: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040810, HPA042037" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA040810: AB_10795627, HPA042037: AB_10804126" "unprognostic (2.47e-2)" "unprognostic (3.68e-1)" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (3.64e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "unprognostic (9.74e-2)" "unprognostic (3.27e-2)" "unprognostic (3.71e-1)" "unprognostic (2.28e-2)" "unprognostic (2.69e-1)" "unprognostic (7.88e-2)" "unprognostic (8.88e-3)" "unprognostic (1.75e-1)" 0.7 0.3 0.3 4.8 0.3 0.1 5.6 0.3 0.7 3.8 66.1 0.6 0.6 19.1 2.1 16.9 1.4 1.9 15.9 0.4 0.4 0.3 0.3 1.8 17.6 0.2 0.3 0.4 1.8 5.4 4.5 1.0 3.7 1.0 8.4 9.8 1.7 18.9 0.2 0.3 0.8 108.7 0.3 0.2 0.3 19.5 2.6 0.2 0.2 0.8 1.7 4.1 1.5 1.1 0.5 0.7 2.2 0.6 0.9 0.8 0.3 3.5 5.8 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 37.3 0.0 0.2 0.0 0.1 2.3 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 1.3 21.6 1.6 0.0 0.0 1.3 0.1 0.1 0.3 0.1 0.0 1.1 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.6 0.2 0.3 0.3 0.2 0.4 0.8 0.3 0.2 0.5 0.2 0.3 2.2 0.9 0.4 0.7 0.1 0.3 0.3 0.3 0.3 0.7 0.4 0.3 0.3 0.4 1.0 0.2 145.9 125.6 0.0 19.6 0.7 0.1 0.8 122.3 547.4 299.1 21.0 2.0 31.1 0.0 107.5 21.7 0.4 170.3 0.0 144.9 1.6 0.8 88.4 5.7 0.0 2.3 3.2 37.4 0.6 0.0 28.2 0.3 0.9 1.7 1.8 97.1 0.1 236.7 190.0 0.7 0.4 1.5 0.0 0.9 1.8 1.1 1.5 13.6 0.0 77.1 46.1 TMC6 "EVER1, EVIN1, LAK-4P" ENSG00000141524 "Transmembrane channel like 6" Q7Z403 17 78110458-78132407 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.6;brain: 43.1;lymphoid tissue: 41.4" "Cell type enhanced" "Detected in many" 4 "monocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 34.4;SK-BR-3: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051430 Uncertain NA NA "HPA051430: AB_2681483" "unprognostic (6.34e-2)" "unprognostic (5.14e-2)" "unprognostic (5.55e-2)" "unprognostic (2.81e-3)" "unprognostic (3.99e-2)" "unprognostic (1.06e-2)" "unprognostic (5.36e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-1)" "unprognostic (9.94e-2)" "unprognostic (1.74e-1)" "unprognostic (6.61e-2)" "unprognostic (1.16e-2)" "prognostic favorable (1.82e-4)" "unprognostic (2.70e-2)" "unprognostic (1.10e-2)" "prognostic favorable (3.20e-4)" 10.5 3.5 7.5 26.1 25.5 39.6 8.3 2.1 12.8 4.1 8.8 33.5 5.6 13.5 3.1 1.7 9.5 5.6 6.5 8.1 12.5 8.1 6.9 3.7 14.4 39.2 43.1 4.6 1.7 6.4 1.8 2.4 6.6 20.3 7.5 4.7 3.6 12.7 7.2 2.3 6.5 17.5 2.7 31.4 41.4 9.1 1.6 31.2 12.1 5.0 2.7 24.8 7.3 6.5 13.5 8.3 9.8 26.7 15.6 27.2 13.2 5.5 4.4 2.4 1.9 0.0 0.0 5.0 0.0 0.0 0.0 0.0 8.0 6.3 6.3 7.8 0.0 2.1 9.9 0.3 1.9 0.0 0.6 3.6 13.1 1.2 9.8 0.6 11.9 22.3 0.3 5.3 0.0 0.4 0.0 4.8 2.9 34.4 23.8 0.0 11.2 5.8 20.4 1.9 10.5 1.6 2.6 0.2 18.4 3.7 20.7 0.6 1.6 1.8 39.2 10.6 3.3 22.3 18.2 1.6 0.0 3.0 0.0 0.1 18.9 8.2 4.0 0.0 19.3 0.3 6.4 4.9 9.8 27.2 16.9 23.7 13.5 20.1 21.9 8.3 10.2 18.1 18.7 6.9 15.6 26.7 2.5 17.0 13.2 7.5 25.5 2.1 12.8 12.5 8.1 43.1 4.6 20.3 31.2 38.7 26.4 66.2 15.9 9.8 3.5 11.8 10.2 5.3 22.7 15.7 0.0 0.9 0.0 38.9 0.3 14.3 19.3 23.3 20.8 23.7 5.3 23.5 39.3 0.9 59.4 1.6 8.7 23.4 44.3 0.4 8.9 34.5 13.5 77.5 10.4 6.3 30.2 43.2 1.1 1.4 1.3 12.9 4.6 0.3 1.9 8.9 3.1 73.4 30.8 33.5 TMC7 FLJ21240 ENSG00000170537 "Transmembrane channel like 7" Q7Z402 16 18983934-19063942 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.8;testis: 14.9" "Cell type enriched" "Detected in many" 4 "Early spermatids: 117.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029465 Uncertain Approved Vesicles NA NA Vesicles "HPA029465: AB_10600914" "unprognostic (1.80e-4)" "unprognostic (6.13e-2)" "unprognostic (1.82e-1)" "unprognostic (2.07e-3)" "unprognostic (1.25e-1)" "unprognostic (1.19e-3)" "unprognostic (7.60e-5)" "prognostic unfavorable (3.20e-4)" "unprognostic (7.60e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.64e-4)" "unprognostic (3.39e-1)" "unprognostic (1.00e-1)" "unprognostic (1.75e-1)" "unprognostic (1.94e-1)" "unprognostic (5.66e-2)" "prognostic favorable (9.20e-4)" 3.6 0.7 6.2 1.9 11.4 0.7 2.0 8.5 11.1 1.1 6.7 24.8 0.0 4.4 1.5 1.3 0.9 1.0 2.6 1.6 9.7 5.3 1.0 0.7 5.2 0.7 15.7 6.6 0.7 0.9 1.4 0.7 7.7 12.8 2.8 8.2 0.6 0.7 1.9 1.6 2.0 4.9 2.2 15.7 1.1 5.4 14.9 12.8 0.0 1.6 0.0 0.6 9.6 1.3 1.6 1.2 2.9 0.8 1.6 1.0 0.2 1.9 4.0 1.2 2.0 0.2 1.7 5.3 0.7 1.1 0.7 1.8 1.3 9.3 0.2 8.9 0.7 2.0 7.3 3.2 3.1 0.9 0.1 2.3 0.2 3.2 5.7 0.2 0.2 0.1 0.4 4.5 7.2 8.1 2.4 3.0 4.1 2.2 0.7 3.2 4.5 0.3 0.3 3.4 12.1 5.9 0.2 3.5 0.3 1.3 9.7 0.7 2.0 2.2 6.1 0.6 5.6 1.8 0.7 2.6 1.2 2.0 1.4 3.5 0.5 1.0 0.3 6.2 0.3 1.0 2.5 0.8 0.8 0.9 0.6 0.5 0.9 0.9 0.7 0.3 1.6 0.9 1.0 2.9 1.6 0.4 1.2 0.5 0.2 6.2 11.4 8.5 8.3 9.7 5.3 15.7 6.6 12.8 12.8 3.0 3.8 0.0 2.5 0.3 0.6 0.8 2.5 0.0 1.2 0.0 0.0 0.1 0.0 2.8 117.6 3.0 3.9 0.0 10.0 1.5 0.4 2.0 0.0 0.2 0.2 0.0 1.2 4.3 0.0 29.3 1.1 1.2 0.0 0.0 5.4 0.2 9.6 6.8 0.4 0.0 2.5 0.0 1.0 5.4 10.0 0.9 0.2 0.0 3.3 15.2 TMC8 "EVER2, EVIN2" ENSG00000167895 "Transmembrane channel like 8" Q8IU68 17 78130770-78142968 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 33.6;intestine: 23.2;lymphoid tissue: 52.9" "Cell type enhanced" "Detected in many" 7 "B-cells: 29.6;granulocytes: 40.4;Hofbauer cells: 25.4;monocytes: 26.2;T-cells: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 15.7;HL-60: 20.9;HMC-1: 42.3;Karpas-707: 36.0;RPMI-8226: 22.2;U-266/70: 17.4;U-937: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047387, HPA054429" Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA047387: , HPA054429: AB_2682485" "unprognostic (8.54e-3)" "prognostic favorable (8.45e-6)" "unprognostic (1.32e-1)" "unprognostic (2.33e-3)" "unprognostic (3.59e-1)" "prognostic favorable (4.19e-5)" "unprognostic (6.38e-3)" "unprognostic (6.47e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-1)" "unprognostic (6.06e-2)" "unprognostic (4.27e-1)" "prognostic unfavorable (1.96e-7)" "unprognostic (6.24e-2)" "unprognostic (1.01e-2)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" 3.6 1.6 2.3 30.1 4.6 33.6 1.9 0.7 2.3 1.7 4.4 3.5 0.1 4.2 2.5 2.1 2.5 2.1 6.2 1.5 2.3 1.7 3.4 3.1 10.7 38.7 4.0 0.8 0.9 1.2 0.1 1.3 1.5 2.8 2.4 1.9 2.6 10.2 1.0 0.6 1.7 23.2 1.0 5.1 52.9 4.1 0.7 3.7 49.7 3.1 1.8 36.6 3.9 2.5 5.0 2.1 5.5 6.6 6.7 13.1 4.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 15.7 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.2 0.0 20.9 42.3 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.3 36.0 0.0 0.4 7.1 0.9 0.0 1.1 0.1 0.4 0.1 22.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 2.3 4.3 0.0 0.0 0.0 0.0 0.0 17.4 0.7 1.5 0.0 17.7 0.0 2.3 1.8 5.5 13.1 3.1 9.4 5.0 10.5 12.9 2.1 5.0 9.4 8.4 3.0 6.7 6.6 1.9 5.7 4.2 2.3 4.6 0.7 2.3 2.3 1.7 4.0 0.8 2.8 3.7 3.0 15.1 29.6 9.3 4.7 0.0 1.6 0.0 1.4 7.9 0.0 0.0 0.3 0.0 0.9 0.3 1.4 2.1 0.0 1.1 1.0 1.5 2.2 40.4 0.4 25.4 0.0 1.2 6.2 22.6 0.0 0.0 15.6 6.8 26.2 0.8 0.2 0.4 3.1 0.4 0.3 0.0 0.0 1.7 0.4 0.5 4.0 0.5 39.2 2.2 11.7 TMCC1 KIAA0779 ENSG00000172765 "Transmembrane and coiled-coil domain family 1" O94876 3 129647792-129893576 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 12.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 12.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053894 Uncertain NA NA "HPA053894: AB_2682295" "unprognostic (4.26e-2)" "unprognostic (1.38e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (2.60e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (9.15e-4)" "unprognostic (7.75e-3)" "unprognostic (1.13e-1)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.50e-2)" "prognostic unfavorable (1.77e-6)" "unprognostic (6.82e-3)" "unprognostic (2.90e-1)" "unprognostic (1.20e-1)" "unprognostic (2.32e-1)" 7.8 8.1 10.0 7.1 10.9 3.5 8.4 28.9 11.5 11.6 6.7 14.1 2.6 4.7 8.9 7.9 8.6 8.0 9.7 8.8 9.8 8.8 6.7 37.2 7.5 5.2 16.1 9.2 9.4 7.2 8.7 19.8 10.7 11.3 8.8 6.0 6.2 6.0 7.5 28.2 7.7 4.8 7.9 13.5 7.2 4.7 14.0 13.1 10.3 7.8 5.6 5.9 8.3 7.3 1.3 1.8 12.2 2.4 1.0 2.2 0.9 8.6 9.6 7.5 6.1 11.3 8.0 7.6 3.4 4.5 3.0 3.2 6.0 4.8 5.3 9.8 6.6 3.6 8.0 4.2 6.8 2.3 7.0 1.4 3.5 2.8 22.0 3.8 2.6 2.2 4.6 12.9 2.4 5.7 6.7 9.3 3.2 1.7 3.9 7.0 9.3 4.6 1.6 5.7 6.3 3.0 4.2 6.3 4.4 7.1 10.7 6.9 4.9 11.7 4.0 3.4 7.6 7.8 2.9 8.0 4.9 8.0 4.4 7.0 5.9 3.9 4.1 3.6 3.1 2.5 0.8 1.2 2.6 1.6 1.1 1.7 0.9 1.3 1.3 0.6 1.3 1.6 2.0 12.2 1.0 2.4 1.8 2.2 0.9 10.0 10.9 28.9 11.3 9.8 8.8 16.1 9.2 11.3 13.1 50.6 6.1 7.5 11.5 6.0 33.3 19.3 7.6 21.4 15.9 21.0 29.5 8.1 6.6 15.6 8.8 9.4 4.9 0.0 7.2 17.9 7.6 20.7 3.5 28.0 8.7 33.4 12.1 9.8 18.3 8.8 12.0 7.4 1.7 2.8 10.4 28.6 19.7 14.8 8.1 11.8 24.9 6.5 10.3 31.0 15.1 6.0 20.0 4.5 6.8 18.6 TMCC2 "FLJ38497, HUCEP11" ENSG00000133069 "Transmembrane and coiled-coil domain family 2" O75069 1 205228176-205273343 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 83.6;brain: 25.9" "Cell type enhanced" "Detected in many" 23 "Erythroid cells: 140.2;Horizontal cells: 38.1;Rod photoreceptor cells: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.1" "Lineage enhanced" "Detected in single" "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "SCLC-21H: 27.3;WM-115: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014254 Approved NA NA "HPA014254: AB_1851326" "unprognostic (2.59e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (2.61e-2)" "unprognostic (4.18e-1)" "unprognostic (5.59e-2)" "unprognostic (2.46e-2)" "unprognostic (4.89e-2)" "unprognostic (2.53e-1)" "unprognostic (5.08e-2)" "unprognostic (1.05e-5)" "unprognostic (3.17e-1)" "unprognostic (1.39e-1)" "unprognostic (1.99e-3)" "unprognostic (3.06e-2)" "unprognostic (4.01e-1)" "unprognostic (3.43e-3)" 2.6 4.5 22.2 2.3 17.4 83.6 1.8 22.7 24.0 2.4 2.0 16.5 0.0 2.2 2.8 1.9 2.1 2.5 2.2 2.5 25.9 16.8 2.5 1.8 2.5 2.2 25.4 13.3 4.2 2.0 3.7 3.3 7.9 22.4 2.2 1.9 9.3 2.3 2.3 6.4 2.9 2.5 2.4 24.1 5.6 2.2 3.4 14.2 0.0 2.1 0.0 2.0 2.1 2.2 0.0 0.0 1.1 0.0 0.0 0.3 4.4 1.6 0.8 1.6 3.5 0.6 0.2 0.8 2.1 1.0 2.2 1.6 0.2 0.2 1.6 0.3 0.6 5.8 2.9 1.0 0.5 0.6 4.3 3.3 5.7 0.4 0.1 0.3 0.3 3.0 0.3 0.1 1.1 0.0 1.8 0.3 1.6 3.4 2.3 0.8 0.1 0.0 0.8 3.8 0.0 4.7 2.2 3.7 7.8 0.4 0.1 27.3 3.9 0.2 0.0 7.0 1.4 0.6 0.4 0.6 1.5 2.2 3.7 2.3 3.9 1.6 1.0 1.2 0.5 9.1 0.0 0.0 1.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 4.4 22.2 17.4 22.7 24.0 25.9 16.8 25.4 13.3 22.4 14.2 0.0 0.0 0.0 0.2 0.9 21.3 3.3 0.0 0.0 0.0 1.8 9.8 0.1 0.0 1.2 1.4 2.2 0.0 140.2 0.0 0.1 0.9 0.1 0.0 0.0 0.7 38.1 3.4 2.5 1.2 0.0 1.1 0.0 3.3 13.6 0.0 13.2 0.3 0.0 0.4 0.2 35.3 0.0 0.8 1.2 5.5 0.6 0.0 0.0 0.0 0.0 TMCC3 KIAA1145 ENSG00000057704 "Transmembrane and coiled-coil domain family 3" Q9ULS5 12 94567124-94650562 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 44.2;Urothelial cells: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 19.2;neutrophil: 30.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 30.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 18.2;Karpas-707: 24.6;U-266/84: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014272 Approved Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA014272: AB_1858059" "unprognostic (1.03e-1)" "unprognostic (2.54e-1)" "unprognostic (1.52e-3)" "prognostic unfavorable (4.87e-4)" "unprognostic (1.30e-1)" "unprognostic (8.63e-2)" "unprognostic (5.87e-2)" "unprognostic (1.17e-2)" "unprognostic (9.12e-2)" "unprognostic (3.45e-3)" "unprognostic (1.24e-1)" "unprognostic (7.73e-2)" "unprognostic (1.80e-3)" "unprognostic (9.11e-2)" "unprognostic (2.32e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" 10.6 4.0 10.2 7.7 20.9 8.1 9.9 2.7 9.9 11.0 19.7 32.6 6.8 13.1 6.9 3.0 6.1 5.5 4.7 4.4 14.7 10.8 7.4 3.5 5.9 3.9 25.8 7.4 5.2 2.8 5.0 4.7 15.7 17.8 7.7 15.0 7.3 5.8 5.1 20.2 7.0 23.0 7.2 25.5 11.6 6.4 2.2 20.4 0.1 12.0 3.3 5.3 7.2 5.9 2.5 1.1 30.0 3.0 1.3 1.5 1.1 4.4 0.2 1.1 0.0 0.4 1.6 8.0 0.0 0.0 0.3 1.1 0.0 1.0 0.1 0.0 0.0 4.0 11.0 6.2 7.5 1.5 2.0 1.5 2.9 0.5 0.0 0.3 0.0 6.0 1.0 1.0 4.2 6.0 6.7 18.2 0.0 0.1 24.6 0.6 0.2 0.0 0.2 0.5 1.5 3.8 0.0 0.3 2.9 1.2 9.4 0.1 0.5 0.1 4.7 0.2 5.4 0.0 0.2 11.0 0.0 0.1 0.0 1.9 11.5 16.4 0.1 2.3 0.9 1.0 6.5 1.8 19.2 1.5 2.6 0.1 2.5 0.6 0.8 1.0 1.4 0.0 1.0 30.0 1.3 3.0 1.1 0.0 1.1 10.2 20.9 2.7 9.9 14.7 10.8 25.8 7.4 17.8 20.4 0.0 2.4 6.0 26.2 18.3 1.7 1.7 5.1 0.0 0.0 7.0 0.0 12.5 0.0 1.4 4.6 12.1 44.2 0.0 3.4 2.7 3.4 12.5 0.0 0.5 3.5 0.0 11.5 21.5 13.7 4.7 1.7 11.0 3.3 22.6 11.3 0.0 7.7 18.7 1.1 8.4 0.2 6.5 3.1 0.0 1.1 14.2 5.9 4.9 5.5 78.1 TMCO1 "HP10122, TMCC4" ENSG00000143183 "Transmembrane and coiled-coil domains 1" Q9UM00 1 165724293-165827755 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation, Glaucoma, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054768, HPA078775" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA054768: AB_2682597, HPA078775: " "unprognostic (1.22e-2)" "unprognostic (3.28e-3)" "unprognostic (2.36e-1)" "unprognostic (1.45e-1)" "unprognostic (2.97e-1)" "prognostic unfavorable (5.17e-7)" "prognostic unfavorable (3.21e-4)" "unprognostic (5.92e-2)" "unprognostic (4.16e-2)" "unprognostic (7.95e-3)" "unprognostic (1.78e-1)" "unprognostic (5.20e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (2.85e-1)" "unprognostic (1.94e-1)" "unprognostic (2.14e-2)" "unprognostic (9.80e-2)" 28.8 48.5 28.1 18.7 29.8 17.2 34.1 21.5 28.7 30.2 47.4 26.9 37.6 43.0 28.4 43.3 34.3 24.9 30.6 25.9 23.8 26.8 62.6 89.8 24.9 23.6 27.2 21.0 30.6 37.3 32.6 50.1 47.0 31.1 30.7 48.8 29.9 43.5 38.5 20.2 20.9 70.9 23.7 31.4 29.4 29.9 34.4 22.4 36.3 53.7 24.1 31.1 29.4 25.2 46.0 76.6 52.5 57.6 45.1 61.7 78.0 28.0 31.7 24.3 14.6 44.8 21.2 23.7 48.2 34.2 28.4 29.6 45.2 42.5 17.9 50.1 34.9 12.5 40.0 31.5 25.3 31.0 45.4 29.2 22.6 36.9 27.9 36.2 38.4 29.8 28.9 29.5 33.0 26.6 26.2 20.6 22.1 58.6 35.1 39.8 21.7 30.4 29.2 31.0 92.2 36.0 22.4 27.2 45.2 34.4 37.0 25.0 43.8 36.9 39.3 29.3 37.4 51.5 48.9 22.6 26.2 21.8 22.9 44.6 67.2 90.9 63.0 21.0 25.1 34.7 52.5 55.6 51.2 53.0 50.8 55.6 46.0 56.5 56.5 41.8 39.8 46.0 53.2 43.1 45.1 57.6 76.6 61.7 78.0 28.1 29.8 21.5 28.7 23.8 26.8 27.2 21.0 31.1 22.4 89.3 64.3 79.5 78.2 75.3 77.8 52.9 242.0 129.8 92.1 202.4 64.8 116.6 36.5 176.6 62.6 87.0 250.8 46.7 166.4 124.7 115.1 88.8 73.0 298.8 125.0 71.5 85.0 87.8 100.9 101.4 114.5 87.4 94.5 55.9 105.0 214.5 177.4 168.4 121.6 108.8 60.1 122.9 83.4 191.2 73.2 81.2 93.1 105.4 127.3 85.0 TMCO2 dJ39G22.2 ENSG00000188800 "Transmembrane and coiled-coil domains 2" Q7Z6W1 1 40245947-40251691 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 74.7" "Group enriched" "Detected in some" 81 "Early spermatids: 2374.6;Late spermatids: 756.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;NB-4: 1.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (5.30e-2)" "unprognostic (2.71e-1)" "unprognostic (3.26e-2)" "unprognostic (3.58e-2)" "unprognostic (1.25e-1)" "unprognostic (3.93e-2)" "unprognostic (2.70e-5)" "unprognostic (6.16e-2)" "unprognostic (2.29e-1)" "unprognostic (1.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2374.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 756.1 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 19.4 0.0 13.0 5.8 0.0 0.1 0.0 0.0 0.0 TMCO3 "C13orf11, FLJ20623" ENSG00000150403 "Transmembrane and coiled-coil domains 3" Q6UWJ1 13 113490995-113554590 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 17.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039561, HPA048126" Uncertain Approved Cytosol NA NA Cytosol "HPA039561: AB_2676573, HPA048126: AB_2680276" "unprognostic (7.89e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (6.78e-2)" "unprognostic (7.88e-2)" "unprognostic (2.89e-1)" "unprognostic (6.01e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (2.93e-2)" "unprognostic (9.44e-2)" "unprognostic (3.08e-3)" "unprognostic (2.76e-2)" "unprognostic (8.47e-3)" "unprognostic (3.70e-3)" "unprognostic (1.05e-1)" "unprognostic (2.06e-1)" "unprognostic (6.27e-3)" "prognostic unfavorable (4.10e-4)" 16.1 20.5 15.1 11.1 14.2 40.3 14.5 38.7 14.6 21.3 15.7 18.6 16.7 13.0 23.1 15.5 13.1 17.2 23.2 17.0 14.4 13.0 18.0 15.5 13.8 9.4 17.4 9.6 16.9 46.1 18.6 18.6 23.2 21.2 16.1 14.1 17.1 25.8 14.5 10.2 7.7 17.6 18.9 20.7 14.8 27.8 11.0 11.3 7.2 7.5 13.4 11.3 13.2 23.9 2.6 5.0 17.4 8.5 4.1 1.8 2.0 27.1 9.2 13.4 9.2 27.7 41.0 7.3 29.8 28.5 13.1 13.3 10.1 12.1 6.5 7.6 32.6 17.9 11.0 7.0 10.8 20.5 13.3 7.2 5.8 14.9 10.0 26.1 9.5 12.3 33.2 25.6 9.8 20.4 34.1 21.4 4.2 8.3 9.3 22.9 4.9 4.9 5.7 6.7 13.0 14.6 6.3 8.2 4.6 21.9 3.7 11.8 9.8 9.2 20.4 9.5 19.9 12.0 18.1 33.3 14.9 15.9 10.8 12.5 11.5 6.5 4.2 49.2 5.0 7.1 2.4 6.9 6.8 1.1 4.4 1.4 2.6 1.4 1.8 5.0 1.4 1.5 1.5 17.4 4.1 8.5 1.1 1.2 2.0 15.1 14.2 38.7 14.6 14.4 13.0 17.4 9.6 21.2 11.3 11.9 13.7 13.7 30.6 8.8 15.6 16.5 25.5 33.5 21.6 24.4 13.7 17.6 5.0 37.3 11.6 32.2 18.2 0.0 32.8 48.1 26.7 79.7 26.5 8.9 17.4 20.6 32.8 31.9 30.8 28.3 33.9 20.1 16.9 30.7 58.9 26.1 43.8 28.3 44.9 12.8 17.6 6.5 32.0 17.7 13.2 6.1 10.9 12.7 15.2 27.6 TMCO4 DKFZp686C23231 ENSG00000162542 "Transmembrane and coiled-coil domains 4" Q5TGY1 1 19682213-19799945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA014601, HPA014620" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA014601: AB_2204302, HPA014620: AB_2669051" "unprognostic (3.31e-3)" "unprognostic (8.94e-2)" "unprognostic (9.71e-2)" "prognostic favorable (3.71e-4)" "unprognostic (6.99e-3)" "unprognostic (5.46e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (9.21e-2)" "unprognostic (2.60e-2)" "unprognostic (2.30e-1)" "unprognostic (1.84e-1)" "unprognostic (2.71e-2)" "prognostic favorable (4.12e-11)" "unprognostic (1.67e-1)" "unprognostic (2.22e-1)" "unprognostic (9.81e-2)" "prognostic favorable (3.64e-4)" 10.6 8.8 2.4 9.0 3.3 2.5 11.3 0.9 2.3 9.1 6.1 2.8 15.2 11.8 16.9 15.1 8.0 7.3 7.4 4.9 1.6 1.3 9.5 7.9 5.2 12.6 2.6 1.2 8.6 15.3 17.3 10.5 7.3 3.3 12.1 3.9 8.8 25.8 19.0 2.0 5.2 6.4 11.2 2.0 9.1 8.7 3.3 2.4 3.5 10.8 7.6 9.5 11.6 10.0 7.2 9.3 2.7 8.1 4.6 6.7 4.4 5.8 3.6 0.0 0.2 5.0 3.6 4.1 4.4 13.4 8.6 4.8 2.9 27.5 10.2 6.5 12.5 3.8 4.5 1.1 4.4 1.7 8.6 1.1 3.9 4.3 1.4 4.1 0.0 5.4 3.7 4.9 2.9 1.6 3.1 4.1 0.2 0.7 6.9 3.7 4.9 0.0 2.2 0.4 7.8 5.1 1.9 11.5 6.2 7.4 4.6 0.0 0.5 5.8 8.0 9.1 0.6 7.0 6.6 2.5 6.7 3.1 4.6 3.0 0.8 0.3 2.9 7.6 8.8 4.1 0.1 4.8 2.7 6.3 8.1 6.2 5.6 6.7 6.6 9.3 7.2 5.2 4.3 0.3 4.6 4.9 0.2 4.9 4.4 2.4 3.3 0.9 2.3 1.6 1.3 2.6 1.2 3.3 2.4 11.9 8.3 8.2 10.2 2.5 0.1 5.6 2.5 24.1 7.9 10.4 0.0 8.0 8.3 9.0 0.3 4.3 6.7 0.0 14.6 16.0 4.5 12.2 3.5 4.4 8.2 0.0 5.8 5.5 6.3 0.0 5.8 5.7 10.1 12.6 10.8 2.8 10.4 5.8 5.3 6.0 0.6 0.0 7.5 0.2 2.0 2.3 6.1 8.2 12.1 6.5 TMCO5A "MGC35118, TMCO5" ENSG00000166069 "Transmembrane and coiled-coil domains 5A" Q8N6Q1 15 37921939-37967724 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 130 "testis: 43.9" "Group enriched" "Detected in some" 135 "Early spermatids: 1004.2;Late spermatids: 3019.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.2;hTERT-HME1: 1.9" "Group enriched" "Detected in many" 4 "amygdala: 6.0;basal ganglia: 2.2;cerebral cortex: 5.7;hippocampal formation: 6.7" "Not detected" "Not detected" HPA056530 Enhanced NA NA "HPA056530: AB_2683167" "unprognostic (2.60e-1)" "unprognostic (1.69e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1004.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3019.1 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 6.5 0.0 14.9 5.2 0.0 0.0 0.0 0.0 0.0 TMED1 "Il1rl1l, IL1RL1LG, MGC1270, p24g1, p24gamma1, ST2L" ENSG00000099203 "Transmembrane p24 trafficking protein 1" Q13445 19 10832438-10836318 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 122.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018507 Uncertain NA NA "HPA018507: AB_1858063" "unprognostic (6.98e-2)" "unprognostic (3.42e-1)" "unprognostic (3.03e-3)" "unprognostic (1.28e-1)" "unprognostic (8.65e-2)" "unprognostic (2.27e-1)" "unprognostic (1.98e-2)" "unprognostic (4.20e-2)" "unprognostic (9.86e-2)" "unprognostic (7.27e-2)" "unprognostic (9.52e-2)" "unprognostic (4.93e-2)" "prognostic favorable (8.66e-5)" "unprognostic (9.49e-2)" "unprognostic (2.56e-1)" "unprognostic (5.16e-2)" "unprognostic (2.45e-2)" 12.1 15.8 9.5 8.7 9.4 10.5 17.0 5.2 11.5 13.5 10.5 13.6 16.8 11.8 13.1 19.7 12.8 15.4 14.8 23.6 10.7 10.2 20.9 32.2 9.3 12.5 13.1 6.5 22.4 19.4 10.5 18.3 35.3 9.9 12.8 4.2 13.2 15.6 10.4 33.5 8.7 10.1 6.3 11.5 14.8 11.6 11.4 10.0 12.5 22.7 18.2 9.2 12.8 10.0 17.6 27.0 14.2 32.2 37.6 20.8 20.9 13.3 23.3 10.0 15.2 9.7 10.9 10.4 20.6 19.1 22.0 31.5 21.7 19.7 9.9 48.9 14.6 11.5 11.7 6.1 11.0 7.9 14.3 15.2 13.5 17.7 17.1 14.2 10.0 32.2 15.6 12.8 13.0 7.2 9.7 12.9 7.9 11.3 27.7 8.8 23.4 7.5 14.2 14.8 8.5 23.8 9.1 7.6 15.4 12.8 11.4 10.6 10.9 11.8 11.5 11.3 4.3 15.3 13.8 13.0 27.5 11.8 27.3 21.5 17.0 17.2 9.0 19.7 22.0 13.5 4.1 32.2 14.2 20.8 30.7 14.5 17.6 14.4 16.9 27.0 14.3 13.5 14.9 11.7 37.6 31.4 19.5 12.2 20.9 9.5 9.4 5.2 11.5 10.7 10.2 13.1 6.5 9.9 10.0 8.9 11.7 20.5 19.6 16.5 9.6 0.3 35.7 34.8 13.6 50.6 7.9 95.0 34.9 45.3 3.6 26.7 25.4 0.0 38.5 78.9 41.1 29.9 27.6 37.7 46.7 4.8 22.7 22.1 20.0 4.9 20.8 20.2 40.5 27.1 20.5 36.4 37.0 28.8 19.1 50.6 16.4 32.3 25.4 15.1 28.2 15.3 122.3 17.5 25.4 18.4 TMED10 "p23, P24(DELTA), p24d1, p24delta1, TMP21" ENSG00000170348 "Transmembrane p24 trafficking protein 10" P49755 14 75131470-75176631 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034442, CAB037251, HPA047139, HPA050539" Enhanced Supported "Golgi apparatus" NA NA 6000000 "Golgi apparatus" "CAB034442: AB_2204336, CAB037251: AB_1841216, HPA047139: AB_2679951, HPA050539: AB_2681163" "unprognostic (2.00e-1)" "unprognostic (1.73e-2)" "unprognostic (2.02e-1)" "unprognostic (2.51e-3)" "unprognostic (4.06e-1)" "unprognostic (1.17e-3)" "unprognostic (5.88e-2)" "unprognostic (1.21e-1)" "unprognostic (3.68e-2)" "unprognostic (6.46e-3)" "unprognostic (1.01e-2)" "unprognostic (1.27e-2)" "unprognostic (1.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.82e-1)" "prognostic unfavorable (8.67e-4)" "unprognostic (2.06e-2)" 34.2 31.5 24.5 19.3 24.6 5.6 35.2 14.0 23.0 55.8 28.2 34.7 47.3 22.9 39.1 52.3 31.3 38.8 30.5 39.5 25.1 25.0 37.4 70.3 28.1 42.1 26.9 15.6 42.5 125.6 28.1 33.8 54.9 23.0 35.6 31.4 33.8 119.7 48.9 35.7 26.0 31.0 30.0 31.8 28.3 28.7 29.0 21.3 34.4 55.5 27.8 39.1 29.6 30.5 15.6 27.3 31.9 17.8 37.5 37.9 30.9 21.6 12.5 20.5 34.0 48.6 45.7 27.0 22.9 38.1 24.1 27.2 12.1 38.4 19.2 19.7 39.4 13.9 21.7 19.1 33.3 39.1 10.2 8.6 11.7 8.2 18.3 41.4 23.2 12.2 33.4 53.6 18.6 53.6 47.5 42.0 21.7 10.2 42.8 34.6 24.3 16.2 18.5 12.4 33.8 13.3 16.3 13.3 26.8 28.9 22.2 20.1 21.1 21.0 35.3 39.8 20.4 33.3 37.9 28.8 23.7 15.7 15.8 11.8 24.2 22.8 21.7 43.2 20.5 22.8 31.9 17.8 10.7 24.7 14.9 37.9 15.6 24.3 23.9 23.9 11.9 21.9 23.2 7.9 37.5 14.7 27.3 14.2 30.9 24.5 24.6 14.0 23.0 25.1 25.0 26.9 15.6 23.0 21.3 59.6 93.7 93.1 148.9 101.4 56.4 133.9 163.1 127.2 101.2 190.1 25.5 167.1 53.0 272.1 10.3 98.9 129.8 23.3 339.3 469.5 170.5 228.3 98.1 305.9 239.1 73.1 135.1 126.4 142.0 22.0 166.0 139.4 281.7 104.6 197.0 131.3 216.3 119.3 197.3 117.9 53.7 77.6 77.3 274.4 108.8 118.2 258.6 117.6 119.5 178.3 TMED2 "P24A, p24b1, p24beta1, RNP24" ENSG00000086598 "Transmembrane p24 trafficking protein 2" Q15363 12 123584531-123598577 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014060 Approved Supported Vesicles NA NA Vesicles "HPA014060: AB_1856389" "unprognostic (6.36e-2)" "unprognostic (3.38e-3)" "unprognostic (5.41e-3)" "unprognostic (1.75e-2)" "unprognostic (2.98e-2)" "prognostic unfavorable (3.36e-6)" "unprognostic (3.57e-3)" "unprognostic (2.20e-2)" "unprognostic (4.31e-2)" "unprognostic (9.76e-3)" "unprognostic (1.03e-2)" "unprognostic (3.94e-2)" "prognostic unfavorable (2.35e-7)" "unprognostic (2.97e-1)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (9.87e-2)" 31.3 31.9 15.7 21.8 21.2 23.5 32.0 13.2 21.5 38.5 31.6 20.4 41.1 27.6 33.4 49.0 41.3 27.4 28.9 41.7 15.7 17.1 32.6 120.1 28.1 29.4 18.2 16.7 37.4 135.4 18.1 36.3 40.0 18.9 33.3 32.8 23.8 90.2 38.0 46.3 27.4 34.2 30.5 22.5 25.6 32.4 17.8 15.0 24.0 49.2 23.8 30.0 34.0 27.8 32.4 69.3 58.9 40.9 39.5 61.2 36.2 41.9 37.4 24.9 43.0 56.8 50.4 59.3 73.0 59.0 46.5 36.9 37.3 36.6 36.0 39.2 72.7 31.9 42.1 33.6 39.3 48.9 27.0 29.0 38.8 22.7 48.1 107.9 52.8 33.5 42.3 65.7 39.9 54.3 66.7 43.4 24.6 39.1 24.7 47.4 31.1 28.0 43.4 35.9 36.3 33.7 29.1 40.6 41.8 56.7 63.6 31.0 26.8 48.9 49.1 48.3 31.5 83.3 42.9 41.1 39.7 25.1 38.3 40.8 54.7 50.7 30.5 46.9 35.0 46.8 58.9 39.8 39.6 46.8 40.9 61.2 32.4 42.4 44.1 44.2 27.2 34.6 40.3 31.5 39.5 37.8 69.3 38.3 36.2 15.7 21.2 13.2 21.5 15.7 17.1 18.2 16.7 18.9 15.0 44.7 63.4 116.9 242.8 370.8 48.2 119.4 201.2 64.3 75.1 146.5 19.6 243.2 99.5 277.5 9.2 101.5 131.7 0.0 218.6 589.4 362.9 393.4 91.1 470.6 200.1 46.1 163.9 139.3 120.4 10.9 168.0 156.4 359.4 130.8 234.1 92.4 213.4 161.4 144.2 138.8 38.3 161.7 234.9 97.7 158.0 436.1 377.9 163.0 207.2 283.9 TMED3 "C15orf22, p24B, p24g4, p24gamma4" ENSG00000166557 "Transmembrane p24 trafficking protein 3" Q9Y3Q3 15 79311062-79427432 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 182.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049314, HPA076949" Enhanced Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA049314: AB_2680708, HPA076949: AB_2686820" "prognostic unfavorable (7.71e-4)" "unprognostic (1.60e-1)" "unprognostic (3.54e-3)" "unprognostic (8.86e-3)" "unprognostic (1.41e-1)" "unprognostic (2.03e-3)" "unprognostic (2.42e-2)" "unprognostic (2.49e-1)" "unprognostic (4.85e-1)" "unprognostic (9.06e-2)" "unprognostic (8.09e-2)" "unprognostic (9.90e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.16e-1)" "unprognostic (2.88e-1)" "unprognostic (2.50e-1)" "unprognostic (1.52e-1)" 6.1 7.0 5.0 6.1 5.8 7.5 16.8 9.6 8.9 15.0 12.0 6.9 32.2 6.0 10.0 34.9 31.2 9.9 18.0 11.4 6.1 10.0 11.0 4.6 7.7 12.2 5.7 7.5 8.1 68.0 6.5 23.5 24.2 8.2 15.0 13.9 7.1 182.4 34.0 2.0 25.0 6.0 9.4 7.1 9.4 16.0 13.9 4.2 7.0 18.8 20.9 23.4 11.2 17.4 28.3 40.9 34.0 33.0 21.7 29.3 32.2 14.2 37.2 7.2 13.6 50.5 38.9 15.5 34.0 46.3 23.2 28.8 31.0 26.2 6.7 26.0 51.9 30.3 27.0 21.3 21.7 12.2 13.3 32.9 22.5 33.6 22.8 29.5 23.9 44.8 28.7 32.1 13.3 19.5 27.8 26.9 23.1 9.9 0.1 22.6 30.0 6.7 21.8 10.0 53.4 20.9 8.2 10.4 33.6 21.1 10.9 22.0 10.9 18.0 34.7 32.1 24.6 30.2 16.9 22.0 18.8 17.0 0.4 23.6 14.1 16.2 9.4 24.1 38.2 21.9 21.7 26.5 34.0 23.3 31.3 24.8 28.3 23.1 25.2 40.1 23.4 29.3 28.1 2.3 21.7 33.0 40.9 26.2 32.2 5.0 5.8 9.6 8.9 6.1 10.0 5.7 7.5 8.2 4.2 26.8 42.4 32.0 84.7 85.2 13.7 13.7 38.2 17.4 33.0 54.1 7.9 144.0 19.9 121.4 36.7 30.9 49.4 0.0 217.2 259.1 80.2 134.4 47.2 6.4 94.4 12.7 80.6 66.3 51.8 91.1 46.1 49.7 81.0 70.3 131.0 35.8 146.0 51.8 25.8 21.4 12.1 19.4 44.5 43.6 58.2 106.4 144.2 35.5 122.8 149.3 TMED4 "HNLF, p24a3, p24alpha3" ENSG00000158604 "Transmembrane p24 trafficking protein 4" Q7Z7H5 7 44577894-44582287 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014650 Approved "Intracellular and membrane" NA NA "HPA014650: AB_1858066" "unprognostic (7.34e-2)" "unprognostic (1.68e-3)" "unprognostic (1.46e-3)" "prognostic unfavorable (7.37e-4)" "unprognostic (2.09e-3)" "unprognostic (4.50e-3)" "unprognostic (2.54e-2)" "unprognostic (3.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.61e-1)" "unprognostic (2.42e-3)" "unprognostic (4.65e-2)" "prognostic favorable (1.37e-4)" "unprognostic (1.21e-1)" "unprognostic (6.12e-2)" "unprognostic (4.11e-1)" "unprognostic (6.61e-2)" 19.5 28.1 19.8 15.5 23.4 20.0 20.7 28.1 32.6 23.2 44.2 34.7 58.3 40.8 26.2 39.3 19.6 26.5 27.4 30.4 20.7 22.6 42.0 25.8 21.8 15.9 23.8 19.2 39.2 52.7 59.3 37.8 55.4 23.9 28.3 23.3 38.3 39.3 45.2 29.2 19.8 55.2 25.7 28.3 20.8 25.4 17.6 19.9 21.9 55.1 14.7 24.8 23.0 21.2 30.3 50.7 35.2 27.7 33.2 46.4 21.3 15.0 18.5 26.7 30.2 24.0 14.4 22.8 18.2 22.6 18.8 23.6 20.1 37.5 14.3 30.5 19.5 40.6 24.7 14.0 15.2 22.9 18.9 22.9 12.7 33.1 19.0 21.7 20.3 24.5 18.6 23.2 19.9 16.2 34.9 16.7 22.6 19.7 31.9 22.2 13.5 19.5 27.4 17.1 23.5 19.1 16.8 12.9 27.7 27.0 24.8 21.4 30.6 19.6 43.9 20.2 31.7 34.4 20.7 15.7 13.9 20.8 15.9 28.4 48.0 43.5 17.4 28.7 22.0 49.0 32.2 26.6 35.2 38.6 26.3 46.4 30.3 38.9 36.9 23.3 25.5 32.5 35.9 24.9 33.2 27.7 50.7 32.3 21.3 19.8 23.4 28.1 32.6 20.7 22.6 23.8 19.2 23.9 19.9 110.2 61.2 54.4 46.3 49.9 140.9 64.4 66.2 71.0 64.8 146.5 70.7 151.4 34.9 65.9 44.0 36.7 130.5 70.0 53.0 45.9 63.2 73.3 39.4 50.8 62.8 106.5 60.4 41.1 36.4 77.5 72.5 48.0 38.8 64.1 67.2 109.0 68.5 72.9 76.4 112.3 117.3 58.2 45.7 46.5 58.3 49.7 133.8 70.8 73.2 57.0 TMED5 "CGI-100, p24g2, p24gamma2" ENSG00000117500 "Transmembrane p24 trafficking protein 5" Q9Y3A6 1 93149742-93180728 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050289 Approved NA NA "HPA050289: AB_2681074" "unprognostic (3.35e-1)" "unprognostic (1.44e-2)" "unprognostic (2.02e-3)" "unprognostic (4.38e-1)" "unprognostic (3.16e-1)" "unprognostic (4.86e-2)" "unprognostic (2.83e-3)" "unprognostic (6.37e-2)" "unprognostic (8.60e-2)" "unprognostic (3.72e-2)" "unprognostic (1.64e-2)" "unprognostic (1.28e-1)" "unprognostic (1.40e-1)" "unprognostic (6.01e-2)" "unprognostic (1.86e-1)" "unprognostic (4.46e-2)" "unprognostic (1.38e-1)" 16.5 22.2 9.4 13.9 11.8 21.0 22.7 7.6 11.1 8.8 11.4 8.5 10.9 12.8 8.6 12.2 10.2 8.1 12.1 20.2 9.5 6.3 30.4 57.4 15.8 11.3 16.5 6.4 9.9 13.6 9.4 15.6 17.3 13.8 9.1 10.8 6.0 14.6 9.2 22.7 6.2 12.5 6.6 17.9 15.2 11.4 7.7 12.4 8.4 19.0 8.4 10.2 12.5 19.2 14.8 15.9 30.2 20.2 8.9 16.8 15.3 21.6 9.3 10.3 10.3 29.7 18.0 22.9 17.3 17.2 14.0 20.8 15.7 17.2 10.5 17.9 14.9 30.1 11.8 11.8 10.5 15.7 12.1 14.5 9.7 10.0 16.0 17.8 11.4 15.1 21.4 15.2 21.8 19.8 15.9 16.4 8.8 16.5 30.2 13.4 3.5 12.8 8.6 6.8 11.7 12.7 9.7 17.4 17.0 17.6 12.2 6.0 6.9 20.9 18.9 19.9 8.9 9.0 9.8 16.3 14.8 15.0 18.8 17.6 21.0 26.3 12.9 9.7 10.8 6.6 30.2 19.5 26.2 14.3 19.3 16.8 14.8 14.7 16.4 15.9 10.6 11.3 13.1 9.7 8.9 20.2 11.0 16.2 15.3 9.4 11.8 7.6 11.1 9.5 6.3 16.5 6.4 13.8 12.4 68.5 41.6 39.4 55.9 63.7 6.1 40.3 25.5 17.4 33.0 55.8 19.6 31.4 10.0 28.6 61.5 30.2 44.4 0.0 35.1 66.7 30.5 83.9 39.3 97.8 63.8 7.9 19.5 17.2 63.2 97.4 21.9 73.1 32.1 42.3 29.1 12.4 33.9 42.1 15.2 56.5 8.1 58.2 41.4 29.0 13.4 56.7 71.4 41.5 29.9 101.7 TMED6 "MGC23911, p24g5, p24gamma5" ENSG00000157315 "Transmembrane p24 trafficking protein 6" Q8WW62 16 69343248-69351809 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "pancreas: 144.2" "Cell type enhanced" "Detected in some" 15 "Exocrine glandular cells: 31.9;Pancreatic endocrine cells: 21.0;Proximal tubular cells: 16.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 17.2;OE19: 8.2" HPA012532 Approved NA NA "HPA012532: AB_1858065" "unprognostic (6.85e-2)" "unprognostic (1.42e-1)" "unprognostic (6.31e-3)" "prognostic favorable (7.74e-5)" "unprognostic (9.84e-3)" "unprognostic (7.57e-2)" "unprognostic (2.40e-1)" "unprognostic (1.20e-1)" "unprognostic (7.94e-2)" "unprognostic (3.74e-1)" "unprognostic (2.94e-2)" "unprognostic (4.76e-2)" "unprognostic (4.58e-3)" "unprognostic (9.71e-2)" "unprognostic (1.50e-1)" "unprognostic (1.36e-1)" "unprognostic (4.52e-3)" 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 0.2 0.4 0.9 0.2 2.0 2.7 0.3 4.5 0.2 5.6 0.3 0.2 0.2 0.1 6.1 3.1 0.7 0.2 0.2 0.2 1.0 144.2 0.0 0.2 0.2 0.2 0.2 1.7 0.2 0.2 3.5 0.2 0.1 2.8 0.2 0.2 0.3 16.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.2 0.0 0.6 0.0 2.0 0.2 0.7 1.8 1.6 1.1 0.1 0.1 1.0 2.3 0.1 0.0 0.3 2.4 1.0 4.7 0.8 0.0 0.7 1.2 0.2 0.2 0.4 0.7 2.0 2.4 0.8 17.2 0.1 2.9 1.1 0.2 0.9 0.1 0.3 0.9 0.1 2.3 1.6 0.6 0.3 1.8 1.3 3.3 2.2 8.2 1.7 2.6 1.4 1.8 0.7 2.0 3.8 1.5 3.1 1.1 1.2 0.6 0.6 2.1 2.1 2.7 1.5 0.9 1.5 1.6 1.4 5.2 1.4 2.5 0.8 0.0 0.4 0.0 0.8 0.6 1.5 0.6 2.0 0.4 0.2 0.3 0.5 2.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.0 0.1 0.0 2.3 0.1 0.0 5.6 0.0 31.9 0.0 0.0 0.2 1.1 3.4 0.3 0.0 8.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.9 0.7 21.0 5.5 0.0 16.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.1 TMED7 "CGI-109, FLJ90481, p24g3, p24gamma3" ENSG00000134970 "Transmembrane p24 trafficking protein 7" Q9Y3B3 5 115613508-115632992 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008960, CAB025883" Supported NA NA 100000 "CAB025883: , HPA008960: AB_1080280" "unprognostic (1.40e-1)" "unprognostic (8.42e-2)" "unprognostic (1.45e-2)" "unprognostic (1.22e-1)" "unprognostic (2.04e-1)" "unprognostic (4.35e-2)" "unprognostic (1.27e-1)" "unprognostic (2.26e-3)" "unprognostic (2.02e-1)" "unprognostic (2.11e-2)" "unprognostic (6.15e-3)" "unprognostic (4.10e-2)" "unprognostic (6.82e-2)" "unprognostic (4.95e-2)" "unprognostic (3.06e-1)" "unprognostic (4.79e-2)" "unprognostic (1.22e-1)" 23.0 25.3 21.6 16.7 23.0 16.1 31.0 12.5 30.0 32.8 24.7 28.6 37.8 21.7 29.9 43.8 23.3 23.8 21.6 30.4 23.5 22.1 33.7 81.7 26.3 26.2 24.8 14.9 27.9 38.0 31.5 35.5 37.0 20.6 30.3 25.9 19.8 34.6 41.1 20.1 15.9 29.0 27.0 35.4 21.4 24.2 16.6 22.2 17.3 47.9 17.0 16.9 32.9 21.6 10.3 18.4 17.4 21.7 12.5 14.7 16.2 18.6 12.6 13.4 16.6 34.9 26.5 21.0 33.2 35.2 24.6 40.4 10.8 33.2 9.7 32.9 34.3 30.8 14.9 12.4 38.5 39.1 22.4 10.5 8.9 13.2 22.5 37.5 9.2 18.1 24.4 18.4 23.5 29.7 30.9 23.6 6.7 8.5 13.5 26.4 8.8 6.9 8.2 9.4 11.2 10.9 7.6 19.8 18.5 29.9 13.3 10.2 12.1 27.1 15.9 19.3 13.4 19.1 12.1 23.9 33.8 14.5 24.3 19.6 9.0 6.9 10.1 27.3 15.4 18.6 16.3 21.7 17.4 13.9 21.4 14.7 10.3 11.1 12.7 18.4 9.0 11.2 11.5 15.0 12.5 16.4 12.2 9.9 16.2 21.6 23.0 12.5 30.0 23.5 22.1 24.8 14.9 20.6 22.2 35.7 24.3 43.1 23.8 40.5 31.5 36.3 56.0 17.4 17.0 43.6 9.8 38.1 11.6 33.6 18.0 27.8 58.8 0.0 24.6 82.3 47.4 54.2 9.3 96.1 44.2 28.6 83.8 41.1 44.0 16.2 43.4 37.1 49.0 17.2 70.4 55.9 31.8 35.1 50.2 35.8 23.2 38.8 40.6 26.5 17.0 38.5 69.2 21.8 36.9 36.0 TMED9 "HSGP25L2G, p24a2, p24alpha2" ENSG00000184840 "Transmembrane p24 trafficking protein 9" Q9BVK6 5 177592158-177596124 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 756.3;Syncytiotrophoblasts: 646.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014650 Approved NA NA 46000 "HPA014650: AB_1858066" "unprognostic (5.75e-3)" "unprognostic (4.35e-2)" "unprognostic (1.37e-1)" "unprognostic (3.82e-2)" "unprognostic (9.37e-3)" "unprognostic (5.14e-3)" "unprognostic (2.55e-2)" "unprognostic (1.90e-2)" "unprognostic (1.37e-1)" "unprognostic (7.00e-2)" "unprognostic (4.01e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (5.88e-5)" "unprognostic (2.88e-1)" "unprognostic (4.71e-2)" "unprognostic (9.07e-2)" "unprognostic (3.65e-2)" 23.3 32.6 22.3 24.5 21.3 20.9 36.3 12.4 21.5 27.1 29.5 13.3 56.0 21.0 24.1 46.2 38.1 22.0 28.4 30.9 17.6 17.1 37.4 91.8 29.9 38.4 19.1 20.4 19.7 134.5 21.6 25.5 80.5 21.0 27.3 31.3 17.5 72.2 55.7 20.5 24.0 21.2 26.7 16.0 31.0 31.3 20.0 15.7 13.8 32.3 24.1 28.2 22.0 28.9 32.3 96.6 35.3 47.6 33.6 44.0 51.5 34.9 40.2 19.1 60.6 50.1 35.8 84.0 61.6 51.5 34.1 47.4 59.1 52.7 20.0 80.0 62.3 65.1 29.3 18.2 89.6 34.1 97.5 24.7 16.9 34.3 53.5 50.9 45.9 63.5 33.4 46.9 35.8 40.5 44.0 50.6 17.8 19.4 37.1 36.7 83.0 10.8 32.6 20.9 30.9 37.4 18.9 23.8 52.7 40.8 31.3 10.0 14.0 31.8 38.3 33.9 30.1 38.7 46.8 43.3 42.6 30.8 34.5 49.9 62.6 37.2 19.0 56.4 57.9 53.8 29.0 47.6 35.3 44.0 44.9 43.6 32.3 35.1 34.1 44.7 30.2 30.1 27.5 19.2 33.6 39.2 96.6 34.0 51.5 22.3 21.3 12.4 21.5 17.6 17.1 19.1 20.4 21.0 15.7 62.5 65.8 89.3 157.5 128.8 69.0 41.6 132.5 49.5 64.8 122.1 29.5 458.0 24.9 378.2 5.2 109.0 134.2 70.0 309.9 756.3 179.8 204.3 110.8 102.5 343.8 57.2 107.7 119.1 80.2 8.5 125.1 137.4 243.0 276.9 174.2 99.5 283.3 157.9 92.3 58.4 59.1 64.7 101.0 58.2 191.6 121.1 646.6 100.1 113.3 191.3 TMEFF1 "C9orf2, CT120.1, H7365" ENSG00000241697 "Transmembrane protein with EGF like and two follistatin like domains 1" Q8IYR6 9 100473113-100577636 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 21.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;BEWO: 9.8;NTERA-2: 19.8;REH: 13.3;SCLC-21H: 16.9;SH-SY5Y: 11.3" "Low region specificity" "Detected in all" HPA051501 Uncertain NA NA "HPA051501: AB_2681509" "unprognostic (1.96e-1)" "unprognostic (2.30e-1)" "unprognostic (9.69e-3)" "unprognostic (2.32e-2)" "unprognostic (9.02e-2)" "unprognostic (3.59e-2)" "unprognostic (2.87e-2)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (1.05e-1)" "unprognostic (5.04e-6)" "unprognostic (1.30e-4)" "unprognostic (1.52e-1)" "unprognostic (3.97e-2)" "unprognostic (3.44e-3)" 1.2 1.2 5.0 1.0 13.9 1.2 1.1 1.4 21.1 1.6 1.3 15.0 0.0 1.0 3.0 1.0 1.0 1.2 1.6 1.0 9.1 8.9 1.2 1.0 1.1 1.4 10.3 7.9 1.0 1.0 1.1 0.4 1.8 11.7 1.5 1.1 0.1 1.1 1.4 1.0 1.0 1.3 1.4 13.8 1.2 1.3 4.1 12.6 0.0 3.1 0.0 1.1 1.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 7.9 0.4 0.1 0.2 9.8 0.6 0.1 0.4 0.5 0.5 0.1 0.0 1.8 0.3 0.1 0.0 3.0 0.0 0.5 0.0 4.3 0.0 0.2 0.4 0.4 0.0 0.0 0.3 0.0 0.4 0.1 0.3 1.2 3.5 0.1 0.0 0.6 0.0 4.9 0.0 19.8 0.0 0.2 13.3 6.8 0.0 0.3 0.0 16.9 11.3 0.0 0.0 0.2 4.7 0.0 0.0 1.8 1.5 2.6 0.1 0.6 3.1 2.2 2.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.0 13.9 1.4 15.4 9.1 8.9 10.3 7.9 11.7 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 TMEFF2 "CT120.2, HPP1, TENB2, TPEF, TR" ENSG00000144339 "Transmembrane protein with EGF like and two follistatin like domains 2" Q9UIK5 2 191949043-192195709 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.6;prostate: 46.3;seminal vesicle: 17.5" "Group enriched" "Detected in some" 6 "Horizontal cells: 96.9;Leydig cells: 24.5" "Cancer enriched" "Detected in some" 21 "prostate cancer: 57.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 17.3;LHCN-M2: 49.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015587 Approved "Secreted in male reproductive system" NA NA "HPA015587: AB_1858069" "unprognostic (2.12e-3)" "unprognostic (5.37e-1)" "unprognostic (3.10e-1)" "unprognostic (5.89e-7)" "unprognostic (4.96e-2)" "unprognostic (1.27e-1)" "unprognostic (8.82e-2)" "unprognostic (1.64e-1)" "unprognostic (1.86e-1)" "unprognostic (5.55e-2)" "unprognostic (2.09e-2)" "unprognostic (3.79e-2)" "unprognostic (4.17e-3)" "unprognostic (1.55e-2)" "unprognostic (2.91e-1)" "unprognostic (1.81e-1)" "unprognostic (1.20e-1)" 1.1 3.8 20.2 1.1 14.7 1.0 1.1 7.4 29.6 1.1 2.0 18.4 1.7 1.7 1.0 11.1 2.4 1.1 3.0 1.4 17.7 18.5 1.0 1.0 1.1 1.0 15.7 17.7 1.1 1.1 1.1 0.4 1.0 11.1 46.3 2.8 2.8 1.1 17.5 1.3 1.1 1.7 1.1 11.1 1.1 1.4 1.8 15.9 0.0 1.1 0.0 1.2 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 17.3 0.0 2.7 2.8 0.0 0.0 0.3 0.8 1.0 0.0 0.0 0.0 0.0 4.7 2.1 0.0 1.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 7.5 0.0 0.9 5.1 4.2 0.0 0.0 0.0 0.0 49.6 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.1 1.3 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 14.7 7.4 22.7 17.7 18.5 15.7 17.7 11.1 15.9 0.0 0.0 0.0 0.1 0.1 9.9 1.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.2 4.0 0.0 0.0 0.0 96.9 0.0 0.0 0.0 0.7 24.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 8.1 0.0 1.3 6.5 0.4 1.2 2.5 0.3 0.0 0.0 0.0 0.0 TMEM100 "FLJ10970, FLJ37856" ENSG00000166292 "Transmembrane protein 100" Q9NV29 17 55719627-55732121 "Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 52.8;lung: 99.5" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 20.4;Leydig cells: 37.7;Peritubular cells: 49.5;Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 18.1;ASC TERT1: 12.3;HHSteC: 28.0;HSkMC: 12.9;U-87 MG: 8.5;WM-115: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055936 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA055936: AB_2682975" "unprognostic (1.35e-1)" "unprognostic (2.75e-1)" "unprognostic (1.57e-1)" "unprognostic (4.02e-2)" "unprognostic (6.78e-3)" "unprognostic (3.07e-1)" "prognostic favorable (2.67e-5)" "unprognostic (5.74e-2)" "unprognostic (1.87e-2)" "unprognostic (4.66e-1)" "unprognostic (1.89e-2)" "unprognostic (8.11e-3)" "prognostic unfavorable (1.32e-4)" "unprognostic (4.91e-3)" "unprognostic (1.12e-1)" "unprognostic (2.07e-2)" "unprognostic (1.26e-3)" 24.7 2.0 3.4 1.5 3.9 0.0 52.8 0.7 5.3 5.1 10.5 0.7 8.8 2.7 1.6 16.7 4.6 3.6 4.8 5.8 1.6 2.8 1.2 5.8 99.5 1.5 3.4 0.6 10.1 1.9 0.0 3.3 23.5 2.6 7.4 5.1 2.6 2.2 11.7 7.0 1.3 6.6 5.2 1.4 2.3 10.7 3.9 0.6 0.5 3.8 3.7 1.3 5.3 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 18.1 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 28.0 0.0 0.0 12.9 0.0 0.9 0.1 0.1 0.0 0.2 0.5 0.1 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 1.2 2.4 0.0 0.5 0.0 0.1 8.5 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.9 0.7 1.7 1.6 2.8 3.4 0.6 2.6 0.6 0.0 5.1 0.0 0.3 2.3 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 14.1 0.0 0.0 0.0 0.0 20.4 0.1 1.1 13.9 0.1 0.0 0.0 7.4 0.0 0.0 37.7 0.6 6.8 0.0 0.0 0.0 0.2 0.0 49.5 0.5 0.0 32.3 12.2 0.0 0.0 2.3 0.1 0.0 0.0 0.1 TMEM101 "FLJ23987, MGC4251" ENSG00000091947 "Transmembrane protein 101" Q96IK0 17 44011188-44023946 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039739, HPA075651" Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039739: AB_2676657, HPA075651: " "unprognostic (1.40e-3)" "unprognostic (1.75e-1)" "unprognostic (1.67e-1)" "prognostic favorable (4.29e-4)" "unprognostic (5.91e-2)" "unprognostic (3.91e-3)" "prognostic unfavorable (7.10e-4)" "unprognostic (1.80e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (1.53e-1)" "unprognostic (1.61e-1)" "prognostic favorable (4.10e-5)" "unprognostic (1.59e-2)" "unprognostic (2.02e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" 11.0 10.9 8.4 7.3 14.2 5.1 58.9 6.3 16.5 22.7 11.4 13.7 7.7 8.4 33.3 14.5 15.1 19.2 15.4 12.4 8.7 8.6 37.2 12.0 11.4 16.1 9.5 9.4 13.0 27.8 10.7 8.5 17.8 11.6 13.9 8.6 11.5 20.9 59.7 15.5 13.8 9.5 11.6 10.1 11.0 13.6 16.9 8.9 10.0 25.4 12.9 13.2 12.5 11.6 23.8 25.9 11.7 25.0 23.8 27.2 17.8 9.8 24.2 8.6 7.2 20.6 19.9 8.7 10.3 15.7 20.5 19.6 17.9 25.7 11.1 2.9 10.6 16.0 15.2 10.0 17.9 15.7 12.0 20.2 8.3 19.4 36.2 17.8 13.4 14.5 17.8 20.5 14.5 20.6 18.5 17.9 19.5 17.1 21.9 12.7 13.2 14.4 15.4 4.0 10.8 27.3 12.5 18.8 20.1 17.1 8.0 11.3 9.0 6.6 0.2 24.5 11.4 11.9 25.8 10.7 18.8 12.7 8.2 20.2 22.8 15.7 5.1 19.7 12.7 16.7 11.7 24.9 8.6 19.4 25.0 21.8 22.7 24.5 22.3 25.9 23.8 27.2 22.1 9.1 23.8 17.8 25.2 25.1 17.8 8.4 14.2 6.3 16.5 8.7 8.6 9.5 9.4 11.6 8.9 17.9 12.5 26.3 26.3 18.3 10.4 28.5 20.4 22.7 13.6 38.4 5.9 59.3 31.5 30.3 10.8 20.2 20.8 0.0 43.1 35.2 18.8 20.8 23.0 18.6 33.4 11.1 22.5 31.3 25.9 8.7 12.0 20.9 32.1 47.7 31.6 16.0 40.2 17.5 11.7 25.6 11.4 6.5 16.0 48.6 17.9 19.7 37.3 17.9 43.5 22.6 TMEM104 "FLJ00021, FLJ20255" ENSG00000109066 "Transmembrane protein 104" Q8NE00 17 74776483-74839779 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044330 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA044330: AB_10960543" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (5.95e-2)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (7.46e-2)" "unprognostic (2.86e-2)" "unprognostic (4.75e-1)" "prognostic favorable (1.97e-5)" "unprognostic (8.14e-2)" "unprognostic (6.17e-2)" "unprognostic (8.46e-2)" "unprognostic (7.95e-2)" "unprognostic (2.82e-3)" "unprognostic (1.00e-2)" 11.5 15.5 10.6 11.6 12.1 15.4 7.7 10.5 13.9 8.1 7.9 19.1 9.5 7.6 7.4 8.9 9.3 6.8 9.6 9.0 11.4 8.2 10.9 19.9 14.7 19.0 17.3 9.1 9.4 18.7 21.0 14.7 12.5 13.1 8.0 6.7 10.0 15.1 9.1 7.5 9.7 7.7 9.4 18.5 10.4 8.3 17.4 14.2 7.5 11.7 6.5 10.2 10.6 6.1 4.9 8.8 5.7 7.7 3.9 7.9 5.0 6.3 15.6 8.4 9.4 11.9 7.4 5.0 11.0 11.1 14.1 15.7 12.8 6.9 3.4 3.5 12.5 14.4 7.2 8.4 6.1 7.5 2.5 11.9 8.4 6.3 8.8 8.7 13.7 7.8 5.9 6.8 14.3 3.1 4.2 10.0 8.3 4.8 5.3 9.6 6.0 8.2 5.6 4.6 8.4 12.5 5.2 13.2 5.6 6.3 5.6 7.1 9.3 6.1 7.9 8.1 6.6 10.1 21.4 7.9 29.8 7.6 11.3 14.2 3.6 3.1 3.8 11.5 14.4 11.3 2.2 7.7 5.7 7.9 6.5 4.0 4.9 7.6 7.2 8.3 1.6 6.3 4.4 3.6 3.9 6.6 8.8 7.5 5.0 10.6 12.1 10.5 13.9 11.4 8.2 17.3 9.1 13.1 14.2 6.0 7.2 0.8 1.0 2.3 2.3 36.1 10.2 0.0 3.4 5.2 2.0 3.3 0.0 3.9 1.6 2.3 3.9 0.0 4.8 3.3 2.7 2.1 1.1 11.5 10.6 0.0 7.9 3.1 6.3 1.7 2.6 5.5 0.0 4.6 4.0 4.0 5.3 3.1 2.1 1.6 3.0 0.0 1.4 4.3 4.1 1.9 3.2 2.9 2.6 1.3 TMEM105 FLJ38792 ENSG00000185332 "Transmembrane protein 105" Q8N8V8 17 81311270-81330674 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 7.5" "Cell type enhanced" "Detected in some" 9 "Hepatocytes: 4.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.3;MCF7: 3.3;OE19: 3.3;T-47d: 2.1;THP-1: 2.7;U-937: 5.1" NA NA "unprognostic (4.99e-3)" "unprognostic (6.49e-3)" "unprognostic (4.62e-2)" "unprognostic (3.67e-2)" "unprognostic (2.54e-1)" "unprognostic (3.65e-4)" "unprognostic (1.11e-1)" "unprognostic (1.10e-1)" "unprognostic (3.32e-3)" "unprognostic (7.49e-2)" "unprognostic (9.81e-4)" "unprognostic (1.33e-1)" "unprognostic (6.04e-6)" "unprognostic (1.17e-2)" "unprognostic (1.55e-1)" "unprognostic (2.48e-2)" "unprognostic (3.38e-1)" 0.1 0.8 0.1 0.1 0.1 0.6 0.7 0.0 0.1 0.5 1.7 0.0 0.0 0.5 0.1 0.2 2.4 0.7 5.0 0.0 0.1 0.0 2.4 7.5 4.7 0.1 0.1 0.0 0.2 0.1 0.0 0.1 1.0 0.5 0.8 0.4 0.7 4.0 0.0 0.5 1.1 2.0 1.3 0.2 1.3 0.3 0.2 0.0 0.0 2.4 3.3 2.4 3.3 1.0 0.5 1.0 1.9 0.4 0.8 0.4 0.1 0.5 1.1 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.2 0.0 3.3 0.1 0.0 0.5 0.0 0.0 0.3 0.3 0.3 0.0 0.1 0.0 0.1 2.1 2.7 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 5.1 0.0 0.6 0.4 0.3 0.3 0.1 0.2 0.3 0.2 0.3 0.0 0.5 0.2 0.4 1.9 0.8 0.1 1.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 2.1 0.0 0.4 0.5 0.0 0.4 2.5 1.4 2.3 0.0 0.0 0.1 0.0 0.1 0.6 0.0 2.6 0.0 0.2 1.1 0.2 0.4 0.0 4.3 0.3 0.0 0.0 1.3 0.3 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.0 2.3 0.0 6.5 0.3 0.0 0.0 0.6 0.1 0.0 2.9 0.4 TMEM106A MGC20235 ENSG00000184988 "Transmembrane protein 106A" Q96A25 17 43211835-43220041 "Predicted membrane proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 31.9" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 36.4;Kupffer cells: 35.3;Macrophages: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 15.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (9.71e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (9.61e-5)" "unprognostic (4.95e-3)" "unprognostic (8.62e-2)" "unprognostic (1.79e-1)" "unprognostic (9.11e-2)" "unprognostic (1.76e-1)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (2.99e-2)" "unprognostic (6.08e-2)" "unprognostic (7.89e-3)" "unprognostic (1.39e-1)" "unprognostic (5.34e-2)" "unprognostic (1.24e-1)" "unprognostic (8.30e-2)" 7.6 4.8 4.7 17.2 5.9 3.5 8.9 1.1 3.6 7.4 4.1 5.0 2.6 4.4 7.3 9.1 2.5 6.2 5.2 5.5 4.1 2.8 24.9 5.5 11.0 31.9 5.7 3.6 9.3 6.2 2.6 3.8 18.7 4.1 5.2 6.3 7.2 5.8 6.0 1.9 2.4 6.2 9.9 7.4 16.5 5.5 5.5 5.4 5.3 7.3 4.1 12.0 5.6 5.2 3.3 5.3 17.4 4.9 1.7 2.2 1.7 2.7 0.9 0.3 0.2 3.5 3.9 2.1 7.0 4.5 6.1 9.6 2.1 5.7 4.0 1.4 10.6 2.4 1.3 0.7 0.9 7.2 6.2 0.0 2.7 2.3 9.4 2.0 0.1 15.4 2.4 0.2 11.3 0.3 2.2 5.3 4.8 0.1 2.9 7.6 1.2 4.7 1.8 0.3 0.0 0.0 3.5 1.2 2.4 2.6 0.2 0.6 0.0 1.3 3.3 1.5 1.6 5.0 4.0 6.1 3.1 0.4 3.1 1.4 4.6 0.4 1.2 2.5 4.8 6.0 17.4 4.3 4.8 1.5 4.9 0.6 1.7 1.0 1.4 3.6 3.3 0.7 1.3 1.3 1.7 1.7 5.3 2.2 1.7 4.7 5.9 1.1 3.6 4.1 2.8 5.7 3.6 4.1 5.4 3.0 5.0 11.5 9.6 2.2 4.7 0.8 0.0 5.3 3.4 7.0 2.0 4.6 3.3 1.9 4.1 3.7 2.1 0.0 3.4 5.5 6.6 9.5 8.1 1.6 36.4 0.0 2.9 3.7 35.3 2.1 13.0 31.1 0.0 9.0 3.1 2.0 4.1 2.5 6.7 13.0 3.4 12.9 3.8 7.7 3.8 1.5 4.3 7.0 2.6 10.5 TMEM106B "FLJ11273, MGC33727" ENSG00000106460 "Transmembrane protein 106B" Q9NUM4 7 12211241-12243367 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Amyotrophic lateral sclerosis, Disease mutation, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058342 Approved Supported Endosomes,Lysosomes NA NA "Endosomes, Lysosomes" "HPA058342: AB_2683684" "unprognostic (5.29e-2)" "unprognostic (2.34e-2)" "unprognostic (4.20e-2)" "unprognostic (6.20e-2)" "unprognostic (2.73e-1)" "unprognostic (1.87e-2)" "unprognostic (3.50e-2)" "unprognostic (5.89e-2)" "unprognostic (4.44e-2)" "unprognostic (1.30e-1)" "unprognostic (3.01e-3)" "unprognostic (2.09e-2)" "unprognostic (1.75e-3)" "unprognostic (5.52e-2)" "unprognostic (3.06e-2)" "unprognostic (2.16e-2)" "unprognostic (1.70e-1)" 17.1 48.3 16.2 11.4 23.7 6.2 17.0 18.5 29.0 26.0 20.3 19.4 13.5 16.1 24.9 19.7 18.5 19.9 18.0 20.8 15.7 16.2 30.9 33.0 12.9 11.7 20.5 21.2 22.1 18.3 17.5 31.3 35.3 26.8 27.2 22.6 15.2 23.2 24.3 23.9 15.5 18.1 24.8 24.8 13.5 15.5 12.0 21.3 14.7 30.7 14.9 12.4 21.4 17.9 7.6 2.8 8.8 6.3 14.1 19.4 7.3 9.3 22.3 9.0 24.0 21.2 20.6 9.6 13.9 31.8 9.8 12.7 5.5 37.0 3.7 15.7 18.5 18.8 10.8 7.8 9.1 13.4 5.4 7.1 4.6 10.4 6.4 17.0 12.1 6.5 16.5 11.8 7.2 17.1 44.0 15.1 6.8 11.0 11.2 14.7 4.0 2.7 6.9 14.5 12.3 9.0 6.8 7.8 7.3 24.3 9.4 11.6 16.5 14.8 13.6 12.8 13.6 12.3 8.7 14.8 14.2 17.1 12.2 11.9 10.4 18.8 4.3 17.7 5.0 32.5 8.8 4.2 4.8 9.4 4.9 13.5 6.3 11.6 11.1 2.8 7.6 19.4 13.5 2.5 14.1 6.3 0.9 9.7 7.3 16.2 23.7 18.5 29.0 15.7 16.2 20.5 21.2 26.8 21.3 68.5 32.3 22.3 34.8 32.6 52.4 35.3 40.8 36.1 27.3 62.8 43.2 47.5 14.9 96.5 3.0 30.3 45.9 0.0 50.6 29.6 53.1 59.5 13.9 60.6 29.3 62.0 55.3 36.8 27.3 4.1 45.5 20.5 35.4 11.8 40.5 88.3 60.8 51.5 57.3 53.1 45.1 32.3 32.3 41.6 27.5 37.9 113.4 30.2 41.7 40.1 TMEM106C MGC5576 ENSG00000134291 "Transmembrane protein 106C" Q9BVX2 12 47963569-47968878 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Enterocytes: 249.4;Undifferentiated cells: 213.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 136.0" "Low region specificity" "Detected in all" HPA047204 Enhanced NA Yes "HPA047204: AB_2679982" "unprognostic (1.63e-2)" "unprognostic (5.84e-2)" "unprognostic (1.56e-2)" "unprognostic (2.40e-1)" "unprognostic (3.13e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (5.27e-8)" "unprognostic (1.05e-1)" "unprognostic (1.90e-2)" "unprognostic (1.52e-3)" "unprognostic (3.60e-1)" "unprognostic (7.29e-2)" "prognostic favorable (4.62e-4)" "unprognostic (1.12e-2)" "unprognostic (1.16e-1)" "unprognostic (2.57e-2)" "unprognostic (1.83e-1)" 10.6 19.1 12.6 18.5 17.3 12.2 20.4 17.5 16.3 16.6 41.2 6.5 29.0 33.9 19.7 43.6 17.5 15.1 23.1 25.8 17.7 14.4 26.4 13.6 16.5 10.4 8.5 14.6 21.4 39.1 33.7 27.4 23.6 12.8 15.9 45.3 30.4 59.0 16.6 8.0 11.3 58.1 16.9 7.1 31.0 21.9 28.3 5.8 23.1 20.5 16.1 15.2 12.1 16.6 14.9 5.1 10.7 4.1 7.3 26.2 16.5 37.2 26.1 24.2 26.7 11.2 8.2 23.0 21.0 30.3 38.4 33.1 39.1 38.6 32.8 29.6 23.0 35.9 25.6 37.9 23.0 36.7 31.3 36.4 25.5 37.5 15.8 8.6 26.0 18.9 5.6 15.7 35.0 18.5 26.4 24.4 35.5 17.1 37.6 26.8 27.0 37.6 11.6 4.3 40.0 36.1 33.3 31.4 27.9 20.3 28.6 16.3 19.4 32.6 22.0 21.9 13.2 80.5 21.2 6.0 16.2 27.8 23.3 37.1 20.9 34.1 36.5 20.6 136.0 15.5 10.7 3.7 9.5 19.5 3.3 23.8 14.9 19.1 20.2 5.1 12.1 17.9 19.6 3.2 7.3 4.1 0.8 26.2 16.5 12.6 17.3 17.5 16.3 17.7 14.4 8.5 14.6 12.8 5.8 29.8 20.2 17.1 26.7 42.6 28.5 32.9 50.9 2.7 12.5 33.2 17.7 49.4 72.9 57.2 2.1 15.7 249.4 23.3 39.1 24.8 34.3 27.1 10.4 15.1 45.2 28.6 34.5 44.8 13.8 3.1 30.2 11.1 20.3 11.8 121.6 146.7 38.5 151.1 38.9 64.1 40.9 12.9 37.6 21.3 32.1 35.8 12.5 24.5 213.7 24.2 TMEM107 MGC10744 ENSG00000179029 "Transmembrane protein 107" Q6UX40 17 8173237-8176399 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 171.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052555, HPA059653" Approved Approved "Nucleoplasm,Plasma membrane,Midbody ring" Yes No "Nucleoplasm, Plasma membrane" "Midbody ring" "HPA052555: AB_2681870, HPA059653: AB_2684096" "unprognostic (2.87e-2)" "unprognostic (2.67e-1)" "unprognostic (2.85e-2)" "prognostic favorable (9.39e-5)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (5.70e-3)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (6.02e-3)" "unprognostic (1.83e-2)" "unprognostic (1.87e-1)" "unprognostic (2.66e-3)" "unprognostic (1.26e-1)" "unprognostic (4.99e-1)" "unprognostic (2.66e-1)" "unprognostic (1.49e-1)" 8.6 11.8 13.7 7.1 19.6 17.5 13.0 7.3 23.2 11.7 8.3 9.9 10.7 4.2 10.0 30.1 8.8 38.7 9.4 8.8 11.0 13.4 12.1 4.0 12.8 17.7 10.9 17.1 7.5 9.6 17.8 20.8 10.0 15.6 5.9 7.8 12.6 8.7 10.1 1.7 12.7 6.0 10.1 10.5 11.9 7.1 15.9 8.2 7.8 19.1 4.3 9.6 9.5 7.8 33.1 18.7 28.4 29.9 14.5 20.8 12.7 31.6 10.0 15.5 7.1 9.4 14.2 3.1 7.4 7.0 6.5 8.6 1.2 18.2 8.7 9.5 7.4 4.6 22.1 6.3 14.5 10.3 10.7 7.4 4.7 17.4 3.4 3.8 1.8 5.2 6.9 9.2 17.1 8.3 13.7 10.8 10.8 4.0 17.1 15.3 9.4 4.3 5.0 1.6 3.9 4.6 7.9 4.2 12.5 12.0 2.4 4.5 7.1 8.6 1.8 6.3 3.7 5.4 6.4 6.8 3.3 6.3 5.2 3.9 6.7 3.7 3.4 19.0 7.1 5.3 10.5 13.3 28.4 18.8 15.8 16.3 26.7 18.1 20.0 11.8 33.1 20.0 20.8 10.9 14.5 29.9 18.7 14.3 12.7 13.7 19.6 7.3 23.2 11.0 13.4 10.9 17.1 15.6 8.2 8.9 9.8 33.9 18.2 17.1 17.7 6.2 40.8 171.3 25.0 31.4 43.2 15.0 11.6 14.4 7.1 20.4 10.3 0.0 9.6 17.4 16.6 14.7 34.8 17.8 39.4 11.1 8.7 23.9 38.4 6.3 11.8 29.7 32.1 21.6 12.1 32.1 11.5 14.4 14.2 15.3 60.3 0.0 11.3 47.4 49.2 25.0 11.1 34.5 15.3 9.7 TMEM108 "CT124, MGC3040" ENSG00000144868 "Transmembrane protein 108" Q6UXF1 3 133038391-133397792 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.6" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 96.2;Early spermatids: 57.1;Late spermatids: 29.1;Rod photoreceptor cells: 56.3" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 11.8;LHCN-M2: 6.6;SCLC-21H: 10.3;SH-SY5Y: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063350 Enhanced Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "Nucleoli, Vesicles" "HPA063350: AB_2684993" "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.07e-3)" "unprognostic (3.17e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.06e-4)" "unprognostic (2.08e-1)" "unprognostic (7.27e-4)" "unprognostic (1.11e-1)" "unprognostic (3.03e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-2)" "unprognostic (6.12e-2)" "unprognostic (1.36e-2)" 2.2 15.1 12.7 2.2 13.8 0.7 2.4 15.6 21.7 3.2 1.8 7.5 0.2 1.1 3.7 1.3 12.7 2.4 1.6 8.4 10.0 8.1 1.0 0.6 12.1 2.5 5.3 13.7 0.8 1.0 6.1 2.8 9.1 4.9 4.0 2.2 16.1 1.8 3.2 25.6 2.2 2.0 10.4 4.4 2.0 2.2 16.8 4.3 0.0 4.1 1.5 3.3 12.0 1.3 0.8 0.4 1.0 0.4 0.6 0.8 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.8 4.0 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.6 0.3 0.0 0.1 1.8 0.0 0.0 0.0 2.3 0.0 0.5 0.0 10.3 45.3 0.0 0.0 0.1 2.8 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.3 0.9 0.0 1.7 1.0 0.3 0.2 0.5 0.3 0.3 0.3 0.2 0.5 0.0 0.8 0.3 0.4 0.9 0.6 0.4 0.4 0.8 0.6 12.7 13.8 15.6 21.7 10.0 8.1 5.3 13.7 4.9 4.3 3.0 2.9 0.0 0.5 2.2 11.4 1.2 0.0 0.0 9.1 0.0 96.2 1.8 0.0 0.0 57.1 1.4 0.0 0.0 0.3 7.2 1.1 0.2 1.1 0.0 0.2 1.6 0.0 0.0 0.0 29.1 0.9 0.0 0.0 0.0 0.0 4.7 0.2 0.0 0.7 0.0 56.3 0.0 1.4 19.1 8.0 1.4 0.9 0.0 0.0 0.3 TMEM109 MGC5508 ENSG00000110108 "Transmembrane protein 109" Q9BVC6 11 60913874-60923443 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011785 Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA011785: AB_1858075" "unprognostic (5.23e-2)" "unprognostic (9.02e-2)" "unprognostic (2.46e-2)" "unprognostic (2.69e-2)" "unprognostic (1.23e-1)" "unprognostic (2.40e-2)" "unprognostic (5.29e-3)" "unprognostic (2.95e-1)" "unprognostic (2.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.52e-1)" "unprognostic (3.63e-2)" "unprognostic (1.83e-1)" "unprognostic (2.82e-1)" "unprognostic (1.51e-1)" "unprognostic (2.84e-2)" "prognostic unfavorable (2.68e-4)" 40.2 21.2 7.7 22.4 11.5 10.4 45.4 13.4 17.4 39.7 28.8 17.0 17.7 12.0 43.1 25.9 38.0 30.0 32.0 32.7 9.9 8.3 27.0 31.7 30.0 26.0 16.5 9.5 42.6 28.5 23.2 18.9 36.2 12.4 38.5 11.8 44.1 43.4 27.5 41.9 28.4 19.2 38.0 10.5 28.8 25.1 16.6 12.1 21.5 36.9 35.2 33.0 35.6 44.7 25.5 83.1 9.5 13.7 19.9 36.2 21.9 24.5 21.7 14.0 23.3 35.5 16.4 11.7 23.1 20.8 24.5 21.3 19.3 26.1 28.3 43.0 25.5 14.7 32.2 14.5 9.9 14.9 22.0 19.3 20.0 10.2 4.2 10.5 40.5 17.9 11.1 12.6 19.0 9.5 8.7 29.6 22.9 10.3 74.5 17.4 44.5 29.8 17.4 24.0 12.5 22.2 29.7 27.3 40.6 12.0 12.6 5.7 10.1 18.3 44.4 21.9 9.8 24.9 7.4 30.3 31.6 15.2 39.8 20.9 25.6 18.8 15.2 28.1 17.5 36.5 6.2 13.7 9.5 35.8 12.1 36.2 22.3 20.8 30.3 40.8 25.5 19.0 24.3 1.5 19.9 8.8 83.1 15.5 21.9 7.7 11.5 13.4 17.4 9.9 8.3 16.5 9.5 12.4 12.1 65.5 21.0 47.9 39.3 45.1 12.5 30.7 20.4 22.7 22.7 24.4 0.0 104.3 21.6 63.3 20.4 85.0 6.5 0.0 69.7 95.5 55.6 29.5 49.7 16.6 62.1 28.6 6.9 50.3 19.6 7.5 82.8 53.7 49.0 53.3 10.1 27.1 44.7 19.5 91.6 13.3 33.9 38.8 64.8 6.0 6.8 44.3 44.5 56.6 16.5 34.5 TMEM110-MUSTN1 ENSG00000248592 "TMEM110-MUSTN1 readthrough" 3 52833121-52897562 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.0" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 2: 1.4;Cholangiocytes: 2.5;Club cells: 1.2;Exocrine glandular cells: 1.6;Ito cells: 1.3;Kupffer cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 8.3;Karpas-707: 9.1" HPA051855 Uncertain Approved Cytosol NA NA Cytosol "HPA051855: AB_2681639" "unprognostic (4.19e-2)" "unprognostic (3.85e-2)" "unprognostic (5.95e-2)" "unprognostic (7.28e-2)" "unprognostic (5.35e-2)" "unprognostic (3.11e-4)" "unprognostic (4.73e-2)" "unprognostic (2.66e-2)" "unprognostic (1.59e-2)" "unprognostic (2.51e-2)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.01e-6)" "unprognostic (5.49e-2)" "unprognostic (7.31e-2)" "unprognostic (4.55e-2)" "unprognostic (5.09e-5)" 13.3 6.7 3.8 5.4 7.6 5.2 5.8 5.2 9.6 4.9 5.5 8.6 3.7 4.1 8.6 3.4 6.4 4.2 3.8 5.8 4.1 3.7 8.0 23.6 5.0 8.6 6.6 3.4 5.2 9.2 2.0 3.8 3.9 6.0 4.1 2.6 6.0 5.5 3.1 58.0 4.2 7.9 7.8 4.8 5.7 5.0 3.9 4.1 8.6 4.4 2.7 6.1 5.8 5.7 0.9 1.6 1.6 1.7 0.0 2.3 0.4 1.5 0.8 1.6 6.2 0.5 0.0 0.0 3.2 1.0 0.2 0.4 0.0 1.0 1.1 0.5 0.0 2.2 1.4 1.6 1.6 0.0 8.3 3.3 2.1 0.0 0.0 0.2 1.4 3.2 0.0 0.6 0.6 1.3 0.0 0.3 4.2 0.9 9.1 0.1 1.0 1.9 1.1 1.1 0.6 4.2 0.3 0.0 2.0 0.3 0.0 0.6 0.4 0.8 0.9 1.9 0.4 0.7 3.1 0.9 1.1 2.9 1.2 1.8 4.2 3.8 1.2 1.4 4.0 1.7 0.0 0.2 1.6 0.4 1.7 2.3 0.9 0.7 0.9 0.8 0.3 0.0 0.0 0.4 0.0 0.0 1.6 0.6 0.4 3.8 7.6 5.2 7.6 4.1 3.7 6.6 3.4 6.0 4.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 1.2 0.0 0.0 0.3 0.0 1.0 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 TMEM114 ENSG00000232258 "Transmembrane protein 114" B3SHH9 16 8537605-8590193 "Disease related genes, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "ductus deferens: 60.1;seminal vesicle: 24.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 19 "hypothalamus: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 1.5;U-2 OS: 2.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 9.6" NA NA "unprognostic (3.72e-5)" "unprognostic (2.26e-1)" "unprognostic (3.98e-3)" "unprognostic (7.33e-2)" "unprognostic (2.19e-1)" "unprognostic (2.51e-1)" "unprognostic (1.62e-1)" "unprognostic (2.21e-1)" 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.4 0.0 60.1 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.4 0.0 0.0 0.0 24.7 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 8.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM115 PL6 ENSG00000126062 "Transmembrane protein 115" Q12893 3 50354749-50359610 "Plasma proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006319, HPA015497" Supported Supported "Golgi apparatus" NA NA "Golgi apparatus" "CAB006319: AB_425880, HPA015497: AB_1858076" "unprognostic (1.62e-2)" "unprognostic (2.37e-1)" "unprognostic (1.59e-2)" "unprognostic (1.65e-3)" "unprognostic (2.32e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.73e-5)" "unprognostic (7.00e-2)" "unprognostic (6.00e-2)" "unprognostic (2.05e-2)" "unprognostic (1.75e-3)" "unprognostic (2.65e-2)" "prognostic favorable (1.04e-7)" "unprognostic (4.88e-3)" "unprognostic (3.00e-1)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" 20.8 23.8 15.1 11.3 15.2 10.1 19.7 19.4 24.3 20.2 23.5 18.7 21.5 23.1 24.5 21.3 20.6 21.3 23.9 19.8 12.5 12.8 22.4 24.1 18.5 15.7 13.6 13.3 24.9 24.0 25.7 14.8 37.3 16.2 22.4 13.0 22.4 26.3 22.5 18.2 28.1 25.5 17.3 10.6 17.6 20.7 18.6 11.8 20.4 42.2 16.9 15.9 19.0 17.3 13.2 17.2 28.4 18.4 17.2 18.3 14.5 11.0 13.6 8.8 14.5 25.3 20.3 11.5 17.2 25.6 21.9 16.8 10.1 13.0 5.4 14.5 22.4 20.2 11.9 10.6 13.9 6.2 9.9 18.4 8.1 12.2 13.6 35.6 8.8 11.9 30.4 18.1 18.0 13.2 19.0 16.6 6.7 8.7 9.4 16.3 10.2 6.1 14.0 15.8 7.3 21.5 3.0 7.1 11.9 16.5 10.4 9.9 21.3 10.4 11.7 14.2 8.1 9.6 9.4 17.2 19.9 10.1 20.9 18.0 14.0 8.0 3.0 18.3 9.8 13.1 28.4 18.4 25.6 18.3 16.5 12.1 12.6 12.3 14.8 15.3 13.2 13.6 13.0 25.3 17.2 14.8 17.2 15.3 14.5 15.1 15.2 19.4 24.3 12.5 12.8 13.6 13.3 16.2 11.8 14.9 11.3 10.2 17.3 26.9 16.9 6.3 17.8 5.3 7.9 10.4 5.9 51.7 3.3 36.7 0.7 18.0 33.8 0.0 23.2 34.3 33.2 28.1 11.5 15.7 31.6 17.5 15.1 19.0 9.2 1.1 27.0 13.8 10.1 25.2 23.7 23.9 28.4 28.6 23.7 21.9 12.0 25.8 19.8 18.6 7.6 30.6 77.6 13.8 23.3 23.0 TMEM116 FLJ90167 ENSG00000198270 "Transmembrane protein 116" Q8NCL8 12 111931282-112013185 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 48.7;Spermatocytes: 128.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in all" 4 "T-cells: 14.9" "Cell line enhanced" "Detected in many" "RT4: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040720 Approved Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA040720: AB_10795623" "unprognostic (8.91e-2)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.71e-1)" "unprognostic (5.48e-2)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (6.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.34e-1)" "unprognostic (3.27e-3)" "unprognostic (9.12e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.41e-1)" "unprognostic (1.33e-1)" "unprognostic (2.85e-2)" "unprognostic (3.19e-3)" 3.7 10.7 4.4 3.0 8.4 1.0 10.2 6.7 6.6 5.3 4.1 11.2 9.1 9.5 3.9 6.4 4.9 4.2 5.8 20.2 5.3 3.7 26.8 10.0 7.2 3.7 8.7 5.5 4.7 4.1 31.2 9.6 2.7 14.0 4.5 3.4 5.9 12.5 7.0 5.0 11.8 9.0 5.1 8.2 3.9 8.7 20.8 7.3 6.0 6.6 3.6 5.6 8.6 4.5 2.5 3.0 3.0 3.3 1.5 14.9 3.4 4.2 4.4 6.3 7.0 6.3 5.0 4.3 3.4 5.6 4.5 4.9 3.3 3.5 4.9 2.2 2.6 5.5 4.3 3.5 3.7 3.9 11.7 2.8 3.1 4.2 4.1 10.1 1.2 0.5 6.1 6.4 5.8 10.1 4.8 1.5 9.4 5.9 4.0 4.6 6.3 1.8 10.0 7.8 10.2 2.9 5.0 2.5 8.4 14.1 23.9 6.0 4.0 3.7 3.3 5.8 8.9 11.9 16.5 1.1 4.3 1.3 3.8 1.5 4.7 8.2 4.6 6.0 3.9 6.0 0.8 1.8 3.0 6.5 3.3 5.2 2.1 14.9 12.1 2.1 2.5 7.9 8.6 0.3 1.5 2.4 3.0 13.5 3.4 4.4 8.4 6.7 6.6 5.3 3.7 8.7 5.5 14.0 7.3 3.0 14.4 1.5 6.8 4.8 10.6 21.6 5.1 12.0 2.3 27.9 15.7 16.1 19.9 3.0 48.7 3.4 7.8 0.0 3.6 4.8 5.6 3.6 5.7 5.0 4.5 9.5 0.0 1.8 5.2 26.7 8.6 3.7 6.8 2.8 2.4 13.0 3.0 1.9 4.6 8.8 17.6 6.5 4.2 128.4 21.3 4.6 33.5 12.9 2.6 5.9 TMEM117 DKFZp434K2435 ENSG00000139173 "Transmembrane protein 117" Q9H0C3 12 43835967-44389762 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 8 "B-cells: 2.6;NK-cells: 1.1;T-cells: 4.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046223 Uncertain NA NA "HPA046223: AB_10960636" "unprognostic (1.37e-2)" "unprognostic (2.99e-1)" "unprognostic (4.32e-1)" "unprognostic (2.39e-2)" "unprognostic (3.57e-2)" "unprognostic (7.08e-2)" "unprognostic (3.07e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (2.89e-1)" "unprognostic (6.26e-2)" "unprognostic (1.99e-3)" "unprognostic (1.74e-2)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (9.20e-3)" "unprognostic (3.80e-1)" 4.5 4.5 4.9 5.0 6.6 0.3 5.5 2.6 6.6 8.6 10.8 3.9 23.5 11.4 8.0 6.8 12.5 4.7 6.9 8.4 5.0 5.1 4.4 4.1 2.8 6.0 6.1 5.3 5.2 6.9 7.3 14.5 5.7 10.0 7.3 7.0 8.2 7.4 16.9 6.6 10.4 21.9 7.9 10.3 2.8 5.2 4.3 4.4 1.9 4.6 9.2 7.0 8.0 10.5 2.6 0.3 0.0 0.0 1.1 4.5 1.0 1.1 0.4 4.0 6.6 4.6 9.9 0.1 12.3 6.2 2.3 2.8 9.7 4.3 4.3 0.9 8.8 0.6 6.3 2.6 2.7 1.7 1.8 7.0 1.1 2.8 3.9 1.4 1.8 4.6 5.1 10.0 1.3 0.7 9.3 0.4 0.5 2.1 1.8 4.4 1.0 0.0 1.1 0.8 0.0 2.4 2.8 4.5 1.7 4.7 2.6 0.6 6.0 4.7 1.5 9.7 1.7 0.3 4.6 1.4 3.5 1.2 1.8 3.2 3.4 3.6 2.6 1.7 1.9 1.2 0.0 0.0 0.0 3.0 0.0 4.5 2.6 0.8 3.2 0.0 1.9 1.3 1.5 0.0 1.1 0.0 0.3 0.4 1.0 4.9 6.6 2.6 6.6 5.0 5.1 6.1 5.3 10.0 4.4 0.0 2.2 4.5 3.9 5.8 4.4 5.3 2.5 2.7 1.2 7.0 3.9 11.7 3.3 2.1 21.0 1.9 7.9 0.0 2.7 2.1 3.5 1.9 2.3 2.6 4.7 4.8 0.0 4.9 2.9 7.3 5.8 1.7 11.8 0.0 3.2 2.6 2.0 14.4 6.0 1.1 4.7 0.0 2.2 0.9 5.7 10.7 9.6 3.8 4.5 4.5 TMEM119 ENSG00000183160 "Transmembrane protein 119" Q4V9L6 12 108589846-108598320 "Predicted intracellular proteins, Predicted membrane proteins" "Biomineralization, Differentiation, Osteogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Early spermatids: 8.2;Fibroblasts: 21.5;Melanocytes: 8.5;Peritubular cells: 22.6;Smooth muscle cells: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 107.3;ASC TERT1: 29.7;BJ hTERT+: 31.1;fHDF/TERT166: 14.9;HSkMC: 45.7" "Low region specificity" "Detected in all" "HPA051870, HPA052650" Enhanced NA NA "HPA051870: AB_2681645, HPA052650: AB_2681901" "unprognostic (4.90e-2)" "unprognostic (2.66e-1)" "unprognostic (6.84e-2)" "unprognostic (5.97e-2)" "unprognostic (2.35e-1)" "unprognostic (3.29e-2)" "unprognostic (6.67e-2)" "unprognostic (8.40e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (8.37e-4)" "unprognostic (1.61e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.06e-6)" "unprognostic (1.29e-2)" "unprognostic (8.76e-3)" "unprognostic (1.40e-2)" "unprognostic (1.87e-2)" 20.3 4.4 8.0 18.7 10.3 1.3 28.7 2.1 7.4 36.4 6.7 13.2 2.8 8.0 14.0 8.0 4.7 9.0 19.4 11.1 6.9 4.3 6.7 0.8 25.6 24.2 11.0 4.2 1.8 5.6 3.3 4.9 3.4 8.3 10.7 8.4 13.7 4.2 15.0 1.2 9.7 12.2 9.2 10.2 10.4 5.7 6.1 10.3 0.8 15.8 4.9 14.2 18.7 14.3 1.5 0.8 4.9 1.4 0.8 1.3 0.2 0.0 0.0 0.2 0.1 107.3 29.7 0.1 2.1 31.1 0.0 0.5 0.0 0.1 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 1.3 0.0 0.2 45.7 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 7.3 0.0 0.0 0.0 0.8 0.0 0.3 0.2 2.5 0.0 2.1 0.0 0.5 0.5 0.1 1.2 0.1 0.0 3.1 0.9 0.8 0.8 0.3 0.7 0.8 1.3 0.9 0.4 1.5 1.3 1.1 4.9 0.8 1.4 0.8 0.4 0.2 8.0 10.3 2.1 7.4 6.9 4.3 11.0 4.2 8.3 10.3 0.0 0.0 0.0 0.1 3.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.2 0.3 0.0 0.0 0.0 0.2 21.5 0.0 0.0 0.0 1.2 0.0 0.0 1.3 1.0 4.7 3.7 0.9 8.5 2.8 0.0 0.0 0.1 0.0 22.6 0.0 0.0 0.0 8.1 0.0 0.0 3.1 0.2 0.0 0.0 0.0 TMEM120A "NET29, TMPIT" ENSG00000189077 "Transmembrane protein 120A" Q9BXJ8 7 75986837-75994659 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 64.3" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 217.5;Late spermatids: 771.6" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 64.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.78e-2)" "unprognostic (3.35e-2)" "unprognostic (1.71e-2)" "unprognostic (4.03e-2)" "unprognostic (1.00e-1)" "unprognostic (1.99e-1)" "unprognostic (3.26e-1)" "unprognostic (2.75e-3)" "unprognostic (6.16e-2)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (6.31e-2)" "unprognostic (1.02e-1)" "unprognostic (6.58e-2)" "unprognostic (6.61e-2)" "unprognostic (1.71e-1)" "unprognostic (5.15e-2)" 8.7 14.0 6.3 2.4 6.2 3.0 11.8 3.5 5.2 5.2 15.2 3.1 11.1 15.5 3.4 5.6 6.4 5.3 7.4 25.0 5.6 8.2 14.9 3.9 5.1 6.0 3.9 12.6 8.9 3.1 1.9 3.8 15.4 5.5 3.7 4.3 7.3 12.7 11.0 2.4 24.0 4.5 3.8 3.9 5.0 10.8 5.0 0.5 4.7 12.5 3.0 4.2 5.0 5.4 8.0 64.3 16.5 7.7 13.6 11.1 4.8 7.7 3.2 27.0 24.7 16.1 8.5 4.6 12.5 6.1 8.4 12.5 6.2 2.6 3.5 13.1 19.4 5.4 3.3 4.8 2.0 4.1 4.1 2.5 5.2 17.3 23.9 0.9 16.3 17.5 4.0 4.7 6.1 6.4 10.3 5.5 4.4 3.4 10.8 8.1 1.4 15.5 1.5 10.7 8.0 1.5 3.9 11.4 12.6 4.4 1.7 9.1 5.0 14.1 8.0 8.2 10.5 5.8 5.3 17.4 6.0 10.3 3.9 4.5 3.2 0.9 10.2 2.5 3.9 24.5 16.5 29.4 7.7 14.6 5.8 4.4 6.4 6.0 8.0 5.4 4.5 4.4 64.3 7.7 14.6 3.0 13.6 11.1 20.8 10.5 14.7 17.4 0.0 5.0 99.7 45.9 8.1 15.9 26.2 5.9 18.4 21.6 38.0 217.5 23.9 179.6 23.3 34.0 12.7 22.1 21.2 23.2 102.6 31.8 11.1 8.1 18.4 36.2 771.6 37.4 28.9 0.0 14.4 31.0 12.6 35.2 112.2 29.0 101.8 5.9 38.8 23.0 80.7 14.5 0.0 9.2 20.8 35.2 23.1 TMEM120B ENSG00000188735 "Transmembrane protein 120B" A0PK00 12 121712752-121783001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 23.1;cerebellum: 35.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014066 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" Cytosol "HPA014066: AB_1845296" "unprognostic (8.80e-3)" "unprognostic (3.31e-2)" "unprognostic (1.95e-2)" "unprognostic (1.40e-2)" "unprognostic (3.10e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.66e-5)" "unprognostic (3.62e-1)" "unprognostic (3.29e-1)" "unprognostic (5.54e-2)" "unprognostic (2.10e-2)" "unprognostic (1.25e-1)" "unprognostic (5.86e-2)" "unprognostic (8.02e-3)" "unprognostic (2.31e-1)" "unprognostic (2.13e-3)" "unprognostic (4.72e-2)" 7.9 7.0 5.6 4.7 23.1 9.3 5.6 35.6 6.9 11.1 4.4 3.3 8.6 4.2 10.0 5.4 2.8 12.2 4.5 3.9 5.9 3.8 4.5 4.7 5.3 4.0 4.5 4.3 5.0 14.3 5.9 11.6 2.4 6.0 5.2 3.1 5.5 14.9 6.2 17.2 5.7 3.8 8.0 2.9 4.3 4.9 3.4 5.8 1.9 10.6 4.0 3.8 3.6 7.1 4.1 4.0 3.6 1.6 2.4 3.4 1.3 4.8 16.6 3.9 11.4 4.9 6.5 8.0 6.4 7.4 6.2 5.0 10.5 5.6 5.2 4.0 6.5 6.1 8.3 9.1 7.7 3.3 3.1 8.4 7.2 5.2 6.5 6.7 5.1 5.7 6.0 6.9 7.0 5.1 11.0 3.8 11.6 6.4 3.8 3.7 7.8 8.4 7.0 7.0 3.3 10.3 10.0 16.1 6.9 3.2 5.3 15.0 10.7 6.3 5.0 5.6 7.5 11.3 4.1 5.3 8.3 9.4 5.3 5.6 8.9 3.1 3.8 10.6 6.6 8.3 3.1 1.4 1.7 3.4 1.6 2.8 2.9 3.3 2.7 1.6 4.1 2.4 2.8 3.6 2.4 1.5 4.0 2.8 1.3 5.6 23.1 35.6 6.9 5.9 3.8 4.5 4.3 6.0 5.8 23.8 12.6 12.3 4.4 5.8 35.4 6.1 12.7 4.0 7.9 10.4 21.6 5.6 6.6 7.6 14.5 4.9 21.9 0.0 10.8 5.8 6.5 5.4 4.6 2.9 5.1 12.7 6.3 1.8 4.0 26.1 6.1 8.5 1.7 36.9 3.0 2.5 19.5 4.5 6.0 4.9 21.7 6.5 7.1 6.2 4.9 6.0 9.5 28.8 3.6 3.9 TMEM121 "hole, MGC4659, TMEM121A" ENSG00000184986 "Transmembrane protein 121" Q9BTD3 14 105526603-105530202 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 9.5;Muller glia cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 1.8;MAIT T-cell: 2.6;memory B-cell: 4.7;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.6;naive B-cell: 1.7;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.2;NK-cell: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 4.7;NK-cells: 1.8;T-cells: 3.1" "Cell line enhanced" "Detected in some" "EFO-21: 9.5;MCF7: 8.9;PC-3: 11.7;REH: 7.5;SCLC-21H: 6.1;WM-115: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049857 Uncertain Approved Cytosol NA NA Cytosol "HPA049857: AB_2680917" "unprognostic (4.25e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-3)" "unprognostic (2.20e-2)" "unprognostic (1.31e-1)" "unprognostic (9.50e-2)" "unprognostic (1.88e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-3)" "unprognostic (5.31e-2)" "unprognostic (5.48e-4)" "unprognostic (2.83e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.90e-2)" 3.2 2.6 7.2 2.5 8.8 1.5 1.7 3.3 12.6 2.5 1.6 7.9 1.9 1.5 3.0 2.9 1.6 3.1 1.3 2.3 7.4 6.0 2.5 3.0 1.9 2.5 5.0 3.9 2.7 2.9 2.5 3.5 1.6 3.0 3.8 0.8 2.7 2.8 2.7 1.1 2.1 1.9 1.6 4.3 7.1 3.4 1.6 1.6 0.0 2.9 0.4 1.0 1.1 4.7 4.7 0.5 0.0 0.0 1.8 3.1 0.6 0.0 4.5 0.4 4.1 0.0 0.2 0.8 2.8 0.6 0.5 0.0 0.0 1.5 1.3 9.5 0.0 0.8 0.4 0.4 0.1 0.0 0.6 2.2 0.1 0.4 1.5 0.7 0.0 1.6 0.3 0.0 0.1 0.0 0.2 0.4 0.5 0.1 0.0 0.2 8.9 0.2 0.0 1.4 0.1 11.7 7.5 0.0 0.1 0.1 0.0 6.1 2.3 0.5 0.0 2.2 0.1 2.7 0.3 1.6 1.3 2.4 0.2 0.5 0.7 0.0 0.0 0.1 0.5 6.2 0.0 0.0 0.0 1.8 0.0 2.6 4.7 3.1 1.6 0.5 1.7 1.9 1.2 0.0 1.8 0.0 0.0 0.2 0.6 7.2 8.8 3.3 8.2 7.4 6.0 5.0 3.9 3.0 1.6 0.0 0.3 0.5 2.4 4.0 4.3 1.2 0.0 1.4 1.2 5.2 0.0 0.2 0.0 1.0 1.3 7.1 0.0 0.0 0.2 1.2 3.8 1.7 0.0 1.7 0.3 9.5 0.0 7.4 0.3 1.5 4.0 0.0 6.8 0.0 0.0 17.0 0.0 0.0 6.0 0.0 1.1 0.0 1.7 0.5 3.1 2.3 0.2 0.0 0.0 0.6 TMEM121B CECR6 ENSG00000183307 "Transmembrane protein 121B" Q9BXQ6 22 17116299-17121367 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 14.1" "Group enriched" "Detected in some" 8 "granulocytes: 1.1;Hofbauer cells: 2.2" "Cancer enhanced" "Detected in some" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 7 "granulocytes: 4.3;monocytes: 3.2" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 15.0;THP-1: 12.1;U-937: 10.0" "Group enriched" "Detected in many" 8 "amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0" "Low region specificity" "Detected in many" HPA068790 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA068790: AB_2686036" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (7.11e-3)" "unprognostic (4.49e-3)" "unprognostic (3.36e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-3)" "unprognostic (5.32e-2)" "unprognostic (1.97e-1)" "unprognostic (2.01e-2)" "unprognostic (6.88e-4)" "unprognostic (6.08e-2)" "unprognostic (3.10e-4)" "unprognostic (1.02e-2)" "unprognostic (4.37e-2)" "unprognostic (3.49e-3)" "unprognostic (1.71e-1)" 1.3 1.8 7.4 2.2 12.0 2.2 2.0 8.1 19.1 1.0 0.8 2.4 0.0 1.1 1.1 2.3 0.8 1.2 1.0 2.3 7.1 4.0 0.8 0.8 0.9 0.8 2.9 6.9 0.9 2.7 0.8 2.0 1.9 2.3 14.1 1.0 0.2 1.2 1.0 2.8 1.5 0.9 1.3 2.5 1.1 1.0 2.4 4.2 0.0 0.6 0.0 0.8 1.0 0.3 0.0 0.5 4.3 3.2 0.0 0.0 0.6 0.0 0.0 6.3 0.9 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.3 0.0 0.8 3.2 2.2 0.0 0.1 0.2 3.1 0.0 0.3 0.1 15.0 2.3 0.0 0.0 0.3 0.9 0.0 12.1 0.6 0.7 0.3 0.2 0.0 0.2 0.3 0.9 0.0 10.0 0.3 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.6 7.4 12.0 8.1 18.0 7.1 4.0 2.9 6.9 2.3 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM123 "KCT3, PORIMIN" ENSG00000152558 "Transmembrane protein 123" Q8N131 11 102396332-102470384 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 142.0" "Low region specificity" "Detected in all" "CAB026001, HPA062862" Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus" "Vesicles, Cytosol" "CAB026001: , HPA062862: AB_2732691" "unprognostic (2.64e-1)" "unprognostic (8.39e-2)" "unprognostic (4.18e-3)" "unprognostic (1.40e-1)" "unprognostic (7.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.08e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.67e-1)" "unprognostic (1.38e-2)" "unprognostic (8.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-2)" "unprognostic (3.65e-2)" 21.3 23.1 18.8 30.1 23.3 39.8 38.6 7.4 18.8 35.2 38.2 19.1 15.1 12.4 65.3 20.8 31.9 21.6 20.8 36.8 20.7 14.0 27.0 95.4 39.5 55.5 22.6 13.7 27.8 24.7 14.5 8.5 23.9 21.1 34.9 19.9 13.9 53.3 22.2 13.2 29.7 17.6 29.7 22.4 39.9 23.7 22.9 24.6 71.9 66.0 20.1 27.1 43.7 39.8 23.3 30.3 48.3 29.2 52.4 55.5 51.3 29.2 26.2 27.2 25.2 34.8 28.5 18.5 22.8 49.4 46.7 52.0 33.2 142.0 49.3 58.8 52.8 33.5 31.8 29.5 37.6 51.7 29.7 10.8 25.7 10.3 49.4 30.7 54.4 19.2 31.8 42.9 33.3 50.0 65.2 52.2 26.6 17.2 0.1 38.5 9.4 47.2 17.1 16.2 48.6 24.1 29.0 75.1 47.3 44.4 29.0 12.9 15.2 27.7 37.9 15.0 30.5 23.4 21.3 61.1 31.4 35.2 27.2 17.1 19.1 10.6 50.1 9.1 60.7 20.7 30.1 26.8 48.3 26.3 29.2 40.0 16.7 41.3 31.8 30.3 23.3 55.5 46.9 17.6 52.4 24.2 8.1 42.9 51.3 18.8 23.3 7.4 18.8 20.7 14.0 22.6 13.7 21.1 24.6 116.1 70.4 106.9 216.5 142.4 0.7 46.0 145.2 156.6 139.9 155.3 0.0 39.5 68.0 142.3 41.1 161.1 25.3 46.7 102.9 31.6 66.8 247.8 57.7 245.2 98.2 1.6 86.9 279.3 203.3 16.8 87.2 149.4 153.5 211.0 157.1 3.3 143.2 24.6 87.7 40.5 1.0 64.7 91.8 25.6 58.6 154.8 25.4 130.8 142.2 235.1 TMEM125 MGC17299 ENSG00000179178 "Transmembrane protein 125" Q96AQ2 1 43269994-43274002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 73.6;salivary gland: 47.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 113.2;Alveolar cells type 2: 120.0;Enterocytes: 84.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 13.4;BEWO: 11.5;CACO-2: 10.5;CAPAN-2: 25.1;OE19: 16.0;SK-BR-3: 21.6;T-47d: 17.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015796 Approved Midbody,Cytosol NA NA "Midbody, Cytosol" "HPA015796: AB_1858081" "unprognostic (2.53e-3)" "unprognostic (8.70e-2)" "unprognostic (1.27e-1)" "unprognostic (1.52e-1)" "unprognostic (3.14e-2)" "unprognostic (8.50e-2)" "unprognostic (8.37e-3)" "prognostic favorable (5.11e-5)" "unprognostic (3.39e-1)" "unprognostic (1.11e-1)" "unprognostic (7.76e-2)" "unprognostic (1.26e-1)" "prognostic favorable (2.91e-9)" "unprognostic (1.86e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-1)" "unprognostic (5.16e-2)" 0.8 0.0 5.3 4.6 7.1 0.0 4.9 0.9 5.0 7.4 14.4 1.0 20.7 15.1 1.8 12.5 3.3 6.6 18.9 1.0 8.9 4.3 9.4 1.4 42.5 0.8 10.7 0.8 2.0 73.6 9.6 15.7 5.6 1.1 8.8 9.1 1.5 47.8 19.0 0.8 3.7 29.4 0.8 21.1 0.8 11.6 1.2 0.8 1.1 33.6 3.8 5.0 1.4 3.5 0.0 0.8 0.0 0.0 1.8 0.9 0.2 13.4 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 10.5 25.1 0.0 0.6 0.0 0.0 6.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.5 16.0 0.0 0.0 0.0 0.3 0.2 4.3 6.5 0.0 0.0 21.6 0.0 2.0 17.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.9 0.2 0.0 1.8 0.0 0.8 0.0 0.2 5.3 7.1 0.9 1.9 8.9 4.3 10.7 0.8 1.1 0.8 113.2 120.0 0.5 1.7 0.0 0.0 0.4 43.3 29.4 47.8 15.7 0.0 26.1 14.9 32.4 3.1 0.0 84.2 0.0 34.1 1.2 0.2 16.8 1.1 0.0 2.0 0.0 20.8 0.0 0.0 6.0 0.3 0.8 0.0 1.0 59.6 1.7 27.0 37.4 1.1 23.1 0.0 0.0 0.2 1.0 0.2 0.4 6.1 0.0 32.2 5.4 TMEM126A "DKFZp586C1924, OPA7" ENSG00000171202 "Transmembrane protein 126A" Q9H061 11 85647967-85656547 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046648 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA046648: AB_2679737" "unprognostic (3.79e-2)" "unprognostic (4.75e-3)" "unprognostic (2.08e-3)" "unprognostic (1.08e-3)" "unprognostic (2.08e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (8.60e-5)" "unprognostic (8.25e-2)" "unprognostic (6.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.02e-2)" "unprognostic (6.93e-2)" "unprognostic (1.25e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-1)" "unprognostic (6.94e-2)" "unprognostic (2.17e-1)" 18.3 17.4 24.9 15.9 23.3 23.7 20.0 13.2 30.0 13.9 16.2 9.5 15.6 19.8 13.2 20.6 17.2 12.5 16.0 44.4 20.9 20.7 22.0 28.5 12.6 15.0 21.8 22.9 13.7 27.7 13.1 19.9 14.1 19.9 14.0 18.3 8.9 25.2 15.7 49.5 12.2 15.1 16.5 18.0 14.1 19.1 21.4 18.8 10.5 16.5 36.4 15.6 14.0 18.7 14.5 19.1 6.3 15.3 8.4 16.5 11.1 14.7 18.6 16.7 11.5 22.5 22.7 13.6 17.6 19.2 26.4 26.1 22.9 23.8 8.5 21.0 21.1 10.1 16.2 17.2 18.6 24.5 21.6 9.6 23.3 22.1 24.9 28.3 29.4 19.7 19.6 22.9 23.3 25.0 14.2 24.1 23.2 16.4 14.0 29.3 19.6 15.9 37.5 17.1 56.2 21.2 16.3 16.8 27.5 18.5 19.5 12.0 12.2 15.9 25.1 14.6 16.2 31.2 20.2 14.2 25.7 18.3 48.0 20.1 9.4 16.5 22.3 13.5 21.2 30.4 2.9 13.4 6.3 12.5 15.3 16.5 14.5 16.4 14.6 19.1 13.2 15.6 15.4 1.2 8.4 13.1 14.4 14.1 11.1 24.9 23.3 13.2 30.0 20.9 20.7 21.8 22.9 19.9 18.8 26.8 18.7 34.9 49.1 28.2 13.7 101.5 20.4 36.1 39.8 36.6 5.9 57.3 124.3 42.5 119.6 29.2 27.0 0.0 80.4 63.4 39.0 59.0 36.9 66.1 83.8 7.9 20.8 21.5 49.7 48.6 27.3 53.8 32.1 67.7 42.7 22.6 54.2 31.6 25.1 79.5 15.1 19.4 51.4 99.1 51.5 36.8 44.3 39.2 55.6 50.7 TMEM126B HT007 ENSG00000171204 "Transmembrane protein 126B" Q8IUX1 11 85628573-85636539 "Predicted membrane proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014480, HPA019186" Uncertain Supported Mitochondria NA NA Mitochondria "HPA014480: AB_1858083, HPA019186: AB_1858084" "unprognostic (1.11e-1)" "unprognostic (4.97e-2)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (5.67e-1)" "unprognostic (1.44e-1)" "unprognostic (5.55e-3)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (6.70e-3)" "unprognostic (4.42e-2)" "unprognostic (4.30e-2)" "unprognostic (1.94e-2)" "unprognostic (1.78e-1)" "unprognostic (6.50e-2)" "unprognostic (5.86e-2)" "unprognostic (2.66e-2)" 15.5 17.0 28.9 13.5 28.0 6.4 22.1 26.7 33.2 19.7 21.2 12.2 15.5 21.7 21.9 35.4 16.5 15.9 19.1 26.2 27.2 31.7 27.5 19.9 16.5 18.9 28.7 25.7 15.9 15.3 13.9 28.0 14.6 28.8 19.8 20.0 14.2 16.8 16.6 15.7 15.1 20.8 24.2 24.9 19.3 18.9 11.7 27.0 15.1 22.6 17.5 18.8 20.8 14.3 14.0 14.9 12.5 13.2 15.8 19.6 11.5 13.8 11.4 13.0 6.1 24.5 19.6 4.1 12.3 13.5 9.8 15.0 31.7 14.1 14.7 27.2 10.4 11.0 16.8 20.7 12.7 9.3 20.4 18.7 11.2 20.2 13.9 13.9 27.3 13.8 14.3 16.2 14.9 18.2 15.8 15.0 18.5 26.5 12.2 24.3 17.8 10.8 33.8 14.0 47.8 18.9 9.4 9.7 12.4 19.3 15.6 11.8 7.3 11.6 9.5 12.0 17.4 19.2 16.9 7.8 15.0 10.6 37.9 12.9 5.7 31.9 17.9 7.6 22.2 7.9 12.5 11.7 5.7 15.4 13.2 19.6 14.0 19.1 18.4 14.9 12.9 19.1 18.9 4.5 15.8 9.6 13.4 18.3 11.5 28.9 28.0 26.7 33.2 27.2 31.7 28.7 25.7 28.8 27.0 20.8 31.8 41.0 29.3 23.2 28.2 69.0 56.0 48.2 33.0 38.4 13.7 35.1 142.6 63.7 3.8 48.7 36.2 0.0 43.2 44.9 49.7 26.1 41.5 37.6 71.4 22.3 33.3 35.0 32.1 5.6 61.5 48.5 69.2 48.7 36.7 41.5 48.0 50.1 83.1 128.5 25.6 38.8 51.5 30.7 40.3 32.2 21.1 60.8 44.7 37.9 TMEM127 "FLJ20507, FLJ22257" ENSG00000135956 "Transmembrane protein 127" O75204 2 96248516-96265994 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.15e-3)" "unprognostic (2.67e-1)" "unprognostic (1.72e-2)" "unprognostic (6.51e-2)" "unprognostic (5.82e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (6.59e-4)" "unprognostic (6.73e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (7.50e-2)" "unprognostic (2.17e-1)" "prognostic favorable (6.69e-5)" "unprognostic (3.59e-1)" "unprognostic (1.52e-1)" "unprognostic (5.15e-2)" "unprognostic (3.65e-2)" 27.6 27.8 16.4 18.7 22.6 31.8 26.1 20.2 40.6 22.9 27.2 18.7 27.3 22.2 24.8 18.9 29.3 18.2 24.2 45.6 15.6 16.5 29.3 43.3 22.9 19.8 14.8 13.1 23.4 26.2 50.7 23.7 21.6 21.4 20.5 21.5 26.5 29.8 31.5 18.7 24.0 41.8 24.4 11.2 28.5 20.0 12.7 12.8 19.6 22.4 19.3 26.9 26.1 22.3 2.4 4.5 14.7 6.7 1.5 3.4 2.9 11.7 15.9 8.5 13.0 37.5 19.0 15.7 15.5 27.8 16.5 15.2 15.7 16.8 7.4 22.7 30.4 29.1 18.9 9.7 14.3 11.6 14.8 7.7 12.8 7.6 15.3 24.3 10.8 23.2 23.0 20.5 20.5 15.2 22.1 18.7 5.1 7.8 15.9 16.7 13.4 7.0 6.8 11.6 13.9 17.2 6.7 10.7 10.9 18.4 20.2 9.5 10.0 11.3 27.0 13.0 18.0 10.0 11.6 21.9 27.6 15.8 23.8 10.6 12.1 11.6 5.8 18.4 12.8 14.6 4.1 6.5 7.9 3.1 6.7 3.4 2.1 2.3 3.3 4.5 2.4 1.8 2.4 14.7 1.5 5.3 2.7 1.6 2.9 16.4 22.6 20.2 40.6 15.6 16.5 14.8 13.1 21.4 12.8 17.9 18.3 14.9 12.0 15.2 18.1 33.9 22.9 9.4 19.4 26.2 25.5 9.8 13.3 28.6 3.4 19.5 45.9 0.0 30.1 11.2 11.8 20.0 12.8 31.6 33.4 20.6 15.6 24.5 48.8 3.9 12.7 30.3 15.1 25.2 19.6 8.0 31.4 28.1 15.9 11.4 14.5 6.5 13.7 5.6 2.9 20.5 20.3 13.8 15.0 31.4 TMEM128 MGC13159 ENSG00000132406 "Transmembrane protein 128" Q5BJH2 4 4235542-4248212 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044809 Uncertain NA NA "HPA044809: AB_10963539" "unprognostic (4.97e-2)" "unprognostic (4.32e-2)" "unprognostic (3.23e-2)" "unprognostic (3.65e-1)" "unprognostic (2.39e-1)" "unprognostic (2.10e-1)" "unprognostic (2.94e-2)" "unprognostic (8.81e-2)" "unprognostic (1.09e-1)" "unprognostic (9.11e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (2.14e-3)" "unprognostic (1.72e-1)" "unprognostic (1.64e-1)" "unprognostic (2.63e-1)" "unprognostic (1.28e-2)" 14.4 19.8 20.7 11.7 22.6 4.8 23.0 16.7 27.6 18.4 15.4 28.0 18.3 13.8 18.9 33.8 14.2 20.6 12.3 17.7 22.1 26.0 23.2 12.9 22.4 26.7 25.6 19.2 26.3 32.7 21.4 14.9 18.0 22.4 19.0 17.3 19.5 15.2 18.9 18.3 15.0 12.8 13.9 36.7 14.2 15.8 27.7 15.8 12.9 25.9 13.5 15.1 12.5 13.9 20.9 33.0 22.4 26.9 23.0 34.8 19.1 7.3 5.8 21.5 16.3 17.5 14.7 15.4 16.0 18.1 17.3 16.4 6.5 29.4 4.3 8.4 14.2 16.3 6.4 10.2 10.9 16.4 11.7 6.4 8.0 4.2 9.0 24.7 19.3 14.8 20.4 19.1 6.6 13.5 15.5 10.1 14.6 11.4 8.8 19.8 8.0 15.7 26.0 17.7 10.8 11.4 6.2 8.7 9.1 25.7 11.7 12.1 19.6 6.6 6.3 18.6 14.8 21.6 19.2 9.9 16.3 6.9 15.2 16.5 24.5 20.1 14.6 17.0 13.6 19.7 12.7 20.7 22.4 21.1 26.9 26.1 20.9 25.6 20.7 20.6 19.3 34.8 29.2 9.5 23.0 22.8 33.0 19.1 19.1 20.7 22.6 16.7 27.6 22.1 26.0 25.6 19.2 22.4 15.8 11.9 20.7 13.7 14.0 15.9 9.5 7.3 17.8 24.1 15.9 29.6 2.0 39.5 24.9 23.1 16.6 21.5 19.1 23.3 20.6 34.3 31.9 18.6 15.1 14.9 27.4 12.7 16.6 23.9 23.5 5.8 37.7 19.4 37.1 24.4 20.8 22.9 17.3 30.3 35.3 30.5 10.7 45.3 14.4 77.0 31.3 22.0 36.6 18.7 18.5 16.7 TMEM129 D4S2561E ENSG00000168936 "Transmembrane protein 129" A0AVI4 4 1715952-1721358 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway, Unfolded protein response" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.07e-2)" "unprognostic (1.54e-1)" "unprognostic (2.12e-1)" "unprognostic (2.85e-1)" "unprognostic (4.04e-2)" "unprognostic (1.22e-3)" "unprognostic (7.35e-3)" "unprognostic (4.82e-2)" "unprognostic (2.27e-1)" "unprognostic (2.94e-2)" "unprognostic (2.51e-3)" "unprognostic (2.81e-1)" "prognostic favorable (9.64e-8)" "unprognostic (1.47e-1)" "unprognostic (6.49e-2)" "unprognostic (3.08e-1)" "unprognostic (2.36e-3)" 18.2 19.8 17.6 11.3 21.7 6.0 11.0 19.3 25.6 16.4 17.9 22.1 21.5 23.7 16.1 14.6 18.7 18.0 16.5 29.0 18.3 16.2 22.4 26.3 14.5 12.8 20.1 14.0 17.3 32.6 25.9 24.9 15.8 16.9 17.5 9.6 20.4 34.0 22.8 20.9 15.7 17.6 12.7 14.9 14.6 16.0 15.0 20.0 11.5 32.4 11.0 12.3 14.6 10.5 2.1 7.7 0.7 3.3 2.0 3.6 2.1 9.1 10.5 8.9 13.2 16.4 9.6 10.3 7.4 12.0 7.7 8.3 7.8 22.7 12.0 8.9 7.9 13.8 9.2 4.6 9.4 1.3 8.2 13.5 6.5 7.6 9.9 13.4 9.2 11.9 15.9 20.3 4.2 3.9 18.0 11.9 11.4 7.4 8.9 7.3 7.1 12.6 15.0 13.8 10.0 13.1 8.2 4.7 14.7 19.2 10.2 20.7 12.7 6.3 11.3 9.7 3.3 23.1 4.3 8.1 9.0 6.9 7.9 7.1 22.4 6.7 5.7 10.4 12.7 9.6 0.3 3.3 0.1 3.6 2.2 3.1 1.6 3.2 2.6 3.4 2.1 2.2 1.5 0.7 2.0 2.4 7.7 1.5 2.1 17.6 21.7 19.3 25.6 18.3 16.2 20.1 14.0 16.9 20.0 20.8 9.4 8.0 14.9 4.5 24.9 10.6 12.7 5.3 2.3 22.7 5.9 17.6 21.6 18.2 0.9 9.2 19.8 0.0 17.0 6.2 14.6 13.1 10.3 17.1 15.5 23.8 12.6 16.5 9.4 2.1 28.1 8.5 10.1 4.6 25.1 37.3 12.1 10.5 33.9 16.1 18.7 12.9 17.6 3.7 5.8 8.3 4.6 11.4 26.7 9.1 TMEM130 "DKFZp761L1417, FLJ42643" ENSG00000166448 "Transmembrane protein 130" Q8N3G9 7 98846488-98870771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 28.2;brain: 82.2;pituitary gland: 24.0;testis: 26.4" "Cell type enriched" "Detected in some" 8 "Bipolar cells: 49.7" "Cancer enhanced" "Detected in many" "renal cancer: 9.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 7.6;EFO-21: 7.4;GAMG: 8.0;hTERT-RPE1: 12.8;NTERA-2: 4.4;SH-SY5Y: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012928 Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA012928: AB_1858085" "unprognostic (1.36e-2)" "unprognostic (1.33e-3)" "unprognostic (3.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.61e-3)" "unprognostic (3.23e-2)" "unprognostic (2.97e-1)" "prognostic favorable (7.84e-4)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "unprognostic (4.69e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-3)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.17e-2)" "unprognostic (1.73e-1)" 1.3 28.2 27.3 2.0 53.8 1.4 1.8 14.1 82.2 3.5 1.8 2.8 0.0 1.6 1.8 8.0 2.2 1.7 2.2 1.4 29.3 47.0 2.8 1.1 5.4 2.4 13.4 35.1 1.7 1.6 1.5 24.0 1.3 25.8 2.7 1.9 1.0 1.3 6.2 2.1 1.3 2.1 1.6 9.2 1.4 1.4 26.4 3.9 0.1 1.4 0.0 1.2 1.7 1.2 1.0 0.6 4.8 0.9 1.0 0.7 0.3 0.0 0.6 0.0 0.0 0.2 0.0 0.2 3.4 7.6 0.6 0.5 0.1 0.1 0.1 7.4 1.9 8.0 0.1 0.0 0.0 0.1 0.2 0.4 0.1 0.2 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 12.8 0.3 0.1 0.1 0.6 0.4 0.6 0.1 0.1 4.4 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.5 9.1 0.1 0.1 0.0 3.0 0.0 0.0 0.0 0.1 0.6 0.0 0.2 0.4 0.2 0.1 0.3 0.4 0.1 2.2 0.9 0.6 0.5 0.4 0.4 0.7 0.5 0.4 0.2 1.0 0.7 0.6 4.8 1.0 0.6 0.6 0.4 0.3 27.3 53.8 14.1 44.2 29.3 47.0 13.4 35.1 25.8 3.9 0.0 0.0 0.0 0.3 0.3 49.7 0.8 2.5 0.0 3.4 1.8 2.0 0.1 0.0 0.0 1.3 0.3 0.0 0.0 0.2 0.1 1.1 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.9 0.9 0.2 0.0 0.0 0.0 1.3 0.0 0.0 6.3 0.0 3.7 0.0 0.3 0.4 0.7 0.3 0.2 0.0 0.0 0.1 TMEM131 "CC28, KIAA0257, PRO1048, RW1, YR-23" ENSG00000075568 "Transmembrane protein 131" Q92545 2 97756333-97995891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017678, HPA017682" Approved Uncertain "Vesicles,Intermediate filaments" NA NA "Vesicles, Intermediate filaments" "HPA017678: AB_1858086, HPA017682: AB_1858087" "unprognostic (1.16e-2)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (7.42e-2)" "unprognostic (8.58e-2)" "unprognostic (4.18e-2)" "unprognostic (7.59e-3)" "unprognostic (3.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (5.10e-3)" "unprognostic (5.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-1)" "unprognostic (1.77e-1)" 16.6 19.4 13.7 33.6 19.2 15.8 15.6 18.5 19.4 21.0 25.5 19.1 14.5 18.6 21.8 15.7 19.9 17.3 20.1 17.3 11.7 12.1 14.6 15.8 15.7 24.0 14.1 14.0 21.2 22.0 31.4 27.8 30.9 15.0 17.7 24.1 14.6 18.6 12.7 31.4 24.2 23.6 21.1 13.2 22.5 26.3 14.4 15.3 23.2 14.7 16.8 27.6 20.5 16.7 4.5 5.2 7.3 3.5 5.4 5.4 2.2 13.6 8.4 15.7 11.4 16.6 20.2 17.2 20.3 19.8 10.4 12.5 10.8 19.8 21.8 11.2 20.9 17.7 9.9 16.5 27.0 15.5 15.3 10.7 15.8 5.9 15.4 18.7 14.6 21.2 19.2 11.1 18.4 19.2 17.7 12.7 10.7 9.3 23.3 31.5 8.2 10.6 9.3 8.6 10.6 18.1 15.5 10.0 9.5 10.7 16.3 17.8 8.6 13.1 9.1 12.4 17.6 7.6 13.6 15.0 27.2 12.5 13.0 7.7 9.9 13.6 11.0 21.3 12.9 18.3 7.3 2.8 7.3 4.0 3.5 4.6 4.5 3.4 4.0 3.7 4.2 4.2 5.4 1.9 5.4 3.2 5.2 2.1 2.2 13.7 19.2 18.5 19.4 11.7 12.1 14.1 14.0 15.0 15.3 14.9 27.5 29.8 15.3 17.5 27.3 31.1 15.3 40.2 23.9 19.2 21.6 12.6 3.3 8.3 10.4 15.3 33.8 0.0 20.6 11.0 15.4 18.0 23.1 19.4 20.0 23.8 28.9 21.5 24.0 13.6 19.2 23.2 11.8 42.3 41.7 13.4 16.0 35.1 18.0 6.2 18.5 12.9 16.4 18.6 26.4 22.3 11.3 14.0 28.1 13.7 TMEM132A "FLJ20539, GBP, HSPA5BP1" ENSG00000006118 "Transmembrane protein 132A" Q24JP5 11 60924463-60937159 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.1" "Cell type enhanced" "Detected in many" 13 "Horizontal cells: 240.0;Muller glia cells: 177.4;Rod photoreceptor cells: 141.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 46.0;MCF7: 45.5;SK-BR-3: 46.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051979, HPA060492" Enhanced Approved Mitochondria No No 1900000 Mitochondria "HPA051979: AB_2681681, HPA060492: " "unprognostic (2.52e-2)" "unprognostic (2.01e-1)" "unprognostic (3.75e-2)" "prognostic favorable (1.98e-5)" "unprognostic (7.94e-3)" "unprognostic (3.74e-1)" "unprognostic (4.42e-3)" "unprognostic (2.39e-2)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (5.98e-2)" "prognostic unfavorable (1.55e-9)" "unprognostic (3.31e-1)" "unprognostic (9.74e-2)" "unprognostic (1.50e-1)" "unprognostic (8.41e-3)" 3.6 6.1 28.6 9.2 25.2 1.2 4.4 23.9 58.1 14.0 3.2 11.3 0.8 3.4 14.4 2.2 4.8 3.2 6.2 4.0 17.0 22.9 3.1 1.3 4.5 2.4 20.4 21.4 6.9 3.9 1.5 6.6 19.8 13.8 4.1 2.0 19.3 21.5 2.9 4.3 1.8 2.6 4.6 9.3 2.5 8.5 3.4 9.7 0.0 2.0 1.0 6.0 4.9 2.0 0.4 0.1 1.6 0.1 0.0 0.1 0.1 9.0 12.7 11.4 24.3 0.9 0.5 20.2 6.8 22.2 6.3 5.2 4.4 8.6 0.0 46.0 2.0 22.1 17.2 2.6 11.9 2.4 0.1 3.7 0.2 8.1 8.3 8.5 0.1 0.3 2.1 2.3 11.7 1.8 10.3 10.8 1.8 0.5 0.6 2.0 45.5 0.2 0.0 15.1 0.3 7.3 0.1 4.8 1.0 9.5 4.7 11.4 27.0 4.9 46.7 4.1 6.0 32.4 0.1 12.6 2.4 11.6 0.7 12.9 0.1 0.0 0.4 20.5 0.0 11.8 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.1 28.6 25.2 23.9 36.8 17.0 22.9 20.4 21.4 13.8 9.7 0.0 0.0 0.0 2.1 1.1 42.9 0.7 2.5 0.0 3.4 5.2 17.7 20.0 1.7 65.2 0.4 8.2 0.0 0.0 11.6 24.7 6.1 6.7 0.0 0.0 2.9 240.0 15.0 8.0 0.3 0.6 1.7 0.0 0.0 5.4 1.8 177.4 47.3 0.0 3.2 0.3 141.6 6.5 1.0 1.0 3.6 0.6 22.7 0.0 2.1 6.3 TMEM132B "KIAA1786, KIAA1906" ENSG00000139364 "Transmembrane protein 132B" Q14DG7 12 125186836-125662377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 19.3" "Group enriched" "Detected in some" 4 "Early spermatids: 22.6;Late spermatids: 28.8" "Cancer enriched" "Detected in single" 7 "glioma: 3.3" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.0" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.0" "Cell line enhanced" "Detected in some" "AF22: 3.6;HSkMC: 8.0;NTERA-2: 9.1;RPMI-8226: 3.9;U-138 MG: 14.2;U-937: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035661, HPA035662" Uncertain NA NA "HPA035661: AB_10669774, HPA035662: AB_2674726" "unprognostic (3.38e-3)" "unprognostic (4.39e-2)" "unprognostic (6.73e-2)" "unprognostic (6.33e-2)" "unprognostic (1.06e-1)" "unprognostic (7.46e-2)" "unprognostic (3.46e-1)" "unprognostic (1.26e-1)" "unprognostic (4.58e-1)" "unprognostic (1.12e-1)" "unprognostic (6.23e-3)" "unprognostic (1.29e-2)" "unprognostic (4.29e-4)" "unprognostic (1.20e-1)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (3.73e-3)" 0.2 0.2 6.1 0.1 7.5 0.0 0.1 0.2 19.3 0.6 0.3 0.2 0.8 1.0 0.5 0.2 0.3 0.7 5.1 2.6 0.1 0.0 0.0 0.1 2.6 0.1 0.2 0.0 1.1 0.2 0.4 0.4 2.8 0.6 0.5 2.4 0.2 0.2 0.5 0.0 0.3 0.8 2.7 0.3 0.1 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 2.7 2.9 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 14.2 0.0 0.1 0.0 0.0 0.2 0.0 2.2 3.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 1.9 2.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 1.6 0.0 0.0 0.0 28.8 0.3 0.0 1.7 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.2 0.0 0.2 0.9 3.6 2.9 0.0 0.0 0.0 0.5 TMEM132C "DKFZp761O2018, PPP1R152" ENSG00000181234 "Transmembrane protein 132C" Q8N3T6 12 128267403-128707915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.5" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 14.3;Cone photoreceptor cells: 5.9;Leydig cells: 8.3;Peritubular cells: 14.2" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.6;testis cancer: 4.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "gdT-cell: 5.4" "Lineage enriched" "Detected in single" 55 "T-cells: 5.4" "Group enriched" "Detected in some" 6 "AF22: 6.1;ASC diff: 8.7;Daudi: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015633, HPA015984" Approved Centrosome,Cytosol NA NA 110000000 "Centrosome, Cytosol" "HPA015633: AB_1858089, HPA015984: AB_1858088" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (7.34e-2)" "unprognostic (8.60e-2)" "unprognostic (2.37e-1)" "unprognostic (1.99e-3)" "unprognostic (5.48e-2)" "unprognostic (1.30e-1)" "unprognostic (2.88e-2)" "unprognostic (1.85e-2)" "unprognostic (6.29e-2)" "unprognostic (7.97e-3)" "unprognostic (2.54e-1)" "unprognostic (5.71e-2)" "unprognostic (6.33e-3)" 37.5 4.2 9.6 1.1 7.0 0.8 23.3 5.0 6.6 22.0 2.5 4.2 8.9 1.2 5.9 5.7 4.7 13.4 5.1 3.5 5.0 3.8 1.3 0.8 1.6 2.0 4.9 3.1 7.9 4.1 0.9 0.6 5.1 4.6 3.7 1.3 5.3 2.9 9.1 1.9 2.2 1.4 2.1 3.9 1.1 1.5 2.1 5.4 0.0 1.1 0.9 1.3 3.8 10.5 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 6.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.6 7.0 5.0 6.6 5.0 3.8 4.9 3.1 4.6 5.4 0.0 0.0 0.0 0.0 0.3 14.3 0.7 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.3 0.0 1.7 0.0 0.0 0.4 0.1 0.0 14.2 0.0 2.1 0.0 1.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 TMEM132D "KIAA1944, MOLT, PPP1R153" ENSG00000151952 "Transmembrane protein 132D" Q14C87 12 129071725-129903666 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 18.0" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 2.3;Early spermatids: 1.9;Intestinal endocrine cells: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.5;Karpas-707: 1.7;MOLT-4: 9.3;NTERA-2: 3.6;SuSa: 1.4;U-266/84: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010739 Approved NA NA 150000 "HPA010739: AB_2204753" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (2.07e-2)" "unprognostic (5.39e-1)" "unprognostic (1.47e-2)" "unprognostic (2.89e-1)" "unprognostic (3.07e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (4.31e-4)" 0.4 0.9 4.5 0.7 6.6 0.7 0.4 0.4 18.0 0.4 0.8 0.6 0.0 0.8 0.5 0.4 0.4 0.4 0.4 0.4 2.9 4.2 0.6 0.7 0.8 0.4 1.7 6.2 0.5 1.1 0.4 0.7 0.4 0.8 1.1 0.7 1.2 0.4 0.4 0.4 0.5 0.9 0.5 0.6 0.4 1.0 1.6 0.8 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 9.3 0.0 3.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 6.6 0.4 11.7 2.9 4.2 1.7 6.2 0.8 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM132E DFNB99 ENSG00000181291 "Transmembrane protein 132E" Q6IEE7 17 34579487-34639318 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.0;kidney: 8.8" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 9.0" "Group enriched" "Detected in some" 8 "glioma: 7.6;renal cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.6" "Group enriched" "Detected in many" 20 "NK-cells: 1.4;T-cells: 2.6" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070608 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 140000 "Nucleoplasm, Golgi apparatus" "Nuclear bodies, Cytosol" "HPA070608: AB_2686286" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.29e-5)" "unprognostic (3.37e-1)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-3)" "unprognostic (1.72e-1)" "unprognostic (1.80e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.67e-2)" "unprognostic (1.51e-2)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 0.4 0.5 4.9 0.4 4.1 0.2 0.3 17.3 8.7 1.2 0.4 1.7 0.3 4.9 0.6 0.5 0.4 0.4 0.8 0.5 2.9 5.1 8.8 1.3 0.4 0.7 4.5 2.8 0.5 0.2 0.3 0.0 0.9 5.3 0.4 0.5 0.0 0.8 0.8 0.3 0.8 2.8 0.6 20.0 0.7 0.6 2.4 2.2 0.0 0.4 0.0 0.6 0.7 0.1 0.0 0.0 0.0 0.0 1.4 2.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.8 3.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.4 0.5 0.0 0.0 2.6 1.8 0.0 1.4 0.0 0.0 0.0 0.4 4.9 4.1 17.3 6.9 2.9 5.1 4.5 2.8 5.3 2.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.4 0.7 1.3 0.0 0.0 0.0 0.0 0.0 TMEM134 FLJ21749 ENSG00000172663 "Transmembrane protein 134" Q9H6X4 11 67461710-67469272 "Predicted membrane proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043744 Approved Supported Cytosol NA NA Cytosol "HPA043744: AB_10794773" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.22e-1)" "unprognostic (4.67e-2)" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-1)" "unprognostic (7.22e-2)" "unprognostic (3.85e-1)" "unprognostic (1.39e-2)" "unprognostic (4.30e-2)" "unprognostic (3.48e-1)" "unprognostic (1.75e-1)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-2)" "unprognostic (4.43e-3)" 7.1 15.3 11.2 11.9 14.9 4.8 7.8 6.5 12.7 10.1 11.2 13.4 16.1 8.8 7.2 16.4 30.2 10.3 14.1 22.7 9.7 7.9 13.1 23.7 8.1 10.9 12.9 7.9 6.9 42.1 6.9 4.7 10.7 10.1 15.6 5.1 7.1 16.9 14.0 46.2 31.8 10.2 6.9 12.5 12.3 14.0 12.0 9.7 11.1 8.3 20.7 21.6 10.4 13.2 51.9 23.9 25.9 44.5 22.7 32.2 19.2 7.1 2.7 3.9 8.4 2.6 4.5 4.3 1.5 2.8 1.8 0.7 3.4 8.5 6.8 16.6 3.6 5.6 6.0 1.7 6.3 1.1 6.5 2.9 1.3 2.4 3.5 4.1 1.3 2.0 4.5 8.2 1.4 4.7 7.7 1.8 4.7 1.7 4.0 3.8 17.0 7.6 4.9 6.6 11.9 9.7 3.7 2.3 22.1 6.7 7.3 3.7 8.1 5.4 8.5 15.6 2.8 20.7 1.3 3.4 6.4 5.6 7.5 1.9 16.9 10.6 4.5 9.5 1.7 5.0 12.5 15.4 25.9 20.9 34.7 22.9 51.9 25.0 23.3 18.2 50.3 25.5 23.9 7.2 22.7 44.5 23.9 32.2 19.2 11.2 14.9 6.5 12.7 9.7 7.9 12.9 7.9 10.1 9.7 14.9 37.4 63.8 71.1 79.9 27.8 45.6 53.5 53.5 48.9 64.6 9.8 58.8 112.7 81.8 42.3 30.4 71.9 0.0 110.6 111.2 35.7 133.5 22.0 66.8 75.8 11.1 68.5 22.1 35.0 27.2 19.2 50.4 104.6 75.7 89.3 29.2 138.9 72.4 23.3 134.2 27.4 6.5 42.2 95.3 76.8 157.5 60.9 50.7 73.6 137.5 TMEM135 FLJ22104 ENSG00000166575 "Transmembrane protein 135" Q86UB9 11 87037844-87323758 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056685, HPA069473" Uncertain Supported Vesicles NA NA Vesicles "HPA056685: AB_2683208, HPA069473: AB_2686139" "unprognostic (1.55e-2)" "unprognostic (1.11e-1)" "unprognostic (2.70e-2)" "unprognostic (6.51e-2)" "unprognostic (3.10e-2)" "unprognostic (4.42e-1)" "unprognostic (1.45e-2)" "unprognostic (2.63e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "prognostic favorable (9.02e-4)" "unprognostic (3.48e-2)" "unprognostic (7.34e-2)" "unprognostic (1.35e-2)" "unprognostic (1.80e-1)" 31.6 28.9 10.5 9.5 12.0 5.9 23.3 11.4 14.8 8.3 14.3 12.8 18.9 21.8 15.1 7.8 7.4 8.4 12.6 12.6 9.9 11.3 16.5 31.2 11.7 9.8 13.8 10.2 14.1 9.2 14.7 24.4 13.5 12.9 15.4 12.1 12.8 16.9 17.8 14.9 7.5 20.1 11.1 11.2 8.3 10.1 15.7 11.4 14.1 15.0 6.4 7.0 10.7 9.9 5.9 7.0 2.2 6.0 8.4 10.4 4.5 4.2 6.9 4.9 6.7 15.8 15.2 6.2 3.3 8.5 4.0 8.4 12.2 19.2 12.0 8.5 4.2 9.2 4.1 6.6 8.0 4.2 10.5 4.1 9.6 7.3 42.3 8.8 5.2 5.0 17.4 4.8 5.2 3.6 5.0 9.9 11.9 8.8 16.5 4.2 3.4 12.8 6.1 5.8 22.0 5.9 6.7 3.9 9.5 8.8 13.2 2.5 6.3 5.1 14.6 7.0 9.5 20.9 5.8 5.2 4.3 5.3 14.8 2.5 6.9 12.4 13.0 3.0 5.9 7.8 0.9 5.8 1.7 9.7 6.0 8.5 5.9 6.3 10.4 6.6 5.2 7.1 6.8 2.2 8.4 2.7 7.0 6.5 4.5 10.5 12.0 11.4 14.8 9.9 11.3 13.8 10.2 12.9 11.4 8.9 6.9 1.5 3.9 3.8 5.8 4.6 0.0 1.4 6.8 1.8 3.9 1.7 5.0 2.6 2.2 6.3 12.6 0.0 2.9 7.1 7.5 9.3 9.2 14.7 4.3 1.6 3.5 8.6 6.3 5.2 6.6 4.2 5.0 3.6 6.5 5.0 2.9 6.2 6.7 8.4 4.2 32.3 5.3 2.1 3.6 4.3 1.3 3.2 7.8 3.7 TMEM136 MGC17839 ENSG00000181264 "Transmembrane protein 136" Q6ZRR5 11 120325129-120333682 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 51.1;Rod photoreceptor cells: 91.0;Sertoli cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 5.7" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074432 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA074432: AB_2686689" "unprognostic (1.02e-1)" "unprognostic (6.56e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (1.65e-2)" "unprognostic (3.31e-2)" "unprognostic (6.81e-3)" "unprognostic (1.22e-1)" "unprognostic (1.39e-2)" "unprognostic (2.58e-1)" "unprognostic (2.86e-3)" "unprognostic (2.39e-1)" "unprognostic (2.71e-2)" "unprognostic (2.78e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (7.28e-2)" 4.4 18.9 9.1 2.7 13.8 1.0 5.7 5.8 15.1 4.6 2.9 13.8 3.2 2.1 7.6 14.0 2.6 7.4 5.6 19.1 8.2 5.7 4.8 1.9 4.9 4.0 13.0 7.7 9.0 9.7 9.4 7.9 10.4 12.0 8.4 2.3 9.0 2.4 5.9 1.8 2.0 3.1 6.9 13.7 4.2 2.8 5.4 8.8 0.0 7.8 0.7 2.9 3.2 4.1 0.0 5.7 0.0 0.0 0.0 0.9 0.0 1.6 4.3 8.2 7.8 8.2 12.9 2.1 3.6 8.9 5.8 9.5 2.2 7.3 0.0 11.3 2.3 12.0 1.2 7.2 2.7 6.5 0.0 4.5 5.4 3.9 3.8 9.2 0.0 0.0 11.1 2.0 8.2 12.7 13.1 6.7 6.7 1.4 10.8 7.8 2.0 0.0 0.0 3.5 0.4 2.7 4.1 3.3 0.5 7.7 1.6 5.3 5.1 5.1 0.6 1.0 9.6 6.8 0.2 4.8 6.4 6.6 1.4 2.1 0.1 0.0 0.0 1.9 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.9 0.0 9.1 13.8 5.8 11.5 8.2 5.7 13.0 7.7 12.0 8.8 8.9 5.1 0.0 16.7 3.3 12.1 21.0 7.6 6.7 9.1 22.7 51.1 9.2 5.0 19.5 1.5 6.3 0.5 0.0 11.4 3.2 11.6 28.9 0.0 0.5 1.1 12.7 18.8 4.9 0.6 1.5 3.1 1.0 5.0 23.4 1.6 17.1 17.9 0.0 2.1 3.7 91.0 45.3 14.6 6.9 6.5 3.1 7.9 0.0 0.7 10.7 TMEM138 "HSPC196, JBTS16" ENSG00000149483 "Transmembrane protein 138" Q9NPI0 11 61362001-61369509 "Disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042373 Approved Approved Microtubules NA Yes Microtubules "HPA042373: AB_10793880" "unprognostic (1.30e-1)" "unprognostic (4.69e-3)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (2.15e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (7.90e-4)" "unprognostic (1.06e-2)" "unprognostic (1.58e-1)" "unprognostic (1.86e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.12e-6)" "unprognostic (2.28e-1)" "unprognostic (4.42e-2)" "unprognostic (3.49e-1)" "unprognostic (4.46e-1)" 12.4 38.3 7.5 13.5 11.3 15.4 13.0 8.2 11.4 13.5 11.6 15.0 7.9 9.2 17.3 22.5 10.2 15.2 11.4 8.6 7.7 7.1 18.7 46.3 14.1 13.8 12.2 10.4 29.4 12.8 16.5 13.0 19.7 9.5 16.1 15.4 28.4 14.8 10.8 6.3 16.2 16.7 15.0 11.2 17.6 11.9 10.7 11.4 13.7 14.5 11.4 17.8 12.9 12.4 15.5 17.0 22.6 15.9 14.9 16.4 13.1 6.8 14.0 6.7 8.3 20.4 9.4 7.3 8.8 13.7 14.2 12.9 7.1 9.8 6.2 7.9 11.5 20.1 12.8 10.9 14.1 17.1 7.5 7.1 4.6 12.4 8.9 15.3 8.7 13.9 13.5 20.0 24.2 16.6 5.4 13.1 7.4 11.6 10.9 23.7 19.7 7.2 10.2 9.2 9.7 15.2 5.9 3.5 12.4 14.0 16.9 6.9 5.4 10.2 11.5 12.1 5.1 17.7 6.7 6.9 19.2 7.4 12.2 9.6 10.0 8.9 6.0 9.5 10.6 9.1 22.6 15.9 15.0 14.8 15.4 15.9 15.5 14.1 13.9 10.1 14.1 15.3 13.7 3.9 14.9 10.0 17.0 16.4 13.1 7.5 11.3 8.2 11.4 7.7 7.1 12.2 10.4 9.5 11.4 14.9 27.5 19.9 14.7 17.6 26.4 3.5 2.5 40.2 19.4 19.2 76.6 48.7 13.3 14.9 22.4 17.5 14.7 0.0 13.8 34.8 19.7 13.2 35.9 13.9 42.9 14.3 9.2 11.6 17.3 5.3 29.4 21.1 35.4 22.6 9.2 25.4 14.7 14.0 26.9 16.5 164.4 0.0 12.2 18.4 17.1 17.9 23.0 27.4 12.1 10.3 TMEM139 FLJ90586 ENSG00000178826 "Transmembrane protein 139" Q8IV31 7 143279957-143288048 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.1;kidney: 22.6;placenta: 28.0" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 48.8;Ductal cells: 42.9;Enterocytes: 54.0;Proximal tubular cells: 67.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.7;CAPAN-2: 18.3;EFO-21: 12.9;RPTEC TERT1: 32.2;SK-BR-3: 11.3;T-47d: 31.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036982, HPA036983" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane" "Focal adhesion sites" "HPA036982: AB_2675413, HPA036983: AB_10672275" "unprognostic (2.58e-1)" "unprognostic (4.38e-1)" "unprognostic (6.62e-3)" "unprognostic (1.41e-1)" "unprognostic (2.10e-1)" "unprognostic (2.16e-3)" "unprognostic (2.83e-2)" "unprognostic (4.90e-2)" "unprognostic (1.60e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (2.89e-1)" "prognostic favorable (3.05e-5)" "unprognostic (1.73e-1)" "unprognostic (1.42e-2)" "unprognostic (2.83e-2)" "unprognostic (9.08e-3)" 1.5 2.2 0.9 2.8 1.9 0.0 2.1 0.6 1.6 6.3 14.7 6.0 1.5 22.7 1.6 3.5 0.4 4.6 4.8 2.3 1.6 1.1 22.6 7.8 5.5 0.1 4.2 0.7 0.9 9.6 6.4 2.0 28.0 4.8 1.6 2.9 1.4 6.1 2.2 0.1 1.1 25.1 0.4 13.4 0.8 2.0 3.0 2.1 0.1 8.8 0.4 0.7 2.1 2.4 0.5 0.3 0.9 3.2 0.0 2.0 0.4 9.7 0.7 0.1 0.0 0.0 0.0 6.5 0.1 0.0 0.0 0.0 2.3 18.3 0.1 12.9 0.0 0.8 8.3 0.0 4.2 0.0 0.1 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.2 0.0 0.6 0.7 0.4 0.0 0.2 0.7 0.1 0.1 0.0 32.2 2.5 0.1 0.0 0.5 11.3 0.0 0.2 31.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 3.2 0.0 0.5 1.3 0.8 0.0 0.0 1.1 0.6 0.0 0.0 2.4 0.3 2.0 0.4 0.9 1.9 0.6 1.6 1.6 1.1 4.2 0.7 4.8 2.1 14.9 5.1 0.0 2.4 0.1 0.0 2.0 35.7 2.7 5.7 48.8 0.0 26.6 29.9 42.9 12.0 0.3 54.0 0.0 4.0 4.7 0.3 0.3 0.0 13.4 1.7 0.0 3.5 1.3 0.6 8.8 0.0 0.1 5.0 1.8 4.3 8.3 23.3 23.0 0.0 67.4 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 7.4 1.2 TMEM140 FLJ11000 ENSG00000146859 "Transmembrane protein 140" Q9NV12 7 135148072-135166215 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 54.0;neutrophil: 75.1" "Lineage enriched" "Detected in all" 9 "granulocytes: 75.1" "Cell line enhanced" "Detected in many" "ASC diff: 36.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (3.52e-2)" "unprognostic (2.34e-2)" "unprognostic (3.26e-1)" "unprognostic (3.11e-1)" "unprognostic (1.79e-1)" "unprognostic (3.37e-2)" "unprognostic (9.72e-2)" "unprognostic (7.65e-3)" "unprognostic (3.41e-1)" "unprognostic (7.59e-2)" "unprognostic (5.20e-2)" "unprognostic (7.19e-2)" "unprognostic (2.35e-2)" "unprognostic (3.17e-2)" "unprognostic (1.83e-2)" "unprognostic (1.37e-1)" "unprognostic (1.05e-1)" 39.1 13.6 4.6 12.4 19.9 6.4 27.9 2.4 14.2 9.0 10.4 15.2 9.2 11.9 13.5 7.3 6.3 6.5 12.9 13.8 6.5 5.0 16.9 32.9 18.8 15.6 30.7 4.8 10.8 10.0 2.5 4.0 22.7 15.4 9.7 5.7 9.9 11.4 7.5 51.6 6.1 11.4 8.0 31.4 17.6 8.3 6.3 22.1 4.4 7.6 3.7 10.7 16.7 14.5 7.7 2.0 75.1 5.1 6.1 8.3 10.1 5.0 12.3 4.4 8.8 36.1 7.1 4.0 3.9 5.9 3.0 7.7 4.7 5.1 6.7 5.1 1.6 21.0 5.0 0.0 0.1 0.5 13.1 5.7 4.0 5.1 4.7 7.6 9.3 6.4 1.8 0.3 1.2 0.0 7.5 4.7 5.1 8.9 22.8 0.9 4.4 8.9 4.2 9.0 7.4 7.0 6.3 6.4 14.3 1.8 7.8 5.0 7.9 3.7 5.6 9.6 3.2 2.3 8.5 4.8 3.7 2.6 8.1 4.8 25.4 19.0 10.0 11.2 11.1 8.9 54.0 4.8 18.0 8.2 4.0 6.0 6.1 6.8 8.0 2.0 7.7 7.7 8.3 75.1 6.1 5.1 0.3 8.3 10.1 4.6 19.9 2.4 14.2 6.5 5.0 30.7 4.8 15.4 22.1 3.0 1.1 20.4 0.4 1.5 0.8 3.0 20.4 2.7 2.3 8.7 0.0 6.9 3.3 14.1 9.1 24.8 10.2 23.3 3.3 1.7 4.8 0.9 4.7 21.7 16.2 3.2 5.1 22.1 6.7 2.0 9.8 6.7 25.3 14.4 1.9 0.1 5.8 17.3 4.9 14.7 0.5 0.0 2.1 0.0 0.1 1.9 40.5 20.8 0.6 0.9 TMEM141 MGC14141 ENSG00000244187 "Transmembrane protein 141" Q96I45 9 136791355-136793257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 530.6;Enterocytes: 541.1;Paneth cells: 627.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 64.4;T-47d: 62.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014615, HPA050244" Approved Supported "Cell Junctions,Mitochondria" NA NA Mitochondria "Cell Junctions" "HPA014615: AB_2204756, HPA050244: AB_2681061" "unprognostic (2.05e-1)" "unprognostic (1.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (2.00e-1)" "unprognostic (8.53e-3)" "unprognostic (1.52e-2)" "unprognostic (3.15e-2)" "unprognostic (2.38e-1)" "unprognostic (1.94e-2)" "unprognostic (2.24e-1)" "unprognostic (8.45e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.49e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-1)" "unprognostic (1.70e-1)" 10.0 15.5 15.7 23.4 15.3 15.5 22.9 11.6 28.3 17.2 54.4 21.0 22.4 21.9 9.4 31.1 35.5 22.6 27.9 22.8 15.2 12.2 38.5 43.4 14.4 23.0 19.9 19.3 13.8 46.3 20.6 23.1 31.7 22.0 49.0 51.4 12.5 32.5 27.5 13.5 22.0 25.6 10.5 19.1 14.1 23.3 16.5 13.8 16.3 28.6 26.0 15.2 16.4 16.3 11.1 42.7 9.0 19.4 12.4 11.3 12.2 15.0 11.0 9.8 6.1 12.4 10.0 21.2 8.5 13.4 10.6 8.5 14.5 13.7 14.5 13.3 9.2 9.6 22.6 4.2 25.0 3.4 10.5 7.6 8.1 6.1 16.1 18.1 8.4 10.1 9.6 42.9 8.1 23.0 12.1 15.7 19.3 8.0 7.8 13.8 30.8 11.5 6.5 4.7 64.4 12.4 9.6 10.3 42.7 24.0 8.5 16.5 7.4 9.2 35.1 9.6 8.8 62.6 8.2 10.7 7.6 6.0 13.8 5.5 5.1 7.9 7.7 11.4 12.2 10.8 6.5 13.8 9.0 11.3 19.4 10.2 8.7 7.9 8.1 11.2 11.1 10.9 10.0 3.3 12.4 16.0 42.7 7.5 12.2 15.7 15.3 11.6 28.3 15.2 12.2 19.9 19.3 22.0 13.8 53.6 66.5 48.0 79.9 36.1 13.8 38.7 140.1 40.2 47.8 111.7 7.9 153.9 530.6 139.6 35.4 42.8 541.1 0.0 69.3 125.8 30.6 159.7 40.5 149.9 127.7 4.8 198.8 60.2 56.6 92.7 34.8 37.5 81.0 99.2 409.6 43.5 87.4 627.8 28.0 354.2 22.0 45.3 28.3 48.3 42.6 54.8 229.4 48.4 378.9 92.2 TMEM143 FLJ10922 ENSG00000161558 "Transmembrane protein 143" Q96AN5 19 48332356-48364237 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.1" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 22.1;Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014476, HPA058645" Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA014476: AB_1858092, HPA058645: " "unprognostic (1.23e-1)" "unprognostic (2.30e-2)" "unprognostic (5.23e-2)" "unprognostic (2.50e-1)" "unprognostic (5.94e-2)" "unprognostic (2.11e-3)" "unprognostic (4.50e-2)" "unprognostic (1.61e-1)" "unprognostic (4.08e-1)" "unprognostic (2.25e-1)" "unprognostic (7.29e-2)" "unprognostic (9.82e-2)" "prognostic favorable (1.53e-7)" "unprognostic (5.46e-2)" "unprognostic (1.24e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-1)" 6.2 5.6 3.3 3.5 5.7 2.7 3.2 5.1 6.6 2.6 4.4 4.4 4.1 4.3 4.1 3.8 4.0 3.0 3.2 27.0 3.4 2.7 6.1 9.7 2.9 3.5 4.7 4.5 3.2 4.2 3.1 3.2 3.0 3.9 3.4 3.1 4.7 4.5 4.1 70.1 4.8 4.8 5.3 3.2 4.6 3.7 2.5 4.3 5.4 3.9 16.5 5.1 3.7 2.5 5.0 3.4 3.6 2.3 7.6 5.7 2.7 3.6 5.7 1.9 3.5 3.9 6.3 3.8 3.4 2.0 2.4 3.1 5.0 4.7 6.6 6.5 2.3 1.1 4.1 1.9 2.5 1.4 9.1 4.3 4.0 4.6 8.3 3.3 3.2 3.9 5.4 3.1 1.2 3.4 2.8 1.9 10.4 2.9 9.9 3.0 2.1 4.4 12.3 2.4 6.7 2.1 7.1 1.4 11.0 3.2 2.7 7.2 7.0 1.9 2.5 1.5 2.3 3.5 2.8 2.3 2.8 3.2 2.0 1.7 20.9 6.2 5.4 2.3 4.3 2.4 3.6 2.3 2.7 4.7 1.5 5.7 5.0 3.7 4.0 3.4 3.4 5.5 3.3 1.7 7.6 2.3 1.3 2.3 2.7 3.3 5.7 5.1 6.6 3.4 2.7 4.7 4.5 3.9 4.3 3.0 0.6 0.8 3.1 0.2 3.2 22.1 0.0 6.7 0.0 1.8 7.9 8.4 11.6 2.4 0.5 1.5 4.3 23.3 2.1 5.0 4.1 0.9 1.1 6.7 4.7 0.0 2.9 0.6 1.0 0.4 2.3 2.2 8.5 2.8 3.0 4.0 1.2 5.8 1.1 12.7 6.5 0.0 3.1 4.7 5.5 0.9 3.1 4.4 3.9 0.8 TMEM144 FLJ11155 ENSG00000164124 "Transmembrane protein 144" Q7Z5S9 4 158201604-158255411 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 88.7" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 195.0;Late spermatids: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.3;intermediate monocyte: 1.4;myeloid DC: 3.7;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 10 "dendritic cells: 4.3;monocytes: 3.3" "Cell line enhanced" "Detected in many" "BEWO: 23.7;hTCEpi: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063554 Approved Mitochondria NA NA Mitochondria "HPA063554: AB_2685039" "unprognostic (1.26e-2)" "unprognostic (7.05e-2)" "unprognostic (2.06e-2)" "prognostic favorable (2.89e-4)" "unprognostic (2.90e-1)" "unprognostic (1.71e-5)" "unprognostic (8.27e-2)" "unprognostic (3.32e-1)" "unprognostic (2.21e-1)" "unprognostic (3.33e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (9.34e-2)" "unprognostic (1.13e-2)" "unprognostic (1.35e-1)" "unprognostic (9.26e-2)" "unprognostic (3.88e-2)" "unprognostic (4.05e-2)" 4.7 6.7 20.7 2.0 60.9 1.5 9.2 4.7 37.7 4.7 7.4 88.7 0.2 14.3 3.7 8.3 3.1 3.9 6.8 8.2 31.5 18.3 1.9 1.7 3.5 0.9 80.4 26.6 8.6 3.8 3.0 1.4 3.5 48.9 5.4 8.6 0.0 3.1 7.2 1.4 1.9 9.6 4.2 79.2 2.2 5.4 15.8 67.4 0.0 9.2 0.0 0.8 5.1 1.9 0.0 4.3 0.1 3.3 0.4 0.1 0.7 2.6 7.1 0.1 1.4 5.2 7.8 23.7 1.2 1.9 1.1 1.7 8.9 9.8 0.0 1.4 0.3 5.1 1.2 3.3 11.0 1.5 0.0 3.2 4.4 2.2 7.9 1.8 5.5 1.4 5.6 13.6 4.6 1.6 0.3 5.9 1.1 2.9 0.1 8.2 3.0 0.0 0.0 1.8 7.3 1.7 0.0 0.0 0.3 2.0 7.5 1.1 0.0 0.2 9.6 2.7 4.3 6.8 1.5 1.2 2.2 1.8 0.4 1.3 0.0 0.6 0.6 3.0 0.8 1.5 0.0 3.3 0.0 0.0 1.4 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.4 0.7 4.3 0.0 0.7 20.7 60.9 4.7 35.1 31.5 18.3 80.4 26.6 48.9 67.4 8.9 7.8 0.0 6.7 2.7 0.0 10.6 17.8 5.3 4.5 0.0 0.0 11.5 0.0 9.5 195.0 3.6 34.8 0.0 11.4 5.8 2.0 5.7 4.6 1.0 24.1 0.0 4.7 3.1 19.9 77.6 9.8 10.7 3.3 3.6 17.2 1.3 10.6 14.7 8.5 5.6 0.0 0.0 2.2 1.2 1.7 4.4 7.3 0.0 14.5 4.2 TMEM145 FLJ90805 ENSG00000167619 "Transmembrane protein 145" Q8NBT3 19 42313325-42325062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 74.5" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 57.8;Cone photoreceptor cells: 27.5;Horizontal cells: 65.2;Rod photoreceptor cells: 30.8" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Region enriched" "Detected in all" 4 "cerebellum: 74.5" "Group enriched" "Detected in some" 8 "basophil: 4.5;neutrophil: 15.5" "Lineage enriched" "Detected in many" 12 "granulocytes: 15.5" "Cell line enhanced" "Detected in many" "HMC-1: 11.9;PC-3: 8.8;SCLC-21H: 22.7;SH-SY5Y: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060462 Enhanced Approved Approved Vesicles NA NA Vesicles "HPA060462: AB_2684285" "unprognostic (9.56e-3)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" "unprognostic (6.62e-2)" "unprognostic (2.14e-1)" "unprognostic (4.27e-3)" "unprognostic (1.53e-2)" "unprognostic (9.85e-2)" "unprognostic (4.20e-4)" "unprognostic (7.35e-2)" "unprognostic (7.64e-2)" "unprognostic (2.30e-1)" "unprognostic (6.31e-2)" 1.6 6.2 8.0 1.2 7.7 2.5 1.3 74.5 30.5 0.6 1.2 3.8 0.0 1.7 1.1 1.6 1.0 1.1 1.4 1.3 5.8 8.5 0.9 1.4 0.8 1.5 5.1 7.6 1.2 3.7 3.0 6.4 0.6 9.3 1.2 1.2 2.8 1.1 0.9 2.3 3.3 1.1 1.2 3.9 1.5 2.0 3.3 3.2 0.0 1.3 0.0 1.1 1.0 0.3 1.3 0.8 15.5 0.9 0.6 0.9 0.8 0.5 2.8 2.1 6.5 0.2 0.2 0.9 0.2 0.1 1.0 2.6 0.5 0.7 1.5 0.3 0.7 0.6 0.2 1.5 0.4 1.2 6.8 1.7 2.8 2.6 2.4 0.2 1.7 11.9 0.6 0.5 0.4 0.6 0.2 1.1 0.8 1.5 5.6 0.1 0.6 0.4 1.9 1.3 2.0 8.8 0.2 0.6 5.3 0.1 1.0 22.7 10.8 1.0 0.7 1.4 0.1 2.0 1.9 0.3 1.9 1.9 1.3 0.7 1.2 3.1 1.4 0.7 1.1 5.2 4.5 0.9 0.9 0.6 0.8 0.3 1.0 0.6 0.4 0.2 1.3 0.6 0.9 15.5 0.6 0.7 0.8 0.4 0.8 8.0 7.7 74.5 18.1 5.8 8.5 5.1 7.6 9.3 3.2 0.0 0.0 0.0 0.4 0.2 57.8 0.4 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.2 0.0 0.0 0.3 1.1 0.0 0.3 65.2 0.0 1.8 1.2 0.0 0.0 0.0 5.0 0.0 0.0 11.9 0.1 0.0 0.4 0.0 30.8 0.0 0.0 5.1 17.9 0.1 0.0 0.0 0.0 0.0 TMEM147 "MGC1936, NIFIE14" ENSG00000105677 "Transmembrane protein 147" Q9BVK8 19 35545595-35547526 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067837 Approved "Golgi apparatus,Actin filaments" NA NA "Golgi apparatus, Actin filaments" "HPA067837: " "unprognostic (6.98e-2)" "unprognostic (1.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.20e-2)" "unprognostic (1.38e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (4.98e-6)" "unprognostic (1.33e-1)" "unprognostic (2.53e-1)" "unprognostic (7.34e-2)" "unprognostic (1.35e-1)" "unprognostic (9.26e-2)" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (4.00e-2)" "unprognostic (1.85e-1)" "unprognostic (2.70e-1)" 22.7 46.2 22.3 19.3 26.8 15.6 53.2 18.9 42.0 23.1 23.4 16.3 30.0 18.9 23.7 47.2 29.5 24.8 30.2 57.5 20.1 22.0 33.3 29.8 29.9 53.2 26.3 19.0 22.6 88.4 31.7 23.3 20.1 22.8 18.1 24.5 23.1 30.5 33.1 39.1 33.1 17.5 26.8 26.6 18.0 22.9 41.8 19.2 9.8 39.4 31.4 18.9 21.0 25.4 40.9 54.9 22.6 51.8 21.8 35.1 47.2 29.8 65.4 13.1 30.5 58.0 26.6 21.5 19.0 31.3 23.7 22.1 30.9 18.2 17.4 30.6 28.9 25.9 11.8 22.5 27.4 19.6 27.5 30.9 18.8 19.7 36.2 46.3 26.5 20.8 28.9 42.9 22.3 56.0 20.6 21.7 23.9 24.3 61.7 25.1 36.6 15.2 14.7 18.5 90.6 28.5 14.7 12.1 41.2 37.3 30.4 11.6 19.4 17.7 40.7 36.4 13.8 14.7 22.3 14.0 27.0 21.6 15.3 38.4 32.4 32.7 9.6 23.5 36.0 21.7 7.3 51.8 22.6 25.1 47.3 35.1 40.9 34.0 28.9 47.0 34.7 25.7 26.0 3.0 21.8 33.3 54.9 32.9 47.2 22.3 26.8 18.9 42.0 20.1 22.0 26.3 19.0 22.8 19.2 41.7 36.1 61.0 106.8 89.9 51.4 92.9 122.3 33.5 42.1 148.3 17.7 150.6 94.5 199.6 77.8 100.8 76.7 0.0 219.9 199.2 111.4 171.1 50.6 97.2 232.5 42.9 85.5 72.4 122.6 242.1 129.2 109.7 227.7 61.3 96.0 111.2 180.6 63.1 113.8 224.3 45.9 116.4 81.2 327.5 106.5 146.7 115.7 69.2 124.9 160.1 TMEM14A "C6orf73, PTD011" ENSG00000096092 "Transmembrane protein 14A" Q9Y6G1 6 52671109-52686588 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A-431: 67.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072536 Approved Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Nucleoplasm, Endoplasmic reticulum" "HPA072536: AB_2686531" "unprognostic (6.75e-2)" "unprognostic (3.65e-2)" "unprognostic (2.04e-1)" "unprognostic (8.10e-3)" "unprognostic (3.55e-2)" "unprognostic (1.06e-1)" "unprognostic (8.05e-2)" "unprognostic (4.10e-2)" "unprognostic (1.45e-1)" "unprognostic (2.56e-3)" "unprognostic (8.88e-2)" "unprognostic (1.17e-1)" "unprognostic (3.52e-2)" "unprognostic (9.60e-2)" "unprognostic (5.44e-2)" "unprognostic (3.37e-1)" "unprognostic (2.64e-1)" 8.7 24.4 26.7 6.2 32.0 4.3 12.9 25.7 40.0 13.9 12.5 13.5 5.8 18.9 14.3 19.3 18.0 16.3 12.6 8.1 25.5 40.7 25.8 52.7 9.0 8.8 28.3 22.6 21.0 23.8 9.2 12.9 7.9 31.7 19.0 13.3 25.7 9.6 11.7 2.0 6.8 17.4 13.4 29.1 6.5 20.3 8.4 10.7 5.8 14.6 11.1 11.6 14.1 11.6 22.3 14.3 6.4 0.2 4.0 25.7 11.9 67.3 10.2 7.6 21.5 20.8 16.1 6.4 13.6 18.7 12.6 19.6 15.6 17.5 8.3 15.2 17.1 26.6 25.8 16.8 22.8 21.3 33.3 13.8 12.2 16.7 25.5 6.8 6.2 15.3 14.4 16.1 13.8 3.1 16.7 17.0 10.6 2.5 23.7 14.9 13.7 12.1 7.1 4.5 44.7 17.9 9.6 10.8 6.5 24.4 13.0 39.6 19.2 15.2 12.2 25.4 9.9 18.8 12.0 12.5 17.5 23.6 6.8 21.9 11.4 9.6 12.5 24.6 3.9 13.9 6.4 0.2 6.4 16.4 0.0 10.6 22.3 21.2 17.2 7.8 13.2 16.4 17.5 0.9 4.0 0.0 14.3 25.7 11.9 26.7 32.0 25.7 40.0 25.5 40.7 28.3 22.6 31.7 10.7 23.8 14.5 18.0 51.6 42.9 20.8 12.5 50.9 61.6 33.0 48.8 7.9 51.8 54.7 95.2 1.1 42.1 22.0 0.0 122.4 120.9 88.8 80.6 25.3 119.7 38.4 4.8 32.1 33.7 7.3 2.0 40.3 16.9 84.4 6.4 47.0 24.6 77.7 28.8 47.0 136.7 10.1 6.5 75.2 4.4 24.5 33.4 12.9 22.7 47.2 49.8 TMEM14B MGC1223 ENSG00000137210 "Transmembrane protein 14B" Q9NUH8 6 10747759-10852753 "Predicted membrane proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (5.45e-3)" "unprognostic (6.80e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (6.51e-4)" "unprognostic (5.45e-1)" "unprognostic (2.58e-3)" "prognostic unfavorable (9.35e-5)" "unprognostic (1.63e-1)" "unprognostic (3.75e-3)" "prognostic favorable (7.41e-4)" "unprognostic (2.14e-1)" "unprognostic (1.58e-1)" "unprognostic (8.24e-2)" "unprognostic (4.77e-2)" "unprognostic (4.83e-2)" "unprognostic (1.92e-1)" "unprognostic (1.07e-1)" 30.0 47.6 31.7 17.5 33.3 63.8 31.8 24.4 38.4 23.0 24.6 25.9 24.7 21.7 23.0 30.2 24.1 31.1 21.5 53.0 27.3 26.8 42.8 58.3 18.5 25.8 28.7 21.8 25.4 34.9 16.9 20.2 27.2 31.8 28.1 25.4 37.9 44.6 20.0 54.1 18.7 35.7 20.5 25.7 27.3 26.7 15.3 20.2 36.5 53.7 34.8 31.6 19.1 18.4 48.0 64.6 57.7 43.2 40.8 54.7 53.0 72.3 32.0 14.6 21.8 16.4 21.2 22.8 15.2 26.9 32.8 39.0 31.6 34.7 26.4 38.3 18.0 76.5 16.4 13.0 26.3 51.4 16.9 19.4 21.5 27.7 45.5 24.5 32.3 20.8 17.2 15.3 35.2 35.1 18.7 18.1 23.9 53.1 10.9 26.4 28.4 28.3 39.5 22.5 38.1 25.0 23.5 21.0 61.2 38.9 19.7 25.6 18.9 19.3 38.4 47.6 29.4 27.6 27.9 18.3 25.4 30.5 16.9 52.1 25.7 54.6 34.0 20.4 18.1 38.0 50.0 43.2 57.7 35.6 39.8 48.5 48.0 49.2 40.2 51.7 44.9 54.7 45.4 24.1 40.8 42.3 64.6 51.5 53.0 31.7 33.3 24.4 38.4 27.3 26.8 28.7 21.8 31.8 20.2 74.5 54.4 90.3 74.6 72.8 83.2 130.8 147.7 235.5 76.2 83.7 56.9 155.7 310.0 144.5 13.8 83.9 81.4 210.2 192.6 152.4 109.4 140.9 80.8 138.6 178.9 101.7 77.4 58.3 98.5 36.4 89.2 113.2 114.7 329.2 133.8 116.3 188.8 87.7 70.7 244.0 134.7 25.8 77.3 40.8 119.3 88.1 88.6 88.8 159.5 94.9 TMEM14C "bA421M1.6, C6orf53, HSPC194, NET26" ENSG00000111843 "Transmembrane protein 14C" Q9P0S9 6 10722915-10731129 "Predicted membrane proteins" "Heme biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (4.08e-3)" "unprognostic (1.10e-1)" "unprognostic (2.82e-2)" "unprognostic (3.53e-2)" "unprognostic (3.77e-1)" "unprognostic (4.61e-2)" "prognostic unfavorable (3.66e-4)" "unprognostic (2.83e-1)" "unprognostic (2.38e-2)" "unprognostic (1.21e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (5.93e-2)" "unprognostic (3.39e-3)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (2.34e-1)" 39.3 53.3 29.5 16.6 27.0 37.2 34.3 21.9 33.7 39.4 44.7 30.1 34.3 33.5 40.5 40.4 38.4 35.5 37.5 53.6 24.5 29.2 53.6 57.3 26.3 22.8 32.7 23.7 38.1 46.6 23.4 22.3 41.6 27.8 45.4 24.1 39.9 57.8 39.2 49.2 22.7 45.6 31.3 30.0 25.9 31.2 22.1 23.4 18.6 58.3 36.5 29.0 37.2 29.3 13.1 28.3 26.8 16.5 11.5 14.0 11.5 33.8 19.5 14.0 20.9 30.0 29.4 15.1 20.2 27.8 20.9 22.8 19.0 25.1 22.2 44.3 21.4 44.2 16.3 8.6 24.4 12.2 14.9 14.3 14.2 18.4 25.2 38.4 10.8 10.7 31.9 23.6 17.9 27.9 22.2 10.6 6.0 34.9 8.3 23.8 17.9 7.7 26.0 17.4 15.2 20.8 14.1 20.1 35.2 26.6 11.2 13.4 16.1 19.9 28.0 33.9 24.8 20.0 12.8 28.9 30.5 18.1 12.7 30.0 19.9 34.8 10.0 17.2 14.4 31.5 14.8 16.5 26.8 4.8 15.4 14.0 13.1 11.8 7.0 28.3 10.1 11.5 9.6 1.5 11.5 13.4 26.2 12.7 11.5 29.5 27.0 21.9 33.7 24.5 29.2 32.7 23.7 27.8 23.4 107.2 58.1 60.2 119.5 88.4 41.2 115.1 152.8 105.7 113.7 148.3 7.9 201.0 228.8 170.8 4.3 120.3 160.8 210.2 121.6 231.4 158.6 163.7 136.0 132.0 323.4 15.9 117.7 94.5 107.4 7.8 166.0 187.1 183.9 408.4 155.6 149.9 165.2 175.4 179.3 249.3 37.2 174.6 131.3 31.5 59.3 100.9 163.3 48.9 192.6 120.7 TMEM150A "FLJ90024, TM6P1, TMEM150, TTN1" ENSG00000168890 "Transmembrane protein 150A" Q86TG1 2 85598548-85603196 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 106.0;Early spermatids: 129.8;Proximal tubular cells: 76.7;Syncytiotrophoblasts: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 27.9;HHSteC: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019015 Uncertain NA NA "HPA019015: AB_2204758" "unprognostic (2.80e-1)" "unprognostic (1.62e-2)" "unprognostic (2.29e-2)" "unprognostic (1.42e-3)" "unprognostic (4.09e-3)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (1.42e-2)" "unprognostic (5.80e-2)" "unprognostic (2.64e-2)" "unprognostic (2.54e-3)" "unprognostic (7.16e-2)" "unprognostic (8.27e-3)" "unprognostic (2.09e-2)" "unprognostic (2.89e-1)" "unprognostic (1.37e-2)" "unprognostic (6.87e-3)" 13.1 10.6 8.4 5.6 11.4 1.3 20.8 5.7 7.7 9.4 12.6 8.8 11.6 6.9 12.2 15.7 9.1 11.3 12.5 11.1 7.6 4.8 23.1 26.8 13.6 6.6 11.4 5.6 12.6 24.7 5.4 11.8 23.8 10.1 13.4 4.7 7.6 14.1 15.1 31.8 6.3 9.3 12.7 13.3 6.7 13.0 14.4 8.8 1.2 14.0 9.6 5.2 13.1 14.8 6.1 10.8 5.7 14.8 6.9 6.5 4.9 1.3 2.6 3.3 4.8 27.9 12.5 7.9 2.7 4.6 2.2 1.0 11.8 3.5 0.4 10.3 7.6 4.0 1.2 3.4 6.9 1.1 0.6 3.4 0.8 1.3 19.8 26.2 0.2 2.4 15.0 9.5 3.6 5.1 10.7 7.7 0.5 6.7 0.7 8.9 5.8 0.2 3.3 5.9 5.4 2.5 2.0 0.2 7.9 6.9 5.3 0.5 2.0 2.7 18.1 6.5 3.2 4.4 3.0 6.3 2.7 2.2 2.2 0.9 5.4 1.3 2.5 4.6 3.0 1.2 0.0 13.2 5.7 5.0 14.8 5.9 4.8 5.5 5.1 10.8 6.1 6.5 3.8 0.6 6.9 11.5 6.4 1.2 4.9 8.4 11.4 5.7 7.7 7.6 4.8 11.4 5.6 10.1 8.8 8.9 12.2 9.3 11.1 3.9 7.6 3.8 10.2 8.1 12.5 14.0 0.0 106.0 24.9 14.9 129.8 11.7 4.2 0.0 12.3 11.7 13.1 11.9 10.3 16.3 33.5 3.2 2.9 11.1 7.8 41.1 18.4 12.8 10.1 17.2 4.6 6.1 12.8 8.7 23.0 76.7 3.3 12.9 16.1 1.8 5.5 3.1 122.1 5.9 7.3 11.1 TMEM150B "TMEM224, TTN2" ENSG00000180061 "Transmembrane protein 150B" A6NC51 19 55312801-55334048 "Predicted membrane proteins" Autophagy "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 37.0" "Cell type enriched" "Detected in some" 5 "Enterocytes: 30.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 9.3" "Group enriched" "Detected in many" 8 "granulocytes: 3.7;monocytes: 9.3" "Cell line enhanced" "Detected in some" "CACO-2: 9.1;HMC-1: 4.7;U-937: 20.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "unprognostic (5.76e-2)" "unprognostic (4.94e-2)" "unprognostic (5.33e-2)" "unprognostic (6.70e-2)" "unprognostic (5.51e-2)" "unprognostic (1.35e-1)" "unprognostic (5.35e-2)" "unprognostic (4.00e-2)" "unprognostic (4.74e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (6.14e-6)" "unprognostic (1.48e-1)" "unprognostic (1.63e-3)" "unprognostic (2.45e-1)" "unprognostic (1.18e-2)" 10.5 2.2 0.5 3.1 1.5 0.3 8.3 0.4 1.1 0.8 6.1 0.4 1.2 37.0 0.7 3.0 1.0 1.4 1.7 3.5 1.8 0.6 2.4 5.4 12.7 7.3 0.6 0.3 2.3 0.8 0.0 0.8 5.4 2.1 2.7 4.2 1.2 1.1 0.2 1.5 0.6 31.5 2.3 1.2 14.1 1.2 1.7 0.4 0.3 1.2 0.2 2.0 1.8 3.0 0.0 0.8 3.7 9.3 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 1.2 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.0 0.0 0.1 0.1 0.1 2.1 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 20.5 0.1 3.7 9.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 1.2 0.5 1.5 0.4 1.1 1.8 0.6 0.6 0.3 2.1 0.4 0.0 0.0 0.0 1.7 0.1 0.0 0.3 2.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.0 0.0 0.0 0.0 5.4 0.0 0.0 2.0 0.0 1.0 2.0 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.1 TMEM150C "FLJ12993, TTN3" ENSG00000249242 "Transmembrane protein 150C" B9EJG8 4 82483170-82562357 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "epididymis: 74.9" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 67.6;Syncytiotrophoblasts: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 9.1;MCF7: 25.1;SCLC-21H: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052921 Enhanced NA NA "HPA052921: AB_2681988" "unprognostic (2.99e-1)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.89e-3)" "unprognostic (1.71e-3)" "prognostic favorable (7.87e-4)" "unprognostic (2.94e-2)" "unprognostic (5.55e-2)" "unprognostic (1.06e-1)" "unprognostic (3.94e-2)" "prognostic favorable (5.68e-4)" "unprognostic (4.57e-2)" "prognostic favorable (4.59e-6)" "unprognostic (4.18e-1)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-3)" 7.0 30.0 10.8 3.2 12.8 1.5 12.4 0.6 16.0 8.4 4.4 8.3 12.9 4.4 3.2 74.9 2.5 4.6 3.9 7.4 12.7 7.9 9.7 7.7 3.6 8.1 7.5 10.3 18.0 2.2 1.7 10.5 5.5 7.3 7.1 2.6 12.4 10.3 4.7 3.5 3.1 4.4 4.0 5.4 7.6 3.0 4.2 6.8 2.7 7.0 1.6 6.9 3.2 3.3 5.5 1.4 5.0 0.9 1.3 0.7 0.3 0.3 0.9 7.0 9.1 0.0 0.1 0.7 1.5 3.8 1.0 1.1 0.0 0.4 0.2 0.7 0.2 2.8 0.2 4.3 0.0 1.1 0.4 2.1 0.5 0.8 0.0 0.0 0.0 1.0 4.2 0.4 0.0 0.0 0.6 2.2 4.4 0.0 0.1 0.1 25.1 0.5 0.6 3.2 0.0 0.4 0.9 0.1 0.8 0.3 3.4 17.7 2.7 0.5 0.3 2.4 3.3 0.4 0.2 0.5 0.4 0.2 0.1 0.8 0.1 0.4 0.3 0.5 0.3 1.9 5.0 0.9 1.0 0.7 0.4 0.4 3.5 0.7 0.6 0.2 5.5 0.5 0.6 3.7 1.3 0.6 1.4 0.2 0.3 10.8 12.8 0.6 16.0 12.7 7.9 7.5 10.3 7.3 6.8 0.0 0.6 0.0 3.0 2.2 0.4 7.2 5.1 12.0 9.1 14.0 2.0 67.6 0.0 5.2 2.6 16.1 0.0 0.0 2.3 0.9 4.8 7.9 5.8 20.3 5.1 1.6 1.2 19.0 1.8 2.2 13.3 0.9 1.7 13.6 0.0 16.7 1.7 0.0 9.2 1.8 1.6 0.0 2.0 0.7 3.4 1.0 98.1 0.5 0.5 0.9 TMEM151B "bA444E17.5, C6orf137, TMEM193" ENSG00000178233 "Transmembrane protein 151B" Q8IW70 6 44270466-44307506 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 52.2" "Group enriched" "Detected in some" 6 "Bipolar cells: 4.5;Cardiomyocytes: 2.2;Horizontal cells: 4.8;Rod photoreceptor cells: 1.2" "Cancer enhanced" "Detected in single" "glioma: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 7 "T-cells: 1.0" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 25.3" "Low region specificity" "Detected in all" HPA055167 Uncertain NA NA "HPA055167: AB_2682723" "unprognostic (1.28e-3)" "unprognostic (6.25e-2)" "unprognostic (5.06e-2)" "unprognostic (7.02e-3)" "unprognostic (6.61e-2)" "unprognostic (1.22e-3)" "unprognostic (2.41e-2)" "unprognostic (3.01e-2)" "unprognostic (6.92e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-4)" "unprognostic (1.48e-1)" "unprognostic (4.56e-3)" "unprognostic (1.85e-1)" "unprognostic (9.15e-2)" "unprognostic (3.86e-2)" "unprognostic (1.66e-1)" 1.0 5.7 16.9 1.6 8.4 1.2 1.0 52.2 39.5 0.9 1.7 1.2 0.0 1.7 1.3 1.0 1.2 1.0 1.0 1.1 21.6 8.9 1.0 0.9 1.0 1.2 7.9 18.1 1.0 1.1 0.9 1.4 1.0 10.0 1.1 1.5 0.0 1.2 0.9 1.2 1.2 2.0 1.1 2.3 1.0 1.4 1.6 3.7 0.0 0.9 0.0 1.0 0.9 0.1 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 5.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.6 0.1 0.2 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.4 0.0 0.0 0.1 0.5 4.3 0.1 0.2 0.4 0.0 0.1 0.0 0.1 25.3 5.2 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.3 0.0 0.1 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 16.9 8.4 52.2 28.1 21.6 8.9 7.9 18.1 10.0 3.7 0.0 0.0 0.0 0.0 0.0 4.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 TMEM154 FLJ32028 ENSG00000170006 "Transmembrane protein 154" Q6P9G4 4 152618632-152680165 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 65.9;Ciliated cells: 60.2;granulocytes: 97.2;Suprabasal keratinocytes: 169.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 7 "basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4" "Lineage enriched" "Detected in many" 9 "granulocytes: 75.4" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.7;HMC-1: 28.5;Karpas-707: 22.2;U-266/70: 27.8;U-937: 22.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA019184, HPA055411" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA019184: AB_2670088, HPA055411: " "unprognostic (1.09e-1)" "unprognostic (3.56e-1)" "unprognostic (5.17e-2)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-1)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (2.64e-1)" "unprognostic (1.65e-1)" "unprognostic (5.00e-3)" "unprognostic (7.67e-2)" "unprognostic (2.23e-3)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" 1.4 0.7 0.8 12.5 0.8 8.3 2.0 0.7 0.7 5.0 1.4 1.3 0.9 1.0 1.1 1.2 36.1 1.1 2.4 1.7 0.8 0.8 1.0 4.8 7.9 20.4 1.3 0.1 0.7 0.8 0.1 3.5 3.5 0.8 3.9 1.1 0.5 16.1 2.5 1.3 28.7 3.0 2.2 1.2 16.2 2.7 0.6 0.1 8.2 1.5 26.0 38.0 7.1 6.3 8.3 2.9 75.4 6.0 0.1 3.4 2.2 12.2 0.0 0.1 0.0 0.2 3.5 5.6 3.1 11.5 3.4 6.5 0.1 1.6 12.6 1.3 2.8 3.7 9.0 0.0 24.7 6.3 0.0 0.0 0.7 0.1 0.0 3.7 9.7 28.5 3.4 11.9 10.9 9.5 0.0 8.4 7.8 0.0 22.2 0.2 0.8 3.8 3.0 0.6 0.0 2.9 0.4 0.0 0.0 19.5 7.5 0.0 0.5 0.7 2.4 0.4 3.5 0.3 6.9 3.4 0.5 2.0 0.3 4.3 27.8 9.4 6.9 4.7 22.1 2.6 49.8 5.8 44.8 0.8 5.9 1.5 8.3 1.8 1.3 2.9 7.2 1.8 1.2 75.4 0.1 6.0 0.3 3.4 2.2 0.8 0.8 0.7 0.7 0.8 0.8 1.3 0.1 0.8 0.1 11.9 22.9 42.2 7.7 65.9 0.0 1.4 0.0 60.2 19.4 21.0 2.0 21.8 0.0 6.1 0.0 5.7 0.0 0.0 3.3 12.7 5.5 5.3 97.2 3.9 4.2 3.2 1.2 0.6 8.7 0.0 0.6 15.0 5.0 0.0 0.6 0.0 12.8 9.1 0.0 0.3 0.4 0.0 1.9 0.0 0.2 169.9 21.6 15.8 3.1 23.5 TMEM156 FLJ23235 ENSG00000121895 "Transmembrane protein 156" Q8N614 4 38966744-39032922 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "blood: 30.6;brain: 12.7;intestine: 8.3;lymphoid tissue: 23.7" "Cell type enhanced" "Detected in some" 23 "B-cells: 75.1;Cholangiocytes: 20.4;T-cells: 28.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 30.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 16.3;GAMG: 12.7;HBEC3-KT: 34.9;hTERT-HME1: 27.5;NB-4: 14.2;PC-3: 15.6;U-698: 18.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "prognostic favorable (4.09e-4)" "unprognostic (7.36e-3)" "unprognostic (3.31e-3)" "unprognostic (4.17e-3)" "unprognostic (1.82e-1)" "unprognostic (1.01e-3)" "unprognostic (4.10e-2)" "unprognostic (1.29e-1)" "unprognostic (1.03e-2)" "unprognostic (1.43e-1)" "unprognostic (9.45e-3)" "unprognostic (5.17e-2)" "unprognostic (8.73e-4)" "unprognostic (3.89e-1)" "unprognostic (1.74e-2)" "unprognostic (3.92e-4)" "unprognostic (9.06e-2)" 0.9 1.7 5.8 11.8 6.6 1.7 1.1 0.7 4.1 0.6 1.7 6.1 0.0 1.7 0.6 0.3 2.0 1.0 1.9 0.6 4.1 2.6 1.4 2.6 1.6 20.2 6.2 0.8 0.5 0.8 0.3 0.7 0.2 5.3 0.9 2.0 0.0 2.0 0.6 0.6 0.5 8.3 0.5 12.7 17.3 2.3 0.6 4.2 7.4 1.0 0.3 23.7 4.5 0.8 30.6 5.0 18.8 0.3 4.8 9.0 3.6 1.0 9.8 0.1 0.1 0.0 0.3 0.1 0.0 2.7 0.0 0.0 0.1 0.1 16.3 0.1 0.0 12.7 0.1 0.1 34.9 0.1 0.2 0.0 0.9 3.3 0.2 5.8 6.7 0.1 0.0 1.8 0.7 27.5 2.1 3.0 2.7 2.3 0.1 1.2 0.1 1.2 14.2 0.0 0.4 15.6 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 7.4 1.2 0.2 0.0 0.3 0.0 0.0 18.6 2.2 6.3 0.0 5.4 0.3 18.8 5.2 0.1 6.1 30.6 9.0 5.2 3.3 21.9 3.5 4.6 0.8 4.8 0.1 5.0 6.0 3.6 5.8 6.6 0.7 4.1 4.1 2.6 6.2 0.8 5.3 4.2 0.0 2.6 75.1 0.5 0.5 0.6 0.3 20.4 1.4 1.2 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.4 1.1 0.7 0.0 0.2 1.6 1.6 0.0 2.5 12.0 1.4 0.0 2.7 10.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.5 0.2 28.7 0.0 0.7 TMEM158 "p40BBp, RIS1" ENSG00000249992 "Transmembrane protein 158 (gene/pseudogene)" Q8WZ71 3 45224466-45226278 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.8;endometrium 1: 31.1" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 21.8;Muller glia cells: 57.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 46.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 66.1;GAMG: 22.4;U-138 MG: 28.0;U-87 MG: 91.7" "Region enhanced" "Detected in many" "basal ganglia: 85.5" "Low region specificity" "Detected in all" HPA074974 Approved NA NA "HPA074974: AB_2732274" "unprognostic (3.84e-1)" "unprognostic (9.83e-3)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (3.77e-2)" "unprognostic (5.73e-2)" "unprognostic (3.31e-2)" "unprognostic (4.67e-3)" "unprognostic (6.23e-2)" "unprognostic (6.41e-2)" "unprognostic (1.84e-3)" "prognostic favorable (6.43e-5)" "prognostic unfavorable (5.42e-9)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (2.86e-2)" "unprognostic (4.49e-3)" 1.8 6.4 16.4 4.5 46.8 2.2 2.3 2.1 10.9 13.1 3.4 2.3 18.5 1.4 31.1 7.3 21.3 2.0 11.0 0.8 9.0 11.2 1.9 1.2 1.0 1.1 2.5 5.0 1.7 2.4 0.7 5.7 1.4 2.6 15.6 2.7 0.5 1.3 27.0 2.4 2.7 1.2 19.6 1.8 0.8 2.2 3.0 4.3 0.0 0.7 0.8 1.7 6.7 1.6 0.0 0.0 0.9 0.1 0.0 0.0 1.1 2.4 0.4 0.8 0.1 1.5 3.7 0.7 6.1 66.1 3.4 5.5 0.1 0.1 0.0 0.3 2.0 22.4 3.3 1.0 0.2 10.1 0.1 0.3 0.0 1.2 0.0 2.2 0.4 1.2 5.0 0.1 6.7 0.5 7.9 0.3 0.0 15.0 0.1 6.0 0.1 0.0 4.2 7.5 0.0 9.1 0.0 0.2 0.9 1.3 2.3 1.2 0.2 2.3 0.0 0.3 0.7 0.0 0.8 1.0 28.0 2.1 17.6 21.2 0.0 0.0 0.0 91.7 2.4 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 16.4 46.8 2.1 10.9 9.0 11.2 2.5 5.0 2.6 4.3 0.0 0.3 0.0 1.8 21.8 3.8 0.8 2.5 0.0 1.2 8.7 0.0 0.1 0.0 3.3 0.1 0.1 0.0 0.0 0.3 0.1 2.9 1.6 0.0 2.6 4.0 1.6 7.5 1.3 0.3 0.2 7.8 4.5 0.0 1.8 0.2 57.5 0.7 0.0 0.0 0.0 2.7 0.0 2.3 0.1 0.4 9.3 0.2 0.0 0.0 2.0 TMEM159 promethin ENSG00000011638 "Transmembrane protein 159" Q96B96 16 21158377-21180616 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 107.6;Suprabasal keratinocytes: 131.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basal ganglia: 14.6;cerebellum: 13.7" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018033, HPA063509" Approved Approved Vesicles NA NA Vesicles "HPA018033: AB_2204762, HPA063509: AB_2685026" "unprognostic (7.62e-3)" "unprognostic (2.42e-1)" "unprognostic (1.99e-2)" "unprognostic (1.06e-1)" "unprognostic (8.68e-2)" "unprognostic (6.80e-2)" "unprognostic (3.32e-1)" "unprognostic (2.93e-1)" "unprognostic (3.35e-1)" "unprognostic (2.93e-3)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.03e-1)" "prognostic favorable (8.11e-5)" "unprognostic (8.28e-2)" "unprognostic (1.28e-1)" "unprognostic (1.84e-2)" "unprognostic (1.57e-2)" 35.6 12.7 2.2 6.0 14.6 1.8 27.4 13.7 2.8 25.3 13.5 1.0 10.1 2.7 28.3 9.8 37.1 8.4 23.9 32.4 1.4 1.6 11.3 1.2 10.7 7.6 1.2 1.6 22.0 6.1 5.6 1.2 5.3 1.7 29.7 6.4 10.9 35.2 7.9 57.5 32.5 7.3 45.5 1.5 3.6 7.9 10.9 1.4 6.1 17.4 35.5 21.9 43.7 21.1 11.4 11.3 12.2 8.6 7.5 13.1 7.3 5.9 2.8 3.1 11.3 29.4 18.9 1.6 2.7 12.0 1.2 2.3 2.1 8.2 7.8 3.2 9.0 5.5 9.0 5.1 4.6 1.3 3.5 1.8 3.6 1.0 4.0 6.8 2.8 9.6 7.0 24.0 6.6 21.3 4.8 6.7 4.4 2.5 2.4 2.1 10.5 2.1 2.1 2.7 5.0 1.7 11.2 1.6 2.9 14.8 17.9 0.4 0.4 7.6 10.4 3.5 6.1 17.2 2.1 4.7 1.7 2.2 9.5 0.7 0.2 0.6 2.5 8.5 2.5 1.9 12.2 8.6 8.0 10.1 5.9 8.7 11.4 13.1 8.6 5.0 9.2 9.6 8.8 3.9 7.5 7.1 11.3 13.0 7.3 2.2 14.6 13.7 2.8 1.4 1.6 1.2 1.6 1.7 1.4 8.9 18.1 0.5 34.8 107.6 0.5 54.1 12.7 4.0 22.7 21.0 0.0 3.4 6.6 16.7 0.5 15.3 21.3 0.0 18.5 1.9 18.8 41.3 15.1 0.0 9.7 1.6 13.9 9.2 11.9 0.0 62.5 15.3 28.7 26.2 28.8 23.3 18.9 40.7 35.0 16.3 1.8 32.3 32.3 2.2 6.1 131.2 1.6 10.1 27.2 56.7 TMEM160 FLJ20512 ENSG00000130748 "Transmembrane protein 160" Q9NX00 19 47045907-47048630 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 47.0;NB-4: 62.4;PC-3: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055904 Uncertain NA NA "HPA055904: AB_2682965" "unprognostic (2.45e-3)" "unprognostic (1.69e-1)" "unprognostic (4.49e-1)" "unprognostic (1.09e-2)" "unprognostic (3.71e-1)" "unprognostic (7.39e-2)" "unprognostic (3.60e-1)" "unprognostic (3.20e-2)" "unprognostic (6.58e-2)" "unprognostic (2.86e-1)" "unprognostic (8.21e-3)" "unprognostic (3.76e-2)" "unprognostic (1.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.03e-1)" "unprognostic (1.86e-2)" "unprognostic (1.37e-2)" 14.8 10.2 32.4 10.3 17.3 9.7 7.9 10.0 28.2 4.1 13.4 7.2 2.8 8.1 5.7 3.3 6.1 4.0 6.4 8.1 26.9 12.9 14.9 16.4 10.1 13.0 16.2 12.2 5.2 8.7 6.3 4.1 4.9 11.7 7.3 3.9 6.7 9.5 4.3 34.0 8.3 11.5 3.8 7.4 13.1 17.2 4.4 7.0 11.1 8.7 6.1 5.2 5.1 4.1 20.1 21.8 27.8 19.2 10.9 25.8 6.5 10.1 3.5 2.1 2.7 0.6 0.6 5.0 5.4 0.9 1.8 1.9 1.7 3.6 10.0 9.5 0.6 1.5 7.3 1.4 1.2 1.0 8.5 47.0 10.2 2.8 2.9 0.3 6.9 15.5 0.5 0.7 1.0 0.4 1.3 1.3 6.4 9.1 3.0 0.9 2.6 8.2 62.4 5.4 3.3 29.3 14.9 4.9 5.9 1.6 1.6 5.7 10.1 6.1 4.4 5.6 3.2 2.3 4.7 5.8 1.7 9.4 3.7 5.5 13.3 12.6 7.6 2.5 7.4 2.4 11.3 19.2 27.8 14.3 13.6 9.7 16.7 22.9 25.8 12.4 20.1 21.6 14.3 1.6 10.9 12.7 21.8 19.6 6.5 32.4 17.3 10.0 28.2 26.9 12.9 16.2 12.2 11.7 7.0 8.9 14.6 93.8 52.9 51.4 43.7 18.2 79.0 1.4 4.5 113.4 17.7 22.9 134.3 106.1 75.2 53.7 200.6 23.3 156.1 81.3 71.0 61.1 58.6 77.0 133.7 19.1 99.8 55.9 118.5 207.8 45.1 97.4 89.4 168.7 86.2 79.6 127.4 119.3 49.5 189.1 24.3 32.3 49.5 24.2 34.9 71.5 11.9 98.0 86.1 61.6 TMEM161A "FLJ20422, FLJ39645" ENSG00000064545 "Transmembrane protein 161A" Q9NX61 19 19119169-19138513 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043365 Approved Approved Cytosol NA NA Cytosol "HPA043365: AB_10796793" "unprognostic (4.31e-2)" "unprognostic (9.13e-2)" "unprognostic (2.34e-2)" "unprognostic (7.42e-3)" "unprognostic (6.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-2)" "unprognostic (3.51e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (9.42e-2)" "unprognostic (2.46e-1)" "unprognostic (9.15e-2)" "prognostic favorable (2.99e-4)" "unprognostic (4.18e-1)" "unprognostic (2.79e-1)" "unprognostic (4.89e-3)" 10.4 18.3 10.6 9.2 13.5 8.1 10.3 12.8 11.7 12.2 10.5 9.8 15.8 10.0 17.2 8.6 11.7 12.4 15.5 12.7 8.6 6.9 12.7 21.1 9.1 12.1 13.4 8.4 14.2 18.6 17.3 6.6 6.4 9.9 12.8 5.3 12.7 17.1 13.6 34.5 13.5 9.1 9.9 7.8 8.8 10.6 5.3 11.6 15.0 20.8 13.8 9.1 10.8 12.6 6.8 23.5 1.5 7.2 6.7 13.5 5.4 16.1 11.3 6.4 13.8 13.9 9.3 10.2 6.8 8.4 8.5 11.2 9.5 20.2 14.1 33.6 5.1 5.8 13.1 10.3 15.8 5.6 6.4 37.5 5.4 6.2 12.8 18.5 7.1 9.0 14.5 13.3 8.4 12.5 8.1 9.4 17.2 18.0 17.1 5.9 19.5 10.3 15.0 6.1 18.7 18.6 16.5 5.4 28.0 6.5 6.6 8.7 8.8 10.3 13.1 8.3 4.7 10.5 12.7 5.5 7.9 3.9 17.7 12.7 15.9 9.9 8.4 8.7 14.7 11.4 1.5 7.2 1.4 10.0 6.3 8.8 5.7 9.1 8.1 10.1 6.8 10.8 9.1 0.8 6.7 6.3 23.5 13.5 5.4 10.6 13.5 12.8 11.7 8.6 6.9 13.4 8.4 9.9 11.6 6.0 16.5 7.3 11.6 5.5 15.3 6.9 25.5 6.7 7.9 10.4 9.8 16.1 6.6 17.7 0.7 9.4 6.3 0.0 11.1 12.3 9.1 11.9 16.1 20.4 14.0 15.9 5.2 9.8 9.1 0.5 10.9 6.7 11.8 5.4 8.4 18.1 11.0 3.5 16.6 25.9 13.1 12.9 13.3 7.9 9.8 7.5 10.3 10.0 16.6 6.7 TMEM161B MGC33214 ENSG00000164180 "Transmembrane protein 161B" Q8NDZ6 5 88189633-88269476 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 36.1;HMC-1: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044562 Uncertain NA NA "HPA044562: AB_10794291" "unprognostic (2.08e-1)" "unprognostic (6.02e-2)" "unprognostic (2.06e-2)" "unprognostic (5.64e-2)" "unprognostic (2.27e-1)" "unprognostic (1.05e-1)" "unprognostic (3.07e-2)" "unprognostic (1.12e-1)" "unprognostic (7.38e-2)" "unprognostic (1.18e-3)" "unprognostic (1.58e-1)" "unprognostic (1.01e-1)" "unprognostic (6.96e-3)" "unprognostic (1.55e-2)" "unprognostic (3.04e-1)" "unprognostic (7.62e-3)" "unprognostic (9.35e-2)" 9.7 11.7 10.5 13.0 12.8 6.7 19.2 34.0 14.7 10.4 12.2 10.4 13.5 14.6 15.4 17.6 13.9 10.6 7.2 10.0 10.8 10.3 13.4 14.5 11.9 10.0 11.1 10.7 13.8 16.2 29.5 24.0 15.3 10.9 15.0 13.8 9.6 15.9 11.4 15.4 17.9 17.2 7.9 11.0 11.9 25.1 16.1 13.6 13.5 24.8 9.7 13.2 11.2 11.8 4.8 5.2 2.8 5.7 5.6 6.3 2.3 5.3 3.6 4.1 4.4 2.6 4.9 8.5 4.6 7.0 6.9 10.2 4.1 14.1 8.1 2.5 3.5 12.6 5.6 4.6 6.1 8.8 7.2 5.1 36.1 4.5 2.6 6.8 7.2 39.4 4.5 8.9 5.9 8.6 5.0 3.0 5.6 17.4 7.5 6.0 2.6 5.1 6.0 2.5 3.8 6.7 4.4 4.8 8.9 6.2 7.5 5.2 4.4 2.8 7.5 10.9 3.8 4.6 6.2 2.5 4.4 4.0 6.5 8.6 9.5 14.8 6.8 10.8 7.0 6.3 2.8 3.0 1.9 6.3 5.7 6.1 4.8 5.4 4.6 1.6 4.8 5.5 4.1 1.7 5.6 2.0 5.2 4.3 2.3 10.5 12.8 34.0 14.7 10.8 10.3 11.1 10.7 10.9 13.6 26.8 16.0 17.1 6.6 6.9 14.7 14.1 12.7 8.1 13.6 8.7 15.7 6.8 3.3 7.6 2.2 5.9 11.9 0.0 8.3 3.3 4.9 6.8 16.1 20.7 4.5 6.4 13.7 15.4 9.7 1.5 9.8 7.7 0.0 4.6 12.8 17.5 9.0 5.8 12.0 3.7 19.3 6.5 3.6 32.1 8.1 6.1 12.6 10.2 13.9 6.2 TMEM163 "DKFZP566N034, SV31" ENSG00000152128 "Transmembrane protein 163" Q8TC26 2 134455759-134719000 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.8;pancreas: 19.7" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 28.8;Exocrine glandular cells: 26.7;Pancreatic endocrine cells: 11.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.6;NK-cells: 2.0;T-cells: 2.5" "Cell line enhanced" "Detected in some" "HEL: 10.7;RPTEC TERT1: 37.0;SCLC-21H: 16.8;U-937: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007224 Uncertain NA NA "HPA007224: AB_2667780" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (7.25e-3)" "unprognostic (3.18e-1)" "unprognostic (1.47e-1)" "unprognostic (2.25e-1)" "unprognostic (6.08e-3)" "prognostic favorable (7.94e-4)" "unprognostic (9.05e-2)" "unprognostic (9.62e-2)" "unprognostic (6.02e-2)" "unprognostic (2.04e-1)" "unprognostic (2.60e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" "unprognostic (6.75e-3)" "prognostic favorable (3.15e-4)" 3.8 6.4 8.1 5.4 5.7 0.5 1.5 31.8 13.4 0.5 0.8 5.8 0.0 0.9 0.8 0.7 0.4 3.4 10.4 7.2 9.1 13.7 1.8 1.7 16.4 10.9 6.9 3.8 1.2 19.7 0.4 11.2 4.2 14.8 0.5 0.9 2.6 3.5 0.5 0.6 0.4 0.8 0.7 13.9 1.9 8.3 6.9 5.0 0.0 1.3 0.0 17.4 9.9 0.3 1.6 0.3 0.1 0.0 2.0 2.5 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 3.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2.9 0.5 1.2 0.0 0.0 0.0 37.0 5.4 16.8 0.6 0.0 0.0 0.9 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.8 0.9 0.0 0.0 0.0 6.7 0.7 0.0 0.0 0.0 1.3 0.0 1.7 1.6 0.5 2.4 0.3 0.6 0.1 0.5 0.1 2.0 0.0 0.0 2.5 0.8 8.1 5.7 31.8 9.7 9.1 13.7 6.9 3.8 14.8 5.0 3.0 28.8 0.0 0.0 0.0 2.0 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 6.6 3.5 0.3 0.0 0.0 26.7 0.2 0.3 0.0 0.0 0.0 4.0 1.6 0.0 0.0 1.0 1.8 0.0 1.3 0.0 4.6 0.1 1.0 11.4 0.0 0.4 0.1 4.0 0.0 0.3 1.5 0.2 0.4 0.1 0.0 0.0 0.5 TMEM164 "FLJ22679, RP13-360B22.2" ENSG00000157600 "Transmembrane protein 164" Q5U3C3 X 110002631-110182734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 69.7" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 25.9;eosinophil: 7.2;neutrophil: 8.8" "Lineage enriched" "Detected in many" 15 "granulocytes: 25.9" "Cell line enhanced" "Detected in all" "HMC-1: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038784 Approved Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA038784: AB_10670790" "unprognostic (2.14e-3)" "unprognostic (3.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.65e-3)" "unprognostic (7.94e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (8.17e-6)" "unprognostic (9.85e-3)" "unprognostic (5.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-2)" "unprognostic (3.95e-1)" "unprognostic (7.66e-2)" "prognostic favorable (3.14e-4)" "unprognostic (1.76e-1)" "unprognostic (1.81e-2)" "unprognostic (4.19e-3)" 15.0 8.6 9.2 6.1 10.9 11.1 9.2 2.6 6.8 3.9 17.0 6.0 36.3 14.5 4.5 4.1 10.5 5.5 8.8 14.7 6.6 5.9 8.4 1.7 35.8 7.6 4.6 3.5 11.9 17.2 11.1 8.7 6.6 7.0 6.2 14.8 18.7 7.6 69.7 32.0 15.2 33.1 4.6 2.9 6.9 9.9 2.2 5.1 4.5 11.4 6.0 5.8 5.0 5.1 0.4 1.4 25.9 1.7 1.1 0.9 0.8 4.8 11.1 9.1 5.9 11.3 8.3 5.5 2.4 5.7 5.2 3.3 8.6 7.6 3.8 16.5 3.7 12.7 7.1 7.9 12.8 5.1 10.6 5.4 26.3 6.0 3.6 6.7 11.5 37.6 11.5 22.6 9.3 12.9 14.2 10.0 7.0 8.1 4.7 9.1 9.7 12.0 14.7 8.1 16.6 8.0 5.5 7.0 3.2 8.2 5.1 8.5 9.5 15.5 15.3 7.1 8.8 4.4 11.5 22.3 4.4 3.2 5.1 3.4 2.8 3.4 3.1 11.5 14.5 11.6 25.9 1.7 7.2 0.3 1.5 0.9 0.1 0.4 0.3 1.4 0.4 0.2 0.3 8.8 1.1 0.9 0.2 0.5 0.8 9.2 10.9 2.6 6.8 6.6 5.9 4.6 3.5 7.0 5.1 3.0 26.0 3.2 3.3 4.2 0.2 19.7 10.2 1.4 6.8 15.7 2.0 1.9 3.3 4.0 0.3 5.2 32.2 0.0 9.9 4.7 3.4 7.9 3.5 1.5 12.0 0.0 26.6 6.2 25.0 0.5 1.7 5.8 1.7 21.6 12.9 0.8 9.8 14.4 1.4 3.0 0.9 0.0 3.1 0.2 0.0 6.9 2.3 4.3 17.8 6.4 TMEM165 "GDT1, TMPT27, TPARL" ENSG00000134851 "Transmembrane protein 165" Q9HC07 4 55395957-55453397 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Urothelial cells: 421.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038299, HPA062424" Supported Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA038299: AB_10675793, HPA062424: AB_2732682" "unprognostic (2.53e-2)" "unprognostic (1.08e-3)" "unprognostic (3.46e-3)" "unprognostic (7.07e-3)" "unprognostic (5.97e-2)" "unprognostic (9.84e-2)" "prognostic unfavorable (2.08e-5)" "unprognostic (1.41e-1)" "unprognostic (1.18e-2)" "unprognostic (8.00e-3)" "unprognostic (1.55e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.18e-8)" "unprognostic (9.05e-2)" "unprognostic (8.96e-2)" "unprognostic (2.72e-1)" "unprognostic (2.18e-2)" 28.5 37.6 19.4 25.6 49.0 6.0 27.3 11.3 26.1 31.1 20.0 54.4 17.6 19.8 22.4 20.7 33.0 19.1 29.4 23.9 29.1 20.0 26.7 11.9 30.4 22.3 65.8 16.2 14.0 23.6 22.9 14.9 37.6 33.1 24.9 21.6 15.7 25.5 20.8 9.9 16.2 16.0 25.0 50.5 22.6 23.8 8.4 49.4 14.4 24.3 16.5 25.5 34.0 23.2 11.3 22.8 17.6 24.8 11.3 11.8 17.8 18.8 7.9 12.5 13.2 39.0 28.9 13.3 36.1 55.8 26.1 28.7 8.8 28.3 19.7 26.3 22.2 15.0 14.0 13.1 14.8 26.6 11.1 12.1 16.8 14.1 16.9 24.3 23.1 20.0 29.6 19.3 14.9 10.0 22.1 29.7 6.6 28.3 12.6 30.6 13.8 18.2 19.4 13.6 25.0 18.6 13.2 9.4 10.6 39.2 18.1 12.9 17.3 18.1 68.9 21.5 12.9 10.8 16.7 25.5 22.3 13.3 9.8 26.1 11.8 9.5 12.1 26.5 19.7 17.8 12.7 24.8 15.5 9.9 20.9 11.3 11.3 9.6 11.8 22.8 7.8 8.2 9.8 17.6 11.3 20.5 17.5 10.8 17.8 19.4 49.0 11.3 26.1 29.1 20.0 65.8 16.2 33.1 49.4 50.6 44.9 77.0 225.4 217.7 52.2 28.4 71.4 24.1 36.4 75.0 76.6 95.8 14.9 148.1 29.0 90.3 40.6 46.7 143.8 136.2 133.6 205.0 20.7 16.1 94.9 27.0 48.4 110.5 75.9 17.9 54.4 126.9 84.4 71.3 52.4 71.5 188.4 45.6 59.8 43.2 75.4 97.0 160.3 38.1 23.7 234.9 67.4 84.1 48.5 421.9 TMEM167A "FLJ30508, MGC23909, TMEM167" ENSG00000174695 "Transmembrane protein 167A" Q8TBQ9 5 83052846-83077863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077278 Approved Vesicles NA NA Vesicles "HPA077278: " "unprognostic (5.38e-3)" "unprognostic (2.84e-3)" "unprognostic (3.78e-2)" "unprognostic (4.40e-2)" "unprognostic (1.66e-1)" "unprognostic (3.34e-1)" "unprognostic (4.06e-3)" "unprognostic (7.74e-2)" "unprognostic (9.94e-3)" "unprognostic (3.99e-3)" "unprognostic (2.72e-1)" "unprognostic (4.09e-2)" "unprognostic (2.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.51e-1)" "unprognostic (1.13e-3)" "unprognostic (1.29e-2)" 22.9 38.0 29.3 20.9 31.3 19.8 23.2 24.2 32.8 24.9 18.8 21.8 12.2 20.5 16.9 20.6 16.7 13.1 21.2 21.8 27.8 28.4 26.2 25.3 21.4 16.3 32.9 20.9 12.9 23.6 22.2 32.9 26.1 35.5 18.0 22.8 15.2 21.3 15.9 15.6 16.1 19.7 17.3 26.7 18.2 17.5 9.7 25.3 22.8 22.2 16.1 17.5 18.4 14.3 2.9 8.4 13.2 15.6 3.9 4.3 6.8 13.1 8.0 30.2 26.8 44.6 31.2 27.7 20.8 16.3 13.5 17.8 12.1 17.1 8.4 13.1 24.6 18.2 11.1 20.1 27.0 22.5 11.6 12.4 22.7 15.0 18.6 17.5 11.6 14.9 24.3 19.1 17.4 16.4 22.1 16.6 12.7 12.5 17.1 19.8 11.5 14.2 12.8 31.2 6.9 13.7 12.7 19.4 23.2 19.0 10.5 14.3 18.7 13.9 14.7 20.6 28.9 26.5 27.5 22.5 8.5 8.4 24.5 18.6 10.0 27.8 8.5 15.7 21.1 20.1 13.2 15.0 6.8 2.6 14.2 3.0 2.9 3.6 3.2 8.4 2.4 3.9 3.0 8.8 3.9 15.6 4.0 4.3 6.8 29.3 31.3 24.2 32.8 27.8 28.4 32.9 20.9 35.5 25.3 32.8 22.1 57.6 46.9 42.6 42.8 42.8 76.5 28.1 26.1 47.1 39.3 88.2 144.2 76.0 12.3 56.7 80.5 0.0 105.9 256.8 99.2 99.3 32.3 96.2 144.4 31.8 48.8 49.7 208.1 14.6 43.7 117.7 89.4 108.2 77.1 46.8 108.0 74.8 46.7 173.3 28.5 32.3 52.7 47.3 64.5 58.7 150.0 55.8 58.1 92.4 TMEM167B "AD-020, C1orf119, FLJ90710" ENSG00000215717 "Transmembrane protein 167B" Q9NRX6 1 109089803-109096934 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.89e-2)" "unprognostic (3.28e-1)" "unprognostic (4.96e-2)" "prognostic favorable (8.86e-4)" "unprognostic (3.76e-1)" "unprognostic (1.19e-1)" "unprognostic (1.41e-3)" "unprognostic (2.37e-2)" "unprognostic (1.28e-1)" "unprognostic (7.20e-2)" "unprognostic (1.74e-1)" "unprognostic (3.01e-1)" "unprognostic (3.21e-2)" "unprognostic (1.43e-1)" "unprognostic (1.94e-1)" "unprognostic (1.15e-2)" "unprognostic (2.25e-1)" 8.4 10.7 9.0 5.6 10.4 12.4 9.3 7.5 8.6 9.4 7.2 5.7 8.3 9.4 6.4 6.5 6.5 9.3 8.5 8.8 9.0 8.7 8.2 5.9 8.5 8.1 7.1 10.5 7.0 8.7 10.7 7.9 7.6 8.0 8.6 10.3 5.9 7.8 8.9 6.9 8.3 5.6 11.7 6.6 7.5 6.7 7.5 9.3 25.4 13.7 8.4 9.9 8.9 13.3 2.6 8.7 12.4 18.2 18.2 7.8 19.8 18.4 11.6 10.8 5.0 5.8 8.8 11.4 20.0 6.8 6.9 5.5 9.0 16.4 13.2 4.6 8.0 3.7 7.0 21.0 15.4 14.0 14.6 25.0 10.4 17.5 15.8 9.9 11.4 9.9 12.6 12.2 8.4 11.3 10.8 6.8 11.3 12.8 7.4 13.7 6.7 15.1 8.6 6.7 6.8 9.7 14.3 19.4 8.2 10.6 12.3 9.3 12.0 12.0 25.2 9.6 12.7 7.4 8.6 19.5 16.5 24.1 16.9 10.2 17.3 7.1 11.4 9.9 7.5 9.4 8.7 9.3 7.3 9.9 9.6 25.4 8.4 13.7 6.1 8.6 8.9 29.8 28.9 20.0 26.3 27.1 29.9 31.7 22.9 14.7 22.7 17.4 11.8 34.1 16.6 23.2 13.5 22.0 18.8 0.0 26.2 29.6 31.0 39.7 31.2 15.3 35.1 23.8 20.1 26.4 35.2 11.7 26.7 39.4 25.3 47.7 24.0 28.7 23.3 20.1 23.7 24.2 26.0 0.0 30.9 26.3 26.2 31.1 52.7 34.6 16.4 36.1 TMEM168 "DKFZp564C012, FLJ13576" ENSG00000146802 "Transmembrane protein 168" Q9H0V1 7 112762382-112790592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020389, HPA077143" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA020389: AB_1858101, HPA077143: " "unprognostic (1.54e-1)" "unprognostic (2.23e-1)" "unprognostic (2.55e-1)" "unprognostic (4.92e-1)" "unprognostic (1.72e-1)" "unprognostic (3.32e-2)" "unprognostic (2.30e-3)" "prognostic favorable (4.07e-6)" "unprognostic (1.60e-3)" "unprognostic (8.73e-2)" "unprognostic (3.07e-3)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.47e-1)" "unprognostic (1.84e-1)" "unprognostic (4.89e-3)" "unprognostic (3.30e-2)" 14.4 14.9 9.0 11.4 14.6 5.6 15.4 6.9 15.7 15.7 21.2 17.9 17.6 13.2 17.4 18.3 19.1 15.0 12.1 18.9 11.8 8.2 18.8 11.8 13.5 21.3 12.6 7.8 17.5 9.9 28.2 12.7 26.3 15.5 16.6 24.3 18.4 19.6 14.5 11.0 25.5 18.4 19.7 15.7 16.4 14.3 13.9 12.4 17.8 17.5 12.6 17.4 14.7 16.9 15.4 17.9 16.5 16.9 13.7 22.4 10.0 9.2 7.9 7.4 6.7 12.8 26.2 10.5 10.4 9.8 3.9 3.4 10.0 9.9 9.9 7.0 10.2 8.9 10.1 7.5 9.0 10.2 15.5 7.7 8.4 9.8 5.7 8.6 9.5 11.0 12.7 23.5 4.5 6.7 3.7 11.4 8.0 11.5 9.1 14.1 14.9 8.2 6.0 6.0 9.8 6.1 5.5 3.7 14.4 9.8 17.8 5.6 11.0 13.6 18.6 7.9 9.5 10.4 8.5 16.2 18.9 9.6 8.7 13.3 15.6 13.2 11.2 12.2 8.4 23.7 16.5 16.9 12.5 14.2 13.7 16.9 12.4 15.3 13.8 17.9 15.4 22.4 15.5 9.4 13.7 13.5 12.2 13.7 10.0 9.0 14.6 6.9 15.7 11.8 8.2 12.6 7.8 15.5 12.4 11.9 18.2 6.4 16.7 27.6 30.5 13.7 10.2 2.7 22.7 31.4 25.5 25.1 0.0 5.4 1.5 13.4 13.1 0.0 7.8 7.0 13.4 17.7 11.5 11.1 7.7 15.9 19.8 18.4 8.9 1.5 17.0 9.4 23.6 1.8 33.2 19.0 4.6 7.0 13.8 7.1 28.6 6.5 8.5 16.2 12.1 22.7 11.9 11.4 26.4 11.9 TMEM169 FLJ34263 ENSG00000163449 "Transmembrane protein 169" Q96HH4 2 216081866-216102783 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 14.3;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.4;LHCN-M2: 6.9;RPTEC TERT1: 12.5;SCLC-21H: 10.7;SH-SY5Y: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062462, HPA062797, HPA070657, HPA074877" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: " "unprognostic (5.15e-2)" "unprognostic (2.93e-1)" "unprognostic (7.87e-3)" "unprognostic (4.69e-7)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (1.97e-1)" "unprognostic (4.43e-1)" "unprognostic (7.16e-2)" "unprognostic (5.72e-2)" "unprognostic (1.00e-1)" "unprognostic (1.35e-1)" "unprognostic (2.79e-2)" "unprognostic (7.51e-3)" "unprognostic (4.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.02e-1)" 1.7 2.9 5.9 2.5 6.2 1.3 0.9 9.7 16.8 2.1 1.3 3.9 1.6 1.9 1.1 1.9 0.9 2.9 2.5 1.1 5.5 6.3 4.9 4.2 2.1 2.4 5.5 4.8 1.1 1.0 0.8 2.4 0.7 9.1 1.4 1.2 4.9 0.9 1.1 1.5 1.6 1.7 1.2 6.6 2.6 1.0 1.3 2.5 0.7 6.7 0.0 2.0 1.1 0.7 3.0 0.2 4.3 5.7 0.7 6.3 1.3 0.1 0.4 8.4 0.2 1.0 0.1 0.0 0.3 0.2 0.2 0.8 0.4 2.5 0.1 6.3 0.4 0.5 0.2 1.1 0.0 0.2 1.2 0.4 2.7 0.1 1.5 1.8 0.2 0.6 0.6 0.6 0.6 0.8 2.0 0.0 0.9 0.0 0.4 6.9 0.7 0.2 0.3 4.4 0.0 0.1 1.5 2.5 0.2 12.5 0.0 10.7 15.4 0.3 0.2 6.1 4.2 0.4 1.1 0.1 0.2 0.5 0.2 0.4 1.9 2.0 0.4 1.9 0.2 1.6 1.3 1.8 0.3 2.3 1.5 1.7 2.4 4.0 2.7 0.0 3.0 4.2 1.9 4.3 0.7 5.7 0.2 6.3 1.3 5.9 6.2 9.7 11.5 5.5 6.3 5.5 4.8 9.1 2.5 0.0 0.0 0.5 0.0 0.0 14.3 0.6 5.1 0.0 0.0 5.2 21.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 4.7 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.4 2.4 11.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 TMEM17 FLJ34583 ENSG00000186889 "Transmembrane protein 17" Q86X19 2 62500221-62511894 "Predicted membrane proteins, Transporters" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 29.4;Spermatocytes: 36.9;Spermatogonia: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018100 Uncertain Approved "Actin filaments" NA NA "Actin filaments" "HPA018100: AB_2240686" "unprognostic (8.09e-2)" "unprognostic (8.43e-2)" "unprognostic (2.11e-1)" "unprognostic (1.14e-1)" "unprognostic (5.02e-3)" "unprognostic (3.78e-1)" "unprognostic (1.87e-4)" "unprognostic (1.21e-1)" "unprognostic (1.47e-1)" "unprognostic (3.44e-2)" "unprognostic (2.26e-1)" "unprognostic (2.36e-1)" "unprognostic (7.68e-3)" "unprognostic (1.11e-2)" "unprognostic (3.06e-2)" "unprognostic (3.62e-1)" "unprognostic (1.49e-6)" 3.3 8.2 6.1 1.0 10.8 0.9 3.7 2.2 10.1 3.0 1.7 4.3 1.5 1.5 3.5 2.9 4.1 6.7 4.4 3.2 13.5 14.6 6.7 3.4 2.6 1.2 6.0 8.2 5.1 6.8 7.6 10.2 2.5 9.3 3.9 1.2 4.1 3.3 3.3 2.5 3.5 1.1 2.4 4.5 1.0 1.9 7.0 4.4 0.9 7.1 1.3 1.6 2.2 1.7 0.3 5.5 1.5 0.7 0.9 0.9 1.0 3.9 5.2 5.5 2.1 2.9 3.6 3.5 2.9 2.7 2.4 2.4 0.4 7.0 0.0 3.9 3.9 7.9 3.8 2.4 1.6 1.8 3.7 1.7 1.8 2.2 0.4 4.2 2.5 2.5 3.3 4.6 2.0 4.6 3.9 3.1 0.4 1.6 0.2 6.0 1.0 0.4 0.6 2.8 3.3 3.3 0.3 0.7 0.3 4.9 1.1 1.4 4.8 3.0 1.2 10.1 2.0 1.7 3.4 1.9 4.8 2.7 5.7 2.9 0.6 0.1 0.0 6.9 0.4 9.6 0.9 0.7 0.1 0.2 0.2 0.0 0.1 0.1 0.1 1.6 0.3 0.1 0.9 1.5 0.9 0.2 5.5 0.1 1.0 6.1 10.8 2.2 10.1 13.5 14.6 6.0 8.2 9.3 4.4 3.0 2.6 0.0 2.3 4.4 6.6 2.2 7.6 29.4 9.1 5.2 7.9 1.9 0.0 4.3 2.4 1.9 0.0 0.0 7.5 1.7 3.5 0.8 1.1 1.8 2.1 9.5 1.2 5.5 1.2 2.1 4.4 0.3 3.3 1.0 0.6 9.0 6.6 0.0 3.5 2.1 3.7 6.5 0.8 36.9 19.6 2.5 0.3 0.0 0.9 0.9 TMEM170A "FLJ37611, TMEM170" ENSG00000166822 "Transmembrane protein 170A" Q8WVE7 16 75443054-75465497 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (3.49e-1)" "unprognostic (1.18e-1)" "unprognostic (2.95e-2)" "unprognostic (1.52e-3)" "unprognostic (1.08e-1)" "unprognostic (3.33e-2)" "unprognostic (1.02e-2)" "unprognostic (8.62e-2)" "unprognostic (7.97e-2)" "unprognostic (3.19e-2)" "unprognostic (1.53e-1)" "unprognostic (7.15e-2)" "prognostic favorable (2.36e-9)" "unprognostic (4.37e-2)" "unprognostic (3.41e-1)" "unprognostic (7.80e-2)" "unprognostic (1.53e-3)" 10.2 12.6 14.8 14.1 18.1 39.9 16.2 11.5 14.7 10.0 16.3 18.9 11.3 20.5 11.3 8.5 10.8 10.5 10.5 8.7 15.1 13.6 10.6 15.2 10.1 15.2 20.5 9.2 13.8 12.5 5.5 11.8 18.8 17.3 9.9 15.0 13.3 8.5 8.5 4.7 9.4 20.4 8.8 23.7 13.2 10.3 20.1 18.7 10.7 14.4 4.2 12.9 9.9 10.0 22.8 20.6 28.5 22.9 18.2 29.6 16.6 7.4 8.9 13.1 11.9 6.4 4.7 22.6 4.8 3.5 5.1 7.3 18.8 15.9 11.7 9.3 2.7 8.8 13.3 12.5 4.9 9.0 6.8 7.3 6.3 7.4 12.3 4.4 15.6 16.6 3.3 3.9 8.0 6.5 4.8 4.5 13.3 12.1 7.4 2.6 15.2 12.9 11.0 16.8 9.6 4.9 24.5 4.8 8.8 2.9 10.0 8.1 7.9 13.0 3.6 6.3 15.2 4.8 6.8 5.3 7.3 10.8 5.3 5.3 6.8 8.1 33.1 5.6 8.7 7.0 9.8 21.0 28.5 22.3 22.9 29.6 22.8 23.7 25.0 18.5 22.2 25.5 22.4 25.7 18.2 20.0 20.6 17.1 16.6 14.8 18.1 11.5 12.1 15.1 13.6 20.5 9.2 17.3 18.7 17.9 12.9 30.3 37.5 17.6 23.1 7.3 35.7 16.0 11.4 19.2 35.3 64.3 21.6 23.8 21.8 31.7 60.4 0.0 16.9 42.8 23.4 49.1 28.8 21.2 33.1 35.0 32.7 31.3 23.8 5.0 22.5 28.6 20.3 39.7 36.9 40.4 19.0 58.5 20.1 23.4 36.2 32.3 20.6 57.5 54.9 17.6 44.6 39.5 49.0 54.2 TMEM170B ENSG00000205269 "Transmembrane protein 170B" Q5T4T1 6 11538278-11583524 "Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 31.1" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 23.8;Kupffer cells: 40.6;Macrophages: 21.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 9 "dendritic cells: 3.2;granulocytes: 2.4;monocytes: 2.9" "Cell line enhanced" "Detected in many" "THP-1: 18.2;U-937: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055134 Uncertain Approved Centrosome NA NA Centrosome "HPA055134: AB_2682709" "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" "unprognostic (2.71e-4)" "unprognostic (6.67e-2)" "unprognostic (2.51e-1)" "unprognostic (2.43e-1)" "unprognostic (4.62e-3)" "unprognostic (8.22e-2)" "unprognostic (6.82e-2)" "unprognostic (2.45e-5)" "unprognostic (3.49e-1)" "unprognostic (1.26e-1)" "unprognostic (4.27e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-4)" "unprognostic (3.97e-2)" 10.1 4.8 11.7 6.4 9.6 31.1 6.1 13.5 18.6 3.1 3.3 4.9 2.0 1.6 4.1 5.2 2.5 2.8 3.0 4.5 10.1 8.8 5.9 12.8 8.8 3.5 8.3 8.7 3.9 3.3 5.8 4.2 4.0 8.4 3.4 2.2 4.2 2.5 3.7 8.3 1.8 2.0 4.7 8.2 5.7 2.4 5.2 6.0 4.2 4.4 1.2 2.2 2.7 3.1 0.2 3.2 2.4 2.9 0.1 0.3 0.5 0.7 1.2 7.5 6.7 1.4 0.1 1.5 0.6 1.7 1.0 1.2 0.4 0.4 5.9 3.4 0.4 1.9 0.0 8.4 0.5 2.7 1.6 4.3 3.3 0.8 1.0 0.5 5.3 3.5 0.5 0.1 1.1 0.0 1.7 0.7 5.6 0.2 0.1 1.5 1.1 6.3 9.2 2.1 0.7 1.0 3.2 7.2 0.9 0.8 1.5 5.1 4.4 0.4 2.4 2.7 11.2 2.4 18.2 0.1 1.4 1.6 2.8 1.7 5.2 10.4 5.3 1.2 13.6 1.8 2.4 2.9 1.5 0.2 1.6 0.1 0.0 0.1 0.1 1.8 0.2 0.3 0.2 1.1 0.1 0.6 3.2 0.0 0.5 11.7 9.6 13.5 13.5 10.1 8.8 8.3 8.7 8.4 6.0 3.0 1.3 0.5 0.7 1.5 12.0 5.2 2.5 0.0 2.3 0.0 3.9 1.8 5.0 0.6 0.4 1.4 0.0 0.0 1.2 0.3 2.3 1.0 1.1 5.8 6.6 23.8 1.7 1.8 40.6 0.2 0.9 21.8 0.0 1.0 0.5 11.8 0.9 0.0 1.4 4.5 8.4 6.5 1.2 5.4 4.6 0.6 1.6 1.7 0.6 0.4 TMEM171 PRP2 ENSG00000157111 "Transmembrane protein 171" Q8WVE6 5 73120292-73131817 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.2;intestine: 20.1;kidney: 25.4;stomach 1: 16.7;thyroid gland: 25.9" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 20.4;Enterocytes: 49.5;Paneth cells: 44.1;Undifferentiated cells: 49.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "MAIT T-cell: 18.2;memory CD8 T-cell: 6.3" "Lineage enriched" "Detected in single" 86 "T-cells: 18.2" "Cell line enhanced" "Detected in many" "LHCN-M2: 20.9;RPTEC TERT1: 16.0;WM-115: 58.5" "Region enriched" "Detected in single" 5 "hippocampal formation: 0.9" "Region enhanced" "Detected in single" "pons and medulla: 3.6" HPA042308 Approved NA NA "HPA042308: AB_10796901" "unprognostic (7.34e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (7.74e-3)" "unprognostic (2.81e-5)" "unprognostic (1.12e-1)" "unprognostic (1.40e-1)" "unprognostic (1.44e-3)" "unprognostic (1.77e-1)" "unprognostic (1.85e-1)" "unprognostic (4.20e-2)" "unprognostic (1.22e-1)" "prognostic favorable (3.93e-10)" "unprognostic (6.13e-3)" "unprognostic (2.43e-1)" "unprognostic (9.10e-3)" "unprognostic (1.57e-1)" 0.2 0.2 0.8 5.6 2.1 0.0 0.7 0.7 3.3 0.4 20.1 3.2 2.2 16.2 0.2 1.4 3.9 0.2 1.5 0.2 1.2 0.7 25.4 3.9 0.4 0.1 0.9 1.6 0.2 0.6 0.0 0.3 0.1 1.1 0.5 18.9 0.6 1.4 2.8 0.6 0.7 18.8 0.6 1.4 14.6 16.7 0.6 0.6 0.0 25.9 3.2 6.3 0.4 0.3 0.0 0.0 0.2 0.0 0.0 18.2 0.5 7.5 0.3 0.0 0.0 2.4 3.3 0.0 2.4 11.2 4.5 7.7 0.2 3.5 0.0 5.2 3.0 0.9 5.7 0.1 0.3 3.5 0.0 1.2 0.0 0.0 0.0 0.8 0.0 0.3 0.7 0.2 6.1 0.5 1.8 2.8 0.0 0.0 0.1 20.9 0.7 0.0 0.0 0.6 0.1 0.5 0.0 0.0 3.8 16.0 0.1 0.0 0.0 1.8 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.4 6.6 0.1 0.0 0.0 0.0 6.1 0.0 58.5 0.0 0.0 0.0 1.3 0.0 18.2 0.0 0.7 6.3 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.5 0.8 2.1 0.7 3.3 1.2 0.7 0.9 1.6 1.1 0.6 0.0 0.0 0.0 0.3 1.5 0.0 0.3 20.4 0.0 0.0 7.0 0.0 0.1 13.3 5.9 0.0 0.0 49.5 0.0 9.0 0.3 0.8 0.0 0.0 1.1 1.0 0.0 2.4 0.6 0.0 0.0 0.0 0.0 1.7 0.0 16.0 0.0 7.2 44.1 0.0 9.1 0.0 0.0 0.1 0.2 0.7 1.5 0.5 0.0 49.5 0.9 TMEM174 "FLJ31268, MGC13034" ENSG00000164325 "Transmembrane protein 174" Q8WUU8 5 73173195-73175143 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 282 "kidney: 61.5" "Cell type enriched" "Detected in some" 11 "Proximal tubular cells: 143.8" "Cancer enriched" "Detected in single" 126 "renal cancer: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.7;RPTEC TERT1: 1.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA037975 Enhanced NA NA "HPA037975: AB_10672732" "unprognostic (8.11e-2)" "prognostic favorable (3.30e-6)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM175 MGC4618 ENSG00000127419 "Transmembrane protein 175" Q9BSA9 4 932387-958656 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057160 Approved Approved "Nucleoplasm,Nuclear membrane" No No "Nucleoplasm, Nuclear membrane" "HPA057160: AB_2683356" "unprognostic (3.84e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-2)" "unprognostic (9.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (1.12e-2)" "unprognostic (3.25e-3)" "unprognostic (1.22e-2)" "unprognostic (1.50e-2)" "prognostic favorable (9.85e-5)" "unprognostic (4.71e-2)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.74e-1)" "unprognostic (1.96e-1)" "unprognostic (7.51e-3)" 17.2 22.9 20.5 13.5 24.0 17.8 12.2 29.0 27.6 17.4 10.8 23.5 16.8 13.6 13.4 14.9 13.4 12.9 16.0 13.3 18.4 19.8 11.7 24.2 14.1 21.9 16.9 25.4 9.3 26.3 18.7 26.4 11.8 20.4 15.0 6.2 17.1 26.8 16.8 14.5 25.8 12.4 10.4 17.2 18.7 14.8 11.8 17.9 13.0 19.7 9.2 12.0 16.2 9.6 13.8 29.3 16.9 23.4 9.5 13.6 11.8 3.3 6.1 3.5 4.8 17.0 8.9 8.2 8.2 6.0 5.0 7.5 2.8 13.4 2.5 5.1 8.6 8.8 5.5 3.2 6.5 2.2 6.2 7.5 5.2 9.0 2.8 9.8 2.7 9.7 12.6 7.9 4.5 3.0 3.6 3.1 5.4 5.2 20.9 4.4 10.9 6.9 11.2 2.2 3.9 17.2 4.8 2.1 7.2 4.8 3.2 9.6 8.5 5.7 3.6 5.4 1.8 16.0 7.5 4.1 9.3 2.1 10.7 6.3 14.2 3.7 4.9 9.0 6.0 7.5 16.9 19.8 15.5 13.6 23.4 9.1 12.5 11.7 10.1 17.2 13.8 8.4 11.9 16.4 9.5 21.6 29.3 11.0 11.8 20.5 24.0 29.0 27.6 18.4 19.8 16.9 25.4 20.4 17.9 11.9 9.9 12.9 8.5 5.6 24.5 8.7 5.1 4.0 5.7 14.0 3.9 21.7 1.7 7.4 4.4 8.2 12.4 0.0 10.0 9.3 12.7 8.2 6.9 23.8 13.5 44.5 15.5 8.6 15.3 3.2 11.5 11.0 18.6 4.6 8.1 43.7 8.0 14.4 15.2 6.7 25.4 12.9 9.5 22.3 10.2 6.8 15.8 13.1 7.0 5.4 TMEM176A "HCA112, MS4B1" ENSG00000002933 "Transmembrane protein 176A" Q96HP8 7 150800403-150805120 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 76.8;liver: 234.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 542.2;Hepatocytes: 864.2;monocytes: 525.8;Paneth cells: 691.0;Proximal tubular cells: 954.7" "Cancer enhanced" "Detected in all" "liver cancer: 210.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 38.4;intermediate monocyte: 27.1" "Lineage enriched" "Detected in many" 4 "monocytes: 38.4" "Cell line enriched" "Detected in some" 30 "HSkMC: 127.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008770 Approved Approved Mitochondria NA NA Mitochondria "HPA008770: AB_2256120" "unprognostic (4.70e-2)" "unprognostic (7.71e-2)" "unprognostic (5.71e-3)" "unprognostic (6.09e-2)" "unprognostic (3.96e-3)" "unprognostic (1.44e-2)" "unprognostic (2.51e-1)" "unprognostic (2.32e-1)" "unprognostic (4.19e-2)" "unprognostic (1.99e-1)" "unprognostic (1.47e-2)" "unprognostic (4.37e-2)" "unprognostic (4.79e-1)" "unprognostic (1.23e-2)" "unprognostic (1.98e-2)" "unprognostic (2.64e-1)" "unprognostic (4.91e-2)" 10.5 4.9 5.8 17.1 6.0 0.7 7.8 1.2 4.3 6.2 32.2 4.8 2.0 16.1 3.6 12.8 7.5 6.3 34.2 15.0 5.2 4.5 76.8 234.5 8.8 23.5 6.9 3.4 19.0 5.0 0.4 2.2 8.9 6.6 6.3 22.3 22.8 3.9 2.0 3.1 3.3 51.2 6.5 6.9 17.3 7.1 3.7 5.4 2.1 4.8 4.8 9.2 13.5 9.1 0.4 9.3 3.3 38.4 0.0 0.1 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 127.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 3.3 0.1 27.1 0.1 0.4 0.0 0.1 9.3 0.0 0.0 0.0 0.5 0.0 12.9 0.6 0.1 10.7 5.8 6.0 1.2 4.3 5.2 4.5 6.9 3.4 6.6 5.4 0.0 6.9 29.6 0.4 6.5 48.5 19.4 150.3 14.7 15.9 190.1 3.9 0.5 129.3 42.7 0.1 9.6 542.2 0.0 23.6 0.8 57.1 2.4 26.7 864.2 53.0 0.0 71.1 29.4 40.2 0.5 55.8 35.8 5.0 525.8 156.3 73.3 68.7 691.0 7.1 954.7 4.4 0.0 20.0 0.7 1.5 7.3 1.1 7.2 159.5 0.9 TMEM176B "LR8, MS4B2" ENSG00000106565 "Transmembrane protein 176B" Q3YBM2 7 150791285-150801360 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.3;liver: 247.9" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 572.0;Hepatocytes: 1056.4;monocytes: 841.4;Paneth cells: 725.5;Proximal tubular cells: 817.7" "Cancer enhanced" "Detected in all" "liver cancer: 537.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 92.3;intermediate monocyte: 68.0" "Lineage enriched" "Detected in many" 5 "monocytes: 92.3" "Group enriched" "Detected in some" 17 "HSkMC: 120.5;THP-1: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047509 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Nucleoplasm, Plasma membrane" "HPA047509: AB_2680072" "unprognostic (5.21e-2)" "unprognostic (7.86e-2)" "unprognostic (1.30e-2)" "unprognostic (8.27e-2)" "unprognostic (3.35e-2)" "unprognostic (6.96e-2)" "unprognostic (7.23e-2)" "unprognostic (2.74e-2)" "unprognostic (5.31e-2)" "unprognostic (1.47e-1)" "unprognostic (5.72e-3)" "unprognostic (7.50e-2)" "unprognostic (3.11e-3)" "unprognostic (5.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.53e-1)" "unprognostic (4.05e-2)" 13.9 5.5 7.8 19.8 10.7 1.1 11.7 2.1 6.3 8.6 27.6 5.7 2.0 18.3 3.8 15.2 9.6 9.0 50.2 26.8 7.6 5.2 62.9 247.9 11.2 22.9 10.5 3.3 20.3 6.8 0.3 3.2 12.5 8.4 6.1 27.9 22.0 5.1 3.2 2.5 4.2 53.1 10.7 13.2 23.5 10.6 5.2 8.7 4.3 4.9 7.0 10.5 14.7 11.6 0.2 20.0 5.7 92.3 0.0 0.4 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 120.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 38.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 92.3 5.7 0.2 68.0 0.4 0.2 0.0 0.0 20.0 0.0 0.0 0.0 1.1 0.0 36.2 0.9 0.0 42.0 7.8 10.7 2.1 6.3 7.6 5.2 10.5 3.3 8.4 8.7 3.0 12.4 33.9 0.5 11.2 135.3 52.1 175.8 12.0 19.4 355.9 2.0 0.8 140.9 63.8 13.3 17.2 572.0 0.0 29.9 1.1 82.5 3.5 52.1 1056.4 94.1 6.4 123.0 27.0 68.8 9.8 40.3 84.1 15.1 841.4 193.4 69.9 82.8 725.5 3.2 817.7 17.3 0.0 22.6 3.2 3.4 13.7 2.3 14.6 213.0 1.0 TMEM178A "MGC33926, TMEM178" ENSG00000152154 "Transmembrane protein 178A" Q8NBL3 2 39664982-39717963 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 87.4" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 12.2;Cone photoreceptor cells: 5.9;Intestinal endocrine cells: 15.4;Rod photoreceptor cells: 5.8" "Cancer enhanced" "Detected in many" "prostate cancer: 19.0" "Region enriched" "Detected in all" 5 "cerebellum: 87.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AF22: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052128 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA052128: AB_2681738" "unprognostic (3.35e-2)" "unprognostic (3.18e-1)" "unprognostic (5.94e-2)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (5.85e-2)" "unprognostic (3.24e-3)" "unprognostic (1.82e-3)" "unprognostic (2.22e-1)" "unprognostic (9.74e-2)" "unprognostic (5.11e-4)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.80e-3)" "unprognostic (3.46e-2)" "unprognostic (2.83e-2)" "unprognostic (3.01e-3)" 2.9 4.2 13.3 0.9 10.6 0.6 6.8 87.4 35.6 1.6 1.9 6.4 0.0 2.3 3.8 2.0 1.8 3.3 3.1 3.6 16.4 7.4 18.9 2.7 5.8 0.8 10.7 10.9 1.8 2.2 1.3 2.5 3.6 17.0 12.2 2.2 3.7 3.8 2.1 2.3 3.5 2.4 2.9 22.6 1.6 3.5 1.2 5.3 0.0 5.7 0.8 2.2 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 0.0 0.1 1.8 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.1 0.1 0.0 0.1 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 7.1 0.1 0.0 0.6 0.0 0.0 0.4 0.1 10.4 0.2 0.0 0.2 0.1 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 10.6 87.4 18.8 16.4 7.4 10.7 10.9 17.0 5.3 0.0 1.3 0.0 0.6 0.3 2.1 3.7 0.0 4.0 1.2 12.2 5.9 0.3 0.0 0.3 0.3 3.1 0.4 0.0 0.2 0.0 0.2 4.1 0.0 0.2 0.2 1.6 15.4 1.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.3 0.3 0.0 0.0 0.7 5.8 0.0 0.4 0.2 0.2 0.5 0.5 0.0 0.4 0.1 TMEM178B DKFZp547G036 ENSG00000261115 "Transmembrane protein 178B" H3BS89 7 141074232-141480380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 23.0;Cardiomyocytes: 39.1;Horizontal cells: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 7.1;HDLM-2: 6.4;NTERA-2: 6.0;RPTEC TERT1: 9.8;SCLC-21H: 7.7;WM-115: 10.4" HPA048771 Uncertain Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA048771: AB_2680517" "unprognostic (7.33e-3)" "unprognostic (2.02e-2)" "unprognostic (2.83e-2)" "unprognostic (7.79e-4)" "unprognostic (1.94e-1)" "unprognostic (1.49e-1)" "unprognostic (2.95e-1)" "unprognostic (1.69e-2)" "unprognostic (6.94e-2)" "unprognostic (2.21e-2)" "unprognostic (7.17e-4)" "unprognostic (1.05e-1)" "prognostic favorable (4.10e-4)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (5.35e-3)" "unprognostic (8.98e-2)" 0.9 1.7 5.2 0.7 7.4 0.1 0.7 3.2 13.4 0.5 0.8 1.0 2.3 0.1 1.1 0.6 1.8 0.3 0.7 11.6 4.8 5.8 2.9 0.6 0.4 1.5 4.9 1.0 0.2 2.6 20.6 18.5 0.1 1.8 2.8 0.4 0.5 4.4 0.8 4.5 0.2 1.2 1.3 2.4 0.8 0.5 0.8 0.4 1.0 9.5 0.1 3.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.6 0.3 1.8 0.1 2.8 0.8 1.0 0.0 0.0 2.2 2.4 0.2 0.5 0.0 7.1 0.0 2.3 6.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 5.1 0.1 0.0 0.0 6.0 0.0 0.0 0.4 1.1 3.0 9.8 2.8 7.7 4.7 0.1 0.3 1.0 1.5 1.0 0.0 0.0 0.1 1.2 3.2 0.0 0.1 0.0 0.0 0.5 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 7.4 3.2 9.6 4.8 5.8 4.9 1.0 1.8 0.4 0.0 0.0 0.0 0.4 0.5 23.0 39.1 0.0 0.0 0.0 1.8 2.0 0.0 1.7 0.0 0.8 0.1 0.0 0.0 0.3 0.0 0.2 3.1 0.0 0.0 0.1 28.6 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 3.8 1.2 0.0 0.7 2.8 1.6 0.0 0.8 0.5 0.7 0.1 0.2 0.0 0.0 1.6 TMEM179 "C14orf90, FLJ42486, TMEM179A" ENSG00000258986 "Transmembrane protein 179" Q6ZVK1 14 104474678-104605647 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 20.2;brain: 30.4;pituitary gland: 23.0" "Group enriched" "Detected in some" 12 "Bipolar cells: 41.7;Horizontal cells: 62.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 6.5;SCLC-21H: 28.3;SH-SY5Y: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002942 Uncertain Mitochondria NA NA Mitochondria "HPA002942: AB_1078113" "unprognostic (8.65e-2)" "unprognostic (8.24e-2)" "unprognostic (3.10e-2)" "unprognostic (1.29e-2)" "unprognostic (1.90e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (2.82e-3)" "unprognostic (1.09e-1)" "unprognostic (1.89e-4)" "unprognostic (8.68e-3)" "unprognostic (1.56e-1)" "unprognostic (9.71e-6)" "unprognostic (1.70e-2)" 1.1 20.2 11.8 1.5 18.9 0.9 0.9 10.3 30.4 1.0 1.8 3.4 0.0 1.4 1.0 1.6 1.1 1.1 1.1 1.2 12.4 21.7 1.0 1.1 0.9 0.9 13.7 7.2 1.0 4.8 1.0 23.0 2.3 8.3 1.4 1.4 2.2 1.1 1.3 1.0 1.0 1.8 1.4 6.1 0.9 1.8 3.1 4.5 0.0 1.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.3 8.9 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 18.9 10.3 16.7 12.4 21.7 13.7 7.2 8.3 4.5 0.0 0.0 0.0 0.0 0.0 41.7 1.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 62.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 4.3 0.0 0.1 0.6 3.2 0.0 0.0 0.0 0.0 0.0 TMEM179B ENSG00000185475 "Transmembrane protein 179B" Q7Z7N9 11 62787415-62790405 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016585, HPA062068" Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA016585: AB_1844357, HPA062068: AB_2684676" "unprognostic (1.18e-2)" "unprognostic (2.83e-1)" "unprognostic (2.20e-1)" "unprognostic (1.78e-2)" "unprognostic (1.68e-1)" "unprognostic (6.11e-3)" "unprognostic (1.96e-2)" "unprognostic (2.35e-1)" "unprognostic (2.44e-1)" "unprognostic (1.25e-2)" "unprognostic (4.61e-3)" "unprognostic (2.76e-2)" "unprognostic (4.56e-1)" "unprognostic (1.64e-1)" "unprognostic (2.16e-1)" "unprognostic (5.74e-3)" "unprognostic (3.60e-2)" 26.1 34.6 13.2 19.5 15.7 13.4 36.0 6.3 15.4 24.9 31.3 23.7 37.7 24.5 27.8 53.6 24.9 28.9 35.0 21.8 12.9 11.1 43.1 55.4 39.0 43.2 17.1 9.8 27.4 47.1 15.5 17.5 39.8 20.9 28.8 29.3 28.0 55.1 54.2 16.7 29.7 44.2 20.4 19.9 30.4 26.5 29.4 14.8 25.5 44.9 21.2 28.2 24.1 24.0 35.5 80.6 70.4 67.6 28.3 35.4 53.5 12.6 25.8 6.4 12.7 50.4 12.8 7.9 13.9 17.1 11.0 12.6 14.7 29.4 5.8 19.9 27.4 15.9 23.2 11.8 12.5 8.5 17.2 16.8 8.4 11.7 13.4 34.0 10.6 11.8 24.6 20.3 20.7 25.6 21.9 11.0 17.3 11.6 16.6 12.4 28.8 13.6 20.6 9.6 26.6 28.5 9.3 10.3 30.2 20.5 15.6 8.8 9.7 17.9 23.2 23.7 13.4 27.1 13.1 14.2 14.4 10.8 26.4 11.4 19.0 11.2 7.5 20.8 6.5 16.7 52.6 67.6 70.4 35.4 64.9 34.8 35.5 32.5 33.9 43.2 31.5 28.9 28.5 49.9 28.3 61.8 80.6 31.3 53.5 13.2 15.7 6.3 15.4 12.9 11.1 17.1 9.8 20.9 14.8 56.6 43.3 42.5 61.1 61.0 12.3 1.1 63.7 73.6 54.6 57.6 0.0 154.6 31.5 119.9 4.5 76.8 91.9 23.3 131.2 131.6 80.8 88.4 54.2 69.2 120.1 7.9 62.6 65.1 70.8 7.8 70.2 79.2 101.3 101.0 82.1 70.3 107.6 133.3 43.2 73.2 12.7 64.7 35.0 93.4 90.3 66.5 154.8 55.4 88.9 75.9 TMEM18 "DKFZp434C1714, lncND" ENSG00000151353 "Transmembrane protein 18" Q96B42 2 667335-677439 "Predicted membrane proteins, Transporters" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040233 Approved Approved "Endoplasmic reticulum,Mitochondria" NA NA Mitochondria "Endoplasmic reticulum" "HPA040233: AB_10794737" "unprognostic (9.01e-3)" "unprognostic (2.45e-1)" "unprognostic (7.48e-2)" "unprognostic (1.77e-3)" "unprognostic (2.68e-2)" "unprognostic (1.61e-1)" "unprognostic (1.27e-2)" "unprognostic (4.11e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (6.05e-2)" "unprognostic (1.86e-1)" "unprognostic (9.45e-2)" "unprognostic (8.20e-2)" "unprognostic (2.49e-1)" "unprognostic (3.65e-1)" "unprognostic (4.98e-3)" "unprognostic (8.08e-2)" 18.9 22.1 13.7 11.3 14.4 12.9 23.4 10.0 18.7 17.6 17.4 16.0 12.0 13.9 19.3 19.5 16.1 15.6 18.1 12.3 13.4 14.5 17.3 18.1 12.2 12.5 14.8 15.6 43.7 31.7 13.2 13.5 19.6 12.3 19.2 9.5 18.3 19.5 16.5 28.3 14.2 15.5 18.4 21.9 12.5 13.4 19.1 11.4 23.9 23.1 19.7 13.8 15.0 14.1 17.3 19.7 5.8 14.4 16.2 14.8 11.2 9.8 9.4 11.6 13.1 12.9 19.8 12.3 13.6 10.8 12.2 11.6 1.8 16.1 14.0 25.6 16.7 6.3 14.0 4.7 15.7 10.1 21.8 11.3 8.2 5.6 20.2 16.6 8.2 7.4 14.1 16.0 20.7 14.1 10.5 3.7 23.8 8.3 8.7 16.3 33.2 19.1 19.8 8.5 8.6 13.9 11.1 6.2 10.6 11.2 10.7 9.6 15.6 7.9 14.6 14.7 5.3 9.8 15.3 11.6 11.2 15.3 7.4 20.5 11.6 19.0 12.1 13.7 9.1 7.8 3.7 14.4 5.8 11.3 13.8 11.8 17.3 12.5 9.2 14.9 13.6 14.8 13.9 1.2 16.2 14.1 19.7 14.4 11.2 13.7 14.4 10.0 18.7 13.4 14.5 14.8 15.6 12.3 11.4 20.8 26.2 26.8 25.3 31.9 18.7 21.3 28.1 34.8 27.3 26.2 7.9 62.0 26.6 32.1 11.2 32.9 25.7 46.7 39.9 50.7 45.7 34.7 28.9 31.8 43.3 19.1 19.0 31.9 30.8 9.1 58.7 29.1 38.8 26.2 36.8 41.0 36.0 43.2 48.1 36.3 27.2 19.4 40.1 80.7 64.7 37.8 67.9 17.3 41.4 31.5 TMEM181 "GPR178, KIAA1423" ENSG00000146433 "Transmembrane protein 181" Q9P2C4 6 158536436-158635428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040189, HPA040228" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Vesicles "Nucleoplasm, Golgi apparatus" "HPA040189: AB_10793959, HPA040228: " "unprognostic (1.93e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (9.87e-2)" "unprognostic (6.51e-2)" "unprognostic (3.09e-1)" "unprognostic (1.49e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (4.07e-2)" "unprognostic (1.46e-1)" "unprognostic (1.93e-1)" "unprognostic (4.36e-1)" "unprognostic (3.26e-1)" 7.1 5.6 32.4 4.8 49.2 3.1 8.6 5.3 36.6 13.4 10.1 4.2 6.5 10.9 8.4 3.9 6.3 5.8 7.3 5.3 18.5 8.7 3.3 6.4 6.7 3.4 5.5 23.3 5.6 18.5 8.1 21.5 6.5 11.2 9.4 11.5 4.3 22.4 10.0 4.9 7.0 12.6 7.8 7.3 7.6 16.3 16.0 8.5 2.3 9.7 2.1 3.2 9.9 7.0 1.0 2.1 7.7 3.4 3.9 4.7 1.4 10.2 5.9 8.4 12.9 22.3 20.5 16.1 23.2 13.6 12.1 13.9 10.0 12.6 4.3 12.0 19.2 26.0 15.2 12.4 15.3 19.3 6.3 8.9 8.0 8.8 21.1 18.2 10.0 7.7 16.9 15.1 13.5 18.3 18.3 19.4 6.2 15.2 5.4 19.8 6.2 4.4 12.5 6.5 20.4 7.6 4.3 9.7 4.9 11.6 8.0 24.9 17.1 17.0 16.0 11.1 12.1 6.1 14.1 18.4 12.6 8.5 20.8 20.0 3.2 2.2 4.8 15.2 12.6 11.9 7.7 2.2 5.7 4.7 2.3 3.6 0.9 2.7 3.7 1.6 1.0 2.4 3.2 1.6 3.9 3.4 2.1 2.6 1.4 32.4 49.2 5.3 36.6 18.5 8.7 5.5 23.3 11.2 8.5 11.9 31.5 2.4 11.3 18.1 13.4 14.8 20.4 5.3 7.9 15.7 17.7 7.7 3.3 22.0 3.2 24.0 29.3 0.0 28.2 10.9 15.0 29.8 10.5 18.6 8.9 19.1 42.6 20.3 14.2 4.0 12.0 13.6 13.5 4.6 34.5 6.0 36.3 28.1 16.6 4.8 14.4 6.5 17.1 14.2 22.6 18.3 4.3 20.1 24.4 29.1 TMEM182 FLJ30294 ENSG00000170417 "Transmembrane protein 182" Q6ZP80 2 102736905-103019900 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 40.3;skeletal muscle: 53.9;tongue: 37.8" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA045861 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA045861: AB_2679475" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (5.10e-2)" "unprognostic (1.12e-4)" "unprognostic (5.35e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-2)" "unprognostic (1.10e-1)" "unprognostic (7.03e-3)" "unprognostic (2.34e-1)" "unprognostic (4.19e-2)" "unprognostic (3.42e-2)" "unprognostic (9.88e-2)" "unprognostic (4.61e-2)" "unprognostic (1.10e-1)" "unprognostic (3.53e-1)" "unprognostic (2.36e-2)" 2.4 1.1 1.2 1.0 1.3 0.3 1.1 1.7 1.8 1.4 1.0 0.5 1.5 1.0 0.6 2.3 1.8 1.1 0.8 40.3 1.2 1.9 1.4 1.7 0.6 0.8 1.2 0.5 1.0 1.1 1.5 6.8 0.8 2.8 1.9 1.0 0.9 3.8 1.2 53.9 0.5 0.9 1.1 1.2 0.8 1.0 0.8 0.4 1.8 2.0 37.8 4.0 1.2 0.7 4.4 3.1 0.3 0.3 2.4 4.1 1.1 4.9 2.8 2.1 6.6 2.7 2.7 7.7 2.7 2.4 2.7 3.9 9.2 6.9 4.1 9.2 0.9 4.4 2.9 2.3 3.7 5.7 9.1 1.8 6.1 1.3 5.8 3.2 5.5 4.9 3.4 6.8 4.3 3.8 1.9 0.4 5.9 4.3 1.6 2.7 3.6 2.9 5.3 3.6 4.7 3.0 3.1 5.6 3.9 3.8 4.3 5.5 1.9 3.6 3.9 8.6 2.9 3.3 2.9 0.3 4.3 3.1 3.3 3.3 4.0 10.0 3.4 4.4 9.1 6.5 0.0 0.0 0.3 3.9 0.3 3.2 4.4 2.8 2.2 1.3 1.9 3.8 4.1 0.1 2.4 0.3 3.1 0.8 1.1 1.2 1.3 1.7 1.8 1.2 1.9 1.2 0.5 2.8 0.4 20.8 10.5 5.9 0.8 0.3 0.1 134.4 0.0 17.4 23.9 3.5 0.0 1.9 0.0 1.3 0.6 0.0 0.4 23.3 2.9 2.1 1.0 1.0 3.5 1.9 1.0 0.0 6.3 0.0 0.6 0.4 0.6 0.7 6.8 0.0 2.2 2.3 1.7 0.0 0.7 2.4 0.3 0.0 0.9 0.9 2.2 0.5 0.9 1.0 1.7 2.7 TMEM183A C1orf37 ENSG00000163444 "Transmembrane protein 183A" Q8IXX5 1 203007386-203024848 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072607 Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA072607: AB_2686539" "unprognostic (2.94e-3)" "unprognostic (1.60e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-2)" "unprognostic (5.99e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (6.46e-2)" "unprognostic (3.21e-2)" "unprognostic (4.82e-3)" "unprognostic (5.28e-2)" "unprognostic (7.84e-2)" "unprognostic (4.83e-2)" "unprognostic (6.01e-3)" "unprognostic (9.55e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" 12.2 12.6 22.4 13.5 20.8 50.1 17.2 31.9 30.4 14.4 21.1 12.4 6.7 20.0 13.6 15.2 19.3 12.0 15.0 11.5 19.8 21.0 16.0 21.1 13.4 20.2 19.3 14.8 15.0 29.9 12.0 8.2 10.9 20.8 15.0 23.6 11.1 22.2 13.6 8.8 16.1 18.8 17.6 12.4 14.5 15.8 27.7 12.3 23.3 20.5 14.8 17.7 15.3 20.7 17.4 27.2 35.6 24.4 26.4 23.7 24.3 12.7 12.4 15.9 26.1 21.1 15.9 26.3 12.8 12.7 14.9 13.1 15.0 13.5 31.9 9.3 16.5 6.0 16.2 21.3 18.0 12.4 10.3 25.9 15.7 14.5 16.5 15.3 28.1 13.9 15.6 20.1 12.2 24.8 15.1 18.7 25.8 32.2 11.6 13.8 28.4 22.9 28.9 43.8 17.3 19.8 17.7 27.2 25.6 23.0 12.5 20.5 25.7 19.2 32.1 18.4 26.5 22.9 22.2 13.8 10.1 14.1 17.2 14.0 11.8 18.9 24.7 11.1 21.9 10.6 21.1 24.4 35.6 18.1 20.4 17.9 16.6 20.5 20.5 27.2 17.4 23.7 19.3 21.3 26.4 18.5 19.5 21.2 24.3 22.4 20.8 31.9 30.4 19.8 21.0 19.3 14.8 20.8 12.3 14.9 15.6 44.9 49.0 65.3 20.7 10.9 48.4 28.1 28.4 33.2 9.8 46.3 59.7 71.4 117.2 35.8 68.3 23.3 66.2 74.0 37.9 74.7 17.3 45.7 54.3 17.5 50.6 32.5 53.2 96.3 25.0 47.0 37.1 59.5 68.9 18.9 55.2 56.1 27.6 74.5 26.2 19.4 47.6 72.3 76.8 71.8 43.1 44.7 83.1 77.4 TMEM184A "MGC9712, SDMG1" ENSG00000164855 "Transmembrane protein 184A" Q6ZMB5 7 1542235-1560821 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.2;intestine: 39.3" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 57.2;Mucus-secreting cells: 31.0;Paneth cells: 31.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 15.2;RT4: 17.3;SCLC-21H: 17.8;SK-BR-3: 27.6;T-47d: 24.4" "Low region specificity" "Detected in many" "HPA053790, HPA071312" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA053790: AB_2682263, HPA071312: AB_2686387" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.38e-1)" "unprognostic (4.41e-3)" "unprognostic (1.07e-1)" "unprognostic (2.36e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-1)" "unprognostic (1.31e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (5.47e-2)" 0.4 0.1 0.2 3.5 0.2 0.1 1.6 0.2 0.3 8.6 15.6 0.2 8.0 15.1 1.7 2.9 40.2 4.4 9.6 0.2 0.2 0.1 5.3 18.0 1.5 0.2 0.2 0.3 0.9 24.7 3.1 5.4 14.3 0.4 5.1 4.0 0.3 10.3 12.0 2.3 17.9 39.3 1.2 0.2 0.2 7.5 3.8 0.2 0.5 0.3 22.9 31.9 10.0 15.8 0.8 0.8 2.0 0.5 0.4 0.5 0.0 9.7 6.6 0.0 0.0 0.0 0.0 2.2 0.3 0.1 0.4 0.0 8.9 11.7 0.2 3.4 0.1 3.6 7.5 0.0 4.4 0.1 0.1 0.2 0.0 6.0 4.0 0.1 0.0 0.0 0.0 4.3 0.1 3.9 0.2 0.0 2.9 0.1 0.0 0.0 15.2 0.0 0.0 0.3 6.0 8.6 0.2 0.0 4.7 3.3 17.3 17.8 0.0 2.9 27.6 0.0 0.2 24.4 0.0 0.0 0.0 3.7 4.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.2 0.5 0.1 0.3 0.2 0.3 0.2 0.1 0.8 0.4 0.3 2.0 0.4 0.2 0.8 0.3 0.0 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.3 0.4 0.2 3.0 4.1 0.8 5.3 3.5 0.9 2.5 17.8 13.4 10.3 8.7 0.0 6.6 1.7 11.9 0.0 0.7 57.2 0.0 9.6 7.7 1.3 11.9 1.1 12.4 0.7 0.0 6.9 0.0 1.2 0.0 0.0 1.7 0.0 1.0 31.0 0.0 12.3 31.6 0.0 3.8 0.4 0.0 1.0 0.0 0.0 8.2 14.1 0.0 13.3 11.3 TMEM184B "C22orf5, DKFZP586A1024, FM08, HS5O6A" ENSG00000198792 "Transmembrane protein 184B" Q9Y519 22 38219291-38273034 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 65.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 60.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024076 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "HPA024076: AB_1858106" "unprognostic (1.52e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-1)" "unprognostic (8.96e-2)" "unprognostic (3.82e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.94e-6)" "unprognostic (1.14e-2)" "unprognostic (5.18e-2)" "unprognostic (4.52e-2)" "unprognostic (9.20e-2)" "unprognostic (1.77e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.96e-1)" 21.8 16.5 23.9 14.7 24.1 6.0 27.5 26.4 40.0 22.4 14.4 31.2 12.2 18.5 12.1 9.5 11.0 14.2 16.1 17.8 25.8 21.5 13.0 7.4 20.5 8.6 26.1 22.2 10.8 18.0 27.3 21.9 41.2 23.8 12.3 12.5 20.1 16.8 17.3 19.0 10.9 16.5 15.7 41.2 14.1 19.3 5.8 20.9 3.9 16.7 10.6 9.2 20.0 15.4 1.6 7.3 12.4 3.1 6.2 5.8 2.6 17.3 15.2 9.0 7.1 17.9 14.4 20.8 18.8 26.8 15.5 13.8 11.1 8.1 3.3 14.8 28.0 14.0 21.6 8.1 18.5 10.5 11.8 14.5 6.6 11.1 9.2 18.9 5.1 9.2 12.0 16.5 18.2 20.4 16.0 19.3 5.1 4.1 11.7 13.4 9.9 3.2 4.3 7.3 13.0 14.0 5.6 8.1 3.3 11.5 19.3 19.5 3.4 14.1 20.7 10.0 10.9 11.4 3.8 28.4 15.8 16.2 13.8 11.4 24.3 60.1 2.7 22.9 3.8 13.5 12.4 3.1 4.6 5.8 2.4 5.3 1.6 3.3 4.3 4.7 1.2 2.3 2.7 11.2 6.2 1.6 7.3 1.0 2.6 23.9 24.1 26.4 35.4 25.8 21.5 26.1 22.2 23.8 20.9 6.0 15.0 1.5 15.0 11.0 17.0 14.6 10.2 4.0 9.1 14.0 2.0 27.6 3.3 15.0 4.9 26.7 7.5 0.0 19.1 38.8 21.0 27.4 2.3 3.4 13.3 14.3 24.9 16.0 7.5 1.7 10.9 10.2 13.5 16.2 16.0 40.7 22.7 7.0 12.7 4.2 8.1 19.4 23.4 2.3 6.6 8.4 65.6 10.1 9.4 30.1 TMEM184C "FLJ10846, TMEM34" ENSG00000164168 "Transmembrane protein 184C" Q9NVA4 4 147617383-147672044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054013 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA054013: AB_2682343" "unprognostic (5.45e-3)" "unprognostic (2.49e-2)" "unprognostic (3.93e-3)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (7.72e-3)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (6.37e-4)" "unprognostic (1.13e-1)" "prognostic favorable (2.31e-7)" "unprognostic (4.68e-2)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.31e-3)" 10.4 18.4 11.3 9.6 13.1 5.5 10.0 12.3 15.9 11.8 13.0 12.3 14.3 11.8 12.4 9.8 10.7 10.0 9.6 14.3 11.8 11.3 18.0 18.7 9.2 7.7 16.1 11.8 15.7 11.6 107.2 10.5 14.0 12.7 12.0 11.6 9.3 12.1 12.8 16.2 9.5 14.8 10.1 14.0 10.0 10.6 8.3 14.1 11.7 32.9 10.3 9.4 11.8 11.2 12.8 17.3 17.7 18.1 14.7 22.8 11.6 9.2 14.5 18.4 14.0 25.2 24.6 12.1 17.3 20.3 12.9 15.0 11.9 17.7 8.6 8.7 13.5 12.8 11.1 14.9 13.3 14.3 19.1 8.7 11.1 11.2 8.6 19.4 14.8 16.6 18.3 18.0 14.2 14.9 18.8 16.6 9.8 14.2 24.3 18.0 13.8 12.8 5.4 11.8 21.1 8.5 12.8 6.3 14.8 14.3 17.3 14.3 18.5 9.4 14.7 15.1 14.9 14.7 9.3 16.2 16.4 8.9 13.3 11.0 26.6 34.8 11.5 19.2 8.9 17.7 17.7 14.1 15.5 18.0 18.0 22.8 12.3 16.7 16.4 17.3 12.8 15.9 14.8 11.0 14.7 18.1 11.9 15.3 11.6 11.3 13.1 12.3 15.9 11.8 11.3 16.1 11.8 12.7 14.1 8.9 5.7 6.4 6.6 4.0 7.7 16.5 10.2 5.3 14.8 5.2 11.8 12.5 1.7 10.6 19.6 9.8 8.5 0.0 11.1 10.6 8.4 7.2 20.8 8.5 9.0 11.1 5.2 6.7 10.4 10.3 10.0 8.8 5.0 4.6 8.3 7.8 7.5 3.5 13.8 5.3 6.2 6.5 7.3 5.4 4.9 3.0 7.2 6.4 9.9 6.4 TMEM185A "CXorf13, FAM11A, FRAXF" ENSG00000269556 "Transmembrane protein 185A" Q8NFB2 X 149596556-149631912 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 45.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048295, HPA071744" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA048295: AB_2680345, HPA071744: AB_2686441" "unprognostic (9.76e-2)" "unprognostic (2.83e-2)" "unprognostic (7.73e-2)" "unprognostic (2.71e-3)" "unprognostic (4.08e-1)" "unprognostic (1.97e-1)" "unprognostic (4.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.78e-2)" "unprognostic (2.69e-1)" "unprognostic (3.17e-1)" "unprognostic (1.37e-2)" "unprognostic (1.90e-1)" "unprognostic (1.07e-1)" "unprognostic (1.40e-1)" 4.3 5.0 6.8 4.8 6.2 1.7 4.1 7.2 8.2 5.1 3.8 3.1 7.3 2.3 6.2 7.4 5.8 5.8 5.3 12.0 4.4 4.4 3.1 3.4 3.3 3.0 3.3 13.8 5.4 7.3 4.8 10.8 6.0 5.5 3.5 6.3 4.8 7.2 4.5 6.2 3.3 6.6 3.7 7.8 2.7 12.3 4.0 3.8 3.8 4.5 4.3 4.6 5.8 5.3 7.7 12.2 5.0 13.5 10.4 6.3 11.1 11.3 13.1 7.7 17.8 12.1 5.2 11.0 13.5 11.2 16.9 6.9 19.3 13.7 24.7 12.2 15.0 14.2 15.1 10.4 12.2 8.8 11.3 7.9 13.2 7.4 12.9 11.5 8.1 11.5 17.7 11.5 7.2 13.0 9.6 10.4 3.3 8.9 8.0 18.3 7.9 7.9 9.8 5.7 12.7 7.8 19.9 7.8 12.9 14.7 4.5 6.5 8.4 14.5 14.4 12.5 7.7 6.6 11.5 8.5 7.8 15.6 13.5 8.4 7.4 20.1 15.1 13.5 11.7 2.2 5.0 12.2 10.1 3.0 9.0 5.3 7.3 10.4 7.7 5.0 10.3 9.2 7.1 13.5 2.5 5.7 9.0 6.3 6.0 1.6 3.9 10.3 9.8 13.3 9.3 2.5 9.4 2.3 14.0 5.9 23.0 3.3 4.1 0.2 10.2 5.5 0.0 8.1 9.7 19.0 9.2 5.7 6.6 9.5 17.5 12.6 23.4 12.5 1.9 21.0 6.9 13.5 19.0 6.9 12.9 8.9 8.7 22.3 4.8 8.1 45.3 14.0 6.9 15.8 17.6 14.4 8.6 5.0 14.1 TMEM185B "FAM11B, FLJ20979" ENSG00000226479 "Transmembrane protein 185B" Q9H7F4 2 120221278-120223408 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048295, HPA071744" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA048295: AB_2680345, HPA071744: AB_2686441" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (5.44e-4)" "prognostic unfavorable (4.96e-6)" "unprognostic (1.35e-2)" "unprognostic (1.55e-2)" "prognostic unfavorable (5.71e-7)" "unprognostic (3.09e-3)" "unprognostic (1.65e-1)" "unprognostic (9.01e-2)" "unprognostic (1.96e-2)" "unprognostic (8.28e-2)" "unprognostic (6.03e-3)" "unprognostic (1.72e-1)" "unprognostic (1.61e-1)" "unprognostic (2.03e-1)" "unprognostic (1.04e-1)" 16.9 14.2 10.4 12.7 14.2 14.4 15.7 8.3 15.2 14.4 12.7 24.7 9.9 9.8 17.7 10.6 16.3 17.1 12.4 18.3 13.2 9.7 12.3 19.1 14.5 18.4 15.3 9.2 14.6 20.2 46.3 12.2 13.8 13.1 16.1 10.4 15.1 16.2 12.6 16.5 11.9 12.6 16.8 14.5 12.6 13.4 19.4 13.4 16.3 19.1 15.5 13.2 15.9 12.9 1.4 2.6 5.8 3.4 4.6 2.4 0.6 24.7 10.4 7.1 11.5 12.3 17.3 18.4 17.9 17.1 17.5 15.4 31.3 24.4 0.0 17.7 15.6 17.8 16.0 7.2 15.0 19.7 10.7 14.2 11.0 7.2 7.1 17.6 0.0 19.8 14.7 18.5 18.7 22.8 11.7 12.3 10.4 12.7 12.8 15.2 17.0 9.4 11.0 10.7 10.0 22.1 7.4 0.0 8.2 13.9 16.7 10.8 9.0 16.2 19.8 14.5 9.0 11.4 12.4 14.7 7.8 21.2 13.9 6.7 8.9 11.0 10.2 9.3 10.9 18.2 0.0 1.9 2.3 1.6 3.4 1.9 0.8 2.0 1.0 2.6 1.4 1.6 2.4 5.8 4.6 2.2 0.8 1.9 0.6 10.4 14.2 8.3 15.2 13.2 9.7 15.3 9.2 13.1 13.4 14.9 1.6 6.4 26.6 7.4 2.1 7.9 5.1 6.7 2.3 7.0 5.9 9.2 1.7 14.8 8.4 7.7 4.9 0.0 10.8 25.8 8.4 11.0 6.9 3.4 13.2 1.6 1.2 5.5 5.1 5.1 4.4 5.6 6.8 5.4 3.7 8.8 9.8 3.5 2.1 3.3 3.6 0.0 8.0 17.3 11.5 3.9 12.1 5.1 4.7 15.8 TMEM186 "C16orf51, DKFZP564K2062" ENSG00000184857 "Transmembrane protein 186" Q96B77 16 8780384-8797648 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018226, HPA063559" Uncertain Approved "Cell Junctions" NA NA "Cell Junctions" "HPA018226: AB_1845579, HPA063559: AB_2685041" "unprognostic (3.49e-1)" "unprognostic (1.07e-2)" "unprognostic (1.11e-2)" "unprognostic (2.98e-2)" "unprognostic (4.81e-2)" "unprognostic (1.18e-1)" "unprognostic (2.32e-2)" "unprognostic (2.08e-2)" "unprognostic (8.06e-2)" "unprognostic (9.35e-2)" "unprognostic (2.45e-1)" "unprognostic (3.99e-2)" "prognostic favorable (1.93e-8)" "unprognostic (1.06e-1)" "unprognostic (3.73e-2)" "unprognostic (1.70e-1)" "unprognostic (3.89e-2)" 6.6 12.0 8.2 6.2 10.4 1.9 11.0 5.4 13.2 7.4 10.6 8.2 9.4 10.1 11.0 14.2 9.6 10.4 9.7 11.5 7.4 7.6 9.6 15.9 6.2 8.2 9.1 12.6 9.7 11.8 16.3 11.8 8.4 7.8 8.4 12.5 10.4 14.0 8.4 16.9 8.8 9.2 15.1 10.3 10.1 9.1 11.7 6.2 7.0 11.9 7.7 11.0 10.4 6.2 14.3 10.4 11.8 13.8 9.5 17.2 8.4 6.8 10.7 8.0 10.1 13.7 7.3 7.6 7.8 8.1 10.4 8.6 10.3 11.4 20.7 6.7 5.7 7.1 13.1 14.1 11.1 11.9 12.0 13.6 8.7 13.8 21.9 15.4 9.6 7.1 8.7 18.9 11.3 16.7 8.5 9.3 17.3 14.8 11.4 6.0 18.3 7.4 9.4 10.1 14.6 9.4 15.7 10.4 22.7 11.0 5.8 12.3 11.7 10.7 15.2 9.2 8.5 18.2 7.8 5.9 7.4 10.4 18.1 6.4 10.5 11.1 10.0 11.5 17.8 5.9 11.8 10.0 7.5 9.4 9.6 12.5 14.3 10.0 10.6 10.4 12.7 17.2 13.2 4.8 9.5 13.8 8.1 13.0 8.4 8.2 10.4 5.4 13.2 7.4 7.6 9.1 12.6 7.8 6.2 6.0 7.0 11.3 6.9 7.2 5.8 2.5 5.1 8.1 11.4 10.4 0.0 19.8 18.3 12.1 34.1 4.4 8.5 0.0 9.7 10.0 4.3 6.0 6.9 11.6 11.6 12.7 13.2 4.3 3.3 62.1 8.6 3.7 6.8 10.0 8.6 8.9 8.9 7.0 6.0 16.1 5.3 12.9 4.7 13.2 10.0 8.3 12.6 6.4 15.3 5.5 TMEM187 "CXorf12, DXS9878E, ITBA1" ENSG00000177854 "Transmembrane protein 187" Q14656 X 153972327-153983195 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA038134 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA038134: AB_10669517" "unprognostic (1.51e-1)" "unprognostic (4.35e-2)" "unprognostic (1.41e-1)" "unprognostic (1.28e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (8.94e-2)" "unprognostic (2.41e-1)" "unprognostic (3.09e-1)" "unprognostic (4.22e-2)" "unprognostic (5.33e-2)" "unprognostic (7.41e-2)" "prognostic favorable (9.14e-8)" "unprognostic (6.73e-2)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (7.04e-2)" 8.8 13.0 9.2 6.8 10.2 3.4 10.5 13.2 9.0 7.6 9.0 10.5 13.9 6.8 8.8 9.3 9.5 12.0 6.8 8.1 9.6 6.0 7.6 10.2 7.7 10.2 10.4 9.0 10.9 24.4 7.5 13.0 7.3 11.0 10.3 4.5 6.7 14.1 10.1 8.5 10.7 10.9 6.8 8.0 10.0 8.0 5.9 8.7 8.4 10.8 2.9 9.9 7.9 7.4 13.4 19.6 17.8 9.8 10.1 22.5 10.9 8.4 9.7 2.1 7.7 8.4 7.5 1.2 3.5 1.7 1.0 3.4 1.9 14.6 1.3 20.0 2.8 5.3 7.7 2.9 5.1 0.8 10.9 4.0 2.3 5.1 3.1 7.1 1.1 2.6 8.4 7.7 3.0 4.3 4.8 2.6 5.1 2.1 11.0 4.4 9.1 4.5 1.5 1.6 9.5 10.7 4.2 1.2 14.1 5.3 2.7 2.9 2.8 5.1 4.3 3.6 2.1 8.1 2.8 4.8 1.7 1.8 7.0 1.9 7.8 5.2 1.7 5.2 5.1 0.9 17.8 9.8 11.9 14.7 7.3 14.7 9.7 18.1 15.9 7.4 13.4 22.5 13.9 9.5 10.1 6.9 19.6 17.6 10.9 9.2 10.2 13.2 9.0 9.6 6.0 10.4 9.0 11.0 8.7 0.0 4.6 4.1 5.2 2.5 3.5 3.6 17.8 2.7 1.2 7.0 5.9 11.8 1.7 9.2 0.3 3.8 6.5 23.3 7.7 9.1 9.6 5.3 3.5 13.5 10.8 1.6 2.4 4.9 6.0 0.0 13.6 4.8 10.1 9.0 6.7 12.4 8.0 3.5 13.4 6.8 4.3 6.5 5.5 0.2 8.8 4.1 8.2 5.1 7.6 3.3 TMEM189 Kua ENSG00000240849 "Transmembrane protein 189" A5PLL7 20 50118254-50153734 "Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 139.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059549 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA059549: AB_2684059" "unprognostic (3.11e-2)" "unprognostic (7.04e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (7.51e-4)" "unprognostic (1.71e-1)" "unprognostic (1.04e-1)" "unprognostic (2.03e-3)" "unprognostic (7.00e-2)" "unprognostic (2.19e-2)" "unprognostic (1.35e-1)" "unprognostic (8.63e-2)" "unprognostic (5.79e-2)" "prognostic unfavorable (5.79e-11)" "unprognostic (1.85e-1)" "unprognostic (1.20e-1)" "unprognostic (9.46e-2)" "unprognostic (4.42e-2)" 15.1 13.9 12.0 11.0 23.8 7.7 13.6 7.9 18.1 13.0 14.5 33.7 20.5 13.2 16.3 17.3 27.0 10.0 12.3 15.5 15.0 10.7 9.1 21.0 14.3 8.3 33.1 9.0 6.5 8.9 19.8 6.5 26.1 20.7 13.3 11.5 7.9 14.6 22.0 17.1 24.3 13.2 32.2 32.1 10.4 14.5 11.3 24.9 10.0 8.5 11.7 14.8 16.0 15.4 2.0 6.2 6.3 13.9 4.1 5.8 3.9 8.6 8.0 9.6 7.5 14.6 11.0 16.0 6.1 5.8 12.9 7.3 21.6 13.9 3.2 9.9 5.8 18.5 24.2 4.8 12.4 4.7 1.7 3.6 4.1 11.6 18.4 8.2 6.6 11.3 9.3 29.1 7.2 7.6 6.3 15.4 5.5 4.2 4.7 4.3 7.6 5.2 16.8 4.6 22.3 8.4 4.3 7.3 3.4 24.3 12.8 5.0 3.3 6.9 24.1 13.8 9.8 3.8 9.5 12.1 10.9 5.6 7.0 6.0 3.5 5.8 1.3 9.4 5.0 8.7 5.3 5.7 6.3 3.7 10.8 2.9 2.0 4.1 3.1 6.2 1.9 3.5 4.1 2.3 4.1 13.9 3.9 5.8 3.9 12.0 23.8 7.9 18.1 15.0 10.7 33.1 9.0 20.7 24.9 35.7 20.7 7.5 38.4 43.6 5.5 13.7 0.0 5.3 9.1 19.2 0.0 74.8 1.7 32.6 43.7 16.1 18.8 0.0 31.5 139.1 23.8 25.4 6.9 10.6 34.3 7.9 11.5 18.4 14.6 86.5 16.4 21.1 8.5 30.7 10.2 4.1 47.3 13.3 17.0 3.8 3.6 19.4 15.1 6.0 11.5 36.9 41.9 13.8 12.7 45.7 TMEM189-UBE2V1 "CROC-1B, Kua-UEV" ENSG00000124208 "TMEM189-UBE2V1 readthrough" 20 50081124-50153637 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 4.5;Ciliated cells: 9.4;Club cells: 9.1;granulocytes: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA052535, HPA053186" Supported Nucleoplasm NA NA Nucleoplasm "HPA052535: AB_2681863, HPA053186: AB_2682073" "unprognostic (3.69e-1)" "unprognostic (1.27e-1)" "unprognostic (2.41e-3)" "unprognostic (2.71e-2)" "unprognostic (1.52e-1)" "unprognostic (6.05e-3)" "unprognostic (2.40e-1)" "unprognostic (8.19e-2)" 9.2 4.4 4.6 7.5 9.7 1.2 5.1 6.1 7.1 4.3 3.9 14.2 6.8 2.0 4.7 3.0 5.9 2.9 3.1 3.9 4.4 4.5 3.4 8.4 5.0 3.6 14.0 3.0 4.3 9.1 5.5 4.3 15.0 8.3 3.8 1.6 2.0 3.7 4.6 8.4 4.0 4.4 4.8 7.9 4.6 7.6 12.2 10.2 3.5 3.2 4.0 5.6 4.5 3.5 6.1 9.1 11.3 15.3 8.0 8.7 9.9 3.4 5.8 2.1 5.4 8.9 6.1 6.4 5.9 3.9 8.1 4.6 12.4 7.3 1.7 8.2 3.2 7.4 14.9 3.2 6.6 1.4 0.8 1.1 2.5 10.2 7.5 4.1 4.3 4.6 6.1 12.2 6.0 2.2 0.6 8.0 0.8 4.1 5.2 3.6 4.2 3.2 0.4 1.5 1.3 1.4 3.1 1.7 2.9 2.3 9.4 3.3 1.5 2.8 12.3 2.6 0.1 2.6 4.0 12.4 9.5 3.6 2.6 3.8 1.3 1.7 0.6 4.2 1.1 6.2 7.5 9.4 11.3 8.7 13.5 7.6 4.1 7.9 8.6 9.1 6.1 7.4 7.8 1.3 8.0 15.3 5.5 8.2 9.9 4.6 9.7 6.1 7.1 4.4 4.5 14.0 3.0 8.3 10.2 8.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 9.4 9.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM19 FLJ10936 ENSG00000139291 "Transmembrane protein 19" Q96HH6 12 71686087-71705046 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016830 Approved NA NA "HPA016830: AB_1858107" "unprognostic (8.22e-2)" "unprognostic (3.47e-2)" "unprognostic (6.76e-2)" "unprognostic (1.44e-1)" "unprognostic (4.45e-1)" "unprognostic (3.43e-2)" "unprognostic (7.60e-2)" "unprognostic (5.60e-2)" "unprognostic (6.45e-2)" "unprognostic (1.25e-1)" "unprognostic (1.21e-1)" "unprognostic (1.11e-2)" "unprognostic (4.27e-2)" "unprognostic (1.49e-2)" "unprognostic (4.42e-1)" "unprognostic (5.32e-3)" "unprognostic (1.00e-1)" 11.0 10.4 8.6 11.0 14.4 4.7 15.2 9.9 14.6 11.5 20.5 14.3 7.6 24.0 8.2 7.3 35.7 8.8 9.2 16.9 9.3 10.1 27.6 17.1 11.5 14.5 9.8 9.4 6.5 11.3 11.6 13.1 8.2 13.2 8.4 14.7 12.1 12.9 9.8 15.8 18.8 24.5 10.6 13.8 19.9 10.3 7.0 10.9 14.6 11.0 14.4 20.9 15.3 17.8 37.1 40.2 7.0 10.1 8.2 10.5 9.4 14.4 18.8 12.9 7.6 20.5 9.5 7.9 11.7 14.0 13.8 12.1 8.9 13.4 26.9 16.1 22.3 11.5 19.1 11.3 12.4 18.6 19.5 13.6 15.6 12.3 10.1 5.6 16.4 15.7 8.6 14.2 17.6 5.7 11.1 14.8 24.1 9.1 15.8 20.8 7.0 15.7 4.8 7.2 9.0 12.5 12.0 19.1 15.2 12.8 33.6 14.2 11.3 20.4 10.3 5.0 10.4 16.0 4.9 14.4 19.5 9.5 8.4 10.5 31.2 39.4 19.3 8.2 4.8 20.7 7.0 8.2 2.9 10.5 10.1 8.1 30.6 8.4 8.9 14.2 37.1 8.3 9.8 0.7 8.2 8.8 40.2 8.5 9.4 8.6 14.4 9.9 14.6 9.3 10.1 9.8 9.4 13.2 10.9 20.8 18.9 54.9 14.4 16.9 12.0 19.4 10.2 37.5 11.4 24.4 11.8 10.4 10.0 12.8 15.3 11.4 30.7 0.0 19.0 20.2 10.1 6.9 15.1 24.9 23.3 14.3 19.1 18.4 21.5 53.8 6.9 28.4 21.9 20.8 10.0 10.8 16.3 14.4 12.7 40.9 8.1 6.5 9.4 3.9 6.4 40.7 4.0 9.6 23.8 17.6 TMEM190 MDAC1 ENSG00000160472 "Transmembrane protein 190" Q8WZ59 19 55376836-55378244 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 63.6;ovary: 17.7;testis: 21.5" "Group enriched" "Detected in some" 9 "Ciliated cells: 338.6;Early spermatids: 390.3;Late spermatids: 112.4" "Group enriched" "Detected in many" 8 "endometrial cancer: 11.5;lung cancer: 2.6;ovarian cancer: 2.6" "Region enhanced" "Detected in some" "hypothalamus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 14.0;hTERT-RPE1: 5.0;SCLC-21H: 7.0" "Region enriched" "Detected in single" 7 "cerebellum: 0.9" "Region enriched" "Detected in single" 6 "cerebellum: 5.6" NA NA "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (5.00e-2)" "unprognostic (6.58e-2)" "unprognostic (6.24e-3)" "unprognostic (3.97e-2)" "unprognostic (1.42e-1)" "unprognostic (5.02e-1)" "unprognostic (2.08e-1)" "unprognostic (4.95e-2)" "unprognostic (1.03e-1)" "unprognostic (5.38e-5)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.93e-1)" 0.1 0.7 0.1 0.1 0.3 0.1 0.1 0.2 0.5 5.7 0.1 0.5 0.1 0.1 1.4 1.1 0.1 63.6 0.1 0.1 0.6 2.7 0.1 0.1 11.8 0.1 0.1 0.1 17.7 0.1 0.0 3.0 0.3 1.0 0.1 0.0 0.1 0.1 0.2 0.1 0.6 0.1 0.1 0.1 0.1 0.5 21.5 0.3 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.4 2.5 0.0 0.5 0.0 0.0 0.2 0.7 0.3 0.6 0.1 1.8 1.5 2.6 0.2 0.7 0.4 4.5 0.0 0.0 0.0 4.3 0.2 0.0 2.7 14.0 0.9 0.0 0.1 0.2 0.0 0.1 0.0 5.0 0.0 0.2 0.0 3.4 0.0 2.0 0.3 0.0 0.5 1.7 0.8 0.2 1.6 1.4 0.0 1.3 7.0 1.3 1.4 1.8 0.6 1.3 0.8 0.0 0.0 0.2 1.1 0.2 0.7 0.5 3.2 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.5 0.6 2.7 0.1 0.1 1.0 0.3 0.0 5.8 0.0 0.0 0.0 0.4 0.0 0.0 338.6 33.0 0.0 0.0 0.1 0.0 0.1 390.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.1 0.0 0.1 0.0 8.5 0.0 0.0 112.4 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 2.4 1.7 0.0 0.3 0.0 0.0 0.0 TMEM191B ENSG00000278558 "Transmembrane protein 191B" P0C7N4 22 18527802-18530573 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "blood: 5.6;testis: 12.7" "Group enriched" "Detected in many" 14 "Early spermatids: 369.4;Late spermatids: 373.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 4.7;CACO-2: 3.5;U-266/70: 3.6;U-87 MG: 2.3" NA NA "unprognostic (1.70e-1)" "unprognostic (8.90e-2)" "unprognostic (3.18e-1)" "unprognostic (9.75e-2)" "unprognostic (1.60e-1)" "unprognostic (3.30e-1)" "unprognostic (1.25e-1)" "unprognostic (2.27e-1)" "unprognostic (1.98e-1)" "unprognostic (6.25e-2)" "unprognostic (4.90e-2)" "unprognostic (4.65e-2)" "unprognostic (4.44e-2)" "unprognostic (2.10e-2)" "unprognostic (3.54e-1)" "unprognostic (9.40e-2)" "unprognostic (9.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 12.7 0.0 0.0 0.0 1.6 2.8 4.2 5.6 0.5 3.1 3.3 1.3 0.0 1.0 0.0 0.0 0.0 4.7 0.3 0.0 0.1 0.0 3.5 0.8 1.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.2 0.3 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 1.1 0.3 1.1 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 1.1 0.9 0.0 3.6 0.6 1.2 2.3 0.0 0.7 4.2 2.7 1.4 1.5 5.6 0.7 0.8 2.4 1.5 2.8 1.6 1.8 3.1 2.0 0.5 4.7 2.4 1.4 3.3 0.0 0.3 1.4 3.8 0.0 2.6 0.8 5.1 0.0 0.0 8.7 0.0 24.6 3.3 6.8 369.4 0.6 25.7 0.0 7.0 8.6 1.3 5.2 0.0 3.6 7.1 1.6 10.5 1.3 5.6 373.7 2.3 2.6 0.0 9.0 16.9 2.3 21.8 0.0 2.1 5.8 2.7 0.0 2.5 9.5 4.3 0.0 9.2 5.0 13.3 2.8 TMEM191C ENSG00000206140 "Transmembrane protein 191C" A6NGB0 22 21466423-21471269 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 11 "blood: 6.1;testis: 4.1" "Group enriched" "Detected in many" 19 "Early spermatids: 745.3;Late spermatids: 836.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 4.2;HEK 293: 1.6;HeLa: 2.2;Hep G2: 1.7;MCF7: 1.9" NA NA "unprognostic (2.55e-1)" "unprognostic (2.18e-2)" "unprognostic (7.12e-3)" "unprognostic (2.83e-2)" "unprognostic (1.19e-1)" "unprognostic (1.86e-1)" "unprognostic (1.77e-2)" "unprognostic (5.97e-2)" "unprognostic (1.25e-1)" "unprognostic (2.40e-2)" "unprognostic (1.59e-3)" "unprognostic (2.09e-1)" "unprognostic (2.41e-1)" "unprognostic (1.78e-1)" "unprognostic (7.63e-2)" "unprognostic (1.36e-1)" "unprognostic (4.12e-3)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 1.9 0.4 3.6 6.1 0.6 3.0 1.3 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.6 0.1 2.2 1.7 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.9 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.5 0.0 0.0 3.6 1.4 0.0 0.2 4.6 1.3 0.6 0.5 1.4 0.4 1.9 3.0 0.7 0.7 0.6 6.1 0.3 0.4 1.3 0.0 2.9 0.5 1.5 4.4 3.6 0.6 5.1 2.7 0.0 5.2 2.0 42.0 0.0 2.5 745.3 1.0 21.0 0.0 0.2 19.4 3.0 1.4 6.9 1.7 8.8 12.7 9.8 1.8 9.4 836.6 4.9 7.1 3.3 3.6 7.1 1.0 3.1 7.4 3.9 3.8 2.4 0.0 2.7 11.5 6.3 5.9 15.9 5.0 6.5 0.7 TMEM192 FLJ38482 ENSG00000170088 "Transmembrane protein 192" Q8IY95 4 165070608-165208549 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014717, HPA024110" Enhanced Supported Nucleoplasm,Endosomes,Lysosomes NA NA "Endosomes, Lysosomes" Nucleoplasm "HPA014717: AB_1844373, HPA024110: AB_2204898" "prognostic unfavorable (9.52e-4)" "unprognostic (5.38e-3)" "unprognostic (9.16e-2)" "unprognostic (4.39e-2)" "unprognostic (2.60e-2)" "unprognostic (1.55e-2)" "unprognostic (2.91e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (3.10e-1)" "unprognostic (3.27e-2)" "unprognostic (5.06e-2)" "prognostic favorable (2.33e-14)" "unprognostic (2.09e-2)" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (9.30e-2)" 12.6 14.4 11.3 7.4 13.6 5.3 12.1 12.0 11.9 11.6 9.7 10.5 6.2 8.3 9.7 10.0 7.8 10.1 8.9 10.4 9.9 9.4 40.7 37.7 9.1 8.5 13.0 10.6 21.8 21.3 20.3 14.2 9.3 13.1 19.4 11.7 24.7 11.3 7.8 19.0 7.4 8.2 8.6 13.3 10.8 10.5 8.6 11.3 3.1 22.9 5.2 6.6 12.1 7.3 18.2 12.0 3.4 12.5 13.4 12.8 7.7 6.3 9.6 3.5 8.8 9.1 3.2 8.1 9.7 14.3 10.1 11.3 5.6 10.5 14.0 5.8 6.2 16.5 5.7 13.0 9.9 11.7 9.0 6.7 7.8 7.2 6.3 23.3 19.1 10.5 11.7 21.2 9.1 18.6 8.8 8.2 7.6 13.2 23.6 12.4 13.8 3.3 5.6 7.3 13.3 8.3 7.5 3.0 12.7 8.2 9.4 7.5 7.8 15.1 24.1 15.3 5.4 11.7 8.8 6.1 4.5 5.5 14.0 10.9 23.2 30.6 19.5 10.7 10.6 17.8 2.0 12.5 3.4 9.7 10.9 12.8 18.2 7.5 9.9 11.6 15.2 8.3 10.0 1.4 13.4 5.8 12.0 6.0 7.7 11.3 13.6 12.0 11.9 9.9 9.4 13.0 10.6 13.1 11.3 29.8 33.4 17.1 16.9 8.7 34.9 28.7 48.4 12.0 22.7 52.4 15.7 23.8 10.0 18.4 13.5 19.6 13.2 0.0 22.3 16.3 19.5 28.7 38.3 68.1 32.6 35.0 20.8 27.0 24.1 7.5 36.8 24.0 27.0 9.0 15.9 31.7 12.7 14.0 31.5 49.7 25.3 6.5 13.2 13.1 11.9 11.3 28.1 19.8 22.9 12.3 TMEM196 MGC42090 ENSG00000173452 "Transmembrane protein 196" Q5HYL7 7 19719310-19773598 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 15.0;pituitary gland: 12.6" "Cell type enriched" "Detected in some" 10 "Bipolar cells: 51.1" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "ASC diff: 8.8;ASC TERT1: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043163 Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA "Nucleoplasm, Golgi apparatus" "HPA043163: AB_10794772" "unprognostic (6.08e-3)" "unprognostic (1.88e-2)" "unprognostic (2.14e-2)" "unprognostic (9.30e-2)" "unprognostic (5.63e-2)" 0.7 3.7 8.0 0.6 8.6 0.4 0.4 0.3 15.0 1.2 0.6 0.3 0.0 0.4 3.8 1.5 0.5 1.2 0.4 0.4 3.6 10.1 0.6 0.4 0.4 0.4 2.9 7.4 0.4 3.0 0.7 12.6 0.4 5.0 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 1.0 1.4 0.4 2.6 0.5 2.8 0.0 0.4 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 8.8 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 8.6 0.3 7.3 3.6 10.1 2.9 7.4 5.0 2.8 0.0 0.0 0.0 0.0 0.0 51.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM198 "MGC99813, TMEM198A" ENSG00000188760 "Transmembrane protein 198" Q66K66 2 219543663-219550595 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 20.6;Intestinal endocrine cells: 18.4;Muller glia cells: 9.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SCLC-21H: 17.3;SH-SY5Y: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042385, HPA062897" Enhanced Approved Vesicles NA NA Vesicles "HPA042385: AB_2677972, HPA062897: " "unprognostic (2.59e-2)" "unprognostic (8.51e-2)" "unprognostic (5.97e-3)" "unprognostic (2.77e-1)" "unprognostic (4.43e-2)" "unprognostic (8.09e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (4.28e-1)" "unprognostic (2.06e-1)" "prognostic favorable (6.89e-4)" "unprognostic (6.39e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" 3.0 9.4 14.4 3.1 10.3 0.9 2.3 14.2 22.0 3.3 2.6 4.1 1.4 16.1 4.0 2.5 2.7 2.5 3.9 3.4 16.5 5.2 3.0 2.6 2.4 1.8 4.1 11.9 10.9 20.0 5.2 13.0 2.6 6.2 4.0 1.8 3.0 7.0 4.3 3.5 2.2 6.4 3.5 7.5 1.8 4.7 5.0 4.9 0.0 4.0 0.5 1.9 3.8 1.2 0.2 2.6 0.1 0.0 0.8 0.4 0.4 0.5 0.1 4.8 8.2 1.0 0.9 4.3 2.5 1.3 2.0 1.7 10.5 1.4 2.1 2.4 1.5 5.0 2.9 1.7 1.2 0.4 7.1 2.0 1.7 2.1 8.6 1.5 0.6 4.0 2.1 0.7 0.9 2.3 2.2 0.0 1.5 6.2 7.0 1.2 1.0 0.1 0.5 6.2 0.8 0.7 0.2 2.9 2.4 1.2 1.1 17.3 15.0 0.6 1.7 4.1 0.9 0.2 3.3 0.1 2.2 0.9 2.0 1.0 6.7 1.9 2.2 2.0 0.1 3.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 2.6 0.0 0.4 14.4 10.3 14.2 22.0 16.5 5.2 4.1 11.9 6.2 4.9 0.0 1.4 0.0 1.1 0.1 8.1 1.6 0.0 0.0 0.0 0.0 2.0 0.8 1.7 2.7 0.7 0.0 1.0 0.0 7.0 0.6 2.2 0.8 0.0 1.5 0.2 20.6 18.4 0.0 0.3 1.3 2.6 0.0 1.7 1.0 0.9 9.8 1.8 0.8 4.6 1.6 6.5 0.0 2.8 9.2 3.1 0.1 2.4 0.5 0.1 0.3 TMEM199 "C17orf32, MGC45714, VMA12, VPH2" ENSG00000244045 "Transmembrane protein 199" Q8N511 17 28357581-28363683 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027051 Uncertain NA NA "HPA027051: AB_10600915" "unprognostic (3.01e-1)" "unprognostic (3.45e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.55e-4)" "unprognostic (9.98e-2)" "unprognostic (4.60e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.78e-1)" "unprognostic (6.38e-3)" "unprognostic (1.09e-1)" "unprognostic (9.25e-2)" "unprognostic (2.75e-1)" "unprognostic (1.99e-1)" "unprognostic (3.51e-3)" "unprognostic (5.95e-2)" 14.5 20.7 16.0 18.3 17.9 21.7 16.7 19.7 23.7 13.2 14.2 19.7 17.9 13.9 17.0 19.1 17.5 13.2 15.7 15.9 16.4 18.2 22.3 23.4 14.5 21.4 17.0 20.1 14.4 15.4 23.9 23.0 23.4 17.1 17.3 15.4 15.9 16.0 15.7 14.3 18.7 14.5 12.1 19.0 23.2 14.4 19.3 13.9 24.8 20.5 15.0 20.2 14.9 14.4 17.1 19.7 22.2 24.0 14.4 17.7 17.0 7.1 12.6 12.0 10.3 5.0 4.2 10.2 8.9 5.7 12.5 11.4 29.1 5.8 10.3 9.2 6.6 16.2 12.4 13.1 8.3 11.0 19.2 11.9 7.6 10.8 14.1 10.0 10.7 13.5 6.2 7.7 11.9 8.0 7.5 6.2 9.7 12.4 13.3 9.2 14.3 12.2 15.0 10.0 12.5 8.5 10.2 14.9 9.6 9.5 12.1 15.3 16.0 10.7 27.7 15.5 12.9 17.4 9.9 8.5 10.8 8.4 9.2 14.9 18.0 22.0 9.7 13.3 6.7 13.4 22.2 24.0 18.8 15.9 23.9 17.3 17.1 14.0 13.9 19.7 16.1 17.7 15.4 18.6 14.4 21.0 13.7 14.1 17.0 16.0 17.9 19.7 23.7 16.4 18.2 17.0 20.1 17.1 13.9 29.8 7.5 21.3 9.8 5.0 12.3 4.3 12.7 9.4 18.2 8.7 7.9 35.1 36.5 35.2 2.9 10.3 16.2 0.0 27.6 30.5 7.4 10.2 7.0 23.1 45.2 11.1 15.0 16.0 26.6 3.3 10.6 17.3 20.3 62.3 15.0 18.4 31.5 15.6 6.0 40.4 12.4 12.9 8.3 19.9 34.3 7.8 40.5 14.9 11.7 9.5 TMEM2 ENSG00000135048 "Transmembrane protein 2" Q9UHN6 9 71683366-71816690 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 67.6" "Cell type enhanced" "Detected in many" 5 "Ito cells: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 36.6;BEWO: 34.0;OE19: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044889 Approved Supported "Vesicles,Plasma membrane" NA NA 130000 "Plasma membrane" Vesicles "HPA044889: AB_10962641" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (6.15e-3)" "unprognostic (1.21e-2)" "unprognostic (2.93e-2)" "unprognostic (3.53e-1)" "unprognostic (3.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.57e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.13e-2)" "unprognostic (2.33e-1)" "unprognostic (7.59e-2)" "unprognostic (1.16e-1)" 23.3 3.9 6.0 10.5 4.4 12.4 13.6 8.9 6.0 3.0 18.6 1.9 10.1 12.2 4.5 5.2 4.4 4.9 19.2 9.5 8.6 3.6 9.3 24.9 35.7 14.0 4.0 4.1 3.1 9.2 24.0 9.5 67.6 4.3 5.5 13.1 7.9 9.5 10.2 5.5 6.4 20.0 5.5 5.1 15.6 14.5 3.7 2.4 6.4 8.0 4.6 8.8 11.4 6.8 6.3 0.9 5.5 2.1 0.5 4.1 1.4 5.8 28.0 36.6 1.7 3.8 6.9 34.0 19.7 12.6 13.7 10.1 7.8 8.0 0.1 5.9 5.0 3.0 8.7 11.8 2.7 18.6 0.7 3.6 10.0 5.9 20.8 5.9 0.0 2.7 7.1 3.0 10.6 2.4 3.6 18.0 0.8 1.4 3.0 7.4 4.9 1.1 0.1 7.6 36.1 2.7 0.9 10.9 0.7 8.6 18.9 1.8 0.2 5.1 3.6 5.3 11.8 2.5 0.3 7.8 9.3 10.5 5.1 9.8 0.6 8.4 0.3 1.8 0.9 11.7 0.2 2.1 5.5 2.7 1.9 0.8 0.7 2.9 2.6 0.9 6.3 4.1 2.0 4.5 0.5 1.8 0.2 3.9 1.4 6.0 4.4 8.9 6.0 8.6 3.6 4.0 4.1 4.3 2.4 32.8 30.4 9.4 38.3 26.8 5.5 0.0 33.1 4.0 17.0 0.0 9.8 36.3 0.0 0.0 10.6 37.9 75.4 0.0 0.0 12.0 19.0 42.5 4.6 27.6 35.9 0.0 9.7 115.4 56.5 2.9 2.8 14.9 16.9 0.0 32.3 73.6 0.0 26.4 1.1 0.0 35.2 6.5 20.8 1.0 0.6 19.2 75.1 62.3 28.3 40.3 TMEM200A "KIAA1913, TTMC" ENSG00000164484 "Transmembrane protein 200A" Q86VY9 6 130365734-130443063 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 36.2" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 25.8;Erythroid cells: 23.3;Horizontal cells: 12.7;Intestinal endocrine cells: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 1.8;NK-cell: 7.1" "Group enriched" "Detected in many" 8 "NK-cells: 7.1;T-cells: 1.8" "Cell line enhanced" "Detected in many" "HBF TERT88: 20.8;hTEC/SVTERT24-B: 33.6;hTERT-RPE1: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014396 Uncertain NA NA "HPA014396: AB_2204904" "unprognostic (1.07e-1)" "unprognostic (4.89e-2)" "unprognostic (2.33e-1)" "unprognostic (4.19e-2)" "unprognostic (7.62e-2)" "unprognostic (2.35e-1)" "unprognostic (3.28e-2)" "unprognostic (2.91e-1)" "unprognostic (7.25e-2)" "unprognostic (9.29e-2)" "unprognostic (3.10e-1)" "unprognostic (2.27e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.27e-3)" "unprognostic (1.01e-1)" "unprognostic (1.50e-1)" "unprognostic (1.91e-3)" 6.0 17.0 4.6 7.6 2.7 0.0 5.6 0.6 6.2 12.1 7.1 1.5 0.0 4.7 36.2 8.1 1.9 10.6 4.2 4.3 3.1 2.2 14.4 1.2 7.0 3.9 1.1 2.5 26.0 3.9 0.4 11.6 2.1 1.4 4.3 15.1 6.8 2.0 0.8 2.6 2.3 5.3 13.5 0.9 1.2 3.9 7.8 0.2 7.4 3.6 0.3 2.1 8.7 4.0 0.5 0.0 0.0 0.0 7.1 1.8 0.4 0.0 0.0 0.1 0.0 6.0 7.6 0.0 5.2 6.4 5.6 9.9 8.1 0.0 0.0 0.0 10.9 1.2 1.2 0.5 0.0 20.8 7.4 0.0 0.0 0.0 0.3 2.7 0.1 0.0 8.5 0.0 33.6 6.7 16.9 0.2 0.1 0.0 0.7 2.6 0.0 0.0 0.0 4.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 6.5 6.4 2.0 0.5 0.9 4.1 0.0 0.0 3.8 0.0 0.6 0.0 0.0 0.0 0.6 0.0 1.0 0.5 1.8 1.0 0.0 0.1 0.3 0.1 0.0 7.1 0.0 0.0 0.0 0.4 4.6 2.7 0.6 6.2 3.1 2.2 1.1 2.5 1.4 0.2 0.0 0.3 0.0 0.0 1.8 25.8 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.2 6.4 23.3 0.0 1.3 4.1 0.0 0.0 0.0 0.2 12.7 23.6 0.0 0.0 1.3 5.5 0.0 1.7 0.0 1.4 0.5 0.2 7.2 9.9 9.2 1.9 0.0 2.3 0.5 1.5 1.3 0.5 1.5 3.3 0.0 TMEM200B TTMB ENSG00000253304 "Transmembrane protein 200B" Q69YZ2 1 29119428-29123935 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 11.8;Melanocytes: 8.5;Peritubular cells: 14.2;Sertoli cells: 6.5;Smooth muscle cells: 8.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 15.8;ASC TERT1: 13.2;BJ hTERT+ SV40 Large T+: 14.6;BJ hTERT+ SV40 Large T+ RasG12V: 16.3;fHDF/TERT166: 15.4;HBF TERT88: 14.0" "Group enriched" "Detected in many" 4 "basal ganglia: 14.0;cerebellum: 23.9" HPA055254 Uncertain NA NA "HPA055254: AB_2682760" "unprognostic (2.55e-1)" "unprognostic (2.12e-2)" "unprognostic (8.25e-3)" "unprognostic (1.39e-1)" "unprognostic (4.71e-3)" "unprognostic (6.84e-2)" "unprognostic (1.91e-1)" "unprognostic (1.52e-2)" "unprognostic (6.25e-2)" "unprognostic (1.33e-1)" "unprognostic (6.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.24e-2)" "unprognostic (1.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-3)" 9.1 2.0 1.4 2.9 3.7 0.0 15.7 9.7 1.3 33.3 10.9 1.2 7.4 1.1 32.8 7.7 6.0 7.0 7.3 2.4 0.5 0.2 3.5 3.0 3.7 1.2 1.3 0.9 21.6 0.7 15.4 1.2 3.5 2.5 17.2 2.3 6.0 1.5 23.9 2.9 2.1 3.4 20.6 1.4 2.4 2.3 13.6 0.6 0.7 2.1 3.5 1.5 13.1 12.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 10.9 0.0 1.8 0.0 15.8 13.2 0.6 7.7 12.2 14.6 16.3 0.6 1.2 0.0 1.9 15.4 5.3 0.2 1.2 0.0 14.0 0.0 0.5 0.0 2.8 0.9 11.0 0.0 0.0 7.0 1.4 11.0 2.2 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.9 11.0 0.0 0.0 5.4 0.0 0.0 0.0 5.2 0.2 10.8 0.2 0.0 0.0 0.0 6.4 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 1.4 3.7 9.7 1.3 0.5 0.2 1.3 0.9 2.5 0.6 3.0 1.1 0.0 0.2 1.6 0.8 1.0 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 5.4 0.2 0.0 1.0 0.1 0.0 0.0 1.3 0.0 0.9 11.8 0.0 8.5 0.0 0.0 0.1 0.0 0.0 14.2 3.8 1.7 6.5 8.3 0.2 0.7 0.5 0.5 0.0 0.0 0.3 TMEM200C TTMA ENSG00000206432 "Transmembrane protein 200C" A6NKL6 18 5882072-5895955 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 10.1" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 6.6;Cone photoreceptor cells: 5.9;Peritubular cells: 2.1" "Cancer enhanced" "Detected in single" "glioma: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.8;NTERA-2: 4.5;PC-3: 20.8;SH-SY5Y: 3.3;U-2 OS: 10.6;U-251 MG: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA047253, HPA050490" Uncertain Approved Microtubules NA NA Microtubules "HPA047253: AB_2680001, HPA050490: AB_2681144" "unprognostic (6.57e-4)" "unprognostic (3.09e-1)" "unprognostic (1.05e-2)" "unprognostic (3.74e-2)" "unprognostic (2.13e-1)" "unprognostic (5.07e-2)" "unprognostic (3.20e-1)" "unprognostic (2.07e-1)" "unprognostic (4.12e-2)" "unprognostic (2.29e-2)" "unprognostic (6.31e-2)" "unprognostic (3.82e-4)" "unprognostic (2.48e-10)" "unprognostic (2.94e-2)" "unprognostic (6.38e-2)" "unprognostic (7.22e-2)" "unprognostic (2.38e-2)" 0.4 6.3 2.6 1.0 3.7 0.1 3.5 0.7 5.7 0.8 0.5 1.7 0.1 0.5 1.6 3.2 0.6 1.1 1.3 2.9 2.7 3.5 2.0 5.3 0.5 1.1 3.7 1.6 1.9 0.2 0.1 3.3 0.1 1.7 0.9 0.3 2.7 10.1 0.7 0.1 0.7 0.6 0.5 1.2 1.6 1.3 3.5 1.5 0.1 0.2 0.1 1.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 20.8 1.2 0.0 0.0 0.0 0.0 1.0 3.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 10.6 0.0 3.6 0.0 0.0 0.0 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.7 0.7 4.7 2.7 3.5 3.7 1.6 1.7 1.5 0.0 1.4 0.0 0.0 0.1 6.6 1.2 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 2.1 0.0 1.2 0.0 0.9 0.1 0.4 0.3 0.0 0.0 0.0 0.1 TMEM201 "Ima1, NET5, RP13-15M17.2, SAMP1" ENSG00000188807 "Transmembrane protein 201" Q5SNT2 1 9588922-9614873 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 37.0" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB039039 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB039039: " "unprognostic (1.75e-2)" "prognostic favorable (5.36e-4)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (4.88e-1)" "unprognostic (1.27e-2)" "prognostic unfavorable (9.61e-8)" "unprognostic (2.22e-1)" "unprognostic (3.60e-1)" "unprognostic (3.87e-2)" "unprognostic (5.59e-3)" "unprognostic (1.63e-1)" "unprognostic (9.38e-2)" "unprognostic (3.87e-2)" "unprognostic (6.25e-2)" "unprognostic (7.99e-2)" "unprognostic (1.45e-1)" 6.2 7.3 9.6 5.7 9.4 10.3 4.0 8.7 11.9 4.4 3.9 10.5 4.4 5.4 6.9 5.1 5.9 5.8 4.0 13.2 9.3 7.9 5.7 2.7 4.5 5.0 9.4 8.3 9.0 9.2 5.5 12.6 4.5 7.9 4.9 2.8 12.6 6.7 5.6 37.0 7.1 3.9 4.9 6.7 5.3 4.0 8.2 7.1 6.9 4.5 13.9 5.4 3.8 4.3 1.4 4.3 0.0 0.8 0.4 1.9 1.0 7.7 10.5 6.6 15.5 2.8 1.9 5.9 9.1 2.8 10.9 7.7 19.3 7.1 13.5 11.6 3.1 5.3 16.2 7.3 7.2 3.7 8.9 18.3 9.5 10.0 9.8 5.1 11.5 9.9 3.4 3.3 14.6 2.4 2.3 4.3 6.4 12.1 3.9 4.3 9.2 10.0 8.4 6.7 6.0 9.8 21.2 11.3 11.1 3.9 4.3 15.9 11.9 7.2 17.6 7.9 2.4 5.4 7.3 3.9 13.0 11.3 14.3 17.1 6.6 5.5 12.1 9.0 19.0 11.4 0.0 0.8 0.0 1.1 0.6 0.6 1.4 1.4 1.9 1.1 1.1 1.0 0.7 0.0 0.4 0.4 4.3 1.8 1.0 9.6 9.4 8.7 11.9 9.3 7.9 9.4 8.3 7.9 7.1 3.0 1.3 1.9 1.7 6.3 14.7 10.6 2.5 2.7 2.3 0.0 25.5 2.8 1.7 2.0 1.1 4.5 0.7 0.0 0.8 1.8 2.3 1.4 4.6 1.5 3.0 9.5 6.4 4.3 3.7 1.3 3.7 2.5 3.3 0.0 3.6 4.8 1.3 0.0 4.2 1.9 16.3 0.0 3.8 4.7 5.3 4.8 0.7 1.0 4.0 1.7 TMEM202 FLJ27523 ENSG00000187806 "Transmembrane protein 202" A6NGA9 15 72398273-72408029 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 219 "testis: 23.5" "Group enriched" "Detected in some" 44 "Early spermatids: 52.5;Late spermatids: 43.7;Spermatocytes: 18.0" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.31e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 18.0 0.9 0.0 0.0 0.0 0.0 0.0 TMEM203 "HBEBP1, MGC14327" ENSG00000187713 "Transmembrane protein 203" Q969S6 9 137204082-137205638 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.31e-1)" "unprognostic (2.65e-2)" "unprognostic (4.53e-2)" "unprognostic (8.72e-2)" "unprognostic (1.10e-1)" "unprognostic (6.54e-2)" "unprognostic (2.72e-2)" "unprognostic (1.78e-1)" "unprognostic (1.43e-1)" "unprognostic (7.16e-2)" "prognostic favorable (4.78e-6)" "unprognostic (2.94e-1)" "prognostic favorable (1.50e-5)" "unprognostic (3.50e-3)" "unprognostic (1.57e-1)" "unprognostic (4.04e-2)" "unprognostic (1.19e-1)" 15.3 21.1 20.6 13.5 22.4 7.6 19.2 18.2 34.1 16.8 20.0 19.0 17.6 18.5 20.0 23.5 19.2 20.2 20.0 31.4 19.7 18.2 23.7 35.5 15.6 20.5 20.0 17.0 24.8 17.4 20.9 16.9 16.5 19.1 17.1 15.8 19.7 22.3 20.0 33.2 26.2 22.8 18.8 14.5 20.0 18.0 17.5 16.3 21.4 25.2 15.6 18.4 15.9 16.9 9.9 6.5 6.4 5.8 9.2 12.7 3.5 17.0 18.2 17.2 28.4 25.7 20.1 20.7 22.4 21.8 26.2 19.7 14.9 15.5 17.8 21.8 19.4 25.2 33.7 21.2 22.3 15.3 32.1 20.4 12.3 21.6 16.9 21.5 28.3 12.7 19.1 35.7 17.0 22.7 17.5 16.7 23.5 28.6 20.9 20.2 29.6 22.4 24.6 28.6 33.0 29.6 24.5 24.1 35.4 21.9 12.5 22.9 22.4 17.9 22.9 17.6 12.4 32.3 23.1 14.8 27.0 14.4 30.0 25.0 11.3 35.2 22.4 20.8 21.1 22.1 6.4 5.3 5.3 7.4 5.8 9.2 9.9 8.5 9.2 6.1 7.1 12.7 8.7 2.8 9.2 5.0 6.5 5.2 3.5 20.6 22.4 18.2 34.1 19.7 18.2 20.0 17.0 19.1 16.3 8.9 5.0 14.4 20.3 15.7 35.3 10.8 25.5 1.4 6.8 29.6 3.9 26.3 44.7 45.2 2.9 15.8 14.2 0.0 36.9 22.8 18.1 25.7 5.7 36.1 25.5 30.2 15.6 13.5 20.2 6.8 20.4 13.2 23.6 66.7 14.0 43.3 31.8 7.0 19.4 46.8 19.4 12.9 13.0 16.7 11.5 23.8 16.2 14.0 18.9 16.2 TMEM204 "C16orf30, CLP24, FLJ20898" ENSG00000131634 "Transmembrane protein 204" Q9BSN7 16 1528688-1555580 "Predicted membrane proteins" "Stress response" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Endothelial cells: 85.4;Ito cells: 126.4;Peritubular cells: 63.3;Sertoli cells: 116.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 44.7" "Lineage enriched" "Detected in many" 5 "T-cells: 44.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.7;BJ: 10.3;BJ hTERT+: 14.0;fHDF/TERT166: 9.4;HHSteC: 25.4;HSkMC: 10.1;TIME: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014028 Approved NA NA "HPA014028: AB_2204906" "unprognostic (1.51e-1)" "unprognostic (6.35e-2)" "unprognostic (3.81e-3)" "unprognostic (2.36e-2)" "unprognostic (4.85e-2)" "unprognostic (1.81e-2)" "prognostic favorable (4.76e-4)" "unprognostic (1.65e-1)" "prognostic unfavorable (7.89e-4)" "unprognostic (8.44e-2)" "unprognostic (2.95e-2)" "unprognostic (4.04e-2)" "unprognostic (7.62e-3)" "unprognostic (5.11e-3)" "unprognostic (3.18e-2)" "unprognostic (1.60e-2)" "unprognostic (2.53e-2)" 36.4 12.9 3.7 9.6 6.2 0.6 33.4 2.9 6.6 20.2 11.5 3.4 9.0 5.9 17.1 11.4 11.5 10.5 13.9 19.8 4.2 3.3 24.3 12.6 29.6 22.9 5.3 6.2 11.5 9.2 3.4 6.4 11.6 5.5 14.6 2.9 18.4 7.7 13.9 13.9 7.6 11.8 10.5 3.4 12.3 9.3 7.8 4.7 4.2 21.0 12.2 9.8 12.1 14.2 0.4 0.5 0.8 0.2 8.2 44.7 12.1 0.0 0.1 0.6 0.1 5.1 8.7 0.1 10.3 14.0 1.7 1.7 0.4 0.0 0.1 0.1 9.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.1 25.4 0.0 0.0 10.1 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.3 0.2 0.3 0.0 1.1 0.3 0.0 0.0 7.8 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.1 0.0 6.8 0.2 12.6 0.1 22.3 15.3 0.5 0.4 44.7 22.9 0.8 8.2 0.2 0.1 9.4 12.1 3.7 6.2 2.9 6.6 4.2 3.3 5.3 6.2 5.5 4.7 0.0 5.9 1.9 9.1 5.0 0.0 5.9 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.3 0.8 85.4 0.0 23.3 0.2 0.1 12.1 0.5 0.0 1.5 0.3 0.0 0.0 126.4 4.5 0.5 21.9 2.1 6.8 0.0 0.0 0.2 0.0 0.0 63.3 0.0 0.4 116.4 34.2 0.0 0.0 2.8 0.3 11.4 0.0 1.1 TMEM205 "MBC3205, UNQ501" ENSG00000105518 "Transmembrane protein 205" Q6UW68 19 11342776-11346518 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 396.4;Hepatocytes: 417.5;Late spermatids: 488.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041504 Approved Approved "Nucleoplasm,Nuclear membrane,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nucleoplasm, Nuclear membrane" "HPA041504: AB_10795595" "unprognostic (2.54e-2)" "unprognostic (2.60e-2)" "unprognostic (7.19e-2)" "unprognostic (1.57e-2)" "unprognostic (6.83e-2)" "unprognostic (1.80e-1)" "unprognostic (5.04e-3)" "unprognostic (3.77e-2)" "unprognostic (1.01e-2)" "unprognostic (5.56e-3)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" "unprognostic (8.10e-2)" "unprognostic (5.78e-2)" "unprognostic (8.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" 15.8 40.5 25.7 10.6 29.4 14.5 19.3 16.2 36.3 30.3 19.2 19.8 34.6 18.7 15.5 29.7 14.6 25.9 27.8 31.7 24.5 23.6 36.1 90.8 19.4 22.9 25.2 21.9 21.7 50.5 52.4 21.7 17.5 20.6 24.3 11.3 31.8 28.6 28.4 30.0 15.0 18.2 16.9 21.4 14.2 17.2 23.1 13.2 11.1 46.6 15.4 13.3 21.3 13.1 21.9 43.1 11.0 71.0 10.4 14.8 32.1 19.3 48.1 5.9 20.1 11.8 14.2 11.2 7.4 17.1 16.2 12.7 14.6 6.2 17.4 44.9 14.9 16.1 19.9 8.5 22.2 10.9 20.4 8.1 4.6 16.7 23.9 29.8 7.8 14.9 13.4 22.7 10.4 17.4 16.3 19.5 16.7 14.0 74.6 10.0 49.0 11.7 21.9 10.6 25.3 36.9 11.1 9.2 46.0 39.4 35.1 10.7 16.3 7.8 32.1 18.0 7.4 27.9 22.8 11.4 20.4 7.8 22.2 16.4 44.5 44.3 10.3 19.7 35.1 15.6 5.2 71.0 7.1 14.6 29.8 14.8 21.9 12.2 12.8 43.1 18.4 9.8 11.8 11.0 10.4 17.5 31.0 14.6 32.1 25.7 29.4 16.2 36.3 24.5 23.6 25.2 21.9 20.6 13.2 62.5 59.8 25.2 116.9 45.7 27.8 62.3 178.3 58.9 89.9 144.8 11.8 101.4 51.4 137.3 396.4 66.1 62.3 0.0 143.8 66.1 80.7 116.5 28.8 417.5 85.9 25.4 113.0 63.3 78.3 488.1 74.8 50.9 91.1 31.5 72.5 72.5 99.5 66.6 64.0 180.1 27.1 45.3 59.3 30.7 14.9 47.2 80.9 37.9 73.4 104.8 TMEM206 "C1orf75, FLJ10874" ENSG00000065600 "Transmembrane protein 206" Q9H813 1 212363931-212414901 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.8" "Cell type enhanced" "Detected in many" 5 "monocytes: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008540 Uncertain NA NA "HPA008540: AB_10794083" "unprognostic (2.18e-1)" "unprognostic (2.22e-1)" "unprognostic (9.23e-2)" "unprognostic (1.02e-1)" "unprognostic (2.74e-2)" "unprognostic (3.09e-2)" "prognostic unfavorable (3.71e-5)" "unprognostic (1.14e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.06e-3)" "unprognostic (6.33e-2)" "unprognostic (1.02e-1)" "unprognostic (9.10e-2)" "unprognostic (6.98e-2)" 3.7 3.7 10.7 5.5 11.7 7.1 3.5 3.8 22.5 2.3 2.6 35.3 2.2 2.9 4.2 3.0 3.8 2.1 4.2 3.3 15.4 11.8 14.3 2.1 4.3 9.9 21.8 7.1 2.0 3.9 3.4 3.1 5.9 19.7 4.4 3.3 1.4 2.8 2.5 2.0 2.9 3.1 4.2 50.8 6.1 2.2 7.7 17.8 7.8 2.7 1.3 7.2 6.5 3.0 7.7 17.7 11.6 10.1 6.2 6.4 5.2 7.5 5.8 8.9 14.6 5.2 2.9 8.8 4.4 3.5 7.4 6.6 4.9 5.6 9.0 3.6 2.1 7.2 6.8 8.4 4.0 7.4 6.7 9.1 8.5 4.2 6.0 7.5 13.5 13.3 2.5 4.3 6.8 4.9 7.4 8.3 13.2 7.6 5.3 5.1 2.9 14.9 13.9 11.7 3.5 7.8 12.3 9.9 8.6 3.7 3.8 13.8 21.4 5.1 7.6 19.4 9.1 11.4 16.7 7.2 4.9 5.5 11.5 11.4 6.9 11.1 12.5 6.5 12.5 13.4 11.6 7.7 4.3 4.9 10.1 6.4 7.7 3.8 5.7 12.5 7.3 5.6 6.0 0.6 6.2 8.7 17.7 5.3 5.2 10.7 11.7 3.8 12.8 15.4 11.8 21.8 7.1 19.7 17.8 3.0 0.0 12.3 2.6 11.2 3.1 3.2 0.0 1.4 1.2 5.2 0.0 11.4 1.7 6.1 1.5 5.2 0.7 0.0 3.6 5.8 5.0 4.2 12.7 0.8 25.2 0.0 4.6 2.5 12.4 0.4 2.3 13.9 6.8 31.5 0.5 26.1 5.7 2.9 1.8 18.7 4.9 6.5 3.3 11.6 25.1 11.2 6.9 5.1 1.9 3.9 TMEM207 ENSG00000198398 "Transmembrane protein 207" Q6UWW9 3 190428655-190449876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 75 "kidney: 21.1" "Cell type enriched" "Detected in some" 17 "Distal tubular cells: 58.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-266/70: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA014332 Uncertain NA NA "HPA014332: AB_2204907" "unprognostic (4.81e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 58.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 TMEM208 HSPC171 ENSG00000168701 "Transmembrane protein 208" Q9BTX3 16 67227103-67229278 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041868, HPA041949" Supported NA NA "HPA041868: AB_10962347, HPA041949: AB_10959903" "unprognostic (9.42e-2)" "unprognostic (7.94e-2)" "unprognostic (1.36e-3)" "unprognostic (2.05e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (9.63e-5)" "unprognostic (2.02e-2)" "unprognostic (1.44e-1)" "unprognostic (1.27e-1)" "unprognostic (2.44e-1)" "unprognostic (6.53e-2)" "unprognostic (6.40e-2)" "unprognostic (1.31e-2)" "unprognostic (2.29e-1)" "unprognostic (5.18e-2)" "unprognostic (7.73e-2)" "unprognostic (9.42e-2)" 14.5 37.0 19.9 15.9 20.5 10.0 22.1 23.3 23.7 19.5 22.0 16.3 26.4 23.7 15.4 32.1 17.3 17.8 19.3 13.2 19.2 21.1 23.0 51.5 25.1 16.7 21.7 20.8 11.8 45.0 31.5 27.9 19.1 21.2 14.8 22.3 17.3 29.6 25.0 10.7 13.6 20.0 14.8 15.8 17.0 19.7 25.4 19.3 9.2 19.4 16.0 16.1 15.6 12.0 23.9 58.6 24.8 39.1 17.2 27.8 31.0 19.1 25.9 12.3 14.6 39.9 18.9 22.7 20.1 25.4 22.5 19.1 31.9 24.1 19.4 24.2 28.6 20.1 26.2 19.7 27.7 14.2 8.5 30.0 10.5 19.2 32.3 40.8 16.8 28.7 25.3 35.0 29.7 26.1 15.9 16.7 17.7 17.9 25.0 26.1 38.7 16.6 24.5 20.9 31.6 18.2 18.1 15.2 55.4 29.9 13.0 20.6 21.1 36.4 15.2 16.2 8.8 20.0 21.0 10.1 17.0 11.1 24.3 22.2 38.5 36.7 39.6 29.8 16.1 24.0 21.7 39.1 20.2 27.8 34.8 25.3 23.9 26.4 24.2 30.2 19.5 21.8 24.0 24.8 17.2 26.8 58.6 25.4 31.0 19.9 20.5 23.3 23.7 19.2 21.1 21.7 20.8 21.2 19.3 23.8 31.7 67.0 60.5 45.9 42.5 27.1 107.0 45.5 40.9 54.1 31.4 84.2 51.4 139.6 9.6 42.4 90.2 46.7 175.0 107.0 67.5 120.5 53.0 175.9 109.8 25.4 73.7 39.9 52.1 3.2 57.5 50.4 84.4 105.6 72.4 84.2 118.6 97.9 39.3 142.5 47.6 25.8 40.1 57.2 61.4 45.4 120.1 34.6 77.4 100.9 TMEM209 "FLJ14803, NET31" ENSG00000146842 "Transmembrane protein 209" Q96SK2 7 130164715-130207770 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031678 Uncertain Approved "Nuclear membrane,Nuclear speckles,Vesicles" NA NA "Nuclear membrane, Nuclear speckles, Vesicles" "HPA031678: AB_10603135" "unprognostic (3.03e-1)" "unprognostic (5.06e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.36e-1)" "unprognostic (4.50e-3)" "unprognostic (5.98e-2)" "unprognostic (1.25e-1)" "unprognostic (1.66e-1)" "unprognostic (3.19e-1)" "unprognostic (6.00e-2)" "unprognostic (2.34e-3)" "unprognostic (1.11e-1)" "unprognostic (3.48e-1)" "unprognostic (1.68e-2)" "unprognostic (3.24e-1)" 12.0 33.5 9.9 9.1 12.1 9.4 12.2 12.7 13.3 9.4 12.2 23.8 9.5 10.4 16.4 11.8 8.8 11.2 8.1 7.9 9.9 10.9 11.6 16.9 10.3 12.2 11.6 12.0 13.7 19.8 19.0 18.7 18.6 16.4 10.3 12.9 19.0 16.5 10.3 10.1 11.1 19.0 10.5 19.1 13.3 8.8 17.8 11.3 24.9 18.6 8.0 13.1 11.1 8.9 14.1 10.8 10.0 13.4 13.8 20.5 10.4 9.5 9.2 12.6 15.5 7.3 7.5 9.3 8.8 8.9 8.0 10.8 10.2 17.4 14.2 6.6 5.6 14.9 14.4 14.7 10.2 14.3 17.5 8.4 7.4 15.6 6.7 13.0 15.5 7.5 8.3 10.5 15.9 16.0 4.9 6.1 14.8 23.9 16.8 9.7 12.4 29.5 9.4 18.7 8.6 8.2 15.9 14.1 23.5 8.0 12.3 11.3 17.4 20.0 32.1 12.6 10.3 10.4 10.4 4.8 14.6 5.7 15.2 21.0 22.3 32.6 29.6 23.7 18.0 22.4 10.0 8.9 9.5 17.0 13.4 17.7 14.1 17.4 15.4 8.6 14.0 20.5 17.3 1.3 13.8 11.3 10.8 17.3 10.4 9.9 12.1 12.7 13.3 9.9 10.9 11.6 12.0 16.4 11.3 3.0 10.5 8.2 3.0 4.1 13.0 6.9 7.6 8.1 11.4 8.7 3.9 6.6 1.7 5.0 22.4 9.0 7.0 0.0 7.9 7.4 8.1 5.0 9.3 8.2 7.0 4.8 13.3 7.4 11.3 4.9 6.1 7.5 6.8 4.6 10.2 19.3 6.0 11.2 4.9 3.9 13.9 0.0 5.8 12.6 15.1 4.6 5.5 11.5 8.1 3.8 TMEM210 ENSG00000185863 "Transmembrane protein 210" A6NLX4 9 137170858-137172409 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 18.7" "Group enriched" "Detected in some" 58 "Early spermatids: 718.1;Late spermatids: 1521.3" "Cancer enhanced" "Detected in single" "prostate cancer: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Group enriched" "Detected in many" 4 "dendritic cells: 4.1;granulocytes: 1.4" "Cell line enriched" "Detected in some" 7 "RPMI-8226: 15.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA066907 Enhanced NA NA "HPA066907: AB_2685747" "unprognostic (5.17e-2)" "unprognostic (5.04e-2)" "unprognostic (2.87e-5)" "unprognostic (4.18e-2)" "unprognostic (3.63e-2)" "unprognostic (3.14e-2)" "unprognostic (8.00e-2)" 0.1 0.0 0.1 0.1 0.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.1 4.0 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.0 18.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.6 4.1 1.4 0.3 0.5 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.7 0.1 15.8 0.0 0.0 0.1 0.1 0.0 2.1 0.1 0.1 1.5 0.0 0.0 0.1 0.1 0.6 0.0 0.3 0.2 0.0 0.3 0.2 0.0 1.4 0.3 0.1 0.2 0.2 0.3 0.1 0.2 0.2 0.2 0.6 0.3 0.3 1.2 0.5 0.2 4.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 718.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1521.3 11.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 6.0 0.0 0.0 19.4 0.1 8.8 3.5 0.1 0.0 0.0 0.0 0.2 TMEM211 bA9F11.1 ENSG00000206069 "Transmembrane protein 211" Q6ICI0 22 24934954-24946695 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "cervix, uterine: 5.3;salivary gland: 6.6;stomach 1: 5.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.8;endometrial cancer: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.1;HEK 293: 1.1;OE19: 2.3" HPA066784 Uncertain NA NA "HPA066784: AB_2685722" "unprognostic (7.89e-3)" "unprognostic (1.19e-1)" "unprognostic (2.15e-1)" "unprognostic (1.09e-2)" "unprognostic (5.97e-3)" "unprognostic (5.88e-2)" "unprognostic (1.31e-3)" "unprognostic (3.26e-2)" "unprognostic (2.06e-1)" "unprognostic (6.42e-2)" "unprognostic (2.65e-2)" "unprognostic (8.61e-3)" "unprognostic (3.59e-1)" "unprognostic (4.43e-2)" 0.0 0.0 0.0 0.4 0.4 0.0 0.8 0.4 0.1 5.3 0.4 0.0 1.2 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.1 6.6 0.0 0.0 1.4 0.1 0.0 0.0 0.0 5.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM212 FLJ23172 ENSG00000186329 "Transmembrane protein 212" A6NML5 3 171843349-171938715 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.2;lung: 10.0;ovary: 12.8" "Cell type enhanced" "Detected in some" 30 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 22.8;Ciliated cells: 167.3;Club cells: 46.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045736 Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA045736: AB_2679436" "unprognostic (3.39e-2)" "unprognostic (1.78e-2)" "unprognostic (3.05e-1)" "unprognostic (5.54e-2)" "unprognostic (3.06e-1)" "unprognostic (2.87e-1)" 0.4 0.4 0.5 0.6 0.8 2.2 0.4 0.4 0.5 1.6 0.8 0.9 0.4 0.2 1.3 2.5 0.8 19.2 0.4 0.4 0.6 0.7 0.4 3.3 10.0 0.6 0.4 0.4 12.8 0.4 0.0 0.4 0.4 0.7 0.4 0.8 0.4 0.4 2.1 1.1 1.5 0.5 0.4 0.4 0.4 0.4 1.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 4.1 3.2 6.3 2.1 3.8 2.7 0.5 4.1 2.5 2.8 3.1 0.8 0.4 5.5 3.0 0.9 1.2 1.2 2.0 3.3 5.4 3.6 1.4 3.1 2.9 1.7 1.3 2.6 7.1 2.8 6.4 6.5 2.7 0.5 3.7 5.4 1.1 1.5 1.4 1.2 1.8 1.3 3.4 4.4 8.6 0.9 2.7 3.2 4.1 4.9 2.1 2.7 2.7 4.4 4.5 1.1 3.2 3.4 3.3 4.1 3.1 2.3 3.3 3.6 3.3 6.6 4.6 5.0 7.2 3.2 5.1 4.0 3.6 2.3 3.4 2.4 6.3 2.1 1.8 2.7 1.8 2.1 1.9 2.0 1.8 1.1 4.1 2.3 2.5 5.0 3.8 2.0 3.2 1.3 0.5 0.5 0.8 0.4 0.4 0.6 0.7 0.4 0.4 0.7 0.4 32.8 22.8 0.0 0.0 0.0 0.0 0.0 0.0 167.3 46.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.0 TMEM213 ENSG00000214128 "Transmembrane protein 213" A2RRL7 7 138797952-138838101 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "kidney: 48.1;salivary gland: 35.6" "Cell type enhanced" "Detected in some" 28 "Collecting duct cells: 50.6;Distal tubular cells: 122.7;Melanocytes: 25.3" "Cancer enriched" "Detected in some" 22 "renal cancer: 21.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 4.5" "Not detected" "Not detected" HPA054059 Enhanced NA NA "HPA054059: AB_2682361" "unprognostic (2.79e-2)" "unprognostic (2.56e-1)" "unprognostic (1.85e-2)" "unprognostic (1.19e-2)" "unprognostic (3.19e-2)" "unprognostic (6.84e-2)" "unprognostic (1.17e-2)" "unprognostic (2.10e-1)" "unprognostic (6.14e-2)" "unprognostic (6.08e-2)" "unprognostic (1.91e-2)" "prognostic favorable (5.54e-7)" "unprognostic (4.33e-1)" "unprognostic (9.99e-2)" "unprognostic (3.06e-1)" "unprognostic (1.05e-2)" 0.1 0.0 0.1 0.0 0.1 0.4 2.1 0.0 0.1 1.2 0.0 0.0 4.3 0.3 0.1 0.2 0.1 0.0 0.4 0.0 0.1 0.1 48.1 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 35.6 2.9 0.0 3.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.3 0.1 0.0 1.1 0.8 4.1 0.7 4.6 1.2 0.2 0.4 0.4 0.7 1.6 0.3 0.3 1.4 0.6 0.2 0.1 0.3 1.1 1.7 0.9 0.6 0.1 0.6 0.9 0.0 0.0 0.3 0.6 1.2 1.4 1.0 0.7 0.1 1.0 0.9 0.5 0.2 0.1 0.4 0.5 0.5 0.8 1.2 1.9 0.3 0.2 0.4 0.9 0.3 0.2 0.3 0.6 0.9 0.7 4.5 1.7 1.3 1.1 0.5 1.1 0.2 1.0 1.2 0.3 0.1 1.8 0.9 1.4 0.8 1.7 0.5 1.2 0.8 0.4 0.9 4.1 0.7 0.7 0.9 0.6 1.2 0.7 0.5 0.6 0.3 1.1 0.6 0.6 3.4 4.6 0.6 0.8 0.4 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.0 6.9 0.0 0.7 0.0 0.3 0.4 0.0 5.3 3.4 50.6 0.0 0.0 122.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.4 1.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 TMEM215 ENSG00000188133 "Transmembrane protein 215" Q68D42 9 32783499-32787399 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 8.0;retina: 6.5;testis: 17.9" "Cell type enhanced" "Detected in some" 32 "Bipolar cells: 564.3;Early spermatids: 108.6;Late spermatids: 188.4" "Cancer enriched" "Detected in single" 14 "thyroid cancer: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NTERA-2: 6.6;SH-SY5Y: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052804, HPA063207" Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA052804: AB_2681957, HPA063207: AB_2732697" "unprognostic (1.31e-2)" "unprognostic (4.57e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-2)" "unprognostic (5.85e-2)" "unprognostic (4.38e-3)" "unprognostic (2.17e-3)" "unprognostic (2.82e-1)" "unprognostic (2.72e-1)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" "unprognostic (2.32e-2)" 0.1 0.0 1.8 0.4 1.5 0.0 0.1 0.1 0.9 1.9 0.0 0.0 0.0 0.0 8.0 0.9 0.1 0.1 0.0 0.9 0.9 1.5 0.0 0.0 0.1 0.0 1.7 0.2 0.7 0.0 0.0 0.1 0.0 0.6 0.1 0.0 6.5 0.1 0.0 0.3 0.1 0.1 0.0 1.0 0.0 0.0 17.9 0.0 0.0 3.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.1 0.8 0.9 1.5 1.7 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 564.3 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 108.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 188.4 2.6 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.7 0.0 21.9 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 TMEM216 "CORS2, HSPC244, JBTS2, MGC13379, MKS2" ENSG00000187049 "Transmembrane protein 216" Q9P0N5 11 61391687-61398863 "Disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 55.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.75e-2)" "unprognostic (1.54e-1)" "unprognostic (6.20e-2)" "unprognostic (1.94e-1)" "unprognostic (1.06e-2)" "unprognostic (1.58e-1)" "unprognostic (9.02e-3)" "unprognostic (4.44e-2)" "unprognostic (1.97e-1)" "unprognostic (1.79e-1)" "unprognostic (1.90e-2)" "unprognostic (9.66e-2)" "unprognostic (2.59e-3)" "unprognostic (2.05e-1)" "unprognostic (2.54e-1)" "unprognostic (1.47e-2)" "unprognostic (8.03e-3)" 9.1 10.3 12.9 10.1 13.0 14.1 23.9 11.6 11.1 14.5 10.0 10.3 8.9 7.7 14.4 17.0 11.7 19.8 10.7 7.1 10.0 10.9 13.9 5.1 9.2 13.1 10.0 5.6 28.1 33.2 9.8 20.2 13.0 7.7 17.1 10.8 16.5 23.9 12.8 3.9 8.4 12.0 10.0 6.6 12.7 9.5 21.2 7.4 11.4 22.4 9.6 17.1 12.0 11.5 14.0 9.5 55.0 8.4 18.2 11.3 6.4 5.7 6.7 10.3 8.4 18.0 8.7 2.6 3.3 5.6 8.0 5.8 9.2 10.9 2.3 11.4 6.0 0.0 8.1 12.0 6.7 9.0 17.0 6.8 4.2 4.0 12.9 10.1 20.9 6.6 7.8 9.3 4.7 9.5 2.7 7.7 0.7 8.6 5.2 5.2 23.8 1.5 33.0 10.9 19.5 14.3 0.2 8.0 7.0 6.5 13.2 4.6 7.1 8.8 4.9 5.8 7.9 5.8 11.1 3.5 0.0 0.2 3.8 0.0 4.1 2.7 3.2 0.1 8.9 3.4 20.4 8.2 55.0 10.2 8.4 9.3 14.0 10.3 9.7 9.5 13.4 10.9 9.3 13.2 18.2 6.9 3.4 11.3 6.4 12.9 13.0 11.6 11.1 10.0 10.9 10.0 5.6 7.7 7.4 6.0 8.9 8.7 15.8 4.1 3.9 2.9 10.2 13.4 7.9 1.8 2.0 15.5 16.6 11.8 4.8 12.1 5.2 0.0 14.8 15.3 13.5 10.0 8.1 2.0 12.5 4.8 9.2 9.8 6.5 2.6 19.5 8.3 6.8 2.8 11.4 16.9 10.5 5.8 12.7 7.0 5.3 12.9 3.8 33.9 17.2 3.0 7.2 15.4 12.8 12.2 TMEM217 "C6orf128, dJ355M6.2" ENSG00000172738 "Transmembrane protein 217" Q8N7C4 6 37212180-37258155 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 20.1" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 13.1;Exocrine glandular cells: 13.9;Pancreatic endocrine cells: 14.4;Spermatocytes: 19.2;Urothelial cells: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HEL: 4.8;hTEC/SVTERT24-B: 3.4;HUVEC TERT2: 5.0;TIME: 13.1" "Not detected" "Not detected" "HPA045432, HPA071187" Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA045432: AB_2732519, HPA071187: AB_2732174" "unprognostic (7.78e-2)" "unprognostic (5.49e-2)" "unprognostic (2.22e-2)" "unprognostic (1.29e-2)" "unprognostic (7.79e-2)" "unprognostic (2.02e-1)" "unprognostic (6.77e-3)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" "unprognostic (4.23e-4)" "unprognostic (8.22e-2)" "unprognostic (2.18e-1)" "unprognostic (5.62e-2)" "unprognostic (7.26e-2)" "unprognostic (1.33e-2)" "unprognostic (6.99e-2)" "unprognostic (1.59e-1)" 0.3 2.7 0.4 0.4 1.4 1.3 0.3 0.4 1.1 0.3 0.3 1.6 0.0 0.4 0.2 1.1 1.4 0.4 0.7 0.4 0.3 0.4 0.9 0.5 0.5 0.1 0.9 1.0 1.1 3.1 0.6 2.3 0.2 1.0 0.4 0.3 1.1 1.5 0.1 1.0 0.5 0.4 0.5 1.6 0.2 0.2 20.1 0.9 0.0 0.5 0.0 0.3 0.4 0.3 0.1 0.4 0.2 0.0 0.0 0.6 0.1 0.1 0.0 0.3 0.0 0.2 1.3 0.0 0.4 2.8 1.0 3.7 0.7 0.5 0.1 0.2 0.0 1.5 0.5 0.3 0.3 1.1 0.1 0.2 4.8 0.0 0.1 0.3 0.0 2.8 0.5 0.7 3.4 0.2 1.2 5.0 0.4 1.3 0.0 0.5 0.0 0.1 0.4 0.2 0.0 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.5 0.0 0.2 0.6 0.0 0.1 13.1 0.2 0.1 0.0 0.2 0.1 0.2 0.5 0.0 1.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.4 0.0 0.1 0.4 1.4 0.4 1.1 0.3 0.4 0.9 1.0 1.0 0.9 0.0 1.1 0.0 8.5 2.3 0.4 0.2 0.0 2.7 2.3 1.8 0.0 0.7 3.3 13.1 12.1 2.1 1.2 0.0 13.9 0.4 2.4 6.4 5.7 0.0 0.8 3.2 1.7 0.0 0.0 11.8 0.6 1.4 1.7 0.0 0.2 6.0 14.4 0.0 0.0 1.0 0.5 0.0 0.8 19.2 0.8 2.6 0.9 0.0 0.4 14.2 TMEM218 ENSG00000150433 "Transmembrane protein 218" A2RU14 11 125096545-125111763 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038489 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038489: AB_10672748" "unprognostic (3.70e-2)" "unprognostic (1.16e-1)" "unprognostic (7.60e-2)" "unprognostic (2.41e-3)" "unprognostic (8.86e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.63e-2)" "unprognostic (7.09e-3)" "unprognostic (2.18e-1)" "unprognostic (6.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.95e-2)" "prognostic favorable (5.50e-4)" "unprognostic (6.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.72e-2)" 24.2 19.0 14.0 13.2 15.7 7.0 13.5 11.9 12.4 14.7 12.3 16.8 12.3 12.5 17.5 16.3 12.8 20.8 16.5 10.4 14.1 9.3 13.1 13.6 11.9 13.7 13.6 10.0 17.8 19.7 12.8 17.4 8.8 10.5 17.4 9.4 18.0 15.0 11.1 9.7 8.8 12.4 14.7 11.7 17.5 13.3 7.8 11.3 10.0 13.0 12.0 12.4 14.2 13.6 18.0 28.7 18.5 25.2 19.1 14.0 15.4 7.6 15.1 9.6 11.6 8.9 12.4 5.8 7.7 5.9 6.0 7.8 1.5 22.8 9.7 19.4 4.7 9.2 9.0 6.0 7.3 8.0 13.5 8.6 21.7 4.1 6.1 8.8 6.8 8.1 9.7 9.8 10.6 12.7 9.7 8.7 12.1 8.7 12.4 10.3 3.9 1.7 14.3 7.8 21.1 14.4 10.0 11.6 7.4 5.3 7.7 8.3 12.5 10.5 4.2 5.4 5.9 20.0 9.8 11.1 7.3 6.7 8.6 8.3 7.2 6.0 8.0 5.9 14.2 12.9 18.5 25.2 10.1 14.0 18.8 12.2 18.0 13.3 13.2 28.7 13.7 11.5 13.5 9.6 19.1 17.4 24.9 11.7 15.4 14.0 15.7 11.9 12.4 14.1 9.3 13.6 10.0 10.5 11.3 17.9 12.0 16.9 15.8 10.8 6.9 7.7 10.2 20.1 6.8 14.0 0.0 24.0 23.2 17.4 1.1 15.8 5.2 0.0 14.1 15.6 17.7 11.9 3.5 13.9 37.3 22.3 10.4 17.2 20.5 1.1 9.5 19.0 16.9 21.6 10.0 21.8 12.4 0.0 15.6 16.2 12.2 25.8 16.5 14.6 10.2 12.4 8.1 13.6 13.3 15.2 TMEM219 IGFBP-3R ENSG00000149932 "Transmembrane protein 219" Q86XT9 16 29940885-29973052 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA059185 Approved NA NA "HPA059185: AB_2683941" "unprognostic (4.13e-2)" "unprognostic (1.94e-3)" "unprognostic (1.51e-1)" "prognostic favorable (5.79e-4)" "unprognostic (2.62e-1)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (9.83e-2)" "unprognostic (8.53e-2)" "unprognostic (1.71e-1)" "unprognostic (4.18e-1)" "unprognostic (1.19e-1)" "unprognostic (3.10e-2)" "unprognostic (1.31e-1)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-3)" 33.0 35.9 49.0 27.8 47.1 22.0 69.7 17.1 31.3 33.9 43.1 25.4 54.5 39.9 24.4 54.0 32.4 43.5 46.9 48.1 38.4 32.2 35.0 37.1 71.9 50.7 41.3 24.8 28.3 59.2 31.9 23.3 18.7 26.8 31.6 27.9 25.8 61.1 71.3 25.8 26.5 55.9 28.3 41.3 29.2 32.8 46.8 24.8 20.1 33.5 22.1 22.2 24.9 37.4 41.9 58.3 83.8 66.2 23.6 46.1 56.3 14.3 16.9 14.9 19.0 40.3 41.3 17.5 14.9 30.1 22.2 29.2 8.3 42.6 12.3 28.4 36.0 16.1 8.5 8.2 20.8 9.8 19.7 16.9 11.1 13.1 26.7 46.9 7.1 27.9 37.9 30.6 15.6 12.9 42.3 34.9 32.2 7.4 23.8 27.7 15.0 10.3 23.1 8.9 28.4 11.4 19.9 9.5 26.0 38.3 9.2 8.6 17.3 5.2 10.3 26.3 20.7 17.1 26.9 19.9 18.0 10.9 9.0 6.9 19.1 6.5 9.9 24.1 25.3 15.0 71.8 66.2 83.8 30.5 47.5 31.1 41.9 43.2 31.6 53.6 40.2 41.0 31.8 31.3 23.6 34.2 58.3 46.1 56.3 49.0 47.1 17.1 31.3 38.4 32.2 41.3 24.8 26.8 24.8 65.5 121.8 77.5 115.3 59.5 24.1 68.3 150.3 128.5 75.1 167.5 9.8 68.8 213.9 167.6 143.1 112.6 336.7 0.0 209.1 192.8 95.5 172.9 138.6 139.5 239.6 15.9 173.2 170.0 219.0 402.4 80.3 197.6 158.6 157.9 237.6 52.4 193.0 244.1 94.4 301.2 24.1 51.8 104.0 89.4 103.1 68.6 59.5 97.8 188.0 187.7 TMEM220 ENSG00000187824 "Transmembrane protein 220" Q6QAJ8 17 10699015-10730316 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 58.2" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 146.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047680 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047680: " "unprognostic (1.71e-2)" "unprognostic (4.60e-2)" "unprognostic (6.31e-3)" "unprognostic (4.04e-3)" "unprognostic (1.05e-3)" "unprognostic (1.84e-4)" "prognostic favorable (2.23e-5)" "unprognostic (4.58e-2)" "unprognostic (4.96e-3)" "unprognostic (2.81e-1)" "prognostic favorable (1.72e-4)" "unprognostic (2.97e-1)" "unprognostic (4.34e-3)" "unprognostic (2.25e-1)" "unprognostic (2.63e-2)" "unprognostic (7.80e-3)" "unprognostic (5.97e-2)" 6.5 7.4 4.5 2.4 4.6 3.3 7.8 1.3 2.8 4.7 6.1 3.8 14.3 8.1 4.9 11.1 3.3 3.9 10.1 6.3 3.8 2.4 6.4 58.2 4.6 3.1 2.9 1.2 4.8 6.0 2.4 2.4 1.7 4.9 12.0 2.8 6.6 3.5 18.5 4.1 3.7 15.4 5.4 2.5 4.7 7.1 17.2 3.5 0.6 9.4 2.6 2.4 4.1 3.4 11.6 2.9 2.3 2.5 4.5 9.0 1.9 0.5 3.5 1.3 8.3 5.2 5.2 1.0 6.9 7.3 4.7 6.8 0.0 0.3 1.2 0.5 4.3 0.4 0.4 3.4 0.6 3.5 0.4 1.5 0.5 0.2 2.9 7.6 0.9 0.8 3.4 0.4 1.5 0.3 1.0 2.2 3.0 0.4 0.3 3.0 0.4 1.1 1.5 5.0 0.4 0.0 4.8 0.2 0.6 11.1 0.2 0.5 6.0 0.3 0.1 0.7 1.9 0.4 1.8 4.8 0.4 1.3 2.6 0.4 0.8 0.3 0.3 4.9 1.4 0.6 1.4 2.5 2.3 0.9 1.8 1.1 4.2 2.2 1.3 2.9 11.6 9.0 6.1 2.1 4.5 0.8 2.3 0.4 1.9 4.5 4.6 1.3 2.8 3.8 2.4 2.9 1.2 4.9 3.5 3.0 8.3 5.6 13.2 8.5 1.5 8.8 56.0 8.1 11.4 17.4 7.9 10.1 18.3 13.7 72.2 7.9 60.8 23.3 20.8 20.6 12.0 37.1 39.3 146.5 20.4 0.0 2.9 10.4 11.8 12.5 16.7 5.4 23.6 6.4 15.2 44.1 14.9 28.8 9.2 20.3 22.1 19.4 9.6 52.0 7.5 6.9 3.8 2.5 10.0 21.1 TMEM221 ENSG00000188051 "Transmembrane protein 221" A6NGB7 19 17435509-17448567 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 11.4" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 13.7;Muller glia cells: 51.3;Rod photoreceptor cells: 22.4" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 7.4;PC-3: 11.3;REH: 6.3" "HPA041580, HPA062945" Supported Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA041580: AB_10795700, HPA062945: " "unprognostic (3.60e-2)" "unprognostic (7.86e-2)" "unprognostic (4.51e-4)" "unprognostic (2.09e-2)" "unprognostic (2.61e-2)" "unprognostic (9.14e-3)" "unprognostic (3.19e-1)" "unprognostic (2.42e-1)" "unprognostic (1.72e-2)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (9.47e-4)" "unprognostic (2.37e-2)" "unprognostic (6.67e-2)" "unprognostic (2.76e-1)" "unprognostic (2.42e-2)" "unprognostic (1.23e-1)" 1.0 6.1 5.4 0.7 2.9 0.5 1.6 1.3 7.0 0.9 0.8 1.1 0.0 0.4 1.2 3.1 0.9 6.2 1.5 1.2 6.0 2.1 0.7 0.4 0.7 0.6 1.2 2.5 11.4 5.4 10.2 2.5 0.5 3.3 3.8 0.4 6.5 3.3 4.6 0.6 1.2 0.6 0.6 3.1 0.5 0.6 2.4 1.8 0.0 1.4 1.1 0.4 0.9 3.3 0.0 1.6 0.0 0.1 0.0 0.7 0.1 0.8 2.5 1.0 7.4 0.0 0.0 0.2 0.3 0.0 0.1 0.4 0.1 0.2 0.2 1.5 0.0 0.6 0.3 2.2 0.1 0.0 0.1 1.9 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.7 0.0 0.5 0.1 0.1 0.0 0.1 0.2 0.3 1.6 0.6 11.3 6.3 0.2 0.0 0.5 0.5 0.1 0.3 0.0 0.0 0.1 0.7 0.3 0.3 0.1 0.1 0.2 0.3 0.1 0.5 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.1 5.4 2.9 1.3 7.0 6.0 2.1 1.2 2.5 3.3 1.8 0.0 0.3 0.0 0.1 0.0 0.9 0.3 2.5 0.0 0.0 0.0 13.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 1.6 0.0 1.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 51.3 0.1 0.0 1.1 0.0 22.4 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 TMEM222 "C1orf160, DKFZP564D0478" ENSG00000186501 "Transmembrane protein 222" Q9H0R3 1 27322145-27336400 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016579, HPA059374" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA016579: AB_2669392, HPA059374: AB_2683995" "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.39e-3)" "unprognostic (1.52e-1)" "unprognostic (1.33e-1)" "unprognostic (4.11e-2)" "unprognostic (1.16e-1)" "unprognostic (2.51e-2)" "unprognostic (1.96e-2)" "unprognostic (2.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.29e-3)" "unprognostic (5.28e-2)" "unprognostic (1.56e-1)" "unprognostic (3.83e-2)" "unprognostic (7.80e-2)" 18.4 22.0 28.0 12.0 31.4 19.5 17.8 23.2 45.4 18.1 17.1 32.1 13.2 14.4 16.5 25.0 22.8 29.8 21.3 27.5 28.9 30.8 20.6 35.0 18.8 15.0 26.0 20.8 22.3 24.6 19.9 22.4 20.0 26.7 22.9 14.3 26.4 21.7 25.2 19.9 15.6 21.3 18.6 21.5 15.2 16.7 20.7 16.4 19.4 24.0 14.9 19.1 17.8 13.3 22.8 19.9 36.5 21.0 19.2 23.2 15.7 12.2 14.9 12.5 20.5 19.6 14.2 10.1 19.0 21.9 26.0 22.2 6.1 25.8 7.8 14.9 20.2 12.1 17.0 13.7 18.5 10.9 10.3 26.3 13.0 12.4 14.0 29.1 12.9 13.0 24.8 10.5 24.9 14.2 12.0 17.3 15.6 9.8 18.1 16.2 10.9 18.5 13.6 23.5 12.7 18.7 15.4 8.7 15.7 25.2 7.2 27.0 23.8 14.7 20.8 18.3 4.7 20.5 20.9 15.8 15.4 13.0 24.7 17.9 19.5 17.3 8.1 23.3 25.1 22.1 19.3 13.7 17.0 22.3 20.3 17.0 22.8 20.7 17.0 12.0 18.9 20.9 21.4 36.5 19.2 21.0 19.9 23.2 15.7 28.0 31.4 23.2 45.4 28.9 30.8 26.0 20.8 26.7 16.4 8.9 15.7 15.7 11.9 10.4 39.6 7.7 10.2 5.3 5.7 12.2 13.7 26.0 33.2 33.2 19.8 15.4 22.2 23.3 35.0 28.5 23.5 15.6 16.2 11.3 24.4 41.3 28.7 9.2 9.1 60.6 18.7 11.4 25.3 29.7 17.4 52.7 36.4 17.5 18.7 17.0 17.1 12.9 14.6 18.9 17.7 11.8 25.7 22.3 19.1 10.1 TMEM223 MGC3196 ENSG00000168569 "Transmembrane protein 223" A0PJW6 11 62771629-62792021 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014504 Approved Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA014504: AB_1853881" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.87e-1)" "unprognostic (3.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-2)" "unprognostic (3.20e-3)" "unprognostic (1.97e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-3)" "unprognostic (1.29e-1)" "unprognostic (2.50e-1)" "unprognostic (5.20e-2)" "unprognostic (7.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.14e-3)" "unprognostic (9.75e-2)" 10.9 20.6 12.8 13.4 19.5 8.7 11.6 11.1 25.5 11.7 15.2 13.4 12.0 16.6 12.7 15.5 12.3 11.9 11.8 21.7 12.6 12.8 19.5 20.4 10.5 16.2 12.4 15.6 12.5 38.7 10.4 13.0 10.9 13.2 14.8 11.6 13.9 22.4 15.0 21.3 16.2 18.2 8.4 11.1 16.1 16.2 8.2 11.6 19.0 13.4 10.6 14.2 11.1 10.2 32.4 28.0 8.9 16.6 23.1 30.7 15.3 15.3 13.2 7.9 10.8 6.3 7.3 10.8 8.3 7.3 9.4 7.9 11.5 18.9 11.6 20.5 5.9 12.4 23.5 9.5 10.2 5.4 18.3 17.8 8.6 14.8 13.7 11.7 10.5 10.2 7.8 10.4 6.2 7.8 11.1 7.2 15.4 13.0 8.7 6.9 22.4 10.5 23.4 15.6 16.1 16.0 13.1 9.6 25.8 14.5 9.8 13.5 17.9 8.7 17.7 21.9 8.4 26.4 9.9 7.5 11.3 13.6 10.3 9.8 17.9 14.2 13.2 13.4 9.5 11.7 7.3 16.1 8.9 28.4 16.6 27.2 28.2 28.1 27.6 17.5 32.4 30.7 29.8 7.5 23.1 10.5 28.0 23.9 15.3 12.8 19.5 11.1 25.5 12.6 12.8 12.4 15.6 13.2 11.6 11.9 3.5 22.6 13.7 11.9 18.5 16.8 40.8 36.1 13.6 19.2 11.8 41.9 53.0 32.8 1.9 17.5 26.1 0.0 38.3 35.7 20.6 16.0 19.6 34.8 32.6 6.4 19.8 31.3 19.6 2.6 30.2 16.6 18.6 16.2 29.2 14.8 31.4 14.0 24.8 47.6 17.3 19.4 9.6 6.3 21.2 12.2 11.9 29.9 38.6 14.5 TMEM225 "PMP22CD, PPP1R154, SPATA47" ENSG00000204300 "Transmembrane protein 225" Q6GV28 11 123882926-123885642 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 79 "testis: 35.8" "Cell type enriched" "Detected in some" 4 "Early spermatids: 78.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.38e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.9 0.8 0.0 0.0 0.0 0.0 0.0 TMEM225B ENSG00000244219 "Transmembrane protein 225B" P0DP42 7 99598066-99610813 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 86.7" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 4.0;Club cells: 1.2;Exocrine glandular cells: 2.2;granulocytes: 1.1;Proximal tubular cells: 1.4;Syncytiotrophoblasts: 1.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 14.6;U-266/70: 8.2" "Low region specificity" "Detected in all" NA NA "unprognostic (1.91e-3)" "unprognostic (5.04e-3)" "unprognostic (1.04e-1)" "unprognostic (1.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.95e-1)" "unprognostic (6.27e-3)" "unprognostic (2.75e-2)" "unprognostic (1.11e-1)" "unprognostic (2.58e-2)" "unprognostic (1.25e-1)" "unprognostic (7.08e-2)" "unprognostic (1.62e-1)" "unprognostic (4.00e-1)" "unprognostic (6.86e-2)" "unprognostic (1.17e-1)" "unprognostic (2.50e-1)" 0.1 0.2 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 1.1 0.1 0.6 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.0 86.7 0.1 0.1 0.4 0.1 0.1 0.1 0.1 4.5 3.6 2.9 0.3 3.0 3.6 1.8 1.2 1.8 0.9 0.2 4.9 1.3 0.0 0.6 3.1 1.7 2.1 0.2 1.1 1.3 0.0 0.1 0.6 0.1 0.5 0.1 3.6 4.6 0.8 0.2 0.0 0.3 1.4 1.0 1.0 0.4 0.6 0.1 2.8 5.9 0.0 2.3 0.8 14.6 0.7 0.0 2.5 5.4 0.1 0.0 0.0 0.8 1.3 1.9 0.5 0.0 0.6 1.4 0.3 0.0 0.5 0.7 0.0 0.7 0.1 0.7 2.3 4.3 0.2 8.2 1.8 2.8 0.8 1.7 1.4 0.0 0.1 2.9 1.7 0.3 3.0 2.9 2.2 1.1 1.2 4.5 2.1 3.6 0.7 3.0 0.3 3.6 1.4 1.8 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 TMEM229A ENSG00000234224 "Transmembrane protein 229A" B2RXF0 7 124030916-124033023 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;intestine: 16.4;testis: 10.6" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 3.3;Cytotrophoblasts: 1.9;Muller glia cells: 1.3" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 44 "SH-SY5Y: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056391 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA056391: AB_2683114" "unprognostic (2.52e-2)" "unprognostic (3.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.50e-1)" "unprognostic (2.89e-2)" "unprognostic (8.21e-2)" "unprognostic (4.74e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 0.4 1.5 6.9 0.5 7.6 0.4 0.4 1.3 9.0 0.8 0.5 7.6 0.0 16.4 0.7 1.2 0.4 1.7 0.6 0.9 8.0 4.6 0.5 0.4 0.5 0.4 10.6 4.9 1.0 0.4 2.5 1.0 0.6 5.6 0.8 0.6 0.6 0.7 0.5 0.4 0.4 7.7 0.7 7.3 0.6 3.7 10.6 8.7 0.0 0.5 0.0 0.4 1.1 0.1 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.1 0.0 6.9 7.6 1.3 6.1 8.0 4.6 10.6 4.9 5.6 8.7 0.0 0.0 0.0 0.0 0.0 3.3 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 TMEM229B "C14orf83, FLJ33387" ENSG00000198133 "Transmembrane protein 229B" Q8NBD8 14 67447084-67533739 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.8;ductus deferens: 27.5" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 13.7;Early spermatids: 11.9;Late spermatids: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 9.3;MCF7: 9.7;SK-MEL-30: 8.2;U-937: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046562 Approved NA NA "HPA046562: AB_10960265" "prognostic favorable (5.38e-4)" "unprognostic (6.55e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.21e-5)" "unprognostic (7.37e-2)" "unprognostic (1.08e-1)" "unprognostic (1.09e-1)" "unprognostic (2.01e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (2.76e-3)" "unprognostic (1.95e-2)" "unprognostic (5.18e-1)" "unprognostic (8.66e-2)" "unprognostic (1.22e-1)" "unprognostic (8.20e-2)" "prognostic favorable (1.79e-5)" 1.6 14.5 9.4 5.2 7.1 1.6 3.8 27.8 11.5 11.8 5.9 2.7 27.5 15.9 1.5 11.9 1.3 2.2 4.2 1.7 10.6 7.9 2.2 1.5 3.5 8.3 9.0 5.7 1.2 5.7 5.8 8.1 7.7 13.3 2.9 3.4 5.1 4.1 11.8 0.6 1.4 14.1 3.3 6.5 9.4 4.2 5.6 2.0 8.9 9.7 0.0 6.1 5.9 1.7 1.2 2.8 8.7 6.9 5.5 11.0 5.0 2.2 0.3 0.0 0.6 0.2 0.0 0.9 0.4 0.5 0.6 2.5 0.0 7.4 9.3 0.0 0.2 2.1 0.0 0.2 0.5 0.1 3.0 0.7 5.6 0.0 0.0 0.8 6.0 1.1 0.1 0.3 0.1 0.0 0.1 0.0 0.6 0.1 0.3 0.0 9.7 3.6 2.3 0.1 4.8 0.4 3.4 0.1 1.3 0.1 4.9 1.4 0.3 0.0 3.6 8.2 0.4 7.6 5.8 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.4 24.8 5.2 6.0 5.1 8.7 11.0 6.7 10.6 1.2 6.5 8.7 2.8 1.1 5.7 7.1 0.1 5.5 6.9 1.6 2.6 5.0 9.4 7.1 27.8 11.5 10.6 7.9 9.0 5.7 13.3 2.0 0.0 0.3 1.3 0.3 0.2 2.9 1.2 2.5 0.0 0.0 0.0 13.7 0.0 0.0 1.2 11.9 1.3 4.2 0.0 3.1 0.0 0.2 0.3 0.0 0.0 1.7 0.0 2.4 3.7 4.3 16.7 0.0 1.1 6.8 1.8 4.7 0.2 0.6 1.9 0.7 0.8 3.7 0.0 0.2 0.5 0.2 0.1 0.1 4.3 1.9 0.7 TMEM230 "C20orf30, HSPC274" ENSG00000089063 "Transmembrane protein 230" Q96A57 20 5068232-5113103 "Predicted membrane proteins, Transporters" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009078, HPA061421" Uncertain Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA009078: AB_1078345, HPA061421: AB_2684513" "unprognostic (1.39e-1)" "unprognostic (3.61e-1)" "unprognostic (3.73e-1)" "unprognostic (1.28e-1)" "unprognostic (3.71e-2)" "unprognostic (9.67e-3)" "unprognostic (5.85e-3)" "unprognostic (4.34e-3)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "unprognostic (2.74e-1)" "unprognostic (4.07e-2)" "unprognostic (9.70e-2)" "unprognostic (2.31e-1)" "unprognostic (2.09e-1)" "unprognostic (2.84e-2)" "unprognostic (1.55e-2)" 40.0 40.4 34.3 17.1 27.9 15.6 80.9 20.2 44.8 35.7 29.9 23.2 33.3 18.7 30.2 39.0 26.0 27.4 31.4 49.7 32.7 36.1 44.6 81.0 32.9 49.2 41.1 23.1 31.5 53.5 22.4 31.5 21.8 25.8 33.8 27.9 27.4 26.8 31.0 32.4 10.6 29.4 28.1 44.3 20.6 25.8 24.0 16.4 18.8 42.5 24.9 22.2 31.5 18.9 45.6 44.7 30.5 49.2 39.1 48.2 78.3 33.3 23.5 30.9 23.2 70.0 62.5 23.6 27.1 40.8 26.8 29.7 18.5 33.4 16.0 22.3 39.1 30.6 27.8 22.9 40.4 38.9 17.8 26.3 28.3 7.3 56.8 44.8 32.7 11.8 43.1 45.2 20.5 41.3 37.5 35.2 35.8 26.4 44.4 43.8 9.5 32.9 30.6 23.5 64.2 33.6 21.4 20.7 34.3 40.2 17.2 26.1 31.7 16.3 34.3 56.3 34.8 27.4 31.3 29.5 34.9 20.4 33.4 29.0 29.7 58.9 31.3 14.0 28.3 36.5 28.4 48.1 30.5 39.3 49.2 48.2 45.6 43.1 41.9 44.7 37.9 45.0 44.3 15.6 39.1 46.1 43.8 38.6 78.3 34.3 27.9 20.2 44.8 32.7 36.1 41.1 23.1 25.8 16.4 53.6 61.3 129.3 107.8 62.5 93.4 47.8 94.3 64.3 48.9 146.5 60.9 146.0 426.1 129.1 144.0 103.4 53.5 46.7 97.3 172.4 154.3 157.7 111.9 118.4 189.6 58.8 91.9 120.3 153.8 67.6 196.5 153.1 189.0 263.3 96.8 65.8 86.4 119.7 207.2 284.9 89.9 84.1 143.4 110.9 90.6 52.9 123.8 145.1 112.1 128.5 TMEM231 "ALYE870, FLJ22167, JBTS20, MKS11, PRO1886" ENSG00000205084 "Transmembrane protein 231" Q9H6L2 16 75536744-75556286 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 58.4" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 119.1;Cone photoreceptor cells: 49.1;Rod photoreceptor cells: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA042081 Enhanced Approved Vesicles NA NA Vesicles "HPA042081: AB_10795391" "unprognostic (4.29e-2)" "unprognostic (9.84e-2)" "unprognostic (8.07e-2)" "unprognostic (2.71e-3)" "unprognostic (1.03e-1)" "unprognostic (9.34e-2)" "unprognostic (2.90e-2)" "unprognostic (2.81e-1)" "unprognostic (2.92e-1)" "unprognostic (1.69e-2)" "unprognostic (3.34e-3)" "unprognostic (7.84e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (1.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.28e-1)" 3.7 5.3 7.9 2.8 14.7 2.5 4.1 5.0 12.4 7.1 4.1 16.6 3.6 4.0 6.4 10.1 3.1 58.4 4.8 7.9 9.1 9.9 4.7 2.5 7.3 2.7 6.5 9.9 14.3 4.7 6.6 7.7 3.6 14.3 5.4 3.5 6.6 3.1 5.6 1.9 3.3 4.2 7.7 6.2 2.7 3.2 8.5 6.6 0.2 8.0 1.0 2.2 3.5 3.0 5.0 3.2 6.2 0.9 1.0 3.5 1.3 3.9 2.4 6.3 10.5 6.1 15.1 3.5 4.3 5.6 5.4 6.6 1.5 6.3 4.3 6.1 6.2 4.6 9.5 0.7 5.0 3.3 0.8 2.6 0.2 3.2 1.4 5.4 2.4 1.9 3.3 6.2 5.5 13.4 9.8 3.8 4.1 4.2 0.2 1.6 10.1 1.5 4.7 3.8 0.6 2.2 0.8 0.9 9.6 7.0 1.4 5.3 3.5 8.7 2.2 4.0 2.2 2.0 2.7 5.6 4.2 3.6 2.7 2.3 8.2 7.2 1.3 10.6 1.2 4.2 3.0 0.9 0.6 1.7 0.9 3.5 5.0 1.8 2.9 2.5 2.4 1.6 2.4 6.2 1.0 0.5 3.2 0.5 1.3 7.9 14.7 5.0 12.4 9.1 9.9 6.5 9.9 14.3 6.6 3.0 4.6 0.0 4.2 0.9 15.3 4.0 0.0 119.1 19.4 7.0 49.1 1.0 0.0 2.5 14.1 4.9 4.6 0.0 2.0 0.9 3.1 3.9 1.1 1.1 0.8 12.7 2.9 3.7 0.8 3.3 1.7 1.8 0.0 4.6 5.9 6.0 1.5 4.5 3.5 1.4 33.5 0.0 3.7 10.8 9.0 0.9 0.2 1.0 5.0 2.2 TMEM233 IFITMD2 ENSG00000224982 "Transmembrane protein 233" B4DJY2 12 119593459-119643066 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 88.0" "Cell type enriched" "Detected in some" 4 "granulocytes: 76.3" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 12.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 11.5;hTERT-RPE1: 4.7;RH-30: 6.1;U-2197: 9.2;U-87 MG: 37.0" "Not detected" "Not detected" "HPA047506, HPA075435" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047506: AB_10963068, HPA075435: " "unprognostic (1.46e-2)" "unprognostic (1.16e-2)" "unprognostic (1.39e-3)" "unprognostic (1.03e-2)" "unprognostic (1.99e-3)" "unprognostic (1.71e-2)" "unprognostic (5.86e-2)" "unprognostic (1.55e-2)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (4.41e-2)" "unprognostic (6.06e-2)" "unprognostic (3.10e-3)" "unprognostic (2.94e-1)" "unprognostic (4.38e-2)" "unprognostic (3.66e-1)" 0.6 0.3 0.8 0.0 0.4 0.0 0.6 0.1 8.8 0.2 0.2 0.0 0.0 0.1 0.9 0.6 0.2 0.2 1.0 0.7 0.2 0.5 0.5 0.3 0.6 0.2 0.1 1.4 0.6 0.1 1.7 0.4 0.0 0.4 0.4 0.1 0.7 0.5 0.3 88.0 0.1 0.2 0.5 0.3 0.2 0.2 0.2 0.0 0.1 11.1 5.2 0.3 0.4 1.8 0.3 0.3 0.7 0.1 0.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 11.5 0.0 4.7 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.2 0.3 0.3 0.2 0.0 0.3 0.2 0.5 0.7 0.6 0.1 0.3 0.1 0.1 0.8 0.4 0.1 1.5 0.2 0.5 0.1 1.4 0.4 0.0 3.0 1.4 0.0 0.3 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 7.2 6.8 0.0 0.0 7.8 0.0 0.4 0.3 76.3 0.0 0.1 7.9 0.0 18.4 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 2.1 0.0 0.2 2.3 0.2 0.1 0.1 0.0 0.0 0.2 TMEM234 "C1orf91, dJ622L5.7, FLJ90779, RP4-622L5" ENSG00000160055 "Transmembrane protein 234" Q8WY98 1 32214472-32222359 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015049 Uncertain Approved Vesicles NA NA Vesicles "HPA015049: AB_1856409" "unprognostic (1.39e-2)" "unprognostic (1.36e-1)" "unprognostic (1.52e-1)" "unprognostic (1.26e-1)" "unprognostic (2.44e-3)" "unprognostic (3.09e-1)" "prognostic unfavorable (2.35e-5)" "unprognostic (2.67e-1)" "unprognostic (1.07e-2)" "unprognostic (6.49e-2)" "unprognostic (2.66e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.12e-5)" "unprognostic (1.95e-1)" "unprognostic (2.44e-1)" "unprognostic (7.92e-2)" "unprognostic (2.37e-2)" 7.9 9.2 7.0 9.5 9.2 5.7 8.6 9.5 12.2 9.4 9.4 9.9 21.9 5.0 9.6 22.2 10.4 11.8 12.3 11.0 7.4 8.4 11.5 7.3 9.8 9.9 6.0 7.6 12.6 10.8 14.5 14.9 12.5 6.6 10.2 9.3 14.8 8.8 25.0 6.3 5.3 7.4 9.6 5.8 9.0 9.4 15.9 4.7 8.6 15.3 4.0 9.4 6.8 9.0 5.2 7.5 23.2 8.3 7.0 6.4 4.1 8.2 6.8 3.6 3.9 10.5 8.3 4.0 12.2 9.0 6.3 4.8 4.5 8.8 2.5 14.2 11.6 4.9 6.9 4.6 9.0 5.6 5.3 5.4 5.2 10.0 5.1 8.0 6.1 3.5 10.7 9.6 6.8 5.0 11.7 9.3 2.7 4.7 1.8 11.0 2.4 2.4 4.9 6.9 2.1 5.0 3.3 2.9 2.9 14.3 4.0 4.7 4.8 9.2 5.2 4.0 12.3 2.4 2.0 11.0 2.4 3.8 9.1 8.7 3.1 1.5 1.2 7.2 2.3 8.4 11.7 8.0 11.9 4.1 8.3 6.4 4.5 3.3 4.4 7.5 5.2 2.4 3.0 23.2 7.0 5.9 5.6 1.9 4.1 7.0 9.2 9.5 12.2 7.4 8.4 6.0 7.6 6.6 4.7 8.9 1.0 5.8 6.2 2.4 5.6 2.8 2.5 22.7 6.8 22.7 2.0 22.7 1.7 18.9 18.4 7.7 12.9 0.0 13.5 19.1 7.5 6.4 3.5 5.8 16.7 1.6 5.8 9.2 7.5 41.2 8.6 6.3 13.5 15.4 10.8 8.0 15.1 11.5 7.4 9.8 11.5 6.5 6.9 26.5 15.3 2.8 17.8 5.7 8.4 5.8 TMEM235 ENSG00000204278 "Transmembrane protein 235" A6NFC5 17 78231310-78240987 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 26 "brain: 33.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 15 "glioma: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.0;HUVEC TERT2: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA053939 Uncertain NA NA "HPA053939: AB_2682316" "unprognostic (1.47e-1)" "unprognostic (6.91e-3)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" 1.0 1.0 12.2 1.0 17.4 1.0 1.0 2.0 25.6 1.0 1.0 33.0 0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 20.9 9.7 1.0 1.0 1.0 1.1 18.3 8.6 1.1 1.0 1.0 0.0 1.2 10.3 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0 1.0 20.7 1.0 1.0 1.2 18.0 0.0 1.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 17.4 2.0 10.2 20.9 9.7 18.3 8.6 10.3 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM236 "bA162I21.2, bA16O1.2, FAM23A, FAM23B" ENSG00000148483 "Transmembrane protein 236" Q5W0B7 10 17752252-17800868 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "intestine: 76.4" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 63.2;Intestinal endocrine cells: 22.5;Mucus-secreting cells: 22.8;Paneth cells: 49.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "MOLT-4: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA045096 Enhanced NA NA "HPA045096: AB_2732516" "unprognostic (4.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.88e-3)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (3.36e-2)" "unprognostic (2.52e-3)" "unprognostic (1.37e-1)" "unprognostic (3.98e-1)" "unprognostic (1.42e-1)" "unprognostic (5.06e-3)" "unprognostic (1.75e-1)" "unprognostic (1.62e-2)" "unprognostic (1.72e-1)" "unprognostic (3.43e-2)" "unprognostic (3.16e-2)" "unprognostic (1.54e-2)" 0.5 0.3 0.3 4.9 0.3 0.0 0.3 0.3 0.3 0.4 32.0 0.1 0.1 13.7 0.5 0.1 0.4 0.2 0.1 0.3 0.3 0.3 0.5 0.4 0.6 0.1 0.3 0.1 0.3 0.7 0.0 0.3 0.6 0.1 0.3 9.1 0.1 0.3 0.1 0.5 0.3 76.4 0.3 0.3 0.3 0.3 0.5 0.1 0.1 0.3 0.1 0.1 0.3 0.3 1.3 0.9 2.6 0.6 1.0 0.6 0.1 0.3 0.2 0.4 0.5 0.1 0.1 0.6 0.3 0.0 0.1 0.3 0.5 0.5 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.8 0.2 0.5 0.6 0.5 0.5 0.1 0.5 1.6 0.2 0.4 0.2 0.3 0.2 0.4 0.7 0.2 0.4 0.2 0.3 15.3 0.3 0.3 0.1 0.1 0.6 0.4 0.3 0.1 0.3 0.4 0.2 0.2 0.1 0.5 0.6 0.2 0.0 0.7 0.5 0.6 0.2 0.3 0.3 0.2 0.3 0.2 0.2 0.2 2.6 0.6 0.9 0.6 0.4 0.4 0.7 0.5 0.4 0.4 1.3 0.5 0.6 2.2 1.0 0.4 0.9 0.4 0.1 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.1 0.1 0.0 0.3 0.0 0.5 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 63.2 0.0 0.8 0.1 0.0 0.3 1.1 0.0 5.4 0.0 22.5 1.8 4.0 0.4 0.0 4.9 0.0 0.0 22.8 0.2 0.8 49.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 12.7 0.4 TMEM237 "ALS2CR4, JBTS14" ENSG00000155755 "Transmembrane protein 237" Q96Q45 2 201620184-201643570 "Disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 75.8;Rod photoreceptor cells: 139.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052596, HPA054732" Enhanced NA NA "HPA052596: AB_2681879, HPA054732: AB_2682587" "unprognostic (1.70e-1)" "unprognostic (7.10e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (1.73e-1)" "unprognostic (4.06e-1)" "unprognostic (8.30e-6)" "unprognostic (4.15e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.62e-3)" "unprognostic (2.46e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (7.96e-6)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" 6.5 21.5 10.2 2.5 9.5 3.0 15.4 13.6 13.2 8.2 5.3 6.5 3.8 1.6 8.7 6.9 8.8 9.7 6.0 10.0 9.3 9.0 8.1 3.0 7.3 4.0 6.8 11.7 12.5 3.1 11.4 7.2 7.4 10.3 13.0 5.6 13.3 7.6 7.6 18.0 25.0 3.4 9.5 14.2 2.3 4.7 4.4 5.7 5.7 6.8 11.1 4.5 7.9 11.5 1.7 3.0 0.0 2.5 2.0 4.2 1.4 1.9 3.7 17.0 8.6 4.2 5.5 1.6 11.7 5.2 7.8 15.2 3.0 2.7 1.8 3.6 11.2 6.7 3.5 2.9 12.6 14.5 3.4 10.8 5.4 11.9 9.8 8.1 5.2 1.1 4.8 2.7 10.7 2.7 13.1 13.2 12.1 3.9 6.7 15.4 2.7 14.6 8.2 17.1 1.0 12.4 21.9 16.2 3.9 6.1 4.9 17.9 25.1 11.0 4.4 6.5 11.2 6.5 9.5 3.4 14.3 3.9 4.5 4.8 3.2 7.3 5.9 12.0 4.9 8.8 0.0 0.2 0.0 2.5 2.5 2.3 1.7 2.5 4.1 3.0 0.4 3.0 3.7 0.0 2.0 1.6 0.8 4.2 1.4 10.2 9.5 13.6 11.7 9.3 9.0 6.8 11.7 10.3 5.7 6.0 8.1 2.2 75.8 63.3 28.3 17.3 2.5 17.4 17.0 17.4 39.3 17.0 11.6 10.4 5.8 9.0 0.5 0.0 6.9 21.4 26.1 18.5 4.7 2.4 8.3 30.2 4.6 8.0 2.6 5.4 20.1 4.6 11.8 9.0 4.3 31.1 6.5 2.3 20.1 3.9 139.6 6.5 12.0 25.9 18.3 39.5 12.6 3.2 3.5 16.2 TMEM238 ENSG00000233493 "Transmembrane protein 238" C9JI98 19 55379245-55384598 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 43.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 14.5;Intestinal endocrine cells: 13.3;Mucus-secreting cells: 19.6;Paneth cells: 14.2;Suprabasal keratinocytes: 22.7;Undifferentiated cells: 17.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 15.8;CAPAN-2: 10.0;HaCaT: 14.6;RPMI-8226: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.90e-2)" "unprognostic (7.93e-2)" "unprognostic (6.31e-2)" "unprognostic (4.69e-2)" "unprognostic (1.39e-2)" "unprognostic (2.61e-1)" "unprognostic (1.19e-1)" "unprognostic (7.35e-2)" "unprognostic (7.21e-2)" "unprognostic (2.25e-2)" "unprognostic (5.49e-2)" "unprognostic (5.33e-2)" "prognostic favorable (8.84e-6)" "unprognostic (1.78e-3)" "unprognostic (5.55e-2)" "unprognostic (7.91e-3)" "unprognostic (1.17e-3)" 1.6 1.4 0.6 13.1 0.7 1.8 3.6 0.9 1.0 3.8 29.5 0.0 11.8 14.6 1.2 4.5 15.8 2.2 19.1 0.7 0.5 0.5 10.3 27.0 12.4 12.2 0.6 0.0 2.7 43.8 2.0 3.7 0.7 0.7 6.4 2.5 1.3 25.2 11.9 1.6 7.0 36.5 0.7 0.5 3.5 17.1 1.0 0.0 9.3 23.3 13.5 14.8 4.4 3.3 1.5 0.6 0.3 0.2 0.5 3.0 0.4 15.8 1.5 0.0 1.1 0.1 0.0 1.0 0.6 0.1 0.0 0.0 1.2 10.0 7.5 2.9 0.0 0.0 14.6 0.4 0.3 0.0 2.3 1.0 0.3 1.2 0.0 0.0 2.1 0.6 0.0 2.0 0.1 0.3 0.1 0.0 2.2 1.0 6.7 0.0 3.2 2.7 0.8 0.6 4.4 4.9 3.8 0.4 9.8 0.6 5.0 5.6 1.8 0.7 8.0 1.1 0.2 6.2 0.9 0.0 0.3 1.7 0.1 0.2 4.4 2.6 1.9 0.1 1.3 0.2 0.0 0.2 0.3 1.3 0.0 2.4 1.5 2.4 1.7 0.1 1.2 1.9 1.5 0.0 0.5 0.0 0.6 3.0 0.4 0.6 0.7 0.9 0.6 0.5 0.5 0.6 0.0 0.7 0.0 0.0 3.7 0.0 1.7 7.6 0.1 0.8 5.1 0.0 0.0 7.0 0.0 0.0 1.7 1.7 0.0 0.1 14.5 0.0 3.7 0.1 0.8 1.7 0.0 9.2 0.3 3.2 13.3 1.3 0.3 0.0 0.0 0.0 1.7 1.0 19.6 4.2 3.2 14.2 0.0 1.1 1.2 0.0 0.4 0.0 0.0 22.7 0.0 1.3 17.4 2.3 TMEM238L LINC00675 ENSG00000263429 "Transmembrane protein 238 like" 17 10794913-10804099 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 19.9;intestine: 19.0;seminal vesicle: 14.6;stomach 1: 23.0" "Cell type enriched" "Detected in some" 15 "Collecting duct cells: 15.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "OE19: 11.0;RT4: 7.1" "Not detected" "Not detected" NA NA "unprognostic (7.23e-3)" "unprognostic (1.55e-1)" "unprognostic (3.49e-2)" "unprognostic (2.38e-1)" "unprognostic (2.43e-1)" "unprognostic (2.59e-2)" "unprognostic (2.99e-2)" "unprognostic (2.71e-1)" "unprognostic (1.20e-1)" "unprognostic (9.30e-3)" "unprognostic (6.09e-2)" "unprognostic (1.74e-1)" "unprognostic (1.27e-1)" "unprognostic (3.13e-1)" "unprognostic (3.11e-1)" "unprognostic (7.56e-2)" "unprognostic (1.19e-2)" 0.0 0.0 0.2 7.5 0.6 0.0 0.6 0.0 1.0 0.0 18.3 0.0 19.9 8.8 0.0 1.1 3.2 0.0 9.5 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.5 19.0 0.0 0.0 14.6 0.0 0.2 14.0 1.2 0.0 0.0 23.0 0.0 0.0 0.0 0.0 2.8 3.1 6.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.1 0.0 0.0 0.2 0.0 7.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM239 ENSG00000198326 "Transmembrane protein 239" Q8WW34 20 2816302-2820284 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 42.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 109.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "HDLM-2: 13.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.12e-3)" "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.7 0.5 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.5 0.2 0.3 0.2 0.0 0.1 0.2 0.1 0.1 0.3 0.2 0.2 1.7 0.3 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TMEM240 "C1orf70, SCA21" ENSG00000205090 "Transmembrane protein 240" Q5SV17 1 1535174-1540453 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.3" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 3.0;Horizontal cells: 3.2;Muller glia cells: 3.4;Peritubular cells: 2.1;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 9.5;HHSteC: 9.1;SCLC-21H: 10.8;SH-SY5Y: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066721 Supported NA NA "HPA066721: AB_2732750" "unprognostic (2.24e-1)" "unprognostic (1.87e-1)" "unprognostic (5.52e-5)" "unprognostic (2.31e-1)" "unprognostic (2.47e-1)" "unprognostic (1.01e-1)" "unprognostic (1.37e-1)" "unprognostic (3.85e-2)" "unprognostic (3.48e-2)" "unprognostic (1.21e-1)" "prognostic favorable (2.52e-4)" "unprognostic (9.13e-2)" "unprognostic (7.96e-3)" "unprognostic (9.50e-4)" "unprognostic (2.64e-1)" "unprognostic (8.38e-2)" "unprognostic (1.93e-1)" 3.8 4.7 10.8 1.7 17.1 0.8 1.7 24.3 21.8 4.6 5.1 1.8 0.9 1.2 9.1 2.2 1.7 4.2 2.5 3.5 12.2 7.9 1.5 0.8 2.4 1.2 5.6 10.3 10.3 2.1 3.3 3.9 3.7 5.0 4.7 1.5 2.5 4.1 7.9 6.9 2.8 2.9 5.1 2.8 2.6 1.7 2.1 4.9 0.3 1.5 0.2 0.9 2.8 5.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 1.0 6.7 0.7 1.2 5.0 1.5 4.1 2.2 4.3 2.4 0.0 0.4 0.8 0.8 2.1 0.3 2.4 0.1 0.2 0.7 4.1 9.5 0.5 3.1 1.2 9.1 0.0 0.9 6.2 1.9 1.5 0.3 5.1 4.4 0.6 1.3 0.3 0.1 0.2 0.6 0.8 4.2 0.1 1.5 3.8 1.2 0.9 0.4 0.0 10.8 13.2 1.4 0.5 4.3 0.1 0.6 0.0 2.2 0.6 1.9 0.8 1.9 2.0 0.5 0.5 2.3 2.7 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 17.1 24.3 16.5 12.2 7.9 5.6 10.3 5.0 4.9 0.0 0.0 0.0 0.2 0.0 3.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 3.2 0.0 1.3 0.0 0.0 1.1 0.0 0.0 0.0 0.9 3.4 0.1 0.0 2.1 0.0 0.5 6.5 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.1 TMEM241 "C18orf45, FLJ44259, MGC11386" ENSG00000134490 "Transmembrane protein 241" Q24JQ0 18 23197144-23437961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029489, HPA059922" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA029489: AB_2673067, HPA059922: AB_2684164" "unprognostic (1.44e-3)" "unprognostic (1.92e-1)" "unprognostic (7.80e-2)" "unprognostic (1.02e-2)" "unprognostic (1.37e-1)" "unprognostic (6.48e-2)" "unprognostic (1.15e-4)" "unprognostic (7.07e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (1.81e-3)" "unprognostic (9.53e-3)" "unprognostic (1.15e-1)" "unprognostic (1.42e-1)" "unprognostic (2.95e-1)" "unprognostic (4.93e-1)" "prognostic unfavorable (5.80e-4)" 5.8 3.6 6.4 4.3 11.3 2.6 6.3 2.0 11.9 6.0 4.3 4.2 2.2 4.1 5.7 5.0 5.2 4.6 4.5 4.0 3.9 4.0 3.1 5.4 4.3 3.6 3.1 5.2 4.9 6.5 7.0 6.5 6.1 5.2 2.7 6.3 3.5 4.8 2.6 3.4 3.9 2.9 7.6 3.5 4.1 3.7 2.1 2.6 1.9 6.8 4.9 5.1 5.4 4.7 3.0 2.3 1.3 3.1 8.4 2.2 1.4 3.1 6.2 1.2 4.1 6.5 5.8 3.7 1.5 1.9 1.5 3.5 1.2 7.4 11.9 3.4 2.9 6.8 6.0 3.2 5.5 5.2 1.4 0.4 2.5 4.5 2.6 3.6 2.6 2.0 6.6 6.1 6.2 7.4 4.0 6.7 5.4 5.2 4.2 5.4 3.4 2.7 0.5 1.4 10.6 1.2 2.0 5.6 11.4 2.6 2.3 4.4 4.2 7.3 3.9 4.7 5.5 4.1 1.2 2.5 10.6 2.5 3.7 4.2 8.4 6.4 5.0 3.4 8.0 6.7 1.3 0.7 0.0 1.3 3.1 2.2 1.8 0.2 1.2 2.3 3.0 1.1 1.9 0.0 8.4 1.2 0.7 1.5 1.4 6.4 11.3 2.0 11.9 3.9 4.0 3.1 5.2 5.2 2.6 0.0 5.8 0.0 2.4 2.5 1.0 1.4 0.0 9.4 5.7 3.5 3.9 6.8 0.0 2.0 0.0 1.6 2.0 0.0 1.9 8.0 2.7 3.0 2.3 3.4 2.8 9.5 1.2 3.7 0.3 0.0 1.7 2.1 1.7 0.0 2.9 1.0 2.5 2.5 1.1 3.0 1.1 0.0 2.2 0.5 5.3 3.9 3.9 1.5 2.3 2.6 TMEM242 "BM033, C6orf35" ENSG00000215712 "Transmembrane protein 242" Q9NWH2 6 157289386-157323601 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025764 Approved NA NA "HPA025764: AB_1845742" "unprognostic (5.42e-3)" "unprognostic (6.02e-2)" "unprognostic (1.82e-1)" "unprognostic (1.23e-1)" "unprognostic (6.24e-2)" "unprognostic (2.21e-3)" "unprognostic (2.27e-1)" "unprognostic (2.09e-1)" "unprognostic (1.85e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (7.14e-2)" "unprognostic (1.18e-3)" "unprognostic (1.28e-1)" "unprognostic (6.50e-2)" "unprognostic (2.17e-1)" "unprognostic (2.06e-1)" 10.6 16.8 16.1 8.3 21.0 16.4 10.8 24.6 20.0 11.7 10.6 12.1 9.7 10.3 13.2 15.1 10.0 9.6 8.9 22.4 15.0 14.9 14.9 17.7 8.6 8.7 14.3 15.5 12.2 9.3 15.1 16.3 11.7 21.7 11.8 11.4 7.9 11.7 9.9 18.3 9.5 9.2 13.7 14.3 8.5 10.0 8.0 13.8 8.4 13.3 11.4 9.9 10.5 10.8 13.8 23.7 10.1 16.0 12.8 12.7 9.2 4.6 3.8 7.7 8.4 15.2 9.7 5.8 8.8 8.5 8.7 10.2 4.8 4.6 7.0 11.2 8.8 12.3 8.4 8.1 8.0 9.7 9.8 13.2 10.0 8.4 9.9 15.2 10.0 7.7 9.6 9.2 6.4 13.0 12.3 10.4 8.4 15.2 9.6 8.0 4.5 5.9 13.7 5.5 2.9 7.0 3.6 5.0 10.2 13.3 4.1 10.0 5.5 8.0 5.5 10.3 7.7 5.2 10.4 9.5 6.3 7.3 13.7 11.8 9.0 9.1 6.7 12.8 11.9 9.4 10.1 16.0 9.3 11.7 12.9 11.3 13.8 12.0 11.6 14.7 12.6 10.4 12.0 2.6 12.8 8.8 23.7 12.7 9.2 16.1 21.0 24.6 20.0 15.0 14.9 14.3 15.5 21.7 13.8 11.9 7.7 24.1 17.3 24.5 23.1 44.0 20.4 26.8 9.1 21.0 3.9 44.3 28.2 46.0 8.2 28.4 18.8 23.3 34.1 43.1 30.0 13.7 15.1 26.2 32.4 36.5 9.2 21.5 14.3 4.9 19.5 24.3 40.5 23.4 17.9 25.7 33.1 27.7 25.1 30.0 29.9 58.2 35.5 29.7 33.2 21.2 34.8 23.5 20.3 14.8 TMEM243 "C7orf23, MGC4175, MM-TRAG" ENSG00000135185 "Transmembrane protein 243" Q9BU79 7 87196160-87220587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014918 Uncertain NA Yes "HPA014918: AB_2067447" "unprognostic (5.14e-3)" "unprognostic (7.27e-2)" "unprognostic (1.36e-1)" "unprognostic (3.22e-2)" "unprognostic (2.59e-2)" "unprognostic (1.50e-1)" "unprognostic (3.39e-2)" "prognostic favorable (5.45e-4)" "prognostic unfavorable (6.84e-4)" "unprognostic (4.58e-2)" "unprognostic (2.69e-1)" "unprognostic (6.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.11e-2)" "unprognostic (1.41e-1)" "unprognostic (2.32e-2)" "prognostic favorable (9.13e-4)" 14.3 8.6 7.9 26.0 7.9 11.3 15.9 6.2 9.0 15.1 13.4 5.5 18.8 11.5 15.6 19.3 12.0 13.0 10.7 8.3 7.1 7.1 23.6 3.8 26.6 29.5 7.2 6.9 19.5 33.8 11.2 12.3 15.2 8.4 14.0 8.4 10.3 27.5 18.3 4.4 10.8 19.3 9.8 10.1 26.8 12.5 6.7 6.1 23.8 42.5 6.4 36.6 11.7 22.3 45.4 32.8 10.3 9.4 16.1 37.8 9.9 11.8 7.2 7.2 9.0 17.3 19.5 17.4 9.7 14.8 7.3 13.5 10.0 14.5 25.6 21.5 9.7 13.3 11.4 6.8 9.8 9.8 10.8 18.2 0.4 12.5 21.1 13.6 9.2 2.0 12.8 9.9 5.6 11.3 14.1 10.9 13.5 1.2 13.8 9.9 19.5 11.4 1.5 8.1 1.3 10.0 22.7 21.7 35.0 21.1 9.3 7.9 7.2 7.2 15.1 10.7 13.1 5.6 1.6 5.8 12.4 10.9 31.5 8.4 19.7 16.9 49.6 11.4 8.5 7.2 10.3 9.2 5.8 12.4 9.4 17.8 45.4 22.3 15.5 15.6 44.1 37.8 26.2 4.0 16.1 6.2 32.8 19.7 9.9 7.9 7.9 6.2 9.0 7.1 7.1 7.2 6.9 8.4 6.1 23.8 79.5 136.8 39.7 37.9 5.5 0.8 33.1 33.5 27.3 21.0 37.3 97.6 44.7 21.0 31.6 29.3 9.2 23.3 37.3 35.0 55.2 32.9 2.3 2.9 44.2 11.1 7.0 24.5 49.1 9.8 76.8 45.9 49.0 19.8 23.5 7.7 23.2 28.1 55.5 54.9 11.9 45.3 24.9 16.1 37.2 33.2 28.0 61.8 35.9 37.9 TMEM244 "bA174C7.4, C6orf191" ENSG00000203756 "Transmembrane protein 244" Q5VVB8 6 129831244-129861547 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "pituitary gland: 12.2;retina: 22.7" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 17.7;Rod photoreceptor cells: 21.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 3.9;T-reg: 4.2" "Lineage enriched" "Detected in single" 8 "T-cells: 4.2" "Cell line enhanced" "Detected in some" "HDLM-2: 7.3;LHCN-M2: 8.4;U-2 OS: 2.9;U-251 MG: 6.3;U-266/70: 6.1;WM-115: 4.1" "Not detected" "Not detected" NA NA "unprognostic (4.65e-1)" "unprognostic (3.65e-2)" "unprognostic (1.10e-1)" "unprognostic (1.54e-1)" "unprognostic (1.15e-1)" "unprognostic (2.15e-1)" "unprognostic (9.57e-2)" 0.3 0.2 2.7 0.4 2.7 0.4 0.4 0.2 5.2 0.4 0.5 1.5 0.0 0.0 0.2 1.6 0.3 0.4 0.3 0.7 2.5 0.7 0.7 0.2 0.6 2.3 4.8 3.3 0.2 0.2 0.0 12.2 0.2 0.9 1.1 0.6 22.7 1.2 0.2 1.0 0.4 0.3 0.0 1.9 0.7 1.1 0.4 2.0 0.0 0.3 0.0 2.5 0.8 0.4 0.5 0.0 0.0 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 8.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.9 1.0 6.3 6.1 0.0 0.0 1.7 0.0 4.1 0.0 0.0 0.0 2.5 0.0 0.0 0.5 3.9 1.1 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 4.2 0.4 2.7 2.7 0.2 2.7 2.5 0.7 4.8 3.3 0.9 2.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 TMEM245 "C9orf5, CG-2" ENSG00000106771 "Transmembrane protein 245" Q9H330 9 109015152-109119945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023892 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023892: AB_1845828" "unprognostic (1.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (9.58e-2)" "unprognostic (1.63e-1)" "unprognostic (6.43e-2)" "unprognostic (1.66e-1)" "unprognostic (5.96e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-1)" "unprognostic (1.85e-1)" "prognostic favorable (4.46e-9)" "unprognostic (6.11e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-1)" "unprognostic (2.24e-2)" 16.5 35.5 14.4 7.2 18.1 4.0 24.2 15.7 20.6 14.0 19.2 14.7 22.0 7.7 18.4 17.3 14.6 18.7 15.3 25.2 12.6 14.9 29.0 16.2 20.5 12.3 14.5 14.8 29.0 20.3 43.2 14.9 17.5 13.7 16.4 10.7 22.1 14.5 22.3 29.8 9.2 16.8 23.1 13.6 10.4 17.2 12.2 14.3 12.3 52.1 8.9 7.5 20.8 11.2 3.5 3.5 6.3 3.3 5.4 9.0 2.7 13.7 18.4 13.6 4.6 32.0 18.4 30.0 19.9 15.4 21.5 17.0 24.6 27.7 12.5 20.4 15.1 20.9 21.8 17.2 12.8 25.5 16.1 7.4 15.4 15.4 14.5 14.0 11.7 12.2 19.6 13.1 20.9 19.4 23.2 17.9 13.8 10.3 13.8 24.4 9.1 15.5 5.4 15.1 18.6 16.6 8.9 27.0 7.7 22.9 13.5 7.5 7.4 13.1 13.2 13.1 21.1 17.5 6.6 19.6 16.8 12.6 15.6 22.6 9.2 23.8 4.0 23.3 6.3 24.3 6.3 2.6 2.2 4.0 1.8 4.9 2.7 6.8 5.6 2.5 3.5 9.0 6.2 1.0 5.4 3.3 3.5 6.5 2.7 14.4 18.1 15.7 20.6 12.6 14.9 14.5 14.8 13.7 14.3 107.2 79.6 16.9 16.5 22.3 43.1 117.8 63.7 32.1 31.8 82.0 100.1 40.7 3.3 19.7 5.9 48.2 31.1 93.5 27.0 14.5 19.9 23.7 30.1 82.0 15.7 60.4 30.0 48.5 21.0 5.4 38.0 15.7 21.9 10.0 34.9 49.9 24.5 34.3 48.1 28.4 30.3 45.3 36.0 28.7 40.4 24.8 12.6 17.3 34.3 19.9 TMEM246 "C9orf125, MGC12992" ENSG00000165152 "Transmembrane protein 246" Q9BRR3 9 101473171-101533537 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 42.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "hTCEpi: 14.4;hTERT-RPE1: 16.4;OE19: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011318, HPA054041" Uncertain Approved Mitochondria NA NA Mitochondria "HPA011318: AB_2668482, HPA054041: AB_2682353" "unprognostic (2.58e-2)" "unprognostic (4.76e-2)" "unprognostic (5.52e-1)" "unprognostic (2.81e-3)" "unprognostic (2.72e-2)" "unprognostic (9.15e-2)" "unprognostic (1.20e-3)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (4.24e-1)" "unprognostic (3.51e-2)" "unprognostic (2.09e-1)" "prognostic favorable (1.55e-8)" "unprognostic (1.62e-1)" "unprognostic (1.91e-1)" "unprognostic (2.50e-1)" "unprognostic (9.16e-2)" 3.4 10.2 10.8 3.1 19.4 0.8 2.9 23.2 31.1 17.1 12.6 7.6 1.6 8.0 5.9 4.0 11.0 13.5 7.0 27.3 17.6 20.6 4.6 2.6 5.4 0.8 10.8 14.3 19.4 10.9 19.6 9.2 1.0 23.2 7.0 10.8 8.1 4.6 9.7 4.3 11.2 7.1 6.7 8.5 1.8 15.1 2.9 4.0 0.0 4.3 4.4 2.9 4.7 8.3 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 8.1 6.3 0.0 0.2 0.1 0.0 5.4 7.9 3.9 7.9 0.4 4.3 0.0 1.8 9.8 0.4 12.8 0.0 8.9 2.4 0.0 3.2 4.4 6.1 0.0 0.3 0.0 0.0 3.5 14.4 0.0 2.1 16.4 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 7.8 26.2 0.0 0.0 3.2 0.0 5.9 1.5 10.7 10.1 3.0 0.0 0.0 1.6 0.0 7.5 0.0 6.1 3.8 0.0 0.0 0.5 0.0 0.0 8.7 0.0 2.7 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 10.8 19.4 23.2 31.1 17.6 20.6 10.8 14.3 23.2 4.0 20.8 0.3 0.0 13.2 4.7 38.3 42.4 33.1 9.4 10.3 15.7 3.9 0.0 0.0 12.9 2.2 5.9 16.1 0.0 15.0 0.1 1.5 11.6 0.0 6.2 0.0 15.9 23.6 1.3 0.3 0.8 4.9 0.0 0.0 1.0 35.3 1.4 12.8 38.6 10.6 4.2 4.4 12.9 5.2 2.3 1.0 8.7 0.0 0.0 26.7 23.0 TMEM247 ENSG00000284701 "Transmembrane protein 247" A6NEH6 2 46479565-46484425 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 21.8" "Group enriched" "Detected in some" 18 "Early spermatids: 326.4;Late spermatids: 284.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "U-266/84: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA079482 Enhanced NA NA "HPA079482: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 326.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 284.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 17.3 5.6 0.0 0.0 0.0 0.0 0.0 TMEM248 "C7orf42, FLJ10099, FLJ13090" ENSG00000106609 "Transmembrane protein 248" Q9NWD8 7 66921225-66958551 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016495 Uncertain Approved Vesicles NA NA 1200000 Vesicles "HPA016495: AB_1848643" "unprognostic (6.74e-2)" "unprognostic (1.73e-2)" "unprognostic (4.86e-2)" "unprognostic (4.64e-2)" "unprognostic (6.67e-3)" "unprognostic (9.36e-2)" "unprognostic (1.39e-2)" "unprognostic (4.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.54e-2)" "unprognostic (9.18e-2)" "unprognostic (2.80e-3)" "unprognostic (1.30e-1)" "unprognostic (8.96e-2)" "unprognostic (5.11e-2)" "unprognostic (8.28e-2)" "unprognostic (5.57e-2)" 32.2 33.0 23.8 30.2 30.6 11.9 44.6 28.0 28.4 38.7 32.8 23.8 39.0 32.1 40.6 32.9 26.0 36.1 40.7 28.2 24.6 30.4 30.9 46.3 31.6 38.3 20.9 21.3 40.8 58.4 47.2 28.9 35.6 21.0 34.7 32.4 39.4 36.9 36.8 19.1 23.7 44.8 34.7 23.8 32.6 33.7 33.3 20.6 40.1 37.7 24.0 35.9 33.2 40.7 10.7 10.1 8.6 5.2 9.0 9.3 2.3 18.2 21.5 18.2 25.9 41.5 32.0 16.0 22.5 38.8 21.5 23.3 15.5 24.0 18.6 27.5 30.3 29.4 16.6 15.6 18.6 26.8 17.0 11.5 13.6 15.4 17.9 26.9 22.5 18.9 28.7 21.6 18.0 15.0 31.4 27.9 14.6 25.9 12.5 34.0 11.1 21.1 27.8 27.0 18.9 14.7 15.5 21.2 31.4 29.1 14.1 12.7 27.2 19.8 36.5 19.9 28.4 18.3 20.8 25.7 30.3 14.9 19.7 24.6 15.4 17.3 20.9 25.3 25.2 28.7 2.3 5.0 8.6 7.9 5.2 9.3 9.6 8.5 8.1 3.9 10.7 8.4 8.8 7.4 9.0 3.1 10.1 5.6 2.3 23.8 30.6 28.0 28.4 24.6 30.4 20.9 21.3 21.0 20.6 47.6 36.0 52.8 43.6 57.4 17.6 20.0 56.0 26.8 22.7 50.6 5.9 43.1 10.0 31.7 90.3 43.5 63.0 23.3 40.8 69.9 58.2 82.8 27.7 96.6 46.4 17.5 26.6 55.9 54.2 141.2 59.0 47.5 47.2 24.4 75.1 91.8 47.7 67.4 61.9 30.6 12.3 32.3 48.4 79.2 60.9 64.5 73.7 59.8 53.0 69.4 TMEM249 C8orfK29 ENSG00000261587 "Transmembrane protein 249" Q2WGJ8 8 144352219-144354914 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 70 "testis: 35.1" "Group enriched" "Detected in some" 8 "Early spermatids: 25.7;Late spermatids: 24.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.5;PC-3: 2.3;SK-MEL-30: 2.1" "Low region specificity" "Detected in all" HPA078901 Approved NA NA "HPA078901: " "unprognostic (2.23e-1)" "unprognostic (8.91e-3)" "unprognostic (1.72e-2)" "unprognostic (1.10e-1)" "unprognostic (4.13e-2)" "unprognostic (2.41e-1)" "unprognostic (1.03e-4)" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.30e-1)" "unprognostic (8.44e-2)" "unprognostic (3.21e-1)" "unprognostic (1.13e-7)" "unprognostic (6.56e-3)" "unprognostic (1.62e-2)" "unprognostic (8.44e-3)" "unprognostic (3.46e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.3 0.0 0.6 0.2 0.2 2.5 0.8 0.0 0.3 0.2 0.0 0.7 1.6 0.0 0.3 0.0 0.2 0.0 0.1 0.0 1.5 0.4 0.4 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.8 0.0 2.3 1.7 0.7 0.0 0.0 1.2 1.3 1.7 0.0 0.3 2.1 0.0 0.9 1.0 0.0 0.5 2.0 0.8 0.2 0.6 0.4 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 24.5 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.2 0.0 TMEM25 FLJ14399 ENSG00000149582 "Transmembrane protein 25" Q86YD3 11 118531041-118547280 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 20.3;SK-BR-3: 19.0;T-47d: 24.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012163, HPA051562" Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 4900000 "Golgi apparatus, Vesicles" "HPA012163: AB_1858112, HPA051562: AB_2681535" "unprognostic (1.53e-2)" "unprognostic (7.18e-2)" "unprognostic (2.43e-1)" "unprognostic (6.69e-2)" "unprognostic (3.61e-1)" "unprognostic (6.50e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (1.58e-1)" "unprognostic (3.42e-1)" "unprognostic (1.66e-2)" "unprognostic (8.19e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.15e-1)" "unprognostic (2.51e-1)" "unprognostic (1.26e-1)" "unprognostic (7.01e-2)" 4.8 15.0 15.0 3.7 23.3 1.7 12.0 28.0 36.5 9.4 19.4 9.5 6.7 35.5 10.1 21.2 9.0 9.2 7.1 6.4 11.9 17.0 14.7 10.6 8.0 3.5 10.7 19.5 19.4 14.1 17.3 15.9 4.9 14.0 12.5 3.2 14.4 16.1 15.5 12.7 6.2 26.2 8.7 9.7 4.0 6.7 3.9 5.1 1.5 12.7 4.3 4.6 8.3 6.1 3.8 3.4 0.5 0.2 6.6 11.1 3.8 1.8 0.4 3.3 5.3 3.4 0.5 3.2 2.9 5.5 2.7 5.6 14.7 10.4 0.1 11.4 2.8 6.2 8.2 0.0 10.0 2.4 6.3 6.1 0.2 2.9 3.4 9.0 0.1 0.2 4.2 6.1 3.0 0.5 20.3 3.9 7.5 1.3 6.5 2.7 2.2 3.1 0.2 2.7 0.0 7.1 4.3 2.3 6.5 14.1 0.2 9.8 6.5 2.8 19.0 0.0 5.1 24.7 0.3 1.3 1.2 6.1 0.2 0.8 6.6 4.3 1.6 0.2 0.1 0.1 0.5 0.2 0.2 5.6 0.2 7.5 3.8 7.9 3.1 0.5 3.0 11.1 5.8 0.4 6.6 0.2 3.4 6.1 3.8 15.0 23.3 28.0 36.5 11.9 17.0 10.7 19.5 14.0 5.1 6.0 3.8 3.4 10.2 5.0 24.2 5.0 2.5 10.7 7.9 15.7 27.5 30.1 10.0 14.8 1.7 4.9 1.4 0.0 5.8 13.6 6.0 5.5 9.2 7.7 2.5 11.1 10.9 2.5 0.0 3.8 21.6 0.2 6.8 5.4 3.2 24.3 5.9 1.4 21.9 20.2 34.1 0.0 6.1 4.1 5.1 3.1 13.6 4.1 2.9 2.7 TMEM250 "bA83N9.1, C9orf69" ENSG00000238227 "Transmembrane protein 250" H0YL14 9 136114581-136118863 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 14.0;Cytotrophoblasts: 14.7;Extravillous trophoblasts: 18.7;Hofbauer cells: 13.1;Pancreatic endocrine cells: 13.9;Proximal tubular cells: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066070 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA066070: AB_2685608" "unprognostic (2.79e-2)" "unprognostic (3.47e-1)" "unprognostic (1.34e-2)" "prognostic favorable (1.09e-4)" "unprognostic (4.99e-2)" "unprognostic (2.34e-2)" "unprognostic (4.34e-2)" "unprognostic (1.27e-3)" "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (6.31e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-2)" "unprognostic (9.33e-3)" "unprognostic (1.09e-2)" "unprognostic (2.41e-2)" "unprognostic (1.64e-1)" 16.4 11.4 16.1 15.0 19.4 5.5 25.3 13.8 28.4 12.4 19.3 9.2 8.2 22.5 12.2 10.9 22.2 14.2 13.8 10.7 17.1 9.5 13.0 17.6 15.2 15.2 9.4 14.2 15.9 12.7 9.4 10.1 15.2 9.8 13.4 11.4 7.4 18.3 13.0 33.9 26.8 18.9 14.1 7.7 14.0 17.3 12.8 10.0 15.4 11.2 12.9 12.0 13.2 11.8 3.0 4.6 5.3 6.3 4.7 9.9 3.0 11.0 21.0 8.2 12.2 11.7 10.7 25.7 13.3 9.6 8.1 5.8 11.9 16.2 8.2 15.7 14.2 12.9 28.4 5.8 9.4 2.5 35.3 11.1 6.9 21.9 8.3 16.3 12.5 9.0 9.6 18.1 8.7 9.2 10.4 12.8 8.2 15.5 8.7 7.0 25.5 15.2 10.1 18.2 19.4 23.0 6.2 11.4 13.5 8.8 8.1 14.2 10.8 14.4 10.0 11.4 5.1 9.1 18.9 14.4 14.2 6.3 18.5 14.7 5.1 4.9 4.9 14.2 9.0 13.3 4.9 4.6 2.7 9.9 6.2 7.4 3.0 7.6 8.3 4.6 2.4 3.7 6.9 5.3 4.7 6.3 3.0 3.8 3.0 16.1 19.4 13.8 28.4 17.1 9.5 9.4 14.2 9.8 10.0 6.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 14.0 0.0 14.7 3.3 10.6 0.0 0.0 0.0 0.0 9.1 18.7 0.0 0.0 2.3 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 6.4 0.0 0.0 13.9 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 TMEM251 "C14orf109, DKFZP564F1123" ENSG00000153485 "Transmembrane protein 251" Q8N6I4 14 93184951-93187089 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 96.2;Hofbauer cells: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048559 Uncertain Approved "Golgi apparatus,Cell Junctions" NA NA "Cell Junctions" "Golgi apparatus" "HPA048559: AB_2680441" "unprognostic (1.21e-2)" "unprognostic (4.56e-2)" "unprognostic (4.61e-3)" "unprognostic (3.37e-2)" "unprognostic (2.14e-1)" "unprognostic (4.03e-2)" "prognostic unfavorable (6.14e-7)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (9.99e-3)" "unprognostic (5.80e-3)" "unprognostic (1.58e-1)" "prognostic favorable (1.10e-4)" "unprognostic (5.17e-2)" "unprognostic (1.61e-1)" "unprognostic (7.47e-2)" "unprognostic (6.17e-2)" 15.8 19.5 12.2 10.7 14.3 3.9 23.1 11.5 14.2 21.9 19.6 11.4 19.6 15.5 13.0 26.2 10.8 15.8 11.5 23.2 12.2 12.8 25.0 14.4 24.1 19.1 19.0 11.1 12.4 23.6 16.4 17.2 12.5 15.8 26.1 19.5 18.3 18.7 18.5 22.6 10.4 17.9 11.5 17.3 13.3 16.5 8.7 15.1 14.2 19.4 11.0 11.7 13.3 11.8 6.0 8.7 13.7 12.7 5.4 6.6 4.4 7.1 7.5 10.1 10.7 11.8 4.6 6.8 4.9 5.8 8.6 11.2 5.3 7.4 8.1 10.1 4.7 11.4 9.5 11.0 8.1 11.8 7.3 8.6 6.9 5.6 10.6 11.2 9.5 11.0 6.1 9.3 6.9 11.1 4.5 8.7 9.0 5.6 7.9 6.9 33.9 6.9 7.8 5.9 18.1 8.1 4.1 10.2 7.1 10.7 14.3 9.8 9.2 7.5 4.1 29.1 9.0 11.3 7.0 3.8 4.3 7.0 9.1 6.3 10.5 12.6 8.2 8.1 4.0 6.5 4.8 10.8 13.7 4.7 9.7 3.1 5.3 5.5 5.3 8.7 6.0 6.1 6.6 10.7 5.4 12.7 7.6 4.4 4.4 12.2 14.3 11.5 14.2 12.2 12.8 19.0 11.1 15.8 15.1 3.0 11.8 14.9 29.1 20.6 14.3 17.3 22.9 10.7 9.1 29.6 25.5 33.6 96.2 24.2 1.6 10.0 23.3 0.0 23.1 15.7 13.9 37.4 17.3 14.7 100.3 12.7 14.5 8.0 21.1 1.5 10.9 26.7 30.4 10.0 33.3 20.5 15.7 17.5 10.3 58.4 25.2 38.8 15.6 3.3 14.3 27.1 22.9 10.7 30.8 29.7 TMEM252 "C9orf71, MGC34760" ENSG00000181778 "Transmembrane protein 252" Q8N6L7 9 68536580-68540867 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 16.0;kidney: 64.2" "Cell type enriched" "Detected in some" 9 "Proximal tubular cells: 15.1" "Cancer enriched" "Detected in many" 17 "renal cancer: 35.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "neutrophil: 7.6" "Lineage enriched" "Detected in single" 37 "granulocytes: 7.6" "Group enriched" "Detected in some" 6 "EFO-21: 1.6;PC-3: 3.4;RH-30: 1.9;RPTEC TERT1: 6.5;SK-BR-3: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA079457 Enhanced NA NA "HPA079457: " "unprognostic (2.64e-1)" "unprognostic (3.28e-3)" "unprognostic (3.72e-1)" "unprognostic (1.51e-1)" "unprognostic (2.53e-2)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (6.47e-2)" "unprognostic (1.64e-2)" "unprognostic (6.42e-2)" "prognostic favorable (1.75e-7)" "unprognostic (7.63e-2)" "unprognostic (6.15e-2)" "unprognostic (7.66e-2)" "unprognostic (2.50e-1)" 0.5 2.0 0.4 0.6 0.4 0.0 0.4 0.9 0.4 0.6 5.6 0.4 0.4 1.0 4.3 0.8 4.3 2.7 0.7 3.0 0.4 0.0 64.2 0.9 0.4 0.4 0.4 0.4 0.6 0.4 0.0 0.4 2.6 0.4 1.8 0.0 0.4 0.4 0.4 0.7 0.2 16.0 0.9 0.4 0.4 1.7 0.6 0.4 0.4 0.4 0.4 0.5 6.0 0.6 0.0 0.1 7.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.4 0.0 1.9 0.0 6.5 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.2 0.0 0.0 0.0 0.4 0.4 0.9 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM253 "C14orf176, C14orf95, NCRNA00220" ENSG00000232070 "Transmembrane protein 253" P0C7T8 14 21098937-21103724 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 31 "intestine: 110.5" "Cell type enriched" "Detected in some" 7 "Enterocytes: 67.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA052329, HPA065092" Enhanced NA NA "HPA052329: AB_2681791, HPA065092: AB_2685420" "unprognostic (7.48e-3)" "unprognostic (1.33e-2)" "unprognostic (7.19e-2)" "unprognostic (3.84e-2)" "unprognostic (1.41e-2)" "unprognostic (1.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.90e-2)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (1.28e-2)" "unprognostic (5.46e-2)" "unprognostic (9.93e-2)" "unprognostic (3.59e-1)" "unprognostic (1.80e-1)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" 0.4 1.5 0.4 2.2 0.4 0.0 0.3 0.5 0.5 0.5 32.6 0.4 2.0 41.8 0.4 0.8 0.9 0.2 3.1 0.9 0.3 0.4 0.4 0.5 0.4 0.2 0.5 0.4 0.4 0.7 0.4 0.3 0.5 0.4 0.5 5.7 0.4 2.8 0.7 0.3 0.6 110.5 0.6 0.3 0.4 0.2 0.4 0.2 0.2 3.6 0.8 0.7 0.3 0.5 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.4 0.9 2.7 2.6 4.0 1.0 4.4 1.0 2.0 0.5 0.9 2.3 2.1 3.2 0.6 0.2 0.2 4.1 0.9 5.0 0.6 1.9 0.2 1.6 3.0 2.7 0.6 0.0 0.1 1.9 4.3 2.1 3.3 1.8 0.3 1.3 1.1 0.2 1.3 0.8 0.1 0.3 3.5 4.6 0.1 0.7 1.3 1.7 2.3 2.0 0.7 1.4 1.1 0.8 2.4 2.6 0.8 0.0 0.0 0.0 1.4 0.5 0.3 0.8 0.4 0.0 0.2 1.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.5 0.5 0.3 0.4 0.5 0.4 0.4 0.2 0.0 0.0 0.0 0.7 0.7 0.4 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.1 67.8 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.6 0.2 0.1 5.8 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.5 0.8 0.0 10.0 0.7 TMEM254 "bA369J21.6, C10orf57, FLJ13263" ENSG00000133678 "Transmembrane protein 254" Q8TBM7 10 80078646-80092557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029105, HPA072613" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA029105: AB_2672909, HPA072613: AB_2732205" "unprognostic (9.40e-2)" "unprognostic (1.76e-1)" "unprognostic (9.52e-2)" "unprognostic (5.74e-3)" "unprognostic (5.39e-2)" "unprognostic (6.04e-2)" "unprognostic (3.66e-1)" "unprognostic (3.90e-1)" "unprognostic (1.64e-2)" "unprognostic (1.87e-3)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (7.65e-2)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" "unprognostic (3.45e-3)" "unprognostic (5.96e-2)" 8.4 13.4 10.8 6.0 14.1 4.7 15.9 6.9 13.5 14.1 13.1 11.7 14.7 10.1 12.4 40.1 35.8 17.3 10.5 4.8 9.4 6.3 10.0 30.8 6.8 9.0 7.7 9.0 8.7 12.1 8.3 10.1 14.8 9.5 25.8 13.7 10.7 16.3 9.1 3.0 43.9 13.4 6.6 8.2 6.9 9.0 21.5 8.8 8.6 11.8 12.4 15.4 13.0 20.5 12.6 14.7 27.7 18.1 9.8 22.9 11.9 7.3 7.0 11.9 9.1 14.6 18.3 18.1 7.1 5.2 5.2 5.3 5.3 22.7 5.6 12.1 9.0 4.9 7.8 4.8 5.9 5.5 9.2 8.5 1.5 2.3 7.4 6.6 6.9 7.5 11.8 26.9 4.6 4.0 11.3 4.6 4.8 4.1 12.2 5.2 14.9 5.6 5.1 6.4 6.4 23.0 6.9 1.4 4.8 7.2 6.1 4.2 6.9 6.6 16.5 7.1 8.3 23.4 4.6 6.7 4.1 7.1 6.9 4.0 8.4 11.9 0.4 10.3 7.1 3.4 27.7 16.2 7.4 11.9 18.1 14.9 12.6 13.8 12.3 13.2 9.6 22.9 15.6 1.7 9.8 17.6 14.7 16.0 11.9 10.8 14.1 6.9 13.5 9.4 6.3 7.7 9.0 9.5 8.8 8.9 8.1 6.0 5.0 7.2 7.4 2.6 15.3 37.5 14.8 8.7 15.7 33.9 18.3 12.1 3.1 5.2 10.5 0.0 7.5 30.9 5.3 21.9 5.7 28.8 17.1 15.9 8.1 5.5 11.1 5.9 8.6 9.2 3.3 16.2 22.8 14.5 9.5 18.2 11.0 17.0 11.1 12.9 3.8 24.2 8.7 21.0 19.0 6.9 18.7 6.5 TMEM255A "FAM70A, FLJ20716" ENSG00000125355 "Transmembrane protein 255A" Q5JRV8 X 120258650-120311556 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.4;ovary: 29.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Melanocytes: 5.0;monocytes: 5.4" "Group enriched" "Detected in many" 10 "glioma: 21.3;melanoma: 8.0;renal cancer: 7.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 10 "T-cells: 5.9" "Cell line enhanced" "Detected in some" "Karpas-707: 17.3;NTERA-2: 6.0;RPMI-8226: 11.1;SK-MEL-30: 18.1;U-2 OS: 7.8;U-87 MG: 19.8" "Low region specificity" "Detected in all" HPA048470 Approved Uncertain "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA048470: AB_2680406" "unprognostic (3.41e-2)" "unprognostic (8.96e-2)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" "unprognostic (8.55e-4)" "unprognostic (7.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (2.02e-1)" "unprognostic (1.32e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.17e-2)" "unprognostic (2.55e-4)" 3.9 5.5 6.8 3.4 14.4 1.5 5.4 6.8 7.8 11.2 3.5 12.4 1.7 1.9 3.2 2.9 4.4 6.3 2.1 2.4 5.3 25.4 2.4 1.5 4.8 5.0 30.4 4.4 29.6 1.1 0.6 6.6 0.8 18.4 3.8 3.9 7.1 1.3 3.3 2.4 4.0 2.8 2.0 13.0 2.8 2.1 0.9 7.8 6.4 0.9 1.8 5.7 1.6 8.0 0.5 0.3 0.0 0.6 0.0 5.9 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.3 0.1 0.0 0.1 0.2 0.0 1.8 0.0 1.1 0.4 0.5 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 17.3 0.3 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 3.5 0.2 0.3 0.0 18.1 0.2 0.0 0.2 0.0 0.0 7.8 0.0 2.8 0.0 3.3 2.4 19.8 0.0 0.0 0.0 0.6 0.0 5.9 0.2 3.3 0.5 0.4 2.2 0.3 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.9 6.8 14.4 6.8 3.9 5.3 25.4 30.4 4.4 18.4 7.8 3.0 0.0 0.0 0.0 0.3 0.6 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.6 1.1 0.6 0.7 5.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 1.1 0.1 0.0 0.0 0.0 TMEM255B "FAM70B, MGC20579" ENSG00000184497 "Transmembrane protein 255B" Q8WV15 13 113759240-113816995 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Endothelial cells: 51.3;granulocytes: 39.2;Ito cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 7 "granulocytes: 17.0;monocytes: 4.8" "Cell line enhanced" "Detected in many" "HMC-1: 15.7;HUVEC TERT2: 20.4;PC-3: 20.7;RPMI-8226: 13.2;TIME: 19.1;U-87 MG: 21.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA043334 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043334: AB_10795982" "unprognostic (2.20e-1)" "unprognostic (2.57e-3)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (4.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.13e-1)" "unprognostic (1.99e-1)" "unprognostic (4.49e-3)" "unprognostic (3.00e-2)" "unprognostic (9.39e-2)" "prognostic unfavorable (4.12e-5)" "unprognostic (4.65e-2)" "unprognostic (1.84e-1)" "unprognostic (4.00e-1)" "unprognostic (2.83e-1)" 18.5 6.6 3.9 7.1 4.5 1.5 11.8 2.0 4.7 11.1 3.9 2.3 4.3 3.5 10.1 5.3 3.9 6.6 7.5 7.3 6.5 3.7 9.0 6.6 11.7 7.9 5.4 2.1 4.6 4.7 3.1 8.0 2.4 6.1 8.8 3.2 3.3 3.8 5.1 4.6 6.0 4.5 10.4 4.9 9.5 4.4 4.6 4.0 0.1 12.4 2.4 3.7 8.1 29.9 1.5 1.3 17.0 4.8 0.0 0.0 1.0 5.3 0.0 0.3 0.0 1.5 0.0 0.0 2.5 5.7 2.9 1.8 0.2 0.1 0.1 0.0 3.9 6.8 0.8 0.5 0.3 1.2 0.0 0.6 0.1 0.2 0.0 0.9 1.4 15.7 1.1 1.3 6.3 2.4 8.4 20.4 0.3 0.0 0.1 6.3 0.1 0.7 0.4 0.6 0.8 20.7 0.9 0.4 13.2 2.9 0.2 1.2 2.8 0.1 0.7 0.0 0.6 0.3 4.2 19.1 0.8 5.8 0.3 0.9 0.0 0.0 1.0 21.8 1.4 0.1 17.0 4.8 0.6 0.0 4.5 0.0 0.8 0.0 0.0 1.3 1.5 0.0 0.0 2.2 0.0 3.2 0.0 0.0 1.0 3.9 4.5 2.0 4.7 6.5 3.7 5.4 2.1 6.1 4.0 6.0 7.4 0.5 1.1 5.3 0.7 6.7 0.0 0.0 0.0 1.8 0.0 0.0 1.7 8.3 0.6 51.3 0.0 23.3 1.5 0.1 3.7 1.3 39.2 0.4 11.0 0.0 1.2 111.1 17.8 0.4 7.2 14.4 8.5 4.6 0.0 0.5 1.5 0.0 2.8 0.0 0.7 6.5 4.1 1.4 17.0 4.1 0.0 0.0 0.4 0.6 TMEM256 "C17orf61, MGC40107" ENSG00000205544 "Transmembrane protein 256" Q8N2U0 17 7402975-7404137 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 456.8;Proximal tubular cells: 475.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA062732 Approved Vesicles NA NA Vesicles "HPA062732: AB_2684852" "unprognostic (3.82e-2)" "unprognostic (1.93e-1)" "unprognostic (2.91e-1)" "unprognostic (2.77e-2)" "unprognostic (1.05e-1)" "unprognostic (1.74e-3)" "unprognostic (3.69e-2)" "unprognostic (5.73e-2)" "unprognostic (7.45e-2)" "unprognostic (2.12e-2)" "unprognostic (3.22e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (9.36e-4)" "unprognostic (1.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.03e-1)" "unprognostic (1.19e-2)" 28.7 23.5 23.4 20.7 31.8 19.8 48.2 15.0 32.9 18.7 40.7 12.1 32.8 48.6 18.7 30.7 19.9 22.1 26.1 54.0 20.2 15.8 32.6 54.8 25.3 54.0 25.0 20.1 21.8 73.8 13.0 12.9 9.4 28.4 22.4 16.2 16.8 38.5 39.7 26.3 16.1 42.4 23.6 37.5 18.9 23.0 7.4 16.3 11.1 16.7 24.4 17.1 20.5 18.0 28.2 30.2 5.0 23.5 13.8 19.5 27.3 22.1 28.9 15.5 21.6 26.5 33.2 14.7 10.2 14.2 16.2 15.3 11.5 12.6 19.2 18.8 10.0 13.4 18.9 9.7 30.3 11.6 10.1 32.6 12.2 11.0 29.7 18.3 4.2 16.8 29.3 14.3 21.3 17.7 22.4 23.4 21.2 9.1 13.2 20.5 11.4 14.2 13.8 7.2 9.5 19.2 22.8 14.1 22.1 38.9 9.2 1.8 13.1 15.9 12.4 16.7 16.2 22.5 7.8 14.5 7.8 14.9 15.8 13.0 11.2 13.7 9.7 20.6 5.7 14.9 3.8 23.5 5.0 14.0 16.9 17.1 28.2 16.8 16.1 21.7 26.3 19.5 17.9 1.4 13.8 12.2 30.2 16.5 27.3 23.4 31.8 15.0 32.9 20.2 15.8 25.0 20.1 28.4 16.3 41.7 45.6 142.1 74.5 77.6 24.2 55.1 117.2 103.1 53.4 125.6 7.9 74.7 252.0 108.1 4.3 65.3 317.0 46.7 166.5 182.0 82.7 95.4 66.9 456.8 174.6 19.1 120.3 103.7 156.8 4.0 127.1 107.5 136.7 150.5 165.7 71.2 171.2 198.6 66.8 475.2 32.2 58.2 87.2 6.6 42.6 117.1 39.0 86.3 181.5 71.4 TMEM258 C11orf10 ENSG00000134825 "Transmembrane protein 258" P61165 11 61768501-61792802 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044602 Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA044602: AB_10961423" "unprognostic (6.35e-2)" "unprognostic (1.70e-1)" "unprognostic (7.49e-2)" "unprognostic (4.99e-3)" "unprognostic (9.95e-2)" "unprognostic (1.24e-2)" "unprognostic (3.18e-2)" "unprognostic (1.24e-1)" "unprognostic (8.48e-2)" "prognostic favorable (4.37e-4)" "unprognostic (1.34e-3)" "unprognostic (7.39e-2)" "unprognostic (4.75e-3)" "unprognostic (2.59e-2)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.58e-1)" 15.3 23.1 18.9 16.5 22.5 23.9 31.0 16.2 25.2 28.2 21.6 19.7 34.6 17.7 21.2 81.8 18.1 26.7 22.4 36.6 19.5 15.8 19.0 32.0 33.2 35.9 24.7 19.0 32.2 117.2 6.8 29.1 19.8 18.8 20.0 24.5 13.3 54.0 31.0 22.2 14.0 16.1 18.4 20.1 19.7 21.2 19.9 19.4 17.3 25.3 24.8 22.9 15.7 19.1 53.3 107.7 87.4 51.7 31.0 51.4 50.2 24.4 42.4 36.9 29.3 57.5 56.0 20.5 19.7 32.3 19.5 22.7 36.5 44.2 17.4 37.4 46.2 38.2 26.5 32.0 37.8 25.8 25.5 28.5 14.6 46.5 56.1 54.3 30.5 17.0 47.4 58.3 24.1 63.6 49.7 36.0 39.7 36.0 66.9 31.7 81.3 21.4 53.3 45.9 57.0 29.1 24.0 24.8 111.2 40.5 40.2 29.1 30.6 17.6 37.5 34.6 35.1 41.6 61.1 17.8 22.4 20.2 28.7 14.0 43.6 34.3 28.7 31.6 18.7 23.2 87.4 51.7 59.1 40.6 43.7 49.7 53.3 48.3 45.1 42.6 42.3 41.6 41.1 39.8 31.0 42.2 107.7 51.4 50.2 18.9 22.5 16.2 25.2 19.5 15.8 24.7 19.0 18.8 19.4 95.3 210.6 191.2 192.8 203.3 34.4 466.4 425.4 301.2 234.3 301.8 17.7 370.2 250.4 433.9 186.9 238.5 290.8 23.3 568.5 499.5 345.7 260.4 219.6 452.5 405.4 35.0 298.8 324.7 368.7 111.6 310.7 338.3 539.9 431.0 448.2 326.7 464.8 390.9 201.5 405.8 52.5 168.1 247.3 313.1 426.1 243.9 424.8 226.6 405.7 222.4 TMEM259 "ASBABP1, C19orf6, MBRL, MGC4022" ENSG00000182087 "Transmembrane protein 259" Q4ZIN3 19 1009648-1021179 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042669, HPA054801" Approved Approved "Nuclear speckles,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nuclear speckles" "HPA042669: AB_10794916, HPA054801: AB_2682604" "unprognostic (1.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "prognostic favorable (1.01e-4)" "unprognostic (4.12e-2)" "unprognostic (6.87e-3)" "unprognostic (2.77e-2)" "unprognostic (1.23e-1)" "unprognostic (2.20e-1)" "unprognostic (2.74e-1)" "unprognostic (4.85e-3)" "unprognostic (4.07e-2)" "unprognostic (4.81e-2)" "prognostic favorable (8.92e-6)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (4.10e-3)" 39.5 39.2 35.7 42.3 39.2 46.4 36.9 54.8 44.3 35.4 41.0 46.1 33.9 43.7 39.6 27.4 37.0 34.8 38.6 43.9 34.8 26.1 37.1 59.2 40.5 44.6 44.1 30.0 38.4 59.0 43.5 55.7 47.9 40.1 41.1 23.3 47.8 49.0 36.2 39.3 62.3 42.9 30.1 27.5 61.8 48.5 36.0 40.2 38.0 47.6 24.9 45.4 37.9 37.0 3.8 6.7 2.5 5.2 2.5 5.5 3.0 36.1 23.3 16.2 18.4 20.0 19.4 28.6 30.8 26.8 25.5 27.5 21.4 20.4 25.1 30.3 23.2 12.0 41.4 16.3 30.2 11.3 32.0 27.5 14.7 28.8 23.5 35.5 28.2 37.4 25.9 30.9 20.4 25.6 24.3 22.1 25.6 24.8 50.8 16.9 15.8 30.9 25.9 24.0 18.4 19.2 35.2 12.3 31.7 20.1 34.1 22.5 23.6 19.5 24.8 21.1 13.7 24.3 36.7 25.6 25.5 14.6 35.6 32.0 72.1 27.0 27.8 30.0 23.2 25.2 0.9 3.9 2.2 5.5 3.5 4.1 3.8 3.2 5.5 6.0 3.4 3.5 3.9 2.5 2.5 5.2 6.7 3.2 3.0 35.7 39.2 54.8 44.3 34.8 26.1 44.1 30.0 40.1 40.2 29.8 50.0 37.4 47.9 55.4 118.9 11.8 33.1 5.3 18.2 62.8 92.3 47.3 10.0 22.9 16.0 38.2 90.7 0.0 29.5 40.4 37.6 50.4 15.0 43.3 44.1 98.5 38.6 31.3 21.9 8.9 39.4 40.7 42.2 27.9 67.4 75.8 34.5 56.2 32.2 18.2 165.0 32.3 46.0 45.3 38.1 56.8 68.9 41.5 49.9 59.1 TMEM26 "Em:AC068892.1, MGC35010" ENSG00000196932 "Transmembrane protein 26" Q6ZUK4 10 61406643-61453450 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 30.2" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 3.0;Ito cells: 7.4;Kupffer cells: 10.1;Late spermatids: 3.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.3;fHDF/TERT166: 2.2;HSkMC: 4.0;HUVEC TERT2: 2.9;MOLT-4: 4.3" "Region enhanced" "Detected in some" "hypothalamus: 2.7" "Low region specificity" "Detected in many" NA NA "unprognostic (1.21e-3)" "unprognostic (2.84e-1)" "unprognostic (7.34e-2)" "unprognostic (7.83e-2)" "unprognostic (1.38e-3)" "unprognostic (1.30e-1)" "unprognostic (7.56e-2)" "unprognostic (3.69e-2)" "unprognostic (3.13e-1)" "unprognostic (9.41e-2)" "unprognostic (5.38e-2)" "unprognostic (5.24e-2)" "unprognostic (2.29e-5)" "unprognostic (2.55e-2)" "unprognostic (1.51e-2)" "unprognostic (8.53e-2)" "unprognostic (1.95e-1)" 1.3 1.2 3.7 1.0 2.1 0.0 7.4 0.3 2.0 3.2 1.1 0.9 1.1 1.8 5.6 0.9 0.6 0.8 1.2 0.6 0.9 1.0 3.6 4.5 1.8 5.8 1.5 1.3 2.1 0.4 5.6 0.7 1.8 1.1 3.5 1.1 3.6 0.5 3.2 0.7 0.3 1.9 2.5 0.9 30.2 0.5 4.4 1.2 6.2 0.7 0.2 0.1 0.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.7 0.2 0.0 9.3 1.0 1.2 0.0 0.0 0.0 0.0 2.2 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 4.0 0.0 1.0 0.0 1.1 2.9 1.1 0.0 0.0 0.3 0.0 4.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.1 0.3 2.0 0.9 1.0 1.5 1.3 1.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 7.4 10.1 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.4 0.4 0.1 0.1 0.0 0.0 0.0 0.0 TMEM260 "C14orf101, FLJ20392" ENSG00000070269 "Transmembrane protein 260" Q9NX78 14 56488354-56650606 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 61.0" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 69.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003502 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA003502: AB_1078314" "unprognostic (4.63e-2)" "unprognostic (2.41e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (2.51e-1)" "unprognostic (3.58e-2)" "unprognostic (2.04e-1)" "prognostic favorable (7.11e-4)" "unprognostic (7.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.95e-3)" "unprognostic (3.22e-1)" "unprognostic (2.23e-3)" "unprognostic (5.81e-2)" "unprognostic (8.11e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-2)" 7.8 7.4 7.3 11.0 10.6 3.8 9.1 13.3 9.9 61.0 8.8 13.7 11.6 8.1 11.8 12.1 6.7 11.4 10.3 6.0 8.9 8.6 10.7 8.7 8.4 8.8 10.8 7.5 14.8 13.6 12.4 17.2 8.7 9.7 8.7 9.1 8.7 7.4 13.0 5.2 8.6 10.7 8.9 12.2 9.2 8.4 10.1 8.3 17.6 12.6 4.6 8.8 10.1 9.7 2.0 4.6 2.9 2.8 6.3 3.5 2.0 7.4 5.2 4.0 8.6 14.4 11.9 7.9 7.9 8.8 5.2 6.3 2.4 5.5 6.0 7.8 5.9 5.9 8.6 9.3 5.8 8.3 7.5 4.7 3.9 2.4 3.3 10.1 5.4 9.4 14.5 10.4 2.9 10.1 9.6 6.8 4.7 4.8 6.5 6.8 4.9 2.8 2.0 3.7 12.2 8.3 4.0 6.4 2.0 8.8 11.0 8.5 4.2 8.9 6.5 5.2 7.9 8.2 8.4 9.5 10.6 4.1 7.9 3.9 3.9 3.1 3.5 6.7 4.0 5.2 0.0 2.8 2.9 3.5 1.9 2.4 1.8 2.4 1.8 2.2 2.0 3.2 2.3 1.4 6.3 1.7 4.6 2.9 2.0 7.3 10.6 13.3 9.9 8.9 8.6 10.8 7.5 9.7 8.3 17.9 12.1 4.2 7.4 4.7 14.2 2.9 0.0 17.4 5.7 21.0 3.9 7.9 1.7 6.8 69.7 4.7 6.3 0.0 3.3 6.5 6.7 8.2 11.5 7.5 5.5 6.4 17.2 8.6 13.9 25.8 14.1 7.8 1.7 5.4 10.8 5.6 5.0 7.0 10.3 3.7 17.1 0.0 4.2 7.9 8.5 4.8 9.3 5.7 10.8 6.8 TMEM262 ENSG00000187066 "Transmembrane protein 262" E9PQX1 11 65084979-65089375 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "testis: 18.1" "Cell type enriched" "Detected in some" 16 "Early spermatids: 137.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 1.5;neutrophil: 1.1" "Group enriched" "Detected in many" 5 "B-cells: 1.5;granulocytes: 1.1" "Cell line enhanced" "Detected in some" "JURKAT: 1.1;Karpas-707: 1.9;T-47d: 1.1" "Low region specificity" "Detected in single" NA NA "unprognostic (4.36e-2)" "unprognostic (2.77e-1)" "unprognostic (1.78e-3)" "unprognostic (1.62e-1)" "unprognostic (1.61e-1)" "unprognostic (1.71e-4)" "unprognostic (1.85e-5)" "unprognostic (3.28e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-1)" "unprognostic (3.19e-3)" "unprognostic (7.18e-3)" "unprognostic (7.13e-9)" "unprognostic (9.53e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.84e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 1.5 0.1 1.1 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.1 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 137.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.3 0.9 0.5 0.3 0.3 0.0 0.0 0.0 TMEM263 "C12orf23, MGC17943" ENSG00000151135 "Transmembrane protein 263" Q8WUH6 12 106955719-106978778 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014453, HPA042339" Uncertain Approved Vesicles NA NA Vesicles "HPA014453: , HPA042339: AB_10795503" "unprognostic (2.56e-2)" "unprognostic (1.41e-1)" "unprognostic (8.99e-2)" "unprognostic (5.65e-2)" "unprognostic (3.90e-1)" "unprognostic (3.46e-2)" "prognostic unfavorable (7.84e-4)" "unprognostic (4.66e-2)" "unprognostic (6.01e-2)" "unprognostic (3.11e-2)" "unprognostic (7.07e-2)" "unprognostic (1.19e-1)" "unprognostic (3.05e-3)" "unprognostic (3.49e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.53e-1)" 14.5 17.6 13.7 15.1 14.7 4.0 25.9 10.6 12.4 29.0 13.9 5.2 26.7 10.8 22.6 27.9 13.2 12.8 19.6 25.3 10.9 16.0 24.4 44.8 12.9 18.2 11.3 10.4 24.0 28.1 12.8 65.3 40.9 11.6 21.1 12.3 10.0 25.2 26.8 10.1 5.6 15.0 18.9 10.4 15.0 18.9 12.4 6.9 32.1 32.8 7.0 12.1 21.2 23.2 11.9 9.1 5.9 0.9 11.5 17.9 8.3 8.9 8.0 15.4 10.3 36.1 40.9 6.4 33.9 31.8 16.8 21.3 8.5 3.9 0.8 10.5 48.3 9.4 4.1 9.6 13.5 23.3 16.0 9.8 12.4 12.6 17.7 18.5 0.6 7.9 28.4 6.4 18.3 15.2 39.0 20.4 9.6 5.8 3.4 22.9 7.3 9.3 5.6 4.9 5.6 15.4 20.7 11.4 2.0 16.7 7.6 7.9 10.7 18.1 8.6 13.4 12.4 10.1 3.6 23.7 14.2 8.7 18.6 8.6 14.2 8.1 8.3 11.2 2.1 22.3 5.9 0.8 0.9 10.2 0.9 12.0 9.2 9.9 8.7 2.6 11.9 17.9 16.0 0.7 11.5 0.3 9.1 10.2 8.3 13.7 14.7 10.6 11.0 10.9 16.0 11.3 10.4 11.6 6.9 8.9 17.6 20.1 43.8 0.0 24.3 46.6 12.7 22.7 20.5 22.7 29.5 34.9 77.9 16.2 24.1 20.3 13.5 0.0 28.5 63.2 46.3 43.7 29.9 42.7 11.8 11.1 27.6 28.8 5.0 29.3 43.7 6.9 0.0 12.6 48.2 31.2 18.5 8.6 41.1 34.0 18.5 25.8 39.5 31.2 23.2 0.0 30.1 14.6 17.4 23.5 TMEM265 ENSG00000281991 "Transmembrane protein 265" A0A087WTH1 16 30740381-30744281 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 8 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 5.8;Ciliated cells: 9.4;Club cells: 11.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 37.3;HaCaT: 15.4;HBEC3-KT: 17.0;hTCEpi: 22.4;SK-BR-3: 17.7;T-47d: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 1.2 0.6 0.3 4.8 0.4 1.2 5.6 0.0 0.4 4.7 3.1 0.2 1.9 1.2 0.8 5.9 14.8 3.0 6.5 1.6 0.0 7.3 0.3 13.7 3.5 0.0 0.0 1.1 8.3 0.0 1.1 11.1 0.7 3.0 0.6 0.7 6.7 2.9 2.8 8.2 1.2 1.6 0.7 1.9 6.1 1.4 0.2 2.3 8.7 18.8 6.3 6.3 2.0 3.7 1.3 4.8 2.1 6.9 4.3 1.7 11.9 2.9 0.0 2.1 0.0 0.9 2.5 0.0 1.4 1.0 0.7 3.2 37.3 0.6 3.4 0.0 2.4 15.4 1.0 17.0 0.0 1.4 0.7 0.0 0.6 2.2 2.7 0.0 1.5 0.2 22.4 0.0 11.3 1.2 0.0 0.5 1.2 0.1 0.2 9.5 0.6 3.4 1.1 8.8 0.0 1.3 0.3 2.6 8.8 15.2 1.3 0.3 0.0 17.7 2.6 0.0 20.7 2.3 1.3 1.1 1.4 0.8 0.8 1.9 1.3 2.3 1.1 3.5 0.9 0.0 2.1 1.5 2.7 1.9 3.1 3.7 3.7 4.1 0.2 3.6 2.3 4.3 4.8 6.9 1.6 1.3 1.7 1.7 8.9 5.8 0.0 0.0 0.0 0.0 0.0 0.0 9.4 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM266 "C15orf27, FLJ38190" ENSG00000169758 "Transmembrane protein 266" Q2M3C6 15 76059837-76229121 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 50.7" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 9.8;Cytotrophoblasts: 12.8;Late spermatids: 11.1;Rod photoreceptor cells: 7.6;Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Region enriched" "Detected in many" 12 "cerebellum: 50.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;HEK 293: 3.6;NTERA-2: 3.7;U-937: 3.3" "Region enriched" "Detected in all" 6 "cerebellum: 65.8" "Region enriched" "Detected in all" 6 "cerebellum: 66.4" "HPA041921, HPA049425" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041921: AB_10796789, HPA049425: AB_2732552" "unprognostic (8.63e-3)" "unprognostic (6.11e-3)" "unprognostic (3.44e-3)" "unprognostic (9.17e-5)" "unprognostic (4.67e-1)" "unprognostic (2.61e-2)" "unprognostic (9.34e-3)" "unprognostic (5.61e-2)" "unprognostic (8.48e-3)" "unprognostic (2.89e-2)" "unprognostic (1.18e-2)" "unprognostic (3.95e-2)" "unprognostic (1.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (7.86e-2)" 0.1 1.9 1.1 0.2 1.9 0.2 0.4 50.7 4.2 0.2 0.2 0.6 0.0 0.3 0.2 0.1 0.3 0.3 0.1 0.1 0.9 1.3 0.9 0.1 1.1 0.3 0.7 0.3 0.1 2.4 0.2 5.1 2.4 1.9 0.4 0.2 1.1 0.2 0.1 10.6 1.5 0.1 0.1 0.4 0.6 0.3 1.4 0.0 0.0 0.2 0.7 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.9 0.1 0.8 0.8 0.0 2.0 3.6 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 50.7 4.2 0.9 1.3 0.7 0.3 1.9 0.0 0.0 0.0 0.0 0.9 0.0 2.6 0.0 0.0 2.7 0.0 1.8 9.8 12.8 1.7 0.0 5.9 0.0 0.0 0.0 0.2 1.7 0.7 0.8 0.0 0.0 4.2 1.6 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.7 0.5 7.6 6.5 0.0 0.5 2.1 0.0 4.9 0.0 0.0 0.4 TMEM267 "C5orf28, FLJ21657" ENSG00000151881 "Transmembrane protein 267" Q0VDI3 5 43444252-43483893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 15.7;Cytotrophoblasts: 23.5;Distal tubular cells: 23.2;Ductal cells: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059946, HPA072991" Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA059946: AB_2684175, HPA072991: " "unprognostic (8.20e-2)" "unprognostic (2.02e-2)" "unprognostic (7.60e-2)" "unprognostic (8.11e-3)" "unprognostic (1.57e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.82e-2)" "unprognostic (4.77e-3)" "unprognostic (9.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.47e-2)" "unprognostic (3.35e-1)" "unprognostic (1.07e-2)" "unprognostic (4.40e-3)" 9.9 8.1 9.0 7.8 9.4 3.9 14.2 13.8 12.5 11.7 7.7 5.7 6.8 7.1 11.1 11.7 9.4 8.9 7.5 8.3 6.3 8.5 12.1 7.1 8.1 9.0 9.9 11.2 10.9 17.3 9.9 23.0 6.3 11.6 9.6 9.7 8.9 12.3 9.9 7.1 9.8 8.6 9.2 9.4 9.5 9.1 7.9 7.9 6.1 36.8 7.6 8.8 10.4 9.0 11.6 9.7 9.0 11.6 13.7 18.0 11.0 10.1 9.3 5.0 11.2 9.5 19.1 5.7 14.6 9.0 7.9 5.8 4.0 21.8 11.3 20.1 14.8 8.3 8.6 4.8 6.6 11.5 13.5 7.8 6.5 20.1 4.5 17.4 13.3 9.5 15.6 18.9 11.8 16.8 8.0 8.8 13.6 8.5 21.0 17.3 8.7 7.3 7.9 2.2 10.2 9.2 5.0 12.4 13.7 9.8 10.3 7.0 5.0 29.1 16.7 14.2 4.8 24.2 9.7 11.4 12.9 10.5 7.9 7.2 9.0 12.8 11.1 9.7 19.3 11.3 9.0 8.6 3.1 12.3 10.0 18.0 11.6 16.4 13.0 9.7 9.6 16.9 14.0 1.6 13.7 11.6 7.5 13.0 11.0 9.0 9.4 13.8 12.5 6.3 8.5 9.9 11.2 11.6 7.9 6.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 12.0 3.4 15.7 0.0 23.5 23.2 13.2 0.0 0.0 0.0 0.0 12.1 8.1 0.0 0.0 2.3 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 5.4 0.0 0.0 10.7 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 TMEM268 "C9orf91, DKFZp547P234, FLJ38045" ENSG00000157693 "Transmembrane protein 268" Q5VZI3 9 114611206-114646422 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 9.3;Ciliated cells: 8.1;Hofbauer cells: 7.8;monocytes: 33.3;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017199 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA017199: AB_1845845" "unprognostic (8.57e-2)" "unprognostic (3.37e-1)" "unprognostic (8.33e-2)" "prognostic favorable (3.61e-4)" "unprognostic (2.09e-1)" "unprognostic (7.16e-2)" "unprognostic (3.55e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.26e-2)" "unprognostic (2.22e-3)" "unprognostic (1.44e-1)" "unprognostic (6.67e-2)" "unprognostic (6.10e-2)" "unprognostic (7.65e-3)" "unprognostic (1.09e-2)" "unprognostic (1.47e-1)" 9.1 9.0 9.6 8.5 15.8 3.8 9.7 4.4 31.0 7.3 6.6 5.1 3.4 4.3 7.7 7.6 4.8 5.7 4.8 3.7 12.5 9.1 3.8 6.3 6.6 10.6 8.5 15.3 10.2 5.6 15.1 4.6 5.9 8.7 15.9 6.8 11.1 8.9 9.1 5.0 4.3 6.4 8.8 7.7 15.5 7.5 4.8 5.0 10.3 7.9 2.0 11.4 7.8 5.4 4.3 8.4 2.3 2.5 1.5 1.9 0.9 2.6 4.6 2.2 4.7 6.3 4.6 1.7 2.6 4.5 3.6 3.6 3.5 1.0 11.6 2.2 2.9 10.2 4.5 4.3 2.1 3.0 5.9 2.9 3.6 3.4 2.1 10.8 7.5 1.8 4.1 3.8 4.9 5.2 4.5 2.3 14.9 7.1 30.3 2.5 7.8 8.7 2.2 5.7 3.3 4.6 9.9 2.5 9.8 2.0 2.1 7.5 4.8 8.5 11.2 22.9 1.4 14.9 7.0 1.3 3.5 4.1 1.4 4.6 16.8 15.7 12.5 1.9 6.4 6.4 0.5 2.5 0.5 1.3 2.1 0.5 2.3 1.3 0.7 1.4 4.3 1.9 1.5 2.3 1.5 1.8 8.4 0.2 0.9 9.6 15.8 4.4 31.0 12.5 9.1 8.5 15.3 8.7 5.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 8.1 2.3 0.0 0.0 3.8 0.0 1.5 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 33.3 0.0 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 TMEM269 ENSG00000274386 "Transmembrane protein 269" A0A1B0GVZ9 1 42785007-42816619 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 3.4;skin 1: 2.1" "Cell type enriched" "Detected in single" 6 "granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.03e-1)" "unprognostic (1.30e-1)" "unprognostic (2.87e-2)" "unprognostic (1.26e-1)" "unprognostic (5.97e-2)" "unprognostic (8.28e-2)" "unprognostic (6.27e-2)" "unprognostic (2.79e-1)" "unprognostic (1.00e-1)" "unprognostic (5.58e-2)" "unprognostic (8.51e-2)" "unprognostic (1.63e-1)" "unprognostic (4.01e-9)" "unprognostic (2.23e-1)" "unprognostic (2.85e-1)" "unprognostic (1.15e-1)" "unprognostic (4.77e-2)" 0.1 0.0 0.0 1.5 0.6 0.6 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.6 0.4 0.0 0.2 0.3 0.0 0.0 1.8 2.1 0.1 0.0 0.5 0.1 1.4 0.0 0.4 0.0 0.9 1.8 3.4 0.6 1.5 0.9 0.1 0.3 1.7 1.2 2.6 1.1 0.1 1.2 0.2 0.2 0.6 0.8 1.4 0.6 2.4 0.4 0.1 0.2 0.3 0.7 0.1 0.2 2.2 0.6 2.5 0.5 0.7 0.1 1.0 0.5 0.7 0.5 0.0 2.1 0.2 0.0 1.7 0.8 2.0 0.0 0.7 0.4 2.7 2.0 0.2 1.1 0.8 1.2 0.3 0.0 0.3 1.6 1.6 0.7 0.7 1.1 1.0 1.1 1.2 0.3 0.6 1.3 2.3 0.5 3.8 6.3 2.7 0.4 0.9 0.6 2.1 0.6 0.4 0.3 0.4 0.3 0.4 0.4 0.3 0.2 0.9 0.9 0.4 3.4 1.5 0.4 1.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TMEM270 "MGC26719, WBSCR28" ENSG00000175877 "Transmembrane protein 270" Q6UE05 7 73861159-73865893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 35.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "T-reg: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.1;GAMG: 1.5;MCF7: 5.3;PC-3: 1.8;RPMI-8226: 1.4;U-2197: 1.4;U-87 MG: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA077196 Approved Vesicles NA NA Vesicles "HPA077196: AB_2732334" "unprognostic (3.84e-2)" "unprognostic (6.91e-2)" "unprognostic (6.87e-5)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (2.81e-3)" "unprognostic (1.34e-1)" "unprognostic (8.31e-3)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-1)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.26e-1)" "unprognostic (1.44e-1)" "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 2.1 0.2 0.0 0.4 1.5 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.4 0.0 0.3 1.8 0.0 0.0 1.4 0.3 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.4 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM272 "FLJ37307, LINC00282, NCRNA00282" ENSG00000281106 "Transmembrane protein 272" 13 51813347-51845175 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 24.5;brain: 35.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 54 "neutrophil: 24.5" "Lineage enriched" "Detected in single" 54 "granulocytes: 24.5" "Cell line enhanced" "Detected in some" "BEWO: 2.4;HEL: 1.5;SK-MEL-30: 6.8" NA NA "unprognostic (2.27e-2)" "unprognostic (2.50e-1)" "unprognostic (5.12e-2)" "unprognostic (8.71e-7)" "unprognostic (4.52e-2)" "unprognostic (1.78e-4)" "unprognostic (6.16e-2)" "unprognostic (5.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.02e-1)" "unprognostic (3.73e-3)" "unprognostic (1.32e-5)" "unprognostic (2.12e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.58e-2)" 0.2 0.0 2.7 3.3 35.4 1.7 0.0 0.0 2.4 0.0 0.0 0.4 0.0 1.0 0.7 0.0 0.0 0.0 0.3 4.1 1.2 0.0 0.1 0.2 4.0 0.1 0.4 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.3 1.0 0.0 0.0 1.4 0.0 1.2 5.6 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.8 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.1 0.1 1.5 0.1 0.5 0.1 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.9 0.5 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 6.8 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM30A "C6orf67, CDC50A, FLJ10856" ENSG00000112697 "Transmembrane protein 30A" Q9NV96 6 75252924-75284968 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014561 Approved NA NA "HPA014561: AB_10601823" "unprognostic (2.00e-1)" "unprognostic (2.00e-2)" "unprognostic (2.52e-1)" "unprognostic (1.27e-2)" "unprognostic (3.48e-1)" "unprognostic (1.02e-2)" "unprognostic (1.11e-1)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (4.80e-2)" "unprognostic (1.88e-1)" "unprognostic (5.06e-2)" "unprognostic (7.12e-2)" "unprognostic (8.96e-2)" "unprognostic (1.00e-1)" 29.9 29.6 42.7 28.3 63.3 23.8 27.2 40.3 55.1 33.4 31.3 36.8 22.3 21.2 31.9 25.7 30.1 24.6 30.6 22.9 45.6 48.2 39.6 48.1 45.0 23.9 43.8 41.0 25.2 41.0 57.0 45.5 29.4 50.5 33.6 36.8 20.5 31.9 31.7 18.6 19.4 22.5 39.8 45.3 28.9 28.0 14.1 40.3 21.1 43.1 17.0 29.3 32.8 22.8 9.1 24.3 42.7 26.8 13.1 16.3 16.7 10.5 10.2 18.9 15.8 47.7 44.9 15.6 43.1 33.9 16.8 25.7 10.9 24.8 12.3 29.8 37.9 15.3 12.4 8.4 24.0 44.9 15.8 12.5 11.9 11.2 11.2 27.2 14.2 20.8 41.5 23.9 23.3 13.1 36.2 53.4 11.2 11.6 21.9 32.7 7.0 5.0 10.4 6.7 8.9 8.8 8.3 13.4 15.5 65.1 26.0 13.3 13.0 21.9 10.8 14.5 22.7 11.9 44.6 46.3 21.3 23.8 13.3 30.4 18.0 24.5 5.3 16.9 27.5 33.3 12.3 26.8 17.7 12.7 26.6 15.3 9.1 13.0 12.2 24.3 7.5 12.5 12.6 42.7 13.1 25.6 10.6 16.3 16.7 42.7 63.3 40.3 52.7 45.6 48.2 43.8 41.0 50.5 40.3 151.8 109.2 38.2 28.7 63.3 24.2 34.7 33.1 68.3 76.2 62.8 43.2 31.3 10.0 43.7 7.5 65.2 34.1 0.0 96.0 46.0 58.6 62.3 37.1 70.2 48.7 19.1 34.9 69.3 81.5 5.9 42.0 50.3 45.5 23.4 43.5 37.2 78.7 37.4 58.7 29.3 20.0 32.3 70.7 36.2 18.8 68.4 78.9 28.9 26.2 42.3 TMEM30B CDC50B ENSG00000182107 "Transmembrane protein 30B" Q3MIR4 14 61277370-61281840 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 50.3" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 101.7;Urothelial cells: 117.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.8" "Lineage enriched" "Detected in single" 4 "T-cells: 2.8" "Cell line enhanced" "Detected in some" "A-431: 25.0;CAPAN-2: 20.4;HaCaT: 11.9;HBEC3-KT: 14.4;hTCEpi: 11.0;MCF7: 16.1;RT4: 35.0;T-47d: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA043162 Uncertain NA NA "HPA043162: AB_10796688" "unprognostic (4.06e-2)" "unprognostic (2.46e-1)" "unprognostic (1.72e-1)" "unprognostic (3.47e-2)" "unprognostic (2.01e-1)" "unprognostic (6.20e-2)" "unprognostic (2.45e-3)" "unprognostic (3.43e-2)" "unprognostic (9.10e-2)" "unprognostic (2.20e-1)" "unprognostic (5.10e-2)" "unprognostic (2.26e-1)" "prognostic favorable (5.89e-5)" "unprognostic (2.21e-1)" "unprognostic (2.89e-1)" "unprognostic (2.60e-1)" "unprognostic (1.85e-1)" 3.7 1.2 0.8 1.6 1.3 0.0 4.7 0.7 1.0 5.4 11.5 0.5 18.0 14.1 3.9 14.6 8.1 4.8 10.6 1.5 0.8 0.8 6.7 5.5 6.4 0.4 0.8 0.7 4.8 23.3 20.3 27.3 11.6 3.4 9.1 8.4 1.0 18.9 14.4 1.6 3.9 19.5 2.0 1.7 0.9 13.3 6.3 0.2 2.3 50.3 6.2 4.7 9.6 5.7 0.0 0.0 0.0 0.0 0.7 2.8 0.5 25.0 0.0 0.0 0.0 2.9 0.7 0.0 0.0 0.0 0.0 0.0 4.3 20.4 0.0 0.0 0.0 0.0 11.9 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.2 10.3 0.5 0.0 0.5 0.0 0.0 35.0 4.2 0.0 0.3 9.7 0.0 0.7 11.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.0 1.2 0.6 0.0 0.0 2.8 1.8 0.0 0.7 0.0 0.0 0.0 0.5 0.8 1.3 0.7 1.0 0.8 0.8 0.8 0.7 3.4 0.2 26.8 29.3 0.0 101.7 57.7 0.0 1.1 40.8 10.7 19.4 38.4 0.0 24.7 11.6 21.2 0.9 2.9 81.5 0.0 32.4 9.3 8.9 91.9 2.3 11.5 1.7 0.0 22.4 3.7 1.3 1.0 8.1 1.0 5.0 1.0 67.9 2.7 28.3 56.1 74.3 0.5 0.2 12.9 2.1 4.3 1.5 55.7 30.0 3.2 55.7 117.4 TMEM31 MGC39655 ENSG00000179363 "Transmembrane protein 31" Q5JXX7 X 103710909-103714028 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 46.6" "Group enriched" "Detected in some" 63 "Early spermatids: 531.0;Late spermatids: 2031.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 3.0;BEWO: 7.3;MCF7: 10.4;NTERA-2: 3.2;U-937: 3.9" HPA052760 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA052760: " "unprognostic (9.42e-5)" "unprognostic (1.46e-2)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (7.75e-3)" "unprognostic (1.22e-2)" "unprognostic (2.43e-1)" "unprognostic (4.50e-2)" "unprognostic (1.06e-2)" "unprognostic (1.59e-1)" "unprognostic (1.39e-2)" "unprognostic (3.77e-1)" "unprognostic (5.91e-5)" "unprognostic (1.75e-2)" "unprognostic (1.12e-1)" "unprognostic (2.72e-1)" "unprognostic (4.68e-2)" 0.2 0.0 0.3 0.2 0.6 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.4 1.4 0.2 0.4 0.2 0.2 0.5 0.8 0.2 0.2 0.2 0.2 0.6 0.2 0.8 0.2 0.4 0.2 0.6 0.2 0.3 0.0 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.7 0.2 0.0 46.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 2.0 1.8 0.0 0.9 0.0 0.8 0.1 0.0 0.0 3.0 0.1 0.3 0.0 7.3 0.1 0.1 0.4 0.5 0.0 0.3 0.1 0.2 0.0 0.5 0.0 1.2 0.0 0.4 0.0 2.7 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.3 10.4 0.3 2.0 3.2 0.5 0.0 1.2 0.0 0.1 0.0 0.0 0.9 0.6 0.7 0.1 0.3 1.5 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.8 0.0 3.9 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.9 0.2 0.0 1.4 2.0 0.8 0.4 0.0 0.0 0.9 1.8 0.0 0.1 0.3 0.6 0.2 0.2 0.5 0.8 0.6 0.2 0.2 0.2 0.0 0.0 0.0 0.6 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.2 531.0 0.0 0.0 0.0 0.6 7.0 0.5 0.3 0.0 0.0 0.3 0.0 0.0 1.3 0.0 2031.4 12.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.1 0.1 0.0 12.9 0.3 20.4 11.3 0.3 2.4 0.0 0.0 0.0 TMEM33 FLJ10525 ENSG00000109133 "Transmembrane protein 33" P57088 4 41935120-41960572 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075863 Approved NA NA "HPA075863: " "unprognostic (7.14e-2)" "unprognostic (9.25e-3)" "unprognostic (1.59e-2)" "unprognostic (1.58e-1)" "unprognostic (1.92e-1)" "unprognostic (2.49e-1)" "unprognostic (2.04e-1)" "unprognostic (3.94e-2)" "unprognostic (5.45e-2)" "unprognostic (2.09e-1)" "unprognostic (1.16e-2)" "unprognostic (3.75e-1)" "prognostic favorable (1.35e-5)" "unprognostic (7.70e-2)" "unprognostic (4.20e-1)" "unprognostic (9.35e-3)" "unprognostic (2.36e-2)" 15.8 24.7 14.7 18.1 17.3 12.6 20.4 11.1 22.3 12.6 17.8 16.7 14.5 20.0 12.6 25.4 30.6 12.0 16.6 14.6 15.2 16.0 24.0 59.4 18.6 20.4 16.0 15.0 14.7 18.1 23.9 31.8 22.3 17.4 17.3 20.6 15.9 22.0 17.9 14.0 16.3 22.2 10.8 21.7 19.2 18.4 11.2 14.0 23.6 22.7 16.4 18.4 17.7 16.5 8.8 15.0 27.0 20.8 9.8 12.3 9.8 13.0 15.1 14.0 19.2 17.9 12.2 16.5 17.8 19.6 15.4 17.7 18.6 44.8 23.0 27.7 14.9 31.7 20.9 45.6 23.8 20.8 5.9 9.3 28.4 19.5 16.7 21.7 38.2 25.1 12.7 25.8 19.4 28.6 10.0 12.2 14.2 30.1 9.2 20.9 11.3 33.9 25.7 24.8 20.7 18.1 15.4 21.4 18.3 21.5 19.1 15.3 21.9 14.6 14.4 23.3 13.9 15.7 13.8 18.9 18.2 24.3 18.1 32.1 16.5 26.3 27.8 19.5 31.6 26.3 19.3 20.8 13.4 10.4 19.5 12.3 8.8 10.7 9.7 15.0 7.4 9.6 10.5 27.0 9.8 19.9 11.7 12.1 9.8 14.7 17.3 11.1 22.3 15.2 16.0 16.0 15.0 17.4 14.0 56.6 26.4 27.6 25.8 65.1 19.0 15.9 28.1 16.0 28.4 52.4 15.7 48.9 19.9 39.5 2.0 22.6 49.6 0.0 33.1 41.7 36.6 65.9 38.1 73.1 53.1 27.0 33.7 22.7 58.5 2.2 18.7 54.6 54.0 24.4 38.2 37.6 42.8 41.9 21.9 34.8 18.4 25.8 22.6 27.0 30.0 58.5 111.3 23.5 32.1 57.0 TMEM35A "FLJ14084, TMEM35" ENSG00000126950 "Transmembrane protein 35A" Q53FP2 X 101078720-101096364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;seminal vesicle: 46.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.5;HUVEC TERT2: 32.3;SH-SY5Y: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048583 Enhanced Supported Supported "Vesicles,Focal adhesion sites,Cytosol" NA NA Vesicles "Focal adhesion sites, Cytosol" "HPA048583: AB_2680451" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-2)" "unprognostic (3.02e-2)" "unprognostic (3.89e-3)" "unprognostic (2.77e-2)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (3.34e-3)" "unprognostic (9.20e-2)" "unprognostic (4.72e-2)" "unprognostic (3.49e-4)" "unprognostic (5.91e-2)" "unprognostic (1.85e-1)" "unprognostic (1.48e-2)" "unprognostic (9.37e-3)" 3.6 6.7 12.8 1.7 28.2 0.7 1.3 21.2 28.6 3.3 17.3 2.5 6.8 3.5 7.4 3.9 10.4 4.3 3.6 1.1 14.4 33.8 1.1 0.7 2.6 0.8 12.2 10.0 7.7 0.9 6.1 1.5 0.8 30.0 20.5 9.1 2.9 1.0 46.4 1.3 0.9 4.1 11.8 3.9 1.3 3.4 1.8 2.3 0.0 1.3 0.0 0.9 13.3 2.7 0.2 0.0 0.2 0.1 0.6 0.8 0.4 0.0 0.0 3.4 0.0 2.5 6.5 0.0 0.6 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 2.2 0.0 1.1 0.0 4.7 32.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 8.3 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.5 0.2 0.5 0.2 0.0 0.0 0.6 0.4 0.2 0.6 0.1 0.0 0.8 0.4 12.8 28.2 21.2 28.6 14.4 33.8 12.2 10.0 30.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM35B ZMYM6NB ENSG00000243749 "Transmembrane protein 35B" Q8NCS4 1 34981535-34985353 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 16 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 8.3;Ciliated cells: 28.1;Club cells: 11.4;granulocytes: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 43.0;CAPAN-2: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051024 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051024: AB_2681316" "unprognostic (3.34e-3)" "unprognostic (2.77e-3)" "unprognostic (4.25e-1)" "unprognostic (2.12e-2)" "unprognostic (5.52e-2)" "unprognostic (2.08e-2)" "unprognostic (2.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "unprognostic (7.51e-3)" "unprognostic (2.32e-1)" "unprognostic (9.41e-2)" "unprognostic (2.03e-2)" "unprognostic (1.86e-1)" "unprognostic (5.49e-2)" "unprognostic (4.53e-3)" "unprognostic (1.07e-1)" 23.1 20.6 6.4 10.7 8.0 5.3 24.4 5.7 7.9 23.7 13.8 9.3 12.6 7.4 22.3 19.0 15.2 19.7 26.1 17.6 6.4 5.8 27.5 24.4 25.3 28.0 9.9 7.6 20.0 20.5 9.2 14.6 29.5 9.6 29.6 12.6 26.6 14.2 17.4 10.5 7.2 16.0 18.3 10.2 19.0 12.9 21.4 7.8 17.9 48.7 9.8 18.4 22.0 19.1 24.9 37.3 29.4 26.8 36.4 53.1 38.4 9.1 7.0 1.7 2.8 43.0 25.5 3.5 10.0 16.8 7.2 9.8 6.9 40.6 4.7 15.6 10.3 11.1 9.9 3.1 8.5 5.8 17.3 4.7 9.8 3.7 8.2 23.6 6.5 10.3 25.3 8.0 6.4 13.6 14.5 14.0 9.7 6.3 13.4 12.5 5.6 4.7 6.5 7.6 0.0 4.9 6.4 13.8 1.5 19.2 9.1 4.2 1.4 15.2 0.2 13.4 8.3 3.8 9.9 14.2 9.6 9.0 8.4 5.7 7.8 4.4 3.2 9.7 10.6 8.0 29.4 24.5 25.4 47.3 26.8 50.7 24.9 52.3 51.9 16.8 21.0 46.1 46.3 7.6 36.4 21.9 37.3 53.1 38.4 6.4 8.0 5.7 7.9 6.4 5.8 9.9 7.6 9.6 7.8 20.8 8.3 0.0 0.0 0.0 0.0 0.0 0.0 28.1 11.4 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 8.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TMEM37 "PR, PR1" ENSG00000171227 "Transmembrane protein 37" Q8WXS4 2 119429901-119438520 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 110.5;kidney: 82.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 276.4;Hepatocytes: 166.8;Muller glia cells: 140.1;Proximal tubular cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.8;naive CD4 T-cell: 3.3" "Group enriched" "Detected in many" 31 "monocytes: 2.8;T-cells: 3.3" "Group enriched" "Detected in some" 5 "EFO-21: 13.4;Hep G2: 35.1;RPTEC TERT1: 29.4" "Low region specificity" "Detected in many" HPA053794 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA053794: AB_2682265" "unprognostic (2.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.01e-1)" "unprognostic (4.59e-3)" "unprognostic (2.56e-1)" "unprognostic (9.60e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.36e-1)" "unprognostic (2.83e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-2)" "unprognostic (2.99e-1)" "unprognostic (2.61e-2)" 18.5 5.2 0.6 5.9 1.0 0.0 10.0 0.5 1.2 6.7 60.3 1.8 3.8 16.2 3.1 3.8 2.8 1.4 18.5 5.7 1.0 0.4 82.5 40.8 9.5 8.7 0.9 0.7 5.9 5.8 20.1 0.7 13.4 1.3 4.5 5.6 6.3 2.8 6.5 1.6 4.4 110.5 1.9 1.4 11.5 6.6 6.4 0.7 1.2 21.0 1.6 2.2 3.4 2.4 0.0 0.0 0.0 2.8 0.0 3.3 0.6 0.0 3.5 0.3 0.1 2.2 0.2 0.5 0.1 0.0 0.0 0.0 5.4 3.1 0.0 13.4 1.6 0.3 0.8 1.4 0.0 0.0 0.0 1.4 0.4 2.0 35.1 3.0 0.0 0.0 4.9 0.0 0.0 0.0 0.1 2.8 0.0 0.1 5.3 0.0 0.3 0.0 0.3 2.6 0.0 0.1 0.0 0.0 4.6 29.4 2.3 0.4 0.2 0.1 1.4 0.0 2.6 0.6 0.8 1.8 0.0 5.3 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.6 1.0 0.5 1.2 1.0 0.4 0.9 0.7 1.3 0.7 23.8 8.1 15.4 0.2 1.8 2.6 1.2 86.6 1.4 3.4 17.4 0.0 40.2 43.1 18.4 0.1 2.9 276.4 0.0 47.2 3.4 14.1 0.1 1.1 166.8 54.9 6.4 8.7 82.3 51.8 0.9 46.1 4.3 1.7 1.0 14.5 140.1 16.0 45.6 3.5 167.4 17.7 0.0 1.9 0.0 1.0 2.5 87.1 1.8 12.4 1.6 TMEM38A "MGC3169, TRIC-A" ENSG00000072954 "Transmembrane protein 38A" Q9H6F2 19 16661127-16690029 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 158.8" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 21.6;Cardiomyocytes: 22.4;Cone photoreceptor cells: 80.5;Peritubular cells: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 20.3" "Cell line enhanced" "Detected in many" "Daudi: 12.1;U-266/70: 12.2;U-698: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048100, HPA050463" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA048100: , HPA050463: AB_2681137" "unprognostic (1.56e-1)" "unprognostic (1.04e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-1)" "unprognostic (2.99e-1)" "unprognostic (3.49e-1)" "prognostic favorable (2.78e-5)" "unprognostic (2.94e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.99e-10)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (4.50e-3)" "unprognostic (1.96e-2)" 1.3 1.6 3.6 1.1 7.9 2.3 1.2 5.1 12.2 1.3 1.4 2.1 3.1 1.3 1.1 6.6 3.5 1.8 1.0 5.4 3.0 3.8 2.0 2.7 2.1 1.3 5.2 3.7 1.2 1.3 1.7 2.2 0.9 4.8 2.9 1.5 8.3 2.7 2.4 158.8 1.0 1.1 1.1 1.9 1.0 5.3 1.6 1.4 0.0 1.8 30.1 1.9 1.1 0.4 3.9 0.5 20.3 2.9 2.1 0.5 0.6 3.0 0.6 0.8 4.7 2.6 0.3 0.4 1.1 0.6 0.7 1.5 0.9 4.4 12.1 1.9 0.2 4.2 2.5 6.2 1.3 0.7 0.8 1.8 0.0 1.8 1.0 0.7 0.1 0.2 1.1 4.8 0.9 0.5 3.6 0.3 2.2 0.1 1.1 0.5 4.6 0.1 1.2 1.2 11.3 7.2 6.3 1.1 3.2 4.6 2.3 7.8 5.4 3.3 0.4 1.5 0.4 2.3 1.0 0.0 0.9 2.3 2.9 0.5 12.2 8.8 20.3 1.1 7.2 0.9 20.3 2.9 8.2 0.0 1.1 0.0 2.8 0.4 0.0 0.2 3.9 0.1 0.1 1.6 2.1 0.7 0.5 0.5 0.6 3.6 7.9 5.1 12.2 3.0 3.8 5.2 3.7 4.8 1.4 3.0 1.0 0.8 2.8 1.0 21.6 22.4 0.0 1.4 1.2 0.0 80.5 0.0 1.7 3.1 0.0 3.3 0.7 0.0 2.2 0.1 2.1 3.6 0.0 6.7 0.4 12.7 4.1 8.0 5.6 0.5 9.8 0.0 3.3 0.0 5.8 12.1 7.1 0.0 21.2 1.0 10.2 0.0 2.8 0.5 0.4 0.3 0.1 0.0 2.4 0.9 TMEM38B "bA219P18.1, C9orf87, D4Ertd89e, FLJ10493, TRIC-B" ENSG00000095209 "Transmembrane protein 38B" Q9NVV0 9 105694544-105776612 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.9" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 220.6;Late spermatids: 366.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018465 Uncertain NA NA "HPA018465: AB_1858116" "unprognostic (3.34e-1)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (2.46e-2)" "unprognostic (2.68e-1)" "unprognostic (7.20e-2)" "unprognostic (1.51e-2)" "unprognostic (3.11e-3)" "unprognostic (1.88e-2)" "unprognostic (3.54e-2)" "unprognostic (5.82e-3)" "unprognostic (5.80e-2)" "prognostic favorable (7.96e-4)" "unprognostic (1.09e-1)" "unprognostic (2.09e-1)" "unprognostic (3.89e-3)" "unprognostic (9.98e-2)" 8.8 10.0 6.0 4.0 7.4 10.4 17.4 4.1 5.7 6.8 7.4 10.4 2.8 4.0 5.5 11.0 4.8 4.5 4.2 28.3 6.6 6.1 18.6 11.7 5.7 8.1 12.5 3.4 11.7 4.1 5.3 16.6 2.9 7.9 5.1 7.3 9.2 4.2 4.4 43.9 4.0 6.4 5.2 10.4 3.6 4.3 21.1 9.0 3.3 17.9 15.6 3.0 7.5 8.2 26.3 24.2 24.5 13.3 12.0 20.2 11.3 5.9 9.3 7.2 11.4 42.1 9.3 15.4 8.8 5.6 8.4 8.8 14.4 8.2 13.8 4.4 3.0 13.6 4.3 10.4 4.9 9.2 10.4 14.1 5.6 6.5 8.8 5.9 17.0 12.2 8.7 4.4 5.7 8.3 2.6 3.3 9.7 29.6 12.4 5.1 16.5 11.7 5.1 5.6 17.4 10.2 7.9 22.8 6.6 3.8 5.0 12.7 3.1 8.8 14.5 6.3 5.1 18.1 12.0 1.7 7.7 7.7 29.3 8.8 15.2 37.6 6.8 14.3 18.8 15.3 5.8 9.7 24.5 6.7 13.3 8.7 26.3 9.2 7.9 10.8 24.7 20.2 12.5 1.4 12.0 11.5 24.2 7.8 11.3 6.0 7.4 4.1 5.7 6.6 6.1 12.5 3.4 7.9 9.0 0.0 2.4 10.3 19.8 27.0 12.2 48.5 17.8 4.0 2.3 24.4 27.5 8.2 56.3 6.4 220.6 8.2 11.8 0.0 5.9 14.5 10.8 30.3 15.1 23.1 29.9 11.1 30.6 2.5 7.3 366.7 78.9 26.7 30.4 25.2 11.2 27.6 7.3 14.0 42.1 31.4 11.8 116.4 51.3 129.7 51.9 28.5 17.7 10.0 19.9 10.7 TMEM39A FLJ10902 ENSG00000176142 "Transmembrane protein 39A" Q9NV64 3 119429500-119468830 "Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039140 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA039140: AB_10673303" "unprognostic (2.16e-1)" "unprognostic (8.75e-2)" "unprognostic (4.25e-2)" "unprognostic (6.86e-2)" "unprognostic (1.56e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (9.68e-2)" "unprognostic (6.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (4.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.88e-1)" "unprognostic (6.41e-2)" 13.7 12.7 5.6 13.0 8.8 9.3 13.2 10.5 6.4 18.3 8.7 10.4 27.0 9.6 20.8 18.3 10.9 13.5 13.4 14.4 5.1 3.8 9.7 16.7 15.2 11.0 8.9 2.4 17.6 37.5 8.3 47.9 19.5 7.6 13.9 9.5 12.1 30.2 30.0 8.7 10.7 10.6 9.6 8.4 11.8 11.5 15.4 8.0 11.3 17.4 9.5 19.2 11.9 13.0 8.6 18.1 11.5 11.2 11.9 13.8 9.2 15.9 8.0 14.3 10.1 28.5 26.7 15.1 15.8 27.1 17.1 23.8 14.0 12.2 6.7 15.0 14.5 21.2 16.6 14.7 6.2 18.9 6.6 5.7 8.2 6.1 14.2 19.2 15.2 12.3 16.1 10.4 12.4 30.3 19.5 11.3 10.4 8.0 19.3 9.5 7.3 8.0 5.5 13.7 15.9 16.0 8.7 7.4 14.3 5.0 6.2 6.2 8.7 14.9 8.6 21.3 10.5 8.1 14.3 9.7 10.6 10.1 7.4 9.9 22.2 6.2 15.9 15.9 11.0 15.1 11.5 11.2 8.0 13.5 6.2 13.8 8.5 8.4 11.3 13.2 8.6 7.0 7.1 4.7 11.9 4.8 18.1 9.8 9.2 5.6 8.8 10.5 6.4 5.1 3.8 8.9 2.4 7.6 8.0 8.9 12.0 7.5 13.8 20.3 4.5 9.8 2.5 12.0 7.9 7.0 5.9 22.9 5.0 10.2 19.6 8.0 5.6 0.0 12.5 45.9 30.1 16.5 1.1 9.8 12.1 1.6 10.4 7.4 21.0 4.2 15.8 13.2 10.1 45.9 14.6 4.8 9.1 3.5 12.4 3.4 6.3 6.5 13.9 23.2 14.7 19.1 50.0 15.8 10.8 17.5 TMEM39B FLJ10315 ENSG00000121775 "Transmembrane protein 39B" Q9GZU3 1 32072031-32102866 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040191, HPA040224" Approved Approved Vesicles NA NA Vesicles "HPA040191: AB_10805706, HPA040224: AB_10795274" "unprognostic (1.74e-2)" "unprognostic (2.20e-2)" "unprognostic (4.38e-2)" "prognostic unfavorable (3.00e-4)" "unprognostic (1.06e-1)" "unprognostic (1.14e-2)" "prognostic unfavorable (2.82e-6)" "unprognostic (1.10e-2)" "unprognostic (3.37e-2)" "unprognostic (1.74e-1)" "unprognostic (3.63e-2)" "unprognostic (4.47e-2)" "prognostic unfavorable (5.11e-9)" "unprognostic (2.20e-1)" "unprognostic (5.80e-2)" "unprognostic (4.45e-2)" "unprognostic (2.10e-1)" 13.4 10.2 6.2 7.4 10.1 6.1 10.8 6.2 14.3 18.2 10.7 11.5 8.2 7.1 18.8 11.9 8.2 11.8 9.4 10.0 5.8 7.9 6.7 13.7 9.3 13.5 7.2 11.7 16.1 6.6 7.8 9.9 16.9 8.3 9.7 8.1 10.8 8.5 13.7 9.9 13.0 8.4 12.6 7.0 9.5 9.0 18.3 7.1 22.9 10.8 10.3 13.1 12.7 11.3 11.5 21.6 5.1 14.1 4.4 10.6 8.3 8.1 2.4 2.9 7.8 10.0 6.0 4.1 7.7 11.8 9.3 9.0 4.2 12.0 8.7 11.6 5.3 5.7 9.3 2.3 11.4 2.6 4.8 7.5 5.7 5.2 2.2 12.1 10.1 5.8 8.8 4.2 14.2 10.3 5.1 5.6 5.0 7.4 7.8 8.0 3.8 6.5 3.0 10.4 9.2 5.8 12.0 11.2 12.3 4.1 4.4 7.2 4.3 10.5 5.4 8.2 1.1 4.2 4.8 8.4 14.6 9.7 5.3 7.5 3.9 5.9 9.5 8.9 8.7 11.1 2.5 14.1 5.1 5.3 12.0 7.2 11.5 7.9 6.6 14.4 11.5 10.6 8.6 3.7 4.4 8.7 21.6 8.2 8.3 6.2 10.1 6.2 14.3 5.8 7.9 7.2 11.7 8.3 7.1 8.9 0.6 14.5 14.4 9.8 7.7 2.2 7.6 2.7 7.9 3.5 17.7 28.7 1.7 7.4 2.4 17.5 4.7 0.0 13.8 18.0 17.0 4.9 15.0 5.5 13.5 6.4 5.2 12.3 15.7 0.9 11.2 12.6 10.1 19.8 7.6 4.3 5.3 2.9 13.1 3.4 5.6 6.5 12.2 10.3 15.1 8.9 34.1 10.1 9.3 3.5 TMEM40 FLJ11036 ENSG00000088726 "Transmembrane protein 40" Q8WWA1 3 12733525-12769457 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 62.9;lymphoid tissue: 41.8;placenta: 53.6;tongue: 40.5" "Cell type enhanced" "Detected in many" 24 "Cytotrophoblasts: 120.6;Suprabasal keratinocytes: 176.4;Syncytiotrophoblasts: 549.0;Urothelial cells: 120.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 13.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 4.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "HBEC3-KT: 73.7;hTCEpi: 16.6;hTERT-HME1: 21.0;RT4: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044165, HPA073122" Enhanced Approved Cytosol NA NA 7000000 Cytosol "HPA044165: AB_10961279, HPA073122: " "unprognostic (2.51e-3)" "unprognostic (1.96e-2)" "unprognostic (2.64e-3)" "unprognostic (8.25e-2)" "unprognostic (2.27e-1)" "unprognostic (1.92e-1)" "unprognostic (5.15e-4)" "unprognostic (5.96e-2)" "unprognostic (3.15e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-3)" "unprognostic (2.47e-1)" "unprognostic (1.20e-3)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (1.46e-2)" "unprognostic (6.77e-2)" 0.0 0.0 0.0 0.0 0.2 1.4 1.8 0.0 0.0 11.7 0.0 0.0 0.4 0.0 0.9 0.6 62.9 1.6 0.1 1.6 0.0 0.0 0.3 0.0 1.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 53.6 0.1 2.3 0.0 0.0 6.6 1.4 0.4 24.0 0.0 0.7 0.0 1.1 0.0 0.4 0.0 0.4 0.0 40.5 41.8 10.6 18.6 0.0 0.5 4.5 0.6 0.0 0.3 21.1 7.4 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.3 0.3 0.4 0.2 1.1 0.0 0.0 0.0 0.2 2.1 0.0 73.7 1.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 16.6 0.0 21.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.4 10.3 0.0 0.0 0.0 9.2 0.0 1.4 0.8 0.2 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.6 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.5 0.0 0.0 0.5 0.0 21.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 71.9 57.1 0.0 3.3 0.0 22.7 6.8 1.8 0.0 120.6 0.0 0.5 0.6 0.4 0.0 0.0 0.0 12.6 4.3 9.6 0.0 0.6 9.6 0.0 0.0 0.0 0.3 1.6 0.3 0.2 10.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.3 0.2 1.9 176.4 549.0 0.0 0.0 120.1 TMEM41A MGC15397 ENSG00000163900 "Transmembrane protein 41A" Q96HV5 3 185476496-185499057 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 54.4" "Cell type enhanced" "Detected in many" 4 "monocytes: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059101, HPA059790" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059101: AB_2683905, HPA059790: AB_2684125" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.99e-2)" "prognostic unfavorable (6.70e-6)" "unprognostic (2.67e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (3.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.73e-1)" "unprognostic (3.68e-1)" "unprognostic (1.46e-2)" "unprognostic (1.02e-2)" 8.1 23.9 7.8 4.8 10.2 9.3 10.1 4.9 11.5 10.6 26.8 11.7 6.3 24.5 9.1 11.1 20.6 9.0 8.6 8.3 7.5 8.4 15.8 26.1 11.3 9.0 8.1 5.4 14.2 10.7 6.7 5.7 9.0 8.6 10.1 8.6 11.9 11.2 9.4 8.3 16.6 54.4 8.0 8.7 12.4 8.7 11.2 7.4 11.3 9.0 18.1 16.7 8.8 12.5 12.8 16.4 7.8 8.4 8.5 16.7 6.5 20.9 7.6 5.1 6.2 8.1 8.7 15.0 8.1 7.1 10.2 7.5 19.8 8.3 6.5 15.5 7.5 14.5 14.6 14.0 8.6 10.4 10.9 12.9 11.3 4.6 19.9 9.0 12.1 6.4 8.1 12.9 9.2 10.6 6.5 7.8 8.3 20.0 16.3 6.5 8.1 7.4 7.0 8.4 16.6 12.1 7.5 7.8 11.9 8.8 15.4 5.1 6.6 7.0 18.0 12.3 7.6 21.5 9.5 5.6 6.1 7.6 12.6 16.8 24.0 36.6 13.1 9.3 7.3 7.3 7.8 6.3 5.1 13.2 6.6 16.7 12.8 13.6 14.3 7.0 12.4 15.0 16.1 2.4 8.5 8.4 16.4 11.1 6.5 7.8 10.2 4.9 11.5 7.5 8.4 8.1 5.4 8.6 7.4 8.9 26.2 17.6 29.0 47.2 17.7 11.3 22.9 4.0 14.8 19.2 17.7 23.4 6.6 28.6 0.4 17.9 38.7 0.0 48.5 20.2 16.7 43.7 8.1 34.2 16.5 15.9 17.9 14.1 11.1 1.8 13.3 14.3 8.5 100.0 26.4 14.6 45.8 15.9 12.7 22.4 29.5 19.4 17.2 23.7 14.2 74.0 38.4 15.2 30.8 81.8 TMEM41B KIAA0033 ENSG00000166471 "Transmembrane protein 41B" Q5BJD5 11 9280654-9314780 "Predicted membrane proteins" "Autophagy, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014946 Uncertain Approved Peroxisomes NA NA Peroxisomes "HPA014946: AB_2205037" "unprognostic (1.21e-1)" "unprognostic (2.19e-1)" "unprognostic (1.35e-1)" "unprognostic (2.75e-3)" "unprognostic (5.78e-3)" "unprognostic (1.94e-1)" "prognostic unfavorable (9.18e-6)" "unprognostic (6.18e-2)" "unprognostic (9.37e-3)" "unprognostic (4.90e-3)" "unprognostic (1.36e-2)" "unprognostic (4.02e-2)" "unprognostic (1.29e-1)" "unprognostic (1.40e-1)" "unprognostic (2.20e-1)" "unprognostic (3.55e-2)" "unprognostic (8.18e-2)" 9.2 11.6 11.9 8.7 13.0 15.5 10.5 13.7 17.6 8.0 14.3 20.1 15.6 21.8 7.3 10.6 13.5 7.8 10.5 10.7 11.9 14.6 14.6 23.0 19.3 9.5 16.2 12.9 9.1 14.6 18.8 13.4 13.8 20.1 14.0 11.3 10.1 11.8 11.1 8.8 15.9 21.2 5.9 13.5 10.2 15.5 14.9 14.6 14.9 21.3 8.5 11.0 9.6 8.8 7.2 6.0 8.0 2.4 7.1 9.2 3.7 13.1 13.8 7.8 6.7 7.6 11.1 18.7 11.8 11.3 7.0 12.9 6.6 42.8 5.7 11.0 7.5 10.5 17.3 9.0 7.1 8.7 9.8 6.9 4.6 9.3 6.8 9.9 4.2 6.5 9.4 10.2 6.7 8.4 6.0 5.9 6.4 9.9 14.4 13.5 4.7 6.8 1.8 24.0 7.8 7.2 4.6 10.8 7.9 10.8 13.2 2.4 8.5 11.8 9.9 8.2 9.1 8.8 6.6 8.2 7.7 9.0 11.9 6.1 4.6 7.1 10.3 8.6 2.7 6.4 6.3 1.9 7.4 4.7 1.6 4.3 7.2 4.4 5.1 3.1 5.9 9.2 7.6 8.0 7.1 2.4 6.0 4.0 3.7 11.9 13.0 13.7 17.6 11.9 14.6 16.2 12.9 20.1 14.6 44.7 63.2 19.3 50.5 67.5 35.1 20.2 38.2 20.1 33.0 29.6 62.8 39.2 6.6 23.1 1.2 17.5 47.2 23.3 34.4 43.5 26.9 51.9 16.2 46.5 19.9 19.1 38.1 19.6 16.5 1.4 16.7 20.5 18.6 27.1 37.0 25.3 41.4 28.5 13.1 18.2 37.4 19.4 24.2 39.0 41.7 55.7 46.9 20.6 29.6 53.6 TMEM42 MGC29956 ENSG00000169964 "Transmembrane protein 42" Q69YG0 3 44861869-44865670 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 73.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052569 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA052569: AB_2681871" "prognostic favorable (5.23e-4)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (3.73e-2)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (6.99e-3)" "unprognostic (1.64e-2)" "unprognostic (9.16e-2)" "unprognostic (9.23e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "prognostic favorable (1.10e-5)" "unprognostic (1.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" 11.1 14.6 18.6 5.7 26.1 4.6 13.4 7.8 17.3 12.7 8.5 17.7 8.5 6.1 10.4 25.9 7.2 16.8 8.9 10.2 18.4 19.7 12.9 19.1 9.7 9.3 19.1 14.1 17.1 17.5 12.7 16.5 8.9 16.4 12.7 8.5 8.5 10.9 12.7 16.6 8.6 6.2 9.2 19.8 8.7 9.9 20.0 15.5 11.6 17.1 6.5 9.1 7.5 8.7 13.9 11.8 4.2 10.2 9.1 15.9 9.2 4.1 4.2 1.2 2.4 16.1 12.7 0.1 3.4 4.8 4.2 4.2 0.9 8.2 2.8 6.7 6.6 1.9 2.8 0.3 5.2 4.2 4.4 0.0 1.7 5.4 4.4 17.1 2.0 0.1 13.1 13.4 4.3 9.7 9.0 7.1 7.2 0.1 5.8 6.3 3.2 1.7 3.4 2.3 5.0 1.9 1.5 0.7 0.6 9.1 1.6 1.3 1.7 4.1 1.4 1.6 4.2 3.0 3.5 4.6 3.7 0.4 5.4 3.7 2.0 1.5 0.8 7.4 2.4 1.6 3.7 8.6 4.2 7.8 7.7 8.2 13.9 11.6 7.2 10.6 11.9 15.9 12.6 1.6 9.1 10.2 11.8 9.2 9.2 18.6 26.1 7.8 17.3 18.4 19.7 19.1 14.1 16.4 15.5 20.8 4.8 10.7 14.4 5.5 8.0 10.1 15.3 16.0 4.5 31.4 2.0 17.6 11.6 15.3 56.7 9.3 5.2 0.0 8.9 11.3 14.2 14.8 3.5 15.3 19.8 17.5 11.5 11.6 13.3 73.6 25.3 10.3 6.8 9.0 9.1 20.9 11.7 8.4 18.4 17.0 15.9 6.5 6.9 36.1 19.3 7.9 8.1 13.1 11.8 6.2 TMEM43 "ARVD5, DKFZp586G1919, LUMA, MGC3222" ENSG00000170876 "Transmembrane protein 43" Q9BTV4 3 14124940-14143679 "Disease related genes, Predicted membrane proteins" "Cardiomyopathy, Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 128.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019198 Approved NA NA 94000 "HPA019198: AB_1858118" "unprognostic (3.65e-3)" "unprognostic (2.52e-1)" "unprognostic (4.03e-2)" "unprognostic (4.66e-1)" "unprognostic (5.45e-3)" "unprognostic (1.72e-1)" "unprognostic (1.28e-3)" "unprognostic (1.08e-1)" "unprognostic (2.57e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (5.77e-2)" "unprognostic (5.45e-2)" "unprognostic (1.35e-3)" "unprognostic (2.19e-1)" "unprognostic (9.78e-2)" "unprognostic (1.18e-1)" 32.3 15.3 14.7 15.0 15.1 7.7 41.5 16.6 15.6 32.3 22.4 13.3 14.9 9.9 45.8 22.2 32.0 27.7 21.4 28.7 12.1 8.6 17.4 13.9 24.8 20.1 14.0 11.2 37.7 20.2 11.1 14.4 50.6 10.9 21.9 13.0 17.2 17.2 29.8 32.7 45.8 16.4 38.4 10.8 14.2 16.6 13.7 12.1 8.8 31.7 27.6 14.9 29.4 28.8 13.3 23.3 54.1 18.0 25.9 25.3 21.3 10.1 11.6 11.3 14.7 45.2 47.5 26.9 20.2 41.4 33.3 24.1 9.5 13.5 4.8 14.5 49.9 16.6 22.1 11.8 17.8 23.9 12.1 9.6 8.6 11.5 13.2 28.6 12.5 10.4 35.5 44.4 27.6 34.2 26.7 23.9 9.2 13.6 12.1 19.3 13.2 5.6 10.5 12.3 15.4 19.1 7.8 11.9 18.9 15.1 17.7 3.3 9.1 25.2 15.0 16.2 10.0 9.4 18.2 21.6 30.5 16.6 30.6 18.6 8.3 13.1 6.2 22.9 16.9 27.3 21.1 18.0 33.4 25.3 15.7 23.3 13.3 24.9 22.9 23.3 10.8 16.9 18.5 54.1 25.9 15.6 14.8 21.8 21.3 14.7 15.1 16.6 15.6 12.1 8.6 14.0 11.2 10.9 12.1 128.1 41.4 8.3 28.0 38.8 5.2 11.8 10.2 18.7 80.8 17.4 13.7 22.4 0.0 27.3 0.7 36.0 8.1 0.0 8.7 56.4 65.8 20.5 26.7 7.8 16.6 6.4 4.7 20.3 15.2 2.8 40.0 27.3 28.7 19.8 6.7 8.9 20.1 11.0 66.4 9.6 8.0 32.3 34.4 4.9 10.9 39.6 31.4 23.5 11.1 25.3 TMEM44 DKFZp686O18124 ENSG00000145014 "Transmembrane protein 44" Q2T9K0 3 194587673-194633689 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ito cells: 50.3;Mucus-secreting cells: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 3.2;NK-cell: 11.5" "Group enriched" "Detected in many" 9 "granulocytes: 3.2;NK-cells: 11.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043718 Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA043718: AB_10794662" "unprognostic (8.94e-2)" "unprognostic (1.01e-1)" "unprognostic (8.31e-3)" "unprognostic (4.53e-2)" "unprognostic (2.78e-3)" "unprognostic (9.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.17e-2)" "unprognostic (1.70e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (6.55e-13)" "unprognostic (1.23e-2)" "unprognostic (3.36e-1)" "unprognostic (1.65e-3)" "unprognostic (5.66e-2)" 13.2 2.8 4.8 6.2 11.8 10.6 21.2 1.9 7.3 6.6 11.8 2.4 9.2 4.6 6.8 22.9 5.1 4.9 7.9 5.9 6.1 6.3 5.6 3.6 15.1 6.3 5.2 7.8 5.1 3.3 1.3 2.3 12.0 6.7 4.8 11.9 3.3 7.0 5.8 6.7 3.4 6.0 5.6 3.7 9.0 6.7 4.1 3.3 4.1 5.3 5.5 3.7 5.0 6.7 0.3 0.6 3.2 0.4 11.5 0.8 0.0 6.3 5.1 7.8 8.3 2.9 9.8 6.9 4.9 9.2 4.1 6.5 2.8 12.6 1.1 23.3 5.7 11.8 7.4 2.6 3.7 2.7 10.4 3.7 7.1 5.3 2.1 5.3 2.2 11.3 6.3 4.1 9.2 4.1 19.4 16.6 7.0 2.0 0.3 13.2 5.9 3.3 5.6 4.1 6.2 8.4 6.3 4.9 0.2 4.2 3.6 2.2 4.7 3.5 1.1 7.2 3.4 5.3 4.7 19.6 12.3 4.6 3.8 6.3 0.9 0.7 2.2 18.4 8.6 6.1 3.2 0.3 0.3 0.5 0.2 0.1 0.2 0.2 0.8 0.0 0.3 0.1 0.3 0.8 11.5 0.4 0.6 0.0 0.0 4.8 11.8 1.9 7.3 6.1 6.3 5.2 7.8 6.7 3.3 0.0 2.9 3.7 3.0 0.5 0.8 1.1 0.0 2.7 3.4 5.2 2.0 6.6 0.0 5.1 0.6 15.2 13.4 0.0 4.3 2.8 4.8 5.1 17.3 0.8 3.0 0.0 5.8 50.3 2.2 0.0 2.8 0.8 1.7 0.0 20.6 0.6 9.6 17.5 1.8 0.1 0.3 6.5 1.2 0.5 5.9 0.5 7.3 1.5 16.2 5.1 TMEM45A "DERP7, FLJ10134" ENSG00000181458 "Transmembrane protein 45A" Q9NWC5 3 100492619-100577444 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 118.9" "Cell type enhanced" "Detected in many" 9 "Club cells: 118.3;Early spermatids: 138.9;Hepatocytes: 109.4;Suprabasal keratinocytes: 222.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 3.3;myeloid DC: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 94.3;ASC TERT1: 27.6;HSkMC: 29.0" "Low region specificity" "Detected in all" HPA062101 Uncertain Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA062101: AB_2684682" "unprognostic (5.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.11e-1)" "unprognostic (1.43e-3)" "unprognostic (7.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (7.42e-4)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (6.18e-11)" "unprognostic (1.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.02e-5)" "unprognostic (2.68e-2)" 5.3 5.2 1.6 3.0 7.3 0.6 12.5 0.3 1.9 8.6 2.7 1.9 2.5 1.0 8.5 5.7 4.4 5.2 5.7 5.7 1.3 0.9 1.4 45.2 5.8 5.2 4.4 0.7 6.4 20.2 0.3 25.1 20.2 2.1 5.9 1.8 3.1 23.9 2.2 2.4 118.9 1.7 6.6 2.2 2.2 2.0 5.4 4.4 0.0 6.5 3.7 12.2 7.7 18.5 0.5 2.9 0.9 3.3 0.0 0.5 2.0 6.1 0.4 0.6 2.1 94.3 27.6 0.0 14.8 13.8 2.1 19.4 0.5 0.1 0.0 7.4 9.7 5.6 7.0 0.5 2.8 5.3 1.5 1.8 5.2 2.3 1.7 5.9 0.0 0.3 29.0 1.6 3.8 5.8 8.9 0.8 0.0 0.1 0.7 5.0 0.0 0.0 0.1 0.7 0.0 3.7 0.0 5.3 0.0 0.1 0.2 0.6 4.4 3.6 1.9 1.5 4.3 0.2 2.9 2.0 14.4 10.1 0.1 3.3 12.2 6.9 0.0 11.3 0.4 9.5 0.0 3.3 0.9 0.3 0.0 0.0 0.5 0.2 0.3 2.9 0.0 0.1 0.5 0.4 0.0 0.5 1.6 0.0 2.0 1.6 7.3 0.3 1.9 1.3 0.9 4.4 0.7 2.1 4.4 56.6 52.0 7.0 4.3 84.0 3.3 1.9 0.0 97.7 118.3 0.0 0.0 2.2 0.0 7.1 138.9 3.8 0.0 0.0 13.5 42.5 64.8 3.2 60.4 109.4 5.6 7.9 1.2 12.3 6.1 11.8 15.0 5.0 21.9 1.8 1.7 1.4 8.9 0.3 26.2 0.0 0.8 6.5 16.4 1.2 1.9 222.8 6.3 3.2 0.0 4.1 TMEM45B "BC016153, FLJ40787" ENSG00000151715 "Transmembrane protein 45B" Q96B21 11 129815819-129860003 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 106.6" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 253.0;Paneth cells: 150.7;Undifferentiated cells: 102.5;Urothelial cells: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 3.6;naive CD4 T-cell: 4.3;neutrophil: 13.1" "Group enriched" "Detected in many" 12 "granulocytes: 13.1;T-cells: 4.3" "Group enriched" "Detected in some" 5 "OE19: 82.8;RT4: 33.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015474, HPA015878" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA015474: , HPA015878: AB_2205046" "unprognostic (4.92e-3)" "unprognostic (7.94e-2)" "unprognostic (5.98e-2)" "unprognostic (1.81e-1)" "unprognostic (5.44e-3)" "unprognostic (7.11e-2)" "unprognostic (1.17e-1)" "unprognostic (6.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.02e-3)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (1.42e-2)" "unprognostic (2.24e-1)" "unprognostic (1.68e-2)" "unprognostic (1.52e-1)" 0.2 0.2 0.6 9.0 0.9 0.0 4.0 0.3 0.7 6.6 50.3 0.5 1.7 40.4 1.2 4.1 29.5 6.5 9.3 0.4 1.2 0.6 9.6 13.2 4.5 1.9 0.4 0.7 1.4 3.1 0.0 2.9 1.2 2.3 4.0 29.0 0.3 7.3 2.4 0.2 10.9 106.6 1.5 0.5 0.6 7.4 0.7 0.2 0.5 9.1 21.9 19.9 9.4 10.9 0.6 0.4 13.1 0.6 0.7 4.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 9.7 4.2 0.0 1.8 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.5 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.0 82.8 12.6 0.0 0.0 0.6 5.4 33.4 1.0 0.1 0.0 2.7 0.0 0.0 9.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.6 0.1 0.3 0.2 0.3 0.2 3.6 0.9 0.0 0.6 4.3 0.7 13.1 0.7 0.2 0.4 0.6 1.3 0.6 0.9 0.3 0.7 1.2 0.6 0.4 0.7 2.3 0.2 17.9 8.4 0.5 10.0 3.0 0.0 0.6 22.9 68.3 21.6 43.6 0.0 4.0 11.6 20.5 0.2 0.3 253.0 0.0 7.3 0.6 0.9 18.6 2.3 2.6 0.5 0.0 53.3 0.0 1.6 0.0 0.3 1.9 3.3 0.0 64.7 0.0 32.6 150.7 0.0 1.2 0.3 0.0 1.0 0.0 0.0 18.2 0.3 0.7 102.5 96.6 TMEM47 "BCMP1, DKFZp564E153, DKFZP761J17121, TM4SF10, VAB-9" ENSG00000147027 "Transmembrane protein 47" Q9BQJ4 X 34627064-34657288 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 68.7;Muller glia cells: 146.8;Peritubular cells: 87.4;Sertoli cells: 90.5;Smooth muscle cells: 67.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 27.5;fHDF/TERT166: 84.5;RPTEC TERT1: 20.8;U-2197: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046658 Approved Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA046658: AB_2679742" "unprognostic (1.50e-1)" "unprognostic (1.44e-1)" "unprognostic (5.97e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-1)" "unprognostic (3.82e-2)" "unprognostic (6.74e-3)" "unprognostic (7.29e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.67e-2)" "unprognostic (4.23e-2)" "unprognostic (1.36e-1)" "prognostic favorable (4.05e-6)" "unprognostic (2.69e-2)" "unprognostic (7.19e-2)" "unprognostic (2.76e-1)" "unprognostic (9.94e-2)" 19.7 11.3 22.3 4.3 28.3 0.0 19.0 8.1 18.5 26.7 13.7 15.0 7.6 4.5 24.8 18.7 19.2 19.5 15.4 18.4 24.1 17.2 15.0 12.8 11.7 2.9 10.5 9.5 15.3 5.9 2.0 4.5 0.6 14.0 18.4 8.1 19.0 17.1 26.0 11.8 3.6 6.3 29.9 6.9 3.7 8.5 7.0 15.7 0.3 10.9 4.8 2.1 21.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 12.6 5.3 11.2 8.5 0.0 27.5 0.0 5.4 4.7 0.0 0.0 0.0 2.3 84.5 0.0 0.0 3.5 0.9 8.1 0.0 2.4 0.0 3.5 0.0 6.4 0.0 0.0 7.6 0.0 2.2 2.4 9.8 6.1 0.0 0.0 0.0 10.2 0.2 0.0 0.0 1.5 0.1 0.0 0.0 6.3 0.0 20.8 8.0 0.1 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.2 11.1 1.1 18.5 1.1 0.0 0.0 0.0 4.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 28.3 8.1 12.4 24.1 17.2 10.5 9.5 14.0 15.7 17.9 1.1 0.0 11.6 7.2 6.6 24.4 10.2 1.4 2.3 15.7 5.9 0.0 6.6 0.8 0.4 30.5 0.0 0.0 4.4 0.1 42.9 11.2 2.3 12.9 0.1 28.6 0.0 39.3 0.6 1.1 68.7 2.1 62.4 0.0 0.0 146.8 3.3 0.0 87.4 11.5 6.1 90.5 67.4 0.3 1.9 4.5 0.1 0.0 0.0 10.9 TMEM50A SMP1 ENSG00000183726 "Transmembrane protein 50A" O95807 1 25337917-25362361 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065192 Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA065192: AB_2685429" "unprognostic (2.41e-2)" "unprognostic (2.74e-1)" "unprognostic (5.17e-3)" "prognostic favorable (8.64e-5)" "unprognostic (1.45e-1)" "unprognostic (2.04e-2)" "prognostic unfavorable (3.34e-4)" "unprognostic (7.39e-2)" "unprognostic (7.92e-3)" "unprognostic (2.53e-1)" "unprognostic (1.02e-2)" "unprognostic (2.44e-2)" "unprognostic (2.39e-3)" "unprognostic (6.66e-2)" "unprognostic (2.91e-1)" "unprognostic (3.91e-3)" "unprognostic (3.44e-2)" 36.2 45.6 29.2 23.2 39.1 19.4 43.4 30.5 29.4 29.7 32.7 21.5 25.6 26.5 29.4 31.5 36.7 23.5 30.9 32.6 30.9 23.6 39.1 31.8 34.2 36.3 29.3 18.5 22.6 29.7 21.7 13.6 40.4 19.9 32.8 38.6 19.1 56.5 33.0 21.5 25.7 39.6 27.8 38.1 39.4 26.5 17.5 20.4 32.7 39.2 29.6 28.1 37.1 31.0 13.0 14.0 56.5 26.8 19.2 25.0 23.1 8.5 9.8 16.5 8.5 31.0 27.9 5.8 17.4 27.9 33.1 37.1 7.9 21.5 9.9 9.8 61.9 12.4 12.5 12.9 14.2 36.2 26.1 18.5 21.2 10.8 12.0 22.9 16.1 17.2 30.4 20.9 24.5 14.2 15.7 23.8 11.2 14.1 15.6 31.2 6.0 10.5 19.7 19.3 14.1 8.1 9.3 18.1 17.5 33.3 6.3 13.8 8.8 18.0 12.7 13.9 15.6 6.5 10.6 35.2 18.5 7.7 30.2 7.2 10.9 11.8 9.1 24.1 24.2 10.2 56.5 19.1 26.3 24.0 23.0 25.0 13.0 21.1 24.4 14.0 10.1 15.5 21.1 39.7 19.2 26.8 13.0 23.4 23.1 29.2 39.1 30.5 29.4 30.9 23.6 29.3 18.5 19.9 20.4 134.0 76.3 88.7 152.8 225.1 40.2 88.4 119.8 104.4 70.5 160.5 25.5 94.3 43.1 257.7 13.8 175.4 107.8 46.7 188.7 283.9 172.6 238.9 122.5 56.8 203.7 23.8 79.6 140.6 162.8 8.4 140.7 195.1 189.0 268.7 149.5 99.5 250.4 140.3 93.0 82.3 29.5 207.0 211.1 93.4 46.0 277.7 151.8 110.7 95.4 208.9 TMEM50B C21orf4 ENSG00000142188 "Transmembrane protein 50B" P56557 21 33432485-33480011 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034199, HPA068995" Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "CAB034199: AB_2205160, HPA068995: AB_2686066" "unprognostic (3.22e-1)" "unprognostic (5.93e-2)" "unprognostic (7.82e-2)" "unprognostic (6.14e-2)" "unprognostic (1.26e-1)" "prognostic favorable (3.00e-4)" "unprognostic (2.24e-2)" "prognostic favorable (3.33e-4)" "unprognostic (8.65e-2)" "unprognostic (3.36e-2)" "unprognostic (1.85e-2)" "unprognostic (3.54e-2)" "unprognostic (9.58e-3)" "unprognostic (3.41e-3)" "unprognostic (8.28e-2)" "unprognostic (3.47e-3)" "unprognostic (3.32e-3)" 12.8 16.1 12.1 12.4 14.6 5.6 20.3 31.1 14.1 16.1 12.0 13.7 25.3 12.9 16.5 32.0 11.8 16.5 16.9 14.0 13.1 13.5 21.0 14.3 14.3 8.9 14.8 11.2 27.8 19.4 14.7 20.3 10.0 16.4 18.1 11.6 19.5 10.5 32.4 16.1 10.9 16.1 22.0 14.1 16.0 15.1 14.9 12.2 6.9 51.0 8.6 8.8 16.5 15.3 9.3 12.4 20.3 10.5 10.9 16.3 11.9 9.3 1.9 3.6 5.1 20.7 15.0 3.0 8.8 9.9 6.1 4.5 2.5 8.0 5.9 8.1 7.2 8.1 3.7 4.9 5.1 4.4 6.3 5.7 10.9 1.6 5.0 9.5 7.1 6.1 7.4 4.9 4.8 3.7 10.2 7.3 5.7 7.5 10.4 8.2 6.0 5.6 7.6 1.5 15.9 4.1 3.0 7.1 9.0 11.0 7.1 3.4 5.3 10.6 11.1 8.8 2.0 12.3 9.5 6.3 4.5 3.3 5.6 2.8 10.7 18.0 7.5 4.2 12.1 7.2 7.9 8.4 20.3 11.3 9.2 9.1 9.3 12.6 11.4 11.3 8.5 13.8 13.5 1.7 10.9 10.5 12.4 16.3 11.9 12.1 14.6 31.1 14.1 13.1 13.5 14.8 11.2 16.4 12.2 26.8 50.7 27.6 88.0 65.8 53.8 42.3 50.9 57.6 30.7 78.5 102.1 30.2 23.2 30.3 32.6 54.4 51.5 0.0 27.5 33.5 55.1 133.9 28.9 51.2 32.7 41.3 20.7 94.5 34.9 29.6 66.2 26.8 79.2 31.5 40.9 66.5 26.7 35.1 112.4 48.1 79.3 97.0 62.6 182.7 78.6 81.9 34.6 41.5 39.2 92.9 TMEM51 "C1orf72, FLJ10199" ENSG00000171729 "Transmembrane protein 51" Q9NW97 1 15152532-15220480 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Urothelial cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "classical monocyte: 1.8;intermediate monocyte: 2.3;myeloid DC: 1.7;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 23 "dendritic cells: 1.7;monocytes: 2.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014547, HPA019441" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA014547: AB_1858121, HPA019441: AB_2670142" "unprognostic (1.21e-1)" "unprognostic (1.84e-1)" "unprognostic (8.74e-2)" "unprognostic (1.89e-2)" "unprognostic (3.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.47e-2)" "unprognostic (7.81e-3)" "unprognostic (7.84e-2)" "unprognostic (1.39e-1)" "unprognostic (3.00e-2)" "unprognostic (8.91e-2)" "prognostic favorable (8.16e-8)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (5.58e-2)" "unprognostic (1.67e-3)" 4.6 14.1 4.7 7.7 4.4 0.4 7.0 14.2 5.1 9.7 22.4 4.5 14.3 15.9 5.3 7.6 12.0 7.2 25.3 3.7 5.0 2.2 23.5 3.9 10.4 7.4 4.1 3.4 15.4 36.7 14.5 5.2 7.5 4.2 12.3 7.8 16.1 7.5 15.5 1.2 5.3 22.9 8.9 5.7 7.1 18.9 3.4 3.9 2.0 3.8 12.3 8.4 18.5 22.2 0.0 1.7 0.0 2.8 0.0 0.0 0.3 19.1 10.3 5.9 1.4 1.0 2.2 0.0 2.2 9.3 6.8 9.3 13.5 21.6 0.0 7.3 1.4 9.8 18.6 2.0 7.2 3.9 0.0 5.1 0.4 0.5 13.3 8.6 0.0 18.8 0.7 6.4 8.9 9.8 4.4 6.3 0.8 2.9 0.0 3.5 6.6 0.0 0.0 1.0 15.3 3.9 2.7 3.7 3.3 17.3 19.9 0.9 17.5 1.8 7.6 18.4 3.7 1.0 2.0 4.4 7.1 6.3 3.1 6.9 0.2 0.3 0.0 7.0 0.3 8.3 0.0 1.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 4.7 4.4 14.2 5.1 5.0 2.2 4.1 3.4 4.2 3.9 0.0 1.6 2.7 51.9 16.3 0.0 1.8 20.4 6.7 4.5 47.1 0.0 4.2 5.0 64.9 0.4 8.7 12.9 0.0 64.3 0.7 5.6 48.2 0.0 0.4 43.7 0.0 18.4 8.6 24.2 0.0 2.6 18.8 13.5 19.8 16.3 0.0 65.3 25.9 13.1 11.8 0.0 32.3 39.4 0.5 1.9 18.4 1.1 0.0 13.2 98.9 TMEM52 ENSG00000178821 "Transmembrane protein 52" Q8NDY8 1 1917590-1919273 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "pancreas: 67.1;skeletal muscle: 77.9;tongue: 38.9" "Cell type enhanced" "Detected in many" 7 "Exocrine glandular cells: 19.1;Hepatocytes: 22.7;Spermatocytes: 23.3;Spermatogonia: 33.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 14.2;OE19: 12.8;RPMI-8226: 25.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (4.39e-2)" "unprognostic (2.60e-1)" "unprognostic (3.76e-2)" "unprognostic (7.35e-3)" "unprognostic (1.04e-5)" "unprognostic (1.46e-1)" "unprognostic (6.71e-3)" "unprognostic (3.68e-2)" "unprognostic (9.49e-2)" "unprognostic (1.69e-1)" "unprognostic (3.83e-3)" "unprognostic (5.80e-2)" "unprognostic (8.95e-2)" "unprognostic (1.18e-1)" "unprognostic (2.16e-1)" "unprognostic (1.15e-1)" "unprognostic (2.18e-2)" 1.7 12.5 0.5 0.2 0.5 0.1 1.3 1.5 0.4 0.3 0.9 0.4 0.1 1.0 0.3 1.5 2.0 0.8 0.4 0.4 0.4 0.5 0.6 3.3 1.0 0.1 0.2 0.5 0.5 67.1 0.9 0.3 0.2 0.4 0.5 0.4 0.5 13.8 0.1 77.9 0.8 1.7 0.2 0.3 0.7 1.2 7.9 0.2 0.2 0.9 38.9 2.5 0.3 0.4 0.2 2.3 0.0 0.4 0.0 0.6 0.0 2.3 0.2 0.6 1.3 0.2 0.1 5.5 0.3 0.1 1.6 1.0 3.9 1.6 0.6 1.6 2.5 0.6 0.8 3.9 1.1 0.3 0.2 2.9 0.0 0.6 14.2 0.8 0.0 0.9 0.0 2.3 0.5 0.2 0.1 0.1 2.8 3.5 1.4 0.0 4.5 0.3 1.1 2.1 12.8 7.7 1.0 0.0 25.8 0.8 0.1 2.7 1.8 0.0 2.2 0.3 1.0 1.5 0.3 0.0 0.0 1.1 0.7 0.0 1.8 0.6 0.7 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.5 1.5 0.4 0.4 0.5 0.2 0.5 0.4 0.2 0.0 0.0 1.5 2.5 3.9 0.2 0.6 5.1 4.0 3.4 0.0 0.0 0.9 1.7 1.8 3.4 0.2 9.1 0.0 19.1 5.3 1.7 4.9 0.0 22.7 0.6 0.0 0.0 1.3 0.3 4.5 13.8 0.7 8.5 1.0 7.3 1.2 10.4 2.9 9.2 8.2 1.0 0.0 0.7 23.3 33.4 2.5 3.1 0.0 7.0 2.7 TMEM52B "C12orf59, FLJ31166" ENSG00000165685 "Transmembrane protein 52B" Q4KMG9 12 10170542-10191801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "kidney: 85.1" "Cell type enriched" "Detected in some" 16 "Distal tubular cells: 603.5" "Cancer enriched" "Detected in some" 5 "renal cancer: 6.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 3.7" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "CACO-2: 46.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA058096 Enhanced Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA058096: AB_2683603" "unprognostic (1.10e-2)" "unprognostic (7.61e-2)" "unprognostic (1.37e-3)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" "unprognostic (5.33e-3)" "unprognostic (1.37e-1)" "unprognostic (8.65e-2)" "unprognostic (7.14e-4)" "unprognostic (2.23e-1)" "unprognostic (6.36e-2)" "unprognostic (7.33e-2)" "unprognostic (3.24e-2)" "unprognostic (5.80e-2)" "unprognostic (5.51e-2)" "unprognostic (1.66e-1)" "unprognostic (3.18e-1)" 0.1 0.0 0.1 0.1 0.6 0.9 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 85.1 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.1 2.0 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 3.7 1.4 1.3 0.6 0.5 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 46.3 0.0 0.0 0.0 0.3 2.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 6.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.4 4.4 0.0 1.6 2.5 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 1.4 1.3 1.0 0.4 0.2 0.4 0.4 0.4 0.5 3.7 0.9 0.5 0.5 1.0 0.6 0.2 0.6 0.4 0.4 0.1 0.6 0.1 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 12.2 0.0 38.1 603.5 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.6 0.0 0.3 4.2 1.7 2.8 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.2 0.0 16.2 0.0 0.0 0.0 TMEM53 "FLJ22353, NET4" ENSG00000126106 "Transmembrane protein 53" Q6P2H8 1 44635238-44674555 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.7;liver: 44.7" "Cell type enriched" "Detected in all" 5 "Late spermatids: 845.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 38.7" "Lineage enriched" "Detected in all" 4 "dendritic cells: 38.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021134 Approved Approved "Golgi apparatus,Focal adhesion sites" NA NA "Golgi apparatus" "Focal adhesion sites" "HPA021134: AB_2205162" "unprognostic (5.28e-2)" "unprognostic (2.60e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-2)" "unprognostic (3.93e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "unprognostic (2.88e-2)" "unprognostic (2.19e-2)" "prognostic favorable (6.96e-4)" "unprognostic (3.00e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.02e-5)" "unprognostic (1.15e-3)" "unprognostic (1.84e-2)" "unprognostic (4.07e-2)" "unprognostic (2.29e-2)" 8.3 9.0 6.0 4.4 8.7 6.0 7.0 2.4 11.8 4.9 11.0 8.8 4.6 16.6 5.7 7.2 4.5 5.3 7.6 9.3 6.2 6.1 14.8 44.7 7.3 6.4 6.8 6.2 7.7 5.4 3.3 6.4 4.3 8.0 5.2 7.2 13.9 6.0 3.8 4.2 3.9 16.4 4.5 6.1 4.8 7.7 18.8 4.4 3.6 8.2 3.1 4.0 7.3 3.7 5.3 38.7 3.6 8.6 2.8 3.1 2.8 7.6 8.8 8.0 5.8 10.4 7.9 9.6 2.2 6.7 4.4 6.6 2.8 24.2 2.4 7.3 2.1 17.0 6.9 2.2 4.7 2.3 3.8 5.6 2.8 3.6 13.4 10.4 2.2 10.3 9.3 7.3 8.8 1.9 4.8 2.4 5.5 1.2 3.1 2.6 4.5 2.5 6.5 4.6 5.9 5.2 4.0 1.1 23.6 13.1 8.0 5.6 5.4 2.4 9.6 12.4 5.9 3.0 5.8 1.0 3.2 5.5 4.6 2.8 2.2 2.6 1.3 8.4 5.7 3.7 3.6 5.2 2.3 3.0 8.6 2.6 5.3 3.1 2.5 2.6 5.0 1.5 2.0 0.5 2.8 6.0 38.7 3.0 2.8 6.0 8.7 2.4 11.8 6.2 6.1 6.8 6.2 8.0 4.4 6.0 11.8 2.4 6.7 1.4 5.6 24.6 10.2 18.7 9.1 19.2 3.9 11.6 38.1 14.3 155.5 8.7 50.1 23.3 22.5 13.2 5.6 7.8 5.8 81.3 29.8 17.5 13.8 8.0 8.3 845.8 8.3 7.2 8.5 1.8 18.4 12.9 16.0 56.1 11.7 39.8 12.4 25.8 7.3 5.1 8.3 1.9 7.8 4.1 15.4 10.3 TMEM54 CAC-1 ENSG00000121900 "Transmembrane protein 54" Q969K7 1 32894594-32901438 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 76.7" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 673.9;Mucus-secreting cells: 310.3;Paneth cells: 422.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 48.3;OE19: 57.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA061992 Approved Vesicles NA NA Vesicles "HPA061992: AB_2684652" "unprognostic (2.67e-1)" "unprognostic (2.57e-2)" "unprognostic (2.55e-1)" "unprognostic (4.98e-2)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (2.42e-2)" "unprognostic (3.48e-2)" "unprognostic (9.43e-2)" "unprognostic (6.82e-3)" "unprognostic (2.13e-2)" "unprognostic (9.06e-2)" "unprognostic (3.12e-2)" "unprognostic (3.40e-2)" 3.2 3.3 16.1 21.5 10.7 0.0 8.5 2.7 10.6 10.0 70.0 8.2 7.0 37.9 8.5 9.4 28.8 5.0 24.2 4.5 9.7 9.4 11.4 4.4 7.2 2.4 10.9 5.7 6.2 12.4 9.0 4.7 47.3 6.8 14.7 37.4 7.4 11.8 8.4 1.9 26.9 76.7 7.3 7.3 3.1 35.0 3.7 6.0 1.1 23.6 16.9 14.2 12.5 15.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 29.9 8.1 0.0 7.8 14.9 9.0 29.3 4.4 7.2 10.7 13.8 20.2 48.3 0.0 13.1 5.9 13.6 18.4 7.0 25.9 3.2 34.8 1.4 0.0 2.9 1.0 10.8 0.1 0.4 7.7 23.7 16.3 4.5 7.2 4.7 3.1 4.1 0.0 5.5 32.1 0.0 0.6 2.5 57.6 14.1 4.0 12.2 0.1 3.9 38.5 0.4 4.0 3.1 20.1 10.1 5.0 21.8 5.8 8.9 10.5 11.2 23.5 9.4 1.1 2.5 3.5 7.5 0.7 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 10.7 2.7 10.6 9.7 9.4 10.9 5.7 6.8 6.0 17.9 25.1 9.7 74.9 18.1 5.9 2.8 76.5 6.7 6.8 45.4 3.9 34.8 23.2 128.9 43.4 11.3 673.9 0.0 180.9 127.1 10.8 130.2 5.7 1.5 7.4 0.0 58.3 12.9 1.8 20.3 18.4 3.7 13.5 5.4 310.3 13.7 137.0 422.1 23.0 38.7 8.7 6.5 11.3 11.1 8.9 55.7 53.8 0.0 231.5 148.6 TMEM56 FLJ31842 ENSG00000152078 "Transmembrane protein 56" Q96MV1 1 95117338-95197607 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.2" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 68.8;Erythroid cells: 186.9;Hepatocytes: 246.3" "Cancer enhanced" "Detected in many" "liver cancer: 13.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 3.3;naive B-cell: 1.6;neutrophil: 1.0" "Group enriched" "Detected in many" 6 "B-cells: 3.3;granulocytes: 1.0" "Cell line enhanced" "Detected in many" "A-431: 13.9;GAMG: 13.1;RH-30: 23.2" HPA046762 Approved "Nuclear speckles" No No "Nuclear speckles" "HPA046762: AB_2679792" "unprognostic (1.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.98e-3)" "unprognostic (2.79e-1)" "unprognostic (3.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.82e-3)" "unprognostic (3.63e-2)" "unprognostic (4.42e-3)" "unprognostic (2.69e-2)" "unprognostic (4.99e-2)" "unprognostic (4.40e-2)" "unprognostic (1.16e-3)" "unprognostic (1.10e-1)" "unprognostic (9.46e-2)" "unprognostic (1.59e-1)" "unprognostic (3.15e-2)" 3.3 6.6 6.1 1.6 6.5 10.4 2.0 10.9 10.6 2.0 8.2 3.8 2.8 3.6 2.5 2.1 1.9 2.2 4.5 15.1 4.2 3.2 3.9 74.2 2.6 0.7 3.5 5.7 1.5 6.5 5.4 6.8 3.1 4.7 3.8 6.6 28.1 4.8 2.7 7.2 1.7 6.6 8.1 4.1 1.0 3.9 3.2 3.2 0.0 4.8 1.7 0.8 4.8 3.1 3.3 0.1 1.0 0.1 0.0 0.3 0.1 13.9 8.0 1.1 1.7 0.5 0.0 1.9 0.5 0.3 1.8 4.3 5.8 6.7 0.0 7.0 0.2 13.1 0.1 4.7 0.7 3.2 9.7 2.6 0.3 6.8 1.2 0.5 0.2 0.4 0.8 0.2 1.4 0.0 2.9 0.0 0.8 12.2 0.7 0.4 1.1 0.8 0.0 1.1 0.4 4.4 0.0 23.2 0.3 7.8 9.1 2.9 2.3 9.9 7.0 4.1 1.2 7.6 0.2 0.1 0.2 6.0 0.7 4.9 2.5 4.8 0.0 1.0 0.0 1.4 0.3 0.1 0.1 0.1 0.0 0.0 3.3 0.2 0.2 0.0 1.6 0.3 0.1 1.0 0.0 0.0 0.1 0.1 0.1 6.1 6.5 10.9 10.6 4.2 3.2 3.5 5.7 4.7 3.2 6.0 22.6 10.7 4.2 1.0 3.2 68.8 25.5 4.0 3.4 14.0 0.0 6.6 1.7 13.6 13.9 1.0 39.2 186.9 21.0 1.3 5.1 21.2 0.0 246.3 0.5 0.0 15.6 17.2 5.0 36.7 2.6 0.0 1.7 0.0 18.7 37.5 10.3 13.6 2.1 12.4 1.0 6.5 4.2 3.3 6.0 0.4 3.8 1.0 13.3 4.2 TMEM56-RWDD3 ENSG00000271092 "TMEM56-RWDD3 readthrough" 1 95117923-95247225 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 42.6;retina: 25.5" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 2.7;granulocytes: 4.6;Intestinal endocrine cells: 1.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 15.1" NA NA "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (9.43e-2)" "unprognostic (1.98e-1)" "unprognostic (1.80e-1)" "unprognostic (1.77e-3)" "unprognostic (4.35e-2)" "unprognostic (7.05e-2)" "unprognostic (1.70e-1)" "unprognostic (4.00e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.29e-2)" "unprognostic (3.42e-1)" "unprognostic (2.72e-1)" "unprognostic (1.99e-1)" "unprognostic (1.42e-2)" 3.1 3.9 4.6 1.8 5.8 2.8 3.9 7.5 9.2 2.9 3.6 3.3 2.3 4.1 3.2 4.9 2.1 3.1 3.7 14.2 3.8 2.4 2.8 42.6 2.7 3.3 2.5 4.9 3.5 6.2 4.1 6.1 4.5 4.1 3.7 3.9 25.5 3.9 2.2 4.7 4.6 5.8 7.0 2.9 2.3 3.9 3.4 2.8 0.0 4.5 1.6 2.6 3.6 2.9 2.7 1.3 1.1 0.8 0.7 2.4 1.0 7.2 4.3 4.0 5.3 1.7 3.2 4.6 1.4 0.9 2.8 3.2 6.6 3.0 2.6 5.0 1.6 7.7 1.8 3.8 1.9 3.0 1.9 2.4 3.2 4.2 1.6 1.5 1.0 1.0 1.9 2.1 2.5 0.7 3.2 1.2 2.4 5.3 1.7 1.5 2.0 2.2 2.5 2.0 1.2 2.2 1.9 15.1 0.4 3.8 7.4 4.0 4.5 5.3 4.2 5.2 3.0 3.0 2.4 2.6 3.0 4.1 2.8 3.9 2.4 1.6 1.6 1.4 0.6 2.1 0.6 0.7 1.1 1.3 0.8 0.7 2.7 2.0 0.8 1.3 2.6 2.4 0.9 0.0 0.7 0.7 0.6 1.6 1.0 4.6 5.8 7.5 9.2 3.8 2.4 2.5 4.9 4.1 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 2.7 1.2 0.0 0.0 1.2 0.0 0.8 0.1 0.0 0.7 0.0 0.4 0.4 0.0 0.1 4.6 0.8 0.7 0.0 1.7 0.6 0.0 1.3 1.1 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.0 TMEM59 "C1orf8, HSPC001" ENSG00000116209 "Transmembrane protein 59" Q9BXS4 1 54026681-54053504 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075447 Approved NA NA "HPA075447: " "unprognostic (2.63e-1)" "unprognostic (9.88e-2)" "unprognostic (2.63e-2)" "unprognostic (2.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (1.63e-2)" "unprognostic (8.28e-2)" "unprognostic (4.10e-1)" "unprognostic (6.57e-2)" "unprognostic (1.19e-1)" "unprognostic (4.49e-2)" "unprognostic (6.34e-3)" "unprognostic (9.84e-2)" "unprognostic (1.70e-1)" "unprognostic (6.83e-3)" "unprognostic (7.38e-2)" 45.1 68.7 41.1 29.8 42.9 36.4 58.8 31.6 47.5 61.8 79.7 68.4 72.3 59.5 47.5 73.1 53.3 68.9 55.5 63.2 43.8 44.5 80.6 85.4 47.8 35.5 62.8 49.2 48.0 96.2 58.8 65.4 78.6 56.9 60.5 82.3 58.9 85.3 58.2 44.5 42.5 77.8 42.7 111.0 41.1 71.6 43.3 55.6 26.4 84.4 36.1 35.5 53.5 58.6 52.4 63.8 146.1 78.9 48.2 67.2 115.3 25.7 17.0 20.5 26.3 124.4 55.2 26.2 48.8 71.0 30.5 40.2 13.6 55.4 13.3 46.7 83.4 37.3 39.7 23.6 33.4 32.3 32.6 24.9 18.2 41.5 22.7 46.9 22.5 38.8 60.1 59.4 29.9 31.9 82.4 35.0 18.1 21.3 46.7 34.9 12.4 13.2 18.8 28.5 73.3 31.9 12.9 35.7 54.8 37.5 34.5 29.9 24.8 53.4 55.1 54.3 40.2 26.4 48.3 36.3 37.7 13.3 27.6 25.8 41.6 45.2 15.8 50.8 38.1 31.4 115.5 78.9 96.7 56.7 63.1 59.6 52.4 61.2 61.7 63.4 46.9 57.3 56.9 146.1 48.2 67.3 63.8 67.2 115.3 41.1 42.9 31.6 47.5 43.8 44.5 62.8 49.2 56.9 55.6 217.4 154.8 203.9 559.3 359.0 145.7 125.5 443.3 431.0 210.4 415.2 111.9 422.4 135.9 388.3 250.3 265.0 704.5 163.5 312.7 461.3 462.7 771.4 151.3 356.8 292.7 125.5 391.8 308.7 279.1 144.4 400.7 261.8 654.6 140.7 617.9 435.3 300.5 929.3 332.7 375.5 125.4 362.2 279.1 321.0 124.1 362.2 574.6 211.6 510.6 638.1 TMEM59L "BSMAP, C19orf4" ENSG00000105696 "Transmembrane protein 59 like" Q9UK28 19 18607430-18621039 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 148.3" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 92.0;Horizontal cells: 47.7;Muller glia cells: 72.1;Rod photoreceptor cells: 22.8" "Cancer enriched" "Detected in many" 8 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 20.4;ASC diff: 24.8;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;hTERT-RPE1: 13.4;SH-SY5Y: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010661 Approved NA NA "HPA010661: AB_1078338" "unprognostic (3.24e-2)" "unprognostic (5.53e-2)" "unprognostic (1.24e-4)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.70e-1)" "unprognostic (5.40e-3)" "unprognostic (3.53e-2)" "unprognostic (6.91e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-3)" "prognostic favorable (8.80e-4)" "unprognostic (4.65e-2)" "unprognostic (9.17e-7)" "unprognostic (1.47e-3)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-5)" 2.6 12.8 36.9 2.5 39.4 1.7 1.9 41.9 148.3 2.2 2.9 7.5 0.0 2.0 2.5 2.0 2.5 2.1 2.9 3.5 39.9 49.6 1.9 1.8 1.9 1.8 17.7 32.8 1.8 2.8 4.9 13.2 2.3 24.1 2.2 2.2 1.9 2.3 2.6 2.5 1.8 3.0 3.1 7.3 1.7 2.0 2.4 5.2 0.0 1.8 0.0 1.7 2.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.4 0.0 0.6 0.2 20.4 24.8 1.2 0.0 2.1 0.4 0.8 0.4 0.0 1.0 0.1 14.6 1.3 2.0 0.3 6.0 0.0 0.7 0.1 0.9 0.0 0.3 14.8 3.8 0.0 0.3 9.1 0.0 0.2 0.7 13.4 0.0 0.8 0.0 0.1 0.5 0.9 0.1 0.0 1.8 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.3 12.1 1.4 0.0 0.0 0.2 0.2 0.0 0.2 0.4 4.9 0.1 1.3 3.0 1.1 0.1 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.4 36.9 39.4 41.9 70.3 39.9 49.6 17.7 32.8 24.1 5.2 0.0 0.0 0.0 0.2 0.0 92.0 0.4 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.2 47.7 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.0 0.0 72.1 0.3 0.0 0.0 0.0 22.8 0.0 2.7 2.6 0.9 0.1 0.1 0.0 0.0 0.0 TMEM60 "C7orf35, DC32" ENSG00000135211 "Transmembrane protein 60" Q9H2L4 7 77793728-77798580 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062625 Approved NA NA "HPA062625: AB_2684811" "prognostic favorable (3.09e-4)" "unprognostic (1.06e-1)" "unprognostic (1.42e-1)" "unprognostic (1.50e-1)" "unprognostic (1.02e-3)" "unprognostic (3.91e-2)" "unprognostic (5.28e-3)" "unprognostic (2.73e-3)" "unprognostic (3.46e-1)" "unprognostic (4.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.04e-1)" "unprognostic (1.21e-2)" "unprognostic (2.72e-2)" "unprognostic (9.44e-2)" "unprognostic (2.07e-3)" "unprognostic (4.43e-3)" 16.4 19.7 14.6 16.2 14.8 6.9 22.8 8.6 21.3 17.4 18.0 10.0 17.1 13.3 16.4 23.1 15.0 14.5 13.6 15.1 14.6 17.8 25.5 25.8 19.3 18.8 15.7 12.2 18.6 24.1 33.9 30.6 20.1 19.7 17.9 18.4 16.0 27.5 21.3 19.2 15.1 19.6 14.7 15.3 22.7 14.2 20.3 9.8 18.8 30.9 17.2 20.5 14.0 14.1 25.9 15.6 48.3 17.2 8.8 23.1 12.2 15.1 10.2 16.2 18.7 21.6 19.2 7.4 14.3 27.0 15.2 24.3 9.4 19.5 11.8 3.5 13.1 52.9 16.1 15.0 8.2 17.2 9.1 14.2 6.3 9.6 13.0 15.3 8.9 11.9 14.0 12.0 11.3 13.8 15.0 10.7 11.0 14.8 23.7 23.7 16.1 6.7 22.8 11.3 18.6 13.3 8.1 12.7 16.8 17.9 11.3 8.1 13.1 10.7 15.1 21.4 17.8 18.3 16.5 7.2 19.7 13.8 17.1 10.5 9.7 14.8 16.8 14.9 18.6 17.3 48.3 16.0 28.6 9.4 17.2 10.1 25.9 16.5 11.6 11.9 20.9 14.0 11.8 15.6 8.8 15.7 15.6 23.1 12.2 14.6 14.8 8.6 21.3 14.6 17.8 15.7 12.2 19.7 9.8 8.9 11.5 29.7 29.5 26.7 6.9 5.6 12.7 21.4 7.9 41.8 7.9 49.2 44.7 24.1 6.5 19.7 20.7 0.0 25.8 34.9 31.9 26.7 24.3 23.5 59.9 12.7 8.7 25.8 36.2 8.4 42.3 34.9 27.0 33.3 30.3 16.2 24.9 24.6 33.2 41.8 9.3 51.8 17.0 43.3 39.5 29.2 36.7 16.6 26.4 33.5 TMEM61 ENSG00000143001 "Transmembrane protein 61" Q8N0U2 1 54980792-54992293 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 22.1;pituitary gland: 29.1;salivary gland: 34.1" "Group enriched" "Detected in many" 4 "Distal tubular cells: 41.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 52.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 5.2;pons and medulla: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 22.6" "Low region specificity" "Detected in many" HPA030614 Uncertain NA NA "HPA030614: AB_10603216" "unprognostic (7.62e-2)" "unprognostic (1.67e-3)" "prognostic favorable (1.07e-4)" "unprognostic (1.00e-1)" "unprognostic (6.63e-4)" "unprognostic (6.15e-2)" "unprognostic (2.67e-3)" "unprognostic (1.49e-1)" "unprognostic (3.05e-1)" "unprognostic (4.46e-2)" "unprognostic (1.91e-2)" "unprognostic (7.24e-2)" "prognostic favorable (1.78e-7)" "unprognostic (8.47e-2)" "unprognostic (2.20e-2)" "unprognostic (4.01e-2)" "unprognostic (4.62e-3)" 0.2 3.9 0.4 0.7 1.0 0.0 2.7 5.2 0.5 0.9 3.7 0.2 4.9 2.4 0.2 3.8 2.9 2.0 1.7 0.0 0.5 0.6 22.1 0.0 2.4 0.0 1.1 0.7 1.1 4.2 7.8 29.1 0.5 5.2 2.4 2.3 0.5 34.1 6.7 0.4 1.8 3.5 5.3 0.8 0.4 2.2 0.2 0.1 0.1 0.6 0.8 1.8 4.7 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 22.6 2.4 0.0 1.1 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 5.2 0.5 0.5 0.6 1.1 0.7 5.2 0.1 0.0 1.9 0.0 6.7 0.8 0.7 0.0 0.0 10.7 2.3 7.0 2.0 0.1 41.4 4.0 0.1 0.0 1.7 0.0 3.0 0.1 0.2 3.1 0.0 0.0 0.1 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 52.9 0.1 4.2 5.8 0.7 0.0 0.8 0.0 0.1 0.1 0.7 2.0 0.2 0.0 2.0 2.6 TMEM62 FLJ23375 ENSG00000137842 "Transmembrane protein 62" Q0P6H9 15 43123279-43185146 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 29.2;U-266/84: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044461, HPA062359" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies" NA NA "Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies" "HPA044461: AB_2678950, HPA062359: AB_2684747" "unprognostic (7.43e-2)" "unprognostic (4.96e-2)" "unprognostic (4.56e-2)" "prognostic favorable (9.72e-7)" "unprognostic (2.53e-1)" "unprognostic (1.98e-1)" "unprognostic (2.39e-2)" "unprognostic (1.41e-2)" "unprognostic (4.83e-2)" "unprognostic (3.30e-1)" "unprognostic (3.90e-2)" "unprognostic (1.77e-1)" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (6.48e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" 11.6 8.6 7.6 9.5 12.0 9.6 28.6 21.1 13.9 10.4 15.5 15.1 9.8 15.5 9.9 15.4 10.7 9.4 14.0 7.3 7.8 9.8 9.5 12.3 13.0 10.5 10.2 8.2 6.1 12.0 16.5 10.8 12.3 12.7 8.6 17.6 11.9 16.9 9.2 14.5 8.5 17.3 11.0 11.9 9.6 12.0 3.1 7.8 4.6 10.5 8.9 13.7 13.2 9.0 2.5 4.6 2.6 1.8 3.8 5.0 0.9 7.0 3.8 1.7 3.3 2.1 2.8 18.2 6.8 8.6 12.1 16.9 6.0 14.0 7.1 3.9 6.4 10.9 13.6 7.3 5.3 4.4 8.4 3.2 5.8 8.4 4.5 4.7 6.0 5.3 2.0 6.4 5.2 3.7 3.4 6.6 1.8 5.1 6.2 1.3 1.6 0.0 1.4 0.6 29.2 1.6 3.5 1.8 3.8 6.4 9.0 11.1 4.7 5.3 13.4 3.2 2.0 7.2 6.1 3.8 6.0 2.5 4.2 10.9 5.2 31.3 5.0 5.5 6.7 5.2 1.5 1.8 2.6 2.4 0.8 2.9 1.9 3.2 2.7 2.0 2.5 1.9 2.6 0.5 3.8 1.0 4.6 5.0 0.9 7.6 12.0 21.1 13.9 7.8 9.8 10.2 8.2 12.7 7.8 14.9 2.9 8.3 3.5 2.1 5.3 2.4 10.2 5.3 4.5 12.2 9.8 18.1 5.0 11.3 1.1 4.7 10.7 0.0 12.9 21.2 3.1 2.2 4.7 5.8 6.7 1.6 4.1 3.7 6.5 2.4 2.3 5.7 5.0 7.2 9.7 7.5 11.1 9.0 1.1 2.9 9.5 6.5 4.7 1.8 0.8 2.5 28.5 3.1 9.1 3.7 TMEM63A KIAA0792 ENSG00000196187 "Transmembrane protein 63A" O94886 1 225845536-225882369 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.4" "Cell type enhanced" "Detected in many" 4 "Glandular cells: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 37.5;SK-BR-3: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066504, HPA066936, HPA068918" Enhanced "Vesicles,Centriolar satellite" NA NA 96000 "Vesicles, Centriolar satellite" "HPA066504: AB_2685680, HPA066936: AB_2685751, HPA068918: AB_2686057" "unprognostic (5.31e-2)" "unprognostic (3.46e-2)" "unprognostic (2.14e-2)" "prognostic favorable (8.79e-4)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-2)" "unprognostic (2.57e-1)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.92e-2)" 10.5 7.4 14.7 11.6 38.8 18.6 12.2 4.1 23.2 14.3 14.0 91.4 17.3 12.2 12.2 11.2 6.6 13.9 12.9 8.5 30.2 15.1 14.3 15.1 12.6 15.4 59.3 16.4 13.1 22.4 11.6 5.3 11.3 34.9 22.3 17.8 5.7 55.8 19.1 6.9 9.9 13.3 8.8 71.0 14.0 22.9 3.0 49.6 11.2 8.0 4.5 12.4 13.3 9.6 5.4 10.0 5.5 4.1 8.7 16.6 5.7 9.2 2.8 2.4 7.0 19.4 6.7 16.8 7.1 7.7 7.9 8.0 10.1 6.9 2.6 13.1 8.6 4.7 14.3 2.6 4.3 3.7 8.6 4.6 11.3 6.5 6.0 4.5 4.2 29.7 7.0 2.7 4.7 2.8 11.0 5.1 5.9 9.3 2.2 6.2 5.8 3.7 4.2 13.2 29.7 4.6 3.7 7.5 37.5 12.1 24.6 0.2 1.3 5.2 41.7 5.1 5.9 9.6 4.0 6.1 4.6 3.2 4.2 6.4 0.9 3.4 0.6 4.2 2.3 8.4 5.5 3.2 3.0 9.4 2.7 10.6 5.2 12.1 8.9 2.5 5.4 10.9 6.3 5.1 8.7 4.1 10.0 16.6 5.7 14.7 38.8 4.1 23.0 30.2 15.1 59.3 16.4 34.9 49.6 6.0 8.6 16.0 22.4 3.0 0.8 3.6 28.1 14.7 11.4 19.2 2.0 32.4 1.7 29.4 9.1 4.6 17.3 0.0 22.5 4.5 7.8 60.8 17.3 16.0 15.3 0.0 18.5 11.1 9.1 8.0 17.0 10.3 3.3 5.4 32.5 18.8 18.4 20.1 12.4 11.1 1.3 25.8 8.2 0.6 4.9 3.6 18.8 17.0 46.1 29.3 TMEM63B "C6orf110, dJ421H19.2, DKFZp434P0531" ENSG00000137216 "Transmembrane protein 63B" Q5T3F8 6 44126914-44155519 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "OE19: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029249, HPA029250, HPA029251" Uncertain Enhanced "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA029249: AB_2672965, HPA029250: AB_2672966, HPA029251: AB_2672967" "unprognostic (8.83e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-3)" "unprognostic (3.61e-1)" "unprognostic (2.89e-1)" "unprognostic (1.85e-1)" "unprognostic (6.97e-3)" "unprognostic (1.25e-2)" "unprognostic (1.87e-1)" "unprognostic (1.75e-1)" "unprognostic (8.60e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.67e-2)" "unprognostic (6.12e-3)" "unprognostic (3.15e-1)" 9.7 13.2 24.4 8.7 21.4 14.0 9.4 33.2 34.3 9.1 19.7 14.8 7.5 17.1 8.2 11.7 21.1 8.6 13.2 16.6 21.6 15.2 10.7 28.6 35.0 5.2 13.1 18.2 8.0 10.6 19.6 10.2 12.8 22.8 12.9 18.4 18.6 13.9 8.8 29.4 29.6 17.0 9.7 13.8 6.3 24.5 22.7 16.0 4.7 11.4 14.8 8.9 14.4 13.4 1.3 1.3 1.7 2.1 0.3 2.6 1.2 15.4 8.2 7.8 13.2 12.3 7.3 13.2 6.3 8.6 7.8 7.4 5.8 5.7 2.6 10.5 9.4 11.6 15.3 9.1 23.6 4.5 7.2 7.9 7.6 6.0 17.0 8.7 1.5 8.0 10.0 20.5 10.0 6.3 14.1 7.1 6.0 24.6 4.6 7.8 15.3 1.6 3.7 4.0 58.7 4.1 2.0 4.8 4.9 19.1 14.7 8.5 6.9 5.9 13.6 14.1 9.9 16.0 4.0 8.4 9.3 11.1 7.1 7.7 5.5 4.0 3.0 14.5 2.6 11.5 1.1 2.1 1.3 1.4 1.1 2.5 1.3 0.7 0.7 0.9 0.8 1.0 1.1 1.7 0.3 1.4 1.3 2.6 1.2 24.4 21.4 33.2 34.3 21.6 15.2 13.1 18.2 22.8 16.0 14.9 29.0 1.4 12.3 12.0 16.3 2.8 10.2 0.0 7.9 10.4 15.7 12.5 1.7 13.4 56.9 6.8 47.1 0.0 13.3 14.8 10.8 15.8 0.0 31.6 21.1 15.9 17.9 12.9 8.3 71.4 10.9 7.0 6.8 7.2 26.3 11.1 25.1 40.4 8.5 10.2 26.6 6.5 9.2 1.6 5.8 15.9 16.7 4.3 18.0 22.6 TMEM63C "C14orf171, CSC1, DKFZp434P0111, hsCSC1" ENSG00000165548 "Transmembrane protein 63C" Q9P1W3 14 77116568-77259495 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.8;pituitary gland: 21.1" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 7.2;Intestinal endocrine cells: 18.4;Late spermatids: 4.8;Paneth cells: 6.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 63.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 11.8;Karpas-707: 15.9;RPMI-8226: 8.1;SCLC-21H: 21.7;SK-BR-3: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030657 Uncertain Approved Centrosome NA NA Centrosome "HPA030657: AB_10601699" "unprognostic (2.74e-1)" "unprognostic (1.79e-2)" "unprognostic (2.30e-1)" "unprognostic (4.30e-8)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (2.68e-3)" "unprognostic (1.61e-3)" "unprognostic (2.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.90e-2)" "unprognostic (1.35e-3)" "unprognostic (3.72e-2)" "unprognostic (1.34e-7)" "unprognostic (5.90e-3)" 0.4 14.1 3.4 1.0 8.4 1.1 5.2 63.8 16.3 1.5 5.8 1.9 0.0 1.8 0.3 6.8 4.8 0.6 0.5 0.3 3.2 9.7 0.7 0.4 0.9 0.6 4.6 6.0 0.4 6.7 1.2 21.1 1.1 6.6 0.4 4.3 0.9 1.3 0.2 0.8 4.4 2.2 1.1 1.8 3.2 3.1 9.9 1.2 0.0 3.2 0.6 0.6 0.3 2.9 0.1 0.7 2.0 1.7 1.7 1.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 11.8 2.3 0.0 2.0 1.6 2.5 0.9 0.0 0.8 0.9 0.2 1.2 0.0 0.0 2.0 0.1 0.0 5.0 0.0 0.1 0.0 0.0 5.6 0.0 15.9 0.0 5.9 1.6 0.1 0.5 0.0 0.0 0.0 0.8 8.1 0.2 0.0 21.7 3.2 0.2 19.2 0.0 0.4 1.9 1.0 0.0 0.0 4.1 0.0 0.0 1.3 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.0 0.5 1.0 0.7 0.1 0.5 0.4 2.0 1.7 1.7 0.0 0.0 0.4 3.4 8.4 63.8 13.0 3.2 9.7 4.6 6.0 6.6 1.2 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 2.0 0.1 1.7 0.0 7.2 0.0 2.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 2.0 3.2 18.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 3.1 0.1 0.3 6.6 0.4 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 TMEM64 DKFZp762C1112 ENSG00000180694 "Transmembrane protein 64" Q6YI46 8 90621995-90791632 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "epididymis: 84.0" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 42.9;Leydig cells: 43.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034221 Uncertain NA NA "CAB034221: AB_1567653" "unprognostic (3.61e-1)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (3.70e-2)" "unprognostic (1.14e-1)" "unprognostic (2.27e-1)" "unprognostic (2.55e-3)" "unprognostic (4.84e-1)" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (3.30e-1)" "unprognostic (2.35e-1)" "unprognostic (2.59e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.17e-2)" "unprognostic (1.97e-1)" 9.2 12.6 4.3 5.2 5.3 2.1 6.1 2.7 6.1 10.6 10.8 16.2 14.5 5.7 11.9 84.0 7.3 5.7 6.3 5.8 6.2 5.5 11.6 11.7 7.2 6.7 11.2 3.3 10.1 11.3 4.1 5.9 6.1 10.0 10.7 3.7 15.1 12.4 11.0 8.2 6.8 11.3 9.6 12.1 7.2 5.4 9.7 7.5 2.3 20.0 5.2 7.2 11.9 10.9 5.7 0.6 3.2 0.8 5.9 3.7 1.6 12.8 10.0 5.1 2.7 23.7 17.3 2.7 9.5 9.1 7.5 8.4 2.8 8.9 8.4 3.8 5.8 3.2 4.5 13.5 6.5 10.0 16.8 4.9 15.6 4.0 6.3 8.4 0.9 2.6 22.5 7.1 3.1 7.0 8.7 7.5 2.0 7.0 18.6 12.6 17.1 0.0 2.2 0.7 6.6 5.3 1.8 11.2 4.2 14.8 25.0 3.6 10.2 6.2 5.5 11.5 7.1 5.5 0.7 7.4 7.6 6.7 5.5 7.7 12.3 0.2 9.2 6.9 1.9 10.0 3.2 0.2 0.3 3.0 0.6 3.7 5.7 3.2 3.4 0.6 2.9 1.5 2.1 0.1 5.9 0.8 0.4 1.4 1.6 4.3 5.3 2.7 6.1 6.2 5.5 11.2 3.3 10.0 7.5 8.9 12.2 16.1 8.7 21.4 0.6 17.1 10.2 4.0 3.4 21.0 0.0 20.2 1.7 3.8 2.4 7.0 3.4 0.0 8.8 5.2 14.6 15.6 13.9 42.9 3.6 1.6 7.5 5.5 7.5 2.1 43.4 6.5 23.6 0.0 4.3 2.6 8.2 3.1 20.1 22.1 0.0 0.0 10.8 3.4 1.6 20.6 13.2 9.6 5.1 6.2 TMEM65 ENSG00000164983 "Transmembrane protein 65" Q6PI78 8 124306189-124372692 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Horizontal cells: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025020 Uncertain NA NA "HPA025020: AB_2205178" "prognostic unfavorable (2.17e-4)" "unprognostic (3.52e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.24e-1)" "unprognostic (7.74e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (2.26e-2)" "unprognostic (1.84e-1)" "unprognostic (4.71e-2)" "unprognostic (7.95e-2)" "unprognostic (8.26e-2)" "unprognostic (5.67e-2)" "unprognostic (8.25e-2)" "unprognostic (1.75e-1)" "unprognostic (1.41e-1)" "unprognostic (3.78e-1)" 6.8 5.7 16.2 7.8 10.7 5.3 8.5 13.2 19.3 8.2 9.5 9.3 2.9 23.9 8.3 4.2 12.0 5.1 8.0 28.5 11.9 15.2 8.1 4.7 6.1 6.9 11.6 12.5 7.5 8.9 18.4 5.3 5.7 11.9 5.1 7.7 4.5 13.1 4.1 19.8 16.0 10.1 6.4 13.1 7.5 4.9 3.8 10.5 7.6 9.0 12.9 7.3 5.7 9.7 1.6 1.2 2.4 0.7 2.4 1.7 0.4 5.0 3.5 7.5 2.7 2.3 4.2 0.6 2.9 2.9 4.6 5.4 0.6 2.1 4.8 3.0 5.3 3.6 2.4 3.8 2.8 5.6 14.9 3.9 3.3 3.0 1.0 6.6 2.1 3.3 3.0 5.4 6.7 5.4 6.4 10.4 2.4 1.5 4.1 5.7 3.9 1.5 0.8 2.0 2.2 5.0 0.9 7.1 2.9 4.9 2.2 6.2 3.7 10.9 28.0 5.0 4.0 2.5 2.8 6.8 4.0 9.5 13.0 5.0 2.8 2.1 1.9 5.6 16.1 5.6 2.4 0.7 1.4 1.3 0.6 1.5 1.6 1.6 1.6 0.5 1.3 1.4 1.1 2.3 2.4 0.6 1.2 1.7 0.4 16.2 10.7 13.2 19.3 11.9 15.2 11.6 12.5 11.9 10.5 11.9 3.8 3.9 7.9 11.8 4.7 31.1 5.1 8.1 5.7 7.0 0.0 0.4 19.9 8.8 3.2 12.6 4.9 0.0 6.7 1.3 7.1 6.7 1.1 4.4 7.6 93.8 1.2 22.7 18.3 0.4 9.2 9.2 8.5 1.8 4.4 3.9 9.8 2.9 11.0 14.6 1.8 6.5 6.0 1.0 3.6 10.9 0.6 7.2 2.7 9.6 TMEM67 "JBTS6, MGC26979, MKS3, NPHP11" ENSG00000164953 "Transmembrane protein 67" Q5HYA8 8 93754844-93819234 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Deafness, Disease mutation, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 57.6;Cone photoreceptor cells: 62.8;Rod photoreceptor cells: 70.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.57e-3)" "unprognostic (1.22e-1)" "unprognostic (2.45e-2)" "unprognostic (1.73e-1)" "unprognostic (5.07e-2)" "unprognostic (3.08e-1)" "unprognostic (2.25e-5)" "unprognostic (2.61e-1)" "unprognostic (1.05e-1)" "unprognostic (1.22e-2)" "unprognostic (2.51e-1)" "unprognostic (4.43e-2)" "prognostic unfavorable (7.62e-4)" "unprognostic (8.41e-2)" "unprognostic (2.21e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" 4.1 4.9 8.3 2.5 12.3 2.3 6.2 6.8 7.6 6.7 3.7 4.9 10.1 2.7 9.8 11.2 3.3 22.4 5.0 8.4 6.8 8.3 5.6 2.3 9.3 4.0 2.9 6.4 8.6 6.2 9.3 21.3 3.7 19.1 5.2 4.0 7.0 3.8 8.9 2.1 6.2 2.6 8.2 3.3 3.3 3.7 22.5 3.7 3.4 10.3 1.8 3.2 5.1 4.4 3.9 2.9 2.9 1.5 4.8 4.0 1.2 6.3 4.1 5.8 4.4 5.2 8.5 3.6 3.6 6.1 4.3 8.6 2.0 14.4 1.6 7.9 3.9 7.9 6.6 2.1 3.7 6.5 1.3 4.9 3.8 6.0 2.0 4.7 2.9 1.7 4.9 3.4 7.7 3.4 8.1 4.5 6.7 2.6 1.0 4.5 1.5 4.9 2.2 4.7 2.5 3.8 1.8 1.9 0.0 5.4 2.8 3.8 6.5 3.7 1.0 6.2 5.5 7.5 1.6 2.3 4.7 2.0 6.5 3.3 2.1 5.6 1.5 8.4 0.8 4.4 2.9 1.5 0.5 3.6 0.7 3.1 1.8 3.4 3.2 2.3 3.9 4.0 3.9 1.5 4.8 0.5 2.9 0.7 1.2 8.3 12.3 6.8 7.6 6.8 8.3 2.9 6.4 19.1 3.7 11.9 8.3 4.7 4.2 2.5 12.3 29.5 7.6 57.6 14.8 19.2 62.8 2.6 0.0 5.4 15.4 6.2 0.4 0.0 2.5 5.0 8.4 1.9 4.7 1.1 2.0 22.3 8.6 7.4 2.7 6.0 15.0 0.6 1.7 1.8 2.3 14.1 2.1 0.0 9.9 2.1 70.0 6.5 5.0 36.3 14.1 1.3 1.9 3.8 2.1 0.8 TMEM68 FLJ32370 ENSG00000167904 "Transmembrane protein 68" Q96MH6 8 55696424-55773407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018216, HPA019173" Uncertain Approved Vesicles NA NA Vesicles "HPA018216: AB_2205185, HPA019173: AB_1858129" "unprognostic (4.43e-2)" "unprognostic (3.10e-2)" "unprognostic (8.04e-2)" "unprognostic (2.40e-1)" "unprognostic (4.61e-2)" "unprognostic (1.15e-1)" "unprognostic (3.46e-3)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (3.37e-2)" "unprognostic (3.28e-2)" "unprognostic (1.03e-1)" "unprognostic (3.92e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.41e-2)" "unprognostic (1.63e-1)" 10.4 18.3 14.0 8.4 18.0 10.6 14.6 18.9 20.5 13.0 15.1 16.3 16.0 14.6 15.4 17.9 16.1 25.4 12.5 7.4 13.8 13.2 20.6 14.6 11.3 10.5 12.7 10.2 15.7 13.5 15.9 18.5 15.6 13.2 15.8 16.6 13.1 14.0 12.2 7.8 17.6 18.3 14.4 13.3 12.9 12.0 9.8 11.7 22.7 18.8 13.4 12.3 17.1 13.0 9.2 7.2 21.7 7.7 8.2 10.5 3.9 12.4 7.5 12.8 7.7 10.8 12.5 22.4 11.0 8.5 10.7 10.4 10.6 23.5 13.7 13.1 7.3 13.7 15.8 9.9 14.7 11.9 18.7 11.2 16.5 6.8 11.1 11.9 7.0 9.2 8.4 22.7 10.8 25.5 15.8 9.7 14.9 15.8 13.8 15.6 6.5 17.4 9.6 13.8 27.2 3.9 12.8 5.3 8.8 17.7 9.7 10.6 9.4 7.4 12.1 21.7 17.4 17.8 9.1 7.6 8.2 10.3 14.0 9.0 11.9 14.9 17.2 11.1 11.7 12.6 21.7 7.1 5.0 7.2 4.4 10.5 9.2 8.6 7.6 7.2 9.2 7.2 10.1 7.9 8.2 7.7 6.4 6.3 3.9 14.0 18.0 18.9 20.5 13.8 13.2 12.7 10.2 13.2 11.7 11.9 10.1 7.5 25.1 30.3 17.3 4.1 20.4 56.2 21.6 24.4 13.7 26.7 11.6 14.9 1.3 9.5 14.5 0.0 7.0 17.4 11.9 20.6 5.7 11.0 11.5 20.6 14.5 10.4 14.9 1.1 12.0 10.1 6.8 13.6 23.7 17.2 12.5 19.2 13.1 17.7 15.2 25.8 9.5 15.8 12.3 31.0 18.5 11.5 14.1 24.8 TMEM69 "C1orf154, FLJ21029" ENSG00000159596 "Transmembrane protein 69" Q5SWH9 1 45687214-45694443 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026993 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA026993: AB_10601824" "prognostic favorable (2.24e-4)" "unprognostic (2.47e-1)" "unprognostic (5.25e-2)" "unprognostic (1.85e-2)" "unprognostic (2.40e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.66e-8)" "unprognostic (4.05e-2)" "unprognostic (1.59e-3)" "unprognostic (5.17e-2)" "unprognostic (3.98e-3)" "unprognostic (1.98e-1)" "unprognostic (1.14e-3)" "unprognostic (1.49e-2)" "unprognostic (1.96e-1)" "unprognostic (4.41e-3)" "unprognostic (3.65e-2)" 6.0 9.0 7.0 5.8 11.0 2.6 12.2 6.8 13.8 5.3 7.5 7.3 2.9 8.3 5.6 9.9 12.1 6.0 5.6 11.6 6.3 6.2 8.4 7.6 8.3 8.8 6.9 5.0 8.9 7.8 10.7 5.5 6.8 10.8 7.0 8.4 4.7 7.9 5.7 8.2 7.7 8.2 6.2 9.1 7.8 5.7 12.1 9.4 10.1 7.5 8.8 9.3 8.4 11.1 8.7 10.9 5.4 15.6 4.6 8.2 6.1 13.1 3.2 9.1 7.4 7.0 9.0 22.4 8.6 10.2 14.6 14.2 9.0 6.9 16.0 6.0 8.2 10.8 17.8 7.3 19.6 15.0 11.1 8.5 32.6 8.0 9.7 12.4 15.6 16.1 10.5 20.4 13.4 8.5 9.4 11.9 15.4 19.5 11.1 9.1 4.8 8.6 11.2 21.7 8.0 8.8 13.5 8.3 16.2 15.4 14.0 10.6 9.5 9.1 24.6 14.7 16.6 12.8 16.0 8.9 6.7 11.5 14.8 10.3 8.9 11.0 12.2 9.4 11.7 9.8 5.0 12.2 5.0 5.1 12.7 6.4 8.7 7.2 5.7 10.9 8.3 8.2 6.3 5.4 4.6 15.6 6.8 6.8 6.1 7.0 11.0 6.8 13.8 6.3 6.2 6.9 5.0 10.8 9.4 0.0 12.2 15.7 21.6 17.9 11.2 7.9 7.6 13.4 17.0 17.4 0.0 53.1 36.5 19.2 1.5 11.6 17.1 0.0 15.4 28.9 13.5 20.5 5.8 12.5 33.1 6.4 23.1 14.1 39.0 3.0 17.3 26.0 16.9 12.6 21.0 12.4 13.5 10.5 12.0 27.2 10.5 12.9 8.6 18.4 14.9 22.7 49.9 14.9 23.6 18.4 TMEM70 FLJ20533 ENSG00000175606 "Transmembrane protein 70" Q9BUB7 8 73972437-73982783 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023187, CAB034226" Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB034226: AB_2205189, HPA023187: AB_2671101" "unprognostic (2.26e-3)" "unprognostic (4.87e-1)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (8.22e-3)" "unprognostic (9.17e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (7.04e-2)" "unprognostic (2.88e-2)" "unprognostic (9.14e-2)" "unprognostic (3.65e-3)" "unprognostic (6.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.13e-1)" "unprognostic (2.70e-2)" 9.5 12.3 7.6 7.4 8.0 7.0 9.4 7.1 12.8 6.0 7.4 3.6 3.9 4.8 6.1 9.0 6.2 9.1 7.4 13.3 9.3 7.9 9.7 38.8 6.2 9.6 6.8 7.3 7.3 17.0 5.1 6.3 8.1 10.0 6.3 8.0 3.8 7.1 5.3 81.1 4.8 6.9 7.7 6.3 9.9 10.6 10.9 5.1 8.5 6.5 13.4 7.9 6.7 5.9 18.4 12.3 7.5 11.0 6.2 12.7 12.7 11.2 9.0 7.2 7.5 8.5 7.3 7.4 9.6 8.7 10.7 8.7 8.4 6.5 15.2 8.3 6.4 9.1 10.2 13.8 9.2 12.1 9.8 9.4 15.2 5.9 11.2 8.5 8.2 8.1 6.8 8.6 6.8 3.6 4.1 9.0 7.7 11.4 7.5 11.4 8.3 18.8 15.6 6.7 14.4 11.2 13.3 7.1 12.9 11.3 10.6 16.4 7.3 5.9 43.0 12.1 6.0 8.9 7.6 5.7 6.3 7.6 11.4 9.0 11.2 9.6 14.9 9.1 6.4 6.9 6.3 10.8 7.0 9.5 11.0 10.9 18.4 10.9 10.8 10.5 10.8 12.7 11.8 7.5 6.2 8.1 12.3 8.6 12.7 7.6 8.0 7.1 12.8 9.3 7.9 6.8 7.3 10.0 5.1 14.9 36.2 37.2 32.5 59.8 24.1 39.1 15.3 42.8 23.9 21.0 7.9 61.6 56.3 28.4 11.2 35.3 22.8 0.0 55.5 44.6 47.0 32.0 38.2 44.2 119.9 9.5 13.3 28.3 89.0 5.6 27.6 68.1 38.8 36.1 27.6 19.7 38.3 37.1 27.3 55.5 15.9 38.8 44.8 32.9 28.3 52.1 58.8 34.8 29.0 23.3 TMEM71 FLJ33069 ENSG00000165071 "Transmembrane protein 71" Q6P5X7 8 132685007-132760712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 65.7;lymphoid tissue: 31.3" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 14.8;Kupffer cells: 23.3;Macrophages: 22.7;T-cells: 41.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 65.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 65.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.2;HDLM-2: 33.0;Karpas-707: 7.0;U-937: 19.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA058401, HPA070655" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA058401: AB_2683707, HPA070655: AB_2686292" "unprognostic (1.39e-3)" "unprognostic (7.27e-2)" "unprognostic (8.82e-2)" "unprognostic (3.10e-3)" "unprognostic (7.94e-2)" "unprognostic (3.91e-3)" "unprognostic (4.18e-2)" "unprognostic (5.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (8.83e-2)" "unprognostic (1.90e-2)" "unprognostic (6.29e-3)" "unprognostic (4.39e-2)" "unprognostic (2.73e-1)" 4.2 1.1 1.4 8.2 1.5 20.8 5.4 0.7 1.2 2.5 9.9 0.8 0.4 1.2 1.0 2.0 4.8 1.9 4.1 25.5 1.8 1.2 1.9 2.3 8.3 20.9 2.2 0.8 1.9 2.9 0.0 1.4 1.0 1.7 2.2 2.2 5.8 5.8 1.3 1.3 1.3 7.2 2.2 4.2 18.2 2.9 0.9 1.4 31.3 2.2 2.5 10.6 7.0 2.8 1.4 8.2 65.7 13.5 2.9 14.8 8.4 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.8 8.2 0.3 0.6 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.2 0.9 33.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 1.3 0.9 0.6 4.2 0.0 7.0 1.4 0.0 1.6 1.3 0.7 0.0 0.2 0.1 1.1 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.2 0.4 0.5 0.7 3.4 0.0 1.6 0.0 5.8 19.5 2.4 12.5 13.5 23.9 8.0 3.9 14.8 1.4 5.9 5.6 8.2 1.3 9.0 6.5 65.7 2.9 3.2 0.2 0.7 8.4 1.4 1.5 0.7 1.2 1.8 1.2 2.2 0.8 1.7 1.4 0.0 4.8 4.2 1.0 0.8 0.0 14.8 0.0 4.0 3.4 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 1.3 0.1 1.1 0.0 3.1 0.0 0.0 1.3 23.3 3.6 0.0 22.7 5.0 0.0 0.0 1.1 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.2 0.3 0.2 41.5 0.0 5.1 TMEM72 "bA285G1.3, C10orf127, KSP37" ENSG00000187783 "Transmembrane protein 72" A0PK05 10 44911200-44937002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 46.5;retina: 17.1" "Group enriched" "Detected in some" 4 "Collecting duct cells: 26.2;Distal tubular cells: 28.2;Late spermatids: 11.4;Paneth cells: 8.6" "Cancer enriched" "Detected in some" 8 "renal cancer: 8.7" "Group enriched" "Detected in some" 6 "hippocampal formation: 1.2;pons and medulla: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 118 "RPMI-8226: 26.1;U-937: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA039894, HPA062907" Enhanced NA NA "HPA039894: AB_10795261, HPA062907: AB_2684900" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (2.67e-2)" "unprognostic (3.22e-1)" "unprognostic (1.08e-1)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (8.58e-2)" "unprognostic (5.45e-2)" "prognostic favorable (1.01e-4)" "unprognostic (4.99e-3)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" 0.1 0.0 0.1 0.9 0.2 0.1 0.0 0.3 0.2 0.0 4.2 1.3 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 1.2 0.3 46.5 0.1 0.0 0.0 0.4 0.0 0.0 5.7 0.1 0.3 0.0 4.9 0.0 4.9 17.1 2.7 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 1.9 0.0 0.4 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.2 1.2 0.3 0.4 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 26.2 0.0 0.0 28.2 0.0 4.6 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 8.6 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.7 0.0 TMEM74 "FLJ30668, NET36" ENSG00000164841 "Transmembrane protein 74" Q96NL1 8 108606850-108787615 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 2.7;Cone photoreceptor cells: 5.9;Rod photoreceptor cells: 7.9;Spermatogonia: 5.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory B-cell: 1.4" "Lineage enriched" "Detected in single" 14 "B-cells: 1.4" "Cell line enhanced" "Detected in some" "HEK 293: 5.2;NTERA-2: 6.5;SCLC-21H: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015672, HPA076461" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA015672: AB_1858132, HPA076461: " "unprognostic (8.99e-2)" "unprognostic (1.18e-1)" "unprognostic (4.25e-2)" "unprognostic (6.33e-2)" "unprognostic (2.05e-1)" "unprognostic (4.18e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-1)" "unprognostic (2.54e-1)" "unprognostic (1.44e-2)" "unprognostic (2.01e-2)" "unprognostic (3.97e-2)" "unprognostic (3.75e-4)" "unprognostic (8.77e-2)" "unprognostic (6.36e-2)" "unprognostic (5.95e-2)" "unprognostic (1.46e-3)" 1.3 1.4 4.8 1.1 4.2 0.4 0.9 13.1 12.0 0.7 2.7 10.4 0.0 0.9 0.7 0.7 2.9 1.0 0.9 7.5 5.9 2.8 0.7 2.2 0.8 0.8 3.2 6.1 0.9 2.7 0.4 1.1 0.5 9.3 1.0 1.3 1.0 0.9 1.1 5.5 2.0 1.4 2.9 14.1 0.6 0.9 2.7 6.8 0.7 0.8 0.8 0.9 0.9 1.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.1 0.0 0.1 3.0 0.7 0.0 0.4 5.2 1.9 0.8 0.3 0.1 0.5 0.7 0.0 0.0 0.1 0.1 0.1 0.5 3.6 0.0 0.2 0.0 0.0 0.2 0.0 6.5 0.0 3.7 0.0 3.7 0.0 0.0 0.0 14.2 0.1 0.0 0.5 0.0 1.6 0.2 0.2 0.0 1.7 3.0 0.0 0.3 0.6 0.1 0.0 2.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 4.2 13.1 7.3 5.9 2.8 3.2 6.1 9.3 6.8 0.0 0.0 0.0 0.6 0.8 2.7 0.6 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.7 0.5 0.2 0.0 0.2 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 7.9 0.0 0.7 0.2 5.1 0.5 0.1 0.0 0.0 0.0 TMEM74B "C20orf46, FLJ11190" ENSG00000125895 "Transmembrane protein 74B" Q9NUR3 20 1180561-1185415 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9;intestine: 16.0" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 10.3;Horizontal cells: 17.5;Intestinal endocrine cells: 15.0;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 7.9;Hep G2: 9.9;K-562: 16.8;Karpas-707: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045213 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA045213: AB_10961999" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.05e-3)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (6.91e-3)" "unprognostic (1.97e-1)" "unprognostic (1.77e-4)" "unprognostic (9.58e-2)" "prognostic favorable (3.07e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.55e-7)" "unprognostic (1.20e-1)" "unprognostic (9.77e-2)" "unprognostic (8.37e-2)" "unprognostic (5.07e-3)" 2.3 0.3 4.3 0.3 13.9 0.0 1.1 2.3 7.3 0.1 0.7 12.5 0.6 0.3 0.7 3.9 2.5 3.9 2.3 6.9 0.6 1.0 9.4 0.9 2.3 0.0 0.6 0.2 3.5 12.2 0.5 0.9 3.3 11.3 2.9 4.6 16.0 1.1 1.1 0.6 2.7 0.9 1.6 0.4 0.7 0.0 1.6 0.1 0.0 0.1 0.0 0.5 0.3 0.0 5.0 2.8 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.7 0.1 1.0 0.0 2.9 0.3 3.7 0.5 0.1 0.0 4.7 1.1 0.0 9.9 0.0 0.0 1.4 0.0 1.1 0.0 0.2 0.2 0.1 0.7 16.8 7.6 0.0 0.1 0.1 0.1 3.4 1.2 0.4 0.0 0.2 0.0 0.8 0.7 0.7 2.1 0.1 0.0 0.1 1.2 0.0 0.1 2.0 0.0 3.3 0.1 0.2 3.3 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.4 0.2 10.3 1.6 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.5 0.8 3.6 2.0 0.0 0.2 1.0 0.2 0.7 0.0 0.6 0.0 17.5 15.0 3.1 0.8 0.4 0.0 0.0 1.7 1.8 2.7 0.2 1.4 1.7 0.0 0.3 2.7 19.4 5.7 0.2 0.2 0.6 1.1 0.0 0.8 0.4 TMEM78 FLJ40168 ENSG00000177800 "Transmembrane protein 78" Q5T7P6 1 229249636-229251810 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.3;bone marrow: 2.5" "Cell type enriched" "Detected in single" 5 "Melanocytes: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" HPA042351 Uncertain NA NA "HPA042351: AB_10961259" "unprognostic (2.45e-2)" "unprognostic (3.07e-1)" "unprognostic (1.23e-1)" "unprognostic (1.51e-1)" "unprognostic (3.33e-1)" "unprognostic (9.45e-2)" "unprognostic (5.59e-2)" "unprognostic (1.29e-1)" 0.1 0.4 0.5 0.2 0.5 2.5 0.4 0.7 0.7 0.1 0.1 0.1 0.5 0.6 0.1 0.3 0.2 0.1 0.4 0.3 0.1 0.6 0.0 0.7 0.3 0.2 0.7 0.5 0.2 0.0 0.4 0.3 0.7 0.0 1.8 1.2 0.2 0.0 0.3 0.6 0.1 0.7 0.3 0.2 0.1 0.1 1.3 2.6 5.3 0.5 1.3 0.9 0.1 0.4 1.3 0.8 2.1 0.2 0.0 0.6 0.4 0.0 0.1 0.1 0.2 1.9 0.5 0.5 0.4 0.2 1.0 0.0 0.0 0.3 0.6 0.6 0.8 1.8 0.3 0.0 0.6 0.5 0.2 0.0 0.1 0.0 0.5 0.1 0.5 0.3 0.7 0.0 0.3 0.6 1.5 0.6 0.4 0.6 0.4 0.4 0.2 0.3 1.1 0.4 0.5 0.5 0.2 0.0 1.1 0.5 0.1 0.0 0.6 0.5 0.5 0.3 0.9 0.6 0.8 0.5 0.6 0.8 5.3 0.5 0.7 0.7 0.3 0.5 0.8 0.6 0.5 0.1 1.3 0.9 0.8 2.6 1.3 0.5 2.6 0.4 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 TMEM79 "FLJ16057, FLJ32254, MATT, MGC13102" ENSG00000163472 "Transmembrane protein 79" Q9BSE2 1 156282935-156293185 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 47.5;skin 1: 35.7;tongue: 37.2" "Cell type enhanced" "Detected in many" 9 "Suprabasal keratinocytes: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 22.0;SK-BR-3: 18.1;T-47d: 19.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA055214 Enhanced Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA055214: AB_2682741" "unprognostic (3.12e-1)" "unprognostic (2.96e-1)" "unprognostic (1.26e-1)" "unprognostic (8.17e-2)" "unprognostic (5.51e-2)" "unprognostic (4.52e-2)" "prognostic unfavorable (2.61e-5)" "unprognostic (6.37e-2)" "unprognostic (2.44e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.12e-3)" "prognostic unfavorable (4.31e-7)" "unprognostic (1.72e-1)" "unprognostic (1.96e-1)" "unprognostic (3.98e-2)" "unprognostic (2.37e-1)" 1.2 1.3 2.4 1.2 5.1 2.0 3.4 3.4 3.7 12.5 1.2 3.6 1.9 1.8 1.3 1.9 47.5 1.5 1.9 1.0 2.0 1.1 1.1 1.4 1.0 1.8 5.6 1.4 1.5 1.0 3.8 2.5 4.5 3.1 19.0 1.1 1.2 9.4 2.1 1.9 35.7 1.3 1.1 3.2 1.6 1.6 0.9 5.2 3.7 1.5 37.2 24.2 3.3 20.5 5.2 4.1 7.8 4.1 3.0 5.2 3.1 8.2 4.9 1.7 3.2 1.2 1.3 4.1 2.4 1.0 4.4 1.7 5.7 2.3 1.6 5.3 0.6 1.6 7.4 1.9 3.7 1.9 5.5 2.8 1.5 2.0 1.6 2.3 1.7 2.3 1.3 22.0 3.3 3.3 3.2 0.9 5.6 6.9 10.3 2.0 9.8 4.8 2.7 2.5 6.2 3.9 5.7 1.6 3.3 0.9 2.6 3.0 3.3 2.9 18.1 4.7 2.1 19.4 5.0 2.3 8.1 2.7 2.9 6.4 8.0 8.3 3.5 5.6 4.1 6.1 0.0 4.1 5.6 3.9 1.4 3.9 3.7 3.4 4.0 3.2 5.2 4.4 5.2 7.8 3.0 2.6 4.1 4.0 3.1 2.4 5.1 3.4 3.7 2.0 1.1 5.6 1.4 3.1 5.2 3.0 1.0 2.0 1.1 11.7 3.2 0.8 5.1 2.7 2.3 1.8 2.0 5.9 1.7 1.9 0.1 1.5 2.6 0.0 2.9 1.6 1.9 11.3 0.0 2.0 3.0 7.9 2.9 1.3 2.4 0.0 1.4 1.4 5.0 6.4 2.1 1.5 3.0 2.5 0.7 1.1 2.2 0.0 0.8 1.2 1.9 29.0 6.2 3.5 2.6 4.9 TMEM80 FLJ38216 ENSG00000177042 "Transmembrane protein 80" Q96HE8 11 695428-705028 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA059592, HPA067046" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA059592: AB_2684076, HPA067046: AB_2685769" "unprognostic (1.48e-1)" "unprognostic (6.55e-3)" "unprognostic (1.70e-2)" "unprognostic (2.64e-2)" "unprognostic (2.71e-3)" "unprognostic (1.68e-3)" "unprognostic (4.36e-2)" "unprognostic (5.39e-3)" "unprognostic (3.85e-2)" "unprognostic (2.04e-1)" "unprognostic (1.41e-3)" "unprognostic (1.03e-1)" "prognostic favorable (2.47e-4)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (3.27e-1)" "unprognostic (4.23e-3)" 12.9 12.7 10.5 17.7 18.9 4.4 20.0 15.9 20.5 14.8 14.1 18.3 12.8 19.1 17.9 21.8 22.9 17.0 10.9 7.7 15.3 9.4 16.5 10.2 12.2 15.5 12.6 15.2 18.2 16.1 16.8 19.7 7.6 13.5 17.9 15.0 18.1 25.2 19.1 12.6 20.4 16.5 15.4 9.4 20.0 19.3 13.8 14.3 33.8 27.2 7.4 18.3 16.3 15.8 21.5 16.1 24.6 21.5 13.9 17.7 14.0 19.7 10.0 6.4 8.3 14.2 6.7 10.1 4.9 2.7 5.2 5.7 11.2 24.1 8.9 4.2 7.6 9.3 15.2 9.4 5.6 3.8 6.1 23.8 5.3 9.9 8.0 8.4 7.0 9.8 15.5 11.5 2.3 3.7 10.3 6.1 10.7 6.6 10.3 6.6 6.5 9.2 4.8 5.9 16.7 4.6 6.4 4.3 17.3 7.4 3.1 17.6 5.7 7.2 13.8 6.8 4.5 10.1 6.7 8.6 8.8 4.3 1.9 3.6 4.9 1.5 8.0 9.3 8.9 3.7 6.1 19.8 24.6 16.3 18.8 14.2 19.8 12.3 12.2 15.7 21.5 17.7 15.5 9.4 13.9 21.5 16.1 14.8 14.0 10.5 18.9 15.9 20.5 15.3 9.4 12.6 15.2 13.5 14.3 6.0 16.5 15.2 16.9 13.6 19.0 14.6 12.7 12.0 9.1 19.2 7.9 28.0 10.0 10.3 5.0 15.7 16.4 23.3 14.9 7.3 14.1 13.9 6.9 5.8 15.3 52.4 11.6 14.7 12.1 9.2 39.4 14.4 11.8 10.0 19.9 20.9 9.4 5.8 26.9 7.9 8.6 32.3 20.8 50.2 65.2 15.1 12.7 15.7 20.0 9.0 TMEM81 "HC3107, KVLA2788, MGC75217, UNQ2788" ENSG00000174529 "Transmembrane protein 81" Q6P7N7 1 205083129-205084460 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.2" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 3.5;Early spermatids: 7.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052515 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA052515: AB_2681858" "unprognostic (9.19e-3)" "unprognostic (3.53e-1)" "unprognostic (1.91e-3)" "unprognostic (6.48e-2)" "unprognostic (2.44e-1)" "unprognostic (2.08e-1)" "prognostic unfavorable (3.25e-6)" "unprognostic (3.66e-2)" "unprognostic (2.68e-2)" "unprognostic (6.18e-2)" "unprognostic (5.86e-2)" "unprognostic (2.48e-2)" "prognostic unfavorable (6.65e-9)" "unprognostic (8.91e-2)" "unprognostic (6.24e-2)" "unprognostic (2.42e-1)" "prognostic favorable (2.67e-4)" 1.5 2.7 2.8 1.6 3.8 2.0 2.1 11.2 5.3 2.1 1.3 1.2 1.5 3.5 1.4 1.2 1.1 2.2 3.3 2.7 4.2 3.3 1.5 2.3 2.8 2.3 1.0 3.4 2.2 2.0 1.8 1.7 1.4 2.1 4.6 4.1 1.2 1.7 2.4 3.0 1.0 6.1 1.4 2.7 0.9 1.6 1.5 1.5 4.3 1.4 0.2 4.6 0.9 2.4 3.7 6.2 8.1 9.1 3.6 3.1 4.5 2.7 2.3 1.4 6.5 1.7 4.5 3.2 2.5 3.4 2.1 9.9 3.8 4.0 3.9 3.9 3.7 5.2 3.2 6.3 1.9 2.1 3.6 6.8 3.6 1.8 6.1 4.5 5.4 8.3 1.9 2.9 4.7 4.3 8.1 4.7 3.0 5.4 3.0 7.1 4.6 5.3 2.3 3.9 6.1 2.8 3.4 7.1 10.0 2.5 8.0 2.1 4.3 2.3 5.5 4.8 4.3 5.3 3.6 6.2 2.9 7.3 4.3 1.2 0.2 4.6 1.4 0.2 1.5 2.3 1.1 1.5 1.4 2.5 4.0 2.5 0.2 1.4 1.5 2.7 0.9 0.0 0.0 0.5 0.5 2.1 0.6 1.2 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.5 7.9 1.0 0.3 0.0 0.5 0.3 0.8 0.6 0.0 1.0 0.5 1.6 0.0 0.6 0.0 1.3 0.0 0.0 1.7 0.0 0.2 1.1 0.7 0.0 0.4 1.4 1.0 0.0 0.6 0.2 1.1 2.3 0.1 0.0 0.8 0.4 TMEM82 ENSG00000162460 "Transmembrane protein 82" A0PJX8 1 15742422-15747982 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 35.6;liver: 30.1" "Group enriched" "Detected in some" 9 "Enterocytes: 86.8;Hepatocytes: 38.2;Paneth cells: 57.5;Proximal tubular cells: 47.1" "Cancer enhanced" "Detected in some" "liver cancer: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "CACO-2: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA060282 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060282: AB_2684241" "unprognostic (2.46e-2)" "unprognostic (7.96e-2)" "unprognostic (4.88e-2)" "unprognostic (1.40e-2)" "unprognostic (6.45e-2)" "unprognostic (6.90e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.80e-7)" "unprognostic (1.41e-1)" "unprognostic (5.80e-2)" "unprognostic (4.75e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 7.5 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.1 6.6 0.0 0.0 0.0 86.8 0.0 0.2 1.9 0.0 0.0 0.0 38.2 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.5 57.5 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 6.3 0.0 TMEM86A FLJ90119 ENSG00000151117 "Transmembrane protein 86A" Q8N2M4 11 18693122-18704785 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 6.5" "Group enriched" "Detected in many" 12 "dendritic cells: 6.5;monocytes: 3.7;T-cells: 1.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057119 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA057119: AB_2683342" "unprognostic (1.25e-1)" "unprognostic (1.09e-3)" "unprognostic (8.08e-3)" "unprognostic (1.89e-1)" "unprognostic (2.53e-1)" "unprognostic (1.10e-1)" "unprognostic (4.05e-2)" "unprognostic (2.94e-1)" "unprognostic (3.73e-1)" "unprognostic (1.74e-1)" "unprognostic (8.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "unprognostic (7.92e-2)" "unprognostic (4.20e-1)" "unprognostic (3.24e-1)" 6.9 4.9 4.7 3.6 5.7 0.7 5.6 3.4 9.7 3.8 3.3 7.0 1.2 2.5 4.0 3.8 3.9 4.4 6.6 8.1 6.9 3.7 15.3 6.7 5.7 11.1 6.7 3.2 12.3 8.2 7.0 3.9 7.1 5.0 2.9 3.2 16.7 4.6 2.7 4.7 24.4 3.2 3.4 7.2 9.2 3.3 4.1 3.7 5.3 3.7 3.9 4.2 5.2 5.4 0.2 6.5 0.3 3.7 0.2 1.7 1.4 0.0 0.2 0.7 3.4 3.1 0.0 0.1 0.7 0.6 0.6 0.5 0.0 0.4 0.0 1.3 0.6 3.4 0.3 0.2 0.1 0.4 0.2 2.0 0.2 0.1 0.0 2.4 0.0 3.0 4.3 1.3 0.1 0.3 0.8 1.8 1.9 0.6 0.0 1.4 1.8 0.0 0.0 0.2 0.5 1.8 0.0 5.6 0.0 19.2 4.1 1.1 1.4 1.0 3.5 1.5 1.3 4.2 0.4 2.1 0.6 0.3 0.2 0.1 3.5 2.7 0.0 1.2 0.0 1.2 0.0 3.7 0.3 0.4 2.8 1.0 0.0 0.4 0.9 6.5 0.2 1.0 1.7 0.0 0.2 0.9 3.8 1.0 1.4 4.7 5.7 3.4 9.7 6.9 3.7 6.7 3.2 5.0 3.7 0.0 0.0 0.0 0.6 0.1 3.9 2.0 0.0 0.0 0.0 10.4 7.9 0.4 6.6 5.3 6.8 0.6 0.0 0.0 6.9 0.3 0.8 0.9 0.0 1.0 34.1 0.0 3.4 4.3 6.4 6.3 2.0 5.7 0.0 1.8 0.6 2.9 7.5 0.0 1.8 5.6 4.5 6.5 0.1 6.5 0.7 0.3 1.9 0.0 0.0 0.3 TMEM86B MGC30208 ENSG00000180089 "Transmembrane protein 86B" Q8N661 19 55226639-55229264 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 15.1" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 30.6;Hepatocytes: 28.9" "Cancer enriched" "Detected in all" 5 "liver cancer: 10.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA057689 Uncertain Uncertain Midbody,Centrosome Yes No Centrosome Midbody "HPA057689: AB_2683504" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.76e-5)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (6.55e-2)" "prognostic favorable (3.13e-4)" "unprognostic (1.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.10e-1)" "prognostic favorable (9.97e-6)" "unprognostic (1.96e-2)" "unprognostic (6.63e-8)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (3.70e-1)" "unprognostic (3.19e-3)" 2.5 2.4 2.8 3.1 4.0 7.8 1.4 4.7 4.2 1.4 7.5 1.4 1.4 5.6 1.5 1.4 1.4 1.8 7.7 2.9 2.2 1.6 2.0 15.1 2.7 5.2 1.4 1.4 1.4 1.4 1.7 2.8 5.2 1.7 1.5 0.4 1.4 1.4 1.4 2.2 3.0 7.7 1.4 1.4 4.3 3.6 2.8 1.4 1.4 2.3 1.4 3.0 1.4 1.4 0.7 1.0 0.6 0.7 0.0 1.6 0.4 4.1 3.9 2.4 3.9 0.4 0.6 3.6 1.5 0.7 1.3 1.8 6.3 2.2 4.8 1.2 1.1 1.3 1.7 0.9 1.0 0.6 0.9 11.2 8.8 2.5 5.9 1.2 4.0 3.7 0.8 1.7 2.1 1.3 1.8 0.5 9.2 6.0 3.5 0.8 2.4 6.4 10.0 0.9 1.9 2.4 6.0 2.8 12.6 1.1 5.1 2.1 3.9 1.8 0.8 4.9 1.3 2.2 8.4 2.8 5.7 3.2 2.5 3.8 2.9 3.4 10.2 4.7 11.1 2.1 0.0 0.7 0.6 1.6 0.1 0.6 0.0 0.5 0.1 0.1 0.7 0.6 1.4 0.1 0.0 0.1 1.0 0.0 0.4 2.8 4.0 4.7 4.2 2.2 1.6 1.4 1.4 1.7 1.4 6.0 2.4 0.8 0.4 3.0 7.6 0.5 30.6 0.0 1.2 0.0 2.0 0.4 0.0 0.9 2.0 1.7 5.2 0.0 0.2 0.3 1.1 1.1 0.0 28.9 0.9 9.5 10.3 0.0 6.2 3.6 0.9 1.7 3.3 1.8 1.9 1.1 0.8 0.0 0.4 0.8 3.6 0.0 0.5 1.6 1.1 1.9 0.2 4.6 1.9 1.7 TMEM87A DKFZP564G2022 ENSG00000103978 "Transmembrane protein 87A" Q8NBN3 15 42210452-42273663 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018104, HPA018189" Enhanced Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA018104: AB_1858135, HPA018189: AB_2205198" "unprognostic (7.07e-2)" "unprognostic (1.62e-2)" "unprognostic (2.19e-1)" "unprognostic (4.05e-2)" "unprognostic (2.49e-1)" "unprognostic (6.39e-3)" "unprognostic (1.19e-2)" "unprognostic (2.44e-1)" "unprognostic (2.95e-1)" "unprognostic (8.13e-3)" "unprognostic (4.31e-3)" "unprognostic (1.38e-1)" "unprognostic (3.41e-2)" "unprognostic (7.90e-2)" "unprognostic (2.19e-1)" "unprognostic (5.49e-3)" "unprognostic (3.63e-1)" 22.0 18.2 15.6 15.6 24.9 38.9 49.1 15.9 19.6 23.2 28.0 35.8 30.6 13.2 26.0 25.8 34.5 23.3 16.4 14.8 17.4 15.2 16.9 16.2 36.3 16.8 38.9 17.9 20.5 25.0 29.3 20.8 35.3 24.9 41.5 31.2 20.8 45.1 27.4 18.9 30.8 19.5 23.7 37.2 14.7 21.1 20.9 32.5 16.0 38.7 24.3 21.2 24.8 25.2 19.2 15.8 29.3 21.0 25.3 26.6 15.8 13.5 6.8 10.5 9.2 20.7 17.6 16.5 18.8 27.8 18.4 18.4 9.9 29.9 5.8 18.7 19.9 20.7 35.4 9.3 17.2 14.8 15.2 8.5 11.8 18.0 11.1 22.3 21.5 16.9 18.4 38.9 13.4 22.7 17.7 14.1 10.3 12.7 23.3 17.5 8.6 7.1 12.7 8.8 20.4 9.9 11.2 16.4 12.1 11.9 43.4 11.6 14.5 18.0 24.1 16.5 8.8 9.3 20.7 14.0 36.6 9.0 23.9 27.7 16.2 30.5 12.5 14.2 16.0 22.7 29.3 17.6 19.8 20.1 20.7 22.9 19.2 24.8 23.3 15.8 15.4 23.8 23.5 10.3 25.3 21.0 14.3 26.6 15.8 15.6 24.9 15.9 19.6 17.4 15.2 38.9 17.9 24.9 32.5 116.1 211.9 35.6 79.3 60.9 30.3 12.0 48.4 97.7 96.7 47.1 47.1 65.0 1.7 51.1 4.3 44.9 54.6 46.7 55.6 59.7 51.6 111.8 57.8 26.1 37.2 19.1 30.9 49.7 38.0 5.5 38.0 40.0 59.1 64.9 67.4 76.8 46.4 45.6 50.5 14.7 60.4 84.1 44.3 47.1 62.2 57.2 92.3 39.2 65.5 90.7 TMEM87B FLJ14681 ENSG00000153214 "Transmembrane protein 87B" Q96K49 2 112055223-112119318 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 77.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035183 Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA035183: AB_10600829" "unprognostic (3.19e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (1.26e-2)" "unprognostic (1.79e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (4.28e-4)" "prognostic unfavorable (4.72e-4)" "unprognostic (4.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.07e-2)" "unprognostic (2.87e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.32e-1)" "unprognostic (5.35e-2)" "unprognostic (1.05e-1)" "unprognostic (3.25e-3)" 10.8 14.5 5.6 19.5 7.1 5.1 17.2 6.5 8.5 11.6 20.8 6.6 36.8 22.1 14.5 14.3 14.5 10.1 17.0 7.3 5.8 6.5 10.0 13.1 14.6 25.8 6.6 5.4 9.6 15.8 11.3 22.8 20.1 7.4 23.5 21.3 7.0 18.3 43.8 3.8 12.0 37.9 10.3 8.2 22.4 17.3 5.5 5.7 11.6 12.3 11.0 17.9 13.9 12.0 8.4 3.7 4.9 8.3 4.6 10.1 4.9 10.4 3.3 2.9 13.2 12.5 17.1 11.3 18.0 24.1 11.6 14.3 8.2 14.7 10.1 9.5 23.4 16.0 17.9 1.9 10.6 14.8 6.5 2.0 14.1 2.2 7.0 12.2 9.7 15.2 11.3 12.9 14.2 11.4 11.0 12.0 4.8 8.3 6.8 16.1 6.5 4.5 4.7 2.4 17.3 8.7 3.8 4.6 8.3 9.8 15.1 2.4 3.2 8.0 19.5 16.2 8.0 10.7 6.8 13.6 11.7 3.6 9.2 4.0 5.5 8.9 6.4 13.3 4.8 8.3 4.9 4.0 3.3 4.7 7.0 8.1 8.4 10.1 6.4 3.6 6.6 9.3 5.1 2.4 4.6 8.3 3.7 9.7 4.9 5.6 7.1 6.5 8.5 5.8 6.5 6.6 5.4 7.4 5.7 26.8 15.2 12.8 12.9 10.9 5.0 4.0 20.4 6.7 15.9 17.4 2.0 14.2 0.0 38.0 16.9 12.0 39.9 0.0 77.9 21.9 14.0 32.4 12.7 8.5 19.4 6.4 16.7 33.2 39.3 19.3 9.2 15.0 3.3 10.8 46.5 3.3 61.0 38.2 2.8 5.7 7.6 0.0 10.3 2.3 5.1 11.2 24.4 9.6 28.8 18.6 TMEM88 "FLJ20025, MGC71744" ENSG00000167874 "Transmembrane protein 88" Q6PEY1 17 7855065-7856099 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Endothelial cells: 89.8;Ito cells: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "eosinophil: 1.5;neutrophil: 4.5" "Lineage enriched" "Detected in single" 20 "granulocytes: 4.5" "Group enriched" "Detected in some" 6 "AN3-CA: 32.3;HHSteC: 21.6;HUVEC TERT2: 25.2;NTERA-2: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052991 Approved NA NA "HPA052991: AB_2682006" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (3.44e-2)" "unprognostic (3.03e-1)" "unprognostic (6.49e-2)" "prognostic favorable (4.43e-6)" "unprognostic (1.98e-1)" "unprognostic (2.64e-2)" "unprognostic (2.18e-1)" "unprognostic (5.68e-3)" "unprognostic (9.04e-2)" "unprognostic (1.09e-2)" "unprognostic (2.68e-3)" "unprognostic (1.71e-1)" "unprognostic (7.56e-2)" "unprognostic (2.72e-1)" 22.3 9.2 2.8 6.5 4.3 5.0 20.0 2.4 5.0 13.5 10.8 5.1 3.8 4.8 15.7 6.7 14.9 10.6 10.8 43.3 3.5 3.9 28.0 2.5 14.5 8.8 4.5 2.0 7.0 8.5 2.0 9.3 27.9 4.9 13.0 2.6 30.5 6.6 10.0 26.2 1.3 6.3 10.4 2.9 7.7 7.1 6.0 0.4 0.9 16.9 13.6 2.0 8.2 16.2 0.0 0.1 4.5 0.2 0.0 0.2 0.1 0.1 0.2 4.0 32.3 0.0 0.1 1.9 0.2 0.1 0.0 0.1 0.7 0.1 0.2 0.1 0.3 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.3 0.4 21.6 0.2 1.2 0.5 0.9 0.6 0.1 0.3 25.2 0.4 0.5 0.0 0.4 2.1 0.2 0.5 13.1 0.1 0.0 0.1 0.1 0.0 0.3 0.7 0.3 1.8 0.2 0.3 0.8 1.1 0.7 0.1 2.5 0.2 0.8 0.9 0.2 0.1 0.0 0.2 0.1 0.2 0.3 0.0 0.2 1.5 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 2.8 4.3 2.4 5.0 3.5 3.9 4.5 2.0 4.9 0.4 6.0 2.1 3.9 3.8 3.7 4.0 4.5 0.0 0.0 2.3 1.8 3.9 2.1 0.0 2.1 2.0 89.8 2.1 0.0 1.9 0.8 9.5 8.6 4.6 2.0 2.4 3.2 6.3 84.7 5.7 4.5 0.9 2.2 0.0 0.0 2.1 0.6 2.5 2.9 0.0 0.4 0.8 0.0 9.9 1.4 1.3 2.8 4.3 1.3 1.1 2.5 TMEM88B ENSG00000205116 "Transmembrane protein 88B" A6NKF7 1 1426128-1427787 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 36.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;Hep G2: 9.2;SCLC-21H: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065743 Enhanced NA NA "HPA065743: AB_2685552" "unprognostic (3.17e-2)" "unprognostic (1.42e-2)" "unprognostic (1.63e-4)" "unprognostic (1.11e-1)" "unprognostic (3.35e-2)" "unprognostic (2.67e-1)" "unprognostic (2.91e-2)" "unprognostic (5.30e-5)" "unprognostic (2.00e-1)" "unprognostic (2.64e-1)" "unprognostic (3.53e-2)" "unprognostic (7.19e-2)" "unprognostic (1.45e-1)" "unprognostic (7.95e-2)" 1.1 1.1 10.2 1.4 24.7 1.2 1.1 1.0 23.3 1.1 1.1 34.0 0.0 1.1 1.1 1.1 1.1 1.4 1.3 1.2 19.6 8.3 1.5 1.1 1.4 1.2 30.8 11.2 1.1 1.1 1.1 0.0 1.2 16.1 1.3 1.1 0.0 1.1 1.1 1.1 1.7 1.1 1.1 36.9 1.1 1.3 2.4 28.5 0.0 1.1 0.0 1.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 24.7 1.0 20.6 19.6 8.3 30.8 11.2 16.1 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM89 ENSG00000183396 "Transmembrane protein 89" A2RUT3 3 48620759-48621855 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 28.3" "Group enriched" "Detected in some" 79 "Early spermatids: 252.0;Late spermatids: 154.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.8;U-2197: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA053577 Uncertain NA NA "HPA053577: AB_2682196" "unprognostic (1.61e-1)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (1.07e-1)" "unprognostic (1.94e-3)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (7.12e-2)" "unprognostic (2.02e-2)" "unprognostic (6.31e-3)" "unprognostic (5.90e-3)" "unprognostic (3.35e-2)" "unprognostic (3.83e-2)" "unprognostic (8.41e-2)" "unprognostic (2.71e-1)" "unprognostic (3.86e-2)" 0.1 0.0 0.1 0.1 0.1 2.8 0.1 0.1 0.5 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.2 0.1 0.1 0.5 0.5 0.1 0.1 0.1 0.7 28.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.7 0.4 1.1 0.3 1.1 0.7 0.0 0.2 0.0 1.1 1.8 0.2 0.4 0.0 0.0 0.3 0.0 0.5 0.8 0.6 0.5 0.0 1.5 0.0 1.4 1.9 0.6 0.2 0.0 0.8 0.0 0.0 0.0 0.8 0.0 2.8 0.6 0.4 0.0 0.7 0.5 0.0 0.7 1.2 0.1 0.9 0.0 0.7 0.4 0.5 0.8 0.0 0.0 1.4 1.5 3.1 1.6 0.5 0.8 0.5 1.8 0.7 2.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 252.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 154.1 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 TMEM8A "M83, PGAP6, TMEM6, TMEM8" ENSG00000129925 "Transmembrane protein 8A" Q9HCN3 16 370773-387113 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Enterocytes: 67.7;Syncytiotrophoblasts: 83.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 24.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051281, HPA064673" Approved Supported "Nucleoplasm,Cytokinetic bridge" Yes No Nucleoplasm "Cytokinetic bridge" "HPA051281: AB_2681418, HPA064673: AB_2685317" "unprognostic (5.84e-2)" "unprognostic (6.13e-2)" "unprognostic (3.85e-2)" "unprognostic (3.21e-2)" "unprognostic (5.77e-2)" "unprognostic (3.19e-2)" "unprognostic (1.13e-3)" "unprognostic (1.56e-2)" "unprognostic (8.89e-2)" "unprognostic (7.73e-2)" "unprognostic (3.43e-1)" "unprognostic (1.38e-2)" "prognostic favorable (1.29e-5)" "unprognostic (4.20e-3)" "unprognostic (3.19e-2)" "unprognostic (4.93e-2)" "unprognostic (2.48e-1)" 8.4 9.3 6.9 9.5 7.8 15.2 13.5 7.7 7.9 6.8 16.6 7.3 24.1 17.7 7.3 29.6 11.8 6.5 15.2 10.0 5.6 4.3 28.7 33.5 13.0 10.7 7.1 3.2 8.3 44.2 11.5 10.7 45.5 6.7 11.4 6.0 8.8 22.5 8.8 12.8 3.7 25.0 5.0 4.7 13.2 17.5 26.3 6.0 12.6 12.3 5.2 14.6 9.3 8.8 2.0 2.9 24.3 5.5 0.9 7.6 3.3 4.4 11.8 6.8 12.5 9.3 8.4 13.6 12.9 13.5 6.6 9.5 46.4 21.1 4.8 17.5 12.4 10.1 6.4 3.0 14.2 1.8 13.6 11.3 7.9 8.0 26.4 21.6 5.9 15.0 9.7 4.3 10.1 2.9 6.7 15.2 5.4 12.6 7.4 8.2 27.8 8.3 11.7 10.8 7.2 4.7 18.1 7.8 10.9 10.7 11.5 8.1 9.3 7.2 7.3 37.9 3.7 13.1 11.9 22.1 18.8 20.3 13.0 6.8 14.9 7.4 9.5 9.5 6.3 11.9 4.6 5.0 6.3 7.4 5.5 5.9 1.8 5.8 5.8 2.5 2.0 7.6 5.5 24.3 0.9 3.8 2.9 4.3 3.3 6.9 7.8 7.7 7.9 5.6 4.3 7.1 3.2 6.7 6.0 14.9 12.5 10.7 3.2 2.6 5.7 12.5 10.2 1.4 1.2 22.7 9.8 46.7 5.0 27.5 15.5 8.7 67.7 23.3 36.8 5.9 6.6 11.5 1.1 25.5 24.7 17.5 26.6 14.7 14.5 58.4 2.6 10.1 6.8 8.2 26.1 8.2 42.6 38.6 1.8 9.9 7.8 12.9 6.1 1.1 2.5 2.8 83.8 7.5 18.9 6.8 TMEM8B "C9orf127, NAG-5, NGX6" ENSG00000137103 "Transmembrane protein 8B" A6NDV4 9 35814451-35865518 "Predicted membrane proteins, Transporters" "Cell adhesion, Growth regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 27.2" "Lineage enriched" "Detected in many" 18 "dendritic cells: 27.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052130, HPA062701" Approved Approved Vesicles NA NA Vesicles "HPA052130: AB_2681740, HPA062701: AB_2684839" "unprognostic (5.54e-2)" "unprognostic (3.32e-1)" "unprognostic (3.96e-1)" "unprognostic (3.53e-2)" "unprognostic (3.81e-1)" "unprognostic (1.42e-1)" "unprognostic (4.09e-2)" "unprognostic (2.67e-2)" "unprognostic (2.97e-1)" "unprognostic (1.62e-1)" "prognostic favorable (3.14e-4)" "unprognostic (5.93e-2)" "prognostic favorable (1.89e-15)" "unprognostic (8.00e-2)" "unprognostic (1.26e-1)" "unprognostic (1.68e-2)" "unprognostic (3.29e-2)" 9.7 19.5 28.2 5.7 30.4 3.4 9.4 22.9 34.4 15.5 13.0 16.9 14.9 8.7 18.4 11.5 9.3 18.3 12.1 17.8 25.3 14.1 11.3 4.7 10.4 5.9 12.9 21.2 33.3 14.6 28.4 23.6 7.7 18.3 19.3 9.4 17.5 19.9 24.0 19.1 9.2 8.4 18.1 13.0 8.7 13.1 13.6 15.4 5.6 17.3 5.1 4.9 14.2 11.9 0.9 27.2 0.6 1.5 0.5 0.6 1.1 2.9 3.1 11.0 8.6 12.4 10.4 1.3 2.6 5.1 2.9 3.6 1.3 0.8 2.3 6.3 7.1 8.5 1.1 2.9 4.3 2.4 1.8 4.9 0.7 2.2 3.1 8.8 0.2 0.3 9.7 5.6 3.0 3.2 9.4 1.6 10.7 1.0 6.5 5.1 1.1 6.0 1.3 1.6 2.4 4.3 6.7 2.2 5.7 3.0 1.3 2.6 7.7 4.0 1.9 3.9 3.8 3.0 1.1 2.6 6.9 2.2 6.7 1.0 8.7 2.6 2.6 6.3 1.1 4.2 0.4 1.5 0.1 0.6 0.3 0.5 0.9 0.6 0.6 4.7 0.9 0.6 0.5 0.6 0.5 0.3 27.2 0.4 1.1 28.2 30.4 22.9 34.4 25.3 14.1 12.9 21.2 18.3 15.4 11.9 13.5 0.9 7.2 3.9 3.9 10.1 10.2 4.0 7.9 14.0 2.0 29.0 1.7 4.4 20.2 2.9 3.9 0.0 3.4 5.3 7.2 9.2 1.1 2.9 2.9 1.6 6.4 1.3 1.9 9.9 13.6 3.3 10.1 0.0 5.6 8.2 3.2 8.6 18.4 4.1 5.0 6.5 6.1 8.0 4.4 1.4 10.9 3.8 6.3 8.2 TMEM9 TMEM9A ENSG00000116857 "Transmembrane protein 9" Q9P0T7 1 201134772-201171574 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008483 Approved "Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Vesicles "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA008483: " "unprognostic (1.88e-1)" "prognostic unfavorable (6.57e-4)" "unprognostic (2.95e-1)" "unprognostic (3.67e-2)" "unprognostic (3.96e-1)" "prognostic unfavorable (3.93e-4)" "unprognostic (1.05e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-2)" "unprognostic (1.69e-2)" "unprognostic (2.46e-2)" "unprognostic (2.99e-1)" "unprognostic (1.88e-2)" "unprognostic (2.38e-1)" "unprognostic (9.17e-2)" "unprognostic (3.32e-1)" "unprognostic (9.90e-2)" 12.4 33.4 32.3 8.4 33.3 10.1 20.4 19.9 43.5 31.3 13.1 23.0 20.1 10.9 24.4 30.4 12.0 34.5 17.2 18.4 31.2 35.9 25.7 21.8 18.2 13.4 24.2 29.4 32.8 36.0 20.2 19.0 12.3 23.0 25.9 11.3 28.3 26.3 22.0 15.9 11.0 9.5 16.6 17.0 9.4 15.2 22.2 12.2 7.8 30.7 7.0 10.8 17.6 14.9 28.0 29.3 21.2 32.7 15.1 36.8 37.2 15.0 28.5 18.1 41.8 9.8 14.0 32.1 11.9 12.7 19.0 17.2 27.9 24.5 8.0 17.4 17.8 17.6 30.2 18.9 19.5 9.4 5.1 32.5 13.9 46.0 18.2 18.9 6.6 13.0 16.6 21.7 17.7 10.8 23.0 11.7 11.3 24.8 8.8 16.3 19.3 8.0 10.9 27.6 13.8 70.5 14.5 27.0 10.4 21.8 11.7 16.9 34.5 21.2 36.4 21.9 28.2 44.7 11.7 8.7 21.4 17.8 17.0 14.3 36.2 31.1 6.1 16.2 7.2 10.3 19.1 32.7 16.9 25.5 20.9 28.7 28.0 24.8 20.9 26.9 27.0 36.8 24.2 21.2 15.1 18.9 29.3 21.5 37.2 32.3 33.3 19.9 43.5 31.2 35.9 24.2 29.4 23.0 12.2 47.6 38.0 4.5 30.3 11.4 64.1 33.1 48.4 54.9 40.9 34.9 29.5 35.6 14.9 74.6 47.8 25.3 7.4 0.0 65.8 41.2 50.3 37.0 12.7 32.1 24.1 7.9 30.6 29.4 15.0 47.1 65.6 14.5 21.9 11.8 25.4 102.0 41.4 18.2 49.8 48.1 26.0 12.9 32.0 44.2 81.2 12.2 10.9 12.8 28.5 22.0 TMEM91 "FLJ27310, IFITMD6" ENSG00000142046 "Transmembrane protein 91" Q6ZNR0 19 41350911-41384083 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 178.4;Late spermatids: 342.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 51.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 51.9" "Cell line enhanced" "Detected in many" "HEL: 15.2;HSkMC: 16.2;TIME: 15.2" "Low region specificity" "Detected in all" HPA053240 Uncertain NA NA "HPA053240: AB_2682085" "unprognostic (3.02e-3)" "unprognostic (1.92e-2)" "unprognostic (5.13e-3)" "unprognostic (2.97e-2)" "unprognostic (1.29e-1)" "unprognostic (9.90e-2)" "unprognostic (4.70e-2)" "unprognostic (2.83e-1)" "unprognostic (1.03e-1)" "unprognostic (5.69e-3)" "prognostic favorable (3.54e-5)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.52e-7)" "unprognostic (1.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.63e-1)" "unprognostic (3.06e-2)" 10.5 6.2 12.1 9.2 42.0 35.5 22.0 5.2 13.0 12.1 9.8 9.5 12.9 4.3 17.3 12.8 11.2 15.8 9.7 7.2 11.3 22.9 8.3 4.2 13.9 6.8 9.3 13.7 9.7 12.9 4.3 19.2 10.8 11.6 12.3 5.1 12.3 8.6 13.5 4.0 29.7 5.4 10.9 8.1 15.7 6.0 15.2 14.7 6.0 10.7 3.8 8.6 14.4 12.1 0.4 3.4 51.9 12.5 0.3 2.0 11.0 2.2 5.5 4.2 1.9 5.1 11.0 3.7 1.7 2.5 0.9 1.7 0.4 2.0 1.1 1.7 2.2 1.6 0.7 1.1 1.9 2.3 1.6 2.5 15.2 3.6 8.1 9.3 2.5 4.1 16.2 9.6 3.1 7.0 11.5 6.9 2.9 2.8 4.5 1.6 5.0 1.4 4.6 1.7 0.7 3.3 3.0 1.1 1.0 2.6 1.3 1.2 2.3 3.9 0.8 2.5 2.9 0.8 7.0 15.2 2.6 2.3 2.3 2.1 3.0 0.4 0.9 5.0 3.1 0.9 7.1 12.5 0.9 1.5 2.6 1.8 0.1 0.8 0.7 2.1 0.4 2.0 0.9 51.9 0.3 1.8 3.4 1.0 11.0 12.1 42.0 5.2 13.0 11.3 22.9 9.3 13.7 11.6 14.7 3.0 21.9 3.0 19.5 15.9 9.2 3.0 0.0 5.3 9.1 7.0 5.9 1.6 1.7 3.0 178.4 13.0 1.0 0.0 2.8 59.8 10.3 5.3 33.5 3.0 13.8 7.9 13.8 16.5 57.3 342.9 13.0 14.6 8.5 1.8 1.9 3.8 5.2 14.4 6.7 2.1 6.0 6.5 4.6 2.8 9.6 18.6 7.2 8.7 1.6 9.6 TMEM92 FLJ33318 ENSG00000167105 "Transmembrane protein 92" Q6UXU6 17 50271406-50281485 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 74.7" "Cell type enhanced" "Detected in many" 15 "Pancreatic endocrine cells: 31.5;Urothelial cells: 92.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "neutrophil: 5.5" "Lineage enriched" "Detected in single" 21 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "A549: 9.1;CACO-2: 15.5;CAPAN-2: 14.8;EFO-21: 30.9;OE19: 17.9;SuSa: 20.9" "Low region specificity" "Detected in all" "HPA063009, HPA069820" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063009: AB_2684921, HPA069820: AB_2686208" "unprognostic (3.54e-3)" "unprognostic (2.39e-2)" "unprognostic (9.85e-2)" "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "prognostic unfavorable (8.35e-4)" "unprognostic (4.37e-3)" "unprognostic (2.45e-2)" "unprognostic (1.11e-1)" "unprognostic (4.39e-1)" "unprognostic (3.88e-3)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (7.81e-2)" 0.2 0.1 0.3 1.9 0.3 0.4 0.3 0.3 0.3 3.3 27.9 0.3 0.1 23.3 1.2 0.3 1.0 0.7 11.7 0.1 0.8 0.3 0.4 10.2 6.1 0.1 0.3 0.2 2.4 1.2 0.0 0.1 0.3 0.9 1.2 1.8 1.1 4.3 1.2 0.1 0.2 74.7 0.4 0.4 0.3 17.9 0.5 0.3 0.1 0.1 0.4 1.6 2.2 3.7 0.1 0.2 5.5 0.1 0.0 0.0 0.0 0.9 9.1 0.2 0.0 0.0 0.4 2.0 0.2 0.3 0.0 0.0 15.5 14.8 0.0 30.9 0.6 3.5 0.0 0.2 1.7 0.0 2.4 0.1 0.0 0.9 1.5 0.1 0.1 0.1 0.1 1.7 0.1 0.5 1.4 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.2 3.4 17.9 4.0 0.2 0.0 3.8 3.3 0.0 0.0 0.0 0.0 0.1 0.0 20.9 1.9 0.5 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.3 0.8 0.3 0.3 0.2 0.9 0.3 3.0 17.1 0.0 6.4 0.5 0.0 0.1 22.9 2.7 1.2 7.0 0.0 0.0 0.0 6.2 0.0 0.0 8.0 0.0 17.8 1.2 1.0 16.8 0.0 11.3 0.4 0.0 5.2 1.8 0.3 0.0 0.0 0.0 0.0 1.8 20.4 0.0 31.5 16.4 0.0 0.0 0.0 0.0 0.1 0.1 1.7 0.9 0.0 0.0 14.9 92.2 TMEM94 KIAA0195 ENSG00000177728 "Transmembrane protein 94" Q12767 17 75441159-75500090 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008423, HPA050660" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA008423: AB_1852283, HPA050660: AB_2681207" "unprognostic (4.05e-2)" "unprognostic (3.43e-1)" "unprognostic (5.78e-2)" "unprognostic (4.32e-2)" "unprognostic (1.01e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (1.70e-1)" "unprognostic (1.42e-1)" "unprognostic (7.27e-2)" "prognostic favorable (2.26e-4)" "unprognostic (9.71e-2)" "unprognostic (1.14e-1)" "unprognostic (1.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.44e-2)" "unprognostic (4.96e-2)" 14.6 25.6 26.6 11.2 32.0 13.9 9.8 24.4 32.7 11.7 16.7 30.3 8.2 15.4 13.0 8.5 14.5 27.4 13.7 21.1 21.7 13.3 14.0 9.6 17.0 10.6 24.0 23.0 17.1 13.9 17.2 18.6 18.6 21.9 12.5 11.5 25.4 11.8 12.5 40.4 16.2 15.2 9.4 15.9 14.3 14.8 16.5 23.4 10.7 18.4 9.6 9.2 13.7 7.1 4.6 6.2 5.5 4.6 4.3 7.1 4.5 7.6 20.1 16.6 26.1 8.3 9.5 23.9 4.6 10.2 7.9 8.1 6.7 12.1 10.9 15.4 8.0 12.2 10.1 8.0 12.7 4.4 9.6 11.3 11.0 9.0 10.1 11.3 12.2 24.0 16.4 7.1 7.8 6.9 6.9 14.3 9.3 11.4 12.7 10.3 8.9 25.3 7.6 6.9 9.4 7.8 18.0 19.7 10.0 7.7 20.2 14.8 15.7 5.5 23.9 13.8 12.8 14.8 14.6 8.2 7.9 10.0 8.2 6.5 27.5 7.8 5.9 9.3 11.3 10.7 0.2 4.6 5.5 7.1 2.9 5.4 2.0 3.3 4.7 4.6 4.6 2.8 4.4 1.2 4.3 2.7 6.2 4.1 4.5 26.6 32.0 24.4 32.7 21.7 13.3 24.0 23.0 21.9 23.4 11.9 12.0 0.0 3.8 0.0 39.1 0.0 7.6 5.3 11.4 8.7 29.5 12.8 0.0 6.3 3.5 3.6 13.2 0.0 8.1 8.9 1.3 3.8 5.8 7.2 13.1 19.1 7.0 14.1 8.9 1.6 6.4 3.6 0.0 2.8 11.6 14.5 5.6 10.5 8.5 3.3 33.4 6.5 0.0 13.3 7.8 0.0 16.8 2.5 11.0 2.4 TMEM95 "MGC129793, UNQ9390" ENSG00000182896 "Transmembrane protein 95" Q3KNT9 17 7355123-7357219 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 21 "testis: 19.3" "Group enriched" "Detected in some" 23 "Early spermatids: 20.4;Late spermatids: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.0;BJ: 1.0;hTERT-RPE1: 1.4" "Intracellular and membrane" NA NA "unprognostic (1.54e-1)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "unprognostic (5.15e-2)" "unprognostic (7.42e-2)" "unprognostic (7.44e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 TMEM97 MAC30 ENSG00000109084 "Transmembrane protein 97" Q5BJF2 17 28319095-28328685 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "pancreas: 228.7" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 94.3;Exocrine glandular cells: 170.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044795, HPA076689" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044795: AB_10959306, HPA076689: " "unprognostic (1.35e-2)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (4.34e-2)" "unprognostic (3.20e-2)" "unprognostic (9.03e-2)" "unprognostic (1.04e-2)" "unprognostic (1.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.99e-1)" "unprognostic (4.01e-2)" 2.0 11.5 3.1 2.8 3.3 1.7 3.4 2.9 4.9 2.6 4.2 2.2 1.2 4.7 2.9 1.9 3.1 4.0 8.1 1.6 2.4 3.0 2.2 33.7 12.5 3.4 2.4 2.7 8.2 228.7 1.7 0.6 2.0 7.7 6.9 3.8 3.2 1.5 2.8 5.7 3.6 3.2 3.4 4.0 1.7 13.2 31.5 1.3 4.6 1.3 3.9 2.5 12.5 6.0 9.0 13.8 1.7 2.3 8.2 10.0 4.6 9.9 25.0 48.1 23.7 6.4 9.2 15.8 9.6 6.2 15.3 20.5 70.9 7.6 27.2 10.5 3.7 31.7 10.7 30.5 16.4 12.1 12.8 21.4 10.2 13.1 30.2 5.8 16.2 8.2 18.7 2.1 14.9 6.2 1.8 4.6 17.6 21.3 20.5 5.1 16.8 25.3 15.3 21.1 40.1 6.5 20.4 52.8 24.6 18.8 45.4 34.7 15.2 15.4 12.2 7.8 28.1 21.6 7.5 3.0 16.5 13.0 14.1 17.6 16.6 32.7 24.9 3.3 11.7 9.7 0.4 2.0 1.7 7.3 2.3 8.5 9.0 6.2 8.8 13.8 5.1 10.0 9.3 0.9 8.2 0.8 8.0 5.8 4.6 3.1 3.3 2.9 4.2 2.4 3.0 2.4 2.7 7.7 1.3 8.9 43.3 13.7 5.6 12.9 11.4 6.8 94.3 16.0 17.0 14.0 15.7 19.3 13.3 16.0 18.3 4.7 3.4 23.3 170.2 63.4 9.1 12.3 1.1 86.2 17.6 3.2 37.2 8.0 6.2 38.1 12.4 8.5 15.1 18.0 13.5 7.8 60.6 0.0 10.6 4.3 8.4 6.5 6.1 87.2 53.0 9.8 8.9 7.1 27.0 7.0 TMEM98 DKFZP564K1964 ENSG00000006042 "Transmembrane protein 98" Q9Y2Y6 17 32927910-32945106 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 96.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 7.9" "Lineage enriched" "Detected in single" 12 "dendritic cells: 7.9" "Cell line enhanced" "Detected in many" "CACO-2: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040473, HPA053385" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA040473: AB_10794876, HPA053385: AB_2682134" "unprognostic (1.55e-2)" "unprognostic (5.15e-2)" "unprognostic (4.36e-3)" "unprognostic (7.20e-2)" "unprognostic (1.19e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (8.14e-4)" "prognostic favorable (7.10e-4)" "unprognostic (6.38e-2)" "unprognostic (2.22e-1)" "unprognostic (3.41e-1)" "unprognostic (9.18e-3)" "prognostic favorable (3.85e-4)" "unprognostic (5.16e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-2)" "unprognostic (2.58e-1)" 15.5 15.9 11.8 7.1 36.8 0.9 13.3 6.5 28.3 21.6 26.1 55.5 5.6 29.7 30.5 23.0 8.2 29.6 27.7 13.5 17.0 9.4 10.8 7.7 17.0 3.1 50.4 18.5 60.2 25.7 6.3 7.4 8.0 40.8 24.7 28.7 96.8 14.8 7.4 2.6 7.1 34.0 19.0 37.1 5.7 29.7 9.7 37.7 0.6 14.2 7.4 3.5 15.6 13.3 0.5 7.9 0.6 0.1 0.2 0.6 0.1 1.5 5.8 25.2 0.0 34.6 31.2 0.2 24.4 33.1 13.0 28.0 58.9 1.7 0.3 0.3 30.6 0.4 0.2 16.0 6.4 7.6 5.1 19.7 0.9 0.0 26.1 16.0 0.0 0.3 26.0 6.5 16.3 2.6 7.0 33.4 8.7 16.0 0.0 35.2 0.0 0.0 0.1 16.7 17.5 9.0 0.0 23.6 0.1 2.9 10.4 2.1 34.8 0.5 0.0 19.0 16.7 7.9 0.0 27.3 18.5 17.4 0.2 0.0 2.0 0.8 0.0 9.4 0.0 9.9 0.5 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.6 0.0 0.5 0.1 0.2 0.6 0.2 0.1 7.9 0.1 0.1 11.8 36.8 6.5 28.3 17.0 9.4 50.4 18.5 40.8 37.7 38.7 19.0 0.0 70.6 22.2 1.7 10.9 73.9 40.2 30.7 43.6 0.0 8.6 5.0 78.8 13.2 5.7 130.7 0.0 58.1 7.3 109.2 105.0 3.5 8.5 5.0 0.0 94.1 22.1 0.6 9.5 111.7 2.8 42.2 0.0 153.0 80.2 76.7 84.2 142.5 30.0 4.4 64.7 32.5 36.8 26.0 11.0 5.9 3.5 154.7 59.9 TMEM99 MGC21518 ENSG00000167920 "Transmembrane protein 99" Q8N816 17 40819106-40836274 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 63.4" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 234.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (8.14e-2)" "unprognostic (1.25e-1)" "unprognostic (1.58e-1)" "unprognostic (5.30e-3)" "unprognostic (8.83e-2)" "unprognostic (4.77e-3)" "unprognostic (1.14e-1)" "unprognostic (1.81e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-1)" "unprognostic (9.44e-2)" "unprognostic (2.18e-1)" "unprognostic (1.04e-1)" "unprognostic (4.73e-2)" "unprognostic (5.24e-2)" "unprognostic (8.68e-3)" "unprognostic (7.19e-2)" 4.5 6.1 4.5 2.6 4.5 0.4 11.8 4.1 4.3 7.1 3.7 4.6 15.8 3.5 4.9 21.5 7.0 8.8 8.3 6.8 3.7 3.4 8.5 11.3 7.1 3.1 4.2 3.3 7.5 22.8 7.8 9.1 4.9 5.5 8.2 3.8 4.8 29.1 9.9 5.2 27.6 4.1 3.8 3.0 4.8 6.1 63.4 3.8 4.9 13.3 6.0 4.0 5.5 8.3 9.5 5.9 7.8 2.4 10.8 14.1 4.0 10.4 13.5 6.8 7.9 16.1 20.4 6.6 9.8 5.4 12.4 14.8 10.2 6.8 4.4 14.9 11.3 15.7 20.4 9.9 15.3 18.0 3.7 21.5 6.6 9.8 22.4 14.8 10.0 9.2 10.3 27.5 19.4 19.6 8.7 4.2 13.3 24.0 6.5 16.4 3.9 8.2 5.7 11.1 11.1 7.7 10.4 13.5 8.4 13.6 6.8 15.1 0.6 4.9 25.1 17.9 16.9 19.2 10.6 2.6 10.6 7.5 17.6 11.4 0.1 3.3 8.0 11.8 5.6 6.1 7.8 1.6 4.6 10.1 2.2 12.8 7.8 8.5 12.7 4.0 9.5 14.1 11.7 0.1 10.8 2.4 5.9 5.2 4.0 4.5 4.5 4.1 4.3 3.7 3.4 4.2 3.3 5.5 3.8 6.0 1.6 11.1 23.3 13.1 5.7 7.9 40.8 10.7 12.5 14.0 0.0 35.5 41.4 21.3 65.9 8.0 8.5 0.0 13.6 35.7 12.5 14.4 5.7 46.6 8.5 4.8 2.9 8.6 8.6 42.9 28.7 5.9 10.1 2.8 10.8 14.6 9.4 8.6 28.0 28.3 7.3 25.8 6.4 234.1 41.7 20.3 21.7 8.7 14.6 28.2 TMEM9B C11orf15 ENSG00000175348 "TMEM9 domain family member B" Q9NQ34 11 8947294-8965011 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037784 Approved NA NA "HPA037784: AB_10671886" "unprognostic (3.18e-1)" "unprognostic (4.68e-2)" "unprognostic (2.58e-1)" "unprognostic (1.84e-3)" "unprognostic (1.13e-1)" "unprognostic (8.48e-3)" "unprognostic (2.56e-2)" "unprognostic (6.34e-2)" "unprognostic (1.52e-1)" "unprognostic (3.78e-2)" "unprognostic (1.89e-2)" "unprognostic (5.06e-1)" "prognostic favorable (4.26e-5)" "unprognostic (1.83e-1)" "unprognostic (1.82e-1)" "unprognostic (5.51e-3)" "unprognostic (9.56e-2)" 18.4 22.8 37.6 17.2 39.3 35.5 30.3 24.8 43.8 22.4 34.8 37.3 19.9 29.6 13.0 35.0 36.7 18.0 22.1 28.9 34.9 33.4 34.3 24.7 34.5 27.2 40.1 24.7 15.1 29.2 33.3 25.2 33.9 31.0 19.8 38.3 24.5 27.6 17.6 26.6 26.1 40.8 12.5 42.0 24.5 31.9 14.8 25.9 17.8 42.8 24.9 23.5 23.3 21.1 36.7 40.5 52.2 50.6 31.3 47.2 49.2 20.8 14.2 8.2 15.7 42.0 24.0 14.0 26.6 24.2 15.7 16.4 10.8 33.2 12.9 14.1 27.7 18.5 28.1 7.6 19.6 16.9 23.8 14.7 8.6 12.8 10.3 23.8 17.4 27.9 21.7 33.4 9.6 19.7 21.6 18.8 8.9 6.8 20.0 30.1 14.6 5.4 11.2 2.5 30.3 16.3 6.2 10.5 10.4 23.8 24.5 9.0 7.7 15.1 31.9 13.1 10.8 19.3 11.9 20.2 19.2 8.6 32.5 16.2 8.3 14.2 9.2 24.3 11.7 16.3 50.2 38.1 52.2 37.9 47.4 39.1 36.7 37.0 41.7 40.5 31.3 31.0 43.0 18.1 31.3 50.6 28.8 47.2 49.2 37.6 39.3 24.8 43.8 34.9 33.4 40.1 24.7 31.0 25.9 38.7 48.3 61.1 59.1 57.8 60.9 25.5 58.6 40.2 44.3 90.7 19.6 90.0 59.7 70.2 12.7 46.0 88.9 0.0 71.4 92.5 51.8 50.8 86.5 25.6 99.3 41.3 30.0 38.6 68.8 10.4 35.4 70.4 57.3 45.1 69.3 76.0 53.3 95.9 26.9 36.5 42.9 19.4 19.8 53.5 56.2 76.4 134.4 62.3 79.8 67.7 TMIE DFNB6 ENSG00000181585 "Transmembrane inner ear" Q8NEW7 3 46694528-46710886 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.7;brain: 11.4" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 3.5;Distal tubular cells: 1.7;Spermatogonia: 3.1" "Cancer enriched" "Detected in many" 5 "glioma: 6.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.1" "Lineage enriched" "Detected in single" 17 "T-cells: 6.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.3;EFO-21: 3.8;JURKAT: 15.0;SH-SY5Y: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038298 Uncertain Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA038298: AB_10675792" "unprognostic (6.59e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-3)" "unprognostic (2.48e-3)" "unprognostic (1.88e-2)" "unprognostic (5.40e-3)" "unprognostic (3.94e-2)" "unprognostic (8.80e-2)" "unprognostic (3.37e-2)" "unprognostic (6.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.35e-2)" "unprognostic (4.58e-2)" "unprognostic (1.23e-1)" "unprognostic (4.41e-2)" "unprognostic (5.29e-2)" "unprognostic (6.78e-2)" 1.2 11.7 6.7 0.7 2.9 0.0 0.5 2.7 7.0 0.8 0.9 2.3 0.4 0.6 0.8 1.2 2.2 1.0 0.4 1.0 5.9 11.4 1.4 0.9 1.8 1.2 5.8 4.8 2.8 0.4 0.0 8.1 0.7 3.8 0.9 0.6 1.1 0.8 1.8 5.8 1.3 0.6 0.7 5.2 1.2 0.3 1.6 1.0 0.4 0.8 1.7 1.3 0.8 0.4 0.0 0.3 0.0 0.1 0.0 6.1 1.2 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.3 0.0 3.8 0.0 0.7 0.2 0.2 0.3 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 2.6 0.0 1.7 0.0 0.7 15.0 0.0 0.4 0.0 0.2 0.1 0.0 0.3 1.0 0.2 1.6 0.0 0.3 0.1 0.1 0.4 3.3 0.4 0.5 0.0 0.2 0.1 0.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.0 1.8 1.0 0.3 0.0 6.1 0.9 0.0 0.0 0.0 0.0 1.0 1.2 6.7 2.9 2.7 7.0 5.9 11.4 5.8 4.8 3.8 1.0 0.0 0.0 0.0 0.1 0.7 3.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.2 0.2 0.0 0.0 0.4 0.1 0.5 0.2 0.0 0.0 0.5 0.0 0.0 0.6 0.0 1.0 0.6 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.4 0.0 0.4 0.0 1.4 1.4 3.1 0.6 0.1 0.0 0.0 0.1 TMIGD1 "TMIGD, UNQ9372" ENSG00000182271 "Transmembrane and immunoglobulin domain containing 1" Q6UXZ0 17 30316333-30334059 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "intestine: 47.3" "Cell type enriched" "Detected in some" 14 "Enterocytes: 341.7" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.4;NB-4: 1.3;U-2197: 1.8;U-698: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA021946 Approved Mitochondria NA NA Mitochondria "HPA021946: AB_1858140" "unprognostic (1.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" 0.2 0.0 0.2 1.1 0.2 0.0 0.2 0.2 0.2 0.2 26.8 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 1.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 33.9 0.2 0.2 0.2 0.2 0.0 47.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 341.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 24.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 TMIGD2 "CD28H, IGPR-1, MGC23244" ENSG00000167664 "Transmembrane and immunoglobulin domain containing 2" Q96BF3 19 4292232-4302431 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 34.0;lymphoid tissue: 43.8" "Cell type enriched" "Detected in some" 14 "T-cells: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 34.0" "Group enriched" "Detected in many" 37 "dendritic cells: 30.8;NK-cells: 23.0;T-cells: 34.0" "Group enriched" "Detected in some" 4 "BEWO: 9.5;HEL: 21.9;MOLT-4: 19.6" "Low region specificity" "Detected in many" HPA011081 Approved NA NA "HPA011081: AB_1079372" "unprognostic (1.08e-3)" "unprognostic (6.55e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-4)" "unprognostic (4.31e-2)" "unprognostic (8.68e-3)" "unprognostic (7.78e-3)" "unprognostic (2.87e-2)" "unprognostic (1.86e-1)" "unprognostic (2.28e-1)" "unprognostic (2.12e-1)" "unprognostic (3.26e-1)" "unprognostic (7.10e-5)" "unprognostic (2.62e-2)" "unprognostic (4.54e-1)" "unprognostic (5.12e-4)" "unprognostic (8.89e-4)" 0.4 0.2 2.8 6.0 1.6 6.4 0.2 0.4 1.8 0.4 3.4 2.2 0.2 2.1 0.7 0.2 0.7 0.6 1.0 0.2 2.1 1.9 0.4 1.0 1.4 9.2 3.4 0.8 0.4 0.2 0.1 0.2 0.9 1.0 0.5 0.6 0.3 0.7 0.2 0.2 0.2 6.1 0.2 2.4 9.7 1.0 0.7 1.2 43.8 0.6 0.5 5.3 1.0 0.3 0.1 30.8 0.7 0.1 23.0 34.0 7.3 0.0 0.1 0.2 0.2 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 21.9 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 19.6 0.1 0.2 0.0 0.0 3.8 1.0 0.0 0.0 0.1 0.1 2.6 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 2.7 0.0 34.0 0.0 4.4 6.6 0.1 0.1 25.5 12.9 0.7 23.0 0.1 30.8 0.4 7.3 2.8 1.6 0.4 1.5 2.1 1.9 3.4 0.8 1.0 1.2 0.0 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.6 0.3 0.0 0.0 1.8 0.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.7 26.1 0.0 0.1 TMIGD3 AD026 ENSG00000121933 "Transmembrane and immunoglobulin domain containing 3" P0DMS9 1 111483348-111563962 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 28.2;brain: 16.4;testis: 50.4" "Group enriched" "Detected in many" 7 "Early spermatids: 216.3;Hofbauer cells: 179.2;Kupffer cells: 81.5;Late spermatids: 88.3" "Cancer enriched" "Detected in all" 5 "glioma: 16.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 39 "eosinophil: 28.2" "Lineage enriched" "Detected in single" 39 "granulocytes: 28.2" "Cell line enhanced" "Detected in some" "HDLM-2: 11.5;HMC-1: 3.1;Karpas-707: 2.2;NB-4: 6.3" NA NA "prognostic unfavorable (3.58e-4)" "unprognostic (7.64e-3)" "unprognostic (7.47e-3)" "unprognostic (2.11e-2)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (9.48e-2)" "unprognostic (5.70e-2)" "unprognostic (1.01e-1)" "unprognostic (2.07e-3)" "unprognostic (4.46e-2)" "unprognostic (9.50e-2)" "unprognostic (4.48e-2)" "unprognostic (5.69e-3)" "unprognostic (3.30e-1)" "unprognostic (1.44e-5)" "unprognostic (9.22e-2)" 5.4 4.1 8.4 1.9 14.4 2.4 1.4 1.2 8.1 1.5 1.5 12.6 0.0 0.9 1.3 0.6 1.4 1.4 1.4 1.4 7.3 1.5 1.3 3.0 2.8 2.9 15.0 3.3 1.3 1.3 0.8 1.3 5.1 8.4 1.4 1.2 0.9 1.3 2.0 1.3 1.3 2.1 1.3 16.4 2.0 1.4 50.4 13.5 0.0 1.4 0.0 1.0 1.4 1.3 0.0 0.3 28.2 0.7 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.7 28.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.2 8.4 14.4 1.2 8.1 7.3 1.5 15.0 3.3 8.4 13.5 0.0 2.9 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 216.3 0.5 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.2 179.2 0.0 0.0 6.2 81.5 88.3 3.4 3.6 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.3 0.3 12.9 0.0 19.1 1.5 0.0 2.4 2.5 0.0 0.0 TMPO "LAP2, LEMD4, TP" ENSG00000120802 Thymopoietin "P42166, P42167" 12 98515512-98550379 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" DNA-binding Cardiomyopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 130.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008150, CAB009847, HPA070805" Enhanced Enhanced "Nuclear membrane" NA Yes "Nuclear membrane" "CAB009847: AB_2205450, HPA008150: AB_1079235, HPA070805: " "unprognostic (2.36e-1)" "unprognostic (4.46e-3)" "unprognostic (5.90e-2)" "unprognostic (2.80e-2)" "unprognostic (1.35e-1)" "unprognostic (2.95e-2)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (1.74e-2)" "unprognostic (3.69e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-3)" "prognostic unfavorable (9.34e-4)" "unprognostic (6.01e-3)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (3.26e-2)" 10.8 9.5 8.1 25.0 9.5 36.8 12.7 19.1 11.0 16.9 22.9 10.7 8.7 15.9 18.4 17.1 23.0 15.4 10.3 9.6 8.5 8.3 15.8 20.5 13.8 34.0 9.0 11.2 34.7 21.6 9.9 9.9 13.6 7.6 15.6 17.6 12.5 14.0 9.7 9.4 11.7 22.6 10.7 9.4 29.1 16.8 11.4 10.3 130.9 13.2 12.2 35.4 13.0 17.9 14.1 10.9 18.1 33.1 9.7 15.6 13.3 30.8 20.4 50.3 25.5 4.2 5.6 29.8 25.4 13.5 34.5 25.1 22.2 15.5 53.9 15.6 14.7 12.6 19.8 42.1 19.1 31.7 37.7 26.1 46.1 18.6 14.6 3.8 53.2 30.8 3.1 6.3 20.3 10.9 12.0 19.6 33.6 38.9 20.9 21.4 19.4 86.8 42.0 30.2 28.6 19.1 72.9 33.3 37.3 12.2 28.8 39.8 23.8 43.5 27.3 13.7 20.6 30.8 25.6 10.5 20.0 17.5 13.6 25.9 22.8 38.8 60.3 5.7 30.9 26.5 18.1 14.4 6.1 9.5 25.0 10.2 10.9 11.1 10.8 10.9 14.1 15.6 11.7 1.1 9.7 33.1 6.1 13.3 13.3 8.1 9.5 19.1 11.0 8.5 8.3 9.0 11.2 7.6 10.3 29.8 18.0 45.4 21.4 24.6 20.8 7.1 25.5 36.1 48.9 29.6 11.8 16.5 26.6 16.3 26.8 36.0 27.6 70.0 27.6 75.5 19.0 17.7 27.8 45.0 32.2 9.5 27.5 32.5 64.7 21.9 26.4 40.1 16.9 34.3 51.4 24.2 21.6 31.5 38.2 27.8 47.9 19.4 15.6 38.6 53.5 20.5 9.8 33.1 42.9 16.3 TMPPE FLJ45032 ENSG00000188167 "Transmembrane protein with metallophosphoesterase domain" Q6ZT21 3 33090421-33096801 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 5 "Alveolar cells type 2: 2.2;Rod photoreceptor cells: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "BEWO: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027019 Approved Approved Nucleoplasm,Mitochondria Yes No "Nucleoplasm, Mitochondria" "HPA027019: AB_1848942" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.37e-1)" "unprognostic (5.03e-2)" "unprognostic (2.96e-2)" "unprognostic (6.34e-3)" "unprognostic (8.14e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-3)" "unprognostic (9.58e-2)" "unprognostic (1.60e-7)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (2.13e-1)" "unprognostic (4.33e-2)" 6.3 5.4 3.7 6.8 5.2 20.3 6.8 5.3 7.4 4.5 6.9 4.1 7.4 6.4 6.5 12.0 7.0 5.4 9.9 4.4 3.6 3.7 13.9 13.1 9.3 9.6 3.5 3.0 5.7 9.7 12.1 5.2 8.4 4.9 4.6 6.5 9.0 7.7 6.5 3.8 10.3 11.0 4.6 3.8 7.2 6.8 3.2 2.3 2.4 9.5 2.2 7.2 5.3 5.0 0.8 2.2 4.2 5.5 0.1 1.4 0.9 1.3 1.7 1.0 1.6 1.2 1.0 25.5 0.6 0.9 1.5 0.9 2.5 3.5 0.7 1.1 1.6 0.8 1.4 1.6 1.4 2.5 3.8 0.6 3.1 1.7 1.9 0.8 2.6 4.5 1.1 1.2 1.9 1.3 0.7 1.8 1.6 2.3 2.7 1.1 1.2 1.1 1.2 1.0 0.3 1.0 1.3 0.5 1.7 1.4 1.7 0.2 0.6 0.8 2.4 0.6 1.3 1.3 3.8 2.5 2.3 2.9 1.2 2.4 2.2 1.4 0.4 2.9 2.0 1.5 0.0 2.3 0.7 0.4 5.5 1.4 0.8 0.5 0.1 2.2 0.3 0.0 0.0 4.2 0.1 2.3 0.4 0.5 0.9 3.7 5.2 5.3 7.4 3.6 3.7 3.5 3.0 4.9 2.3 0.0 2.2 0.0 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.1 1.3 0.0 0.7 1.2 0.3 0.2 0.0 0.2 0.8 1.6 0.0 0.6 1.2 0.0 0.0 0.5 0.0 0.0 0.2 0.4 0.4 0.9 0.4 0.3 2.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.6 0.1 TMPRSS11A ECRG1 ENSG00000187054 "Transmembrane serine protease 11A" Q6ZMR5 4 67909385-67964140 "Enzymes, Predicted membrane proteins" "Cell cycle" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 19.5;esophagus: 48.4;lymphoid tissue: 18.7;tongue: 47.6" "Group enriched" "Detected in some" 6 "Early spermatids: 4.6;Urothelial cells: 6.2" "Group enriched" "Detected in some" 9 "cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.1;OE19: 2.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA078316 Enhanced NA NA "HPA078316: " "unprognostic (1.63e-1)" "unprognostic (4.60e-2)" "unprognostic (1.76e-2)" "unprognostic (6.98e-2)" "unprognostic (1.98e-1)" "unprognostic (2.66e-1)" "unprognostic (4.58e-1)" "unprognostic (1.32e-1)" "unprognostic (4.36e-2)" "unprognostic (1.05e-1)" "unprognostic (3.50e-1)" "unprognostic (2.33e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 48.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 47.6 18.7 0.3 8.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 TMPRSS11B ENSG00000185873 "Transmembrane serine protease 11B" Q86T26 4 68226653-68245720 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 138.8;lymphoid tissue: 57.0;tongue: 44.0" "Group enriched" "Detected in some" 35 "Early spermatids: 8.5;Late spermatids: 11.5" "Group enriched" "Detected in some" 12 "cervical cancer: 2.6;head and neck cancer: 2.6;stomach cancer: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.24e-2)" "prognostic favorable (6.91e-4)" "unprognostic (2.92e-1)" "unprognostic (3.96e-1)" 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 11.2 0.1 0.0 0.0 0.1 0.5 0.1 138.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 13.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.1 44.0 57.0 0.1 23.2 0.7 0.6 2.4 0.5 0.4 0.7 0.0 0.3 1.4 0.8 0.1 0.1 0.0 0.3 0.3 0.1 0.0 0.3 0.9 0.4 1.4 0.2 0.4 0.4 1.1 0.2 0.1 0.0 0.1 1.6 0.8 1.9 2.1 0.1 1.1 1.4 0.5 0.2 0.0 0.1 0.2 0.0 0.5 0.7 2.0 0.1 0.7 0.5 1.3 0.1 0.3 1.0 0.6 0.6 0.5 0.2 1.5 0.9 0.3 0.1 0.2 0.1 0.6 0.4 0.2 1.3 1.0 0.3 0.5 0.1 0.3 0.9 0.8 0.3 1.0 0.1 0.3 0.4 0.2 0.4 0.1 0.3 0.3 0.3 0.4 0.0 0.7 0.3 0.7 2.4 0.4 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 TMPRSS11D ENSG00000153802 "Transmembrane serine protease 11D" O60235 4 67820876-67884032 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 18.1;esophagus: 41.2;lymphoid tissue: 20.3;tongue: 67.6;vagina: 23.1" "Cell type enriched" "Detected in single" 32 "Urothelial cells: 8.6" "Group enriched" "Detected in many" 5 "cervical cancer: 36.0;head and neck cancer: 30.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA077704 Enhanced "Intracellular and membrane" NA NA "HPA077704: " "unprognostic (1.19e-1)" "unprognostic (6.83e-2)" "unprognostic (8.82e-2)" "unprognostic (2.10e-2)" "unprognostic (1.21e-2)" "unprognostic (1.12e-1)" "unprognostic (3.22e-1)" "unprognostic (2.88e-1)" "unprognostic (1.32e-1)" "unprognostic (4.79e-1)" "unprognostic (4.38e-3)" "unprognostic (1.96e-1)" "unprognostic (6.91e-2)" "unprognostic (4.48e-2)" "unprognostic (2.19e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.6 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 67.6 20.3 0.4 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 TMPRSS11E "DESC1, TMPRSS11E2" ENSG00000087128 "Transmembrane serine protease 11E" Q9UL52 4 68447449-68497604 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.8;lymphoid tissue: 39.1;tongue: 40.5;vagina: 36.6" "Group enriched" "Detected in some" 6 "Basal glandular cells: 12.6;Urothelial cells: 38.8" "Group enriched" "Detected in many" 6 "cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.8" "Lineage enhanced" "Detected in single" "B-cells: 1.8" "Group enriched" "Detected in some" 6 "HaCaT: 5.0;HBEC3-KT: 1.9;OE19: 5.2;SuSa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA051062 Enhanced "Intracellular and membrane" NA NA "HPA051062: AB_2681329" "unprognostic (2.53e-1)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" "unprognostic (9.14e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (6.73e-4)" "unprognostic (2.22e-1)" "unprognostic (9.70e-3)" "unprognostic (2.16e-1)" "unprognostic (3.74e-2)" "unprognostic (4.03e-2)" "unprognostic (8.39e-2)" "unprognostic (1.27e-1)" "unprognostic (3.08e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 28.9 0.0 0.0 1.2 0.0 1.1 10.5 103.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 1.4 0.0 0.0 13.6 0.5 0.0 1.6 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 40.5 39.1 2.6 36.6 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 5.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 38.8 TMPRSS11F FLJ16046 ENSG00000198092 "Transmembrane serine protease 11F" Q6ZWK6 4 68053198-68129880 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 18.3;lymphoid tissue: 11.4;skin 1: 10.9;tongue: 13.1" "Cell type enhanced" "Detected in single" 19 "Cytotrophoblasts: 1.1" "Group enriched" "Detected in some" 7 "cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 2.5;K-562: 5.5;Karpas-707: 1.6;U-266/70: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA026911 Uncertain NA NA "HPA026911: AB_2205589" "unprognostic (9.46e-2)" "unprognostic (5.30e-1)" "unprognostic (7.16e-2)" "unprognostic (8.79e-3)" "unprognostic (1.09e-1)" "unprognostic (2.40e-1)" "unprognostic (1.22e-1)" "unprognostic (5.08e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.1 0.0 0.0 1.4 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 13.1 11.4 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.2 0.0 0.0 0.3 TMPRSS12 "CT151, MGC57341" ENSG00000186452 "Transmembrane serine protease 12" Q86WS5 12 50842920-50887884 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 52.7" "Group enriched" "Detected in some" 9 "Early spermatids: 21.7;Spermatocytes: 50.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.9;Karpas-707: 1.1;NTERA-2: 1.4;SK-BR-3: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.04e-1)" "unprognostic (9.09e-2)" "unprognostic (3.03e-2)" "unprognostic (7.25e-3)" "unprognostic (1.70e-1)" "unprognostic (1.39e-1)" "unprognostic (3.88e-1)" "unprognostic (2.98e-2)" "unprognostic (2.60e-1)" "unprognostic (1.88e-1)" "unprognostic (1.29e-1)" "unprognostic (5.65e-3)" "unprognostic (1.03e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 52.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.6 0.1 0.4 0.3 0.0 0.0 0.8 0.0 0.5 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.1 1.1 0.0 0.0 0.3 0.4 1.4 0.0 0.5 0.2 0.0 0.2 0.0 0.3 0.3 0.1 0.6 1.1 0.0 0.2 0.1 0.2 0.3 0.3 0.1 0.0 0.0 0.5 0.1 0.1 0.3 0.2 0.2 1.3 0.1 0.5 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.4 0.3 0.3 1.6 0.4 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.7 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 3.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 50.5 1.5 0.3 0.6 0.0 0.0 0.1 TMPRSS13 "MSPL, TMPRSS11" ENSG00000137747 "Transmembrane serine protease 13" Q9BYE2 11 117900643-117929459 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 22.1;salivary gland: 16.6;skin 1: 26.0" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 7.6;Cytotrophoblasts: 12.9;Extravillous trophoblasts: 12.2;Syncytiotrophoblasts: 16.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 7.5;BEWO: 17.9;MCF7: 15.1;SK-BR-3: 25.9;T-47d: 26.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.08e-3)" "unprognostic (5.18e-2)" "unprognostic (6.59e-2)" "unprognostic (1.06e-3)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (5.61e-2)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "unprognostic (1.92e-2)" "unprognostic (2.03e-1)" "unprognostic (3.16e-6)" "unprognostic (2.05e-1)" "unprognostic (7.75e-2)" "unprognostic (1.08e-1)" "unprognostic (3.44e-1)" 0.2 0.3 0.2 0.6 0.2 0.3 6.2 0.2 0.2 5.8 0.2 0.2 0.2 0.2 0.9 0.7 14.8 0.1 0.2 0.2 0.4 0.0 0.7 0.2 4.0 0.7 0.2 0.2 0.3 5.7 0.0 0.5 22.1 0.2 0.9 0.2 0.6 16.6 0.2 0.2 26.0 0.5 0.2 0.2 1.0 0.1 0.3 0.2 0.4 9.5 13.7 10.6 0.3 5.6 1.0 2.6 1.0 0.7 1.9 1.2 0.8 7.5 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 5.7 0.1 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 15.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 2.1 0.2 0.0 0.0 25.9 0.3 0.9 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.0 0.6 0.0 0.9 0.7 0.0 1.0 0.1 1.2 1.8 0.5 0.4 0.1 0.0 1.9 0.5 2.6 0.7 0.8 0.2 0.2 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.0 2.9 0.0 3.7 1.4 0.0 1.4 7.6 0.0 2.3 0.0 0.0 12.9 0.0 6.2 0.3 0.0 0.4 0.0 1.0 12.2 0.5 5.3 0.0 0.0 2.5 0.0 0.0 0.0 1.2 0.6 0.0 0.7 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.9 16.2 0.0 0.4 6.9 TMPRSS15 "ENTK, MGC133046, PRSS7" ENSG00000154646 "Transmembrane serine protease 15" P98073 21 18269116-18485879 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 67 "intestine: 154.6" "Cell type enriched" "Detected in single" 11 "Early spermatids: 4.2" "Group enriched" "Detected in some" 12 "liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 20 "U-138 MG: 20.3;U-87 MG: 56.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "olfactory region: 9.3" "HPA015611, HPA034857, HPA072934" Enhanced Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214" "unprognostic (9.26e-2)" "unprognostic (4.14e-1)" "unprognostic (3.52e-1)" "unprognostic (8.33e-2)" "unprognostic (1.19e-1)" "unprognostic (7.20e-2)" "unprognostic (4.70e-2)" "unprognostic (6.35e-2)" "unprognostic (5.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 80.5 0.0 0.0 154.6 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 42.4 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.5 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.1 0.0 0.3 0.0 0.1 56.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 TMPRSS2 PRSS10 ENSG00000184012 "Transmembrane serine protease 2" O15393 21 41464551-41531116 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 75.6;pancreas: 64.5;prostate: 68.2" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 190.3;Glandular cells: 290.4;Paneth cells: 127.7;Urothelial cells: 115.9" "Cancer enriched" "Detected in many" 7 "prostate cancer: 250.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 14.1;MCF7: 6.1;OE19: 20.6;RT4: 33.9;SK-BR-3: 6.9" "Not detected" "Not detected" "HPA034493, HPA035787" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" Nucleoplasm "HPA034493: , HPA035787: AB_2674782" "unprognostic (4.80e-3)" "unprognostic (3.49e-1)" "unprognostic (2.16e-1)" "prognostic favorable (2.56e-4)" "unprognostic (1.72e-1)" "unprognostic (1.05e-2)" "unprognostic (4.28e-2)" "unprognostic (1.51e-3)" "unprognostic (9.43e-2)" "unprognostic (9.02e-3)" "unprognostic (6.24e-2)" "unprognostic (6.43e-2)" "prognostic favorable (7.86e-6)" "unprognostic (2.00e-2)" "unprognostic (1.68e-1)" "unprognostic (1.41e-1)" "unprognostic (2.15e-2)" 0.2 0.1 0.2 15.5 0.4 0.0 6.1 0.2 0.5 1.3 38.7 0.4 24.4 17.5 0.5 0.9 10.7 2.2 17.3 0.2 0.3 0.1 19.4 18.4 20.7 0.2 0.2 0.2 0.7 64.5 0.0 1.3 1.0 0.4 68.2 18.5 0.3 52.3 35.7 0.2 2.1 75.6 0.9 0.2 0.3 36.7 0.8 0.3 0.5 19.9 3.9 10.2 5.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 14.1 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.1 0.5 1.2 20.6 0.0 0.0 0.0 1.3 0.5 33.9 0.0 0.4 0.0 6.9 0.1 0.2 5.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.4 0.2 0.5 0.3 0.1 0.2 0.2 0.4 0.3 47.6 88.6 0.0 31.0 0.2 0.0 0.6 25.5 14.7 38.7 45.4 0.0 0.5 19.9 30.0 19.4 0.0 190.3 0.0 52.6 0.1 0.6 290.4 6.9 28.7 0.1 0.0 17.3 0.0 0.8 3.5 0.0 1.5 10.1 1.0 79.6 0.0 53.4 127.7 0.0 3.7 0.0 0.0 1.0 0.2 0.0 0.1 0.2 0.0 73.2 115.9 TMPRSS3 "DFNB10, DFNB8" ENSG00000160183 "Transmembrane serine protease 3" P57727 21 42371837-42396846 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.7" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 11.9;Cholangiocytes: 28.1;Ciliated cells: 17.4;Ductal cells: 14.4;Exocrine glandular cells: 12.6;Muller glia cells: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 6.3" "Lineage enriched" "Detected in single" 7 "T-cells: 6.3" "Group enriched" "Detected in some" 5 "HEL: 18.8;U-266/84: 75.2" "Region enriched" "Detected in single" 7 "cerebellum: 0.9" "Not detected" "Not detected" NA NA "unprognostic (8.47e-3)" "unprognostic (2.83e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.85e-1)" "unprognostic (2.45e-3)" "unprognostic (3.97e-2)" "unprognostic (1.43e-1)" "unprognostic (8.17e-2)" "unprognostic (9.62e-2)" "unprognostic (4.81e-2)" "unprognostic (2.65e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.66e-2)" "unprognostic (2.73e-1)" "unprognostic (8.00e-2)" "unprognostic (1.33e-1)" 1.8 0.7 8.6 0.3 7.7 0.3 9.4 0.3 7.1 6.8 0.4 0.0 0.0 1.7 0.9 0.4 0.4 24.7 8.6 0.2 1.8 1.6 3.5 3.5 3.7 0.6 3.7 2.0 2.8 7.4 0.2 5.8 5.7 3.3 0.8 0.4 2.4 12.3 0.6 0.3 0.6 1.3 0.2 0.2 0.6 15.9 0.2 0.8 0.0 9.8 0.2 0.6 1.9 0.0 0.0 0.1 0.7 0.8 0.0 6.3 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.0 18.8 7.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 4.1 0.0 0.4 1.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.4 0.0 0.0 9.8 0.4 0.0 0.0 0.9 0.1 0.0 0.0 0.5 0.0 0.0 0.2 75.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 6.3 0.0 3.5 3.6 0.1 0.0 0.7 1.8 0.7 0.0 0.8 0.0 1.6 1.0 8.6 7.7 0.3 7.1 1.8 1.6 3.7 2.0 3.3 0.8 11.9 3.0 0.0 1.9 0.2 0.1 0.6 28.1 17.4 3.4 7.0 0.0 0.0 5.0 14.4 1.3 0.0 1.3 0.0 12.6 0.1 0.1 1.9 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.3 0.1 0.0 0.0 0.7 23.8 7.9 0.6 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 1.3 0.4 3.9 TMPRSS4 "MT-SP2, TMPRSS3" ENSG00000137648 "Transmembrane serine protease 4" Q9NRS4 11 118077012-118121890 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9" "Cell type enhanced" "Detected in many" 18 "Enterocytes: 108.9;Paneth cells: 61.7;Undifferentiated cells: 54.6;Urothelial cells: 226.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 4.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.5" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.9;HaCaT: 16.2;OE19: 64.5;RPTEC TERT1: 26.6;RT4: 33.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006238 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006238: AB_1080316" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (1.19e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-2)" "unprognostic (5.50e-2)" "unprognostic (8.17e-3)" "unprognostic (1.95e-2)" "unprognostic (2.41e-1)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-2)" "unprognostic (9.96e-3)" 0.3 0.3 0.2 14.2 0.3 0.0 0.3 0.3 0.2 11.4 23.5 0.1 0.0 16.1 3.1 2.8 60.9 0.6 45.4 0.3 0.3 0.3 17.7 0.3 3.2 0.0 0.2 0.0 0.3 0.4 0.0 0.3 0.8 0.1 9.9 26.2 0.2 4.0 0.0 0.3 2.4 27.4 4.2 0.2 0.3 13.7 0.7 0.0 0.6 0.3 13.7 41.0 43.9 22.3 0.5 0.1 4.5 0.7 0.2 0.1 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 37.9 0.0 1.4 0.0 0.0 16.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 1.1 0.0 64.5 0.0 0.0 0.0 0.0 26.6 33.2 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.1 0.9 0.2 0.7 0.1 0.1 0.0 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.0 1.7 0.0 21.5 1.0 0.0 0.6 0.0 17.4 36.4 10.4 0.0 0.1 0.0 0.1 2.6 0.0 108.9 0.0 6.6 1.6 0.2 6.8 5.7 0.0 0.2 0.0 4.1 0.0 0.0 1.3 0.0 1.0 0.0 0.0 49.1 0.0 30.7 61.7 0.0 1.4 0.0 0.0 0.7 0.0 0.1 5.5 0.2 0.0 54.6 226.3 TMPRSS5 "MGC141886, MGC148044" ENSG00000166682 "Transmembrane serine protease 5" Q9H3S3 11 113687546-113706373 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 24.0;salivary gland: 15.0;skeletal muscle: 6.0" "Cell type enhanced" "Detected in some" 14 "Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Horizontal cells: 4.8;Muller glia cells: 3.4" "Cancer enhanced" "Detected in some" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.3;CAPAN-2: 7.1;WM-115: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010992 Approved Nucleoplasm NA NA Nucleoplasm "HPA010992: AB_1858152" "unprognostic (1.53e-2)" "unprognostic (3.81e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (2.99e-3)" "unprognostic (3.08e-1)" "unprognostic (5.19e-3)" "unprognostic (8.49e-2)" "unprognostic (8.13e-2)" "unprognostic (3.38e-2)" "unprognostic (1.96e-3)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (4.04e-3)" 2.1 1.7 10.8 1.0 24.0 3.2 2.2 2.1 14.8 1.2 1.0 21.6 0.0 1.0 1.2 0.9 1.8 1.1 2.2 1.2 11.5 5.7 0.9 0.9 0.9 1.1 11.6 12.7 1.4 1.2 0.6 1.5 1.2 16.5 1.2 1.3 0.9 15.0 1.4 6.0 2.7 0.7 1.2 16.9 1.1 2.4 2.3 8.8 0.0 1.1 0.4 1.3 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.8 4.3 2.5 0.5 0.4 0.6 1.2 0.5 0.6 0.9 2.5 7.1 0.3 3.2 0.5 0.8 0.8 0.3 0.4 0.3 0.4 1.3 1.0 0.6 0.0 0.3 1.0 0.8 0.6 0.6 0.5 1.2 0.5 0.8 1.7 0.8 0.5 0.9 0.0 0.8 1.2 0.5 4.3 0.2 0.9 0.5 0.0 0.7 0.4 0.6 1.0 0.5 0.1 3.5 0.6 0.5 0.5 0.5 0.9 1.7 0.6 0.7 0.5 0.2 0.1 0.4 0.9 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 24.0 2.1 12.3 11.5 5.7 11.6 12.7 16.5 8.8 0.0 0.0 0.0 0.2 0.2 0.5 0.4 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.4 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.1 TMPRSS6 FLJ30744 ENSG00000187045 "Transmembrane serine protease 6" Q8IU80 22 37065436-37109563 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 59.3" "Group enriched" "Detected in some" 14 "Early spermatids: 60.9;Hepatocytes: 67.0;Late spermatids: 87.3" "Group enriched" "Detected in many" 14 "liver cancer: 51.3;thyroid cancer: 14.1" "Region enriched" "Detected in single" 10 "basal ganglia: 1.8" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "Hep G2: 7.7;SCLC-21H: 13.2" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 2.2" NA NA "unprognostic (3.93e-1)" "unprognostic (3.28e-1)" "unprognostic (8.62e-2)" "unprognostic (6.29e-5)" "unprognostic (7.95e-2)" "unprognostic (1.62e-1)" "prognostic favorable (8.16e-6)" "unprognostic (2.44e-1)" "unprognostic (3.07e-1)" "unprognostic (2.41e-1)" "unprognostic (1.16e-2)" "unprognostic (3.58e-2)" "unprognostic (1.15e-7)" "unprognostic (2.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.39e-2)" "unprognostic (3.86e-5)" 0.1 0.0 0.1 0.1 1.8 0.0 0.8 0.1 0.1 0.1 0.3 0.1 0.1 1.1 0.1 0.4 0.1 0.2 0.4 0.1 0.1 0.0 0.1 59.3 1.9 0.1 0.1 0.1 0.5 0.9 0.0 5.3 0.6 0.1 0.2 0.2 0.1 0.1 0.1 0.1 1.1 0.6 0.1 0.1 0.1 2.3 2.6 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.0 0.1 0.0 1.3 0.0 0.2 0.8 0.2 0.4 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.9 2.3 0.3 0.1 7.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.1 0.6 0.0 1.3 0.0 0.0 0.3 0.2 0.1 0.5 0.2 0.3 0.0 0.0 13.2 0.4 0.2 1.0 0.0 0.2 0.1 0.0 0.6 0.5 1.6 0.1 0.0 1.6 0.4 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.8 0.5 0.2 1.3 0.1 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 60.9 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 67.0 0.1 0.0 5.1 2.5 2.9 87.3 0.3 0.0 0.0 0.0 1.0 0.0 0.3 1.5 0.4 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.2 0.0 0.6 0.0 TMPRSS7 ENSG00000176040 "Transmembrane serine protease 7" Q7RTY8 3 112034843-112081269 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.2;testis: 5.2" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 3.4;Ciliated cells: 10.7;Early spermatids: 3.3;Urothelial cells: 2.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 1.4;hTCEpi: 2.8;RT4: 1.3;U-266/70: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040630 Uncertain NA NA "HPA040630: AB_10796124" "unprognostic (4.02e-2)" "unprognostic (9.87e-2)" "unprognostic (9.05e-2)" "unprognostic (2.16e-2)" "unprognostic (2.24e-1)" "unprognostic (4.64e-3)" "unprognostic (6.63e-2)" "unprognostic (2.16e-1)" "unprognostic (2.29e-2)" "unprognostic (4.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.94e-1)" "unprognostic (7.23e-2)" "unprognostic (2.96e-1)" "unprognostic (2.06e-2)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.2 0.1 0.1 0.0 0.5 0.8 0.0 0.0 0.0 1.0 5.2 0.3 0.0 0.2 0.0 0.8 0.5 2.2 0.3 0.5 0.7 0.1 0.3 0.0 0.7 0.2 0.4 0.1 0.9 0.6 0.7 0.2 0.5 0.6 0.2 0.0 0.0 0.0 0.8 1.4 0.0 0.9 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.8 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.1 0.9 0.4 0.0 0.8 0.0 0.5 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 2.2 0.3 0.7 0.2 0.2 0.1 0.6 0.3 0.2 0.0 0.8 0.7 0.2 1.7 0.5 0.2 0.5 0.2 0.1 0.0 0.0 0.0 3.4 0.5 0.0 0.3 0.0 10.7 2.3 0.0 0.0 0.3 0.0 0.2 3.3 0.0 1.4 0.0 0.2 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.7 0.0 0.1 2.6 TMPRSS9 ENSG00000178297 "Transmembrane serine protease 9" Q7Z410 19 2389771-2426239 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 6.3;lymphoid tissue: 4.6;testis: 5.9" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 19.9;Erythroid cells: 23.3;Late spermatids: 37.0;Spermatocytes: 8.6" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "eosinophil: 2.4" "Lineage enhanced" "Detected in single" "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "Karpas-707: 6.3;SK-BR-3: 3.2;U-266/70: 5.5" "Region enhanced" "Detected in single" "basal ganglia: 0.5" "Low region specificity" "Detected in all" HPA051483 Uncertain NA NA "HPA051483: AB_2681501" "unprognostic (1.63e-1)" "unprognostic (1.94e-2)" "unprognostic (5.62e-3)" "unprognostic (1.86e-1)" "unprognostic (1.54e-2)" "unprognostic (1.87e-3)" "unprognostic (3.30e-1)" "unprognostic (6.44e-2)" "unprognostic (7.29e-2)" "unprognostic (2.07e-1)" "unprognostic (6.30e-2)" "unprognostic (9.20e-3)" "unprognostic (2.28e-3)" "unprognostic (8.67e-2)" "unprognostic (1.96e-1)" "unprognostic (3.07e-3)" "unprognostic (6.73e-2)" 0.1 1.1 0.9 0.4 0.2 2.0 1.3 0.0 0.2 0.0 0.4 0.3 0.4 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 6.3 0.0 0.1 0.0 0.2 1.2 0.0 0.2 0.1 0.1 0.0 0.5 0.0 1.5 1.8 0.4 0.0 0.0 4.6 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.9 2.4 0.0 0.0 0.0 0.1 1.7 0.3 0.2 0.6 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.6 0.6 0.4 0.6 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.8 0.2 2.2 2.3 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.6 1.0 6.3 0.0 1.2 0.2 0.4 0.5 0.1 0.8 1.1 0.0 0.9 0.0 0.3 0.1 0.2 0.2 3.2 0.1 0.3 0.4 1.6 0.4 1.1 0.8 1.1 0.7 5.5 1.3 1.5 0.2 0.9 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 23.3 0.0 0.1 0.3 0.0 0.0 2.4 0.2 0.0 0.0 1.3 0.0 37.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 2.7 0.0 0.5 0.0 0.0 0.0 TMTC1 "ARG99, FLJ31400, FLJ41625, OLF" ENSG00000133687 "Transmembrane and tetratricopeptide repeat containing 1" Q8IUR5 12 29500840-29784759 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 23.2;Endothelial cells: 46.9;Ito cells: 33.2;Sertoli cells: 45.3;Smooth muscle cells: 28.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 2.3" "Lineage enriched" "Detected in single" 5 "monocytes: 2.3" "Cell line enhanced" "Detected in many" "HHSteC: 29.2;HSkMC: 19.9;hTERT-HME1: 35.8;LHCN-M2: 19.9;RH-30: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016720 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA016720: AB_1858155" "unprognostic (1.67e-1)" "unprognostic (6.35e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.63e-3)" "unprognostic (4.53e-2)" "unprognostic (3.88e-2)" "unprognostic (8.36e-2)" "unprognostic (1.77e-1)" "unprognostic (8.90e-3)" "unprognostic (3.08e-3)" "unprognostic (1.21e-1)" "prognostic unfavorable (5.49e-4)" "unprognostic (5.89e-3)" "unprognostic (6.38e-2)" "unprognostic (2.90e-1)" "unprognostic (4.51e-3)" 29.3 12.8 12.9 4.6 30.8 0.5 25.8 2.2 9.0 11.4 8.4 2.9 4.3 3.0 7.4 2.9 6.1 12.6 6.2 15.7 15.2 8.1 13.1 2.4 6.7 2.4 5.4 7.8 8.7 2.9 10.0 18.7 2.7 9.1 6.4 5.4 7.1 3.7 8.3 13.7 2.9 4.6 12.7 4.9 34.1 7.4 2.8 6.2 0.8 3.7 4.4 2.0 8.9 10.5 0.1 0.1 0.4 2.3 0.1 0.1 0.3 0.0 0.0 5.2 0.0 16.6 11.2 0.0 5.4 11.1 1.4 1.2 0.0 0.0 0.0 2.7 3.4 6.1 0.0 0.1 0.1 0.0 0.1 1.6 0.0 15.7 0.2 29.2 0.7 0.0 19.9 1.9 13.8 35.8 4.2 0.8 0.0 0.0 0.7 19.9 0.0 0.0 0.0 4.0 0.0 7.2 0.0 41.8 0.7 0.0 0.1 0.4 0.4 0.6 0.0 1.3 2.0 0.0 0.2 2.2 1.3 0.8 0.7 4.3 7.3 0.0 0.0 9.5 0.0 0.1 0.2 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 2.3 0.1 0.0 0.3 12.9 30.8 2.2 7.6 15.2 8.1 5.4 7.8 9.1 6.2 3.0 1.1 0.0 1.0 3.0 7.1 23.2 0.0 1.4 0.0 3.5 0.0 0.0 0.0 0.0 6.5 46.9 0.0 0.0 0.0 0.0 7.5 2.4 0.0 4.9 0.5 0.0 0.0 33.2 14.6 4.8 7.5 2.4 10.1 0.0 0.0 0.4 0.0 0.0 17.3 0.6 1.2 45.3 28.9 0.5 0.4 1.8 1.6 0.0 0.0 0.1 TMTC2 DKFZp762A217 ENSG00000179104 "Transmembrane and tetratricopeptide repeat containing 2" Q8N394 12 82686880-83134870 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 30.2;Melanocytes: 30.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.1;myeloid DC: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 16.6;WM-115: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026954, HPA026955" Uncertain Approved "Plasma membrane,Actin filaments" No No "Plasma membrane" "Actin filaments" "HPA026954: AB_2256025, HPA026955: AB_10602282" "unprognostic (1.56e-1)" "unprognostic (5.62e-2)" "unprognostic (9.61e-2)" "unprognostic (7.38e-2)" "unprognostic (2.60e-2)" "unprognostic (3.66e-2)" "unprognostic (1.05e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (7.16e-2)" "unprognostic (1.73e-3)" "unprognostic (5.06e-2)" "prognostic favorable (2.84e-5)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (2.06e-2)" "unprognostic (8.06e-2)" 4.7 1.7 9.1 8.9 19.7 2.9 5.9 8.1 15.7 8.1 12.5 27.3 15.2 4.6 8.5 7.4 11.4 15.4 11.9 3.1 13.4 8.7 10.6 1.7 9.6 2.8 17.6 15.3 3.1 6.6 6.5 4.7 5.1 14.3 9.9 9.1 2.5 8.3 30.3 2.0 7.4 6.2 10.4 22.5 2.2 13.1 4.6 18.0 0.4 7.9 1.1 4.3 10.5 11.5 0.8 2.6 0.0 3.1 0.0 0.3 0.9 0.8 3.3 16.6 0.1 2.2 2.1 1.5 1.0 0.3 0.9 0.1 0.2 1.7 0.0 0.3 5.9 0.6 1.4 4.8 2.5 0.2 3.7 2.8 0.0 2.5 0.1 0.2 1.1 0.5 0.6 2.2 0.1 0.8 1.7 1.4 1.8 0.0 2.2 0.2 1.7 0.8 4.3 0.6 3.0 2.8 0.0 0.7 0.3 1.5 7.2 4.4 8.0 1.5 2.4 10.8 3.0 2.5 0.2 0.8 2.9 0.9 3.7 1.3 4.1 2.8 0.6 0.6 1.9 40.4 0.0 3.1 0.0 0.1 1.0 0.3 0.8 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 9.1 19.7 8.1 11.6 13.4 8.7 17.6 15.3 14.3 18.0 8.9 6.2 2.4 14.8 12.8 30.2 1.1 15.3 10.7 15.9 14.0 7.9 9.2 0.0 3.9 5.6 8.0 2.6 0.0 7.1 1.6 7.9 11.3 0.0 1.0 1.8 7.9 2.4 1.3 9.8 4.0 5.5 5.5 30.4 1.8 8.2 12.1 8.1 2.9 1.1 1.4 1.6 6.5 2.1 0.4 0.9 10.0 3.4 1.3 4.8 12.8 TMTC3 "FLJ90492, SMILE" ENSG00000139324 "Transmembrane and tetratricopeptide repeat containing 3" Q6ZXV5 12 88142296-88199887 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transferase "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038550 Approved NA NA "HPA038550: AB_10672715" "unprognostic (1.05e-1)" "unprognostic (6.16e-2)" "unprognostic (1.50e-2)" "unprognostic (1.18e-2)" "unprognostic (1.90e-1)" "unprognostic (5.28e-2)" "unprognostic (3.62e-3)" "unprognostic (1.71e-2)" "unprognostic (1.46e-1)" "unprognostic (4.44e-1)" "unprognostic (8.07e-3)" "unprognostic (2.56e-2)" "unprognostic (2.28e-1)" "unprognostic (5.37e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.68e-1)" 12.4 7.8 9.9 6.3 9.4 2.8 14.0 15.1 12.0 13.8 9.6 5.7 10.7 8.5 12.0 9.2 18.4 8.1 9.8 7.4 8.3 9.5 14.0 18.1 8.8 4.6 8.3 7.9 9.7 6.6 12.6 18.3 18.5 10.1 13.0 8.3 8.3 11.0 11.4 5.1 20.4 10.5 15.3 9.5 6.6 8.2 7.4 7.7 6.1 10.7 10.5 7.4 13.2 12.2 4.1 1.7 9.5 2.7 2.2 4.8 1.4 7.3 7.9 7.3 6.8 17.1 15.2 13.0 15.4 14.9 9.2 9.9 11.4 5.2 2.2 2.9 14.3 5.6 16.4 7.7 12.7 15.5 1.3 5.8 2.2 5.8 5.2 8.9 2.3 1.5 12.9 6.9 17.7 7.0 9.3 14.2 1.9 4.8 0.8 10.2 4.4 1.6 3.0 5.6 2.7 4.2 1.4 15.8 2.2 8.0 12.0 6.2 6.1 12.9 9.1 4.0 8.1 14.8 2.4 14.9 12.8 7.1 11.3 7.6 2.6 3.3 2.7 4.0 2.8 9.4 9.5 2.5 4.0 3.6 2.2 4.4 4.1 4.1 2.8 1.7 3.7 4.8 3.9 2.4 2.2 2.7 1.7 3.0 1.4 9.9 9.4 15.1 12.0 8.3 9.5 8.3 7.9 10.1 7.7 11.9 5.1 6.4 21.6 30.3 12.8 10.2 0.0 26.8 11.4 7.0 25.5 23.6 3.3 12.5 20.6 12.7 5.6 0.0 9.5 15.8 20.8 14.5 9.2 16.3 6.8 12.7 3.5 19.0 4.1 14.6 18.7 3.9 8.5 1.8 6.2 9.7 10.0 5.8 18.4 10.2 23.5 19.4 17.6 10.9 8.4 35.4 14.9 4.4 6.6 9.8 TMTC4 "FLJ14624, FLJ22153" ENSG00000125247 "Transmembrane and tetratricopeptide repeat containing 4" Q5T4D3 13 100603927-100675093 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.7" "Cell type enhanced" "Detected in many" 6 "Ito cells: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016489, HPA057056" Approved Approved Vesicles NA NA Vesicles "HPA016489: AB_1858157, HPA057056: " "unprognostic (1.49e-1)" "unprognostic (1.87e-1)" "unprognostic (8.34e-2)" "unprognostic (1.35e-1)" "unprognostic (2.43e-2)" "unprognostic (1.96e-1)" "unprognostic (1.50e-2)" "unprognostic (1.96e-1)" "unprognostic (1.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.99e-1)" "unprognostic (6.04e-2)" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" 4.1 4.4 11.4 4.4 13.7 1.9 5.7 10.6 21.8 6.6 7.0 45.7 8.3 8.5 8.7 7.5 4.8 13.2 4.9 3.2 16.9 8.7 11.5 9.8 3.5 3.6 16.9 10.0 5.3 12.8 7.5 3.3 4.0 29.6 7.9 7.6 4.6 6.9 5.6 9.4 6.5 7.3 6.0 25.2 3.9 7.9 9.7 11.3 4.2 7.2 3.9 4.6 7.7 4.3 2.4 6.4 0.2 3.3 1.3 4.4 1.4 5.0 4.3 22.2 11.7 2.9 6.0 24.9 2.9 2.5 2.7 2.2 4.3 9.3 15.0 9.6 2.4 5.2 3.6 6.9 3.0 3.3 8.5 4.9 6.3 8.0 6.7 3.1 8.2 0.1 8.4 5.9 1.0 5.0 7.6 12.1 8.2 4.7 1.9 3.2 4.4 5.9 4.7 6.0 14.8 4.2 6.5 3.9 3.3 11.2 3.9 11.4 11.9 5.5 10.8 2.8 14.0 7.9 23.2 18.9 2.4 4.2 2.2 4.9 5.0 4.1 2.9 11.9 5.4 7.1 0.0 2.0 0.2 2.7 2.1 2.4 2.0 2.6 4.4 6.4 2.4 3.0 1.1 0.0 1.3 3.3 4.2 3.8 1.4 11.4 13.7 10.6 21.8 16.9 8.7 16.9 10.0 29.6 11.3 6.0 3.8 4.6 6.6 2.7 17.6 9.0 17.8 6.7 6.8 5.2 7.9 9.1 1.7 9.8 4.1 4.6 7.9 0.0 16.4 15.9 5.7 9.1 0.0 12.4 3.8 25.4 10.3 52.2 8.7 4.7 3.7 4.1 3.3 0.0 11.2 9.6 12.0 7.0 6.3 12.4 7.5 6.5 4.2 8.8 31.8 5.1 2.6 2.6 12.6 4.7 TMUB1 "C7orf21, SB144" ENSG00000164897 "Transmembrane and ubiquitin like domain containing 1" Q9BVT8 7 151081080-151083546 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029429 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029429: AB_10601825" "unprognostic (8.14e-2)" "unprognostic (2.19e-2)" "unprognostic (2.76e-3)" "unprognostic (1.30e-1)" "unprognostic (7.23e-3)" "unprognostic (7.04e-2)" "unprognostic (2.12e-3)" "unprognostic (7.73e-2)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (1.74e-2)" "unprognostic (2.24e-1)" "unprognostic (1.97e-2)" "unprognostic (2.49e-3)" "unprognostic (2.74e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" 10.6 15.2 10.3 16.1 11.0 13.7 17.8 9.1 16.0 9.7 27.5 9.0 17.0 31.8 10.4 15.4 21.6 9.6 18.0 17.3 10.6 9.6 25.5 35.5 12.9 15.6 10.2 10.0 13.1 51.5 9.5 21.1 18.9 8.3 16.1 6.0 12.7 29.6 12.9 33.8 15.1 39.2 12.8 8.7 16.1 24.0 11.5 8.5 23.9 23.6 12.9 19.1 18.7 11.8 8.0 4.2 18.2 3.6 3.1 9.5 1.8 24.4 22.1 5.2 26.8 3.4 4.2 19.5 10.0 8.5 9.0 10.0 19.0 29.9 16.4 21.6 4.9 11.6 16.7 5.8 8.9 2.0 30.0 20.5 7.0 20.5 28.8 8.8 8.6 24.8 6.5 7.4 7.5 2.0 6.8 6.6 17.0 43.7 22.4 4.0 39.5 28.7 37.2 22.3 14.4 13.4 18.0 6.6 30.3 9.3 19.0 19.1 21.3 8.1 12.5 13.1 3.2 9.8 12.0 8.0 11.4 8.4 14.3 16.5 35.3 19.4 11.2 26.4 16.2 14.4 3.5 2.7 18.2 5.4 3.6 4.7 4.4 8.0 5.8 2.8 8.0 7.8 4.5 4.7 3.1 2.2 4.2 9.5 1.8 10.3 11.0 9.1 16.0 10.6 9.6 10.2 10.0 8.3 8.5 6.0 5.6 49.1 25.7 23.5 14.7 8.1 22.9 0.0 0.0 21.0 13.7 83.6 29.9 61.9 8.5 23.9 135.7 0.0 95.6 50.7 20.3 31.1 16.1 44.1 39.1 19.1 39.6 21.5 20.8 2.5 11.5 25.8 30.4 58.7 75.9 22.0 80.5 108.7 15.6 34.6 14.8 38.8 29.9 25.1 10.6 32.2 79.1 52.4 64.5 33.0 TMUB2 MGC3123 ENSG00000168591 "Transmembrane and ubiquitin like domain containing 2" Q71RG4 17 44186970-44191731 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043137 Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043137: AB_10794388" "unprognostic (4.57e-2)" "unprognostic (1.58e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-2)" "unprognostic (6.37e-2)" "unprognostic (1.85e-2)" "unprognostic (6.43e-3)" "unprognostic (1.07e-1)" "unprognostic (2.05e-1)" "unprognostic (3.35e-2)" "unprognostic (1.80e-1)" "unprognostic (1.58e-1)" "unprognostic (2.12e-1)" "unprognostic (9.75e-3)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "unprognostic (2.78e-3)" 22.5 27.0 21.2 22.6 26.7 39.9 37.6 32.4 39.0 27.3 24.0 25.9 30.5 25.2 27.4 26.4 31.0 24.2 26.6 21.2 21.2 20.4 28.9 29.4 22.9 24.7 19.9 23.1 27.9 33.5 30.7 25.2 38.9 21.0 30.3 23.6 23.3 30.7 34.1 22.9 29.0 29.6 23.4 18.8 40.0 25.8 46.0 19.6 21.1 34.6 20.9 23.1 26.0 25.0 10.0 10.2 29.9 13.3 5.5 8.1 8.2 11.4 22.6 14.4 13.4 22.8 18.1 11.3 15.2 16.5 28.4 29.0 11.7 21.5 8.0 16.5 18.8 21.6 21.9 10.1 14.4 17.9 19.5 21.0 8.3 20.5 17.8 23.6 9.3 18.7 21.9 21.1 19.3 12.1 24.1 19.8 13.4 9.5 23.9 18.5 8.1 12.9 12.5 4.8 9.8 19.1 11.7 17.5 12.8 17.9 13.0 11.6 11.8 7.9 7.5 15.0 15.6 22.0 12.0 16.3 23.7 14.6 16.6 13.5 17.6 12.8 7.7 18.2 7.9 15.9 29.9 13.3 24.1 8.1 11.7 6.8 7.7 6.7 7.7 8.5 10.0 6.5 7.3 29.3 5.5 11.7 10.2 7.6 8.2 21.2 26.7 32.4 39.0 21.2 20.4 19.9 23.1 21.0 19.6 32.8 32.9 37.3 18.6 11.6 29.4 15.3 20.4 16.0 23.9 21.0 29.5 39.5 3.3 17.1 42.2 20.1 33.5 0.0 16.3 24.5 18.8 21.2 20.9 10.4 35.9 20.6 32.1 20.3 30.1 22.0 20.1 27.2 13.5 27.1 22.9 27.2 20.1 34.5 22.6 6.8 25.9 25.8 17.9 60.2 26.6 13.0 80.9 25.4 23.4 20.9 TMX1 "PDIA11, TMX, TXNDC, TXNDC1" ENSG00000139921 "Thioredoxin related transmembrane protein 1" Q9H3N1 14 51240162-51257546 "Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003085 Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA 740000 "Endoplasmic reticulum" Nucleoli "HPA003085: AB_1080424" "unprognostic (1.83e-1)" "unprognostic (7.42e-2)" "unprognostic (6.97e-3)" "unprognostic (1.49e-2)" "unprognostic (2.63e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.29e-6)" "unprognostic (3.70e-2)" "unprognostic (1.51e-1)" "unprognostic (6.84e-2)" "unprognostic (2.44e-3)" "unprognostic (5.07e-2)" "unprognostic (9.30e-2)" "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (3.21e-3)" 21.8 24.2 13.6 18.5 18.3 15.5 19.7 14.1 12.3 14.4 20.7 17.2 27.0 17.7 17.5 19.2 25.0 13.3 15.0 11.3 13.5 11.9 24.9 29.2 20.0 25.3 22.6 9.2 15.5 23.9 18.4 19.0 21.9 16.3 14.2 21.2 13.3 21.0 27.9 12.5 16.7 23.4 17.0 24.9 29.1 18.1 12.9 17.9 37.5 23.5 17.6 17.4 20.2 19.9 9.4 17.0 9.6 17.5 12.6 12.5 13.3 13.7 12.7 17.7 9.5 14.1 11.1 19.0 17.4 14.1 17.6 22.6 12.9 25.4 19.7 16.3 11.6 8.3 13.6 31.2 11.4 32.1 19.8 10.7 14.4 11.1 12.6 12.3 33.0 14.6 13.3 10.5 11.8 8.7 12.7 15.5 16.3 11.8 13.6 16.7 17.0 14.7 17.8 20.1 21.5 16.0 15.6 32.0 11.9 17.0 18.0 11.2 8.3 13.9 9.3 12.4 12.2 13.6 14.7 10.0 18.6 17.3 13.1 15.8 12.0 12.0 16.2 8.2 18.8 17.4 9.6 15.4 7.2 10.2 17.5 12.5 9.4 10.9 10.5 16.2 7.4 10.8 12.0 5.7 12.6 12.6 17.0 12.1 13.3 13.6 18.3 14.1 12.3 13.5 11.9 22.6 9.2 16.3 17.9 35.7 23.2 35.8 51.8 96.5 10.8 6.7 48.4 37.5 36.4 33.2 11.8 67.4 8.3 51.3 2.1 45.4 23.8 0.0 59.1 119.6 52.3 42.1 41.7 33.6 66.6 9.5 16.7 39.3 52.2 3.1 23.0 71.7 52.3 61.3 31.4 24.3 42.4 52.6 26.9 27.4 31.6 58.2 50.9 43.2 74.1 85.1 48.3 58.6 44.9 56.5 TMX2 "PDIA12, TXNDC14" ENSG00000213593 "Thioredoxin related transmembrane protein 2" Q9Y320 11 57712600-57740973 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Lissencephaly, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040282, HPA063763" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA040282: AB_10697715, HPA063763: AB_2685116" "unprognostic (3.66e-3)" "unprognostic (6.96e-2)" "unprognostic (6.69e-3)" "unprognostic (2.73e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.64e-4)" "prognostic unfavorable (4.11e-4)" "unprognostic (4.48e-2)" "unprognostic (2.98e-1)" "unprognostic (7.26e-3)" "unprognostic (1.90e-2)" "unprognostic (2.22e-1)" "prognostic favorable (1.55e-5)" "unprognostic (5.88e-3)" "unprognostic (4.19e-2)" "unprognostic (3.40e-1)" "prognostic unfavorable (3.37e-4)" 29.5 40.5 33.6 21.0 39.0 13.7 30.8 26.5 60.5 28.0 40.6 50.7 29.0 33.3 22.5 36.7 32.7 25.5 20.0 33.0 32.6 32.1 47.4 71.7 24.4 22.1 40.4 30.4 25.9 40.6 49.8 25.8 26.2 45.3 31.1 49.3 38.4 27.9 34.4 21.9 21.9 34.0 26.1 42.3 25.4 29.9 19.1 31.3 24.0 34.4 25.8 27.0 22.2 22.6 17.7 23.1 17.9 37.5 16.5 21.8 18.8 28.5 33.5 19.3 34.7 36.0 19.3 21.1 34.5 26.8 34.0 28.9 31.8 49.2 26.8 38.6 27.7 50.6 52.8 48.8 27.6 36.1 19.2 21.2 25.9 27.1 31.8 29.7 36.1 35.7 23.6 40.4 37.6 60.0 18.7 19.3 22.6 44.4 31.7 37.9 14.6 21.3 41.2 37.3 53.3 46.0 29.0 24.2 56.7 42.3 32.3 22.1 31.6 26.6 61.9 38.3 19.6 55.3 23.9 16.1 32.1 21.0 42.7 35.6 31.2 60.8 27.1 36.1 25.7 47.5 15.9 19.6 17.9 17.1 33.1 21.6 17.7 17.3 20.0 19.0 15.3 21.8 21.8 5.2 16.5 37.5 23.1 14.3 18.8 33.6 39.0 26.5 60.5 32.6 32.1 40.4 30.4 45.3 31.3 35.7 30.6 38.1 36.3 28.5 43.9 38.7 40.8 34.8 34.2 47.1 29.5 94.9 36.5 67.4 1.6 34.9 38.2 0.0 37.5 68.8 35.4 39.2 42.7 45.2 57.0 28.6 27.6 33.7 27.3 1.9 45.1 35.0 45.5 31.5 45.0 90.9 45.2 35.1 41.1 38.0 52.4 38.8 26.2 56.1 68.8 28.5 83.3 22.4 61.2 41.0 TMX3 "FLJ20793, KIAA1830, PDIA13, TXNDC10" ENSG00000166479 "Thioredoxin related transmembrane protein 3" Q96JJ7 18 68673688-68715298 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014157 Uncertain "Intracellular and membrane" NA NA "HPA014157: AB_1858469" "unprognostic (2.11e-1)" "unprognostic (5.15e-2)" "unprognostic (2.14e-2)" "unprognostic (9.47e-2)" "unprognostic (6.82e-2)" "unprognostic (7.20e-2)" "unprognostic (4.96e-3)" "unprognostic (1.54e-1)" "unprognostic (3.21e-3)" "unprognostic (5.20e-2)" "unprognostic (9.83e-3)" "unprognostic (2.73e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (2.69e-2)" "unprognostic (1.53e-2)" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" 22.8 16.8 14.7 22.8 31.3 12.2 20.5 28.0 34.2 16.4 15.4 14.0 16.0 17.8 22.1 21.7 16.9 18.3 16.8 20.2 17.1 18.2 19.2 19.9 23.3 25.6 14.2 18.7 16.0 16.3 20.4 19.3 19.6 26.8 18.7 16.9 18.2 14.6 16.3 14.1 16.5 21.1 21.1 16.7 26.3 15.2 11.1 11.1 29.6 19.2 13.4 22.1 19.9 14.8 4.9 9.6 3.4 6.9 7.6 8.7 4.1 3.4 5.5 10.7 8.3 22.1 23.7 7.9 27.2 29.1 19.8 22.2 2.6 10.2 9.8 5.4 39.5 8.4 13.0 7.0 13.6 30.5 9.3 6.3 9.0 8.7 4.5 23.5 19.0 14.9 18.8 8.8 21.4 19.4 20.3 25.1 8.6 5.7 13.7 23.5 2.1 10.2 6.0 4.5 2.8 9.0 9.5 21.2 11.9 16.8 7.5 10.3 8.0 13.2 8.6 10.0 11.1 5.6 16.3 24.0 35.5 9.7 7.9 19.8 9.2 9.2 9.2 21.5 15.8 25.9 2.6 4.3 3.4 6.1 6.9 8.7 4.9 6.3 5.6 6.9 3.6 7.1 6.9 1.1 7.6 4.7 9.6 6.4 4.1 14.7 31.3 28.0 34.2 17.1 18.2 14.2 18.7 26.8 11.1 26.8 23.8 18.0 14.7 18.0 26.7 19.3 15.3 33.5 17.0 15.7 17.7 12.5 1.7 13.7 2.1 24.0 10.8 0.0 8.8 17.9 26.7 15.3 19.7 22.1 16.4 25.4 17.2 30.1 22.9 2.3 22.5 24.0 23.6 7.2 13.0 24.1 13.2 11.9 15.6 5.7 31.8 38.8 20.6 18.2 26.0 21.2 10.4 19.3 7.6 14.0 TMX4 "DJ971N18.2, KIAA1162, PDIA14, TXNDC13" ENSG00000125827 "Thioredoxin related transmembrane protein 4" Q9H1E5 20 7977348-8019829 "Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 607.5;Late spermatids: 1164.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000399, HPA015752" Enhanced Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA000399: AB_1858471, HPA015752: AB_1858470" "unprognostic (3.93e-2)" "unprognostic (5.96e-2)" "unprognostic (1.86e-2)" "unprognostic (1.18e-3)" "unprognostic (5.14e-2)" "unprognostic (8.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.22e-1)" "unprognostic (3.66e-1)" "unprognostic (2.96e-1)" "unprognostic (5.80e-3)" "unprognostic (3.16e-1)" "prognostic favorable (2.60e-5)" "unprognostic (1.34e-1)" "unprognostic (2.56e-1)" "unprognostic (1.55e-1)" "unprognostic (7.06e-2)" 11.2 24.6 15.4 10.6 20.8 15.7 12.2 19.9 30.5 27.5 17.6 11.7 34.2 8.0 18.0 21.6 10.0 18.6 13.3 35.0 15.5 30.9 18.5 17.3 11.6 14.7 15.6 16.2 23.0 11.0 23.9 40.9 7.6 21.8 16.7 8.2 14.7 24.2 31.4 21.7 6.5 10.2 19.2 10.7 9.9 13.7 48.2 7.2 8.5 16.3 8.8 8.7 14.8 11.2 10.1 9.9 51.2 8.0 11.5 17.8 13.5 4.2 6.4 6.4 7.2 14.3 15.9 1.9 11.1 15.4 7.1 5.1 4.3 10.7 11.5 8.8 11.1 10.4 3.9 4.6 6.8 7.4 5.8 5.1 5.7 2.8 7.0 13.5 21.0 8.5 9.6 8.7 6.1 14.4 17.1 8.1 8.7 7.0 29.6 7.8 2.9 0.6 13.2 5.1 6.5 7.1 6.6 22.9 12.0 10.1 2.5 12.8 15.7 18.4 0.8 10.9 4.2 7.8 10.3 10.7 19.1 5.3 7.1 10.8 29.9 8.3 23.1 9.2 10.5 13.3 22.6 8.0 23.3 12.2 4.7 12.0 10.1 12.5 17.8 9.9 8.1 7.6 10.2 51.2 11.5 5.0 3.3 15.9 13.5 15.4 20.8 19.9 30.5 15.5 30.9 15.6 16.2 21.8 7.2 32.8 26.9 44.7 51.6 14.5 52.6 198.1 50.9 28.1 23.9 55.8 55.0 16.8 18.3 23.8 607.5 41.3 21.6 0.0 28.7 5.3 46.6 47.3 59.9 47.0 23.0 87.4 53.6 33.7 36.0 1164.8 71.4 37.5 43.9 7.2 21.4 79.0 22.5 19.8 52.6 20.7 90.7 32.3 28.1 158.4 45.1 13.7 6.9 66.0 23.9 26.3 TNC "DFNA56, HXB, MGC167029, TN" ENSG00000041982 "Tenascin C" P24821 9 115019578-115118257 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 111.4" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 47.4;Basal glandular cells: 45.4;Smooth muscle cells: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 85.5;hTEC/SVTERT24-B: 69.9;U-138 MG: 58.8;U-251 MG: 51.6;U-87 MG: 78.4;WM-115: 134.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004592, HPA004823" Approved "Secreted to extracellular matrix" NA NA 560000000 760000000 "CAB004592: AB_628342, HPA004823: AB_1080243" "unprognostic (5.46e-2)" "unprognostic (3.76e-2)" "unprognostic (7.57e-2)" "unprognostic (1.69e-1)" "unprognostic (9.20e-2)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (9.68e-2)" "unprognostic (7.86e-3)" "unprognostic (2.68e-3)" "unprognostic (1.59e-2)" "unprognostic (1.82e-1)" "unprognostic (4.87e-3)" "unprognostic (1.79e-2)" "unprognostic (1.92e-2)" "unprognostic (7.60e-2)" "unprognostic (1.97e-3)" 20.6 2.5 1.4 50.9 11.4 0.5 12.6 0.4 6.4 19.4 63.6 18.6 24.1 5.3 42.4 23.9 18.5 12.0 16.9 13.6 3.4 2.8 16.4 2.6 21.0 66.3 4.3 3.3 10.6 1.8 0.6 3.3 3.2 14.7 13.0 9.3 0.0 8.5 10.8 10.8 10.3 21.2 111.4 5.7 26.9 31.3 5.4 6.8 4.7 5.5 15.4 16.1 20.4 6.6 0.3 0.3 1.9 0.3 0.2 0.3 0.1 2.5 0.6 0.7 0.1 4.2 1.1 0.0 22.0 85.5 46.6 23.0 0.5 6.0 0.0 3.4 31.0 0.7 9.2 0.0 1.3 28.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.4 0.6 0.1 69.9 32.5 4.8 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 7.2 0.1 9.4 0.0 49.4 0.0 42.4 0.0 0.0 0.6 9.2 0.0 2.2 16.9 0.0 0.1 0.0 58.8 9.7 10.1 51.6 1.6 0.0 0.0 78.4 0.0 134.1 0.1 0.3 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.3 0.3 0.1 0.2 1.9 0.2 0.0 0.2 0.0 0.1 1.4 11.4 0.4 3.9 3.4 2.8 4.3 3.3 14.7 6.8 11.9 47.4 0.0 45.4 10.8 0.0 1.1 0.0 1.4 14.8 1.8 0.0 0.7 0.0 19.5 15.8 5.4 0.0 0.0 4.1 0.2 24.2 6.4 2.3 0.0 1.0 0.0 0.0 3.7 0.6 12.7 3.1 2.6 5.0 0.0 0.0 0.5 3.4 0.0 0.4 0.1 0.2 0.0 91.7 0.4 0.2 4.0 0.8 0.7 0.0 5.1 TNF "DIF, TNF-alpha, TNFA, TNFSF2" ENSG00000232810 "Tumor necrosis factor" P01375 6 31575567-31578336 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.6;lymphoid tissue: 28.0" "Cell type enhanced" "Detected in many" 10 "Hofbauer cells: 32.8;Macrophages: 42.1;T-cells: 34.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "non-classical monocyte: 10.8" "Group enriched" "Detected in many" 5 "granulocytes: 3.5;monocytes: 10.8;T-cells: 6.6" "Group enriched" "Detected in some" 5 "HDLM-2: 10.2;HMC-1: 9.8;NB-4: 29.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB078469 Supported "Secreted to blood" NA NA 10100 "CAB078469: AB_908070" "unprognostic (1.93e-1)" "unprognostic (1.07e-2)" "unprognostic (3.85e-2)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (2.19e-2)" "unprognostic (1.67e-1)" "unprognostic (3.46e-1)" "unprognostic (1.19e-2)" "unprognostic (1.94e-1)" "unprognostic (3.07e-2)" "unprognostic (1.38e-1)" "unprognostic (1.46e-2)" "unprognostic (1.82e-1)" "unprognostic (9.85e-3)" "unprognostic (1.09e-1)" "unprognostic (2.04e-1)" 2.3 1.2 0.6 15.6 1.0 14.6 1.2 0.4 1.8 1.7 1.3 3.7 0.3 1.3 1.1 0.4 1.5 0.9 2.3 2.0 0.5 0.3 2.6 1.9 9.5 8.0 0.8 0.0 0.6 0.7 0.5 0.5 3.2 2.0 0.7 0.7 0.4 2.2 0.8 0.4 2.7 4.1 0.7 1.0 28.0 1.0 0.4 0.5 2.1 0.6 5.3 14.7 1.2 0.4 1.3 1.2 3.5 10.8 0.5 6.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 10.2 0.0 1.9 0.0 0.0 0.0 0.8 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.0 1.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 4.1 6.5 6.6 1.3 3.1 2.4 1.2 1.3 0.9 1.0 3.5 0.5 10.8 0.7 2.2 2.1 0.6 1.0 0.4 1.8 0.5 0.3 0.8 0.0 2.0 0.5 0.0 4.0 13.4 0.2 7.4 0.1 2.0 5.1 1.4 2.3 0.0 2.0 0.3 0.0 6.7 0.1 2.8 0.0 0.0 2.9 1.5 2.1 0.9 11.6 0.0 32.8 0.0 0.0 1.3 8.7 0.0 0.3 42.1 5.0 1.0 0.1 0.1 10.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 3.6 0.9 34.1 0.0 0.3 TNFRSF10A "Apo2, CD261, DR4, TRAILR-1, TRAILR1" ENSG00000104689 "TNF receptor superfamily member 10a" O00220 8 23190452-23225126 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 24.0;Urothelial cells: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA050958, HPA054475" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050958: AB_2681290, HPA054475: AB_2682500" "unprognostic (3.66e-1)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (4.89e-2)" "unprognostic (9.44e-2)" "unprognostic (8.39e-2)" "unprognostic (5.32e-2)" "unprognostic (2.18e-2)" "unprognostic (2.72e-1)" "unprognostic (4.48e-2)" "prognostic unfavorable (1.00e-4)" "unprognostic (1.49e-1)" "unprognostic (1.99e-3)" "unprognostic (1.91e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-1)" "unprognostic (2.87e-1)" 11.9 4.0 2.1 13.0 3.4 8.4 9.7 2.0 2.8 6.0 10.9 1.4 4.5 5.9 5.3 5.6 13.6 4.1 12.7 6.3 2.2 2.0 10.9 10.6 11.0 12.4 3.0 0.7 2.7 12.9 3.6 1.8 6.9 4.0 5.1 7.2 2.1 8.2 4.3 3.8 7.1 10.2 3.8 2.9 13.2 6.1 2.6 3.0 9.5 5.8 14.9 25.4 6.7 8.7 13.2 4.5 3.8 4.3 3.9 13.9 4.2 8.0 14.5 0.7 0.0 0.5 3.0 0.0 1.6 1.0 0.8 2.4 11.2 14.2 18.6 19.0 1.0 4.1 15.3 13.1 20.8 1.4 4.6 0.1 9.8 8.8 6.3 7.5 5.2 9.4 5.0 17.2 18.5 16.0 2.5 9.8 0.6 15.1 6.7 3.9 6.3 0.2 3.3 10.1 14.3 8.9 0.1 0.0 13.4 11.1 17.4 0.4 0.5 4.1 10.3 0.0 3.2 5.5 4.0 13.8 0.0 0.1 0.8 0.0 7.9 11.1 14.4 0.1 1.7 0.2 2.0 4.3 3.8 3.8 1.9 10.3 10.4 12.3 7.7 4.5 13.2 12.1 7.0 0.5 3.9 1.7 0.0 13.9 4.2 2.1 3.4 2.0 2.8 2.2 2.0 3.0 0.7 4.0 3.0 3.0 8.3 6.4 16.2 20.9 0.1 0.8 12.7 6.7 19.4 10.4 0.0 0.1 0.0 9.2 0.0 11.8 6.2 0.0 3.5 0.4 1.3 10.0 7.0 4.0 3.0 0.0 2.4 1.3 2.1 0.0 0.0 7.1 3.3 1.8 6.0 0.0 14.3 7.4 0.0 2.4 0.0 0.0 1.1 0.0 0.2 24.0 0.0 2.9 6.3 27.1 TNFRSF10B "CD262, DR5, KILLER, TRAIL-R2, TRAILR2, TRICK2A, TRICKB" ENSG00000120889 "TNF receptor superfamily member 10b" O14763 8 23020133-23069179 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA023625 Approved NA NA "HPA023625: AB_1847860" "unprognostic (8.43e-3)" "unprognostic (7.43e-3)" "unprognostic (3.04e-2)" "unprognostic (4.94e-3)" "unprognostic (1.13e-1)" "unprognostic (7.74e-2)" "unprognostic (2.15e-1)" "unprognostic (9.51e-3)" "unprognostic (2.70e-1)" "unprognostic (2.82e-2)" "unprognostic (2.30e-3)" "unprognostic (1.96e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (4.01e-2)" "unprognostic (1.03e-1)" "unprognostic (1.86e-1)" "unprognostic (5.52e-2)" 29.6 18.5 5.2 16.4 7.3 7.6 19.6 2.3 5.8 11.5 23.1 7.5 13.3 14.1 10.4 13.9 12.1 11.4 22.1 13.2 6.4 3.2 14.3 36.1 21.3 11.6 7.9 2.6 16.2 20.0 14.8 6.1 8.5 8.2 15.1 14.3 7.9 11.5 14.5 15.5 6.1 31.2 10.5 8.6 17.4 11.2 7.8 6.4 4.1 17.7 13.0 15.2 17.9 9.9 3.1 12.1 2.8 12.9 0.8 4.0 5.2 8.6 22.9 33.6 10.3 15.8 20.6 33.0 20.9 26.8 11.3 17.7 9.5 8.7 5.1 14.2 11.3 21.1 8.4 8.8 39.4 20.3 5.1 7.4 0.0 9.0 17.8 52.9 1.9 8.7 30.7 35.4 25.2 26.9 29.0 35.9 6.4 3.6 0.0 22.3 2.8 0.2 2.8 8.4 11.1 8.3 4.6 12.2 3.2 22.0 13.6 0.0 5.7 10.4 3.0 11.1 23.6 5.1 2.5 31.8 16.6 8.6 5.2 15.0 6.7 1.1 2.4 16.9 3.8 23.7 2.8 12.9 0.4 1.6 9.3 2.7 3.1 1.9 1.6 12.1 1.6 4.0 1.6 2.6 0.8 11.9 0.0 1.3 5.2 5.2 7.3 2.3 5.8 6.4 3.2 7.9 2.6 8.2 6.4 11.9 35.2 11.9 24.4 28.0 0.4 3.6 12.7 5.3 17.0 12.2 0.0 3.4 3.3 25.5 0.2 30.1 34.4 0.0 23.0 7.4 22.8 23.9 9.2 23.1 8.8 0.0 0.0 15.4 20.8 1.5 6.6 18.8 18.6 2.8 15.3 3.9 37.2 19.3 6.3 8.2 0.4 0.0 18.9 0.2 2.0 15.8 3.5 6.9 19.1 42.3 TNFRSF10C "CD263, DcR1, LIT, TRAILR3, TRID" ENSG00000173535 "TNF receptor superfamily member 10c" O14798 8 23102590-23117437 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "blood: 173.4" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 9.3;Cholangiocytes: 5.1;granulocytes: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "neutrophil: 173.4" "Lineage enriched" "Detected in many" 113 "granulocytes: 173.4" "Group enriched" "Detected in some" 5 "BEWO: 37.9;HUVEC TERT2: 31.6" CAB025635 Enhanced NA NA 14600000 "CAB025635: " "unprognostic (2.63e-1)" "unprognostic (4.49e-3)" "unprognostic (7.21e-3)" "unprognostic (2.07e-2)" "unprognostic (3.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.81e-2)" "unprognostic (2.11e-3)" "unprognostic (5.56e-2)" "unprognostic (4.37e-2)" "unprognostic (8.98e-2)" "unprognostic (1.94e-3)" "unprognostic (2.74e-3)" "unprognostic (4.83e-1)" "unprognostic (1.84e-1)" "unprognostic (1.34e-3)" "unprognostic (6.54e-2)" 5.5 1.5 1.9 14.0 3.6 12.6 2.0 1.4 3.9 2.9 1.5 0.7 0.1 1.2 1.5 1.2 1.4 3.7 13.5 5.6 1.9 1.1 2.8 3.2 13.7 28.4 9.2 0.0 2.4 2.1 2.5 4.5 12.8 3.1 2.7 1.8 1.7 1.7 0.8 2.3 0.8 2.2 1.9 4.4 26.4 1.8 1.4 2.3 0.8 4.4 0.5 0.9 5.2 1.9 0.0 0.3 173.4 1.5 0.0 0.0 0.4 0.4 1.4 0.5 2.4 0.0 0.4 37.9 1.6 0.0 0.1 0.2 0.0 1.4 0.1 0.8 1.4 0.1 0.2 0.1 0.1 0.1 2.6 0.5 0.1 0.3 1.1 3.7 0.2 1.0 4.2 0.3 0.7 0.3 0.6 31.6 0.0 0.0 0.0 0.2 1.0 0.0 0.9 1.6 0.3 0.1 0.1 0.1 0.0 6.1 0.1 0.0 0.1 0.1 0.2 0.7 2.9 5.2 0.2 6.7 0.6 1.2 1.5 0.1 1.6 0.9 0.0 2.3 0.3 0.9 2.7 1.5 25.4 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 173.4 0.0 1.1 0.0 0.0 0.4 1.9 3.6 1.4 3.9 1.9 1.1 9.2 0.0 3.1 2.3 6.0 9.3 0.0 0.5 0.2 0.0 0.3 5.1 1.4 3.4 3.5 0.0 0.8 0.0 0.3 0.8 3.6 0.4 0.0 0.4 0.7 0.3 0.4 8.1 0.0 2.1 0.0 1.7 1.8 1.5 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.9 0.1 0.9 0.0 0.0 0.3 TNFRSF10D "CD264, DcR2, TRAILR4, TRUNDD" ENSG00000173530 "TNF receptor superfamily member 10d" Q9UBN6 8 23135588-23164030 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 24.5;LHCN-M2: 61.9;WM-115: 58.8" HPA070971 Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA070971: AB_2686330" "unprognostic (1.49e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.41e-1)" "unprognostic (8.78e-2)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (2.69e-1)" "unprognostic (7.06e-2)" "unprognostic (3.56e-2)" "unprognostic (1.66e-1)" "unprognostic (1.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.12e-2)" "unprognostic (2.70e-1)" "unprognostic (1.35e-2)" "unprognostic (6.32e-2)" "unprognostic (1.72e-1)" 16.0 3.1 4.9 7.3 10.0 10.5 10.2 3.4 10.3 5.9 8.5 2.6 5.5 6.2 8.9 5.7 4.1 8.0 11.5 6.5 7.0 3.4 12.1 31.5 12.5 5.1 9.0 0.9 9.8 5.2 2.5 4.3 4.1 9.0 9.0 10.9 3.9 3.9 4.4 3.9 3.1 11.2 10.9 6.3 6.9 7.2 4.3 9.2 2.9 6.0 6.8 6.6 7.3 26.0 2.1 4.5 2.4 3.3 0.3 9.0 2.4 3.5 3.1 4.0 2.3 3.1 12.3 0.0 19.2 7.3 1.4 2.0 5.9 3.0 0.0 4.0 11.4 0.0 1.2 3.3 16.8 12.7 0.0 3.0 1.0 1.8 5.0 13.5 0.6 1.3 15.4 18.8 5.1 3.5 18.0 24.5 0.1 0.0 0.0 61.9 0.0 0.0 1.9 3.2 10.6 0.0 0.7 0.0 0.9 4.7 1.6 0.0 0.0 2.0 0.0 0.0 9.5 0.0 2.4 14.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.0 0.9 58.8 2.4 3.3 1.5 0.0 1.4 0.1 2.1 3.2 1.1 4.5 0.8 9.0 3.5 2.2 0.3 1.9 0.0 1.0 2.4 4.9 10.0 3.4 10.3 7.0 3.4 9.0 0.9 9.0 9.2 0.0 12.7 0.5 3.2 4.4 0.0 1.4 2.5 5.3 5.7 1.8 0.0 0.1 0.0 5.7 0.4 31.4 5.9 0.0 1.8 0.2 2.5 4.7 7.0 6.6 2.6 0.0 1.7 11.6 9.8 0.0 0.3 3.6 8.5 1.0 4.8 0.3 8.4 2.9 0.4 2.1 0.0 0.0 11.7 0.7 2.7 2.0 0.1 1.3 6.3 3.3 TNFRSF11A "CD265, FEO, LOH18CR1, PDB2, RANK" ENSG00000141655 "TNF receptor superfamily member 11a" Q9Y6Q6 18 62325287-62391292 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 28.7;intestine: 23.9;salivary gland: 34.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 21.1;monocytes: 34.3;Mucus-secreting cells: 23.6;Paneth cells: 28.1;Undifferentiated cells: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "NK-cell: 8.9" "Lineage enriched" "Detected in many" 8 "NK-cells: 8.9" "Cell line enriched" "Detected in some" 6 "HDLM-2: 52.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010391, HPA047976" Approved Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" Cytosol "CAB010391: AB_2205352, HPA047976: AB_2680227" "unprognostic (4.08e-1)" "unprognostic (2.71e-1)" "unprognostic (3.23e-3)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "unprognostic (1.35e-1)" "unprognostic (9.96e-4)" "unprognostic (4.24e-3)" "unprognostic (7.79e-4)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (2.88e-1)" "unprognostic (4.69e-5)" "unprognostic (1.56e-1)" "unprognostic (1.78e-1)" "unprognostic (4.02e-2)" "unprognostic (7.07e-2)" 6.5 1.7 1.7 4.8 1.2 0.2 4.3 0.4 2.3 1.5 18.4 0.8 7.6 23.1 0.9 1.9 3.8 1.3 28.7 1.1 1.3 0.7 0.9 0.8 2.3 7.4 1.0 1.0 0.7 2.9 0.1 10.1 2.8 0.7 2.1 13.9 1.3 34.3 12.9 0.6 3.3 23.9 1.3 2.9 1.2 4.3 1.2 0.8 0.7 2.0 1.8 2.3 2.3 2.3 0.0 0.6 0.2 0.0 8.9 1.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.0 1.5 0.1 0.6 0.9 3.5 0.3 0.1 52.5 2.3 0.0 0.5 0.7 0.0 0.2 0.5 0.1 0.1 0.3 1.3 1.8 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.5 2.9 8.3 0.1 0.0 0.2 0.6 0.6 8.9 0.3 0.2 1.3 0.0 0.3 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 8.9 0.0 0.6 1.0 0.0 1.7 1.2 0.4 2.3 1.3 0.7 1.0 1.0 0.7 0.8 0.0 2.1 0.0 2.9 1.1 0.4 1.1 10.2 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.2 2.2 21.1 0.0 6.5 0.6 0.3 2.6 0.0 0.0 12.8 3.2 10.4 3.7 15.0 0.0 0.6 2.5 1.7 34.3 23.6 0.0 9.6 28.1 0.0 0.0 0.0 0.0 0.3 0.7 1.4 1.9 0.1 0.0 33.6 3.8 TNFRSF12A "CD266, FN14, TweakR" ENSG00000006327 "TNF receptor superfamily member 12A" Q9NP84 16 3018445-3022383 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 1094.9;Ductal cells: 954.3;Exocrine glandular cells: 607.7;Pancreatic endocrine cells: 874.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 25.0" "Group enriched" "Detected in many" 8 "eosinophil: 38.1;neutrophil: 29.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 38.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA007853 Approved Approved "Plasma membrane,Cytosol" NA Yes 170000 "Plasma membrane, Cytosol" "HPA007853: AB_1858463" "unprognostic (1.44e-1)" "unprognostic (2.46e-3)" "unprognostic (8.90e-2)" "unprognostic (2.60e-1)" "unprognostic (4.06e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.04e-3)" "unprognostic (1.98e-3)" "unprognostic (4.17e-3)" "unprognostic (2.85e-1)" "unprognostic (5.02e-3)" "unprognostic (3.88e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.98e-2)" "unprognostic (6.00e-2)" "unprognostic (2.80e-3)" "unprognostic (2.17e-2)" 10.8 14.2 2.4 11.3 5.1 2.7 21.2 0.9 3.0 8.0 18.9 3.2 4.1 14.5 11.6 10.2 10.7 6.4 28.1 27.0 5.0 2.6 50.4 36.2 23.0 2.6 4.8 0.5 6.4 47.0 51.1 20.0 81.3 25.0 11.1 1.9 2.8 17.3 6.9 23.3 5.0 31.0 16.8 4.3 3.9 13.2 5.3 3.3 1.2 11.5 11.5 4.7 14.8 5.2 0.0 4.1 38.1 3.5 2.0 2.4 1.1 24.5 19.9 2.2 4.1 4.1 9.3 13.2 51.8 37.5 44.4 28.6 8.6 43.9 0.1 68.6 34.4 51.6 27.2 0.5 37.9 17.0 0.9 1.3 0.1 6.7 7.2 28.0 0.4 1.8 8.6 26.3 46.6 55.9 38.3 12.8 0.0 2.7 0.3 46.7 46.5 0.0 3.3 10.7 11.0 43.8 0.2 24.9 1.0 44.9 4.9 2.5 0.9 36.9 17.2 30.5 7.7 9.0 0.7 22.5 80.0 36.9 52.9 84.9 0.8 0.3 0.3 25.0 2.3 62.8 3.5 3.5 38.1 1.8 2.0 2.4 0.0 0.8 1.5 4.1 0.0 0.4 0.8 29.9 2.0 1.3 0.1 1.0 1.1 2.4 5.1 0.9 3.0 5.0 2.6 4.8 0.5 25.0 3.3 95.3 43.1 5.0 1094.9 544.0 0.9 57.7 163.1 50.9 130.8 172.7 2.0 112.5 54.7 954.3 0.6 22.7 41.3 0.0 607.7 131.7 179.4 600.3 58.8 15.3 38.1 0.0 26.1 28.8 4.6 0.4 5.8 29.4 106.3 16.2 4.6 20.6 874.5 25.8 6.3 93.5 5.1 6.5 212.1 7.7 4.1 314.4 158.1 8.6 12.4 560.0 TNFRSF13B "CD267, IGAD2, TACI" ENSG00000240505 "TNF receptor superfamily member 13B" O14836 17 16929816-16972118 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 45.1;lymphoid tissue: 44.6;skeletal muscle: 30.5" "Group enriched" "Detected in some" 31 "B-cells: 83.4;Melanocytes: 30.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 42 "memory B-cell: 45.1;naive B-cell: 13.1" "Lineage enriched" "Detected in single" 65 "B-cells: 45.1" "Group enriched" "Detected in some" 8 "Karpas-707: 55.9;RPMI-8226: 35.1;U-266/70: 24.8" "Low region specificity" "Detected in all" HPA030453 Uncertain NA NA "HPA030453: AB_10601700" "unprognostic (3.94e-5)" "unprognostic (1.11e-3)" "unprognostic (4.88e-2)" "unprognostic (4.30e-3)" "unprognostic (1.23e-4)" "unprognostic (2.16e-1)" "unprognostic (1.62e-3)" "unprognostic (1.47e-2)" "unprognostic (1.61e-4)" "unprognostic (2.22e-1)" "unprognostic (9.78e-2)" "unprognostic (1.59e-5)" "unprognostic (1.20e-1)" "unprognostic (4.49e-1)" "unprognostic (1.39e-1)" "unprognostic (2.05e-1)" 0.5 0.3 0.4 17.6 0.3 0.2 0.5 0.2 0.3 0.7 3.0 0.1 0.0 1.9 0.3 0.0 2.7 0.5 0.5 2.5 0.3 0.3 0.6 0.5 1.2 12.5 0.3 0.2 0.3 0.3 0.0 0.3 0.0 0.1 0.9 1.2 0.6 9.0 1.1 30.5 0.3 14.8 0.0 0.4 44.6 2.4 0.3 0.1 0.9 0.6 0.9 37.8 2.3 0.4 45.1 0.0 0.1 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.0 13.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.1 0.1 0.0 0.0 83.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 TNFRSF13C "BAFFR, CD268" ENSG00000159958 "TNF receptor superfamily member 13C" Q96RJ3 22 41922023-41926818 "CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 20.3;intestine: 18.9;lymphoid tissue: 69.1" "Cell type enriched" "Detected in some" 13 "B-cells: 100.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 51 "memory B-cell: 14.5;naive B-cell: 20.3" "Lineage enriched" "Detected in single" 59 "B-cells: 20.3" "Group enriched" "Detected in some" 6 "REH: 20.4;U-698: 11.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA003246, CAB008380" Enhanced NA NA "CAB008380: AB_590602, HPA003246: AB_1078264" "unprognostic (3.43e-4)" "prognostic favorable (4.44e-7)" "unprognostic (6.52e-2)" "unprognostic (9.10e-2)" "unprognostic (7.64e-3)" "unprognostic (4.83e-3)" "unprognostic (2.89e-2)" "unprognostic (3.78e-3)" "unprognostic (1.95e-1)" "unprognostic (1.27e-1)" "unprognostic (2.51e-2)" "unprognostic (1.66e-1)" "unprognostic (4.79e-8)" "unprognostic (2.21e-1)" "unprognostic (1.89e-1)" "unprognostic (1.77e-1)" "unprognostic (9.44e-2)" 0.9 0.8 0.8 41.0 1.0 3.3 0.6 1.0 2.0 0.5 1.2 4.4 0.0 0.7 0.4 0.2 5.0 0.5 0.6 0.6 0.8 0.9 0.9 0.5 1.8 48.4 1.0 0.6 0.4 0.4 0.0 0.4 0.1 1.8 0.6 0.7 0.5 5.8 0.0 1.2 2.0 18.9 0.1 1.1 69.1 1.4 0.7 0.6 2.0 0.8 0.3 51.4 9.5 0.7 20.3 0.2 0.3 0.2 0.2 0.2 0.5 0.3 0.2 1.1 2.3 0.0 0.0 0.5 0.1 0.1 0.2 0.8 0.9 0.5 1.8 0.4 0.2 0.2 0.4 0.7 0.0 0.3 0.4 2.2 0.2 0.3 0.3 0.1 1.6 0.4 0.1 0.0 0.4 0.1 0.1 0.0 0.7 0.4 1.9 0.2 0.7 1.5 1.8 0.8 0.2 0.1 20.4 2.4 1.5 0.0 0.2 1.3 0.3 0.1 0.4 0.3 0.2 0.4 2.2 0.2 0.5 2.6 1.0 0.3 2.1 1.0 11.0 0.1 1.7 0.5 0.3 0.1 0.1 0.1 0.1 0.2 14.5 0.2 0.1 0.0 20.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.5 0.8 1.0 1.0 2.0 0.8 0.9 1.0 0.6 1.8 0.6 0.0 1.4 100.8 0.4 0.1 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 7.9 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.9 0.0 0.1 0.0 0.4 0.1 TNFRSF14 "ATAR, CD270, HVEA, HVEM, LIGHTR, TR2" ENSG00000157873 "TNF receptor superfamily member 14" Q92956 1 2555639-2565382 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.6;HDLM-2: 14.8;HHSteC: 17.3;Karpas-707: 13.6;SK-MEL-30: 28.5" "HPA006404, CAB026150, CAB030007" Approved NA NA "CAB026150: , CAB030007: AB_2303380, HPA006404: AB_1851348" "prognostic favorable (4.39e-5)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "prognostic favorable (8.01e-6)" "unprognostic (1.11e-2)" "unprognostic (6.83e-3)" "unprognostic (9.62e-3)" "unprognostic (2.32e-1)" "unprognostic (3.25e-1)" "unprognostic (1.62e-1)" "unprognostic (2.31e-1)" "unprognostic (1.64e-1)" "unprognostic (1.86e-2)" "unprognostic (1.16e-2)" "unprognostic (2.72e-2)" "unprognostic (1.58e-1)" "prognostic favorable (7.79e-6)" 15.9 24.9 4.9 38.9 2.8 11.0 21.9 2.0 4.5 16.8 36.3 3.2 18.5 36.3 15.2 20.5 13.7 12.3 36.7 12.7 4.9 2.5 19.3 20.5 30.3 33.2 3.6 5.7 12.8 7.3 3.5 9.3 8.3 3.9 21.5 8.2 44.1 20.9 22.6 5.2 8.4 41.9 14.6 4.1 36.7 16.7 5.9 2.7 23.5 10.8 10.6 25.0 15.4 17.2 18.2 9.7 30.2 25.8 8.1 25.1 14.2 1.3 0.1 0.1 2.4 5.2 2.8 0.8 0.7 2.4 1.4 1.9 0.2 14.6 0.8 0.1 2.2 1.4 1.3 0.0 0.9 0.2 14.8 0.0 8.5 0.4 2.7 17.3 1.1 10.6 2.7 1.4 0.7 0.1 2.1 3.8 0.8 1.2 13.6 1.3 0.0 4.7 1.3 0.0 4.6 1.3 3.8 0.0 4.2 0.2 2.1 0.4 0.0 0.6 0.1 28.5 0.0 0.4 0.3 9.6 0.2 0.6 0.3 0.1 11.1 2.7 0.4 2.4 1.2 1.0 3.0 15.1 8.2 17.2 25.8 14.9 16.6 18.0 14.8 9.7 18.2 17.3 14.9 30.2 8.1 24.1 8.7 25.1 14.2 4.9 2.8 2.0 4.5 4.9 2.5 3.6 5.7 3.9 2.7 17.9 38.9 54.7 30.5 14.5 1.5 6.7 56.0 26.8 31.8 33.2 0.0 1.0 3.3 16.7 0.3 48.4 116.5 0.0 29.0 0.8 16.0 32.4 50.9 18.3 78.8 0.0 34.7 35.0 60.9 1.3 19.2 62.9 43.9 111.0 60.4 15.8 19.7 86.3 13.1 30.9 0.5 19.4 17.5 0.0 0.3 11.7 1.0 77.3 72.2 38.8 TNFRSF17 "BCM, BCMA, CD269, TNFRSF13A" ENSG00000048462 "TNF receptor superfamily member 17" Q02223 16 11965107-11968068 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.1;intestine: 17.8;lymphoid tissue: 28.8" "Group enriched" "Detected in some" 9 "B-cells: 29.3;Erythroid cells: 46.7;Melanocytes: 101.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 59 "memory B-cell: 34.1;naive B-cell: 26.9;plasmacytoid DC: 27.9" "Group enriched" "Detected in many" 62 "B-cells: 34.1;dendritic cells: 27.9" "Cell line enhanced" "Detected in some" "Karpas-707: 25.9;RPMI-8226: 40.8;U-266/70: 121.4;U-266/84: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 2200000 "prognostic favorable (1.35e-5)" "unprognostic (3.41e-2)" "unprognostic (4.00e-3)" "unprognostic (1.41e-2)" "unprognostic (6.47e-2)" "prognostic favorable (1.58e-6)" "unprognostic (9.75e-3)" "unprognostic (5.93e-2)" "unprognostic (2.13e-2)" "unprognostic (7.96e-3)" "unprognostic (2.46e-1)" "unprognostic (2.58e-1)" "unprognostic (2.85e-6)" "unprognostic (2.06e-1)" "unprognostic (2.48e-1)" "unprognostic (3.54e-2)" "unprognostic (1.10e-1)" 0.6 0.4 0.4 24.0 0.9 0.3 5.4 0.5 0.4 1.5 17.8 0.2 0.2 12.3 0.5 0.2 3.7 1.1 4.9 0.7 0.4 0.4 1.3 0.8 3.0 22.4 0.4 0.2 0.9 3.1 0.0 0.5 0.3 0.2 1.0 9.4 0.6 14.2 0.2 0.4 0.4 11.7 0.2 0.4 22.2 9.4 2.2 0.3 3.1 1.1 1.4 28.8 7.6 0.7 34.1 27.9 0.5 0.1 0.2 0.1 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.4 60.3 9.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 34.1 0.0 0.0 0.0 26.9 0.0 0.0 0.5 0.2 0.0 27.9 0.0 3.7 0.4 0.9 0.5 0.4 0.4 0.4 0.4 0.2 0.2 0.3 0.0 0.0 29.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 46.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.6 0.0 0.0 101.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.5 0.4 0.5 0.0 0.0 0.0 0.0 TNFRSF18 "AITR, CD357, GITR" ENSG00000186891 "TNF receptor superfamily member 18" Q9Y5U5 1 1203508-1206691 "CD markers, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 46.6;skin 1: 28.9" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 167.9;granulocytes: 46.0;Melanocytes: 47.2;Suprabasal keratinocytes: 131.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 46.6" "Group enriched" "Detected in many" 11 "NK-cells: 46.6;T-cells: 19.0" "Group enriched" "Detected in some" 11 "RPMI-8226: 62.6;SCLC-21H: 45.0" HPA008025 Approved "Secreted to blood" NA NA "HPA008025: AB_1849696" "unprognostic (1.20e-3)" "unprognostic (4.61e-2)" "unprognostic (4.59e-2)" "prognostic favorable (7.72e-6)" "unprognostic (2.73e-4)" "prognostic favorable (4.12e-4)" "unprognostic (3.43e-2)" "unprognostic (2.31e-1)" "unprognostic (3.33e-2)" "unprognostic (1.01e-1)" "unprognostic (1.00e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (4.40e-11)" "unprognostic (1.02e-3)" "unprognostic (2.39e-1)" "unprognostic (3.74e-1)" "unprognostic (2.08e-1)" 1.4 0.5 1.0 8.9 1.0 1.9 4.2 4.9 2.5 14.3 8.3 0.3 0.1 5.7 2.1 1.1 4.7 1.0 3.7 0.2 0.5 0.3 1.1 1.7 3.0 9.1 0.4 2.4 0.3 2.7 9.4 3.8 1.3 1.7 1.9 1.2 0.5 9.0 2.6 1.0 28.9 5.0 0.2 0.3 6.7 3.8 0.8 0.1 4.4 0.9 2.7 8.2 1.5 2.2 2.9 0.0 0.2 0.0 46.6 19.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 4.7 0.0 0.0 62.6 0.1 0.0 45.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.6 1.3 8.5 1.2 0.0 2.9 0.3 0.4 0.2 46.6 0.0 0.0 19.0 2.1 1.0 1.0 4.9 2.5 0.5 0.3 0.4 2.4 1.7 0.1 0.0 2.2 7.5 10.8 167.9 0.0 2.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.5 0.9 11.2 7.3 46.0 0.0 0.8 0.0 3.4 1.3 0.8 0.0 0.0 1.8 47.2 21.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 131.6 0.0 20.8 0.0 3.3 TNFRSF19 "TAJ, TAJ-alpha, TRADE, TROY" ENSG00000127863 "TNF receptor superfamily member 19" Q9NS68 13 23570370-23676104 "Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 60.5;skin 1: 47.9" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 55.3;Ciliated cells: 84.3;Suprabasal keratinocytes: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "naive B-cell: 1.9;T-reg: 4.0" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 4.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.5;BJ hTERT+: 26.9;fHDF/TERT166: 20.4;Hep G2: 27.9;SK-MEL-30: 46.5;WM-115: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010135 Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA010135: AB_1079797" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" "unprognostic (1.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.86e-3)" "unprognostic (2.01e-2)" "prognostic favorable (3.87e-4)" "unprognostic (3.74e-1)" "unprognostic (5.47e-2)" "unprognostic (4.41e-2)" "unprognostic (6.56e-2)" "prognostic favorable (9.13e-7)" "unprognostic (3.44e-2)" "unprognostic (6.05e-2)" "unprognostic (3.25e-3)" "unprognostic (5.38e-3)" 1.3 1.3 1.0 0.4 1.4 0.6 4.6 0.8 2.0 3.4 1.5 3.0 17.1 0.7 5.3 7.3 5.1 14.3 2.3 14.7 1.5 1.5 7.1 0.5 7.9 0.6 3.0 1.3 3.4 2.2 0.1 8.0 3.8 2.8 12.7 0.8 11.4 60.5 13.0 1.2 47.9 0.9 4.1 1.9 2.5 2.4 2.7 1.1 0.8 5.7 8.0 3.7 2.7 4.0 1.9 0.7 0.7 0.0 0.6 4.0 0.2 0.0 1.0 1.2 0.0 1.6 16.5 1.2 1.2 26.9 0.6 0.9 7.8 0.0 0.0 0.0 20.4 0.1 0.0 1.1 0.9 1.2 0.0 0.9 0.2 0.8 27.9 0.7 0.0 0.3 7.8 0.2 7.8 0.1 0.5 0.0 0.0 0.0 0.0 4.4 0.3 0.0 0.0 0.7 9.6 1.7 0.0 4.5 0.0 2.8 0.1 10.7 1.8 0.0 0.0 46.5 1.3 0.0 0.1 0.0 3.9 0.2 0.0 1.1 0.0 0.0 0.0 1.5 0.0 28.9 0.0 0.0 0.7 0.0 0.0 0.4 0.7 0.4 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.7 4.0 0.2 1.0 1.4 0.8 2.0 1.5 1.5 3.0 1.3 2.8 1.1 0.0 17.3 0.0 3.6 55.3 0.6 19.1 2.5 84.3 14.8 8.7 7.9 0.2 0.0 9.9 1.1 2.9 0.0 0.0 0.9 0.0 9.8 18.5 1.1 0.6 0.1 0.0 0.0 0.0 0.0 0.8 10.6 0.2 13.5 0.0 0.0 3.0 7.4 0.0 13.1 18.8 2.5 0.0 5.7 0.9 2.1 70.1 0.0 0.5 0.0 0.5 TNFRSF1A "CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60" ENSG00000067182 "TNF receptor superfamily member 1A" P19438 12 6328757-6342114 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Apoptosis, Host-virus interaction" Receptor "Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 86.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004102, CAB010309" Approved "Secreted to blood" NA NA 170000 "CAB010309: AB_2206639, HPA004102: AB_1846232" "unprognostic (2.19e-2)" "unprognostic (3.76e-2)" "unprognostic (8.14e-2)" "prognostic favorable (8.22e-4)" "unprognostic (3.07e-2)" "prognostic unfavorable (3.68e-4)" "unprognostic (1.50e-1)" "unprognostic (1.41e-3)" "unprognostic (1.00e-1)" "unprognostic (8.05e-2)" "unprognostic (4.78e-2)" "unprognostic (1.54e-2)" "prognostic unfavorable (2.70e-7)" "unprognostic (1.43e-2)" "unprognostic (2.92e-2)" "unprognostic (5.14e-3)" "unprognostic (1.74e-1)" 55.1 43.9 16.8 28.9 16.8 13.7 40.6 7.2 15.6 40.3 41.5 14.1 22.6 39.2 38.2 27.5 39.4 34.2 37.1 26.8 14.0 7.5 49.3 61.6 40.9 37.2 19.2 6.4 59.5 21.4 20.3 19.9 45.3 18.3 37.0 23.0 31.1 25.7 22.2 34.2 30.9 81.7 38.8 25.1 43.6 28.2 21.8 15.7 31.6 42.7 25.4 22.3 49.1 58.5 0.0 20.8 86.5 27.1 1.8 11.6 15.9 7.4 57.8 8.1 11.5 56.0 57.3 15.3 15.9 27.5 21.4 18.6 6.9 29.7 0.6 5.5 34.3 17.1 20.8 2.5 18.6 14.8 0.1 4.8 4.1 16.0 15.3 49.7 19.3 13.0 59.0 18.7 17.7 26.1 49.7 26.0 8.0 6.2 5.7 24.5 10.6 6.1 18.2 19.7 27.7 16.9 5.3 12.9 5.7 16.5 13.5 0.0 0.4 22.5 11.8 11.8 21.7 3.2 21.1 28.3 16.8 14.4 12.6 14.7 0.0 1.8 2.4 20.1 18.0 20.8 2.2 27.1 15.0 11.6 21.8 11.1 0.0 4.9 9.5 20.8 0.0 4.5 6.6 86.5 1.8 17.5 6.0 4.8 15.9 16.8 16.8 7.2 15.6 14.0 7.5 19.2 6.4 18.3 15.7 47.6 42.8 9.0 92.6 109.3 0.1 8.4 63.7 10.7 42.1 26.2 0.0 53.2 13.3 86.6 0.6 80.7 166.1 23.3 104.3 104.8 112.3 113.8 7.0 128.2 148.0 0.0 32.3 138.1 133.7 3.3 94.6 103.1 67.4 101.0 44.9 16.3 93.0 210.5 61.9 94.3 0.3 122.9 122.4 0.5 1.1 117.7 124.3 45.7 42.3 123.4 TNFRSF1B "CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80" ENSG00000028137 "TNF receptor superfamily member 1B" P20333 1 12167003-12209228 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 70.1" "Cell type enhanced" "Detected in many" 10 "Kupffer cells: 168.8;Macrophages: 143.1;monocytes: 73.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 70.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.5;K-562: 21.4;THP-1: 25.1;U-87 MG: 17.2;U-937: 18.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004796 Approved "Secreted to blood" NA NA 3230000 2500000 "HPA004796: AB_1078436" "unprognostic (4.45e-2)" "unprognostic (2.27e-3)" "unprognostic (7.62e-2)" "unprognostic (3.82e-3)" "unprognostic (6.30e-2)" "unprognostic (4.47e-3)" "unprognostic (5.28e-3)" "unprognostic (2.79e-1)" "unprognostic (1.69e-2)" "unprognostic (1.73e-2)" "unprognostic (7.26e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (8.35e-5)" "unprognostic (2.02e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (3.26e-2)" "unprognostic (1.10e-1)" 43.4 4.7 4.6 44.3 13.8 29.2 42.3 2.1 6.1 13.3 13.1 6.6 1.9 11.9 9.7 10.2 6.5 11.3 11.6 21.8 8.5 6.2 6.2 22.2 24.5 60.6 9.1 2.2 9.4 4.2 2.3 4.4 24.9 15.0 7.3 8.2 8.3 5.7 3.7 11.5 6.2 17.3 11.5 22.6 48.3 10.5 6.0 6.1 10.9 6.2 5.6 16.2 18.3 8.4 2.7 13.2 25.7 70.1 2.5 12.7 19.9 0.0 0.1 2.1 0.0 5.6 7.7 4.4 0.5 1.0 2.0 2.2 0.8 17.5 0.1 0.3 1.8 2.9 0.0 0.4 0.0 1.1 6.9 0.0 0.0 0.1 0.0 13.2 0.1 1.9 7.6 0.0 7.0 0.0 3.6 10.6 0.1 21.4 3.2 0.9 0.0 0.0 4.0 0.1 2.7 0.6 0.5 0.2 12.3 0.0 0.4 0.0 0.0 0.3 0.1 0.6 3.3 0.0 25.1 3.7 3.0 0.1 13.3 0.0 1.0 0.0 0.0 17.2 18.1 0.7 0.0 20.7 3.0 9.4 49.3 5.4 2.7 6.6 7.7 13.2 1.7 2.0 3.0 25.7 2.5 70.1 2.8 12.7 19.9 4.6 13.8 2.1 6.1 8.5 6.2 9.1 2.2 15.0 6.1 8.9 22.3 30.3 2.5 14.9 0.1 2.8 7.6 2.7 11.4 3.5 0.0 0.7 0.0 0.4 0.3 40.2 11.8 23.3 0.5 4.3 9.7 4.3 2.3 14.0 63.4 0.0 0.0 22.7 168.8 0.4 2.0 143.1 15.1 73.9 3.1 0.3 0.5 1.4 0.4 0.3 1.0 32.3 13.7 0.0 0.9 9.3 25.2 58.9 3.9 9.8 TNFRSF21 "CD358, DR6" ENSG00000146072 "TNF receptor superfamily member 21" O75509 6 47231532-47309905 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Apoptosis, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.4" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 142.4;Glandular cells: 135.6;Syncytiotrophoblasts: 149.4;Urothelial cells: 360.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 35 "plasmacytoid DC: 31.6" "Lineage enriched" "Detected in single" 309 "dendritic cells: 31.6" "Cell line enhanced" "Detected in many" "OE19: 39.2;RT4: 99.8;SuSa: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006746, CAB009805" Approved Supported "Plasma membrane,Cytosol" NA NA 1300000 "Plasma membrane, Cytosol" "CAB009805: AB_2206956, HPA006746: AB_1078701" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (3.26e-1)" "unprognostic (7.85e-2)" "unprognostic (1.44e-1)" "unprognostic (3.41e-2)" "unprognostic (9.80e-3)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (7.53e-2)" "unprognostic (1.38e-3)" "unprognostic (1.74e-1)" "prognostic favorable (7.23e-6)" "unprognostic (1.48e-1)" "unprognostic (1.34e-1)" "unprognostic (9.78e-2)" "unprognostic (1.45e-2)" 25.9 3.7 9.7 8.7 13.6 5.9 7.8 7.4 20.8 9.6 19.3 26.9 1.0 6.4 9.1 3.0 21.8 9.9 18.7 4.1 13.8 16.0 26.2 4.6 9.5 11.5 26.8 7.9 5.0 17.9 35.6 4.4 17.0 29.5 10.2 18.5 3.0 15.2 2.4 3.5 2.7 10.2 8.2 63.4 11.6 30.4 5.8 10.1 11.5 2.9 19.2 16.5 41.2 11.6 0.0 31.6 0.1 0.0 0.0 0.0 0.2 29.2 9.5 9.3 2.9 25.5 7.5 10.5 3.4 6.7 1.0 0.4 16.4 20.7 2.1 13.8 2.4 20.0 17.7 1.3 12.6 0.6 0.0 2.9 0.0 1.2 16.5 14.9 0.4 0.1 13.4 15.1 0.6 11.5 0.8 4.9 1.9 0.7 0.0 0.3 5.7 2.5 0.2 7.3 39.2 9.8 5.4 2.8 3.1 17.7 99.8 6.7 1.4 2.9 2.8 2.4 43.8 2.1 2.0 1.0 2.8 2.5 0.1 3.1 0.0 0.0 3.0 4.5 2.1 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.2 9.7 13.6 7.4 20.8 13.8 16.0 26.8 7.9 29.5 10.1 0.0 12.7 0.0 142.4 21.1 0.6 7.6 35.7 10.7 25.0 1.8 0.0 24.6 13.3 69.3 45.6 5.6 30.3 0.0 25.8 16.8 14.1 135.6 19.6 0.0 20.6 0.0 11.5 1.8 36.8 29.9 2.6 5.8 11.8 0.0 40.2 4.4 63.5 46.7 1.1 48.5 1.3 77.6 16.2 0.6 1.4 8.7 149.4 1.3 14.0 360.8 TNFRSF25 "APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR" ENSG00000215788 "TNF receptor superfamily member 25" Q93038 1 6461151-6466195 "Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1" "Cell type enhanced" "Detected in many" 7 "Suprabasal keratinocytes: 25.0;T-cells: 36.2;Undifferentiated cells: 28.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 11 "cerebellum: 19.2" "Cell type enhanced" "Detected in many" "T-reg: 9.5" "Lineage enriched" "Detected in single" 10 "T-cells: 9.5" "Cell line enhanced" "Detected in many" "HDLM-2: 20.2;NB-4: 8.0;RPMI-8226: 19.7" "Group enriched" "Detected in some" 6 "amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3" "Not detected" "Not detected" HPA069834 Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" "Secreted - unknown location" NA NA "Plasma membrane, Actin filaments, Focal adhesion sites" Nucleoplasm "HPA069834: " "unprognostic (8.09e-3)" "unprognostic (6.91e-3)" "prognostic unfavorable (4.46e-4)" "unprognostic (1.97e-1)" "unprognostic (9.63e-3)" "prognostic favorable (3.09e-4)" "unprognostic (2.16e-1)" "unprognostic (1.46e-1)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (6.01e-2)" "unprognostic (3.98e-2)" "prognostic unfavorable (1.65e-7)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (3.44e-1)" "unprognostic (8.68e-3)" 2.2 1.6 1.2 20.3 1.6 0.4 1.4 19.2 1.8 1.4 13.4 0.7 0.6 2.8 1.2 0.6 4.1 2.4 2.1 2.3 1.8 0.9 1.4 2.3 6.3 13.9 1.1 0.6 1.1 0.6 1.4 14.0 4.1 1.3 1.9 1.3 1.1 10.5 2.3 0.8 24.1 11.2 0.6 0.6 18.9 0.8 1.0 0.8 11.7 1.1 3.2 26.0 3.2 1.5 0.0 0.4 0.0 0.9 0.6 9.5 1.3 1.4 0.3 0.8 1.6 0.0 0.4 0.8 0.6 0.4 0.2 0.0 1.3 2.2 0.0 3.0 0.0 1.0 3.2 0.4 3.7 0.0 20.2 1.5 0.8 1.1 0.0 0.6 0.0 0.0 0.0 2.4 1.2 3.2 1.9 3.2 0.9 0.0 0.0 0.0 1.6 0.0 8.0 1.0 1.1 5.5 0.6 0.2 19.7 0.8 0.5 3.9 5.4 0.0 1.9 0.1 0.3 1.7 2.2 1.7 1.0 1.5 0.0 1.5 0.0 3.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.7 0.3 8.0 0.0 6.9 3.2 0.4 0.0 6.4 1.1 0.0 0.6 0.9 0.0 9.5 1.3 1.2 1.6 19.2 1.8 1.8 0.9 1.1 0.6 1.3 0.8 3.0 5.3 0.5 1.8 21.9 0.8 0.8 2.5 2.7 2.3 1.8 2.0 0.4 0.0 0.1 0.3 5.5 16.9 0.0 0.4 1.6 3.2 1.1 6.9 1.1 3.2 4.8 6.4 9.8 1.6 0.0 2.6 2.1 6.8 1.0 17.6 11.2 0.9 11.5 8.9 0.3 9.3 0.0 0.8 0.5 1.1 25.0 0.1 36.2 28.4 6.7 TNFRSF4 "ACT35, CD134, OX40, TXGP1L" ENSG00000186827 "TNF receptor superfamily member 4" P43489 1 1211326-1214138 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 12.5;blood: 18.4;lymphoid tissue: 13.6" "Cell type enhanced" "Detected in some" 19 "Endothelial cells: 15.3;granulocytes: 67.9;monocytes: 30.7;T-cells: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 15.9;T-reg: 18.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "MOLT-4: 8.0;NB-4: 15.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" CAB016128 Enhanced NA NA "CAB016128: AB_626897" "unprognostic (2.24e-1)" "unprognostic (8.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.55e-3)" "unprognostic (1.02e-1)" "prognostic favorable (3.50e-6)" "prognostic unfavorable (6.03e-4)" "unprognostic (3.30e-1)" "unprognostic (1.48e-2)" "unprognostic (7.04e-3)" "unprognostic (1.04e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.52e-6)" "unprognostic (1.61e-1)" "unprognostic (5.46e-2)" "unprognostic (2.42e-1)" "unprognostic (5.91e-2)" 12.5 0.2 0.6 8.8 0.4 0.7 7.3 0.3 1.2 1.1 3.1 0.3 0.3 2.6 0.8 0.7 1.7 0.9 0.8 6.7 0.8 0.1 2.2 0.4 5.3 8.4 0.3 0.6 0.5 0.9 0.0 1.3 5.9 0.6 3.2 0.3 0.6 2.2 1.1 4.4 0.8 4.3 0.3 0.3 13.5 3.5 2.0 0.3 13.6 4.1 0.8 10.9 1.4 0.7 0.0 0.6 4.1 0.0 8.1 18.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 8.0 15.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.2 0.0 1.8 0.0 15.9 1.7 0.0 0.0 1.5 0.0 0.2 8.1 0.0 0.6 18.4 1.5 0.6 0.4 0.3 1.2 0.8 0.1 0.3 0.6 0.6 0.3 0.0 0.0 2.2 0.3 8.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.3 0.0 0.0 0.2 0.4 2.8 0.3 67.9 0.0 1.6 0.0 0.0 8.6 1.0 0.0 0.3 5.8 10.1 30.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.7 0.0 0.2 7.3 0.1 15.8 0.0 0.1 TNFRSF8 "CD30, D1S166E, KI-1" ENSG00000120949 "TNF receptor superfamily member 8" P28908 1 12063377-12144207 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.3" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 2.8;Kupffer cells: 6.0;Late spermatids: 7.2" "Cancer enriched" "Detected in some" 12 "testis cancer: 9.3" "Region enriched" "Detected in single" 14 "basal ganglia: 13.1" "Cell type enhanced" "Detected in some" "intermediate monocyte: 21.7;non-classical monocyte: 33.3" "Lineage enriched" "Detected in many" 5 "monocytes: 33.3" "Cell line enriched" "Detected in some" 21 "HDLM-2: 112.6" "Low region specificity" "Detected in many" "CAB000016, HPA014823, HPA032081, HPA032082" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142" "unprognostic (1.07e-2)" "unprognostic (2.06e-2)" "unprognostic (2.52e-2)" "unprognostic (5.98e-2)" "unprognostic (2.50e-1)" "unprognostic (1.46e-3)" "unprognostic (2.19e-1)" "unprognostic (3.93e-2)" "unprognostic (1.18e-1)" "unprognostic (9.18e-3)" "unprognostic (1.86e-1)" "unprognostic (2.06e-1)" "unprognostic (3.17e-8)" "unprognostic (3.31e-1)" "unprognostic (8.56e-2)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" 10.7 0.2 0.1 7.2 13.1 1.4 5.8 0.2 0.4 1.1 0.8 0.0 1.5 0.2 1.7 1.3 0.9 2.1 1.4 3.8 0.1 0.2 0.9 0.2 3.9 2.9 0.5 0.5 1.2 0.4 0.0 0.1 6.2 0.5 1.0 0.5 0.0 0.7 0.3 3.1 1.6 1.3 1.3 1.4 2.9 6.4 2.5 0.9 3.0 0.7 2.7 5.3 2.6 3.8 0.0 3.2 6.8 33.3 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 112.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 5.2 0.3 0.0 0.0 0.3 0.0 4.5 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.3 0.0 21.7 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 6.8 0.0 33.3 0.8 0.3 2.7 0.1 13.1 0.2 0.4 0.1 0.2 0.5 0.5 0.5 0.9 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 1.4 0.0 0.0 1.3 6.0 7.2 0.3 1.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.1 0.2 0.0 0.0 0.0 TNFRSF9 "4-1BB, CD137, ILA" ENSG00000049249 "TNF receptor superfamily member 9" Q07011 1 7915894-7943165 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 13.5;lymphoid tissue: 18.3" "Group enriched" "Detected in some" 4 "granulocytes: 62.3;monocytes: 53.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5" "Group enriched" "Detected in many" 5 "granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5" "Cell line enriched" "Detected in some" 8 "HDLM-2: 47.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA071425 Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA071425: AB_2686394" "unprognostic (7.23e-2)" "unprognostic (1.72e-2)" "unprognostic (8.26e-3)" "unprognostic (1.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-4)" "unprognostic (9.47e-3)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (2.69e-8)" "unprognostic (1.64e-2)" "unprognostic (2.25e-2)" "unprognostic (1.19e-1)" "unprognostic (9.55e-2)" 0.8 1.0 0.3 11.0 0.3 1.9 0.5 0.2 0.3 0.4 0.5 0.1 0.1 0.6 0.3 0.1 0.6 0.8 1.6 1.8 0.3 1.0 0.7 0.7 2.1 10.8 0.3 0.1 0.3 0.6 0.0 0.5 0.2 0.5 0.4 0.7 0.3 2.1 0.1 0.3 0.5 2.3 0.1 0.3 7.9 0.7 0.5 0.1 18.3 0.7 0.9 17.5 1.4 0.4 0.5 1.1 6.6 1.5 4.1 13.5 1.1 1.2 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 1.0 0.4 0.1 0.4 0.0 0.8 0.2 0.0 0.2 0.5 47.0 0.1 0.2 0.2 0.0 0.9 0.0 0.5 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.7 0.0 0.2 0.2 0.2 1.6 0.1 0.2 0.1 0.1 0.1 5.8 0.2 0.0 1.1 1.5 0.2 1.5 0.4 0.2 0.2 1.0 8.0 1.1 0.5 0.3 1.6 6.6 4.1 0.1 0.3 13.5 1.1 0.3 0.3 0.2 0.3 0.3 1.0 0.3 0.1 0.5 0.1 0.0 1.7 0.0 0.4 0.2 0.0 0.3 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 1.0 0.0 0.4 0.3 62.3 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 1.8 5.0 53.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 12.9 0.0 0.3 TNFSF10 "Apo-2L, CD253, TL2, TRAIL" ENSG00000121858 "TNF superfamily member 10" P50591 3 172505508-172523507 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 115.1" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 542.5;Exocrine glandular cells: 368.6;Proximal tubular cells: 449.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 42.4;classical monocyte: 25.6;intermediate monocyte: 39.5;neutrophil: 50.3;non-classical monocyte: 38.3" "Group enriched" "Detected in all" 5 "granulocytes: 50.3;monocytes: 39.5" "Cell line enhanced" "Detected in many" "BEWO: 21.0;CAPAN-2: 14.9;HaCaT: 14.7;HMC-1: 69.1;RPTEC TERT1: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054938 Uncertain "Secreted to blood" NA NA 67400 "HPA054938: AB_2682643" "unprognostic (9.16e-2)" "unprognostic (2.79e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-3)" "unprognostic (2.52e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-1)" "unprognostic (2.01e-1)" "unprognostic (1.99e-1)" "unprognostic (1.71e-2)" "prognostic unfavorable (9.43e-4)" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (3.68e-2)" "unprognostic (1.32e-1)" "unprognostic (6.27e-2)" 30.9 22.1 3.4 14.6 4.7 2.0 23.3 3.0 5.4 31.4 25.8 4.4 17.1 20.6 13.0 10.3 33.3 9.6 10.7 9.9 3.8 3.2 115.1 44.4 91.5 23.5 5.5 3.4 13.5 11.6 10.9 6.7 100.8 6.7 37.6 19.5 12.0 50.6 12.9 13.9 13.0 54.0 7.9 5.6 35.8 9.5 6.0 4.6 8.3 28.2 17.7 16.1 22.4 24.0 3.4 9.5 50.3 39.5 9.3 7.0 11.9 3.4 0.1 0.0 0.0 2.4 1.8 21.0 0.0 0.1 1.0 1.6 0.0 14.9 2.1 10.1 0.0 0.9 14.7 0.0 1.8 0.2 5.3 0.0 0.0 0.4 0.3 0.1 3.9 69.1 2.4 2.4 0.4 0.0 0.0 7.6 0.4 0.0 2.5 0.0 0.0 0.5 5.2 0.0 0.1 0.1 0.8 0.0 0.9 34.8 1.3 0.1 0.1 7.7 0.3 0.1 0.1 4.2 2.2 0.3 0.0 0.0 0.0 0.2 2.6 0.3 2.6 0.2 2.2 0.0 42.4 25.6 2.7 2.3 39.5 3.1 3.2 6.4 3.5 9.5 3.4 4.7 1.8 50.3 9.3 38.3 0.6 7.0 11.9 3.4 4.7 3.0 5.4 3.8 3.2 5.5 3.4 6.7 4.6 65.5 119.9 15.2 153.0 19.6 0.1 4.5 63.7 99.0 113.7 62.8 0.0 1.1 38.1 542.5 3.9 163.8 223.5 23.3 368.6 166.3 27.9 96.6 248.5 58.7 22.3 1.6 46.3 140.0 77.7 2.8 17.0 51.4 6.8 16.2 96.5 21.7 249.5 190.0 4.6 449.0 0.8 0.0 10.3 0.0 0.2 22.3 9.2 43.6 68.5 109.1 TNFSF11 "CD254, ODF, OPGL, RANKL, TRANCE" ENSG00000120659 "TNF superfamily member 11" O14788 13 42562736-42608013 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Differentiation "Cytokine, Developmental protein, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 14.3;lymphoid tissue: 19.8" "Cell type enhanced" "Detected in some" 22 "Ductal cells: 3.3;Early spermatids: 5.8;Late spermatids: 14.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "NK-cell: 14.3" "Lineage enriched" "Detected in many" 8 "NK-cells: 14.3" "Cell line enhanced" "Detected in some" "Daudi: 1.8;HSkMC: 5.4;NTERA-2: 7.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB009193, HPA045142" Enhanced "Secreted to blood" NA NA 17200 "CAB009193: , HPA045142: AB_2679231" "unprognostic (3.97e-4)" "unprognostic (1.40e-1)" "unprognostic (9.01e-3)" "unprognostic (3.81e-3)" "unprognostic (1.12e-1)" "unprognostic (1.09e-1)" "unprognostic (7.09e-2)" "unprognostic (7.70e-2)" "unprognostic (2.29e-1)" "unprognostic (1.25e-3)" "unprognostic (1.00e-1)" "unprognostic (1.50e-1)" "unprognostic (3.94e-5)" "unprognostic (1.87e-1)" "unprognostic (9.67e-2)" "unprognostic (5.46e-2)" "unprognostic (7.74e-2)" 0.5 0.2 0.2 19.5 0.2 0.0 4.6 0.1 0.2 0.8 0.8 0.1 2.4 0.2 0.2 0.1 3.7 0.2 1.3 0.3 0.1 0.7 0.6 5.3 0.4 19.8 0.1 0.1 0.1 0.6 0.0 0.3 0.3 0.4 0.5 2.2 0.1 1.6 1.0 0.2 0.5 6.0 0.1 0.1 0.8 0.3 3.3 0.1 2.8 0.4 0.1 5.2 2.3 0.7 0.0 0.1 1.8 0.0 14.3 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.6 0.0 0.1 5.4 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.5 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.1 0.7 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.3 5.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.3 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 TNFSF12 "APO3L, DR3LG, TWEAK" ENSG00000239697 "TNF superfamily member 12" O43508 17 7548891-7557890 "Predicted secreted proteins" "Angiogenesis, Apoptosis, Differentiation" "Cytokine, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 11.8;BJ hTERT+: 11.2;fHDF/TERT166: 9.7;HDLM-2: 9.9;HSkMC: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035984, HPA052967" Uncertain Approved Vesicles "Secreted to blood" NA NA 853000 150000 Vesicles "HPA035984: , HPA052967: AB_2682000" "unprognostic (2.96e-3)" "unprognostic (2.96e-1)" "unprognostic (4.71e-2)" "prognostic favorable (5.70e-5)" "unprognostic (5.31e-2)" "unprognostic (7.91e-2)" "unprognostic (6.45e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (6.09e-2)" "unprognostic (6.20e-2)" "unprognostic (8.62e-2)" "unprognostic (3.29e-2)" "unprognostic (4.11e-2)" "unprognostic (3.15e-2)" "unprognostic (8.74e-2)" "unprognostic (2.38e-1)" 32.9 16.7 23.0 14.0 16.9 2.9 20.4 15.7 21.8 22.1 27.4 9.5 18.0 9.5 17.6 18.6 24.5 19.8 30.1 23.3 16.3 13.3 15.0 8.8 23.8 16.8 14.8 13.9 31.3 20.6 9.0 8.4 13.4 7.8 27.8 6.2 19.7 26.7 32.7 12.8 8.2 11.3 24.2 9.1 21.6 18.0 7.4 8.5 2.6 11.3 9.6 11.0 26.0 37.7 2.6 2.4 10.5 5.7 2.4 6.9 0.8 0.0 0.0 0.5 0.0 9.1 11.8 2.5 4.0 11.2 4.5 2.7 0.0 1.4 0.0 3.5 9.7 0.4 0.9 0.4 0.4 0.4 9.9 1.7 0.6 0.3 0.8 8.9 0.0 0.0 10.3 1.1 1.5 0.1 2.1 7.3 0.0 0.1 0.0 3.9 0.0 0.0 0.3 0.4 0.0 5.0 0.1 0.0 0.1 7.2 0.0 0.0 4.7 1.3 0.0 3.8 0.1 0.7 0.4 7.0 6.1 0.5 0.0 2.1 0.0 0.0 0.0 1.1 0.0 5.4 4.0 3.1 10.5 5.2 5.7 6.9 2.6 3.8 2.8 1.8 2.5 4.4 4.1 2.2 2.4 1.4 2.4 4.1 0.8 23.0 16.9 15.7 21.8 16.3 13.3 14.8 13.9 7.8 8.5 8.9 9.8 8.7 9.8 5.5 7.7 3.8 12.7 0.0 4.5 15.7 0.0 1.2 6.6 12.4 0.4 20.4 1.1 0.0 10.6 0.8 13.3 9.0 34.5 2.9 40.2 19.1 1.2 28.8 42.6 0.0 46.9 42.4 18.6 28.9 1.7 29.4 7.9 0.0 47.4 29.4 2.2 58.2 36.0 0.2 1.2 6.6 0.7 21.4 3.7 4.6 TNFSF12-TNFSF13 TWE-PRIL ENSG00000248871 "TNFSF12-TNFSF13 readthrough" 17 7549099-7561601 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 40 "Alveolar cells type 2: 3.0;Ciliated cells: 2.7;Club cells: 6.8;granulocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 3.9;eosinophil: 10.5;intermediate monocyte: 6.5;myeloid DC: 2.7" "Group enriched" "Detected in many" 5 "dendritic cells: 2.7;granulocytes: 10.5;monocytes: 6.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.5;fHDF/TERT166: 3.2;HUVEC TERT2: 2.9;U-138 MG: 4.6;U-251 MG: 4.7" "Low region specificity" "Detected in many" "HPA004863, HPA035984, HPA052967" Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA004863: AB_1078187, HPA035984: , HPA052967: AB_2682000" "unprognostic (1.59e-1)" "unprognostic (1.48e-1)" "unprognostic (2.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (3.04e-1)" "unprognostic (2.19e-1)" "unprognostic (1.05e-2)" "unprognostic (1.40e-1)" "unprognostic (8.96e-3)" "unprognostic (1.38e-2)" "unprognostic (2.05e-1)" "unprognostic (8.23e-2)" 10.0 8.6 3.2 6.1 3.1 5.6 5.6 3.2 6.1 5.9 3.5 1.9 4.8 2.7 3.8 5.0 7.0 3.1 8.9 4.3 3.1 3.1 3.1 3.1 6.6 7.1 3.1 3.4 5.9 3.3 2.0 3.1 2.4 1.3 8.2 1.7 5.4 4.4 4.4 3.1 3.1 3.6 6.9 3.1 5.6 5.7 3.1 1.6 0.0 3.1 1.9 4.8 7.5 11.5 1.2 2.7 10.5 6.5 0.4 1.1 1.6 0.0 0.4 0.0 0.0 0.0 0.6 0.4 1.3 4.5 1.6 2.5 0.0 0.2 0.0 0.8 3.2 0.0 0.0 1.4 0.0 0.9 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.2 0.5 1.0 0.9 0.0 0.0 2.9 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.4 0.9 0.0 0.0 0.0 1.7 0.0 0.0 2.2 0.4 0.0 1.1 0.0 0.0 0.0 1.3 4.6 0.3 0.0 4.7 0.0 0.0 0.0 1.0 0.0 0.6 0.8 3.9 10.5 0.4 6.5 0.5 0.8 0.7 0.4 2.7 1.2 0.4 0.3 0.5 0.4 0.5 1.4 1.1 1.6 3.2 3.1 3.2 6.1 3.1 3.1 3.1 3.4 1.3 1.6 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TNFSF13 "APRIL, CD256" ENSG00000161955 "TNF superfamily member 13" O75888 17 7558292-7561608 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Immunity Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 102.8" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 7.2;Ciliated cells: 2.7;Club cells: 3.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 63.5;eosinophil: 22.8;intermediate monocyte: 62.7;myeloid DC: 43.0;non-classical monocyte: 37.3;plasmacytoid DC: 19.8" "Group enriched" "Detected in many" 10 "dendritic cells: 43.0;granulocytes: 22.8;monocytes: 63.5" "Cell line enhanced" "Detected in many" "EFO-21: 18.8;RPTEC TERT1: 47.5;U-937: 18.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004863 Uncertain "Secreted to blood" NA NA 6770000 29000 "HPA004863: AB_1078187" "unprognostic (2.46e-2)" "unprognostic (2.20e-1)" "unprognostic (3.42e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (9.73e-4)" "unprognostic (3.57e-1)" "unprognostic (3.32e-2)" "unprognostic (3.70e-2)" "unprognostic (3.75e-1)" "unprognostic (1.15e-1)" "unprognostic (6.95e-2)" "unprognostic (2.65e-1)" "prognostic favorable (1.30e-9)" "unprognostic (4.69e-2)" "unprognostic (1.42e-2)" "unprognostic (3.46e-1)" "unprognostic (3.38e-2)" 12.1 14.4 18.7 15.4 24.2 18.3 12.9 5.7 15.3 15.7 20.4 8.7 27.4 32.0 7.7 12.8 6.1 14.4 29.1 9.5 11.1 10.7 34.1 11.9 43.0 39.0 14.3 9.4 14.0 20.7 5.7 10.8 6.4 31.6 13.7 18.7 22.0 102.8 69.4 3.0 5.3 18.5 10.9 13.1 16.2 23.4 5.0 9.0 3.3 14.1 8.2 11.5 10.4 8.4 4.1 43.0 22.8 63.5 1.3 0.4 30.6 8.5 3.5 1.2 2.3 1.4 0.7 1.4 1.5 1.1 0.6 0.5 1.9 5.3 3.8 18.8 1.5 2.2 5.5 0.0 1.5 0.6 6.6 2.9 2.4 7.7 4.0 2.9 2.1 2.5 1.5 1.5 0.4 2.5 3.8 2.0 2.7 1.8 1.5 0.5 1.2 0.9 6.7 1.1 8.3 2.5 6.7 1.4 16.2 47.5 5.6 2.2 2.1 3.0 8.0 1.0 1.8 10.7 5.1 1.0 2.0 2.5 0.9 3.3 0.3 1.1 0.9 0.8 18.2 4.0 9.0 63.5 22.8 0.1 62.7 0.1 2.0 0.0 0.1 43.0 4.1 0.4 0.2 8.6 1.3 37.3 19.8 0.1 30.6 18.7 24.2 5.7 15.3 11.1 10.7 14.3 9.4 31.6 9.0 6.0 7.2 0.0 0.2 0.0 0.0 0.0 0.0 2.7 3.4 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.2 2.3 0.0 0.4 0.0 1.2 0.0 2.2 0.0 0.0 0.6 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 TNFSF13B "BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20" ENSG00000102524 "TNF superfamily member 13b" Q9Y275 13 108251240-108308484 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 76.5;lymphoid tissue: 39.6" "Cell type enhanced" "Detected in many" 23 "Hofbauer cells: 88.9;Kupffer cells: 144.9;Macrophages: 141.3;monocytes: 457.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 76.5" "Group enriched" "Detected in many" 10 "dendritic cells: 31.0;granulocytes: 76.5;monocytes: 53.7" "Cell line enriched" "Detected in some" 7 "U-937: 61.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009188, HPA030526" Enhanced Supported "Vesicles,Plasma membrane,Focal adhesion sites" "Secreted to blood" NA NA 393000 530000 "Plasma membrane" "Vesicles, Focal adhesion sites" "CAB009188: , HPA030526: " "unprognostic (6.48e-2)" "unprognostic (3.05e-3)" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" "unprognostic (2.61e-2)" "unprognostic (7.99e-2)" "unprognostic (8.19e-2)" "unprognostic (1.37e-1)" "unprognostic (1.63e-1)" "unprognostic (1.02e-2)" "unprognostic (2.64e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.53e-11)" "unprognostic (1.23e-1)" "unprognostic (4.14e-2)" "unprognostic (1.88e-1)" "unprognostic (1.25e-1)" 7.2 8.2 3.0 18.5 8.2 13.2 3.4 1.4 5.2 1.6 4.2 2.1 1.0 7.8 1.2 6.5 3.5 2.9 9.4 9.4 5.7 2.9 3.1 5.0 13.2 39.6 7.2 2.6 2.9 2.7 0.5 2.1 6.4 5.7 3.7 6.4 2.6 5.4 1.8 1.6 1.6 6.8 3.5 11.6 23.5 3.4 1.0 4.9 7.2 5.1 1.7 12.7 8.5 3.8 1.0 31.0 76.5 53.7 0.6 5.3 20.8 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.3 0.2 0.8 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.3 0.1 0.0 0.1 3.6 0.1 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.1 0.0 0.0 0.1 0.1 0.0 8.1 0.0 0.1 0.0 0.0 0.1 3.8 0.1 0.0 3.9 61.0 0.6 1.2 53.7 14.4 0.8 39.8 5.3 0.6 3.5 0.7 31.0 1.0 1.7 0.5 76.5 0.6 31.7 11.5 2.8 20.8 3.0 8.2 1.4 5.2 5.7 2.9 7.2 2.6 5.7 4.9 14.9 17.5 3.7 0.7 6.4 0.3 0.5 12.7 2.7 5.7 5.2 0.0 0.5 1.7 2.0 1.0 1.3 0.5 0.0 29.2 0.9 13.3 1.6 4.7 1.5 88.9 0.0 1.2 4.9 144.9 0.2 4.9 141.3 8.5 457.1 0.2 0.4 1.9 0.0 1.8 1.0 0.0 6.5 5.0 0.1 0.1 4.1 0.9 6.2 1.2 1.3 TNFSF14 "CD258, HVEM-L, LIGHT, LTg" ENSG00000125735 "TNF superfamily member 14" O43557 19 6661253-6670588 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.8;liver: 50.6" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 22.9;granulocytes: 26.4;T-cells: 51.1" "Cancer enhanced" "Detected in many" "liver cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 50.8" "Group enriched" "Detected in many" 5 "granulocytes: 50.8;T-cells: 16.6" "Cell line enhanced" "Detected in some" "HDLM-2: 21.6;NB-4: 4.8;THP-1: 3.4;U-937: 12.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA012700 Approved "Secreted to blood" NA NA 41000 "HPA012700: AB_1852870" "unprognostic (2.78e-3)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (2.35e-3)" "unprognostic (3.82e-4)" "unprognostic (4.51e-2)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (1.05e-2)" "unprognostic (9.23e-2)" "unprognostic (9.22e-2)" "unprognostic (3.59e-1)" "prognostic unfavorable (6.07e-13)" "unprognostic (1.09e-1)" "unprognostic (9.56e-3)" "unprognostic (1.75e-1)" "unprognostic (3.62e-2)" 11.2 0.9 0.6 4.6 0.6 2.5 1.3 1.2 1.5 0.8 2.4 0.4 0.2 2.8 2.7 2.3 1.8 3.6 2.0 2.1 0.6 0.1 1.0 50.6 4.3 8.3 3.8 0.2 2.9 2.5 0.0 0.9 1.8 1.4 1.2 1.8 1.9 1.4 1.5 0.2 0.7 3.8 1.6 0.3 8.2 1.8 1.6 0.2 1.5 1.4 0.9 5.9 2.1 14.1 0.3 1.7 50.8 4.5 7.2 16.6 2.9 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.5 0.0 0.0 0.0 21.6 0.0 0.1 0.2 1.1 0.0 0.6 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.4 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.7 12.3 0.0 28.3 4.5 27.4 11.4 1.0 16.6 0.1 4.9 9.2 1.7 0.3 0.8 4.2 50.8 7.2 0.1 0.1 3.9 2.9 0.6 0.6 1.2 1.5 0.6 0.1 3.8 0.2 1.4 0.2 8.9 22.9 0.9 0.5 2.6 0.0 0.8 10.2 1.4 7.9 0.0 0.0 0.1 0.0 2.3 1.0 0.3 0.0 0.0 3.2 0.2 2.4 0.5 26.4 10.6 13.5 0.0 0.0 1.8 3.0 0.0 0.3 8.4 3.3 2.8 0.0 0.0 9.8 0.0 0.0 0.3 0.0 0.0 1.6 0.2 0.2 2.9 0.0 51.1 0.0 0.3 TNFSF15 "MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A" ENSG00000181634 "TNF superfamily member 15" O95150 9 114784635-114806126 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.0;kidney: 16.2;salivary gland: 28.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.9;monocytes: 9.0;Proximal tubular cells: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "myeloid DC: 2.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8" "Cell line enhanced" "Detected in some" "HaCaT: 11.1;hTEC/SVTERT24-B: 7.3;HUVEC TERT2: 14.0;OE19: 13.1;RT4: 13.7;TIME: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012948, HPA046522" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted to blood" NA NA 1110000 "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA012948: AB_1858024, HPA046522: AB_2679683" "unprognostic (3.41e-1)" "unprognostic (2.06e-2)" "unprognostic (3.76e-1)" "unprognostic (1.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.67e-2)" "unprognostic (1.64e-1)" "unprognostic (2.29e-2)" "unprognostic (5.40e-2)" "unprognostic (1.38e-1)" "unprognostic (7.78e-2)" "unprognostic (2.09e-1)" "unprognostic (8.64e-5)" "unprognostic (1.97e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-3)" "unprognostic (4.46e-3)" 1.2 1.3 0.3 3.1 0.5 0.0 0.7 0.2 0.9 1.9 7.3 0.1 1.3 10.8 0.9 1.3 2.8 0.8 2.0 0.3 1.7 0.3 16.2 0.5 5.2 0.5 0.4 0.1 0.7 1.4 0.2 0.5 6.0 0.7 9.8 2.2 0.6 28.7 4.4 0.3 0.6 15.0 2.0 0.4 1.5 3.0 0.6 0.1 0.9 1.3 1.8 2.4 6.4 1.6 0.3 2.8 1.2 1.8 0.3 0.1 0.4 0.4 3.6 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.1 0.2 2.5 1.3 0.0 0.0 0.4 11.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 7.3 0.0 0.0 14.0 0.0 0.0 0.8 0.4 0.5 0.0 0.0 0.2 13.1 0.0 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.0 0.6 0.0 5.0 1.0 0.0 6.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.8 0.1 0.1 1.8 0.0 0.3 0.1 0.0 2.8 0.3 0.1 0.1 1.2 0.3 0.2 1.5 0.0 0.4 0.3 0.5 0.2 0.9 1.7 0.3 0.4 0.1 0.7 0.1 11.9 8.9 0.0 4.4 0.5 0.1 0.5 0.0 0.0 1.2 7.0 0.0 0.5 0.0 4.0 0.2 0.0 6.9 0.0 1.8 0.1 0.8 4.6 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 9.0 1.8 0.2 1.1 0.0 0.4 9.6 0.1 0.0 1.0 0.0 0.0 0.5 0.2 0.0 3.9 5.1 TNFSF18 "AITRL, hGITRL, TL6" ENSG00000120337 "TNF superfamily member 18" Q9UNG2 1 173039960-173050963 "Predicted membrane proteins" "Adaptive immunity, Immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.3;tongue: 9.9" "Cell type enriched" "Detected in single" 8 "Hofbauer cells: 4.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "hippocampal formation: 7.3" "Cell type enriched" "Detected in single" 19 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 19 "monocytes: 1.8" "Group enriched" "Detected in some" 11 "EFO-21: 21.0;HUVEC TERT2: 31.6;TIME: 43.8" "Low region specificity" "Detected in many" NA NA "unprognostic (2.78e-1)" "unprognostic (7.40e-2)" "unprognostic (3.08e-3)" "unprognostic (1.32e-2)" "unprognostic (3.39e-2)" "unprognostic (5.72e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (2.22e-2)" "unprognostic (3.53e-2)" "unprognostic (1.13e-1)" "unprognostic (6.34e-2)" "unprognostic (2.71e-4)" "unprognostic (8.42e-3)" "unprognostic (6.21e-2)" "unprognostic (1.99e-1)" "unprognostic (8.74e-2)" 0.9 0.4 0.4 0.3 0.8 0.0 0.4 1.1 4.6 0.4 0.4 3.2 0.0 1.1 0.3 0.0 3.6 0.3 5.0 1.5 7.3 0.4 0.7 1.9 1.0 0.2 0.4 1.0 0.3 0.3 2.2 0.7 1.3 1.4 0.4 1.0 0.2 0.3 0.0 0.3 0.4 3.5 0.1 0.6 0.6 0.4 0.3 0.0 0.0 0.7 9.9 1.4 0.6 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.0 0.2 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 2.8 0.0 31.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.4 0.8 1.1 2.4 7.3 0.4 0.4 1.0 1.4 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 TNFSF4 "CD252, gp34, OX-40L, TXGP1" ENSG00000117586 "TNF superfamily member 4" P23510 1 173183734-173207313 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins" Cytokine "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.5;testis: 14.4" "Group enriched" "Detected in some" 4 "Early spermatids: 4.3;monocytes: 12.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 18.7;HHSteC: 8.1;HUVEC TERT2: 36.8;LHCN-M2: 30.6" HPA059579 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059579: AB_2684071" "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (4.58e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (1.74e-1)" "unprognostic (1.13e-3)" "unprognostic (2.13e-1)" "unprognostic (8.65e-2)" "unprognostic (5.17e-2)" "unprognostic (1.26e-2)" "unprognostic (1.18e-1)" "unprognostic (1.11e-7)" "unprognostic (3.73e-3)" "unprognostic (2.66e-1)" "unprognostic (9.49e-2)" "unprognostic (2.98e-2)" 2.1 4.0 1.7 8.2 2.3 0.9 3.7 4.5 3.4 1.7 1.8 1.0 0.8 0.3 1.5 1.5 1.6 1.4 2.1 2.1 3.0 2.0 1.5 1.6 2.5 11.5 1.9 0.8 2.7 2.1 1.0 3.3 1.2 1.2 2.8 2.5 1.0 0.8 1.0 0.8 0.3 2.5 1.6 1.9 9.7 1.4 14.4 1.2 9.3 0.8 0.8 3.7 1.6 1.6 1.3 2.6 1.7 0.2 3.4 1.2 6.5 0.0 0.0 0.2 0.5 1.3 6.7 0.0 1.8 0.4 0.1 0.1 0.0 0.0 0.0 0.3 18.7 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.7 8.1 0.1 0.0 2.9 0.1 0.9 0.1 0.6 36.8 0.7 0.0 0.2 30.6 0.0 0.3 0.1 0.1 0.0 0.3 0.9 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.1 0.3 0.6 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.4 0.6 0.1 0.1 3.4 2.0 0.0 0.2 0.3 1.1 0.1 0.8 1.1 0.7 0.9 0.8 1.3 1.2 1.1 1.7 3.4 0.1 2.6 0.9 6.5 1.7 2.3 4.5 3.4 3.0 2.0 1.9 0.8 1.2 1.2 0.0 0.3 0.0 0.4 0.7 0.0 1.2 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.0 4.3 0.7 0.0 0.0 0.0 0.1 1.2 0.5 0.0 0.9 0.4 0.0 0.0 0.0 0.8 0.9 0.3 0.2 1.7 12.6 0.0 1.0 0.2 0.0 1.8 0.0 0.3 0.0 1.9 0.2 0.2 0.5 0.0 1.5 0.0 0.1 TNFSF8 "CD153, CD30LG" ENSG00000106952 "TNF superfamily member 8" P32971 9 114893343-114930595 "Cancer-related genes, CD markers, Predicted membrane proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.6;lymphoid tissue: 48.1" "Group enriched" "Detected in some" 4 "B-cells: 4.4;Hofbauer cells: 3.2;Kupffer cells: 6.5;Macrophages: 4.4;T-cells: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Daudi: 34.1;SuSa: 16.1;U-698: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.82e-2)" "unprognostic (6.56e-3)" "unprognostic (7.79e-2)" "unprognostic (6.05e-2)" "unprognostic (2.67e-1)" "unprognostic (5.58e-3)" "unprognostic (5.26e-3)" "unprognostic (1.82e-2)" "unprognostic (2.37e-1)" "unprognostic (1.24e-1)" "unprognostic (1.70e-1)" "unprognostic (2.02e-1)" "unprognostic (4.75e-2)" "unprognostic (3.01e-2)" "unprognostic (2.76e-2)" "unprognostic (9.61e-2)" "unprognostic (1.82e-1)" 3.6 1.7 1.1 12.0 1.7 12.7 1.8 0.5 0.9 1.6 2.4 1.4 0.6 0.3 1.1 2.5 1.4 1.5 4.6 2.8 1.1 1.2 1.8 1.4 4.9 48.1 1.6 0.6 0.9 1.1 0.0 0.8 2.2 1.0 1.3 1.9 1.4 3.7 0.9 0.7 1.0 7.0 1.3 2.8 14.9 1.7 1.1 1.0 45.6 1.6 0.8 18.5 3.2 1.3 1.7 7.3 3.9 14.1 1.0 18.6 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 28.0 0.0 0.0 0.0 0.0 14.1 0.0 4.1 7.3 13.8 1.0 16.4 9.8 7.3 1.7 18.6 13.5 3.9 1.0 0.9 4.0 5.9 8.7 1.1 1.7 0.5 0.9 1.1 1.2 1.6 0.6 1.0 1.0 0.0 0.0 4.4 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.2 0.0 0.0 1.3 6.5 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 9.2 0.0 0.0 TNFSF9 4-1BB-L ENSG00000125657 "TNF superfamily member 9" P41273 19 6530999-6535928 "Plasma proteins, Predicted intracellular proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "B-cells: 7.5;granulocytes: 9.2;Intestinal endocrine cells: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 40.8" "Low region specificity" "Detected in all" HPA059857 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA059857: AB_2684144" "unprognostic (2.21e-1)" "unprognostic (1.84e-1)" "unprognostic (1.26e-1)" "unprognostic (7.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.19e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-1)" "unprognostic (2.93e-2)" "unprognostic (2.41e-3)" "unprognostic (4.88e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (5.10e-2)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (8.07e-3)" 3.2 2.3 3.9 5.6 7.7 10.7 1.3 4.8 7.4 11.7 3.8 7.2 0.3 1.5 1.0 1.4 11.2 2.5 3.7 1.6 4.8 4.9 1.3 1.5 14.3 3.4 6.2 1.7 1.0 1.4 0.5 0.5 3.2 5.5 1.5 6.4 0.1 2.3 0.8 1.7 1.9 1.6 1.9 4.9 2.4 1.4 5.9 5.5 0.8 0.7 7.7 7.1 3.0 10.2 2.0 0.9 0.1 0.0 0.1 3.4 0.0 4.8 6.2 0.1 2.2 1.2 2.9 0.2 0.7 2.2 1.7 8.2 0.1 8.4 5.2 3.2 1.4 0.0 8.9 2.5 1.0 0.4 0.0 1.2 0.8 8.7 2.0 0.1 0.1 40.8 0.5 4.8 9.5 2.6 1.2 0.3 0.7 4.9 0.0 0.6 0.7 0.4 0.8 0.8 0.3 4.4 0.5 0.0 1.2 10.8 0.1 0.0 0.0 13.8 0.8 2.1 0.3 0.5 7.5 2.8 0.0 4.6 12.3 0.0 12.8 4.5 9.5 4.9 2.7 2.8 0.1 0.0 0.0 0.5 0.0 0.3 2.0 0.1 3.4 0.3 0.4 0.2 0.3 0.0 0.1 0.0 0.9 0.0 0.0 3.9 7.7 4.8 7.4 4.8 4.9 6.2 1.7 5.5 5.5 0.0 5.0 7.5 0.4 2.4 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.5 0.0 0.2 0.0 1.0 0.5 9.2 0.0 3.4 0.0 13.6 0.0 1.9 0.0 0.0 4.1 3.3 2.8 1.0 0.5 0.6 1.5 0.0 0.0 0.1 0.0 1.9 0.0 0.0 1.1 0.1 0.0 1.5 0.1 TNMD "BRICD4, ChM1L, myodulin, TEM, tendin" ENSG00000000005 Tenomodulin Q9H2S6 X 100584802-100599885 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 18.4;seminal vesicle: 25.0" "Cell type enhanced" "Detected in some" 23 "Basal keratinocytes: 1.8;Distal tubular cells: 3.3;Leydig cells: 8.6;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HAP1: 7.3;NTERA-2: 17.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA034961, HPA055634" Uncertain NA NA "HPA034961: AB_10670285, HPA055634: AB_2682868" "unprognostic (3.60e-2)" "unprognostic (9.84e-3)" "unprognostic (3.19e-2)" "unprognostic (7.77e-3)" "unprognostic (2.42e-1)" "unprognostic (2.15e-1)" "unprognostic (2.36e-2)" "unprognostic (1.37e-1)" "unprognostic (9.40e-2)" "unprognostic (9.60e-4)" "unprognostic (6.82e-2)" "unprognostic (5.67e-2)" "unprognostic (1.48e-1)" 18.4 0.1 0.1 0.4 0.0 0.0 10.9 0.0 0.1 0.4 0.6 0.0 11.1 0.0 0.2 8.9 0.4 0.2 0.3 0.7 0.9 0.1 0.7 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 1.9 0.6 1.1 0.4 4.7 1.3 25.0 5.9 2.9 0.5 0.5 0.0 0.1 0.1 0.2 0.0 0.2 0.1 2.6 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.1 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 8.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 TOMM20 "KIAA0016, MAS20, MOM19, TOM20" ENSG00000173726 "Translocase of outer mitochondrial membrane 20" Q15388 1 235109336-235128936 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005585, HPA011562" Supported Enhanced Mitochondria NA NA Mitochondria "CAB005585: AB_628381, HPA011562: AB_1080326" "unprognostic (1.30e-1)" "unprognostic (3.08e-3)" "unprognostic (1.66e-2)" "unprognostic (4.49e-2)" "unprognostic (8.65e-3)" "unprognostic (1.17e-2)" "unprognostic (7.09e-2)" "unprognostic (3.28e-1)" "unprognostic (3.18e-2)" "unprognostic (1.75e-1)" "unprognostic (1.16e-3)" "unprognostic (5.05e-2)" "unprognostic (7.08e-3)" "unprognostic (2.33e-2)" "unprognostic (1.17e-1)" "unprognostic (1.11e-1)" "unprognostic (3.97e-1)" 27.2 35.0 46.3 15.3 60.2 32.7 52.8 40.0 66.2 36.1 25.5 28.4 29.0 24.4 34.5 39.0 28.0 40.0 27.9 33.9 47.1 48.7 41.2 35.2 24.2 33.6 42.5 40.5 50.9 63.6 38.6 25.4 27.1 48.2 34.0 28.2 23.5 47.8 30.7 33.4 33.0 21.3 33.8 54.5 19.0 27.2 16.3 23.0 18.0 58.7 28.4 21.9 36.2 28.9 15.9 20.9 16.4 13.8 9.8 22.6 14.2 35.9 19.0 25.0 21.0 19.7 39.8 38.8 25.9 22.4 24.4 17.8 24.5 25.4 43.8 34.5 22.4 6.9 28.8 27.7 25.1 32.2 10.5 59.2 26.7 25.4 46.3 33.0 59.8 16.1 35.5 34.5 24.4 33.7 33.2 26.4 17.2 56.0 16.2 26.7 10.5 25.4 27.1 56.2 24.0 10.3 31.1 19.1 56.7 27.4 25.9 32.9 77.1 20.1 28.2 55.1 10.7 43.6 65.8 23.3 21.5 13.0 27.1 54.9 38.4 36.1 32.1 25.2 28.7 36.3 16.4 12.4 4.1 13.9 12.9 17.1 15.9 18.1 17.3 15.1 12.7 22.6 17.6 3.9 9.8 13.8 20.9 15.5 14.2 46.3 60.2 40.0 66.2 47.1 48.7 42.5 40.5 48.2 23.0 128.1 138.6 191.4 199.9 237.5 49.8 120.5 135.0 99.0 162.7 47.1 27.5 147.0 135.9 142.1 230.8 135.2 112.6 46.7 180.7 308.9 116.9 237.5 153.6 148.6 144.2 47.7 154.1 102.5 169.4 269.0 143.5 148.5 141.7 101.0 251.0 122.3 199.7 133.3 144.2 188.2 47.6 103.5 156.9 79.9 69.4 250.1 166.8 109.0 224.1 238.8 TOMM20L UNQ9438 ENSG00000196860 "Translocase of outer mitochondrial membrane 20 like" Q6UXN7 14 58395916-58408701 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 28.3" "Cell type enriched" "Detected in some" 8 "Early spermatids: 116.6" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.9" "Group enriched" "Detected in many" 10 "B-cells: 1.0;T-cells: 1.9" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA076397 Enhanced NA NA "HPA076397: " "unprognostic (1.72e-1)" "unprognostic (2.34e-4)" "unprognostic (8.13e-2)" "unprognostic (7.80e-3)" "unprognostic (5.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.35e-1)" "unprognostic (4.28e-2)" "unprognostic (4.93e-1)" "unprognostic (1.37e-3)" "unprognostic (3.06e-2)" "unprognostic (5.66e-3)" "unprognostic (4.57e-6)" "unprognostic (8.75e-2)" "unprognostic (1.50e-1)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" 0.5 0.4 0.2 0.2 0.6 0.1 0.5 0.6 0.8 0.5 0.5 0.8 0.0 0.0 0.9 1.8 0.2 0.4 0.5 0.3 0.2 0.2 0.7 0.3 0.4 2.2 0.3 0.0 0.7 1.2 1.1 0.5 0.3 0.6 0.8 0.5 1.7 0.5 0.5 0.2 0.3 0.4 1.4 0.3 0.3 0.6 28.3 0.0 0.0 0.9 0.0 0.6 0.3 0.2 1.0 0.1 0.0 0.1 0.0 1.9 0.4 1.8 0.0 0.5 1.9 0.0 0.0 2.1 0.3 0.0 0.3 0.0 0.0 0.5 1.6 0.2 1.0 0.0 0.3 0.0 0.0 0.0 2.8 0.6 0.5 0.0 0.5 0.0 1.9 1.3 0.0 0.0 0.0 0.0 0.2 0.9 0.7 0.3 0.2 0.0 0.9 1.2 0.5 0.8 0.3 2.0 2.2 0.8 0.3 0.3 0.5 3.4 2.3 0.5 0.4 0.5 1.2 1.4 2.8 0.0 0.2 0.4 0.0 0.5 0.0 0.4 0.2 1.5 1.5 0.5 0.0 0.0 0.0 0.4 0.1 0.0 1.0 0.1 0.5 0.0 0.2 0.1 1.9 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.6 0.6 0.8 0.2 0.2 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 116.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.5 0.9 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.7 0.4 0.0 0.0 0.0 6.7 0.9 0.4 0.0 0.0 0.2 0.1 TOMM22 TOM22 ENSG00000100216 "Translocase of outer mitochondrial membrane 22" Q9NS69 22 38681948-38685421 "Predicted membrane proteins" "Protein transport, Translocation, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003037 Supported Enhanced Mitochondria NA NA Mitochondria "HPA003037: AB_1080329" "unprognostic (5.54e-2)" "unprognostic (5.04e-3)" "unprognostic (2.74e-3)" "unprognostic (1.48e-2)" "unprognostic (1.32e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (2.90e-5)" "unprognostic (1.01e-1)" "unprognostic (4.28e-1)" "unprognostic (7.01e-2)" "unprognostic (1.64e-2)" "unprognostic (7.39e-2)" "unprognostic (5.44e-2)" "unprognostic (5.32e-2)" "unprognostic (1.99e-1)" "unprognostic (7.86e-2)" "unprognostic (1.64e-1)" 27.6 26.2 25.6 30.1 24.3 29.5 29.4 17.6 28.2 22.2 26.8 14.7 22.4 28.0 20.1 25.6 34.1 24.4 23.8 31.6 23.2 21.0 29.4 46.0 18.1 32.1 24.0 19.8 27.8 47.5 10.9 12.6 27.6 18.5 21.0 32.8 15.8 31.4 26.7 38.2 24.6 29.7 22.8 20.0 27.7 23.3 24.7 11.3 44.2 27.4 40.4 33.5 24.1 30.2 22.5 29.7 6.9 22.9 18.0 21.3 28.6 19.9 11.8 18.1 19.2 13.4 12.5 19.6 16.6 11.5 24.3 18.3 21.4 12.0 20.3 13.7 16.2 16.7 16.6 27.5 25.1 19.6 17.5 30.2 27.3 9.3 20.5 17.5 72.2 19.4 17.1 17.9 21.8 14.3 12.7 17.8 19.9 20.6 16.3 16.1 15.5 21.6 33.6 27.8 26.5 24.1 24.1 23.5 19.2 16.1 14.7 21.3 14.1 19.3 24.6 18.8 12.9 17.0 23.9 18.0 14.9 28.0 13.6 24.9 22.5 27.2 31.4 18.7 25.1 20.3 4.7 22.9 6.9 16.9 22.0 21.3 22.5 18.3 17.8 29.7 18.0 18.7 20.0 2.2 18.0 18.1 25.8 21.1 28.6 25.6 24.3 17.6 28.2 23.2 21.0 24.0 19.8 18.5 11.3 23.8 38.6 136.2 98.0 148.4 29.1 63.5 89.2 22.7 36.4 68.0 15.7 155.1 189.0 110.6 102.3 74.4 68.7 23.3 115.2 191.6 75.3 74.7 74.8 86.3 145.2 27.0 100.8 54.6 102.5 107.7 51.2 105.1 108.0 150.5 120.6 48.5 110.8 66.6 51.2 199.7 22.3 71.1 82.1 92.7 139.6 183.8 113.4 104.6 157.8 129.1 TOMM7 Tom7 ENSG00000196683 "Translocase of outer mitochondrial membrane 7" Q9P0U1 7 22812628-22822852 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 253.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.69e-2)" "unprognostic (1.93e-1)" "unprognostic (4.91e-2)" "unprognostic (2.25e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (6.30e-4)" "unprognostic (2.25e-2)" "unprognostic (7.63e-2)" "unprognostic (1.52e-1)" "unprognostic (6.36e-2)" "unprognostic (2.49e-3)" "unprognostic (1.36e-1)" "unprognostic (1.75e-1)" "unprognostic (3.69e-3)" "unprognostic (2.08e-1)" "unprognostic (3.86e-2)" "unprognostic (1.01e-2)" 63.5 76.7 66.0 36.7 63.2 48.5 70.1 41.3 58.1 42.7 46.2 19.8 41.4 51.3 41.8 36.0 41.1 40.1 39.1 61.6 50.2 42.6 42.1 43.7 37.0 70.0 58.4 42.5 106.7 96.4 23.0 43.4 22.7 44.0 41.7 30.1 39.5 62.4 42.1 253.0 37.5 41.7 71.5 52.0 45.4 43.6 24.4 47.4 21.1 36.6 81.9 44.2 49.1 70.8 117.8 81.0 47.7 51.3 49.5 151.7 130.5 57.3 17.4 19.4 40.9 48.4 51.6 23.4 49.3 37.1 18.7 15.1 12.2 33.7 35.2 51.8 37.7 101.8 40.0 31.9 27.0 17.3 23.4 36.5 19.3 45.2 17.1 45.2 54.3 27.0 74.7 54.0 31.5 45.6 121.1 26.8 37.3 53.4 38.1 30.7 24.3 25.6 59.0 74.7 88.1 44.1 23.6 23.5 55.6 15.8 18.1 16.8 34.7 32.6 73.2 107.1 68.6 52.6 88.5 37.0 21.3 42.5 43.5 46.5 98.2 83.0 64.1 32.1 49.1 80.4 20.4 51.3 47.7 65.5 44.0 81.2 117.8 112.6 79.2 51.8 102.3 151.7 106.3 17.8 49.5 44.2 81.0 84.2 130.5 66.0 63.2 41.3 58.1 50.2 42.6 58.4 42.5 44.0 47.4 241.2 277.9 735.1 671.2 787.2 247.2 1080.5 685.3 305.1 280.9 331.5 62.8 408.1 1125.7 384.0 287.0 426.3 659.7 420.4 808.5 601.1 500.9 701.8 487.8 1059.1 606.1 143.0 510.4 635.3 808.8 297.8 919.7 682.5 747.3 555.5 881.1 452.3 538.0 770.5 714.2 838.1 229.6 478.6 571.8 454.7 180.7 810.0 339.6 682.9 815.4 663.4 TOMM70 "KIAA0719, Tom70, TOMM70A" ENSG00000154174 "Translocase of outer mitochondrial membrane 70" O94826 3 100363431-100401398 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 22.5;Extravillous trophoblasts: 28.8;Proximal tubular cells: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014589, CAB017156, HPA048020" Enhanced Enhanced Mitochondria NA NA 120000 Mitochondria "CAB017156: , HPA014589: AB_1858185, HPA048020: AB_2680234" "unprognostic (2.74e-2)" "unprognostic (2.25e-1)" "unprognostic (2.57e-2)" "unprognostic (2.69e-3)" "unprognostic (2.12e-2)" "unprognostic (5.96e-2)" "unprognostic (2.06e-3)" "unprognostic (5.01e-2)" "unprognostic (9.86e-2)" "unprognostic (1.21e-1)" "unprognostic (9.73e-3)" "unprognostic (5.38e-2)" "unprognostic (2.62e-3)" "unprognostic (1.73e-1)" "unprognostic (3.53e-1)" "unprognostic (3.34e-2)" "unprognostic (6.98e-3)" 21.7 16.1 16.2 12.4 52.4 9.6 21.3 23.6 26.5 16.9 18.2 12.5 13.8 19.4 17.4 15.0 20.8 14.2 12.2 25.2 16.5 19.8 24.9 40.7 10.5 13.5 16.1 20.6 21.7 18.0 20.1 17.1 15.5 29.0 19.0 20.6 13.3 14.5 19.4 42.8 13.3 17.8 22.3 14.0 12.1 14.8 14.7 15.6 18.7 20.5 19.9 16.6 22.3 22.5 4.3 3.0 2.5 2.5 5.6 5.4 1.8 23.5 16.5 14.1 20.2 20.0 21.8 18.4 20.3 17.2 18.5 19.2 23.4 13.6 28.2 17.8 17.0 16.7 23.4 25.4 18.5 27.4 10.7 11.8 32.4 11.0 22.7 12.5 39.4 14.9 19.4 17.1 16.5 26.9 16.5 13.5 13.9 23.0 23.1 22.0 17.4 26.6 15.9 19.4 36.5 35.3 24.5 28.6 30.0 15.0 17.8 25.6 21.3 14.7 23.6 26.4 14.1 30.6 22.4 12.1 16.4 21.7 9.1 15.0 25.2 35.9 48.0 15.7 23.9 12.4 2.2 2.2 2.5 4.1 2.2 5.1 4.3 5.1 4.5 2.9 3.1 5.3 5.4 0.6 5.6 2.5 3.0 2.0 1.8 16.2 52.4 23.6 26.5 16.5 19.8 16.1 20.6 29.0 15.6 6.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 18.7 20.5 14.0 0.0 22.5 10.0 17.3 0.0 0.0 0.0 0.0 16.9 28.8 0.0 0.0 7.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 10.0 0.0 0.0 19.2 0.0 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 TOR1AIP1 "FLJ13142, LAP1B" ENSG00000143337 "Torsin 1A interacting protein 1" Q5JTV8 1 179882042-179925000 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 252.7;Late spermatids: 162.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047151, HPA050546, HPA070991" Enhanced Enhanced "Nuclear membrane" NA NA 17000 "Nuclear membrane" "HPA047151: AB_2679956, HPA050546: AB_2681167, HPA070991: " "unprognostic (1.41e-1)" "unprognostic (3.95e-3)" "unprognostic (1.24e-1)" "unprognostic (2.37e-1)" "unprognostic (8.53e-2)" "unprognostic (1.15e-1)" "unprognostic (9.00e-2)" "unprognostic (6.33e-2)" "unprognostic (7.04e-2)" "unprognostic (8.62e-2)" "unprognostic (1.93e-1)" "unprognostic (9.10e-2)" "unprognostic (4.40e-2)" "unprognostic (4.41e-2)" "unprognostic (2.87e-1)" "unprognostic (7.75e-2)" "unprognostic (4.02e-2)" 29.3 26.4 27.1 25.1 28.1 52.2 25.4 28.6 30.5 33.2 40.0 24.6 38.2 11.6 33.6 33.0 30.1 27.6 27.2 29.3 28.3 20.8 27.2 27.1 25.5 28.2 31.7 23.6 42.5 24.6 31.1 30.5 20.3 27.3 33.6 17.0 27.0 21.9 42.9 44.7 17.8 21.6 46.9 26.1 27.8 30.9 23.5 32.2 24.9 34.5 28.8 21.8 40.7 30.5 19.0 27.9 61.0 35.9 21.4 29.4 29.9 13.2 13.3 9.2 11.8 41.8 28.1 17.8 18.0 21.4 16.9 17.4 10.4 25.1 3.4 20.0 18.3 11.9 23.3 8.6 14.4 19.8 22.5 8.7 9.5 12.6 10.1 19.2 32.0 29.4 22.6 11.3 20.6 19.4 18.9 15.0 14.5 13.7 17.6 17.6 11.8 13.1 10.0 13.2 17.2 5.2 8.1 14.5 9.1 16.3 25.9 7.9 10.9 22.2 21.4 29.9 14.3 16.7 33.1 15.4 23.8 10.0 15.6 21.0 20.0 26.1 7.0 8.9 17.8 35.8 45.8 26.4 61.0 24.9 29.1 29.4 17.7 23.0 24.9 27.9 19.0 23.8 24.4 41.0 21.4 35.9 20.2 24.2 29.9 27.1 28.1 28.6 30.5 28.3 20.8 31.7 23.6 27.3 32.2 29.8 29.7 21.3 56.6 38.5 11.5 22.2 17.8 25.4 25.0 19.2 15.7 14.9 11.6 16.7 252.7 29.5 10.5 0.0 21.9 20.2 28.2 41.1 34.7 27.6 24.0 6.4 19.4 31.9 46.0 162.0 44.0 27.6 13.5 20.8 9.9 36.5 21.9 11.5 55.2 15.6 12.9 25.8 37.5 11.2 19.5 32.9 15.2 37.1 8.1 46.4 TOR1AIP2 "IFRG15, LULL1, NET9" ENSG00000169905 "Torsin 1A interacting protein 2" "Q8NFQ8, Q9H496" 1 179839967-179877803 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051849, HPA058348, HPA070542" Uncertain Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA051849: AB_2681637, HPA058348: AB_2683687, HPA070542: AB_2686278" "unprognostic (1.22e-1)" "unprognostic (8.49e-3)" "unprognostic (2.61e-1)" "unprognostic (2.25e-2)" "unprognostic (2.15e-1)" "unprognostic (1.92e-2)" "unprognostic (4.35e-2)" "unprognostic (1.82e-1)" "unprognostic (6.17e-2)" "unprognostic (7.64e-3)" "unprognostic (3.06e-1)" "unprognostic (3.45e-1)" "prognostic unfavorable (2.29e-4)" "unprognostic (9.99e-2)" "unprognostic (1.05e-1)" "unprognostic (8.36e-2)" "unprognostic (1.36e-1)" 13.3 16.4 11.2 7.3 13.1 30.4 17.5 12.1 11.6 9.1 19.8 10.0 26.9 15.2 11.4 18.7 15.9 8.5 10.1 11.2 11.1 10.0 11.7 37.9 13.2 9.5 9.7 10.4 13.5 16.4 17.4 19.3 41.3 11.0 9.3 8.3 10.0 9.9 16.9 23.0 12.0 30.7 11.6 12.0 9.0 12.2 8.8 11.2 6.7 17.4 10.5 9.5 10.4 13.4 6.9 9.2 17.7 8.7 4.9 7.4 2.5 12.8 12.9 10.3 21.1 25.4 14.2 40.5 17.0 20.9 13.9 14.2 19.1 22.4 10.4 21.7 18.5 7.7 19.4 17.7 17.7 18.8 11.7 9.6 12.7 21.1 15.8 18.6 13.4 14.7 22.3 13.8 18.7 20.4 12.3 19.5 10.0 24.4 11.2 16.7 7.5 9.6 9.3 24.4 14.4 3.2 10.7 14.4 14.8 10.7 22.3 8.6 21.8 19.3 21.6 16.6 20.8 21.5 9.8 25.1 20.2 18.6 11.2 13.4 17.8 25.3 20.9 11.1 9.8 19.0 17.7 6.6 7.7 7.1 8.7 6.8 6.9 6.8 6.1 4.4 6.9 7.4 7.2 13.4 4.9 7.9 9.2 5.7 2.5 11.2 13.1 12.1 11.2 11.1 10.0 9.7 10.4 11.0 11.2 142.9 48.3 19.0 58.0 222.7 27.1 30.5 122.3 32.1 64.8 73.3 35.3 86.6 21.6 52.0 23.9 50.1 79.9 46.7 55.0 166.0 51.6 49.3 18.5 210.0 37.5 30.2 21.1 42.4 43.5 15.3 54.1 35.3 45.5 47.7 44.5 44.6 76.2 32.8 80.2 38.5 31.3 51.8 41.2 27.2 29.1 218.2 150.8 44.9 38.5 99.9 TOR1B "DQ1, MGC4386" ENSG00000136816 "Torsin family 1 member B" O14657 9 129803153-129811281 "Predicted intracellular proteins" "Chaperone, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013403, HPA013697, CAB022709" Approved Uncertain "Nuclear speckles,Cytosol" "Intracellular and membrane" NA NA "Nuclear speckles" Cytosol "CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196" "unprognostic (2.91e-3)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.23e-1)" "unprognostic (3.72e-2)" "unprognostic (1.75e-1)" "unprognostic (5.73e-3)" "unprognostic (1.95e-1)" "unprognostic (7.47e-2)" "unprognostic (1.40e-1)" "unprognostic (2.13e-2)" "unprognostic (2.07e-3)" "unprognostic (4.09e-2)" "unprognostic (1.23e-1)" "unprognostic (5.40e-3)" "unprognostic (1.69e-3)" 14.2 14.4 9.7 13.8 12.2 14.0 18.4 23.6 11.9 11.3 22.5 10.5 11.6 12.3 14.0 8.2 13.5 10.5 15.0 13.3 11.7 11.5 11.8 35.3 13.0 10.8 9.4 9.0 10.8 21.1 13.3 13.6 20.0 10.6 12.9 25.8 10.8 12.8 13.7 13.5 13.0 18.1 14.2 8.9 12.4 14.9 19.5 8.3 16.8 16.4 10.0 11.9 14.9 18.0 4.6 6.2 17.2 14.6 7.3 12.3 8.4 5.3 12.3 5.1 13.7 25.9 19.4 12.0 19.2 12.5 13.2 13.1 10.1 12.2 3.8 12.2 18.8 20.6 21.8 5.6 7.9 13.6 13.9 5.9 3.3 10.4 7.1 11.1 6.3 14.9 11.0 13.9 18.8 9.3 9.8 11.7 10.1 11.5 8.9 12.3 14.9 8.6 9.9 10.8 25.1 9.7 3.5 9.0 11.5 10.1 5.6 7.1 8.3 12.4 14.3 7.6 9.7 20.6 6.2 10.7 25.0 11.9 29.7 16.4 6.5 24.2 3.2 13.7 8.2 16.9 6.3 11.5 17.2 12.2 14.6 12.3 3.9 9.5 10.5 6.2 4.6 7.1 7.1 14.2 7.3 8.5 3.8 9.1 8.4 9.7 12.2 23.6 11.9 11.7 11.5 9.4 9.0 10.6 8.3 8.9 3.7 4.5 5.2 5.8 2.5 5.1 5.1 5.3 1.2 5.2 3.9 9.7 0.0 8.8 9.2 6.7 8.0 0.0 12.2 15.2 8.5 9.2 4.6 13.5 10.8 6.4 18.4 11.6 4.3 10.9 4.0 7.6 3.3 12.6 15.5 4.8 10.0 3.5 5.3 3.0 2.5 19.4 9.5 10.3 7.0 4.6 12.7 10.0 10.7 10.1 TOR2A "FLJ14771, TORP1" ENSG00000160404 "Torsin family 2 member A" "Q5JU69, Q8N2E6" 9 127731524-127735317 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071229 Approved "Secreted to blood" NA NA "HPA071229: AB_2732175" "unprognostic (1.67e-1)" "unprognostic (9.19e-3)" "unprognostic (1.47e-1)" "unprognostic (1.27e-3)" "unprognostic (3.04e-2)" "unprognostic (6.97e-2)" "unprognostic (2.43e-3)" "unprognostic (4.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.33e-1)" "unprognostic (6.51e-3)" "unprognostic (1.05e-2)" "unprognostic (6.98e-2)" "prognostic favorable (7.51e-4)" "unprognostic (1.72e-1)" "unprognostic (3.27e-1)" "unprognostic (2.82e-2)" 7.3 10.1 6.2 11.8 6.2 33.3 10.9 11.3 9.1 7.2 13.5 6.1 8.2 16.4 6.3 10.1 9.9 7.9 11.8 5.8 5.8 5.6 10.2 16.2 12.8 22.8 4.9 7.3 7.9 18.3 3.2 8.3 15.0 5.1 7.1 8.4 6.1 9.7 10.2 2.8 8.3 20.9 4.5 4.0 18.9 12.6 16.9 5.6 18.6 8.0 6.8 10.9 7.2 6.3 6.2 26.3 34.5 28.8 10.0 13.1 13.4 4.0 6.2 5.4 6.6 2.7 2.6 7.1 3.1 3.5 4.4 3.5 4.2 6.9 7.5 4.3 2.4 3.4 12.9 1.7 3.5 1.2 11.9 6.1 2.9 5.5 5.1 4.4 5.9 15.4 4.2 6.5 4.1 2.2 2.2 6.3 8.9 8.6 20.6 2.6 22.9 7.5 18.5 4.8 12.9 5.8 12.9 2.5 16.2 4.6 3.8 11.7 4.7 2.6 9.1 2.6 3.1 20.3 11.5 3.9 2.8 3.4 5.1 3.2 13.3 11.4 3.0 3.6 9.6 2.8 8.8 25.3 34.5 13.1 28.8 10.2 4.8 7.6 12.6 26.3 6.2 5.8 10.2 17.1 10.0 26.6 6.1 11.6 13.4 6.2 6.2 11.3 9.1 5.8 5.6 4.9 7.3 5.1 5.6 3.0 6.1 19.7 3.6 1.3 12.3 0.6 12.7 4.0 3.4 3.5 0.0 32.4 1.7 16.6 51.5 3.5 22.2 46.7 24.4 32.1 2.9 4.9 5.7 6.4 49.3 7.9 21.9 14.7 28.1 6.2 10.6 16.9 3.3 16.2 20.3 12.8 13.5 21.0 10.6 7.3 12.1 0.0 3.1 30.4 7.5 1.3 43.4 15.0 18.5 4.0 TP53I11 PIG11 ENSG00000175274 "Tumor protein p53 inducible protein 11" O14683 11 44885903-44951306 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 322.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 23.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 85.0;T-47d: 47.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059727, HPA061276" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" NA NA "Endoplasmic reticulum, Golgi apparatus" "HPA059727: AB_2684113, HPA061276: AB_2684461" "prognostic unfavorable (7.33e-5)" "unprognostic (1.87e-1)" "unprognostic (4.03e-2)" "unprognostic (3.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (6.55e-2)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.65e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" 33.3 8.0 20.0 13.3 10.7 19.0 27.6 36.0 26.2 14.7 21.1 8.6 17.6 13.6 16.8 10.4 15.6 21.5 28.5 33.1 8.4 12.3 12.5 7.8 21.4 12.8 5.8 8.6 18.2 18.5 3.0 9.5 16.6 14.1 20.6 19.4 17.6 18.9 11.9 12.6 14.5 21.1 23.5 7.4 28.2 18.4 9.9 5.5 6.7 18.9 12.7 14.9 15.1 19.1 5.2 14.1 23.7 11.1 4.6 4.4 2.1 0.0 17.7 6.0 8.6 6.5 0.5 0.1 5.7 11.1 2.0 2.6 1.0 0.1 3.0 4.9 1.5 4.8 3.4 3.4 0.1 0.7 6.5 3.5 0.2 0.2 0.0 12.0 0.1 23.9 27.7 0.4 2.8 1.2 0.4 6.6 6.9 0.4 0.0 2.5 15.1 0.3 27.8 11.1 11.0 5.9 13.5 3.7 1.4 0.0 1.1 85.0 3.1 9.9 21.6 0.0 7.7 47.9 1.7 1.6 13.3 9.4 20.4 0.0 0.1 0.0 0.0 0.0 1.7 3.7 0.0 3.1 0.0 3.1 3.2 4.4 4.9 0.6 3.2 2.6 5.2 0.0 1.1 23.7 4.6 11.1 14.1 0.5 2.1 20.0 10.7 36.0 26.2 8.4 12.3 5.8 8.6 14.1 5.5 20.8 25.7 5.4 31.5 9.6 0.6 6.7 22.9 9.4 14.8 40.1 0.0 47.0 1.7 26.0 74.9 13.5 12.7 0.0 18.6 15.1 11.8 25.6 0.0 0.9 32.0 0.0 34.5 80.4 10.5 322.1 11.2 9.6 10.1 13.6 24.2 0.5 28.8 7.0 7.1 0.0 0.9 12.9 12.6 2.1 6.0 3.9 57.1 4.4 45.7 36.0 TP53I13 DSCP1 ENSG00000167543 "Tumor protein p53 inducible protein 13" Q8NBR0 17 29566052-29573157 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 41.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.93e-1)" "unprognostic (4.90e-2)" "unprognostic (2.50e-3)" "unprognostic (9.31e-3)" "unprognostic (4.94e-3)" "unprognostic (1.05e-2)" "unprognostic (2.17e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (5.47e-2)" "prognostic favorable (3.13e-5)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.10e-6)" "unprognostic (1.93e-1)" "unprognostic (1.94e-1)" "unprognostic (1.41e-1)" "unprognostic (2.92e-2)" 28.2 10.4 10.2 19.4 10.5 19.6 24.2 4.8 8.2 17.9 17.6 9.3 14.7 27.3 16.3 17.3 9.7 10.2 17.4 28.5 9.8 5.3 20.4 30.2 14.6 22.9 13.8 5.6 16.1 33.3 8.7 30.2 21.9 8.8 17.1 5.6 11.2 15.4 13.9 14.5 8.8 27.1 15.7 10.3 24.3 25.1 33.5 12.0 13.3 18.9 7.3 12.4 15.2 16.3 9.7 41.6 16.8 5.3 9.4 10.6 5.1 9.7 26.6 8.2 23.3 14.0 9.6 14.9 16.2 7.5 10.0 10.8 11.0 4.0 6.8 17.9 10.0 14.2 23.9 3.8 4.8 1.4 29.5 14.3 4.1 26.5 10.0 12.5 6.8 12.6 8.3 6.9 8.8 3.1 6.9 6.0 14.3 5.9 12.7 4.4 15.9 16.7 27.4 3.5 11.5 10.0 31.7 19.5 24.0 9.2 6.4 3.6 11.7 20.3 7.6 7.7 3.1 22.0 29.1 6.8 9.9 15.1 10.5 12.7 26.3 11.5 5.4 17.5 4.2 11.6 16.8 4.3 7.4 10.5 5.3 10.6 9.3 10.2 7.9 9.6 9.7 8.1 7.2 0.3 9.4 3.5 41.6 9.1 5.1 10.2 10.5 4.8 8.2 9.8 5.3 13.8 5.6 8.8 12.0 0.0 4.8 25.1 34.4 12.2 0.6 24.5 7.6 2.7 5.7 38.4 5.9 41.8 6.6 32.4 9.4 11.3 28.2 0.0 25.0 31.8 50.5 24.6 16.1 17.4 24.6 6.4 19.1 10.4 10.5 5.7 31.9 29.3 28.7 33.3 26.3 19.3 27.3 28.8 17.7 14.9 6.8 19.4 15.6 62.6 38.7 6.5 18.9 27.7 26.9 31.5 TPBG "5T4, 5T4-AG" ENSG00000146242 "Trophoblast glycoprotein" Q13641 6 82363206-82370828 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 67.5;Urothelial cells: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 3.2" "Lineage enriched" "Detected in single" 16 "T-cells: 3.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.9;hTCEpi: 30.5;hTEC/SVTERT24-B: 27.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010554 Enhanced Approved Nucleoplasm NA NA 330000 Nucleoplasm "HPA010554: AB_1858206" "unprognostic (3.03e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (6.68e-4)" "unprognostic (1.06e-1)" "unprognostic (4.52e-3)" "unprognostic (7.47e-3)" "unprognostic (8.55e-2)" "unprognostic (3.55e-3)" "unprognostic (8.39e-2)" "unprognostic (3.42e-2)" "unprognostic (8.02e-2)" "unprognostic (4.94e-1)" "unprognostic (3.77e-1)" "unprognostic (7.46e-2)" "unprognostic (1.06e-1)" "unprognostic (1.54e-1)" "unprognostic (5.57e-2)" 10.2 2.9 0.4 4.8 15.7 1.2 10.2 0.0 8.8 22.0 4.6 1.9 12.1 4.2 12.6 4.6 35.2 8.4 9.3 5.3 0.7 2.0 6.6 1.7 4.1 3.0 4.3 1.4 5.8 4.8 4.1 11.2 16.9 17.6 14.1 4.6 5.1 11.5 9.4 2.6 12.6 4.9 16.2 4.5 5.7 6.2 3.3 7.9 4.2 13.0 6.8 4.5 22.9 25.5 0.0 0.0 0.0 0.1 0.0 3.2 0.0 4.5 6.8 2.5 5.0 9.1 13.1 4.3 21.4 24.9 4.3 5.9 0.8 6.4 0.0 2.3 11.7 12.1 8.9 2.8 11.7 4.6 0.0 3.6 2.6 3.3 0.2 7.4 0.2 2.2 8.3 30.5 27.9 10.4 3.9 1.0 0.2 0.4 0.0 1.1 9.3 0.0 0.0 2.9 2.0 5.4 0.0 4.8 0.0 6.3 6.4 1.2 3.9 4.7 6.8 0.0 4.9 11.3 0.9 3.1 3.7 3.7 7.9 4.6 0.0 0.0 0.0 18.2 0.3 3.9 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 15.7 0.0 8.8 0.7 2.0 4.3 1.4 17.6 7.9 11.9 6.2 0.0 63.5 60.3 0.1 2.0 12.7 5.3 18.2 52.4 0.0 36.6 0.0 30.7 6.2 17.9 2.6 0.0 40.7 67.5 22.6 45.6 0.0 0.0 3.2 1.6 1.2 6.7 1.2 4.1 11.8 4.0 16.9 0.0 16.1 1.7 26.7 16.4 5.6 0.4 0.2 32.3 19.1 1.9 5.3 27.4 55.2 2.9 9.7 71.2 TPBGL ENSG00000261594 "Trophoblast glycoprotein like" P0DKB5 11 75240905-75243697 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.2;testis: 10.8" "Group enriched" "Detected in some" 5 "Bipolar cells: 3.5;Horizontal cells: 1.6;Melanocytes: 3.3;Muller glia cells: 5.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.0;HMC-1: 5.1;OE19: 1.8;SCLC-21H: 5.1;SK-MEL-30: 2.2;WM-115: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.55e-2)" "unprognostic (4.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.70e-3)" "unprognostic (1.93e-2)" "unprognostic (5.52e-2)" "unprognostic (1.50e-1)" "unprognostic (2.27e-2)" "unprognostic (1.02e-1)" "unprognostic (3.73e-2)" "unprognostic (3.12e-2)" "unprognostic (3.47e-2)" "unprognostic (1.49e-14)" "unprognostic (3.04e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (4.62e-2)" 1.4 6.5 3.7 1.8 14.2 0.6 0.6 0.4 11.0 1.2 0.9 0.0 0.0 0.7 1.5 0.7 0.6 1.2 1.4 0.6 3.4 1.7 0.6 0.5 1.0 1.2 0.9 1.8 0.6 0.9 0.6 0.6 0.6 10.2 0.7 0.8 1.5 0.6 0.8 0.3 0.8 1.0 2.7 0.7 0.7 0.7 10.8 0.8 0.0 0.7 0.0 1.3 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.6 1.8 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.3 0.8 0.0 2.2 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 14.2 0.4 11.0 3.4 1.7 0.9 1.8 10.2 0.8 0.0 0.0 0.0 0.0 0.0 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 5.7 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 TPCN1 "FLJ20612, KIAA1169, TPC1" ENSG00000186815 "Two pore segment channel 1" Q9ULQ1 12 113221050-113298585 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 49.6;hTERT-RPE1: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039757 Approved NA NA "HPA039757: AB_10795156" "unprognostic (7.87e-2)" "unprognostic (7.98e-2)" "unprognostic (1.10e-2)" "unprognostic (1.22e-1)" "unprognostic (7.34e-2)" "unprognostic (3.07e-2)" "unprognostic (1.32e-3)" "unprognostic (4.53e-1)" "unprognostic (5.34e-2)" "unprognostic (1.48e-2)" "unprognostic (1.74e-3)" "unprognostic (1.52e-1)" "unprognostic (1.11e-1)" "unprognostic (2.23e-1)" "unprognostic (9.08e-2)" "unprognostic (1.39e-1)" "unprognostic (2.47e-3)" 18.1 28.6 16.0 15.8 24.8 9.7 17.7 67.8 28.1 19.1 19.1 30.8 23.6 17.0 23.9 19.7 21.8 19.2 25.3 46.5 18.0 11.4 31.2 15.2 18.6 13.6 34.4 17.9 25.6 30.3 28.5 25.0 16.4 28.4 16.3 17.5 26.7 29.9 28.7 28.4 13.2 19.4 16.9 22.1 18.0 11.3 9.7 27.8 5.4 32.5 16.1 24.8 17.4 15.5 5.5 9.3 5.0 13.7 8.6 3.4 3.8 4.8 14.8 1.7 2.1 13.3 15.1 5.0 6.9 49.6 3.7 4.4 10.9 16.9 11.2 10.5 7.1 12.1 6.1 3.9 12.4 5.0 1.3 3.0 4.2 7.5 6.0 17.3 1.4 9.5 14.3 6.3 7.2 12.7 41.5 5.6 3.2 4.7 4.0 4.5 5.9 0.4 22.1 2.8 6.0 7.5 0.8 2.1 21.8 11.9 17.9 2.1 3.3 5.6 14.5 5.8 3.6 4.6 13.5 2.3 5.5 2.7 7.5 4.3 6.7 4.0 9.7 16.2 3.5 4.1 5.0 13.7 1.2 1.7 2.3 2.1 3.5 2.4 2.3 9.3 5.5 3.4 2.1 0.5 8.6 0.3 4.9 1.1 3.8 16.0 24.8 67.8 28.1 18.0 11.4 34.4 17.9 28.4 27.8 8.9 18.7 3.7 4.9 4.0 16.8 28.8 12.7 12.0 9.1 26.2 15.7 5.9 1.7 11.7 10.3 4.4 26.0 0.0 15.9 2.6 8.7 9.8 31.1 17.1 18.6 47.7 27.6 19.6 17.3 8.7 19.8 9.6 6.8 4.6 24.8 20.4 10.4 19.9 20.1 17.5 13.4 0.0 10.3 3.0 2.0 3.4 5.5 6.1 15.8 14.8 TPCN2 TPC2 ENSG00000162341 "Two pore segment channel 2" Q8NHX9 11 69048897-69162440 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Melanocytes: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 21.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA016561, HPA027080" Supported Approved Nucleoli NA NA Nucleoli "HPA016561: AB_1858207, HPA027080: AB_10600917" "unprognostic (1.29e-1)" "unprognostic (1.53e-2)" "unprognostic (1.39e-1)" "unprognostic (2.95e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.96e-4)" "unprognostic (7.60e-2)" "unprognostic (7.04e-2)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.15e-2)" "unprognostic (1.89e-2)" "unprognostic (6.87e-2)" "unprognostic (2.22e-1)" "unprognostic (2.24e-3)" "unprognostic (5.01e-2)" "unprognostic (4.88e-2)" 11.0 6.2 6.3 8.7 11.1 9.2 9.4 14.5 14.0 18.0 18.0 9.2 11.3 15.0 22.4 12.4 11.2 13.8 12.1 7.5 6.2 4.9 11.6 15.7 8.7 10.4 6.0 7.7 12.1 6.8 6.4 7.2 7.1 8.8 13.1 7.4 20.7 8.1 17.8 8.1 16.1 13.7 15.6 6.0 10.9 11.4 8.5 4.9 6.4 7.3 7.4 10.1 11.0 11.2 2.0 7.5 7.1 9.9 6.9 3.2 3.6 3.4 8.9 2.7 4.2 2.6 2.1 11.7 3.9 4.7 4.7 2.8 7.6 10.9 4.5 5.6 4.8 3.7 8.0 2.2 4.4 1.4 2.8 2.3 6.1 9.5 2.5 2.5 4.3 8.3 3.3 2.3 2.4 2.5 1.9 3.2 7.4 2.9 21.1 2.9 8.1 3.6 10.3 3.2 10.1 3.2 3.4 2.2 5.5 4.7 5.6 2.4 3.2 4.5 10.2 15.7 4.1 6.6 5.7 2.9 3.2 4.7 5.9 3.6 5.5 2.3 2.3 5.2 4.6 6.7 4.3 9.8 2.9 1.0 9.8 0.9 2.0 2.1 2.1 7.5 1.5 1.7 2.0 7.1 6.9 9.9 3.2 3.2 3.6 6.3 11.1 14.5 14.0 6.2 4.9 6.0 7.7 8.8 4.9 8.9 1.0 7.5 2.1 3.5 1.5 3.2 7.6 0.0 1.2 12.2 2.0 2.3 14.9 6.0 16.2 2.9 6.2 23.3 7.6 3.7 3.5 1.2 2.3 12.9 10.5 0.0 0.0 6.2 15.4 1.7 5.8 7.4 33.7 4.6 2.9 2.5 3.7 3.5 6.3 9.6 4.2 6.5 5.9 1.9 3.8 3.0 1.6 2.6 3.4 1.4 TPM1 "C15orf13, CMH3" ENSG00000140416 "Tropomyosin 1" P09493 15 63042632-63071915 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 544.2;skeletal muscle: 589.5" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 12627.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 23.8" "Group enriched" "Detected in all" 4 "dendritic cells: 8.4;granulocytes: 23.8;monocytes: 11.6" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 206.7;SuSa: 259.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000261, HPA009066, CAB017698, HPA047089, HPA053624" Supported Approved "Actin filaments,Cytosol" NA NA 280000000 "Actin filaments" Cytosol "CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.00e-2)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.35e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-2)" "unprognostic (1.20e-1)" "unprognostic (1.66e-3)" "unprognostic (3.38e-2)" "unprognostic (1.78e-1)" "unprognostic (5.53e-2)" "prognostic unfavorable (7.30e-4)" 17.9 5.7 5.5 32.4 5.2 1.2 15.2 5.6 5.1 48.1 119.7 2.4 84.2 14.6 72.4 38.3 121.6 36.2 75.3 544.2 4.1 2.6 14.5 4.4 10.5 3.3 3.3 7.0 27.0 29.3 1.9 3.2 17.7 4.1 72.5 28.0 19.1 12.9 81.3 589.5 6.5 39.5 245.2 2.7 6.5 51.7 9.6 2.3 0.4 7.7 121.7 5.9 193.8 38.7 2.7 8.4 23.8 11.6 1.2 3.4 9.9 33.8 22.3 27.0 1.3 9.4 5.9 88.9 95.4 35.1 58.7 43.6 15.7 6.7 0.1 43.8 95.3 39.4 18.8 22.9 15.3 39.1 0.8 3.2 5.0 24.1 7.6 26.5 0.2 1.1 8.3 8.8 48.2 12.8 206.7 15.3 0.8 0.5 1.2 44.8 17.5 1.5 0.4 32.1 8.0 3.8 0.5 9.5 0.9 83.8 18.7 6.4 4.4 11.4 18.1 4.0 259.0 13.2 0.9 70.7 77.6 38.1 11.5 67.6 0.3 0.2 0.4 21.9 1.3 53.7 23.8 6.1 2.9 2.5 11.6 2.0 2.7 2.4 2.7 8.4 2.6 2.6 2.3 6.7 1.2 7.9 1.7 3.4 9.9 5.5 5.2 5.6 5.1 4.1 2.6 3.3 7.0 4.1 2.3 53.6 87.9 11.7 166.6 63.8 52.3 12627.3 392.4 116.4 116.0 301.8 361.3 128.4 159.2 2265.1 4.5 128.8 537.1 0.0 1464.0 2646.2 335.9 214.6 50.8 122.9 165.5 49.3 257.1 251.7 29.3 13.2 189.8 54.2 77.6 57.7 811.2 43.7 1740.7 585.7 1062.5 207.5 461.5 1021.9 1520.7 21.6 75.4 44.2 86.2 21.9 280.4 186.5 TPO TPX ENSG00000115705 "Thyroid peroxidase" P07202 2 1374223-1543711 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "thyroid gland: 411.3" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 2.2;Early spermatids: 3.0;Endothelial cells: 1.1;Late spermatids: 3.8;Peritubular cells: 3.5" "Cancer enriched" "Detected in some" 364 "thyroid cancer: 188.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "memory CD4 T-cell: 5.1;T-reg: 3.0" "Lineage enriched" "Detected in single" 21 "T-cells: 5.1" "Group enriched" "Detected in some" 5 "Karpas-707: 14.3;RPMI-8226: 6.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007987, CAB009587" Enhanced "Intracellular and membrane" NA NA "CAB009587: , HPA007987: AB_1080270" "unprognostic (1.55e-1)" "unprognostic (1.04e-1)" "unprognostic (2.88e-1)" "unprognostic (1.77e-2)" "unprognostic (3.56e-2)" "unprognostic (9.11e-2)" "unprognostic (2.24e-2)" "unprognostic (1.85e-1)" "unprognostic (1.32e-1)" "unprognostic (1.19e-4)" "unprognostic (2.61e-2)" "unprognostic (3.29e-1)" "unprognostic (5.44e-4)" "unprognostic (1.21e-1)" "unprognostic (3.73e-2)" "unprognostic (4.98e-3)" "unprognostic (7.10e-3)" 1.1 0.0 0.1 0.1 0.1 0.0 0.9 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.4 1.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.1 0.5 0.0 0.2 0.1 0.1 7.1 0.2 0.1 0.1 0.1 411.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 5.1 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.3 0.0 1.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.1 1.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.3 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 3.0 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TPRA1 "FLJ32197, GPR175, TMEM227, TPRA40" ENSG00000163870 "Transmembrane protein adipocyte associated 1" Q86W33 3 127573069-127598251 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019784 Approved Approved Vesicles NA NA Vesicles "HPA019784: AB_2670266" "unprognostic (1.52e-1)" "unprognostic (1.33e-2)" "unprognostic (9.41e-3)" "unprognostic (1.66e-2)" "unprognostic (6.91e-3)" "unprognostic (9.74e-2)" "prognostic unfavorable (6.46e-4)" "unprognostic (3.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.91e-1)" "unprognostic (1.17e-1)" "unprognostic (1.11e-1)" "unprognostic (2.02e-2)" "unprognostic (1.73e-2)" "unprognostic (4.42e-2)" "unprognostic (2.09e-1)" "unprognostic (4.28e-2)" 17.6 21.0 14.6 11.4 13.5 22.4 22.1 20.3 16.7 22.6 25.8 15.9 26.9 17.1 21.5 16.7 19.5 21.9 18.2 15.4 14.9 12.4 18.1 23.5 20.4 13.1 16.3 11.6 21.9 30.4 24.0 15.9 35.7 14.0 19.5 11.1 21.0 24.3 19.5 31.3 28.7 18.2 16.9 10.7 17.7 16.8 18.3 12.5 13.9 30.2 15.8 14.5 19.5 19.8 9.5 19.2 13.7 16.3 6.5 14.1 7.3 21.5 15.5 6.2 12.3 24.0 13.3 23.3 13.5 15.2 11.2 10.2 10.0 14.1 18.9 24.6 16.6 36.9 22.8 10.2 15.5 5.9 11.9 9.1 12.4 21.1 9.6 26.3 7.8 24.3 13.2 13.1 7.7 19.1 23.4 8.4 13.0 7.5 17.6 13.7 17.9 8.7 21.2 10.5 11.3 12.0 16.3 9.4 16.8 13.1 8.8 12.5 4.8 21.0 25.8 17.1 5.1 13.0 18.3 15.4 13.7 8.3 29.4 7.4 15.1 11.2 18.2 15.2 18.8 10.4 3.6 16.3 13.7 10.2 11.0 12.9 9.5 12.4 14.1 19.2 8.2 9.9 10.0 10.3 6.5 9.6 13.4 8.7 7.3 14.6 13.5 20.3 16.7 14.9 12.4 16.3 11.6 14.0 12.5 20.8 6.5 13.8 19.1 44.4 7.0 11.1 10.2 4.0 9.1 24.4 3.9 48.5 5.0 23.8 2.4 25.4 18.2 0.0 17.0 37.2 30.5 18.2 18.4 17.9 30.0 4.8 16.7 19.6 16.2 1.1 31.1 22.0 28.7 81.2 16.1 11.2 24.3 15.9 18.4 12.3 8.6 12.9 24.4 7.7 18.1 47.6 57.0 12.1 19.6 17.8 TPSG1 "PRSS31, TMT" ENSG00000116176 "Tryptase gamma 1" Q9NRR2 16 1221651-1225257 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 16.0" "Cell type enriched" "Detected in some" 6 "Mucus-secreting cells: 264.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HMC-1: 22.8;MCF7: 7.4" "Not detected" "Not detected" HPA060458 Enhanced NA NA "HPA060458: AB_2684283" "unprognostic (1.86e-1)" "unprognostic (3.46e-1)" "unprognostic (5.21e-3)" "unprognostic (1.27e-1)" "unprognostic (5.58e-2)" "unprognostic (1.18e-2)" "unprognostic (3.45e-2)" "unprognostic (4.60e-2)" "unprognostic (9.97e-2)" "unprognostic (1.34e-1)" "unprognostic (8.92e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.76e-8)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (8.65e-4)" "unprognostic (5.70e-2)" 1.3 0.6 0.4 4.5 0.4 0.0 3.1 0.4 0.4 0.6 14.4 0.4 0.4 14.0 1.2 0.4 0.7 0.5 1.0 0.4 0.4 0.0 0.4 0.4 0.6 0.4 0.4 0.4 2.0 0.4 0.0 3.2 0.4 0.4 1.1 8.8 0.4 0.4 0.4 0.4 1.1 16.0 1.2 0.4 0.4 1.0 1.3 0.4 0.4 0.4 1.1 0.4 1.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 1.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 41.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 264.6 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 TPST1 TANGO13A ENSG00000169902 "Tyrosylprotein sulfotransferase 1" O60507 7 66205199-66420543 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Fibroblasts: 72.5;Spermatocytes: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 21.3;neutrophil: 17.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047415, HPA061837" Approved Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA047415: AB_10964056, HPA061837: AB_2732672" "unprognostic (7.46e-2)" "unprognostic (1.45e-1)" "unprognostic (8.62e-2)" "unprognostic (3.43e-2)" "unprognostic (3.52e-2)" "unprognostic (1.78e-3)" "unprognostic (5.71e-2)" "unprognostic (8.21e-2)" "unprognostic (3.59e-1)" "unprognostic (9.25e-3)" "unprognostic (4.12e-2)" "unprognostic (4.98e-1)" "prognostic unfavorable (8.16e-6)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.48e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (3.73e-5)" 15.4 12.8 16.7 9.8 28.2 5.6 11.2 12.2 19.2 34.0 7.7 8.8 3.4 3.4 20.2 13.8 10.8 10.9 34.2 6.6 26.1 22.2 13.4 38.9 9.0 5.9 15.3 12.2 11.5 7.1 8.1 19.6 23.2 28.1 15.5 7.9 9.7 5.4 15.8 2.9 6.2 5.9 35.7 27.5 9.0 10.0 19.6 11.4 0.3 10.7 3.2 5.2 27.2 19.9 6.3 0.1 21.3 1.1 3.9 2.0 0.8 4.3 2.6 6.8 8.6 20.7 16.6 2.1 8.2 19.0 10.2 14.4 8.3 2.5 0.5 6.6 16.8 16.2 3.4 6.3 9.3 13.5 1.2 3.6 0.9 6.4 6.3 24.5 0.7 0.7 23.5 7.4 19.4 8.6 11.3 12.3 1.1 0.4 3.9 15.5 2.3 0.0 1.1 6.1 0.1 3.5 3.0 5.5 4.4 10.5 4.6 3.9 16.8 10.4 0.8 22.1 14.1 3.3 1.7 23.4 13.0 8.3 9.3 14.9 3.5 4.8 1.7 11.5 2.6 18.3 21.3 1.1 10.7 0.4 0.0 0.3 2.4 0.2 0.3 0.1 6.3 1.1 2.0 17.3 3.9 0.0 0.0 0.0 0.8 16.7 28.2 12.2 19.2 26.1 22.2 15.3 12.2 28.1 11.4 0.0 6.2 6.2 7.4 9.6 9.4 1.2 2.5 18.7 5.7 29.6 2.0 1.7 8.3 19.8 7.2 17.9 0.0 0.0 42.8 3.7 72.5 4.4 4.6 28.0 14.3 6.4 7.5 12.9 5.1 9.1 44.5 5.6 13.5 27.1 0.7 4.9 20.9 0.0 35.0 3.1 3.7 6.5 26.4 81.4 24.5 6.6 3.2 0.0 0.4 7.0 TPST2 TANGO13B ENSG00000128294 "Tyrosylprotein sulfotransferase 2" O60704 22 26521983-26596717 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 71.0;pancreas: 192.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 157.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 57.1" "Low region specificity" "Detected in all" HPA021054 Enhanced "Intracellular and membrane" NA NA 33000 "HPA021054: AB_1858221" "unprognostic (2.24e-1)" "unprognostic (1.70e-1)" "unprognostic (1.74e-2)" "prognostic favorable (8.08e-5)" "unprognostic (8.88e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-2)" "unprognostic (9.70e-2)" "unprognostic (3.18e-2)" "unprognostic (3.38e-1)" "unprognostic (2.70e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (2.34e-6)" "unprognostic (9.68e-2)" "unprognostic (9.21e-3)" "unprognostic (5.62e-2)" "unprognostic (2.01e-1)" 5.8 8.4 4.7 3.7 3.6 5.2 9.0 2.1 6.9 4.6 2.9 3.0 7.4 3.5 4.7 31.8 4.5 4.1 3.2 5.2 5.2 3.2 5.7 20.0 10.7 4.8 3.7 3.6 2.4 192.5 1.1 2.9 11.0 3.2 3.8 2.3 4.0 2.8 7.9 8.6 4.0 3.1 3.2 2.8 8.9 3.0 4.8 3.1 3.0 12.2 2.2 5.2 4.5 6.7 4.3 20.0 71.0 15.1 57.2 46.4 35.2 4.3 3.2 4.2 2.1 8.9 6.9 5.8 9.8 17.6 8.0 7.3 2.1 2.2 7.4 2.6 17.5 4.2 6.8 3.1 6.7 4.6 3.0 5.9 17.8 2.0 4.4 3.7 2.0 57.1 7.4 10.8 8.0 2.7 8.1 14.7 3.4 17.8 23.2 6.1 4.9 8.2 13.9 5.5 3.4 3.2 7.7 5.6 20.5 2.4 4.9 3.1 2.2 4.5 4.0 5.4 6.4 1.8 8.5 11.6 9.9 22.4 8.0 9.4 7.5 10.4 7.1 7.5 8.0 8.9 71.0 13.4 18.6 46.4 14.5 13.0 4.1 10.9 34.5 8.4 4.3 5.4 31.4 28.4 57.2 15.1 20.0 12.2 35.2 4.7 3.6 2.1 6.9 5.2 3.2 3.7 3.6 3.2 3.1 14.9 13.0 19.3 70.7 33.9 7.0 10.6 38.2 13.4 4.5 21.0 5.9 157.8 23.2 11.5 8.4 57.7 7.8 0.0 56.2 41.8 11.9 27.5 49.9 68.4 105.1 6.4 0.0 93.9 52.0 2.6 4.9 37.1 27.0 10.8 9.2 2.0 65.3 10.5 3.9 7.6 4.3 6.5 17.3 2.9 16.6 31.5 119.6 57.3 12.3 71.9 TPTE "CT44, PTEN2" ENSG00000274391 "Transmembrane phosphatase with tensin homology" P56180 21 10521553-10606140 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 69 "testis: 78.6" "Group enriched" "Detected in some" 14 "Spermatocytes: 282.4;Spermatogonia: 73.0" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.4;K-562: 8.6;Karpas-707: 7.0;MCF7: 5.1;PC-3: 5.2;RPMI-8226: 9.5;SuSa: 8.9;U-2 OS: 4.6;U-266/70: 8.5" "HPA049690, HPA068342" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA049690: AB_2680850, HPA068342: AB_2685976" "unprognostic (3.63e-2)" 0.1 0.0 0.0 0.7 0.2 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.8 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.7 0.3 0.0 0.0 0.2 0.4 0.0 0.9 0.0 78.6 0.0 0.4 0.1 0.4 0.8 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 7.0 0.0 5.1 0.0 0.0 1.2 0.0 5.2 0.0 0.0 9.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 8.9 0.0 0.0 0.0 2.0 4.6 2.4 0.0 8.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.6 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 12.9 0.0 282.4 73.0 0.0 0.9 0.0 0.0 0.0 TPTE2 TPIP ENSG00000132958 "Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2" Q6XPS3 13 19422877-19536762 "Enzymes, Plasma proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 12.3" "Cell type enhanced" "Detected in some" 23 "Collecting duct cells: 1.8;Early spermatids: 3.5;Spermatocytes: 9.3;Spermatogonia: 2.5" "Cancer enriched" "Detected in single" 6 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 10.1;Karpas-707: 2.9" HPA068342 Approved "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA068342: AB_2685976" "unprognostic (2.50e-1)" "unprognostic (2.10e-1)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (1.25e-2)" "unprognostic (5.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (5.40e-2)" "unprognostic (3.67e-2)" "unprognostic (2.81e-1)" "unprognostic (1.05e-12)" "unprognostic (1.04e-1)" "unprognostic (1.47e-1)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" 0.0 0.1 0.4 0.2 1.0 0.0 0.1 0.7 0.8 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.2 12.3 0.0 0.6 0.0 0.0 0.5 0.4 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 10.1 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 2.9 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.4 0.0 0.0 0.1 0.0 0.0 1.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 9.3 2.5 0.1 0.1 0.0 0.0 0.0 TRAF3IP3 T3JAM ENSG00000009790 "TRAF3 interacting protein 3" Q9Y228 1 209756032-209782320 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 86.5;lymphoid tissue: 69.5" "Cell type enhanced" "Detected in many" 20 "B-cells: 61.1;granulocytes: 55.6;T-cells: 188.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 39.7;JURKAT: 22.7;Karpas-707: 16.5;MOLT-4: 20.5;NB-4: 23.6;THP-1: 22.3;U-266/70: 24.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040796 Enhanced Approved Vesicles NA NA Vesicles "HPA040796: AB_10794861" "prognostic favorable (4.11e-4)" "unprognostic (1.11e-1)" "unprognostic (1.51e-3)" "unprognostic (1.36e-4)" "unprognostic (2.67e-1)" "unprognostic (1.91e-5)" "unprognostic (3.83e-3)" "prognostic favorable (8.15e-4)" "unprognostic (5.30e-2)" "unprognostic (3.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.39e-1)" "unprognostic (1.38e-4)" "unprognostic (3.08e-1)" "unprognostic (2.93e-2)" "unprognostic (3.16e-2)" "unprognostic (4.21e-2)" 2.2 0.8 1.7 30.6 2.1 9.8 1.3 0.6 1.5 1.5 3.8 2.2 0.3 2.3 1.5 1.4 2.5 1.7 4.6 1.2 1.7 1.4 3.4 2.4 5.8 32.6 3.8 0.6 1.2 1.3 0.0 1.0 1.0 2.7 2.2 3.6 1.7 8.4 1.3 0.7 1.1 19.8 1.0 3.8 38.3 4.1 1.4 2.6 69.5 2.4 1.5 33.6 5.7 1.9 43.9 25.3 54.9 29.5 50.1 86.5 56.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 39.7 0.0 3.7 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 16.5 0.0 0.0 20.5 23.6 0.0 0.0 0.0 2.4 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 24.5 8.5 1.5 0.0 11.1 0.0 54.9 24.1 24.8 48.9 25.7 51.8 43.9 67.8 55.9 25.3 41.4 76.9 60.8 6.5 50.1 29.5 18.6 86.5 56.3 1.7 2.1 0.6 1.5 1.7 1.4 3.8 0.6 2.7 2.6 3.0 14.8 61.1 3.6 2.1 1.5 0.6 2.5 1.4 0.0 0.0 0.0 0.3 10.0 0.1 8.9 0.7 0.2 0.0 0.2 0.3 1.1 0.4 55.6 3.2 22.1 0.0 0.0 4.3 27.4 5.7 0.3 22.8 10.1 5.4 0.2 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.3 0.5 0.2 1.9 0.3 188.4 0.4 2.0 TRAM1 "TRAM, TRAMP" ENSG00000067167 "Translocation associated membrane protein 1" Q15629 8 70573442-70608387 "Plasma proteins, Predicted membrane proteins" "Host-virus interaction, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023929 Approved NA NA "HPA023929: AB_1858239" "unprognostic (3.85e-2)" "prognostic unfavorable (2.06e-4)" "unprognostic (8.34e-3)" "unprognostic (1.31e-1)" "unprognostic (3.52e-2)" "unprognostic (5.93e-2)" "unprognostic (8.94e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-1)" "unprognostic (2.12e-1)" "unprognostic (3.39e-3)" "unprognostic (3.61e-2)" "prognostic unfavorable (7.79e-4)" "unprognostic (7.45e-2)" "unprognostic (1.61e-1)" "unprognostic (2.31e-1)" "unprognostic (3.85e-2)" 38.0 31.3 14.6 22.8 15.5 20.8 33.4 10.3 13.0 36.6 36.0 18.5 37.7 21.6 32.9 37.7 26.6 28.7 28.7 30.7 15.7 15.0 59.4 123.7 58.6 31.9 19.0 10.4 32.9 89.0 23.6 30.9 45.9 14.6 32.2 19.4 23.5 84.4 45.1 16.1 19.2 40.0 23.2 24.0 46.8 24.9 26.9 16.0 49.1 60.9 19.0 31.5 33.0 30.6 34.2 59.3 35.4 33.2 40.0 51.0 63.5 26.9 26.7 11.7 7.2 56.8 59.8 16.7 48.7 47.2 36.8 44.6 16.8 42.9 26.0 10.6 40.2 14.6 34.8 10.6 40.4 35.5 17.6 11.9 18.8 9.4 19.0 83.4 14.1 10.7 71.1 39.4 18.2 66.3 38.0 30.6 13.5 12.0 67.9 45.0 7.1 31.6 9.9 7.6 20.2 13.2 15.7 9.0 17.0 96.5 24.7 8.6 9.3 31.2 62.1 27.2 17.2 23.2 15.4 31.1 22.5 19.8 25.7 15.8 55.5 22.2 13.3 25.6 14.4 16.6 35.4 30.4 19.5 39.8 32.7 51.0 34.2 43.3 44.8 36.5 27.0 41.0 41.8 8.7 40.0 33.2 59.3 44.1 63.5 14.6 15.5 10.3 13.0 15.7 15.0 19.0 10.4 14.6 16.0 256.1 99.4 104.2 74.6 76.0 23.0 36.6 129.9 75.0 175.1 169.3 13.7 130.5 58.0 150.4 99.0 124.2 64.6 23.3 213.2 179.9 168.6 172.6 72.5 183.4 161.4 22.3 42.4 136.2 117.2 171.7 117.9 113.3 192.3 85.6 64.0 64.1 303.3 52.6 88.8 107.5 21.9 122.9 95.2 95.1 53.5 77.3 162.5 123.6 53.9 80.2 TRAM1L1 MGC26568 ENSG00000174599 "Translocation associated membrane protein 1 like 1" Q8N609 4 117083554-117085576 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 6.9;Horizontal cells: 4.8;Spermatogonia: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.6;U-138 MG: 11.8;U-266/70: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044560 Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA044560: AB_10796097" "unprognostic (9.06e-2)" "unprognostic (2.87e-2)" "unprognostic (4.40e-2)" "unprognostic (2.17e-3)" "unprognostic (9.77e-2)" "unprognostic (2.37e-2)" "unprognostic (5.97e-2)" "unprognostic (3.02e-1)" "unprognostic (1.14e-1)" "unprognostic (3.25e-1)" "unprognostic (1.09e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.82e-3)" "unprognostic (1.23e-2)" 2.1 4.3 7.8 1.1 10.0 0.3 7.3 5.6 14.9 4.6 1.8 9.4 0.0 0.9 3.4 10.5 1.6 6.8 3.1 2.2 8.8 8.6 11.9 0.5 2.9 1.0 8.5 5.9 4.1 5.0 0.6 8.5 1.2 10.3 7.5 2.2 4.5 2.5 4.7 0.7 4.1 1.1 3.6 10.3 1.2 3.2 5.9 7.4 0.0 8.4 0.3 0.9 3.2 1.2 0.1 0.2 0.0 0.0 0.1 0.2 0.0 1.4 1.0 4.5 2.2 0.0 0.0 0.0 0.6 0.5 0.9 2.7 0.1 5.2 0.0 0.5 1.2 5.8 0.1 2.1 2.4 3.7 0.0 0.1 1.2 1.2 0.6 1.3 1.3 0.0 4.9 2.1 1.1 0.0 3.8 0.0 0.0 0.0 2.7 7.3 0.3 2.3 0.0 0.3 0.0 1.1 0.0 5.8 0.0 0.8 0.3 2.6 9.6 0.0 3.8 4.4 2.5 6.5 1.4 3.1 11.8 5.2 0.1 1.8 9.6 2.1 0.0 4.5 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 7.8 10.0 5.6 13.9 8.8 8.6 8.5 5.9 10.3 7.4 0.0 1.0 0.0 0.2 0.8 6.9 0.6 0.0 4.0 2.3 1.8 3.9 1.7 1.7 2.1 0.1 1.0 0.0 0.0 0.6 0.2 2.2 0.2 0.0 0.0 0.3 4.8 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 0.1 3.1 0.3 0.0 1.8 1.8 2.9 0.0 0.9 1.7 5.1 1.3 0.2 0.0 0.0 0.0 TRAM2 KIAA0057 ENSG00000065308 "Translocation associated membrane protein 2" Q15035 6 52497402-52576915 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 84.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 54.4;ASC TERT1: 58.3;fHDF/TERT166: 52.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA035092, HPA057925" Approved Approved Cytosol NA NA Cytosol "HPA035092: AB_10610562, HPA057925: AB_2683557" "unprognostic (2.32e-2)" "unprognostic (2.19e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (1.12e-1)" "unprognostic (4.07e-2)" "unprognostic (8.90e-3)" "unprognostic (1.14e-1)" "unprognostic (1.65e-1)" "unprognostic (3.03e-1)" "unprognostic (3.01e-1)" "unprognostic (5.05e-1)" "prognostic unfavorable (1.41e-9)" "unprognostic (1.37e-2)" "unprognostic (1.60e-1)" "unprognostic (6.64e-2)" "unprognostic (1.19e-2)" 17.3 4.9 2.0 11.8 3.7 2.7 29.4 2.0 3.3 13.3 12.5 4.3 4.4 9.2 12.7 9.0 8.3 11.5 11.8 10.5 3.3 2.2 7.7 23.7 12.6 13.1 4.0 2.2 15.6 6.8 1.9 4.0 46.7 6.0 9.9 10.2 12.0 6.2 4.0 6.3 7.6 15.9 17.6 5.3 20.0 8.4 11.6 2.7 4.9 11.7 6.0 12.1 14.0 19.6 3.6 3.1 2.8 5.4 2.0 2.8 1.8 9.1 4.1 4.8 4.7 54.4 58.3 8.4 27.0 27.4 22.7 21.1 8.8 1.9 2.2 4.5 52.3 16.2 2.0 3.1 16.9 28.7 5.0 1.6 4.9 4.1 11.1 15.5 1.2 2.7 21.1 1.7 19.8 8.8 33.2 26.0 1.9 3.0 16.5 32.4 3.3 1.7 3.6 2.2 3.6 1.8 2.2 12.6 18.5 5.4 1.5 1.1 1.8 6.2 2.8 6.5 10.6 4.3 2.6 41.1 38.2 8.3 13.7 14.7 11.3 19.2 6.4 13.9 3.3 23.2 0.2 2.8 2.8 2.8 3.4 1.5 3.6 2.2 1.7 3.1 2.0 1.2 2.0 0.8 2.0 5.4 1.5 0.8 1.8 2.0 3.7 2.0 3.3 3.3 2.2 4.0 2.2 6.0 2.7 6.0 2.7 11.5 2.5 7.2 3.0 7.1 5.1 5.3 4.5 7.0 23.6 31.3 3.3 3.4 31.2 13.7 4.1 23.3 2.7 25.0 27.7 2.3 2.3 25.6 13.0 4.8 8.6 23.4 12.1 84.2 19.2 4.2 25.3 0.0 15.0 1.7 5.6 0.0 21.9 2.9 13.7 12.9 12.0 22.4 4.9 3.6 17.3 6.4 4.7 1.4 TRAT1 "HSPC062, TCRIM, TRIM" ENSG00000163519 "T cell receptor associated transmembrane adaptor 1" Q6PIZ9 3 108822698-108855005 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 17 "blood: 57.9;lymphoid tissue: 128.9" "Cell type enriched" "Detected in some" 10 "T-cells: 74.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 57.9" "Group enriched" "Detected in many" 160 "granulocytes: 53.1;T-cells: 57.9" "Group enriched" "Detected in some" 23 "JURKAT: 16.4;MOLT-4: 38.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002356, CAB026130, HPA072760" Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" NA NA "Plasma membrane" "Mitotic spindle, Centriolar satellite" "CAB026130: , HPA002356: AB_1080375, HPA072760: " "unprognostic (1.54e-4)" "unprognostic (1.41e-3)" "unprognostic (6.82e-2)" "unprognostic (4.95e-3)" "unprognostic (2.84e-2)" "unprognostic (2.19e-3)" "unprognostic (1.87e-3)" "unprognostic (2.02e-2)" "unprognostic (7.21e-3)" "unprognostic (8.96e-3)" "unprognostic (8.03e-2)" "unprognostic (4.32e-1)" "unprognostic (2.86e-5)" "unprognostic (3.12e-1)" "unprognostic (3.01e-2)" "unprognostic (2.90e-4)" "unprognostic (4.36e-2)" 2.6 0.3 0.2 8.2 0.2 1.8 1.3 0.2 0.3 0.8 1.0 0.1 0.1 0.9 0.7 0.3 0.9 0.8 1.9 0.7 0.2 0.2 1.1 1.0 4.0 17.8 0.2 0.2 0.5 0.5 0.0 0.4 0.3 0.3 1.1 1.0 0.1 1.9 0.3 0.4 1.0 5.5 0.2 0.3 9.0 1.6 0.5 0.1 128.9 1.1 1.0 9.8 2.8 1.1 0.1 0.1 53.1 0.1 0.3 57.9 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 1.1 0.0 0.0 38.6 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.1 0.1 0.0 10.5 0.0 21.2 0.1 42.1 21.6 0.0 0.0 57.9 14.2 0.6 0.3 0.1 0.1 17.9 22.9 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.1 0.0 5.6 0.9 0.1 7.4 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 2.3 0.6 0.2 0.0 0.0 1.8 0.0 1.4 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 6.9 0.1 74.0 0.0 0.0 TRDN ENSG00000186439 Triadin Q13061 6 123216339-123637093 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1" "Group enriched" "Detected in some" 21 "Cardiomyocytes: 855.7;Muller glia cells: 805.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "basophil: 2.9" "Lineage enriched" "Detected in single" 30 "granulocytes: 2.9" "Cell line enhanced" "Detected in some" "HAP1: 1.6;K-562: 1.8;MCF7: 6.1;SCLC-21H: 1.2;SK-BR-3: 2.0" "Region enriched" "Detected in single" 10 "olfactory region: 13.6" "HPA038226, HPA058226" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038226: AB_10795574, HPA058226: AB_2683643" "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.20e-2)" "unprognostic (3.06e-3)" "unprognostic (2.40e-1)" "unprognostic (2.38e-1)" "unprognostic (2.42e-1)" "unprognostic (8.42e-2)" "unprognostic (8.71e-2)" "unprognostic (9.93e-3)" "unprognostic (2.12e-1)" "unprognostic (2.55e-2)" "unprognostic (3.97e-2)" 3.8 0.4 0.4 0.0 0.5 0.0 0.3 0.2 0.2 0.3 0.1 0.0 0.7 0.1 0.3 9.2 3.0 1.9 0.1 52.8 1.6 1.3 0.1 0.1 0.1 0.1 1.6 0.1 1.5 0.1 0.0 3.2 0.1 1.3 1.9 0.1 1.3 2.0 0.2 215.5 0.1 0.1 0.2 3.4 0.1 0.1 0.7 0.5 0.0 1.2 80.1 1.6 0.1 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 6.1 0.0 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.2 1.6 1.3 1.6 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 5.8 855.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 40.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 22.9 12.0 0.0 1.7 0.0 0.0 805.6 0.0 0.0 10.6 0.0 13.4 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 TREM1 "CD354, TREM-1" ENSG00000124731 "Triggering receptor expressed on myeloid cells 1" Q9NP99 6 41267926-41286719 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 96.9;bone marrow: 38.5;lung: 34.2" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 31.6;Hofbauer cells: 25.6;Kupffer cells: 32.3;Macrophages: 79.4" "Cancer enhanced" "Detected in many" "lung cancer: 9.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 96.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 96.9" "Group enriched" "Detected in some" 5 "SuSa: 6.5;U-87 MG: 23.8" "HPA005563, HPA053612" Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA005563: AB_1858259, HPA053612: " "unprognostic (6.41e-2)" "unprognostic (1.47e-3)" "unprognostic (1.22e-1)" "unprognostic (3.39e-2)" "unprognostic (6.07e-3)" "unprognostic (2.97e-2)" "unprognostic (5.73e-5)" "unprognostic (1.29e-1)" "unprognostic (1.24e-2)" "unprognostic (4.13e-3)" "unprognostic (2.24e-3)" "unprognostic (7.65e-2)" "unprognostic (3.18e-7)" "unprognostic (6.32e-3)" "unprognostic (4.95e-2)" "unprognostic (1.08e-1)" "unprognostic (7.26e-2)" 10.2 0.6 0.7 21.1 1.5 38.5 1.0 0.6 2.1 0.7 0.9 0.7 0.5 0.1 1.0 1.5 0.6 4.2 5.1 3.7 1.2 0.9 1.1 3.7 34.2 8.0 2.7 0.1 2.1 1.8 0.2 2.7 31.2 2.3 0.9 0.0 2.5 1.3 0.1 2.4 0.4 1.1 3.8 3.9 12.1 1.0 2.6 0.6 0.3 2.2 1.9 1.0 3.9 0.7 0.2 5.0 96.9 12.8 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 6.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 1.5 0.0 0.0 12.8 0.3 0.0 3.1 0.0 0.0 0.0 0.0 5.0 0.2 0.0 0.0 96.9 0.0 1.4 0.1 0.0 4.1 0.7 1.5 0.6 2.1 1.2 0.9 2.7 0.1 2.3 0.6 6.0 31.6 2.7 0.1 0.3 0.0 0.3 2.5 13.4 19.4 0.0 0.0 0.3 0.0 0.3 10.6 0.5 0.0 0.0 0.2 0.9 0.7 0.1 5.8 0.2 25.6 0.0 0.0 1.3 32.3 13.1 0.0 79.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 12.2 0.0 0.0 0.0 TREM2 "TREM-2, Trem2a, Trem2b, Trem2c" ENSG00000095970 "Triggering receptor expressed on myeloid cells 2" Q9NZC2 6 41158506-41163186 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.6;brain: 34.8;lung: 24.6" "Cell type enriched" "Detected in some" 12 "Hofbauer cells: 939.0" "Cancer enhanced" "Detected in all" "glioma: 93.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.9" "Group enriched" "Detected in many" 6 "dendritic cells: 4.9;monocytes: 1.3" "Group enriched" "Detected in some" 4 "hTCEpi: 37.4;THP-1: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010917, HPA012571" Approved "Intracellular and membrane" NA NA 19000 "HPA010917: AB_1080365, HPA012571: AB_1858260" "unprognostic (3.89e-1)" "unprognostic (4.44e-3)" "unprognostic (2.77e-2)" "unprognostic (1.80e-2)" "unprognostic (1.29e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (4.83e-2)" "unprognostic (1.07e-1)" "unprognostic (8.57e-3)" "unprognostic (1.33e-1)" "unprognostic (2.09e-1)" "unprognostic (3.58e-3)" "unprognostic (8.04e-2)" "unprognostic (1.04e-2)" "unprognostic (3.16e-3)" "unprognostic (1.85e-2)" 35.6 11.8 10.1 3.0 13.4 0.3 8.6 1.6 21.7 5.9 2.9 24.1 0.0 0.9 1.5 2.1 0.6 6.5 8.4 1.7 10.4 9.5 1.0 2.1 24.6 1.7 21.7 5.2 2.7 2.5 2.7 2.9 8.8 13.4 1.8 3.9 2.1 4.4 3.0 0.8 0.4 1.2 3.8 34.8 0.5 2.2 0.8 12.9 0.0 1.6 0.8 0.5 4.2 0.5 0.5 4.9 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.6 37.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.1 10.1 13.4 1.6 8.3 10.4 9.5 21.7 5.2 13.4 12.9 6.0 9.8 0.0 0.0 0.7 0.1 0.2 2.5 2.7 12.5 0.0 0.0 4.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.8 0.4 0.0 2.3 0.0 939.0 0.0 0.0 3.1 28.7 0.4 0.6 78.3 0.0 13.6 0.0 0.4 0.0 0.0 0.0 0.0 0.6 6.5 0.0 0.0 0.0 0.1 6.1 0.0 0.0 0.0 TREML1 "dJ238O23.3, TLT1" ENSG00000161911 "Triggering receptor expressed on myeloid cells like 1" Q86YW5 6 41149342-41154337 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7" "Cell type enriched" "Detected in some" 11 "monocytes: 44.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "basophil: 19.2" "Lineage enriched" "Detected in single" 31 "granulocytes: 19.2" "Cell line enriched" "Detected in single" 167 "HEL: 38.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016700, HPA017860" Enhanced Approved "Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol" NA NA 94000000 "Nuclear speckles, Cytosol" "Golgi apparatus, Plasma membrane" "HPA016700: AB_1858262, HPA017860: AB_1858261" "unprognostic (6.70e-2)" "unprognostic (3.50e-3)" "unprognostic (1.15e-3)" "unprognostic (1.62e-1)" "unprognostic (3.48e-2)" "unprognostic (4.53e-5)" "unprognostic (1.10e-2)" "unprognostic (2.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.12e-3)" "unprognostic (2.34e-2)" "unprognostic (7.04e-2)" "unprognostic (1.11e-4)" "unprognostic (1.36e-1)" "unprognostic (8.38e-2)" "unprognostic (7.51e-2)" "unprognostic (3.41e-2)" 1.2 1.2 2.1 3.7 1.2 10.5 0.6 0.5 1.3 0.4 0.3 0.3 0.3 0.0 0.3 0.6 0.3 0.6 1.3 10.0 2.1 1.6 0.3 0.3 2.9 7.7 3.3 0.3 1.9 0.5 0.2 0.6 1.7 1.2 0.3 1.3 0.6 1.3 0.3 0.8 0.3 0.4 0.3 4.3 26.7 0.2 0.8 0.3 1.4 0.6 0.3 7.1 1.1 0.3 0.1 0.3 19.2 0.6 0.0 0.2 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 38.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.6 0.8 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 3.9 0.0 0.1 0.3 0.0 37.9 2.1 1.2 0.5 0.7 2.1 1.6 3.3 0.3 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TREML2 "C6orf76, dJ238O23.1, FLJ13693, TLT2" ENSG00000112195 "Triggering receptor expressed on myeloid cells like 2" Q5T2D2 6 41190277-41201194 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 20.8;bone marrow: 13.6;placenta: 54.3" "Group enriched" "Detected in some" 12 "Early spermatids: 19.0;Late spermatids: 25.1;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive B-cell: 16.1;neutrophil: 20.8" "Group enriched" "Detected in many" 15 "B-cells: 16.1;dendritic cells: 5.5;granulocytes: 20.8" "Cell line enhanced" "Detected in some" "HEL: 24.6;HL-60: 5.7;JURKAT: 7.0;SuSa: 4.3;U-698: 7.0;U-937: 4.5" "Not detected" "Not detected" NA NA 2300000 "unprognostic (3.76e-3)" "unprognostic (2.39e-1)" "unprognostic (9.05e-3)" "unprognostic (1.30e-3)" "unprognostic (3.22e-3)" "unprognostic (2.02e-2)" "unprognostic (1.01e-1)" "unprognostic (1.83e-1)" "unprognostic (7.46e-2)" "unprognostic (2.51e-1)" "unprognostic (2.40e-3)" "unprognostic (2.46e-1)" "unprognostic (2.02e-2)" "unprognostic (7.45e-2)" "unprognostic (1.54e-2)" "unprognostic (6.23e-2)" "unprognostic (6.71e-2)" 1.7 0.2 0.2 6.3 0.2 13.6 0.2 0.2 0.2 0.2 0.4 0.1 0.1 0.1 0.2 0.1 0.4 0.9 0.3 0.5 0.2 0.2 0.3 0.4 1.5 9.2 0.2 0.1 0.2 0.2 0.0 0.2 54.3 0.3 0.2 0.0 0.1 1.5 0.1 0.2 0.2 1.9 0.1 0.3 12.3 0.4 5.9 0.2 4.9 0.3 0.1 7.5 0.8 0.2 16.1 5.5 20.8 0.8 0.4 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 0.3 0.0 0.0 1.3 1.8 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 4.5 0.0 1.4 0.3 7.7 0.2 0.7 0.3 3.6 0.6 0.1 1.3 16.1 0.9 0.2 20.8 0.4 0.8 5.5 0.4 1.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.0 1.4 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 25.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 7.3 0.0 0.0 0.0 TREX1 "AGS1, DRN3" ENSG00000213689 "Three prime repair exonuclease 1" Q9NSU2 3 48465811-48467645 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Exonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease mutation, Neurodegeneration, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 8.0;Cardiomyocytes: 5.0;Melanocytes: 23.6;Smooth muscle cells: 7.6;Suprabasal keratinocytes: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 30.9" "Low region specificity" "Detected in all" "HPA035437, HPA046721" Supported Supported Cytosol NA NA Cytosol "HPA035437: AB_10672092, HPA046721: AB_2732531" 14.2 14.3 16.7 14.6 10.6 20.7 17.2 13.0 16.9 13.4 11.0 12.8 17.5 10.3 8.1 14.9 16.6 14.5 12.3 9.8 14.4 14.2 11.6 12.7 12.5 26.2 14.6 17.4 7.3 13.0 6.8 31.2 11.6 11.2 15.4 9.3 10.8 32.2 19.3 10.8 22.9 10.9 8.2 12.6 25.5 12.4 4.6 10.1 18.5 7.4 18.3 21.7 13.3 10.6 24.9 35.5 23.3 41.8 8.6 13.1 20.1 8.0 7.4 6.2 4.4 7.7 7.9 0.0 2.6 13.1 22.0 30.9 0.1 9.6 9.5 5.4 11.1 20.8 9.4 0.4 11.8 3.1 8.0 0.7 5.5 26.5 0.4 9.7 5.0 3.9 6.9 1.1 11.1 4.4 4.5 9.3 6.6 0.0 14.6 9.3 0.1 7.0 3.6 0.0 4.7 4.6 5.8 1.6 18.5 5.8 1.6 0.0 3.7 9.6 13.0 6.3 0.4 0.4 8.4 9.8 4.1 3.9 8.7 6.1 11.8 6.8 4.0 9.1 10.7 3.3 2.1 41.8 3.0 9.8 32.5 5.6 24.6 13.1 9.4 35.5 24.9 12.4 10.3 23.3 8.6 24.3 28.0 11.6 20.1 16.7 10.6 13.0 16.9 14.4 14.2 14.6 17.4 11.2 10.1 0.0 0.3 0.0 0.0 8.0 0.0 5.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 12.2 0.0 0.0 0.0 0.0 TRHDE "PAP-II, PGPEP2, TRH-DE" ENSG00000072657 "Thyrotropin releasing hormone degrading enzyme" Q9UKU6 12 72087266-72670757 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;pancreas: 19.4" "Group enriched" "Detected in some" 4 "Early spermatids: 30.7;Late spermatids: 47.8;Leydig cells: 27.3;Peritubular cells: 12.7" "Cancer enhanced" "Detected in some" "renal cancer: 1.9" "Region enhanced" "Detected in many" "cerebellum: 30.3" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 20.8;BJ hTERT+: 20.2;EFO-21: 10.9;HBF TERT88: 7.4;hTERT-RPE1: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 6200000 "unprognostic (3.56e-2)" "unprognostic (4.06e-3)" "unprognostic (6.01e-2)" "unprognostic (1.44e-6)" "unprognostic (1.77e-1)" "unprognostic (6.37e-2)" "unprognostic (7.79e-2)" "unprognostic (6.96e-2)" "unprognostic (3.99e-2)" "unprognostic (1.48e-1)" "unprognostic (5.14e-4)" "unprognostic (2.40e-1)" "prognostic favorable (1.53e-7)" "unprognostic (2.55e-2)" "unprognostic (2.48e-1)" "unprognostic (8.91e-3)" "unprognostic (2.94e-2)" 6.2 2.2 2.9 1.0 4.7 1.0 7.6 30.3 12.3 10.2 2.4 0.1 2.5 4.8 2.7 1.7 0.9 2.5 2.5 2.2 7.3 2.8 9.9 1.5 3.0 0.6 1.2 5.5 6.5 19.4 0.4 1.6 0.7 1.5 5.5 1.5 1.0 2.4 5.8 0.7 0.8 4.2 1.2 0.9 4.8 1.1 1.7 0.5 0.0 0.5 0.4 1.0 2.8 7.6 0.2 0.0 1.0 0.3 0.3 0.0 0.0 2.4 0.0 0.4 0.0 1.1 0.0 6.7 20.8 20.2 2.0 1.4 0.0 0.0 0.0 10.9 3.0 2.1 0.2 3.8 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.6 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.0 0.0 0.0 0.0 6.9 4.6 2.0 0.0 0.0 0.0 0.0 0.4 0.0 4.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.1 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 2.9 4.7 30.3 12.3 7.3 2.8 1.2 5.5 1.5 0.5 0.0 0.3 0.0 0.0 0.0 0.2 0.8 0.0 1.4 0.0 1.8 0.0 0.0 3.3 0.0 30.7 0.0 6.9 0.0 2.2 0.3 0.5 0.2 0.0 1.3 0.2 0.0 0.0 0.0 0.0 47.8 27.3 0.3 0.0 0.0 1.5 0.3 2.1 2.9 12.7 7.4 0.6 0.0 0.4 0.1 0.7 0.0 0.1 0.0 0.7 0.1 TRHR ENSG00000174417 "Thyrotropin releasing hormone receptor" P34981 8 109086621-109119584 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 1.0;pituitary gland: 3.3;thyroid gland: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 1.6;SH-SY5Y: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055162 Approved NA NA "HPA055162: AB_2732592" "unprognostic (1.92e-2)" "unprognostic (8.58e-2)" "unprognostic (1.17e-1)" 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 1.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.2 0.3 0.6 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIL KIAA0644 ENSG00000255690 "TLR4 interactor with leucine rich repeats" Q7L0X0 7 28953358-28958292 "Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.7" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 11.9;Horizontal cells: 6.4;Muller glia cells: 13.7;Sertoli cells: 12.9" "Cancer enhanced" "Detected in many" "glioma: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 14.0;SH-SY5Y: 25.3;SK-BR-3: 22.4;T-47d: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.26e-3)" "unprognostic (3.29e-2)" "unprognostic (5.89e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (2.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-2)" "unprognostic (8.77e-2)" "prognostic unfavorable (8.52e-4)" "unprognostic (4.27e-3)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (2.07e-2)" 3.5 2.9 14.7 0.6 13.2 0.0 5.1 11.2 19.2 2.6 2.2 19.5 0.0 2.4 2.5 2.2 1.9 2.3 1.2 3.0 18.2 6.6 0.7 3.1 0.4 9.1 11.5 1.8 0.4 0.6 0.0 1.3 20.7 2.4 2.3 0.3 9.6 1.8 3.3 0.5 2.7 4.1 17.0 2.9 2.8 0.3 14.4 0.0 2.8 0.2 0.3 2.0 0.0 0.0 0.1 0.1 0.1 0.0 0.7 0.0 0.0 0.0 14.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.5 25.3 0.0 22.4 0.0 2.1 9.9 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 11.9 4.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 1.2 1.8 0.0 0.1 3.3 0.0 0.0 2.1 0.0 0.0 0.0 1.8 0.8 0.0 0.0 0.2 0.1 6.4 0.0 2.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 1.6 0.7 12.9 0.2 0.2 0.7 0.0 0.1 0.0 0.6 0.1 TRIM13 "DLEU5, Leu5, RFP2, RNF77" ENSG00000204977 "Tripartite motif containing 13" O60858 13 49995888-50020481 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 8 "Early spermatids: 422.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000367 Enhanced NA NA "HPA000367: AB_1856196" "unprognostic (1.14e-1)" "unprognostic (8.22e-2)" "unprognostic (6.14e-2)" "unprognostic (2.23e-3)" "unprognostic (4.75e-3)" "unprognostic (5.01e-2)" "unprognostic (4.60e-2)" "unprognostic (2.83e-2)" "unprognostic (2.59e-2)" "unprognostic (2.38e-2)" "unprognostic (2.44e-1)" "unprognostic (5.07e-1)" "unprognostic (7.28e-3)" "unprognostic (4.66e-2)" "unprognostic (9.01e-2)" "unprognostic (2.37e-2)" "unprognostic (1.55e-2)" 13.2 9.8 9.9 11.9 11.4 37.5 19.6 18.5 13.5 13.1 11.7 12.3 15.2 8.6 13.9 10.7 18.8 12.2 8.7 12.4 10.1 9.2 16.6 9.9 14.7 12.4 12.2 8.0 13.8 14.0 10.8 14.4 10.0 11.5 14.5 14.0 9.6 16.2 15.6 16.3 18.2 13.0 10.4 10.8 15.3 10.6 49.0 12.1 25.1 17.3 13.9 15.5 13.0 12.9 28.4 20.6 21.6 13.0 15.4 17.2 8.4 5.1 6.1 21.1 16.3 11.9 18.6 9.6 8.5 12.4 6.9 4.9 8.4 11.9 19.3 2.7 9.2 6.3 8.1 9.2 11.2 8.6 7.3 8.2 19.1 4.6 9.2 13.3 18.2 11.2 13.6 16.6 6.3 10.6 17.5 15.3 16.5 10.1 6.1 13.6 4.7 15.1 28.6 19.1 12.0 4.5 18.5 0.9 5.7 14.8 8.5 8.5 13.9 7.8 8.1 11.9 15.6 9.1 23.1 14.2 7.2 6.7 5.8 4.8 4.4 3.7 14.1 3.2 8.4 9.7 12.1 10.8 16.1 12.2 9.3 15.3 28.2 16.5 15.9 13.5 28.4 14.6 13.6 21.6 15.4 13.0 20.6 17.2 8.4 9.9 11.4 18.5 13.5 10.1 9.2 12.2 8.0 11.5 12.1 23.8 23.2 36.1 36.2 24.5 23.5 16.2 17.8 36.1 21.6 26.2 19.6 29.2 16.6 21.0 422.5 29.4 20.1 23.3 17.5 13.3 23.7 28.6 38.1 13.7 16.3 11.1 43.1 22.1 17.3 42.4 23.9 27.2 16.9 23.4 24.2 13.2 17.6 31.1 28.0 24.9 52.1 19.4 29.7 55.2 19.6 29.2 26.9 36.3 22.4 26.3 TRIM59 "Mrf1, RNF104, TRIM57, TSBF1" ENSG00000213186 "Tripartite motif containing 59" Q8IWR1 3 160432445-160485773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6;lymphoid tissue: 24.6" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017750 Uncertain Approved "Rods & Rings" NA Yes "Rods & Rings" "HPA017750: AB_1858312" "unprognostic (3.74e-1)" "prognostic favorable (4.36e-4)" "unprognostic (1.76e-1)" "unprognostic (1.03e-1)" "unprognostic (1.10e-1)" "unprognostic (3.02e-1)" "unprognostic (8.00e-4)" "unprognostic (1.88e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (1.15e-5)" "unprognostic (1.02e-3)" "unprognostic (2.44e-11)" "unprognostic (7.92e-2)" "unprognostic (2.42e-1)" "unprognostic (4.03e-2)" "unprognostic (5.91e-3)" 1.3 1.4 8.0 6.0 19.3 18.6 2.7 2.1 14.5 1.8 3.5 30.6 0.3 3.6 4.1 1.3 6.6 2.8 3.6 1.2 13.4 6.4 2.0 1.6 2.6 13.8 28.3 6.3 2.1 2.4 2.7 2.5 2.6 14.3 2.9 3.5 0.1 2.6 1.6 1.6 6.8 4.0 3.8 14.5 6.3 3.3 10.4 28.4 24.6 2.8 0.3 14.5 6.1 3.1 7.8 4.7 16.1 2.2 8.8 15.2 2.6 8.9 7.1 9.1 0.6 3.6 5.0 12.0 14.2 12.3 17.8 17.1 0.7 15.6 23.9 10.6 10.6 5.6 15.3 0.0 5.8 23.5 21.7 8.6 0.8 2.1 1.0 5.1 10.5 1.4 4.2 1.7 8.6 6.1 10.8 12.4 3.6 11.2 10.2 16.6 9.4 6.4 0.7 23.9 5.8 11.9 9.0 7.9 10.7 6.2 2.9 5.9 1.3 4.0 11.9 0.3 12.8 14.1 9.8 9.4 1.3 4.2 2.1 1.3 17.0 6.1 6.0 1.5 13.8 1.4 16.1 2.2 3.7 8.3 2.2 9.4 7.8 13.6 11.2 3.2 6.9 9.4 11.1 2.7 8.8 1.0 4.7 15.2 2.6 8.0 19.3 2.1 11.8 13.4 6.4 28.3 6.3 14.3 28.4 0.0 6.2 12.3 4.2 4.2 0.4 0.7 2.5 1.4 1.2 1.8 5.9 4.1 0.0 1.7 23.4 1.8 1.1 0.0 1.7 9.8 1.8 1.8 1.1 0.0 2.5 0.0 10.4 2.5 3.0 10.7 0.3 2.1 3.3 1.0 2.2 0.5 1.4 3.5 0.7 1.4 1.3 0.0 0.5 12.5 13.9 3.9 2.1 12.8 4.4 2.7 TRIQK "C8orf83, DKFZp779L1068, LOC286144, PRO0845" ENSG00000205133 "Triple QxxK/R motif containing" Q629K1 8 92883530-93017673 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 10.8;eosinophil: 9.3;intermediate monocyte: 11.5;MAIT T-cell: 5.2;myeloid DC: 5.7;neutrophil: 8.9;non-classical monocyte: 18.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.47e-3)" "unprognostic (3.09e-1)" "unprognostic (6.03e-3)" "unprognostic (4.32e-2)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (5.13e-2)" "unprognostic (7.78e-2)" "unprognostic (2.50e-1)" "unprognostic (2.31e-1)" "unprognostic (1.56e-1)" "unprognostic (2.52e-1)" "unprognostic (1.79e-1)" "unprognostic (5.11e-3)" "unprognostic (9.23e-2)" "unprognostic (7.15e-2)" "unprognostic (2.79e-2)" 12.7 19.7 16.4 6.8 33.1 11.4 12.7 26.9 23.9 18.0 17.4 8.7 11.3 10.5 11.0 8.9 10.5 14.0 19.7 16.5 19.2 16.2 17.1 29.8 14.3 4.3 16.7 16.3 17.6 14.9 18.5 33.5 16.6 18.5 16.1 18.2 5.8 10.0 10.4 3.1 6.1 10.1 10.0 20.3 11.8 14.9 5.5 18.3 4.6 20.5 5.9 4.4 19.3 11.4 1.5 5.7 9.3 18.5 1.1 5.2 2.7 3.6 4.6 10.1 3.5 14.0 22.3 3.3 12.9 14.2 7.5 10.8 0.6 11.5 0.0 16.1 12.3 5.0 5.9 8.0 7.9 12.2 0.0 3.8 13.9 5.6 7.5 11.9 3.9 12.2 16.6 18.1 4.0 13.7 17.0 7.9 8.1 2.6 8.4 10.8 9.6 6.0 3.0 3.4 15.3 17.1 0.0 10.4 4.6 14.1 4.5 5.8 8.1 4.9 2.0 12.5 8.6 13.5 3.5 10.2 11.2 3.5 19.3 3.9 2.9 0.0 0.0 17.2 0.0 11.3 0.5 10.8 9.3 0.1 11.5 5.2 1.5 0.6 0.5 5.7 1.3 0.0 0.0 8.9 1.1 18.5 1.5 0.1 2.7 16.4 33.1 26.9 23.9 19.2 16.2 16.7 16.3 18.5 18.3 17.9 14.1 4.7 17.9 13.4 17.9 11.8 20.4 34.8 11.4 15.7 5.9 5.7 43.1 10.9 3.8 15.7 13.1 0.0 14.3 17.4 23.6 33.6 2.3 16.8 11.1 6.4 18.4 12.3 19.2 6.4 15.3 12.4 21.9 5.4 31.2 18.0 10.5 17.5 20.5 25.0 5.9 32.3 14.6 10.1 3.8 7.3 3.1 4.3 19.0 18.7 TRPA1 ANKTM1 ENSG00000104321 "Transient receptor potential cation channel subfamily A member 1" O75762 8 72019917-72075617 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 20.8;urinary bladder: 20.1;vagina: 12.1" "Group enriched" "Detected in some" 10 "Early spermatids: 6.4;Mucus-secreting cells: 5.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "HHSteC: 24.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (2.14e-2)" "unprognostic (2.50e-2)" "prognostic favorable (6.57e-4)" "unprognostic (1.28e-2)" "unprognostic (2.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.37e-2)" "unprognostic (8.11e-3)" "unprognostic (4.22e-2)" "unprognostic (2.47e-1)" "unprognostic (2.78e-3)" "unprognostic (1.49e-1)" "unprognostic (2.16e-4)" "unprognostic (2.37e-1)" "unprognostic (9.67e-2)" "unprognostic (1.57e-1)" "unprognostic (2.90e-1)" 0.3 0.2 0.2 9.1 0.2 0.0 0.2 0.2 0.4 0.4 16.8 0.3 0.0 4.8 0.2 0.3 2.2 0.2 5.7 0.3 0.2 0.2 0.2 0.2 0.3 0.8 0.3 0.0 0.4 0.2 0.0 0.2 0.3 0.1 4.7 7.5 0.0 0.2 0.0 0.2 0.2 20.8 3.8 0.2 0.4 7.9 0.4 0.0 0.6 0.2 0.3 1.4 20.1 12.1 0.5 0.6 0.1 1.1 0.3 2.6 0.2 0.0 2.5 0.7 0.0 0.0 0.1 0.0 0.3 2.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.8 0.4 1.4 0.1 0.0 0.5 0.0 24.5 0.0 0.2 1.6 0.0 1.1 0.2 5.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.1 0.4 0.0 2.4 0.2 0.0 0.3 0.0 0.1 3.8 1.1 0.0 0.3 0.3 0.0 1.8 0.0 1.7 0.0 0.0 0.0 0.3 0.0 1.1 0.5 0.5 2.6 0.0 0.5 0.0 0.4 0.1 0.3 1.1 0.6 1.0 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 TRPC1 HTRP-1 ENSG00000144935 "Transient receptor potential cation channel subfamily C member 1" P48995 3 142724074-142807888 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 18.1;Cone photoreceptor cells: 15.7;Horizontal cells: 12.7;Rod photoreceptor cells: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009387, HPA021130" Supported Approved Vesicles NA NA Vesicles "CAB009387: AB_2240941, HPA021130: AB_1858361" "unprognostic (1.66e-1)" "unprognostic (7.38e-2)" "unprognostic (1.56e-2)" "unprognostic (4.37e-5)" "unprognostic (5.53e-1)" "unprognostic (1.40e-2)" "unprognostic (5.90e-3)" "unprognostic (1.59e-2)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (8.46e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (2.72e-5)" "unprognostic (1.44e-3)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.49e-2)" 6.8 8.3 8.5 3.5 13.4 1.2 6.8 23.0 15.9 17.7 8.3 11.4 4.3 2.6 20.4 9.2 6.5 10.1 9.1 15.9 10.0 11.4 6.0 2.0 5.4 3.3 9.4 12.2 24.5 3.0 12.2 14.4 6.1 14.7 12.3 4.9 13.0 3.7 13.6 2.4 6.2 4.7 17.6 11.4 5.0 4.4 8.0 7.9 0.4 8.9 3.9 2.3 9.3 8.9 0.6 0.0 0.0 0.0 0.3 1.3 0.3 3.2 4.6 8.4 1.0 7.6 18.7 3.8 5.1 8.1 6.5 9.6 1.4 0.9 0.0 1.7 5.3 11.4 0.3 2.3 2.4 9.4 0.8 3.4 5.1 1.9 2.2 3.1 0.2 0.0 9.0 2.4 6.0 7.3 11.0 3.7 0.0 0.2 0.0 9.1 2.0 0.3 0.4 4.7 0.0 2.4 0.0 4.0 0.0 4.5 0.1 5.4 4.0 6.3 0.0 1.1 8.0 2.6 0.0 3.4 8.2 1.3 11.0 6.9 3.4 1.4 1.6 6.2 0.1 2.4 0.0 0.0 0.0 0.2 0.0 1.2 0.6 1.3 0.6 0.0 0.3 1.2 1.3 0.0 0.3 0.0 0.0 0.0 0.3 8.5 13.4 23.0 15.9 10.0 11.4 9.4 12.2 14.7 7.9 3.0 0.3 0.0 2.2 2.6 18.1 10.1 0.0 2.7 0.0 5.2 15.7 0.1 0.0 0.2 2.1 2.9 0.0 0.0 0.2 0.2 7.2 0.8 0.0 0.0 0.1 12.7 1.7 4.3 0.0 1.7 7.8 0.0 1.7 0.0 0.0 6.8 0.1 0.0 10.3 0.3 15.0 0.0 9.0 10.3 2.1 1.0 0.2 0.0 0.0 0.2 TRPC3 ENSG00000138741 "Transient receptor potential cation channel subfamily C member 3" Q13507 4 121879027-121951754 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.3;pituitary gland: 12.0;smooth muscle: 9.4" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 28.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "HEK 293: 3.7;HEL: 5.6;Karpas-707: 5.9;U-2 OS: 3.7;U-251 MG: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (2.39e-1)" "unprognostic (3.12e-2)" "unprognostic (5.57e-2)" "unprognostic (1.93e-2)" "unprognostic (7.12e-3)" "unprognostic (9.80e-2)" "unprognostic (4.80e-3)" "unprognostic (2.38e-1)" "unprognostic (3.26e-1)" "unprognostic (1.06e-1)" "unprognostic (4.33e-3)" "unprognostic (2.67e-3)" "unprognostic (1.39e-1)" "unprognostic (2.23e-1)" "unprognostic (8.42e-3)" 1.4 0.4 1.8 0.7 9.3 0.3 0.5 5.8 7.4 3.3 0.8 1.7 0.8 0.8 1.6 1.2 0.6 1.1 7.3 0.5 1.8 2.3 0.7 0.5 2.9 0.5 2.3 1.9 0.8 0.2 0.6 12.0 4.2 7.3 1.1 0.8 0.3 0.8 2.5 0.6 0.5 1.2 9.4 1.1 1.0 0.9 1.6 3.6 0.0 0.6 0.0 0.4 3.6 2.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.3 1.0 1.5 0.6 0.0 0.0 0.0 0.0 1.0 0.7 0.0 0.9 0.0 0.1 0.0 3.7 5.6 0.1 0.0 0.2 1.5 0.5 0.6 0.0 0.1 0.0 2.5 0.0 0.2 0.0 5.9 1.3 0.0 1.6 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 3.7 0.0 3.3 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 9.3 5.8 7.4 1.8 2.3 2.3 1.9 7.3 3.6 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 28.1 0.0 0.6 0.1 0.7 0.0 0.0 0.0 0.0 0.0 TRPC4 "HTRP4, TRP4" ENSG00000133107 "Transient receptor potential cation channel subfamily C member 4" Q9UBN4 13 37636636-37870425 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 31.0;smooth muscle: 17.2" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 2.4;Smooth muscle cells: 1.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.2;BJ: 16.7;BJ hTERT+ SV40 Large T+: 7.2;fHDF/TERT166: 15.9;U-2197: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.52e-4)" "unprognostic (9.99e-2)" "unprognostic (5.42e-2)" "unprognostic (2.38e-1)" "unprognostic (1.19e-1)" "unprognostic (2.57e-1)" "unprognostic (3.28e-1)" "unprognostic (1.60e-1)" "unprognostic (5.10e-2)" "unprognostic (1.99e-1)" "unprognostic (1.47e-2)" "unprognostic (3.95e-2)" "unprognostic (1.07e-6)" "unprognostic (3.73e-3)" "unprognostic (1.93e-2)" "unprognostic (3.24e-1)" "unprognostic (1.43e-2)" 1.3 0.8 4.6 1.2 4.0 0.2 0.6 2.1 4.0 5.5 4.1 0.6 6.9 0.8 31.0 2.1 0.4 1.9 4.5 1.9 4.8 2.1 3.0 0.5 4.2 0.3 2.5 0.4 3.8 1.8 0.7 0.5 4.6 3.9 9.5 1.1 0.1 0.5 12.6 0.4 0.5 1.6 17.2 2.5 0.5 3.6 0.8 2.5 0.0 1.1 0.0 0.3 3.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 1.1 2.4 0.0 16.7 2.3 7.2 3.8 0.0 0.2 0.0 0.0 15.9 2.4 0.0 0.1 0.0 3.6 0.0 0.1 0.0 0.3 0.0 2.8 0.0 0.0 1.0 0.0 2.0 0.0 1.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.1 7.6 1.5 4.0 1.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 4.0 2.1 4.0 4.8 2.1 2.5 0.4 3.9 2.5 0.0 0.0 0.0 0.4 0.0 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TRPC5 PPP1R159 ENSG00000072315 "Transient receptor potential cation channel subfamily C member 5" Q9UL62 X 111774315-112082776 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 5.3;liver: 3.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "testis cancer: 0.8;thyroid cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "NTERA-2: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.29e-2)" "unprognostic (6.15e-2)" "unprognostic (7.32e-2)" "unprognostic (2.60e-3)" "unprognostic (3.68e-2)" "unprognostic (5.69e-2)" "unprognostic (5.09e-2)" "unprognostic (2.78e-2)" 0.0 0.2 0.6 0.0 0.3 0.0 0.0 0.6 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.3 0.4 3.2 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRPC6 "FSGS2, TRP6" ENSG00000137672 "Transient receptor potential cation channel subfamily C member 6" Q9Y210 11 101451564-101872562 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 35.3;placenta: 20.6" "Cell type enhanced" "Detected in some" 16 "Club cells: 19.4;Leydig cells: 5.8;Smooth muscle cells: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "eosinophil: 5.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "A549: 4.7;ASC diff: 8.8;BJ hTERT+: 4.7;HEL: 4.4;RPTEC TERT1: 21.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 7.1;hippocampal formation: 12.5;midbrain: 9.6" HPA045098 Approved NA NA 140000 "HPA045098: AB_10959600" "unprognostic (1.45e-1)" "unprognostic (4.21e-1)" "unprognostic (2.43e-1)" "unprognostic (8.71e-5)" "unprognostic (1.86e-1)" "unprognostic (1.36e-2)" "unprognostic (4.33e-2)" "unprognostic (1.14e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (5.47e-4)" "unprognostic (1.99e-3)" "unprognostic (4.88e-2)" "unprognostic (7.16e-2)" "unprognostic (1.32e-2)" 6.0 0.5 1.5 0.6 2.4 0.1 9.7 0.8 2.0 7.6 3.9 1.1 7.5 1.1 6.6 7.0 10.8 5.3 3.2 1.1 2.0 1.5 1.6 0.4 35.3 0.9 2.2 3.4 2.2 1.0 1.0 0.6 20.6 2.9 2.3 1.6 0.3 3.3 7.2 0.8 3.0 1.9 3.9 0.7 2.0 1.5 1.0 0.1 0.1 9.6 2.7 1.1 1.6 3.8 0.0 1.0 5.5 0.5 0.0 0.0 0.3 0.0 4.7 0.2 0.0 8.8 2.2 0.0 3.0 4.7 0.7 0.1 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.3 1.5 2.4 0.8 2.0 2.0 1.5 2.2 3.4 2.9 0.1 0.0 1.6 0.0 1.7 2.1 0.8 0.4 0.0 1.4 19.4 3.5 0.0 0.9 0.0 0.0 0.6 0.8 0.0 0.0 0.2 0.0 1.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.8 2.6 1.7 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 9.8 0.0 0.0 3.0 0.3 0.0 0.0 1.0 TRPC7 ENSG00000069018 "Transient receptor potential cation channel subfamily C member 7" Q9HCX4 5 136213320-136365545 "Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022592, HPA031126" Uncertain Uncertain "Actin filaments,Focal adhesion sites" NA NA "Focal adhesion sites" "Actin filaments" "CAB022592: , HPA031126: AB_10603221" "unprognostic (1.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.89e-5)" "unprognostic (3.26e-1)" "unprognostic (2.75e-1)" "unprognostic (9.99e-2)" "unprognostic (1.77e-1)" "unprognostic (6.78e-2)" 0.0 2.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TRPM1 "CSNB1C, LTRPC1, MLSN1" ENSG00000134160 "Transient receptor potential cation channel subfamily M member 1" Q7Z4N2 15 31001061-31161273 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 99.0" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 705.2" "Cancer enriched" "Detected in single" 179 "melanoma: 14.6" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 113 "SK-MEL-30: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014779, HPA071139" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Centriolar satellite" NA NA "Centriolar satellite" "Golgi apparatus, Plasma membrane" "HPA014779: AB_2669090, HPA071139: " "unprognostic (5.28e-2)" "unprognostic (1.35e-1)" "unprognostic (9.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-3)" "unprognostic (2.83e-1)" "unprognostic (2.89e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (7.84e-2)" "unprognostic (6.20e-4)" "unprognostic (1.48e-1)" "unprognostic (2.63e-2)" 0.1 0.0 0.4 0.0 0.6 0.0 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.3 0.1 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 99.0 0.4 0.0 0.2 10.4 0.0 0.1 1.9 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.1 0.3 0.7 0.2 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 3.8 705.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 30.8 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.0 2.4 0.0 0.0 150.1 0.0 0.0 10.0 0.0 0.0 0.0 0.6 18.1 0.0 0.0 7.9 3.8 0.9 0.8 0.0 0.0 0.0 TRPM2 "EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7" ENSG00000142185 "Transient receptor potential cation channel subfamily M member 2" O94759 21 44350163-44443081 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Sodium transport, Transport" "Calcium channel, Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 29.9" "Group enriched" "Detected in some" 5 "Extravillous trophoblasts: 7.0;Hofbauer cells: 15.8;Kupffer cells: 12.5;Macrophages: 9.0;Sertoli cells: 6.5;T-cells: 4.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.3;plasmacytoid DC: 14.5" "Group enriched" "Detected in many" 8 "dendritic cells: 14.5;monocytes: 7.3" "Cell line enhanced" "Detected in some" "HL-60: 16.8;NB-4: 23.8;OE19: 16.9;THP-1: 29.4;U-937: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035260 Enhanced NA NA "HPA035260: AB_2674540" "unprognostic (3.61e-2)" "unprognostic (2.18e-1)" "unprognostic (7.55e-2)" "prognostic favorable (9.28e-4)" "unprognostic (6.49e-2)" "unprognostic (4.54e-2)" "unprognostic (5.17e-2)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (2.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (4.39e-6)" "unprognostic (1.40e-1)" "unprognostic (3.31e-2)" "unprognostic (8.88e-3)" "prognostic favorable (7.59e-4)" 5.4 4.5 7.4 8.6 7.8 29.9 3.9 14.5 16.3 2.9 4.5 6.9 0.0 4.4 1.9 1.5 2.1 2.6 5.7 1.8 7.8 8.9 2.1 2.0 3.8 8.2 8.5 10.4 1.5 2.4 2.1 2.1 7.1 11.7 1.9 3.0 2.6 2.9 1.3 1.3 2.3 5.1 3.2 9.7 8.1 3.1 1.9 7.3 2.0 1.7 0.0 4.8 4.9 1.7 1.4 14.5 0.4 7.3 0.5 1.1 1.8 8.3 3.1 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.2 0.1 0.0 0.0 0.2 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.5 0.0 0.0 16.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.6 23.8 0.0 16.9 9.9 0.9 3.0 3.2 0.0 0.0 6.1 0.0 0.0 9.9 0.0 0.0 11.6 29.4 0.0 0.5 8.9 0.0 0.3 0.1 12.5 0.0 0.0 27.7 0.0 0.0 7.3 0.0 1.0 2.6 0.6 0.3 0.3 0.4 2.5 1.4 0.3 0.4 0.4 0.5 2.0 14.5 1.1 1.8 7.4 7.8 14.5 16.3 7.8 8.9 8.5 10.4 11.7 7.3 0.0 0.3 0.0 0.0 0.3 0.5 1.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 2.0 1.0 0.0 0.0 0.2 7.0 0.2 0.0 1.1 0.0 15.8 0.0 0.0 0.6 12.5 1.2 0.6 9.0 0.0 1.0 0.1 0.5 0.8 0.0 0.0 0.1 0.4 6.5 0.0 0.5 0.0 0.3 1.1 4.8 0.0 0.0 TRPM3 "GON-2, KIAA1616, LTRPC3" ENSG00000083067 "Transient receptor potential cation channel subfamily M member 3" Q9HCF6 9 70529063-71446904 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 36.6;kidney: 28.0;retina: 105.2" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 278.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "NK-cell: 2.1" "Lineage enriched" "Detected in single" 16 "NK-cells: 2.1" "Cell line enriched" "Detected in some" 4 "HAP1: 19.4" "Low region specificity" "Detected in all" "HPA072650, HPA074393" Enhanced Approved Vesicles NA NA Vesicles "HPA072650: , HPA074393: " "unprognostic (3.74e-1)" "unprognostic (6.30e-2)" "unprognostic (4.79e-2)" "unprognostic (4.81e-2)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-2)" "unprognostic (6.10e-2)" "unprognostic (1.15e-2)" "unprognostic (1.82e-7)" "unprognostic (3.51e-2)" "unprognostic (5.64e-2)" "unprognostic (1.74e-2)" "unprognostic (1.50e-2)" 0.9 1.7 6.0 0.7 4.5 1.1 0.8 36.6 5.1 0.8 0.7 9.6 2.1 1.8 2.4 3.0 0.7 1.3 1.3 1.4 9.4 6.0 28.0 0.9 0.8 0.7 8.3 3.5 5.3 1.5 0.7 6.8 0.8 34.8 1.4 0.7 105.2 0.8 5.0 1.1 0.8 0.7 1.0 8.1 1.1 1.6 5.3 5.9 0.0 2.1 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 1.1 0.1 1.3 3.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 19.4 0.0 0.1 0.0 0.1 0.1 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 2.7 0.2 0.0 0.0 1.2 4.5 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.2 0.0 1.0 0.0 1.3 0.0 0.2 0.0 0.4 0.2 0.0 0.0 3.6 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 6.0 4.5 36.6 3.8 9.4 6.0 8.3 3.5 34.8 5.9 3.0 4.0 0.0 0.9 0.3 9.5 4.8 2.5 1.4 4.5 15.7 62.8 0.0 5.0 0.0 3.9 1.3 0.0 0.0 0.2 0.0 1.5 0.4 0.0 0.0 0.2 1.6 14.8 0.6 0.0 1.7 5.2 1.1 0.0 0.0 0.0 278.6 0.1 0.0 8.5 25.8 4.7 0.0 1.0 1.5 0.4 0.6 0.2 0.8 0.0 0.3 TRPM4 FLJ20041 ENSG00000130529 "Transient receptor potential cation channel subfamily M member 4" Q8TD43 19 49157741-49211836 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Immunity, Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 120.1;Mucus-secreting cells: 88.2;Paneth cells: 80.4;Undifferentiated cells: 78.1" "Cancer enhanced" "Detected in all" "prostate cancer: 85.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8" "Cell line enhanced" "Detected in many" "OE19: 15.6;RT4: 32.4;SK-BR-3: 21.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA041169 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 6500 "Nucleoplasm, Plasma membrane" "HPA041169: AB_2677343" "unprognostic (8.20e-3)" "unprognostic (1.41e-1)" "unprognostic (7.86e-2)" "prognostic favorable (2.88e-7)" "unprognostic (1.62e-2)" "unprognostic (9.78e-2)" "unprognostic (1.77e-2)" "unprognostic (2.90e-1)" "unprognostic (3.33e-2)" "unprognostic (3.38e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "prognostic favorable (2.53e-7)" "unprognostic (8.46e-3)" "unprognostic (2.16e-1)" "unprognostic (5.70e-2)" "unprognostic (1.00e-2)" 6.7 3.8 3.5 13.7 3.7 4.3 8.5 3.0 6.8 8.2 25.2 4.5 8.6 20.6 7.9 9.1 7.7 5.4 24.8 9.3 2.7 2.2 14.2 23.6 9.4 3.5 2.6 5.7 2.7 17.4 3.4 3.3 5.0 6.9 20.2 11.4 10.6 16.2 13.2 16.4 16.1 26.8 9.4 2.5 3.4 18.3 4.2 2.2 0.4 10.1 11.5 6.8 9.9 8.6 1.1 5.4 4.9 6.8 1.0 0.7 2.1 6.0 4.5 1.1 5.0 3.8 3.6 3.6 5.1 3.0 1.4 1.9 3.3 9.5 0.2 1.3 3.4 1.9 7.9 0.7 1.5 0.6 0.1 1.6 1.0 1.9 2.0 3.4 0.1 6.6 4.3 7.0 2.6 1.2 1.7 2.4 0.5 2.4 1.2 3.5 9.0 0.4 0.5 0.6 15.6 6.9 2.2 1.0 0.3 2.4 32.4 0.4 1.1 2.1 21.3 1.1 0.4 11.6 2.0 6.1 7.6 4.2 4.2 0.1 2.2 2.2 0.2 4.3 3.9 2.8 2.7 6.8 1.1 0.6 4.0 0.5 0.8 0.5 0.4 5.4 1.1 0.6 0.7 4.9 1.0 1.5 4.9 0.3 2.1 3.5 3.7 3.0 6.8 2.7 2.2 2.6 5.7 6.9 2.2 29.8 1.6 11.7 13.4 11.1 2.1 14.9 22.9 2.7 3.4 14.0 0.0 5.3 16.6 7.6 2.1 9.2 120.1 0.0 16.1 5.7 6.6 47.1 5.7 64.7 16.1 0.0 20.8 15.4 9.7 3.1 6.4 7.9 37.1 14.4 88.2 6.3 25.2 80.4 6.7 3.8 2.4 32.3 9.1 6.6 11.9 10.0 2.9 0.0 78.1 25.3 TRPM5 "LTRPC5, MTR1" ENSG00000070985 "Transient receptor potential cation channel subfamily M member 5" Q9NZQ8 11 2404515-2423045 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 4.1;intestine: 6.3;pancreas: 4.5;seminal vesicle: 4.0" "Cell type enhanced" "Detected in single" 14 "Undifferentiated cells: 1.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MCF7: 2.6;OE19: 3.6;RPMI-8226: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (6.47e-5)" "unprognostic (6.81e-4)" "unprognostic (7.90e-3)" "unprognostic (1.18e-1)" "unprognostic (1.13e-2)" "unprognostic (2.24e-2)" "unprognostic (4.75e-1)" "unprognostic (1.53e-1)" "unprognostic (2.36e-1)" "unprognostic (3.19e-1)" "unprognostic (5.07e-3)" "unprognostic (2.40e-1)" "unprognostic (5.21e-1)" "unprognostic (5.72e-2)" "unprognostic (4.91e-2)" 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.1 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.5 0.0 0.2 0.5 0.0 4.0 0.0 0.0 6.3 0.0 0.0 0.0 0.5 0.9 3.1 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.1 0.0 3.6 0.1 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 TRPM6 "CHAK2, FLJ22628, HOMG, HSH" ENSG00000119121 "Transient receptor potential cation channel subfamily M member 6" Q9BX84 9 74722495-74888094 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.1;intestine: 19.5" "Group enriched" "Detected in many" 4 "Enterocytes: 28.8;Paneth cells: 10.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 16.1;neutrophil: 6.6" "Lineage enriched" "Detected in single" 30 "granulocytes: 16.1" "Cell line enhanced" "Detected in some" "BEWO: 7.7;HeLa: 4.5;Karpas-707: 2.6;RT4: 7.4;U-266/70: 2.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (3.95e-2)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "unprognostic (1.65e-1)" "unprognostic (7.80e-2)" "unprognostic (9.20e-2)" "unprognostic (1.59e-2)" "unprognostic (1.72e-1)" "unprognostic (2.82e-1)" "unprognostic (1.84e-1)" "unprognostic (5.72e-4)" "unprognostic (1.58e-1)" "unprognostic (1.71e-2)" "unprognostic (8.10e-2)" "unprognostic (7.54e-2)" "unprognostic (1.89e-2)" "unprognostic (2.11e-2)" 2.9 0.0 1.3 0.5 1.2 2.5 1.1 1.3 1.2 0.8 13.3 0.2 1.0 7.2 0.4 0.2 0.6 0.4 1.0 0.5 1.9 1.2 3.1 0.2 1.5 0.2 2.6 0.0 0.4 0.2 3.8 4.9 0.2 1.6 1.7 17.5 0.4 1.1 0.0 1.6 0.8 19.5 0.7 5.0 3.9 0.2 1.7 0.5 1.6 0.3 1.1 2.1 0.5 0.6 0.3 0.3 16.1 0.1 0.5 0.1 0.0 0.1 1.7 0.2 0.2 0.0 0.0 7.7 0.1 0.0 0.0 0.1 2.1 0.2 0.6 0.0 0.1 0.3 0.3 0.5 0.5 0.0 0.1 0.2 0.2 4.5 0.3 0.1 0.1 0.2 0.3 0.2 0.0 0.0 0.1 0.2 0.3 0.0 2.6 0.1 0.9 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.3 0.0 7.4 0.3 0.0 0.0 0.1 0.1 0.4 0.3 0.0 0.0 0.2 1.1 0.2 0.0 2.8 0.0 0.2 0.1 0.1 0.3 16.1 0.1 1.9 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 6.6 0.5 0.1 0.3 0.0 0.0 1.3 1.2 1.3 1.2 1.9 1.2 2.6 0.0 1.6 0.5 0.0 1.7 0.0 1.7 0.1 0.2 0.6 0.0 1.4 2.3 3.5 0.0 0.2 0.0 0.0 2.5 0.7 28.8 0.0 0.0 0.1 0.3 1.1 0.0 0.0 0.0 0.0 3.5 4.9 0.3 0.4 0.0 0.2 0.0 0.0 3.3 0.1 0.0 10.5 0.4 0.0 2.3 0.0 0.3 1.5 2.3 0.9 0.1 0.0 2.6 0.9 TRPM7 "CHAK1, LTRPC7, TRP-PLIK" ENSG00000092439 "Transient receptor potential cation channel subfamily M member 7" Q96QT4 15 50552473-50686815 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Necrosis, Transport" "Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 91.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035522, HPA052173" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Vesicles, Cytosol" "HPA035522: , HPA052173: AB_2681749" "unprognostic (3.14e-2)" "unprognostic (1.86e-1)" "unprognostic (1.58e-1)" "unprognostic (1.42e-2)" "unprognostic (1.89e-1)" "unprognostic (1.60e-2)" "unprognostic (1.85e-2)" "unprognostic (2.59e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (2.91e-1)" "unprognostic (1.59e-2)" "unprognostic (3.20e-2)" "unprognostic (2.08e-1)" "unprognostic (7.59e-2)" "unprognostic (9.45e-2)" "unprognostic (1.97e-1)" 13.3 10.8 6.6 14.7 9.0 12.8 12.1 19.5 9.3 11.8 11.7 8.1 9.7 9.9 16.5 10.7 9.4 11.0 8.2 19.1 5.5 4.9 16.0 20.0 10.8 10.6 12.4 5.2 16.6 11.6 91.8 14.6 14.3 10.2 9.7 10.3 28.6 11.5 13.5 10.8 11.7 12.8 12.8 9.8 11.1 10.3 6.9 10.0 14.5 12.6 6.9 12.6 12.9 12.3 7.0 4.7 4.4 3.4 5.7 7.6 2.0 8.5 8.5 7.1 7.9 20.6 15.5 8.7 10.8 15.0 6.9 9.1 11.7 4.7 18.6 5.3 12.4 17.8 14.4 9.5 7.9 9.9 10.3 5.7 14.8 13.1 6.1 18.8 15.3 11.5 14.4 9.4 7.8 14.7 10.1 5.5 11.8 16.7 14.3 12.5 13.4 9.8 7.5 5.4 11.8 5.3 10.8 9.9 9.1 9.6 20.2 5.9 7.5 7.4 11.9 14.5 13.1 7.4 16.7 8.4 11.0 5.2 50.9 12.4 9.7 21.5 17.9 11.9 31.3 10.2 3.8 3.4 3.9 6.6 3.2 7.6 5.6 4.8 4.4 3.7 7.0 4.4 5.2 4.4 5.7 3.2 4.7 4.8 2.0 6.6 9.0 19.5 9.3 5.5 4.9 12.4 5.2 10.2 10.0 17.9 25.3 18.2 14.9 28.0 22.9 21.4 28.1 24.1 7.9 12.2 11.8 18.5 3.3 9.7 25.2 18.5 16.9 23.3 11.1 8.0 17.0 21.2 16.3 35.0 12.7 20.6 17.7 15.4 18.6 17.9 24.5 17.0 18.6 14.4 17.3 9.1 12.8 12.9 19.1 9.6 21.5 12.9 13.7 13.6 19.4 21.1 13.6 17.5 16.3 9.0 TRPM8 ENSG00000144481 "Transient receptor potential cation channel subfamily M member 8" Q7Z2W7 2 233917398-234019522 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "liver: 16.7;prostate: 44.1" "Group enriched" "Detected in some" 7 "Glandular cells: 24.4;Hepatocytes: 42.4" "Cancer enriched" "Detected in some" 27 "prostate cancer: 72.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 3.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 4.4;Karpas-707: 7.1;RPTEC TERT1: 10.7;SK-MEL-30: 10.7;WM-115: 6.5" "Region enhanced" "Detected in single" "cerebellum: 0.8" "Low region specificity" "Detected in many" NA NA "unprognostic (4.41e-3)" "unprognostic (7.91e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-3)" "unprognostic (1.05e-1)" "unprognostic (4.60e-3)" "prognostic favorable (7.15e-4)" "unprognostic (3.28e-2)" "unprognostic (3.71e-1)" "unprognostic (9.88e-3)" "unprognostic (7.10e-3)" "unprognostic (4.69e-2)" "unprognostic (3.36e-5)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (1.18e-1)" "unprognostic (5.53e-2)" 3.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 44.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.9 0.2 3.0 0.3 0.0 0.0 0.7 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 7.1 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.6 0.7 10.7 0.0 0.7 0.4 0.0 0.1 10.7 0.0 0.4 0.7 0.0 0.0 0.1 0.3 0.1 1.6 2.5 0.0 0.9 0.0 6.5 0.5 0.2 0.1 0.3 0.1 0.2 0.2 0.3 0.2 0.0 0.4 0.3 0.3 0.9 3.0 0.1 0.2 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.7 0.9 0.0 0.0 0.0 5.0 0.3 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 1.6 0.0 0.0 24.4 0.0 42.4 0.2 0.0 0.0 1.3 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.3 1.1 0.4 0.1 0.0 0.0 0.0 2.5 TRPV1 VR1 ENSG00000196689 "Transient receptor potential cation channel subfamily V member 1" Q8NER1 17 3565444-3609411 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 11.7" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 25.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (3.96e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (1.33e-2)" "unprognostic (6.83e-2)" "unprognostic (3.21e-4)" "unprognostic (9.90e-2)" "unprognostic (2.95e-1)" "unprognostic (2.03e-1)" "unprognostic (2.56e-2)" "unprognostic (3.43e-3)" "unprognostic (6.17e-3)" "unprognostic (6.97e-4)" "unprognostic (4.25e-1)" "unprognostic (4.78e-1)" "unprognostic (3.81e-2)" "unprognostic (5.12e-3)" 1.4 1.2 3.5 0.7 2.9 0.3 1.7 2.7 2.1 2.1 1.4 6.5 2.3 1.5 0.8 2.8 1.1 1.9 3.2 3.6 2.5 11.7 0.7 1.3 4.7 5.1 2.5 1.0 2.0 1.2 1.5 1.7 2.1 1.0 2.8 4.7 5.1 0.9 2.3 1.2 2.2 1.2 1.3 0.8 1.2 1.1 1.1 1.4 1.5 0.8 0.5 2.2 0.3 3.0 5.6 4.5 5.0 4.9 4.7 4.1 1.7 2.4 2.6 2.4 1.4 1.7 1.2 2.3 1.8 1.8 13.2 2.8 0.9 1.9 7.3 6.7 0.7 2.9 5.6 2.2 0.4 5.7 5.6 3.0 3.8 1.5 2.5 0.5 2.9 0.3 2.2 1.5 3.8 2.1 1.0 3.0 0.6 2.7 6.2 2.9 0.9 2.2 2.7 1.9 4.2 2.3 4.4 2.2 3.5 8.3 2.3 1.7 1.1 2.7 4.5 2.2 1.9 1.3 0.5 1.9 2.4 2.4 0.9 0.8 1.5 0.7 0.2 0.9 0.4 0.6 0.2 0.1 1.1 0.8 2.2 1.5 0.5 0.3 1.4 0.2 0.3 0.0 1.6 0.0 0.4 0.0 8.6 0.2 2.5 4.0 2.3 5.2 15.7 1.0 0.0 0.4 1.8 0.0 2.6 0.0 0.6 0.3 0.4 0.6 0.0 6.4 0.7 6.4 1.2 2.5 0.6 0.2 4.4 1.2 0.0 0.0 1.5 2.8 0.4 0.0 3.5 1.4 25.1 0.0 0.1 0.7 0.7 0.0 0.7 0.0 2.2 0.3 TRPV2 "VRL, VRL-1, VRL1" ENSG00000187688 "Transient receptor potential cation channel subfamily V member 2" Q9Y5S1 17 16415542-16437003 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "granulocytes: 48.5;Hofbauer cells: 48.6;monocytes: 52.3" "Cancer enriched" "Detected in all" 8 "melanoma: 59.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.1;fHDF/TERT166: 35.4;HMC-1: 29.8;SK-MEL-30: 30.7;TIME: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044993 Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA044993: AB_10960889" "unprognostic (1.57e-1)" "unprognostic (4.34e-3)" "unprognostic (2.05e-2)" "unprognostic (1.58e-2)" "unprognostic (2.85e-2)" "unprognostic (6.16e-3)" "unprognostic (5.25e-2)" "unprognostic (1.25e-1)" "unprognostic (8.40e-3)" "unprognostic (2.43e-1)" "unprognostic (3.11e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.19e-6)" "unprognostic (7.94e-2)" "prognostic unfavorable (5.53e-4)" "unprognostic (8.07e-2)" "unprognostic (1.23e-1)" 25.4 17.6 5.9 14.3 4.9 15.6 11.3 1.9 7.6 6.7 6.0 4.2 0.5 5.4 8.2 6.1 5.7 6.8 6.7 8.9 5.0 8.1 4.4 4.5 25.8 24.9 6.0 4.2 8.9 8.4 7.7 1.8 15.6 8.1 6.3 5.0 4.9 4.4 2.1 3.8 5.0 8.8 9.2 4.1 23.4 5.3 2.8 2.5 23.4 5.7 4.2 18.0 8.1 6.7 9.0 25.9 20.4 22.3 26.5 29.8 17.4 0.1 0.5 0.0 0.0 8.7 27.1 1.6 2.7 3.1 3.0 3.0 0.1 0.1 3.1 0.7 35.4 2.6 0.0 0.0 0.0 1.7 13.7 0.2 3.4 0.0 8.4 10.4 4.7 29.8 12.0 0.0 18.2 0.2 1.4 1.2 4.2 11.6 8.6 14.4 0.1 6.0 6.5 0.0 0.0 0.0 3.6 0.1 1.3 13.5 0.3 0.4 0.0 0.0 0.0 30.7 14.5 0.0 4.1 27.6 0.0 0.1 0.1 0.3 0.0 0.1 1.6 2.8 6.9 4.1 20.4 12.2 15.2 29.8 22.3 25.9 9.0 21.9 27.6 25.9 8.7 12.5 21.7 3.0 26.5 19.8 22.7 21.2 17.4 5.9 4.9 1.9 7.6 5.0 8.1 6.0 4.2 8.1 2.5 0.0 7.7 9.3 0.1 2.5 0.5 1.0 2.5 1.4 1.2 0.0 0.0 1.9 0.0 0.2 0.3 8.7 0.0 0.0 3.1 1.3 8.9 0.0 48.5 0.5 48.6 0.0 0.0 11.1 17.4 0.0 1.7 26.8 27.0 52.3 0.0 0.0 4.0 0.0 4.2 0.0 0.4 25.8 17.3 0.5 0.9 1.5 13.5 29.9 0.0 0.1 TRPV3 VRL3 ENSG00000167723 "Transient receptor potential cation channel subfamily V member 3" Q8NET8 17 3510502-3557995 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation, FDA approved drug targets, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 15.4;skeletal muscle: 29.1" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 16.7;Enterocytes: 10.8;Suprabasal keratinocytes: 21.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "basal ganglia: 2.4" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 3.6;BEWO: 5.4;CACO-2: 4.3;RH-30: 13.3;T-47d: 5.6;U-266/70: 3.5" "Low region specificity" "Detected in some" "Region enriched" "Detected in many" 6 "cerebellum: 14.0" HPA069550 Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane" "Centrosome, Cytosol" "HPA069550: AB_2686149" "unprognostic (1.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.22e-2)" "unprognostic (3.92e-4)" "unprognostic (4.87e-3)" "unprognostic (2.96e-2)" "unprognostic (6.66e-2)" "unprognostic (4.88e-2)" "unprognostic (7.02e-2)" "unprognostic (2.68e-1)" "unprognostic (4.88e-2)" "unprognostic (3.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (8.64e-2)" "unprognostic (2.93e-2)" 0.4 0.2 0.4 3.2 2.4 0.9 4.1 0.3 1.2 0.6 10.6 0.1 0.3 3.2 0.2 0.2 2.3 0.3 0.8 0.3 0.4 0.3 0.2 1.1 0.3 0.5 0.4 0.2 0.3 0.9 0.0 0.7 0.4 0.0 0.2 2.9 0.3 0.5 0.4 29.1 8.4 15.4 0.5 0.5 0.4 1.6 0.8 0.0 0.0 0.2 9.7 3.0 0.7 2.1 0.7 0.6 2.9 0.6 0.6 0.7 0.1 3.6 0.0 0.5 0.1 0.3 0.6 5.4 0.2 0.0 0.0 0.0 4.3 1.0 0.2 1.1 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.6 0.1 0.2 0.8 0.3 0.0 0.7 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.2 0.1 0.3 0.5 0.1 13.3 0.2 0.0 0.2 0.1 0.0 0.2 0.6 0.0 0.0 5.6 0.2 0.1 0.1 0.2 0.1 0.1 3.5 2.8 0.0 0.1 0.1 0.0 2.9 0.4 0.4 0.7 0.2 0.5 0.7 0.4 0.7 0.1 0.5 0.4 0.6 1.0 0.6 0.6 0.6 0.2 0.1 0.4 2.4 0.3 1.2 0.4 0.3 0.4 0.2 0.0 0.0 0.0 4.5 1.4 4.0 16.7 0.8 2.4 2.5 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.2 1.6 10.8 0.0 0.0 0.7 4.3 2.9 0.0 0.4 0.2 4.8 0.0 0.0 0.0 0.0 2.8 2.2 6.8 0.0 0.7 2.0 0.8 0.8 3.2 0.8 0.9 0.0 0.9 0.0 1.1 21.5 0.5 2.1 0.6 2.2 TRPV4 "CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC" ENSG00000111199 "Transient receptor potential cation channel subfamily V member 4" Q9HBA0 12 109783085-109833401 "Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Charcot-Marie-Tooth disease, Disease mutation, Dwarfism, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 32.6" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 15.3;Cytotrophoblasts: 16.0;Syncytiotrophoblasts: 17.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 11 "pons and medulla: 15.0" "Cell type enriched" "Detected in single" 7 "classical monocyte: 3.0" "Lineage enriched" "Detected in single" 7 "monocytes: 3.0" "Cell line enhanced" "Detected in many" "BEWO: 9.0;BJ hTERT+: 9.3;EFO-21: 8.2;HaCaT: 14.8;HUVEC TERT2: 8.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA007150 Uncertain NA NA "HPA007150: AB_1080393" "unprognostic (2.98e-2)" "unprognostic (1.12e-2)" "unprognostic (2.33e-2)" "unprognostic (4.20e-3)" "unprognostic (6.25e-3)" "unprognostic (1.09e-2)" "unprognostic (7.95e-2)" "unprognostic (2.03e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.24e-1)" "unprognostic (1.68e-1)" "prognostic favorable (4.12e-5)" "unprognostic (1.20e-1)" "unprognostic (2.30e-1)" "unprognostic (1.72e-1)" "unprognostic (1.73e-2)" 1.3 0.9 0.3 0.9 0.4 0.1 3.3 0.2 0.6 2.3 0.4 3.2 0.0 0.6 0.8 3.7 9.5 5.6 5.2 1.6 1.3 0.2 11.6 7.8 2.6 1.8 0.2 0.0 0.6 7.1 0.1 4.3 11.1 15.0 6.2 0.3 12.6 32.6 1.4 0.2 6.5 0.3 0.9 0.3 3.5 0.9 0.7 0.1 0.2 0.9 2.6 8.7 2.6 1.7 0.0 0.4 0.0 3.0 0.0 0.0 0.4 2.6 0.1 0.0 0.0 1.9 1.9 9.0 4.3 9.3 1.3 0.5 0.0 6.4 0.0 8.2 5.5 0.0 14.8 1.1 0.0 0.3 0.0 2.1 0.0 0.0 3.6 0.7 0.0 0.0 3.3 2.0 3.3 0.0 0.5 8.4 0.0 0.8 0.0 0.4 5.4 0.0 0.0 1.7 0.0 0.3 0.0 0.5 0.0 0.0 5.2 0.0 0.0 0.3 0.6 2.6 4.1 1.2 0.4 5.1 0.0 3.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.0 3.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.2 0.6 1.3 0.2 0.2 0.0 15.0 0.1 0.0 0.0 1.3 8.2 3.0 0.0 1.1 15.3 5.3 6.8 10.4 0.0 16.0 3.3 2.2 0.2 0.5 0.0 0.0 8.4 4.3 0.7 3.7 0.0 6.4 3.6 0.0 0.0 0.6 10.7 0.0 0.9 1.6 6.8 1.0 0.0 0.0 1.5 0.0 0.0 11.1 0.0 0.0 0.8 0.2 1.3 3.3 17.6 0.0 0.0 2.0 TRPV5 "CaT2, ECAC1" ENSG00000127412 "Transient receptor potential cation channel subfamily V member 5" Q9NQA5 7 142908101-142933808 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 26.0" "Cell type enriched" "Detected in single" 8 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.2" "Cell line enhanced" "Detected in single" "RT4: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA063175 Uncertain NA NA "HPA063175: AB_2684954" "unprognostic (7.44e-2)" "unprognostic (3.93e-2)" "unprognostic (1.22e-2)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (3.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.78e-2)" "unprognostic (1.07e-1)" "unprognostic (7.95e-2)" "unprognostic (7.73e-4)" "unprognostic (4.87e-2)" "unprognostic (3.41e-1)" "unprognostic (4.58e-1)" "unprognostic (7.76e-3)" 0.1 0.0 0.8 0.4 0.7 0.5 0.5 0.1 0.8 0.1 0.1 0.1 0.1 0.7 0.1 0.3 0.1 0.1 0.1 0.1 1.1 0.7 26.0 0.1 0.1 0.2 1.6 0.4 0.1 0.3 0.0 0.1 0.1 0.7 0.1 0.0 0.1 0.3 0.1 0.2 0.1 0.1 0.1 3.5 0.2 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.2 0.3 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.5 1.1 0.7 1.6 0.4 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRPV6 "CaT1, ECAC2" ENSG00000165125 "Transient receptor potential cation channel subfamily V member 6" Q9H1D0 7 142871203-142885762 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 26.1;placenta: 65.1;salivary gland: 34.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 25.5;Collecting duct cells: 26.2;Ductal cells: 63.7;Early spermatids: 26.4;Late spermatids: 28.8" "Cancer enriched" "Detected in many" 5 "prostate cancer: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.7;HaCaT: 10.5;RT4: 18.7;SK-BR-3: 13.8;T-47d: 30.8" "Low region specificity" "Detected in some" HPA062864 Approved NA NA "HPA062864: AB_2684885" "unprognostic (9.85e-2)" "unprognostic (1.60e-2)" "unprognostic (6.29e-2)" "unprognostic (8.72e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (5.43e-2)" "unprognostic (3.50e-1)" "unprognostic (4.56e-2)" "unprognostic (3.89e-2)" "unprognostic (3.27e-2)" "unprognostic (8.49e-2)" "unprognostic (9.39e-3)" "unprognostic (1.69e-1)" "unprognostic (7.17e-3)" "unprognostic (3.53e-2)" 0.3 0.0 0.3 0.3 0.3 0.0 2.1 0.3 0.3 0.4 1.2 0.3 0.3 4.1 0.3 0.4 1.7 0.1 4.1 0.3 0.3 0.2 2.5 0.6 0.8 0.3 0.8 0.3 0.3 26.1 0.0 0.4 65.1 0.4 12.6 0.0 0.4 34.2 0.7 0.3 3.7 1.0 0.5 2.0 0.3 2.4 0.7 0.3 0.3 0.7 0.6 1.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 1.1 0.0 0.0 13.8 0.3 0.6 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.2 0.8 0.3 0.4 0.3 3.0 0.0 0.0 0.9 0.5 0.4 1.6 25.5 1.4 2.3 26.2 0.0 13.3 0.0 63.7 26.4 0.0 0.0 0.0 2.8 0.6 0.4 14.3 0.0 0.0 1.4 3.2 0.0 0.0 0.0 28.8 0.9 0.0 0.0 3.6 0.0 0.8 13.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.6 5.0 0.0 0.0 3.1 TSC1 "hamartin, KIAA0243, LAM, TSC" ENSG00000165699 "TSC complex subunit 1" Q92574 9 132891348-132946874 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 99.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011568, CAB012481, HPA074132" Supported Enhanced Cytosol NA NA Cytosol "CAB011568: AB_732752, CAB012481: , HPA074132: AB_2686666" "unprognostic (1.88e-1)" "unprognostic (1.51e-1)" "unprognostic (1.40e-2)" "unprognostic (2.56e-1)" "unprognostic (6.67e-2)" "unprognostic (4.23e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (1.96e-2)" "unprognostic (3.48e-2)" "unprognostic (1.24e-1)" "prognostic favorable (8.01e-4)" "unprognostic (1.84e-2)" "prognostic favorable (7.91e-4)" "unprognostic (9.49e-2)" "unprognostic (1.46e-1)" "unprognostic (2.35e-1)" "unprognostic (1.16e-1)" 10.4 13.6 15.8 8.8 26.8 13.6 11.4 32.1 28.3 12.7 10.8 22.6 7.9 9.1 14.6 12.3 10.9 12.4 9.7 17.6 13.0 12.1 13.1 9.4 11.6 10.2 12.5 15.1 21.2 12.1 15.9 19.5 15.8 21.1 11.8 12.6 13.1 11.6 10.4 20.0 13.8 11.2 14.2 12.4 13.7 10.6 36.2 14.9 10.5 16.2 8.6 14.2 10.9 11.1 2.8 3.1 4.8 7.0 4.9 7.1 2.6 6.2 7.4 10.1 8.3 10.4 9.9 19.0 8.4 13.6 8.8 8.7 12.5 7.3 14.6 3.7 16.0 13.4 16.2 11.9 8.5 9.0 7.0 6.3 4.6 14.7 10.2 12.4 6.8 6.3 10.7 6.4 11.2 13.8 8.8 10.1 13.0 8.1 8.0 10.0 11.5 6.1 5.8 13.9 9.2 6.2 7.4 19.1 8.2 3.9 8.2 5.1 7.8 9.8 6.1 4.8 12.5 11.1 4.0 10.4 14.4 8.7 8.6 5.7 4.5 10.0 14.2 8.2 4.0 6.4 4.1 4.4 4.8 6.5 7.0 7.1 1.9 3.6 5.7 3.1 2.8 5.9 5.3 1.7 4.9 3.2 1.8 5.7 2.6 15.8 26.8 32.1 28.3 13.0 12.1 12.5 15.1 21.1 14.9 20.8 25.6 10.8 4.8 6.6 26.0 26.6 7.6 21.4 12.5 10.4 35.3 12.8 11.6 9.5 39.6 8.7 6.3 0.0 6.2 19.5 9.1 6.5 8.1 5.0 7.8 23.8 16.1 12.3 8.7 99.6 14.4 7.4 11.8 8.2 7.9 10.4 10.9 8.4 10.6 7.5 25.2 19.4 8.0 18.9 17.8 7.5 17.6 7.1 9.9 6.5 TSC2 "LAM, PPP1R160, TSC4, tuberin" ENSG00000103197 "TSC complex subunit 2" P49815 16 2047465-2089487 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "GTPase activation" "Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002225, HPA030409, HPA049679" Approved Enhanced Cytosol NA NA Cytosol "CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: AB_2680848" "unprognostic (2.80e-1)" "unprognostic (1.01e-1)" "unprognostic (1.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.02e-1)" "unprognostic (1.03e-3)" "unprognostic (2.04e-2)" "unprognostic (6.05e-3)" "unprognostic (3.43e-1)" "unprognostic (8.94e-2)" "prognostic favorable (5.06e-4)" "unprognostic (4.32e-2)" "unprognostic (3.91e-2)" "unprognostic (2.14e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-2)" "unprognostic (8.96e-2)" 13.9 11.9 16.9 12.4 20.0 10.9 13.2 35.1 26.9 20.5 17.0 19.4 17.9 14.0 20.1 12.2 13.0 18.6 15.0 14.0 13.3 8.8 11.8 9.8 12.7 10.1 13.8 14.7 21.1 16.1 20.0 18.1 10.6 14.6 13.8 10.8 16.7 22.9 19.6 31.7 14.5 13.2 13.5 11.4 12.9 16.6 21.4 12.9 14.1 20.1 11.3 10.9 18.0 14.0 4.7 5.6 7.7 4.9 3.6 7.0 3.7 7.2 11.6 16.1 18.2 19.2 16.2 13.6 17.4 11.9 13.1 11.2 13.9 13.8 10.9 15.5 14.3 6.1 12.0 9.6 12.6 9.8 8.3 15.8 10.3 22.5 5.7 13.2 12.8 12.5 19.1 8.0 10.6 7.9 15.8 12.3 7.9 10.0 9.8 11.6 14.4 15.2 3.7 16.7 5.4 11.4 24.2 17.6 13.9 5.3 6.5 12.2 23.1 24.8 16.4 8.8 16.7 15.0 9.5 19.4 13.8 9.4 12.3 8.8 21.9 21.8 21.8 5.7 5.2 16.3 6.2 4.9 5.4 7.0 4.7 6.7 4.4 4.4 4.1 5.6 4.7 3.1 4.8 7.7 3.6 3.7 1.5 3.2 3.7 16.9 20.0 35.1 26.9 13.3 8.8 13.8 14.7 14.6 12.9 23.8 17.6 14.9 7.2 8.1 44.2 38.9 20.4 9.4 10.3 19.2 88.4 10.1 3.3 12.8 11.0 19.5 25.8 0.0 12.2 6.5 14.6 9.4 8.1 29.2 9.8 42.9 31.2 34.4 10.5 22.4 26.2 16.6 8.5 7.2 23.8 24.1 15.9 17.5 24.4 6.7 69.1 12.9 11.8 19.4 39.6 8.5 7.8 20.0 24.7 9.2 TSHR LGR3 ENSG00000165409 "Thyroid stimulating hormone receptor" P16473 14 80954989-81146302 "Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "thyroid gland: 158.0" "Cell type enhanced" "Detected in some" 15 "Club cells: 2.3;Intestinal endocrine cells: 1.7" "Cancer enriched" "Detected in some" 116 "thyroid cancer: 100.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 9.9" "Lineage enriched" "Detected in many" 5 "T-cells: 9.9" "Cell line enhanced" "Detected in some" "JURKAT: 34.0;MOLT-4: 13.3;SCLC-21H: 13.7;U-266/70: 6.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" CAB000473 Approved "Intracellular and membrane" NA NA "CAB000473: AB_2303782" "unprognostic (3.36e-3)" "unprognostic (1.31e-3)" "unprognostic (1.02e-2)" "unprognostic (4.17e-6)" "unprognostic (3.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.83e-1)" "unprognostic (2.66e-2)" "unprognostic (3.39e-2)" "unprognostic (2.60e-2)" "unprognostic (1.70e-1)" "unprognostic (7.11e-3)" "unprognostic (5.08e-7)" "unprognostic (1.32e-1)" "unprognostic (7.40e-2)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" 0.1 0.2 0.1 0.2 0.4 0.3 0.2 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.3 0.3 0.5 0.1 0.0 0.8 0.2 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.1 0.1 0.1 27.3 158.0 0.2 0.4 0.1 0.1 1.8 0.8 1.3 0.3 0.1 9.9 0.1 0.2 0.1 0.4 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.3 0.4 0.1 0.1 0.2 0.1 0.5 0.0 0.1 0.2 0.1 0.2 0.4 0.2 0.0 0.1 0.2 0.2 0.0 0.1 0.2 0.1 0.0 34.0 0.2 0.4 0.1 0.3 13.3 0.3 0.3 0.1 0.1 0.5 0.1 0.5 0.0 0.3 13.7 0.2 0.1 0.1 0.1 0.3 0.2 0.0 0.1 0.4 0.3 0.3 0.2 6.7 3.5 0.3 0.2 0.1 0.2 0.6 0.2 0.2 0.2 0.1 0.2 1.0 0.8 0.5 0.1 1.8 0.3 0.2 1.3 0.1 0.3 0.8 9.9 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TSNARE1 FLJ31164 ENSG00000171045 "T-SNARE domain containing 1" Q96NA8 8 142212080-142403240 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 18.8" HPA074249 Approved Approved Cytosol NA NA Cytosol "HPA074249: " "unprognostic (2.92e-2)" "unprognostic (1.44e-1)" "unprognostic (3.94e-3)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (1.09e-2)" "unprognostic (1.48e-2)" "unprognostic (3.72e-3)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (6.87e-3)" "unprognostic (1.66e-1)" "unprognostic (6.26e-2)" "unprognostic (1.46e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "prognostic favorable (7.33e-4)" 9.0 8.4 14.3 10.1 14.3 5.3 9.0 14.4 18.4 11.2 8.9 15.6 7.4 15.2 12.6 10.5 7.4 13.2 8.2 7.2 8.6 8.0 8.6 6.6 9.2 8.2 12.7 12.9 17.9 24.3 9.0 9.8 4.8 11.6 10.5 4.3 10.5 17.1 11.5 11.7 31.9 16.5 7.4 8.4 13.2 11.3 8.9 14.3 6.3 12.3 6.5 9.7 9.3 8.8 1.2 1.5 3.9 5.0 1.2 2.3 1.4 5.0 5.0 3.3 4.1 2.6 2.4 10.4 1.5 2.4 1.5 1.6 1.5 5.5 2.7 8.2 1.2 2.6 4.5 1.5 5.2 0.6 3.0 4.7 2.9 1.2 5.4 6.9 7.1 7.4 4.6 4.9 0.0 3.5 3.1 1.6 14.2 6.0 0.3 1.0 6.6 5.9 6.4 3.3 5.0 11.9 0.0 1.7 4.5 2.9 6.2 13.7 8.3 6.7 5.6 9.9 1.7 3.7 6.4 4.1 2.4 6.6 4.5 3.1 0.4 2.0 4.2 4.5 18.8 2.5 3.9 1.3 0.3 2.3 5.0 1.6 0.8 1.3 0.6 1.5 1.2 0.5 0.9 0.1 1.2 3.5 0.0 1.5 1.4 14.3 14.3 14.4 18.4 8.6 8.0 12.7 12.9 11.6 14.3 0.0 1.4 0.0 1.9 3.9 2.0 3.1 2.5 2.7 0.0 1.8 2.0 0.2 3.3 1.4 1.8 1.4 1.3 0.0 1.6 1.5 0.6 1.2 0.0 1.1 1.7 0.0 1.7 1.3 3.0 3.9 0.9 1.2 3.3 1.8 0.7 2.9 1.4 0.0 1.4 1.4 0.7 0.0 1.3 3.9 3.2 6.6 0.2 2.2 0.8 0.9 TSPAN1 "NET-1, TSPAN-1" ENSG00000117472 "Tetraspanin 1" O60635 1 46175073-46185958 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.0;testis: 119.0" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 1113.5;Collecting duct cells: 549.6;Enterocytes: 573.6;Late spermatids: 654.5;Paneth cells: 587.5" "Cancer enhanced" "Detected in all" "prostate cancer: 455.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 90 "plasmacytoid DC: 8.9" "Lineage enriched" "Detected in single" 90 "dendritic cells: 8.9" "Cell line enhanced" "Detected in some" "A-431: 21.3;CAPAN-2: 36.8;HaCaT: 25.7;hTCEpi: 29.8;OE19: 42.8;RPTEC TERT1: 107.8;RT4: 51.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA011909 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA011909: AB_2668565" "unprognostic (1.21e-1)" "unprognostic (3.11e-1)" "unprognostic (3.67e-2)" "unprognostic (4.12e-1)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "unprognostic (1.44e-1)" "unprognostic (1.88e-3)" "unprognostic (8.73e-2)" "prognostic favorable (9.28e-6)" "unprognostic (5.90e-2)" "unprognostic (2.61e-1)" "unprognostic (4.90e-2)" "unprognostic (4.30e-2)" 1.7 0.6 1.7 4.8 2.4 0.0 1.5 11.4 3.5 9.0 59.9 1.8 1.5 2.2 1.8 4.6 1.9 13.9 2.6 2.6 2.2 0.0 46.0 1.9 5.7 2.1 2.4 1.7 1.5 1.5 15.4 3.3 1.5 2.1 22.7 70.0 3.3 16.1 7.8 1.5 0.1 18.3 1.9 1.8 1.6 24.6 119.0 1.9 1.6 13.9 1.8 1.9 21.0 1.5 0.0 8.9 0.0 0.0 0.0 0.0 0.0 21.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 36.8 0.0 6.9 0.0 0.0 25.7 0.0 18.8 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 29.8 0.1 10.6 0.6 0.0 0.2 0.0 0.0 0.2 0.8 0.0 0.0 0.0 42.8 1.3 0.0 0.0 0.2 107.8 51.7 0.3 0.0 0.0 2.2 0.1 0.1 1.5 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 1.7 2.4 11.4 3.5 2.2 0.0 2.4 1.7 2.1 1.9 23.8 19.0 15.7 180.5 0.9 0.0 0.6 15.3 1113.5 208.1 549.6 0.0 0.1 39.7 40.8 130.9 1.2 573.6 0.0 480.2 0.1 1.0 212.2 11.5 2.6 0.2 0.0 193.7 2.5 0.3 654.5 4.6 4.0 5.0 2.8 525.2 0.0 292.8 587.5 1.8 400.8 0.0 0.0 0.3 4.2 1.9 1.1 0.0 0.8 136.2 439.3 TSPAN10 OCSP ENSG00000182612 "Tetraspanin 10" 17 81637171-81648749 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 29 "retina: 117.4" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 12.2;Horizontal cells: 12.7" "Cancer enriched" "Detected in many" 15 "melanoma: 32.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 6.2;SK-MEL-30: 17.9;U-138 MG: 6.5;U-87 MG: 8.2" "Region enriched" "Detected in single" 12 "olfactory region: 1.6" "Low region specificity" "Detected in all" NA NA "unprognostic (1.81e-2)" "unprognostic (3.67e-1)" "unprognostic (2.17e-3)" "unprognostic (1.08e-3)" "unprognostic (3.74e-1)" "unprognostic (3.48e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" "unprognostic (2.33e-1)" "unprognostic (1.95e-1)" "unprognostic (5.59e-3)" "unprognostic (1.21e-1)" "unprognostic (1.01e-1)" "unprognostic (2.43e-2)" "unprognostic (7.31e-2)" "unprognostic (2.81e-1)" "unprognostic (1.58e-1)" 1.0 0.1 0.1 1.3 0.1 0.0 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.9 1.1 0.5 0.3 0.7 0.1 0.1 0.1 0.2 0.5 2.2 0.1 0.1 0.2 0.9 0.0 0.1 1.4 0.2 1.1 0.0 117.4 0.3 1.0 0.1 4.0 0.1 0.1 0.1 0.2 0.2 0.5 0.1 0.4 0.1 0.5 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 1.9 0.2 0.2 0.6 0.7 0.2 1.9 6.0 2.9 1.7 0.6 3.2 0.8 0.7 1.8 1.6 0.1 0.1 0.4 0.3 0.6 3.6 0.0 0.4 0.4 0.4 0.0 1.1 0.7 0.8 3.4 0.1 6.2 0.0 0.7 0.0 0.2 2.8 0.2 0.1 0.4 0.2 0.0 2.9 1.3 0.0 0.0 0.2 0.5 0.0 1.3 3.3 0.4 17.9 1.7 3.6 0.4 0.1 6.5 2.0 0.5 1.7 0.0 0.0 0.0 8.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 8.2 0.5 2.3 0.0 1.7 1.4 5.1 6.7 4.5 12.2 3.9 1.6 8.3 2.4 0.6 1.0 1.3 0.0 2.0 4.6 1.4 1.9 7.0 1.0 7.5 12.7 0.0 3.7 1.3 1.8 1.4 0.9 0.0 0.0 0.8 5.2 1.0 0.0 1.1 2.2 4.9 0.0 0.5 2.6 6.4 0.0 1.1 0.0 0.9 0.9 TSPAN11 ENSG00000110900 "Tetraspanin 11" A1L157 12 30926428-30996599 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 25.6" "Cell type enhanced" "Detected in some" 10 "Ito cells: 7.4;Late spermatids: 8.4;Leydig cells: 4.4;Muller glia cells: 4.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.6;HSkMC: 18.4;NTERA-2: 14.8;SCLC-21H: 7.1;SH-SY5Y: 14.2;SuSa: 9.1" "Low region specificity" "Detected in many" HPA066789 Approved Vesicles NA NA Vesicles "HPA066789: AB_2685723" "unprognostic (4.10e-2)" "unprognostic (4.27e-2)" "unprognostic (4.38e-3)" "unprognostic (1.18e-2)" "unprognostic (4.51e-1)" "prognostic favorable (5.28e-4)" "unprognostic (4.28e-2)" "prognostic favorable (3.43e-4)" "unprognostic (7.89e-3)" "unprognostic (8.05e-2)" "unprognostic (1.51e-2)" "unprognostic (3.03e-2)" "unprognostic (5.77e-3)" "unprognostic (2.04e-2)" "unprognostic (5.81e-2)" "unprognostic (2.90e-3)" "unprognostic (1.79e-1)" 3.1 2.5 6.4 16.0 3.8 0.0 2.5 15.2 12.7 9.0 25.6 9.0 3.0 4.4 6.4 7.8 8.8 2.4 12.2 8.8 5.0 4.7 1.6 1.0 8.5 2.6 4.1 3.8 1.9 1.4 0.3 1.5 0.8 3.8 5.4 11.0 12.2 3.8 6.8 0.8 6.5 10.9 8.3 2.6 2.6 4.5 1.6 3.7 0.0 4.0 12.3 8.9 6.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.6 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.5 0.0 1.1 1.6 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 14.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 7.1 14.2 0.1 0.0 0.0 9.1 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 3.8 15.2 4.3 5.0 4.7 4.1 3.8 3.8 3.7 0.0 0.0 0.0 0.0 0.7 1.5 0.8 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 3.0 0.7 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.1 0.0 0.0 7.4 0.0 8.4 4.4 1.1 1.7 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.2 0.2 1.0 0.0 0.0 0.0 0.0 TSPAN12 "NET-2, TM4SF12" ENSG00000106025 "Tetraspanin 12" O95859 7 120787320-120858402 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 110.2;Collecting duct cells: 97.7;Distal tubular cells: 160.8;Proximal tubular cells: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 21.2;HUVEC TERT2: 23.7;RH-30: 21.7;RPTEC TERT1: 34.7;RT4: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051570, HPA058244" Uncertain Approved Vesicles,Microtubules NA NA Microtubules Vesicles "HPA051570: , HPA058244: AB_2683652" "unprognostic (2.40e-2)" "unprognostic (7.60e-2)" "unprognostic (3.66e-3)" "unprognostic (1.82e-2)" "unprognostic (3.97e-1)" "unprognostic (7.34e-3)" "unprognostic (1.60e-1)" "unprognostic (8.12e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.63e-2)" "unprognostic (1.05e-1)" "unprognostic (9.53e-2)" "unprognostic (7.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.18e-2)" "unprognostic (1.43e-1)" 6.8 40.9 3.1 4.3 3.9 0.0 4.5 2.2 3.3 8.1 19.3 2.1 36.8 13.5 6.1 8.7 3.6 3.7 13.6 22.2 3.2 2.7 40.7 12.6 16.9 1.6 2.7 2.3 2.5 12.8 1.1 10.3 9.9 3.3 7.9 7.1 2.9 33.7 15.1 2.3 1.2 31.0 4.1 1.8 18.4 7.6 3.0 2.2 0.5 18.7 3.5 3.2 10.4 3.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 6.2 0.1 1.3 0.4 6.0 0.1 0.2 0.5 2.0 1.0 1.5 0.0 4.3 0.1 0.7 0.1 3.1 0.6 0.8 0.0 21.2 1.1 6.2 0.9 3.4 0.0 1.0 0.1 0.0 0.1 0.1 0.8 23.7 0.0 0.2 0.7 2.7 0.8 0.0 0.1 9.9 4.1 3.8 0.0 21.7 0.7 34.7 26.4 5.1 3.0 0.2 0.5 0.0 8.7 3.2 0.7 1.0 5.1 1.6 0.0 2.6 6.5 0.0 0.0 0.7 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.9 2.2 3.3 3.2 2.7 2.7 2.3 3.3 2.2 110.2 36.0 1.7 16.9 2.3 0.0 56.0 43.3 9.4 29.6 97.7 0.0 34.8 160.8 6.2 0.4 28.0 15.4 0.0 6.4 39.5 5.6 12.3 2.3 28.6 3.7 0.0 9.2 8.6 0.3 1.2 3.7 1.5 5.0 0.0 22.1 0.5 4.2 26.2 0.7 93.5 0.0 0.0 13.4 0.1 6.9 1.8 20.3 0.5 26.6 20.7 TSPAN13 "NET-6, TM4SF13" ENSG00000106537 "Tetraspanin 13" O95857 7 16753535-16784536 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 461.6;Mucus-secreting cells: 362.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 24.7;plasmacytoid DC: 51.3" "Group enriched" "Detected in many" 41 "B-cells: 24.7;dendritic cells: 51.3" "Cell line enhanced" "Detected in many" "OE19: 74.3;SCLC-21H: 34.3;SK-BR-3: 49.6;T-47d: 92.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007426 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA007426: AB_10603137" "unprognostic (3.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.56e-5)" "unprognostic (2.63e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (5.69e-2)" "unprognostic (6.63e-2)" "prognostic favorable (2.20e-4)" "unprognostic (1.50e-1)" "unprognostic (3.07e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" 20.8 24.2 17.7 7.6 24.9 6.2 25.6 10.7 33.0 18.6 23.6 3.0 21.0 25.2 5.9 12.3 8.8 5.7 16.0 6.8 14.5 21.7 3.3 22.2 53.4 14.8 12.0 15.9 2.1 55.2 4.6 48.0 19.0 14.0 15.1 29.1 8.5 49.1 19.2 4.1 4.7 27.8 5.9 3.6 12.9 31.3 3.1 3.4 3.6 13.0 7.1 18.5 12.1 10.6 24.7 51.3 0.9 0.0 0.8 0.0 1.2 7.1 5.9 7.6 8.0 0.9 0.0 2.1 15.4 2.5 0.4 0.7 20.8 11.1 0.2 3.9 5.5 1.9 11.1 8.7 12.9 3.4 0.2 9.4 3.0 2.4 2.2 2.1 0.2 0.6 0.9 5.6 0.8 0.9 4.4 4.7 3.2 10.0 0.0 0.4 20.4 0.4 0.4 5.3 74.3 7.2 8.2 0.0 7.4 24.0 13.6 34.3 5.2 2.8 49.6 0.7 11.3 92.8 0.8 0.4 0.2 2.7 0.2 5.0 4.5 0.1 0.1 7.1 0.1 10.8 0.1 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.2 24.7 0.0 0.0 0.9 0.8 0.0 51.3 0.0 1.2 17.7 24.9 10.7 33.0 14.5 21.7 12.0 15.9 14.0 3.4 461.6 65.1 58.0 67.1 37.8 65.4 15.8 38.2 25.4 58.0 27.9 7.9 258.0 6.6 62.2 1.0 52.8 83.8 46.7 178.4 88.6 42.3 128.5 9.2 25.9 34.7 14.3 103.4 9.8 15.8 1.8 0.6 4.3 30.4 105.6 362.8 2.3 99.4 94.7 0.7 0.7 7.4 32.3 10.8 0.7 16.8 34.6 168.2 8.7 117.0 107.7 TSPAN14 "DC-TM4F2, MGC11352, TM4SF14" ENSG00000108219 "Tetraspanin 14" Q8NG11 10 80454166-80533123 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ito cells: 166.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 64.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014773, HPA057174" Uncertain Supported Vesicles NA NA 170000 Vesicles "HPA014773: AB_2208670, HPA057174: " "unprognostic (7.52e-2)" "prognostic favorable (3.56e-4)" "unprognostic (6.55e-3)" "unprognostic (1.56e-1)" "unprognostic (4.40e-2)" "unprognostic (1.18e-1)" "unprognostic (2.11e-2)" "unprognostic (8.90e-2)" "unprognostic (5.21e-2)" "unprognostic (3.13e-1)" "unprognostic (5.15e-3)" "unprognostic (4.12e-3)" "prognostic favorable (4.20e-4)" "unprognostic (2.52e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (2.57e-3)" 56.8 10.3 15.4 17.2 14.1 22.0 45.1 5.2 16.8 30.0 14.1 15.1 28.1 13.3 18.9 22.4 44.6 22.2 15.1 15.2 13.4 7.7 22.9 16.0 32.9 47.4 18.8 10.8 21.7 14.4 12.3 7.4 39.0 13.0 20.0 12.3 22.7 24.8 16.5 11.3 33.3 17.3 15.3 16.5 28.2 12.6 12.9 14.5 16.0 26.2 19.1 26.7 30.5 28.4 4.4 10.1 16.2 47.7 26.1 29.0 21.3 21.9 32.5 30.2 10.4 46.5 14.9 14.2 11.3 21.7 12.3 9.0 31.3 12.8 7.1 21.8 6.1 4.4 22.9 8.4 20.5 10.1 12.5 3.2 20.1 3.8 26.8 15.6 7.5 4.9 14.3 18.2 12.4 22.7 22.4 45.9 7.3 11.1 5.2 3.5 18.8 10.8 5.3 6.9 13.7 0.0 37.5 3.5 1.1 48.3 31.5 6.5 9.9 4.5 31.5 34.8 10.8 12.7 18.0 64.7 3.1 12.9 3.0 7.9 2.5 9.3 2.5 10.2 15.1 13.6 3.8 14.8 16.0 29.0 30.4 13.2 4.4 22.7 25.7 10.1 4.2 27.1 25.2 16.2 26.1 47.7 4.0 17.9 21.3 15.4 14.1 5.2 16.8 13.4 7.7 18.8 10.8 13.0 14.5 14.9 59.8 19.7 37.8 31.0 1.9 11.8 35.7 9.4 17.0 31.4 72.6 5.4 6.6 35.7 1.9 70.2 22.1 0.0 21.7 57.5 18.8 31.3 7.0 17.9 43.6 3.2 61.8 166.3 95.3 1.7 36.2 45.9 13.5 14.4 32.7 26.6 48.5 11.5 38.5 7.2 7.0 97.0 20.8 3.9 20.0 31.9 6.4 40.7 24.8 62.8 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451473-69507669 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 106.8;Exocrine glandular cells: 167.5;Mucus-secreting cells: 103.1;Pancreatic endocrine cells: 141.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 17.4" "Lineage enriched" "Detected in many" 6 "T-cells: 17.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.9;EFO-21: 48.7;MCF7: 36.8;OE19: 33.8;PC-3: 60.5;SK-BR-3: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044657, HPA071160" Approved Approved "Nuclear bodies,Vesicles,Plasma membrane,Cytosol" NA NA "Nuclear bodies, Plasma membrane" "Vesicles, Cytosol" "HPA044657: AB_10967927, HPA071160: " "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavorable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 34.2 3.1 11.5 9.7 22.7 0.9 24.9 40.4 17.0 8.9 30.4 49.2 12.5 24.0 15.1 8.4 7.1 16.2 17.1 8.3 18.0 9.2 10.2 3.0 20.4 4.9 33.1 11.2 3.0 10.8 1.4 3.3 17.7 16.8 17.6 24.9 5.4 16.8 17.0 9.9 4.6 21.5 23.0 43.0 13.5 46.4 4.0 28.3 0.8 6.7 2.7 4.8 22.6 6.8 0.0 2.7 0.0 0.0 0.1 17.4 0.5 11.1 23.2 0.4 0.0 0.5 0.0 2.7 0.0 0.4 0.6 1.5 10.0 34.9 0.0 48.7 0.5 2.1 22.8 1.6 2.5 0.7 9.2 4.6 0.6 0.7 2.2 0.2 0.0 0.4 0.5 0.7 0.3 0.3 1.7 8.9 4.6 0.2 0.0 0.2 36.8 0.1 0.2 0.6 33.8 60.5 0.8 0.4 0.4 6.8 20.7 7.9 3.0 0.1 30.7 3.8 4.1 13.4 0.5 7.7 0.0 0.1 0.0 3.8 0.2 1.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 17.4 0.0 2.7 2.5 2.7 0.0 0.9 0.2 0.0 0.1 0.0 0.2 0.9 0.5 11.5 22.7 40.4 17.0 18.0 9.2 33.1 11.2 16.8 28.3 29.8 5.8 2.7 9.7 3.2 3.0 0.8 25.5 14.7 6.8 27.9 5.9 1.5 3.3 106.8 26.3 18.7 73.5 0.0 167.5 9.1 4.7 50.7 1.1 0.0 20.5 1.6 38.6 11.1 5.6 4.9 0.6 10.5 27.0 27.1 103.1 36.7 141.3 88.3 0.0 1.3 1.4 12.9 7.6 0.9 17.7 2.8 2.5 2.5 61.6 27.1 TSPAN16 "TM-8, TM4-B, TM4SF16" ENSG00000130167 "Tetraspanin 16" Q9UKR8 19 11296139-11326996 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "blood: 21.8;testis: 46.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 4024.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "basophil: 6.9;eosinophil: 10.8;neutrophil: 21.8" "Lineage enriched" "Detected in many" 16 "granulocytes: 21.8" "Cell line enhanced" "Detected in some" "MCF7: 3.0;THP-1: 1.1;U-937: 3.0" "Not detected" "Not detected" HPA076551 Enhanced NA NA "HPA076551: " "unprognostic (1.06e-1)" "unprognostic (2.82e-2)" "unprognostic (1.73e-2)" "unprognostic (4.74e-3)" "unprognostic (1.53e-1)" "unprognostic (2.06e-3)" "unprognostic (1.37e-1)" "unprognostic (2.21e-1)" "unprognostic (7.68e-2)" "unprognostic (1.90e-1)" "unprognostic (8.69e-4)" "unprognostic (8.81e-8)" "unprognostic (1.98e-1)" "unprognostic (1.12e-1)" "unprognostic (1.95e-3)" "unprognostic (2.67e-1)" 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 21.8 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.7 0.0 3.0 0.0 0.9 0.3 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.6 1.1 0.0 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.0 3.0 0.0 6.9 1.3 10.8 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 21.8 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 855.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4024.1 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 6.5 0.0 18.6 10.1 0.0 0.0 0.0 0.0 0.0 TSPAN17 "FBX23, FBXO23, TM4SF17" ENSG00000048140 "Tetraspanin 17" Q96FV3 5 176647387-176659054 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030447 Approved Nucleoplasm NA NA Nucleoplasm "HPA030447: AB_2673484" "unprognostic (1.70e-2)" "unprognostic (7.92e-2)" "unprognostic (2.91e-1)" "unprognostic (3.47e-2)" "unprognostic (3.97e-2)" "unprognostic (3.71e-3)" "unprognostic (1.21e-3)" "unprognostic (3.82e-1)" "unprognostic (2.30e-1)" "unprognostic (3.60e-1)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.41e-2)" "unprognostic (7.11e-3)" "unprognostic (2.32e-1)" "unprognostic (4.50e-1)" "unprognostic (1.46e-1)" 11.1 29.3 18.7 12.8 12.6 39.1 14.7 18.3 20.9 8.7 14.7 7.1 12.4 13.1 9.0 10.5 16.6 11.2 16.8 16.5 13.3 10.4 16.4 15.0 13.5 19.8 9.2 9.2 8.6 30.5 12.3 19.5 10.3 10.4 12.4 11.8 9.1 11.7 15.8 30.2 11.2 14.6 11.7 6.6 15.7 15.3 18.4 11.2 3.4 11.9 13.7 15.8 14.5 9.4 2.6 3.1 0.8 4.9 3.7 9.3 3.4 16.0 16.3 10.9 19.9 15.2 13.1 17.0 12.1 17.7 17.9 17.9 4.9 18.5 7.2 22.1 20.8 37.0 12.3 5.4 28.1 11.0 53.0 11.4 2.7 7.1 5.8 13.9 5.8 10.1 15.5 15.9 14.2 8.7 12.2 24.5 5.6 13.5 7.8 18.1 26.5 1.2 2.5 8.8 15.7 17.9 6.1 9.3 4.0 16.8 11.9 16.6 11.7 13.1 15.3 16.3 9.5 12.5 7.4 18.9 19.5 20.3 14.6 15.1 4.4 5.7 3.1 21.3 12.4 11.3 0.0 3.1 0.8 5.4 3.1 4.3 1.6 4.1 8.8 3.1 2.6 2.9 3.9 0.5 3.7 4.9 0.8 9.3 3.4 18.7 12.6 18.3 20.9 13.3 10.4 9.2 9.2 10.4 11.2 11.9 9.8 8.2 9.5 2.6 9.7 12.3 12.7 1.4 5.7 10.4 11.8 0.8 5.0 32.2 0.8 7.9 26.0 23.3 49.2 16.3 9.1 11.8 0.0 11.6 13.6 1.6 13.8 12.3 8.9 0.4 6.4 8.6 6.8 14.4 19.4 6.5 35.7 19.5 6.7 11.0 24.8 0.0 8.6 1.1 2.4 4.6 1.0 13.1 20.4 11.9 TSPAN18 TSPAN ENSG00000157570 "Tetraspanin 18" Q96SJ8 11 44726465-44932421 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 24.2;Early spermatids: 32.7;Endothelial cells: 35.8;Ito cells: 55.3;Proximal tubular cells: 23.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 28.1;hippocampal formation: 12.2" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 3.7;NK-cells: 1.0;T-cells: 3.3" "Cell line enhanced" "Detected in some" "AF22: 14.5;CAPAN-2: 23.9;GAMG: 14.1;HDLM-2: 19.4;NTERA-2: 13.6;RH-30: 15.2;SCLC-21H: 13.0;SH-SY5Y: 14.7;SuSa: 41.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.09e-1)" "unprognostic (1.97e-1)" "unprognostic (8.53e-3)" "unprognostic (3.48e-2)" "unprognostic (6.30e-2)" "unprognostic (8.64e-2)" "unprognostic (7.17e-2)" "unprognostic (2.91e-2)" "unprognostic (8.75e-2)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.29e-1)" "unprognostic (1.04e-3)" "unprognostic (6.78e-3)" "unprognostic (3.22e-1)" "unprognostic (2.19e-1)" "unprognostic (5.59e-2)" 10.1 22.4 1.4 11.1 2.0 0.3 4.7 28.1 2.7 12.8 21.1 4.5 30.6 3.0 23.6 8.9 15.0 10.6 14.3 40.0 12.2 2.5 13.5 4.1 10.6 4.7 1.7 1.6 17.4 1.0 2.3 3.0 14.3 3.1 15.3 4.9 16.7 2.5 28.0 6.8 2.9 8.0 23.3 2.5 8.0 9.7 2.8 1.8 1.4 7.1 7.4 2.6 14.9 11.9 0.5 0.2 3.7 0.1 1.0 3.3 4.5 0.0 0.2 14.5 0.2 0.0 0.0 0.0 0.2 0.2 0.9 0.0 2.8 23.9 0.0 7.1 0.4 14.1 0.0 2.6 0.0 0.2 19.4 0.9 0.1 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.4 0.0 15.2 0.0 0.0 0.0 13.0 14.7 0.1 0.0 0.0 41.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 3.7 0.3 0.0 2.1 0.5 2.9 1.3 0.0 0.1 3.3 0.5 0.9 1.0 0.0 0.2 0.8 4.5 1.4 2.0 28.1 2.7 12.2 2.5 1.7 1.6 3.1 1.8 0.0 5.9 2.4 0.1 1.4 1.3 24.2 0.0 0.0 0.0 7.0 0.0 0.1 0.0 0.6 32.7 35.8 0.0 0.0 0.2 0.2 9.1 0.1 1.1 0.6 0.4 1.6 0.0 55.3 3.4 4.2 2.6 0.0 6.8 0.0 0.0 0.2 0.4 0.0 1.4 23.1 0.2 0.0 2.1 0.7 0.7 1.0 0.2 0.9 0.0 0.0 TSPAN19 ENSG00000231738 "Tetraspanin 19" P0C672 12 85014311-85036277 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lung: 9.7;pituitary gland: 20.0" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 360.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.4;SK-BR-3: 4.3" "Low region specificity" "Detected in all" HPA057066 Uncertain NA NA "HPA057066: AB_2683325" "unprognostic (1.94e-1)" "unprognostic (9.81e-4)" "unprognostic (8.57e-2)" "unprognostic (8.37e-2)" "unprognostic (2.33e-1)" "unprognostic (6.57e-2)" "unprognostic (2.26e-3)" "unprognostic (9.52e-2)" "unprognostic (5.09e-3)" "unprognostic (2.22e-1)" "unprognostic (3.78e-2)" 0.4 0.8 1.5 0.5 1.9 2.3 0.2 1.0 2.6 0.5 0.4 1.4 0.0 1.1 0.5 2.5 0.8 1.8 0.8 0.4 3.2 4.4 0.7 0.1 9.7 0.5 2.3 4.4 0.4 1.6 0.4 20.0 0.5 4.9 1.0 0.2 2.4 0.8 0.0 1.6 4.5 0.6 0.0 1.6 0.5 0.5 8.4 1.4 0.0 4.1 1.3 0.2 0.5 0.2 1.8 0.9 5.4 1.0 0.8 1.1 0.0 0.9 0.0 1.6 0.5 0.9 1.4 1.8 0.9 0.1 0.0 0.5 0.8 0.0 1.0 0.1 0.0 1.1 0.3 0.2 0.3 0.0 0.8 1.6 0.0 0.5 0.7 2.1 1.5 1.7 1.0 1.1 0.9 0.6 3.2 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 1.4 0.2 0.0 0.0 0.3 6.4 2.7 0.0 4.3 0.9 0.7 1.0 0.3 1.2 3.0 0.9 1.3 0.8 3.8 0.0 0.5 3.3 0.0 1.4 1.1 1.0 1.1 1.0 0.7 0.7 0.9 0.8 0.5 0.1 1.8 1.1 1.0 5.4 0.8 0.4 0.9 0.3 0.0 1.5 1.9 1.0 2.6 3.2 4.4 2.3 4.4 4.9 1.4 3.0 1.3 0.0 0.0 0.1 2.4 0.8 0.0 360.0 34.2 0.0 7.9 0.0 0.0 0.0 46.9 0.1 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.4 0.0 7.9 6.5 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 TSPAN2 "FLJ12082, TSN2, TSPAN-2" ENSG00000134198 "Tetraspanin 2" O60636 1 115048011-115089500 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 44.6" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 22.5;Intestinal endocrine cells: 37.7;Smooth muscle cells: 20.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "pons and medulla: 11.9" "Cell type enhanced" "Detected in many" "neutrophil: 35.0" "Group enriched" "Detected in many" 4 "granulocytes: 35.0;NK-cells: 25.9" "Cell line enhanced" "Detected in many" "EFO-21: 35.1;hTERT-RPE1: 9.8;U-937: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015640, HPA073306" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015640: AB_1858405, HPA073306: " "unprognostic (4.56e-2)" "unprognostic (6.86e-2)" "unprognostic (2.60e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (1.57e-3)" "unprognostic (1.64e-1)" "unprognostic (9.73e-6)" "unprognostic (6.06e-3)" "unprognostic (3.07e-2)" "unprognostic (4.74e-2)" "unprognostic (7.66e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (8.48e-7)" "unprognostic (5.40e-2)" "unprognostic (1.59e-1)" "unprognostic (1.48e-3)" "unprognostic (7.80e-3)" 3.7 0.6 1.1 4.7 2.5 9.6 3.2 0.9 2.0 20.1 31.0 1.5 8.9 2.5 30.6 6.9 12.3 14.2 10.6 6.1 1.1 2.6 4.0 0.6 3.0 1.5 1.9 1.9 6.5 2.0 6.4 2.0 1.5 11.9 15.2 6.2 1.9 2.2 15.7 2.0 1.6 7.0 44.6 1.6 2.2 10.0 4.4 0.8 2.6 4.0 4.9 0.9 25.4 7.0 0.2 1.2 35.0 2.9 25.9 7.4 3.8 8.5 0.1 0.7 0.0 0.0 0.1 0.0 1.4 0.5 1.4 2.2 1.7 5.2 0.0 35.1 1.9 1.9 1.2 1.1 0.0 1.5 1.7 0.7 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 9.8 0.0 6.9 0.0 0.5 0.0 0.4 4.6 0.7 8.0 1.7 0.9 0.0 0.5 0.0 0.2 3.2 1.8 2.9 2.1 0.9 0.1 4.9 0.1 0.3 0.1 0.1 3.4 0.2 8.0 7.3 0.2 0.0 0.0 15.4 3.8 27.8 2.9 16.6 5.9 0.0 1.9 0.2 7.0 7.4 1.2 0.1 1.2 6.0 35.0 25.9 0.0 1.2 0.9 3.8 1.1 2.5 0.9 2.0 1.1 2.6 1.9 1.9 11.9 0.8 0.0 1.1 0.0 22.5 7.1 0.2 9.2 0.0 10.7 2.3 10.4 0.0 0.1 0.0 16.3 10.8 15.0 0.0 0.0 2.2 3.1 3.1 10.9 0.0 0.0 0.6 0.0 37.7 5.5 0.8 2.7 0.6 0.9 3.3 0.0 0.8 0.0 7.7 0.0 2.8 1.0 0.4 6.5 20.2 0.1 0.9 2.4 0.2 5.0 1.0 9.2 TSPAN3 "TM4-A, TM4SF8, TSPAN-3" ENSG00000140391 "Tetraspanin 3" O60637 15 77041404-77083984 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Muller glia cells: 483.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 69.4;naive B-cell: 69.7;plasmacytoid DC: 46.7" "Group enriched" "Detected in all" 5 "B-cells: 69.7;dendritic cells: 46.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015996 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA015996: AB_1858406" "unprognostic (5.94e-2)" "unprognostic (3.05e-1)" "unprognostic (7.32e-2)" "unprognostic (2.15e-2)" "unprognostic (4.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.92e-2)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (5.41e-3)" "unprognostic (3.51e-3)" "unprognostic (2.90e-2)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-1)" "unprognostic (3.79e-3)" "unprognostic (1.35e-1)" 64.0 31.4 71.6 16.9 66.5 6.0 43.3 36.8 67.5 31.4 75.3 49.4 74.2 70.6 28.4 95.9 16.8 53.8 39.4 24.6 58.1 63.7 44.9 17.8 41.9 22.9 64.4 45.8 33.0 31.6 53.6 44.0 23.1 54.1 21.3 82.7 44.3 30.8 60.9 79.3 16.3 71.2 27.6 49.2 19.1 46.1 21.3 40.4 14.2 43.0 24.7 25.4 23.2 15.2 69.7 46.7 1.5 10.8 8.3 6.9 12.1 20.8 56.9 47.3 29.8 83.1 51.2 15.6 33.4 36.4 41.2 45.1 34.6 43.6 20.5 49.7 34.5 39.4 47.4 44.8 22.9 31.0 22.9 67.9 14.6 43.6 32.7 40.3 18.8 10.8 48.1 27.7 22.7 20.3 63.0 50.4 13.7 15.4 18.1 40.3 7.9 16.6 17.9 33.4 67.0 25.3 21.0 58.8 21.6 67.8 11.9 42.9 47.5 22.9 19.4 62.1 47.4 20.8 35.7 47.7 38.3 15.0 23.0 46.7 39.9 54.2 10.9 33.9 28.2 21.8 0.8 7.5 1.5 5.1 9.9 5.4 69.4 2.6 3.7 14.8 69.7 6.9 6.3 0.7 8.3 10.8 46.7 0.6 12.1 71.6 66.5 36.8 64.2 58.1 63.7 64.4 45.8 54.1 40.4 104.2 182.8 49.0 53.9 30.8 241.7 81.1 112.1 176.7 158.1 64.6 172.8 77.0 21.6 218.3 24.0 52.8 344.7 0.0 309.7 26.2 81.8 155.9 22.0 27.0 57.7 120.8 87.8 60.2 53.5 44.3 59.5 31.1 69.2 23.4 234.6 483.1 209.9 302.5 48.4 50.7 133.3 25.8 63.7 84.0 50.0 29.9 63.5 26.1 164.4 170.4 TSPAN31 SAS ENSG00000135452 "Tetraspanin 31" Q12999 12 57738013-57750211 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "glioma: 54.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030758, HPA057489" Approved Approved "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol" Yes No "Golgi apparatus" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA030758: , HPA057489: AB_2683447" "unprognostic (2.66e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (8.96e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (4.31e-3)" "unprognostic (1.19e-1)" "unprognostic (6.51e-3)" "unprognostic (5.31e-2)" "unprognostic (2.68e-1)" "unprognostic (2.79e-1)" "prognostic favorable (9.91e-5)" "unprognostic (1.68e-1)" "unprognostic (1.59e-1)" "unprognostic (6.32e-2)" "unprognostic (1.58e-1)" 27.0 26.4 19.4 18.2 22.5 5.4 21.8 14.3 20.5 21.9 20.1 30.5 23.0 16.3 23.1 37.6 21.3 27.7 23.3 23.3 19.1 17.8 32.1 29.2 20.7 14.5 20.3 16.0 32.0 32.1 31.4 22.7 31.5 19.4 23.3 19.0 32.1 24.6 22.0 19.8 15.2 24.0 17.5 24.3 23.1 18.2 11.4 17.1 14.6 42.4 16.5 20.7 20.2 16.8 17.6 35.4 18.6 24.8 23.7 22.0 18.8 3.6 8.8 9.1 2.3 21.0 13.9 5.9 5.8 7.6 3.1 3.1 6.1 19.6 3.3 12.8 13.2 3.8 7.6 2.4 12.2 4.4 8.7 6.5 4.4 7.3 2.5 20.8 4.4 7.8 12.3 14.5 6.0 12.7 9.4 8.1 1.7 3.2 9.6 9.9 7.3 3.4 2.6 1.9 6.6 2.8 4.2 60.0 8.5 12.7 7.4 3.1 7.8 6.2 9.1 4.5 2.2 17.1 6.9 11.1 5.0 4.1 2.7 3.0 11.9 2.6 1.6 13.5 3.0 7.6 18.6 15.7 11.1 22.0 15.7 21.3 17.6 17.8 18.9 15.6 16.8 17.8 16.7 5.3 23.7 24.8 35.4 12.1 18.8 19.4 22.5 14.3 18.5 19.1 17.8 20.3 16.0 19.4 17.1 44.7 25.9 22.0 37.5 10.0 39.9 4.2 22.9 25.4 21.6 29.6 39.3 16.4 8.3 31.1 0.9 23.2 21.6 0.0 34.1 12.3 23.7 26.6 43.9 17.4 19.7 20.6 25.4 20.3 15.6 2.1 23.9 24.1 30.4 24.4 20.3 54.9 31.7 21.0 16.3 15.9 55.1 19.4 23.6 8.7 4.8 11.0 20.5 14.9 21.2 28.5 TSPAN32 "PHEMX, TSSC6" ENSG00000064201 "Tetraspanin 32" Q96QS1 11 2301997-2318200 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.3;bone marrow: 17.5;heart muscle: 11.9;lymphoid tissue: 11.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 10.7;Cardiomyocytes: 13.4;granulocytes: 29.0;Macrophages: 13.0;T-cells: 23.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "HEL: 15.8;HL-60: 6.9;NB-4: 5.7;THP-1: 6.1;U-937: 9.6" "Low region specificity" "Detected in many" HPA024135 Uncertain Approved Nucleoplasm NA NA 37000 Nucleoplasm "HPA024135: AB_1858409" "unprognostic (7.50e-3)" "unprognostic (4.88e-4)" "unprognostic (1.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.45e-3)" "unprognostic (2.10e-4)" "unprognostic (7.72e-3)" "unprognostic (8.25e-3)" "unprognostic (9.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.02e-1)" "unprognostic (2.28e-7)" "unprognostic (1.07e-1)" "unprognostic (4.20e-1)" "unprognostic (4.35e-1)" "unprognostic (8.13e-2)" 1.2 0.4 0.3 6.3 0.5 17.5 0.5 0.4 1.0 1.3 1.3 2.1 0.0 0.2 1.6 1.6 0.9 0.6 1.4 11.9 0.3 0.4 0.9 0.8 3.1 5.1 0.5 0.3 0.8 0.4 0.0 0.4 0.9 0.5 1.2 0.1 1.7 5.6 0.9 0.3 0.5 1.1 1.8 0.8 5.8 1.4 0.4 1.1 7.4 0.5 2.1 11.5 1.0 0.8 1.1 14.9 17.9 19.3 25.3 13.2 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 15.8 0.0 0.1 0.7 6.9 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 9.6 0.0 17.9 15.2 2.0 13.0 17.9 8.1 1.1 4.7 11.1 14.9 0.6 3.7 13.2 8.4 25.3 19.3 0.7 5.8 9.5 0.3 0.5 0.4 1.0 0.3 0.4 0.5 0.3 0.5 1.1 0.0 10.7 2.7 0.0 0.8 0.0 13.4 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.9 0.0 29.0 0.0 4.4 0.0 0.0 0.0 6.6 3.5 0.9 13.0 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.5 0.0 23.5 0.0 0.0 TSPAN33 "MGC50844, Penumbra" ENSG00000158457 "Tetraspanin 33" Q86UF1 7 129144892-129169697 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 56.8" "Cell type enhanced" "Detected in many" 11 "Macrophages: 25.0;monocytes: 64.9;Peritubular cells: 30.8;Proximal tubular cells: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 5.3;naive B-cell: 6.4" "Group enriched" "Detected in many" 5 "B-cells: 6.4;dendritic cells: 2.8;monocytes: 3.2" "Cell line enhanced" "Detected in many" "AN3-CA: 20.9;HEL: 32.6;U-266/70: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020357 Enhanced Approved Microtubules NA NA Microtubules "HPA020357: AB_1858410" "unprognostic (3.95e-2)" "unprognostic (1.27e-2)" "unprognostic (4.41e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (5.62e-2)" "unprognostic (2.29e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (2.66e-1)" "prognostic favorable (8.88e-4)" "unprognostic (1.67e-1)" "prognostic favorable (8.74e-5)" "unprognostic (2.50e-2)" "unprognostic (2.73e-1)" "unprognostic (1.55e-2)" "unprognostic (1.16e-2)" 2.8 3.5 7.4 13.4 7.7 3.8 3.5 7.5 10.0 1.9 4.3 9.9 8.7 3.8 1.5 15.9 3.4 2.6 3.8 5.4 7.2 12.4 56.8 17.2 3.2 15.9 12.1 6.5 1.8 13.0 9.4 13.0 4.6 7.9 8.0 4.8 5.5 20.5 9.5 7.1 4.5 7.1 2.8 8.0 13.7 4.3 6.8 6.0 10.4 8.5 2.9 19.6 6.2 2.4 6.4 2.8 0.2 3.2 0.4 0.9 2.1 1.2 2.7 0.8 20.9 0.0 0.0 1.0 0.0 0.2 0.5 0.2 0.4 1.9 15.8 1.6 0.5 12.2 1.4 10.8 3.3 0.8 13.4 8.3 32.6 0.8 5.9 0.8 4.5 0.6 0.6 3.3 0.1 1.1 0.0 0.5 9.4 0.3 2.0 0.0 3.6 9.5 0.1 6.0 0.9 2.9 2.9 0.4 0.4 1.7 3.9 4.9 5.9 2.0 0.6 11.0 6.2 4.5 1.9 0.0 0.0 1.5 1.7 0.5 38.6 4.5 6.8 0.3 14.5 2.0 0.0 1.1 0.0 0.1 3.2 0.0 5.3 0.1 0.0 2.8 6.4 0.9 0.1 0.2 0.4 0.2 1.1 0.0 2.1 7.4 7.7 7.5 10.0 7.2 12.4 12.1 6.5 7.9 6.0 0.0 1.1 24.2 0.8 2.3 3.8 5.6 0.0 2.7 0.0 5.2 3.9 0.1 11.6 2.0 2.0 0.4 0.8 0.0 7.4 0.2 1.1 2.5 0.0 12.5 7.1 0.0 3.4 0.6 17.8 3.3 2.6 25.0 1.7 64.9 0.3 4.8 3.0 0.0 30.8 50.8 1.4 0.0 0.0 0.5 0.7 2.6 0.1 1.5 0.2 1.0 TSPAN4 "NAG-2, TETRASPAN, TM4SF7, TSPAN-4" ENSG00000214063 "Tetraspanin 4" O14817 11 842808-867116 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 204.2;Leydig cells: 159.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 38.8;intermediate monocyte: 36.6" "Group enriched" "Detected in many" 9 "dendritic cells: 25.8;monocytes: 38.8;NK-cells: 22.0" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 179.6" "Low region specificity" "Detected in all" NA NA "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" "unprognostic (6.39e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (2.91e-4)" "unprognostic (1.88e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.24e-1)" "unprognostic (6.13e-2)" "unprognostic (1.18e-1)" "unprognostic (1.23e-1)" "unprognostic (9.49e-2)" "unprognostic (2.41e-2)" "unprognostic (1.29e-2)" "unprognostic (2.61e-2)" "unprognostic (2.41e-2)" "unprognostic (1.18e-1)" 42.2 14.0 4.5 19.3 4.6 3.8 42.5 8.0 6.6 29.3 19.9 5.2 11.1 5.3 26.2 30.2 18.7 22.6 30.9 23.1 4.3 5.6 23.0 16.4 48.1 44.4 5.4 5.0 31.9 13.0 7.2 7.6 33.4 6.7 26.5 4.1 35.0 23.8 15.0 15.7 16.6 11.9 32.7 5.0 44.3 11.4 16.7 3.2 7.5 36.3 20.2 10.7 24.1 22.8 1.5 25.8 0.8 38.8 22.0 3.1 13.7 6.2 49.0 8.6 15.5 13.3 26.6 5.8 31.8 38.6 25.3 17.5 10.1 7.8 0.4 12.9 45.8 14.5 2.3 3.0 30.4 4.8 4.1 3.6 6.6 15.6 14.3 44.0 2.0 8.2 46.1 5.5 9.1 27.7 24.9 16.5 2.6 2.7 39.0 24.3 12.9 1.4 2.6 11.1 8.0 35.9 4.9 6.1 11.1 29.2 0.4 10.2 6.1 15.7 17.7 33.3 3.9 25.0 1.5 23.9 28.9 11.5 5.7 10.7 2.1 0.3 0.8 29.8 2.2 25.5 0.0 38.8 0.0 2.0 36.6 1.2 1.5 0.9 1.8 25.8 1.5 1.7 3.1 0.8 22.0 9.4 1.7 0.8 13.7 4.5 4.6 8.0 6.6 4.3 5.6 5.4 5.0 6.7 3.2 98.3 62.2 5.2 21.9 42.2 7.4 7.7 58.6 6.7 26.1 29.6 3.9 37.2 6.6 54.1 1.7 85.0 1.3 0.0 14.3 23.6 121.4 11.3 34.8 21.2 204.2 12.7 0.0 96.3 82.9 3.6 159.9 57.3 140.0 15.4 2.9 41.7 42.9 0.0 89.5 27.8 6.1 58.2 40.6 3.2 27.9 28.7 14.1 9.6 0.9 5.2 TSPAN5 "NET-4, TM4SF9, Tspan-5" ENSG00000168785 "Tetraspanin 5" P62079 4 98470367-98658629 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.5;ovary: 38.2" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 104.9;Intestinal endocrine cells: 77.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 30 "B-cells: 2.5;NK-cells: 4.5;T-cells: 6.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.7;BJ hTERT+: 35.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.29e-1)" "unprognostic (3.47e-1)" "unprognostic (1.17e-1)" "unprognostic (2.00e-3)" "unprognostic (2.65e-1)" "unprognostic (2.44e-3)" "unprognostic (1.41e-2)" "unprognostic (1.54e-2)" "unprognostic (9.27e-2)" "unprognostic (1.79e-1)" "unprognostic (3.30e-3)" "unprognostic (1.90e-1)" "prognostic unfavorable (7.83e-5)" "prognostic unfavorable (8.56e-4)" "unprognostic (2.15e-1)" "unprognostic (3.23e-3)" "unprognostic (1.23e-1)" 1.9 1.5 14.1 3.1 17.1 7.0 12.7 47.5 37.5 11.8 3.8 20.9 2.1 1.6 13.4 23.4 10.4 4.9 4.3 2.9 15.5 10.1 4.4 0.9 3.7 7.4 13.7 13.8 38.2 1.0 0.9 5.7 6.3 17.3 4.7 3.5 8.6 7.9 7.5 2.6 15.3 2.4 13.2 16.7 7.5 7.2 9.7 13.9 5.7 14.8 2.9 7.2 4.9 5.9 2.5 0.1 0.1 0.0 4.5 6.9 1.2 7.7 3.1 3.2 0.2 12.3 36.7 1.1 32.2 35.1 11.6 14.3 2.7 4.2 0.0 0.3 11.4 6.3 2.0 2.7 15.0 26.1 9.6 1.5 4.7 0.4 0.1 12.7 2.6 0.2 20.9 0.4 21.3 26.4 17.9 18.7 3.2 1.8 8.4 27.7 0.2 7.9 0.0 2.1 6.6 14.3 2.4 3.0 1.1 1.0 2.3 22.8 4.3 0.5 10.2 0.0 1.1 0.3 0.4 19.1 24.4 11.0 8.7 11.2 5.9 8.7 0.0 9.5 6.3 8.3 0.0 0.0 0.0 4.6 0.0 5.0 1.3 6.4 6.4 0.1 2.5 3.2 2.2 0.1 4.5 0.0 0.0 6.9 1.2 14.1 17.1 47.5 24.9 15.5 10.1 13.7 13.8 17.3 13.9 20.8 7.8 5.0 13.2 19.6 43.8 1.7 0.0 0.0 6.8 27.9 25.5 1.1 5.0 2.5 64.2 10.1 0.5 46.7 6.5 0.8 16.0 33.6 2.3 1.0 1.9 104.9 77.7 6.7 2.7 68.0 42.6 2.8 27.0 0.0 4.4 20.5 15.7 0.0 15.9 0.3 39.0 6.5 15.9 3.7 6.3 50.4 2.4 20.8 2.5 44.4 TSPAN6 "T245, TM4SF6, TSPAN-6" ENSG00000000003 "Tetraspanin 6" O43657 X 100627109-100639991 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 88.4" "Group enriched" "Detected in many" 6 "Early spermatids: 313.3;Late spermatids: 1149.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "pons and medulla: 34.2" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.6" "Lineage enriched" "Detected in single" 8 "T-cells: 6.6" "Cell line enhanced" "Detected in many" "NTERA-2: 43.2;RT4: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004109 Approved Approved "Nucleoli fibrillar center,Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "Nucleoli fibrillar center" "HPA004109: AB_1080301" "unprognostic (7.71e-2)" "unprognostic (8.97e-2)" "unprognostic (3.56e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-3)" "unprognostic (5.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-3)" "unprognostic (2.04e-3)" "unprognostic (8.76e-2)" "unprognostic (3.83e-3)" "unprognostic (4.28e-2)" "unprognostic (1.14e-1)" "unprognostic (2.24e-1)" "unprognostic (9.54e-3)" 27.0 9.8 7.0 4.4 6.6 0.1 33.0 2.9 4.9 15.9 17.8 12.6 6.4 9.7 11.1 10.4 27.1 24.2 10.0 5.7 7.4 7.3 26.7 68.2 8.3 3.6 6.9 4.1 27.6 25.1 19.6 17.7 23.6 34.2 15.5 20.3 16.7 88.4 6.7 3.5 4.7 11.6 4.7 10.4 8.6 8.0 17.5 6.6 2.9 24.6 11.0 19.8 17.2 11.5 0.3 0.2 0.8 0.2 0.3 6.6 1.4 7.9 10.6 28.7 14.5 12.6 6.8 11.6 4.5 7.1 9.0 21.1 23.8 13.9 0.0 19.1 4.6 6.2 6.5 0.1 8.6 10.6 0.0 15.4 1.4 6.9 26.5 7.0 0.0 1.1 13.3 4.2 7.9 3.1 13.1 19.1 0.0 0.0 0.0 9.2 8.2 0.0 0.1 43.2 12.0 8.0 0.0 13.6 0.0 14.1 65.2 1.8 7.8 4.5 3.9 6.0 24.1 5.7 1.0 5.3 5.6 8.6 9.2 2.9 0.0 0.0 0.0 5.0 0.0 4.0 0.5 0.1 0.2 1.0 0.1 3.5 0.3 2.4 0.8 0.0 0.2 6.6 3.8 0.8 0.3 0.2 0.2 0.1 1.4 7.0 6.6 2.9 4.9 7.4 7.3 6.9 4.1 34.2 6.6 3.0 8.5 7.8 36.0 6.4 0.7 7.3 61.1 115.1 21.6 89.0 0.0 26.5 19.9 64.9 313.3 22.2 51.9 0.0 11.1 33.5 17.7 46.5 0.0 94.2 3.8 0.0 32.3 58.9 11.8 1149.4 30.5 2.9 10.1 1.8 42.7 38.6 20.9 46.0 33.6 37.7 1.5 19.4 7.5 19.0 32.2 4.6 11.3 3.5 78.3 78.2 TSPAN7 "A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2" ENSG00000156298 "Tetraspanin 7" P41732 X 38561370-38688920 "CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 131.1" "Cell type enhanced" "Detected in many" 15 "Endothelial cells: 113.7;Ito cells: 372.0" "Cancer enhanced" "Detected in all" "glioma: 71.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 68.6;MOLT-4: 45.1;SCLC-21H: 25.2;U-266/70: 16.7" "HPA003140, CAB062566, CAB068245" Enhanced NA NA "CAB062566: AB_2665608, CAB068245: AB_2665609, HPA003140: AB_1078454" "unprognostic (1.12e-2)" "unprognostic (1.42e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.40e-4)" "unprognostic (5.06e-2)" "unprognostic (3.90e-3)" "unprognostic (3.88e-3)" "unprognostic (1.37e-2)" "unprognostic (1.14e-1)" "unprognostic (2.01e-2)" "prognostic favorable (1.70e-4)" "unprognostic (1.54e-1)" "prognostic favorable (5.48e-7)" "unprognostic (5.65e-3)" "unprognostic (9.53e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-3)" 15.2 28.7 39.6 3.5 83.0 0.8 7.3 83.8 131.1 12.4 18.5 11.5 2.3 7.9 11.6 9.2 7.9 10.5 5.8 17.1 34.5 30.7 15.8 12.0 16.2 8.8 19.4 37.7 5.2 4.4 4.1 11.4 6.6 23.8 5.6 17.3 8.1 3.3 7.4 17.9 4.9 7.8 14.5 11.9 21.3 4.6 1.7 9.5 0.0 11.8 5.4 8.2 8.2 4.2 0.9 0.5 0.3 0.2 0.3 2.9 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.3 0.0 10.9 2.0 0.0 0.0 8.6 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.2 0.1 45.1 0.0 2.3 0.0 0.0 2.2 0.9 0.0 1.1 0.2 25.2 2.6 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.2 16.7 4.7 0.0 1.0 0.1 0.3 0.2 0.1 0.0 0.6 0.2 0.7 0.4 1.1 2.9 0.1 0.9 2.1 1.8 0.3 0.3 0.0 0.5 0.0 0.1 39.6 83.0 83.8 86.3 34.5 30.7 19.4 37.7 23.8 9.5 11.9 18.4 0.5 2.3 9.4 87.2 35.4 2.5 1.4 4.5 10.4 41.2 0.3 19.9 0.4 0.0 113.7 34.6 0.0 0.5 0.4 6.8 2.4 9.3 2.9 33.9 92.2 18.0 372.0 20.5 1.1 0.6 1.5 13.5 0.0 25.1 94.7 1.4 17.3 2.8 8.3 66.4 58.2 4.4 0.6 3.2 5.6 0.7 4.3 31.0 0.9 TSPAN8 "CO-029, TM4SF3" ENSG00000127324 "Tetraspanin 8" P19075 12 71125085-71441898 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 235.3" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 1761.5;Mucus-secreting cells: 790.5;Paneth cells: 2064.2;Undifferentiated cells: 1231.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 283.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "OE19: 211.9" "Low region specificity" "Detected in many" "HPA022273, CAB026009, HPA044337" Enhanced Approved Vesicles NA NA Vesicles "CAB026009: , HPA022273: , HPA044337: AB_2678899" "unprognostic (1.64e-1)" "unprognostic (2.18e-2)" "unprognostic (1.64e-1)" "unprognostic (6.40e-2)" "unprognostic (6.81e-2)" "unprognostic (7.29e-3)" "unprognostic (1.90e-1)" "unprognostic (1.15e-1)" "unprognostic (5.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.01e-3)" "unprognostic (2.93e-1)" "prognostic unfavorable (9.66e-5)" "unprognostic (1.88e-2)" "unprognostic (1.00e-1)" "unprognostic (2.97e-2)" "prognostic favorable (7.36e-5)" 1.9 0.8 0.7 24.1 2.3 0.0 1.1 0.6 1.3 2.0 139.5 2.8 1.5 83.2 1.2 1.5 1.1 1.3 30.8 1.0 0.7 0.7 7.6 3.7 5.1 1.0 4.7 1.0 6.9 9.9 0.0 0.8 0.7 3.5 14.2 79.5 2.6 11.7 1.0 12.5 2.4 235.3 3.4 9.7 0.6 55.5 1.6 2.7 0.6 1.8 3.1 5.0 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 211.9 17.7 0.0 0.0 0.4 3.4 4.1 0.4 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.3 0.6 1.3 0.7 0.7 4.7 1.0 3.5 2.7 0.0 2.1 2.7 36.6 18.4 0.2 0.4 346.5 45.5 54.6 41.8 0.0 0.8 107.8 562.4 25.2 2.2 1761.5 0.0 594.9 0.6 38.2 601.4 4.6 21.3 0.2 0.0 167.5 1.8 2.1 10.6 40.9 3.5 60.8 13.6 790.5 7.2 214.1 2064.2 30.1 2.1 0.4 0.0 20.6 0.5 0.9 11.8 0.9 1.5 1231.3 12.4 TSPAN9 NET-5 ENSG00000011105 "Tetraspanin 9" O75954 12 3077355-3286564 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.2;heart muscle: 58.5" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 66.4;Extravillous trophoblasts: 79.2;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 58.2" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RH-30: 63.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 125.3" HPA014002 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 1900000 "Nucleoplasm, Golgi apparatus" Cytosol "HPA014002: AB_2304038" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-2)" "unprognostic (3.53e-2)" "unprognostic (3.11e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" "unprognostic (1.26e-2)" "unprognostic (1.89e-1)" "unprognostic (6.70e-2)" "unprognostic (1.57e-1)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" 12.7 5.3 2.6 4.0 5.9 0.3 16.2 58.2 11.5 17.6 6.6 3.0 16.1 3.6 20.9 11.2 6.8 8.8 13.8 58.5 2.9 2.7 21.3 25.3 13.6 3.9 2.8 3.3 15.3 6.5 17.4 3.8 27.7 4.5 10.7 2.7 21.8 8.4 17.7 7.1 13.3 5.4 9.5 2.6 8.4 5.6 5.7 2.3 6.0 9.4 9.4 4.3 8.1 13.6 0.0 0.0 0.6 0.1 0.0 1.1 3.6 0.4 3.5 6.0 5.1 4.9 4.7 14.1 6.8 20.6 4.4 5.8 8.2 3.2 0.2 6.8 3.9 4.2 0.9 2.4 2.5 2.6 1.1 2.7 9.3 2.7 5.8 13.5 0.0 0.7 6.0 2.2 9.1 4.2 14.8 15.0 0.3 0.2 0.2 3.8 5.3 0.0 0.2 8.4 2.1 1.9 2.7 63.6 0.8 18.4 1.6 10.7 7.2 4.5 11.5 4.4 12.9 4.0 0.0 8.8 2.4 7.3 3.9 6.4 0.0 0.0 0.0 6.1 0.1 2.6 0.0 0.1 0.0 1.1 0.1 0.3 0.0 0.2 0.6 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 3.6 2.6 5.9 58.2 11.5 2.9 2.7 2.8 3.3 4.5 2.3 0.0 2.6 0.9 10.8 17.1 66.4 45.8 10.2 1.4 3.4 12.2 2.0 49.9 5.0 16.1 1.4 32.2 2.4 0.0 7.8 79.2 21.2 16.1 0.0 33.3 5.4 31.8 5.8 38.1 3.3 2.4 16.1 0.9 11.8 1.0 2.6 3.3 9.1 0.0 16.3 18.2 4.2 19.4 19.5 1.4 3.4 10.5 67.5 0.0 1.9 9.7 TSPO "BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS" ENSG00000100300 "Translocator protein" "B1AH88, P30536" 22 43151514-43163242 "Cancer-related genes, FDA approved drug targets, Predicted membrane proteins" "Lipid transport, Transport" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 139.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB011232, HPA046260, HPA072304" Uncertain Supported Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "CAB011232: , HPA046260: , HPA072304: " "unprognostic (5.29e-3)" "unprognostic (1.41e-1)" "unprognostic (3.31e-1)" "unprognostic (4.02e-3)" "unprognostic (3.95e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.16e-1)" "unprognostic (1.17e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.34e-3)" 33.9 21.2 9.8 17.8 11.0 117.3 48.7 2.7 8.1 24.9 23.9 12.3 10.3 20.5 12.3 13.6 83.2 14.3 36.8 32.1 8.0 5.4 18.0 22.0 39.8 40.0 15.4 5.2 13.3 13.2 4.0 6.7 15.5 9.7 23.1 9.7 16.4 34.6 9.2 13.2 46.6 23.0 12.7 11.4 27.2 39.0 10.5 10.0 9.4 17.9 44.3 50.0 19.1 41.3 22.9 99.9 91.4 139.5 28.5 43.8 104.8 47.6 23.6 1.6 22.4 9.0 29.9 1.8 35.6 17.4 17.9 19.1 4.6 36.5 0.0 24.7 27.6 8.8 39.5 4.5 27.6 2.3 7.9 18.6 4.8 25.9 1.6 32.7 10.8 24.4 23.2 45.5 10.6 9.5 21.1 42.4 0.0 3.9 9.0 18.3 39.9 0.1 30.2 1.9 24.6 59.0 10.7 0.0 81.4 22.9 28.8 2.3 11.0 16.9 33.8 41.5 0.0 12.7 42.0 43.7 22.3 16.7 22.7 14.9 3.6 0.6 0.4 28.9 35.1 28.5 43.8 139.5 75.3 28.4 86.3 22.2 16.3 39.5 27.8 99.9 22.9 30.4 24.5 91.4 28.5 57.1 17.7 43.8 104.8 9.8 11.0 2.7 8.1 8.0 5.4 15.4 5.2 9.7 10.0 148.9 135.1 105.0 344.2 325.8 2.2 79.7 336.3 127.2 167.2 195.4 2.0 9.0 313.4 570.0 2.1 215.5 499.4 46.7 512.5 126.3 307.4 297.1 261.1 99.0 745.0 3.2 187.3 163.2 688.0 6.1 76.5 573.3 686.7 477.9 485.1 116.9 963.2 644.9 148.2 97.5 17.1 103.5 217.3 1.1 4.9 468.6 16.7 155.6 529.3 666.0 TSPO2 "BZRPL1, dJ34B21.2" ENSG00000112212 "Translocator protein 2" Q5TGU0 6 41042554-41044337 "Predicted intracellular proteins, Predicted membrane proteins" Transport Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 32.4" "Cell type enriched" "Detected in some" 84 "Erythroid cells: 210.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 15.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA060691, HPA066996" Approved "Plasma membrane" NA NA "Plasma membrane" "HPA060691: , HPA066996: AB_2685761" "unprognostic (1.89e-3)" "unprognostic (8.35e-3)" "unprognostic (2.57e-3)" "unprognostic (2.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-2)" "unprognostic (6.61e-3)" "unprognostic (2.29e-1)" "unprognostic (3.37e-1)" "unprognostic (2.89e-1)" "unprognostic (2.71e-1)" "unprognostic (4.92e-2)" "unprognostic (1.86e-2)" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (5.37e-2)" "unprognostic (1.76e-2)" 0.1 0.0 0.1 0.1 0.1 32.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 1.3 2.5 0.4 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.9 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 1.3 0.1 3.3 4.5 1.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 1.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.3 0.2 0.5 0.0 15.8 0.0 0.4 0.0 0.0 0.3 0.1 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.4 0.2 0.8 0.2 0.2 0.0 0.4 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.0 0.3 210.2 0.8 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TTC13 FLJ22584 ENSG00000143643 "Tetratricopeptide repeat domain 13" Q8NBP0 1 230906243-230978875 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018022, HPA051558" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018022: AB_2211524, HPA051558: AB_2681534" "unprognostic (2.68e-1)" "unprognostic (1.64e-1)" "unprognostic (3.42e-1)" "unprognostic (9.59e-3)" "unprognostic (8.10e-2)" "prognostic favorable (7.66e-4)" "unprognostic (2.60e-2)" "unprognostic (5.40e-3)" "unprognostic (1.97e-1)" "unprognostic (1.80e-2)" "prognostic favorable (4.59e-5)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.60e-11)" "unprognostic (4.48e-2)" "unprognostic (3.01e-1)" "unprognostic (5.96e-2)" "unprognostic (7.54e-3)" 10.5 7.1 8.9 16.6 26.7 13.1 9.6 11.2 12.4 7.3 13.6 12.5 8.6 10.5 9.3 9.2 8.5 9.2 8.9 7.0 9.9 7.9 6.9 9.0 12.2 23.4 13.3 9.3 8.2 13.7 13.5 15.5 9.9 12.6 8.1 21.6 7.9 9.6 9.5 15.6 12.8 15.6 8.4 14.7 21.3 15.6 3.9 13.7 18.4 9.8 6.2 18.9 8.0 9.1 4.2 10.8 7.6 7.7 11.9 10.0 5.1 7.6 7.8 7.7 14.9 7.2 4.7 15.8 11.2 8.8 6.3 7.1 11.4 8.3 14.1 10.3 6.7 6.3 12.3 5.0 4.1 4.2 15.7 15.4 4.2 8.3 7.7 7.6 8.6 3.9 4.1 7.3 5.9 5.5 6.3 11.1 6.1 4.4 8.2 5.8 3.9 4.5 8.2 8.7 25.5 9.7 7.4 11.0 19.6 6.6 5.3 10.6 9.2 8.5 8.8 14.9 3.5 9.4 11.2 5.6 7.5 1.0 10.0 19.7 10.2 16.7 4.3 7.3 5.5 12.2 7.6 7.6 6.8 10.0 5.8 6.8 4.2 7.0 8.2 10.8 3.9 5.7 6.8 2.9 11.9 7.7 7.4 5.4 5.1 8.9 26.7 11.2 12.4 9.9 7.9 13.3 9.3 12.6 13.7 6.0 9.0 9.9 1.2 3.0 4.0 2.5 0.0 0.0 4.5 1.8 5.9 3.7 1.7 4.4 1.4 4.5 2.6 0.0 7.5 4.4 2.8 1.5 9.2 5.9 4.6 11.1 5.8 2.5 7.0 1.7 2.6 7.1 1.7 1.0 10.7 4.0 3.5 8.6 6.3 1.1 10.0 6.5 3.9 2.3 2.4 2.4 1.4 12.8 7.0 1.0 TTC33 OSRF ENSG00000113638 "Tetratricopeptide repeat domain 33" Q6PID6 5 40512333-40755975 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038252, HPA038253" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA038252: AB_10674551, HPA038253: AB_10671739" "unprognostic (2.86e-1)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.04e-3)" "unprognostic (3.01e-2)" "unprognostic (1.99e-1)" "unprognostic (2.01e-1)" "unprognostic (2.60e-1)" "prognostic favorable (1.83e-4)" "unprognostic (8.50e-2)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (4.28e-3)" 11.0 11.8 13.5 6.9 27.7 1.5 11.0 20.4 20.1 11.7 9.9 6.4 8.1 8.2 12.3 7.8 9.1 10.1 9.0 13.4 11.5 12.1 14.7 15.0 9.0 8.9 8.8 19.4 15.2 8.6 15.6 15.1 9.0 13.1 11.5 9.2 7.3 9.3 10.6 24.2 6.4 9.1 10.5 9.5 8.4 8.7 9.0 9.8 14.3 12.8 5.5 9.2 10.8 9.0 7.2 5.3 15.9 10.8 7.8 10.0 8.2 5.2 4.6 9.0 11.5 6.3 9.1 4.1 7.2 7.6 7.9 8.1 2.3 5.5 16.6 4.4 5.4 9.3 2.8 8.6 3.9 13.1 18.7 6.5 3.6 15.6 6.5 6.4 9.3 5.3 5.4 7.4 7.4 7.6 9.9 10.9 10.5 8.4 12.8 9.5 1.3 16.4 9.1 2.7 3.6 4.5 15.9 17.9 9.3 8.4 3.2 6.5 7.4 18.1 8.9 9.7 7.3 7.1 10.6 7.5 9.5 8.6 6.0 5.9 10.5 11.3 9.0 6.4 12.5 7.5 15.9 6.1 11.1 8.1 9.0 8.7 7.2 8.5 7.5 5.3 6.9 10.0 8.0 9.0 7.8 10.8 3.9 9.0 8.2 13.5 27.7 20.4 20.1 11.5 12.1 8.8 19.4 13.1 9.8 14.9 6.1 11.5 4.6 12.8 12.1 15.9 5.1 14.7 4.5 7.0 5.9 4.5 16.6 6.9 9.6 11.3 5.8 0.0 5.4 3.4 12.8 5.9 12.7 7.9 4.6 4.8 2.9 11.1 8.2 5.9 13.0 6.3 10.1 18.0 6.8 17.3 6.6 7.0 13.1 8.5 20.6 12.9 11.3 27.0 15.7 15.9 2.2 7.5 5.8 4.0 TTYH1 ENSG00000167614 "Tweety family member 1" Q9H313 19 54415219-54436900 "Predicted membrane proteins, Transporters" "Cell adhesion, Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 66.9" "Group enriched" "Detected in many" 4 "Muller glia cells: 594.3;Rod photoreceptor cells: 149.3" "Cancer enriched" "Detected in many" 15 "glioma: 63.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 6.3;AN3-CA: 19.6;U-2 OS: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023617, HPA050655" Approved NA NA "HPA023617: AB_10600836, HPA050655: AB_2681204" "prognostic favorable (3.64e-4)" "unprognostic (1.71e-1)" "unprognostic (1.24e-2)" "unprognostic (1.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.50e-3)" "unprognostic (8.93e-2)" "unprognostic (1.51e-2)" "unprognostic (5.94e-3)" "unprognostic (1.11e-1)" "unprognostic (3.66e-1)" "unprognostic (1.60e-1)" "unprognostic (0.00e+0)" "unprognostic (2.09e-1)" "unprognostic (1.41e-1)" "unprognostic (4.45e-2)" "unprognostic (1.69e-1)" 2.2 2.7 49.5 2.1 55.4 2.1 2.3 17.9 66.9 2.4 2.3 33.9 0.0 2.4 2.6 2.1 2.2 4.4 2.3 2.3 31.0 23.4 2.1 2.1 2.1 2.1 39.3 24.4 2.2 10.4 2.1 1.9 2.1 19.7 2.5 2.1 1.9 2.8 2.4 3.0 2.2 2.1 2.2 29.7 2.4 2.2 7.4 18.0 0.0 2.1 0.0 2.1 2.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.3 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 49.5 55.4 17.9 42.9 31.0 23.4 39.3 24.4 19.7 18.0 3.0 1.1 0.0 1.0 0.7 84.6 1.1 0.0 1.4 1.2 0.0 19.6 0.4 0.0 25.4 3.1 0.6 0.0 0.0 0.5 0.6 0.5 2.1 0.0 0.0 0.2 9.5 1.2 1.3 0.0 4.0 1.7 0.0 21.9 0.0 0.0 594.3 2.2 0.0 0.7 0.6 149.3 6.5 1.4 2.1 4.4 0.6 3.5 0.0 0.2 1.0 TTYH2 C17orf29 ENSG00000141540 "Tweety family member 2" Q9BSA4 17 74213514-74262020 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 84.1" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 58.7;granulocytes: 21.8;Melanocytes: 21.9" "Group enriched" "Detected in all" 6 "glioma: 16.7;melanoma: 20.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 16.6" "Group enriched" "Detected in many" 5 "dendritic cells: 11.5;monocytes: 16.6" "Cell line enhanced" "Detected in many" "HSkMC: 11.8;SK-MEL-30: 41.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.19e-1)" "unprognostic (5.08e-1)" "unprognostic (1.58e-3)" "unprognostic (3.51e-4)" "unprognostic (1.59e-1)" "unprognostic (2.44e-1)" "unprognostic (1.67e-2)" "unprognostic (5.90e-2)" "unprognostic (8.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.81e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (9.74e-5)" "unprognostic (8.98e-3)" "unprognostic (5.70e-3)" "unprognostic (2.50e-3)" "unprognostic (3.51e-3)" 4.6 4.4 20.7 5.8 32.1 2.8 2.9 4.6 63.5 3.8 3.1 84.1 0.0 2.6 4.4 3.4 3.1 4.8 4.5 12.8 31.6 15.9 1.8 1.9 4.3 5.9 59.3 19.0 12.9 4.9 5.4 3.1 8.2 28.7 2.8 2.6 8.5 5.4 3.9 10.5 4.5 3.2 3.6 48.6 8.8 2.3 9.2 45.6 0.7 8.5 2.1 4.8 3.0 2.1 0.2 11.5 0.8 16.6 0.1 3.1 3.8 0.1 1.0 4.7 4.4 0.5 0.6 0.1 0.2 0.0 0.3 0.0 3.0 0.0 2.6 0.7 0.1 0.5 7.4 4.6 0.1 0.1 6.2 2.6 2.8 0.1 0.2 3.3 0.3 1.9 11.8 2.4 0.1 0.8 0.3 0.1 1.9 0.5 1.3 0.1 0.5 1.3 0.2 0.9 4.3 8.1 4.4 8.4 5.0 0.1 0.3 1.6 5.7 0.0 2.8 41.1 2.5 1.5 0.6 0.1 0.0 2.3 0.0 0.1 0.2 0.1 0.0 0.1 0.8 2.5 0.6 8.0 0.7 1.6 13.9 0.2 0.2 3.1 2.6 9.0 0.2 0.5 1.1 0.8 0.1 16.6 11.5 2.7 3.8 20.7 32.1 4.6 29.8 31.6 15.9 59.3 19.0 28.7 45.6 0.0 5.5 2.2 0.7 2.1 58.7 1.4 2.5 0.0 0.0 0.0 5.9 0.3 0.0 0.1 20.0 2.1 0.0 0.0 0.2 0.4 3.1 0.5 21.8 0.4 4.2 3.2 1.7 0.6 13.0 8.7 8.9 10.1 21.9 15.4 0.0 15.3 0.2 0.0 2.5 0.1 9.1 19.4 3.8 1.5 1.6 2.3 0.2 1.3 0.0 0.3 TTYH3 KIAA1691 ENSG00000136295 "Tweety family member 3" Q9C0H2 7 2631951-2664802 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 112.1;Kupffer cells: 64.9;Melanocytes: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 10.8;non-classical monocyte: 8.6" "Lineage enriched" "Detected in many" 5 "monocytes: 10.8" "Cell line enhanced" "Detected in many" "U-2 OS: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053520 Uncertain NA NA "HPA053520: AB_2682176" "unprognostic (2.53e-2)" "unprognostic (6.65e-3)" "unprognostic (3.86e-3)" "unprognostic (1.35e-1)" "unprognostic (5.25e-2)" "unprognostic (7.42e-2)" "prognostic unfavorable (2.53e-5)" "unprognostic (5.53e-2)" "unprognostic (1.96e-1)" "unprognostic (8.59e-3)" "unprognostic (5.40e-2)" "unprognostic (2.06e-2)" "prognostic unfavorable (2.58e-5)" "unprognostic (7.90e-2)" "unprognostic (5.45e-2)" "unprognostic (1.03e-1)" "unprognostic (8.85e-2)" 23.2 15.2 18.9 27.4 17.3 9.6 13.8 48.2 37.0 8.4 10.2 9.3 6.7 18.6 14.1 10.3 4.8 7.8 17.5 9.8 14.9 11.5 24.4 25.3 11.7 26.7 12.1 12.4 8.3 7.0 5.0 7.1 22.2 9.4 10.0 6.9 8.3 12.2 7.9 3.1 11.2 20.2 10.1 9.3 22.5 12.4 8.4 7.6 10.3 10.4 3.8 7.6 13.1 7.4 0.4 2.4 1.6 10.8 0.3 0.3 2.8 10.6 21.2 22.5 31.3 6.3 5.7 25.2 17.3 15.7 7.6 9.0 8.7 7.8 0.8 21.1 16.4 20.2 4.8 3.2 7.9 2.2 1.4 10.7 5.3 4.5 24.0 8.4 1.0 3.4 13.6 3.8 8.1 2.1 14.3 25.2 5.4 1.6 1.2 5.0 6.2 3.9 11.5 28.7 15.2 8.3 16.2 16.3 1.0 11.8 11.7 9.4 47.4 10.7 2.1 9.9 15.6 5.6 29.0 29.4 17.9 54.0 10.4 19.3 2.0 1.2 3.0 12.9 4.0 38.5 0.0 5.1 1.6 0.2 10.8 0.3 0.3 0.1 0.2 2.4 0.4 0.3 0.1 0.6 0.3 8.6 1.0 0.2 2.8 18.9 17.3 48.2 29.7 14.9 11.5 12.1 12.4 9.4 7.6 0.0 3.4 1.9 1.5 5.8 8.0 2.0 28.1 0.0 2.3 8.7 3.9 1.4 3.3 16.9 0.4 13.1 9.3 0.0 4.5 23.6 12.2 3.1 2.3 15.8 112.1 28.6 7.5 16.0 64.9 3.8 7.5 24.9 54.0 15.4 18.7 3.5 14.5 0.0 3.5 38.2 1.9 6.5 2.8 0.2 2.3 3.1 2.1 4.3 10.1 2.2 TUBA8 TUBAL2 ENSG00000183785 "Tubulin alpha 8" Q9NY65 22 18110331-18146554 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 50.3;skeletal muscle: 125.4" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 16.2;Late spermatids: 15.1;Sertoli cells: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.2;NK-cell: 5.8" "Group enriched" "Detected in many" 14 "granulocytes: 4.2;NK-cells: 5.8" "Group enriched" "Detected in many" 6 "NB-4: 20.9;SCLC-21H: 10.3;TIME: 26.0" "Group enriched" "Detected in many" 4 "cerebellum: 61.3;olfactory region: 66.2" "Low region specificity" "Detected in all" "HPA043684, CAB046031, HPA063394" Approved Supported Microtubules NA NA 260000000 Microtubules "CAB046031: AB_11124541, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (1.07e-1)" "unprognostic (1.34e-2)" "unprognostic (2.79e-3)" "unprognostic (1.52e-2)" "unprognostic (2.74e-1)" "unprognostic (8.92e-2)" "unprognostic (6.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.64e-2)" "unprognostic (1.92e-2)" "unprognostic (3.36e-1)" "unprognostic (2.90e-5)" "unprognostic (9.12e-2)" "unprognostic (6.05e-2)" "unprognostic (4.08e-2)" "unprognostic (5.61e-4)" 3.2 1.2 5.3 1.2 10.5 2.4 2.5 20.5 23.4 1.4 1.2 1.5 0.2 1.5 1.2 4.3 2.6 1.6 1.3 50.3 7.5 5.6 1.2 2.0 1.2 2.2 3.9 9.2 1.3 2.2 1.8 4.3 1.0 2.5 1.7 1.1 0.4 2.1 1.2 125.4 1.4 1.4 1.2 1.1 1.6 1.7 19.2 1.0 0.0 3.5 13.3 1.3 1.1 0.3 0.0 0.2 4.2 0.1 5.8 0.3 15.7 0.4 0.9 0.7 0.8 1.3 0.8 0.3 0.7 0.7 1.2 1.2 0.3 0.9 0.7 3.3 0.6 0.5 0.3 2.1 0.1 0.3 2.0 2.0 2.3 0.4 0.3 0.7 1.4 1.3 0.7 0.7 0.8 0.1 0.4 1.9 0.8 1.0 0.8 0.4 2.7 1.7 20.9 0.9 0.4 1.0 1.7 0.0 0.2 0.5 0.3 10.3 1.1 0.4 0.5 1.3 0.2 0.5 3.4 26.0 0.1 0.2 0.7 0.5 2.4 1.1 0.7 0.9 1.0 0.2 1.2 0.1 2.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 4.2 5.8 0.1 0.2 0.0 15.7 5.3 10.5 20.5 23.4 7.5 5.6 3.9 9.2 2.5 1.0 0.0 1.7 0.0 0.0 0.0 0.6 2.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 16.2 0.1 0.2 0.0 1.0 0.0 0.0 0.0 2.3 0.0 0.1 3.2 0.0 0.6 0.0 15.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 6.5 0.0 0.1 0.2 0.3 0.1 0.0 0.0 0.0 TUBD1 "FLJ12709, TUBD" ENSG00000108423 "Tubulin delta 1" Q9UJT1 17 59859482-59892945 "FDA approved drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004609, HPA023980, HPA027090" Approved Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457" "unprognostic (1.92e-1)" "unprognostic (5.95e-2)" "prognostic favorable (2.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.32e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (2.86e-2)" "unprognostic (8.87e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (6.06e-4)" "unprognostic (4.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-1)" "unprognostic (8.83e-2)" 8.7 8.0 9.3 8.1 13.8 6.8 12.4 19.9 12.2 12.3 11.2 13.5 16.6 6.7 13.6 16.4 18.2 10.0 8.3 8.4 8.9 7.2 8.5 9.3 8.8 10.2 16.1 8.5 16.3 13.2 10.4 18.7 7.2 12.3 12.3 8.2 11.7 11.4 12.2 9.9 11.6 7.5 9.3 13.4 9.3 9.6 9.2 16.4 16.2 15.5 10.3 13.8 14.1 13.0 10.1 8.8 14.1 7.6 8.1 17.6 6.9 6.0 8.3 6.5 6.8 3.7 2.6 5.5 4.7 2.8 6.3 5.2 9.0 3.9 5.5 8.1 1.1 4.3 5.1 9.1 2.8 6.0 3.2 11.1 6.4 7.0 10.6 2.0 3.8 3.5 1.4 4.5 5.4 2.0 2.2 4.9 5.5 13.8 3.8 2.1 42.9 7.8 4.4 5.7 6.7 3.7 8.4 9.6 8.6 2.4 2.8 6.1 3.7 3.4 2.7 3.2 8.2 6.4 3.7 1.5 4.5 10.1 3.1 5.1 4.5 6.8 8.4 2.1 4.3 4.0 5.6 7.6 14.1 10.9 5.0 12.4 10.1 13.5 11.5 5.2 8.6 17.6 14.2 8.2 8.1 5.3 8.8 14.1 6.9 9.3 13.8 19.9 12.2 8.9 7.2 16.1 8.5 12.3 16.4 11.9 45.1 5.4 12.7 14.0 7.1 4.8 7.6 12.0 20.5 3.5 5.9 5.1 10.0 4.6 1.3 7.7 2.6 0.0 4.2 6.5 8.2 11.1 10.5 3.2 3.5 3.2 9.9 6.7 4.8 0.4 5.2 6.2 6.8 3.6 5.5 7.7 3.3 4.9 7.8 3.1 7.7 6.5 10.3 11.4 28.1 14.8 3.3 13.6 5.4 5.7 TUNAR "HI-LNC78, LINC00617, TUNA" ENSG00000250366 "TCL1 upstream neural differentiation-associated RNA" 14 95876392-95925571 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 28.7" "Group enriched" "Detected in some" 8 "Bipolar cells: 2.4;Cone photoreceptor cells: 2.0;Early spermatids: 2.1;Rod photoreceptor cells: 1.7;Spermatogonia: 4.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.9;EFO-21: 2.8;NTERA-2: 10.2;SCLC-21H: 10.3" "Low region specificity" "Detected in all" NA NA "unprognostic (1.28e-3)" "unprognostic (3.94e-1)" "unprognostic (4.10e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-2)" "unprognostic (1.34e-1)" "prognostic favorable (1.55e-4)" "unprognostic (5.33e-2)" "unprognostic (2.92e-2)" "unprognostic (1.18e-1)" 0.2 0.2 0.9 0.2 18.6 0.5 0.4 1.2 8.8 0.4 0.3 1.3 0.0 0.5 3.7 0.2 0.2 5.1 0.5 0.3 6.0 0.3 0.2 0.2 0.4 0.0 3.7 0.2 6.1 0.2 0.0 0.3 28.7 0.2 0.4 0.7 0.2 3.4 0.2 0.7 0.2 0.3 1.3 0.2 0.3 1.1 6.8 0.0 0.9 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 1.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 10.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 10.3 1.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 TUSC3 "MGC13453, MRT7, N33, OST3A" ENSG00000104723 "Tumor suppressor candidate 3" Q13454 8 15417215-15766649 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 127.8" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 406.6;Extravillous trophoblasts: 249.7;Syncytiotrophoblasts: 655.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049851, HPA049974" Approved NA NA "HPA049851: AB_2680913, HPA049974: AB_2680976" "unprognostic (3.31e-2)" "unprognostic (7.17e-2)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (4.46e-1)" "unprognostic (2.34e-1)" "unprognostic (7.15e-3)" "unprognostic (5.02e-2)" "unprognostic (7.39e-2)" "unprognostic (4.79e-2)" "unprognostic (1.59e-3)" "unprognostic (4.81e-1)" "unprognostic (1.60e-3)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" "prognostic favorable (7.86e-4)" "unprognostic (1.55e-1)" 10.5 35.3 10.5 4.0 23.0 0.1 19.7 21.5 19.8 12.1 6.2 5.4 5.1 4.5 16.0 50.5 6.1 27.0 8.1 16.1 10.4 21.4 11.6 3.2 8.5 3.3 6.0 15.6 35.5 15.8 24.8 50.6 127.8 13.4 23.9 7.1 11.6 5.7 14.1 2.8 3.8 4.1 14.4 4.3 3.6 5.2 10.2 3.3 2.9 4.7 3.6 2.4 15.0 9.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 13.2 9.6 26.5 24.7 30.9 35.8 0.0 18.8 40.4 20.8 34.9 0.0 0.0 0.1 6.6 25.0 23.0 10.1 9.2 18.0 30.3 0.0 12.6 0.0 7.8 1.5 13.4 0.0 1.3 28.4 5.7 29.1 10.9 29.9 1.7 3.9 17.5 4.0 31.6 9.5 4.8 0.1 13.2 0.0 8.3 5.9 22.0 0.1 28.8 33.0 10.5 20.3 0.0 10.7 14.6 20.2 12.6 0.0 8.1 19.2 19.0 8.0 9.3 0.0 2.3 0.0 0.3 0.0 26.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.5 23.0 21.5 19.8 10.4 21.4 6.0 15.6 13.4 3.3 0.0 9.3 0.0 50.9 8.9 49.5 42.5 20.4 75.0 29.6 75.0 7.9 406.6 14.9 137.4 9.6 16.8 0.2 0.0 10.2 249.7 45.2 77.9 1.1 0.0 36.4 30.2 92.1 10.4 0.0 5.7 32.2 2.2 23.6 2.8 20.2 33.8 32.0 0.0 21.5 18.8 20.0 38.8 18.3 50.1 42.8 3.6 655.5 0.5 8.3 40.9 TUSC5 "BEC-1, IFITMD3, LOST1" ENSG00000184811 "Tumor suppressor candidate 5" Q8IXB3 17 1279663-1300987 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "adipose tissue: 79.1;breast: 63.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 268 "ASC diff: 26.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA050825 Approved NA NA "HPA050825: AB_2681252" "unprognostic (5.84e-2)" "unprognostic (7.21e-2)" "unprognostic (1.15e-1)" "unprognostic (3.00e-1)" "unprognostic (2.01e-1)" "unprognostic (2.91e-2)" "unprognostic (1.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.73e-1)" "unprognostic (1.83e-2)" "unprognostic (2.66e-1)" "unprognostic (5.79e-2)" "unprognostic (1.90e-3)" "unprognostic (6.26e-2)" "unprognostic (3.12e-1)" "unprognostic (5.10e-1)" 79.1 0.9 0.0 2.1 0.0 0.1 63.0 0.0 0.1 0.2 4.1 0.0 0.0 0.1 0.1 0.9 0.2 0.2 3.4 5.2 0.0 0.0 0.4 0.1 0.1 2.2 0.0 0.0 0.2 0.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 2.5 1.4 4.4 0.8 1.1 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.6 2.7 0.1 0.8 2.5 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 TVP23A "FAM18A, YDR084C" ENSG00000166676 "Trans-golgi network vesicle protein 23 homolog A" A6NH52 16 10760919-10818794 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.3" "Cell type enriched" "Detected in many" 8 "monocytes: 50.5" "Cancer enhanced" "Detected in some" "glioma: 2.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 3.6;SH-SY5Y: 6.1;U-266/70: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060582 Uncertain Approved Vesicles NA NA Vesicles "HPA060582: AB_2684326" "unprognostic (6.70e-4)" "unprognostic (1.64e-3)" "unprognostic (2.38e-2)" "unprognostic (8.24e-3)" "unprognostic (2.72e-2)" "unprognostic (4.39e-5)" "unprognostic (4.96e-2)" "unprognostic (4.68e-2)" "unprognostic (4.42e-2)" "unprognostic (9.22e-2)" "unprognostic (1.73e-2)" "unprognostic (2.42e-1)" "unprognostic (8.78e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.87e-2)" "unprognostic (2.87e-4)" 1.9 4.3 10.1 3.3 11.0 5.5 1.1 5.6 13.3 1.7 1.4 2.3 1.6 2.4 2.4 2.3 1.2 2.3 3.2 2.5 9.4 8.0 1.3 1.5 2.3 6.1 6.6 11.8 8.7 2.0 0.5 3.6 0.8 5.7 4.6 1.4 3.1 2.1 3.7 1.9 2.5 2.6 2.8 2.9 3.2 2.1 2.8 3.1 1.3 1.5 0.0 2.6 2.4 1.4 1.6 3.8 0.8 0.8 0.5 0.8 0.4 0.4 0.8 0.9 1.0 0.0 0.3 0.8 0.2 0.0 0.0 0.1 0.2 0.8 1.3 0.5 0.2 0.7 1.2 0.0 0.0 0.0 2.8 0.6 0.4 1.7 1.2 0.0 0.3 1.6 0.4 0.0 0.4 0.0 0.6 0.0 0.7 0.4 1.2 0.0 0.8 0.8 1.1 3.6 0.3 0.1 2.0 0.3 0.3 0.1 1.3 0.6 6.1 0.2 0.6 0.1 0.7 0.6 0.5 0.9 1.0 0.8 1.2 0.5 3.2 0.5 0.9 0.9 1.1 0.5 0.6 0.8 0.2 0.6 0.6 0.4 0.9 0.8 0.2 3.8 1.6 0.4 0.4 0.8 0.5 0.6 0.8 0.2 0.4 10.1 11.0 5.6 13.3 9.4 8.0 6.6 11.8 5.7 3.1 0.0 2.6 0.0 0.0 1.0 6.4 0.5 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.6 0.6 0.0 0.0 0.5 0.2 1.5 0.0 0.0 0.0 0.8 1.6 0.0 0.0 1.3 0.0 2.6 5.0 1.7 50.5 0.0 4.8 0.2 0.0 1.4 1.0 0.9 0.0 0.8 1.4 2.7 0.9 1.1 0.0 0.0 0.1 TVP23B "CGI-148, FAM18B, FAM18B1, YDR084C" ENSG00000171928 "Trans-golgi network vesicle protein 23 homolog B" Q9NYZ1 17 18780995-18806714 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019585, HPA065603" Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA019585: AB_1848385, HPA065603: AB_2685517" "unprognostic (1.91e-1)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (9.32e-3)" "unprognostic (1.13e-2)" "unprognostic (8.51e-2)" "unprognostic (2.37e-1)" "unprognostic (3.32e-2)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (2.30e-1)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (3.54e-1)" "unprognostic (5.27e-1)" "unprognostic (7.78e-2)" "unprognostic (8.55e-2)" 10.0 16.4 7.8 6.1 27.0 5.7 24.2 11.3 9.0 14.6 8.7 8.3 12.5 10.2 19.2 15.1 24.6 12.4 10.7 10.4 10.7 7.5 15.2 26.9 22.1 10.3 11.1 10.5 12.7 16.0 14.7 19.3 13.5 23.1 12.2 11.1 14.3 18.1 9.1 7.5 8.5 9.9 7.4 13.3 7.7 14.1 13.2 10.6 8.1 17.1 10.5 11.3 10.7 15.3 20.1 17.4 29.9 16.8 20.0 27.3 18.7 17.7 21.4 7.9 8.9 23.8 21.4 19.0 31.1 25.1 14.5 18.8 12.2 12.9 5.8 11.5 20.0 14.2 24.8 6.4 13.3 21.8 14.2 13.2 5.5 14.8 15.1 17.0 4.2 12.1 11.2 32.6 15.7 23.2 27.0 12.0 4.3 4.5 4.4 21.1 9.0 5.5 5.7 3.6 32.4 8.5 5.7 17.6 7.3 17.8 11.8 4.5 10.1 16.3 10.9 18.9 46.1 15.7 6.4 13.9 11.2 9.6 23.6 18.6 8.7 10.0 3.0 17.2 7.1 22.8 29.9 12.8 27.0 20.0 16.8 27.3 20.1 22.7 21.7 10.7 15.7 24.5 24.1 15.5 20.0 15.9 17.4 16.3 18.7 7.8 27.0 11.3 9.0 10.7 7.5 11.1 10.5 23.1 10.6 11.9 10.4 13.7 20.6 22.3 7.9 3.2 7.6 37.5 15.9 8.7 9.8 11.7 10.0 11.8 7.2 8.7 7.3 23.3 10.3 24.7 12.7 22.4 21.9 9.0 9.2 1.6 5.8 11.6 12.0 2.8 15.5 10.6 25.3 10.0 12.2 8.5 12.9 10.2 15.9 12.8 9.5 12.9 9.9 45.0 45.1 26.7 21.9 17.0 6.6 27.3 TVP23C "FAM18B2, MGC8763" ENSG00000175106 "Trans-golgi network vesicle protein 23 homolog C" Q96ET8 17 15502264-15563595 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA019585, HPA065603" Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA019585: AB_1848385, HPA065603: AB_2685517" "unprognostic (2.87e-3)" "unprognostic (5.35e-3)" "unprognostic (1.01e-1)" "unprognostic (8.39e-3)" "unprognostic (1.33e-3)" "unprognostic (3.00e-1)" "unprognostic (6.35e-2)" "unprognostic (1.12e-1)" "unprognostic (2.57e-2)" "unprognostic (3.01e-1)" "unprognostic (1.10e-3)" "unprognostic (3.43e-1)" "unprognostic (8.09e-5)" "unprognostic (2.42e-2)" "unprognostic (1.61e-1)" "unprognostic (3.50e-1)" "unprognostic (2.45e-2)" 5.2 5.8 4.4 4.7 6.1 15.8 6.6 15.0 9.1 5.5 3.6 4.7 12.0 2.9 6.8 7.3 6.1 5.0 5.2 4.2 4.2 4.2 4.3 3.8 4.6 4.2 4.2 6.6 10.0 6.2 5.4 19.0 6.2 10.2 6.7 3.2 8.2 6.8 7.4 3.7 5.6 3.8 3.5 5.6 5.3 3.8 8.8 3.1 1.6 9.0 1.3 4.6 5.4 6.0 8.2 4.3 12.1 5.4 6.1 8.0 4.8 7.8 6.8 2.9 3.4 3.2 1.6 3.7 6.1 10.2 10.8 12.8 9.6 3.0 0.0 3.4 5.1 6.1 3.4 7.8 5.4 7.9 4.8 4.8 4.7 6.8 12.1 3.3 2.0 5.6 2.8 1.6 10.7 6.2 9.3 9.7 3.1 5.8 3.8 5.0 2.8 3.0 5.3 3.5 2.8 2.5 0.5 0.3 0.4 3.0 4.3 0.9 2.2 7.9 1.2 1.6 10.8 4.6 1.0 6.6 1.8 2.8 2.8 2.5 1.9 1.7 0.0 2.2 0.0 1.6 12.1 2.5 11.1 5.1 5.4 6.4 8.2 6.5 7.2 4.1 5.1 8.0 7.2 4.0 6.1 3.8 4.3 6.0 4.8 4.4 6.1 15.0 9.1 4.2 4.2 4.2 6.6 10.2 3.1 3.0 8.0 2.2 4.7 3.5 5.8 17.1 0.0 2.7 9.1 0.0 13.7 5.3 1.7 2.6 1.1 5.6 2.9 0.0 0.6 8.9 4.0 4.2 2.3 0.6 2.8 6.4 1.7 0.6 2.6 0.4 3.1 2.0 1.7 2.8 2.1 2.6 1.2 2.9 2.1 0.6 11.8 0.0 2.1 7.1 8.1 2.5 4.6 4.3 3.5 5.9 TVP23C-CDRT4 FAM18B2-CDRT4 ENSG00000259024 "TVP23C-CDRT4 readthrough" 17 15436021-15563561 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 1.3;Ciliated cells: 4.0;Club cells: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 26.8" HPA065603 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA065603: AB_2685517" "unprognostic (3.95e-3)" "unprognostic (1.58e-1)" "unprognostic (2.42e-2)" "unprognostic (1.59e-1)" "unprognostic (8.67e-3)" "unprognostic (9.05e-2)" "unprognostic (4.71e-2)" "unprognostic (9.40e-3)" "unprognostic (3.49e-2)" "unprognostic (1.07e-1)" "unprognostic (2.24e-1)" "unprognostic (4.40e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.57e-1)" "unprognostic (2.07e-1)" "unprognostic (2.08e-1)" 4.1 8.3 3.4 3.6 4.8 1.4 2.8 12.3 7.3 7.5 2.8 3.6 9.8 4.5 5.4 7.2 5.0 8.1 4.1 3.4 3.0 5.0 4.5 1.8 3.1 1.8 4.2 5.3 7.9 7.6 10.5 15.6 3.5 8.3 4.7 3.2 6.6 6.1 5.9 1.8 3.1 5.1 2.5 4.5 4.1 3.4 7.1 2.3 1.0 7.4 0.8 3.6 4.0 3.6 1.9 1.9 7.9 0.6 5.3 4.8 1.5 4.1 3.2 2.6 5.0 2.6 3.2 6.7 2.8 11.3 5.1 6.0 3.3 0.8 0.0 6.0 6.0 1.9 3.8 2.6 2.0 4.9 5.1 2.6 1.6 2.5 5.7 6.1 2.0 4.2 2.0 1.2 3.0 12.4 13.5 4.5 2.7 2.2 2.2 1.1 1.7 3.0 4.2 1.7 3.2 2.3 0.5 0.0 0.0 2.8 2.8 1.7 4.1 2.7 0.5 1.4 26.8 2.1 1.2 2.0 0.2 2.0 1.3 1.8 4.7 2.4 0.0 0.5 0.0 0.7 7.9 0.6 6.9 4.5 0.4 4.8 1.9 3.8 4.0 1.6 1.3 2.3 2.9 0.2 5.3 0.3 1.9 3.4 1.5 3.4 4.8 12.3 7.3 3.0 5.0 4.2 5.3 8.3 2.3 0.0 1.3 0.0 0.0 0.0 0.4 0.0 0.0 4.0 2.3 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.6 0.0 0.2 0.0 0.0 0.3 TXNDC12 "AGR1, ERP18, ERP19, hAG-1, PDIA16, TLP19" ENSG00000117862 "Thioredoxin domain containing 12" O95881 1 52020131-52056171 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 95000 "unprognostic (6.54e-2)" "unprognostic (5.46e-2)" "prognostic favorable (4.44e-4)" "unprognostic (2.33e-3)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.61e-4)" "prognostic unfavorable (1.28e-5)" "unprognostic (1.25e-1)" "unprognostic (3.28e-2)" "unprognostic (1.17e-1)" "unprognostic (6.14e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.40e-12)" "unprognostic (2.13e-1)" "unprognostic (5.83e-2)" "unprognostic (1.73e-2)" "unprognostic (1.17e-1)" 30.5 24.6 20.4 19.8 20.1 19.5 22.7 19.2 20.4 23.1 25.6 15.3 20.9 20.4 18.6 28.5 18.9 25.1 20.2 21.6 18.2 22.1 30.7 60.3 24.5 20.6 23.5 12.5 28.0 51.9 14.0 29.4 32.4 18.5 19.7 29.1 15.4 30.3 22.0 15.5 17.2 35.0 17.7 21.0 35.1 24.3 16.7 18.3 31.8 38.6 18.3 26.6 20.8 21.6 24.2 28.6 62.8 36.4 22.3 33.3 36.7 18.1 16.7 18.9 26.9 31.3 16.7 15.0 28.0 27.6 25.4 29.4 18.6 15.0 14.1 18.4 22.0 28.4 24.4 26.2 21.3 34.1 18.5 23.8 18.0 15.4 29.8 37.7 33.2 36.2 24.3 29.1 26.3 42.4 19.6 25.4 19.3 16.0 10.8 20.9 16.6 18.5 43.3 41.7 26.3 16.3 18.9 27.9 38.8 33.7 15.7 15.0 19.6 27.6 24.4 26.5 38.3 13.7 43.7 16.2 18.3 20.2 20.9 31.5 22.0 33.1 15.9 26.6 31.2 20.7 46.7 36.4 54.6 23.2 33.2 29.0 24.2 28.5 24.8 26.9 20.9 27.4 26.3 62.8 22.3 34.4 28.6 33.3 36.7 20.4 20.1 19.2 20.4 18.2 22.1 23.5 12.5 18.5 18.3 8.9 10.5 52.4 53.7 39.2 18.1 12.7 45.9 25.4 9.1 41.8 13.7 96.2 14.9 64.8 5.6 58.2 36.0 0.0 78.0 136.0 41.8 60.0 33.4 29.0 107.7 20.6 46.6 43.6 52.6 4.5 51.8 56.6 49.0 71.3 56.4 36.1 65.7 59.6 29.0 25.4 12.5 32.3 36.0 49.4 9.6 39.6 99.1 50.0 68.5 55.2 TXNDC15 "2310047H23Rik, C5orf14, FLJ22625" ENSG00000113621 "Thioredoxin domain containing 15" Q96J42 5 134873803-134901525 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015483 Approved Approved "Golgi apparatus" NA NA 48000000 "Golgi apparatus" "HPA015483: AB_1845722" "unprognostic (1.56e-1)" "unprognostic (1.22e-2)" "unprognostic (2.29e-2)" "unprognostic (3.73e-2)" "unprognostic (2.14e-2)" "unprognostic (3.10e-1)" "unprognostic (2.35e-1)" "unprognostic (2.86e-2)" "unprognostic (7.95e-2)" "unprognostic (6.68e-2)" "unprognostic (9.71e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (1.44e-4)" "unprognostic (2.36e-1)" "unprognostic (4.37e-1)" "unprognostic (1.41e-3)" "unprognostic (1.50e-1)" 23.5 40.5 16.3 22.8 28.1 5.6 22.6 24.9 30.5 30.3 26.1 23.8 36.1 17.0 32.4 40.8 19.0 24.6 24.8 30.7 14.8 16.3 26.3 26.9 25.7 26.2 18.2 20.4 26.5 38.8 23.6 40.9 28.1 19.9 26.5 18.6 27.7 37.8 33.9 24.3 16.3 18.3 28.6 18.8 31.7 23.0 16.6 18.4 13.1 40.4 16.7 21.1 25.6 22.6 23.2 22.5 20.2 24.5 19.3 24.9 20.7 8.9 24.3 12.2 21.0 18.5 26.7 1.7 35.8 39.3 12.4 28.1 17.7 11.6 11.1 20.3 29.6 24.5 6.2 8.4 14.6 11.2 25.2 11.2 5.9 14.9 12.9 17.1 3.7 15.6 17.1 12.2 17.1 10.5 18.6 18.7 5.3 2.8 32.9 17.3 10.8 5.8 7.5 5.5 8.6 10.2 8.6 16.2 35.0 9.5 8.8 8.3 9.9 21.8 5.2 17.2 6.2 7.9 5.4 25.5 18.7 11.2 17.1 12.0 22.5 35.2 9.6 28.9 7.9 12.1 20.2 24.5 13.8 24.2 23.7 24.9 23.2 19.6 24.9 22.5 15.9 16.7 19.2 5.8 19.3 22.6 22.2 21.2 20.7 16.3 28.1 24.9 30.5 14.8 16.3 18.2 20.4 19.9 18.4 56.6 29.3 23.1 24.0 22.6 34.5 31.1 28.1 30.8 31.8 22.7 19.6 28.0 11.6 31.8 3.4 35.1 10.5 0.0 28.9 37.1 52.6 24.2 29.0 23.2 31.5 60.4 12.1 38.6 30.6 4.5 58.7 28.1 65.8 34.3 14.3 38.9 19.7 15.2 42.8 23.7 27.8 45.3 38.7 20.9 73.7 20.6 25.1 27.7 13.3 16.1 TXNDC16 KIAA1344 ENSG00000087301 "Thioredoxin domain containing 16" Q9P2K2 14 52430590-52552522 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 49.1;Rod photoreceptor cells: 45.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002543 Approved Approved Mitochondria "Secreted - unknown location" NA NA Mitochondria "HPA002543: AB_1079199" "unprognostic (1.37e-1)" "unprognostic (7.79e-3)" "unprognostic (5.95e-3)" "unprognostic (2.36e-1)" "unprognostic (5.95e-3)" "unprognostic (9.73e-2)" "unprognostic (2.50e-1)" "unprognostic (1.43e-2)" "unprognostic (7.01e-2)" "unprognostic (1.49e-1)" "unprognostic (2.07e-2)" "unprognostic (1.21e-1)" "prognostic favorable (6.79e-4)" "unprognostic (1.39e-1)" "unprognostic (1.56e-1)" "unprognostic (3.55e-3)" "unprognostic (2.04e-1)" 7.0 5.2 10.2 5.9 12.5 5.4 8.6 20.5 15.0 12.1 7.0 7.4 16.1 5.1 8.5 18.4 4.8 5.4 6.5 5.6 9.2 9.4 6.4 8.9 6.1 5.0 9.5 11.3 13.4 7.8 8.6 9.4 7.0 8.9 32.8 7.4 8.1 5.6 24.2 4.2 6.5 5.9 5.6 14.0 11.5 7.4 8.2 10.5 9.7 5.1 3.4 4.8 7.8 7.3 1.2 5.3 3.6 6.3 1.1 4.7 2.2 6.1 0.6 6.9 3.8 5.1 3.8 5.4 2.0 2.7 3.5 6.8 2.2 5.0 10.0 6.9 1.6 2.1 5.8 7.9 2.8 5.4 4.1 10.3 4.6 5.1 2.0 3.7 5.4 2.2 7.0 2.6 4.4 3.3 3.1 3.8 4.4 5.8 15.6 3.0 2.9 6.7 3.8 7.6 4.1 3.7 13.6 13.0 9.0 4.4 6.3 22.5 7.8 9.9 10.4 2.8 6.0 6.6 4.0 2.1 4.7 2.4 5.3 3.4 4.3 5.8 10.1 1.3 5.7 2.7 2.4 6.3 2.5 2.7 4.8 2.9 1.2 2.8 2.0 5.3 0.8 1.4 1.4 3.6 1.1 5.2 2.2 4.7 2.2 10.2 12.5 20.5 15.0 9.2 9.4 9.5 11.3 8.9 10.5 8.9 5.4 5.2 5.3 6.0 35.7 7.9 7.6 5.3 6.8 7.0 7.9 1.7 1.7 3.1 3.3 6.3 5.2 23.3 3.5 1.5 3.3 19.5 2.3 10.5 3.0 9.5 17.7 12.9 15.9 2.7 25.6 5.0 1.7 1.0 17.2 8.4 1.5 9.5 49.1 2.6 45.5 0.0 4.4 9.8 8.4 7.3 0.9 5.7 8.7 3.5 TYR "OCA1, OCA1A, OCAIA" ENSG00000077498 Tyrosinase P14679 11 89177452-89295759 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase, Tumor antigen" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 70 "retina: 82.0;skin 1: 25.2" "Cell type enriched" "Detected in some" 8 "Melanocytes: 175.5" "Cancer enriched" "Detected in single" 1755 "melanoma: 351.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 864 "SK-MEL-30: 86.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000079, HPA043241, HPA050889, HPA064583" Enhanced Enhanced Vesicles NA NA Vesicles "CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: " "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (1.85e-3)" "unprognostic (9.75e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 82.0 0.7 0.0 0.0 25.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.3 0.0 175.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.8 0.0 0.0 0.0 0.0 TYRO3 "Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif" ENSG00000092445 "TYRO3 protein tyrosine kinase" Q06418 15 41557675-41583586 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.2;ovary: 48.2" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 41.1;Peritubular cells: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.0" "Cell line enhanced" "Detected in many" "BEWO: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071245 Approved NA NA 6400000 "HPA071245: AB_2686371" "unprognostic (1.26e-1)" "unprognostic (6.34e-2)" "unprognostic (1.47e-1)" "unprognostic (2.68e-1)" "unprognostic (3.29e-1)" "unprognostic (6.77e-2)" "unprognostic (1.56e-3)" "unprognostic (5.41e-2)" "unprognostic (3.72e-1)" "unprognostic (3.21e-1)" "unprognostic (2.69e-1)" "unprognostic (1.37e-1)" "unprognostic (1.92e-10)" "unprognostic (7.59e-2)" "unprognostic (5.22e-1)" "unprognostic (4.04e-3)" "unprognostic (1.84e-2)" 18.3 4.1 18.7 2.1 16.6 1.5 7.7 27.3 39.2 2.3 1.8 25.6 1.2 2.3 5.0 4.2 12.7 11.7 3.1 2.5 15.1 7.8 6.4 1.6 3.2 1.9 19.6 18.2 48.2 9.5 1.3 0.8 5.9 14.0 3.3 1.7 1.7 2.4 6.7 1.4 13.0 2.9 4.8 23.1 5.4 3.6 17.9 16.6 0.0 1.8 2.2 4.1 2.9 2.8 1.2 1.0 5.0 0.9 1.0 0.8 0.2 4.8 3.2 10.1 11.0 9.5 6.4 33.9 7.0 4.5 7.0 6.5 17.8 1.6 0.1 9.0 5.6 9.8 11.4 11.2 1.7 3.2 2.7 7.5 1.4 10.1 8.5 6.6 2.4 0.2 2.0 3.6 5.3 1.8 2.8 5.1 4.7 8.8 2.1 3.8 4.6 1.1 0.4 23.2 7.5 3.2 14.9 9.1 1.8 0.6 9.3 12.1 3.4 6.5 10.5 7.8 15.3 8.6 2.8 4.0 13.9 6.1 10.2 10.5 0.8 1.6 1.4 8.4 16.0 8.3 2.6 0.9 0.8 0.6 0.5 0.6 0.7 0.6 0.8 0.3 1.2 0.7 0.7 5.0 1.0 0.5 1.0 0.5 0.2 18.7 16.6 27.3 32.7 15.1 7.8 19.6 18.2 14.0 16.6 3.0 1.4 0.9 6.2 6.1 1.2 3.7 2.5 0.0 0.0 3.5 5.9 2.4 0.0 3.4 2.7 4.9 0.9 0.0 3.1 8.9 5.6 4.8 0.0 0.2 1.0 0.0 1.7 12.3 0.6 4.0 41.1 1.1 8.5 0.0 0.1 6.5 3.7 0.0 44.2 1.5 3.9 0.0 2.8 2.4 5.4 9.5 15.8 0.0 1.6 4.7 TYROBP "DAP12, KARAP, PLO-SL, PLOSL" ENSG00000011600 "TYRO protein tyrosine kinase binding protein" O43914 19 35904401-35908295 "Disease related genes, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 267.2;bone marrow: 125.7;lymphoid tissue: 123.6" "Group enriched" "Detected in many" 4 "Hofbauer cells: 3494.1;Kupffer cells: 3415.8;Macrophages: 2767.6;monocytes: 2409.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 267.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 10 "HMC-1: 118.8;THP-1: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009493, HPA041899" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB009493: AB_638987, HPA041899: AB_10795266" "unprognostic (7.09e-2)" "unprognostic (8.38e-3)" "unprognostic (7.87e-2)" "unprognostic (4.76e-2)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (5.27e-2)" "unprognostic (8.04e-2)" "unprognostic (2.07e-2)" "unprognostic (2.47e-1)" "unprognostic (2.91e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.47e-2)" "unprognostic (1.72e-2)" "unprognostic (4.27e-2)" "unprognostic (4.39e-2)" 76.0 21.4 13.3 54.9 20.7 125.7 16.4 2.8 11.3 11.9 14.3 24.0 2.3 17.1 8.1 19.3 7.2 14.0 25.7 17.5 12.9 14.2 17.6 29.8 75.3 80.0 20.8 5.6 11.7 8.7 1.8 9.0 32.0 17.2 14.9 12.3 15.0 12.4 7.2 7.3 6.7 18.9 16.0 36.3 123.6 10.4 7.3 18.6 8.5 6.7 6.6 10.3 22.3 8.4 0.7 79.3 267.2 190.6 62.8 20.3 162.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.1 5.4 118.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 65.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.8 0.0 32.8 190.6 100.9 20.3 134.4 10.6 0.7 0.4 2.8 79.3 0.3 0.5 2.3 267.2 62.8 130.3 68.5 0.3 162.3 13.3 20.7 2.8 11.3 12.9 14.2 20.8 5.6 17.2 18.6 53.6 239.1 119.8 2.3 49.0 0.0 5.3 56.0 37.5 79.6 19.2 0.0 18.6 1.7 0.8 2.5 35.9 0.7 0.0 4.8 19.4 38.6 1.2 723.1 19.1 3494.1 0.0 0.0 89.6 3415.8 4.7 8.6 2767.6 54.0 2409.4 0.0 0.5 1.2 0.2 1.1 6.8 1.1 77.6 17.2 0.7 2.8 39.0 32.5 348.1 0.1 1.0 TYRP1 "b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP" ENSG00000107165 "Tyrosinase related protein 1" P17643 9 12685439-12710290 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase" "Albinism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 277.3" "Cell type enriched" "Detected in some" 19 "Melanocytes: 2358.5" "Cancer enriched" "Detected in some" 262 "melanoma: 313.2" "Region enriched" "Detected in some" 5 "pons and medulla: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 52 "SK-MEL-30: 177.7" "Group enriched" "Detected in some" 5 "olfactory region: 5.6;thalamus: 2.0" "Low region specificity" "Detected in all" "HPA000937, CAB002520" Enhanced Approved Vesicles NA NA 16000 Vesicles "CAB002520: AB_564153, HPA000937: AB_1080437" "unprognostic (7.48e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-1)" "unprognostic (3.16e-3)" "unprognostic (8.10e-2)" "unprognostic (3.82e-3)" "unprognostic (1.53e-1)" "unprognostic (2.25e-3)" "unprognostic (4.46e-1)" "unprognostic (8.71e-2)" "unprognostic (6.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.68e-6)" "unprognostic (1.27e-1)" "unprognostic (5.99e-2)" "unprognostic (1.95e-2)" 0.2 0.0 0.2 0.2 0.3 0.0 1.7 0.2 1.0 0.2 0.5 1.3 0.2 1.6 0.2 0.3 3.6 0.2 1.4 21.5 0.9 0.1 5.7 0.2 2.1 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 5.0 0.2 1.8 277.3 1.1 0.2 1.3 51.1 1.4 0.4 1.1 0.2 0.6 0.5 0.2 0.2 0.2 0.9 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 177.7 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 1.0 0.9 0.1 0.2 0.3 5.0 0.2 0.0 0.0 0.0 0.0 82.0 0.6 39.7 0.0 0.0 0.0 3.5 2.0 0.0 122.7 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.3 0.3 0.0 2358.5 0.0 0.0 15.4 0.0 0.0 0.0 0.8 1.3 0.0 3.1 0.5 0.7 14.6 0.0 0.0 0.0 0.1 TYW1 "FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W" ENSG00000198874 "TRNA-yW synthesizing protein 1 homolog" Q9NV66 7 66995173-67239519 "Enzymes, Predicted membrane proteins" "tRNA processing" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (1.53e-1)" "unprognostic (5.49e-3)" "unprognostic (1.62e-1)" "unprognostic (3.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.20e-1)" "unprognostic (1.83e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.86e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-2)" "unprognostic (4.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (1.79e-2)" 15.4 19.1 10.2 12.3 15.4 11.9 15.1 14.9 15.3 18.8 12.9 21.2 18.2 14.1 22.7 15.3 12.0 15.5 10.8 12.9 10.8 9.8 15.2 17.7 11.1 15.5 14.1 10.8 19.4 23.9 22.9 28.0 13.2 14.5 14.9 16.5 17.8 15.3 14.7 26.2 14.4 12.8 14.0 13.9 15.1 12.6 13.7 13.4 19.7 19.0 13.6 23.3 15.3 15.2 9.6 8.3 3.6 9.1 11.2 11.8 5.3 10.6 13.6 8.3 17.2 12.5 8.7 9.7 11.4 8.7 9.0 8.5 15.5 13.9 18.5 17.5 10.5 12.7 12.6 17.2 14.0 13.1 14.5 13.2 8.0 11.3 10.5 12.4 18.4 10.6 8.9 14.2 12.2 18.8 7.1 8.2 13.5 21.0 11.2 10.3 10.5 11.6 15.5 14.6 18.0 12.2 13.2 11.6 23.3 12.2 10.8 12.8 12.7 13.7 26.6 11.4 16.6 18.1 13.1 9.6 10.4 7.4 8.2 15.5 11.3 15.9 22.3 8.5 17.4 14.3 2.0 7.0 3.6 8.6 7.8 11.7 8.5 9.4 9.8 8.3 9.6 11.5 11.8 2.0 11.2 9.1 6.6 6.8 5.3 10.2 15.4 14.9 15.3 10.8 9.8 14.1 10.8 14.5 13.4 6.0 15.4 4.5 4.9 9.3 9.0 8.1 10.2 9.4 4.5 10.4 3.9 16.5 0.0 6.6 5.5 6.7 4.7 0.0 6.0 10.7 7.7 4.9 33.5 12.5 6.9 3.2 4.6 6.7 4.3 3.1 7.8 8.9 8.5 10.0 12.1 7.7 6.1 3.5 7.8 2.1 11.7 19.4 7.1 17.0 22.7 14.8 12.7 8.5 9.7 2.8 TYW1B "LINC00069, MGC87315, NCRNA00069, RSAFD2" ENSG00000277149 "TRNA-yW synthesizing protein 1 homolog B" 7 72558744-72828198 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 8.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (2.61e-1)" "unprognostic (3.54e-1)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (1.91e-2)" "unprognostic (6.22e-3)" "unprognostic (3.88e-2)" "unprognostic (1.64e-2)" "unprognostic (1.19e-2)" "unprognostic (8.96e-3)" "unprognostic (5.78e-2)" "unprognostic (2.90e-2)" "unprognostic (4.33e-4)" "unprognostic (1.02e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (5.90e-2)" 2.7 1.6 1.8 4.5 3.8 4.4 4.2 6.0 3.3 5.6 2.9 5.8 7.4 1.5 6.0 5.2 3.4 4.1 1.5 2.3 1.9 3.1 7.9 2.9 2.4 3.9 1.7 10.1 5.7 2.0 11.6 3.0 3.4 4.1 4.4 4.7 4.1 5.9 4.4 2.5 2.9 3.6 4.7 3.0 3.1 7.2 3.8 6.0 5.9 1.8 6.0 3.1 1.1 7.5 5.4 5.7 3.5 2.4 3.0 0.9 2.3 2.5 1.0 2.0 1.6 0.5 1.1 1.2 0.5 1.1 1.1 8.0 4.2 7.3 0.7 0.8 1.0 1.1 1.9 0.8 1.3 7.9 2.3 0.7 1.2 4.7 0.8 7.4 2.1 3.8 0.6 1.3 0.9 0.7 0.7 1.6 10.0 7.7 1.1 1.0 2.4 3.8 1.8 3.1 4.6 1.4 5.5 2.6 1.1 0.8 1.8 0.9 1.5 8.4 4.3 3.3 2.1 2.6 3.2 1.8 4.3 9.7 1.4 6.7 8.1 8.3 0.5 2.1 9.7 4.0 3.5 5.7 3.0 1.8 2.8 7.5 2.0 1.8 1.4 5.2 2.3 2.7 4.3 2.4 1.7 5.4 2.0 0.9 0.0 1.3 4.7 1.8 0.0 3.4 4.8 2.5 2.7 1.2 0.0 9.8 3.5 0.0 2.0 3.3 1.4 1.2 0.0 0.6 1.5 2.1 1.6 1.1 1.5 2.9 1.6 0.0 1.3 1.5 0.4 0.9 0.7 0.0 2.8 2.3 1.6 1.0 0.3 0.7 0.5 8.1 0.0 1.7 5.5 5.1 0.0 1.6 2.2 1.1 0.9 UBA2 "ARX, FLJ13058, HRIHFB2115, SAE2" ENSG00000126261 "Ubiquitin like modifier activating enzyme 2" Q9UBT2 19 34428352-34471251 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Sertoli cells: 265.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041436 Supported Supported Nucleoplasm NA NA 9400000 Nucleoplasm "HPA041436: AB_2677479" "unprognostic (2.37e-1)" "unprognostic (3.17e-1)" "unprognostic (2.13e-2)" "unprognostic (1.36e-3)" "unprognostic (6.39e-3)" "unprognostic (8.72e-3)" "prognostic unfavorable (3.76e-4)" "unprognostic (1.96e-2)" "unprognostic (2.14e-2)" "unprognostic (1.21e-1)" "unprognostic (2.58e-1)" "unprognostic (2.65e-2)" "prognostic unfavorable (8.02e-4)" "unprognostic (1.63e-2)" "unprognostic (2.11e-2)" "unprognostic (2.00e-1)" "unprognostic (1.88e-1)" 49.2 23.5 25.1 29.5 28.4 30.6 70.9 44.3 30.4 26.5 25.4 20.7 24.0 17.8 32.3 24.2 27.4 25.1 23.7 31.0 25.6 27.7 22.8 25.5 24.5 37.8 26.9 23.2 30.3 29.4 28.8 26.8 39.1 25.1 25.1 23.9 20.7 20.9 31.5 56.3 29.2 20.4 28.8 27.4 28.6 20.9 56.7 19.9 55.9 25.9 27.1 34.4 29.2 38.9 8.6 10.8 7.7 6.2 8.5 13.0 3.6 28.9 42.4 43.5 18.0 23.6 19.3 17.8 22.6 19.5 29.3 32.8 36.3 17.7 54.2 35.0 18.4 18.2 11.8 46.0 17.6 41.4 38.8 31.1 57.5 21.7 36.2 30.5 45.6 25.0 13.9 22.5 20.7 36.5 19.7 22.9 23.4 56.9 30.8 25.7 28.9 35.1 25.3 32.6 45.3 14.7 28.0 30.0 24.1 20.6 30.3 37.0 36.3 20.6 19.0 30.4 29.6 13.6 56.0 14.8 33.0 23.0 21.0 40.5 32.5 46.1 52.5 20.9 34.9 29.0 5.9 4.8 7.7 8.4 5.0 11.2 8.5 10.5 12.1 6.0 8.6 13.0 10.4 0.6 8.5 6.2 10.8 8.0 3.6 25.1 28.4 44.3 30.4 25.6 27.7 26.9 23.2 25.1 19.9 23.8 33.6 45.4 55.0 77.3 59.3 31.9 22.9 29.4 30.7 17.4 39.3 60.6 28.2 38.5 10.7 46.7 15.5 23.3 36.4 83.5 49.3 42.2 38.1 23.6 41.7 44.5 44.2 20.3 31.3 18.0 40.3 35.2 72.6 45.1 28.5 45.3 35.2 21.0 49.8 28.3 35.0 265.1 176.3 193.3 196.1 81.2 77.6 35.2 44.9 68.2 UBA5 "FLJ23251, UBE1DC1" ENSG00000081307 "Ubiquitin like modifier activating enzyme 5" Q9GZZ9 3 132654446-132678097 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 126.0;Late spermatids: 301.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017235 Uncertain Enhanced Vesicles,Cytosol NA NA Cytosol Vesicles "HPA017235: AB_1858507" "unprognostic (4.34e-3)" "unprognostic (6.44e-2)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.06e-1)" "unprognostic (3.28e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-2)" "unprognostic (1.84e-2)" "unprognostic (3.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" 14.8 30.3 17.8 12.3 19.8 13.2 17.4 17.9 26.2 14.5 15.0 10.5 27.8 16.2 13.4 24.2 15.1 13.3 12.7 21.2 15.3 16.3 22.7 29.8 13.7 14.8 16.0 25.0 15.1 41.4 29.3 32.7 18.1 21.2 18.8 16.7 11.7 37.8 33.5 32.5 15.7 17.9 14.6 13.6 18.9 18.5 15.3 12.7 17.9 23.5 17.5 17.4 15.1 12.5 11.1 14.1 5.0 6.6 18.9 15.0 7.9 27.3 10.2 18.0 14.8 12.7 14.6 18.9 23.7 24.4 14.9 17.3 18.5 10.2 21.8 17.4 17.1 9.8 16.7 17.8 18.7 22.2 20.7 7.6 26.5 16.5 20.7 12.7 32.5 15.6 12.7 11.0 14.1 21.3 13.9 16.7 11.9 16.5 32.4 16.6 24.3 17.9 12.2 16.4 23.5 9.8 15.7 15.7 41.3 13.7 21.2 17.4 15.7 13.9 14.0 20.0 17.2 16.8 16.5 14.9 15.8 15.5 7.6 12.4 30.6 20.5 40.4 18.0 11.9 14.0 4.1 5.1 5.0 9.6 5.8 11.6 11.1 10.8 15.0 11.8 6.9 12.9 12.8 1.1 18.9 6.6 14.1 10.7 7.9 17.8 19.8 17.9 26.2 15.3 16.3 16.0 25.0 21.2 12.7 32.8 23.4 11.1 16.1 15.2 19.2 32.5 15.3 17.4 19.4 7.0 13.7 52.9 58.0 21.3 126.0 17.0 14.5 0.0 39.4 38.1 22.6 19.5 23.1 20.2 20.4 20.6 20.7 15.4 6.4 301.4 15.5 11.7 16.9 27.9 20.1 24.6 21.2 15.9 25.5 29.4 19.8 32.3 25.0 27.9 14.9 16.2 83.4 17.5 15.6 14.8 UBAC2 "FLJ30548, PHGDHL1, RP11-178C10.1" ENSG00000134882 "UBA domain containing 2" Q8NBM4 13 99200774-99386434 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013448 Approved Approved Cytosol NA NA Cytosol "HPA013448: AB_1855301" "unprognostic (7.04e-2)" "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "unprognostic (7.30e-3)" "unprognostic (2.23e-1)" "unprognostic (2.79e-3)" "unprognostic (9.48e-3)" "unprognostic (6.50e-3)" "unprognostic (1.58e-1)" "unprognostic (6.95e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (6.44e-2)" "unprognostic (6.13e-3)" "unprognostic (3.33e-2)" "unprognostic (1.16e-1)" "unprognostic (6.08e-2)" "unprognostic (3.26e-2)" 16.7 15.6 9.1 15.6 10.4 11.0 24.2 8.2 13.9 14.6 14.6 10.0 18.3 16.7 17.2 17.1 29.6 18.1 15.4 15.5 11.0 7.6 15.1 20.0 20.6 36.5 8.2 10.1 15.1 25.5 11.8 9.5 22.1 9.8 11.1 14.6 11.9 19.5 13.7 26.9 26.3 17.6 13.8 11.7 13.4 14.9 24.8 8.1 21.6 20.6 17.3 24.5 17.2 15.8 25.3 23.9 24.7 23.1 31.3 37.5 31.8 13.1 8.3 6.3 9.1 16.0 17.4 15.2 6.9 24.7 12.6 9.8 8.0 28.6 5.5 12.3 10.5 7.8 12.1 9.1 11.8 7.3 9.3 9.0 9.1 4.4 4.9 13.6 11.4 7.0 13.5 14.9 7.2 22.8 16.7 11.0 10.5 8.0 2.8 10.2 3.5 8.7 2.9 7.9 27.4 6.5 7.0 5.5 4.0 8.6 6.7 6.8 10.1 5.7 17.2 10.0 10.5 11.5 36.8 7.8 4.9 4.9 5.1 7.5 3.9 3.3 1.9 10.7 17.7 9.6 20.8 23.1 17.3 27.3 22.1 37.5 19.6 23.4 27.3 18.6 25.3 32.7 32.2 24.7 31.3 21.2 23.9 15.1 31.8 9.1 10.4 8.2 13.9 11.0 7.6 8.2 10.1 9.8 8.1 6.0 18.4 15.9 23.5 24.2 26.2 19.7 17.8 25.4 14.8 22.7 25.5 99.9 19.9 38.6 19.2 23.6 34.4 0.0 30.4 70.7 31.5 23.0 21.9 25.0 43.6 30.2 8.1 12.9 33.8 16.7 32.5 40.2 28.7 16.2 26.9 44.7 25.3 35.1 47.7 18.3 21.9 32.3 24.0 59.0 37.8 29.0 110.8 50.4 33.9 23.3 UBE2J1 "CGI-76, HSPC153, NCUBE1, UBC6" ENSG00000198833 "Ubiquitin conjugating enzyme E2 J1" Q9Y385 6 89326625-89352848 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 501.0;Late spermatids: 1092.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 63.8;Karpas-707: 55.2;U-266/70: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003509, CAB073419" Enhanced NA NA "CAB073419: , HPA003509: AB_1858531" "unprognostic (1.82e-1)" "unprognostic (3.20e-2)" "unprognostic (1.55e-3)" "prognostic favorable (2.87e-4)" "unprognostic (3.41e-1)" "unprognostic (7.93e-3)" "prognostic unfavorable (6.90e-5)" "unprognostic (1.19e-1)" "unprognostic (9.36e-2)" "prognostic favorable (7.43e-4)" "unprognostic (1.74e-1)" "unprognostic (9.33e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (5.11e-2)" "unprognostic (2.83e-1)" "unprognostic (3.87e-2)" "unprognostic (9.38e-2)" 18.7 17.3 14.6 47.1 15.4 52.7 28.2 19.1 13.6 18.8 25.9 11.3 24.4 28.0 19.5 18.4 19.2 18.0 19.9 17.1 14.4 14.7 18.7 33.5 20.4 52.0 17.0 9.5 17.2 46.1 11.5 13.6 27.5 13.0 22.9 26.3 10.7 42.1 33.2 12.5 11.3 36.3 17.9 18.9 45.8 24.4 17.7 14.4 42.5 17.6 16.4 47.7 21.7 21.4 20.7 23.7 15.9 17.8 6.4 6.4 6.1 8.3 2.9 8.1 10.3 8.5 11.1 0.0 13.3 11.8 8.2 9.1 4.7 5.2 63.8 7.4 13.7 6.9 3.4 5.3 7.7 13.5 8.9 8.2 11.6 3.8 7.7 22.6 14.5 7.6 8.4 7.7 6.9 11.8 11.1 18.4 7.6 9.3 55.2 9.6 5.1 6.0 11.2 2.8 5.9 4.2 23.9 10.5 30.5 10.3 5.9 4.1 8.3 5.6 12.4 12.3 12.3 4.9 32.3 12.3 4.6 4.4 8.1 10.2 62.1 30.8 17.5 9.1 10.5 7.6 10.3 6.6 12.3 3.4 11.1 4.0 20.7 4.6 4.2 6.5 13.4 4.3 3.9 15.9 6.4 17.8 23.7 6.4 6.1 14.6 15.4 19.1 13.6 14.4 14.7 17.0 9.5 13.0 14.4 14.9 33.4 95.3 52.5 22.0 31.9 8.1 30.6 22.7 18.2 19.2 27.5 69.3 43.1 55.4 501.0 59.9 55.1 0.0 88.1 72.0 50.7 96.3 24.3 37.6 70.2 22.3 74.2 98.8 102.2 1092.2 50.6 55.8 69.2 46.9 54.1 14.7 86.7 70.2 44.9 36.1 13.7 32.3 55.6 20.7 19.6 30.4 108.2 36.2 57.4 100.2 UBE2J2 "NCUBE2, Ubc6p" ENSG00000160087 "Ubiquitin conjugating enzyme E2 J2" Q8N2K1 1 1253909-1273885 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway, Unfolded protein response" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 350.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.39e-2)" "unprognostic (1.17e-1)" "unprognostic (2.25e-1)" "unprognostic (3.04e-2)" "unprognostic (1.88e-2)" "unprognostic (4.46e-2)" "unprognostic (1.67e-3)" "unprognostic (1.60e-1)" "unprognostic (1.60e-2)" "unprognostic (9.57e-2)" "unprognostic (1.28e-3)" "unprognostic (1.32e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (2.09e-2)" "unprognostic (6.19e-2)" "unprognostic (1.87e-1)" "unprognostic (3.46e-2)" 24.4 22.2 17.5 21.6 17.1 19.4 33.0 23.8 24.9 17.8 22.0 17.9 19.9 22.0 22.9 21.4 25.2 21.8 20.7 21.2 17.5 17.1 21.6 27.3 17.4 27.4 15.9 15.4 19.4 36.3 14.4 22.8 22.6 15.9 16.9 16.2 18.7 24.2 20.2 29.8 23.2 23.6 19.3 13.1 25.2 22.2 68.3 12.8 26.1 22.8 21.7 23.8 18.3 19.3 24.5 22.3 39.6 23.0 22.0 25.3 17.7 25.7 10.7 15.3 14.6 12.4 12.8 11.9 19.9 15.8 27.2 19.9 19.0 18.8 13.9 21.3 18.4 15.0 18.8 15.5 19.8 21.7 23.5 27.8 20.9 21.0 17.1 24.1 19.1 20.1 12.0 11.1 21.3 15.9 14.9 19.1 19.0 28.8 13.8 15.7 12.8 27.7 21.5 16.5 17.0 26.9 25.8 14.2 22.9 14.1 8.7 56.4 27.9 13.7 29.6 31.4 14.5 15.2 21.8 15.6 16.5 15.8 19.1 20.3 30.4 29.5 38.8 21.2 30.4 13.0 38.2 23.0 39.6 22.0 22.2 20.1 24.5 23.4 22.8 22.3 21.7 21.2 20.9 32.6 22.0 21.3 20.8 25.3 17.7 17.5 17.1 23.8 24.9 17.5 17.1 15.9 15.4 15.9 12.8 8.9 15.9 25.3 40.7 37.9 27.4 16.7 33.1 6.7 21.6 27.9 7.9 59.9 48.0 58.6 187.2 33.6 39.3 0.0 81.4 63.5 40.5 45.1 16.1 24.1 46.5 22.3 16.8 23.9 23.0 350.9 34.8 33.1 38.8 45.1 36.5 29.9 79.3 31.6 35.3 57.4 25.4 32.3 40.3 121.4 83.7 38.1 73.0 44.7 38.2 51.2 UBIAD1 "SCCD, TERE1" ENSG00000120942 "UbiA prenyltransferase domain containing 1" Q9Y5Z9 1 11273206-11296049 "Disease related genes, Predicted membrane proteins" "Menaquinone biosynthesis, Ubiquinone biosynthesis" "Prenyltransferase, Transferase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044862 Approved Vesicles NA NA Vesicles "HPA044862: AB_2679117" "unprognostic (1.79e-2)" "unprognostic (2.26e-1)" "unprognostic (5.06e-2)" "unprognostic (1.74e-1)" "unprognostic (7.95e-3)" "unprognostic (7.55e-2)" "unprognostic (1.16e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-1)" "unprognostic (2.55e-1)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "prognostic favorable (6.80e-5)" "unprognostic (3.00e-1)" "unprognostic (3.89e-1)" "unprognostic (2.03e-2)" "unprognostic (1.25e-1)" 12.1 11.8 9.2 10.2 11.8 9.2 12.0 10.2 13.1 9.6 9.8 17.6 5.0 7.8 13.0 9.7 8.8 14.4 11.9 11.6 9.0 8.3 9.9 38.1 8.7 18.6 14.1 6.1 17.5 23.4 14.6 10.0 9.1 11.0 10.6 10.0 11.9 11.2 10.2 24.8 11.3 9.5 11.5 15.5 12.9 10.7 17.7 13.6 17.9 12.2 9.6 17.5 11.7 8.7 22.0 10.7 9.5 8.7 9.6 27.0 11.4 8.5 8.5 6.8 13.0 5.0 4.7 9.1 9.4 7.7 10.2 9.3 9.8 7.9 16.9 9.7 6.7 9.6 11.8 17.1 11.3 12.5 11.8 14.7 11.3 9.1 13.0 9.2 17.2 9.9 7.1 15.4 13.7 16.4 5.4 7.4 15.7 13.4 14.1 6.8 8.7 11.1 8.7 8.1 16.1 12.6 10.6 15.1 20.5 7.8 5.7 8.4 9.0 10.0 10.0 12.7 2.9 7.4 9.1 6.1 9.0 9.7 9.3 12.2 11.5 15.9 31.5 5.7 22.9 11.1 4.8 6.5 9.5 13.1 8.7 14.6 22.0 17.8 13.3 8.6 20.7 27.0 18.3 2.0 9.6 7.3 10.7 16.6 11.4 9.2 11.8 10.2 13.1 9.0 8.3 14.1 6.1 11.0 13.6 8.9 13.4 15.8 11.6 13.7 11.1 8.4 7.6 10.7 23.9 5.2 7.9 8.9 10.0 8.9 26.6 8.4 5.1 23.3 11.2 12.1 10.3 9.4 6.9 18.6 7.9 12.7 4.7 4.3 6.9 17.6 11.5 11.3 5.0 5.4 9.7 9.8 9.3 3.5 10.3 7.9 13.9 0.0 10.3 16.1 13.8 11.0 15.8 12.1 13.1 8.9 UBXN8 "D8S2298E, REP8, UBXD6" ENSG00000104691 "UBX domain protein 8" O00124 8 30732247-30767006 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 30.6" "Group enriched" "Detected in many" 4 "Early spermatids: 162.1;Hepatocytes: 56.2;Late spermatids: 132.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017725, HPA077538" Enhanced Supported "Nucleoplasm,Nucleoli,Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "Nucleoplasm, Nucleoli" "HPA017725: AB_1847462, HPA077538: AB_2686844" "unprognostic (3.00e-2)" "unprognostic (2.30e-1)" "prognostic favorable (6.13e-4)" "unprognostic (7.71e-2)" "unprognostic (2.24e-1)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (1.84e-2)" "unprognostic (1.90e-1)" "unprognostic (5.13e-2)" "unprognostic (1.58e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.25e-5)" "unprognostic (2.49e-1)" "unprognostic (1.96e-1)" "unprognostic (1.51e-1)" "unprognostic (6.88e-2)" 5.0 5.3 3.9 1.4 4.8 1.4 4.3 1.5 9.2 3.0 3.5 4.0 6.7 3.1 3.8 14.3 4.1 3.6 3.8 2.8 5.7 8.2 21.5 2.1 3.9 7.6 4.0 30.6 10.3 6.2 3.5 6.2 6.2 4.8 4.7 1.6 1.8 6.1 1.7 4.1 2.9 2.9 7.1 5.7 3.3 11.5 6.1 0.9 9.1 2.8 2.3 2.9 3.7 6.0 8.2 1.0 6.1 3.3 8.4 3.4 7.6 7.7 5.6 5.8 9.1 12.2 6.3 13.7 8.0 7.5 9.2 12.2 2.8 12.2 11.3 11.1 12.4 6.8 1.1 7.6 11.6 6.4 12.5 34.3 6.3 14.9 13.7 7.8 19.4 9.6 7.9 12.0 5.9 6.4 6.5 5.6 33.5 9.2 16.5 7.2 7.9 6.0 10.8 22.8 5.8 9.5 5.4 8.5 12.8 10.0 3.2 8.1 3.8 11.3 24.7 7.0 8.4 13.6 8.3 8.5 3.7 3.8 12.7 4.0 12.5 9.2 7.6 12.6 12.1 0.0 6.0 0.7 8.4 6.1 7.3 6.0 4.5 8.0 6.7 2.9 4.4 7.4 1.0 3.3 3.0 8.2 4.3 3.4 3.0 8.0 3.0 4.1 0.0 1.9 3.2 15.3 1.4 5.7 14.0 19.6 20.6 6.6 7.1 162.1 6.2 6.3 0.0 4.5 16.0 9.4 4.1 13.9 56.2 19.0 11.1 8.2 27.0 14.2 132.0 13.3 6.9 0.0 10.0 6.4 6.6 3.9 3.5 9.2 22.0 1.8 6.5 3.9 14.1 20.4 0.0 12.7 7.2 10.0 2.4 UCN2 "SRP, UCN-II, UCNI, URP" ENSG00000145040 "Urocortin 2" Q96RP3 3 48561727-48563773 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 18.6;vagina: 6.3" "Cell type enriched" "Detected in single" 5 "Basal keratinocytes: 2.6" "Cancer enhanced" "Detected in many" "melanoma: 18.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 15.7;hTEC/SVTERT24-B: 12.4;SiHa: 10.8;U-251 MG: 11.4;WM-115: 31.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA066841 Uncertain Approved Vesicles "Secreted to blood" NA NA 98600 Vesicles "HPA066841: AB_2685735" "unprognostic (7.98e-2)" "unprognostic (1.35e-1)" "unprognostic (4.80e-2)" "unprognostic (1.96e-2)" "unprognostic (2.39e-2)" "unprognostic (4.26e-2)" "unprognostic (1.92e-3)" "unprognostic (2.02e-3)" "unprognostic (1.62e-1)" "unprognostic (2.93e-3)" "unprognostic (2.52e-3)" "unprognostic (1.09e-1)" "unprognostic (3.34e-14)" "unprognostic (4.39e-2)" "unprognostic (2.75e-1)" "unprognostic (1.36e-1)" "unprognostic (2.88e-2)" 1.7 0.0 0.3 0.5 0.9 0.1 0.6 0.3 0.3 2.0 0.3 0.3 0.3 0.1 1.8 1.1 3.7 0.1 0.6 0.3 0.3 0.5 0.9 0.3 0.3 0.3 1.6 0.3 0.3 0.3 0.0 0.3 0.3 0.9 3.3 0.1 0.3 1.6 0.7 0.3 18.6 0.3 0.4 0.3 0.5 0.1 1.1 0.3 0.3 0.3 0.3 0.3 0.3 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 1.0 0.6 1.5 5.4 6.8 3.4 2.5 0.0 0.0 0.0 0.2 1.3 4.1 1.0 0.0 6.5 1.8 5.0 0.1 0.1 8.9 0.8 1.1 0.0 0.3 0.7 15.7 12.4 2.5 2.4 0.0 0.1 0.0 0.1 0.5 0.0 0.0 1.0 0.4 0.0 0.1 0.1 0.1 0.0 1.0 0.0 0.0 0.0 10.8 0.0 8.1 1.0 0.1 0.2 0.0 1.5 1.0 0.1 11.4 0.0 0.1 0.0 5.1 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.3 0.3 0.3 0.5 1.6 0.3 0.9 0.3 0.0 0.0 0.0 0.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGCG GCS ENSG00000148154 "UDP-glucose ceramide glucosyltransferase" Q16739 9 111896766-111935369 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Urothelial cells: 446.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 19 "plasmacytoid DC: 39.7" "Lineage enriched" "Detected in many" 19 "dendritic cells: 39.7" "Cell line enhanced" "Detected in all" "LHCN-M2: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024124 Approved NA NA "HPA024124: AB_1858595" "unprognostic (1.22e-2)" "prognostic favorable (6.62e-4)" "unprognostic (5.39e-2)" "prognostic favorable (4.44e-5)" "unprognostic (1.53e-2)" "unprognostic (9.70e-2)" "unprognostic (3.20e-2)" "unprognostic (2.04e-1)" "unprognostic (3.40e-1)" "unprognostic (1.31e-1)" "unprognostic (1.95e-2)" "unprognostic (3.22e-1)" "unprognostic (9.84e-3)" "unprognostic (2.24e-2)" "unprognostic (4.92e-2)" "unprognostic (1.99e-1)" "unprognostic (3.77e-2)" 33.7 37.7 5.9 21.4 7.8 55.2 20.5 9.5 11.2 14.6 19.6 5.0 3.3 13.3 10.6 8.6 34.0 11.1 24.5 17.5 8.6 9.0 23.8 18.4 28.1 35.4 7.1 5.8 15.9 11.4 3.5 11.9 15.3 6.8 12.4 10.5 11.9 10.8 5.4 14.0 21.7 25.5 12.4 12.9 33.1 26.1 11.7 6.2 17.9 8.5 16.9 27.7 34.2 25.9 2.0 39.7 0.4 0.3 0.5 1.2 0.5 23.1 2.4 4.0 2.7 8.8 10.6 2.1 14.5 15.3 17.0 23.1 4.9 17.8 5.5 11.5 9.6 37.3 11.9 4.7 6.3 18.3 2.2 2.7 2.2 3.7 2.4 6.3 2.4 3.6 10.5 4.9 16.2 23.4 39.5 5.2 2.7 12.1 10.7 50.2 3.9 2.6 2.7 4.6 7.8 2.6 3.0 28.9 1.7 39.1 8.8 1.9 3.1 6.4 5.4 15.9 25.1 29.2 2.5 24.4 7.8 4.0 21.9 10.3 2.0 7.3 2.5 9.7 1.5 10.6 0.0 0.1 0.0 0.4 0.2 0.7 1.6 0.8 0.6 0.6 2.0 0.7 0.7 0.4 0.5 0.3 39.7 1.2 0.5 5.9 7.8 9.5 11.2 8.6 9.0 7.1 5.8 6.8 6.2 38.7 48.5 29.9 123.9 67.2 26.0 9.2 30.6 115.1 113.7 27.9 58.9 5.7 14.9 98.3 14.5 72.6 52.6 0.0 43.7 10.2 46.0 156.5 10.4 15.5 19.6 17.5 17.7 92.7 30.2 3.6 45.5 30.8 55.6 69.5 41.5 7.8 67.4 21.0 36.0 56.0 14.2 12.9 60.8 1.6 1.5 106.9 2.9 26.6 12.8 446.9 UGGT1 "HUGT1, UGCGL1" ENSG00000136731 "UDP-glucose glycoprotein glucosyltransferase 1" Q9NYU2 2 128091200-128195677 "Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012761, HPA015127" Enhanced Uncertain Cytosol NA NA 3800000 Cytosol "HPA012761: AB_1858597, HPA015127: AB_1858596" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (6.14e-2)" "unprognostic (1.87e-1)" "unprognostic (4.63e-2)" "unprognostic (6.45e-2)" "unprognostic (7.03e-3)" "unprognostic (3.13e-2)" "unprognostic (3.02e-2)" "unprognostic (1.05e-1)" "unprognostic (4.09e-3)" "unprognostic (7.05e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (3.86e-1)" "unprognostic (1.50e-1)" "unprognostic (2.23e-2)" "unprognostic (8.38e-3)" 13.7 14.7 7.6 16.4 10.2 23.8 11.3 10.7 10.8 12.7 15.2 10.0 21.1 11.4 12.3 26.3 13.1 10.6 11.3 13.0 7.7 7.9 13.7 33.4 13.9 14.6 11.0 5.7 10.4 44.1 13.4 11.2 22.1 9.1 11.7 13.5 9.7 15.5 20.5 19.3 11.1 17.4 8.9 9.0 16.1 13.0 9.9 9.5 24.3 13.8 6.4 15.7 11.4 11.0 6.3 7.4 8.8 6.2 4.7 5.9 2.8 16.5 5.8 11.1 23.8 14.6 11.7 16.9 19.1 8.4 6.4 5.8 12.8 12.3 23.5 7.7 14.0 5.8 12.3 8.4 8.3 13.1 14.9 4.0 20.6 7.6 39.1 14.5 27.5 13.0 8.5 6.6 12.9 11.8 12.8 14.9 9.8 13.2 12.8 13.5 11.6 11.1 15.8 19.6 11.7 6.0 9.1 10.6 10.0 11.8 12.3 5.8 8.8 13.2 18.1 11.2 11.9 7.1 19.5 20.5 17.7 12.1 10.1 13.6 13.4 18.6 10.8 15.0 15.1 16.3 7.1 6.2 5.4 5.9 6.0 5.8 4.0 4.8 5.3 4.5 6.3 4.1 5.9 8.8 4.7 5.7 7.4 3.8 2.8 7.6 10.2 10.7 10.8 7.7 7.9 11.0 5.7 9.1 9.5 32.8 24.8 6.7 4.9 7.2 20.0 14.1 17.8 6.7 25.0 3.5 21.6 9.5 1.7 12.2 7.0 11.3 19.4 0.0 16.8 15.8 10.8 11.7 10.5 33.0 14.7 19.1 21.9 19.6 23.0 1.8 13.8 15.5 13.5 12.6 20.8 9.7 18.4 10.5 12.7 8.7 18.9 6.5 11.1 8.9 8.1 9.4 9.0 13.8 17.5 9.8 UGT1A1 "GNT1, UGT1, UGT1A" ENSG00000241635 "UDP glucuronosyltransferase family 1 member A1" P22309 2 233760248-233773299 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "intestine: 48.6;liver: 120.3" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 83.9" "Cancer enriched" "Detected in some" 19 "liver cancer: 16.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 8.1;OE19: 35.4;RT4: 19.3" "Not detected" "Not detected" NA NA "unprognostic (7.28e-2)" "unprognostic (2.49e-2)" "unprognostic (3.60e-1)" "unprognostic (5.69e-2)" "unprognostic (4.17e-3)" "unprognostic (6.31e-3)" "unprognostic (1.94e-5)" "unprognostic (2.78e-3)" "unprognostic (2.99e-4)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.2 35.6 0.1 0.1 48.6 0.1 0.1 4.3 0.0 0.3 0.1 0.1 0.0 4.5 120.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.4 0.1 0.7 0.1 0.1 0.9 48.2 0.5 0.1 0.1 1.3 0.2 0.1 0.1 0.2 0.1 0.1 5.2 0.8 1.0 0.4 4.7 0.4 1.1 0.5 0.2 0.2 0.6 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 3.1 0.2 0.1 1.4 0.0 0.0 8.1 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.8 0.0 0.3 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.4 0.0 0.2 0.3 35.4 3.6 0.0 0.1 0.3 0.0 19.3 0.1 0.2 1.4 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.4 0.2 0.1 2.1 0.4 0.4 0.4 0.3 0.3 0.4 0.4 0.3 0.1 1.0 0.4 0.5 4.7 1.1 0.4 0.4 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.7 6.8 1.8 0.0 0.0 0.0 0.2 2.8 0.0 3.5 0.0 0.0 0.0 0.0 0.9 0.0 83.9 0.0 0.0 0.0 1.3 3.3 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.5 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 6.2 UGT1A10 UGT1J ENSG00000242515 "UDP glucuronosyltransferase family 1 member A10" Q9HAW8 2 233636454-233773305 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 9.4;gallbladder: 8.4;intestine: 31.1;stomach 1: 12.4" "Cell type enhanced" "Detected in some" 22 "Club cells: 1.2;Enterocytes: 2.1" "Cancer enhanced" "Detected in many" "urothelial cancer: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 142 "RT4: 109.0" "Intracellular and membrane" NA NA "unprognostic (9.33e-2)" "unprognostic (7.64e-2)" "unprognostic (2.45e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (4.55e-4)" "unprognostic (1.49e-10)" "unprognostic (2.90e-1)" "unprognostic (1.50e-1)" "unprognostic (3.59e-3)" 0.3 0.0 0.3 2.6 0.3 0.0 0.3 0.3 0.3 0.3 19.2 0.3 0.3 31.1 0.3 0.3 9.4 0.1 8.4 0.3 0.3 0.0 0.3 1.4 0.6 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 14.3 0.3 0.9 0.3 0.3 0.3 20.2 0.5 0.3 0.3 12.4 1.0 0.3 0.3 0.3 0.3 1.4 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 UGT1A3 UGT1C ENSG00000243135 "UDP glucuronosyltransferase family 1 member A3" P35503 2 233729108-233773299 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "liver: 40.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "liver cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HaCaT: 16.7" NA NA "unprognostic (5.15e-2)" "unprognostic (9.93e-2)" "unprognostic (2.97e-1)" "unprognostic (4.59e-2)" "unprognostic (1.04e-4)" "unprognostic (8.22e-2)" "unprognostic (2.08e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A4 "HUG-BR2, UGT1D" ENSG00000244474 "UDP glucuronosyltransferase family 1 member A4" P22310 2 233718778-233773299 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "liver: 99.4" "Group enriched" "Detected in some" 8 "Club cells: 4.5;Hepatocytes: 10.5" "Cancer enriched" "Detected in single" 487 "liver cancer: 24.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.6;HL-60: 1.4;RH-30: 2.2" NA NA "unprognostic (9.89e-3)" "unprognostic (6.77e-5)" "unprognostic (2.59e-1)" "unprognostic (3.50e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 99.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A5 UGT1E ENSG00000240224 "UDP glucuronosyltransferase family 1 member A5" P35504 2 233712992-233773299 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 3.7;intestine: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.7;RT4: 1.6" NA NA "unprognostic (2.18e-3)" "unprognostic (1.36e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 11.2 0.0 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 9.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A6 "GNT1, HLUGP, UGT1F" ENSG00000167165 "UDP glucuronosyltransferase family 1 member A6" P19224 2 233691607-233773300 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 111.7;liver: 50.1;urinary bladder: 32.7" "Group enriched" "Detected in some" 5 "Early spermatids: 37.7;Late spermatids: 19.3" "Cancer enhanced" "Detected in many" "renal cancer: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 40.4;OE19: 160.5" "CAB009819, HPA054065" Enhanced NA NA "CAB009819: AB_2241481, HPA054065: AB_2682367" "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (5.43e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.79e-1)" "unprognostic (6.18e-2)" "unprognostic (2.09e-3)" "unprognostic (9.97e-2)" "unprognostic (2.16e-2)" "unprognostic (3.52e-1)" "unprognostic (7.50e-2)" "unprognostic (2.01e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.8 0.5 0.2 0.5 2.0 0.3 0.9 13.0 0.0 1.1 0.1 0.1 0.0 111.7 50.1 1.9 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.3 0.1 3.3 0.4 0.1 1.3 1.2 0.1 3.8 1.2 2.3 0.1 0.1 8.1 0.2 0.1 0.5 0.2 5.6 8.7 32.7 2.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.2 0.0 11.3 0.0 0.1 40.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 160.5 0.0 0.0 0.0 0.0 0.4 20.4 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.8 0.0 0.3 0.0 0.0 4.5 1.8 0.0 0.0 0.0 0.0 37.7 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.6 0.0 19.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.0 2.1 UGT1A7 UGT1G ENSG00000244122 "UDP glucuronosyltransferase family 1 member A7" Q9HAW7 2 233681938-233773299 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "esophagus: 54.4;lymphoid tissue: 40.2;tongue: 23.6" "Cell type enriched" "Detected in some" 5 "Urothelial cells: 8.4" "Group enriched" "Detected in some" 10 "cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 14 "SiHa: 50.6" NA NA "unprognostic (6.27e-2)" "unprognostic (1.02e-1)" "unprognostic (7.76e-2)" "unprognostic (1.03e-2)" "unprognostic (1.09e-1)" "unprognostic (7.92e-2)" "unprognostic (1.71e-7)" "unprognostic (2.14e-1)" "unprognostic (4.57e-2)" 0.1 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.1 0.0 0.0 0.1 0.0 0.0 54.4 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 40.2 0.2 2.8 0.2 0.1 1.6 0.2 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 50.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.2 0.6 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 8.4 UGT1A8 UGT1H ENSG00000242366 "UDP glucuronosyltransferase family 1 member A8" Q9HAW9 2 233617645-233773310 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 13.0;urinary bladder: 15.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 58 "RT4: 52.5" NA NA "unprognostic (1.27e-2)" "unprognostic (1.35e-1)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (4.78e-1)" "unprognostic (9.71e-12)" "unprognostic (9.26e-2)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 7.3 0.0 0.0 0.0 0.0 0.0 3.3 5.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 3.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 UGT1A9 "HLUGP4, LUGP4, UGT1AI" ENSG00000241119 "UDP glucuronosyltransferase family 1 member A9" O60656 2 233671853-233773300 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 169.8" "Cell type enhanced" "Detected in some" 29 "Club cells: 1.2;Hepatocytes: 5.9;Proximal tubular cells: 3.3" "Group enriched" "Detected in some" 157 "liver cancer: 16.1;renal cancer: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "A549: 4.9;RT4: 4.0" NA NA "unprognostic (2.46e-2)" "unprognostic (3.56e-1)" "prognostic unfavorable (5.04e-5)" "unprognostic (4.26e-2)" "unprognostic (1.60e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.8 39.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2A1 ENSG00000173610 "UDP glucuronosyltransferase family 2 member A1 complex locus" Q9Y4X1 4 69588417-69653249 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "kidney: 10.6;liver: 14.5;pituitary gland: 21.2" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 32.3" "Cancer enhanced" "Detected in some" "liver cancer: 0.7" "Region enriched" "Detected in single" 17 "pons and medulla: 1.7" "Cell type enhanced" "Detected in some" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 3.2;HUVEC TERT2: 1.9;U-266/70: 3.6" "HPA017261, HPA045108" Uncertain NA NA "HPA017261: AB_10963582, HPA045108: AB_2679218" "unprognostic (3.93e-3)" "unprognostic (5.62e-1)" "unprognostic (1.28e-4)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 14.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 1.7 0.0 0.0 1.5 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 2.0 0.5 0.9 0.4 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.2 1.7 0.5 0.4 0.2 0.2 0.1 0.1 0.4 0.2 0.1 0.3 0.2 0.1 2.0 0.9 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2A2 ENSG00000271271 "UDP glucuronosyltransferase family 2 member A2" Q9Y4X1 4 69589309-69639642 "Enzymes, Predicted membrane proteins" "Olfaction, Sensory transduction" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "cervix, uterine: 1.6;kidney: 2.6;liver: 5.4;pituitary gland: 3.8;skin 1: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 2.6" "Not detected" "Not detected" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 5.4 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2A3 FLJ21934 ENSG00000135220 "UDP glucuronosyltransferase family 2 member A3" Q6UWM9 4 68928463-68951791 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 150.5;kidney: 43.2" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 94.3;Enterocytes: 115.5;Hepatocytes: 49.3;Paneth cells: 52.6;Proximal tubular cells: 125.8;Undifferentiated cells: 72.7" "Cancer enriched" "Detected in many" 5 "renal cancer: 46.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 53 "granulocytes: 5.3" "Cell line enriched" "Detected in some" 9 "Hep G2: 21.0" HPA045108 Supported NA NA "HPA045108: AB_2679218" "prognostic favorable (3.31e-4)" "unprognostic (3.97e-3)" "unprognostic (8.87e-3)" "prognostic favorable (6.07e-7)" "unprognostic (2.10e-2)" 0.1 0.1 0.1 4.3 0.1 0.0 0.7 0.1 0.1 0.1 63.8 0.1 0.1 31.9 0.1 1.7 0.1 0.1 14.6 0.3 0.1 0.1 43.2 9.6 0.1 0.1 0.1 0.1 0.1 12.0 0.0 0.1 0.1 0.1 0.1 8.6 0.1 0.1 0.1 0.1 0.1 150.5 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 94.3 0.0 0.0 3.5 0.0 0.0 10.0 21.3 0.0 0.0 115.5 0.0 2.3 0.0 0.0 0.0 0.0 49.3 0.0 0.0 11.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 28.2 0.0 6.0 52.6 0.0 125.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.7 0.0 UGT2B10 ENSG00000109181 "UDP glucuronosyltransferase family 2 member B10" P36537 4 68815993-68831196 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 277 "liver: 120.4" "Cell type enriched" "Detected in some" 15 "Hepatocytes: 221.7" "Cancer enriched" "Detected in single" 296 "liver cancer: 93.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 39 "Hep G2: 16.1" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (3.50e-3)" "unprognostic (1.92e-3)" "unprognostic (4.17e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 120.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 221.7 0.0 0.0 0.0 1.3 4.7 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 UGT2B11 ENSG00000213759 "UDP glucuronosyltransferase family 2 member B11" O75310 4 69199951-69214731 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "breast: 77.4" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 12.7" "Group enriched" "Detected in some" 17 "breast cancer: 17.4;liver cancer: 13.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 62 "basophil: 6.8;eosinophil: 5.6" "Lineage enriched" "Detected in single" 68 "granulocytes: 6.8" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;HL-60: 3.1;NB-4: 2.5;RPTEC TERT1: 3.7;U-2197: 1.5" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (1.12e-1)" "unprognostic (1.18e-3)" "unprognostic (1.49e-1)" "unprognostic (6.53e-2)" "unprognostic (2.26e-2)" "unprognostic (1.65e-1)" "unprognostic (7.84e-3)" "unprognostic (5.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.51e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 77.4 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 3.3 0.1 0.1 0.0 1.2 7.3 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 7.0 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.1 0.0 3.7 0.2 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.6 0.0 0.0 6.8 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B15 UGT2B8 ENSG00000196620 "UDP glucuronosyltransferase family 2 member B15" P54855 4 68646630-68670628 "Enzymes, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "gallbladder: 22.4;intestine: 50.7;liver: 65.4" "Group enriched" "Detected in some" 6 "Cholangiocytes: 168.2;Hepatocytes: 134.4" "Cancer enriched" "Detected in many" 10 "liver cancer: 120.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 2.7" "Lineage enhanced" "Detected in single" "B-cells: 2.7" "Cell line enhanced" "Detected in some" "A549: 3.2;HL-60: 2.2;RH-30: 1.2;RPMI-8226: 1.1" HPA045108 Approved NA NA "HPA045108: AB_2679218" "unprognostic (1.40e-1)" "unprognostic (2.25e-1)" "unprognostic (2.22e-2)" "unprognostic (3.86e-1)" "unprognostic (1.94e-1)" "prognostic favorable (9.82e-4)" "unprognostic (6.73e-2)" "unprognostic (3.49e-2)" "unprognostic (7.84e-2)" "unprognostic (5.81e-3)" "unprognostic (2.39e-2)" "unprognostic (5.38e-2)" "prognostic favorable (4.50e-4)" 0.1 0.0 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 48.0 0.1 0.1 5.4 0.1 0.1 0.2 0.0 22.4 0.1 0.1 0.0 0.1 65.4 0.1 0.1 0.1 0.1 0.1 5.3 0.0 0.1 0.1 0.1 0.2 1.6 0.1 0.1 0.1 0.1 0.0 50.7 0.1 0.1 0.1 5.7 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 2.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 1.2 1.1 0.0 0.2 0.1 0.6 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.8 0.2 0.4 0.1 0.5 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 168.2 0.0 0.0 0.0 0.0 0.0 0.0 14.9 1.9 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 134.4 0.0 0.0 0.0 1.8 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.5 UGT2B17 ENSG00000197888 "UDP glucuronosyltransferase family 2 member B17" O75795 4 68537184-68568527 "Enzymes, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 68.1;liver: 21.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 2.2;Cholangiocytes: 2.5;Ciliated cells: 1.4;Club cells: 1.2;Hepatocytes: 1.3;Intestinal endocrine cells: 1.7;Melanocytes: 3.3" "Group enriched" "Detected in many" 7 "colorectal cancer: 16.3;liver cancer: 10.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "memory B-cell: 3.3;naive B-cell: 11.9" "Lineage enriched" "Detected in single" 59 "B-cells: 11.9" "Group enriched" "Detected in some" 7 "BEWO: 3.1;NB-4: 3.6;RPMI-8226: 5.2;SH-SY5Y: 2.3;U-2197: 2.1" HPA045108 Supported NA NA "HPA045108: AB_2679218" "unprognostic (1.66e-1)" "unprognostic (2.97e-2)" "unprognostic (2.96e-2)" "unprognostic (2.41e-1)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.36e-1)" "unprognostic (8.44e-3)" "unprognostic (9.67e-2)" "unprognostic (4.80e-3)" "unprognostic (8.52e-2)" "unprognostic (2.45e-1)" "unprognostic (6.44e-2)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" 0.4 0.1 0.4 4.7 0.4 0.0 0.4 0.4 0.4 0.4 55.6 0.4 0.4 54.1 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.1 0.4 21.6 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 20.7 0.4 0.4 0.4 0.4 0.1 68.1 1.1 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 11.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.0 0.0 0.0 5.2 0.2 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 UGT2B28 ENSG00000135226 "UDP glucuronosyltransferase family 2 member B28" Q9BY64 4 69280499-69295050 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "breast: 71.7;salivary gland: 25.6" "Cell type enriched" "Detected in single" 178 "Cholangiocytes: 17.8" "Cancer enriched" "Detected in single" 8 "breast cancer: 1.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 2.5;eosinophil: 4.0" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.0" "Group enriched" "Detected in some" 10 "Daudi: 7.1;NB-4: 6.5" HPA045108 Uncertain "Intracellular and membrane" NA NA "HPA045108: AB_2679218" "unprognostic (1.81e-1)" "unprognostic (1.40e-1)" "unprognostic (7.20e-3)" "unprognostic (1.51e-2)" "unprognostic (4.37e-5)" "unprognostic (9.79e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 71.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 25.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.2 4.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B4 UGT2B11 ENSG00000156096 "UDP glucuronosyltransferase family 2 member B4" P06133 4 69480165-69526014 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 105 "liver: 175.1" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 831.9" "Cancer enriched" "Detected in some" 96 "liver cancer: 351.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RH-30: 10.4" "CAB033260, HPA045108" Enhanced "Intracellular and membrane" NA NA "CAB033260: AB_2241496, HPA045108: AB_2679218" "unprognostic (7.46e-2)" "unprognostic (1.50e-1)" "unprognostic (9.37e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-2)" "unprognostic (1.47e-1)" "unprognostic (9.43e-3)" "unprognostic (3.52e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.1 175.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 10.4 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 34.2 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.0 0.0 0.0 0.0 831.9 0.1 0.0 0.0 14.7 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B7 UGT2B9 ENSG00000171234 "UDP glucuronosyltransferase family 2 member B7" P16662 4 69051363-69112987 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 125.4;liver: 156.0" "Group enriched" "Detected in many" 6 "Hepatocytes: 539.4;Proximal tubular cells: 775.7" "Group enriched" "Detected in many" 7 "liver cancer: 116.4;renal cancer: 101.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 21.0;RPTEC TERT1: 83.6" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "prognostic favorable (7.65e-5)" "unprognostic (1.11e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-2)" "unprognostic (5.41e-3)" "unprognostic (1.68e-1)" "unprognostic (1.74e-2)" "unprognostic (1.17e-3)" "unprognostic (1.98e-1)" "prognostic favorable (3.79e-4)" "unprognostic (1.08e-2)" "unprognostic (2.55e-1)" "unprognostic (6.23e-3)" "prognostic favorable (5.38e-4)" 0.1 0.1 0.1 0.2 0.1 0.0 0.4 0.1 0.1 3.1 7.9 0.1 2.5 6.4 0.6 4.7 0.1 4.7 1.5 0.1 0.1 0.1 125.4 156.0 0.2 0.1 0.1 0.1 0.6 14.7 0.0 0.1 0.2 0.1 0.3 0.4 0.2 1.0 2.7 0.3 0.2 27.7 0.1 0.1 0.2 0.1 0.6 0.1 0.2 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 83.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 3.9 0.6 0.1 0.0 0.0 58.6 0.0 0.0 118.7 0.0 0.0 82.9 5.6 0.2 0.0 6.7 0.0 9.1 0.0 0.0 0.4 0.0 539.4 0.1 0.0 3.4 6.2 10.7 0.0 1.7 0.0 3.3 0.0 20.1 0.0 11.8 11.9 0.0 775.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 2.0 UGT3A1 FLJ34658 ENSG00000145626 "UDP glycosyltransferase family 3 member A1" Q6NUS8 5 35951010-36001028 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 44.0;liver: 47.7" "Group enriched" "Detected in some" 5 "Collecting duct cells: 47.1;Early spermatids: 91.4;Hepatocytes: 63.1;Proximal tubular cells: 58.6" "Group enriched" "Detected in some" 15 "liver cancer: 6.7;renal cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 42 "RH-30: 25.3" "HPA047697, HPA056290" Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA047697: AB_2680122, HPA056290: AB_2683088" "unprognostic (2.41e-3)" "unprognostic (4.47e-1)" "unprognostic (4.04e-1)" "unprognostic (4.62e-1)" "unprognostic (1.42e-2)" "unprognostic (6.05e-2)" "unprognostic (9.14e-2)" "unprognostic (1.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 5.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 44.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 3.2 0.1 6.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.4 0.2 0.2 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 47.1 0.0 0.0 3.3 0.0 91.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.1 0.1 0.0 0.0 2.5 2.2 12.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 58.6 0.3 6.5 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035017-36071358 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Early spermatids: 3.6;Late spermatids: 5.7;Proximal tubular cells: 3.3" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Region enhanced" "Detected in single" "pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;SuSa: 9.8;T-47d: 5.7;THP-1: 12.8" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: AB_2684031" "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.1 1.1 0.1 0.0 0.2 6.4 1.6 0.1 0.6 0.1 0.1 0.5 0.4 0.0 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.6 5.6 0.8 0.1 0.0 0.5 0.0 0.2 0.0 0.0 1.7 0.2 2.0 0.6 0.0 2.9 0.1 0.0 0.1 14.4 0.1 0.0 0.3 1.4 0.1 13.2 0.0 37.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.0 0.0 0.4 5.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 9.3 0.0 3.9 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 5.7 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.6 0.1 0.6 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 UGT8 CGT ENSG00000174607 "UDP glycosyltransferase 8" Q16880 4 114598455-114678224 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 96.6" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 24.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 25.7;Spermatogonia: 36.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 7.3;naive B-cell: 10.6" "Lineage enriched" "Detected in single" 12 "B-cells: 10.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.5;OE19: 41.1;RPTEC TERT1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014405, HPA065785" Enhanced Approved Mitochondria No No Mitochondria "HPA014405: AB_1858606, HPA065785: AB_2685559" "unprognostic (7.38e-3)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (2.38e-1)" "unprognostic (1.63e-1)" "unprognostic (1.63e-2)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-3)" "unprognostic (4.49e-2)" "unprognostic (2.76e-1)" "prognostic favorable (8.55e-5)" "unprognostic (2.80e-1)" "unprognostic (1.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.49e-1)" 0.9 0.8 13.2 2.8 30.0 1.0 3.1 2.7 44.8 4.9 15.5 66.6 0.0 18.4 2.7 0.6 1.2 3.0 7.1 0.9 24.2 12.4 20.1 0.8 1.0 3.2 53.9 15.9 0.8 4.8 0.3 0.9 0.5 38.3 0.9 17.3 0.0 4.5 0.8 0.8 1.8 16.1 1.5 96.6 1.3 10.0 3.3 42.6 0.0 8.5 0.0 3.4 0.8 1.0 10.6 0.0 0.9 0.0 0.0 0.6 0.3 0.2 0.1 1.7 0.3 0.1 0.0 0.3 0.1 0.0 0.0 1.2 5.8 21.5 6.4 0.5 0.1 5.1 9.1 0.0 0.0 0.0 0.1 4.5 0.1 9.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.1 5.4 1.3 0.0 0.1 0.1 0.7 2.5 41.1 3.2 0.6 10.3 0.1 21.3 0.2 12.1 1.8 0.0 1.9 0.3 0.4 0.3 2.1 0.4 0.5 7.3 0.3 6.8 2.1 0.3 0.2 10.6 0.3 6.6 0.2 0.0 0.9 0.0 0.0 0.6 7.3 0.1 0.0 0.0 10.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.3 13.2 30.0 2.7 24.4 24.2 12.4 53.9 15.9 38.3 42.6 6.0 1.0 8.1 1.2 0.0 0.0 0.4 7.6 2.7 6.8 24.4 0.0 0.0 8.3 1.8 5.5 0.1 20.6 0.0 11.4 0.0 0.2 0.5 0.0 0.0 0.0 0.0 46.4 0.0 0.0 1.7 1.1 0.7 1.7 0.0 25.7 0.0 9.1 17.5 0.0 1.3 0.0 0.0 0.2 10.6 36.2 0.1 0.0 0.0 21.1 0.9 ULBP1 RAET1I ENSG00000111981 "UL16 binding protein 1" Q9BZM6 6 149964007-149973710 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.9;lung: 9.7;testis: 10.5" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 13.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 23.1;JURKAT: 17.8" "HPA007547, HPA071005" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007547: AB_1079430, HPA071005: AB_2686332" "unprognostic (8.94e-3)" "unprognostic (2.44e-1)" "unprognostic (2.85e-2)" "unprognostic (2.33e-2)" "unprognostic (3.28e-4)" "unprognostic (6.69e-3)" "unprognostic (5.27e-2)" "unprognostic (2.47e-2)" "unprognostic (5.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.57e-12)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 0.7 0.6 2.0 0.4 0.6 0.5 0.5 13.9 1.5 0.4 0.7 0.2 0.0 0.4 0.5 0.5 0.8 0.9 0.5 1.2 1.5 0.3 1.2 0.9 9.7 0.2 0.3 0.0 1.2 0.4 0.6 0.6 1.3 1.0 0.8 0.4 0.5 1.0 0.2 1.6 0.6 0.3 0.3 1.2 0.3 0.9 10.5 0.2 0.2 3.8 0.6 0.5 0.7 4.9 0.7 0.1 0.9 1.8 0.3 3.5 0.3 2.7 1.3 2.6 1.4 2.6 7.7 2.7 3.6 1.1 1.6 2.8 1.8 3.1 2.7 2.9 12.4 6.6 2.6 23.1 4.5 4.3 12.0 3.8 0.2 0.9 0.0 13.6 0.1 1.0 8.4 5.6 11.4 3.0 1.3 2.3 17.8 2.2 0.0 4.0 3.2 2.8 0.0 0.9 1.7 4.2 1.2 2.4 0.3 4.9 2.0 0.9 0.3 5.3 3.3 0.8 1.6 2.6 5.3 1.9 1.3 2.3 5.1 3.2 0.4 0.4 2.5 7.9 4.0 3.3 0.1 0.2 0.1 2.4 1.3 3.5 0.7 1.2 2.8 0.1 0.2 0.7 1.2 0.9 0.3 1.8 0.0 1.9 0.3 2.0 0.6 13.9 1.5 1.5 0.3 0.3 0.0 1.0 0.2 6.0 2.1 0.0 0.4 0.1 0.0 0.4 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.5 0.0 0.0 0.0 0.1 ULBP2 RAET1H ENSG00000131015 "UL16 binding protein 2" Q9BZM5 6 149942000-149949235 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 10.8" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 6.9;Exocrine glandular cells: 7.4;Ito cells: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "gdT-cell: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0" "Lineage enriched" "Detected in single" 7 "T-cells: 5.5" "Cell line enhanced" "Detected in many" "SiHa: 32.0;U-2197: 23.1" CAB018974 Approved Supported "Vesicles,Plasma membrane" "Secreted in other tissues" NA NA "Vesicles, Plasma membrane" "CAB018974: " "unprognostic (2.09e-5)" "prognostic unfavorable (8.07e-4)" "unprognostic (2.38e-3)" "unprognostic (3.90e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.26e-2)" "unprognostic (2.38e-3)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (1.75e-2)" "unprognostic (1.42e-4)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (4.86e-1)" 3.3 1.7 4.5 1.9 2.3 4.3 5.9 5.3 6.5 1.6 0.6 0.0 0.0 0.9 0.6 0.5 10.8 0.5 1.6 4.1 4.4 1.0 1.9 1.7 6.2 1.1 1.0 2.1 0.2 1.6 0.3 1.1 4.4 3.9 0.6 0.7 0.3 1.5 0.4 0.6 1.0 0.4 2.0 0.6 0.5 0.7 3.6 0.1 0.5 3.5 4.6 2.4 4.1 5.2 0.0 0.0 0.0 0.0 0.8 5.5 0.9 9.2 0.8 0.2 2.9 0.5 2.8 1.6 9.6 5.6 10.1 8.3 3.5 5.3 0.0 14.7 10.9 14.5 6.6 3.6 8.8 5.8 4.2 1.9 0.5 1.4 0.0 3.6 0.0 0.7 1.3 6.8 8.9 3.9 8.2 5.7 8.0 1.1 0.0 7.4 6.4 0.8 0.0 0.0 1.7 4.9 1.4 2.2 0.0 14.3 2.7 0.3 0.0 32.0 0.7 0.9 1.6 0.9 4.0 8.9 6.6 8.3 23.1 11.0 0.0 0.0 0.4 9.5 5.1 4.7 0.0 0.0 0.0 5.5 0.0 0.6 0.0 1.8 3.2 0.0 0.0 0.6 3.9 0.0 0.8 0.0 0.0 3.0 0.9 4.5 2.3 5.3 6.5 4.4 1.0 1.0 2.1 3.9 0.1 0.0 2.2 0.0 5.4 3.3 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 6.9 6.3 3.8 0.0 0.0 7.4 0.2 0.9 0.9 0.0 0.0 1.8 0.0 0.0 9.2 1.2 6.4 0.0 1.7 1.7 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 1.0 2.3 3.2 2.5 0.0 2.9 0.0 3.2 UMOD ENSG00000169344 Uromodulin P07911 16 20333052-20356301 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Ciliopathy, Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 417 "kidney: 237.4" "Group enriched" "Detected in some" 383 "Collecting duct cells: 235.5;Distal tubular cells: 805.7" "Cancer enriched" "Detected in single" 39 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "EFO-21: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009446, HPA043420, HPA054721" Enhanced "Secreted in other tissues" NA NA 55000000 83000000 "CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (6.45e-2)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "unprognostic (1.43e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 237.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 235.5 0.0 0.0 805.7 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UMODL1 ENSG00000177398 "Uromodulin like 1" Q5DID0 21 42062959-42143453 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 22.7" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 1.2;Early spermatids: 3.1;Late spermatids: 1.7;Spermatocytes: 2.3" "Group enriched" "Detected in some" 7 "lung cancer: 0.6;testis cancer: 2.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "SCLC-21H: 3.7;U-266/70: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA067245 Uncertain NA NA "HPA067245: AB_2685810" "unprognostic (4.70e-3)" "unprognostic (3.75e-5)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (4.92e-2)" "unprognostic (1.32e-2)" "unprognostic (2.72e-7)" "unprognostic (2.38e-1)" "unprognostic (9.47e-2)" "unprognostic (2.63e-2)" "unprognostic (3.82e-1)" "unprognostic (9.24e-3)" "unprognostic (4.37e-2)" "unprognostic (1.78e-1)" "unprognostic (4.02e-4)" "unprognostic (2.68e-1)" 0.6 0.1 0.4 3.6 0.1 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 4.9 0.0 0.2 0.2 0.3 0.4 0.4 0.6 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.2 3.8 0.0 22.7 0.1 0.0 2.0 0.1 0.0 0.5 0.1 0.3 0.5 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.5 0.5 0.0 0.1 0.3 0.7 0.6 0.0 0.0 0.5 0.0 1.0 0.2 0.4 0.1 0.1 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 UNC45A "GC-UNC45, SMAP-1" ENSG00000140553 "Unc-45 myosin chaperone A" Q9H3U1 15 90930180-90954093 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Myogenesis" "Chaperone, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039228 Approved Supported "Nuclear speckles,Cytosol" NA NA 21000000 "Nuclear speckles" Cytosol "HPA039228: AB_2676402" "unprognostic (1.46e-1)" "unprognostic (3.83e-2)" "unprognostic (4.51e-2)" "unprognostic (1.97e-1)" "unprognostic (2.68e-2)" "unprognostic (1.70e-3)" "prognostic unfavorable (7.72e-4)" "unprognostic (2.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (1.98e-1)" "unprognostic (9.85e-2)" "prognostic favorable (7.46e-7)" "unprognostic (9.30e-2)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (2.28e-2)" 19.1 21.0 10.1 14.4 10.1 11.9 20.6 21.8 14.6 20.3 27.6 10.7 23.2 13.0 29.7 15.5 24.9 20.4 24.8 12.8 9.5 7.3 16.2 15.9 15.2 13.2 11.9 12.3 22.1 19.4 25.8 14.1 22.8 11.5 23.8 10.9 15.3 20.2 29.6 6.9 26.6 16.9 35.8 9.7 15.7 22.4 18.4 10.8 18.0 20.8 12.6 16.9 33.2 30.4 10.1 12.0 12.1 11.9 10.8 14.5 9.8 15.3 31.2 12.9 11.3 35.5 16.4 11.5 17.4 15.0 23.8 19.1 24.9 20.4 18.1 23.5 21.9 13.7 34.0 21.9 22.4 11.2 20.0 32.0 34.9 32.7 17.7 20.1 8.6 23.7 20.3 27.5 23.3 17.1 22.9 32.2 14.5 15.3 14.9 17.8 24.7 11.0 7.4 17.4 28.2 15.8 22.0 19.7 19.2 16.2 36.5 18.3 16.6 23.4 23.5 21.7 16.2 21.3 17.9 31.6 20.3 14.6 17.1 18.2 14.3 19.7 8.5 19.9 20.2 20.6 12.1 9.0 5.4 14.5 8.3 14.0 10.1 11.9 11.2 12.0 8.3 10.0 9.1 1.8 10.8 11.9 10.7 10.5 9.8 10.1 10.1 21.8 14.6 9.5 7.3 11.9 12.3 11.5 10.8 20.8 21.9 23.1 21.9 14.4 22.5 11.2 35.7 9.4 21.6 17.4 17.7 45.4 11.6 29.7 18.8 21.2 22.6 0.0 15.8 18.5 21.6 16.1 28.8 12.4 24.1 17.5 35.5 16.0 15.4 22.0 27.3 15.4 18.6 37.9 15.4 20.7 19.8 25.9 48.4 16.6 30.0 32.3 30.1 18.4 6.0 16.4 38.7 21.0 18.3 20.6 UNC50 "GMH1, UNCL, URP" ENSG00000115446 "Unc-50 inner nuclear membrane RNA binding protein" Q53HI1 2 98608579-98618515 "Predicted membrane proteins" "Protein transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 200.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027009 Approved NA NA "HPA027009: AB_1858620" "prognostic unfavorable (4.79e-4)" "unprognostic (3.28e-2)" "unprognostic (1.23e-1)" "unprognostic (1.74e-2)" "unprognostic (5.54e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (4.89e-5)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" "unprognostic (5.31e-2)" "unprognostic (6.31e-2)" "unprognostic (1.58e-1)" "unprognostic (1.43e-1)" "unprognostic (2.14e-1)" "unprognostic (4.38e-1)" "unprognostic (7.12e-3)" "unprognostic (4.82e-3)" 25.8 34.1 26.4 22.3 34.6 20.0 29.9 23.1 30.9 26.0 22.5 29.3 38.4 23.6 30.0 46.2 23.2 28.0 24.5 26.1 25.6 25.9 33.8 29.0 24.5 23.2 34.7 29.9 29.6 39.0 42.8 35.1 44.4 27.1 27.4 28.1 31.3 33.7 41.0 22.5 25.0 23.2 25.8 29.8 28.7 30.4 44.3 27.8 22.4 42.2 14.8 25.8 24.6 37.0 39.0 39.6 46.4 40.7 38.2 41.8 29.7 20.1 13.4 24.9 16.8 37.4 32.6 28.1 19.2 27.0 23.7 21.0 20.5 24.1 6.2 29.2 16.3 36.1 19.6 17.3 15.5 19.6 20.7 18.4 13.8 17.8 32.9 40.4 26.2 21.8 21.3 35.5 12.6 23.3 27.5 20.7 16.3 22.2 19.1 24.0 14.4 11.4 29.4 18.9 17.0 15.9 7.4 18.1 21.5 26.2 18.1 9.3 13.8 13.5 18.0 30.6 30.4 15.4 34.0 16.0 26.1 16.1 13.2 12.8 29.4 22.5 16.4 24.6 19.1 22.7 35.5 40.7 46.4 39.4 38.6 34.0 39.0 33.3 36.8 39.6 34.7 36.6 41.8 32.7 38.2 34.7 37.3 26.4 29.7 26.4 34.6 23.1 30.9 25.6 25.9 34.7 29.9 27.1 27.8 23.8 26.5 22.3 43.4 41.9 34.8 35.6 28.1 41.5 43.3 33.2 15.7 103.6 28.2 45.8 35.6 47.2 23.1 0.0 46.8 66.7 62.1 46.1 26.5 34.5 63.5 31.8 20.7 38.6 32.8 23.0 50.6 33.4 42.2 34.3 29.6 70.8 35.4 31.3 70.4 39.0 37.9 45.3 49.4 200.6 41.3 43.4 127.6 25.4 30.0 35.4 UNC5A "KIAA1976, UNC5H1" ENSG00000113763 "Unc-5 netrin receptor A" Q6ZN44 5 176810477-176880898 "Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.9;brain: 35.3" "Cell type enhanced" "Detected in some" 24 "Horizontal cells: 4.8;Late spermatids: 1.9;Muller glia cells: 10.3;Rod photoreceptor cells: 2.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.8;eosinophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 2.8" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 44.3" "Group enriched" "Detected in all" 4 "amygdala: 42.5;basal ganglia: 24.9;cerebral cortex: 36.4;hippocampal formation: 44.5;hypothalamus: 19.1" "Low region specificity" "Detected in all" HPA071450 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA071450: AB_2686397" "unprognostic (5.95e-2)" "unprognostic (1.15e-1)" "unprognostic (4.18e-3)" "prognostic unfavorable (2.23e-4)" "unprognostic (5.26e-2)" "unprognostic (2.23e-1)" "unprognostic (6.66e-3)" "unprognostic (5.06e-3)" "unprognostic (3.52e-1)" "unprognostic (1.36e-1)" "unprognostic (5.07e-1)" "unprognostic (9.95e-2)" "unprognostic (3.77e-5)" "unprognostic (6.39e-2)" "unprognostic (2.89e-1)" "unprognostic (2.27e-1)" "unprognostic (5.17e-2)" 0.9 11.9 10.5 1.1 11.1 1.2 1.4 35.3 30.9 1.1 0.7 0.4 0.0 1.3 0.8 0.9 0.7 1.5 1.0 0.7 7.6 4.6 0.7 0.7 0.9 1.7 1.6 12.6 0.9 3.2 0.6 5.1 0.6 2.1 0.8 0.7 0.3 0.9 0.7 0.6 0.7 0.9 0.8 0.8 0.6 1.2 1.3 0.5 0.0 0.8 0.0 0.7 0.9 0.2 0.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 1.7 0.0 0.0 0.0 1.2 5.1 0.0 44.3 1.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.3 1.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 10.5 11.1 35.3 22.2 7.6 4.6 1.6 12.6 2.1 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 10.3 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 UNC5B "p53RDL1, UNC5H2" ENSG00000107731 "Unc-5 netrin receptor B" Q8IZJ1 10 71212570-71302864 "Plasma proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 43.7" "Cell type enhanced" "Detected in many" 14 "Horizontal cells: 106.5;Muller glia cells: 63.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.5" "Lineage enriched" "Detected in single" 6 "monocytes: 1.5" "Cell line enhanced" "Detected in many" "HHSteC: 47.1;hTCEpi: 41.5;SH-SY5Y: 38.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA076687 Approved NA NA "HPA076687: " "unprognostic (3.98e-2)" "unprognostic (3.14e-2)" "unprognostic (9.28e-2)" "unprognostic (2.71e-1)" "unprognostic (5.64e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.01e-5)" "unprognostic (8.82e-3)" "unprognostic (6.79e-3)" "prognostic unfavorable (3.80e-5)" "unprognostic (7.70e-3)" "unprognostic (6.67e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.17e-2)" "unprognostic (4.62e-2)" "unprognostic (9.89e-3)" "unprognostic (2.25e-1)" 3.8 12.4 9.1 4.6 19.8 0.5 2.3 23.1 12.5 5.7 8.3 29.5 33.6 3.2 5.4 7.5 14.2 9.1 10.5 13.8 12.2 6.8 6.6 2.1 9.3 3.9 27.1 9.7 4.5 5.2 1.5 5.3 6.0 15.0 10.1 6.0 7.1 4.5 43.7 3.0 5.9 4.5 5.5 17.5 8.5 9.9 6.0 20.4 2.2 4.6 5.2 3.6 9.6 8.9 0.0 0.2 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.2 1.2 3.7 6.1 0.1 2.0 6.0 0.0 0.1 1.1 5.5 0.0 2.1 12.7 0.1 14.3 0.4 0.8 0.0 0.0 1.3 3.2 0.2 0.0 47.1 0.0 0.3 5.2 41.5 0.5 2.6 0.5 0.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 3.2 2.9 0.1 0.0 1.4 0.0 0.0 6.2 6.4 38.9 0.4 0.5 0.3 6.0 0.6 0.2 2.4 0.4 1.9 0.8 0.8 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 9.1 19.8 23.1 12.5 12.2 6.8 27.1 9.7 15.0 20.4 0.0 3.5 0.0 15.5 2.7 1.5 7.3 0.0 6.7 3.4 5.2 0.0 0.3 0.0 3.6 0.4 9.5 13.4 0.0 1.4 0.3 10.6 9.4 23.0 0.0 1.2 106.5 2.9 8.0 4.5 0.8 0.6 3.6 1.7 1.0 7.0 63.8 7.4 20.1 0.7 0.1 3.7 0.0 3.6 0.5 4.4 3.8 0.2 0.0 1.5 29.5 UNC5C ENSG00000182168 "Unc-5 netrin receptor C" O95185 4 95162504-95549206 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.3" "Group enriched" "Detected in some" 7 "Leydig cells: 19.5;Paneth cells: 11.5;Peritubular cells: 11.0;Rod photoreceptor cells: 10.3;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 6.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 230000 "unprognostic (1.55e-1)" "unprognostic (2.72e-1)" "unprognostic (1.35e-2)" "unprognostic (8.45e-2)" "unprognostic (3.03e-1)" "unprognostic (3.20e-1)" "unprognostic (3.48e-1)" "unprognostic (3.40e-1)" "unprognostic (3.12e-1)" "unprognostic (1.11e-3)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (2.70e-5)" "unprognostic (1.25e-2)" "unprognostic (1.16e-1)" "unprognostic (1.86e-1)" "unprognostic (3.62e-4)" 3.2 17.4 13.5 2.4 16.2 0.7 3.2 4.7 14.2 4.2 5.9 31.3 1.8 3.0 5.1 4.1 1.9 4.3 4.4 5.8 10.7 7.3 2.9 2.6 5.0 1.5 13.7 10.8 6.2 1.3 1.0 2.6 3.8 19.6 7.2 7.0 6.4 11.4 8.3 0.8 1.0 4.0 5.1 13.1 7.9 4.4 5.3 19.9 0.0 22.7 0.0 1.3 4.7 7.9 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.2 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 2.1 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 42.0 0.0 0.0 0.1 2.7 0.1 6.3 0.0 0.0 0.6 0.0 3.9 0.0 0.0 0.0 0.0 4.6 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 13.5 16.2 4.7 14.2 10.7 7.3 13.7 10.8 19.6 19.9 0.0 0.0 0.0 0.0 0.1 1.0 1.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.1 1.5 0.2 0.0 0.0 1.4 0.0 1.2 0.6 0.0 0.2 19.5 0.0 1.7 0.0 0.2 1.4 0.0 11.5 11.0 0.0 10.3 6.5 1.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 UNC5CL "MGC34763, ZUD" ENSG00000124602 "Unc-5 family C-terminal like" Q8IV45 6 41026911-41039217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 52.2;kidney: 60.9;liver: 29.9" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 40.8;Collecting duct cells: 21.0;Exocrine glandular cells: 59.0;Hepatocytes: 25.2;Pancreatic endocrine cells: 25.3;Proximal tubular cells: 29.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 2.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "OE19: 31.1;RPTEC TERT1: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015725 Enhanced Approved Centrosome NA NA Centrosome "HPA015725: AB_2669283" "unprognostic (1.10e-2)" "unprognostic (3.59e-2)" "unprognostic (1.60e-1)" "unprognostic (2.57e-1)" "unprognostic (7.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.16e-1)" "unprognostic (8.55e-3)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" "unprognostic (9.30e-2)" "unprognostic (2.35e-1)" "unprognostic (2.31e-1)" "unprognostic (1.19e-1)" "unprognostic (5.60e-6)" 0.4 0.2 0.4 0.6 0.4 0.3 0.5 0.4 0.4 0.4 9.9 0.5 0.4 23.7 0.8 0.8 0.5 0.7 10.2 0.4 0.4 0.1 60.9 29.9 0.9 0.4 0.4 0.4 0.5 17.7 0.1 0.6 0.8 0.4 0.5 0.7 0.4 0.5 0.4 0.4 0.6 52.2 0.4 0.4 1.2 15.9 0.6 0.4 0.4 0.7 0.4 0.4 0.4 0.4 0.3 1.0 0.7 0.3 0.0 2.4 0.2 0.3 0.1 0.4 0.6 0.1 0.1 0.4 0.0 0.0 0.0 0.0 4.9 0.1 0.0 1.8 0.0 0.0 0.1 0.1 0.2 0.0 0.7 0.9 0.4 0.0 2.6 0.1 0.2 0.1 0.1 0.4 0.0 0.3 0.0 0.0 2.0 0.3 0.3 0.0 0.1 0.6 1.5 0.2 31.1 0.1 0.6 0.0 0.3 9.5 0.0 0.4 0.4 0.0 0.0 0.9 0.5 0.1 0.1 0.1 0.0 0.3 0.2 0.0 3.1 1.5 0.4 0.0 1.0 0.0 0.0 0.0 0.7 1.3 0.0 0.1 0.2 0.7 0.2 0.1 0.3 0.4 0.0 0.0 0.0 0.3 1.0 2.4 0.2 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 3.0 1.4 0.9 0.6 0.7 0.2 0.6 40.8 0.0 0.0 21.0 3.9 0.4 3.3 14.5 1.7 0.2 5.9 0.0 59.0 0.7 0.4 0.5 0.0 25.2 0.3 1.6 1.2 1.3 0.6 0.0 0.3 1.0 1.7 1.0 2.7 0.3 25.3 1.5 0.7 29.6 0.3 0.0 0.3 0.4 0.7 0.1 0.7 0.5 4.1 0.3 UNC5D "KIAA1777, Unc5h4" ENSG00000156687 "Unc-5 netrin receptor D" Q6UXZ4 8 35235457-35796550 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.4;intestine: 11.7;pituitary gland: 14.2;prostate: 10.6" "Group enriched" "Detected in some" 7 "Bipolar cells: 12.4;Early spermatids: 21.6;Horizontal cells: 38.1" "Cancer enhanced" "Detected in some" "prostate cancer: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.1;HeLa: 3.9;NTERA-2: 13.6;SH-SY5Y: 4.8;SuSa: 4.4;U-251 MG: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042940 Uncertain NA NA "HPA042940: AB_10959525" "unprognostic (7.88e-2)" "unprognostic (1.28e-1)" "unprognostic (1.41e-2)" "unprognostic (2.29e-1)" "unprognostic (7.60e-2)" "unprognostic (1.87e-1)" "unprognostic (8.47e-2)" "unprognostic (3.82e-2)" "unprognostic (2.04e-1)" "unprognostic (4.13e-2)" "unprognostic (1.99e-1)" "unprognostic (4.48e-8)" "unprognostic (1.34e-1)" "unprognostic (9.15e-2)" "unprognostic (4.28e-1)" 0.3 3.9 8.4 0.4 13.5 0.3 0.4 2.8 15.4 5.0 0.9 0.5 0.1 11.7 3.8 0.5 0.4 0.6 0.3 0.3 3.6 9.4 5.0 0.3 0.5 0.3 1.3 8.1 0.3 0.6 0.4 14.2 0.3 4.7 10.6 1.5 3.3 0.4 0.8 0.3 0.4 3.9 2.4 0.8 0.4 0.6 1.6 0.8 0.0 2.1 0.0 0.3 0.3 0.4 0.0 0.0 0.8 0.2 0.3 0.1 0.0 0.0 1.4 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.6 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.1 0.9 0.3 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 8.4 13.5 2.8 15.4 3.6 9.4 1.3 8.1 4.7 0.8 0.0 0.0 0.0 0.0 0.0 12.4 0.6 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 38.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 2.7 0.0 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 UNC93A "dJ366N23.1, dJ366N23.2" ENSG00000112494 "Unc-93 homolog A" Q86WB7 6 167271169-167316019 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 9.8;liver: 17.4;skin 1: 18.8" "Cell type enhanced" "Detected in some" 25 "Collecting duct cells: 10.4;Hepatocytes: 4.9;Mucus-secreting cells: 2.4;Undifferentiated cells: 1.7" "Cancer enhanced" "Detected in many" "liver cancer: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "CACO-2: 10.4;Hep G2: 4.3;OE19: 10.6;SCLC-21H: 4.6" "Not detected" "Not detected" HPA035729 Uncertain NA NA "HPA035729: AB_10696508" "unprognostic (2.49e-1)" "unprognostic (2.67e-1)" "unprognostic (2.32e-1)" "unprognostic (1.28e-1)" "unprognostic (2.28e-1)" "unprognostic (2.26e-1)" "unprognostic (2.32e-1)" "unprognostic (2.10e-1)" "unprognostic (3.32e-3)" "unprognostic (2.99e-2)" "unprognostic (5.97e-3)" "unprognostic (1.85e-1)" "unprognostic (4.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.5 1.4 0.1 0.1 9.2 0.1 0.5 5.9 1.0 1.6 0.1 0.1 0.0 2.5 17.4 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.5 0.1 0.1 18.8 9.8 0.1 0.1 0.1 0.1 0.1 0.1 1.6 0.1 3.9 2.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 UNC93B1 UNC93 ENSG00000110057 "Unc-93 homolog B1, TLR signaling regulator" Q9H1C4 11 67991104-68004982 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 28.6" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 87.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "CAPAN-2: 31.3;RPMI-8226: 87.0;SK-BR-3: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038716, HPA038717, HPA042803" Approved Approved Nucleoplasm No No Nucleoplasm "HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176" "unprognostic (3.32e-2)" "unprognostic (1.75e-1)" "unprognostic (3.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (7.66e-2)" "unprognostic (1.29e-2)" "unprognostic (9.36e-2)" "unprognostic (5.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.76e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.73e-2)" "unprognostic (1.85e-2)" "unprognostic (7.05e-3)" "unprognostic (5.23e-3)" 8.0 2.7 5.7 9.7 7.4 9.2 5.0 6.2 7.0 4.7 11.9 5.3 6.9 11.8 2.3 5.7 5.5 4.1 13.9 4.6 8.7 6.0 5.9 7.1 13.4 20.8 3.6 0.4 3.0 5.2 0.8 3.3 6.7 2.7 5.3 1.2 5.0 12.3 9.0 6.1 3.7 16.9 2.7 3.5 28.6 10.7 4.1 2.2 2.6 5.3 2.4 13.3 5.9 2.8 2.5 13.6 5.7 6.6 1.8 0.2 0.9 4.5 8.2 0.6 3.3 1.8 0.6 7.1 2.0 1.8 3.2 2.9 0.6 31.3 10.0 7.8 0.9 2.7 10.9 0.2 1.7 0.1 3.5 2.3 1.0 2.6 1.5 2.8 7.1 5.7 1.5 1.8 0.9 0.3 1.2 0.6 1.5 0.7 4.7 0.5 4.3 0.0 5.6 1.5 11.0 4.4 5.9 0.0 87.0 2.8 2.5 0.9 1.4 3.4 23.4 4.5 0.2 8.7 9.3 2.2 2.1 3.1 3.1 0.2 3.3 4.4 1.6 4.0 7.3 2.5 0.1 3.6 5.7 0.1 6.6 0.2 2.4 0.2 0.2 4.7 2.5 0.0 0.0 3.1 1.8 6.6 13.6 0.0 0.9 5.7 7.4 6.2 7.0 8.7 6.0 3.6 0.4 2.7 2.2 8.9 7.8 29.4 21.8 3.5 0.0 1.6 35.7 36.1 6.8 15.7 0.0 9.0 1.7 33.6 0.6 5.8 24.2 0.0 20.5 41.1 8.3 14.1 6.9 4.0 87.3 4.8 4.1 5.5 53.9 0.0 4.0 51.3 21.9 53.3 14.2 4.8 34.0 21.0 3.9 5.7 0.3 0.0 4.2 0.0 0.9 5.6 6.1 9.6 18.7 30.4 UPK1A TSPAN21 ENSG00000105668 "Uroplakin 1A" O00322 19 35666516-35678483 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 20.3;urinary bladder: 80.6" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 28.0" "Cancer enriched" "Detected in many" 41 "urothelial cancer: 148.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "RT4: 29.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA049879 Enhanced NA NA "HPA049879: AB_2680929" "unprognostic (3.29e-1)" "unprognostic (1.78e-1)" "unprognostic (1.19e-3)" "unprognostic (3.40e-4)" "unprognostic (4.05e-2)" "unprognostic (1.04e-1)" "unprognostic (1.74e-2)" "unprognostic (3.11e-3)" "unprognostic (2.30e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (2.34e-1)" "unprognostic (2.48e-9)" "unprognostic (1.48e-1)" "unprognostic (4.14e-2)" "unprognostic (2.45e-2)" "unprognostic (1.72e-1)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.0 0.1 0.1 0.1 0.0 0.4 0.1 12.8 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 20.3 0.0 0.1 0.9 0.1 0.1 6.7 0.1 4.5 0.1 0.1 0.0 0.2 0.1 0.1 0.1 1.1 1.0 80.6 8.6 1.7 0.5 1.8 0.5 1.6 2.0 0.8 0.2 0.9 0.1 0.2 0.3 0.1 0.3 0.2 0.0 0.1 0.4 1.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 2.8 0.7 0.0 0.3 0.2 0.1 0.1 0.4 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.4 6.1 0.2 0.0 0.1 0.0 0.0 29.6 0.1 0.3 0.4 0.3 0.5 0.2 0.2 0.3 0.9 0.0 1.2 0.1 0.2 0.1 0.4 0.0 0.1 0.1 0.2 1.1 0.5 0.2 0.3 0.4 0.5 0.6 2.0 0.6 0.2 1.7 0.1 0.6 1.8 1.6 0.1 0.5 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.4 0.1 0.0 0.0 28.0 UPK1B "TSPAN20, UPK1" ENSG00000114638 "Uroplakin 1B" O75841 3 119173517-119205153 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 56.4;urinary bladder: 41.9" "Cell type enhanced" "Detected in some" 16 "Cholangiocytes: 35.7;Club cells: 9.1;Ductal cells: 10.8;Proximal tubular cells: 11.2;Urothelial cells: 19.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 147.3" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CACO-2: 15.4;RPTEC TERT1: 14.4;RT4: 55.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA031799, HPA031800" Enhanced NA NA "HPA031799: AB_10671579, HPA031800: AB_10671580" "unprognostic (1.20e-2)" "unprognostic (7.18e-2)" "prognostic favorable (3.87e-5)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (8.77e-3)" "unprognostic (3.67e-1)" "unprognostic (2.71e-1)" "unprognostic (3.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.76e-4)" "unprognostic (1.68e-1)" "unprognostic (6.76e-2)" "unprognostic (2.95e-2)" 6.1 0.2 0.2 0.2 1.2 0.0 0.2 0.2 0.3 3.6 0.7 0.0 0.0 0.0 1.5 0.3 2.4 5.1 12.9 1.8 0.2 0.2 6.6 0.6 1.4 0.0 0.2 0.1 0.8 11.6 0.0 0.4 56.4 1.1 15.4 0.0 0.0 0.4 0.0 0.2 0.6 0.2 4.3 1.8 0.2 22.9 0.7 0.0 1.4 0.2 1.4 12.9 41.9 1.1 0.7 1.1 2.5 0.5 0.6 1.9 0.5 0.0 6.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 15.4 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.4 55.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.5 0.3 0.3 0.2 0.4 0.2 0.3 0.5 0.7 1.9 0.3 1.8 0.6 0.4 1.1 0.2 0.5 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.1 1.1 0.0 0.0 1.0 0.0 0.3 0.2 0.4 0.1 35.7 0.0 9.1 0.0 0.0 1.0 0.0 10.8 3.0 0.1 0.0 0.0 0.6 7.7 0.2 0.8 2.3 0.0 0.5 1.6 0.0 0.0 0.0 1.0 0.0 1.4 1.7 1.8 0.0 0.2 0.6 0.0 0.0 11.2 0.6 0.0 0.2 0.2 0.2 0.0 1.3 0.0 0.0 19.0 UPK2 "MGC138598, UP2, UPII" ENSG00000110375 "Uroplakin 2" O00526 11 118925164-118958559 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "prostate: 39.0;urinary bladder: 52.4;vagina: 25.9" "Group enriched" "Detected in some" 6 "Club cells: 3.4;Cytotrophoblasts: 5.1;Syncytiotrophoblasts: 8.0;Urothelial cells: 6.9" "Cancer enriched" "Detected in many" 72 "urothelial cancer: 339.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.0;T-reg: 1.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "MCF7: 47.0;RT4: 53.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043312, HPA061106" Enhanced NA NA "HPA043312: AB_2678420, HPA061106: AB_2684429" "unprognostic (6.04e-3)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (3.97e-2)" "unprognostic (1.21e-1)" "unprognostic (4.12e-4)" "unprognostic (1.65e-1)" "prognostic unfavorable (9.57e-4)" "unprognostic (3.13e-3)" "unprognostic (1.37e-1)" "unprognostic (1.05e-3)" "unprognostic (6.35e-3)" "prognostic unfavorable (7.30e-7)" "unprognostic (6.69e-2)" "unprognostic (7.45e-2)" "unprognostic (2.98e-1)" "unprognostic (1.00e-1)" 1.0 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.1 0.0 0.0 0.2 0.2 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 3.8 0.0 39.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 6.8 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.2 1.3 52.4 25.9 0.7 0.6 0.0 0.1 2.0 1.9 0.2 1.2 0.1 0.0 0.1 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 53.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.6 1.9 0.2 0.2 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 3.4 0.0 0.0 5.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.4 0.2 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 8.0 0.0 0.0 6.9 UPK3A UPK3 ENSG00000100373 "Uroplakin 3A" O75631 22 45284982-45295874 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;skeletal muscle: 24.5;urinary bladder: 45.5" "Cell type enhanced" "Detected in some" 20 "Basal glandular cells: 20.5;Glandular cells: 61.9;monocytes: 13.6;Urothelial cells: 21.4" "Group enriched" "Detected in many" 6 "prostate cancer: 35.3;urothelial cancer: 78.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "classical monocyte: 8.5;intermediate monocyte: 9.6;myeloid DC: 33.7;non-classical monocyte: 11.3;plasmacytoid DC: 13.0" "Group enriched" "Detected in many" 16 "dendritic cells: 33.7;monocytes: 11.3" "Group enriched" "Detected in some" 5 "Hep G2: 18.7;RT4: 31.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018407, HPA018415" Enhanced Uncertain "Nuclear membrane,Nuclear bodies" NA NA "Nuclear membrane" "Nuclear bodies" "HPA018407: AB_1858641, HPA018415: AB_1858640" "unprognostic (1.27e-2)" "unprognostic (3.20e-3)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (3.98e-5)" "unprognostic (1.69e-2)" "unprognostic (4.82e-4)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-5)" "unprognostic (2.01e-2)" "unprognostic (5.45e-2)" "unprognostic (1.83e-1)" "unprognostic (6.05e-3)" 0.2 0.1 0.3 1.6 0.4 0.9 0.3 0.2 0.5 0.4 0.7 0.0 0.0 0.0 0.2 2.3 0.2 0.2 0.6 0.2 0.3 0.3 0.2 0.2 0.2 1.0 0.4 0.1 0.2 0.2 6.4 0.5 0.0 0.7 17.9 0.5 0.6 12.9 1.8 24.5 0.2 1.8 13.0 0.3 0.7 0.2 0.2 0.0 1.3 4.6 1.7 0.6 45.5 2.7 0.3 33.7 1.4 11.3 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.2 0.0 2.9 0.0 0.0 0.0 0.1 0.0 31.3 0.1 0.0 0.1 0.5 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 9.6 0.0 0.3 0.0 0.0 33.7 0.2 0.0 0.0 1.4 0.1 11.3 13.0 0.0 2.8 0.3 0.4 0.2 0.5 0.3 0.3 0.4 0.1 0.7 0.0 0.0 0.0 0.5 20.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.0 61.9 0.0 0.0 1.6 0.0 0.0 0.0 6.4 0.9 0.3 6.3 0.0 13.6 3.1 0.7 0.0 7.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.4 0.1 0.0 2.8 21.4 UPK3B "FLJ32198, MGC10902, p35, UPIIIb" ENSG00000243566 "Uroplakin 3B" Q9BT76 7 76510428-76516521 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0" "Cell type enriched" "Detected in some" 10 "Alveolar cells type 1: 113.2" "Group enriched" "Detected in many" 12 "ovarian cancer: 64.6;urothelial cancer: 78.4" "Region enriched" "Detected in single" 58 "pons and medulla: 5.8" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "A549: 7.8;CAPAN-2: 28.5;HaCaT: 5.8;RT4: 19.5;T-47d: 16.2" HPA010506 Approved NA NA "HPA010506: AB_1080479" "unprognostic (8.33e-2)" "unprognostic (1.30e-1)" "unprognostic (3.62e-3)" "unprognostic (2.26e-3)" "unprognostic (7.87e-2)" "unprognostic (8.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.63e-1)" "unprognostic (4.03e-1)" "unprognostic (5.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.06e-2)" "unprognostic (8.37e-9)" "unprognostic (3.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-1)" "unprognostic (6.34e-2)" 28.5 0.3 0.0 7.1 0.0 0.4 0.3 0.0 0.3 1.5 6.9 0.1 0.0 0.3 0.8 7.9 40.2 2.8 3.0 9.4 0.0 0.0 0.3 0.4 34.1 0.4 0.0 0.0 13.2 0.3 0.3 0.1 0.3 5.8 1.4 0.3 0.8 1.4 0.3 0.4 1.1 0.5 1.5 0.2 0.4 0.6 6.1 0.0 0.2 0.3 6.1 25.0 20.5 2.1 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.6 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.5 0.0 0.2 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.2 2.3 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 113.2 3.5 0.0 0.2 1.4 0.0 0.3 2.5 4.0 9.1 3.5 3.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 1.1 0.0 0.1 1.6 0.0 0.6 0.0 0.0 11.2 0.9 3.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 2.5 0.1 0.0 0.1 2.5 UPK3BL1 "UPK3BL, UPLP" ENSG00000267368 "Uroplakin 3B like 1" "B0FP48, E5RIL1" 7 102637025-102642791 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 45.1;lymphoid tissue: 34.6" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 10.7;Ciliated cells: 9.4;Club cells: 5.7;granulocytes: 7.0;monocytes: 3.6;Pancreatic endocrine cells: 2.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 48.8" HPA011403 Supported NA NA "HPA011403: AB_2668503" "unprognostic (4.63e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-2)" "unprognostic (2.45e-1)" "unprognostic (3.28e-1)" "unprognostic (6.19e-3)" "unprognostic (3.35e-1)" "unprognostic (2.88e-1)" "unprognostic (9.39e-3)" "unprognostic (4.00e-1)" "unprognostic (8.11e-2)" "unprognostic (6.46e-3)" "unprognostic (1.15e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-1)" "unprognostic (1.79e-1)" "unprognostic (3.93e-2)" 3.0 2.2 2.1 3.3 2.7 7.9 3.0 4.5 2.1 6.5 2.9 3.6 3.4 1.7 45.1 3.7 1.0 2.2 3.0 1.9 4.6 4.0 3.4 7.1 2.1 3.7 3.8 3.4 4.3 1.7 5.9 1.5 7.7 23.7 6.5 5.1 4.6 0.9 2.0 8.8 3.0 1.3 13.1 34.6 11.8 15.1 5.3 6.8 13.6 5.9 7.1 9.6 4.7 7.4 5.9 3.8 1.6 1.6 0.2 5.2 0.0 0.8 0.9 2.2 0.9 4.0 1.1 1.4 0.9 1.2 48.8 1.1 5.4 0.6 6.6 8.6 1.1 2.4 1.7 0.5 1.9 2.0 3.2 7.1 0.0 1.3 6.7 6.9 0.2 2.8 4.1 2.5 16.9 3.0 16.2 1.7 6.4 1.8 3.0 2.1 6.1 7.0 5.9 2.6 6.0 10.1 2.6 2.4 3.2 0.8 3.0 2.3 14.5 6.2 5.1 2.8 4.3 2.0 0.7 3.1 4.5 2.4 13.6 5.9 8.5 9.6 5.2 4.4 5.3 5.0 4.7 6.8 4.9 6.3 4.8 7.1 7.1 1.7 6.8 7.9 4.7 8.9 10.7 0.0 0.0 0.0 0.0 0.0 0.0 9.4 5.7 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 7.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.6 0.0 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 UPK3BL2 ENSG00000284981 "Uroplakin 3B like 2" E5RIL1 7 102538417-102543849 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 12.2;lymphoid tissue: 12.8" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA011403 Approved NA NA "HPA011403: AB_2668503" 0.8 0.0 1.5 6.5 1.0 0.3 0.0 0.6 1.0 0.7 0.4 12.2 0.9 0.6 0.0 0.0 0.1 0.8 3.4 0.4 0.7 0.2 0.3 1.2 0.8 1.5 3.6 2.7 2.8 0.9 0.1 3.2 0.4 0.0 4.5 12.8 2.5 5.0 8.4 6.1 3.7 1.0 7.9 1.3 5.8 9.0 3.9 6.8 1.9 0.6 13.4 10.7 13.4 13.5 16.7 3.1 9.8 6.6 5.3 4.0 1.4 18.9 0.4 5.0 3.7 7.3 11.0 2.3 14.8 5.3 7.8 5.7 7.3 6.5 7.4 3.9 3.6 3.1 6.1 8.6 6.1 15.3 4.9 23.9 6.4 9.6 1.5 2.8 1.8 5.0 2.1 9.6 7.6 22.9 5.0 5.5 6.0 2.9 5.4 7.0 3.1 5.4 2.7 7.2 3.2 4.6 4.3 15.3 4.8 4.1 2.0 10.3 5.2 0.2 3.7 2.6 7.9 1.9 2.9 4.7 3.1 2.5 1.5 5.0 5.6 2.8 6.1 1.0 2.0 8.4 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673687 "Disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA046851: AB_2679839" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 10.0 13.4 8.9 11.4 8.5 10.6 14.7 8.7 9.9 7.3 15.4 4.7 19.7 16.5 7.3 8.5 14.5 6.5 12.4 13.2 8.0 8.7 10.7 13.4 5.6 8.3 8.5 8.7 9.5 15.4 5.3 7.6 6.2 7.7 12.3 4.9 7.1 22.9 14.1 27.8 8.6 14.8 6.0 6.2 9.6 12.2 5.7 5.4 6.4 13.5 12.3 9.1 8.0 18.1 23.7 21.2 15.2 20.8 14.0 19.4 15.5 12.0 24.5 3.6 5.6 2.2 2.2 3.0 4.8 1.6 3.6 3.6 14.3 10.5 7.8 10.0 1.6 4.9 12.0 3.4 5.6 1.1 3.9 12.7 4.4 12.8 9.1 3.0 7.1 3.6 2.1 4.8 3.2 3.6 2.3 2.8 3.8 9.4 5.7 2.0 36.8 6.9 17.5 4.0 4.8 13.9 8.1 5.5 13.9 2.7 6.0 7.3 7.4 5.3 19.4 7.1 1.1 18.4 6.7 3.6 7.9 9.3 8.2 10.6 8.8 4.8 8.1 6.5 6.2 5.7 9.1 20.8 15.2 18.1 14.4 17.1 23.5 18.0 15.9 15.8 23.7 16.6 13.3 8.9 14.0 12.7 21.2 19.4 15.5 8.9 8.5 8.7 9.9 8.0 8.7 8.5 8.7 7.7 5.4 41.7 23.5 61.4 42.6 0.0 20.8 31.7 66.2 22.7 29.6 61.1 15.7 44.7 119.3 51.7 1.4 26.8 115.3 46.7 67.1 41.2 21.0 70.4 4.7 99.1 47.7 17.5 33.9 39.9 38.4 2.3 44.8 22.9 0.0 43.3 98.1 39.6 57.0 91.2 33.9 137.3 26.2 38.8 31.1 2.7 33.7 0.0 24.3 25.9 101.8 45.4 UQCR10 "HSPC051, QCR9, UCCR7.2, UCRC" ENSG00000184076 "Ubiquinol-cytochrome c reductase, complex III subunit X" Q9UDW1 22 29767369-29770413 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 144.4;skeletal muscle: 144.7" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 4128.5;Distal tubular cells: 1946.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.09e-1)" "unprognostic (2.96e-3)" "unprognostic (1.56e-1)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (2.73e-2)" "unprognostic (1.25e-1)" "unprognostic (1.75e-3)" "unprognostic (3.05e-2)" "unprognostic (9.24e-3)" "unprognostic (2.94e-1)" "unprognostic (1.12e-2)" "prognostic favorable (5.45e-5)" "unprognostic (1.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.80e-3)" 23.0 37.0 42.5 18.2 42.9 20.1 23.8 25.2 48.5 17.2 35.5 14.7 24.3 35.9 12.6 24.9 23.7 23.7 19.9 97.9 38.3 30.2 38.3 43.6 22.6 25.2 39.8 25.8 16.1 39.4 19.3 22.5 17.5 25.4 22.2 29.1 21.6 25.2 25.6 144.7 14.7 33.1 17.6 24.2 19.8 29.9 28.5 20.6 20.9 23.6 62.9 20.8 22.8 15.0 132.9 126.0 141.5 118.4 73.9 123.2 144.4 30.9 32.5 31.4 24.4 29.5 19.5 17.5 17.2 21.6 30.9 32.4 41.9 17.9 23.4 18.8 27.3 22.7 31.0 37.2 40.4 19.3 29.2 78.3 29.2 39.5 91.6 21.2 37.5 32.0 32.5 24.8 32.2 21.8 26.0 22.9 25.3 19.9 31.7 30.3 78.1 28.1 44.1 18.0 74.7 43.1 30.7 25.2 42.4 53.2 59.2 34.7 17.5 20.1 43.1 27.1 20.8 30.6 36.0 18.0 32.0 38.7 19.6 25.4 23.9 24.1 31.1 28.8 29.1 20.1 112.9 118.4 141.5 71.0 115.5 77.6 132.9 98.0 90.9 123.1 107.0 106.8 91.6 82.2 73.9 102.8 126.0 123.2 144.4 42.5 42.9 25.2 48.5 38.3 30.2 39.8 25.8 25.4 20.6 229.3 250.2 242.5 180.2 161.5 158.1 4128.5 537.6 353.3 215.0 594.9 72.6 608.3 1946.4 397.6 222.6 157.6 904.3 373.8 481.7 445.1 188.1 297.9 145.6 1099.7 633.2 108.1 365.2 164.5 360.2 448.1 217.1 268.7 295.3 421.2 634.0 208.4 426.1 624.3 194.1 1057.8 204.8 207.0 152.7 328.9 185.1 246.2 486.6 198.4 623.5 323.4 UQCR11 "QCR10, UQCR" ENSG00000127540 "Ubiquinol-cytochrome c reductase, complex III subunit XI" O14957 19 1597172-1605490 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 125.4;skeletal muscle: 149.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (1.90e-1)" "unprognostic (6.67e-3)" "unprognostic (1.78e-1)" "prognostic favorable (1.23e-4)" "unprognostic (5.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.06e-1)" "unprognostic (5.42e-3)" "unprognostic (9.10e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.86e-4)" "unprognostic (1.03e-1)" "prognostic favorable (1.65e-4)" "unprognostic (2.40e-1)" "unprognostic (1.43e-1)" "unprognostic (2.22e-2)" "unprognostic (1.06e-2)" 24.9 23.6 35.1 15.8 29.5 20.3 18.5 13.2 25.1 12.5 28.5 13.1 20.3 34.4 12.4 18.2 22.9 14.1 21.7 106.4 26.9 21.1 24.4 46.1 11.9 17.2 31.0 19.2 9.8 30.0 8.8 16.7 15.4 18.5 18.3 13.3 14.5 29.6 23.6 149.2 11.5 27.5 16.8 21.5 18.3 27.6 8.8 15.1 10.9 22.0 47.1 12.9 15.8 14.1 63.8 78.6 88.2 75.6 43.8 67.9 125.4 22.5 21.2 10.5 23.8 17.5 12.0 25.5 16.3 12.8 16.0 14.3 34.2 15.2 13.3 16.9 11.5 4.1 14.4 15.4 17.3 7.5 21.8 47.1 11.7 26.2 32.1 18.2 19.3 18.3 18.5 17.9 10.1 11.8 8.3 14.5 19.5 25.8 24.2 10.1 31.0 19.2 23.4 27.4 18.2 51.0 11.6 11.0 44.4 20.9 45.5 20.8 22.3 11.2 27.1 28.7 8.2 19.2 23.1 20.2 15.6 10.1 41.1 18.9 34.2 28.1 16.3 27.4 20.2 21.1 83.7 75.6 87.0 52.6 61.8 52.9 63.8 64.3 58.2 63.1 54.1 61.7 59.3 88.2 43.8 57.4 78.6 67.9 125.4 35.1 29.5 13.2 25.1 26.9 21.1 31.0 19.2 18.5 15.1 250.1 365.3 312.4 147.9 0.0 116.7 1545.7 580.9 491.2 293.5 601.9 37.3 421.8 1518.6 593.8 133.9 281.1 1267.5 350.4 708.1 511.1 324.6 312.1 183.7 1781.4 835.4 84.2 436.5 444.4 741.4 307.4 234.1 456.9 0.0 926.1 940.5 193.7 712.8 958.2 244.0 853.5 119.2 219.9 179.7 157.0 128.1 0.0 428.8 332.1 797.4 248.2 USE1 "D12, MDS032, p31, SLT1" ENSG00000053501 "Unconventional SNARE in the ER 1" Q9NZ43 19 17215346-17219829 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026851, HPA047562" Approved NA NA "HPA026851: AB_10602903, HPA047562: AB_2680089" "unprognostic (3.03e-3)" "unprognostic (2.61e-3)" "unprognostic (2.24e-2)" "unprognostic (3.09e-2)" "unprognostic (1.03e-1)" "unprognostic (2.34e-1)" "unprognostic (2.00e-1)" "unprognostic (3.04e-2)" "unprognostic (4.24e-1)" "unprognostic (2.94e-2)" "unprognostic (1.15e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (3.59e-4)" "unprognostic (8.14e-2)" "unprognostic (3.23e-1)" "unprognostic (6.61e-2)" "unprognostic (1.31e-2)" 20.8 24.3 31.9 16.2 25.2 21.2 17.6 18.4 35.2 14.6 17.9 22.0 11.4 14.7 15.6 17.3 16.0 16.8 17.4 24.9 28.0 20.4 15.6 29.7 13.0 21.2 25.7 20.9 23.6 29.9 11.7 12.1 14.5 20.7 14.3 9.7 14.9 32.1 13.9 39.3 18.5 13.0 12.9 21.6 20.7 16.8 10.7 16.8 22.8 15.5 16.3 15.1 17.3 12.5 40.0 26.9 11.0 18.4 15.3 38.8 20.6 12.7 7.6 4.2 17.5 14.4 13.8 14.6 9.3 10.9 10.5 13.2 9.9 15.4 8.6 21.7 12.7 3.7 7.4 3.7 12.7 3.6 18.3 16.9 15.9 14.5 10.4 29.6 17.6 14.7 18.7 6.8 9.1 18.1 12.0 6.9 21.3 10.1 30.0 10.9 15.4 16.8 13.0 8.2 9.9 26.9 13.4 4.7 33.2 12.0 10.4 11.4 10.1 10.3 15.0 15.5 4.4 9.7 27.9 10.1 7.0 6.7 12.6 11.5 34.0 30.9 11.2 18.8 28.4 11.5 11.0 18.4 5.2 17.9 15.2 20.1 39.5 26.6 21.4 21.9 40.0 38.8 28.4 3.3 15.3 11.3 26.9 25.2 20.6 31.9 25.2 18.4 35.2 28.0 20.4 25.7 20.9 20.7 16.8 29.8 29.3 49.5 47.9 40.2 20.6 42.7 28.1 18.7 13.6 15.7 17.7 38.6 61.3 32.6 27.0 25.3 47.9 0.0 53.7 28.5 36.8 35.1 48.4 42.3 35.0 11.1 13.2 27.0 35.9 110.4 44.5 27.8 20.3 33.3 25.1 26.8 33.0 42.1 25.1 89.1 32.3 38.8 40.0 21.7 23.2 30.5 63.3 30.0 28.5 30.1 USH2A "RP39, USH2" ENSG00000042781 Usherin O75445 1 215622894-216423396 "Disease related genes, Predicted membrane proteins" "Hearing, Sensory transduction, Vision" "Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "liver: 13.7;retina: 36.6" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 190.5;Rod photoreceptor cells: 174.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 1.6;SCLC-21H: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (3.92e-3)" "unprognostic (1.74e-1)" "unprognostic (2.97e-2)" "unprognostic (5.38e-2)" "unprognostic (9.19e-2)" "unprognostic (2.04e-1)" "unprognostic (6.62e-4)" "unprognostic (1.00e-1)" "unprognostic (3.68e-1)" "unprognostic (2.06e-1)" "unprognostic (6.07e-3)" "unprognostic (3.15e-2)" "unprognostic (3.28e-11)" "unprognostic (2.02e-2)" "unprognostic (1.91e-1)" "unprognostic (3.35e-2)" "unprognostic (9.09e-4)" 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.4 0.1 0.2 0.3 13.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 5.1 0.1 0.5 0.0 0.0 36.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.7 0.1 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.7 3.6 2.5 0.0 0.0 0.0 190.5 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.7 0.0 3.2 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.4 0.0 174.1 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 USP19 "KIAA0891, ZMYND9" ENSG00000172046 "Ubiquitin specific peptidase 19" O94966 3 49108046-49120938 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.23e-2)" "unprognostic (2.12e-1)" "unprognostic (5.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.92e-2)" "unprognostic (3.90e-3)" "unprognostic (2.99e-2)" "unprognostic (3.00e-3)" "unprognostic (2.69e-1)" "unprognostic (3.65e-2)" "unprognostic (2.31e-2)" "unprognostic (1.26e-1)" "prognostic favorable (7.05e-9)" "unprognostic (2.99e-1)" "unprognostic (2.11e-1)" "unprognostic (1.72e-3)" "unprognostic (7.54e-2)" 13.9 19.5 10.3 14.6 12.2 16.2 14.9 19.4 37.1 17.0 16.3 12.5 19.6 14.6 18.7 17.9 14.3 17.2 19.9 17.9 10.3 9.4 14.8 16.5 14.7 13.8 11.9 9.5 17.2 15.2 22.4 13.2 17.6 11.4 14.2 10.9 14.9 24.7 26.0 57.3 18.4 16.1 13.9 8.5 17.5 15.1 14.9 11.7 23.0 17.7 15.2 12.6 17.4 14.1 5.1 6.7 12.3 5.7 4.3 8.4 5.3 8.3 12.0 14.4 20.3 17.7 12.2 18.4 9.4 12.6 17.6 13.3 12.0 12.8 18.0 9.6 11.8 17.5 11.1 18.2 13.6 7.3 14.1 14.0 17.5 24.1 11.0 18.4 19.8 18.5 17.3 10.6 16.6 12.1 12.3 11.5 16.1 13.7 13.6 8.8 10.8 18.7 20.5 27.3 12.5 17.6 9.1 10.7 20.8 10.9 15.9 7.9 22.7 13.9 18.2 16.3 12.5 12.3 26.4 9.1 11.7 14.3 17.3 14.2 34.4 33.3 15.9 15.1 15.7 14.5 12.3 4.9 7.5 7.2 5.3 6.8 4.6 5.8 8.4 6.7 5.1 5.7 6.2 8.8 4.3 5.7 3.0 4.1 5.3 10.3 12.2 19.4 37.1 10.3 9.4 11.9 9.5 11.4 11.7 11.9 9.7 2.9 4.0 5.6 11.4 9.6 2.5 10.7 10.3 7.0 17.7 8.5 5.0 6.6 2.7 7.1 13.1 0.0 6.7 4.4 5.8 4.6 2.3 12.1 7.8 12.7 8.7 7.4 6.1 4.1 12.0 8.4 3.3 1.8 11.3 7.7 9.8 11.8 11.7 6.3 11.2 12.9 5.2 10.5 10.0 4.6 11.3 6.4 10.9 2.6 USP27X USP27 ENSG00000273820 "Ubiquitin specific peptidase 27, X-linked" A6NNY8 X 49879948-49882565 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 17.9;Ciliated cells: 24.1;Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 21.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077264 Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA077264: AB_2686831" "unprognostic (4.12e-2)" "unprognostic (9.58e-3)" "unprognostic (2.29e-1)" "unprognostic (4.66e-2)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.14e-4)" "unprognostic (3.10e-3)" "unprognostic (3.91e-2)" "unprognostic (1.31e-2)" "prognostic favorable (9.31e-4)" "unprognostic (5.37e-2)" "unprognostic (7.45e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.58e-1)" 1.8 3.3 1.8 5.9 2.9 0.3 7.7 1.7 7.4 3.9 5.9 4.8 2.2 1.1 12.7 4.1 3.1 4.7 3.8 3.9 2.2 3.5 3.5 6.1 1.9 1.3 3.2 8.8 3.2 4.1 0.8 15.5 2.8 4.1 1.7 4.1 5.2 3.9 7.5 2.6 4.7 3.9 1.3 2.0 1.9 3.8 1.9 2.8 3.2 3.6 2.2 3.7 3.1 1.7 1.0 0.7 0.7 0.3 1.3 0.4 1.8 4.7 5.5 6.3 5.2 4.3 4.6 2.1 3.4 2.4 2.0 8.5 2.1 1.2 2.0 5.4 7.9 3.0 7.8 5.2 3.5 2.4 3.7 2.0 1.4 7.7 3.5 0.6 4.3 6.0 3.6 3.4 3.4 5.9 3.3 5.5 3.9 2.0 3.8 4.5 2.9 1.7 6.0 3.5 3.3 3.1 4.8 0.4 3.9 1.8 1.4 4.1 4.0 3.8 4.9 17.9 4.4 1.4 2.5 2.8 5.4 4.8 0.8 1.9 0.5 0.8 3.2 1.7 3.0 0.7 0.4 0.1 0.6 0.4 0.8 0.6 0.5 0.3 1.0 1.7 0.8 0.6 0.7 0.3 0.7 0.4 1.3 0.4 17.9 13.3 0.0 4.1 2.6 9.7 2.3 0.0 24.1 13.6 0.0 0.0 34.3 5.0 1.1 0.0 3.1 0.7 0.0 0.6 2.0 1.8 2.5 2.3 1.7 3.4 4.8 4.1 3.1 0.3 0.0 2.0 1.1 0.0 1.0 1.2 10.2 1.2 0.0 3.2 2.6 2.0 6.5 1.7 0.0 1.4 1.9 21.9 1.3 1.7 1.7 USP30 "FLJ40511, MGC10702" ENSG00000135093 "Ubiquitin specific peptidase 30" Q70CQ3 12 109023089-109088026 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016952 Approved NA NA "HPA016952: AB_1858680" "unprognostic (2.34e-1)" "unprognostic (1.57e-2)" "unprognostic (7.04e-2)" "unprognostic (9.91e-2)" "unprognostic (2.48e-1)" "unprognostic (5.89e-2)" "unprognostic (1.91e-1)" "unprognostic (3.60e-3)" "unprognostic (1.98e-1)" "unprognostic (4.96e-2)" "unprognostic (5.07e-2)" "unprognostic (1.07e-1)" "prognostic favorable (5.23e-6)" "unprognostic (2.49e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-3)" 11.7 18.9 12.7 9.0 17.6 12.2 10.4 11.9 21.0 10.3 13.2 29.2 13.6 14.9 12.4 8.5 9.2 11.1 8.4 9.0 10.3 10.6 12.4 21.7 8.9 10.4 16.6 7.8 17.5 12.4 14.7 13.0 6.7 16.0 9.4 11.3 16.4 10.1 12.4 16.4 13.6 14.1 8.6 14.3 9.8 8.5 21.3 16.3 8.7 11.1 5.3 7.1 10.8 8.1 14.2 12.2 12.7 11.0 18.3 17.4 6.0 4.6 3.6 9.5 8.2 6.7 7.7 5.3 5.2 6.8 6.1 5.4 4.2 3.6 11.7 4.4 5.1 5.6 5.2 8.3 5.4 7.0 13.5 10.4 3.8 3.2 6.0 7.2 7.4 4.2 9.2 6.6 5.4 5.3 15.8 7.0 12.1 5.6 5.7 5.1 5.4 11.7 4.2 3.0 5.6 10.1 12.7 6.8 7.0 4.9 5.6 8.7 7.7 7.0 5.3 5.5 7.3 13.1 5.8 5.0 5.6 3.1 5.4 3.4 14.3 11.9 17.5 6.0 4.5 6.2 9.5 7.1 12.7 15.4 11.0 17.4 14.2 12.9 14.3 4.6 14.2 13.7 12.6 4.2 18.3 8.8 12.2 11.2 6.0 12.7 17.6 11.9 21.0 10.3 10.6 16.6 7.8 16.0 16.3 0.0 2.9 0.8 2.3 1.8 7.7 6.4 10.2 4.0 5.7 5.2 7.9 4.9 0.0 3.9 22.7 2.9 9.7 0.0 4.9 3.5 3.3 2.0 0.0 13.9 4.9 6.4 6.4 1.8 4.6 37.3 3.4 1.4 1.7 1.0 10.2 6.5 4.6 3.5 3.5 5.1 14.1 12.9 2.1 16.9 5.3 2.9 6.1 1.9 10.4 2.6 USP48 "FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31" ENSG00000090686 "Ubiquitin specific peptidase 48" Q86UV5 1 21678298-21783606 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030045, HPA030046" Approved Supported Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA030045: AB_10670833, HPA030046: AB_10603325" "unprognostic (1.35e-1)" "unprognostic (3.72e-1)" "unprognostic (5.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (6.09e-8)" "unprognostic (1.04e-2)" "unprognostic (3.01e-3)" "unprognostic (9.30e-2)" "unprognostic (7.54e-2)" "unprognostic (4.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-1)" "unprognostic (5.70e-2)" "unprognostic (2.80e-2)" 20.1 38.8 18.6 28.9 30.9 30.9 22.1 48.2 27.5 19.9 18.4 25.6 15.4 17.6 21.3 17.6 19.0 17.4 20.5 17.8 16.9 15.8 15.5 18.3 18.3 26.2 26.6 22.5 27.0 19.8 24.6 35.4 23.1 26.8 21.6 22.0 22.1 24.5 16.3 17.0 23.9 22.2 22.2 19.7 29.1 26.2 15.8 23.6 25.8 23.9 14.0 29.0 19.8 21.0 13.7 10.5 33.7 9.6 5.6 11.2 5.6 14.9 7.1 16.8 12.1 14.6 18.0 16.6 18.8 12.8 12.7 16.8 6.5 15.3 16.8 12.7 17.0 9.9 13.8 20.6 15.2 19.3 16.3 14.1 35.9 26.5 11.8 13.0 18.0 19.2 14.6 13.1 12.8 14.3 17.4 37.2 12.8 28.2 47.5 15.5 7.4 14.9 23.4 10.5 15.3 12.8 21.0 16.9 19.6 14.5 12.6 20.5 12.8 17.7 16.3 42.5 23.5 8.3 21.8 26.4 13.7 11.2 16.7 10.9 38.2 27.1 16.7 13.2 22.3 20.0 33.7 9.6 16.7 6.4 4.6 7.6 13.7 9.5 9.5 10.5 12.8 11.2 7.0 8.9 5.6 5.0 7.7 10.1 5.6 18.6 30.9 48.2 27.5 16.9 15.8 26.6 22.5 26.8 23.6 50.6 38.5 34.3 22.6 19.7 74.8 58.2 22.9 32.1 20.5 19.2 58.9 51.8 21.6 25.0 51.8 24.5 18.7 70.0 17.5 50.1 30.9 20.6 47.5 21.2 26.0 47.7 20.8 28.3 22.2 33.0 32.2 24.7 55.6 47.7 26.9 29.1 20.0 17.5 48.4 16.5 69.2 32.3 25.0 42.9 48.2 22.5 27.2 35.5 30.2 17.1 USP51 ENSG00000247746 "Ubiquitin specific peptidase 51" Q70EK9 X 55484616-55489202 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 34.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 24.4;Ciliated cells: 17.4;Muller glia cells: 29.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 2.4;naive CD4 T-cell: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 10.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA001942 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA001942: AB_1080536" "unprognostic (1.19e-2)" "unprognostic (4.65e-2)" "unprognostic (3.67e-2)" "unprognostic (1.02e-3)" "unprognostic (8.08e-2)" "unprognostic (3.26e-1)" "unprognostic (3.17e-3)" "unprognostic (2.07e-3)" "unprognostic (5.69e-2)" "prognostic favorable (5.70e-4)" "unprognostic (1.01e-3)" "unprognostic (1.27e-1)" "prognostic favorable (2.63e-5)" "unprognostic (2.81e-3)" "unprognostic (5.92e-2)" "unprognostic (5.85e-2)" "unprognostic (1.63e-1)" 0.6 2.7 2.0 0.3 2.9 0.1 0.9 2.3 1.8 1.4 0.6 0.0 1.8 34.1 0.2 3.4 0.3 1.0 1.8 3.7 2.2 0.5 0.7 0.4 1.6 4.1 0.8 3.6 1.8 1.3 1.3 0.3 0.3 1.5 0.0 0.5 0.5 1.1 1.4 0.9 0.3 1.3 3.2 0.5 0.7 0.5 0.9 0.0 2.4 0.0 0.6 2.4 0.1 0.0 0.8 5.4 1.6 2.7 1.4 0.0 0.9 0.4 1.0 1.3 1.7 0.7 0.0 6.4 1.2 1.1 0.3 1.4 0.6 1.6 1.7 0.1 1.4 0.3 0.0 1.1 3.3 0.3 5.5 0.1 0.6 0.0 0.4 0.3 4.1 4.1 4.1 0.9 3.5 3.2 1.7 6.7 0.0 0.3 4.6 1.0 2.1 1.3 0.2 0.0 1.1 1.5 0.2 5.0 10.2 1.3 1.7 0.2 2.1 2.9 0.5 0.1 6.5 2.6 1.3 1.4 1.8 1.4 0.0 0.0 2.4 0.3 0.0 0.0 0.6 0.6 0.0 0.0 0.9 2.4 0.2 0.0 0.6 0.0 0.0 0.0 0.1 3.0 5.6 0.0 1.7 0.8 24.4 5.0 0.0 17.4 3.4 3.5 5.9 3.4 8.3 1.0 0.3 5.8 0.0 0.0 0.0 2.1 4.3 1.1 1.1 0.8 6.1 6.4 3.5 4.9 3.9 0.8 3.7 2.5 5.0 0.0 0.3 29.9 0.3 0.0 7.8 12.2 15.2 0.0 3.9 3.6 6.7 0.4 2.3 1.7 0.2 0.4 UST 2OST ENSG00000111962 "Uronyl 2-sulfotransferase" Q9Y2C2 6 148747328-149076990 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 17.0;Muller glia cells: 13.3;Peritubular cells: 10.6;Suprabasal keratinocytes: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032022 Approved NA NA "HPA032022: AB_10603326" "unprognostic (3.43e-1)" "unprognostic (1.90e-1)" "unprognostic (7.87e-3)" "unprognostic (3.22e-5)" "unprognostic (1.83e-3)" "unprognostic (1.50e-1)" "unprognostic (5.71e-2)" "unprognostic (1.96e-2)" "unprognostic (8.31e-3)" "unprognostic (2.67e-2)" "unprognostic (3.63e-2)" "unprognostic (1.11e-1)" "unprognostic (9.25e-3)" "unprognostic (9.48e-2)" "unprognostic (1.07e-1)" "unprognostic (2.51e-2)" "unprognostic (3.02e-2)" 8.6 16.0 4.8 7.1 9.3 0.8 8.5 20.9 10.8 12.8 8.6 6.0 6.6 2.6 10.8 8.1 8.2 10.4 12.2 4.5 6.3 12.6 5.2 2.2 8.6 4.9 14.1 4.5 15.6 19.0 0.7 2.3 6.1 13.0 9.8 4.0 10.7 4.3 6.9 3.7 8.6 5.6 11.5 9.1 8.0 5.7 12.1 6.5 3.1 37.5 5.7 4.9 10.6 21.0 1.5 1.3 0.1 0.9 6.2 1.7 0.4 0.0 2.1 12.0 9.2 14.6 12.2 0.1 5.1 13.4 2.5 6.5 0.0 0.8 4.2 1.1 7.9 6.3 3.7 8.5 4.3 5.1 5.6 6.4 0.1 6.8 0.1 5.4 0.2 1.8 6.2 9.7 6.5 12.1 5.1 0.1 7.1 0.0 0.0 2.0 5.3 0.0 0.0 7.0 20.7 2.7 2.0 1.6 4.9 0.1 9.6 6.2 0.0 17.0 4.2 3.1 9.0 3.1 0.2 0.2 7.3 0.8 1.6 4.5 0.0 0.0 0.0 8.1 3.4 4.1 0.0 0.2 0.0 1.7 0.7 1.4 0.8 1.3 1.5 1.1 1.5 0.1 0.7 0.1 6.2 0.9 1.3 0.4 0.4 4.8 9.3 20.9 7.4 6.3 12.6 14.1 4.5 13.0 6.5 3.0 2.7 0.5 4.2 8.4 0.0 1.2 0.0 1.4 1.2 1.8 0.0 1.4 0.0 0.1 0.6 0.1 0.0 0.0 1.7 0.2 8.1 4.2 0.0 0.0 1.4 0.0 0.0 2.5 1.3 2.6 17.0 1.1 5.0 1.0 1.4 13.3 1.5 0.0 10.6 0.4 0.4 0.0 2.2 1.7 3.2 10.2 1.1 1.5 0.6 6.8 UTS2B "U2B, URP, UTS2D" ENSG00000188958 "Urotensin 2B" Q765I0 3 191267168-191330536 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 19.0" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Early spermatids: 5.1;Late spermatids: 1.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "amygdala: 19.0" "Cell type enhanced" "Detected in some" "memory B-cell: 6.2;naive B-cell: 3.0" "Lineage enriched" "Detected in many" 5 "B-cells: 6.2" "Cell line enhanced" "Detected in many" "PC-3: 7.2" HPA026992 Uncertain "Secreted - unknown location" NA NA "HPA026992: AB_1858703" "unprognostic (1.73e-2)" "unprognostic (4.38e-2)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (1.92e-1)" "unprognostic (2.17e-2)" "unprognostic (2.77e-2)" "unprognostic (2.14e-2)" "unprognostic (3.09e-1)" "unprognostic (2.63e-2)" "unprognostic (3.39e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (7.58e-2)" "unprognostic (2.08e-1)" "unprognostic (1.29e-1)" "unprognostic (3.10e-2)" 1.1 1.5 19.0 0.7 0.8 0.2 1.6 0.5 2.5 0.6 0.6 0.8 0.5 7.7 1.5 0.5 0.6 1.0 3.0 0.9 1.5 1.2 0.5 4.8 0.6 0.9 0.8 0.5 1.7 4.1 0.0 0.5 0.5 1.0 0.5 0.1 0.5 0.5 0.5 0.5 1.3 4.2 0.5 1.1 1.1 1.9 2.9 0.5 0.5 0.5 0.5 0.8 0.9 0.7 6.2 1.2 0.1 0.1 0.0 0.1 0.1 0.9 2.1 2.9 1.4 0.8 3.7 0.9 2.1 1.2 0.8 0.4 1.5 1.1 1.4 1.1 1.0 5.8 1.1 0.9 0.0 3.5 1.4 1.0 1.3 2.8 6.1 0.7 1.6 0.8 1.5 0.4 0.5 0.6 1.9 0.8 1.2 0.9 1.4 1.1 1.2 0.4 1.2 1.6 2.7 7.2 1.8 3.4 0.5 0.4 3.6 1.6 1.0 1.3 1.5 0.8 1.3 1.2 1.0 3.0 1.6 0.9 2.8 0.8 2.3 1.3 1.4 1.9 1.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 6.2 0.1 0.0 0.0 3.0 0.1 0.1 0.1 0.0 0.1 1.2 0.1 0.1 19.0 0.8 0.5 2.5 1.5 1.2 0.8 0.5 1.0 0.5 3.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.7 0.9 0.3 0.2 0.0 0.0 0.0 UTS2R GPR14 ENSG00000181408 "Urotensin 2 receptor" Q9UKP6 17 82374230-82375586 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 6.2;thyroid gland: 3.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "stomach cancer: 0.7;testis cancer: 2.2;thyroid cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Karpas-707: 7.8;U-266/70: 19.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (1.55e-3)" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (3.92e-1)" "unprognostic (1.46e-2)" "unprognostic (8.26e-2)" "unprognostic (2.30e-2)" "unprognostic (3.98e-1)" "unprognostic (6.38e-2)" "unprognostic (4.44e-2)" "unprognostic (8.73e-2)" "unprognostic (1.81e-1)" "unprognostic (1.32e-1)" "unprognostic (7.84e-2)" 0.0 0.0 0.1 0.5 0.0 0.4 0.2 0.4 1.7 0.0 0.7 1.5 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.1 0.7 0.0 0.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.6 0.0 1.1 0.0 0.7 0.0 0.0 0.7 0.7 6.2 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.2 0.0 2.2 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 19.2 3.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UTY "KDM6AL, KDM6C" ENSG00000183878 "Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked" O14607 Y 13248379-13480673 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 14.9;U-266/84: 11.4;U-698: 14.9" "HPA000568, HPA001165" Supported Approved "Nucleoplasm,Nucleoli,Nucleoli rim" "Intracellular and membrane" NA NA Nucleoplasm "Nucleoli, Nucleoli rim" "HPA000568: AB_1858705, HPA001165: AB_1080541" "unprognostic (7.52e-2)" "unprognostic (6.60e-2)" "unprognostic (4.04e-6)" "unprognostic (6.47e-2)" "unprognostic (9.34e-2)" "unprognostic (2.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (1.41e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.46e-2)" 5.3 5.1 3.0 15.4 10.3 9.0 5.1 6.1 11.0 0.4 8.4 18.0 18.4 4.3 0.4 16.5 7.2 0.4 6.5 4.7 3.5 3.4 5.0 6.9 11.9 19.0 3.3 0.0 0.5 15.1 0.4 6.3 5.9 13.0 14.0 10.6 16.8 10.9 16.1 9.3 7.4 10.1 18.6 4.8 17.4 5.7 6.7 0.0 37.7 6.3 10.3 22.0 7.2 0.0 6.1 4.8 6.6 3.8 9.9 6.7 1.3 0.0 1.8 0.0 0.0 0.0 0.0 6.6 3.3 5.7 3.7 5.7 0.0 0.0 9.0 0.0 3.8 0.0 0.0 0.0 0.0 5.3 4.9 0.0 14.9 0.1 0.0 4.9 0.0 0.0 6.0 5.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 4.1 0.0 5.1 0.1 0.0 0.0 0.0 0.0 2.4 4.0 4.1 6.1 3.7 0.0 0.0 0.0 10.7 6.8 0.0 3.2 4.3 6.6 0.0 0.0 2.3 10.2 11.4 14.9 0.6 0.0 0.0 1.8 2.8 5.8 4.7 3.4 6.7 5.0 4.6 3.6 3.0 6.1 6.5 4.7 6.6 9.9 3.8 4.8 5.3 1.3 3.0 10.3 6.1 11.0 3.5 3.4 3.3 0.0 13.0 0.0 14.9 22.3 25.2 17.2 10.1 30.4 5.2 2.5 10.7 13.6 17.4 60.9 8.5 0.0 2.9 0.3 7.7 1.0 0.0 0.0 2.7 7.6 12.2 15.1 0.0 2.4 35.0 1.7 8.6 13.3 0.9 10.0 15.3 8.5 10.8 0.0 18.3 2.5 0.0 11.0 1.3 38.6 0.0 6.2 1.8 5.9 13.4 11.1 21.3 0.0 16.0 UXS1 "FLJ23591, SDR6E1, UGD" ENSG00000115652 "UDP-glucuronate decarboxylase 1" Q8NBZ7 2 106093303-106194339 "Enzymes, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 83.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008825 Uncertain "Intracellular and membrane" NA NA 10000 "HPA008825: AB_1858708" "unprognostic (4.08e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (3.63e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (5.45e-4)" "prognostic unfavorable (1.38e-4)" "unprognostic (3.20e-3)" "unprognostic (2.07e-1)" "prognostic favorable (7.94e-4)" "unprognostic (3.95e-2)" "unprognostic (1.40e-2)" "unprognostic (8.46e-2)" "unprognostic (3.96e-2)" "unprognostic (6.18e-2)" "unprognostic (1.86e-2)" "unprognostic (5.32e-2)" 12.3 11.7 15.2 17.3 19.9 20.7 20.1 23.0 20.5 14.1 13.3 11.9 27.6 9.5 16.1 22.3 15.6 19.2 16.2 20.0 17.0 18.2 40.2 16.1 28.8 20.7 15.1 11.6 16.3 17.0 18.6 13.4 37.9 19.6 16.2 15.6 14.7 11.6 17.6 18.0 11.5 9.9 13.8 22.9 19.7 17.9 19.4 10.6 15.0 26.2 14.1 19.1 21.6 15.3 11.6 7.5 11.2 9.8 11.9 34.1 15.1 16.5 12.5 13.2 10.0 23.6 17.6 28.6 18.3 17.2 13.0 16.2 24.5 28.3 3.0 22.8 18.9 29.2 8.4 5.7 15.0 14.2 15.9 10.0 9.1 5.6 27.5 9.3 7.4 10.1 11.4 16.6 13.2 8.9 15.1 13.6 5.8 5.3 7.3 26.8 11.8 8.2 15.9 15.5 16.0 16.8 15.3 10.0 8.5 83.9 15.6 4.4 4.9 13.1 11.8 10.8 18.6 4.4 23.6 12.2 14.6 15.3 11.8 11.3 9.0 12.4 4.1 14.5 16.6 26.7 3.9 9.8 11.2 8.8 8.0 9.5 4.9 19.6 14.3 7.5 11.6 25.4 17.6 2.0 11.9 5.3 5.4 34.1 15.1 15.2 19.9 23.0 20.5 17.0 18.2 15.1 11.6 19.6 10.6 83.4 72.6 12.3 22.3 14.9 9.1 15.3 22.9 29.4 61.4 82.0 3.9 59.1 43.1 42.5 42.6 18.9 11.0 23.3 21.9 60.0 31.9 15.7 28.9 12.9 29.5 7.9 6.3 8.6 19.8 11.4 14.1 25.4 13.5 80.2 14.3 10.0 25.7 10.5 12.0 16.7 6.8 19.4 20.8 11.9 59.8 11.5 20.6 30.5 19.9 15.5 VAMP1 "SYB1, VAMP-1" ENSG00000139190 "Vesicle associated membrane protein 1" P23763 12 6462237-6470987 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.7;brain: 85.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "U-698: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002779, CAB016119, CAB079000" Approved Supported NA NA "CAB002779: , CAB016119: AB_628309, CAB079000: " "unprognostic (2.33e-1)" "unprognostic (6.72e-3)" "prognostic unfavorable (6.37e-5)" "unprognostic (8.09e-3)" "unprognostic (2.17e-1)" "unprognostic (1.14e-3)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.22e-2)" "unprognostic (6.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.40e-3)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.04e-11)" "unprognostic (1.47e-2)" "unprognostic (5.99e-2)" "unprognostic (1.62e-1)" "unprognostic (3.65e-2)" 3.4 6.8 10.2 13.7 12.8 38.7 4.2 9.8 53.1 5.7 8.0 11.1 1.6 4.7 8.7 5.4 3.9 5.1 5.2 4.0 14.1 25.4 3.2 4.3 5.3 24.3 33.5 10.0 3.8 2.4 1.1 3.1 2.4 85.2 8.6 8.8 4.8 6.3 7.6 4.0 4.2 7.9 7.7 31.3 12.4 5.4 3.7 8.3 3.7 7.9 0.8 23.0 5.0 4.7 5.5 2.5 13.4 1.0 2.1 7.0 2.5 0.9 3.5 1.9 2.6 5.7 6.6 2.2 1.8 3.5 1.9 5.5 1.1 3.2 9.9 0.4 4.4 1.9 3.0 2.3 1.0 2.8 7.8 5.5 1.5 10.4 1.2 2.7 3.8 3.8 4.8 0.4 2.5 1.4 6.5 1.7 4.4 0.5 2.9 4.3 1.0 5.0 4.4 9.4 0.4 1.5 5.5 3.1 1.8 1.2 1.3 0.4 0.8 3.8 2.0 1.4 10.8 0.6 1.5 2.1 0.9 3.0 2.0 1.2 2.6 1.0 67.8 3.6 8.0 0.7 6.9 1.0 13.4 6.7 0.4 5.3 5.5 5.5 6.2 1.1 1.3 5.8 4.8 5.5 2.1 0.5 2.5 7.0 2.5 10.2 12.8 9.8 53.1 14.1 25.4 33.5 10.0 85.2 8.3 6.0 1.3 8.2 2.7 1.0 16.3 1.4 2.5 4.0 2.3 0.0 5.9 0.3 1.7 0.2 0.3 2.2 1.7 0.0 0.4 0.7 2.6 2.4 10.4 3.2 1.4 1.6 4.6 2.5 1.8 0.4 3.4 2.4 0.0 4.6 1.2 6.1 0.5 0.9 4.6 0.3 6.8 6.5 3.6 2.3 2.6 0.6 0.1 9.2 1.5 0.8 VAMP2 "SYB2, VAMP-2" ENSG00000220205 "Vesicle associated membrane protein 2" P63027 17 8159149-8163546 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 168.0" "Cell type enhanced" "Detected in all" 7 "Bipolar cells: 1189.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB078785 Supported NA NA "CAB078785: " "unprognostic (8.25e-2)" "unprognostic (4.41e-2)" "unprognostic (1.58e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.81e-2)" "unprognostic (1.15e-1)" "unprognostic (1.43e-2)" "unprognostic (7.28e-2)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "prognostic favorable (3.83e-6)" "unprognostic (8.27e-2)" "prognostic favorable (9.76e-8)" "unprognostic (1.21e-2)" "unprognostic (7.00e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" 22.0 38.3 65.1 16.2 111.7 57.4 20.2 72.2 168.0 20.1 16.3 51.6 11.6 15.7 27.4 24.1 11.6 26.8 14.4 22.1 61.7 56.5 23.5 11.4 21.0 23.1 52.7 71.1 48.4 22.6 52.2 40.6 15.4 88.4 25.1 19.3 37.5 19.5 27.0 33.6 25.0 17.9 25.2 30.7 27.2 17.4 15.1 35.1 9.2 22.0 8.8 22.8 11.7 16.0 25.1 15.4 37.8 8.8 25.1 33.4 9.3 13.8 10.4 25.8 13.8 22.7 17.8 11.6 13.0 16.5 13.3 18.3 4.1 9.5 15.8 9.3 20.8 12.5 16.9 16.9 14.0 15.4 18.3 18.5 11.0 26.7 5.6 20.4 7.3 17.1 19.6 21.1 15.3 23.0 27.5 12.9 27.7 8.5 18.4 22.5 7.3 19.1 10.1 5.9 9.3 7.7 24.4 11.8 12.4 17.2 9.3 12.0 19.2 10.2 5.7 12.7 11.8 13.0 9.5 19.7 8.1 11.2 14.8 12.0 20.3 11.5 11.4 20.6 12.8 18.3 13.7 7.4 24.5 28.4 6.9 24.4 25.1 28.2 30.0 5.7 22.1 33.4 30.8 37.8 25.1 8.8 15.4 20.1 9.3 65.1 111.7 72.2 168.0 61.7 56.5 52.7 71.1 88.4 35.1 38.7 21.2 219.6 147.9 101.1 1189.4 24.3 147.7 17.4 34.2 219.8 233.7 157.6 334.9 66.7 5.4 128.8 97.5 23.3 73.0 75.1 142.8 110.4 150.8 68.4 95.0 440.2 310.2 154.7 94.0 5.9 242.4 101.2 183.9 129.8 134.5 437.1 85.1 111.2 202.6 152.5 445.5 291.1 199.4 106.5 119.6 131.7 267.6 252.2 82.9 115.3 VAMP3 CEB ENSG00000049245 "Vesicle associated membrane protein 3" Q15836 1 7771269-7781432 "Cancer-related genes, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.09e-2)" "unprognostic (4.03e-1)" "unprognostic (3.39e-3)" "unprognostic (2.95e-1)" "unprognostic (9.15e-3)" "unprognostic (3.86e-3)" "unprognostic (9.49e-3)" "unprognostic (2.00e-1)" "unprognostic (7.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.83e-3)" "unprognostic (2.17e-1)" "prognostic favorable (2.36e-4)" "unprognostic (1.02e-1)" "unprognostic (2.85e-1)" "unprognostic (9.52e-2)" "unprognostic (3.30e-2)" 52.6 35.6 36.0 20.3 43.9 42.4 35.9 14.8 37.6 37.1 28.8 92.8 19.3 27.0 45.3 30.1 40.5 29.4 28.2 32.8 38.9 30.4 38.3 27.2 39.3 25.8 63.3 26.1 35.9 17.8 31.7 24.9 45.4 50.2 31.4 32.9 41.3 23.1 37.9 34.8 33.6 41.5 37.7 90.6 34.2 26.3 25.4 48.2 14.7 30.0 37.1 26.8 36.4 29.9 5.1 15.8 31.2 26.0 6.8 7.4 9.5 19.1 13.7 14.8 17.6 40.6 45.9 10.4 34.7 39.4 37.4 35.4 14.9 24.9 2.5 19.6 43.6 19.1 16.8 16.1 23.4 48.1 2.0 20.1 12.4 12.8 20.7 26.4 7.3 12.3 37.3 17.6 26.5 21.7 37.0 45.0 5.7 12.7 11.8 52.0 8.6 5.5 6.5 6.5 21.6 24.1 4.6 21.5 7.8 29.2 11.1 4.0 15.5 30.1 14.9 31.0 18.5 15.0 7.8 39.8 33.7 11.6 34.8 16.6 9.8 13.2 7.5 38.5 29.8 26.4 17.4 22.6 22.3 6.3 26.0 6.4 5.1 6.0 5.5 15.8 4.4 4.9 5.2 31.2 6.8 22.5 5.2 7.4 9.5 36.0 43.9 14.8 37.6 38.9 30.4 63.3 26.1 50.2 48.2 44.7 33.7 17.9 51.0 38.7 12.1 38.3 22.9 33.5 28.4 38.4 3.9 70.0 54.7 60.2 19.5 76.7 51.9 0.0 44.0 93.9 39.8 49.7 55.6 30.6 70.0 7.9 30.0 58.9 66.5 9.8 30.0 70.1 54.0 65.9 37.0 79.1 68.1 40.3 44.2 73.6 8.3 45.3 66.3 48.4 39.6 44.8 95.8 20.8 36.2 80.6 VAMP4 ENSG00000117533 "Vesicle associated membrane protein 4" O75379 1 171700160-171742247 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050418 Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA050418: AB_2681121" "unprognostic (9.38e-2)" "unprognostic (7.09e-2)" "unprognostic (1.85e-1)" "unprognostic (2.53e-1)" "unprognostic (9.66e-2)" "unprognostic (6.97e-2)" "unprognostic (1.05e-2)" "unprognostic (3.69e-3)" "unprognostic (5.10e-2)" "unprognostic (3.14e-2)" "unprognostic (2.87e-1)" "unprognostic (4.80e-2)" "prognostic unfavorable (5.43e-6)" "unprognostic (8.92e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-2)" "unprognostic (1.15e-1)" 16.0 20.1 14.3 13.0 25.3 7.3 14.1 24.3 22.9 13.2 12.3 12.7 15.6 12.3 13.9 14.4 13.8 10.9 13.2 12.1 16.1 16.1 13.1 13.0 16.3 16.0 16.0 21.6 11.7 15.7 19.8 30.3 16.0 26.8 12.2 11.6 17.2 15.5 20.6 9.0 15.4 12.1 12.9 20.6 14.9 13.3 18.3 15.3 13.2 18.5 7.5 13.0 14.2 13.7 9.5 7.3 12.8 10.4 10.4 14.6 10.8 6.7 2.2 6.1 4.9 9.2 10.9 3.9 12.4 9.9 3.1 3.9 1.9 9.1 4.3 11.2 10.0 4.7 4.6 2.4 4.1 4.5 7.6 3.6 3.6 3.0 1.6 5.6 3.1 2.8 4.9 7.3 3.8 7.3 8.9 5.7 5.9 8.8 5.3 6.6 2.3 7.4 4.3 2.9 13.2 8.7 6.3 4.7 11.1 6.5 2.2 3.7 7.1 6.2 6.6 5.2 7.0 9.0 5.9 6.6 9.8 3.3 13.8 11.8 19.4 16.1 5.8 15.0 2.8 7.7 10.0 10.4 12.8 10.5 8.4 14.6 9.5 14.2 12.0 4.9 7.6 10.2 10.9 3.8 10.4 8.3 7.3 12.4 10.8 14.3 25.3 24.3 22.6 16.1 16.1 16.0 21.6 26.8 15.3 20.8 9.4 6.5 12.4 13.7 11.3 10.7 7.6 9.4 9.1 3.5 21.6 9.7 13.3 7.2 21.1 18.0 10.3 0.0 6.7 12.0 18.5 15.5 24.3 12.9 13.6 9.5 9.8 14.7 13.3 31.4 8.6 10.6 11.8 9.0 12.2 13.4 8.5 14.4 12.4 11.1 8.5 19.4 12.9 28.6 17.6 15.2 11.2 20.3 6.9 12.8 VAMP5 ENSG00000168899 "Vesicle associated membrane protein 5" O95183 2 85584408-85593412 "Predicted membrane proteins" "Differentiation, Myogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 294.0;Ito cells: 443.2;Kupffer cells: 298.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 34.3;HUVEC TERT2: 64.1;LHCN-M2: 75.3;TIME: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035082 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA035082: AB_10610564" "unprognostic (1.92e-1)" "unprognostic (3.09e-2)" "unprognostic (6.09e-2)" "unprognostic (1.13e-2)" "unprognostic (4.16e-2)" "unprognostic (1.25e-3)" "unprognostic (1.28e-2)" "unprognostic (5.29e-2)" "unprognostic (1.17e-2)" "unprognostic (3.49e-2)" "unprognostic (2.22e-1)" "unprognostic (7.59e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (9.61e-3)" "unprognostic (3.46e-2)" "unprognostic (1.71e-2)" "unprognostic (2.60e-1)" 26.2 25.8 12.6 18.9 14.1 11.7 27.5 4.3 9.2 17.9 22.1 8.5 9.2 7.6 18.9 27.2 24.3 18.3 18.8 37.0 11.0 10.9 18.5 31.2 28.8 32.1 16.8 9.6 19.6 6.3 3.2 7.2 24.4 17.7 29.0 6.9 16.0 7.7 13.0 70.9 9.5 17.0 25.5 14.1 33.3 12.3 13.7 8.1 18.0 17.5 19.8 13.0 21.8 25.8 10.2 13.8 27.5 80.4 14.3 39.4 39.3 0.1 0.0 0.4 0.0 16.3 28.6 0.4 17.3 27.5 17.0 18.8 6.8 2.6 0.0 0.4 29.9 9.2 0.2 0.0 0.4 7.6 24.5 0.5 0.3 0.4 9.5 34.3 0.7 0.1 19.8 1.7 7.1 0.2 25.1 64.1 10.9 0.0 0.0 75.3 2.4 10.6 2.3 0.0 4.7 0.1 15.9 0.0 0.4 0.4 0.6 0.0 0.6 0.1 4.9 0.1 0.4 0.5 0.8 43.8 0.4 1.2 1.3 0.0 0.0 0.5 0.4 20.0 0.9 11.6 8.2 38.1 27.5 31.7 80.4 29.8 9.7 24.1 23.5 12.8 10.2 18.5 22.3 11.8 14.3 64.4 13.8 39.4 39.3 12.6 14.1 4.3 9.2 11.0 10.9 16.8 9.6 17.7 8.1 17.9 30.0 50.0 38.6 54.0 0.8 75.5 81.5 29.4 37.5 41.8 0.0 16.6 24.9 28.6 1.2 294.0 58.6 0.0 43.2 6.9 187.6 42.9 43.8 141.5 73.6 3.2 12.1 443.2 298.8 4.7 178.4 77.9 261.5 100.0 11.0 11.5 39.6 48.9 155.2 64.7 0.5 58.2 94.7 4.8 3.2 39.5 18.1 106.6 7.6 32.9 VAMP7 "SYBL1, TI-VAMP, VAMP-7" ENSG00000124333 "Vesicle associated membrane protein 7" P51809 X 155881293-155943769 "Predicted intracellular proteins, Predicted membrane proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036733 Approved Supported Vesicles NA NA 14000 Vesicles "HPA036733: AB_10672228" "unprognostic (7.54e-3)" "unprognostic (1.35e-2)" "unprognostic (2.07e-1)" "unprognostic (1.04e-1)" "unprognostic (6.15e-3)" "unprognostic (2.70e-2)" "unprognostic (5.77e-2)" "unprognostic (7.95e-2)" "unprognostic (7.18e-2)" "unprognostic (3.38e-3)" "unprognostic (1.02e-1)" "unprognostic (1.15e-1)" "prognostic favorable (2.83e-4)" "unprognostic (1.29e-1)" "unprognostic (3.42e-1)" "unprognostic (2.47e-1)" "unprognostic (2.97e-1)" 11.9 12.7 43.9 9.5 51.2 13.4 51.9 21.2 41.1 38.4 9.3 2.5 2.5 9.6 36.5 6.6 10.4 8.5 9.3 26.9 46.8 12.5 61.4 20.5 10.3 9.8 50.6 44.8 34.5 7.9 12.8 35.0 68.7 58.5 9.4 10.5 2.5 8.3 9.0 12.0 9.3 11.3 12.0 63.0 8.4 8.4 5.6 47.6 2.5 10.4 2.5 11.6 10.2 26.1 6.6 13.5 34.8 13.8 11.2 11.0 10.6 22.4 9.8 6.8 14.0 18.8 18.1 18.2 17.5 15.6 15.9 32.2 10.6 14.8 31.3 32.6 21.0 18.0 8.1 15.2 12.3 21.1 13.0 13.3 13.0 14.6 7.5 21.1 26.6 20.4 16.8 12.3 17.7 16.3 13.9 17.6 13.8 27.7 17.4 17.9 11.3 10.3 15.2 4.8 16.8 14.5 7.9 13.3 23.2 21.0 11.3 5.1 14.9 10.3 10.5 15.3 18.6 10.2 22.4 18.5 14.6 15.3 20.9 24.8 40.1 50.6 43.8 12.8 32.7 16.2 34.8 12.9 19.7 8.3 13.8 10.5 6.5 9.9 10.2 13.5 6.6 9.2 9.8 11.2 11.2 12.8 7.7 11.0 10.6 43.9 51.2 21.2 41.1 46.8 12.5 50.6 44.8 58.5 47.6 3.0 8.6 21.6 11.9 17.4 6.6 9.9 7.6 4.0 9.1 7.0 5.9 42.4 34.9 22.9 5.2 19.6 15.5 46.7 22.8 35.9 25.1 14.3 31.1 21.3 28.1 6.4 12.7 19.6 24.4 4.9 16.4 30.8 18.6 24.4 14.5 10.4 23.3 14.0 18.4 39.8 4.1 25.8 22.8 23.4 25.8 16.9 58.4 26.6 14.5 14.2 VAMP8 EDB ENSG00000118640 "Vesicle associated membrane protein 8" Q9BV40 2 85561562-85582031 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 172.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 82.0;NB-4: 128.2;THP-1: 63.7;U-937: 85.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006882, HPA007215, CAB037132, CAB037147" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 210000 "Golgi apparatus, Plasma membrane" Nucleoplasm "CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: " "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "unprognostic (7.46e-3)" "unprognostic (1.13e-1)" "unprognostic (7.33e-2)" "unprognostic (1.31e-1)" "unprognostic (1.76e-2)" "unprognostic (3.79e-3)" "unprognostic (3.83e-2)" "unprognostic (4.15e-1)" "unprognostic (2.74e-2)" "unprognostic (8.62e-2)" "unprognostic (1.57e-3)" "unprognostic (1.92e-2)" "unprognostic (2.16e-1)" "prognostic favorable (8.07e-9)" "prognostic favorable (1.59e-6)" 16.5 8.2 7.1 20.7 11.2 27.6 24.2 1.9 6.2 16.3 49.4 5.7 43.5 24.1 6.0 25.5 65.4 17.1 28.8 13.0 4.7 3.8 67.7 46.5 53.1 48.0 10.5 3.2 7.1 58.0 15.4 8.3 108.1 11.9 22.1 31.9 7.7 90.7 40.4 9.0 43.3 87.1 6.8 10.4 53.5 28.7 5.5 8.4 24.5 47.5 35.4 34.9 20.6 30.4 39.2 172.5 37.7 69.7 41.4 51.3 100.9 23.9 3.1 0.2 0.2 0.2 0.1 23.9 0.0 0.0 0.0 0.0 17.8 22.0 5.3 17.4 0.1 1.8 17.0 0.2 42.9 0.0 21.8 16.6 27.6 10.6 20.2 0.3 82.0 28.6 0.2 30.5 0.0 7.1 0.1 5.5 0.1 19.7 1.1 9.8 33.6 0.0 128.2 0.3 30.0 2.5 0.5 0.9 36.0 49.7 36.0 0.8 0.3 11.7 62.1 1.9 13.0 22.8 63.7 11.0 0.0 1.5 0.3 0.2 0.3 13.5 31.4 0.3 85.1 0.1 37.7 69.7 25.2 40.4 57.7 38.8 39.2 46.8 39.5 63.5 37.8 37.3 39.1 4.5 41.4 34.3 172.5 51.3 100.9 7.1 11.2 1.9 6.2 4.7 3.8 10.5 3.2 11.9 8.4 345.4 256.8 171.2 244.0 230.2 1.1 5.5 331.2 341.3 271.8 347.2 0.0 869.6 648.2 536.4 20.3 29.2 900.3 0.0 637.4 386.9 34.1 294.8 263.2 244.8 1050.6 0.0 124.1 155.3 836.3 34.0 8.6 660.7 334.0 762.0 322.8 2.4 674.2 501.5 7.1 797.0 1.6 45.3 25.8 28.4 6.4 288.3 734.1 248.2 230.6 528.7 VANGL1 STB2 ENSG00000173218 "VANGL planar cell polarity protein 1" Q8TAA9 1 115641953-115698224 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 37.3;Ito cells: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.5;NK-cells: 8.9;T-cells: 4.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA025235, CAB076375" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "CAB076375: AB_2665604, HPA025235: AB_1858718" "unprognostic (1.04e-2)" "unprognostic (2.04e-2)" "prognostic favorable (7.53e-4)" "unprognostic (9.94e-2)" "unprognostic (1.71e-2)" "unprognostic (5.18e-2)" "unprognostic (2.18e-3)" "unprognostic (5.11e-3)" "unprognostic (2.11e-1)" "unprognostic (6.43e-3)" "prognostic unfavorable (7.89e-4)" "unprognostic (1.88e-2)" "unprognostic (1.74e-2)" "unprognostic (7.71e-3)" "unprognostic (1.21e-1)" "unprognostic (4.50e-3)" "unprognostic (9.06e-3)" 7.0 8.6 2.2 5.8 3.1 2.0 16.4 1.2 2.5 14.0 9.3 5.3 8.3 4.0 13.2 8.8 14.4 13.7 5.3 12.7 3.2 2.3 11.8 7.1 12.1 7.4 2.1 1.9 8.9 11.5 5.5 2.2 5.3 2.4 9.4 7.1 6.6 9.5 11.0 2.1 9.8 6.6 15.9 2.0 4.7 6.6 7.9 2.6 18.0 11.8 10.0 10.0 10.2 9.4 0.3 3.5 0.0 0.8 8.9 4.3 1.4 21.5 9.2 3.0 4.0 11.2 10.1 6.0 8.4 6.1 11.0 8.8 5.3 10.8 0.0 14.5 9.7 10.4 27.3 5.0 14.9 7.3 25.2 6.1 12.0 8.5 4.3 4.1 3.5 5.2 5.3 10.5 7.8 8.4 5.8 10.9 20.6 7.2 6.7 11.0 28.8 17.6 1.4 7.5 12.6 8.8 0.0 8.7 6.2 5.1 14.5 2.7 3.6 15.1 10.0 7.2 5.9 5.1 3.9 11.6 7.6 12.0 16.5 15.2 0.9 1.0 0.0 10.2 6.3 18.5 0.0 0.8 0.0 3.0 0.5 0.8 0.3 1.9 2.9 3.5 0.0 0.7 3.3 0.0 8.9 0.8 3.0 4.3 1.4 2.2 3.1 1.2 2.5 3.2 2.3 2.1 1.9 2.4 2.6 3.0 2.7 1.9 6.3 6.5 4.0 6.3 2.5 6.7 1.2 8.7 37.3 3.7 0.0 14.9 4.6 7.7 7.7 0.0 12.1 5.8 6.4 7.0 0.0 2.4 3.8 0.0 6.4 31.9 1.5 1.9 5.5 1.8 0.0 19.0 7.9 4.2 16.1 5.8 7.8 5.7 0.7 6.5 5.7 1.0 9.4 5.6 0.3 1.8 8.3 6.5 VANGL2 "KIAA1215, LPP1, LTAP, MGC119403, MGC119404, STB1, STBM, STBM1" ENSG00000162738 "VANGL planar cell polarity protein 2" Q9ULK5 1 160400586-160428678 "Disease related genes, Predicted membrane proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 39.5" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 31.4;Intestinal endocrine cells: 16.1;Mucus-secreting cells: 15.6;Suprabasal keratinocytes: 14.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 45.8;AN3-CA: 11.3;NTERA-2: 18.5;SH-SY5Y: 12.5;SuSa: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027043 Uncertain NA NA "HPA027043: AB_10601709" "unprognostic (4.32e-3)" "unprognostic (1.86e-1)" "unprognostic (1.59e-2)" "unprognostic (1.07e-3)" "unprognostic (3.05e-1)" "unprognostic (2.55e-1)" "unprognostic (1.72e-1)" "unprognostic (2.13e-1)" "unprognostic (1.84e-3)" "unprognostic (9.83e-2)" "unprognostic (3.84e-1)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (6.58e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-1)" "unprognostic (1.18e-2)" 1.4 2.1 7.5 2.9 6.9 0.6 6.6 18.4 12.6 10.6 6.0 13.5 9.9 5.9 8.1 7.5 11.2 7.1 3.8 4.5 11.7 8.8 3.7 0.7 4.9 5.0 9.5 4.3 10.9 5.6 6.8 4.3 6.8 10.9 10.0 6.4 13.0 11.3 9.8 2.2 39.5 6.8 4.6 11.9 2.5 4.6 2.8 11.8 5.3 9.6 5.4 7.6 7.8 11.6 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.5 0.6 45.8 11.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.2 0.0 5.8 0.0 0.0 2.6 7.5 0.4 0.0 0.0 0.5 2.2 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.1 0.0 1.7 3.4 0.0 0.3 0.0 2.9 0.1 18.5 0.2 0.0 6.0 2.4 0.0 0.0 0.0 4.2 12.5 0.0 0.0 4.0 16.6 0.0 0.6 0.0 0.0 7.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 7.5 6.9 18.4 7.5 11.7 8.8 9.5 4.3 10.9 11.8 0.0 0.3 0.0 2.2 14.1 3.1 2.4 2.5 2.7 1.2 0.0 31.4 0.0 0.0 4.2 1.0 2.0 1.1 0.0 1.4 0.0 2.3 6.4 0.0 0.0 0.1 9.5 16.1 0.6 0.0 0.7 3.4 0.0 6.8 0.0 15.6 4.5 3.3 0.0 6.7 0.4 0.0 0.0 3.8 0.5 3.4 14.9 0.0 0.0 6.4 4.5 VAPA "hVAP-33, VAP-A" ENSG00000101558 "VAMP associated protein A" Q9P0L0 18 9914002-9960021 "Plasma proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009174 Approved Enhanced "Endoplasmic reticulum" NA NA 5300000 "Endoplasmic reticulum" "HPA009174: AB_1080549" "unprognostic (4.03e-2)" "unprognostic (7.47e-2)" "unprognostic (9.36e-2)" "unprognostic (5.20e-2)" "unprognostic (2.00e-1)" "unprognostic (2.99e-2)" "unprognostic (4.79e-3)" "unprognostic (1.80e-1)" "unprognostic (5.39e-2)" "unprognostic (6.80e-3)" "unprognostic (2.99e-2)" "unprognostic (8.11e-2)" "prognostic favorable (5.72e-7)" "unprognostic (1.03e-1)" "unprognostic (1.66e-1)" "unprognostic (1.23e-1)" "unprognostic (5.77e-2)" 27.5 64.8 28.8 21.0 35.5 73.5 27.4 32.9 39.4 24.9 34.3 30.7 19.3 27.8 30.8 23.8 42.3 27.9 29.4 39.9 28.0 30.2 32.7 33.2 35.1 24.6 33.4 28.8 40.6 36.5 25.0 19.4 35.2 48.1 25.2 32.7 18.0 27.9 21.8 55.4 27.6 32.3 28.5 39.1 27.7 34.0 25.2 28.8 36.3 36.4 28.3 22.9 36.0 30.2 24.5 30.6 62.5 37.3 22.2 24.6 39.7 17.3 10.5 12.7 8.3 15.0 16.3 17.8 21.5 17.9 19.6 21.6 14.1 17.3 17.1 20.1 18.8 17.0 12.2 12.3 20.5 22.5 10.6 15.4 27.8 11.2 21.7 35.7 37.5 53.4 15.3 20.8 18.5 22.1 15.4 19.8 14.0 28.0 17.9 17.1 9.3 28.8 21.8 8.2 59.8 16.8 15.1 17.3 23.1 19.1 17.5 18.0 9.8 24.9 15.2 15.4 12.2 14.2 19.4 21.1 32.0 23.8 33.1 26.1 32.1 26.0 20.4 18.1 16.2 21.9 26.1 37.3 62.5 19.3 32.4 22.7 24.5 20.3 20.7 30.6 22.7 22.2 20.4 59.2 22.2 26.4 21.8 24.6 39.7 28.8 35.5 32.9 39.4 28.0 30.2 33.4 28.8 48.1 28.8 119.1 156.9 129.2 289.0 598.2 103.5 201.2 160.5 211.5 124.0 197.1 58.9 238.9 388.0 249.4 7.6 182.0 272.4 70.0 315.1 261.3 247.0 278.9 222.5 128.2 255.8 128.7 138.8 187.9 265.3 9.5 168.5 232.2 264.9 418.4 154.5 119.8 283.7 174.6 203.3 294.2 76.5 187.5 270.9 168.9 212.6 544.1 378.5 153.4 155.5 360.2 VAPB "ALS8, VAP-B, VAP-C" ENSG00000124164 "VAMP associated protein B and C" O95292 20 58389122-58451101 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Unfolded protein response" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013144, CAB013722" Supported Enhanced "Endoplasmic reticulum" NA NA 220000 "Endoplasmic reticulum" "CAB013722: , HPA013144: AB_1858717" "unprognostic (3.28e-3)" "unprognostic (3.88e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" "unprognostic (9.36e-2)" "unprognostic (3.15e-2)" "unprognostic (4.76e-3)" "unprognostic (2.80e-1)" "unprognostic (4.47e-2)" "unprognostic (8.06e-3)" "unprognostic (3.11e-2)" "unprognostic (2.99e-1)" "prognostic favorable (1.08e-8)" "unprognostic (1.05e-1)" "unprognostic (5.31e-1)" "unprognostic (6.34e-3)" "unprognostic (2.99e-2)" 17.4 31.1 21.8 12.6 24.3 4.8 13.2 16.5 31.8 11.7 16.1 17.0 13.3 22.5 13.0 13.1 14.8 13.7 12.7 24.5 21.4 22.1 21.8 23.5 13.6 10.4 23.2 25.1 17.7 15.5 28.5 16.3 11.1 31.6 15.0 12.1 11.4 17.9 15.7 46.8 15.3 20.6 15.2 24.9 11.4 14.7 9.4 15.8 6.7 26.7 18.8 9.4 11.6 18.5 5.6 4.3 6.8 5.2 6.6 9.5 4.6 10.9 11.0 12.4 6.6 11.4 4.8 11.0 9.8 4.1 15.2 7.5 44.3 10.6 9.7 14.1 6.6 12.1 21.0 9.8 14.1 9.1 4.5 7.4 5.8 12.2 13.9 11.5 5.4 7.4 10.9 16.4 8.4 7.0 7.4 7.5 9.7 13.7 5.5 7.3 34.4 8.5 10.8 6.5 21.5 14.6 8.6 11.5 6.3 11.6 14.7 17.5 12.1 16.2 43.2 16.9 7.1 17.7 8.3 10.3 24.6 12.0 12.3 13.1 7.4 7.9 11.1 20.8 6.0 12.4 3.9 4.4 5.2 7.8 4.4 9.1 5.6 9.0 6.2 4.3 4.7 6.7 9.5 6.8 6.6 5.2 4.3 5.0 4.6 21.8 24.3 16.5 31.8 21.4 22.1 23.2 25.1 31.6 15.8 41.7 23.2 11.7 12.1 10.4 26.4 43.1 25.5 18.7 13.6 29.6 27.5 28.5 29.9 29.7 4.2 20.4 30.7 0.0 26.6 42.2 18.8 15.2 9.2 32.1 14.0 33.4 20.8 14.7 14.0 5.1 17.3 13.9 13.5 24.4 22.3 34.0 29.0 19.2 23.7 31.6 29.2 12.9 20.5 20.4 28.3 9.3 37.2 18.7 24.2 13.6 VASN SLITL2 ENSG00000168140 Vasorin Q6EMK4 16 4371848-4383528 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 108.9;Peritubular cells: 57.3;Sertoli cells: 97.0;Smooth muscle cells: 96.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 12 "U-2197: 126.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011246, HPA016992" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted - unknown location" NA Yes 2400000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA011246: AB_1858720, HPA016992: AB_2732418" "unprognostic (2.20e-1)" "unprognostic (2.75e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.35e-3)" "unprognostic (8.91e-3)" "unprognostic (3.15e-3)" "unprognostic (5.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.82e-3)" "unprognostic (4.23e-2)" "unprognostic (4.95e-3)" "unprognostic (5.27e-2)" 22.4 10.2 4.9 7.7 6.7 3.8 28.6 1.6 6.5 19.9 5.1 5.6 6.4 5.1 14.3 13.6 16.2 9.9 10.2 12.9 4.4 1.8 21.6 14.1 17.2 5.2 2.7 2.9 21.0 9.8 1.7 5.9 30.2 4.8 12.9 2.0 33.6 7.9 13.1 7.0 16.0 4.0 9.4 3.6 7.9 6.5 14.7 3.5 0.0 15.2 5.5 8.2 16.6 19.0 0.3 0.2 0.4 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 2.8 3.2 1.2 5.3 5.2 1.6 2.7 0.3 0.6 0.0 1.9 3.5 0.2 0.0 0.0 0.1 0.2 1.2 0.1 0.1 1.5 1.6 10.2 0.0 0.0 3.3 0.0 4.0 0.1 2.7 0.0 0.0 0.2 0.0 0.2 1.8 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.1 0.9 2.5 4.2 0.0 0.2 0.9 0.2 0.0 4.9 1.3 126.7 0.6 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 6.7 1.6 6.5 4.4 1.8 2.7 2.9 4.8 3.5 6.0 12.5 0.9 6.0 8.5 0.0 12.9 35.7 1.4 3.4 22.7 0.0 3.0 6.6 10.3 1.0 3.3 0.2 0.0 2.6 6.4 108.9 7.4 3.5 12.9 2.8 0.0 0.0 4.9 0.3 1.8 46.3 1.2 13.5 0.0 0.4 16.3 17.4 0.0 57.3 12.5 0.7 97.0 96.8 0.5 5.1 6.6 8.4 1.8 0.2 3.3 VCAM1 CD106 ENSG00000162692 "Vascular cell adhesion molecule 1" P19320 1 100719742-100739045 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "kidney: 69.6;lymphoid tissue: 129.2" "Cell type enhanced" "Detected in many" 21 "Ductal cells: 130.8;Ito cells: 82.3;Kupffer cells: 410.3;Proximal tubular cells: 200.7" "Cancer enriched" "Detected in all" 8 "renal cancer: 89.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "gdT-cell: 1.3;memory CD8 T-cell: 2.9;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 17 "T-cells: 2.9" "Group enriched" "Detected in some" 5 "HHSteC: 58.3;HSkMC: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000154, HPA034796, HPA069867" Enhanced Supported "Cell Junctions" NA NA 624000000 960000000 "Cell Junctions" "CAB000154: , HPA034796: AB_2674333, HPA069867: AB_2686215" "unprognostic (2.96e-1)" "prognostic favorable (3.82e-4)" "unprognostic (1.31e-1)" "unprognostic (7.49e-3)" "unprognostic (1.04e-1)" "prognostic favorable (7.19e-5)" "unprognostic (1.60e-2)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (1.20e-1)" "unprognostic (3.95e-2)" "unprognostic (8.23e-2)" "unprognostic (1.80e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.55e-2)" 10.9 18.1 1.5 20.2 3.2 1.3 5.2 0.9 1.1 3.7 5.0 3.3 1.4 3.3 4.9 4.5 5.3 4.9 6.8 7.2 1.7 2.3 69.6 11.8 9.8 26.8 2.8 1.7 11.1 6.6 10.6 3.5 10.9 4.2 8.3 5.5 15.3 4.9 1.1 4.7 1.8 6.3 4.2 3.7 129.2 3.0 2.5 1.6 13.3 3.5 2.8 20.9 8.2 2.8 0.0 0.1 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.3 0.1 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 8.4 0.0 0.0 0.0 0.0 58.3 0.0 0.0 38.9 0.0 10.2 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 2.9 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 3.2 0.9 1.1 1.7 2.3 2.8 1.7 4.2 1.6 0.0 6.4 2.4 0.1 8.9 0.0 2.0 0.0 2.7 0.0 3.5 0.0 0.9 8.3 130.8 0.1 16.1 0.0 0.0 2.7 0.8 67.5 0.6 1.1 2.5 3.0 0.0 0.0 82.3 410.3 0.0 15.8 1.9 1.7 0.0 0.0 3.0 2.6 0.0 7.1 200.7 0.0 0.0 14.0 0.0 0.0 6.5 2.3 1.5 0.0 0.0 VEZT DKFZP761C241 ENSG00000028203 "Vezatin, adherens junctions transmembrane protein" Q9HBM0 12 95217746-95302790 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004811, HPA017066" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA004811: AB_1080563, HPA017066: AB_1858742" "unprognostic (3.91e-1)" "unprognostic (6.34e-3)" "unprognostic (3.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.47e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (2.28e-1)" "unprognostic (9.93e-2)" "unprognostic (4.18e-1)" "unprognostic (1.10e-3)" "unprognostic (3.37e-3)" "prognostic unfavorable (1.93e-5)" "prognostic unfavorable (3.68e-4)" "unprognostic (1.51e-1)" "unprognostic (4.06e-1)" "unprognostic (5.02e-2)" 12.3 21.4 15.4 14.3 17.2 5.1 14.6 28.3 27.2 12.9 14.4 9.1 19.0 9.5 17.1 15.9 15.6 11.5 12.1 14.7 11.8 9.5 12.1 10.4 13.8 9.6 11.0 14.0 13.3 12.6 15.7 20.4 19.6 11.4 15.8 10.6 10.3 10.9 13.9 42.7 16.1 11.0 16.2 12.5 7.2 10.7 7.2 12.2 13.6 29.8 14.5 10.0 15.7 12.2 5.2 4.4 1.1 3.5 2.4 5.0 1.2 10.3 9.6 13.3 7.2 10.2 7.3 5.1 7.6 9.6 6.1 9.7 3.5 4.9 13.4 5.0 6.6 3.3 5.4 9.5 6.7 11.4 9.0 5.3 5.1 2.5 3.6 5.5 10.1 3.0 9.2 11.7 5.7 16.5 14.2 12.8 6.6 3.0 5.3 5.5 2.8 8.7 4.8 6.7 3.3 9.8 7.9 6.3 4.3 17.7 7.5 9.0 7.8 7.3 11.1 3.5 12.4 13.7 1.7 10.2 5.5 2.1 2.4 4.2 5.2 7.8 11.4 2.1 3.7 2.8 0.5 3.1 1.1 3.6 3.5 4.7 5.2 5.0 2.1 4.4 3.6 2.4 2.0 0.3 2.4 0.9 1.8 3.5 1.2 15.4 17.2 28.3 18.8 11.8 9.5 11.0 14.0 11.4 12.2 65.5 43.0 27.5 49.9 69.0 66.8 41.6 33.1 29.4 47.8 31.4 80.5 32.2 8.3 45.1 8.5 39.8 29.7 0.0 39.7 17.6 29.0 46.9 28.8 32.6 18.8 58.8 36.9 40.5 28.3 8.3 30.2 23.7 35.4 20.8 26.8 23.0 54.7 29.1 31.1 18.9 146.1 6.5 34.3 27.3 17.9 63.2 92.6 20.3 20.7 66.0 VIP ENSG00000146469 "Vasoactive intestinal peptide" P01282 6 152750798-152759765 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 32.5;lymphoid tissue: 64.7" "Group enriched" "Detected in some" 4 "Early spermatids: 7.7;Melanocytes: 27.0" "Group enriched" "Detected in some" 6 "colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HeLa: 2.2;SH-SY5Y: 7.0;TIME: 4.9;U-2 OS: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA017324, CAB018649, HPA072701, CAB079780" Supported Supported Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 122000 "Endoplasmic reticulum" "CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550" "unprognostic (9.58e-2)" "unprognostic (2.29e-2)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" "unprognostic (3.34e-2)" "unprognostic (3.33e-2)" "unprognostic (2.48e-2)" "unprognostic (7.21e-2)" "unprognostic (2.22e-2)" "unprognostic (2.89e-2)" "unprognostic (2.36e-1)" "unprognostic (3.62e-1)" "unprognostic (2.92e-3)" "unprognostic (7.47e-2)" "unprognostic (1.94e-1)" "unprognostic (1.30e-1)" "unprognostic (5.90e-2)" 1.2 5.7 9.7 64.7 8.3 0.3 0.9 1.5 20.1 0.6 31.5 0.5 0.3 7.5 0.7 0.4 13.1 0.5 4.2 1.1 12.4 7.7 0.9 0.6 1.7 0.4 2.7 8.3 0.4 3.8 0.5 0.4 0.5 1.6 6.3 28.3 3.2 0.4 6.9 0.8 0.4 32.5 18.0 0.4 5.2 13.2 0.5 0.1 0.0 1.3 0.5 0.4 9.1 4.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.4 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 7.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 2.0 0.2 0.2 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 9.7 8.3 1.5 20.1 12.4 7.7 2.7 8.3 1.6 0.1 0.0 0.0 0.0 0.0 0.3 0.5 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 7.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 4.2 0.0 0.0 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 VIPR1 "HVR1, RDC1, VPAC1, VPAC1R" ENSG00000114812 "Vasoactive intestinal peptide receptor 1" P32241 3 42489299-42537573 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 83.1" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 40.7;Mucus-secreting cells: 38.5;Paneth cells: 92.0;Sertoli cells: 32.3" "Cancer enhanced" "Detected in many" "prostate cancer: 10.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 3.2;intermediate monocyte: 2.6;MAIT T-cell: 1.9;memory CD4 T-cell: 4.8;memory CD8 T-cell: 1.9;myeloid DC: 3.9;naive CD4 T-cell: 5.5;naive CD8 T-cell: 1.7;non-classical monocyte: 2.3" "Group enriched" "Detected in many" 32 "dendritic cells: 3.9;monocytes: 3.2;T-cells: 5.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 27.3;OE19: 15.9;RT4: 19.5;SK-BR-3: 11.1;WM-115: 35.4" "Group enriched" "Detected in many" 5 "amygdala: 6.5;basal ganglia: 4.1;cerebral cortex: 9.2;hippocampal formation: 8.5" "Low region specificity" "Detected in all" HPA026777 Approved NA NA "HPA026777: AB_10604003" "unprognostic (9.02e-2)" "unprognostic (9.34e-3)" "unprognostic (3.70e-1)" "unprognostic (1.57e-1)" "unprognostic (1.28e-1)" "unprognostic (1.47e-2)" "unprognostic (8.89e-4)" "unprognostic (4.00e-3)" "unprognostic (1.03e-1)" "unprognostic (2.95e-2)" "unprognostic (1.28e-2)" "unprognostic (2.72e-1)" "unprognostic (1.82e-3)" "unprognostic (7.70e-2)" "unprognostic (1.69e-1)" "unprognostic (1.03e-2)" "unprognostic (1.05e-2)" 8.1 1.8 5.6 6.4 11.8 1.3 7.4 10.2 13.8 2.0 17.7 0.6 27.8 22.0 0.9 4.6 2.7 1.0 10.6 3.1 2.9 1.2 1.4 15.4 83.1 5.1 1.3 8.4 0.5 1.4 2.9 1.2 1.9 1.9 13.0 18.1 2.2 9.7 29.0 0.8 12.2 25.9 1.3 0.9 2.7 3.7 0.9 1.3 0.0 7.2 3.2 3.1 6.0 2.4 0.1 3.9 0.1 3.2 0.0 5.5 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.9 27.3 0.1 1.3 0.0 0.0 1.1 0.0 0.7 0.0 0.0 2.1 1.6 0.8 0.0 0.1 0.0 0.2 0.0 1.7 0.1 0.5 0.0 0.3 0.2 0.0 0.0 0.0 2.2 0.0 0.1 1.7 15.9 0.1 0.2 0.0 1.2 0.0 19.5 0.6 0.0 0.0 11.1 0.0 3.3 6.8 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.4 0.0 3.2 0.0 0.4 2.6 1.9 0.1 4.8 1.9 3.9 0.0 5.5 1.7 0.1 0.0 2.3 0.0 0.7 1.3 5.6 11.8 10.2 13.8 2.9 1.2 1.3 8.4 1.9 1.3 3.0 5.9 2.0 4.2 6.8 0.1 1.2 5.1 1.4 2.3 1.8 7.9 0.0 0.0 0.4 0.7 1.4 40.7 0.0 0.8 0.3 0.4 9.6 0.0 0.0 0.6 0.0 4.6 14.7 8.9 0.4 0.0 2.4 0.0 0.0 38.5 1.2 0.8 92.0 0.0 0.0 5.1 32.3 2.2 0.0 0.0 6.8 0.2 1.3 22.9 3.2 VIPR2 "VPAC2, VPAC2R" ENSG00000106018 "Vasoactive intestinal peptide receptor 2" P41587 7 159028175-159144957 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Muller glia cells: 32.3;Rod photoreceptor cells: 44.5" "Cancer enhanced" "Detected in some" "glioma: 2.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 13.1" "Lineage enriched" "Detected in single" 16 "dendritic cells: 13.1" "Cell line enhanced" "Detected in some" "HeLa: 4.2;HMC-1: 6.5;MOLT-4: 8.8;U-266/70: 29.8" "Region enhanced" "Detected in some" "olfactory region: 33.2" "Low region specificity" "Detected in all" HPA062707 Approved Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA062707: AB_2684842" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (4.26e-2)" "unprognostic (2.04e-2)" "unprognostic (6.31e-2)" "unprognostic (4.10e-2)" "unprognostic (1.03e-1)" "unprognostic (8.58e-2)" "unprognostic (2.32e-2)" "unprognostic (1.02e-1)" "unprognostic (9.60e-2)" "unprognostic (1.74e-1)" "unprognostic (1.88e-1)" "unprognostic (2.49e-2)" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (8.89e-2)" 9.6 1.2 2.1 2.9 1.3 0.6 2.1 0.9 10.2 18.0 10.6 1.5 14.1 2.1 11.5 14.3 3.1 3.3 4.7 13.3 2.6 1.8 1.0 0.6 0.6 3.0 1.9 2.3 10.8 15.7 0.3 2.6 6.4 2.1 8.4 1.5 4.9 1.1 24.0 7.3 0.6 3.9 7.1 2.4 1.1 8.3 2.4 1.1 16.9 0.4 0.7 0.8 5.7 9.9 0.0 13.1 0.1 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.2 8.8 0.0 0.7 0.0 0.0 2.2 0.1 0.5 0.0 0.0 2.1 1.7 0.1 0.1 0.0 0.2 0.0 0.5 0.0 0.0 0.3 0.0 0.0 29.8 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.1 0.2 0.1 0.0 0.0 13.1 0.0 0.1 2.1 1.3 0.9 10.2 2.6 1.8 1.9 2.3 2.1 1.1 0.0 0.0 0.0 2.2 0.6 1.4 6.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 5.8 0.0 1.5 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 9.5 0.0 1.7 0.0 0.0 32.3 0.8 0.0 2.5 0.3 44.5 0.0 8.0 3.7 2.1 0.0 0.0 2.9 0.0 0.1 VKORC1 VKCFD2 ENSG00000167397 "Vitamin K epoxide reductase complex subunit 1" Q9BQB6 16 31090842-31095980 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 173.3" "Cell type enhanced" "Detected in all" 8 "Hepatocytes: 682.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 98.9" "Low region specificity" "Detected in all" HPA042720 Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA042720: AB_10961864" "unprognostic (5.99e-2)" "unprognostic (2.98e-1)" "unprognostic (7.11e-3)" "unprognostic (7.68e-3)" "unprognostic (5.49e-2)" "unprognostic (3.23e-3)" "unprognostic (3.02e-2)" "unprognostic (2.32e-2)" "unprognostic (2.42e-1)" "unprognostic (2.66e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.09e-10)" "unprognostic (1.11e-2)" "unprognostic (6.65e-2)" "unprognostic (3.12e-2)" "unprognostic (9.66e-2)" 21.3 23.0 9.3 11.5 11.0 12.9 28.1 9.4 14.5 24.3 19.3 17.1 16.5 12.6 24.0 27.4 18.5 17.8 22.6 20.1 9.8 10.2 29.9 173.3 16.4 17.5 13.7 9.1 25.5 55.5 14.0 25.0 22.5 13.3 22.3 12.6 20.8 34.8 21.4 11.4 15.9 26.8 27.7 12.5 15.4 17.5 18.2 10.6 15.8 25.6 13.8 14.6 28.4 18.7 32.3 49.9 59.6 40.6 24.7 43.7 33.6 10.5 27.1 8.9 25.5 98.9 58.9 9.9 39.1 34.0 19.3 32.8 11.2 12.1 8.3 21.2 48.9 13.6 9.8 12.3 15.3 22.0 11.7 29.9 7.5 37.5 53.9 15.6 14.6 11.3 34.0 8.2 26.6 22.9 52.3 20.8 11.8 9.8 19.8 37.6 38.2 10.7 30.0 16.1 14.6 26.1 19.4 23.7 41.2 19.0 9.2 18.2 22.1 17.1 12.5 19.0 15.0 20.6 17.8 18.1 25.9 9.3 23.7 14.7 12.0 11.1 7.3 67.4 25.3 13.3 21.5 40.6 59.6 40.3 28.1 39.7 29.9 40.5 40.7 39.6 32.3 36.4 35.4 34.2 24.7 28.3 49.9 43.7 33.6 9.3 11.0 9.4 14.5 9.8 10.2 13.7 9.1 13.3 10.6 53.6 38.2 37.9 58.4 75.2 11.2 20.0 119.8 32.1 40.9 102.9 7.9 64.0 53.0 183.3 4.8 87.9 36.0 46.7 112.2 211.1 138.5 58.9 55.3 682.4 166.1 9.5 64.4 119.7 79.0 8.3 146.4 85.1 109.6 129.8 41.2 64.7 107.2 24.6 161.9 160.1 16.9 58.2 95.7 23.7 24.7 97.9 33.1 47.3 51.3 46.5 VKORC1L1 ENSG00000196715 "Vitamin K epoxide reductase complex subunit 1 like 1" Q8N0U8 7 65873267-65959563 "Enzymes, FDA approved drug targets, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA053954 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA053954: AB_2682319" "unprognostic (3.01e-1)" "unprognostic (1.76e-3)" "unprognostic (4.64e-2)" "unprognostic (4.65e-2)" "unprognostic (3.00e-3)" "unprognostic (7.15e-3)" "unprognostic (1.30e-3)" "unprognostic (8.84e-3)" "unprognostic (5.12e-2)" "unprognostic (5.59e-2)" "unprognostic (9.23e-3)" "unprognostic (1.07e-1)" "unprognostic (1.59e-2)" "unprognostic (1.17e-1)" "unprognostic (7.03e-3)" "unprognostic (4.30e-1)" "unprognostic (5.06e-2)" 38.2 9.2 10.5 8.3 16.7 3.0 23.7 9.0 19.7 10.4 11.1 14.2 9.2 8.6 10.1 8.8 10.0 8.8 8.0 9.3 10.3 11.4 8.2 17.8 14.3 6.2 12.0 12.1 14.4 11.7 28.5 8.0 9.7 14.1 9.9 10.0 8.0 9.0 10.5 14.9 11.4 9.7 9.3 13.2 5.7 9.9 9.4 7.6 9.1 11.1 4.5 6.6 9.7 9.3 2.8 7.5 5.6 4.2 6.5 3.4 1.8 22.4 14.5 11.7 14.7 37.4 14.9 21.3 24.4 15.8 14.6 14.8 14.0 22.2 19.6 19.8 17.5 22.2 15.5 16.7 9.9 24.5 12.2 16.5 13.3 13.3 11.9 18.3 18.4 10.3 11.9 12.8 14.8 20.7 11.4 14.5 11.2 28.0 15.0 17.4 8.8 15.1 21.5 28.1 21.3 10.9 16.6 17.1 24.4 14.1 9.0 14.1 20.2 18.9 34.3 10.7 17.4 17.2 14.3 16.4 23.7 16.2 14.8 24.7 13.6 22.1 22.5 14.5 21.0 20.6 3.8 2.7 5.6 2.9 2.5 2.4 2.8 3.4 3.2 2.8 2.5 2.3 2.3 3.1 6.5 4.2 7.5 3.1 1.8 10.5 16.7 9.0 19.7 10.3 11.4 12.0 12.1 14.1 7.6 68.5 29.5 0.8 14.6 22.0 20.5 21.3 30.6 8.1 26.1 15.7 11.8 10.0 5.0 15.9 28.9 15.9 16.9 23.3 21.7 18.4 16.7 23.4 4.7 44.5 14.4 28.6 13.3 8.6 7.0 5.5 16.4 9.0 6.8 4.6 23.5 8.5 24.2 2.9 17.3 10.2 17.4 6.5 13.4 17.9 6.6 28.0 7.3 5.2 18.7 16.9 VLDLR "CARMQ1, CHRMQ1, VLDLRCH" ENSG00000147852 "Very low density lipoprotein receptor" P98155 9 2621834-2660053 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Receptor "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 50.5" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 72.2;Cone photoreceptor cells: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "eosinophil: 14.1" "Lineage enriched" "Detected in many" 12 "granulocytes: 14.1" "Cell line enhanced" "Detected in many" "BEWO: 27.2;JURKAT: 21.2;THP-1: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032462, HPA051312" Uncertain Uncertain "Vesicles,Cytokinetic bridge,Centriolar satellite" NA NA 180000 Vesicles "Cytokinetic bridge, Centriolar satellite" "CAB032462: AB_2216805, HPA051312: " "unprognostic (5.31e-2)" "unprognostic (2.65e-1)" "unprognostic (6.92e-2)" "prognostic favorable (5.95e-4)" "unprognostic (1.15e-1)" "unprognostic (2.67e-2)" "unprognostic (2.48e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-2)" "unprognostic (3.79e-2)" "unprognostic (2.33e-1)" "unprognostic (6.75e-2)" "unprognostic (1.48e-2)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (4.34e-2)" 11.3 13.7 7.2 3.7 9.6 1.3 11.2 8.7 7.3 6.9 3.9 12.8 6.5 1.2 12.1 4.3 11.6 15.1 5.5 38.0 7.6 4.5 8.8 2.5 6.9 0.9 13.2 5.3 50.5 20.8 43.6 5.9 9.4 7.7 5.7 2.9 12.3 7.5 4.4 21.2 3.4 1.6 15.7 10.1 5.5 5.8 5.6 10.3 0.0 8.8 12.5 3.9 11.9 6.1 0.1 0.8 14.1 0.1 0.1 1.1 0.0 0.0 2.9 18.8 0.8 2.8 0.2 27.2 8.5 2.8 2.2 6.5 4.7 0.3 0.0 9.2 5.2 1.4 0.2 5.2 5.7 7.3 9.9 1.9 0.1 2.5 2.2 3.0 11.8 2.1 1.2 4.2 0.8 0.4 9.7 1.1 21.2 0.0 16.7 1.3 0.8 2.1 1.6 9.5 1.5 1.1 0.2 0.6 0.0 10.9 1.1 4.2 3.0 0.6 0.9 11.8 14.2 0.4 28.0 0.3 3.1 5.8 0.0 5.6 12.7 5.1 3.0 20.2 9.9 1.1 0.1 0.1 14.1 0.2 0.0 1.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 2.0 0.1 0.0 0.8 0.0 0.0 7.2 9.6 8.7 7.3 7.6 4.5 13.2 5.3 7.7 10.3 14.9 9.1 0.0 1.0 2.4 17.9 72.2 2.5 8.1 2.3 5.2 98.2 11.4 1.7 10.1 4.5 2.7 0.9 0.0 8.9 18.7 14.0 5.0 0.0 1.3 2.1 11.1 10.5 1.3 0.3 1.9 7.2 0.6 10.1 1.8 0.3 2.7 11.2 2.6 10.3 4.4 30.4 0.0 10.3 1.5 7.0 1.8 2.9 1.8 0.6 3.0 VMA21 "MEAX, XMEA" ENSG00000160131 "VMA21, vacuolar ATPase assembly factor" Q3ZAQ7 X 151396515-151409364 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA010972 Uncertain NA NA "HPA010972: AB_1853034" "unprognostic (1.17e-1)" "prognostic favorable (2.30e-5)" "unprognostic (6.75e-2)" "unprognostic (9.78e-3)" "unprognostic (6.48e-2)" "unprognostic (4.68e-2)" "unprognostic (1.88e-3)" "unprognostic (4.36e-2)" "unprognostic (5.16e-2)" "unprognostic (1.74e-2)" "unprognostic (2.55e-1)" "unprognostic (8.30e-2)" "unprognostic (7.88e-2)" "unprognostic (4.17e-2)" "unprognostic (3.21e-2)" "unprognostic (3.90e-2)" "unprognostic (2.76e-1)" 14.7 18.0 22.2 11.3 21.5 27.9 30.1 23.3 40.8 15.2 9.4 13.7 8.3 9.3 13.7 21.6 13.4 20.5 10.1 27.9 23.0 28.7 19.1 14.1 20.3 39.8 23.4 18.6 16.4 19.0 17.2 16.4 17.4 20.6 13.3 10.2 13.8 12.1 13.1 11.1 18.1 9.4 14.9 20.3 13.7 10.3 14.2 11.6 14.9 19.8 14.1 17.5 11.4 11.0 8.7 14.5 9.7 14.9 13.9 13.6 11.1 9.3 10.4 12.1 12.8 12.0 11.6 11.9 10.5 11.4 9.8 9.7 7.8 12.3 27.7 34.6 10.7 11.0 8.6 16.8 10.0 15.3 9.6 8.4 12.0 12.4 14.1 16.1 22.6 13.9 12.0 12.4 11.0 15.7 10.4 11.1 12.2 6.4 14.6 18.3 8.8 15.3 22.5 15.0 11.3 11.1 15.6 14.5 17.9 11.5 7.7 4.4 9.3 8.2 11.1 12.4 11.6 6.8 14.9 11.3 16.0 7.2 20.1 16.8 12.4 21.5 41.0 16.2 28.1 15.9 9.7 13.5 8.0 7.5 14.9 9.9 8.7 9.9 9.5 14.5 7.2 13.6 12.0 3.2 13.9 12.9 13.2 9.9 11.1 22.2 21.5 23.3 40.8 23.0 28.7 23.4 18.6 20.6 11.6 20.8 26.1 43.1 23.1 40.0 38.5 43.3 22.9 21.4 13.6 29.6 17.7 28.1 16.6 26.4 39.7 29.7 21.3 23.3 28.4 52.3 24.3 28.2 23.1 35.0 129.8 19.1 21.2 27.0 134.4 33.5 17.0 84.0 37.1 134.3 20.2 46.2 39.4 14.0 21.2 24.8 24.7 51.8 31.9 15.4 57.0 45.0 26.7 29.9 21.0 24.5 VMP1 "EPG3, TANGO5, TMEM49" ENSG00000062716 "Vacuole membrane protein 1" Q96GC9 17 59707192-59842255 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "blood: 193.2" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 872.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 193.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 193.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030773, HPA064780" Approved Approved "Nucleoli,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoli "HPA030773: AB_10602248, HPA064780: AB_2685348" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (3.14e-2)" "unprognostic (3.17e-1)" "prognostic unfavorable (8.02e-4)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" "unprognostic (2.98e-1)" "unprognostic (8.43e-2)" "unprognostic (4.21e-2)" "prognostic unfavorable (2.77e-8)" "unprognostic (1.88e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (7.96e-3)" 22.0 37.8 20.4 21.9 24.9 13.0 18.6 20.0 28.7 18.2 32.0 27.8 16.7 40.5 18.3 15.4 22.9 14.4 25.2 19.6 21.7 22.3 22.9 43.0 22.4 20.1 23.1 15.6 16.5 22.9 19.0 20.1 27.9 29.8 17.3 29.3 20.0 17.8 13.9 19.8 19.2 39.7 14.3 26.4 36.6 19.0 17.6 16.2 14.4 18.1 12.5 16.8 19.5 17.6 3.3 10.9 193.2 39.9 3.8 4.1 24.7 20.3 41.0 13.3 20.5 28.5 17.5 21.4 32.4 23.1 20.2 27.2 26.8 29.3 11.7 48.4 21.9 22.1 25.3 15.4 18.6 25.2 30.0 19.3 15.0 23.5 28.2 27.8 17.0 18.4 26.8 15.9 26.0 22.1 16.2 21.4 10.0 19.6 20.7 20.9 56.0 15.8 8.9 15.0 42.3 21.1 8.7 23.4 24.1 25.0 23.8 9.6 21.7 18.5 15.7 21.5 19.1 32.5 14.6 30.2 27.2 26.0 21.6 26.7 32.2 36.9 16.3 30.0 10.4 27.4 7.0 35.1 4.4 3.8 24.4 4.0 3.3 3.7 4.0 10.9 2.8 3.5 3.8 193.2 3.8 39.9 3.6 4.1 24.7 20.4 24.9 20.0 28.7 21.7 22.3 23.1 15.6 29.8 16.2 83.4 125.2 71.3 872.7 143.1 32.8 26.9 112.1 278.4 247.9 261.7 55.0 83.1 19.9 167.6 5.2 128.4 394.9 0.0 118.5 105.1 178.7 606.4 129.6 93.2 107.6 27.0 298.1 52.2 269.6 8.8 33.1 306.0 123.2 55.9 173.1 46.7 132.9 326.1 33.2 57.2 44.2 90.5 178.6 63.8 38.3 113.3 147.0 90.6 149.1 526.3 VN1R1 "V1RL1, VNR19I1, ZVNH1, ZVNR1" ENSG00000178201 "Vomeronasal 1 receptor 1" Q9GZP7 19 57454790-57457142 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 4.8;Cone photoreceptor cells: 2.0;Horizontal cells: 6.4;Rod photoreceptor cells: 3.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 6.2;U-266/70: 5.6;U-266/84: 6.7" HPA062209 Uncertain Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA062209: " "unprognostic (7.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (1.51e-2)" "unprognostic (5.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.21e-2)" "unprognostic (5.41e-2)" "unprognostic (5.68e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-2)" "unprognostic (4.59e-5)" 0.1 1.4 2.0 0.3 2.9 0.3 1.5 9.2 3.5 0.2 0.7 0.0 0.5 5.3 0.9 0.8 0.6 1.9 1.9 2.0 0.8 0.9 0.9 0.7 1.5 1.6 0.4 3.6 3.5 1.1 2.0 0.4 0.8 1.3 3.6 4.0 0.5 0.5 1.5 1.1 0.9 1.4 2.7 0.4 0.5 0.3 2.3 0.3 0.5 0.3 0.6 0.4 0.1 0.5 0.1 1.8 1.9 0.1 0.5 0.9 0.5 0.7 0.4 1.9 0.0 0.2 0.2 0.9 0.2 0.3 0.0 0.4 0.2 0.7 0.0 6.2 0.9 0.0 0.6 0.3 0.4 1.2 0.7 0.7 0.1 0.4 1.0 0.2 0.6 0.3 0.9 0.9 0.3 0.4 2.1 0.5 0.1 0.6 0.4 1.2 0.9 0.6 1.1 3.4 1.4 0.0 0.5 0.1 1.0 0.9 0.6 0.1 1.5 0.2 0.4 0.6 5.6 6.7 0.5 0.5 0.1 1.1 0.5 0.3 0.3 0.4 0.0 0.2 1.3 0.3 0.3 0.2 2.3 0.4 0.3 0.5 0.6 0.2 0.3 0.0 0.1 0.0 0.6 0.5 0.0 0.0 4.8 0.2 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.7 0.0 3.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 VN1R2 V1RL2 ENSG00000196131 "Vomeronasal 1 receptor 2" Q8NFZ6 19 53258292-53261837 "G-protein coupled receptors, Predicted membrane proteins" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 5.0;testis: 3.2" "Group enriched" "Detected in some" 10 "Early spermatids: 16.0;Late spermatids: 7.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" HPA044551 Uncertain NA NA "HPA044551: AB_2678982" "unprognostic (9.54e-2)" "unprognostic (3.17e-1)" "unprognostic (1.06e-1)" 0.2 0.2 0.4 0.8 0.4 0.5 0.3 0.6 0.8 0.2 0.3 0.2 0.5 1.6 0.3 0.2 0.0 5.0 0.4 0.4 0.3 0.3 0.2 1.7 0.3 0.6 0.2 0.3 0.2 0.0 0.3 0.0 0.4 0.0 0.4 0.9 0.6 0.0 0.3 0.3 0.2 3.2 0.5 0.0 0.3 0.3 0.8 0.5 1.3 0.5 0.6 1.1 0.2 0.8 0.8 0.8 1.3 0.0 0.0 0.3 1.1 0.0 0.0 0.3 0.0 2.2 2.0 0.5 0.5 0.7 0.6 0.0 0.0 0.0 0.8 0.8 1.2 2.7 1.6 0.0 0.2 1.7 0.6 0.4 0.2 0.0 0.6 0.0 0.7 0.8 0.7 0.4 0.9 0.4 1.1 0.5 0.3 0.7 1.1 2.1 0.0 0.5 2.3 1.3 1.3 0.2 0.8 0.3 0.4 1.4 0.1 1.7 1.0 0.8 1.3 0.4 1.7 0.6 0.8 1.2 0.5 0.8 0.4 0.5 0.5 1.1 0.3 0.4 0.2 0.4 0.2 0.2 0.8 0.3 1.0 1.3 0.6 0.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 VN1R4 V1RL4 ENSG00000228567 "Vomeronasal 1 receptor 4" Q7Z5H5 19 53266676-53267723 "G-protein coupled receptors, Predicted membrane proteins" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.3" HPA027018 Uncertain NA NA "HPA027018: AB_10603142" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 VNN2 "FOAP-4, GPI-80" ENSG00000112303 "Vanin 2" O95498 6 132743870-132763459 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 85.2;lung: 36.4;lymphoid tissue: 43.6" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 17.4;Ductal cells: 36.1;Kupffer cells: 27.8;Macrophages: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 8 "neutrophil: 85.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 85.2" "Cell line enriched" "Detected in some" 8 "Daudi: 35.7" "Not detected" "Not detected" NA NA 270000 "unprognostic (2.13e-1)" "unprognostic (1.15e-1)" "unprognostic (9.60e-3)" "unprognostic (5.71e-2)" "unprognostic (2.14e-1)" "unprognostic (5.61e-3)" "unprognostic (1.98e-3)" "unprognostic (4.38e-1)" "unprognostic (3.07e-1)" "unprognostic (3.46e-1)" "unprognostic (2.84e-1)" "unprognostic (8.30e-2)" "prognostic unfavorable (2.72e-7)" "unprognostic (1.62e-1)" "unprognostic (8.17e-2)" "unprognostic (2.01e-1)" "unprognostic (5.45e-2)" 10.1 1.4 1.1 9.5 1.1 10.8 1.4 1.4 1.4 1.8 1.9 0.8 0.0 0.7 0.9 3.1 2.1 4.3 10.2 10.5 1.1 1.1 2.8 5.6 36.4 39.8 3.8 0.3 2.1 2.4 0.0 1.2 8.6 1.5 2.4 0.9 1.8 1.3 0.2 1.0 0.7 3.6 2.4 2.2 43.6 2.8 3.6 0.6 3.4 1.4 0.7 17.7 7.3 10.9 6.4 2.2 85.2 10.9 5.8 6.7 5.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.7 0.0 0.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.9 0.0 0.0 1.5 10.9 0.0 4.2 2.4 1.7 6.4 1.4 4.9 2.2 5.5 4.5 6.7 85.2 5.8 1.5 0.4 0.9 5.7 1.1 1.1 1.4 1.4 1.1 1.1 3.8 0.3 1.5 0.6 0.0 10.7 0.0 0.0 0.0 0.0 1.2 2.5 17.4 3.4 0.0 0.0 0.6 0.0 36.1 0.0 0.0 0.0 0.0 0.3 0.1 0.5 5.6 4.7 0.0 11.3 0.0 0.0 4.3 27.8 0.0 0.0 17.1 0.0 1.8 0.0 0.0 4.0 0.0 0.0 0.3 0.0 6.5 0.5 0.0 0.0 0.0 1.1 6.1 0.0 8.4 VNN3 HSA238982 ENSG00000093134 "Vanin 3" Q9NY84 6 132722787-132734765 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "blood: 39.5;bone marrow: 29.8;liver: 29.4" "Group enriched" "Detected in some" 5 "Ciliated cells: 69.6;Club cells: 19.4" "Cancer enhanced" "Detected in some" "liver cancer: 3.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "neutrophil: 39.5" "Lineage enriched" "Detected in single" 40 "granulocytes: 39.5" "Cell line enhanced" "Detected in some" "Daudi: 2.5;EFO-21: 3.7;GAMG: 1.6;hTCEpi: 2.3" "Secreted to blood" NA NA 150000000 "unprognostic (3.20e-2)" "unprognostic (2.70e-1)" "unprognostic (7.92e-3)" "unprognostic (1.71e-2)" "unprognostic (3.05e-3)" "unprognostic (1.06e-3)" "unprognostic (1.19e-1)" "unprognostic (1.01e-1)" "unprognostic (2.42e-2)" "unprognostic (7.68e-2)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "unprognostic (5.84e-8)" "unprognostic (1.25e-2)" "unprognostic (1.52e-1)" "unprognostic (9.32e-2)" "unprognostic (1.56e-1)" 1.1 0.1 0.4 3.3 0.4 29.8 0.2 0.2 0.6 2.4 1.2 0.2 0.2 0.0 0.2 0.8 0.9 2.4 1.3 1.0 0.4 0.0 0.3 29.4 6.1 1.2 0.4 0.2 1.2 0.2 0.0 0.2 5.8 0.3 0.5 0.0 0.4 1.1 0.2 0.2 0.1 0.2 0.2 0.2 7.6 0.4 0.3 0.2 0.2 0.3 2.4 0.7 0.6 0.3 0.0 0.0 39.5 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 2.5 3.7 0.0 1.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 6.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.2 0.6 0.4 0.0 0.4 0.2 0.3 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.3 0.0 69.6 19.4 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 9.7 0.1 0.0 0.0 0.6 9.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 VOPP1 "DKFZp564K0822, ECop, FLJ20532, GASP, WBP1L2" ENSG00000154978 "VOPP1, WBP1/VOPP1 family member" Q96AW1 7 55436056-55572988 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 200.3;monocytes: 192.0;Rod photoreceptor cells: 193.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 79.8;HDLM-2: 69.6;Karpas-707: 89.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.59e-2)" "unprognostic (2.51e-2)" "unprognostic (2.60e-2)" "unprognostic (9.13e-2)" "unprognostic (7.14e-2)" "unprognostic (3.69e-2)" "prognostic unfavorable (4.35e-5)" "unprognostic (8.65e-2)" "unprognostic (3.74e-1)" "unprognostic (5.98e-2)" "unprognostic (1.91e-3)" "unprognostic (5.15e-2)" "prognostic unfavorable (6.99e-8)" "unprognostic (3.32e-1)" "unprognostic (6.09e-2)" "unprognostic (1.23e-1)" "unprognostic (4.60e-2)" 13.3 7.9 24.0 27.8 19.1 14.3 19.5 15.0 26.2 16.8 17.8 11.6 10.0 15.4 14.7 13.7 9.1 17.7 14.5 12.7 17.1 21.1 15.5 13.4 15.3 38.5 20.5 14.4 13.7 10.2 11.4 27.6 9.0 12.1 10.5 19.2 20.4 16.3 10.0 18.6 6.3 20.8 12.8 24.3 36.4 17.1 7.9 11.6 40.5 10.2 8.3 33.7 19.0 14.1 37.0 13.3 16.0 9.0 13.5 18.7 10.9 79.8 15.5 8.2 7.9 18.3 10.4 3.6 20.3 18.6 17.8 17.8 7.2 20.1 17.8 14.1 18.3 29.3 12.9 8.6 17.1 19.1 69.6 4.9 0.0 9.5 10.0 4.2 6.4 8.0 8.9 9.0 16.0 6.2 12.0 23.4 6.0 4.5 89.9 29.9 5.9 2.5 4.4 18.1 10.1 9.3 4.2 8.4 42.6 19.6 7.7 16.7 6.3 11.7 8.4 4.2 14.6 9.4 7.9 19.9 18.3 27.3 24.2 21.3 43.1 30.3 19.1 7.8 5.9 27.8 7.3 4.6 16.0 12.6 5.4 9.8 37.0 16.0 16.6 12.1 16.2 12.7 13.8 11.8 13.5 9.0 13.3 18.7 10.9 24.0 19.1 15.0 26.2 17.1 21.1 20.5 14.4 12.1 11.6 3.0 12.7 87.0 21.7 11.2 50.8 6.6 35.7 5.3 13.6 47.1 200.3 1.0 8.3 33.8 10.9 31.2 31.5 23.3 28.3 5.1 14.2 24.1 5.8 19.8 35.4 39.7 51.2 40.5 74.3 7.3 17.8 89.3 37.1 192.0 45.8 64.4 43.8 37.4 21.2 9.2 193.8 32.3 12.7 1.5 28.8 7.3 1.0 41.5 32.2 22.0 VRK1 ENSG00000100749 "Vaccinia related kinase 1" Q99986 14 96797304-96931722 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.0" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 93.5;Spermatocytes: 141.1;Spermatogonia: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000660, HPA017929" Enhanced Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA000660: AB_1080579, HPA017929: AB_1858770" "unprognostic (1.03e-1)" "unprognostic (1.17e-2)" "unprognostic (1.84e-2)" "unprognostic (2.24e-3)" "unprognostic (5.42e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (4.15e-4)" "unprognostic (4.20e-2)" "unprognostic (2.11e-2)" "unprognostic (5.47e-2)" "unprognostic (5.14e-2)" "unprognostic (1.60e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (4.56e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-1)" 6.0 4.4 7.1 9.8 17.1 39.0 8.7 8.6 10.2 6.1 7.8 4.4 4.1 5.2 5.9 5.7 9.4 6.9 3.3 6.0 7.4 6.5 6.2 4.3 4.5 18.3 6.9 6.1 5.9 3.7 3.8 5.1 7.1 6.7 5.3 9.1 4.1 4.8 4.1 4.3 6.4 6.9 5.4 6.1 15.7 6.7 33.3 6.9 33.0 4.9 6.1 18.4 5.9 5.7 20.8 13.5 20.1 9.5 28.5 22.3 12.5 15.8 9.1 22.7 10.1 2.7 5.0 14.1 12.0 9.3 19.2 19.2 10.9 15.8 40.4 8.1 7.1 11.8 17.6 21.2 15.7 26.5 23.0 11.3 25.1 6.0 11.1 3.0 48.4 15.8 2.7 2.8 14.5 10.6 3.9 13.3 31.0 21.4 25.6 16.5 18.1 38.4 20.8 14.5 12.1 17.5 36.0 39.7 13.7 8.8 16.4 16.0 9.1 10.6 10.8 8.1 11.9 12.4 19.2 7.1 8.8 7.8 15.1 12.0 13.4 15.8 39.1 13.7 21.2 10.4 20.1 7.6 14.5 15.1 9.3 18.4 20.3 17.6 18.5 9.9 20.8 19.1 19.3 4.5 28.5 9.5 13.5 22.3 12.5 7.1 17.1 8.6 10.2 7.4 6.5 6.9 6.1 6.7 6.9 3.0 2.9 30.5 11.8 14.9 12.3 10.6 15.3 42.8 13.6 14.0 7.9 19.7 10.0 9.8 13.3 11.3 2.4 93.5 16.8 39.6 10.4 5.3 27.7 2.4 16.3 9.5 2.9 6.2 9.7 10.8 5.2 11.5 11.8 12.6 8.0 5.2 7.6 0.0 9.2 8.4 6.6 19.4 11.3 141.1 122.1 12.2 12.6 26.7 11.2 8.4 VRK2 ENSG00000028116 "Vaccinia related kinase 2" Q86Y07 2 57907651-58159920 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046459, HPA047503" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB046459: AB_1858773, HPA047503: AB_2680071" "unprognostic (1.87e-1)" "unprognostic (5.84e-2)" "unprognostic (4.65e-2)" "unprognostic (1.33e-3)" "unprognostic (1.27e-1)" "unprognostic (1.60e-2)" "prognostic unfavorable (6.32e-6)" "unprognostic (3.90e-2)" "unprognostic (4.76e-2)" "unprognostic (2.96e-2)" "prognostic unfavorable (4.65e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.66e-5)" "unprognostic (3.48e-1)" "unprognostic (1.62e-1)" "unprognostic (2.99e-1)" "unprognostic (3.56e-1)" 18.7 17.7 10.9 21.9 28.3 14.9 16.1 2.4 15.1 15.6 13.5 27.3 16.3 9.9 18.4 16.7 26.8 13.2 10.9 21.6 14.4 8.9 12.4 15.2 15.6 19.5 29.2 13.5 14.2 20.0 16.1 18.7 16.1 18.7 15.7 15.6 9.3 20.5 17.6 21.5 12.8 12.9 20.1 19.0 20.1 13.5 12.5 31.2 13.6 17.4 16.7 23.0 18.1 19.4 19.7 17.0 21.6 21.3 11.3 12.2 9.2 14.2 9.5 1.1 6.3 7.1 13.1 19.7 13.2 13.2 9.1 9.3 19.4 15.1 17.4 17.4 11.6 15.0 10.9 13.8 14.4 13.7 31.2 9.3 19.6 7.7 13.8 11.3 16.6 11.7 7.2 17.2 14.6 21.1 10.9 26.2 2.4 19.2 11.2 15.2 8.2 0.1 12.7 12.0 22.6 4.8 19.0 4.8 11.8 15.1 11.7 3.8 0.1 20.9 12.5 10.5 10.9 8.8 10.2 14.6 0.2 30.3 8.2 0.2 16.5 13.0 9.3 7.4 20.6 15.0 13.7 16.8 21.6 10.1 21.3 12.2 19.7 9.8 11.8 16.6 19.0 7.4 9.5 6.0 11.3 20.6 17.0 11.5 9.2 10.9 28.3 2.4 15.1 14.4 8.9 29.2 13.5 18.7 31.2 20.8 9.1 14.1 11.3 8.8 1.0 17.1 10.2 30.8 15.9 17.4 0.0 19.7 13.3 22.0 16.8 15.0 2.9 46.7 22.8 18.5 8.5 8.1 16.3 6.8 17.1 0.0 6.3 4.9 17.7 6.5 5.5 21.4 10.1 49.5 4.3 4.6 21.8 7.8 5.6 7.1 3.6 6.5 13.7 8.3 12.6 7.3 16.2 12.7 7.1 12.2 VSIG1 MGC44287 ENSG00000101842 "V-set and immunoglobulin domain containing 1" Q86XK7 X 108044970-108079184 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 29.5;stomach 1: 66.6;testis: 87.4" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 14.1;Late spermatids: 8.0;Pancreatic endocrine cells: 19.7" "Group enriched" "Detected in many" 17 "lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.7;T-reg: 11.2" "Lineage enriched" "Detected in many" 4 "T-cells: 11.7" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.8;HUVEC TERT2: 11.9;PC-3: 4.0;TIME: 3.0" "Not detected" "Not detected" "HPA001445, HPA036310, HPA036311" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350" "unprognostic (4.33e-3)" "unprognostic (4.60e-2)" "unprognostic (3.22e-2)" "unprognostic (1.60e-1)" "unprognostic (2.51e-1)" "unprognostic (4.80e-2)" "unprognostic (3.25e-2)" "unprognostic (9.79e-2)" "unprognostic (4.58e-1)" "unprognostic (2.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.25e-1)" "unprognostic (6.31e-7)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-3)" 0.1 0.0 0.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 0.3 0.8 0.1 0.3 0.1 0.2 0.2 0.0 29.5 0.1 0.1 0.1 0.1 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.0 1.3 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 66.6 87.4 0.1 0.1 0.1 0.1 0.4 1.5 0.1 2.6 0.1 0.6 0.1 0.2 11.7 2.5 0.2 1.0 0.0 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.5 0.0 5.8 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.3 0.4 1.0 0.1 1.9 0.1 11.9 0.1 0.1 0.3 0.0 0.4 0.4 0.3 0.4 1.1 4.0 0.4 0.0 0.0 0.7 1.1 0.2 0.1 0.2 0.2 0.6 0.0 0.1 0.0 3.0 0.3 0.9 0.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 1.0 0.0 3.7 2.6 7.7 3.3 0.0 1.0 11.7 5.4 0.4 0.2 0.1 0.1 11.2 2.5 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 23.8 14.1 0.0 0.6 0.6 0.8 0.4 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.0 4.9 0.3 0.0 0.0 4.1 0.0 0.2 0.6 2.3 0.0 0.1 0.0 0.0 0.0 0.0 8.0 0.6 0.2 0.0 0.0 0.0 0.1 19.7 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.5 0.0 0.1 0.5 0.0 0.9 VSIG10 ENSG00000176834 "V-set and immunoglobulin domain containing 10" Q8N0Z9 12 118063593-118136026 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 60.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 22.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062022 Enhanced Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA062022: AB_2732675" "unprognostic (1.32e-1)" "unprognostic (7.76e-2)" "unprognostic (2.05e-1)" "unprognostic (4.62e-3)" "unprognostic (1.09e-1)" "unprognostic (6.42e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.53e-4)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (1.75e-1)" "unprognostic (2.85e-2)" "unprognostic (1.17e-1)" "unprognostic (1.80e-2)" "unprognostic (1.48e-2)" 8.1 10.2 2.6 9.8 3.1 0.4 18.0 2.9 2.6 8.2 31.6 2.7 5.2 11.7 4.5 4.5 8.9 4.0 7.6 3.6 2.4 2.2 6.2 11.9 11.6 3.8 3.2 1.4 5.9 10.9 8.9 4.0 12.2 3.4 8.4 13.9 4.0 6.3 6.4 12.9 4.6 60.9 3.8 2.5 3.3 5.5 3.9 2.5 1.7 26.3 6.1 4.9 6.1 8.6 0.7 2.4 3.5 2.0 0.4 0.6 0.4 4.9 7.3 3.1 10.5 13.1 5.9 7.9 8.5 5.5 4.2 3.5 2.1 11.8 0.7 3.4 6.3 7.9 12.1 22.0 2.2 5.0 2.4 3.3 1.1 6.9 3.2 2.6 0.6 1.8 2.7 6.4 3.2 2.0 12.3 9.2 2.4 1.4 0.1 3.9 5.2 0.0 0.7 9.7 14.5 4.6 1.8 8.6 0.0 6.2 16.1 2.7 3.4 8.3 3.5 2.2 7.0 7.7 3.3 10.7 4.9 3.1 6.0 4.3 0.1 0.1 0.0 7.1 3.5 9.7 0.6 2.0 2.3 0.4 0.6 0.6 0.0 0.4 0.2 2.4 0.7 0.4 0.6 3.5 0.4 0.2 0.7 0.6 0.4 2.6 3.1 2.9 2.2 2.4 2.2 3.2 1.4 3.4 2.5 17.9 22.9 0.8 12.2 2.2 9.7 9.2 20.4 4.0 6.8 27.9 11.8 33.6 16.6 22.4 5.1 15.5 75.3 0.0 17.6 31.6 6.0 13.2 2.3 24.2 9.5 4.8 48.5 16.5 4.3 6.5 16.7 7.2 3.3 10.8 45.7 23.2 20.5 45.6 13.8 9.9 8.0 0.0 5.6 3.9 6.5 2.8 11.7 2.9 51.9 14.0 VSIG10L ENSG00000186806 "V-set and immunoglobulin domain containing 10 like" Q86VR7 19 51331536-51342124 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 70.9;lymphoid tissue: 52.2;salivary gland: 72.9;tongue: 37.6" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 9.5;Melanocytes: 5.0;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 5.9;OE19: 13.7;T-47d: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA060453, HPA066745" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA060453: AB_2684280, HPA066745: AB_2685712" "unprognostic (1.70e-2)" "unprognostic (1.95e-2)" "unprognostic (1.30e-2)" "unprognostic (2.98e-3)" "unprognostic (1.08e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (8.75e-4)" "unprognostic (2.40e-3)" "unprognostic (2.78e-1)" "unprognostic (9.87e-2)" "unprognostic (2.62e-2)" "unprognostic (1.87e-1)" "unprognostic (2.90e-4)" "unprognostic (1.42e-2)" "unprognostic (8.51e-2)" "unprognostic (7.74e-2)" "unprognostic (5.19e-3)" 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.1 9.8 0.1 0.0 2.0 0.1 0.6 0.0 70.9 0.0 0.9 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 1.2 0.1 0.0 72.9 2.6 0.2 4.9 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 37.6 52.2 0.1 10.8 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.1 1.2 0.1 0.5 0.5 0.1 0.2 0.1 0.1 0.0 0.1 0.4 0.9 0.7 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.7 0.1 0.2 5.9 0.0 0.0 1.0 0.0 0.7 0.2 0.0 0.0 0.0 0.3 0.5 1.7 0.0 0.5 0.0 0.1 0.8 13.7 0.6 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.2 10.8 0.0 0.1 0.0 0.2 0.9 0.0 1.4 0.9 0.1 0.7 0.2 0.3 0.0 0.6 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 1.1 0.6 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.1 0.4 0.7 0.0 0.0 0.7 1.4 0.9 1.1 1.0 4.0 9.5 1.2 1.3 3.2 0.0 2.0 1.8 5.0 1.8 0.6 1.2 0.4 0.2 3.9 0.8 0.4 6.5 1.0 0.5 2.2 0.4 0.5 0.0 0.4 0.3 VSIG10L2 ENSG00000283703 "V-set and immunoglobulin domain containing 10 like 2" P0DP72 11 125946056-125958647 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.6;skin 1: 20.4" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 4.0;Club cells: 3.4;Ductal cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;AN3-CA: 1.1;SH-SY5Y: 2.7;SK-BR-3: 1.4" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 2.3 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 2.8 0.0 0.0 20.4 0.2 0.6 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 1.4 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VSIG2 "CTH, CTXL" ENSG00000019102 "V-set and immunoglobulin domain containing 2" Q96IQ7 11 124747472-124752238 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 38.2;stomach 1: 105.5" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 296.5;Mucus-secreting cells: 283.0;Paneth cells: 482.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "OE19: 98.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035919, HPA050147" Enhanced Approved Nucleoplasm NA NA 81000 Nucleoplasm "HPA035919: AB_10669981, HPA050147: AB_2681032" "unprognostic (1.64e-3)" "unprognostic (1.21e-1)" "unprognostic (1.10e-2)" "unprognostic (1.90e-1)" "unprognostic (2.00e-1)" "unprognostic (2.18e-3)" "unprognostic (2.16e-1)" "unprognostic (2.22e-2)" "unprognostic (3.47e-3)" "unprognostic (2.02e-1)" "unprognostic (6.01e-2)" "unprognostic (2.78e-2)" "unprognostic (2.99e-2)" "unprognostic (2.61e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.36e-2)" 1.3 0.1 0.3 11.2 0.4 0.2 3.3 0.3 0.5 5.2 23.5 0.7 0.3 0.7 1.0 0.8 8.6 2.9 38.2 0.6 0.3 0.2 1.6 0.7 25.3 0.3 0.3 0.3 2.2 0.4 0.0 0.3 0.7 0.5 18.5 24.3 0.4 12.4 0.8 0.3 0.3 2.0 3.5 0.3 0.3 105.5 1.2 0.3 0.3 28.9 3.1 5.3 26.0 14.7 0.3 1.4 0.6 3.8 0.8 2.1 2.7 0.0 0.0 1.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 1.7 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 98.4 0.8 0.0 0.8 0.0 0.0 16.0 0.0 0.2 0.0 1.0 0.0 0.1 0.1 0.5 0.9 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.0 3.8 0.0 0.0 0.6 1.6 0.0 1.8 0.3 1.4 0.3 2.0 1.6 0.6 0.8 0.5 0.0 2.1 2.7 0.3 0.4 0.3 0.5 0.3 0.2 0.3 0.3 0.5 0.3 116.1 39.3 0.0 14.5 0.7 0.6 0.4 76.5 17.4 43.3 3.5 0.0 0.0 1.7 4.7 0.0 4.5 296.5 0.0 82.7 0.0 0.5 69.3 1.1 0.0 0.1 0.0 64.2 4.3 0.3 0.0 1.4 2.3 3.3 0.0 283.0 0.0 152.0 482.9 0.0 0.0 0.0 0.0 4.4 0.3 0.4 0.4 0.0 0.0 145.8 135.8 VSIG4 Z39IG ENSG00000155659 "V-set and immunoglobulin domain containing 4" Q9Y279 X 66021738-66040125 "Plasma proteins, Predicted membrane proteins" "Complement alternate pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 31 "Hofbauer cells: 772.9;Kupffer cells: 436.3;Macrophages: 389.0" "Cancer enhanced" "Detected in all" "glioma: 88.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 26 "classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1" "Group enriched" "Detected in many" 30 "dendritic cells: 13.1;monocytes: 13.9" "Cell line enhanced" "Detected in some" "BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.1;U-937: 2.7" "Low region specificity" "Detected in many" "HPA003903, CAB026000" Enhanced Uncertain "Nucleoli,Plasma membrane,Cytosol" NA NA 41000000 "Plasma membrane, Cytosol" Nucleoli "CAB026000: , HPA003903: AB_1858776" "unprognostic (6.87e-3)" "unprognostic (4.79e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (3.19e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (9.37e-3)" "unprognostic (1.24e-1)" "unprognostic (3.10e-1)" "unprognostic (1.37e-3)" "unprognostic (1.06e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (1.95e-6)" "unprognostic (3.70e-2)" "unprognostic (5.45e-2)" "unprognostic (3.37e-2)" "unprognostic (3.47e-2)" 67.1 28.1 15.9 17.6 16.6 2.6 19.0 1.8 10.4 6.3 18.0 5.6 1.0 9.2 6.1 14.2 9.3 28.7 15.5 15.9 11.5 3.5 18.5 22.9 61.4 37.0 17.9 3.4 8.2 8.2 3.7 7.9 52.4 12.0 10.9 12.6 8.1 11.3 4.0 10.5 4.0 14.6 39.9 16.7 28.5 9.4 13.5 17.8 0.0 10.7 1.7 1.8 14.4 9.0 0.1 13.1 0.4 13.9 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.0 0.0 0.1 3.1 0.2 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.8 2.7 0.0 0.0 13.9 0.0 0.0 8.1 0.0 0.0 0.0 0.2 13.1 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 3.3 15.9 16.6 1.8 10.1 11.5 3.5 17.9 3.4 12.0 17.8 3.0 17.3 3.0 0.1 2.1 0.0 0.8 7.6 8.1 5.7 0.0 0.0 4.4 0.0 0.0 5.8 1.9 0.0 0.0 0.0 3.7 3.8 0.2 3.5 2.4 772.9 0.0 0.0 5.5 436.3 13.2 1.4 389.0 3.3 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 6.5 0.2 0.2 0.9 1.5 10.3 0.0 0.0 0.2 VSIG8 ENSG00000243284 "V-set and immunoglobulin domain containing 8" P0DPA2 1 159854316-159862657 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 83.5" "Cell type enhanced" "Detected in some" 14 "Basal keratinocytes: 10.0;Collecting duct cells: 5.2;Intestinal endocrine cells: 3.5;Suprabasal keratinocytes: 4.0" "Group enriched" "Detected in some" 6 "cervical cancer: 3.0;endometrial cancer: 3.0;head and neck cancer: 4.6;urothelial cancer: 1.0" "Region enriched" "Detected in single" 13 "cerebellum: 4.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 3.5;Karpas-707: 1.7;U-2 OS: 1.1;U-266/70: 1.4;U-87 MG: 2.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA023219 Uncertain NA NA "HPA023219: AB_1845635" "unprognostic (8.66e-3)" "unprognostic (2.17e-1)" "unprognostic (2.74e-1)" "unprognostic (9.13e-3)" "unprognostic (4.50e-3)" "unprognostic (1.15e-2)" "unprognostic (9.26e-2)" "unprognostic (6.28e-2)" "unprognostic (1.68e-2)" "unprognostic (2.79e-1)" "unprognostic (2.93e-3)" "unprognostic (9.32e-2)" "unprognostic (7.94e-7)" "unprognostic (1.72e-2)" "unprognostic (4.25e-1)" "unprognostic (1.81e-3)" "unprognostic (1.99e-1)" 0.4 0.1 0.2 0.2 0.3 0.0 0.2 4.2 0.2 2.2 0.2 0.2 0.2 0.2 0.2 0.2 2.5 1.0 0.2 0.2 0.2 0.2 2.7 0.2 0.2 0.2 0.2 0.2 1.2 0.2 0.0 0.2 0.3 0.2 0.2 0.0 0.2 4.3 0.2 0.2 18.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.8 0.4 83.5 9.2 0.2 2.0 0.6 0.0 0.1 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.6 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.1 0.2 0.2 0.4 1.0 1.1 0.2 0.0 1.4 0.0 0.0 2.1 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.5 0.6 0.3 0.5 0.0 0.0 0.7 0.5 0.1 0.7 0.0 0.0 0.3 0.0 0.2 0.3 4.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.5 10.0 2.6 0.0 0.0 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.3 0.1 1.0 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.2 0.0 3.5 0.6 0.0 0.0 0.6 0.0 0.0 0.0 1.7 1.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 4.0 0.1 0.5 1.1 0.6 VSIR "B7-H5, B7H5, C10orf54, GI24, PD-1H, SISP1, VISTA" ENSG00000107738 "V-set immunoregulatory receptor" Q9H7M9 10 71747559-71773498 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 111.3" "Cell type enhanced" "Detected in many" 19 "Cytotrophoblasts: 279.2;Extravillous trophoblasts: 255.7;monocytes: 118.2;Syncytiotrophoblasts: 566.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 111.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.5;HaCaT: 20.2;HMC-1: 33.8;U-937: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007968 Approved Nucleoplasm NA NA 360000 Nucleoplasm "HPA007968: AB_1845518" "unprognostic (1.19e-1)" "unprognostic (1.76e-3)" "unprognostic (1.64e-1)" "unprognostic (6.67e-2)" "unprognostic (9.29e-2)" "unprognostic (2.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (1.02e-2)" "unprognostic (6.82e-2)" "unprognostic (8.70e-2)" "unprognostic (2.57e-3)" "unprognostic (2.72e-1)" "prognostic unfavorable (6.93e-4)" "unprognostic (2.37e-3)" "unprognostic (3.29e-1)" 20.8 5.7 13.3 23.4 14.8 55.3 30.4 3.4 10.2 10.7 12.9 10.5 5.4 16.6 14.7 8.8 13.7 15.0 10.8 13.6 13.0 9.8 5.8 4.1 20.1 60.0 12.4 7.2 17.5 4.4 2.4 3.8 48.2 11.8 11.0 7.1 8.1 8.6 8.7 4.7 9.1 16.3 12.7 11.1 55.1 10.2 6.4 11.8 4.6 7.7 10.1 17.6 14.1 24.8 1.9 24.4 111.3 44.9 5.8 11.7 40.1 3.3 6.5 0.0 0.1 3.5 2.9 3.1 1.2 7.9 1.5 2.6 2.6 26.5 0.2 1.7 11.2 0.0 20.2 0.0 0.7 0.4 0.1 0.0 4.4 1.4 0.2 4.9 0.7 33.8 2.4 0.8 0.2 0.1 2.3 0.5 0.6 0.1 2.5 0.9 0.1 0.7 5.5 0.0 5.0 1.3 0.0 0.3 1.5 0.0 1.5 0.0 0.1 1.7 1.3 1.2 0.4 0.1 9.5 1.7 0.0 0.0 5.4 0.0 1.8 0.9 0.0 0.1 29.5 0.1 22.0 42.3 81.0 8.9 40.5 11.7 1.8 8.9 8.4 24.4 1.9 8.3 8.3 111.3 5.8 44.9 6.4 8.8 40.1 13.3 14.8 3.4 10.2 13.0 9.8 12.4 7.2 11.8 11.8 26.8 11.6 0.0 0.0 0.0 0.0 0.0 0.0 6.7 11.4 10.4 0.0 279.2 0.0 37.3 0.0 0.0 0.0 0.0 9.6 255.7 0.0 0.0 29.1 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 118.2 0.0 0.0 36.4 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 566.7 0.0 0.0 0.0 VSTM1 UNQ3033 ENSG00000189068 "V-set and transmembrane domain containing 1" Q6UX27 19 54040825-54063953 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 53.5;bone marrow: 39.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 15.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 15 "eosinophil: 53.5" "Lineage enriched" "Detected in many" 15 "granulocytes: 53.5" "Group enriched" "Detected in some" 7 "EFO-21: 1.0;HMC-1: 2.5;hTERT-HME1: 4.0;U-2 OS: 3.6" HPA059365 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA059365: " "unprognostic (5.13e-2)" "unprognostic (5.31e-2)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.36e-3)" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (3.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-1)" "unprognostic (9.47e-2)" "unprognostic (1.31e-5)" "unprognostic (3.73e-1)" "unprognostic (1.14e-1)" "unprognostic (9.74e-2)" "unprognostic (4.67e-2)" 0.9 0.2 0.7 0.1 0.2 39.4 0.1 0.0 0.5 0.2 0.1 1.3 0.0 0.1 0.3 0.1 0.1 0.6 0.1 4.2 0.7 0.2 0.5 1.2 4.0 7.2 0.6 0.0 0.2 1.1 0.1 8.7 2.0 0.2 0.1 0.1 0.2 0.1 0.1 2.1 0.1 0.8 0.3 0.1 7.9 0.1 0.5 0.3 3.0 0.4 0.0 0.1 0.8 0.0 0.0 0.0 53.5 3.6 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.0 53.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.6 0.0 0.0 2.1 0.7 0.2 0.0 0.5 0.7 0.2 0.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 2.2 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 VSTM2A "MGC33530, VSTM2" ENSG00000170419 "V-set and transmembrane domain containing 2A" Q8TAG5 7 54542325-54571080 "Plasma proteins, Predicted secreted proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 13.7;brain: 51.7;prostate: 13.7" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 38.3" "Cancer enhanced" "Detected in some" "breast cancer: 4.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Karpas-707: 3.4;SCLC-21H: 10.5;SH-SY5Y: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (1.15e-1)" "unprognostic (1.02e-1)" "unprognostic (1.89e-1)" "unprognostic (1.14e-2)" "unprognostic (4.66e-1)" "prognostic favorable (5.34e-4)" "unprognostic (4.34e-2)" "unprognostic (6.79e-2)" "unprognostic (7.15e-2)" 0.7 13.7 18.4 0.7 22.7 0.7 1.1 0.5 51.7 0.7 6.0 1.4 0.0 2.4 0.7 0.7 0.7 0.7 0.9 0.7 9.4 15.5 0.8 0.7 0.8 0.7 4.4 13.6 0.7 1.8 0.7 0.4 0.7 6.7 13.7 5.8 1.1 0.7 0.7 0.8 0.7 1.1 0.8 3.2 0.7 7.2 1.2 3.0 0.0 0.7 0.0 0.7 0.9 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.5 7.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.4 22.7 0.5 51.7 9.4 15.5 4.4 13.6 6.7 3.0 0.0 0.0 0.0 0.0 0.0 38.3 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 VSTM2B ENSG00000187135 "V-set and transmembrane domain containing 2B" A6NLU5 19 29526499-29564479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 40.8" "Group enriched" "Detected in some" 7 "Bipolar cells: 32.2;Horizontal cells: 14.3" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.8;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 19 "T-cells: 1.8" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.74e-1)" "unprognostic (1.87e-3)" "unprognostic (6.64e-2)" "unprognostic (1.08e-2)" "unprognostic (5.35e-2)" 1.0 1.2 16.2 1.0 17.0 0.9 1.0 13.4 40.8 3.1 1.0 8.6 0.0 1.0 1.0 1.6 0.9 1.0 1.0 1.0 14.2 9.4 1.0 0.9 0.9 1.1 12.5 9.2 1.0 0.9 0.9 0.0 0.9 4.5 0.9 1.0 0.3 0.9 1.0 0.9 1.0 1.0 1.3 11.7 1.0 1.0 1.0 2.2 0.0 0.9 0.0 1.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 13.4 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 17.0 13.4 16.6 14.2 9.4 12.5 9.2 4.5 2.2 0.0 0.0 0.0 0.0 0.0 32.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 VSTM4 "C10orf72, FLJ31737" ENSG00000165633 "V-set and transmembrane domain containing 4" Q8IW00 10 49014245-49115509 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 81.0;Late spermatids: 104.4;Sertoli cells: 58.2" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 22.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 6.9;RH-30: 8.0;SH-SY5Y: 6.8;U-138 MG: 9.1;U-2197: 20.4;U-87 MG: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017279 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA "Nucleoplasm, Vesicles" "HPA017279: AB_10959519" "unprognostic (8.46e-2)" "unprognostic (5.41e-1)" "unprognostic (1.89e-1)" "unprognostic (2.07e-1)" "unprognostic (1.80e-1)" "unprognostic (2.84e-2)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" "unprognostic (3.03e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.62e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.25e-4)" 13.0 31.6 7.2 3.4 6.7 0.4 10.5 3.3 7.1 18.2 6.2 9.3 3.1 2.0 13.2 5.9 6.1 6.5 11.7 10.3 7.2 4.4 9.3 3.0 8.9 7.0 8.9 5.4 27.2 1.3 22.8 4.6 7.7 10.1 11.2 4.4 15.1 2.8 9.2 3.8 4.2 4.1 12.5 7.9 2.8 5.4 7.8 6.0 2.9 20.8 6.9 3.4 9.4 8.6 1.8 0.9 2.7 0.9 1.7 0.7 0.2 0.0 0.1 2.7 0.1 1.1 0.6 0.1 2.1 3.5 0.8 0.2 0.1 0.1 0.1 0.1 5.0 2.9 0.1 0.1 0.0 0.4 2.6 1.2 0.1 0.0 0.1 0.1 0.1 0.0 4.1 0.0 3.6 0.0 0.0 0.0 0.7 6.9 0.1 0.6 0.1 0.0 0.1 0.5 0.0 0.0 0.0 8.0 4.1 0.0 0.1 0.1 6.8 0.1 0.1 0.0 0.3 0.1 0.2 0.0 9.1 1.1 20.4 0.1 0.0 5.5 0.0 10.0 0.1 0.1 1.9 0.9 0.4 0.6 0.3 0.5 0.8 0.4 0.3 0.2 1.8 0.7 0.6 2.7 1.7 0.5 0.9 0.3 0.2 7.2 6.7 3.3 7.1 7.2 4.4 8.9 5.4 10.1 6.0 3.0 17.4 0.0 1.7 5.8 5.0 12.1 0.0 6.7 17.0 0.0 2.0 0.4 1.7 0.1 81.0 6.4 0.0 0.0 0.0 0.3 22.4 0.7 11.6 3.2 0.5 4.8 0.0 3.7 1.9 104.4 8.9 4.0 6.8 1.0 0.0 10.9 0.2 0.0 13.8 6.1 2.7 58.2 30.0 1.4 3.4 3.8 0.3 1.3 0.0 0.6 VSTM5 "C11orf90, LOC387804" ENSG00000214376 "V-set and transmembrane domain containing 5" A8MXK1 11 93818232-93850531 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 9.9;placenta: 10.7" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 16.9;Syncytiotrophoblasts: 4.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.3;OE19: 6.8;PC-3: 10.0;SH-SY5Y: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029525, HPA063591" Uncertain Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029525: AB_10600789, HPA063591: AB_2732704" "unprognostic (1.26e-1)" "unprognostic (4.48e-3)" "unprognostic (2.78e-1)" "unprognostic (1.54e-4)" "unprognostic (2.45e-2)" "unprognostic (9.91e-2)" "unprognostic (8.56e-2)" "unprognostic (1.37e-2)" "unprognostic (1.68e-2)" "unprognostic (1.04e-1)" "unprognostic (2.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.31e-1)" "unprognostic (3.53e-2)" "unprognostic (2.37e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" 0.5 0.6 3.1 0.4 2.9 0.1 1.1 2.2 8.2 2.8 3.0 0.4 0.6 0.5 0.9 3.2 0.5 0.5 1.5 0.8 3.2 9.9 2.1 0.1 0.3 0.2 4.7 3.5 0.3 1.3 0.1 1.2 10.7 4.9 1.6 4.4 0.3 1.4 1.3 0.2 0.3 1.3 1.9 1.3 0.1 4.9 0.4 0.0 0.0 0.4 0.0 0.3 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.9 0.2 1.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 10.0 0.0 0.0 0.3 0.0 0.3 0.2 4.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.9 2.2 8.2 3.2 9.9 4.7 3.5 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.3 0.0 0.0 0.5 0.0 2.7 0.3 0.2 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.8 2.5 0.4 1.0 0.3 0.0 0.0 0.0 0.0 0.1 4.9 0.0 1.6 0.0 VTCN1 "B7-H4, B7H4, B7S1, B7X, FLJ22418" ENSG00000134258 "V-set domain containing T cell activation inhibitor 1" Q7Z7D3 1 117143587-117210960 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9" "Group enriched" "Detected in some" 5 "Collecting duct cells: 52.4;Ductal cells: 73.6;Exocrine glandular cells: 31.1" "Group enriched" "Detected in many" 6 "breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 74.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054200 Approved Approved "Plasma membrane,Cell Junctions,Focal adhesion sites" No NA "Plasma membrane" "Cell Junctions, Focal adhesion sites" "HPA054200: AB_2682415" "unprognostic (4.13e-1)" "unprognostic (1.71e-3)" "unprognostic (2.95e-1)" "unprognostic (3.44e-2)" "unprognostic (1.71e-3)" "unprognostic (2.56e-1)" "unprognostic (7.94e-2)" "unprognostic (4.86e-2)" "unprognostic (3.53e-1)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (5.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-1)" "unprognostic (3.07e-1)" "unprognostic (1.45e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 46.4 0.1 0.1 6.7 0.1 0.1 7.0 0.0 2.6 29.9 0.4 14.2 1.9 0.2 0.1 0.1 27.0 0.9 0.3 0.1 0.1 0.1 4.5 35.9 0.0 1.4 3.0 0.1 1.5 0.0 0.1 17.5 3.6 0.2 2.2 0.1 0.8 0.1 0.1 1.5 2.5 0.1 0.2 0.1 0.5 1.5 2.1 0.7 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.0 74.4 0.0 9.6 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 2.4 0.0 0.0 1.2 0.0 4.0 10.3 52.4 0.0 1.7 0.0 73.6 1.6 0.0 0.0 0.0 31.1 1.1 0.0 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.9 VTI1A "MVti1, Vti1-rp2, Vti1a" ENSG00000151532 "Vesicle transport through interaction with t-SNAREs 1A" Q96AJ9 10 112446998-112818744 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054108 Supported Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA054108: AB_2682382" "unprognostic (9.81e-2)" "unprognostic (6.42e-2)" "unprognostic (4.49e-2)" "unprognostic (1.50e-1)" "unprognostic (1.66e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (6.50e-5)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (1.22e-1)" "unprognostic (8.05e-2)" "prognostic favorable (7.27e-5)" "unprognostic (3.74e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-3)" "unprognostic (2.61e-1)" 16.8 12.8 14.5 17.9 17.9 25.2 14.6 16.7 18.6 10.0 13.8 14.3 14.4 15.2 11.8 11.6 21.1 9.5 10.3 13.1 13.4 11.1 15.4 11.8 15.7 15.4 12.8 12.2 10.5 12.8 17.4 13.7 11.0 14.6 11.4 17.0 11.2 14.3 13.6 18.4 17.1 16.5 12.8 12.7 16.0 12.3 9.8 13.0 18.8 14.2 9.7 19.6 13.1 15.6 7.3 6.8 14.8 11.7 7.3 8.8 5.5 11.0 9.2 8.8 12.0 13.7 12.1 5.2 11.8 15.0 9.7 10.9 10.4 11.5 11.5 4.6 13.5 8.2 13.3 7.5 9.5 13.2 14.4 6.6 9.9 6.8 10.9 9.7 13.7 14.5 9.2 12.3 10.9 22.9 10.9 10.2 11.9 9.0 14.5 12.8 7.6 10.9 10.6 3.7 8.8 5.4 11.5 12.7 5.1 10.1 9.9 4.0 7.7 8.4 7.4 7.8 7.7 6.6 7.7 14.3 7.6 6.5 9.2 13.2 6.3 8.8 13.5 12.4 12.7 7.3 8.9 8.9 11.9 7.5 11.7 7.0 7.3 6.3 6.0 6.8 6.7 6.2 6.4 14.8 7.3 10.4 6.4 8.8 5.5 14.5 17.9 16.7 18.6 13.4 11.1 12.8 12.2 14.6 13.0 11.9 10.1 18.0 12.4 10.0 16.9 10.6 7.6 13.4 12.5 5.2 41.2 6.9 6.6 11.1 32.9 11.1 16.3 23.3 21.6 9.8 7.6 10.6 18.5 7.3 16.5 20.6 17.7 7.4 17.0 60.8 6.4 21.7 11.8 13.6 8.7 5.4 21.2 8.4 5.3 7.8 20.1 0.0 9.8 10.7 7.0 14.3 12.0 20.3 9.9 15.7 VTI1B VTI2 ENSG00000100568 "Vesicle transport through interaction with t-SNAREs 1B" Q9UEU0 14 67647075-67674831 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 380.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044121, HPA048150, HPA060118" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206" "unprognostic (2.26e-1)" "unprognostic (4.83e-2)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (3.00e-2)" "unprognostic (2.36e-3)" "unprognostic (3.25e-3)" "unprognostic (9.12e-2)" "unprognostic (1.90e-2)" "unprognostic (3.86e-1)" "unprognostic (2.60e-1)" "unprognostic (2.11e-2)" "prognostic favorable (3.53e-12)" "unprognostic (8.35e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (8.02e-3)" 37.5 21.4 49.3 14.9 39.3 14.3 32.1 12.6 32.9 11.3 22.8 16.8 16.1 21.3 12.5 42.5 34.1 14.6 22.0 49.6 36.9 30.4 39.0 30.5 14.8 16.3 38.1 20.5 12.7 27.9 20.3 11.3 21.0 24.2 16.2 27.4 15.4 25.7 18.8 31.0 21.8 20.2 22.9 37.1 15.6 20.7 15.4 20.2 8.2 25.9 18.8 19.5 19.4 24.2 18.7 22.4 52.1 29.6 20.1 21.7 18.9 38.5 19.5 11.4 6.6 22.7 13.5 16.4 17.1 10.6 8.3 8.5 9.7 13.9 11.6 14.6 19.0 10.1 10.9 13.0 12.9 13.5 11.8 8.2 11.7 11.8 12.3 9.7 7.2 8.4 13.1 14.1 9.2 9.5 22.0 9.5 8.1 7.6 9.1 12.0 45.8 9.0 26.8 7.4 26.7 31.5 11.0 12.9 4.2 12.3 23.2 6.4 13.1 12.1 16.4 24.2 9.1 15.3 20.4 13.7 23.0 34.4 18.5 15.8 8.5 9.1 17.8 19.4 13.6 10.5 28.6 23.4 52.1 19.8 29.6 16.9 18.7 17.5 20.2 22.4 16.4 16.7 20.4 10.6 20.1 24.7 14.7 21.7 18.9 49.3 39.3 12.6 32.9 36.9 30.4 38.1 20.5 24.2 20.2 23.8 34.1 49.1 46.9 37.5 22.4 26.0 53.5 48.2 38.7 62.8 21.6 89.3 184.1 93.0 115.6 46.6 134.6 116.8 115.1 143.6 54.1 81.6 62.4 79.1 116.8 14.3 44.7 56.4 74.2 380.3 38.6 65.2 67.4 137.1 84.4 35.2 113.0 108.7 37.4 203.8 35.3 19.4 41.0 101.0 65.5 46.2 105.3 34.1 80.0 77.1 WBP1 WBP-1 ENSG00000239779 "WW domain binding protein 1" Q96G27 2 74458329-74460891 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 21.4;monocytes: 9.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057067 Approved Approved Cytosol No No Cytosol "HPA057067: AB_2683326" "unprognostic (5.94e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (6.05e-2)" "unprognostic (2.98e-1)" "unprognostic (1.11e-1)" "unprognostic (5.80e-2)" "unprognostic (1.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "prognostic favorable (6.83e-4)" "unprognostic (1.17e-2)" "unprognostic (1.87e-2)" "unprognostic (1.78e-1)" "unprognostic (1.57e-1)" "unprognostic (5.09e-2)" "prognostic favorable (6.36e-4)" 17.6 23.5 37.6 12.6 34.8 15.1 18.1 12.1 27.5 22.4 14.9 34.4 23.6 15.9 19.2 26.1 19.0 31.0 20.6 21.2 30.9 22.7 23.0 26.4 15.4 15.5 28.6 17.2 27.6 35.9 27.7 22.1 15.4 20.8 29.8 10.2 32.1 49.1 25.5 15.3 19.7 15.8 16.4 25.2 14.7 17.9 10.6 17.0 40.5 36.0 17.2 17.6 18.7 19.2 19.2 30.3 15.3 18.5 21.5 24.0 16.5 6.1 29.3 17.8 20.1 22.8 17.5 13.4 6.6 12.3 6.6 5.4 15.2 11.7 6.0 11.8 15.2 10.1 9.1 7.2 17.1 6.4 23.7 17.0 8.4 13.8 21.3 14.6 3.0 8.3 24.6 18.3 8.8 13.1 31.8 13.1 15.9 3.3 21.5 16.7 41.7 10.3 7.7 12.7 16.1 15.6 10.4 20.1 9.0 17.5 26.0 10.5 26.4 8.8 14.6 18.1 16.6 19.5 8.1 8.1 16.0 13.2 6.2 6.4 32.9 11.4 7.0 17.2 7.9 14.1 15.3 18.5 12.2 18.1 14.2 15.9 19.2 16.0 17.6 19.4 18.8 22.4 19.4 13.0 21.5 12.0 30.3 24.0 16.5 37.6 34.8 12.1 27.5 30.9 22.7 28.6 17.2 20.8 17.0 3.0 3.4 0.0 0.4 0.8 1.7 0.4 0.0 21.4 5.7 1.8 2.0 1.1 1.7 4.1 1.3 1.1 3.4 0.0 3.5 1.2 1.2 1.6 1.1 0.8 1.4 0.0 1.7 0.6 3.5 1.3 2.0 1.4 0.0 9.0 4.4 1.5 5.0 3.5 1.1 3.1 1.8 0.0 1.2 0.1 0.2 1.1 1.5 1.5 4.5 0.3 WBP1L "C10orf26, FLJ20154, OPAL1" ENSG00000166272 "WW domain binding protein 1 like" Q9NX94 10 102743970-102816267 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037635, HPA038371" Uncertain Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA037635: AB_10672462, HPA038371: AB_2675980" "unprognostic (3.28e-2)" "unprognostic (6.46e-2)" "unprognostic (1.14e-2)" "prognostic favorable (4.03e-4)" "unprognostic (5.35e-3)" "unprognostic (2.73e-2)" "unprognostic (3.33e-2)" "unprognostic (1.25e-1)" "unprognostic (1.69e-1)" "unprognostic (2.43e-3)" "unprognostic (2.55e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.56e-6)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (4.88e-2)" "unprognostic (1.53e-1)" 23.8 23.0 11.5 12.9 13.7 2.3 14.2 9.5 14.2 19.0 14.5 12.2 13.3 9.0 18.9 14.9 13.1 18.9 15.3 23.6 11.9 8.9 11.6 21.3 13.3 11.5 14.9 8.0 23.6 9.3 12.5 13.5 14.1 17.5 15.2 9.2 20.2 21.8 14.9 77.3 20.1 12.3 16.3 15.0 12.5 15.0 11.0 10.1 23.2 26.1 35.5 11.1 17.6 11.4 6.1 8.2 14.7 16.7 12.4 8.7 8.9 10.1 13.2 7.3 12.3 24.3 19.8 14.9 10.4 28.3 10.4 13.1 9.0 15.9 8.8 14.1 16.0 8.4 11.3 5.3 9.0 7.9 8.8 5.6 17.8 6.0 6.4 15.8 8.5 21.2 21.3 16.2 13.3 10.3 23.9 20.2 10.7 8.6 11.1 17.7 13.3 10.3 9.5 5.5 7.8 6.5 20.7 19.2 5.6 9.2 10.1 1.7 7.0 5.7 5.8 11.7 13.7 23.7 9.5 15.0 10.0 10.4 11.3 9.2 20.6 10.8 6.5 14.2 16.5 4.4 6.6 11.8 14.7 8.7 13.7 6.9 6.1 7.4 8.4 8.2 6.0 6.8 7.2 14.4 12.4 16.7 5.2 7.5 8.9 11.5 13.7 9.5 14.2 11.9 8.9 14.9 8.0 17.5 10.1 20.8 21.3 12.6 8.9 7.2 5.5 12.1 15.3 20.1 17.0 12.2 0.0 27.0 1.7 13.1 1.9 18.4 17.0 0.0 22.1 12.1 18.9 19.8 38.0 44.0 23.3 12.7 8.7 23.9 39.9 1.0 12.0 16.5 10.1 18.0 15.7 8.3 18.1 11.5 18.4 9.2 3.7 19.4 19.6 5.0 6.1 10.3 33.4 8.7 10.9 8.9 WDR19 "DYF-2, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp" ENSG00000157796 "WD repeat domain 19" Q8NEZ3 4 39182404-39285810 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 41.1" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 41.5;Spermatocytes: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 25.4;ASC TERT1: 28.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039616, HPA058847" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039616: AB_10796331, HPA058847: AB_2683834" "unprognostic (1.80e-1)" "unprognostic (9.32e-2)" "unprognostic (6.40e-2)" "unprognostic (5.69e-2)" "unprognostic (1.37e-1)" "unprognostic (1.26e-3)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.06e-1)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "prognostic favorable (2.70e-4)" "prognostic unfavorable (8.58e-4)" "unprognostic (3.52e-2)" "unprognostic (2.40e-2)" "unprognostic (5.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.56e-2)" 8.5 7.6 8.1 4.8 12.9 3.4 9.2 21.0 14.5 13.2 7.8 5.7 7.8 1.9 15.5 11.2 5.4 20.9 8.6 5.1 11.7 4.1 8.6 7.0 8.6 4.4 6.0 11.0 19.0 6.6 10.1 41.1 6.3 14.6 8.1 4.3 6.9 7.6 8.2 3.1 6.0 5.7 9.5 9.7 4.3 8.0 12.7 7.3 6.8 17.1 3.8 5.0 9.9 8.9 3.9 1.1 1.5 2.0 2.3 2.4 0.8 3.2 2.3 5.5 6.6 25.4 28.5 2.5 4.3 9.7 4.5 6.0 1.4 3.7 5.3 2.1 4.1 9.7 1.9 5.4 2.8 5.0 0.3 3.9 1.0 4.4 2.7 7.9 5.2 1.4 17.3 6.1 6.0 3.8 12.5 5.4 5.4 4.7 5.3 5.4 1.1 3.5 3.6 1.8 1.9 2.6 4.3 5.6 2.4 3.7 1.3 6.1 5.6 4.2 1.4 2.8 6.9 2.8 1.9 3.9 4.4 3.0 9.7 4.2 3.9 3.6 3.7 6.6 1.5 2.0 0.7 1.2 0.9 1.7 2.0 1.3 3.4 2.1 2.4 1.1 3.9 2.1 2.1 1.5 2.3 1.7 0.7 1.4 0.8 8.1 12.9 21.0 14.5 11.7 4.1 6.0 11.0 14.6 7.3 11.9 5.7 3.2 4.9 4.2 7.6 3.8 2.5 41.5 12.5 17.4 9.8 1.0 0.0 4.5 3.0 4.5 0.0 0.0 3.1 2.0 5.6 3.1 2.3 10.6 2.7 23.8 2.4 4.3 1.9 2.6 15.3 2.9 1.7 1.0 2.2 7.3 2.9 0.0 17.7 3.4 22.5 0.0 3.8 30.3 10.2 4.1 1.1 1.0 1.0 1.8 WDR33 "FLJ11294, NET14, WDC146" ENSG00000136709 "WD repeat domain 33" Q9C0J8 2 127701022-127811187 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026897, HPA046527" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA026897: AB_1858803, HPA046527: AB_2679686" "unprognostic (1.26e-1)" "unprognostic (7.22e-2)" "unprognostic (1.50e-1)" "unprognostic (1.79e-2)" "unprognostic (6.63e-2)" "unprognostic (8.32e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (1.01e-1)" "unprognostic (1.66e-2)" "unprognostic (8.13e-2)" "unprognostic (5.72e-3)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" "unprognostic (3.64e-1)" "unprognostic (2.04e-1)" "unprognostic (9.85e-2)" "unprognostic (1.03e-2)" 19.8 19.2 18.1 22.5 22.5 18.8 21.7 51.4 24.3 20.9 19.8 22.0 22.8 18.2 32.2 19.0 20.6 18.6 17.9 16.8 17.7 16.5 22.3 32.3 18.5 25.0 19.4 14.5 29.2 21.8 26.4 41.8 20.9 22.0 21.9 19.5 24.4 25.3 17.4 22.0 27.8 21.3 21.0 22.2 28.1 18.0 24.5 20.8 39.5 25.2 16.6 30.5 21.5 22.4 24.4 21.6 26.7 18.3 25.9 26.3 14.4 18.5 10.5 18.4 14.9 10.9 11.4 19.1 17.0 13.6 18.0 17.1 24.4 14.3 23.6 18.9 11.2 16.6 15.2 20.7 14.4 23.7 21.6 12.4 22.7 13.4 26.0 12.3 27.3 17.0 11.1 15.3 17.2 14.7 12.9 15.3 21.4 18.8 21.2 12.6 11.7 28.3 20.0 22.3 12.1 12.0 19.9 18.6 18.7 10.3 24.2 17.2 13.4 15.2 14.1 12.0 18.1 10.9 16.0 14.2 14.2 20.8 15.8 14.5 20.7 31.6 45.0 11.6 10.9 13.2 21.2 16.7 26.7 21.5 18.3 21.9 24.4 21.9 20.6 21.6 23.0 23.3 22.1 11.4 25.9 18.2 15.8 26.3 14.4 18.1 22.5 51.4 24.3 17.7 16.5 19.4 14.5 22.0 20.8 32.8 38.9 53.6 65.1 97.7 50.6 43.7 50.9 26.8 25.0 34.9 60.9 70.6 39.7 41.7 25.0 53.7 27.8 46.7 39.3 76.0 51.5 42.9 63.5 58.0 43.8 57.2 37.8 42.4 42.9 17.6 46.6 47.4 72.6 84.8 34.6 30.4 34.6 31.7 47.4 42.1 55.4 45.3 50.9 89.8 72.4 101.3 92.5 69.8 38.3 50.3 WDR45 "JM5, NBIA5, WDRX1, WIPI4" ENSG00000196998 "WD repeat domain 45" Q9Y484 X 49071470-49101170 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 124.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027562 Uncertain Uncertain "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA027562: AB_10610565" "unprognostic (1.39e-1)" "prognostic favorable (1.21e-4)" "unprognostic (1.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.32e-1)" "prognostic favorable (1.61e-4)" "unprognostic (4.30e-2)" "unprognostic (6.66e-3)" "unprognostic (7.12e-2)" "unprognostic (3.57e-1)" "unprognostic (3.22e-2)" "unprognostic (1.77e-1)" "unprognostic (5.06e-3)" "unprognostic (2.85e-1)" "unprognostic (5.27e-1)" "unprognostic (3.60e-2)" "unprognostic (1.11e-3)" 21.2 30.3 16.7 13.5 22.6 21.4 20.3 16.1 29.8 19.4 20.7 16.6 30.6 16.2 21.1 124.8 16.5 18.1 21.9 28.6 16.4 15.1 24.6 34.4 17.1 18.4 19.1 12.7 20.7 23.7 26.3 17.6 28.4 17.0 18.6 12.3 20.0 28.2 26.6 40.7 17.9 16.8 15.1 12.2 18.2 21.5 7.6 13.6 18.8 32.4 24.5 17.1 20.5 16.4 19.8 27.1 44.0 36.0 32.4 25.5 26.4 12.6 14.8 8.5 8.6 18.7 24.2 16.5 13.9 28.9 11.0 15.5 7.7 18.6 8.8 8.0 27.7 14.1 11.1 12.9 11.3 8.0 9.9 21.8 5.4 27.1 11.7 42.8 4.2 12.7 21.4 20.0 18.1 19.4 17.7 11.0 8.5 11.4 16.0 14.4 14.1 8.8 10.7 8.6 5.6 12.9 7.2 12.5 29.3 19.5 11.6 11.3 16.7 17.9 13.7 42.2 11.7 8.7 15.6 15.1 12.0 10.9 23.9 5.8 24.5 16.5 6.3 22.3 6.9 8.7 44.0 36.0 31.5 23.1 32.1 22.8 19.8 17.6 21.8 26.7 18.6 14.0 15.9 36.5 32.4 35.4 27.1 25.5 26.4 16.7 22.6 16.1 29.8 16.4 15.1 19.1 12.7 17.0 13.6 29.8 38.3 23.8 41.6 41.3 15.9 30.3 35.7 13.4 34.2 33.2 11.8 27.4 48.0 57.6 0.8 29.2 33.3 23.3 86.2 44.8 53.1 51.2 26.5 44.8 37.4 25.4 27.6 31.3 37.3 1.5 37.4 39.7 33.7 92.0 30.1 29.0 88.8 30.2 30.4 90.2 20.8 19.4 45.3 1.8 2.5 41.4 51.9 42.6 24.2 58.5 WDR83OS "C19orf56, PTD008" ENSG00000105583 "WD repeat domain 83 opposite strand" Q9Y284 19 12668071-12671356 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065685 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA065685: AB_2685531" "unprognostic (1.73e-1)" "unprognostic (5.37e-3)" "unprognostic (1.03e-1)" "unprognostic (4.86e-2)" "unprognostic (1.27e-1)" "unprognostic (3.29e-2)" "unprognostic (7.47e-2)" "prognostic favorable (2.09e-4)" "unprognostic (1.71e-1)" "prognostic favorable (8.84e-4)" "unprognostic (4.17e-3)" "unprognostic (1.09e-1)" "unprognostic (7.87e-3)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (1.02e-1)" "unprognostic (8.34e-2)" 43.7 59.8 39.3 29.4 39.4 48.7 64.6 25.3 42.7 51.2 52.0 37.1 53.0 29.7 43.3 84.9 60.6 68.2 66.6 53.2 35.1 35.9 54.2 70.2 49.5 47.7 38.6 29.1 69.6 104.0 33.0 45.8 64.6 27.4 60.0 45.4 35.4 69.7 55.7 56.3 46.7 53.3 51.3 42.2 40.9 41.2 43.3 30.1 30.7 84.8 60.3 49.0 45.1 61.8 87.0 94.2 99.3 101.3 84.2 77.9 107.6 29.6 28.6 36.1 40.7 47.1 38.9 15.6 22.0 28.2 25.9 22.5 24.7 25.9 11.8 51.5 50.3 23.4 23.7 32.8 33.9 22.2 27.8 48.0 15.4 28.3 39.8 36.6 26.8 24.9 39.5 43.9 28.0 33.3 49.8 33.7 25.5 27.3 30.7 33.0 95.1 20.1 64.9 30.2 39.0 83.6 17.1 18.1 47.0 31.7 33.6 29.4 46.1 24.3 26.1 30.5 24.8 32.0 47.8 23.6 46.8 13.1 51.2 32.1 55.4 62.6 18.5 40.3 46.4 30.2 98.0 101.3 96.1 70.3 92.3 65.9 87.0 67.4 71.9 94.2 79.1 62.0 68.8 99.3 84.2 95.4 64.6 77.9 107.6 39.3 39.4 25.3 42.7 35.1 35.9 38.6 29.1 27.4 30.1 74.5 37.5 152.6 167.3 152.5 39.0 119.0 183.4 42.8 61.4 324.5 25.5 375.2 339.8 234.8 5.0 170.5 280.3 46.7 221.1 281.1 204.6 188.6 147.4 250.1 254.1 47.7 187.6 164.5 230.9 14.5 157.9 197.6 281.7 241.7 209.3 164.9 220.3 245.4 136.2 435.1 44.1 97.0 189.6 99.3 110.7 193.5 338.8 153.0 222.7 198.5 WFDC10A "C20orf146, dJ688G8.3, WAP10" ENSG00000180305 "WAP four-disulfide core domain 10A" Q9H1F0 20 45629526-45631196 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "epididymis: 62.4" "Group enriched" "Detected in some" 4 "granulocytes: 4.6;Late spermatids: 2.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebral cortex: 1.6" "Cell type enriched" "Detected in single" 7 "naive CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 8 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "BEWO: 1.2;CACO-2: 2.5" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.76e-1)" "unprognostic (2.95e-1)" 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.5 0.0 0.1 62.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 1.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WFDC10B WAP12 ENSG00000182931 "WAP four-disulfide core domain 10B" Q8IUB3 20 45684653-45705019 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 27.3;testis: 5.9;urinary bladder: 8.0" "Group enriched" "Detected in some" 5 "Early spermatids: 4.4;Late spermatids: 7.3;Rod photoreceptor cells: 8.7;Spermatocytes: 3.2" "Cancer enhanced" "Detected in some" "lung cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;Daudi: 2.7;HHSteC: 2.3;hTEC/SVTERT24-B: 1.8;PC-3: 5.7;U-87 MG: 2.6" "Secreted in male reproductive system" NA NA "unprognostic (1.14e-1)" "unprognostic (2.31e-1)" "unprognostic (1.37e-4)" "unprognostic (1.60e-1)" "unprognostic (2.69e-1)" "unprognostic (4.81e-2)" "unprognostic (4.30e-3)" "unprognostic (5.64e-2)" "unprognostic (1.14e-2)" "unprognostic (3.36e-1)" "unprognostic (0.00e+0)" "unprognostic (1.39e-1)" "unprognostic (3.15e-2)" "unprognostic (2.21e-2)" "unprognostic (3.17e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 0.6 0.2 0.2 0.0 0.3 27.3 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.2 0.9 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.2 1.0 0.5 0.2 0.2 0.2 0.2 1.5 0.2 0.3 0.2 0.2 0.4 5.9 0.2 0.2 0.2 0.2 0.2 8.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 2.0 2.7 0.1 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.0 1.8 0.0 1.7 0.0 0.1 0.0 0.0 0.7 0.7 0.0 0.0 0.8 1.8 5.7 0.0 0.3 0.0 0.6 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.0 0.0 0.0 8.7 0.0 0.0 3.2 0.2 0.0 0.1 0.0 0.0 0.3 WFDC11 WAP11 ENSG00000180083 "WAP four-disulfide core domain 11" Q8NEX6 20 45648563-45670270 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "epididymis: 46.2" "Cell type enriched" "Detected in some" 25 "Early spermatids: 50.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HeLa: 13.0;RPMI-8226: 7.9" "Secreted in male reproductive system" NA NA 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 46.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.4 0.0 0.8 0.7 4.7 0.4 1.3 0.8 0.1 0.2 1.1 0.1 0.2 0.6 0.8 1.2 1.1 0.1 0.0 0.0 0.7 0.3 0.7 0.4 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.8 1.1 13.0 0.8 0.0 0.6 0.8 0.3 0.0 0.0 0.2 0.2 0.0 0.4 0.6 0.2 0.0 0.2 0.5 1.1 1.1 0.4 0.6 0.2 0.5 7.9 0.0 0.4 0.1 0.0 0.0 0.4 0.0 1.0 0.1 1.1 0.0 0.2 0.7 0.3 0.1 0.5 0.5 0.0 0.1 2.2 0.3 4.7 0.4 0.2 0.4 0.2 0.4 0.3 0.3 0.3 0.1 0.8 0.4 0.8 1.2 1.3 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 WFDC2 "dJ461P17.6, EDDM4, HE4, WAP5" ENSG00000101443 "WAP four-disulfide core domain 2" Q14508 20 45469706-45481532 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Aspartic protease inhibitor, Protease inhibitor, Serine protease inhibitor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix, uterine: 352.3;ductus deferens: 143.4;epididymis: 385.4;kidney: 135.1;salivary gland: 343.7" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 1206.7;Ciliated cells: 1080.1;Club cells: 1101.0;Collecting duct cells: 1886.1;Mucus-secreting cells: 1147.4;Urothelial cells: 3035.7" "Cancer enhanced" "Detected in all" "endometrial cancer: 1815.6" "Region enriched" "Detected in single" 5 "basal ganglia: 3.0" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Group enriched" "Detected in some" 9 "A-431: 26.9;CAPAN-2: 50.2;EFO-21: 42.0;HaCaT: 36.6;RPTEC TERT1: 38.9" "Low region specificity" "Detected in some" HPA042302 Enhanced "Secreted in other tissues" NA NA 1300000 "HPA042302: AB_2677939" "unprognostic (5.75e-2)" "unprognostic (2.23e-1)" "unprognostic (4.37e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (3.04e-5)" "unprognostic (7.19e-3)" "unprognostic (1.94e-1)" "unprognostic (5.49e-3)" "unprognostic (3.71e-1)" "unprognostic (2.01e-1)" "unprognostic (1.42e-1)" "unprognostic (1.40e-1)" "prognostic favorable (4.44e-5)" "unprognostic (1.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.00e-1)" "unprognostic (3.20e-2)" 1.2 0.1 0.3 1.5 3.0 0.0 10.6 0.2 0.6 352.3 11.0 0.4 143.4 0.7 19.4 385.4 4.5 44.6 10.4 0.4 0.3 0.3 135.1 9.9 31.6 0.2 0.3 0.3 20.4 5.0 5.0 14.9 1.3 0.5 27.2 14.7 2.2 343.7 60.9 0.2 2.8 5.0 10.9 0.2 0.1 3.8 15.6 0.5 0.7 45.5 15.3 29.1 21.9 6.9 0.0 1.2 0.0 0.0 0.0 0.0 0.1 26.9 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 50.2 0.0 42.0 0.0 0.1 36.6 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.6 4.4 0.1 0.0 0.0 0.0 0.0 38.9 0.3 1.2 0.2 2.5 0.0 0.2 0.5 0.7 0.1 0.0 0.0 0.7 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 3.0 0.2 0.6 0.3 0.3 0.3 0.3 0.5 0.5 157.8 201.9 2.7 1206.7 7.9 23.5 1.2 107.0 1080.1 1101.0 1886.1 21.6 0.7 187.3 214.0 0.9 0.6 87.9 0.0 117.6 0.6 4.1 847.7 9.3 1.1 1.6 0.0 406.4 3.1 1.2 2.7 33.4 5.6 10.1 10.0 1147.4 14.8 130.4 454.8 0.0 77.8 4.2 6.5 11.9 11.6 11.0 12.3 0.6 1.3 278.2 3035.7 WFDC9 "dJ688G8.2, WAP9" ENSG00000180205 "WAP four-disulfide core domain 9" Q8NEX5 20 45607939-45631268 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "epididymis: 162.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;NB-4: 4.8;SH-SY5Y: 2.1" "Group enriched" "Detected in some" 6 "basal ganglia: 0.5;thalamus: 0.9" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.5 0.1 0.1 0.0 10.1 0.0 0.1 162.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.3 0.1 0.0 0.1 0.1 0.1 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WFIKKN2 "WFDC20B, WFIKKNRP" ENSG00000173714 "WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2" Q8TEU8 17 50834650-50842348 "Predicted intracellular proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "brain: 89.1;ovary: 56.4" "Group enriched" "Detected in some" 7 "Leydig cells: 8.3;Peritubular cells: 22.6" "Group enriched" "Detected in some" 5 "glioma: 0.7;testis cancer: 2.2" "Region enriched" "Detected in some" 10 "pons and medulla: 89.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.6;T-47d: 3.8;U-87 MG: 3.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "midbrain: 6.0;pons and medulla: 13.1;thalamus: 6.8" "Secreted in other tissues" NA NA 1700000 "unprognostic (7.31e-2)" "unprognostic (7.31e-2)" "unprognostic (1.31e-2)" "unprognostic (4.80e-2)" "unprognostic (3.46e-2)" "unprognostic (5.72e-2)" "unprognostic (5.42e-3)" "unprognostic (2.54e-3)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (2.19e-1)" "unprognostic (4.08e-3)" "unprognostic (1.42e-3)" "unprognostic (2.17e-1)" "unprognostic (2.75e-2)" "unprognostic (1.14e-1)" 0.1 0.5 0.2 0.1 0.3 0.0 0.0 0.8 0.5 0.2 0.3 6.8 0.0 0.1 0.7 0.4 0.2 0.6 0.2 0.3 9.1 0.2 0.1 0.0 1.0 0.0 0.4 0.0 56.4 0.3 0.1 0.8 0.0 89.1 0.3 0.1 4.5 0.1 0.5 1.3 0.6 0.1 0.2 0.3 0.1 0.1 1.6 0.5 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.5 9.1 0.2 0.4 0.0 89.1 0.5 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 WFS1 "DFNA14, DFNA38, DFNA6, DIDMOAD, WFS" ENSG00000109501 "Wolframin ER transmembrane glycoprotein" O76024 4 6269849-6303265 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 122.1;Extravillous trophoblasts: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029128 Approved NA NA "HPA029128: AB_10603460" "unprognostic (4.27e-2)" "unprognostic (5.05e-2)" "unprognostic (1.58e-1)" "prognostic favorable (1.13e-6)" "unprognostic (7.35e-2)" "unprognostic (1.29e-2)" "unprognostic (2.73e-2)" "unprognostic (6.97e-3)" "unprognostic (2.37e-1)" "unprognostic (1.78e-1)" "unprognostic (8.36e-3)" "unprognostic (5.33e-3)" "unprognostic (6.20e-2)" "unprognostic (5.02e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (3.64e-2)" 28.5 13.3 17.9 7.0 52.5 1.5 16.5 9.4 24.2 22.3 15.5 13.2 21.9 12.0 31.2 15.1 12.1 28.9 24.0 27.8 19.4 12.2 7.1 7.6 30.2 7.4 13.5 16.5 51.0 12.4 8.8 20.7 25.4 13.6 22.6 4.5 16.6 12.1 39.0 10.3 10.0 11.1 28.1 14.2 16.9 12.5 18.3 14.9 1.3 23.4 4.4 3.2 24.2 12.2 4.4 0.6 0.0 1.6 2.5 6.9 2.4 5.2 10.8 3.6 13.0 15.0 3.9 39.4 9.3 12.3 6.4 5.6 9.2 14.4 2.4 13.7 10.1 29.3 2.4 2.6 5.2 2.6 2.1 5.4 0.0 4.8 28.5 13.4 0.0 0.3 13.3 7.3 5.5 5.2 5.3 9.8 0.9 0.1 9.6 3.8 9.7 0.4 0.1 5.1 7.6 15.2 1.2 3.6 2.7 2.5 22.8 2.3 6.1 5.4 6.7 5.1 4.3 11.7 0.1 8.0 7.4 9.5 7.2 5.6 10.6 3.5 0.0 9.3 0.0 7.4 0.0 1.0 0.0 4.9 1.6 6.9 4.4 2.6 3.5 0.3 2.3 2.3 2.8 0.0 2.5 1.6 0.6 1.3 2.4 17.9 52.5 9.4 24.2 19.4 12.2 13.5 16.5 13.6 14.9 122.1 18.0 0.0 1.5 2.2 3.8 37.8 2.5 9.4 5.7 24.4 0.0 18.0 0.0 4.7 9.3 18.4 2.0 0.0 3.8 107.4 6.7 3.8 1.1 11.0 15.1 3.2 32.1 27.0 1.6 16.6 37.2 2.2 11.8 1.0 2.8 37.2 9.3 1.4 54.5 3.7 3.8 12.9 10.8 10.2 15.3 3.0 33.2 0.5 2.8 2.0 WLS "C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls" ENSG00000116729 "Wntless Wnt ligand secretion mediator" Q5T9L3 1 68098473-68233120 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 160.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 10.0;neutrophil: 29.1" "Group enriched" "Detected in many" 46 "granulocytes: 29.1;monocytes: 10.0" "Cell line enhanced" "Detected in many" "AF22: 70.0;ASC TERT1: 54.2;SuSa: 66.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069520 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA069520: AB_2686144" "prognostic favorable (4.03e-4)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (8.13e-3)" "unprognostic (5.93e-2)" "unprognostic (4.51e-3)" "unprognostic (5.41e-3)" "unprognostic (7.46e-3)" "unprognostic (7.70e-2)" "prognostic favorable (9.43e-4)" "unprognostic (1.34e-1)" "unprognostic (4.82e-2)" "prognostic favorable (3.67e-7)" "unprognostic (4.48e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-2)" "prognostic unfavorable (3.51e-4)" 13.7 17.2 33.5 14.3 39.0 1.5 14.5 6.8 26.6 20.0 28.3 25.8 51.6 9.1 19.5 55.1 26.7 19.9 37.1 24.1 23.1 25.4 36.8 8.9 20.3 6.9 27.0 18.6 31.4 34.7 12.1 9.8 29.2 44.5 29.0 22.8 37.8 14.5 47.4 5.3 19.3 14.1 46.2 30.5 10.8 24.4 12.2 22.3 1.9 8.9 13.5 8.2 29.6 17.0 0.0 0.4 29.1 10.0 0.0 0.0 1.9 1.9 2.9 70.0 0.0 38.8 54.2 40.6 9.7 23.9 13.5 18.8 4.2 4.6 0.0 9.8 2.7 12.6 20.3 15.7 15.9 11.5 0.1 11.7 0.0 8.4 0.0 33.9 0.0 0.1 38.7 10.7 33.1 10.9 13.7 31.7 3.7 0.0 0.1 19.9 0.3 0.0 0.2 3.1 4.2 4.7 0.0 14.7 0.0 2.3 10.5 3.9 8.2 8.9 0.4 11.6 66.2 1.9 0.2 36.7 13.0 10.4 20.8 13.1 4.7 0.1 0.0 29.9 0.3 23.7 0.0 10.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 29.1 0.0 0.3 0.1 0.0 1.9 33.5 39.0 6.8 23.8 23.1 25.4 27.0 18.6 44.5 22.3 44.7 28.8 2.4 56.2 37.7 7.2 27.1 35.7 115.1 44.3 26.2 131.6 119.4 8.3 69.5 13.0 20.8 38.0 0.0 52.3 3.0 31.4 26.5 5.7 10.2 20.8 12.7 9.2 34.4 10.2 7.0 30.2 10.7 18.6 12.6 24.7 7.3 63.3 28.8 51.9 30.0 160.2 38.8 20.8 0.5 0.7 26.2 46.1 1.8 33.6 39.6 WNT1 INT1 ENSG00000125084 "Wnt family member 1" P04628 12 48978453-48981676 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease mutation, Osteogenesis imperfecta, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 7.7;brain: 6.5;placenta: 17.5" "Cell type enriched" "Detected in single" 36 "Cardiomyocytes: 3.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basal ganglia: 6.5;cerebral cortex: 1.8" "Group enriched" "Detected in some" 8 "gdT-cell: 5.3;MAIT T-cell: 7.7;memory CD4 T-cell: 3.0;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 24 "T-cells: 7.7" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;JURKAT: 2.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebral cortex: 1.3;hippocampal formation: 1.5;midbrain: 3.5;olfactory region: 2.1" "Secreted to extracellular matrix" NA NA "unprognostic (2.02e-2)" "unprognostic (5.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-3)" "unprognostic (5.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.63e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-2)" "unprognostic (4.97e-2)" "unprognostic (1.32e-2)" "unprognostic (1.67e-2)" "unprognostic (1.70e-1)" "unprognostic (7.35e-3)" "unprognostic (2.76e-2)" 0.3 0.1 0.4 1.5 6.5 2.3 0.3 0.3 2.9 0.3 0.3 0.3 0.3 1.5 0.3 0.3 0.5 0.1 0.7 0.3 0.6 0.5 0.3 0.3 0.7 2.9 0.3 0.3 0.3 0.3 0.0 0.3 17.5 0.3 0.3 0.0 0.3 1.2 0.3 0.3 0.0 1.8 0.3 0.3 1.9 1.2 1.4 0.3 0.3 0.3 0.3 0.3 0.6 0.3 0.3 0.0 0.0 0.0 0.0 7.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 7.7 0.3 3.0 4.8 0.0 0.0 0.5 3.2 0.0 0.0 0.0 0.0 0.4 0.8 0.4 6.5 0.3 1.8 0.6 0.5 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WNT10A ENSG00000135925 "Wnt family member 10A" Q9GZT5 2 218880363-218899581 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation, Ectodermal dysplasia, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 24.8" "Cell type enhanced" "Detected in some" 9 "B-cells: 11.1;Basal glandular cells: 7.2;Basal keratinocytes: 15.1;Bipolar cells: 15.4;Collecting duct cells: 8.7;Melanocytes: 6.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.9" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 8.4" "Lineage enriched" "Detected in many" 6 "dendritic cells: 8.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 16.4;HaCaT: 47.3;HDLM-2: 19.5;RPTEC TERT1: 9.1;U-266/70: 24.8" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "basal ganglia: 2.2" HPA013898 Uncertain "Secreted to extracellular matrix" NA NA "HPA013898: AB_1858847" "unprognostic (2.99e-4)" "unprognostic (4.31e-2)" "unprognostic (8.55e-2)" "unprognostic (1.17e-3)" "unprognostic (2.87e-2)" "unprognostic (2.59e-1)" "unprognostic (1.62e-1)" "unprognostic (2.56e-2)" "unprognostic (1.04e-1)" "unprognostic (6.34e-2)" "unprognostic (2.23e-3)" "unprognostic (9.52e-2)" "unprognostic (6.64e-9)" "unprognostic (1.22e-1)" "unprognostic (1.72e-1)" "unprognostic (4.89e-3)" "unprognostic (1.82e-1)" 0.9 0.4 0.5 10.6 2.5 0.6 0.8 0.1 1.7 2.0 4.2 0.3 2.3 5.5 0.3 1.7 10.5 1.8 0.9 0.6 1.5 0.9 3.6 0.3 1.9 3.3 0.3 0.0 1.0 0.1 0.0 6.0 5.0 0.1 2.2 1.5 3.4 8.0 7.5 0.9 12.4 3.0 1.1 0.1 4.2 3.7 0.6 0.6 2.1 0.3 24.8 10.2 8.0 3.7 1.1 8.4 0.0 0.0 0.0 1.4 0.1 5.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 16.4 0.9 3.7 0.0 1.2 47.3 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 9.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 24.8 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 1.1 0.4 0.1 0.0 0.0 0.0 8.4 1.4 0.1 0.5 2.5 0.1 1.7 1.5 0.9 0.3 0.0 0.1 0.6 0.0 0.0 11.1 7.2 15.1 15.4 1.2 0.0 0.0 0.0 8.7 2.0 0.2 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.4 2.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 6.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.5 0.5 0.6 4.1 0.1 1.9 0.0 1.3 WNT11 ENSG00000085741 "Wnt family member 11" O96014 11 76186325-76210736 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 25.9;breast: 24.1" "Cell type enhanced" "Detected in some" 8 "Cardiomyocytes: 4.9;Extravillous trophoblasts: 2.7;Fibroblasts: 5.2;Paneth cells: 3.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "NK-cell: 6.6" "Lineage enriched" "Detected in many" 6 "NK-cells: 6.6" "Cell line enhanced" "Detected in some" "BEWO: 20.8;CACO-2: 6.7;CAPAN-2: 10.0;EFO-21: 33.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA050101 Uncertain "Secreted to extracellular matrix" NA NA "HPA050101: AB_2681015" "prognostic favorable (5.97e-4)" "unprognostic (9.27e-2)" "unprognostic (2.01e-2)" "unprognostic (2.52e-1)" "unprognostic (1.87e-2)" "unprognostic (8.43e-2)" "unprognostic (7.88e-2)" "unprognostic (1.03e-2)" "unprognostic (1.44e-1)" "unprognostic (3.85e-2)" "unprognostic (2.88e-2)" "unprognostic (4.36e-2)" "unprognostic (3.10e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (3.16e-3)" "unprognostic (1.09e-3)" 25.9 14.1 0.8 1.6 1.0 0.9 24.1 1.8 0.9 3.4 7.6 1.4 0.7 2.6 1.9 6.0 4.7 3.1 3.4 7.2 0.4 0.4 1.2 8.5 4.8 2.3 0.5 0.1 4.3 7.8 0.5 2.3 6.3 2.2 4.0 1.2 1.0 3.4 1.3 11.1 4.5 7.9 3.1 0.3 3.5 0.7 3.7 0.5 0.3 10.8 5.4 0.7 4.6 10.2 0.0 0.0 0.8 0.1 6.6 1.1 0.4 0.0 0.0 0.0 0.0 1.7 0.1 20.8 0.0 0.0 0.0 0.1 6.7 10.0 0.0 33.0 0.0 0.1 3.1 0.6 0.0 0.0 3.0 1.2 1.6 0.7 1.2 0.0 0.0 0.2 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.5 0.0 1.6 0.2 0.0 1.2 0.1 0.0 1.5 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.4 0.8 1.0 1.8 0.9 0.4 0.4 0.5 0.1 2.2 0.5 0.0 0.0 0.0 0.2 1.1 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.2 2.7 5.2 0.0 0.0 2.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.1 3.5 0.7 0.0 0.0 0.0 1.8 0.3 0.1 0.6 1.1 0.0 1.4 0.0 WNT16 ENSG00000002745 "Wnt family member 16" Q9UBV4 7 121325367-121341104 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.1;cervix, uterine: 19.7;ductus deferens: 11.7;skin 1: 24.4" "Group enriched" "Detected in some" 49 "Basal keratinocytes: 9.0;Suprabasal keratinocytes: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 125 "memory B-cell: 13.1;naive B-cell: 11.8" "Lineage enriched" "Detected in single" 132 "B-cells: 13.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.2;HEK 293: 10.0;hTEC/SVTERT24-B: 3.0;U-2197: 4.9;U-266/70: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" NA NA "unprognostic (6.53e-2)" "unprognostic (3.63e-2)" "unprognostic (7.24e-2)" "unprognostic (1.90e-2)" "unprognostic (2.94e-3)" "unprognostic (5.23e-2)" "unprognostic (1.77e-2)" "unprognostic (1.16e-1)" "unprognostic (1.12e-1)" "unprognostic (1.94e-1)" "unprognostic (3.77e-1)" "unprognostic (2.18e-2)" "unprognostic (3.57e-10)" "unprognostic (5.89e-3)" "unprognostic (2.73e-1)" "unprognostic (5.50e-2)" "unprognostic (1.66e-1)" 0.3 0.5 0.8 0.7 1.0 0.2 2.0 0.9 2.2 19.7 1.0 0.2 11.7 0.2 2.1 7.9 0.3 0.4 0.3 0.2 0.8 0.4 0.2 0.4 0.4 1.3 0.8 0.9 0.1 0.2 0.1 0.6 0.8 1.6 1.0 0.3 0.0 0.5 4.0 0.3 24.4 0.7 0.3 2.3 1.2 0.3 0.6 0.8 0.0 0.2 0.0 0.6 0.5 5.5 13.1 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 1.8 0.0 0.1 0.0 0.1 0.2 0.3 4.2 0.3 0.0 0.9 0.2 1.0 0.0 0.0 0.1 0.0 10.0 0.0 0.4 0.1 0.0 0.0 0.0 1.9 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 4.9 0.5 3.0 0.1 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 1.0 0.9 2.2 0.8 0.4 0.8 0.9 1.6 0.8 0.0 0.0 0.0 0.0 9.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.0 0.0 0.0 0.0 0.0 WNT3 "INT4, MGC131950, MGC138321, MGC138323" ENSG00000108379 "Wnt family member 3" P56703 17 46762506-46833154 "Disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 7.8;skin 1: 17.2" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 39.5;Early spermatids: 27.0;Late spermatids: 45.9;Suprabasal keratinocytes: 15.4" "Cancer enriched" "Detected in many" 6 "testis cancer: 13.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 10.3;U-698: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066281 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA066281: AB_2685647" "unprognostic (1.84e-1)" "unprognostic (2.90e-2)" "unprognostic (2.35e-1)" "unprognostic (6.41e-4)" "unprognostic (4.73e-2)" "unprognostic (5.26e-2)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (4.97e-2)" "unprognostic (2.20e-2)" "unprognostic (2.16e-1)" "unprognostic (2.66e-1)" "unprognostic (1.10e-8)" "unprognostic (1.77e-1)" "unprognostic (2.08e-1)" "unprognostic (1.61e-1)" "unprognostic (1.38e-1)" 0.5 0.6 1.0 0.6 3.9 0.4 0.4 1.4 4.7 0.2 0.2 3.8 0.1 4.7 0.3 0.4 0.6 0.4 0.4 0.6 1.4 2.9 0.6 7.8 0.3 2.9 2.1 3.5 0.6 0.3 6.0 0.9 0.7 4.1 0.8 0.6 0.1 1.2 0.3 0.5 17.2 1.4 0.5 1.6 0.5 0.4 2.4 2.3 0.1 0.6 1.4 0.5 0.2 0.3 1.0 1.4 0.2 0.3 0.0 1.2 0.1 2.6 0.0 10.3 0.0 0.0 0.0 0.9 0.8 0.6 1.8 0.0 2.6 2.0 1.9 1.1 0.4 2.0 1.2 0.4 0.0 2.3 0.0 0.2 0.0 0.5 2.3 0.0 0.0 0.3 0.0 1.4 0.3 0.6 1.7 0.5 0.2 1.6 0.0 0.3 0.4 0.0 1.6 0.1 1.0 1.2 1.1 1.9 0.1 0.1 0.0 0.2 0.7 1.4 0.0 0.5 0.8 0.0 2.5 0.0 3.2 1.4 0.5 0.7 0.3 0.2 11.3 0.5 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.3 1.4 1.2 0.1 1.0 3.9 1.4 4.7 1.4 2.9 2.1 3.5 4.1 2.3 0.0 1.0 0.0 0.5 39.5 1.1 0.9 0.0 0.0 0.0 0.0 0.0 1.8 1.7 0.7 27.0 0.1 1.0 0.0 2.1 0.1 0.9 1.1 0.0 3.9 0.2 7.9 0.0 0.0 0.0 45.9 0.3 0.0 1.7 1.0 0.5 0.2 1.9 0.6 0.4 0.3 0.6 0.0 0.6 0.4 1.1 15.4 0.2 0.0 0.6 0.3 WNT4 WNT-4 ENSG00000162552 "Wnt family member 4" P56705 1 22117305-22143969 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 34.3;skin 1: 28.6" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 14.8;Intestinal endocrine cells: 28.3;Mucus-secreting cells: 10.2;Suprabasal keratinocytes: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "eosinophil: 2.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.8" "Cell line enhanced" "Detected in some" "HaCaT: 10.2;SCLC-21H: 12.5;SK-BR-3: 10.6;T-47d: 4.2" "Low region specificity" "Detected in many" HPA011397 Uncertain Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA011397: AB_1858854" "unprognostic (1.85e-1)" "unprognostic (9.08e-2)" "unprognostic (6.67e-3)" "unprognostic (1.75e-2)" "unprognostic (7.17e-2)" "unprognostic (4.30e-3)" "unprognostic (2.77e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.34e-4)" "unprognostic (2.14e-2)" "prognostic favorable (4.90e-4)" "unprognostic (1.01e-1)" "unprognostic (2.95e-2)" "unprognostic (4.21e-1)" "unprognostic (2.32e-1)" "unprognostic (4.74e-2)" "unprognostic (9.49e-2)" 0.5 6.5 1.0 0.3 1.0 0.0 1.4 0.6 1.7 4.3 1.7 1.1 1.0 2.0 3.1 6.6 6.9 6.4 6.4 0.6 1.5 3.1 1.1 1.2 1.4 0.3 1.0 1.7 34.3 1.9 0.0 3.7 11.8 1.7 7.7 1.0 1.7 3.0 1.8 2.7 28.6 4.1 1.2 1.5 0.3 2.8 0.9 0.8 1.4 2.2 5.4 2.8 2.0 3.5 0.0 0.0 2.8 0.0 0.0 0.4 0.0 1.5 0.1 3.1 0.1 0.1 0.0 2.7 0.6 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.1 0.3 10.2 0.0 0.8 0.0 0.3 0.3 0.3 0.3 0.0 0.2 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 1.4 0.2 0.4 0.0 0.0 0.0 1.9 12.5 0.0 0.1 10.6 0.7 0.8 4.2 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.6 1.7 1.5 3.1 1.0 1.7 1.7 0.8 3.0 7.5 0.0 3.4 14.8 0.0 0.6 0.0 2.7 6.8 0.0 0.0 0.6 0.0 2.2 0.0 0.0 0.3 0.0 0.5 0.1 0.9 3.8 0.0 0.4 0.1 0.0 28.3 1.3 0.0 0.0 0.0 0.0 5.0 0.0 10.2 0.0 0.9 0.0 3.5 0.0 0.0 0.0 0.2 0.0 0.0 9.2 0.2 0.0 0.5 2.6 WNT5A hWNT5A ENSG00000114251 "Wnt family member 5A" P41221 3 55465715-55490539 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Wnt signaling pathway" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 26.8" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 47.6;Club cells: 47.8;Peritubular cells: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 43.0;BJ hTERT+: 59.3;HeLa: 45.3;SiHa: 67.1;U-87 MG: 48.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (2.34e-3)" "unprognostic (1.35e-1)" "prognostic favorable (2.94e-5)" "unprognostic (1.37e-1)" "unprognostic (3.45e-3)" "unprognostic (1.14e-1)" "unprognostic (2.16e-2)" "unprognostic (3.91e-2)" "unprognostic (5.89e-2)" "unprognostic (9.58e-2)" "unprognostic (8.34e-3)" "unprognostic (1.10e-1)" "unprognostic (4.81e-3)" "unprognostic (9.70e-3)" "unprognostic (2.40e-1)" "unprognostic (5.42e-3)" "unprognostic (3.63e-2)" 2.1 0.8 3.4 3.8 2.0 0.0 3.4 2.5 3.8 6.1 2.3 1.6 6.8 2.2 19.6 2.8 15.8 4.8 5.0 2.3 2.6 2.0 2.7 1.6 3.6 4.6 2.3 1.3 8.2 5.3 0.1 1.9 25.6 2.0 5.0 2.1 1.0 26.8 18.2 1.1 2.3 2.5 4.2 4.8 2.5 2.2 1.6 2.5 1.9 2.7 13.1 6.8 21.0 10.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 3.0 7.3 0.0 43.0 59.3 8.8 15.5 0.2 0.0 1.2 0.1 24.4 3.7 0.0 1.8 0.0 9.2 0.0 1.2 1.2 45.3 0.0 6.8 0.0 0.0 4.8 1.1 26.6 1.4 4.3 0.0 0.0 0.0 21.0 21.3 0.0 0.0 0.0 2.1 0.1 2.6 0.0 2.7 0.1 1.1 1.4 0.0 0.2 67.1 8.2 0.0 3.6 0.0 0.0 0.0 14.9 2.6 13.5 3.4 5.0 0.0 0.4 48.3 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 2.0 2.5 3.8 2.6 2.0 2.3 1.3 2.0 2.5 47.6 18.0 0.0 1.7 1.3 6.9 3.2 0.0 1.4 47.8 12.2 0.0 2.4 0.0 0.2 16.8 1.7 0.3 0.0 0.2 0.4 8.6 0.8 2.3 2.5 1.2 0.0 0.0 1.8 2.2 3.6 18.1 1.1 0.0 7.2 0.0 1.5 0.4 0.0 28.3 0.8 1.3 0.0 0.3 0.0 0.9 1.4 1.3 0.0 0.9 6.7 WNT6 ENSG00000115596 "Wnt family member 6" Q9Y6F9 2 218859821-218874233 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.4" "Cell type enriched" "Detected in some" 9 "Sertoli cells: 90.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 8.7" "Group enriched" "Detected in many" 7 "basal ganglia: 23.4;thalamus: 7.4" "Cell type enhanced" "Detected in some" "myeloid DC: 1.1;NK-cell: 1.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "BEWO: 28.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070759 Approved "Secreted to extracellular matrix" NA NA "HPA070759: AB_2732164" "unprognostic (1.86e-2)" "unprognostic (6.03e-2)" "unprognostic (5.14e-2)" "unprognostic (2.06e-1)" "unprognostic (5.32e-2)" "unprognostic (7.34e-2)" "unprognostic (8.08e-3)" "unprognostic (4.73e-2)" "unprognostic (1.27e-2)" "unprognostic (1.19e-1)" "unprognostic (1.21e-2)" "unprognostic (2.66e-1)" "unprognostic (1.24e-3)" "unprognostic (5.26e-2)" "unprognostic (4.82e-2)" "unprognostic (1.55e-1)" "unprognostic (2.07e-1)" 2.5 3.5 0.8 1.4 23.4 0.6 15.0 0.9 2.1 4.0 5.7 0.2 1.1 1.3 2.3 2.0 3.1 2.3 2.1 4.8 0.9 0.3 1.6 0.7 0.7 1.3 2.1 0.1 2.9 1.7 0.6 1.7 9.8 1.4 4.0 0.9 4.3 1.9 2.1 2.4 2.3 2.3 2.0 2.4 6.4 2.3 3.7 7.4 0.0 0.7 0.8 1.2 1.5 11.1 0.7 1.1 0.0 0.6 1.5 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 28.1 0.0 0.0 0.0 0.0 2.6 0.4 0.0 3.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 4.1 1.3 0.0 0.0 3.2 0.1 3.7 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.0 1.5 0.0 0.7 0.0 0.0 0.8 23.4 0.9 0.9 0.9 0.3 2.1 0.1 1.4 7.4 0.0 0.0 0.5 10.5 0.5 0.8 0.4 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 1.6 0.0 0.0 0.0 0.0 1.5 0.8 3.2 0.0 0.0 0.7 1.6 0.0 3.1 0.0 3.4 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.4 0.0 1.8 90.5 3.3 2.1 0.3 0.1 0.6 0.0 0.0 0.9 WNT7A ENSG00000154764 "Wnt family member 7A" O00755 3 13816258-13880121 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.5;gallbladder: 8.7;placenta: 19.4" "Group enriched" "Detected in some" 7 "Cytotrophoblasts: 48.0;Extravillous trophoblasts: 129.2;Pancreatic endocrine cells: 57.6;Syncytiotrophoblasts: 155.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 4.4;naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 45 "T-cells: 4.4" "Cell line enhanced" "Detected in some" "BEWO: 25.3;EFO-21: 23.8;PC-3: 8.3;RPTEC TERT1: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015719, CAB025894" Approved "Secreted to extracellular matrix" NA NA "CAB025894: , HPA015719: AB_1858856" "unprognostic (1.26e-2)" "unprognostic (4.60e-1)" "unprognostic (2.98e-1)" "prognostic unfavorable (2.96e-5)" "unprognostic (3.02e-1)" "unprognostic (1.14e-3)" "unprognostic (2.49e-1)" "unprognostic (3.32e-4)" "unprognostic (2.20e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (7.89e-2)" "unprognostic (3.78e-2)" "unprognostic (6.49e-4)" "unprognostic (1.90e-1)" "unprognostic (3.74e-1)" "unprognostic (8.88e-3)" 0.4 0.4 7.8 0.6 6.1 0.7 0.4 1.2 11.5 1.1 0.4 2.1 0.0 0.4 3.4 1.0 1.6 0.7 8.7 0.4 3.3 2.8 0.7 0.5 5.7 1.4 3.1 3.2 0.4 0.8 0.4 0.2 19.4 3.9 0.5 0.4 0.0 0.5 1.4 0.4 2.8 0.4 0.5 4.4 3.1 0.4 2.3 2.3 0.0 0.4 0.0 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.0 4.4 0.5 3.4 0.0 0.3 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.0 3.1 0.0 23.8 0.0 0.0 4.6 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.6 42.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.6 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.5 7.8 6.1 1.2 7.2 3.3 2.8 3.1 3.2 3.9 2.3 11.9 0.0 0.0 2.3 5.3 0.0 0.6 0.0 0.0 1.2 0.0 0.0 48.0 0.0 13.3 14.3 0.0 0.0 0.0 8.2 129.2 0.5 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 57.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 1.1 155.3 0.5 0.0 4.7 WNT7B ENSG00000188064 "Wnt family member 7B" P56706 22 45920362-45977129 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 25.9" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 29.9;Club cells: 23.9;Pancreatic endocrine cells: 25.3;Urothelial cells: 38.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 40.7;HeLa: 36.2;RPTEC TERT1: 14.4;SK-BR-3: 17.8;U-87 MG: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "unprognostic (2.02e-3)" "unprognostic (7.83e-3)" "unprognostic (8.51e-2)" "unprognostic (2.93e-2)" "unprognostic (3.26e-2)" "unprognostic (1.31e-1)" "unprognostic (1.85e-2)" "unprognostic (2.74e-1)" "unprognostic (2.01e-1)" "unprognostic (4.05e-2)" "unprognostic (3.85e-3)" "unprognostic (1.69e-2)" "unprognostic (8.58e-4)" "unprognostic (1.90e-1)" "unprognostic (6.73e-2)" "unprognostic (1.36e-1)" "unprognostic (1.22e-2)" 0.5 0.4 9.6 0.5 4.7 0.5 2.3 2.4 7.6 4.2 0.4 1.2 0.7 0.5 0.6 2.0 10.8 2.2 10.9 0.4 6.4 5.4 2.4 0.6 4.9 0.4 2.0 2.2 0.5 2.1 0.4 0.3 1.1 1.3 4.4 0.4 0.0 2.0 3.5 0.5 25.9 0.4 0.7 0.7 0.4 0.5 0.9 1.4 0.1 0.8 4.9 5.3 10.0 10.0 1.4 0.8 1.3 0.4 0.2 0.5 0.0 7.7 40.7 0.1 0.0 0.0 0.0 5.3 0.1 0.4 0.0 0.0 0.1 5.3 0.0 1.3 0.0 0.4 8.8 0.3 5.2 0.0 0.0 0.3 0.0 36.2 0.2 0.0 0.0 0.0 0.0 3.6 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 3.2 7.7 0.0 0.0 0.4 14.4 11.5 1.5 0.0 3.5 17.8 0.0 0.0 2.9 4.6 0.0 0.7 0.6 0.0 0.3 0.0 0.0 0.0 33.0 0.0 0.0 0.6 0.4 0.3 0.4 0.3 0.5 0.7 0.5 0.3 0.2 1.4 0.5 0.5 1.3 0.2 0.2 0.8 0.3 0.0 9.6 4.7 2.4 7.6 6.4 5.4 2.0 2.2 1.3 1.4 6.0 17.0 0.0 18.3 29.9 0.3 1.2 10.2 13.4 23.9 12.2 3.9 2.7 0.0 5.2 0.2 0.3 0.0 0.0 0.4 0.2 1.7 12.4 2.3 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.6 0.0 1.8 0.0 0.0 25.3 0.0 0.4 0.0 1.1 0.0 2.5 0.0 1.6 17.9 0.6 0.0 0.0 38.3 WNT9A WNT14 ENSG00000143816 "Wnt family member 9A" O14904 1 227918656-227947898 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 9.4;Club cells: 5.7;Leydig cells: 4.0;Peritubular cells: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 13.1;PC-3: 8.8;RH-30: 13.5;SCLC-21H: 12.3;SiHa: 11.9;U-2197: 8.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (2.27e-2)" "unprognostic (3.24e-1)" "unprognostic (3.77e-3)" "unprognostic (4.57e-2)" "unprognostic (2.93e-2)" "unprognostic (1.60e-1)" "unprognostic (2.39e-2)" "unprognostic (1.44e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (1.48e-1)" "unprognostic (1.38e-2)" "unprognostic (1.70e-2)" "unprognostic (3.72e-2)" "unprognostic (8.71e-2)" "unprognostic (5.04e-2)" "unprognostic (9.93e-2)" 2.4 1.4 1.0 13.1 0.5 0.2 2.6 1.4 1.0 4.0 14.1 2.6 2.2 1.9 6.3 4.7 9.5 5.4 15.3 14.6 0.7 0.9 0.8 0.4 9.2 2.1 0.8 0.1 8.9 7.5 0.8 4.3 4.3 3.1 4.7 1.6 4.9 4.9 4.2 20.2 1.0 6.8 8.3 0.6 1.2 5.7 1.8 1.0 0.6 1.8 10.6 4.0 7.1 3.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.7 2.6 0.3 0.1 0.3 0.6 6.7 0.9 0.8 0.1 0.0 0.0 7.1 0.0 3.9 1.2 2.7 13.1 0.3 0.6 0.0 1.3 0.5 0.0 4.4 0.2 0.3 0.0 0.4 0.1 3.3 0.1 0.1 0.2 0.8 0.0 0.0 0.1 1.5 1.7 0.0 0.0 0.8 0.0 8.8 0.2 13.5 1.3 3.7 0.8 12.3 0.0 11.9 5.4 0.0 4.5 6.8 1.4 0.5 1.8 1.1 8.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.5 1.4 0.7 0.7 0.9 0.8 0.1 3.1 1.0 3.0 1.1 0.0 1.1 0.8 0.0 1.1 0.0 9.4 5.7 1.8 0.0 0.1 0.0 0.4 0.1 0.4 0.0 0.0 1.2 0.1 1.8 1.3 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 4.0 0.0 0.0 0.0 1.8 0.0 1.6 0.0 4.2 0.0 0.0 0.0 0.4 0.0 2.3 0.3 0.0 0.0 0.0 3.3 WNT9B "WNT14B, WNT15" ENSG00000158955 "Wnt family member 9B" O14905 17 46833201-46886730 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 31.6;epididymis: 13.0;seminal vesicle: 19.1" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 1.1;Collecting duct cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "AF22: 1.9;SuSa: 5.7" "Region enriched" "Detected in single" 7 "thalamus: 6.4" "Low region specificity" "Detected in all" "HPA058361, HPA059572" Approved "Secreted to extracellular matrix" NA NA "HPA058361: AB_2683691, HPA059572: AB_2684067" "unprognostic (1.18e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-2)" "unprognostic (3.18e-2)" "unprognostic (7.48e-3)" "unprognostic (3.37e-3)" "unprognostic (1.78e-1)" "unprognostic (8.11e-2)" "unprognostic (1.59e-2)" "unprognostic (3.66e-2)" "unprognostic (6.19e-4)" "unprognostic (1.13e-1)" "unprognostic (3.69e-2)" "unprognostic (7.52e-4)" "unprognostic (1.27e-1)" "unprognostic (2.70e-1)" "unprognostic (1.37e-1)" 1.0 0.4 0.3 0.2 0.4 0.3 0.8 1.4 1.6 0.4 0.5 0.1 31.6 1.5 0.8 13.0 0.2 0.6 0.2 2.1 1.1 1.0 7.4 2.4 2.4 0.5 1.0 0.0 0.3 0.3 4.2 0.1 0.5 2.0 0.5 0.2 6.7 0.2 19.1 0.6 2.5 4.5 0.4 0.7 1.8 0.2 0.9 0.0 0.0 0.3 0.0 0.1 0.8 0.3 0.6 0.5 2.0 0.5 0.3 0.4 0.0 0.0 0.3 1.9 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 5.7 0.3 0.0 0.0 0.2 0.0 0.4 0.1 0.4 0.0 0.6 0.1 0.1 0.0 2.0 0.3 0.3 0.3 0.1 0.2 0.3 0.2 0.2 0.1 0.6 0.4 0.4 1.8 0.3 0.5 0.5 0.2 0.0 0.3 0.4 1.4 1.6 1.1 1.0 1.0 0.0 2.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WRB "CHD5, GET1" ENSG00000182093 "Tryptophan rich basic protein" O00258 21 39380244-39428528 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 200.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018527 Approved NA NA "HPA018527: AB_1858860" "unprognostic (4.34e-3)" "unprognostic (3.28e-1)" "unprognostic (2.88e-2)" "unprognostic (4.37e-2)" "unprognostic (2.56e-1)" "unprognostic (5.08e-2)" "unprognostic (6.86e-2)" "unprognostic (1.57e-3)" "unprognostic (8.74e-2)" "unprognostic (1.15e-2)" "unprognostic (4.02e-3)" "unprognostic (9.48e-2)" "unprognostic (6.50e-3)" "unprognostic (2.21e-2)" "unprognostic (2.67e-2)" "unprognostic (5.78e-3)" "unprognostic (8.13e-2)" 11.8 28.1 41.2 7.0 34.4 4.9 15.9 25.1 35.7 18.2 10.5 32.1 10.3 12.1 18.1 29.4 9.5 42.4 11.5 17.0 35.9 46.2 23.2 20.0 11.4 7.9 35.0 24.3 26.2 9.4 5.6 17.1 13.2 32.1 15.6 9.5 16.6 9.1 13.8 22.4 6.0 11.6 14.0 40.8 8.0 10.6 32.4 23.3 5.8 17.1 6.2 8.7 10.4 8.0 19.2 26.2 31.2 17.6 16.8 19.2 24.6 14.6 13.5 24.2 14.6 31.7 29.8 7.7 21.0 20.9 9.8 9.1 12.4 20.4 24.4 15.0 21.8 12.1 5.5 19.4 12.7 13.9 10.6 12.5 17.3 12.8 19.9 19.0 13.0 6.5 19.0 12.6 15.9 14.7 28.3 24.0 24.8 26.0 15.5 25.8 33.5 14.9 10.0 22.4 26.5 9.8 16.9 14.8 17.6 27.9 7.7 12.2 18.5 17.9 9.4 21.2 13.7 17.8 15.1 14.6 12.7 4.6 17.1 9.2 19.6 27.5 10.8 30.8 22.5 14.2 18.4 17.6 17.1 13.5 12.7 11.9 19.2 16.5 14.2 19.4 12.1 19.2 17.9 31.2 16.8 12.5 26.2 14.6 24.6 41.2 34.4 25.1 33.6 35.9 46.2 35.0 24.3 32.1 23.3 14.9 12.6 16.4 26.4 9.8 61.1 32.9 22.9 132.5 23.9 38.4 51.1 31.4 31.5 41.2 85.9 29.4 12.2 46.7 30.9 28.9 28.9 28.2 15.0 29.7 27.5 38.1 24.2 33.7 23.0 71.4 44.0 10.4 27.0 19.8 14.3 65.1 30.5 17.3 54.1 99.7 109.4 45.3 33.2 200.7 70.7 11.7 11.4 16.0 19.0 11.2 WSCD1 KIAA0523 ENSG00000179314 "WSC domain containing 1" Q658N2 17 6057807-6124427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;lymphoid tissue: 16.7" "Group enriched" "Detected in many" 6 "Early spermatids: 70.9;Enterocytes: 18.3;Late spermatids: 67.5" "Group enriched" "Detected in many" 7 "glioma: 18.8;renal cancer: 4.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 21.9;HUVEC TERT2: 13.4;OE19: 13.9;PC-3: 13.5;RH-30: 27.7;SCLC-21H: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015919 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA Nucleoplasm "Golgi apparatus" "HPA015919: AB_2216211" "unprognostic (1.50e-1)" "unprognostic (7.10e-2)" "unprognostic (5.32e-2)" "unprognostic (1.15e-2)" "unprognostic (2.61e-1)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-1)" "unprognostic (3.46e-4)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" 3.9 2.6 11.2 1.6 7.3 0.4 1.3 17.1 24.7 1.5 8.7 11.2 0.0 4.7 1.5 1.4 1.2 1.7 1.6 3.8 10.5 9.7 6.2 1.1 1.8 1.9 11.9 5.3 0.8 2.4 2.3 2.7 6.5 8.5 1.2 5.4 1.1 1.8 1.3 13.3 2.0 5.7 2.1 12.2 16.7 1.4 12.9 10.5 0.6 1.3 0.0 1.6 1.0 2.3 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 3.1 21.9 1.7 0.1 0.0 1.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 5.4 0.1 0.0 0.0 7.4 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 13.4 0.0 0.0 0.5 0.6 0.4 0.0 0.0 7.3 13.9 13.5 0.0 27.7 0.8 4.6 1.1 8.5 0.0 0.1 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.2 7.3 17.1 7.3 10.5 9.7 11.9 5.3 8.5 10.5 0.0 0.0 0.0 0.0 0.3 5.6 2.8 0.0 0.0 0.0 1.8 0.0 0.7 1.7 0.3 70.9 3.0 18.3 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.9 1.6 0.0 8.0 0.3 67.5 0.6 0.0 1.7 0.0 2.8 9.1 0.3 5.7 0.0 1.2 2.8 0.0 1.4 0.5 2.8 0.5 0.0 0.0 5.6 0.1 WSCD2 KIAA0789 ENSG00000075035 "WSC domain containing 2" Q2TBF2 12 108129471-108250537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;seminal vesicle: 18.2;thyroid gland: 21.8" "Group enriched" "Detected in some" 10 "Bipolar cells: 35.7;Horizontal cells: 20.6" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.6" "Region enhanced" "Detected in all" "cerebellum: 44.0" "Cell type enhanced" "Detected in single" "T-reg: 2.5" "Lineage enhanced" "Detected in single" "T-cells: 2.5" "Cell line enriched" "Detected in some" 21 "RT4: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013346, HPA048133" Approved Uncertain Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA013346: AB_1858865, HPA048133: AB_2797236" "unprognostic (1.50e-1)" "unprognostic (1.64e-3)" "unprognostic (1.50e-2)" "unprognostic (4.27e-3)" "unprognostic (1.68e-1)" "unprognostic (3.43e-1)" "unprognostic (1.80e-2)" "unprognostic (3.43e-3)" "unprognostic (3.03e-2)" "unprognostic (3.05e-1)" "unprognostic (3.15e-1)" "unprognostic (7.43e-2)" "unprognostic (5.99e-2)" "unprognostic (3.73e-2)" "unprognostic (2.11e-1)" "unprognostic (2.32e-3)" "unprognostic (7.62e-3)" 1.4 1.2 6.5 0.5 12.5 0.4 1.0 44.0 15.2 5.4 1.7 1.6 0.0 0.7 6.9 3.0 3.8 2.0 0.5 0.5 10.0 3.0 1.3 0.4 0.8 0.5 1.3 6.0 0.6 2.1 0.4 0.9 0.6 1.9 6.0 0.7 9.9 0.5 18.2 0.5 0.6 0.9 9.2 1.5 0.5 2.0 0.6 2.0 0.0 21.8 0.2 0.5 3.0 0.9 0.8 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 6.5 12.5 44.0 15.2 10.0 3.0 1.3 6.0 1.9 2.0 0.0 0.0 0.5 0.0 0.1 35.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.6 0.0 1.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 XCR1 "CCXCR1, GPR5" ENSG00000173578 "X-C motif chemokine receptor 1" P46094 3 46017024-46027742 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.5" "Cell type enhanced" "Detected in some" 16 "Late spermatids: 1.3;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "myeloid DC: 7.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 7.2" "Cell line enhanced" "Detected in many" "Karpas-707: 5.6;RT4: 4.4;U-266/84: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013169 Uncertain NA NA "HPA013169: AB_1846211" "unprognostic (3.49e-3)" "unprognostic (4.23e-3)" "unprognostic (1.15e-2)" "unprognostic (5.91e-3)" "unprognostic (7.91e-2)" "unprognostic (8.53e-6)" "unprognostic (3.89e-6)" "unprognostic (9.27e-3)" "unprognostic (4.41e-3)" "unprognostic (3.40e-3)" "unprognostic (2.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.87e-1)" "unprognostic (5.98e-2)" "unprognostic (1.60e-2)" "unprognostic (1.30e-2)" "unprognostic (1.80e-1)" 0.7 0.5 0.4 4.0 0.5 2.5 0.7 0.4 0.5 1.1 2.5 0.1 0.1 1.1 0.6 4.9 2.5 0.7 3.3 0.9 0.4 0.4 0.8 0.7 1.8 9.8 0.4 0.1 0.9 0.6 0.0 0.5 9.4 0.2 0.5 0.8 1.7 2.1 0.2 0.6 7.6 3.3 1.1 0.5 6.8 0.8 0.7 0.1 27.5 0.8 6.3 5.1 1.0 1.2 0.1 7.2 0.9 0.3 0.3 0.7 0.6 0.1 1.9 0.9 0.0 0.0 0.0 1.6 0.8 1.9 0.0 0.0 1.6 0.0 1.6 0.1 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.4 3.1 0.0 0.9 0.0 0.0 1.0 0.6 1.1 5.6 0.0 1.8 0.9 0.0 0.0 1.0 0.0 1.1 0.0 0.6 0.8 4.4 0.4 0.0 0.0 0.5 0.1 1.7 0.5 0.1 0.0 1.0 2.2 0.4 0.2 2.7 4.6 1.5 3.2 0.0 0.4 0.9 0.1 0.3 0.7 0.1 0.1 0.0 0.1 0.6 7.2 0.1 0.1 0.4 0.7 0.3 0.3 0.2 0.1 0.6 0.4 0.5 0.4 0.5 0.4 0.4 0.4 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 XG PBDX ENSG00000124343 "Xg blood group" P55808 X 2752048-2816500 "Blood group antigen proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 22.8;placenta: 18.4;skin 1: 25.8" "Group enriched" "Detected in some" 8 "Basal keratinocytes: 12.8;Melanocytes: 10.1;Suprabasal keratinocytes: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 16 "memory B-cell: 2.1;naive B-cell: 1.0" "Lineage enriched" "Detected in single" 21 "B-cells: 2.1" "Group enriched" "Detected in some" 6 "ASC diff: 34.4;ASC TERT1: 25.6;fHDF/TERT166: 16.1;hTCEpi: 23.9;T-47d: 12.9" "Low region specificity" "Detected in all" NA NA "prognostic unfavorable (4.25e-4)" "unprognostic (1.69e-2)" "unprognostic (1.40e-1)" "unprognostic (8.55e-3)" "unprognostic (1.89e-1)" "unprognostic (3.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-2)" "unprognostic (8.62e-2)" "unprognostic (7.21e-2)" "unprognostic (2.30e-1)" "unprognostic (8.10e-6)" "unprognostic (3.96e-3)" "unprognostic (7.98e-2)" "unprognostic (5.83e-3)" "unprognostic (6.77e-3)" 8.9 0.0 0.3 0.3 0.6 0.8 9.1 0.5 0.6 22.8 0.3 0.3 0.3 0.0 2.6 0.3 7.1 0.6 3.0 1.2 1.4 0.0 1.3 0.3 0.3 0.3 0.6 0.3 1.1 0.3 0.0 0.3 18.4 1.9 0.5 0.0 0.3 4.1 0.4 1.4 25.8 0.3 0.3 4.2 0.3 0.1 0.3 0.3 0.3 0.9 0.3 2.4 1.2 7.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 25.6 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 23.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.1 1.7 0.0 12.9 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.5 0.6 1.4 0.0 0.6 0.3 1.9 0.3 0.0 0.0 0.0 0.6 12.8 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.5 19.2 0.5 0.0 0.0 0.1 XK "Kx, NA, NAC, X1k, XKR1" ENSG00000047597 "X-linked Kx blood group" P51811 X 37685756-37732130 "Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Blood group antigen" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.6" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 21.1;Erythroid cells: 23.3;Mucus-secreting cells: 12.1;Undifferentiated cells: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 40 "basophil: 9.4;eosinophil: 6.8" "Lineage enriched" "Detected in single" 94 "granulocytes: 9.4" "Cell line enhanced" "Detected in many" "HEL: 25.2;HL-60: 13.0;K-562: 16.2;NB-4: 11.9;RPMI-8226: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019036 Approved Approved Nucleoplasm,Vesicles,Mitochondria No No Mitochondria "Nucleoplasm, Vesicles" "HPA019036: AB_1846286" "unprognostic (2.37e-2)" "unprognostic (7.13e-3)" "unprognostic (5.03e-2)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "unprognostic (4.56e-1)" "unprognostic (3.59e-2)" "unprognostic (4.00e-2)" "unprognostic (4.77e-3)" "unprognostic (5.07e-2)" "unprognostic (6.63e-2)" "unprognostic (5.90e-2)" "unprognostic (4.44e-8)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" 0.6 2.9 4.9 3.0 5.1 14.0 1.1 10.2 8.3 1.8 16.5 1.2 0.0 12.9 1.2 0.8 2.7 4.8 2.0 8.1 4.7 6.6 1.4 2.1 1.5 0.7 3.0 5.9 1.2 7.9 2.2 3.8 1.4 4.4 2.1 13.8 1.0 8.6 1.5 5.9 1.2 23.6 3.2 1.6 1.2 13.3 3.5 0.2 0.1 1.4 5.9 0.8 2.9 2.5 0.0 0.0 9.4 0.0 0.0 0.0 0.7 9.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 8.4 0.1 0.0 0.4 1.6 8.9 0.0 0.0 0.0 2.4 25.2 1.4 0.0 0.0 13.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 16.2 6.4 0.1 0.9 0.1 11.9 3.2 0.4 3.2 0.0 0.0 11.4 0.0 0.6 2.4 0.0 0.4 0.8 0.0 0.5 1.2 3.2 0.0 0.0 0.4 0.0 1.4 5.5 9.1 0.0 0.1 6.9 0.0 9.4 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 4.9 5.1 10.2 8.3 4.7 6.6 3.0 5.9 4.4 0.2 0.0 0.6 0.0 0.2 0.3 0.5 5.9 0.0 1.4 0.0 0.0 5.9 0.1 0.0 0.0 0.9 0.0 21.1 23.3 2.6 0.1 0.0 1.1 0.0 0.8 0.1 3.2 5.8 0.0 0.0 0.2 0.0 0.0 1.7 0.0 12.1 0.0 1.2 8.6 0.7 0.0 0.9 0.0 1.7 4.6 4.3 1.0 0.0 0.0 10.8 0.4 XKR3 "MGC57211, XTES" ENSG00000172967 "XK related 3" Q5GH77 22 16783412-16821699 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 44 "blood: 4.7;testis: 13.5" "Cell type enriched" "Detected in some" 15 "Early spermatids: 93.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basophil: 1.5;neutrophil: 4.7" "Lineage enriched" "Detected in single" 13 "granulocytes: 4.7" "Cell line enriched" "Detected in some" 16 "Karpas-707: 73.1" "HPA003379, HPA035081" Uncertain NA NA "HPA003379: AB_10602682, HPA035081: AB_2674451" "unprognostic (4.57e-1)" "unprognostic (3.37e-1)" "unprognostic (3.11e-2)" "unprognostic (3.13e-2)" "unprognostic (5.77e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 4.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.5 73.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 1.5 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.1 0.0 0.0 0.0 XKR4 KIAA1889 ENSG00000206579 "XK related 4" Q5GH76 8 55102389-55542054 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.7" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 25.5;Club cells: 17.0;Cone photoreceptor cells: 33.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "REH: 3.7;RPTEC TERT1: 15.0" "Low region specificity" "Detected in all" "HPA025072, HPA028083" Uncertain Approved Vesicles NA NA Vesicles "HPA025072: AB_1858886, HPA028083: AB_10601025" "unprognostic (7.15e-4)" "unprognostic (1.28e-3)" "unprognostic (6.98e-2)" "unprognostic (5.63e-3)" "unprognostic (7.39e-2)" "unprognostic (5.68e-3)" "unprognostic (6.33e-2)" "unprognostic (5.14e-2)" "unprognostic (1.88e-1)" "unprognostic (2.63e-1)" "unprognostic (2.38e-3)" "unprognostic (6.63e-2)" "unprognostic (3.46e-4)" "unprognostic (2.08e-2)" "unprognostic (2.39e-2)" "unprognostic (7.36e-2)" "unprognostic (4.96e-2)" 1.2 1.4 18.7 4.3 5.6 0.8 0.7 4.4 12.1 2.1 5.1 0.6 0.3 1.5 1.0 1.4 2.5 1.1 1.4 2.6 8.6 4.5 0.9 0.7 0.7 2.0 2.0 8.8 0.9 1.1 0.5 5.3 0.6 2.0 1.2 2.2 2.5 2.0 2.9 0.8 1.4 2.0 3.5 1.2 0.9 1.5 0.9 3.4 0.6 0.7 0.6 2.3 1.0 1.6 0.8 0.3 2.2 0.2 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.7 0.0 0.0 15.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.2 0.3 0.2 0.1 0.1 0.6 0.2 0.1 0.0 0.8 0.2 0.3 1.2 0.7 0.1 0.3 0.1 0.1 18.7 5.6 4.4 11.5 8.6 4.5 2.0 8.8 2.0 3.4 8.9 25.5 0.0 0.5 0.3 6.5 1.4 0.0 9.4 17.0 3.5 33.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.1 0.7 0.5 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 1.1 8.5 2.8 0.0 0.6 0.7 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.7 XKR5 ENSG00000275591 "XK related 5" 8 6808517-6835644 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 6.0;NTERA-2: 4.0;SCLC-21H: 3.3;SH-SY5Y: 5.9;U-2 OS: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.95e-2)" "unprognostic (1.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.46e-2)" "unprognostic (1.78e-1)" "unprognostic (6.73e-2)" "unprognostic (9.91e-2)" "unprognostic (2.16e-3)" "unprognostic (1.30e-1)" "unprognostic (7.91e-3)" "unprognostic (3.13e-2)" "unprognostic (9.19e-2)" "unprognostic (1.03e-2)" "unprognostic (1.76e-1)" "unprognostic (2.77e-2)" "unprognostic (4.06e-2)" 0.0 0.0 0.0 0.9 0.0 2.0 0.0 0.3 0.6 2.7 0.0 0.2 0.0 0.0 1.3 0.6 0.4 0.6 0.7 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.6 0.1 0.5 0.0 0.0 1.8 0.0 9.5 0.0 0.0 0.5 0.0 0.0 0.2 1.2 0.4 0.1 0.1 0.1 0.0 0.0 0.0 6.0 1.1 0.0 0.0 0.0 2.1 1.0 1.1 1.7 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.6 4.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 3.3 5.9 0.4 0.0 0.0 0.5 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 XKR6 "C8orf21, C8orf5, C8orf7" ENSG00000171044 "XK related 6" Q5GH73 8 10896045-11201366 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Group enriched" "Detected in many" 4 "Bipolar cells: 39.8;Cone photoreceptor cells: 13.7;Horizontal cells: 25.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 6.2;U-266/84: 10.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA024828, HPA064769" Uncertain Approved "Actin filaments" NA NA "Actin filaments" "HPA024828: AB_2215165, HPA064769: AB_2732720" "unprognostic (8.63e-3)" "unprognostic (8.45e-2)" "unprognostic (1.50e-1)" "unprognostic (9.92e-6)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (1.18e-1)" "unprognostic (8.75e-3)" "unprognostic (8.65e-2)" "unprognostic (7.09e-2)" "unprognostic (2.87e-1)" "unprognostic (1.31e-1)" "unprognostic (3.78e-2)" "unprognostic (3.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.58e-1)" "unprognostic (3.29e-3)" 2.0 2.9 3.0 4.8 13.1 4.1 2.5 21.4 6.3 1.9 2.7 1.4 1.9 1.7 2.4 1.3 3.8 2.2 2.0 1.5 3.4 1.6 2.3 1.0 2.7 3.9 1.3 4.4 0.9 5.1 3.3 8.8 1.2 5.3 3.2 2.1 1.1 5.2 5.0 0.8 3.9 3.3 1.6 1.4 3.8 3.3 7.5 2.4 0.1 3.0 0.2 3.6 3.0 2.3 1.3 0.6 0.0 0.0 1.2 0.3 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.0 0.6 0.6 1.8 0.0 0.5 5.0 0.0 1.0 3.0 0.2 2.2 2.7 0.9 0.1 0.6 1.6 0.2 0.0 0.9 0.0 4.3 0.5 1.8 0.0 2.2 2.2 1.1 0.0 0.1 6.2 0.8 0.5 0.0 0.0 3.3 0.3 1.2 0.0 0.0 1.2 2.4 1.8 3.3 1.9 1.0 0.1 0.0 2.7 0.0 0.8 0.0 2.6 1.3 0.0 0.9 1.8 10.2 4.6 1.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 0.2 1.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 1.2 0.0 0.6 0.2 0.1 3.0 13.1 21.4 6.3 3.4 1.6 1.3 4.4 5.3 2.4 6.0 0.3 6.4 3.7 1.5 39.8 1.5 5.1 0.0 1.2 3.5 13.7 0.0 1.7 2.0 6.5 1.0 1.0 0.0 4.5 0.0 0.4 3.2 0.0 0.0 0.4 25.4 4.1 4.3 1.0 1.4 0.0 0.0 1.7 0.0 0.7 6.6 3.1 0.9 0.0 0.8 6.0 0.0 1.0 3.5 4.5 1.1 0.0 1.5 1.2 3.1 XKR7 "C20orf159, dJ310O13.4" ENSG00000260903 "XK related 7" Q5GH72 20 31968002-32003387 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 28.0;pituitary gland: 12.3" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 4.0;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Early spermatids: 1.3;Horizontal cells: 1.6;Rod photoreceptor cells: 2.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 21.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 25.6" HPA040854 Uncertain NA NA "HPA040854: AB_10795481" "unprognostic (2.74e-2)" "unprognostic (5.60e-3)" "unprognostic (8.03e-2)" "unprognostic (3.74e-7)" "unprognostic (4.29e-2)" "unprognostic (9.34e-2)" "unprognostic (1.45e-1)" "unprognostic (2.69e-2)" "unprognostic (4.47e-2)" "unprognostic (2.68e-3)" "unprognostic (2.12e-1)" "unprognostic (1.26e-3)" "unprognostic (3.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.82e-5)" "unprognostic (1.99e-1)" 0.5 1.5 2.9 0.6 4.4 0.5 0.4 28.0 10.0 0.4 0.5 0.0 0.0 0.6 0.4 0.5 0.4 0.5 0.5 0.4 1.2 1.5 0.5 0.4 0.5 0.4 0.8 4.6 0.4 1.8 0.4 12.3 0.4 3.5 0.4 0.6 2.0 0.4 0.5 0.4 0.5 0.5 0.4 0.6 0.5 1.7 1.2 0.0 0.0 0.4 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 21.7 4.9 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.9 4.4 28.0 8.7 1.2 1.5 0.8 4.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.8 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XKR8 FLJ10307 ENSG00000158156 "XK related 8" Q9H6D3 1 27959462-27968096 "Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 47.1" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 47.7;monocytes: 27.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 10 "eosinophil: 47.1;neutrophil: 24.3" "Lineage enriched" "Detected in all" 15 "granulocytes: 47.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049984, HPA053529" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA049984: AB_2680982, HPA053529: AB_2682179" "prognostic favorable (8.63e-4)" "unprognostic (2.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.10e-3)" "unprognostic (1.97e-2)" "unprognostic (1.38e-2)" "unprognostic (6.25e-3)" "unprognostic (1.64e-1)" "unprognostic (7.87e-2)" "unprognostic (8.41e-2)" "unprognostic (1.83e-3)" "unprognostic (6.29e-2)" "unprognostic (8.55e-2)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (4.20e-2)" 2.6 2.3 2.8 4.2 3.8 10.3 1.8 8.3 1.8 2.3 2.5 4.1 3.3 2.9 2.4 3.2 2.9 3.2 2.8 1.9 3.3 8.6 3.1 3.0 3.0 3.6 8.7 3.5 2.4 7.8 3.5 2.4 5.6 3.7 2.9 2.0 3.1 3.5 4.9 5.6 4.7 1.6 3.5 2.4 2.8 2.4 1.3 2.6 47.1 2.5 2.8 3.0 1.9 4.6 2.5 3.0 2.9 3.3 6.2 7.6 6.9 7.5 8.8 9.0 6.6 3.7 0.0 5.7 7.6 1.9 2.6 5.5 3.3 3.1 7.5 10.0 6.1 2.0 4.5 5.4 0.0 0.0 6.5 5.5 9.5 2.7 9.4 8.6 4.6 0.0 1.8 5.0 2.2 3.3 2.2 13.9 4.4 5.7 5.4 0.0 3.3 5.7 2.4 2.1 0.0 2.0 2.8 0.1 6.6 2.0 4.7 3.6 7.0 0.2 13.1 2.2 7.3 7.0 0.8 17.3 0.0 0.3 3.5 2.5 47.1 3.0 2.4 2.9 1.3 3.0 2.6 2.6 1.3 2.6 2.6 24.3 2.8 1.7 1.2 2.9 1.9 3.0 0.6 8.8 3.3 1.6 3.9 2.4 2.5 0.0 4.5 3.5 0.0 47.7 3.3 6.8 0.4 5.2 4.5 0.0 9.9 12.2 4.8 4.7 1.1 4.3 12.1 3.2 1.7 6.2 6.6 0.5 3.1 5.4 1.7 27.9 5.2 15.4 6.3 0.0 3.5 3.6 0.9 6.5 2.5 0.6 5.9 2.6 18.8 8.7 4.5 3.4 XKR9 ENSG00000221947 "XK related 9" Q5GH70 8 70669365-70790371 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 17.1" "Cell type enriched" "Detected in many" 11 "Spermatocytes: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 5.4;hTCEpi: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA044430 Enhanced Approved Mitochondria NA NA Mitochondria "HPA044430: AB_10961283" "unprognostic (1.79e-2)" "unprognostic (7.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (9.33e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "prognostic unfavorable (7.20e-4)" "unprognostic (2.29e-1)" "unprognostic (6.96e-6)" "unprognostic (3.65e-1)" "unprognostic (3.26e-1)" "unprognostic (4.04e-3)" "unprognostic (3.71e-2)" 0.9 3.4 1.9 0.8 4.3 0.9 1.1 0.6 6.4 0.9 1.7 1.9 0.0 4.9 0.7 2.5 1.1 0.7 4.1 1.0 2.3 1.5 1.0 7.5 2.1 1.0 1.3 7.3 1.0 1.3 0.3 2.1 0.8 7.4 1.4 1.0 2.6 2.0 0.2 0.9 1.7 9.6 3.5 1.7 1.0 3.6 17.1 0.7 0.0 1.0 0.0 1.0 2.5 1.2 1.2 0.3 0.9 0.2 0.6 3.1 0.2 3.9 0.3 0.8 0.4 0.0 1.0 0.6 1.6 0.8 0.5 1.7 5.4 0.4 0.5 2.7 0.1 1.9 0.1 0.1 0.9 2.0 0.8 0.5 0.4 0.3 0.6 0.1 1.2 2.2 1.1 11.1 0.3 0.0 0.5 0.0 2.6 0.2 3.9 0.3 0.5 0.7 0.6 2.2 0.1 0.5 0.5 1.1 0.2 0.3 2.9 2.4 0.4 0.9 1.6 0.5 0.3 0.5 0.2 0.4 0.5 1.1 0.8 0.6 3.4 0.9 2.5 0.2 0.5 0.3 0.9 0.1 0.3 0.9 0.1 1.7 0.9 1.7 0.8 0.1 1.2 2.6 1.7 0.6 0.6 0.2 0.3 3.1 0.2 1.9 4.3 0.6 6.4 2.3 1.5 1.3 7.3 7.4 0.7 6.0 2.1 0.0 3.1 2.4 2.3 0.4 2.5 4.0 4.5 0.0 7.9 0.8 0.0 1.0 4.0 0.1 1.2 0.0 3.9 0.3 0.7 1.1 0.0 0.5 0.3 1.6 0.0 0.0 0.0 2.9 0.9 0.2 0.0 0.0 1.0 1.5 5.3 0.2 0.4 0.3 5.4 0.0 0.3 89.2 5.1 0.6 0.8 0.0 0.1 1.8 XKRX "XKR2, XPLAC" ENSG00000182489 "XK related, X-linked" Q6PP77 X 100913445-100929433 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 12.0;placenta: 12.2;skin 1: 12.9;thyroid gland: 11.0" "Cell type enhanced" "Detected in some" 17 "Melanocytes: 1.7;Syncytiotrophoblasts: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "naive B-cell: 5.0;naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.8" "Group enriched" "Detected in many" 44 "B-cells: 5.0;T-cells: 3.7" "Cell line enriched" "Detected in some" 5 "CACO-2: 13.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (3.35e-1)" "unprognostic (2.38e-2)" "unprognostic (4.51e-3)" "unprognostic (1.87e-1)" "unprognostic (8.53e-2)" "unprognostic (2.67e-2)" "unprognostic (2.96e-2)" "unprognostic (5.18e-2)" "unprognostic (3.69e-2)" "unprognostic (7.37e-2)" "unprognostic (5.70e-2)" "unprognostic (1.58e-2)" "unprognostic (5.60e-6)" "unprognostic (1.25e-1)" "unprognostic (2.60e-1)" "prognostic favorable (3.52e-4)" "unprognostic (1.18e-1)" 0.1 1.0 0.2 2.1 0.3 0.1 1.1 0.1 0.1 1.2 7.2 0.2 8.3 0.4 0.2 1.9 3.5 1.1 0.5 0.1 0.2 0.4 0.3 0.1 3.3 2.4 0.2 0.0 0.3 0.2 0.0 12.0 12.2 0.2 0.5 1.3 0.0 1.0 1.8 0.2 12.9 6.8 0.0 0.2 0.6 0.5 0.4 0.0 0.8 11.0 1.9 5.4 0.5 2.4 5.0 0.0 0.0 0.0 0.0 3.7 0.6 0.3 1.0 0.1 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 13.2 1.6 1.0 0.1 0.0 1.1 0.2 0.0 0.9 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.3 2.5 1.0 0.0 0.1 0.1 0.6 0.1 0.0 0.4 2.5 0.0 0.0 0.0 2.5 0.1 2.1 0.3 1.1 0.2 1.1 0.0 0.3 0.4 0.0 2.3 0.0 0.3 0.0 0.0 2.0 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.1 0.0 0.0 5.0 3.7 2.8 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.1 0.1 0.2 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 2.2 0.0 0.1 0.3 XPR1 "SLC53A1, SYG1, X3" ENSG00000143324 "Xenotropic and polytropic retrovirus receptor 1" Q9UBH6 1 180632004-180890251 "Disease related genes, Predicted membrane proteins" "Host cell receptor for virus entry, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 57.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016557 Supported NA NA "HPA016557: AB_2669382" "unprognostic (2.65e-1)" "unprognostic (2.68e-2)" "unprognostic (1.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.86e-1)" "unprognostic (1.30e-3)" "prognostic unfavorable (3.04e-4)" "unprognostic (2.76e-1)" "unprognostic (2.59e-1)" "unprognostic (3.78e-2)" "unprognostic (4.72e-2)" "unprognostic (6.44e-2)" "unprognostic (8.82e-2)" "unprognostic (7.04e-2)" "unprognostic (1.38e-1)" "unprognostic (2.59e-1)" "unprognostic (8.44e-2)" 10.1 13.6 10.6 7.4 13.1 5.7 9.5 13.5 14.7 21.7 16.0 8.4 14.3 11.3 11.9 8.2 9.8 16.3 9.0 30.3 9.2 15.7 21.4 6.7 12.1 5.8 11.0 9.1 9.9 13.6 20.3 27.3 14.5 11.4 8.3 10.7 10.2 10.7 11.5 8.8 6.4 20.3 10.3 8.1 7.8 5.3 16.7 9.5 9.6 14.4 5.3 8.7 12.0 7.3 2.4 4.3 4.9 13.5 3.0 3.8 3.5 6.0 8.6 21.3 7.4 7.2 9.8 20.3 7.0 9.3 4.7 5.1 12.4 9.0 5.7 16.7 8.0 7.6 16.5 8.5 12.4 7.1 8.0 5.5 7.4 6.1 8.8 8.4 6.2 8.1 8.1 12.3 6.7 14.1 7.8 10.3 7.8 22.7 9.6 11.2 5.5 5.9 2.8 20.1 7.7 1.9 6.2 7.7 7.6 12.1 12.5 13.6 57.6 9.6 8.6 6.1 15.3 7.6 7.1 8.5 6.3 6.1 8.9 8.7 10.7 10.1 11.5 4.5 6.2 10.2 0.9 5.2 2.3 3.8 9.4 3.2 2.0 3.5 3.4 4.3 2.4 3.3 3.3 4.9 3.0 13.5 1.2 3.5 3.5 10.6 13.1 13.5 14.7 9.2 15.7 11.0 9.1 11.4 9.5 8.9 15.6 5.1 16.1 22.8 16.7 42.0 15.3 12.0 14.8 5.2 25.5 11.6 3.3 15.9 15.8 18.8 17.8 0.0 38.1 5.6 10.0 10.6 7.0 9.4 8.4 12.7 11.5 16.5 19.8 8.2 4.4 14.6 10.1 5.4 7.0 10.2 25.2 7.4 13.4 20.0 10.7 6.5 6.8 13.5 17.4 14.9 6.4 7.4 8.1 12.4 XXYLT1 "C3orf21, FLJ35155" ENSG00000173950 "Xyloside xylosyltransferase 1" Q8NBI6 3 195068279-195271167 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 12.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 34000 "unprognostic (1.39e-2)" "unprognostic (2.31e-2)" "unprognostic (3.42e-2)" "unprognostic (2.32e-3)" "unprognostic (9.57e-2)" "unprognostic (2.34e-1)" "unprognostic (6.29e-3)" "unprognostic (5.67e-2)" "unprognostic (5.50e-2)" "unprognostic (6.57e-2)" "unprognostic (3.13e-2)" "unprognostic (4.13e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.07e-1)" "unprognostic (2.23e-2)" "unprognostic (8.20e-2)" "unprognostic (1.07e-2)" 10.1 7.0 7.4 10.3 8.8 8.1 10.2 8.1 13.6 11.1 8.5 11.0 3.6 7.0 14.5 8.0 16.7 9.6 9.5 8.3 6.7 9.5 7.0 5.2 10.3 10.7 8.5 8.7 11.3 4.6 9.9 8.7 16.3 10.7 7.9 7.8 9.8 7.8 9.5 3.4 13.4 6.7 13.8 7.5 9.1 6.8 6.6 6.1 8.1 7.0 10.0 10.8 9.7 11.7 2.3 12.7 2.1 4.8 2.1 1.9 1.4 7.6 6.6 19.9 32.4 11.4 9.9 7.1 12.3 8.5 12.2 10.6 6.9 5.4 9.1 13.2 9.6 9.4 9.2 8.3 7.2 6.4 5.1 13.2 9.1 5.4 7.4 5.3 11.4 14.8 7.1 9.6 4.3 4.8 6.7 25.5 6.1 11.1 2.7 4.1 19.2 7.6 14.6 15.3 7.3 11.7 13.0 8.1 9.9 8.9 2.6 18.4 17.0 7.6 6.0 7.6 11.1 18.2 6.4 16.8 7.1 1.8 6.8 12.4 2.3 6.9 22.4 4.6 14.7 7.5 1.1 4.8 2.1 1.9 3.4 1.6 1.7 1.7 1.9 3.3 2.3 1.7 1.7 1.4 2.1 2.9 12.7 0.9 1.4 7.4 8.8 8.1 13.6 6.7 9.5 8.5 8.7 10.7 6.1 3.0 4.1 4.5 4.0 3.8 7.1 2.8 5.1 5.3 5.7 7.0 3.9 9.0 3.3 9.1 0.2 6.8 1.3 0.0 4.6 12.7 11.5 3.9 2.3 0.8 7.2 0.0 8.1 13.5 8.9 1.6 6.1 4.0 0.0 4.6 2.0 5.1 6.6 0.0 9.9 3.1 2.6 6.5 5.1 0.4 6.1 6.1 4.0 2.2 4.3 4.4 XYLT1 "PXYLT1, XT-I" ENSG00000103489 "Xylosyltransferase 1" Q86Y38 16 17101769-17470881 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 92.3;Peritubular cells: 47.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.2;ASC TERT1: 11.9;U-2197: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007478, HPA007966" Approved Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to blood" NA NA 30000 "Plasma membrane" "Endoplasmic reticulum" "HPA007478: AB_1080616, HPA007966: AB_1080618" "unprognostic (1.82e-1)" "unprognostic (7.17e-2)" "unprognostic (1.63e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (9.12e-2)" "unprognostic (8.13e-2)" "unprognostic (9.40e-2)" "unprognostic (2.41e-3)" "unprognostic (2.82e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (8.66e-3)" "unprognostic (2.49e-1)" "unprognostic (1.76e-1)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" 5.7 5.9 6.3 21.6 3.1 5.9 7.0 3.8 6.7 8.0 7.4 1.4 0.9 3.9 7.4 3.0 4.9 3.2 4.4 3.8 6.3 4.2 1.9 0.9 2.9 7.5 4.3 2.2 5.5 2.6 0.2 1.8 5.4 2.6 4.4 4.9 3.4 2.6 4.3 1.3 4.1 4.7 5.1 3.9 6.3 3.2 3.0 2.1 4.6 2.7 6.7 6.6 4.7 4.2 1.2 0.8 1.2 3.6 0.9 0.7 0.5 0.0 0.1 2.7 0.0 19.2 11.9 3.3 8.5 4.3 1.0 0.4 0.2 0.2 2.1 0.0 10.3 0.3 0.2 0.0 1.7 1.5 4.1 0.2 2.6 0.0 0.0 0.2 3.7 3.5 4.4 0.2 5.5 0.8 1.6 0.0 0.2 0.3 8.0 1.0 0.3 0.0 4.0 2.9 1.4 0.0 1.2 0.0 0.4 0.0 3.9 0.7 5.2 0.6 2.6 0.5 2.1 0.7 2.3 0.0 9.0 1.0 19.7 0.0 9.0 0.5 3.9 10.0 4.2 7.6 0.6 0.6 1.2 0.6 2.5 0.7 1.2 0.5 0.3 0.8 1.2 0.5 0.4 0.3 0.9 3.6 0.2 0.7 0.5 6.3 3.1 3.8 5.3 6.3 4.2 4.3 2.2 2.6 2.1 3.0 4.5 7.5 1.5 7.0 13.3 2.7 0.0 0.0 1.2 0.0 92.3 9.8 0.0 1.2 0.4 2.2 5.1 0.0 1.4 16.8 16.2 3.4 2.3 0.0 3.3 0.0 12.1 2.5 8.5 0.4 11.8 8.0 3.3 2.8 3.8 1.3 2.6 7.0 47.0 0.2 4.1 6.5 5.7 0.2 2.5 16.2 11.0 4.4 6.5 4.2 XYLT2 "PXYLT2, XT-II" ENSG00000015532 "Xylosyltransferase 2" Q9H1B5 17 50346092-50363138 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 53.4" "Group enriched" "Detected in many" 7 "Early spermatids: 305.8;Late spermatids: 85.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 990000 "unprognostic (1.52e-1)" "unprognostic (2.84e-1)" "unprognostic (1.65e-1)" "unprognostic (8.07e-2)" "unprognostic (1.90e-3)" "unprognostic (1.90e-1)" "unprognostic (7.29e-3)" "unprognostic (2.52e-2)" "unprognostic (1.92e-1)" "unprognostic (2.30e-1)" "unprognostic (1.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.63e-2)" "unprognostic (5.15e-2)" "unprognostic (7.38e-2)" "unprognostic (1.52e-2)" "unprognostic (2.68e-2)" 6.9 8.5 5.8 11.3 10.6 4.1 7.4 10.3 10.9 10.7 9.2 5.4 15.8 10.0 9.6 12.2 8.5 10.4 14.9 9.4 5.3 4.8 9.2 6.1 6.1 10.2 4.7 8.8 11.8 13.5 9.1 5.8 9.0 5.4 12.1 3.9 13.1 12.7 11.7 7.9 15.6 6.9 17.0 3.8 8.4 53.4 5.8 3.7 10.2 9.5 6.7 10.4 11.7 9.0 5.3 4.9 6.6 4.0 7.8 7.8 4.3 9.9 12.7 3.5 2.9 4.9 4.8 9.1 9.3 8.6 8.4 9.5 13.5 7.5 5.2 23.7 8.3 7.4 7.7 1.1 13.1 1.7 25.7 9.1 11.7 3.9 5.8 6.7 3.6 6.3 6.5 8.1 6.7 3.1 8.4 7.1 4.6 2.0 4.3 5.5 13.0 6.7 5.0 3.1 6.6 9.0 3.4 10.2 4.3 4.7 5.2 1.9 4.4 6.2 5.9 9.8 4.1 28.2 3.5 8.4 19.2 9.8 10.4 8.3 23.9 10.9 1.8 20.3 5.9 5.2 6.6 4.0 3.2 5.9 2.8 6.3 2.9 5.9 7.8 4.9 5.3 6.0 5.3 4.7 7.8 2.5 3.4 5.2 4.3 5.8 10.6 10.3 10.9 5.3 4.8 4.7 8.8 5.4 3.7 8.9 6.7 4.2 4.0 5.0 8.2 6.4 15.3 0.0 2.3 1.8 27.5 6.0 0.0 6.2 305.8 7.4 4.2 0.0 5.5 4.7 9.1 1.4 1.1 7.2 3.4 6.4 10.4 8.6 4.1 85.8 11.5 3.8 6.8 1.8 9.9 5.7 5.8 0.0 16.3 2.1 5.6 25.8 7.2 1.4 4.5 2.8 1.3 3.1 11.8 0.6 YIF1A "54TM, FinGER7, YIF1, YIF1P" ENSG00000174851 "Yip1 interacting factor homolog A, membrane trafficking protein" O95070 11 66284580-66289170 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 138.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014840, HPA076194" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA014840: AB_2217189, HPA076194: " "unprognostic (9.35e-2)" "unprognostic (7.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "unprognostic (3.23e-1)" "unprognostic (4.38e-3)" "unprognostic (2.25e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (2.13e-1)" "unprognostic (6.39e-3)" "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.03e-1)" "unprognostic (2.64e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (8.70e-4)" 16.0 19.7 11.3 12.4 11.7 6.4 18.9 8.0 16.5 17.3 21.4 19.3 18.5 26.1 19.4 24.8 18.5 16.4 24.6 20.1 9.8 9.2 26.2 138.8 16.5 16.0 12.8 9.4 21.2 55.2 18.9 26.8 24.7 12.3 16.8 17.9 16.5 24.4 19.2 32.3 14.3 32.1 19.1 15.2 12.8 19.4 16.9 10.7 16.4 28.2 26.4 17.7 18.2 13.7 27.4 40.4 5.5 38.9 13.3 23.6 26.1 20.8 34.6 10.8 19.6 36.5 39.4 19.8 30.7 33.0 26.3 26.0 32.7 25.7 17.8 30.2 43.1 29.8 31.8 16.4 28.9 21.0 20.2 18.9 11.0 26.9 40.5 40.8 15.4 16.8 27.1 39.3 27.1 44.1 21.3 24.5 17.9 20.5 31.3 22.8 50.6 18.5 16.4 10.9 39.0 36.1 14.3 16.5 53.0 22.2 19.0 15.8 15.6 16.6 28.8 27.2 14.3 42.3 11.5 21.6 22.2 18.8 44.7 14.2 21.0 21.7 15.9 34.8 14.7 24.4 4.9 28.0 5.5 21.8 38.9 23.6 27.4 18.8 20.3 33.2 22.6 15.1 17.2 2.8 13.3 37.2 40.4 15.2 26.1 11.3 11.7 8.0 16.5 9.8 9.2 12.8 9.4 12.3 10.7 35.7 49.5 40.9 73.7 32.1 25.8 28.6 66.2 69.6 35.2 43.6 21.6 105.1 54.7 124.9 21.6 45.3 78.6 0.0 130.4 213.7 96.8 110.9 29.9 155.3 96.6 25.4 84.0 49.7 32.3 35.0 69.9 39.6 69.2 37.9 97.4 73.4 109.8 89.6 77.4 112.8 27.8 38.8 58.4 32.7 49.9 40.5 129.1 42.6 93.3 84.8 YIF1B FinGER8 ENSG00000167645 "Yip1 interacting factor homolog B, membrane trafficking protein" Q5BJH7 19 38305104-38317273 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 83.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039328, HPA055257, HPA062675" Approved Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA039328: AB_2676445, HPA055257: AB_2682762, HPA062675: AB_2684830" "unprognostic (2.51e-1)" "unprognostic (3.34e-1)" "unprognostic (1.38e-1)" "unprognostic (6.81e-2)" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.53e-5)" "unprognostic (1.37e-1)" "unprognostic (1.45e-2)" "unprognostic (5.53e-2)" "prognostic favorable (1.88e-4)" "unprognostic (4.57e-2)" "unprognostic (2.40e-2)" "unprognostic (3.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.64e-1)" "unprognostic (3.94e-3)" 15.8 16.5 18.6 24.1 21.3 46.0 17.1 19.3 34.4 13.9 15.8 27.4 13.9 15.7 12.4 12.4 17.5 14.8 13.0 18.4 21.8 19.6 16.7 59.7 17.6 25.2 23.5 24.0 13.9 21.0 10.8 15.1 18.2 25.9 12.4 12.9 13.5 21.2 12.0 20.3 14.3 14.2 14.2 27.1 24.3 11.5 13.5 20.9 18.2 11.7 16.6 15.7 15.6 12.5 10.8 67.3 38.5 35.9 9.1 14.6 24.3 11.9 30.6 13.7 16.2 20.0 18.6 10.9 29.2 22.3 21.7 31.9 14.9 9.0 21.0 12.8 33.5 23.3 7.7 24.2 15.2 8.3 22.2 12.8 32.2 13.7 15.4 27.7 22.4 38.2 15.2 13.6 22.2 9.7 21.9 20.1 28.0 41.4 58.3 19.2 12.7 23.5 26.9 10.5 20.5 9.8 24.4 16.7 32.1 13.9 11.3 10.0 16.8 9.5 21.7 15.5 11.1 8.4 45.0 19.1 21.5 21.5 30.9 23.0 21.9 32.2 13.9 27.8 41.3 15.4 15.4 35.9 38.5 14.6 26.2 12.8 10.8 13.8 13.0 67.3 8.4 11.5 11.6 9.8 9.1 14.7 28.4 12.8 24.3 18.6 21.3 19.3 34.4 21.8 19.6 23.5 24.0 25.9 20.9 0.0 5.6 13.7 16.9 15.8 10.7 3.7 12.7 9.4 1.2 21.0 11.8 40.5 0.0 33.6 4.5 16.1 10.9 0.0 24.4 43.9 31.0 17.7 23.0 28.2 83.7 11.1 13.8 42.4 37.3 8.2 8.3 37.6 33.7 28.9 14.7 19.4 18.4 14.0 8.5 12.9 11.0 6.5 4.2 17.9 28.5 17.6 23.1 12.9 20.9 18.0 YIPF1 "DJ167A19.1, FinGER1" ENSG00000058799 "Yip1 domain family member 1" Q9Y548 1 53851719-53889834 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 108.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014716, HPA073931" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA014716: AB_1847686, HPA073931: " "unprognostic (4.94e-2)" "unprognostic (4.50e-1)" "unprognostic (6.37e-2)" "unprognostic (2.06e-2)" "unprognostic (3.93e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.34e-4)" "unprognostic (1.96e-1)" "unprognostic (6.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.49e-1)" "unprognostic (2.76e-1)" "unprognostic (1.24e-2)" "unprognostic (7.75e-3)" "unprognostic (2.38e-1)" "unprognostic (5.39e-3)" "unprognostic (6.35e-1)" 10.1 15.6 12.8 9.1 13.9 8.0 18.2 6.9 12.8 11.2 12.1 8.8 11.5 11.0 6.6 12.2 14.0 10.2 10.8 13.4 10.6 12.1 16.1 31.8 11.9 14.1 12.4 9.1 11.8 13.7 7.2 15.5 15.4 14.4 17.8 14.4 10.2 17.1 14.3 18.7 13.9 10.6 9.4 10.6 13.3 13.0 10.8 11.1 10.3 33.5 9.8 15.7 12.9 16.2 8.1 11.4 26.7 14.5 6.9 16.0 10.2 6.9 4.2 6.7 4.7 7.9 8.9 6.0 5.0 7.9 9.3 12.2 4.8 2.1 2.3 8.5 6.0 14.3 8.3 8.8 11.1 9.6 17.6 7.0 5.8 4.7 7.2 10.9 6.4 5.5 8.9 10.5 7.4 9.0 7.9 10.0 8.7 6.0 6.7 9.0 5.9 6.5 9.3 4.9 8.2 7.0 4.1 6.3 9.9 7.9 3.6 3.0 3.8 4.7 9.0 23.0 22.1 13.9 7.2 4.5 3.8 3.9 6.7 4.3 13.5 15.4 4.3 5.8 5.3 3.3 12.5 12.5 13.2 8.5 11.3 8.0 8.1 7.3 8.5 11.4 7.7 7.1 6.7 26.7 6.9 14.5 7.8 16.0 10.2 12.8 13.9 6.9 12.8 10.6 12.1 12.4 9.1 14.4 11.1 6.0 13.0 10.7 15.1 7.6 6.5 8.5 28.1 14.7 15.9 8.7 0.0 65.7 10.0 23.6 22.9 8.7 11.7 0.0 28.3 23.0 8.3 37.4 9.2 17.4 34.5 9.5 9.2 13.5 19.9 41.4 5.5 15.8 10.1 16.2 23.0 16.2 25.6 12.9 8.9 13.5 5.4 0.0 6.2 12.7 18.3 9.5 108.4 13.8 9.5 22.0 YIPF2 "FinGER2, MGC3262" ENSG00000130733 "Yip1 domain family member 2" Q9BWQ6 19 10922185-10928681 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 137.6;Syncytiotrophoblasts: 145.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019902 Approved Approved "Golgi apparatus,Mitochondria" No No "Golgi apparatus, Mitochondria" "HPA019902: AB_1858925" "unprognostic (1.27e-1)" "unprognostic (8.56e-2)" "unprognostic (2.90e-3)" "unprognostic (8.38e-2)" "unprognostic (3.66e-1)" "unprognostic (3.96e-1)" "unprognostic (1.93e-1)" "unprognostic (7.65e-2)" "unprognostic (4.30e-2)" "unprognostic (5.62e-3)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.92e-2)" "unprognostic (5.99e-2)" "unprognostic (2.00e-2)" 11.8 16.4 9.2 8.3 9.3 13.5 12.9 12.0 16.8 16.0 13.8 11.9 15.3 17.0 14.4 26.7 17.1 17.6 16.7 11.9 9.7 10.6 16.4 34.3 11.8 9.6 10.7 10.3 18.4 56.4 11.1 40.7 35.5 11.9 14.0 8.4 16.6 53.5 20.7 11.1 11.2 14.6 8.8 8.4 10.2 18.4 52.0 10.6 11.0 22.1 12.9 12.5 13.9 13.8 10.8 22.3 16.2 14.7 7.2 9.8 6.7 23.4 8.7 5.8 9.2 14.7 13.8 11.9 18.8 21.8 12.8 18.2 25.8 19.4 4.6 30.7 19.3 6.3 18.3 4.5 18.0 3.6 15.1 16.3 9.1 9.7 13.9 24.0 15.3 19.0 13.5 12.8 9.0 14.0 18.5 9.9 11.6 11.4 25.1 8.7 40.0 9.6 15.6 11.1 16.3 20.9 8.4 5.4 23.4 12.2 11.1 17.4 8.7 13.1 20.9 17.7 5.9 19.9 21.3 14.5 16.1 6.0 23.4 13.3 37.4 14.5 8.5 25.7 26.9 17.1 16.2 13.2 5.6 9.8 14.7 7.6 10.8 7.9 9.0 14.8 7.2 7.0 9.8 2.1 7.2 12.4 22.3 7.8 6.7 9.2 9.3 12.0 16.8 9.7 10.6 10.7 10.3 11.9 10.6 14.9 20.5 9.3 35.0 6.1 17.3 0.4 20.4 21.4 17.0 33.2 15.7 94.1 23.2 58.8 86.2 17.8 35.4 23.3 70.3 97.9 24.7 46.0 21.8 21.7 35.3 17.5 41.7 19.0 13.7 19.8 32.5 13.1 5.0 26.2 53.9 20.9 45.9 45.6 24.1 19.5 15.3 6.5 13.3 137.6 10.6 6.0 145.8 12.8 47.0 38.9 YIPF3 "C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1" ENSG00000137207 "Yip1 domain family member 3" Q9GZM5 6 43511827-43516990 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 99.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014859, HPA063699" Supported Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA014859: AB_1845729, HPA063699: AB_2685095" "unprognostic (2.82e-2)" "unprognostic (1.29e-1)" "unprognostic (2.29e-2)" "unprognostic (4.71e-2)" "unprognostic (1.74e-1)" "unprognostic (2.05e-1)" "unprognostic (2.15e-3)" "unprognostic (3.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.70e-3)" "unprognostic (1.70e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-1)" "unprognostic (1.94e-2)" "unprognostic (3.55e-1)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" 26.8 51.0 26.1 20.3 36.8 19.3 28.1 24.2 48.9 33.5 30.4 38.1 40.3 31.9 31.2 50.5 31.9 34.4 39.9 30.9 26.2 25.5 44.2 62.0 30.0 21.1 26.1 21.4 34.0 73.7 47.0 38.9 59.3 29.7 36.0 29.9 36.8 75.4 31.8 30.6 26.9 38.4 27.4 28.1 28.0 38.8 27.8 22.6 27.9 51.2 31.3 32.9 32.8 26.5 11.7 18.5 74.3 19.7 14.6 18.3 16.0 19.0 13.4 19.8 38.3 44.6 36.1 11.9 23.0 35.7 19.1 24.2 16.0 13.9 7.8 18.4 42.2 16.5 19.2 14.5 22.4 12.1 14.3 20.8 12.2 19.8 30.4 34.6 12.9 18.4 36.0 29.3 16.2 16.1 32.5 28.7 13.3 13.2 18.1 22.7 29.2 9.8 16.5 10.2 99.8 14.9 8.7 9.1 20.6 34.0 20.3 16.0 22.9 10.4 13.9 24.3 15.7 22.9 27.2 27.3 21.7 11.4 11.9 15.8 21.3 17.1 15.5 15.4 11.2 14.6 26.2 19.7 28.3 15.3 18.5 13.3 11.7 13.8 13.5 18.5 11.7 11.3 12.6 74.3 14.6 18.4 17.0 18.3 16.0 26.1 36.8 24.2 48.9 26.2 25.5 26.1 21.4 29.7 22.6 32.8 25.2 38.7 57.7 36.1 56.4 26.7 56.0 32.1 39.8 52.4 35.3 167.5 41.4 124.0 24.9 56.8 99.6 23.3 88.8 180.7 66.2 64.5 40.3 62.3 87.8 55.6 102.8 65.7 41.3 59.8 64.7 40.3 62.4 92.8 108.3 110.5 105.8 94.7 62.9 58.6 49.3 32.3 47.5 38.7 38.1 31.0 220.8 42.4 69.7 72.1 YIPF4 "FinGER4, MGC11061" ENSG00000119820 "Yip1 domain family member 4" Q9BSR8 2 32277910-32316594 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017884 Supported Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus" "Vesicles, Plasma membrane" "HPA017884: AB_1853855" "unprognostic (5.61e-3)" "unprognostic (8.50e-2)" "unprognostic (3.88e-2)" "unprognostic (3.17e-3)" "unprognostic (3.05e-1)" "unprognostic (7.64e-2)" "unprognostic (3.45e-2)" "unprognostic (3.61e-2)" "unprognostic (3.69e-1)" "unprognostic (8.70e-2)" "unprognostic (4.15e-1)" "unprognostic (1.54e-1)" "unprognostic (2.29e-3)" "unprognostic (1.90e-1)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (6.11e-2)" 15.2 15.3 15.7 12.3 19.2 6.0 19.5 24.9 27.2 15.6 16.0 21.7 16.9 13.6 19.6 17.7 15.3 13.3 12.3 19.1 17.7 16.5 18.7 24.0 13.4 12.9 18.5 13.3 17.9 32.9 14.2 22.3 19.2 17.6 16.1 15.0 15.4 24.1 14.2 16.8 16.5 14.6 15.8 17.7 15.4 14.7 15.2 16.3 18.7 23.6 12.2 13.6 14.6 14.2 5.0 5.8 16.5 6.0 7.0 5.4 4.4 8.4 4.3 8.5 7.6 9.9 12.7 4.5 7.3 7.4 7.7 5.1 5.7 6.5 4.5 5.1 7.9 7.5 6.7 9.0 6.4 10.0 7.3 14.0 7.3 10.0 10.3 11.8 9.6 6.3 8.9 12.4 6.9 11.0 10.6 6.5 5.1 10.0 9.5 8.3 5.6 7.5 10.1 6.9 9.1 7.4 5.3 12.6 8.5 8.2 3.7 9.7 9.2 6.2 6.4 10.9 5.8 3.5 8.3 7.2 10.2 4.8 7.1 6.9 14.2 17.4 5.5 16.1 9.4 5.6 12.5 6.0 5.9 5.0 5.4 4.3 5.0 5.1 4.7 4.9 4.8 5.4 4.7 16.5 7.0 5.2 5.8 4.7 4.4 15.7 19.2 24.9 18.9 17.7 16.5 18.5 13.3 17.6 16.3 86.4 64.5 59.0 48.6 45.6 109.0 77.0 50.9 49.5 40.9 40.1 100.1 58.6 28.2 42.9 22.0 54.1 56.2 46.7 34.1 57.3 61.5 64.5 39.3 72.0 43.8 95.3 54.9 63.8 64.4 15.3 80.3 61.7 77.6 48.7 58.6 63.3 40.9 62.2 70.4 50.8 120.9 77.6 52.3 130.7 39.6 57.6 161.2 62.3 46.1 46.3 YIPF5 "FinGER5, SMAP-5" ENSG00000145817 "Yip1 domain family member 5" Q969M3 5 144158159-144170714 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 64.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042338, HPA073622" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Endoplasmic reticulum, Golgi apparatus, Vesicles" Nucleoplasm "HPA042338: AB_2677953, HPA073622: AB_2686618" "prognostic unfavorable (7.83e-5)" "unprognostic (1.13e-3)" "unprognostic (1.95e-2)" "unprognostic (8.35e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.12e-5)" "prognostic unfavorable (3.26e-5)" "unprognostic (2.89e-2)" "unprognostic (1.99e-1)" "unprognostic (3.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.79e-2)" "unprognostic (8.79e-2)" "unprognostic (1.69e-1)" "unprognostic (1.24e-2)" "unprognostic (5.11e-2)" "unprognostic (6.49e-2)" 26.6 26.6 18.4 14.7 21.2 15.8 22.5 19.2 22.6 23.9 22.2 17.2 22.5 26.5 25.7 22.0 27.2 18.9 19.0 18.3 15.1 18.5 23.0 27.8 20.4 21.0 16.2 20.5 19.6 41.7 21.5 45.3 37.1 21.8 16.8 23.4 18.9 32.7 18.3 11.9 24.5 30.5 25.2 19.7 18.8 23.8 20.7 16.2 14.0 20.2 21.2 20.1 24.1 19.9 22.3 27.2 28.8 28.1 23.7 36.7 23.4 11.5 7.7 10.1 8.0 24.2 26.2 9.2 39.5 26.9 17.8 28.8 12.3 12.2 6.3 19.1 42.8 20.5 10.7 9.6 19.4 24.1 8.8 8.3 4.7 13.5 12.5 19.6 10.4 7.8 19.8 18.2 15.9 13.1 30.8 16.9 7.0 4.9 10.7 24.0 6.0 5.1 5.9 6.5 7.4 8.5 5.4 15.0 10.5 11.1 10.3 6.9 8.5 13.7 7.4 17.5 10.7 15.3 6.9 64.9 21.0 10.2 20.3 15.5 9.7 16.1 8.0 20.1 10.0 15.3 25.6 21.0 28.8 30.3 28.1 34.3 22.3 31.0 33.6 25.0 21.5 32.8 30.8 15.6 23.7 25.4 27.2 36.7 23.4 18.4 21.2 19.2 22.6 15.1 18.5 16.2 20.5 21.8 16.2 35.7 24.3 40.2 21.0 26.2 39.5 19.3 22.9 49.5 26.1 19.2 31.4 48.9 26.6 36.5 8.3 38.7 36.0 46.7 60.0 68.2 45.1 27.2 35.8 30.5 33.0 31.8 14.3 33.2 27.9 5.3 32.8 24.3 28.7 34.3 44.6 54.8 46.2 31.9 31.8 30.4 43.2 38.8 28.8 78.4 48.5 22.7 56.4 34.5 25.2 18.5 YIPF6 "FinGER6, MGC21416" ENSG00000181704 "Yip1 domain family member 6" Q96EC8 X 68498323-68537285 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 233.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003720 Uncertain Approved Vesicles NA NA Vesicles "HPA003720: AB_1080626" "unprognostic (5.07e-3)" "unprognostic (2.13e-1)" "unprognostic (1.53e-1)" "unprognostic (1.72e-1)" "unprognostic (7.17e-2)" "unprognostic (5.90e-3)" "unprognostic (1.64e-1)" "unprognostic (1.28e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (1.33e-2)" "unprognostic (3.15e-1)" "unprognostic (8.85e-3)" "unprognostic (8.48e-2)" "unprognostic (2.90e-2)" "unprognostic (3.25e-1)" "unprognostic (6.32e-2)" 13.3 15.6 16.5 7.2 17.7 4.9 15.8 12.9 17.1 16.0 12.3 17.3 11.6 11.5 14.0 16.2 13.6 13.7 11.2 11.9 14.9 14.4 19.6 28.3 12.7 6.2 17.6 13.1 11.5 26.8 18.0 32.9 32.4 16.1 21.1 14.6 11.7 16.0 16.1 18.1 10.9 14.4 16.9 17.1 8.8 14.9 6.9 15.3 4.3 22.4 7.4 10.9 13.4 11.4 4.0 3.8 12.4 4.6 3.1 2.7 3.1 11.5 9.5 12.2 4.0 16.9 10.7 11.6 9.4 12.1 7.5 9.5 9.7 12.4 0.1 16.4 8.2 11.6 9.4 16.0 6.6 13.2 3.4 9.4 4.7 11.2 9.3 15.3 5.6 7.6 10.2 12.7 11.0 14.5 13.7 7.6 6.6 7.8 10.8 10.8 10.2 3.3 5.0 12.9 18.1 12.2 3.2 14.9 6.5 13.3 11.3 12.8 14.1 15.0 11.2 11.2 11.9 7.0 5.7 9.1 7.5 6.6 27.4 17.6 6.3 7.5 2.5 13.0 8.9 13.3 5.4 4.6 5.2 2.7 4.6 1.8 4.0 2.7 2.3 3.3 2.5 2.7 2.4 12.4 3.1 4.2 3.8 2.6 3.1 16.5 17.7 12.9 15.6 14.9 14.4 17.6 13.1 16.1 15.3 65.5 102.0 29.5 53.1 31.0 52.2 31.9 35.7 56.2 60.3 54.1 45.2 87.0 29.9 37.4 20.1 38.0 36.0 23.3 38.3 78.0 44.1 79.2 51.0 53.4 38.8 42.9 52.2 41.1 19.9 45.3 39.4 40.2 33.7 17.2 48.8 63.4 44.2 31.6 44.6 57.6 50.2 25.8 43.8 21.3 29.6 37.9 233.2 30.6 31.6 72.1 YIPF7 "FinGER9, FLJ39576" ENSG00000177752 "Yip1 domain family member 7" Q8N8F6 4 44622065-44678556 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skeletal muscle: 45.3;tongue: 14.8" "Cell type enhanced" "Detected in single" 32 "Cardiomyocytes: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 1.5;fHDF/TERT166: 1.3;GAMG: 1.8;PC-3: 1.3;SCLC-21H: 2.8;WM-115: 1.6" "Region enriched" "Detected in single" 6 "cerebellum: 0.7" "Region enriched" "Detected in single" 29 "cerebellum: 14.8" HPA030642 Uncertain NA NA "HPA030642: AB_10601027" "unprognostic (9.41e-4)" "unprognostic (2.27e-1)" "unprognostic (2.90e-2)" "unprognostic (2.24e-1)" "unprognostic (2.63e-2)" "unprognostic (1.34e-1)" "unprognostic (9.46e-2)" "unprognostic (9.81e-2)" "unprognostic (2.32e-2)" "unprognostic (3.05e-2)" "unprognostic (1.52e-2)" "unprognostic (2.46e-2)" "unprognostic (1.35e-1)" "unprognostic (4.73e-2)" "unprognostic (2.98e-2)" 1.5 0.0 0.3 0.0 0.5 0.0 0.1 0.8 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.9 0.0 0.0 0.5 0.3 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.6 0.1 45.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 14.8 0.7 0.0 0.0 2.3 3.3 0.3 1.0 0.3 0.9 0.3 0.2 0.0 0.1 0.0 0.0 0.0 1.5 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.8 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 1.0 0.0 0.3 0.3 0.0 0.7 0.0 0.6 0.3 0.0 0.3 0.5 1.1 0.0 0.0 0.0 1.6 0.0 1.0 0.0 0.5 0.7 0.4 2.3 0.9 0.7 0.6 0.6 0.3 0.4 0.3 0.3 0.2 3.3 0.1 0.3 0.3 0.5 0.8 0.3 0.3 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 YME1L1 ENSG00000136758 "YME1 like 1 ATPase" Q96TA2 10 27110112-27155266 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066953 Approved Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA066953: AB_2685753" "unprognostic (2.28e-3)" "unprognostic (3.00e-2)" "unprognostic (1.34e-1)" "unprognostic (7.19e-2)" "unprognostic (8.12e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (8.25e-6)" "unprognostic (7.08e-2)" "unprognostic (2.91e-1)" "unprognostic (9.24e-2)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (1.44e-2)" "unprognostic (7.09e-2)" 27.8 37.3 22.7 25.0 26.2 41.4 39.2 27.8 27.5 27.6 24.3 15.7 29.8 22.3 29.9 35.9 34.5 25.3 24.4 34.1 23.4 21.5 26.8 45.4 26.9 38.7 19.3 25.5 32.5 33.8 27.8 28.6 33.4 22.0 25.9 26.3 23.3 28.1 31.3 79.0 26.8 25.3 34.6 20.2 26.5 24.7 24.7 20.9 41.7 30.9 32.0 28.9 36.4 28.9 55.6 79.2 73.9 53.0 45.5 56.0 45.9 40.9 30.8 36.8 18.2 36.2 38.9 30.1 40.5 23.7 41.5 47.7 41.5 50.4 43.6 26.9 44.6 29.8 39.6 44.2 35.7 45.9 39.6 26.5 41.5 27.4 29.1 39.7 28.3 34.1 31.9 42.3 36.2 36.7 36.7 43.4 39.9 48.1 44.5 45.8 27.7 52.3 16.4 29.2 34.2 14.4 45.3 59.1 40.4 33.9 19.5 28.4 36.4 40.4 31.4 40.5 31.8 30.1 35.5 42.5 25.2 35.2 42.2 36.2 22.4 32.8 55.8 35.8 52.6 19.2 53.0 53.0 55.2 55.3 44.8 56.0 51.4 53.8 51.2 42.6 55.6 49.7 51.9 73.9 45.5 47.3 79.2 52.6 45.9 22.7 26.2 27.8 27.5 23.4 21.5 19.3 25.5 22.0 20.9 62.5 66.8 93.1 70.6 62.3 52.1 93.2 25.5 80.3 70.5 27.9 78.5 53.8 13.3 45.6 37.7 61.8 166.4 0.0 41.6 60.0 62.5 67.3 107.5 64.8 64.5 47.7 48.2 55.3 92.4 21.3 53.5 112.2 54.0 43.3 68.3 59.1 53.7 84.2 40.7 38.2 67.9 71.1 75.6 83.7 30.3 56.8 79.3 84.7 70.3 58.6 Z84492.2 ENSG00000272104 3 50350892-50367923 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 10.3;Karpas-707: 12.0" NA NA "unprognostic (2.51e-1)" "unprognostic (9.06e-2)" 3.3 3.3 4.1 4.7 4.2 2.2 4.4 3.9 4.7 2.7 6.0 4.2 4.8 9.0 3.8 8.9 2.6 4.3 6.2 2.7 4.1 3.9 5.2 18.2 3.3 7.2 4.5 3.5 5.1 11.4 4.1 10.3 4.5 2.5 5.4 2.3 3.0 7.4 7.2 2.9 6.7 9.3 1.7 3.9 5.0 7.3 2.3 4.6 4.5 5.6 1.9 4.0 2.6 2.7 8.7 1.9 4.8 1.0 9.9 14.2 3.8 3.2 2.0 0.0 1.4 1.5 0.0 0.6 4.7 1.6 0.4 1.8 0.0 2.2 1.5 6.6 0.0 0.3 1.8 0.0 1.0 1.2 3.5 0.6 3.1 2.5 0.0 0.8 0.0 10.3 0.0 1.1 0.8 0.0 0.3 0.4 3.7 0.4 12.0 0.0 0.7 4.8 0.0 1.0 2.8 0.0 1.1 0.5 5.0 0.3 0.0 2.0 4.9 0.0 6.1 0.4 0.7 2.0 0.0 3.2 0.5 1.1 0.0 5.0 5.0 6.9 3.5 0.0 0.8 0.0 4.8 0.1 4.2 7.5 0.4 9.3 8.7 11.4 9.9 0.1 8.7 14.2 9.7 0.8 9.9 1.0 1.9 13.9 3.8 4.1 4.2 3.9 4.7 4.1 3.9 4.5 3.5 2.5 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZACN "L2, LGICZ, LGICZ1, ZAC, ZAC1" ENSG00000186919 "Zinc activated ion channel" Q401N2 17 76071961-76083666 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "intestine: 2.1" "Cell type enhanced" "Detected in single" 15 "Ciliated cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SiHa: 2.1" "Low region specificity" "Detected in many" NA NA "unprognostic (8.27e-2)" "unprognostic (2.89e-2)" "unprognostic (8.92e-2)" "unprognostic (7.43e-2)" "unprognostic (5.46e-2)" "unprognostic (1.13e-2)" "unprognostic (5.10e-3)" "unprognostic (5.17e-2)" "unprognostic (4.49e-2)" "unprognostic (7.42e-2)" "unprognostic (3.16e-5)" "unprognostic (2.70e-2)" "unprognostic (5.19e-7)" "unprognostic (6.27e-2)" "unprognostic (3.59e-1)" "unprognostic (2.14e-1)" "unprognostic (1.16e-2)" 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.1 2.1 1.2 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.7 0.2 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.4 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.6 0.3 0.2 0.2 0.0 0.4 0.2 0.3 0.5 0.1 0.2 0.3 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 ZAN ENSG00000146839 "Zonadhesin (gene/pseudogene)" 7 100733626-100797797 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 14.3" "Group enriched" "Detected in some" 8 "Early spermatids: 8.0;Late spermatids: 9.6" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.3" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.6" "Group enriched" "Detected in some" 6 "REH: 1.1;SK-BR-3: 1.4" "Not detected" "Not detected" NA NA "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (3.69e-1)" "unprognostic (4.60e-2)" "unprognostic (5.83e-6)" "unprognostic (9.44e-2)" "unprognostic (4.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.97e-1)" "unprognostic (5.70e-2)" "unprognostic (4.10e-9)" "unprognostic (5.70e-2)" "unprognostic (2.58e-1)" "unprognostic (8.43e-2)" "unprognostic (3.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.0 ZDHHC1 "C16orf1, HSU90653, ZNF377" ENSG00000159714 "Zinc finger DHHC-type containing 1" Q8WTX9 16 67394419-67416833 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 24.6;Late spermatids: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 2.6;intermediate monocyte: 3.6;myeloid DC: 2.4;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 10 "dendritic cells: 2.4;monocytes: 3.6" "Cell line enhanced" "Detected in many" "ASC diff: 13.6;ASC TERT1: 15.1;U-138 MG: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042531, HPA048659" Uncertain Approved Cytosol NA NA Cytosol "HPA042531: AB_2678041, HPA048659: AB_2680483" "unprognostic (8.96e-2)" "unprognostic (1.43e-2)" "unprognostic (1.05e-3)" "prognostic favorable (1.25e-6)" "unprognostic (1.68e-2)" "unprognostic (9.33e-2)" "unprognostic (6.03e-2)" "unprognostic (1.82e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" "prognostic favorable (5.99e-4)" "unprognostic (2.17e-1)" "prognostic favorable (1.55e-6)" "unprognostic (2.10e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (5.63e-3)" 9.6 6.3 4.3 3.9 6.6 0.5 10.2 5.3 10.5 16.9 7.4 5.5 7.9 3.8 13.5 16.4 6.3 22.6 14.0 6.2 4.5 3.7 11.2 3.8 7.8 4.9 5.3 3.5 17.1 16.2 11.5 14.0 15.1 6.5 11.6 3.2 11.2 14.7 12.1 8.0 10.8 3.9 9.3 3.3 10.1 6.2 25.7 2.6 0.6 31.3 9.3 4.9 6.9 9.7 0.0 2.4 0.3 3.6 0.0 0.0 0.8 5.1 6.2 1.5 8.2 13.6 15.1 0.0 2.9 11.1 2.9 3.5 0.0 3.2 0.0 1.3 5.2 3.0 3.3 0.5 0.5 0.6 1.6 4.7 0.4 0.1 0.4 6.9 0.3 4.3 7.2 6.4 3.2 0.9 6.9 3.8 0.0 0.0 0.0 2.0 0.5 0.0 0.0 3.0 2.0 0.1 0.0 0.1 0.0 4.2 3.1 2.2 7.5 0.5 0.2 6.7 0.6 2.1 1.2 5.0 13.1 2.1 6.3 3.5 1.5 0.3 0.0 8.0 0.1 5.4 0.0 2.6 0.0 0.0 3.6 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.8 4.3 6.6 5.3 10.5 4.5 3.7 5.3 3.5 6.5 2.6 0.0 0.0 0.0 5.5 6.4 2.4 0.8 15.3 1.4 1.2 7.0 3.9 1.4 8.3 2.9 24.6 4.5 2.1 0.0 3.4 0.1 6.6 6.0 0.0 1.6 2.0 3.2 8.6 7.4 15.2 44.2 13.6 1.3 5.0 0.0 12.5 8.3 2.2 3.5 10.3 5.1 0.3 0.0 6.4 8.7 5.1 6.1 4.8 0.0 6.2 4.4 ZDHHC11 "FLJ13153, ZNF399" ENSG00000188818 "Zinc finger DHHC-type containing 11" Q9H8X9 5 795606-850986 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.2" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 17.9;Ciliated cells: 42.8;Club cells: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 11.5" "HPA057886, HPA069008" Uncertain Approved Mitochondria NA NA Mitochondria "HPA057886: AB_2683548, HPA069008: AB_2686068" "unprognostic (2.67e-1)" "unprognostic (9.76e-3)" "unprognostic (4.47e-5)" "unprognostic (5.43e-2)" "unprognostic (7.46e-2)" "unprognostic (4.68e-2)" "unprognostic (3.71e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-2)" "unprognostic (2.32e-1)" "unprognostic (2.28e-2)" "unprognostic (2.65e-1)" "unprognostic (5.23e-5)" "unprognostic (4.80e-2)" "unprognostic (3.98e-1)" "unprognostic (1.86e-2)" "unprognostic (3.51e-2)" 1.8 1.4 3.4 1.0 4.2 0.7 2.7 11.0 3.8 1.6 1.5 6.3 1.0 9.5 1.7 2.9 3.2 10.3 1.2 6.4 4.2 3.8 2.0 2.6 7.5 1.0 15.2 1.9 1.5 1.9 1.8 7.8 1.2 10.9 2.7 1.2 1.0 1.4 3.4 2.1 2.7 1.7 1.0 5.0 2.4 5.9 6.3 6.1 1.0 1.1 2.3 1.8 1.0 1.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.3 7.4 4.1 0.8 1.3 0.3 5.5 0.3 0.1 0.2 0.1 1.0 0.3 3.0 0.8 0.1 0.9 6.9 2.2 0.0 0.1 9.0 4.8 0.3 2.6 3.7 0.3 4.3 0.3 0.4 0.3 0.9 1.0 0.3 0.0 1.2 0.7 1.7 0.2 3.3 0.4 2.6 7.3 0.0 2.9 4.5 2.8 4.1 0.2 1.5 4.1 0.7 0.2 0.1 3.1 8.4 11.5 0.7 0.4 0.2 6.9 3.9 0.1 5.5 7.7 0.9 0.3 8.9 0.2 0.0 0.0 0.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.2 11.0 3.8 4.2 3.8 15.2 1.9 10.9 6.1 17.9 9.6 0.0 0.3 1.6 2.0 6.7 0.0 42.8 23.9 0.0 0.0 0.2 0.0 0.4 6.6 0.8 1.7 0.0 0.0 0.1 1.7 0.4 3.5 1.7 0.3 6.4 1.7 1.3 0.0 6.8 0.6 0.0 0.0 0.0 2.0 0.3 0.2 1.1 0.0 0.8 1.7 6.5 1.0 9.3 3.8 1.4 0.2 0.0 1.1 0.3 ZDHHC11B ENSG00000206077 "Zinc finger DHHC-type containing 11B" P0C7U3 5 710360-766952 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 11.7" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 16.5;Ciliated cells: 36.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "HAP1: 5.1;RPMI-8226: 4.5;SCLC-21H: 6.6;THP-1: 7.2" "HPA057886, HPA069008" Uncertain Approved Mitochondria NA NA Mitochondria "HPA057886: AB_2683548, HPA069008: AB_2686068" "unprognostic (2.81e-1)" "unprognostic (8.38e-3)" "unprognostic (3.79e-2)" "unprognostic (5.11e-3)" "unprognostic (7.18e-2)" "unprognostic (4.02e-3)" "unprognostic (1.19e-1)" "prognostic favorable (3.98e-4)" "unprognostic (4.39e-3)" "unprognostic (1.29e-1)" "unprognostic (1.45e-4)" "unprognostic (6.94e-2)" "unprognostic (1.43e-2)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (2.31e-1)" 0.3 1.8 2.9 0.0 3.7 0.0 0.6 11.7 5.3 0.0 1.1 3.8 0.5 0.4 2.8 3.4 0.5 3.8 3.9 2.9 0.4 0.6 5.3 0.0 2.8 0.8 2.4 1.5 3.7 0.1 0.6 1.9 1.0 0.4 3.3 4.8 5.9 0.0 2.5 3.3 3.8 0.8 0.7 0.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.9 0.8 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.2 1.0 0.3 0.0 0.8 2.4 5.1 0.2 0.0 3.1 2.3 0.1 1.9 0.9 0.0 1.6 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.1 0.3 0.0 0.0 4.5 0.1 1.5 6.6 1.9 0.1 0.0 0.6 0.6 0.1 7.2 0.1 0.0 2.6 0.0 0.0 2.5 0.8 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 17.9 16.5 0.0 1.0 2.4 6.1 7.3 2.5 36.1 10.3 3.5 0.0 0.0 0.0 0.6 1.1 1.1 2.4 0.0 0.7 0.0 1.1 0.4 1.1 1.6 1.3 9.5 2.9 0.6 0.0 0.0 0.9 0.0 0.0 0.0 2.3 0.5 0.1 0.6 0.0 0.3 0.2 6.5 2.1 1.0 0.8 2.8 0.0 0.0 1.7 0.8 ZDHHC12 "FLJ14524, ZNF400" ENSG00000160446 "Zinc finger DHHC-type containing 12" Q96GR4 9 128720869-128724127 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 77.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 54.8" "Low region specificity" "Detected in all" HPA059339 Uncertain Approved "Nucleoplasm,Intermediate filaments" No No Nucleoplasm "Intermediate filaments" "HPA059339: AB_2683985" "unprognostic (2.05e-1)" "unprognostic (5.81e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-3)" "unprognostic (5.34e-3)" "unprognostic (3.11e-2)" "unprognostic (1.50e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-1)" "unprognostic (6.42e-2)" "unprognostic (9.97e-2)" "unprognostic (9.41e-2)" "unprognostic (1.09e-2)" "unprognostic (8.82e-3)" "unprognostic (2.18e-1)" "unprognostic (1.95e-2)" "unprognostic (3.23e-1)" 7.3 10.9 3.9 15.3 4.5 21.8 11.2 2.5 6.5 7.5 21.2 6.8 19.3 16.2 5.9 8.3 27.2 6.9 21.5 9.2 3.5 3.1 20.6 23.6 14.2 28.0 3.8 3.8 5.0 40.5 4.3 5.0 24.7 4.8 11.1 8.4 7.7 26.3 13.3 7.5 16.8 33.0 5.4 5.8 14.9 18.7 9.2 2.7 23.6 10.3 16.4 24.4 10.1 11.7 22.2 50.6 77.4 28.7 17.4 26.1 18.8 14.2 39.0 1.6 8.4 5.1 3.5 16.4 9.2 8.2 10.1 6.8 31.9 16.5 9.9 8.6 6.9 17.6 37.7 3.5 18.2 1.0 18.2 9.4 5.2 29.7 14.0 10.4 8.7 24.2 5.6 12.6 8.2 3.1 4.8 7.4 18.8 5.2 25.3 1.9 54.8 11.9 17.5 7.2 31.7 32.3 5.4 5.9 28.5 7.7 13.4 11.6 8.4 12.5 17.3 4.9 2.7 26.7 9.3 7.4 0.0 10.5 7.1 12.3 16.4 28.9 4.4 16.8 10.1 11.1 39.2 26.5 77.4 23.5 24.7 20.3 20.3 21.8 22.5 21.0 22.2 22.7 20.6 56.8 17.4 28.7 50.6 26.1 18.8 3.9 4.5 2.5 6.5 3.5 3.1 3.8 3.8 4.8 2.7 14.9 8.1 54.1 42.0 14.3 0.9 9.6 79.0 4.0 11.4 43.6 0.0 147.4 11.6 94.7 58.6 14.7 157.1 70.0 176.4 191.0 11.1 49.6 18.4 48.9 121.4 0.0 49.2 28.3 52.9 22.4 8.9 39.8 40.5 159.7 93.7 14.5 109.4 171.9 6.7 32.7 1.7 6.5 9.5 23.1 17.5 24.6 112.1 48.4 94.2 52.6 ZDHHC13 "FLJ10852, FLJ10941, HIP14L" ENSG00000177054 "Zinc finger DHHC-type containing 13" Q8IUH4 11 19117099-19176422 "Enzymes, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 73.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 54.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016759, HPA018791" Uncertain Supported "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA016759: AB_1858993, HPA018791: AB_1858992" "unprognostic (1.43e-2)" "unprognostic (4.00e-3)" "unprognostic (1.08e-1)" "unprognostic (1.11e-3)" "unprognostic (2.95e-2)" "unprognostic (1.34e-2)" "unprognostic (1.55e-2)" "unprognostic (1.57e-1)" "unprognostic (3.57e-3)" "unprognostic (3.03e-2)" "unprognostic (1.63e-1)" "unprognostic (2.16e-1)" "unprognostic (6.95e-3)" "unprognostic (1.15e-1)" "unprognostic (7.93e-2)" "unprognostic (2.17e-1)" "unprognostic (2.76e-2)" 4.7 5.2 6.3 9.3 8.0 6.8 7.3 13.2 9.7 8.8 13.2 5.8 7.1 8.7 6.4 5.6 36.4 10.5 6.9 7.7 6.2 7.1 10.8 2.3 4.7 6.9 5.4 5.2 5.8 14.0 10.9 20.1 9.4 9.4 7.1 14.7 6.4 11.2 5.9 2.1 14.9 12.3 4.9 4.7 6.3 14.4 11.2 4.8 15.0 7.7 18.2 27.5 15.3 14.5 6.3 4.3 23.4 5.8 4.3 7.5 3.5 15.9 7.6 7.3 6.2 2.6 3.0 7.0 7.7 7.1 8.6 10.0 4.6 3.8 8.2 5.3 6.4 19.4 24.4 10.4 5.0 9.5 10.1 9.1 4.3 4.8 3.7 6.0 5.8 7.4 3.4 6.0 3.6 5.1 8.1 54.4 11.5 4.1 4.1 8.8 5.2 7.4 4.7 6.0 15.1 7.0 8.2 10.1 1.9 8.9 10.6 12.7 9.3 9.2 11.2 4.1 7.3 5.3 6.7 15.6 7.7 5.4 11.7 6.1 3.5 10.8 7.5 9.2 6.0 13.4 7.4 3.5 23.4 6.8 5.8 6.1 6.3 5.3 7.5 4.3 4.2 5.1 6.5 4.4 4.3 4.6 4.2 6.8 3.5 6.3 8.0 13.2 9.7 6.2 7.1 5.4 5.2 9.4 4.8 8.9 12.5 4.9 19.3 21.5 10.4 32.9 10.2 33.5 21.6 15.7 9.8 7.5 5.0 17.2 73.0 9.3 13.5 0.0 17.0 15.7 10.6 33.7 11.5 0.8 5.5 15.9 15.0 9.2 5.9 36.4 7.2 7.4 3.3 29.7 21.1 61.2 17.7 14.0 2.1 2.2 8.5 0.0 5.6 38.7 22.6 31.7 5.3 8.7 18.7 44.2 ZDHHC14 "FLJ20984, NEW1CP" ENSG00000175048 "Zinc finger DHHC-type containing 14" Q8IZN3 6 157381133-157678146 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Horizontal cells: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 33.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063754 Approved Approved Nucleoli,Mitochondria NA NA Nucleoli Mitochondria "HPA063754: AB_2685113" "unprognostic (1.66e-2)" "unprognostic (1.27e-2)" "unprognostic (1.58e-2)" "unprognostic (3.98e-2)" "unprognostic (1.59e-1)" "unprognostic (6.78e-3)" "unprognostic (1.84e-1)" "unprognostic (6.02e-2)" "unprognostic (2.87e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.93e-4)" "unprognostic (3.94e-2)" "unprognostic (5.01e-3)" "unprognostic (1.89e-1)" "unprognostic (7.95e-2)" "unprognostic (4.43e-1)" "unprognostic (2.63e-1)" 6.4 3.9 9.0 4.4 10.8 4.8 3.6 15.6 16.2 7.4 5.3 22.1 2.9 6.2 22.6 2.6 4.2 4.8 5.3 11.1 10.6 8.8 6.9 8.7 6.4 4.8 15.8 7.1 3.3 5.7 12.7 3.7 5.1 15.3 7.9 4.0 9.1 4.6 3.8 4.7 3.3 8.6 13.7 22.0 6.4 8.1 6.3 11.8 0.7 3.8 1.5 5.7 5.3 5.0 1.5 4.2 0.0 0.1 0.4 0.9 0.4 1.7 1.8 0.6 2.6 1.4 1.1 5.9 2.7 2.5 1.9 1.7 2.2 1.3 4.3 0.9 2.2 3.7 0.9 1.5 1.5 1.8 33.4 2.1 8.4 0.7 1.0 1.9 1.1 1.9 0.7 1.6 2.0 0.8 1.7 2.9 1.9 6.7 3.2 1.1 1.1 0.7 2.8 1.1 3.4 2.2 0.1 0.3 2.5 4.0 0.7 4.3 1.3 3.2 2.1 2.3 1.2 0.3 1.3 4.0 2.9 2.1 5.7 3.5 0.7 0.8 0.6 1.0 3.0 3.2 0.0 0.1 0.0 0.5 0.0 0.9 1.5 0.4 0.4 0.0 0.8 0.0 0.3 0.0 0.4 0.0 4.2 0.0 0.4 9.0 10.8 15.6 16.2 10.6 8.8 15.8 7.1 15.3 11.8 3.0 0.0 2.7 2.3 11.4 14.5 14.4 15.3 0.0 1.2 7.0 5.9 8.9 10.0 5.2 7.8 10.5 6.6 0.0 2.8 1.8 7.9 14.3 0.0 21.2 9.2 116.0 2.4 24.5 12.1 4.0 7.5 3.6 10.1 1.8 12.2 4.8 2.5 9.9 9.6 3.3 5.7 0.0 7.2 2.4 4.1 7.3 17.6 5.0 9.7 2.4 ZDHHC15 "DHHC15, FLJ31812, MRX91" ENSG00000102383 "Zinc finger DHHC-type containing 15" Q96MV8 X 75368427-75523502 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 6.0;Cardiomyocytes: 6.9;Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 5.7;K-562: 3.6;LHCN-M2: 4.0;MOLT-4: 4.2;NTERA-2: 3.7;RH-30: 5.8;RPTEC TERT1: 3.2;SH-SY5Y: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003618 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA003618: AB_2217686" "unprognostic (8.28e-2)" "unprognostic (1.73e-1)" "unprognostic (8.05e-2)" "unprognostic (1.62e-5)" "unprognostic (1.64e-2)" "unprognostic (1.00e-1)" "unprognostic (4.00e-4)" "unprognostic (1.96e-2)" "unprognostic (3.19e-1)" "unprognostic (8.70e-2)" "unprognostic (3.77e-3)" "unprognostic (1.40e-1)" "unprognostic (4.78e-13)" "unprognostic (2.60e-3)" "unprognostic (1.17e-2)" "unprognostic (1.09e-1)" "unprognostic (9.67e-4)" 3.0 5.4 4.9 1.5 6.8 1.1 5.3 6.2 9.9 5.8 3.4 3.9 2.4 1.3 6.5 3.7 3.2 4.5 3.3 5.4 5.9 8.7 5.3 1.2 4.1 1.6 4.8 5.3 8.5 4.7 5.0 8.7 0.7 7.0 4.0 2.3 5.4 12.7 6.9 1.6 2.8 1.8 5.2 6.4 2.9 2.1 2.6 3.1 2.0 6.6 2.1 1.5 2.6 3.1 0.3 0.4 0.7 0.2 0.5 1.6 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.6 3.6 0.1 4.0 0.0 4.2 0.1 3.7 0.0 0.0 0.0 5.8 0.0 3.2 0.0 1.6 4.8 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.5 1.0 0.0 0.7 2.9 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.0 0.1 0.3 0.6 0.0 0.0 0.2 1.6 1.1 0.7 0.5 0.1 0.4 0.0 0.3 4.9 6.8 6.2 9.6 5.9 8.7 4.8 5.3 7.0 3.1 6.0 1.9 0.0 1.4 3.5 3.7 6.9 2.5 0.0 2.3 5.2 3.9 0.0 0.0 0.7 0.0 2.1 0.0 0.0 0.6 0.0 0.9 1.0 1.1 0.0 0.1 0.0 1.7 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.3 0.3 0.0 3.5 1.0 2.1 6.5 1.4 0.1 0.4 3.1 0.0 0.0 0.0 0.3 ZDHHC16 APH2 ENSG00000171307 "Zinc finger DHHC-type containing 16" Q969W1 10 97446131-97457370 "Enzymes, Predicted membrane proteins" "Apoptosis, DNA damage" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039893, HPA040214" Uncertain Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA039893: AB_10794757, HPA040214: AB_2676886" "unprognostic (4.44e-2)" "unprognostic (3.14e-2)" "unprognostic (3.34e-1)" "unprognostic (1.20e-2)" "unprognostic (8.75e-2)" "unprognostic (8.35e-3)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (5.49e-2)" "unprognostic (1.57e-1)" "unprognostic (2.31e-1)" "unprognostic (6.34e-2)" "unprognostic (1.93e-3)" "unprognostic (1.34e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-1)" 12.0 13.7 15.9 10.8 17.3 6.4 17.9 17.6 24.6 17.1 17.9 15.6 18.1 15.1 15.5 21.2 17.6 11.5 14.4 18.1 13.2 11.0 23.3 37.4 20.8 11.1 10.9 13.0 15.1 22.5 21.8 15.4 30.7 10.5 16.0 18.9 18.1 28.5 14.1 20.7 14.0 15.7 17.6 8.5 13.2 19.4 16.4 10.8 14.7 19.6 15.4 16.1 15.1 20.0 9.3 14.2 9.4 10.4 13.0 12.0 5.8 21.7 25.5 17.0 21.0 27.3 18.7 17.8 23.9 31.9 27.6 26.5 19.8 19.5 19.2 27.6 34.9 24.2 25.6 21.4 33.8 24.7 19.0 24.8 12.2 17.9 18.8 21.9 14.4 17.9 20.9 22.4 32.3 23.3 30.0 28.3 17.8 9.7 14.6 35.0 20.7 21.8 19.8 13.9 19.8 22.2 15.0 17.3 17.6 23.4 10.1 8.3 11.8 14.6 15.1 12.9 17.7 19.9 14.2 17.3 17.4 16.2 11.2 27.9 14.0 22.6 11.8 20.1 22.5 9.1 0.3 9.8 9.4 7.0 10.4 8.0 8.2 12.0 11.1 14.2 9.3 9.9 9.8 0.5 13.0 10.4 10.9 9.4 5.8 15.9 17.3 17.6 24.6 13.2 11.0 10.9 13.0 10.5 10.8 17.9 17.2 14.5 15.7 4.6 15.1 9.7 15.3 6.7 27.3 12.2 3.9 35.3 21.6 31.3 20.3 9.2 12.9 0.0 28.4 55.1 10.0 16.3 6.9 15.8 21.8 12.7 6.9 8.0 7.3 5.7 8.1 7.5 3.3 24.4 16.7 10.4 30.7 10.5 3.5 17.8 10.6 6.5 4.9 16.1 12.7 3.8 31.7 7.5 17.9 14.1 ZDHHC17 "HIP14, HYPH, KIAA0946" ENSG00000186908 "Zinc finger DHHC-type containing 17" Q8IUH5 12 76763588-76853696 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 16.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016807, HPA058674" Approved Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA016807: AB_1858999, HPA058674: AB_2732626" "unprognostic (1.06e-1)" "unprognostic (2.26e-2)" "unprognostic (2.63e-2)" "unprognostic (3.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.83e-2)" "unprognostic (2.35e-3)" "unprognostic (3.09e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.56e-3)" "unprognostic (5.42e-2)" "prognostic unfavorable (7.11e-5)" "unprognostic (1.77e-2)" "unprognostic (2.69e-1)" "unprognostic (2.98e-1)" "unprognostic (1.71e-2)" 7.9 7.8 10.0 5.8 14.0 11.3 8.8 18.1 18.1 8.0 5.9 9.2 3.8 3.6 12.0 6.8 6.4 7.0 5.5 6.4 8.7 6.5 9.1 13.1 5.4 7.1 11.3 10.7 11.5 5.2 9.5 10.3 8.7 13.2 7.9 5.4 5.9 5.7 7.3 5.4 5.9 6.4 8.0 10.0 7.1 6.1 6.4 11.6 7.5 6.2 4.1 5.7 5.6 6.3 3.8 16.3 5.8 2.2 1.7 3.6 1.4 5.2 6.4 20.1 10.2 12.1 12.8 9.8 10.6 8.8 7.1 6.2 5.0 3.8 7.3 6.4 10.3 7.0 4.9 7.9 6.6 11.0 6.0 8.4 10.5 7.9 7.7 8.2 10.5 9.4 12.0 6.9 6.6 9.9 23.8 8.1 10.0 11.3 3.4 9.2 4.9 7.5 14.1 14.9 2.3 7.4 10.2 7.1 7.8 8.1 8.0 7.9 13.6 11.6 4.3 6.8 18.1 9.5 10.6 11.1 9.7 7.3 5.9 6.0 5.4 5.3 7.9 3.6 5.0 10.0 5.7 2.1 5.2 3.6 2.2 2.9 2.6 2.9 2.7 2.6 3.8 3.1 2.6 5.8 1.7 2.1 16.3 1.2 1.4 10.0 14.0 18.1 13.8 8.7 6.5 11.3 10.7 13.2 11.6 29.8 16.5 7.3 9.8 6.4 45.0 18.5 10.2 18.7 19.4 12.2 37.3 14.4 0.0 7.7 7.3 19.6 4.1 23.3 4.0 8.2 15.1 9.9 40.4 9.8 7.6 27.0 18.4 18.4 13.2 10.6 18.7 14.9 5.0 7.2 5.9 26.4 6.4 5.5 19.8 4.4 32.3 0.0 16.0 17.4 22.1 4.8 4.7 10.9 5.2 4.5 ZDHHC18 DKFZp667O2416 ENSG00000204160 "Zinc finger DHHC-type containing 18" Q9NUE0 1 26826710-26857602 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 86.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 27.0" "Lineage enriched" "Detected in many" 20 "granulocytes: 27.0" "Cell line enhanced" "Detected in all" "HDLM-2: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040234 Approved Approved Microtubules NA NA Microtubules "HPA040234: AB_10805709" "unprognostic (2.68e-1)" "unprognostic (1.21e-2)" "unprognostic (2.35e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.01e-1)" "prognostic unfavorable (7.42e-7)" "unprognostic (1.53e-1)" "unprognostic (2.90e-2)" "unprognostic (2.38e-2)" "unprognostic (2.13e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (1.36e-10)" "unprognostic (3.85e-2)" "unprognostic (2.70e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" 20.5 8.2 13.3 22.7 18.9 86.2 39.0 21.4 18.4 10.2 13.0 11.9 7.5 11.7 12.4 6.4 19.3 9.9 13.5 9.8 13.5 20.0 7.8 14.5 16.2 23.5 16.3 12.8 9.6 10.8 7.1 10.5 20.3 15.2 10.7 13.9 11.2 14.1 9.8 8.7 16.3 12.2 16.6 10.4 27.1 10.8 7.0 9.5 11.7 14.6 10.1 23.3 16.5 24.7 0.2 0.4 27.0 0.6 0.5 1.3 0.2 18.5 8.3 13.5 9.3 11.3 7.9 13.3 11.2 13.3 19.7 14.7 7.6 11.9 8.6 7.2 14.8 10.3 13.1 14.3 6.7 17.0 54.3 12.2 8.3 6.1 10.5 9.7 7.3 7.3 6.8 9.1 18.1 12.0 7.1 11.0 13.3 8.6 17.9 7.8 9.0 13.9 5.9 12.9 11.6 8.0 11.6 11.6 9.1 8.3 4.7 6.3 7.6 7.5 5.7 8.1 10.8 5.1 7.3 9.3 13.7 10.5 22.3 12.8 21.3 15.3 7.4 7.7 13.4 9.3 0.0 0.2 5.1 0.9 0.6 0.7 0.2 0.6 0.6 0.4 0.1 0.4 0.4 27.0 0.5 0.4 0.2 1.3 0.2 13.3 18.9 21.4 18.4 13.5 20.0 16.3 12.8 15.2 9.5 8.9 9.3 9.8 7.5 22.8 39.0 4.8 12.7 0.0 6.8 1.8 25.5 8.9 0.0 3.2 2.9 8.0 12.3 23.3 2.5 6.3 7.1 12.5 1.1 10.4 6.6 17.5 2.9 6.7 6.9 1.4 5.8 8.9 10.1 36.9 4.3 4.8 6.7 9.5 3.5 2.2 33.0 0.0 5.5 2.2 11.1 31.7 5.1 8.7 5.2 13.2 ZDHHC19 MGC33345 ENSG00000163958 "Zinc finger DHHC-type containing 19" Q8WVZ1 3 196197449-196211437 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 53.4" "Group enriched" "Detected in some" 15 "Early spermatids: 298.7;Late spermatids: 632.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "eosinophil: 2.4;memory B-cell: 3.9;naive B-cell: 5.2;neutrophil: 3.4" "Group enriched" "Detected in many" 24 "B-cells: 5.2;granulocytes: 3.4" "Cell line enhanced" "Detected in some" "HMC-1: 1.7;K-562: 1.2;NTERA-2: 1.1;SH-SY5Y: 1.9;THP-1: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.15e-1)" "unprognostic (7.50e-4)" "unprognostic (2.87e-3)" "unprognostic (6.72e-3)" "unprognostic (3.79e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (3.66e-3)" "unprognostic (4.63e-2)" "unprognostic (6.52e-2)" "unprognostic (2.86e-2)" "unprognostic (3.46e-7)" "unprognostic (8.05e-4)" "unprognostic (4.71e-1)" "unprognostic (7.08e-3)" "unprognostic (4.28e-2)" 0.0 0.6 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.1 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 3.9 0.0 0.0 0.0 5.2 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 298.7 0.7 0.0 0.0 0.0 0.4 0.3 0.1 0.0 3.4 1.3 0.0 0.0 0.0 1.5 632.3 15.3 1.4 0.0 0.0 0.0 0.2 0.0 0.0 30.1 0.4 0.0 0.0 0.0 4.9 3.0 0.0 2.1 0.0 0.0 0.0 ZDHHC2 "DHHC2, ZNF372" ENSG00000104219 "Zinc finger DHHC-type containing 2" Q9UIJ5 8 17156029-17224799 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 72.6;Rod photoreceptor cells: 80.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023331, HPA023334" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023331: AB_2671165, HPA023334: " "unprognostic (8.92e-2)" "unprognostic (4.23e-1)" "unprognostic (1.80e-2)" "unprognostic (2.53e-1)" "unprognostic (6.89e-2)" "unprognostic (2.25e-1)" "unprognostic (6.12e-2)" "unprognostic (1.78e-2)" "unprognostic (1.04e-1)" "unprognostic (2.37e-2)" "unprognostic (2.16e-1)" "unprognostic (1.58e-1)" "prognostic favorable (3.24e-4)" "unprognostic (5.00e-2)" "unprognostic (3.87e-1)" "unprognostic (2.87e-2)" "unprognostic (5.10e-2)" 10.1 22.5 14.8 9.4 14.5 24.4 14.8 22.8 12.2 12.9 13.4 17.5 17.4 9.3 7.0 10.5 5.3 12.8 6.4 10.1 13.0 14.0 24.2 7.5 12.7 10.3 13.6 10.9 13.0 27.0 19.2 20.2 6.1 14.7 12.0 10.3 21.2 15.9 13.7 15.9 3.4 9.1 8.8 25.9 11.2 14.1 14.2 14.5 13.8 32.3 10.4 10.2 17.3 8.7 5.3 4.6 4.9 2.7 4.4 7.0 1.5 0.9 5.2 10.2 2.1 9.0 16.1 6.0 17.6 21.4 10.0 11.9 1.6 14.7 10.6 6.9 15.3 25.2 0.6 13.7 8.7 18.6 6.9 6.9 9.6 7.6 2.1 9.0 10.1 1.1 6.7 1.4 12.5 11.4 23.1 16.4 12.7 1.1 28.6 12.0 0.2 7.4 6.1 6.5 7.8 8.1 7.4 10.2 3.9 18.1 11.3 5.5 3.6 7.5 0.0 1.6 15.9 0.4 4.6 13.5 5.1 15.6 11.2 17.5 5.7 21.3 12.5 14.1 9.3 2.3 2.6 2.6 4.9 4.1 2.7 7.0 5.3 5.1 4.9 2.2 4.6 4.7 5.0 1.8 4.4 1.6 4.6 2.6 1.5 14.8 14.5 22.8 12.2 13.0 14.0 13.6 10.9 14.7 14.5 41.7 20.1 11.5 11.9 2.7 37.3 11.3 10.2 6.7 14.8 48.8 72.6 0.5 18.3 19.5 6.7 9.0 6.3 0.0 29.1 0.9 7.4 32.3 8.1 7.3 11.7 11.1 18.9 5.5 21.8 8.2 4.6 15.5 21.9 4.6 15.0 23.4 34.3 10.5 2.8 19.8 80.1 12.9 7.6 5.5 2.5 2.4 0.3 13.4 13.7 23.7 ZDHHC20 "DHHC20, FLJ25952" ENSG00000180776 "Zinc finger DHHC-type containing 20" Q5W0Z9 13 21372573-21459370 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.4" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 77.2;Kupffer cells: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014483, HPA014702" Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA014483: AB_1859000, HPA014702: AB_1859001" "unprognostic (1.31e-1)" "unprognostic (2.16e-3)" "unprognostic (7.31e-3)" "unprognostic (8.89e-2)" "unprognostic (3.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.24e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (6.55e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.76e-2)" "unprognostic (7.65e-2)" "unprognostic (6.15e-2)" "unprognostic (1.13e-2)" 7.5 7.0 8.3 9.4 33.6 14.9 11.3 6.4 15.3 10.3 10.9 21.0 7.6 10.8 9.3 5.6 18.4 7.1 10.0 5.4 12.7 11.8 3.8 7.6 10.6 12.3 47.4 4.9 6.5 6.1 4.0 5.3 10.8 26.1 9.2 9.6 3.1 10.4 9.9 5.5 12.2 15.4 8.9 45.0 8.6 23.1 22.0 35.8 10.4 10.0 5.1 10.9 16.2 9.6 4.6 7.8 8.8 15.2 10.1 10.2 11.1 13.2 7.7 11.2 7.1 10.5 11.1 27.5 14.6 14.7 9.8 8.7 13.9 40.9 14.2 7.9 17.8 10.3 21.7 12.9 11.2 18.5 15.4 8.2 24.9 4.8 7.7 5.9 16.8 10.8 10.0 7.9 9.6 6.8 12.4 15.1 18.4 6.9 6.0 14.4 11.2 23.5 6.4 9.1 35.2 7.6 18.9 20.2 4.9 11.6 24.9 10.7 4.9 19.1 12.0 7.8 12.0 11.0 8.6 26.2 10.3 9.9 17.3 10.8 6.2 7.6 14.7 7.4 9.7 29.1 8.8 15.2 3.4 10.2 14.2 9.4 4.6 8.8 8.7 7.8 3.7 8.3 8.5 2.7 10.1 12.0 3.9 9.3 11.1 8.3 33.6 6.4 15.3 12.7 11.8 47.4 4.9 26.1 35.8 47.6 26.9 15.8 6.9 0.9 8.3 6.4 17.8 20.1 36.4 10.4 7.9 18.2 0.0 8.6 77.2 15.0 29.0 0.0 10.5 16.6 10.3 19.1 13.9 17.4 19.9 17.5 23.1 19.6 86.8 67.8 14.4 35.8 1.7 7.2 29.0 4.4 18.7 23.0 10.3 6.2 9.6 19.4 6.9 9.7 12.3 1.4 37.3 20.8 23.4 16.9 ZDHHC21 "DHHC21, DNZ1, HSPC097" ENSG00000175893 "Zinc finger DHHC-type containing 21" Q8IVQ6 9 14611071-14693471 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Muller glia cells: 75.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065254 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA065254: AB_2685446" "unprognostic (2.95e-2)" "unprognostic (1.45e-1)" "unprognostic (2.06e-2)" "unprognostic (2.01e-1)" "unprognostic (4.19e-2)" "unprognostic (2.58e-2)" "unprognostic (2.81e-2)" "unprognostic (1.13e-2)" "unprognostic (2.18e-2)" "unprognostic (8.37e-2)" "unprognostic (9.79e-3)" "unprognostic (3.97e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.21e-1)" "unprognostic (1.14e-1)" "unprognostic (8.87e-2)" "prognostic favorable (9.28e-6)" 6.5 10.8 15.9 7.9 16.8 4.2 11.6 29.0 22.6 7.8 8.5 9.3 3.8 12.2 9.8 11.7 14.4 7.5 6.7 9.0 13.8 10.4 9.4 4.8 9.2 11.1 9.4 16.5 10.0 8.4 11.5 22.2 7.8 14.8 10.0 9.9 6.6 8.3 7.4 7.7 15.7 12.6 7.7 9.9 9.5 7.9 7.3 9.7 4.7 11.3 9.9 10.7 7.7 11.3 5.2 1.4 0.5 0.8 2.8 1.7 0.6 5.4 2.8 5.6 3.6 0.9 1.0 4.3 7.0 2.2 2.5 2.9 1.4 2.6 5.4 1.7 4.9 3.1 3.6 3.8 2.3 3.6 10.8 2.9 23.0 6.1 2.7 3.0 4.0 7.7 1.9 5.3 2.9 1.9 4.6 14.6 2.2 1.9 0.6 4.4 3.0 0.9 3.9 3.9 2.3 5.3 0.0 2.6 2.7 7.7 6.1 3.4 9.1 3.2 4.0 2.1 4.4 5.0 6.6 10.3 1.8 2.7 1.8 6.4 2.3 4.2 0.0 3.8 0.2 1.8 0.5 0.4 0.1 1.2 0.8 1.3 5.2 1.2 1.1 0.2 3.5 0.8 1.2 0.0 2.8 0.6 1.4 1.7 0.6 15.9 16.8 29.0 22.6 13.8 10.4 9.4 16.5 14.8 9.7 20.8 17.9 23.9 7.6 8.5 42.8 16.2 20.4 10.7 22.7 41.8 41.2 7.1 5.0 13.7 4.0 14.8 33.7 0.0 15.6 5.4 9.4 16.4 10.4 6.8 9.6 35.0 15.0 30.7 15.1 4.5 17.8 11.7 1.7 12.6 13.4 75.7 25.7 10.5 29.4 7.9 50.3 6.5 11.3 14.6 16.1 17.6 6.4 10.2 10.2 13.2 ZDHHC22 C14orf59 ENSG00000177108 "Zinc finger DHHC-type containing 22" Q8N966 14 77131270-77142734 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 52.3" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 9.9;Cone photoreceptor cells: 3.9;Late spermatids: 3.3" "Cancer enriched" "Detected in single" 40 "glioma: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 5.3;NTERA-2: 5.6;RH-30: 9.4;SCLC-21H: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049471, HPA072213" Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA049471: AB_2732553, HPA072213: AB_2686496" "unprognostic (1.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.22e-4)" "unprognostic (1.66e-1)" "unprognostic (8.86e-2)" "unprognostic (2.68e-1)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "unprognostic (6.94e-4)" "unprognostic (3.05e-1)" "unprognostic (6.30e-2)" "unprognostic (1.16e-1)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" "unprognostic (4.79e-1)" 1.1 1.5 11.2 1.1 12.6 1.1 1.1 8.4 52.3 1.1 1.2 6.7 0.0 1.1 1.1 1.4 1.3 1.2 1.1 1.2 14.5 18.4 1.1 1.1 1.1 1.1 10.7 19.5 1.1 1.1 1.1 3.1 1.1 9.2 1.1 1.3 0.5 1.1 1.1 1.3 1.1 1.1 1.2 3.6 1.1 1.3 1.4 5.1 0.0 1.3 0.0 1.1 1.4 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 5.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 5.6 0.0 0.7 0.0 9.4 0.0 0.0 0.0 10.4 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 11.2 12.6 8.4 29.5 14.5 18.4 10.7 19.5 9.2 5.1 0.0 0.0 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ZDHHC23 MGC42530 ENSG00000184307 "Zinc finger DHHC-type containing 23" Q8IYP9 3 113947901-113965401 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.8" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 20.4;Late spermatids: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.7;naive B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016808 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA016808: AB_1859002" "unprognostic (2.10e-3)" "unprognostic (2.86e-1)" "unprognostic (4.48e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.49e-1)" "unprognostic (3.98e-3)" "unprognostic (1.37e-2)" "unprognostic (2.48e-1)" "unprognostic (3.19e-1)" "unprognostic (6.63e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-2)" "prognostic favorable (1.48e-7)" "unprognostic (2.58e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (5.90e-4)" "unprognostic (3.29e-3)" 1.0 0.8 6.3 2.1 5.9 0.4 1.9 2.7 10.4 1.4 7.7 0.9 2.2 6.0 1.5 1.6 1.7 2.1 1.8 1.3 8.9 1.9 4.7 3.2 2.4 2.7 0.9 4.7 1.1 4.4 8.2 3.5 0.4 1.4 1.8 9.9 1.2 4.9 1.4 1.2 2.9 5.4 0.7 0.9 1.9 5.0 25.8 0.6 0.8 5.5 0.9 2.8 1.7 1.5 2.7 1.1 0.5 0.0 0.0 0.5 0.1 13.1 3.3 0.4 7.8 1.2 0.2 11.5 5.2 1.6 1.0 1.6 5.4 8.9 6.1 4.6 3.0 8.6 8.7 10.0 1.4 1.7 3.6 4.6 5.6 4.8 3.3 0.4 6.2 5.2 0.2 1.7 0.2 0.6 1.2 0.8 6.5 0.0 3.6 0.1 7.6 5.1 0.4 2.4 13.6 3.7 0.9 4.5 5.0 5.6 6.5 13.7 3.5 4.0 13.5 2.6 3.2 8.1 2.1 0.2 3.8 7.6 0.8 2.3 4.0 5.2 9.8 3.2 4.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.1 0.0 1.7 0.1 0.0 0.5 0.0 0.0 1.1 0.1 0.1 6.3 5.9 2.7 10.4 8.9 1.9 0.9 4.7 1.4 0.6 0.0 1.0 5.9 1.6 2.7 1.8 1.2 10.2 5.3 2.3 15.7 7.9 0.6 0.0 2.1 20.4 1.4 15.7 0.0 1.6 1.2 0.6 3.5 0.0 5.4 0.4 0.0 13.3 1.8 0.3 26.8 1.1 1.2 3.3 1.0 12.2 3.8 0.7 9.5 0.0 3.4 0.7 0.0 0.3 11.6 1.9 2.4 0.2 0.0 11.4 1.7 ZDHHC24 ENSG00000174165 "Zinc finger DHHC-type containing 24" Q6UX98 11 66520637-66546238 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016619 Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA016619: AB_2288672" "unprognostic (2.77e-1)" "unprognostic (2.51e-1)" "unprognostic (2.52e-1)" "unprognostic (1.55e-3)" "prognostic unfavorable (3.28e-4)" "unprognostic (8.76e-2)" "unprognostic (7.74e-3)" "unprognostic (7.11e-2)" "unprognostic (6.20e-2)" "unprognostic (1.41e-1)" "unprognostic (3.73e-2)" "unprognostic (1.48e-1)" "unprognostic (8.10e-2)" "unprognostic (6.99e-3)" "unprognostic (3.10e-1)" "unprognostic (4.88e-1)" "unprognostic (1.35e-1)" 11.7 17.4 10.5 10.3 12.8 14.1 12.3 5.7 15.5 7.7 8.3 13.8 10.8 9.1 9.4 17.0 12.2 9.0 11.3 9.9 10.7 11.8 17.3 13.4 11.1 20.4 12.8 10.3 6.5 19.4 22.6 9.6 13.7 9.3 11.4 7.7 10.0 12.4 13.1 7.9 13.2 9.4 7.1 10.0 16.0 12.4 9.9 10.5 11.7 17.7 7.9 13.4 10.0 7.8 5.8 17.2 2.4 5.5 6.6 7.2 4.6 4.7 7.6 2.5 6.5 6.2 5.1 6.3 4.0 3.4 3.2 2.2 6.6 7.7 1.4 10.9 3.4 8.5 11.6 1.9 3.5 2.3 6.8 4.8 2.9 3.7 4.1 5.8 3.0 7.2 6.1 6.3 2.7 3.8 3.8 5.3 11.0 4.2 4.2 4.0 10.3 5.7 8.3 5.0 12.0 6.5 7.3 5.3 8.9 3.9 3.8 3.5 5.5 6.4 6.7 11.0 2.9 9.3 2.4 8.3 7.4 2.3 8.6 2.9 6.3 2.0 2.0 6.5 1.4 8.0 2.4 5.5 1.0 6.2 4.8 5.7 5.4 5.0 7.2 6.3 5.8 3.0 5.4 2.4 6.6 4.4 17.2 5.1 4.6 10.5 12.8 5.7 15.5 10.7 11.8 12.8 10.3 9.3 10.5 11.9 8.8 14.9 12.3 7.1 8.8 3.8 12.7 5.3 2.3 22.7 9.8 28.2 8.3 42.7 10.7 17.0 37.0 0.0 42.7 30.1 14.0 21.3 9.2 14.3 58.2 22.3 13.8 20.3 38.9 10.2 6.9 18.7 16.9 38.7 17.0 17.5 34.3 31.6 9.2 24.8 10.3 19.4 12.2 31.9 2.7 7.0 20.1 28.7 19.6 19.7 ZDHHC3 "DHHC3, GODZ, ZNF373" ENSG00000163812 "Zinc finger DHHC-type containing 3" Q9NYG2 3 44915257-44976185 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 8 "Early spermatids: 493.4;Late spermatids: 1185.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012465, HPA016616" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB012465: , HPA016616: AB_1859004" "unprognostic (2.80e-1)" "unprognostic (6.07e-2)" "prognostic favorable (3.43e-4)" "unprognostic (3.10e-2)" "unprognostic (2.47e-2)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (4.20e-2)" "unprognostic (1.04e-1)" "unprognostic (6.37e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "prognostic favorable (1.81e-8)" "unprognostic (2.64e-1)" "unprognostic (1.49e-1)" "unprognostic (5.33e-2)" "unprognostic (4.26e-2)" 23.1 25.8 11.7 17.5 14.0 29.5 39.8 12.5 20.8 17.2 27.9 13.7 17.8 18.4 19.2 17.9 29.1 13.0 22.7 34.6 11.2 9.1 21.7 19.0 20.2 16.1 12.1 7.7 16.5 15.0 16.9 8.8 19.5 19.4 16.1 28.9 14.7 17.4 22.5 20.0 43.0 33.2 15.4 13.6 15.4 20.9 48.0 10.1 14.1 20.4 22.1 20.6 21.4 20.7 5.4 11.4 17.1 10.0 6.0 7.1 5.2 12.0 9.7 8.8 12.1 37.5 19.0 9.8 10.6 13.3 13.6 12.3 11.6 15.9 11.0 5.8 18.8 8.2 15.5 13.5 18.8 14.5 10.8 5.7 9.7 13.4 8.5 8.5 25.1 7.9 16.3 23.3 13.0 12.9 10.7 14.3 11.0 14.2 9.8 12.5 7.8 7.6 18.3 11.7 27.2 19.4 5.7 7.4 8.3 13.5 37.8 2.7 10.6 12.8 13.2 5.8 13.9 10.0 17.4 15.2 11.8 10.9 13.8 13.9 6.7 12.5 10.8 10.8 38.5 8.8 17.1 10.0 13.8 6.5 5.5 6.1 4.7 4.7 7.1 11.4 5.4 4.9 6.3 11.4 6.0 7.2 6.7 6.9 5.2 11.7 14.0 12.5 20.8 11.2 9.1 12.1 7.7 19.4 10.1 38.7 75.1 15.7 29.8 42.7 9.4 24.0 25.5 16.0 18.2 50.6 5.9 40.9 61.3 37.0 493.4 30.7 99.2 23.3 69.9 48.5 26.6 52.0 18.5 25.9 43.7 14.3 34.4 38.1 31.1 1185.8 48.1 27.2 23.6 30.7 65.3 25.6 78.0 59.6 42.1 23.7 8.6 19.4 23.7 52.6 40.9 52.7 85.0 20.8 60.2 82.9 ZDHHC4 "FLJ10479, ZNF374" ENSG00000136247 "Zinc finger DHHC-type containing 4" Q9NPG8 7 6577434-6589374 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032124 Approved NA NA "HPA032124: AB_10610699" "unprognostic (1.07e-1)" "prognostic unfavorable (9.35e-4)" "unprognostic (6.82e-2)" "unprognostic (8.36e-2)" "unprognostic (3.66e-1)" "prognostic unfavorable (3.95e-6)" "unprognostic (9.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.37e-1)" "unprognostic (4.60e-2)" "unprognostic (1.52e-1)" "unprognostic (1.43e-1)" "prognostic favorable (1.18e-7)" "unprognostic (8.75e-2)" "unprognostic (9.41e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (8.94e-4)" 17.7 24.3 20.7 13.5 22.0 11.4 23.6 8.2 29.9 20.7 24.9 22.5 18.2 14.0 21.6 26.9 16.1 25.5 18.8 21.9 17.3 19.7 25.7 34.5 17.0 19.7 19.8 17.7 22.7 46.5 27.2 18.7 14.1 20.4 20.0 16.3 28.0 29.8 22.4 34.9 9.5 16.3 22.7 17.1 13.6 23.5 27.0 12.3 18.1 30.5 17.4 16.5 23.3 13.7 17.6 50.6 20.9 14.9 11.9 15.4 12.6 21.7 13.9 5.2 31.0 28.5 21.5 23.7 12.3 3.1 15.1 18.8 17.3 31.3 12.9 19.6 22.7 32.4 20.0 18.2 12.2 15.7 7.7 10.6 14.3 16.6 18.5 25.3 17.0 15.7 22.5 18.0 11.8 0.0 19.2 13.4 25.7 29.3 19.3 20.9 22.8 9.1 16.7 27.1 20.1 12.1 12.6 26.4 19.2 12.0 17.3 12.5 32.0 16.3 6.0 21.4 28.7 20.7 22.4 9.0 17.8 25.9 17.0 17.8 28.6 22.8 29.9 10.7 21.4 24.9 20.9 11.7 18.0 11.5 14.9 12.5 17.6 11.6 12.7 13.2 16.1 15.4 14.7 1.3 11.9 10.8 50.6 10.3 12.6 20.7 22.0 8.2 29.9 17.3 19.7 19.8 17.7 20.4 12.3 35.7 15.3 25.1 40.1 10.1 30.0 3.6 56.0 26.8 31.8 33.2 9.8 58.4 72.9 53.9 2.0 10.8 10.2 0.0 58.4 56.0 26.7 32.7 10.3 38.4 48.4 20.6 31.2 20.9 26.0 2.2 16.7 18.1 20.3 38.7 19.1 45.6 49.0 17.5 30.8 58.5 19.8 12.9 30.9 76.1 50.3 8.2 40.8 22.4 29.3 26.5 ZDHHC5 "DHHC5, KIAA1748, ZNF375" ENSG00000156599 "Zinc finger DHHC-type containing 5" Q9C0B5 11 57667747-57701187 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014670 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA014670: AB_2257442" "unprognostic (1.34e-1)" "unprognostic (3.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (5.32e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-3)" "unprognostic (1.74e-3)" "unprognostic (4.36e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (6.74e-5)" "unprognostic (1.76e-1)" "unprognostic (4.72e-3)" "unprognostic (2.16e-1)" "unprognostic (6.80e-2)" "unprognostic (2.06e-2)" "unprognostic (1.74e-3)" 19.6 18.2 6.9 14.2 16.1 13.0 17.3 12.4 19.2 20.0 18.7 14.1 20.9 14.6 19.8 15.9 45.8 16.0 19.1 18.2 8.2 8.1 27.8 24.8 18.7 18.0 8.5 8.2 16.2 21.3 31.4 13.9 31.4 12.8 15.5 18.2 19.1 29.3 18.4 31.3 33.2 25.9 15.2 8.7 21.5 16.3 35.7 7.8 26.4 25.5 23.9 39.1 23.3 26.0 9.4 13.4 15.5 11.3 6.9 13.1 9.0 28.4 31.6 12.4 12.6 27.5 21.2 23.4 26.8 32.1 22.4 16.8 19.1 35.1 19.2 34.8 31.6 19.3 40.3 19.3 31.7 20.0 23.6 8.7 16.3 14.5 17.0 30.8 30.5 27.7 29.8 28.7 33.1 33.7 18.6 25.2 16.2 21.4 24.3 28.3 17.1 17.1 8.5 15.0 21.1 19.0 17.1 25.1 23.7 25.6 42.2 9.0 11.5 24.9 28.2 26.1 17.5 30.2 17.5 29.5 29.1 15.1 30.5 18.6 17.7 21.9 16.5 21.6 15.8 25.2 15.5 8.1 9.8 11.1 10.1 13.1 9.0 10.9 9.4 8.0 9.4 11.0 11.1 10.2 6.9 11.3 13.4 9.8 9.0 6.9 16.1 12.4 19.2 8.2 8.1 8.5 8.2 12.8 7.8 14.9 10.9 5.3 10.2 14.3 17.5 18.1 12.7 14.7 20.5 12.2 35.3 8.5 3.3 13.1 15.8 11.7 31.9 0.0 15.7 8.4 8.5 14.0 19.6 13.2 11.0 12.7 11.1 13.5 16.1 6.8 10.9 12.0 1.7 9.0 16.2 9.6 19.0 19.3 7.1 10.2 45.0 0.0 9.2 6.5 6.6 17.3 15.6 8.7 15.8 15.9 ZDHHC6 "FLJ21952, ZNF376" ENSG00000023041 "Zinc finger DHHC-type containing 6" Q9H6R6 10 112424428-112446917 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014357 Approved NA NA "HPA014357: AB_2304658" "unprognostic (1.21e-1)" "unprognostic (1.00e-1)" "unprognostic (6.31e-2)" "unprognostic (2.51e-2)" "unprognostic (1.80e-1)" "unprognostic (2.07e-1)" "unprognostic (3.29e-2)" "unprognostic (6.24e-2)" "unprognostic (5.21e-1)" "unprognostic (3.54e-2)" "unprognostic (1.56e-1)" "unprognostic (7.14e-3)" "unprognostic (3.00e-2)" "unprognostic (9.30e-2)" "unprognostic (8.87e-2)" "unprognostic (7.64e-2)" "unprognostic (1.22e-2)" 17.6 17.7 14.4 21.6 17.2 13.9 17.7 17.5 19.1 16.6 21.3 15.4 25.6 32.2 21.6 25.7 21.1 16.5 17.1 15.1 15.4 13.2 41.7 21.3 17.6 20.3 20.1 15.2 24.5 19.0 15.6 17.6 19.3 19.8 18.6 22.6 18.2 21.4 23.5 13.8 14.8 43.8 16.7 15.5 22.3 18.8 10.7 15.0 20.2 20.5 12.9 21.6 16.7 17.9 16.8 16.4 20.2 17.2 15.5 23.0 15.0 20.6 16.2 16.9 20.9 16.4 12.5 12.0 20.3 19.3 16.1 19.3 15.3 37.1 11.5 9.3 12.3 18.1 24.7 14.0 12.9 18.8 26.8 17.2 11.8 18.6 18.9 10.6 27.0 20.9 9.4 8.7 17.6 20.8 24.9 20.1 17.3 12.8 19.2 17.3 17.3 15.0 30.3 9.9 23.1 13.3 12.6 21.4 10.7 19.0 11.5 6.3 8.8 10.5 16.7 19.1 13.8 9.3 19.9 14.3 18.5 11.7 12.3 19.1 10.8 12.4 15.2 16.4 47.9 12.0 9.3 17.2 20.2 15.5 15.8 20.1 16.8 17.9 19.5 16.4 13.3 15.2 17.1 11.4 15.5 12.4 13.6 23.0 15.0 14.4 17.2 17.5 19.1 15.4 13.2 20.1 15.2 19.8 15.0 20.8 19.0 24.4 27.9 18.0 10.0 11.3 38.2 12.0 28.4 33.2 7.9 29.6 51.4 30.8 61.9 18.0 37.6 0.0 26.1 38.6 18.6 25.9 23.1 19.0 30.0 14.3 10.9 19.0 19.4 13.2 15.0 28.1 11.8 15.4 20.6 16.6 24.8 21.0 18.4 33.5 12.4 6.5 16.0 8.6 12.0 19.4 30.6 33.0 20.7 40.4 ZDHHC7 "DHHC7, FLJ10792, FLJ20279, SERZ-B, SERZ1, ZNF370" ENSG00000153786 "Zinc finger DHHC-type containing 7" Q9NXF8 16 84974181-85011535 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019215, HPA059054, HPA059642" Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA019215: AB_2670102, HPA059054: AB_2683892, HPA059642: AB_2684093" "unprognostic (9.77e-2)" "unprognostic (2.12e-1)" "unprognostic (6.70e-2)" "unprognostic (1.09e-1)" "unprognostic (2.31e-1)" "unprognostic (8.76e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.41e-2)" "unprognostic (5.78e-2)" "unprognostic (2.21e-2)" "unprognostic (7.79e-3)" "unprognostic (8.04e-2)" "prognostic favorable (1.12e-5)" "unprognostic (1.67e-1)" "unprognostic (1.36e-2)" "unprognostic (2.45e-1)" "unprognostic (5.42e-2)" 23.4 20.9 17.7 25.4 14.7 40.3 45.8 17.8 20.0 23.7 26.8 15.5 15.6 19.7 27.7 18.6 20.4 19.2 29.1 24.9 13.0 11.6 23.4 21.3 31.3 36.3 15.5 14.5 21.8 30.0 31.1 15.2 25.1 14.8 24.1 24.3 18.1 18.7 18.4 36.5 23.1 25.5 31.1 14.9 27.1 32.3 18.6 13.9 16.1 19.9 25.8 18.8 27.7 28.9 2.0 6.9 8.5 10.6 1.5 3.0 3.5 20.4 18.0 9.5 11.4 42.3 32.0 13.1 18.9 36.7 29.8 14.8 18.9 24.0 9.4 11.1 30.5 9.8 21.6 12.2 25.0 37.7 5.4 9.8 7.3 7.7 21.4 17.7 12.7 7.1 26.4 28.7 24.3 14.0 19.0 15.3 8.9 21.8 3.2 18.8 24.4 8.7 12.2 14.7 17.2 13.1 10.8 8.7 5.1 29.3 26.9 8.1 10.3 24.4 13.7 11.8 15.1 25.9 7.8 22.2 18.0 13.7 16.9 11.0 11.3 15.6 21.2 17.1 9.5 14.2 6.7 10.6 8.5 2.5 8.8 3.0 1.6 2.4 2.0 6.9 2.0 1.8 2.6 7.1 1.5 7.2 4.7 0.6 3.5 17.7 14.7 17.8 20.0 13.0 11.6 15.5 14.5 14.8 13.9 29.8 25.1 8.2 20.6 11.7 8.2 18.5 15.3 20.1 9.1 15.7 5.9 15.1 1.7 12.1 6.5 8.9 21.7 0.0 13.5 21.1 17.0 18.9 3.5 9.4 25.9 14.3 12.1 12.9 49.0 7.1 16.1 22.8 15.1 16.2 31.0 5.6 22.2 28.1 19.8 7.4 5.7 12.9 13.0 8.4 11.4 11.2 13.5 13.8 29.1 28.5 ZDHHC8 "KIAA1292, ZNF378" ENSG00000099904 "Zinc finger DHHC-type containing 8" Q9ULC8 22 20129456-20148007 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003422 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA003422: AB_1080640" "unprognostic (1.00e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (3.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (5.14e-2)" "unprognostic (1.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.43e-3)" "unprognostic (9.34e-3)" "unprognostic (3.20e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (1.11e-1)" "unprognostic (1.02e-1)" "unprognostic (9.88e-2)" "unprognostic (9.57e-2)" 20.7 19.2 25.7 16.9 23.0 9.2 23.4 24.4 35.3 14.3 9.9 14.0 17.3 11.6 16.0 10.9 13.9 13.6 14.4 16.0 18.7 10.6 15.2 16.5 14.6 15.4 17.7 17.6 18.0 23.9 17.4 21.0 16.4 19.0 13.4 7.0 17.5 20.4 16.6 20.5 22.2 11.2 13.0 10.4 19.8 15.9 8.4 18.6 8.9 18.5 7.9 11.1 12.9 14.5 2.0 4.1 4.0 1.5 1.3 2.5 0.5 11.5 7.4 11.8 15.5 17.3 10.4 10.6 21.8 14.9 14.8 13.3 3.8 6.0 0.0 9.0 18.1 8.0 15.9 6.2 16.7 7.3 16.6 23.7 5.6 19.4 8.8 14.3 0.0 7.9 18.1 11.3 11.4 9.6 9.1 16.5 8.3 38.6 9.1 13.1 5.6 6.8 15.1 6.0 5.1 11.7 14.6 10.3 4.1 6.4 14.1 19.0 9.6 8.8 4.3 10.4 5.6 0.3 7.9 18.9 33.7 24.7 18.9 9.7 13.2 4.3 4.4 9.9 7.3 9.9 4.0 1.2 0.3 2.5 1.5 1.3 0.8 0.7 1.2 0.4 2.0 1.3 1.8 0.0 1.3 0.8 4.1 2.0 0.5 25.7 23.0 24.4 35.3 18.7 10.6 17.7 17.6 19.0 18.6 3.0 1.9 2.7 3.4 8.0 11.5 6.8 5.1 0.0 3.4 10.4 13.7 3.1 1.7 4.5 0.5 9.0 2.4 0.0 3.8 6.1 8.0 4.0 5.7 7.8 4.2 12.7 4.1 11.6 4.9 1.3 10.0 5.0 5.0 2.8 5.5 8.3 6.2 4.3 13.8 1.9 11.0 6.5 5.5 0.3 2.3 8.5 2.9 2.5 4.8 2.7 ZDHHC9 "CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380" ENSG00000188706 "Zinc finger DHHC-type containing 9" Q9Y397 X 129803288-129843909 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031814 Uncertain Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA031814: AB_10610700" "prognostic unfavorable (9.77e-5)" "prognostic unfavorable (4.64e-5)" "unprognostic (2.83e-2)" "unprognostic (7.53e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (4.01e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-1)" "unprognostic (3.49e-2)" "unprognostic (9.70e-3)" "unprognostic (4.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-2)" "unprognostic (4.11e-2)" 18.2 7.3 16.7 6.7 24.7 3.2 14.2 7.8 33.9 14.1 14.7 78.3 5.1 21.1 8.4 8.4 9.8 7.9 10.4 7.4 24.1 15.2 25.4 27.0 15.6 3.0 24.9 13.9 8.0 17.4 19.6 7.1 11.5 28.4 13.4 17.3 3.8 13.2 8.3 7.4 19.7 22.2 10.4 32.7 2.4 12.8 2.8 25.3 1.2 9.6 5.7 4.3 10.8 9.4 4.6 7.8 2.6 6.8 3.4 7.6 3.3 15.0 7.9 11.4 23.0 39.4 31.1 9.3 14.9 17.1 7.2 9.0 12.5 19.7 0.5 25.5 15.9 18.6 10.2 12.8 15.0 10.4 0.8 8.0 3.0 8.3 16.4 15.6 2.0 5.4 33.7 24.4 11.7 17.4 12.6 13.5 5.0 3.2 6.1 11.5 13.1 2.8 3.7 6.1 33.8 13.7 2.7 7.3 8.8 10.4 8.4 9.0 7.6 4.2 22.1 6.9 14.0 9.4 3.3 10.9 7.3 2.5 17.1 12.0 5.7 4.0 1.8 13.1 8.3 3.6 0.0 3.3 2.6 4.8 2.9 6.1 4.6 5.8 4.7 3.7 2.7 7.6 4.3 0.0 3.4 6.8 7.8 2.5 3.3 16.7 24.7 7.8 33.9 24.1 15.2 24.9 13.9 28.4 25.3 20.8 28.7 3.0 9.8 16.6 9.1 3.5 28.1 5.3 17.0 43.6 2.0 5.0 3.3 16.9 1.1 10.3 26.8 0.0 17.0 17.3 20.5 23.0 2.3 41.5 4.4 1.6 17.3 6.7 2.1 1.3 11.2 4.6 10.1 0.0 24.9 1.2 26.6 10.5 7.1 24.6 2.4 0.0 13.7 6.1 6.0 16.8 8.6 2.5 25.5 13.6 ZFPL1 "D11S750, MCG4" ENSG00000162300 "Zinc finger protein like 1" O95159 11 65084223-65088400 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014909, HPA017347" Enhanced Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA014909: AB_1859055, HPA017347: AB_1859056" "unprognostic (2.03e-1)" "unprognostic (5.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.12e-6)" "unprognostic (1.19e-2)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" "unprognostic (3.63e-1)" "unprognostic (7.34e-2)" "prognostic favorable (2.73e-5)" "unprognostic (1.88e-1)" "unprognostic (1.44e-1)" "unprognostic (4.34e-2)" "unprognostic (6.94e-2)" 22.2 23.6 20.9 17.3 25.0 34.9 20.4 17.3 31.8 19.1 23.2 30.6 24.9 24.7 23.6 27.6 24.5 26.3 24.1 26.5 21.6 18.4 21.8 28.8 16.2 15.4 29.1 19.2 26.4 40.0 16.9 30.4 33.0 21.2 22.4 14.0 23.1 38.4 25.7 33.0 24.2 26.4 18.5 21.6 18.6 24.7 28.5 23.7 17.7 26.0 22.0 21.6 24.5 18.7 11.1 11.6 33.1 12.2 12.2 13.9 6.5 27.1 19.0 12.0 12.6 10.7 15.3 19.2 12.9 15.9 15.2 12.0 12.7 19.0 9.4 25.7 18.3 14.9 14.8 6.9 15.8 5.3 13.6 12.8 9.7 14.7 26.1 23.2 7.4 13.1 14.3 21.3 11.4 19.8 9.9 14.4 14.9 11.5 14.6 11.3 38.3 11.3 16.2 8.2 9.0 16.8 10.5 6.9 24.2 11.8 13.6 13.1 11.2 10.3 19.6 28.0 6.2 29.0 11.6 14.0 10.2 17.1 22.2 10.4 10.2 9.9 11.6 15.8 6.9 19.0 33.1 11.5 23.0 9.2 12.2 9.7 10.7 8.6 9.5 11.6 11.1 9.6 8.5 15.9 12.2 11.0 10.9 13.9 6.5 20.9 25.0 17.3 31.8 21.6 18.4 29.1 19.2 21.2 23.7 11.9 13.6 9.0 25.8 9.7 19.8 4.8 20.4 14.7 18.2 12.2 3.9 42.8 49.7 31.7 12.8 15.1 46.4 0.0 42.1 37.6 17.3 30.4 9.2 17.9 28.0 22.3 21.9 17.2 17.0 35.7 19.0 12.7 16.9 32.5 35.3 31.0 35.7 37.4 19.1 20.5 16.1 19.4 16.5 24.7 16.8 10.9 57.1 12.5 33.9 26.5 ZFYVE27 "FLJ32919, SPG33" ENSG00000155256 "Zinc finger FYVE-type containing 27" Q5T4F4 10 97737121-97760907 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037523, HPA069876" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA037523: AB_10672351, HPA069876: AB_2686218" "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.30e-2)" "unprognostic (2.48e-2)" "unprognostic (7.15e-2)" "unprognostic (2.05e-3)" "unprognostic (5.24e-2)" "unprognostic (3.38e-3)" "prognostic favorable (7.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.26e-2)" "prognostic favorable (7.80e-4)" 10.1 22.6 16.1 12.7 20.8 20.7 11.8 28.6 33.0 10.3 17.4 15.7 17.4 25.6 11.6 25.4 9.8 17.9 14.1 12.8 17.6 20.7 15.5 18.2 11.3 15.2 15.1 23.4 17.1 15.4 19.6 24.3 14.3 17.6 13.3 17.5 25.6 14.0 11.8 7.9 17.1 24.0 9.4 14.7 18.1 14.9 14.2 13.3 12.2 13.1 5.5 14.7 8.5 10.4 11.2 8.5 13.4 12.6 9.0 15.2 11.7 10.4 12.9 7.8 17.2 8.9 6.2 10.6 10.7 11.3 12.5 12.3 11.4 21.8 16.2 12.3 7.7 16.1 23.5 11.3 10.4 6.7 16.7 11.3 7.6 12.7 10.6 11.4 12.2 15.4 10.1 12.6 12.3 9.5 20.2 7.0 13.7 11.4 11.0 9.3 8.1 9.8 23.3 6.3 9.1 10.0 11.4 7.8 7.6 12.0 6.5 6.3 12.2 7.2 6.1 27.8 7.4 13.3 12.2 7.4 6.3 7.5 9.6 20.3 12.8 10.7 8.5 15.8 15.8 7.2 7.1 8.4 13.4 15.2 9.1 13.1 10.9 10.5 12.0 8.0 11.2 12.1 12.9 12.1 9.0 12.6 8.5 13.4 11.7 16.1 20.8 28.6 33.0 17.6 20.7 15.1 23.4 17.6 13.3 3.0 10.7 11.5 10.1 7.2 28.2 7.7 15.3 6.7 3.4 14.0 55.0 6.5 6.6 13.2 4.6 9.5 29.9 0.0 13.9 5.2 6.2 10.4 13.9 9.6 7.3 35.0 19.4 6.2 8.6 1.3 8.9 8.4 10.1 11.8 12.3 15.2 11.2 22.8 8.5 7.0 41.6 19.4 7.8 6.6 7.7 4.8 11.3 15.0 12.0 14.8 ZG16B "HRPE773, JCLN2, PRO1567" ENSG00000162078 "Zymogen granule protein 16B" Q96DA0 16 2830169-2839585 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "salivary gland: 1069.4" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 160.9;Glandular cells: 457.9;Mucus-secreting cells: 224.9;Urothelial cells: 223.9" "Cancer enhanced" "Detected in many" "prostate cancer: 47.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 6.7;intermediate monocyte: 11.4;non-classical monocyte: 7.3" "Lineage enriched" "Detected in many" 7 "monocytes: 11.4" "Cell line enhanced" "Detected in some" "MCF7: 15.2;OE19: 32.4;SK-BR-3: 14.0;T-47d: 12.8" "HPA041125, HPA053549" Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" NA NA 1200000 Vesicles Nucleoplasm "HPA041125: AB_10794264, HPA053549: AB_2682184" "unprognostic (5.29e-2)" "unprognostic (2.71e-1)" "unprognostic (4.37e-2)" "prognostic favorable (3.48e-6)" "unprognostic (1.39e-3)" "unprognostic (1.94e-2)" "unprognostic (2.34e-3)" "unprognostic (4.13e-2)" "unprognostic (1.01e-1)" "unprognostic (3.45e-3)" "unprognostic (1.37e-1)" "unprognostic (1.47e-2)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.17e-1)" "unprognostic (1.04e-1)" "unprognostic (8.33e-2)" 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.7 0.2 0.0 0.2 0.1 0.1 0.1 0.5 0.0 1.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.0 0.6 0.0 0.0 0.0 1.6 0.3 0.0 1069.4 0.2 0.1 0.8 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 78.5 3.7 0.2 0.2 0.0 1.1 1.7 11.4 1.1 0.4 1.7 0.0 0.6 0.0 0.0 0.2 1.1 0.1 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.1 0.0 0.1 1.2 0.0 2.5 0.0 0.0 0.0 5.0 1.4 1.3 1.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.1 2.1 0.1 15.2 0.0 0.2 0.1 32.4 2.9 0.0 0.0 4.8 0.1 3.6 0.0 0.0 0.0 14.0 0.0 0.1 12.8 0.0 1.8 0.0 0.3 1.1 0.0 0.0 0.2 0.2 0.2 3.7 0.1 1.7 6.7 0.0 0.0 11.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.5 1.1 7.3 0.0 0.4 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.9 8.0 0.0 0.0 89.2 1.4 5.7 1.8 0.0 0.0 0.0 3.6 5.3 0.1 36.1 0.0 25.2 2.7 0.8 457.9 5.7 0.0 13.1 0.0 55.9 0.6 2.9 3.1 0.0 2.6 79.2 1.8 224.9 0.0 30.0 80.9 0.0 0.0 0.0 0.0 0.3 1.0 0.1 21.0 0.2 0.0 68.0 223.9 ZMPSTE24 "FACE-1, HGPS, PRO1, STE24, Ste24p" ENSG00000084073 "Zinc metallopeptidase STE24" O75844 1 40258107-40294184 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006988 Approved NA NA 13000 "HPA006988: AB_1080659" "unprognostic (6.32e-2)" "unprognostic (1.63e-2)" "unprognostic (3.75e-3)" "unprognostic (4.63e-2)" "unprognostic (4.16e-3)" "unprognostic (1.37e-1)" "prognostic unfavorable (5.73e-6)" "unprognostic (1.86e-1)" "unprognostic (1.17e-1)" "unprognostic (1.84e-3)" "unprognostic (4.78e-2)" "unprognostic (7.96e-2)" "unprognostic (5.06e-2)" "unprognostic (3.65e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (6.34e-4)" "unprognostic (2.71e-2)" 21.6 24.2 17.6 15.4 19.6 6.5 18.6 10.7 21.3 20.9 20.6 14.9 27.0 17.9 29.7 19.7 21.4 19.9 20.7 20.8 17.1 16.9 34.2 48.7 16.2 23.1 21.9 17.0 16.0 20.4 39.8 17.0 23.0 23.5 21.7 23.3 15.6 18.9 19.0 19.1 14.7 20.9 25.2 19.2 17.7 19.0 10.7 17.9 20.9 20.6 14.7 18.4 19.1 16.7 15.1 25.8 15.1 23.9 24.2 22.5 20.3 20.9 14.0 10.9 8.1 29.0 23.3 21.2 22.0 18.4 24.9 22.8 15.3 36.4 18.1 15.3 26.9 9.7 21.8 22.3 20.3 28.7 17.0 14.3 17.4 15.0 14.0 16.6 28.1 21.9 16.8 20.8 21.2 9.2 14.0 17.4 9.0 18.5 18.2 23.5 9.8 17.0 8.4 21.0 13.9 14.6 14.8 19.4 22.4 22.0 20.3 11.4 13.5 20.3 45.3 27.3 17.6 16.7 77.7 17.3 22.5 16.5 20.9 26.7 11.2 30.0 15.8 24.7 19.8 23.8 15.1 20.0 13.6 17.9 23.9 21.5 15.1 19.1 18.9 25.8 11.6 17.0 22.5 11.8 24.2 22.7 16.9 22.3 20.3 17.6 19.6 10.7 21.3 17.1 16.9 21.9 17.0 23.5 17.9 35.7 23.7 17.1 19.8 28.4 5.7 18.7 50.9 49.5 28.4 69.8 0.0 33.1 26.6 47.9 2.1 31.5 34.1 0.0 31.7 32.0 28.1 33.2 20.7 56.7 30.7 9.5 26.5 20.3 28.9 0.5 26.4 29.6 23.6 31.5 26.3 29.0 37.5 25.9 30.8 33.7 6.3 0.0 21.5 7.0 5.5 23.7 32.6 17.5 28.0 19.9 ZMYM6 "Buster2, MYM, ZBED7, ZNF198L4, ZNF258" ENSG00000163867 "Zinc finger MYM-type containing 6" O95789 1 34986165-35031968 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011004, HPA071865" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011004: AB_1859075, HPA071865: AB_2686464" "prognostic favorable (1.30e-5)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (3.06e-2)" "unprognostic (3.92e-2)" "unprognostic (2.11e-6)" "unprognostic (1.77e-3)" "unprognostic (4.83e-3)" "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.70e-2)" "unprognostic (9.29e-2)" "unprognostic (7.15e-2)" "unprognostic (2.28e-1)" "unprognostic (1.72e-1)" "unprognostic (4.84e-3)" 12.8 14.7 9.4 13.3 15.9 21.3 11.6 16.3 16.0 10.7 10.9 14.6 9.8 11.0 13.3 13.6 12.8 11.7 10.7 10.8 8.6 8.3 11.7 9.7 12.2 14.9 13.8 10.2 15.9 11.5 13.7 33.7 7.9 17.0 11.0 12.9 12.5 12.9 11.0 8.0 13.6 15.3 11.9 16.7 20.1 11.6 14.9 10.1 16.2 15.4 8.4 14.7 12.5 11.2 10.1 12.3 9.0 9.3 6.5 9.3 4.3 9.3 5.1 9.4 8.9 10.7 13.5 5.8 7.8 11.7 9.5 10.3 4.0 10.3 13.0 8.4 11.5 6.4 9.2 10.4 8.3 11.6 8.9 6.1 11.4 7.4 5.4 9.4 15.8 13.4 11.3 11.9 10.4 8.7 7.2 10.5 10.3 17.5 14.2 9.4 3.1 7.3 10.7 9.4 5.3 8.3 10.3 12.4 7.3 7.8 7.3 9.8 9.1 9.1 8.6 10.7 9.7 5.7 8.8 10.7 11.8 8.7 12.4 11.5 8.8 13.4 9.5 12.0 15.2 9.4 4.6 9.3 9.0 9.3 7.5 8.1 8.1 6.4 5.3 8.3 10.1 9.1 6.1 4.9 6.5 9.1 12.3 6.8 4.3 9.4 15.9 16.3 16.0 8.6 8.3 13.8 10.2 17.0 10.1 11.9 13.9 8.8 4.6 5.4 12.2 13.7 10.2 6.7 6.8 15.7 19.6 3.1 5.0 5.1 1.3 5.2 7.3 0.0 4.7 2.8 5.4 3.5 9.3 6.8 6.8 12.7 3.5 6.7 21.1 1.1 7.8 15.2 1.7 11.8 7.1 7.7 4.7 6.8 10.6 5.8 18.2 12.9 8.2 13.4 17.7 5.6 4.5 6.9 7.9 5.4 ZMYND11 BS69 ENSG00000015171 "Zinc finger MYND-type containing 11" Q15326 10 134465-254637 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015816 Supported Nucleoplasm NA NA Nucleoplasm "HPA015816: AB_1845427" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (3.00e-1)" "unprognostic (1.12e-1)" "unprognostic (9.12e-2)" "unprognostic (2.33e-2)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (1.80e-2)" "unprognostic (3.73e-2)" "unprognostic (4.47e-3)" "unprognostic (6.35e-2)" "prognostic favorable (4.76e-7)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (9.04e-2)" "unprognostic (1.42e-1)" 19.9 19.6 35.7 12.8 35.0 5.1 23.9 38.0 32.5 26.4 26.9 27.3 18.5 15.4 28.8 24.8 23.0 21.8 18.5 28.7 34.1 27.7 26.9 17.8 19.7 12.0 33.3 26.2 30.0 24.2 63.6 24.0 17.6 27.5 28.0 17.9 17.0 21.6 30.2 29.1 16.2 15.4 49.2 38.0 15.5 19.5 15.9 28.9 7.1 46.0 13.4 12.4 31.3 29.6 4.4 4.0 16.2 2.8 12.3 10.7 4.3 23.8 25.4 20.7 16.5 23.4 22.8 12.5 24.4 14.2 17.3 16.3 15.2 24.0 0.0 7.8 30.5 5.5 14.4 11.3 17.5 22.2 9.4 9.2 26.2 13.8 16.3 25.5 7.1 14.8 15.8 22.8 16.8 15.6 22.3 21.4 12.6 7.0 17.4 28.5 29.2 11.0 9.6 6.5 25.8 4.4 10.5 13.4 12.5 21.9 28.1 9.2 17.0 27.0 32.1 12.6 12.2 28.9 13.8 27.7 17.4 6.1 34.0 18.4 14.0 17.7 1.7 17.3 13.4 11.6 9.8 2.0 16.2 10.7 2.8 9.5 4.4 7.7 10.7 3.1 3.0 8.3 8.3 0.9 12.3 1.2 4.0 7.2 4.3 35.7 35.0 38.0 31.4 34.1 27.7 33.3 26.2 27.5 28.9 56.6 41.4 13.5 22.3 23.0 34.4 88.2 28.1 30.8 43.3 31.4 11.8 12.6 43.1 24.9 22.3 40.7 12.7 0.0 27.4 5.0 32.9 37.2 44.0 24.9 12.0 19.1 24.9 27.0 21.8 20.1 36.2 14.0 23.6 9.0 27.6 64.0 24.4 10.5 52.6 34.6 19.8 12.9 40.1 22.4 25.8 24.3 10.4 17.9 17.9 21.6 ZNF138 pHZ-32 ENSG00000197008 "Zinc finger protein 138" P52744 7 64794388-64833681 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (1.12e-2)" "unprognostic (3.25e-1)" "unprognostic (1.10e-2)" "unprognostic (3.12e-3)" "unprognostic (2.12e-1)" "unprognostic (1.60e-1)" "unprognostic (5.56e-3)" "unprognostic (1.29e-1)" "unprognostic (4.81e-3)" "unprognostic (1.25e-2)" "unprognostic (1.43e-1)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (1.78e-1)" "unprognostic (3.40e-1)" "unprognostic (1.23e-3)" "unprognostic (5.04e-2)" 6.2 10.3 15.3 6.5 24.7 5.7 15.0 41.5 18.7 7.6 6.0 5.9 1.5 5.5 4.5 8.2 7.7 4.3 5.5 5.7 14.2 9.7 8.3 8.9 5.0 11.0 16.2 12.6 5.9 4.3 3.1 10.5 5.1 16.3 7.2 8.0 3.5 7.8 5.4 7.0 15.2 5.5 5.4 16.6 6.2 7.9 9.5 17.1 10.0 7.4 5.6 11.2 5.5 6.4 9.6 6.9 11.2 3.9 4.0 8.9 3.3 3.9 2.9 5.8 11.0 4.0 4.8 6.1 2.5 2.5 3.5 5.9 5.2 6.4 15.7 6.2 1.6 8.3 2.5 9.2 2.7 6.4 6.1 5.9 4.7 4.1 3.6 1.9 9.4 4.7 2.7 2.8 6.0 4.9 4.6 3.1 11.1 12.1 5.9 4.1 7.0 9.1 5.9 13.2 4.3 6.2 7.0 6.5 5.4 4.7 8.8 9.6 9.8 4.3 7.3 5.8 16.3 11.4 8.9 1.7 4.0 4.5 3.5 6.2 8.9 10.4 19.0 2.6 6.3 3.0 11.2 2.2 4.0 5.3 3.9 5.9 9.5 8.3 8.4 2.7 9.6 8.9 8.3 3.4 4.0 3.6 6.9 7.6 3.3 15.3 24.7 41.5 18.7 14.2 9.7 16.2 12.6 16.3 17.1 0.0 3.2 4.2 6.2 8.1 20.2 12.1 0.0 0.0 4.5 5.2 5.9 8.8 6.6 6.3 8.5 8.0 3.8 0.0 12.2 8.3 6.6 3.6 13.9 5.9 6.5 22.3 4.1 4.3 7.0 8.0 6.4 9.3 1.7 7.2 7.0 10.3 7.6 7.0 4.6 5.4 12.4 0.0 4.7 17.6 13.9 9.3 4.7 10.8 7.6 5.9 ZNF286A "KIAA1874, ZNF286" ENSG00000187607 "Zinc finger protein 286A" Q9HBT8 17 15699577-15720787 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SuSa: 49.4" HPA021594 Approved Nucleoli No No Nucleoli "HPA021594: AB_2670768" "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (2.05e-1)" "unprognostic (1.91e-2)" "unprognostic (1.24e-1)" "unprognostic (8.83e-2)" "unprognostic (2.47e-4)" "unprognostic (4.66e-2)" "unprognostic (9.68e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-4)" "unprognostic (5.60e-2)" "unprognostic (1.66e-3)" "unprognostic (4.95e-2)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (4.94e-2)" 3.7 5.9 6.6 5.5 9.5 2.0 6.0 8.2 7.8 9.7 5.3 6.5 10.0 2.5 11.3 10.0 7.6 6.6 6.6 11.5 7.6 6.5 6.1 3.2 3.5 7.0 8.7 4.7 14.3 2.9 9.8 15.9 4.0 9.4 7.1 3.5 7.1 4.7 8.3 3.8 4.0 3.5 8.4 10.7 4.5 3.4 14.2 9.0 5.2 8.0 3.8 6.0 6.9 6.0 6.4 2.7 1.0 3.6 6.0 9.8 2.5 13.4 15.2 22.2 10.7 6.5 9.4 7.1 6.3 5.5 10.5 8.4 9.1 4.8 12.0 5.2 5.3 9.0 11.9 15.7 7.4 13.1 8.8 12.2 8.2 15.6 7.8 6.4 4.0 4.0 8.8 4.7 9.9 10.0 12.2 13.8 20.2 7.1 2.4 14.7 3.7 17.6 3.7 20.5 8.0 3.6 13.2 32.3 5.9 7.6 5.2 7.0 15.9 13.7 5.9 4.8 49.4 5.5 2.4 6.1 6.6 7.0 5.7 9.5 5.3 8.3 0.0 8.0 0.1 7.3 0.8 1.6 1.0 6.9 1.9 7.1 4.0 7.9 7.0 2.5 6.4 9.2 9.8 1.0 6.0 3.6 2.7 9.5 2.5 6.6 9.5 8.2 7.8 7.6 6.5 8.7 4.7 9.4 9.0 17.9 0.0 4.9 4.1 6.3 2.1 3.6 2.5 2.7 6.8 1.8 2.0 1.2 1.7 3.4 10.2 3.0 0.2 0.0 1.4 1.5 3.3 2.9 3.5 0.5 1.1 3.2 5.2 1.8 0.6 8.2 4.6 1.1 1.7 1.0 2.0 1.3 3.4 0.8 4.9 2.1 1.6 0.0 3.5 10.5 5.4 4.8 1.0 2.5 1.2 4.1 ZNF304 ENSG00000131845 "Zinc finger protein 304" Q9HCX3 19 57351307-57359898 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ito cells: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050531 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA050531: AB_2681160" "unprognostic (4.44e-1)" "unprognostic (1.73e-3)" "unprognostic (5.63e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (9.72e-2)" "unprognostic (2.86e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.95e-4)" "unprognostic (1.54e-1)" "unprognostic (1.28e-3)" "unprognostic (5.97e-2)" "prognostic favorable (1.52e-7)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (4.31e-1)" "unprognostic (9.00e-3)" 8.5 11.3 8.5 7.8 13.5 6.0 10.8 20.1 12.0 7.7 8.5 7.7 7.2 4.2 9.3 12.6 8.8 8.9 7.1 10.6 7.1 7.0 7.6 5.6 8.7 11.8 8.8 11.0 11.7 5.2 16.4 9.6 9.0 8.6 9.7 5.2 7.4 8.1 10.9 8.5 9.9 7.1 8.8 6.7 11.0 6.8 6.9 8.6 11.1 11.7 9.9 11.4 9.2 6.1 5.5 3.9 5.7 5.6 5.9 6.1 3.8 5.6 2.8 6.9 8.7 5.7 5.4 4.3 5.6 8.7 6.5 14.8 0.0 2.6 4.6 3.6 6.5 3.4 2.0 3.9 7.5 9.6 1.5 18.4 7.4 7.3 3.9 4.1 4.0 4.6 6.6 10.0 6.2 8.8 6.9 4.1 10.5 2.2 0.0 6.8 1.5 8.5 2.3 4.6 0.0 8.9 5.5 11.1 5.9 4.6 12.1 5.5 5.9 5.9 4.6 4.0 6.5 5.6 5.9 4.6 9.3 5.5 2.8 6.0 7.5 6.4 6.9 5.7 0.1 4.7 5.7 2.8 2.3 3.3 2.3 6.1 5.5 5.6 4.6 3.9 4.6 4.7 4.8 0.2 5.9 5.6 2.1 4.4 3.8 8.5 13.5 20.1 12.0 7.1 7.0 8.8 11.0 8.6 8.6 0.0 0.3 2.0 0.6 5.7 6.0 4.0 7.6 6.7 5.7 0.0 0.0 1.5 1.7 1.4 0.3 3.7 0.4 0.0 0.9 0.7 1.3 1.4 0.0 2.1 1.3 3.2 0.0 9.2 1.9 0.6 1.7 1.4 3.3 0.0 1.5 1.0 0.8 0.0 2.1 1.3 2.3 0.0 2.0 1.6 4.2 4.8 0.9 2.5 0.9 1.0 ZNF546 "MGC43537, ZNF49" ENSG00000187187 "Zinc finger protein 546" Q86UE3 19 39984134-40021041 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 25.9;Spermatocytes: 50.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA030838 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030838: AB_10603332" "unprognostic (4.38e-6)" "unprognostic (3.29e-1)" "unprognostic (1.80e-1)" "unprognostic (1.69e-2)" "unprognostic (6.10e-2)" "unprognostic (7.18e-4)" "unprognostic (1.05e-1)" "unprognostic (1.73e-2)" "unprognostic (8.20e-3)" "unprognostic (4.99e-2)" "unprognostic (2.03e-3)" "unprognostic (2.70e-1)" "unprognostic (5.69e-3)" "unprognostic (2.23e-1)" "unprognostic (6.46e-2)" "unprognostic (2.28e-1)" "unprognostic (2.58e-5)" 4.1 5.1 5.0 3.7 7.1 2.5 4.7 7.9 6.6 4.2 3.6 7.6 7.3 2.0 6.3 3.8 2.8 5.7 2.9 4.9 4.7 3.8 4.8 5.5 3.2 3.8 7.9 4.4 7.3 3.7 6.5 8.5 3.1 6.8 4.6 2.7 5.2 2.9 6.1 5.6 3.8 3.4 5.3 8.3 5.4 3.1 20.8 7.9 6.6 6.0 2.8 4.4 3.6 3.3 2.7 2.8 2.6 2.4 2.5 4.7 1.2 0.2 4.6 2.0 2.6 4.7 3.4 0.3 1.8 2.8 2.2 3.0 0.2 0.6 2.5 2.1 1.6 1.2 0.2 1.0 0.3 3.3 2.6 3.3 3.2 3.2 1.7 2.5 3.2 2.2 2.7 2.0 1.3 3.5 2.8 2.8 4.5 4.0 6.1 2.3 0.6 1.5 0.7 0.7 0.3 0.6 1.8 1.7 1.2 1.1 0.4 1.4 1.5 1.0 0.2 1.8 2.7 0.9 1.4 1.1 0.7 1.5 0.3 1.4 4.6 4.4 0.5 1.7 1.3 1.4 1.6 1.5 2.6 3.7 2.4 2.5 2.7 2.4 2.2 2.8 2.4 4.7 4.1 1.1 2.5 1.2 0.7 3.0 1.2 5.0 7.1 7.9 6.6 4.7 3.8 7.9 4.4 6.8 7.9 0.0 5.8 1.9 0.7 0.5 8.2 5.1 2.5 5.3 1.2 3.5 11.8 1.0 1.7 1.0 25.9 2.9 0.3 0.0 0.4 0.1 1.3 0.7 0.0 2.9 1.6 1.6 0.0 5.5 2.1 4.8 4.0 1.8 0.0 0.0 0.0 5.6 0.5 0.0 3.9 3.1 9.1 0.0 1.2 50.8 2.6 0.0 0.2 1.3 0.8 0.6 ZNF559 MGC13105 ENSG00000188321 "Zinc finger protein 559" Q9BR84 19 9323772-9351162 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA059632, HPA065485" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA059632: AB_2684089, HPA065485: AB_2685497" "unprognostic (1.35e-3)" "unprognostic (1.98e-1)" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (2.36e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-1)" "unprognostic (1.38e-1)" "unprognostic (2.64e-3)" "prognostic favorable (6.99e-4)" "unprognostic (7.28e-3)" "unprognostic (4.04e-2)" "unprognostic (8.48e-2)" "unprognostic (2.21e-2)" "unprognostic (6.20e-2)" "unprognostic (2.24e-1)" "unprognostic (1.75e-3)" 9.3 11.1 17.7 8.4 16.2 2.7 14.1 39.5 16.1 13.6 10.4 17.2 11.4 5.1 18.8 18.8 5.9 17.3 8.2 11.9 14.2 8.2 11.2 7.5 10.4 11.8 17.6 15.5 24.0 7.6 22.1 29.2 9.8 16.2 13.6 9.3 11.2 8.3 11.4 3.3 8.7 9.8 16.3 16.2 14.9 8.8 13.7 19.8 10.7 14.0 3.4 10.3 10.2 11.3 12.5 5.3 18.9 4.3 14.2 15.8 6.2 8.7 4.7 9.3 11.3 5.5 5.0 2.4 5.3 11.0 8.0 6.8 2.3 1.0 7.1 6.3 7.7 10.9 3.1 5.6 5.0 10.2 11.4 7.5 9.6 7.8 3.1 9.8 8.4 10.6 10.5 9.1 9.0 11.2 6.8 6.7 10.7 7.0 25.2 5.0 0.0 11.4 26.6 15.1 1.5 7.8 5.6 11.3 9.6 4.9 12.3 10.5 8.8 10.4 1.7 12.5 14.2 7.5 6.4 5.6 14.7 3.3 12.0 8.0 2.0 0.0 6.9 2.6 5.3 9.2 18.9 3.4 7.5 9.1 3.2 12.0 11.9 9.6 9.6 5.3 12.5 15.8 12.7 1.9 14.2 4.3 4.4 8.4 6.2 17.7 16.2 39.5 16.1 14.2 8.2 17.6 15.5 16.2 19.8 3.0 3.5 6.2 5.8 3.4 26.6 7.1 10.2 6.7 3.4 3.5 25.5 5.9 1.7 5.9 7.0 10.5 1.7 0.0 2.7 3.8 8.9 4.1 2.3 2.1 4.2 25.4 2.9 12.3 3.8 1.8 11.8 5.7 3.3 5.4 3.7 25.1 2.8 2.9 12.7 2.4 27.1 6.5 11.3 15.7 34.5 2.6 2.4 10.1 3.8 2.2 ZNF566 "FLJ14779, MGC12515" ENSG00000186017 "Zinc finger protein 566" Q969W8 19 36445119-36489902 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 33.4;Horizontal cells: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023456 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA023456: AB_2221143" "unprognostic (1.68e-1)" "unprognostic (6.34e-2)" "unprognostic (7.77e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (3.89e-3)" "unprognostic (5.71e-4)" "unprognostic (1.74e-1)" "unprognostic (3.21e-2)" "unprognostic (1.92e-2)" "unprognostic (7.56e-2)" "unprognostic (8.19e-4)" "unprognostic (7.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (9.48e-2)" "unprognostic (3.00e-1)" "unprognostic (5.47e-3)" 8.2 8.2 10.4 7.2 11.4 5.9 9.0 22.7 14.2 8.7 7.0 9.4 5.8 6.7 12.1 10.3 6.1 9.7 6.2 8.1 10.9 11.7 8.8 8.4 7.9 9.1 11.6 11.8 14.3 6.3 10.4 14.0 5.5 12.7 8.1 5.9 11.6 6.3 7.2 7.3 8.5 6.4 9.1 10.7 7.6 6.0 5.1 13.8 5.1 10.3 5.3 8.9 8.4 6.1 8.1 2.8 5.6 1.6 4.6 8.6 3.2 3.6 8.7 10.1 11.1 7.6 7.7 7.0 7.0 6.0 8.9 9.4 3.6 1.5 6.8 7.7 4.5 4.0 2.5 9.0 2.5 10.2 11.0 6.9 6.9 6.0 3.1 5.6 7.4 8.3 6.6 3.7 4.7 7.5 4.2 3.4 7.2 10.0 0.2 6.0 5.7 9.5 3.8 12.1 6.3 3.8 6.3 8.0 4.6 2.7 7.0 9.4 14.3 8.4 4.9 6.7 5.0 4.3 10.1 3.8 7.7 10.6 3.3 6.7 2.9 7.7 9.4 0.4 4.9 10.1 5.6 1.5 1.9 5.3 1.4 8.6 8.1 6.5 6.5 2.8 6.1 7.9 8.0 1.4 4.6 1.6 2.0 6.7 3.2 10.4 11.4 22.7 14.2 10.9 11.7 11.6 11.8 12.7 13.8 8.9 7.7 3.7 3.7 3.0 20.8 8.7 5.1 4.0 10.3 5.2 33.4 5.6 10.0 4.0 1.7 7.1 2.3 0.0 2.2 2.9 7.6 4.4 2.3 4.7 3.7 30.2 2.9 9.2 2.8 0.4 7.8 4.3 10.1 1.0 4.3 7.5 1.9 5.9 13.8 5.4 20.7 19.4 8.5 6.5 4.2 2.9 1.6 9.5 4.6 2.6 ZNF66 "FLJ16537, ZNF66P" ENSG00000160229 "Zinc finger protein 66" Q6ZN08 19 20776304-20807322 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 3.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 13.7" "Cell line enhanced" "Detected in many" "RT4: 16.5" NA NA "unprognostic (4.67e-2)" "unprognostic (6.81e-2)" "unprognostic (1.63e-1)" "unprognostic (2.41e-3)" "unprognostic (1.30e-2)" "unprognostic (8.88e-2)" "unprognostic (3.07e-2)" "unprognostic (2.16e-2)" "unprognostic (1.87e-1)" "unprognostic (1.57e-2)" "unprognostic (2.43e-2)" "unprognostic (5.88e-2)" "unprognostic (4.62e-3)" "unprognostic (1.58e-1)" "unprognostic (3.22e-1)" "unprognostic (1.77e-1)" "unprognostic (4.25e-2)" 3.6 4.4 3.7 7.2 7.1 5.9 5.0 12.4 4.9 3.3 2.4 3.6 17.3 2.9 5.0 4.0 3.7 4.0 3.7 2.6 2.5 2.3 2.9 1.3 3.4 8.1 3.8 4.7 19.1 5.7 2.3 3.1 3.0 3.6 3.8 3.6 5.7 7.2 12.0 2.2 5.5 3.8 4.5 3.5 4.3 4.9 4.2 5.0 11.0 6.6 1.5 5.9 7.6 5.0 2.5 1.9 13.7 0.8 2.0 1.5 0.6 0.0 0.3 3.3 7.1 1.2 0.5 6.2 1.2 0.8 3.5 3.1 2.9 2.1 2.9 4.7 1.3 2.5 0.4 0.0 0.1 2.7 1.5 3.3 0.3 0.9 1.0 0.1 0.6 0.7 0.7 1.8 1.6 1.5 0.6 0.3 1.9 2.4 0.8 2.2 2.7 5.8 2.6 2.2 0.4 0.7 3.7 4.9 2.7 3.1 16.5 4.3 3.5 0.0 0.1 0.7 4.1 1.9 2.9 0.0 2.4 0.1 5.3 1.9 2.3 2.6 4.6 0.1 0.5 0.2 6.0 0.8 2.2 1.2 0.5 0.6 2.0 1.1 0.9 0.6 2.5 1.5 1.4 13.7 2.0 0.6 1.9 0.9 0.6 3.7 7.1 12.4 4.9 2.5 2.3 3.8 4.7 3.6 5.0 3.0 0.6 3.0 0.5 0.1 1.2 0.8 0.0 0.0 2.3 3.5 2.0 0.5 1.7 0.3 0.0 0.6 0.0 0.0 0.6 0.5 0.5 0.3 1.1 0.0 0.3 1.6 2.9 1.3 0.6 0.2 1.1 0.6 1.7 0.0 0.0 0.3 0.7 0.3 0.4 0.2 1.7 0.0 0.7 1.5 1.9 0.4 0.1 1.3 0.2 0.3 ZNF7 "HF.16, KOX4" ENSG00000147789 "Zinc finger protein 7" P17097 8 144827464-144847509 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030296, HPA059090" Uncertain Approved Mitochondria NA NA Mitochondria "HPA030296: AB_10671095, HPA059090: AB_2683901" "unprognostic (1.11e-1)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-2)" "unprognostic (2.52e-1)" "unprognostic (2.97e-1)" "unprognostic (8.42e-3)" "unprognostic (3.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-2)" "unprognostic (2.68e-1)" "unprognostic (7.95e-2)" "prognostic unfavorable (8.46e-8)" "unprognostic (1.15e-1)" "unprognostic (5.00e-1)" "unprognostic (5.43e-2)" "unprognostic (6.53e-2)" 18.5 12.7 11.4 14.9 17.5 14.7 20.4 34.1 21.1 18.3 15.5 17.9 19.8 12.1 18.4 22.2 18.1 16.7 15.5 14.3 11.9 11.0 13.3 14.7 14.1 16.0 15.1 18.3 22.8 21.3 19.1 16.2 17.0 14.7 19.5 15.5 15.7 16.0 17.4 24.3 21.0 16.0 15.7 11.8 21.2 13.6 24.8 15.2 15.8 19.0 14.9 17.8 16.7 18.0 15.7 10.4 22.5 14.6 12.9 18.6 7.6 10.1 13.9 13.6 13.3 11.7 17.9 12.5 10.9 13.9 14.8 12.7 7.0 13.1 14.2 12.8 11.8 8.1 8.9 12.3 15.9 16.2 9.4 10.2 25.3 18.2 8.1 13.6 7.3 11.9 17.1 19.4 11.5 28.6 14.4 9.1 12.0 25.2 10.2 16.4 16.7 19.8 8.0 13.9 13.5 16.8 13.8 12.1 11.2 10.4 14.0 13.4 16.4 23.8 13.7 13.2 13.7 16.5 11.8 10.2 11.2 20.0 8.4 10.4 8.3 5.8 15.5 11.6 9.5 13.7 22.5 9.3 8.8 12.5 8.4 15.2 15.7 14.1 10.8 10.4 13.6 18.6 12.7 9.4 12.9 14.6 8.3 13.1 7.6 11.4 17.5 34.1 21.1 11.9 11.0 15.1 18.3 14.7 15.2 17.9 12.3 9.6 14.4 6.3 34.1 10.1 2.5 8.1 9.1 3.5 27.5 13.8 5.0 11.1 9.6 9.7 7.4 0.0 9.8 10.7 12.0 13.5 3.5 7.4 7.9 27.0 9.2 11.6 6.7 3.2 16.4 10.9 8.5 10.0 7.9 18.9 10.7 7.0 14.9 5.6 29.0 6.5 7.5 40.5 25.2 8.2 16.2 15.2 9.2 11.7 ZNF816 ZNF816A ENSG00000180257 "Zinc finger protein 816" Q0VGE8 19 52949379-52962911 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 33.6" HPA042466 Uncertain Approved "Nucleoli rim" NA NA "Nucleoli rim" "HPA042466: AB_10797497" "unprognostic (1.83e-2)" "unprognostic (1.90e-1)" "unprognostic (1.64e-1)" "unprognostic (4.81e-2)" "unprognostic (3.12e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-4)" "unprognostic (1.69e-1)" "unprognostic (1.33e-3)" "unprognostic (4.82e-2)" "unprognostic (1.01e-1)" "unprognostic (3.72e-2)" "unprognostic (5.36e-3)" "unprognostic (6.21e-2)" "unprognostic (5.45e-1)" "unprognostic (8.59e-2)" "unprognostic (1.39e-2)" 6.2 6.4 4.9 8.0 8.3 2.8 8.0 14.7 6.6 10.2 8.9 4.5 12.5 4.7 6.7 10.1 8.4 12.1 9.8 5.8 5.0 3.3 9.6 3.2 7.0 7.1 10.4 3.4 9.5 8.7 6.7 11.8 9.2 6.1 15.5 10.4 4.5 8.6 9.8 2.4 5.3 7.3 8.0 9.1 11.0 9.4 5.4 8.9 18.9 10.2 5.8 8.5 14.3 9.4 11.6 8.4 14.4 7.7 17.6 17.5 7.4 4.1 0.1 3.8 9.7 7.1 7.8 11.1 3.5 3.5 4.5 6.6 3.3 2.8 11.2 7.3 3.0 6.9 2.5 5.4 4.0 4.3 5.5 11.4 5.2 4.3 5.0 2.4 0.0 8.1 3.7 5.1 2.6 5.2 5.3 3.8 5.2 8.2 0.4 5.6 3.2 8.9 5.9 4.5 2.3 5.1 5.0 8.2 5.5 7.1 33.6 2.9 5.3 0.4 5.9 2.3 7.8 3.9 6.0 3.6 3.3 3.3 2.2 3.9 3.9 11.1 10.4 0.4 5.6 3.9 10.0 7.3 14.4 13.6 6.2 17.5 9.9 12.7 13.1 8.4 11.6 17.2 13.8 4.1 17.6 7.7 8.3 11.5 7.4 4.9 8.3 14.7 6.6 5.0 3.3 10.4 3.4 6.1 8.9 3.0 1.0 0.0 2.8 0.8 1.1 1.7 0.0 1.4 5.7 1.8 5.9 3.9 6.6 3.3 2.1 2.1 1.3 0.0 1.4 3.0 1.3 1.6 7.0 0.0 2.1 0.0 0.0 0.6 1.0 1.6 1.4 1.8 5.0 3.6 2.6 1.0 1.6 2.9 1.1 0.7 0.9 0.0 1.3 1.4 4.3 1.4 3.0 2.5 3.0 4.2 ZNF98 "F7175, ZNF739" ENSG00000197360 "Zinc finger protein 98" A6NK75 19 22391019-22532485 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 36.9" "Group enriched" "Detected in some" 5 "Distal tubular cells: 13.3;Early spermatids: 10.7;Spermatocytes: 8.8;Spermatogonia: 23.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "memory B-cell: 1.0;naive B-cell: 1.5;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 5 "B-cells: 1.5;dendritic cells: 1.9" "Cell line enhanced" "Detected in some" "BEWO: 3.0;GAMG: 8.8;NB-4: 7.4;RPMI-8226: 3.1;SuSa: 3.5;T-47d: 5.5;U-2197: 5.8" NA NA "unprognostic (1.11e-1)" "unprognostic (1.31e-2)" "unprognostic (6.95e-3)" "unprognostic (1.36e-3)" "unprognostic (3.07e-3)" "unprognostic (1.56e-1)" "unprognostic (7.20e-2)" "unprognostic (1.63e-1)" "unprognostic (1.81e-1)" "unprognostic (3.81e-2)" "unprognostic (1.99e-2)" "unprognostic (2.14e-1)" "unprognostic (2.66e-1)" "unprognostic (7.56e-2)" 1.3 1.0 3.2 0.6 9.2 0.6 4.2 0.9 13.2 3.9 0.8 2.1 2.1 0.5 1.8 6.3 0.6 2.7 0.8 1.5 4.2 1.6 3.7 0.5 0.6 0.7 2.6 7.2 12.6 36.9 4.5 1.1 0.9 3.8 1.3 0.5 0.4 1.1 1.2 0.5 0.6 0.6 1.7 1.4 0.6 0.7 10.2 3.1 0.0 5.1 0.0 0.4 1.2 0.8 1.5 1.9 0.2 0.1 0.2 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 3.0 0.2 0.0 0.4 0.2 0.0 0.0 0.0 1.3 0.0 8.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.3 0.2 7.4 1.6 0.0 0.3 0.5 0.0 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.5 5.5 1.8 0.0 0.0 0.6 5.8 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.0 1.0 0.3 0.0 0.0 1.5 0.3 0.2 0.0 0.2 0.1 1.9 0.1 0.0 3.2 9.2 0.9 13.2 4.2 1.6 2.6 7.2 3.8 3.1 0.0 0.0 0.0 0.4 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.9 13.3 2.0 10.7 0.0 0.0 0.0 1.2 0.3 0.0 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 2.9 1.1 0.0 0.0 0.0 0.0 0.8 0.5 0.0 1.8 0.6 0.0 0.0 0.3 8.8 23.7 0.0 0.3 0.0 0.0 0.1 ZNRF3 "BK747E2.3, FLJ22057, KIAA1133, RNF203" ENSG00000183579 "Zinc and ring finger 3" Q9ULT6 22 28883592-29057487 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036702, HPA036703" Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA036702: , HPA036703: AB_10672227" "unprognostic (1.07e-1)" "unprognostic (2.13e-3)" "unprognostic (7.48e-3)" "unprognostic (5.72e-2)" "unprognostic (6.81e-2)" "unprognostic (1.36e-1)" "unprognostic (2.22e-2)" "unprognostic (1.75e-2)" "unprognostic (1.37e-1)" "unprognostic (3.68e-2)" "unprognostic (5.18e-2)" "unprognostic (3.94e-1)" "unprognostic (9.55e-5)" "unprognostic (6.49e-2)" "unprognostic (1.02e-1)" "unprognostic (3.70e-2)" "unprognostic (2.55e-2)" 4.6 11.8 16.8 2.5 14.7 1.0 4.5 12.2 18.1 7.8 5.7 7.7 21.8 5.1 8.3 22.2 5.9 8.1 3.8 4.3 22.0 5.0 13.6 7.5 8.7 1.2 6.1 17.7 10.0 5.4 16.3 4.2 8.0 8.1 12.0 5.9 4.9 12.1 13.4 5.6 7.6 4.7 7.8 8.9 2.2 6.4 6.7 10.5 0.0 6.9 1.9 1.5 5.7 4.9 0.2 0.4 1.5 1.0 2.0 0.5 0.1 3.7 8.9 8.3 2.3 1.5 1.8 15.8 2.3 1.1 1.8 1.7 13.4 2.1 0.0 3.6 1.2 3.3 6.4 5.7 3.5 2.2 4.9 5.8 1.5 1.6 29.2 1.4 4.3 1.5 1.8 3.3 2.9 2.9 1.5 1.6 2.7 3.1 2.1 2.5 3.5 0.1 2.2 3.0 4.7 3.6 4.4 5.4 3.4 7.7 5.5 13.8 5.1 4.0 4.0 2.3 2.7 2.7 2.0 1.5 6.9 6.0 5.4 3.7 2.8 3.9 5.2 3.0 2.5 3.6 1.0 0.2 1.3 0.2 1.0 0.4 0.1 0.2 0.1 0.4 0.2 0.1 0.5 1.5 2.0 0.2 0.3 0.1 0.1 16.8 14.7 12.2 18.1 22.0 5.0 6.1 17.7 8.1 10.5 11.9 17.6 0.0 4.4 11.2 3.7 6.2 5.1 6.7 6.8 12.2 0.0 23.0 1.7 4.7 12.1 5.2 1.3 23.3 2.1 1.5 4.7 6.0 0.0 16.1 2.9 1.6 8.1 1.8 1.0 11.0 10.0 0.2 0.0 0.0 8.3 6.6 4.0 0.0 12.0 9.8 4.1 0.0 4.4 3.4 2.9 6.6 6.4 0.7 14.1 2.0 ZNRF4 "RNF204, spzn, Ssrzf1" ENSG00000105428 "Zinc and ring finger 4" Q8WWF5 19 5455431-5456856 "Enzymes, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 243 "testis: 90.2" "Group enriched" "Detected in some" 94 "Early spermatids: 525.4;Late spermatids: 405.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 525.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 405.2 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 4.7 3.1 0.0 0.0 0.0 0.0 0.0 ZP1 ENSG00000149506 "Zona pellucida glycoprotein 1" P60852 11 60867562-60875693 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.5;epididymis: 2.2;pituitary gland: 3.3" "Group enriched" "Detected in some" 7 "Early spermatids: 25.5;Late spermatids: 62.7" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 66 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in single" 66 "dendritic cells: 6.5" "Group enriched" "Detected in some" 36 "RPMI-8226: 16.2;SK-BR-3: 4.6" "Region enriched" "Detected in single" 7 "basal ganglia: 0.7" "Secreted in female reproductive system" NA NA "unprognostic (6.40e-3)" "unprognostic (2.18e-4)" "unprognostic (1.63e-1)" "unprognostic (1.15e-2)" "unprognostic (1.14e-1)" "unprognostic (7.02e-2)" "unprognostic (8.27e-2)" "unprognostic (9.95e-2)" "unprognostic (1.94e-2)" "unprognostic (8.15e-3)" "unprognostic (2.52e-1)" "unprognostic (9.25e-4)" "unprognostic (5.31e-13)" "unprognostic (4.13e-2)" "unprognostic (2.38e-1)" "unprognostic (6.27e-2)" "unprognostic (5.61e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.3 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.1 0.0 2.2 0.0 0.0 0.1 1.4 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 62.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 6.5 2.0 0.5 0.0 0.1 0.2 0.0 0.0 0.0 ZP2 ZPA ENSG00000103310 "Zona pellucida glycoprotein 2" Q05996 16 21197450-21214510 "Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 22 "cerebellum: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 35 "HDLM-2: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA011296 Enhanced "Secreted in female reproductive system" NA NA "HPA011296: AB_1859485" "unprognostic (2.35e-2)" "unprognostic (3.12e-2)" "unprognostic (6.60e-2)" "unprognostic (9.83e-2)" "unprognostic (3.44e-3)" "unprognostic (3.12e-1)" "unprognostic (1.66e-1)" "unprognostic (4.41e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 1.1 35.2 0.1 0.8 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.9 1.6 0.0 0.1 0.0 3.1 0.0 0.0 0.1 1.5 0.1 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZP3 "ZP3-372, ZP3-424, ZP3A, ZP3B, ZPC" ENSG00000188372 "Zona pellucida glycoprotein 3" P21754 7 76397518-76442071 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 36.5;Late spermatids: 52.3;Spermatocytes: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 16.5;hTCEpi: 17.6;Karpas-707: 24.4;MCF7: 32.5" HPA054061 Supported "Secreted in female reproductive system" NA NA "HPA054061: AB_2682363" "unprognostic (6.48e-2)" "unprognostic (3.08e-1)" "unprognostic (7.74e-2)" "unprognostic (1.59e-1)" "unprognostic (9.04e-2)" "unprognostic (2.68e-2)" "unprognostic (1.99e-3)" "unprognostic (1.29e-1)" "unprognostic (9.20e-2)" "unprognostic (1.94e-1)" "unprognostic (3.10e-3)" "unprognostic (1.15e-2)" "prognostic unfavorable (1.02e-6)" "unprognostic (1.33e-1)" "unprognostic (1.42e-2)" "unprognostic (6.72e-2)" "unprognostic (2.13e-1)" 2.4 5.6 3.3 1.9 13.9 4.3 6.7 1.7 4.4 3.1 5.1 3.2 1.8 4.2 2.6 5.3 7.4 8.7 1.5 1.4 2.1 2.4 2.0 2.0 1.2 6.9 2.6 2.2 5.8 11.9 1.4 3.1 1.4 4.6 3.3 5.7 5.6 3.7 3.4 2.7 8.7 2.6 2.5 2.8 3.6 2.5 2.3 4.0 0.8 2.0 4.4 4.7 1.7 4.1 2.8 10.3 0.9 9.9 0.3 5.2 3.4 7.9 16.5 0.1 8.5 0.4 0.5 0.4 0.5 1.3 0.1 1.5 0.6 7.1 0.0 0.3 2.0 0.2 2.0 1.7 0.5 0.1 4.3 4.1 1.3 4.6 0.1 3.7 0.3 2.4 0.7 17.6 1.7 0.5 0.0 0.3 4.3 1.8 24.4 0.0 32.5 0.7 4.1 1.8 13.4 4.7 0.0 0.7 1.7 0.7 0.1 3.6 0.0 2.2 11.1 0.2 0.2 7.3 1.3 1.0 0.1 0.9 0.1 0.1 7.4 6.0 0.1 0.7 9.2 1.4 0.5 9.9 0.1 0.2 3.9 0.5 2.8 1.3 0.6 10.3 1.5 5.2 3.7 0.9 0.3 4.2 2.2 0.2 3.4 3.3 13.9 1.7 4.4 2.1 2.4 2.6 2.2 4.6 4.0 3.0 2.2 2.2 3.6 7.6 1.4 0.8 5.1 5.3 1.2 1.8 0.0 5.5 0.0 2.7 36.5 1.6 2.0 0.0 3.6 3.3 2.8 1.8 0.0 1.0 6.3 1.6 4.1 2.5 6.5 52.3 4.0 4.8 3.3 1.8 3.8 4.6 3.0 8.4 5.3 1.6 1.6 6.5 1.2 26.6 14.0 8.7 7.8 2.2 7.4 12.0 ZP4 ZPB ENSG00000116996 "Zona pellucida glycoprotein 4" Q12836 1 237877864-237890922 "Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.1;ovary: 2.3;placenta: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "BJ hTERT+: 8.5" "Not detected" "Not detected" HPA008547 Supported "Secreted in female reproductive system" NA NA "HPA008547: AB_1080766" "unprognostic (7.12e-2)" "unprognostic (2.70e-1)" "unprognostic (4.59e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZPBP "SP38, ZPBP1" ENSG00000042813 "Zona pellucida binding protein" Q9BS86 7 49850421-50121329 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 95 "testis: 90.4" "Group enriched" "Detected in some" 16 "Early spermatids: 705.4;Spermatocytes: 420.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.4;NTERA-2: 1.2;SCLC-21H: 1.7;U-698: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058673 Enhanced "Secreted in male reproductive system" NA NA "HPA058673: AB_2683794" "unprognostic (1.16e-1)" "unprognostic (6.46e-2)" "unprognostic (7.80e-2)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.15e-7)" "unprognostic (9.49e-2)" "unprognostic (2.34e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.4 0.1 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 9.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 705.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.4 10.3 0.0 0.0 0.0 0.0 2.0 0.2 0.0 7.4 0.3 19.4 6.5 0.0 420.4 8.1 0.3 0.0 0.0 0.0 0.1 ZPLD1 ENSG00000170044 "Zona pellucida like domain containing 1" Q8TCW7 3 102099244-102479841 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.0;gallbladder: 6.7;kidney: 2.6" "Cell type enhanced" "Detected in some" 18 "Cholangiocytes: 7.6;Ductal cells: 2.6;Late spermatids: 3.6;Muller glia cells: 11.4;Pancreatic endocrine cells: 3.1" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 8 "non-classical monocyte: 3.0" "Lineage enriched" "Detected in single" 11 "monocytes: 3.0" "Cell line enriched" "Detected in some" 8 "RPTEC TERT1: 12.4" "Region enriched" "Detected in single" 7 "olfactory region: 3.4" "Low region specificity" "Detected in all" HPA077519 Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA077519: AB_2732349" "unprognostic (2.49e-1)" "unprognostic (2.83e-3)" "unprognostic (6.38e-3)" "unprognostic (1.88e-1)" "unprognostic (5.02e-2)" "unprognostic (1.37e-2)" "unprognostic (2.68e-1)" "unprognostic (2.63e-1)" "unprognostic (4.63e-1)" "unprognostic (2.89e-4)" "unprognostic (4.59e-2)" "unprognostic (1.05e-3)" "unprognostic (1.97e-2)" "unprognostic (9.65e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 2.5 1.0 0.0 0.0 0.2 6.7 0.3 0.0 0.6 2.6 0.3 0.0 0.0 0.3 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 1.3 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 12.4 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 11.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0